<Pegylated_liposomal_doxorubicin> <Has_accepted_use> "Plasma_cell_leukemia" .
<Pegylated_liposomal_doxorubicin> <Has_accepted_use> "Ovarian_cancer" .
<Pegylated_liposomal_doxorubicin> <Has_accepted_use> "Multiple_myeloma" .
<Pegylated_liposomal_doxorubicin> <Has_accepted_use> "Kaposi_sarcoma" .
<Pegylated_liposomal_doxorubicin> <Has_accepted_use> "Hodgkin_lymphoma" .
<Pegylated_liposomal_doxorubicin> <Has_accepted_use> "Hemophagocytic_lymphohistiocytosis" .
<Pegylated_liposomal_doxorubicin> <Has_accepted_use> "HIV-associated_lymphoma" .
<Pegylated_liposomal_doxorubicin> <Has_accepted_use> "Esophageal_cancer" .
<Pegylated_liposomal_doxorubicin> <Has_accepted_use> "Endometrial_cancer" .
<Pegylated_liposomal_doxorubicin> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Pegylated_liposomal_doxorubicin> <Has_accepted_use> "Burkitt_lymphoma" .
<Pegylated_liposomal_doxorubicin> <Has_accepted_use> "Breast_cancer" .
<Alemtuzumab_and_Rituximab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<AspaMetDex> <Has_context> "Non-curative_therapy" .
<Cardioaspirina> <Brand_name_of> "Aspirin" .
<BEACOPP> <Has_context> "Non-curative_therapy" .
<BEACOPP> <Has_context> "Induction_therapy" .
<Brongenit> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Gilteritinib_monotherapy> <Maps_to> "Gilteritinib_monotherapy" .
<ddEC> <Has_antineoplastic> "Epirubicin" .
<ddEC> <Has_antineoplastic> "Cyclophosphamide" .
<Colotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bone_marrow_failure_syndrome> <Is_a> "Cross-disciplinary_condition" .
<triple_negative_Breast_cancer> <Is_a> "Breast_cancer" .
<FUOX> <Mapped_from> "FUOX" .
<Uracil_mustard> <May_have_route> "Oral" .
<Ruxolitinib> <Is_a> "PMDA_approved_drug" .
<Ruxolitinib> <Is_a> "Kinase_inhibitor" .
<Ruxolitinib> <Is_a> "JAK_inhibitor" .
<Frixitas> <Brand_name_of> "Alprazolam" .
<Ixazomib_monotherapy> <Has_accepted_use> "Multiple_myeloma" .
<Ixazomib_monotherapy> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Dara-PD> <Mapped_from> "Dara-PD" .
<Transformed_lymphoma> <Current_treated_by> "Tisagenlecleucel_monotherapy" .
<Transformed_lymphoma> <Current_treated_by> "R-GDP" .
<Transformed_lymphoma> <Current_treated_by> "R-EPOCH" .
<Transformed_lymphoma> <Current_treated_by> "R-DHAP" .
<Transformed_lymphoma> <Current_treated_by> "Pembrolizumab_monotherapy" .
<Transformed_lymphoma> <Current_treated_by> "OFAR" .
<Transformed_lymphoma> <Current_treated_by> "Lenalidomide_monotherapy" .
<Transformed_lymphoma> <Current_treated_by> "Lenalidomide_and_Rituximab" .
<Transformed_lymphoma> <Current_treated_by> "Bendamustine_monotherapy" .
<Transformed_lymphoma> <Current_treated_by> "BFR,_then_allo_HSCT" .
<Transformed_lymphoma> <Current_treated_by> "Axicabtagene_ciloleucel_monotherapy" .
<Transformed_lymphoma> <Current_treated_by> "131Iodine-Tositumomab_monotherapy" .
<mFOLFOX6_and_Bevacizumab> <Has_antineoplastic> "Oxaliplatin" .
<mFOLFOX6_and_Bevacizumab> <Has_antineoplastic> "Folinic_acid" .
<mFOLFOX6_and_Bevacizumab> <Has_antineoplastic> "Fluorouracil" .
<mFOLFOX6_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Cytarabine,_Idarubicin,_Rituximab> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<VIE> <Has_modality> "Chemotherapy" .
<VA> <Has_context> "All_lines_of_therapy" .
<Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA> <Has_context> "Consolidation_after_upfront_therapy" .
<Cisplatin_and_Raltitrexed> <Is_current_in> "Mesothelioma" .
<Neper> <Brand_name_of> "Mesna" .
<ATG_(Rabbit)_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<VEBEP> <Has_modality> "Chemotherapy" .
<APO-Bactotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Classical_hematology_medication> <Subsumes> "Vasopressin_analog" .
<Classical_hematology_medication> <Subsumes> "Phosphodiesterase_inhibitor" .
<Classical_hematology_medication> <Subsumes> "Iron" .
<Classical_hematology_medication> <Subsumes> "Fibrinolysis_inhibitor" .
<Classical_hematology_medication> <Subsumes> "Coagulopathy_medication" .
<Classical_hematology_medication> <Subsumes> "Coagulation_factor" .
<Classical_hematology_medication> <Subsumes> "Chelator" .
<Classical_hematology_medication> <Subsumes> "Anticoagulant" .
<BVB> <Has_context> "Non-curative_therapy" .
<Bortezomib_and_Doxorubicin_liposomal> <Has_supportive_med> "Bisphosphonates" .
<Zactima> <Brand_name_of> "Vandetanib" .
<BID> <Is_current_in> "Multiple_myeloma" .
<FCR_(Rituximab_Hycela)> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<GCD-R> <Has_context> "Non-curative_therapy" .
<Apazol> <Brand_name_of> "Alprazolam" .
<Whole_abdominal_radiation_(WAI)> <Has_antineoplastic> "External_beam_radiotherapy" .
<LD-ACOP-B> <Has_context> "Induction_therapy" .
<Fludarabine_monotherapy> <Has_antineoplastic> "Fludarabine" .
<Cladribine_and_Rituximab> <Mapped_from> "Cladribine_and_Rituximab" .
<Prednisone_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Prednisone_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Prednisone_monotherapy> <Has_context> "Induction_therapy" .
<Prednisone_monotherapy> <Has_context> "All_lines_of_therapy" .
<Dexacortin> <Brand_name_of> "Dexamethasone" .
<R-CODOX-M/R-IVAC> <Has_context> "Upfront_therapy" .
<R-CODOX-M/R-IVAC> <Has_context> "Induction_therapy" .
<Voriconazole> <Has_brand_name> "Vorzu" .
<Voriconazole> <Has_brand_name> "Vorzole" .
<Voriconazole> <Has_brand_name> "Vorwell" .
<Voriconazole> <Has_brand_name> "Vorizol" .
<Voriconazole> <Has_brand_name> "Voriva" .
<Voriconazole> <Has_brand_name> "Voritrol" .
<Voriconazole> <Has_brand_name> "Voritek" .
<Voriconazole> <Has_brand_name> "Vorirx" .
<Voriconazole> <Has_brand_name> "Vorier" .
<Voriconazole> <Has_brand_name> "Voricort" .
<Voriconazole> <Has_brand_name> "Voraze" .
<Voriconazole> <Has_brand_name> "Vonaz" .
<Voriconazole> <Has_brand_name> "Vfend" .
<Voriconazole> <Has_brand_name> "Verz" .
<Voriconazole> <Has_brand_name> "Reconaz" .
<Voriconazole> <Has_brand_name> "Orvor" .
<Voriconazole> <Has_brand_name> "Ortrex" .
<PEFG> <Is_current_in> "Pancreatic_cancer" .
<CX_and_Trastuzumab> <Has_antineoplastic> "Trastuzumab" .
<CX_and_Trastuzumab> <Has_antineoplastic> "Cisplatin" .
<CX_and_Trastuzumab> <Has_antineoplastic> "Capecitabine" .
<LD-ACOP-B> <Mapped_from> "LD-ACOP-B" .
<Paclitaxel> <Has_accepted_use> "Vulvar_cancer" .
<Paclitaxel> <Has_accepted_use> "Vascular_sarcoma" .
<Paclitaxel> <Has_accepted_use> "Thymoma" .
<Paclitaxel> <Has_accepted_use> "Testicular_cancer" .
<Paclitaxel> <Has_accepted_use> "Small_cell_lung_cancer" .
<Paclitaxel> <Has_accepted_use> "SCC_of_unknown_primary" .
<Paclitaxel> <Has_accepted_use> "Prostate_cancer" .
<Paclitaxel> <Has_accepted_use> "Penile_cancer" .
<Paclitaxel> <Has_accepted_use> "Ovarian_cancer" .
<Paclitaxel> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Paclitaxel> <Has_accepted_use> "Melanoma" .
<Paclitaxel> <Has_accepted_use> "Kaposi_sarcoma" .
<Paclitaxel> <Has_accepted_use> "Head_and_neck_cancer" .
<Paclitaxel> <Has_accepted_use> "Gastric_cancer" .
<Paclitaxel> <Has_accepted_use> "Esophageal_cancer" .
<Paclitaxel> <Has_accepted_use> "Endometrial_cancer" .
<Paclitaxel> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Paclitaxel> <Has_accepted_use> "Cutaneous_basal_cell_carcinoma" .
<Paclitaxel> <Has_accepted_use> "Cervical_cancer" .
<Paclitaxel> <Has_accepted_use> "Breast_cancer" .
<Paclitaxel> <Has_accepted_use> "Bladder_cancer" .
<Paclitaxel> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<MVP_(Vindesine)> <Maps_to> "MVP_(Vindesine)" .
<FOLFIRI_and_Cetuximab> <Mapped_from> "FOLFIRI_and_Cetuximab" .
<Alenmax> <Brand_name_of> "Alendronate" .
<ACVBP> <Has_antineoplastic> "Vindesine" .
<ACVBP> <Has_antineoplastic> "Prednisone" .
<ACVBP> <Has_antineoplastic> "Methotrexate" .
<ACVBP> <Has_antineoplastic> "Ifosfamide" .
<ACVBP> <Has_antineoplastic> "Etoposide" .
<ACVBP> <Has_antineoplastic> "Doxorubicin" .
<ACVBP> <Has_antineoplastic> "Cytarabine" .
<ACVBP> <Has_antineoplastic> "Cyclophosphamide" .
<ACVBP> <Has_antineoplastic> "Bleomycin" .
<Carmustine> <Is_a> "Vesicant" .
<Carmustine> <Is_a> "Nitrosourea" .
<Carmustine> <Is_a> "Irritant" .
<Carmustine> <Is_a> "Alkylating_agent" .
<EVI> <Is_a> "Anthracycline-containing_regimen" .
<Ramucirumab_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<PVeBV> <Mapped_from> "PVeBV" .
<Targretin> <Brand_name_of> "Bexarotene" .
<Ramucirumab_monotherapy> <Mapped_from> "Ramucirumab_monotherapy" .
<CODOX-M/IVAC> <Is_a> "Anthracycline-containing_regimen" .
<Cotrimel> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Gemtuzumab_ozogamicin_monotherapy> <Is_historical_in> "Acute_myeloid_leukemia" .
<Afatinib_and_Bevacizumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Afatinib_and_Bevacizumab> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<mFOLFOX6_and_Bevacizumab_(L-Leucovorin)> <Is_current_in> "Colon_cancer" .
<Ixabepilone> <Is_a> "Microtubule_inhibitor" .
<Ixabepilone> <Is_a> "Irritant" .
<T-DM1_and_ET> <Has_context> "Neoadjuvant_therapy" .
<Fluorouracil_monotherapy> <Mapped_from> "Fluorouracil_monotherapy" .
<DD-CHOP> <Is_a> "Anthracycline-containing_regimen" .
<Anagrelide> <Has_brand_name> "Xagrid" .
<Anagrelide> <Has_brand_name> "Agrylin" .
<Rasat> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Graft_versus_host_disease> <FDA_indication_of> "Ruxolitinib" .
<Graft_versus_host_disease> <FDA_indication_of> "Ibrutinib" .
<R-INO> <Mapped_from> "R-INO" .
<APO> <Is_current_in> "Anaplastic_large_cell_lymphoma" .
<ADT_and_Docetaxel> <Maps_to> "ADT_and_Docetaxel" .
<DCTER> <Has_modality> "Chemotherapy" .
<CTD> <Maps_to> "CTD" .
<FELV> <Has_antineoplastic> "Folinic_acid" .
<FELV> <Has_antineoplastic> "Fluorouracil" .
<FELV> <Has_antineoplastic> "Etoposide" .
<mFOLFOX7_(L-Leucovorin)> <Is_current_in> "Colon_cancer" .
<Xanax> <Brand_name_of> "Alprazolam" .
<Steroidal_androgen_receptor_inhibitor> <Subsumes> "Galeterone" .
<Cisplatin,_Interferon_alfa-2a,_Isotretinoin> <Has_context> "Non-curative_therapy" .
<Dacortin_H> <Brand_name_of> "Prednisolone" .
<Temozolomide_and_RT> <Has_antineoplastic> "Temozolomide" .
<Temozolomide_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Cyclosporine,_Sirolimus,_Prednisone> <Is_current_in> "Graft_versus_host_disease" .
<CFP> <Maps_to> "CFP" .
<Trimsul> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bleomycin_and_Vinblastine> <Has_accepted_use> "Testicular_cancer" .
<FELV> <Has_modality> "Chemotherapy" .
<Degarelix> <Has_brand_name> "Firmagon" .
<Phenytoin> <Is_a> "Supportive_medication" .
<FOLFIRI_and_Ziv-aflibercept> <Maps_to> "FOLFIRI_and_Ziv-aflibercept" .
<MINE> <Mapped_from> "MINE" .
<Cisplatin_and_Pemetrexed> <Has_context> "Non-curative_therapy" .
<Cisplatin_and_Pemetrexed> <Has_context> "Non-curative_first-line_therapy" .
<Cisplatin_and_Pemetrexed> <Has_context> "Adjuvant_therapy" .
<Metotrexate> <Brand_name_of> "Methotrexate" .
<Venetoclax_and_Obinutuzumab> <Maps_to> "Venetoclax_and_Obinutuzumab" .
<Dexaril> <Brand_name_of> "Dexamethasone" .
<Methotrexate> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Methotrexate> <Is_a> "Inflammitant" .
<Methotrexate> <Is_a> "Immunosuppressant" .
<Methotrexate> <Is_a> "Antimetabolite" .
<Methotrexate> <Is_a> "Antifolate" .
<Cisplatin_and_Paclitaxel> <Has_antineoplastic> "Paclitaxel" .
<Cisplatin_and_Paclitaxel> <Has_antineoplastic> "Cisplatin" .
<Tymtran> <Brand_name_of> "Cyclophosphamide" .
<APO> <Maps_to> "APO" .
<Asparaginase> <May_have_route> "Subcutaneous" .
<Asparaginase> <May_have_route> "Intravenous" .
<Asparaginase> <May_have_route> "Intramuscular" .
<Doxorubicin_and_Fluorouracil> <Is_historical_in> "Gastric_cancer" .
<AC> <Has_antineoplastic> "Doxorubicin" .
<AC> <Has_antineoplastic> "Cyclophosphamide" .
<Hydrocortisone_monotherapy> <Mapped_from> "Hydrocortisone_monotherapy" .
<Cyclophosphamide_and_TBI,_then_allo_HSCT> <Maps_to> "Cyclophosphamide_and_TBI,_then_allo_HSCT" .
<ACE> <Has_modality> "Chemotherapy" .
<Rociletinib> <Is_a> "Kinase_inhibitor" .
<Rociletinib> <Is_a> "Investigational_drug" .
<Rociletinib> <Is_a> "EGFR_inhibitor" .
<Dinutuximab> <Has_FDA_indication> "Neuroblastoma" .
<Renal_cell_carcinoma> <FDA_indication_of> "Temsirolimus" .
<Renal_cell_carcinoma> <FDA_indication_of> "Sunitinib" .
<Renal_cell_carcinoma> <FDA_indication_of> "Sorafenib" .
<Renal_cell_carcinoma> <FDA_indication_of> "Pembrolizumab" .
<Renal_cell_carcinoma> <FDA_indication_of> "Pazopanib" .
<Renal_cell_carcinoma> <FDA_indication_of> "Nivolumab" .
<Renal_cell_carcinoma> <FDA_indication_of> "Lenvatinib" .
<Renal_cell_carcinoma> <FDA_indication_of> "Ipilimumab" .
<Renal_cell_carcinoma> <FDA_indication_of> "Everolimus" .
<Renal_cell_carcinoma> <FDA_indication_of> "Cabozantinib" .
<Renal_cell_carcinoma> <FDA_indication_of> "Bevacizumab-awwb" .
<Renal_cell_carcinoma> <FDA_indication_of> "Bevacizumab" .
<Renal_cell_carcinoma> <FDA_indication_of> "Axitinib" .
<Renal_cell_carcinoma> <FDA_indication_of> "Avelumab" .
<Dovitinib> <May_have_route> "Oral" .
<PVD> <Has_accepted_use> "Multiple_myeloma" .
<7_plus_3i_and_Sorafenib> <Is_current_in> "Acute_myeloid_leukemia" .
<Atarax> <Brand_name_of> "Hydroxyzine" .
<Best_supportive_care> <Maps_to> "Best_supportive_care" .
<Rapact> <Brand_name_of> "Everolimus" .
<VAIA> <Has_accepted_use> "Ewing_sarcoma" .
<Rozlytrek> <Brand_name_of> "Entrectinib" .
<Carmustine_and_RT> <Has_accepted_use> "Glioblastoma" .
<C-BOP> <Mapped_from> "C-BOP" .
<BEAM,_then_allo_HSCT> <Has_accepted_use> "Hodgkin_lymphoma" .
<BEAM,_then_allo_HSCT> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<ACVBP,_dose-adjusted> <Has_context> "All_lines_of_therapy" .
<Trifluridine_and_tipiracil> <Is_a> "Fluoropyrimidine" .
<Trifluridine_and_tipiracil> <Is_a> "DNA_synthesis_inhibitor" .
<Colizole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Vargatef> <Brand_name_of> "Nintedanib" .
<Carmustine_and_Doxorubicin> <Has_modality> "Chemotherapy" .
<Brentuximab_vedotin_and_Dacarbazine> <Has_accepted_use> "Hodgkin_lymphoma" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA> <Has_modality> "Chemotherapy" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine> <Has_context> "Consolidation_after_upfront_therapy" .
<VIDE> <Maps_to> "VIDE" .
<Docetaxel_and_Nintedanib> <Has_antineoplastic> "Nintedanib" .
<Docetaxel_and_Nintedanib> <Has_antineoplastic> "Docetaxel" .
<Zuricade> <Brand_name_of> "Bortezomib" .
<PCDE> <Is_historical_in> "Small_cell_lung_cancer" .
<Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin> <Mapped_from> "Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin" .
<Bortezomib_and_Vorinostat> <Is_current_in> "Multiple_myeloma" .
<Prednisone> <May_have_route> "Oral" .
<Hydroxyurea_and_Plicamycin> <Is_current_in> "Chronic_myelogenous_leukemia" .
<Interferon_alfa-2b_and_Zidovudine> <Mapped_from> "Interferon_alfa-2b_and_Zidovudine" .
<Temozolomide_monotherapy> <Mapped_from> "Temozolomide_monotherapy" .
<CAF_and_MPA> <Is_historical_in> "Breast_cancer" .
<Palbociclib> <Antineoplastic_of> "Letrozole_and_Palbociclib" .
<Palbociclib> <Antineoplastic_of> "Fulvestrant_and_Palbociclib" .
<Palbociclib> <Antineoplastic_of> "Anastrozole_and_Palbociclib" .
<Vinorelbine> <May_have_route> "Intravenous" .
<Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT> <Mapped_from> "Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT" .
<VAdCA/IE> <Has_supportive_med> "Mesna" .
<AT_(Taxol)> <Has_antineoplastic> "Paclitaxel" .
<AT_(Taxol)> <Has_antineoplastic> "Doxorubicin" .
<Belotecan> <Has_accepted_use> "Small_cell_lung_cancer" .
<Belotecan> <Has_accepted_use> "Ovarian_cancer" .
<Capecitabine,_Cisplatin,_RT> <Has_context> "Neoadjuvant_therapy" .
<Capecitabine,_Cisplatin,_RT> <Has_context> "Definitive_therapy" .
<PEP-C> <Has_supportive_med> "Ondansetron" .
<Total_Therapy> <Is_a> "Anthracycline-containing_regimen" .
<R-CEOP90_(Epirubicin)> <Has_context> "Induction_therapy" .
<HOP> <Maps_to> "HOP" .
<Koate-HP> <Brand_name_of> "Factor_VIII_human" .
<MAP2K2_inhibitor> <Is_a> "MEK_inhibitor" .
<PIK3CA-mutated_Breast_cancer> <Is_a> "Breast_cancer" .
<Neutral> <Subsumes> "Trastuzumab-qyyp" .
<Neutral> <Subsumes> "Trastuzumab-pkrb" .
<Neutral> <Subsumes> "Trastuzumab-dttb" .
<Neutral> <Subsumes> "Trastuzumab-dkst" .
<Neutral> <Subsumes> "Trastuzumab-anns" .
<Neutral> <Subsumes> "Trastuzumab_and_hyaluronidase" .
<Neutral> <Subsumes> "Trastuzumab" .
<Neutral> <Subsumes> "Thiotepa" .
<Neutral> <Subsumes> "Rituximab-pvvr" .
<Neutral> <Subsumes> "Rituximab-abbs" .
<Neutral> <Subsumes> "Rituximab" .
<Neutral> <Subsumes> "Pentostatin" .
<Neutral> <Subsumes> "Pemetrexed" .
<Neutral> <Subsumes> "Pegaspargase" .
<Neutral> <Subsumes> "Nelarabine" .
<Neutral> <Subsumes> "Melphalan" .
<Neutral> <Subsumes> "Ifosfamide" .
<Neutral> <Subsumes> "Gemcitabine" .
<Neutral> <Subsumes> "Fludarabine" .
<Neutral> <Subsumes> "Cytarabine" .
<Neutral> <Subsumes> "Cyclophosphamide" .
<Neutral> <Subsumes> "Clofarabine" .
<Neutral> <Subsumes> "Cladribine" .
<Neutral> <Subsumes> "Cetuximab" .
<Neutral> <Subsumes> "Calaspargase" .
<Neutral> <Subsumes> "Bleomycin" .
<Neutral> <Subsumes> "Bevacizumab-bvzr" .
<Neutral> <Subsumes> "Bevacizumab-awwb" .
<Neutral> <Subsumes> "Bevacizumab" .
<Neutral> <Subsumes> "Asparaginase" .
<Neutral> <Subsumes> "Alemtuzumab" .
<Placebo> <Is_historical_in> "Prostate_cancer" .
<Placebo> <Is_historical_in> "Non-small_cell_lung_cancer" .
<L-Asparaginase,_Vincristine,_Prednisone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<High-dose_Interleukin-2> <Has_context> "Non-curative_therapy" .
<High-dose_Interleukin-2> <Has_context> "Non-curative_first-line_therapy" .
<Prazaxa> <Brand_name_of> "Dabigatran" .
<MCF> <Has_modality> "Chemotherapy" .
<Fosanet> <Brand_name_of> "Alendronate" .
<OLF> <Has_antineoplastic> "Oxaliplatin" .
<OLF> <Has_antineoplastic> "Folinic_acid" .
<OLF> <Has_antineoplastic> "Fluorouracil" .
<VIM> <Has_context> "Salvage_therapy" .
<FOLFIRI_and_Ramucirumab> <Has_context> "Non-curative_second-line_therapy" .
<Folaxin> <Brand_name_of> "Folinic_acid" .
<Trastuzumab> <May_have_route> "Intravenous" .
<T-cell_acute_lymphoblastic_leukemia> <FDA_indication_of> "Nelarabine" .
<Doxorubicin_pegylated_liposomal_and_Trabectedin> <Is_current_in> "Ovarian_cancer" .
<Carboplatin_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Carboplatin_and_RT> <Has_antineoplastic> "Carboplatin" .
<Thalix> <Brand_name_of> "Thalidomide" .
<IT_Cytarabine_and_WBRT> <Maps_to> "IT_Cytarabine_and_WBRT" .
<Vemurafenib_monotherapy> <Has_context> "Non-curative_therapy" .
<Vemurafenib_monotherapy> <Has_context> "All_lines_of_therapy" .
<Temozolomide_and_NovoTTF-100A> <Has_antineoplastic> "Temozolomide" .
<CODOX-M> <Is_a> "Anthracycline-containing_regimen" .
<Gemcitabine_and_Sunitinib> <Mapped_from> "Gemcitabine_and_Sunitinib" .
<Mycophenolate_mofetil_monotherapy> <Has_context> "Non-curative_therapy" .
<Cytoblastine> <Brand_name_of> "Vinblastine" .
<Lupride_Depot> <Brand_name_of> "Leuprolide" .
<Lapatinib_and_Trastuzumab> <Has_context> "Non-curative_third-line_therapy" .
<Lapatinib_and_Trastuzumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<Lapatinib_and_Trastuzumab> <Has_context> "Neoadjuvant_therapy" .
<Lapatinib_and_Trastuzumab> <Has_context> "Adjuvant_therapy" .
<Axicabtagene_ciloleucel> <Has_accepted_use> "Transformed_lymphoma" .
<Axicabtagene_ciloleucel> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<Axicabtagene_ciloleucel> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<BEP> <Mapped_from> "BEP" .
<Bersen> <Brand_name_of> "Prednisone" .
<LOPP/EVAP> <Maps_to> "LOPP/EVAP" .
<L-Asparaginase,_Vincristine,_Prednisone> <Maps_to> "L-Asparaginase,_Vincristine,_Prednisone" .
<Tecnomet> <Brand_name_of> "Methotrexate" .
<LVP_.22Sandwich.22> <Has_context> "Induction_therapy" .
<Everolimus_monotherapy> <Has_context> "Non-curative_therapy" .
<Everolimus_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Everolimus_monotherapy> <Has_context> "Non-curative_subsequent-line_maintenance_therapy" .
<Everolimus_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Everolimus_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Everolimus_monotherapy> <Has_context> "All_lines_of_therapy" .
<Solpyron> <Brand_name_of> "Aspirin" .
<Drenex> <Brand_name_of> "Dexamethasone" .
<Acetylsalicylsyre> <Brand_name_of> "Aspirin" .
<Bristaxol> <Brand_name_of> "Paclitaxel" .
<Leprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<GemOx_and_Sorafenib> <Maps_to> "GemOx_and_Sorafenib" .
<CFP> <Has_modality> "Hormonotherapy" .
<CFP> <Has_modality> "Chemotherapy" .
<Alunbrig> <Brand_name_of> "Brigatinib" .
<Dexamethasone> <Has_brand_name> "Zydexa" .
<Dexamethasone> <Has_brand_name> "Zenos" .
<Dexamethasone> <Has_brand_name> "Zecaxon" .
<Dexamethasone> <Has_brand_name> "Zalucs" .
<Dexamethasone> <Has_brand_name> "Xine" .
<Dexamethasone> <Has_brand_name> "Xasone" .
<Dexamethasone> <Has_brand_name> "Wymesone" .
<Dexamethasone> <Has_brand_name> "Windex" .
<Dexamethasone> <Has_brand_name> "Voalla" .
<Dexamethasone> <Has_brand_name> "Visumetazone" .
<Dexamethasone> <Has_brand_name> "Visualin" .
<Dexamethasone> <Has_brand_name> "Unisone" .
<Dexamethasone> <Has_brand_name> "Unidexa" .
<Dexamethasone> <Has_brand_name> "Unidex" .
<Dexamethasone> <Has_brand_name> "Udicort" .
<Dexamethasone> <Has_brand_name> "Ucalon" .
<Dexamethasone> <Has_brand_name> "Tuttozem_N" .
<Dexamethasone> <Has_brand_name> "Totocortin" .
<Dexamethasone> <Has_brand_name> "Thilodexine" .
<Dexamethasone> <Has_brand_name> "Thilodex" .
<Dexamethasone> <Has_brand_name> "Tekuron" .
<Dexamethasone> <Has_brand_name> "Teikason_Nidek" .
<Dexamethasone> <Has_brand_name> "Teanlang" .
<Dexamethasone> <Has_brand_name> "Tavesona" .
<Dexamethasone> <Has_brand_name> "Syndexa" .
<Dexamethasone> <Has_brand_name> "Sydencort" .
<Dexamethasone> <Has_brand_name> "Surodex" .
<Dexamethasone> <Has_brand_name> "Suprason" .
<Dexamethasone> <Has_brand_name> "Supertendin-Depot_N" .
<Dexamethasone> <Has_brand_name> "Superprednol" .
<Dexamethasone> <Has_brand_name> "Steron" .
<Dexamethasone> <Has_brand_name> "Sterasone" .
<Dexamethasone> <Has_brand_name> "Steralol" .
<Dexamethasone> <Has_brand_name> "Stedex" .
<Dexamethasone> <Has_brand_name> "Spondy-Dexa" .
<Dexamethasone> <Has_brand_name> "Spersadex" .
<Dexamethasone> <Has_brand_name> "Sonexa" .
<Dexamethasone> <Has_brand_name> "Solupen" .
<Dexamethasone> <Has_brand_name> "Soludecadron" .
<Dexamethasone> <Has_brand_name> "Soldex" .
<Dexamethasone> <Has_brand_name> "Soldesanil" .
<Dexamethasone> <Has_brand_name> "Soldesam" .
<Dexamethasone> <Has_brand_name> "Solcort" .
<Dexamethasone> <Has_brand_name> "Smile" .
<Dexamethasone> <Has_brand_name> "Shuayan" .
<Dexamethasone> <Has_brand_name> "Shirodex" .
<Dexamethasone> <Has_brand_name> "Selftison" .
<Dexamethasone> <Has_brand_name> "Scandexon" .
<Dexamethasone> <Has_brand_name> "Sawasone" .
<Dexamethasone> <Has_brand_name> "Santeson" .
<Dexamethasone> <Has_brand_name> "SP_Cordexa" .
<Dexamethasone> <Has_brand_name> "Rupedex" .
<Dexamethasone> <Has_brand_name> "Roximeth" .
<Dexamethasone> <Has_brand_name> "Ronic" .
<Dexamethasone> <Has_brand_name> "Rocolone" .
<Dexamethasone> <Has_brand_name> "Reusan" .
<Dexamethasone> <Has_brand_name> "Rednisone" .
<Dexamethasone> <Has_brand_name> "Redexon" .
<Dexamethasone> <Has_brand_name> "Randexa" .
<Dexamethasone> <Has_brand_name> "Rally-A" .
<Dexamethasone> <Has_brand_name> "Pyradexon" .
<Dexamethasone> <Has_brand_name> "Pyderma" .
<Dexamethasone> <Has_brand_name> "Prodexon" .
<Dexamethasone> <Has_brand_name> "Plidexa" .
<Dexamethasone> <Has_brand_name> "Plavex" .
<Dexamethasone> <Has_brand_name> "Pidexon" .
<Dexamethasone> <Has_brand_name> "Phenodex" .
<Dexamethasone> <Has_brand_name> "Penodex" .
<Dexamethasone> <Has_brand_name> "Penatone" .
<Dexamethasone> <Has_brand_name> "Orgadrone" .
<Dexamethasone> <Has_brand_name> "Ordex" .
<Dexamethasone> <Has_brand_name> "Orazone" .
<Dexamethasone> <Has_brand_name> "Opticort" .
<Dexamethasone> <Has_brand_name> "Ophthasona" .
<Dexamethasone> <Has_brand_name> "Ophth-DEX" .
<Dexamethasone> <Has_brand_name> "Onadron" .
<Dexamethasone> <Has_brand_name> "Omedexon" .
<Dexamethasone> <Has_brand_name> "Oftadex" .
<Dexamethasone> <Has_brand_name> "Oftadek" .
<Dexamethasone> <Has_brand_name> "Ocudex" .
<Dexamethasone> <Has_brand_name> "Ocedran" .
<Dexamethasone> <Has_brand_name> "Nufadex_M" .
<Dexamethasone> <Has_brand_name> "Nodevex" .
<Dexamethasone> <Has_brand_name> "Nexadron" .
<Dexamethasone> <Has_brand_name> "Neodex" .
<Dexamethasone> <Has_brand_name> "Mycidex" .
<Dexamethasone> <Has_brand_name> "Molacort" .
<Dexamethasone> <Has_brand_name> "Mitasone" .
<Dexamethasone> <Has_brand_name> "Minidex" .
<Dexamethasone> <Has_brand_name> "Millicorten" .
<Dexamethasone> <Has_brand_name> "Migradexan" .
<Dexamethasone> <Has_brand_name> "Mexaton" .
<Dexamethasone> <Has_brand_name> "Mexasone" .
<Dexamethasone> <Has_brand_name> "Methasone" .
<Dexamethasone> <Has_brand_name> "Methaderm" .
<Dexamethasone> <Has_brand_name> "Metcort" .
<Dexamethasone> <Has_brand_name> "Metaxon" .
<Dexamethasone> <Has_brand_name> "Metax" .
<Dexamethasone> <Has_brand_name> "Metasolon" .
<Dexamethasone> <Has_brand_name> "Metalexina" .
<Dexamethasone> <Has_brand_name> "Mesadoron" .
<Dexamethasone> <Has_brand_name> "Merideca" .
<Dexamethasone> <Has_brand_name> "Meradexon" .
<Dexamethasone> <Has_brand_name> "Mephamesone-4" .
<Dexamethasone> <Has_brand_name> "Mephamesone" .
<Dexamethasone> <Has_brand_name> "Mephamesona" .
<Dexamethasone> <Has_brand_name> "Mephameson" .
<Dexamethasone> <Has_brand_name> "Megadex" .
<Dexamethasone> <Has_brand_name> "Megacort" .
<Dexamethasone> <Has_brand_name> "Medidex" .
<Dexamethasone> <Has_brand_name> "Medicort" .
<Dexamethasone> <Has_brand_name> "Mediamethasone" .
<Dexamethasone> <Has_brand_name> "Medexasone" .
<Dexamethasone> <Has_brand_name> "Medesone" .
<Dexamethasone> <Has_brand_name> "Mecoxon" .
<Dexamethasone> <Has_brand_name> "Maxidex" .
<Dexamethasone> <Has_brand_name> "Maradex" .
<Dexamethasone> <Has_brand_name> "Luxazone" .
<Dexamethasone> <Has_brand_name> "Lupidexa" .
<Dexamethasone> <Has_brand_name> "Loverine" .
<Dexamethasone> <Has_brand_name> "Lormine" .
<Dexamethasone> <Has_brand_name> "Lokalison-F" .
<Dexamethasone> <Has_brand_name> "Lodexa" .
<Dexamethasone> <Has_brand_name> "Lodex" .
<Dexamethasone> <Has_brand_name> "Lisoderme" .
<Dexamethasone> <Has_brand_name> "Lipotalon" .
<Dexamethasone> <Has_brand_name> "Limethason" .
<Dexamethasone> <Has_brand_name> "Licoson" .
<Dexamethasone> <Has_brand_name> "Lanadexon" .
<Dexamethasone> <Has_brand_name> "Kovintong" .
<Dexamethasone> <Has_brand_name> "Kosa" .
<Dexamethasone> <Has_brand_name> "Kodolo" .
<Dexamethasone> <Has_brand_name> "Kanadex" .
<Dexamethasone> <Has_brand_name> "Kalmethasone" .
<Dexamethasone> <Has_brand_name> "Kaarmepakkaus" .
<Dexamethasone> <Has_brand_name> "Isopto" .
<Dexamethasone> <Has_brand_name> "Isodexam" .
<Dexamethasone> <Has_brand_name> "Irzamethazone" .
<Dexamethasone> <Has_brand_name> "Inthesa-5" .
<Dexamethasone> <Has_brand_name> "Indexon" .
<Dexamethasone> <Has_brand_name> "Idizone" .
<Dexamethasone> <Has_brand_name> "Hopamethasone" .
<Dexamethasone> <Has_brand_name> "Hexadrol" .
<Dexamethasone> <Has_brand_name> "Hexadecadrol" .
<Dexamethasone> <Has_brand_name> "HI-Methasone" .
<Dexamethasone> <Has_brand_name> "Grathazon" .
<Dexamethasone> <Has_brand_name> "Glymesason" .
<Dexamethasone> <Has_brand_name> "Gemisona" .
<Dexamethasone> <Has_brand_name> "Gammacorten" .
<Dexamethasone> <Has_brand_name> "Fosfato_Dissodico_Dexametasona" .
<Dexamethasone> <Has_brand_name> "Fortecortin" .
<Dexamethasone> <Has_brand_name> "Fexadron" .
<Dexamethasone> <Has_brand_name> "Faridexon" .
<Dexamethasone> <Has_brand_name> "Fadametasona" .
<Dexamethasone> <Has_brand_name> "Fada_Dexametasona" .
<Dexamethasone> <Has_brand_name> "Euromethasone" .
<Dexamethasone> <Has_brand_name> "Etason" .
<Dexamethasone> <Has_brand_name> "Ermethasone" .
<Dexamethasone> <Has_brand_name> "Erladexone" .
<Dexamethasone> <Has_brand_name> "Epidrone" .
<Dexamethasone> <Has_brand_name> "Epidexone" .
<Dexamethasone> <Has_brand_name> "Elixirmethasone" .
<Dexamethasone> <Has_brand_name> "ETA_Cortilen" .
<Dexamethasone> <Has_brand_name> "Drxaline" .
<Dexamethasone> <Has_brand_name> "Drenex" .
<Dexamethasone> <Has_brand_name> "Doronil" .
<Dexamethasone> <Has_brand_name> "Dorison" .
<Dexamethasone> <Has_brand_name> "Donray" .
<Dexamethasone> <Has_brand_name> "Dison" .
<Dexamethasone> <Has_brand_name> "Diometa" .
<Dexamethasone> <Has_brand_name> "Dicosheun" .
<Dexamethasone> <Has_brand_name> "Dicorsone" .
<Dexamethasone> <Has_brand_name> "Dextrasone" .
<Dexamethasone> <Has_brand_name> "Dexton" .
<Dexamethasone> <Has_brand_name> "Dexthasol" .
<Dexamethasone> <Has_brand_name> "Dextason" .
<Dexamethasone> <Has_brand_name> "Dexstar" .
<Dexamethasone> <Has_brand_name> "Dexsol" .
<Dexamethasone> <Has_brand_name> "Dexpak" .
<Dexamethasone> <Has_brand_name> "Dexoptic" .
<Dexamethasone> <Has_brand_name> "Dexonium" .
<Dexamethasone> <Has_brand_name> "Dexone" .
<Dexamethasone> <Has_brand_name> "Dexona" .
<Dexamethasone> <Has_brand_name> "Dexmethsone" .
<Dexamethasone> <Has_brand_name> "Dexmethasone" .
<Dexamethasone> <Has_brand_name> "Dexmetha" .
<Dexamethasone> <Has_brand_name> "Dexmesone" .
<Dexamethasone> <Has_brand_name> "Dexmene" .
<Dexamethasone> <Has_brand_name> "Dexion" .
<Dexamethasone> <Has_brand_name> "Dexinga" .
<Dexamethasone> <Has_brand_name> "Dexin" .
<Dexamethasone> <Has_brand_name> "Dexicorta" .
<Dexamethasone> <Has_brand_name> "Dexazone" .
<Dexamethasone> <Has_brand_name> "Dexazona" .
<Dexamethasone> <Has_brand_name> "Dexazen" .
<Dexamethasone> <Has_brand_name> "Dexawieb" .
<Dexamethasone> <Has_brand_name> "Dexawal" .
<Dexamethasone> <Has_brand_name> "Dexavet" .
<Dexamethasone> <Has_brand_name> "Dexaven" .
<Dexamethasone> <Has_brand_name> "Dexaval" .
<Dexamethasone> <Has_brand_name> "Dexatotal" .
<Dexamethasone> <Has_brand_name> "Dexatop" .
<Dexamethasone> <Has_brand_name> "Dexaton" .
<Dexamethasone> <Has_brand_name> "Dexatab" .
<Dexamethasone> <Has_brand_name> "Dexasonlin" .
<Dexamethasone> <Has_brand_name> "Dexasone" .
<Dexamethasone> <Has_brand_name> "Dexason" .
<Dexamethasone> <Has_brand_name> "Dexasolone" .
<Dexamethasone> <Has_brand_name> "Dexasol" .
<Dexamethasone> <Has_brand_name> "Dexasine" .
<Dexamethasone> <Has_brand_name> "Dexasin" .
<Dexamethasone> <Has_brand_name> "Dexart" .
<Dexamethasone> <Has_brand_name> "Dexaron" .
<Dexamethasone> <Has_brand_name> "Dexaroid" .
<Dexamethasone> <Has_brand_name> "Dexaril" .
<Dexamethasone> <Has_brand_name> "Dexapro" .
<Dexamethasone> <Has_brand_name> "Dexapolcort" .
<Dexamethasone> <Has_brand_name> "Dexaphos" .
<Dexamethasone> <Has_brand_name> "Dexano" .
<Dexamethasone> <Has_brand_name> "Dexanil" .
<Dexamethasone> <Has_brand_name> "Dexanel" .
<Dexamethasone> <Has_brand_name> "Dexan" .
<Dexamethasone> <Has_brand_name> "Dexamonozon_N" .
<Dexamethasone> <Has_brand_name> "Dexamo" .
<Dexamethasone> <Has_brand_name> "Dexaminor" .
<Dexamethasone> <Has_brand_name> "Dexamine" .
<Dexamethasone> <Has_brand_name> "Dexamil" .
<Dexamethasone> <Has_brand_name> "Dexamex" .
<Dexamethasone> <Has_brand_name> "Dexametrat" .
<Dexamethasone> <Has_brand_name> "Dexametonal" .
<Dexamethasone> <Has_brand_name> "Dexametisona" .
<Dexamethasone> <Has_brand_name> "Dexametin" .
<Dexamethasone> <Has_brand_name> "Dexamethazone" .
<Dexamethasone> <Has_brand_name> "Dexamethazon" .
<Dexamethasone> <Has_brand_name> "Dexamethasonum" .
<Dexamethasone> <Has_brand_name> "Dexamethason" .
<Dexamethasone> <Has_brand_name> "Dexameth" .
<Dexamethasone> <Has_brand_name> "Dexametazona" .
<Dexamethasone> <Has_brand_name> "Dexametazon" .
<Dexamethasone> <Has_brand_name> "Dexametax" .
<Dexamethasone> <Has_brand_name> "Dexametasona" .
<Dexamethasone> <Has_brand_name> "Dexametason" .
<Dexamethasone> <Has_brand_name> "Dexamet" .
<Dexamethasone> <Has_brand_name> "Dexamesone" .
<Dexamethasone> <Has_brand_name> "Dexameson" .
<Dexamethasone> <Has_brand_name> "Dexameral" .
<Dexamethasone> <Has_brand_name> "Dexamedron" .
<Dexamethasone> <Has_brand_name> "Dexamedix" .
<Dexamethasone> <Has_brand_name> "Dexamedis" .
<Dexamethasone> <Has_brand_name> "Dexamecortin" .
<Dexamethasone> <Has_brand_name> "Dexame" .
<Dexamethasone> <Has_brand_name> "Dexamark" .
<Dexamethasone> <Has_brand_name> "Dexamag" .
<Dexamethasone> <Has_brand_name> "Dexam" .
<Dexamethasone> <Has_brand_name> "Dexaltin" .
<Dexamethasone> <Has_brand_name> "Dexalocal" .
<Dexamethasone> <Has_brand_name> "Dexaleniens" .
<Dexamethasone> <Has_brand_name> "Dexahexal" .
<Dexamethasone> <Has_brand_name> "Dexagrin" .
<Dexamethasone> <Has_brand_name> "Dexagreen" .
<Dexamethasone> <Has_brand_name> "Dexaglos" .
<Dexamethasone> <Has_brand_name> "Dexagenta" .
<Dexamethasone> <Has_brand_name> "Dexagel" .
<Dexamethasone> <Has_brand_name> "Dexagee" .
<Dexamethasone> <Has_brand_name> "Dexagalen" .
<Dexamethasone> <Has_brand_name> "Dexaflan" .
<Dexamethasone> <Has_brand_name> "Dexaflam" .
<Dexamethasone> <Has_brand_name> "Dexafarm" .
<Dexamethasone> <Has_brand_name> "Dexafar" .
<Dexamethasone> <Has_brand_name> "Dexaedo" .
<Dexamethasone> <Has_brand_name> "Dexadron" .
<Dexamethasone> <Has_brand_name> "Dexadrol" .
<Dexamethasone> <Has_brand_name> "Dexadon" .
<Dexamethasone> <Has_brand_name> "Dexadermil" .
<Dexamethasone> <Has_brand_name> "Dexaderme" .
<Dexamethasone> <Has_brand_name> "Dexaderm" .
<Dexamethasone> <Has_brand_name> "Dexaden" .
<Dexamethasone> <Has_brand_name> "Dexacutis" .
<Dexamethasone> <Has_brand_name> "Dexacron" .
<Dexamethasone> <Has_brand_name> "Dexacotsil" .
<Dexamethasone> <Has_brand_name> "Dexacortisyl" .
<Dexamethasone> <Has_brand_name> "Dexacortisone" .
<Dexamethasone> <Has_brand_name> "Dexacortin" .
<Dexamethasone> <Has_brand_name> "Dexacortal" .
<Dexamethasone> <Has_brand_name> "Dexacort" .
<Dexamethasone> <Has_brand_name> "Dexacom" .
<Dexamethasone> <Has_brand_name> "Dexacollyre" .
<Dexamethasone> <Has_brand_name> "Dexacip" .
<Dexamethasone> <Has_brand_name> "Dexacilin" .
<Dexamethasone> <Has_brand_name> "Dexacen-4" .
<Dexamethasone> <Has_brand_name> "Dexabeta" .
<Dexamethasone> <Has_brand_name> "Dexabene" .
<Dexamethasone> <Has_brand_name> "Dexa_Clinit" .
<Dexamethasone> <Has_brand_name> "Dexa" .
<Dexamethasone> <Has_brand_name> "Dethamedin" .
<Dexamethasone> <Has_brand_name> "Detasone" .
<Dexamethasone> <Has_brand_name> "Detametazon" .
<Dexamethasone> <Has_brand_name> "Deson" .
<Dexamethasone> <Has_brand_name> "Desason" .
<Dexamethasone> <Has_brand_name> "Desametasone_Fosf" .
<Dexamethasone> <Has_brand_name> "Desalark" .
<Dexamethasone> <Has_brand_name> "Dersone" .
<Dexamethasone> <Has_brand_name> "Derson" .
<Dexamethasone> <Has_brand_name> "Deronil" .
<Dexamethasone> <Has_brand_name> "Deron_S" .
<Dexamethasone> <Has_brand_name> "Dermidron" .
<Dexamethasone> <Has_brand_name> "Dermadex" .
<Dexamethasone> <Has_brand_name> "Demeson" .
<Dexamethasone> <Has_brand_name> "Demasone" .
<Dexamethasone> <Has_brand_name> "Deltafluorene" .
<Dexamethasone> <Has_brand_name> "Dellamethasone" .
<Dexamethasone> <Has_brand_name> "Deksamet" .
<Dexamethasone> <Has_brand_name> "Deksalon" .
<Dexamethasone> <Has_brand_name> "Deksa" .
<Dexamethasone> <Has_brand_name> "Dekort" .
<Dexamethasone> <Has_brand_name> "Dekisachosei" .
<Dexamethasone> <Has_brand_name> "Dekesu" .
<Dexamethasone> <Has_brand_name> "Deflaren" .
<Dexamethasone> <Has_brand_name> "Deexa" .
<Dexamethasone> <Has_brand_name> "Dectancyl" .
<Dexamethasone> <Has_brand_name> "Dectan" .
<Dexamethasone> <Has_brand_name> "Decorten" .
<Dexamethasone> <Has_brand_name> "Decoron" .
<Dexamethasone> <Has_brand_name> "Decorex" .
<Dexamethasone> <Has_brand_name> "Decordex" .
<Dexamethasone> <Has_brand_name> "Decone" .
<Dexamethasone> <Has_brand_name> "Decolite" .
<Dexamethasone> <Has_brand_name> "Decobel" .
<Dexamethasone> <Has_brand_name> "Decilone" .
<Dexamethasone> <Has_brand_name> "Decicort" .
<Dexamethasone> <Has_brand_name> "Decdan" .
<Dexamethasone> <Has_brand_name> "Decdak" .
<Dexamethasone> <Has_brand_name> "Decazol" .
<Dexamethasone> <Has_brand_name> "Decaspray" .
<Dexamethasone> <Has_brand_name> "Decasone" .
<Dexamethasone> <Has_brand_name> "Decason" .
<Dexamethasone> <Has_brand_name> "Decaron" .
<Dexamethasone> <Has_brand_name> "Decans" .
<Dexamethasone> <Has_brand_name> "Decan" .
<Dexamethasone> <Has_brand_name> "Decalona" .
<Dexamethasone> <Has_brand_name> "Decalon" .
<Dexamethasone> <Has_brand_name> "Decalin" .
<Dexamethasone> <Has_brand_name> "Decafos" .
<Dexamethasone> <Has_brand_name> "Decadronfosfat" .
<Dexamethasone> <Has_brand_name> "Decadronal" .
<Dexamethasone> <Has_brand_name> "Decadron" .
<Dexamethasone> <Has_brand_name> "Decadran" .
<Dexamethasone> <Has_brand_name> "Decadolone" .
<Dexamethasone> <Has_brand_name> "Decaderm" .
<Dexamethasone> <Has_brand_name> "Decacin" .
<Dexamethasone> <Has_brand_name> "Deca_Forte" .
<Dexamethasone> <Has_brand_name> "Daxilone" .
<Dexamethasone> <Has_brand_name> "Danasone" .
<Dexamethasone> <Has_brand_name> "Danason" .
<Dexamethasone> <Has_brand_name> "Dalalone" .
<Dexamethasone> <Has_brand_name> "Daidoron" .
<Dexamethasone> <Has_brand_name> "Dacrosone" .
<Dexamethasone> <Has_brand_name> "DM_Solone" .
<Dexamethasone> <Has_brand_name> "D-Cort" .
<Dexamethasone> <Has_brand_name> "Coyensu" .
<Dexamethasone> <Has_brand_name> "Cortitop" .
<Dexamethasone> <Has_brand_name> "Cortidexason" .
<Dexamethasone> <Has_brand_name> "Cortidex" .
<Dexamethasone> <Has_brand_name> "Cortidax" .
<Dexamethasone> <Has_brand_name> "Corticoidex" .
<Dexamethasone> <Has_brand_name> "Corsum" .
<Dexamethasone> <Has_brand_name> "Corsone" .
<Dexamethasone> <Has_brand_name> "Corsona" .
<Dexamethasone> <Has_brand_name> "Corson" .
<Dexamethasone> <Has_brand_name> "Corodex" .
<Dexamethasone> <Has_brand_name> "Colircusi_Dexametasona" .
<Dexamethasone> <Has_brand_name> "Cetadexon" .
<Dexamethasone> <Has_brand_name> "Celudex" .
<Dexamethasone> <Has_brand_name> "Cellacort" .
<Dexamethasone> <Has_brand_name> "Cebedex" .
<Dexamethasone> <Has_brand_name> "Carulon" .
<Dexamethasone> <Has_brand_name> "Carbidu" .
<Dexamethasone> <Has_brand_name> "Canalon" .
<Dexamethasone> <Has_brand_name> "Butiol" .
<Dexamethasone> <Has_brand_name> "Bufadexon" .
<Dexamethasone> <Has_brand_name> "Bucokon" .
<Dexamethasone> <Has_brand_name> "Brulin" .
<Dexamethasone> <Has_brand_name> "Bisuo_DS" .
<Dexamethasone> <Has_brand_name> "Beyonas_Dexa" .
<Dexamethasone> <Has_brand_name> "Bexine" .
<Dexamethasone> <Has_brand_name> "B_Dexzol" .
<Dexamethasone> <Has_brand_name> "Auxisone" .
<Dexamethasone> <Has_brand_name> "Auxison" .
<Dexamethasone> <Has_brand_name> "Auxiloson" .
<Dexamethasone> <Has_brand_name> "Arcodexan" .
<Dexamethasone> <Has_brand_name> "Apidex" .
<Dexamethasone> <Has_brand_name> "Aphtasolon" .
<Dexamethasone> <Has_brand_name> "Anemul" .
<Dexamethasone> <Has_brand_name> "Amumetazon" .
<Dexamethasone> <Has_brand_name> "Alpermell" .
<Dexamethasone> <Has_brand_name> "Alfalyl" .
<Dexamethasone> <Has_brand_name> "Aldron" .
<Dexamethasone> <Has_brand_name> "Afpred_Forte-Dexa" .
<Dexamethasone> <Has_brand_name> "Aeroseb-DEX" .
<Dexamethasone> <Has_brand_name> "Adrekon" .
<Dexamethasone> <Has_brand_name> "Adrecort" .
<Dexamethasone> <Has_brand_name> "Acolon" .
<Dexamethasone> <Has_brand_name> "Acetazona" .
<Dexamethasone> <Has_brand_name> "Acetato_DE_Dexametasona" .
<Dexamethasone> <Has_brand_name> "Aacidexam" .
<Dexamethasone> <Has_brand_name> "AK-DEX" .
<Capecitabine_and_Fulvestrant> <Has_antineoplastic> "Fulvestrant" .
<Capecitabine_and_Fulvestrant> <Has_antineoplastic> "Capecitabine" .
<eBEACOPP_(Prednisolone)> <Is_current_in> "Hodgkin_lymphoma" .
<OEPA> <Has_context> "Induction_therapy" .
<DDGP> <Mapped_from> "DDGP" .
<TH_(Taxol)> <Is_current_in> "Breast_cancer" .
<T-cell_prolymphocytic_leukemia> <Current_treated_by> "Pentostatin_and_Alemtuzumab" .
<T-cell_prolymphocytic_leukemia> <Current_treated_by> "Ibrutinib_and_Venetoclax" .
<T-cell_prolymphocytic_leukemia> <Current_treated_by> "Bendamustine_monotherapy" .
<T-cell_prolymphocytic_leukemia> <Current_treated_by> "Alemtuzumab_monotherapy" .
<Dacotin> <Brand_name_of> "Oxaliplatin" .
<Mediastinal_gray-zone_lymphoma> <Current_treated_by> "DA-R-EPOCH" .
<Mediastinal_gray-zone_lymphoma> <Current_treated_by> "Brentuximab_vedotin_monotherapy" .
<Cytarabine,_Ifosfamide,_G-CSF> <Is_current_in> "Stem_cell_mobilization" .
<IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone> <Maps_to> "IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone" .
<Trastuzumab-dttb> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Trastuzumab-dttb> <Is_a> "Protein_expression-specific_medication" .
<Trastuzumab-dttb> <Is_a> "Neutral" .
<Trastuzumab-dttb> <Is_a> "Biosimilar" .
<Trastuzumab-dttb> <Is_a> "Antibody_medication" .
<Trastuzumab-dttb> <Is_a> "Anti-HER2_antibody" .
<Aurora_kinase_inhibitor> <Is_a> "Kinase_inhibitor" .
<Dexamethasone_and_Eltrombopag> <Has_accepted_use> "Immune_thrombocytopenia" .
<RBC_transfusions> <Mapped_from> "RBC_transfusions" .
<Medulloblastoma> <Is_a> "Pediatric_cancer" .
<Anastraze> <Brand_name_of> "Anastrozole" .
<Biovinate> <Brand_name_of> "Carboplatin" .
<FCR> <Has_context> "Non-curative_therapy" .
<FCR> <Has_context> "Non-curative_first-line_therapy" .
<FCR> <Has_context> "All_lines_of_therapy" .
<Everolimus_and_Octreotide> <Maps_to> "Everolimus_and_Octreotide" .
<CISCA/VB> <Has_modality> "Chemotherapy" .
<Doxorubicin_and_Olaratumab> <Has_context> "Non-curative_therapy" .
<Folex_PFS> <Brand_name_of> "Methotrexate" .
<MVBP> <Maps_to> "MVBP" .
<VMP,_then_Rd> <Has_supportive_med> "Low_molecular_weight_heparins" .
<VMP,_then_Rd> <Has_supportive_med> "Bisphosphonates" .
<VMP,_then_Rd> <Has_supportive_med> "Aspirin" .
<VMP,_then_Rd> <Has_supportive_med> "Antivirals" .
<BRCA-mutated_Breast_cancer> <Accepted_use_of> "Vinorelbine_monotherapy" .
<BRCA-mutated_Breast_cancer> <Accepted_use_of> "Talazoparib_monotherapy" .
<BRCA-mutated_Breast_cancer> <Accepted_use_of> "Olaparib_monotherapy" .
<BRCA-mutated_Breast_cancer> <Accepted_use_of> "Eribulin_monotherapy" .
<BRCA-mutated_Breast_cancer> <Accepted_use_of> "Capecitabine_monotherapy" .
<Enasidenib_monotherapy> <Maps_to> "Enasidenib_monotherapy" .
<Megestrol_and_Tamoxifen> <Is_current_in> "Endometrial_cancer" .
<Dactinomycin> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Dactinomycin> <Is_a> "Vesicant" .
<Dactinomycin> <Is_a> "DNA_synthesis_inhibitor" .
<Cytarabine_and_Thioguanine> <Maps_to> "Cytarabine_and_Thioguanine" .
<Pegaspargase> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Pegaspargase> <Has_accepted_use> "NK-_and_T-cell_lymphoma" .
<Pegaspargase> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Pegaspargase> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<RT,_then_Temozolomide> <Has_antineoplastic> "Temozolomide" .
<RT,_then_Temozolomide> <Has_antineoplastic> "External_beam_radiotherapy" .
<ACT> <Is_historical_in> "Breast_cancer" .
<POMP> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Cisplatin_and_RT> <Has_supportive_med> "Prochlorperazine" .
<Cisplatin_and_RT> <Has_supportive_med> "Ondansetron" .
<Cisplatin_and_RT> <Has_supportive_med> "Emesis_prevention" .
<Cisplatin_and_RT> <Has_supportive_med> "Dexamethasone" .
<MVPP> <Is_historical_in> "Hodgkin_lymphoma" .
<Ipilimumab_and_Nivolumab> <Has_context> "Non-curative_therapy" .
<Ipilimumab_and_Nivolumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<Ipilimumab_and_Nivolumab> <Has_context> "Non-curative_first-line_therapy" .
<Ipilimumab_and_Nivolumab> <Has_context> "All_lines_of_therapy" .
<Aldesleukin> <May_have_route> "Intravenous" .
<MA> <Maps_to> "MA" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan> <Has_context> "All_lines_of_therapy" .
<Prelone> <Brand_name_of> "Prednisolone" .
<Hufacid> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Apixaban_monotherapy> <Mapped_from> "Apixaban_monotherapy" .
<Gemcitabine_monotherapy> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Gemcitabine_monotherapy> <Has_supportive_med> "Sargramostim" .
<Gemcitabine_monotherapy> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Gemcitabine_monotherapy> <Has_supportive_med> "Folic_acid" .
<Gemcitabine_monotherapy> <Has_supportive_med> "Emesis_prevention" .
<Antithrombin_III> <Has_accepted_use> "Inherited_coagulopathy" .
<Letrozole_and_Ribociclib> <Has_antineoplastic> "Ribociclib" .
<Letrozole_and_Ribociclib> <Has_antineoplastic> "Letrozole" .
<Necitumumab_monotherapy> <Has_modality> "Chemotherapy" .
<Everolimus_monotherapy> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Everolimus_monotherapy> <Has_accepted_use> "Thymoma" .
<Everolimus_monotherapy> <Has_accepted_use> "Renal_cell_carcinoma" .
<Everolimus_monotherapy> <Has_accepted_use> "Pancreatic_NET" .
<Everolimus_monotherapy> <Has_accepted_use> "Neuroendocrine_tumor" .
<Everolimus_monotherapy> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Everolimus_monotherapy> <Has_accepted_use> "Hodgkin_lymphoma" .
<Everolimus_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Carboplatine> <Brand_name_of> "Carboplatin" .
<Dexacen-4> <Brand_name_of> "Dexamethasone" .
<Elixirmethasone> <Brand_name_of> "Dexamethasone" .
<Anzemet> <Brand_name_of> "Dolasetron" .
<CNOP> <Has_context> "Induction_therapy" .
<Trinotecan> <Brand_name_of> "Irinotecan" .
<Irinotecan,_Temozolomide,_Dinutuximab> <Has_antineoplastic> "Temozolomide" .
<Irinotecan,_Temozolomide,_Dinutuximab> <Has_antineoplastic> "Irinotecan" .
<Irinotecan,_Temozolomide,_Dinutuximab> <Has_antineoplastic> "Dinutuximab" .
<Altretamine_and_Cisplatin> <Is_historical_in> "Ovarian_cancer" .
<Innomustine> <Brand_name_of> "Bendamustine" .
<Cisplatin,_Docetaxel,_RT> <Maps_to> "Cisplatin,_Docetaxel,_RT" .
<Alemtuzumab> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Alemtuzumab> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Alemtuzumab> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Alemtuzumab> <Has_accepted_use> "Hypereosinophilic_syndrome" .
<Alemtuzumab> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Alemtuzumab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Alemtuzumab> <Has_accepted_use> "Autoimmune_cytopenia" .
<Alemtuzumab> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<Pazopanib_monotherapy> <Is_current_in> "Thyroid_cancer" .
<Pazopanib_monotherapy> <Is_current_in> "Soft_tissue_sarcoma" .
<Pazopanib_monotherapy> <Is_current_in> "Renal_cell_carcinoma" .
<Pazopanib_monotherapy> <Is_current_in> "Ovarian_cancer" .
<Pazopanib_monotherapy> <Is_current_in> "Gastrointestinal_stromal_tumor" .
<Fluconazole> <Has_brand_name> "Diflucan" .
<Penile_cancer> <Is_a> "Genitourinary_cancer" .
<Everolimus_and_Tamoxifen> <Mapped_from> "Everolimus_and_Tamoxifen" .
<MVBP> <Has_context> "Upfront_therapy" .
<Emesis_prevention> <Supportive_med_of> "Vinorelbine_monotherapy" .
<Emesis_prevention> <Supportive_med_of> "Temozolomide_monotherapy" .
<Emesis_prevention> <Supportive_med_of> "Paclitaxel_monotherapy" .
<Emesis_prevention> <Supportive_med_of> "Irinotecan_monotherapy" .
<Emesis_prevention> <Supportive_med_of> "Ifosfamide_monotherapy" .
<Emesis_prevention> <Supportive_med_of> "Gemcitabine,_Oxaliplatin,_Paclitaxel" .
<Emesis_prevention> <Supportive_med_of> "Gemcitabine_monotherapy" .
<Emesis_prevention> <Supportive_med_of> "Gemcitabine_and_Vinorelbine" .
<Emesis_prevention> <Supportive_med_of> "Fluorouracil_and_Levoleucovorin" .
<Emesis_prevention> <Supportive_med_of> "Fluorouracil_and_Folinic_acid" .
<Emesis_prevention> <Supportive_med_of> "FOLFIRI_and_Ziv-aflibercept" .
<Emesis_prevention> <Supportive_med_of> "Docetaxel_monotherapy" .
<Emesis_prevention> <Supportive_med_of> "Docetaxel_and_Prednisone" .
<Emesis_prevention> <Supportive_med_of> "DCF" .
<Emesis_prevention> <Supportive_med_of> "Cyclophosphamide_and_Topotecan" .
<Emesis_prevention> <Supportive_med_of> "Cisplatin_and_RT" .
<Emesis_prevention> <Supportive_med_of> "Cisplatin_and_Paclitaxel" .
<Emesis_prevention> <Supportive_med_of> "Cisplatin_and_Fluorouracil" .
<Emesis_prevention> <Supportive_med_of> "CVD_(Vinblastine)" .
<COR-30> <Brand_name_of> "Aspirin" .
<Brentuximab_vedotin_monotherapy> <Mapped_from> "Brentuximab_vedotin_monotherapy" .
<ACH> <Has_context> "Non-curative_first-line_therapy" .
<7_plus_3d> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Dara-Rd> <Has_context> "Non-curative_therapy" .
<Dara-Rd> <Has_context> "Non-curative_first-line_therapy" .
<Tegafur_gimeracil_oteracil> <Has_brand_name> "Teysuno" .
<Metcort> <Brand_name_of> "Dexamethasone" .
<CBV-Mx> <Maps_to> "CBV-Mx" .
<Palbociclib> <Has_accepted_use> "Breast_cancer" .
<CYM> <Maps_to> "CYM" .
<VA> <Maps_to> "VA" .
<Lomustine,_Vincristine,_Prednisone> <Maps_to> "Lomustine,_Vincristine,_Prednisone" .
<Resolmin> <Brand_name_of> "Dalteparin" .
<Siltuximab> <Immunosuppressor_of> "Siltuximab_monotherapy" .
<Lutamide> <Brand_name_of> "Flutamide" .
<FEIBA_NF> <Brand_name_of> "Anti-inhibitor_coagulant_complex" .
<Cyclosporine_and_Prednisone> <Is_current_in> "Graft_versus_host_disease" .
<Genetaxyl> <Brand_name_of> "Paclitaxel" .
<Cytarabine,_Idarubicin,_Sorafenib> <Has_context> "Consolidation_after_upfront_therapy" .
<Cortidax> <Brand_name_of> "Dexamethasone" .
<BEACOPP-14> <Has_accepted_use> "Hodgkin_lymphoma" .
<Avapritinib> <Has_brand_name> "Ayvakit" .
<Docetaxel_and_S-1> <Has_modality> "Chemotherapy" .
<Octreotide_LAR> <May_have_route> "Intramuscular" .
<Plasma_cell_leukemia> <Current_treated_by> "Rd" .
<Plasma_cell_leukemia> <Current_treated_by> "PAD/VCD" .
<Plasma_cell_leukemia> <Current_treated_by> "Melphalan,_then_auto_HSCT" .
<Plasma_cell_leukemia> <Current_treated_by> "Lenalidomide_monotherapy" .
<Doxorubicin_and_Strontium-89> <Has_accepted_use> "Prostate_cancer" .
<Capecitabine,_Paclitaxel,_RT> <Has_modality> "Radiotherapy" .
<Capecitabine,_Paclitaxel,_RT> <Has_modality> "Chemotherapy" .
<DAC> <Is_a> "Anthracycline-containing_regimen" .
<AquaMephyton> <Brand_name_of> "Phytonadione" .
<Intermittent_ADT> <Maps_to> "Intermittent_ADT" .
<Aminoglutethimide_monotherapy> <Has_antineoplastic> "Aminoglutethimide" .
<TACE> <Has_context> "Non-curative_therapy" .
<TACE> <Has_context> "Local_therapy" .
<TACE> <Has_context> "Adjuvant_therapy" .
<BCHOP> <Has_context> "Non-curative_therapy" .
<Kaposi_sarcoma> <Is_a> "Vascular_sarcoma" .
<Isatuximab> <Is_a> "Investigational_drug" .
<Isatuximab> <Is_a> "Antibody_medication" .
<Isatuximab> <Is_a> "Anti-CD38_antibody" .
<Irinotecan_and_S-1> <Has_context> "Non-curative_subsequent-line_therapy" .
<Gemcitabine,_Cetuximab,_RT> <Maps_to> "Gemcitabine,_Cetuximab,_RT" .
<Mitoxantrone> <Is_a> "Topoisomerase_inhibitor" .
<Mitoxantrone> <Is_a> "Irritant" .
<Mitoxantrone> <Is_a> "Anthracycline" .
<Celltop> <Brand_name_of> "Etoposide" .
<Atypical_hemolytic_uremic_syndrome> <Current_treated_by> "Eculizumab_monotherapy" .
<Mycophenolate_mofetil_monotherapy> <Is_current_in> "Immune_thrombocytopenia" .
<Iressa> <Brand_name_of> "Gefitinib" .
<Capecitabine_and_Lapatinib> <Maps_to> "Capecitabine_and_Lapatinib" .
<Afatinib_monotherapy> <Has_modality> "Chemotherapy" .
<Fluorouracil_and_Methotrexate> <Is_historical_in> "Colon_cancer" .
<CAMF> <Mapped_from> "CAMF" .
<Refametinib> <May_have_route> "Oral" .
<CTD> <Mapped_from> "CTD" .
<Lenvatinib> <Has_accepted_use> "Thyroid_cancer" .
<Lenvatinib> <Has_accepted_use> "Renal_cell_carcinoma" .
<Lenvatinib> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Lenvatinib> <Has_accepted_use> "Endometrial_cancer" .
<Cisplatin,_Pemetrexed,_Bevacizumab> <Maps_to> "Cisplatin,_Pemetrexed,_Bevacizumab" .
<Paclitaxel_monotherapy> <Has_antineoplastic> "Paclitaxel" .
<L-glutamine_monotherapy> <Has_modality> "Supportive_therapy" .
<Atezolizumab> <Has_FDA_indication> "Small_cell_lung_cancer" .
<Atezolizumab> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Atezolizumab> <Has_FDA_indication> "Breast_cancer" .
<Atezolizumab> <Has_FDA_indication> "Bladder_cancer" .
<Theraprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Geftinat> <Brand_name_of> "Gefitinib" .
<(90)YFC> <Has_modality> "Immunosuppressive_therapy" .
<(90)YFC> <Has_modality> "Chemoradioimmunotherapy" .
<Mitotane_and_EDP> <Is_a> "Anthracycline-containing_regimen" .
<Docetaxel_and_S-1> <Is_current_in> "Gastric_cancer" .
<Idelalisib_and_Ofatumumab> <Has_antineoplastic> "Ofatumumab" .
<Idelalisib_and_Ofatumumab> <Has_antineoplastic> "Idelalisib" .
<FDA_approved_drug> <Subsumes> "REMS_program" .
<FDA_approved_drug> <Subsumes> "Panobinostat" .
<FDA_approved_drug> <Subsumes> "Palbociclib" .
<FDA_approved_drug> <Subsumes> "Midostaurin" .
<FDA_approved_drug> <Subsumes> "Gemtuzumab_ozogamicin" .
<FDA_approved_drug> <Subsumes> "Enzalutamide" .
<FDA_approved_drug> <Subsumes> "Danazol" .
<FDA_approved_drug> <Subsumes> "Cyanocobalamin" .
<FDA_approved_drug> <Subsumes> "Ceritinib" .
<FDA_approved_drug> <Subsumes> "Carfilzomib" .
<FDA_approved_drug> <Subsumes> "Brigatinib" .
<FDA_approved_drug> <Subsumes> "Bortezomib" .
<FDA_approved_drug> <Subsumes> "Bacillus_Calmette-Guerin" .
<FDA_approved_drug> <Subsumes> "Axicabtagene_ciloleucel" .
<FDA_approved_drug> <Subsumes> "Aspirin_and_dipyridamole" .
<FDA_approved_drug> <Subsumes> "Alectinib" .
<FDA_approved_drug> <Subsumes> "Acetaminophen" .
<O-FC> <Mapped_from> "O-FC" .
<Metoprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<ddAC> <Mapped_from> "ddAC" .
<Capecitabine,_Mitomycin,_RT> <Maps_to> "Capecitabine,_Mitomycin,_RT" .
<Rituximab_monotherapy> <Has_modality> "Immunosuppressive_therapy" .
<Rituximab_monotherapy> <Has_modality> "Chemotherapy" .
<Paclitaxel_and_Pazopanib> <Is_current_in> "Ovarian_cancer" .
<Decadran> <Brand_name_of> "Dexamethasone" .
<Selective_inhibitors_of_nuclear_export> <Subsumes> "XPO1_inhibitor" .
<Mitotane_and_Streptozocin> <Maps_to> "Mitotane_and_Streptozocin" .
<Metasolon> <Brand_name_of> "Dexamethasone" .
<Carboplatin,_Paclitaxel,_Ipilimumab> <Has_supportive_med> "Steroids" .
<LSG15> <Maps_to> "LSG15" .
<Decitabine_and_Valproate> <Maps_to> "Decitabine_and_Valproate" .
<FOLFIRI_(L-Leucovorin)> <Has_antineoplastic> "Levoleucovorin" .
<FOLFIRI_(L-Leucovorin)> <Has_antineoplastic> "Irinotecan" .
<FOLFIRI_(L-Leucovorin)> <Has_antineoplastic> "Fluorouracil" .
<FAS> <Is_current_in> "Pancreatic_NET" .
<Plinabulin> <Is_a> "Investigational_drug" .
<Cabazitaxel_and_Prednisone> <Mapped_from> "Cabazitaxel_and_Prednisone" .
<Trisulcom> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Oxaliplatin_and_Bevacizumab> <Is_current_in> "Testicular_cancer" .
<Ofatumumab> <Has_FDA_indication> "Chronic_lymphocytic_leukemia" .
<Gemcitabine,_Oxaliplatin,_Paclitaxel> <Is_current_in> "Testicular_cancer" .
<Tisagenlecleucel_monotherapy> <Is_historical_in> "Multiple_myeloma" .
<Tisagenlecleucel_monotherapy> <Is_historical_in> "Chronic_lymphocytic_leukemia" .
<ECH> <Has_modality> "Chemotherapy" .
<IRd> <Maps_to> "IRd" .
<Hepatic_arterial_chemotherapy> <Has_modality> "Chemotherapy" .
<7_plus_3m> <Is_current_in> "Acute_myeloid_leukemia" .
<Defitelio> <Brand_name_of> "Defibrotide" .
<Eculizumab_monotherapy> <Has_immunosuppressor> "Eculizumab" .
<MCV> <Has_accepted_use> "Bladder_cancer" .
<Cyclophosphamide_and_Prednisone> <Has_modality> "Immunosuppressive_therapy" .
<Cyclophosphamide_and_Prednisone> <Has_modality> "Chemotherapy" .
<Degarelix> <Is_a> "GnRH_antagonist" .
<Degarelix> <Is_a> "Endocrine_therapeutic" .
<CVD_(Vinblastine)> <Is_current_in> "Melanoma" .
<DES_monotherapy> <Is_historical_in> "Prostate_cancer" .
<DES_monotherapy> <Is_historical_in> "Breast_cancer" .
<Axicabtagene_ciloleucel_monotherapy> <Has_antineoplastic> "Fludarabine" .
<Axicabtagene_ciloleucel_monotherapy> <Has_antineoplastic> "Cyclophosphamide" .
<Axicabtagene_ciloleucel_monotherapy> <Has_antineoplastic> "Axicabtagene_ciloleucel" .
<G-FC> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Levofloxacin> <May_have_route> "Oral" .
<Levofloxacin> <May_have_route> "Intravenous" .
<NovoTTF-100A_system_(Optune)> <Has_brand_name> "Optune" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Has_modality> "Chemotherapy" .
<Lovir> <Brand_name_of> "Acyclovir" .
<CODOX-M> <Has_modality> "Chemotherapy" .
<PAD> <Is_a> "Anthracycline-containing_regimen" .
<ddTH_(Taxotere)> <Has_antineoplastic> "Trastuzumab" .
<ddTH_(Taxotere)> <Has_antineoplastic> "Docetaxel" .
<Gemcitabine,_Cetuximab,_RT> <Has_modality> "Radiotherapy" .
<Gemcitabine,_Cetuximab,_RT> <Has_modality> "Chemotherapy" .
<Estradiol_monotherapy> <Has_antineoplastic> "Estradiol" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Current_treated_by> "VIPD" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Current_treated_by> "SMILE" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Current_treated_by> "MESA/RT" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Current_treated_by> "LVP_.22Sandwich.22" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Current_treated_by> "L-Asparaginase,_Vincristine,_Prednisolone" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Current_treated_by> "GELOX/RT" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Current_treated_by> "DeVIC_and_RT" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Current_treated_by> "DEP_and_RT" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Current_treated_by> "Cisplatin_and_RT" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Current_treated_by> "AspaMetDex_(Erwinaze)" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Current_treated_by> "AspaMetDex" .
<CBV-Mx> <Has_context> "All_lines_of_therapy" .
<GemOx> <Is_a> "Platinum_doublet" .
<CMF> <Has_accepted_use> "triple_negative_Breast_cancer" .
<CMF> <Has_accepted_use> "Prostate_cancer" .
<CMF> <Has_accepted_use> "Breast_cancer" .
<Busulfan_and_Fludarabine> <Mapped_from> "Busulfan_and_Fludarabine" .
<Fivocil> <Brand_name_of> "Fluorouracil" .
<Vafu> <Brand_name_of> "Fluorouracil" .
<Fulvestrant_and_Ribociclib> <Has_antineoplastic> "Ribociclib" .
<Fulvestrant_and_Ribociclib> <Has_antineoplastic> "Fulvestrant" .
<Doxorubicin_and_Olaratumab> <Is_a> "Anthracycline-containing_regimen" .
<Capecitabine_and_Paclitaxel,_nanoparticle_albumin-bound> <Has_modality> "Chemotherapy" .
<KCD> <Has_context> "Non-curative_first-line_therapy" .
<Tropidrol> <Brand_name_of> "Methylprednisolone" .
<Gemcitabine_and_Sunitinib> <Has_accepted_use> "Renal_cell_carcinoma" .
<Doxorubicin_pegylated_liposomal_and_Gemcitabine> <Has_antineoplastic> "Pegylated_liposomal_doxorubicin" .
<Doxorubicin_pegylated_liposomal_and_Gemcitabine> <Has_antineoplastic> "Gemcitabine" .
<BR_and_Ibrutinib> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<VAIA> <Has_modality> "Chemotherapy" .
<Gefitinib> <Has_brand_name> "KabiGef" .
<Gefitinib> <Has_brand_name> "Iressa" .
<Gefitinib> <Has_brand_name> "Geftiwel" .
<Gefitinib> <Has_brand_name> "Geftinat" .
<Gefitinib> <Has_brand_name> "Geftilon" .
<Gefitinib> <Has_brand_name> "Gefticip" .
<Gefitinib> <Has_brand_name> "Geftican" .
<Gefitinib> <Has_brand_name> "Geftib" .
<Gefitinib> <Has_brand_name> "Gefonib" .
<Gefitinib> <Has_brand_name> "Gefitero" .
<Gefitinib> <Has_brand_name> "Gefitec" .
<Gefitinib> <Has_brand_name> "Geffy" .
<Gefitinib> <Has_brand_name> "Denrit" .
<Gefitinib> <Has_brand_name> "Cangib" .
<EGFR-mutated_malignancy> <Is_a> "Malignant_solid_neoplasm" .
<AC_and_Bevacizumab> <Is_current_in> "Breast_cancer" .
<BCVPP> <Maps_to> "BCVPP" .
<Fluorouracil_and_Mitomycin> <Has_accepted_use> "Gastric_cancer" .
<Fluorouracil_and_Mitomycin> <Has_accepted_use> "Colon_cancer" .
<RVD> <Has_accepted_use> "Multiple_myeloma" .
<R-IFE> <Is_a> "Rituximab-containing_regimen" .
<Cisplatin,_Vinorelbine,_Cetuximab> <Has_modality> "Chemotherapy" .
<Bortezomib,_Dexamethasone,_Panobinostat> <Has_modality> "Chemotherapy" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "VMD" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "VDC" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "VD" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Thalidomide" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Rd" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "RD" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Prednisone" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Pomalidomide" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Pd" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "No_induction" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "NEOD001" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Melphalan,_then_auto_HSCT" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Melphalan" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "MRD" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "MP" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "M-DEX" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Lenalidomide_monotherapy" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Lenalidomide" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Ixazomib_monotherapy" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Ixazomib_and_Dexamethasone" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Ixazomib" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Dexamethasone" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Daratumumab_monotherapy" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Daratumumab" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Cyclophosphamide" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Colchicine_monotherapy" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "CTD" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "CRd" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Bortezomib_monotherapy" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Bortezomib_and_Melphalan,_then_auto_HSCT" .
<Light-chain_(AL)_amyloidosis> <Accepted_use_of> "Bortezomib" .
<Ifosfamide_and_Vinorelbine> <Maps_to> "Ifosfamide_and_Vinorelbine" .
<mFOLFOX7> <Has_modality> "Chemotherapy" .
<CAP> <Mapped_from> "CAP" .
<VD> <Has_supportive_med> "Zoledronic_acid" .
<VD> <Has_supportive_med> "Proton_pump_inhibitors" .
<VD> <Has_supportive_med> "Pamidronate" .
<VD> <Has_supportive_med> "Antivirals" .
<VD> <Has_supportive_med> "Acyclovir" .
<Mitoxantrone_and_Hydrocortisone> <Maps_to> "Mitoxantrone_and_Hydrocortisone" .
<Busulfan_and_Cyclophosphamide,_then_allo_HSCT> <Has_accepted_use> "Myelodysplastic_syndrome" .
<DD-CHOP> <Has_context> "Induction_therapy" .
<Fluorouracil,_Folinic_acid,_RT> <Mapped_from> "Fluorouracil,_Folinic_acid,_RT" .
<m-BNCOD> <Has_antineoplastic> "Vincristine" .
<m-BNCOD> <Has_antineoplastic> "Mitoxantrone" .
<m-BNCOD> <Has_antineoplastic> "Methotrexate" .
<m-BNCOD> <Has_antineoplastic> "Dexamethasone" .
<m-BNCOD> <Has_antineoplastic> "Cyclophosphamide" .
<m-BNCOD> <Has_antineoplastic> "Bleomycin" .
<L-asparaginase_monotherapy> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<CVB> <Has_modality> "Chemotherapy" .
<Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant> <Has_antineoplastic> "Fludarabine" .
<Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant> <Has_antineoplastic> "External_beam_radiotherapy" .
<Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant> <Has_antineoplastic> "Cyclophosphamide" .
<7_plus_3i_and_Sorafenib> <Has_accepted_use> "Acute_myeloid_leukemia" .
<R-CHOEP-14> <Has_context> "Induction_therapy" .
<Ovastat> <Brand_name_of> "Treosulfan" .
<Carboplatin_and_nab-Paclitaxel> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Carboplatin_and_nab-Paclitaxel> <Has_supportive_med> "Pentamidine" .
<Carboplatin_and_nab-Paclitaxel> <Has_supportive_med> "Filgrastim" .
<Carboplatin_and_nab-Paclitaxel> <Has_supportive_med> "Darbepoetin_alfa" .
<Carboplatin_and_nab-Paclitaxel> <Has_supportive_med> "Atovaquone" .
<Exemestane_and_Tucidinostat> <Is_current_in> "Breast_cancer" .
<Oropharyngeal_cancer> <Accepted_use_of> "Cisplatin_and_RT" .
<dmCODOX-M_-_Modified_Magrath> <Has_modality> "Chemotherapy" .
<Megaset> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CAVE> <Has_accepted_use> "Small_cell_lung_cancer" .
<Infigratinib> <May_have_route> "Oral" .
<Goserelin_and_RT> <Is_current_in> "Prostate_cancer" .
<Ponatinib> <Antineoplastic_of> "Ponatinib_monotherapy" .
<Ponatinib> <Antineoplastic_of> "Hyper-CVAD_and_Ponatinib" .
<MA-BCD/AP> <Mapped_from> "MA-BCD/AP" .
<Cyclosporine_monotherapy> <Has_context> "Non-curative_therapy" .
<Cyclosporine_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Cyclosporine_monotherapy> <Has_context> "Induction_therapy" .
<Cyclosporine_monotherapy> <Has_context> "All_lines_of_therapy" .
<Aldronac> <Brand_name_of> "Alendronate" .
<Laxative> <Subsumes> "Sennosides" .
<Laxative> <Subsumes> "Lactulose" .
<Laxative> <Subsumes> "Docusate" .
<VEBEP> <Is_a> "Anthracycline-containing_regimen" .
<FRD> <Maps_to> "FRD" .
<Levoleucovorin> <Antineoplastic_of> "mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)" .
<Levoleucovorin> <Antineoplastic_of> "mFOLFOX7_(L-Leucovorin)" .
<Levoleucovorin> <Antineoplastic_of> "mFOLFOX6_and_Bevacizumab_(L-Leucovorin)" .
<Levoleucovorin> <Antineoplastic_of> "mFOLFOX6_(L-Leucovorin)" .
<Levoleucovorin> <Antineoplastic_of> "Fluorouracil_and_Levoleucovorin" .
<Levoleucovorin> <Antineoplastic_of> "FOLFOXIRI_and_Panitumumab" .
<Levoleucovorin> <Antineoplastic_of> "FOLFOX4_(L-Leucovorin)" .
<Levoleucovorin> <Antineoplastic_of> "FOLFOX_7/sLV5FU2_(L-Leucovorin)" .
<Levoleucovorin> <Antineoplastic_of> "FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)" .
<Levoleucovorin> <Antineoplastic_of> "FOLFIRI_and_Cetuximab_(L-Leucovorin)" .
<Levoleucovorin> <Antineoplastic_of> "FOLFIRI_and_Bevacizumab_(L-Leucovorin)" .
<Levoleucovorin> <Antineoplastic_of> "FOLFIRI_(L-Leucovorin)" .
<Gemcitabine/Fluorouracil_and_RT> <Maps_to> "Gemcitabine/Fluorouracil_and_RT" .
<CHOP-AL> <Has_context> "Induction_therapy" .
<CC_COR> <Brand_name_of> "Aspirin" .
<Foliment> <Brand_name_of> "Folinic_acid" .
<VBMCP/VBAD> <Maps_to> "VBMCP/VBAD" .
<DA-R-EPOCH> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<DA-R-EPOCH> <Has_accepted_use> "Mediastinal_gray-zone_lymphoma" .
<DA-R-EPOCH> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<DA-R-EPOCH> <Has_accepted_use> "Burkitt_lymphoma" .
<MBVP> <Mapped_from> "MBVP" .
<mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)> <Maps_to> "mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)" .
<Irinotecan_and_Cetuximab> <Has_accepted_use> "KRAS_wild-type_Colon_cancer" .
<Irinotecan_and_Cetuximab> <Has_accepted_use> "Colon_cancer" .
<Nelarabine> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Pipobroman_monotherapy> <Has_accepted_use> "Polycythemia_vera" .
<Anti-PD-L1_antibody> <Subsumes> "Durvalumab" .
<Anti-PD-L1_antibody> <Subsumes> "Avelumab" .
<Anti-PD-L1_antibody> <Subsumes> "Atezolizumab" .
<F-MACHOP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<BeEAM> <Has_antineoplastic> "Melphalan" .
<BeEAM> <Has_antineoplastic> "Etoposide" .
<BeEAM> <Has_antineoplastic> "Cytarabine" .
<BeEAM> <Has_antineoplastic> "Bendamustine" .
<Hextrate> <Brand_name_of> "Methotrexate" .
<C-MOPP> <Has_antineoplastic> "Vincristine" .
<C-MOPP> <Has_antineoplastic> "Procarbazine" .
<C-MOPP> <Has_antineoplastic> "Prednisone" .
<C-MOPP> <Has_antineoplastic> "Cyclophosphamide" .
<Nosipren> <Brand_name_of> "Prednisone" .
<EIA> <Maps_to> "EIA" .
<Cisplatin_and_Vindesine> <Is_a> "Platinum_doublet" .
<CHOP-B> <Has_context> "Non-curative_first-line_therapy" .
<CHOP-B> <Has_context> "Induction_therapy" .
<IGEV_and_G-CSF> <Has_accepted_use> "Stem_cell_mobilization" .
<Bleomycin_and_Vinblastine> <Has_context> "Upfront_therapy" .
<Pomalidomide_monotherapy> <Has_accepted_use> "Myelofibrosis" .
<Pomalidomide_monotherapy> <Has_accepted_use> "Multiple_myeloma" .
<Pomalidomide_monotherapy> <Has_accepted_use> "Kaposi_sarcoma" .
<Carmustine_monotherapy> <Is_historical_in> "Hodgkin_lymphoma" .
<Maintenance_after_upfront_therapy> <Maps_to> "Maintenance_after_upfront_therapy" .
<CapeOx,_Cetuximab,_RT> <Mapped_from> "CapeOx,_Cetuximab,_RT" .
<Eunades_CS> <Brand_name_of> "Etoposide" .
<CEV_(Carboplatin/Etoposide)> <Maps_to> "CEV_(Carboplatin/Etoposide)" .
<Methotrexate,_Vinblastine,_Prednisone> <Maps_to> "Methotrexate,_Vinblastine,_Prednisone" .
<Enasidenib> <Has_brand_name> "Idhifa" .
<Vinorelbine_monotherapy> <Maps_to> "Vinorelbine_monotherapy" .
<Dasatinib_monotherapy> <Is_current_in> "Systemic_mastocytosis" .
<Dasatinib_monotherapy> <Is_current_in> "Chronic_myelogenous_leukemia" .
<Dasatinib_monotherapy> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Xaloplat> <Brand_name_of> "Oxaliplatin" .
<Azacitidine_and_Gemtuzumab_ozogamicin> <Is_current_in> "Acute_myeloid_leukemia" .
<Adrenergic_receptor_agonist> <Subsumes> "Epinephrine_autoinjector" .
<5_plus_3i> <Mapped_from> "5_plus_3i" .
<O-CHOP> <Has_modality> "Chemotherapy" .
<Fludarabine_and_TBI> <Has_antineoplastic> "Fludarabine" .
<Fludarabine_and_TBI> <Has_antineoplastic> "External_beam_radiotherapy" .
<Prax> <Brand_name_of> "Prasugrel" .
<Skemca> <Brand_name_of> "Capecitabine" .
<Mercaptopurine,_Methotrexate,_WB-XRT> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Corplus> <Brand_name_of> "Aspirin" .
<R-CODOX-M> <Has_local_therapy> "Methotrexate" .
<R-CODOX-M> <Has_local_therapy> "Hydrocortisone" .
<R-CODOX-M> <Has_local_therapy> "Cytarabine" .
<MP_(Prednisolone)> <Maps_to> "MP_(Prednisolone)" .
<Reotan> <Brand_name_of> "Folinic_acid" .
<Werifrin> <Brand_name_of> "Warfarin" .
<ATG_(Horse),_Cyclosporine,_G-CSF> <Mapped_from> "ATG_(Horse),_Cyclosporine,_G-CSF" .
<Bleomycin,_Methotrexate,_Vinblastine/RT> <Has_accepted_use> "Head_and_neck_cancer" .
<Ofoxel> <Brand_name_of> "Paclitaxel" .
<Quizartinib> <Is_a> "Kinase_inhibitor" .
<Quizartinib> <Is_a> "Investigational_drug" .
<Quizartinib> <Is_a> "FLT3_inhibitor" .
<Ondena> <Brand_name_of> "Daunorubicin" .
<ADE_(standard-dose_Ara-C)> <Is_a> "Anthracycline-containing_regimen" .
<Factor_VIII_human> <May_have_route> "Intravenous" .
<Fosfato_Dissodico_Dexametasona> <Brand_name_of> "Dexamethasone" .
<R-FM> <Maps_to> "R-FM" .
<IT_Cytarabine,_Methotrexate,_Methylprednisolone> <Maps_to> "IT_Cytarabine,_Methotrexate,_Methylprednisolone" .
<Alprazolam> <Is_a> "Emesis_prevention" .
<Alprazolam> <Is_a> "Benzodiazepine" .
<Gerical> <Brand_name_of> "Alendronate" .
<SCAB> <Has_context> "Salvage_therapy" .
<SCAB> <Has_context> "Induction_therapy" .
<Fosalan> <Brand_name_of> "Alendronate" .
<Soldex> <Brand_name_of> "Dexamethasone" .
<PEFG> <Has_modality> "Chemotherapy" .
<ADE_(standard-dose_Ara-C)> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Dexamethasone_and_WBRT> <Is_current_in> "CNS_carcinoma" .
<Altretamine_and_Cisplatin> <Mapped_from> "Altretamine_and_Cisplatin" .
<BCG_and_Dacarbazine> <Is_historical_in> "Melanoma" .
<Gemcitabine_and_Trastuzumab> <Is_current_in> "Breast_cancer" .
<Methotrexate_and_Thiotepa> <Maps_to> "Methotrexate_and_Thiotepa" .
<IFL> <Maps_to> "IFL" .
<Interferon_alfa-2b> <May_have_route> "Subcutaneous" .
<Interferon_alfa-2b> <May_have_route> "Intravenous" .
<Interferon_alfa-2b> <May_have_route> "Intramuscular" .
<Interferon_alfa-2b> <May_have_route> "Intralesional" .
<Cisplatin_and_Doxorubicin> <Has_antineoplastic> "Doxorubicin" .
<Cisplatin_and_Doxorubicin> <Has_antineoplastic> "Cisplatin" .
<R-CODOX-M/R-IVAC> <Has_local_therapy> "Methotrexate" .
<R-CODOX-M/R-IVAC> <Has_local_therapy> "Hydrocortisone" .
<R-CODOX-M/R-IVAC> <Has_local_therapy> "Cytarabine" .
<Bexarotene_monotherapy> <Maps_to> "Bexarotene_monotherapy" .
<Giant-cell_tumor_of_bone> <Is_a> "Bone_sarcoma" .
<Metoprin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Borvex> <Brand_name_of> "Bortezomib" .
<Ifavor> <Brand_name_of> "Folinic_acid" .
<Arzerra> <Brand_name_of> "Ofatumumab" .
<Talimogene_laherparepvec> <May_have_route> "Intralesional" .
<VMCP/VBAP> <Has_accepted_use> "Multiple_myeloma" .
<VA> <Mapped_from> "VA" .
<Cyclophosphamide_and_Prednisone> <Has_antineoplastic> "Prednisone" .
<Cyclophosphamide_and_Prednisone> <Has_antineoplastic> "Cyclophosphamide" .
<Fluoxymesterone_monotherapy> <Has_context> "Non-curative_therapy" .
<RT-PEPC> <Has_antineoplastic> "Thalidomide" .
<RT-PEPC> <Has_antineoplastic> "Rituximab" .
<RT-PEPC> <Has_antineoplastic> "Procarbazine" .
<RT-PEPC> <Has_antineoplastic> "Prednisone" .
<RT-PEPC> <Has_antineoplastic> "Etoposide" .
<RT-PEPC> <Has_antineoplastic> "Cyclophosphamide" .
<Entinostat> <May_have_route> "Oral" .
<Avapritinib> <May_have_route> "Oral" .
<Docetaxel,_Fluorouracil,_RT> <Has_accepted_use> "Esophageal_cancer" .
<SMO_inhibitor> <Is_a> "Hedgehog_pathway_inhibitor" .
<Doxorubicin_and_Strontium-89> <Is_a> "Anthracycline-containing_regimen" .
<mFOLFIRINOX,_Gemcitabine,_RT> <Has_modality> "Radiotherapy" .
<mFOLFIRINOX,_Gemcitabine,_RT> <Has_modality> "Chemotherapy" .
<Denosumab_monotherapy> <Is_current_in> "Giant-cell_tumor_of_bone" .
<Valrubicin_monotherapy> <Has_modality> "Chemotherapy" .
<Zejula> <Brand_name_of> "Niraparib" .
<Cytarabine,_Idarubicin,_Rituximab> <Has_context> "Non-curative_therapy" .
<Enfortumab_vedotin> <May_have_route> "Intravenous" .
<BiRd> <Is_current_in> "Multiple_myeloma" .
<Alcot> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<BiRd> <Maps_to> "BiRd" .
<Platinoxan> <Brand_name_of> "Cisplatin" .
<Imatinib> <Has_brand_name> "Veenat" .
<Imatinib> <Has_brand_name> "Temsan" .
<Imatinib> <Has_brand_name> "Imatib" .
<Imatinib> <Has_brand_name> "Imalek" .
<Imatinib> <Has_brand_name> "Glivec" .
<Imatinib> <Has_brand_name> "Gleevec" .
<Imatinib> <Has_brand_name> "Gleevac" .
<Imatinib> <Has_brand_name> "Enliven" .
<VP> <Has_antineoplastic> "Prednisone" .
<VP> <Has_antineoplastic> "Bortezomib" .
<Cisplatin_and_Paclitaxel> <Is_a> "Platinum_doublet" .
<Pegaspargase,_Vincristine,_Prednisone> <Has_context> "Induction_therapy" .
<Gemcitabine_and_Sunitinib> <Is_current_in> "Renal_cell_carcinoma" .
<Oxaliplatin_monotherapy> <Has_antineoplastic> "Oxaliplatin" .
<KCD> <Has_antineoplastic> "Dexamethasone" .
<KCD> <Has_antineoplastic> "Cyclophosphamide" .
<KCD> <Has_antineoplastic> "Carfilzomib" .
<Oncocarb> <Brand_name_of> "Carboplatin" .
<Cyclophosphamide> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Cyclophosphamide> <Is_a> "PMDA_approved_drug" .
<Cyclophosphamide> <Is_a> "Nitrogen_mustard" .
<Cyclophosphamide> <Is_a> "Neutral" .
<Cyclophosphamide> <Is_a> "Light-chain_(AL)_amyloidosis_medication" .
<Cyclophosphamide> <Is_a> "Irritant" .
<Cyclophosphamide> <Is_a> "Immunosuppressant" .
<Cyclophosphamide> <Is_a> "Alkylating_agent" .
<Cyclophosphamide_and_TBI,_then_auto_HSCT> <Has_context> "Non-curative_subsequent-line_consolidation_therapy" .
<Cyclophosphamide_and_TBI,_then_auto_HSCT> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Cyclophosphamide_and_TBI,_then_auto_HSCT> <Has_context> "Consolidation_after_upfront_therapy" .
<Cyclophosphamide_and_TBI,_then_auto_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<EVI> <Has_modality> "Chemotherapy" .
<Accelerated_BEP> <Has_modality> "Chemotherapy" .
<Cisplatin,_Dacarbazine,_Paclitaxel> <Has_antineoplastic> "Paclitaxel" .
<Cisplatin,_Dacarbazine,_Paclitaxel> <Has_antineoplastic> "Dacarbazine" .
<Cisplatin,_Dacarbazine,_Paclitaxel> <Has_antineoplastic> "Cisplatin" .
<Temozolomide_and_Thalidomide> <Has_context> "All_lines_of_therapy" .
<Paroxysmal_nocturnal_hemoglobinuria> <Current_treated_by> "Ravulizumab_monotherapy" .
<Paroxysmal_nocturnal_hemoglobinuria> <Current_treated_by> "Placebo" .
<Paroxysmal_nocturnal_hemoglobinuria> <Current_treated_by> "Eculizumab_monotherapy" .
<ICE> <Mapped_from> "ICE" .
<Vinorelbine> <Has_brand_name> "Vinotec" .
<Vinorelbine> <Has_brand_name> "Vinorelbel" .
<Vinorelbine> <Has_brand_name> "Vinelbine" .
<Vinorelbine> <Has_brand_name> "Relbovin" .
<Vinorelbine> <Has_brand_name> "Neoben" .
<Vinorelbine> <Has_brand_name> "Navelbine" .
<Vinorelbine> <Has_brand_name> "Flonorbin" .
<Vinorelbine> <Has_brand_name> "Eunades" .
<Vinorelbine> <Has_brand_name> "Biovelbin" .
<Vinorelbine> <Has_brand_name> "Binorel" .
<Cisplatin,_Epirubicin,_Ifosfamide> <Mapped_from> "Cisplatin,_Epirubicin,_Ifosfamide" .
<VAIA> <Has_local_therapy> "External_beam_radiotherapy" .
<Anti-vWF_medication> <Subsumes> "Caplacizumab" .
<Emeset> <Brand_name_of> "Ondansetron" .
<Stan> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Semuloparin> <May_have_route> "Subcutaneous" .
<Gemcitabine_and_Trastuzumab> <Maps_to> "Gemcitabine_and_Trastuzumab" .
<Dexavet> <Brand_name_of> "Dexamethasone" .
<Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin> <Has_context> "Consolidation_after_upfront_therapy" .
<Megestrol_monotherapy> <Is_current_in> "Endometrial_cancer" .
<CPR> <Mapped_from> "CPR" .
<BEACOPP-14> <Mapped_from> "BEACOPP-14" .
<ECF/5-FU_and_RT> <Is_current_in> "Esophageal_cancer" .
<CHOP,_then_131Iodine-Tositumomab> <Has_modality> "Radioimmunotherapy" .
<CHOP,_then_131Iodine-Tositumomab> <Has_modality> "Chemotherapy" .
<Ixazomib_and_Dexamethasone> <Has_antineoplastic> "Ixazomib" .
<Ixazomib_and_Dexamethasone> <Has_antineoplastic> "Dexamethasone" .
<Forenmax> <Brand_name_of> "Alendronate" .
<Masitinib> <Is_a> "PTK2_inhibitor" .
<Masitinib> <Is_a> "PDGFR_inhibitor" .
<Masitinib> <Is_a> "Kinase_inhibitor" .
<Masitinib> <Is_a> "KIT_inhibitor" .
<Masitinib> <Is_a> "Investigational_drug" .
<Masitinib> <Is_a> "FGFR_inhibitor" .
<Bevacizumab_and_Rituximab> <Has_modality> "Chemotherapy" .
<Brentuximab_vedotin_and_Nivolumab> <Has_context> "Non-curative_therapy" .
<Mycophenolate_mofetil_monotherapy> <Mapped_from> "Mycophenolate_mofetil_monotherapy" .
<Temozolomide_and_Thalidomide> <Has_antineoplastic> "Thalidomide" .
<Temozolomide_and_Thalidomide> <Has_antineoplastic> "Temozolomide" .
<Palonosetron> <Supportive_med_of> "Carfilzomib_monotherapy" .
<CAP> <Maps_to> "CAP" .
<Nolatrexed> <May_have_route> "Intravenous" .
<Low-dose_Interleukin-2> <Has_modality> "Immunotherapy" .
<Reusan> <Brand_name_of> "Dexamethasone" .
<Fludarabine,_Melphalan,_Alemtuzumab> <Is_current_in> "Allogeneic_HSCT" .
<Xlotabin> <Brand_name_of> "Capecitabine" .
<Pracinostat> <Is_a> "Orphan_drug" .
<Pracinostat> <Is_a> "Kinase_inhibitor" .
<Pracinostat> <Is_a> "HDAC_inhibitor" .
<Nirypan> <Brand_name_of> "Methylprednisolone" .
<Radioimmunotherapeutic> <Is_a> "Radiotherapy_medication" .
<Radioimmunotherapeutic> <Is_a> "Immunotherapeutic" .
<Belotecan> <May_have_route> "Intravenous" .
<Odanse> <Brand_name_of> "Ondansetron" .
<Clodron> <Brand_name_of> "Clodronate" .
<Carboplatin_and_Doxorubicin_liposomal> <Has_accepted_use> "Ovarian_cancer" .
<Carboplatin_and_Doxorubicin_liposomal> <Has_accepted_use> "Endometrial_cancer" .
<Cytarabine> <Antineoplastic_of> "maxi-R-CHOP/R-HiDAC" .
<Cytarabine> <Antineoplastic_of> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Cytarabine> <Antineoplastic_of> "Z-BEAM,_then_auto_HSCT" .
<Cytarabine> <Antineoplastic_of> "Z-BEAM" .
<Cytarabine> <Antineoplastic_of> "Vosaroxin_and_Cytarabine" .
<Cytarabine> <Antineoplastic_of> "TAM6,_then_auto_HSCT" .
<Cytarabine> <Antineoplastic_of> "TAM6" .
<Cytarabine> <Antineoplastic_of> "SHAI" .
<Cytarabine> <Antineoplastic_of> "R-MACLO/R-IVAM" .
<Cytarabine> <Antineoplastic_of> "R-Hyper-CVAD/R-MA" .
<Cytarabine> <Antineoplastic_of> "R-HiDAC" .
<Cytarabine> <Antineoplastic_of> "R-ESHAP" .
<Cytarabine> <Antineoplastic_of> "R-DexaBEAM" .
<Cytarabine> <Antineoplastic_of> "R-DHAP/R-VIM" .
<Cytarabine> <Antineoplastic_of> "R-DHAP" .
<Cytarabine> <Antineoplastic_of> "R-DHAOx" .
<Cytarabine> <Antineoplastic_of> "R-DHAC" .
<Cytarabine> <Antineoplastic_of> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Cytarabine> <Antineoplastic_of> "R-CODOX-M/R-IVAC" .
<Cytarabine> <Antineoplastic_of> "R-CHOP/R-DHAP" .
<Cytarabine> <Antineoplastic_of> "R-BEAM,_then_auto_HSCT" .
<Cytarabine> <Antineoplastic_of> "R-BEAM" .
<Cytarabine> <Antineoplastic_of> "R-BAC" .
<Cytarabine> <Antineoplastic_of> "ProMACE-CytaBOM" .
<Cytarabine> <Antineoplastic_of> "Pediatric-like_GRAALL_consolidation" .
<Cytarabine> <Antineoplastic_of> "PATCO" .
<Cytarabine> <Antineoplastic_of> "OFAR" .
<Cytarabine> <Antineoplastic_of> "O-ESHAP" .
<Cytarabine> <Antineoplastic_of> "O-DHAP" .
<Cytarabine> <Antineoplastic_of> "Nordic_Regimen,_younger_patients" .
<Cytarabine> <Antineoplastic_of> "Nordic_Regimen,_older_patients" .
<Cytarabine> <Antineoplastic_of> "Nilotinib-based_consolidation" .
<Cytarabine> <Antineoplastic_of> "Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin" .
<Cytarabine> <Antineoplastic_of> "Mini-BEAM" .
<Cytarabine> <Antineoplastic_of> "Methotrexate,_then_Cytarabine_and_Thiotepa" .
<Cytarabine> <Antineoplastic_of> "Methotrexate,_then_Cytarabine" .
<Cytarabine> <Antineoplastic_of> "MEC" .
<Cytarabine> <Antineoplastic_of> "MATRix" .
<Cytarabine> <Antineoplastic_of> "LoDAC_and_Venetoclax" .
<Cytarabine> <Antineoplastic_of> "LoDAC" .
<Cytarabine> <Antineoplastic_of> "Linker_regimen_(consolidation)" .
<Cytarabine> <Antineoplastic_of> "International_ALL_Trial" .
<Cytarabine> <Antineoplastic_of> "Imatinib-based_consolidation" .
<Cytarabine> <Antineoplastic_of> "Imatinib_and_LoDAC" .
<Cytarabine> <Antineoplastic_of> "IDAC_and_Sorafenib" .
<Cytarabine> <Antineoplastic_of> "IDAC" .
<Cytarabine> <Antineoplastic_of> "ICL" .
<Cytarabine> <Antineoplastic_of> "IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone" .
<Cytarabine> <Antineoplastic_of> "IAP" .
<Cytarabine> <Antineoplastic_of> "HyperCHidam" .
<Cytarabine> <Antineoplastic_of> "Hyper-CVAD/MA_and_Everolimus" .
<Cytarabine> <Antineoplastic_of> "Hyper-CVAD/MA" .
<Cytarabine> <Antineoplastic_of> "Hyper-CVAD_and_Ponatinib" .
<Cytarabine> <Antineoplastic_of> "Hyper-CVAD_and_Imatinib" .
<Cytarabine> <Antineoplastic_of> "Hyper-CVAD_and_Dasatinib" .
<Cytarabine> <Antineoplastic_of> "HiDAC_and_Midostaurin" .
<Cytarabine> <Antineoplastic_of> "HiDAC" .
<Cytarabine> <Antineoplastic_of> "HDAC_and_G-CSF" .
<Cytarabine> <Antineoplastic_of> "HAM_and_Imatinib" .
<Cytarabine> <Antineoplastic_of> "HAM" .
<Cytarabine> <Antineoplastic_of> "HAD" .
<Cytarabine> <Antineoplastic_of> "HAA" .
<Cytarabine> <Antineoplastic_of> "Glasdegib_and_LoDAC" .
<Cytarabine> <Antineoplastic_of> "GMALL-R" .
<Cytarabine> <Antineoplastic_of> "FLAG-Ida" .
<Cytarabine> <Antineoplastic_of> "FLAG-DNX" .
<Cytarabine> <Antineoplastic_of> "FLAG" .
<Cytarabine> <Antineoplastic_of> "FEAM,_then_auto_HSCT" .
<Cytarabine> <Antineoplastic_of> "FEAM" .
<Cytarabine> <Antineoplastic_of> "F-SHAI" .
<Cytarabine> <Antineoplastic_of> "F-MACHOP" .
<Cytarabine> <Antineoplastic_of> "ESHAP" .
<Cytarabine> <Antineoplastic_of> "EDAP" .
<Cytarabine> <Antineoplastic_of> "EAR_and_G-CSF" .
<Cytarabine> <Antineoplastic_of> "DexaBEAM_and_G-CSF" .
<Cytarabine> <Antineoplastic_of> "DexaBEAM" .
<Cytarabine> <Antineoplastic_of> "DHAP_-_time_intensified" .
<Cytarabine> <Antineoplastic_of> "DHAP" .
<Cytarabine> <Antineoplastic_of> "DCTER" .
<Cytarabine> <Antineoplastic_of> "DAT" .
<Cytarabine> <Antineoplastic_of> "DAC" .
<Cytarabine> <Antineoplastic_of> "DA_3_plus_10,_GO" .
<Cytarabine> <Antineoplastic_of> "DA_3_plus_10" .
<Cytarabine> <Antineoplastic_of> "D-ZAPO" .
<Cytarabine> <Antineoplastic_of> "Cytarabine,_Methotrexate,_Rituximab" .
<Cytarabine> <Antineoplastic_of> "Cytarabine,_Ifosfamide,_G-CSF" .
<Cytarabine> <Antineoplastic_of> "Cytarabine,_Idarubicin,_Vorinostat" .
<Cytarabine> <Antineoplastic_of> "Cytarabine,_Idarubicin,_Sorafenib" .
<Cytarabine> <Antineoplastic_of> "Cytarabine,_Idarubicin,_Rituximab" .
<Cytarabine> <Antineoplastic_of> "Cytarabine,_Idarubicin,_Imatinib" .
<Cytarabine> <Antineoplastic_of> "Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone" .
<Cytarabine> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_Vincristine" .
<Cytarabine> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone" .
<Cytarabine> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone" .
<Cytarabine> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone" .
<Cytarabine> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin" .
<Cytarabine> <Antineoplastic_of> "Cytarabine_monotherapy" .
<Cytarabine> <Antineoplastic_of> "Cytarabine_and_Thioguanine" .
<Cytarabine> <Antineoplastic_of> "Cytarabine_and_Mitoxantrone" .
<Cytarabine> <Antineoplastic_of> "Cytarabine_and_Interferon_alfa-2b" .
<Cytarabine> <Antineoplastic_of> "Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA" .
<Cytarabine> <Antineoplastic_of> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA" .
<Cytarabine> <Antineoplastic_of> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine" .
<Cytarabine> <Antineoplastic_of> "Cytarabine_and_Idarubicin" .
<Cytarabine> <Antineoplastic_of> "Cytarabine_and_G-CSF" .
<Cytarabine> <Antineoplastic_of> "Cytarabine_and_Daunorubicin" .
<Cytarabine> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone" .
<Cytarabine> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine" .
<Cytarabine> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine" .
<Cytarabine> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine" .
<Cytarabine> <Antineoplastic_of> "Clofarabine_and_LoDAC/Decitabine" .
<Cytarabine> <Antineoplastic_of> "Clofarabine_and_LoDAC" .
<Cytarabine> <Antineoplastic_of> "Clofarabine_and_Cytarabine" .
<Cytarabine> <Antineoplastic_of> "Cladribine_and_Cytarabine" .
<Cytarabine> <Antineoplastic_of> "CYVE_and_G-CSF" .
<Cytarabine> <Antineoplastic_of> "CYVE" .
<Cytarabine> <Antineoplastic_of> "CYM" .
<Cytarabine> <Antineoplastic_of> "COPAD/CYVE" .
<Cytarabine> <Antineoplastic_of> "CODOX-M/IVAC" .
<Cytarabine> <Antineoplastic_of> "CLARA" .
<Cytarabine> <Antineoplastic_of> "CLAG-M" .
<Cytarabine> <Antineoplastic_of> "CLAG" .
<Cytarabine> <Antineoplastic_of> "CIA" .
<Cytarabine> <Antineoplastic_of> "CALGB_8811_late_intensification" .
<Cytarabine> <Antineoplastic_of> "CALGB_8811_early_intensification" .
<Cytarabine> <Antineoplastic_of> "CALGB_10-002_regimen" .
<Cytarabine> <Antineoplastic_of> "BeEAM,_then_auto_HSCT" .
<Cytarabine> <Antineoplastic_of> "BeEAM" .
<Cytarabine> <Antineoplastic_of> "BEAM,_then_auto_HSCT" .
<Cytarabine> <Antineoplastic_of> "BEAM,_then_allo_HSCT" .
<Cytarabine> <Antineoplastic_of> "BEAM" .
<Cytarabine> <Antineoplastic_of> "BEAC,_then_auto_HSCT" .
<Cytarabine> <Antineoplastic_of> "BEAC" .
<Cytarabine> <Antineoplastic_of> "Augmented_BFM_consolidation" .
<Cytarabine> <Antineoplastic_of> "Amsacrine_and_Cytarabine" .
<Cytarabine> <Antineoplastic_of> "ATRA,_Cytarabine,_Idarubicin" .
<Cytarabine> <Antineoplastic_of> "ATRA,_Cytarabine,_Daunorubicin" .
<Cytarabine> <Antineoplastic_of> "AIE" .
<Cytarabine> <Antineoplastic_of> "ADE_and_ATRA" .
<Cytarabine> <Antineoplastic_of> "ADE_(standard-dose_Ara-C)" .
<Cytarabine> <Antineoplastic_of> "ADE_(high-dose_Ara-C)" .
<Cytarabine> <Antineoplastic_of> "ACVBP" .
<Cytarabine> <Antineoplastic_of> "ACOMLA" .
<Cytarabine> <Antineoplastic_of> "AALL0232_consolidation" .
<Cytarabine> <Antineoplastic_of> "7_plus_5i" .
<Cytarabine> <Antineoplastic_of> "7_plus_3m" .
<Cytarabine> <Antineoplastic_of> "7_plus_3i_and_Vorinostat" .
<Cytarabine> <Antineoplastic_of> "7_plus_3i_and_Sorafenib" .
<Cytarabine> <Antineoplastic_of> "7_plus_3i_and_Panobinostat" .
<Cytarabine> <Antineoplastic_of> "7_plus_3i" .
<Cytarabine> <Antineoplastic_of> "7_plus_3d_and_Sorafenib" .
<Cytarabine> <Antineoplastic_of> "7_plus_3d_and_Midostaurin" .
<Cytarabine> <Antineoplastic_of> "7_plus_3d_and_Glasdegib" .
<Cytarabine> <Antineoplastic_of> "7_plus_3d_and_GO" .
<Cytarabine> <Antineoplastic_of> "7_plus_3d" .
<Cytarabine> <Antineoplastic_of> "5_plus_3i" .
<Cytarabine> <Antineoplastic_of> "5_plus_3d" .
<Cytarabine> <Antineoplastic_of> "5_plus_2d" .
<Everolimus_and_Rituximab> <Has_context> "Non-curative_subsequent-line_therapy" .
<Norethandrolone> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Sulfotrimin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<ALK_inhibitor> <Is_a> "Kinase_inhibitor" .
<Flutamide_and_Leuprolide> <Maps_to> "Flutamide_and_Leuprolide" .
<ATRA,_Cytarabine,_Daunorubicin> <Has_antineoplastic> "Daunorubicin" .
<ATRA,_Cytarabine,_Daunorubicin> <Has_antineoplastic> "Cytarabine" .
<ATRA,_Cytarabine,_Daunorubicin> <Has_antineoplastic> "All-trans_retinoic_acid" .
<Etoposide> <Has_FDA_indication> "Testicular_cancer" .
<Etoposide> <Has_FDA_indication> "Small_cell_lung_cancer" .
<Taceedo> <Brand_name_of> "Docetaxel" .
<Regorafenib> <Is_a> "VEGFR_inhibitor" .
<Regorafenib> <Is_a> "TEK_inhibitor" .
<Regorafenib> <Is_a> "RET_inhibitor" .
<Regorafenib> <Is_a> "PDGFR_inhibitor" .
<Regorafenib> <Is_a> "Kinase_inhibitor" .
<Regorafenib> <Is_a> "KIT_inhibitor" .
<Regorafenib> <Is_a> "FGFR_inhibitor" .
<Regorafenib> <Is_a> "BRAF_inhibitor" .
<Cisplatin_and_Dacarbazine> <Has_antineoplastic> "Dacarbazine" .
<Cisplatin_and_Dacarbazine> <Has_antineoplastic> "Cisplatin" .
<Cladribine_and_Cytarabine> <Has_modality> "Chemotherapy" .
<ACVBP-R> <Has_supportive_med> "Filgrastim" .
<Cerubidin> <Brand_name_of> "Daunorubicin" .
<CDE> <Has_context> "Non-curative_therapy" .
<CDE> <Has_context> "Induction_therapy" .
<CAP-BOP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Doxorubicin_and_Bevacizumab> <Mapped_from> "Doxorubicin_and_Bevacizumab" .
<Isotrexin> <Brand_name_of> "Isotretinoin" .
<Arsenox> <Brand_name_of> "Arsenic_trioxide" .
<R-MegaCHOP> <Is_a> "Rituximab-containing_regimen" .
<R-MegaCHOP> <Is_a> "Anthracycline-containing_regimen" .
<Thyroid_cancer> <Accepted_use_of> "Vemurafenib_monotherapy" .
<Thyroid_cancer> <Accepted_use_of> "Vemurafenib" .
<Thyroid_cancer> <Accepted_use_of> "Vandetanib_monotherapy" .
<Thyroid_cancer> <Accepted_use_of> "Vandetanib" .
<Thyroid_cancer> <Accepted_use_of> "Trametinib" .
<Thyroid_cancer> <Accepted_use_of> "Sunitinib_monotherapy" .
<Thyroid_cancer> <Accepted_use_of> "Sunitinib" .
<Thyroid_cancer> <Accepted_use_of> "Sorafenib_monotherapy" .
<Thyroid_cancer> <Accepted_use_of> "Sorafenib" .
<Thyroid_cancer> <Accepted_use_of> "Selumetinib" .
<Thyroid_cancer> <Accepted_use_of> "Radioiodine_ablation" .
<Thyroid_cancer> <Accepted_use_of> "Placebo" .
<Thyroid_cancer> <Accepted_use_of> "Pazopanib_monotherapy" .
<Thyroid_cancer> <Accepted_use_of> "Pazopanib" .
<Thyroid_cancer> <Accepted_use_of> "Motesanib" .
<Thyroid_cancer> <Accepted_use_of> "Lenvatinib_monotherapy" .
<Thyroid_cancer> <Accepted_use_of> "Lenvatinib" .
<Thyroid_cancer> <Accepted_use_of> "Iodine-131" .
<Thyroid_cancer> <Accepted_use_of> "Doxorubicin_monotherapy" .
<Thyroid_cancer> <Accepted_use_of> "Dabrafenib_and_Trametinib" .
<Thyroid_cancer> <Accepted_use_of> "Dabrafenib" .
<Thyroid_cancer> <Accepted_use_of> "Cabozantinib_monotherapy" .
<Thyroid_cancer> <Accepted_use_of> "Cabozantinib" .
<Thyroid_cancer> <Accepted_use_of> "Axitinib_monotherapy" .
<Thyroid_cancer> <Accepted_use_of> "Axitinib" .
<Otobrol> <Brand_name_of> "Ondansetron" .
<Montelukast> <Has_brand_name> "Singulair" .
<Montelukast> <Has_brand_name> "Plenair" .
<Montelukast> <Has_brand_name> "Montair" .
<Montelukast> <Has_brand_name> "Monkast" .
<Montelukast> <Has_brand_name> "Alecast" .
<Texorate> <Brand_name_of> "Methotrexate" .
<Zortress> <Brand_name_of> "Everolimus" .
<Arsenic_trioxide_and_ATRA> <Has_modality> "Chemotherapy" .
<Aminopterin_monotherapy> <Has_antineoplastic> "Aminopterin" .
<PMitCEBO> <Maps_to> "PMitCEBO" .
<Nerlynx> <Brand_name_of> "Neratinib" .
<Mesa> <Brand_name_of> "Mesna" .
<Cycloxan> <Brand_name_of> "Cyclophosphamide" .
<Talzenna> <Brand_name_of> "Talazoparib" .
<MBVP> <Has_accepted_use> "CNS_lymphoma" .
<Epirubicin> <May_have_route> "Intravenous" .
<Abemaciclib_and_Anastrozole> <Has_context> "Non-curative_first-line_therapy" .
<Dara-VTD> <Has_antineoplastic> "Thalidomide" .
<Dara-VTD> <Has_antineoplastic> "Dexamethasone" .
<Dara-VTD> <Has_antineoplastic> "Daratumumab" .
<Dara-VTD> <Has_antineoplastic> "Bortezomib" .
<Whole_abdominal_radiation_(WAI)> <Has_context> "Adjuvant_therapy" .
<Degarelix_monotherapy> <Mapped_from> "Degarelix_monotherapy" .
<PCDE> <Maps_to> "PCDE" .
<CIA> <Has_antineoplastic> "Idarubicin" .
<CIA> <Has_antineoplastic> "Cytarabine" .
<CIA> <Has_antineoplastic> "Clofarabine" .
<C-MOPP> <Is_current_in> "Hodgkin_lymphoma" .
<Anastrozole> <Has_brand_name> "Trozolite" .
<Anastrozole> <Has_brand_name> "Trozolet" .
<Anastrozole> <Has_brand_name> "RUI_Ting" .
<Anastrozole> <Has_brand_name> "RUI_SI_YI" .
<Anastrozole> <Has_brand_name> "Leprofen" .
<Anastrozole> <Has_brand_name> "Karomex" .
<Anastrozole> <Has_brand_name> "Asiolex" .
<Anastrozole> <Has_brand_name> "Arimidex" .
<Anastrozole> <Has_brand_name> "Anastrol" .
<Anastrozole> <Has_brand_name> "Anastrazol_Rontag" .
<Anastrozole> <Has_brand_name> "Anastraze" .
<Anastrozole> <Has_brand_name> "Anabrez" .
<Anastrozole> <Has_brand_name> "Altraz" .
<CVD_(Vinblastine)> <Has_modality> "Chemotherapy" .
<Zanosar> <Brand_name_of> "Streptozocin" .
<Temsirolimus> <Has_brand_name> "Torisel" .
<Molacort> <Brand_name_of> "Dexamethasone" .
<RICER> <Maps_to> "RICER" .
<Luporal> <Brand_name_of> "Tegafur_and_uracil" .
<Erdafitinib_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<FEAM,_then_auto_HSCT> <Maps_to> "FEAM,_then_auto_HSCT" .
<Carmustine_and_Doxorubicin> <Has_context> "Non-curative_therapy" .
<Prednisolone_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Prednisolone_monotherapy> <Has_context> "Induction_therapy" .
<Prednisolone_monotherapy> <Has_context> "All_lines_of_therapy" .
<Idelalisib_monotherapy> <Mapped_from> "Idelalisib_monotherapy" .
<Emapalumab> <Has_accepted_use> "Hemophagocytic_lymphohistiocytosis" .
<Amrubicin> <Is_a> "Topoisomerase_inhibitor" .
<Amrubicin> <Is_a> "PMDA_approved_drug" .
<Amrubicin> <Is_a> "Anthracycline" .
<Meningioma> <Is_a> "CNS_cancer" .
<CM> <Maps_to> "CM" .
<CHOP-B> <Has_accepted_use> "Follicular_lymphoma" .
<CHOP-B> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Talazoparib_monotherapy> <Maps_to> "Talazoparib_monotherapy" .
<TD> <Has_accepted_use> "Multiple_myeloma" .
<Carebin> <Brand_name_of> "Fluorouracil" .
<COPAD> <Has_antineoplastic> "Vincristine" .
<COPAD> <Has_antineoplastic> "Prednisone" .
<COPAD> <Has_antineoplastic> "Doxorubicin" .
<COPAD> <Has_antineoplastic> "Cyclophosphamide" .
<Adriblastin> <Brand_name_of> "Doxorubicin" .
<Treosulfan_monotherapy> <Has_antineoplastic> "Treosulfan" .
<Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone> <Has_modality> "Chemotherapy" .
<Lenmid> <Brand_name_of> "Lenalidomide" .
<Quinine> <Has_accepted_use> "Multiple_myeloma" .
<Melphalan> <Has_brand_name> "Melfalan" .
<Melphalan> <Has_brand_name> "Levofolan" .
<Melphalan> <Has_brand_name> "Alkerana" .
<Melphalan> <Has_brand_name> "Alkeran" .
<Rabeprazole> <Is_a> "Proton_pump_inhibitor" .
<Protein_expression-specific_medication> <Is_a> "Biomarker-specific_medication" .
<Veltuzumab> <Is_a> "Investigational_drug" .
<Veltuzumab> <Is_a> "Antibody_medication" .
<Veltuzumab> <Is_a> "Anti-CD20_medication" .
<Veltuzumab> <Is_a> "Anti-CD20_antibody" .
<Thalidomide_and_Prednisone> <Has_supportive_med> "Bisphosphonates" .
<Capecitabine_and_Paclitaxel,_nanoparticle_albumin-bound> <Has_antineoplastic> "Paclitaxel_nanoparticle_albumin-bound" .
<Capecitabine_and_Paclitaxel,_nanoparticle_albumin-bound> <Has_antineoplastic> "Capecitabine" .
<Hexa-CAF> <Is_historical_in> "Ovarian_cancer" .
<Interferon_alfa-2b_and_Thalidomide> <Has_antineoplastic> "Thalidomide" .
<Interferon_alfa-2b_and_Thalidomide> <Has_antineoplastic> "Interferon_alfa-2b" .
<Antiphospholipid_antibody_syndrome> <Current_treated_by> "Warfarin_monotherapy" .
<Antiphospholipid_antibody_syndrome> <Current_treated_by> "Rivaroxaban_monotherapy" .
<Antiphospholipid_antibody_syndrome> <Current_treated_by> "Rituximab_monotherapy" .
<Antiphospholipid_antibody_syndrome> <Current_treated_by> "Aspirin_and_Warfarin" .
<Asiolex> <Brand_name_of> "Anastrozole" .
<Paclitaxel_and_Vinorelbine> <Mapped_from> "Paclitaxel_and_Vinorelbine" .
<BVCPP> <Has_modality> "Chemotherapy" .
<Denileukin_diftitox_monotherapy> <Has_supportive_med> "Promethazine" .
<Denileukin_diftitox_monotherapy> <Has_supportive_med> "Prochlorperazine" .
<Denileukin_diftitox_monotherapy> <Has_supportive_med> "Acetaminophen" .
<CRd> <Has_context> "Non-curative_therapy" .
<CRd> <Has_context> "Non-curative_first-line_therapy" .
<M-BCD> <Mapped_from> "M-BCD" .
<ATRA,_Cytarabine,_Idarubicin> <Is_a> "Anthracycline-containing_regimen" .
<Dexagenta> <Brand_name_of> "Dexamethasone" .
<Epinephrine_autoinjector> <Is_a> "Adrenergic_receptor_agonist" .
<ME_Korti> <Brand_name_of> "Prednisone" .
<Diethylstilbestrol> <Has_brand_name> "Stilbest" .
<Diethylstilbestrol> <Has_brand_name> "Stibrol" .
<Diethylstilbestrol> <Has_brand_name> "Dibestrol" .
<Diethylstilbestrol> <Has_brand_name> "Desplex" .
<VD> <Is_current_in> "Multiple_myeloma" .
<VD> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<CODOX-M/IVAC> <Has_antineoplastic> "Vincristine" .
<CODOX-M/IVAC> <Has_antineoplastic> "Methotrexate" .
<CODOX-M/IVAC> <Has_antineoplastic> "Ifosfamide" .
<CODOX-M/IVAC> <Has_antineoplastic> "Etoposide" .
<CODOX-M/IVAC> <Has_antineoplastic> "Doxorubicin" .
<CODOX-M/IVAC> <Has_antineoplastic> "Cytarabine" .
<CODOX-M/IVAC> <Has_antineoplastic> "Cyclophosphamide" .
<Estradiol_monotherapy> <Has_context> "Non-curative_therapy" .
<Axicabtagene_ciloleucel_monotherapy> <Is_current_in> "Transformed_lymphoma" .
<Axicabtagene_ciloleucel_monotherapy> <Is_current_in> "Primary_mediastinal_B-cell_lymphoma" .
<Axicabtagene_ciloleucel_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Dara-VD> <Is_current_in> "Multiple_myeloma" .
<Cyclophosphamide_and_TBI> <Has_context> "Consolidation_after_upfront_therapy" .
<Cyclophosphamide_and_TBI> <Has_context> "All_lines_of_therapy" .
<Varimesna> <Brand_name_of> "Mesna" .
<Pixuvri> <Brand_name_of> "Pixantrone" .
<Antipsychotic> <Is_a> "Emesis_prevention" .
<DOLP> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<DOLP> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Melphalan,_then_auto_HSCT> <Has_antineoplastic> "Melphalan" .
<Cisplatin,_Lomustine,_Vincristine> <Is_current_in> "Medulloblastoma" .
<TD> <Is_current_in> "Multiple_myeloma" .
<Xeloda> <Brand_name_of> "Capecitabine" .
<R-CMD> <Has_antineoplastic> "Rituximab" .
<R-CMD> <Has_antineoplastic> "Mitoxantrone" .
<R-CMD> <Has_antineoplastic> "Dexamethasone" .
<R-CMD> <Has_antineoplastic> "Cladribine" .
<Anti-RANKL_antibody> <Subsumes> "Denosumab" .
<Anakinra_monotherapy> <Is_current_in> "Castleman_disease" .
<Xgeva> <Brand_name_of> "Denosumab" .
<Irgagen> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Aksotran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Chemotran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Suprax> <Brand_name_of> "Cefixime" .
<DA-EPOCH> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Altretamine_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Rabbit_ATG> <Has_modality> "Immunosuppressive_therapy" .
<Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Maps_to> "Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Clastoban> <Brand_name_of> "Clodronate" .
<Ceritinib> <May_have_route> "Oral" .
<Azacitidine_and_Venetoclax> <Has_accepted_use> "Acute_myeloid_leukemia" .
<nab-Paclitaxel_and_Trastuzumab> <Mapped_from> "nab-Paclitaxel_and_Trastuzumab" .
<Bivalirudin_monotherapy> <Has_context> "All_lines_of_therapy" .
<Vinorelbine_monotherapy> <Has_antineoplastic> "Vinorelbine" .
<Cisplatin> <Supportive_med_of> "nab-Paclitaxel_monotherapy" .
<Cisplatin> <Supportive_med_of> "Methotrexate_monotherapy" .
<Onpro> <Brand_name_of> "Pegfilgrastim" .
<Everolimus_monotherapy> <Mapped_from> "Everolimus_monotherapy" .
<Dutasteride> <Antineoplastic_of> "Ketoconazole,_Hydrocortisone,_Dutasteride" .
<Trimzol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Folic_acid> <Supportive_med_of> "Vinorelbine_monotherapy" .
<Folic_acid> <Supportive_med_of> "Pralatrexate_monotherapy" .
<Folic_acid> <Supportive_med_of> "Pemetrexed_monotherapy" .
<Folic_acid> <Supportive_med_of> "Pemetrexed_and_Pembrolizumab" .
<Folic_acid> <Supportive_med_of> "Pemetrexed_and_Bevacizumab" .
<Folic_acid> <Supportive_med_of> "Gemcitabine_monotherapy" .
<Folic_acid> <Supportive_med_of> "Cisplatin,_Pemetrexed,_Pembrolizumab" .
<Folic_acid> <Supportive_med_of> "Cisplatin,_Pemetrexed,_Bevacizumab" .
<Folic_acid> <Supportive_med_of> "Cisplatin_and_Pemetrexed" .
<Folic_acid> <Supportive_med_of> "Carboplatin,_Pemetrexed,_Pembrolizumab" .
<Folic_acid> <Supportive_med_of> "Carboplatin,_Pemetrexed,_Bevacizumab" .
<Folic_acid> <Supportive_med_of> "Carboplatin_and_Pemetrexed" .
<Folic_acid> <Supportive_med_of> "131I-Metaiodobenzylguanidine_(131I-MIBG)" .
<Istodax> <Brand_name_of> "Romidepsin" .
<Alvocidib> <Is_a> "Orphan_drug" .
<Alvocidib> <Is_a> "Kinase_inhibitor" .
<Alvocidib> <Is_a> "Investigational_drug" .
<Alvocidib> <Is_a> "CDK_inhibitor" .
<L-Ginase> <Brand_name_of> "Asparaginase" .
<Luspatercept_monotherapy> <Maps_to> "Luspatercept_monotherapy" .
<Calaspargase> <Antineoplastic_of> "Calaspargase,_Daunorubicin,_Vincristine,_Prednisone" .
<Vinflunine_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Warfarin> <Supportive_med_of> "Warfarin_monotherapy" .
<Warfarin> <Supportive_med_of> "VTD" .
<Warfarin> <Supportive_med_of> "VDC" .
<Warfarin> <Supportive_med_of> "TD" .
<Warfarin> <Supportive_med_of> "Rd" .
<Warfarin> <Supportive_med_of> "RVDC" .
<Warfarin> <Supportive_med_of> "RP" .
<Warfarin> <Supportive_med_of> "R2CHOP" .
<Warfarin> <Supportive_med_of> "Pomalidomide_monotherapy" .
<Warfarin> <Supportive_med_of> "PVD" .
<Warfarin> <Supportive_med_of> "PD" .
<Warfarin> <Supportive_med_of> "OLF" .
<Warfarin> <Supportive_med_of> "MPR" .
<Warfarin> <Supportive_med_of> "MCF" .
<Warfarin> <Supportive_med_of> "Lenalidomide_monotherapy" .
<Warfarin> <Supportive_med_of> "KRd" .
<Warfarin> <Supportive_med_of> "EOF" .
<Warfarin> <Supportive_med_of> "ECF" .
<Warfarin> <Supportive_med_of> "Cyclophosphamide,_Prednisone,_Diethylstilbestrol" .
<Warfarin> <Supportive_med_of> "CTD" .
<Warfarin> <Supportive_med_of> "CRd" .
<Warfarin> <Supportive_med_of> "CPR" .
<Warfarin> <Supportive_med_of> "Bortezomib_monotherapy" .
<Warfarin> <Supportive_med_of> "Aspirin_and_Warfarin" .
<Hydrine> <Brand_name_of> "Hydroxyurea" .
<Brentuximab_vedotin_and_Nivolumab> <Has_modality> "Chemotherapy" .
<Chemoradiotherapy> <Modality_of> "FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation" .
<Micogyl> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bleomycin_and_Vinblastine> <Has_modality> "Chemotherapy" .
<WHIM_syndrome> <Accepted_use_of> "Plerixafor_monotherapy" .
<WHIM_syndrome> <Accepted_use_of> "Plerixafor" .
<DCF> <Mapped_from> "DCF" .
<Indomethacin> <Supportive_med_of> "High-dose_Interleukin-2" .
<Carboplatin,_nab-Paclitaxel,_Atezolizumab> <Mapped_from> "Carboplatin,_nab-Paclitaxel,_Atezolizumab" .
<mCOP/MP> <Has_context> "Non-curative_first-line_therapy" .
<MAPI> <Has_modality> "Chemotherapy" .
<CIM> <Has_supportive_med> "Mesna" .
<Lifactrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Treosulfan_monotherapy> <Has_modality> "Chemotherapy" .
<CaRD> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<BEACOPP-14> <Has_modality> "Chemotherapy" .
<Lomustine,_Methotrexate,_Procarbazine> <Has_modality> "Chemotherapy" .
<Florac> <Brand_name_of> "Fluorouracil" .
<RABVD> <Maps_to> "RABVD" .
<CALGB_8811_late_intensification> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Vinblastine_and_Prednisone> <Maps_to> "Vinblastine_and_Prednisone" .
<Cis-GRY> <Brand_name_of> "Cisplatin" .
<Decadronfosfat> <Brand_name_of> "Dexamethasone" .
<Hepatic_arterial_chemotherapy> <Mapped_from> "Hepatic_arterial_chemotherapy" .
<COP> <Has_local_therapy> "Methotrexate" .
<COP> <Has_local_therapy> "Hydrocortisone" .
<COP> <Has_local_therapy> "Cytarabine" .
<Acute_lymphoblastic_leukemia> <Subsumes> "T-cell_acute_lymphoblastic_leukemia" .
<Acute_lymphoblastic_leukemia> <Subsumes> "B-cell_acute_lymphoblastic_leukemia" .
<Emesis_prevention> <Is_a> "Supportive_medication" .
<AspaMetDex> <Mapped_from> "AspaMetDex" .
<Durofolin> <Brand_name_of> "Folinic_acid" .
<Gemcitabine_and_Mitomycin> <Is_current_in> "Gallbladder_cancer" .
<Gemcitabine_and_Mitomycin> <Is_current_in> "Cholangiocarcinoma" .
<Ciplexal> <Brand_name_of> "Cisplatin" .
<Humate-P> <Brand_name_of> "Von_Willebrand_factor_and_factor_VIII_complex_human" .
<Cutason> <Brand_name_of> "Prednisone" .
<Teniposide> <May_have_route> "Intravenous" .
<Biofur> <Brand_name_of> "Fluorouracil" .
<Omacetaxine_monotherapy> <Has_supportive_med> "Epoetin_alfa" .
<Omacetaxine_monotherapy> <Has_supportive_med> "Darbepoetin_alfa" .
<Mercaptopurine_and_WBRT> <Has_accepted_use> "CNS_leukemia" .
<PCF> <Is_current_in> "SCC_of_unknown_primary" .
<PCF> <Is_current_in> "Penile_cancer" .
<PCF> <Is_current_in> "Head_and_neck_cancer" .
<PCF> <Is_current_in> "Esophageal_cancer" .
<Anti-GPIIb-IIIa_antibody> <Subsumes> "Abciximab" .
<Aminoglutethimide_monotherapy> <Has_supportive_med> "Hydrocortisone" .
<Bosutinib> <Has_FDA_indication> "Chronic_myelogenous_leukemia" .
<Docetaxel_and_Gemcitabine> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Docetaxel_and_Gemcitabine> <Has_accepted_use> "Osteosarcoma" .
<Docetaxel_and_Gemcitabine> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Docetaxel_and_Gemcitabine> <Has_accepted_use> "Leiomyosarcoma" .
<Docetaxel_and_Gemcitabine> <Has_accepted_use> "Ewing_sarcoma" .
<Docetaxel_and_Gemcitabine> <Has_accepted_use> "Breast_cancer" .
<Docetaxel_and_Gemcitabine> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<B-CAVe> <Is_a> "Anthracycline-containing_regimen" .
<R-NIMP> <Mapped_from> "R-NIMP" .
<R-CHMP> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Tritenk> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Megatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Non-curative_therapy> <Maps_to> "Non-curative_therapy" .
<Cisplatin_and_Vindesine> <Maps_to> "Cisplatin_and_Vindesine" .
<CVD_(Vinblastine)> <Maps_to> "CVD_(Vinblastine)" .
<COPP/ABVD> <Has_accepted_use> "Hodgkin_lymphoma" .
<Elspar> <Brand_name_of> "Asparaginase" .
<CISCA> <Is_a> "Anthracycline-containing_regimen" .
<Peginterferon_alfa-2b_monotherapy> <Has_modality> "Immunotherapy" .
<Olaratumab> <Antineoplastic_of> "Doxorubicin_and_Olaratumab" .
<Temozolomide_and_Bevacizumab> <Has_antineoplastic> "Temozolomide" .
<Temozolomide_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Paclitaxel> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Paclitaxel> <Is_a> "Vesicant" .
<Paclitaxel> <Is_a> "Taxane" .
<Paclitaxel> <Is_a> "PMDA_approved_drug" .
<Paclitaxel> <Is_a> "Microtubule_inhibitor" .
<Paclitaxel> <Is_a> "Irritant" .
<Temozolomide_monotherapy> <Has_context> "Salvage_therapy" .
<Temozolomide_monotherapy> <Has_context> "Non-curative_therapy" .
<Temozolomide_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Temozolomide_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Temozolomide_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Temozolomide_monotherapy> <Has_context> "Non-curative_first-line_induction_therapy" .
<Temozolomide_monotherapy> <Has_context> "Consolidation_after_upfront_therapy" .
<Temozolomide_monotherapy> <Has_context> "All_lines_of_therapy" .
<Temozolomide_monotherapy> <Has_context> "Adjuvant_therapy" .
<Colchicine_monotherapy> <Has_modality> "Chemotherapy" .
<Antibacterial> <Is_a> "Antibiotic" .
<CEEP> <Has_context> "Induction_therapy" .
<Bisuo_DS> <Brand_name_of> "Dexamethasone" .
<Carboplatin_and_Cyclophosphamide> <Has_accepted_use> "Ovarian_cancer" .
<Eribulin_monotherapy> <Has_accepted_use> "Liposarcoma" .
<Eribulin_monotherapy> <Has_accepted_use> "Leiomyosarcoma" .
<Eribulin_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Eribulin_monotherapy> <Has_accepted_use> "BRCA-mutated_Breast_cancer" .
<Thalidomide> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Thalidomide> <Is_a> "REMS_program" .
<Thalidomide> <Is_a> "Light-chain_(AL)_amyloidosis_medication" .
<Thalidomide> <Is_a> "Immunotherapeutic" .
<Thalidomide> <Is_a> "Immunomodulatory_drugs_(IMiDs)" .
<Thalidomide> <Is_a> "Emesis_prevention" .
<Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone> <Is_a> "Anthracycline-containing_regimen" .
<Mismatch_repair_deficient_malignancy> <Is_a> "Malignant_solid_neoplasm" .
<Cisplatin,_Gemcitabine,_nab-Paclitaxel> <Is_current_in> "Gallbladder_cancer" .
<Cisplatin,_Gemcitabine,_nab-Paclitaxel> <Is_current_in> "Cholangiocarcinoma" .
<Cyclosporine,_Sirolimus,_Prednisone> <Has_accepted_use> "Graft_versus_host_disease" .
<O.N.D.> <Brand_name_of> "Ondansetron" .
<Lutetium_Lu_177_dotatate> <Has_accepted_use> "Neuroendocrine_tumor" .
<Clofarabine> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Clofarabine> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Clofarabine> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Clofarabine> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Mercaptopurine_monotherapy> <Has_modality> "Chemotherapy" .
<TAM6,_then_auto_HSCT> <Has_supportive_med> "Filgrastim" .
<Factor_Xa_recombinant_inactivated-zhzo> <May_have_route> "Intravenous" .
<Neuroprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Temozolomide_and_RT> <Has_context> "Adjuvant_therapy" .
<Trastuzumab_and_hyaluronidase> <Antineoplastic_of> "Trastuzumab_and_hyaluronidase_monotherapy" .
<Trastuzumab_and_hyaluronidase> <Antineoplastic_of> "TH_(Taxotere/SC)" .
<Trastuzumab_and_hyaluronidase> <Antineoplastic_of> "FEC_and_H_(SC)" .
<Peginterferon_alfa-2a> <Is_a> "Pegylated_medication" .
<Peginterferon_alfa-2a> <Is_a> "Interferon" .
<Peginterferon_alfa-2a> <Is_a> "Immunotherapeutic" .
<Novacarel> <Brand_name_of> "Mesna" .
<MOR208> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<MOR208> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Cisplatin,_Etoposide,_Durvalumab> <Has_antineoplastic> "Etoposide" .
<Cisplatin,_Etoposide,_Durvalumab> <Has_antineoplastic> "Durvalumab" .
<Cisplatin,_Etoposide,_Durvalumab> <Has_antineoplastic> "Cisplatin" .
<Bladder_cancer> <Current_treated_by> "nab-Paclitaxel_monotherapy" .
<Bladder_cancer> <Current_treated_by> "Vinflunine_monotherapy" .
<Bladder_cancer> <Current_treated_by> "Valrubicin_monotherapy" .
<Bladder_cancer> <Current_treated_by> "Thiotepa_monotherapy" .
<Bladder_cancer> <Current_treated_by> "Radiation_therapy" .
<Bladder_cancer> <Current_treated_by> "Placebo" .
<Bladder_cancer> <Current_treated_by> "Pirarubicin_monotherapy" .
<Bladder_cancer> <Current_treated_by> "Pemetrexed_monotherapy" .
<Bladder_cancer> <Current_treated_by> "Pembrolizumab_monotherapy" .
<Bladder_cancer> <Current_treated_by> "Paclitaxel_monotherapy" .
<Bladder_cancer> <Current_treated_by> "Paclitaxel_and_RT" .
<Bladder_cancer> <Current_treated_by> "PGC" .
<Bladder_cancer> <Current_treated_by> "Observation" .
<Bladder_cancer> <Current_treated_by> "No_neoadjuvant_therapy" .
<Bladder_cancer> <Current_treated_by> "Nivolumab_monotherapy" .
<Bladder_cancer> <Current_treated_by> "Mitomycin_monotherapy" .
<Bladder_cancer> <Current_treated_by> "MVAC,_dose-dense" .
<Bladder_cancer> <Current_treated_by> "MVAC" .
<Bladder_cancer> <Current_treated_by> "MCV" .
<Bladder_cancer> <Current_treated_by> "Gemcitabine_monotherapy" .
<Bladder_cancer> <Current_treated_by> "Gemcitabine_and_RT" .
<Bladder_cancer> <Current_treated_by> "Gemcitabine_and_Paclitaxel" .
<Bladder_cancer> <Current_treated_by> "Fluorouracil,_Mitomycin,_RT" .
<Bladder_cancer> <Current_treated_by> "Erdafitinib_monotherapy" .
<Bladder_cancer> <Current_treated_by> "Enfortumab_vedotin_monotherapy" .
<Bladder_cancer> <Current_treated_by> "Durvalumab_monotherapy" .
<Bladder_cancer> <Current_treated_by> "Doxorubicin_monotherapy" .
<Bladder_cancer> <Current_treated_by> "Docetaxel_monotherapy" .
<Bladder_cancer> <Current_treated_by> "Docetaxel_and_Ramucirumab" .
<Bladder_cancer> <Current_treated_by> "Cisplatin,_Paclitaxel,_RT" .
<Bladder_cancer> <Current_treated_by> "Cisplatin,_Fluorouracil,_RT" .
<Bladder_cancer> <Current_treated_by> "Cisplatin_monotherapy" .
<Bladder_cancer> <Current_treated_by> "Cisplatin_and_RT" .
<Bladder_cancer> <Current_treated_by> "Cisplatin_and_Methotrexate" .
<Bladder_cancer> <Current_treated_by> "Cisplatin_and_Gemcitabine" .
<Bladder_cancer> <Current_treated_by> "Carboplatin_and_Paclitaxel" .
<Bladder_cancer> <Current_treated_by> "Carboplatin_and_Gemcitabine" .
<Bladder_cancer> <Current_treated_by> "CISCA" .
<Bladder_cancer> <Current_treated_by> "Best_supportive_care" .
<Bladder_cancer> <Current_treated_by> "Bacillus_Calmette-Guerin_(BCG)_monotherapy" .
<Bladder_cancer> <Current_treated_by> "Avelumab_monotherapy" .
<Bladder_cancer> <Current_treated_by> "Atezolizumab_monotherapy" .
<TH_(Taxotere)> <Is_current_in> "Breast_cancer" .
<Caplacizumab> <Has_accepted_use> "Thrombotic_thrombocytopenic_purpura" .
<Avelumab> <Has_brand_name> "Bavencio" .
<Intraperitoneal_hyperthermic_mitomycin> <Has_modality> "Chemotherapy" .
<ROS1_inhibitor> <Subsumes> "Lorlatinib" .
<ROS1_inhibitor> <Subsumes> "Entrectinib" .
<ROS1_inhibitor> <Subsumes> "Ensartinib" .
<ROS1_inhibitor> <Subsumes> "Crizotinib" .
<ROS1_inhibitor> <Subsumes> "Ceritinib" .
<ROS1_inhibitor> <Subsumes> "Cabozantinib" .
<ROS1_inhibitor> <Subsumes> "Brigatinib" .
<Triptorelin_monotherapy> <Has_modality> "Hormonotherapy" .
<CTCb,_then_auto_HSCT> <Maps_to> "CTCb,_then_auto_HSCT" .
<DEB-TACE> <Has_antineoplastic> "TACE" .
<DEB-TACE> <Has_antineoplastic> "Doxorubicin" .
<Fludarabine,_Busulfan,_Cyclophosphamide> <Maps_to> "Fludarabine,_Busulfan,_Cyclophosphamide" .
<Pemetrexed> <May_have_route> "Intravenous" .
<FCM> <Has_accepted_use> "Mantle_cell_lymphoma" .
<FCM> <Has_accepted_use> "Follicular_lymphoma" .
<FCM> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Trima> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Acetaminophen> <Is_a> "WHO_Essential_Pain_and_Palliative_Care_Medicine" .
<Acetaminophen> <Is_a> "OTC_medication" .
<Acetaminophen> <Is_a> "FDA_approved_drug" .
<Acetaminophen> <Is_a> "Antipyretic" .
<Carboplatin,_Etoposide,_Bevacizumab> <Is_current_in> "Small_cell_lung_cancer" .
<ADOC> <Has_accepted_use> "Thymoma" .
<Danaparoid> <Supportive_med_of> "Danaparoid_monotherapy" .
<Biotecan> <Brand_name_of> "Irinotecan" .
<Enoxol> <Brand_name_of> "Enoxaparin" .
<Belinostat> <May_have_route> "Intravenous" .
<DoceXan> <Brand_name_of> "Docetaxel" .
<Duvelisib_monotherapy> <Is_current_in> "Follicular_lymphoma" .
<Duvelisib_monotherapy> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Low-dose_TBI> <Has_context> "All_lines_of_therapy" .
<Carboplatin_and_Teniposide> <Has_modality> "Chemotherapy" .
<Dara-VMP> <Is_current_in> "Multiple_myeloma" .
<ATG_(Rabbit)_monotherapy> <Has_supportive_med> "Prednisone" .
<ATG_(Rabbit)_monotherapy> <Has_supportive_med> "Antibiotics" .
<FOLFOX2> <Has_antineoplastic> "Oxaliplatin" .
<FOLFOX2> <Has_antineoplastic> "Folinic_acid" .
<FOLFOX2> <Has_antineoplastic> "Fluorouracil" .
<Clofarabine_and_LoDAC/Decitabine> <Has_context> "Consolidation_after_upfront_therapy" .
<Aracitin> <Brand_name_of> "Cytarabine" .
<Tritosul> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CNOP_(Prednisolone)> <Has_antineoplastic> "Vincristine" .
<CNOP_(Prednisolone)> <Has_antineoplastic> "Prednisolone" .
<CNOP_(Prednisolone)> <Has_antineoplastic> "Mitoxantrone" .
<CNOP_(Prednisolone)> <Has_antineoplastic> "Cyclophosphamide" .
<Docetaxel_and_Bevacizumab> <Has_accepted_use> "triple_negative_Breast_cancer" .
<Docetaxel_and_Bevacizumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Docetaxel_and_Bevacizumab> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<Docetaxel_and_Bevacizumab> <Has_accepted_use> "Breast_cancer" .
<Epanutin> <Brand_name_of> "Phenytoin" .
<Actinium_Ac_225_lintuzumab> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Limethason> <Brand_name_of> "Dexamethasone" .
<Avatrombopag_monotherapy> <Has_accepted_use> "Thrombocytopenia_in_liver_disease" .
<Avatrombopag_monotherapy> <Has_accepted_use> "Immune_thrombocytopenia" .
<7_plus_3i_and_Vorinostat> <Has_antineoplastic> "Vorinostat" .
<7_plus_3i_and_Vorinostat> <Has_antineoplastic> "Idarubicin" .
<7_plus_3i_and_Vorinostat> <Has_antineoplastic> "Cytarabine" .
<FEAM> <Is_current_in> "Autologous_HSCT" .
<SHAI> <Has_context> "Salvage_therapy" .
<AVD> <Mapped_from> "AVD" .
<Fludarabine_and_Prednisone> <Mapped_from> "Fludarabine_and_Prednisone" .
<Chlorambucil_and_Ofatumumab> <Has_context> "Non-curative_first-line_therapy" .
<Ibrutinib_and_Venetoclax> <Maps_to> "Ibrutinib_and_Venetoclax" .
<Cisplatin,_Fluorouracil,_Cetuximab> <Has_antineoplastic> "Fluorouracil" .
<Cisplatin,_Fluorouracil,_Cetuximab> <Has_antineoplastic> "Cisplatin" .
<Cisplatin,_Fluorouracil,_Cetuximab> <Has_antineoplastic> "Cetuximab" .
<Capecitabine_and_Fulvestrant> <Is_a> "Antiestrogen-containing_regimen" .
<FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)> <Is_current_in> "Colon_cancer" .
<Argatroban_monotherapy> <Has_context> "Anticoagulation" .
<Argatroban_monotherapy> <Has_context> "All_lines_of_therapy" .
<Daunorubicin_monotherapy> <Has_modality> "Chemotherapy" .
<Zoledronic_acid_therapy> <Has_context> "Non-curative_first-line_therapy" .
<Amrubicin_monotherapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<Amrubicin_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Bactar> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Mukadryl> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Carboplatin_and_Gemcitabine> <Is_a> "Platinum_doublet" .
<Docetaxel_and_S-1> <Maps_to> "Docetaxel_and_S-1" .
<Non-small_cell_lung_cancer> <Subsumes> "ROS1-positive_Non-small_cell_lung_cancer" .
<Non-small_cell_lung_cancer> <Subsumes> "KRAS-mutated_Non-small_cell_lung_cancer" .
<Non-small_cell_lung_cancer> <Subsumes> "EGFR-mutated_Non-small_cell_lung_cancer" .
<Non-small_cell_lung_cancer> <Subsumes> "BRAF-mutated_Non-small_cell_lung_cancer" .
<Non-small_cell_lung_cancer> <Subsumes> "ALK-positive_Non-small_cell_lung_cancer" .
<Methotrexate,_then_Cytarabine_and_Thiotepa> <Maps_to> "Methotrexate,_then_Cytarabine_and_Thiotepa" .
<Raloxifene> <Has_brand_name> "Razylan" .
<Raloxifene> <Has_brand_name> "Ralista" .
<Raloxifene> <Has_brand_name> "Evista" .
<Cyclosporine,_Methotrexate,_Methylprednisolone> <Maps_to> "Cyclosporine,_Methotrexate,_Methylprednisolone" .
<CYVE_and_G-CSF> <Mapped_from> "CYVE_and_G-CSF" .
<Pegaspargase,_Vincristine,_Prednisone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Emapalumab> <Has_brand_name> "Gamifant" .
<Placebo> <Maps_to> "Placebo" .
<Oxaliplatin> <Antineoplastic_of> "mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)" .
<Oxaliplatin> <Antineoplastic_of> "mFOLFOX7_(L-Leucovorin)" .
<Oxaliplatin> <Antineoplastic_of> "mFOLFOX7" .
<Oxaliplatin> <Antineoplastic_of> "mFOLFOX6_and_RT" .
<Oxaliplatin> <Antineoplastic_of> "mFOLFOX6_and_Cetuximab" .
<Oxaliplatin> <Antineoplastic_of> "mFOLFOX6_and_Bevacizumab_(L-Leucovorin)" .
<Oxaliplatin> <Antineoplastic_of> "mFOLFOX6_and_Bevacizumab" .
<Oxaliplatin> <Antineoplastic_of> "mFOLFOX6_(L-Leucovorin)" .
<Oxaliplatin> <Antineoplastic_of> "mFOLFOX6" .
<Oxaliplatin> <Antineoplastic_of> "mFOLFOX_and_Sorafenib" .
<Oxaliplatin> <Antineoplastic_of> "mFOLFIRINOX,_Gemcitabine,_RT" .
<Oxaliplatin> <Antineoplastic_of> "mFOLFIRINOX" .
<Oxaliplatin> <Antineoplastic_of> "SOX_and_Bevacizumab" .
<Oxaliplatin> <Antineoplastic_of> "SOX" .
<Oxaliplatin> <Antineoplastic_of> "R-GemOx" .
<Oxaliplatin> <Antineoplastic_of> "R-DHAOx" .
<Oxaliplatin> <Antineoplastic_of> "Oxaliplatin_monotherapy" .
<Oxaliplatin> <Antineoplastic_of> "Oxaliplatin_and_RT" .
<Oxaliplatin> <Antineoplastic_of> "Oxaliplatin_and_Bevacizumab" .
<Oxaliplatin> <Antineoplastic_of> "Ox-P" .
<Oxaliplatin> <Antineoplastic_of> "OXAFAFU" .
<Oxaliplatin> <Antineoplastic_of> "OLF" .
<Oxaliplatin> <Antineoplastic_of> "OFAR" .
<Oxaliplatin> <Antineoplastic_of> "Nordic_FLOX" .
<Oxaliplatin> <Antineoplastic_of> "IROX" .
<Oxaliplatin> <Antineoplastic_of> "HAIC_and_Sorafenib" .
<Oxaliplatin> <Antineoplastic_of> "Gemcitabine,_Oxaliplatin,_Paclitaxel" .
<Oxaliplatin> <Antineoplastic_of> "GemOx_and_Sorafenib" .
<Oxaliplatin> <Antineoplastic_of> "GemOx" .
<Oxaliplatin> <Antineoplastic_of> "GEMOX-B" .
<Oxaliplatin> <Antineoplastic_of> "GELOX/RT" .
<Oxaliplatin> <Antineoplastic_of> "Fluorouracil,_Oxaliplatin,_RT" .
<Oxaliplatin> <Antineoplastic_of> "FUOX" .
<Oxaliplatin> <Antineoplastic_of> "FOLFOXIRI_and_Panitumumab" .
<Oxaliplatin> <Antineoplastic_of> "FOLFOX4_and_RT" .
<Oxaliplatin> <Antineoplastic_of> "FOLFOX4_and_Panitumumab" .
<Oxaliplatin> <Antineoplastic_of> "FOLFOX4_and_Cetuximab" .
<Oxaliplatin> <Antineoplastic_of> "FOLFOX4_and_Bevacizumab" .
<Oxaliplatin> <Antineoplastic_of> "FOLFOX4_(L-Leucovorin)" .
<Oxaliplatin> <Antineoplastic_of> "FOLFOX4" .
<Oxaliplatin> <Antineoplastic_of> "FOLFOX2" .
<Oxaliplatin> <Antineoplastic_of> "FOLFOX_chronotherapy" .
<Oxaliplatin> <Antineoplastic_of> "FOLFOX_7/sLV5FU2_(L-Leucovorin)" .
<Oxaliplatin> <Antineoplastic_of> "FOLFOX_7/sLV5FU2" .
<Oxaliplatin> <Antineoplastic_of> "FOLFOX" .
<Oxaliplatin> <Antineoplastic_of> "FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation" .
<Oxaliplatin> <Antineoplastic_of> "FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)" .
<Oxaliplatin> <Antineoplastic_of> "FOLFIRINOX" .
<Oxaliplatin> <Antineoplastic_of> "FLOX" .
<Oxaliplatin> <Antineoplastic_of> "FLOT" .
<Oxaliplatin> <Antineoplastic_of> "EOX" .
<Oxaliplatin> <Antineoplastic_of> "EOF" .
<Oxaliplatin> <Antineoplastic_of> "Capecitabine,_Oxaliplatin,_RT" .
<Oxaliplatin> <Antineoplastic_of> "Capecitabine,_Docetaxel,_Oxaliplatin,_RT" .
<Oxaliplatin> <Antineoplastic_of> "CapeOx,_Cetuximab,_RT" .
<Oxaliplatin> <Antineoplastic_of> "CapeOx_and_Panitumumab" .
<Oxaliplatin> <Antineoplastic_of> "CapeOx_and_Bevacizumab" .
<Oxaliplatin> <Antineoplastic_of> "CapeOx" .
<Cytarabine,_Ifosfamide,_G-CSF> <Has_antineoplastic> "Ifosfamide" .
<Cytarabine,_Ifosfamide,_G-CSF> <Has_antineoplastic> "Cytarabine" .
<GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab> <Maps_to> "GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab" .
<CMFPT> <Has_accepted_use> "Breast_cancer" .
<EAR_and_G-CSF> <Is_a> "Rituximab-containing_regimen" .
<Cladribine_monotherapy> <Mapped_from> "Cladribine_monotherapy" .
<Cobimetinib> <Antineoplastic_of> "Cobimetinib_monotherapy" .
<Cobimetinib> <Antineoplastic_of> "Cobimetinib_and_Vemurafenib" .
<FOLFOX4_and_RT> <Is_current_in> "Esophageal_cancer" .
<Mantle_cell_lymphoma> <Current_treated_by> "maxi-R-CHOP/R-HiDAC" .
<Mantle_cell_lymphoma> <Current_treated_by> "Zanubrutinib_monotherapy" .
<Mantle_cell_lymphoma> <Current_treated_by> "VcR-CVAD" .
<Mantle_cell_lymphoma> <Current_treated_by> "VR-CHOP" .
<Mantle_cell_lymphoma> <Current_treated_by> "VR-CAP" .
<Mantle_cell_lymphoma> <Current_treated_by> "VR" .
<Mantle_cell_lymphoma> <Current_treated_by> "VAD_plus_C" .
<Mantle_cell_lymphoma> <Current_treated_by> "Temsirolimus_monotherapy" .
<Mantle_cell_lymphoma> <Current_treated_by> "Temsirolimus_and_Rituximab" .
<Mantle_cell_lymphoma> <Current_treated_by> "TAM6,_then_auto_HSCT" .
<Mantle_cell_lymphoma> <Current_treated_by> "Rituximab_monotherapy" .
<Mantle_cell_lymphoma> <Current_treated_by> "RiPAD_plus_C" .
<Mantle_cell_lymphoma> <Current_treated_by> "RT-PEPC" .
<Mantle_cell_lymphoma> <Current_treated_by> "R-VAD_plus_C" .
<Mantle_cell_lymphoma> <Current_treated_by> "R-MACLO/R-IVAM" .
<Mantle_cell_lymphoma> <Current_treated_by> "R-M-CHOP" .
<Mantle_cell_lymphoma> <Current_treated_by> "R-Hyper-CVAD/R-MA" .
<Mantle_cell_lymphoma> <Current_treated_by> "R-HiDAC" .
<Mantle_cell_lymphoma> <Current_treated_by> "R-FCM" .
<Mantle_cell_lymphoma> <Current_treated_by> "R-DHAP" .
<Mantle_cell_lymphoma> <Current_treated_by> "R-DHAOx" .
<Mantle_cell_lymphoma> <Current_treated_by> "R-DHAC" .
<Mantle_cell_lymphoma> <Current_treated_by> "R-CVP" .
<Mantle_cell_lymphoma> <Current_treated_by> "R-CHOP/R-DHAP" .
<Mantle_cell_lymphoma> <Current_treated_by> "R-CHOP-14_(Prednisolone)" .
<Mantle_cell_lymphoma> <Current_treated_by> "R-CHOP_(Prednisolone)" .
<Mantle_cell_lymphoma> <Current_treated_by> "R-CHOP" .
<Mantle_cell_lymphoma> <Current_treated_by> "R-BL" .
<Mantle_cell_lymphoma> <Current_treated_by> "R-BEAM,_then_auto_HSCT" .
<Mantle_cell_lymphoma> <Current_treated_by> "R-BAC" .
<Mantle_cell_lymphoma> <Current_treated_by> "PEP-C" .
<Mantle_cell_lymphoma> <Current_treated_by> "Observation" .
<Mantle_cell_lymphoma> <Current_treated_by> "Obinutuzumab_monotherapy" .
<Mantle_cell_lymphoma> <Current_treated_by> "Melphalan_and_TBI,_then_auto_HSCT" .
<Mantle_cell_lymphoma> <Current_treated_by> "MCP" .
<Mantle_cell_lymphoma> <Current_treated_by> "Lenalidomide_monotherapy" .
<Mantle_cell_lymphoma> <Current_treated_by> "Lenalidomide_and_Rituximab" .
<Mantle_cell_lymphoma> <Current_treated_by> "Interferon_alfa_monotherapy" .
<Mantle_cell_lymphoma> <Current_treated_by> "Ibrutinib_monotherapy" .
<Mantle_cell_lymphoma> <Current_treated_by> "Ibrutinib_and_Venetoclax" .
<Mantle_cell_lymphoma> <Current_treated_by> "Ibrutinib_and_Rituximab" .
<Mantle_cell_lymphoma> <Current_treated_by> "Ibritumomab_tiuxetan_monotherapy" .
<Mantle_cell_lymphoma> <Current_treated_by> "FluBuCy,_then_allo_HSCT" .
<Mantle_cell_lymphoma> <Current_treated_by> "FR" .
<Mantle_cell_lymphoma> <Current_treated_by> "FCR" .
<Mantle_cell_lymphoma> <Current_treated_by> "FCM" .
<Mantle_cell_lymphoma> <Current_treated_by> "FC" .
<Mantle_cell_lymphoma> <Current_treated_by> "Everolimus_monotherapy" .
<Mantle_cell_lymphoma> <Current_treated_by> "Cyclophosphamide_and_TBI,_then_auto_HSCT" .
<Mantle_cell_lymphoma> <Current_treated_by> "Cladribine_monotherapy" .
<Mantle_cell_lymphoma> <Current_treated_by> "Cladribine_and_Rituximab" .
<Mantle_cell_lymphoma> <Current_treated_by> "Chlorambucil_and_Rituximab" .
<Mantle_cell_lymphoma> <Current_treated_by> "CVP_(Prednisolone)" .
<Mantle_cell_lymphoma> <Current_treated_by> "CHOP_(Prednisolone)" .
<Mantle_cell_lymphoma> <Current_treated_by> "CHOP" .
<Mantle_cell_lymphoma> <Current_treated_by> "CBV,_then_auto_HSCT" .
<Mantle_cell_lymphoma> <Current_treated_by> "Bortezomib_monotherapy" .
<Mantle_cell_lymphoma> <Current_treated_by> "BeRT" .
<Mantle_cell_lymphoma> <Current_treated_by> "BR" .
<Mantle_cell_lymphoma> <Current_treated_by> "BFR,_then_allo_HSCT" .
<Mantle_cell_lymphoma> <Current_treated_by> "BEAM,_then_auto_HSCT" .
<Mantle_cell_lymphoma> <Current_treated_by> "BEAC,_then_auto_HSCT" .
<Mantle_cell_lymphoma> <Current_treated_by> "BDR" .
<Mantle_cell_lymphoma> <Current_treated_by> "BCHOP" .
<Mantle_cell_lymphoma> <Current_treated_by> "Arsenic_trioxide_and_Chlorambucil" .
<Mantle_cell_lymphoma> <Current_treated_by> "Acalabrutinib_monotherapy" .
<Pentamidine> <Supportive_med_of> "Temozolomide_and_RT" .
<Pentamidine> <Supportive_med_of> "SMILE" .
<Pentamidine> <Supportive_med_of> "R2CHOP" .
<Pentamidine> <Supportive_med_of> "R-EPOCH" .
<Pentamidine> <Supportive_med_of> "R-CHOP" .
<Pentamidine> <Supportive_med_of> "Fludarabine_monotherapy" .
<Pentamidine> <Supportive_med_of> "EPOCH" .
<Pentamidine> <Supportive_med_of> "DA-R-EPOCH" .
<Pentamidine> <Supportive_med_of> "DA-EPOCH" .
<Pentamidine> <Supportive_med_of> "Chlorambucil_monotherapy" .
<Pentamidine> <Supportive_med_of> "Carboplatin_and_nab-Paclitaxel" .
<Pentamidine> <Supportive_med_of> "CHOP" .
<Pentamidine> <Supportive_med_of> "Alemtuzumab_monotherapy" .
<Pentamidine> <Supportive_med_of> "ATG_(Rabbit)_and_Cyclosporine" .
<Pentamidine> <Supportive_med_of> "ATG_(Horse),_Cyclosporine,_Sirolimus" .
<Pentamidine> <Supportive_med_of> "ATG_(Horse),_Cyclosporine,_Eltrombopag" .
<Pentamidine> <Supportive_med_of> "ATG_(Horse)_and_Cyclosporine" .
<Ofatumumab> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Ofatumumab> <Has_accepted_use> "Hodgkin_lymphoma" .
<Ofatumumab> <Has_accepted_use> "Follicular_lymphoma" .
<Ofatumumab> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Ofatumumab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<OFAR> <Is_a> "Rituximab-containing_regimen" .
<Vadastuximab_talirine> <Is_a> "Investigational_drug" .
<Vadastuximab_talirine> <Is_a> "Antibody-drug_conjugate" .
<Vadastuximab_talirine> <Is_a> "Antibody_medication" .
<Vadastuximab_talirine> <Is_a> "Anti-CD33_antibody" .
<Vadastuximab_talirine> <Is_a> "Alkylating_agent" .
<Unitaxel> <Brand_name_of> "Paclitaxel" .
<Exemestane_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Exemestane_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Exemestane_monotherapy> <Has_context> "Adjuvant_therapy" .
<CVP,_then_131Iodine-Tositumomab> <Has_context> "Non-curative_first-line_therapy" .
<Nelarabine> <Has_FDA_indication> "T-cell_acute_lymphoblastic_leukemia" .
<Belotecan_and_Cisplatin> <Is_a> "Platinum_doublet" .
<Apatinib> <Has_accepted_use> "Gastric_cancer" .
<Apatinib> <Has_accepted_use> "Esophageal_cancer" .
<Omnatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<R-CHOP-14> <Has_local_therapy> "Methotrexate" .
<FAM> <Has_context> "Non-curative_first-line_therapy" .
<Mepsolone> <Brand_name_of> "Methylprednisolone" .
<Idarubicin,_then_Mitoxantrone,_then_Idarubicin> <Mapped_from> "Idarubicin,_then_Mitoxantrone,_then_Idarubicin" .
<F-MACHOP> <Has_antineoplastic> "Vincristine" .
<F-MACHOP> <Has_antineoplastic> "Prednisone" .
<F-MACHOP> <Has_antineoplastic> "Methotrexate" .
<F-MACHOP> <Has_antineoplastic> "Fluorouracil" .
<F-MACHOP> <Has_antineoplastic> "Doxorubicin" .
<F-MACHOP> <Has_antineoplastic> "Cytarabine" .
<F-MACHOP> <Has_antineoplastic> "Cyclophosphamide" .
<Fluorouracil_and_Semustine> <Mapped_from> "Fluorouracil_and_Semustine" .
<Total_Therapy> <Has_accepted_use> "Multiple_myeloma" .
<Lexcomet> <Brand_name_of> "Methylprednisolone" .
<Capecitabine_and_Bevacizumab> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Capecitabine_and_Bevacizumab> <Has_accepted_use> "Colon_cancer" .
<Capecitabine_and_Bevacizumab> <Has_accepted_use> "Breast_cancer" .
<Prednisone_and_Rituximab> <Has_accepted_use> "Warm_autoimmune_hemolytic_anemia" .
<Capnat> <Brand_name_of> "Capecitabine" .
<IGEV> <Has_accepted_use> "Hodgkin_lymphoma" .
<Dectan> <Brand_name_of> "Dexamethasone" .
<CODOX-M/IVAC> <Mapped_from> "CODOX-M/IVAC" .
<BCOP> <Has_modality> "Chemotherapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Whole_brain_irradiation" .
<Small_cell_lung_cancer> <Current_treated_by> "Vinorelbine_monotherapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Topotecan_monotherapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Teniposide_monotherapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Temozolomide_monotherapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Sunitinib_monotherapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Radiation_therapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Placebo" .
<Small_cell_lung_cancer> <Current_treated_by> "Pembrolizumab_monotherapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Paclitaxel_monotherapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Observation" .
<Small_cell_lung_cancer> <Current_treated_by> "Nivolumab_monotherapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Irinotecan_monotherapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Ipilimumab_monotherapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Ipilimumab_and_Nivolumab" .
<Small_cell_lung_cancer> <Current_treated_by> "Ifosfamide_monotherapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Ifosfamide_and_Paclitaxel" .
<Small_cell_lung_cancer> <Current_treated_by> "Gemcitabine_monotherapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Etoposide_monotherapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Epirubicin_and_Ifosfamide" .
<Small_cell_lung_cancer> <Current_treated_by> "Durvalumab_monotherapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Docetaxel_monotherapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Cisplatin,_Etoposide,_RT" .
<Small_cell_lung_cancer> <Current_treated_by> "Cisplatin,_Etoposide,_Irinotecan" .
<Small_cell_lung_cancer> <Current_treated_by> "Cisplatin,_Etoposide,_Durvalumab" .
<Small_cell_lung_cancer> <Current_treated_by> "Cisplatin,_Etoposide,_Bevacizumab" .
<Small_cell_lung_cancer> <Current_treated_by> "Cisplatin_and_Irinotecan" .
<Small_cell_lung_cancer> <Current_treated_by> "Cisplatin_and_Etoposide" .
<Small_cell_lung_cancer> <Current_treated_by> "Carboplatin,_Paclitaxel,_Ipilimumab" .
<Small_cell_lung_cancer> <Current_treated_by> "Carboplatin,_Etoposide,_RT" .
<Small_cell_lung_cancer> <Current_treated_by> "Carboplatin,_Etoposide,_Durvalumab" .
<Small_cell_lung_cancer> <Current_treated_by> "Carboplatin,_Etoposide,_Bevacizumab" .
<Small_cell_lung_cancer> <Current_treated_by> "Carboplatin,_Etoposide,_Atezolizumab" .
<Small_cell_lung_cancer> <Current_treated_by> "Carboplatin_and_Irinotecan" .
<Small_cell_lung_cancer> <Current_treated_by> "Carboplatin_and_Etoposide" .
<Small_cell_lung_cancer> <Current_treated_by> "Bevacizumab_monotherapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Best_supportive_care" .
<Small_cell_lung_cancer> <Current_treated_by> "Bendamustine_monotherapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Belotecan_and_Cisplatin" .
<Small_cell_lung_cancer> <Current_treated_by> "Atezolizumab_monotherapy" .
<Small_cell_lung_cancer> <Current_treated_by> "Amrubicin_monotherapy" .
<Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone> <Maps_to> "Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone" .
<Brentuximab_vedotin_monotherapy> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<Brentuximab_vedotin_monotherapy> <Is_current_in> "Mediastinal_gray-zone_lymphoma" .
<Brentuximab_vedotin_monotherapy> <Is_current_in> "Hodgkin_lymphoma" .
<Brentuximab_vedotin_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Brentuximab_vedotin_monotherapy> <Is_current_in> "Cutaneous_T-cell_lymphoma" .
<Brentuximab_vedotin_monotherapy> <Is_current_in> "Anaplastic_large_cell_lymphoma" .
<GIP> <Maps_to> "GIP" .
<Vorinostat_and_Rituximab> <Has_accepted_use> "Follicular_lymphoma" .
<HAA> <Has_accepted_use> "Acute_myeloid_leukemia" .
<LoDAC_and_Venetoclax> <Mapped_from> "LoDAC_and_Venetoclax" .
<Chlorambucil_and_Prednisone> <Has_context> "Non-curative_first-line_therapy" .
<RD> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<Merkel_cell_carcinoma> <Current_treated_by> "Pembrolizumab_monotherapy" .
<Merkel_cell_carcinoma> <Current_treated_by> "Avelumab_monotherapy" .
<FEC_and_H_(SC)> <Has_modality> "Chemotherapy" .
<Glucarpidase> <Is_a> "Enzyme" .
<Glucarpidase> <Is_a> "Chemotherapy_protective_agent" .
<Clodronate> <Has_brand_name> "Sindronat" .
<Clodronate> <Has_brand_name> "Osteostab" .
<Clodronate> <Has_brand_name> "Osteonorm" .
<Clodronate> <Has_brand_name> "Ostac" .
<Clodronate> <Has_brand_name> "Ossiten" .
<Clodronate> <Has_brand_name> "Niklod" .
<Clodronate> <Has_brand_name> "Moticlod" .
<Clodronate> <Has_brand_name> "Mebonat" .
<Clodronate> <Has_brand_name> "Lytos" .
<Clodronate> <Has_brand_name> "Loron" .
<Clodronate> <Has_brand_name> "Lodronat" .
<Clodronate> <Has_brand_name> "Disdual" .
<Clodronate> <Has_brand_name> "Difosfonal" .
<Clodronate> <Has_brand_name> "Clody" .
<Clodronate> <Has_brand_name> "Clodron" .
<Clodronate> <Has_brand_name> "Clodran" .
<Clodronate> <Has_brand_name> "Clodeosten" .
<Clodronate> <Has_brand_name> "Climaclod" .
<Clodronate> <Has_brand_name> "Clastoban" .
<Clodronate> <Has_brand_name> "Clasteon" .
<Follicular_lymphoma> <Is_a> "Non-Hodgkin_lymphoma" .
<Follicular_lymphoma> <Is_a> "Indolent_lymphoma" .
<Ftorafur> <Brand_name_of> "Tegafur_and_uracil" .
<BVDS> <Has_antineoplastic> "Vinblastine" .
<BVDS> <Has_antineoplastic> "Streptozocin" .
<BVDS> <Has_antineoplastic> "Doxorubicin" .
<BVDS> <Has_antineoplastic> "Bleomycin" .
<Doxorubicin_pegylated_liposomal_monotherapy> <Has_antineoplastic> "Pegylated_liposomal_doxorubicin" .
<SC-EPOCH-RR> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<SC-EPOCH-RR> <Has_supportive_med> "Sennosides" .
<SC-EPOCH-RR> <Has_supportive_med> "Omeprazole" .
<SC-EPOCH-RR> <Has_supportive_med> "Lactulose" .
<SC-EPOCH-RR> <Has_supportive_med> "Filgrastim" .
<SC-EPOCH-RR> <Has_supportive_med> "Docusate" .
<Capecitabine_and_Lapatinib> <Has_context> "Non-curative_subsequent-line_therapy" .
<Capecitabine_and_Lapatinib> <Has_context> "Non-curative_first-line_therapy" .
<Capecitabine_and_Lapatinib> <Has_context> "All_lines_of_therapy" .
<Hyper-CVAD_and_Ponatinib> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Hyper-CVAD_and_Ponatinib> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<UFT_monotherapy> <Has_context> "Adjuvant_therapy" .
<Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone> <Maps_to> "Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Binimetinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Pradaxa> <Brand_name_of> "Dabigatran" .
<Septerin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Busulfan_and_Fludarabine> <Is_current_in> "Allogeneic_HSCT" .
<Doxorubicin,_Ifosfamide,_RT> <Mapped_from> "Doxorubicin,_Ifosfamide,_RT" .
<FMP> <Mapped_from> "FMP" .
<Hyper-CVAD/MA_and_Everolimus> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Microtrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Ibritumomab_tiuxetan> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Ibritumomab_tiuxetan> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Ibritumomab_tiuxetan> <Has_accepted_use> "Follicular_lymphoma" .
<Ibritumomab_tiuxetan> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<ddT_(Taxotere)> <Has_context> "Adjuvant_therapy" .
<Carboplatin_and_Gemcitabine> <Has_accepted_use> "triple_negative_Breast_cancer" .
<Carboplatin_and_Gemcitabine> <Has_accepted_use> "Ovarian_cancer" .
<Carboplatin_and_Gemcitabine> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Carboplatin_and_Gemcitabine> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<Carboplatin_and_Gemcitabine> <Has_accepted_use> "Breast_cancer" .
<Carboplatin_and_Gemcitabine> <Has_accepted_use> "Bladder_cancer" .
<Dutran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Carboplatin,_Vinorelbine,_RT> <Has_antineoplastic> "Vinorelbine" .
<Carboplatin,_Vinorelbine,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Carboplatin,_Vinorelbine,_RT> <Has_antineoplastic> "Carboplatin" .
<Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<Purine_nucleoside_phosphorylase_(PNP)_inhibitor> <Is_a> "Enzyme_inhibitor" .
<Anakinra_monotherapy> <Has_context> "All_lines_of_therapy" .
<Chlorambucil_and_Prednisone> <Has_antineoplastic> "Prednisone" .
<Chlorambucil_and_Prednisone> <Has_antineoplastic> "Chlorambucil" .
<Ixazomib_monotherapy> <Maps_to> "Ixazomib_monotherapy" .
<R-VAD_plus_C> <Is_current_in> "Mantle_cell_lymphoma" .
<Dexamethasone_and_Rituximab> <Has_context> "Non-curative_therapy" .
<Dexamethasone_and_Rituximab> <Has_context> "Induction_therapy" .
<Estradiol> <Antineoplastic_of> "Estradiol_monotherapy" .
<Tecnotecan> <Brand_name_of> "Irinotecan" .
<CHOEP-14> <Is_a> "Anthracycline-containing_regimen" .
<Cyclophosphamide_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<Cyclophosphamide_monotherapy> <Has_accepted_use> "Neuroblastoma" .
<Cyclophosphamide_monotherapy> <Has_accepted_use> "Multiple_myeloma" .
<Cyclophosphamide_monotherapy> <Has_accepted_use> "Large_granular_lymphocytic_leukemia" .
<Cyclophosphamide_monotherapy> <Has_accepted_use> "Glioblastoma" .
<Cyclophosphamide_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<Cyclophosphamide_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Cyclophosphamide_monotherapy> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Cyclophosphamide_monotherapy> <Has_accepted_use> "Anaplastic_glioma" .
<ADE_(high-dose_Ara-C)> <Has_context> "Induction_therapy" .
<L-Asparaginase,_Vincristine,_Dexamethasone> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<Histrelin_monotherapy> <Is_current_in> "Prostate_cancer" .
<Gros> <Brand_name_of> "Paclitaxel" .
<MA-BCD> <Has_modality> "Chemotherapy" .
<Pamidronate> <Is_a> "Bisphosphonate" .
<EVAIA> <Is_current_in> "Ewing_sarcoma" .
<Lentaron> <Brand_name_of> "Formestane" .
<Medroxyprogesterone_monotherapy> <Mapped_from> "Medroxyprogesterone_monotherapy" .
<Interferon_alfa-2b_monotherapy> <Is_current_in> "Systemic_mastocytosis" .
<Interferon_alfa-2b_monotherapy> <Is_current_in> "Renal_cell_carcinoma" .
<Interferon_alfa-2b_monotherapy> <Is_current_in> "Neuroendocrine_tumor" .
<Interferon_alfa-2b_monotherapy> <Is_current_in> "Melanoma" .
<Interferon_alfa-2b_monotherapy> <Is_current_in> "Kaposi_sarcoma" .
<Interferon_alfa-2b_monotherapy> <Is_current_in> "Hairy_cell_leukemia" .
<Interferon_alfa-2b_monotherapy> <Is_current_in> "Chronic_myelogenous_leukemia" .
<TCHP_(Taxotere)> <Is_current_in> "Breast_cancer" .
<Lysoprin> <Brand_name_of> "Aspirin" .
<Leuprolide_monotherapy> <Has_antineoplastic> "Leuprolide" .
<Antithrombin_III> <May_have_route> "Intravenous" .
<R-CHOP-14_(Prednisolone)> <Has_local_therapy> "Methotrexate" .
<Flu-Mel,_then_allo_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<Low_molecular_weight_heparins> <Supportive_med_of> "VTP" .
<Low_molecular_weight_heparins> <Supportive_med_of> "VTD" .
<Low_molecular_weight_heparins> <Supportive_med_of> "VT" .
<Low_molecular_weight_heparins> <Supportive_med_of> "VMP/Rd" .
<Low_molecular_weight_heparins> <Supportive_med_of> "VMP,_then_Rd" .
<Low_molecular_weight_heparins> <Supportive_med_of> "TD" .
<Low_molecular_weight_heparins> <Supportive_med_of> "Rd" .
<Low_molecular_weight_heparins> <Supportive_med_of> "RVD" .
<Low_molecular_weight_heparins> <Supportive_med_of> "RP" .
<Low_molecular_weight_heparins> <Supportive_med_of> "R2CHOP" .
<Low_molecular_weight_heparins> <Supportive_med_of> "Pomalidomide_monotherapy" .
<Low_molecular_weight_heparins> <Supportive_med_of> "Pomalidomide_and_Prednisone" .
<Low_molecular_weight_heparins> <Supportive_med_of> "PVD" .
<Low_molecular_weight_heparins> <Supportive_med_of> "PD" .
<Low_molecular_weight_heparins> <Supportive_med_of> "PCP" .
<Low_molecular_weight_heparins> <Supportive_med_of> "MRD" .
<Low_molecular_weight_heparins> <Supportive_med_of> "MPT" .
<Low_molecular_weight_heparins> <Supportive_med_of> "MPR" .
<Low_molecular_weight_heparins> <Supportive_med_of> "Lenalidomide_monotherapy" .
<Low_molecular_weight_heparins> <Supportive_med_of> "Lenalidomide_and_Rituximab" .
<Low_molecular_weight_heparins> <Supportive_med_of> "KRd" .
<Low_molecular_weight_heparins> <Supportive_med_of> "KPD" .
<Low_molecular_weight_heparins> <Supportive_med_of> "Edoxaban_monotherapy" .
<Low_molecular_weight_heparins> <Supportive_med_of> "CYKLONE" .
<Low_molecular_weight_heparins> <Supportive_med_of> "CTD" .
<Low_molecular_weight_heparins> <Supportive_med_of> "CRd" .
<Low_molecular_weight_heparins> <Supportive_med_of> "CPR" .
<Mebryn> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Exemestane> <Is_a> "Steroid_synthesis_inhibitor" .
<Exemestane> <Is_a> "Protein_expression-specific_medication" .
<Exemestane> <Is_a> "Endocrine_therapeutic" .
<Exemestane> <Is_a> "Aromatase_inhibitor" .
<R-FM> <Has_modality> "Chemotherapy" .
<Ceruvin> <Brand_name_of> "Clopidogrel" .
<Claravis> <Brand_name_of> "Isotretinoin" .
<TT4> <Has_immunosuppressor> "Rituximab" .
<TT4> <Has_immunosuppressor> "Dexamethasone" .
<TT4> <Has_immunosuppressor> "Cyclosporines" .
<Lymphoproliferative_disorder> <Subsumes> "Post-transplant_lymphoproliferative_disorder" .
<Lymphoproliferative_disorder> <Subsumes> "Castleman_disease" .
<Vinotec> <Brand_name_of> "Vinorelbine" .
<Sargramostim> <Is_a> "Granulocyte_macrophage_colony-stimulating_factor" .
<BRCA-mutated_Ovarian_cancer> <Accepted_use_of> "Placebo" .
<BRCA-mutated_Ovarian_cancer> <Accepted_use_of> "Olaparib_monotherapy" .
<Cisplatin_and_Mitomycin> <Is_a> "Platinum_doublet" .
<Cabozantinib> <May_have_route> "Oral" .
<Soldesanil> <Brand_name_of> "Dexamethasone" .
<Cisplatin,_Pemetrexed,_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Epirubicin_monotherapy> <Is_current_in> "Soft_tissue_sarcoma" .
<Epirubicin_monotherapy> <Is_current_in> "Breast_cancer" .
<R-CHOP/R-DHAP> <Is_a> "Rituximab-containing_regimen" .
<R-CHOP/R-DHAP> <Is_a> "Anthracycline-containing_regimen" .
<Flu-Mel,_then_allo_HSCT> <Has_immunosuppressor> "Tacrolimus" .
<Flu-Mel,_then_allo_HSCT> <Has_immunosuppressor> "Methotrexate" .
<Flu-Mel,_then_allo_HSCT> <Has_immunosuppressor> "Cyclosporines" .
<Flu-Mel,_then_allo_HSCT> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<Flu-Mel,_then_allo_HSCT> <Has_immunosuppressor> "Antithymocyte_globulin" .
<Tryptophan_hydroxylase_inhibitor> <Subsumes> "Telotristat" .
<Dexaflam> <Brand_name_of> "Dexamethasone" .
<Trifluridine_and_tipiracil> <Antineoplastic_of> "Trifluridine_and_tipiracil_monotherapy" .
<Hydroxyurea_monotherapy> <Has_antineoplastic> "Hydroxyurea" .
<VTD-PACE> <Has_modality> "Chemotherapy" .
<Lenalidomide_and_Rituximab> <Is_current_in> "Transformed_lymphoma" .
<Lenalidomide_and_Rituximab> <Is_current_in> "Marginal_zone_lymphoma" .
<Lenalidomide_and_Rituximab> <Is_current_in> "Mantle_cell_lymphoma" .
<Lenalidomide_and_Rituximab> <Is_current_in> "Follicular_lymphoma" .
<Lenalidomide_and_Rituximab> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Lenalidomide_and_Rituximab> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Osficar> <Brand_name_of> "Alendronate" .
<Bactifor> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Idarubicin,_then_Mitoxantrone,_then_Idarubicin> <Has_context> "Consolidation_after_upfront_therapy" .
<Upfront_therapy> <Context_of> "m-BACOD" .
<Upfront_therapy> <Context_of> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Upfront_therapy> <Context_of> "dmCODOX-M_-_Modified_Magrath" .
<Upfront_therapy> <Context_of> "VIP" .
<Upfront_therapy> <Context_of> "VAB-6" .
<Upfront_therapy> <Context_of> "Stanford_V" .
<Upfront_therapy> <Context_of> "SC-EPOCH-RR" .
<Upfront_therapy> <Context_of> "R-MPV" .
<Upfront_therapy> <Context_of> "R-MP" .
<Upfront_therapy> <Context_of> "R-MCP_(CCNU)" .
<Upfront_therapy> <Context_of> "R-EPOCH,_dose-escalated" .
<Upfront_therapy> <Context_of> "R-CODOX-M/R-IVAC" .
<Upfront_therapy> <Context_of> "R-CODOX-M" .
<Upfront_therapy> <Context_of> "R-CHOP" .
<Upfront_therapy> <Context_of> "R-CDOP" .
<Upfront_therapy> <Context_of> "PVeBV" .
<Upfront_therapy> <Context_of> "PUVA" .
<Upfront_therapy> <Context_of> "Nordic_Regimen,_younger_patients" .
<Upfront_therapy> <Context_of> "Nordic_Regimen,_older_patients" .
<Upfront_therapy> <Context_of> "Methotrexate,_then_Cytarabine_and_Thiotepa" .
<Upfront_therapy> <Context_of> "Methotrexate,_then_Cytarabine" .
<Upfront_therapy> <Context_of> "Methotrexate_monotherapy" .
<Upfront_therapy> <Context_of> "Methotrexate_and_Rituximab" .
<Upfront_therapy> <Context_of> "MVBP" .
<Upfront_therapy> <Context_of> "MT-R" .
<Upfront_therapy> <Context_of> "MPV" .
<Upfront_therapy> <Context_of> "MBVP" .
<Upfront_therapy> <Context_of> "MATRix" .
<Upfront_therapy> <Context_of> "M-TIP" .
<Upfront_therapy> <Context_of> "Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone" .
<Upfront_therapy> <Context_of> "Lomustine,_Methotrexate,_Procarbazine" .
<Upfront_therapy> <Context_of> "GMALL-R" .
<Upfront_therapy> <Context_of> "EPOCH,_dose-escalated" .
<Upfront_therapy> <Context_of> "Cytarabine,_Methotrexate,_Rituximab" .
<Upfront_therapy> <Context_of> "Cisplatin_and_Etoposide" .
<Upfront_therapy> <Context_of> "Chlorambucil,_Dactinomycin,_Methotrexate" .
<Upfront_therapy> <Context_of> "CYM" .
<Upfront_therapy> <Context_of> "CODOX-M/IVAC" .
<Upfront_therapy> <Context_of> "CODOX-M" .
<Upfront_therapy> <Context_of> "CISCA/VB" .
<Upfront_therapy> <Context_of> "CHOP" .
<Upfront_therapy> <Context_of> "C-BOP" .
<Upfront_therapy> <Context_of> "Bleomycin_and_Vinblastine" .
<Upfront_therapy> <Context_of> "BVP" .
<Upfront_therapy> <Context_of> "BO" .
<Upfront_therapy> <Context_of> "BEP" .
<Upfront_therapy> <Context_of> "Accelerated_BEP" .
<Vandetanib> <May_have_route> "Oral" .
<Jestrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Penile_cancer> <Accepted_use_of> "Vincristine" .
<Penile_cancer> <Accepted_use_of> "VBM" .
<Penile_cancer> <Accepted_use_of> "TIP" .
<Penile_cancer> <Accepted_use_of> "Panitumumab_monotherapy" .
<Penile_cancer> <Accepted_use_of> "Panitumumab" .
<Penile_cancer> <Accepted_use_of> "Paclitaxel_monotherapy" .
<Penile_cancer> <Accepted_use_of> "Paclitaxel" .
<Penile_cancer> <Accepted_use_of> "PCF" .
<Penile_cancer> <Accepted_use_of> "Methotrexate" .
<Penile_cancer> <Accepted_use_of> "Irinotecan" .
<Penile_cancer> <Accepted_use_of> "Ifosfamide" .
<Penile_cancer> <Accepted_use_of> "Fluorouracil" .
<Penile_cancer> <Accepted_use_of> "Docetaxel" .
<Penile_cancer> <Accepted_use_of> "DCF" .
<Penile_cancer> <Accepted_use_of> "Cisplatin_and_Irinotecan" .
<Penile_cancer> <Accepted_use_of> "Cisplatin_and_Fluorouracil" .
<Penile_cancer> <Accepted_use_of> "Cisplatin" .
<Penile_cancer> <Accepted_use_of> "Bleomycin" .
<Penile_cancer> <Accepted_use_of> "BMP" .
<Balversa> <Brand_name_of> "Erdafitinib" .
<Etoposide_and_TBI,_then_allo_HSCT> <Mapped_from> "Etoposide_and_TBI,_then_allo_HSCT" .
<Lifzol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CVP_(Prednisolone)> <Has_antineoplastic> "Vincristine" .
<CVP_(Prednisolone)> <Has_antineoplastic> "Prednisolone" .
<CVP_(Prednisolone)> <Has_antineoplastic> "Cyclophosphamide" .
<Hemax> <Brand_name_of> "Epoetin_alfa" .
<Dalalone> <Brand_name_of> "Dexamethasone" .
<LoDAC> <Has_accepted_use> "Myelodysplastic_syndrome" .
<LoDAC> <Has_accepted_use> "FLT3-positive_Acute_myeloid_leukemia" .
<LoDAC> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Oxsoralen-Ultra> <Brand_name_of> "Methoxsalen" .
<Libtayo> <Brand_name_of> "Cemiplimab" .
<ddC> <Has_supportive_med> "Filgrastim" .
<Ibrutinib_monotherapy> <Has_modality> "Immunosuppressive_therapy" .
<Ibrutinib_monotherapy> <Has_modality> "Chemotherapy" .
<Factor_XIII_concentrate_human> <Has_brand_name> "Corifact" .
<DHAP> <Has_antineoplastic> "Dexamethasone" .
<DHAP> <Has_antineoplastic> "Cytarabine" .
<DHAP> <Has_antineoplastic> "Cisplatin" .
<R-CHOEP-14> <Mapped_from> "R-CHOEP-14" .
<Clarithromycin> <Has_brand_name> "Biaxin" .
<Detasone> <Brand_name_of> "Dexamethasone" .
<Compazine> <Brand_name_of> "Prochlorperazine" .
<BCOP> <Maps_to> "BCOP" .
<BVP> <Is_historical_in> "Testicular_cancer" .
<Trihexal> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<LOPP/EVAP> <Has_context> "Induction_therapy" .
<Cholangiocarcinoma> <Accepted_use_of> "Tegafur_gimeracil_oteracil" .
<Cholangiocarcinoma> <Accepted_use_of> "Regorafenib_monotherapy" .
<Cholangiocarcinoma> <Accepted_use_of> "Regorafenib" .
<Cholangiocarcinoma> <Accepted_use_of> "Pembrolizumab_monotherapy" .
<Cholangiocarcinoma> <Accepted_use_of> "Oxaliplatin" .
<Cholangiocarcinoma> <Accepted_use_of> "Observation" .
<Cholangiocarcinoma> <Accepted_use_of> "Mitomycin" .
<Cholangiocarcinoma> <Accepted_use_of> "Levoleucovorin" .
<Cholangiocarcinoma> <Accepted_use_of> "Ivosidenib_monotherapy" .
<Cholangiocarcinoma> <Accepted_use_of> "Gemcitabine/Fluorouracil_and_RT" .
<Cholangiocarcinoma> <Accepted_use_of> "Gemcitabine,_Cisplatin,_S-1" .
<Cholangiocarcinoma> <Accepted_use_of> "Gemcitabine_monotherapy" .
<Cholangiocarcinoma> <Accepted_use_of> "Gemcitabine_and_nab-Paclitaxel" .
<Cholangiocarcinoma> <Accepted_use_of> "Gemcitabine_and_S-1" .
<Cholangiocarcinoma> <Accepted_use_of> "Gemcitabine_and_Mitomycin" .
<Cholangiocarcinoma> <Accepted_use_of> "Gemcitabine" .
<Cholangiocarcinoma> <Accepted_use_of> "GemOx" .
<Cholangiocarcinoma> <Accepted_use_of> "GEMOX-B" .
<Cholangiocarcinoma> <Accepted_use_of> "Folinic_acid" .
<Cholangiocarcinoma> <Accepted_use_of> "Fluorouracil,_Folinic_acid,_Gemcitabine" .
<Cholangiocarcinoma> <Accepted_use_of> "Fluorouracil_and_Folinic_acid" .
<Cholangiocarcinoma> <Accepted_use_of> "Fluorouracil" .
<Cholangiocarcinoma> <Accepted_use_of> "FELV" .
<Cholangiocarcinoma> <Accepted_use_of> "Etoposide" .
<Cholangiocarcinoma> <Accepted_use_of> "Erlotinib_and_Bevacizumab" .
<Cholangiocarcinoma> <Accepted_use_of> "Erlotinib" .
<Cholangiocarcinoma> <Accepted_use_of> "Epirubicin" .
<Cholangiocarcinoma> <Accepted_use_of> "ECF" .
<Cholangiocarcinoma> <Accepted_use_of> "Cisplatin,_Gemcitabine,_nab-Paclitaxel" .
<Cholangiocarcinoma> <Accepted_use_of> "Cisplatin_and_Gemcitabine" .
<Cholangiocarcinoma> <Accepted_use_of> "Cisplatin" .
<Cholangiocarcinoma> <Accepted_use_of> "Capecitabine_monotherapy" .
<Cholangiocarcinoma> <Accepted_use_of> "Capecitabine_and_Mitomycin" .
<Cholangiocarcinoma> <Accepted_use_of> "Capecitabine_and_Gemcitabine" .
<Cholangiocarcinoma> <Accepted_use_of> "Capecitabine" .
<Cholangiocarcinoma> <Accepted_use_of> "CapeOx" .
<Cholangiocarcinoma> <Accepted_use_of> "Bevacizumab-bvzr" .
<Cholangiocarcinoma> <Accepted_use_of> "Bevacizumab-awwb" .
<Cholangiocarcinoma> <Accepted_use_of> "Bevacizumab" .
<Cholangiocarcinoma> <Accepted_use_of> "Best_supportive_care" .
<Factor_VIII_recombinant> <May_have_route> "Intravenous" .
<Danofran> <Brand_name_of> "Ondansetron" .
<Anzatax> <Brand_name_of> "Paclitaxel" .
<Betrixaban_monotherapy> <Is_current_in> "Venous_thromboembolism" .
<O-CHOP> <Has_antineoplastic> "Vincristine" .
<O-CHOP> <Has_antineoplastic> "Prednisone" .
<O-CHOP> <Has_antineoplastic> "Ofatumumab" .
<O-CHOP> <Has_antineoplastic> "Doxorubicin" .
<O-CHOP> <Has_antineoplastic> "Cyclophosphamide" .
<CAPIRI> <Has_antineoplastic> "Irinotecan" .
<CAPIRI> <Has_antineoplastic> "Capecitabine" .
<Goserelin_and_RT> <Has_antineoplastic> "Goserelin" .
<Goserelin_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Cabozantinib_monotherapy> <Has_antineoplastic> "Cabozantinib" .
<Induction_therapy> <Mapped_from> "Induction_therapy" .
<Axitinib_and_TACE> <Mapped_from> "Axitinib_and_TACE" .
<Bactostab> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Docetaxel_and_Estramustine> <Has_context> "Non-curative_therapy" .
<Whole_brain_irradiation> <Has_context> "Salvage_therapy" .
<Whole_brain_irradiation> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Whole_brain_irradiation> <Has_context> "Consolidation_after_upfront_therapy" .
<Whole_brain_irradiation> <Has_context> "All_lines_of_therapy" .
<Colon_cancer> <FDA_indication_of> "Ziv-aflibercept" .
<Colon_cancer> <FDA_indication_of> "Ramucirumab" .
<Colon_cancer> <FDA_indication_of> "Panitumumab" .
<Colon_cancer> <FDA_indication_of> "Oxaliplatin" .
<Colon_cancer> <FDA_indication_of> "Irinotecan" .
<Colon_cancer> <FDA_indication_of> "Cetuximab" .
<Colon_cancer> <FDA_indication_of> "Capecitabine" .
<Colon_cancer> <FDA_indication_of> "Bevacizumab" .
<Topotecan_and_Bevacizumab> <Has_accepted_use> "Ovarian_cancer" .
<Vincristine_monotherapy> <Mapped_from> "Vincristine_monotherapy" .
<Reumatrex> <Brand_name_of> "Methotrexate" .
<TCHP_(Taxotere)> <Maps_to> "TCHP_(Taxotere)" .
<CX> <Maps_to> "CX" .
<Amsacrine_and_Cytarabine> <Has_antineoplastic> "Cytarabine" .
<Amsacrine_and_Cytarabine> <Has_antineoplastic> "Amsacrine" .
<Sulfamer> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Alemtuzumab_and_Methylprednisolone> <Mapped_from> "Alemtuzumab_and_Methylprednisolone" .
<BuCy,_then_auto_HSCT> <Maps_to> "BuCy,_then_auto_HSCT" .
<DOLP> <Mapped_from> "DOLP" .
<Vinorelbine_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<MAP2K1_inhibitor> <Subsumes> "Trametinib" .
<MAP2K1_inhibitor> <Subsumes> "Selumetinib" .
<MAP2K1_inhibitor> <Subsumes> "Refametinib" .
<MAP2K1_inhibitor> <Subsumes> "Cobimetinib" .
<MAP2K1_inhibitor> <Subsumes> "Binimetinib" .
<Uracil_mustard_monotherapy> <Mapped_from> "Uracil_mustard_monotherapy" .
<VBM> <Mapped_from> "VBM" .
<R-CHOEP-14> <Is_a> "Rituximab-containing_regimen" .
<R-CHOEP-14> <Is_a> "Anthracycline-containing_regimen" .
<Cyclophosphamide_and_TBI> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Teniposide> <Has_accepted_use> "Small_cell_lung_cancer" .
<Teniposide> <Has_accepted_use> "Low-grade_glioma" .
<Teniposide> <Has_accepted_use> "HIV-associated_lymphoma" .
<Teniposide> <Has_accepted_use> "CNS_lymphoma" .
<Teniposide> <Has_accepted_use> "Burkitt_lymphoma" .
<Teniposide> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<CMFV> <Is_historical_in> "Breast_cancer" .
<Acute_myeloid_leukemia> <Subsumes> "IDH-mutated_Acute_myeloid_leukemia" .
<Acute_myeloid_leukemia> <Subsumes> "FLT3-positive_Acute_myeloid_leukemia" .
<Histiocytosis> <Subsumes> "Rosai-Dorfman-Destombes_disease" .
<Histiocytosis> <Subsumes> "Langerhans_cell_histiocytosis" .
<Histiocytosis> <Subsumes> "Hemophagocytic_lymphohistiocytosis" .
<Histiocytosis> <Subsumes> "Erdheim-Chester_disease" .
<Ramucirumab_monotherapy> <Has_antineoplastic> "Ramucirumab" .
<Lomustine,_Methotrexate,_Procarbazine> <Has_antineoplastic> "Procarbazine" .
<Lomustine,_Methotrexate,_Procarbazine> <Has_antineoplastic> "Methotrexate" .
<Lomustine,_Methotrexate,_Procarbazine> <Has_antineoplastic> "Lomustine" .
<Predeltin> <Brand_name_of> "Prednisone" .
<Lobact> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CAP_(Platinol)> <Has_antineoplastic> "Doxorubicin" .
<CAP_(Platinol)> <Has_antineoplastic> "Cyclophosphamide" .
<CAP_(Platinol)> <Has_antineoplastic> "Cisplatin" .
<Aspirin_and_Dexamethasone> <Has_context> "Non-curative_therapy" .
<Benectrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<R-CP> <Is_a> "Rituximab-containing_regimen" .
<R-BAC> <Has_accepted_use> "Mantle_cell_lymphoma" .
<R-BAC> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<MAPI> <Is_a> "Anthracycline-containing_regimen" .
<Droxol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Vitrakvi> <Brand_name_of> "Larotrectinib" .
<Irinotecan_liposomal_monotherapy> <Is_a> "Irinotecan-containing_regimen" .
<CHOP_and_Everolimus> <Has_antineoplastic> "Vincristine" .
<CHOP_and_Everolimus> <Has_antineoplastic> "Prednisone" .
<CHOP_and_Everolimus> <Has_antineoplastic> "Everolimus" .
<CHOP_and_Everolimus> <Has_antineoplastic> "Doxorubicin" .
<CHOP_and_Everolimus> <Has_antineoplastic> "Cyclophosphamide" .
<Ublituximab> <May_have_route> "Intravenous" .
<Siruta> <Brand_name_of> "Mesna" .
<Capecitabine,_Carboplatin,_Paclitaxel,_RT> <Is_current_in> "Esophageal_cancer" .
<Folmigor> <Brand_name_of> "Folinic_acid" .
<Sennosides> <Supportive_med_of> "SC-EPOCH-RR" .
<Sennosides> <Supportive_med_of> "DA-R-EPOCH" .
<Sennosides> <Supportive_med_of> "DA-EPOCH" .
<Neomit> <Brand_name_of> "Ondansetron" .
<Pomalidomide,_Dexamethasone,_Pembrolizumab> <Maps_to> "Pomalidomide,_Dexamethasone,_Pembrolizumab" .
<MA> <Mapped_from> "MA" .
<Erlotinib_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<FOLFIRI> <Maps_to> "FOLFIRI" .
<ECF/5-FU_and_RT> <Has_accepted_use> "Esophageal_cancer" .
<CAF_and_MPA> <Has_antineoplastic> "Medroxyprogesterone" .
<CAF_and_MPA> <Has_antineoplastic> "Fluorouracil" .
<CAF_and_MPA> <Has_antineoplastic> "Doxorubicin" .
<CAF_and_MPA> <Has_antineoplastic> "Cyclophosphamide" .
<Proton_pump_inhibitor> <Is_a> "Supportive_medication" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_context> "Non-curative_therapy" .
<Oncotor> <Brand_name_of> "Ondansetron" .
<ZRd> <Has_modality> "Chemotherapy" .
<Triptorelin_monotherapy> <Is_current_in> "Prostate_cancer" .
<Pantoprazole> <May_have_route> "Oral" .
<Pantoprazole> <May_have_route> "Intravenous" .
<CHOP> <Maps_to> "CHOP" .
<Denileukin_diftitox> <Has_brand_name> "Ontak" .
<ADT,_Docetaxel,_Estramustine> <Has_context> "Non-curative_therapy" .
<Gefitinib> <May_have_route> "Oral" .
<Isotretinoin> <Antineoplastic_of> "Isotretinoin_monotherapy" .
<Isotretinoin> <Antineoplastic_of> "Isotretinoin_and_Dinutuximab" .
<Isotretinoin> <Antineoplastic_of> "Interferon_alfa-2a_and_Isotretinoin" .
<Isotretinoin> <Antineoplastic_of> "GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab" .
<Isotretinoin> <Antineoplastic_of> "Cisplatin,_Interferon_alfa-2a,_Isotretinoin" .
<LoDAC_and_Venetoclax> <Has_antineoplastic> "Venetoclax" .
<LoDAC_and_Venetoclax> <Has_antineoplastic> "Cytarabine" .
<VAMP_(Amethopterin)> <Mapped_from> "VAMP_(Amethopterin)" .
<Isoxan> <Brand_name_of> "Ifosfamide" .
<Cyclophosphamide,_Prednisone,_Diethylstilbestrol> <Mapped_from> "Cyclophosphamide,_Prednisone,_Diethylstilbestrol" .
<FOLFOX_7/sLV5FU2> <Is_current_in> "Colon_cancer" .
<Inflammitant> <Is_a> "Chemotherapeutic" .
<Cisplatin,_Etoposide,_Irinotecan> <Has_antineoplastic> "Irinotecan" .
<Cisplatin,_Etoposide,_Irinotecan> <Has_antineoplastic> "Etoposide" .
<Cisplatin,_Etoposide,_Irinotecan> <Has_antineoplastic> "Cisplatin" .
<Dusil> <Brand_name_of> "Aspirin" .
<Pemetrexed> <Antineoplastic_of> "Pemetrexed_monotherapy" .
<Pemetrexed> <Antineoplastic_of> "Pemetrexed_and_Pembrolizumab" .
<Pemetrexed> <Antineoplastic_of> "Pemetrexed_and_Bevacizumab" .
<Pemetrexed> <Antineoplastic_of> "Nintedanib_and_Pemetrexed" .
<Pemetrexed> <Antineoplastic_of> "Gefitinib_and_Pemetrexed" .
<Pemetrexed> <Antineoplastic_of> "GCP" .
<Pemetrexed> <Antineoplastic_of> "Cisplatin,_Pemetrexed,_TTFields" .
<Pemetrexed> <Antineoplastic_of> "Cisplatin,_Pemetrexed,_Pembrolizumab" .
<Pemetrexed> <Antineoplastic_of> "Cisplatin,_Pemetrexed,_Bevacizumab" .
<Pemetrexed> <Antineoplastic_of> "Cisplatin_and_Pemetrexed" .
<Pemetrexed> <Antineoplastic_of> "Carboplatin,_Pemetrexed,_Pembrolizumab" .
<Pemetrexed> <Antineoplastic_of> "Carboplatin,_Pemetrexed,_Bevacizumab" .
<Pemetrexed> <Antineoplastic_of> "Carboplatin_and_Pemetrexed" .
<Orphan_drug> <Subsumes> "Volasertib" .
<Orphan_drug> <Subsumes> "Trabectedin" .
<Orphan_drug> <Subsumes> "Pracinostat" .
<Orphan_drug> <Subsumes> "Perifosine" .
<Orphan_drug> <Subsumes> "Forodesine" .
<Orphan_drug> <Subsumes> "Amsacrine" .
<Orphan_drug> <Subsumes> "Alvocidib" .
<Fentul> <Brand_name_of> "Ifosfamide" .
<MP_(Prednisolone)> <Has_modality> "Chemotherapy" .
<Cyclophosphamide_monotherapy> <Is_current_in> "Neuroblastoma" .
<Cyclophosphamide_monotherapy> <Is_current_in> "Large_granular_lymphocytic_leukemia" .
<Cyclophosphamide_monotherapy> <Is_current_in> "Glioblastoma" .
<Cyclophosphamide_monotherapy> <Is_current_in> "Follicular_lymphoma" .
<Cyclophosphamide_monotherapy> <Is_current_in> "Breast_cancer" .
<Cyclophosphamide_monotherapy> <Is_current_in> "Anaplastic_glioma" .
<OEPA> <Mapped_from> "OEPA" .
<Bactrimel> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bleomycin> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Bleomycin> <Is_a> "Neutral" .
<Bleomycin> <Is_a> "Irritant" .
<Bleomycin> <Is_a> "DNA_synthesis_inhibitor" .
<IGEV> <Has_modality> "Chemotherapy" .
<CAPIRI> <Has_supportive_med> "Loperamide" .
<CAPIRI> <Has_supportive_med> "Ciprofloxacin" .
<CAPIRI> <Has_supportive_med> "Atropine" .
<IP-BCD> <Has_modality> "Chemotherapy" .
<Hycamtin> <Brand_name_of> "Topotecan" .
<Siltran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Xepaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Polatuzumab_vedotin> <May_have_route> "Intravenous" .
<PCD> <Has_supportive_med> "Aspirin" .
<KMP> <Is_current_in> "Multiple_myeloma" .
<Capecitabine_and_Neratinib> <Has_context> "Non-curative_subsequent-line_therapy" .
<Brentuximab_vedotin_and_Dacarbazine> <Maps_to> "Brentuximab_vedotin_and_Dacarbazine" .
<Anti-VEGFR_antibody> <Is_a> "VEGFR_inhibitor" .
<Anti-VEGFR_antibody> <Is_a> "Antibody_medication" .
<Docegem> <Brand_name_of> "Docetaxel" .
<MAID> <Mapped_from> "MAID" .
<Levoleucovorin> <May_have_route> "Intravenous" .
<FAC> <Maps_to> "FAC" .
<FLAG-Ida> <Has_supportive_med> "Lenograstim" .
<FLAG-Ida> <Has_supportive_med> "Filgrastim" .
<Warfarin_monotherapy> <Mapped_from> "Warfarin_monotherapy" .
<Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<VI,_then_VDC/IE,_then_VAC,_then_VI> <Has_antineoplastic> "Vincristine" .
<VI,_then_VDC/IE,_then_VAC,_then_VI> <Has_antineoplastic> "Irinotecan" .
<VI,_then_VDC/IE,_then_VAC,_then_VI> <Has_antineoplastic> "Ifosfamide" .
<VI,_then_VDC/IE,_then_VAC,_then_VI> <Has_antineoplastic> "Etoposide" .
<VI,_then_VDC/IE,_then_VAC,_then_VI> <Has_antineoplastic> "Doxorubicin" .
<VI,_then_VDC/IE,_then_VAC,_then_VI> <Has_antineoplastic> "Dactinomycin" .
<VI,_then_VDC/IE,_then_VAC,_then_VI> <Has_antineoplastic> "Cyclophosphamide" .
<ABV_(Vinblastine)> <Is_current_in> "Kaposi_sarcoma" .
<Cytarine> <Brand_name_of> "Cytarabine" .
<Retacrit> <Brand_name_of> "Epoetin_alfa-epbx" .
<Pravastatin> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Mexate> <Brand_name_of> "Methotrexate" .
<Cytarabine_and_Idarubicin> <Maps_to> "Cytarabine_and_Idarubicin" .
<Narfoz> <Brand_name_of> "Ondansetron" .
<Lorelin_Depot> <Brand_name_of> "Leuprolide" .
<Ifosfamide_and_Vinorelbine> <Has_accepted_use> "Hodgkin_lymphoma" .
<Motesanib> <Has_accepted_use> "Thyroid_cancer" .
<Dicorsone> <Brand_name_of> "Dexamethasone" .
<Fluorouracil_and_RT> <Has_modality> "Radiotherapy" .
<Fluorouracil_and_RT> <Has_modality> "Chemotherapy" .
<Fostamatinib> <Has_accepted_use> "Immune_thrombocytopenia" .
<Tamoxifen_and_Prednisolone> <Has_context> "Non-curative_first-line_therapy" .
<Methotrexate,_Tacrolimus,_Tocilizumab> <Is_current_in> "Graft_versus_host_disease" .
<Lictora> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CLF> <Mapped_from> "CLF" .
<Enoxaparin_monotherapy> <Has_supportive_med> "Enoxaparin" .
<Ocudex> <Brand_name_of> "Dexamethasone" .
<Winol> <Brand_name_of> "Irinotecan" .
<ADE_(high-dose_Ara-C)> <Is_current_in> "Acute_myeloid_leukemia" .
<Levoleucovorin> <Has_brand_name> "Fusilev" .
<TCH_(Taxotere,_Cyclophosphamide)> <Maps_to> "TCH_(Taxotere,_Cyclophosphamide)" .
<Aminopterin_monotherapy> <Maps_to> "Aminopterin_monotherapy" .
<Setronon> <Brand_name_of> "Ondansetron" .
<Necitumumab_monotherapy> <Mapped_from> "Necitumumab_monotherapy" .
<Thrombate_III> <Brand_name_of> "Antithrombin_III" .
<Dexamag> <Brand_name_of> "Dexamethasone" .
<Observation> <Has_context> "Non-curative_therapy" .
<Observation> <Has_context> "Non-curative_subsequent-line_consolidation_therapy" .
<Observation> <Has_context> "Non-curative_second-line_maintenance_therapy" .
<Observation> <Has_context> "Non-curative_first-line_therapy" .
<Observation> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Observation> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Observation> <Has_context> "Maintenance_after_upfront_therapy" .
<Observation> <Has_context> "Maintenance_after_salvage_therapy" .
<Observation> <Has_context> "Local_therapy" .
<Observation> <Has_context> "Consolidation_after_upfront_therapy" .
<Observation> <Has_context> "All_lines_of_therapy" .
<Observation> <Has_context> "Adjuvant_therapy" .
<Dinutuximab> <Antineoplastic_of> "Isotretinoin_and_Dinutuximab" .
<Dinutuximab> <Antineoplastic_of> "Irinotecan,_Temozolomide,_Dinutuximab" .
<Dinutuximab> <Antineoplastic_of> "GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab" .
<Lisoderme> <Brand_name_of> "Dexamethasone" .
<CAPIRI> <Has_modality> "Chemotherapy" .
<ATG_(Horse),_Cyclosporine,_Methylprednisolone> <Has_accepted_use> "Aplastic_anemia" .
<CHOP_Modified> <Has_context> "Induction_therapy" .
<Multiple_myeloma> <Current_treated_by> "Zoledronic_acid_therapy" .
<Multiple_myeloma> <Current_treated_by> "ZRd" .
<Multiple_myeloma> <Current_treated_by> "Vemurafenib_monotherapy" .
<Multiple_myeloma> <Current_treated_by> "VTP" .
<Multiple_myeloma> <Current_treated_by> "VTD-PACE" .
<Multiple_myeloma> <Current_treated_by> "VTD" .
<Multiple_myeloma> <Current_treated_by> "VT" .
<Multiple_myeloma> <Current_treated_by> "VP" .
<Multiple_myeloma> <Current_treated_by> "VMPT" .
<Multiple_myeloma> <Current_treated_by> "VMP/Rd" .
<Multiple_myeloma> <Current_treated_by> "VMP,_then_Rd" .
<Multiple_myeloma> <Current_treated_by> "VMP" .
<Multiple_myeloma> <Current_treated_by> "VDC" .
<Multiple_myeloma> <Current_treated_by> "VD" .
<Multiple_myeloma> <Current_treated_by> "VAD-P/Q" .
<Multiple_myeloma> <Current_treated_by> "VAD-P" .
<Multiple_myeloma> <Current_treated_by> "VAD_doxil" .
<Multiple_myeloma> <Current_treated_by> "V-HyperCAD" .
<Multiple_myeloma> <Current_treated_by> "Total_Therapy" .
<Multiple_myeloma> <Current_treated_by> "Thalidomide_monotherapy" .
<Multiple_myeloma> <Current_treated_by> "Thalidomide_and_Prednisone" .
<Multiple_myeloma> <Current_treated_by> "Thalidomide_and_Prednisolone" .
<Multiple_myeloma> <Current_treated_by> "Tandem_melphalan,_then_auto_HSCT" .
<Multiple_myeloma> <Current_treated_by> "TVAD_doxil" .
<Multiple_myeloma> <Current_treated_by> "TD" .
<Multiple_myeloma> <Current_treated_by> "TAD_(Thalidomide)" .
<Multiple_myeloma> <Current_treated_by> "Selinexor_and_Dexamethasone" .
<Multiple_myeloma> <Current_treated_by> "Rd" .
<Multiple_myeloma> <Current_treated_by> "RVDC" .
<Multiple_myeloma> <Current_treated_by> "RVD" .
<Multiple_myeloma> <Current_treated_by> "RP" .
<Multiple_myeloma> <Current_treated_by> "Pomalidomide_monotherapy" .
<Multiple_myeloma> <Current_treated_by> "Pomalidomide_and_Prednisone" .
<Multiple_myeloma> <Current_treated_by> "Placebo" .
<Multiple_myeloma> <Current_treated_by> "PVD" .
<Multiple_myeloma> <Current_treated_by> "PD" .
<Multiple_myeloma> <Current_treated_by> "PCP" .
<Multiple_myeloma> <Current_treated_by> "PCD" .
<Multiple_myeloma> <Current_treated_by> "PAD_doxil" .
<Multiple_myeloma> <Current_treated_by> "PAD" .
<Multiple_myeloma> <Current_treated_by> "Observation" .
<Multiple_myeloma> <Current_treated_by> "Melphalan,_then_auto_HSCT" .
<Multiple_myeloma> <Current_treated_by> "MPT" .
<Multiple_myeloma> <Current_treated_by> "MPR" .
<Multiple_myeloma> <Current_treated_by> "MP" .
<Multiple_myeloma> <Current_treated_by> "Lenalidomide_monotherapy" .
<Multiple_myeloma> <Current_treated_by> "KTD" .
<Multiple_myeloma> <Current_treated_by> "KRd" .
<Multiple_myeloma> <Current_treated_by> "KPD" .
<Multiple_myeloma> <Current_treated_by> "KMP" .
<Multiple_myeloma> <Current_treated_by> "KD" .
<Multiple_myeloma> <Current_treated_by> "KCD" .
<Multiple_myeloma> <Current_treated_by> "Ixazomib_monotherapy" .
<Multiple_myeloma> <Current_treated_by> "Ixazomib_and_Dexamethasone" .
<Multiple_myeloma> <Current_treated_by> "IRd" .
<Multiple_myeloma> <Current_treated_by> "Hyper-CVAD" .
<Multiple_myeloma> <Current_treated_by> "FRD" .
<Multiple_myeloma> <Current_treated_by> "Elo-VD" .
<Multiple_myeloma> <Current_treated_by> "Elo-Rd" .
<Multiple_myeloma> <Current_treated_by> "Elo-PD" .
<Multiple_myeloma> <Current_treated_by> "Daratumumab_monotherapy" .
<Multiple_myeloma> <Current_treated_by> "Dara-VTD" .
<Multiple_myeloma> <Current_treated_by> "Dara-VMP" .
<Multiple_myeloma> <Current_treated_by> "Dara-VD" .
<Multiple_myeloma> <Current_treated_by> "Dara-Rd" .
<Multiple_myeloma> <Current_treated_by> "Dara-PD" .
<Multiple_myeloma> <Current_treated_by> "Dara-KD" .
<Multiple_myeloma> <Current_treated_by> "DTPACE" .
<Multiple_myeloma> <Current_treated_by> "DCEP" .
<Multiple_myeloma> <Current_treated_by> "Cyclophosphamide_and_Prednisone" .
<Multiple_myeloma> <Current_treated_by> "Cyclophosphamide_and_Dexamethasone" .
<Multiple_myeloma> <Current_treated_by> "Carfilzomib_monotherapy" .
<Multiple_myeloma> <Current_treated_by> "Carfilzomib_and_Panobinostat" .
<Multiple_myeloma> <Current_treated_by> "CYKLONE" .
<Multiple_myeloma> <Current_treated_by> "CVAD" .
<Multiple_myeloma> <Current_treated_by> "CTD" .
<Multiple_myeloma> <Current_treated_by> "CRd" .
<Multiple_myeloma> <Current_treated_by> "CRD" .
<Multiple_myeloma> <Current_treated_by> "CPR" .
<Multiple_myeloma> <Current_treated_by> "Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat" .
<Multiple_myeloma> <Current_treated_by> "Bortezomib,_Dexamethasone,_Panobinostat" .
<Multiple_myeloma> <Current_treated_by> "Bortezomib_monotherapy" .
<Multiple_myeloma> <Current_treated_by> "Bortezomib_and_Vorinostat" .
<Multiple_myeloma> <Current_treated_by> "Bortezomib_and_Melphalan,_then_auto_HSCT" .
<Multiple_myeloma> <Current_treated_by> "Bortezomib_and_Doxorubicin_liposomal" .
<Multiple_myeloma> <Current_treated_by> "Bortezomib_and_Cyclophosphamide" .
<Multiple_myeloma> <Current_treated_by> "BiRd" .
<Multiple_myeloma> <Current_treated_by> "BTD" .
<Multiple_myeloma> <Current_treated_by> "BLD" .
<Multiple_myeloma> <Current_treated_by> "BID" .
<Multiple_myeloma> <Current_treated_by> "BBD" .
<Vemurafenib_monotherapy> <Has_antineoplastic> "Vemurafenib" .
<Gynecologic_cancer> <Is_a> "Malignant_solid_neoplasm" .
<Acute_promyelocytic_leukemia> <Is_a> "Acute_leukemia" .
<Lenangio> <Brand_name_of> "Lenalidomide" .
<Trabectedin> <Has_FDA_indication> "Liposarcoma" .
<Trabectedin> <Has_FDA_indication> "Leiomyosarcoma" .
<ALK-positive_Non-small_cell_lung_cancer> <Is_a> "Non-small_cell_lung_cancer" .
<Interferon_alfa-2b_monotherapy> <Has_modality> "Immunotherapy" .
<Anti-IL-6_antibody> <Subsumes> "Siltuximab" .
<Somatostatin_analog> <Is_a> "Endocrine_therapeutic" .
<Interferon_alfa-2b> <Has_accepted_use> "Systemic_mastocytosis" .
<Interferon_alfa-2b> <Has_accepted_use> "Renal_cell_carcinoma" .
<Interferon_alfa-2b> <Has_accepted_use> "Pancreatic_NET" .
<Interferon_alfa-2b> <Has_accepted_use> "Neuroendocrine_tumor" .
<Interferon_alfa-2b> <Has_accepted_use> "Multiple_myeloma" .
<Interferon_alfa-2b> <Has_accepted_use> "Melanoma" .
<Interferon_alfa-2b> <Has_accepted_use> "Kaposi_sarcoma" .
<Interferon_alfa-2b> <Has_accepted_use> "Hairy_cell_leukemia" .
<Interferon_alfa-2b> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Interferon_alfa-2b> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<O-FC> <Maps_to> "O-FC" .
<mFOLFOX_and_Sorafenib> <Mapped_from> "mFOLFOX_and_Sorafenib" .
<Vosaroxin_and_Cytarabine> <Has_antineoplastic> "Vosaroxin" .
<Vosaroxin_and_Cytarabine> <Has_antineoplastic> "Cytarabine" .
<FOLFIRI_and_Cetuximab_(L-Leucovorin)> <Is_current_in> "Colon_cancer" .
<Cydoxan> <Brand_name_of> "Cyclophosphamide" .
<Vosaroxin> <Has_accepted_use> "Acute_myeloid_leukemia" .
<iddEPC> <Has_supportive_med> "Pegfilgrastim" .
<LVP_.22Sandwich.22> <Is_current_in> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Cisplatin_and_Pemetrexed> <Mapped_from> "Cisplatin_and_Pemetrexed" .
<Suprin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Trisuprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Rivaroxaban_monotherapy> <Has_accepted_use> "Venous_thromboembolism" .
<Rivaroxaban_monotherapy> <Has_accepted_use> "Heparin-induced_thrombocytopenia" .
<Rivaroxaban_monotherapy> <Has_accepted_use> "Antiphospholipid_antibody_syndrome" .
<Privigen> <Brand_name_of> "Intravenous_immunoglobulin_(IVIG)" .
<Tosuben> <Brand_name_of> "Etoposide" .
<BEAM,_then_auto_HSCT> <Maps_to> "BEAM,_then_auto_HSCT" .
<Siltuximab> <Is_a> "Antibody_medication" .
<Siltuximab> <Is_a> "Anti-IL-6_antibody" .
<VABE> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Betrixaban> <May_have_route> "Oral" .
<Antibiotic> <Subsumes> "PCP_prophylaxis" .
<Antibiotic> <Subsumes> "Antiviral" .
<Antibiotic> <Subsumes> "Antifungal" .
<Antibiotic> <Subsumes> "Antibacterial" .
<Eritrelan> <Brand_name_of> "Epoetin_alfa" .
<Vismodegib> <May_have_route> "Oral" .
<Posidon> <Brand_name_of> "Etoposide" .
<ddC> <Has_modality> "Chemotherapy" .
<Kyprolis> <Brand_name_of> "Carfilzomib" .
<Cytarabine_monotherapy> <Is_historical_in> "Acute_myeloid_leukemia" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA> <Is_a> "Anthracycline-containing_regimen" .
<Busulfan_and_Melphalan> <Has_context> "All_lines_of_therapy" .
<Baczole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<IT_Cytarabine,_Methotrexate,_Prednisone> <Has_context> "Local_therapy" .
<XA-Zole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CaloMist> <Brand_name_of> "Cyanocobalamin" .
<FAC_and_Bevacizumab> <Mapped_from> "FAC_and_Bevacizumab" .
<R-GCVP> <Has_modality> "Chemotherapy" .
<Rilotumumab> <May_have_route> "Intravenous" .
<Rd> <Has_supportive_med> "Zoledronic_acid" .
<Rd> <Has_supportive_med> "Warfarin" .
<Rd> <Has_supportive_med> "Valacyclovir" .
<Rd> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Rd> <Has_supportive_med> "Proton_pump_inhibitors" .
<Rd> <Has_supportive_med> "Pamidronate" .
<Rd> <Has_supportive_med> "Omeprazole" .
<Rd> <Has_supportive_med> "Low_molecular_weight_heparins" .
<Rd> <Has_supportive_med> "Lansoprazole" .
<Rd> <Has_supportive_med> "Clopidogrel" .
<Rd> <Has_supportive_med> "Ciprofloxacin" .
<Rd> <Has_supportive_med> "Bisphosphonates" .
<Rd> <Has_supportive_med> "Aspirin" .
<Rd> <Has_supportive_med> "Antivirals" .
<Rd> <Has_supportive_med> "Antiplatelet_agents" .
<Rd> <Has_supportive_med> "Anticoagulants" .
<Rd> <Has_supportive_med> "Amoxicillin" .
<Trifluridine_and_tipiracil_monotherapy> <Maps_to> "Trifluridine_and_tipiracil_monotherapy" .
<VMV-VAC> <Has_antineoplastic> "Vincristine" .
<VMV-VAC> <Has_antineoplastic> "Methotrexate" .
<VMV-VAC> <Has_antineoplastic> "Etoposide" .
<VMV-VAC> <Has_antineoplastic> "Doxorubicin" .
<VMV-VAC> <Has_antineoplastic> "Cyclophosphamide" .
<Bivalirudin_monotherapy> <Has_modality> "Anticoagulation" .
<FOLFIRI_and_Bevacizumab_(L-Leucovorin)> <Is_a> "Irinotecan-containing_regimen" .
<FOLFIRI_and_Bevacizumab_(L-Leucovorin)> <Is_a> "Bevacizumab-containing_regimen" .
<CX> <Is_current_in> "Gastric_cancer" .
<CX> <Is_current_in> "Esophageal_cancer" .
<7_plus_3d_and_Sorafenib> <Has_modality> "Chemotherapy" .
<Non-curative_first-line_induction_therapy> <Is_a> "Non-curative_first-line_therapy" .
<FOLFIRI_and_Cetuximab_(L-Leucovorin)> <Is_a> "Irinotecan-containing_regimen" .
<Ipilimumab_monotherapy> <Has_context> "Non-curative_therapy" .
<Ipilimumab_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Ipilimumab_monotherapy> <Has_context> "Adjuvant_therapy" .
<R-DexaBEAM> <Has_accepted_use> "Follicular_lymphoma" .
<R-DexaBEAM> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<ADE_and_ATRA> <Mapped_from> "ADE_and_ATRA" .
<Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone> <Has_modality> "Chemotherapy" .
<R-MPV> <Has_accepted_use> "CNS_lymphoma" .
<Non-curative_subsequent-line_consolidation_therapy> <Mapped_from> "Non-curative_subsequent-line_consolidation_therapy" .
<COPAD/CYVE> <Has_context> "Maintenance_after_upfront_therapy" .
<ACT> <Is_a> "Antiestrogen-containing_regimen" .
<ACT> <Is_a> "Anthracycline-containing_regimen" .
<Bortezomib_and_Vorinostat> <Has_accepted_use> "Multiple_myeloma" .
<GEMOX-B> <Has_accepted_use> "Gallbladder_cancer" .
<GEMOX-B> <Has_accepted_use> "Cholangiocarcinoma" .
<Ocedran> <Brand_name_of> "Dexamethasone" .
<PCP> <Mapped_from> "PCP" .
<KD> <Has_context> "Non-curative_therapy" .
<Cisplatin_and_Mitomycin> <Has_accepted_use> "Cervical_cancer" .
<Gilteritinib_monotherapy> <Is_current_in> "Acute_myeloid_leukemia" .
<Apalutamide> <Antineoplastic_of> "Apalutamide_monotherapy" .
<Apalutamide> <Antineoplastic_of> "ADT_and_Apalutamide" .
<Edoxaban_monotherapy> <Has_supportive_med> "Low_molecular_weight_heparins" .
<Edoxaban_monotherapy> <Has_supportive_med> "Edoxaban" .
<ATG_(Horse),_Cyclosporine,_Sirolimus> <Has_context> "Induction_therapy" .
<Cotrexel> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<FCR,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<FCR,_then_allo_HSCT> <Has_modality> "Immunosuppressive_therapy" .
<FCR,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<Heparin-induced_thrombocytopenia> <Accepted_use_of> "Rivaroxaban_monotherapy" .
<Heparin-induced_thrombocytopenia> <Accepted_use_of> "Rivaroxaban" .
<Heparin-induced_thrombocytopenia> <Accepted_use_of> "Lepirudin_monotherapy" .
<Heparin-induced_thrombocytopenia> <Accepted_use_of> "Lepirudin" .
<Heparin-induced_thrombocytopenia> <Accepted_use_of> "Intravenous_Immunoglobulin" .
<Heparin-induced_thrombocytopenia> <Accepted_use_of> "Fondaparinux_monotherapy" .
<Heparin-induced_thrombocytopenia> <Accepted_use_of> "Fondaparinux" .
<Heparin-induced_thrombocytopenia> <Accepted_use_of> "Danaparoid_monotherapy" .
<Heparin-induced_thrombocytopenia> <Accepted_use_of> "Danaparoid" .
<Heparin-induced_thrombocytopenia> <Accepted_use_of> "Argatroban_monotherapy" .
<Heparin-induced_thrombocytopenia> <Accepted_use_of> "Argatroban" .
<COX-1_inhibitor> <Is_a> "Nonsteroidal_anti-inflammatory_drugs_(NSAIDs)" .
<COX-1_inhibitor> <Is_a> "Antiplatelet_agent" .
<Osalen> <Brand_name_of> "Alendronate" .
<BV-CHP> <Mapped_from> "BV-CHP" .
<Proclose> <Brand_name_of> "Octreotide" .
<VMV-VAC> <Is_historical_in> "Small_cell_lung_cancer" .
<Dexonium> <Brand_name_of> "Dexamethasone" .
<Berlocid> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Binimetinib,_Encorafenib,_Cetuximab> <Has_antineoplastic> "Encorafenib" .
<Binimetinib,_Encorafenib,_Cetuximab> <Has_antineoplastic> "Cetuximab" .
<Binimetinib,_Encorafenib,_Cetuximab> <Has_antineoplastic> "Binimetinib" .
<Acalabrutinib> <Has_FDA_indication> "Mantle_cell_lymphoma" .
<Acalabrutinib> <Has_FDA_indication> "Chronic_lymphocytic_leukemia" .
<Granix> <Brand_name_of> "Tbo-filgrastim" .
<Ladogal> <Brand_name_of> "Danazol" .
<EPOCH,_dose-escalated> <Is_a> "Anthracycline-containing_regimen" .
<Fam-trastuzumab_deruxtecan> <May_have_route> "Intravenous" .
<Capsy> <Brand_name_of> "Capecitabine" .
<ABVE-PC> <Has_supportive_med> "Filgrastim" .
<ABVE-PC> <Has_supportive_med> "Dexrazoxane" .
<R2CHOP> <Has_antineoplastic> "Vincristine" .
<R2CHOP> <Has_antineoplastic> "Rituximab" .
<R2CHOP> <Has_antineoplastic> "Prednisone" .
<R2CHOP> <Has_antineoplastic> "Lenalidomide" .
<R2CHOP> <Has_antineoplastic> "Doxorubicin" .
<R2CHOP> <Has_antineoplastic> "Cyclophosphamide" .
<No_neoadjuvant_therapy> <Has_modality> "Null_therapy" .
<BuCyTBI,_then_allo_HSCT> <Mapped_from> "BuCyTBI,_then_allo_HSCT" .
<Interferonum_Leucocyticum> <Brand_name_of> "Interferon_alfa-2b" .
<Alpelisib> <Antineoplastic_of> "Alpelisib_and_Fulvestrant" .
<Rivaroxaban> <Has_brand_name> "Xarelto" .
<Osteosarcoma> <Accepted_use_of> "Topotecan" .
<Osteosarcoma> <Accepted_use_of> "Samarium-153_with_stem_cell_support" .
<Osteosarcoma> <Accepted_use_of> "Samarium-153" .
<Osteosarcoma> <Accepted_use_of> "Observation" .
<Osteosarcoma> <Accepted_use_of> "Methotrexate_and_Vincristine" .
<Osteosarcoma> <Accepted_use_of> "Methotrexate" .
<Osteosarcoma> <Accepted_use_of> "MAPIE" .
<Osteosarcoma> <Accepted_use_of> "MAPI" .
<Osteosarcoma> <Accepted_use_of> "MAP" .
<Osteosarcoma> <Accepted_use_of> "MA-BCD/AP" .
<Osteosarcoma> <Accepted_use_of> "MA-BCD" .
<Osteosarcoma> <Accepted_use_of> "MA" .
<Osteosarcoma> <Accepted_use_of> "M-EI" .
<Osteosarcoma> <Accepted_use_of> "M-BCD" .
<Osteosarcoma> <Accepted_use_of> "Ifosfamide" .
<Osteosarcoma> <Accepted_use_of> "IP-BCD" .
<Osteosarcoma> <Accepted_use_of> "IE" .
<Osteosarcoma> <Accepted_use_of> "ICE" .
<Osteosarcoma> <Accepted_use_of> "Gemcitabine_monotherapy" .
<Osteosarcoma> <Accepted_use_of> "Gemcitabine" .
<Osteosarcoma> <Accepted_use_of> "Etoposide" .
<Osteosarcoma> <Accepted_use_of> "Epirubicin" .
<Osteosarcoma> <Accepted_use_of> "Doxorubicin_monotherapy" .
<Osteosarcoma> <Accepted_use_of> "Doxorubicin" .
<Osteosarcoma> <Accepted_use_of> "Docetaxel_and_Gemcitabine" .
<Osteosarcoma> <Accepted_use_of> "Docetaxel" .
<Osteosarcoma> <Accepted_use_of> "Dactinomycin" .
<Osteosarcoma> <Accepted_use_of> "Cyclophosphamide_and_Topotecan" .
<Osteosarcoma> <Accepted_use_of> "Cyclophosphamide_and_Etoposide" .
<Osteosarcoma> <Accepted_use_of> "Cyclophosphamide" .
<Osteosarcoma> <Accepted_use_of> "Cixutumumab" .
<Osteosarcoma> <Accepted_use_of> "Cisplatin,_Epirubicin,_Ifosfamide" .
<Osteosarcoma> <Accepted_use_of> "Cisplatin_and_Doxorubicin" .
<Osteosarcoma> <Accepted_use_of> "Cisplatin" .
<Osteosarcoma> <Accepted_use_of> "Carboplatin" .
<Osteosarcoma> <Accepted_use_of> "Bleomycin" .
<Immunotherapy> <Modality_of> "Tisagenlecleucel_monotherapy" .
<Immunotherapy> <Modality_of> "Talimogene_laherparepvec_monotherapy" .
<Immunotherapy> <Modality_of> "TILs" .
<Immunotherapy> <Modality_of> "TFC,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "Sipuleucel-T_monotherapy" .
<Immunotherapy> <Modality_of> "Pomalidomide,_Dexamethasone,_Pembrolizumab" .
<Immunotherapy> <Modality_of> "Pembrolizumab_monotherapy" .
<Immunotherapy> <Modality_of> "Peginterferon_alfa-2b_monotherapy" .
<Immunotherapy> <Modality_of> "Peginterferon_alfa-2a_monotherapy" .
<Immunotherapy> <Modality_of> "Octreotide_and_Interferon_alfa" .
<Immunotherapy> <Modality_of> "Nivolumab,_then_Ipilimumab" .
<Immunotherapy> <Modality_of> "Nivolumab_monotherapy" .
<Immunotherapy> <Modality_of> "Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "Low-dose_TBI,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "Low-dose_Interleukin-2" .
<Immunotherapy> <Modality_of> "Levamisole_monotherapy" .
<Immunotherapy> <Modality_of> "Lenvatinib_and_Pembrolizumab" .
<Immunotherapy> <Modality_of> "Lanreotide_and_Interferon_alfa-2b" .
<Immunotherapy> <Modality_of> "Isotretinoin_and_Dinutuximab" .
<Immunotherapy> <Modality_of> "Irinotecan,_Temozolomide,_Dinutuximab" .
<Immunotherapy> <Modality_of> "Ipilimumab,_then_Nivolumab" .
<Immunotherapy> <Modality_of> "Ipilimumab_monotherapy" .
<Immunotherapy> <Modality_of> "Ipilimumab_and_RT" .
<Immunotherapy> <Modality_of> "Ipilimumab_and_Nivolumab" .
<Immunotherapy> <Modality_of> "Interferon_alfa-n1_monotherapy" .
<Immunotherapy> <Modality_of> "Interferon_alfa-2c_monotherapy" .
<Immunotherapy> <Modality_of> "Interferon_alfa-2b_monotherapy" .
<Immunotherapy> <Modality_of> "Interferon_alfa-2b_and_Zidovudine" .
<Immunotherapy> <Modality_of> "Interferon_alfa-2b_and_Thalidomide" .
<Immunotherapy> <Modality_of> "Interferon_alfa-2b_and_Prednisone" .
<Immunotherapy> <Modality_of> "Interferon_alfa-2b_and_DLI" .
<Immunotherapy> <Modality_of> "Interferon_alfa-2a_monotherapy" .
<Immunotherapy> <Modality_of> "Interferon_alfa-2a_and_Isotretinoin" .
<Immunotherapy> <Modality_of> "Interferon_alfa-2a_and_Interleukin-2" .
<Immunotherapy> <Modality_of> "Interferon_alfa_monotherapy" .
<Immunotherapy> <Modality_of> "Interferon_alfa_and_Dexamethasone" .
<Immunotherapy> <Modality_of> "Imatinib_and_Interferon" .
<Immunotherapy> <Modality_of> "IL-2_monotherapy" .
<Immunotherapy> <Modality_of> "Hydroxyurea_and_Interferon_alfa-2a" .
<Immunotherapy> <Modality_of> "High-dose_Interleukin-2" .
<Immunotherapy> <Modality_of> "GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab" .
<Immunotherapy> <Modality_of> "Fluorouracil,_Folinic_acid,_Levamisole" .
<Immunotherapy> <Modality_of> "Fluorouracil_and_Levamisole" .
<Immunotherapy> <Modality_of> "Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "Fludarabine_and_TBI,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "FluBuCy,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "Flu-Mel,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "FCR,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "FC,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "FAC_and_BCG" .
<Immunotherapy> <Modality_of> "Etoposide_and_TBI,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "Durvalumab_monotherapy" .
<Immunotherapy> <Modality_of> "Dacarbazine_and_Interferon_alfa-2a" .
<Immunotherapy> <Modality_of> "DEX-IFN" .
<Immunotherapy> <Modality_of> "Cytarabine_and_Interferon_alfa-2b" .
<Immunotherapy> <Modality_of> "Cyclophosphamide_and_TBI,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "Clofarabine_and_Melphalan,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "Cisplatin,_Pemetrexed,_Pembrolizumab" .
<Immunotherapy> <Modality_of> "Cisplatin,_Interferon_alfa-2a,_Isotretinoin" .
<Immunotherapy> <Modality_of> "Cisplatin,_Fluorouracil,_Pembrolizumab" .
<Immunotherapy> <Modality_of> "Cisplatin,_Dacarbazine,_Interferon_alfa-2b" .
<Immunotherapy> <Modality_of> "Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine" .
<Immunotherapy> <Modality_of> "Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b" .
<Immunotherapy> <Modality_of> "Cemiplimab_monotherapy" .
<Immunotherapy> <Modality_of> "Carboplatin,_nab-Paclitaxel,_Pembrolizumab" .
<Immunotherapy> <Modality_of> "Carboplatin,_nab-Paclitaxel,_Atezolizumab" .
<Immunotherapy> <Modality_of> "Carboplatin,_Pemetrexed,_Pembrolizumab" .
<Immunotherapy> <Modality_of> "Carboplatin,_Paclitaxel,_Pembrolizumab" .
<Immunotherapy> <Modality_of> "Carboplatin,_Paclitaxel,_Ipilimumab" .
<Immunotherapy> <Modality_of> "Carboplatin,_Etoposide,_Atezolizumab" .
<Immunotherapy> <Modality_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Immunotherapy> <Modality_of> "CHVP-I" .
<Immunotherapy> <Modality_of> "CHOP-BCG" .
<Immunotherapy> <Modality_of> "Busulfan_and_Cyclophosphamide,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "BuFlu,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "BuCyTBI,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "BuCy,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "Bevacizumab_and_Interferon_alfa-2a" .
<Immunotherapy> <Modality_of> "Bacillus_Calmette-Guerin_(BCG)_monotherapy" .
<Immunotherapy> <Modality_of> "BFR,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "BEAM,_then_allo_HSCT" .
<Immunotherapy> <Modality_of> "BCG_and_Dacarbazine" .
<Immunotherapy> <Modality_of> "Axitinib_and_Pembrolizumab" .
<Immunotherapy> <Modality_of> "Axitinib_and_Avelumab" .
<Immunotherapy> <Modality_of> "Axicabtagene_ciloleucel_monotherapy" .
<Immunotherapy> <Modality_of> "Avelumab_monotherapy" .
<Immunotherapy> <Modality_of> "Atezolizumab_monotherapy" .
<Immunotherapy> <Modality_of> "Atezolizumab_and_Bevacizumab" .
<Immunotherapy> <Modality_of> "ABCP" .
<Immunotherapy> <Modality_of> "(90)YFC,_then_allo_HSCT" .
<Carboplatin,_Etoposide,_RT> <Maps_to> "Carboplatin,_Etoposide,_RT" .
<ADT_and_Apalutamide> <Maps_to> "ADT_and_Apalutamide" .
<DDGP> <Has_modality> "Chemotherapy" .
<Cytarabine,_Idarubicin,_Vorinostat> <Is_a> "Anthracycline-containing_regimen" .
<Blinatumomab_monotherapy> <Mapped_from> "Blinatumomab_monotherapy" .
<Paclitaxel_and_Topotecan> <Mapped_from> "Paclitaxel_and_Topotecan" .
<Danazol> <Is_a> "FDA_approved_drug" .
<Danazol> <Is_a> "Endocrine_therapeutic" .
<RVR> <Is_a> "Rituximab-containing_regimen" .
<OFAR> <Mapped_from> "OFAR" .
<Intermittent_ADT> <Is_current_in> "Prostate_cancer" .
<TAD_(Tamoxifen)> <Has_modality> "Hormonotherapy" .
<CAMFP> <Has_antineoplastic> "Prednisone" .
<CAMFP> <Has_antineoplastic> "Methotrexate" .
<CAMFP> <Has_antineoplastic> "Fluorouracil" .
<CAMFP> <Has_antineoplastic> "Doxorubicin" .
<CAMFP> <Has_antineoplastic> "Cyclophosphamide" .
<VeIP> <Has_antineoplastic> "Vinblastine" .
<VeIP> <Has_antineoplastic> "Ifosfamide" .
<VeIP> <Has_antineoplastic> "Cisplatin" .
<Peginterferon_alfa-2a_monotherapy> <Maps_to> "Peginterferon_alfa-2a_monotherapy" .
<Clopalvix> <Brand_name_of> "Clopidogrel" .
<Gefticip> <Brand_name_of> "Gefitinib" .
<Buateron> <Brand_name_of> "Folinic_acid" .
<Fludarabine_and_Melphalan> <Mapped_from> "Fludarabine_and_Melphalan" .
<Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab> <Has_accepted_use> "Breast_cancer" .
<R-GCVP> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<CAMP> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Alectinib> <Has_brand_name> "Alecensa" .
<TD> <Has_supportive_med> "Warfarin" .
<TD> <Has_supportive_med> "Valacyclovir" .
<TD> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<TD> <Has_supportive_med> "Proton_pump_inhibitors" .
<TD> <Has_supportive_med> "Low_molecular_weight_heparins" .
<TD> <Has_supportive_med> "Lenalidomide" .
<TD> <Has_supportive_med> "Lansoprazole" .
<TD> <Has_supportive_med> "Enoxaparin" .
<TD> <Has_supportive_med> "Clopidogrel" .
<TD> <Has_supportive_med> "Ciprofloxacin" .
<TD> <Has_supportive_med> "Bisphosphonates" .
<TD> <Has_supportive_med> "Aspirin" .
<TD> <Has_supportive_med> "Antivirals" .
<TD> <Has_supportive_med> "Antiplatelet_agents" .
<TD> <Has_supportive_med> "Anticoagulants" .
<TD> <Has_supportive_med> "Amoxicillin" .
<TD> <Has_supportive_med> "Acyclovir" .
<Doxorubicin_pegylated_liposomal_and_Gemcitabine> <Has_supportive_med> "Metoclopramide" .
<CHOP_(Prednisolone)> <Maps_to> "CHOP_(Prednisolone)" .
<Loron> <Brand_name_of> "Clodronate" .
<CHAD> <Is_historical_in> "Ovarian_cancer" .
<EOF> <Is_current_in> "Gastric_cancer" .
<EOF> <Is_current_in> "Esophageal_cancer" .
<Cellular_therapy> <Subsumes> "Lapuleucel-T" .
<Cellular_therapy> <Subsumes> "Immune_effector_cell" .
<Cellular_therapy> <Subsumes> "Hematopoetic_progenitor_cells_cord_blood" .
<Capecitabine,_Docetaxel,_Oxaliplatin,_RT> <Has_modality> "Radiotherapy" .
<Capecitabine,_Docetaxel,_Oxaliplatin,_RT> <Has_modality> "Chemotherapy" .
<SOX_and_Bevacizumab> <Mapped_from> "SOX_and_Bevacizumab" .
<Treosulfan_monotherapy> <Mapped_from> "Treosulfan_monotherapy" .
<L-asparaginase_monotherapy> <Has_context> "Consolidation_after_upfront_therapy" .
<Spren> <Brand_name_of> "Aspirin" .
<Monkast> <Brand_name_of> "Montelukast" .
<Cytarabine,_Ifosfamide,_G-CSF> <Mapped_from> "Cytarabine,_Ifosfamide,_G-CSF" .
<FULV_and_Bevacizumab> <Has_accepted_use> "Colon_cancer" .
<Geftib> <Brand_name_of> "Gefitinib" .
<R-CDOP> <Is_a> "Rituximab-containing_regimen" .
<R-CDOP> <Is_a> "Anthracycline-containing_regimen" .
<Kabidarba> <Brand_name_of> "Darbepoetin_alfa" .
<Demeson> <Brand_name_of> "Dexamethasone" .
<Erdafitinib> <Has_brand_name> "Balversa" .
<Baktrisid_DS> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<MATRix> <Has_antineoplastic> "Thiotepa" .
<MATRix> <Has_antineoplastic> "Rituximab" .
<MATRix> <Has_antineoplastic> "Methotrexate" .
<MATRix> <Has_antineoplastic> "Cytarabine" .
<HLH-2004_regimen> <Has_local_therapy> "Prednisolone" .
<HLH-2004_regimen> <Has_local_therapy> "Methotrexate" .
<Carplanil> <Brand_name_of> "Carboplatin" .
<Dexam> <Brand_name_of> "Dexchlorpheniramine" .
<Dexam> <Brand_name_of> "Dexamethasone" .
<Methotrexate_and_Tacrolimus> <Is_current_in> "Graft_versus_host_disease" .
<DHAP> <Has_modality> "Chemotherapy" .
<Enzalutamide> <Is_a> "Nonsteroidal_antiandrogen" .
<Enzalutamide> <Is_a> "FDA_approved_drug" .
<Total_Therapy> <Is_current_in> "Multiple_myeloma" .
<Doxifluridine_and_Mitomycin> <Has_accepted_use> "Gastric_cancer" .
<Trimexole-F> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CEV_and_RT> <Has_context> "Definitive_therapy" .
<ATRA_monotherapy> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Bortezomib,_Dexamethasone,_Panobinostat> <Has_antineoplastic> "Panobinostat" .
<Bortezomib,_Dexamethasone,_Panobinostat> <Has_antineoplastic> "Dexamethasone" .
<Bortezomib,_Dexamethasone,_Panobinostat> <Has_antineoplastic> "Bortezomib" .
<Duvelisib_monotherapy> <Has_antineoplastic> "Duvelisib" .
<Nilutamide> <Has_accepted_use> "Prostate_cancer" .
<Bendamustine_and_Obinutuzumab> <Is_current_in> "Follicular_lymphoma" .
<Bendamustine_and_Obinutuzumab> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<ABVDm> <Maps_to> "ABVDm" .
<Atezolizumab_monotherapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<Atezolizumab_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Atezolizumab_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<OFAR> <Has_context> "Non-curative_therapy" .
<OFAR> <Has_context> "All_lines_of_therapy" .
<Melphalan> <Has_accepted_use> "Plasma_cell_leukemia" .
<Melphalan> <Has_accepted_use> "Multiple_myeloma" .
<Melphalan> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Melphalan> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Melphalan> <Has_accepted_use> "Hodgkin_lymphoma" .
<Melphalan> <Has_accepted_use> "HIV-associated_lymphoma" .
<Melphalan> <Has_accepted_use> "Follicular_lymphoma" .
<Melphalan> <Has_accepted_use> "Ewing_sarcoma" .
<Melphalan> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Melphalan> <Has_accepted_use> "CNS_lymphoma" .
<Melphalan> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Cabita> <Brand_name_of> "Capecitabine" .
<Toremifene> <Antineoplastic_of> "Toremifene_monotherapy" .
<Anti-PDGFR_antibody> <Is_a> "PDGFR_inhibitor" .
<Anti-PDGFR_antibody> <Is_a> "Antibody_medication" .
<M-TIP> <Has_modality> "Chemotherapy" .
<Estrogen_receptor_inhibitor> <Subsumes> "Fulvestrant" .
<Vandetanib> <Has_FDA_indication> "Thyroid_cancer" .
<Docetaxel_and_Prednisolone> <Has_modality> "Hormonotherapy" .
<Docetaxel_and_Prednisolone> <Has_modality> "Chemotherapy" .
<Isatuximab> <Has_accepted_use> "Multiple_myeloma" .
<Docetaxel_and_Ramucirumab> <Has_antineoplastic> "Ramucirumab" .
<Docetaxel_and_Ramucirumab> <Has_antineoplastic> "Docetaxel" .
<Cemiplimab_monotherapy> <Has_modality> "Immunotherapy" .
<Veripred> <Brand_name_of> "Prednisolone" .
<Lanreotide> <May_have_route> "Subcutaneous" .
<Docetaxel_and_Vandetanib> <Is_current_in> "Non-small_cell_lung_cancer" .
<C-MOPP> <Has_context> "Induction_therapy" .
<C-MOPP> <Has_context> "Consolidation_after_upfront_therapy" .
<7_plus_3d_and_Sorafenib> <Has_antineoplastic> "Sorafenib" .
<7_plus_3d_and_Sorafenib> <Has_antineoplastic> "Daunorubicin" .
<7_plus_3d_and_Sorafenib> <Has_antineoplastic> "Cytarabine" .
<Chidamide_monotherapy> <Maps_to> "Chidamide_monotherapy" .
<Capecitabine_and_RT> <Has_accepted_use> "Rectal_cancer" .
<Aspirin> <Has_brand_name> "Zorprin" .
<Aspirin> <Has_brand_name> "Zoprin" .
<Aspirin> <Has_brand_name> "Zenaspirin" .
<Aspirin> <Has_brand_name> "Winsprin" .
<Aspirin> <Has_brand_name> "Venopirin" .
<Aspirin> <Has_brand_name> "Upsarin" .
<Aspirin> <Has_brand_name> "Upsalgina" .
<Aspirin> <Has_brand_name> "Uniaspirin" .
<Aspirin> <Has_brand_name> "Trombyl" .
<Aspirin> <Has_brand_name> "Tromalyt" .
<Aspirin> <Has_brand_name> "Tooprin" .
<Aspirin> <Has_brand_name> "Toldex" .
<Aspirin> <Has_brand_name> "Togal_ASS" .
<Aspirin> <Has_brand_name> "Thrombo_ASS" .
<Aspirin> <Has_brand_name> "Thrombo_AS" .
<Aspirin> <Has_brand_name> "Thrombo" .
<Aspirin> <Has_brand_name> "Thrombace_NEO" .
<Aspirin> <Has_brand_name> "Thomapyrin_Akut" .
<Aspirin> <Has_brand_name> "Tampyrine" .
<Aspirin> <Has_brand_name> "Supasa" .
<Aspirin> <Has_brand_name> "Stanback_Analgesic" .
<Aspirin> <Has_brand_name> "Stanback" .
<Aspirin> <Has_brand_name> "Spren" .
<Aspirin> <Has_brand_name> "Solusprin" .
<Aspirin> <Has_brand_name> "Soluble_AAC" .
<Aspirin> <Has_brand_name> "Solpyron" .
<Aspirin> <Has_brand_name> "Solprin" .
<Aspirin> <Has_brand_name> "Sinaspir" .
<Aspirin> <Has_brand_name> "Saspryl" .
<Aspirin> <Has_brand_name> "Salospir-A" .
<Aspirin> <Has_brand_name> "Salospir" .
<Aspirin> <Has_brand_name> "Salitison" .
<Aspirin> <Has_brand_name> "SAL-Adult" .
<Aspirin> <Has_brand_name> "S.R.A." .
<Aspirin> <Has_brand_name> "Ronal" .
<Aspirin> <Has_brand_name> "Rivasa" .
<Aspirin> <Has_brand_name> "Rhusal" .
<Aspirin> <Has_brand_name> "Rhonal" .
<Aspirin> <Has_brand_name> "Rhodine" .
<Aspirin> <Has_brand_name> "Reumyl" .
<Aspirin> <Has_brand_name> "Remin_S" .
<Aspirin> <Has_brand_name> "Quinton" .
<Aspirin> <Has_brand_name> "Primaspan" .
<Aspirin> <Has_brand_name> "Premaspin" .
<Aspirin> <Has_brand_name> "Polopiryna_S" .
<Aspirin> <Has_brand_name> "Polopiryna" .
<Aspirin> <Has_brand_name> "Platet" .
<Aspirin> <Has_brand_name> "Phenaspirine" .
<Aspirin> <Has_brand_name> "Pharmaspirin" .
<Aspirin> <Has_brand_name> "Pharmacin" .
<Aspirin> <Has_brand_name> "Novid" .
<Aspirin> <Has_brand_name> "Novasen" .
<Aspirin> <Has_brand_name> "Nova-Phase" .
<Aspirin> <Has_brand_name> "Nichiaspirin" .
<Aspirin> <Has_brand_name> "Naspro" .
<Aspirin> <Has_brand_name> "Minimax" .
<Aspirin> <Has_brand_name> "Miniasal" .
<Aspirin> <Has_brand_name> "Migraspirina" .
<Aspirin> <Has_brand_name> "Micropirin" .
<Aspirin> <Has_brand_name> "Micristin" .
<Aspirin> <Has_brand_name> "Metaspirine" .
<Aspirin> <Has_brand_name> "Melhoral_Infantil" .
<Aspirin> <Has_brand_name> "Mejoral_Infantil" .
<Aspirin> <Has_brand_name> "Medisyl" .
<Aspirin> <Has_brand_name> "Medi-RUB" .
<Aspirin> <Has_brand_name> "Measurin" .
<Aspirin> <Has_brand_name> "Magnecyl" .
<Aspirin> <Has_brand_name> "Lysoprin" .
<Aspirin> <Has_brand_name> "Lowasa" .
<Aspirin> <Has_brand_name> "Lisaspin" .
<Aspirin> <Has_brand_name> "Licyl" .
<Aspirin> <Has_brand_name> "Levius" .
<Aspirin> <Has_brand_name> "Lasdol" .
<Aspirin> <Has_brand_name> "LO-Aspirin" .
<Aspirin> <Has_brand_name> "Kilios" .
<Aspirin> <Has_brand_name> "Karmyl" .
<Aspirin> <Has_brand_name> "Jusprin" .
<Aspirin> <Has_brand_name> "Junior_Asprin" .
<Aspirin> <Has_brand_name> "Hybin" .
<Aspirin> <Has_brand_name> "Huma_ASA" .
<Aspirin> <Has_brand_name> "Hjertealbyl" .
<Aspirin> <Has_brand_name> "Hjerdyl" .
<Aspirin> <Has_brand_name> "Herzass" .
<Aspirin> <Has_brand_name> "Halfprin" .
<Aspirin> <Has_brand_name> "Godamed_TAH" .
<Aspirin> <Has_brand_name> "Globentyl" .
<Aspirin> <Has_brand_name> "Genprin" .
<Aspirin> <Has_brand_name> "Geniolito" .
<Aspirin> <Has_brand_name> "Geniol_SC_SIN_Cafeina" .
<Aspirin> <Has_brand_name> "Geniol_SC" .
<Aspirin> <Has_brand_name> "Geniol_AP" .
<Aspirin> <Has_brand_name> "Garaspirine" .
<Aspirin> <Has_brand_name> "Flectadol" .
<Aspirin> <Has_brand_name> "Fitoaspirin" .
<Aspirin> <Has_brand_name> "Equate_Daily" .
<Aspirin> <Has_brand_name> "Entrophen" .
<Aspirin> <Has_brand_name> "Enterosarine" .
<Aspirin> <Has_brand_name> "Encoprin" .
<Aspirin> <Has_brand_name> "Encaprin" .
<Aspirin> <Has_brand_name> "Empirin" .
<Aspirin> <Has_brand_name> "Egicalm" .
<Aspirin> <Has_brand_name> "Ecotrin_Maximum_Strenght" .
<Aspirin> <Has_brand_name> "Ecotrin_650" .
<Aspirin> <Has_brand_name> "Ecotrin" .
<Aspirin> <Has_brand_name> "Ecosprin" .
<Aspirin> <Has_brand_name> "Ecoprin" .
<Aspirin> <Has_brand_name> "Ecopirin" .
<Aspirin> <Has_brand_name> "Easprin" .
<Aspirin> <Has_brand_name> "Dusil" .
<Aspirin> <Has_brand_name> "Dulcipirina" .
<Aspirin> <Has_brand_name> "Draspir" .
<Aspirin> <Has_brand_name> "Dolorosan" .
<Aspirin> <Has_brand_name> "Doloprin" .
<Aspirin> <Has_brand_name> "Doloderm" .
<Aspirin> <Has_brand_name> "Disprina" .
<Aspirin> <Has_brand_name> "Disprin" .
<Aspirin> <Has_brand_name> "Dispril" .
<Aspirin> <Has_brand_name> "Disperin" .
<Aspirin> <Has_brand_name> "Demoprin_Novum" .
<Aspirin> <Has_brand_name> "Delgesic" .
<Aspirin> <Has_brand_name> "Coryphen" .
<Aspirin> <Has_brand_name> "Corsalbene" .
<Aspirin> <Has_brand_name> "Corplus" .
<Aspirin> <Has_brand_name> "Coraspirina" .
<Aspirin> <Has_brand_name> "Coraspin" .
<Aspirin> <Has_brand_name> "Contra-Schmerz_ASS" .
<Aspirin> <Has_brand_name> "Colsprin" .
<Aspirin> <Has_brand_name> "Colfarit" .
<Aspirin> <Has_brand_name> "Clariprin" .
<Aspirin> <Has_brand_name> "Claragine" .
<Aspirin> <Has_brand_name> "Claradin" .
<Aspirin> <Has_brand_name> "Cemirit" .
<Aspirin> <Has_brand_name> "Cebaspirine" .
<Aspirin> <Has_brand_name> "Catalgix" .
<Aspirin> <Has_brand_name> "Catalgine" .
<Aspirin> <Has_brand_name> "Casprium" .
<Aspirin> <Has_brand_name> "Cardirene" .
<Aspirin> <Has_brand_name> "Cardiopirin" .
<Aspirin> <Has_brand_name> "Cardioaspirine" .
<Aspirin> <Has_brand_name> "Cardioaspirina" .
<Aspirin> <Has_brand_name> "Cardegic" .
<Aspirin> <Has_brand_name> "Capsasal" .
<Aspirin> <Has_brand_name> "Caprin" .
<Aspirin> <Has_brand_name> "Cafiaspirina" .
<Aspirin> <Has_brand_name> "Cafenol" .
<Aspirin> <Has_brand_name> "COR-30" .
<Aspirin> <Has_brand_name> "CC_COR" .
<Aspirin> <Has_brand_name> "Bufferin" .
<Aspirin> <Has_brand_name> "Buferin" .
<Aspirin> <Has_brand_name> "Bufacyl" .
<Aspirin> <Has_brand_name> "Breoprin" .
<Aspirin> <Has_brand_name> "Bokey_EMC" .
<Aspirin> <Has_brand_name> "Bioplak" .
<Aspirin> <Has_brand_name> "Bestpirin" .
<Aspirin> <Has_brand_name> "Bayaspirina" .
<Aspirin> <Has_brand_name> "Bayaspirin" .
<Aspirin> <Has_brand_name> "Bamyl_S" .
<Aspirin> <Has_brand_name> "Bamyl" .
<Aspirin> <Has_brand_name> "Bamycor" .
<Aspirin> <Has_brand_name> "Baludon" .
<Aspirin> <Has_brand_name> "Babypyrin" .
<Aspirin> <Has_brand_name> "Babyprin" .
<Aspirin> <Has_brand_name> "Avasyl" .
<Aspirin> <Has_brand_name> "Ataspin" .
<Aspirin> <Has_brand_name> "Astrix" .
<Aspirin> <Has_brand_name> "Asrin" .
<Aspirin> <Has_brand_name> "Aspro" .
<Aspirin> <Has_brand_name> "Asprimox_ID" .
<Aspirin> <Has_brand_name> "Asprim" .
<Aspirin> <Has_brand_name> "Aspocid" .
<Aspirin> <Has_brand_name> "Aspisol" .
<Aspirin> <Has_brand_name> "Aspirtab" .
<Aspirin> <Has_brand_name> "Aspirisucre" .
<Aspirin> <Has_brand_name> "Aspirinetta" .
<Aspirin> <Has_brand_name> "Aspirinetas" .
<Aspirin> <Has_brand_name> "Aspirine" .
<Aspirin> <Has_brand_name> "Aspirina-G" .
<Aspirin> <Has_brand_name> "Aspirina" .
<Aspirin> <Has_brand_name> "Aspilets" .
<Aspirin> <Has_brand_name> "Aspeter" .
<Aspirin> <Has_brand_name> "Aspergum" .
<Aspirin> <Has_brand_name> "Aspergic" .
<Aspirin> <Has_brand_name> "Asperan" .
<Aspirin> <Has_brand_name> "Aspenter" .
<Aspirin> <Has_brand_name> "Aspent" .
<Aspirin> <Has_brand_name> "Aspecard" .
<Aspirin> <Has_brand_name> "Asdol" .
<Aspirin> <Has_brand_name> "Ascardia" .
<Aspirin> <Has_brand_name> "Asarid" .
<Aspirin> <Has_brand_name> "Asaphen" .
<Aspirin> <Has_brand_name> "Asalite" .
<Aspirin> <Has_brand_name> "Asalent" .
<Aspirin> <Has_brand_name> "Asaflow" .
<Aspirin> <Has_brand_name> "Asaferm" .
<Aspirin> <Has_brand_name> "Asacard" .
<Aspirin> <Has_brand_name> "Artria-SR" .
<Aspirin> <Has_brand_name> "Anopyrin" .
<Aspirin> <Has_brand_name> "Angettes" .
<Aspirin> <Has_brand_name> "Andol" .
<Aspirin> <Has_brand_name> "Ancasal" .
<Aspirin> <Has_brand_name> "Anbol" .
<Aspirin> <Has_brand_name> "Albyl-Selters" .
<Aspirin> <Has_brand_name> "Albyl_Minor" .
<Aspirin> <Has_brand_name> "Albyl" .
<Aspirin> <Has_brand_name> "Adiprin" .
<Aspirin> <Has_brand_name> "Acylpyrin" .
<Aspirin> <Has_brand_name> "Actispirine" .
<Aspirin> <Has_brand_name> "Acisal" .
<Aspirin> <Has_brand_name> "Acetysal" .
<Aspirin> <Has_brand_name> "Acetylsalisylsyre" .
<Aspirin> <Has_brand_name> "Acetylsalicylzuur" .
<Aspirin> <Has_brand_name> "Acetylsalicylsyre" .
<Aspirin> <Has_brand_name> "Acetylsalicylsyra" .
<Aspirin> <Has_brand_name> "Acetylsalicylsaeure" .
<Aspirin> <Has_brand_name> "Acetosal" .
<Aspirin> <Has_brand_name> "Acetophen" .
<Aspirin> <Has_brand_name> "Acetisal" .
<Aspirin> <Has_brand_name> "Acetard" .
<Aspirin> <Has_brand_name> "Acesan" .
<Aspirin> <Has_brand_name> "Acesal" .
<Aspirin> <Has_brand_name> "Acenterine" .
<Aspirin> <Has_brand_name> "Acard" .
<Testicular_cancer> <Historic_treated_by> "VAB-6" .
<Testicular_cancer> <Historic_treated_by> "Plicamycin_monotherapy" .
<Testicular_cancer> <Historic_treated_by> "Chlorambucil,_Dactinomycin,_Methotrexate" .
<Testicular_cancer> <Historic_treated_by> "CISCA/VB" .
<Testicular_cancer> <Historic_treated_by> "Bleomycin_and_Vinblastine" .
<Testicular_cancer> <Historic_treated_by> "BVP" .
<AIE> <Is_current_in> "Acute_myeloid_leukemia" .
<Meperidine> <Is_a> "Supportive_medication" .
<R-CHMP> <Is_a> "Rituximab-containing_regimen" .
<R-CHMP> <Is_a> "Anthracycline-containing_regimen" .
<(90)YFC> <Is_a> "Rituximab-containing_regimen" .
<OLF> <Has_supportive_med> "Warfarin" .
<OLF> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<OLF> <Has_supportive_med> "Filgrastim" .
<Cyproterone_acetate> <May_have_route> "Oral" .
<Cyproterone_acetate> <May_have_route> "Intramuscular" .
<Fludarabine_and_Melphalan> <Has_immunosuppressor> "Tacrolimus" .
<Fludarabine_and_Melphalan> <Has_immunosuppressor> "Methotrexate" .
<Fludarabine_and_Melphalan> <Has_immunosuppressor> "Cyclosporines" .
<Fludarabine_and_Melphalan> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<Fludarabine_and_Melphalan> <Has_immunosuppressor> "Antithymocyte_globulin" .
<T-DM1_and_ET> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<T-DM1_and_ET> <Has_accepted_use> "Breast_cancer" .
<PGC> <Mapped_from> "PGC" .
<Trastuzumab-pkrb> <Has_FDA_indication> "Breast_cancer" .
<Anticoagulation> <Modality_of> "Warfarin_monotherapy" .
<Anticoagulation> <Modality_of> "Tinzaparin_monotherapy" .
<Anticoagulation> <Modality_of> "Rivaroxaban_monotherapy" .
<Anticoagulation> <Modality_of> "Lepirudin_monotherapy" .
<Anticoagulation> <Modality_of> "Heparin_monotherapy" .
<Anticoagulation> <Modality_of> "Fondaparinux_monotherapy" .
<Anticoagulation> <Modality_of> "Enoxaparin_monotherapy" .
<Anticoagulation> <Modality_of> "Edoxaban_monotherapy" .
<Anticoagulation> <Modality_of> "Danaparoid_monotherapy" .
<Anticoagulation> <Modality_of> "Dalteparin_monotherapy" .
<Anticoagulation> <Modality_of> "Dabigatran_monotherapy" .
<Anticoagulation> <Modality_of> "Bivalirudin_monotherapy" .
<Anticoagulation> <Modality_of> "Betrixaban_monotherapy" .
<Anticoagulation> <Modality_of> "Aspirin_monotherapy" .
<Anticoagulation> <Modality_of> "Aspirin_and_Warfarin" .
<Anticoagulation> <Modality_of> "Aspirin_and_Anagrelide" .
<Anticoagulation> <Modality_of> "Argatroban_monotherapy" .
<Anticoagulation> <Modality_of> "Apixaban_monotherapy" .
<Anticoagulation> <Modality_of> "Anagrelide_monotherapy" .
<Teniposide_monotherapy> <Has_context> "Induction_therapy" .
<Aminopeptidase_inhibitor> <Subsumes> "Tosedostat" .
<Epithelioid_sarcoma> <Is_a> "Soft_tissue_sarcoma" .
<Epithelioid_sarcoma> <Is_a> "Pediatric_cancer" .
<Benralizumab_monotherapy> <Maps_to> "Benralizumab_monotherapy" .
<Mycidex> <Brand_name_of> "Dexamethasone" .
<Treosulfan> <Has_brand_name> "Trecondi" .
<Treosulfan> <Has_brand_name> "Ovastat" .
<Chemoradiotherapy> <Mapped_from> "Chemoradiotherapy" .
<Biotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<FLAG> <Mapped_from> "FLAG" .
<Metrex> <Brand_name_of> "Methotrexate" .
<Samarium-153_monotherapy> <Is_current_in> "Prostate_cancer" .
<Cutenox> <Brand_name_of> "Enoxaparin" .
<Bortecad> <Brand_name_of> "Bortezomib" .
<TLI_and_ATG> <Has_accepted_use> "Allogeneic_HSCT" .
<Macprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<MC> <Is_current_in> "Breast_cancer" .
<Gilteritinib> <Antineoplastic_of> "Gilteritinib_monotherapy" .
<Neratinib_and_Paclitaxel> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<Neratinib_and_Paclitaxel> <Has_accepted_use> "Breast_cancer" .
<Antibiotics> <Supportive_med_of> "Clofarabine_monotherapy" .
<Antibiotics> <Supportive_med_of> "Azacitidine_monotherapy" .
<Antibiotics> <Supportive_med_of> "ATG_(Rabbit)_monotherapy" .
<ddTH_(Taxotere)> <Mapped_from> "ddTH_(Taxotere)" .
<Lanreotide_and_Interferon_alfa-2b> <Maps_to> "Lanreotide_and_Interferon_alfa-2b" .
<Nimustine> <Has_brand_name> "Nidran" .
<BAC-Sulfitrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<DA_3_plus_10,_GO> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Dexicorta> <Brand_name_of> "Dexamethasone" .
<VAdCA> <Is_a> "Anthracycline-containing_regimen" .
<Rituxim> <Brand_name_of> "Rituximab" .
<Excelin> <Brand_name_of> "Methylprednisolone" .
<O-ESHAP> <Is_current_in> "Hodgkin_lymphoma" .
<Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin> <Is_current_in> "Acute_myeloid_leukemia" .
<ATG_(Horse),_Cyclosporine,_Methylprednisolone> <Maps_to> "ATG_(Horse),_Cyclosporine,_Methylprednisolone" .
<FEC> <Has_antineoplastic> "Fluorouracil" .
<FEC> <Has_antineoplastic> "Epirubicin" .
<FEC> <Has_antineoplastic> "Cyclophosphamide" .
<Cytarabinum> <Brand_name_of> "Cytarabine" .
<Temozolomide_monotherapy> <Maps_to> "Temozolomide_monotherapy" .
<Methotrexate_and_Tacrolimus> <Has_modality> "Immunosuppressive_therapy" .
<KD> <Mapped_from> "KD" .
<ddAC-T> <Has_supportive_med> "Sargramostim" .
<ddAC-T> <Has_supportive_med> "Ranitidine" .
<ddAC-T> <Has_supportive_med> "Pegfilgrastim" .
<ddAC-T> <Has_supportive_med> "Filgrastim" .
<ddAC-T> <Has_supportive_med> "Famotidine" .
<ddAC-T> <Has_supportive_med> "Diphenhydramine" .
<ddAC-T> <Has_supportive_med> "Dexamethasone" .
<ddAC-T> <Has_supportive_med> "Cimetidine" .
<R-CP> <Has_accepted_use> "Post-transplant_lymphoproliferative_disorder" .
<ERBB3-mutated_malignancy> <Current_treated_by> "Neratinib_monotherapy" .
<Vindesine> <Antineoplastic_of> "mLSG15" .
<Vindesine> <Antineoplastic_of> "Vindesine_monotherapy" .
<Vindesine> <Antineoplastic_of> "VCAP" .
<Vindesine> <Antineoplastic_of> "Nordic_Regimen,_younger_patients" .
<Vindesine> <Antineoplastic_of> "Nordic_Regimen,_older_patients" .
<Vindesine> <Antineoplastic_of> "MVP_and_RT" .
<Vindesine> <Antineoplastic_of> "MVP_(Vindesine)" .
<Vindesine> <Antineoplastic_of> "LSG15" .
<Vindesine> <Antineoplastic_of> "GMALL-R" .
<Vindesine> <Antineoplastic_of> "EVI" .
<Vindesine> <Antineoplastic_of> "Cisplatin_and_Vindesine" .
<Vindesine> <Antineoplastic_of> "CVD_(Vindesine)" .
<Vindesine> <Antineoplastic_of> "CEEP" .
<Vindesine> <Antineoplastic_of> "ACVBP-R" .
<Vindesine> <Antineoplastic_of> "ACVBP,_dose-adjusted" .
<Vindesine> <Antineoplastic_of> "ACVBP" .
<DHAP_-_time_intensified> <Is_current_in> "Hodgkin_lymphoma" .
<VDC/IE> <Mapped_from> "VDC/IE" .
<Dacarbazine_and_Doxorubicin> <Is_a> "Anthracycline-containing_regimen" .
<DICEP> <Has_context> "Non-curative_subsequent-line_therapy" .
<DICEP> <Has_context> "Induction_therapy" .
<Fluorouracil,_Hydroxyurea,_RT> <Has_context> "Definitive_therapy" .
<Idelalisib_and_Rituximab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib> <Has_modality> "Chemotherapy" .
<Histrelin> <Has_accepted_use> "Prostate_cancer" .
<Zophost> <Brand_name_of> "Alendronate" .
<DCEP> <Mapped_from> "DCEP" .
<Eculizumab_monotherapy> <Has_accepted_use> "Paroxysmal_nocturnal_hemoglobinuria" .
<Eculizumab_monotherapy> <Has_accepted_use> "Cold_agglutinin_disease" .
<Eculizumab_monotherapy> <Has_accepted_use> "Atypical_hemolytic_uremic_syndrome" .
<Folidar> <Brand_name_of> "Folinic_acid" .
<Dexamethasone> <Is_a> "WHO_Essential_Pain_and_Palliative_Care_Medicine" .
<Dexamethasone> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Dexamethasone> <Is_a> "Steroid" .
<Dexamethasone> <Is_a> "Light-chain_(AL)_amyloidosis_medication" .
<Vorinostat_and_Rituximab> <Has_antineoplastic> "Vorinostat" .
<Vorinostat_and_Rituximab> <Has_antineoplastic> "Rituximab" .
<Bu/TT/Cy,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Thalidomide_and_Prednisone> <Has_antineoplastic> "Thalidomide" .
<Thalidomide_and_Prednisone> <Has_antineoplastic> "Prednisone" .
<Panobinostat> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Panobinostat> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Panobinostat> <Has_accepted_use> "Multiple_myeloma" .
<Panobinostat> <Has_accepted_use> "Hodgkin_lymphoma" .
<Panobinostat> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Xazotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone> <Has_antineoplastic> "Vincristine" .
<Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone> <Has_antineoplastic> "Prednisolone" .
<Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone> <Has_antineoplastic> "Doxorubicin" .
<Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone> <Has_antineoplastic> "Cytarabine" .
<Ovarian_cancer> <Is_a> "Gynecologic_cancer" .
<Temozolomide> <Is_a> "Triazene" .
<Temozolomide> <Is_a> "Alkylating_agent" .
<Topotecan_monotherapy> <Is_current_in> "Small_cell_lung_cancer" .
<Topotecan_monotherapy> <Is_current_in> "Ovarian_cancer" .
<Topotecan_monotherapy> <Is_current_in> "Endometrial_cancer" .
<Topotecan_monotherapy> <Is_current_in> "Cervical_cancer" .
<Topotecan_monotherapy> <Is_current_in> "CNS_lymphoma" .
<Gilteritinib> <Is_a> "Mutation-specific_medication" .
<Gilteritinib> <Is_a> "Kinase_inhibitor" .
<Gilteritinib> <Is_a> "FLT3_inhibitor" .
<Gilteritinib> <Is_a> "AXL_inhibitor" .
<Gilteritinib> <Is_a> "ALK_inhibitor" .
<ABV_(Vincristine)> <Is_a> "Anthracycline-containing_regimen" .
<ATRA,_Cytarabine,_Daunorubicin> <Mapped_from> "ATRA,_Cytarabine,_Daunorubicin" .
<Lenome> <Brand_name_of> "Lenalidomide" .
<VIM> <Mapped_from> "VIM" .
<Doxorubicin_pegylated_liposomal_monotherapy> <Has_supportive_med> "Methylprednisolone" .
<Doxorubicin_pegylated_liposomal_monotherapy> <Has_supportive_med> "Filgrastim" .
<CHAD> <Is_a> "Anthracycline-containing_regimen" .
<Venetoclax> <May_have_route> "Oral" .
<VDC> <Has_context> "Non-curative_therapy" .
<VDC> <Has_context> "Non-curative_first-line_therapy" .
<CAD_and_G-CSF> <Has_supportive_med> "Filgrastim" .
<CapeOx_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<FluBuCy,_then_allo_HSCT> <Has_antineoplastic> "Fludarabine" .
<FluBuCy,_then_allo_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<FluBuCy,_then_allo_HSCT> <Has_antineoplastic> "Busulfan" .
<FluBuCy,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<Interferon_alfa-2a_monotherapy> <Maps_to> "Interferon_alfa-2a_monotherapy" .
<Temozolomide_and_low-dose_RT> <Has_antineoplastic> "Temozolomide" .
<Temozolomide_and_low-dose_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Lapatinib,_Letrozole,_Trastuzumab> <Is_a> "Antiestrogen-containing_regimen" .
<Emetron> <Brand_name_of> "Ondansetron" .
<Entinostat> <Is_a> "Investigational_drug" .
<Entinostat> <Is_a> "HDAC_inhibitor" .
<Temsirolimus_monotherapy> <Mapped_from> "Temsirolimus_monotherapy" .
<R-DHAP> <Is_current_in> "Transformed_lymphoma" .
<R-DHAP> <Is_current_in> "Primary_mediastinal_B-cell_lymphoma" .
<R-DHAP> <Is_current_in> "Mantle_cell_lymphoma" .
<R-DHAP> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Vinblastine> <Antineoplastic_of> "Vinblastine_monotherapy" .
<Vinblastine> <Antineoplastic_of> "Vinblastine_and_Prednisone" .
<Vinblastine> <Antineoplastic_of> "VeIP" .
<Vinblastine> <Antineoplastic_of> "VIP" .
<Vinblastine> <Antineoplastic_of> "VEPEMB" .
<Vinblastine> <Antineoplastic_of> "VAMP_(Methotrexate)" .
<Vinblastine> <Antineoplastic_of> "VAB-6" .
<Vinblastine> <Antineoplastic_of> "Stanford_V" .
<Vinblastine> <Antineoplastic_of> "RABVD" .
<Vinblastine> <Antineoplastic_of> "R-miniCEOP" .
<Vinblastine> <Antineoplastic_of> "PVeBV" .
<Vinblastine> <Antineoplastic_of> "PVAG" .
<Vinblastine> <Antineoplastic_of> "PEV" .
<Vinblastine> <Antineoplastic_of> "NOVP" .
<Vinblastine> <Antineoplastic_of> "Methotrexate,_Vinblastine,_Prednisone" .
<Vinblastine> <Antineoplastic_of> "Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone" .
<Vinblastine> <Antineoplastic_of> "MVPP" .
<Vinblastine> <Antineoplastic_of> "MVP_(Vinblastine)" .
<Vinblastine> <Antineoplastic_of> "MVAC,_dose-dense" .
<Vinblastine> <Antineoplastic_of> "MVAC" .
<Vinblastine> <Antineoplastic_of> "MV" .
<Vinblastine> <Antineoplastic_of> "MOPP/ABVD" .
<Vinblastine> <Antineoplastic_of> "MOPP-ABV" .
<Vinblastine> <Antineoplastic_of> "MCV" .
<Vinblastine> <Antineoplastic_of> "LOPP/EVAP" .
<Vinblastine> <Antineoplastic_of> "Etoposide,_Vinblastine,_Prednisone" .
<Vinblastine> <Antineoplastic_of> "EBVP" .
<Vinblastine> <Antineoplastic_of> "Doxorubicin_and_Vinblastine" .
<Vinblastine> <Antineoplastic_of> "Cisplatin,_Vinblastine,_RT" .
<Vinblastine> <Antineoplastic_of> "Cisplatin_and_Vinblastine" .
<Vinblastine> <Antineoplastic_of> "ChlVPP/PABIOE" .
<Vinblastine> <Antineoplastic_of> "ChlVPP/EVA" .
<Vinblastine> <Antineoplastic_of> "ChlVPP" .
<Vinblastine> <Antineoplastic_of> "CVPP" .
<Vinblastine> <Antineoplastic_of> "CVP_(Vinblastine/Prednisone)" .
<Vinblastine> <Antineoplastic_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Vinblastine> <Antineoplastic_of> "CVD_(Vinblastine)" .
<Vinblastine> <Antineoplastic_of> "CVB" .
<Vinblastine> <Antineoplastic_of> "COPP/ABVD" .
<Vinblastine> <Antineoplastic_of> "CISCA/VB" .
<Vinblastine> <Antineoplastic_of> "C-MOPP/ABV" .
<Vinblastine> <Antineoplastic_of> "Bleomycin,_Methotrexate,_Vinblastine/RT" .
<Vinblastine> <Antineoplastic_of> "Bleomycin_and_Vinblastine" .
<Vinblastine> <Antineoplastic_of> "BVP" .
<Vinblastine> <Antineoplastic_of> "BVDS" .
<Vinblastine> <Antineoplastic_of> "BVCPP" .
<Vinblastine> <Antineoplastic_of> "B-CAVe" .
<Vinblastine> <Antineoplastic_of> "AVD" .
<Vinblastine> <Antineoplastic_of> "AV-CMF" .
<Vinblastine> <Antineoplastic_of> "ABVDm" .
<Vinblastine> <Antineoplastic_of> "ABVD,_DD-DI" .
<Vinblastine> <Antineoplastic_of> "ABVD" .
<Vinblastine> <Antineoplastic_of> "ABV_(Vinblastine)" .
<Vinblastine> <Antineoplastic_of> "A-AVD" .
<FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)> <Has_modality> "Chemotherapy" .
<Leiomyosarcoma> <Accepted_use_of> "Trabectedin_monotherapy" .
<Leiomyosarcoma> <Accepted_use_of> "Trabectedin" .
<Leiomyosarcoma> <Accepted_use_of> "Regorafenib_monotherapy" .
<Leiomyosarcoma> <Accepted_use_of> "Regorafenib" .
<Leiomyosarcoma> <Accepted_use_of> "Observation" .
<Leiomyosarcoma> <Accepted_use_of> "Gemcitabine" .
<Leiomyosarcoma> <Accepted_use_of> "Eribulin_monotherapy" .
<Leiomyosarcoma> <Accepted_use_of> "Eribulin" .
<Leiomyosarcoma> <Accepted_use_of> "Docetaxel_and_Gemcitabine" .
<Leiomyosarcoma> <Accepted_use_of> "Docetaxel" .
<Leiomyosarcoma> <Accepted_use_of> "Dacarbazine_monotherapy" .
<Leiomyosarcoma> <Accepted_use_of> "Dacarbazine_and_Gemcitabine" .
<Leiomyosarcoma> <Accepted_use_of> "Dacarbazine" .
<Paclitaxel_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Gefitinib_monotherapy> <Mapped_from> "Gefitinib_monotherapy" .
<Fam-trastuzumab_deruxtecan> <Is_a> "Topoisomerase_inhibitor" .
<Fam-trastuzumab_deruxtecan> <Is_a> "Protein_expression-specific_medication" .
<Fam-trastuzumab_deruxtecan> <Is_a> "Antibody-drug_conjugate" .
<Fam-trastuzumab_deruxtecan> <Is_a> "Antibody_medication" .
<Fam-trastuzumab_deruxtecan> <Is_a> "Anti-HER2_antibody" .
<CODOX-M/IVAC> <Is_current_in> "HIV-associated_lymphoma" .
<CODOX-M/IVAC> <Is_current_in> "Burkitt_lymphoma" .
<Avelumab> <Antineoplastic_of> "Axitinib_and_Avelumab" .
<Avelumab> <Antineoplastic_of> "Avelumab_monotherapy" .
<Platiran> <Brand_name_of> "Cisplatin" .
<Lapatinib_and_Letrozole> <Has_antineoplastic> "Letrozole" .
<Lapatinib_and_Letrozole> <Has_antineoplastic> "Lapatinib" .
<Bosutinib> <May_have_route> "Oral" .
<Triptorelin> <Has_accepted_use> "Prostate_cancer" .
<Triptorelin> <Has_accepted_use> "Breast_cancer" .
<Capecitabine_and_Erlotinib> <Mapped_from> "Capecitabine_and_Erlotinib" .
<ATG_(Horse)_and_Cyclosporine> <Has_modality> "Immunosuppressive_therapy" .
<VACOP-B> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Buparlisib> <May_have_route> "Oral" .
<AC> <Has_accepted_use> "triple_negative_Breast_cancer" .
<AC> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<AC> <Has_accepted_use> "HER2-positive_-_historical_Breast_cancer" .
<AC> <Has_accepted_use> "Breast_cancer" .
<CFP> <Has_antineoplastic> "Prednisone" .
<CFP> <Has_antineoplastic> "Fluorouracil" .
<CFP> <Has_antineoplastic> "Cyclophosphamide" .
<VACA> <Has_local_therapy> "External_beam_radiotherapy" .
<TBI,_then_auto_HSCT> <Maps_to> "TBI,_then_auto_HSCT" .
<AC-T> <Maps_to> "AC-T" .
<Baklinger> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<G-CVP> <Has_context> "Non-curative_first-line_therapy" .
<Nexvep> <Brand_name_of> "Etoposide" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_accepted_use> "Melanoma" .
<FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation> <Has_supportive_med> "Pegfilgrastim" .
<Melphalan,_then_auto_HSCT,_then_Melphalan_and_TBI,_then_auto_HSCT> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Zelboraf> <Brand_name_of> "Vemurafenib" .
<CALGB_10-002_regimen> <Mapped_from> "CALGB_10-002_regimen" .
<Kathrex> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Fauldcarbo> <Brand_name_of> "Carboplatin" .
<Upfront_therapy> <Mapped_from> "Upfront_therapy" .
<Cyclophosphamid> <Brand_name_of> "Cyclophosphamide" .
<L-Asparaginase_and_Methotrexate> <Has_antineoplastic> "Methotrexate" .
<L-Asparaginase_and_Methotrexate> <Has_antineoplastic> "Asparaginase" .
<F-SHAI> <Has_accepted_use> "Acute_myeloid_leukemia" .
<CAD_and_G-CSF> <Mapped_from> "CAD_and_G-CSF" .
<O-DHAP> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Irondex> <Brand_name_of> "Iron_dextran" .
<Fluorouracil_and_Streptozocin> <Maps_to> "Fluorouracil_and_Streptozocin" .
<Cisplatin,_Irinotecan,_RT> <Is_current_in> "Esophageal_cancer" .
<DEX-IFN> <Mapped_from> "DEX-IFN" .
<TMF> <Mapped_from> "TMF" .
<Cortiprex> <Brand_name_of> "Prednisone" .
<5_plus_2d> <Has_accepted_use> "Acute_myeloid_leukemia" .
<PACEBOM> <Maps_to> "PACEBOM" .
<Ibrutinib_and_Venetoclax> <Is_current_in> "T-cell_prolymphocytic_leukemia" .
<Ibrutinib_and_Venetoclax> <Is_current_in> "Mantle_cell_lymphoma" .
<Ibrutinib_and_Venetoclax> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Adriblastine> <Brand_name_of> "Doxorubicin" .
<Fluorouracil_and_Mitomycin> <Mapped_from> "Fluorouracil_and_Mitomycin" .
<Binosto> <Brand_name_of> "Alendronate" .
<Cyclosporine_and_Methotrexate> <Has_context> "Prophylaxis" .
<Temozolomide_monotherapy> <Has_accepted_use> "Uveal_melanoma" .
<Temozolomide_monotherapy> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Temozolomide_monotherapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<Temozolomide_monotherapy> <Has_accepted_use> "Pancreatic_NET" .
<Temozolomide_monotherapy> <Has_accepted_use> "Neuroendocrine_tumor" .
<Temozolomide_monotherapy> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Temozolomide_monotherapy> <Has_accepted_use> "Melanoma" .
<Temozolomide_monotherapy> <Has_accepted_use> "Low-grade_glioma" .
<Temozolomide_monotherapy> <Has_accepted_use> "Glioblastoma" .
<Temozolomide_monotherapy> <Has_accepted_use> "CNS_lymphoma" .
<Temozolomide_monotherapy> <Has_accepted_use> "Anaplastic_glioma" .
<Temozolomide_monotherapy> <Has_accepted_use> "Acute_myeloid_leukemia" .
<R-MegaCHOP> <Has_antineoplastic> "Vincristine" .
<R-MegaCHOP> <Has_antineoplastic> "Rituximab" .
<R-MegaCHOP> <Has_antineoplastic> "Prednisone" .
<R-MegaCHOP> <Has_antineoplastic> "Doxorubicin" .
<R-MegaCHOP> <Has_antineoplastic> "Cyclophosphamide" .
<Artrait> <Brand_name_of> "Methotrexate" .
<Faulblastina> <Brand_name_of> "Vinblastine" .
<Cisplatin_and_Paclitaxel> <Has_supportive_med> "Ranitidine" .
<Cisplatin_and_Paclitaxel> <Has_supportive_med> "Ondansetron" .
<Cisplatin_and_Paclitaxel> <Has_supportive_med> "Irinotecan" .
<Cisplatin_and_Paclitaxel> <Has_supportive_med> "Granisetron" .
<Cisplatin_and_Paclitaxel> <Has_supportive_med> "Filgrastim" .
<Cisplatin_and_Paclitaxel> <Has_supportive_med> "Emesis_prevention" .
<Cisplatin_and_Paclitaxel> <Has_supportive_med> "Diphenhydramine" .
<Cisplatin_and_Paclitaxel> <Has_supportive_med> "Dexamethasone" .
<Cisplatin_and_Paclitaxel> <Has_supportive_med> "Clemastine" .
<Cisplatin_and_Paclitaxel> <Has_supportive_med> "Cimetidine" .
<Cisplatin_and_Paclitaxel> <Has_supportive_med> "Atropine" .
<Anti-diarrheals> <Supportive_med_of> "Fluorouracil_and_Levoleucovorin" .
<Anti-diarrheals> <Supportive_med_of> "Fluorouracil_and_Folinic_acid" .
<Docetaxel_and_Bevacizumab> <Has_antineoplastic> "Docetaxel" .
<Docetaxel_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Gemcitabine_and_Mitomycin> <Maps_to> "Gemcitabine_and_Mitomycin" .
<Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone> <Maps_to> "Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone" .
<Amrubicin_monotherapy> <Is_current_in> "Small_cell_lung_cancer" .
<Amrubicin_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Ado-trastuzumab_emtansine> <Has_accepted_use> "Breast_cancer" .
<Cisplatin,_Fluorouracil,_Panitumumab> <Has_modality> "Chemotherapy" .
<Daratumumab_monotherapy> <Has_antineoplastic> "Daratumumab" .
<Silidral> <Brand_name_of> "Alendronate" .
<Dasatinib_and_Prednisone> <Maps_to> "Dasatinib_and_Prednisone" .
<Doxorubicin_and_Streptozocin> <Has_context> "All_lines_of_therapy" .
<Cemiplimab_monotherapy> <Mapped_from> "Cemiplimab_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "TBI,_then_auto_HSCT" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "Prednisone_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "Prednisolone_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "Pentostatin_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "POMP" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "Methotrexate_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "Mercaptopurine_and_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "Mercaptopurine_and_Methotrexate" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "L-Asparaginase,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "L-Asparaginase,_Vincristine,_Prednisolone" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "L-Asparaginase,_Vincristine,_Dexamethasone" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "Doxorubicin,_Methotrexate,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "Daunorubicin_and_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "Cyclophosphamide_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "COMP" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "Bacillus_Calmette-Guerin_(BCG)_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Historic_treated_by> "Aminopterin_monotherapy" .
<Ciprofloxacin> <Supportive_med_of> "TD" .
<Ciprofloxacin> <Supportive_med_of> "TAC_(Taxotere)" .
<Ciprofloxacin> <Supportive_med_of> "Rd" .
<Ciprofloxacin> <Supportive_med_of> "R-Hyper-CVAD/R-MA" .
<Ciprofloxacin> <Supportive_med_of> "R-EPOCH,_dose-escalated" .
<Ciprofloxacin> <Supportive_med_of> "Mini-BEAM" .
<Ciprofloxacin> <Supportive_med_of> "MPR" .
<Ciprofloxacin> <Supportive_med_of> "M-DEX" .
<Ciprofloxacin> <Supportive_med_of> "Lenalidomide_monotherapy" .
<Ciprofloxacin> <Supportive_med_of> "KRd" .
<Ciprofloxacin> <Supportive_med_of> "Hyper-CVAD/MA" .
<Ciprofloxacin> <Supportive_med_of> "Hyper-CVAD_and_Ponatinib" .
<Ciprofloxacin> <Supportive_med_of> "Hyper-CVAD_and_Imatinib" .
<Ciprofloxacin> <Supportive_med_of> "Hyper-CVAD_and_Dasatinib" .
<Ciprofloxacin> <Supportive_med_of> "High-dose_Interleukin-2" .
<Ciprofloxacin> <Supportive_med_of> "FAC" .
<Ciprofloxacin> <Supportive_med_of> "Docetaxel_monotherapy" .
<Ciprofloxacin> <Supportive_med_of> "DCF" .
<Ciprofloxacin> <Supportive_med_of> "Carfilzomib_monotherapy" .
<Ciprofloxacin> <Supportive_med_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Ciprofloxacin> <Supportive_med_of> "CAPIRI" .
<Ciprofloxacin> <Supportive_med_of> "BEAM,_then_auto_HSCT" .
<Ciprofloxacin> <Supportive_med_of> "BEAM" .
<Ciprofloxacin> <Supportive_med_of> "Alemtuzumab_monotherapy" .
<M-EI> <Mapped_from> "M-EI" .
<Doxokebir> <Brand_name_of> "Doxorubicin" .
<nab-Paclitaxel_and_Trastuzumab> <Has_context> "Non-curative_first-line_therapy" .
<Hairy_cell_leukemia> <Current_treated_by> "Vemurafenib_monotherapy" .
<Hairy_cell_leukemia> <Current_treated_by> "Rituximab_monotherapy" .
<Hairy_cell_leukemia> <Current_treated_by> "Pentostatin_monotherapy" .
<Hairy_cell_leukemia> <Current_treated_by> "Moxetumomab_pasudotox_monotherapy" .
<Hairy_cell_leukemia> <Current_treated_by> "Interferon_alfa-2b_monotherapy" .
<Hairy_cell_leukemia> <Current_treated_by> "Cladribine_monotherapy" .
<Hairy_cell_leukemia> <Current_treated_by> "Cladribine_and_Rituximab" .
<Hairy_cell_leukemia> <Current_treated_by> "BR" .
<IRIS> <Is_current_in> "Colon_cancer" .
<Cleveron> <Brand_name_of> "Alendronate" .
<Dacarbazine_and_Tamoxifen> <Is_a> "Antiestrogen-containing_regimen" .
<Nintedanib> <May_have_route> "Oral" .
<Romidepsin> <Has_FDA_indication> "Peripheral_T-cell_lymphoma" .
<Romidepsin> <Has_FDA_indication> "Cutaneous_T-cell_lymphoma" .
<Alkaban-AQ> <Brand_name_of> "Vinblastine" .
<Sirolimus_and_Vorinostat> <Is_historical_in> "Hodgkin_lymphoma" .
<Rivoprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Panitumumab_monotherapy> <Has_accepted_use> "Penile_cancer" .
<Panitumumab_monotherapy> <Has_accepted_use> "KRAS_wild-type_Colon_cancer" .
<Panitumumab_monotherapy> <Has_accepted_use> "Colon_cancer" .
<Ado-trastuzumab_emtansine> <Has_brand_name> "Kadcyla" .
<Xpreza> <Brand_name_of> "Azacitidine" .
<Imnovid> <Brand_name_of> "Pomalidomide" .
<Bone_sarcoma> <Subsumes> "Osteosarcoma" .
<Bone_sarcoma> <Subsumes> "Giant-cell_tumor_of_bone" .
<Bone_sarcoma> <Subsumes> "Ewing_sarcoma" .
<Hyper-CVAD/MA> <Has_context> "Induction_therapy" .
<Vincrin> <Brand_name_of> "Vincristine" .
<FLEC> <Has_antineoplastic> "Folinic_acid" .
<FLEC> <Has_antineoplastic> "Fluorouracil" .
<FLEC> <Has_antineoplastic> "Epirubicin" .
<FLEC> <Has_antineoplastic> "Carboplatin" .
<Docetaxel> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Docetaxel> <Has_accepted_use> "Small_cell_lung_cancer" .
<Docetaxel> <Has_accepted_use> "SCC_of_unknown_primary" .
<Docetaxel> <Has_accepted_use> "Prostate_cancer" .
<Docetaxel> <Has_accepted_use> "Penile_cancer" .
<Docetaxel> <Has_accepted_use> "Pancreatic_cancer" .
<Docetaxel> <Has_accepted_use> "Ovarian_cancer" .
<Docetaxel> <Has_accepted_use> "Osteosarcoma" .
<Docetaxel> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Docetaxel> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<Docetaxel> <Has_accepted_use> "Melanoma" .
<Docetaxel> <Has_accepted_use> "Leiomyosarcoma" .
<Docetaxel> <Has_accepted_use> "Head_and_neck_cancer" .
<Docetaxel> <Has_accepted_use> "Gastric_cancer" .
<Docetaxel> <Has_accepted_use> "Ewing_sarcoma" .
<Docetaxel> <Has_accepted_use> "Esophageal_cancer" .
<Docetaxel> <Has_accepted_use> "Cervical_cancer" .
<Docetaxel> <Has_accepted_use> "Breast_cancer" .
<Docetaxel> <Has_accepted_use> "Bladder_cancer" .
<Docetaxel> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<Vincristine_liposomal> <Has_FDA_indication> "B-cell_acute_lymphoblastic_leukemia" .
<Imatinib,_Vincristine,_Dexamethasone> <Mapped_from> "Imatinib,_Vincristine,_Dexamethasone" .
<Synostep> <Brand_name_of> "Alendronate" .
<Encorafenib> <Has_accepted_use> "Melanoma" .
<Nivolumab,_then_Ipilimumab> <Has_context> "Non-curative_therapy" .
<Vindesine> <Is_a> "Vinca_alkaloid" .
<Vindesine> <Is_a> "Vesicant" .
<Vindesine> <Is_a> "Microtubule_inhibitor" .
<IT_Cytarabine,_Methotrexate,_WBRT> <Is_current_in> "CNS_leukemia" .
<Ciclokebir> <Brand_name_of> "Cyclophosphamide" .
<RABVD> <Mapped_from> "RABVD" .
<CEV_and_RT> <Maps_to> "CEV_and_RT" .
<R,_then_CHOP> <Maps_to> "R,_then_CHOP" .
<Cyclophosphamide,_Prednisone,_Diethylstilbestrol> <Has_accepted_use> "Prostate_cancer" .
<Caplacizumab_and_Plasma_exchange> <Has_modality> "Supportive_therapy" .
<Cytarabine,_Idarubicin,_Imatinib> <Has_antineoplastic> "Imatinib" .
<Cytarabine,_Idarubicin,_Imatinib> <Has_antineoplastic> "Idarubicin" .
<Cytarabine,_Idarubicin,_Imatinib> <Has_antineoplastic> "Cytarabine" .
<Erbabin> <Brand_name_of> "Cytarabine" .
<Sulfatalpin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Meladinine> <Brand_name_of> "Methoxsalen" .
<Alpelisib_and_Fulvestrant> <Has_modality> "Hormonotherapy" .
<Alpelisib_and_Fulvestrant> <Has_modality> "Chemotherapy" .
<Temozolomide_and_NovoTTF-100A> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Lapatinib_and_Trastuzumab> <Maps_to> "Lapatinib_and_Trastuzumab" .
<TC_and_Nintedanib> <Has_modality> "Chemotherapy" .
<Interferon_alfa-2b_monotherapy> <Has_context> "Non-curative_therapy" .
<Interferon_alfa-2b_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Interferon_alfa-2b_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Interferon_alfa-2b_monotherapy> <Has_context> "All_lines_of_therapy" .
<Interferon_alfa-2b_monotherapy> <Has_context> "Adjuvant_therapy" .
<Acyclovir> <Has_brand_name> "Zovirax" .
<Acyclovir> <Has_brand_name> "Zovir" .
<Acyclovir> <Has_brand_name> "Zoviax" .
<Acyclovir> <Has_brand_name> "Zoraxin" .
<Acyclovir> <Has_brand_name> "Zorax" .
<Acyclovir> <Has_brand_name> "Zoral" .
<Acyclovir> <Has_brand_name> "Zirax" .
<Acyclovir> <Has_brand_name> "Zevin" .
<Acyclovir> <Has_brand_name> "Xovir" .
<Acyclovir> <Has_brand_name> "Virupos" .
<Acyclovir> <Has_brand_name> "Virucid" .
<Acyclovir> <Has_brand_name> "Virox" .
<Acyclovir> <Has_brand_name> "Virless" .
<Acyclovir> <Has_brand_name> "Virest" .
<Acyclovir> <Has_brand_name> "Virax" .
<Acyclovir> <Has_brand_name> "Vicide" .
<Acyclovir> <Has_brand_name> "Vacrax" .
<Acyclovir> <Has_brand_name> "Saforax" .
<Acyclovir> <Has_brand_name> "Pharmaniaga" .
<Acyclovir> <Has_brand_name> "Medovir" .
<Acyclovir> <Has_brand_name> "Lovir" .
<Acyclovir> <Has_brand_name> "Klovireks-l" .
<Acyclovir> <Has_brand_name> "Herzovir" .
<Acyclovir> <Has_brand_name> "Herpex" .
<Acyclovir> <Has_brand_name> "Herpevex" .
<Acyclovir> <Has_brand_name> "Hepirax" .
<Acyclovir> <Has_brand_name> "Dravyr" .
<Acyclovir> <Has_brand_name> "Declovir" .
<Acyclovir> <Has_brand_name> "Cyclovir" .
<Acyclovir> <Has_brand_name> "Cyclovax" .
<Acyclovir> <Has_brand_name> "Cusiviral" .
<Acyclovir> <Has_brand_name> "Axcel" .
<Acyclovir> <Has_brand_name> "Avorax" .
<Acyclovir> <Has_brand_name> "Apo-acyclovir" .
<Acyclovir> <Has_brand_name> "Acylete" .
<Acyclovir> <Has_brand_name> "Acivirax" .
<Acyclovir> <Has_brand_name> "Acivir" .
<Acyclovir> <Has_brand_name> "Acic" .
<Doxifluridine_and_Mitomycin> <Has_context> "Adjuvant_therapy" .
<R-FM> <Mapped_from> "R-FM" .
<Cytarabine_and_Thioguanine> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Dexagalen> <Brand_name_of> "Dexamethasone" .
<M-BCD> <Maps_to> "M-BCD" .
<Isotretinoin_monotherapy> <Has_modality> "Chemotherapy" .
<Endoxana> <Brand_name_of> "Cyclophosphamide" .
<Coagulopathy_medication> <Is_a> "Classical_hematology_medication" .
<Ketoconazole,_Hydrocortisone,_Dutasteride> <Maps_to> "Ketoconazole,_Hydrocortisone,_Dutasteride" .
<Mexasone> <Brand_name_of> "Dexamethasone" .
<Danaparoid_monotherapy> <Has_context> "Anticoagulation" .
<Idarucizumab> <Has_brand_name> "Praxbind" .
<Dexacortisyl> <Brand_name_of> "Dexamethasone" .
<CMED> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<Pd> <Maps_to> "Pd" .
<CAV_and_RT> <Has_accepted_use> "Small_cell_lung_cancer" .
<Gemcitabine_and_S-1> <Has_modality> "Chemotherapy" .
<TD> <Mapped_from> "TD" .
<Haemofarin> <Brand_name_of> "Warfarin" .
<VMP/Rd> <Maps_to> "VMP/Rd" .
<DAC> <Maps_to> "DAC" .
<Ednaprom> <Brand_name_of> "Prednisone" .
<Panobinostat> <Is_a> "REMS_program" .
<Panobinostat> <Is_a> "PMDA_approved_drug" .
<Panobinostat> <Is_a> "HDAC_inhibitor" .
<Panobinostat> <Is_a> "FDA_approved_drug" .
<Docetaxel,_Gemcitabine,_RT> <Mapped_from> "Docetaxel,_Gemcitabine,_RT" .
<Corticorten> <Brand_name_of> "Prednisone" .
<AC-T> <Is_current_in> "Breast_cancer" .
<Methotrexate_and_Pegaspargase> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone> <Is_a> "Anthracycline-containing_regimen" .
<Ebetaxel> <Brand_name_of> "Paclitaxel" .
<Dalisol> <Brand_name_of> "Folinic_acid" .
<ATRA_and_Danazol> <Has_accepted_use> "Immune_thrombocytopenia" .
<ATG_(Rabbit)_and_Cyclosporine> <Is_current_in> "Aplastic_anemia" .
<Carboplatin_and_Etoposide> <Maps_to> "Carboplatin_and_Etoposide" .
<Decalon> <Brand_name_of> "Dexamethasone" .
<RVR> <Has_antineoplastic> "Rituximab" .
<RVR> <Has_antineoplastic> "Everolimus" .
<RVR> <Has_antineoplastic> "Bortezomib" .
<FCR,_then_allo_HSCT> <Has_immunosuppressor> "Tacrolimus" .
<FCR,_then_allo_HSCT> <Has_immunosuppressor> "Methotrexate" .
<FCR,_then_allo_HSCT> <Has_immunosuppressor> "Antithymocyte_globulin_horse_ATG" .
<Daunorubicin> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Daunorubicin> <Is_a> "Vesicant" .
<Daunorubicin> <Is_a> "Topoisomerase_inhibitor" .
<Daunorubicin> <Is_a> "Anthracycline" .
<VCP> <Is_historical_in> "Multiple_myeloma" .
<Cisplatin_monotherapy> <Has_accepted_use> "triple_negative_Breast_cancer" .
<Cisplatin_monotherapy> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Cisplatin_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Cisplatin_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cisplatin_monotherapy> <Has_accepted_use> "Mesothelioma" .
<Cisplatin_monotherapy> <Has_accepted_use> "Hepatoblastoma" .
<Cisplatin_monotherapy> <Has_accepted_use> "Head_and_neck_cancer" .
<Cisplatin_monotherapy> <Has_accepted_use> "Cervical_cancer" .
<Cisplatin_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Cisplatin_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<Cisplatin_monotherapy> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone> <Mapped_from> "Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone" .
<Benadryl> <Brand_name_of> "Diphenhydramine" .
<Docetaxel_and_Ramucirumab> <Has_supportive_med> "Dexamethasone" .
<Methotrexate,_then_Cytarabine_and_Thiotepa> <Has_supportive_med> "Folinic_acid" .
<Ipilimumab,_then_Nivolumab> <Is_current_in> "Melanoma" .
<Vosaroxin_and_Cytarabine> <Mapped_from> "Vosaroxin_and_Cytarabine" .
<R,_then_CHOP> <Has_supportive_med> "PCP_prophylaxis" .
<R,_then_CHOP> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Rucaparib_monotherapy> <Maps_to> "Rucaparib_monotherapy" .
<Flu-Mel,_then_allo_HSCT> <Has_accepted_use> "Hodgkin_lymphoma" .
<Ipilimumab_monotherapy> <Mapped_from> "Ipilimumab_monotherapy" .
<CDE> <Maps_to> "CDE" .
<Carboplatin_and_Irinotecan> <Is_a> "Platinum_doublet" .
<Carboplatin_and_Irinotecan> <Is_a> "Irinotecan-containing_regimen" .
<Chlorambucil> <Antineoplastic_of> "VAD_plus_C" .
<Chlorambucil> <Antineoplastic_of> "RiPAD_plus_C" .
<Chlorambucil> <Antineoplastic_of> "R-VAD_plus_C" .
<Chlorambucil> <Antineoplastic_of> "R-MCP" .
<Chlorambucil> <Antineoplastic_of> "MCP_(Prednisolone)" .
<Chlorambucil> <Antineoplastic_of> "MCP" .
<Chlorambucil> <Antineoplastic_of> "LOPP/EVAP" .
<Chlorambucil> <Antineoplastic_of> "LOPP" .
<Chlorambucil> <Antineoplastic_of> "Chlorambucil,_Dactinomycin,_Methotrexate" .
<Chlorambucil> <Antineoplastic_of> "Chlorambucil_monotherapy" .
<Chlorambucil> <Antineoplastic_of> "Chlorambucil_and_Rituximab" .
<Chlorambucil> <Antineoplastic_of> "Chlorambucil_and_Prednisone" .
<Chlorambucil> <Antineoplastic_of> "Chlorambucil_and_Prednisolone" .
<Chlorambucil> <Antineoplastic_of> "Chlorambucil_and_Ofatumumab" .
<Chlorambucil> <Antineoplastic_of> "Chlorambucil_and_Obinutuzumab" .
<Chlorambucil> <Antineoplastic_of> "Chlorambucil_and_Cisplatin" .
<Chlorambucil> <Antineoplastic_of> "ChlVPP/PABIOE" .
<Chlorambucil> <Antineoplastic_of> "ChlVPP/EVA" .
<Chlorambucil> <Antineoplastic_of> "ChlVPP" .
<Chlorambucil> <Antineoplastic_of> "Arsenic_trioxide_and_Chlorambucil" .
<Carmustine_wafer_polifeprosan_20> <Is_a> "Nitrosourea" .
<Carmustine_wafer_polifeprosan_20> <Is_a> "Alkylating_agent" .
<VEBEP> <Maps_to> "VEBEP" .
<Cyclosporine,_Methotrexate,_Methylprednisolone> <Has_modality> "Immunosuppressive_therapy" .
<Idizone> <Brand_name_of> "Dexamethasone" .
<TCH_(Taxotere,_Carboplatin)> <Is_current_in> "Breast_cancer" .
<PCO> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Fondaparinux> <May_have_route> "Subcutaneous" .
<Rubidomycin> <Brand_name_of> "Daunorubicin" .
<Cisplatin,_Dacarbazine,_Tamoxifen> <Is_a> "Antiestrogen-containing_regimen" .
<BASIC> <Has_context> "Induction_therapy" .
<BASIC> <Has_context> "Consolidation_after_upfront_therapy" .
<Capecitabine_and_Erlotinib> <Has_antineoplastic> "Erlotinib" .
<Capecitabine_and_Erlotinib> <Has_antineoplastic> "Capecitabine" .
<BEAM> <Has_immunosuppressor> "Tacrolimus" .
<BEAM> <Has_immunosuppressor> "Methotrexate" .
<BEAM> <Has_immunosuppressor> "Filgrastim" .
<Gemtuzumab_ozogamicin_monotherapy> <Maps_to> "Gemtuzumab_ozogamicin_monotherapy" .
<Abexinostat> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Abexinostat> <Has_accepted_use> "Follicular_lymphoma" .
<Broncoflam> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Abemaciclib_monotherapy> <Is_current_in> "Breast_cancer" .
<Fotemustine_monotherapy> <Has_modality> "Chemotherapy" .
<GDP> <Has_modality> "Chemotherapy" .
<Angiox> <Brand_name_of> "Bivalirudin" .
<OxaLitin> <Brand_name_of> "Oxaliplatin" .
<Barasertib> <Is_a> "Kinase_inhibitor" .
<Barasertib> <Is_a> "Investigational_drug" .
<Barasertib> <Is_a> "Aurora_kinase_inhibitor" .
<Sulphatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Daunorubicin> <Has_brand_name> "Runabicon" .
<Daunorubicin> <Has_brand_name> "Rubomycin" .
<Daunorubicin> <Has_brand_name> "Rubilem" .
<Daunorubicin> <Has_brand_name> "Rubidomycin" .
<Daunorubicin> <Has_brand_name> "Ondena" .
<Daunorubicin> <Has_brand_name> "Maxidauno" .
<Daunorubicin> <Has_brand_name> "Daurocina" .
<Daunorubicin> <Has_brand_name> "Daunorubicine" .
<Daunorubicin> <Has_brand_name> "Daunomicina" .
<Daunorubicin> <Has_brand_name> "Daunocin" .
<Daunorubicin> <Has_brand_name> "Daunoblastina" .
<Daunorubicin> <Has_brand_name> "Daunoblastin" .
<Daunorubicin> <Has_brand_name> "D-Blastin" .
<Daunorubicin> <Has_brand_name> "Cerubidine" .
<Daunorubicin> <Has_brand_name> "Cerubidin" .
<Z-BEAM> <Has_context> "All_lines_of_therapy" .
<Cisplatin,_Pemetrexed,_Bevacizumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<Cisplatin,_Pemetrexed,_Bevacizumab> <Is_current_in> "Mesothelioma" .
<Siltuximab_monotherapy> <Maps_to> "Siltuximab_monotherapy" .
<SOX_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Capecitabine,_Cisplatin,_RT> <Mapped_from> "Capecitabine,_Cisplatin,_RT" .
<FP/Capecitabine_and_RT> <Is_current_in> "Gastric_cancer" .
<mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)> <Has_context> "Non-curative_first-line_therapy" .
<Imatinib_and_Interferon> <Is_current_in> "Chronic_myelogenous_leukemia" .
<Carboplatin_and_Docetaxel> <Has_supportive_med> "Steroids" .
<Carboplatin_and_Docetaxel> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Carboplatin_and_Docetaxel> <Has_supportive_med> "Ranitidine" .
<Carboplatin_and_Docetaxel> <Has_supportive_med> "Phenothiazines" .
<Carboplatin_and_Docetaxel> <Has_supportive_med> "Ondansetron" .
<Carboplatin_and_Docetaxel> <Has_supportive_med> "Granisetron" .
<Carboplatin_and_Docetaxel> <Has_supportive_med> "Filgrastim" .
<Carboplatin_and_Docetaxel> <Has_supportive_med> "Diphenhydramine" .
<Carboplatin_and_Docetaxel> <Has_supportive_med> "Dexamethasone" .
<Carboplatin_and_Docetaxel> <Has_supportive_med> "Cabazitaxel" .
<Carboplatin_and_Docetaxel> <Has_supportive_med> "Antihistamines" .
<Thoracic_cancer> <Is_a> "Malignant_solid_neoplasm" .
<CX-C> <Is_current_in> "Esophageal_cancer" .
<BCG_and_Dacarbazine> <Has_antineoplastic> "Dacarbazine" .
<BCG_and_Dacarbazine> <Has_antineoplastic> "Bacillus_Calmette-Guerin" .
<Mesadoron> <Brand_name_of> "Dexamethasone" .
<Lenalidomide,_Dexamethasone,_Rituximab> <Has_accepted_use> "Follicular_lymphoma" .
<Cortiol> <Brand_name_of> "Prednisone" .
<Stanback> <Brand_name_of> "Aspirin" .
<Epirubicin_and_Vinorelbine> <Is_current_in> "Breast_cancer" .
<FEC_and_H_(SC)> <Mapped_from> "FEC_and_H_(SC)" .
<Cyclosporine_monotherapy> <Mapped_from> "Cyclosporine_monotherapy" .
<Paclitaxel_and_Ramucirumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<CHVmP-VB> <Has_antineoplastic> "Vincristine" .
<CHVmP-VB> <Has_antineoplastic> "Teniposide" .
<CHVmP-VB> <Has_antineoplastic> "Prednisone" .
<CHVmP-VB> <Has_antineoplastic> "Doxorubicin" .
<CHVmP-VB> <Has_antineoplastic> "Cyclophosphamide" .
<CHVmP-VB> <Has_antineoplastic> "Bleomycin" .
<EC> <Has_context> "Non-curative_first-line_therapy" .
<EC> <Has_context> "Neoadjuvant_therapy" .
<EC> <Has_context> "Adjuvant_therapy" .
<IT_Cytarabine,_Methotrexate,_Methylprednisolone> <Mapped_from> "IT_Cytarabine,_Methotrexate,_Methylprednisolone" .
<Fostamatinib_monotherapy> <Maps_to> "Fostamatinib_monotherapy" .
<Syltrifil> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Fludarabine_and_Prednisone> <Has_antineoplastic> "Prednisone" .
<Fludarabine_and_Prednisone> <Has_antineoplastic> "Fludarabine" .
<Ranitidine> <Is_a> "H2-receptor_antagonist" .
<Osteofene> <Brand_name_of> "Alendronate" .
<mFOLFOX7_(L-Leucovorin)> <Has_antineoplastic> "Oxaliplatin" .
<mFOLFOX7_(L-Leucovorin)> <Has_antineoplastic> "Levoleucovorin" .
<mFOLFOX7_(L-Leucovorin)> <Has_antineoplastic> "Fluorouracil" .
<Direct_thrombin_inhibitor> <Subsumes> "Lepirudin" .
<Direct_thrombin_inhibitor> <Subsumes> "Dabigatran" .
<Direct_thrombin_inhibitor> <Subsumes> "Bivalirudin" .
<Direct_thrombin_inhibitor> <Subsumes> "Argatroban" .
<ECT,_then_auto_HSCT> <Has_antineoplastic> "Thiotepa" .
<ECT,_then_auto_HSCT> <Has_antineoplastic> "Epirubicin" .
<ECT,_then_auto_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<CC> <Has_context> "Non-curative_first-line_therapy" .
<Entrectinib> <Antineoplastic_of> "Entrectinib_monotherapy" .
<Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone> <Has_antineoplastic> "Vincristine" .
<Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone> <Has_antineoplastic> "Prednisolone" .
<Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone> <Has_antineoplastic> "Doxorubicin" .
<Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone> <Has_antineoplastic> "Cyclophosphamide" .
<Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone> <Has_antineoplastic> "Asparaginase" .
<7_plus_3d_and_Midostaurin> <Maps_to> "7_plus_3d_and_Midostaurin" .
<FluCam> <Has_supportive_med> "Valacyclovir" .
<FluCam> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<FluCam> <Has_supportive_med> "Prednisone" .
<FluCam> <Has_supportive_med> "Fluconazole" .
<FluCam> <Has_supportive_med> "Clemastine" .
<FluCam> <Has_supportive_med> "Allopurinol" .
<FluCam> <Has_supportive_med> "Acetaminophen" .
<R-MCP> <Has_context> "Non-curative_first-line_therapy" .
<Erlotinib> <Antineoplastic_of> "Erlotinib_monotherapy" .
<Erlotinib> <Antineoplastic_of> "Erlotinib_and_Ramucirumab" .
<Erlotinib> <Antineoplastic_of> "Erlotinib_and_Gemcitabine" .
<Erlotinib> <Antineoplastic_of> "Erlotinib_and_Bevacizumab" .
<Erlotinib> <Antineoplastic_of> "Cisplatin_and_Gemcitabine/Erlotinib" .
<Erlotinib> <Antineoplastic_of> "Carboplatin_and_Gemcitabine/Erlotinib" .
<Erlotinib> <Antineoplastic_of> "Capecitabine_and_Erlotinib" .
<Erlotinib> <Antineoplastic_of> "Cabozantinib_and_Erlotinib" .
<Clofarabine_and_Melphalan> <Has_context> "All_lines_of_therapy" .
<Toremifene> <Has_FDA_indication> "Breast_cancer" .
<Alecensa> <Brand_name_of> "Alectinib" .
<BVR> <Has_modality> "Chemotherapy" .
<ABV_(Vincristine)> <Has_context> "All_lines_of_therapy" .
<Total_Therapy> <Maps_to> "Total_Therapy" .
<CMFP> <Has_accepted_use> "Breast_cancer" .
<Indomethacin> <Is_a> "COX-2_inhibitor" .
<Indomethacin> <Is_a> "COX-1_inhibitor" .
<Indomethacin> <Is_a> "Antipyretic" .
<7_plus_3i_and_Vorinostat> <Maps_to> "7_plus_3i_and_Vorinostat" .
<R-CHOP_(Prednisolone)> <Maps_to> "R-CHOP_(Prednisolone)" .
<IT_Cytarabine_and_WBRT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Romidepsin> <May_have_route> "Intravenous" .
<ERBB2-mutated_malignancy> <Current_treated_by> "Pertuzumab_and_Trastuzumab" .
<ERBB2-mutated_malignancy> <Current_treated_by> "Neratinib_monotherapy" .
<ERBB2-mutated_malignancy> <Current_treated_by> "Ado-trastuzumab_emtansine_monotherapy" .
<CISCA> <Mapped_from> "CISCA" .
<BeGEV> <Is_current_in> "Hodgkin_lymphoma" .
<Flutamide_monotherapy> <Mapped_from> "Flutamide_monotherapy" .
<VAD-P> <Maps_to> "VAD-P" .
<Eposido> <Brand_name_of> "Etoposide" .
<Exitop> <Brand_name_of> "Etoposide" .
<IE> <Has_antineoplastic> "Mesna" .
<IE> <Has_antineoplastic> "Ifosfamide" .
<IE> <Has_antineoplastic> "Etoposide" .
<Lenvatinib_monotherapy> <Is_current_in> "Thyroid_cancer" .
<Lenvatinib_monotherapy> <Is_current_in> "Renal_cell_carcinoma" .
<Lenvatinib_monotherapy> <Is_current_in> "Hepatocellular_carcinoma" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Vincristine" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Venetoclax_monotherapy" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Venetoclax_and_Rituximab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Venetoclax_and_Obinutuzumab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Venetoclax" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Uracil_mustard_monotherapy" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Ublituximab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Tisagenlecleucel_monotherapy" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Ruxolitinib_monotherapy" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Ruxolitinib" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Rituximab-pvvr" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Rituximab-abbs" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Rituximab_monotherapy" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Rituximab_and_hyaluronidase_human" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Rituximab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "RCC" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "R-FCM" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "R-BAC" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Prednisone" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Prednisolone" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Placebo" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Pentostatin" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "PCR" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "PCO" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Oxaliplatin" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Ofatumumab_monotherapy" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Ofatumumab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Observation" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Obinutuzumab_monotherapy" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Obinutuzumab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "OFAR" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "O-FC" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Mitoxantrone" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Methylprednisolone" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "MOR208" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Lenalidomide_monotherapy" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Lenalidomide_and_Rituximab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Lenalidomide_and_Ofatumumab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Lenalidomide" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Idelalisib_monotherapy" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Idelalisib_and_Rituximab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Idelalisib_and_Ofatumumab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Idelalisib" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Ibrutinib_monotherapy" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Ibrutinib_and_Venetoclax" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Ibrutinib_and_Rituximab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Ibrutinib_and_Ofatumumab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Ibrutinib_and_Obinutuzumab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Ibrutinib" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "HDMP-R" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "HDMP" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "G-FC" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Fludarabine_monotherapy" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Fludarabine_and_TBI,_then_allo_HSCT" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Fludarabine_and_Prednisone" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Fludarabine_and_Alemtuzumab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Fludarabine" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "FluCam" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "FR" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "FCR_(Rituximab_Hycela)" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "FCR" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "FCM" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "FCA" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "FC,_then_allo_HSCT" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "FC" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Duvelisib_monotherapy" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Duvelisib" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Doxorubicin" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Cytarabine" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Cyclophosphamide" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Cladribine_monotherapy" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Cladribine" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Chlorambucil_monotherapy" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Chlorambucil_and_Rituximab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Chlorambucil_and_Prednisone" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Chlorambucil_and_Ofatumumab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Chlorambucil_and_Obinutuzumab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Chlorambucil" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "CVP" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "CMC" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "CHOP" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "CFAR" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "CC" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "CAP" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Busulfan" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Bendamustine_monotherapy" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Bendamustine_and_Ofatumumab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Bendamustine_and_Obinutuzumab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Bendamustine" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "BR_and_Idelalisib" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "BR_and_Ibrutinib" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "BR" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Alemtuzumab_monotherapy" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Alemtuzumab_and_Rituximab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Alemtuzumab_and_Methylprednisolone" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Alemtuzumab" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Acalabrutinib_monotherapy" .
<Chronic_lymphocytic_leukemia> <Accepted_use_of> "Acalabrutinib" .
<CPX-351_monotherapy> <Has_accepted_use> "Acute_myeloid_leukemia" .
<KIT-mutated_Melanoma> <Accepted_use_of> "Imatinib_monotherapy" .
<DCF> <Has_modality> "Chemotherapy" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Vincristine_and_Prednisone" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Radotinib_monotherapy" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Ponatinib_monotherapy" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Omacetaxine_monotherapy" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Nilotinib_monotherapy" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Interferon_alfa-n1_monotherapy" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Interferon_alfa-2b_monotherapy" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Interferon_alfa-2b_and_DLI" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Interferon_alfa-2a_monotherapy" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Interferon_alfa_monotherapy" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Imatinib_monotherapy" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Imatinib_and_LoDAC" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Imatinib_and_Interferon" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Hydroxyurea_and_Plicamycin" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Hydroxyurea_and_Interferon_alfa-2a" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Dasatinib_monotherapy" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Cytarabine_and_Interferon_alfa-2b" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Cyclophosphamide_and_TBI,_then_allo_HSCT" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Busulfan_monotherapy" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "BuCyTBI,_then_allo_HSCT" .
<Chronic_myelogenous_leukemia> <Current_treated_by> "Bosutinib_monotherapy" .
<MVAC,_dose-dense> <Has_modality> "Chemotherapy" .
<Lapatinib> <Is_a> "Protein_expression-specific_medication" .
<Lapatinib> <Is_a> "Kinase_inhibitor" .
<Lapatinib> <Is_a> "ERBB2_inhibitor" .
<Lapatinib> <Is_a> "EGFR_inhibitor" .
<R-CHOP/R-DHAP> <Mapped_from> "R-CHOP/R-DHAP" .
<SCC_of_unknown_primary> <Current_treated_by> "PCF" .
<SCC_of_unknown_primary> <Current_treated_by> "DCF" .
<ZRd> <Has_antineoplastic> "Vorinostat" .
<ZRd> <Has_antineoplastic> "Lenalidomide" .
<ZRd> <Has_antineoplastic> "Dexamethasone" .
<Anastrozole_and_Ribociclib> <Mapped_from> "Anastrozole_and_Ribociclib" .
<Denosumab> <Has_brand_name> "Xgeva" .
<Denosumab> <Has_brand_name> "Prolia" .
<Copanlisib> <May_have_route> "Intravenous" .
<Carboplatin,_Paclitaxel,_RT> <Has_modality> "Radiotherapy" .
<Carboplatin,_Paclitaxel,_RT> <Has_modality> "Chemotherapy" .
<Dabigatran> <Is_a> "Direct_thrombin_inhibitor" .
<Dabigatran> <Is_a> "Direct_oral_anticoagulant" .
<Methotrexate,_Tacrolimus,_Vorinostat> <Has_immunosuppressor> "Vorinostat" .
<Methotrexate,_Tacrolimus,_Vorinostat> <Has_immunosuppressor> "Tacrolimus" .
<Methotrexate,_Tacrolimus,_Vorinostat> <Has_immunosuppressor> "Methotrexate" .
<Melphalan_and_TBI,_then_auto_HSCT> <Maps_to> "Melphalan_and_TBI,_then_auto_HSCT" .
<Chemotherapeutic> <Is_a> "Drugs_by_class_effect" .
<Ibandronate> <Is_a> "Bisphosphonate" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine> <Has_local_therapy> "Methotrexate" .
<Talimogene_laherparepvec> <Has_brand_name> "OncoVEX^GM-CSF" .
<Talimogene_laherparepvec> <Has_brand_name> "Imlygic" .
<MVAC> <Maps_to> "MVAC" .
<Emcyt> <Brand_name_of> "Estramustine" .
<Cyclophosphamide_and_Prednisolone> <Mapped_from> "Cyclophosphamide_and_Prednisolone" .
<Clofarabine_and_LoDAC> <Has_context> "Non-curative_first-line_induction_therapy" .
<Fludarabine,_then_131Iodine-Tositumomab> <Has_antineoplastic> "Tositumomab_and_I-131_(Bexxar)" .
<Fludarabine,_then_131Iodine-Tositumomab> <Has_antineoplastic> "Fludarabine" .
<Hemophagocytic_lymphohistiocytosis> <Is_a> "Histiocytosis" .
<TD> <Has_antineoplastic> "Thalidomide" .
<TD> <Has_antineoplastic> "Dexamethasone" .
<Tasigna> <Brand_name_of> "Nilotinib" .
<Notrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bavencio> <Brand_name_of> "Avelumab" .
<EBVP> <Has_context> "Induction_therapy" .
<Blinatumomab_monotherapy> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Blinatumomab_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Blinatumomab_monotherapy> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Pembrolizumab_monotherapy> <Has_context> "Non-curative_therapy" .
<Pembrolizumab_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Pembrolizumab_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Pembrolizumab_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Pembrolizumab_monotherapy> <Has_context> "Neoadjuvant_therapy" .
<Pembrolizumab_monotherapy> <Has_context> "Local_therapy" .
<Pembrolizumab_monotherapy> <Has_context> "All_lines_of_therapy" .
<Pembrolizumab_monotherapy> <Has_context> "Adjuvant_therapy" .
<DHAP> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<DHAP> <Has_accepted_use> "Hodgkin_lymphoma" .
<DHAP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<DHAP> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<Alemtuzumab> <Supportive_med_of> "CC" .
<IL-2_monotherapy> <Has_context> "Non-curative_therapy" .
<MRD> <Has_modality> "Chemotherapy" .
<PEN> <Has_context> "Induction_therapy" .
<ADT_and_Docetaxel> <Has_context> "Non-curative_therapy" .
<Gallbladder_cancer> <Accepted_use_of> "Regorafenib_monotherapy" .
<Gallbladder_cancer> <Accepted_use_of> "Oxaliplatin" .
<Gallbladder_cancer> <Accepted_use_of> "Gemcitabine,_Cisplatin,_S-1" .
<Gallbladder_cancer> <Accepted_use_of> "Gemcitabine_monotherapy" .
<Gallbladder_cancer> <Accepted_use_of> "Gemcitabine_and_S-1" .
<Gallbladder_cancer> <Accepted_use_of> "Gemcitabine_and_Mitomycin" .
<Gallbladder_cancer> <Accepted_use_of> "Gemcitabine" .
<Gallbladder_cancer> <Accepted_use_of> "GemOx" .
<Gallbladder_cancer> <Accepted_use_of> "GEMOX-B" .
<Gallbladder_cancer> <Accepted_use_of> "Fluorouracil,_Folinic_acid,_Gemcitabine" .
<Gallbladder_cancer> <Accepted_use_of> "FELV" .
<Gallbladder_cancer> <Accepted_use_of> "Erlotinib_and_Bevacizumab" .
<Gallbladder_cancer> <Accepted_use_of> "ECF" .
<Gallbladder_cancer> <Accepted_use_of> "Cisplatin,_Gemcitabine,_nab-Paclitaxel" .
<Gallbladder_cancer> <Accepted_use_of> "Cisplatin_and_Gemcitabine" .
<Gallbladder_cancer> <Accepted_use_of> "Capecitabine_monotherapy" .
<Gallbladder_cancer> <Accepted_use_of> "Capecitabine_and_Mitomycin" .
<Gallbladder_cancer> <Accepted_use_of> "Capecitabine_and_Gemcitabine" .
<Gallbladder_cancer> <Accepted_use_of> "Capecitabine" .
<Gallbladder_cancer> <Accepted_use_of> "CapeOx" .
<Gallbladder_cancer> <Accepted_use_of> "Best_supportive_care" .
<Warfarin_monotherapy> <Has_supportive_med> "Warfarin" .
<Warfarin_monotherapy> <Has_supportive_med> "Enoxaparin" .
<Uftoral> <Brand_name_of> "Tegafur_and_uracil" .
<PFT> <Has_modality> "Hormonotherapy" .
<PFT> <Has_modality> "Chemotherapy" .
<Gemcitabine_and_S-1> <Has_context> "Non-curative_therapy" .
<Combi-Methoxan> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Eltrombopag_monotherapy> <Maps_to> "Eltrombopag_monotherapy" .
<Enzalutamide_monotherapy> <Is_current_in> "Prostate_cancer" .
<Enzalutamide_monotherapy> <Is_current_in> "Breast_cancer" .
<Flutamide_and_Goserelin> <Mapped_from> "Flutamide_and_Goserelin" .
<Aspirin_and_Hydroxyurea> <Mapped_from> "Aspirin_and_Hydroxyurea" .
<Pediatric_cancer> <Subsumes> "Wilms_tumor" .
<Pediatric_cancer> <Subsumes> "T-cell_acute_lymphoblastic_leukemia" .
<Pediatric_cancer> <Subsumes> "Rhabdomyosarcoma" .
<Pediatric_cancer> <Subsumes> "Osteosarcoma" .
<Pediatric_cancer> <Subsumes> "Neuroblastoma" .
<Pediatric_cancer> <Subsumes> "Medulloblastoma" .
<Pediatric_cancer> <Subsumes> "Hepatoblastoma" .
<Pediatric_cancer> <Subsumes> "Ewing_sarcoma" .
<Pediatric_cancer> <Subsumes> "Epithelioid_sarcoma" .
<Pediatric_cancer> <Subsumes> "B-cell_acute_lymphoblastic_leukemia" .
<Ziv-aflibercept> <Has_accepted_use> "Colon_cancer" .
<Virolfi> <Brand_name_of> "Valganciclovir" .
<R-COPADM> <Has_context> "Induction_therapy" .
<ADE_(high-dose_Ara-C)> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine> <Has_modality> "Chemotherapy" .
<VDC/IE> <Has_modality> "Chemotherapy" .
<VAdCA/IE> <Mapped_from> "VAdCA/IE" .
<Dacarbazine_and_Doxorubicin> <Is_current_in> "Soft_tissue_sarcoma" .
<Lupron> <Brand_name_of> "Leuprolide" .
<Cytarabine> <Has_accepted_use> "Transformed_lymphoma" .
<Cytarabine> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Cytarabine> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<Cytarabine> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Cytarabine> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Cytarabine> <Has_accepted_use> "Langerhans_cell_histiocytosis" .
<Cytarabine> <Has_accepted_use> "Hypereosinophilic_syndrome" .
<Cytarabine> <Has_accepted_use> "Hodgkin_lymphoma" .
<Cytarabine> <Has_accepted_use> "HIV-associated_lymphoma" .
<Cytarabine> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Cytarabine> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Cytarabine> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Cytarabine> <Has_accepted_use> "CNS_lymphoma" .
<Cytarabine> <Has_accepted_use> "Burkitt_lymphoma" .
<Cytarabine> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Cytarabine> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<Cytarabine> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<Cytarabine> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Cytarabine> <Has_accepted_use> "Acute_myeloid_leukemia" .
<WHO_Essential_Pain_and_Palliative_Care_Medicine> <Subsumes> "Sennosides" .
<WHO_Essential_Pain_and_Palliative_Care_Medicine> <Subsumes> "Ondansetron" .
<WHO_Essential_Pain_and_Palliative_Care_Medicine> <Subsumes> "Metoclopramide" .
<WHO_Essential_Pain_and_Palliative_Care_Medicine> <Subsumes> "Loperamide" .
<WHO_Essential_Pain_and_Palliative_Care_Medicine> <Subsumes> "Lactulose" .
<WHO_Essential_Pain_and_Palliative_Care_Medicine> <Subsumes> "Haloperidol" .
<WHO_Essential_Pain_and_Palliative_Care_Medicine> <Subsumes> "Docusate" .
<WHO_Essential_Pain_and_Palliative_Care_Medicine> <Subsumes> "Dexamethasone" .
<WHO_Essential_Pain_and_Palliative_Care_Medicine> <Subsumes> "Aspirin" .
<WHO_Essential_Pain_and_Palliative_Care_Medicine> <Subsumes> "Acetaminophen" .
<BASIC> <Has_accepted_use> "Burkitt_lymphoma" .
<Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone> <Is_a> "Anthracycline-containing_regimen" .
<Xine> <Brand_name_of> "Dexamethasone" .
<Elo-PD> <Has_context> "Non-curative_therapy" .
<dmCODOX-M_-_Modified_Magrath> <Has_local_therapy> "Methotrexate" .
<dmCODOX-M_-_Modified_Magrath> <Has_local_therapy> "Folinic_acid" .
<dmCODOX-M_-_Modified_Magrath> <Has_local_therapy> "Cytarabine" .
<Clonea> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Mogamulizumab> <Has_brand_name> "Poteligeo" .
<Lanreotide_Depot/Autogel_monotherapy> <Mapped_from> "Lanreotide_Depot/Autogel_monotherapy" .
<Anticoagulation> <Mapped_from> "Anticoagulation" .
<R-COPADM> <Mapped_from> "R-COPADM" .
<VABE> <Has_modality> "Chemotherapy" .
<CNS_melanoma> <Accepted_use_of> "Vemurafenib_monotherapy" .
<CNS_melanoma> <Accepted_use_of> "Ipilimumab_and_Nivolumab" .
<CNS_melanoma> <Accepted_use_of> "Fotemustine_monotherapy" .
<CNS_melanoma> <Accepted_use_of> "Dabrafenib_monotherapy" .
<CNS_melanoma> <Accepted_use_of> "Dabrafenib_and_Trametinib" .
<Citaza> <Brand_name_of> "Azacitidine" .
<TFC,_then_allo_HSCT> <Has_context> "Consolidation_after_upfront_therapy" .
<CAFVP> <Has_antineoplastic> "Vincristine" .
<CAFVP> <Has_antineoplastic> "Prednisone" .
<CAFVP> <Has_antineoplastic> "Fluorouracil" .
<CAFVP> <Has_antineoplastic> "Doxorubicin" .
<CAFVP> <Has_antineoplastic> "Cyclophosphamide" .
<Granulocyte_growth_factor> <Is_a> "Hematopoietic_growth_factor" .
<Paclitaxel_and_S-1> <Has_context> "Non-curative_first-line_therapy" .
<Lorazepam> <May_have_route> "Oral" .
<Lorazepam> <May_have_route> "Intravenous" .
<Ftouracil> <Brand_name_of> "Fluorouracil" .
<Asparaginase> <Has_brand_name> "Paronal" .
<Asparaginase> <Has_brand_name> "Onconase" .
<Asparaginase> <Has_brand_name> "Leunase" .
<Asparaginase> <Has_brand_name> "Leucoginase" .
<Asparaginase> <Has_brand_name> "Laspar" .
<Asparaginase> <Has_brand_name> "L-Ginase" .
<Asparaginase> <Has_brand_name> "L-Asperone" .
<Asparaginase> <Has_brand_name> "L_Asparaginasum" .
<Asparaginase> <Has_brand_name> "L_Asparaginasa" .
<Asparaginase> <Has_brand_name> "Kidrolase" .
<Asparaginase> <Has_brand_name> "Engenase" .
<Asparaginase> <Has_brand_name> "Elspar" .
<Asparaginase> <Has_brand_name> "Crasnitin" .
<Asparaginase> <Has_brand_name> "Chephacardin" .
<Asparaginase> <Has_brand_name> "Asparaginasa" .
<(90)YFC> <Has_antineoplastic> "Rituximab" .
<(90)YFC> <Has_antineoplastic> "Ibritumomab_tiuxetan" .
<(90)YFC> <Has_antineoplastic> "Fludarabine" .
<(90)YFC> <Has_antineoplastic> "Cyclophosphamide" .
<R-CEOP_(Etoposide)> <Maps_to> "R-CEOP_(Etoposide)" .
<Carboplatin_and_Paclitaxel> <Mapped_from> "Carboplatin_and_Paclitaxel" .
<Cisplatin,_Paclitaxel,_RT> <Has_supportive_med> "Filgrastim" .
<Cisplatin,_Paclitaxel,_RT> <Has_supportive_med> "Diphenhydramine" .
<Cisplatin,_Paclitaxel,_RT> <Has_supportive_med> "Dexamethasone" .
<Cisplatin,_Paclitaxel,_RT> <Has_supportive_med> "Cimetidine" .
<MOPP> <Has_accepted_use> "Hodgkin_lymphoma" .
<Lapuleucel-T> <Is_a> "Investigational_drug" .
<Lapuleucel-T> <Is_a> "Immunotherapeutic" .
<Lapuleucel-T> <Is_a> "Cellular_therapy" .
<Lapuleucel-T> <Is_a> "Anti-HER2_medication" .
<Aminocaproic_acid> <Is_a> "Hemostasis_medication" .
<Aminocaproic_acid> <Is_a> "Hematology_medication" .
<Aminocaproic_acid> <Is_a> "Fibrinolysis_inhibitor" .
<Fedratinib> <Has_brand_name> "Inrebic" .
<Fludarabine,_Cyclophosphamide,_ATG> <Mapped_from> "Fludarabine,_Cyclophosphamide,_ATG" .
<Midostaurin_monotherapy> <Has_context> "Salvage_therapy" .
<Midostaurin_monotherapy> <Has_context> "Non-curative_therapy" .
<Midostaurin_monotherapy> <Has_context> "Maintenance_after_upfront_therapy" .
<Midostaurin_monotherapy> <Has_context> "All_lines_of_therapy" .
<Bevarest> <Brand_name_of> "Bevacizumab" .
<Cisplatin_and_Ifosfamide> <Mapped_from> "Cisplatin_and_Ifosfamide" .
<UFT_monotherapy> <Is_current_in> "Rectal_cancer" .
<Carboplatin_and_RT> <Mapped_from> "Carboplatin_and_RT" .
<Paroxysmal_nocturnal_hemoglobinuria> <Is_a> "Hemolytic_process" .
<Paroxysmal_nocturnal_hemoglobinuria> <Is_a> "Complementopathy" .
<Paroxysmal_nocturnal_hemoglobinuria> <Is_a> "Bone_marrow_failure_syndrome" .
<DAC> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Melphalan,_then_auto_HSCT,_then_Melphalan_and_TBI,_then_auto_HSCT> <Maps_to> "Melphalan,_then_auto_HSCT,_then_Melphalan_and_TBI,_then_auto_HSCT" .
<Doxorubicin_and_Fluorouracil> <Has_accepted_use> "Gastric_cancer" .
<Voritek> <Brand_name_of> "Voriconazole" .
<CHOEP-21> <Has_modality> "Chemotherapy" .
<Crizanlizumab> <Is_a> "Antibody_medication" .
<Crizanlizumab> <Is_a> "Anti-P-selectin_antibody" .
<Aztec> <Brand_name_of> "Zidovudine" .
<Augmented_Hyper-CVAD_and_Asparaginase> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Non-Hodgkin_lymphoma> <Is_a> "Lymphoma" .
<Dexamethasone_monotherapy> <Is_historical_in> "Multiple_myeloma" .
<Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone> <Has_local_therapy> "Methotrexate" .
<Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone> <Has_local_therapy> "Cytarabine" .
<Edoxaban> <Is_a> "Factor_Xa_inhibitor" .
<Edoxaban> <Is_a> "Direct_oral_anticoagulant" .
<Cabozantinib_and_Erlotinib> <Is_current_in> "Non-small_cell_lung_cancer" .
<Pralatrexate> <Has_FDA_indication> "Peripheral_T-cell_lymphoma" .
<ChlVPP/EVA> <Has_context> "Induction_therapy" .
<Prednisolone> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Prednisolone> <Is_a> "Steroid" .
<Prednisolone> <Is_a> "PMDA_approved_drug" .
<Prednisolone> <Is_a> "Immunosuppressant" .
<Dara-VD> <Has_context> "Non-curative_therapy" .
<Unitran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Uroplus_DS> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Amatuximab> <May_have_route> "Intravenous" .
<VAC> <Maps_to> "VAC" .
<Capecitabine,_Docetaxel,_Oxaliplatin,_RT> <Maps_to> "Capecitabine,_Docetaxel,_Oxaliplatin,_RT" .
<TRK_inhibitor> <Is_a> "Kinase_inhibitor" .
<Butiol> <Brand_name_of> "Dexamethasone" .
<Alphanate> <Brand_name_of> "Von_Willebrand_factor_and_factor_VIII_complex_human" .
<Lendronal> <Brand_name_of> "Alendronate" .
<ADT_and_Enzalutamide> <Has_modality> "Hormonotherapy" .
<VcR-CVAD> <Mapped_from> "VcR-CVAD" .
<VAdCA> <Has_modality> "Chemotherapy" .
<Sulfoid_Trimetho> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Pidilizumab> <May_have_route> "Intravenous" .
<Capecitabine,_Carboplatin,_Paclitaxel,_RT> <Mapped_from> "Capecitabine,_Carboplatin,_Paclitaxel,_RT" .
<Letrozole_and_Palbociclib> <Has_context> "Non-curative_first-line_therapy" .
<mFOLFIRINOX,_Gemcitabine,_RT> <Mapped_from> "mFOLFIRINOX,_Gemcitabine,_RT" .
<R-TBI/Cy> <Is_current_in> "Autologous_HSCT" .
<Etoposide_and_Mitoxantrone> <Is_current_in> "Acute_myeloid_leukemia" .
<Carfilzomib> <May_have_route> "Intravenous" .
<Abemaciclib> <Antineoplastic_of> "Abemaciclib_monotherapy" .
<Abemaciclib> <Antineoplastic_of> "Abemaciclib_and_Letrozole" .
<Abemaciclib> <Antineoplastic_of> "Abemaciclib_and_Fulvestrant" .
<Abemaciclib> <Antineoplastic_of> "Abemaciclib_and_Anastrozole" .
<Bu/TT/Cy,_then_auto_HSCT> <Maps_to> "Bu/TT/Cy,_then_auto_HSCT" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan> <Has_modality> "Radioimmunotherapy" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan> <Has_modality> "Chemotherapy" .
<Azacytin> <Brand_name_of> "Azacitidine" .
<Nizoral> <Brand_name_of> "Ketoconazole" .
<mFOLFOX6_and_RT> <Has_modality> "Radiotherapy" .
<mFOLFOX6_and_RT> <Has_modality> "Chemotherapy" .
<Mediprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<MET_inhibitor> <Subsumes> "Tivantinib" .
<MET_inhibitor> <Subsumes> "Crizotinib" .
<MET_inhibitor> <Subsumes> "Cabozantinib" .
<Mycophenolate_mofetil_monotherapy> <Has_accepted_use> "Immune_thrombocytopenia" .
<Rituximab_and_hyaluronidase_human> <Has_accepted_use> "Follicular_lymphoma" .
<Rituximab_and_hyaluronidase_human> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Rituximab_and_hyaluronidase_human> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Antibiotic_therapy> <Modality_of> "Helicobacter_pylori_eradication_therapy" .
<Antibiotic_therapy> <Modality_of> "Doxycycline_monotherapy" .
<Antibiotic_therapy> <Modality_of> "Clarithromycin_monotherapy" .
<Levamisole_monotherapy> <Maps_to> "Levamisole_monotherapy" .
<HDMP-R> <Has_antineoplastic> "Rituximab" .
<HDMP-R> <Has_antineoplastic> "Methylprednisolone" .
<Cabozantinib_and_Erlotinib> <Has_modality> "Chemotherapy" .
<mLSG15> <Maps_to> "mLSG15" .
<Cytarabine_liposomal> <Has_brand_name> "Depocyt" .
<Mercaptopurine_and_Prednisone> <Has_context> "Induction_therapy" .
<IT_Cytarabine_and_WBRT> <Is_current_in> "CNS_leukemia" .
<Pomalidomide,_Dexamethasone,_Pembrolizumab> <Has_modality> "Immunotherapy" .
<Pomalidomide,_Dexamethasone,_Pembrolizumab> <Has_modality> "Chemotherapy" .
<Neotacs> <Brand_name_of> "Paclitaxel" .
<Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone> <Is_a> "Anthracycline-containing_regimen" .
<Trastuzumab-pkrb> <Has_accepted_use> "Gastric_cancer" .
<Trastuzumab-pkrb> <Has_accepted_use> "Esophageal_cancer" .
<Trastuzumab-pkrb> <Has_accepted_use> "Breast_cancer" .
<Cisplatin_and_Raltitrexed> <Mapped_from> "Cisplatin_and_Raltitrexed" .
<Zoladex> <Brand_name_of> "Goserelin" .
<Omstron> <Brand_name_of> "Ondansetron" .
<VACA> <Has_modality> "Chemotherapy" .
<Nedaplatin> <Antineoplastic_of> "Docetaxel_and_Nedaplatin" .
<Ivosidenib_monotherapy> <Mapped_from> "Ivosidenib_monotherapy" .
<Cisplatin,_Doxorubicin_liposomal,_Fluorouracil> <Is_a> "Anthracycline-containing_regimen" .
<Gemcitabine_and_RT> <Is_current_in> "Pancreatic_cancer" .
<Gemcitabine_and_RT> <Is_current_in> "Bladder_cancer" .
<Scopolamine> <May_have_route> "Topical" .
<COPP_(CCNU)> <Has_context> "Induction_therapy" .
<Sinersul> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone> <Mapped_from> "Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone" .
<ADT,_Docetaxel,_Estramustine> <Has_modality> "Hormonotherapy" .
<ADT,_Docetaxel,_Estramustine> <Has_modality> "Chemotherapy" .
<Mitoxantrone_and_Hydrocortisone> <Has_antineoplastic> "Mitoxantrone" .
<Mitoxantrone_and_Hydrocortisone> <Has_antineoplastic> "Hydrocortisone" .
<R-DexaBEAM> <Has_modality> "Chemotherapy" .
<CBV,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Dactinomycin_monotherapy> <Has_context> "Non-curative_therapy" .
<Dactinomycin_monotherapy> <Has_context> "All_lines_of_therapy" .
<Benralizumab_monotherapy> <Has_context> "All_lines_of_therapy" .
<PCP> <Has_context> "Non-curative_therapy" .
<Metipred> <Brand_name_of> "Methylprednisolone" .
<Daratumumab_monotherapy> <Mapped_from> "Daratumumab_monotherapy" .
<MVAC,_dose-dense> <Mapped_from> "MVAC,_dose-dense" .
<Jakavi> <Brand_name_of> "Ruxolitinib" .
<Niraparib> <Has_brand_name> "Zejula" .
<Totocortin> <Brand_name_of> "Dexamethasone" .
<Asparaginase_Erwinia_chrysanthemi> <Has_brand_name> "Erwinaze" .
<Asparaginase_Erwinia_chrysanthemi> <Has_brand_name> "Erwinase" .
<Cisplatin_and_Gemcitabine> <Has_context> "Non-curative_therapy" .
<Cisplatin_and_Gemcitabine> <Has_context> "Non-curative_subsequent-line_therapy" .
<Cisplatin_and_Gemcitabine> <Has_context> "Non-curative_second-line_therapy" .
<Cisplatin_and_Gemcitabine> <Has_context> "Non-curative_first-line_therapy" .
<Cisplatin_and_Gemcitabine> <Has_context> "Neoadjuvant_therapy" .
<Cisplatin_and_Gemcitabine> <Has_context> "Induction_therapy" .
<Cisplatin_and_Gemcitabine> <Has_context> "All_lines_of_therapy" .
<Cisplatin_and_Gemcitabine> <Has_context> "Adjuvant_therapy" .
<Cyclophosphamide,_Mycophenolate_mofetil,_Tacrolimus> <Has_accepted_use> "Graft_versus_host_disease" .
<BR_and_Idelalisib> <Is_a> "Rituximab-containing_regimen" .
<Mednin> <Brand_name_of> "Methylprednisolone" .
<LOPP> <Maps_to> "LOPP" .
<Bevacizumab-containing_therapy> <Has_antineoplastic> "Bevacizumab" .
<AALL0232_consolidation> <Has_modality> "Chemotherapy" .
<Trabectedin_monotherapy> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Trabectedin_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Trabectedin_monotherapy> <Has_accepted_use> "Liposarcoma" .
<Trabectedin_monotherapy> <Has_accepted_use> "Leiomyosarcoma" .
<Gemtuzumab_ozogamicin_monotherapy> <Has_antineoplastic> "Gemtuzumab_ozogamicin" .
<VMP> <Has_accepted_use> "Multiple_myeloma" .
<Cisplatin,_Gemcitabine,_Necitumumab> <Maps_to> "Cisplatin,_Gemcitabine,_Necitumumab" .
<7_plus_3i_and_Panobinostat> <Has_context> "Induction_therapy" .
<Malignant_solid_neoplasm> <Subsumes> "Thoracic_cancer" .
<Malignant_solid_neoplasm> <Subsumes> "Sarcoma" .
<Malignant_solid_neoplasm> <Subsumes> "SCC_of_unknown_primary" .
<Malignant_solid_neoplasm> <Subsumes> "NET_of_unknown_primary" .
<Malignant_solid_neoplasm> <Subsumes> "Mismatch_repair_deficient_malignancy" .
<Malignant_solid_neoplasm> <Subsumes> "Malignant_breast_neoplasm" .
<Malignant_solid_neoplasm> <Subsumes> "Hedgehog_pathway-mutated_malignancy" .
<Malignant_solid_neoplasm> <Subsumes> "Head_and_neck_cancer" .
<Malignant_solid_neoplasm> <Subsumes> "Gynecologic_cancer" .
<Malignant_solid_neoplasm> <Subsumes> "Genitourinary_cancer" .
<Malignant_solid_neoplasm> <Subsumes> "Gastrointestinal_cancer" .
<Malignant_solid_neoplasm> <Subsumes> "Endocrine_cancer" .
<Malignant_solid_neoplasm> <Subsumes> "ERBB3-mutated_malignancy" .
<Malignant_solid_neoplasm> <Subsumes> "ERBB2-mutated_malignancy" .
<Malignant_solid_neoplasm> <Subsumes> "EGFR-mutated_malignancy" .
<Malignant_solid_neoplasm> <Subsumes> "BRAF-mutated_malignancy" .
<Malignant_solid_neoplasm> <Subsumes> "Adenocarcinoma_of_unknown_primary" .
<5_plus_3d> <Maps_to> "5_plus_3d" .
<Abemaciclib_and_Anastrozole> <Mapped_from> "Abemaciclib_and_Anastrozole" .
<FOLFIRINOX> <Is_current_in> "Pancreatic_cancer" .
<FOLFIRINOX> <Is_current_in> "Colon_cancer" .
<mCOP/MP> <Has_accepted_use> "Multiple_myeloma" .
<Triptorelin> <Supportive_med_of> "Tamoxifen_and_OFS" .
<Triptorelin> <Supportive_med_of> "Exemestane_monotherapy" .
<BR_and_Idelalisib> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Bevacizumab_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Bevacizumab_and_RT> <Has_antineoplastic> "Bevacizumab" .
<Decolite> <Brand_name_of> "Dexamethasone" .
<Methotrexate,_RT,_Cyclophosphamide> <Has_antineoplastic> "Methotrexate" .
<Methotrexate,_RT,_Cyclophosphamide> <Has_antineoplastic> "External_beam_radiotherapy" .
<Methotrexate,_RT,_Cyclophosphamide> <Has_antineoplastic> "Cyclophosphamide" .
<DES_monotherapy> <Has_modality> "Hormonotherapy" .
<MATRix> <Is_a> "Rituximab-containing_regimen" .
<Ibritumomab_tiuxetan_monotherapy> <Is_a> "Rituximab-containing_regimen" .
<Colon_cancer> <Is_a> "Colorectal_cancer" .
<Ecosprin> <Brand_name_of> "Aspirin" .
<Delcortin> <Brand_name_of> "Prednisone" .
<Temozolomide_and_RT,_then_Temozolomide> <Mapped_from> "Temozolomide_and_RT,_then_Temozolomide" .
<Pictilisib> <May_have_route> "Oral" .
<CAV/PE> <Has_context> "Induction_therapy" .
<MT-R> <Has_antineoplastic> "Temozolomide" .
<MT-R> <Has_antineoplastic> "Rituximab" .
<MT-R> <Has_antineoplastic> "Methotrexate" .
<Kymriah> <Brand_name_of> "Tisagenlecleucel" .
<Carboplatin,_Olaparib,_Paclitaxel> <Is_current_in> "Ovarian_cancer" .
<FAM> <Mapped_from> "FAM" .
<Goserelin_monotherapy> <Mapped_from> "Goserelin_monotherapy" .
<Anastrozole_monotherapy> <Maps_to> "Anastrozole_monotherapy" .
<Pralatrexate> <May_have_route> "Intravenous" .
<Lenisolone> <Brand_name_of> "Prednisolone" .
<Afatinib_monotherapy> <Mapped_from> "Afatinib_monotherapy" .
<VAMP_(Methotrexate)> <Has_context> "Induction_therapy" .
<Dvometil> <Brand_name_of> "Prochlorperazine" .
<MPV> <Has_antineoplastic> "Vincristine" .
<MPV> <Has_antineoplastic> "Procarbazine" .
<MPV> <Has_antineoplastic> "Methotrexate" .
<IRd> <Has_context> "Non-curative_therapy" .
<IRd> <Has_context> "Non-curative_first-line_therapy" .
<Vorinostat_monotherapy> <Is_historical_in> "Acute_myeloid_leukemia" .
<Cyclophosphamide,_Etoposide,_TBI> <Maps_to> "Cyclophosphamide,_Etoposide,_TBI" .
<Mitoxantrone_and_Prednisone> <Maps_to> "Mitoxantrone_and_Prednisone" .
<DRC> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Orimeten> <Brand_name_of> "Aminoglutethimide" .
<Health_Canada_approved_drug> <Subsumes> "Raltitrexed" .
<Health_Canada_approved_drug> <Subsumes> "Non-pegylated_liposomal_doxorubicin" .
<Health_Canada_approved_drug> <Subsumes> "Nadroparin" .
<Health_Canada_approved_drug> <Subsumes> "Amsacrine" .
<SC-EPOCH-RR> <Has_context> "Upfront_therapy" .
<Leuren> <Brand_name_of> "Leuprolide" .
<Cisplatin_and_Ifosfamide> <Has_antineoplastic> "Ifosfamide" .
<Cisplatin_and_Ifosfamide> <Has_antineoplastic> "Cisplatin" .
<ACH> <Has_antineoplastic> "Trastuzumab" .
<ACH> <Has_antineoplastic> "Doxorubicin" .
<ACH> <Has_antineoplastic> "Cyclophosphamide" .
<R-CODOX-M/R-IVAC> <Is_current_in> "HIV-associated_lymphoma" .
<R-CODOX-M/R-IVAC> <Is_current_in> "Burkitt_lymphoma" .
<Histrelin> <Has_brand_name> "Vantas" .
<Lenalidomide> <Supportive_med_of> "TD" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone> <Has_local_therapy> "Methotrexate" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone> <Has_local_therapy> "Cytarabine" .
<Docetaxel_and_Estramustine> <Has_accepted_use> "Prostate_cancer" .
<Methotrexate,_Tacrolimus,_Vorinostat> <Mapped_from> "Methotrexate,_Tacrolimus,_Vorinostat" .
<Carboplatin_and_Vincristine> <Has_antineoplastic> "Vincristine" .
<Carboplatin_and_Vincristine> <Has_antineoplastic> "Carboplatin" .
<Veliparib> <Is_a> "PARP_inhibitor" .
<Veliparib> <Is_a> "Investigational_drug" .
<Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone> <Has_context> "Induction_therapy" .
<Zantron> <Brand_name_of> "Ondansetron" .
<Irinotecan,_Temozolomide,_Dinutuximab> <Maps_to> "Irinotecan,_Temozolomide,_Dinutuximab" .
<Melphalan,_then_auto_HSCT,_then_Melphalan_and_TBI,_then_auto_HSCT> <Is_historical_in> "Multiple_myeloma" .
<Elo-VD> <Has_supportive_med> "Ranitidine" .
<Elo-VD> <Has_supportive_med> "Diphenhydramine" .
<Elo-VD> <Has_supportive_med> "Acetaminophen" .
<Cisplatin,_Vinblastine,_RT> <Has_context> "Definitive_therapy" .
<Vinblastine_and_Prednisone> <Has_modality> "Chemotherapy" .
<TCH_(Taxotere,_Cyclophosphamide)> <Has_modality> "Chemotherapy" .
<Roytrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<HOP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<PVeBV> <Has_modality> "Chemotherapy" .
<Pegaspargase> <Antineoplastic_of> "Pegaspargase,_Vincristine,_Prednisone" .
<Pegaspargase> <Antineoplastic_of> "Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Pegaspargase> <Antineoplastic_of> "Methotrexate,_Pegaspargase,_Vincristine" .
<Pegaspargase> <Antineoplastic_of> "Methotrexate_and_Pegaspargase" .
<Pegaspargase> <Antineoplastic_of> "MESA/RT" .
<Pegaspargase> <Antineoplastic_of> "Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone" .
<Pegaspargase> <Antineoplastic_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone" .
<Pegaspargase> <Antineoplastic_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Pegaspargase> <Antineoplastic_of> "DDGP" .
<Pegaspargase> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone" .
<Pegaspargase> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine" .
<Pegaspargase> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine" .
<Pegaspargase> <Antineoplastic_of> "Augmented_Hyper-CVAD_and_Asparaginase" .
<Pegaspargase> <Antineoplastic_of> "AALL0232_consolidation" .
<Teniposide_monotherapy> <Maps_to> "Teniposide_monotherapy" .
<Etoposid> <Brand_name_of> "Etoposide" .
<Xanor> <Brand_name_of> "Alprazolam" .
<Dabrafenib_monotherapy> <Is_current_in> "Melanoma" .
<Dabrafenib_monotherapy> <Is_current_in> "CNS_melanoma" .
<TAM6> <Maps_to> "TAM6" .
<PF> <Mapped_from> "PF" .
<Velcade> <Brand_name_of> "Bortezomib" .
<Tremelimumab> <Is_a> "T-cell_activator" .
<Tremelimumab> <Is_a> "Investigational_drug" .
<Tremelimumab> <Is_a> "Immunotherapeutic" .
<Tremelimumab> <Is_a> "Antibody_medication" .
<Tremelimumab> <Is_a> "Anti-CTLA-4_antibody" .
<BVB> <Has_antineoplastic> "Brentuximab_vedotin" .
<BVB> <Has_antineoplastic> "Bendamustine" .
<Paclitaxel_and_Pazopanib> <Has_accepted_use> "Ovarian_cancer" .
<Microparin> <Brand_name_of> "Enoxaparin" .
<Ketoconazole,_Hydrocortisone,_Dutasteride> <Has_modality> "Hormonotherapy" .
<Samilstin> <Brand_name_of> "Octreotide" .
<Cisplatin,_Fluorouracil,_Hydroxyurea,_RT> <Has_accepted_use> "Cervical_cancer" .
<5_plus_2d> <Mapped_from> "5_plus_2d" .
<MAPIE> <Is_a> "Anthracycline-containing_regimen" .
<VCP> <Has_accepted_use> "Multiple_myeloma" .
<Melphalan,_then_auto_HSCT,_then_Melphalan_and_TBI,_then_auto_HSCT> <Has_accepted_use> "Multiple_myeloma" .
<Proteasome_inhibitor> <Subsumes> "Oprozomib" .
<Proteasome_inhibitor> <Subsumes> "Ixazomib" .
<Proteasome_inhibitor> <Subsumes> "Carfilzomib" .
<Proteasome_inhibitor> <Subsumes> "Bortezomib" .
<PMitCEBO> <Is_a> "Anthracycline-containing_regimen" .
<7_plus_3d_and_Sorafenib> <Maps_to> "7_plus_3d_and_Sorafenib" .
<Formitex> <Brand_name_of> "Cyclophosphamide" .
<Dexabeta> <Brand_name_of> "Dexamethasone" .
<Indicarb> <Brand_name_of> "Procarbazine" .
<Fluorouracil,_Folinic_acid,_Gemcitabine> <Maps_to> "Fluorouracil,_Folinic_acid,_Gemcitabine" .
<Uromitexan> <Brand_name_of> "Mesna" .
<OEPA> <Maps_to> "OEPA" .
<FLAG-Ida> <Is_a> "Anthracycline-containing_regimen" .
<DCTER> <Has_antineoplastic> "Thioguanine" .
<DCTER> <Has_antineoplastic> "Etoposide" .
<DCTER> <Has_antineoplastic> "Dexamethasone" .
<DCTER> <Has_antineoplastic> "Daunorubicin" .
<DCTER> <Has_antineoplastic> "Cytarabine" .
<IT_Methotrexate_and_Methylprednisolone> <Is_current_in> "CNS_leukemia" .
<Cobimetinib_and_Vemurafenib> <Is_current_in> "Melanoma" .
<Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab> <Mapped_from> "Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab" .
<Certican> <Brand_name_of> "Everolimus" .
<Predni_M> <Brand_name_of> "Methylprednisolone" .
<PVeBV> <Has_antineoplastic> "Vinblastine" .
<PVeBV> <Has_antineoplastic> "Etoposide" .
<PVeBV> <Has_antineoplastic> "Cisplatin" .
<PVeBV> <Has_antineoplastic> "Bleomycin" .
<Cisplatin_and_Cyclophosphamide> <Is_a> "Platinum_doublet" .
<Cyklokapron> <Brand_name_of> "Tranexamic_acid" .
<Doxolem> <Brand_name_of> "Doxorubicin" .
<Capsasal> <Brand_name_of> "Aspirin" .
<FLOT> <Has_antineoplastic> "Oxaliplatin" .
<FLOT> <Has_antineoplastic> "Folinic_acid" .
<FLOT> <Has_antineoplastic> "Fluorouracil" .
<FLOT> <Has_antineoplastic> "Docetaxel" .
<Fluorouracil_and_Levoleucovorin> <Has_supportive_med> "Metoclopramide" .
<Fluorouracil_and_Levoleucovorin> <Has_supportive_med> "Loperamide" .
<Fluorouracil_and_Levoleucovorin> <Has_supportive_med> "Emesis_prevention" .
<Fluorouracil_and_Levoleucovorin> <Has_supportive_med> "Anti-diarrheals" .
<Ketoconazole_and_Hydrocortisone> <Maps_to> "Ketoconazole_and_Hydrocortisone" .
<Lucrin> <Brand_name_of> "Leuprolide" .
<Plerixafor_and_G-CSF> <Has_supportive_med> "Plerixafor" .
<Plerixafor_and_G-CSF> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Anti-PD-1_antibody> <Subsumes> "Pidilizumab" .
<Anti-PD-1_antibody> <Subsumes> "Pembrolizumab" .
<Anti-PD-1_antibody> <Subsumes> "Nivolumab" .
<Anti-PD-1_antibody> <Subsumes> "Cemiplimab" .
<Axitinib_monotherapy> <Has_antineoplastic> "Axitinib" .
<Olaparib> <Is_a> "Protein_expression-specific_medication" .
<Olaparib> <Is_a> "PARP_inhibitor" .
<Olaparib> <Is_a> "Mutation-specific_medication" .
<CAP-BOP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Fluorouracil_and_RT> <Is_current_in> "Rectal_cancer" .
<Fluorouracil_and_RT> <Is_current_in> "Pancreatic_cancer" .
<Fluorouracil_and_RT> <Is_current_in> "Head_and_neck_cancer" .
<Fluorouracil_and_RT> <Is_current_in> "Cervical_cancer" .
<Pomalidomide> <Has_FDA_indication> "Multiple_myeloma" .
<LSG15> <Has_context> "Induction_therapy" .
<Custirsen> <Has_accepted_use> "Prostate_cancer" .
<Custirsen> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Lyomit> <Brand_name_of> "Mitomycin" .
<Maktrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Lovorin> <Brand_name_of> "Folinic_acid" .
<ECF> <Has_supportive_med> "Warfarin" .
<ECF> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<ECF> <Has_supportive_med> "Filgrastim" .
<Everolimus_and_Lenvatinib> <Has_modality> "Chemotherapy" .
<Irinotecan,_Temozolomide,_Dinutuximab> <Has_context> "Non-curative_therapy" .
<Plasma_exchange> <Maps_to> "Plasma_exchange" .
<FLAG-Ida> <Has_modality> "Growth_factor_therapy" .
<FLAG-Ida> <Has_modality> "Chemotherapy" .
<CapeOx,_Cetuximab,_RT> <Has_accepted_use> "Rectal_cancer" .
<R2CHOP> <Has_supportive_med> "Warfarin" .
<R2CHOP> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<R2CHOP> <Has_supportive_med> "Pentamidine" .
<R2CHOP> <Has_supportive_med> "Pegfilgrastim" .
<R2CHOP> <Has_supportive_med> "Low_molecular_weight_heparins" .
<R2CHOP> <Has_supportive_med> "Lamivudine" .
<R2CHOP> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<R2CHOP> <Has_supportive_med> "Aspirin" .
<KMP> <Mapped_from> "KMP" .
<CTCb> <Mapped_from> "CTCb" .
<Zevalin> <Brand_name_of> "Ibritumomab_tiuxetan" .
<Rituximab> <May_have_route> "Intravenous" .
<Bevacizumab_and_Interferon_alfa-2a> <Has_antineoplastic> "Interferon_alfa-2a" .
<Bevacizumab_and_Interferon_alfa-2a> <Has_antineoplastic> "Bevacizumab" .
<COPAD/CYVE> <Has_modality> "Chemotherapy" .
<VR-CHOP> <Has_context> "Non-curative_first-line_therapy" .
<VR-CHOP> <Has_context> "Induction_therapy" .
<Autoimmune_hematologic_condition> <Subsumes> "Warm_autoimmune_hemolytic_anemia" .
<Autoimmune_hematologic_condition> <Subsumes> "Thrombotic_thrombocytopenic_purpura" .
<Autoimmune_hematologic_condition> <Subsumes> "Immune_thrombocytopenia" .
<Autoimmune_hematologic_condition> <Subsumes> "Heparin-induced_thrombocytopenia" .
<Autoimmune_hematologic_condition> <Subsumes> "Autoimmune_cytopenia" .
<Autoimmune_hematologic_condition> <Subsumes> "Antiphospholipid_antibody_syndrome" .
<Autoimmune_hematologic_condition> <Subsumes> "Acquired_coagulopathy" .
<Genitourinary_cancer> <Subsumes> "Testicular_cancer" .
<Genitourinary_cancer> <Subsumes> "Renal_cell_carcinoma" .
<Genitourinary_cancer> <Subsumes> "Prostate_cancer" .
<Genitourinary_cancer> <Subsumes> "Penile_cancer" .
<Genitourinary_cancer> <Subsumes> "Bladder_cancer" .
<Elotuzumab> <Has_brand_name> "Empliciti" .
<R-CEOP90_(Epirubicin)> <Mapped_from> "R-CEOP90_(Epirubicin)" .
<ACVBP> <Mapped_from> "ACVBP" .
<EC> <Is_historical_in> "Breast_cancer" .
<Hydroxyurea_and_Plicamycin> <Has_antineoplastic> "Plicamycin" .
<Hydroxyurea_and_Plicamycin> <Has_antineoplastic> "Hydroxyurea" .
<Kengreal> <Brand_name_of> "Cangrelor" .
<Methoxsalen> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<PCP_prophylaxis> <Is_a> "Antibiotic" .
<Cetuximab_and_RT> <Is_current_in> "Head_and_neck_cancer" .
<Carboplatin_monotherapy> <Mapped_from> "Carboplatin_monotherapy" .
<PAC> <Is_current_in> "Thymoma" .
<R-GemOx> <Has_supportive_med> "Methylprednisolone" .
<R-GemOx> <Has_supportive_med> "Dexchlorpheniramine" .
<R-GemOx> <Has_supportive_med> "Acetaminophen" .
<Theratrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Ipilimumab_and_RT> <Mapped_from> "Ipilimumab_and_RT" .
<Leuprolide> <Has_brand_name> "Viadur" .
<Leuprolide> <Has_brand_name> "Valeuprox" .
<Leuprolide> <Has_brand_name> "Uno-Enantone" .
<Leuprolide> <Has_brand_name> "Trenantone" .
<Leuprolide> <Has_brand_name> "Prostap" .
<Leuprolide> <Has_brand_name> "Procrin" .
<Leuprolide> <Has_brand_name> "Procren" .
<Leuprolide> <Has_brand_name> "Lupron_Depot" .
<Leuprolide> <Has_brand_name> "Lupron" .
<Leuprolide> <Has_brand_name> "Luprodex_Depot" .
<Leuprolide> <Has_brand_name> "Lupride_Depot" .
<Leuprolide> <Has_brand_name> "Lupoide_Depot" .
<Leuprolide> <Has_brand_name> "Lupard_Depot" .
<Leuprolide> <Has_brand_name> "Lucrin_Depot" .
<Leuprolide> <Has_brand_name> "Lucrin" .
<Leuprolide> <Has_brand_name> "Lorelin_Depot" .
<Leuprolide> <Has_brand_name> "Leuren" .
<Leuprolide> <Has_brand_name> "Leuprorelin" .
<Leuprolide> <Has_brand_name> "Leupromer" .
<Leuprolide> <Has_brand_name> "Leuplin" .
<Leuprolide> <Has_brand_name> "Ginecrin" .
<Leuprolide> <Has_brand_name> "Enantone-Gyn" .
<Leuprolide> <Has_brand_name> "Enantone" .
<Leuprolide> <Has_brand_name> "Enanton" .
<Leuprolide> <Has_brand_name> "Eligard" .
<Leuprolide> <Has_brand_name> "Depo-Eligard" .
<Leuprolide> <Has_brand_name> "Carcinil" .
<R-CODOX-M_(Doxil_substituted)> <Maps_to> "R-CODOX-M_(Doxil_substituted)" .
<Cometriq_is_the_brand_name_for_cabozantinib's_medullary_thyroid_cancer_indication._Cabometyx_is_the_brand_name_for_cabozantinib's_renal_cell_carcinoma_indication> <Brand_name_of> "Cabozantinib" .
<COPP/ABVD> <Has_antineoplastic> "Vincristine" .
<COPP/ABVD> <Has_antineoplastic> "Vinblastine" .
<COPP/ABVD> <Has_antineoplastic> "Procarbazine" .
<COPP/ABVD> <Has_antineoplastic> "Prednisone" .
<COPP/ABVD> <Has_antineoplastic> "Doxorubicin" .
<COPP/ABVD> <Has_antineoplastic> "Dacarbazine" .
<COPP/ABVD> <Has_antineoplastic> "Cyclophosphamide" .
<COPP/ABVD> <Has_antineoplastic> "Bleomycin" .
<Fractionated_plasma_product> <Is_a> "Biologic_product" .
<Ansentron> <Brand_name_of> "Ondansetron" .
<Fludarabine> <Has_FDA_indication> "Chronic_lymphocytic_leukemia" .
<Tagraxofusp> <Has_brand_name> "Elzonris" .
<Praxel> <Brand_name_of> "Paclitaxel" .
<Dexchlorpheniramine> <Has_brand_name> "Topmine" .
<Dexchlorpheniramine> <Has_brand_name> "Polaramine" .
<Dexchlorpheniramine> <Has_brand_name> "Oramin" .
<Dexchlorpheniramine> <Has_brand_name> "Dexam" .
<Cisplatin_and_Vindesine> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Fluorouracil_and_Methotrexate> <Mapped_from> "Fluorouracil_and_Methotrexate" .
<Kaposi_sarcoma> <Accepted_use_of> "Vincristine" .
<Kaposi_sarcoma> <Accepted_use_of> "Vinblastine" .
<Kaposi_sarcoma> <Accepted_use_of> "Pomalidomide_monotherapy" .
<Kaposi_sarcoma> <Accepted_use_of> "Pomalidomide" .
<Kaposi_sarcoma> <Accepted_use_of> "Placebo" .
<Kaposi_sarcoma> <Accepted_use_of> "Pegylated_liposomal_doxorubicin" .
<Kaposi_sarcoma> <Accepted_use_of> "Paclitaxel_monotherapy" .
<Kaposi_sarcoma> <Accepted_use_of> "Paclitaxel" .
<Kaposi_sarcoma> <Accepted_use_of> "Interferon_alfa-2b_monotherapy" .
<Kaposi_sarcoma> <Accepted_use_of> "Interferon_alfa-2b" .
<Kaposi_sarcoma> <Accepted_use_of> "Interferon_alfa-2a_monotherapy" .
<Kaposi_sarcoma> <Accepted_use_of> "Interferon_alfa-2a" .
<Kaposi_sarcoma> <Accepted_use_of> "Etoposide_monotherapy" .
<Kaposi_sarcoma> <Accepted_use_of> "Etoposide" .
<Kaposi_sarcoma> <Accepted_use_of> "Doxorubicin_pegylated_liposomal_monotherapy" .
<Kaposi_sarcoma> <Accepted_use_of> "Doxorubicin" .
<Kaposi_sarcoma> <Accepted_use_of> "Daunorubicin_liposomal_monotherapy" .
<Kaposi_sarcoma> <Accepted_use_of> "Daunorubicin_liposomal" .
<Kaposi_sarcoma> <Accepted_use_of> "Bleomycin" .
<Kaposi_sarcoma> <Accepted_use_of> "Bevacizumab_monotherapy" .
<Kaposi_sarcoma> <Accepted_use_of> "Bevacizumab" .
<Kaposi_sarcoma> <Accepted_use_of> "ABV_(Vincristine)" .
<Kaposi_sarcoma> <Accepted_use_of> "ABV_(Vinblastine)" .
<Emovis> <Brand_name_of> "Folinic_acid" .
<Octran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<DAT> <Has_antineoplastic> "Thioguanine" .
<DAT> <Has_antineoplastic> "Daunorubicin" .
<DAT> <Has_antineoplastic> "Cytarabine" .
<Dexamedron> <Brand_name_of> "Dexamethasone" .
<Pediatric-like_GRAALL_consolidation> <Has_context> "Consolidation_after_upfront_therapy" .
<eBEACOPP> <Maps_to> "eBEACOPP" .
<Brentuximab_vedotin_and_Nivolumab> <Maps_to> "Brentuximab_vedotin_and_Nivolumab" .
<Docetaxel_and_Nedaplatin> <Has_modality> "Chemotherapy" .
<Clopidogrel> <May_have_route> "Oral" .
<Arsenic_trioxide,_ATRA,_Idarubicin> <Is_a> "Anthracycline-containing_regimen" .
<RP> <Is_current_in> "Multiple_myeloma" .
<Anastrozole_and_Ribociclib> <Maps_to> "Anastrozole_and_Ribociclib" .
<Docetaxel> <Supportive_med_of> "Carboplatin_and_Fluorouracil" .
<Docetaxel> <Supportive_med_of> "Carboplatin_and_Doxorubicin_liposomal" .
<Neoadjuvant_therapy> <Maps_to> "Neoadjuvant_therapy" .
<Cisplatin,_Gemcitabine,_Necitumumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<IT_Cytarabine_and_Methotrexate> <Mapped_from> "IT_Cytarabine_and_Methotrexate" .
<Defibrotide_monotherapy> <Has_context> "All_lines_of_therapy" .
<Oxaliplatin_and_Bevacizumab> <Has_antineoplastic> "Oxaliplatin" .
<Oxaliplatin_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Cisplatin_and_Vinorelbine> <Has_modality> "Chemotherapy" .
<Fostamatinib_monotherapy> <Has_antineoplastic> "Fostamatinib" .
<Docetaxel_and_Prednisone> <Is_current_in> "Prostate_cancer" .
<Hereditary_hemorrhagic_telangiectasia> <Accepted_use_of> "Tranexamic_acid_monotherapy" .
<Hereditary_hemorrhagic_telangiectasia> <Accepted_use_of> "Tranexamic_acid" .
<Hereditary_hemorrhagic_telangiectasia> <Accepted_use_of> "Tamoxifen_monotherapy" .
<Hereditary_hemorrhagic_telangiectasia> <Accepted_use_of> "Placebo" .
<Abemaciclib_and_Anastrozole> <Maps_to> "Abemaciclib_and_Anastrozole" .
<Non-curative_third-line_consolidation_therapy> <Is_a> "Non-curative_third-line_therapy" .
<EGFR_inhibitor> <Is_a> "Kinase_inhibitor" .
<EGFR_inhibitor> <Is_a> "Growth_factor_inhibitor" .
<Discontinued_drug> <Subsumes> "Uracil_mustard" .
<Discontinued_drug> <Subsumes> "Tositumomab_&_I-131" .
<Discontinued_drug> <Subsumes> "Tinzaparin" .
<Discontinued_drug> <Subsumes> "Semustine" .
<Discontinued_drug> <Subsumes> "Plicamycin" .
<Discontinued_drug> <Subsumes> "Olaratumab" .
<Discontinued_drug> <Subsumes> "Levamisole" .
<Discontinued_drug> <Subsumes> "Lepirudin" .
<Discontinued_drug> <Subsumes> "Formestane" .
<Discontinued_drug> <Subsumes> "Fluoxymesterone" .
<Discontinued_drug> <Subsumes> "Edrecolomab" .
<Discontinued_drug> <Subsumes> "Diethylstilbestrol" .
<Discontinued_drug> <Subsumes> "Dexchlorpheniramine" .
<Discontinued_drug> <Subsumes> "Denileukin_diftitox" .
<Discontinued_drug> <Subsumes> "Daunorubicin_liposomal" .
<Discontinued_drug> <Subsumes> "Danaparoid" .
<Discontinued_drug> <Subsumes> "Catumaxomab" .
<Discontinued_drug> <Subsumes> "Asparaginase" .
<Discontinued_drug> <Subsumes> "Aminopterin" .
<UFT_monotherapy> <Has_modality> "Chemotherapy" .
<BTK_inhibitor> <Is_a> "Kinase_inhibitor" .
<Trifluridine_and_tipiracil> <May_have_route> "Oral" .
<Necitumumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Entrectinib_monotherapy> <Has_accepted_use> "ROS1-positive_Non-small_cell_lung_cancer" .
<Entrectinib_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Entrectinib_monotherapy> <Has_accepted_use> "NTRK-mutated_malignancy" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan> <Has_accepted_use> "Allogeneic_HSCT" .
<ddA> <Has_context> "Adjuvant_therapy" .
<SCC_of_unknown_primary> <Is_a> "Malignant_solid_neoplasm" .
<G-FC> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<IGEV_and_G-CSF> <Maps_to> "IGEV_and_G-CSF" .
<COP-Bleo> <Maps_to> "COP-Bleo" .
<Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat> <Mapped_from> "Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat" .
<DA-R-EPOCH> <Has_context> "Induction_therapy" .
<Azacitidine_and_Lenalidomide> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Azacitidine_and_Lenalidomide> <Has_accepted_use> "Chronic_myelomonocytic_leukemia" .
<Fortecortin> <Brand_name_of> "Dexamethasone" .
<Apalutamide_monotherapy> <Is_current_in> "Prostate_cancer" .
<Ramucirumab> <Is_a> "VEGFR_inhibitor" .
<Ramucirumab> <Is_a> "PMDA_approved_drug" .
<Ramucirumab> <Is_a> "Antibody_medication" .
<Ramucirumab> <Is_a> "Anti-VEGFR_antibody" .
<Pemetrexed_and_Bevacizumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<Rectal_cancer> <Is_a> "Colorectal_cancer" .
<R-CHOP> <Has_modality> "Chemotherapy" .
<Doxorubicin_and_Bevacizumab> <Is_current_in> "Breast_cancer" .
<Mepolizumab_monotherapy> <Maps_to> "Mepolizumab_monotherapy" .
<BuCyTBI> <Has_modality> "Radiotherapy" .
<BuCyTBI> <Has_modality> "Chemotherapy" .
<Plicamycin_monotherapy> <Is_historical_in> "Testicular_cancer" .
<Dactinomycin> <Antineoplastic_of> "VI,_then_VDC/IE,_then_VAC,_then_VI" .
<Dactinomycin> <Antineoplastic_of> "VAdCA/IE" .
<Dactinomycin> <Antineoplastic_of> "VAdCA" .
<Dactinomycin> <Antineoplastic_of> "VAIA" .
<Dactinomycin> <Antineoplastic_of> "VAI" .
<Dactinomycin> <Antineoplastic_of> "VACA/IE" .
<Dactinomycin> <Antineoplastic_of> "VACA" .
<Dactinomycin> <Antineoplastic_of> "VAC" .
<Dactinomycin> <Antineoplastic_of> "VAB-6" .
<Dactinomycin> <Antineoplastic_of> "VA" .
<Dactinomycin> <Antineoplastic_of> "MA-BCD/AP" .
<Dactinomycin> <Antineoplastic_of> "MA-BCD" .
<Dactinomycin> <Antineoplastic_of> "M-BCD" .
<Dactinomycin> <Antineoplastic_of> "IP-BCD" .
<Dactinomycin> <Antineoplastic_of> "EVAIA" .
<Dactinomycin> <Antineoplastic_of> "EMA-CO" .
<Dactinomycin> <Antineoplastic_of> "Dactinomycin_monotherapy" .
<Dactinomycin> <Antineoplastic_of> "Dactinomycin_and_Vincristine" .
<Dactinomycin> <Antineoplastic_of> "Chlorambucil,_Dactinomycin,_Methotrexate" .
<Etoposide,_Ifosfamide,_Imatinib> <Has_modality> "Chemotherapy" .
<Methotrexate_and_Rituximab> <Has_context> "Upfront_therapy" .
<ABCP> <Has_context> "Non-curative_first-line_therapy" .
<Gesidine> <Brand_name_of> "Vindesine" .
<Prophylaxis> <Mapped_from> "Prophylaxis" .
<Non-curative_second-line_maintenance_therapy> <Is_a> "Non-curative_second-line_therapy" .
<Temsirolimus_and_Rituximab> <Has_context> "Non-curative_therapy" .
<CALGB_8811_late_intensification> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Waran> <Brand_name_of> "Warfarin" .
<Glasdegib> <Has_brand_name> "Daurismo" .
<ATG_(Rabbit)_monotherapy> <Mapped_from> "ATG_(Rabbit)_monotherapy" .
<Temsirolimus_monotherapy> <Is_current_in> "Renal_cell_carcinoma" .
<Temsirolimus_monotherapy> <Is_current_in> "Mantle_cell_lymphoma" .
<Temsirolimus_monotherapy> <Is_current_in> "Follicular_lymphoma" .
<Temsirolimus_monotherapy> <Is_current_in> "Endometrial_cancer" .
<Temsirolimus_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Temsirolimus_monotherapy> <Is_current_in> "CNS_lymphoma" .
<Blastolem> <Brand_name_of> "Cisplatin" .
<5_plus_3i> <Is_historical_in> "Acute_myeloid_leukemia" .
<Capecitabine,_Bevacizumab,_Trastuzumab> <Maps_to> "Capecitabine,_Bevacizumab,_Trastuzumab" .
<FOLFIRI_(L-Leucovorin)> <Is_a> "Irinotecan-containing_regimen" .
<Bicalutamide_monotherapy> <Mapped_from> "Bicalutamide_monotherapy" .
<Docetaxel_and_Vandetanib> <Has_context> "Non-curative_second-line_therapy" .
<PET> <Maps_to> "PET" .
<Aminoglutethimide_monotherapy> <Maps_to> "Aminoglutethimide_monotherapy" .
<BBD> <Is_current_in> "Multiple_myeloma" .
<Rhodine> <Brand_name_of> "Aspirin" .
<IAP> <Is_historical_in> "Acute_myeloid_leukemia" .
<Mepolizumab_monotherapy> <Mapped_from> "Mepolizumab_monotherapy" .
<Brigatinib_monotherapy> <Has_modality> "Chemotherapy" .
<Trombyl> <Brand_name_of> "Aspirin" .
<Esophageal_cancer> <Current_treated_by> "mFOLFOX6_and_Cetuximab" .
<Esophageal_cancer> <Current_treated_by> "S-1_monotherapy" .
<Esophageal_cancer> <Current_treated_by> "Ramucirumab_monotherapy" .
<Esophageal_cancer> <Current_treated_by> "Radiation_therapy" .
<Esophageal_cancer> <Current_treated_by> "Placebo" .
<Esophageal_cancer> <Current_treated_by> "Pembrolizumab_monotherapy" .
<Esophageal_cancer> <Current_treated_by> "Paclitaxel_monotherapy" .
<Esophageal_cancer> <Current_treated_by> "Paclitaxel_and_Ramucirumab" .
<Esophageal_cancer> <Current_treated_by> "PCF" .
<Esophageal_cancer> <Current_treated_by> "Observation" .
<Esophageal_cancer> <Current_treated_by> "No_neoadjuvant_therapy" .
<Esophageal_cancer> <Current_treated_by> "Nivolumab_monotherapy" .
<Esophageal_cancer> <Current_treated_by> "MCF" .
<Esophageal_cancer> <Current_treated_by> "Irinotecan_monotherapy" .
<Esophageal_cancer> <Current_treated_by> "Irinotecan_liposomal_monotherapy" .
<Esophageal_cancer> <Current_treated_by> "Irinotecan_and_S-1" .
<Esophageal_cancer> <Current_treated_by> "Irinotecan_and_Mitomycin" .
<Esophageal_cancer> <Current_treated_by> "Fluorouracil,_Paclitaxel,_RT" .
<Esophageal_cancer> <Current_treated_by> "Fluorouracil,_Oxaliplatin,_RT" .
<Esophageal_cancer> <Current_treated_by> "Fluorouracil,_Folinic_acid,_Gemcitabine" .
<Esophageal_cancer> <Current_treated_by> "Fluorouracil_and_Paclitaxel" .
<Esophageal_cancer> <Current_treated_by> "Fluorouracil_and_Folinic_acid" .
<Esophageal_cancer> <Current_treated_by> "FULV/FULV_and_RT" .
<Esophageal_cancer> <Current_treated_by> "FOLFOX4_and_RT" .
<Esophageal_cancer> <Current_treated_by> "FOLFOX4" .
<Esophageal_cancer> <Current_treated_by> "FOLFIRI" .
<Esophageal_cancer> <Current_treated_by> "FLOT" .
<Esophageal_cancer> <Current_treated_by> "FLEP" .
<Esophageal_cancer> <Current_treated_by> "Etoposide_monotherapy" .
<Esophageal_cancer> <Current_treated_by> "Erlotinib_monotherapy" .
<Esophageal_cancer> <Current_treated_by> "EOX" .
<Esophageal_cancer> <Current_treated_by> "EOF" .
<Esophageal_cancer> <Current_treated_by> "ECX" .
<Esophageal_cancer> <Current_treated_by> "ECF/5-FU_and_RT" .
<Esophageal_cancer> <Current_treated_by> "ECF" .
<Esophageal_cancer> <Current_treated_by> "Docetaxel,_Fluorouracil,_RT" .
<Esophageal_cancer> <Current_treated_by> "Docetaxel_monotherapy" .
<Esophageal_cancer> <Current_treated_by> "Docetaxel_and_Irinotecan" .
<Esophageal_cancer> <Current_treated_by> "Cisplatin,_Vinorelbine,_RT" .
<Esophageal_cancer> <Current_treated_by> "Cisplatin,_Paclitaxel,_RT" .
<Esophageal_cancer> <Current_treated_by> "Cisplatin,_Irinotecan,_RT" .
<Esophageal_cancer> <Current_treated_by> "Cisplatin,_Fluorouracil,_RT" .
<Esophageal_cancer> <Current_treated_by> "Cisplatin,_Fluorouracil,_Cetuximab" .
<Esophageal_cancer> <Current_treated_by> "Cisplatin,_Etoposide,_RT" .
<Esophageal_cancer> <Current_treated_by> "Cisplatin,_Doxorubicin_liposomal,_Fluorouracil" .
<Esophageal_cancer> <Current_treated_by> "Cisplatin,_Docetaxel,_RT" .
<Esophageal_cancer> <Current_treated_by> "Cisplatin_and_Paclitaxel" .
<Esophageal_cancer> <Current_treated_by> "Cisplatin_and_Irinotecan" .
<Esophageal_cancer> <Current_treated_by> "Cisplatin_and_Fluorouracil" .
<Esophageal_cancer> <Current_treated_by> "Cisplatin_and_Etoposide" .
<Esophageal_cancer> <Current_treated_by> "Cisplatin_and_Docetaxel" .
<Esophageal_cancer> <Current_treated_by> "Cetuximab_monotherapy" .
<Esophageal_cancer> <Current_treated_by> "Carboplatin,_Paclitaxel,_RT" .
<Esophageal_cancer> <Current_treated_by> "Carboplatin,_Fluorouracil,_RT" .
<Esophageal_cancer> <Current_treated_by> "Carboplatin_and_Paclitaxel" .
<Esophageal_cancer> <Current_treated_by> "Capecitabine,_Paclitaxel,_RT" .
<Esophageal_cancer> <Current_treated_by> "Capecitabine,_Oxaliplatin,_RT" .
<Esophageal_cancer> <Current_treated_by> "Capecitabine,_Docetaxel,_RT" .
<Esophageal_cancer> <Current_treated_by> "Capecitabine,_Docetaxel,_Oxaliplatin,_RT" .
<Esophageal_cancer> <Current_treated_by> "Capecitabine,_Cisplatin,_RT" .
<Esophageal_cancer> <Current_treated_by> "Capecitabine,_Carboplatin,_Paclitaxel,_RT" .
<Esophageal_cancer> <Current_treated_by> "CapeOx" .
<Esophageal_cancer> <Current_treated_by> "CX-C" .
<Esophageal_cancer> <Current_treated_by> "CX_and_Trastuzumab" .
<Esophageal_cancer> <Current_treated_by> "CX" .
<Esophageal_cancer> <Current_treated_by> "CLF" .
<Esophageal_cancer> <Current_treated_by> "CF_and_Trastuzumab" .
<Esophageal_cancer> <Current_treated_by> "CAPIRI" .
<Esophageal_cancer> <Current_treated_by> "Best_supportive_care" .
<Esophageal_cancer> <Current_treated_by> "Apatinib_monotherapy" .
<Ofatumumab> <Supportive_med_of> "Cladribine_monotherapy" .
<Urethrax> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Fosaqueen> <Brand_name_of> "Alendronate" .
<Oribact> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Erladexone> <Brand_name_of> "Dexamethasone" .
<Tryptophan_hydroxylase_inhibitor> <Is_a> "Enzyme_inhibitor" .
<Tryptophan_hydroxylase_inhibitor> <Is_a> "Endocrine_therapeutic" .
<Doxorubicin_and_Vinblastine> <Has_context> "Induction_therapy" .
<7_plus_3d_and_GO> <Mapped_from> "7_plus_3d_and_GO" .
<Cyclophosphamide,_Dacarbazine,_Vincristine> <Has_antineoplastic> "Vincristine" .
<Cyclophosphamide,_Dacarbazine,_Vincristine> <Has_antineoplastic> "Dacarbazine" .
<Cyclophosphamide,_Dacarbazine,_Vincristine> <Has_antineoplastic> "Cyclophosphamide" .
<FAMTX> <Has_modality> "Chemotherapy" .
<mFOLFOX6_and_RT> <Has_antineoplastic> "Oxaliplatin" .
<mFOLFOX6_and_RT> <Has_antineoplastic> "Folinic_acid" .
<mFOLFOX6_and_RT> <Has_antineoplastic> "Fluorouracil" .
<mFOLFOX6_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<PCF> <Has_accepted_use> "SCC_of_unknown_primary" .
<PCF> <Has_accepted_use> "Penile_cancer" .
<PCF> <Has_accepted_use> "Head_and_neck_cancer" .
<PCF> <Has_accepted_use> "Esophageal_cancer" .
<Trifluridine_and_tipiracil> <Has_accepted_use> "Gastric_cancer" .
<Trifluridine_and_tipiracil> <Has_accepted_use> "Colon_cancer" .
<Asprim> <Brand_name_of> "Aspirin" .
<Erythrocyte_growth_factors> <Supportive_med_of> "VR" .
<Erythrocyte_growth_factors> <Supportive_med_of> "R-Hyper-CVAD/R-MA" .
<Erythrocyte_growth_factors> <Supportive_med_of> "Prednisolone_and_Rituximab" .
<Erythrocyte_growth_factors> <Supportive_med_of> "Everolimus_monotherapy" .
<CAV> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Plinabulin> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Dacarbazine_and_Tamoxifen> <Has_accepted_use> "Melanoma" .
<Docetaxel,_Fluorouracil,_Hydroxyurea,_RT> <Mapped_from> "Docetaxel,_Fluorouracil,_Hydroxyurea,_RT" .
<Cyclomide> <Brand_name_of> "Cyclophosphamide" .
<TT4> <Has_modality> "Immunosuppressive_therapy" .
<Capecitabine_and_Bevacizumab> <Is_current_in> "Hepatocellular_carcinoma" .
<Capecitabine_and_Bevacizumab> <Is_current_in> "Colon_cancer" .
<Capecitabine_and_Bevacizumab> <Is_current_in> "Breast_cancer" .
<Alfalyl> <Brand_name_of> "Dexamethasone" .
<7_plus_3i> <Has_modality> "Chemotherapy" .
<Malignant_breast_neoplasm> <Subsumes> "Breast_cancer" .
<ATRA_and_Idarubicin> <Is_current_in> "Acute_promyelocytic_leukemia" .
<SHAI> <Has_antineoplastic> "Idarubicin" .
<SHAI> <Has_antineoplastic> "Cytarabine" .
<Orgadrone> <Brand_name_of> "Dexamethasone" .
<R-M-CHOP> <Has_context> "Non-curative_first-line_therapy" .
<EPOCH> <Has_modality> "Chemotherapy" .
<m-BACOD> <Has_supportive_med> "Sargramostim" .
<m-BACOD> <Has_supportive_med> "Folinic_acid" .
<Novantron> <Brand_name_of> "Mitoxantrone" .
<TD> <Has_context> "Non-curative_therapy" .
<TD> <Has_context> "Non-curative_first-line_therapy" .
<TD> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<TD> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Clofarabine_and_Melphalan,_then_allo_HSCT> <Mapped_from> "Clofarabine_and_Melphalan,_then_allo_HSCT" .
<Decalin> <Brand_name_of> "Dexamethasone" .
<FluCam> <Mapped_from> "FluCam" .
<Septrin_Paediatric> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<VIPD> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<MT-R> <Has_context> "Upfront_therapy" .
<Eribulin> <Has_brand_name> "Halaven" .
<ABCP> <Is_a> "Bevacizumab-containing_regimen" .
<Hydeltra> <Brand_name_of> "Prednisolone" .
<Panobinostat_and_Rituximab> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<AT_(Taxotere)> <Has_context> "Non-curative_first-line_therapy" .
<Cyclophosphamide_and_TBI,_then_auto_HSCT> <Maps_to> "Cyclophosphamide_and_TBI,_then_auto_HSCT" .
<APO> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Anti-KIR_antibody> <Subsumes> "IPH_2101" .
<Afatinib> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Afatinib_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Post-transplant_lymphoproliferative_disorder> <Accepted_use_of> "Vindesine" .
<Post-transplant_lymphoproliferative_disorder> <Accepted_use_of> "Vincristine" .
<Post-transplant_lymphoproliferative_disorder> <Accepted_use_of> "Rituximab-pvvr" .
<Post-transplant_lymphoproliferative_disorder> <Accepted_use_of> "Rituximab-abbs" .
<Post-transplant_lymphoproliferative_disorder> <Accepted_use_of> "Rituximab_monotherapy" .
<Post-transplant_lymphoproliferative_disorder> <Accepted_use_of> "Rituximab" .
<Post-transplant_lymphoproliferative_disorder> <Accepted_use_of> "Reduction_of_immunosuppression" .
<Post-transplant_lymphoproliferative_disorder> <Accepted_use_of> "R-CP" .
<Post-transplant_lymphoproliferative_disorder> <Accepted_use_of> "R-CHOP" .
<Post-transplant_lymphoproliferative_disorder> <Accepted_use_of> "R,_then_CHOP" .
<Post-transplant_lymphoproliferative_disorder> <Accepted_use_of> "Prednisone" .
<Post-transplant_lymphoproliferative_disorder> <Accepted_use_of> "Methylprednisolone" .
<Post-transplant_lymphoproliferative_disorder> <Accepted_use_of> "Doxorubicin" .
<Post-transplant_lymphoproliferative_disorder> <Accepted_use_of> "Cyclophosphamide" .
<Post-transplant_lymphoproliferative_disorder> <Accepted_use_of> "Bleomycin" .
<Post-transplant_lymphoproliferative_disorder> <Accepted_use_of> "ACVBP,_dose-adjusted" .
<IT_Cytarabine_liposomal_monotherapy> <Is_current_in> "CNS_lymphoma" .
<Siltuximab_monotherapy> <Has_supportive_med> "Folinic_acid" .
<CVAP> <Has_antineoplastic> "Vincristine" .
<CVAP> <Has_antineoplastic> "Prednisolone" .
<CVAP> <Has_antineoplastic> "Doxorubicin" .
<CVAP> <Has_antineoplastic> "Cyclophosphamide" .
<CALGB_8811_early_intensification> <Has_context> "Consolidation_after_upfront_therapy" .
<ddEC> <Maps_to> "ddEC" .
<Fluoxymesterone_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Dvaseptol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CFP> <Is_historical_in> "Breast_cancer" .
<Cytarabine,_Idarubicin,_Vorinostat> <Maps_to> "Cytarabine,_Idarubicin,_Vorinostat" .
<Dabrafenib,_Trametinib,_Panitumumab> <Has_antineoplastic> "Trametinib" .
<Dabrafenib,_Trametinib,_Panitumumab> <Has_antineoplastic> "Panitumumab" .
<Dabrafenib,_Trametinib,_Panitumumab> <Has_antineoplastic> "Dabrafenib" .
<Cetuximab_monotherapy> <Has_modality> "Chemotherapy" .
<High-dose_Interleukin-2> <Mapped_from> "High-dose_Interleukin-2" .
<RVD> <Has_antineoplastic> "Lenalidomide" .
<RVD> <Has_antineoplastic> "Dexamethasone" .
<RVD> <Has_antineoplastic> "Bortezomib" .
<Gemcitabine_and_Bevacizumab> <Maps_to> "Gemcitabine_and_Bevacizumab" .
<MCP> <Maps_to> "MCP" .
<R-CODOX-M> <Has_modality> "Chemotherapy" .
<Alemtuzumab> <May_have_route> "Intravenous" .
<ECF/5-FU_and_RT> <Maps_to> "ECF/5-FU_and_RT" .
<ABCP> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<BRCA-mutated_Breast_cancer> <Is_a> "Breast_cancer" .
<GCD> <Maps_to> "GCD" .
<Rapamune> <Brand_name_of> "Sirolimus" .
<Imatinib_and_LoDAC> <Has_antineoplastic> "Imatinib" .
<Imatinib_and_LoDAC> <Has_antineoplastic> "Cytarabine" .
<Trastuzumab_and_hyaluronidase_monotherapy> <Has_context> "Adjuvant_therapy" .
<Kosa> <Brand_name_of> "Dexamethasone" .
<Lomustine_monotherapy> <Has_accepted_use> "Glioblastoma" .
<Bendawel> <Brand_name_of> "Bendamustine" .
<Apo-acyclovir> <Brand_name_of> "Acyclovir" .
<VAD_and_Cyclosporine> <Is_a> "Anthracycline-containing_regimen" .
<NovoTTF-100A_monotherapy> <Has_context> "Non-curative_therapy" .
<Defibrotide> <Supportive_med_of> "Defibrotide_monotherapy" .
<Notrime> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone> <Has_antineoplastic> "Vincristine" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone> <Has_antineoplastic> "Prednisolone" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone> <Has_antineoplastic> "Daunorubicin" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone> <Has_antineoplastic> "Cyclophosphamide" .
<Cytarabine_monotherapy> <Has_antineoplastic> "Cytarabine" .
<IAP> <Has_modality> "Chemotherapy" .
<Capecitabine/Capecitabine_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Capecitabine/Capecitabine_and_RT> <Has_antineoplastic> "Capecitabine" .
<MBVP> <Has_modality> "Chemotherapy" .
<Cervical_cancer> <Accepted_use_of> "Vinorelbine_monotherapy" .
<Cervical_cancer> <Accepted_use_of> "Vinorelbine" .
<Cervical_cancer> <Accepted_use_of> "Topotecan_monotherapy" .
<Cervical_cancer> <Accepted_use_of> "Topotecan" .
<Cervical_cancer> <Accepted_use_of> "Radiation_therapy" .
<Cervical_cancer> <Accepted_use_of> "Pemetrexed_monotherapy" .
<Cervical_cancer> <Accepted_use_of> "Pemetrexed" .
<Cervical_cancer> <Accepted_use_of> "Pembrolizumab_monotherapy" .
<Cervical_cancer> <Accepted_use_of> "Pembrolizumab" .
<Cervical_cancer> <Accepted_use_of> "Paclitaxel,_Topotecan,_Bevacizumab" .
<Cervical_cancer> <Accepted_use_of> "Paclitaxel_monotherapy" .
<Cervical_cancer> <Accepted_use_of> "Paclitaxel_and_Topotecan" .
<Cervical_cancer> <Accepted_use_of> "Paclitaxel" .
<Cervical_cancer> <Accepted_use_of> "No_neoadjuvant_therapy" .
<Cervical_cancer> <Accepted_use_of> "Mitomycin" .
<Cervical_cancer> <Accepted_use_of> "Levoleucovorin" .
<Cervical_cancer> <Accepted_use_of> "Irinotecan_monotherapy" .
<Cervical_cancer> <Accepted_use_of> "Irinotecan" .
<Cervical_cancer> <Accepted_use_of> "Ifosfamide_monotherapy" .
<Cervical_cancer> <Accepted_use_of> "Ifosfamide" .
<Cervical_cancer> <Accepted_use_of> "Hydroxyurea_and_RT" .
<Cervical_cancer> <Accepted_use_of> "Hydroxyurea" .
<Cervical_cancer> <Accepted_use_of> "Gemcitabine_monotherapy" .
<Cervical_cancer> <Accepted_use_of> "Gemcitabine" .
<Cervical_cancer> <Accepted_use_of> "Folinic_acid" .
<Cervical_cancer> <Accepted_use_of> "Fluorouracil,_Mitomycin,_RT" .
<Cervical_cancer> <Accepted_use_of> "Fluorouracil_and_RT" .
<Cervical_cancer> <Accepted_use_of> "Fluorouracil_and_Folinic_acid" .
<Cervical_cancer> <Accepted_use_of> "Fluorouracil" .
<Cervical_cancer> <Accepted_use_of> "Docetaxel_monotherapy" .
<Cervical_cancer> <Accepted_use_of> "Docetaxel" .
<Cervical_cancer> <Accepted_use_of> "Cisplatin,_Paclitaxel,_Bevacizumab" .
<Cervical_cancer> <Accepted_use_of> "Cisplatin,_Gemcitabine,_RT" .
<Cervical_cancer> <Accepted_use_of> "Cisplatin,_Fluorouracil,_RT" .
<Cervical_cancer> <Accepted_use_of> "Cisplatin,_Fluorouracil,_Hydroxyurea,_RT" .
<Cervical_cancer> <Accepted_use_of> "Cisplatin_monotherapy" .
<Cervical_cancer> <Accepted_use_of> "Cisplatin_and_Vinorelbine" .
<Cervical_cancer> <Accepted_use_of> "Cisplatin_and_Topotecan" .
<Cervical_cancer> <Accepted_use_of> "Cisplatin_and_RT" .
<Cervical_cancer> <Accepted_use_of> "Cisplatin_and_Paclitaxel" .
<Cervical_cancer> <Accepted_use_of> "Cisplatin_and_Mitomycin" .
<Cervical_cancer> <Accepted_use_of> "Cisplatin_and_Ifosfamide" .
<Cervical_cancer> <Accepted_use_of> "Cisplatin_and_Gemcitabine" .
<Cervical_cancer> <Accepted_use_of> "Cisplatin" .
<Cervical_cancer> <Accepted_use_of> "Carboplatin_monotherapy" .
<Cervical_cancer> <Accepted_use_of> "Carboplatin_and_RT" .
<Cervical_cancer> <Accepted_use_of> "Carboplatin_and_Paclitaxel" .
<Cervical_cancer> <Accepted_use_of> "Carboplatin_and_Ifosfamide" .
<Cervical_cancer> <Accepted_use_of> "Carboplatin_and_Docetaxel" .
<Cervical_cancer> <Accepted_use_of> "Carboplatin" .
<Cervical_cancer> <Accepted_use_of> "Bevacizumab-bvzr" .
<Cervical_cancer> <Accepted_use_of> "Bevacizumab-awwb" .
<Cervical_cancer> <Accepted_use_of> "Bevacizumab_monotherapy" .
<Cervical_cancer> <Accepted_use_of> "Bevacizumab" .
<Romiplostim_monotherapy> <Has_context> "Non-curative_therapy" .
<IT_Cytarabine,_Methotrexate,_Methylprednisolone> <Is_current_in> "CNS_leukemia" .
<Alexan> <Brand_name_of> "Cytarabine" .
<Prednisone> <Antineoplastic_of> "maxi-R-CHOP/R-HiDAC" .
<Prednisone> <Antineoplastic_of> "mLSG15" .
<Prednisone> <Antineoplastic_of> "eBEACOPP" .
<Prednisone> <Antineoplastic_of> "Vincristine_and_Prednisone" .
<Prednisone> <Antineoplastic_of> "Vinblastine_and_Prednisone" .
<Prednisone> <Antineoplastic_of> "VTP" .
<Prednisone> <Antineoplastic_of> "VR-CP" .
<Prednisone> <Antineoplastic_of> "VR-CHOP" .
<Prednisone> <Antineoplastic_of> "VR-CAP" .
<Prednisone> <Antineoplastic_of> "VP" .
<Prednisone> <Antineoplastic_of> "VNCOP-B" .
<Prednisone> <Antineoplastic_of> "VMPT" .
<Prednisone> <Antineoplastic_of> "VMP/Rd" .
<Prednisone> <Antineoplastic_of> "VMP,_then_Rd" .
<Prednisone> <Antineoplastic_of> "VMP" .
<Prednisone> <Antineoplastic_of> "VMCP/VCAP" .
<Prednisone> <Antineoplastic_of> "VMCP/VBAP" .
<Prednisone> <Antineoplastic_of> "VMCP" .
<Prednisone> <Antineoplastic_of> "VEPEMB" .
<Prednisone> <Antineoplastic_of> "VCP" .
<Prednisone> <Antineoplastic_of> "VCAP" .
<Prednisone> <Antineoplastic_of> "VBMCP/VBAD" .
<Prednisone> <Antineoplastic_of> "VBMCP" .
<Prednisone> <Antineoplastic_of> "VAMP_(Methotrexate)" .
<Prednisone> <Antineoplastic_of> "VAMP_(Amethopterin)" .
<Prednisone> <Antineoplastic_of> "VAD-P/Q" .
<Prednisone> <Antineoplastic_of> "VAD-P" .
<Prednisone> <Antineoplastic_of> "VACOP-B" .
<Prednisone> <Antineoplastic_of> "VABE" .
<Prednisone> <Antineoplastic_of> "Thalidomide_and_Prednisone" .
<Prednisone> <Antineoplastic_of> "TCP" .
<Prednisone> <Antineoplastic_of> "Stanford_V" .
<Prednisone> <Antineoplastic_of> "SC-EPOCH-RR" .
<Prednisone> <Antineoplastic_of> "RT-PEPC" .
<Prednisone> <Antineoplastic_of> "RP" .
<Prednisone> <Antineoplastic_of> "R2CHOP" .
<Prednisone> <Antineoplastic_of> "R-miniCHOP" .
<Prednisone> <Antineoplastic_of> "R-miniCEOP" .
<Prednisone> <Antineoplastic_of> "R-NIMP" .
<Prednisone> <Antineoplastic_of> "R-MegaCHOP-14" .
<Prednisone> <Antineoplastic_of> "R-MegaCHOP" .
<Prednisone> <Antineoplastic_of> "R-M-CHOP" .
<Prednisone> <Antineoplastic_of> "R-EPOCH,_dose-escalated" .
<Prednisone> <Antineoplastic_of> "R-EPOCH" .
<Prednisone> <Antineoplastic_of> "R-CVP" .
<Prednisone> <Antineoplastic_of> "R-CVEP" .
<Prednisone> <Antineoplastic_of> "R-CP" .
<Prednisone> <Antineoplastic_of> "R-CHOP/R-DHAP" .
<Prednisone> <Antineoplastic_of> "R-CHOP-14_(Rituximab_Hycela)" .
<Prednisone> <Antineoplastic_of> "R-CHOP-14" .
<Prednisone> <Antineoplastic_of> "R-CHOP_(Rituximab_Hycela)" .
<Prednisone> <Antineoplastic_of> "R-CHOP" .
<Prednisone> <Antineoplastic_of> "R-CHOEP-14" .
<Prednisone> <Antineoplastic_of> "R-CHMP" .
<Prednisone> <Antineoplastic_of> "R-CEOP_(Etoposide)" .
<Prednisone> <Antineoplastic_of> "R-CDOP" .
<Prednisone> <Antineoplastic_of> "R,_then_CHOP" .
<Prednisone> <Antineoplastic_of> "ProMACE-MOPP" .
<Prednisone> <Antineoplastic_of> "ProMACE-CytaBOM" .
<Prednisone> <Antineoplastic_of> "Prednisone_monotherapy" .
<Prednisone> <Antineoplastic_of> "Pomalidomide_and_Prednisone" .
<Prednisone> <Antineoplastic_of> "Pegaspargase,_Vincristine,_Prednisone" .
<Prednisone> <Antineoplastic_of> "PVAG" .
<Prednisone> <Antineoplastic_of> "PT" .
<Prednisone> <Antineoplastic_of> "POMP" .
<Prednisone> <Antineoplastic_of> "PEP-C" .
<Prednisone> <Antineoplastic_of> "PEN" .
<Prednisone> <Antineoplastic_of> "PCP" .
<Prednisone> <Antineoplastic_of> "PATCO" .
<Prednisone> <Antineoplastic_of> "PAC" .
<Prednisone> <Antineoplastic_of> "P/DOCE" .
<Prednisone> <Antineoplastic_of> "Ox-P" .
<Prednisone> <Antineoplastic_of> "Octreotide_and_Prednisone" .
<Prednisone> <Antineoplastic_of> "OPPA" .
<Prednisone> <Antineoplastic_of> "OEPA" .
<Prednisone> <Antineoplastic_of> "O-miniCHOP" .
<Prednisone> <Antineoplastic_of> "O-CHOP" .
<Prednisone> <Antineoplastic_of> "NOVP" .
<Prednisone> <Antineoplastic_of> "Mitoxantrone_and_Prednisone" .
<Prednisone> <Antineoplastic_of> "Methotrexate,_Vinblastine,_Prednisone" .
<Prednisone> <Antineoplastic_of> "Mercaptopurine_and_Prednisone" .
<Prednisone> <Antineoplastic_of> "MVPP" .
<Prednisone> <Antineoplastic_of> "MPT" .
<Prednisone> <Antineoplastic_of> "MPR" .
<Prednisone> <Antineoplastic_of> "MP" .
<Prednisone> <Antineoplastic_of> "MOPP/ABVD" .
<Prednisone> <Antineoplastic_of> "MOPP-ABV" .
<Prednisone> <Antineoplastic_of> "MOPP" .
<Prednisone> <Antineoplastic_of> "MCP" .
<Prednisone> <Antineoplastic_of> "MBVP" .
<Prednisone> <Antineoplastic_of> "MACOP-B" .
<Prednisone> <Antineoplastic_of> "Lomustine,_Vincristine,_Prednisone" .
<Prednisone> <Antineoplastic_of> "Linker_regimen_(consolidation)" .
<Prednisone> <Antineoplastic_of> "LSG15" .
<Prednisone> <Antineoplastic_of> "LOPP/EVAP" .
<Prednisone> <Antineoplastic_of> "LOPP" .
<Prednisone> <Antineoplastic_of> "LD-ACOP-B" .
<Prednisone> <Antineoplastic_of> "L-Asparaginase,_Vincristine,_Prednisone" .
<Prednisone> <Antineoplastic_of> "KMP" .
<Prednisone> <Antineoplastic_of> "Interferon_alfa-2b_and_Prednisone" .
<Prednisone> <Antineoplastic_of> "Imatinib,_Vincristine,_Prednisone" .
<Prednisone> <Antineoplastic_of> "Imatinib_and_Prednisone" .
<Prednisone> <Antineoplastic_of> "HOP" .
<Prednisone> <Antineoplastic_of> "GMALL-R" .
<Prednisone> <Antineoplastic_of> "GDPT" .
<Prednisone> <Antineoplastic_of> "G-CVP" .
<Prednisone> <Antineoplastic_of> "G-CHOP" .
<Prednisone> <Antineoplastic_of> "Fludarabine_and_Prednisone" .
<Prednisone> <Antineoplastic_of> "FMP" .
<Prednisone> <Antineoplastic_of> "F-MACHOP" .
<Prednisone> <Antineoplastic_of> "Etoposide,_Vinblastine,_Prednisone" .
<Prednisone> <Antineoplastic_of> "Etoposide_and_Prednisone" .
<Prednisone> <Antineoplastic_of> "EPOCH,_dose-escalated" .
<Prednisone> <Antineoplastic_of> "EPOCH" .
<Prednisone> <Antineoplastic_of> "EBVP" .
<Prednisone> <Antineoplastic_of> "Doxorubicin,_Methotrexate,_Vincristine,_Prednisone" .
<Prednisone> <Antineoplastic_of> "Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone" .
<Prednisone> <Antineoplastic_of> "Docetaxel_and_Prednisone" .
<Prednisone> <Antineoplastic_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone" .
<Prednisone> <Antineoplastic_of> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib" .
<Prednisone> <Antineoplastic_of> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Prednisone> <Antineoplastic_of> "Daunorubicin_and_Prednisone" .
<Prednisone> <Antineoplastic_of> "Dasatinib,_Vincristine,_Prednisone" .
<Prednisone> <Antineoplastic_of> "Dasatinib_and_Prednisone" .
<Prednisone> <Antineoplastic_of> "Dara-VMP" .
<Prednisone> <Antineoplastic_of> "DOLP" .
<Prednisone> <Antineoplastic_of> "DD-CHOP" .
<Prednisone> <Antineoplastic_of> "DA-R-EPOCH" .
<Prednisone> <Antineoplastic_of> "DA-EPOCH" .
<Prednisone> <Antineoplastic_of> "D-ZAPO" .
<Prednisone> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone" .
<Prednisone> <Antineoplastic_of> "Cyclophosphamide,_Prednisone,_Diethylstilbestrol" .
<Prednisone> <Antineoplastic_of> "Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone" .
<Prednisone> <Antineoplastic_of> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone" .
<Prednisone> <Antineoplastic_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab" .
<Prednisone> <Antineoplastic_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Prednisone> <Antineoplastic_of> "Cyclophosphamide_and_Prednisone" .
<Prednisone> <Antineoplastic_of> "Chlorambucil_and_Prednisone" .
<Prednisone> <Antineoplastic_of> "ChlVPP" .
<Prednisone> <Antineoplastic_of> "Carboplatin,_Docetaxel,_Prednisone" .
<Prednisone> <Antineoplastic_of> "Calaspargase,_Daunorubicin,_Vincristine,_Prednisone" .
<Prednisone> <Antineoplastic_of> "Cabazitaxel_and_Prednisone" .
<Prednisone> <Antineoplastic_of> "CVPP" .
<Prednisone> <Antineoplastic_of> "CVP,_then_131Iodine-Tositumomab" .
<Prednisone> <Antineoplastic_of> "CVP" .
<Prednisone> <Antineoplastic_of> "CPR" .
<Prednisone> <Antineoplastic_of> "COPP/ABVD" .
<Prednisone> <Antineoplastic_of> "COPP_(CCNU)" .
<Prednisone> <Antineoplastic_of> "COPDAC" .
<Prednisone> <Antineoplastic_of> "COPADM" .
<Prednisone> <Antineoplastic_of> "COPAD/CYVE" .
<Prednisone> <Antineoplastic_of> "COPAD" .
<Prednisone> <Antineoplastic_of> "COPA" .
<Prednisone> <Antineoplastic_of> "COP-Bleo" .
<Prednisone> <Antineoplastic_of> "COP" .
<Prednisone> <Antineoplastic_of> "COMP" .
<Prednisone> <Antineoplastic_of> "CNOP" .
<Prednisone> <Antineoplastic_of> "CMFVP" .
<Prednisone> <Antineoplastic_of> "CMFPT" .
<Prednisone> <Antineoplastic_of> "CMFP" .
<Prednisone> <Antineoplastic_of> "CHVmP-VB" .
<Prednisone> <Antineoplastic_of> "CHVmP" .
<Prednisone> <Antineoplastic_of> "CHVP-I" .
<Prednisone> <Antineoplastic_of> "CHVP" .
<Prednisone> <Antineoplastic_of> "CHOP-BCG" .
<Prednisone> <Antineoplastic_of> "CHOP-B" .
<Prednisone> <Antineoplastic_of> "CHOP-AL" .
<Prednisone> <Antineoplastic_of> "CHOP-14" .
<Prednisone> <Antineoplastic_of> "CHOP,_then_131Iodine-Tositumomab" .
<Prednisone> <Antineoplastic_of> "CHOP_and_Everolimus" .
<Prednisone> <Antineoplastic_of> "CHOP_Modified" .
<Prednisone> <Antineoplastic_of> "CHOP" .
<Prednisone> <Antineoplastic_of> "CHOEP-21" .
<Prednisone> <Antineoplastic_of> "CHOEP-14" .
<Prednisone> <Antineoplastic_of> "CFP_and_Oophorectomy" .
<Prednisone> <Antineoplastic_of> "CFP" .
<Prednisone> <Antineoplastic_of> "CEPP(B)" .
<Prednisone> <Antineoplastic_of> "CEOP" .
<Prednisone> <Antineoplastic_of> "CEEP" .
<Prednisone> <Antineoplastic_of> "CCOP" .
<Prednisone> <Antineoplastic_of> "CBV,_then_auto_HSCT" .
<Prednisone> <Antineoplastic_of> "CAP-BOP" .
<Prednisone> <Antineoplastic_of> "CAP" .
<Prednisone> <Antineoplastic_of> "CAMFP" .
<Prednisone> <Antineoplastic_of> "CAFVP" .
<Prednisone> <Antineoplastic_of> "C-MOPP/ABV" .
<Prednisone> <Antineoplastic_of> "C-MOPP" .
<Prednisone> <Antineoplastic_of> "BVCPP" .
<Prednisone> <Antineoplastic_of> "BV-CHP" .
<Prednisone> <Antineoplastic_of> "BEACOPP-14" .
<Prednisone> <Antineoplastic_of> "BEACOPP" .
<Prednisone> <Antineoplastic_of> "BCVPP" .
<Prednisone> <Antineoplastic_of> "BCOP" .
<Prednisone> <Antineoplastic_of> "BASIC" .
<Prednisone> <Antineoplastic_of> "Abiraterone_and_Prednisone" .
<Prednisone> <Antineoplastic_of> "APO" .
<Prednisone> <Antineoplastic_of> "ACVBP-R" .
<Prednisone> <Antineoplastic_of> "ACVBP,_dose-adjusted" .
<Prednisone> <Antineoplastic_of> "ACVBP" .
<Prednisone> <Antineoplastic_of> "ABVE-PC" .
<Prednisone> <Antineoplastic_of> "ABP" .
<Prednisone> <Antineoplastic_of> "ABDIC" .
<Alemtuzumab_and_Methylprednisolone> <Has_antineoplastic> "Methylprednisolone" .
<Alemtuzumab_and_Methylprednisolone> <Has_antineoplastic> "Alemtuzumab" .
<Pediatric-like_GRAALL_consolidation> <Has_modality> "Chemotherapy" .
<CX-C> <Mapped_from> "CX-C" .
<Everolimus_and_Rituximab> <Maps_to> "Everolimus_and_Rituximab" .
<Nordic_Regimen,_older_patients> <Maps_to> "Nordic_Regimen,_older_patients" .
<MIC> <Has_modality> "Chemotherapy" .
<Cisplatin_and_Etoposide> <Has_modality> "Chemotherapy" .
<ATRA,_Mercaptopurine,_Methotrexate> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<MT-R> <Has_accepted_use> "CNS_lymphoma" .
<Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin> <Mapped_from> "Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin" .
<Dersone> <Brand_name_of> "Dexamethasone" .
<Bendamustine_and_Brentuximab_vedotin> <Mapped_from> "Bendamustine_and_Brentuximab_vedotin" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone> <Maps_to> "Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone" .
<Phenytoin> <Immunosuppressor_of> "Busulfan_and_Fludarabine" .
<Phenytoin> <Immunosuppressor_of> "BuFlu,_then_allo_HSCT" .
<FOLFIRI> <Is_current_in> "Pancreatic_cancer" .
<FOLFIRI> <Is_current_in> "Esophageal_cancer" .
<FOLFIRI> <Is_current_in> "Colon_cancer" .
<FAC_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Cladribine_monotherapy> <Has_supportive_med> "Valacyclovir" .
<Cladribine_monotherapy> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Cladribine_monotherapy> <Has_supportive_med> "Steroids" .
<Cladribine_monotherapy> <Has_supportive_med> "Ofatumumab" .
<Cladribine_monotherapy> <Has_supportive_med> "Fluconazole" .
<Cladribine_monotherapy> <Has_supportive_med> "Dexamethasone" .
<Cladribine_monotherapy> <Has_supportive_med> "Clemastine" .
<Cladribine_monotherapy> <Has_supportive_med> "Antihistamines" .
<Cladribine_monotherapy> <Has_supportive_med> "Acetaminophen" .
<Rituximab_and_hyaluronidase_monotherapy> <Has_antineoplastic> "Rituximab_and_hyaluronidase_human" .
<Alecast> <Brand_name_of> "Montelukast" .
<FLEC> <Maps_to> "FLEC" .
<Thiotepa> <Antineoplastic_of> "Thiotepa_monotherapy" .
<Thiotepa> <Antineoplastic_of> "TMF" .
<Thiotepa> <Antineoplastic_of> "TFC,_then_allo_HSCT" .
<Thiotepa> <Antineoplastic_of> "Methotrexate,_then_Cytarabine_and_Thiotepa" .
<Thiotepa> <Antineoplastic_of> "Methotrexate_and_Thiotepa" .
<Thiotepa> <Antineoplastic_of> "MATRix" .
<Thiotepa> <Antineoplastic_of> "ECT,_then_auto_HSCT" .
<Thiotepa> <Antineoplastic_of> "Cyclophosphamide,_Fludarabine,_Thiotepa" .
<Thiotepa> <Antineoplastic_of> "CTCb,_then_auto_HSCT" .
<Thiotepa> <Antineoplastic_of> "CTCb" .
<Thiotepa> <Antineoplastic_of> "CHUT,_then_auto_HSCT" .
<Thiotepa> <Antineoplastic_of> "CHUT" .
<Thiotepa> <Antineoplastic_of> "Bu/TT/Cy,_then_auto_HSCT" .
<Thiotepa> <Antineoplastic_of> "Bu/TT/Cy" .
<Thiotepa> <Antineoplastic_of> "Bu/TT,_then_auto_HSCT" .
<Thiotepa> <Antineoplastic_of> "Bu/TT" .
<Thiotepa> <Antineoplastic_of> "BCNU/TT,_then_auto_HSCT" .
<Thiotepa> <Antineoplastic_of> "BCNU/TT" .
<Doxorubicin_and_Strontium-89> <Maps_to> "Doxorubicin_and_Strontium-89" .
<VAMP_(Amethopterin)> <Has_modality> "Chemotherapy" .
<Aspirin_and_Hydroxyurea> <Is_current_in> "Essential_thrombocythemia" .
<MPT> <Has_accepted_use> "Multiple_myeloma" .
<Doxorubicin_and_Bevacizumab> <Maps_to> "Doxorubicin_and_Bevacizumab" .
<Etoposide_and_TBI,_then_allo_HSCT> <Has_context> "Consolidation_after_upfront_therapy" .
<RICER> <Has_supportive_med> "Filgrastim" .
<RICER> <Has_supportive_med> "Aspirin" .
<Zanubrutinib_monotherapy> <Has_accepted_use> "Mantle_cell_lymphoma" .
<NovoTTF-100A_monotherapy> <Has_local_therapy> "NovoTTF-100A_system_(Optune)" .
<7_plus_3d_and_Midostaurin> <Is_current_in> "Acute_myeloid_leukemia" .
<BR> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<BR> <Has_accepted_use> "Marginal_zone_lymphoma" .
<BR> <Has_accepted_use> "Mantle_cell_lymphoma" .
<BR> <Has_accepted_use> "Hairy_cell_leukemia" .
<BR> <Has_accepted_use> "Follicular_lymphoma" .
<BR> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<BR> <Has_accepted_use> "Cold_agglutinin_disease" .
<BR> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Cispatin> <Brand_name_of> "Cisplatin" .
<Cozol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Roceron-A> <Brand_name_of> "Interferon_alfa-2b" .
<Decitabine_monotherapy> <Has_supportive_med> "Hydroxyurea" .
<Neoadjuvant_therapy> <Is_a> "Pre-definitive_therapy" .
<Irinotecan_liposomal_monotherapy> <Has_antineoplastic> "Irinotecan_liposome" .
<Padium> <Brand_name_of> "Pamidronate" .
<Melanoma> <Accepted_use_of> "nab-Paclitaxel_monotherapy" .
<Melanoma> <Accepted_use_of> "Vindesine" .
<Melanoma> <Accepted_use_of> "Vinblastine" .
<Melanoma> <Accepted_use_of> "Vemurafenib_monotherapy" .
<Melanoma> <Accepted_use_of> "Vemurafenib" .
<Melanoma> <Accepted_use_of> "Trametinib_monotherapy" .
<Melanoma> <Accepted_use_of> "Trametinib" .
<Melanoma> <Accepted_use_of> "Temozolomide_monotherapy" .
<Melanoma> <Accepted_use_of> "Temozolomide_and_Bevacizumab" .
<Melanoma> <Accepted_use_of> "Temozolomide" .
<Melanoma> <Accepted_use_of> "Talimogene_laherparepvec_monotherapy" .
<Melanoma> <Accepted_use_of> "Talimogene_laherparepvec" .
<Melanoma> <Accepted_use_of> "Placebo" .
<Melanoma> <Accepted_use_of> "Pembrolizumab_monotherapy" .
<Melanoma> <Accepted_use_of> "Pembrolizumab" .
<Melanoma> <Accepted_use_of> "Peginterferon_alfa-2b_monotherapy" .
<Melanoma> <Accepted_use_of> "Peginterferon_alfa-2b" .
<Melanoma> <Accepted_use_of> "Paclitaxel_nanoparticle_albumin-bound" .
<Melanoma> <Accepted_use_of> "Paclitaxel_monotherapy" .
<Melanoma> <Accepted_use_of> "Paclitaxel" .
<Melanoma> <Accepted_use_of> "Observation" .
<Melanoma> <Accepted_use_of> "Nivolumab,_then_Ipilimumab" .
<Melanoma> <Accepted_use_of> "Nivolumab_monotherapy" .
<Melanoma> <Accepted_use_of> "Nivolumab" .
<Melanoma> <Accepted_use_of> "Low-dose_Interleukin-2" .
<Melanoma> <Accepted_use_of> "Ipilimumab,_then_Nivolumab" .
<Melanoma> <Accepted_use_of> "Ipilimumab_monotherapy" .
<Melanoma> <Accepted_use_of> "Ipilimumab_and_Nivolumab" .
<Melanoma> <Accepted_use_of> "Ipilimumab" .
<Melanoma> <Accepted_use_of> "Interferon_alfa-2b_monotherapy" .
<Melanoma> <Accepted_use_of> "Interferon_alfa-2b" .
<Melanoma> <Accepted_use_of> "Interferon_alfa-2a_monotherapy" .
<Melanoma> <Accepted_use_of> "Interferon_alfa-2a" .
<Melanoma> <Accepted_use_of> "Imatinib_monotherapy" .
<Melanoma> <Accepted_use_of> "Imatinib" .
<Melanoma> <Accepted_use_of> "IL-2_monotherapy" .
<Melanoma> <Accepted_use_of> "High-dose_Interleukin-2" .
<Melanoma> <Accepted_use_of> "Fotemustine_monotherapy" .
<Melanoma> <Accepted_use_of> "Fotemustine" .
<Melanoma> <Accepted_use_of> "Encorafenib" .
<Melanoma> <Accepted_use_of> "Docetaxel_monotherapy" .
<Melanoma> <Accepted_use_of> "Docetaxel" .
<Melanoma> <Accepted_use_of> "Dacarbazine_monotherapy" .
<Melanoma> <Accepted_use_of> "Dacarbazine_and_Tamoxifen" .
<Melanoma> <Accepted_use_of> "Dacarbazine_and_Ipilimumab" .
<Melanoma> <Accepted_use_of> "Dacarbazine_and_Interferon_alfa-2a" .
<Melanoma> <Accepted_use_of> "Dacarbazine" .
<Melanoma> <Accepted_use_of> "Dabrafenib_monotherapy" .
<Melanoma> <Accepted_use_of> "Dabrafenib_and_Trametinib" .
<Melanoma> <Accepted_use_of> "Dabrafenib" .
<Melanoma> <Accepted_use_of> "Cobimetinib_and_Vemurafenib" .
<Melanoma> <Accepted_use_of> "Cobimetinib" .
<Melanoma> <Accepted_use_of> "Cisplatin,_Dacarbazine,_Tamoxifen" .
<Melanoma> <Accepted_use_of> "Cisplatin,_Dacarbazine,_Paclitaxel" .
<Melanoma> <Accepted_use_of> "Cisplatin,_Dacarbazine,_Interferon_alfa-2b" .
<Melanoma> <Accepted_use_of> "Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine" .
<Melanoma> <Accepted_use_of> "Cisplatin_and_Dacarbazine" .
<Melanoma> <Accepted_use_of> "Cisplatin" .
<Melanoma> <Accepted_use_of> "Carmustine" .
<Melanoma> <Accepted_use_of> "Carboplatin_and_nab-Paclitaxel" .
<Melanoma> <Accepted_use_of> "Carboplatin_and_Paclitaxel" .
<Melanoma> <Accepted_use_of> "Carboplatin" .
<Melanoma> <Accepted_use_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Melanoma> <Accepted_use_of> "CVD_(Vindesine)" .
<Melanoma> <Accepted_use_of> "CVD_(Vinblastine)" .
<Melanoma> <Accepted_use_of> "CDB" .
<Melanoma> <Accepted_use_of> "Binimetinib_monotherapy" .
<Melanoma> <Accepted_use_of> "Binimetinib_and_Encorafenib" .
<Melanoma> <Accepted_use_of> "Binimetinib" .
<Melanoma> <Accepted_use_of> "Bevacizumab-bvzr" .
<Melanoma> <Accepted_use_of> "Bevacizumab-awwb" .
<Melanoma> <Accepted_use_of> "Bevacizumab" .
<Melanoma> <Accepted_use_of> "BVD" .
<Melanoma> <Accepted_use_of> "BHD" .
<Melanoma> <Accepted_use_of> "BCG_and_Dacarbazine" .
<Melanoma> <Accepted_use_of> "Aldesleukin" .
<Melanoma> <Accepted_use_of> "ABC" .
<Eparin> <Brand_name_of> "Enoxaparin" .
<Dipyridamole> <Is_a> "PDE_inhibitor" .
<Osteosarcoma> <Current_treated_by> "Samarium-153_with_stem_cell_support" .
<Osteosarcoma> <Current_treated_by> "Observation" .
<Osteosarcoma> <Current_treated_by> "Methotrexate_and_Vincristine" .
<Osteosarcoma> <Current_treated_by> "MAPIE" .
<Osteosarcoma> <Current_treated_by> "MAPI" .
<Osteosarcoma> <Current_treated_by> "MAP" .
<Osteosarcoma> <Current_treated_by> "MA-BCD/AP" .
<Osteosarcoma> <Current_treated_by> "MA-BCD" .
<Osteosarcoma> <Current_treated_by> "MA" .
<Osteosarcoma> <Current_treated_by> "M-EI" .
<Osteosarcoma> <Current_treated_by> "M-BCD" .
<Osteosarcoma> <Current_treated_by> "IP-BCD" .
<Osteosarcoma> <Current_treated_by> "IE" .
<Osteosarcoma> <Current_treated_by> "ICE" .
<Osteosarcoma> <Current_treated_by> "Gemcitabine_monotherapy" .
<Osteosarcoma> <Current_treated_by> "Doxorubicin_monotherapy" .
<Osteosarcoma> <Current_treated_by> "Docetaxel_and_Gemcitabine" .
<Osteosarcoma> <Current_treated_by> "Cyclophosphamide_and_Topotecan" .
<Osteosarcoma> <Current_treated_by> "Cyclophosphamide_and_Etoposide" .
<Osteosarcoma> <Current_treated_by> "Cisplatin,_Epirubicin,_Ifosfamide" .
<Osteosarcoma> <Current_treated_by> "Cisplatin_and_Doxorubicin" .
<Octreotide_LAR_monotherapy> <Has_accepted_use> "Pancreatic_NET" .
<Octreotide_LAR_monotherapy> <Has_accepted_use> "Neuroendocrine_tumor" .
<Methotrexate_and_Thiotepa> <Has_accepted_use> "Breast_cancer" .
<Low-dose_TBI> <Maps_to> "Low-dose_TBI" .
<FCR> <Is_a> "Rituximab-containing_regimen" .
<Vinorelbine_and_Bevacizumab> <Is_current_in> "Breast_cancer" .
<BLD> <Mapped_from> "BLD" .
<Bendeka> <Brand_name_of> "Bendamustine" .
<R-BL> <Has_accepted_use> "Mantle_cell_lymphoma" .
<R-BL> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Carboplatin,_Fluorouracil,_Cetuximab> <Maps_to> "Carboplatin,_Fluorouracil,_Cetuximab" .
<Histrelin_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<Lutetium_Lu_177_dotatate> <May_have_route> "Intravenous" .
<Letrozole> <Is_a> "Steroid_synthesis_inhibitor" .
<Letrozole> <Is_a> "Protein_expression-specific_medication" .
<Letrozole> <Is_a> "Endocrine_therapeutic" .
<Letrozole> <Is_a> "Aromatase_inhibitor" .
<Fluorouracil_and_Mitomycin> <Maps_to> "Fluorouracil_and_Mitomycin" .
<Folitrax> <Brand_name_of> "Methotrexate" .
<Sunitinib> <Is_a> "VEGFR_inhibitor" .
<Sunitinib> <Is_a> "RET_inhibitor" .
<Sunitinib> <Is_a> "PDGFR_inhibitor" .
<Sunitinib> <Is_a> "Kinase_inhibitor" .
<Sunitinib> <Is_a> "KIT_inhibitor" .
<Sunitinib> <Is_a> "FLT3_inhibitor" .
<FUIRI> <Has_context> "Non-curative_first-line_therapy" .
<Lenalidomide_and_Rituximab> <Is_a> "Rituximab-containing_regimen" .
<EDC> <Is_current_in> "Breast_cancer" .
<MCV> <Mapped_from> "MCV" .
<Fondaparinux_monotherapy> <Has_accepted_use> "Venous_thromboembolism" .
<Fondaparinux_monotherapy> <Has_accepted_use> "Heparin-induced_thrombocytopenia" .
<Radotinib> <Has_brand_name> "Supect" .
<CISCA/VB> <Mapped_from> "CISCA/VB" .
<Melphalan_and_TBI,_then_auto_HSCT> <Is_historical_in> "Multiple_myeloma" .
<MVPP> <Mapped_from> "MVPP" .
<FLT3-positive_Acute_myeloid_leukemia> <Is_a> "Acute_myeloid_leukemia" .
<S.R.A.> <Brand_name_of> "Aspirin" .
<Plerixafor> <Supportive_med_of> "Plerixafor_monotherapy" .
<Plerixafor> <Supportive_med_of> "Plerixafor_and_G-CSF" .
<Imatinib> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Imatinib> <Is_a> "Protein_expression-specific_medication" .
<Imatinib> <Is_a> "PDGFR_inhibitor" .
<Imatinib> <Is_a> "Mutation-specific_medication" .
<Imatinib> <Is_a> "Kinase_inhibitor" .
<Imatinib> <Is_a> "KIT_inhibitor" .
<Imatinib> <Is_a> "Bcr-Abl_inhibitor" .
<B.S.> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<IFN_Alpha> <Brand_name_of> "Interferon_alfa-2b" .
<PAD/VCD> <Has_antineoplastic> "Pegylated_liposomal_doxorubicin" .
<PAD/VCD> <Has_antineoplastic> "Dexamethasone" .
<PAD/VCD> <Has_antineoplastic> "Cyclophosphamide" .
<PAD/VCD> <Has_antineoplastic> "Bortezomib" .
<Cisplatin,_Gemcitabine,_RT> <Has_context> "Definitive_therapy" .
<Carboplatin_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Depo-Medrate> <Brand_name_of> "Methylprednisolone" .
<Irritant> <Subsumes> "Vincristine_liposomal" .
<Irritant> <Subsumes> "Topotecan" .
<Irritant> <Subsumes> "Thiotepa" .
<Irritant> <Subsumes> "Teniposide" .
<Irritant> <Subsumes> "Plicamycin" .
<Irritant> <Subsumes> "Pegylated_liposomal_doxorubicin" .
<Irritant> <Subsumes> "Paclitaxel_nanoparticle_albumin-bound" .
<Irritant> <Subsumes> "Paclitaxel" .
<Irritant> <Subsumes> "Mitoxantrone" .
<Irritant> <Subsumes> "Melphalan" .
<Irritant> <Subsumes> "Ixabepilone" .
<Irritant> <Subsumes> "Irinotecan" .
<Irritant> <Subsumes> "Ifosfamide" .
<Irritant> <Subsumes> "Gemcitabine" .
<Irritant> <Subsumes> "Fluorouracil" .
<Irritant> <Subsumes> "Floxuridine" .
<Irritant> <Subsumes> "Etoposide" .
<Irritant> <Subsumes> "Docetaxel" .
<Irritant> <Subsumes> "Daunorubicin_liposomal" .
<Irritant> <Subsumes> "Dacarbazine" .
<Irritant> <Subsumes> "Cytarabine_liposomal" .
<Irritant> <Subsumes> "Cytarabine" .
<Irritant> <Subsumes> "Cyclophosphamide" .
<Irritant> <Subsumes> "Cladribine" .
<Irritant> <Subsumes> "Cisplatin" .
<Irritant> <Subsumes> "Carmustine" .
<Irritant> <Subsumes> "Carboplatin" .
<Irritant> <Subsumes> "Busulfan" .
<Irritant> <Subsumes> "Bortezomib" .
<Irritant> <Subsumes> "Bleomycin" .
<Irritant> <Subsumes> "Belotecan" .
<Irritant> <Subsumes> "Ado-trastuzumab_emtansine" .
<MP_(Prednisolone)> <Has_antineoplastic> "Prednisolone" .
<MP_(Prednisolone)> <Has_antineoplastic> "Melphalan" .
<Fluoroquinolone> <Is_a> "Antibacterial" .
<Zultrop> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Ruxolitinib> <May_have_route> "Oral" .
<Trastuzumab> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Trastuzumab> <Is_a> "Protein_expression-specific_medication" .
<Trastuzumab> <Is_a> "Neutral" .
<Trastuzumab> <Is_a> "ERBB2_(HER2)_medication" .
<Trastuzumab> <Is_a> "Antibody_medication" .
<Trastuzumab> <Is_a> "Anti-HER2_antibody" .
<Rabbit_ATG> <Mapped_from> "Rabbit_ATG" .
<Capecitabine_and_Gemcitabine> <Has_modality> "Chemotherapy" .
<Methylprednis> <Brand_name_of> "Methylprednisolone" .
<Carboplatin_and_Pemetrexed> <Is_a> "Platinum_doublet" .
<No_neoadjuvant_therapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<No_neoadjuvant_therapy> <Is_current_in> "Gastric_cancer" .
<No_neoadjuvant_therapy> <Is_current_in> "Esophageal_cancer" .
<No_neoadjuvant_therapy> <Is_current_in> "Cervical_cancer" .
<No_neoadjuvant_therapy> <Is_current_in> "Bladder_cancer" .
<Enzyme_inhibitor> <Subsumes> "Tryptophan_hydroxylase_inhibitor" .
<Enzyme_inhibitor> <Subsumes> "Telomerase_inhibitor" .
<Enzyme_inhibitor> <Subsumes> "Purine_nucleoside_phosphorylase_(PNP)_inhibitor" .
<Enzyme_inhibitor> <Subsumes> "PARP_inhibitor" .
<Enzyme_inhibitor> <Subsumes> "IDH2_inhibitor" .
<Enzyme_inhibitor> <Subsumes> "IDH1_inhibitor" .
<Enzyme_inhibitor> <Subsumes> "HDAC_inhibitor" .
<Enzyme_inhibitor> <Subsumes> "Farnesyltransferase_inhibitor" .
<Enzyme_inhibitor> <Subsumes> "DNA_methyltransferase_inhibitor" .
<Enzyme_inhibitor> <Subsumes> "Aminopeptidase_inhibitor" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone> <Maps_to> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone" .
<Monarc-M> <Brand_name_of> "Factor_VIII_human" .
<Thioplex> <Brand_name_of> "Thiotepa" .
<Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b> <Has_antineoplastic> "Interferon_gamma-1b" .
<Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b> <Has_antineoplastic> "Cyclophosphamide" .
<Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b> <Has_antineoplastic> "Cisplatin" .
<Tamoxifen_and_OFS> <Is_current_in> "Breast_cancer" .
<Dispril> <Brand_name_of> "Aspirin" .
<Cisplatin,_Interferon_alfa-2a,_Isotretinoin> <Has_antineoplastic> "Isotretinoin" .
<Cisplatin,_Interferon_alfa-2a,_Isotretinoin> <Has_antineoplastic> "Interferon_alfa-2a" .
<Cisplatin,_Interferon_alfa-2a,_Isotretinoin> <Has_antineoplastic> "Cisplatin" .
<Campath> <Brand_name_of> "Alemtuzumab" .
<Acetophen> <Brand_name_of> "Aspirin" .
<Pyderma> <Brand_name_of> "Dexamethasone" .
<Prednisolone_and_Rituximab> <Has_context> "All_lines_of_therapy" .
<Zecatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Trorix> <Brand_name_of> "Ondansetron" .
<Levamisole> <Is_a> "Discontinued_drug" .
<Glasdegib_and_LoDAC> <Maps_to> "Glasdegib_and_LoDAC" .
<Idelalisib_and_Rituximab> <Is_a> "Rituximab-containing_regimen" .
<Decalona> <Brand_name_of> "Dexamethasone" .
<Epricin> <Brand_name_of> "Epirubicin" .
<Cisplatin_and_Cetuximab> <Has_context> "Non-curative_first-line_therapy" .
<Imferon> <Brand_name_of> "Iron_dextran" .
<IFL_and_Bevacizumab> <Is_a> "Irinotecan-containing_regimen" .
<IFL_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Temsy> <Brand_name_of> "Tranexamic_acid" .
<Idarubicin,_then_Mitoxantrone,_then_Idarubicin> <Is_current_in> "Acute_promyelocytic_leukemia" .
<Anti-EGFR_antibody> <Is_a> "EGFR_inhibitor" .
<Anti-EGFR_antibody> <Is_a> "Antibody_medication" .
<FP/Capecitabine_and_RT> <Has_context> "Adjuvant_therapy" .
<Fosaprepitant> <May_have_route> "Intravenous" .
<Piriteze> <Brand_name_of> "Cetirizine" .
<Bu/TT/Cy,_then_auto_HSCT> <Has_supportive_med> "Clonazepam" .
<AVD> <Has_context> "Induction_therapy" .
<Tamoxifen> <Has_accepted_use> "Endometrial_cancer" .
<Tamoxifen> <Has_accepted_use> "Breast_cancer" .
<Romiplostim> <Has_brand_name> "Nplate" .
<ChlVPP/EVA> <Is_current_in> "Hodgkin_lymphoma" .
<R-CODOX-M> <Is_a> "Rituximab-containing_regimen" .
<R-CODOX-M> <Is_a> "Anthracycline-containing_regimen" .
<Feosol> <Brand_name_of> "Ferrous_sulfate" .
<CBV-Mx,_then_auto_HSCT> <Maps_to> "CBV-Mx,_then_auto_HSCT" .
<mLSG15> <Is_a> "Anthracycline-containing_regimen" .
<Inherited_hemoglobinopathy> <Is_a> "Hemoglobinopathy" .
<Lunachol> <Brand_name_of> "Fluorouracil" .
<Carboplatin,_Pemetrexed,_Pembrolizumab> <Has_supportive_med> "Steroids" .
<Carboplatin,_Pemetrexed,_Pembrolizumab> <Has_supportive_med> "Folic_acid" .
<Carboplatin,_Pemetrexed,_Pembrolizumab> <Has_supportive_med> "Cyanocobalamin" .
<R-CHOP/R-DHAP> <Maps_to> "R-CHOP/R-DHAP" .
<ECH> <Has_context> "Non-curative_first-line_therapy" .
<ECH> <Has_context> "Neoadjuvant_therapy" .
<Comixco> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<VAMP> <Has_context> "Non-curative_first-line_therapy" .
<FUIRI> <Is_a> "Irinotecan-containing_regimen" .
<Mitoxantrone_monotherapy> <Has_context> "Non-curative_therapy" .
<Mitoxantrone_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Carboplatin,_Fluorouracil,_Cetuximab,_RT> <Maps_to> "Carboplatin,_Fluorouracil,_Cetuximab,_RT" .
<Doxobin> <Brand_name_of> "Doxorubicin" .
<Alcalm> <Brand_name_of> "Alprazolam" .
<GnRH_antagonist> <Subsumes> "Degarelix" .
<R-INO> <Is_current_in> "Follicular_lymphoma" .
<CEV_(Cyclophosphamide/Epirubicin)> <Has_context> "Induction_therapy" .
<Bu/TT/Cy,_then_auto_HSCT> <Has_context> "Consolidation_after_upfront_therapy" .
<Bu/TT/Cy,_then_auto_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<TAD_(Thalidomide)> <Has_accepted_use> "Multiple_myeloma" .
<RICER> <Has_context> "Salvage_therapy" .
<Bevacizumab-awwb> <Has_accepted_use> "Vascular_sarcoma" .
<Bevacizumab-awwb> <Has_accepted_use> "Testicular_cancer" .
<Bevacizumab-awwb> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Bevacizumab-awwb> <Has_accepted_use> "Small_cell_lung_cancer" .
<Bevacizumab-awwb> <Has_accepted_use> "Renal_cell_carcinoma" .
<Bevacizumab-awwb> <Has_accepted_use> "Pancreatic_NET" .
<Bevacizumab-awwb> <Has_accepted_use> "Ovarian_cancer" .
<Bevacizumab-awwb> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Bevacizumab-awwb> <Has_accepted_use> "Neuroendocrine_tumor" .
<Bevacizumab-awwb> <Has_accepted_use> "Mesothelioma" .
<Bevacizumab-awwb> <Has_accepted_use> "Melanoma" .
<Bevacizumab-awwb> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Bevacizumab-awwb> <Has_accepted_use> "Glioblastoma" .
<Bevacizumab-awwb> <Has_accepted_use> "Follicular_lymphoma" .
<Bevacizumab-awwb> <Has_accepted_use> "Esophageal_cancer" .
<Bevacizumab-awwb> <Has_accepted_use> "Endometrial_cancer" .
<Bevacizumab-awwb> <Has_accepted_use> "Colon_cancer" .
<Bevacizumab-awwb> <Has_accepted_use> "Cholangiocarcinoma" .
<Bevacizumab-awwb> <Has_accepted_use> "Cervical_cancer" .
<Bevacizumab-awwb> <Has_accepted_use> "Breast_cancer" .
<Bevacizumab-awwb> <Has_accepted_use> "Anaplastic_glioma" .
<Bevacizumab-awwb> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<PUVA> <Mapped_from> "PUVA" .
<BEP> <Has_modality> "Chemotherapy" .
<Novgos> <Brand_name_of> "Goserelin" .
<Gemcitabine_and_nab-Paclitaxel> <Is_current_in> "Pancreatic_cancer" .
<Gemcitabine_and_nab-Paclitaxel> <Is_current_in> "Cholangiocarcinoma" .
<T-DM1_and_ET> <Has_antineoplastic> "Tamoxifen" .
<T-DM1_and_ET> <Has_antineoplastic> "GnRH_agonists" .
<T-DM1_and_ET> <Has_antineoplastic> "Aromatase_inhibitors" .
<T-DM1_and_ET> <Has_antineoplastic> "Ado-trastuzumab_emtansine" .
<Axitinib_and_Pembrolizumab> <Has_context> "Non-curative_first-line_therapy" .
<MOF> <Is_historical_in> "Colon_cancer" .
<CHOP_Modified> <Mapped_from> "CHOP_Modified" .
<Anti-Factor_IXa_antibody> <Subsumes> "Emicizumab" .
<Dalteparin_monotherapy> <Has_modality> "Anticoagulation" .
<Temsirolimus_and_Rituximab> <Is_a> "Rituximab-containing_regimen" .
<Cyclophosphamide,_Dacarbazine,_Vincristine> <Mapped_from> "Cyclophosphamide,_Dacarbazine,_Vincristine" .
<Elo-Rd> <Has_antineoplastic> "Lenalidomide" .
<Elo-Rd> <Has_antineoplastic> "Elotuzumab" .
<Elo-Rd> <Has_antineoplastic> "Dexamethasone" .
<FOLFIRI_(L-Leucovorin)> <Has_accepted_use> "Colon_cancer" .
<STAMP-I> <Has_antineoplastic> "Cyclophosphamide" .
<STAMP-I> <Has_antineoplastic> "Cisplatin" .
<STAMP-I> <Has_antineoplastic> "Carmustine" .
<CBV,_then_auto_HSCT> <Has_antineoplastic> "Rituximab" .
<CBV,_then_auto_HSCT> <Has_antineoplastic> "Prednisone" .
<CBV,_then_auto_HSCT> <Has_antineoplastic> "Etoposide" .
<CBV,_then_auto_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<CBV,_then_auto_HSCT> <Has_antineoplastic> "Carmustine" .
<DCF> <Is_current_in> "SCC_of_unknown_primary" .
<DCF> <Is_current_in> "Penile_cancer" .
<DCF> <Is_current_in> "Nasopharyngeal_carcinoma" .
<DCF> <Is_current_in> "Head_and_neck_cancer" .
<DCF> <Is_current_in> "Gastric_cancer" .
<Melphalan,_then_auto_HSCT> <Mapped_from> "Melphalan,_then_auto_HSCT" .
<GEMOX-B> <Has_modality> "Chemotherapy" .
<Zanubrutinib_monotherapy> <Mapped_from> "Zanubrutinib_monotherapy" .
<TACE> <Has_antineoplastic> "Mitomycin" .
<TACE> <Has_antineoplastic> "Epirubicin" .
<TACE> <Has_antineoplastic> "Doxorubicin" .
<TACE> <Has_antineoplastic> "Carboplatin" .
<IE> <Maps_to> "IE" .
<CAV> <Mapped_from> "CAV" .
<Enzalutamide> <Antineoplastic_of> "Enzalutamide_monotherapy" .
<Enzalutamide> <Antineoplastic_of> "ADT_and_Enzalutamide" .
<Tisagenlecleucel_monotherapy> <Has_antineoplastic> "Tisagenlecleucel" .
<Tisagenlecleucel_monotherapy> <Has_antineoplastic> "Fludarabine" .
<Tisagenlecleucel_monotherapy> <Has_antineoplastic> "Cyclophosphamide" .
<Tisagenlecleucel_monotherapy> <Has_antineoplastic> "Bendamustine" .
<DICE> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Fluorouracil_and_Folinic_acid> <Maps_to> "Fluorouracil_and_Folinic_acid" .
<Idelalisib> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Idelalisib> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Idelalisib> <Has_accepted_use> "Follicular_lymphoma" .
<Idelalisib> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Thalidomide_and_Prednisolone> <Maps_to> "Thalidomide_and_Prednisolone" .
<Afpred_Forte-Dexa> <Brand_name_of> "Dexamethasone" .
<FAC> <Has_supportive_med> "Lenograstim" .
<FAC> <Has_supportive_med> "Filgrastim" .
<FAC> <Has_supportive_med> "Ciprofloxacin" .
<Cisplatin_and_Gemcitabine> <Has_modality> "Chemotherapy" .
<CVAP> <Has_modality> "Hormonotherapy" .
<CVAP> <Has_modality> "Chemotherapy" .
<Levaquin> <Brand_name_of> "Levofloxacin" .
<CHOEP-21> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<DeVIC_and_RT> <Is_current_in> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<SMO_or_PTCH-1_(Hedgehog)_medication> <Subsumes> "Vismodegib" .
<Cisplatin,_Fluorouracil,_Pembrolizumab> <Has_antineoplastic> "Pembrolizumab" .
<Cisplatin,_Fluorouracil,_Pembrolizumab> <Has_antineoplastic> "Fluorouracil" .
<Cisplatin,_Fluorouracil,_Pembrolizumab> <Has_antineoplastic> "Cisplatin" .
<Doxycycline_monotherapy> <Has_antineoplastic> "Doxycycline" .
<Tacrolimus> <Has_brand_name> "Prograf" .
<Tacrolimus> <Has_brand_name> "Advagraf" .
<Mesolone> <Brand_name_of> "Methylprednisolone" .
<Epogen> <Brand_name_of> "Epoetin_alfa" .
<Cisplatin_and_Vindesine> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Selinexor_and_Dexamethasone> <Has_antineoplastic> "Selinexor" .
<Selinexor_and_Dexamethasone> <Has_antineoplastic> "Dexamethasone" .
<R-CHOP-14> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<CVP_(Prednisolone)> <Has_modality> "Chemotherapy" .
<Cobimetinib_monotherapy> <Maps_to> "Cobimetinib_monotherapy" .
<Interferon_alfa-2c_monotherapy> <Has_modality> "Immunotherapy" .
<Carboplatin_and_Etoposide,_then_auto_HSCT> <Has_accepted_use> "Testicular_cancer" .
<Hepirax> <Brand_name_of> "Acyclovir" .
<Dexasine> <Brand_name_of> "Dexamethasone" .
<Sulfonamide> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<O-DHAP> <Has_antineoplastic> "Ofatumumab" .
<O-DHAP> <Has_antineoplastic> "Dexamethasone" .
<O-DHAP> <Has_antineoplastic> "Cytarabine" .
<O-DHAP> <Has_antineoplastic> "Cisplatin" .
<Panasol-S> <Brand_name_of> "Prednisone" .
<Thrombotic_thrombocytopenic_purpura> <Current_treated_by> "Vincristine_monotherapy" .
<Thrombotic_thrombocytopenic_purpura> <Current_treated_by> "Rituximab_monotherapy" .
<Thrombotic_thrombocytopenic_purpura> <Current_treated_by> "Plasma_exchange" .
<Thrombotic_thrombocytopenic_purpura> <Current_treated_by> "Methylprednisolone_monotherapy" .
<Thrombotic_thrombocytopenic_purpura> <Current_treated_by> "Caplacizumab_and_Plasma_exchange" .
<Onda> <Brand_name_of> "Ondansetron" .
<mFOLFOX6_and_RT> <Mapped_from> "mFOLFOX6_and_RT" .
<Vandetanib> <Antineoplastic_of> "Vandetanib_monotherapy" .
<Vandetanib> <Antineoplastic_of> "Docetaxel_and_Vandetanib" .
<Carboplatin_and_Doxorubicin_liposomal> <Has_modality> "Chemotherapy" .
<Indomethacin> <May_have_route> "Topical" .
<Indomethacin> <May_have_route> "Rectal" .
<Indomethacin> <May_have_route> "Oral" .
<Indomethacin> <May_have_route> "Intravenous" .
<CLAG> <Has_antineoplastic> "Cytarabine" .
<CLAG> <Has_antineoplastic> "Cladribine" .
<Cytarabine,_Idarubicin,_Vorinostat> <Has_context> "Consolidation_after_upfront_therapy" .
<Goserelin> <Has_accepted_use> "Prostate_cancer" .
<Goserelin> <Has_accepted_use> "Breast_cancer" .
<DCTER> <Is_a> "Anthracycline-containing_regimen" .
<Estradiol_monotherapy> <Maps_to> "Estradiol_monotherapy" .
<Aspirin_and_Anagrelide> <Has_supportive_med> "Aspirin" .
<Aspirin_and_Anagrelide> <Has_supportive_med> "Anagrelide" .
<Fondaparinux_monotherapy> <Has_supportive_med> "Fondaparinux" .
<Balkatrine> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<7_plus_3m> <Maps_to> "7_plus_3m" .
<Mortin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Axicabtagene_ciloleucel_monotherapy> <Mapped_from> "Axicabtagene_ciloleucel_monotherapy" .
<Crizotinib_monotherapy> <Has_modality> "Chemotherapy" .
<Altretamine_monotherapy> <Mapped_from> "Altretamine_monotherapy" .
<D-Blastin> <Brand_name_of> "Daunorubicin" .
<DexaBEAM_and_G-CSF> <Mapped_from> "DexaBEAM_and_G-CSF" .
<Capecitabine_and_Paclitaxel> <Has_context> "Non-curative_first-line_therapy" .
<ACH> <Maps_to> "ACH" .
<Anticoag> <Brand_name_of> "Warfarin" .
<Azacitidine_and_Gemtuzumab_ozogamicin> <Has_antineoplastic> "Gemtuzumab_ozogamicin" .
<Azacitidine_and_Gemtuzumab_ozogamicin> <Has_antineoplastic> "Azacitidine" .
<Urtium> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<R-BEAM> <Maps_to> "R-BEAM" .
<Enzalutamide_monotherapy> <Mapped_from> "Enzalutamide_monotherapy" .
<BRAF-mutated_Colon_cancer> <Accepted_use_of> "Irinotecan,_Vemurafenib,_Cetuximab" .
<BRAF-mutated_Colon_cancer> <Accepted_use_of> "Dabrafenib,_Trametinib,_Panitumumab" .
<BRAF-mutated_Colon_cancer> <Accepted_use_of> "Binimetinib,_Encorafenib,_Cetuximab" .
<Fluorouracil_and_Levamisole> <Has_modality> "Immunotherapy" .
<Fluorouracil_and_Levamisole> <Has_modality> "Chemotherapy" .
<Omeprazole> <Antineoplastic_of> "Helicobacter_pylori_eradication_therapy" .
<KTD> <Has_antineoplastic> "Thalidomide" .
<KTD> <Has_antineoplastic> "Dexamethasone" .
<KTD> <Has_antineoplastic> "Carfilzomib" .
<Dara-PD> <Has_modality> "Chemotherapy" .
<Venetoclax_monotherapy> <Mapped_from> "Venetoclax_monotherapy" .
<TCH_(Taxotere,_Carboplatin)> <Has_modality> "Chemotherapy" .
<Medicofolin> <Brand_name_of> "Folinic_acid" .
<Famotidine> <Supportive_med_of> "ddAC-T" .
<Famotidine> <Supportive_med_of> "TIP" .
<Famotidine> <Supportive_med_of> "SMILE" .
<Famotidine> <Supportive_med_of> "Paclitaxel_monotherapy" .
<Famotidine> <Supportive_med_of> "High-dose_Interleukin-2" .
<Famotidine> <Supportive_med_of> "CaRD" .
<Eribulin> <Has_FDA_indication> "Liposarcoma" .
<Eribulin> <Has_FDA_indication> "Breast_cancer" .
<Cisplatin_and_Vinblastine> <Has_modality> "Chemotherapy" .
<mFOLFOX7> <Has_accepted_use> "Colon_cancer" .
<OLF> <Is_current_in> "Pancreatic_cancer" .
<OLF> <Is_current_in> "Gastric_cancer" .
<Prednisone_and_Rituximab> <Mapped_from> "Prednisone_and_Rituximab" .
<Cisplatin,_Doxorubicin,_Paclitaxel> <Has_context> "Non-curative_therapy" .
<Non-curative_second-line_induction_therapy> <Maps_to> "Non-curative_second-line_induction_therapy" .
<Arsenic_trioxide,_then_ATRA_and_Daunorubicin> <Has_antineoplastic> "Daunorubicin" .
<Arsenic_trioxide,_then_ATRA_and_Daunorubicin> <Has_antineoplastic> "Arsenic_trioxide" .
<Arsenic_trioxide,_then_ATRA_and_Daunorubicin> <Has_antineoplastic> "All-trans_retinoic_acid" .
<VAP> <Is_a> "Anthracycline-containing_regimen" .
<Aminopterin_monotherapy> <Mapped_from> "Aminopterin_monotherapy" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine> <Is_current_in> "T-cell_acute_lymphoblastic_leukemia" .
<Terost> <Brand_name_of> "Alendronate" .
<CMC> <Has_modality> "Chemotherapy" .
<Geniol_SC_SIN_Cafeina> <Brand_name_of> "Aspirin" .
<Capecitabine_and_Temozolomide> <Has_antineoplastic> "Temozolomide" .
<Capecitabine_and_Temozolomide> <Has_antineoplastic> "Capecitabine" .
<Arsenic_trioxide,_then_ATRA_and_Daunorubicin> <Is_current_in> "Acute_promyelocytic_leukemia" .
<Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b> <Mapped_from> "Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b" .
<Moxetumomab_pasudotox_monotherapy> <Has_modality> "Chemotherapy" .
<BFR,_then_allo_HSCT> <Is_a> "Rituximab-containing_regimen" .
<Arsenic_trioxide_and_Chlorambucil> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Bicalutamide_and_Leuprolide> <Maps_to> "Bicalutamide_and_Leuprolide" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine> <Has_supportive_med> "Mesna" .
<Diethylstilbestrol> <Is_a> "Endocrine_therapeutic" .
<Diethylstilbestrol> <Is_a> "Discontinued_drug" .
<R-FM> <Has_context> "Non-curative_first-line_therapy" .
<Antifol> <Brand_name_of> "Pemetrexed" .
<RhIG_monotherapy> <Has_accepted_use> "Immune_thrombocytopenia" .
<Hydroxyurea> <Supportive_med_of> "Decitabine_monotherapy" .
<Hydroxyurea> <Supportive_med_of> "Azacitidine_and_Sorafenib" .
<Hydroxyurea> <Supportive_med_of> "Azacitidine_and_Gemtuzumab_ozogamicin" .
<Hydroxyurea> <Supportive_med_of> "Arsenic_trioxide_and_ATRA" .
<Hydroxyurea> <Supportive_med_of> "7_plus_3d_and_Midostaurin" .
<Docistin> <Brand_name_of> "Cisplatin" .
<Tisplal> <Brand_name_of> "Cisplatin" .
<Tamibarotene> <Is_a> "Retinoid" .
<Tamibarotene> <Is_a> "PMDA_approved_drug" .
<CX_and_Trastuzumab> <Is_current_in> "Gastric_cancer" .
<CX_and_Trastuzumab> <Is_current_in> "Esophageal_cancer" .
<7_plus_3i_and_Vorinostat> <Is_a> "Anthracycline-containing_regimen" .
<Fluorouracil/Fluorouracil_and_RT> <Has_modality> "Radiotherapy" .
<Fluorouracil/Fluorouracil_and_RT> <Has_modality> "Chemotherapy" .
<Cobimetinib_and_Vemurafenib> <Has_antineoplastic> "Vemurafenib" .
<Cobimetinib_and_Vemurafenib> <Has_antineoplastic> "Cobimetinib" .
<ADT,_Docetaxel,_Estramustine> <Has_antineoplastic> "Nonsteroidal_androgen_receptor_inhibitors" .
<ADT,_Docetaxel,_Estramustine> <Has_antineoplastic> "GnRH_agonists" .
<ADT,_Docetaxel,_Estramustine> <Has_antineoplastic> "Estramustine" .
<ADT,_Docetaxel,_Estramustine> <Has_antineoplastic> "Endocrine_ablation_surgery" .
<ADT,_Docetaxel,_Estramustine> <Has_antineoplastic> "Docetaxel" .
<Danasone> <Brand_name_of> "Dexamethasone" .
<Giotrif> <Brand_name_of> "Afatinib" .
<Capecitabine,_Pertuzumab,_Trastuzumab> <Mapped_from> "Capecitabine,_Pertuzumab,_Trastuzumab" .
<Klonopin> <Brand_name_of> "Clonazepam" .
<mFOLFOX7_(L-Leucovorin)> <Has_context> "Non-curative_first-line_therapy" .
<Biomox> <Brand_name_of> "Amoxicillin" .
<Blinatumomab> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Blinatumomab> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<LOPP> <Has_accepted_use> "Hodgkin_lymphoma" .
<Kogenate> <Brand_name_of> "Factor_VIII_recombinant" .
<Vinblastine_and_Prednisone> <Has_antineoplastic> "Vinblastine" .
<Vinblastine_and_Prednisone> <Has_antineoplastic> "Prednisone" .
<AC> <Mapped_from> "AC" .
<Doxorubicin_and_Strontium-89> <Has_context> "Non-curative_therapy" .
<MVP_(Vinblastine)> <Has_antineoplastic> "Vinblastine" .
<MVP_(Vinblastine)> <Has_antineoplastic> "Mitomycin" .
<MVP_(Vinblastine)> <Has_antineoplastic> "Cisplatin" .
<Letus> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Radium-223_monotherapy> <Has_modality> "Radiotherapy" .
<Cisplatin_and_Cyclophosphamide> <Has_modality> "Chemotherapy" .
<Aromatase_inhibitor> <Subsumes> "Letrozole" .
<Aromatase_inhibitor> <Subsumes> "Exemestane" .
<Aromatase_inhibitor> <Subsumes> "Anastrozole" .
<Aromatase_inhibitor> <Subsumes> "Aminoglutethimide" .
<Trozolite> <Brand_name_of> "Anastrozole" .
<Carboplatin,_Fluorouracil,_Cetuximab,_RT> <Mapped_from> "Carboplatin,_Fluorouracil,_Cetuximab,_RT" .
<MP_(Prednisolone)> <Has_context> "Non-curative_first-line_therapy" .
<Lesol> <Brand_name_of> "Methylprednisolone" .
<Axitinib> <Has_FDA_indication> "Renal_cell_carcinoma" .
<Cisplatin_and_Gemcitabine/Erlotinib> <Mapped_from> "Cisplatin_and_Gemcitabine/Erlotinib" .
<BeEAM> <Has_context> "All_lines_of_therapy" .
<Augmented_BFM_consolidation> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Folinic_acid> <Has_brand_name> "Zytofolin" .
<Folinic_acid> <Has_brand_name> "Zyofolin" .
<Folinic_acid> <Has_brand_name> "Wellcovorin" .
<Folinic_acid> <Has_brand_name> "Vorina" .
<Folinic_acid> <Has_brand_name> "Veravorin" .
<Folinic_acid> <Has_brand_name> "Tonofolin" .
<Folinic_acid> <Has_brand_name> "Tecnovorin" .
<Folinic_acid> <Has_brand_name> "Sanifolin" .
<Folinic_acid> <Has_brand_name> "Rontafor" .
<Folinic_acid> <Has_brand_name> "Ribofolin" .
<Folinic_acid> <Has_brand_name> "Resfolin" .
<Folinic_acid> <Has_brand_name> "Rescuvolin" .
<Folinic_acid> <Has_brand_name> "Reotan" .
<Folinic_acid> <Has_brand_name> "Recovorin" .
<Folinic_acid> <Has_brand_name> "Prevax" .
<Folinic_acid> <Has_brand_name> "Prefolic" .
<Folinic_acid> <Has_brand_name> "Perfolate" .
<Folinic_acid> <Has_brand_name> "Osfolato" .
<Folinic_acid> <Has_brand_name> "Osfolate" .
<Folinic_acid> <Has_brand_name> "O_Folin" .
<Folinic_acid> <Has_brand_name> "Nyrin" .
<Folinic_acid> <Has_brand_name> "Neofolin" .
<Folinic_acid> <Has_brand_name> "Medsavorina" .
<Folinic_acid> <Has_brand_name> "Medifolin" .
<Folinic_acid> <Has_brand_name> "Medicofolin" .
<Folinic_acid> <Has_brand_name> "Lovorin" .
<Folinic_acid> <Has_brand_name> "Leukovorin" .
<Folinic_acid> <Has_brand_name> "Leucovorine" .
<Folinic_acid> <Has_brand_name> "Leucovorina" .
<Folinic_acid> <Has_brand_name> "Leucovorin" .
<Folinic_acid> <Has_brand_name> "Leuconolver" .
<Folinic_acid> <Has_brand_name> "Leucocalcin" .
<Folinic_acid> <Has_brand_name> "Legifol" .
<Folinic_acid> <Has_brand_name> "Ledervorin" .
<Folinic_acid> <Has_brand_name> "Lederfoline" .
<Folinic_acid> <Has_brand_name> "Lederfolin" .
<Folinic_acid> <Has_brand_name> "Lederfolat" .
<Folinic_acid> <Has_brand_name> "Kunyrin" .
<Folinic_acid> <Has_brand_name> "Kalsiumfolinat" .
<Folinic_acid> <Has_brand_name> "Kalciumfolinat_Perivita" .
<Folinic_acid> <Has_brand_name> "Isovorin" .
<Folinic_acid> <Has_brand_name> "Ifavor" .
<Folinic_acid> <Has_brand_name> "Folmigor" .
<Folinic_acid> <Has_brand_name> "Foliplus" .
<Folinic_acid> <Has_brand_name> "Folinvit" .
<Folinic_acid> <Has_brand_name> "Folinoxan" .
<Folinic_acid> <Has_brand_name> "Folinoral" .
<Folinic_acid> <Has_brand_name> "Folinfabra" .
<Folinic_acid> <Has_brand_name> "Folinato" .
<Folinic_acid> <Has_brand_name> "Folinac" .
<Folinic_acid> <Has_brand_name> "Foliment" .
<Folinic_acid> <Has_brand_name> "Folidar" .
<Folinic_acid> <Has_brand_name> "Folidan" .
<Folinic_acid> <Has_brand_name> "Foliben" .
<Folinic_acid> <Has_brand_name> "Foli_Cell" .
<Folinic_acid> <Has_brand_name> "Folaxin" .
<Folinic_acid> <Has_brand_name> "Folaren" .
<Folinic_acid> <Has_brand_name> "Ferbon" .
<Folinic_acid> <Has_brand_name> "Fedolen" .
<Folinic_acid> <Has_brand_name> "Fayining" .
<Folinic_acid> <Has_brand_name> "Fauldleuco" .
<Folinic_acid> <Has_brand_name> "Fastovorin" .
<Folinic_acid> <Has_brand_name> "Estroquin" .
<Folinic_acid> <Has_brand_name> "Erbanfol" .
<Folinic_acid> <Has_brand_name> "Emovis" .
<Folinic_acid> <Has_brand_name> "Elvefocal" .
<Folinic_acid> <Has_brand_name> "Ecofol" .
<Folinic_acid> <Has_brand_name> "Durofolin" .
<Folinic_acid> <Has_brand_name> "Divifolin" .
<Folinic_acid> <Has_brand_name> "Degalin" .
<Folinic_acid> <Has_brand_name> "Dalisol" .
<Folinic_acid> <Has_brand_name> "Cromatonbic_Folinico" .
<Folinic_acid> <Has_brand_name> "Claro" .
<Folinic_acid> <Has_brand_name> "Citofolin" .
<Folinic_acid> <Has_brand_name> "Cehafolin" .
<Folinic_acid> <Has_brand_name> "Calinat" .
<Folinic_acid> <Has_brand_name> "Calfolin" .
<Folinic_acid> <Has_brand_name> "Calfolex" .
<Folinic_acid> <Has_brand_name> "Calcivoran" .
<Folinic_acid> <Has_brand_name> "Calciumfolinat" .
<Folinic_acid> <Has_brand_name> "Calciumfolin" .
<Folinic_acid> <Has_brand_name> "Calcium_Leucovorn" .
<Folinic_acid> <Has_brand_name> "Calcium_Leucovorin" .
<Folinic_acid> <Has_brand_name> "Calcium_Folint" .
<Folinic_acid> <Has_brand_name> "Calcium_Folinato" .
<Folinic_acid> <Has_brand_name> "Calcifolin" .
<Folinic_acid> <Has_brand_name> "Calc_Leucovorn" .
<Folinic_acid> <Has_brand_name> "Buateron" .
<Folinic_acid> <Has_brand_name> "Biovorin" .
<Folinic_acid> <Has_brand_name> "Asovorin" .
<Folinic_acid> <Has_brand_name> "Antrex" .
<ADT_and_Darolutamide> <Maps_to> "ADT_and_Darolutamide" .
<Anthracycline> <Is_a> "Chemotherapeutic" .
<Fam-trastuzumab_deruxtecan_monotherapy> <Has_modality> "Chemotherapy" .
<HPV-positive_Oropharyngeal_cancer> <Accepted_use_of> "Cisplatin_and_RT" .
<Feron> <Brand_name_of> "Interferon_alfa-2b" .
<Carboplatin_and_Etoposide,_then_auto_HSCT> <Mapped_from> "Carboplatin_and_Etoposide,_then_auto_HSCT" .
<Cobimetinib_and_Vemurafenib> <Has_accepted_use> "Melanoma" .
<Cobimetinib_and_Vemurafenib> <Has_accepted_use> "BRAF-mutated_Melanoma" .
<Zykadia> <Brand_name_of> "Ceritinib" .
<CHOEP-14> <Has_supportive_med> "Filgrastim" .
<R-CHOP_(Prednisolone)> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<R-CHOP_(Prednisolone)> <Has_accepted_use> "Mantle_cell_lymphoma" .
<R-CHOP_(Prednisolone)> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Deltacortene> <Brand_name_of> "Prednisone" .
<Crizanlizumab> <Has_FDA_indication> "Sickle_cell_anemia" .
<Flutamide_and_Goserelin> <Has_antineoplastic> "Goserelin" .
<Flutamide_and_Goserelin> <Has_antineoplastic> "Flutamide" .
<Bleomycin_and_Cisplatin> <Maps_to> "Bleomycin_and_Cisplatin" .
<Cisplatin,_Gemcitabine,_nab-Paclitaxel> <Mapped_from> "Cisplatin,_Gemcitabine,_nab-Paclitaxel" .
<PDGFR_inhibitor> <Subsumes> "Vandetanib" .
<PDGFR_inhibitor> <Subsumes> "Sunitinib" .
<PDGFR_inhibitor> <Subsumes> "Sorafenib" .
<PDGFR_inhibitor> <Subsumes> "Regorafenib" .
<PDGFR_inhibitor> <Subsumes> "Radotinib" .
<PDGFR_inhibitor> <Subsumes> "Ponatinib" .
<PDGFR_inhibitor> <Subsumes> "Pazopanib" .
<PDGFR_inhibitor> <Subsumes> "Nintedanib" .
<PDGFR_inhibitor> <Subsumes> "Nilotinib" .
<PDGFR_inhibitor> <Subsumes> "Motesanib" .
<PDGFR_inhibitor> <Subsumes> "Midostaurin" .
<PDGFR_inhibitor> <Subsumes> "Masitinib" .
<PDGFR_inhibitor> <Subsumes> "Lenvatinib" .
<PDGFR_inhibitor> <Subsumes> "Imatinib" .
<PDGFR_inhibitor> <Subsumes> "Dasatinib" .
<PDGFR_inhibitor> <Subsumes> "Crenolanib" .
<PDGFR_inhibitor> <Subsumes> "Axitinib" .
<PDGFR_inhibitor> <Subsumes> "Avapritinib" .
<PDGFR_inhibitor> <Subsumes> "Anti-PDGFR_antibody" .
<Cisplatin,_Cetuximab,_RT> <Has_accepted_use> "Head_and_neck_cancer" .
<Idarubicin> <Antineoplastic_of> "SHAI" .
<Idarubicin> <Antineoplastic_of> "Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA" .
<Idarubicin> <Antineoplastic_of> "Idarubicin,_then_Mitoxantrone,_then_Idarubicin" .
<Idarubicin> <Antineoplastic_of> "ICL" .
<Idarubicin> <Antineoplastic_of> "IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone" .
<Idarubicin> <Antineoplastic_of> "IAP" .
<Idarubicin> <Antineoplastic_of> "FLAG-Ida" .
<Idarubicin> <Antineoplastic_of> "F-SHAI" .
<Idarubicin> <Antineoplastic_of> "Cytarabine,_Idarubicin,_Vorinostat" .
<Idarubicin> <Antineoplastic_of> "Cytarabine,_Idarubicin,_Sorafenib" .
<Idarubicin> <Antineoplastic_of> "Cytarabine,_Idarubicin,_Rituximab" .
<Idarubicin> <Antineoplastic_of> "Cytarabine,_Idarubicin,_Imatinib" .
<Idarubicin> <Antineoplastic_of> "Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA" .
<Idarubicin> <Antineoplastic_of> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA" .
<Idarubicin> <Antineoplastic_of> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine" .
<Idarubicin> <Antineoplastic_of> "Cytarabine_and_Idarubicin" .
<Idarubicin> <Antineoplastic_of> "Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone" .
<Idarubicin> <Antineoplastic_of> "CIA" .
<Idarubicin> <Antineoplastic_of> "Arsenic_trioxide,_ATRA,_Idarubicin" .
<Idarubicin> <Antineoplastic_of> "Arsenic_trioxide_and_Idarubicin" .
<Idarubicin> <Antineoplastic_of> "ATRA,_Cytarabine,_Idarubicin" .
<Idarubicin> <Antineoplastic_of> "ATRA_and_Idarubicin" .
<Idarubicin> <Antineoplastic_of> "AIE" .
<Idarubicin> <Antineoplastic_of> "7_plus_5i" .
<Idarubicin> <Antineoplastic_of> "7_plus_3i_and_Vorinostat" .
<Idarubicin> <Antineoplastic_of> "7_plus_3i_and_Sorafenib" .
<Idarubicin> <Antineoplastic_of> "7_plus_3i_and_Panobinostat" .
<Idarubicin> <Antineoplastic_of> "7_plus_3i" .
<Idarubicin> <Antineoplastic_of> "5_plus_3i" .
<DTPACE> <Has_modality> "Chemotherapy" .
<Nasopharyngeal_carcinoma> <Current_treated_by> "Radiation_therapy" .
<Nasopharyngeal_carcinoma> <Current_treated_by> "Oxaliplatin_and_RT" .
<Nasopharyngeal_carcinoma> <Current_treated_by> "Observation" .
<Nasopharyngeal_carcinoma> <Current_treated_by> "No_induction" .
<Nasopharyngeal_carcinoma> <Current_treated_by> "Gemcitabine_monotherapy" .
<Nasopharyngeal_carcinoma> <Current_treated_by> "DCF" .
<Nasopharyngeal_carcinoma> <Current_treated_by> "Cisplatin,_Fluorouracil,_RT" .
<Nasopharyngeal_carcinoma> <Current_treated_by> "Cisplatin_and_RT" .
<Nasopharyngeal_carcinoma> <Current_treated_by> "Cisplatin_and_Gemcitabine" .
<Nasopharyngeal_carcinoma> <Current_treated_by> "Cisplatin_and_Fluorouracil" .
<Nasopharyngeal_carcinoma> <Current_treated_by> "Cisplatin_and_Epirubicin" .
<Nasopharyngeal_carcinoma> <Current_treated_by> "Carboplatin_and_RT" .
<Nasopharyngeal_carcinoma> <Current_treated_by> "Carboplatin_and_Fluorouracil" .
<Adriacin> <Brand_name_of> "Doxorubicin" .
<Binimetinib_monotherapy> <Has_antineoplastic> "Binimetinib" .
<Gemtuzumab_ozogamicin_monotherapy> <Has_modality> "Chemotherapy" .
<Panobinostat_and_Rituximab> <Maps_to> "Panobinostat_and_Rituximab" .
<ABDIC> <Mapped_from> "ABDIC" .
<Dacogen> <Brand_name_of> "Decitabine" .
<Interferon_alfa-2a_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Interferon_alfa-2a_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Interferon_alfa-2a_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Interferon_alfa-2a_monotherapy> <Has_context> "All_lines_of_therapy" .
<Interferon_alfa-2a_monotherapy> <Has_context> "Adjuvant_therapy" .
<Vinblastine_monotherapy> <Is_historical_in> "Renal_cell_carcinoma" .
<Vinblastine_monotherapy> <Is_historical_in> "Prostate_cancer" .
<Vinblastine_monotherapy> <Is_historical_in> "Hodgkin_lymphoma" .
<Melphalan_and_Methylprednisolone,_then_auto_HSCT> <Maps_to> "Melphalan_and_Methylprednisolone,_then_auto_HSCT" .
<Lutathera> <Brand_name_of> "Lutetium_Lu_177_dotatate" .
<Antihistamines> <Supportive_med_of> "Temsirolimus_monotherapy" .
<Antihistamines> <Supportive_med_of> "Sipuleucel-T_monotherapy" .
<Antihistamines> <Supportive_med_of> "Samarium-153_monotherapy" .
<Antihistamines> <Supportive_med_of> "Ofatumumab_monotherapy" .
<Antihistamines> <Supportive_med_of> "Obinutuzumab_monotherapy" .
<Antihistamines> <Supportive_med_of> "Irinotecan_and_Cetuximab" .
<Antihistamines> <Supportive_med_of> "G-FC" .
<Antihistamines> <Supportive_med_of> "Dara-PD" .
<Antihistamines> <Supportive_med_of> "Cladribine_monotherapy" .
<Antihistamines> <Supportive_med_of> "Cladribine_and_Rituximab" .
<Antihistamines> <Supportive_med_of> "Chlorambucil_and_Ofatumumab" .
<Antihistamines> <Supportive_med_of> "Cetuximab_monotherapy" .
<Antihistamines> <Supportive_med_of> "Carboplatin,_Docetaxel,_Prednisone" .
<Antihistamines> <Supportive_med_of> "Carboplatin_and_Docetaxel" .
<Antihistamines> <Supportive_med_of> "Cabazitaxel_and_Prednisone" .
<Antihistamines> <Supportive_med_of> "Bendamustine_and_Obinutuzumab" .
<Antihistamines> <Supportive_med_of> "Avelumab_monotherapy" .
<Atovaquone> <Is_a> "PCP_prophylaxis" .
<EIA> <Has_antineoplastic> "Ifosfamide" .
<EIA> <Has_antineoplastic> "Etoposide" .
<EIA> <Has_antineoplastic> "Doxorubicin" .
<Antiplatelet_agent> <Is_a> "Supportive_medication" .
<Gefitec> <Brand_name_of> "Gefitinib" .
<Bu/TT> <Maps_to> "Bu/TT" .
<Multiple_myeloma> <Is_a> "Plasma_cell_dyscrasia" .
<Carfilzomib_monotherapy> <Has_accepted_use> "Multiple_myeloma" .
<Cyclosporine,_Methotrexate,_Methylprednisolone> <Mapped_from> "Cyclosporine,_Methotrexate,_Methylprednisolone" .
<Cisplatin_and_Raltitrexed> <Has_accepted_use> "Mesothelioma" .
<BDR> <Mapped_from> "BDR" .
<R-ICE> <Has_supportive_med> "Mesna" .
<R-ICE> <Has_supportive_med> "Filgrastim" .
<R-ICE> <Has_supportive_med> "Diphenhydramine" .
<R-ICE> <Has_supportive_med> "Acetaminophen" .
<VABE> <Is_a> "Anthracycline-containing_regimen" .
<Doxorubicin_and_Ifosfamide> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Zoviax> <Brand_name_of> "Acyclovir" .
<Rolapitant> <May_have_route> "Oral" .
<Rolapitant> <May_have_route> "Intravenous" .
<nab-Paclitaxel_and_Atezolizumab> <Mapped_from> "nab-Paclitaxel_and_Atezolizumab" .
<R-M-CHOP> <Is_current_in> "Mantle_cell_lymphoma" .
<Paclitaxel_and_S-1> <Has_accepted_use> "Gastric_cancer" .
<ABCM> <Maps_to> "ABCM" .
<CCOP> <Has_context> "Induction_therapy" .
<Lansoprazole> <Supportive_med_of> "TD" .
<Lansoprazole> <Supportive_med_of> "Rd" .
<Lansoprazole> <Supportive_med_of> "KRd" .
<ECF> <Has_antineoplastic> "Fluorouracil" .
<ECF> <Has_antineoplastic> "Epirubicin" .
<ECF> <Has_antineoplastic> "Cisplatin" .
<Fludarabine> <May_have_route> "Oral" .
<Fludarabine> <May_have_route> "Intravenous" .
<Platicis> <Brand_name_of> "Cisplatin" .
<Novactil> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bonaplatin> <Brand_name_of> "Carboplatin" .
<ChlVPP/EVA> <Has_antineoplastic> "Vincristine" .
<ChlVPP/EVA> <Has_antineoplastic> "Vinblastine" .
<ChlVPP/EVA> <Has_antineoplastic> "Procarbazine" .
<ChlVPP/EVA> <Has_antineoplastic> "Prednisolone" .
<ChlVPP/EVA> <Has_antineoplastic> "Etoposide" .
<ChlVPP/EVA> <Has_antineoplastic> "Doxorubicin" .
<ChlVPP/EVA> <Has_antineoplastic> "Chlorambucil" .
<Aliot> <Brand_name_of> "Alendronate" .
<Cagin> <Brand_name_of> "Caspofungin" .
<Trixzol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<R-BEAM,_then_auto_HSCT> <Has_accepted_use> "Mantle_cell_lymphoma" .
<R-BEAM,_then_auto_HSCT> <Has_accepted_use> "Follicular_lymphoma" .
<R-BEAM,_then_auto_HSCT> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<R-IFE> <Maps_to> "R-IFE" .
<Gemcitabine_and_nab-Paclitaxel> <Has_accepted_use> "Pancreatic_cancer" .
<Gemcitabine_and_nab-Paclitaxel> <Has_accepted_use> "Cholangiocarcinoma" .
<No_induction> <Has_modality> "Null_therapy" .
<Carboplatin_and_Fluorouracil> <Is_current_in> "Nasopharyngeal_carcinoma" .
<Carboplatin_and_Fluorouracil> <Is_current_in> "Head_and_neck_cancer" .
<ATG_(Rabbit)_and_Cyclosporine> <Has_immunosuppressor> "Cyclosporines" .
<ATG_(Rabbit)_and_Cyclosporine> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<Subcutaneous> <May_be_route_of> "Unfractionated_heparin" .
<Subcutaneous> <May_be_route_of> "Trastuzumab_and_hyaluronidase" .
<Subcutaneous> <May_be_route_of> "Tinzaparin" .
<Subcutaneous> <May_be_route_of> "Tbo-filgrastim" .
<Subcutaneous> <May_be_route_of> "Semuloparin" .
<Subcutaneous> <May_be_route_of> "Sargramostim" .
<Subcutaneous> <May_be_route_of> "Ropeginterferon_alfa-2b" .
<Subcutaneous> <May_be_route_of> "Rituximab_and_hyaluronidase_human" .
<Subcutaneous> <May_be_route_of> "Plerixafor" .
<Subcutaneous> <May_be_route_of> "Phytonadione" .
<Subcutaneous> <May_be_route_of> "Peginterferon_alfa-2b" .
<Subcutaneous> <May_be_route_of> "Peginterferon_alfa-2a" .
<Subcutaneous> <May_be_route_of> "Pegfilgrastim-jmdb" .
<Subcutaneous> <May_be_route_of> "Pegfilgrastim-cbqv" .
<Subcutaneous> <May_be_route_of> "Pegfilgrastim" .
<Subcutaneous> <May_be_route_of> "Omacetaxine" .
<Subcutaneous> <May_be_route_of> "Octreotide" .
<Subcutaneous> <May_be_route_of> "Nadroparin" .
<Subcutaneous> <May_be_route_of> "Methotrexate" .
<Subcutaneous> <May_be_route_of> "Medroxyprogesterone" .
<Subcutaneous> <May_be_route_of> "Luspatercept" .
<Subcutaneous> <May_be_route_of> "Lipefilgrastim" .
<Subcutaneous> <May_be_route_of> "Lenograstim" .
<Subcutaneous> <May_be_route_of> "Lanreotide" .
<Subcutaneous> <May_be_route_of> "Interferon_gamma-1b" .
<Subcutaneous> <May_be_route_of> "Interferon_alfa-2b" .
<Subcutaneous> <May_be_route_of> "Interferon_alfa-2a" .
<Subcutaneous> <May_be_route_of> "Histrelin" .
<Subcutaneous> <May_be_route_of> "Granisetron" .
<Subcutaneous> <May_be_route_of> "Goserelin" .
<Subcutaneous> <May_be_route_of> "Fondaparinux" .
<Subcutaneous> <May_be_route_of> "Filgrastim-sndz" .
<Subcutaneous> <May_be_route_of> "Filgrastim" .
<Subcutaneous> <May_be_route_of> "Epoetin_alfa" .
<Subcutaneous> <May_be_route_of> "Enoxaparin" .
<Subcutaneous> <May_be_route_of> "Emicizumab" .
<Subcutaneous> <May_be_route_of> "Desmopressin" .
<Subcutaneous> <May_be_route_of> "Degarelix" .
<Subcutaneous> <May_be_route_of> "Deferoxamine" .
<Subcutaneous> <May_be_route_of> "Darbepoetin_alfa" .
<Subcutaneous> <May_be_route_of> "Danaparoid" .
<Subcutaneous> <May_be_route_of> "Dalteparin" .
<Subcutaneous> <May_be_route_of> "Cytarabine" .
<Subcutaneous> <May_be_route_of> "Cyanocobalamin" .
<Subcutaneous> <May_be_route_of> "Cladribine" .
<Subcutaneous> <May_be_route_of> "Bortezomib" .
<Subcutaneous> <May_be_route_of> "Bleomycin" .
<Subcutaneous> <May_be_route_of> "Azacitidine" .
<Subcutaneous> <May_be_route_of> "Asparaginase" .
<Cyclophosphamide,_Mycophenolate_mofetil,_Tacrolimus> <Has_context> "Prophylaxis" .
<Custirsen> <May_have_route> "Intravenous" .
<Carboplatin_and_Fluorouracil> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<Carboplatin_and_Fluorouracil> <Has_accepted_use> "Head_and_neck_cancer" .
<Imatinib_and_Prednisone> <Mapped_from> "Imatinib_and_Prednisone" .
<Dexamethasone_and_WBRT> <Has_modality> "Radiotherapy" .
<Valacyclovir> <Is_a> "DNA_synthesis_inhibitor" .
<Valacyclovir> <Is_a> "Antiviral" .
<M-EI> <Maps_to> "M-EI" .
<Epoetin_alfa> <Supportive_med_of> "ddEC" .
<Epoetin_alfa> <Supportive_med_of> "R-CDOP" .
<Epoetin_alfa> <Supportive_med_of> "Omacetaxine_monotherapy" .
<Epoetin_alfa> <Supportive_med_of> "Erythropoietin_monotherapy" .
<Epoetin_alfa> <Supportive_med_of> "Erythropoetin_and_Lenalidomide" .
<R-CHOP-14_(Prednisolone)> <Has_modality> "Chemotherapy" .
<Fondaparinux_monotherapy> <Is_current_in> "Venous_thromboembolism" .
<Fondaparinux_monotherapy> <Is_current_in> "Heparin-induced_thrombocytopenia" .
<Bitrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<P/DOCE> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Hepatic_arterial_chemotherapy> <Maps_to> "Hepatic_arterial_chemotherapy" .
<Megestrol_and_Tamoxifen> <Has_accepted_use> "Endometrial_cancer" .
<Bu/TT,_then_auto_HSCT> <Has_context> "Consolidation_after_upfront_therapy" .
<Cisplatin_and_Pemetrexed> <Has_supportive_med> "Folic_acid" .
<Cisplatin_and_Pemetrexed> <Has_supportive_med> "Dexamethasone" .
<Cisplatin_and_Pemetrexed> <Has_supportive_med> "Cyanocobalamin" .
<Ciplin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Leucin> <Brand_name_of> "Filgrastim" .
<TSC1_inhibitor> <Subsumes> "Everolimus" .
<Eribulin> <Antineoplastic_of> "Eribulin_monotherapy" .
<COPAD/CYVE> <Is_a> "Anthracycline-containing_regimen" .
<Medtrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Iribo> <Brand_name_of> "Ramosetron" .
<EBVP> <Has_antineoplastic> "Vinblastine" .
<EBVP> <Has_antineoplastic> "Prednisone" .
<EBVP> <Has_antineoplastic> "Epirubicin" .
<EBVP> <Has_antineoplastic> "Bleomycin" .
<Trametinib_monotherapy> <Is_current_in> "Melanoma" .
<Anti-CD27_antibody> <Is_a> "Antibody_medication" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Z-BEAM,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Vinorelbine_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Vincristine_and_Prednisone" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Tisagenlecleucel_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Temsirolimus_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "TTR" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "TBI,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Rituximab_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Radiation_therapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "RICER" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R2CHOP" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-miniCHOP" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-miniCEOP" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-TBI/Cy,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-NIMP" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-MegaCHOP-14" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-MegaCHOP" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-IFE" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-ICE" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-Hyper-CVAD/R-MA" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-GemOx" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-GDP" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-GCVP" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-ESHAP" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-EPOCH" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-DexaBEAM" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-DHAP/R-VIM" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-DHAP" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-DHAOx" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-CVEP" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-CHOP-14_(Rituximab_Hycela)" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-CHOP-14_(Prednisolone)" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-CHOP-14" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-CHOP_(Rituximab_Hycela)" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-CHOP_(Prednisolone)" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-CHOP" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-CHOEP-14" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-CHMP" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-CEOP90_(Epirubicin)" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-CEOP_(Etoposide)" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-CDOP" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-BL" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "R-BEAM,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Placebo" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Pixantrone_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Panobinostat_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Panobinostat_and_Rituximab" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Oxaliplatin_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Ofatumumab_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Observation" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Obinutuzumab_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "O-miniCHOP" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "O-ICE" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "O-DHAP" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Mitoxantrone_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Methotrexate_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Lenalidomide_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Lenalidomide_and_Rituximab" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "LEED,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Ifosfamide_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Ibrutinib_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Ibritumomab_tiuxetan_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Helicobacter_pylori_eradication_therapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Gemcitabine_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Gemcitabine_and_Rituximab" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "GVD" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "FluBuCy,_then_allo_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "FEAM,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Everolimus_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Everolimus_and_Rituximab" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Etoposide_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "DA-R-EPOCH" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Cytarabine_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Cyclophosphamide_and_TBI,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "CBVM,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "CBV,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Brentuximab_vedotin_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Blinatumomab_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Bendamustine_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "BeEAM,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "BR_and_Polatuzumab_vedotin" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "BR" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "BEAM,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "BEAM,_then_allo_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "BEAC,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "Axicabtagene_ciloleucel_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Current_treated_by> "ACVBP-R" .
<Denosumab> <Antineoplastic_of> "Denosumab_monotherapy" .
<Bibakrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Volasertib> <Is_a> "PLK1_inhibitor" .
<Volasertib> <Is_a> "Orphan_drug" .
<Volasertib> <Is_a> "Kinase_inhibitor" .
<Volasertib> <Is_a> "Investigational_drug" .
<VAD-P> <Has_context> "Non-curative_first-line_therapy" .
<RCC> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Lansoprazole> <May_have_route> "Oral" .
<Pemetrexed> <Has_brand_name> "Pexotra" .
<Pemetrexed> <Has_brand_name> "Pemnat" .
<Pemetrexed> <Has_brand_name> "Pemibenz" .
<Pemetrexed> <Has_brand_name> "Pemgem" .
<Pemetrexed> <Has_brand_name> "Pemex" .
<Pemetrexed> <Has_brand_name> "Pemetrex" .
<Pemetrexed> <Has_brand_name> "Pemetra" .
<Pemetrexed> <Has_brand_name> "Pemetero" .
<Pemetrexed> <Has_brand_name> "Kabipem" .
<Pemetrexed> <Has_brand_name> "Antifol" .
<Pemetrexed> <Has_brand_name> "Alimta" .
<Pri-Cortin> <Brand_name_of> "Prednisolone" .
<FEAM> <Has_modality> "Chemotherapy" .
<Interferon_alfa-2b_and_Thalidomide> <Has_modality> "Immunotherapy" .
<Interferon_alfa-2b_and_Thalidomide> <Has_modality> "Chemotherapy" .
<Erlotinib_and_Ramucirumab> <Has_context> "Non-curative_therapy" .
<Carboplatin,_Pemetrexed,_Bevacizumab> <Has_supportive_med> "Folic_acid" .
<AIE> <Has_context> "Induction_therapy" .
<Hemoglobinopathy> <Is_a> "Classical_hematologic_condition" .
<Z-BEAM,_then_auto_HSCT> <Mapped_from> "Z-BEAM,_then_auto_HSCT" .
<Hydrocortisone_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<Null_therapy> <Maps_to> "Null_therapy" .
<R-CVEP> <Has_context> "Non-curative_subsequent-line_therapy" .
<Busulfan> <May_have_route> "Oral" .
<Busulfan> <May_have_route> "Intravenous" .
<Docetaxel,_Fluorouracil,_Hydroxyurea,_RT> <Maps_to> "Docetaxel,_Fluorouracil,_Hydroxyurea,_RT" .
<Cisplatin,_Pemetrexed,_Pembrolizumab> <Mapped_from> "Cisplatin,_Pemetrexed,_Pembrolizumab" .
<Avapritinib> <Has_accepted_use> "Gastrointestinal_stromal_tumor" .
<Radiotherapy> <Modality_of> "mFOLFOX6_and_RT" .
<Radiotherapy> <Modality_of> "mFOLFIRINOX,_Gemcitabine,_RT" .
<Radiotherapy> <Modality_of> "Whole_brain_irradiation" .
<Radiotherapy> <Modality_of> "Whole_abdominal_radiation_(WAI)" .
<Radiotherapy> <Modality_of> "WBRT" .
<Radiotherapy> <Modality_of> "Teniposide_and_WBRT" .
<Radiotherapy> <Modality_of> "Temozolomide,_then_Temozolomide_and_RT,_then_Temozolomide" .
<Radiotherapy> <Modality_of> "Temozolomide_and_low-dose_RT" .
<Radiotherapy> <Modality_of> "Temozolomide_and_RT,_then_Temozolomide" .
<Radiotherapy> <Modality_of> "Temozolomide_and_RT" .
<Radiotherapy> <Modality_of> "TLI_and_ATG" .
<Radiotherapy> <Modality_of> "TBI,_then_auto_HSCT" .
<Radiotherapy> <Modality_of> "TBI" .
<Radiotherapy> <Modality_of> "TAM6,_then_auto_HSCT" .
<Radiotherapy> <Modality_of> "TAM6" .
<Radiotherapy> <Modality_of> "Samarium-153_with_stem_cell_support" .
<Radiotherapy> <Modality_of> "Samarium-153_monotherapy" .
<Radiotherapy> <Modality_of> "Radium-223_monotherapy" .
<Radiotherapy> <Modality_of> "Radioiodine_ablation" .
<Radiotherapy> <Modality_of> "Radioembolization" .
<Radiotherapy> <Modality_of> "Radiation_therapy" .
<Radiotherapy> <Modality_of> "RT,_then_Temozolomide" .
<Radiotherapy> <Modality_of> "RT,_then_Carmustine" .
<Radiotherapy> <Modality_of> "R-TBI/Cy,_then_auto_HSCT" .
<Radiotherapy> <Modality_of> "R-TBI/Cy" .
<Radiotherapy> <Modality_of> "Paclitaxel_and_RT" .
<Radiotherapy> <Modality_of> "Oxaliplatin_and_RT" .
<Radiotherapy> <Modality_of> "Nimustine_and_RT" .
<Radiotherapy> <Modality_of> "Methotrexate,_RT,_Cyclophosphamide" .
<Radiotherapy> <Modality_of> "Mercaptopurine,_Methotrexate,_WB-XRT" .
<Radiotherapy> <Modality_of> "Mercaptopurine_and_WBRT" .
<Radiotherapy> <Modality_of> "Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT" .
<Radiotherapy> <Modality_of> "Melphalan,_then_auto_HSCT,_then_Melphalan_and_TBI,_then_auto_HSCT" .
<Radiotherapy> <Modality_of> "Melphalan_and_TBI,_then_auto_HSCT" .
<Radiotherapy> <Modality_of> "Melphalan_and_TBI" .
<Radiotherapy> <Modality_of> "MVP_and_RT" .
<Radiotherapy> <Modality_of> "MESA/RT" .
<Radiotherapy> <Modality_of> "Lutetium_Lu_177_dotatate_and_Octreotide_LAR" .
<Radiotherapy> <Modality_of> "Low-dose_TBI,_then_allo_HSCT" .
<Radiotherapy> <Modality_of> "Low-dose_TBI" .
<Radiotherapy> <Modality_of> "Lomustine,_Temozolomide,_RT" .
<Radiotherapy> <Modality_of> "LVP_.22Sandwich.22" .
<Radiotherapy> <Modality_of> "Ipilimumab_and_RT" .
<Radiotherapy> <Modality_of> "IT_Methotrexate_and_WBRT" .
<Radiotherapy> <Modality_of> "IT_Cytarabine,_Methotrexate,_WBRT" .
<Radiotherapy> <Modality_of> "IT_Cytarabine_and_WBRT" .
<Radiotherapy> <Modality_of> "Hydroxyurea_and_RT" .
<Radiotherapy> <Modality_of> "Goserelin_and_RT" .
<Radiotherapy> <Modality_of> "Gemcitabine/Fluorouracil_and_RT" .
<Radiotherapy> <Modality_of> "Gemcitabine,_Cetuximab,_RT" .
<Radiotherapy> <Modality_of> "Gemcitabine_and_RT" .
<Radiotherapy> <Modality_of> "GELOX/RT" .
<Radiotherapy> <Modality_of> "Flutamide,_Leuprolide,_RT" .
<Radiotherapy> <Modality_of> "Flutamide,_Goserelin,_RT" .
<Radiotherapy> <Modality_of> "Fluorouracil/Fluorouracil_and_RT" .
<Radiotherapy> <Modality_of> "Fluorouracil,_Paclitaxel,_RT" .
<Radiotherapy> <Modality_of> "Fluorouracil,_Oxaliplatin,_RT" .
<Radiotherapy> <Modality_of> "Fluorouracil,_Mitomycin,_RT" .
<Radiotherapy> <Modality_of> "Fluorouracil,_Hydroxyurea,_RT" .
<Radiotherapy> <Modality_of> "Fluorouracil,_Folinic_acid,_RT" .
<Radiotherapy> <Modality_of> "Fluorouracil_and_RT" .
<Radiotherapy> <Modality_of> "Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant" .
<Radiotherapy> <Modality_of> "Fludarabine_and_TBI,_then_allo_HSCT" .
<Radiotherapy> <Modality_of> "Fludarabine_and_TBI" .
<Radiotherapy> <Modality_of> "FULV/FULV_and_RT" .
<Radiotherapy> <Modality_of> "FP/Capecitabine_and_RT" .
<Radiotherapy> <Modality_of> "FOLFOX4_and_RT" .
<Radiotherapy> <Modality_of> "Etoposide_and_TBI,_then_allo_HSCT" .
<Radiotherapy> <Modality_of> "Etoposide_and_TBI" .
<Radiotherapy> <Modality_of> "ECF/5-FU_and_RT" .
<Radiotherapy> <Modality_of> "Doxorubicin,_Ifosfamide,_RT" .
<Radiotherapy> <Modality_of> "Doxorubicin_and_Strontium-89" .
<Radiotherapy> <Modality_of> "Docetaxel,_Gemcitabine,_RT" .
<Radiotherapy> <Modality_of> "Docetaxel,_Fluorouracil,_RT" .
<Radiotherapy> <Modality_of> "Docetaxel,_Fluorouracil,_Hydroxyurea,_RT" .
<Radiotherapy> <Modality_of> "Docetaxel,_Cetuximab,_RT" .
<Radiotherapy> <Modality_of> "Dexamethasone_and_WBRT" .
<Radiotherapy> <Modality_of> "DeVIC_and_RT" .
<Radiotherapy> <Modality_of> "DEP_and_RT" .
<Radiotherapy> <Modality_of> "Cyclophosphamide,_Etoposide,_TBI" .
<Radiotherapy> <Modality_of> "Cyclophosphamide_and_TBI,_then_auto_HSCT" .
<Radiotherapy> <Modality_of> "Cyclophosphamide_and_TBI,_then_allo_HSCT" .
<Radiotherapy> <Modality_of> "Cyclophosphamide_and_TBI" .
<Radiotherapy> <Modality_of> "Cisplatin,_Vinorelbine,_RT" .
<Radiotherapy> <Modality_of> "Cisplatin,_Vinblastine,_RT" .
<Radiotherapy> <Modality_of> "Cisplatin,_Paclitaxel,_RT" .
<Radiotherapy> <Modality_of> "Cisplatin,_Irinotecan,_RT" .
<Radiotherapy> <Modality_of> "Cisplatin,_Gemcitabine,_RT" .
<Radiotherapy> <Modality_of> "Cisplatin,_Fluorouracil,_RT" .
<Radiotherapy> <Modality_of> "Cisplatin,_Fluorouracil,_Hydroxyurea,_RT" .
<Radiotherapy> <Modality_of> "Cisplatin,_Etoposide,_RT" .
<Radiotherapy> <Modality_of> "Cisplatin,_Docetaxel,_RT" .
<Radiotherapy> <Modality_of> "Cisplatin,_Cetuximab,_RT" .
<Radiotherapy> <Modality_of> "Cisplatin_and_RT" .
<Radiotherapy> <Modality_of> "Cetuximab_and_RT" .
<Radiotherapy> <Modality_of> "Carmustine_and_RT" .
<Radiotherapy> <Modality_of> "Carboplatin,_Vinorelbine,_RT" .
<Radiotherapy> <Modality_of> "Carboplatin,_Paclitaxel,_RT" .
<Radiotherapy> <Modality_of> "Carboplatin,_Fluorouracil,_RT" .
<Radiotherapy> <Modality_of> "Carboplatin,_Fluorouracil,_Cetuximab,_RT" .
<Radiotherapy> <Modality_of> "Carboplatin,_Etoposide,_RT" .
<Radiotherapy> <Modality_of> "Carboplatin_and_RT" .
<Radiotherapy> <Modality_of> "Capecitabine/Capecitabine_and_RT" .
<Radiotherapy> <Modality_of> "Capecitabine,_Sorafenib,_RT" .
<Radiotherapy> <Modality_of> "Capecitabine,_Paclitaxel,_RT" .
<Radiotherapy> <Modality_of> "Capecitabine,_Oxaliplatin,_RT" .
<Radiotherapy> <Modality_of> "Capecitabine,_Mitomycin,_RT" .
<Radiotherapy> <Modality_of> "Capecitabine,_Docetaxel,_RT" .
<Radiotherapy> <Modality_of> "Capecitabine,_Docetaxel,_Oxaliplatin,_RT" .
<Radiotherapy> <Modality_of> "Capecitabine,_Cisplatin,_RT" .
<Radiotherapy> <Modality_of> "Capecitabine,_Carboplatin,_Paclitaxel,_RT" .
<Radiotherapy> <Modality_of> "Capecitabine_and_RT" .
<Radiotherapy> <Modality_of> "CapeOx,_Cetuximab,_RT" .
<Radiotherapy> <Modality_of> "CEV_and_RT" .
<Radiotherapy> <Modality_of> "CC/DE_and_RT" .
<Radiotherapy> <Modality_of> "CAV_and_RT" .
<Radiotherapy> <Modality_of> "BuCyTBI,_then_allo_HSCT" .
<Radiotherapy> <Modality_of> "BuCyTBI" .
<Radiotherapy> <Modality_of> "Bleomycin,_Methotrexate,_Vinblastine/RT" .
<Radiotherapy> <Modality_of> "Bicalutamide_and_RT" .
<Radiotherapy> <Modality_of> "Bevacizumab_and_RT" .
<Radiotherapy> <Modality_of> "ADT_and_RT" .
<Radiotherapy> <Modality_of> "131I-Metaiodobenzylguanidine_(131I-MIBG)" .
<Prophylaxis> <Maps_to> "Prophylaxis" .
<Dacomitinib> <May_have_route> "Oral" .
<IT_Methotrexate_and_WBRT> <Mapped_from> "IT_Methotrexate_and_WBRT" .
<Romiplostim_monotherapy> <Is_current_in> "Immune_thrombocytopenia" .
<BEACOPP> <Mapped_from> "BEACOPP" .
<L-Asparaginase,_Vincristine,_Prednisolone> <Has_context> "Non-curative_therapy" .
<L-Asparaginase,_Vincristine,_Prednisolone> <Has_context> "Induction_therapy" .
<Cisplatin_and_Topotecan> <Maps_to> "Cisplatin_and_Topotecan" .
<Fluorouracil/Fluorouracil_and_RT> <Is_current_in> "Rectal_cancer" .
<Fluorouracil/Fluorouracil_and_RT> <Is_current_in> "Pancreatic_cancer" .
<Hydeltrasol> <Brand_name_of> "Prednisolone" .
<Clemastine> <May_have_route> "Oral" .
<Droxia> <Brand_name_of> "Hydroxyurea" .
<Rituximab-pvvr> <Has_FDA_indication> "Follicular_lymphoma" .
<Rituximab-pvvr> <Has_FDA_indication> "Diffuse_large_B-cell_lymphoma" .
<Rituximab-pvvr> <Has_FDA_indication> "Chronic_lymphocytic_leukemia" .
<Amrubicin> <May_have_route> "Intravenous" .
<R-M-CHOP> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Trametinib_monotherapy> <Has_modality> "Chemotherapy" .
<Sirolimus_monotherapy> <Is_current_in> "Castleman_disease" .
<Sirolimus_monotherapy> <Is_current_in> "Autoimmune_cytopenia" .
<Methotrexate,_Pegaspargase,_Vincristine> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Bu/TT/Cy> <Mapped_from> "Bu/TT/Cy" .
<Fulvestrant_and_Ribociclib> <Has_context> "Non-curative_subsequent-line_therapy" .
<Fulvestrant_and_Ribociclib> <Has_context> "Non-curative_first-line_therapy" .
<Trimfasul> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Econosone> <Brand_name_of> "Prednisone" .
<Citofolin> <Brand_name_of> "Folinic_acid" .
<Ferra_T.D._Caps> <Brand_name_of> "Ferrous_sulfate" .
<Busulfan_and_Cyclophosphamide,_then_allo_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<Busulfan_and_Cyclophosphamide,_then_allo_HSCT> <Has_antineoplastic> "Busulfan" .
<Busulfan_and_Cyclophosphamide,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<Dabigatran> <Supportive_med_of> "Dabigatran_monotherapy" .
<Zirabev> <Brand_name_of> "Bevacizumab-bvzr" .
<Neoadjuvant_therapy> <Context_of> "nab-Paclitaxel_monotherapy" .
<Neoadjuvant_therapy> <Context_of> "mFOLFOX6_and_RT" .
<Neoadjuvant_therapy> <Context_of> "ddAC" .
<Neoadjuvant_therapy> <Context_of> "VIDE" .
<Neoadjuvant_therapy> <Context_of> "VDC/IE" .
<Neoadjuvant_therapy> <Context_of> "VBM" .
<Neoadjuvant_therapy> <Context_of> "VAIA" .
<Neoadjuvant_therapy> <Context_of> "VACA/IE" .
<Neoadjuvant_therapy> <Context_of> "VACA" .
<Neoadjuvant_therapy> <Context_of> "Trastuzumab_monotherapy" .
<Neoadjuvant_therapy> <Context_of> "Trastuzumab_and_ET" .
<Neoadjuvant_therapy> <Context_of> "TX_(Taxotere)" .
<Neoadjuvant_therapy> <Context_of> "TL_(Taxol)" .
<Neoadjuvant_therapy> <Context_of> "TIP" .
<Neoadjuvant_therapy> <Context_of> "THP_(Taxotere)" .
<Neoadjuvant_therapy> <Context_of> "THL_(Taxol)" .
<Neoadjuvant_therapy> <Context_of> "TH_(Taxotere/SC)" .
<Neoadjuvant_therapy> <Context_of> "TH_(Taxotere)" .
<Neoadjuvant_therapy> <Context_of> "TH_(Taxol)" .
<Neoadjuvant_therapy> <Context_of> "TCHP_(Taxotere)" .
<Neoadjuvant_therapy> <Context_of> "TCHP_(Taxol)" .
<Neoadjuvant_therapy> <Context_of> "TAC_(Taxotere)" .
<Neoadjuvant_therapy> <Context_of> "T-DM1_and_ET" .
<Neoadjuvant_therapy> <Context_of> "Radiation_therapy" .
<Neoadjuvant_therapy> <Context_of> "Placebo" .
<Neoadjuvant_therapy> <Context_of> "Pembrolizumab_monotherapy" .
<Neoadjuvant_therapy> <Context_of> "Paclitaxel_monotherapy" .
<Neoadjuvant_therapy> <Context_of> "PET" .
<Neoadjuvant_therapy> <Context_of> "PAC" .
<Neoadjuvant_therapy> <Context_of> "No_neoadjuvant_therapy" .
<Neoadjuvant_therapy> <Context_of> "Neratinib_and_Paclitaxel" .
<Neoadjuvant_therapy> <Context_of> "MVAC,_dose-dense" .
<Neoadjuvant_therapy> <Context_of> "MVAC" .
<Neoadjuvant_therapy> <Context_of> "MIC" .
<Neoadjuvant_therapy> <Context_of> "MCV" .
<Neoadjuvant_therapy> <Context_of> "MAPI" .
<Neoadjuvant_therapy> <Context_of> "MAP" .
<Neoadjuvant_therapy> <Context_of> "MA-BCD" .
<Neoadjuvant_therapy> <Context_of> "MA" .
<Neoadjuvant_therapy> <Context_of> "M-EI" .
<Neoadjuvant_therapy> <Context_of> "M-BCD" .
<Neoadjuvant_therapy> <Context_of> "Letrozole_monotherapy" .
<Neoadjuvant_therapy> <Context_of> "Lapatinib_and_Trastuzumab" .
<Neoadjuvant_therapy> <Context_of> "Imatinib_monotherapy" .
<Neoadjuvant_therapy> <Context_of> "Goserelin_and_Tamoxifen" .
<Neoadjuvant_therapy> <Context_of> "Fluorouracil,_Paclitaxel,_RT" .
<Neoadjuvant_therapy> <Context_of> "Fluorouracil,_Oxaliplatin,_RT" .
<Neoadjuvant_therapy> <Context_of> "Fluorouracil,_Folinic_acid,_RT" .
<Neoadjuvant_therapy> <Context_of> "Fluorouracil_and_RT" .
<Neoadjuvant_therapy> <Context_of> "FLOT" .
<Neoadjuvant_therapy> <Context_of> "FEC_and_H_(SC)" .
<Neoadjuvant_therapy> <Context_of> "FEC_and_H" .
<Neoadjuvant_therapy> <Context_of> "FEC" .
<Neoadjuvant_therapy> <Context_of> "FAC" .
<Neoadjuvant_therapy> <Context_of> "Epirubicin_monotherapy" .
<Neoadjuvant_therapy> <Context_of> "Epirubicin_and_Ifosfamide" .
<Neoadjuvant_therapy> <Context_of> "EVAIA" .
<Neoadjuvant_therapy> <Context_of> "EP" .
<Neoadjuvant_therapy> <Context_of> "EOX" .
<Neoadjuvant_therapy> <Context_of> "EOF" .
<Neoadjuvant_therapy> <Context_of> "EIA" .
<Neoadjuvant_therapy> <Context_of> "EDC" .
<Neoadjuvant_therapy> <Context_of> "ECX" .
<Neoadjuvant_therapy> <Context_of> "ECH" .
<Neoadjuvant_therapy> <Context_of> "ECF" .
<Neoadjuvant_therapy> <Context_of> "EC_and_Bevacizumab" .
<Neoadjuvant_therapy> <Context_of> "EC" .
<Neoadjuvant_therapy> <Context_of> "Docetaxel,_Fluorouracil,_RT" .
<Neoadjuvant_therapy> <Context_of> "Docetaxel_monotherapy" .
<Neoadjuvant_therapy> <Context_of> "Docetaxel_and_Bevacizumab" .
<Neoadjuvant_therapy> <Context_of> "DI_EC" .
<Neoadjuvant_therapy> <Context_of> "DE" .
<Neoadjuvant_therapy> <Context_of> "Cisplatin,_Vinorelbine,_RT" .
<Neoadjuvant_therapy> <Context_of> "Cisplatin,_Paclitaxel,_RT" .
<Neoadjuvant_therapy> <Context_of> "Cisplatin,_Irinotecan,_RT" .
<Neoadjuvant_therapy> <Context_of> "Cisplatin,_Fluorouracil,_RT" .
<Neoadjuvant_therapy> <Context_of> "Cisplatin,_Etoposide,_RT" .
<Neoadjuvant_therapy> <Context_of> "Cisplatin,_Epirubicin,_Ifosfamide" .
<Neoadjuvant_therapy> <Context_of> "Cisplatin,_Docetaxel,_RT" .
<Neoadjuvant_therapy> <Context_of> "Cisplatin_monotherapy" .
<Neoadjuvant_therapy> <Context_of> "Cisplatin_and_RT" .
<Neoadjuvant_therapy> <Context_of> "Cisplatin_and_Paclitaxel" .
<Neoadjuvant_therapy> <Context_of> "Cisplatin_and_Gemcitabine" .
<Neoadjuvant_therapy> <Context_of> "Cisplatin_and_Fluorouracil" .
<Neoadjuvant_therapy> <Context_of> "Cisplatin_and_Doxorubicin" .
<Neoadjuvant_therapy> <Context_of> "Cisplatin_and_Docetaxel" .
<Neoadjuvant_therapy> <Context_of> "Carboplatin,_Paclitaxel,_RT" .
<Neoadjuvant_therapy> <Context_of> "Carboplatin,_Fluorouracil,_RT" .
<Neoadjuvant_therapy> <Context_of> "Carboplatin_and_nab-Paclitaxel" .
<Neoadjuvant_therapy> <Context_of> "Carboplatin_and_Paclitaxel" .
<Neoadjuvant_therapy> <Context_of> "Carboplatin_and_Docetaxel" .
<Neoadjuvant_therapy> <Context_of> "Capecitabine,_Sorafenib,_RT" .
<Neoadjuvant_therapy> <Context_of> "Capecitabine,_Paclitaxel,_RT" .
<Neoadjuvant_therapy> <Context_of> "Capecitabine,_Oxaliplatin,_RT" .
<Neoadjuvant_therapy> <Context_of> "Capecitabine,_Docetaxel,_RT" .
<Neoadjuvant_therapy> <Context_of> "Capecitabine,_Docetaxel,_Oxaliplatin,_RT" .
<Neoadjuvant_therapy> <Context_of> "Capecitabine,_Cisplatin,_RT" .
<Neoadjuvant_therapy> <Context_of> "Capecitabine,_Carboplatin,_Paclitaxel,_RT" .
<Neoadjuvant_therapy> <Context_of> "Capecitabine_and_RT" .
<Neoadjuvant_therapy> <Context_of> "CapeOx,_Cetuximab,_RT" .
<Neoadjuvant_therapy> <Context_of> "CapeOx" .
<Neoadjuvant_therapy> <Context_of> "CVAP" .
<Neoadjuvant_therapy> <Context_of> "Bleomycin_and_Cisplatin" .
<Neoadjuvant_therapy> <Context_of> "Atezolizumab_monotherapy" .
<Neoadjuvant_therapy> <Context_of> "Anastrozole_monotherapy" .
<Neoadjuvant_therapy> <Context_of> "Anastrozole_and_Palbociclib" .
<Neoadjuvant_therapy> <Context_of> "Anastrozole_and_Goserelin" .
<Neoadjuvant_therapy> <Context_of> "Ado-trastuzumab_emtansine_monotherapy" .
<Neoadjuvant_therapy> <Context_of> "AC-T" .
<Neoadjuvant_therapy> <Context_of> "AC_and_Bevacizumab" .
<Neoadjuvant_therapy> <Context_of> "AC" .
<Low-grade_glioma> <Is_a> "CNS_cancer" .
<Carboplatin,_Pemetrexed,_Pembrolizumab> <Mapped_from> "Carboplatin,_Pemetrexed,_Pembrolizumab" .
<KPD> <Mapped_from> "KPD" .
<WHO_Essential_Anti-infective_Medicine> <Is_a> "WHO_Essential_Medicine" .
<CAV> <Is_historical_in> "Small_cell_lung_cancer" .
<Cisplatin,_Fluorouracil,_Vincristine> <Mapped_from> "Cisplatin,_Fluorouracil,_Vincristine" .
<Methylprednisolone> <Immunosuppressor_of> "Methylprednisolone_monotherapy" .
<Methylprednisolone> <Immunosuppressor_of> "Cyclosporine,_Methotrexate,_Methylprednisolone" .
<Methylprednisolone> <Immunosuppressor_of> "ATG_(Horse),_Cyclosporine,_Methylprednisolone" .
<TCP> <Is_current_in> "Castleman_disease" .
<Romidepsin_monotherapy> <Maps_to> "Romidepsin_monotherapy" .
<MOR202> <Is_a> "Halted_drug" .
<MOR202> <Is_a> "Antibody_medication" .
<MOR202> <Is_a> "Anti-CD38_antibody" .
<Tamoxifen_and_OFS> <Mapped_from> "Tamoxifen_and_OFS" .
<FCR_(Rituximab_Hycela)> <Mapped_from> "FCR_(Rituximab_Hycela)" .
<TT4> <Has_accepted_use> "Immune_thrombocytopenia" .
<Granisetron> <Has_brand_name> "Sustol" .
<Granisetron> <Has_brand_name> "Sancuso" .
<Granisetron> <Has_brand_name> "Naurif" .
<Granisetron> <Has_brand_name> "Kytril" .
<Granisetron> <Has_brand_name> "Gratryl" .
<Granisetron> <Has_brand_name> "Granovell" .
<Granisetron> <Has_brand_name> "Granny" .
<Granisetron> <Has_brand_name> "Granney" .
<Granisetron> <Has_brand_name> "Graniz" .
<Granisetron> <Has_brand_name> "Granitero" .
<Granisetron> <Has_brand_name> "Granisol" .
<Granisetron> <Has_brand_name> "Granisev" .
<Granisetron> <Has_brand_name> "Graniset" .
<Granisetron> <Has_brand_name> "Granicip" .
<Granisetron> <Has_brand_name> "Gramatic" .
<Melanoma> <Is_a> "Skin_cancer" .
<ddEC> <Is_current_in> "Breast_cancer" .
<Gemcitabine_and_Rituximab> <Has_context> "Non-curative_therapy" .
<Gemcitabine_and_Rituximab> <Has_context> "Non-curative_subsequent-line_therapy" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Has_context> "Upfront_therapy" .
<DHAP> <Has_supportive_med> "Metoclopramide" .
<DHAP> <Has_supportive_med> "Diphenhydramine" .
<PAD_doxil> <Has_supportive_med> "Aspirin" .
<PAD_doxil> <Has_supportive_med> "Acyclovir" .
<Intron-A> <Brand_name_of> "Interferon_alfa-2b" .
<Clofarabine_and_LoDAC> <Has_antineoplastic> "Cytarabine" .
<Clofarabine_and_LoDAC> <Has_antineoplastic> "Clofarabine" .
<Caspofungin> <Supportive_med_of> "Clofarabine_and_Cytarabine" .
<Cytoferon> <Brand_name_of> "Interferon_alfa-2b" .
<Caspoliv> <Brand_name_of> "Caspofungin" .
<FM> <Has_antineoplastic> "Mitoxantrone" .
<FM> <Has_antineoplastic> "Fludarabine" .
<BMP> <Has_context> "Non-curative_therapy" .
<Dexamedix> <Brand_name_of> "Dexamethasone" .
<Pemgem> <Brand_name_of> "Pemetrexed" .
<MTOR_inhibitor> <Is_a> "Kinase_inhibitor" .
<MTOR_inhibitor> <Is_a> "Immunosuppressant" .
<IT_Cytarabine_monotherapy> <Has_context> "Local_therapy" .
<Preditec> <Brand_name_of> "Prednisone" .
<Eltrombopag_monotherapy> <Has_context> "Non-curative_therapy" .
<VAD> <Has_antineoplastic> "Vincristine" .
<VAD> <Has_antineoplastic> "Doxorubicin" .
<VAD> <Has_antineoplastic> "Dexamethasone" .
<Edrecolomab_monotherapy> <Has_modality> "Chemotherapy" .
<MACC> <Mapped_from> "MACC" .
<mFOLFOX6_(L-Leucovorin)> <Has_modality> "Chemotherapy" .
<Dexamethasone_and_Rituximab> <Is_current_in> "Immune_thrombocytopenia" .
<mFOLFOX6_and_Bevacizumab> <Is_current_in> "Colon_cancer" .
<Auxisone> <Brand_name_of> "Dexamethasone" .
<Enoxaparin_monotherapy> <Maps_to> "Enoxaparin_monotherapy" .
<Consolidation_after_upfront_therapy> <Maps_to> "Consolidation_after_upfront_therapy" .
<Calcivoran> <Brand_name_of> "Folinic_acid" .
<Glasdegib_and_LoDAC> <Mapped_from> "Glasdegib_and_LoDAC" .
<Methotrexate_and_Rituximab> <Has_modality> "Chemotherapy" .
<Dispersona> <Brand_name_of> "Prednisone" .
<Leprofen> <Brand_name_of> "Anastrozole" .
<Non-curative_subsequent-line_maintenance_therapy> <Mapped_from> "Non-curative_subsequent-line_maintenance_therapy" .
<UFTM> <Has_antineoplastic> "Tegafur_and_uracil" .
<UFTM> <Has_antineoplastic> "Mitomycin" .
<Alendrate> <Brand_name_of> "Alendronate" .
<Larotrectinib_monotherapy> <Is_current_in> "NTRK-mutated_malignancy" .
<Mercaptopurine_and_Methotrexate> <Has_antineoplastic> "Methotrexate" .
<Mercaptopurine_and_Methotrexate> <Has_antineoplastic> "Mercaptopurine" .
<Darolutamide> <Has_brand_name> "Nubeqa" .
<Gefitinib_and_Pemetrexed> <Has_modality> "Chemotherapy" .
<R-HiDAC> <Is_a> "Rituximab-containing_regimen" .
<Carboplatin,_Docetaxel,_Prednisone> <Has_antineoplastic> "Prednisone" .
<Carboplatin,_Docetaxel,_Prednisone> <Has_antineoplastic> "Docetaxel" .
<Carboplatin,_Docetaxel,_Prednisone> <Has_antineoplastic> "Carboplatin" .
<FNC> <Has_accepted_use> "Breast_cancer" .
<Mepolizumab_monotherapy> <Has_antineoplastic> "Mepolizumab" .
<CVP_(Vinblastine/Prednisone)> <Has_modality> "Chemotherapy" .
<Etosid> <Brand_name_of> "Etoposide" .
<Nilutamide_and_Orchiectomy> <Has_modality> "Hormonotherapy" .
<Bleomycin_and_Cisplatin> <Mapped_from> "Bleomycin_and_Cisplatin" .
<PCR> <Has_modality> "Chemotherapy" .
<Venetoclax> <Antineoplastic_of> "Venetoclax_monotherapy" .
<Venetoclax> <Antineoplastic_of> "Venetoclax_and_Rituximab" .
<Venetoclax> <Antineoplastic_of> "Venetoclax_and_Obinutuzumab" .
<Venetoclax> <Antineoplastic_of> "LoDAC_and_Venetoclax" .
<Venetoclax> <Antineoplastic_of> "Ibrutinib_and_Venetoclax" .
<Venetoclax> <Antineoplastic_of> "Decitabine_and_Venetoclax" .
<Venetoclax> <Antineoplastic_of> "Azacitidine_and_Venetoclax" .
<Gemcitabine_and_S-1> <Is_current_in> "Gallbladder_cancer" .
<Gemcitabine_and_S-1> <Is_current_in> "Cholangiocarcinoma" .
<Valrubicin_monotherapy> <Is_current_in> "Bladder_cancer" .
<R-CHVP_plus_I> <Mapped_from> "R-CHVP_plus_I" .
<Capecitabine_and_Lapatinib> <Has_modality> "Chemotherapy" .
<CCI> <Mapped_from> "CCI" .
<RT-PEPC> <Has_context> "Non-curative_therapy" .
<AV-CMF> <Is_historical_in> "Breast_cancer" .
<B-cell_acute_lymphoblastic_leukemia> <Is_a> "Pediatric_cancer" .
<B-cell_acute_lymphoblastic_leukemia> <Is_a> "Acute_lymphoblastic_leukemia" .
<Doxorubicin_monotherapy> <Is_historical_in> "Prostate_cancer" .
<Trimidar_M> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Leucocim> <Brand_name_of> "Filgrastim" .
<Cyclosporine_non-modified> <Immunosuppressor_of> "Low-dose_TBI,_then_allo_HSCT" .
<Cyclosporine_non-modified> <Immunosuppressor_of> "Low-dose_TBI" .
<Cyclosporine_non-modified> <Immunosuppressor_of> "Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant" .
<Cyclosporine_non-modified> <Immunosuppressor_of> "Busulfan_and_Fludarabine" .
<Cyclosporine_non-modified> <Immunosuppressor_of> "BuFlu,_then_allo_HSCT" .
<Cyclosporine_non-modified> <Immunosuppressor_of> "ATG_(Horse),_Cyclosporine,_Methylprednisolone" .
<Edoxaban_monotherapy> <Mapped_from> "Edoxaban_monotherapy" .
<Hyper-CVAD_and_Imatinib> <Has_antineoplastic> "Vincristine" .
<Hyper-CVAD_and_Imatinib> <Has_antineoplastic> "Methotrexate" .
<Hyper-CVAD_and_Imatinib> <Has_antineoplastic> "Imatinib" .
<Hyper-CVAD_and_Imatinib> <Has_antineoplastic> "Doxorubicin" .
<Hyper-CVAD_and_Imatinib> <Has_antineoplastic> "Dexamethasone" .
<Hyper-CVAD_and_Imatinib> <Has_antineoplastic> "Cytarabine" .
<Hyper-CVAD_and_Imatinib> <Has_antineoplastic> "Cyclophosphamide" .
<R-CHMP> <Has_modality> "Chemotherapy" .
<Medicort> <Brand_name_of> "Prednisolone" .
<Medicort> <Brand_name_of> "Dexamethasone" .
<Dasatinib_monotherapy> <Mapped_from> "Dasatinib_monotherapy" .
<Plerixafor_monotherapy> <Has_supportive_med> "Plerixafor" .
<Cytarabine,_Methotrexate,_Rituximab> <Has_antineoplastic> "Rituximab" .
<Cytarabine,_Methotrexate,_Rituximab> <Has_antineoplastic> "Methotrexate" .
<Cytarabine,_Methotrexate,_Rituximab> <Has_antineoplastic> "Cytarabine" .
<Ontak> <Brand_name_of> "Denileukin_diftitox" .
<BuCy,_then_auto_HSCT> <Mapped_from> "BuCy,_then_auto_HSCT" .
<FOLFOX4_(L-Leucovorin)> <Is_current_in> "Colon_cancer" .
<Arsenic_trioxide_and_ATRA> <Mapped_from> "Arsenic_trioxide_and_ATRA" .
<Doxorubicin_non-pegylated_liposomal_monotherapy> <Is_a> "Anthracycline-containing_regimen" .
<M-DEX> <Has_context> "Non-curative_first-line_therapy" .
<Afatinib_and_Paclitaxel> <Has_context> "Non-curative_subsequent-line_therapy" .
<BVB> <Mapped_from> "BVB" .
<Intrafort> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA> <Is_current_in> "Acute_promyelocytic_leukemia" .
<Cladribine_and_Cytarabine> <Has_accepted_use> "Langerhans_cell_histiocytosis" .
<Cladribine_and_Cytarabine> <Has_accepted_use> "Hypereosinophilic_syndrome" .
<CNS_carcinoma> <Is_a> "CNS_cancer" .
<Raloxifene> <May_have_route> "Oral" .
<O-miniCHOP> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Lutetium_Lu_177_dotatate> <Has_FDA_indication> "Neuroendocrine_tumor" .
<Isotretinoin_monotherapy> <Has_accepted_use> "Neuroblastoma" .
<FULV_and_Bevacizumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<MACOP-B> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<BVD> <Has_antineoplastic> "Vincristine" .
<BVD> <Has_antineoplastic> "Dacarbazine" .
<BVD> <Has_antineoplastic> "Carmustine" .
<Capecitabine> <Has_brand_name> "Xlotabin" .
<Capecitabine> <Has_brand_name> "Xeloda" .
<Capecitabine> <Has_brand_name> "Skemca" .
<Capecitabine> <Has_brand_name> "Naprocap" .
<Capecitabine> <Has_brand_name> "Flagoda" .
<Capecitabine> <Has_brand_name> "Citabin" .
<Capecitabine> <Has_brand_name> "Caxeta" .
<Capecitabine> <Has_brand_name> "Capsy" .
<Capecitabine> <Has_brand_name> "Caposib" .
<Capecitabine> <Has_brand_name> "Capnat" .
<Capecitabine> <Has_brand_name> "Capegard" .
<Capecitabine> <Has_brand_name> "Capebin" .
<Capecitabine> <Has_brand_name> "Cabita" .
<CTCb,_then_auto_HSCT> <Has_accepted_use> "Breast_cancer" .
<IRIS_and_Bevacizumab> <Is_current_in> "Colon_cancer" .
<IT_Cytarabine,_Methotrexate,_WBRT> <Has_modality> "Radiotherapy" .
<IT_Cytarabine,_Methotrexate,_WBRT> <Has_modality> "Chemotherapy" .
<Samarium-153_with_stem_cell_support> <Has_supportive_med> "Sargramostim" .
<Samarium-153_with_stem_cell_support> <Has_supportive_med> "Filgrastim" .
<Valodex> <Brand_name_of> "Tamoxifen" .
<R-CODOX-M_(Doxil_substituted)> <Has_supportive_med> "Folinic_acid" .
<R-CODOX-M_(Doxil_substituted)> <Has_supportive_med> "Filgrastim" .
<Denosumab_monotherapy> <Has_modality> "Chemotherapy" .
<Glivec> <Brand_name_of> "Imatinib" .
<Lapatinib,_Letrozole,_Trastuzumab> <Mapped_from> "Lapatinib,_Letrozole,_Trastuzumab" .
<Photofrin> <Brand_name_of> "Porfimer" .
<Mitoxana> <Brand_name_of> "Ifosfamide" .
<Supim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Tazemetostat_monotherapy> <Has_context> "All_lines_of_therapy" .
<Doxorubicin_and_Olaratumab> <Maps_to> "Doxorubicin_and_Olaratumab" .
<dmCODOX-M_-_Modified_Magrath> <Has_accepted_use> "HIV-associated_lymphoma" .
<BEAC> <Has_supportive_med> "Mesna" .
<VAD_doxil> <Is_current_in> "Multiple_myeloma" .
<Venetoclax_monotherapy> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Aspergic> <Brand_name_of> "Aspirin" .
<Sandostatina_LAR> <Brand_name_of> "Octreotide_LAR" .
<Doxorubicin_pegylated_liposomal_and_Gemcitabine> <Has_accepted_use> "Ovarian_cancer" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA> <Has_antineoplastic> "Thioguanine" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA> <Has_antineoplastic> "Mitoxantrone" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA> <Has_antineoplastic> "Idarubicin" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA> <Has_antineoplastic> "Etoposide" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA> <Has_antineoplastic> "Cytarabine" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA> <Has_antineoplastic> "All-trans_retinoic_acid" .
<Doxorubicin_and_Lomustine> <Is_a> "Anthracycline-containing_regimen" .
<Cesamet> <Brand_name_of> "Nabilone" .
<mCOP/MP> <Has_modality> "Chemotherapy" .
<BeRT> <Is_current_in> "Mantle_cell_lymphoma" .
<ADT,_Docetaxel,_Estramustine> <Has_accepted_use> "Prostate_cancer" .
<Oxaliplatin> <Has_brand_name> "Zildox" .
<Oxaliplatin> <Has_brand_name> "Xylotin" .
<Oxaliplatin> <Has_brand_name> "Xaloplat" .
<Oxaliplatin> <Has_brand_name> "X-Plat" .
<Oxaliplatin> <Has_brand_name> "Sibatin" .
<Oxaliplatin> <Has_brand_name> "Oxzucia" .
<Oxaliplatin> <Has_brand_name> "Oxitan" .
<Oxaliplatin> <Has_brand_name> "Oxiplat" .
<Oxaliplatin> <Has_brand_name> "OxaLitin" .
<Oxaliplatin> <Has_brand_name> "Oplatin" .
<Oxaliplatin> <Has_brand_name> "Eloxatine" .
<Oxaliplatin> <Has_brand_name> "Eloxatin" .
<Oxaliplatin> <Has_brand_name> "Eloplat" .
<Oxaliplatin> <Has_brand_name> "Dacplat" .
<Oxaliplatin> <Has_brand_name> "Dacotin" .
<Oxaliplatin> <Has_brand_name> "Cure-X" .
<Oxaliplatin> <Has_brand_name> "Curaplat" .
<Oxaliplatin> <Has_brand_name> "Coxatin" .
<Efudex> <Brand_name_of> "Fluorouracil" .
<ddTH_(Taxotere)> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<ddTH_(Taxotere)> <Has_accepted_use> "Breast_cancer" .
<Meditrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<COPAD> <Has_accepted_use> "Burkitt_lymphoma" .
<Somerol> <Brand_name_of> "Methylprednisolone" .
<Plurisul> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Toremifene_monotherapy> <Mapped_from> "Toremifene_monotherapy" .
<Radiation_therapy> <Is_historical_in> "Prostate_cancer" .
<Radiation_therapy> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Olaratumab> <May_have_route> "Intravenous" .
<Bacillus_Calmette-Guerin_(BCG)_monotherapy> <Maps_to> "Bacillus_Calmette-Guerin_(BCG)_monotherapy" .
<R-MPV> <Is_a> "Rituximab-containing_regimen" .
<Bisphosphonate> <Is_a> "Bone_protective_medication" .
<Fluorouracil_and_Folinic_acid> <Has_modality> "Chemotherapy" .
<Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan> <Is_a> "Irinotecan-containing_regimen" .
<Imcotran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bexarotene> <May_have_route> "Topical" .
<Bexarotene> <May_have_route> "Oral" .
<Halfprin> <Brand_name_of> "Aspirin" .
<DA-R-EPOCH> <Has_antineoplastic> "Vincristine" .
<DA-R-EPOCH> <Has_antineoplastic> "Rituximab" .
<DA-R-EPOCH> <Has_antineoplastic> "Prednisone" .
<DA-R-EPOCH> <Has_antineoplastic> "Etoposide" .
<DA-R-EPOCH> <Has_antineoplastic> "Doxorubicin" .
<DA-R-EPOCH> <Has_antineoplastic> "Cyclophosphamide" .
<Erlotinib_and_Ramucirumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Erlotinib_and_Ramucirumab> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<VAD_and_Cyclosporine> <Has_antineoplastic> "Vincristine" .
<VAD_and_Cyclosporine> <Has_antineoplastic> "Doxorubicin" .
<VAD_and_Cyclosporine> <Has_antineoplastic> "Dexamethasone" .
<VAD_and_Cyclosporine> <Has_antineoplastic> "Cyclosporines" .
<Mexaton> <Brand_name_of> "Dexamethasone" .
<Necitumumab_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Oramin> <Brand_name_of> "Dexchlorpheniramine" .
<Altretamine> <May_have_route> "Oral" .
<Cyclophosphamide_and_Prednisone> <Maps_to> "Cyclophosphamide_and_Prednisone" .
<Unfractionated_heparin> <Has_accepted_use> "Venous_thromboembolism" .
<Bortezomib_and_Panobinostat> <Maps_to> "Bortezomib_and_Panobinostat" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Cytarabine,_Ifosfamide,_G-CSF> <Has_accepted_use> "Stem_cell_mobilization" .
<Otlertuzumab> <Is_a> "Investigational_drug" .
<Otlertuzumab> <Is_a> "Antibody_medication" .
<Otlertuzumab> <Is_a> "Anti-CD37_antibody" .
<Nordic_FLOX> <Has_context> "Non-curative_first-line_therapy" .
<Bevacizumab-bvzr> <Has_brand_name> "Zirabev" .
<mFOLFOX6_and_RT> <Has_accepted_use> "Rectal_cancer" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone> <Mapped_from> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone" .
<Tagraxofusp> <Antineoplastic_of> "Tagraxofusp_monotherapy" .
<EC> <Is_a> "Anthracycline-containing_regimen" .
<FEAM,_then_auto_HSCT> <Has_antineoplastic> "Melphalan" .
<FEAM,_then_auto_HSCT> <Has_antineoplastic> "Fotemustine" .
<FEAM,_then_auto_HSCT> <Has_antineoplastic> "Etoposide" .
<FEAM,_then_auto_HSCT> <Has_antineoplastic> "Cytarabine" .
<Fludarabine_and_TBI,_then_allo_HSCT> <Mapped_from> "Fludarabine_and_TBI,_then_allo_HSCT" .
<PVAG> <Maps_to> "PVAG" .
<Mercaptopurine,_Methotrexate,_Vincristine> <Maps_to> "Mercaptopurine,_Methotrexate,_Vincristine" .
<KIT_inhibitor> <Subsumes> "Sunitinib" .
<KIT_inhibitor> <Subsumes> "Sorafenib" .
<KIT_inhibitor> <Subsumes> "Regorafenib" .
<KIT_inhibitor> <Subsumes> "Ponatinib" .
<KIT_inhibitor> <Subsumes> "Pazopanib" .
<KIT_inhibitor> <Subsumes> "Nilotinib" .
<KIT_inhibitor> <Subsumes> "Motesanib" .
<KIT_inhibitor> <Subsumes> "Midostaurin" .
<KIT_inhibitor> <Subsumes> "Masitinib" .
<KIT_inhibitor> <Subsumes> "Lenvatinib" .
<KIT_inhibitor> <Subsumes> "Imatinib" .
<KIT_inhibitor> <Subsumes> "Dasatinib" .
<KIT_inhibitor> <Subsumes> "Cabozantinib" .
<KIT_inhibitor> <Subsumes> "Axitinib" .
<KIT_inhibitor> <Subsumes> "Avapritinib" .
<KIT_inhibitor> <Subsumes> "Apatinib" .
<Dexamesone> <Brand_name_of> "Dexamethasone" .
<R-CMD> <Has_accepted_use> "Follicular_lymphoma" .
<Bleomycin,_Methotrexate,_Vinblastine/RT> <Has_modality> "Radiotherapy" .
<Bleomycin,_Methotrexate,_Vinblastine/RT> <Has_modality> "Chemotherapy" .
<Berubigen> <Brand_name_of> "Cyanocobalamin" .
<Belotecan_and_Cisplatin> <Has_antineoplastic> "Cisplatin" .
<Belotecan_and_Cisplatin> <Has_antineoplastic> "Belotecan" .
<Docetaxel_and_Irinotecan> <Has_antineoplastic> "Irinotecan" .
<Docetaxel_and_Irinotecan> <Has_antineoplastic> "Docetaxel" .
<SOX> <Has_antineoplastic> "Tegafur_gimeracil_oteracil" .
<SOX> <Has_antineoplastic> "Oxaliplatin" .
<TC,_then_IE,_VDoxoC,_VEC> <Has_antineoplastic> "Vincristine" .
<TC,_then_IE,_VDoxoC,_VEC> <Has_antineoplastic> "Topotecan" .
<TC,_then_IE,_VDoxoC,_VEC> <Has_antineoplastic> "Ifosfamide" .
<TC,_then_IE,_VDoxoC,_VEC> <Has_antineoplastic> "Etoposide" .
<TC,_then_IE,_VDoxoC,_VEC> <Has_antineoplastic> "Doxorubicin" .
<TC,_then_IE,_VDoxoC,_VEC> <Has_antineoplastic> "Cyclophosphamide" .
<Best_supportive_care> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Best_supportive_care> <Is_historical_in> "Gastric_cancer" .
<FOLFIRI_and_Panitumumab> <Has_antineoplastic> "Panitumumab" .
<FOLFIRI_and_Panitumumab> <Has_antineoplastic> "Irinotecan" .
<FOLFIRI_and_Panitumumab> <Has_antineoplastic> "Folinic_acid" .
<FOLFIRI_and_Panitumumab> <Has_antineoplastic> "Fluorouracil" .
<Cutaneous_basal_cell_carcinoma> <Is_a> "Non-melanoma_skin_cancer" .
<Pacxel> <Brand_name_of> "Paclitaxel" .
<Lomustine,_Vincristine,_Prednisone> <Has_context> "Adjuvant_therapy" .
<Vinorelbine_and_Bevacizumab> <Has_antineoplastic> "Vinorelbine" .
<Vinorelbine_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Blindafe> <Brand_name_of> "Alendronate" .
<TCHP_(Taxol)> <Has_antineoplastic> "Trastuzumab" .
<TCHP_(Taxol)> <Has_antineoplastic> "Pertuzumab" .
<TCHP_(Taxol)> <Has_antineoplastic> "Paclitaxel" .
<TCHP_(Taxol)> <Has_antineoplastic> "Carboplatin" .
<Capecitabine_monotherapy> <Has_antineoplastic> "Capecitabine" .
<Capecitabine_and_Paclitaxel,_nanoparticle_albumin-bound> <Has_context> "Non-curative_first-line_therapy" .
<Arumel> <Brand_name_of> "Fluorouracil" .
<Doxorubicin,_Methotrexate,_Vincristine,_Prednisone> <Maps_to> "Doxorubicin,_Methotrexate,_Vincristine,_Prednisone" .
<Granitero> <Brand_name_of> "Granisetron" .
<COPP_(CCNU)> <Maps_to> "COPP_(CCNU)" .
<Vismodegib_monotherapy> <Has_context> "Non-curative_therapy" .
<Vismodegib_monotherapy> <Has_context> "All_lines_of_therapy" .
<Cyclophosphamide_and_Prednisone> <Has_supportive_med> "Allopurinol" .
<Pegaspargase,_Vincristine,_Prednisone> <Has_modality> "Chemotherapy" .
<Kogenate_FS> <Brand_name_of> "Factor_VIII_recombinant" .
<VIE> <Has_antineoplastic> "Vincristine" .
<VIE> <Has_antineoplastic> "Ifosfamide" .
<VIE> <Has_antineoplastic> "Etoposide" .
<Pentostatin_monotherapy> <Has_context> "Non-curative_therapy" .
<Pentostatin_monotherapy> <Has_context> "Induction_therapy" .
<Obinutuzumab_monotherapy> <Is_current_in> "Mantle_cell_lymphoma" .
<Obinutuzumab_monotherapy> <Is_current_in> "Follicular_lymphoma" .
<Obinutuzumab_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Obinutuzumab_monotherapy> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<ChlVPP> <Has_antineoplastic> "Vinblastine" .
<ChlVPP> <Has_antineoplastic> "Procarbazine" .
<ChlVPP> <Has_antineoplastic> "Prednisone" .
<ChlVPP> <Has_antineoplastic> "Chlorambucil" .
<Phenaspirine> <Brand_name_of> "Aspirin" .
<Fludarabine_and_Alemtuzumab> <Maps_to> "Fludarabine_and_Alemtuzumab" .
<Letrozole> <Has_FDA_indication> "Breast_cancer" .
<Goserelin_and_Tamoxifen> <Has_antineoplastic> "Tamoxifen" .
<Goserelin_and_Tamoxifen> <Has_antineoplastic> "Goserelin" .
<iddEPC> <Has_antineoplastic> "Paclitaxel" .
<iddEPC> <Has_antineoplastic> "Epirubicin" .
<iddEPC> <Has_antineoplastic> "Cyclophosphamide" .
<Cisplatin_and_Raltitrexed> <Has_context> "Non-curative_first-line_therapy" .
<Capecitabine/Capecitabine_and_RT> <Has_accepted_use> "Rectal_cancer" .
<Erlotinib_and_Bevacizumab> <Has_context> "Non-curative_therapy" .
<Erlotinib_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<Erlotinib_and_Bevacizumab> <Has_context> "All_lines_of_therapy" .
<CHOP_Modified_(Prednisolone)> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Dacarbazine_and_Doxorubicin> <Mapped_from> "Dacarbazine_and_Doxorubicin" .
<Ixabepilone_monotherapy> <Has_modality> "Chemotherapy" .
<Dorison> <Brand_name_of> "Dexamethasone" .
<Levofloxacin> <Has_brand_name> "Levaquin" .
<mLSG15> <Has_context> "Induction_therapy" .
<VDC/IE> <Is_a> "Anthracycline-containing_regimen" .
<Sendoxan> <Brand_name_of> "Cyclophosphamide" .
<Giant-cell_tumor_of_bone> <Accepted_use_of> "Denosumab_monotherapy" .
<Giant-cell_tumor_of_bone> <Accepted_use_of> "Denosumab" .
<Edrecolomab_monotherapy> <Mapped_from> "Edrecolomab_monotherapy" .
<Capecitabine_and_Trastuzumab> <Has_modality> "Chemotherapy" .
<Thalidomide_and_Prednisone> <Maps_to> "Thalidomide_and_Prednisone" .
<Erlotinib_monotherapy> <Mapped_from> "Erlotinib_monotherapy" .
<TAC_(Taxotere)> <Has_supportive_med> "Lenograstim" .
<TAC_(Taxotere)> <Has_supportive_med> "Filgrastim" .
<TAC_(Taxotere)> <Has_supportive_med> "Dexamethasone" .
<TAC_(Taxotere)> <Has_supportive_med> "Ciprofloxacin" .
<Clotrizol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Clexane> <Brand_name_of> "Enoxaparin" .
<Paroxysmal_nocturnal_hemoglobinuria> <Accepted_use_of> "Ravulizumab_monotherapy" .
<Paroxysmal_nocturnal_hemoglobinuria> <Accepted_use_of> "Ravulizumab" .
<Paroxysmal_nocturnal_hemoglobinuria> <Accepted_use_of> "Placebo" .
<Paroxysmal_nocturnal_hemoglobinuria> <Accepted_use_of> "Eculizumab_monotherapy" .
<Paroxysmal_nocturnal_hemoglobinuria> <Accepted_use_of> "Eculizumab" .
<BR_and_Polatuzumab_vedotin> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Perjeta> <Brand_name_of> "Pertuzumab" .
<Cytarabine_and_Thioguanine> <Is_historical_in> "Acute_myeloid_leukemia" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT> <Is_a> "Rituximab-containing_regimen" .
<Denileukin_diftitox_monotherapy> <Mapped_from> "Denileukin_diftitox_monotherapy" .
<Bortezomib_and_Doxorubicin_liposomal> <Has_modality> "Chemotherapy" .
<R-CMD> <Is_a> "Rituximab-containing_regimen" .
<R-CMD> <Is_a> "Anthracycline-containing_regimen" .
<VIE> <Maps_to> "VIE" .
<Chlorambucil_and_Cisplatin> <Has_antineoplastic> "Cisplatin" .
<Chlorambucil_and_Cisplatin> <Has_antineoplastic> "Chlorambucil" .
<ATRA_and_Daunorubicin> <Mapped_from> "ATRA_and_Daunorubicin" .
<Binimetinib_and_Encorafenib> <Mapped_from> "Binimetinib_and_Encorafenib" .
<VeIP> <Maps_to> "VeIP" .
<Pixantrone_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<CPR> <Has_modality> "Chemotherapy" .
<Colon_cancer> <Historic_treated_by> "mFOLFOX6_and_Bevacizumab" .
<Colon_cancer> <Historic_treated_by> "MOF" .
<Colon_cancer> <Historic_treated_by> "Fluorouracil,_Folinic_acid,_Levamisole" .
<Colon_cancer> <Historic_treated_by> "Fluorouracil_monotherapy" .
<Colon_cancer> <Historic_treated_by> "Fluorouracil_and_Semustine" .
<Colon_cancer> <Historic_treated_by> "Fluorouracil_and_Mitomycin" .
<Colon_cancer> <Historic_treated_by> "Fluorouracil_and_Methotrexate" .
<Colon_cancer> <Historic_treated_by> "Fluorouracil_and_Levamisole" .
<Colon_cancer> <Historic_treated_by> "FOLFOX_chronotherapy" .
<Colon_cancer> <Historic_treated_by> "Edrecolomab_monotherapy" .
<Colon_cancer> <Historic_treated_by> "Bacillus_Calmette-Guerin_(BCG)_monotherapy" .
<Calcium_phosphate_rinse> <Has_brand_name> "Caphosol" .
<Hormonoradiotherapy> <Maps_to> "Hormonoradiotherapy" .
<CHOP_Modified> <Maps_to> "CHOP_Modified" .
<Blinatumomab_monotherapy> <Has_antineoplastic> "Blinatumomab" .
<Herzovir> <Brand_name_of> "Acyclovir" .
<Peginterferon_alfa-2b> <Has_brand_name> "ViraferonPeg" .
<Peginterferon_alfa-2b> <Has_brand_name> "Sylatron" .
<Peginterferon_alfa-2b> <Has_brand_name> "PegIntron" .
<Peginterferon_alfa-2b> <Has_brand_name> "PEG-Intron" .
<Lomustine,_Methotrexate,_Procarbazine> <Has_local_therapy> "Methotrexate" .
<Lomustine,_Methotrexate,_Procarbazine> <Has_local_therapy> "Cytarabine" .
<VAdCA> <Has_accepted_use> "Ewing_sarcoma" .
<BuCyTBI> <Has_context> "All_lines_of_therapy" .
<Vitazon> <Brand_name_of> "Prednisone" .
<PF> <Maps_to> "PF" .
<Capecitabine_and_Mitomycin> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Capecitabine_and_Mitomycin> <Has_supportive_med> "Dexamethasone" .
<Bevacizumab_monotherapy> <Maps_to> "Bevacizumab_monotherapy" .
<ddT_(Taxotere)> <Mapped_from> "ddT_(Taxotere)" .
<Dibestrol> <Brand_name_of> "Diethylstilbestrol" .
<HDMP> <Has_modality> "Chemotherapy" .
<CHOP-AL> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Octreotide_and_Prednisone> <Has_antineoplastic> "Prednisone" .
<Octreotide_and_Prednisone> <Has_antineoplastic> "Octreotide" .
<7_plus_3i_and_Vorinostat> <Has_supportive_med> "Methylprednisolone" .
<Hedgehog_pathway-mutated_malignancy> <Accepted_use_of> "Vismodegib_monotherapy" .
<Hedgehog_pathway-mutated_malignancy> <Accepted_use_of> "Vismodegib" .
<Ibrutinib_and_Obinutuzumab> <Has_modality> "Chemotherapy" .
<Neoplaxol> <Brand_name_of> "Etoposide" .
<Idelalisib> <Has_FDA_indication> "Follicular_lymphoma" .
<Idelalisib> <Has_FDA_indication> "Chronic_lymphocytic_leukemia" .
<Varfine> <Brand_name_of> "Warfarin" .
<Vincristine_liposomal_monotherapy> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Crizotinib_monotherapy> <Maps_to> "Crizotinib_monotherapy" .
<BEACOPP-14_(Prednisolone)> <Has_context> "Non-curative_therapy" .
<Regorafenib_monotherapy> <Has_antineoplastic> "Regorafenib" .
<MIC> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<HER2-positive_-_historical_Breast_cancer> <Accepted_use_of> "Vinorelbine_monotherapy" .
<HER2-positive_-_historical_Breast_cancer> <Accepted_use_of> "Paclitaxel_monotherapy" .
<HER2-positive_-_historical_Breast_cancer> <Accepted_use_of> "EC" .
<HER2-positive_-_historical_Breast_cancer> <Accepted_use_of> "Docetaxel_monotherapy" .
<HER2-positive_-_historical_Breast_cancer> <Accepted_use_of> "Capecitabine_monotherapy" .
<HER2-positive_-_historical_Breast_cancer> <Accepted_use_of> "AC" .
<Bevacizumab-containing_therapy> <Has_context> "Adjuvant_therapy" .
<BuFlu,_then_allo_HSCT> <Has_antineoplastic> "Fludarabine" .
<BuFlu,_then_allo_HSCT> <Has_antineoplastic> "Busulfan" .
<BuFlu,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<Daunorubicin_liposomal_monotherapy> <Has_antineoplastic> "Daunorubicin_liposomal" .
<Fluorouracil_and_Semustine> <Is_historical_in> "Colon_cancer" .
<Ulfaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Pazopanib> <Is_a> "VEGFR_inhibitor" .
<Pazopanib> <Is_a> "SRC_inhibitor" .
<Pazopanib> <Is_a> "PDGFR_inhibitor" .
<Pazopanib> <Is_a> "Kinase_inhibitor" .
<Pazopanib> <Is_a> "KIT_inhibitor" .
<Pazopanib> <Is_a> "FGFR_inhibitor" .
<CapeOx_and_Panitumumab> <Has_context> "Non-curative_first-line_therapy" .
<Doxycycline_monotherapy> <Is_current_in> "Marginal_zone_lymphoma" .
<MOPP-ABV> <Is_a> "Anthracycline-containing_regimen" .
<Edrecolomab_monotherapy> <Has_accepted_use> "Colon_cancer" .
<Dactinomycin_and_Vincristine> <Has_modality> "Chemotherapy" .
<Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone> <Is_current_in> "Langerhans_cell_histiocytosis" .
<Fludarabine_and_TBI> <Has_modality> "Radiotherapy" .
<Fludarabine_and_TBI> <Has_modality> "Chemotherapy" .
<Irinotecan> <Has_FDA_indication> "Rectal_cancer" .
<Irinotecan> <Has_FDA_indication> "Colon_cancer" .
<Fludarabine,_Busulfan,_Cyclophosphamide> <Mapped_from> "Fludarabine,_Busulfan,_Cyclophosphamide" .
<Augmented_BFM_consolidation> <Has_context> "Consolidation_after_upfront_therapy" .
<Azacitidine_and_Venetoclax> <Maps_to> "Azacitidine_and_Venetoclax" .
<Radiotherapy> <Mapped_from> "Radiotherapy" .
<Immunotoxin> <Subsumes> "Moxetumomab_pasudotox" .
<Immunotoxin> <Subsumes> "Denileukin_diftitox" .
<Immunotoxin> <Subsumes> "BL22_immunotoxin" .
<Carac> <Brand_name_of> "Fluorouracil" .
<Arimidex> <Brand_name_of> "Anastrozole" .
<Momelotinib> <May_have_route> "Oral" .
<CMFP> <Has_modality> "Hormonotherapy" .
<CMFP> <Has_modality> "Chemotherapy" .
<Cisplatin,_Gemcitabine,_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<eBEACOPP_(Prednisolone)> <Has_context> "Non-curative_therapy" .
<Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine> <Maps_to> "Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine" .
<Aromadex> <Brand_name_of> "Exemestane" .
<TH_(Taxotere)> <Mapped_from> "TH_(Taxotere)" .
<CYKLONE> <Maps_to> "CYKLONE" .
<L-Asparaginase,_Vincristine,_Dexamethasone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<CBV> <Has_antineoplastic> "Etoposide" .
<CBV> <Has_antineoplastic> "Cyclophosphamide" .
<CBV> <Has_antineoplastic> "Carmustine" .
<EMA-CO> <Has_accepted_use> "Gestational_trophoblastic_neoplasia" .
<CLAG-M> <Has_antineoplastic> "Mitoxantrone" .
<CLAG-M> <Has_antineoplastic> "Cytarabine" .
<CLAG-M> <Has_antineoplastic> "Cladribine" .
<Arsenic_trioxide> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Arsenic_trioxide> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Epoetin_alfa> <May_have_route> "Subcutaneous" .
<Epoetin_alfa> <May_have_route> "Intravenous" .
<Azacitidine,_Vorinostat,_Gemtuzumab_ozogamicin> <Mapped_from> "Azacitidine,_Vorinostat,_Gemtuzumab_ozogamicin" .
<FC> <Has_accepted_use> "Mantle_cell_lymphoma" .
<FC> <Has_accepted_use> "Follicular_lymphoma" .
<FC> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<FC> <Has_accepted_use> "Autologous_HSCT" .
<FC> <Has_accepted_use> "Allogeneic_HSCT" .
<Temsirolimus_monotherapy> <Maps_to> "Temsirolimus_monotherapy" .
<Carboplatin,_Paclitaxel,_Ipilimumab> <Is_current_in> "Small_cell_lung_cancer" .
<Carboplatin,_Paclitaxel,_Ipilimumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<Bicalutamide_monotherapy> <Is_current_in> "Prostate_cancer" .
<Linker_regimen_(consolidation)> <Has_modality> "Chemotherapy" .
<T-cell_leukemia> <Is_a> "T-cell_neoplasm" .
<Plasma_cell_leukemia> <Is_a> "Plasma_cell_dyscrasia" .
<Orfarin> <Brand_name_of> "Warfarin" .
<Mycostatin> <Supportive_med_of> "BEAM,_then_auto_HSCT" .
<Mycostatin> <Supportive_med_of> "BEAM" .
<Interferon_alfa-2b_and_Zidovudine> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<Romidepsin_monotherapy> <Has_antineoplastic> "Romidepsin" .
<Cafiaspirina> <Brand_name_of> "Aspirin" .
<Antithymocyte_globulin_horse_ATG> <May_have_route> "Intravenous" .
<Aldesleukin> <Antineoplastic_of> "Low-dose_Interleukin-2" .
<Aldesleukin> <Antineoplastic_of> "Interferon_alfa-2a_and_Interleukin-2" .
<Aldesleukin> <Antineoplastic_of> "IL-2_monotherapy" .
<Aldesleukin> <Antineoplastic_of> "High-dose_Interleukin-2" .
<Aldesleukin> <Antineoplastic_of> "GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab" .
<Aldesleukin> <Antineoplastic_of> "Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine" .
<Aldesleukin> <Antineoplastic_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Pentamidine> <Has_brand_name> "Pneumopent" .
<Pentamidine> <Has_brand_name> "Pentamidina" .
<Pentamidine> <Has_brand_name> "Pentam" .
<Pentamidine> <Has_brand_name> "Nebupent" .
<Pentamidine> <Has_brand_name> "Lomidine" .
<Pentamidine> <Has_brand_name> "Benambax" .
<Fluroblastin> <Brand_name_of> "Fluorouracil" .
<Osimertinib_monotherapy> <Maps_to> "Osimertinib_monotherapy" .
<Myezom> <Brand_name_of> "Bortezomib" .
<Alcrist> <Brand_name_of> "Vincristine" .
<Epofer> <Brand_name_of> "Epoetin_alfa" .
<Z-BEAM> <Is_a> "Rituximab-containing_regimen" .
<Azacitidine,_Vorinostat,_Gemtuzumab_ozogamicin> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Anti-PS_antibody> <Is_a> "Antibody_medication" .
<TH_(Taxotere/SC)> <Mapped_from> "TH_(Taxotere/SC)" .
<Letrozole_monotherapy> <Has_supportive_med> "Goserelin" .
<Confidex> <Brand_name_of> "Prothrombin_Complex_Concentrate_human" .
<Citosin> <Brand_name_of> "Cisplatin" .
<VTD> <Has_modality> "Chemotherapy" .
<R-miniCEOP> <Has_modality> "Chemotherapy" .
<Tecnoplatin> <Brand_name_of> "Cisplatin" .
<Letrozole_and_Bevacizumab> <Has_modality> "Hormonotherapy" .
<Letrozole_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<BASIC> <Maps_to> "BASIC" .
<Gamifant> <Brand_name_of> "Emapalumab" .
<Osteonato> <Brand_name_of> "Alendronate" .
<Migraspirina> <Brand_name_of> "Aspirin" .
<Fludarabine,_Busulfan,_Cyclophosphamide> <Has_context> "All_lines_of_therapy" .
<MAPI> <Has_context> "Neoadjuvant_therapy" .
<MAPI> <Has_context> "Adjuvant_therapy" .
<Abiraterone_and_Prednisone> <Has_modality> "Hormonotherapy" .
<7_plus_3i_and_Sorafenib> <Mapped_from> "7_plus_3i_and_Sorafenib" .
<Complementopathy> <Is_a> "Classical_hematologic_condition" .
<Nufaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Anti-EGFR_antibody> <Subsumes> "Panitumumab" .
<Anti-EGFR_antibody> <Subsumes> "Necitumumab" .
<Anti-EGFR_antibody> <Subsumes> "Cetuximab" .
<BeEAM> <Maps_to> "BeEAM" .
<Mephameson> <Brand_name_of> "Dexamethasone" .
<O-miniCHOP> <Has_context> "Induction_therapy" .
<R-INO> <Has_modality> "Chemotherapy" .
<CNS_carcinoma> <Current_treated_by> "Whole_brain_irradiation" .
<CNS_carcinoma> <Current_treated_by> "Teniposide_and_WBRT" .
<CNS_carcinoma> <Current_treated_by> "Osimertinib_monotherapy" .
<CNS_carcinoma> <Current_treated_by> "Icotinib_monotherapy" .
<CNS_carcinoma> <Current_treated_by> "Dexamethasone_monotherapy" .
<CNS_carcinoma> <Current_treated_by> "Dexamethasone_and_WBRT" .
<CNS_carcinoma> <Current_treated_by> "Ceritinib_monotherapy" .
<CNS_carcinoma> <Current_treated_by> "Capecitabine_and_Trastuzumab" .
<CNS_carcinoma> <Current_treated_by> "Capecitabine_and_Lapatinib" .
<CNS_carcinoma> <Current_treated_by> "Alectinib_monotherapy" .
<CNS_carcinoma> <Current_treated_by> "Afatinib_monotherapy" .
<Cytarabine_and_Thioguanine> <Has_antineoplastic> "Thioguanine" .
<Cytarabine_and_Thioguanine> <Has_antineoplastic> "Cytarabine" .
<MATRix> <Maps_to> "MATRix" .
<RVD> <Maps_to> "RVD" .
<ddEC> <Has_modality> "Chemotherapy" .
<TX_(Taxotere)> <Is_current_in> "Breast_cancer" .
<Rituximab-containing_regimen> <Subsumes> "maxi-R-CHOP/R-HiDAC" .
<Rituximab-containing_regimen> <Subsumes> "Z-BEAM,_then_auto_HSCT" .
<Rituximab-containing_regimen> <Subsumes> "Z-BEAM" .
<Rituximab-containing_regimen> <Subsumes> "Vorinostat_and_Rituximab" .
<Rituximab-containing_regimen> <Subsumes> "Venetoclax_and_Rituximab" .
<Rituximab-containing_regimen> <Subsumes> "VcR-CVAD" .
<Rituximab-containing_regimen> <Subsumes> "VR-CP" .
<Rituximab-containing_regimen> <Subsumes> "VR-CHOP" .
<Rituximab-containing_regimen> <Subsumes> "VR-CAP" .
<Rituximab-containing_regimen> <Subsumes> "VR" .
<Rituximab-containing_regimen> <Subsumes> "Thalidomide_and_Rituximab" .
<Rituximab-containing_regimen> <Subsumes> "Temsirolimus_and_Rituximab" .
<Rituximab-containing_regimen> <Subsumes> "TTR" .
<Rituximab-containing_regimen> <Subsumes> "SC-EPOCH-RR" .
<Rituximab-containing_regimen> <Subsumes> "Rituximab_monotherapy" .
<Rituximab-containing_regimen> <Subsumes> "Rituximab_and_hyaluronidase_monotherapy" .
<Rituximab-containing_regimen> <Subsumes> "RiPAD_plus_C" .
<Rituximab-containing_regimen> <Subsumes> "RVR" .
<Rituximab-containing_regimen> <Subsumes> "RT-PEPC" .
<Rituximab-containing_regimen> <Subsumes> "RICER" .
<Rituximab-containing_regimen> <Subsumes> "RCC" .
<Rituximab-containing_regimen> <Subsumes> "RABVD" .
<Rituximab-containing_regimen> <Subsumes> "R2CHOP" .
<Rituximab-containing_regimen> <Subsumes> "R-miniCHOP" .
<Rituximab-containing_regimen> <Subsumes> "R-miniCEOP" .
<Rituximab-containing_regimen> <Subsumes> "R-VAD_plus_C" .
<Rituximab-containing_regimen> <Subsumes> "R-TBI/Cy,_then_auto_HSCT" .
<Rituximab-containing_regimen> <Subsumes> "R-TBI/Cy" .
<Rituximab-containing_regimen> <Subsumes> "R-NIMP" .
<Rituximab-containing_regimen> <Subsumes> "R-MegaCHOP-14" .
<Rituximab-containing_regimen> <Subsumes> "R-MegaCHOP" .
<Rituximab-containing_regimen> <Subsumes> "R-MPV" .
<Rituximab-containing_regimen> <Subsumes> "R-MP" .
<Rituximab-containing_regimen> <Subsumes> "R-MCP_(CCNU)" .
<Rituximab-containing_regimen> <Subsumes> "R-MCP" .
<Rituximab-containing_regimen> <Subsumes> "R-MACLO/R-IVAM" .
<Rituximab-containing_regimen> <Subsumes> "R-M-CHOP" .
<Rituximab-containing_regimen> <Subsumes> "R-INO" .
<Rituximab-containing_regimen> <Subsumes> "R-IFE" .
<Rituximab-containing_regimen> <Subsumes> "R-ICE" .
<Rituximab-containing_regimen> <Subsumes> "R-Hyper-CVAD/R-MA" .
<Rituximab-containing_regimen> <Subsumes> "R-HiDAC" .
<Rituximab-containing_regimen> <Subsumes> "R-GemOx" .
<Rituximab-containing_regimen> <Subsumes> "R-GDP" .
<Rituximab-containing_regimen> <Subsumes> "R-GCVP" .
<Rituximab-containing_regimen> <Subsumes> "R-FND" .
<Rituximab-containing_regimen> <Subsumes> "R-FM" .
<Rituximab-containing_regimen> <Subsumes> "R-FCM" .
<Rituximab-containing_regimen> <Subsumes> "R-ESHAP" .
<Rituximab-containing_regimen> <Subsumes> "R-EPOCH,_dose-escalated" .
<Rituximab-containing_regimen> <Subsumes> "R-EPOCH" .
<Rituximab-containing_regimen> <Subsumes> "R-DexaBEAM" .
<Rituximab-containing_regimen> <Subsumes> "R-DHAP/R-VIM" .
<Rituximab-containing_regimen> <Subsumes> "R-DHAP" .
<Rituximab-containing_regimen> <Subsumes> "R-DHAOx" .
<Rituximab-containing_regimen> <Subsumes> "R-DHAC" .
<Rituximab-containing_regimen> <Subsumes> "R-CVP" .
<Rituximab-containing_regimen> <Subsumes> "R-CVEP" .
<Rituximab-containing_regimen> <Subsumes> "R-CP" .
<Rituximab-containing_regimen> <Subsumes> "R-COPADM" .
<Rituximab-containing_regimen> <Subsumes> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Rituximab-containing_regimen> <Subsumes> "R-CODOX-M/R-IVAC" .
<Rituximab-containing_regimen> <Subsumes> "R-CODOX-M_(Doxil_substituted)" .
<Rituximab-containing_regimen> <Subsumes> "R-CODOX-M" .
<Rituximab-containing_regimen> <Subsumes> "R-CMD" .
<Rituximab-containing_regimen> <Subsumes> "R-CHVP_plus_I" .
<Rituximab-containing_regimen> <Subsumes> "R-CHOP/R-DHAP" .
<Rituximab-containing_regimen> <Subsumes> "R-CHOP-14_(Rituximab_Hycela)" .
<Rituximab-containing_regimen> <Subsumes> "R-CHOP-14_(Prednisolone)" .
<Rituximab-containing_regimen> <Subsumes> "R-CHOP-14" .
<Rituximab-containing_regimen> <Subsumes> "R-CHOP_(Rituximab_Hycela)" .
<Rituximab-containing_regimen> <Subsumes> "R-CHOP_(Prednisolone)" .
<Rituximab-containing_regimen> <Subsumes> "R-CHOP" .
<Rituximab-containing_regimen> <Subsumes> "R-CHOEP-14" .
<Rituximab-containing_regimen> <Subsumes> "R-CHMP" .
<Rituximab-containing_regimen> <Subsumes> "R-CEOP90_(Epirubicin)" .
<Rituximab-containing_regimen> <Subsumes> "R-CEOP_(Etoposide)" .
<Rituximab-containing_regimen> <Subsumes> "R-CDOP" .
<Rituximab-containing_regimen> <Subsumes> "R-BL" .
<Rituximab-containing_regimen> <Subsumes> "R-BEAM,_then_auto_HSCT" .
<Rituximab-containing_regimen> <Subsumes> "R-BEAM" .
<Rituximab-containing_regimen> <Subsumes> "R-BAC" .
<Rituximab-containing_regimen> <Subsumes> "R,_then_CHOP" .
<Rituximab-containing_regimen> <Subsumes> "Panobinostat_and_Rituximab" .
<Rituximab-containing_regimen> <Subsumes> "PCR" .
<Rituximab-containing_regimen> <Subsumes> "OFAR" .
<Rituximab-containing_regimen> <Subsumes> "Nordic_Regimen,_younger_patients" .
<Rituximab-containing_regimen> <Subsumes> "Nordic_Regimen,_older_patients" .
<Rituximab-containing_regimen> <Subsumes> "Methotrexate_and_Rituximab" .
<Rituximab-containing_regimen> <Subsumes> "MT-R" .
<Rituximab-containing_regimen> <Subsumes> "MATRix" .
<Rituximab-containing_regimen> <Subsumes> "Lenalidomide,_Dexamethasone,_Rituximab" .
<Rituximab-containing_regimen> <Subsumes> "Lenalidomide_and_Rituximab" .
<Rituximab-containing_regimen> <Subsumes> "Idelalisib_and_Rituximab" .
<Rituximab-containing_regimen> <Subsumes> "Ibrutinib_and_Rituximab" .
<Rituximab-containing_regimen> <Subsumes> "Ibritumomab_tiuxetan_monotherapy" .
<Rituximab-containing_regimen> <Subsumes> "HDMP-R" .
<Rituximab-containing_regimen> <Subsumes> "Gemcitabine_and_Rituximab" .
<Rituximab-containing_regimen> <Subsumes> "GMALL-R" .
<Rituximab-containing_regimen> <Subsumes> "GCD-R" .
<Rituximab-containing_regimen> <Subsumes> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT" .
<Rituximab-containing_regimen> <Subsumes> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan" .
<Rituximab-containing_regimen> <Subsumes> "FR" .
<Rituximab-containing_regimen> <Subsumes> "FCR,_then_allo_HSCT" .
<Rituximab-containing_regimen> <Subsumes> "FCR_(Rituximab_Hycela)" .
<Rituximab-containing_regimen> <Subsumes> "FCR" .
<Rituximab-containing_regimen> <Subsumes> "Everolimus_and_Rituximab" .
<Rituximab-containing_regimen> <Subsumes> "EAR_and_G-CSF" .
<Rituximab-containing_regimen> <Subsumes> "DRC" .
<Rituximab-containing_regimen> <Subsumes> "DA-R-EPOCH" .
<Rituximab-containing_regimen> <Subsumes> "Cytarabine,_Methotrexate,_Rituximab" .
<Rituximab-containing_regimen> <Subsumes> "Cytarabine,_Idarubicin,_Rituximab" .
<Rituximab-containing_regimen> <Subsumes> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab" .
<Rituximab-containing_regimen> <Subsumes> "Cladribine_and_Rituximab" .
<Rituximab-containing_regimen> <Subsumes> "Chlorambucil_and_Rituximab" .
<Rituximab-containing_regimen> <Subsumes> "CaRD" .
<Rituximab-containing_regimen> <Subsumes> "CFAR" .
<Rituximab-containing_regimen> <Subsumes> "CBV,_then_auto_HSCT" .
<Rituximab-containing_regimen> <Subsumes> "CALGB_10-002_regimen" .
<Rituximab-containing_regimen> <Subsumes> "Bevacizumab_and_Rituximab" .
<Rituximab-containing_regimen> <Subsumes> "BeRT" .
<Rituximab-containing_regimen> <Subsumes> "BVR" .
<Rituximab-containing_regimen> <Subsumes> "BR_and_Polatuzumab_vedotin" .
<Rituximab-containing_regimen> <Subsumes> "BR_and_Idelalisib" .
<Rituximab-containing_regimen> <Subsumes> "BR_and_Ibrutinib" .
<Rituximab-containing_regimen> <Subsumes> "BR" .
<Rituximab-containing_regimen> <Subsumes> "BFR,_then_allo_HSCT" .
<Rituximab-containing_regimen> <Subsumes> "BFR" .
<Rituximab-containing_regimen> <Subsumes> "BDR" .
<Rituximab-containing_regimen> <Subsumes> "BASIC" .
<Rituximab-containing_regimen> <Subsumes> "Alemtuzumab_and_Rituximab" .
<Rituximab-containing_regimen> <Subsumes> "ACVBP-R" .
<Rituximab-containing_regimen> <Subsumes> "(90)YFC,_then_allo_HSCT" .
<Rituximab-containing_regimen> <Subsumes> "(90)YFC" .
<Cyclosporine_non-modified> <Is_a> "Cyclosporine" .
<Cyclosporine_non-modified> <Is_a> "Calcineurin_inhibitor" .
<R-CHOP-14_(Rituximab_Hycela)> <Is_a> "Rituximab-containing_regimen" .
<R-CHOP-14_(Rituximab_Hycela)> <Is_a> "Anthracycline-containing_regimen" .
<All-trans_retinoic_acid> <Has_brand_name> "Vesanoid" .
<All-trans_retinoic_acid> <Has_brand_name> "Ves-ATRA" .
<All-trans_retinoic_acid> <Has_brand_name> "CA_ATRA" .
<Vorinostat> <Is_a> "HDAC_inhibitor" .
<MAPI> <Maps_to> "MAPI" .
<Doxorubicin_and_Ifosfamide> <Has_supportive_med> "Mesna" .
<Doxorubicin_and_Ifosfamide> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Docetaxel_and_Irinotecan> <Is_a> "Irinotecan-containing_regimen" .
<BuCyTBI,_then_allo_HSCT> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Linola-H_N> <Brand_name_of> "Prednisolone" .
<Penatone> <Brand_name_of> "Dexamethasone" .
<Fluroblastine> <Brand_name_of> "Fluorouracil" .
<VAIA> <Has_context> "Neoadjuvant_therapy" .
<VAIA> <Has_context> "Adjuvant_therapy" .
<Carboplatin,_Pemetrexed,_Bevacizumab> <Has_modality> "Chemotherapy" .
<DNA_methyltransferase_inhibitor> <Is_a> "Enzyme_inhibitor" .
<Cytarabine,_Methotrexate,_Rituximab> <Is_a> "Rituximab-containing_regimen" .
<Oncovin> <Brand_name_of> "Vincristine" .
<Carboplatin,_Etoposide,_Atezolizumab> <Is_current_in> "Small_cell_lung_cancer" .
<Biofigran> <Brand_name_of> "Filgrastim" .
<Raltitrexed> <May_have_route> "Intravenous" .
<Nautah> <Brand_name_of> "Ondansetron" .
<Acetisal> <Brand_name_of> "Aspirin" .
<Granisetron> <Is_a> "Serotonin_5-HT3_antagonist" .
<Granisetron> <Is_a> "Emesis_prevention" .
<mDCF> <Mapped_from> "mDCF" .
<Rednisone> <Brand_name_of> "Dexamethasone" .
<Zoledronic_acid> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Zoledronic_acid> <Is_a> "Bisphosphonate" .
<FCA> <Mapped_from> "FCA" .
<Danazol> <May_have_route> "Oral" .
<ddFEC> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<ddFEC> <Has_accepted_use> "Breast_cancer" .
<Mitomycin> <Antineoplastic_of> "UFTM" .
<Mitomycin> <Antineoplastic_of> "TACE" .
<Mitomycin> <Antineoplastic_of> "Mitomycin_monotherapy" .
<Mitomycin> <Antineoplastic_of> "MVP_and_RT" .
<Mitomycin> <Antineoplastic_of> "MVP_(Vindesine)" .
<Mitomycin> <Antineoplastic_of> "MVP_(Vinblastine)" .
<Mitomycin> <Antineoplastic_of> "MIC" .
<Mitomycin> <Antineoplastic_of> "MCF" .
<Mitomycin> <Antineoplastic_of> "Irinotecan_and_Mitomycin" .
<Mitomycin> <Antineoplastic_of> "Intraperitoneal_hyperthermic_mitomycin" .
<Mitomycin> <Antineoplastic_of> "Gemcitabine_and_Mitomycin" .
<Mitomycin> <Antineoplastic_of> "Fluorouracil,_Mitomycin,_RT" .
<Mitomycin> <Antineoplastic_of> "Fluorouracil,_Folinic_acid,_Mitomycin" .
<Mitomycin> <Antineoplastic_of> "Fluorouracil_and_Mitomycin" .
<Mitomycin> <Antineoplastic_of> "FAM" .
<Mitomycin> <Antineoplastic_of> "Doxifluridine_and_Mitomycin" .
<Mitomycin> <Antineoplastic_of> "Cisplatin_and_Mitomycin" .
<Mitomycin> <Antineoplastic_of> "Capecitabine,_Mitomycin,_RT" .
<Mitomycin> <Antineoplastic_of> "Capecitabine_and_Mitomycin" .
<Carboplatin_and_Ifosfamide> <Has_accepted_use> "Cervical_cancer" .
<mFOLFOX6> <Has_accepted_use> "KRAS_wild-type_Colon_cancer" .
<mFOLFOX6> <Has_accepted_use> "Colon_cancer" .
<Cyclosporine,_Methotrexate,_ATG> <Has_accepted_use> "Graft_versus_host_disease" .
<OPPA> <Is_current_in> "Hodgkin_lymphoma" .
<Nuaze> <Brand_name_of> "Doxorubicin" .
<Hemolytic_process> <Subsumes> "Warm_autoimmune_hemolytic_anemia" .
<Hemolytic_process> <Subsumes> "Sickle_cell_anemia" .
<Hemolytic_process> <Subsumes> "Paroxysmal_nocturnal_hemoglobinuria" .
<Hemolytic_process> <Subsumes> "Hereditary_hemorrhagic_telangiectasia" .
<Hemolytic_process> <Subsumes> "Cold_agglutinin_disease" .
<Hemolytic_process> <Subsumes> "Autoimmune_cytopenia" .
<Hemolytic_process> <Subsumes> "Atypical_hemolytic_uremic_syndrome" .
<Moxetumomab_pasudotox_monotherapy> <Has_antineoplastic> "Moxetumomab_pasudotox" .
<Levoleucovorin> <Has_FDA_indication> "Bone_sarcoma" .
<Azacitidine_and_Sorafenib> <Has_supportive_med> "Hydroxyurea" .
<MA> <Has_accepted_use> "Osteosarcoma" .
<Azacitidine_and_Vorinostat> <Has_modality> "Chemotherapy" .
<Fitoaspirin> <Brand_name_of> "Aspirin" .
<Vinorelbine> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Vinorelbine> <Has_accepted_use> "Small_cell_lung_cancer" .
<Vinorelbine> <Has_accepted_use> "Ovarian_cancer" .
<Vinorelbine> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Vinorelbine> <Has_accepted_use> "Mesothelioma" .
<Vinorelbine> <Has_accepted_use> "Hodgkin_lymphoma" .
<Vinorelbine> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Vinorelbine> <Has_accepted_use> "Cervical_cancer" .
<Vinorelbine> <Has_accepted_use> "Breast_cancer" .
<Compro> <Brand_name_of> "Prochlorperazine" .
<Guadecitabine> <Is_a> "Investigational_drug" .
<Guadecitabine> <Is_a> "Hypomethylating_agent" .
<Guadecitabine> <Is_a> "DNA_methyltransferase_inhibitor" .
<SOX_and_Bevacizumab> <Is_current_in> "Colon_cancer" .
<ECF> <Has_context> "Non-curative_therapy" .
<ECF> <Has_context> "Non-curative_first-line_therapy" .
<ECF> <Has_context> "Neoadjuvant_therapy" .
<ECF> <Has_context> "Induction_therapy" .
<ECF> <Has_context> "Adjuvant_therapy" .
<Bayaspirina> <Brand_name_of> "Aspirin" .
<Panobinostat_monotherapy> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Panobinostat_monotherapy> <Has_accepted_use> "Hodgkin_lymphoma" .
<Panobinostat_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Panobinostat_monotherapy> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Nilotinib-based_consolidation> <Has_supportive_med> "Folinic_acid" .
<PT> <Has_context> "Adjuvant_therapy" .
<MVP_and_RT> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Irinotecan_liposome> <May_have_route> "Intravenous" .
<FOLFOX_7/sLV5FU2_(L-Leucovorin)> <Has_accepted_use> "Colon_cancer" .
<Onetrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<RICER> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Trastuzumab-anns> <Has_brand_name> "Kanjinti" .
<Methotrexate_and_Pegaspargase> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Everolimus> <Is_a> "TSC2_inhibitor" .
<Everolimus> <Is_a> "TSC1_inhibitor" .
<Everolimus> <Is_a> "Protein_expression-specific_medication" .
<Everolimus> <Is_a> "PMDA_approved_drug" .
<Everolimus> <Is_a> "MTOR_inhibitor" .
<Everolimus> <Is_a> "Kinase_inhibitor" .
<EVAIA> <Has_accepted_use> "Ewing_sarcoma" .
<Fluorouracil,_Oxaliplatin,_RT> <Has_antineoplastic> "Oxaliplatin" .
<Fluorouracil,_Oxaliplatin,_RT> <Has_antineoplastic> "Fluorouracil" .
<Fluorouracil,_Oxaliplatin,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Bivalirudin_monotherapy> <Mapped_from> "Bivalirudin_monotherapy" .
<Jiebaishu> <Brand_name_of> "Nedaplatin" .
<Burkitt_lymphoma> <Current_treated_by> "R-Hyper-CVAD/R-MA" .
<Burkitt_lymphoma> <Current_treated_by> "R-COPADM" .
<Burkitt_lymphoma> <Current_treated_by> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Burkitt_lymphoma> <Current_treated_by> "R-CODOX-M/R-IVAC" .
<Burkitt_lymphoma> <Current_treated_by> "R-CODOX-M_(Doxil_substituted)" .
<Burkitt_lymphoma> <Current_treated_by> "R-CODOX-M" .
<Burkitt_lymphoma> <Current_treated_by> "GMALL-R" .
<Burkitt_lymphoma> <Current_treated_by> "DA-R-EPOCH" .
<Burkitt_lymphoma> <Current_treated_by> "Cyclophosphamide_and_Prednisone" .
<Burkitt_lymphoma> <Current_treated_by> "CYVE" .
<Burkitt_lymphoma> <Current_treated_by> "CYM" .
<Burkitt_lymphoma> <Current_treated_by> "COPADM" .
<Burkitt_lymphoma> <Current_treated_by> "COPAD/CYVE" .
<Burkitt_lymphoma> <Current_treated_by> "COPAD" .
<Burkitt_lymphoma> <Current_treated_by> "COP" .
<Burkitt_lymphoma> <Current_treated_by> "CODOX-M/IVAC" .
<Burkitt_lymphoma> <Current_treated_by> "CODOX-M" .
<Burkitt_lymphoma> <Current_treated_by> "CALGB_10-002_regimen" .
<Burkitt_lymphoma> <Current_treated_by> "BASIC" .
<Carboplatinum> <Brand_name_of> "Carboplatin" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab> <Maps_to> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab" .
<Trebananib> <May_have_route> "Intravenous" .
<Flutamide,_Leuprolide,_RT> <Has_accepted_use> "Prostate_cancer" .
<VAB-6> <Has_accepted_use> "Testicular_cancer" .
<Dexaton> <Brand_name_of> "Dexamethasone" .
<Tranexamic_acid_monotherapy> <Maps_to> "Tranexamic_acid_monotherapy" .
<Ribomustin> <Brand_name_of> "Bendamustine" .
<VBMCP> <Is_historical_in> "Multiple_myeloma" .
<Cisplatin_monotherapy> <Is_historical_in> "Ovarian_cancer" .
<Cisplatin_monotherapy> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Casprium> <Brand_name_of> "Aspirin" .
<Anti-DKK1_antibody> <Subsumes> "BHQ880" .
<Lomustine_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<VMPT> <Maps_to> "VMPT" .
<FLAG-Ida> <Has_context> "Salvage_therapy" .
<FLAG-Ida> <Has_context> "Non-curative_subsequent-line_therapy" .
<FLAG-Ida> <Has_context> "Induction_therapy" .
<Ifosfamide_and_Paclitaxel> <Has_antineoplastic> "Paclitaxel" .
<Ifosfamide_and_Paclitaxel> <Has_antineoplastic> "Ifosfamide" .
<TAC_(Taxotere)> <Is_current_in> "Breast_cancer" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Is_a> "Rituximab-containing_regimen" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Is_a> "Anthracycline-containing_regimen" .
<Cisplatin,_Dacarbazine,_Interferon_alfa-2b> <Has_modality> "Immunotherapy" .
<Cisplatin,_Dacarbazine,_Interferon_alfa-2b> <Has_modality> "Chemotherapy" .
<Axinotecan> <Brand_name_of> "Irinotecan" .
<VACA/IE> <Has_supportive_med> "Mesna" .
<Somatuline_PR> <Brand_name_of> "Lanreotide" .
<Lenvatinib_monotherapy> <Has_accepted_use> "Thyroid_cancer" .
<Lenvatinib_monotherapy> <Has_accepted_use> "Renal_cell_carcinoma" .
<Lenvatinib_monotherapy> <Has_accepted_use> "Hepatocellular_carcinoma" .
<CAV> <Maps_to> "CAV" .
<R-CODOX-M_(Doxil_substituted)> <Has_antineoplastic> "Vincristine" .
<R-CODOX-M_(Doxil_substituted)> <Has_antineoplastic> "Rituximab" .
<R-CODOX-M_(Doxil_substituted)> <Has_antineoplastic> "Pegylated_liposomal_doxorubicin" .
<R-CODOX-M_(Doxil_substituted)> <Has_antineoplastic> "Methotrexate" .
<R-CODOX-M_(Doxil_substituted)> <Has_antineoplastic> "Cyclophosphamide" .
<Triazene> <Is_a> "Alkylating_agent" .
<BRAF-mutated_malignancy> <Current_treated_by> "Vemurafenib_monotherapy" .
<BRAF-mutated_malignancy> <Current_treated_by> "Dabrafenib_and_Trametinib" .
<Emeran> <Brand_name_of> "Ondansetron" .
<Gemcitabine_monotherapy> <Maps_to> "Gemcitabine_monotherapy" .
<Apidex> <Brand_name_of> "Dexamethasone" .
<Rucaparib> <Has_accepted_use> "Ovarian_cancer" .
<R-EPOCH> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<R-EPOCH> <Has_supportive_med> "Pentamidine" .
<R-EPOCH> <Has_supportive_med> "Filgrastim" .
<R-EPOCH> <Has_supportive_med> "Atovaquone" .
<BVCPP> <Has_context> "Salvage_therapy" .
<Pembrolizumab> <Has_brand_name> "Keytruda" .
<MPR> <Is_current_in> "Multiple_myeloma" .
<Prevax> <Brand_name_of> "Folinic_acid" .
<G-FC> <Maps_to> "G-FC" .
<MEK_inhibitor> <Is_a> "Kinase_inhibitor" .
<R-GemOx> <Is_a> "Rituximab-containing_regimen" .
<Cisplatin_and_Epirubicin> <Is_a> "Platinum_doublet" .
<Cisplatin_and_Epirubicin> <Is_a> "Anthracycline-containing_regimen" .
<Geniol_AP> <Brand_name_of> "Aspirin" .
<VAMP_(Amethopterin)> <Has_context> "Induction_therapy" .
<Pyrimidine_analogue> <Is_a> "Antimetabolite" .
<CapeOx,_Cetuximab,_RT> <Has_antineoplastic> "Oxaliplatin" .
<CapeOx,_Cetuximab,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<CapeOx,_Cetuximab,_RT> <Has_antineoplastic> "Cetuximab" .
<CapeOx,_Cetuximab,_RT> <Has_antineoplastic> "Capecitabine" .
<Prednovare> <Brand_name_of> "Methylprednisolone" .
<Dexacotsil> <Brand_name_of> "Dexamethasone" .
<Alkylating_agent> <Subsumes> "Vadastuximab_talirine" .
<Alkylating_agent> <Subsumes> "Uracil_mustard" .
<Alkylating_agent> <Subsumes> "Triazene" .
<Alkylating_agent> <Subsumes> "Treosulfan" .
<Alkylating_agent> <Subsumes> "Thiotepa" .
<Alkylating_agent> <Subsumes> "Temozolomide" .
<Alkylating_agent> <Subsumes> "Streptozocin" .
<Alkylating_agent> <Subsumes> "Procarbazine" .
<Alkylating_agent> <Subsumes> "Nitrosourea" .
<Alkylating_agent> <Subsumes> "Nitrogen_mustard" .
<Alkylating_agent> <Subsumes> "Nedaplatin" .
<Alkylating_agent> <Subsumes> "Melphalan" .
<Alkylating_agent> <Subsumes> "Mechlorethamine" .
<Alkylating_agent> <Subsumes> "Lobaplatin" .
<Alkylating_agent> <Subsumes> "Heptaplatin" .
<Alkylating_agent> <Subsumes> "Dacarbazine" .
<Alkylating_agent> <Subsumes> "Cyclophosphamide" .
<Alkylating_agent> <Subsumes> "Cisplatin" .
<Alkylating_agent> <Subsumes> "Chlorambucil" .
<Alkylating_agent> <Subsumes> "Carmustine_wafer_polifeprosan_20" .
<Alkylating_agent> <Subsumes> "Carmustine" .
<Alkylating_agent> <Subsumes> "Carboplatin" .
<Alkylating_agent> <Subsumes> "Busulfan" .
<Alkylating_agent> <Subsumes> "Bendamustine" .
<Alkylating_agent> <Subsumes> "Altretamine" .
<Dacarbazine_and_Gemcitabine> <Maps_to> "Dacarbazine_and_Gemcitabine" .
<Binimetinib_monotherapy> <Mapped_from> "Binimetinib_monotherapy" .
<FCM> <Is_historical_in> "Follicular_lymphoma" .
<AV-CMF> <Has_modality> "Chemotherapy" .
<Nilutamide> <Has_brand_name> "Zandron" .
<Nilutamide> <Has_brand_name> "Nilandron" .
<Nilutamide> <Has_brand_name> "Anandron" .
<CEEP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Dexstar> <Brand_name_of> "Dexamethasone" .
<Farmitrexat> <Brand_name_of> "Methotrexate" .
<Isophosphamide> <Brand_name_of> "Ifosfamide" .
<HAD> <Is_current_in> "Acute_myeloid_leukemia" .
<Carboplatin_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Dexrazoxane> <Is_a> "Chemotherapy_protective_agent" .
<Dexrazoxane> <Is_a> "Chelator" .
<Methotrexate,_Pegaspargase,_Vincristine> <Has_modality> "Chemotherapy" .
<Binimetinib> <Antineoplastic_of> "Binimetinib,_Encorafenib,_Cetuximab" .
<Binimetinib> <Antineoplastic_of> "Binimetinib_monotherapy" .
<Binimetinib> <Antineoplastic_of> "Binimetinib_and_Encorafenib" .
<FOLFOX2> <Has_accepted_use> "Colon_cancer" .
<Methotrexate_and_Vincristine> <Has_antineoplastic> "Vincristine" .
<Methotrexate_and_Vincristine> <Has_antineoplastic> "Methotrexate" .
<Factor_IX_recombinant> <Has_brand_name> "BeneFix" .
<Cisplatin_and_Mitomycin> <Is_current_in> "Cervical_cancer" .
<Ganitumab> <May_have_route> "Intravenous" .
<Cyproterone_acetate> <Is_a> "Antiandrogen" .
<Defibrotide_monotherapy> <Has_supportive_med> "Defibrotide" .
<Factor_VIIa_recombinant> <Is_a> "Hemostasis_medication" .
<Factor_VIIa_recombinant> <Is_a> "Hematology_medication" .
<Factor_VIIa_recombinant> <Is_a> "Coagulation_factor" .
<Ferumoxytol> <Has_brand_name> "Feraheme" .
<Busulfan_monotherapy> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Asaferm> <Brand_name_of> "Aspirin" .
<Brigatinib_monotherapy> <Mapped_from> "Brigatinib_monotherapy" .
<Lenvatinib_and_Pembrolizumab> <Has_context> "Non-curative_therapy" .
<FUDF> <Brand_name_of> "Floxuridine" .
<Eracin> <Brand_name_of> "Epirubicin" .
<Depomedrone> <Brand_name_of> "Methylprednisolone" .
<Follicular_lymphoma> <FDA_indication_of> "Rituximab-pvvr" .
<Follicular_lymphoma> <FDA_indication_of> "Rituximab-abbs" .
<Follicular_lymphoma> <FDA_indication_of> "Rituximab_and_hyaluronidase_human" .
<Follicular_lymphoma> <FDA_indication_of> "Rituximab" .
<Follicular_lymphoma> <FDA_indication_of> "Obinutuzumab" .
<Follicular_lymphoma> <FDA_indication_of> "Lenalidomide" .
<Follicular_lymphoma> <FDA_indication_of> "Interferon_alfa-2b" .
<Follicular_lymphoma> <FDA_indication_of> "Idelalisib" .
<Follicular_lymphoma> <FDA_indication_of> "Ibritumomab_tiuxetan" .
<Follicular_lymphoma> <FDA_indication_of> "Duvelisib" .
<Follicular_lymphoma> <FDA_indication_of> "Copanlisib" .
<Enduxan> <Brand_name_of> "Cyclophosphamide" .
<No_induction> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<No_induction> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<No_induction> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<No_induction> <Has_accepted_use> "Head_and_neck_cancer" .
<CVP,_then_131Iodine-Tositumomab> <Has_antineoplastic> "Vincristine" .
<CVP,_then_131Iodine-Tositumomab> <Has_antineoplastic> "Tositumomab_and_I-131_(Bexxar)" .
<CVP,_then_131Iodine-Tositumomab> <Has_antineoplastic> "Prednisone" .
<CVP,_then_131Iodine-Tositumomab> <Has_antineoplastic> "Cyclophosphamide" .
<Stanford_V> <Has_modality> "Chemotherapy" .
<L-asparaginase_monotherapy> <Mapped_from> "L-asparaginase_monotherapy" .
<Fauldfluor> <Brand_name_of> "Fluorouracil" .
<Doxorubicin_monotherapy> <Is_a> "Anthracycline-containing_regimen" .
<Temozolomide> <Supportive_med_of> "Lutetium_Lu_177_dotatate_and_Octreotide_LAR" .
<Nintedanib> <Is_a> "VEGFR_inhibitor" .
<Nintedanib> <Is_a> "SRC_inhibitor" .
<Nintedanib> <Is_a> "PDGFR_inhibitor" .
<Nintedanib> <Is_a> "Kinase_inhibitor" .
<Nintedanib> <Is_a> "FGFR_inhibitor" .
<Nintedanib> <Is_a> "EMA_approved_drug" .
<Dison> <Brand_name_of> "Dexamethasone" .
<Aminopterin_monotherapy> <Has_modality> "Chemotherapy" .
<Pentostatin_and_Alemtuzumab> <Has_context> "Salvage_therapy" .
<Pentostatin_and_Alemtuzumab> <Has_context> "Induction_therapy" .
<CMFP> <Has_context> "Non-curative_therapy" .
<CMFP> <Has_context> "Adjuvant_therapy" .
<Voriconazole> <Is_a> "WHO_Essential_Anti-infective_Medicine" .
<Voriconazole> <Is_a> "Antifungal" .
<Folinic_acid> <Has_accepted_use> "Rectal_cancer" .
<Folinic_acid> <Has_accepted_use> "Pancreatic_cancer" .
<Folinic_acid> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Folinic_acid> <Has_accepted_use> "Gastric_cancer" .
<Folinic_acid> <Has_accepted_use> "Esophageal_cancer" .
<Folinic_acid> <Has_accepted_use> "Colon_cancer" .
<Folinic_acid> <Has_accepted_use> "Cholangiocarcinoma" .
<Folinic_acid> <Has_accepted_use> "Cervical_cancer" .
<RVD> <Has_modality> "Chemotherapy" .
<Bortezomib,_Dexamethasone,_Panobinostat> <Mapped_from> "Bortezomib,_Dexamethasone,_Panobinostat" .
<Tivozanib> <Is_a> "VEGFR_inhibitor" .
<Tivozanib> <Is_a> "Investigational_drug" .
<Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA> <Has_modality> "Chemotherapy" .
<Bevacizumab> <Has_accepted_use> "Vascular_sarcoma" .
<Bevacizumab> <Has_accepted_use> "Testicular_cancer" .
<Bevacizumab> <Has_accepted_use> "Small_cell_lung_cancer" .
<Bevacizumab> <Has_accepted_use> "Renal_cell_carcinoma" .
<Bevacizumab> <Has_accepted_use> "Pancreatic_NET" .
<Bevacizumab> <Has_accepted_use> "Ovarian_cancer" .
<Bevacizumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Bevacizumab> <Has_accepted_use> "Neuroendocrine_tumor" .
<Bevacizumab> <Has_accepted_use> "Mesothelioma" .
<Bevacizumab> <Has_accepted_use> "Melanoma" .
<Bevacizumab> <Has_accepted_use> "Kaposi_sarcoma" .
<Bevacizumab> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Bevacizumab> <Has_accepted_use> "Glioblastoma" .
<Bevacizumab> <Has_accepted_use> "Follicular_lymphoma" .
<Bevacizumab> <Has_accepted_use> "Esophageal_cancer" .
<Bevacizumab> <Has_accepted_use> "Endometrial_cancer" .
<Bevacizumab> <Has_accepted_use> "Colon_cancer" .
<Bevacizumab> <Has_accepted_use> "Cholangiocarcinoma" .
<Bevacizumab> <Has_accepted_use> "Cervical_cancer" .
<Bevacizumab> <Has_accepted_use> "Breast_cancer" .
<Bevacizumab> <Has_accepted_use> "Anaplastic_glioma" .
<Bevacizumab> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<Castration> <Mapped_from> "Castration" .
<Cisplatin_and_Topotecan> <Mapped_from> "Cisplatin_and_Topotecan" .
<Anastrozole_monotherapy> <Has_context> "Non-curative_therapy" .
<Anastrozole_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Anastrozole_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Anastrozole_monotherapy> <Has_context> "Neoadjuvant_therapy" .
<Anastrozole_monotherapy> <Has_context> "Adjuvant_therapy" .
<Epidaza> <Brand_name_of> "Chidamide" .
<CALGB_8811_late_intensification> <Has_antineoplastic> "Vincristine" .
<CALGB_8811_late_intensification> <Has_antineoplastic> "Thioguanine" .
<CALGB_8811_late_intensification> <Has_antineoplastic> "Doxorubicin" .
<CALGB_8811_late_intensification> <Has_antineoplastic> "Dexamethasone" .
<CALGB_8811_late_intensification> <Has_antineoplastic> "Cytarabine" .
<CALGB_8811_late_intensification> <Has_antineoplastic> "Cyclophosphamide" .
<Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant> <Has_context> "All_lines_of_therapy" .
<Metax> <Brand_name_of> "Dexamethasone" .
<R-GCVP> <Is_a> "Rituximab-containing_regimen" .
<Sipuleucel-T_monotherapy> <Has_antineoplastic> "Sipuleucel-T" .
<Lapatinib_and_Letrozole> <Is_a> "Antiestrogen-containing_regimen" .
<NovoSeven_RT> <Brand_name_of> "Factor_VIIa_recombinant" .
<Z-BEAM> <Has_accepted_use> "Autologous_HSCT" .
<FluBuCy,_then_allo_HSCT> <Has_context> "Non-curative_second-line_consolidation_therapy" .
<FluBuCy,_then_allo_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<FluBuCy,_then_allo_HSCT> <Has_context> "All_lines_of_therapy" .
<CHVmP-VB> <Is_a> "Anthracycline-containing_regimen" .
<HiDAC> <Has_accepted_use> "CNS_lymphoma" .
<HiDAC> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Bacillus_Calmette-Guerin> <May_have_route> "Intravesical" .
<Bexarotene> <Has_brand_name> "Targretin" .
<Bexarotene> <Has_brand_name> "Bexgratin" .
<Eposid> <Brand_name_of> "Etoposide" .
<Ifosfamide_monotherapy> <Has_context> "Non-curative_therapy" .
<Ifosfamide_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Ifosfamide_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Ifosfamide_monotherapy> <Has_context> "Induction_therapy" .
<Nilotinib-based_consolidation> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Nilotinib-based_consolidation> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Docetaxel_and_Irinotecan> <Is_current_in> "Esophageal_cancer" .
<HAM> <Maps_to> "HAM" .
<ATG_(Rabbit)_monotherapy> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<Cotrizole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Lamivudine> <Supportive_med_of> "R2CHOP" .
<Erlotinib_and_Bevacizumab> <Maps_to> "Erlotinib_and_Bevacizumab" .
<MV> <Has_context> "Adjuvant_therapy" .
<IFL> <Has_modality> "Chemotherapy" .
<Rabbit_ATG> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<R-NIMP> <Has_antineoplastic> "Vinorelbine" .
<R-NIMP> <Has_antineoplastic> "Rituximab" .
<R-NIMP> <Has_antineoplastic> "Prednisone" .
<R-NIMP> <Has_antineoplastic> "Mitoxantrone" .
<R-NIMP> <Has_antineoplastic> "Ifosfamide" .
<Cytarabine_and_Idarubicin> <Has_supportive_med> "Lenograstim" .
<Teniposide> <Has_brand_name> "Vumon" .
<Risedol> <Brand_name_of> "Risedronate" .
<Inotuzumab_ozogamicin_monotherapy> <Has_modality> "Chemotherapy" .
<R-MP> <Is_a> "Rituximab-containing_regimen" .
<Nilotinib_monotherapy> <Has_accepted_use> "Systemic_mastocytosis" .
<Nilotinib_monotherapy> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Nilotinib_monotherapy> <Has_accepted_use> "Hypereosinophilic_syndrome" .
<Nilotinib_monotherapy> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Nilotinib_monotherapy> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Dacarbazine_monotherapy> <Has_antineoplastic> "Dacarbazine" .
<Sunitinib_monotherapy> <Has_accepted_use> "Thyroid_cancer" .
<Sunitinib_monotherapy> <Has_accepted_use> "Thymoma" .
<Sunitinib_monotherapy> <Has_accepted_use> "Testicular_cancer" .
<Sunitinib_monotherapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<Sunitinib_monotherapy> <Has_accepted_use> "Renal_cell_carcinoma" .
<Sunitinib_monotherapy> <Has_accepted_use> "Pancreatic_NET" .
<Sunitinib_monotherapy> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Sunitinib_monotherapy> <Has_accepted_use> "Gastrointestinal_stromal_tumor" .
<CVB> <Has_context> "Salvage_therapy" .
<Ketoconazole,_Hydrocortisone,_Dutasteride> <Has_context> "Non-curative_second-line_therapy" .
<PCO> <Has_antineoplastic> "Pentostatin" .
<PCO> <Has_antineoplastic> "Ofatumumab" .
<PCO> <Has_antineoplastic> "Cyclophosphamide" .
<Cytarabine,_Idarubicin,_Rituximab> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Levamisole_monotherapy> <Has_antineoplastic> "Levamisole" .
<CIA> <Has_supportive_med> "Valacyclovir" .
<CIA> <Has_supportive_med> "Levofloxacin" .
<CIA> <Has_supportive_med> "Itraconazole" .
<CIA> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Tamibarotene_monotherapy> <Has_context> "Induction_therapy" .
<Reduction_of_immunosuppression> <Has_accepted_use> "Post-transplant_lymphoproliferative_disorder" .
<BuFlu,_then_allo_HSCT> <Is_current_in> "Acute_myeloid_leukemia" .
<ADT_and_RT> <Has_modality> "Radiotherapy" .
<ADT_and_RT> <Has_modality> "Hormonotherapy" .
<Cobimetinib_and_Vemurafenib> <Has_context> "Non-curative_therapy" .
<Venetoclax> <Has_accepted_use> "Multiple_myeloma" .
<Venetoclax> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Venetoclax> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Venetoclax> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Ranimustine> <Has_brand_name> "Cymerin" .
<Ranimustine> <Has_brand_name> "Cymer" .
<CHAD> <Has_antineoplastic> "Doxorubicin" .
<CHAD> <Has_antineoplastic> "Cyclophosphamide" .
<CHAD> <Has_antineoplastic> "Cisplatin" .
<CHAD> <Has_antineoplastic> "Altretamine" .
<TAD_(Thalidomide)> <Has_context> "Non-curative_first-line_therapy" .
<Peginterferon_alfa-2a_monotherapy> <Mapped_from> "Peginterferon_alfa-2a_monotherapy" .
<Aspirin_monotherapy> <Maps_to> "Aspirin_monotherapy" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine> <Mapped_from> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine" .
<Duobact> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<GemOx> <Mapped_from> "GemOx" .
<TAD_(Thalidomide)> <Has_modality> "Chemotherapy" .
<Lenalidomide_monotherapy> <Has_supportive_med> "Warfarin" .
<Lenalidomide_monotherapy> <Has_supportive_med> "Pamidronate" .
<Lenalidomide_monotherapy> <Has_supportive_med> "Low_molecular_weight_heparins" .
<Lenalidomide_monotherapy> <Has_supportive_med> "Ciprofloxacin" .
<Lenalidomide_monotherapy> <Has_supportive_med> "Aspirin" .
<Lenalidomide_monotherapy> <Has_supportive_med> "Allopurinol" .
<Irinotecan_and_Temozolomide> <Has_supportive_med> "Loperamide" .
<Irinotecan_and_Temozolomide> <Has_supportive_med> "Cefixime" .
<Aspirin_and_Dexamethasone> <Has_modality> "Hormonotherapy" .
<Temozolomide_and_low-dose_RT> <Is_current_in> "Glioblastoma" .
<Cyclophosphamide_and_TBI,_then_allo_HSCT> <Has_context> "Non-curative_therapy" .
<Cyclophosphamide_and_TBI,_then_allo_HSCT> <Has_context> "Consolidation_after_upfront_therapy" .
<Cyclophosphamide_and_TBI,_then_allo_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<Gemcitabine_and_S-1> <Mapped_from> "Gemcitabine_and_S-1" .
<Dexapro> <Brand_name_of> "Dexamethasone" .
<HAM> <Is_a> "Anthracycline-containing_regimen" .
<Cisplatin> <May_have_route> "Intravenous" .
<Cisplatin> <May_have_route> "Intracavitary" .
<MVPP> <Has_modality> "Chemotherapy" .
<Cortalone> <Brand_name_of> "Prednisolone" .
<Leuprolide> <Antineoplastic_of> "Leuprolide_monotherapy" .
<Leuprolide> <Antineoplastic_of> "Flutamide,_Leuprolide,_RT" .
<Leuprolide> <Antineoplastic_of> "Flutamide_and_Leuprolide" .
<Leuprolide> <Antineoplastic_of> "Bicalutamide_and_Leuprolide" .
<Anti-CD47_antibody> <Is_a> "Antibody_medication" .
<Cyclophosphamide_and_Topotecan> <Has_context> "Non-curative_therapy" .
<Cyclophosphamide_and_Topotecan> <Has_context> "Non-curative_subsequent-line_therapy" .
<Tamoxifen_and_OFS> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Tamoxifen_and_OFS> <Has_accepted_use> "Breast_cancer" .
<Stedex> <Brand_name_of> "Dexamethasone" .
<BV-CHP> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<BV-CHP> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<RCC> <Has_antineoplastic> "Rituximab" .
<RCC> <Has_antineoplastic> "Cyclophosphamide" .
<RCC> <Has_antineoplastic> "Cladribine" .
<RABVD> <Has_antineoplastic> "Vinblastine" .
<RABVD> <Has_antineoplastic> "Rituximab" .
<RABVD> <Has_antineoplastic> "Doxorubicin" .
<RABVD> <Has_antineoplastic> "Dacarbazine" .
<RABVD> <Has_antineoplastic> "Bleomycin" .
<EC> <Is_current_in> "Breast_cancer" .
<TCP> <Maps_to> "TCP" .
<Cisplatin,_Vinblastine,_RT> <Has_modality> "Radiotherapy" .
<Cisplatin,_Vinblastine,_RT> <Has_modality> "Chemotherapy" .
<Abatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Lanreotide_Depot/Autogel_monotherapy> <Has_context> "All_lines_of_therapy" .
<Anaplastic_large_cell_lymphoma> <FDA_indication_of> "Brentuximab_vedotin" .
<ATRA,_Cytarabine,_Idarubicin> <Maps_to> "ATRA,_Cytarabine,_Idarubicin" .
<Tripur> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<All-trans_retinoic_acid> <Has_FDA_indication> "Acute_promyelocytic_leukemia" .
<Ibrutinib_monotherapy> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Ibrutinib_monotherapy> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Ibrutinib_monotherapy> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Ibrutinib_monotherapy> <Has_accepted_use> "Graft_versus_host_disease" .
<Ibrutinib_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<Ibrutinib_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Ibrutinib_monotherapy> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Beposid> <Brand_name_of> "Etoposide" .
<Bacterial> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Dexamethasone_and_Eltrombopag> <Maps_to> "Dexamethasone_and_Eltrombopag" .
<TH_(Taxol)> <Has_modality> "Chemotherapy" .
<Belinostat> <Has_brand_name> "Beleodaq" .
<BLD> <Has_context> "Non-curative_therapy" .
<Cetuximab> <Is_a> "Protein_expression-specific_medication" .
<Cetuximab> <Is_a> "Neutral" .
<Cetuximab> <Is_a> "Mutation-specific_medication" .
<Cetuximab> <Is_a> "Antibody_medication" .
<Cetuximab> <Is_a> "Anti-EGFR_antibody" .
<Ondasetron> <Brand_name_of> "Ondansetron" .
<TH_(Taxol)> <Mapped_from> "TH_(Taxol)" .
<Carboplatin_and_Cyclophosphamide> <Has_context> "Non-curative_first-line_therapy" .
<TH_(Taxotere/SC)> <Maps_to> "TH_(Taxotere/SC)" .
<MF> <Mapped_from> "MF" .
<Abiraterone> <May_have_route> "Oral" .
<OPPA> <Maps_to> "OPPA" .
<Irinotecan_and_Mitomycin> <Has_antineoplastic> "Mitomycin" .
<Irinotecan_and_Mitomycin> <Has_antineoplastic> "Irinotecan" .
<Ibrutinib_and_Obinutuzumab> <Has_context> "Non-curative_first-line_therapy" .
<Flutamide,_Goserelin,_RT> <Has_context> "Definitive_therapy" .
<ATG_(Horse),_Cyclosporine,_Methylprednisolone> <Is_current_in> "Aplastic_anemia" .
<Nevkine> <Brand_name_of> "Filgrastim" .
<C-BOP> <Is_current_in> "Testicular_cancer" .
<Doxorubicin_pegylated_liposomal_and_Trabectedin> <Has_context> "Non-curative_therapy" .
<Osimertinib> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Carboplatin_and_Vinorelbine> <Has_context> "Non-curative_first-line_therapy" .
<Cyclophosphamide_and_TBI,_then_allo_HSCT> <Is_current_in> "Chronic_myelogenous_leukemia" .
<Cyclophosphamide_and_TBI,_then_allo_HSCT> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Cyclophosphamide_and_TBI,_then_allo_HSCT> <Is_current_in> "Acute_myeloid_leukemia" .
<Thioguanine> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Thioguanine> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Thioguanine> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Thioguanine> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Belotecan_and_Cisplatin> <Has_context> "Induction_therapy" .
<G-CVP> <Has_accepted_use> "Follicular_lymphoma" .
<Doxorubicin_and_Vinblastine> <Has_accepted_use> "Hodgkin_lymphoma" .
<Somatuline_LA> <Brand_name_of> "Lanreotide" .
<ESHAP> <Is_current_in> "Hodgkin_lymphoma" .
<OFAR> <Is_current_in> "Transformed_lymphoma" .
<OFAR> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Chlorambucil_monotherapy> <Has_antineoplastic> "Chlorambucil" .
<Inotuzumab_ozogamicin_monotherapy> <Has_antineoplastic> "Inotuzumab_ozogamicin" .
<Nevexitin> <Brand_name_of> "Vincristine" .
<Non-curative_second-line_therapy> <Maps_to> "Non-curative_second-line_therapy" .
<IPH_2101> <Is_a> "Investigational_drug" .
<IPH_2101> <Is_a> "Immunotherapeutic" .
<IPH_2101> <Is_a> "Antibody_medication" .
<IPH_2101> <Is_a> "Anti-KIR_antibody" .
<TTR> <Has_supportive_med> "Filgrastim" .
<TTR> <Has_supportive_med> "Diphenhydramine" .
<TTR> <Has_supportive_med> "Dexamethasone" .
<Rivaroxaban_monotherapy> <Has_context> "Prophylaxis" .
<Rivaroxaban_monotherapy> <Has_context> "Anticoagulation" .
<Rivaroxaban_monotherapy> <Has_context> "All_lines_of_therapy" .
<BCNU/TT> <Has_modality> "Chemotherapy" .
<Octreotide_and_Interferon_alfa> <Mapped_from> "Octreotide_and_Interferon_alfa" .
<Paclitaxel_and_RT> <Is_current_in> "Head_and_neck_cancer" .
<Paclitaxel_and_RT> <Is_current_in> "Bladder_cancer" .
<Cabazitaxel_and_Prednisone> <Is_current_in> "Prostate_cancer" .
<CRD> <Maps_to> "CRD" .
<iddEPC> <Has_modality> "Chemotherapy" .
<Capecitabine_and_Neratinib> <Has_antineoplastic> "Neratinib" .
<Capecitabine_and_Neratinib> <Has_antineoplastic> "Capecitabine" .
<Vismodegib> <Has_brand_name> "Erivedge" .
<Carboplatin_and_Docetaxel> <Is_current_in> "Prostate_cancer" .
<Carboplatin_and_Docetaxel> <Is_current_in> "Ovarian_cancer" .
<Carboplatin_and_Docetaxel> <Is_current_in> "Non-small_cell_lung_cancer" .
<Carboplatin_and_Docetaxel> <Is_current_in> "Head_and_neck_cancer" .
<Carboplatin_and_Docetaxel> <Is_current_in> "Gastric_cancer" .
<Carboplatin_and_Docetaxel> <Is_current_in> "Cervical_cancer" .
<Carboplatin_and_Docetaxel> <Is_current_in> "Breast_cancer" .
<Carboplatin_and_Docetaxel> <Is_current_in> "Adenocarcinoma_of_unknown_primary" .
<Inherited_thrombophilia> <Is_a> "Thrombotic_disorder" .
<Letrozole> <Has_accepted_use> "Breast_cancer" .
<Flutamide,_Goserelin,_RT> <Has_modality> "Radiotherapy" .
<Flutamide,_Goserelin,_RT> <Has_modality> "Hormonotherapy" .
<Immune_thrombocytopenia> <Is_a> "Cytopenia" .
<Immune_thrombocytopenia> <Is_a> "Bleeding_disorder" .
<Immune_thrombocytopenia> <Is_a> "Autoimmune_hematologic_condition" .
<TPC> <Mapped_from> "TPC" .
<Ciprofloxacin> <Is_a> "Fluoroquinolone" .
<Domperidone> <Supportive_med_of> "PCV" .
<Myeloproliferative_neoplasm> <Is_a> "Malignant_hematologic_neoplasm" .
<CAMP> <Is_historical_in> "Non-small_cell_lung_cancer" .
<nab-Paclitaxel_monotherapy> <Maps_to> "nab-Paclitaxel_monotherapy" .
<VAD> <Has_accepted_use> "Multiple_myeloma" .
<ACVBP> <Has_local_therapy> "Methotrexate" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Inherited_coagulopathy> <Is_a> "Bleeding_disorder" .
<Lanreotide_and_Interferon_alfa-2b> <Is_current_in> "Pancreatic_NET" .
<Lanreotide_and_Interferon_alfa-2b> <Is_current_in> "Neuroendocrine_tumor" .
<CHOP-14> <Has_antineoplastic> "Vincristine" .
<CHOP-14> <Has_antineoplastic> "Prednisone" .
<CHOP-14> <Has_antineoplastic> "Doxorubicin" .
<CHOP-14> <Has_antineoplastic> "Cyclophosphamide" .
<CMC> <Is_a> "Anthracycline-containing_regimen" .
<Niraparib_monotherapy> <Mapped_from> "Niraparib_monotherapy" .
<P2Y12_ADP_inhibitor> <Subsumes> "Ticlopidine" .
<P2Y12_ADP_inhibitor> <Subsumes> "Ticagrelor" .
<P2Y12_ADP_inhibitor> <Subsumes> "Prasugrel" .
<P2Y12_ADP_inhibitor> <Subsumes> "Clopidogrel" .
<P2Y12_ADP_inhibitor> <Subsumes> "Cangrelor" .
<Pd> <Has_supportive_med> "Aspirin" .
<Zorax> <Brand_name_of> "Acyclovir" .
<Chlorambusil> <Brand_name_of> "Chlorambucil" .
<CPR> <Has_context> "Non-curative_therapy" .
<CPR> <Has_context> "Non-curative_first-line_therapy" .
<Aspirin_and_dipyridamole> <Has_brand_name> "Aggrenox" .
<Letrozole_monotherapy> <Has_antineoplastic> "Letrozole" .
<TSC2_inhibitor> <Subsumes> "Everolimus" .
<Cycloplatinum> <Brand_name_of> "Carboplatin" .
<Busulfan_and_Fludarabine> <Has_modality> "Immunosuppressive_therapy" .
<Busulfan_and_Fludarabine> <Has_modality> "Chemotherapy" .
<FLAG-DNX> <Has_antineoplastic> "Fludarabine" .
<FLAG-DNX> <Has_antineoplastic> "Daunorubicin_liposomal" .
<FLAG-DNX> <Has_antineoplastic> "Cytarabine" .
<Carboplatin_and_Fluorouracil> <Mapped_from> "Carboplatin_and_Fluorouracil" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine> <Has_context> "Consolidation_after_upfront_therapy" .
<Esbesul> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Uroprot> <Brand_name_of> "Mesna" .
<Glitax> <Brand_name_of> "Prasugrel" .
<PEN> <Has_modality> "Chemotherapy" .
<eBEACOPP_(Prednisolone)> <Mapped_from> "eBEACOPP_(Prednisolone)" .
<Abemaciclib_and_Anastrozole> <Has_modality> "Hormonotherapy" .
<Abemaciclib_and_Anastrozole> <Has_modality> "Chemotherapy" .
<Actispirine> <Brand_name_of> "Aspirin" .
<Xerazole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Fedratinib> <Has_accepted_use> "Myelofibrosis" .
<FAS> <Maps_to> "FAS" .
<Novozole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<VBMCP/VBAD> <Has_modality> "Chemotherapy" .
<Radotinib_monotherapy> <Has_modality> "Chemotherapy" .
<R-CHOP-14_(Prednisolone)> <Is_a> "Rituximab-containing_regimen" .
<R-CHOP-14_(Prednisolone)> <Is_a> "Anthracycline-containing_regimen" .
<R-EPOCH> <Has_accepted_use> "Transformed_lymphoma" .
<R-EPOCH> <Has_accepted_use> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<R-EPOCH> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Aclarubicin> <Is_a> "Topoisomerase_inhibitor" .
<Aclarubicin> <Is_a> "PMDA_approved_drug" .
<Aclarubicin> <Is_a> "Anthracycline" .
<Tbo-filgrastim> <Is_a> "Granulocyte_colony-stimulating_factor" .
<CAV_and_RT> <Mapped_from> "CAV_and_RT" .
<Temoz> <Brand_name_of> "Temozolomide" .
<Ifaxol> <Brand_name_of> "Paclitaxel" .
<CEV_(Carboplatin/Etoposide)> <Has_modality> "Chemotherapy" .
<DexaBEAM> <Has_accepted_use> "Hodgkin_lymphoma" .
<Wiatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CHUT,_then_auto_HSCT> <Has_accepted_use> "Breast_cancer" .
<FELV> <Has_accepted_use> "Gallbladder_cancer" .
<FELV> <Has_accepted_use> "Cholangiocarcinoma" .
<Trexan> <Brand_name_of> "Methotrexate" .
<Cicloxal> <Brand_name_of> "Cyclophosphamide" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone> <Has_modality> "Chemotherapy" .
<Quisulyn> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Gemcitabine_and_Paclitaxel> <Has_supportive_med> "Ranitidine" .
<Gemcitabine_and_Paclitaxel> <Has_supportive_med> "Diphenhydramine" .
<Gemcitabine_and_Paclitaxel> <Has_supportive_med> "Dexamethasone" .
<Gemcitabine_and_Paclitaxel> <Has_supportive_med> "Cimetidine" .
<Gemcitabine,_Cetuximab,_RT> <Is_current_in> "Pancreatic_cancer" .
<Aclarubicin> <Antineoplastic_of> "HAA" .
<Streptozocin> <Is_a> "Nitrosourea" .
<Streptozocin> <Is_a> "Alkylating_agent" .
<Predval> <Brand_name_of> "Prednisone" .
<Moxalas> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Doxorubicin_and_Streptozocin> <Has_antineoplastic> "Streptozocin" .
<Doxorubicin_and_Streptozocin> <Has_antineoplastic> "Doxorubicin" .
<CLAG-M> <Maps_to> "CLAG-M" .
<Cytarabine,_Idarubicin,_Vorinostat> <Has_antineoplastic> "Vorinostat" .
<Cytarabine,_Idarubicin,_Vorinostat> <Has_antineoplastic> "Idarubicin" .
<Cytarabine,_Idarubicin,_Vorinostat> <Has_antineoplastic> "Cytarabine" .
<Semustine> <Antineoplastic_of> "MOF" .
<Semustine> <Antineoplastic_of> "Fluorouracil_and_Semustine" .
<CCOP> <Mapped_from> "CCOP" .
<Rosai-Dorfman-Destombes_disease> <Is_a> "Histiocytosis" .
<Mitoxantrone_and_Prednisone> <Has_accepted_use> "Prostate_cancer" .
<Alisertib> <Is_a> "Kinase_inhibitor" .
<Alisertib> <Is_a> "Investigational_drug" .
<Alisertib> <Is_a> "Aurora_kinase_inhibitor" .
<TLI_and_ATG> <Maps_to> "TLI_and_ATG" .
<Benambax> <Brand_name_of> "Pentamidine" .
<Oropharyngeal_cancer> <Is_a> "Head_and_neck_cancer" .
<Axitinib_and_Avelumab> <Maps_to> "Axitinib_and_Avelumab" .
<R-CODOX-M/R-IVAC> <Has_modality> "Chemotherapy" .
<Arendal> <Brand_name_of> "Alendronate" .
<Fer-Iron> <Brand_name_of> "Ferrous_sulfate" .
<Everolimus_and_Lenvatinib> <Has_accepted_use> "Renal_cell_carcinoma" .
<Pegfilgrastim-cbqv> <May_have_route> "Subcutaneous" .
<Non-curative_subsequent-line_induction_therapy> <Is_a> "Non-curative_subsequent-line_therapy" .
<Cisplatin,_Gemcitabine,_Bevacizumab> <Mapped_from> "Cisplatin,_Gemcitabine,_Bevacizumab" .
<DRC> <Has_context> "Non-curative_first-line_therapy" .
<Bendit> <Brand_name_of> "Bendamustine" .
<Entinostat> <Has_accepted_use> "Breast_cancer" .
<VACOP-B> <Has_antineoplastic> "Vincristine" .
<VACOP-B> <Has_antineoplastic> "Prednisone" .
<VACOP-B> <Has_antineoplastic> "Etoposide" .
<VACOP-B> <Has_antineoplastic> "Doxorubicin" .
<VACOP-B> <Has_antineoplastic> "Cyclophosphamide" .
<VACOP-B> <Has_antineoplastic> "Bleomycin" .
<Axoparin> <Brand_name_of> "Enoxaparin" .
<Ketoconazole> <Supportive_med_of> "Stanford_V" .
<Interferon_alfa-2a_and_Interleukin-2> <Has_antineoplastic> "Interferon_alfa-2a" .
<Interferon_alfa-2a_and_Interleukin-2> <Has_antineoplastic> "Aldesleukin" .
<Ergamisol> <Brand_name_of> "Levamisole" .
<Lenograstim> <Supportive_med_of> "TAC_(Taxotere)" .
<Lenograstim> <Supportive_med_of> "R-CHOP-14_(Prednisolone)" .
<Lenograstim> <Supportive_med_of> "R-CHOP-14" .
<Lenograstim> <Supportive_med_of> "R-CHOP_(Prednisolone)" .
<Lenograstim> <Supportive_med_of> "R-CHOP" .
<Lenograstim> <Supportive_med_of> "Pediatric-like_GRAALL_consolidation" .
<Lenograstim> <Supportive_med_of> "IGEV_and_G-CSF" .
<Lenograstim> <Supportive_med_of> "FLAG-Ida" .
<Lenograstim> <Supportive_med_of> "FLAG" .
<Lenograstim> <Supportive_med_of> "FAC" .
<Lenograstim> <Supportive_med_of> "Cytarabine,_Idarubicin,_Rituximab" .
<Lenograstim> <Supportive_med_of> "Cytarabine_and_Idarubicin" .
<Lenograstim> <Supportive_med_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab" .
<Lenograstim> <Supportive_med_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Lenograstim> <Supportive_med_of> "Cyclophosphamide_and_G-CSF" .
<Lenograstim> <Supportive_med_of> "Cisplatin_and_Doxorubicin" .
<Lenograstim> <Supportive_med_of> "ATG_(Horse),_Cyclosporine,_G-CSF" .
<Lenograstim> <Supportive_med_of> "ABVD,_DD-DI" .
<Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<ChlVPP/EVA> <Has_accepted_use> "Hodgkin_lymphoma" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA> <Mapped_from> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA" .
<EP> <Is_a> "Anthracycline-containing_regimen" .
<Mesnex> <Brand_name_of> "Mesna" .
<All-trans_retinoic_acid> <Supportive_med_of> "ATRA_and_Danazol" .
<Fludarabine,_then_131Iodine-Tositumomab> <Has_context> "Non-curative_first-line_therapy" .
<L-Asparaginase,_Vincristine,_Prednisone> <Has_context> "Non-curative_therapy" .
<L-Asparaginase,_Vincristine,_Prednisone> <Has_context> "Induction_therapy" .
<FOLFOX_chronotherapy> <Has_accepted_use> "Colon_cancer" .
<Caplacizumab> <Has_FDA_indication> "Thrombotic_thrombocytopenic_purpura" .
<Capecitabine> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Capecitabine> <Is_a> "PMDA_approved_drug" .
<Capecitabine> <Is_a> "Fluoropyrimidine" .
<Multiple_myeloma> <Historic_treated_by> "mCOP/MP" .
<Multiple_myeloma> <Historic_treated_by> "VMCP/VCAP" .
<Multiple_myeloma> <Historic_treated_by> "VMCP/VBAP" .
<Multiple_myeloma> <Historic_treated_by> "VMCP" .
<Multiple_myeloma> <Historic_treated_by> "VCP" .
<Multiple_myeloma> <Historic_treated_by> "VBMCP/VBAD" .
<Multiple_myeloma> <Historic_treated_by> "VBMCP" .
<Multiple_myeloma> <Historic_treated_by> "VBMC" .
<Multiple_myeloma> <Historic_treated_by> "VAMP" .
<Multiple_myeloma> <Historic_treated_by> "VAD_and_Cyclosporine" .
<Multiple_myeloma> <Historic_treated_by> "VAD" .
<Multiple_myeloma> <Historic_treated_by> "Tisagenlecleucel_monotherapy" .
<Multiple_myeloma> <Historic_treated_by> "RD" .
<Multiple_myeloma> <Historic_treated_by> "Prednisone_monotherapy" .
<Multiple_myeloma> <Historic_treated_by> "Prednisolone_monotherapy" .
<Multiple_myeloma> <Historic_treated_by> "Pomalidomide,_Dexamethasone,_Pembrolizumab" .
<Multiple_myeloma> <Historic_treated_by> "Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT" .
<Multiple_myeloma> <Historic_treated_by> "Melphalan,_then_auto_HSCT,_then_Melphalan_and_TBI,_then_auto_HSCT" .
<Multiple_myeloma> <Historic_treated_by> "Melphalan,_then_auto_HSCT,_then_Melphalan_and_Busulfan,_then_auto_HSCT" .
<Multiple_myeloma> <Historic_treated_by> "Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Multiple_myeloma> <Historic_treated_by> "Melphalan_monotherapy" .
<Multiple_myeloma> <Historic_treated_by> "Melphalan_and_TBI,_then_auto_HSCT" .
<Multiple_myeloma> <Historic_treated_by> "Melphalan_and_Methylprednisolone,_then_auto_HSCT" .
<Multiple_myeloma> <Historic_treated_by> "MP_(Prednisolone)" .
<Multiple_myeloma> <Historic_treated_by> "MP" .
<Multiple_myeloma> <Historic_treated_by> "MEL200,_then_auto_HSCT,_then_MEL220_and_Dexamethasone,_then_auto_HSCT" .
<Multiple_myeloma> <Historic_treated_by> "M-DEX" .
<Multiple_myeloma> <Historic_treated_by> "Interferon_alfa-2b_monotherapy" .
<Multiple_myeloma> <Historic_treated_by> "Interferon_alfa-2b_and_Thalidomide" .
<Multiple_myeloma> <Historic_treated_by> "Interferon_alfa-2b_and_Prednisone" .
<Multiple_myeloma> <Historic_treated_by> "Interferon_alfa-2a_monotherapy" .
<Multiple_myeloma> <Historic_treated_by> "Interferon_alfa_monotherapy" .
<Multiple_myeloma> <Historic_treated_by> "Interferon_alfa_and_Dexamethasone" .
<Multiple_myeloma> <Historic_treated_by> "EDAP" .
<Multiple_myeloma> <Historic_treated_by> "Dexamethasone_monotherapy" .
<Multiple_myeloma> <Historic_treated_by> "DEX-IFN" .
<Multiple_myeloma> <Historic_treated_by> "Cyclophosphamide_monotherapy" .
<Multiple_myeloma> <Historic_treated_by> "Carmustine_and_Doxorubicin" .
<Multiple_myeloma> <Historic_treated_by> "C-VAMP" .
<Multiple_myeloma> <Historic_treated_by> "ABCM" .
<Cisplatin_and_Doxorubicin> <Has_accepted_use> "Osteosarcoma" .
<Cisplatin_and_Doxorubicin> <Has_accepted_use> "Hepatoblastoma" .
<Cisplatin_and_Doxorubicin> <Has_accepted_use> "Endometrial_cancer" .
<Cisplatin_and_Doxorubicin> <Has_accepted_use> "Cutaneous_squamous_cell_carcinoma" .
<Cisplatin_and_Doxorubicin> <Has_accepted_use> "Cutaneous_basal_cell_carcinoma" .
<Letrozole> <Has_brand_name> "Lezole" .
<Letrozole> <Has_brand_name> "Lexel" .
<Letrozole> <Has_brand_name> "Letrozol" .
<Letrozole> <Has_brand_name> "Letroz" .
<Letrozole> <Has_brand_name> "Letroplex" .
<Letrozole> <Has_brand_name> "Letromina" .
<Letrozole> <Has_brand_name> "Letpro" .
<Letrozole> <Has_brand_name> "Letoval" .
<Letrozole> <Has_brand_name> "Lerozol" .
<Letrozole> <Has_brand_name> "Latrotal" .
<Letrozole> <Has_brand_name> "Gynotril" .
<Letrozole> <Has_brand_name> "Fempro" .
<Letrozole> <Has_brand_name> "Femara" .
<JAK_inhibitor> <Subsumes> "Tofacitinib" .
<JAK_inhibitor> <Subsumes> "Ruxolitinib" .
<JAK_inhibitor> <Subsumes> "Pacritinib" .
<JAK_inhibitor> <Subsumes> "Momelotinib" .
<JAK_inhibitor> <Subsumes> "Lestaurtinib" .
<JAK_inhibitor> <Subsumes> "Fedratinib" .
<Ranitidine> <May_have_route> "Oral" .
<Phenytoin> <May_have_route> "Oral" .
<MPV> <Has_context> "Upfront_therapy" .
<Avapritinib_monotherapy> <Has_antineoplastic> "Avapritinib" .
<Dexaroid> <Brand_name_of> "Dexamethasone" .
<Decitabine_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Decitabine_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Decitabine_monotherapy> <Has_context> "Non-curative_first-line_induction_therapy" .
<Moxadden> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CYM> <Mapped_from> "CYM" .
<Fluorouracil,_Folinic_acid,_Levamisole> <Mapped_from> "Fluorouracil,_Folinic_acid,_Levamisole" .
<SMO_or_PTCH-1_(Hedgehog)_medication> <Is_a> "Site-agnostic_medication" .
<RVR> <Has_context> "Non-curative_therapy" .
<Cisplatin,_Paclitaxel,_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<Trimephar> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin,_Etoposide,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Cisplatin,_Etoposide,_RT> <Has_antineoplastic> "Etoposide" .
<Cisplatin,_Etoposide,_RT> <Has_antineoplastic> "Cisplatin" .
<R-FCM> <Has_accepted_use> "Mantle_cell_lymphoma" .
<R-FCM> <Has_accepted_use> "Follicular_lymphoma" .
<R-FCM> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine> <Is_current_in> "Breast_cancer" .
<Carboplatin_and_Vincristine> <Maps_to> "Carboplatin_and_Vincristine" .
<ABVD> <Has_context> "Salvage_therapy" .
<ABVD> <Has_context> "Non-curative_therapy" .
<ABVD> <Has_context> "Induction_therapy" .
<Hyper-CVAD/MA> <Mapped_from> "Hyper-CVAD/MA" .
<Methylprednisolon> <Brand_name_of> "Methylprednisolone" .
<AV-CMF> <Mapped_from> "AV-CMF" .
<Ado-trastuzumab_emtansine_monotherapy> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<Ado-trastuzumab_emtansine_monotherapy> <Has_accepted_use> "ERBB2-mutated_malignancy" .
<Ado-trastuzumab_emtansine_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Atezolizumab_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Atezolizumab_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Atezolizumab_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Atezolizumab_monotherapy> <Has_context> "Neoadjuvant_therapy" .
<Nublexa> <Brand_name_of> "Regorafenib" .
<Blastovin> <Brand_name_of> "Vinblastine" .
<Cisplatin,_Dacarbazine,_Tamoxifen> <Maps_to> "Cisplatin,_Dacarbazine,_Tamoxifen" .
<R-MACLO/R-IVAM> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Romcis> <Brand_name_of> "Cisplatin" .
<Globaxol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cycram> <Brand_name_of> "Cyclophosphamide" .
<Isotretinoin_and_Dinutuximab> <Maps_to> "Isotretinoin_and_Dinutuximab" .
<Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib> <Has_antineoplastic> "Vincristine" .
<Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib> <Has_antineoplastic> "Prednisolone" .
<Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib> <Has_antineoplastic> "Nilotinib" .
<Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib> <Has_antineoplastic> "Daunorubicin" .
<Ibritumomab_tiuxetan_monotherapy> <Mapped_from> "Ibritumomab_tiuxetan_monotherapy" .
<Trimethoprim-Sulfamethoxazole> <May_have_route> "Oral" .
<Trimethoprim-Sulfamethoxazole> <May_have_route> "Intravenous" .
<Supect> <Brand_name_of> "Radotinib" .
<7_plus_3d> <Mapped_from> "7_plus_3d" .
<mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)> <Is_current_in> "Colon_cancer" .
<Methotrexate> <Has_brand_name> "Zexate" .
<Methotrexate> <Has_brand_name> "Unitrexate" .
<Methotrexate> <Has_brand_name> "Trixilem" .
<Methotrexate> <Has_brand_name> "Trexeron" .
<Methotrexate> <Has_brand_name> "Trexan" .
<Methotrexate> <Has_brand_name> "Trexall" .
<Methotrexate> <Has_brand_name> "Tremetex" .
<Methotrexate> <Has_brand_name> "Tratoben" .
<Methotrexate> <Has_brand_name> "Texorate" .
<Methotrexate> <Has_brand_name> "Texate" .
<Methotrexate> <Has_brand_name> "Tecnomet" .
<Methotrexate> <Has_brand_name> "Rheumatrex" .
<Methotrexate> <Has_brand_name> "Rextop" .
<Methotrexate> <Has_brand_name> "Reumatrex" .
<Methotrexate> <Has_brand_name> "Remtrex" .
<Methotrexate> <Has_brand_name> "Pharmatrexate" .
<Methotrexate> <Has_brand_name> "Oncotrex" .
<Methotrexate> <Has_brand_name> "O_Trexat" .
<Methotrexate> <Has_brand_name> "Novatrex" .
<Methotrexate> <Has_brand_name> "Neotrexate" .
<Methotrexate> <Has_brand_name> "Neometho" .
<Methotrexate> <Has_brand_name> "Miantrex_CS" .
<Methotrexate> <Has_brand_name> "Mexate" .
<Methotrexate> <Has_brand_name> "Metrotex" .
<Methotrexate> <Has_brand_name> "Metrexato" .
<Methotrexate> <Has_brand_name> "Metrexan" .
<Methotrexate> <Has_brand_name> "Metrex" .
<Methotrexate> <Has_brand_name> "Metotrexol" .
<Methotrexate> <Has_brand_name> "Metotrexato" .
<Methotrexate> <Has_brand_name> "Metotrexate" .
<Methotrexate> <Has_brand_name> "Metotressato" .
<Methotrexate> <Has_brand_name> "Metolate" .
<Methotrexate> <Has_brand_name> "Meticil" .
<Methotrexate> <Has_brand_name> "Methotrexatum" .
<Methotrexate> <Has_brand_name> "Methotrexato" .
<Methotrexate> <Has_brand_name> "Methotrexat" .
<Methotrexate> <Has_brand_name> "Methotrexaat" .
<Methotrexate> <Has_brand_name> "Methorex" .
<Methotrexate> <Has_brand_name> "Methoblastin" .
<Methotrexate> <Has_brand_name> "Methobax" .
<Methotrexate> <Has_brand_name> "Metex" .
<Methotrexate> <Has_brand_name> "Merex" .
<Methotrexate> <Has_brand_name> "Medsatrexate" .
<Methotrexate> <Has_brand_name> "Maxtrex" .
<Methotrexate> <Has_brand_name> "Matrex" .
<Methotrexate> <Has_brand_name> "Lumexon" .
<Methotrexate> <Has_brand_name> "Ledertrexato" .
<Methotrexate> <Has_brand_name> "Ledertrexate" .
<Methotrexate> <Has_brand_name> "Imutrex" .
<Methotrexate> <Has_brand_name> "Ifamet" .
<Methotrexate> <Has_brand_name> "Hextrate" .
<Methotrexate> <Has_brand_name> "Folitrax" .
<Methotrexate> <Has_brand_name> "Folex_PFS" .
<Methotrexate> <Has_brand_name> "Fauldmetro" .
<Methotrexate> <Has_brand_name> "Farmitrexat" .
<Methotrexate> <Has_brand_name> "Ervemin" .
<Methotrexate> <Has_brand_name> "Emthexate" .
<Methotrexate> <Has_brand_name> "Emthexat" .
<Methotrexate> <Has_brand_name> "Ebetrexat" .
<Methotrexate> <Has_brand_name> "Cytotrexate" .
<Methotrexate> <Has_brand_name> "Caditrex" .
<Methotrexate> <Has_brand_name> "Biotrexate" .
<Methotrexate> <Has_brand_name> "Biometrox" .
<Methotrexate> <Has_brand_name> "Artrait" .
<Methotrexate> <Has_brand_name> "Antifolan" .
<Methotrexate> <Has_brand_name> "Alltrex" .
<Methotrexate> <Has_brand_name> "Abitrexate" .
<Oprozomib> <Has_accepted_use> "Multiple_myeloma" .
<Formestane_monotherapy> <Has_context> "Non-curative_therapy" .
<Ivosidenib> <Has_accepted_use> "Acute_myeloid_leukemia" .
<ddAC> <Is_current_in> "Breast_cancer" .
<Tinzaparin_monotherapy> <Has_context> "All_lines_of_therapy" .
<Fytosid> <Brand_name_of> "Etoposide" .
<Carboplatin,_Paclitaxel,_Ipilimumab> <Maps_to> "Carboplatin,_Paclitaxel,_Ipilimumab" .
<Radioimmunotherapy> <Maps_to> "Radioimmunotherapy" .
<Cisplatin,_Pemetrexed,_Pembrolizumab> <Has_modality> "Immunotherapy" .
<Cisplatin,_Pemetrexed,_Pembrolizumab> <Has_modality> "Chemotherapy" .
<Bevacizumab-containing_therapy> <Is_a> "Bevacizumab-containing_regimen" .
<Herzass> <Brand_name_of> "Aspirin" .
<IT_Methotrexate_and_Methylprednisolone> <Has_context> "Local_therapy" .
<Idelalisib_monotherapy> <Has_context> "Non-curative_therapy" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Mapped_from> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Sorafenib> <Antineoplastic_of> "mFOLFOX_and_Sorafenib" .
<Sorafenib> <Antineoplastic_of> "Sorafenib_monotherapy" .
<Sorafenib> <Antineoplastic_of> "IDAC_and_Sorafenib" .
<Sorafenib> <Antineoplastic_of> "HAIC_and_Sorafenib" .
<Sorafenib> <Antineoplastic_of> "GemOx_and_Sorafenib" .
<Sorafenib> <Antineoplastic_of> "Cytarabine,_Idarubicin,_Sorafenib" .
<Sorafenib> <Antineoplastic_of> "Capecitabine,_Sorafenib,_RT" .
<Sorafenib> <Antineoplastic_of> "Azacitidine_and_Sorafenib" .
<Sorafenib> <Antineoplastic_of> "7_plus_3i_and_Sorafenib" .
<Sorafenib> <Antineoplastic_of> "7_plus_3d_and_Sorafenib" .
<WBRT> <Mapped_from> "WBRT" .
<Avodart> <Brand_name_of> "Dutasteride" .
<R-DexaBEAM> <Has_antineoplastic> "Rituximab" .
<R-DexaBEAM> <Has_antineoplastic> "Melphalan" .
<R-DexaBEAM> <Has_antineoplastic> "Etoposide" .
<R-DexaBEAM> <Has_antineoplastic> "Dexamethasone" .
<R-DexaBEAM> <Has_antineoplastic> "Cytarabine" .
<R-DexaBEAM> <Has_antineoplastic> "Carmustine" .
<Pentostatin_and_Alemtuzumab> <Mapped_from> "Pentostatin_and_Alemtuzumab" .
<Roxtrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<FOLFIRI_and_Panitumumab> <Maps_to> "FOLFIRI_and_Panitumumab" .
<Axitinib> <Has_brand_name> "Inlyta" .
<Stilbest> <Brand_name_of> "Diethylstilbestrol" .
<TAD_(Tamoxifen)> <Mapped_from> "TAD_(Tamoxifen)" .
<Tegafur,_Uracil,_Folinic_acid> <Is_current_in> "Colon_cancer" .
<Pravastatin> <Has_brand_name> "Pravachol" .
<Mitoxantrone_and_Prednisone> <Is_a> "Anthracycline-containing_regimen" .
<Bionesp> <Brand_name_of> "Darbepoetin_alfa" .
<EZH2_inhibitor> <Subsumes> "Tazemetostat" .
<Tivorbex> <Brand_name_of> "Indomethacin" .
<FLAG> <Has_modality> "Growth_factor_therapy" .
<FLAG> <Has_modality> "Chemotherapy" .
<Mechlorethamine_monotherapy> <Has_antineoplastic> "Mechlorethamine" .
<Siltuximab> <Has_accepted_use> "Castleman_disease" .
<Paclitaxel_and_Pazopanib> <Maps_to> "Paclitaxel_and_Pazopanib" .
<CALGB_8811_late_intensification> <Is_a> "Anthracycline-containing_regimen" .
<Ondavell> <Brand_name_of> "Ondansetron" .
<Interferon_alfa-n1_monotherapy> <Maps_to> "Interferon_alfa-n1_monotherapy" .
<Cardioaspirine> <Brand_name_of> "Aspirin" .
<Etoposide_and_Mitoxantrone> <Has_antineoplastic> "Mitoxantrone" .
<Etoposide_and_Mitoxantrone> <Has_antineoplastic> "Etoposide" .
<Cisplatin,_Docetaxel,_RT> <Has_context> "Neoadjuvant_therapy" .
<Cisplatin,_Docetaxel,_RT> <Has_context> "Definitive_therapy" .
<ABVE-PC> <Mapped_from> "ABVE-PC" .
<7_plus_3d_and_Midostaurin> <Is_a> "Anthracycline-containing_regimen" .
<Sultrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Dactinomycin_monotherapy> <Has_antineoplastic> "Dactinomycin" .
<R-ICE> <Has_modality> "Chemotherapy" .
<CC> <Has_modality> "Chemotherapy" .
<Lenvatinib> <Is_a> "VEGFR_inhibitor" .
<Lenvatinib> <Is_a> "RET_inhibitor" .
<Lenvatinib> <Is_a> "PDGFR_inhibitor" .
<Lenvatinib> <Is_a> "Kinase_inhibitor" .
<Lenvatinib> <Is_a> "KIT_inhibitor" .
<Lenvatinib> <Is_a> "FGFR_inhibitor" .
<Bendamustine_and_Obinutuzumab> <Has_accepted_use> "Follicular_lymphoma" .
<Bendamustine_and_Obinutuzumab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<RVDC> <Has_modality> "Chemotherapy" .
<Desason> <Brand_name_of> "Dexamethasone" .
<MPT> <Mapped_from> "MPT" .
<Leuprolide_monotherapy> <Mapped_from> "Leuprolide_monotherapy" .
<Mocetinostat> <Is_a> "Investigational_drug" .
<Mocetinostat> <Is_a> "HDAC_inhibitor" .
<AT_(Taxol)> <Has_modality> "Chemotherapy" .
<Azacitidine_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Azacitidine_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Azacitidine_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Azacitidine_monotherapy> <Has_context> "Non-curative_first-line_induction_therapy" .
<Azacitidine_monotherapy> <Has_context> "Consolidation_after_upfront_therapy" .
<Zometa> <Brand_name_of> "Zoledronic_acid" .
<mFOLFOX6_and_RT> <Is_current_in> "Rectal_cancer" .
<Heparin_monotherapy> <Has_accepted_use> "Venous_thromboembolism" .
<MT-R> <Has_modality> "Chemotherapy" .
<CVP_(Prednisolone)> <Maps_to> "CVP_(Prednisolone)" .
<Axitinib_and_TACE> <Maps_to> "Axitinib_and_TACE" .
<m-BNCOD> <Has_modality> "Chemotherapy" .
<MOR208> <Is_a> "Investigational_drug" .
<MOR208> <Is_a> "Antibody_medication" .
<MOR208> <Is_a> "Anti-CD19_antibody" .
<Solumedrol> <Brand_name_of> "Methylprednisolone" .
<LoDAC> <Maps_to> "LoDAC" .
<Capecitabine,_Pertuzumab,_Trastuzumab> <Has_antineoplastic> "Trastuzumab" .
<Capecitabine,_Pertuzumab,_Trastuzumab> <Has_antineoplastic> "Pertuzumab" .
<Capecitabine,_Pertuzumab,_Trastuzumab> <Has_antineoplastic> "Capecitabine" .
<Isotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cyclophosphamide_and_G-CSF> <Has_context> "All_lines_of_therapy" .
<Brigatinib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cytarabine_and_Mitoxantrone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Cytarabine_and_Mitoxantrone> <Is_current_in> "Acute_myeloid_leukemia" .
<KRd> <Has_context> "Non-curative_therapy" .
<KRd> <Has_context> "Non-curative_first-line_therapy" .
<KRd> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<CCE> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Pegfilgrastim> <May_have_route> "Subcutaneous" .
<Sandostatin_LAR_Depot> <Brand_name_of> "Octreotide_LAR" .
<7_plus_3i_and_Sorafenib> <Has_modality> "Chemotherapy" .
<Tytrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Chidamide_monotherapy> <Has_context> "Non-curative_therapy" .
<Fluoroquinolone> <Subsumes> "Levofloxacin" .
<Fluoroquinolone> <Subsumes> "Ciprofloxacin" .
<Fluorouracil,_Folinic_acid,_Levamisole> <Has_context> "Adjuvant_therapy" .
<Z-BEAM,_then_auto_HSCT> <Maps_to> "Z-BEAM,_then_auto_HSCT" .
<Dexa_Clinit> <Brand_name_of> "Dexamethasone" .
<RBC_transfusions> <Is_current_in> "Sickle_cell_anemia" .
<Radiation_therapy> <Has_antineoplastic> "External_beam_radiotherapy" .
<Radiation_therapy> <Has_antineoplastic> "Brachytherapy" .
<R-CHOP-14> <Mapped_from> "R-CHOP-14" .
<DA-EPOCH> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<DA-EPOCH> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<DA-EPOCH> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<C-Platin> <Brand_name_of> "Cisplatin" .
<Tivantinib> <Is_a> "MET_inhibitor" .
<Tivantinib> <Is_a> "Kinase_inhibitor" .
<Tivantinib> <Is_a> "Investigational_drug" .
<Eucalen> <Brand_name_of> "Alendronate" .
<Norethandrolone> <Has_brand_name> "Nilevar" .
<Cisplatin_and_Paclitaxel> <Is_current_in> "Ovarian_cancer" .
<Cisplatin_and_Paclitaxel> <Is_current_in> "Non-small_cell_lung_cancer" .
<Cisplatin_and_Paclitaxel> <Is_current_in> "Head_and_neck_cancer" .
<Cisplatin_and_Paclitaxel> <Is_current_in> "Esophageal_cancer" .
<Cisplatin_and_Paclitaxel> <Is_current_in> "Endometrial_cancer" .
<Cisplatin_and_Paclitaxel> <Is_current_in> "Cutaneous_basal_cell_carcinoma" .
<Cisplatin_and_Paclitaxel> <Is_current_in> "Cervical_cancer" .
<DEB-TACE> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Ribociclib_and_Tamoxifen> <Has_context> "Non-curative_first-line_therapy" .
<Bone_protective_medication> <Is_a> "Supportive_medication" .
<Capecitabine,_Bevacizumab,_Trastuzumab> <Has_modality> "Chemotherapy" .
<Fluorouracil_and_Streptozocin> <Has_context> "All_lines_of_therapy" .
<Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib> <Maps_to> "Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib" .
<ERBB4_inhibitor> <Is_a> "Kinase_inhibitor" .
<LOPP> <Is_historical_in> "Hodgkin_lymphoma" .
<ProMACE-CytaBOM> <Has_antineoplastic> "Vincristine" .
<ProMACE-CytaBOM> <Has_antineoplastic> "Prednisone" .
<ProMACE-CytaBOM> <Has_antineoplastic> "Methotrexate" .
<ProMACE-CytaBOM> <Has_antineoplastic> "Etoposide" .
<ProMACE-CytaBOM> <Has_antineoplastic> "Doxorubicin" .
<ProMACE-CytaBOM> <Has_antineoplastic> "Cytarabine" .
<ProMACE-CytaBOM> <Has_antineoplastic> "Cyclophosphamide" .
<ProMACE-CytaBOM> <Has_antineoplastic> "Bleomycin" .
<FOLFOX4_(L-Leucovorin)> <Has_accepted_use> "Colon_cancer" .
<Letrozole_monotherapy> <Is_a> "Antiestrogen-containing_regimen" .
<Carboplatin,_Pemetrexed,_Bevacizumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<Laspar> <Brand_name_of> "Asparaginase" .
<Testicular_cancer> <FDA_indication_of> "Etoposide" .
<Testicular_cancer> <FDA_indication_of> "Dactinomycin" .
<ATG_(Horse),_Cyclosporine,_Eltrombopag> <Maps_to> "ATG_(Horse),_Cyclosporine,_Eltrombopag" .
<Ibritumomab_tiuxetan_monotherapy> <Has_antineoplastic> "Rituximab" .
<Ibritumomab_tiuxetan_monotherapy> <Has_antineoplastic> "Ibritumomab_tiuxetan" .
<Infesin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Tegafur_gimeracil_oteracil> <May_have_route> "Oral" .
<CVP_(Vinblastine/Prednisone)> <Has_accepted_use> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<Dexafarm> <Brand_name_of> "Dexamethasone" .
<Carboplatin_and_Cisplatin> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Adakveo> <Brand_name_of> "Crizanlizumab" .
<Cisplatin,_Etoposide,_Durvalumab> <Is_current_in> "Small_cell_lung_cancer" .
<Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone> <Is_historical_in> "Acute_myeloid_leukemia" .
<Octreotide> <May_have_route> "Subcutaneous" .
<Octreotide> <May_have_route> "Intravenous" .
<Imexim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin_and_Vindesine> <Is_current_in> "Non-small_cell_lung_cancer" .
<WHO_Essential_Medicine> <Subsumes> "WHO_Essential_Pain_and_Palliative_Care_Medicine" .
<WHO_Essential_Medicine> <Subsumes> "WHO_Essential_Cancer_Medicine" .
<WHO_Essential_Medicine> <Subsumes> "WHO_Essential_Anti-infective_Medicine" .
<HDMP-R> <Has_context> "Non-curative_therapy" .
<HDMP-R> <Has_context> "Non-curative_first-line_therapy" .
<Altretamine_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Glasdegib> <May_have_route> "Oral" .
<OXAFAFU> <Mapped_from> "OXAFAFU" .
<CPR> <Is_current_in> "Multiple_myeloma" .
<Dacarbazine_monotherapy> <Has_accepted_use> "Uveal_melanoma" .
<Dacarbazine_monotherapy> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Dacarbazine_monotherapy> <Has_accepted_use> "NRAS-mutated_Melanoma" .
<Dacarbazine_monotherapy> <Has_accepted_use> "Melanoma" .
<Dacarbazine_monotherapy> <Has_accepted_use> "Liposarcoma" .
<Dacarbazine_monotherapy> <Has_accepted_use> "Leiomyosarcoma" .
<Dacarbazine_monotherapy> <Has_accepted_use> "BRAF-mutated_Melanoma" .
<Ferevan> <Brand_name_of> "Warfarin" .
<Recormon> <Brand_name_of> "Epoetin_alfa" .
<Bortezomib_and_Melphalan> <Has_accepted_use> "Autologous_HSCT" .
<BDR> <Has_modality> "Chemotherapy" .
<Bevyxxa> <Brand_name_of> "Betrixaban" .
<FluBuCy,_then_allo_HSCT> <Has_immunosuppressor> "Tacrolimus" .
<FluBuCy,_then_allo_HSCT> <Has_immunosuppressor> "Mycophenolate_mofetil" .
<FluBuCy,_then_allo_HSCT> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<Lartruvo> <Brand_name_of> "Olaratumab" .
<Nintedanib_and_Pemetrexed> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Goserelin_and_Tamoxifen> <Is_a> "Antiestrogen-containing_regimen" .
<Pharmatrexate> <Brand_name_of> "Methotrexate" .
<Verz> <Brand_name_of> "Voriconazole" .
<Cyclophosphamide,_Mycophenolate_mofetil,_Tacrolimus> <Is_current_in> "Graft_versus_host_disease" .
<ALK_inhibitor> <Subsumes> "Lorlatinib" .
<ALK_inhibitor> <Subsumes> "Gilteritinib" .
<ALK_inhibitor> <Subsumes> "Entrectinib" .
<ALK_inhibitor> <Subsumes> "Ensartinib" .
<ALK_inhibitor> <Subsumes> "Crizotinib" .
<ALK_inhibitor> <Subsumes> "Ceritinib" .
<ALK_inhibitor> <Subsumes> "Brigatinib" .
<ALK_inhibitor> <Subsumes> "Alectinib" .
<Clody> <Brand_name_of> "Clodronate" .
<TH_(Taxotere)> <Has_supportive_med> "Dexamethasone" .
<HAA> <Has_context> "Induction_therapy" .
<MP_(Prednisolone)> <Is_historical_in> "Multiple_myeloma" .
<CHOP,_then_131Iodine-Tositumomab> <Has_accepted_use> "Follicular_lymphoma" .
<Tonofolin> <Brand_name_of> "Folinic_acid" .
<Lestaurtinib> <Is_a> "Kinase_inhibitor" .
<Lestaurtinib> <Is_a> "JAK_inhibitor" .
<Lestaurtinib> <Is_a> "Investigational_drug" .
<Lestaurtinib> <Is_a> "FLT3_inhibitor" .
<Dabrafenib> <May_have_route> "Oral" .
<CAMF> <Has_modality> "Chemotherapy" .
<ABCP> <Has_modality> "Immunotherapy" .
<ABCP> <Has_modality> "Chemotherapy" .
<Ossifix> <Brand_name_of> "Alendronate" .
<FOLFOX4_and_Bevacizumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<FOLFOX4_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<TACE,_then_5-FU> <Maps_to> "TACE,_then_5-FU" .
<Erlotinib_and_Bevacizumab> <Is_current_in> "Renal_cell_carcinoma" .
<Erlotinib_and_Bevacizumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<Erlotinib_and_Bevacizumab> <Is_current_in> "Hepatocellular_carcinoma" .
<Erlotinib_and_Bevacizumab> <Is_current_in> "Gallbladder_cancer" .
<Erlotinib_and_Bevacizumab> <Is_current_in> "Cholangiocarcinoma" .
<Erlotinib_and_Bevacizumab> <Is_current_in> "Adenocarcinoma_of_unknown_primary" .
<Decitabine_monotherapy> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Decitabine_monotherapy> <Has_accepted_use> "Chronic_myelomonocytic_leukemia" .
<Decitabine_monotherapy> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Enediyne_antibiotic> <Subsumes> "Gemtuzumab_ozogamicin" .
<Ravulizumab> <Has_FDA_indication> "Paroxysmal_nocturnal_hemoglobinuria" .
<Ostolek> <Brand_name_of> "Alendronate" .
<Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone> <Maps_to> "Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone" .
<Neratinib_monotherapy> <Has_modality> "Chemotherapy" .
<Cisplatin,_Interferon_alfa-2a,_Isotretinoin> <Is_current_in> "Cutaneous_squamous_cell_carcinoma" .
<Capecitabine_and_Lapatinib> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<Capecitabine_and_Lapatinib> <Has_accepted_use> "CNS_carcinoma" .
<Capecitabine_and_Lapatinib> <Has_accepted_use> "Breast_cancer" .
<CPB> <Has_antineoplastic> "Cyclophosphamide" .
<CPB> <Has_antineoplastic> "Cisplatin" .
<CPB> <Has_antineoplastic> "Carmustine" .
<7_plus_5i> <Is_a> "Anthracycline-containing_regimen" .
<Cyklofosfamid> <Brand_name_of> "Cyclophosphamide" .
<Doxorubicin_and_Fluorouracil> <Is_a> "Anthracycline-containing_regimen" .
<R-GCVP> <Has_antineoplastic> "Vincristine" .
<R-GCVP> <Has_antineoplastic> "Rituximab" .
<R-GCVP> <Has_antineoplastic> "Prednisolone" .
<R-GCVP> <Has_antineoplastic> "Gemcitabine" .
<R-GCVP> <Has_antineoplastic> "Cyclophosphamide" .
<Cortisone_monotherapy> <Has_context> "Non-curative_therapy" .
<Brigatinib_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<CCE> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Hydrocortisone> <Has_brand_name> "Cortef" .
<Norvelzo> <Brand_name_of> "Bortezomib" .
<ddAC> <Is_a> "Anthracycline-containing_regimen" .
<Augmented_Hyper-CVAD_and_Asparaginase> <Has_modality> "Chemotherapy" .
<Cytarabine_and_Mitoxantrone> <Has_antineoplastic> "Mitoxantrone" .
<Cytarabine_and_Mitoxantrone> <Has_antineoplastic> "Cytarabine" .
<Enfortumab_vedotin> <Has_FDA_indication> "Bladder_cancer" .
<Aspirin_monotherapy> <Mapped_from> "Aspirin_monotherapy" .
<Pomalidomide_monotherapy> <Has_supportive_med> "Warfarin" .
<Pomalidomide_monotherapy> <Has_supportive_med> "Low_molecular_weight_heparins" .
<Pomalidomide_monotherapy> <Has_supportive_med> "Aspirin" .
<Pomalidomide_monotherapy> <Has_supportive_med> "Acyclovir" .
<Bactosain> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<BeEAM,_then_auto_HSCT> <Is_current_in> "Hodgkin_lymphoma" .
<BeEAM,_then_auto_HSCT> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Dasatinib> <Has_FDA_indication> "Chronic_myelogenous_leukemia" .
<Nanoparticle_albumin_bound_chemotherapy> <Subsumes> "Paclitaxel_nanoparticle_albumin-bound" .
<Fedratinib_monotherapy> <Has_modality> "Chemotherapy" .
<Gentrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<MV> <Maps_to> "MV" .
<Goserelin_and_Tamoxifen> <Mapped_from> "Goserelin_and_Tamoxifen" .
<ITK_inhibitor> <Is_a> "Kinase_inhibitor" .
<Portrazza> <Brand_name_of> "Necitumumab" .
<Antibiotic_therapy> <Maps_to> "Antibiotic_therapy" .
<Indocin> <Brand_name_of> "Indomethacin" .
<Temozolomide_monotherapy> <Has_antineoplastic> "Temozolomide" .
<BR_and_Idelalisib> <Has_modality> "Chemotherapy" .
<Cisplatin_and_Topotecan> <Is_a> "Platinum_doublet" .
<Leusenox> <Brand_name_of> "Arsenic_trioxide" .
<Eduprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<BACO> <Has_modality> "Chemotherapy" .
<CHOP-AL> <Has_antineoplastic> "Vincristine" .
<CHOP-AL> <Has_antineoplastic> "Prednisone" .
<CHOP-AL> <Has_antineoplastic> "Doxorubicin" .
<CHOP-AL> <Has_antineoplastic> "Cyclophosphamide" .
<CHOP-AL> <Has_antineoplastic> "Alemtuzumab" .
<Pomalidomide,_Dexamethasone,_Pembrolizumab> <Has_context> "Non-curative_therapy" .
<VAC_(Adriamycin)> <Has_antineoplastic> "Vincristine" .
<VAC_(Adriamycin)> <Has_antineoplastic> "Doxorubicin" .
<VAC_(Adriamycin)> <Has_antineoplastic> "Cyclophosphamide" .
<Bevacizumab_and_RT> <Has_context> "Adjuvant_therapy" .
<Anti-CD37_antibody> <Subsumes> "Otlertuzumab" .
<BCVPP> <Has_antineoplastic> "Vincristine" .
<BCVPP> <Has_antineoplastic> "Procarbazine" .
<BCVPP> <Has_antineoplastic> "Prednisone" .
<BCVPP> <Has_antineoplastic> "Cyclophosphamide" .
<BCVPP> <Has_antineoplastic> "Carmustine" .
<Anastrozole> <Has_FDA_indication> "Breast_cancer" .
<R-CEOP_(Etoposide)> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Ranxas> <Brand_name_of> "Doxorubicin" .
<Bendamustine_monotherapy> <Mapped_from> "Bendamustine_monotherapy" .
<Bortezomib_and_Melphalan> <Has_context> "All_lines_of_therapy" .
<Flutamide,_Leuprolide,_RT> <Has_context> "Definitive_therapy" .
<Irinotecan_and_Bevacizumab> <Has_accepted_use> "Glioblastoma" .
<Irinotecan_and_Bevacizumab> <Has_accepted_use> "Anaplastic_glioma" .
<Bisphosphonate> <Subsumes> "Zoledronic_acid" .
<Bisphosphonate> <Subsumes> "Risedronate" .
<Bisphosphonate> <Subsumes> "Pamidronate" .
<Bisphosphonate> <Subsumes> "Ibandronate" .
<Bisphosphonate> <Subsumes> "Clodronate" .
<Bisphosphonate> <Subsumes> "Alendronate" .
<Artrizona> <Brand_name_of> "Prednisone" .
<Talimogene_laherparepvec_monotherapy> <Has_context> "Local_therapy" .
<maxi-R-CHOP/R-HiDAC> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Mucolene> <Brand_name_of> "Mesna" .
<Belotecan_and_Cisplatin> <Has_modality> "Chemotherapy" .
<Lanreotide> <Has_accepted_use> "Pancreatic_NET" .
<Lanreotide> <Has_accepted_use> "Neuroendocrine_tumor" .
<Pemetrexed_and_Pembrolizumab> <Mapped_from> "Pemetrexed_and_Pembrolizumab" .
<Epizolone> <Brand_name_of> "Methylprednisolone" .
<Brek> <Brand_name_of> "Alendronate" .
<Lomustine,_Vincristine,_Prednisone> <Has_modality> "Chemotherapy" .
<Benton> <Brand_name_of> "Fluorouracil" .
<Carfilzomib_monotherapy> <Has_context> "Non-curative_therapy" .
<Carfilzomib_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Anti-IGF-1R_antibody> <Subsumes> "Ganitumab" .
<Anti-IGF-1R_antibody> <Subsumes> "Cixutumumab" .
<Metxaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Omacetaxine_monotherapy> <Maps_to> "Omacetaxine_monotherapy" .
<Abiraterone_and_Prednisone> <Maps_to> "Abiraterone_and_Prednisone" .
<Geftican> <Brand_name_of> "Gefitinib" .
<Syndal> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cymerin> <Brand_name_of> "Ranimustine" .
<VTD> <Has_antineoplastic> "Thalidomide" .
<VTD> <Has_antineoplastic> "Dexamethasone" .
<VTD> <Has_antineoplastic> "Bortezomib" .
<Sargramostim> <Supportive_med_of> "m-BACOD" .
<Sargramostim> <Supportive_med_of> "ddAC-T" .
<Sargramostim> <Supportive_med_of> "ddAC" .
<Sargramostim> <Supportive_med_of> "Samarium-153_with_stem_cell_support" .
<Sargramostim> <Supportive_med_of> "R-CDOP" .
<Sargramostim> <Supportive_med_of> "Paclitaxel_monotherapy" .
<Sargramostim> <Supportive_med_of> "Irinotecan,_Temozolomide,_Dinutuximab" .
<Sargramostim> <Supportive_med_of> "IL-2_monotherapy" .
<Sargramostim> <Supportive_med_of> "Gemcitabine_monotherapy" .
<Sargramostim> <Supportive_med_of> "CODOX-M/IVAC" .
<Sargramostim> <Supportive_med_of> "Alemtuzumab_monotherapy" .
<Dacarbazine_monotherapy> <Has_context> "Non-curative_therapy" .
<Dacarbazine_monotherapy> <Has_context> "All_lines_of_therapy" .
<Heloper> <Brand_name_of> "Haloperidol" .
<MINE> <Has_accepted_use> "Hodgkin_lymphoma" .
<MINE> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Melphalan,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<FOLFIRINOX> <Has_accepted_use> "Pancreatic_cancer" .
<FOLFIRINOX> <Has_accepted_use> "Colon_cancer" .
<Trimesul> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Zemitron> <Brand_name_of> "Ondansetron" .
<VD> <Has_modality> "Chemotherapy" .
<Carboplatin_and_Gemcitabine/Erlotinib> <Is_current_in> "Non-small_cell_lung_cancer" .
<Alendro> <Brand_name_of> "Alendronate" .
<Anakinra_monotherapy> <Mapped_from> "Anakinra_monotherapy" .
<VR> <Has_context> "Non-curative_therapy" .
<VR> <Has_context> "Non-curative_subsequent-line_maintenance_therapy" .
<VR> <Has_context> "Non-curative_second-line_maintenance_therapy" .
<VR> <Has_context> "Non-curative_first-line_therapy" .
<VR> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<VR> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Leuprolide_monotherapy> <Has_modality> "Hormonotherapy" .
<O-miniCHOP> <Has_supportive_med> "Diphenhydramine" .
<O-miniCHOP> <Has_supportive_med> "Acetaminophen" .
<Atovaquone> <Has_brand_name> "Mepron" .
<Acylete> <Brand_name_of> "Acyclovir" .
<Aacidexam> <Brand_name_of> "Dexamethasone" .
<Cisplatin,_Dacarbazine,_Paclitaxel> <Mapped_from> "Cisplatin,_Dacarbazine,_Paclitaxel" .
<BASIC> <Mapped_from> "BASIC" .
<Mepson> <Brand_name_of> "Methylprednisolone" .
<ADT_and_Apalutamide> <Has_accepted_use> "Prostate_cancer" .
<Precortil> <Brand_name_of> "Prednisone" .
<Epirubicin_and_Ifosfamide> <Has_context> "Non-curative_therapy" .
<Epirubicin_and_Ifosfamide> <Has_context> "Neoadjuvant_therapy" .
<Cisplatin_and_RT> <Mapped_from> "Cisplatin_and_RT" .
<Penicillin> <Is_a> "Antibacterial" .
<Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone> <Has_local_therapy> "Methotrexate" .
<Mercaptopurine_and_Methotrexate> <Has_modality> "Chemotherapy" .
<Carboplatin,_Olaparib,_Paclitaxel> <Has_modality> "Chemotherapy" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<MVAC> <Mapped_from> "MVAC" .
<MVBP> <Has_supportive_med> "Folinic_acid" .
<Cyclosporine_and_Mycophenolate_mofetil> <Mapped_from> "Cyclosporine_and_Mycophenolate_mofetil" .
<ATG_(Horse),_Cyclosporine,_G-CSF> <Maps_to> "ATG_(Horse),_Cyclosporine,_G-CSF" .
<Pemetrexed_and_Bevacizumab> <Maps_to> "Pemetrexed_and_Bevacizumab" .
<EBVP> <Is_current_in> "Hodgkin_lymphoma" .
<PCE> <Has_antineoplastic> "Paclitaxel" .
<PCE> <Has_antineoplastic> "Etoposide" .
<PCE> <Has_antineoplastic> "Carboplatin" .
<Metypred> <Brand_name_of> "Methylprednisolone" .
<Doxorubicin,_Methotrexate,_Vincristine,_Prednisone> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Imatinib_and_LoDAC> <Maps_to> "Imatinib_and_LoDAC" .
<Azacitidine_and_Lenalidomide> <Is_current_in> "Myelodysplastic_syndrome" .
<Azacitidine_and_Lenalidomide> <Is_current_in> "Chronic_myelomonocytic_leukemia" .
<Cutaneous_T-cell_lymphoma> <FDA_indication_of> "Vorinostat" .
<Cutaneous_T-cell_lymphoma> <FDA_indication_of> "Romidepsin" .
<Cutaneous_T-cell_lymphoma> <FDA_indication_of> "Mogamulizumab" .
<Cutaneous_T-cell_lymphoma> <FDA_indication_of> "Methoxsalen" .
<Cutaneous_T-cell_lymphoma> <FDA_indication_of> "Denileukin_diftitox" .
<Cutaneous_T-cell_lymphoma> <FDA_indication_of> "Cyclophosphamide" .
<Cutaneous_T-cell_lymphoma> <FDA_indication_of> "Brentuximab_vedotin" .
<Cutaneous_T-cell_lymphoma> <FDA_indication_of> "Bexarotene" .
<Linker_regimen_(consolidation)> <Mapped_from> "Linker_regimen_(consolidation)" .
<Prednisolone_and_Rituximab> <Has_accepted_use> "Warm_autoimmune_hemolytic_anemia" .
<Prednol> <Brand_name_of> "Methylprednisolone" .
<Chlorambucil_and_Ofatumumab> <Mapped_from> "Chlorambucil_and_Ofatumumab" .
<Cabazitaxel> <Has_brand_name> "Jevtana" .
<ADT,_Docetaxel,_Estramustine> <Mapped_from> "ADT,_Docetaxel,_Estramustine" .
<Mephamesona> <Brand_name_of> "Dexamethasone" .
<Tykerb> <Brand_name_of> "Lapatinib" .
<VMP/Rd> <Is_current_in> "Multiple_myeloma" .
<BR_and_Idelalisib> <Mapped_from> "BR_and_Idelalisib" .
<SOX_and_Bevacizumab> <Has_accepted_use> "Colon_cancer" .
<Pentostatin_monotherapy> <Has_supportive_med> "Valacyclovir" .
<Pentostatin_monotherapy> <Has_supportive_med> "Levofloxacin" .
<Pentostatin_monotherapy> <Has_supportive_med> "Fluconazole" .
<Pentostatin_monotherapy> <Has_supportive_med> "Filgrastim" .
<Dexasin> <Brand_name_of> "Dexamethasone" .
<HAM_and_Imatinib> <Has_antineoplastic> "Mitoxantrone" .
<HAM_and_Imatinib> <Has_antineoplastic> "Imatinib" .
<HAM_and_Imatinib> <Has_antineoplastic> "Cytarabine" .
<Anti_Uron> <Brand_name_of> "Mesna" .
<CVD_(Vinblastine)> <Has_accepted_use> "Melanoma" .
<AIE> <Has_antineoplastic> "Idarubicin" .
<AIE> <Has_antineoplastic> "Etoposide" .
<AIE> <Has_antineoplastic> "Cytarabine" .
<Azacitidine_and_Lenalidomide> <Has_modality> "Chemotherapy" .
<Tisagenlecleucel_monotherapy> <Has_modality> "Immunotherapy" .
<mFOLFOX_and_Sorafenib> <Has_context> "Non-curative_first-line_therapy" .
<Cabazitaxel_and_Prednisone> <Has_antineoplastic> "Prednisone" .
<Cabazitaxel_and_Prednisone> <Has_antineoplastic> "Cabazitaxel" .
<Cytomega> <Brand_name_of> "Valganciclovir" .
<Dexion> <Brand_name_of> "Dexamethasone" .
<Injectafer> <Brand_name_of> "Ferric_carboxymaltose" .
<Low_molecular_weight_heparin> <Is_a> "Anticoagulant" .
<Methotrexate,_Tacrolimus,_Tocilizumab> <Mapped_from> "Methotrexate,_Tacrolimus,_Tocilizumab" .
<Carboplatin,_nab-Paclitaxel,_Atezolizumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Carboplatin_and_Bevacizumab> <Has_accepted_use> "Glioblastoma" .
<Carboplatin_and_Bevacizumab> <Has_accepted_use> "Anaplastic_glioma" .
<Cisplatin,_Pemetrexed,_Bevacizumab> <Mapped_from> "Cisplatin,_Pemetrexed,_Bevacizumab" .
<COP> <Has_accepted_use> "HIV-associated_lymphoma" .
<COP> <Has_accepted_use> "Burkitt_lymphoma" .
<Dalteparin> <Is_a> "Low_molecular_weight_heparin" .
<Dalteparin> <Is_a> "Heparin" .
<Dalteparin> <Is_a> "Anticoagulant" .
<Vinorelbine_monotherapy> <Has_context> "Non-curative_therapy" .
<Vinorelbine_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Vinorelbine_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Vinorelbine_monotherapy> <Has_context> "Adjuvant_therapy" .
<Fluorouracil_and_Methotrexate> <Has_antineoplastic> "Methotrexate" .
<Fluorouracil_and_Methotrexate> <Has_antineoplastic> "Fluorouracil" .
<Cancidas> <Brand_name_of> "Caspofungin" .
<Ziv-aflibercept> <Has_FDA_indication> "Colon_cancer" .
<Pegfilgrastim> <Is_a> "Pegylated_medication" .
<Pegfilgrastim> <Is_a> "Granulocyte_colony-stimulating_factor" .
<Capecitabine,_Docetaxel,_Oxaliplatin,_RT> <Has_antineoplastic> "Oxaliplatin" .
<Capecitabine,_Docetaxel,_Oxaliplatin,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Capecitabine,_Docetaxel,_Oxaliplatin,_RT> <Has_antineoplastic> "Docetaxel" .
<Capecitabine,_Docetaxel,_Oxaliplatin,_RT> <Has_antineoplastic> "Capecitabine" .
<Zontivity> <Brand_name_of> "Vorapaxar" .
<Pipobroman_monotherapy> <Is_current_in> "Polycythemia_vera" .
<MESA/RT> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Liposarcoma> <Current_treated_by> "Trabectedin_monotherapy" .
<Liposarcoma> <Current_treated_by> "Eribulin_monotherapy" .
<Liposarcoma> <Current_treated_by> "Dacarbazine_monotherapy" .
<VAP> <Has_modality> "Hormonotherapy" .
<VAP> <Has_modality> "Chemotherapy" .
<Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin> <Has_antineoplastic> "Gemtuzumab_ozogamicin" .
<Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin> <Has_antineoplastic> "Daunorubicin" .
<Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin> <Has_antineoplastic> "Cytarabine" .
<Omacetaxine> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Omacetaxine> <Has_accepted_use> "Acute_myeloid_leukemia" .
<LEED,_then_auto_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<Afatinib_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Afatinib_monotherapy> <Is_current_in> "Head_and_neck_cancer" .
<Afatinib_monotherapy> <Is_current_in> "CNS_carcinoma" .
<Caspofungin> <May_have_route> "Intravenous" .
<Busulfan_and_Cyclophosphamide> <Mapped_from> "Busulfan_and_Cyclophosphamide" .
<Semuloparin> <Is_a> "Ultralow_molecular_weight_heparin" .
<Semuloparin> <Is_a> "Investigational_drug" .
<Semuloparin> <Is_a> "Heparin" .
<Semuloparin> <Is_a> "Hematology_medication" .
<Semuloparin> <Is_a> "Anticoagulant" .
<ABVD> <Maps_to> "ABVD" .
<LVP_.22Sandwich.22> <Maps_to> "LVP_.22Sandwich.22" .
<Cisplatin,_Paclitaxel,_RT> <Has_context> "Neoadjuvant_therapy" .
<Cisplatin,_Paclitaxel,_RT> <Has_context> "Induction_therapy" .
<Cisplatin,_Paclitaxel,_RT> <Has_context> "Definitive_therapy" .
<Cisplatin,_Paclitaxel,_RT> <Has_context> "Consolidation_after_upfront_therapy" .
<GCD-R> <Maps_to> "GCD-R" .
<Cephalexin> <Has_brand_name> "Keflex" .
<Valrubicin> <Is_a> "Anthracycline" .
<Boplatex> <Brand_name_of> "Carboplatin" .
<Adrenocortical_carcinoma> <Current_treated_by> "Placebo" .
<Adrenocortical_carcinoma> <Current_treated_by> "Mitotane_monotherapy" .
<Adrenocortical_carcinoma> <Current_treated_by> "Mitotane_and_Streptozocin" .
<Adrenocortical_carcinoma> <Current_treated_by> "Mitotane_and_EDP" .
<VEPA> <Mapped_from> "VEPA" .
<Citagenin> <Brand_name_of> "Cytarabine" .
<BEP> <Has_antineoplastic> "Etoposide" .
<BEP> <Has_antineoplastic> "Cisplatin" .
<BEP> <Has_antineoplastic> "Bleomycin" .
<Carboplatin,_Paclitaxel,_RT> <Has_antineoplastic> "Paclitaxel" .
<Carboplatin,_Paclitaxel,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Carboplatin,_Paclitaxel,_RT> <Has_antineoplastic> "Carboplatin" .
<Doxycycline_monotherapy> <Mapped_from> "Doxycycline_monotherapy" .
<MAID> <Has_antineoplastic> "Ifosfamide" .
<MAID> <Has_antineoplastic> "Doxorubicin" .
<MAID> <Has_antineoplastic> "Dacarbazine" .
<VAMP> <Has_accepted_use> "Multiple_myeloma" .
<CIM> <Maps_to> "CIM" .
<Temozolomide> <Has_FDA_indication> "Glioblastoma" .
<Temozolomide> <Has_FDA_indication> "Anaplastic_glioma" .
<Warfarin_monotherapy> <Maps_to> "Warfarin_monotherapy" .
<Gemcitabine_and_Rituximab> <Is_current_in> "Hodgkin_lymphoma" .
<Gemcitabine_and_Rituximab> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Cisplatin,_Dacarbazine,_Interferon_alfa-2b> <Mapped_from> "Cisplatin,_Dacarbazine,_Interferon_alfa-2b" .
<Carboplatin,_Fluorouracil,_Cetuximab> <Mapped_from> "Carboplatin,_Fluorouracil,_Cetuximab" .
<FMP> <Maps_to> "FMP" .
<R-CODOX-M> <Has_supportive_med> "Pegfilgrastim" .
<R-CODOX-M> <Has_supportive_med> "Folinic_acid" .
<R-CODOX-M> <Has_supportive_med> "Filgrastim" .
<Cotrimox> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Osteofar> <Brand_name_of> "Alendronate" .
<Dactinomycin_monotherapy> <Has_accepted_use> "Wilms_tumor" .
<Dactinomycin_monotherapy> <Has_accepted_use> "Rhabdomyosarcoma" .
<Dactinomycin_monotherapy> <Has_accepted_use> "Gestational_trophoblastic_neoplasia" .
<Dactinomycin_monotherapy> <Has_accepted_use> "Endometrial_cancer" .
<Panitumumab> <Has_accepted_use> "Penile_cancer" .
<Panitumumab> <Has_accepted_use> "Head_and_neck_cancer" .
<Panitumumab> <Has_accepted_use> "Colon_cancer" .
<mFOLFOX6> <Is_current_in> "Colon_cancer" .
<Warfarin> <May_have_route> "Oral" .
<Carfilzomib> <Has_brand_name> "Kyprolis" .
<Alemtuzumab_and_Rituximab> <Has_context> "Non-curative_therapy" .
<Hydroxyurea_and_Interferon_alfa-2a> <Has_antineoplastic> "Interferon_alfa-2a" .
<Hydroxyurea_and_Interferon_alfa-2a> <Has_antineoplastic> "Hydroxyurea" .
<PT> <Has_accepted_use> "Breast_cancer" .
<Ultralow_molecular_weight_heparin> <Subsumes> "Semuloparin" .
<CBV-Mx,_then_auto_HSCT> <Has_antineoplastic> "Mitoxantrone" .
<CBV-Mx,_then_auto_HSCT> <Has_antineoplastic> "Etoposide" .
<CBV-Mx,_then_auto_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<CBV-Mx,_then_auto_HSCT> <Has_antineoplastic> "Carmustine" .
<CEOP_(Prednisolone)> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<PAD> <Maps_to> "PAD" .
<ECF> <Has_modality> "Chemotherapy" .
<UFTM> <Has_context> "Non-curative_first-line_therapy" .
<Mercaptopurine,_Methotrexate,_Vincristine> <Is_current_in> "T-cell_acute_lymphoblastic_leukemia" .
<Mercaptopurine,_Methotrexate,_Vincristine> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Docetaxel_and_Nintedanib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Lepirudin> <Supportive_med_of> "Lepirudin_monotherapy" .
<ddE> <Has_context> "Adjuvant_therapy" .
<Topoisomerase_inhibitor> <Is_a> "Chemotherapeutic" .
<Oncodocel> <Brand_name_of> "Docetaxel" .
<Methylprednisolone_monotherapy> <Is_current_in> "Thrombotic_thrombocytopenic_purpura" .
<FEC_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<FEC_and_Bevacizumab> <Is_a> "Anthracycline-containing_regimen" .
<VR-CAP> <Has_antineoplastic> "Rituximab" .
<VR-CAP> <Has_antineoplastic> "Prednisone" .
<VR-CAP> <Has_antineoplastic> "Doxorubicin" .
<VR-CAP> <Has_antineoplastic> "Cyclophosphamide" .
<VR-CAP> <Has_antineoplastic> "Bortezomib" .
<Meradexon> <Brand_name_of> "Dexamethasone" .
<Benralizumab> <Antineoplastic_of> "Benralizumab_monotherapy" .
<Consolidation_after_upfront_therapy> <Is_a> "Post-definitive_therapy" .
<Apalutamide_monotherapy> <Has_modality> "Hormonotherapy" .
<Zofer> <Brand_name_of> "Ondansetron" .
<Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone> <Mapped_from> "Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone" .
<Bendamustine_monotherapy> <Has_supportive_med> "Pegfilgrastim" .
<Bendamustine_monotherapy> <Has_supportive_med> "Filgrastim" .
<BFR,_then_allo_HSCT> <Has_antineoplastic> "Rituximab" .
<BFR,_then_allo_HSCT> <Has_antineoplastic> "Fludarabine" .
<BFR,_then_allo_HSCT> <Has_antineoplastic> "Bendamustine" .
<BFR,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<DOLP> <Has_local_therapy> "Methotrexate" .
<DOLP> <Has_local_therapy> "Cytarabine" .
<Daurocina> <Brand_name_of> "Daunorubicin" .
<Etoposide_and_Mitoxantrone> <Is_a> "Anthracycline-containing_regimen" .
<Uracil_mustard_monotherapy> <Is_historical_in> "Chronic_lymphocytic_leukemia" .
<Methotrexate_and_Rituximab> <Has_antineoplastic> "Rituximab" .
<Methotrexate_and_Rituximab> <Has_antineoplastic> "Methotrexate" .
<CFDA_approved_drug> <Is_a> "Approved_drug" .
<BID> <Has_accepted_use> "Multiple_myeloma" .
<VDC/IE> <Has_supportive_med> "Mesna" .
<VDC/IE> <Has_supportive_med> "Filgrastim" .
<Cyclosporine_and_Mycophenolate_mofetil> <Has_context> "Prophylaxis" .
<TBI> <Mapped_from> "TBI" .
<CMFT> <Mapped_from> "CMFT" .
<Carboplatin,_Paclitaxel,_Pembrolizumab> <Has_context> "Non-curative_first-line_therapy" .
<CLARA> <Has_context> "Salvage_therapy" .
<CLARA> <Has_context> "Consolidation_after_upfront_therapy" .
<Vepside> <Brand_name_of> "Etoposide" .
<Cisplatin_and_Vinorelbine> <Mapped_from> "Cisplatin_and_Vinorelbine" .
<Acute_myeloid_leukemia> <Historic_treated_by> "Vosaroxin_and_Cytarabine" .
<Acute_myeloid_leukemia> <Historic_treated_by> "Vorinostat_monotherapy" .
<Acute_myeloid_leukemia> <Historic_treated_by> "VAMP_(Amethopterin)" .
<Acute_myeloid_leukemia> <Historic_treated_by> "SHAI" .
<Acute_myeloid_leukemia> <Historic_treated_by> "Panobinostat_monotherapy" .
<Acute_myeloid_leukemia> <Historic_treated_by> "POMP" .
<Acute_myeloid_leukemia> <Historic_treated_by> "PATCO" .
<Acute_myeloid_leukemia> <Historic_treated_by> "Mercaptopurine_monotherapy" .
<Acute_myeloid_leukemia> <Historic_treated_by> "IDAC" .
<Acute_myeloid_leukemia> <Historic_treated_by> "IAP" .
<Acute_myeloid_leukemia> <Historic_treated_by> "HiDAC" .
<Acute_myeloid_leukemia> <Historic_treated_by> "Gemtuzumab_ozogamicin_monotherapy" .
<Acute_myeloid_leukemia> <Historic_treated_by> "FLAG-DNX" .
<Acute_myeloid_leukemia> <Historic_treated_by> "Decitabine_and_Valproate" .
<Acute_myeloid_leukemia> <Historic_treated_by> "Daunorubicin_monotherapy" .
<Acute_myeloid_leukemia> <Historic_treated_by> "DCTER" .
<Acute_myeloid_leukemia> <Historic_treated_by> "DAT" .
<Acute_myeloid_leukemia> <Historic_treated_by> "D-ZAPO" .
<Acute_myeloid_leukemia> <Historic_treated_by> "Cytarabine,_Idarubicin,_Vorinostat" .
<Acute_myeloid_leukemia> <Historic_treated_by> "Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone" .
<Acute_myeloid_leukemia> <Historic_treated_by> "Cytarabine,_Daunorubicin,_Vincristine" .
<Acute_myeloid_leukemia> <Historic_treated_by> "Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone" .
<Acute_myeloid_leukemia> <Historic_treated_by> "Cytarabine_monotherapy" .
<Acute_myeloid_leukemia> <Historic_treated_by> "Cytarabine_and_Thioguanine" .
<Acute_myeloid_leukemia> <Historic_treated_by> "Clofarabine_monotherapy" .
<Acute_myeloid_leukemia> <Historic_treated_by> "Cladribine_monotherapy" .
<Acute_myeloid_leukemia> <Historic_treated_by> "Azacitidine,_Vorinostat,_Gemtuzumab_ozogamicin" .
<Acute_myeloid_leukemia> <Historic_treated_by> "Amsacrine_and_Cytarabine" .
<Acute_myeloid_leukemia> <Historic_treated_by> "7_plus_5i" .
<Acute_myeloid_leukemia> <Historic_treated_by> "7_plus_3i_and_Vorinostat" .
<Acute_myeloid_leukemia> <Historic_treated_by> "7_plus_3i_and_Panobinostat" .
<Acute_myeloid_leukemia> <Historic_treated_by> "7_plus_3d" .
<Acute_myeloid_leukemia> <Historic_treated_by> "5_plus_3i" .
<Acute_myeloid_leukemia> <Historic_treated_by> "5_plus_3d" .
<Mucositis_prevention> <Subsumes> "Palifermin" .
<Mucositis_prevention> <Subsumes> "Calcium_phosphate_rinse" .
<Mitoxantrone_monotherapy> <Maps_to> "Mitoxantrone_monotherapy" .
<Carboplatin_and_Pemetrexed> <Has_supportive_med> "Folic_acid" .
<Carboplatin_and_Pemetrexed> <Has_supportive_med> "Dexamethasone" .
<Carboplatin_and_Pemetrexed> <Has_supportive_med> "Cyanocobalamin" .
<Bcl-2_inhibitor> <Subsumes> "Venetoclax" .
<R-VAD_plus_C> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Bacris> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Prednisone_monotherapy> <Has_modality> "Immunosuppressive_therapy" .
<Prednisone_monotherapy> <Has_modality> "Hormonotherapy" .
<Prednisone_monotherapy> <Has_modality> "Chemotherapy" .
<CHVP-I> <Is_a> "Anthracycline-containing_regimen" .
<Cytarabine,_Idarubicin,_Sorafenib> <Is_current_in> "Acute_myeloid_leukemia" .
<Low-dose_Interleukin-2> <Mapped_from> "Low-dose_Interleukin-2" .
<Ricolinostat> <Has_accepted_use> "Multiple_myeloma" .
<Cisplatin_and_Docetaxel> <Mapped_from> "Cisplatin_and_Docetaxel" .
<Texate> <Brand_name_of> "Methotrexate" .
<THP_(Taxotere)> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<THP_(Taxotere)> <Has_accepted_use> "Breast_cancer" .
<TILs> <Has_context> "Non-curative_therapy" .
<EOF> <Has_accepted_use> "Gastric_cancer" .
<EOF> <Has_accepted_use> "Esophageal_cancer" .
<Augmented_Hyper-CVAD_and_Asparaginase> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Gemcitabine_and_Rituximab> <Is_a> "Rituximab-containing_regimen" .
<CMC> <Mapped_from> "CMC" .
<LEED> <Has_modality> "Chemotherapy" .
<Cisplatin_and_Pemetrexed> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cisplatin_and_Pemetrexed> <Has_accepted_use> "Mesothelioma" .
<Cisplatin_and_Pemetrexed> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<Cisplatin_and_Pemetrexed> <Has_accepted_use> "ALK-positive_Non-small_cell_lung_cancer" .
<Sulfamethoprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cyclophosphamide_and_Etoposide> <Has_accepted_use> "Osteosarcoma" .
<Castleman_disease> <Current_treated_by> "Tocilizumab_monotherapy" .
<Castleman_disease> <Current_treated_by> "TCP" .
<Castleman_disease> <Current_treated_by> "Sirolimus_monotherapy" .
<Castleman_disease> <Current_treated_by> "Siltuximab_monotherapy" .
<Castleman_disease> <Current_treated_by> "Rituximab_monotherapy" .
<Castleman_disease> <Current_treated_by> "Placebo" .
<Castleman_disease> <Current_treated_by> "Cyclosporine_monotherapy" .
<Castleman_disease> <Current_treated_by> "Bortezomib_monotherapy" .
<Castleman_disease> <Current_treated_by> "Anakinra_monotherapy" .
<Calcium_Folinato> <Brand_name_of> "Folinic_acid" .
<Dasatinib> <Has_accepted_use> "Systemic_mastocytosis" .
<Dasatinib> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Dasatinib> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Efurix> <Brand_name_of> "Fluorouracil" .
<131Iodine-Tositumomab_monotherapy> <Has_supportive_med> "Diphenhydramine" .
<131Iodine-Tositumomab_monotherapy> <Has_supportive_med> "Acetaminophen" .
<Vomiset> <Brand_name_of> "Ondansetron" .
<Ravulizumab_monotherapy> <Has_modality> "Immunosuppressive_therapy" .
<CTCb> <Is_current_in> "Autologous_HSCT" .
<DDGP> <Has_antineoplastic> "Pegaspargase" .
<DDGP> <Has_antineoplastic> "Gemcitabine" .
<DDGP> <Has_antineoplastic> "Dexamethasone" .
<DDGP> <Has_antineoplastic> "Cisplatin" .
<ZRd> <Has_accepted_use> "Multiple_myeloma" .
<R-NIMP> <Has_context> "Salvage_therapy" .
<Chronic_myelomonocytic_leukemia> <Is_a> "Myeloproliferative_neoplasm" .
<Olanzapine> <Has_brand_name> "Zyprexa" .
<Gemcitabine_monotherapy> <Mapped_from> "Gemcitabine_monotherapy" .
<Chlorambucil,_Dactinomycin,_Methotrexate> <Is_historical_in> "Testicular_cancer" .
<Dronabinol> <May_have_route> "Oral" .
<Neratinib_and_Paclitaxel> <Mapped_from> "Neratinib_and_Paclitaxel" .
<Hepatocellular_carcinoma> <Current_treated_by> "mFOLFOX_and_Sorafenib" .
<Hepatocellular_carcinoma> <Current_treated_by> "TACE,_then_5-FU" .
<Hepatocellular_carcinoma> <Current_treated_by> "TACE" .
<Hepatocellular_carcinoma> <Current_treated_by> "Sorafenib_monotherapy" .
<Hepatocellular_carcinoma> <Current_treated_by> "Regorafenib_monotherapy" .
<Hepatocellular_carcinoma> <Current_treated_by> "Ramucirumab_monotherapy" .
<Hepatocellular_carcinoma> <Current_treated_by> "Radioembolization" .
<Hepatocellular_carcinoma> <Current_treated_by> "Placebo" .
<Hepatocellular_carcinoma> <Current_treated_by> "Pembrolizumab_monotherapy" .
<Hepatocellular_carcinoma> <Current_treated_by> "Observation" .
<Hepatocellular_carcinoma> <Current_treated_by> "Nivolumab_monotherapy" .
<Hepatocellular_carcinoma> <Current_treated_by> "Lenvatinib_monotherapy" .
<Hepatocellular_carcinoma> <Current_treated_by> "HAIC_and_Sorafenib" .
<Hepatocellular_carcinoma> <Current_treated_by> "GemOx_and_Sorafenib" .
<Hepatocellular_carcinoma> <Current_treated_by> "GemOx" .
<Hepatocellular_carcinoma> <Current_treated_by> "Fluorouracil_and_Folinic_acid" .
<Hepatocellular_carcinoma> <Current_treated_by> "FOLFOX4" .
<Hepatocellular_carcinoma> <Current_treated_by> "Erlotinib_and_Bevacizumab" .
<Hepatocellular_carcinoma> <Current_treated_by> "Doxorubicin_monotherapy" .
<Hepatocellular_carcinoma> <Current_treated_by> "DEB-TACE" .
<Hepatocellular_carcinoma> <Current_treated_by> "Capecitabine_monotherapy" .
<Hepatocellular_carcinoma> <Current_treated_by> "Capecitabine_and_Bevacizumab" .
<Hepatocellular_carcinoma> <Current_treated_by> "CapeOx_and_Bevacizumab" .
<Hepatocellular_carcinoma> <Current_treated_by> "CapeOx" .
<Hepatocellular_carcinoma> <Current_treated_by> "Cabozantinib_monotherapy" .
<Hepatocellular_carcinoma> <Current_treated_by> "Bevacizumab_monotherapy" .
<Hepatocellular_carcinoma> <Current_treated_by> "Best_supportive_care" .
<Hepatocellular_carcinoma> <Current_treated_by> "Axitinib_and_TACE" .
<VDC> <Has_antineoplastic> "Dexamethasone" .
<VDC> <Has_antineoplastic> "Cyclophosphamide" .
<VDC> <Has_antineoplastic> "Bortezomib" .
<Cytarabine,_Daunorubicin,_Vincristine> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Biocrystin> <Brand_name_of> "Vincristine" .
<Non-curative_third-line_induction_therapy> <Maps_to> "Non-curative_third-line_induction_therapy" .
<ESHAP> <Has_supportive_med> "Metoclopramide" .
<ESHAP> <Has_supportive_med> "Mannitol" .
<ESHAP> <Has_supportive_med> "Filgrastim" .
<Malignant_hematologic_neoplasm> <Is_a> "Condition" .
<TIP> <Is_current_in> "Testicular_cancer" .
<TIP> <Is_current_in> "Penile_cancer" .
<Thalidomide> <May_have_route> "Oral" .
<Chlorambucil_and_Obinutuzumab> <Maps_to> "Chlorambucil_and_Obinutuzumab" .
<Azacitidine_and_Gemtuzumab_ozogamicin> <Has_context> "Non-curative_first-line_induction_therapy" .
<Azacitidine_and_Gemtuzumab_ozogamicin> <Has_context> "Consolidation_after_upfront_therapy" .
<Endoxan> <Brand_name_of> "Cyclophosphamide" .
<KD> <Is_current_in> "Multiple_myeloma" .
<Cytarabine_and_Idarubicin> <Is_a> "Anthracycline-containing_regimen" .
<R-CHVP_plus_I> <Has_context> "Non-curative_first-line_therapy" .
<Pixantrone> <Antineoplastic_of> "Pixantrone_monotherapy" .
<Anabolic_steroid> <Is_a> "Endocrine_therapeutic" .
<Lusutrombopag> <Supportive_med_of> "Lusutrombopag_monotherapy" .
<Arsenic_trioxide_and_Idarubicin> <Has_antineoplastic> "Idarubicin" .
<Arsenic_trioxide_and_Idarubicin> <Has_antineoplastic> "Arsenic_trioxide" .
<Pertuzumab_and_T-DM1> <Is_current_in> "Breast_cancer" .
<Sulprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Neoral> <Brand_name_of> "Cyclosporine_modified" .
<DHAP_-_time_intensified> <Mapped_from> "DHAP_-_time_intensified" .
<Methotrexaat> <Brand_name_of> "Methotrexate" .
<Azacitidine_and_Sorafenib> <Has_modality> "Chemotherapy" .
<Letrozole_monotherapy> <Is_current_in> "Breast_cancer" .
<Ado-trastuzumab_emtansine_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Ado-trastuzumab_emtansine_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Ado-trastuzumab_emtansine_monotherapy> <Has_context> "Neoadjuvant_therapy" .
<Ado-trastuzumab_emtansine_monotherapy> <Has_context> "All_lines_of_therapy" .
<Ado-trastuzumab_emtansine_monotherapy> <Has_context> "Adjuvant_therapy" .
<Calcium_phosphate_rinse> <May_have_route> "Oral" .
<Fasnorm> <Brand_name_of> "Fulvestrant" .
<DNA_synthesis_inhibitor> <Is_a> "Chemotherapeutic" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Maps_to> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Dexadon> <Brand_name_of> "Dexamethasone" .
<TAD_(Thalidomide)> <Mapped_from> "TAD_(Thalidomide)" .
<MOPP> <Is_current_in> "Hodgkin_lymphoma" .
<Dacomitinib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cozole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Samarium-153> <Antineoplastic_of> "Samarium-153_with_stem_cell_support" .
<Samarium-153> <Antineoplastic_of> "Samarium-153_monotherapy" .
<Anaplastic_glioma> <Is_a> "High-grade_glioma" .
<International_ALL_Trial> <Maps_to> "International_ALL_Trial" .
<Deoxycytidine_analogue> <Is_a> "Antimetabolite" .
<IE> <Has_accepted_use> "Osteosarcoma" .
<IE> <Has_accepted_use> "Ewing_sarcoma" .
<DA_3_plus_10> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Xaparin> <Brand_name_of> "Enoxaparin" .
<Ponatinib> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Ponatinib> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Interferon_alfa-2c_monotherapy> <Maps_to> "Interferon_alfa-2c_monotherapy" .
<R-CVEP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Tamoxifen_and_OFS> <Is_a> "Antiestrogen-containing_regimen" .
<TCP> <Has_antineoplastic> "Thalidomide" .
<TCP> <Has_antineoplastic> "Prednisone" .
<TCP> <Has_antineoplastic> "Cyclophosphamide" .
<Doxorubicin_monotherapy> <Has_modality> "Chemotherapy" .
<Brisplatin> <Brand_name_of> "Cisplatin" .
<Apatinib_monotherapy> <Has_accepted_use> "Gastric_cancer" .
<Apatinib_monotherapy> <Has_accepted_use> "Esophageal_cancer" .
<Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine> <Has_context> "Non-curative_subsequent-line_therapy" .
<Dexamethasone_and_Eltrombopag> <Is_current_in> "Immune_thrombocytopenia" .
<Nilotinib_monotherapy> <Maps_to> "Nilotinib_monotherapy" .
<Cotrimol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<BEAC> <Mapped_from> "BEAC" .
<Cetzine> <Brand_name_of> "Cetirizine" .
<FOLFIRI_and_Cetuximab> <Has_context> "Non-curative_therapy" .
<FOLFIRI_and_Cetuximab> <Has_context> "Non-curative_first-line_therapy" .
<Rivaroxaban> <May_have_route> "Oral" .
<CEOP> <Has_modality> "Chemotherapy" .
<BCHOP> <Has_antineoplastic> "Vincristine" .
<BCHOP> <Has_antineoplastic> "Prednisolone" .
<BCHOP> <Has_antineoplastic> "Doxorubicin" .
<BCHOP> <Has_antineoplastic> "Cyclophosphamide" .
<BCHOP> <Has_antineoplastic> "Bortezomib" .
<MP> <Has_context> "Non-curative_first-line_therapy" .
<MP> <Has_context> "All_lines_of_therapy" .
<Dacarbazine_and_Doxorubicin> <Has_antineoplastic> "Doxorubicin" .
<Dacarbazine_and_Doxorubicin> <Has_antineoplastic> "Dacarbazine" .
<Miniasal> <Brand_name_of> "Aspirin" .
<Grasalva> <Brand_name_of> "Filgrastim" .
<Cytarabine,_Methotrexate,_Rituximab> <Has_accepted_use> "CNS_lymphoma" .
<R-DHAOx> <Maps_to> "R-DHAOx" .
<Antipyretic> <Subsumes> "Indomethacin" .
<Antipyretic> <Subsumes> "Aspirin_and_dipyridamole" .
<Antipyretic> <Subsumes> "Aspirin" .
<Antipyretic> <Subsumes> "Acetaminophen" .
<Doxorubicin_and_Vinblastine> <Maps_to> "Doxorubicin_and_Vinblastine" .
<AC> <Is_current_in> "Breast_cancer" .
<Ecopirin> <Brand_name_of> "Aspirin" .
<Carboplatin,_Fluorouracil,_Cetuximab> <Has_antineoplastic> "Fluorouracil" .
<Carboplatin,_Fluorouracil,_Cetuximab> <Has_antineoplastic> "Cetuximab" .
<Carboplatin,_Fluorouracil,_Cetuximab> <Has_antineoplastic> "Carboplatin" .
<Bicotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Vfend> <Brand_name_of> "Voriconazole" .
<Sumetoprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Seton> <Brand_name_of> "Ondansetron" .
<Decatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Toposide> <Brand_name_of> "Etoposide" .
<Carboplatin,_Docetaxel,_Prednisone> <Has_supportive_med> "Steroids" .
<Carboplatin,_Docetaxel,_Prednisone> <Has_supportive_med> "Dexamethasone" .
<Carboplatin,_Docetaxel,_Prednisone> <Has_supportive_med> "Cabazitaxel" .
<Carboplatin,_Docetaxel,_Prednisone> <Has_supportive_med> "Antihistamines" .
<Atezolizumab_and_Bevacizumab> <Has_accepted_use> "Renal_cell_carcinoma" .
<Atezolizumab_and_Bevacizumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Oplatin> <Brand_name_of> "Oxaliplatin" .
<Etocris> <Brand_name_of> "Etoposide" .
<FLT3_inhibitor> <Is_a> "Kinase_inhibitor" .
<Cytarabine_and_daunorubicin_liposomal> <Is_a> "Topoisomerase_inhibitor" .
<Cytarabine_and_daunorubicin_liposomal> <Is_a> "Liposomal_chemotherapy" .
<Cytarabine_and_daunorubicin_liposomal> <Is_a> "Deoxycytidine_analogue" .
<Cytarabine_and_daunorubicin_liposomal> <Is_a> "Antimetabolite" .
<Cytarabine_and_daunorubicin_liposomal> <Is_a> "Anthracycline" .
<Interferon_alfa-2b_and_Prednisone> <Has_modality> "Immunotherapy" .
<Interferon_alfa-2b_and_Prednisone> <Has_modality> "Chemotherapy" .
<IRIS_and_Bevacizumab> <Is_a> "Irinotecan-containing_regimen" .
<IRIS_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Gliadel_wafer> <Brand_name_of> "Carmustine_wafer_polifeprosan_20" .
<Panafcortelone> <Brand_name_of> "Prednisolone" .
<Acute_myeloid_leukemia> <FDA_indication_of> "Venetoclax" .
<Acute_myeloid_leukemia> <FDA_indication_of> "Midostaurin" .
<Acute_myeloid_leukemia> <FDA_indication_of> "Ivosidenib" .
<Acute_myeloid_leukemia> <FDA_indication_of> "Idarubicin" .
<Acute_myeloid_leukemia> <FDA_indication_of> "Glasdegib" .
<Acute_myeloid_leukemia> <FDA_indication_of> "Gilteritinib" .
<Acute_myeloid_leukemia> <FDA_indication_of> "Gemtuzumab_ozogamicin" .
<Acute_myeloid_leukemia> <FDA_indication_of> "Enasidenib" .
<Acute_myeloid_leukemia> <FDA_indication_of> "Doxorubicin" .
<Acute_myeloid_leukemia> <FDA_indication_of> "Cytarabine_and_daunorubicin_liposomal" .
<Acute_myeloid_leukemia> <FDA_indication_of> "Alvocidib" .
<Mechlorethamine_monotherapy> <Maps_to> "Mechlorethamine_monotherapy" .
<FCM> <Has_modality> "Chemotherapy" .
<Cefixime> <Is_a> "WHO_Essential_Anti-infective_Medicine" .
<Cefixime> <Is_a> "Cephalosporin" .
<COPA> <Has_modality> "Chemotherapy" .
<Paclitaxel_and_Ramucirumab> <Mapped_from> "Paclitaxel_and_Ramucirumab" .
<Neumega> <Brand_name_of> "Oprelvekin" .
<Breast_cancer> <Is_a> "Malignant_breast_neoplasm" .
<Leiomyosarcoma> <FDA_indication_of> "Trabectedin" .
<Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide> <Mapped_from> "Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide" .
<Temozolomide,_then_Temozolomide_and_RT,_then_Temozolomide> <Mapped_from> "Temozolomide,_then_Temozolomide_and_RT,_then_Temozolomide" .
<HIV-associated_lymphoma> <Accepted_use_of> "m-BACOD" .
<HIV-associated_lymphoma> <Accepted_use_of> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<HIV-associated_lymphoma> <Accepted_use_of> "dmCODOX-M_-_Modified_Magrath" .
<HIV-associated_lymphoma> <Accepted_use_of> "Vindesine" .
<HIV-associated_lymphoma> <Accepted_use_of> "Vincristine" .
<HIV-associated_lymphoma> <Accepted_use_of> "Vinblastine" .
<HIV-associated_lymphoma> <Accepted_use_of> "Teniposide" .
<HIV-associated_lymphoma> <Accepted_use_of> "Stanford_V" .
<HIV-associated_lymphoma> <Accepted_use_of> "SC-EPOCH-RR" .
<HIV-associated_lymphoma> <Accepted_use_of> "Rituximab-pvvr" .
<HIV-associated_lymphoma> <Accepted_use_of> "Rituximab-abbs" .
<HIV-associated_lymphoma> <Accepted_use_of> "Rituximab_monotherapy" .
<HIV-associated_lymphoma> <Accepted_use_of> "Rituximab" .
<HIV-associated_lymphoma> <Accepted_use_of> "Radiation_therapy" .
<HIV-associated_lymphoma> <Accepted_use_of> "R-EPOCH,_dose-escalated" .
<HIV-associated_lymphoma> <Accepted_use_of> "R-CODOX-M/R-IVAC" .
<HIV-associated_lymphoma> <Accepted_use_of> "R-CODOX-M" .
<HIV-associated_lymphoma> <Accepted_use_of> "R-CHOP" .
<HIV-associated_lymphoma> <Accepted_use_of> "R-CDOP" .
<HIV-associated_lymphoma> <Accepted_use_of> "Prednisone" .
<HIV-associated_lymphoma> <Accepted_use_of> "Pegylated_liposomal_doxorubicin" .
<HIV-associated_lymphoma> <Accepted_use_of> "Methotrexate" .
<HIV-associated_lymphoma> <Accepted_use_of> "Melphalan" .
<HIV-associated_lymphoma> <Accepted_use_of> "Ifosfamide" .
<HIV-associated_lymphoma> <Accepted_use_of> "GMALL-R" .
<HIV-associated_lymphoma> <Accepted_use_of> "Etoposide" .
<HIV-associated_lymphoma> <Accepted_use_of> "EPOCH,_dose-escalated" .
<HIV-associated_lymphoma> <Accepted_use_of> "Doxorubicin" .
<HIV-associated_lymphoma> <Accepted_use_of> "Dexamethasone" .
<HIV-associated_lymphoma> <Accepted_use_of> "Cytarabine" .
<HIV-associated_lymphoma> <Accepted_use_of> "Cyclophosphamide" .
<HIV-associated_lymphoma> <Accepted_use_of> "Carmustine" .
<HIV-associated_lymphoma> <Accepted_use_of> "COP" .
<HIV-associated_lymphoma> <Accepted_use_of> "CODOX-M/IVAC" .
<HIV-associated_lymphoma> <Accepted_use_of> "CODOX-M" .
<HIV-associated_lymphoma> <Accepted_use_of> "CHOP" .
<HIV-associated_lymphoma> <Accepted_use_of> "Bleomycin" .
<HIV-associated_lymphoma> <Accepted_use_of> "BEAM,_then_auto_HSCT" .
<Spebrutinib> <Is_a> "Kinase_inhibitor" .
<Spebrutinib> <Is_a> "Investigational_drug" .
<Spebrutinib> <Is_a> "BTK_inhibitor" .
<MVP_(Vinblastine)> <Maps_to> "MVP_(Vinblastine)" .
<Platamine_CS> <Brand_name_of> "Carboplatin" .
<Mitoxantrone> <Has_brand_name> "Novantrone" .
<Mitoxantrone> <Has_brand_name> "Novantron" .
<Mitoxantrone> <Has_brand_name> "Nitrol" .
<Docemax> <Brand_name_of> "Docetaxel" .
<Pentostatin> <Supportive_med_of> "Bortezomib_monotherapy" .
<Altretamine> <Has_accepted_use> "Ovarian_cancer" .
<Doxorubicin_and_Ifosfamide> <Has_modality> "Chemotherapy" .
<Rucaparib_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Rucaparib_monotherapy> <Has_context> "Non-curative_second-line_maintenance_therapy" .
<Piriton> <Brand_name_of> "Chlorpheniramine" .
<Albutrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Osimertinib_monotherapy> <Mapped_from> "Osimertinib_monotherapy" .
<Fosaprepitant> <Has_brand_name> "Emend_for_Injection" .
<Microcetim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<R-FCM> <Has_context> "Non-curative_therapy" .
<R-FCM> <Has_context> "Non-curative_first-line_therapy" .
<Peginterferon_alfa-2a> <Has_accepted_use> "Polycythemia_vera" .
<Peginterferon_alfa-2a> <Has_accepted_use> "Hypereosinophilic_syndrome" .
<Peginterferon_alfa-2a> <Has_accepted_use> "Essential_thrombocythemia" .
<Peginterferon_alfa-2a> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<7_plus_3i> <Is_current_in> "Acute_myeloid_leukemia" .
<C-MOPP/ABV> <Is_a> "Anthracycline-containing_regimen" .
<Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib> <Mapped_from> "Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib" .
<Polivy> <Brand_name_of> "Polatuzumab_vedotin" .
<Anastrozole_and_Fulvestrant> <Has_context> "Non-curative_subsequent-line_therapy" .
<Anastrozole_and_Fulvestrant> <Has_context> "Non-curative_first-line_therapy" .
<Bu/TT> <Has_antineoplastic> "Thiotepa" .
<Bu/TT> <Has_antineoplastic> "Busulfan" .
<Alpelisib_and_Fulvestrant> <Has_context> "Non-curative_therapy" .
<Mercaptopurine_and_Methotrexate> <Maps_to> "Mercaptopurine_and_Methotrexate" .
<ADT_and_Enzalutamide> <Maps_to> "ADT_and_Enzalutamide" .
<Lamivudine> <Has_brand_name> "Epivir" .
<Tipifarnib> <May_have_route> "Oral" .
<FC,_then_allo_HSCT> <Has_accepted_use> "Renal_cell_carcinoma" .
<FC,_then_allo_HSCT> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Peginterferon_alfa-2b> <Has_FDA_indication> "Melanoma" .
<5_plus_3d> <Mapped_from> "5_plus_3d" .
<Gliadel_wafer_monotherapy> <Has_context> "Non-curative_therapy" .
<Ibrutinib_and_Rituximab> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<Ibrutinib_and_Rituximab> <Is_current_in> "Mantle_cell_lymphoma" .
<Ibrutinib_and_Rituximab> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Alendroninezuur> <Brand_name_of> "Alendronate" .
<Neukine> <Brand_name_of> "Filgrastim" .
<Dexacortisone> <Brand_name_of> "Dexamethasone" .
<Decapeptyl> <Brand_name_of> "Triptorelin" .
<Enfortumab_vedotin> <Has_brand_name> "Padcev" .
<Zofran> <Brand_name_of> "Ondansetron" .
<Everolimus_and_Tamoxifen> <Has_context> "Non-curative_subsequent-line_therapy" .
<HAIC_and_Sorafenib> <Is_current_in> "Hepatocellular_carcinoma" .
<DexaBEAM_and_G-CSF> <Has_modality> "Growth_factor_therapy" .
<DexaBEAM_and_G-CSF> <Has_modality> "Chemotherapy" .
<Doxorubicin_non-pegylated_liposomal_monotherapy> <Has_accepted_use> "Breast_cancer" .
<IGEV_and_G-CSF> <Has_supportive_med> "Mesna" .
<IGEV_and_G-CSF> <Has_supportive_med> "Lenograstim" .
<Baxolex> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<LoDAC_and_Venetoclax> <Maps_to> "LoDAC_and_Venetoclax" .
<Ketoconazole,_Hydrocortisone,_Dutasteride> <Mapped_from> "Ketoconazole,_Hydrocortisone,_Dutasteride" .
<KFDA_approved_drug> <Subsumes> "Tropisetron" .
<KFDA_approved_drug> <Subsumes> "Radotinib" .
<KFDA_approved_drug> <Subsumes> "Heptaplatin" .
<KFDA_approved_drug> <Subsumes> "Belotecan" .
<Capecitabine_and_Erlotinib> <Has_context> "Non-curative_therapy" .
<Abemaciclib> <Is_a> "Protein_expression-specific_medication" .
<Abemaciclib> <Is_a> "Kinase_inhibitor" .
<Abemaciclib> <Is_a> "CDK_inhibitor" .
<(90)YFC,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<(90)YFC,_then_allo_HSCT> <Has_modality> "Immunosuppressive_therapy" .
<(90)YFC,_then_allo_HSCT> <Has_modality> "Chemoradioimmunotherapy" .
<Cots> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bicalutamide_and_RT> <Mapped_from> "Bicalutamide_and_RT" .
<Doxorubicin,_Methotrexate,_Vincristine,_Prednisone> <Has_context> "Induction_therapy" .
<mFOLFOX_and_Sorafenib> <Has_modality> "Chemotherapy" .
<Bendamustine_monotherapy> <Has_modality> "Chemotherapy" .
<mFOLFOX6> <Has_modality> "Chemotherapy" .
<Platiblastin> <Brand_name_of> "Cisplatin" .
<Clop-75> <Brand_name_of> "Clopidogrel" .
<BVB> <Maps_to> "BVB" .
<Hepatic_arterial_chemotherapy> <Has_context> "Non-curative_therapy" .
<Hu5F9-G4> <Is_a> "Investigational_drug" .
<Hu5F9-G4> <Is_a> "Immunotherapeutic" .
<Hu5F9-G4> <Is_a> "Antibody_medication" .
<Hu5F9-G4> <Is_a> "Anti-CD47_antibody" .
<Paclitaxel_nanoparticle_albumin-bound> <Is_a> "Taxane" .
<Paclitaxel_nanoparticle_albumin-bound> <Is_a> "Nanoparticle_albumin_bound_chemotherapy" .
<Paclitaxel_nanoparticle_albumin-bound> <Is_a> "Microtubule_inhibitor" .
<Paclitaxel_nanoparticle_albumin-bound> <Is_a> "Irritant" .
<Oxaliplatin_and_RT> <Has_antineoplastic> "Oxaliplatin" .
<Oxaliplatin_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Fludarabine,_Busulfan,_ATG> <Has_modality> "Immunosuppressive_therapy" .
<Fludarabine,_Busulfan,_ATG> <Has_modality> "Chemotherapy" .
<PET> <Is_a> "Anthracycline-containing_regimen" .
<Gemcitabine,_Oxaliplatin,_Paclitaxel> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Gemcitabine,_Oxaliplatin,_Paclitaxel> <Has_supportive_med> "Emesis_prevention" .
<Gemcitabine,_Oxaliplatin,_Paclitaxel> <Has_supportive_med> "Diphenhydramine" .
<Gemcitabine,_Oxaliplatin,_Paclitaxel> <Has_supportive_med> "Dexamethasone" .
<Gemcitabine,_Oxaliplatin,_Paclitaxel> <Has_supportive_med> "Cimetidine" .
<Lanreotide_and_Interferon_alfa-2b> <Has_accepted_use> "Pancreatic_NET" .
<Lanreotide_and_Interferon_alfa-2b> <Has_accepted_use> "Neuroendocrine_tumor" .
<FEC_and_H_(SC)> <Is_current_in> "Breast_cancer" .
<Irritant> <Is_a> "Chemotherapeutic" .
<MAP> <Has_supportive_med> "Furosemide" .
<MAP> <Has_supportive_med> "Folinic_acid" .
<Mechlorethamine> <Has_accepted_use> "Hodgkin_lymphoma" .
<Leuprorelin> <Brand_name_of> "Leuprolide" .
<131I-Metaiodobenzylguanidine_(131I-MIBG)> <Mapped_from> "131I-Metaiodobenzylguanidine_(131I-MIBG)" .
<7_plus_3i_and_Vorinostat> <Has_modality> "Chemotherapy" .
<Cipro> <Brand_name_of> "Ciprofloxacin" .
<PD> <Has_modality> "Chemotherapy" .
<Cisplatin,_Lomustine,_Vincristine> <Has_modality> "Chemotherapy" .
<Vomiban> <Brand_name_of> "Ondansetron" .
<ESHAP> <Mapped_from> "ESHAP" .
<CLARA> <Has_supportive_med> "Filgrastim" .
<Gemcitabine,_Cisplatin,_S-1> <Is_current_in> "Gallbladder_cancer" .
<Gemcitabine,_Cisplatin,_S-1> <Is_current_in> "Cholangiocarcinoma" .
<Fauldcita> <Brand_name_of> "Cytarabine" .
<Suprex> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Sulfinam> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<RVR> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<Ofatumumab_monotherapy> <Has_supportive_med> "Steroids" .
<Ofatumumab_monotherapy> <Has_supportive_med> "Prednisolone" .
<Ofatumumab_monotherapy> <Has_supportive_med> "Diphenhydramine" .
<Ofatumumab_monotherapy> <Has_supportive_med> "Cetirizine" .
<Ofatumumab_monotherapy> <Has_supportive_med> "Antihistamines" .
<Ofatumumab_monotherapy> <Has_supportive_med> "Acetaminophen" .
<Factor_IX_recombinant_Fc_fusion_protein> <Is_a> "Hematology_medication" .
<Clofarabine_and_Cytarabine> <Has_supportive_med> "Voriconazole" .
<Clofarabine_and_Cytarabine> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Clofarabine_and_Cytarabine> <Has_supportive_med> "Levofloxacin" .
<Clofarabine_and_Cytarabine> <Has_supportive_med> "Dexamethasone" .
<Clofarabine_and_Cytarabine> <Has_supportive_med> "Caspofungin" .
<Clofarabine_and_Cytarabine> <Has_supportive_med> "Acyclovir" .
<DexaBEAM_and_G-CSF> <Is_current_in> "Stem_cell_mobilization" .
<Sulftran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Octreotide_LAR_monotherapy> <Has_modality> "Hormonotherapy" .
<Dexadermil> <Brand_name_of> "Dexamethasone" .
<Inmecin> <Brand_name_of> "Indomethacin" .
<MESA/RT> <Has_context> "Induction_therapy" .
<Erlotinib_and_Ramucirumab> <Has_antineoplastic> "Ramucirumab" .
<Erlotinib_and_Ramucirumab> <Has_antineoplastic> "Erlotinib" .
<HDMP-R> <Maps_to> "HDMP-R" .
<Inotuzumab_ozogamicin_monotherapy> <Mapped_from> "Inotuzumab_ozogamicin_monotherapy" .
<Doxorubicin_and_Gemcitabine> <Has_context> "Non-curative_first-line_therapy" .
<FEC_and_H> <Has_context> "Neoadjuvant_therapy" .
<FEC_and_H> <Has_context> "Adjuvant_therapy" .
<Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Prednisolone_monotherapy> <Has_antineoplastic> "Prednisolone" .
<Bu/TT/Cy,_then_auto_HSCT> <Has_antineoplastic> "Thiotepa" .
<Bu/TT/Cy,_then_auto_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<Bu/TT/Cy,_then_auto_HSCT> <Has_antineoplastic> "Busulfan" .
<Duvaxan> <Brand_name_of> "Ifosfamide" .
<PF> <Is_historical_in> "Breast_cancer" .
<Cemiplimab_monotherapy> <Is_current_in> "Cutaneous_squamous_cell_carcinoma" .
<IT_Methotrexate_and_WBRT> <Is_current_in> "CNS_leukemia" .
<Low-dose_TBI,_then_allo_HSCT> <Has_immunosuppressor> "Tacrolimus" .
<Low-dose_TBI,_then_allo_HSCT> <Has_immunosuppressor> "Mycophenolate_mofetil" .
<Low-dose_TBI,_then_allo_HSCT> <Has_immunosuppressor> "Cyclosporine_non-modified" .
<Cisplatin,_Vinorelbine,_Cetuximab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cisplatin,_Etoposide,_Irinotecan> <Maps_to> "Cisplatin,_Etoposide,_Irinotecan" .
<ADE_and_ATRA> <Has_antineoplastic> "Etoposide" .
<ADE_and_ATRA> <Has_antineoplastic> "Daunorubicin" .
<ADE_and_ATRA> <Has_antineoplastic> "Cytarabine" .
<ADE_and_ATRA> <Has_antineoplastic> "All-trans_retinoic_acid" .
<Bisbon> <Brand_name_of> "Alendronate" .
<DDGP> <Maps_to> "DDGP" .
<Ketoconazole,_Hydrocortisone,_Dutasteride> <Has_accepted_use> "Prostate_cancer" .
<Methotrexate,_RT,_Cyclophosphamide> <Has_context> "Definitive_therapy" .
<Alendros> <Brand_name_of> "Alendronate" .
<FOLFIRI_and_Ziv-aflibercept> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<FOLFIRI_and_Ziv-aflibercept> <Has_supportive_med> "Emesis_prevention" .
<FOLFIRI_and_Ziv-aflibercept> <Has_supportive_med> "Atropine" .
<Thalidomide_and_Prednisone> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<BCHOP> <Is_a> "Anthracycline-containing_regimen" .
<Radiation_therapy> <Has_modality> "Radiotherapy" .
<Bondronat> <Brand_name_of> "Ibandronate" .
<Cisplatin,_Fluorouracil,_RT> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<Cisplatin,_Fluorouracil,_RT> <Has_accepted_use> "Head_and_neck_cancer" .
<Cisplatin,_Fluorouracil,_RT> <Has_accepted_use> "Esophageal_cancer" .
<Cisplatin,_Fluorouracil,_RT> <Has_accepted_use> "Cervical_cancer" .
<Cisplatin,_Fluorouracil,_RT> <Has_accepted_use> "Bladder_cancer" .
<Cisplatin,_Fluorouracil,_RT> <Has_accepted_use> "Anal_cancer" .
<RiPAD_plus_C> <Has_modality> "Chemotherapy" .
<Irinotecan_liposomal_monotherapy> <Is_current_in> "Pancreatic_cancer" .
<Irinotecan_liposomal_monotherapy> <Is_current_in> "Gastric_cancer" .
<Irinotecan_liposomal_monotherapy> <Is_current_in> "Esophageal_cancer" .
<Hexilon> <Brand_name_of> "Methylprednisolone" .
<Lastet> <Brand_name_of> "Etoposide" .
<Ensartinib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<RiPAD_plus_C> <Is_current_in> "Mantle_cell_lymphoma" .
<Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone> <Is_a> "Anthracycline-containing_regimen" .
<BEAM,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Polatuzumab_vedotin> <Antineoplastic_of> "BR_and_Polatuzumab_vedotin" .
<LOPP/EVAP> <Is_historical_in> "Hodgkin_lymphoma" .
<Domperidone> <Is_a> "Phenothiazine" .
<Domperidone> <Is_a> "Emesis_prevention" .
<Domperidone> <Is_a> "Dopamine_receptor_antagonist" .
<Niraparib_monotherapy> <Has_modality> "Chemotherapy" .
<Whole_brain_irradiation> <Is_current_in> "Small_cell_lung_cancer" .
<Whole_brain_irradiation> <Is_current_in> "CNS_lymphoma" .
<Whole_brain_irradiation> <Is_current_in> "CNS_carcinoma" .
<R-CHMP> <Maps_to> "R-CHMP" .
<ddTH_(Taxol)> <Has_modality> "Chemotherapy" .
<TAM6> <Is_current_in> "Autologous_HSCT" .
<Dara-VD> <Has_accepted_use> "Multiple_myeloma" .
<Immunotherapy> <Mapped_from> "Immunotherapy" .
<Lusutrombopag_monotherapy> <Has_context> "All_lines_of_therapy" .
<Cehafolin> <Brand_name_of> "Folinic_acid" .
<CHOP> <Mapped_from> "CHOP" .
<VMCP> <Has_antineoplastic> "Vincristine" .
<VMCP> <Has_antineoplastic> "Prednisone" .
<VMCP> <Has_antineoplastic> "Melphalan" .
<VMCP> <Has_antineoplastic> "Cyclophosphamide" .
<CRd> <Has_modality> "Chemotherapy" .
<Axitinib_and_Avelumab> <Has_context> "Non-curative_first-line_therapy" .
<P/DOCE> <Has_antineoplastic> "Vincristine" .
<P/DOCE> <Has_antineoplastic> "Prednisone" .
<P/DOCE> <Has_antineoplastic> "Etoposide" .
<P/DOCE> <Has_antineoplastic> "Doxorubicin" .
<P/DOCE> <Has_antineoplastic> "Cyclophosphamide" .
<mFOLFIRINOX,_Gemcitabine,_RT> <Is_a> "Irinotecan-containing_regimen" .
<R-CHOP-14_(Prednisolone)> <Maps_to> "R-CHOP-14_(Prednisolone)" .
<Cladribine_monotherapy> <Has_antineoplastic> "Cladribine" .
<Paclitaxel_and_Vinorelbine> <Has_context> "Non-curative_first-line_therapy" .
<Augmented_Hyper-CVAD_and_Asparaginase> <Has_context> "Non-curative_therapy" .
<Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone> <Has_local_therapy> "Methotrexate" .
<Treosulfan> <Antineoplastic_of> "Treosulfan_monotherapy" .
<Cyclovax> <Brand_name_of> "Acyclovir" .
<Bicalutamide> <Has_brand_name> "Kalumid" .
<Bicalutamide> <Has_brand_name> "Cosudex" .
<Bicalutamide> <Has_brand_name> "Casodex" .
<Bicalutamide> <Has_brand_name> "Calutide" .
<Estroquin> <Brand_name_of> "Folinic_acid" .
<TTR> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Chlorambucil_and_Rituximab> <Is_a> "Rituximab-containing_regimen" .
<Goserelin> <Antineoplastic_of> "Goserelin_monotherapy" .
<Goserelin> <Antineoplastic_of> "Goserelin_and_Tamoxifen" .
<Goserelin> <Antineoplastic_of> "Goserelin_and_RT" .
<Goserelin> <Antineoplastic_of> "Flutamide,_Goserelin,_RT" .
<Goserelin> <Antineoplastic_of> "Flutamide_and_Goserelin" .
<Goserelin> <Antineoplastic_of> "Bicalutamide_and_Goserelin" .
<Goserelin> <Antineoplastic_of> "Anastrozole_and_Goserelin" .
<Thalidomide_and_Prednisolone> <Is_current_in> "Multiple_myeloma" .
<Phytonadione> <Is_a> "Hematology_medication" .
<PI3K_delta_inhibitor> <Is_a> "PI3K_inhibitor" .
<Small_cell_lung_cancer> <Historic_treated_by> "VMV-VAC" .
<Small_cell_lung_cancer> <Historic_treated_by> "VIP" .
<Small_cell_lung_cancer> <Historic_treated_by> "PCE" .
<Small_cell_lung_cancer> <Historic_treated_by> "PCDE" .
<Small_cell_lung_cancer> <Historic_treated_by> "Methotrexate,_RT,_Cyclophosphamide" .
<Small_cell_lung_cancer> <Historic_treated_by> "MACC" .
<Small_cell_lung_cancer> <Historic_treated_by> "ICE" .
<Small_cell_lung_cancer> <Historic_treated_by> "EVI" .
<Small_cell_lung_cancer> <Historic_treated_by> "Cyclophosphamide,_Lomustine,_Methotrexate" .
<Small_cell_lung_cancer> <Historic_treated_by> "CEV_and_RT" .
<Small_cell_lung_cancer> <Historic_treated_by> "CEV_(Cyclophosphamide/Etoposide)" .
<Small_cell_lung_cancer> <Historic_treated_by> "CEV_(Cyclophosphamide/Epirubicin)" .
<Small_cell_lung_cancer> <Historic_treated_by> "CEV_(Carboplatin/Etoposide)" .
<Small_cell_lung_cancer> <Historic_treated_by> "CDE" .
<Small_cell_lung_cancer> <Historic_treated_by> "CC/DE_and_RT" .
<Small_cell_lung_cancer> <Historic_treated_by> "CAVE" .
<Small_cell_lung_cancer> <Historic_treated_by> "CAV/PE" .
<Small_cell_lung_cancer> <Historic_treated_by> "CAV_and_RT" .
<Small_cell_lung_cancer> <Historic_treated_by> "CAV" .
<Small_cell_lung_cancer> <Historic_treated_by> "BACO" .
<Small_cell_lung_cancer> <Historic_treated_by> "ACE" .
<Melacyte> <Brand_name_of> "Erlotinib" .
<MIC> <Mapped_from> "MIC" .
<R-BAC> <Has_modality> "Chemotherapy" .
<Darolutamide> <Has_accepted_use> "Prostate_cancer" .
<mFOLFOX6> <Mapped_from> "mFOLFOX6" .
<Mitoxantrone_monotherapy> <Has_modality> "Chemotherapy" .
<R-GemOx> <Has_context> "Non-curative_subsequent-line_therapy" .
<Trifluridine_and_tipiracil_monotherapy> <Is_current_in> "Gastric_cancer" .
<Trifluridine_and_tipiracil_monotherapy> <Is_current_in> "Colon_cancer" .
<Nilotinib> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Nilotinib> <Is_a> "PDGFR_inhibitor" .
<Nilotinib> <Is_a> "Mutation-specific_medication" .
<Nilotinib> <Is_a> "Kinase_inhibitor" .
<Nilotinib> <Is_a> "KIT_inhibitor" .
<Nilotinib> <Is_a> "DDR_inhibitor" .
<Nilotinib> <Is_a> "CSF1R_inhibitor" .
<Nilotinib> <Is_a> "Bcr-Abl_inhibitor" .
<Darolutamide> <May_have_route> "Oral" .
<FOLFOX_7/sLV5FU2> <Mapped_from> "FOLFOX_7/sLV5FU2" .
<Netupitant_and_palonosetron> <May_have_route> "Oral" .
<Cisplatin,_Pemetrexed,_Bevacizumab> <Has_antineoplastic> "Pemetrexed" .
<Cisplatin,_Pemetrexed,_Bevacizumab> <Has_antineoplastic> "Cisplatin" .
<Cisplatin,_Pemetrexed,_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Vemurafenib> <Has_FDA_indication> "Melanoma" .
<Vemurafenib> <Has_FDA_indication> "Erdheim-Chester_disease" .
<Vemurafenib> <Has_FDA_indication> "BRAF-mutated_malignancy" .
<Dehydrocortison> <Brand_name_of> "Prednisone" .
<Comazole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Anti-CD33_antibody> <Is_a> "Antibody_medication" .
<Mitotane_and_Streptozocin> <Has_modality> "Chemotherapy" .
<Ixazomib_monotherapy> <Is_current_in> "Multiple_myeloma" .
<Ixazomib_monotherapy> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<Carboplatin_and_RT> <Is_current_in> "Non-small_cell_lung_cancer" .
<Carboplatin_and_RT> <Is_current_in> "Nasopharyngeal_carcinoma" .
<Carboplatin_and_RT> <Is_current_in> "Head_and_neck_cancer" .
<Carboplatin_and_RT> <Is_current_in> "Cervical_cancer" .
<Breast_cancer> <Historic_treated_by> "Vinorelbine_monotherapy" .
<Breast_cancer> <Historic_treated_by> "VAP" .
<Breast_cancer> <Historic_treated_by> "VAC_(Adriamycin)" .
<Breast_cancer> <Historic_treated_by> "Thiotepa_monotherapy" .
<Breast_cancer> <Historic_treated_by> "TMF" .
<Breast_cancer> <Historic_treated_by> "TAD_(Tamoxifen)" .
<Breast_cancer> <Historic_treated_by> "STAMP-I" .
<Breast_cancer> <Historic_treated_by> "Paclitaxel_monotherapy" .
<Breast_cancer> <Historic_treated_by> "PT" .
<Breast_cancer> <Historic_treated_by> "PFT" .
<Breast_cancer> <Historic_treated_by> "PF" .
<Breast_cancer> <Historic_treated_by> "PAF" .
<Breast_cancer> <Historic_treated_by> "Oophorectomy" .
<Breast_cancer> <Historic_treated_by> "Mitoxantrone_monotherapy" .
<Breast_cancer> <Historic_treated_by> "Methotrexate_and_Thiotepa" .
<Breast_cancer> <Historic_treated_by> "Melphalan_monotherapy" .
<Breast_cancer> <Historic_treated_by> "Megestrol_monotherapy" .
<Breast_cancer> <Historic_treated_by> "Medroxyprogesterone_monotherapy" .
<Breast_cancer> <Historic_treated_by> "MV" .
<Breast_cancer> <Historic_treated_by> "MF" .
<Breast_cancer> <Historic_treated_by> "Levamisole_monotherapy" .
<Breast_cancer> <Historic_treated_by> "Formestane_monotherapy" .
<Breast_cancer> <Historic_treated_by> "Fluoxymesterone_monotherapy" .
<Breast_cancer> <Historic_treated_by> "FNC" .
<Breast_cancer> <Historic_treated_by> "FAC_and_BCG" .
<Breast_cancer> <Historic_treated_by> "Estradiol_monotherapy" .
<Breast_cancer> <Historic_treated_by> "Epirubicin_monotherapy" .
<Breast_cancer> <Historic_treated_by> "ECT,_then_auto_HSCT" .
<Breast_cancer> <Historic_treated_by> "EC" .
<Breast_cancer> <Historic_treated_by> "Docetaxel_monotherapy" .
<Breast_cancer> <Historic_treated_by> "DES_monotherapy" .
<Breast_cancer> <Historic_treated_by> "Cyclophosphamide_monotherapy" .
<Breast_cancer> <Historic_treated_by> "Chlorambucil_and_Prednisolone" .
<Breast_cancer> <Historic_treated_by> "Capecitabine_monotherapy" .
<Breast_cancer> <Historic_treated_by> "CVAP" .
<Breast_cancer> <Historic_treated_by> "CTCb,_then_auto_HSCT" .
<Breast_cancer> <Historic_treated_by> "CPB" .
<Breast_cancer> <Historic_treated_by> "CMFVP" .
<Breast_cancer> <Historic_treated_by> "CMFV" .
<Breast_cancer> <Historic_treated_by> "CMFPT" .
<Breast_cancer> <Historic_treated_by> "CMFP" .
<Breast_cancer> <Historic_treated_by> "CMFL" .
<Breast_cancer> <Historic_treated_by> "CHUT,_then_auto_HSCT" .
<Breast_cancer> <Historic_treated_by> "CFP_and_Oophorectomy" .
<Breast_cancer> <Historic_treated_by> "CFP" .
<Breast_cancer> <Historic_treated_by> "CEF/CMF" .
<Breast_cancer> <Historic_treated_by> "CAMFP" .
<Breast_cancer> <Historic_treated_by> "CAMF" .
<Breast_cancer> <Historic_treated_by> "CAFVP" .
<Breast_cancer> <Historic_treated_by> "CAF_and_MPA" .
<Breast_cancer> <Historic_treated_by> "Aminoglutethimide_monotherapy" .
<Breast_cancer> <Historic_treated_by> "AVCF" .
<Breast_cancer> <Historic_treated_by> "AV-CMF" .
<Breast_cancer> <Historic_treated_by> "ACT" .
<Breast_cancer> <Historic_treated_by> "AC" .
<Dexmethasone> <Brand_name_of> "Dexamethasone" .
<IT_Cytarabine_liposomal_monotherapy> <Has_context> "Local_therapy" .
<Ravulizumab> <Is_a> "Hematology_medication" .
<Ravulizumab> <Is_a> "Antibody_medication" .
<Ravulizumab> <Is_a> "Anti-C5_antibody" .
<Prednisolone_and_Rituximab> <Maps_to> "Prednisolone_and_Rituximab" .
<Mylocel> <Brand_name_of> "Hydroxyurea" .
<Dontisolon_D> <Brand_name_of> "Prednisolone" .
<BuCy,_then_allo_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<Osimertinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Osimertinib_monotherapy> <Has_context> "All_lines_of_therapy" .
<BFR,_then_allo_HSCT> <Mapped_from> "BFR,_then_allo_HSCT" .
<Epoetin_alfa-epbx> <Has_brand_name> "Retacrit" .
<Everolimus_and_Lenvatinib> <Has_antineoplastic> "Lenvatinib" .
<Everolimus_and_Lenvatinib> <Has_antineoplastic> "Everolimus" .
<ETO> <Brand_name_of> "Etoposide" .
<Myelostim> <Brand_name_of> "Filgrastim" .
<Irinotecan,_Vemurafenib,_Cetuximab> <Has_antineoplastic> "Vemurafenib" .
<Irinotecan,_Vemurafenib,_Cetuximab> <Has_antineoplastic> "Irinotecan" .
<Irinotecan,_Vemurafenib,_Cetuximab> <Has_antineoplastic> "Cetuximab" .
<FLAG-Ida> <Mapped_from> "FLAG-Ida" .
<Ipilimumab,_then_Nivolumab> <Has_context> "Non-curative_therapy" .
<FNC> <Is_a> "Anthracycline-containing_regimen" .
<Nelarabine_monotherapy> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Cisplatin,_Pemetrexed,_Pembrolizumab> <Maps_to> "Cisplatin,_Pemetrexed,_Pembrolizumab" .
<COPA> <Has_context> "Non-curative_first-line_therapy" .
<MRD> <Mapped_from> "MRD" .
<Sorafenat> <Brand_name_of> "Sorafenib" .
<Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA> <Is_a> "Anthracycline-containing_regimen" .
<Axcel> <Brand_name_of> "Acyclovir" .
<CHOP-BCG> <Maps_to> "CHOP-BCG" .
<IP-BCD> <Maps_to> "IP-BCD" .
<CM> <Has_modality> "Chemotherapy" .
<Ranitidine> <Supportive_med_of> "ddAC-T" .
<Ranitidine> <Supportive_med_of> "TIP" .
<Ranitidine> <Supportive_med_of> "Stanford_V" .
<Ranitidine> <Supportive_med_of> "Rituximab_monotherapy" .
<Ranitidine> <Supportive_med_of> "Paclitaxel_monotherapy" .
<Ranitidine> <Supportive_med_of> "PCF" .
<Ranitidine> <Supportive_med_of> "Ixazomib_and_Dexamethasone" .
<Ranitidine> <Supportive_med_of> "Ifosfamide_and_Paclitaxel" .
<Ranitidine> <Supportive_med_of> "IRd" .
<Ranitidine> <Supportive_med_of> "High-dose_Interleukin-2" .
<Ranitidine> <Supportive_med_of> "Gemcitabine_and_Paclitaxel" .
<Ranitidine> <Supportive_med_of> "Elo-VD" .
<Ranitidine> <Supportive_med_of> "Elo-Rd" .
<Ranitidine> <Supportive_med_of> "Elo-PD" .
<Ranitidine> <Supportive_med_of> "Docetaxel_monotherapy" .
<Ranitidine> <Supportive_med_of> "Docetaxel_and_Gemcitabine" .
<Ranitidine> <Supportive_med_of> "DCF" .
<Ranitidine> <Supportive_med_of> "Cisplatin_and_Paclitaxel" .
<Ranitidine> <Supportive_med_of> "Carboplatin,_Paclitaxel,_RT" .
<Ranitidine> <Supportive_med_of> "Carboplatin_and_Paclitaxel" .
<Ranitidine> <Supportive_med_of> "Carboplatin_and_Docetaxel" .
<Ranitidine> <Supportive_med_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Cisplatin,_Doxorubicin_liposomal,_Fluorouracil> <Mapped_from> "Cisplatin,_Doxorubicin_liposomal,_Fluorouracil" .
<TPC> <Has_antineoplastic> "Trastuzumab" .
<TPC> <Has_antineoplastic> "Paclitaxel" .
<TPC> <Has_antineoplastic> "Carboplatin" .
<BR_and_Polatuzumab_vedotin> <Maps_to> "BR_and_Polatuzumab_vedotin" .
<Roacutan> <Brand_name_of> "Isotretinoin" .
<ADT_and_Abiraterone> <Maps_to> "ADT_and_Abiraterone" .
<Accelerated_BEP> <Has_antineoplastic> "Etoposide" .
<Accelerated_BEP> <Has_antineoplastic> "Cisplatin" .
<Accelerated_BEP> <Has_antineoplastic> "Bleomycin" .
<Sirolimus_monotherapy> <Maps_to> "Sirolimus_monotherapy" .
<FR> <Has_context> "Non-curative_therapy" .
<FR> <Has_context> "Non-curative_first-line_therapy" .
<FR> <Has_context> "All_lines_of_therapy" .
<Heptaplatin> <Has_brand_name> "SunPla" .
<R-BAC> <Has_antineoplastic> "Rituximab" .
<R-BAC> <Has_antineoplastic> "Cytarabine" .
<R-BAC> <Has_antineoplastic> "Bendamustine" .
<Gemcitabine_and_S-1> <Has_accepted_use> "Gallbladder_cancer" .
<Gemcitabine_and_S-1> <Has_accepted_use> "Cholangiocarcinoma" .
<Docetaxel_and_Prednisone> <Maps_to> "Docetaxel_and_Prednisone" .
<Tegafur,_Uracil,_Folinic_acid> <Maps_to> "Tegafur,_Uracil,_Folinic_acid" .
<R-TBI/Cy> <Has_context> "All_lines_of_therapy" .
<BBD> <Has_context> "Non-curative_therapy" .
<BBD> <Has_context> "Non-curative_first-line_therapy" .
<Intraperitoneal_5-FU> <Has_accepted_use> "Colon_cancer" .
<Doxotec> <Brand_name_of> "Doxorubicin" .
<PMitCEBO> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<ddAC> <Has_context> "Neoadjuvant_therapy" .
<ddAC> <Has_context> "Adjuvant_therapy" .
<Onkoposid> <Brand_name_of> "Etoposide" .
<Vascular_sarcoma> <Current_treated_by> "Paclitaxel_monotherapy" .
<Vascular_sarcoma> <Current_treated_by> "Bevacizumab_monotherapy" .
<THP_(Taxol)> <Mapped_from> "THP_(Taxol)" .
<L-glutamine> <Supportive_med_of> "RBC_transfusions" .
<L-glutamine> <Supportive_med_of> "L-glutamine_monotherapy" .
<Platamin> <Brand_name_of> "Cisplatin" .
<Sulfamet> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Ascorbic_acid> <Is_a> "OTC_medication" .
<R-NIMP> <Has_supportive_med> "Pegfilgrastim" .
<R-NIMP> <Has_supportive_med> "Mesna" .
<Aromasin> <Brand_name_of> "Exemestane" .
<Okeron> <Brand_name_of> "Octreotide" .
<F-SHAI> <Maps_to> "F-SHAI" .
<Amsidyl> <Brand_name_of> "Amsacrine" .
<Cytarabine,_Ifosfamide,_G-CSF> <Has_context> "All_lines_of_therapy" .
<R-DHAOx> <Has_context> "Salvage_therapy" .
<R-DHAOx> <Has_context> "Non-curative_first-line_therapy" .
<Capecitabine_and_Fulvestrant> <Mapped_from> "Capecitabine_and_Fulvestrant" .
<Defibrotide> <Has_brand_name> "Defitelio" .
<Fostamatinib> <Has_FDA_indication> "Immune_thrombocytopenia" .
<Purine_analogue> <Subsumes> "Thioguanine" .
<Purine_analogue> <Subsumes> "Pentostatin" .
<Purine_analogue> <Subsumes> "Nelarabine" .
<Purine_analogue> <Subsumes> "Mercaptopurine" .
<Purine_analogue> <Subsumes> "Fludarabine" .
<Purine_analogue> <Subsumes> "Dacarbazine" .
<Purine_analogue> <Subsumes> "Clofarabine" .
<Purine_analogue> <Subsumes> "Cladribine" .
<Mini-BEAM> <Is_current_in> "Hodgkin_lymphoma" .
<International_ALL_Trial> <Has_context> "Consolidation_after_upfront_therapy" .
<Seco_Uracil> <Brand_name_of> "Fluorouracil" .
<Cyclophosphamide_and_TBI> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Cyclophosphamide_and_TBI> <Has_accepted_use> "Autologous_HSCT" .
<Cyclophosphamide_and_TBI> <Has_accepted_use> "Allogeneic_HSCT" .
<Intravenous_immunoglobulin_monotherapy> <Maps_to> "Intravenous_immunoglobulin_monotherapy" .
<Metoxaleno> <Brand_name_of> "Methoxsalen" .
<Lomustine_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<COPP/ABVD> <Has_context> "Induction_therapy" .
<Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT> <Has_antineoplastic> "Melphalan" .
<Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT> <Has_antineoplastic> "Fludarabine" .
<Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT> <Has_antineoplastic> "Alemtuzumab" .
<CVP> <Is_historical_in> "Follicular_lymphoma" .
<CVP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<CVP> <Is_historical_in> "Chronic_lymphocytic_leukemia" .
<Doxonolver> <Brand_name_of> "Doxorubicin" .
<Emend_Trifold> <Brand_name_of> "Aprepitant" .
<Talimogene_laherparepvec_monotherapy> <Is_current_in> "Melanoma" .
<Calcium_Folint> <Brand_name_of> "Folinic_acid" .
<Epirubicin_and_Ifosfamide> <Mapped_from> "Epirubicin_and_Ifosfamide" .
<Gemcitabine/Fluorouracil_and_RT> <Is_current_in> "Pancreatic_cancer" .
<Gemcitabine/Fluorouracil_and_RT> <Is_current_in> "Cholangiocarcinoma" .
<TC_and_Nintedanib> <Mapped_from> "TC_and_Nintedanib" .
<Alkyloxan> <Brand_name_of> "Cyclophosphamide" .
<T-cell_prolymphocytic_leukemia> <Accepted_use_of> "Pentostatin_and_Alemtuzumab" .
<T-cell_prolymphocytic_leukemia> <Accepted_use_of> "Ibrutinib_and_Venetoclax" .
<T-cell_prolymphocytic_leukemia> <Accepted_use_of> "Bendamustine_monotherapy" .
<T-cell_prolymphocytic_leukemia> <Accepted_use_of> "Alemtuzumab_monotherapy" .
<(90)YFC,_then_allo_HSCT> <Has_immunosuppressor> "Tacrolimus" .
<(90)YFC,_then_allo_HSCT> <Has_immunosuppressor> "Methotrexate" .
<(90)YFC,_then_allo_HSCT> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<Fe_Tabs> <Brand_name_of> "Ferrous_sulfate" .
<AVCF> <Is_a> "Anthracycline-containing_regimen" .
<Lorlatinib> <Antineoplastic_of> "Lorlatinib_monotherapy" .
<Fluorouracil,_Folinic_acid,_RT> <Is_current_in> "Rectal_cancer" .
<Alemtuzumab_monotherapy> <Has_antineoplastic> "Alemtuzumab" .
<Trabectedin> <May_have_route> "Intravenous" .
<Cabozantinib_monotherapy> <Has_context> "Non-curative_third-line_therapy" .
<Cabozantinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Cabozantinib_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Cabozantinib_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Cabozantinib_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Cabozantinib_monotherapy> <Has_context> "All_lines_of_therapy" .
<VIP> <Has_accepted_use> "Thymoma" .
<VIP> <Has_accepted_use> "Testicular_cancer" .
<VIP> <Has_accepted_use> "Small_cell_lung_cancer" .
<VIP> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<MPR> <Mapped_from> "MPR" .
<Abemaciclib_and_Letrozole> <Is_a> "Antiestrogen-containing_regimen" .
<D-ZAPO> <Has_modality> "Chemotherapy" .
<Danazol_monotherapy> <Has_context> "Non-curative_therapy" .
<Gemcitabine_and_S-1> <Maps_to> "Gemcitabine_and_S-1" .
<Antithrombin_III> <Has_brand_name> "Thrombate_III" .
<Antithrombin_III> <Has_brand_name> "ATryn" .
<Methotrexate,_Vinblastine,_Prednisone> <Is_current_in> "Langerhans_cell_histiocytosis" .
<FOLFOX> <Has_accepted_use> "Rectal_cancer" .
<FOLFOX> <Has_accepted_use> "Pancreatic_cancer" .
<Tropisetron> <Supportive_med_of> "Temozolomide_monotherapy" .
<Tropisetron> <Supportive_med_of> "Cladribine_and_Rituximab" .
<ddEC> <Is_a> "Anthracycline-containing_regimen" .
<5_plus_2d> <Maps_to> "5_plus_2d" .
<Cisplatin,_Gemcitabine,_nab-Paclitaxel> <Has_context> "Non-curative_therapy" .
<Betrixaban> <Supportive_med_of> "Betrixaban_monotherapy" .
<R-FND> <Has_accepted_use> "Follicular_lymphoma" .
<Panadol> <Brand_name_of> "Acetaminophen" .
<Thiotepa> <May_have_route> "Intravesical" .
<Thiotepa> <May_have_route> "Intravenous" .
<Thiotepa> <May_have_route> "Intrathecal" .
<Thiotepa> <May_have_route> "Intracavitary" .
<Abiraterone_and_Prednisone> <Mapped_from> "Abiraterone_and_Prednisone" .
<Nidran> <Brand_name_of> "Nimustine" .
<Colchicine_monotherapy> <Mapped_from> "Colchicine_monotherapy" .
<Fluorouracil_and_Paclitaxel> <Has_modality> "Chemotherapy" .
<Vandetanib> <Has_brand_name> "Zactima" .
<Vandetanib> <Has_brand_name> "Caprelsa" .
<Sutrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<M-BCD> <Has_supportive_med> "Folinic_acid" .
<R-CHOP_(Prednisolone)> <Has_local_therapy> "Methotrexate" .
<Quizartinib_monotherapy> <Has_modality> "Chemotherapy" .
<nab-Paclitaxel_and_Trastuzumab> <Has_antineoplastic> "Trastuzumab" .
<nab-Paclitaxel_and_Trastuzumab> <Has_antineoplastic> "Paclitaxel_nanoparticle_albumin-bound" .
<Radium-223> <Antineoplastic_of> "Radium-223_monotherapy" .
<Prednisolone> <Supportive_med_of> "R-Hyper-CVAD/R-MA" .
<Prednisolone> <Supportive_med_of> "Ofatumumab_monotherapy" .
<Prednisolone> <Supportive_med_of> "Obinutuzumab_monotherapy" .
<Prednisolone> <Supportive_med_of> "O-FC" .
<Prednisolone> <Supportive_med_of> "O-CHOP" .
<Prednisolone> <Supportive_med_of> "G-FC" .
<Prednisolone> <Supportive_med_of> "FC" .
<Prednisolone> <Supportive_med_of> "Cyclosporine_monotherapy" .
<Prednisolone> <Supportive_med_of> "Chlorambucil_monotherapy" .
<Prednisolone> <Supportive_med_of> "Bendamustine_and_Obinutuzumab" .
<Prednisolone> <Supportive_med_of> "ATG_(Horse),_Cyclosporine,_G-CSF" .
<Prednisolone> <Supportive_med_of> "ATG_(Horse)_and_Cyclosporine" .
<Prednisolone> <Supportive_med_of> "ADT_and_Abiraterone" .
<TBI> <Maps_to> "TBI" .
<TACE> <Is_current_in> "Uveal_melanoma" .
<TACE> <Is_current_in> "Hepatocellular_carcinoma" .
<GIP> <Is_current_in> "Testicular_cancer" .
<Oxiplat> <Brand_name_of> "Oxaliplatin" .
<Ixazomib_and_Dexamethasone> <Mapped_from> "Ixazomib_and_Dexamethasone" .
<Clofarabine_monotherapy> <Has_supportive_med> "Prednisone" .
<Clofarabine_monotherapy> <Has_supportive_med> "Antibiotics" .
<Antibody_medication> <Subsumes> "Veltuzumab" .
<Antibody_medication> <Subsumes> "Varlilumab" .
<Antibody_medication> <Subsumes> "Vadastuximab_talirine" .
<Antibody_medication> <Subsumes> "Ublituximab" .
<Antibody_medication> <Subsumes> "Tremelimumab" .
<Antibody_medication> <Subsumes> "Trastuzumab-qyyp" .
<Antibody_medication> <Subsumes> "Trastuzumab-pkrb" .
<Antibody_medication> <Subsumes> "Trastuzumab-dttb" .
<Antibody_medication> <Subsumes> "Trastuzumab-dkst" .
<Antibody_medication> <Subsumes> "Trastuzumab-anns" .
<Antibody_medication> <Subsumes> "Trastuzumab_and_hyaluronidase" .
<Antibody_medication> <Subsumes> "Trastuzumab" .
<Antibody_medication> <Subsumes> "Tositumomab_&_I-131" .
<Antibody_medication> <Subsumes> "Tocilizumab" .
<Antibody_medication> <Subsumes> "Tigatuzumab" .
<Antibody_medication> <Subsumes> "Siltuximab" .
<Antibody_medication> <Subsumes> "Sacituzumab_govitecan" .
<Antibody_medication> <Subsumes> "Rituximab-pvvr" .
<Antibody_medication> <Subsumes> "Rituximab-abbs" .
<Antibody_medication> <Subsumes> "Rituximab_and_hyaluronidase_human" .
<Antibody_medication> <Subsumes> "Rituximab" .
<Antibody_medication> <Subsumes> "Rilotumumab" .
<Antibody_medication> <Subsumes> "Ravulizumab" .
<Antibody_medication> <Subsumes> "Ramucirumab" .
<Antibody_medication> <Subsumes> "Polatuzumab_vedotin" .
<Antibody_medication> <Subsumes> "Pidilizumab" .
<Antibody_medication> <Subsumes> "Pertuzumab" .
<Antibody_medication> <Subsumes> "Pembrolizumab" .
<Antibody_medication> <Subsumes> "Panitumumab" .
<Antibody_medication> <Subsumes> "Otlertuzumab" .
<Antibody_medication> <Subsumes> "Onartuzumab" .
<Antibody_medication> <Subsumes> "Olaratumab" .
<Antibody_medication> <Subsumes> "Ofatumumab" .
<Antibody_medication> <Subsumes> "Obinutuzumab" .
<Antibody_medication> <Subsumes> "Nivolumab" .
<Antibody_medication> <Subsumes> "Necitumumab" .
<Antibody_medication> <Subsumes> "NEOD001" .
<Antibody_medication> <Subsumes> "Moxetumomab_pasudotox" .
<Antibody_medication> <Subsumes> "Mogamulizumab" .
<Antibody_medication> <Subsumes> "Mepolizumab" .
<Antibody_medication> <Subsumes> "Mapatumumab" .
<Antibody_medication> <Subsumes> "MOR208" .
<Antibody_medication> <Subsumes> "MOR202" .
<Antibody_medication> <Subsumes> "Isatuximab" .
<Antibody_medication> <Subsumes> "Ipilimumab" .
<Antibody_medication> <Subsumes> "Inotuzumab_ozogamicin" .
<Antibody_medication> <Subsumes> "Idarucizumab" .
<Antibody_medication> <Subsumes> "Ibritumomab_tiuxetan" .
<Antibody_medication> <Subsumes> "IPH_2101" .
<Antibody_medication> <Subsumes> "Hu5F9-G4" .
<Antibody_medication> <Subsumes> "Gemtuzumab_ozogamicin" .
<Antibody_medication> <Subsumes> "Ganitumab" .
<Antibody_medication> <Subsumes> "Fam-trastuzumab_deruxtecan" .
<Antibody_medication> <Subsumes> "Epratuzumab" .
<Antibody_medication> <Subsumes> "Enfortumab_vedotin" .
<Antibody_medication> <Subsumes> "Emapalumab" .
<Antibody_medication> <Subsumes> "Elotuzumab" .
<Antibody_medication> <Subsumes> "Edrecolomab" .
<Antibody_medication> <Subsumes> "Eculizumab" .
<Antibody_medication> <Subsumes> "Durvalumab" .
<Antibody_medication> <Subsumes> "Dinutuximab" .
<Antibody_medication> <Subsumes> "Denosumab" .
<Antibody_medication> <Subsumes> "Denintuzumab_mafodotin" .
<Antibody_medication> <Subsumes> "Daratumumab" .
<Antibody_medication> <Subsumes> "Crizanlizumab" .
<Antibody_medication> <Subsumes> "Coltuximab_ravtansine" .
<Antibody_medication> <Subsumes> "Cixutumumab" .
<Antibody_medication> <Subsumes> "Cetuximab" .
<Antibody_medication> <Subsumes> "Cemiplimab" .
<Antibody_medication> <Subsumes> "Catumaxomab" .
<Antibody_medication> <Subsumes> "Caplacizumab" .
<Antibody_medication> <Subsumes> "Brentuximab_vedotin" .
<Antibody_medication> <Subsumes> "Blinatumomab" .
<Antibody_medication> <Subsumes> "Bispecific_antibody_medication" .
<Antibody_medication> <Subsumes> "Bevacizumab-bvzr" .
<Antibody_medication> <Subsumes> "Bevacizumab-awwb" .
<Antibody_medication> <Subsumes> "Bevacizumab" .
<Antibody_medication> <Subsumes> "Benralizumab" .
<Antibody_medication> <Subsumes> "Bavituximab" .
<Antibody_medication> <Subsumes> "BL22_immunotoxin" .
<Antibody_medication> <Subsumes> "BHQ880" .
<Antibody_medication> <Subsumes> "Avelumab" .
<Antibody_medication> <Subsumes> "Atezolizumab" .
<Antibody_medication> <Subsumes> "Antithymocyte_globulin_horse_ATG" .
<Antibody_medication> <Subsumes> "Antibody-drug_conjugate" .
<Antibody_medication> <Subsumes> "Anti-vWF_medication" .
<Antibody_medication> <Subsumes> "Anti-mesothelin_antibody" .
<Antibody_medication> <Subsumes> "Anti-c-Met_antibody" .
<Antibody_medication> <Subsumes> "Anti-amyloid_antibody" .
<Antibody_medication> <Subsumes> "Anti-VEGFR_antibody" .
<Antibody_medication> <Subsumes> "Anti-TRAIL-R2_antibody" .
<Antibody_medication> <Subsumes> "Anti-TRAIL-R1_antibody" .
<Antibody_medication> <Subsumes> "Anti-TACSTD2_antibody" .
<Antibody_medication> <Subsumes> "Anti-SLAMF7_antibody" .
<Antibody_medication> <Subsumes> "Anti-RANKL_antibody" .
<Antibody_medication> <Subsumes> "Anti-PS_antibody" .
<Antibody_medication> <Subsumes> "Anti-PDGFR_antibody" .
<Antibody_medication> <Subsumes> "Anti-PD-L1_antibody" .
<Antibody_medication> <Subsumes> "Anti-PD-1_antibody" .
<Antibody_medication> <Subsumes> "Anti-P-selectin_antibody" .
<Antibody_medication> <Subsumes> "Anti-KIR_antibody" .
<Antibody_medication> <Subsumes> "Anti-IL-6R_antibody" .
<Antibody_medication> <Subsumes> "Anti-IL-6_antibody" .
<Antibody_medication> <Subsumes> "Anti-IL-5_antibody" .
<Antibody_medication> <Subsumes> "Anti-IGF-1R_antibody" .
<Antibody_medication> <Subsumes> "Anti-IFNg_antibody" .
<Antibody_medication> <Subsumes> "Anti-HER2_antibody" .
<Antibody_medication> <Subsumes> "Anti-GPIIb-IIIa_antibody" .
<Antibody_medication> <Subsumes> "Anti-GD2_antibody" .
<Antibody_medication> <Subsumes> "Anti-Factor_Xa_antibody" .
<Antibody_medication> <Subsumes> "Anti-Factor_IXa_antibody" .
<Antibody_medication> <Subsumes> "Anti-EpCAM_antibody" .
<Antibody_medication> <Subsumes> "Anti-EGFR_antibody" .
<Antibody_medication> <Subsumes> "Anti-DKK1_antibody" .
<Antibody_medication> <Subsumes> "Anti-CTLA-4_antibody" .
<Antibody_medication> <Subsumes> "Anti-CD52_antibody" .
<Antibody_medication> <Subsumes> "Anti-CD47_antibody" .
<Antibody_medication> <Subsumes> "Anti-CD38_antibody" .
<Antibody_medication> <Subsumes> "Anti-CD37_antibody" .
<Antibody_medication> <Subsumes> "Anti-CD33_antibody" .
<Antibody_medication> <Subsumes> "Anti-CD30_antibody" .
<Antibody_medication> <Subsumes> "Anti-CD3_antibody" .
<Antibody_medication> <Subsumes> "Anti-CD27_antibody" .
<Antibody_medication> <Subsumes> "Anti-CD22_antibody" .
<Antibody_medication> <Subsumes> "Anti-CD20_antibody" .
<Antibody_medication> <Subsumes> "Anti-CD194_antibody" .
<Antibody_medication> <Subsumes> "Anti-CD19_antibody" .
<Antibody_medication> <Subsumes> "Anti-CCR4_antibody" .
<Antibody_medication> <Subsumes> "Anti-C5_antibody" .
<Antibody_medication> <Subsumes> "Amatuximab" .
<Antibody_medication> <Subsumes> "Alemtuzumab" .
<Antibody_medication> <Subsumes> "Ado-trastuzumab_emtansine" .
<Antibody_medication> <Subsumes> "Actinium_Ac_225_lintuzumab" .
<Antibody_medication> <Subsumes> "AMG_330" .
<Afuresertib> <May_have_route> "Oral" .
<Cytarabine_monotherapy> <Mapped_from> "Cytarabine_monotherapy" .
<R-CHVP_plus_I> <Maps_to> "R-CHVP_plus_I" .
<TCH_(Taxotere,_Cyclophosphamide)> <Has_context> "Adjuvant_therapy" .
<Neofolin> <Brand_name_of> "Folinic_acid" .
<FCR,_then_allo_HSCT> <Maps_to> "FCR,_then_allo_HSCT" .
<Epsotoin> <Brand_name_of> "Phenytoin" .
<Fluorouracil,_Folinic_acid,_Mitomycin> <Has_accepted_use> "Gastric_cancer" .
<Cisplatin_and_Gemcitabine> <Is_current_in> "Pancreatic_cancer" .
<Cisplatin_and_Gemcitabine> <Is_current_in> "Ovarian_cancer" .
<Cisplatin_and_Gemcitabine> <Is_current_in> "Non-small_cell_lung_cancer" .
<Cisplatin_and_Gemcitabine> <Is_current_in> "Nasopharyngeal_carcinoma" .
<Cisplatin_and_Gemcitabine> <Is_current_in> "Mesothelioma" .
<Cisplatin_and_Gemcitabine> <Is_current_in> "Gallbladder_cancer" .
<Cisplatin_and_Gemcitabine> <Is_current_in> "Cholangiocarcinoma" .
<Cisplatin_and_Gemcitabine> <Is_current_in> "Cervical_cancer" .
<Cisplatin_and_Gemcitabine> <Is_current_in> "Breast_cancer" .
<Cisplatin_and_Gemcitabine> <Is_current_in> "Bladder_cancer" .
<Cisplatin_and_Gemcitabine> <Is_current_in> "Adenocarcinoma_of_unknown_primary" .
<Topneuter> <Brand_name_of> "Filgrastim" .
<Apixaban> <Has_accepted_use> "Venous_thromboembolism" .
<Carboplatin_and_Fluorouracil> <Is_a> "Platinum_doublet" .
<Vindesine> <Has_brand_name> "Gesidine" .
<Vindesine> <Has_brand_name> "Fildesin" .
<Vindesine> <Has_brand_name> "Enison" .
<Vindesine> <Has_brand_name> "Eldisin" .
<Vindesine> <Has_brand_name> "Eldesine" .
<Vesicant> <Is_a> "Chemotherapeutic" .
<Mercaptopurine> <Antineoplastic_of> "VAMP_(Amethopterin)" .
<Mercaptopurine> <Antineoplastic_of> "Pediatric-like_GRAALL_consolidation" .
<Mercaptopurine> <Antineoplastic_of> "POMP" .
<Mercaptopurine> <Antineoplastic_of> "Mercaptopurine,_Methotrexate,_WB-XRT" .
<Mercaptopurine> <Antineoplastic_of> "Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone" .
<Mercaptopurine> <Antineoplastic_of> "Mercaptopurine,_Methotrexate,_Vincristine" .
<Mercaptopurine> <Antineoplastic_of> "Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone" .
<Mercaptopurine> <Antineoplastic_of> "Mercaptopurine_monotherapy" .
<Mercaptopurine> <Antineoplastic_of> "Mercaptopurine_and_WBRT" .
<Mercaptopurine> <Antineoplastic_of> "Mercaptopurine_and_Prednisone" .
<Mercaptopurine> <Antineoplastic_of> "Mercaptopurine_and_Methotrexate" .
<Mercaptopurine> <Antineoplastic_of> "Imatinib-based_consolidation" .
<Mercaptopurine> <Antineoplastic_of> "IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone" .
<Mercaptopurine> <Antineoplastic_of> "Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone" .
<Mercaptopurine> <Antineoplastic_of> "Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone" .
<Mercaptopurine> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone" .
<Mercaptopurine> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine" .
<Mercaptopurine> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine" .
<Mercaptopurine> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine" .
<Mercaptopurine> <Antineoplastic_of> "CALGB_8811_early_intensification" .
<Mercaptopurine> <Antineoplastic_of> "Augmented_BFM_consolidation" .
<Mercaptopurine> <Antineoplastic_of> "ATRA,_Mercaptopurine,_Methotrexate" .
<Mercaptopurine> <Antineoplastic_of> "AALL0232_consolidation" .
<Megestrol_and_Tamoxifen> <Is_a> "Antiestrogen-containing_regimen" .
<Ribociclib> <Has_FDA_indication> "Breast_cancer" .
<VAC> <Has_antineoplastic> "Vincristine" .
<VAC> <Has_antineoplastic> "Dactinomycin" .
<VAC> <Has_antineoplastic> "Cyclophosphamide" .
<Cediranib> <Is_a> "VEGFR_inhibitor" .
<Cediranib> <Is_a> "Investigational_drug" .
<Dabrafenib_and_Trametinib> <Mapped_from> "Dabrafenib_and_Trametinib" .
<VIDE> <Is_a> "Anthracycline-containing_regimen" .
<CODOX-M> <Maps_to> "CODOX-M" .
<VMV-VAC> <Has_context> "Induction_therapy" .
<Intraperitoneal_hyperthermic_mitomycin> <Has_antineoplastic> "Mitomycin" .
<Ixazomib> <Antineoplastic_of> "Ixazomib_monotherapy" .
<Ixazomib> <Antineoplastic_of> "Ixazomib_and_Dexamethasone" .
<Ixazomib> <Antineoplastic_of> "IRd" .
<Ixazomib> <Antineoplastic_of> "BID" .
<Faridak> <Brand_name_of> "Panobinostat" .
<Azor> <Brand_name_of> "Alprazolam" .
<R-ESHAP> <Mapped_from> "R-ESHAP" .
<MACOP-B> <Mapped_from> "MACOP-B" .
<Bacteriof.klebs_PN> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Nodevex> <Brand_name_of> "Dexamethasone" .
<Doxorubicin_and_Strontium-89> <Is_historical_in> "Prostate_cancer" .
<TC,_then_IE,_VDoxoC,_VEC> <Is_current_in> "Ewing_sarcoma" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab> <Has_local_therapy> "Methylprednisolone" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab> <Has_local_therapy> "Methotrexate" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab> <Has_local_therapy> "Cytarabine" .
<MOR208> <May_have_route> "Intravenous" .
<AVCF> <Has_accepted_use> "Breast_cancer" .
<Radiation_therapy> <Has_context> "Salvage_therapy" .
<Radiation_therapy> <Has_context> "Neoadjuvant_therapy" .
<Radiation_therapy> <Has_context> "Induction_therapy" .
<Radiation_therapy> <Has_context> "Definitive_therapy" .
<Radiation_therapy> <Has_context> "Consolidation_after_upfront_therapy" .
<Radiation_therapy> <Has_context> "Consolidation_after_salvage_therapy" .
<Radiation_therapy> <Has_context> "Adjuvant_therapy" .
<Leukovorin> <Brand_name_of> "Folinic_acid" .
<Voalla> <Brand_name_of> "Dexamethasone" .
<Etopofos> <Brand_name_of> "Etoposide" .
<Vinorelbine> <Antineoplastic_of> "Vinorelbine_monotherapy" .
<Vinorelbine> <Antineoplastic_of> "Vinorelbine_and_Bevacizumab" .
<Vinorelbine> <Antineoplastic_of> "VH" .
<Vinorelbine> <Antineoplastic_of> "R-NIMP" .
<Vinorelbine> <Antineoplastic_of> "Paclitaxel_and_Vinorelbine" .
<Vinorelbine> <Antineoplastic_of> "Ifosfamide_and_Vinorelbine" .
<Vinorelbine> <Antineoplastic_of> "IGEV_and_G-CSF" .
<Vinorelbine> <Antineoplastic_of> "IGEV" .
<Vinorelbine> <Antineoplastic_of> "Gemcitabine_and_Vinorelbine" .
<Vinorelbine> <Antineoplastic_of> "GVP" .
<Vinorelbine> <Antineoplastic_of> "GVD" .
<Vinorelbine> <Antineoplastic_of> "Epirubicin_and_Vinorelbine" .
<Vinorelbine> <Antineoplastic_of> "Docetaxel_and_Vinorelbine" .
<Vinorelbine> <Antineoplastic_of> "Cisplatin,_Vinorelbine,_RT" .
<Vinorelbine> <Antineoplastic_of> "Cisplatin,_Vinorelbine,_Cetuximab" .
<Vinorelbine> <Antineoplastic_of> "Cisplatin_and_Vinorelbine" .
<Vinorelbine> <Antineoplastic_of> "Carboplatin,_Vinorelbine,_RT" .
<Vinorelbine> <Antineoplastic_of> "Carboplatin_and_Vinorelbine" .
<Vinorelbine> <Antineoplastic_of> "BeGEV" .
<Altuzan> <Brand_name_of> "Bevacizumab" .
<Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Cytarabin> <Brand_name_of> "Cytarabine" .
<Paroxysmal_nocturnal_hemoglobinuria> <FDA_indication_of> "Ravulizumab" .
<Paroxysmal_nocturnal_hemoglobinuria> <FDA_indication_of> "Eculizumab" .
<R-GDP> <Has_antineoplastic> "Rituximab" .
<R-GDP> <Has_antineoplastic> "Gemcitabine" .
<R-GDP> <Has_antineoplastic> "Dexamethasone" .
<R-GDP> <Has_antineoplastic> "Cisplatin" .
<Belinostat_monotherapy> <Has_context> "Non-curative_therapy" .
<Vincristine_monotherapy> <Is_current_in> "Wilms_tumor" .
<Vincristine_monotherapy> <Is_current_in> "Thrombotic_thrombocytopenic_purpura" .
<Radioimmunotherapy> <Modality_of> "Ibritumomab_tiuxetan_monotherapy" .
<Radioimmunotherapy> <Modality_of> "Fludarabine,_then_131Iodine-Tositumomab" .
<Radioimmunotherapy> <Modality_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT" .
<Radioimmunotherapy> <Modality_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan" .
<Radioimmunotherapy> <Modality_of> "CVP,_then_131Iodine-Tositumomab" .
<Radioimmunotherapy> <Modality_of> "CHOP,_then_131Iodine-Tositumomab" .
<Radioimmunotherapy> <Modality_of> "131Iodine-Tositumomab_monotherapy" .
<Afatinib> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Afatinib> <Is_a> "Mutation-specific_medication" .
<Afatinib> <Is_a> "Kinase_inhibitor" .
<Afatinib> <Is_a> "ERBB4_inhibitor" .
<Afatinib> <Is_a> "ERBB2_inhibitor" .
<Afatinib> <Is_a> "EGFR_inhibitor" .
<ddTH_(Taxol)> <Mapped_from> "ddTH_(Taxol)" .
<mDCF_and_Bevacizumab> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<mDCF_and_Bevacizumab> <Has_supportive_med> "Filgrastim" .
<mDCF_and_Bevacizumab> <Has_supportive_med> "Dexamethasone" .
<Onsett> <Brand_name_of> "Ondansetron" .
<Capecitabine/Capecitabine_and_RT> <Mapped_from> "Capecitabine/Capecitabine_and_RT" .
<Cistane> <Brand_name_of> "Isotretinoin" .
<CAV/PE> <Mapped_from> "CAV/PE" .
<Aminocaproic_acid> <Has_brand_name> "Amicar" .
<Sirolimus,_Tacrolimus,_Prednisone> <Has_modality> "Immunosuppressive_therapy" .
<MINE> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<PIK3CA-mutated_Breast_cancer> <Accepted_use_of> "Alpelisib_and_Fulvestrant" .
<VEGFR_inhibitor> <Subsumes> "Ziv-aflibercept" .
<VEGFR_inhibitor> <Subsumes> "Vandetanib" .
<VEGFR_inhibitor> <Subsumes> "Tivozanib" .
<VEGFR_inhibitor> <Subsumes> "Sunitinib" .
<VEGFR_inhibitor> <Subsumes> "Sorafenib" .
<VEGFR_inhibitor> <Subsumes> "Regorafenib" .
<VEGFR_inhibitor> <Subsumes> "Ramucirumab" .
<VEGFR_inhibitor> <Subsumes> "Ponatinib" .
<VEGFR_inhibitor> <Subsumes> "Pazopanib" .
<VEGFR_inhibitor> <Subsumes> "Nintedanib" .
<VEGFR_inhibitor> <Subsumes> "Motesanib" .
<VEGFR_inhibitor> <Subsumes> "Lenvatinib" .
<VEGFR_inhibitor> <Subsumes> "Fruquintinib" .
<VEGFR_inhibitor> <Subsumes> "Cediranib" .
<VEGFR_inhibitor> <Subsumes> "Cabozantinib" .
<VEGFR_inhibitor> <Subsumes> "Bevacizumab-bvzr" .
<VEGFR_inhibitor> <Subsumes> "Bevacizumab-awwb" .
<VEGFR_inhibitor> <Subsumes> "Bevacizumab" .
<VEGFR_inhibitor> <Subsumes> "Axitinib" .
<VEGFR_inhibitor> <Subsumes> "Apatinib" .
<VEGFR_inhibitor> <Subsumes> "Anti-VEGFR_antibody" .
<Lenvima> <Brand_name_of> "Lenvatinib" .
<Tagrisso> <Brand_name_of> "Osimertinib" .
<International_ALL_Trial> <Is_a> "Anthracycline-containing_regimen" .
<TEC_inhibitor> <Is_a> "Kinase_inhibitor" .
<Torrid> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bortezomib_and_Cyclophosphamide> <Has_accepted_use> "Multiple_myeloma" .
<CO-Trimazole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Fameprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<ACVBP,_dose-adjusted> <Is_a> "Anthracycline-containing_regimen" .
<Hepatic_arterial_chemotherapy> <Is_current_in> "Colon_cancer" .
<Cabozantinib> <Has_brand_name> "Cometriq_is_the_brand_name_for_cabozantinib's_medullary_thyroid_cancer_indication._Cabometyx_is_the_brand_name_for_cabozantinib's_renal_cell_carcinoma_indication" .
<Trecondi> <Brand_name_of> "Treosulfan" .
<Decan> <Brand_name_of> "Dexamethasone" .
<Idelalisib> <Has_brand_name> "Zydelig" .
<ACOMLA> <Maps_to> "ACOMLA" .
<Fluorouracil_and_Mitomycin> <Has_context> "Non-curative_first-line_therapy" .
<Fluorouracil_and_Mitomycin> <Has_context> "Adjuvant_therapy" .
<Zarnestra> <Brand_name_of> "Tipifarnib" .
<Bicalutamide_and_Goserelin> <Has_context> "Non-curative_therapy" .
<Bicalutamide_and_Goserelin> <Has_context> "Adjuvant_therapy" .
<M-BCD> <Has_antineoplastic> "Methotrexate" .
<M-BCD> <Has_antineoplastic> "Dactinomycin" .
<M-BCD> <Has_antineoplastic> "Cyclophosphamide" .
<M-BCD> <Has_antineoplastic> "Bleomycin" .
<Doxorubicin> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Doxorubicin> <Has_accepted_use> "Transformed_lymphoma" .
<Doxorubicin> <Has_accepted_use> "Thymoma" .
<Doxorubicin> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Doxorubicin> <Has_accepted_use> "Small_cell_lung_cancer" .
<Doxorubicin> <Has_accepted_use> "Rhabdomyosarcoma" .
<Doxorubicin> <Has_accepted_use> "Renal_cell_carcinoma" .
<Doxorubicin> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<Doxorubicin> <Has_accepted_use> "Post-transplant_lymphoproliferative_disorder" .
<Doxorubicin> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Doxorubicin> <Has_accepted_use> "Pancreatic_NET" .
<Doxorubicin> <Has_accepted_use> "Osteosarcoma" .
<Doxorubicin> <Has_accepted_use> "Multiple_myeloma" .
<Doxorubicin> <Has_accepted_use> "Mediastinal_gray-zone_lymphoma" .
<Doxorubicin> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Doxorubicin> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Doxorubicin> <Has_accepted_use> "Kaposi_sarcoma" .
<Doxorubicin> <Has_accepted_use> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<Doxorubicin> <Has_accepted_use> "Hodgkin_lymphoma" .
<Doxorubicin> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Doxorubicin> <Has_accepted_use> "Hepatoblastoma" .
<Doxorubicin> <Has_accepted_use> "HIV-associated_lymphoma" .
<Doxorubicin> <Has_accepted_use> "Follicular_lymphoma" .
<Doxorubicin> <Has_accepted_use> "Ewing_sarcoma" .
<Doxorubicin> <Has_accepted_use> "Endometrial_cancer" .
<Doxorubicin> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Doxorubicin> <Has_accepted_use> "Cutaneous_squamous_cell_carcinoma" .
<Doxorubicin> <Has_accepted_use> "Cutaneous_basal_cell_carcinoma" .
<Doxorubicin> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Doxorubicin> <Has_accepted_use> "Burkitt_lymphoma" .
<Doxorubicin> <Has_accepted_use> "Breast_cancer" .
<Doxorubicin> <Has_accepted_use> "Bladder_cancer" .
<Doxorubicin> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Doxorubicin> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<Doxorubicin> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<Doxorubicin> <Has_accepted_use> "Adrenocortical_carcinoma" .
<Pemex> <Brand_name_of> "Pemetrexed" .
<WHO_Essential_Cancer_Medicine> <Is_a> "WHO_Essential_Medicine" .
<Thyroid_cancer> <FDA_indication_of> "Vandetanib" .
<Thyroid_cancer> <FDA_indication_of> "Trametinib" .
<Thyroid_cancer> <FDA_indication_of> "Sorafenib" .
<Thyroid_cancer> <FDA_indication_of> "Lenvatinib" .
<Thyroid_cancer> <FDA_indication_of> "Doxorubicin" .
<Thyroid_cancer> <FDA_indication_of> "Dabrafenib" .
<Thyroid_cancer> <FDA_indication_of> "Cabozantinib" .
<Cyclophosphamide,_Lomustine,_Methotrexate> <Has_context> "Induction_therapy" .
<Varlilumab> <Is_a> "Investigational_drug" .
<Varlilumab> <Is_a> "Immunotherapeutic" .
<Varlilumab> <Is_a> "Antibody_medication" .
<Varlilumab> <Is_a> "Anti-CD27_antibody" .
<Anastrozole_monotherapy> <Is_a> "Antiestrogen-containing_regimen" .
<Diseptyl> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<COP-Bleo> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Forodesine> <Is_a> "Purine_nucleoside_phosphorylase_(PNP)_inhibitor" .
<Forodesine> <Is_a> "Orphan_drug" .
<Forodesine> <Is_a> "Drugs_PMDA_approved_in_2017" .
<Lomustine,_Temozolomide,_RT> <Mapped_from> "Lomustine,_Temozolomide,_RT" .
<CLF> <Maps_to> "CLF" .
<VAIA> <Maps_to> "VAIA" .
<Aspirin_and_Warfarin> <Has_supportive_med> "Warfarin" .
<Aspirin_and_Warfarin> <Has_supportive_med> "Aspirin" .
<Tigatuzumab> <Is_a> "Investigational_drug" .
<Tigatuzumab> <Is_a> "Antibody_medication" .
<Tigatuzumab> <Is_a> "Anti-TRAIL-R2_antibody" .
<Lomustine_and_Bevacizumab> <Maps_to> "Lomustine_and_Bevacizumab" .
<Ceritinib_monotherapy> <Has_antineoplastic> "Ceritinib" .
<Cebedex> <Brand_name_of> "Dexamethasone" .
<Docshil> <Brand_name_of> "Docetaxel" .
<Brentuximab_vedotin> <Antineoplastic_of> "Brentuximab_vedotin_monotherapy" .
<Brentuximab_vedotin> <Antineoplastic_of> "Brentuximab_vedotin_and_Nivolumab" .
<Brentuximab_vedotin> <Antineoplastic_of> "Brentuximab_vedotin_and_Dacarbazine" .
<Brentuximab_vedotin> <Antineoplastic_of> "Bendamustine_and_Brentuximab_vedotin" .
<Brentuximab_vedotin> <Antineoplastic_of> "BVB" .
<Brentuximab_vedotin> <Antineoplastic_of> "BV-CHP" .
<Brentuximab_vedotin> <Antineoplastic_of> "A-AVD" .
<Docetaxel_and_Prednisolone> <Mapped_from> "Docetaxel_and_Prednisolone" .
<Ropeginterferon_alfa-2b> <Has_accepted_use> "Polycythemia_vera" .
<Neotaxan> <Brand_name_of> "Paclitaxel" .
<Anti-TRAIL-R2_antibody> <Subsumes> "Tigatuzumab" .
<Plerixafor_monotherapy> <Has_modality> "Growth_factor_therapy" .
<Eltrombopag> <May_have_route> "Oral" .
<GemOx> <Has_antineoplastic> "Oxaliplatin" .
<GemOx> <Has_antineoplastic> "Gemcitabine" .
<MAP> <Has_accepted_use> "Osteosarcoma" .
<Epifil> <Brand_name_of> "Epirubicin" .
<TAD_(Thalidomide)> <Has_antineoplastic> "Thalidomide" .
<TAD_(Thalidomide)> <Has_antineoplastic> "Doxorubicin" .
<TAD_(Thalidomide)> <Has_antineoplastic> "Dexamethasone" .
<CAPIRI> <Has_accepted_use> "Esophageal_cancer" .
<CAPIRI> <Has_accepted_use> "Colon_cancer" .
<RT-PEPC> <Has_modality> "Chemotherapy" .
<Maxol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Everolimus_and_Tamoxifen> <Maps_to> "Everolimus_and_Tamoxifen" .
<Sonidegib_monotherapy> <Has_accepted_use> "Cutaneous_basal_cell_carcinoma" .
<Fulvenat> <Brand_name_of> "Fulvestrant" .
<Gliotem> <Brand_name_of> "Temozolomide" .
<CCI> <Has_modality> "Chemotherapy" .
<EC_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<International_ALL_Trial> <Has_modality> "Chemotherapy" .
<IRIS_and_Bevacizumab> <Mapped_from> "IRIS_and_Bevacizumab" .
<Bortezomib_and_Panobinostat> <Has_antineoplastic> "Panobinostat" .
<Bortezomib_and_Panobinostat> <Has_antineoplastic> "Bortezomib" .
<CMF> <Mapped_from> "CMF" .
<BEACOPP-14> <Has_antineoplastic> "Vincristine" .
<BEACOPP-14> <Has_antineoplastic> "Procarbazine" .
<BEACOPP-14> <Has_antineoplastic> "Prednisone" .
<BEACOPP-14> <Has_antineoplastic> "Etoposide" .
<BEACOPP-14> <Has_antineoplastic> "Doxorubicin" .
<BEACOPP-14> <Has_antineoplastic> "Cyclophosphamide" .
<BEACOPP-14> <Has_antineoplastic> "Bleomycin" .
<Daunorubicin_monotherapy> <Is_historical_in> "Acute_myeloid_leukemia" .
<Pralatrexate_monotherapy> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Pralatrexate_monotherapy> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Ribociclib_and_Tamoxifen> <Is_current_in> "Breast_cancer" .
<Pomalidomide_and_Prednisone> <Maps_to> "Pomalidomide_and_Prednisone" .
<Azacitidine> <Antineoplastic_of> "D-ZAPO" .
<Azacitidine> <Antineoplastic_of> "Azacitidine,_Vorinostat,_Gemtuzumab_ozogamicin" .
<Azacitidine> <Antineoplastic_of> "Azacitidine_monotherapy" .
<Azacitidine> <Antineoplastic_of> "Azacitidine_and_Vorinostat" .
<Azacitidine> <Antineoplastic_of> "Azacitidine_and_Venetoclax" .
<Azacitidine> <Antineoplastic_of> "Azacitidine_and_Sorafenib" .
<Azacitidine> <Antineoplastic_of> "Azacitidine_and_Lenalidomide" .
<Azacitidine> <Antineoplastic_of> "Azacitidine_and_Gemtuzumab_ozogamicin" .
<Cisplatin,_Paclitaxel,_RT> <Mapped_from> "Cisplatin,_Paclitaxel,_RT" .
<Acyclovir> <May_have_route> "Topical" .
<Acyclovir> <May_have_route> "Oral" .
<Acyclovir> <May_have_route> "Intravenous" .
<Capecitabine_and_Trastuzumab> <Mapped_from> "Capecitabine_and_Trastuzumab" .
<EOX> <Maps_to> "EOX" .
<Synerzole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CMFVP> <Has_modality> "Hormonotherapy" .
<CMFVP> <Has_modality> "Chemotherapy" .
<Histrelin_monotherapy> <Has_modality> "Hormonotherapy" .
<Onadron> <Brand_name_of> "Dexamethasone" .
<ECH> <Maps_to> "ECH" .
<Etoposide,_Ifosfamide,_Imatinib> <Maps_to> "Etoposide,_Ifosfamide,_Imatinib" .
<LOPP/EVAP> <Has_accepted_use> "Hodgkin_lymphoma" .
<Copanlisib_monotherapy> <Has_context> "Non-curative_therapy" .
<VMCP/VCAP> <Has_modality> "Chemotherapy" .
<XPO1_inhibitor> <Is_a> "Selective_inhibitors_of_nuclear_export" .
<Clopidogrel> <Has_brand_name> "Stroka" .
<Clopidogrel> <Has_brand_name> "Plavix" .
<Clopidogrel> <Has_brand_name> "Plagril" .
<Clopidogrel> <Has_brand_name> "Lopigrol" .
<Clopidogrel> <Has_brand_name> "Deviplat" .
<Clopidogrel> <Has_brand_name> "Clopinam" .
<Clopidogrel> <Has_brand_name> "Clopidro" .
<Clopidogrel> <Has_brand_name> "Clopicard" .
<Clopidogrel> <Has_brand_name> "Clopalvix" .
<Clopidogrel> <Has_brand_name> "Clop-75" .
<Clopidogrel> <Has_brand_name> "Ceruvin" .
<Clopidogrel> <Has_brand_name> "Bio-Clopi" .
<VMD> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<IT_Cytarabine_monotherapy> <Has_local_therapy> "Cytarabine" .
<Vistogard> <Brand_name_of> "Uridine_triacetate" .
<IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone> <Has_modality> "Hormonotherapy" .
<IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone> <Has_modality> "Chemotherapy" .
<Talimogene_laherparepvec_monotherapy> <Has_antineoplastic> "Talimogene_laherparepvec" .
<Pirarubicin_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<TAD_(Thalidomide)> <Is_current_in> "Multiple_myeloma" .
<CAP> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Vorinostat_and_Rituximab> <Maps_to> "Vorinostat_and_Rituximab" .
<CDB> <Mapped_from> "CDB" .
<ddTH_(Taxol)> <Is_current_in> "Breast_cancer" .
<Anti-HER2_antibody> <Is_a> "Antibody_medication" .
<Anti-HER2_antibody> <Is_a> "Anti-HER2_medication" .
<Capecitabine,_Docetaxel,_RT> <Mapped_from> "Capecitabine,_Docetaxel,_RT" .
<Fludarabine_monotherapy> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<Fludarabine_monotherapy> <Is_current_in> "Marginal_zone_lymphoma" .
<Fludarabine_monotherapy> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Capecitabine,_Mitomycin,_RT> <Is_current_in> "Anal_cancer" .
<Pegylated_liposomal_doxorubicin> <Has_brand_name> "Doxil" .
<Pegylated_liposomal_doxorubicin> <Has_brand_name> "Caelyx" .
<Bivalirudin_monotherapy> <Has_accepted_use> "Venous_thromboembolism" .
<Hyper-CVAD/MA> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Predicor> <Brand_name_of> "Prednisone" .
<R-CEOP90_(Epirubicin)> <Is_a> "Rituximab-containing_regimen" .
<R-CEOP90_(Epirubicin)> <Is_a> "Anthracycline-containing_regimen" .
<Bortezomib_and_Doxorubicin_liposomal> <Is_current_in> "Multiple_myeloma" .
<Cyclosporine,_Methotrexate,_ATG> <Has_modality> "Immunosuppressive_therapy" .
<Neratinib_and_Paclitaxel> <Maps_to> "Neratinib_and_Paclitaxel" .
<Dalys> <Brand_name_of> "Paclitaxel" .
<GTX> <Has_modality> "Chemotherapy" .
<VR> <Mapped_from> "VR" .
<Ixabepilone_monotherapy> <Mapped_from> "Ixabepilone_monotherapy" .
<Formestane_monotherapy> <Maps_to> "Formestane_monotherapy" .
<Wilms_tumor> <FDA_indication_of> "Dactinomycin" .
<Cytrosar> <Brand_name_of> "Cytarabine" .
<Hexa-CAF> <Has_accepted_use> "Ovarian_cancer" .
<Non-curative_subsequent-line_induction_therapy> <Maps_to> "Non-curative_subsequent-line_induction_therapy" .
<BO> <Is_current_in> "Testicular_cancer" .
<MET_inhibitor> <Is_a> "Kinase_inhibitor" .
<VAdCA> <Has_context> "Non-curative_therapy" .
<Ostrin_Forte> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<AVCF> <Has_antineoplastic> "Vincristine" .
<AVCF> <Has_antineoplastic> "Fluorouracil" .
<AVCF> <Has_antineoplastic> "Doxorubicin" .
<AVCF> <Has_antineoplastic> "Cyclophosphamide" .
<HAD> <Maps_to> "HAD" .
<PVAG> <Has_antineoplastic> "Vinblastine" .
<PVAG> <Has_antineoplastic> "Prednisone" .
<PVAG> <Has_antineoplastic> "Gemcitabine" .
<PVAG> <Has_antineoplastic> "Doxorubicin" .
<Acalabrutinib> <May_have_route> "Oral" .
<Thrombocytopenia_in_liver_disease> <Current_treated_by> "Placebo" .
<Thrombocytopenia_in_liver_disease> <Current_treated_by> "Lusutrombopag_monotherapy" .
<Thrombocytopenia_in_liver_disease> <Current_treated_by> "Avatrombopag_monotherapy" .
<CPB> <Has_accepted_use> "Breast_cancer" .
<Cold_agglutinin_disease> <Current_treated_by> "Rituximab_monotherapy" .
<Cold_agglutinin_disease> <Current_treated_by> "FR" .
<Cold_agglutinin_disease> <Current_treated_by> "Eculizumab_monotherapy" .
<Cold_agglutinin_disease> <Current_treated_by> "BR" .
<R-EPOCH> <Mapped_from> "R-EPOCH" .
<M-DEX> <Has_modality> "Chemotherapy" .
<FR> <Is_historical_in> "Follicular_lymphoma" .
<FR> <Is_historical_in> "Chronic_lymphocytic_leukemia" .
<Afatinib_and_Cetuximab> <Has_context> "Non-curative_therapy" .
<Antimetabolite> <Is_a> "Chemotherapeutic" .
<DOLP_(Prednisolone)> <Mapped_from> "DOLP_(Prednisolone)" .
<ADT_and_Docetaxel> <Is_current_in> "Prostate_cancer" .
<Sirolimus> <Has_accepted_use> "Hodgkin_lymphoma" .
<Sirolimus> <Has_accepted_use> "Erdheim-Chester_disease" .
<Sirolimus> <Has_accepted_use> "Castleman_disease" .
<Sirolimus> <Has_accepted_use> "Autoimmune_cytopenia" .
<Sirolimus> <Has_accepted_use> "Aplastic_anemia" .
<Omeprazole> <Has_brand_name> "Prilosec" .
<Cetirizine> <May_have_route> "Oral" .
<CEOP_(Prednisolone)> <Has_modality> "Chemotherapy" .
<Hepatic_arterial_chemotherapy> <Has_antineoplastic> "Floxuridine" .
<Hyper-CVAD/MA> <Has_modality> "Chemotherapy" .
<Tooprin> <Brand_name_of> "Aspirin" .
<Omacetaxine_monotherapy> <Mapped_from> "Omacetaxine_monotherapy" .
<R-CHOP_(Rituximab_Hycela)> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Exemestane_monotherapy> <Is_current_in> "Breast_cancer" .
<COPAD> <Has_context> "Induction_therapy" .
<Doxorubicin_and_Ifosfamide> <Maps_to> "Doxorubicin_and_Ifosfamide" .
<Total_Therapy> <Has_supportive_med> "Filgrastim" .
<Temozolomide_and_Thalidomide> <Is_current_in> "Pancreatic_NET" .
<Whole_brain_irradiation> <Has_modality> "Radiotherapy" .
<Carboplatin,_Etoposide,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Carboplatin,_Etoposide,_RT> <Has_antineoplastic> "Etoposide" .
<Carboplatin,_Etoposide,_RT> <Has_antineoplastic> "Carboplatin" .
<Sorafenib_monotherapy> <Mapped_from> "Sorafenib_monotherapy" .
<Stanback_Analgesic> <Brand_name_of> "Aspirin" .
<VIP> <Has_antineoplastic> "Vinblastine" .
<VIP> <Has_antineoplastic> "Ifosfamide" .
<VIP> <Has_antineoplastic> "Etoposide" .
<VIP> <Has_antineoplastic> "Cisplatin" .
<TH_(Taxotere)> <Maps_to> "TH_(Taxotere)" .
<Methotrexate,_Tacrolimus,_Vorinostat> <Has_modality> "Immunosuppressive_therapy" .
<Cyclosporine,_Sirolimus,_Prednisone> <Has_immunosuppressor> "Sirolimus" .
<Cyclosporine,_Sirolimus,_Prednisone> <Has_immunosuppressor> "Prednisone" .
<Cyclosporine,_Sirolimus,_Prednisone> <Has_immunosuppressor> "Cyclosporines" .
<Estramin> <Brand_name_of> "Estramustine" .
<TC_and_Nintedanib> <Maps_to> "TC_and_Nintedanib" .
<VEPA> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<ATG_(Horse)_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Toremifene> <Has_accepted_use> "Breast_cancer" .
<Denosumab_monotherapy> <Maps_to> "Denosumab_monotherapy" .
<Post-definitive_therapy> <Maps_to> "Post-definitive_therapy" .
<Factor_IX_human> <Has_brand_name> "Mononine" .
<Factor_IX_human> <Has_brand_name> "Alphanine_SD" .
<MOPP-ABV> <Maps_to> "MOPP-ABV" .
<Fludarabine> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Fludarabine> <Is_a> "Purine_analogue" .
<Fludarabine> <Is_a> "Neutral" .
<Fludarabine> <Is_a> "DNA_synthesis_inhibitor" .
<Fludarabine> <Is_a> "Antimetabolite" .
<FOLFIRINOX> <Mapped_from> "FOLFIRINOX" .
<GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab> <Has_accepted_use> "Neuroblastoma" .
<Ibritumomab_tiuxetan> <Has_brand_name> "Zevalin" .
<Sorafenib_monotherapy> <Has_context> "Non-curative_third-line_therapy" .
<Sorafenib_monotherapy> <Has_context> "Non-curative_therapy" .
<Sorafenib_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Sorafenib_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Sorafenib_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Sorafenib_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Sorafenib_monotherapy> <Has_context> "Maintenance_after_upfront_therapy" .
<Sorafenib_monotherapy> <Has_context> "All_lines_of_therapy" .
<MRD> <Has_antineoplastic> "Melphalan" .
<MRD> <Has_antineoplastic> "Lenalidomide" .
<MRD> <Has_antineoplastic> "Dexamethasone" .
<Danazol_monotherapy> <Is_current_in> "Immune_thrombocytopenia" .
<MBVP> <Has_context> "Upfront_therapy" .
<Ramosetron> <May_have_route> "Oral" .
<Ramosetron> <May_have_route> "Intravenous" .
<FLAG-Ida> <Has_accepted_use> "FLT3-positive_Acute_myeloid_leukemia" .
<FLAG-Ida> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Interferon_alfa-2b_and_Zidovudine> <Has_modality> "Immunotherapy" .
<Paklitaxfil> <Brand_name_of> "Paclitaxel" .
<RBC_transfusions> <Has_accepted_use> "Sickle_cell_anemia" .
<FLOT> <Mapped_from> "FLOT" .
<Gemcitabine_monotherapy> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Necitumumab_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Nelarabine_monotherapy> <Has_context> "Non-curative_therapy" .
<INFeD> <Brand_name_of> "Iron_dextran" .
<Ibritumomab_tiuxetan> <Is_a> "Radiotherapy_medication" .
<Ibritumomab_tiuxetan> <Is_a> "Radioimmunotherapeutic" .
<Ibritumomab_tiuxetan> <Is_a> "Antibody_medication" .
<Ibritumomab_tiuxetan> <Is_a> "Anti-CD20_medication" .
<Ibritumomab_tiuxetan> <Is_a> "Anti-CD20_antibody" .
<Fluorouracil,_Mitomycin,_RT> <Maps_to> "Fluorouracil,_Mitomycin,_RT" .
<Anagrelide_monotherapy> <Maps_to> "Anagrelide_monotherapy" .
<Bexarotene_monotherapy> <Has_context> "Non-curative_therapy" .
<mDCF> <Has_context> "Non-curative_first-line_therapy" .
<CIM> <Has_antineoplastic> "Mesna" .
<CIM> <Has_antineoplastic> "Ifosfamide" .
<CIM> <Has_antineoplastic> "Cisplatin" .
<Isotretinoin_and_Dinutuximab> <Has_accepted_use> "Neuroblastoma" .
<R-MCP> <Mapped_from> "R-MCP" .
<R-CMD> <Is_current_in> "Follicular_lymphoma" .
<Panobinostat_monotherapy> <Is_historical_in> "Acute_myeloid_leukemia" .
<Temsirolimus_monotherapy> <Has_supportive_med> "Diphenhydramine" .
<Temsirolimus_monotherapy> <Has_supportive_med> "Antihistamines" .
<Kepinol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Non-curative_subsequent-line_consolidation_therapy> <Is_a> "Non-curative_subsequent-line_therapy" .
<Cytarabine,_Idarubicin,_Rituximab> <Has_modality> "Chemotherapy" .
<Prostate_cancer> <Current_treated_by> "Triptorelin_monotherapy" .
<Prostate_cancer> <Current_treated_by> "Sipuleucel-T_monotherapy" .
<Prostate_cancer> <Current_treated_by> "Samarium-153_monotherapy" .
<Prostate_cancer> <Current_treated_by> "Radium-223_monotherapy" .
<Prostate_cancer> <Current_treated_by> "Prednisone_monotherapy" .
<Prostate_cancer> <Current_treated_by> "Placebo" .
<Prostate_cancer> <Current_treated_by> "Olaparib_monotherapy" .
<Prostate_cancer> <Current_treated_by> "Observation" .
<Prostate_cancer> <Current_treated_by> "Nilutamide_and_Orchiectomy" .
<Prostate_cancer> <Current_treated_by> "Mitoxantrone_and_Prednisone" .
<Prostate_cancer> <Current_treated_by> "Mitoxantrone_and_Hydrocortisone" .
<Prostate_cancer> <Current_treated_by> "Leuprolide_monotherapy" .
<Prostate_cancer> <Current_treated_by> "Ketoconazole,_Hydrocortisone,_Dutasteride" .
<Prostate_cancer> <Current_treated_by> "Ketoconazole_and_Hydrocortisone" .
<Prostate_cancer> <Current_treated_by> "Ipilimumab_and_RT" .
<Prostate_cancer> <Current_treated_by> "Intermittent_ADT" .
<Prostate_cancer> <Current_treated_by> "Hydrocortisone_monotherapy" .
<Prostate_cancer> <Current_treated_by> "Histrelin_monotherapy" .
<Prostate_cancer> <Current_treated_by> "Goserelin_monotherapy" .
<Prostate_cancer> <Current_treated_by> "Goserelin_and_RT" .
<Prostate_cancer> <Current_treated_by> "Flutamide,_Leuprolide,_RT" .
<Prostate_cancer> <Current_treated_by> "Flutamide,_Goserelin,_RT" .
<Prostate_cancer> <Current_treated_by> "Flutamide_monotherapy" .
<Prostate_cancer> <Current_treated_by> "Flutamide_and_Leuprolide" .
<Prostate_cancer> <Current_treated_by> "Flutamide_and_Goserelin" .
<Prostate_cancer> <Current_treated_by> "Enzalutamide_monotherapy" .
<Prostate_cancer> <Current_treated_by> "Docetaxel_and_Prednisone" .
<Prostate_cancer> <Current_treated_by> "Docetaxel_and_Prednisolone" .
<Prostate_cancer> <Current_treated_by> "Docetaxel_and_Estramustine" .
<Prostate_cancer> <Current_treated_by> "Degarelix_monotherapy" .
<Prostate_cancer> <Current_treated_by> "Cyclophosphamide,_Prednisone,_Diethylstilbestrol" .
<Prostate_cancer> <Current_treated_by> "Carboplatin,_Docetaxel,_Prednisone" .
<Prostate_cancer> <Current_treated_by> "Carboplatin_and_Paclitaxel" .
<Prostate_cancer> <Current_treated_by> "Carboplatin_and_Docetaxel" .
<Prostate_cancer> <Current_treated_by> "Cabozantinib_monotherapy" .
<Prostate_cancer> <Current_treated_by> "Cabazitaxel_and_Prednisone" .
<Prostate_cancer> <Current_treated_by> "Bicalutamide_monotherapy" .
<Prostate_cancer> <Current_treated_by> "Bicalutamide_and_RT" .
<Prostate_cancer> <Current_treated_by> "Bicalutamide_and_Leuprolide" .
<Prostate_cancer> <Current_treated_by> "Bicalutamide_and_Goserelin" .
<Prostate_cancer> <Current_treated_by> "Apalutamide_monotherapy" .
<Prostate_cancer> <Current_treated_by> "Antiandrogen_withdrawal" .
<Prostate_cancer> <Current_treated_by> "Active_surveillance" .
<Prostate_cancer> <Current_treated_by> "Abiraterone_and_Prednisone" .
<Prostate_cancer> <Current_treated_by> "ADT,_Docetaxel,_Estramustine" .
<Prostate_cancer> <Current_treated_by> "ADT_and_RT" .
<Prostate_cancer> <Current_treated_by> "ADT_and_Enzalutamide" .
<Prostate_cancer> <Current_treated_by> "ADT_and_Docetaxel" .
<Prostate_cancer> <Current_treated_by> "ADT_and_Darolutamide" .
<Prostate_cancer> <Current_treated_by> "ADT_and_Apalutamide" .
<Prostate_cancer> <Current_treated_by> "ADT_and_Abiraterone" .
<Prostate_cancer> <Current_treated_by> "ADT" .
<Necitumumab_monotherapy> <Has_antineoplastic> "Necitumumab" .
<Fondaparinux_monotherapy> <Has_context> "Anticoagulation" .
<Fondaparinux_monotherapy> <Has_context> "All_lines_of_therapy" .
<Curative_therapy> <Subsumes> "Upfront_therapy" .
<Curative_therapy> <Subsumes> "Salvage_therapy" .
<VMD> <Has_modality> "Chemotherapy" .
<Protonix> <Brand_name_of> "Pantoprazole" .
<Cytarabine_and_Interferon_alfa-2b> <Has_modality> "Immunotherapy" .
<Cytarabine_and_Interferon_alfa-2b> <Has_modality> "Chemotherapy" .
<CAMF> <Is_a> "Anthracycline-containing_regimen" .
<Anabolic_steroid> <Subsumes> "Fluoxymesterone" .
<Dexchlorpheniramine> <May_have_route> "Oral" .
<Methotrexate> <May_have_route> "Subcutaneous" .
<Methotrexate> <May_have_route> "Oral" .
<Methotrexate> <May_have_route> "Intravenous" .
<Methotrexate> <May_have_route> "Intrathecal" .
<Methotrexate> <May_have_route> "Intramuscular" .
<CISCA> <Has_modality> "Chemotherapy" .
<ddT_(Taxotere)> <Maps_to> "ddT_(Taxotere)" .
<PEFG> <Mapped_from> "PEFG" .
<Cimetidine> <Is_a> "OTC_medication" .
<Cimetidine> <Is_a> "Nonsteroidal_antiandrogen" .
<Cimetidine> <Is_a> "H2-receptor_antagonist" .
<FLOX> <Is_current_in> "Colon_cancer" .
<VAD-P> <Has_accepted_use> "Multiple_myeloma" .
<Temozolomide_and_Bevacizumab> <Maps_to> "Temozolomide_and_Bevacizumab" .
<Rancotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Clopidogrel> <Is_a> "P2Y12_ADP_inhibitor" .
<Gliadel_wafer_monotherapy> <Has_modality> "Chemotherapy" .
<Dexatop> <Brand_name_of> "Dexamethasone" .
<Pegfilgrastim-cbqv> <Is_a> "Pegylated_medication" .
<Pegfilgrastim-cbqv> <Is_a> "Granulocyte_colony-stimulating_factor" .
<Pegfilgrastim-cbqv> <Is_a> "Biosimilar" .
<Bendamustine_and_Obinutuzumab> <Maps_to> "Bendamustine_and_Obinutuzumab" .
<Lafedam> <Brand_name_of> "Alendronate" .
<Lenalidomide> <May_have_route> "Oral" .
<Denileukin_diftitox_monotherapy> <Has_modality> "Chemotherapy" .
<Mitoxan> <Brand_name_of> "Cyclophosphamide" .
<Gemcitabine> <Has_accepted_use> "Transformed_lymphoma" .
<Gemcitabine> <Has_accepted_use> "Thymoma" .
<Gemcitabine> <Has_accepted_use> "Testicular_cancer" .
<Gemcitabine> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Gemcitabine> <Has_accepted_use> "Small_cell_lung_cancer" .
<Gemcitabine> <Has_accepted_use> "Renal_cell_carcinoma" .
<Gemcitabine> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<Gemcitabine> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Gemcitabine> <Has_accepted_use> "Pancreatic_cancer" .
<Gemcitabine> <Has_accepted_use> "Ovarian_cancer" .
<Gemcitabine> <Has_accepted_use> "Osteosarcoma" .
<Gemcitabine> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Gemcitabine> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<Gemcitabine> <Has_accepted_use> "NK-_and_T-cell_lymphoma" .
<Gemcitabine> <Has_accepted_use> "Mesothelioma" .
<Gemcitabine> <Has_accepted_use> "Leiomyosarcoma" .
<Gemcitabine> <Has_accepted_use> "Hodgkin_lymphoma" .
<Gemcitabine> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Gemcitabine> <Has_accepted_use> "Gallbladder_cancer" .
<Gemcitabine> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Gemcitabine> <Has_accepted_use> "Ewing_sarcoma" .
<Gemcitabine> <Has_accepted_use> "Esophageal_cancer" .
<Gemcitabine> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Gemcitabine> <Has_accepted_use> "Cholangiocarcinoma" .
<Gemcitabine> <Has_accepted_use> "Cervical_cancer" .
<Gemcitabine> <Has_accepted_use> "Breast_cancer" .
<Gemcitabine> <Has_accepted_use> "Bladder_cancer" .
<Gemcitabine> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<Gemcitabine> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<Vismodegib_monotherapy> <Mapped_from> "Vismodegib_monotherapy" .
<Actemra> <Brand_name_of> "Tocilizumab" .
<Caprelsa> <Brand_name_of> "Vandetanib" .
<CAV/PE> <Is_a> "Anthracycline-containing_regimen" .
<Supportive_therapy> <Mapped_from> "Supportive_therapy" .
<Carboplatin_and_Vinorelbine> <Mapped_from> "Carboplatin_and_Vinorelbine" .
<Anastrozole_and_Ribociclib> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Anastrozole_and_Ribociclib> <Has_accepted_use> "Breast_cancer" .
<COPDAC> <Has_context> "Consolidation_after_upfront_therapy" .
<Aspocid> <Brand_name_of> "Aspirin" .
<EOF> <Has_context> "Non-curative_first-line_therapy" .
<EOF> <Has_context> "Neoadjuvant_therapy" .
<EOF> <Has_context> "Induction_therapy" .
<EOF> <Has_context> "Adjuvant_therapy" .
<Apoptosis_promoter> <Subsumes> "Bcl-2_inhibitor" .
<Tamoxifen_monotherapy> <Has_context> "Non-curative_therapy" .
<Tamoxifen_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Tamoxifen_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Tamoxifen_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Tamoxifen_monotherapy> <Has_context> "All_lines_of_therapy" .
<Tamoxifen_monotherapy> <Has_context> "Adjuvant_therapy" .
<Melphalan_and_TBI> <Mapped_from> "Melphalan_and_TBI" .
<Filgrastim> <May_have_route> "Subcutaneous" .
<Filgrastim> <May_have_route> "Intravenous" .
<MOPP/ABVD> <Mapped_from> "MOPP/ABVD" .
<FLOT> <Has_modality> "Chemotherapy" .
<VACA> <Has_context> "Neoadjuvant_therapy" .
<VACA> <Has_context> "Adjuvant_therapy" .
<Amrubicin> <Has_accepted_use> "Small_cell_lung_cancer" .
<Amrubicin> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<BEAM,_then_allo_HSCT> <Is_current_in> "Hodgkin_lymphoma" .
<BEAM,_then_allo_HSCT> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<FAS> <Is_a> "Anthracycline-containing_regimen" .
<Vincristine_and_Prednisone> <Mapped_from> "Vincristine_and_Prednisone" .
<Acetaminophen> <Supportive_med_of> "VR-CHOP" .
<Acetaminophen> <Supportive_med_of> "VR" .
<Acetaminophen> <Supportive_med_of> "Sipuleucel-T_monotherapy" .
<Acetaminophen> <Supportive_med_of> "Samarium-153_monotherapy" .
<Acetaminophen> <Supportive_med_of> "Rituximab_monotherapy" .
<Acetaminophen> <Supportive_med_of> "RhIG_monotherapy" .
<Acetaminophen> <Supportive_med_of> "R-ICE" .
<Acetaminophen> <Supportive_med_of> "R-GemOx" .
<Acetaminophen> <Supportive_med_of> "R-GCVP" .
<Acetaminophen> <Supportive_med_of> "R-FCM" .
<Acetaminophen> <Supportive_med_of> "Ofatumumab_monotherapy" .
<Acetaminophen> <Supportive_med_of> "Obinutuzumab_monotherapy" .
<Acetaminophen> <Supportive_med_of> "O-miniCHOP" .
<Acetaminophen> <Supportive_med_of> "O-FC" .
<Acetaminophen> <Supportive_med_of> "O-CHOP" .
<Acetaminophen> <Supportive_med_of> "Ixazomib_and_Dexamethasone" .
<Acetaminophen> <Supportive_med_of> "IRd" .
<Acetaminophen> <Supportive_med_of> "IL-2_monotherapy" .
<Acetaminophen> <Supportive_med_of> "High-dose_Interleukin-2" .
<Acetaminophen> <Supportive_med_of> "HDMP-R" .
<Acetaminophen> <Supportive_med_of> "G-FC" .
<Acetaminophen> <Supportive_med_of> "FluCam" .
<Acetaminophen> <Supportive_med_of> "FR" .
<Acetaminophen> <Supportive_med_of> "FCR" .
<Acetaminophen> <Supportive_med_of> "Elo-VD" .
<Acetaminophen> <Supportive_med_of> "Elo-Rd" .
<Acetaminophen> <Supportive_med_of> "Elo-PD" .
<Acetaminophen> <Supportive_med_of> "Docetaxel_monotherapy" .
<Acetaminophen> <Supportive_med_of> "Denileukin_diftitox_monotherapy" .
<Acetaminophen> <Supportive_med_of> "Daratumumab_monotherapy" .
<Acetaminophen> <Supportive_med_of> "Dara-PD" .
<Acetaminophen> <Supportive_med_of> "Dara-KD" .
<Acetaminophen> <Supportive_med_of> "DD-CHOP" .
<Acetaminophen> <Supportive_med_of> "Cladribine_monotherapy" .
<Acetaminophen> <Supportive_med_of> "Cladribine_and_Rituximab" .
<Acetaminophen> <Supportive_med_of> "Chlorambucil_and_Ofatumumab" .
<Acetaminophen> <Supportive_med_of> "CVP,_then_131Iodine-Tositumomab" .
<Acetaminophen> <Supportive_med_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Acetaminophen> <Supportive_med_of> "CHOP-AL" .
<Acetaminophen> <Supportive_med_of> "CHOP,_then_131Iodine-Tositumomab" .
<Acetaminophen> <Supportive_med_of> "CFAR" .
<Acetaminophen> <Supportive_med_of> "CC" .
<Acetaminophen> <Supportive_med_of> "Bendamustine_and_Ofatumumab" .
<Acetaminophen> <Supportive_med_of> "Bendamustine_and_Obinutuzumab" .
<Acetaminophen> <Supportive_med_of> "BDR" .
<Acetaminophen> <Supportive_med_of> "Axicabtagene_ciloleucel_monotherapy" .
<Acetaminophen> <Supportive_med_of> "Avelumab_monotherapy" .
<Acetaminophen> <Supportive_med_of> "Alemtuzumab_monotherapy" .
<Acetaminophen> <Supportive_med_of> "131Iodine-Tositumomab_monotherapy" .
<Bendamustine_and_Ofatumumab> <Mapped_from> "Bendamustine_and_Ofatumumab" .
<Warfarin_monotherapy> <Is_current_in> "Venous_thromboembolism" .
<Warfarin_monotherapy> <Is_current_in> "Antiphospholipid_antibody_syndrome" .
<Trimexazole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cyclosporine,_Sirolimus,_Prednisone> <Has_context> "All_lines_of_therapy" .
<Endronal> <Brand_name_of> "Alendronate" .
<Nuset> <Brand_name_of> "Ondansetron" .
<Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab> <Maps_to> "Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab" .
<Factor_VIIa_recombinant> <Has_brand_name> "NovoSeven_room_temperature_stable" .
<Factor_VIIa_recombinant> <Has_brand_name> "NovoSeven_RT" .
<Factor_VIIa_recombinant> <Has_brand_name> "NovoSeven" .
<Factor_VIIa_recombinant> <Has_brand_name> "Novo-Seven" .
<Factor_VIIa_recombinant> <Has_brand_name> "AryoSeven" .
<Bicalutamide_and_Leuprolide> <Has_modality> "Hormonotherapy" .
<FDA_approved_drug> <Is_a> "Approved_drug" .
<Anti-CD22_antibody> <Is_a> "Antibody_medication" .
<Bicalutamide_and_Goserelin> <Has_antineoplastic> "Goserelin" .
<Bicalutamide_and_Goserelin> <Has_antineoplastic> "Bicalutamide" .
<Tirofiban> <May_have_route> "Intravenous" .
<Carboplatin_and_nab-Paclitaxel> <Has_accepted_use> "triple_negative_Breast_cancer" .
<Carboplatin_and_nab-Paclitaxel> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Carboplatin_and_nab-Paclitaxel> <Has_accepted_use> "Melanoma" .
<Carboplatin_and_nab-Paclitaxel> <Has_accepted_use> "Breast_cancer" .
<Pomalidomide> <Has_accepted_use> "Myelofibrosis" .
<Pomalidomide> <Has_accepted_use> "Multiple_myeloma" .
<Pomalidomide> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Pomalidomide> <Has_accepted_use> "Kaposi_sarcoma" .
<Neuroblastoma> <Current_treated_by> "Isotretinoin_monotherapy" .
<Neuroblastoma> <Current_treated_by> "Isotretinoin_and_Dinutuximab" .
<Neuroblastoma> <Current_treated_by> "Irinotecan,_Temozolomide,_Dinutuximab" .
<Neuroblastoma> <Current_treated_by> "GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab" .
<Neuroblastoma> <Current_treated_by> "Cyclophosphamide_monotherapy" .
<Neuroblastoma> <Current_treated_by> "Cyclophosphamide_and_Vincristine" .
<Neuroblastoma> <Current_treated_by> "Busulfan_and_Melphalan,_then_auto_HSCT" .
<CMFP> <Maps_to> "CMFP" .
<DA-R-EPOCH> <Mapped_from> "DA-R-EPOCH" .
<Intraperitoneal_5-FU> <Mapped_from> "Intraperitoneal_5-FU" .
<CVAP> <Has_context> "Neoadjuvant_therapy" .
<Anandron> <Brand_name_of> "Nilutamide" .
<MC> <Is_a> "Anthracycline-containing_regimen" .
<Fluorouracil,_Folinic_acid,_Levamisole> <Has_accepted_use> "Colon_cancer" .
<CHOP-14> <Has_modality> "Chemotherapy" .
<Adrosal> <Brand_name_of> "Doxorubicin" .
<R-GCVP> <Mapped_from> "R-GCVP" .
<Valrubicin_monotherapy> <Maps_to> "Valrubicin_monotherapy" .
<Avapritinib> <Has_FDA_indication> "Gastrointestinal_stromal_tumor" .
<U-Prin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<THL_(Taxol)> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<THL_(Taxol)> <Has_accepted_use> "Breast_cancer" .
<CYM> <Is_current_in> "CNS_lymphoma" .
<CYM> <Is_current_in> "Burkitt_lymphoma" .
<Intravenous_immunoglobulin_monotherapy> <Has_modality> "Supportive_therapy" .
<Caposib> <Brand_name_of> "Capecitabine" .
<Adrenergic_receptor_agonist> <Is_a> "Supportive_medication" .
<Methotrexate_and_Prednisone> <Is_current_in> "Large_granular_lymphocytic_leukemia" .
<Luspatercept> <May_have_route> "Subcutaneous" .
<Capecitabine,_Cisplatin,_RT> <Maps_to> "Capecitabine,_Cisplatin,_RT" .
<COX-1_inhibitor> <Subsumes> "Indomethacin" .
<COX-1_inhibitor> <Subsumes> "Aspirin_and_dipyridamole" .
<COX-1_inhibitor> <Subsumes> "Aspirin" .
<Hydroxyurea_and_RT> <Has_antineoplastic> "Hydroxyurea" .
<Hydroxyurea_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Hydroxyurea_and_RT> <Has_antineoplastic> "Brachytherapy" .
<STAMP-I> <Is_historical_in> "Breast_cancer" .
<Carboplatin_and_nab-Paclitaxel> <Mapped_from> "Carboplatin_and_nab-Paclitaxel" .
<IDAC_and_Sorafenib> <Maps_to> "IDAC_and_Sorafenib" .
<AVD> <Is_a> "Anthracycline-containing_regimen" .
<Doxorubicin,_Ifosfamide,_RT> <Has_accepted_use> "Soft_tissue_sarcoma" .
<SC-EPOCH-RR> <Has_antineoplastic> "Vincristine" .
<SC-EPOCH-RR> <Has_antineoplastic> "Rituximab" .
<SC-EPOCH-RR> <Has_antineoplastic> "Prednisone" .
<SC-EPOCH-RR> <Has_antineoplastic> "Etoposide" .
<SC-EPOCH-RR> <Has_antineoplastic> "Doxorubicin" .
<SC-EPOCH-RR> <Has_antineoplastic> "Cyclophosphamide" .
<BHD> <Mapped_from> "BHD" .
<Tagremin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<BCVPP> <Mapped_from> "BCVPP" .
<Elotuzumab> <Antineoplastic_of> "Elo-VD" .
<Elotuzumab> <Antineoplastic_of> "Elo-Rd" .
<Elotuzumab> <Antineoplastic_of> "Elo-PD" .
<CISCA/VB> <Is_historical_in> "Testicular_cancer" .
<Tesetaxel> <Is_a> "Taxane" .
<Tesetaxel> <Is_a> "Investigational_drug" .
<Myelodysplastic_syndrome> <Current_treated_by> "Temozolomide_monotherapy" .
<Myelodysplastic_syndrome> <Current_treated_by> "Placebo" .
<Myelodysplastic_syndrome> <Current_treated_by> "Midostaurin_monotherapy" .
<Myelodysplastic_syndrome> <Current_treated_by> "Luspatercept_monotherapy" .
<Myelodysplastic_syndrome> <Current_treated_by> "LoDAC" .
<Myelodysplastic_syndrome> <Current_treated_by> "Lenalidomide_monotherapy" .
<Myelodysplastic_syndrome> <Current_treated_by> "Erythropoietin_monotherapy" .
<Myelodysplastic_syndrome> <Current_treated_by> "Erythropoetin_and_Lenalidomide" .
<Myelodysplastic_syndrome> <Current_treated_by> "Erlotinib_monotherapy" .
<Myelodysplastic_syndrome> <Current_treated_by> "Decitabine_monotherapy" .
<Myelodysplastic_syndrome> <Current_treated_by> "Cyclosporine_monotherapy" .
<Myelodysplastic_syndrome> <Current_treated_by> "Clofarabine_monotherapy" .
<Myelodysplastic_syndrome> <Current_treated_by> "Busulfan_and_Cyclophosphamide,_then_allo_HSCT" .
<Myelodysplastic_syndrome> <Current_treated_by> "Best_supportive_care" .
<Myelodysplastic_syndrome> <Current_treated_by> "Azacitidine_monotherapy" .
<Myelodysplastic_syndrome> <Current_treated_by> "Azacitidine_and_Vorinostat" .
<Myelodysplastic_syndrome> <Current_treated_by> "Azacitidine_and_Lenalidomide" .
<Myelodysplastic_syndrome> <Current_treated_by> "Alemtuzumab_monotherapy" .
<Myelodysplastic_syndrome> <Current_treated_by> "ATG_(Rabbit)_monotherapy" .
<Myelodysplastic_syndrome> <Current_treated_by> "ATG_(Horse)_monotherapy" .
<Myelodysplastic_syndrome> <Current_treated_by> "ATG_(Horse)_and_Cyclosporine" .
<Hyper-CVAD_and_Ponatinib> <Has_supportive_med> "Valacyclovir" .
<Hyper-CVAD_and_Ponatinib> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Hyper-CVAD_and_Ponatinib> <Has_supportive_med> "Rasburicase" .
<Hyper-CVAD_and_Ponatinib> <Has_supportive_med> "Mesna" .
<Hyper-CVAD_and_Ponatinib> <Has_supportive_med> "Levofloxacin" .
<Hyper-CVAD_and_Ponatinib> <Has_supportive_med> "Folinic_acid" .
<Hyper-CVAD_and_Ponatinib> <Has_supportive_med> "Fluconazole" .
<Hyper-CVAD_and_Ponatinib> <Has_supportive_med> "Filgrastim" .
<Hyper-CVAD_and_Ponatinib> <Has_supportive_med> "Ciprofloxacin" .
<Hyper-CVAD_and_Ponatinib> <Has_supportive_med> "Allopurinol" .
<Hyper-CVAD_and_Ponatinib> <Has_supportive_med> "Acyclovir" .
<Tamoxifen_and_Prednisolone> <Is_a> "Antiestrogen-containing_regimen" .
<Trimoxin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin_and_Gemcitabine> <Has_antineoplastic> "Gemcitabine" .
<Cisplatin_and_Gemcitabine> <Has_antineoplastic> "Cisplatin" .
<Natira_U> <Brand_name_of> "Fluorouracil" .
<Temozolomide_and_Thalidomide> <Has_modality> "Chemotherapy" .
<BeGEV> <Has_accepted_use> "Hodgkin_lymphoma" .
<Lorlatinib> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<R-GDP> <Mapped_from> "R-GDP" .
<Tedicumar> <Brand_name_of> "Warfarin" .
<Pre-definitive_therapy> <Is_a> "Upfront_therapy" .
<Melanoma> <Historic_treated_by> "Dacarbazine_and_Tamoxifen" .
<Melanoma> <Historic_treated_by> "Cisplatin,_Dacarbazine,_Tamoxifen" .
<Melanoma> <Historic_treated_by> "Cisplatin,_Dacarbazine,_Interferon_alfa-2b" .
<Melanoma> <Historic_treated_by> "CDB" .
<Melanoma> <Historic_treated_by> "BVD" .
<Melanoma> <Historic_treated_by> "BHD" .
<Melanoma> <Historic_treated_by> "BCG_and_Dacarbazine" .
<PEFG> <Has_antineoplastic> "Gemcitabine" .
<PEFG> <Has_antineoplastic> "Fluorouracil" .
<PEFG> <Has_antineoplastic> "Epirubicin" .
<PEFG> <Has_antineoplastic> "Cisplatin" .
<Brentuximab_vedotin> <May_have_route> "Intravenous" .
<Total_Therapy> <Has_antineoplastic> "Thalidomide" .
<Total_Therapy> <Has_antineoplastic> "Melphalan" .
<Total_Therapy> <Has_antineoplastic> "Etoposide" .
<Total_Therapy> <Has_antineoplastic> "Doxorubicin" .
<Total_Therapy> <Has_antineoplastic> "Dexamethasone" .
<Total_Therapy> <Has_antineoplastic> "Cyclophosphamide" .
<Total_Therapy> <Has_antineoplastic> "Cisplatin" .
<Total_Therapy> <Has_antineoplastic> "Bortezomib" .
<Pharmapred> <Brand_name_of> "Prednisone" .
<R-Hyper-CVAD/R-MA> <Has_local_therapy> "Vincristine" .
<R-Hyper-CVAD/R-MA> <Has_local_therapy> "Methotrexate" .
<R-Hyper-CVAD/R-MA> <Has_local_therapy> "Doxorubicin" .
<R-Hyper-CVAD/R-MA> <Has_local_therapy> "Cytarabine" .
<B-cell_acute_lymphoblastic_leukemia> <FDA_indication_of> "Vincristine_liposomal" .
<B-cell_acute_lymphoblastic_leukemia> <FDA_indication_of> "Tisagenlecleucel" .
<B-cell_acute_lymphoblastic_leukemia> <FDA_indication_of> "Inotuzumab_ozogamicin" .
<B-cell_acute_lymphoblastic_leukemia> <FDA_indication_of> "Imatinib" .
<B-cell_acute_lymphoblastic_leukemia> <FDA_indication_of> "Blinatumomab" .
<Aminocaproic_acid> <May_have_route> "Oral" .
<Aminocaproic_acid> <May_have_route> "Intravenous" .
<Dexamark> <Brand_name_of> "Dexamethasone" .
<TL_(Taxol)> <Has_modality> "Chemotherapy" .
<FOLFIRI> <Has_accepted_use> "Pancreatic_cancer" .
<FOLFIRI> <Has_accepted_use> "KRAS_wild-type_Colon_cancer" .
<FOLFIRI> <Has_accepted_use> "Esophageal_cancer" .
<FOLFIRI> <Has_accepted_use> "Colon_cancer" .
<Cisplatin_and_Mitomycin> <Has_context> "Non-curative_first-line_therapy" .
<Seematrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Lormine> <Brand_name_of> "Dexamethasone" .
<Rituximab-abbs> <May_have_route> "Intravenous" .
<Cisplatin_and_Mitomycin> <Has_supportive_med> "Mannitol" .
<Cisplatin_and_Mitomycin> <Has_supportive_med> "Furosemide" .
<Dexazone> <Brand_name_of> "Dexamethasone" .
<TH_(Taxotere/SC)> <Has_antineoplastic> "Trastuzumab_and_hyaluronidase" .
<TH_(Taxotere/SC)> <Has_antineoplastic> "Docetaxel" .
<Estradiol_monotherapy> <Is_historical_in> "Breast_cancer" .
<IT_Methotrexate_monotherapy> <Has_modality> "Chemotherapy" .
<Melphalan_monotherapy> <Has_context> "Non-curative_therapy" .
<Melphalan_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Melphalan_monotherapy> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Melphalan_monotherapy> <Has_context> "All_lines_of_therapy" .
<Melphalan_monotherapy> <Has_context> "Adjuvant_therapy" .
<Cetirizine> <Is_a> "Antihistamine" .
<KIT-mutated_Melanoma> <Is_a> "Melanoma" .
<Delta_Cortelan> <Brand_name_of> "Prednisone" .
<Citarabina> <Brand_name_of> "Cytarabine" .
<Trastuzumab_monotherapy> <Maps_to> "Trastuzumab_monotherapy" .
<Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine> <Has_context> "Non-curative_therapy" .
<Teniposide_monotherapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<CALGB_8811_late_intensification> <Maps_to> "CALGB_8811_late_intensification" .
<VR-CAP> <Has_modality> "Chemotherapy" .
<Clofarabine_and_Cytarabine> <Is_current_in> "Acute_myeloid_leukemia" .
<DAT> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Carboplatin_and_Vincristine> <Is_current_in> "Low-grade_glioma" .
<Doxorubicin_and_Olaratumab> <Mapped_from> "Doxorubicin_and_Olaratumab" .
<BHD> <Maps_to> "BHD" .
<Hepatocellular_carcinoma> <Accepted_use_of> "mFOLFOX_and_Sorafenib" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Tamoxifen_monotherapy" .
<Hepatocellular_carcinoma> <Accepted_use_of> "TACE,_then_5-FU" .
<Hepatocellular_carcinoma> <Accepted_use_of> "TACE" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Sunitinib_monotherapy" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Sunitinib" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Sorafenib_monotherapy" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Sorafenib" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Regorafenib_monotherapy" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Regorafenib" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Ramucirumab_monotherapy" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Ramucirumab" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Radioembolization" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Placebo" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Pembrolizumab_monotherapy" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Pembrolizumab" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Oxaliplatin" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Observation" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Nivolumab_monotherapy" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Nivolumab" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Levoleucovorin" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Lenvatinib_monotherapy" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Lenvatinib" .
<Hepatocellular_carcinoma> <Accepted_use_of> "HAIC_and_Sorafenib" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Gemcitabine" .
<Hepatocellular_carcinoma> <Accepted_use_of> "GemOx_and_Sorafenib" .
<Hepatocellular_carcinoma> <Accepted_use_of> "GemOx" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Folinic_acid" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Fluorouracil_and_Folinic_acid" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Fluorouracil" .
<Hepatocellular_carcinoma> <Accepted_use_of> "FOLFOX4" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Erlotinib_and_Bevacizumab" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Erlotinib" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Doxorubicin_monotherapy" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Doxorubicin" .
<Hepatocellular_carcinoma> <Accepted_use_of> "DEB-TACE" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Capecitabine_monotherapy" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Capecitabine_and_Bevacizumab" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Capecitabine" .
<Hepatocellular_carcinoma> <Accepted_use_of> "CapeOx_and_Bevacizumab" .
<Hepatocellular_carcinoma> <Accepted_use_of> "CapeOx" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Cabozantinib_monotherapy" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Cabozantinib" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Bevacizumab-bvzr" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Bevacizumab-awwb" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Bevacizumab_monotherapy" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Bevacizumab" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Best_supportive_care" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Axitinib_and_TACE" .
<Hepatocellular_carcinoma> <Accepted_use_of> "Axitinib" .
<Durea> <Brand_name_of> "Hydroxyurea" .
<Dasatinib_and_Prednisone> <Has_modality> "Chemotherapy" .
<Elandur> <Brand_name_of> "Alendronate" .
<Cytopenia> <Subsumes> "WHIM_syndrome" .
<Cytopenia> <Subsumes> "Thrombotic_thrombocytopenic_purpura" .
<Cytopenia> <Subsumes> "Thrombocytopenia_in_liver_disease" .
<Cytopenia> <Subsumes> "Immune_thrombocytopenia" .
<Cytopenia> <Subsumes> "Autoimmune_cytopenia" .
<Cytopenia> <Subsumes> "Aplastic_anemia" .
<Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin> <Has_context> "Induction_therapy" .
<CMFT> <Has_context> "Non-curative_first-line_therapy" .
<CMFT> <Has_context> "Adjuvant_therapy" .
<Mesna> <Immunosuppressor_of> "Busulfan_and_Fludarabine" .
<Mesna> <Immunosuppressor_of> "BuFlu,_then_allo_HSCT" .
<Zalucs> <Brand_name_of> "Dexamethasone" .
<R-CODOX-M> <Has_antineoplastic> "Vincristine" .
<R-CODOX-M> <Has_antineoplastic> "Rituximab" .
<R-CODOX-M> <Has_antineoplastic> "Methotrexate" .
<R-CODOX-M> <Has_antineoplastic> "Doxorubicin" .
<R-CODOX-M> <Has_antineoplastic> "Cyclophosphamide" .
<MVP_(Vindesine)> <Has_antineoplastic> "Vindesine" .
<MVP_(Vindesine)> <Has_antineoplastic> "Mitomycin" .
<MVP_(Vindesine)> <Has_antineoplastic> "Cisplatin" .
<Etoposide_monotherapy> <Mapped_from> "Etoposide_monotherapy" .
<Atriance> <Brand_name_of> "Nelarabine" .
<Dara-VMP> <Mapped_from> "Dara-VMP" .
<Vorier> <Brand_name_of> "Voriconazole" .
<VACOP-B> <Mapped_from> "VACOP-B" .
<Ifosfamide_monotherapy> <Is_current_in> "Thymoma" .
<Ifosfamide_monotherapy> <Is_current_in> "Soft_tissue_sarcoma" .
<Ifosfamide_monotherapy> <Is_current_in> "Small_cell_lung_cancer" .
<Ifosfamide_monotherapy> <Is_current_in> "Endometrial_cancer" .
<Ifosfamide_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Ifosfamide_monotherapy> <Is_current_in> "Cervical_cancer" .
<RVR> <Mapped_from> "RVR" .
<Elo-Rd> <Maps_to> "Elo-Rd" .
<Finasteride> <May_have_route> "Oral" .
<Busulfan_monotherapy> <Has_modality> "Chemotherapy" .
<Docetaxel_and_Ramucirumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<Docetaxel_and_Ramucirumab> <Is_current_in> "Bladder_cancer" .
<Tabrol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Mini-BEAM> <Has_supportive_med> "Ciprofloxacin" .
<CCOP> <Maps_to> "CCOP" .
<CYVE_and_G-CSF> <Is_current_in> "Stem_cell_mobilization" .
<EOX> <Is_a> "Anthracycline-containing_regimen" .
<VAB-6> <Has_modality> "Chemotherapy" .
<Versatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Platil> <Brand_name_of> "Cisplatin" .
<Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant> <Has_accepted_use> "Allogeneic_HSCT" .
<R-BAC> <Has_context> "Non-curative_therapy" .
<R-BAC> <Has_context> "Non-curative_first-line_therapy" .
<Fluorouracil_monotherapy> <Has_accepted_use> "Rectal_cancer" .
<Fluorouracil_monotherapy> <Has_accepted_use> "Pancreatic_cancer" .
<Fluorouracil_monotherapy> <Has_accepted_use> "Head_and_neck_cancer" .
<Fluorouracil_monotherapy> <Has_accepted_use> "Gastric_cancer" .
<Fluorouracil_monotherapy> <Has_accepted_use> "Colon_cancer" .
<Nordic_Regimen,_older_patients> <Has_antineoplastic> "Vindesine" .
<Nordic_Regimen,_older_patients> <Has_antineoplastic> "Rituximab" .
<Nordic_Regimen,_older_patients> <Has_antineoplastic> "Methotrexate" .
<Nordic_Regimen,_older_patients> <Has_antineoplastic> "Ifosfamide" .
<Nordic_Regimen,_older_patients> <Has_antineoplastic> "Dexamethasone" .
<Nordic_Regimen,_older_patients> <Has_antineoplastic> "Cytarabine_liposomal" .
<Nordic_Regimen,_older_patients> <Has_antineoplastic> "Cytarabine" .
<Nordic_Regimen,_older_patients> <Has_antineoplastic> "Cyclophosphamide" .
<ATG_(Horse),_Cyclosporine,_Eltrombopag> <Has_modality> "Immunosuppressive_therapy" .
<IT_Cytarabine,_Methotrexate,_Prednisone> <Is_current_in> "CNS_leukemia" .
<Interferon_alfa_monotherapy> <Mapped_from> "Interferon_alfa_monotherapy" .
<MVAC,_dose-dense> <Has_supportive_med> "Pegfilgrastim" .
<MVAC,_dose-dense> <Has_supportive_med> "Ondansetron" .
<MVAC,_dose-dense> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<MVAC,_dose-dense> <Has_supportive_med> "Dexamethasone" .
<MVAC,_dose-dense> <Has_supportive_med> "Aprepitant" .
<R-TBI/Cy> <Maps_to> "R-TBI/Cy" .
<Enzalutamide_monotherapy> <Has_modality> "Hormonotherapy" .
<AC-T> <Is_a> "Anthracycline-containing_regimen" .
<Axitinib_and_TACE> <Is_current_in> "Hepatocellular_carcinoma" .
<Carboplatin,_Paclitaxel,_Ipilimumab> <Has_antineoplastic> "Paclitaxel" .
<Carboplatin,_Paclitaxel,_Ipilimumab> <Has_antineoplastic> "Ipilimumab" .
<Carboplatin,_Paclitaxel,_Ipilimumab> <Has_antineoplastic> "Carboplatin" .
<Ortez> <Brand_name_of> "Bortezomib" .
<VDC/IE> <Has_context> "Neoadjuvant_therapy" .
<Vinflunine_monotherapy> <Has_antineoplastic> "Vinflunine" .
<Apatinib> <Has_brand_name> "Aitan" .
<Mitotane_and_EDP> <Has_accepted_use> "Adrenocortical_carcinoma" .
<Imatinib_monotherapy> <Mapped_from> "Imatinib_monotherapy" .
<Epoch> <Brand_name_of> "Epoetin_alfa" .
<Capecitabine_and_Trastuzumab> <Maps_to> "Capecitabine_and_Trastuzumab" .
<CLAG-M> <Is_current_in> "Acute_myeloid_leukemia" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Thioguanine" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Tamibarotene_monotherapy" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Tamibarotene" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Observation" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Mitoxantrone" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Methotrexate" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Mercaptopurine_and_Methotrexate" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Mercaptopurine" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Melphalan" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Idarubicin,_then_Mitoxantrone,_then_Idarubicin" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Idarubicin" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Hydroxyurea" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Gemtuzumab_ozogamicin" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Etoposide" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Daunorubicin_monotherapy" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Daunorubicin" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Cytarabine_and_Idarubicin" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Cytarabine_and_Daunorubicin" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Cytarabine" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Busulfan_and_Melphalan,_then_auto_HSCT" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Busulfan" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Arsenic_trioxide,_then_ATRA_and_Daunorubicin" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Arsenic_trioxide,_ATRA,_Idarubicin" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Arsenic_trioxide_monotherapy" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Arsenic_trioxide_and_Idarubicin" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Arsenic_trioxide_and_ATRA" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "Arsenic_trioxide" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "All-trans_retinoic_acid" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "ATRA,_Mercaptopurine,_Methotrexate" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "ATRA,_Cytarabine,_Idarubicin" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "ATRA,_Cytarabine,_Daunorubicin" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "ATRA_monotherapy" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "ATRA_and_Idarubicin" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "ATRA_and_Daunorubicin" .
<Acute_promyelocytic_leukemia> <Accepted_use_of> "ADE_and_ATRA" .
<MP> <Has_antineoplastic> "Prednisone" .
<MP> <Has_antineoplastic> "Melphalan" .
<ADT_and_Apalutamide> <Has_antineoplastic> "GnRH_agonists" .
<ADT_and_Apalutamide> <Has_antineoplastic> "Endocrine_ablation_surgery" .
<ADT_and_Apalutamide> <Has_antineoplastic> "Apalutamide" .
<BMP> <Has_accepted_use> "Penile_cancer" .
<nab-Paclitaxel_monotherapy> <Has_accepted_use> "triple_negative_Breast_cancer" .
<nab-Paclitaxel_monotherapy> <Has_accepted_use> "Pancreatic_cancer" .
<nab-Paclitaxel_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<nab-Paclitaxel_monotherapy> <Has_accepted_use> "Melanoma" .
<nab-Paclitaxel_monotherapy> <Has_accepted_use> "Gastric_cancer" .
<nab-Paclitaxel_monotherapy> <Has_accepted_use> "Breast_cancer" .
<nab-Paclitaxel_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<Rucaparib> <Has_FDA_indication> "Ovarian_cancer" .
<CAPIRI-Bev> <Is_a> "Irinotecan-containing_regimen" .
<CAPIRI-Bev> <Is_a> "Bevacizumab-containing_regimen" .
<Warm_autoimmune_hemolytic_anemia> <Accepted_use_of> "Prednisone_monotherapy" .
<Warm_autoimmune_hemolytic_anemia> <Accepted_use_of> "Prednisone_and_Rituximab" .
<Warm_autoimmune_hemolytic_anemia> <Accepted_use_of> "Prednisolone_monotherapy" .
<Warm_autoimmune_hemolytic_anemia> <Accepted_use_of> "Prednisolone_and_Rituximab" .
<Bivalirudin_monotherapy> <Has_supportive_med> "Bivalirudin" .
<Busulfex> <Brand_name_of> "Busulfan" .
<Ifosfamide_and_Gemcitabine> <Maps_to> "Ifosfamide_and_Gemcitabine" .
<Vismodegib_monotherapy> <Has_modality> "Chemotherapy" .
<CC> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<CC> <Has_supportive_med> "Famciclovir" .
<CC> <Has_supportive_med> "Diphenhydramine" .
<CC> <Has_supportive_med> "Alemtuzumab" .
<CC> <Has_supportive_med> "Acetaminophen" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Zultrop" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Zoltrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Zoltrijem" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Zolmed" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Zolebid" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Zerrprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Zeptra" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Zecatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Zaxol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Zantran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Zamboprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Zactron" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Yekaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Xeroprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Xerazole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Xepaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Xazotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "XA-Zole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "X-Trim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Wypal" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Wiltran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Wiatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Weiditrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Virin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Versatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Utrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Urtium" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Uroplus_DS" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Urodown" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Urethrax" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Uprina" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Unitran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Ultrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Ultrazole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Ultrasept" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Ulfaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "U-Prin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Tytrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Tryseptolum" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trizole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trixzol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trixazol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Tritosul" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Tritenk" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trisural" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trisuprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trisulfose" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trisulfa" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trisulcom" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trisul" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trisolvat" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trisolak_Forte" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trisfides" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trisep" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Tripur" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Triphimox" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimzol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimsul" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimozol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimoxsul" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimoxis" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimoxin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimoxazole-BC" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimoxazol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimoxavin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimosulfa" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimosul" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimoks" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimocom" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Triminex" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimidar_M" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimfasul" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimezole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimezol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimexole-F" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimexazole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimexazol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimexasol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimetsol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimetrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimetox" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimetotal" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimetop_Duplo" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimetoger" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimethox" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimeta" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimesulf" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimesul" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimesol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimeril" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimerazin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimeran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimephar" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimel" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trimaxazole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trima" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trihexal" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Triforam" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trifides" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Tricot" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Tricomox" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Tricban" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trib" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Trelibec" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Tprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Torrid" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Thriazol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Thoprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Theratrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Therasept" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Theraprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Teutrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Terbosulfa" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Terasulf" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Teof" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Tagremin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Tabrol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "System" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Syntoprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Synotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Synetra" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Synerzole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Synermed" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Syndal" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Synco-Smzt" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Synbac" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Synastat" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Synac" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Syltrifil" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Suxprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sutrisan" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sutrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sutaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Suptrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Suptrex" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Suprin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Suprimass" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Suprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Supribac" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Suprex" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Suprasulf" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Supracombin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Supim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Suntrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sumitran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sumetrolin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sumetrolim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sumetoprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sultropim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sultrivon-F" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sultrimmix" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sultrima" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sultrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sultrex" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sultra" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sultorim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sultiprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulthrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sultase" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulprimed" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulphytrim_Forte" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulphax" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulphatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulphatran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulphathoprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulphaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulgotri" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulftran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulfotrimin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulfotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulfort" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulfonamide" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulfometh" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulfoid_Trimetho" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulfinam" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulfawal-T" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulfatropim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulfatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulfaton" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulfatalpin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulfarim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulfaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulfametoxazol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulfamethoprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulfamet" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulfamer" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulfagrand" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sulbacta" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Suftrex" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Strim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Stopan" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Stan" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Spectrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Spectrem" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sosetran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Soptrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Soltrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Smartrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Skytrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sitrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sistrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sisoprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sinotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sinersul" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sinatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Siltran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Silpin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sigatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sigaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Servitrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Septrin-S" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Septrin_Paediatric" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Septran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Septra" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Septoprin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Septocid_R_+" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Septiolan" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Septinix" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Septerin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Septazole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Septazol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Septabid" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sepmax" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sepiran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Semozol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Selectrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Seftrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Seematrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Scribcin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sbpa_Trimeth_Smeth" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Satrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Saptrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Sanprima" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Saltrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Salgatran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Roytrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Roxtrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Roubac" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Rolprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Rizol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Rivoprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Rimezone" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Rimazole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Ribatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Rexaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Retrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Resprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Renatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Rematrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Regtin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Ratrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Raseptol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Rasat" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Rancotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Quisulyn" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Quimio-PED" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Qiftrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Qiftrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Purbac" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Pulkrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Protrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Primzole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Primsulfon" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Primox" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Primotren" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Primazole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Primazol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Primavon" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Primatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Primasulf" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Primasul" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Primadex" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Pribac" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Polytran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Politrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Polibatrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Plurisul" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Pisatrina" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Phartex" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Pharmazol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Pharmatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Penzole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Pentrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Penetrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Pehatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Patrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Pantrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Pakzole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Oxaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Ottoprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Otrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Ostrin_Forte" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Ormoprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Oribact" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Orgastran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Orbak" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Oradin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Onetrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Omsat" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Omnatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Omegtrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Okatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Oecotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Octrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Octran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Octil-S" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Nuruzole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Nufaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Nucotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Novozole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Novotrimox" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Novotrimel" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Novotrim_Plus" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Novidrine" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Novactil" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Notrime" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Notrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Nortrime" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Nortrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Norisep" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Nopil" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Nodilon" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Nilium" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Nicotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Neuroprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Netocur" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Neotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Neoset" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Necorzole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Navatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Napatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Naftran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Myctrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Mukadryl" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Moxzole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Moxatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Moxalas" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Moxadden" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Mortin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Moly" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Miratrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Mikrosid" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Mikotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Microtrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Microsupos_Amigdalar" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Microdyn" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Microcetim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Microbid" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Micogyl" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Micinovo" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Mezenol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Mexazole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Mexaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Metxaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Metrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Metoxiprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Metoprin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Metoprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Methotrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Methoprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Meprotrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Meprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Megatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Megaset" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Megabroncoflam" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Medtrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Meditrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Meditran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Mediprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Medcotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Mebryn" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Mazatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Maxzol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Maxtrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Maxol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Maxitrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Maxiprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Maxaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Martiprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Maktrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Madroxin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Mactran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Macromed" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Macprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "M-Trim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "M-Moxa" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Lykaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Lusaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Lupectrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Longasal" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Lobact" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Litrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Lisaprin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Lifzol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Lifactrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Lictora" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Letus" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Lescot" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Leprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Leotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Lastrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Larprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Laratrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Lapikot" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Lagatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Lacreozole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "L-Trim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Krobactrol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Kotrimoksazol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Kotazol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Kombina" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Kindoprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Kepinol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Kentricid" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Kemoprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Kemocid" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Kaytran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Katrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Kathrex" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Kaftrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "KO-Kure" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "K.B.famate" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Justeprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Jestrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Jenamoxazol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Jasotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Japtrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Isotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Isoprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Irgagen" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Introcin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Intrafort" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Infesin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Infectrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Infectrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Infectran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Infatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Inatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Imexim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Imcotran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Ibtrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Huma-Trimel" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Hufacid" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Hicot" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Hexaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Herixina" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Helveprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Hatrix" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Gunametrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Groseptol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Graprima" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Gobens_Trim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Globaxol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Getrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Genzaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Gentrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Genoxzole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Genoctrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Gatrima" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Gamactrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Forteprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Forcrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Flocot" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Flatran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Fisat" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Fedimed" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Fectrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Fameprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Falprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Fakzol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Fabubac" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Exazol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Eutrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Eusaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Eurotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Ethitrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Espectroprima" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Espectrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Escoprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Esbesul" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Erphatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Erotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Eroprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Eliprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Eduprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Editrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Ectrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Ectaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Dynaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Dvaseptol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Dutran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Duratrimet" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Duoctrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Duobiocin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Duobact" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Dumotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Dubac" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Drylin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Droxol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Drossul" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Drilozole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Dosatran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Doctrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Diseptyl" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Dino-BAC" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Dhatrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Dertrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Deotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Decatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Daiphen" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "DUO_Septol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Curaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Creptrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cozole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cozol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cots" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotrizole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotrizol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotrixyl-L" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotrisul" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotripharm" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotrimstada" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotrimoxin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotrimoxazol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotrimox" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotrimol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotrimhexal" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotrimel" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotrimaxazole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotrimaxazol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotrimax" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotrilin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotril" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotribid" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotribene" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotribase" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotri" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotrexel" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotrazen" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cotoram" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cosulf" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Costazole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cosig" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cosat" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Coprime" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Coprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Contrimoxazole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Comoxol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Comox" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Comixco" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Combi-Methoxan" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Combact" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Comazole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Comax" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Colotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Colizole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Colitran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cofatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cocydal" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cobal_ST" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cobact" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Clotrizol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Clonea" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Clinitran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cladon" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Citrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Ciplin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cipaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Cidaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Chromo-Z" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Chemozole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Chemotrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Chemotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Chemotran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Chemoprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Chemizol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Chemix" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Chemitrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Centrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Caretran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Canprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "CO-Trimoxazol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "CO-Trimoxa" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "CO-Trimed" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "CO-Trimazole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "CO-Trim-Tablinen" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "CO-Traisole_480" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "CO-Tasian" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "CO-Sultrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Brongenit" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Broncoflam" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Brifeseptol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Boschtrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Blexon" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bitrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bisultrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bismoral" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Biseptrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Biseptol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Biseptin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Biprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Biotrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Biotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Biotran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Biosulten" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bioprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bimatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bicotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bibakrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bethaprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bestofens" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Berlocid" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Benectrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bencole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Belfactrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Baxolex" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Batrox" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Baserin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Basatin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bantizol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Balkatrine" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Balkatrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Baktrisid_DS" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bakton" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Baktar" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Baklinger" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Baczole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Baczin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bacxal" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactropin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactronil" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactron" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactrizole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactrium_DS" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactrisan" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactrimel" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactrilac" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactricin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactricida" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactricid" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactramin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactostab" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactosain" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactoreduct" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactoprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactiver" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactiseptol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactipront" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactille-TS" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactigram" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactifor" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactide" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bacticel" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bacterol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bacteriof.klebs_PN" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bacteric" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bacterial" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bacteracin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactelan" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactekod" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactazol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bactar" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bacsultrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bacsulfaprin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bacris" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bacprotin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bacotrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bacoprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bacmetrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bacitran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bacin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bacidal" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Bacfar" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "BS" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "BAC-Sulfitrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "B.S." .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Avlotrin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Atomexin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Assepium" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Aspen" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Ascotran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Aratran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Aptrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Apotrinelax" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Apcetrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Antrimox" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Antrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Antibac" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Anprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Anitrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Andoprim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Amtril" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Amtran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Amoxazol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Amazole" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Altrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Allibac" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Alcot" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Alcorim-F" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Albutrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Albrotran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Aksotran" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Adtrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Adrenol" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Aditrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Actrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Abetrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Abditri" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Abatrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Abactrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "Abacin" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "APO-Bactotrim" .
<Trimethoprim-Sulfamethoxazole> <Has_brand_name> "APO_Sulfatrim" .
<CYVE> <Has_modality> "Chemotherapy" .
<VAB-6> <Is_historical_in> "Testicular_cancer" .
<Cytarabine,_Methotrexate,_Rituximab> <Has_supportive_med> "Levoleucovorin" .
<Arsenic_trioxide,_ATRA,_Idarubicin> <Mapped_from> "Arsenic_trioxide,_ATRA,_Idarubicin" .
<VIPD> <Maps_to> "VIPD" .
<VIP> <Mapped_from> "VIP" .
<Brukinsa> <Brand_name_of> "Zanubrutinib" .
<Hepatic_arterial_chemotherapy> <Has_supportive_med> "Dexamethasone" .
<Imatinib_and_LoDAC> <Has_context> "Non-curative_first-line_therapy" .
<Onkofluor> <Brand_name_of> "Fluorouracil" .
<Flutamide_monotherapy> <Is_current_in> "Prostate_cancer" .
<Cotrilin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cyclosporine_and_Methotrexate> <Is_current_in> "Graft_versus_host_disease" .
<Cyclophosphamide_and_TBI> <Has_antineoplastic> "External_beam_radiotherapy" .
<Cyclophosphamide_and_TBI> <Has_antineoplastic> "Cyclophosphamide" .
<PFT> <Is_a> "Antiestrogen-containing_regimen" .
<Amifostine> <Is_a> "Chemotherapy_protective_agent" .
<Levamisole> <May_have_route> "Oral" .
<Site-agnostic_medication> <Subsumes> "SMO_or_PTCH-1_(Hedgehog)_medication" .
<Site-agnostic_medication> <Subsumes> "ERBB3_(HER3)_medication" .
<Site-agnostic_medication> <Subsumes> "ERBB2_(HER2)_medication" .
<Site-agnostic_medication> <Subsumes> "Cancer_of_unknown_primary_medication" .
<MAP> <Maps_to> "MAP" .
<EPOCH,_dose-escalated> <Has_antineoplastic> "Vincristine" .
<EPOCH,_dose-escalated> <Has_antineoplastic> "Prednisone" .
<EPOCH,_dose-escalated> <Has_antineoplastic> "Etoposide" .
<EPOCH,_dose-escalated> <Has_antineoplastic> "Doxorubicin" .
<EPOCH,_dose-escalated> <Has_antineoplastic> "Cyclophosphamide" .
<L-Asparaginase_and_Methotrexate> <Has_context> "Consolidation_after_upfront_therapy" .
<R-MPV> <Has_antineoplastic> "Vincristine" .
<R-MPV> <Has_antineoplastic> "Rituximab" .
<R-MPV> <Has_antineoplastic> "Procarbazine" .
<R-MPV> <Has_antineoplastic> "Methotrexate" .
<CEV_and_RT> <Has_accepted_use> "Small_cell_lung_cancer" .
<Bimatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Oncolytic_viral_therapy> <Is_a> "Chemotherapeutic" .
<FOLFIRI_and_Bevacizumab_(L-Leucovorin)> <Mapped_from> "FOLFIRI_and_Bevacizumab_(L-Leucovorin)" .
<Tamoxifen_monotherapy> <Is_a> "Antiestrogen-containing_regimen" .
<Cisplatin,_Gemcitabine,_Necitumumab> <Has_modality> "Chemotherapy" .
<Chlorambucil_and_Cisplatin> <Has_accepted_use> "Ovarian_cancer" .
<Sporanox> <Brand_name_of> "Itraconazole" .
<Romidepsin_monotherapy> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<Romidepsin_monotherapy> <Is_current_in> "Cutaneous_T-cell_lymphoma" .
<COPADM> <Is_current_in> "Burkitt_lymphoma" .
<BMP> <Is_current_in> "Penile_cancer" .
<ADT_and_Docetaxel> <Has_modality> "Hormonotherapy" .
<ADT_and_Docetaxel> <Has_modality> "Chemotherapy" .
<Cisplatin_and_Methotrexate> <Is_current_in> "Bladder_cancer" .
<Histrelin> <Is_a> "GnRH_agonist" .
<Histrelin> <Is_a> "Endocrine_therapeutic" .
<SOX> <Is_a> "Platinum_doublet" .
<Imatinib_monotherapy> <Has_antineoplastic> "Imatinib" .
<Eltrombopag_monotherapy> <Is_current_in> "Immune_thrombocytopenia" .
<Eltrombopag_monotherapy> <Is_current_in> "Aplastic_anemia" .
<FOLFIRI_(L-Leucovorin)> <Is_current_in> "Colon_cancer" .
<Procarbazine_monotherapy> <Is_current_in> "Glioblastoma" .
<Procarbazine_monotherapy> <Is_current_in> "CNS_lymphoma" .
<VA> <Is_current_in> "Rhabdomyosarcoma" .
<Glasdegib> <Has_accepted_use> "Acute_myeloid_leukemia" .
<RET_inhibitor> <Subsumes> "Vandetanib" .
<RET_inhibitor> <Subsumes> "Sunitinib" .
<RET_inhibitor> <Subsumes> "Sorafenib" .
<RET_inhibitor> <Subsumes> "Regorafenib" .
<RET_inhibitor> <Subsumes> "Ponatinib" .
<RET_inhibitor> <Subsumes> "Motesanib" .
<RET_inhibitor> <Subsumes> "Lenvatinib" .
<RET_inhibitor> <Subsumes> "Cabozantinib" .
<Paclitaxel_and_Topotecan> <Has_modality> "Chemotherapy" .
<Ensartinib> <Is_a> "ROS1_inhibitor" .
<Ensartinib> <Is_a> "Kinase_inhibitor" .
<Ensartinib> <Is_a> "Investigational_drug" .
<Ensartinib> <Is_a> "ALK_inhibitor" .
<Pamidronate> <Has_brand_name> "Pamisol" .
<Pamidronate> <Has_brand_name> "Padium" .
<Pamidronate> <Has_brand_name> "Aredia" .
<ATG_(Horse),_Cyclosporine,_Eltrombopag> <Mapped_from> "ATG_(Horse),_Cyclosporine,_Eltrombopag" .
<Cisplatin,_Fluorouracil,_Vincristine> <Maps_to> "Cisplatin,_Fluorouracil,_Vincristine" .
<Sirolimus_and_Prednisone> <Has_context> "All_lines_of_therapy" .
<Ramucirumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Ramucirumab> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Ramucirumab> <Has_accepted_use> "Gastric_cancer" .
<Ramucirumab> <Has_accepted_use> "Colon_cancer" .
<Ramucirumab> <Has_accepted_use> "Bladder_cancer" .
<Bosutinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Bosutinib_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Bosutinib_monotherapy> <Has_context> "Induction_therapy" .
<Tagraxofusp_monotherapy> <Maps_to> "Tagraxofusp_monotherapy" .
<Sirolimus_monotherapy> <Has_accepted_use> "Castleman_disease" .
<Sirolimus_monotherapy> <Has_accepted_use> "Autoimmune_cytopenia" .
<Ziv-aflibercept> <May_have_route> "Intravenous" .
<COMP> <Is_historical_in> "Hodgkin_lymphoma" .
<COMP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<COMP> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<Breast_cancer_medications_(historic)> <Subsumes> "Vincristine" .
<M-TIP> <Has_accepted_use> "Testicular_cancer" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<IT_Cytarabine,_Methotrexate,_Methylprednisolone> <Has_context> "Local_therapy" .
<R-BEAM,_then_auto_HSCT> <Has_antineoplastic> "Rituximab" .
<R-BEAM,_then_auto_HSCT> <Has_antineoplastic> "Melphalan" .
<R-BEAM,_then_auto_HSCT> <Has_antineoplastic> "Etoposide" .
<R-BEAM,_then_auto_HSCT> <Has_antineoplastic> "Cytarabine" .
<R-BEAM,_then_auto_HSCT> <Has_antineoplastic> "Carmustine" .
<CMFP> <Has_antineoplastic> "Prednisone" .
<CMFP> <Has_antineoplastic> "Methotrexate" .
<CMFP> <Has_antineoplastic> "Fluorouracil" .
<CMFP> <Has_antineoplastic> "Cyclophosphamide" .
<Duvelisib_monotherapy> <Mapped_from> "Duvelisib_monotherapy" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan> <Has_immunosuppressor> "Methotrexate" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan> <Has_immunosuppressor> "Cyclosporines" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<(90)YFC> <Is_current_in> "Allogeneic_HSCT" .
<Cotoram> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Danaparoid_monotherapy> <Mapped_from> "Danaparoid_monotherapy" .
<Onivyde> <Brand_name_of> "Irinotecan_liposome" .
<Onivyde> <Brand_name_of> "Irinotecan" .
<Cisplatin> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Cisplatin> <Is_a> "Vesicant" .
<Cisplatin> <Is_a> "Platinum_agent" .
<Cisplatin> <Is_a> "Irritant" .
<Cisplatin> <Is_a> "Alkylating_agent" .
<Capecitabine_and_Mitomycin> <Has_modality> "Chemotherapy" .
<Nimustine> <Antineoplastic_of> "Nimustine_and_RT" .
<CABO> <Mapped_from> "CABO" .
<Meticortelone> <Brand_name_of> "Prednisolone" .
<Anti-TACSTD2_antibody> <Subsumes> "Sacituzumab_govitecan" .
<R2CHOP> <Mapped_from> "R2CHOP" .
<CHOP> <Has_modality> "Chemotherapy" .
<PAF> <Is_historical_in> "Breast_cancer" .
<Cyclophosphamide,_Prednisone,_Diethylstilbestrol> <Is_current_in> "Prostate_cancer" .
<VAdCA> <Has_antineoplastic> "Vincristine" .
<VAdCA> <Has_antineoplastic> "Doxorubicin" .
<VAdCA> <Has_antineoplastic> "Dactinomycin" .
<VAdCA> <Has_antineoplastic> "Cyclophosphamide" .
<Carboplatin_monotherapy> <Has_context> "Non-curative_therapy" .
<Carboplatin_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Carboplatin_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Carboplatin_monotherapy> <Has_context> "Adjuvant_therapy" .
<Paclitaxel_monotherapy> <Maps_to> "Paclitaxel_monotherapy" .
<VAC_(Adriamycin)> <Is_historical_in> "Breast_cancer" .
<dmCODOX-M_-_Modified_Magrath> <Has_context> "Upfront_therapy" .
<Hydroxyurea_and_Interferon_alfa-2a> <Maps_to> "Hydroxyurea_and_Interferon_alfa-2a" .
<PFT> <Has_context> "Adjuvant_therapy" .
<Intravenous_Immunoglobulin> <Has_antineoplastic> "Intravenous_immunoglobulin_(IVIG)" .
<Dacomitinib_monotherapy> <Maps_to> "Dacomitinib_monotherapy" .
<Erypo> <Brand_name_of> "Epoetin_alfa" .
<Bendamustine> <Has_brand_name> "Xyotin" .
<Bendamustine> <Has_brand_name> "Treanda" .
<Bendamustine> <Has_brand_name> "Treakisym" .
<Bendamustine> <Has_brand_name> "Ribomustin" .
<Bendamustine> <Has_brand_name> "Purplz" .
<Bendamustine> <Has_brand_name> "MyMust" .
<Bendamustine> <Has_brand_name> "Maxtorin" .
<Bendamustine> <Has_brand_name> "Levact" .
<Bendamustine> <Has_brand_name> "Leuben" .
<Bendamustine> <Has_brand_name> "Innomustine" .
<Bendamustine> <Has_brand_name> "Bendit" .
<Bendamustine> <Has_brand_name> "Bendeka" .
<Bendamustine> <Has_brand_name> "Bendawel" .
<Bendamustine> <Has_brand_name> "Bendamax" .
<Larotrectinib> <Is_a> "TRK_inhibitor" .
<Larotrectinib> <Is_a> "Mutation-specific_medication" .
<Larotrectinib> <Is_a> "Kinase_inhibitor" .
<Gefitinib_and_Pemetrexed> <Is_current_in> "Non-small_cell_lung_cancer" .
<Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone> <Has_context> "Consolidation_after_upfront_therapy" .
<Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Cyclophosphamide_and_Topotecan> <Has_supportive_med> "Mesna" .
<Cyclophosphamide_and_Topotecan> <Has_supportive_med> "Furosemide" .
<Cyclophosphamide_and_Topotecan> <Has_supportive_med> "Filgrastim" .
<Cyclophosphamide_and_Topotecan> <Has_supportive_med> "Emesis_prevention" .
<ADT_and_Abiraterone> <Has_modality> "Hormonotherapy" .
<Cyclosporine,_Corticosteroids,_Rituximab> <Mapped_from> "Cyclosporine,_Corticosteroids,_Rituximab" .
<Kytril> <Brand_name_of> "Granisetron" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_modality> "Immunotherapy" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_modality> "Chemotherapy" .
<Doxorubicin_and_Lomustine> <Is_historical_in> "Hodgkin_lymphoma" .
<BuCyTBI> <Maps_to> "BuCyTBI" .
<Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin> <Has_antineoplastic> "Gemtuzumab_ozogamicin" .
<Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin> <Has_antineoplastic> "Arsenic_trioxide" .
<Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin> <Has_antineoplastic> "All-trans_retinoic_acid" .
<Bacillus_Calmette-Guerin> <Has_accepted_use> "Bladder_cancer" .
<FOLFOX4_and_Cetuximab> <Mapped_from> "FOLFOX4_and_Cetuximab" .
<Corsone> <Brand_name_of> "Dexamethasone" .
<Decorten> <Brand_name_of> "Dexamethasone" .
<Myleran> <Brand_name_of> "Busulfan" .
<POMP> <Has_antineoplastic> "Vincristine" .
<POMP> <Has_antineoplastic> "Prednisone" .
<POMP> <Has_antineoplastic> "Methotrexate" .
<POMP> <Has_antineoplastic> "Mercaptopurine" .
<L-Asparaginase,_Vincristine,_Prednisolone> <Is_current_in> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<CODOX-M> <Has_context> "Upfront_therapy" .
<CODOX-M> <Has_context> "Induction_therapy" .
<Binimetinib_and_Encorafenib> <Has_context> "Non-curative_therapy" .
<Dexapolcort> <Brand_name_of> "Dexamethasone" .
<BO> <Has_antineoplastic> "Vincristine" .
<BO> <Has_antineoplastic> "Bleomycin" .
<ECH> <Has_antineoplastic> "Trastuzumab" .
<ECH> <Has_antineoplastic> "Epirubicin" .
<ECH> <Has_antineoplastic> "Cyclophosphamide" .
<Gallbladder_cancer> <Current_treated_by> "Regorafenib_monotherapy" .
<Gallbladder_cancer> <Current_treated_by> "Gemcitabine,_Cisplatin,_S-1" .
<Gallbladder_cancer> <Current_treated_by> "Gemcitabine_monotherapy" .
<Gallbladder_cancer> <Current_treated_by> "Gemcitabine_and_S-1" .
<Gallbladder_cancer> <Current_treated_by> "Gemcitabine_and_Mitomycin" .
<Gallbladder_cancer> <Current_treated_by> "GemOx" .
<Gallbladder_cancer> <Current_treated_by> "GEMOX-B" .
<Gallbladder_cancer> <Current_treated_by> "Fluorouracil,_Folinic_acid,_Gemcitabine" .
<Gallbladder_cancer> <Current_treated_by> "FELV" .
<Gallbladder_cancer> <Current_treated_by> "Erlotinib_and_Bevacizumab" .
<Gallbladder_cancer> <Current_treated_by> "ECF" .
<Gallbladder_cancer> <Current_treated_by> "Cisplatin,_Gemcitabine,_nab-Paclitaxel" .
<Gallbladder_cancer> <Current_treated_by> "Cisplatin_and_Gemcitabine" .
<Gallbladder_cancer> <Current_treated_by> "Capecitabine_monotherapy" .
<Gallbladder_cancer> <Current_treated_by> "Capecitabine_and_Mitomycin" .
<Gallbladder_cancer> <Current_treated_by> "Capecitabine_and_Gemcitabine" .
<Gallbladder_cancer> <Current_treated_by> "CapeOx" .
<Gallbladder_cancer> <Current_treated_by> "Best_supportive_care" .
<Fluorouracil_monotherapy> <Maps_to> "Fluorouracil_monotherapy" .
<Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan> <Maps_to> "Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan" .
<CBV-Mx> <Mapped_from> "CBV-Mx" .
<Bexarotene> <Antineoplastic_of> "Bexarotene_monotherapy" .
<Bexarotene> <Antineoplastic_of> "Bexarotene_and_Pralatrexate" .
<Denosumab> <Is_a> "RANK_ligand_inhibitor" .
<Denosumab> <Is_a> "Antibody_medication" .
<Denosumab> <Is_a> "Anti-RANKL_antibody" .
<Flectadol> <Brand_name_of> "Aspirin" .
<FULV/FULV_and_RT> <Has_context> "Adjuvant_therapy" .
<Doceglob> <Brand_name_of> "Docetaxel" .
<Muscarinic_receptor_antagonist> <Subsumes> "Scopolamine" .
<Bexine> <Brand_name_of> "Dexamethasone" .
<CLAG> <Is_current_in> "Acute_myeloid_leukemia" .
<Jaclacin> <Brand_name_of> "Aclarubicin" .
<Enox> <Brand_name_of> "Enoxaparin" .
<Methoxsalen> <May_have_route> "Intravenous" .
<DHAP_-_time_intensified> <Has_modality> "Chemotherapy" .
<iddEPC> <Mapped_from> "iddEPC" .
<Paclitaxel_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Brentuximab_vedotin_monotherapy> <Maps_to> "Brentuximab_vedotin_monotherapy" .
<Eribulin_monotherapy> <Is_current_in> "Liposarcoma" .
<Eribulin_monotherapy> <Is_current_in> "Leiomyosarcoma" .
<Eribulin_monotherapy> <Is_current_in> "Breast_cancer" .
<Myelotex> <Brand_name_of> "Azacitidine" .
<V-HyperCAD> <Has_antineoplastic> "Doxorubicin" .
<V-HyperCAD> <Has_antineoplastic> "Dexamethasone" .
<V-HyperCAD> <Has_antineoplastic> "Cyclophosphamide" .
<V-HyperCAD> <Has_antineoplastic> "Bortezomib" .
<Malignant_hematologic_neoplasm> <Subsumes> "T-cell_neoplasm" .
<Malignant_hematologic_neoplasm> <Subsumes> "Plasma_cell_dyscrasia" .
<Malignant_hematologic_neoplasm> <Subsumes> "Myeloproliferative_neoplasm" .
<Malignant_hematologic_neoplasm> <Subsumes> "Lymphoproliferative_disorder" .
<Malignant_hematologic_neoplasm> <Subsumes> "Lymphoma" .
<Malignant_hematologic_neoplasm> <Subsumes> "Leukemia" .
<Malignant_hematologic_neoplasm> <Subsumes> "Histiocytosis" .
<Docetaxel_and_Bevacizumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<Docetaxel_and_Bevacizumab> <Is_current_in> "Breast_cancer" .
<GELOX/RT> <Has_modality> "Radiotherapy" .
<GELOX/RT> <Has_modality> "Chemotherapy" .
<Mitocyte> <Brand_name_of> "Mitomycin" .
<Durvalumab> <Antineoplastic_of> "Durvalumab_monotherapy" .
<Durvalumab> <Antineoplastic_of> "Cisplatin,_Etoposide,_Durvalumab" .
<Durvalumab> <Antineoplastic_of> "Carboplatin,_Etoposide,_Durvalumab" .
<Wypal> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bevacizumab-awwb> <Is_a> "VEGFR_inhibitor" .
<Bevacizumab-awwb> <Is_a> "Neutral" .
<Bevacizumab-awwb> <Is_a> "Biosimilar" .
<Bevacizumab-awwb> <Is_a> "Antibody_medication" .
<Bevacizumab-awwb> <Is_a> "Anti-VEGFR_antibody" .
<Irinotecan_and_Temozolomide> <Is_a> "Irinotecan-containing_regimen" .
<CMED> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Tabin> <Brand_name_of> "Cytarabine" .
<Teniposide_monotherapy> <Mapped_from> "Teniposide_monotherapy" .
<Plicamycin_monotherapy> <Has_modality> "Chemotherapy" .
<Macdafen> <Brand_name_of> "Ifosfamide" .
<BFR,_then_allo_HSCT> <Maps_to> "BFR,_then_allo_HSCT" .
<GEMOX-B> <Maps_to> "GEMOX-B" .
<Duobiocin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Tisagenlecleucel> <May_have_route> "Intravenous" .
<PCE> <Mapped_from> "PCE" .
<Etoposide_and_TBI> <Has_accepted_use> "Autologous_HSCT" .
<Etoposide_and_TBI> <Has_accepted_use> "Allogeneic_HSCT" .
<SMILE> <Maps_to> "SMILE" .
<TMF> <Has_modality> "Chemotherapy" .
<Imatinib_and_LoDAC> <Mapped_from> "Imatinib_and_LoDAC" .
<BuCy,_then_allo_HSCT> <Is_current_in> "Acute_myeloid_leukemia" .
<Ipilimumab,_then_Nivolumab> <Has_antineoplastic> "Nivolumab" .
<Ipilimumab,_then_Nivolumab> <Has_antineoplastic> "Ipilimumab" .
<Temozolomide_and_low-dose_RT> <Mapped_from> "Temozolomide_and_low-dose_RT" .
<Methotrexate,_Tacrolimus,_Tocilizumab> <Has_context> "Prophylaxis" .
<Chlorobutin> <Brand_name_of> "Chlorambucil" .
<Alentop> <Brand_name_of> "Alendronate" .
<ATRA_monotherapy> <Has_context> "Maintenance_after_upfront_therapy" .
<ATRA_monotherapy> <Has_context> "Induction_therapy" .
<Pemetrexed_and_Pembrolizumab> <Has_antineoplastic> "Pemetrexed" .
<Pemetrexed_and_Pembrolizumab> <Has_antineoplastic> "Pembrolizumab" .
<Best_supportive_care> <Has_modality> "Null_therapy" .
<Interferon_alfa-2a_monotherapy> <Has_accepted_use> "Renal_cell_carcinoma" .
<Interferon_alfa-2a_monotherapy> <Has_accepted_use> "Multiple_myeloma" .
<Interferon_alfa-2a_monotherapy> <Has_accepted_use> "Melanoma" .
<Interferon_alfa-2a_monotherapy> <Has_accepted_use> "Kaposi_sarcoma" .
<Interferon_alfa-2a_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<Interferon_alfa-2a_monotherapy> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Cutaneous_T-cell_lymphoma> <Is_a> "T-cell_lymphoma" .
<Cutaneous_T-cell_lymphoma> <Is_a> "Cutaneous_lymphoma" .
<VACOP-B> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Linker_regimen_(consolidation)> <Has_context> "Consolidation_after_upfront_therapy" .
<MCP> <Has_accepted_use> "Marginal_zone_lymphoma" .
<MCP> <Has_accepted_use> "Mantle_cell_lymphoma" .
<MCP> <Has_accepted_use> "Follicular_lymphoma" .
<ATG_(Horse),_Cyclosporine,_G-CSF> <Is_current_in> "Aplastic_anemia" .
<EVAIA> <Is_a> "Anthracycline-containing_regimen" .
<Tazemetostat> <Antineoplastic_of> "Tazemetostat_monotherapy" .
<DexaBEAM> <Maps_to> "DexaBEAM" .
<Fakzol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CPR> <Has_antineoplastic> "Prednisone" .
<CPR> <Has_antineoplastic> "Lenalidomide" .
<CPR> <Has_antineoplastic> "Cyclophosphamide" .
<IDH1_inhibitor> <Subsumes> "Ivosidenib" .
<Flu-Mel,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<Flu-Mel,_then_allo_HSCT> <Has_modality> "Immunosuppressive_therapy" .
<Flu-Mel,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<PAD_doxil> <Mapped_from> "PAD_doxil" .
<Decitabine_and_Venetoclax> <Has_context> "Non-curative_first-line_induction_therapy" .
<Fluorouracil_and_Paclitaxel> <Has_accepted_use> "Esophageal_cancer" .
<Aldesleukin> <Is_a> "T-cell_activator" .
<Aldesleukin> <Is_a> "Immunotherapeutic" .
<Aldesleukin> <Is_a> "Cytokine" .
<Elo-Rd> <Has_modality> "Chemotherapy" .
<FULV/FULV_and_RT> <Maps_to> "FULV/FULV_and_RT" .
<Gestational_trophoblastic_neoplasia> <Current_treated_by> "Methotrexate_monotherapy" .
<Gestational_trophoblastic_neoplasia> <Current_treated_by> "Mercaptopurine_and_Methotrexate" .
<Gestational_trophoblastic_neoplasia> <Current_treated_by> "EMA-CO" .
<Gestational_trophoblastic_neoplasia> <Current_treated_by> "Dactinomycin_monotherapy" .
<m-BACOD> <Maps_to> "m-BACOD" .
<Aspirine> <Brand_name_of> "Aspirin" .
<DCEP> <Has_accepted_use> "Multiple_myeloma" .
<Mezenol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Supertendin-Depot_N> <Brand_name_of> "Dexamethasone" .
<Apatinib_monotherapy> <Has_modality> "Chemotherapy" .
<Pazopanib> <Has_accepted_use> "Thyroid_cancer" .
<Pazopanib> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Pazopanib> <Has_accepted_use> "Renal_cell_carcinoma" .
<Pazopanib> <Has_accepted_use> "Ovarian_cancer" .
<Pazopanib> <Has_accepted_use> "Gastrointestinal_stromal_tumor" .
<Gilteritinib> <May_have_route> "Oral" .
<Prednisolone> <Has_accepted_use> "Prostate_cancer" .
<Prednisolone> <Has_accepted_use> "Multiple_myeloma" .
<Prednisolone> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Prednisolone> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Prednisolone> <Has_accepted_use> "Langerhans_cell_histiocytosis" .
<Prednisolone> <Has_accepted_use> "Hodgkin_lymphoma" .
<Prednisolone> <Has_accepted_use> "Follicular_lymphoma" .
<Prednisolone> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Prednisolone> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Prednisolone> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Prednisolone> <Has_accepted_use> "Burkitt_lymphoma" .
<Prednisolone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Prednisolone> <Has_accepted_use> "Acquired_coagulopathy" .
<ddA> <Is_a> "Anthracycline-containing_regimen" .
<Talazoparib_monotherapy> <Has_context> "Non-curative_therapy" .
<Testicular_cancer> <Current_treated_by> "VeIP" .
<Testicular_cancer> <Current_treated_by> "VIP" .
<Testicular_cancer> <Current_treated_by> "TIP" .
<Testicular_cancer> <Current_treated_by> "Sunitinib_monotherapy" .
<Testicular_cancer> <Current_treated_by> "Radiation_therapy" .
<Testicular_cancer> <Current_treated_by> "PVeBV" .
<Testicular_cancer> <Current_treated_by> "Oxaliplatin_and_Bevacizumab" .
<Testicular_cancer> <Current_treated_by> "M-TIP" .
<Testicular_cancer> <Current_treated_by> "Ifosfamide_and_Paclitaxel" .
<Testicular_cancer> <Current_treated_by> "Gemcitabine,_Oxaliplatin,_Paclitaxel" .
<Testicular_cancer> <Current_treated_by> "Gemcitabine_and_Paclitaxel" .
<Testicular_cancer> <Current_treated_by> "GemOx" .
<Testicular_cancer> <Current_treated_by> "GIP" .
<Testicular_cancer> <Current_treated_by> "Etoposide_monotherapy" .
<Testicular_cancer> <Current_treated_by> "Cisplatin_and_Etoposide" .
<Testicular_cancer> <Current_treated_by> "Cisplatin_and_Epirubicin" .
<Testicular_cancer> <Current_treated_by> "Carboplatin_monotherapy" .
<Testicular_cancer> <Current_treated_by> "Carboplatin_and_Etoposide,_then_auto_HSCT" .
<Testicular_cancer> <Current_treated_by> "C-BOP" .
<Testicular_cancer> <Current_treated_by> "BO" .
<Testicular_cancer> <Current_treated_by> "BEP" .
<Testicular_cancer> <Current_treated_by> "Accelerated_BEP" .
<EC> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<EC> <Has_accepted_use> "HER2-positive_-_historical_Breast_cancer" .
<EC> <Has_accepted_use> "Breast_cancer" .
<Leiomyosarcoma> <Is_a> "Soft_tissue_sarcoma" .
<Pegfilgrastim> <Supportive_med_of> "mFOLFIRINOX,_Gemcitabine,_RT" .
<Pegfilgrastim> <Supportive_med_of> "iddEPC" .
<Pegfilgrastim> <Supportive_med_of> "eBEACOPP_(Prednisolone)" .
<Pegfilgrastim> <Supportive_med_of> "ddTH_(Taxol)" .
<Pegfilgrastim> <Supportive_med_of> "ddFEC" .
<Pegfilgrastim> <Supportive_med_of> "ddEC" .
<Pegfilgrastim> <Supportive_med_of> "ddAC-T" .
<Pegfilgrastim> <Supportive_med_of> "ddAC" .
<Pegfilgrastim> <Supportive_med_of> "VcR-CVAD" .
<Pegfilgrastim> <Supportive_med_of> "V-HyperCAD" .
<Pegfilgrastim> <Supportive_med_of> "TCH_(Taxotere,_Cyclophosphamide)" .
<Pegfilgrastim> <Supportive_med_of> "R2CHOP" .
<Pegfilgrastim> <Supportive_med_of> "R-NIMP" .
<Pegfilgrastim> <Supportive_med_of> "R-MegaCHOP" .
<Pegfilgrastim> <Supportive_med_of> "R-IFE" .
<Pegfilgrastim> <Supportive_med_of> "R-Hyper-CVAD/R-MA" .
<Pegfilgrastim> <Supportive_med_of> "R-GCVP" .
<Pegfilgrastim> <Supportive_med_of> "R-FCM" .
<Pegfilgrastim> <Supportive_med_of> "R-EPOCH,_dose-escalated" .
<Pegfilgrastim> <Supportive_med_of> "R-DHAOx" .
<Pegfilgrastim> <Supportive_med_of> "R-CODOX-M/R-IVAC" .
<Pegfilgrastim> <Supportive_med_of> "R-CODOX-M" .
<Pegfilgrastim> <Supportive_med_of> "R-CHOP-14_(Rituximab_Hycela)" .
<Pegfilgrastim> <Supportive_med_of> "R-CHOP-14" .
<Pegfilgrastim> <Supportive_med_of> "R-CHOEP-14" .
<Pegfilgrastim> <Supportive_med_of> "R-CDOP" .
<Pegfilgrastim> <Supportive_med_of> "Paclitaxel_monotherapy" .
<Pegfilgrastim> <Supportive_med_of> "PCO" .
<Pegfilgrastim> <Supportive_med_of> "OFAR" .
<Pegfilgrastim> <Supportive_med_of> "O-ICE" .
<Pegfilgrastim> <Supportive_med_of> "O-DHAP" .
<Pegfilgrastim> <Supportive_med_of> "MVAC,_dose-dense" .
<Pegfilgrastim> <Supportive_med_of> "Hyper-CVAD/MA_and_Everolimus" .
<Pegfilgrastim> <Supportive_med_of> "Hyper-CVAD" .
<Pegfilgrastim> <Supportive_med_of> "FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation" .
<Pegfilgrastim> <Supportive_med_of> "FCR" .
<Pegfilgrastim> <Supportive_med_of> "Doxorubicin_and_Gemcitabine" .
<Pegfilgrastim> <Supportive_med_of> "Docetaxel_and_Gemcitabine" .
<Pegfilgrastim> <Supportive_med_of> "DA-R-EPOCH" .
<Pegfilgrastim> <Supportive_med_of> "Cladribine_and_Rituximab" .
<Pegfilgrastim> <Supportive_med_of> "Cisplatin_and_Epirubicin" .
<Pegfilgrastim> <Supportive_med_of> "Cisplatin_and_Doxorubicin" .
<Pegfilgrastim> <Supportive_med_of> "CFAR" .
<Pegfilgrastim> <Supportive_med_of> "Brentuximab_vedotin_monotherapy" .
<Pegfilgrastim> <Supportive_med_of> "Bendamustine_monotherapy" .
<Pegfilgrastim> <Supportive_med_of> "BeGEV" .
<Pegfilgrastim> <Supportive_med_of> "BEACOPP-14_(Prednisolone)" .
<Pegfilgrastim> <Supportive_med_of> "Accelerated_BEP" .
<Ferumoxytol> <May_have_route> "Intravenous" .
<Midostaurin_monotherapy> <Has_modality> "Chemotherapy" .
<Ercar> <Brand_name_of> "Carboplatin" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_antineoplastic> "Vinblastine" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_antineoplastic> "Interferon_alfa-2b" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_antineoplastic> "Dacarbazine" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_antineoplastic> "Cisplatin" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_antineoplastic> "Aldesleukin" .
<Isotretinoin_and_Dinutuximab> <Has_antineoplastic> "Isotretinoin" .
<Isotretinoin_and_Dinutuximab> <Has_antineoplastic> "Dinutuximab" .
<PCF> <Maps_to> "PCF" .
<Immunomodulatory_drugs_(IMiDs)> <Is_a> "Immunotherapeutic" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Has_local_therapy> "Methotrexate" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Has_local_therapy> "Cytarabine" .
<Vinca_alkaloid> <Subsumes> "Vinorelbine" .
<Vinca_alkaloid> <Subsumes> "Vinflunine" .
<Vinca_alkaloid> <Subsumes> "Vindesine" .
<Vinca_alkaloid> <Subsumes> "Vincristine_liposomal" .
<Vinca_alkaloid> <Subsumes> "Vincristine" .
<Vinca_alkaloid> <Subsumes> "Vinblastine" .
<CHVmP-VB> <Mapped_from> "CHVmP-VB" .
<Mercaptopurine_and_Prednisone> <Maps_to> "Mercaptopurine_and_Prednisone" .
<Crivosin> <Brand_name_of> "Vincristine" .
<Breast_cancer> <FDA_indication_of> "Trastuzumab-qyyp" .
<Breast_cancer> <FDA_indication_of> "Trastuzumab-pkrb" .
<Breast_cancer> <FDA_indication_of> "Trastuzumab-dttb" .
<Breast_cancer> <FDA_indication_of> "Trastuzumab-dkst" .
<Breast_cancer> <FDA_indication_of> "Trastuzumab-anns" .
<Breast_cancer> <FDA_indication_of> "Trastuzumab_and_hyaluronidase" .
<Breast_cancer> <FDA_indication_of> "Trastuzumab" .
<Breast_cancer> <FDA_indication_of> "Toremifene" .
<Breast_cancer> <FDA_indication_of> "Tamoxifen" .
<Breast_cancer> <FDA_indication_of> "Talazoparib" .
<Breast_cancer> <FDA_indication_of> "Ribociclib" .
<Breast_cancer> <FDA_indication_of> "Pertuzumab" .
<Breast_cancer> <FDA_indication_of> "Palbociclib" .
<Breast_cancer> <FDA_indication_of> "Paclitaxel_nanoparticle_albumin-bound" .
<Breast_cancer> <FDA_indication_of> "Paclitaxel" .
<Breast_cancer> <FDA_indication_of> "Olaparib" .
<Breast_cancer> <FDA_indication_of> "Neratinib" .
<Breast_cancer> <FDA_indication_of> "Letrozole" .
<Breast_cancer> <FDA_indication_of> "Lapatinib" .
<Breast_cancer> <FDA_indication_of> "Ixabepilone" .
<Breast_cancer> <FDA_indication_of> "Gemcitabine" .
<Breast_cancer> <FDA_indication_of> "Fulvestrant" .
<Breast_cancer> <FDA_indication_of> "Fam-trastuzumab_deruxtecan" .
<Breast_cancer> <FDA_indication_of> "Exemestane" .
<Breast_cancer> <FDA_indication_of> "Everolimus" .
<Breast_cancer> <FDA_indication_of> "Eribulin" .
<Breast_cancer> <FDA_indication_of> "Epirubicin" .
<Breast_cancer> <FDA_indication_of> "Doxorubicin" .
<Breast_cancer> <FDA_indication_of> "Docetaxel" .
<Breast_cancer> <FDA_indication_of> "Cyclophosphamide" .
<Breast_cancer> <FDA_indication_of> "Capecitabine" .
<Breast_cancer> <FDA_indication_of> "Bevacizumab" .
<Breast_cancer> <FDA_indication_of> "Atezolizumab" .
<Breast_cancer> <FDA_indication_of> "Anastrozole" .
<Breast_cancer> <FDA_indication_of> "Alpelisib" .
<Breast_cancer> <FDA_indication_of> "Ado-trastuzumab_emtansine" .
<Breast_cancer> <FDA_indication_of> "Abemaciclib" .
<Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone> <Maps_to> "Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone" .
<Minimax> <Brand_name_of> "Aspirin" .
<R-miniCHOP> <Has_context> "Induction_therapy" .
<Abatoarin> <Brand_name_of> "Tropisetron" .
<Carboplatin_and_nab-Paclitaxel> <Is_current_in> "Non-small_cell_lung_cancer" .
<Carboplatin_and_nab-Paclitaxel> <Is_current_in> "Melanoma" .
<Carboplatin_and_nab-Paclitaxel> <Is_current_in> "Breast_cancer" .
<TC,_then_IE,_VDoxoC,_VEC> <Mapped_from> "TC,_then_IE,_VDoxoC,_VEC" .
<VIDE> <Mapped_from> "VIDE" .
<PI3K_alpha_inhibitor> <Subsumes> "Pictilisib" .
<PI3K_alpha_inhibitor> <Subsumes> "Copanlisib" .
<Docetaxel_and_Vinorelbine> <Maps_to> "Docetaxel_and_Vinorelbine" .
<Nivolumab_monotherapy> <Has_antineoplastic> "Nivolumab" .
<Zenaspirin> <Brand_name_of> "Aspirin" .
<Samarium-153_with_stem_cell_support> <Maps_to> "Samarium-153_with_stem_cell_support" .
<Sterasone> <Brand_name_of> "Dexamethasone" .
<CPX-351_monotherapy> <Is_a> "Anthracycline-containing_regimen" .
<Carbidu> <Brand_name_of> "Dexamethasone" .
<ABDIC> <Has_context> "Salvage_therapy" .
<Gastrointestinal_stromal_tumor> <Accepted_use_of> "Sunitinib_monotherapy" .
<Gastrointestinal_stromal_tumor> <Accepted_use_of> "Sunitinib" .
<Gastrointestinal_stromal_tumor> <Accepted_use_of> "Sorafenib_monotherapy" .
<Gastrointestinal_stromal_tumor> <Accepted_use_of> "Regorafenib_monotherapy" .
<Gastrointestinal_stromal_tumor> <Accepted_use_of> "Regorafenib" .
<Gastrointestinal_stromal_tumor> <Accepted_use_of> "Placebo" .
<Gastrointestinal_stromal_tumor> <Accepted_use_of> "Pazopanib_monotherapy" .
<Gastrointestinal_stromal_tumor> <Accepted_use_of> "Pazopanib" .
<Gastrointestinal_stromal_tumor> <Accepted_use_of> "Imatinib_monotherapy" .
<Gastrointestinal_stromal_tumor> <Accepted_use_of> "Imatinib" .
<Gastrointestinal_stromal_tumor> <Accepted_use_of> "Best_supportive_care" .
<Gastrointestinal_stromal_tumor> <Accepted_use_of> "Avapritinib_monotherapy" .
<Gastrointestinal_stromal_tumor> <Accepted_use_of> "Avapritinib" .
<PUVA> <Has_antineoplastic> "Methoxsalen" .
<PEV> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Bevacizumab-bvzr> <Has_accepted_use> "Vascular_sarcoma" .
<Bevacizumab-bvzr> <Has_accepted_use> "Testicular_cancer" .
<Bevacizumab-bvzr> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Bevacizumab-bvzr> <Has_accepted_use> "Small_cell_lung_cancer" .
<Bevacizumab-bvzr> <Has_accepted_use> "Renal_cell_carcinoma" .
<Bevacizumab-bvzr> <Has_accepted_use> "Pancreatic_NET" .
<Bevacizumab-bvzr> <Has_accepted_use> "Ovarian_cancer" .
<Bevacizumab-bvzr> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Bevacizumab-bvzr> <Has_accepted_use> "Neuroendocrine_tumor" .
<Bevacizumab-bvzr> <Has_accepted_use> "Mesothelioma" .
<Bevacizumab-bvzr> <Has_accepted_use> "Melanoma" .
<Bevacizumab-bvzr> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Bevacizumab-bvzr> <Has_accepted_use> "Glioblastoma" .
<Bevacizumab-bvzr> <Has_accepted_use> "Follicular_lymphoma" .
<Bevacizumab-bvzr> <Has_accepted_use> "Esophageal_cancer" .
<Bevacizumab-bvzr> <Has_accepted_use> "Endometrial_cancer" .
<Bevacizumab-bvzr> <Has_accepted_use> "Colon_cancer" .
<Bevacizumab-bvzr> <Has_accepted_use> "Cholangiocarcinoma" .
<Bevacizumab-bvzr> <Has_accepted_use> "Cervical_cancer" .
<Bevacizumab-bvzr> <Has_accepted_use> "Breast_cancer" .
<Bevacizumab-bvzr> <Has_accepted_use> "Anaplastic_glioma" .
<Bevacizumab-bvzr> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<A-AVD> <Is_current_in> "Hodgkin_lymphoma" .
<Forodesine> <Has_brand_name> "Mundesine" .
<Forodesine> <Has_brand_name> "Fodosine" .
<Hybin> <Brand_name_of> "Aspirin" .
<Atomexin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<ABCP> <Is_current_in> "Non-small_cell_lung_cancer" .
<FOLFOX_7/sLV5FU2_(L-Leucovorin)> <Has_antineoplastic> "Oxaliplatin" .
<FOLFOX_7/sLV5FU2_(L-Leucovorin)> <Has_antineoplastic> "Levoleucovorin" .
<FOLFOX_7/sLV5FU2_(L-Leucovorin)> <Has_antineoplastic> "Fluorouracil" .
<Bendamustine_and_Ofatumumab> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Bendamustine_and_Ofatumumab> <Has_supportive_med> "Rasburicase" .
<Bendamustine_and_Ofatumumab> <Has_supportive_med> "Methylprednisolone" .
<Bendamustine_and_Ofatumumab> <Has_supportive_med> "Diphenhydramine" .
<Bendamustine_and_Ofatumumab> <Has_supportive_med> "Allopurinol" .
<Bendamustine_and_Ofatumumab> <Has_supportive_med> "Acyclovir" .
<Bendamustine_and_Ofatumumab> <Has_supportive_med> "Acetaminophen" .
<Pegylated_liposomal_doxorubicin> <Is_a> "Topoisomerase_inhibitor" .
<Pegylated_liposomal_doxorubicin> <Is_a> "Pegylated_medication" .
<Pegylated_liposomal_doxorubicin> <Is_a> "Liposomal_chemotherapy" .
<Pegylated_liposomal_doxorubicin> <Is_a> "Irritant" .
<Pegylated_liposomal_doxorubicin> <Is_a> "Anthracycline" .
<Somatuline_Depot> <Brand_name_of> "Lanreotide" .
<PAD/VCD> <Has_accepted_use> "Plasma_cell_leukemia" .
<ATRA_and_Daunorubicin> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Cisplatin,_Dacarbazine,_Tamoxifen> <Has_modality> "Hormonotherapy" .
<Cisplatin,_Dacarbazine,_Tamoxifen> <Has_modality> "Chemotherapy" .
<Removab> <Brand_name_of> "Catumaxomab" .
<Dacarbazine_and_Interferon_alfa-2a> <Has_accepted_use> "Melanoma" .
<IT_Cytarabine,_Methotrexate,_WBRT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Reblozyl> <Brand_name_of> "Luspatercept" .
<Fludarabine,_then_131Iodine-Tositumomab> <Is_historical_in> "Follicular_lymphoma" .
<Fotemustine_monotherapy> <Has_antineoplastic> "Fotemustine" .
<ACH> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<ACH> <Has_accepted_use> "Breast_cancer" .
<Tagraxofusp_monotherapy> <Has_accepted_use> "Blastic_plasmacytoid_dendritic_cell_neoplasm" .
<Cisplatin_and_Irinotecan> <Is_a> "Platinum_doublet" .
<Cisplatin_and_Irinotecan> <Is_a> "Irinotecan-containing_regimen" .
<Doxycycline_monotherapy> <Maps_to> "Doxycycline_monotherapy" .
<Pralatrexate> <Antineoplastic_of> "Pralatrexate_monotherapy" .
<Pralatrexate> <Antineoplastic_of> "Bexarotene_and_Pralatrexate" .
<CHVP> <Maps_to> "CHVP" .
<Doxorubin> <Brand_name_of> "Doxorubicin" .
<Chronic_lymphocytic_leukemia> <FDA_indication_of> "Venetoclax" .
<Chronic_lymphocytic_leukemia> <FDA_indication_of> "Rituximab-pvvr" .
<Chronic_lymphocytic_leukemia> <FDA_indication_of> "Rituximab_and_hyaluronidase_human" .
<Chronic_lymphocytic_leukemia> <FDA_indication_of> "Rituximab" .
<Chronic_lymphocytic_leukemia> <FDA_indication_of> "Ofatumumab" .
<Chronic_lymphocytic_leukemia> <FDA_indication_of> "Obinutuzumab" .
<Chronic_lymphocytic_leukemia> <FDA_indication_of> "Idelalisib" .
<Chronic_lymphocytic_leukemia> <FDA_indication_of> "Ibrutinib" .
<Chronic_lymphocytic_leukemia> <FDA_indication_of> "Fludarabine" .
<Chronic_lymphocytic_leukemia> <FDA_indication_of> "Duvelisib" .
<Chronic_lymphocytic_leukemia> <FDA_indication_of> "Cyclophosphamide" .
<Chronic_lymphocytic_leukemia> <FDA_indication_of> "Bendamustine" .
<Chronic_lymphocytic_leukemia> <FDA_indication_of> "Alvocidib" .
<Chronic_lymphocytic_leukemia> <FDA_indication_of> "Alemtuzumab" .
<Chronic_lymphocytic_leukemia> <FDA_indication_of> "Acalabrutinib" .
<Altretamine> <Is_a> "Alkylating_agent" .
<VEPA> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Uracil_mustard_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Forodesine_monotherapy> <Maps_to> "Forodesine_monotherapy" .
<VAD_and_Cyclosporine> <Maps_to> "VAD_and_Cyclosporine" .
<Fluorouracil_and_Semustine> <Has_modality> "Chemotherapy" .
<Oophorectomy> <Has_antineoplastic> "Endocrine_ablation_surgery" .
<BR> <Mapped_from> "BR" .
<CAPIRI-Bev> <Has_modality> "Chemotherapy" .
<CVAD> <Has_supportive_med> "Zoledronic_acid" .
<CVAD> <Has_supportive_med> "Clodronate" .
<FC> <Has_antineoplastic> "Fludarabine" .
<FC> <Has_antineoplastic> "Cyclophosphamide" .
<Dinutuximab> <Is_a> "Antibody_medication" .
<Dinutuximab> <Is_a> "Anti-GD2_antibody" .
<Clofarabine_monotherapy> <Has_modality> "Chemotherapy" .
<M-Moxa> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Gilteritinib> <Has_FDA_indication> "Acute_myeloid_leukemia" .
<G-CVP> <Has_antineoplastic> "Vincristine" .
<G-CVP> <Has_antineoplastic> "Prednisone" .
<G-CVP> <Has_antineoplastic> "Obinutuzumab" .
<G-CVP> <Has_antineoplastic> "Cyclophosphamide" .
<Ribone> <Brand_name_of> "Risedronate" .
<Mercaptopurine_and_Methotrexate> <Has_accepted_use> "Gestational_trophoblastic_neoplasia" .
<Mercaptopurine_and_Methotrexate> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Mercaptopurine_and_Methotrexate> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Dacomitinib> <Is_a> "Mutation-specific_medication" .
<Dacomitinib> <Is_a> "Kinase_inhibitor" .
<Dacomitinib> <Is_a> "EGFR_inhibitor" .
<Etoposide,_Vinblastine,_Prednisone> <Maps_to> "Etoposide,_Vinblastine,_Prednisone" .
<BiRd> <Has_modality> "Chemotherapy" .
<Talazoparib> <Antineoplastic_of> "Talazoparib_monotherapy" .
<Warm_autoimmune_hemolytic_anemia> <Is_a> "Hemolytic_process" .
<Warm_autoimmune_hemolytic_anemia> <Is_a> "Autoimmune_hematologic_condition" .
<Thymogam> <Brand_name_of> "Antithymocyte_globulin_horse_ATG" .
<FOLFOX> <Has_antineoplastic> "Oxaliplatin" .
<FOLFOX> <Has_antineoplastic> "Folinic_acid" .
<FOLFOX> <Has_antineoplastic> "Fluorouracil" .
<VDC/IE> <Is_current_in> "Ewing_sarcoma" .
<MyeloSar> <Brand_name_of> "Lenalidomide" .
<ddAC-T> <Has_accepted_use> "Breast_cancer" .
<Afatinib_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Afatinib_monotherapy> <Has_accepted_use> "Head_and_neck_cancer" .
<Afatinib_monotherapy> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<Afatinib_monotherapy> <Has_accepted_use> "CNS_carcinoma" .
<Lenalidomide_and_Rituximab> <Has_antineoplastic> "Rituximab" .
<Lenalidomide_and_Rituximab> <Has_antineoplastic> "Lenalidomide" .
<Variopeptyl> <Brand_name_of> "Triptorelin" .
<CapeOx_and_Panitumumab> <Has_modality> "Chemotherapy" .
<Dexahexal> <Brand_name_of> "Dexamethasone" .
<Axicabtagene_ciloleucel> <Is_a> "REMS_program" .
<Axicabtagene_ciloleucel> <Is_a> "FDA_approved_drug" .
<Axicabtagene_ciloleucel> <Is_a> "Chimeric_antigen_receptor_T-cell" .
<Idarubicin> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Idarubicin> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Idarubicin> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Blenoxane> <Brand_name_of> "Bleomycin" .
<Paclitaxel_monotherapy> <Mapped_from> "Paclitaxel_monotherapy" .
<Prograf> <Brand_name_of> "Tacrolimus" .
<Docetaxel_and_Gemcitabine> <Has_modality> "Chemotherapy" .
<CALGB_8811_early_intensification> <Mapped_from> "CALGB_8811_early_intensification" .
<BR_and_Ibrutinib> <Has_antineoplastic> "Rituximab" .
<BR_and_Ibrutinib> <Has_antineoplastic> "Ibrutinib" .
<BR_and_Ibrutinib> <Has_antineoplastic> "Bendamustine" .
<Enfortumab_vedotin_monotherapy> <Is_current_in> "Bladder_cancer" .
<Mitotax> <Brand_name_of> "Paclitaxel" .
<Lenalidomide,_Dexamethasone,_Rituximab> <Has_modality> "Chemotherapy" .
<Lomustine_and_Bevacizumab> <Has_accepted_use> "Glioblastoma" .
<TIP> <Maps_to> "TIP" .
<Daunorubicin_liposomal_monotherapy> <Maps_to> "Daunorubicin_liposomal_monotherapy" .
<RT,_then_Carmustine> <Has_accepted_use> "Anaplastic_glioma" .
<Anastrozole_and_Goserelin> <Has_modality> "Hormonotherapy" .
<Bestofens> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Caspofungin> <Has_brand_name> "Wofungin" .
<Caspofungin> <Has_brand_name> "Profung" .
<Caspofungin> <Has_brand_name> "Letocan" .
<Caspofungin> <Has_brand_name> "Kabifungin" .
<Caspofungin> <Has_brand_name> "Guficap" .
<Caspofungin> <Has_brand_name> "Casponova" .
<Caspofungin> <Has_brand_name> "Caspoliv" .
<Caspofungin> <Has_brand_name> "Caspogin" .
<Caspofungin> <Has_brand_name> "Capsain" .
<Caspofungin> <Has_brand_name> "Cancidas" .
<Caspofungin> <Has_brand_name> "Cagin" .
<Tandem_melphalan,_then_auto_HSCT> <Has_antineoplastic> "Melphalan" .
<BuFlu,_then_allo_HSCT> <Has_accepted_use> "Acute_myeloid_leukemia" .
<VEBEP> <Mapped_from> "VEBEP" .
<Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT> <Has_accepted_use> "Multiple_myeloma" .
<Comax> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<7_plus_3m> <Mapped_from> "7_plus_3m" .
<CHOP-BCG> <Has_context> "Induction_therapy" .
<Oxaliplatin_and_Bevacizumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<mFOLFOX6_and_Bevacizumab> <Is_historical_in> "Colon_cancer" .
<TBI> <Is_current_in> "Autologous_HSCT" .
<Atezolizumab_monotherapy> <Maps_to> "Atezolizumab_monotherapy" .
<Tivozanib> <May_have_route> "Oral" .
<Luspatercept_monotherapy> <Mapped_from> "Luspatercept_monotherapy" .
<GVP> <Has_context> "Non-curative_therapy" .
<Carboplatin,_Paclitaxel,_RT> <Mapped_from> "Carboplatin,_Paclitaxel,_RT" .
<Goserelin_and_RT> <Maps_to> "Goserelin_and_RT" .
<Ifosfamide_and_Paclitaxel> <Has_modality> "Chemotherapy" .
<Necitumumab> <Has_brand_name> "Portrazza" .
<FUOX> <Maps_to> "FUOX" .
<Izofran> <Brand_name_of> "Ondansetron" .
<FOLFIRI_and_Panitumumab> <Is_current_in> "Colon_cancer" .
<Fostamatinib> <Antineoplastic_of> "Fostamatinib_monotherapy" .
<Di-Adreson-F> <Brand_name_of> "Prednisolone" .
<Durvalumab> <Has_brand_name> "Imfinzi" .
<FGFR_inhibitor> <Is_a> "Kinase_inhibitor" .
<FGFR_inhibitor> <Is_a> "Growth_factor_inhibitor" .
<Irinotecan-containing_regimen> <Subsumes> "mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)" .
<Irinotecan-containing_regimen> <Subsumes> "mFOLFIRINOX,_Gemcitabine,_RT" .
<Irinotecan-containing_regimen> <Subsumes> "mFOLFIRINOX" .
<Irinotecan-containing_regimen> <Subsumes> "VI,_then_VDC/IE,_then_VAC,_then_VI" .
<Irinotecan-containing_regimen> <Subsumes> "Irinotecan,_Vemurafenib,_Cetuximab" .
<Irinotecan-containing_regimen> <Subsumes> "Irinotecan,_Temozolomide,_Dinutuximab" .
<Irinotecan-containing_regimen> <Subsumes> "Irinotecan_monotherapy" .
<Irinotecan-containing_regimen> <Subsumes> "Irinotecan_liposomal_monotherapy" .
<Irinotecan-containing_regimen> <Subsumes> "Irinotecan_and_Temozolomide" .
<Irinotecan-containing_regimen> <Subsumes> "Irinotecan_and_S-1" .
<Irinotecan-containing_regimen> <Subsumes> "Irinotecan_and_Mitomycin" .
<Irinotecan-containing_regimen> <Subsumes> "Irinotecan_and_Cetuximab" .
<Irinotecan-containing_regimen> <Subsumes> "Irinotecan_and_Bevacizumab" .
<Irinotecan-containing_regimen> <Subsumes> "IROX" .
<Irinotecan-containing_regimen> <Subsumes> "IRIS_and_Bevacizumab" .
<Irinotecan-containing_regimen> <Subsumes> "IRIS" .
<Irinotecan-containing_regimen> <Subsumes> "IFL_and_Bevacizumab" .
<Irinotecan-containing_regimen> <Subsumes> "IFL" .
<Irinotecan-containing_regimen> <Subsumes> "Gemcitabine_and_Irinotecan" .
<Irinotecan-containing_regimen> <Subsumes> "Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan" .
<Irinotecan-containing_regimen> <Subsumes> "FUIRI" .
<Irinotecan-containing_regimen> <Subsumes> "FOLFOXIRI_and_Panitumumab" .
<Irinotecan-containing_regimen> <Subsumes> "FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation" .
<Irinotecan-containing_regimen> <Subsumes> "FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)" .
<Irinotecan-containing_regimen> <Subsumes> "FOLFIRINOX" .
<Irinotecan-containing_regimen> <Subsumes> "FOLFIRI_and_Ziv-aflibercept" .
<Irinotecan-containing_regimen> <Subsumes> "FOLFIRI_and_Ramucirumab" .
<Irinotecan-containing_regimen> <Subsumes> "FOLFIRI_and_Panitumumab" .
<Irinotecan-containing_regimen> <Subsumes> "FOLFIRI_and_Cetuximab_(L-Leucovorin)" .
<Irinotecan-containing_regimen> <Subsumes> "FOLFIRI_and_Cetuximab" .
<Irinotecan-containing_regimen> <Subsumes> "FOLFIRI_and_Bevacizumab_(L-Leucovorin)" .
<Irinotecan-containing_regimen> <Subsumes> "FOLFIRI_and_Bevacizumab" .
<Irinotecan-containing_regimen> <Subsumes> "FOLFIRI_(L-Leucovorin)" .
<Irinotecan-containing_regimen> <Subsumes> "FOLFIRI" .
<Irinotecan-containing_regimen> <Subsumes> "Docetaxel_and_Irinotecan" .
<Irinotecan-containing_regimen> <Subsumes> "Cisplatin,_Irinotecan,_RT" .
<Irinotecan-containing_regimen> <Subsumes> "Cisplatin,_Etoposide,_Irinotecan" .
<Irinotecan-containing_regimen> <Subsumes> "Cisplatin_and_Irinotecan" .
<Irinotecan-containing_regimen> <Subsumes> "Carboplatin_and_Irinotecan" .
<Irinotecan-containing_regimen> <Subsumes> "CAPIRI-Bev" .
<Irinotecan-containing_regimen> <Subsumes> "CAPIRI" .
<Aminoglutethimide_monotherapy> <Is_a> "Antiestrogen-containing_regimen" .
<Belinostat_monotherapy> <Mapped_from> "Belinostat_monotherapy" .
<dmCODOX-M_-_Modified_Magrath> <Has_supportive_med> "Rasburicase" .
<dmCODOX-M_-_Modified_Magrath> <Has_supportive_med> "Folinic_acid" .
<dmCODOX-M_-_Modified_Magrath> <Has_supportive_med> "Filgrastim" .
<dmCODOX-M_-_Modified_Magrath> <Has_supportive_med> "Allopurinol" .
<Benzodiazepine> <Subsumes> "Lorazepam" .
<Benzodiazepine> <Subsumes> "Clonazepam" .
<Benzodiazepine> <Subsumes> "Alprazolam" .
<Biotran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Leotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<mFOLFOX6_and_Cetuximab> <Has_antineoplastic> "Oxaliplatin" .
<mFOLFOX6_and_Cetuximab> <Has_antineoplastic> "Folinic_acid" .
<mFOLFOX6_and_Cetuximab> <Has_antineoplastic> "Fluorouracil" .
<mFOLFOX6_and_Cetuximab> <Has_antineoplastic> "Cetuximab" .
<Tranofast> <Brand_name_of> "Tranexamic_acid" .
<Suprasulf> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Vinelbine> <Brand_name_of> "Vinorelbine" .
<Amoxicillin> <Has_brand_name> "Biomox" .
<Amoxicillin> <Has_brand_name> "Amoxil" .
<Amoxicillin> <Has_brand_name> "Amoxihexal" .
<Amoxicillin> <Has_brand_name> "Amoxi" .
<Dexamethasonum> <Brand_name_of> "Dexamethasone" .
<Busulfan_and_Cyclophosphamide> <Is_current_in> "Autologous_HSCT" .
<Busulfan_and_Cyclophosphamide> <Is_current_in> "Allogeneic_HSCT" .
<VBMCP> <Has_accepted_use> "Multiple_myeloma" .
<Rubraca> <Brand_name_of> "Rucaparib" .
<Methotrexate_monotherapy> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<Meperidine> <Has_brand_name> "Demerol" .
<Durvalumab_monotherapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<Durvalumab_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Durvalumab_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<Metaxon> <Brand_name_of> "Dexamethasone" .
<Alemtuzumab_and_Rituximab> <Is_a> "Rituximab-containing_regimen" .
<Dextason> <Brand_name_of> "Dexamethasone" .
<Kanadex> <Brand_name_of> "Dexamethasone" .
<Capecitabine_and_Ixabepilone> <Has_modality> "Chemotherapy" .
<Lusaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<VCAP> <Has_modality> "Chemotherapy" .
<TXK_inhibitor> <Is_a> "Kinase_inhibitor" .
<Anastrozole_monotherapy> <Has_supportive_med> "Goserelin" .
<Emivox> <Brand_name_of> "Ondansetron" .
<Topotecan> <Has_brand_name> "Topotec" .
<Topotecan> <Has_brand_name> "Topecan" .
<Topotecan> <Has_brand_name> "Hycamtin" .
<Matrex> <Brand_name_of> "Methotrexate" .
<CVPP> <Has_modality> "Chemotherapy" .
<Alendrin> <Brand_name_of> "Alendronate" .
<Crisabon> <Brand_name_of> "Epirubicin" .
<TCHP_(Taxol)> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<TCHP_(Taxol)> <Has_accepted_use> "Breast_cancer" .
<Indoga> <Brand_name_of> "Indomethacin" .
<OPPA> <Has_context> "Induction_therapy" .
<Cortef> <Brand_name_of> "Hydrocortisone" .
<Capecitabine,_Pertuzumab,_Trastuzumab> <Maps_to> "Capecitabine,_Pertuzumab,_Trastuzumab" .
<FOLFIRI_and_Bevacizumab> <Is_a> "Irinotecan-containing_regimen" .
<FOLFIRI_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Gemcitabine_and_Irinotecan> <Is_a> "Irinotecan-containing_regimen" .
<Antiandrogen_withdrawal> <Has_accepted_use> "Prostate_cancer" .
<DexaBEAM> <Has_modality> "Chemotherapy" .
<Kotrimoksazol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Isolone> <Brand_name_of> "Prednisone" .
<Imatinib_monotherapy> <Maps_to> "Imatinib_monotherapy" .
<Oropharyngeal_cancer> <Current_treated_by> "Cisplatin_and_RT" .
<Coxatin> <Brand_name_of> "Oxaliplatin" .
<FELV> <Has_context> "Non-curative_therapy" .
<ddEC> <Mapped_from> "ddEC" .
<PCDE> <Has_antineoplastic> "Etoposide" .
<PCDE> <Has_antineoplastic> "Epirubicin" .
<PCDE> <Has_antineoplastic> "Cyclophosphamide" .
<PCDE> <Has_antineoplastic> "Cisplatin" .
<Kemodoxa> <Brand_name_of> "Doxorubicin" .
<Suptrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Pediatric-like_GRAALL_consolidation> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Doxorubicin,_Ifosfamide,_RT> <Has_modality> "Radiotherapy" .
<Doxorubicin,_Ifosfamide,_RT> <Has_modality> "Chemotherapy" .
<EMA_approved_drug> <Subsumes> "Vinflunine" .
<EMA_approved_drug> <Subsumes> "Tropisetron" .
<EMA_approved_drug> <Subsumes> "Tegafur_gimeracil_oteracil" .
<EMA_approved_drug> <Subsumes> "Raltitrexed" .
<EMA_approved_drug> <Subsumes> "Pembrolizumab" .
<EMA_approved_drug> <Subsumes> "Non-pegylated_liposomal_doxorubicin" .
<EMA_approved_drug> <Subsumes> "Nintedanib" .
<EMA_approved_drug> <Subsumes> "Midostaurin" .
<EMA_approved_drug> <Subsumes> "Lenograstim" .
<EMA_approved_drug> <Subsumes> "Fotemustine" .
<EMA_approved_drug> <Subsumes> "Edrecolomab" .
<EMA_approved_drug> <Subsumes> "Drugs_EMA_approved_in_the_21st_century" .
<EMA_approved_drug> <Subsumes> "Catumaxomab" .
<MCF> <Has_context> "Non-curative_first-line_therapy" .
<MOF> <Maps_to> "MOF" .
<Oxaliplatin_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<FAC_and_Bevacizumab> <Is_current_in> "Breast_cancer" .
<Cisplatin_and_Methotrexate> <Mapped_from> "Cisplatin_and_Methotrexate" .
<FEAM,_then_auto_HSCT> <Has_accepted_use> "Hodgkin_lymphoma" .
<FEAM,_then_auto_HSCT> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Actimid> <Brand_name_of> "Pomalidomide" .
<Mithracin> <Brand_name_of> "Plicamycin" .
<GnRH_antagonists> <Antineoplastic_of> "ADT_and_Enzalutamide" .
<GnRH_antagonists> <Antineoplastic_of> "ADT_and_Docetaxel" .
<GnRH_antagonists> <Antineoplastic_of> "ADT_and_Darolutamide" .
<GnRH_antagonists> <Antineoplastic_of> "ADT_and_Abiraterone" .
<GnRH_antagonists> <Antineoplastic_of> "ADT" .
<Carboplatin,_Docetaxel,_Prednisone> <Maps_to> "Carboplatin,_Docetaxel,_Prednisone" .
<Irinotecan_and_S-1> <Is_current_in> "Esophageal_cancer" .
<Uracil_mustard> <Is_a> "Discontinued_drug" .
<Uracil_mustard> <Is_a> "Alkylating_agent" .
<Hyper-CVAD_and_Imatinib> <Is_a> "Anthracycline-containing_regimen" .
<Aplastic_anemia> <Current_treated_by> "Eltrombopag_monotherapy" .
<Aplastic_anemia> <Current_treated_by> "Cyclosporine_monotherapy" .
<Aplastic_anemia> <Current_treated_by> "ATG_(Rabbit)_and_Cyclosporine" .
<Aplastic_anemia> <Current_treated_by> "ATG_(Horse),_Cyclosporine,_Sirolimus" .
<Aplastic_anemia> <Current_treated_by> "ATG_(Horse),_Cyclosporine,_Methylprednisolone" .
<Aplastic_anemia> <Current_treated_by> "ATG_(Horse),_Cyclosporine,_G-CSF" .
<Aplastic_anemia> <Current_treated_by> "ATG_(Horse),_Cyclosporine,_Eltrombopag" .
<Aplastic_anemia> <Current_treated_by> "ATG_(Horse)_and_Cyclosporine" .
<Plasma_exchange> <Has_context> "Induction_therapy" .
<ABP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<SMILE> <Is_current_in> "NK-_and_T-cell_lymphoma" .
<SMILE> <Is_current_in> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<ATRA_monotherapy> <Is_current_in> "Acute_promyelocytic_leukemia" .
<Trastuzumab> <Antineoplastic_of> "nab-Paclitaxel_and_Trastuzumab" .
<Trastuzumab> <Antineoplastic_of> "ddTH_(Taxotere)" .
<Trastuzumab> <Antineoplastic_of> "ddTH_(Taxol)" .
<Trastuzumab> <Antineoplastic_of> "VH" .
<Trastuzumab> <Antineoplastic_of> "Trastuzumab_monotherapy" .
<Trastuzumab> <Antineoplastic_of> "Trastuzumab_and_ET" .
<Trastuzumab> <Antineoplastic_of> "TPC" .
<Trastuzumab> <Antineoplastic_of> "THP_(Taxotere)" .
<Trastuzumab> <Antineoplastic_of> "THP_(Taxol)" .
<Trastuzumab> <Antineoplastic_of> "THL_(Taxol)" .
<Trastuzumab> <Antineoplastic_of> "TH_(Taxotere)" .
<Trastuzumab> <Antineoplastic_of> "TH_(Taxol)" .
<Trastuzumab> <Antineoplastic_of> "TCHP_(Taxotere)" .
<Trastuzumab> <Antineoplastic_of> "TCHP_(Taxol)" .
<Trastuzumab> <Antineoplastic_of> "TCH_(Taxotere,_Cyclophosphamide)" .
<Trastuzumab> <Antineoplastic_of> "TCH_(Taxotere,_Carboplatin)" .
<Trastuzumab> <Antineoplastic_of> "Pertuzumab_and_Trastuzumab" .
<Trastuzumab> <Antineoplastic_of> "Lapatinib,_Letrozole,_Trastuzumab" .
<Trastuzumab> <Antineoplastic_of> "Lapatinib_and_Trastuzumab" .
<Trastuzumab> <Antineoplastic_of> "Gemcitabine_and_Trastuzumab" .
<Trastuzumab> <Antineoplastic_of> "FEC_and_H" .
<Trastuzumab> <Antineoplastic_of> "ECH" .
<Trastuzumab> <Antineoplastic_of> "Capecitabine,_Pertuzumab,_Trastuzumab" .
<Trastuzumab> <Antineoplastic_of> "Capecitabine,_Bevacizumab,_Trastuzumab" .
<Trastuzumab> <Antineoplastic_of> "Capecitabine_and_Trastuzumab" .
<Trastuzumab> <Antineoplastic_of> "CX_and_Trastuzumab" .
<Trastuzumab> <Antineoplastic_of> "CF_and_Trastuzumab" .
<Trastuzumab> <Antineoplastic_of> "Anastrozole_and_Trastuzumab" .
<Trastuzumab> <Antineoplastic_of> "ACH" .
<ERBB2_(HER2)_medication> <Is_a> "Site-agnostic_medication" .
<Plerixafor_and_G-CSF> <Maps_to> "Plerixafor_and_G-CSF" .
<LEED,_then_auto_HSCT> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Naurif> <Brand_name_of> "Granisetron" .
<EPIC_regimen> <Mapped_from> "EPIC_regimen" .
<FAS> <Has_accepted_use> "Pancreatic_NET" .
<Sultrex> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Melphalan,_then_auto_HSCT,_then_Melphalan_and_Busulfan,_then_auto_HSCT> <Mapped_from> "Melphalan,_then_auto_HSCT,_then_Melphalan_and_Busulfan,_then_auto_HSCT" .
<Axitinib_monotherapy> <Is_current_in> "Thyroid_cancer" .
<Axitinib_monotherapy> <Is_current_in> "Renal_cell_carcinoma" .
<Etoposide_and_TBI> <Mapped_from> "Etoposide_and_TBI" .
<V-HyperCAD> <Has_context> "Non-curative_therapy" .
<BCG_and_Dacarbazine> <Has_context> "Non-curative_therapy" .
<ddTH_(Taxol)> <Has_context> "Adjuvant_therapy" .
<Vincristine_liposomal> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Vincristine_liposomal> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Methotrexate_and_Rituximab> <Is_current_in> "CNS_lymphoma" .
<Alendromax> <Brand_name_of> "Alendronate" .
<Gemcitabine> <Has_brand_name> "Gemzar" .
<Gemcitabine> <Has_brand_name> "Gemcite" .
<Capecitabine/Capecitabine_and_RT> <Has_context> "Adjuvant_therapy" .
<iddEPC> <Is_a> "Anthracycline-containing_regimen" .
<Avancort> <Brand_name_of> "Methylprednisolone" .
<Fluorouracil,_Paclitaxel,_RT> <Has_context> "Neoadjuvant_therapy" .
<Fluorouracil,_Paclitaxel,_RT> <Has_context> "Definitive_therapy" .
<Metycortin> <Brand_name_of> "Methylprednisolone" .
<ABVD,_DD-DI> <Mapped_from> "ABVD,_DD-DI" .
<Bevacizumab_and_Rituximab> <Maps_to> "Bevacizumab_and_Rituximab" .
<R-CHOP-14> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Sirolimus_and_Vorinostat> <Has_modality> "Chemotherapy" .
<Tegafur_gimeracil_oteracil> <Antineoplastic_of> "SOX_and_Bevacizumab" .
<Tegafur_gimeracil_oteracil> <Antineoplastic_of> "SOX" .
<Tegafur_gimeracil_oteracil> <Antineoplastic_of> "S-1_monotherapy" .
<Tegafur_gimeracil_oteracil> <Antineoplastic_of> "Paclitaxel_and_S-1" .
<Tegafur_gimeracil_oteracil> <Antineoplastic_of> "Irinotecan_and_S-1" .
<Tegafur_gimeracil_oteracil> <Antineoplastic_of> "IRIS_and_Bevacizumab" .
<Tegafur_gimeracil_oteracil> <Antineoplastic_of> "IRIS" .
<Tegafur_gimeracil_oteracil> <Antineoplastic_of> "Gemcitabine,_Cisplatin,_S-1" .
<Tegafur_gimeracil_oteracil> <Antineoplastic_of> "Gemcitabine_and_S-1" .
<Tegafur_gimeracil_oteracil> <Antineoplastic_of> "Docetaxel_and_S-1" .
<Tegafur_gimeracil_oteracil> <Antineoplastic_of> "Cisplatin_and_S-1" .
<Coltuximab_ravtansine> <Is_a> "Microtubule_inhibitor" .
<Coltuximab_ravtansine> <Is_a> "Investigational_drug" .
<Coltuximab_ravtansine> <Is_a> "Immunotherapeutic" .
<Coltuximab_ravtansine> <Is_a> "Antibody-drug_conjugate" .
<Coltuximab_ravtansine> <Is_a> "Antibody_medication" .
<Coltuximab_ravtansine> <Is_a> "Anti-CD19_antibody" .
<R-CVP> <Has_modality> "Chemotherapy" .
<CAVE> <Is_a> "Anthracycline-containing_regimen" .
<Interferon_alfa-2a> <Has_accepted_use> "Renal_cell_carcinoma" .
<Interferon_alfa-2a> <Has_accepted_use> "Neuroendocrine_tumor" .
<Interferon_alfa-2a> <Has_accepted_use> "Melanoma" .
<Interferon_alfa-2a> <Has_accepted_use> "Kaposi_sarcoma" .
<Interferon_alfa-2a> <Has_accepted_use> "Hairy_cell_leukemia" .
<Interferon_alfa-2a> <Has_accepted_use> "Follicular_lymphoma" .
<Interferon_alfa-2a> <Has_accepted_use> "Cutaneous_squamous_cell_carcinoma" .
<Interferon_alfa-2a> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<mFOLFOX6_and_Bevacizumab_(L-Leucovorin)> <Mapped_from> "mFOLFOX6_and_Bevacizumab_(L-Leucovorin)" .
<C-MOPP/ABV> <Has_modality> "Chemotherapy" .
<AspaMetDex> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Nilutamide_and_Orchiectomy> <Maps_to> "Nilutamide_and_Orchiectomy" .
<GnRH_antagonist> <Is_a> "Endocrine_therapeutic" .
<VR-CAP> <Has_context> "Non-curative_first-line_therapy" .
<Temozolomide_and_Bevacizumab> <Is_current_in> "Pancreatic_NET" .
<Temozolomide_and_Bevacizumab> <Is_current_in> "Melanoma" .
<Ometic> <Brand_name_of> "Ondansetron" .
<Gefitinib_monotherapy> <Has_antineoplastic> "Gefitinib" .
<VAD_doxil> <Has_context> "Non-curative_first-line_therapy" .
<CHOP> <Is_historical_in> "Follicular_lymphoma" .
<CHOP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<CHOP> <Is_historical_in> "Chronic_lymphocytic_leukemia" .
<Mitomycin_monotherapy> <Mapped_from> "Mitomycin_monotherapy" .
<Paclitaxel_and_Vinorelbine> <Has_antineoplastic> "Vinorelbine" .
<Paclitaxel_and_Vinorelbine> <Has_antineoplastic> "Paclitaxel" .
<BiTE_antibody> <Is_a> "Bispecific_antibody_medication" .
<7_plus_3i_and_Panobinostat> <Is_historical_in> "Acute_myeloid_leukemia" .
<RiPAD_plus_C> <Mapped_from> "RiPAD_plus_C" .
<Lorbrena> <Brand_name_of> "Lorlatinib" .
<Clofarabine_and_LoDAC> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Cisplatin_and_Paclitaxel> <Maps_to> "Cisplatin_and_Paclitaxel" .
<Topmine> <Brand_name_of> "Dexchlorpheniramine" .
<ADE_and_ATRA> <Has_modality> "Chemotherapy" .
<Zoprin> <Brand_name_of> "Aspirin" .
<AALL0232_consolidation> <Maps_to> "AALL0232_consolidation" .
<BiTE_antibody> <Subsumes> "Catumaxomab" .
<BiTE_antibody> <Subsumes> "Blinatumomab" .
<BiTE_antibody> <Subsumes> "AMG_330" .
<Drilozole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Benralizumab_monotherapy> <Has_accepted_use> "Hypereosinophilic_syndrome" .
<Mistabron> <Brand_name_of> "Mesna" .
<VAdCA/IE> <Has_local_therapy> "External_beam_radiotherapy" .
<Prednilonga-Retard> <Brand_name_of> "Prednisone" .
<Drifen> <Brand_name_of> "Paclitaxel" .
<Idelalisib_and_Ofatumumab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<MA-BCD/AP> <Has_antineoplastic> "Methotrexate" .
<MA-BCD/AP> <Has_antineoplastic> "Doxorubicin" .
<MA-BCD/AP> <Has_antineoplastic> "Dactinomycin" .
<MA-BCD/AP> <Has_antineoplastic> "Cyclophosphamide" .
<MA-BCD/AP> <Has_antineoplastic> "Cisplatin" .
<MA-BCD/AP> <Has_antineoplastic> "Bleomycin" .
<Bendamustine_monotherapy> <Is_current_in> "Transformed_lymphoma" .
<Bendamustine_monotherapy> <Is_current_in> "T-cell_prolymphocytic_leukemia" .
<Bendamustine_monotherapy> <Is_current_in> "Small_cell_lung_cancer" .
<Bendamustine_monotherapy> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<Bendamustine_monotherapy> <Is_current_in> "Marginal_zone_lymphoma" .
<Bendamustine_monotherapy> <Is_current_in> "Hodgkin_lymphoma" .
<Bendamustine_monotherapy> <Is_current_in> "Follicular_lymphoma" .
<Bendamustine_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Bendamustine_monotherapy> <Is_current_in> "Cutaneous_T-cell_lymphoma" .
<Bendamustine_monotherapy> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Bendamustine_monotherapy> <Is_current_in> "Autologous_HSCT" .
<PI3K_gamma_inhibitor> <Is_a> "PI3K_inhibitor" .
<Glasdegib_and_LoDAC> <Has_modality> "Chemotherapy" .
<Decobel> <Brand_name_of> "Dexamethasone" .
<Intraperitoneal_hyperthermic_mitomycin> <Has_context> "Non-curative_therapy" .
<Carboplatin_and_Cisplatin> <Maps_to> "Carboplatin_and_Cisplatin" .
<Cetuximab> <Has_brand_name> "Erbitux" .
<Cetuximab> <Has_brand_name> "Cetuxim" .
<Cisplatin_and_Doxorubicin> <Is_current_in> "Osteosarcoma" .
<Cisplatin_and_Doxorubicin> <Is_current_in> "Hepatoblastoma" .
<Cisplatin_and_Doxorubicin> <Is_current_in> "Endometrial_cancer" .
<Cisplatin_and_Doxorubicin> <Is_current_in> "Cutaneous_squamous_cell_carcinoma" .
<Cisplatin_and_Doxorubicin> <Is_current_in> "Cutaneous_basal_cell_carcinoma" .
<Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine> <Mapped_from> "Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine" .
<Dacarba> <Brand_name_of> "Dacarbazine" .
<Porosin> <Brand_name_of> "Alendronate" .
<PEP-C> <Maps_to> "PEP-C" .
<Methotrexate_monotherapy> <Has_supportive_med> "Paclitaxel" .
<Methotrexate_monotherapy> <Has_supportive_med> "Folinic_acid" .
<Methotrexate_monotherapy> <Has_supportive_med> "Diphenhydramine" .
<Methotrexate_monotherapy> <Has_supportive_med> "Dexamethasone" .
<Methotrexate_monotherapy> <Has_supportive_med> "Cisplatin" .
<CABO> <Is_historical_in> "Head_and_neck_cancer" .
<Bondenza> <Brand_name_of> "Ibandronate" .
<Taycovit> <Brand_name_of> "Paclitaxel" .
<Lemblastine> <Brand_name_of> "Vinblastine" .
<R-GCVP> <Maps_to> "R-GCVP" .
<Factor_IX_recombinant> <Is_a> "Hematology_medication" .
<Factor_IX_recombinant> <Is_a> "Coagulation_factor" .
<MV> <Mapped_from> "MV" .
<BFR,_then_allo_HSCT> <Is_current_in> "Transformed_lymphoma" .
<BFR,_then_allo_HSCT> <Is_current_in> "Mantle_cell_lymphoma" .
<Cosmegen> <Brand_name_of> "Dactinomycin" .
<Carboplatin_and_Irinotecan> <Mapped_from> "Carboplatin_and_Irinotecan" .
<Chlorambucil_and_Prednisolone> <Has_accepted_use> "Breast_cancer" .
<Cytarabine_and_G-CSF> <Is_current_in> "Stem_cell_mobilization" .
<Dacarbazine_and_Ipilimumab> <Has_accepted_use> "Melanoma" .
<R-MPV> <Has_modality> "Chemotherapy" .
<Cyclophosphamide,_Etoposide,_TBI> <Has_modality> "Radiotherapy" .
<Cyclophosphamide,_Etoposide,_TBI> <Has_modality> "Chemotherapy" .
<Temozolomide_and_Thalidomide> <Mapped_from> "Temozolomide_and_Thalidomide" .
<Valacyclovir> <Has_brand_name> "Zelitrex" .
<Valacyclovir> <Has_brand_name> "Virval" .
<Valacyclovir> <Has_brand_name> "Valtrex" .
<Valacyclovir> <Has_brand_name> "Valcivir" .
<Valacyclovir> <Has_brand_name> "Talavir" .
<Enoxaparin> <Is_a> "Low_molecular_weight_heparin" .
<Enoxaparin> <Is_a> "Heparin" .
<Enoxaparin> <Is_a> "Anticoagulant" .
<Cytarabine_and_Idarubicin> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Cytarabine_and_Idarubicin> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Cytarabine_and_Idarubicin> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Atropine> <Is_a> "Supportive_medication" .
<Capecitabine,_Pertuzumab,_Trastuzumab> <Is_current_in> "Breast_cancer" .
<VMV-VAC> <Mapped_from> "VMV-VAC" .
<Vandetanib_monotherapy> <Maps_to> "Vandetanib_monotherapy" .
<Erlotinib_and_Ramucirumab> <Has_modality> "Chemotherapy" .
<KPD> <Maps_to> "KPD" .
<Anti-TRAIL-R1_antibody> <Is_a> "Antibody_medication" .
<Fluorouracil> <May_have_route> "Topical" .
<Fluorouracil> <May_have_route> "Intravenous" .
<Pacliteva> <Brand_name_of> "Paclitaxel" .
<Melphalan,_then_auto_HSCT> <Has_context> "Non-curative_second-line_consolidation_therapy" .
<Melphalan,_then_auto_HSCT> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<EAR_and_G-CSF> <Has_context> "All_lines_of_therapy" .
<Octreotide_and_Interferon_alfa> <Is_current_in> "Pancreatic_NET" .
<Octreotide_and_Interferon_alfa> <Is_current_in> "Neuroendocrine_tumor" .
<R-CVP> <Mapped_from> "R-CVP" .
<Nichospor> <Brand_name_of> "Alendronate" .
<Dipyridamole> <Supportive_med_of> "Plasma_exchange" .
<Nivolumab,_then_Ipilimumab> <Maps_to> "Nivolumab,_then_Ipilimumab" .
<Tocilizumab_monotherapy> <Has_context> "All_lines_of_therapy" .
<PGC> <Has_modality> "Chemotherapy" .
<CYKLONE> <Has_accepted_use> "Multiple_myeloma" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone> <Is_current_in> "T-cell_acute_lymphoblastic_leukemia" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Ticlopidine> <May_have_route> "Oral" .
<Metoclopramide> <Supportive_med_of> "Vinorelbine_monotherapy" .
<Metoclopramide> <Supportive_med_of> "Temozolomide_monotherapy" .
<Metoclopramide> <Supportive_med_of> "Temozolomide_and_RT" .
<Metoclopramide> <Supportive_med_of> "R-ESHAP" .
<Metoclopramide> <Supportive_med_of> "Paclitaxel_monotherapy" .
<Metoclopramide> <Supportive_med_of> "PCV" .
<Metoclopramide> <Supportive_med_of> "PAC" .
<Metoclopramide> <Supportive_med_of> "Mitotane_monotherapy" .
<Metoclopramide> <Supportive_med_of> "Fluorouracil_and_Levoleucovorin" .
<Metoclopramide> <Supportive_med_of> "Fluorouracil_and_Folinic_acid" .
<Metoclopramide> <Supportive_med_of> "Everolimus_monotherapy" .
<Metoclopramide> <Supportive_med_of> "ESHAP" .
<Metoclopramide> <Supportive_med_of> "Doxorubicin_pegylated_liposomal_and_Gemcitabine" .
<Metoclopramide> <Supportive_med_of> "DHAP" .
<Metoclopramide> <Supportive_med_of> "Cisplatin_and_Fluorouracil" .
<Metoclopramide> <Supportive_med_of> "Cisplatin_and_Etoposide" .
<Dactinomycin_and_Vincristine> <Maps_to> "Dactinomycin_and_Vincristine" .
<Nuruzole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Haloperidol> <Has_brand_name> "Trancodol" .
<Haloperidol> <Has_brand_name> "Serenace" .
<Haloperidol> <Has_brand_name> "Heloper" .
<Haloperidol> <Has_brand_name> "Haldol" .
<Delgesic> <Brand_name_of> "Aspirin" .
<TAM6> <Has_modality> "Radiotherapy" .
<TAM6> <Has_modality> "Chemotherapy" .
<Docetaxel_and_Nedaplatin> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Interferon_alfa-2a_monotherapy> <Has_modality> "Immunotherapy" .
<Carboplatin_and_Etoposide> <Mapped_from> "Carboplatin_and_Etoposide" .
<Decortancyl> <Brand_name_of> "Prednisone" .
<Capecitabine,_Bevacizumab,_Trastuzumab> <Is_a> "Bevacizumab-containing_regimen" .
<Prednisolone_and_Rituximab> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Prednisolone_and_Rituximab> <Has_supportive_med> "Erythrocyte_growth_factors" .
<Carmustine_and_Doxorubicin> <Maps_to> "Carmustine_and_Doxorubicin" .
<VMCP/VBAP> <Has_context> "Non-curative_first-line_therapy" .
<CTCb,_then_auto_HSCT> <Is_historical_in> "Breast_cancer" .
<Inotuzumab_ozogamicin> <May_have_route> "Intravenous" .
<Ifex> <Brand_name_of> "Ifosfamide" .
<Quizartinib_monotherapy> <Has_accepted_use> "FLT3-positive_Acute_myeloid_leukemia" .
<Quizartinib_monotherapy> <Has_accepted_use> "Acute_myeloid_leukemia" .
<CNOP_(Prednisolone)> <Maps_to> "CNOP_(Prednisolone)" .
<G-FC> <Has_supportive_med> "Steroids" .
<G-FC> <Has_supportive_med> "Rasburicase" .
<G-FC> <Has_supportive_med> "Prednisolone" .
<G-FC> <Has_supportive_med> "PCP_prophylaxis" .
<G-FC> <Has_supportive_med> "Diphenhydramine" .
<G-FC> <Has_supportive_med> "Antivirals" .
<G-FC> <Has_supportive_med> "Antihistamines" .
<G-FC> <Has_supportive_med> "Allopurinol" .
<G-FC> <Has_supportive_med> "Acetaminophen" .
<Paclitaxel_and_Topotecan> <Has_context> "Non-curative_first-line_therapy" .
<Nitrol> <Brand_name_of> "Mitoxantrone" .
<CEV_(Cyclophosphamide/Etoposide)> <Has_modality> "Chemotherapy" .
<Argatroban> <Supportive_med_of> "Argatroban_monotherapy" .
<Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone> <Has_antineoplastic> "Vinblastine" .
<Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone> <Has_antineoplastic> "Prednisolone" .
<Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone> <Has_antineoplastic> "Methotrexate" .
<Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone> <Has_antineoplastic> "Mercaptopurine" .
<Carboplatin> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Carboplatin> <Is_a> "Platinum_agent" .
<Carboplatin> <Is_a> "Irritant" .
<Carboplatin> <Is_a> "Cancer_of_unknown_primary_medication" .
<Carboplatin> <Is_a> "Alkylating_agent" .
<ROS1_inhibitor> <Is_a> "Kinase_inhibitor" .
<GPIIb-IIIa_inhibitor> <Subsumes> "Tirofiban" .
<GPIIb-IIIa_inhibitor> <Subsumes> "Eptifibatide" .
<GPIIb-IIIa_inhibitor> <Subsumes> "Abciximab" .
<VeIP> <Is_current_in> "Testicular_cancer" .
<Classical_hematologic_condition> <Subsumes> "Thrombotic_disorder" .
<Classical_hematologic_condition> <Subsumes> "Hemolytic_process" .
<Classical_hematologic_condition> <Subsumes> "Hemoglobinopathy" .
<Classical_hematologic_condition> <Subsumes> "Cytopenia" .
<Classical_hematologic_condition> <Subsumes> "Complementopathy" .
<Classical_hematologic_condition> <Subsumes> "Bleeding_disorder" .
<Classical_hematologic_condition> <Subsumes> "Autoimmune_hematologic_condition" .
<L-asparaginase_monotherapy> <Is_current_in> "T-cell_acute_lymphoblastic_leukemia" .
<Peginterferon_alfa-2a_monotherapy> <Has_accepted_use> "Polycythemia_vera" .
<Peginterferon_alfa-2a_monotherapy> <Has_accepted_use> "Hypereosinophilic_syndrome" .
<Peginterferon_alfa-2a_monotherapy> <Has_accepted_use> "Essential_thrombocythemia" .
<Carboplatin,_nab-Paclitaxel,_Pembrolizumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Bexarotene_monotherapy> <Has_modality> "Chemotherapy" .
<Fluorouracil_and_Mitomycin> <Has_antineoplastic> "Mitomycin" .
<Fluorouracil_and_Mitomycin> <Has_antineoplastic> "Fluorouracil" .
<EPOCH> <Maps_to> "EPOCH" .
<Gleostine> <Brand_name_of> "Lomustine" .
<Megestrol_monotherapy> <Maps_to> "Megestrol_monotherapy" .
<Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone> <Has_context> "Induction_therapy" .
<ddEC> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<ddEC> <Has_accepted_use> "Breast_cancer" .
<Sutrisan> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Fludarabine_and_Melphalan> <Is_current_in> "Allogeneic_HSCT" .
<Clopicard> <Brand_name_of> "Clopidogrel" .
<Immune_thrombocytopenia> <FDA_indication_of> "Fostamatinib" .
<Immune_thrombocytopenia> <FDA_indication_of> "Eltrombopag" .
<7_plus_3d> <Has_antineoplastic> "Daunorubicin" .
<7_plus_3d> <Has_antineoplastic> "Cytarabine" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Has_accepted_use> "HIV-associated_lymphoma" .
<Platinox> <Brand_name_of> "Cisplatin" .
<FOLFIRI> <Has_context> "Non-curative_third-line_therapy" .
<FOLFIRI> <Has_context> "Non-curative_therapy" .
<FOLFIRI> <Has_context> "Non-curative_second-line_therapy" .
<FOLFIRI> <Has_context> "Non-curative_first-line_therapy" .
<maxi-R-CHOP/R-HiDAC> <Mapped_from> "maxi-R-CHOP/R-HiDAC" .
<Cytarabine_liposomal> <May_have_route> "Intrathecal" .
<Ifosfamide_and_Methotrexate> <Is_current_in> "CNS_lymphoma" .
<Cyclosporine,_Mycophenolate_mofetil,_Sirolimus> <Has_accepted_use> "Graft_versus_host_disease" .
<ProMACE-MOPP> <Has_modality> "Chemotherapy" .
<Phtoruracil> <Brand_name_of> "Fluorouracil" .
<Avastin> <Brand_name_of> "Bevacizumab" .
<Cyclophosphamide_and_TBI,_then_auto_HSCT> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<Cyclophosphamide_and_TBI,_then_auto_HSCT> <Is_current_in> "Mantle_cell_lymphoma" .
<Cyclophosphamide_and_TBI,_then_auto_HSCT> <Is_current_in> "Follicular_lymphoma" .
<Cyclophosphamide_and_TBI,_then_auto_HSCT> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Pirarubicin_monotherapy> <Mapped_from> "Pirarubicin_monotherapy" .
<Lerozol> <Brand_name_of> "Letrozole" .
<Caelyx> <Brand_name_of> "Pegylated_liposomal_doxorubicin" .
<Ibrutinib> <Immunosuppressor_of> "Ibrutinib_monotherapy" .
<Alvocidib> <Has_FDA_indication> "Chronic_lymphocytic_leukemia" .
<Alvocidib> <Has_FDA_indication> "Acute_myeloid_leukemia" .
<Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone> <Has_context> "Consolidation_after_upfront_therapy" .
<Radioiodine_ablation> <Has_accepted_use> "Thyroid_cancer" .
<Doxorubicin> <Local_therapy_of> "R-Hyper-CVAD/R-MA" .
<Interferon_alfa-2b_and_Prednisone> <Mapped_from> "Interferon_alfa-2b_and_Prednisone" .
<R-CHOP-14_(Prednisolone)> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<R-CHOP-14_(Prednisolone)> <Has_accepted_use> "Mantle_cell_lymphoma" .
<R-CHOP-14_(Prednisolone)> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<IT_Cytarabine_liposomal_monotherapy> <Maps_to> "IT_Cytarabine_liposomal_monotherapy" .
<ADT_and_RT> <Has_accepted_use> "Prostate_cancer" .
<CC/DE_and_RT> <Mapped_from> "CC/DE_and_RT" .
<Asperan> <Brand_name_of> "Aspirin" .
<EP> <Mapped_from> "EP" .
<Pancreatic_NET> <Is_a> "Gastrointestinal_cancer" .
<Pancreatic_NET> <Is_a> "Endocrine_cancer" .
<Enasidenib> <Antineoplastic_of> "Enasidenib_monotherapy" .
<Prednilem> <Brand_name_of> "Methylprednisolone" .
<Bispecific_antibody_medication> <Subsumes> "Emicizumab" .
<Bispecific_antibody_medication> <Subsumes> "BiTE_antibody" .
<GEMOX-B> <Is_a> "Bevacizumab-containing_regimen" .
<Plasma_exchange> <Has_accepted_use> "Thrombotic_thrombocytopenic_purpura" .
<Bladder_cancer> <FDA_indication_of> "Valrubicin" .
<Bladder_cancer> <FDA_indication_of> "Pembrolizumab" .
<Bladder_cancer> <FDA_indication_of> "Nivolumab" .
<Bladder_cancer> <FDA_indication_of> "Erdafitinib" .
<Bladder_cancer> <FDA_indication_of> "Enfortumab_vedotin" .
<Bladder_cancer> <FDA_indication_of> "Durvalumab" .
<Bladder_cancer> <FDA_indication_of> "Doxorubicin" .
<Bladder_cancer> <FDA_indication_of> "Avelumab" .
<Bladder_cancer> <FDA_indication_of> "Atezolizumab" .
<R-CVEP> <Has_antineoplastic> "Vorinostat" .
<R-CVEP> <Has_antineoplastic> "Rituximab" .
<R-CVEP> <Has_antineoplastic> "Prednisone" .
<R-CVEP> <Has_antineoplastic> "Etoposide" .
<R-CVEP> <Has_antineoplastic> "Cyclophosphamide" .
<BEACOPP> <Is_current_in> "Hodgkin_lymphoma" .
<R-CVP> <Has_antineoplastic> "Vincristine" .
<R-CVP> <Has_antineoplastic> "Rituximab" .
<R-CVP> <Has_antineoplastic> "Prednisone" .
<R-CVP> <Has_antineoplastic> "Cyclophosphamide" .
<Argatroban_monotherapy> <Is_current_in> "Venous_thromboembolism" .
<Argatroban_monotherapy> <Is_current_in> "Heparin-induced_thrombocytopenia" .
<Antraciclin> <Brand_name_of> "Doxorubicin" .
<Cosig> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<ATG_(Rabbit)_and_Cyclosporine> <Has_context> "Non-curative_therapy" .
<ATG_(Rabbit)_and_Cyclosporine> <Has_context> "Induction_therapy" .
<Procrin> <Brand_name_of> "Leuprolide" .
<THP_(Taxol)> <Is_current_in> "Breast_cancer" .
<Ifosfamide_and_Methotrexate> <Has_antineoplastic> "Methotrexate" .
<Ifosfamide_and_Methotrexate> <Has_antineoplastic> "Ifosfamide" .
<Lanreotide_Depot/Autogel_monotherapy> <Has_antineoplastic> "Lanreotide" .
<Olaratumab> <Is_a> "Discontinued_drug" .
<Olaratumab> <Is_a> "Antibody_medication" .
<Olaratumab> <Is_a> "Anti-PDGFR_antibody" .
<Doxorubicin_and_Lomustine> <Has_antineoplastic> "Lomustine" .
<Doxorubicin_and_Lomustine> <Has_antineoplastic> "Doxorubicin" .
<M-EI> <Has_supportive_med> "Folinic_acid" .
<ADT_and_RT> <Maps_to> "ADT_and_RT" .
<EC_and_Bevacizumab> <Is_current_in> "Breast_cancer" .
<Tranexamic_acid> <Is_a> "Hemostasis_medication" .
<Tranexamic_acid> <Is_a> "Fibrinolysis_inhibitor" .
<VAD-P/Q> <Has_accepted_use> "Multiple_myeloma" .
<CAPIRI-Bev> <Has_context> "Non-curative_second-line_therapy" .
<CAPIRI-Bev> <Has_context> "Non-curative_first-line_therapy" .
<SC-EPOCH-RR> <Maps_to> "SC-EPOCH-RR" .
<Arabine> <Brand_name_of> "Cytarabine" .
<Non-curative_second-line_therapy> <Subsumes> "Non-curative_second-line_maintenance_therapy" .
<Non-curative_second-line_therapy> <Subsumes> "Non-curative_second-line_induction_therapy" .
<Non-curative_second-line_therapy> <Subsumes> "Non-curative_second-line_consolidation_therapy" .
<Lenalidomide_and_Rituximab> <Has_accepted_use> "Transformed_lymphoma" .
<Lenalidomide_and_Rituximab> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Lenalidomide_and_Rituximab> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Lenalidomide_and_Rituximab> <Has_accepted_use> "Follicular_lymphoma" .
<Lenalidomide_and_Rituximab> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Lenalidomide_and_Rituximab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Cisplatin_and_Cyclophosphamide> <Maps_to> "Cisplatin_and_Cyclophosphamide" .
<Nimustine> <May_have_route> "Oral" .
<Lupard_Depot> <Brand_name_of> "Leuprolide" .
<Dexasone> <Brand_name_of> "Dexamethasone" .
<PET> <Has_antineoplastic> "Paclitaxel" .
<PET> <Has_antineoplastic> "Epirubicin" .
<PET> <Has_antineoplastic> "Cisplatin" .
<TILs> <Is_current_in> "Uveal_melanoma" .
<BevaciRel> <Brand_name_of> "Bevacizumab" .
<Sarcoma> <Subsumes> "Soft_tissue_sarcoma" .
<Sarcoma> <Subsumes> "Bone_sarcoma" .
<Citarabins> <Brand_name_of> "Cytarabine" .
<HOP> <Mapped_from> "HOP" .
<Ifadox> <Brand_name_of> "Doxorubicin" .
<Kaytran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<VMCP/VBAP> <Is_historical_in> "Multiple_myeloma" .
<Olaparib_monotherapy> <Mapped_from> "Olaparib_monotherapy" .
<Chemoimmunotherapy> <Maps_to> "Chemoimmunotherapy" .
<Fluorouracil_and_Paclitaxel> <Has_antineoplastic> "Paclitaxel" .
<Fluorouracil_and_Paclitaxel> <Has_antineoplastic> "Fluorouracil" .
<Pomalidomide,_Dexamethasone,_Pembrolizumab> <Has_antineoplastic> "Pomalidomide" .
<Pomalidomide,_Dexamethasone,_Pembrolizumab> <Has_antineoplastic> "Pembrolizumab" .
<Pomalidomide,_Dexamethasone,_Pembrolizumab> <Has_antineoplastic> "Dexamethasone" .
<Pancreatic_NET> <FDA_indication_of> "Sunitinib" .
<Pancreatic_NET> <FDA_indication_of> "Streptozocin" .
<Pancreatic_NET> <FDA_indication_of> "Everolimus" .
<Etason> <Brand_name_of> "Dexamethasone" .
<HIV-associated_lymphoma> <Is_a> "Aggressive_lymphoma" .
<Biogamma> <Brand_name_of> "Interferon_alfa-2b" .
<Eloplat> <Brand_name_of> "Oxaliplatin" .
<Lomustine_and_Bevacizumab> <Has_antineoplastic> "Lomustine" .
<Lomustine_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<FM> <Is_a> "Anthracycline-containing_regimen" .
<R-CDOP> <Mapped_from> "R-CDOP" .
<HiDAC_and_Midostaurin> <Has_context> "Consolidation_after_upfront_therapy" .
<Buferin> <Brand_name_of> "Aspirin" .
<Cyclosporine_monotherapy> <Has_modality> "Immunosuppressive_therapy" .
<ChlVPP> <Has_accepted_use> "Hodgkin_lymphoma" .
<Eltrombopag> <Has_accepted_use> "Immune_thrombocytopenia" .
<Eltrombopag> <Has_accepted_use> "Aplastic_anemia" .
<Capecitabine_and_Paclitaxel> <Has_accepted_use> "Breast_cancer" .
<CM> <Has_accepted_use> "Breast_cancer" .
<L-Asparaginase,_Vincristine,_Dexamethasone> <Has_modality> "Chemotherapy" .
<Alont> <Brand_name_of> "Alendronate" .
<Valcyclovir> <Brand_name_of> "Valganciclovir" .
<Neratinib_and_Paclitaxel> <Is_current_in> "Breast_cancer" .
<Hydrocortisone_monotherapy> <Maps_to> "Hydrocortisone_monotherapy" .
<Vicide> <Brand_name_of> "Acyclovir" .
<Argatroban_monotherapy> <Maps_to> "Argatroban_monotherapy" .
<Thalidomide> <Antineoplastic_of> "VTP" .
<Thalidomide> <Antineoplastic_of> "VTD-PACE" .
<Thalidomide> <Antineoplastic_of> "VTD" .
<Thalidomide> <Antineoplastic_of> "VT" .
<Thalidomide> <Antineoplastic_of> "VMPT" .
<Thalidomide> <Antineoplastic_of> "Total_Therapy" .
<Thalidomide> <Antineoplastic_of> "Thalidomide_monotherapy" .
<Thalidomide> <Antineoplastic_of> "Thalidomide_and_Rituximab" .
<Thalidomide> <Antineoplastic_of> "Thalidomide_and_Prednisone" .
<Thalidomide> <Antineoplastic_of> "Thalidomide_and_Prednisolone" .
<Thalidomide> <Antineoplastic_of> "Temozolomide_and_Thalidomide" .
<Thalidomide> <Antineoplastic_of> "TVAD_doxil" .
<Thalidomide> <Antineoplastic_of> "TD" .
<Thalidomide> <Antineoplastic_of> "TCP" .
<Thalidomide> <Antineoplastic_of> "TAD_(Thalidomide)" .
<Thalidomide> <Antineoplastic_of> "RT-PEPC" .
<Thalidomide> <Antineoplastic_of> "MPT" .
<Thalidomide> <Antineoplastic_of> "KTD" .
<Thalidomide> <Antineoplastic_of> "Interferon_alfa-2b_and_Thalidomide" .
<Thalidomide> <Antineoplastic_of> "GDPT" .
<Thalidomide> <Antineoplastic_of> "Dara-VTD" .
<Thalidomide> <Antineoplastic_of> "DTPACE" .
<Thalidomide> <Antineoplastic_of> "CYKLONE" .
<Thalidomide> <Antineoplastic_of> "CTD" .
<Thalidomide> <Antineoplastic_of> "Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat" .
<Thalidomide> <Antineoplastic_of> "BTD" .
<ATRA_and_Daunorubicin> <Has_modality> "Chemotherapy" .
<CEEP> <Maps_to> "CEEP" .
<Plavex> <Brand_name_of> "Dexamethasone" .
<Breast_cancer> <Accepted_use_of> "nab-Paclitaxel_monotherapy" .
<Breast_cancer> <Accepted_use_of> "nab-Paclitaxel_and_Trastuzumab" .
<Breast_cancer> <Accepted_use_of> "nab-Paclitaxel_and_Atezolizumab" .
<Breast_cancer> <Accepted_use_of> "iddEPC" .
<Breast_cancer> <Accepted_use_of> "ddTH_(Taxotere)" .
<Breast_cancer> <Accepted_use_of> "ddTH_(Taxol)" .
<Breast_cancer> <Accepted_use_of> "ddT_(Taxotere)" .
<Breast_cancer> <Accepted_use_of> "ddFEC" .
<Breast_cancer> <Accepted_use_of> "ddEC" .
<Breast_cancer> <Accepted_use_of> "ddE" .
<Breast_cancer> <Accepted_use_of> "ddC" .
<Breast_cancer> <Accepted_use_of> "ddAC-T" .
<Breast_cancer> <Accepted_use_of> "ddAC" .
<Breast_cancer> <Accepted_use_of> "ddA" .
<Breast_cancer> <Accepted_use_of> "Vinorelbine_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Vinorelbine_and_Bevacizumab" .
<Breast_cancer> <Accepted_use_of> "Vinorelbine" .
<Breast_cancer> <Accepted_use_of> "Vinblastine" .
<Breast_cancer> <Accepted_use_of> "Veliparib" .
<Breast_cancer> <Accepted_use_of> "VH" .
<Breast_cancer> <Accepted_use_of> "VAP" .
<Breast_cancer> <Accepted_use_of> "VAC_(Adriamycin)" .
<Breast_cancer> <Accepted_use_of> "Triptorelin" .
<Breast_cancer> <Accepted_use_of> "Trastuzumab-qyyp" .
<Breast_cancer> <Accepted_use_of> "Trastuzumab-pkrb" .
<Breast_cancer> <Accepted_use_of> "Trastuzumab-dttb" .
<Breast_cancer> <Accepted_use_of> "Trastuzumab-dkst" .
<Breast_cancer> <Accepted_use_of> "Trastuzumab-anns" .
<Breast_cancer> <Accepted_use_of> "Trastuzumab_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Trastuzumab_and_hyaluronidase_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Trastuzumab_and_hyaluronidase" .
<Breast_cancer> <Accepted_use_of> "Trastuzumab_and_ET" .
<Breast_cancer> <Accepted_use_of> "Trastuzumab" .
<Breast_cancer> <Accepted_use_of> "Toremifene_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Toremifene" .
<Breast_cancer> <Accepted_use_of> "Thiotepa_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Thiotepa" .
<Breast_cancer> <Accepted_use_of> "Tegafur_gimeracil_oteracil" .
<Breast_cancer> <Accepted_use_of> "Tamoxifen_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Tamoxifen_and_Prednisolone" .
<Breast_cancer> <Accepted_use_of> "Tamoxifen_and_OFS" .
<Breast_cancer> <Accepted_use_of> "Tamoxifen" .
<Breast_cancer> <Accepted_use_of> "Talazoparib_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Talazoparib" .
<Breast_cancer> <Accepted_use_of> "TX_(Taxotere)" .
<Breast_cancer> <Accepted_use_of> "TPC" .
<Breast_cancer> <Accepted_use_of> "TMF" .
<Breast_cancer> <Accepted_use_of> "TL_(Taxol)" .
<Breast_cancer> <Accepted_use_of> "THP_(Taxotere)" .
<Breast_cancer> <Accepted_use_of> "THP_(Taxol)" .
<Breast_cancer> <Accepted_use_of> "THL_(Taxol)" .
<Breast_cancer> <Accepted_use_of> "TH_(Taxotere/SC)" .
<Breast_cancer> <Accepted_use_of> "TH_(Taxotere)" .
<Breast_cancer> <Accepted_use_of> "TH_(Taxol)" .
<Breast_cancer> <Accepted_use_of> "TCHP_(Taxotere)" .
<Breast_cancer> <Accepted_use_of> "TCHP_(Taxol)" .
<Breast_cancer> <Accepted_use_of> "TCH_(Taxotere,_Cyclophosphamide)" .
<Breast_cancer> <Accepted_use_of> "TCH_(Taxotere,_Carboplatin)" .
<Breast_cancer> <Accepted_use_of> "TC_(Taxotere)" .
<Breast_cancer> <Accepted_use_of> "TAD_(Tamoxifen)" .
<Breast_cancer> <Accepted_use_of> "TAC_(Taxotere)" .
<Breast_cancer> <Accepted_use_of> "T-DM1_and_ET" .
<Breast_cancer> <Accepted_use_of> "STAMP-I" .
<Breast_cancer> <Accepted_use_of> "S-1_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Ribociclib_and_Tamoxifen" .
<Breast_cancer> <Accepted_use_of> "Ribociclib" .
<Breast_cancer> <Accepted_use_of> "Placebo" .
<Breast_cancer> <Accepted_use_of> "Pertuzumab_and_Trastuzumab" .
<Breast_cancer> <Accepted_use_of> "Pertuzumab_and_T-DM1" .
<Breast_cancer> <Accepted_use_of> "Pertuzumab" .
<Breast_cancer> <Accepted_use_of> "Pemetrexed_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Pemetrexed" .
<Breast_cancer> <Accepted_use_of> "Pegylated_liposomal_doxorubicin" .
<Breast_cancer> <Accepted_use_of> "Palbociclib" .
<Breast_cancer> <Accepted_use_of> "Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab" .
<Breast_cancer> <Accepted_use_of> "Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine" .
<Breast_cancer> <Accepted_use_of> "Paclitaxel_nanoparticle_albumin-bound" .
<Breast_cancer> <Accepted_use_of> "Paclitaxel_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Paclitaxel_and_Vinorelbine" .
<Breast_cancer> <Accepted_use_of> "Paclitaxel_and_Bevacizumab" .
<Breast_cancer> <Accepted_use_of> "Paclitaxel" .
<Breast_cancer> <Accepted_use_of> "PT" .
<Breast_cancer> <Accepted_use_of> "PFT" .
<Breast_cancer> <Accepted_use_of> "PF" .
<Breast_cancer> <Accepted_use_of> "PET" .
<Breast_cancer> <Accepted_use_of> "PAF" .
<Breast_cancer> <Accepted_use_of> "Oophorectomy" .
<Breast_cancer> <Accepted_use_of> "Olaparib_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Olaparib" .
<Breast_cancer> <Accepted_use_of> "Observation" .
<Breast_cancer> <Accepted_use_of> "Non-pegylated_liposomal_doxorubicin" .
<Breast_cancer> <Accepted_use_of> "Neratinib_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Neratinib_and_Paclitaxel" .
<Breast_cancer> <Accepted_use_of> "Neratinib" .
<Breast_cancer> <Accepted_use_of> "Mitoxantrone_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Methotrexate_and_Thiotepa" .
<Breast_cancer> <Accepted_use_of> "Methotrexate" .
<Breast_cancer> <Accepted_use_of> "Melphalan_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Megestrol_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Medroxyprogesterone_monotherapy" .
<Breast_cancer> <Accepted_use_of> "MV" .
<Breast_cancer> <Accepted_use_of> "MF" .
<Breast_cancer> <Accepted_use_of> "MC" .
<Breast_cancer> <Accepted_use_of> "Levamisole_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Leuprolide_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Leuprolide" .
<Breast_cancer> <Accepted_use_of> "Letrozole_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Letrozole_and_Ribociclib" .
<Breast_cancer> <Accepted_use_of> "Letrozole_and_Palbociclib" .
<Breast_cancer> <Accepted_use_of> "Letrozole_and_Bevacizumab" .
<Breast_cancer> <Accepted_use_of> "Letrozole" .
<Breast_cancer> <Accepted_use_of> "Lapatinib,_Letrozole,_Trastuzumab" .
<Breast_cancer> <Accepted_use_of> "Lapatinib_and_Trastuzumab" .
<Breast_cancer> <Accepted_use_of> "Lapatinib_and_Letrozole" .
<Breast_cancer> <Accepted_use_of> "Lapatinib" .
<Breast_cancer> <Accepted_use_of> "Ixabepilone_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Ixabepilone" .
<Breast_cancer> <Accepted_use_of> "Ipatasertib" .
<Breast_cancer> <Accepted_use_of> "Goserelin_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Goserelin_and_Tamoxifen" .
<Breast_cancer> <Accepted_use_of> "Goserelin" .
<Breast_cancer> <Accepted_use_of> "Gemcitabine_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Gemcitabine_and_Trastuzumab" .
<Breast_cancer> <Accepted_use_of> "Gemcitabine_and_Paclitaxel" .
<Breast_cancer> <Accepted_use_of> "Gemcitabine_and_Bevacizumab" .
<Breast_cancer> <Accepted_use_of> "Gemcitabine" .
<Breast_cancer> <Accepted_use_of> "Fulvestrant_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Fulvestrant_and_Ribociclib" .
<Breast_cancer> <Accepted_use_of> "Fulvestrant_and_Palbociclib" .
<Breast_cancer> <Accepted_use_of> "Fulvestrant" .
<Breast_cancer> <Accepted_use_of> "Formestane_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Fluoxymesterone_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Fluoxymesterone" .
<Breast_cancer> <Accepted_use_of> "Fluorouracil" .
<Breast_cancer> <Accepted_use_of> "Fam-trastuzumab_deruxtecan_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Fam-trastuzumab_deruxtecan" .
<Breast_cancer> <Accepted_use_of> "FNC" .
<Breast_cancer> <Accepted_use_of> "FEC_and_H_(SC)" .
<Breast_cancer> <Accepted_use_of> "FEC_and_H" .
<Breast_cancer> <Accepted_use_of> "FEC_and_Bevacizumab" .
<Breast_cancer> <Accepted_use_of> "FEC" .
<Breast_cancer> <Accepted_use_of> "FAC_and_Bevacizumab" .
<Breast_cancer> <Accepted_use_of> "FAC_and_BCG" .
<Breast_cancer> <Accepted_use_of> "FAC" .
<Breast_cancer> <Accepted_use_of> "Exemestane_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Exemestane_and_Tucidinostat" .
<Breast_cancer> <Accepted_use_of> "Exemestane" .
<Breast_cancer> <Accepted_use_of> "Everolimus_and_Tamoxifen" .
<Breast_cancer> <Accepted_use_of> "Everolimus_and_Exemestane" .
<Breast_cancer> <Accepted_use_of> "Everolimus" .
<Breast_cancer> <Accepted_use_of> "Estradiol_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Eribulin_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Eribulin" .
<Breast_cancer> <Accepted_use_of> "Epirubicin_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Epirubicin_and_Vinorelbine" .
<Breast_cancer> <Accepted_use_of> "Epirubicin" .
<Breast_cancer> <Accepted_use_of> "Enzalutamide_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Enzalutamide" .
<Breast_cancer> <Accepted_use_of> "Entinostat" .
<Breast_cancer> <Accepted_use_of> "EP" .
<Breast_cancer> <Accepted_use_of> "EDC" .
<Breast_cancer> <Accepted_use_of> "ECT,_then_auto_HSCT" .
<Breast_cancer> <Accepted_use_of> "ECH" .
<Breast_cancer> <Accepted_use_of> "EC_and_Bevacizumab" .
<Breast_cancer> <Accepted_use_of> "EC" .
<Breast_cancer> <Accepted_use_of> "Doxorubicin_pegylated_liposomal_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Doxorubicin_pegylated_liposomal_and_Bevacizumab" .
<Breast_cancer> <Accepted_use_of> "Doxorubicin_non-pegylated_liposomal_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Doxorubicin_non-pegylated_liposomal_and_Bevacizumab" .
<Breast_cancer> <Accepted_use_of> "Doxorubicin_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Doxorubicin_and_Bevacizumab" .
<Breast_cancer> <Accepted_use_of> "Doxorubicin" .
<Breast_cancer> <Accepted_use_of> "Docetaxel_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Docetaxel_and_Gemcitabine" .
<Breast_cancer> <Accepted_use_of> "Docetaxel_and_Bevacizumab" .
<Breast_cancer> <Accepted_use_of> "Docetaxel" .
<Breast_cancer> <Accepted_use_of> "Diethylstilbestrol" .
<Breast_cancer> <Accepted_use_of> "DI_EC" .
<Breast_cancer> <Accepted_use_of> "DES_monotherapy" .
<Breast_cancer> <Accepted_use_of> "DE" .
<Breast_cancer> <Accepted_use_of> "Cyclophosphamide_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Cyclophosphamide" .
<Breast_cancer> <Accepted_use_of> "Cisplatin_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Cisplatin_and_Vinorelbine" .
<Breast_cancer> <Accepted_use_of> "Cisplatin_and_Gemcitabine" .
<Breast_cancer> <Accepted_use_of> "Cisplatin_and_Docetaxel" .
<Breast_cancer> <Accepted_use_of> "Cisplatin" .
<Breast_cancer> <Accepted_use_of> "Chlorambucil_and_Prednisolone" .
<Breast_cancer> <Accepted_use_of> "Chidamide" .
<Breast_cancer> <Accepted_use_of> "Carboplatin_and_nab-Paclitaxel" .
<Breast_cancer> <Accepted_use_of> "Carboplatin_and_Paclitaxel" .
<Breast_cancer> <Accepted_use_of> "Carboplatin_and_Gemcitabine" .
<Breast_cancer> <Accepted_use_of> "Carboplatin_and_Docetaxel" .
<Breast_cancer> <Accepted_use_of> "Carboplatin" .
<Breast_cancer> <Accepted_use_of> "Capecitabine,_Pertuzumab,_Trastuzumab" .
<Breast_cancer> <Accepted_use_of> "Capecitabine,_Bevacizumab,_Trastuzumab" .
<Breast_cancer> <Accepted_use_of> "Capecitabine_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Capecitabine_and_Trastuzumab" .
<Breast_cancer> <Accepted_use_of> "Capecitabine_and_Paclitaxel,_nanoparticle_albumin-bound" .
<Breast_cancer> <Accepted_use_of> "Capecitabine_and_Paclitaxel" .
<Breast_cancer> <Accepted_use_of> "Capecitabine_and_Neratinib" .
<Breast_cancer> <Accepted_use_of> "Capecitabine_and_Lapatinib" .
<Breast_cancer> <Accepted_use_of> "Capecitabine_and_Ixabepilone" .
<Breast_cancer> <Accepted_use_of> "Capecitabine_and_Fulvestrant" .
<Breast_cancer> <Accepted_use_of> "Capecitabine_and_Bevacizumab" .
<Breast_cancer> <Accepted_use_of> "Capecitabine" .
<Breast_cancer> <Accepted_use_of> "CVAP" .
<Breast_cancer> <Accepted_use_of> "CTCb,_then_auto_HSCT" .
<Breast_cancer> <Accepted_use_of> "CPB" .
<Breast_cancer> <Accepted_use_of> "CMFVP" .
<Breast_cancer> <Accepted_use_of> "CMFV" .
<Breast_cancer> <Accepted_use_of> "CMFT" .
<Breast_cancer> <Accepted_use_of> "CMFPT" .
<Breast_cancer> <Accepted_use_of> "CMFP" .
<Breast_cancer> <Accepted_use_of> "CMFL" .
<Breast_cancer> <Accepted_use_of> "CMF" .
<Breast_cancer> <Accepted_use_of> "CM" .
<Breast_cancer> <Accepted_use_of> "CHUT,_then_auto_HSCT" .
<Breast_cancer> <Accepted_use_of> "CFP_and_Oophorectomy" .
<Breast_cancer> <Accepted_use_of> "CFP" .
<Breast_cancer> <Accepted_use_of> "CEF/CMF" .
<Breast_cancer> <Accepted_use_of> "CAMFP" .
<Breast_cancer> <Accepted_use_of> "CAMF" .
<Breast_cancer> <Accepted_use_of> "CAFVP" .
<Breast_cancer> <Accepted_use_of> "CAF_and_MPA" .
<Breast_cancer> <Accepted_use_of> "Bevacizumab-containing_therapy" .
<Breast_cancer> <Accepted_use_of> "Bevacizumab-bvzr" .
<Breast_cancer> <Accepted_use_of> "Bevacizumab-awwb" .
<Breast_cancer> <Accepted_use_of> "Bevacizumab_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Bevacizumab" .
<Breast_cancer> <Accepted_use_of> "Atezolizumab" .
<Breast_cancer> <Accepted_use_of> "Anastrozole_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Anastrozole_and_Trastuzumab" .
<Breast_cancer> <Accepted_use_of> "Anastrozole_and_Ribociclib" .
<Breast_cancer> <Accepted_use_of> "Anastrozole_and_Palbociclib" .
<Breast_cancer> <Accepted_use_of> "Anastrozole_and_Goserelin" .
<Breast_cancer> <Accepted_use_of> "Anastrozole_and_Fulvestrant" .
<Breast_cancer> <Accepted_use_of> "Anastrozole" .
<Breast_cancer> <Accepted_use_of> "Aminoglutethimide_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Aminoglutethimide" .
<Breast_cancer> <Accepted_use_of> "Alpelisib_and_Fulvestrant" .
<Breast_cancer> <Accepted_use_of> "Alpelisib" .
<Breast_cancer> <Accepted_use_of> "Ado-trastuzumab_emtansine_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Ado-trastuzumab_emtansine" .
<Breast_cancer> <Accepted_use_of> "Abemaciclib_monotherapy" .
<Breast_cancer> <Accepted_use_of> "Abemaciclib_and_Letrozole" .
<Breast_cancer> <Accepted_use_of> "Abemaciclib_and_Fulvestrant" .
<Breast_cancer> <Accepted_use_of> "Abemaciclib_and_Anastrozole" .
<Breast_cancer> <Accepted_use_of> "Abemaciclib" .
<Breast_cancer> <Accepted_use_of> "AVCF" .
<Breast_cancer> <Accepted_use_of> "AV-CMF" .
<Breast_cancer> <Accepted_use_of> "AT_(Taxotere)" .
<Breast_cancer> <Accepted_use_of> "AT_(Taxol)" .
<Breast_cancer> <Accepted_use_of> "ACT" .
<Breast_cancer> <Accepted_use_of> "ACH" .
<Breast_cancer> <Accepted_use_of> "AC-T" .
<Breast_cancer> <Accepted_use_of> "AC_and_Bevacizumab" .
<Breast_cancer> <Accepted_use_of> "AC" .
<Unfractionated_heparin> <Supportive_med_of> "Heparin_monotherapy" .
<Unfractionated_heparin> <Supportive_med_of> "Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin" .
<ATG_(Horse)_and_Cyclosporine> <Is_current_in> "Myelodysplastic_syndrome" .
<ATG_(Horse)_and_Cyclosporine> <Is_current_in> "Aplastic_anemia" .
<AspaMetDex> <Is_current_in> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<BeEAM,_then_auto_HSCT> <Has_accepted_use> "Hodgkin_lymphoma" .
<BeEAM,_then_auto_HSCT> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Trastuzumab_and_ET> <Maps_to> "Trastuzumab_and_ET" .
<SCAB> <Has_antineoplastic> "Streptozocin" .
<SCAB> <Has_antineoplastic> "Lomustine" .
<SCAB> <Has_antineoplastic> "Doxorubicin" .
<SCAB> <Has_antineoplastic> "Bleomycin" .
<Blastic_plasmacytoid_dendritic_cell_neoplasm> <Is_a> "Acute_leukemia" .
<Zanubrutinib> <Has_brand_name> "Brukinsa" .
<Cyclophosphamide_and_Etoposide> <Is_current_in> "Osteosarcoma" .
<Hydrocortisone_monotherapy> <Is_current_in> "Prostate_cancer" .
<DD-CHOP> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Chidamide> <Is_a> "HDAC_inhibitor" .
<Chidamide> <Is_a> "CFDA_approved_drug" .
<Clofarabine_and_Cytarabine> <Maps_to> "Clofarabine_and_Cytarabine" .
<Bactron> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Everolimus_and_Exemestane> <Is_a> "Antiestrogen-containing_regimen" .
<Methotrexate_and_Thiotepa> <Is_historical_in> "Breast_cancer" .
<Pantoprazole> <Has_brand_name> "Protonix" .
<Carboplatin_and_RT> <Has_modality> "Radiotherapy" .
<Carboplatin_and_RT> <Has_modality> "Chemotherapy" .
<BuCy,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Vinflunine_monotherapy> <Maps_to> "Vinflunine_monotherapy" .
<VIDE> <Has_context> "Non-curative_therapy" .
<VIDE> <Has_context> "Neoadjuvant_therapy" .
<Thyroid_cancer> <Subsumes> "BRAF-mutated_Thyroid_cancer" .
<Capecitabine,_Bevacizumab,_Trastuzumab> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<Capecitabine,_Bevacizumab,_Trastuzumab> <Has_accepted_use> "Breast_cancer" .
<Vintor> <Brand_name_of> "Epoetin_alfa" .
<Doxorubicin,_Ifosfamide,_RT> <Maps_to> "Doxorubicin,_Ifosfamide,_RT" .
<Stenirol> <Brand_name_of> "Methylprednisolone" .
<Cyclophosphamide_and_Prednisone> <Is_current_in> "Multiple_myeloma" .
<Cyclophosphamide_and_Prednisone> <Is_current_in> "Large_granular_lymphocytic_leukemia" .
<Cyclophosphamide_and_Prednisone> <Is_current_in> "Burkitt_lymphoma" .
<Cyclophosphamide_and_Prednisone> <Is_current_in> "Acquired_coagulopathy" .
<MOPP/ABVD> <Has_modality> "Chemotherapy" .
<Irinotecan,_Vemurafenib,_Cetuximab> <Has_modality> "Chemotherapy" .
<Cisplatin,_Irinotecan,_RT> <Has_modality> "Radiotherapy" .
<Cisplatin,_Irinotecan,_RT> <Has_modality> "Chemotherapy" .
<Bleomycin> <Has_accepted_use> "Testicular_cancer" .
<Bleomycin> <Has_accepted_use> "Post-transplant_lymphoproliferative_disorder" .
<Bleomycin> <Has_accepted_use> "Penile_cancer" .
<Bleomycin> <Has_accepted_use> "Osteosarcoma" .
<Bleomycin> <Has_accepted_use> "Kaposi_sarcoma" .
<Bleomycin> <Has_accepted_use> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<Bleomycin> <Has_accepted_use> "Hodgkin_lymphoma" .
<Bleomycin> <Has_accepted_use> "HIV-associated_lymphoma" .
<Bleomycin> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Bleomycin> <Has_accepted_use> "Cutaneous_squamous_cell_carcinoma" .
<Bleomycin> <Has_accepted_use> "Cutaneous_basal_cell_carcinoma" .
<Bleomycin> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<Edoxaban> <Has_brand_name> "Savaysa" .
<Capecitabine,_Docetaxel,_RT> <Has_accepted_use> "Esophageal_cancer" .
<ATG_(Horse)_monotherapy> <Is_current_in> "Myelodysplastic_syndrome" .
<BR_and_Ibrutinib> <Maps_to> "BR_and_Ibrutinib" .
<Colon_cancer> <Accepted_use_of> "mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)" .
<Colon_cancer> <Accepted_use_of> "mFOLFOX7_(L-Leucovorin)" .
<Colon_cancer> <Accepted_use_of> "mFOLFOX7" .
<Colon_cancer> <Accepted_use_of> "mFOLFOX6_and_Cetuximab" .
<Colon_cancer> <Accepted_use_of> "mFOLFOX6_and_Bevacizumab_(L-Leucovorin)" .
<Colon_cancer> <Accepted_use_of> "mFOLFOX6_and_Bevacizumab" .
<Colon_cancer> <Accepted_use_of> "mFOLFOX6_(L-Leucovorin)" .
<Colon_cancer> <Accepted_use_of> "mFOLFOX6" .
<Colon_cancer> <Accepted_use_of> "Ziv-aflibercept" .
<Colon_cancer> <Accepted_use_of> "Trifluridine_and_tipiracil_monotherapy" .
<Colon_cancer> <Accepted_use_of> "Trifluridine_and_tipiracil" .
<Colon_cancer> <Accepted_use_of> "Tegafur,_Uracil,_Folinic_acid" .
<Colon_cancer> <Accepted_use_of> "Tegafur_gimeracil_oteracil" .
<Colon_cancer> <Accepted_use_of> "Tegafur_and_uracil" .
<Colon_cancer> <Accepted_use_of> "Semustine" .
<Colon_cancer> <Accepted_use_of> "SOX_and_Bevacizumab" .
<Colon_cancer> <Accepted_use_of> "SOX" .
<Colon_cancer> <Accepted_use_of> "S-1_monotherapy" .
<Colon_cancer> <Accepted_use_of> "Regorafenib_monotherapy" .
<Colon_cancer> <Accepted_use_of> "Regorafenib" .
<Colon_cancer> <Accepted_use_of> "Ramucirumab" .
<Colon_cancer> <Accepted_use_of> "Raltitrexed" .
<Colon_cancer> <Accepted_use_of> "Placebo" .
<Colon_cancer> <Accepted_use_of> "Pertuzumab_and_Trastuzumab" .
<Colon_cancer> <Accepted_use_of> "Pembrolizumab_monotherapy" .
<Colon_cancer> <Accepted_use_of> "Pembrolizumab" .
<Colon_cancer> <Accepted_use_of> "Panitumumab_monotherapy" .
<Colon_cancer> <Accepted_use_of> "Panitumumab" .
<Colon_cancer> <Accepted_use_of> "Oxaliplatin" .
<Colon_cancer> <Accepted_use_of> "Observation" .
<Colon_cancer> <Accepted_use_of> "OXAFAFU" .
<Colon_cancer> <Accepted_use_of> "Nordic_FLOX" .
<Colon_cancer> <Accepted_use_of> "Nivolumab_monotherapy" .
<Colon_cancer> <Accepted_use_of> "MOF" .
<Colon_cancer> <Accepted_use_of> "Levoleucovorin" .
<Colon_cancer> <Accepted_use_of> "Lapatinib_and_Trastuzumab" .
<Colon_cancer> <Accepted_use_of> "Irinotecan,_Vemurafenib,_Cetuximab" .
<Colon_cancer> <Accepted_use_of> "Irinotecan_monotherapy" .
<Colon_cancer> <Accepted_use_of> "Irinotecan_and_Cetuximab" .
<Colon_cancer> <Accepted_use_of> "Irinotecan" .
<Colon_cancer> <Accepted_use_of> "Ipilimumab_and_Nivolumab" .
<Colon_cancer> <Accepted_use_of> "Intraperitoneal_hyperthermic_mitomycin" .
<Colon_cancer> <Accepted_use_of> "Intraperitoneal_5-FU" .
<Colon_cancer> <Accepted_use_of> "IROX" .
<Colon_cancer> <Accepted_use_of> "IRIS_and_Bevacizumab" .
<Colon_cancer> <Accepted_use_of> "IRIS" .
<Colon_cancer> <Accepted_use_of> "IFL_and_Bevacizumab" .
<Colon_cancer> <Accepted_use_of> "IFL" .
<Colon_cancer> <Accepted_use_of> "Hepatic_arterial_chemotherapy" .
<Colon_cancer> <Accepted_use_of> "Folinic_acid" .
<Colon_cancer> <Accepted_use_of> "Fluorouracil,_Folinic_acid,_Levamisole" .
<Colon_cancer> <Accepted_use_of> "Fluorouracil_monotherapy" .
<Colon_cancer> <Accepted_use_of> "Fluorouracil_and_Semustine" .
<Colon_cancer> <Accepted_use_of> "Fluorouracil_and_Mitomycin" .
<Colon_cancer> <Accepted_use_of> "Fluorouracil_and_Methotrexate" .
<Colon_cancer> <Accepted_use_of> "Fluorouracil_and_Levoleucovorin" .
<Colon_cancer> <Accepted_use_of> "Fluorouracil_and_Levamisole" .
<Colon_cancer> <Accepted_use_of> "Fluorouracil_and_Folinic_acid" .
<Colon_cancer> <Accepted_use_of> "Fluorouracil" .
<Colon_cancer> <Accepted_use_of> "Floxuridine" .
<Colon_cancer> <Accepted_use_of> "FUOX" .
<Colon_cancer> <Accepted_use_of> "FULV_and_Bevacizumab" .
<Colon_cancer> <Accepted_use_of> "FUIRI" .
<Colon_cancer> <Accepted_use_of> "FOLFOXIRI_and_Panitumumab" .
<Colon_cancer> <Accepted_use_of> "FOLFOX4_and_Panitumumab" .
<Colon_cancer> <Accepted_use_of> "FOLFOX4_and_Cetuximab" .
<Colon_cancer> <Accepted_use_of> "FOLFOX4_and_Bevacizumab" .
<Colon_cancer> <Accepted_use_of> "FOLFOX4_(L-Leucovorin)" .
<Colon_cancer> <Accepted_use_of> "FOLFOX4" .
<Colon_cancer> <Accepted_use_of> "FOLFOX2" .
<Colon_cancer> <Accepted_use_of> "FOLFOX_chronotherapy" .
<Colon_cancer> <Accepted_use_of> "FOLFOX_7/sLV5FU2_(L-Leucovorin)" .
<Colon_cancer> <Accepted_use_of> "FOLFOX_7/sLV5FU2" .
<Colon_cancer> <Accepted_use_of> "FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)" .
<Colon_cancer> <Accepted_use_of> "FOLFIRINOX" .
<Colon_cancer> <Accepted_use_of> "FOLFIRI_and_Ziv-aflibercept" .
<Colon_cancer> <Accepted_use_of> "FOLFIRI_and_Ramucirumab" .
<Colon_cancer> <Accepted_use_of> "FOLFIRI_and_Panitumumab" .
<Colon_cancer> <Accepted_use_of> "FOLFIRI_and_Cetuximab_(L-Leucovorin)" .
<Colon_cancer> <Accepted_use_of> "FOLFIRI_and_Cetuximab" .
<Colon_cancer> <Accepted_use_of> "FOLFIRI_and_Bevacizumab_(L-Leucovorin)" .
<Colon_cancer> <Accepted_use_of> "FOLFIRI_and_Bevacizumab" .
<Colon_cancer> <Accepted_use_of> "FOLFIRI_(L-Leucovorin)" .
<Colon_cancer> <Accepted_use_of> "FOLFIRI" .
<Colon_cancer> <Accepted_use_of> "FLOX" .
<Colon_cancer> <Accepted_use_of> "Edrecolomab_monotherapy" .
<Colon_cancer> <Accepted_use_of> "Dabrafenib,_Trametinib,_Panitumumab" .
<Colon_cancer> <Accepted_use_of> "Cetuximab_monotherapy" .
<Colon_cancer> <Accepted_use_of> "Cetuximab" .
<Colon_cancer> <Accepted_use_of> "Capecitabine_monotherapy" .
<Colon_cancer> <Accepted_use_of> "Capecitabine_and_Bevacizumab" .
<Colon_cancer> <Accepted_use_of> "Capecitabine" .
<Colon_cancer> <Accepted_use_of> "CapeOx_and_Panitumumab" .
<Colon_cancer> <Accepted_use_of> "CapeOx_and_Bevacizumab" .
<Colon_cancer> <Accepted_use_of> "CapeOx" .
<Colon_cancer> <Accepted_use_of> "CAPIRI-Bev" .
<Colon_cancer> <Accepted_use_of> "CAPIRI" .
<Colon_cancer> <Accepted_use_of> "Binimetinib,_Encorafenib,_Cetuximab" .
<Colon_cancer> <Accepted_use_of> "Bevacizumab-bvzr" .
<Colon_cancer> <Accepted_use_of> "Bevacizumab-awwb" .
<Colon_cancer> <Accepted_use_of> "Bevacizumab_monotherapy" .
<Colon_cancer> <Accepted_use_of> "Bevacizumab" .
<Colon_cancer> <Accepted_use_of> "Best_supportive_care" .
<Colon_cancer> <Accepted_use_of> "Bacillus_Calmette-Guerin_(BCG)_monotherapy" .
<Carboplatin,_Etoposide,_RT> <Is_current_in> "Small_cell_lung_cancer" .
<Clofarabine_and_LoDAC> <Mapped_from> "Clofarabine_and_LoDAC" .
<Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine> <Is_current_in> "Medulloblastoma" .
<Abacin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<DA_3_plus_10,_GO> <Has_antineoplastic> "Gemtuzumab_ozogamicin" .
<DA_3_plus_10,_GO> <Has_antineoplastic> "Daunorubicin" .
<DA_3_plus_10,_GO> <Has_antineoplastic> "Cytarabine" .
<GemOx_and_Sorafenib> <Is_current_in> "Hepatocellular_carcinoma" .
<Togal_ASS> <Brand_name_of> "Aspirin" .
<Temozolomide_monotherapy> <Is_current_in> "Uveal_melanoma" .
<Temozolomide_monotherapy> <Is_current_in> "Soft_tissue_sarcoma" .
<Temozolomide_monotherapy> <Is_current_in> "Small_cell_lung_cancer" .
<Temozolomide_monotherapy> <Is_current_in> "Pancreatic_NET" .
<Temozolomide_monotherapy> <Is_current_in> "Neuroendocrine_tumor" .
<Temozolomide_monotherapy> <Is_current_in> "Myelodysplastic_syndrome" .
<Temozolomide_monotherapy> <Is_current_in> "Melanoma" .
<Temozolomide_monotherapy> <Is_current_in> "Low-grade_glioma" .
<Temozolomide_monotherapy> <Is_current_in> "Glioblastoma" .
<Temozolomide_monotherapy> <Is_current_in> "CNS_lymphoma" .
<Temozolomide_monotherapy> <Is_current_in> "Anaplastic_glioma" .
<Temozolomide_monotherapy> <Is_current_in> "Acute_myeloid_leukemia" .
<Irinotecan_and_Bevacizumab> <Has_supportive_med> "Steroids" .
<Irinotecan_and_Bevacizumab> <Has_supportive_med> "Prochlorperazine" .
<Irinotecan_and_Bevacizumab> <Has_supportive_med> "Ondansetron" .
<Irinotecan_and_Bevacizumab> <Has_supportive_med> "Loperamide" .
<Irinotecan_and_Bevacizumab> <Has_supportive_med> "Granisetron" .
<Irinotecan_and_Bevacizumab> <Has_supportive_med> "Dolasetron" .
<Irinotecan_and_Bevacizumab> <Has_supportive_med> "Dexamethasone" .
<Irinotecan_and_Bevacizumab> <Has_supportive_med> "Atropine" .
<GemOx> <Maps_to> "GemOx" .
<Clofarabine_and_Cytarabine> <Has_antineoplastic> "Cytarabine" .
<Clofarabine_and_Cytarabine> <Has_antineoplastic> "Clofarabine" .
<Dexanel> <Brand_name_of> "Dexamethasone" .
<Capecitabine,_Docetaxel,_Oxaliplatin,_RT> <Has_accepted_use> "Esophageal_cancer" .
<Fragmine> <Brand_name_of> "Dalteparin" .
<Pembrolizumab_monotherapy> <Is_current_in> "Transformed_lymphoma" .
<Pembrolizumab_monotherapy> <Is_current_in> "Small_cell_lung_cancer" .
<Pembrolizumab_monotherapy> <Is_current_in> "Primary_mediastinal_B-cell_lymphoma" .
<Pembrolizumab_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Pembrolizumab_monotherapy> <Is_current_in> "Mismatch_repair_deficient_malignancy" .
<Pembrolizumab_monotherapy> <Is_current_in> "Merkel_cell_carcinoma" .
<Pembrolizumab_monotherapy> <Is_current_in> "Melanoma" .
<Pembrolizumab_monotherapy> <Is_current_in> "Hodgkin_lymphoma" .
<Pembrolizumab_monotherapy> <Is_current_in> "Hepatocellular_carcinoma" .
<Pembrolizumab_monotherapy> <Is_current_in> "Head_and_neck_cancer" .
<Pembrolizumab_monotherapy> <Is_current_in> "Gastric_cancer" .
<Pembrolizumab_monotherapy> <Is_current_in> "Esophageal_cancer" .
<Pembrolizumab_monotherapy> <Is_current_in> "Endometrial_cancer" .
<Pembrolizumab_monotherapy> <Is_current_in> "Colon_cancer" .
<Pembrolizumab_monotherapy> <Is_current_in> "Cholangiocarcinoma" .
<Pembrolizumab_monotherapy> <Is_current_in> "Cervical_cancer" .
<Pembrolizumab_monotherapy> <Is_current_in> "Bladder_cancer" .
<Pembrolizumab_monotherapy> <Is_current_in> "Anal_cancer" .
<EMA-CO> <Has_modality> "Chemotherapy" .
<Cladribine_and_Rituximab> <Has_antineoplastic> "Rituximab" .
<Cladribine_and_Rituximab> <Has_antineoplastic> "Cladribine" .
<Laratrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Ricolinostat> <May_have_route> "Oral" .
<R,_then_CHOP> <Has_antineoplastic> "Vincristine" .
<R,_then_CHOP> <Has_antineoplastic> "Rituximab" .
<R,_then_CHOP> <Has_antineoplastic> "Prednisone" .
<R,_then_CHOP> <Has_antineoplastic> "Doxorubicin" .
<R,_then_CHOP> <Has_antineoplastic> "Cyclophosphamide" .
<Bevacizumab> <May_have_route> "Intravenous" .
<mFOLFOX6_and_Cetuximab> <Has_context> "Non-curative_therapy" .
<mFOLFOX6_and_Cetuximab> <Has_context> "Non-curative_first-line_therapy" .
<mFOLFOX6_and_Cetuximab> <Has_context> "Adjuvant_therapy" .
<Capecitabine,_Oxaliplatin,_RT> <Is_current_in> "Esophageal_cancer" .
<BTD> <Has_modality> "Chemotherapy" .
<ACE> <Mapped_from> "ACE" .
<Ibipolid> <Brand_name_of> "Pomalidomide" .
<Bactiver> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<C-BOP> <Has_accepted_use> "Testicular_cancer" .
<Elo-Rd> <Has_accepted_use> "Multiple_myeloma" .
<Restofos> <Brand_name_of> "Alendronate" .
<EDAP> <Has_accepted_use> "Multiple_myeloma" .
<BO> <Has_accepted_use> "Testicular_cancer" .
<7_plus_5i> <Has_antineoplastic> "Idarubicin" .
<7_plus_5i> <Has_antineoplastic> "Cytarabine" .
<Docetaxel_and_Prednisolone> <Has_antineoplastic> "Prednisolone" .
<Docetaxel_and_Prednisolone> <Has_antineoplastic> "Docetaxel" .
<Factor_XIII_concentrate_human> <Has_accepted_use> "Inherited_coagulopathy" .
<Amsacrine> <Is_a> "Vesicant" .
<Amsacrine> <Is_a> "Topoisomerase_inhibitor" .
<Amsacrine> <Is_a> "Orphan_drug" .
<Amsacrine> <Is_a> "Health_Canada_approved_drug" .
<Amsacrine> <Is_a> "DNA_synthesis_inhibitor" .
<ProMACE-CytaBOM> <Maps_to> "ProMACE-CytaBOM" .
<Fedratinib_monotherapy> <Is_current_in> "Myelofibrosis" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA> <Maps_to> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA" .
<Antiandrogen> <Is_a> "Endocrine_therapeutic" .
<Chidamide_monotherapy> <Has_antineoplastic> "Chidamide" .
<CMED> <Has_antineoplastic> "Methotrexate" .
<CMED> <Has_antineoplastic> "Etoposide" .
<CMED> <Has_antineoplastic> "Dexamethasone" .
<CMED> <Has_antineoplastic> "Cyclophosphamide" .
<APO> <Has_context> "Induction_therapy" .
<Doxorubicin_pegylated_liposomal_and_Gemcitabine> <Has_context> "Non-curative_therapy" .
<Clodran> <Brand_name_of> "Clodronate" .
<Cytarabine_and_G-CSF> <Maps_to> "Cytarabine_and_G-CSF" .
<Treosulfan> <May_have_route> "Oral" .
<Treosulfan> <May_have_route> "Intravenous" .
<Cyclophosphamide_and_Topotecan> <Has_modality> "Chemotherapy" .
<VIP> <Has_supportive_med> "Mesna" .
<VIP> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<VIP> <Has_supportive_med> "Filgrastim" .
<CMC> <Has_context> "Non-curative_first-line_therapy" .
<Ifosfamide_and_Methotrexate> <Has_accepted_use> "CNS_lymphoma" .
<MT-R> <Is_current_in> "CNS_lymphoma" .
<CX-C> <Has_accepted_use> "Esophageal_cancer" .
<VIPD> <Is_current_in> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<AT_(Taxol)> <Mapped_from> "AT_(Taxol)" .
<Bleomycin_and_Cisplatin> <Is_a> "Platinum_doublet" .
<Lorlatinib_monotherapy> <Has_accepted_use> "ROS1-positive_Non-small_cell_lung_cancer" .
<Lorlatinib_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Lorlatinib_monotherapy> <Has_accepted_use> "ALK-positive_Non-small_cell_lung_cancer" .
<Cisplatin,_Vinblastine,_RT> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<(90)YFC> <Has_immunosuppressor> "Tacrolimus" .
<(90)YFC> <Has_immunosuppressor> "Methotrexate" .
<(90)YFC> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<Arsenic_trioxide_and_Chlorambucil> <Maps_to> "Arsenic_trioxide_and_Chlorambucil" .
<Cisplatin_and_Vinblastine> <Is_current_in> "Non-small_cell_lung_cancer" .
<O-CHOP> <Has_accepted_use> "Follicular_lymphoma" .
<Rasbelon> <Brand_name_of> "Rasburicase" .
<RT,_then_Temozolomide> <Has_modality> "Radiotherapy" .
<RT,_then_Temozolomide> <Has_modality> "Chemotherapy" .
<MACOP-B> <Is_a> "Anthracycline-containing_regimen" .
<FAC> <Has_context> "Non-curative_first-line_therapy" .
<FAC> <Has_context> "Neoadjuvant_therapy" .
<FAC> <Has_context> "Adjuvant_therapy" .
<MVAC,_dose-dense> <Has_context> "Non-curative_first-line_therapy" .
<MVAC,_dose-dense> <Has_context> "Neoadjuvant_therapy" .
<Ipilimumab_and_Nivolumab> <Has_antineoplastic> "Nivolumab" .
<Ipilimumab_and_Nivolumab> <Has_antineoplastic> "Ipilimumab" .
<KFDA_approved_drug> <Is_a> "Approved_drug" .
<Bifemelan> <Brand_name_of> "Alendronate" .
<Warfa> <Brand_name_of> "Warfarin" .
<Daunorubicin_and_Prednisone> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<Pertuzumab_and_Trastuzumab> <Has_modality> "Chemotherapy" .
<CHOP_(Prednisolone)> <Has_antineoplastic> "Vincristine" .
<CHOP_(Prednisolone)> <Has_antineoplastic> "Prednisolone" .
<CHOP_(Prednisolone)> <Has_antineoplastic> "Doxorubicin" .
<CHOP_(Prednisolone)> <Has_antineoplastic> "Cyclophosphamide" .
<Anti-amyloid_antibody> <Subsumes> "NEOD001" .
<Cytarabine> <Local_therapy_of> "mLSG15" .
<Cytarabine> <Local_therapy_of> "m-BACOD" .
<Cytarabine> <Local_therapy_of> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Cytarabine> <Local_therapy_of> "dmCODOX-M_-_Modified_Magrath" .
<Cytarabine> <Local_therapy_of> "R-Hyper-CVAD/R-MA" .
<Cytarabine> <Local_therapy_of> "R-DHAP" .
<Cytarabine> <Local_therapy_of> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Cytarabine> <Local_therapy_of> "R-CODOX-M/R-IVAC" .
<Cytarabine> <Local_therapy_of> "R-CODOX-M_(Doxil_substituted)" .
<Cytarabine> <Local_therapy_of> "R-CODOX-M" .
<Cytarabine> <Local_therapy_of> "R-CHOP" .
<Cytarabine> <Local_therapy_of> "MVBP" .
<Cytarabine> <Local_therapy_of> "Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone" .
<Cytarabine> <Local_therapy_of> "Lomustine,_Methotrexate,_Procarbazine" .
<Cytarabine> <Local_therapy_of> "International_ALL_Trial" .
<Cytarabine> <Local_therapy_of> "IT_Cytarabine,_Methotrexate,_WBRT" .
<Cytarabine> <Local_therapy_of> "IT_Cytarabine,_Methotrexate,_Prednisone" .
<Cytarabine> <Local_therapy_of> "IT_Cytarabine,_Methotrexate,_Methylprednisolone" .
<Cytarabine> <Local_therapy_of> "IT_Cytarabine_monotherapy" .
<Cytarabine> <Local_therapy_of> "IT_Cytarabine_and_WBRT" .
<Cytarabine> <Local_therapy_of> "IT_Cytarabine_and_Methotrexate" .
<Cytarabine> <Local_therapy_of> "Hyper-CVAD/MA" .
<Cytarabine> <Local_therapy_of> "Hyper-CVAD_and_Imatinib" .
<Cytarabine> <Local_therapy_of> "Hyper-CVAD_and_Dasatinib" .
<Cytarabine> <Local_therapy_of> "GMALL-R" .
<Cytarabine> <Local_therapy_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone" .
<Cytarabine> <Local_therapy_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Cytarabine> <Local_therapy_of> "DOLP" .
<Cytarabine> <Local_therapy_of> "Cytarabine_and_Daunorubicin" .
<Cytarabine> <Local_therapy_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab" .
<Cytarabine> <Local_therapy_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Cytarabine> <Local_therapy_of> "Cyclophosphamide_and_Prednisone" .
<Cytarabine> <Local_therapy_of> "CYM" .
<Cytarabine> <Local_therapy_of> "COPADM" .
<Cytarabine> <Local_therapy_of> "COPAD/CYVE" .
<Cytarabine> <Local_therapy_of> "COP" .
<Cytarabine> <Local_therapy_of> "CODOX-M/IVAC" .
<Cytarabine> <Local_therapy_of> "CODOX-M" .
<Cytarabine> <Local_therapy_of> "CHOP-14" .
<Cytarabine> <Local_therapy_of> "CALGB_10-002_regimen" .
<Cytarabine> <Local_therapy_of> "BASIC" .
<Cytarabine> <Local_therapy_of> "Arsenic_trioxide_monotherapy" .
<Cytarabine> <Local_therapy_of> "Arsenic_trioxide_and_Idarubicin" .
<Bevacizumab_and_Rituximab> <Mapped_from> "Bevacizumab_and_Rituximab" .
<Hemofil-M> <Brand_name_of> "Factor_VIII_human" .
<VAD> <Is_historical_in> "Multiple_myeloma" .
<Onsetron> <Brand_name_of> "Ondansetron" .
<Temozolomide_and_NovoTTF-100A> <Has_modality> "Tumor_treating_fields" .
<Temozolomide_and_NovoTTF-100A> <Has_modality> "Chemotherapy" .
<CHOP_(Prednisolone)> <Has_modality> "Chemotherapy" .
<FluBuCy,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<FluBuCy,_then_allo_HSCT> <Has_modality> "Immunosuppressive_therapy" .
<FluBuCy,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<Denrit> <Brand_name_of> "Gefitinib" .
<R-MegaCHOP> <Has_modality> "Chemotherapy" .
<Mibor> <Brand_name_of> "Bortezomib" .
<BEAM> <Maps_to> "BEAM" .
<Trimoks> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Interferon_alfa-2a_and_Interleukin-2> <Maps_to> "Interferon_alfa-2a_and_Interleukin-2" .
<Colon_cancer> <Subsumes> "KRAS_wild-type_Colon_cancer" .
<Colon_cancer> <Subsumes> "HER2-positive_Colon_cancer" .
<Colon_cancer> <Subsumes> "BRAF-mutated_Colon_cancer" .
<MCP_(Prednisolone)> <Has_modality> "Chemotherapy" .
<Donray> <Brand_name_of> "Dexamethasone" .
<Coprime> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<eBEACOPP> <Has_context> "Non-curative_therapy" .
<eBEACOPP> <Has_context> "Induction_therapy" .
<FOLFIRI_and_Bevacizumab_(L-Leucovorin)> <Has_modality> "Chemotherapy" .
<DOLP_(Prednisolone)> <Has_antineoplastic> "Vincristine" .
<DOLP_(Prednisolone)> <Has_antineoplastic> "Prednisolone" .
<DOLP_(Prednisolone)> <Has_antineoplastic> "Daunorubicin" .
<DOLP_(Prednisolone)> <Has_antineoplastic> "Asparaginase" .
<Imetelstat> <Has_accepted_use> "Myelofibrosis" .
<Imetelstat> <Has_accepted_use> "Essential_thrombocythemia" .
<Pantrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CEOP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<CC> <Maps_to> "CC" .
<Sigatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Farnesyltransferase_inhibitor> <Subsumes> "Tipifarnib" .
<Midostaurin_monotherapy> <Maps_to> "Midostaurin_monotherapy" .
<MPR> <Has_accepted_use> "Multiple_myeloma" .
<IL-2_monotherapy> <Is_current_in> "Melanoma" .
<Peginterferon_alfa-2b_monotherapy> <Has_antineoplastic> "Peginterferon_alfa-2b" .
<Methotrexate_and_Pegaspargase> <Mapped_from> "Methotrexate_and_Pegaspargase" .
<CHVmP-VB> <Has_modality> "Chemotherapy" .
<Cytomegalovirus_Immune_Globulin> <Has_brand_name> "Atgam" .
<VIE> <Has_accepted_use> "Rhabdomyosarcoma" .
<Capecitabine> <Has_accepted_use> "Thymoma" .
<Capecitabine> <Has_accepted_use> "Rectal_cancer" .
<Capecitabine> <Has_accepted_use> "Pancreatic_cancer" .
<Capecitabine> <Has_accepted_use> "Pancreatic_NET" .
<Capecitabine> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Capecitabine> <Has_accepted_use> "Gastric_cancer" .
<Capecitabine> <Has_accepted_use> "Gallbladder_cancer" .
<Capecitabine> <Has_accepted_use> "Esophageal_cancer" .
<Capecitabine> <Has_accepted_use> "Colon_cancer" .
<Capecitabine> <Has_accepted_use> "Cholangiocarcinoma" .
<Capecitabine> <Has_accepted_use> "Breast_cancer" .
<Temsirolimus_and_Rituximab> <Has_antineoplastic> "Temsirolimus" .
<Temsirolimus_and_Rituximab> <Has_antineoplastic> "Rituximab" .
<Anti-CD3_antibody> <Subsumes> "Catumaxomab" .
<Anti-CD3_antibody> <Subsumes> "Blinatumomab" .
<Anti-CD3_antibody> <Subsumes> "AMG_330" .
<Asciminib> <May_have_route> "Oral" .
<Ovarian_cancer> <FDA_indication_of> "Topotecan" .
<Ovarian_cancer> <FDA_indication_of> "Rucaparib" .
<Ovarian_cancer> <FDA_indication_of> "Pegylated_liposomal_doxorubicin" .
<Ovarian_cancer> <FDA_indication_of> "Paclitaxel" .
<Ovarian_cancer> <FDA_indication_of> "Olaparib" .
<Ovarian_cancer> <FDA_indication_of> "Niraparib" .
<Ovarian_cancer> <FDA_indication_of> "Melphalan" .
<Ovarian_cancer> <FDA_indication_of> "Gemcitabine" .
<Ovarian_cancer> <FDA_indication_of> "Doxorubicin" .
<Ovarian_cancer> <FDA_indication_of> "Cyclophosphamide" .
<Ovarian_cancer> <FDA_indication_of> "Bevacizumab" .
<Ovarian_cancer> <FDA_indication_of> "Altretamine" .
<CHVmP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<WHO_Essential_Anti-infective_Medicine> <Subsumes> "Voriconazole" .
<WHO_Essential_Anti-infective_Medicine> <Subsumes> "Penicillin_V" .
<WHO_Essential_Anti-infective_Medicine> <Subsumes> "Mycostatin" .
<WHO_Essential_Anti-infective_Medicine> <Subsumes> "Itraconazole" .
<WHO_Essential_Anti-infective_Medicine> <Subsumes> "Fluconazole" .
<WHO_Essential_Anti-infective_Medicine> <Subsumes> "Cephalexin" .
<WHO_Essential_Anti-infective_Medicine> <Subsumes> "Cefixime" .
<WHO_Essential_Anti-infective_Medicine> <Subsumes> "Amoxicillin" .
<Uvadex> <Brand_name_of> "Methoxsalen" .
<Selinexor> <Is_a> "XPO1_inhibitor" .
<COPA> <Mapped_from> "COPA" .
<Ipilimumab_monotherapy> <Is_current_in> "Small_cell_lung_cancer" .
<Ipilimumab_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Ipilimumab_monotherapy> <Is_current_in> "Melanoma" .
<IFL> <Has_accepted_use> "Colon_cancer" .
<Bosutinib> <Is_a> "SRC_inhibitor" .
<Bosutinib> <Is_a> "Mutation-specific_medication" .
<Bosutinib> <Is_a> "Kinase_inhibitor" .
<Bosutinib> <Is_a> "Bcr-Abl_inhibitor" .
<ATRA_and_Idarubicin> <Has_context> "Induction_therapy" .
<Non-curative_third-line_maintenance_therapy> <Mapped_from> "Non-curative_third-line_maintenance_therapy" .
<Etoposido> <Brand_name_of> "Etoposide" .
<Quinine> <May_have_route> "Oral" .
<Vincasar> <Brand_name_of> "Vincristine" .
<IRIS> <Has_context> "Non-curative_second-line_therapy" .
<T-cell_activator> <Is_a> "Immunotherapeutic" .
<Daunorubicin_liposomal> <Has_accepted_use> "Kaposi_sarcoma" .
<Daunorubicin_liposomal> <Has_accepted_use> "Acute_myeloid_leukemia" .
<FAC_and_Bevacizumab> <Maps_to> "FAC_and_Bevacizumab" .
<Everolimus_monotherapy> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Everolimus_monotherapy> <Has_supportive_med> "Metoclopramide" .
<Everolimus_monotherapy> <Has_supportive_med> "Mannitol" .
<Everolimus_monotherapy> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Everolimus_monotherapy> <Has_supportive_med> "Filgrastim" .
<Everolimus_monotherapy> <Has_supportive_med> "Erythrocyte_growth_factors" .
<Everolimus_monotherapy> <Has_supportive_med> "Acyclovir" .
<PMitCEBO> <Has_context> "Induction_therapy" .
<Enzalutamide_monotherapy> <Has_accepted_use> "triple_negative_Breast_cancer" .
<Enzalutamide_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<Enzalutamide_monotherapy> <Has_accepted_use> "Breast_cancer" .
<VR-CP> <Has_accepted_use> "Follicular_lymphoma" .
<Terasulf> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CMF> <Has_modality> "Chemotherapy" .
<Azafect> <Brand_name_of> "Azacitidine" .
<Carboplatin_and_Ifosfamide> <Has_supportive_med> "Mesna" .
<Trastuzumab-pkrb> <Has_brand_name> "Herzuma" .
<R-DHAC> <Has_modality> "Chemotherapy" .
<EMA-CO> <Mapped_from> "EMA-CO" .
<AIE> <Maps_to> "AIE" .
<ADE_and_ATRA> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Vincrisin> <Brand_name_of> "Vincristine" .
<Methotrexate> <Local_therapy_of> "mLSG15" .
<Methotrexate> <Local_therapy_of> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Methotrexate> <Local_therapy_of> "dmCODOX-M_-_Modified_Magrath" .
<Methotrexate> <Local_therapy_of> "SC-EPOCH-RR" .
<Methotrexate> <Local_therapy_of> "R2CHOP" .
<Methotrexate> <Local_therapy_of> "R-MPV" .
<Methotrexate> <Local_therapy_of> "R-M-CHOP" .
<Methotrexate> <Local_therapy_of> "R-Hyper-CVAD/R-MA" .
<Methotrexate> <Local_therapy_of> "R-GCVP" .
<Methotrexate> <Local_therapy_of> "R-DHAP" .
<Methotrexate> <Local_therapy_of> "R-COPADM" .
<Methotrexate> <Local_therapy_of> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Methotrexate> <Local_therapy_of> "R-CODOX-M/R-IVAC" .
<Methotrexate> <Local_therapy_of> "R-CODOX-M_(Doxil_substituted)" .
<Methotrexate> <Local_therapy_of> "R-CODOX-M" .
<Methotrexate> <Local_therapy_of> "R-CHOP-14_(Prednisolone)" .
<Methotrexate> <Local_therapy_of> "R-CHOP-14" .
<Methotrexate> <Local_therapy_of> "R-CHOP_(Prednisolone)" .
<Methotrexate> <Local_therapy_of> "R-CHOP" .
<Methotrexate> <Local_therapy_of> "Prednisone_monotherapy" .
<Methotrexate> <Local_therapy_of> "Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Methotrexate> <Local_therapy_of> "Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone" .
<Methotrexate> <Local_therapy_of> "Methotrexate_and_Pegaspargase" .
<Methotrexate> <Local_therapy_of> "Mercaptopurine,_Methotrexate,_WB-XRT" .
<Methotrexate> <Local_therapy_of> "Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone" .
<Methotrexate> <Local_therapy_of> "Mercaptopurine,_Methotrexate,_Vincristine" .
<Methotrexate> <Local_therapy_of> "MVBP" .
<Methotrexate> <Local_therapy_of> "MPV" .
<Methotrexate> <Local_therapy_of> "MACOP-B" .
<Methotrexate> <Local_therapy_of> "Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone" .
<Methotrexate> <Local_therapy_of> "Lomustine,_Methotrexate,_Procarbazine" .
<Methotrexate> <Local_therapy_of> "Imatinib-based_consolidation" .
<Methotrexate> <Local_therapy_of> "Imatinib_and_Prednisone" .
<Methotrexate> <Local_therapy_of> "IT_Methotrexate_monotherapy" .
<Methotrexate> <Local_therapy_of> "IT_Methotrexate_and_WBRT" .
<Methotrexate> <Local_therapy_of> "IT_Methotrexate_and_Methylprednisolone" .
<Methotrexate> <Local_therapy_of> "IT_Methotrexate_and_Hydrocortisone" .
<Methotrexate> <Local_therapy_of> "IT_Cytarabine,_Methotrexate,_WBRT" .
<Methotrexate> <Local_therapy_of> "IT_Cytarabine,_Methotrexate,_Prednisone" .
<Methotrexate> <Local_therapy_of> "IT_Cytarabine,_Methotrexate,_Methylprednisolone" .
<Methotrexate> <Local_therapy_of> "IT_Cytarabine_and_Methotrexate" .
<Methotrexate> <Local_therapy_of> "Hyper-CVAD/MA" .
<Methotrexate> <Local_therapy_of> "Hyper-CVAD_and_Imatinib" .
<Methotrexate> <Local_therapy_of> "Hyper-CVAD_and_Dasatinib" .
<Methotrexate> <Local_therapy_of> "HLH-2004_regimen" .
<Methotrexate> <Local_therapy_of> "HAM_and_Imatinib" .
<Methotrexate> <Local_therapy_of> "GMALL-R" .
<Methotrexate> <Local_therapy_of> "Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone" .
<Methotrexate> <Local_therapy_of> "Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib" .
<Methotrexate> <Local_therapy_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone" .
<Methotrexate> <Local_therapy_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Methotrexate> <Local_therapy_of> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib" .
<Methotrexate> <Local_therapy_of> "Dasatinib_and_Prednisone" .
<Methotrexate> <Local_therapy_of> "DOLP" .
<Methotrexate> <Local_therapy_of> "DA-R-EPOCH" .
<Methotrexate> <Local_therapy_of> "Cytarabine,_Idarubicin,_Imatinib" .
<Methotrexate> <Local_therapy_of> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA" .
<Methotrexate> <Local_therapy_of> "Cytarabine_and_Daunorubicin" .
<Methotrexate> <Local_therapy_of> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone" .
<Methotrexate> <Local_therapy_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab" .
<Methotrexate> <Local_therapy_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Methotrexate> <Local_therapy_of> "Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone" .
<Methotrexate> <Local_therapy_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine" .
<Methotrexate> <Local_therapy_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine" .
<Methotrexate> <Local_therapy_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine" .
<Methotrexate> <Local_therapy_of> "Cyclophosphamide_and_Prednisone" .
<Methotrexate> <Local_therapy_of> "Cisplatin_and_Etoposide" .
<Methotrexate> <Local_therapy_of> "CYM" .
<Methotrexate> <Local_therapy_of> "COPADM" .
<Methotrexate> <Local_therapy_of> "COPAD/CYVE" .
<Methotrexate> <Local_therapy_of> "COP" .
<Methotrexate> <Local_therapy_of> "CODOX-M/IVAC" .
<Methotrexate> <Local_therapy_of> "CODOX-M" .
<Methotrexate> <Local_therapy_of> "CHOP-14" .
<Methotrexate> <Local_therapy_of> "CALGB_8811_early_intensification" .
<Methotrexate> <Local_therapy_of> "CALGB_10-002_regimen" .
<Methotrexate> <Local_therapy_of> "Arsenic_trioxide_monotherapy" .
<Methotrexate> <Local_therapy_of> "Arsenic_trioxide_and_Idarubicin" .
<Methotrexate> <Local_therapy_of> "ACVBP-R" .
<Methotrexate> <Local_therapy_of> "ACVBP" .
<Cisplatin_and_Ifosfamide> <Is_a> "Platinum_doublet" .
<Docetaxel,_Gemcitabine,_RT> <Has_accepted_use> "Pancreatic_cancer" .
<Dabigatran_monotherapy> <Maps_to> "Dabigatran_monotherapy" .
<EOX> <Has_context> "Non-curative_first-line_therapy" .
<EOX> <Has_context> "Neoadjuvant_therapy" .
<EOX> <Has_context> "Induction_therapy" .
<EOX> <Has_context> "Adjuvant_therapy" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone> <Has_context> "Induction_therapy" .
<Ibrutinib_and_Venetoclax> <Has_modality> "Chemotherapy" .
<Dexaval> <Brand_name_of> "Dexamethasone" .
<O-DHAP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Methotrexate,_Vinblastine,_Prednisone> <Has_modality> "Chemotherapy" .
<Mepolizumab_monotherapy> <Has_modality> "Chemotherapy" .
<Rituximab_monotherapy> <Has_context> "Non-curative_therapy" .
<Rituximab_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Rituximab_monotherapy> <Has_context> "Non-curative_subsequent-line_maintenance_therapy" .
<Rituximab_monotherapy> <Has_context> "Non-curative_subsequent-line_consolidation_therapy" .
<Rituximab_monotherapy> <Has_context> "Non-curative_second-line_maintenance_therapy" .
<Rituximab_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Rituximab_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Rituximab_monotherapy> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Rituximab_monotherapy> <Has_context> "Maintenance_after_upfront_therapy" .
<Rituximab_monotherapy> <Has_context> "Maintenance_after_salvage_therapy" .
<Rituximab_monotherapy> <Has_context> "Induction_therapy" .
<Rituximab_monotherapy> <Has_context> "Consolidation_after_upfront_therapy" .
<Rituximab_monotherapy> <Has_context> "All_lines_of_therapy" .
<Rd> <Maps_to> "Rd" .
<Amsacrine_and_Cytarabine> <Has_modality> "Chemotherapy" .
<Omapro> <Brand_name_of> "Omacetaxine" .
<CCOP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Alemtuzumab> <Has_FDA_indication> "Chronic_lymphocytic_leukemia" .
<Mercaptopurine,_Methotrexate,_WB-XRT> <Has_modality> "Radiotherapy" .
<Mercaptopurine,_Methotrexate,_WB-XRT> <Has_modality> "Chemotherapy" .
<Idelalisib_and_Ofatumumab> <Has_context> "Non-curative_therapy" .
<FCR,_then_allo_HSCT> <Mapped_from> "FCR,_then_allo_HSCT" .
<Ramosetron> <Is_a> "Serotonin_5-HT3_antagonist" .
<Ramosetron> <Is_a> "PMDA_approved_drug" .
<Ramosetron> <Is_a> "Emesis_prevention" .
<L-Asparaginase,_Vincristine,_Dexamethasone> <Has_context> "Induction_therapy" .
<Cisplatin,_Fluorouracil,_RT> <Mapped_from> "Cisplatin,_Fluorouracil,_RT" .
<Carboplatin_and_Pemetrexed> <Mapped_from> "Carboplatin_and_Pemetrexed" .
<Elotuzumab> <Is_a> "PMDA_approved_drug" .
<Elotuzumab> <Is_a> "Antibody_medication" .
<Elotuzumab> <Is_a> "Anti-SLAMF7_antibody" .
<Cisplatin,_Interferon_alfa-2a,_Isotretinoin> <Maps_to> "Cisplatin,_Interferon_alfa-2a,_Isotretinoin" .
<Ferric_carboxymaltose> <Is_a> "Iron" .
<Ferric_carboxymaltose> <Is_a> "Hematology_medication" .
<Panitumumab_monotherapy> <Has_modality> "Chemotherapy" .
<Zofran_ODT> <Brand_name_of> "Ondansetron" .
<BVD> <Maps_to> "BVD" .
<Immunosuppressant> <Is_a> "Drugs_by_class_effect" .
<Abemaciclib_and_Letrozole> <Mapped_from> "Abemaciclib_and_Letrozole" .
<Filgrastim> <Immunosuppressor_of> "Busulfan_and_Fludarabine" .
<Filgrastim> <Immunosuppressor_of> "BuFlu,_then_allo_HSCT" .
<Filgrastim> <Immunosuppressor_of> "BEAM,_then_allo_HSCT" .
<Filgrastim> <Immunosuppressor_of> "BEAM" .
<Cisplatin,_Docetaxel,_RT> <Has_supportive_med> "Granisetron" .
<Cisplatin,_Docetaxel,_RT> <Has_supportive_med> "Diphenhydramine" .
<Cisplatin,_Docetaxel,_RT> <Has_supportive_med> "Dexamethasone" .
<Cisplatin,_Docetaxel,_RT> <Has_supportive_med> "Cimetidine" .
<Ofatumumab_monotherapy> <Maps_to> "Ofatumumab_monotherapy" .
<Methylprednisolone_monotherapy> <Has_context> "Non-curative_therapy" .
<Trimetox> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Methylprednisolone> <Has_accepted_use> "Thrombotic_thrombocytopenic_purpura" .
<Methylprednisolone> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Methylprednisolone> <Has_accepted_use> "Post-transplant_lymphoproliferative_disorder" .
<Methylprednisolone> <Has_accepted_use> "Immune_thrombocytopenia" .
<Methylprednisolone> <Has_accepted_use> "Hodgkin_lymphoma" .
<Methylprednisolone> <Has_accepted_use> "Hemophagocytic_lymphohistiocytosis" .
<Methylprednisolone> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Methylprednisolone> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Methylprednisolone> <Has_accepted_use> "CNS_lymphoma" .
<Methylprednisolone> <Has_accepted_use> "CNS_leukemia" .
<Methylprednisolone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<ABVE-PC> <Has_context> "Induction_therapy" .
<Doxorubicin_and_Gemcitabine> <Maps_to> "Doxorubicin_and_Gemcitabine" .
<MCP> <Is_a> "Anthracycline-containing_regimen" .
<Best_supportive_care> <Mapped_from> "Best_supportive_care" .
<Factor_X_human_(Coagadex)> <Has_brand_name> "Coagadex" .
<Erythrocyte_growth_factor> <Subsumes> "Luspatercept" .
<Erythrocyte_growth_factor> <Subsumes> "Epoetin_alfa-epbx" .
<Erythrocyte_growth_factor> <Subsumes> "Epoetin_alfa" .
<Erythrocyte_growth_factor> <Subsumes> "Darbepoetin_alfa" .
<FCR_(Rituximab_Hycela)> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Larprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Mitotane_and_EDP> <Mapped_from> "Mitotane_and_EDP" .
<Elvecis> <Brand_name_of> "Cisplatin" .
<FOLFOX4_and_Cetuximab> <Has_context> "Non-curative_first-line_therapy" .
<VcR-CVAD> <Has_supportive_med> "Pegfilgrastim" .
<VcR-CVAD> <Has_supportive_med> "Mesna" .
<VcR-CVAD> <Has_supportive_med> "Filgrastim" .
<Decitabine_and_Valproate> <Has_modality> "Chemotherapy" .
<FOLFOX4_and_Bevacizumab> <Has_accepted_use> "Colon_cancer" .
<Calciumfolinat> <Brand_name_of> "Folinic_acid" .
<CRD> <Has_modality> "Chemotherapy" .
<Godamed_TAH> <Brand_name_of> "Aspirin" .
<Etoposide,_Ifosfamide,_Methotrexate> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Belinostat_monotherapy> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Belinostat_monotherapy> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Pegfilgrastim-jmdb> <Is_a> "Pegylated_medication" .
<Pegfilgrastim-jmdb> <Is_a> "Granulocyte_colony-stimulating_factor" .
<Pegfilgrastim-jmdb> <Is_a> "Biosimilar" .
<Ewing_sarcoma> <Current_treated_by> "VIDE" .
<Ewing_sarcoma> <Current_treated_by> "VDC/IE" .
<Ewing_sarcoma> <Current_treated_by> "VAdCA/IE" .
<Ewing_sarcoma> <Current_treated_by> "VAdCA" .
<Ewing_sarcoma> <Current_treated_by> "VAIA" .
<Ewing_sarcoma> <Current_treated_by> "VAI" .
<Ewing_sarcoma> <Current_treated_by> "VACA/IE" .
<Ewing_sarcoma> <Current_treated_by> "VACA" .
<Ewing_sarcoma> <Current_treated_by> "TC,_then_IE,_VDoxoC,_VEC" .
<Ewing_sarcoma> <Current_treated_by> "Irinotecan_and_Temozolomide" .
<Ewing_sarcoma> <Current_treated_by> "IE" .
<Ewing_sarcoma> <Current_treated_by> "ICE" .
<Ewing_sarcoma> <Current_treated_by> "EVAIA" .
<Ewing_sarcoma> <Current_treated_by> "Docetaxel_and_Gemcitabine" .
<Ewing_sarcoma> <Current_treated_by> "Cyclophosphamide_and_Topotecan" .
<Ewing_sarcoma> <Current_treated_by> "Busulfan_and_Melphalan,_then_auto_HSCT" .
<CHUT> <Has_modality> "Chemotherapy" .
<Bactiseptol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Valtaxin> <Brand_name_of> "Valrubicin" .
<SMILE> <Has_context> "Non-curative_therapy" .
<SMILE> <Has_context> "Induction_therapy" .
<SMILE> <Has_context> "All_lines_of_therapy" .
<Dexferrum> <Brand_name_of> "Iron_dextran" .
<Claro> <Brand_name_of> "Folinic_acid" .
<Etoposide,_Ifosfamide,_Imatinib> <Has_context> "Consolidation_after_upfront_therapy" .
<Sylvant> <Brand_name_of> "Siltuximab" .
<Dexametrat> <Brand_name_of> "Dexamethasone" .
<Pacritinib> <May_have_route> "Oral" .
<Cyclophosphamide_and_Vincristine> <Has_accepted_use> "Neuroblastoma" .
<Crobextin> <Brand_name_of> "Carboplatin" .
<Alemtuzumab_and_Methylprednisolone> <Has_context> "Non-curative_first-line_therapy" .
<BFR> <Maps_to> "BFR" .
<Cyclosporine,_Methotrexate,_Prednisone> <Has_accepted_use> "Graft_versus_host_disease" .
<Androgen_receptor_inhibitor> <Subsumes> "Steroidal_androgen_receptor_inhibitor" .
<T-cell_neoplasm> <Subsumes> "T-cell_lymphoma" .
<T-cell_neoplasm> <Subsumes> "T-cell_leukemia" .
<Cytarabine_and_Mitoxantrone> <Has_modality> "Chemotherapy" .
<BTD> <Maps_to> "BTD" .
<BVB> <Is_current_in> "Hodgkin_lymphoma" .
<FOLFOXIRI_and_Panitumumab> <Has_antineoplastic> "Panitumumab" .
<FOLFOXIRI_and_Panitumumab> <Has_antineoplastic> "Oxaliplatin" .
<FOLFOXIRI_and_Panitumumab> <Has_antineoplastic> "Levoleucovorin" .
<FOLFOXIRI_and_Panitumumab> <Has_antineoplastic> "Irinotecan" .
<FOLFOXIRI_and_Panitumumab> <Has_antineoplastic> "Fluorouracil" .
<Genuxal> <Brand_name_of> "Cyclophosphamide" .
<Primazol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<PVD> <Is_current_in> "Multiple_myeloma" .
<M-EI> <Is_current_in> "Osteosarcoma" .
<Avatrombopag_monotherapy> <Has_supportive_med> "Avatrombopag" .
<Kotazol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<UFTM> <Is_current_in> "Gastric_cancer" .
<FluCam> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Floxuridine> <Antineoplastic_of> "Hepatic_arterial_chemotherapy" .
<CEEP> <Has_modality> "Chemotherapy" .
<CRd> <Has_supportive_med> "Warfarin" .
<CRd> <Has_supportive_med> "Valacyclovir" .
<CRd> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<CRd> <Has_supportive_med> "Proton_pump_inhibitors" .
<CRd> <Has_supportive_med> "Low_molecular_weight_heparins" .
<CRd> <Has_supportive_med> "Aspirin" .
<FOLFOX_chronotherapy> <Is_historical_in> "Colon_cancer" .
<Lioplim> <Brand_name_of> "Filgrastim" .
<DHAP> <Mapped_from> "DHAP" .
<ABV_(Vinblastine)> <Maps_to> "ABV_(Vinblastine)" .
<R-CHOP-14_(Rituximab_Hycela)> <Mapped_from> "R-CHOP-14_(Rituximab_Hycela)" .
<Bacillus_Calmette-Guerin_(BCG)_monotherapy> <Mapped_from> "Bacillus_Calmette-Guerin_(BCG)_monotherapy" .
<Biodel> <Brand_name_of> "Carmustine_wafer_polifeprosan_20" .
<VBM> <Has_modality> "Chemotherapy" .
<CCE> <Maps_to> "CCE" .
<Plicamycin_monotherapy> <Maps_to> "Plicamycin_monotherapy" .
<Doxorubicin_pegylated_liposomal_and_Bevacizumab> <Mapped_from> "Doxorubicin_pegylated_liposomal_and_Bevacizumab" .
<Malignant_breast_neoplasm> <Is_a> "Malignant_solid_neoplasm" .
<eBEACOPP_(Prednisolone)> <Has_modality> "Chemotherapy" .
<CVP_(Vinblastine/Prednisone)> <Maps_to> "CVP_(Vinblastine/Prednisone)" .
<m-BACOD> <Has_accepted_use> "HIV-associated_lymphoma" .
<m-BACOD> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<MA> <Has_antineoplastic> "Methotrexate" .
<MA> <Has_antineoplastic> "Doxorubicin" .
<BRAF_inhibitor> <Is_a> "Kinase_inhibitor" .
<Ipilimumab_and_Nivolumab> <Has_modality> "Immunotherapy" .
<Arsenic_trioxide_and_Idarubicin> <Has_modality> "Chemotherapy" .
<Docetaxel_and_Vinorelbine> <Has_antineoplastic> "Vinorelbine" .
<Docetaxel_and_Vinorelbine> <Has_antineoplastic> "Docetaxel" .
<VAdCA/IE> <Is_current_in> "Ewing_sarcoma" .
<Cyclophosphamide,_Etoposide,_TBI> <Mapped_from> "Cyclophosphamide,_Etoposide,_TBI" .
<IT_Cytarabine_and_WBRT> <Mapped_from> "IT_Cytarabine_and_WBRT" .
<CHOEP-21> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<CHOEP-21> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<IT_Cytarabine,_Methotrexate,_WBRT> <Has_accepted_use> "CNS_leukemia" .
<Sandostatine> <Brand_name_of> "Octreotide" .
<VIP> <Maps_to> "VIP" .
<Ketoconazole,_Hydrocortisone,_Dutasteride> <Has_antineoplastic> "Ketoconazole" .
<Ketoconazole,_Hydrocortisone,_Dutasteride> <Has_antineoplastic> "Hydrocortisone" .
<Ketoconazole,_Hydrocortisone,_Dutasteride> <Has_antineoplastic> "Dutasteride" .
<FCR> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<FCR> <Has_accepted_use> "Mantle_cell_lymphoma" .
<FCR> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<FCR> <Has_accepted_use> "Allogeneic_HSCT" .
<Cetuximab> <Has_FDA_indication> "Head_and_neck_cancer" .
<Cetuximab> <Has_FDA_indication> "Colon_cancer" .
<Chemoradiotherapy> <Maps_to> "Chemoradiotherapy" .
<Rivaroxaban_monotherapy> <Mapped_from> "Rivaroxaban_monotherapy" .
<DICE> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Folinic_acid> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Folinic_acid> <Is_a> "Chemotherapy_protective_agent" .
<VTP> <Has_context> "Non-curative_first-line_therapy" .
<Motilium> <Brand_name_of> "Domperidone" .
<Ethyol> <Brand_name_of> "Amifostine" .
<Pralatrexate_monotherapy> <Has_modality> "Chemotherapy" .
<Defibrotide_monotherapy> <Has_accepted_use> "Allogeneic_HSCT" .
<Kinase_inhibitor> <Is_a> "Chemotherapeutic" .
<Epox> <Brand_name_of> "Epoetin_alfa" .
<Rituximab_and_hyaluronidase_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<Fotemustine> <Has_accepted_use> "Uveal_melanoma" .
<Fotemustine> <Has_accepted_use> "Melanoma" .
<Phosphodiesterase_inhibitor> <Is_a> "Classical_hematology_medication" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Vinorelbine_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Tegafur_and_Uracil" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Sorafenib_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "S-1_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Radiation_therapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Placebo" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Pemetrexed_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Pemetrexed_and_Pembrolizumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Pemetrexed_and_Bevacizumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Pembrolizumab_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Osimertinib_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Observation" .
<Non-small_cell_lung_cancer> <Current_treated_by> "No_neoadjuvant_therapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "No_induction" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Nivolumab_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Nintedanib_and_Pemetrexed" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Necitumumab_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Lorlatinib_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Ipilimumab_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Ipilimumab_and_Nivolumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Icotinib_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Gemcitabine_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Gemcitabine_and_Vinorelbine" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Gemcitabine_and_Paclitaxel" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Gefitinib_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Gefitinib_and_Pemetrexed" .
<Non-small_cell_lung_cancer> <Current_treated_by> "GCP" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Erlotinib_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Erlotinib_and_Ramucirumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Erlotinib_and_Bevacizumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Entrectinib_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Durvalumab_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Docetaxel_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Docetaxel_and_Vinorelbine" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Docetaxel_and_Vandetanib" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Docetaxel_and_Ramucirumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Docetaxel_and_Nintedanib" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Docetaxel_and_Nedaplatin" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Docetaxel_and_Bevacizumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Dacomitinib_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Dabrafenib_and_Trametinib" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Crizotinib_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin,_Vinorelbine,_RT" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin,_Vinorelbine,_Cetuximab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin,_Vinblastine,_RT" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin,_Pemetrexed,_Pembrolizumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin,_Pemetrexed,_Bevacizumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin,_Gemcitabine,_Necitumumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin,_Gemcitabine,_Bevacizumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin,_Etoposide,_RT" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin,_Docetaxel,_RT" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin_and_Vinorelbine" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin_and_Vindesine" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin_and_Vinblastine" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin_and_RT" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin_and_Pemetrexed" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin_and_Paclitaxel" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin_and_Irinotecan" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin_and_Gemcitabine/Erlotinib" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin_and_Gemcitabine" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin_and_Etoposide" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cisplatin_and_Docetaxel" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Ceritinib_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Carboplatin,_nab-Paclitaxel,_Pembrolizumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Carboplatin,_nab-Paclitaxel,_Atezolizumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Carboplatin,_Vinorelbine,_RT" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Carboplatin,_Pemetrexed,_Pembrolizumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Carboplatin,_Pemetrexed,_Bevacizumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Carboplatin,_Paclitaxel,_RT" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Carboplatin,_Paclitaxel,_Pembrolizumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Carboplatin,_Paclitaxel,_Ipilimumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Carboplatin,_Paclitaxel,_Bevacizumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Carboplatin_and_nab-Paclitaxel" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Carboplatin_and_Vinorelbine" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Carboplatin_and_RT" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Carboplatin_and_Pemetrexed" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Carboplatin_and_Paclitaxel" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Carboplatin_and_Gemcitabine/Erlotinib" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Carboplatin_and_Gemcitabine" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Carboplatin_and_Etoposide" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Carboplatin_and_Docetaxel" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cabozantinib_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Cabozantinib_and_Erlotinib" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Brigatinib_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Bevacizumab_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Best_supportive_care" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Atezolizumab_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Atezolizumab_and_Bevacizumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Amrubicin_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Alectinib_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Afatinib_monotherapy" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Afatinib_and_Paclitaxel" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Afatinib_and_Cetuximab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "Afatinib_and_Bevacizumab" .
<Non-small_cell_lung_cancer> <Current_treated_by> "ABCP" .
<IFL_and_Bevacizumab> <Has_antineoplastic> "Irinotecan" .
<IFL_and_Bevacizumab> <Has_antineoplastic> "Folinic_acid" .
<IFL_and_Bevacizumab> <Has_antineoplastic> "Fluorouracil" .
<IFL_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Procytox> <Brand_name_of> "Cyclophosphamide" .
<CAV> <Has_context> "Non-curative_therapy" .
<CAV> <Has_context> "Induction_therapy" .
<Steerometz> <Brand_name_of> "Prednisone" .
<COPA> <Has_antineoplastic> "Vincristine" .
<COPA> <Has_antineoplastic> "Prednisone" .
<COPA> <Has_antineoplastic> "Doxorubicin" .
<COPA> <Has_antineoplastic> "Cyclophosphamide" .
<Tazemetostat_monotherapy> <Has_accepted_use> "Epithelioid_sarcoma" .
<Fluorouracil> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Fluorouracil> <Is_a> "Irritant" .
<Fluorouracil> <Is_a> "Fluoropyrimidine" .
<Intermittent_ADT> <Has_modality> "Hormonotherapy" .
<BR_and_Polatuzumab_vedotin> <Has_modality> "Chemotherapy" .
<eBEACOPP> <Has_antineoplastic> "Vincristine" .
<eBEACOPP> <Has_antineoplastic> "Procarbazine" .
<eBEACOPP> <Has_antineoplastic> "Prednisone" .
<eBEACOPP> <Has_antineoplastic> "Etoposide" .
<eBEACOPP> <Has_antineoplastic> "Doxorubicin" .
<eBEACOPP> <Has_antineoplastic> "Cyclophosphamide" .
<eBEACOPP> <Has_antineoplastic> "Bleomycin" .
<Arsenic_trioxide> <Antineoplastic_of> "Arsenic_trioxide,_then_ATRA_and_Daunorubicin" .
<Arsenic_trioxide> <Antineoplastic_of> "Arsenic_trioxide,_ATRA,_Idarubicin" .
<Arsenic_trioxide> <Antineoplastic_of> "Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin" .
<Arsenic_trioxide> <Antineoplastic_of> "Arsenic_trioxide_monotherapy" .
<Arsenic_trioxide> <Antineoplastic_of> "Arsenic_trioxide_and_Idarubicin" .
<Arsenic_trioxide> <Antineoplastic_of> "Arsenic_trioxide_and_Chlorambucil" .
<Arsenic_trioxide> <Antineoplastic_of> "Arsenic_trioxide_and_ATRA" .
<Tocilizumab> <Immunosuppressor_of> "Tocilizumab_monotherapy" .
<Tocilizumab> <Immunosuppressor_of> "Methotrexate,_Tacrolimus,_Tocilizumab" .
<MAID> <Has_context> "Non-curative_therapy" .
<R-MCP_(CCNU)> <Has_modality> "Chemotherapy" .
<Trisulfa> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Carboplatin,_nab-Paclitaxel,_Pembrolizumab> <Has_antineoplastic> "Pembrolizumab" .
<Carboplatin,_nab-Paclitaxel,_Pembrolizumab> <Has_antineoplastic> "Paclitaxel_nanoparticle_albumin-bound" .
<Carboplatin,_nab-Paclitaxel,_Pembrolizumab> <Has_antineoplastic> "Carboplatin" .
<7_plus_3d_and_Sorafenib> <Has_context> "Non-curative_first-line_induction_therapy" .
<Zoledronic_acid> <Has_brand_name> "Zyfoss" .
<Zoledronic_acid> <Has_brand_name> "Zometa" .
<Zoledronic_acid> <Has_brand_name> "Zomera" .
<Zoledronic_acid> <Has_brand_name> "Zoldonat" .
<Zoledronic_acid> <Has_brand_name> "Zobone" .
<Zoledronic_acid> <Has_brand_name> "Servycal" .
<Zoledronic_acid> <Has_brand_name> "Reclast" .
<Zoledronic_acid> <Has_brand_name> "Cytozol" .
<Zoledronic_acid> <Has_brand_name> "Blaztere" .
<Zoledronic_acid> <Has_brand_name> "Aclasta" .
<Lupidexa> <Brand_name_of> "Dexamethasone" .
<Corsum> <Brand_name_of> "Dexamethasone" .
<Thrombocytopenia_in_liver_disease> <Is_a> "Cytopenia" .
<Pipobroman_monotherapy> <Mapped_from> "Pipobroman_monotherapy" .
<Antibody-drug_conjugate> <Is_a> "Chemotherapeutic" .
<Antibody-drug_conjugate> <Is_a> "Antibody_medication" .
<Anti-PD-1_antibody> <Is_a> "Antibody_medication" .
<Talazoparib_monotherapy> <Has_modality> "Chemotherapy" .
<Ormoprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<ACVBP-R> <Has_modality> "Chemotherapy" .
<Doxorubicin_and_Strontium-89> <Mapped_from> "Doxorubicin_and_Strontium-89" .
<TC_(Taxotere)> <Has_accepted_use> "Breast_cancer" .
<Doxorubicin_and_Streptozocin> <Has_accepted_use> "Pancreatic_NET" .
<Cladribine_and_Cytarabine> <Has_antineoplastic> "Cytarabine" .
<Cladribine_and_Cytarabine> <Has_antineoplastic> "Cladribine" .
<ABVD> <Is_a> "Anthracycline-containing_regimen" .
<Idarubicin,_then_Mitoxantrone,_then_Idarubicin> <Is_a> "Anthracycline-containing_regimen" .
<Vinblastine> <Has_accepted_use> "Testicular_cancer" .
<Vinblastine> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Vinblastine> <Has_accepted_use> "Melanoma" .
<Vinblastine> <Has_accepted_use> "Langerhans_cell_histiocytosis" .
<Vinblastine> <Has_accepted_use> "Kaposi_sarcoma" .
<Vinblastine> <Has_accepted_use> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<Vinblastine> <Has_accepted_use> "Hodgkin_lymphoma" .
<Vinblastine> <Has_accepted_use> "HIV-associated_lymphoma" .
<Vinblastine> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Vinblastine> <Has_accepted_use> "Breast_cancer" .
<Vinblastine> <Has_accepted_use> "Bladder_cancer" .
<CCI> <Has_context> "Non-curative_first-line_therapy" .
<Ibrutinib_and_Rituximab> <Mapped_from> "Ibrutinib_and_Rituximab" .
<Topotecan_monotherapy> <Has_context> "Non-curative_therapy" .
<Topotecan_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Topotecan_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<EBVP> <Has_modality> "Chemotherapy" .
<Doxorubicin_and_Strontium-89> <Has_modality> "Radiotherapy" .
<Doxorubicin_and_Strontium-89> <Has_modality> "Chemotherapy" .
<Goserelin> <May_have_route> "Subcutaneous" .
<Hydroxyurea_and_Plicamycin> <Has_context> "Induction_therapy" .
<7_plus_3d_and_Midostaurin> <Has_antineoplastic> "Midostaurin" .
<7_plus_3d_and_Midostaurin> <Has_antineoplastic> "Daunorubicin" .
<7_plus_3d_and_Midostaurin> <Has_antineoplastic> "Cytarabine" .
<Enoxaparin_monotherapy> <Mapped_from> "Enoxaparin_monotherapy" .
<Alimta> <Brand_name_of> "Pemetrexed" .
<Heparin_monotherapy> <Has_context> "All_lines_of_therapy" .
<FC,_then_allo_HSCT> <Has_antineoplastic> "Fludarabine" .
<FC,_then_allo_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<FC,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<Cismaplat> <Brand_name_of> "Cisplatin" .
<CPB> <Maps_to> "CPB" .
<Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA> <Has_antineoplastic> "Mitoxantrone" .
<Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA> <Has_antineoplastic> "Idarubicin" .
<Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA> <Has_antineoplastic> "Cytarabine" .
<Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA> <Has_antineoplastic> "All-trans_retinoic_acid" .
<CALGB_8811_early_intensification> <Has_modality> "Chemotherapy" .
<Chemohormonotherapy> <Mapped_from> "Chemohormonotherapy" .
<Defibrotide_monotherapy> <Maps_to> "Defibrotide_monotherapy" .
<Metex> <Brand_name_of> "Methotrexate" .
<Cisplatin,_Dacarbazine,_Tamoxifen> <Has_accepted_use> "Melanoma" .
<EC> <Has_modality> "Chemotherapy" .
<GVP> <Is_current_in> "Hodgkin_lymphoma" .
<IT_Cytarabine_monotherapy> <Is_current_in> "CNS_lymphoma" .
<Sulprimed> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Sbpa_Trimeth_Smeth> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Tinzaparin> <Supportive_med_of> "Tinzaparin_monotherapy" .
<Cyclosporine> <Is_a> "Calcineurin_inhibitor" .
<M-DEX> <Maps_to> "M-DEX" .
<ABP> <Has_context> "Induction_therapy" .
<Deferiprone> <Has_brand_name> "Ferriprox" .
<CLF> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<CLF> <Has_supportive_med> "Methylprednisolone" .
<Dexaderme> <Brand_name_of> "Dexamethasone" .
<Glasdegib> <Antineoplastic_of> "Glasdegib_and_LoDAC" .
<Glasdegib> <Antineoplastic_of> "7_plus_3d_and_Glasdegib" .
<Brifeseptol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bevacizumab_monotherapy> <Has_supportive_med> "Steroids" .
<Bevacizumab_monotherapy> <Has_supportive_med> "Filgrastim" .
<VR> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<VR> <Is_current_in> "Mantle_cell_lymphoma" .
<VR> <Is_current_in> "Follicular_lymphoma" .
<Bortezomib_and_Cyclophosphamide> <Has_supportive_med> "Valacyclovir" .
<Everolimus> <Has_FDA_indication> "Renal_cell_carcinoma" .
<Everolimus> <Has_FDA_indication> "Pancreatic_NET" .
<Everolimus> <Has_FDA_indication> "Neuroendocrine_tumor" .
<Everolimus> <Has_FDA_indication> "Breast_cancer" .
<Gastric_cancer> <Is_a> "Gastroesophageal_cancer" .
<Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant> <Maps_to> "Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant" .
<R-BAC> <Mapped_from> "R-BAC" .
<Drylin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Defibrotide_monotherapy> <Has_modality> "Supportive_therapy" .
<EverGraf> <Brand_name_of> "Everolimus" .
<POMP> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<POMP> <Is_historical_in> "Acute_myeloid_leukemia" .
<Cisplatin,_Fluorouracil,_Vincristine> <Has_antineoplastic> "Vincristine" .
<Cisplatin,_Fluorouracil,_Vincristine> <Has_antineoplastic> "Fluorouracil" .
<Cisplatin,_Fluorouracil,_Vincristine> <Has_antineoplastic> "Cisplatin" .
<CHOP-B> <Mapped_from> "CHOP-B" .
<Dexamethasone_and_Eltrombopag> <Has_modality> "Immunosuppressive_therapy" .
<Dexamethasone_and_Eltrombopag> <Has_modality> "Growth_factor_therapy" .
<Copanlisib> <Is_a> "PI3K_delta_inhibitor" .
<Copanlisib> <Is_a> "PI3K_alpha_inhibitor" .
<Copanlisib> <Is_a> "Kinase_inhibitor" .
<Infigratinib> <Is_a> "Investigational_drug" .
<Infigratinib> <Is_a> "FGFR_inhibitor" .
<Ulup> <Brand_name_of> "Fluorouracil" .
<VeIP> <Has_modality> "Chemotherapy" .
<Panobinostat_monotherapy> <Has_context> "Non-curative_therapy" .
<Panobinostat_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Panobinostat_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<MAP> <Is_current_in> "Osteosarcoma" .
<Dalteparin> <Supportive_med_of> "Dalteparin_monotherapy" .
<ATG_(Rabbit)_and_Cyclosporine> <Mapped_from> "ATG_(Rabbit)_and_Cyclosporine" .
<Toremifene> <Is_a> "Selective_estrogen_receptor_modulator" .
<Toremifene> <Is_a> "Protein_expression-specific_medication" .
<Toremifene> <Is_a> "Endocrine_therapeutic" .
<Busulfan_monotherapy> <Is_current_in> "Chronic_myelogenous_leukemia" .
<ddC> <Mapped_from> "ddC" .
<Megestrol> <Has_accepted_use> "Endometrial_cancer" .
<Non-curative_second-line_induction_therapy> <Is_a> "Non-curative_second-line_therapy" .
<Vorinostat_monotherapy> <Has_modality> "Chemotherapy" .
<Vinorelbine_and_Bevacizumab> <Has_accepted_use> "Breast_cancer" .
<Arsenic_trioxide_monotherapy> <Has_modality> "Chemotherapy" .
<Flutamide_and_Goserelin> <Has_accepted_use> "Prostate_cancer" .
<Cisplatin_and_Fluorouracil> <Has_supportive_med> "Ondansetron" .
<Cisplatin_and_Fluorouracil> <Has_supportive_med> "Metoclopramide" .
<Cisplatin_and_Fluorouracil> <Has_supportive_med> "Loperamide" .
<Cisplatin_and_Fluorouracil> <Has_supportive_med> "Filgrastim" .
<Cisplatin_and_Fluorouracil> <Has_supportive_med> "Emesis_prevention" .
<Cisplatin_and_Fluorouracil> <Has_supportive_med> "Dexamethasone" .
<Cisplatin_and_Fluorouracil> <Has_supportive_med> "Atropine" .
<CMFL> <Has_antineoplastic> "Methotrexate" .
<CMFL> <Has_antineoplastic> "Folinic_acid" .
<CMFL> <Has_antineoplastic> "Fluorouracil" .
<CMFL> <Has_antineoplastic> "Cyclophosphamide" .
<Clofarabine_monotherapy> <Is_current_in> "Myelodysplastic_syndrome" .
<Clofarabine_monotherapy> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Clofarabine_monotherapy> <Is_current_in> "Acute_myeloid_leukemia" .
<MAID> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Huma_ASA> <Brand_name_of> "Aspirin" .
<Methotrexate,_then_Cytarabine> <Has_supportive_med> "Folinic_acid" .
<Methotrexate,_then_Cytarabine> <Has_supportive_med> "Filgrastim" .
<Brentuximab_vedotin_monotherapy> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Brentuximab_vedotin_monotherapy> <Has_accepted_use> "Mediastinal_gray-zone_lymphoma" .
<Brentuximab_vedotin_monotherapy> <Has_accepted_use> "Hodgkin_lymphoma" .
<Brentuximab_vedotin_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Brentuximab_vedotin_monotherapy> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Brentuximab_vedotin_monotherapy> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<DA-R-EPOCH> <Has_modality> "Chemotherapy" .
<Tricot> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<THP_(Taxotere)> <Is_current_in> "Breast_cancer" .
<Sunitinib_monotherapy> <Has_antineoplastic> "Sunitinib" .
<Graprima> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Megestrol_monotherapy> <Mapped_from> "Megestrol_monotherapy" .
<Allibac> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<ERBB2_inhibitor> <Is_a> "Kinase_inhibitor" .
<ERBB2_inhibitor> <Is_a> "Anti-HER2_medication" .
<Intravenous_immunoglobulin_monotherapy> <Has_accepted_use> "Immune_thrombocytopenia" .
<ddAC> <Has_modality> "Chemotherapy" .
<R-DHAP/R-VIM> <Maps_to> "R-DHAP/R-VIM" .
<Minusorb> <Brand_name_of> "Alendronate" .
<Everolimus> <Antineoplastic_of> "RVR" .
<Everolimus> <Antineoplastic_of> "Hyper-CVAD/MA_and_Everolimus" .
<Everolimus> <Antineoplastic_of> "Everolimus_monotherapy" .
<Everolimus> <Antineoplastic_of> "Everolimus_and_Tamoxifen" .
<Everolimus> <Antineoplastic_of> "Everolimus_and_Rituximab" .
<Everolimus> <Antineoplastic_of> "Everolimus_and_Octreotide" .
<Everolimus> <Antineoplastic_of> "Everolimus_and_Lenvatinib" .
<Everolimus> <Antineoplastic_of> "Everolimus_and_Exemestane" .
<Everolimus> <Antineoplastic_of> "CHOP_and_Everolimus" .
<PVeBV> <Maps_to> "PVeBV" .
<Pemibenz> <Brand_name_of> "Pemetrexed" .
<LSG15> <Has_antineoplastic> "Vindesine" .
<LSG15> <Has_antineoplastic> "Vincristine" .
<LSG15> <Has_antineoplastic> "Ranimustine" .
<LSG15> <Has_antineoplastic> "Prednisone" .
<LSG15> <Has_antineoplastic> "Etoposide" .
<LSG15> <Has_antineoplastic> "Doxorubicin" .
<LSG15> <Has_antineoplastic> "Cyclophosphamide" .
<LSG15> <Has_antineoplastic> "Carboplatin" .
<mFOLFOX6_and_Bevacizumab_(L-Leucovorin)> <Maps_to> "mFOLFOX6_and_Bevacizumab_(L-Leucovorin)" .
<Pancreatic_cancer> <Current_treated_by> "nab-Paclitaxel_monotherapy" .
<Pancreatic_cancer> <Current_treated_by> "mFOLFIRINOX,_Gemcitabine,_RT" .
<Pancreatic_cancer> <Current_treated_by> "mFOLFIRINOX" .
<Pancreatic_cancer> <Current_treated_by> "S-1_monotherapy" .
<Pancreatic_cancer> <Current_treated_by> "Radiation_therapy" .
<Pancreatic_cancer> <Current_treated_by> "Placebo" .
<Pancreatic_cancer> <Current_treated_by> "PEFG" .
<Pancreatic_cancer> <Current_treated_by> "Olaparib_monotherapy" .
<Pancreatic_cancer> <Current_treated_by> "Observation" .
<Pancreatic_cancer> <Current_treated_by> "OLF" .
<Pancreatic_cancer> <Current_treated_by> "Irinotecan_liposomal_monotherapy" .
<Pancreatic_cancer> <Current_treated_by> "Gemcitabine/Fluorouracil_and_RT" .
<Pancreatic_cancer> <Current_treated_by> "Gemcitabine,_Cetuximab,_RT" .
<Pancreatic_cancer> <Current_treated_by> "Gemcitabine_monotherapy" .
<Pancreatic_cancer> <Current_treated_by> "Gemcitabine_and_nab-Paclitaxel" .
<Pancreatic_cancer> <Current_treated_by> "Gemcitabine_and_RT" .
<Pancreatic_cancer> <Current_treated_by> "GemOx" .
<Pancreatic_cancer> <Current_treated_by> "GTX" .
<Pancreatic_cancer> <Current_treated_by> "Fluorouracil/Fluorouracil_and_RT" .
<Pancreatic_cancer> <Current_treated_by> "Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan" .
<Pancreatic_cancer> <Current_treated_by> "Fluorouracil_monotherapy" .
<Pancreatic_cancer> <Current_treated_by> "Fluorouracil_and_RT" .
<Pancreatic_cancer> <Current_treated_by> "Fluorouracil_and_Folinic_acid" .
<Pancreatic_cancer> <Current_treated_by> "FOLFOX" .
<Pancreatic_cancer> <Current_treated_by> "FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation" .
<Pancreatic_cancer> <Current_treated_by> "FOLFIRINOX" .
<Pancreatic_cancer> <Current_treated_by> "FOLFIRI" .
<Pancreatic_cancer> <Current_treated_by> "FLEC" .
<Pancreatic_cancer> <Current_treated_by> "Erlotinib_and_Gemcitabine" .
<Pancreatic_cancer> <Current_treated_by> "Docetaxel,_Gemcitabine,_RT" .
<Pancreatic_cancer> <Current_treated_by> "Cisplatin_and_Gemcitabine" .
<Pancreatic_cancer> <Current_treated_by> "Capecitabine_monotherapy" .
<Pancreatic_cancer> <Current_treated_by> "Capecitabine_and_Gemcitabine" .
<Pancreatic_cancer> <Current_treated_by> "Capecitabine_and_Erlotinib" .
<Pancreatic_cancer> <Current_treated_by> "CapeOx" .
<Pancreatic_cancer> <Current_treated_by> "Best_supportive_care" .
<L-glutamine> <Has_FDA_indication> "Sickle_cell_anemia" .
<Axicabtagene_ciloleucel> <May_have_route> "Intravenous" .
<Betrixaban> <Has_accepted_use> "Venous_thromboembolism" .
<Olaparib_monotherapy> <Has_context> "Non-curative_therapy" .
<Olaparib_monotherapy> <Has_context> "Non-curative_second-line_maintenance_therapy" .
<Olaparib_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Pamisol> <Brand_name_of> "Pamidronate" .
<Chlorambucil_monotherapy> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Chlorambucil_monotherapy> <Has_supportive_med> "Prednisolone" .
<Chlorambucil_monotherapy> <Has_supportive_med> "Pentamidine" .
<Prednisolone> <Immunosuppressor_of> "Prednisolone_monotherapy" .
<Prednisolone> <Immunosuppressor_of> "Prednisolone_and_Rituximab" .
<Prednisolone> <Immunosuppressor_of> "Cyclophosphamide_and_Prednisolone" .
<Thalidomide_monotherapy> <Has_context> "Non-curative_therapy" .
<Thalidomide_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Thalidomide_monotherapy> <Has_context> "All_lines_of_therapy" .
<Chlorambucil_and_Ofatumumab> <Has_supportive_med> "Steroids" .
<Chlorambucil_and_Ofatumumab> <Has_supportive_med> "Antihistamines" .
<Chlorambucil_and_Ofatumumab> <Has_supportive_med> "Acetaminophen" .
<ABVE-PC> <Has_antineoplastic> "Vincristine" .
<ABVE-PC> <Has_antineoplastic> "Prednisone" .
<ABVE-PC> <Has_antineoplastic> "Etoposide" .
<ABVE-PC> <Has_antineoplastic> "Doxorubicin" .
<ABVE-PC> <Has_antineoplastic> "Cyclophosphamide" .
<ABVE-PC> <Has_antineoplastic> "Bleomycin" .
<Fosaalen> <Brand_name_of> "Alendronate" .
<Noveldexis> <Brand_name_of> "Cisplatin" .
<PAD/VCD> <Maps_to> "PAD/VCD" .
<Vincristine> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Vincristine> <Is_a> "Vinca_alkaloid" .
<Vincristine> <Is_a> "Vesicant" .
<Vincristine> <Is_a> "Microtubule_inhibitor" .
<Vincristine> <Is_a> "Colon_cancer_medications_(historic)" .
<Vincristine> <Is_a> "Breast_cancer_medications_(historic)" .
<mFOLFOX6_(L-Leucovorin)> <Has_context> "Non-curative_therapy" .
<mFOLFOX6_(L-Leucovorin)> <Has_context> "Non-curative_first-line_therapy" .
<mFOLFOX6_(L-Leucovorin)> <Has_context> "Adjuvant_therapy" .
<Cisplatin_and_Dacarbazine> <Is_a> "Platinum_doublet" .
<R-CHOP_(Rituximab_Hycela)> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone> <Maps_to> "Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone" .
<Thrombocytopenia_in_liver_disease> <FDA_indication_of> "Lusutrombopag" .
<Thrombocytopenia_in_liver_disease> <FDA_indication_of> "Avatrombopag" .
<RVDC> <Maps_to> "RVDC" .
<CHVmP-VB> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Antithymocyte_globulin_rabbit_ATG> <Is_a> "Fractionated_plasma_product" .
<Antithymocyte_globulin_rabbit_ATG> <Is_a> "Antithymocyte_globulin" .
<Trastuzumab_monotherapy> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<Trastuzumab_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Romiplostim_monotherapy> <Maps_to> "Romiplostim_monotherapy" .
<TX_(Taxotere)> <Has_accepted_use> "Breast_cancer" .
<Imatinib-based_consolidation> <Has_local_therapy> "Methotrexate" .
<VCP> <Has_modality> "Chemotherapy" .
<CTCb> <Has_antineoplastic> "Thiotepa" .
<CTCb> <Has_antineoplastic> "Cyclophosphamide" .
<CTCb> <Has_antineoplastic> "Carboplatin" .
<Avapritinib_monotherapy> <Has_modality> "Chemotherapy" .
<Doxorubicin_and_Streptozocin> <Is_current_in> "Pancreatic_NET" .
<Anastrozole_monotherapy> <Mapped_from> "Anastrozole_monotherapy" .
<Ruxolitinib_monotherapy> <Has_modality> "Chemotherapy" .
<CCOP> <Has_modality> "Chemotherapy" .
<Obinutuzumab> <Antineoplastic_of> "Venetoclax_and_Obinutuzumab" .
<Obinutuzumab> <Antineoplastic_of> "Obinutuzumab_monotherapy" .
<Obinutuzumab> <Antineoplastic_of> "Ibrutinib_and_Obinutuzumab" .
<Obinutuzumab> <Antineoplastic_of> "G-FC" .
<Obinutuzumab> <Antineoplastic_of> "G-CVP" .
<Obinutuzumab> <Antineoplastic_of> "G-CHOP" .
<Obinutuzumab> <Antineoplastic_of> "Chlorambucil_and_Obinutuzumab" .
<Obinutuzumab> <Antineoplastic_of> "Bendamustine_and_Obinutuzumab" .
<Lutetium_Lu_177_dotatate> <Is_a> "Radiotherapy_medication" .
<Lutetium_Lu_177_dotatate> <Is_a> "Protein_expression-specific_medication" .
<Gonapeptyl> <Brand_name_of> "Triptorelin" .
<Docetaxel_and_Vinorelbine> <Has_context> "Non-curative_first-line_therapy" .
<Accelerated_BEP> <Mapped_from> "Accelerated_BEP" .
<R-EPOCH> <Has_modality> "Chemotherapy" .
<O-DHAP> <Has_modality> "Chemotherapy" .
<TAM6> <Has_antineoplastic> "Melphalan" .
<TAM6> <Has_antineoplastic> "External_beam_radiotherapy" .
<TAM6> <Has_antineoplastic> "Cytarabine" .
<Proscar> <Brand_name_of> "Finasteride" .
<CAMP> <Is_a> "Anthracycline-containing_regimen" .
<Docetaxel_and_S-1> <Has_context> "Non-curative_first-line_therapy" .
<Docetaxel_and_S-1> <Has_context> "Adjuvant_therapy" .
<Temozolomide> <May_have_route> "Oral" .
<Temozolomide> <May_have_route> "Intravenous" .
<Carboplatin,_Etoposide,_Bevacizumab> <Has_modality> "Chemotherapy" .
<Doxorubicin_pegylated_liposomal_and_Gemcitabine> <Mapped_from> "Doxorubicin_pegylated_liposomal_and_Gemcitabine" .
<Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b> <Maps_to> "Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b" .
<Idelalisib_monotherapy> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<Idelalisib_monotherapy> <Is_current_in> "Marginal_zone_lymphoma" .
<Idelalisib_monotherapy> <Is_current_in> "Follicular_lymphoma" .
<Idelalisib_monotherapy> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<R-M-CHOP> <Has_local_therapy> "Methotrexate" .
<R-M-CHOP> <Has_local_therapy> "External_beam_radiotherapy" .
<DAC> <Has_context> "Induction_therapy" .
<Doxorubicin_and_Ifosfamide> <Has_context> "Non-curative_therapy" .
<Iron> <Subsumes> "Iron_sucrose" .
<Iron> <Subsumes> "Iron_dextran" .
<Iron> <Subsumes> "Ferumoxytol" .
<Iron> <Subsumes> "Ferrous_sulfate" .
<Iron> <Subsumes> "Ferric_gluconate" .
<Iron> <Subsumes> "Ferric_carboxymaltose" .
<m-BACOD> <Has_antineoplastic> "Vincristine" .
<m-BACOD> <Has_antineoplastic> "Methotrexate" .
<m-BACOD> <Has_antineoplastic> "Doxorubicin" .
<m-BACOD> <Has_antineoplastic> "Dexamethasone" .
<m-BACOD> <Has_antineoplastic> "Cyclophosphamide" .
<m-BACOD> <Has_antineoplastic> "Bleomycin" .
<Zytoxan> <Brand_name_of> "Cyclophosphamide" .
<Moxzole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Radilem> <Brand_name_of> "Methylprednisolone" .
<Etoposide_and_Prednisone> <Mapped_from> "Etoposide_and_Prednisone" .
<COPAD> <Maps_to> "COPAD" .
<BRAF-mutated_Melanoma> <Is_a> "Melanoma" .
<Samarium-153_with_stem_cell_support> <Mapped_from> "Samarium-153_with_stem_cell_support" .
<Arsenic_trioxide_and_Idarubicin> <Maps_to> "Arsenic_trioxide_and_Idarubicin" .
<Bosatria> <Brand_name_of> "Mepolizumab" .
<Paclitaxel_and_Vinorelbine> <Is_current_in> "Breast_cancer" .
<Raloxifene> <Is_a> "Selective_estrogen_receptor_modulator" .
<Raloxifene> <Is_a> "Endocrine_therapeutic" .
<VCAP> <Is_a> "Anthracycline-containing_regimen" .
<CEEP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Provera> <Brand_name_of> "Medroxyprogesterone" .
<Vinblastine_monotherapy> <Has_antineoplastic> "Vinblastine" .
<Radium-223> <Has_FDA_indication> "Prostate_cancer" .
<M-BCD> <Is_current_in> "Osteosarcoma" .
<Savene> <Brand_name_of> "Dexrazoxane" .
<Plasma_cell_dyscrasia> <Is_a> "Malignant_hematologic_neoplasm" .
<Anti-vWF_medication> <Is_a> "Antibody_medication" .
<Cotribid> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<HAM> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<HAM> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Fragminject> <Brand_name_of> "Dalteparin" .
<BDR> <Has_antineoplastic> "Rituximab" .
<BDR> <Has_antineoplastic> "Dexamethasone" .
<BDR> <Has_antineoplastic> "Bortezomib" .
<Aldesleukin> <Has_brand_name> "Proleukin" .
<Aldesleukin> <Has_brand_name> "Macrolin" .
<Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat> <Is_current_in> "Multiple_myeloma" .
<Vasopressin_analog> <Subsumes> "Desmopressin" .
<Mercaptopurine_monotherapy> <Has_antineoplastic> "Mercaptopurine" .
<Feraheme> <Brand_name_of> "Ferumoxytol" .
<MACC> <Is_historical_in> "Small_cell_lung_cancer" .
<MACC> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Lenalidomide> <Antineoplastic_of> "ZRd" .
<Lenalidomide> <Antineoplastic_of> "VMP/Rd" .
<Lenalidomide> <Antineoplastic_of> "VMP,_then_Rd" .
<Lenalidomide> <Antineoplastic_of> "Rd" .
<Lenalidomide> <Antineoplastic_of> "RVDC" .
<Lenalidomide> <Antineoplastic_of> "RVD" .
<Lenalidomide> <Antineoplastic_of> "RP" .
<Lenalidomide> <Antineoplastic_of> "RICER" .
<Lenalidomide> <Antineoplastic_of> "RD" .
<Lenalidomide> <Antineoplastic_of> "R2CHOP" .
<Lenalidomide> <Antineoplastic_of> "R-BL" .
<Lenalidomide> <Antineoplastic_of> "MRD" .
<Lenalidomide> <Antineoplastic_of> "MPR" .
<Lenalidomide> <Antineoplastic_of> "Lenalidomide,_Dexamethasone,_Rituximab" .
<Lenalidomide> <Antineoplastic_of> "Lenalidomide_monotherapy" .
<Lenalidomide> <Antineoplastic_of> "Lenalidomide_and_Rituximab" .
<Lenalidomide> <Antineoplastic_of> "Lenalidomide_and_Ofatumumab" .
<Lenalidomide> <Antineoplastic_of> "KRd" .
<Lenalidomide> <Antineoplastic_of> "IRd" .
<Lenalidomide> <Antineoplastic_of> "FRD" .
<Lenalidomide> <Antineoplastic_of> "Erythropoetin_and_Lenalidomide" .
<Lenalidomide> <Antineoplastic_of> "Elo-Rd" .
<Lenalidomide> <Antineoplastic_of> "Dara-Rd" .
<Lenalidomide> <Antineoplastic_of> "CRd" .
<Lenalidomide> <Antineoplastic_of> "CRD" .
<Lenalidomide> <Antineoplastic_of> "CPR" .
<Lenalidomide> <Antineoplastic_of> "BiRd" .
<Lenalidomide> <Antineoplastic_of> "BLD" .
<Lenalidomide> <Antineoplastic_of> "Azacitidine_and_Lenalidomide" .
<Pomalid> <Brand_name_of> "Pomalidomide" .
<PF> <Has_context> "Adjuvant_therapy" .
<Plerixafor_and_G-CSF> <Is_current_in> "Stem_cell_mobilization" .
<Goserelin_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<Goserelin_monotherapy> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Goserelin_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Topotecan_monotherapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<Topotecan_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Topotecan_monotherapy> <Has_accepted_use> "Endometrial_cancer" .
<Topotecan_monotherapy> <Has_accepted_use> "Cervical_cancer" .
<Topotecan_monotherapy> <Has_accepted_use> "CNS_lymphoma" .
<Ecoprin> <Brand_name_of> "Aspirin" .
<Hyper-CVAD_and_Dasatinib> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Hyper-CVAD_and_Dasatinib> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Vandetanib> <Has_accepted_use> "Thyroid_cancer" .
<Vandetanib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Aspent> <Brand_name_of> "Aspirin" .
<Vomitron> <Brand_name_of> "Ondansetron" .
<Cytarabine,_Idarubicin,_Rituximab> <Has_supportive_med> "Lenograstim" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Vincristine_and_Prednisone" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Radotinib_monotherapy" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Radotinib" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Ponatinib_monotherapy" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Ponatinib" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Peginterferon_alfa-2a" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Omacetaxine_monotherapy" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Omacetaxine" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Nilotinib_monotherapy" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Nilotinib" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Interferon_alfa-n1_monotherapy" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Interferon_alfa-2b_monotherapy" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Interferon_alfa-2b_and_DLI" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Interferon_alfa-2b" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Interferon_alfa-2a_monotherapy" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Interferon_alfa-2a" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Interferon_alfa_monotherapy" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Imatinib_monotherapy" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Imatinib_and_LoDAC" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Imatinib_and_Interferon" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Imatinib" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Hydroxyurea_and_Plicamycin" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Hydroxyurea_and_Interferon_alfa-2a" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Dasatinib_monotherapy" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Dasatinib" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Cytarabine_and_Interferon_alfa-2b" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Cytarabine" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Cyclophosphamide_and_TBI,_then_allo_HSCT" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Cyclophosphamide" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Busulfan_monotherapy" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Busulfan" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "BuCyTBI,_then_allo_HSCT" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Bosutinib_monotherapy" .
<Chronic_myelogenous_leukemia> <Accepted_use_of> "Bosutinib" .
<CNOP_(Prednisolone)> <Is_a> "Anthracycline-containing_regimen" .
<CAV_and_RT> <Is_historical_in> "Small_cell_lung_cancer" .
<Carfilzomib> <Is_a> "Proteasome_inhibitor" .
<Carfilzomib> <Is_a> "PMDA_approved_drug" .
<Carfilzomib> <Is_a> "FDA_approved_drug" .
<Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan> <Has_accepted_use> "Pancreatic_cancer" .
<mFOLFIRINOX,_Gemcitabine,_RT> <Has_antineoplastic> "Oxaliplatin" .
<mFOLFIRINOX,_Gemcitabine,_RT> <Has_antineoplastic> "Irinotecan" .
<mFOLFIRINOX,_Gemcitabine,_RT> <Has_antineoplastic> "Gemcitabine" .
<mFOLFIRINOX,_Gemcitabine,_RT> <Has_antineoplastic> "Folinic_acid" .
<mFOLFIRINOX,_Gemcitabine,_RT> <Has_antineoplastic> "Fluorouracil" .
<mFOLFIRINOX,_Gemcitabine,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Nivolumab_monotherapy> <Has_modality> "Immunotherapy" .
<Castration> <Has_modality> "Hormonotherapy" .
<IDAC> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Beleodaq> <Brand_name_of> "Belinostat" .
<Anastrozole_and_Goserelin> <Mapped_from> "Anastrozole_and_Goserelin" .
<Irinotecan_and_Cetuximab> <Is_current_in> "Colon_cancer" .
<GVP> <Has_modality> "Chemotherapy" .
<FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation> <Maps_to> "FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation" .
<Warm_autoimmune_hemolytic_anemia> <Current_treated_by> "Prednisone_monotherapy" .
<Warm_autoimmune_hemolytic_anemia> <Current_treated_by> "Prednisone_and_Rituximab" .
<Warm_autoimmune_hemolytic_anemia> <Current_treated_by> "Prednisolone_monotherapy" .
<Warm_autoimmune_hemolytic_anemia> <Current_treated_by> "Prednisolone_and_Rituximab" .
<Carboplatin_and_Etoposide,_then_auto_HSCT> <Is_current_in> "Testicular_cancer" .
<ABVD> <Has_accepted_use> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<ABVD> <Has_accepted_use> "Hodgkin_lymphoma" .
<Lymfuda> <Brand_name_of> "Fludarabine" .
<R-Hyper-CVAD/R-MA> <Has_supportive_med> "Valacyclovir" .
<R-Hyper-CVAD/R-MA> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<R-Hyper-CVAD/R-MA> <Has_supportive_med> "Prednisolone" .
<R-Hyper-CVAD/R-MA> <Has_supportive_med> "Pegfilgrastim" .
<R-Hyper-CVAD/R-MA> <Has_supportive_med> "Mesna" .
<R-Hyper-CVAD/R-MA> <Has_supportive_med> "Levofloxacin" .
<R-Hyper-CVAD/R-MA> <Has_supportive_med> "Folinic_acid" .
<R-Hyper-CVAD/R-MA> <Has_supportive_med> "Fluoroquinolone" .
<R-Hyper-CVAD/R-MA> <Has_supportive_med> "Fluconazole" .
<R-Hyper-CVAD/R-MA> <Has_supportive_med> "Filgrastim" .
<R-Hyper-CVAD/R-MA> <Has_supportive_med> "Erythrocyte_growth_factors" .
<R-Hyper-CVAD/R-MA> <Has_supportive_med> "Ciprofloxacin" .
<R-Hyper-CVAD/R-MA> <Has_supportive_med> "Acyclovir" .
<Vincristine_and_Prednisone> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Vincristine_and_Prednisone> <Is_current_in> "Chronic_myelogenous_leukemia" .
<Vincristine_and_Prednisone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<7_plus_3d> <Maps_to> "7_plus_3d" .
<Tamibarotene_monotherapy> <Maps_to> "Tamibarotene_monotherapy" .
<ATRA,_Mercaptopurine,_Methotrexate> <Has_antineoplastic> "Methotrexate" .
<ATRA,_Mercaptopurine,_Methotrexate> <Has_antineoplastic> "Mercaptopurine" .
<ATRA,_Mercaptopurine,_Methotrexate> <Has_antineoplastic> "All-trans_retinoic_acid" .
<Dara-KD> <Has_accepted_use> "Multiple_myeloma" .
<Hyper-CVAD/MA> <Is_a> "Anthracycline-containing_regimen" .
<Nadroparin> <Has_brand_name> "Fraxodi" .
<Nadroparin> <Has_brand_name> "Fraxiparine" .
<AIE> <Has_accepted_use> "Acute_myeloid_leukemia" .
<FOLFIRI_and_Bevacizumab> <Is_current_in> "Colon_cancer" .
<Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant> <Has_supportive_med> "Mesna" .
<Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant> <Has_supportive_med> "Filgrastim" .
<Nizon> <Brand_name_of> "Prednisone" .
<Nilutamide> <Is_a> "Nonsteroidal_antiandrogen" .
<Carboplatin,_Paclitaxel,_Bevacizumab> <Has_antineoplastic> "Paclitaxel" .
<Carboplatin,_Paclitaxel,_Bevacizumab> <Has_antineoplastic> "Carboplatin" .
<Carboplatin,_Paclitaxel,_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Zenos> <Brand_name_of> "Dexamethasone" .
<R-CHOP-14_(Rituximab_Hycela)> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<MVAC> <Is_a> "Anthracycline-containing_regimen" .
<Arsenic_trioxide_and_Idarubicin> <Has_local_therapy> "Prednisolone" .
<Arsenic_trioxide_and_Idarubicin> <Has_local_therapy> "Methotrexate" .
<Arsenic_trioxide_and_Idarubicin> <Has_local_therapy> "Dexamethasone" .
<Arsenic_trioxide_and_Idarubicin> <Has_local_therapy> "Cytarabine" .
<Melphalan_and_Methylprednisolone,_then_auto_HSCT> <Has_antineoplastic> "Methylprednisolone" .
<Melphalan_and_Methylprednisolone,_then_auto_HSCT> <Has_antineoplastic> "Melphalan" .
<Dexamethasone_and_Rituximab> <Has_accepted_use> "Immune_thrombocytopenia" .
<ddE> <Has_supportive_med> "Filgrastim" .
<Farin> <Brand_name_of> "Warfarin" .
<TAM6,_then_auto_HSCT> <Has_accepted_use> "Mantle_cell_lymphoma" .
<131I-Metaiodobenzylguanidine_(131I-MIBG)> <Has_modality> "Radiotherapy" .
<VBM> <Has_context> "Neoadjuvant_therapy" .
<Windex> <Brand_name_of> "Dexamethasone" .
<Complementopathy> <Subsumes> "Paroxysmal_nocturnal_hemoglobinuria" .
<Complementopathy> <Subsumes> "Cold_agglutinin_disease" .
<Complementopathy> <Subsumes> "Atypical_hemolytic_uremic_syndrome" .
<Cyclosporine_monotherapy> <Has_immunosuppressor> "Cyclosporines" .
<Cyclosporine_monotherapy> <Has_immunosuppressor> "Cyclosporine_modified" .
<TBI,_then_auto_HSCT> <Mapped_from> "TBI,_then_auto_HSCT" .
<Tarvexol> <Brand_name_of> "Paclitaxel" .
<Renal_cell_carcinoma> <Is_a> "Genitourinary_cancer" .
<CHUT,_then_auto_HSCT> <Mapped_from> "CHUT,_then_auto_HSCT" .
<Fluorouracil_and_RT> <Has_antineoplastic> "Fluorouracil" .
<Fluorouracil_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Fluorouracil_and_RT> <Has_antineoplastic> "Brachytherapy" .
<DEP_and_RT> <Is_current_in> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Interferon_Lymphoblastoid> <Brand_name_of> "Interferon_alfa-2b" .
<Interferon_alfa-2a_and_Isotretinoin> <Maps_to> "Interferon_alfa-2a_and_Isotretinoin" .
<Eculizumab_monotherapy> <Has_modality> "Immunosuppressive_therapy" .
<Granulocyte_growth_factor> <Subsumes> "Granulocyte_macrophage_colony-stimulating_factor" .
<Granulocyte_growth_factor> <Subsumes> "Granulocyte_colony-stimulating_factor" .
<Garaspirine> <Brand_name_of> "Aspirin" .
<Proton_pump_inhibitor> <Subsumes> "Rabeprazole" .
<Proton_pump_inhibitor> <Subsumes> "Pantoprazole" .
<Proton_pump_inhibitor> <Subsumes> "Omeprazole" .
<Proton_pump_inhibitor> <Subsumes> "Lansoprazole" .
<CLF> <Has_context> "Non-curative_first-line_therapy" .
<CLF> <Has_context> "Induction_therapy" .
<CAVE> <Maps_to> "CAVE" .
<Fluorouracil_and_RT> <Is_historical_in> "Gastric_cancer" .
<IROX> <Has_context> "Non-curative_second-line_therapy" .
<IROX> <Has_context> "Non-curative_first-line_therapy" .
<Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<TFC,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<TFC,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<Neutral> <Is_a> "Chemotherapeutic" .
<Interferon_alfa-2a_monotherapy> <Is_historical_in> "Renal_cell_carcinoma" .
<Interferon_alfa-2a_monotherapy> <Is_historical_in> "Multiple_myeloma" .
<Interferon_alfa-2a_monotherapy> <Is_historical_in> "Follicular_lymphoma" .
<Capecitabine> <May_have_route> "Oral" .
<Biseptin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Mabtas> <Brand_name_of> "Rituximab" .
<CHOEP-21> <Is_current_in> "Anaplastic_large_cell_lymphoma" .
<BACO> <Mapped_from> "BACO" .
<MVP_(Vinblastine)> <Has_context> "Non-curative_first-line_therapy" .
<Cyclophosphamide,_Fludarabine,_Thiotepa> <Has_modality> "Chemotherapy" .
<Pentostatin_monotherapy> <Mapped_from> "Pentostatin_monotherapy" .
<RCC> <Is_a> "Rituximab-containing_regimen" .
<Gemcitabine_and_nab-Paclitaxel> <Mapped_from> "Gemcitabine_and_nab-Paclitaxel" .
<CX> <Has_antineoplastic> "Cisplatin" .
<CX> <Has_antineoplastic> "Capecitabine" .
<FLEC> <Is_a> "Anthracycline-containing_regimen" .
<Bufferin> <Brand_name_of> "Aspirin" .
<Onco_Carbide> <Brand_name_of> "Hydroxyurea" .
<SOX> <Mapped_from> "SOX" .
<Capecitabine_and_Paclitaxel> <Is_current_in> "Breast_cancer" .
<MAP3K20_inhibitor> <Subsumes> "Vemurafenib" .
<Leucovorina> <Brand_name_of> "Folinic_acid" .
<Doxorubicin_and_Gemcitabine> <Is_current_in> "Renal_cell_carcinoma" .
<Carboplatin_and_Vincristine> <Has_modality> "Chemotherapy" .
<Gemcitabine/Fluorouracil_and_RT> <Has_context> "Adjuvant_therapy" .
<Clonazepam> <Is_a> "Benzodiazepine" .
<Niraparib> <Is_a> "PARP_inhibitor" .
<Niraparib> <Is_a> "Mutation-specific_medication" .
<Ledoxan> <Brand_name_of> "Cyclophosphamide" .
<Krobactrol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Dinutuximab> <Has_accepted_use> "Neuroblastoma" .
<TC_(Taxotere)> <Has_modality> "Chemotherapy" .
<mDCF_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Cocydal> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Tandem_melphalan,_then_auto_HSCT> <Has_accepted_use> "Multiple_myeloma" .
<ATRA,_Cytarabine,_Idarubicin> <Has_modality> "Chemotherapy" .
<Dexamethasone_and_Rituximab> <Has_modality> "Immunosuppressive_therapy" .
<Doxorubicin_pegylated_liposomal_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Doxorubicin_pegylated_liposomal_and_Bevacizumab> <Is_a> "Anthracycline-containing_regimen" .
<RP> <Has_supportive_med> "Warfarin" .
<RP> <Has_supportive_med> "Low_molecular_weight_heparins" .
<RP> <Has_supportive_med> "Aspirin" .
<Biseptol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Duxocin> <Brand_name_of> "Doxorubicin" .
<R-MP> <Has_accepted_use> "CNS_lymphoma" .
<MEL200,_then_auto_HSCT,_then_MEL220_and_Dexamethasone,_then_auto_HSCT> <Maps_to> "MEL200,_then_auto_HSCT,_then_MEL220_and_Dexamethasone,_then_auto_HSCT" .
<Bleeding_disorder> <Is_a> "Classical_hematologic_condition" .
<Novastan> <Brand_name_of> "Argatroban" .
<BuCy,_then_allo_HSCT> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Carboplatin,_Pemetrexed,_Pembrolizumab> <Maps_to> "Carboplatin,_Pemetrexed,_Pembrolizumab" .
<Metoclopramide> <May_have_route> "Oral" .
<Metoclopramide> <May_have_route> "Intravenous" .
<Acylpyrin> <Brand_name_of> "Aspirin" .
<CAV_and_RT> <Has_context> "Definitive_therapy" .
<Etoposide_and_TBI,_then_allo_HSCT> <Maps_to> "Etoposide_and_TBI,_then_allo_HSCT" .
<Isotretinoin_monotherapy> <Has_context> "Consolidation_after_upfront_therapy" .
<Bacillus_Calmette-Guerin> <Antineoplastic_of> "Observation" .
<Bacillus_Calmette-Guerin> <Antineoplastic_of> "FAC_and_BCG" .
<Bacillus_Calmette-Guerin> <Antineoplastic_of> "CHOP-BCG" .
<Bacillus_Calmette-Guerin> <Antineoplastic_of> "Bacillus_Calmette-Guerin_(BCG)_monotherapy" .
<Bacillus_Calmette-Guerin> <Antineoplastic_of> "BCG_and_Dacarbazine" .
<Cyclosporine,_Methotrexate,_Prednisone> <Mapped_from> "Cyclosporine,_Methotrexate,_Prednisone" .
<PAF> <Has_modality> "Chemotherapy" .
<Sapacitabine> <Has_accepted_use> "Acute_myeloid_leukemia" .
<R-CHOEP-14> <Has_modality> "Chemotherapy" .
<Docetec> <Brand_name_of> "Docetaxel" .
<Ibrutinib_monotherapy> <Mapped_from> "Ibrutinib_monotherapy" .
<Cytarabine_and_Interferon_alfa-2b> <Maps_to> "Cytarabine_and_Interferon_alfa-2b" .
<R-MACLO/R-IVAM> <Has_context> "Non-curative_first-line_therapy" .
<ATG_(Horse)_monotherapy> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Acyclovir> <Is_a> "Antiviral" .
<Peyrone's_Salt> <Brand_name_of> "Cisplatin" .
<Clonazepam> <May_have_route> "Oral" .
<Aprepitant> <Supportive_med_of> "MVAC,_dose-dense" .
<VAMP> <Is_a> "Anthracycline-containing_regimen" .
<Linker_regimen_(consolidation)> <Has_supportive_med> "Folinic_acid" .
<Dacarbazine_and_Doxorubicin> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Gefitinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Gefitinib_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Gefitinib_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Gefitinib_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Gefitinib_monotherapy> <Has_context> "Adjuvant_therapy" .
<Low-dose_TBI,_then_allo_HSCT> <Is_current_in> "Acute_myeloid_leukemia" .
<Fraxodi> <Brand_name_of> "Nadroparin" .
<FCM> <Has_context> "Non-curative_therapy" .
<FCM> <Has_context> "Non-curative_first-line_therapy" .
<Rally-A> <Brand_name_of> "Dexamethasone" .
<FLEP> <Mapped_from> "FLEP" .
<Radium-223> <Has_brand_name> "Xofigo" .
<Radium-223> <Has_brand_name> "Alpharadin" .
<RICER> <Is_a> "Rituximab-containing_regimen" .
<Cisplatin,_Fluorouracil,_Vincristine> <Has_context> "All_lines_of_therapy" .
<RiPAD_plus_C> <Has_antineoplastic> "Rituximab" .
<RiPAD_plus_C> <Has_antineoplastic> "Doxorubicin" .
<RiPAD_plus_C> <Has_antineoplastic> "Dexamethasone" .
<RiPAD_plus_C> <Has_antineoplastic> "Chlorambucil" .
<RiPAD_plus_C> <Has_antineoplastic> "Bortezomib" .
<Mitoxantrone_and_Hydrocortisone> <Has_context> "Non-curative_therapy" .
<Ibtrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin_and_Dacarbazine> <Mapped_from> "Cisplatin_and_Dacarbazine" .
<Abemaciclib> <Has_brand_name> "Verzenio" .
<Proleukin> <Brand_name_of> "Aldesleukin" .
<Biskam> <Brand_name_of> "Irinotecan" .
<ATG_(Horse),_Cyclosporine,_Eltrombopag> <Has_immunosuppressor> "Cyclosporines" .
<ATG_(Horse),_Cyclosporine,_Eltrombopag> <Has_immunosuppressor> "Antithymocyte_globulin_horse_ATG" .
<ATG_(Horse),_Cyclosporine,_G-CSF> <Has_immunosuppressor> "Cyclosporines" .
<ATG_(Horse),_Cyclosporine,_G-CSF> <Has_immunosuppressor> "Antithymocyte_globulin_horse_ATG" .
<Cisplatin_and_Vinorelbine> <Has_antineoplastic> "Vinorelbine" .
<Cisplatin_and_Vinorelbine> <Has_antineoplastic> "Cisplatin" .
<CAF_and_MPA> <Is_a> "Anthracycline-containing_regimen" .
<Venetoclax_monotherapy> <Has_antineoplastic> "Venetoclax" .
<TC,_then_IE,_VDoxoC,_VEC> <Maps_to> "TC,_then_IE,_VDoxoC,_VEC" .
<Fludarabine,_Melphalan,_Alemtuzumab> <Has_context> "All_lines_of_therapy" .
<R-CHOP> <Has_context> "Upfront_therapy" .
<R-CHOP> <Has_context> "Non-curative_therapy" .
<R-CHOP> <Has_context> "Non-curative_first-line_therapy" .
<R-CHOP> <Has_context> "Induction_therapy" .
<R-CHOP> <Has_context> "All_lines_of_therapy" .
<Carmustine_and_Doxorubicin> <Mapped_from> "Carmustine_and_Doxorubicin" .
<F-SHAI> <Has_antineoplastic> "Idarubicin" .
<F-SHAI> <Has_antineoplastic> "Fludarabine" .
<F-SHAI> <Has_antineoplastic> "Cytarabine" .
<Doxorubicin_non-pegylated_liposomal_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<BDR> <Has_context> "Non-curative_therapy" .
<BDR> <Has_context> "Non-curative_first-line_therapy" .
<Thiotepa_monotherapy> <Is_current_in> "Bladder_cancer" .
<CHOP_Modified_(Prednisolone)> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Oxaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Exemestane_and_Tucidinostat> <Has_modality> "Hormonotherapy" .
<Exemestane_and_Tucidinostat> <Has_modality> "Chemotherapy" .
<Oftadex> <Brand_name_of> "Dexamethasone" .
<BLD> <Has_accepted_use> "Multiple_myeloma" .
<PFT> <Has_accepted_use> "Breast_cancer" .
<Uveal_melanoma> <Is_a> "Skin_cancer" .
<Fludarabine_and_TBI> <Is_current_in> "Allogeneic_HSCT" .
<CAFVP> <Has_context> "Non-curative_therapy" .
<Bevacizumab-containing_therapy> <Maps_to> "Bevacizumab-containing_therapy" .
<Isotretinoin> <May_have_route> "Oral" .
<Medroxyprogesterone_and_Tamoxifen> <Maps_to> "Medroxyprogesterone_and_Tamoxifen" .
<Cisplatin_and_Topotecan> <Is_current_in> "Cervical_cancer" .
<NOVP> <Has_modality> "Chemotherapy" .
<Denosumab_monotherapy> <Mapped_from> "Denosumab_monotherapy" .
<Essential_thrombocythemia> <Current_treated_by> "Ruxolitinib_monotherapy" .
<Essential_thrombocythemia> <Current_treated_by> "Peginterferon_alfa-2a_monotherapy" .
<Essential_thrombocythemia> <Current_treated_by> "Observation" .
<Essential_thrombocythemia> <Current_treated_by> "Hydroxyurea_monotherapy" .
<Essential_thrombocythemia> <Current_treated_by> "Aspirin_and_Hydroxyurea" .
<Essential_thrombocythemia> <Current_treated_by> "Aspirin_and_Anagrelide" .
<Essential_thrombocythemia> <Current_treated_by> "Anagrelide_monotherapy" .
<FOLFOX> <Maps_to> "FOLFOX" .
<Cisplatin_and_Cyclophosphamide> <Is_historical_in> "Ovarian_cancer" .
<VMP> <Maps_to> "VMP" .
<CNS_leukemia> <Current_treated_by> "WBRT" .
<CNS_leukemia> <Current_treated_by> "Mercaptopurine_and_WBRT" .
<CNS_leukemia> <Current_treated_by> "IT_Methotrexate_monotherapy" .
<CNS_leukemia> <Current_treated_by> "IT_Methotrexate_and_WBRT" .
<CNS_leukemia> <Current_treated_by> "IT_Methotrexate_and_Methylprednisolone" .
<CNS_leukemia> <Current_treated_by> "IT_Methotrexate_and_Hydrocortisone" .
<CNS_leukemia> <Current_treated_by> "IT_Cytarabine,_Methotrexate,_WBRT" .
<CNS_leukemia> <Current_treated_by> "IT_Cytarabine,_Methotrexate,_Prednisone" .
<CNS_leukemia> <Current_treated_by> "IT_Cytarabine,_Methotrexate,_Methylprednisolone" .
<CNS_leukemia> <Current_treated_by> "IT_Cytarabine_and_WBRT" .
<CNS_leukemia> <Current_treated_by> "IT_Cytarabine_and_Methotrexate" .
<Nordic_Regimen,_older_patients> <Is_current_in> "CNS_lymphoma" .
<COPP_(CCNU)> <Has_modality> "Chemotherapy" .
<Pentostatin> <Has_brand_name> "Nipent" .
<Bortemib> <Brand_name_of> "Bortezomib" .
<Amnesteem> <Brand_name_of> "Isotretinoin" .
<Gemtuzumab_ozogamicin_monotherapy> <Is_current_in> "Acute_myeloid_leukemia" .
<Dacmed> <Brand_name_of> "Dacarbazine" .
<IAP> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Xanthine_oxidase_inhibitor> <Subsumes> "Allopurinol" .
<Argatroban_monotherapy> <Mapped_from> "Argatroban_monotherapy" .
<Folaren> <Brand_name_of> "Folinic_acid" .
<Zidovudine> <Antineoplastic_of> "Interferon_alfa-2b_and_Zidovudine" .
<Dexamedis> <Brand_name_of> "Dexamethasone" .
<Intracavitary> <May_be_route_of> "Thiotepa" .
<Intracavitary> <May_be_route_of> "Paclitaxel" .
<Intracavitary> <May_be_route_of> "Mechlorethamine" .
<Intracavitary> <May_be_route_of> "Cisplatin" .
<Intracavitary> <May_be_route_of> "Catumaxomab" .
<Intracavitary> <May_be_route_of> "Bleomycin" .
<Fluorouracil,_Folinic_acid,_Mitomycin> <Has_modality> "Chemotherapy" .
<Elo-PD> <Has_modality> "Chemotherapy" .
<Romiplostim_monotherapy> <Has_modality> "Growth_factor_therapy" .
<Cisplatin_and_Irinotecan> <Has_antineoplastic> "Irinotecan" .
<Cisplatin_and_Irinotecan> <Has_antineoplastic> "Cisplatin" .
<CX> <Has_context> "Non-curative_first-line_therapy" .
<CX> <Has_context> "Induction_therapy" .
<CX> <Has_context> "Adjuvant_therapy" .
<Cisplatin,_Paclitaxel,_Bevacizumab> <Has_accepted_use> "Cervical_cancer" .
<BL22_immunotoxin> <May_have_route> "Intravenous" .
<R-DHAP/R-VIM> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Formestane> <May_have_route> "Intramuscular" .
<Endometrial_cancer> <Accepted_use_of> "Whole_abdominal_radiation_(WAI)" .
<Endometrial_cancer> <Accepted_use_of> "Topotecan_monotherapy" .
<Endometrial_cancer> <Accepted_use_of> "Topotecan" .
<Endometrial_cancer> <Accepted_use_of> "Temsirolimus_monotherapy" .
<Endometrial_cancer> <Accepted_use_of> "Temsirolimus" .
<Endometrial_cancer> <Accepted_use_of> "Tamoxifen_monotherapy" .
<Endometrial_cancer> <Accepted_use_of> "Tamoxifen" .
<Endometrial_cancer> <Accepted_use_of> "Radiation_therapy" .
<Endometrial_cancer> <Accepted_use_of> "Placebo" .
<Endometrial_cancer> <Accepted_use_of> "Pembrolizumab_monotherapy" .
<Endometrial_cancer> <Accepted_use_of> "Pembrolizumab" .
<Endometrial_cancer> <Accepted_use_of> "Pegylated_liposomal_doxorubicin" .
<Endometrial_cancer> <Accepted_use_of> "Paclitaxel_monotherapy" .
<Endometrial_cancer> <Accepted_use_of> "Paclitaxel" .
<Endometrial_cancer> <Accepted_use_of> "Observation" .
<Endometrial_cancer> <Accepted_use_of> "Megestrol_monotherapy" .
<Endometrial_cancer> <Accepted_use_of> "Megestrol_and_Tamoxifen" .
<Endometrial_cancer> <Accepted_use_of> "Megestrol" .
<Endometrial_cancer> <Accepted_use_of> "Medroxyprogesterone_monotherapy" .
<Endometrial_cancer> <Accepted_use_of> "Medroxyprogesterone_and_Tamoxifen" .
<Endometrial_cancer> <Accepted_use_of> "Medroxyprogesterone" .
<Endometrial_cancer> <Accepted_use_of> "Lenvatinib_and_Pembrolizumab" .
<Endometrial_cancer> <Accepted_use_of> "Lenvatinib" .
<Endometrial_cancer> <Accepted_use_of> "Ifosfamide_monotherapy" .
<Endometrial_cancer> <Accepted_use_of> "Ifosfamide_and_Paclitaxel" .
<Endometrial_cancer> <Accepted_use_of> "Ifosfamide" .
<Endometrial_cancer> <Accepted_use_of> "Doxorubicin_monotherapy" .
<Endometrial_cancer> <Accepted_use_of> "Doxorubicin" .
<Endometrial_cancer> <Accepted_use_of> "Dactinomycin_monotherapy" .
<Endometrial_cancer> <Accepted_use_of> "Dactinomycin" .
<Endometrial_cancer> <Accepted_use_of> "Cisplatin,_Doxorubicin,_Paclitaxel" .
<Endometrial_cancer> <Accepted_use_of> "Cisplatin_and_RT" .
<Endometrial_cancer> <Accepted_use_of> "Cisplatin_and_Paclitaxel" .
<Endometrial_cancer> <Accepted_use_of> "Cisplatin_and_Doxorubicin" .
<Endometrial_cancer> <Accepted_use_of> "Cisplatin" .
<Endometrial_cancer> <Accepted_use_of> "Carboplatin_monotherapy" .
<Endometrial_cancer> <Accepted_use_of> "Carboplatin_and_Paclitaxel" .
<Endometrial_cancer> <Accepted_use_of> "Carboplatin_and_Doxorubicin_liposomal" .
<Endometrial_cancer> <Accepted_use_of> "Carboplatin" .
<Endometrial_cancer> <Accepted_use_of> "CIM" .
<Endometrial_cancer> <Accepted_use_of> "Bevacizumab-bvzr" .
<Endometrial_cancer> <Accepted_use_of> "Bevacizumab-awwb" .
<Endometrial_cancer> <Accepted_use_of> "Bevacizumab_monotherapy" .
<Endometrial_cancer> <Accepted_use_of> "Bevacizumab" .
<Endometrial_cancer> <Accepted_use_of> "Anastrozole_monotherapy" .
<Endometrial_cancer> <Accepted_use_of> "Anastrozole" .
<Lysodren> <Brand_name_of> "Mitotane" .
<THL_(Taxol)> <Is_current_in> "Breast_cancer" .
<Tamoxifen> <May_have_route> "Oral" .
<Bendamustine_and_Obinutuzumab> <Has_context> "Non-curative_therapy" .
<Bendamustine_and_Obinutuzumab> <Has_context> "Non-curative_first-line_therapy" .
<Gemcitabine,_Cetuximab,_RT> <Has_supportive_med> "Proton_pump_inhibitors" .
<Doxorubicin_monotherapy> <Mapped_from> "Doxorubicin_monotherapy" .
<Fluorouracil_and_Paclitaxel> <Is_current_in> "Esophageal_cancer" .
<Doxorubicin_and_Strontium-89> <Has_antineoplastic> "Strontium-89" .
<Doxorubicin_and_Strontium-89> <Has_antineoplastic> "Doxorubicin" .
<Edrecolomab_monotherapy> <Has_antineoplastic> "Edrecolomab" .
<UFTM> <Mapped_from> "UFTM" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine> <Maps_to> "Cyclophosphamide,_Cytarabine,_Mercaptopurine" .
<PAC> <Maps_to> "PAC" .
<Careptin> <Brand_name_of> "Carboplatin" .
<Etoposide,_Ifosfamide,_Methotrexate> <Has_modality> "Chemotherapy" .
<VAI> <Maps_to> "VAI" .
<DA-R-EPOCH> <Is_current_in> "Primary_mediastinal_B-cell_lymphoma" .
<DA-R-EPOCH> <Is_current_in> "Mediastinal_gray-zone_lymphoma" .
<DA-R-EPOCH> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<DA-R-EPOCH> <Is_current_in> "Burkitt_lymphoma" .
<Vinorelbine_and_Bevacizumab> <Maps_to> "Vinorelbine_and_Bevacizumab" .
<Omeprazole> <Supportive_med_of> "SC-EPOCH-RR" .
<Omeprazole> <Supportive_med_of> "Rd" .
<Omeprazole> <Supportive_med_of> "M-DEX" .
<Omeprazole> <Supportive_med_of> "IL-2_monotherapy" .
<Omeprazole> <Supportive_med_of> "DA-R-EPOCH" .
<Omeprazole> <Supportive_med_of> "DA-EPOCH" .
<Omeprazole> <Supportive_med_of> "BiRd" .
<Actonel> <Brand_name_of> "Risedronate" .
<Lanreotide_Autogel> <Brand_name_of> "Lanreotide" .
<Hydroxyurea_and_RT> <Mapped_from> "Hydroxyurea_and_RT" .
<MA> <Has_context> "Neoadjuvant_therapy" .
<MA> <Has_context> "Adjuvant_therapy" .
<Carmustine_monotherapy> <Has_accepted_use> "Hodgkin_lymphoma" .
<Carmustine_monotherapy> <Has_accepted_use> "Glioblastoma" .
<Carmustine_monotherapy> <Has_accepted_use> "Anaplastic_glioma" .
<Anastrozole_and_Goserelin> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Anastrozole_and_Goserelin> <Has_accepted_use> "Breast_cancer" .
<Actrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Irinotecan> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Irinotecan> <Is_a> "Topoisomerase_inhibitor" .
<Irinotecan> <Is_a> "Irritant" .
<Tisagenlecleucel> <Antineoplastic_of> "Tisagenlecleucel_monotherapy" .
<MA-BCD> <Has_context> "Neoadjuvant_therapy" .
<Fluorouracil,_Hydroxyurea,_RT> <Has_antineoplastic> "Hydroxyurea" .
<Fluorouracil,_Hydroxyurea,_RT> <Has_antineoplastic> "Fluorouracil" .
<Fluorouracil,_Hydroxyurea,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<IFX> <Brand_name_of> "Ifosfamide" .
<Senokot> <Brand_name_of> "Sennosides" .
<Lenvatinib> <Antineoplastic_of> "Lenvatinib_monotherapy" .
<Lenvatinib> <Antineoplastic_of> "Lenvatinib_and_Pembrolizumab" .
<Lenvatinib> <Antineoplastic_of> "Everolimus_and_Lenvatinib" .
<Metaspirine> <Brand_name_of> "Aspirin" .
<L-Asparaginase,_Vincristine,_Prednisolone> <Has_antineoplastic> "Vincristine" .
<L-Asparaginase,_Vincristine,_Prednisolone> <Has_antineoplastic> "Prednisolone" .
<L-Asparaginase,_Vincristine,_Prednisolone> <Has_antineoplastic> "Asparaginase" .
<Sydencort> <Brand_name_of> "Dexamethasone" .
<ddFEC> <Has_modality> "Chemotherapy" .
<Docetax> <Brand_name_of> "Docetaxel" .
<Gemcitabine_and_Paclitaxel> <Has_context> "Non-curative_subsequent-line_therapy" .
<Gemcitabine_and_Paclitaxel> <Has_context> "Non-curative_first-line_therapy" .
<Gemcitabine_and_Paclitaxel> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Eptifibatide> <May_have_route> "Intravenous" .
<Plavix> <Brand_name_of> "Clopidogrel" .
<Akynzeo> <Brand_name_of> "Netupitant_and_palonosetron" .
<Cytarabine_and_G-CSF> <Has_context> "All_lines_of_therapy" .
<Phadilon> <Brand_name_of> "Methylprednisolone" .
<Temozolomide_and_NovoTTF-100A> <Is_current_in> "Glioblastoma" .
<Cangrelor> <Is_a> "P2Y12_ADP_inhibitor" .
<Pulmison> <Brand_name_of> "Prednisone" .
<TPC> <Has_context> "Non-curative_first-line_therapy" .
<Interferon_alfa-2b_monotherapy> <Mapped_from> "Interferon_alfa-2b_monotherapy" .
<Vismodegib_monotherapy> <Has_accepted_use> "Hedgehog_pathway-mutated_malignancy" .
<Vismodegib_monotherapy> <Has_accepted_use> "Cutaneous_basal_cell_carcinoma" .
<Pembrolizumab> <May_have_route> "Intravenous" .
<Fludarabine,_Busulfan,_ATG> <Maps_to> "Fludarabine,_Busulfan,_ATG" .
<GCD-R> <Has_modality> "Chemotherapy" .
<Fam-trastuzumab_deruxtecan_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Bacmetrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Anbol> <Brand_name_of> "Aspirin" .
<Epithelioid_sarcoma> <Current_treated_by> "Tazemetostat_monotherapy" .
<CapeOx_and_Bevacizumab> <Mapped_from> "CapeOx_and_Bevacizumab" .
<CVP,_then_131Iodine-Tositumomab> <Is_historical_in> "Follicular_lymphoma" .
<Fluorouracil,_Folinic_acid,_Mitomycin> <Has_antineoplastic> "Mitomycin" .
<Fluorouracil,_Folinic_acid,_Mitomycin> <Has_antineoplastic> "Folinic_acid" .
<Fluorouracil,_Folinic_acid,_Mitomycin> <Has_antineoplastic> "Fluorouracil" .
<Thalidomide_and_Rituximab> <Has_context> "Non-curative_first-line_therapy" .
<Chelator> <Is_a> "Supportive_medication" .
<Chelator> <Is_a> "Classical_hematology_medication" .
<Flutamide,_Leuprolide,_RT> <Is_current_in> "Prostate_cancer" .
<BV-CHP> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<BV-CHP> <Is_current_in> "Anaplastic_large_cell_lymphoma" .
<Venetoclax_and_Obinutuzumab> <Has_antineoplastic> "Venetoclax" .
<Venetoclax_and_Obinutuzumab> <Has_antineoplastic> "Obinutuzumab" .
<R-EPOCH> <Is_current_in> "Transformed_lymphoma" .
<R-EPOCH> <Is_current_in> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<R-EPOCH> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<External_beam_radiotherapy> <Antineoplastic_of> "mFOLFOX6_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "mFOLFIRINOX,_Gemcitabine,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Whole_brain_irradiation" .
<External_beam_radiotherapy> <Antineoplastic_of> "Whole_abdominal_radiation_(WAI)" .
<External_beam_radiotherapy> <Antineoplastic_of> "WBRT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Teniposide_and_WBRT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Temozolomide,_then_Temozolomide_and_RT,_then_Temozolomide" .
<External_beam_radiotherapy> <Antineoplastic_of> "Temozolomide_and_low-dose_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Temozolomide_and_RT,_then_Temozolomide" .
<External_beam_radiotherapy> <Antineoplastic_of> "Temozolomide_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "TLI_and_ATG" .
<External_beam_radiotherapy> <Antineoplastic_of> "TBI,_then_auto_HSCT" .
<External_beam_radiotherapy> <Antineoplastic_of> "TBI" .
<External_beam_radiotherapy> <Antineoplastic_of> "TAM6,_then_auto_HSCT" .
<External_beam_radiotherapy> <Antineoplastic_of> "TAM6" .
<External_beam_radiotherapy> <Antineoplastic_of> "Radiation_therapy" .
<External_beam_radiotherapy> <Antineoplastic_of> "RT,_then_Temozolomide" .
<External_beam_radiotherapy> <Antineoplastic_of> "RT,_then_Carmustine" .
<External_beam_radiotherapy> <Antineoplastic_of> "R-TBI/Cy,_then_auto_HSCT" .
<External_beam_radiotherapy> <Antineoplastic_of> "R-TBI/Cy" .
<External_beam_radiotherapy> <Antineoplastic_of> "Paclitaxel_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Oxaliplatin_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Nimustine_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Methotrexate,_RT,_Cyclophosphamide" .
<External_beam_radiotherapy> <Antineoplastic_of> "Mercaptopurine,_Methotrexate,_WB-XRT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Mercaptopurine_and_WBRT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Melphalan,_then_auto_HSCT,_then_Melphalan_and_TBI,_then_auto_HSCT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Melphalan_and_TBI,_then_auto_HSCT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Melphalan_and_TBI" .
<External_beam_radiotherapy> <Antineoplastic_of> "MVP_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "MESA/RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Low-dose_TBI,_then_allo_HSCT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Low-dose_TBI" .
<External_beam_radiotherapy> <Antineoplastic_of> "Lomustine,_Temozolomide,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "LVP_.22Sandwich.22" .
<External_beam_radiotherapy> <Antineoplastic_of> "Ipilimumab_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "IT_Methotrexate_and_WBRT" .
<External_beam_radiotherapy> <Antineoplastic_of> "IT_Cytarabine,_Methotrexate,_WBRT" .
<External_beam_radiotherapy> <Antineoplastic_of> "IT_Cytarabine_and_WBRT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Hydroxyurea_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Goserelin_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Gemcitabine/Fluorouracil_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Gemcitabine,_Cetuximab,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Gemcitabine_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "GELOX/RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Flutamide,_Leuprolide,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Flutamide,_Goserelin,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Fluorouracil/Fluorouracil_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Fluorouracil,_Paclitaxel,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Fluorouracil,_Oxaliplatin,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Fluorouracil,_Mitomycin,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Fluorouracil,_Hydroxyurea,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Fluorouracil,_Folinic_acid,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Fluorouracil_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant" .
<External_beam_radiotherapy> <Antineoplastic_of> "Fludarabine_and_TBI,_then_allo_HSCT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Fludarabine_and_TBI" .
<External_beam_radiotherapy> <Antineoplastic_of> "FULV/FULV_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "FP/Capecitabine_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "FOLFOX4_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Etoposide_and_TBI,_then_allo_HSCT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Etoposide_and_TBI" .
<External_beam_radiotherapy> <Antineoplastic_of> "ECF/5-FU_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Doxorubicin,_Ifosfamide,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Docetaxel,_Gemcitabine,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Docetaxel,_Fluorouracil,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Docetaxel,_Fluorouracil,_Hydroxyurea,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Docetaxel,_Cetuximab,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Dexamethasone_and_WBRT" .
<External_beam_radiotherapy> <Antineoplastic_of> "DeVIC_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "DEP_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Cyclophosphamide,_Etoposide,_TBI" .
<External_beam_radiotherapy> <Antineoplastic_of> "Cyclophosphamide_and_TBI,_then_auto_HSCT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Cyclophosphamide_and_TBI,_then_allo_HSCT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Cyclophosphamide_and_TBI" .
<External_beam_radiotherapy> <Antineoplastic_of> "Cisplatin,_Vinorelbine,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Cisplatin,_Vinblastine,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Cisplatin,_Paclitaxel,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Cisplatin,_Irinotecan,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Cisplatin,_Gemcitabine,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_Hydroxyurea,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Cisplatin,_Etoposide,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Cisplatin,_Docetaxel,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Cisplatin,_Cetuximab,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Cisplatin_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Cetuximab_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Carmustine_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Carboplatin,_Vinorelbine,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Carboplatin,_Paclitaxel,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Carboplatin,_Fluorouracil,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Carboplatin,_Fluorouracil,_Cetuximab,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Carboplatin,_Etoposide,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Carboplatin_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Capecitabine/Capecitabine_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Capecitabine,_Sorafenib,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Capecitabine,_Paclitaxel,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Capecitabine,_Oxaliplatin,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Capecitabine,_Mitomycin,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Capecitabine,_Docetaxel,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Capecitabine,_Docetaxel,_Oxaliplatin,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Capecitabine,_Cisplatin,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Capecitabine,_Carboplatin,_Paclitaxel,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Capecitabine_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "CapeOx,_Cetuximab,_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "CEV_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "CC/DE_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "CAV_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "BuCyTBI,_then_allo_HSCT" .
<External_beam_radiotherapy> <Antineoplastic_of> "BuCyTBI" .
<External_beam_radiotherapy> <Antineoplastic_of> "Bleomycin,_Methotrexate,_Vinblastine/RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Bicalutamide_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "Bevacizumab_and_RT" .
<External_beam_radiotherapy> <Antineoplastic_of> "ADT_and_RT" .
<BuCyTBI> <Has_accepted_use> "Allogeneic_HSCT" .
<Methotrexate_and_Thiotepa> <Has_context> "Non-curative_therapy" .
<Vincristine_and_Prednisone> <Has_modality> "Chemotherapy" .
<Sultrimmix> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Rucaparib_monotherapy> <Has_antineoplastic> "Rucaparib" .
<Axitinib_and_Pembrolizumab> <Maps_to> "Axitinib_and_Pembrolizumab" .
<SYK_inhibitor> <Is_a> "Kinase_inhibitor" .
<Nivolumab,_then_Ipilimumab> <Mapped_from> "Nivolumab,_then_Ipilimumab" .
<R-MACLO/R-IVAM> <Has_antineoplastic> "Vincristine" .
<R-MACLO/R-IVAM> <Has_antineoplastic> "Rituximab" .
<R-MACLO/R-IVAM> <Has_antineoplastic> "Methotrexate" .
<R-MACLO/R-IVAM> <Has_antineoplastic> "Ifosfamide" .
<R-MACLO/R-IVAM> <Has_antineoplastic> "Etoposide" .
<R-MACLO/R-IVAM> <Has_antineoplastic> "Doxorubicin" .
<R-MACLO/R-IVAM> <Has_antineoplastic> "Cytarabine" .
<R-MACLO/R-IVAM> <Has_antineoplastic> "Cyclophosphamide" .
<Cutaneous_squamous_cell_carcinoma> <Is_a> "Non-melanoma_skin_cancer" .
<Anzatec> <Brand_name_of> "Paclitaxel" .
<WHO_Essential_Pain_and_Palliative_Care_Medicine> <Is_a> "WHO_Essential_Medicine" .
<Cytarabine_and_daunorubicin_liposomal> <Has_brand_name> "Vyxeos" .
<Uromes> <Brand_name_of> "Mesna" .
<Endronax> <Brand_name_of> "Alendronate" .
<Docetaxel_and_Ramucirumab> <Mapped_from> "Docetaxel_and_Ramucirumab" .
<Afatinib_and_Bevacizumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<Temozolomide_and_RT,_then_Temozolomide> <Has_context> "Adjuvant_therapy" .
<IT_Methotrexate_monotherapy> <Maps_to> "IT_Methotrexate_monotherapy" .
<R-DHAP> <Has_supportive_med> "Filgrastim" .
<CAF_and_MPA> <Has_modality> "Hormonotherapy" .
<CAF_and_MPA> <Has_modality> "Chemotherapy" .
<ICE> <Has_modality> "Chemotherapy" .
<Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT> <Has_modality> "Immunosuppressive_therapy" .
<Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<R-NIMP> <Has_modality> "Chemotherapy" .
<Dactinomycin> <Has_FDA_indication> "Wilms_tumor" .
<Dactinomycin> <Has_FDA_indication> "Testicular_cancer" .
<Dactinomycin> <Has_FDA_indication> "Rhabdomyosarcoma" .
<Dactinomycin> <Has_FDA_indication> "Gestational_trophoblastic_neoplasia" .
<Dactinomycin> <Has_FDA_indication> "Ewing_sarcoma" .
<FOLFOX4_and_Panitumumab> <Is_current_in> "Colon_cancer" .
<Lenalid> <Brand_name_of> "Lenalidomide" .
<Metysolon> <Brand_name_of> "Methylprednisolone" .
<FRD> <Has_antineoplastic> "Panobinostat" .
<FRD> <Has_antineoplastic> "Lenalidomide" .
<FRD> <Has_antineoplastic> "Dexamethasone" .
<Intravenous_immunoglobulin_monotherapy> <Has_supportive_med> "Intravenous_immunoglobulin_(IVIG)" .
<Octagam> <Brand_name_of> "Intravenous_immunoglobulin_(IVIG)" .
<Bonemax> <Brand_name_of> "Alendronate" .
<Anti-amyloid_antibody> <Is_a> "Antibody_medication" .
<ACOMLA> <Has_antineoplastic> "Vincristine" .
<ACOMLA> <Has_antineoplastic> "Methotrexate" .
<ACOMLA> <Has_antineoplastic> "Doxorubicin" .
<ACOMLA> <Has_antineoplastic> "Cytarabine" .
<ACOMLA> <Has_antineoplastic> "Cyclophosphamide" .
<Tagraxofusp_monotherapy> <Mapped_from> "Tagraxofusp_monotherapy" .
<7_plus_3i_and_Panobinostat> <Mapped_from> "7_plus_3i_and_Panobinostat" .
<Eculizumab> <Has_brand_name> "Soliris" .
<Cellacort> <Brand_name_of> "Dexamethasone" .
<BVR> <Is_current_in> "Follicular_lymphoma" .
<Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_immunosuppressor> "Methotrexate" .
<Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_immunosuppressor> "Cyclosporines" .
<Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<DHAP_-_time_intensified> <Has_antineoplastic> "Dexamethasone" .
<DHAP_-_time_intensified> <Has_antineoplastic> "Cytarabine" .
<DHAP_-_time_intensified> <Has_antineoplastic> "Cisplatin" .
<Neuroblastoma> <FDA_indication_of> "Perifosine" .
<Neuroblastoma> <FDA_indication_of> "Dinutuximab" .
<Neuroblastoma> <FDA_indication_of> "Cyclophosphamide" .
<Trifides> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin,_Etoposide,_RT> <Has_modality> "Radiotherapy" .
<Cisplatin,_Etoposide,_RT> <Has_modality> "Chemotherapy" .
<EVI> <Has_antineoplastic> "Vindesine" .
<EVI> <Has_antineoplastic> "Ifosfamide" .
<EVI> <Has_antineoplastic> "Epirubicin" .
<Interferon_alfa-2b_and_DLI> <Has_antineoplastic> "Interferon_alfa-2b" .
<Blinatumomab_monotherapy> <Has_supportive_med> "Dexamethasone" .
<SRC_inhibitor> <Subsumes> "Vandetanib" .
<SRC_inhibitor> <Subsumes> "Ponatinib" .
<SRC_inhibitor> <Subsumes> "Pazopanib" .
<SRC_inhibitor> <Subsumes> "Nintedanib" .
<SRC_inhibitor> <Subsumes> "Dasatinib" .
<SRC_inhibitor> <Subsumes> "Bosutinib" .
<SRC_inhibitor> <Subsumes> "Apatinib" .
<Cabazitaxel> <Has_FDA_indication> "Prostate_cancer" .
<RUI_SI_YI> <Brand_name_of> "Anastrozole" .
<Aracytine> <Brand_name_of> "Cytarabine" .
<Temozolomide_monotherapy> <Has_supportive_med> "Tropisetron" .
<Temozolomide_monotherapy> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Temozolomide_monotherapy> <Has_supportive_med> "Steroids" .
<Temozolomide_monotherapy> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Temozolomide_monotherapy> <Has_supportive_med> "Ondansetron" .
<Temozolomide_monotherapy> <Has_supportive_med> "Metoclopramide" .
<Temozolomide_monotherapy> <Has_supportive_med> "Emesis_prevention" .
<FCR,_then_allo_HSCT> <Has_context> "Non-curative_subsequent-line_consolidation_therapy" .
<TILs> <Maps_to> "TILs" .
<Pemetrexed_and_Bevacizumab> <Has_antineoplastic> "Pemetrexed" .
<Pemetrexed_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Busulfan_monotherapy> <Has_antineoplastic> "Busulfan" .
<CAP-BOP> <Maps_to> "CAP-BOP" .
<Radium-223> <Is_a> "Radiotherapy_medication" .
<Radium-223> <Is_a> "Alpha_emitter" .
<Ifosfamide_and_Vinorelbine> <Has_supportive_med> "Prednisone" .
<Ifosfamide_and_Vinorelbine> <Has_supportive_med> "Filgrastim" .
<Gemcitabine_and_Trastuzumab> <Has_antineoplastic> "Trastuzumab" .
<Gemcitabine_and_Trastuzumab> <Has_antineoplastic> "Gemcitabine" .
<Tinzaparin_monotherapy> <Is_current_in> "Venous_thromboembolism" .
<HLH-2004_regimen> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<HLH-2004_regimen> <Has_supportive_med> "Intravenous_immunoglobulin_(IVIG)" .
<HLH-2004_regimen> <Has_supportive_med> "Antifungals" .
<Blinatumomab_monotherapy> <Has_modality> "Chemotherapy" .
<CBVM,_then_auto_HSCT> <Has_context> "Consolidation_after_upfront_therapy" .
<Zamboprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Dabrafenib_monotherapy> <Maps_to> "Dabrafenib_monotherapy" .
<Ermethasone> <Brand_name_of> "Dexamethasone" .
<ddFEC> <Is_current_in> "Breast_cancer" .
<Latran> <Brand_name_of> "Ondansetron" .
<Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Is_current_in> "Acute_myeloid_leukemia" .
<Gemcitabine_and_Vinorelbine> <Maps_to> "Gemcitabine_and_Vinorelbine" .
<Tamoxifen_monotherapy> <Has_antineoplastic> "Tamoxifen" .
<mFOLFOX6_and_RT> <Maps_to> "mFOLFOX6_and_RT" .
<Pediatric-like_GRAALL_consolidation> <Has_supportive_med> "Lenograstim" .
<Carboplatin_and_Fluorouracil> <Has_supportive_med> "Docetaxel" .
<Carboplatin_and_Fluorouracil> <Has_supportive_med> "Diphenhydramine" .
<Carboplatin_and_Fluorouracil> <Has_supportive_med> "Dexamethasone" .
<Carboplatin_and_Fluorouracil> <Has_supportive_med> "Cetuximab" .
<Lomustine,_Temozolomide,_RT> <Is_current_in> "Glioblastoma" .
<Folinic_acid> <May_have_route> "Oral" .
<Folinic_acid> <May_have_route> "Intravenous" .
<Folinic_acid> <May_have_route> "Intramuscular" .
<CDE> <Mapped_from> "CDE" .
<VAMP_(Amethopterin)> <Has_antineoplastic> "Vincristine" .
<VAMP_(Amethopterin)> <Has_antineoplastic> "Prednisone" .
<VAMP_(Amethopterin)> <Has_antineoplastic> "Methotrexate" .
<VAMP_(Amethopterin)> <Has_antineoplastic> "Mercaptopurine" .
<Teniposide_and_WBRT> <Maps_to> "Teniposide_and_WBRT" .
<(90)YFC,_then_allo_HSCT> <Has_antineoplastic> "Rituximab" .
<(90)YFC,_then_allo_HSCT> <Has_antineoplastic> "Ibritumomab_tiuxetan" .
<(90)YFC,_then_allo_HSCT> <Has_antineoplastic> "Fludarabine" .
<(90)YFC,_then_allo_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<(90)YFC,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<R-CHOP-14> <Is_a> "Rituximab-containing_regimen" .
<R-CHOP-14> <Is_a> "Anthracycline-containing_regimen" .
<Talimogene_laherparepvec_monotherapy> <Maps_to> "Talimogene_laherparepvec_monotherapy" .
<CEP> <Has_modality> "Chemotherapy" .
<Chlorambucil_and_Rituximab> <Is_current_in> "Marginal_zone_lymphoma" .
<Chlorambucil_and_Rituximab> <Is_current_in> "Mantle_cell_lymphoma" .
<Chlorambucil_and_Rituximab> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Carboplatin_and_Vincristine> <Has_accepted_use> "Low-grade_glioma" .
<ICL> <Has_context> "Induction_therapy" .
<Cyclosporine,_Methotrexate,_Methylprednisolone> <Has_context> "Prophylaxis" .
<Darolutamide> <Is_a> "Nonsteroidal_antiandrogen" .
<Tecnocris> <Brand_name_of> "Vincristine" .
<DHAP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant> <Mapped_from> "Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant" .
<L-Asparaginase,_Vincristine,_Prednisone> <Has_modality> "Chemotherapy" .
<Pixantrone> <Has_brand_name> "Pixuvri" .
<O-ICE> <Has_modality> "Chemotherapy" .
<BuCyTBI> <Has_antineoplastic> "External_beam_radiotherapy" .
<BuCyTBI> <Has_antineoplastic> "Cyclophosphamide" .
<BuCyTBI> <Has_antineoplastic> "Busulfan" .
<Emicizumab> <Has_brand_name> "Hemlibra" .
<L_Asparaginasa> <Brand_name_of> "Asparaginase" .
<Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin> <Is_a> "Anthracycline-containing_regimen" .
<BEP> <Maps_to> "BEP" .
<Oxtalen> <Brand_name_of> "Alendronate" .
<VTP> <Maps_to> "VTP" .
<ATRA_and_Daunorubicin> <Is_a> "Anthracycline-containing_regimen" .
<Pexotra> <Brand_name_of> "Pemetrexed" .
<Claradin> <Brand_name_of> "Aspirin" .
<Emicizumab_monotherapy> <Has_modality> "Supportive_therapy" .
<M-EI> <Has_modality> "Chemotherapy" .
<DEP> <Has_antineoplastic> "Pegylated_liposomal_doxorubicin" .
<DEP> <Has_antineoplastic> "Methylprednisolone" .
<DEP> <Has_antineoplastic> "Etoposide" .
<Alpermell> <Brand_name_of> "Dexamethasone" .
<Unisone> <Brand_name_of> "Dexamethasone" .
<Cisplatin,_Gemcitabine,_Bevacizumab> <Has_modality> "Chemotherapy" .
<BEAM> <Has_supportive_med> "Valacyclovir" .
<BEAM> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<BEAM> <Has_supportive_med> "Mycostatin" .
<BEAM> <Has_supportive_med> "Fluconazole" .
<BEAM> <Has_supportive_med> "Filgrastim" .
<BEAM> <Has_supportive_med> "Ciprofloxacin" .
<BEAM> <Has_supportive_med> "Acyclovir" .
<Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Immune_thrombocytopenia> <Accepted_use_of> "TT4" .
<Immune_thrombocytopenia> <Accepted_use_of> "Romiplostim_monotherapy" .
<Immune_thrombocytopenia> <Accepted_use_of> "Romiplostim" .
<Immune_thrombocytopenia> <Accepted_use_of> "Rituximab-pvvr" .
<Immune_thrombocytopenia> <Accepted_use_of> "Rituximab-abbs" .
<Immune_thrombocytopenia> <Accepted_use_of> "Rituximab_monotherapy" .
<Immune_thrombocytopenia> <Accepted_use_of> "Rituximab" .
<Immune_thrombocytopenia> <Accepted_use_of> "Rho(D)_immune_globulin" .
<Immune_thrombocytopenia> <Accepted_use_of> "RhIG_monotherapy" .
<Immune_thrombocytopenia> <Accepted_use_of> "Prednisone_monotherapy" .
<Immune_thrombocytopenia> <Accepted_use_of> "Prednisone" .
<Immune_thrombocytopenia> <Accepted_use_of> "Placebo" .
<Immune_thrombocytopenia> <Accepted_use_of> "Mycophenolate_mofetil_monotherapy" .
<Immune_thrombocytopenia> <Accepted_use_of> "Mycophenolate_mofetil" .
<Immune_thrombocytopenia> <Accepted_use_of> "Methylprednisolone" .
<Immune_thrombocytopenia> <Accepted_use_of> "Intravenous_immunoglobulin_monotherapy" .
<Immune_thrombocytopenia> <Accepted_use_of> "Fostamatinib_monotherapy" .
<Immune_thrombocytopenia> <Accepted_use_of> "Fostamatinib" .
<Immune_thrombocytopenia> <Accepted_use_of> "Eltrombopag_monotherapy" .
<Immune_thrombocytopenia> <Accepted_use_of> "Eltrombopag" .
<Immune_thrombocytopenia> <Accepted_use_of> "Dexamethasone_monotherapy" .
<Immune_thrombocytopenia> <Accepted_use_of> "Dexamethasone_and_Rituximab" .
<Immune_thrombocytopenia> <Accepted_use_of> "Dexamethasone_and_Eltrombopag" .
<Immune_thrombocytopenia> <Accepted_use_of> "Dexamethasone" .
<Immune_thrombocytopenia> <Accepted_use_of> "Danazol_monotherapy" .
<Immune_thrombocytopenia> <Accepted_use_of> "Danazol" .
<Immune_thrombocytopenia> <Accepted_use_of> "Cyclosporine_monotherapy" .
<Immune_thrombocytopenia> <Accepted_use_of> "Avatrombopag_monotherapy" .
<Immune_thrombocytopenia> <Accepted_use_of> "Avatrombopag" .
<Immune_thrombocytopenia> <Accepted_use_of> "All-trans_retinoic_acid" .
<Immune_thrombocytopenia> <Accepted_use_of> "ATRA_and_Danazol" .
<Anti-Factor_Xa_antibody> <Is_a> "Antibody_medication" .
<HAD> <Mapped_from> "HAD" .
<Trastuzumab_monotherapy> <Has_antineoplastic> "Trastuzumab" .
<Carboplatin,_Paclitaxel,_Pembrolizumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<Docetaxel> <Antineoplastic_of> "mDCF_and_Bevacizumab" .
<Docetaxel> <Antineoplastic_of> "mDCF" .
<Docetaxel> <Antineoplastic_of> "ddTH_(Taxotere)" .
<Docetaxel> <Antineoplastic_of> "ddT_(Taxotere)" .
<Docetaxel> <Antineoplastic_of> "TX_(Taxotere)" .
<Docetaxel> <Antineoplastic_of> "THP_(Taxotere)" .
<Docetaxel> <Antineoplastic_of> "TH_(Taxotere/SC)" .
<Docetaxel> <Antineoplastic_of> "TH_(Taxotere)" .
<Docetaxel> <Antineoplastic_of> "TCHP_(Taxotere)" .
<Docetaxel> <Antineoplastic_of> "TCH_(Taxotere,_Cyclophosphamide)" .
<Docetaxel> <Antineoplastic_of> "TCH_(Taxotere,_Carboplatin)" .
<Docetaxel> <Antineoplastic_of> "TC_(Taxotere)" .
<Docetaxel> <Antineoplastic_of> "TAC_(Taxotere)" .
<Docetaxel> <Antineoplastic_of> "GTX" .
<Docetaxel> <Antineoplastic_of> "FLOT" .
<Docetaxel> <Antineoplastic_of> "EDC" .
<Docetaxel> <Antineoplastic_of> "Docetaxel,_Gemcitabine,_RT" .
<Docetaxel> <Antineoplastic_of> "Docetaxel,_Fluorouracil,_RT" .
<Docetaxel> <Antineoplastic_of> "Docetaxel,_Fluorouracil,_Hydroxyurea,_RT" .
<Docetaxel> <Antineoplastic_of> "Docetaxel,_Cetuximab,_RT" .
<Docetaxel> <Antineoplastic_of> "Docetaxel_monotherapy" .
<Docetaxel> <Antineoplastic_of> "Docetaxel_and_Vinorelbine" .
<Docetaxel> <Antineoplastic_of> "Docetaxel_and_Vandetanib" .
<Docetaxel> <Antineoplastic_of> "Docetaxel_and_S-1" .
<Docetaxel> <Antineoplastic_of> "Docetaxel_and_Ramucirumab" .
<Docetaxel> <Antineoplastic_of> "Docetaxel_and_Prednisone" .
<Docetaxel> <Antineoplastic_of> "Docetaxel_and_Prednisolone" .
<Docetaxel> <Antineoplastic_of> "Docetaxel_and_Nintedanib" .
<Docetaxel> <Antineoplastic_of> "Docetaxel_and_Nedaplatin" .
<Docetaxel> <Antineoplastic_of> "Docetaxel_and_Irinotecan" .
<Docetaxel> <Antineoplastic_of> "Docetaxel_and_Gemcitabine" .
<Docetaxel> <Antineoplastic_of> "Docetaxel_and_Estramustine" .
<Docetaxel> <Antineoplastic_of> "Docetaxel_and_Bevacizumab" .
<Docetaxel> <Antineoplastic_of> "DE" .
<Docetaxel> <Antineoplastic_of> "DCF" .
<Docetaxel> <Antineoplastic_of> "Cisplatin,_Docetaxel,_RT" .
<Docetaxel> <Antineoplastic_of> "Cisplatin_and_Docetaxel" .
<Docetaxel> <Antineoplastic_of> "Carboplatin,_Docetaxel,_Prednisone" .
<Docetaxel> <Antineoplastic_of> "Carboplatin_and_Docetaxel" .
<Docetaxel> <Antineoplastic_of> "Capecitabine,_Docetaxel,_RT" .
<Docetaxel> <Antineoplastic_of> "Capecitabine,_Docetaxel,_Oxaliplatin,_RT" .
<Docetaxel> <Antineoplastic_of> "AT_(Taxotere)" .
<Docetaxel> <Antineoplastic_of> "ADT,_Docetaxel,_Estramustine" .
<Docetaxel> <Antineoplastic_of> "ADT_and_Docetaxel" .
<Servitrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Uflahex> <Brand_name_of> "Fluorouracil" .
<Syntoprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Thalidomide_monotherapy> <Mapped_from> "Thalidomide_monotherapy" .
<Espectrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Doxorubicin_monotherapy> <Has_accepted_use> "Thyroid_cancer" .
<Doxorubicin_monotherapy> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Doxorubicin_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<Doxorubicin_monotherapy> <Has_accepted_use> "Osteosarcoma" .
<Doxorubicin_monotherapy> <Has_accepted_use> "Mesothelioma" .
<Doxorubicin_monotherapy> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Doxorubicin_monotherapy> <Has_accepted_use> "Endometrial_cancer" .
<Doxorubicin_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Doxorubicin_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<Doxorubicin_and_Gemcitabine> <Has_antineoplastic> "Gemcitabine" .
<Doxorubicin_and_Gemcitabine> <Has_antineoplastic> "Doxorubicin" .
<Melphalan_monotherapy> <Maps_to> "Melphalan_monotherapy" .
<Stem_cell_mobilization> <Accepted_use_of> "Plerixafor_and_G-CSF" .
<Stem_cell_mobilization> <Accepted_use_of> "IGEV_and_G-CSF" .
<Stem_cell_mobilization> <Accepted_use_of> "EAR_and_G-CSF" .
<Stem_cell_mobilization> <Accepted_use_of> "DexaBEAM_and_G-CSF" .
<Stem_cell_mobilization> <Accepted_use_of> "DCEP_and_G-CSF" .
<Stem_cell_mobilization> <Accepted_use_of> "Cytarabine,_Ifosfamide,_G-CSF" .
<Stem_cell_mobilization> <Accepted_use_of> "Cytarabine_and_G-CSF" .
<Stem_cell_mobilization> <Accepted_use_of> "Cyclophosphamide_and_G-CSF" .
<Stem_cell_mobilization> <Accepted_use_of> "CYVE_and_G-CSF" .
<Stem_cell_mobilization> <Accepted_use_of> "CAD_and_G-CSF" .
<Dexamethasone_monotherapy> <Is_current_in> "Immune_thrombocytopenia" .
<Dexamethasone_monotherapy> <Is_current_in> "CNS_carcinoma" .
<Anti-CD3_antibody> <Is_a> "Antibody_medication" .
<V-HyperCAD> <Has_supportive_med> "Pegfilgrastim" .
<V-HyperCAD> <Has_supportive_med> "Mesna" .
<V-HyperCAD> <Has_supportive_med> "Acyclovir" .
<LOPP/EVAP> <Has_antineoplastic> "Vincristine" .
<LOPP/EVAP> <Has_antineoplastic> "Vinblastine" .
<LOPP/EVAP> <Has_antineoplastic> "Procarbazine" .
<LOPP/EVAP> <Has_antineoplastic> "Prednisone" .
<LOPP/EVAP> <Has_antineoplastic> "Etoposide" .
<LOPP/EVAP> <Has_antineoplastic> "Doxorubicin" .
<LOPP/EVAP> <Has_antineoplastic> "Chlorambucil" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine> <Maps_to> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine" .
<Diflucan> <Brand_name_of> "Fluconazole" .
<Pisatrina> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Forodesine_monotherapy> <Mapped_from> "Forodesine_monotherapy" .
<Tazemetostat> <Is_a> "EZH2_inhibitor" .
<Escoprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<AspaMetDex_(Erwinaze)> <Has_modality> "Chemotherapy" .
<Bu/TT> <Has_accepted_use> "Autologous_HSCT" .
<Tositumomab_and_I-131_(Bexxar)> <Antineoplastic_of> "Fludarabine,_then_131Iodine-Tositumomab" .
<Tositumomab_and_I-131_(Bexxar)> <Antineoplastic_of> "CVP,_then_131Iodine-Tositumomab" .
<Tositumomab_and_I-131_(Bexxar)> <Antineoplastic_of> "CHOP,_then_131Iodine-Tositumomab" .
<Tositumomab_and_I-131_(Bexxar)> <Antineoplastic_of> "131Iodine-Tositumomab_monotherapy" .
<MV> <Has_antineoplastic> "Vinblastine" .
<MV> <Has_antineoplastic> "Methotrexate" .
<Cisplatin_and_Doxorubicin> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Cisplatin_and_Doxorubicin> <Has_supportive_med> "Pegfilgrastim" .
<Cisplatin_and_Doxorubicin> <Has_supportive_med> "Lenograstim" .
<Cisplatin_and_Doxorubicin> <Has_supportive_med> "Furosemide" .
<Cisplatin_and_Doxorubicin> <Has_supportive_med> "Filgrastim" .
<Cisplatin_and_Doxorubicin> <Has_supportive_med> "Dexamethasone" .
<Isotretinoin> <Has_brand_name> "Sotret" .
<Isotretinoin> <Has_brand_name> "Roacutan" .
<Isotretinoin> <Has_brand_name> "Roaccutane" .
<Isotretinoin> <Has_brand_name> "Roaccutan" .
<Isotretinoin> <Has_brand_name> "Oratane" .
<Isotretinoin> <Has_brand_name> "Isotrexin" .
<Isotretinoin> <Has_brand_name> "Isotrex" .
<Isotretinoin> <Has_brand_name> "Claravis" .
<Isotretinoin> <Has_brand_name> "Cistane" .
<Isotretinoin> <Has_brand_name> "Amnesteem" .
<Isotretinoin> <Has_brand_name> "Accutane" .
<Isotretinoin> <Has_brand_name> "Accure" .
<Chemotherapy_protective_agent> <Subsumes> "Uridine_triacetate" .
<Chemotherapy_protective_agent> <Subsumes> "Palifermin" .
<Chemotherapy_protective_agent> <Subsumes> "Mesna" .
<Chemotherapy_protective_agent> <Subsumes> "Mannitol" .
<Chemotherapy_protective_agent> <Subsumes> "Levoleucovorin" .
<Chemotherapy_protective_agent> <Subsumes> "Glucarpidase" .
<Chemotherapy_protective_agent> <Subsumes> "Folinic_acid" .
<Chemotherapy_protective_agent> <Subsumes> "Folic_acid" .
<Chemotherapy_protective_agent> <Subsumes> "Dexrazoxane" .
<Chemotherapy_protective_agent> <Subsumes> "Defibrotide" .
<Chemotherapy_protective_agent> <Subsumes> "Cyanocobalamin" .
<Chemotherapy_protective_agent> <Subsumes> "Amifostine" .
<Encorafenib> <Antineoplastic_of> "Binimetinib,_Encorafenib,_Cetuximab" .
<Encorafenib> <Antineoplastic_of> "Binimetinib_and_Encorafenib" .
<Flutamide_and_Goserelin> <Has_context> "Non-curative_therapy" .
<Flutamide_and_Goserelin> <Has_context> "Induction_therapy" .
<HDMP-R> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<HDMP-R> <Has_supportive_med> "Fluconazole" .
<HDMP-R> <Has_supportive_med> "Diphenhydramine" .
<HDMP-R> <Has_supportive_med> "Cimetidine" .
<HDMP-R> <Has_supportive_med> "Allopurinol" .
<HDMP-R> <Has_supportive_med> "Acyclovir" .
<HDMP-R> <Has_supportive_med> "Acetaminophen" .
<Dacomitinib_monotherapy> <Mapped_from> "Dacomitinib_monotherapy" .
<SC-EPOCH-RR> <Is_current_in> "HIV-associated_lymphoma" .
<Hematopoetic_progenitor_cells_cord_blood> <Is_a> "Cellular_therapy" .
<Bortezomib_and_Doxorubicin_liposomal> <Is_a> "Anthracycline-containing_regimen" .
<Chlorambucil_and_Obinutuzumab> <Has_modality> "Chemotherapy" .
<Copanlisib_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<VR-CHOP> <Is_a> "Rituximab-containing_regimen" .
<VR-CHOP> <Is_a> "Anthracycline-containing_regimen" .
<ESHAP> <Maps_to> "ESHAP" .
<Flu-Mel,_then_allo_HSCT> <Has_antineoplastic> "Melphalan" .
<Flu-Mel,_then_allo_HSCT> <Has_antineoplastic> "Fludarabine" .
<Flu-Mel,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<MAID> <Has_modality> "Chemotherapy" .
<nab-Paclitaxel_and_Trastuzumab> <Has_modality> "Chemotherapy" .
<Cytarabine_and_daunorubicin_liposomal> <May_have_route> "Intravenous" .
<HER2-positive_-_historical_Breast_cancer> <Is_a> "Breast_cancer" .
<FLEP> <Has_antineoplastic> "Folinic_acid" .
<FLEP> <Has_antineoplastic> "Fluorouracil" .
<FLEP> <Has_antineoplastic> "Etoposide" .
<FLEP> <Has_antineoplastic> "Cisplatin" .
<Onaset> <Brand_name_of> "Ondansetron" .
<Injectrax> <Brand_name_of> "Ondansetron" .
<Erbanfol> <Brand_name_of> "Folinic_acid" .
<Fondaparinux> <Supportive_med_of> "Fondaparinux_monotherapy" .
<Alisertib> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Alisertib> <Has_accepted_use> "Mantle_cell_lymphoma" .
<BO> <Has_context> "Upfront_therapy" .
<Servycal> <Brand_name_of> "Zoledronic_acid" .
<FOLFIRI_and_Bevacizumab> <Has_antineoplastic> "Irinotecan" .
<FOLFIRI_and_Bevacizumab> <Has_antineoplastic> "Folinic_acid" .
<FOLFIRI_and_Bevacizumab> <Has_antineoplastic> "Fluorouracil" .
<FOLFIRI_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<V-Gavir> <Brand_name_of> "Valganciclovir" .
<Dobixin> <Brand_name_of> "Doxorubicin" .
<Cisplatin_and_Vinblastine> <Is_a> "Platinum_doublet" .
<Alectinib> <May_have_route> "Oral" .
<VCP> <Has_antineoplastic> "Vincristine" .
<VCP> <Has_antineoplastic> "Prednisone" .
<VCP> <Has_antineoplastic> "Cyclophosphamide" .
<T-DM1_and_ET> <Mapped_from> "T-DM1_and_ET" .
<Cisplatin,_Fluorouracil,_Panitumumab> <Maps_to> "Cisplatin,_Fluorouracil,_Panitumumab" .
<Cyclophosphamide_and_Prednisolone> <Has_modality> "Immunosuppressive_therapy" .
<PEP-C> <Has_accepted_use> "Mantle_cell_lymphoma" .
<PEP-C> <Has_accepted_use> "Follicular_lymphoma" .
<Fulvestrant_monotherapy> <Mapped_from> "Fulvestrant_monotherapy" .
<Brigatinib_monotherapy> <Maps_to> "Brigatinib_monotherapy" .
<Tamoxifen_and_OFS> <Has_antineoplastic> "Tamoxifen" .
<AVD> <Is_current_in> "Hodgkin_lymphoma" .
<PI3K_inhibitor> <Is_a> "Kinase_inhibitor" .
<Alisertib> <May_have_route> "Oral" .
<Arsenic_trioxide,_then_ATRA_and_Daunorubicin> <Has_modality> "Chemotherapy" .
<Pharmatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<TAC_(Taxotere)> <Has_context> "Neoadjuvant_therapy" .
<TAC_(Taxotere)> <Has_context> "Adjuvant_therapy" .
<Bactropin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<ABV_(Vinblastine)> <Has_antineoplastic> "Vinblastine" .
<ABV_(Vinblastine)> <Has_antineoplastic> "Doxorubicin" .
<ABV_(Vinblastine)> <Has_antineoplastic> "Bleomycin" .
<Fluorouracil_and_Streptozocin> <Has_antineoplastic> "Streptozocin" .
<Fluorouracil_and_Streptozocin> <Has_antineoplastic> "Fluorouracil" .
<VR-CP> <Has_antineoplastic> "Rituximab" .
<VR-CP> <Has_antineoplastic> "Prednisone" .
<VR-CP> <Has_antineoplastic> "Cyclophosphamide" .
<VR-CP> <Has_antineoplastic> "Bortezomib" .
<Sterapred> <Brand_name_of> "Prednisone" .
<FLAG-Ida> <Is_current_in> "Acute_myeloid_leukemia" .
<Idelalisib_and_Rituximab> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Neutroval> <Brand_name_of> "Tbo-filgrastim" .
<Octreotide_LAR_monotherapy> <Mapped_from> "Octreotide_LAR_monotherapy" .
<IT_Cytarabine_and_WBRT> <Has_context> "Local_therapy" .
<Isotretinoin> <Is_a> "Retinoid" .
<Gefitinib> <Antineoplastic_of> "Gefitinib_monotherapy" .
<Gefitinib> <Antineoplastic_of> "Gefitinib_and_Pemetrexed" .
<Gefitinib> <Antineoplastic_of> "GCP" .
<VEPEMB> <Has_antineoplastic> "Vinblastine" .
<VEPEMB> <Has_antineoplastic> "Procarbazine" .
<VEPEMB> <Has_antineoplastic> "Prednisone" .
<VEPEMB> <Has_antineoplastic> "Mitoxantrone" .
<VEPEMB> <Has_antineoplastic> "Etoposide" .
<VEPEMB> <Has_antineoplastic> "Cyclophosphamide" .
<VEPEMB> <Has_antineoplastic> "Bleomycin" .
<R-IFE> <Has_antineoplastic> "Rituximab" .
<R-IFE> <Has_antineoplastic> "Ifosfamide" .
<R-IFE> <Has_antineoplastic> "Etoposide" .
<IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone> <Mapped_from> "IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone" .
<Iron_dextran> <Has_brand_name> "Uniferon" .
<Iron_dextran> <Has_brand_name> "Saferon" .
<Iron_dextran> <Has_brand_name> "Irondex" .
<Iron_dextran> <Has_brand_name> "Imferon" .
<Iron_dextran> <Has_brand_name> "INFeD" .
<Iron_dextran> <Has_brand_name> "Ferrodex" .
<Iron_dextran> <Has_brand_name> "DextraCare" .
<Iron_dextran> <Has_brand_name> "Dexferrum" .
<DEP_and_RT> <Has_modality> "Radiotherapy" .
<DEP_and_RT> <Has_modality> "Chemotherapy" .
<CNS_cancer> <Is_a> "Cross-disciplinary_condition" .
<MVP_(Vinblastine)> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Busulfan_and_Melphalan> <Has_accepted_use> "Autologous_HSCT" .
<Kcentra> <Brand_name_of> "Prothrombin_Complex_Concentrate_human" .
<PD> <Maps_to> "PD" .
<Irinotecan_and_Cetuximab> <Has_antineoplastic> "Irinotecan" .
<Irinotecan_and_Cetuximab> <Has_antineoplastic> "Cetuximab" .
<Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone> <Mapped_from> "Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone" .
<IDAC_and_Sorafenib> <Mapped_from> "IDAC_and_Sorafenib" .
<VMD> <Maps_to> "VMD" .
<Doxorubicin,_Ifosfamide,_RT> <Is_current_in> "Soft_tissue_sarcoma" .
<Nilutamide_and_Orchiectomy> <Has_context> "Non-curative_therapy" .
<Haloxan> <Brand_name_of> "Ifosfamide" .
<Fludarabine,_Cyclophosphamide,_ATG> <Has_accepted_use> "Allogeneic_HSCT" .
<Ibrutinib_and_Obinutuzumab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Doctrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin,_Paclitaxel,_RT> <Has_accepted_use> "Head_and_neck_cancer" .
<Cisplatin,_Paclitaxel,_RT> <Has_accepted_use> "Esophageal_cancer" .
<Cisplatin,_Paclitaxel,_RT> <Has_accepted_use> "Bladder_cancer" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_antineoplastic> "Vincristine" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_antineoplastic> "Prednisone" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_antineoplastic> "Daunorubicin" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_antineoplastic> "Asparaginase" .
<Septran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Brentuximab_vedotin_monotherapy> <Has_modality> "Chemotherapy" .
<Myelofibrosis> <Accepted_use_of> "Ruxolitinib_monotherapy" .
<Myelofibrosis> <Accepted_use_of> "Ruxolitinib" .
<Myelofibrosis> <Accepted_use_of> "Prednisone_monotherapy" .
<Myelofibrosis> <Accepted_use_of> "Prednisone" .
<Myelofibrosis> <Accepted_use_of> "Pomalidomide_monotherapy" .
<Myelofibrosis> <Accepted_use_of> "Pomalidomide_and_Prednisone" .
<Myelofibrosis> <Accepted_use_of> "Pomalidomide" .
<Myelofibrosis> <Accepted_use_of> "Placebo" .
<Myelofibrosis> <Accepted_use_of> "Pentraxin_2" .
<Myelofibrosis> <Accepted_use_of> "Pacritinib" .
<Myelofibrosis> <Accepted_use_of> "Momelotinib" .
<Myelofibrosis> <Accepted_use_of> "Lenalidomide_monotherapy" .
<Myelofibrosis> <Accepted_use_of> "Lenalidomide" .
<Myelofibrosis> <Accepted_use_of> "Imetelstat" .
<Myelofibrosis> <Accepted_use_of> "Hydroxyurea_monotherapy" .
<Myelofibrosis> <Accepted_use_of> "Hydroxyurea" .
<Myelofibrosis> <Accepted_use_of> "Fedratinib_monotherapy" .
<Myelofibrosis> <Accepted_use_of> "Fedratinib" .
<Famciclovir> <Has_brand_name> "Famvir" .
<DD-CHOP> <Mapped_from> "DD-CHOP" .
<Erythropoetin_and_Lenalidomide> <Is_current_in> "Myelodysplastic_syndrome" .
<Bevacizumab_and_RT> <Has_modality> "Radiotherapy" .
<Bevacizumab_and_RT> <Has_modality> "Chemotherapy" .
<TILs> <Mapped_from> "TILs" .
<Cortisone_monotherapy> <Mapped_from> "Cortisone_monotherapy" .
<X-Trim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CLAG-M> <Has_context> "Salvage_therapy" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_modality> "Chemotherapy" .
<G-CHOP> <Has_modality> "Chemotherapy" .
<DRC> <Has_antineoplastic> "Rituximab" .
<DRC> <Has_antineoplastic> "Dexamethasone" .
<DRC> <Has_antineoplastic> "Cyclophosphamide" .
<Temozolomide_and_RT> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Temozolomide_and_RT> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Temozolomide_and_RT> <Has_supportive_med> "Pentamidine" .
<Temozolomide_and_RT> <Has_supportive_med> "Metoclopramide" .
<Capecitabine_and_RT> <Has_context> "Neoadjuvant_therapy" .
<Capecitabine_and_RT> <Has_context> "Adjuvant_therapy" .
<Temozolomide_and_RT> <Mapped_from> "Temozolomide_and_RT" .
<Nedaplatin> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Nedaplatin> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<Irinotecan_liposomal_monotherapy> <Has_modality> "Chemotherapy" .
<Triforam> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<AT_(Taxol)> <Is_a> "Anthracycline-containing_regimen" .
<Imatinib,_Vincristine,_Dexamethasone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Pancreatic_cancer> <Subsumes> "BRCA-mutated_Pancreatic_cancer" .
<Solomet> <Brand_name_of> "Methylprednisolone" .
<Imatinib_monotherapy> <Has_modality> "Chemotherapy" .
<VcR-CVAD> <Has_antineoplastic> "Vincristine" .
<VcR-CVAD> <Has_antineoplastic> "Rituximab" .
<VcR-CVAD> <Has_antineoplastic> "Doxorubicin" .
<VcR-CVAD> <Has_antineoplastic> "Dexamethasone" .
<VcR-CVAD> <Has_antineoplastic> "Cyclophosphamide" .
<VcR-CVAD> <Has_antineoplastic> "Bortezomib" .
<CHOP-AL> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<Trastuzumab-dkst> <May_have_route> "Intravenous" .
<R-MCP_(CCNU)> <Has_accepted_use> "CNS_lymphoma" .
<CVD_(Vindesine)> <Has_modality> "Chemotherapy" .
<Fluconazole> <Is_a> "WHO_Essential_Anti-infective_Medicine" .
<Fluconazole> <Is_a> "Antifungal" .
<BVD> <Has_context> "Non-curative_therapy" .
<FC,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<FC,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<Soft_tissue_sarcoma> <Current_treated_by> "Trabectedin_monotherapy" .
<Soft_tissue_sarcoma> <Current_treated_by> "Temozolomide_monotherapy" .
<Soft_tissue_sarcoma> <Current_treated_by> "Sorafenib_monotherapy" .
<Soft_tissue_sarcoma> <Current_treated_by> "Regorafenib_monotherapy" .
<Soft_tissue_sarcoma> <Current_treated_by> "Placebo" .
<Soft_tissue_sarcoma> <Current_treated_by> "Pazopanib_monotherapy" .
<Soft_tissue_sarcoma> <Current_treated_by> "Observation" .
<Soft_tissue_sarcoma> <Current_treated_by> "MAID" .
<Soft_tissue_sarcoma> <Current_treated_by> "Imatinib_monotherapy" .
<Soft_tissue_sarcoma> <Current_treated_by> "Ifosfamide_monotherapy" .
<Soft_tissue_sarcoma> <Current_treated_by> "Gemcitabine_and_Vinorelbine" .
<Soft_tissue_sarcoma> <Current_treated_by> "Epirubicin_monotherapy" .
<Soft_tissue_sarcoma> <Current_treated_by> "Epirubicin_and_Ifosfamide" .
<Soft_tissue_sarcoma> <Current_treated_by> "EIA" .
<Soft_tissue_sarcoma> <Current_treated_by> "Doxorubicin,_Ifosfamide,_RT" .
<Soft_tissue_sarcoma> <Current_treated_by> "Doxorubicin_monotherapy" .
<Soft_tissue_sarcoma> <Current_treated_by> "Doxorubicin_and_Ifosfamide" .
<Soft_tissue_sarcoma> <Current_treated_by> "Docetaxel_and_Gemcitabine" .
<Soft_tissue_sarcoma> <Current_treated_by> "Dacarbazine_monotherapy" .
<Soft_tissue_sarcoma> <Current_treated_by> "Dacarbazine_and_Gemcitabine" .
<Soft_tissue_sarcoma> <Current_treated_by> "Dacarbazine_and_Doxorubicin" .
<Soft_tissue_sarcoma> <Current_treated_by> "Cisplatin_monotherapy" .
<Tocilizumab_monotherapy> <Has_accepted_use> "Castleman_disease" .
<GDPT> <Maps_to> "GDPT" .
<Hepagumin> <Brand_name_of> "Dalteparin" .
<Folidan> <Brand_name_of> "Folinic_acid" .
<R-ESHAP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<LOPP/EVAP> <Has_modality> "Chemotherapy" .
<Flutamide,_Leuprolide,_RT> <Has_modality> "Radiotherapy" .
<Flutamide,_Leuprolide,_RT> <Has_modality> "Hormonotherapy" .
<M-BCD> <Has_context> "Neoadjuvant_therapy" .
<M-BCD> <Has_context> "Adjuvant_therapy" .
<RhIG_monotherapy> <Is_current_in> "Immune_thrombocytopenia" .
<5_plus_3d> <Has_modality> "Chemotherapy" .
<IAP> <Maps_to> "IAP" .
<ProMACE-MOPP> <Is_a> "Anthracycline-containing_regimen" .
<Mercaptopurine_monotherapy> <Mapped_from> "Mercaptopurine_monotherapy" .
<Dacarbazine_and_Tamoxifen> <Mapped_from> "Dacarbazine_and_Tamoxifen" .
<GVP> <Maps_to> "GVP" .
<CVAD> <Has_context> "Non-curative_first-line_therapy" .
<Disdual> <Brand_name_of> "Clodronate" .
<Vincristine_liposomal_monotherapy> <Mapped_from> "Vincristine_liposomal_monotherapy" .
<CFAR> <Maps_to> "CFAR" .
<TTR> <Is_a> "Rituximab-containing_regimen" .
<Idhifa> <Brand_name_of> "Enasidenib" .
<Intaxel> <Brand_name_of> "Paclitaxel" .
<Anagrelide> <Has_accepted_use> "Polycythemia_vera" .
<Anagrelide> <Has_accepted_use> "Essential_thrombocythemia" .
<Frazon> <Brand_name_of> "Ondansetron" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "TFC,_then_allo_HSCT" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "Romidepsin_monotherapy" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "Radiation_therapy" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "Pralatrexate_monotherapy" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "Mogamulizumab_monotherapy" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "Lenalidomide_monotherapy" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "HyperCHidam" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "Gemcitabine_monotherapy" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "GDPT" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "GDP" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "Forodesine_monotherapy" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "FluBuCy,_then_allo_HSCT" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "DHAP" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "DD-CHOP" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "DA-EPOCH" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "Cyclophosphamide_and_TBI,_then_auto_HSCT" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "Chidamide_monotherapy" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "CMED" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "CHOP-AL" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "CHOP_and_Everolimus" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "CHOP" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "CHOEP-14" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "Brentuximab_vedotin_monotherapy" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "Bortezomib_and_Panobinostat" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "Bendamustine_monotherapy" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "Belinostat_monotherapy" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "BV-CHP" .
<Peripheral_T-cell_lymphoma> <Current_treated_by> "BEAM,_then_auto_HSCT" .
<AspaMetDex> <Maps_to> "AspaMetDex" .
<FELV> <Is_current_in> "Gallbladder_cancer" .
<FELV> <Is_current_in> "Cholangiocarcinoma" .
<Low_molecular_weight_heparin> <Subsumes> "Tinzaparin" .
<Low_molecular_weight_heparin> <Subsumes> "Nadroparin" .
<Low_molecular_weight_heparin> <Subsumes> "Enoxaparin" .
<Low_molecular_weight_heparin> <Subsumes> "Danaparoid" .
<Low_molecular_weight_heparin> <Subsumes> "Dalteparin" .
<Senterlic> <Brand_name_of> "Prednisone" .
<RT,_then_Temozolomide> <Maps_to> "RT,_then_Temozolomide" .
<IRd> <Mapped_from> "IRd" .
<CEV_(Cyclophosphamide/Etoposide)> <Has_context> "Induction_therapy" .
<H2-receptor_antagonist> <Is_a> "Antihistamine" .
<Bolend> <Brand_name_of> "Alendronate" .
<Arsenic_trioxide_monotherapy> <Has_context> "Maintenance_after_upfront_therapy" .
<Arsenic_trioxide_monotherapy> <Has_context> "Induction_therapy" .
<Arsenic_trioxide_monotherapy> <Has_context> "Consolidation_after_upfront_therapy" .
<Arsenic_trioxide_monotherapy> <Has_context> "Consolidation_after_salvage_therapy" .
<Gestational_trophoblastic_neoplasia> <Is_a> "Gynecologic_cancer" .
<AC_and_Bevacizumab> <Has_accepted_use> "Breast_cancer" .
<Sipuleucel-T_monotherapy> <Maps_to> "Sipuleucel-T_monotherapy" .
<P/DOCE> <Maps_to> "P/DOCE" .
<Cutaneous_T-cell_lymphoma> <Current_treated_by> "Vorinostat_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Current_treated_by> "Romidepsin_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Current_treated_by> "Pralatrexate_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Current_treated_by> "Placebo" .
<Cutaneous_T-cell_lymphoma> <Current_treated_by> "PUVA" .
<Cutaneous_T-cell_lymphoma> <Current_treated_by> "Mogamulizumab_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Current_treated_by> "Methotrexate_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Current_treated_by> "Lenalidomide_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Current_treated_by> "Denileukin_diftitox_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Current_treated_by> "Brentuximab_vedotin_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Current_treated_by> "Bexarotene_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Current_treated_by> "Bexarotene_and_Pralatrexate" .
<Cutaneous_T-cell_lymphoma> <Current_treated_by> "Bendamustine_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Current_treated_by> "Belinostat_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Current_treated_by> "Alemtuzumab_monotherapy" .
<Vandetanib_monotherapy> <Has_context> "All_lines_of_therapy" .
<Dasatinib> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Dasatinib> <Is_a> "SYK_inhibitor" .
<Dasatinib> <Is_a> "SRC_inhibitor" .
<Dasatinib> <Is_a> "PDGFR_inhibitor" .
<Dasatinib> <Is_a> "Mutation-specific_medication" .
<Dasatinib> <Is_a> "Kinase_inhibitor" .
<Dasatinib> <Is_a> "KIT_inhibitor" .
<Dasatinib> <Is_a> "Bcr-Abl_inhibitor" .
<Dasatinib> <Is_a> "BTK_inhibitor" .
<Topotecan_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<DA-R-EPOCH> <Has_local_therapy> "Methotrexate" .
<DCEP> <Maps_to> "DCEP" .
<GCD-R> <Has_accepted_use> "Hodgkin_lymphoma" .
<Avelumab_monotherapy> <Maps_to> "Avelumab_monotherapy" .
<Neotaxl> <Brand_name_of> "Paclitaxel" .
<Dabrafenib_and_Trametinib> <Has_accepted_use> "Thyroid_cancer" .
<Dabrafenib_and_Trametinib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Dabrafenib_and_Trametinib> <Has_accepted_use> "Melanoma" .
<Dabrafenib_and_Trametinib> <Has_accepted_use> "CNS_melanoma" .
<Dabrafenib_and_Trametinib> <Has_accepted_use> "BRAF-mutated_malignancy" .
<Dabrafenib_and_Trametinib> <Has_accepted_use> "BRAF-mutated_Thyroid_cancer" .
<Dabrafenib_and_Trametinib> <Has_accepted_use> "BRAF-mutated_Non-small_cell_lung_cancer" .
<Dabrafenib_and_Trametinib> <Has_accepted_use> "BRAF-mutated_Melanoma" .
<Irinotecan_monotherapy> <Has_antineoplastic> "Irinotecan" .
<Epirubicin_monotherapy> <Has_modality> "Chemotherapy" .
<Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide> <Has_context> "Adjuvant_therapy" .
<R-FND> <Maps_to> "R-FND" .
<Amoxicillin> <Antineoplastic_of> "Helicobacter_pylori_eradication_therapy" .
<Sinatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Mesna> <Supportive_med_of> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Mesna> <Supportive_med_of> "VeIP" .
<Mesna> <Supportive_med_of> "VcR-CVAD" .
<Mesna> <Supportive_med_of> "VIPD" .
<Mesna> <Supportive_med_of> "VIP" .
<Mesna> <Supportive_med_of> "VIDE" .
<Mesna> <Supportive_med_of> "VDC/IE" .
<Mesna> <Supportive_med_of> "VAdCA/IE" .
<Mesna> <Supportive_med_of> "VAIA" .
<Mesna> <Supportive_med_of> "VAI" .
<Mesna> <Supportive_med_of> "VACA/IE" .
<Mesna> <Supportive_med_of> "VACA" .
<Mesna> <Supportive_med_of> "V-HyperCAD" .
<Mesna> <Supportive_med_of> "TIP" .
<Mesna> <Supportive_med_of> "TC,_then_IE,_VDoxoC,_VEC" .
<Mesna> <Supportive_med_of> "SMILE" .
<Mesna> <Supportive_med_of> "R-NIMP" .
<Mesna> <Supportive_med_of> "R-MACLO/R-IVAM" .
<Mesna> <Supportive_med_of> "R-IFE" .
<Mesna> <Supportive_med_of> "R-ICE" .
<Mesna> <Supportive_med_of> "R-Hyper-CVAD/R-MA" .
<Mesna> <Supportive_med_of> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Mesna> <Supportive_med_of> "R-CODOX-M/R-IVAC" .
<Mesna> <Supportive_med_of> "MINE" .
<Mesna> <Supportive_med_of> "MAPIE" .
<Mesna> <Supportive_med_of> "MAID" .
<Mesna> <Supportive_med_of> "Irinotecan_monotherapy" .
<Mesna> <Supportive_med_of> "Ifosfamide_monotherapy" .
<Mesna> <Supportive_med_of> "Ifosfamide_and_Paclitaxel" .
<Mesna> <Supportive_med_of> "Ifosfamide_and_Methotrexate" .
<Mesna> <Supportive_med_of> "IGEV_and_G-CSF" .
<Mesna> <Supportive_med_of> "IGEV" .
<Mesna> <Supportive_med_of> "IE" .
<Mesna> <Supportive_med_of> "Hyper-CVAD/MA_and_Everolimus" .
<Mesna> <Supportive_med_of> "Hyper-CVAD/MA" .
<Mesna> <Supportive_med_of> "Hyper-CVAD_and_Ponatinib" .
<Mesna> <Supportive_med_of> "Hyper-CVAD_and_Imatinib" .
<Mesna> <Supportive_med_of> "Hyper-CVAD_and_Dasatinib" .
<Mesna> <Supportive_med_of> "Hyper-CVAD" .
<Mesna> <Supportive_med_of> "Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant" .
<Mesna> <Supportive_med_of> "Epirubicin_and_Ifosfamide" .
<Mesna> <Supportive_med_of> "Doxorubicin,_Ifosfamide,_RT" .
<Mesna> <Supportive_med_of> "Doxorubicin_and_Ifosfamide" .
<Mesna> <Supportive_med_of> "Dacarbazine_monotherapy" .
<Mesna> <Supportive_med_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine" .
<Mesna> <Supportive_med_of> "Cyclophosphamide_and_Topotecan" .
<Mesna> <Supportive_med_of> "Cyclophosphamide_and_Etoposide" .
<Mesna> <Supportive_med_of> "Carboplatin_and_Ifosfamide" .
<Mesna> <Supportive_med_of> "CODOX-M/IVAC" .
<Mesna> <Supportive_med_of> "CIM" .
<Mesna> <Supportive_med_of> "CALGB_10-002_regimen" .
<Mesna> <Supportive_med_of> "BEAC,_then_auto_HSCT" .
<Mesna> <Supportive_med_of> "BEAC" .
<Mesna> <Supportive_med_of> "BASIC" .
<Mesna> <Supportive_med_of> "Amrubicin_monotherapy" .
<Mesna> <Supportive_med_of> "ACVBP" .
<Carboplatin_and_Gemcitabine/Erlotinib> <Mapped_from> "Carboplatin_and_Gemcitabine/Erlotinib" .
<L-Asparaginase,_Vincristine,_Prednisolone> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<L-Asparaginase,_Vincristine,_Prednisolone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Ex-Lax> <Brand_name_of> "Sennosides" .
<Zanubrutinib_monotherapy> <Is_current_in> "Mantle_cell_lymphoma" .
<Ordex> <Brand_name_of> "Dexamethasone" .
<Langerhans_cell_histiocytosis> <Accepted_use_of> "Vinblastine_and_Prednisone" .
<Langerhans_cell_histiocytosis> <Accepted_use_of> "Vinblastine" .
<Langerhans_cell_histiocytosis> <Accepted_use_of> "Vemurafenib_monotherapy" .
<Langerhans_cell_histiocytosis> <Accepted_use_of> "Vemurafenib" .
<Langerhans_cell_histiocytosis> <Accepted_use_of> "Prednisone" .
<Langerhans_cell_histiocytosis> <Accepted_use_of> "Prednisolone" .
<Langerhans_cell_histiocytosis> <Accepted_use_of> "Methotrexate,_Vinblastine,_Prednisone" .
<Langerhans_cell_histiocytosis> <Accepted_use_of> "Methotrexate" .
<Langerhans_cell_histiocytosis> <Accepted_use_of> "Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone" .
<Langerhans_cell_histiocytosis> <Accepted_use_of> "Mercaptopurine" .
<Langerhans_cell_histiocytosis> <Accepted_use_of> "Etoposide,_Vinblastine,_Prednisone" .
<Langerhans_cell_histiocytosis> <Accepted_use_of> "Etoposide_and_Prednisone" .
<Langerhans_cell_histiocytosis> <Accepted_use_of> "Etoposide" .
<Langerhans_cell_histiocytosis> <Accepted_use_of> "Cytarabine" .
<Langerhans_cell_histiocytosis> <Accepted_use_of> "Cobimetinib_monotherapy" .
<Langerhans_cell_histiocytosis> <Accepted_use_of> "Cladribine_monotherapy" .
<Langerhans_cell_histiocytosis> <Accepted_use_of> "Cladribine_and_Cytarabine" .
<Langerhans_cell_histiocytosis> <Accepted_use_of> "Cladribine" .
<CHOP-14> <Maps_to> "CHOP-14" .
<Erlotinib_and_Gemcitabine> <Has_modality> "Chemotherapy" .
<Prednisolone> <Has_brand_name> "Veripred" .
<Prednisolone> <Has_brand_name> "Pri-Cortin" .
<Prednisolone> <Has_brand_name> "Prenilone" .
<Prednisolone> <Has_brand_name> "Prelone" .
<Prednisolone> <Has_brand_name> "Prednicortelone" .
<Prednisolone> <Has_brand_name> "Predni-Helvacort" .
<Prednisolone> <Has_brand_name> "Predni-Coelin" .
<Prednisolone> <Has_brand_name> "Predicort" .
<Prednisolone> <Has_brand_name> "Predeltilone" .
<Prednisolone> <Has_brand_name> "Predcor" .
<Prednisolone> <Has_brand_name> "Pred-Clysma" .
<Prednisolone> <Has_brand_name> "Precortisyl" .
<Prednisolone> <Has_brand_name> "Panafcortelone" .
<Prednisolone> <Has_brand_name> "Orapred" .
<Prednisolone> <Has_brand_name> "Opredsone" .
<Prednisolone> <Has_brand_name> "Millipred" .
<Prednisolone> <Has_brand_name> "Meticortelone" .
<Prednisolone> <Has_brand_name> "Meti-derm" .
<Prednisolone> <Has_brand_name> "Medicort" .
<Prednisolone> <Has_brand_name> "Longiprednil" .
<Prednisolone> <Has_brand_name> "Linola-H-Fett_N" .
<Prednisolone> <Has_brand_name> "Linola-H_N" .
<Prednisolone> <Has_brand_name> "Lepi-Cortinolo" .
<Prednisolone> <Has_brand_name> "Lenisolone" .
<Prednisolone> <Has_brand_name> "Kuhlprednon" .
<Prednisolone> <Has_brand_name> "Klismacort" .
<Prednisolone> <Has_brand_name> "Hydeltrasol" .
<Prednisolone> <Has_brand_name> "Hydeltra" .
<Prednisolone> <Has_brand_name> "Hostacortin_H" .
<Prednisolone> <Has_brand_name> "Gupisone" .
<Prednisolone> <Has_brand_name> "Frisolona" .
<Prednisolone> <Has_brand_name> "Fisopred" .
<Prednisolone> <Has_brand_name> "Estilsona" .
<Prednisolone> <Has_brand_name> "Dontisolon_D" .
<Prednisolone> <Has_brand_name> "Di-Adreson-F" .
<Prednisolone> <Has_brand_name> "Dhasolone" .
<Prednisolone> <Has_brand_name> "Deltidrosol" .
<Prednisolone> <Has_brand_name> "Deltasolone" .
<Prednisolone> <Has_brand_name> "Deltacortril" .
<Prednisolone> <Has_brand_name> "Delta-Phoricol" .
<Prednisolone> <Has_brand_name> "Delta-Diona" .
<Prednisolone> <Has_brand_name> "Delta-Cortef" .
<Prednisolone> <Has_brand_name> "Decortin_H" .
<Prednisolone> <Has_brand_name> "Decaprednil" .
<Prednisolone> <Has_brand_name> "Dacortin_H" .
<Prednisolone> <Has_brand_name> "Cotolone" .
<Prednisolone> <Has_brand_name> "Cortisolone" .
<Prednisolone> <Has_brand_name> "Cortalone" .
<Prednisolone> <Has_brand_name> "Capsoid" .
<Prednisolone> <Has_brand_name> "Aprednislon" .
<Prednisolone> <Has_brand_name> "Adnisolone" .
<Neratinib_and_Paclitaxel> <Has_modality> "Chemotherapy" .
<Suxprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<MA-BCD/AP> <Has_accepted_use> "Osteosarcoma" .
<Docetaxel_and_Vinorelbine> <Is_current_in> "Non-small_cell_lung_cancer" .
<ABVD> <Has_modality> "Chemotherapy" .
<Cemiplimab> <May_have_route> "Intravenous" .
<Pemetrexed_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Neuroendocrine_tumor> <Current_treated_by> "Temozolomide_monotherapy" .
<Neuroendocrine_tumor> <Current_treated_by> "Placebo" .
<Neuroendocrine_tumor> <Current_treated_by> "Octreotide_monotherapy" .
<Neuroendocrine_tumor> <Current_treated_by> "Octreotide_and_Interferon_alfa" .
<Neuroendocrine_tumor> <Current_treated_by> "Octreotide_LAR_monotherapy" .
<Neuroendocrine_tumor> <Current_treated_by> "Lutetium_Lu_177_dotatate_and_Octreotide_LAR" .
<Neuroendocrine_tumor> <Current_treated_by> "Lanreotide_monotherapy" .
<Neuroendocrine_tumor> <Current_treated_by> "Lanreotide_and_Interferon_alfa-2b" .
<Neuroendocrine_tumor> <Current_treated_by> "Interferon_alfa-2b_monotherapy" .
<Neuroendocrine_tumor> <Current_treated_by> "Fluorouracil_and_Streptozocin" .
<Neuroendocrine_tumor> <Current_treated_by> "Everolimus_monotherapy" .
<Neuroendocrine_tumor> <Current_treated_by> "Everolimus_and_Octreotide" .
<Docetere> <Brand_name_of> "Docetaxel" .
<VH> <Maps_to> "VH" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine> <Has_modality> "Chemotherapy" .
<Capecitabine_and_Lapatinib> <Has_antineoplastic> "Lapatinib" .
<Capecitabine_and_Lapatinib> <Has_antineoplastic> "Capecitabine" .
<R-miniCHOP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<HLH-94_regimen> <Has_immunosuppressor> "Methotrexate" .
<HLH-94_regimen> <Has_immunosuppressor> "Etoposide" .
<HLH-94_regimen> <Has_immunosuppressor> "Dexamethasone" .
<HLH-94_regimen> <Has_immunosuppressor> "Cyclosporines" .
<Tinzaparin> <Is_a> "Low_molecular_weight_heparin" .
<Tinzaparin> <Is_a> "Heparin" .
<Tinzaparin> <Is_a> "Discontinued_drug" .
<Tinzaparin> <Is_a> "Anticoagulant" .
<GMALL-R> <Has_accepted_use> "HIV-associated_lymphoma" .
<GMALL-R> <Has_accepted_use> "Burkitt_lymphoma" .
<Epidoxo> <Brand_name_of> "Epirubicin" .
<GemOx> <Is_current_in> "Testicular_cancer" .
<GemOx> <Is_current_in> "Pancreatic_cancer" .
<GemOx> <Is_current_in> "Hepatocellular_carcinoma" .
<GemOx> <Is_current_in> "Gallbladder_cancer" .
<GemOx> <Is_current_in> "Cholangiocarcinoma" .
<Niraparib> <May_have_route> "Oral" .
<Heptaplatin> <May_have_route> "Intravenous" .
<Prolia> <Brand_name_of> "Denosumab" .
<Everolimus_monotherapy> <Has_modality> "Chemotherapy" .
<IT_Cytarabine,_Methotrexate,_WBRT> <Has_context> "Local_therapy" .
<Exemestane> <Has_accepted_use> "Breast_cancer" .
<Cyclophosphamide_monotherapy> <Has_context> "Salvage_therapy" .
<Cyclophosphamide_monotherapy> <Has_context> "Non-curative_therapy" .
<Cyclophosphamide_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Cyclophosphamide_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Cyclophosphamide_monotherapy> <Has_context> "Induction_therapy" .
<Cyclophosphamide_monotherapy> <Has_context> "Adjuvant_therapy" .
<MCV> <Has_antineoplastic> "Vinblastine" .
<MCV> <Has_antineoplastic> "Methotrexate" .
<MCV> <Has_antineoplastic> "Cisplatin" .
<Systemic_mastocytosis> <FDA_indication_of> "Midostaurin" .
<Systemic_mastocytosis> <FDA_indication_of> "Imatinib" .
<MRD> <Maps_to> "MRD" .
<Gemcitabine_and_RT> <Has_modality> "Radiotherapy" .
<Gemcitabine_and_RT> <Has_modality> "Chemotherapy" .
<Cisplatin_and_Dacarbazine> <Maps_to> "Cisplatin_and_Dacarbazine" .
<Dara-VD> <Has_antineoplastic> "Dexamethasone" .
<Dara-VD> <Has_antineoplastic> "Daratumumab" .
<Dara-VD> <Has_antineoplastic> "Bortezomib" .
<Nimustine_and_RT> <Is_current_in> "Glioblastoma" .
<BR> <Has_context> "Non-curative_therapy" .
<BR> <Has_context> "Non-curative_subsequent-line_therapy" .
<BR> <Has_context> "Non-curative_first-line_therapy" .
<BR> <Has_context> "Induction_therapy" .
<BR> <Has_context> "All_lines_of_therapy" .
<Decoron> <Brand_name_of> "Dexamethasone" .
<Cisplatin_monotherapy> <Maps_to> "Cisplatin_monotherapy" .
<R-FCM> <Is_current_in> "Mantle_cell_lymphoma" .
<R-FCM> <Is_current_in> "Follicular_lymphoma" .
<Cetrine> <Brand_name_of> "Cetirizine" .
<Tandem_melphalan,_then_auto_HSCT> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Vinblastine> <Has_brand_name> "Vinblastina" .
<Vinblastine> <Has_brand_name> "Vinblastin" .
<Vinblastine> <Has_brand_name> "Vinblasin" .
<Vinblastine> <Has_brand_name> "Velbe" .
<Vinblastine> <Has_brand_name> "Velbastine" .
<Vinblastine> <Has_brand_name> "Velban" .
<Vinblastine> <Has_brand_name> "Rabinefil" .
<Vinblastine> <Has_brand_name> "Periblastine" .
<Vinblastine> <Has_brand_name> "Lemblastine" .
<Vinblastine> <Has_brand_name> "Faulblastina" .
<Vinblastine> <Has_brand_name> "Exal" .
<Vinblastine> <Has_brand_name> "Erbablas" .
<Vinblastine> <Has_brand_name> "Cytoblastine" .
<Vinblastine> <Has_brand_name> "Cellblastin" .
<Vinblastine> <Has_brand_name> "Blastovin" .
<Vinblastine> <Has_brand_name> "Alkaban-AQ" .
<Fluorouracil,_Paclitaxel,_RT> <Mapped_from> "Fluorouracil,_Paclitaxel,_RT" .
<VBMCP/VBAD> <Is_historical_in> "Multiple_myeloma" .
<Hyper-CVAD/MA_and_Everolimus> <Is_a> "Anthracycline-containing_regimen" .
<Fam-trastuzumab_deruxtecan_monotherapy> <Maps_to> "Fam-trastuzumab_deruxtecan_monotherapy" .
<RVDC> <Is_current_in> "Multiple_myeloma" .
<Biosimilar> <Subsumes> "Trastuzumab-qyyp" .
<Biosimilar> <Subsumes> "Trastuzumab-pkrb" .
<Biosimilar> <Subsumes> "Trastuzumab-dttb" .
<Biosimilar> <Subsumes> "Trastuzumab-dkst" .
<Biosimilar> <Subsumes> "Trastuzumab-anns" .
<Biosimilar> <Subsumes> "Rituximab-pvvr" .
<Biosimilar> <Subsumes> "Rituximab-abbs" .
<Biosimilar> <Subsumes> "Pegfilgrastim-jmdb" .
<Biosimilar> <Subsumes> "Pegfilgrastim-cbqv" .
<Biosimilar> <Subsumes> "Filgrastim-sndz" .
<Biosimilar> <Subsumes> "Epoetin_alfa-epbx" .
<Biosimilar> <Subsumes> "Bevacizumab-bvzr" .
<Biosimilar> <Subsumes> "Bevacizumab-awwb" .
<Docetaxel_and_Prednisolone> <Maps_to> "Docetaxel_and_Prednisolone" .
<M-TIP> <Has_context> "Upfront_therapy" .
<Thalidomide_monotherapy> <Has_supportive_med> "Zoledronic_acid" .
<Thalidomide_monotherapy> <Has_supportive_med> "Pamidronate" .
<Thalidomide_monotherapy> <Has_supportive_med> "Clodronate" .
<Thalidomide_monotherapy> <Has_supportive_med> "Bisphosphonates" .
<Thalidomide_monotherapy> <Has_supportive_med> "Aspirin" .
<Aclasta> <Brand_name_of> "Zoledronic_acid" .
<Fluorouracil_and_Levamisole> <Maps_to> "Fluorouracil_and_Levamisole" .
<Epizin> <Brand_name_of> "Epirubicin" .
<TAD_(Thalidomide)> <Is_a> "Anthracycline-containing_regimen" .
<TAM6> <Has_context> "All_lines_of_therapy" .
<Megestrol_and_Tamoxifen> <Has_antineoplastic> "Tamoxifen" .
<Megestrol_and_Tamoxifen> <Has_antineoplastic> "Megestrol" .
<VEBEP> <Has_accepted_use> "Hodgkin_lymphoma" .
<CHOEP-14> <Maps_to> "CHOEP-14" .
<CFP_and_Oophorectomy> <Maps_to> "CFP_and_Oophorectomy" .
<Interferon_alfa-2b> <Has_FDA_indication> "Melanoma" .
<Interferon_alfa-2b> <Has_FDA_indication> "Kaposi_sarcoma" .
<Interferon_alfa-2b> <Has_FDA_indication> "Hairy_cell_leukemia" .
<Interferon_alfa-2b> <Has_FDA_indication> "Follicular_lymphoma" .
<Crizanlizumab> <Has_accepted_use> "Sickle_cell_anemia" .
<Erythrocyte_growth_factor> <Is_a> "Hematopoietic_growth_factor" .
<Cabozantinib_and_Erlotinib> <Mapped_from> "Cabozantinib_and_Erlotinib" .
<Cyclosporine_and_Methotrexate> <Has_modality> "Immunosuppressive_therapy" .
<Allogeneic_stem_cells> <Antineoplastic_of> "TFC,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "Low-dose_TBI,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "Fludarabine_and_TBI,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "FluBuCy,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "Flu-Mel,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "FCR,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "FC,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "Etoposide_and_TBI,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "Cyclophosphamide_and_TBI,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "Clofarabine_and_Melphalan,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "Busulfan_and_Cyclophosphamide,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "BuFlu,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "BuCyTBI,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "BuCy,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "BFR,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "BEAM,_then_allo_HSCT" .
<Allogeneic_stem_cells> <Antineoplastic_of> "(90)YFC,_then_allo_HSCT" .
<m-BNCOD> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Plasma_exchange> <Has_modality> "Supportive_therapy" .
<FP/Capecitabine_and_RT> <Has_accepted_use> "Gastric_cancer" .
<R-IFE> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Nilotinib_monotherapy> <Mapped_from> "Nilotinib_monotherapy" .
<PCR> <Has_context> "Non-curative_therapy" .
<PCR> <Has_context> "Non-curative_first-line_therapy" .
<Letrozole> <May_have_route> "Oral" .
<Bevacizumab_and_Rituximab> <Has_antineoplastic> "Rituximab" .
<Bevacizumab_and_Rituximab> <Has_antineoplastic> "Bevacizumab" .
<Magytax> <Brand_name_of> "Paclitaxel" .
<Pharmaspirin> <Brand_name_of> "Aspirin" .
<Observation> <Has_modality> "Null_therapy" .
<CX> <Has_modality> "Chemotherapy" .
<Satrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Abemaciclib_and_Fulvestrant> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Abemaciclib_and_Fulvestrant> <Has_accepted_use> "Breast_cancer" .
<Bivalirudin> <Has_brand_name> "Angiox" .
<Bivalirudin> <Has_brand_name> "Angiomax" .
<Fluoxymesterone> <Has_brand_name> "Ultandren" .
<Fluoxymesterone> <Has_brand_name> "Halotestin" .
<PTK2_inhibitor> <Subsumes> "Masitinib" .
<MEK_inhibitor> <Subsumes> "Perifosine" .
<MEK_inhibitor> <Subsumes> "MAP2K4_inhibitor" .
<MEK_inhibitor> <Subsumes> "MAP2K2_inhibitor" .
<MEK_inhibitor> <Subsumes> "MAP2K1_inhibitor" .
<Mecoxon> <Brand_name_of> "Dexamethasone" .
<Fludarabine,_then_131Iodine-Tositumomab> <Has_accepted_use> "Follicular_lymphoma" .
<ABV_(Vincristine)> <Has_antineoplastic> "Vincristine" .
<ABV_(Vincristine)> <Has_antineoplastic> "Doxorubicin" .
<ABV_(Vincristine)> <Has_antineoplastic> "Bleomycin" .
<VT> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Rizol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Carmustine_and_RT> <Is_current_in> "Glioblastoma" .
<Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan> <Has_modality> "Chemotherapy" .
<Luxazone> <Brand_name_of> "Dexamethasone" .
<BeEAM,_then_auto_HSCT> <Mapped_from> "BeEAM,_then_auto_HSCT" .
<Post-definitive_therapy> <Is_a> "Upfront_therapy" .
<Warfant> <Brand_name_of> "Warfarin" .
<7_plus_3i> <Mapped_from> "7_plus_3i" .
<Dabrafenib,_Trametinib,_Panitumumab> <Maps_to> "Dabrafenib,_Trametinib,_Panitumumab" .
<VP> <Maps_to> "VP" .
<GDPT> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<HAIC_and_Sorafenib> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Carboplatin,_Fluorouracil,_Cetuximab,_RT> <Is_current_in> "Head_and_neck_cancer" .
<Radiotherapy_medication> <Is_a> "Radiation" .
<Interferon_alfa-2b_and_Zidovudine> <Has_context> "Induction_therapy" .
<Cyclosporine,_Methotrexate,_Methylprednisolone> <Has_immunosuppressor> "Methylprednisolone" .
<Cyclosporine,_Methotrexate,_Methylprednisolone> <Has_immunosuppressor> "Methotrexate" .
<Cyclosporine,_Methotrexate,_Methylprednisolone> <Has_immunosuppressor> "Cyclosporine_modified" .
<Bongard> <Brand_name_of> "Alendronate" .
<COPA> <Maps_to> "COPA" .
<Bleomycin> <May_have_route> "Subcutaneous" .
<Bleomycin> <May_have_route> "Intravenous" .
<Bleomycin> <May_have_route> "Intramuscular" .
<Bleomycin> <May_have_route> "Intracavitary" .
<VMD> <Mapped_from> "VMD" .
<R-CHVP_plus_I> <Is_a> "Rituximab-containing_regimen" .
<R-CHVP_plus_I> <Is_a> "Anthracycline-containing_regimen" .
<Bevacizumab_and_Rituximab> <Has_accepted_use> "Follicular_lymphoma" .
<Mactran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Lorlatinib> <May_have_route> "Oral" .
<Methotrexate_and_Tacrolimus> <Has_context> "Prophylaxis" .
<Danaparoid_monotherapy> <Maps_to> "Danaparoid_monotherapy" .
<Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Nortrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bactoprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Docetaxel_and_Gemcitabine> <Has_supportive_med> "Steroids" .
<Docetaxel_and_Gemcitabine> <Has_supportive_med> "Ranitidine" .
<Docetaxel_and_Gemcitabine> <Has_supportive_med> "Pegfilgrastim" .
<Docetaxel_and_Gemcitabine> <Has_supportive_med> "Ondansetron" .
<Docetaxel_and_Gemcitabine> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Docetaxel_and_Gemcitabine> <Has_supportive_med> "Filgrastim" .
<Docetaxel_and_Gemcitabine> <Has_supportive_med> "Diphenhydramine" .
<Docetaxel_and_Gemcitabine> <Has_supportive_med> "Dexamethasone" .
<Low-dose_TBI,_then_allo_HSCT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Low-dose_TBI,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<Lenvatinib_monotherapy> <Mapped_from> "Lenvatinib_monotherapy" .
<Anti-CD52_antibody> <Is_a> "Antibody_medication" .
<AALL0232_consolidation> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<DexaBEAM> <Mapped_from> "DexaBEAM" .
<CPX-351_monotherapy> <Is_current_in> "Acute_myeloid_leukemia" .
<eBEACOPP> <Is_a> "Anthracycline-containing_regimen" .
<DesmoMelt> <Brand_name_of> "Desmopressin" .
<Clofarabine_and_Melphalan,_then_allo_HSCT> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Capecitabine,_Bevacizumab,_Trastuzumab> <Is_current_in> "Breast_cancer" .
<Fludarabine_and_TBI> <Has_context> "All_lines_of_therapy" .
<Infatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Radioembolization> <Has_modality> "Radiotherapy" .
<Dino-BAC> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<R-TBI/Cy> <Mapped_from> "R-TBI/Cy" .
<Lanreotide_Depot/Autogel_monotherapy> <Maps_to> "Lanreotide_Depot/Autogel_monotherapy" .
<Mitomycin> <Has_brand_name> "Mutamycin" .
<Mitomycin> <Has_brand_name> "Mitozytrex" .
<Mitomycin> <Has_brand_name> "Mitosol" .
<Mitomycin> <Has_brand_name> "Mitocyte" .
<Mitomycin> <Has_brand_name> "Mitocin" .
<Mitomycin> <Has_brand_name> "Lyomit" .
<MOPP-ABV> <Mapped_from> "MOPP-ABV" .
<Doloderm> <Brand_name_of> "Aspirin" .
<Zoraxin> <Brand_name_of> "Acyclovir" .
<Nordic_Regimen,_younger_patients> <Has_accepted_use> "CNS_lymphoma" .
<ddE> <Has_antineoplastic> "Epirubicin" .
<Enantone-Gyn> <Brand_name_of> "Leuprolide" .
<MVP_(Vindesine)> <Is_historical_in> "Non-small_cell_lung_cancer" .
<MP> <Has_accepted_use> "Multiple_myeloma" .
<MP> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Niraparib_monotherapy> <Has_antineoplastic> "Niraparib" .
<Emorzim> <Brand_name_of> "Carboplatin" .
<Clinitran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Fluorouracil,_Mitomycin,_RT> <Has_modality> "Radiotherapy" .
<Fluorouracil,_Mitomycin,_RT> <Has_modality> "Chemotherapy" .
<Recovorin> <Brand_name_of> "Folinic_acid" .
<PVD> <Maps_to> "PVD" .
<Everolimus_and_Tamoxifen> <Is_a> "Antiestrogen-containing_regimen" .
<Ondaren> <Brand_name_of> "Ondansetron" .
<Cervical_cancer> <Current_treated_by> "Vinorelbine_monotherapy" .
<Cervical_cancer> <Current_treated_by> "Topotecan_monotherapy" .
<Cervical_cancer> <Current_treated_by> "Radiation_therapy" .
<Cervical_cancer> <Current_treated_by> "Pemetrexed_monotherapy" .
<Cervical_cancer> <Current_treated_by> "Pembrolizumab_monotherapy" .
<Cervical_cancer> <Current_treated_by> "Paclitaxel,_Topotecan,_Bevacizumab" .
<Cervical_cancer> <Current_treated_by> "Paclitaxel_monotherapy" .
<Cervical_cancer> <Current_treated_by> "Paclitaxel_and_Topotecan" .
<Cervical_cancer> <Current_treated_by> "No_neoadjuvant_therapy" .
<Cervical_cancer> <Current_treated_by> "Irinotecan_monotherapy" .
<Cervical_cancer> <Current_treated_by> "Ifosfamide_monotherapy" .
<Cervical_cancer> <Current_treated_by> "Hydroxyurea_and_RT" .
<Cervical_cancer> <Current_treated_by> "Gemcitabine_monotherapy" .
<Cervical_cancer> <Current_treated_by> "Fluorouracil,_Mitomycin,_RT" .
<Cervical_cancer> <Current_treated_by> "Fluorouracil_and_RT" .
<Cervical_cancer> <Current_treated_by> "Fluorouracil_and_Folinic_acid" .
<Cervical_cancer> <Current_treated_by> "Docetaxel_monotherapy" .
<Cervical_cancer> <Current_treated_by> "Cisplatin,_Paclitaxel,_Bevacizumab" .
<Cervical_cancer> <Current_treated_by> "Cisplatin,_Gemcitabine,_RT" .
<Cervical_cancer> <Current_treated_by> "Cisplatin,_Fluorouracil,_RT" .
<Cervical_cancer> <Current_treated_by> "Cisplatin,_Fluorouracil,_Hydroxyurea,_RT" .
<Cervical_cancer> <Current_treated_by> "Cisplatin_monotherapy" .
<Cervical_cancer> <Current_treated_by> "Cisplatin_and_Vinorelbine" .
<Cervical_cancer> <Current_treated_by> "Cisplatin_and_Topotecan" .
<Cervical_cancer> <Current_treated_by> "Cisplatin_and_RT" .
<Cervical_cancer> <Current_treated_by> "Cisplatin_and_Paclitaxel" .
<Cervical_cancer> <Current_treated_by> "Cisplatin_and_Mitomycin" .
<Cervical_cancer> <Current_treated_by> "Cisplatin_and_Ifosfamide" .
<Cervical_cancer> <Current_treated_by> "Cisplatin_and_Gemcitabine" .
<Cervical_cancer> <Current_treated_by> "Carboplatin_monotherapy" .
<Cervical_cancer> <Current_treated_by> "Carboplatin_and_RT" .
<Cervical_cancer> <Current_treated_by> "Carboplatin_and_Paclitaxel" .
<Cervical_cancer> <Current_treated_by> "Carboplatin_and_Ifosfamide" .
<Cervical_cancer> <Current_treated_by> "Carboplatin_and_Docetaxel" .
<Cervical_cancer> <Current_treated_by> "Bevacizumab_monotherapy" .
<Chlorambucil_monotherapy> <Maps_to> "Chlorambucil_monotherapy" .
<MVBP> <Is_current_in> "CNS_lymphoma" .
<Temozolomide_and_NovoTTF-100A> <Mapped_from> "Temozolomide_and_NovoTTF-100A" .
<Supracombin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Anti-CD20_antibody> <Subsumes> "Veltuzumab" .
<Anti-CD20_antibody> <Subsumes> "Ublituximab" .
<Anti-CD20_antibody> <Subsumes> "Tositumomab_&_I-131" .
<Anti-CD20_antibody> <Subsumes> "Rituximab-pvvr" .
<Anti-CD20_antibody> <Subsumes> "Rituximab-abbs" .
<Anti-CD20_antibody> <Subsumes> "Rituximab_and_hyaluronidase_human" .
<Anti-CD20_antibody> <Subsumes> "Rituximab" .
<Anti-CD20_antibody> <Subsumes> "Ofatumumab" .
<Anti-CD20_antibody> <Subsumes> "Obinutuzumab" .
<Anti-CD20_antibody> <Subsumes> "Ibritumomab_tiuxetan" .
<CEV_(Cyclophosphamide/Epirubicin)> <Has_modality> "Chemotherapy" .
<HLH-2004_regimen> <Is_current_in> "Hemophagocytic_lymphohistiocytosis" .
<Pemetrexed_monotherapy> <Is_current_in> "Ovarian_cancer" .
<Pemetrexed_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Pemetrexed_monotherapy> <Is_current_in> "Mesothelioma" .
<Pemetrexed_monotherapy> <Is_current_in> "Cervical_cancer" .
<Pemetrexed_monotherapy> <Is_current_in> "Breast_cancer" .
<Pemetrexed_monotherapy> <Is_current_in> "Bladder_cancer" .
<Doxorubicin_and_Lomustine> <Has_modality> "Chemotherapy" .
<Ibrutinib> <May_have_route> "Oral" .
<BTD> <Has_supportive_med> "Bisphosphonates" .
<Fluorouracil_and_Semustine> <Maps_to> "Fluorouracil_and_Semustine" .
<Hepatoblastoma> <Accepted_use_of> "Doxorubicin" .
<Hepatoblastoma> <Accepted_use_of> "Cisplatin,_Fluorouracil,_Vincristine" .
<Hepatoblastoma> <Accepted_use_of> "Cisplatin_monotherapy" .
<Hepatoblastoma> <Accepted_use_of> "Cisplatin_and_Doxorubicin" .
<Hepatoblastoma> <Accepted_use_of> "Cisplatin" .
<VTP> <Has_accepted_use> "Multiple_myeloma" .
<Lorlatinib_monotherapy> <Has_antineoplastic> "Lorlatinib" .
<Uraciflor> <Brand_name_of> "Fluorouracil" .
<Ivosidenib_monotherapy> <Has_antineoplastic> "Ivosidenib" .
<Lamivudine> <Is_a> "Antiviral" .
<Prednitone> <Brand_name_of> "Prednisone" .
<PFT> <Is_historical_in> "Breast_cancer" .
<Geniol_SC> <Brand_name_of> "Aspirin" .
<TT4> <Maps_to> "TT4" .
<R-NIMP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<DA_3_plus_10> <Has_context> "Induction_therapy" .
<Mini-BEAM> <Maps_to> "Mini-BEAM" .
<Megestrol> <Antineoplastic_of> "Megestrol_monotherapy" .
<Megestrol> <Antineoplastic_of> "Megestrol_and_Tamoxifen" .
<Bazipar> <Brand_name_of> "Dacarbazine" .
<Geralen> <Brand_name_of> "Methoxsalen" .
<Glioblastoma> <Current_treated_by> "Temozolomide_monotherapy" .
<Glioblastoma> <Current_treated_by> "Temozolomide_and_low-dose_RT" .
<Glioblastoma> <Current_treated_by> "Temozolomide_and_RT" .
<Glioblastoma> <Current_treated_by> "Temozolomide_and_NovoTTF-100A" .
<Glioblastoma> <Current_treated_by> "Radiation_therapy" .
<Glioblastoma> <Current_treated_by> "Procarbazine_monotherapy" .
<Glioblastoma> <Current_treated_by> "PCV" .
<Glioblastoma> <Current_treated_by> "NovoTTF-100A_monotherapy" .
<Glioblastoma> <Current_treated_by> "Nimustine_and_RT" .
<Glioblastoma> <Current_treated_by> "Lomustine,_Temozolomide,_RT" .
<Glioblastoma> <Current_treated_by> "Lomustine_monotherapy" .
<Glioblastoma> <Current_treated_by> "Lomustine_and_Bevacizumab" .
<Glioblastoma> <Current_treated_by> "Irinotecan_monotherapy" .
<Glioblastoma> <Current_treated_by> "Irinotecan_and_Bevacizumab" .
<Glioblastoma> <Current_treated_by> "Hydroxyurea_monotherapy" .
<Glioblastoma> <Current_treated_by> "Hydroxyurea_and_Imatinib" .
<Glioblastoma> <Current_treated_by> "Gliadel_wafer_monotherapy" .
<Glioblastoma> <Current_treated_by> "Cyclophosphamide_monotherapy" .
<Glioblastoma> <Current_treated_by> "Carmustine_monotherapy" .
<Glioblastoma> <Current_treated_by> "Carmustine_and_RT" .
<Glioblastoma> <Current_treated_by> "Carboplatin_and_Bevacizumab" .
<Glioblastoma> <Current_treated_by> "Bevacizumab_monotherapy" .
<Glioblastoma> <Current_treated_by> "Bevacizumab_and_RT" .
<Glioblastoma> <Current_treated_by> "Best_supportive_care" .
<Hydroxyurea> <Antineoplastic_of> "Hydroxyurea_monotherapy" .
<Hydroxyurea> <Antineoplastic_of> "Hydroxyurea_and_RT" .
<Hydroxyurea> <Antineoplastic_of> "Hydroxyurea_and_Plicamycin" .
<Hydroxyurea> <Antineoplastic_of> "Hydroxyurea_and_Interferon_alfa-2a" .
<Hydroxyurea> <Antineoplastic_of> "Hydroxyurea_and_Imatinib" .
<Hydroxyurea> <Antineoplastic_of> "Fluorouracil,_Hydroxyurea,_RT" .
<Hydroxyurea> <Antineoplastic_of> "Docetaxel,_Fluorouracil,_Hydroxyurea,_RT" .
<Hydroxyurea> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_Hydroxyurea,_RT" .
<Hydroxyurea> <Antineoplastic_of> "BHD" .
<Hydroxyurea> <Antineoplastic_of> "Aspirin_and_Hydroxyurea" .
<Trisulfose> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bevacizumab_and_Interferon_alfa-2a> <Has_modality> "Immunotherapy" .
<Bevacizumab_and_Interferon_alfa-2a> <Has_modality> "Chemotherapy" .
<Sorafenib> <Has_brand_name> "Soranib" .
<Sorafenib> <Has_brand_name> "Sorafenat" .
<Sorafenib> <Has_brand_name> "Nexavar" .
<VT> <Mapped_from> "VT" .
<Meticort> <Brand_name_of> "Methylprednisolone" .
<Celudex> <Brand_name_of> "Dexamethasone" .
<CVP,_then_131Iodine-Tositumomab> <Has_modality> "Radioimmunotherapy" .
<CVP,_then_131Iodine-Tositumomab> <Has_modality> "Chemotherapy" .
<Abexinostat> <Is_a> "Investigational_drug" .
<Abexinostat> <Is_a> "HDAC_inhibitor" .
<CapeOx> <Is_current_in> "Rectal_cancer" .
<CapeOx> <Is_current_in> "Pancreatic_cancer" .
<CapeOx> <Is_current_in> "Hepatocellular_carcinoma" .
<CapeOx> <Is_current_in> "Gastric_cancer" .
<CapeOx> <Is_current_in> "Gallbladder_cancer" .
<CapeOx> <Is_current_in> "Esophageal_cancer" .
<CapeOx> <Is_current_in> "Colon_cancer" .
<CapeOx> <Is_current_in> "Cholangiocarcinoma" .
<Anagrelide> <Supportive_med_of> "Aspirin_and_Anagrelide" .
<Anagrelide> <Supportive_med_of> "Anagrelide_monotherapy" .
<HiDAC> <Mapped_from> "HiDAC" .
<RBC_transfusions> <Has_context> "All_lines_of_therapy" .
<Gemcitabine_and_Irinotecan> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<ADOC> <Mapped_from> "ADOC" .
<FOLFOX2> <Is_current_in> "Colon_cancer" .
<Ifosfamide_and_Paclitaxel> <Has_supportive_med> "Ranitidine" .
<Ifosfamide_and_Paclitaxel> <Has_supportive_med> "Mesna" .
<Ifosfamide_and_Paclitaxel> <Has_supportive_med> "Filgrastim" .
<Ifosfamide_and_Paclitaxel> <Has_supportive_med> "Diphenhydramine" .
<Ifosfamide_and_Paclitaxel> <Has_supportive_med> "Dexamethasone" .
<Ifosfamide_and_Paclitaxel> <Has_supportive_med> "Cimetidine" .
<PCP> <Maps_to> "PCP" .
<Neratinib_monotherapy> <Has_context> "All_lines_of_therapy" .
<Neratinib_monotherapy> <Has_context> "Adjuvant_therapy" .
<Anagrelide> <Is_a> "Phosphodiesterase_inhibitor" .
<Anagrelide> <Is_a> "Hematology_medication" .
<Afatinib_monotherapy> <Has_antineoplastic> "Afatinib" .
<Moxetumomab_pasudotox> <Has_accepted_use> "Hairy_cell_leukemia" .
<Acolon> <Brand_name_of> "Dexamethasone" .
<Lusutrombopag> <Has_brand_name> "Mulpleta" .
<Daunorubicin_monotherapy> <Has_context> "Induction_therapy" .
<Daunorubicin_monotherapy> <Has_context> "Consolidation_after_upfront_therapy" .
<Desplex> <Brand_name_of> "Diethylstilbestrol" .
<ACH> <Is_a> "Anthracycline-containing_regimen" .
<Warfil> <Brand_name_of> "Warfarin" .
<Docetaxel_and_Irinotecan> <Maps_to> "Docetaxel_and_Irinotecan" .
<Litalir> <Brand_name_of> "Hydroxyurea" .
<Docetaxel_monotherapy> <Has_antineoplastic> "Docetaxel" .
<Biocarb> <Brand_name_of> "Carboplatin" .
<Cetuximab_monotherapy> <Has_accepted_use> "KRAS_wild-type_Colon_cancer" .
<Cetuximab_monotherapy> <Has_accepted_use> "Head_and_neck_cancer" .
<Cetuximab_monotherapy> <Has_accepted_use> "Esophageal_cancer" .
<Cetuximab_monotherapy> <Has_accepted_use> "Cutaneous_squamous_cell_carcinoma" .
<Cetuximab_monotherapy> <Has_accepted_use> "Colon_cancer" .
<IGEV> <Mapped_from> "IGEV" .
<Idelalisib_and_Ofatumumab> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Clofarabine_and_LoDAC/Decitabine> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Bendamustine_monotherapy> <Has_antineoplastic> "Bendamustine" .
<EIA> <Is_a> "Anthracycline-containing_regimen" .
<Curative_therapy> <Maps_to> "Curative_therapy" .
<Rd> <Is_current_in> "Plasma_cell_leukemia" .
<Rd> <Is_current_in> "POEMS_syndrome" .
<Rd> <Is_current_in> "Multiple_myeloma" .
<Rd> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<PVAG> <Has_context> "Induction_therapy" .
<Masitinib> <Has_accepted_use> "Systemic_mastocytosis" .
<Masitinib> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Masitinib> <Has_accepted_use> "Pancreatic_cancer" .
<HAM_and_Imatinib> <Has_modality> "Chemotherapy" .
<CHOP-AL> <Has_modality> "Chemotherapy" .
<Biosulten> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Pazopanib> <Has_FDA_indication> "Soft_tissue_sarcoma" .
<Pazopanib> <Has_FDA_indication> "Renal_cell_carcinoma" .
<Hyper-CVAD> <Has_antineoplastic> "Vincristine" .
<Hyper-CVAD> <Has_antineoplastic> "Doxorubicin" .
<Hyper-CVAD> <Has_antineoplastic> "Dexamethasone" .
<Hyper-CVAD> <Has_antineoplastic> "Cyclophosphamide" .
<PCV> <Has_context> "Salvage_therapy" .
<PCV> <Has_context> "Non-curative_therapy" .
<PCV> <Has_context> "Adjuvant_therapy" .
<Aeroseb-DEX> <Brand_name_of> "Dexamethasone" .
<BMP> <Mapped_from> "BMP" .
<Pirarubicin_monotherapy> <Has_modality> "Chemotherapy" .
<Cyclophosphamide,_Fludarabine,_Thiotepa> <Has_antineoplastic> "Thiotepa" .
<Cyclophosphamide,_Fludarabine,_Thiotepa> <Has_antineoplastic> "Fludarabine" .
<Cyclophosphamide,_Fludarabine,_Thiotepa> <Has_antineoplastic> "Cyclophosphamide" .
<Aspirin_and_Dexamethasone> <Mapped_from> "Aspirin_and_Dexamethasone" .
<Solprin> <Brand_name_of> "Aspirin" .
<Dumotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Doxycycline> <Antineoplastic_of> "Doxycycline_monotherapy" .
<Bevacizumab_and_RT> <Has_accepted_use> "Glioblastoma" .
<HAM> <Has_modality> "Chemotherapy" .
<R-HiDAC> <Has_modality> "Chemotherapy" .
<CHOP_and_Everolimus> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<Observation> <Is_current_in> "Soft_tissue_sarcoma" .
<Observation> <Is_current_in> "Small_cell_lung_cancer" .
<Observation> <Is_current_in> "Renal_cell_carcinoma" .
<Observation> <Is_current_in> "Rectal_cancer" .
<Observation> <Is_current_in> "Prostate_cancer" .
<Observation> <Is_current_in> "Periampullary_adenocarcinoma" .
<Observation> <Is_current_in> "Pancreatic_cancer" .
<Observation> <Is_current_in> "Ovarian_cancer" .
<Observation> <Is_current_in> "Osteosarcoma" .
<Observation> <Is_current_in> "Non-small_cell_lung_cancer" .
<Observation> <Is_current_in> "Nasopharyngeal_carcinoma" .
<Observation> <Is_current_in> "Multiple_myeloma" .
<Observation> <Is_current_in> "Melanoma" .
<Observation> <Is_current_in> "Marginal_zone_lymphoma" .
<Observation> <Is_current_in> "Mantle_cell_lymphoma" .
<Observation> <Is_current_in> "Low-grade_glioma" .
<Observation> <Is_current_in> "Leiomyosarcoma" .
<Observation> <Is_current_in> "Hodgkin_lymphoma" .
<Observation> <Is_current_in> "Hepatocellular_carcinoma" .
<Observation> <Is_current_in> "Gastric_cancer" .
<Observation> <Is_current_in> "Follicular_lymphoma" .
<Observation> <Is_current_in> "Essential_thrombocythemia" .
<Observation> <Is_current_in> "Esophageal_cancer" .
<Observation> <Is_current_in> "Endometrial_cancer" .
<Observation> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Observation> <Is_current_in> "Cutaneous_squamous_cell_carcinoma" .
<Observation> <Is_current_in> "Colon_cancer" .
<Observation> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Observation> <Is_current_in> "Cholangiocarcinoma" .
<Observation> <Is_current_in> "CNS_lymphoma" .
<Observation> <Is_current_in> "Breast_cancer" .
<Observation> <Is_current_in> "Bladder_cancer" .
<Observation> <Is_current_in> "Anaplastic_glioma" .
<Observation> <Is_current_in> "Acute_promyelocytic_leukemia" .
<Observation> <Is_current_in> "Acute_myeloid_leukemia" .
<Fluorouracil,_Paclitaxel,_RT> <Is_current_in> "Esophageal_cancer" .
<Erlotinib_monotherapy> <Has_accepted_use> "Renal_cell_carcinoma" .
<Erlotinib_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Erlotinib_monotherapy> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Erlotinib_monotherapy> <Has_accepted_use> "Esophageal_cancer" .
<Erlotinib_monotherapy> <Has_accepted_use> "EGFR-mutated_malignancy" .
<Erlotinib_monotherapy> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<O-ICE> <Has_antineoplastic> "Ofatumumab" .
<O-ICE> <Has_antineoplastic> "Mesna" .
<O-ICE> <Has_antineoplastic> "Ifosfamide" .
<O-ICE> <Has_antineoplastic> "Etoposide" .
<O-ICE> <Has_antineoplastic> "Carboplatin" .
<CAVE> <Is_historical_in> "Small_cell_lung_cancer" .
<Ostonat> <Brand_name_of> "Alendronate" .
<Purine_analogue> <Is_a> "Antimetabolite" .
<Carboplatin,_Gemcitabine,_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<ADT> <Has_accepted_use> "Prostate_cancer" .
<Doxorubicin_and_Vinblastine> <Has_modality> "Chemotherapy" .
<Dexton> <Brand_name_of> "Dexamethasone" .
<Tocilizumab> <May_have_route> "Intravenous" .
<Ectrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Methotrexate,_Tacrolimus,_Tocilizumab> <Has_immunosuppressor> "Tocilizumab" .
<Methotrexate,_Tacrolimus,_Tocilizumab> <Has_immunosuppressor> "Tacrolimus" .
<Methotrexate,_Tacrolimus,_Tocilizumab> <Has_immunosuppressor> "Methotrexate" .
<Cisplatin_and_Fluorouracil> <Has_modality> "Chemotherapy" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Mapped_from> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Cisplatin_and_Mitomycin> <Has_antineoplastic> "Mitomycin" .
<Cisplatin_and_Mitomycin> <Has_antineoplastic> "Cisplatin" .
<TX_(Taxotere)> <Mapped_from> "TX_(Taxotere)" .
<Ixabepilone_monotherapy> <Has_accepted_use> "Breast_cancer" .
<FAC_and_Bevacizumab> <Has_antineoplastic> "Fluorouracil" .
<FAC_and_Bevacizumab> <Has_antineoplastic> "Doxorubicin" .
<FAC_and_Bevacizumab> <Has_antineoplastic> "Cyclophosphamide" .
<FAC_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<CVAD> <Is_a> "Anthracycline-containing_regimen" .
<KCD> <Has_modality> "Chemotherapy" .
<Definitive_therapy> <Is_a> "Upfront_therapy" .
<DE> <Is_current_in> "Breast_cancer" .
<DICE> <Mapped_from> "DICE" .
<Altretamine_and_Cisplatin> <Is_current_in> "Ovarian_cancer" .
<Vindesine_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Triptorelin_monotherapy> <Has_antineoplastic> "Triptorelin" .
<Tecnocarb> <Brand_name_of> "Carboplatin" .
<Doxorubicin_and_Fluorouracil> <Maps_to> "Doxorubicin_and_Fluorouracil" .
<Sunitinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Sunitinib_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Sunitinib_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Sunitinib_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Sunitinib_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Sunitinib_monotherapy> <Has_context> "All_lines_of_therapy" .
<Sunitinib_monotherapy> <Has_context> "Adjuvant_therapy" .
<Abiraterone> <Has_accepted_use> "Prostate_cancer" .
<Danatrol> <Brand_name_of> "Danazol" .
<Tranexamic_acid> <Antineoplastic_of> "Tranexamic_acid_monotherapy" .
<Daxotel> <Brand_name_of> "Doxorubicin" .
<Daxotel> <Brand_name_of> "Docetaxel" .
<Ifoxan> <Brand_name_of> "Ifosfamide" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine> <Maps_to> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine" .
<Idarubicin> <May_have_route> "Intravenous" .
<Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone> <Has_modality> "Chemotherapy" .
<Fludarabine_and_TBI,_then_allo_HSCT> <Maps_to> "Fludarabine_and_TBI,_then_allo_HSCT" .
<DA-EPOCH> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<DA-EPOCH> <Has_supportive_med> "Sennosides" .
<DA-EPOCH> <Has_supportive_med> "Pentamidine" .
<DA-EPOCH> <Has_supportive_med> "Omeprazole" .
<DA-EPOCH> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<DA-EPOCH> <Has_supportive_med> "Fluconazole" .
<DA-EPOCH> <Has_supportive_med> "Filgrastim" .
<DA-EPOCH> <Has_supportive_med> "Docusate" .
<DA-EPOCH> <Has_supportive_med> "Atovaquone" .
<Large_granular_lymphocytic_leukemia> <Is_a> "T-cell_lymphoma" .
<R2CHOP> <Maps_to> "R2CHOP" .
<Pembrolizumab_monotherapy> <Has_modality> "Immunotherapy" .
<Ifosfamide_and_Paclitaxel> <Has_accepted_use> "Testicular_cancer" .
<Ifosfamide_and_Paclitaxel> <Has_accepted_use> "Small_cell_lung_cancer" .
<Ifosfamide_and_Paclitaxel> <Has_accepted_use> "Endometrial_cancer" .
<Tropisetron> <Is_a> "Serotonin_5-HT3_antagonist" .
<Tropisetron> <Is_a> "PMDA_approved_drug" .
<Tropisetron> <Is_a> "KFDA_approved_drug" .
<Tropisetron> <Is_a> "Emesis_prevention" .
<Tropisetron> <Is_a> "EMA_approved_drug" .
<Skin_cancer> <Is_a> "Cross-disciplinary_condition" .
<Methotrexate_and_Vincristine> <Has_modality> "Chemotherapy" .
<Factor_Xa_inhibitor> <Subsumes> "Rivaroxaban" .
<Factor_Xa_inhibitor> <Subsumes> "Edoxaban" .
<Factor_Xa_inhibitor> <Subsumes> "Betrixaban" .
<Factor_Xa_inhibitor> <Subsumes> "Apixaban" .
<Ralista> <Brand_name_of> "Raloxifene" .
<Azacitidine_monotherapy> <Maps_to> "Azacitidine_monotherapy" .
<Cytotrexate> <Brand_name_of> "Methotrexate" .
<Cisplatin_and_Doxorubicin> <Maps_to> "Cisplatin_and_Doxorubicin" .
<Etoposide_and_Mitoxantrone> <Mapped_from> "Etoposide_and_Mitoxantrone" .
<RhIG_monotherapy> <Has_modality> "Supportive_therapy" .
<Fluorouracil_and_Folinic_acid> <Is_current_in> "Rectal_cancer" .
<Fluorouracil_and_Folinic_acid> <Is_current_in> "Pancreatic_cancer" .
<Fluorouracil_and_Folinic_acid> <Is_current_in> "Hepatocellular_carcinoma" .
<Fluorouracil_and_Folinic_acid> <Is_current_in> "Esophageal_cancer" .
<Fluorouracil_and_Folinic_acid> <Is_current_in> "Colon_cancer" .
<Fluorouracil_and_Folinic_acid> <Is_current_in> "Cholangiocarcinoma" .
<Fluorouracil_and_Folinic_acid> <Is_current_in> "Cervical_cancer" .
<Predeltilone> <Brand_name_of> "Prednisolone" .
<Caplacizumab_and_Plasma_exchange> <Maps_to> "Caplacizumab_and_Plasma_exchange" .
<Anti-nectin-4_antibody> <Subsumes> "Enfortumab_vedotin" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Is_a> "B-cell_acute_lymphoblastic_leukemia" .
<Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Ipilimumab_and_RT> <Has_accepted_use> "Prostate_cancer" .
<DEB-TACE> <Is_a> "Anthracycline-containing_regimen" .
<DHAP_-_time_intensified> <Has_supportive_med> "Ondansetron" .
<DHAP_-_time_intensified> <Has_supportive_med> "Filgrastim" .
<Hormonotherapy> <Maps_to> "Hormonotherapy" .
<CFP> <Has_context> "Non-curative_therapy" .
<CFP> <Has_context> "Adjuvant_therapy" .
<ADT_and_Docetaxel> <Has_accepted_use> "Prostate_cancer" .
<Z-BEAM> <Has_supportive_med> "Valacyclovir" .
<Z-BEAM> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Z-BEAM> <Has_supportive_med> "Filgrastim" .
<Z-BEAM> <Has_supportive_med> "Acyclovir" .
<Rituximab_monotherapy> <Maps_to> "Rituximab_monotherapy" .
<DeVIC_and_RT> <Has_context> "Induction_therapy" .
<Rosai-Dorfman-Destombes_disease> <Current_treated_by> "Cobimetinib_monotherapy" .
<Omacetaxine_monotherapy> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Nopil> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Enoxaparin_monotherapy> <Has_modality> "Anticoagulation" .
<Capecitabine,_Pertuzumab,_Trastuzumab> <Has_modality> "Chemotherapy" .
<Carboplatin,_Paclitaxel,_RT> <Has_context> "Neoadjuvant_therapy" .
<Carboplatin,_Paclitaxel,_RT> <Has_context> "Definitive_therapy" .
<mCOP/MP> <Has_antineoplastic> "Vincristine" .
<mCOP/MP> <Has_antineoplastic> "Prednisolone" .
<mCOP/MP> <Has_antineoplastic> "Melphalan" .
<mCOP/MP> <Has_antineoplastic> "Cyclophosphamide" .
<DD-CHOP> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<DD-CHOP> <Has_supportive_med> "Diphenhydramine" .
<DD-CHOP> <Has_supportive_med> "Dexamethasone" .
<DD-CHOP> <Has_supportive_med> "Acetaminophen" .
<OXAFAFU> <Is_current_in> "Colon_cancer" .
<Alprazolam> <May_have_route> "Oral" .
<Calpol> <Brand_name_of> "Acetaminophen" .
<Adricept> <Brand_name_of> "Doxorubicin" .
<Azacitidine_and_Gemtuzumab_ozogamicin> <Has_accepted_use> "Acute_myeloid_leukemia" .
<PACEBOM> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Brentuximab_vedotin_and_Dacarbazine> <Has_context> "Induction_therapy" .
<Pre-definitive_therapy> <Subsumes> "Neoadjuvant_therapy" .
<Pre-definitive_therapy> <Subsumes> "Induction_therapy" .
<Gemcitabine_and_nab-Paclitaxel> <Has_antineoplastic> "Paclitaxel_nanoparticle_albumin-bound" .
<Gemcitabine_and_nab-Paclitaxel> <Has_antineoplastic> "Gemcitabine" .
<Decitabine_and_Venetoclax> <Has_modality> "Chemotherapy" .
<Dalteparin_monotherapy> <Maps_to> "Dalteparin_monotherapy" .
<R-DHAOx> <Has_modality> "Chemotherapy" .
<5_plus_3i> <Maps_to> "5_plus_3i" .
<FAC_and_BCG> <Mapped_from> "FAC_and_BCG" .
<BCNU/TT,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<FEAM,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Cytarabine,_Daunorubicin,_Vincristine> <Has_context> "Induction_therapy" .
<CHOEP-14> <Has_antineoplastic> "Vincristine" .
<CHOEP-14> <Has_antineoplastic> "Prednisone" .
<CHOEP-14> <Has_antineoplastic> "Etoposide" .
<CHOEP-14> <Has_antineoplastic> "Doxorubicin" .
<CHOEP-14> <Has_antineoplastic> "Cyclophosphamide" .
<Phenothiazines> <Supportive_med_of> "Cisplatin_and_Gemcitabine" .
<Phenothiazines> <Supportive_med_of> "Carboplatin_and_Docetaxel" .
<R-CHVP_plus_I> <Has_modality> "Chemotherapy" .
<Rituximab_and_hyaluronidase_monotherapy> <Has_modality> "Chemotherapy" .
<L-Asparaginase,_Vincristine,_Prednisone> <Has_antineoplastic> "Vincristine" .
<L-Asparaginase,_Vincristine,_Prednisone> <Has_antineoplastic> "Prednisone" .
<L-Asparaginase,_Vincristine,_Prednisone> <Has_antineoplastic> "Asparaginase" .
<Tazemetostat_monotherapy> <Has_antineoplastic> "Tazemetostat" .
<Paclitaxel_nanoparticle_albumin-bound> <Has_accepted_use> "Pancreatic_cancer" .
<Paclitaxel_nanoparticle_albumin-bound> <Has_accepted_use> "Ovarian_cancer" .
<Paclitaxel_nanoparticle_albumin-bound> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Paclitaxel_nanoparticle_albumin-bound> <Has_accepted_use> "Melanoma" .
<Paclitaxel_nanoparticle_albumin-bound> <Has_accepted_use> "Gastric_cancer" .
<Paclitaxel_nanoparticle_albumin-bound> <Has_accepted_use> "Breast_cancer" .
<Paclitaxel_nanoparticle_albumin-bound> <Has_accepted_use> "Bladder_cancer" .
<Nilotinib_monotherapy> <Has_modality> "Chemotherapy" .
<Dactinomycin_and_Vincristine> <Mapped_from> "Dactinomycin_and_Vincristine" .
<Lenvatinib_monotherapy> <Has_antineoplastic> "Lenvatinib" .
<Phenytoin> <Has_brand_name> "Fentinol" .
<Phenytoin> <Has_brand_name> "Eptoin" .
<Phenytoin> <Has_brand_name> "Epsotoin" .
<Phenytoin> <Has_brand_name> "Epanutin" .
<Phenytoin> <Has_brand_name> "Dilantin" .
<Eposin> <Brand_name_of> "Etoposide" .
<Capecitabine_and_Bevacizumab> <Mapped_from> "Capecitabine_and_Bevacizumab" .
<Bortezomib_and_Cyclophosphamide> <Has_antineoplastic> "Cyclophosphamide" .
<Bortezomib_and_Cyclophosphamide> <Has_antineoplastic> "Bortezomib" .
<FOLFIRI_and_Bevacizumab_(L-Leucovorin)> <Has_context> "Non-curative_second-line_therapy" .
<FOLFIRI_and_Bevacizumab_(L-Leucovorin)> <Has_context> "Non-curative_first-line_therapy" .
<Transformed_lymphoma> <Accepted_use_of> "Vincristine" .
<Transformed_lymphoma> <Accepted_use_of> "Tositumomab_&_I-131" .
<Transformed_lymphoma> <Accepted_use_of> "Tisagenlecleucel_monotherapy" .
<Transformed_lymphoma> <Accepted_use_of> "Tisagenlecleucel" .
<Transformed_lymphoma> <Accepted_use_of> "Rituximab-pvvr" .
<Transformed_lymphoma> <Accepted_use_of> "Rituximab-abbs" .
<Transformed_lymphoma> <Accepted_use_of> "Rituximab" .
<Transformed_lymphoma> <Accepted_use_of> "R-GDP" .
<Transformed_lymphoma> <Accepted_use_of> "R-EPOCH" .
<Transformed_lymphoma> <Accepted_use_of> "R-DHAP" .
<Transformed_lymphoma> <Accepted_use_of> "Prednisone" .
<Transformed_lymphoma> <Accepted_use_of> "Pembrolizumab_monotherapy" .
<Transformed_lymphoma> <Accepted_use_of> "Oxaliplatin" .
<Transformed_lymphoma> <Accepted_use_of> "OFAR" .
<Transformed_lymphoma> <Accepted_use_of> "Lenalidomide_monotherapy" .
<Transformed_lymphoma> <Accepted_use_of> "Lenalidomide_and_Rituximab" .
<Transformed_lymphoma> <Accepted_use_of> "Lenalidomide" .
<Transformed_lymphoma> <Accepted_use_of> "Gemcitabine" .
<Transformed_lymphoma> <Accepted_use_of> "Fludarabine" .
<Transformed_lymphoma> <Accepted_use_of> "Etoposide" .
<Transformed_lymphoma> <Accepted_use_of> "Doxorubicin" .
<Transformed_lymphoma> <Accepted_use_of> "Dexamethasone" .
<Transformed_lymphoma> <Accepted_use_of> "Cytarabine" .
<Transformed_lymphoma> <Accepted_use_of> "Cyclophosphamide" .
<Transformed_lymphoma> <Accepted_use_of> "Cisplatin" .
<Transformed_lymphoma> <Accepted_use_of> "Bendamustine_monotherapy" .
<Transformed_lymphoma> <Accepted_use_of> "Bendamustine" .
<Transformed_lymphoma> <Accepted_use_of> "BFR,_then_allo_HSCT" .
<Transformed_lymphoma> <Accepted_use_of> "Axicabtagene_ciloleucel_monotherapy" .
<Transformed_lymphoma> <Accepted_use_of> "Axicabtagene_ciloleucel" .
<Transformed_lymphoma> <Accepted_use_of> "131Iodine-Tositumomab_monotherapy" .
<Biotrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<R-BEAM,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Polyferon> <Brand_name_of> "Interferon_alfa-2b" .
<CPX-351_monotherapy> <Has_antineoplastic> "Cytarabine_and_daunorubicin_liposomal" .
<ABV_(Vincristine)> <Maps_to> "ABV_(Vincristine)" .
<Arsenic_trioxide,_ATRA,_Idarubicin> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Bevacizumab_and_Interferon_alfa-2a> <Mapped_from> "Bevacizumab_and_Interferon_alfa-2a" .
<TVAD_doxil> <Has_context> "Non-curative_first-line_therapy" .
<Busulfan_and_Cyclophosphamide,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<Busulfan_and_Cyclophosphamide,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<Ponatinib> <Has_FDA_indication> "Chronic_myelogenous_leukemia" .
<Pirarubicin> <Antineoplastic_of> "Pirarubicin_monotherapy" .
<CVAP> <Mapped_from> "CVAP" .
<Inlyta> <Brand_name_of> "Axitinib" .
<Bokey_EMC> <Brand_name_of> "Aspirin" .
<Sirolimus_monotherapy> <Has_modality> "Immunosuppressive_therapy" .
<VT> <Is_current_in> "Multiple_myeloma" .
<Tazemetostat_monotherapy> <Has_modality> "Chemotherapy" .
<mFOLFOX_and_Sorafenib> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Immunosuppressive_therapy> <Maps_to> "Immunosuppressive_therapy" .
<CLAG> <Has_modality> "Growth_factor_therapy" .
<CLAG> <Has_modality> "Chemotherapy" .
<Dacarbazine_and_Doxorubicin> <Has_context> "Non-curative_therapy" .
<Anastrol> <Brand_name_of> "Anastrozole" .
<Denileukin_diftitox_monotherapy> <Has_antineoplastic> "Denileukin_diftitox" .
<Ifosfamide_and_Methotrexate> <Has_supportive_med> "Mesna" .
<Ifosfamide_and_Methotrexate> <Has_supportive_med> "Folinic_acid" .
<CBVM,_then_auto_HSCT> <Is_a> "Anthracycline-containing_regimen" .
<CAP-BOP> <Is_a> "Anthracycline-containing_regimen" .
<Stopan> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<TAD_(Tamoxifen)> <Is_a> "Antiestrogen-containing_regimen" .
<Goserelin_monotherapy> <Has_antineoplastic> "Goserelin" .
<Clofarabine_and_LoDAC/Decitabine> <Maps_to> "Clofarabine_and_LoDAC/Decitabine" .
<FLAG-DNX> <Has_modality> "Growth_factor_therapy" .
<FLAG-DNX> <Has_modality> "Chemotherapy" .
<Multiple_myeloma> <Accepted_use_of> "mCOP/MP" .
<Multiple_myeloma> <Accepted_use_of> "Zoledronic_acid_therapy" .
<Multiple_myeloma> <Accepted_use_of> "ZRd" .
<Multiple_myeloma> <Accepted_use_of> "Vorinostat" .
<Multiple_myeloma> <Accepted_use_of> "Vincristine" .
<Multiple_myeloma> <Accepted_use_of> "Venetoclax" .
<Multiple_myeloma> <Accepted_use_of> "Vemurafenib_monotherapy" .
<Multiple_myeloma> <Accepted_use_of> "Vemurafenib" .
<Multiple_myeloma> <Accepted_use_of> "VTP" .
<Multiple_myeloma> <Accepted_use_of> "VTD-PACE" .
<Multiple_myeloma> <Accepted_use_of> "VTD" .
<Multiple_myeloma> <Accepted_use_of> "VT" .
<Multiple_myeloma> <Accepted_use_of> "VP" .
<Multiple_myeloma> <Accepted_use_of> "VMPT" .
<Multiple_myeloma> <Accepted_use_of> "VMP/Rd" .
<Multiple_myeloma> <Accepted_use_of> "VMP,_then_Rd" .
<Multiple_myeloma> <Accepted_use_of> "VMP" .
<Multiple_myeloma> <Accepted_use_of> "VMCP/VCAP" .
<Multiple_myeloma> <Accepted_use_of> "VMCP/VBAP" .
<Multiple_myeloma> <Accepted_use_of> "VMCP" .
<Multiple_myeloma> <Accepted_use_of> "VDC" .
<Multiple_myeloma> <Accepted_use_of> "VD" .
<Multiple_myeloma> <Accepted_use_of> "VCP" .
<Multiple_myeloma> <Accepted_use_of> "VBMCP/VBAD" .
<Multiple_myeloma> <Accepted_use_of> "VBMCP" .
<Multiple_myeloma> <Accepted_use_of> "VBMC" .
<Multiple_myeloma> <Accepted_use_of> "VAMP" .
<Multiple_myeloma> <Accepted_use_of> "VAD-P/Q" .
<Multiple_myeloma> <Accepted_use_of> "VAD-P" .
<Multiple_myeloma> <Accepted_use_of> "VAD_doxil" .
<Multiple_myeloma> <Accepted_use_of> "VAD_and_Cyclosporine" .
<Multiple_myeloma> <Accepted_use_of> "VAD" .
<Multiple_myeloma> <Accepted_use_of> "V-HyperCAD" .
<Multiple_myeloma> <Accepted_use_of> "Total_Therapy" .
<Multiple_myeloma> <Accepted_use_of> "Tisagenlecleucel_monotherapy" .
<Multiple_myeloma> <Accepted_use_of> "Thalidomide_monotherapy" .
<Multiple_myeloma> <Accepted_use_of> "Thalidomide_and_Prednisone" .
<Multiple_myeloma> <Accepted_use_of> "Thalidomide_and_Prednisolone" .
<Multiple_myeloma> <Accepted_use_of> "Thalidomide" .
<Multiple_myeloma> <Accepted_use_of> "Tandem_melphalan,_then_auto_HSCT" .
<Multiple_myeloma> <Accepted_use_of> "TVAD_doxil" .
<Multiple_myeloma> <Accepted_use_of> "TD" .
<Multiple_myeloma> <Accepted_use_of> "TAD_(Thalidomide)" .
<Multiple_myeloma> <Accepted_use_of> "Selinexor_and_Dexamethasone" .
<Multiple_myeloma> <Accepted_use_of> "Selinexor" .
<Multiple_myeloma> <Accepted_use_of> "Ricolinostat" .
<Multiple_myeloma> <Accepted_use_of> "Rd" .
<Multiple_myeloma> <Accepted_use_of> "RVDC" .
<Multiple_myeloma> <Accepted_use_of> "RVD" .
<Multiple_myeloma> <Accepted_use_of> "RP" .
<Multiple_myeloma> <Accepted_use_of> "RD" .
<Multiple_myeloma> <Accepted_use_of> "Quinine" .
<Multiple_myeloma> <Accepted_use_of> "Prednisone_monotherapy" .
<Multiple_myeloma> <Accepted_use_of> "Prednisone" .
<Multiple_myeloma> <Accepted_use_of> "Prednisolone_monotherapy" .
<Multiple_myeloma> <Accepted_use_of> "Prednisolone" .
<Multiple_myeloma> <Accepted_use_of> "Pomalidomide,_Dexamethasone,_Pembrolizumab" .
<Multiple_myeloma> <Accepted_use_of> "Pomalidomide_monotherapy" .
<Multiple_myeloma> <Accepted_use_of> "Pomalidomide_and_Prednisone" .
<Multiple_myeloma> <Accepted_use_of> "Pomalidomide" .
<Multiple_myeloma> <Accepted_use_of> "Placebo" .
<Multiple_myeloma> <Accepted_use_of> "Pegylated_liposomal_doxorubicin" .
<Multiple_myeloma> <Accepted_use_of> "Panobinostat" .
<Multiple_myeloma> <Accepted_use_of> "PVD" .
<Multiple_myeloma> <Accepted_use_of> "PD" .
<Multiple_myeloma> <Accepted_use_of> "PCP" .
<Multiple_myeloma> <Accepted_use_of> "PCD" .
<Multiple_myeloma> <Accepted_use_of> "PAD_doxil" .
<Multiple_myeloma> <Accepted_use_of> "PAD" .
<Multiple_myeloma> <Accepted_use_of> "Oprozomib" .
<Multiple_myeloma> <Accepted_use_of> "Observation" .
<Multiple_myeloma> <Accepted_use_of> "Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT" .
<Multiple_myeloma> <Accepted_use_of> "Melphalan,_then_auto_HSCT,_then_Melphalan_and_TBI,_then_auto_HSCT" .
<Multiple_myeloma> <Accepted_use_of> "Melphalan,_then_auto_HSCT,_then_Melphalan_and_Busulfan,_then_auto_HSCT" .
<Multiple_myeloma> <Accepted_use_of> "Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Multiple_myeloma> <Accepted_use_of> "Melphalan,_then_auto_HSCT" .
<Multiple_myeloma> <Accepted_use_of> "Melphalan_monotherapy" .
<Multiple_myeloma> <Accepted_use_of> "Melphalan_and_TBI,_then_auto_HSCT" .
<Multiple_myeloma> <Accepted_use_of> "Melphalan_and_Methylprednisolone,_then_auto_HSCT" .
<Multiple_myeloma> <Accepted_use_of> "Melphalan" .
<Multiple_myeloma> <Accepted_use_of> "MPT" .
<Multiple_myeloma> <Accepted_use_of> "MPR" .
<Multiple_myeloma> <Accepted_use_of> "MP_(Prednisolone)" .
<Multiple_myeloma> <Accepted_use_of> "MP" .
<Multiple_myeloma> <Accepted_use_of> "MEL200,_then_auto_HSCT,_then_MEL220_and_Dexamethasone,_then_auto_HSCT" .
<Multiple_myeloma> <Accepted_use_of> "M-DEX" .
<Multiple_myeloma> <Accepted_use_of> "Lenalidomide_monotherapy" .
<Multiple_myeloma> <Accepted_use_of> "Lenalidomide" .
<Multiple_myeloma> <Accepted_use_of> "KTD" .
<Multiple_myeloma> <Accepted_use_of> "KRd" .
<Multiple_myeloma> <Accepted_use_of> "KPD" .
<Multiple_myeloma> <Accepted_use_of> "KMP" .
<Multiple_myeloma> <Accepted_use_of> "KD" .
<Multiple_myeloma> <Accepted_use_of> "KCD" .
<Multiple_myeloma> <Accepted_use_of> "Ixazomib_monotherapy" .
<Multiple_myeloma> <Accepted_use_of> "Ixazomib_and_Dexamethasone" .
<Multiple_myeloma> <Accepted_use_of> "Ixazomib" .
<Multiple_myeloma> <Accepted_use_of> "Isatuximab" .
<Multiple_myeloma> <Accepted_use_of> "Interferon_alfa-2b_monotherapy" .
<Multiple_myeloma> <Accepted_use_of> "Interferon_alfa-2b_and_Thalidomide" .
<Multiple_myeloma> <Accepted_use_of> "Interferon_alfa-2b_and_Prednisone" .
<Multiple_myeloma> <Accepted_use_of> "Interferon_alfa-2b" .
<Multiple_myeloma> <Accepted_use_of> "Interferon_alfa-2a_monotherapy" .
<Multiple_myeloma> <Accepted_use_of> "Interferon_alfa_monotherapy" .
<Multiple_myeloma> <Accepted_use_of> "Interferon_alfa_and_Dexamethasone" .
<Multiple_myeloma> <Accepted_use_of> "IRd" .
<Multiple_myeloma> <Accepted_use_of> "Hyper-CVAD" .
<Multiple_myeloma> <Accepted_use_of> "FRD" .
<Multiple_myeloma> <Accepted_use_of> "Etoposide" .
<Multiple_myeloma> <Accepted_use_of> "Elotuzumab" .
<Multiple_myeloma> <Accepted_use_of> "Elo-VD" .
<Multiple_myeloma> <Accepted_use_of> "Elo-Rd" .
<Multiple_myeloma> <Accepted_use_of> "Elo-PD" .
<Multiple_myeloma> <Accepted_use_of> "EDAP" .
<Multiple_myeloma> <Accepted_use_of> "Doxorubicin" .
<Multiple_myeloma> <Accepted_use_of> "Dexamethasone_monotherapy" .
<Multiple_myeloma> <Accepted_use_of> "Dexamethasone" .
<Multiple_myeloma> <Accepted_use_of> "Daratumumab_monotherapy" .
<Multiple_myeloma> <Accepted_use_of> "Daratumumab" .
<Multiple_myeloma> <Accepted_use_of> "Dara-VTD" .
<Multiple_myeloma> <Accepted_use_of> "Dara-VMP" .
<Multiple_myeloma> <Accepted_use_of> "Dara-VD" .
<Multiple_myeloma> <Accepted_use_of> "Dara-Rd" .
<Multiple_myeloma> <Accepted_use_of> "Dara-PD" .
<Multiple_myeloma> <Accepted_use_of> "Dara-KD" .
<Multiple_myeloma> <Accepted_use_of> "DTPACE" .
<Multiple_myeloma> <Accepted_use_of> "DEX-IFN" .
<Multiple_myeloma> <Accepted_use_of> "DCEP" .
<Multiple_myeloma> <Accepted_use_of> "Cyclophosphamide_monotherapy" .
<Multiple_myeloma> <Accepted_use_of> "Cyclophosphamide_and_Prednisone" .
<Multiple_myeloma> <Accepted_use_of> "Cyclophosphamide_and_Dexamethasone" .
<Multiple_myeloma> <Accepted_use_of> "Cyclophosphamide" .
<Multiple_myeloma> <Accepted_use_of> "Clarithromycin" .
<Multiple_myeloma> <Accepted_use_of> "Cisplatin" .
<Multiple_myeloma> <Accepted_use_of> "Carmustine_and_Doxorubicin" .
<Multiple_myeloma> <Accepted_use_of> "Carfilzomib_monotherapy" .
<Multiple_myeloma> <Accepted_use_of> "Carfilzomib_and_Panobinostat" .
<Multiple_myeloma> <Accepted_use_of> "Carfilzomib" .
<Multiple_myeloma> <Accepted_use_of> "CYKLONE" .
<Multiple_myeloma> <Accepted_use_of> "CVAD" .
<Multiple_myeloma> <Accepted_use_of> "CTD" .
<Multiple_myeloma> <Accepted_use_of> "CRd" .
<Multiple_myeloma> <Accepted_use_of> "CRD" .
<Multiple_myeloma> <Accepted_use_of> "CPR" .
<Multiple_myeloma> <Accepted_use_of> "C-VAMP" .
<Multiple_myeloma> <Accepted_use_of> "Busulfan" .
<Multiple_myeloma> <Accepted_use_of> "Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat" .
<Multiple_myeloma> <Accepted_use_of> "Bortezomib,_Dexamethasone,_Panobinostat" .
<Multiple_myeloma> <Accepted_use_of> "Bortezomib_monotherapy" .
<Multiple_myeloma> <Accepted_use_of> "Bortezomib_and_Vorinostat" .
<Multiple_myeloma> <Accepted_use_of> "Bortezomib_and_Melphalan,_then_auto_HSCT" .
<Multiple_myeloma> <Accepted_use_of> "Bortezomib_and_Doxorubicin_liposomal" .
<Multiple_myeloma> <Accepted_use_of> "Bortezomib_and_Cyclophosphamide" .
<Multiple_myeloma> <Accepted_use_of> "Bortezomib" .
<Multiple_myeloma> <Accepted_use_of> "BiRd" .
<Multiple_myeloma> <Accepted_use_of> "Bendamustine" .
<Multiple_myeloma> <Accepted_use_of> "BTD" .
<Multiple_myeloma> <Accepted_use_of> "BLD" .
<Multiple_myeloma> <Accepted_use_of> "BID" .
<Multiple_myeloma> <Accepted_use_of> "BBD" .
<Multiple_myeloma> <Accepted_use_of> "Afuresertib" .
<Multiple_myeloma> <Accepted_use_of> "ABCM" .
<IT_Methotrexate_and_Hydrocortisone> <Has_local_therapy> "Methotrexate" .
<IT_Methotrexate_and_Hydrocortisone> <Has_local_therapy> "Hydrocortisone" .
<Lenalidomide_and_Ofatumumab> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Lenalidomide_and_Ofatumumab> <Has_supportive_med> "Allopurinol" .
<BEAM,_then_allo_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<FOLFOX4_and_Cetuximab> <Has_antineoplastic> "Oxaliplatin" .
<FOLFOX4_and_Cetuximab> <Has_antineoplastic> "Folinic_acid" .
<FOLFOX4_and_Cetuximab> <Has_antineoplastic> "Fluorouracil" .
<FOLFOX4_and_Cetuximab> <Has_antineoplastic> "Cetuximab" .
<CHAD> <Mapped_from> "CHAD" .
<Eculizumab> <May_have_route> "Intravenous" .
<Gastroesophageal_cancer> <Subsumes> "Gastric_cancer" .
<Gastroesophageal_cancer> <Subsumes> "Esophageal_cancer" .
<EPIC_regimen> <Has_context> "Salvage_therapy" .
<CAV_and_RT> <Has_modality> "Radiotherapy" .
<CAV_and_RT> <Has_modality> "Chemotherapy" .
<Nilotinib> <May_have_route> "Oral" .
<R-CHOP/R-DHAP> <Has_antineoplastic> "Vincristine" .
<R-CHOP/R-DHAP> <Has_antineoplastic> "Rituximab" .
<R-CHOP/R-DHAP> <Has_antineoplastic> "Prednisone" .
<R-CHOP/R-DHAP> <Has_antineoplastic> "Doxorubicin" .
<R-CHOP/R-DHAP> <Has_antineoplastic> "Dexamethasone" .
<R-CHOP/R-DHAP> <Has_antineoplastic> "Cytarabine" .
<R-CHOP/R-DHAP> <Has_antineoplastic> "Cyclophosphamide" .
<R-CHOP/R-DHAP> <Has_antineoplastic> "Cisplatin" .
<Entrectinib_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Entrectinib_monotherapy> <Is_current_in> "NTRK-mutated_malignancy" .
<OEPA> <Is_a> "Anthracycline-containing_regimen" .
<Siltuximab> <Has_FDA_indication> "Castleman_disease" .
<Ibrutinib_and_Obinutuzumab> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Anti-IL-5_antibody> <Subsumes> "Mepolizumab" .
<Anti-IL-5_antibody> <Subsumes> "Benralizumab" .
<Bivalirudin> <Has_accepted_use> "Venous_thromboembolism" .
<Tagraxofusp_monotherapy> <Has_antineoplastic> "Tagraxofusp" .
<R-MCP> <Is_a> "Rituximab-containing_regimen" .
<R-MCP> <Is_a> "Anthracycline-containing_regimen" .
<Cisplatin_and_Fluorouracil> <Has_antineoplastic> "Fluorouracil" .
<Cisplatin_and_Fluorouracil> <Has_antineoplastic> "Cisplatin" .
<Oncofu> <Brand_name_of> "Fluorouracil" .
<Cyclosporine_monotherapy> <Has_supportive_med> "Prednisolone" .
<DAT> <Has_context> "Induction_therapy" .
<Cisplatin,_Etoposide,_Bevacizumab> <Is_current_in> "Small_cell_lung_cancer" .
<Uric_acid_lowering_agent> <Subsumes> "Xanthine_oxidase_inhibitor" .
<Uric_acid_lowering_agent> <Subsumes> "Rasburicase" .
<EPOCH,_dose-escalated> <Has_accepted_use> "HIV-associated_lymphoma" .
<Sunitinib> <Has_brand_name> "Sutent" .
<Sunitinib> <Has_brand_name> "Suninat" .
<Fedratinib> <Has_FDA_indication> "Myelofibrosis" .
<HGF_inhibitor> <Subsumes> "Rilotumumab" .
<Flurac> <Brand_name_of> "Fluorouracil" .
<PCF> <Has_context> "Non-curative_therapy" .
<PCF> <Has_context> "Induction_therapy" .
<PCF> <Has_context> "All_lines_of_therapy" .
<R-CODOX-M_(Doxil_substituted)> <Has_local_therapy> "Methotrexate" .
<R-CODOX-M_(Doxil_substituted)> <Has_local_therapy> "Cytarabine" .
<Etoposide,_Ifosfamide,_Imatinib> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Immune_effector_cell> <Subsumes> "Dendritic_cell_vaccine" .
<Immune_effector_cell> <Subsumes> "Chimeric_antigen_receptor_T-cell" .
<Enasidenib> <Is_a> "Mutation-specific_medication" .
<Enasidenib> <Is_a> "IDH2_inhibitor" .
<Topresid> <Brand_name_of> "Etoposide" .
<Poris> <Brand_name_of> "Alendronate" .
<Kaftrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Fayining> <Brand_name_of> "Folinic_acid" .
<Fruquintinib> <May_have_route> "Oral" .
<Nintedanib_and_Pemetrexed> <Has_modality> "Chemotherapy" .
<HLH-94_regimen> <Is_current_in> "Hemophagocytic_lymphohistiocytosis" .
<Anthracycline> <Subsumes> "Valrubicin" .
<Anthracycline> <Subsumes> "Pirarubicin" .
<Anthracycline> <Subsumes> "Pegylated_liposomal_doxorubicin" .
<Anthracycline> <Subsumes> "Non-pegylated_liposomal_doxorubicin" .
<Anthracycline> <Subsumes> "Mitoxantrone" .
<Anthracycline> <Subsumes> "Idarubicin" .
<Anthracycline> <Subsumes> "Epirubicin" .
<Anthracycline> <Subsumes> "Doxorubicin" .
<Anthracycline> <Subsumes> "Daunorubicin_liposomal" .
<Anthracycline> <Subsumes> "Daunorubicin" .
<Anthracycline> <Subsumes> "Cytarabine_and_daunorubicin_liposomal" .
<Anthracycline> <Subsumes> "Amrubicin" .
<Anthracycline> <Subsumes> "Aclarubicin" .
<VAdCA> <Is_current_in> "Ewing_sarcoma" .
<R-ICE> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Megabroncoflam> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Nelarabine_monotherapy> <Maps_to> "Nelarabine_monotherapy" .
<Xeljanz> <Brand_name_of> "Tofacitinib" .
<Lmwx> <Brand_name_of> "Enoxaparin" .
<Iron_sucrose> <May_have_route> "Intravenous" .
<BEAM,_then_allo_HSCT> <Maps_to> "BEAM,_then_allo_HSCT" .
<Low-dose_Interleukin-2> <Maps_to> "Low-dose_Interleukin-2" .
<Abiraterone_and_Prednisone> <Has_accepted_use> "Prostate_cancer" .
<Methotrexate,_Tacrolimus,_Tocilizumab> <Maps_to> "Methotrexate,_Tacrolimus,_Tocilizumab" .
<BVP> <Has_context> "Upfront_therapy" .
<BVP> <Has_context> "Adjuvant_therapy" .
<Thriazol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CapeOx_and_Bevacizumab> <Has_antineoplastic> "Oxaliplatin" .
<CapeOx_and_Bevacizumab> <Has_antineoplastic> "Capecitabine" .
<CapeOx_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Belinostat_monotherapy> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<Belinostat_monotherapy> <Is_current_in> "Cutaneous_T-cell_lymphoma" .
<Carboplatin,_Etoposide,_Durvalumab> <Is_current_in> "Small_cell_lung_cancer" .
<Boschtrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Temizole> <Brand_name_of> "Temozolomide" .
<Clofarabine> <Is_a> "Purine_analogue" .
<Clofarabine> <Is_a> "Neutral" .
<Clofarabine> <Is_a> "Antimetabolite" .
<Daunorubicin_liposomal_monotherapy> <Is_current_in> "Kaposi_sarcoma" .
<Gilteritinib_monotherapy> <Has_antineoplastic> "Gilteritinib" .
<Hyper-CVAD_and_Ponatinib> <Has_modality> "Chemotherapy" .
<Carboplatin_and_Gemcitabine/Erlotinib> <Has_antineoplastic> "Gemcitabine" .
<Carboplatin_and_Gemcitabine/Erlotinib> <Has_antineoplastic> "Erlotinib" .
<Carboplatin_and_Gemcitabine/Erlotinib> <Has_antineoplastic> "Carboplatin" .
<Infectrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<ATG_(Horse),_Cyclosporine,_G-CSF> <Has_modality> "Immunosuppressive_therapy" .
<ATG_(Horse),_Cyclosporine,_G-CSF> <Has_modality> "Growth_factor_therapy" .
<Lederfolin> <Brand_name_of> "Folinic_acid" .
<IL-2_monotherapy> <Has_accepted_use> "Melanoma" .
<Cyclosporine,_Methotrexate,_ATG> <Has_context> "Prophylaxis" .
<CEOP> <Mapped_from> "CEOP" .
<R-CODOX-M/R-IVAC> <Has_antineoplastic> "Vincristine" .
<R-CODOX-M/R-IVAC> <Has_antineoplastic> "Rituximab" .
<R-CODOX-M/R-IVAC> <Has_antineoplastic> "Methotrexate" .
<R-CODOX-M/R-IVAC> <Has_antineoplastic> "Ifosfamide" .
<R-CODOX-M/R-IVAC> <Has_antineoplastic> "Etoposide" .
<R-CODOX-M/R-IVAC> <Has_antineoplastic> "Doxorubicin" .
<R-CODOX-M/R-IVAC> <Has_antineoplastic> "Cytarabine" .
<R-CODOX-M/R-IVAC> <Has_antineoplastic> "Cyclophosphamide" .
<Ziv-aflibercept> <Is_a> "VEGFR_inhibitor" .
<Ziv-aflibercept> <Is_a> "Soluble_decoy_receptor" .
<L-glutamine> <May_have_route> "Oral" .
<IRIS_and_Bevacizumab> <Maps_to> "IRIS_and_Bevacizumab" .
<Lenalidomide> <Has_brand_name> "Revlimid" .
<Lenalidomide> <Has_brand_name> "MyeloSar" .
<Lenalidomide> <Has_brand_name> "Lenzest" .
<Lenalidomide> <Has_brand_name> "Lenome" .
<Lenalidomide> <Has_brand_name> "Lenmid" .
<Lenalidomide> <Has_brand_name> "Lenangio" .
<Lenalidomide> <Has_brand_name> "Lenalid" .
<Lenalidomide> <Has_brand_name> "Kabillon" .
<Vinblastine_monotherapy> <Has_modality> "Chemotherapy" .
<MRD> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<TLI_and_ATG> <Has_context> "All_lines_of_therapy" .
<Trastuzumab_and_hyaluronidase> <Has_brand_name> "Herceptin_Hylecta" .
<Paclitaxel_and_Ramucirumab> <Maps_to> "Paclitaxel_and_Ramucirumab" .
<Olaparib_monotherapy> <Is_current_in> "Prostate_cancer" .
<Olaparib_monotherapy> <Is_current_in> "Pancreatic_cancer" .
<Olaparib_monotherapy> <Is_current_in> "Ovarian_cancer" .
<Olaparib_monotherapy> <Is_current_in> "Breast_cancer" .
<CEV_and_RT> <Is_a> "Anthracycline-containing_regimen" .
<Benralizumab_monotherapy> <Has_modality> "Chemotherapy" .
<Bortezomib> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Bortezomib> <Is_a> "Proteasome_inhibitor" .
<Bortezomib> <Is_a> "PMDA_approved_drug" .
<Bortezomib> <Is_a> "Light-chain_(AL)_amyloidosis_medication" .
<Bortezomib> <Is_a> "Irritant" .
<Bortezomib> <Is_a> "FDA_approved_drug" .
<Dasatinib_monotherapy> <Has_antineoplastic> "Dasatinib" .
<TACE> <Has_accepted_use> "Uveal_melanoma" .
<TACE> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Cyclophosphamide_and_G-CSF> <Maps_to> "Cyclophosphamide_and_G-CSF" .
<Platistin> <Brand_name_of> "Cisplatin" .
<FNC> <Mapped_from> "FNC" .
<Pemetrexed> <Is_a> "Neutral" .
<Pemetrexed> <Is_a> "Antimetabolite" .
<Pemetrexed> <Is_a> "Antifolate" .
<Bufadexon> <Brand_name_of> "Dexamethasone" .
<Sunitinib_monotherapy> <Maps_to> "Sunitinib_monotherapy" .
<Argatroban_monotherapy> <Has_modality> "Anticoagulation" .
<Finasteride> <Has_accepted_use> "Prostate_cancer" .
<Avelumab_monotherapy> <Has_antineoplastic> "Avelumab" .
<Fivoflu> <Brand_name_of> "Fluorouracil" .
<Olaparib> <May_have_route> "Oral" .
<ACVBP-R> <Mapped_from> "ACVBP-R" .
<Ribociclib_and_Tamoxifen> <Is_a> "Antiestrogen-containing_regimen" .
<Dabigatran_monotherapy> <Mapped_from> "Dabigatran_monotherapy" .
<C-VAMP> <Has_accepted_use> "Multiple_myeloma" .
<FOLFOXIRI_and_Panitumumab> <Has_context> "Non-curative_first-line_therapy" .
<VAD_and_Cyclosporine> <Has_modality> "Chemotherapy" .
<Divifolin> <Brand_name_of> "Folinic_acid" .
<Rubilem> <Brand_name_of> "Daunorubicin" .
<Pazopanib_monotherapy> <Has_accepted_use> "Thyroid_cancer" .
<Pazopanib_monotherapy> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Pazopanib_monotherapy> <Has_accepted_use> "Renal_cell_carcinoma" .
<Pazopanib_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Pazopanib_monotherapy> <Has_accepted_use> "Gastrointestinal_stromal_tumor" .
<All_lines_of_therapy> <Mapped_from> "All_lines_of_therapy" .
<Ribociclib_and_Tamoxifen> <Has_modality> "Hormonotherapy" .
<Ribociclib_and_Tamoxifen> <Has_modality> "Chemotherapy" .
<Phthoruracil> <Brand_name_of> "Fluorouracil" .
<Histrelin_monotherapy> <Maps_to> "Histrelin_monotherapy" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "Tamibarotene_monotherapy" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "Observation" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "Mercaptopurine_and_Methotrexate" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "Idarubicin,_then_Mitoxantrone,_then_Idarubicin" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "Daunorubicin_monotherapy" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "Cytarabine_and_Idarubicin" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "Cytarabine_and_Daunorubicin" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "Busulfan_and_Melphalan,_then_auto_HSCT" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "Arsenic_trioxide,_then_ATRA_and_Daunorubicin" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "Arsenic_trioxide,_ATRA,_Idarubicin" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "Arsenic_trioxide_monotherapy" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "Arsenic_trioxide_and_Idarubicin" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "Arsenic_trioxide_and_ATRA" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "ATRA,_Mercaptopurine,_Methotrexate" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "ATRA,_Cytarabine,_Idarubicin" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "ATRA,_Cytarabine,_Daunorubicin" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "ATRA_monotherapy" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "ATRA_and_Idarubicin" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "ATRA_and_Daunorubicin" .
<Acute_promyelocytic_leukemia> <Current_treated_by> "ADE_and_ATRA" .
<ICE> <Has_antineoplastic> "Mesna" .
<ICE> <Has_antineoplastic> "Ifosfamide" .
<ICE> <Has_antineoplastic> "Etoposide" .
<ICE> <Has_antineoplastic> "Carboplatin" .
<Ledertrexato> <Brand_name_of> "Methotrexate" .
<Goserelin_and_RT> <Has_accepted_use> "Prostate_cancer" .
<Erlotinib_and_Gemcitabine> <Has_context> "Non-curative_first-line_therapy" .
<Erlotinib_and_Gemcitabine> <Has_context> "Induction_therapy" .
<RD> <Mapped_from> "RD" .
<Abemaciclib_and_Anastrozole> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Abemaciclib_and_Anastrozole> <Has_accepted_use> "Breast_cancer" .
<Zyloric> <Brand_name_of> "Allopurinol" .
<Bicalutamide_monotherapy> <Maps_to> "Bicalutamide_monotherapy" .
<Pomalidomide_and_Prednisone> <Has_context> "Non-curative_second-line_maintenance_therapy" .
<Pomalidomide_and_Prednisone> <Has_context> "All_lines_of_therapy" .
<OXAFAFU> <Has_antineoplastic> "Oxaliplatin" .
<OXAFAFU> <Has_antineoplastic> "Folinic_acid" .
<OXAFAFU> <Has_antineoplastic> "Fluorouracil" .
<Apixaban> <Supportive_med_of> "Apixaban_monotherapy" .
<Enasidenib> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Apatinib_monotherapy> <Maps_to> "Apatinib_monotherapy" .
<Zoledronic_acid> <May_have_route> "Intravenous" .
<CFP_and_Oophorectomy> <Has_accepted_use> "Breast_cancer" .
<Abiplatin> <Brand_name_of> "Cisplatin" .
<OFAR> <Has_accepted_use> "Transformed_lymphoma" .
<OFAR> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Trametinib> <Has_brand_name> "Mekinist" .
<Jusprin> <Brand_name_of> "Aspirin" .
<Avapritinib_monotherapy> <Is_current_in> "Gastrointestinal_stromal_tumor" .
<Lepirudin_monotherapy> <Maps_to> "Lepirudin_monotherapy" .
<Hyper-CVAD> <Has_context> "Non-curative_therapy" .
<KPD> <Has_supportive_med> "Low_molecular_weight_heparins" .
<KPD> <Has_supportive_med> "Aspirin" .
<KPD> <Has_supportive_med> "Antivirals" .
<Betrixaban_monotherapy> <Has_modality> "Anticoagulation" .
<Anastrozole_and_Palbociclib> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Anastrozole_and_Palbociclib> <Has_accepted_use> "Breast_cancer" .
<Dacomitinib> <Has_brand_name> "Vizimpro" .
<POEMS_syndrome> <Current_treated_by> "Rd" .
<Amsacrine> <May_have_route> "Intravenous" .
<TAC_(Taxotere)> <Mapped_from> "TAC_(Taxotere)" .
<Oxaliplatin_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Cytarabine,_Daunorubicin,_Vincristine> <Is_historical_in> "Acute_myeloid_leukemia" .
<Estram> <Brand_name_of> "Estramustine" .
<Cangrelor> <Has_brand_name> "Kengreal" .
<Carboplatin,_Fluorouracil,_Cetuximab,_RT> <Has_modality> "Radiotherapy" .
<Carboplatin,_Fluorouracil,_Cetuximab,_RT> <Has_modality> "Chemotherapy" .
<Belotecan> <Antineoplastic_of> "Belotecan_and_Cisplatin" .
<IDH-mutated_Acute_myeloid_leukemia> <Is_a> "Acute_myeloid_leukemia" .
<MPT> <Has_context> "Non-curative_first-line_therapy" .
<Empliciti> <Brand_name_of> "Elotuzumab" .
<Cotrixyl-L> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Temsirolimus_monotherapy> <Has_antineoplastic> "Temsirolimus" .
<Goserelin_and_Tamoxifen> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Goserelin_and_Tamoxifen> <Has_accepted_use> "Breast_cancer" .
<Durvalumab_monotherapy> <Maps_to> "Durvalumab_monotherapy" .
<Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA> <Is_current_in> "Acute_promyelocytic_leukemia" .
<Carboplatin_and_Pemetrexed> <Has_modality> "Chemotherapy" .
<FOLFIRI_and_Ziv-aflibercept> <Has_context> "Non-curative_second-line_therapy" .
<Dactinomycin_monotherapy> <Maps_to> "Dactinomycin_monotherapy" .
<Tazemetostat> <Has_FDA_indication> "Epithelioid_sarcoma" .
<Carfilzomib_and_Panobinostat> <Mapped_from> "Carfilzomib_and_Panobinostat" .
<Bicalutamide_monotherapy> <Has_context> "Non-curative_therapy" .
<Bicalutamide_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Gemcitabine_and_Rituximab> <Has_accepted_use> "Hodgkin_lymphoma" .
<Gemcitabine_and_Rituximab> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<ACH> <Has_modality> "Chemotherapy" .
<FP/Capecitabine_and_RT> <Mapped_from> "FP/Capecitabine_and_RT" .
<Hyper-CVAD> <Maps_to> "Hyper-CVAD" .
<Dexona> <Brand_name_of> "Dexamethasone" .
<IT_Cytarabine_and_WBRT> <Has_modality> "Radiotherapy" .
<IT_Cytarabine_and_WBRT> <Has_modality> "Chemotherapy" .
<Thrombotic_disorder> <Subsumes> "Venous_thromboembolism" .
<Thrombotic_disorder> <Subsumes> "Thrombotic_thrombocytopenic_purpura" .
<Thrombotic_disorder> <Subsumes> "Inherited_thrombophilia" .
<Thrombotic_disorder> <Subsumes> "Heparin-induced_thrombocytopenia" .
<Thrombotic_disorder> <Subsumes> "Antiphospholipid_antibody_syndrome" .
<Gemcitabine_and_Vinorelbine> <Mapped_from> "Gemcitabine_and_Vinorelbine" .
<Hyper-CVAD_and_Dasatinib> <Has_context> "Induction_therapy" .
<R-Hyper-CVAD/R-MA> <Is_a> "Rituximab-containing_regimen" .
<R-Hyper-CVAD/R-MA> <Is_a> "Anthracycline-containing_regimen" .
<COX-2_inhibitor> <Subsumes> "Indomethacin" .
<BeEAM> <Has_modality> "Chemotherapy" .
<Xermelo> <Brand_name_of> "Telotristat" .
<Vepesid> <Brand_name_of> "Etoposide" .
<Novid> <Brand_name_of> "Aspirin" .
<Epratuzumab> <Is_a> "Investigational_drug" .
<Epratuzumab> <Is_a> "Immunotherapeutic" .
<Epratuzumab> <Is_a> "Antibody_medication" .
<Epratuzumab> <Is_a> "Anti-CD22_antibody" .
<Famotidine> <Is_a> "H2-receptor_antagonist" .
<TCHP_(Taxotere)> <Has_antineoplastic> "Trastuzumab" .
<TCHP_(Taxotere)> <Has_antineoplastic> "Pertuzumab" .
<TCHP_(Taxotere)> <Has_antineoplastic> "Docetaxel" .
<TCHP_(Taxotere)> <Has_antineoplastic> "Carboplatin" .
<Irinotecan_and_S-1> <Is_a> "Irinotecan-containing_regimen" .
<MF> <Has_accepted_use> "Breast_cancer" .
<International_ALL_Trial> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Brilinta> <Brand_name_of> "Ticagrelor" .
<Axitinib_and_Avelumab> <Has_modality> "Immunotherapy" .
<Axitinib_and_Avelumab> <Has_modality> "Chemotherapy" .
<Hodgkin_lymphoma> <Accepted_use_of> "eBEACOPP_(Prednisolone)" .
<Hodgkin_lymphoma> <Accepted_use_of> "eBEACOPP" .
<Hodgkin_lymphoma> <Accepted_use_of> "Vorinostat" .
<Hodgkin_lymphoma> <Accepted_use_of> "Vinorelbine_monotherapy" .
<Hodgkin_lymphoma> <Accepted_use_of> "Vinorelbine" .
<Hodgkin_lymphoma> <Accepted_use_of> "Vincristine" .
<Hodgkin_lymphoma> <Accepted_use_of> "Vinblastine_monotherapy" .
<Hodgkin_lymphoma> <Accepted_use_of> "Vinblastine" .
<Hodgkin_lymphoma> <Accepted_use_of> "VEPEMB" .
<Hodgkin_lymphoma> <Accepted_use_of> "VEBEP" .
<Hodgkin_lymphoma> <Accepted_use_of> "VAMP_(Methotrexate)" .
<Hodgkin_lymphoma> <Accepted_use_of> "Stanford_V" .
<Hodgkin_lymphoma> <Accepted_use_of> "Sirolimus_and_Vorinostat" .
<Hodgkin_lymphoma> <Accepted_use_of> "Sirolimus" .
<Hodgkin_lymphoma> <Accepted_use_of> "SCAB" .
<Hodgkin_lymphoma> <Accepted_use_of> "Rituximab-pvvr" .
<Hodgkin_lymphoma> <Accepted_use_of> "Rituximab-abbs" .
<Hodgkin_lymphoma> <Accepted_use_of> "Rituximab_monotherapy" .
<Hodgkin_lymphoma> <Accepted_use_of> "Rituximab" .
<Hodgkin_lymphoma> <Accepted_use_of> "Radiation_therapy" .
<Hodgkin_lymphoma> <Accepted_use_of> "RABVD" .
<Hodgkin_lymphoma> <Accepted_use_of> "Procarbazine" .
<Hodgkin_lymphoma> <Accepted_use_of> "Prednisone" .
<Hodgkin_lymphoma> <Accepted_use_of> "Prednisolone" .
<Hodgkin_lymphoma> <Accepted_use_of> "Placebo" .
<Hodgkin_lymphoma> <Accepted_use_of> "Pembrolizumab_monotherapy" .
<Hodgkin_lymphoma> <Accepted_use_of> "Pembrolizumab" .
<Hodgkin_lymphoma> <Accepted_use_of> "Pegylated_liposomal_doxorubicin" .
<Hodgkin_lymphoma> <Accepted_use_of> "Panobinostat_monotherapy" .
<Hodgkin_lymphoma> <Accepted_use_of> "Panobinostat" .
<Hodgkin_lymphoma> <Accepted_use_of> "PVAG" .
<Hodgkin_lymphoma> <Accepted_use_of> "Ofatumumab" .
<Hodgkin_lymphoma> <Accepted_use_of> "Observation" .
<Hodgkin_lymphoma> <Accepted_use_of> "OPPA" .
<Hodgkin_lymphoma> <Accepted_use_of> "OEPA" .
<Hodgkin_lymphoma> <Accepted_use_of> "O-ESHAP" .
<Hodgkin_lymphoma> <Accepted_use_of> "Nivolumab_monotherapy" .
<Hodgkin_lymphoma> <Accepted_use_of> "Nivolumab" .
<Hodgkin_lymphoma> <Accepted_use_of> "NOVP" .
<Hodgkin_lymphoma> <Accepted_use_of> "Mocetinostat" .
<Hodgkin_lymphoma> <Accepted_use_of> "Mitoxantrone" .
<Hodgkin_lymphoma> <Accepted_use_of> "Mini-BEAM" .
<Hodgkin_lymphoma> <Accepted_use_of> "Methylprednisolone" .
<Hodgkin_lymphoma> <Accepted_use_of> "Melphalan" .
<Hodgkin_lymphoma> <Accepted_use_of> "Mechlorethamine_monotherapy" .
<Hodgkin_lymphoma> <Accepted_use_of> "Mechlorethamine" .
<Hodgkin_lymphoma> <Accepted_use_of> "MVPP" .
<Hodgkin_lymphoma> <Accepted_use_of> "MOPP/ABVD" .
<Hodgkin_lymphoma> <Accepted_use_of> "MOPP-ABV" .
<Hodgkin_lymphoma> <Accepted_use_of> "MOPP" .
<Hodgkin_lymphoma> <Accepted_use_of> "MINE" .
<Hodgkin_lymphoma> <Accepted_use_of> "Lenalidomide_monotherapy" .
<Hodgkin_lymphoma> <Accepted_use_of> "Lenalidomide" .
<Hodgkin_lymphoma> <Accepted_use_of> "LOPP/EVAP" .
<Hodgkin_lymphoma> <Accepted_use_of> "LOPP" .
<Hodgkin_lymphoma> <Accepted_use_of> "Ifosfamide_and_Vinorelbine" .
<Hodgkin_lymphoma> <Accepted_use_of> "Ifosfamide" .
<Hodgkin_lymphoma> <Accepted_use_of> "IGEV" .
<Hodgkin_lymphoma> <Accepted_use_of> "ICE" .
<Hodgkin_lymphoma> <Accepted_use_of> "Gemcitabine_monotherapy" .
<Hodgkin_lymphoma> <Accepted_use_of> "Gemcitabine_and_Rituximab" .
<Hodgkin_lymphoma> <Accepted_use_of> "Gemcitabine" .
<Hodgkin_lymphoma> <Accepted_use_of> "GVP" .
<Hodgkin_lymphoma> <Accepted_use_of> "GVD" .
<Hodgkin_lymphoma> <Accepted_use_of> "GCD-R" .
<Hodgkin_lymphoma> <Accepted_use_of> "GCD" .
<Hodgkin_lymphoma> <Accepted_use_of> "Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT" .
<Hodgkin_lymphoma> <Accepted_use_of> "Fludarabine" .
<Hodgkin_lymphoma> <Accepted_use_of> "Flu-Mel,_then_allo_HSCT" .
<Hodgkin_lymphoma> <Accepted_use_of> "FEAM,_then_auto_HSCT" .
<Hodgkin_lymphoma> <Accepted_use_of> "Everolimus_monotherapy" .
<Hodgkin_lymphoma> <Accepted_use_of> "Everolimus" .
<Hodgkin_lymphoma> <Accepted_use_of> "Etoposide" .
<Hodgkin_lymphoma> <Accepted_use_of> "Epirubicin" .
<Hodgkin_lymphoma> <Accepted_use_of> "ESHAP" .
<Hodgkin_lymphoma> <Accepted_use_of> "EBVP" .
<Hodgkin_lymphoma> <Accepted_use_of> "Doxorubicin_and_Vinblastine" .
<Hodgkin_lymphoma> <Accepted_use_of> "Doxorubicin_and_Lomustine" .
<Hodgkin_lymphoma> <Accepted_use_of> "Doxorubicin" .
<Hodgkin_lymphoma> <Accepted_use_of> "Dexamethasone" .
<Hodgkin_lymphoma> <Accepted_use_of> "DexaBEAM" .
<Hodgkin_lymphoma> <Accepted_use_of> "Dacarbazine" .
<Hodgkin_lymphoma> <Accepted_use_of> "DHAP_-_time_intensified" .
<Hodgkin_lymphoma> <Accepted_use_of> "DHAP" .
<Hodgkin_lymphoma> <Accepted_use_of> "Cytarabine" .
<Hodgkin_lymphoma> <Accepted_use_of> "Cyclophosphamide" .
<Hodgkin_lymphoma> <Accepted_use_of> "Cisplatin" .
<Hodgkin_lymphoma> <Accepted_use_of> "Chlorambucil" .
<Hodgkin_lymphoma> <Accepted_use_of> "ChlVPP/PABIOE" .
<Hodgkin_lymphoma> <Accepted_use_of> "ChlVPP/EVA" .
<Hodgkin_lymphoma> <Accepted_use_of> "ChlVPP" .
<Hodgkin_lymphoma> <Accepted_use_of> "Carmustine_monotherapy" .
<Hodgkin_lymphoma> <Accepted_use_of> "Carmustine" .
<Hodgkin_lymphoma> <Accepted_use_of> "Carboplatin" .
<Hodgkin_lymphoma> <Accepted_use_of> "CVPP" .
<Hodgkin_lymphoma> <Accepted_use_of> "CVB" .
<Hodgkin_lymphoma> <Accepted_use_of> "COPP/ABVD" .
<Hodgkin_lymphoma> <Accepted_use_of> "COPP_(CCNU)" .
<Hodgkin_lymphoma> <Accepted_use_of> "COPDAC" .
<Hodgkin_lymphoma> <Accepted_use_of> "COMP" .
<Hodgkin_lymphoma> <Accepted_use_of> "CEP" .
<Hodgkin_lymphoma> <Accepted_use_of> "CBV-Mx,_then_auto_HSCT" .
<Hodgkin_lymphoma> <Accepted_use_of> "CBV,_then_auto_HSCT" .
<Hodgkin_lymphoma> <Accepted_use_of> "C-MOPP/ABV" .
<Hodgkin_lymphoma> <Accepted_use_of> "C-MOPP" .
<Hodgkin_lymphoma> <Accepted_use_of> "Brentuximab_vedotin_monotherapy" .
<Hodgkin_lymphoma> <Accepted_use_of> "Brentuximab_vedotin_and_Nivolumab" .
<Hodgkin_lymphoma> <Accepted_use_of> "Brentuximab_vedotin_and_Dacarbazine" .
<Hodgkin_lymphoma> <Accepted_use_of> "Brentuximab_vedotin" .
<Hodgkin_lymphoma> <Accepted_use_of> "Bleomycin" .
<Hodgkin_lymphoma> <Accepted_use_of> "Bendamustine_monotherapy" .
<Hodgkin_lymphoma> <Accepted_use_of> "Bendamustine_and_Brentuximab_vedotin" .
<Hodgkin_lymphoma> <Accepted_use_of> "Bendamustine" .
<Hodgkin_lymphoma> <Accepted_use_of> "BeGEV" .
<Hodgkin_lymphoma> <Accepted_use_of> "BeEAM,_then_auto_HSCT" .
<Hodgkin_lymphoma> <Accepted_use_of> "Bacillus_Calmette-Guerin_(BCG)_monotherapy" .
<Hodgkin_lymphoma> <Accepted_use_of> "BVDS" .
<Hodgkin_lymphoma> <Accepted_use_of> "BVCPP" .
<Hodgkin_lymphoma> <Accepted_use_of> "BVB" .
<Hodgkin_lymphoma> <Accepted_use_of> "BEAM,_then_auto_HSCT" .
<Hodgkin_lymphoma> <Accepted_use_of> "BEAM,_then_allo_HSCT" .
<Hodgkin_lymphoma> <Accepted_use_of> "BEACOPP-14_(Prednisolone)" .
<Hodgkin_lymphoma> <Accepted_use_of> "BEACOPP-14" .
<Hodgkin_lymphoma> <Accepted_use_of> "BEACOPP" .
<Hodgkin_lymphoma> <Accepted_use_of> "BCVPP" .
<Hodgkin_lymphoma> <Accepted_use_of> "B-CAVe" .
<Hodgkin_lymphoma> <Accepted_use_of> "AVD" .
<Hodgkin_lymphoma> <Accepted_use_of> "ABVE-PC" .
<Hodgkin_lymphoma> <Accepted_use_of> "ABVDm" .
<Hodgkin_lymphoma> <Accepted_use_of> "ABVD,_DD-DI" .
<Hodgkin_lymphoma> <Accepted_use_of> "ABVD" .
<Hodgkin_lymphoma> <Accepted_use_of> "ABDIC" .
<Hodgkin_lymphoma> <Accepted_use_of> "A-AVD" .
<Arsenic_trioxide,_then_ATRA_and_Daunorubicin> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Docetaxel_and_Estramustine> <Is_current_in> "Prostate_cancer" .
<Octaplex> <Brand_name_of> "Prothrombin_Complex_Concentrate_human" .
<Hyper-CVAD_and_Ponatinib> <Maps_to> "Hyper-CVAD_and_Ponatinib" .
<Carboplatin,_Gemcitabine,_Bevacizumab> <Has_context> "Non-curative_second-line_therapy" .
<Atezolizumab_monotherapy> <Has_antineoplastic> "Atezolizumab" .
<CHOP-BCG> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Cyclophosphamide,_Dacarbazine,_Vincristine> <Has_accepted_use> "Pheochromocytoma" .
<Radioiodine_ablation> <Has_modality> "Radiotherapy" .
<Barasertib> <Has_accepted_use> "Acute_myeloid_leukemia" .
<FOLFIRI_and_Panitumumab> <Mapped_from> "FOLFIRI_and_Panitumumab" .
<Warfarin> <Has_accepted_use> "Venous_thromboembolism" .
<Warfarin> <Has_accepted_use> "Antiphospholipid_antibody_syndrome" .
<Apalutamide> <Has_brand_name> "Erleada" .
<G-FC> <Has_antineoplastic> "Obinutuzumab" .
<G-FC> <Has_antineoplastic> "Fludarabine" .
<G-FC> <Has_antineoplastic> "Cyclophosphamide" .
<TL_(Taxol)> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<TL_(Taxol)> <Has_accepted_use> "Breast_cancer" .
<FOLFOX2> <Has_modality> "Chemotherapy" .
<EDAP> <Maps_to> "EDAP" .
<Cisplatin_and_Ifosfamide> <Has_modality> "Chemotherapy" .
<DCF> <Has_antineoplastic> "Fluorouracil" .
<DCF> <Has_antineoplastic> "Docetaxel" .
<DCF> <Has_antineoplastic> "Cisplatin" .
<R-CHOP_(Prednisolone)> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<R-CHOP_(Prednisolone)> <Has_supportive_med> "Lenograstim" .
<R-CHOP_(Prednisolone)> <Has_supportive_med> "Allopurinol" .
<Advantan> <Brand_name_of> "Methylprednisolone" .
<Obinutuzumab> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Obinutuzumab> <Has_accepted_use> "Follicular_lymphoma" .
<Obinutuzumab> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Obinutuzumab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<FLEC> <Mapped_from> "FLEC" .
<Venetoclax> <Has_FDA_indication> "Chronic_lymphocytic_leukemia" .
<Venetoclax> <Has_FDA_indication> "Acute_myeloid_leukemia" .
<VMPT> <Has_context> "Non-curative_therapy" .
<VMPT> <Has_context> "Non-curative_first-line_therapy" .
<MC> <Maps_to> "MC" .
<Vemurafenib_monotherapy> <Has_accepted_use> "Thyroid_cancer" .
<Vemurafenib_monotherapy> <Has_accepted_use> "Multiple_myeloma" .
<Vemurafenib_monotherapy> <Has_accepted_use> "Melanoma" .
<Vemurafenib_monotherapy> <Has_accepted_use> "Langerhans_cell_histiocytosis" .
<Vemurafenib_monotherapy> <Has_accepted_use> "Hairy_cell_leukemia" .
<Vemurafenib_monotherapy> <Has_accepted_use> "Erdheim-Chester_disease" .
<Vemurafenib_monotherapy> <Has_accepted_use> "CNS_melanoma" .
<Vemurafenib_monotherapy> <Has_accepted_use> "BRAF-mutated_malignancy" .
<Vemurafenib_monotherapy> <Has_accepted_use> "BRAF-mutated_Thyroid_cancer" .
<Vemurafenib_monotherapy> <Has_accepted_use> "BRAF-mutated_Melanoma" .
<Circuvit> <Brand_name_of> "Warfarin" .
<Samarium-153> <May_have_route> "Intravenous" .
<Ziv-aflibercept> <Has_brand_name> "Zaltrap" .
<Ziv-aflibercept> <Has_brand_name> "Eylea" .
<Perdiem> <Brand_name_of> "Sennosides" .
<Penile_cancer> <Current_treated_by> "VBM" .
<Penile_cancer> <Current_treated_by> "TIP" .
<Penile_cancer> <Current_treated_by> "Panitumumab_monotherapy" .
<Penile_cancer> <Current_treated_by> "Paclitaxel_monotherapy" .
<Penile_cancer> <Current_treated_by> "PCF" .
<Penile_cancer> <Current_treated_by> "DCF" .
<Penile_cancer> <Current_treated_by> "Cisplatin_and_Irinotecan" .
<Penile_cancer> <Current_treated_by> "Cisplatin_and_Fluorouracil" .
<Penile_cancer> <Current_treated_by> "BMP" .
<Alectinib_monotherapy> <Mapped_from> "Alectinib_monotherapy" .
<Pegfilgrastim-jmdb> <May_have_route> "Subcutaneous" .
<R-VAD_plus_C> <Is_a> "Rituximab-containing_regimen" .
<R-VAD_plus_C> <Is_a> "Anthracycline-containing_regimen" .
<Docetaxel,_Gemcitabine,_RT> <Is_current_in> "Pancreatic_cancer" .
<Torisel> <Brand_name_of> "Temsirolimus" .
<Docetaxel_and_Vinorelbine> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Interferon_alfa-2b_and_Thalidomide> <Is_historical_in> "Multiple_myeloma" .
<Etoposide,_Vinblastine,_Prednisone> <Mapped_from> "Etoposide,_Vinblastine,_Prednisone" .
<AT_(Taxol)> <Has_context> "Non-curative_first-line_therapy" .
<AT_(Taxol)> <Has_context> "Adjuvant_therapy" .
<Everolimus_and_Rituximab> <Has_modality> "Chemotherapy" .
<Coumadin> <Brand_name_of> "Warfarin" .
<CTCb,_then_auto_HSCT> <Has_antineoplastic> "Thiotepa" .
<CTCb,_then_auto_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<CTCb,_then_auto_HSCT> <Has_antineoplastic> "Carboplatin" .
<Doxorubicin_and_Olaratumab> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Carmustine_and_RT> <Has_context> "Adjuvant_therapy" .
<Fauldcispla> <Brand_name_of> "Cisplatin" .
<Genalen> <Brand_name_of> "Alendronate" .
<Marinol> <Brand_name_of> "Dronabinol" .
<HAM> <Mapped_from> "HAM" .
<Azacitidine_and_Venetoclax> <Mapped_from> "Azacitidine_and_Venetoclax" .
<Consolidation_after_salvage_therapy> <Mapped_from> "Consolidation_after_salvage_therapy" .
<Cytarabine_and_Idarubicin> <Mapped_from> "Cytarabine_and_Idarubicin" .
<Cladribine_monotherapy> <Has_modality> "Chemotherapy" .
<Docetaxel,_Fluorouracil,_RT> <Has_modality> "Radiotherapy" .
<Docetaxel,_Fluorouracil,_RT> <Has_modality> "Chemotherapy" .
<Fedratinib_monotherapy> <Maps_to> "Fedratinib_monotherapy" .
<Capecitabine_monotherapy> <Is_current_in> "Rectal_cancer" .
<Capecitabine_monotherapy> <Is_current_in> "Pancreatic_cancer" .
<Capecitabine_monotherapy> <Is_current_in> "Hepatocellular_carcinoma" .
<Capecitabine_monotherapy> <Is_current_in> "Gastric_cancer" .
<Capecitabine_monotherapy> <Is_current_in> "Gallbladder_cancer" .
<Capecitabine_monotherapy> <Is_current_in> "Colon_cancer" .
<Capecitabine_monotherapy> <Is_current_in> "Cholangiocarcinoma" .
<Capecitabine_monotherapy> <Is_current_in> "Breast_cancer" .
<Scopolamine> <Has_brand_name> "Transderm_Scop" .
<Scopolamine> <Has_brand_name> "Scopoderm" .
<Bamyl> <Brand_name_of> "Aspirin" .
<M-TIP> <Is_current_in> "Testicular_cancer" .
<Vorzu> <Brand_name_of> "Voriconazole" .
<Platikem> <Brand_name_of> "Cisplatin" .
<5_plus_3i> <Has_accepted_use> "Acute_myeloid_leukemia" .
<VAMP> <Has_modality> "Chemotherapy" .
<LD-ACOP-B> <Is_a> "Anthracycline-containing_regimen" .
<Lapuleucel-T> <May_have_route> "Intravenous" .
<Nilotinib-based_consolidation> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<ROS1-positive_Non-small_cell_lung_cancer> <Is_a> "Non-small_cell_lung_cancer" .
<MF> <Has_antineoplastic> "Methotrexate" .
<MF> <Has_antineoplastic> "Fluorouracil" .
<Amifostine> <Has_brand_name> "Ethyol" .
<Amifostine> <Has_brand_name> "Cytofos" .
<Necorzole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Lenograstim> <May_have_route> "Subcutaneous" .
<Dexalocal> <Brand_name_of> "Dexamethasone" .
<Drossul> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Deltasolone> <Brand_name_of> "Prednisolone" .
<CHUT> <Has_context> "All_lines_of_therapy" .
<Nilutamide> <May_have_route> "Oral" .
<TC,_then_IE,_VDoxoC,_VEC> <Has_accepted_use> "Ewing_sarcoma" .
<Ondatie> <Brand_name_of> "Ondansetron" .
<Methotrexate_and_Thiotepa> <Mapped_from> "Methotrexate_and_Thiotepa" .
<Irinotecan_and_Mitomycin> <Has_context> "Non-curative_subsequent-line_therapy" .
<Irinotecan_and_Mitomycin> <Has_context> "Non-curative_first-line_therapy" .
<Deferasirox> <Is_a> "Hematology_medication" .
<Deferasirox> <Is_a> "Chelator" .
<Laxative> <Is_a> "Bowel_management" .
<Carboplatin,_Etoposide,_Bevacizumab> <Mapped_from> "Carboplatin,_Etoposide,_Bevacizumab" .
<Dacarbazine_and_Gemcitabine> <Has_modality> "Chemotherapy" .
<Carboplatin,_nab-Paclitaxel,_Pembrolizumab> <Has_context> "Non-curative_first-line_therapy" .
<Sulphax> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Carboplatin_and_Fluorouracil> <Maps_to> "Carboplatin_and_Fluorouracil" .
<Sulfaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Anagrelide_monotherapy> <Has_supportive_med> "Clopidogrel" .
<Anagrelide_monotherapy> <Has_supportive_med> "Aspirin" .
<Anagrelide_monotherapy> <Has_supportive_med> "Anagrelide" .
<Isotretinoin> <Has_accepted_use> "Neuroblastoma" .
<Isotretinoin> <Has_accepted_use> "Cutaneous_squamous_cell_carcinoma" .
<Cyclophosphamide_and_Prednisone> <Has_local_therapy> "Methotrexate" .
<Cyclophosphamide_and_Prednisone> <Has_local_therapy> "Dexamethasone" .
<Cyclophosphamide_and_Prednisone> <Has_local_therapy> "Cytarabine" .
<Cisplatin,_Fluorouracil,_Pembrolizumab> <Has_accepted_use> "Gastric_cancer" .
<Neratinib> <May_have_route> "Oral" .
<Enzyme> <Subsumes> "Rasburicase" .
<Enzyme> <Subsumes> "Pegaspargase" .
<Enzyme> <Subsumes> "Glucarpidase" .
<Enzyme> <Subsumes> "Calaspargase" .
<Enzyme> <Subsumes> "Asparaginase_Erwinia_chrysanthemi" .
<Enzyme> <Subsumes> "Asparaginase" .
<Paclitaxel_and_Ramucirumab> <Has_modality> "Chemotherapy" .
<Apixaban> <Is_a> "Factor_Xa_inhibitor" .
<Apixaban> <Is_a> "Direct_oral_anticoagulant" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab> <Is_a> "Rituximab-containing_regimen" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab> <Is_a> "Anthracycline-containing_regimen" .
<Temsirolimus_monotherapy> <Has_context> "Non-curative_therapy" .
<Temsirolimus_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Temsirolimus_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Sistrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cresp> <Brand_name_of> "Darbepoetin_alfa" .
<Cladribine> <Is_a> "Purine_analogue" .
<Cladribine> <Is_a> "Neutral" .
<Cladribine> <Is_a> "Irritant" .
<Cladribine> <Is_a> "Antimetabolite" .
<Cisplatin_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Cisplatin_and_RT> <Has_antineoplastic> "Cisplatin" .
<Cisplatin_and_RT> <Has_antineoplastic> "Brachytherapy" .
<Fam-trastuzumab_deruxtecan> <Has_brand_name> "Enhertu" .
<Cyclophar> <Brand_name_of> "Cyclophosphamide" .
<Neratinib> <Has_accepted_use> "ERBB3-mutated_malignancy" .
<Neratinib> <Has_accepted_use> "ERBB2-mutated_malignancy" .
<Neratinib> <Has_accepted_use> "Breast_cancer" .
<BR_and_Ibrutinib> <Has_context> "Non-curative_therapy" .
<CBV-Mx,_then_auto_HSCT> <Is_current_in> "Hodgkin_lymphoma" .
<Ramucirumab> <Has_brand_name> "Cyramza" .
<Fabubac> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Hjertealbyl> <Brand_name_of> "Aspirin" .
<COPA> <Has_accepted_use> "Follicular_lymphoma" .
<Blastic_plasmacytoid_dendritic_cell_neoplasm> <Accepted_use_of> "Tagraxofusp_monotherapy" .
<Blastic_plasmacytoid_dendritic_cell_neoplasm> <Accepted_use_of> "Tagraxofusp" .
<Interferon_alfa-2a_monotherapy> <Has_antineoplastic> "Interferon_alfa-2a" .
<Trastuzumab-qyyp> <Has_FDA_indication> "Gastric_cancer" .
<Trastuzumab-qyyp> <Has_FDA_indication> "Breast_cancer" .
<Lomustine,_Vincristine,_Prednisone> <Has_antineoplastic> "Vincristine" .
<Lomustine,_Vincristine,_Prednisone> <Has_antineoplastic> "Prednisone" .
<Lomustine,_Vincristine,_Prednisone> <Has_antineoplastic> "Lomustine" .
<Interfero> <Brand_name_of> "Interferon_alfa-2b" .
<Dara-KD> <Maps_to> "Dara-KD" .
<VH> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<VH> <Has_accepted_use> "Breast_cancer" .
<Mercaptopurine,_Methotrexate,_WB-XRT> <Has_antineoplastic> "Methotrexate" .
<Mercaptopurine,_Methotrexate,_WB-XRT> <Has_antineoplastic> "Mercaptopurine" .
<Mercaptopurine,_Methotrexate,_WB-XRT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Bacotrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<FLT3_inhibitor> <Subsumes> "Sunitinib" .
<FLT3_inhibitor> <Subsumes> "Sorafenib" .
<FLT3_inhibitor> <Subsumes> "Quizartinib" .
<FLT3_inhibitor> <Subsumes> "Ponatinib" .
<FLT3_inhibitor> <Subsumes> "Pacritinib" .
<FLT3_inhibitor> <Subsumes> "Midostaurin" .
<FLT3_inhibitor> <Subsumes> "Lestaurtinib" .
<FLT3_inhibitor> <Subsumes> "Gilteritinib" .
<FLT3_inhibitor> <Subsumes> "Crenolanib" .
<FLT3_inhibitor> <Subsumes> "Cabozantinib" .
<FLT3_inhibitor> <Subsumes> "Brigatinib" .
<R-ICE> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Vinorelbine_monotherapy> <Mapped_from> "Vinorelbine_monotherapy" .
<Tecflu> <Brand_name_of> "Fluorouracil" .
<Breast_cancer> <Subsumes> "triple_negative_Breast_cancer" .
<Breast_cancer> <Subsumes> "PIK3CA-mutated_Breast_cancer" .
<Breast_cancer> <Subsumes> "HER2-positive_Breast_cancer" .
<Breast_cancer> <Subsumes> "HER2-positive_-_historical_Breast_cancer" .
<Breast_cancer> <Subsumes> "ER-positive_Breast_cancer" .
<Breast_cancer> <Subsumes> "BRCA-mutated_Breast_cancer" .
<CapeOx_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<Vandetanib_monotherapy> <Mapped_from> "Vandetanib_monotherapy" .
<Irinotecan_and_Bevacizumab> <Is_current_in> "Glioblastoma" .
<Irinotecan_and_Bevacizumab> <Is_current_in> "Anaplastic_glioma" .
<Lanreotide_monotherapy> <Is_current_in> "Neuroendocrine_tumor" .
<Ofatumumab_monotherapy> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Ofatumumab_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<Ofatumumab_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Ofatumumab_monotherapy> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Leuben> <Brand_name_of> "Bendamustine" .
<Dabrafenib> <Antineoplastic_of> "Dabrafenib,_Trametinib,_Panitumumab" .
<Dabrafenib> <Antineoplastic_of> "Dabrafenib_monotherapy" .
<Dabrafenib> <Antineoplastic_of> "Dabrafenib_and_Trametinib" .
<Dexametasona> <Brand_name_of> "Dexamethasone" .
<FELV> <Maps_to> "FELV" .
<FOLFIRI_and_Panitumumab> <Is_a> "Irinotecan-containing_regimen" .
<Supribac> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin,_Etoposide,_Bevacizumab> <Has_context> "Induction_therapy" .
<TC,_then_IE,_VDoxoC,_VEC> <Has_modality> "Chemotherapy" .
<ddAC> <Has_antineoplastic> "Doxorubicin" .
<ddAC> <Has_antineoplastic> "Cyclophosphamide" .
<Primary_mediastinal_B-cell_lymphoma> <Current_treated_by> "Radiation_therapy" .
<Primary_mediastinal_B-cell_lymphoma> <Current_treated_by> "R-GDP" .
<Primary_mediastinal_B-cell_lymphoma> <Current_treated_by> "R-DHAP" .
<Primary_mediastinal_B-cell_lymphoma> <Current_treated_by> "R-CHOP-14_(Prednisolone)" .
<Primary_mediastinal_B-cell_lymphoma> <Current_treated_by> "R-CHOP_(Prednisolone)" .
<Primary_mediastinal_B-cell_lymphoma> <Current_treated_by> "R-CHOP" .
<Primary_mediastinal_B-cell_lymphoma> <Current_treated_by> "Pembrolizumab_monotherapy" .
<Primary_mediastinal_B-cell_lymphoma> <Current_treated_by> "FluBuCy,_then_allo_HSCT" .
<Primary_mediastinal_B-cell_lymphoma> <Current_treated_by> "DA-R-EPOCH" .
<Primary_mediastinal_B-cell_lymphoma> <Current_treated_by> "Axicabtagene_ciloleucel_monotherapy" .
<Oforta> <Brand_name_of> "Fludarabine" .
<Topotecan_and_Bevacizumab> <Maps_to> "Topotecan_and_Bevacizumab" .
<CYVE> <Is_current_in> "CNS_lymphoma" .
<CYVE> <Is_current_in> "Burkitt_lymphoma" .
<CYVE> <Is_current_in> "Autologous_HSCT" .
<CYVE> <Is_current_in> "Acute_myeloid_leukemia" .
<Temozolomide_and_RT,_then_Temozolomide> <Has_modality> "Radiotherapy" .
<Temozolomide_and_RT,_then_Temozolomide> <Has_modality> "Chemotherapy" .
<Cisplatin,_Fluorouracil,_Hydroxyurea,_RT> <Mapped_from> "Cisplatin,_Fluorouracil,_Hydroxyurea,_RT" .
<Alpelisib> <Has_brand_name> "Piqray" .
<Methotrexate> <Antineoplastic_of> "m-BNCOD" .
<Methotrexate> <Antineoplastic_of> "m-BACOD" .
<Methotrexate> <Antineoplastic_of> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Methotrexate> <Antineoplastic_of> "dmCODOX-M_-_Modified_Magrath" .
<Methotrexate> <Antineoplastic_of> "VMV-VAC" .
<Methotrexate> <Antineoplastic_of> "VBM" .
<Methotrexate> <Antineoplastic_of> "VAMP_(Methotrexate)" .
<Methotrexate> <Antineoplastic_of> "VAMP_(Amethopterin)" .
<Methotrexate> <Antineoplastic_of> "TMF" .
<Methotrexate> <Antineoplastic_of> "SMILE" .
<Methotrexate> <Antineoplastic_of> "R-MPV" .
<Methotrexate> <Antineoplastic_of> "R-MP" .
<Methotrexate> <Antineoplastic_of> "R-MCP_(CCNU)" .
<Methotrexate> <Antineoplastic_of> "R-MACLO/R-IVAM" .
<Methotrexate> <Antineoplastic_of> "R-M-CHOP" .
<Methotrexate> <Antineoplastic_of> "R-Hyper-CVAD/R-MA" .
<Methotrexate> <Antineoplastic_of> "R-DHAP/R-VIM" .
<Methotrexate> <Antineoplastic_of> "R-COPADM" .
<Methotrexate> <Antineoplastic_of> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Methotrexate> <Antineoplastic_of> "R-CODOX-M/R-IVAC" .
<Methotrexate> <Antineoplastic_of> "R-CODOX-M_(Doxil_substituted)" .
<Methotrexate> <Antineoplastic_of> "R-CODOX-M" .
<Methotrexate> <Antineoplastic_of> "ProMACE-MOPP" .
<Methotrexate> <Antineoplastic_of> "ProMACE-CytaBOM" .
<Methotrexate> <Antineoplastic_of> "Pediatric-like_GRAALL_consolidation" .
<Methotrexate> <Antineoplastic_of> "POMP" .
<Methotrexate> <Antineoplastic_of> "PACEBOM" .
<Methotrexate> <Antineoplastic_of> "Nordic_Regimen,_younger_patients" .
<Methotrexate> <Antineoplastic_of> "Nordic_Regimen,_older_patients" .
<Methotrexate> <Antineoplastic_of> "Nilotinib-based_consolidation" .
<Methotrexate> <Antineoplastic_of> "Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin" .
<Methotrexate> <Antineoplastic_of> "Methotrexate,_then_Cytarabine_and_Thiotepa" .
<Methotrexate> <Antineoplastic_of> "Methotrexate,_then_Cytarabine" .
<Methotrexate> <Antineoplastic_of> "Methotrexate,_Vinblastine,_Prednisone" .
<Methotrexate> <Antineoplastic_of> "Methotrexate,_RT,_Cyclophosphamide" .
<Methotrexate> <Antineoplastic_of> "Methotrexate,_Pegaspargase,_Vincristine" .
<Methotrexate> <Antineoplastic_of> "Methotrexate_monotherapy" .
<Methotrexate> <Antineoplastic_of> "Methotrexate_and_Vincristine" .
<Methotrexate> <Antineoplastic_of> "Methotrexate_and_Thiotepa" .
<Methotrexate> <Antineoplastic_of> "Methotrexate_and_Rituximab" .
<Methotrexate> <Antineoplastic_of> "Methotrexate_and_Pegaspargase" .
<Methotrexate> <Antineoplastic_of> "Mercaptopurine,_Methotrexate,_WB-XRT" .
<Methotrexate> <Antineoplastic_of> "Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone" .
<Methotrexate> <Antineoplastic_of> "Mercaptopurine,_Methotrexate,_Vincristine" .
<Methotrexate> <Antineoplastic_of> "Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone" .
<Methotrexate> <Antineoplastic_of> "Mercaptopurine_and_Methotrexate" .
<Methotrexate> <Antineoplastic_of> "MVBP" .
<Methotrexate> <Antineoplastic_of> "MVAC,_dose-dense" .
<Methotrexate> <Antineoplastic_of> "MVAC" .
<Methotrexate> <Antineoplastic_of> "MV" .
<Methotrexate> <Antineoplastic_of> "MT-R" .
<Methotrexate> <Antineoplastic_of> "MPV" .
<Methotrexate> <Antineoplastic_of> "MF" .
<Methotrexate> <Antineoplastic_of> "MESA/RT" .
<Methotrexate> <Antineoplastic_of> "MCV" .
<Methotrexate> <Antineoplastic_of> "MBVP" .
<Methotrexate> <Antineoplastic_of> "MATRix" .
<Methotrexate> <Antineoplastic_of> "MAPIE" .
<Methotrexate> <Antineoplastic_of> "MAPI" .
<Methotrexate> <Antineoplastic_of> "MAP" .
<Methotrexate> <Antineoplastic_of> "MACOP-B" .
<Methotrexate> <Antineoplastic_of> "MACC" .
<Methotrexate> <Antineoplastic_of> "MA-BCD/AP" .
<Methotrexate> <Antineoplastic_of> "MA-BCD" .
<Methotrexate> <Antineoplastic_of> "MA" .
<Methotrexate> <Antineoplastic_of> "M-TIP" .
<Methotrexate> <Antineoplastic_of> "M-EI" .
<Methotrexate> <Antineoplastic_of> "M-BCD" .
<Methotrexate> <Antineoplastic_of> "Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone" .
<Methotrexate> <Antineoplastic_of> "Lomustine,_Methotrexate,_Procarbazine" .
<Methotrexate> <Antineoplastic_of> "Linker_regimen_(consolidation)" .
<Methotrexate> <Antineoplastic_of> "L-Asparaginase_and_Methotrexate" .
<Methotrexate> <Antineoplastic_of> "Ifosfamide_and_Methotrexate" .
<Methotrexate> <Antineoplastic_of> "IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone" .
<Methotrexate> <Antineoplastic_of> "HyperCHidam" .
<Methotrexate> <Antineoplastic_of> "Hyper-CVAD/MA_and_Everolimus" .
<Methotrexate> <Antineoplastic_of> "Hyper-CVAD/MA" .
<Methotrexate> <Antineoplastic_of> "Hyper-CVAD_and_Ponatinib" .
<Methotrexate> <Antineoplastic_of> "Hyper-CVAD_and_Imatinib" .
<Methotrexate> <Antineoplastic_of> "Hyper-CVAD_and_Dasatinib" .
<Methotrexate> <Antineoplastic_of> "Hexa-CAF" .
<Methotrexate> <Antineoplastic_of> "GMALL-R" .
<Methotrexate> <Antineoplastic_of> "Fluorouracil_and_Methotrexate" .
<Methotrexate> <Antineoplastic_of> "FEMTX" .
<Methotrexate> <Antineoplastic_of> "FAMTX" .
<Methotrexate> <Antineoplastic_of> "F-MACHOP" .
<Methotrexate> <Antineoplastic_of> "Etoposide,_Ifosfamide,_Methotrexate" .
<Methotrexate> <Antineoplastic_of> "EMA-CO" .
<Methotrexate> <Antineoplastic_of> "Doxorubicin,_Methotrexate,_Vincristine,_Prednisone" .
<Methotrexate> <Antineoplastic_of> "Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone" .
<Methotrexate> <Antineoplastic_of> "Cytarabine,_Methotrexate,_Rituximab" .
<Methotrexate> <Antineoplastic_of> "Cyclophosphamide,_Lomustine,_Methotrexate" .
<Methotrexate> <Antineoplastic_of> "Cisplatin_and_Methotrexate" .
<Methotrexate> <Antineoplastic_of> "Chlorambucil,_Dactinomycin,_Methotrexate" .
<Methotrexate> <Antineoplastic_of> "Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine" .
<Methotrexate> <Antineoplastic_of> "CYM" .
<Methotrexate> <Antineoplastic_of> "COPADM" .
<Methotrexate> <Antineoplastic_of> "COMP" .
<Methotrexate> <Antineoplastic_of> "CODOX-M/IVAC" .
<Methotrexate> <Antineoplastic_of> "CODOX-M" .
<Methotrexate> <Antineoplastic_of> "CMFVP" .
<Methotrexate> <Antineoplastic_of> "CMFV" .
<Methotrexate> <Antineoplastic_of> "CMFT" .
<Methotrexate> <Antineoplastic_of> "CMFPT" .
<Methotrexate> <Antineoplastic_of> "CMFP" .
<Methotrexate> <Antineoplastic_of> "CMFL" .
<Methotrexate> <Antineoplastic_of> "CMF" .
<Methotrexate> <Antineoplastic_of> "CMED" .
<Methotrexate> <Antineoplastic_of> "CM" .
<Methotrexate> <Antineoplastic_of> "CEF/CMF" .
<Methotrexate> <Antineoplastic_of> "CAMP" .
<Methotrexate> <Antineoplastic_of> "CAMFP" .
<Methotrexate> <Antineoplastic_of> "CAMF" .
<Methotrexate> <Antineoplastic_of> "CALGB_10-002_regimen" .
<Methotrexate> <Antineoplastic_of> "CABO" .
<Methotrexate> <Antineoplastic_of> "Bleomycin,_Methotrexate,_Vinblastine/RT" .
<Methotrexate> <Antineoplastic_of> "BMP" .
<Methotrexate> <Antineoplastic_of> "BASIC" .
<Methotrexate> <Antineoplastic_of> "AspaMetDex_(Erwinaze)" .
<Methotrexate> <Antineoplastic_of> "AspaMetDex" .
<Methotrexate> <Antineoplastic_of> "AV-CMF" .
<Methotrexate> <Antineoplastic_of> "ATRA,_Mercaptopurine,_Methotrexate" .
<Methotrexate> <Antineoplastic_of> "ACVBP" .
<Methotrexate> <Antineoplastic_of> "ACOMLA" .
<Pomalidomide> <Is_a> "REMS_program" .
<Pomalidomide> <Is_a> "Light-chain_(AL)_amyloidosis_medication" .
<Pomalidomide> <Is_a> "Immunomodulatory_drugs_(IMiDs)" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone> <Has_local_therapy> "Methotrexate" .
<Blinatumomab> <Is_a> "T-cell_activator" .
<Blinatumomab> <Is_a> "REMS_program" .
<Blinatumomab> <Is_a> "Immunotherapeutic" .
<Blinatumomab> <Is_a> "BiTE_antibody" .
<Blinatumomab> <Is_a> "Antibody_medication" .
<Blinatumomab> <Is_a> "Anti-CD3_antibody" .
<Blinatumomab> <Is_a> "Anti-CD19_antibody" .
<Sunitinib> <Has_accepted_use> "Thyroid_cancer" .
<Sunitinib> <Has_accepted_use> "Thymoma" .
<Sunitinib> <Has_accepted_use> "Testicular_cancer" .
<Sunitinib> <Has_accepted_use> "Small_cell_lung_cancer" .
<Sunitinib> <Has_accepted_use> "Renal_cell_carcinoma" .
<Sunitinib> <Has_accepted_use> "Pancreatic_NET" .
<Sunitinib> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Sunitinib> <Has_accepted_use> "Gastrointestinal_stromal_tumor" .
<Tegafur_and_Uracil> <Mapped_from> "Tegafur_and_Uracil" .
<Carboplatin,_Pemetrexed,_Pembrolizumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Valacyclovir> <May_have_route> "Oral" .
<FOLFOX_7/sLV5FU2> <Maps_to> "FOLFOX_7/sLV5FU2" .
<R-CVP> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<CEPP(B)> <Maps_to> "CEPP(B)" .
<Docetaxel,_Cetuximab,_RT> <Mapped_from> "Docetaxel,_Cetuximab,_RT" .
<Fulvestrant_monotherapy> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Fulvestrant_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Warfarin_monotherapy> <Has_accepted_use> "Venous_thromboembolism" .
<Warfarin_monotherapy> <Has_accepted_use> "Antiphospholipid_antibody_syndrome" .
<L-Asperone> <Brand_name_of> "Asparaginase" .
<Ifapla> <Brand_name_of> "Cisplatin" .
<Cisplatin,_Gemcitabine,_RT> <Has_accepted_use> "Cervical_cancer" .
<DHAP_-_time_intensified> <Has_accepted_use> "Hodgkin_lymphoma" .
<Irinotecan_and_Mitomycin> <Has_accepted_use> "Esophageal_cancer" .
<Innohep> <Brand_name_of> "Tinzaparin" .
<Tositumomab_&_I-131> <Has_brand_name> "Bexxar" .
<Brigatinib> <Is_a> "ROS1_inhibitor" .
<Brigatinib> <Is_a> "Mutation-specific_medication" .
<Brigatinib> <Is_a> "Kinase_inhibitor" .
<Brigatinib> <Is_a> "IGFR_inhibitor" .
<Brigatinib> <Is_a> "FLT3_inhibitor" .
<Brigatinib> <Is_a> "FDA_approved_drug" .
<Brigatinib> <Is_a> "EGFR_inhibitor" .
<Brigatinib> <Is_a> "ALK_inhibitor" .
<Dexametason> <Brand_name_of> "Dexamethasone" .
<Polibatrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<ESHAP> <Has_modality> "Chemotherapy" .
<Aromex> <Brand_name_of> "Exemestane" .
<Desalark> <Brand_name_of> "Dexamethasone" .
<MCP_(Prednisolone)> <Maps_to> "MCP_(Prednisolone)" .
<NOVP> <Is_a> "Anthracycline-containing_regimen" .
<Fempro> <Brand_name_of> "Letrozole" .
<Epilim> <Brand_name_of> "Valproate" .
<Filgrastim-sndz> <May_have_route> "Subcutaneous" .
<MCV> <Maps_to> "MCV" .
<Cyclophosphamide_and_TBI> <Has_modality> "Radiotherapy" .
<Cyclophosphamide_and_TBI> <Has_modality> "Chemotherapy" .
<Doxorubicin_pegylated_liposomal_and_Gemcitabine> <Is_current_in> "Ovarian_cancer" .
<FCM> <Is_a> "Anthracycline-containing_regimen" .
<Trimoxazol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<MVAC,_dose-dense> <Has_accepted_use> "Bladder_cancer" .
<eBEACOPP> <Mapped_from> "eBEACOPP" .
<ACVBP-R> <Has_antineoplastic> "Vindesine" .
<ACVBP-R> <Has_antineoplastic> "Rituximab" .
<ACVBP-R> <Has_antineoplastic> "Prednisone" .
<ACVBP-R> <Has_antineoplastic> "Doxorubicin" .
<ACVBP-R> <Has_antineoplastic> "Cyclophosphamide" .
<ACVBP-R> <Has_antineoplastic> "Bleomycin" .
<mDCF> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<mDCF> <Has_supportive_med> "Filgrastim" .
<mDCF> <Has_supportive_med> "Dexamethasone" .
<Kindoprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<DOLP> <Is_a> "Anthracycline-containing_regimen" .
<Chemotherapeutic> <Subsumes> "Vinca_alkaloid" .
<Chemotherapeutic> <Subsumes> "Vesicant" .
<Chemotherapeutic> <Subsumes> "Topoisomerase_inhibitor" .
<Chemotherapeutic> <Subsumes> "Taxane" .
<Chemotherapeutic> <Subsumes> "TSC2_inhibitor" .
<Chemotherapeutic> <Subsumes> "Soluble_decoy_receptor" .
<Chemotherapeutic> <Subsumes> "Selective_inhibitors_of_nuclear_export" .
<Chemotherapeutic> <Subsumes> "Retinoid" .
<Chemotherapeutic> <Subsumes> "Proteasome_inhibitor" .
<Chemotherapeutic> <Subsumes> "Platinum_agent" .
<Chemotherapeutic> <Subsumes> "Peptibody_medication" .
<Chemotherapeutic> <Subsumes> "Oncolytic_viral_therapy" .
<Chemotherapeutic> <Subsumes> "Neutral" .
<Chemotherapeutic> <Subsumes> "Molecular_chaperone_inhibitor" .
<Chemotherapeutic> <Subsumes> "Microtubule_inhibitor" .
<Chemotherapeutic> <Subsumes> "Kinase_inhibitor" .
<Chemotherapeutic> <Subsumes> "KSP_inhibitor" .
<Chemotherapeutic> <Subsumes> "Irritant" .
<Chemotherapeutic> <Subsumes> "Inflammitant" .
<Chemotherapeutic> <Subsumes> "Immunotoxin" .
<Chemotherapeutic> <Subsumes> "Hedgehog_pathway_inhibitor" .
<Chemotherapeutic> <Subsumes> "Growth_factor_inhibitor" .
<Chemotherapeutic> <Subsumes> "GTPase-activating_protein_inhibitor" .
<Chemotherapeutic> <Subsumes> "Enzyme_inhibitor" .
<Chemotherapeutic> <Subsumes> "Enediyne_antibiotic" .
<Chemotherapeutic> <Subsumes> "DNA_synthesis_inhibitor" .
<Chemotherapeutic> <Subsumes> "Cephalotaxine" .
<Chemotherapeutic> <Subsumes> "Apoptosis_promoter" .
<Chemotherapeutic> <Subsumes> "Antimetabolite" .
<Chemotherapeutic> <Subsumes> "Antibody-drug_conjugate" .
<Chemotherapeutic> <Subsumes> "Anti-HER2_medication" .
<Chemotherapeutic> <Subsumes> "Anti-CD20_medication" .
<Chemotherapeutic> <Subsumes> "Anthracycline" .
<Chemotherapeutic> <Subsumes> "Alkylating_agent" .
<Doxorubicin_and_Streptozocin> <Has_modality> "Chemotherapy" .
<VMP,_then_Rd> <Has_modality> "Chemotherapy" .
<7_plus_3i> <Maps_to> "7_plus_3i" .
<VIDE> <Has_supportive_med> "Mesna" .
<VIDE> <Has_supportive_med> "Filgrastim" .
<Binimetinib,_Encorafenib,_Cetuximab> <Has_accepted_use> "Colon_cancer" .
<Binimetinib,_Encorafenib,_Cetuximab> <Has_accepted_use> "BRAF-mutated_Colon_cancer" .
<Doxorrubicina> <Brand_name_of> "Doxorubicin" .
<Deferiprone> <May_have_route> "Oral" .
<ACE> <Has_antineoplastic> "Etoposide" .
<ACE> <Has_antineoplastic> "Doxorubicin" .
<ACE> <Has_antineoplastic> "Cyclophosphamide" .
<VACA> <Has_antineoplastic> "Vincristine" .
<VACA> <Has_antineoplastic> "Doxorubicin" .
<VACA> <Has_antineoplastic> "Dactinomycin" .
<VACA> <Has_antineoplastic> "Cyclophosphamide" .
<Mercaptopurine_and_Prednisone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Dara-VMP> <Has_modality> "Chemotherapy" .
<BeGEV> <Has_modality> "Chemotherapy" .
<Venofer> <Brand_name_of> "Iron_sucrose" .
<Bactelan> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Afatinib_and_Paclitaxel> <Has_antineoplastic> "Paclitaxel" .
<Afatinib_and_Paclitaxel> <Has_antineoplastic> "Afatinib" .
<CAFVP> <Is_a> "Anthracycline-containing_regimen" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Maps_to> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<ERBB4_inhibitor> <Subsumes> "Neratinib" .
<ERBB4_inhibitor> <Subsumes> "Afatinib" .
<FEAM,_then_auto_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<Methotrexate,_then_Cytarabine> <Has_modality> "Chemotherapy" .
<TH_(Taxotere/SC)> <Has_context> "Neoadjuvant_therapy" .
<TH_(Taxotere/SC)> <Has_context> "Adjuvant_therapy" .
<PAC> <Has_antineoplastic> "Prednisone" .
<PAC> <Has_antineoplastic> "Doxorubicin" .
<PAC> <Has_antineoplastic> "Cyclophosphamide" .
<PAC> <Has_antineoplastic> "Cisplatin" .
<MVPP> <Has_accepted_use> "Hodgkin_lymphoma" .
<Doxorubicin> <Has_FDA_indication> "Thyroid_cancer" .
<Doxorubicin> <Has_FDA_indication> "Soft_tissue_sarcoma" .
<Doxorubicin> <Has_FDA_indication> "Small_cell_lung_cancer" .
<Doxorubicin> <Has_FDA_indication> "Ovarian_cancer" .
<Doxorubicin> <Has_FDA_indication> "Hodgkin_lymphoma" .
<Doxorubicin> <Has_FDA_indication> "Gastric_cancer" .
<Doxorubicin> <Has_FDA_indication> "Breast_cancer" .
<Doxorubicin> <Has_FDA_indication> "Bladder_cancer" .
<Doxorubicin> <Has_FDA_indication> "Acute_myeloid_leukemia" .
<Bacillus_Calmette-Guerin_(BCG)_monotherapy> <Has_antineoplastic> "Bacillus_Calmette-Guerin" .
<PD> <Mapped_from> "PD" .
<Ledervorin> <Brand_name_of> "Folinic_acid" .
<DEP_and_RT> <Maps_to> "DEP_and_RT" .
<Obinutuzumab_monotherapy> <Has_supportive_med> "Steroids" .
<Obinutuzumab_monotherapy> <Has_supportive_med> "Rituximab" .
<Obinutuzumab_monotherapy> <Has_supportive_med> "Prednisolone" .
<Obinutuzumab_monotherapy> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Obinutuzumab_monotherapy> <Has_supportive_med> "Diphenhydramine" .
<Obinutuzumab_monotherapy> <Has_supportive_med> "Antihistamines" .
<Obinutuzumab_monotherapy> <Has_supportive_med> "Acetaminophen" .
<Adult_T-cell_leukemia-lymphoma> <Is_a> "T-cell_lymphoma" .
<Adult_T-cell_leukemia-lymphoma> <Is_a> "T-cell_leukemia" .
<Adult_T-cell_leukemia-lymphoma> <Is_a> "Acute_leukemia" .
<Obinutuzumab_monotherapy> <Maps_to> "Obinutuzumab_monotherapy" .
<CAMP> <Has_modality> "Chemotherapy" .
<CEEP> <Has_antineoplastic> "Vindesine" .
<CEEP> <Has_antineoplastic> "Prednisone" .
<CEEP> <Has_antineoplastic> "Epirubicin" .
<CEEP> <Has_antineoplastic> "Cyclophosphamide" .
<Cyclosporine_and_Mycophenolate_mofetil> <Has_accepted_use> "Graft_versus_host_disease" .
<R-CDOP> <Has_modality> "Chemotherapy" .
<DexaBEAM_and_G-CSF> <Has_accepted_use> "Stem_cell_mobilization" .
<Necitumumab> <Antineoplastic_of> "Necitumumab_monotherapy" .
<Necitumumab> <Antineoplastic_of> "Cisplatin,_Gemcitabine,_Necitumumab" .
<Anti-HER2_antibody> <Subsumes> "Trastuzumab-qyyp" .
<Anti-HER2_antibody> <Subsumes> "Trastuzumab-pkrb" .
<Anti-HER2_antibody> <Subsumes> "Trastuzumab-dttb" .
<Anti-HER2_antibody> <Subsumes> "Trastuzumab-dkst" .
<Anti-HER2_antibody> <Subsumes> "Trastuzumab-anns" .
<Anti-HER2_antibody> <Subsumes> "Trastuzumab_and_hyaluronidase" .
<Anti-HER2_antibody> <Subsumes> "Trastuzumab" .
<Anti-HER2_antibody> <Subsumes> "Pertuzumab" .
<Anti-HER2_antibody> <Subsumes> "Fam-trastuzumab_deruxtecan" .
<Anti-HER2_antibody> <Subsumes> "Ado-trastuzumab_emtansine" .
<BeEAM,_then_auto_HSCT> <Has_antineoplastic> "Melphalan" .
<BeEAM,_then_auto_HSCT> <Has_antineoplastic> "Etoposide" .
<BeEAM,_then_auto_HSCT> <Has_antineoplastic> "Cytarabine" .
<BeEAM,_then_auto_HSCT> <Has_antineoplastic> "Bendamustine" .
<Vindesine_monotherapy> <Mapped_from> "Vindesine_monotherapy" .
<VH> <Mapped_from> "VH" .
<Glucarpidase> <May_have_route> "Intravenous" .
<Cytoxan_Lyophilized> <Brand_name_of> "Cyclophosphamide" .
<Salvage_therapy> <Subsumes> "Maintenance_after_salvage_therapy" .
<Salvage_therapy> <Subsumes> "Consolidation_after_salvage_therapy" .
<Ewing_sarcoma> <FDA_indication_of> "Dactinomycin" .
<Tazemetostat_monotherapy> <Mapped_from> "Tazemetostat_monotherapy" .
<Carboplatin,_Fluorouracil,_Cetuximab> <Has_context> "Non-curative_first-line_therapy" .
<PCE> <Is_historical_in> "Small_cell_lung_cancer" .
<Cobimetinib_monotherapy> <Has_accepted_use> "Rosai-Dorfman-Destombes_disease" .
<Cobimetinib_monotherapy> <Has_accepted_use> "Langerhans_cell_histiocytosis" .
<Cobimetinib_monotherapy> <Has_accepted_use> "Erdheim-Chester_disease" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "Vincristine" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "Rituximab-pvvr" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "Rituximab-abbs" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "Rituximab" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "Radiation_therapy" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "R-GDP" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "R-DHAP" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "R-CHOP-14_(Prednisolone)" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "R-CHOP_(Prednisolone)" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "R-CHOP" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "Prednisone" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "Pembrolizumab_monotherapy" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "Pembrolizumab" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "Gemcitabine" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "FluBuCy,_then_allo_HSCT" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "Etoposide" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "Doxorubicin" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "Dexamethasone" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "DA-R-EPOCH" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "Cytarabine" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "Cyclophosphamide" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "Cisplatin" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "Axicabtagene_ciloleucel_monotherapy" .
<Primary_mediastinal_B-cell_lymphoma> <Accepted_use_of> "Axicabtagene_ciloleucel" .
<Carboplatin,_Fluorouracil,_Cetuximab> <Has_modality> "Chemotherapy" .
<Medroxyprogesterone> <Has_brand_name> "Provera" .
<Medroxyprogesterone> <Has_brand_name> "Depo-Provera" .
<Cytarabine,_Daunorubicin,_Vincristine> <Is_a> "Anthracycline-containing_regimen" .
<Medroxyprogesterone_and_Tamoxifen> <Has_accepted_use> "Endometrial_cancer" .
<Fedratinib> <May_have_route> "Oral" .
<High-grade_glioma> <Subsumes> "Glioblastoma" .
<High-grade_glioma> <Subsumes> "Anaplastic_glioma" .
<7_plus_3d_and_Glasdegib> <Has_context> "Induction_therapy" .
<Dasatinib_monotherapy> <Has_accepted_use> "Systemic_mastocytosis" .
<Dasatinib_monotherapy> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Dasatinib_monotherapy> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Dasatinib_monotherapy> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Daunorubicin_and_Prednisone> <Maps_to> "Daunorubicin_and_Prednisone" .
<BEACOPP-14> <Has_context> "Induction_therapy" .
<FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation> <Has_antineoplastic> "Oxaliplatin" .
<FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation> <Has_antineoplastic> "Irinotecan" .
<FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation> <Has_antineoplastic> "Folinic_acid" .
<FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation> <Has_antineoplastic> "Fluorouracil" .
<Plidexa> <Brand_name_of> "Dexamethasone" .
<NovoTTF-100A_monotherapy> <Has_modality> "Tumor_treating_fields" .
<Vomikind> <Brand_name_of> "Ondansetron" .
<Hydroxyurea_and_Interferon_alfa-2a> <Mapped_from> "Hydroxyurea_and_Interferon_alfa-2a" .
<R-FCM> <Has_modality> "Chemotherapy" .
<Icotinib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Icotinib> <Has_accepted_use> "CNS_carcinoma" .
<Ranitidine> <Has_brand_name> "Zantac" .
<DA-R-EPOCH> <Maps_to> "DA-R-EPOCH" .
<Mogamulizumab> <Is_a> "Antibody_medication" .
<Mogamulizumab> <Is_a> "Anti-CD194_antibody" .
<Mogamulizumab> <Is_a> "Anti-CCR4_antibody" .
<MACOP-B> <Maps_to> "MACOP-B" .
<Cyclosporine_and_Methotrexate> <Has_accepted_use> "Graft_versus_host_disease" .
<Vincrifil> <Brand_name_of> "Vincristine" .
<Folinato> <Brand_name_of> "Folinic_acid" .
<Methotrexate_monotherapy> <Mapped_from> "Methotrexate_monotherapy" .
<WBRT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Epirubicin_and_Ifosfamide> <Is_a> "Anthracycline-containing_regimen" .
<Nplate> <Brand_name_of> "Romiplostim" .
<Mitomycin_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<CEF/CMF> <Has_modality> "Chemotherapy" .
<Inmutag> <Brand_name_of> "Interferon_alfa-2b" .
<Cholangiocarcinoma> <Is_a> "Hepatobiliary_cancer" .
<R-CHVP_plus_I> <Is_current_in> "Follicular_lymphoma" .
<O-ESHAP> <Has_accepted_use> "Hodgkin_lymphoma" .
<Non-curative_therapy> <Subsumes> "Non-curative_third-line_therapy" .
<Non-curative_therapy> <Subsumes> "Non-curative_subsequent-line_therapy" .
<Non-curative_therapy> <Subsumes> "Non-curative_second-line_therapy" .
<Non-curative_therapy> <Subsumes> "Non-curative_first-line_therapy" .
<HAM_and_Imatinib> <Has_local_therapy> "Methotrexate" .
<HDMP> <Mapped_from> "HDMP" .
<Bicalutamide_and_Leuprolide> <Mapped_from> "Bicalutamide_and_Leuprolide" .
<Hydrourea> <Brand_name_of> "Hydroxyurea" .
<Vinorelbine_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Gemcitabine,_Cisplatin,_S-1> <Has_accepted_use> "Gallbladder_cancer" .
<Gemcitabine,_Cisplatin,_S-1> <Has_accepted_use> "Cholangiocarcinoma" .
<BCNU/TT,_then_auto_HSCT> <Has_antineoplastic> "Thiotepa" .
<BCNU/TT,_then_auto_HSCT> <Has_antineoplastic> "Carmustine" .
<Carboplatin_monotherapy> <Has_supportive_med> "Trabectedin" .
<Carboplatin_monotherapy> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Carboplatin_monotherapy> <Has_supportive_med> "Dexamethasone" .
<Nilutamide_and_Orchiectomy> <Mapped_from> "Nilutamide_and_Orchiectomy" .
<R-CHOP/R-DHAP> <Has_context> "Non-curative_first-line_therapy" .
<Consolidation_after_upfront_therapy> <Mapped_from> "Consolidation_after_upfront_therapy" .
<TCH_(Taxotere,_Cyclophosphamide)> <Is_current_in> "Breast_cancer" .
<Votrient> <Brand_name_of> "Pazopanib" .
<Mepolizumab> <Is_a> "Antibody_medication" .
<Mepolizumab> <Is_a> "Anti-IL-5_antibody" .
<Cytarabine,_Methotrexate,_Rituximab> <Has_context> "Upfront_therapy" .
<Aspirin_and_Hydroxyurea> <Has_antineoplastic> "Hydroxyurea" .
<Gefitinib_and_Pemetrexed> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Gefitinib_and_Pemetrexed> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<Insetron> <Brand_name_of> "Ondansetron" .
<Epirubicin> <Is_a> "Vesicant" .
<Epirubicin> <Is_a> "Topoisomerase_inhibitor" .
<Epirubicin> <Is_a> "DNA_synthesis_inhibitor" .
<Epirubicin> <Is_a> "Anthracycline" .
<BASIC> <Has_modality> "Chemotherapy" .
<F-SHAI> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Mvasi> <Brand_name_of> "Bevacizumab-awwb" .
<Doxorubicin_and_Fluorouracil> <Has_modality> "Chemotherapy" .
<Bicalutamide_and_RT> <Has_modality> "Radiotherapy" .
<Bicalutamide_and_RT> <Has_modality> "Hormonotherapy" .
<Prednisone_and_Rituximab> <Maps_to> "Prednisone_and_Rituximab" .
<Clotinab> <Brand_name_of> "Abciximab" .
<Carboplatin_and_Vinorelbine> <Has_modality> "Chemotherapy" .
<BEACOPP-14> <Is_a> "Anthracycline-containing_regimen" .
<Fluorouracil_and_Folinic_acid> <Has_accepted_use> "Rectal_cancer" .
<Fluorouracil_and_Folinic_acid> <Has_accepted_use> "Pancreatic_cancer" .
<Fluorouracil_and_Folinic_acid> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Fluorouracil_and_Folinic_acid> <Has_accepted_use> "Esophageal_cancer" .
<Fluorouracil_and_Folinic_acid> <Has_accepted_use> "Colon_cancer" .
<Fluorouracil_and_Folinic_acid> <Has_accepted_use> "Cholangiocarcinoma" .
<Fluorouracil_and_Folinic_acid> <Has_accepted_use> "Cervical_cancer" .
<Trimethoprim-Sulfamethoxazole> <Is_a> "PCP_prophylaxis" .
<Trimethoprim-Sulfamethoxazole> <Is_a> "Antimetabolite" .
<Trimethoprim-Sulfamethoxazole> <Is_a> "Antifolate" .
<Trimethoprim-Sulfamethoxazole> <Is_a> "Antibacterial" .
<Cerubidine> <Brand_name_of> "Daunorubicin" .
<Cisplatin,_Epirubicin,_Ifosfamide> <Maps_to> "Cisplatin,_Epirubicin,_Ifosfamide" .
<Alenbon> <Brand_name_of> "Alendronate" .
<ECF/5-FU_and_RT> <Has_modality> "Radiotherapy" .
<ECF/5-FU_and_RT> <Has_modality> "Chemotherapy" .
<Gemcitabine,_Cetuximab,_RT> <Mapped_from> "Gemcitabine,_Cetuximab,_RT" .
<R-CHOP-14> <Has_supportive_med> "Pegfilgrastim" .
<R-CHOP-14> <Has_supportive_med> "Lenograstim" .
<R-CHOP-14> <Has_supportive_med> "Filgrastim" .
<Carboplatin,_Etoposide,_Durvalumab> <Has_antineoplastic> "Etoposide" .
<Carboplatin,_Etoposide,_Durvalumab> <Has_antineoplastic> "Durvalumab" .
<Carboplatin,_Etoposide,_Durvalumab> <Has_antineoplastic> "Carboplatin" .
<Mitotane_monotherapy> <Has_antineoplastic> "Mitotane" .
<Onset> <Brand_name_of> "Ondansetron" .
<Medroxyprogesterone> <Is_a> "Endocrine_therapeutic" .
<Semustine> <Is_a> "Nitrosourea" .
<Semustine> <Is_a> "Discontinued_drug" .
<Gemcitabine_and_Paclitaxel> <Maps_to> "Gemcitabine_and_Paclitaxel" .
<Pegasys> <Brand_name_of> "Peginterferon_alfa-2a" .
<Interferon_Leucocyticum> <Brand_name_of> "Interferon_alfa-2b" .
<Vorinostat> <Has_FDA_indication> "Cutaneous_T-cell_lymphoma" .
<Rabbit_ATG> <Has_accepted_use> "Graft_versus_host_disease" .
<FCR> <Has_immunosuppressor> "Tacrolimus" .
<FCR> <Has_immunosuppressor> "Methotrexate" .
<FCR> <Has_immunosuppressor> "Antithymocyte_globulin_horse_ATG" .
<Placebo> <Mapped_from> "Placebo" .
<Cytarabine_liposomal> <Local_therapy_of> "IT_Cytarabine_liposomal_monotherapy" .
<Cytarabine_liposomal> <Local_therapy_of> "Cytarabine,_Methotrexate,_Rituximab" .
<Flutamide,_Goserelin,_RT> <Has_antineoplastic> "Goserelin" .
<Flutamide,_Goserelin,_RT> <Has_antineoplastic> "Flutamide" .
<Flutamide,_Goserelin,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Rectal> <May_be_route_of> "Promethazine" .
<Rectal> <May_be_route_of> "Prochlorperazine" .
<Rectal> <May_be_route_of> "Indomethacin" .
<Rectal> <May_be_route_of> "Domperidone" .
<Rectal> <May_be_route_of> "Acetaminophen" .
<Everolimus_and_Tamoxifen> <Is_current_in> "Breast_cancer" .
<ADE_(standard-dose_Ara-C)> <Mapped_from> "ADE_(standard-dose_Ara-C)" .
<Sosetran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<ABVDm> <Has_modality> "Chemotherapy" .
<Thymitaq> <Brand_name_of> "Nolatrexed" .
<Carmustine> <May_have_route> "Intravenous" .
<Beyonas_Dexa> <Brand_name_of> "Dexamethasone" .
<Paclitaxel_and_Bevacizumab> <Has_accepted_use> "Ovarian_cancer" .
<Paclitaxel_and_Bevacizumab> <Has_accepted_use> "Breast_cancer" .
<Panitumumab> <Is_a> "Protein_expression-specific_medication" .
<Panitumumab> <Is_a> "Mutation-specific_medication" .
<Panitumumab> <Is_a> "EGFR_inhibitor" .
<Panitumumab> <Is_a> "Antibody_medication" .
<Panitumumab> <Is_a> "Anti-EGFR_antibody" .
<Lapuleucel-T> <Has_accepted_use> "Bladder_cancer" .
<ACOMLA> <Is_a> "Anthracycline-containing_regimen" .
<CYKLONE> <Has_antineoplastic> "Thalidomide" .
<CYKLONE> <Has_antineoplastic> "Dexamethasone" .
<CYKLONE> <Has_antineoplastic> "Cyclophosphamide" .
<CYKLONE> <Has_antineoplastic> "Carfilzomib" .
<ADT,_Docetaxel,_Estramustine> <Maps_to> "ADT,_Docetaxel,_Estramustine" .
<Cisplatin_and_RT> <Has_modality> "Radiotherapy" .
<Cisplatin_and_RT> <Has_modality> "Chemotherapy" .
<Fludarabine,_Melphalan,_Alemtuzumab> <Has_antineoplastic> "Melphalan" .
<Fludarabine,_Melphalan,_Alemtuzumab> <Has_antineoplastic> "Fludarabine" .
<Fludarabine,_Melphalan,_Alemtuzumab> <Has_antineoplastic> "Alemtuzumab" .
<Cisplatin,_Fluorouracil,_RT> <Has_antineoplastic> "Fluorouracil" .
<Cisplatin,_Fluorouracil,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Cisplatin,_Fluorouracil,_RT> <Has_antineoplastic> "Cisplatin" .
<TC,_then_IE,_VDoxoC,_VEC> <Has_supportive_med> "Mesna" .
<TC,_then_IE,_VDoxoC,_VEC> <Has_supportive_med> "Filgrastim" .
<FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)> <Mapped_from> "FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)" .
<Gemcitabine_and_RT> <Mapped_from> "Gemcitabine_and_RT" .
<O-ICE> <Has_context> "Salvage_therapy" .
<Epirubicin_monotherapy> <Mapped_from> "Epirubicin_monotherapy" .
<Axitinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Axitinib_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Axitinib_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<CVP_(Vinblastine/Prednisone)> <Has_antineoplastic> "Vinblastine" .
<CVP_(Vinblastine/Prednisone)> <Has_antineoplastic> "Prednisolone" .
<CVP_(Vinblastine/Prednisone)> <Has_antineoplastic> "Cyclophosphamide" .
<Stanford_V> <Mapped_from> "Stanford_V" .
<Idamycin> <Brand_name_of> "Idarubicin" .
<Fluorouracil,_Folinic_acid,_RT> <Has_context> "Neoadjuvant_therapy" .
<Platidiam> <Brand_name_of> "Cisplatin" .
<Asparaginase> <Antineoplastic_of> "SMILE" .
<Asparaginase> <Antineoplastic_of> "Pediatric-like_GRAALL_consolidation" .
<Asparaginase> <Antineoplastic_of> "Linker_regimen_(consolidation)" .
<Asparaginase> <Antineoplastic_of> "LVP_.22Sandwich.22" .
<Asparaginase> <Antineoplastic_of> "L-asparaginase_monotherapy" .
<Asparaginase> <Antineoplastic_of> "L-Asparaginase,_Vincristine,_Prednisone" .
<Asparaginase> <Antineoplastic_of> "L-Asparaginase,_Vincristine,_Prednisolone" .
<Asparaginase> <Antineoplastic_of> "L-Asparaginase,_Vincristine,_Dexamethasone" .
<Asparaginase> <Antineoplastic_of> "L-Asparaginase_and_Methotrexate" .
<Asparaginase> <Antineoplastic_of> "GELOX/RT" .
<Asparaginase> <Antineoplastic_of> "Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone" .
<Asparaginase> <Antineoplastic_of> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib" .
<Asparaginase> <Antineoplastic_of> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Asparaginase> <Antineoplastic_of> "DOLP_(Prednisolone)" .
<Asparaginase> <Antineoplastic_of> "DOLP" .
<Asparaginase> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone" .
<Asparaginase> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone" .
<Asparaginase> <Antineoplastic_of> "Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone" .
<Asparaginase> <Antineoplastic_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab" .
<Asparaginase> <Antineoplastic_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Asparaginase> <Antineoplastic_of> "CALGB_8811_early_intensification" .
<Asparaginase> <Antineoplastic_of> "Augmented_BFM_consolidation" .
<Asparaginase> <Antineoplastic_of> "AspaMetDex" .
<Interferon_gamma-1b> <May_have_route> "Subcutaneous" .
<Capecitabine,_Oxaliplatin,_RT> <Has_antineoplastic> "Oxaliplatin" .
<Capecitabine,_Oxaliplatin,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Capecitabine,_Oxaliplatin,_RT> <Has_antineoplastic> "Capecitabine" .
<Irinotecan_and_Temozolomide> <Has_context> "Non-curative_therapy" .
<Abemaciclib_and_Letrozole> <Is_current_in> "Breast_cancer" .
<VMCP> <Maps_to> "VMCP" .
<Merkel_cell_carcinoma> <Accepted_use_of> "Pembrolizumab_monotherapy" .
<Merkel_cell_carcinoma> <Accepted_use_of> "Pembrolizumab" .
<Merkel_cell_carcinoma> <Accepted_use_of> "Avelumab_monotherapy" .
<Merkel_cell_carcinoma> <Accepted_use_of> "Avelumab" .
<Alpha_emitter> <Subsumes> "Radium-223" .
<AC> <Has_context> "Non-curative_first-line_therapy" .
<AC> <Has_context> "Neoadjuvant_therapy" .
<AC> <Has_context> "Adjuvant_therapy" .
<IFL_and_Bevacizumab> <Mapped_from> "IFL_and_Bevacizumab" .
<Emapalumab> <May_have_route> "Intravenous" .
<IL-2_monotherapy> <Has_modality> "Immunotherapy" .
<Ifosfamide_and_Paclitaxel> <Mapped_from> "Ifosfamide_and_Paclitaxel" .
<Carboplatin_and_Teniposide> <Has_accepted_use> "Low-grade_glioma" .
<Fludarabine,_Cyclophosphamide,_ATG> <Has_antineoplastic> "Fludarabine" .
<Fludarabine,_Cyclophosphamide,_ATG> <Has_antineoplastic> "Cyclophosphamide" .
<ATRA,_Cytarabine,_Idarubicin> <Has_context> "Induction_therapy" .
<HAIC_and_Sorafenib> <Has_modality> "Chemotherapy" .
<Paclitaxel_nanoparticle_albumin-bound> <Antineoplastic_of> "nab-Paclitaxel_monotherapy" .
<Paclitaxel_nanoparticle_albumin-bound> <Antineoplastic_of> "nab-Paclitaxel_and_Trastuzumab" .
<Paclitaxel_nanoparticle_albumin-bound> <Antineoplastic_of> "nab-Paclitaxel_and_Atezolizumab" .
<Paclitaxel_nanoparticle_albumin-bound> <Antineoplastic_of> "Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab" .
<Paclitaxel_nanoparticle_albumin-bound> <Antineoplastic_of> "Gemcitabine_and_nab-Paclitaxel" .
<Paclitaxel_nanoparticle_albumin-bound> <Antineoplastic_of> "Cisplatin,_Gemcitabine,_nab-Paclitaxel" .
<Paclitaxel_nanoparticle_albumin-bound> <Antineoplastic_of> "Carboplatin,_nab-Paclitaxel,_Pembrolizumab" .
<Paclitaxel_nanoparticle_albumin-bound> <Antineoplastic_of> "Carboplatin,_nab-Paclitaxel,_Atezolizumab" .
<Paclitaxel_nanoparticle_albumin-bound> <Antineoplastic_of> "Carboplatin_and_nab-Paclitaxel" .
<Paclitaxel_nanoparticle_albumin-bound> <Antineoplastic_of> "Capecitabine_and_Paclitaxel,_nanoparticle_albumin-bound" .
<Paclitaxel_nanoparticle_albumin-bound> <Antineoplastic_of> "ABC" .
<Deltidrosol> <Brand_name_of> "Prednisolone" .
<Flutamide> <May_have_route> "Oral" .
<BCNU/TT,_then_auto_HSCT> <Mapped_from> "BCNU/TT,_then_auto_HSCT" .
<Azacitidine_monotherapy> <Mapped_from> "Azacitidine_monotherapy" .
<Thalidomide_and_Prednisone> <Is_current_in> "Multiple_myeloma" .
<Non-curative_third-line_induction_therapy> <Mapped_from> "Non-curative_third-line_induction_therapy" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Venous_thromboembolism> <Accepted_use_of> "Warfarin_monotherapy" .
<Venous_thromboembolism> <Accepted_use_of> "Warfarin" .
<Venous_thromboembolism> <Accepted_use_of> "Unfractionated_heparin" .
<Venous_thromboembolism> <Accepted_use_of> "Tinzaparin_monotherapy" .
<Venous_thromboembolism> <Accepted_use_of> "Tinzaparin" .
<Venous_thromboembolism> <Accepted_use_of> "Rivaroxaban_monotherapy" .
<Venous_thromboembolism> <Accepted_use_of> "Rivaroxaban" .
<Venous_thromboembolism> <Accepted_use_of> "Placebo" .
<Venous_thromboembolism> <Accepted_use_of> "Nadroparin" .
<Venous_thromboembolism> <Accepted_use_of> "Lepirudin_monotherapy" .
<Venous_thromboembolism> <Accepted_use_of> "Lepirudin" .
<Venous_thromboembolism> <Accepted_use_of> "Heparin_monotherapy" .
<Venous_thromboembolism> <Accepted_use_of> "Fondaparinux_monotherapy" .
<Venous_thromboembolism> <Accepted_use_of> "Fondaparinux" .
<Venous_thromboembolism> <Accepted_use_of> "Enoxaparin_monotherapy" .
<Venous_thromboembolism> <Accepted_use_of> "Enoxaparin" .
<Venous_thromboembolism> <Accepted_use_of> "Edoxaban_monotherapy" .
<Venous_thromboembolism> <Accepted_use_of> "Edoxaban" .
<Venous_thromboembolism> <Accepted_use_of> "Danaparoid" .
<Venous_thromboembolism> <Accepted_use_of> "Dalteparin_monotherapy" .
<Venous_thromboembolism> <Accepted_use_of> "Dalteparin" .
<Venous_thromboembolism> <Accepted_use_of> "Dabigatran_monotherapy" .
<Venous_thromboembolism> <Accepted_use_of> "Bivalirudin_monotherapy" .
<Venous_thromboembolism> <Accepted_use_of> "Bivalirudin" .
<Venous_thromboembolism> <Accepted_use_of> "Betrixaban_monotherapy" .
<Venous_thromboembolism> <Accepted_use_of> "Betrixaban" .
<Venous_thromboembolism> <Accepted_use_of> "Aspirin_monotherapy" .
<Venous_thromboembolism> <Accepted_use_of> "Aspirin" .
<Venous_thromboembolism> <Accepted_use_of> "Argatroban_monotherapy" .
<Venous_thromboembolism> <Accepted_use_of> "Argatroban" .
<Venous_thromboembolism> <Accepted_use_of> "Apixaban_monotherapy" .
<Venous_thromboembolism> <Accepted_use_of> "Apixaban" .
<Nyrin> <Brand_name_of> "Folinic_acid" .
<LEED> <Has_context> "All_lines_of_therapy" .
<Peptibody_medication> <Is_a> "Chemotherapeutic" .
<FAM> <Is_historical_in> "Gastric_cancer" .
<FAS> <Mapped_from> "FAS" .
<Metotressato> <Brand_name_of> "Methotrexate" .
<Binimetinib_and_Encorafenib> <Has_antineoplastic> "Encorafenib" .
<Binimetinib_and_Encorafenib> <Has_antineoplastic> "Binimetinib" .
<DCF> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<DCF> <Has_supportive_med> "Ranitidine" .
<DCF> <Has_supportive_med> "Ondansetron" .
<DCF> <Has_supportive_med> "Levofloxacin" .
<DCF> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<DCF> <Has_supportive_med> "Filgrastim" .
<DCF> <Has_supportive_med> "Emesis_prevention" .
<DCF> <Has_supportive_med> "Dexamethasone" .
<DCF> <Has_supportive_med> "Ciprofloxacin" .
<DCF> <Has_supportive_med> "Chlorpheniramine" .
<Mercaptopurine_monotherapy> <Is_historical_in> "Acute_myeloid_leukemia" .
<Napatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CCE> <Has_context> "Non-curative_therapy" .
<VIP> <Is_historical_in> "Small_cell_lung_cancer" .
<VIP> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Apixaban> <Has_brand_name> "Eliquis" .
<EDC> <Has_antineoplastic> "Epirubicin" .
<EDC> <Has_antineoplastic> "Docetaxel" .
<EDC> <Has_antineoplastic> "Capecitabine" .
<Cisplatin,_Docetaxel,_RT> <Has_modality> "Radiotherapy" .
<Cisplatin,_Docetaxel,_RT> <Has_modality> "Chemotherapy" .
<Doxorubicin> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Doxorubicin> <Is_a> "Vesicant" .
<Doxorubicin> <Is_a> "Topoisomerase_inhibitor" .
<Doxorubicin> <Is_a> "Anthracycline" .
<Bendamustine_and_Brentuximab_vedotin> <Has_context> "Non-curative_therapy" .
<Ibrutinib_and_Obinutuzumab> <Maps_to> "Ibrutinib_and_Obinutuzumab" .
<Capecitabine_and_Lapatinib> <Mapped_from> "Capecitabine_and_Lapatinib" .
<Tagraxofusp> <May_have_route> "Intravenous" .
<Leucovorin> <Brand_name_of> "Folinic_acid" .
<7_plus_5i> <Is_historical_in> "Acute_myeloid_leukemia" .
<HAA> <Mapped_from> "HAA" .
<Borviz> <Brand_name_of> "Bortezomib" .
<Cisplatin_and_Vinblastine> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Dexoptic> <Brand_name_of> "Dexamethasone" .
<FC> <Is_current_in> "Mantle_cell_lymphoma" .
<FC> <Is_current_in> "Autologous_HSCT" .
<FC> <Is_current_in> "Allogeneic_HSCT" .
<Vosaroxin_and_Cytarabine> <Is_historical_in> "Acute_myeloid_leukemia" .
<Simarc> <Brand_name_of> "Warfarin" .
<O_Trexat> <Brand_name_of> "Methotrexate" .
<Sulotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin_monotherapy> <Has_modality> "Chemotherapy" .
<Atropine> <May_have_route> "Oral" .
<Valrubicin_monotherapy> <Has_context> "Local_therapy" .
<nab-Paclitaxel_and_Trastuzumab> <Is_current_in> "Breast_cancer" .
<Kanjinti> <Brand_name_of> "Trastuzumab-anns" .
<Arabitin> <Brand_name_of> "Cytarabine" .
<Doxorubicin_and_Streptozocin> <Mapped_from> "Doxorubicin_and_Streptozocin" .
<Alectinib> <Antineoplastic_of> "Alectinib_monotherapy" .
<MPR> <Has_supportive_med> "Warfarin" .
<MPR> <Has_supportive_med> "Pamidronate" .
<MPR> <Has_supportive_med> "Low_molecular_weight_heparins" .
<MPR> <Has_supportive_med> "Ciprofloxacin" .
<MPR> <Has_supportive_med> "Bisphosphonates" .
<MPR> <Has_supportive_med> "Aspirin" .
<Chemoradioimmunotherapy> <Mapped_from> "Chemoradioimmunotherapy" .
<Capecitabine_and_Gemcitabine> <Has_context> "Non-curative_subsequent-line_therapy" .
<Capecitabine_and_Gemcitabine> <Has_context> "Non-curative_first-line_therapy" .
<Capecitabine_and_Gemcitabine> <Has_context> "Adjuvant_therapy" .
<CALGB_8811_early_intensification> <Maps_to> "CALGB_8811_early_intensification" .
<Mesothelioma> <Is_a> "Thoracic_cancer" .
<CC/DE_and_RT> <Has_context> "Definitive_therapy" .
<Busulfan_and_Cyclophosphamide,_then_allo_HSCT> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Gemcitabine_and_Irinotecan> <Has_context> "All_lines_of_therapy" .
<Cyclophosphamide_and_Prednisolone> <Maps_to> "Cyclophosphamide_and_Prednisolone" .
<mFOLFOX7> <Has_context> "Non-curative_first-line_therapy" .
<Thilodex> <Brand_name_of> "Dexamethasone" .
<Pravachol> <Brand_name_of> "Pravastatin" .
<Antibiotic> <Is_a> "Supportive_medication" .
<Protamine_sulfate> <May_have_route> "Intravenous" .
<Dara-KD> <Has_context> "Non-curative_therapy" .
<Hemapo> <Brand_name_of> "Epoetin_alfa" .
<Clofarabine_and_Melphalan> <Has_accepted_use> "Allogeneic_HSCT" .
<CODOX-M/IVAC> <Has_local_therapy> "Methotrexate" .
<CODOX-M/IVAC> <Has_local_therapy> "Hydrocortisone" .
<CODOX-M/IVAC> <Has_local_therapy> "Cytarabine" .
<Whole_abdominal_radiation_(WAI)> <Mapped_from> "Whole_abdominal_radiation_(WAI)" .
<VP> <Is_current_in> "Multiple_myeloma" .
<Mechlorethamine_monotherapy> <Has_context> "Induction_therapy" .
<Carboplatin,_Paclitaxel,_RT> <Has_supportive_med> "Ranitidine" .
<Carboplatin,_Paclitaxel,_RT> <Has_supportive_med> "Ondansetron" .
<Carboplatin,_Paclitaxel,_RT> <Has_supportive_med> "Granisetron" .
<Carboplatin,_Paclitaxel,_RT> <Has_supportive_med> "Diphenhydramine" .
<Carboplatin,_Paclitaxel,_RT> <Has_supportive_med> "Dexamethasone" .
<Carboplatin,_Paclitaxel,_RT> <Has_supportive_med> "Clemastine" .
<EPOCH> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Epibest> <Brand_name_of> "Valproate" .
<R-BEAM> <Is_current_in> "Autologous_HSCT" .
<Aspirin_monotherapy> <Has_supportive_med> "Aspirin" .
<VMP,_then_Rd> <Has_antineoplastic> "Prednisone" .
<VMP,_then_Rd> <Has_antineoplastic> "Melphalan" .
<VMP,_then_Rd> <Has_antineoplastic> "Lenalidomide" .
<VMP,_then_Rd> <Has_antineoplastic> "Dexamethasone" .
<VMP,_then_Rd> <Has_antineoplastic> "Bortezomib" .
<Thrombotic_disorder> <Is_a> "Classical_hematologic_condition" .
<Sonidegib_monotherapy> <Has_antineoplastic> "Sonidegib" .
<Medroxyprogesterone_and_Tamoxifen> <Has_modality> "Hormonotherapy" .
<Erythropoetin_and_Lenalidomide> <Has_supportive_med> "Epoetin_alfa" .
<mFOLFOX6_(L-Leucovorin)> <Mapped_from> "mFOLFOX6_(L-Leucovorin)" .
<Flutatec> <Brand_name_of> "Flutamide" .
<Virval> <Brand_name_of> "Valacyclovir" .
<Ox-P> <Maps_to> "Ox-P" .
<Interferon_alfa-2b_and_DLI> <Maps_to> "Interferon_alfa-2b_and_DLI" .
<FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation> <Has_context> "Induction_therapy" .
<Dexazen> <Brand_name_of> "Dexamethasone" .
<FOLFIRI> <Has_modality> "Chemotherapy" .
<Dexame> <Brand_name_of> "Dexamethasone" .
<Thiotepa> <Has_brand_name> "Thioplex" .
<Thiotepa> <Has_brand_name> "Tepadina" .
<Bisphosphonates> <Supportive_med_of> "VTP" .
<Bisphosphonates> <Supportive_med_of> "VT" .
<Bisphosphonates> <Supportive_med_of> "VP" .
<Bisphosphonates> <Supportive_med_of> "VMP/Rd" .
<Bisphosphonates> <Supportive_med_of> "VMP,_then_Rd" .
<Bisphosphonates> <Supportive_med_of> "VMP" .
<Bisphosphonates> <Supportive_med_of> "VDC" .
<Bisphosphonates> <Supportive_med_of> "Thalidomide_monotherapy" .
<Bisphosphonates> <Supportive_med_of> "Thalidomide_and_Prednisone" .
<Bisphosphonates> <Supportive_med_of> "TD" .
<Bisphosphonates> <Supportive_med_of> "Rd" .
<Bisphosphonates> <Supportive_med_of> "RVDC" .
<Bisphosphonates> <Supportive_med_of> "RVD" .
<Bisphosphonates> <Supportive_med_of> "PAD" .
<Bisphosphonates> <Supportive_med_of> "MPT" .
<Bisphosphonates> <Supportive_med_of> "MPR" .
<Bisphosphonates> <Supportive_med_of> "KRd" .
<Bisphosphonates> <Supportive_med_of> "Bortezomib_monotherapy" .
<Bisphosphonates> <Supportive_med_of> "Bortezomib_and_Doxorubicin_liposomal" .
<Bisphosphonates> <Supportive_med_of> "BTD" .
<CHOP_Modified> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Alendronate> <May_have_route> "Oral" .
<Cylocide> <Brand_name_of> "Cytarabine" .
<Flutamide> <Has_brand_name> "Tamid" .
<Flutamide> <Has_brand_name> "Proscan" .
<Flutamide> <Has_brand_name> "Lutamide" .
<Flutamide> <Has_brand_name> "Flutatec" .
<Flutamide> <Has_brand_name> "Flutamid" .
<Flutamide> <Has_brand_name> "Eulexin" .
<Flutamide> <Has_brand_name> "Euflex" .
<Flutamide> <Has_brand_name> "Cytomid" .
<BMP> <Has_supportive_med> "Folinic_acid" .
<Anthracycline-containing_regimen> <Subsumes> "maxi-R-CHOP/R-HiDAC" .
<Anthracycline-containing_regimen> <Subsumes> "mLSG15" .
<Anthracycline-containing_regimen> <Subsumes> "m-BNCOD" .
<Anthracycline-containing_regimen> <Subsumes> "m-BACOD" .
<Anthracycline-containing_regimen> <Subsumes> "iddEPC" .
<Anthracycline-containing_regimen> <Subsumes> "eBEACOPP_(Prednisolone)" .
<Anthracycline-containing_regimen> <Subsumes> "eBEACOPP" .
<Anthracycline-containing_regimen> <Subsumes> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Anthracycline-containing_regimen> <Subsumes> "dmCODOX-M_-_Modified_Magrath" .
<Anthracycline-containing_regimen> <Subsumes> "ddFEC" .
<Anthracycline-containing_regimen> <Subsumes> "ddEC" .
<Anthracycline-containing_regimen> <Subsumes> "ddE" .
<Anthracycline-containing_regimen> <Subsumes> "ddAC-T" .
<Anthracycline-containing_regimen> <Subsumes> "ddAC" .
<Anthracycline-containing_regimen> <Subsumes> "ddA" .
<Anthracycline-containing_regimen> <Subsumes> "VcR-CVAD" .
<Anthracycline-containing_regimen> <Subsumes> "Valrubicin_monotherapy" .
<Anthracycline-containing_regimen> <Subsumes> "VTD-PACE" .
<Anthracycline-containing_regimen> <Subsumes> "VR-CHOP" .
<Anthracycline-containing_regimen> <Subsumes> "VR-CAP" .
<Anthracycline-containing_regimen> <Subsumes> "VNCOP-B" .
<Anthracycline-containing_regimen> <Subsumes> "VMV-VAC" .
<Anthracycline-containing_regimen> <Subsumes> "VMCP/VCAP" .
<Anthracycline-containing_regimen> <Subsumes> "VMCP/VBAP" .
<Anthracycline-containing_regimen> <Subsumes> "VIM" .
<Anthracycline-containing_regimen> <Subsumes> "VIDE" .
<Anthracycline-containing_regimen> <Subsumes> "VI,_then_VDC/IE,_then_VAC,_then_VI" .
<Anthracycline-containing_regimen> <Subsumes> "VEPEMB" .
<Anthracycline-containing_regimen> <Subsumes> "VEPA" .
<Anthracycline-containing_regimen> <Subsumes> "VEBEP" .
<Anthracycline-containing_regimen> <Subsumes> "VDC/IE" .
<Anthracycline-containing_regimen> <Subsumes> "VCAP" .
<Anthracycline-containing_regimen> <Subsumes> "VBMCP/VBAD" .
<Anthracycline-containing_regimen> <Subsumes> "VAdCA/IE" .
<Anthracycline-containing_regimen> <Subsumes> "VAdCA" .
<Anthracycline-containing_regimen> <Subsumes> "VAP" .
<Anthracycline-containing_regimen> <Subsumes> "VAMP_(Methotrexate)" .
<Anthracycline-containing_regimen> <Subsumes> "VAMP" .
<Anthracycline-containing_regimen> <Subsumes> "VAIA" .
<Anthracycline-containing_regimen> <Subsumes> "VAD-P/Q" .
<Anthracycline-containing_regimen> <Subsumes> "VAD-P" .
<Anthracycline-containing_regimen> <Subsumes> "VAD_plus_C" .
<Anthracycline-containing_regimen> <Subsumes> "VAD_doxil" .
<Anthracycline-containing_regimen> <Subsumes> "VAD_and_Cyclosporine" .
<Anthracycline-containing_regimen> <Subsumes> "VAD" .
<Anthracycline-containing_regimen> <Subsumes> "VACOP-B" .
<Anthracycline-containing_regimen> <Subsumes> "VACA/IE" .
<Anthracycline-containing_regimen> <Subsumes> "VACA" .
<Anthracycline-containing_regimen> <Subsumes> "VAC_(Adriamycin)" .
<Anthracycline-containing_regimen> <Subsumes> "VABE" .
<Anthracycline-containing_regimen> <Subsumes> "V-HyperCAD" .
<Anthracycline-containing_regimen> <Subsumes> "Total_Therapy" .
<Anthracycline-containing_regimen> <Subsumes> "TVAD_doxil" .
<Anthracycline-containing_regimen> <Subsumes> "TC,_then_IE,_VDoxoC,_VEC" .
<Anthracycline-containing_regimen> <Subsumes> "TAD_(Thalidomide)" .
<Anthracycline-containing_regimen> <Subsumes> "TACE,_then_5-FU" .
<Anthracycline-containing_regimen> <Subsumes> "TACE" .
<Anthracycline-containing_regimen> <Subsumes> "TAC_(Taxotere)" .
<Anthracycline-containing_regimen> <Subsumes> "Stanford_V" .
<Anthracycline-containing_regimen> <Subsumes> "SHAI" .
<Anthracycline-containing_regimen> <Subsumes> "SCAB" .
<Anthracycline-containing_regimen> <Subsumes> "SC-EPOCH-RR" .
<Anthracycline-containing_regimen> <Subsumes> "RiPAD_plus_C" .
<Anthracycline-containing_regimen> <Subsumes> "RABVD" .
<Anthracycline-containing_regimen> <Subsumes> "R2CHOP" .
<Anthracycline-containing_regimen> <Subsumes> "R-miniCHOP" .
<Anthracycline-containing_regimen> <Subsumes> "R-miniCEOP" .
<Anthracycline-containing_regimen> <Subsumes> "R-VAD_plus_C" .
<Anthracycline-containing_regimen> <Subsumes> "R-NIMP" .
<Anthracycline-containing_regimen> <Subsumes> "R-MegaCHOP-14" .
<Anthracycline-containing_regimen> <Subsumes> "R-MegaCHOP" .
<Anthracycline-containing_regimen> <Subsumes> "R-MCP" .
<Anthracycline-containing_regimen> <Subsumes> "R-MACLO/R-IVAM" .
<Anthracycline-containing_regimen> <Subsumes> "R-M-CHOP" .
<Anthracycline-containing_regimen> <Subsumes> "R-Hyper-CVAD/R-MA" .
<Anthracycline-containing_regimen> <Subsumes> "R-FND" .
<Anthracycline-containing_regimen> <Subsumes> "R-FM" .
<Anthracycline-containing_regimen> <Subsumes> "R-FCM" .
<Anthracycline-containing_regimen> <Subsumes> "R-EPOCH,_dose-escalated" .
<Anthracycline-containing_regimen> <Subsumes> "R-EPOCH" .
<Anthracycline-containing_regimen> <Subsumes> "R-COPADM" .
<Anthracycline-containing_regimen> <Subsumes> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Anthracycline-containing_regimen> <Subsumes> "R-CODOX-M/R-IVAC" .
<Anthracycline-containing_regimen> <Subsumes> "R-CODOX-M_(Doxil_substituted)" .
<Anthracycline-containing_regimen> <Subsumes> "R-CODOX-M" .
<Anthracycline-containing_regimen> <Subsumes> "R-CMD" .
<Anthracycline-containing_regimen> <Subsumes> "R-CHVP_plus_I" .
<Anthracycline-containing_regimen> <Subsumes> "R-CHOP/R-DHAP" .
<Anthracycline-containing_regimen> <Subsumes> "R-CHOP-14_(Rituximab_Hycela)" .
<Anthracycline-containing_regimen> <Subsumes> "R-CHOP-14_(Prednisolone)" .
<Anthracycline-containing_regimen> <Subsumes> "R-CHOP-14" .
<Anthracycline-containing_regimen> <Subsumes> "R-CHOP_(Rituximab_Hycela)" .
<Anthracycline-containing_regimen> <Subsumes> "R-CHOP_(Prednisolone)" .
<Anthracycline-containing_regimen> <Subsumes> "R-CHOP" .
<Anthracycline-containing_regimen> <Subsumes> "R-CHOEP-14" .
<Anthracycline-containing_regimen> <Subsumes> "R-CHMP" .
<Anthracycline-containing_regimen> <Subsumes> "R-CEOP90_(Epirubicin)" .
<Anthracycline-containing_regimen> <Subsumes> "R-CDOP" .
<Anthracycline-containing_regimen> <Subsumes> "R,_then_CHOP" .
<Anthracycline-containing_regimen> <Subsumes> "ProMACE-MOPP" .
<Anthracycline-containing_regimen> <Subsumes> "ProMACE-CytaBOM" .
<Anthracycline-containing_regimen> <Subsumes> "Pirarubicin_monotherapy" .
<Anthracycline-containing_regimen> <Subsumes> "PVAG" .
<Anthracycline-containing_regimen> <Subsumes> "PMitCEBO" .
<Anthracycline-containing_regimen> <Subsumes> "PET" .
<Anthracycline-containing_regimen> <Subsumes> "PEN" .
<Anthracycline-containing_regimen> <Subsumes> "PEFG" .
<Anthracycline-containing_regimen> <Subsumes> "PCDE" .
<Anthracycline-containing_regimen> <Subsumes> "PAF" .
<Anthracycline-containing_regimen> <Subsumes> "PAD/VCD" .
<Anthracycline-containing_regimen> <Subsumes> "PAD_doxil" .
<Anthracycline-containing_regimen> <Subsumes> "PAD" .
<Anthracycline-containing_regimen> <Subsumes> "PACEBOM" .
<Anthracycline-containing_regimen> <Subsumes> "PAC" .
<Anthracycline-containing_regimen> <Subsumes> "P/DOCE" .
<Anthracycline-containing_regimen> <Subsumes> "OPPA" .
<Anthracycline-containing_regimen> <Subsumes> "OEPA" .
<Anthracycline-containing_regimen> <Subsumes> "O-miniCHOP" .
<Anthracycline-containing_regimen> <Subsumes> "O-CHOP" .
<Anthracycline-containing_regimen> <Subsumes> "Nilotinib-based_consolidation" .
<Anthracycline-containing_regimen> <Subsumes> "NOVP" .
<Anthracycline-containing_regimen> <Subsumes> "Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Anthracycline-containing_regimen> <Subsumes> "Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone" .
<Anthracycline-containing_regimen> <Subsumes> "Mitoxantrone_monotherapy" .
<Anthracycline-containing_regimen> <Subsumes> "Mitoxantrone_and_Prednisone" .
<Anthracycline-containing_regimen> <Subsumes> "Mitoxantrone_and_Hydrocortisone" .
<Anthracycline-containing_regimen> <Subsumes> "Mitotane_and_EDP" .
<Anthracycline-containing_regimen> <Subsumes> "MVAC,_dose-dense" .
<Anthracycline-containing_regimen> <Subsumes> "MVAC" .
<Anthracycline-containing_regimen> <Subsumes> "MOPP/ABVD" .
<Anthracycline-containing_regimen> <Subsumes> "MOPP-ABV" .
<Anthracycline-containing_regimen> <Subsumes> "MINE" .
<Anthracycline-containing_regimen> <Subsumes> "MEC" .
<Anthracycline-containing_regimen> <Subsumes> "MCP_(Prednisolone)" .
<Anthracycline-containing_regimen> <Subsumes> "MCP" .
<Anthracycline-containing_regimen> <Subsumes> "MC" .
<Anthracycline-containing_regimen> <Subsumes> "MAPIE" .
<Anthracycline-containing_regimen> <Subsumes> "MAPI" .
<Anthracycline-containing_regimen> <Subsumes> "MAP" .
<Anthracycline-containing_regimen> <Subsumes> "MAID" .
<Anthracycline-containing_regimen> <Subsumes> "MACOP-B" .
<Anthracycline-containing_regimen> <Subsumes> "MACC" .
<Anthracycline-containing_regimen> <Subsumes> "MA-BCD/AP" .
<Anthracycline-containing_regimen> <Subsumes> "MA-BCD" .
<Anthracycline-containing_regimen> <Subsumes> "MA" .
<Anthracycline-containing_regimen> <Subsumes> "Linker_regimen_(consolidation)" .
<Anthracycline-containing_regimen> <Subsumes> "LSG15" .
<Anthracycline-containing_regimen> <Subsumes> "LOPP/EVAP" .
<Anthracycline-containing_regimen> <Subsumes> "LD-ACOP-B" .
<Anthracycline-containing_regimen> <Subsumes> "International_ALL_Trial" .
<Anthracycline-containing_regimen> <Subsumes> "Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA" .
<Anthracycline-containing_regimen> <Subsumes> "Idarubicin,_then_Mitoxantrone,_then_Idarubicin" .
<Anthracycline-containing_regimen> <Subsumes> "ICL" .
<Anthracycline-containing_regimen> <Subsumes> "IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone" .
<Anthracycline-containing_regimen> <Subsumes> "IAP" .
<Anthracycline-containing_regimen> <Subsumes> "Hyper-CVAD/MA_and_Everolimus" .
<Anthracycline-containing_regimen> <Subsumes> "Hyper-CVAD/MA" .
<Anthracycline-containing_regimen> <Subsumes> "Hyper-CVAD_and_Ponatinib" .
<Anthracycline-containing_regimen> <Subsumes> "Hyper-CVAD_and_Imatinib" .
<Anthracycline-containing_regimen> <Subsumes> "Hyper-CVAD_and_Dasatinib" .
<Anthracycline-containing_regimen> <Subsumes> "Hyper-CVAD" .
<Anthracycline-containing_regimen> <Subsumes> "HOP" .
<Anthracycline-containing_regimen> <Subsumes> "HAM_and_Imatinib" .
<Anthracycline-containing_regimen> <Subsumes> "HAM" .
<Anthracycline-containing_regimen> <Subsumes> "HAD" .
<Anthracycline-containing_regimen> <Subsumes> "HAA" .
<Anthracycline-containing_regimen> <Subsumes> "GVD" .
<Anthracycline-containing_regimen> <Subsumes> "GMALL-R" .
<Anthracycline-containing_regimen> <Subsumes> "G-CHOP" .
<Anthracycline-containing_regimen> <Subsumes> "FND" .
<Anthracycline-containing_regimen> <Subsumes> "FNC" .
<Anthracycline-containing_regimen> <Subsumes> "FMP" .
<Anthracycline-containing_regimen> <Subsumes> "FM" .
<Anthracycline-containing_regimen> <Subsumes> "FLEC" .
<Anthracycline-containing_regimen> <Subsumes> "FLAG-Ida" .
<Anthracycline-containing_regimen> <Subsumes> "FLAG-DNX" .
<Anthracycline-containing_regimen> <Subsumes> "FEMTX" .
<Anthracycline-containing_regimen> <Subsumes> "FEC_and_H_(SC)" .
<Anthracycline-containing_regimen> <Subsumes> "FEC_and_H" .
<Anthracycline-containing_regimen> <Subsumes> "FEC_and_Bevacizumab" .
<Anthracycline-containing_regimen> <Subsumes> "FEC" .
<Anthracycline-containing_regimen> <Subsumes> "FCM" .
<Anthracycline-containing_regimen> <Subsumes> "FAS" .
<Anthracycline-containing_regimen> <Subsumes> "FAMTX" .
<Anthracycline-containing_regimen> <Subsumes> "FAM" .
<Anthracycline-containing_regimen> <Subsumes> "FAC_and_Bevacizumab" .
<Anthracycline-containing_regimen> <Subsumes> "FAC_and_BCG" .
<Anthracycline-containing_regimen> <Subsumes> "FAC" .
<Anthracycline-containing_regimen> <Subsumes> "F-SHAI" .
<Anthracycline-containing_regimen> <Subsumes> "F-MACHOP" .
<Anthracycline-containing_regimen> <Subsumes> "Etoposide_and_Mitoxantrone" .
<Anthracycline-containing_regimen> <Subsumes> "Epirubicin_monotherapy" .
<Anthracycline-containing_regimen> <Subsumes> "Epirubicin_and_Vinorelbine" .
<Anthracycline-containing_regimen> <Subsumes> "Epirubicin_and_Ifosfamide" .
<Anthracycline-containing_regimen> <Subsumes> "EVI" .
<Anthracycline-containing_regimen> <Subsumes> "EVAIA" .
<Anthracycline-containing_regimen> <Subsumes> "EPOCH,_dose-escalated" .
<Anthracycline-containing_regimen> <Subsumes> "EPOCH" .
<Anthracycline-containing_regimen> <Subsumes> "EP" .
<Anthracycline-containing_regimen> <Subsumes> "EOX" .
<Anthracycline-containing_regimen> <Subsumes> "EOF" .
<Anthracycline-containing_regimen> <Subsumes> "EIA" .
<Anthracycline-containing_regimen> <Subsumes> "EDC" .
<Anthracycline-containing_regimen> <Subsumes> "ECX" .
<Anthracycline-containing_regimen> <Subsumes> "ECT,_then_auto_HSCT" .
<Anthracycline-containing_regimen> <Subsumes> "ECH" .
<Anthracycline-containing_regimen> <Subsumes> "ECF/5-FU_and_RT" .
<Anthracycline-containing_regimen> <Subsumes> "ECF" .
<Anthracycline-containing_regimen> <Subsumes> "EC_and_Bevacizumab" .
<Anthracycline-containing_regimen> <Subsumes> "EC" .
<Anthracycline-containing_regimen> <Subsumes> "EBVP" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin,_Methotrexate,_Vincristine,_Prednisone" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin,_Ifosfamide,_RT" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin_pegylated_liposomal_monotherapy" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin_pegylated_liposomal_and_Trabectedin" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin_pegylated_liposomal_and_Gemcitabine" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin_pegylated_liposomal_and_Bevacizumab" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin_non-pegylated_liposomal_monotherapy" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin_non-pegylated_liposomal_and_Bevacizumab" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin_monotherapy" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin_and_Vinblastine" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin_and_Strontium-89" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin_and_Streptozocin" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin_and_Olaratumab" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin_and_Lomustine" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin_and_Ifosfamide" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin_and_Gemcitabine" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin_and_Fluorouracil" .
<Anthracycline-containing_regimen> <Subsumes> "Doxorubicin_and_Bevacizumab" .
<Anthracycline-containing_regimen> <Subsumes> "Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib" .
<Anthracycline-containing_regimen> <Subsumes> "Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone" .
<Anthracycline-containing_regimen> <Subsumes> "Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Anthracycline-containing_regimen> <Subsumes> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib" .
<Anthracycline-containing_regimen> <Subsumes> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Anthracycline-containing_regimen> <Subsumes> "Daunorubicin_monotherapy" .
<Anthracycline-containing_regimen> <Subsumes> "Daunorubicin_liposomal_monotherapy" .
<Anthracycline-containing_regimen> <Subsumes> "Daunorubicin_and_Prednisone" .
<Anthracycline-containing_regimen> <Subsumes> "Dacarbazine_and_Doxorubicin" .
<Anthracycline-containing_regimen> <Subsumes> "DTPACE" .
<Anthracycline-containing_regimen> <Subsumes> "DOLP_(Prednisolone)" .
<Anthracycline-containing_regimen> <Subsumes> "DOLP" .
<Anthracycline-containing_regimen> <Subsumes> "DI_EC" .
<Anthracycline-containing_regimen> <Subsumes> "DEP" .
<Anthracycline-containing_regimen> <Subsumes> "DEB-TACE" .
<Anthracycline-containing_regimen> <Subsumes> "DE" .
<Anthracycline-containing_regimen> <Subsumes> "DD-CHOP" .
<Anthracycline-containing_regimen> <Subsumes> "DCTER" .
<Anthracycline-containing_regimen> <Subsumes> "DAT" .
<Anthracycline-containing_regimen> <Subsumes> "DAC" .
<Anthracycline-containing_regimen> <Subsumes> "DA-R-EPOCH" .
<Anthracycline-containing_regimen> <Subsumes> "DA-EPOCH" .
<Anthracycline-containing_regimen> <Subsumes> "DA_3_plus_10,_GO" .
<Anthracycline-containing_regimen> <Subsumes> "DA_3_plus_10" .
<Anthracycline-containing_regimen> <Subsumes> "D-ZAPO" .
<Anthracycline-containing_regimen> <Subsumes> "Cytarabine,_Idarubicin,_Vorinostat" .
<Anthracycline-containing_regimen> <Subsumes> "Cytarabine,_Idarubicin,_Sorafenib" .
<Anthracycline-containing_regimen> <Subsumes> "Cytarabine,_Idarubicin,_Rituximab" .
<Anthracycline-containing_regimen> <Subsumes> "Cytarabine,_Idarubicin,_Imatinib" .
<Anthracycline-containing_regimen> <Subsumes> "Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone" .
<Anthracycline-containing_regimen> <Subsumes> "Cytarabine,_Daunorubicin,_Vincristine" .
<Anthracycline-containing_regimen> <Subsumes> "Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone" .
<Anthracycline-containing_regimen> <Subsumes> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone" .
<Anthracycline-containing_regimen> <Subsumes> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone" .
<Anthracycline-containing_regimen> <Subsumes> "Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin" .
<Anthracycline-containing_regimen> <Subsumes> "Cytarabine_and_Mitoxantrone" .
<Anthracycline-containing_regimen> <Subsumes> "Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA" .
<Anthracycline-containing_regimen> <Subsumes> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA" .
<Anthracycline-containing_regimen> <Subsumes> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine" .
<Anthracycline-containing_regimen> <Subsumes> "Cytarabine_and_Idarubicin" .
<Anthracycline-containing_regimen> <Subsumes> "Cytarabine_and_Daunorubicin" .
<Anthracycline-containing_regimen> <Subsumes> "Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone" .
<Anthracycline-containing_regimen> <Subsumes> "Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone" .
<Anthracycline-containing_regimen> <Subsumes> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone" .
<Anthracycline-containing_regimen> <Subsumes> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone" .
<Anthracycline-containing_regimen> <Subsumes> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab" .
<Anthracycline-containing_regimen> <Subsumes> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Anthracycline-containing_regimen> <Subsumes> "Cisplatin,_Epirubicin,_Ifosfamide" .
<Anthracycline-containing_regimen> <Subsumes> "Cisplatin,_Doxorubicin,_Paclitaxel" .
<Anthracycline-containing_regimen> <Subsumes> "Cisplatin,_Doxorubicin_liposomal,_Fluorouracil" .
<Anthracycline-containing_regimen> <Subsumes> "Cisplatin_and_Epirubicin" .
<Anthracycline-containing_regimen> <Subsumes> "Cisplatin_and_Doxorubicin" .
<Anthracycline-containing_regimen> <Subsumes> "ChlVPP/PABIOE" .
<Anthracycline-containing_regimen> <Subsumes> "ChlVPP/EVA" .
<Anthracycline-containing_regimen> <Subsumes> "Carmustine_and_Doxorubicin" .
<Anthracycline-containing_regimen> <Subsumes> "Carboplatin_and_Doxorubicin_liposomal" .
<Anthracycline-containing_regimen> <Subsumes> "Calaspargase,_Daunorubicin,_Vincristine,_Prednisone" .
<Anthracycline-containing_regimen> <Subsumes> "CVAP" .
<Anthracycline-containing_regimen> <Subsumes> "CVAD" .
<Anthracycline-containing_regimen> <Subsumes> "CPX-351_monotherapy" .
<Anthracycline-containing_regimen> <Subsumes> "COPP/ABVD" .
<Anthracycline-containing_regimen> <Subsumes> "COPADM" .
<Anthracycline-containing_regimen> <Subsumes> "COPAD/CYVE" .
<Anthracycline-containing_regimen> <Subsumes> "COPAD" .
<Anthracycline-containing_regimen> <Subsumes> "COPA" .
<Anthracycline-containing_regimen> <Subsumes> "CODOX-M/IVAC" .
<Anthracycline-containing_regimen> <Subsumes> "CODOX-M" .
<Anthracycline-containing_regimen> <Subsumes> "CNOP_(Prednisolone)" .
<Anthracycline-containing_regimen> <Subsumes> "CNOP" .
<Anthracycline-containing_regimen> <Subsumes> "CMC" .
<Anthracycline-containing_regimen> <Subsumes> "CLAG-M" .
<Anthracycline-containing_regimen> <Subsumes> "CISCA/VB" .
<Anthracycline-containing_regimen> <Subsumes> "CISCA" .
<Anthracycline-containing_regimen> <Subsumes> "CIA" .
<Anthracycline-containing_regimen> <Subsumes> "CHVmP-VB" .
<Anthracycline-containing_regimen> <Subsumes> "CHVmP" .
<Anthracycline-containing_regimen> <Subsumes> "CHVP-I" .
<Anthracycline-containing_regimen> <Subsumes> "CHVP" .
<Anthracycline-containing_regimen> <Subsumes> "CHOP-BCG" .
<Anthracycline-containing_regimen> <Subsumes> "CHOP-B" .
<Anthracycline-containing_regimen> <Subsumes> "CHOP-AL" .
<Anthracycline-containing_regimen> <Subsumes> "CHOP-14" .
<Anthracycline-containing_regimen> <Subsumes> "CHOP,_then_131Iodine-Tositumomab" .
<Anthracycline-containing_regimen> <Subsumes> "CHOP_and_Everolimus" .
<Anthracycline-containing_regimen> <Subsumes> "CHOP_Modified_(Prednisolone)" .
<Anthracycline-containing_regimen> <Subsumes> "CHOP_Modified" .
<Anthracycline-containing_regimen> <Subsumes> "CHOP_(Prednisolone)" .
<Anthracycline-containing_regimen> <Subsumes> "CHOP" .
<Anthracycline-containing_regimen> <Subsumes> "CHOEP-21" .
<Anthracycline-containing_regimen> <Subsumes> "CHOEP-14" .
<Anthracycline-containing_regimen> <Subsumes> "CHAD" .
<Anthracycline-containing_regimen> <Subsumes> "CEV_and_RT" .
<Anthracycline-containing_regimen> <Subsumes> "CEV_(Cyclophosphamide/Epirubicin)" .
<Anthracycline-containing_regimen> <Subsumes> "CEP" .
<Anthracycline-containing_regimen> <Subsumes> "CEOP_(Prednisolone)" .
<Anthracycline-containing_regimen> <Subsumes> "CEOP" .
<Anthracycline-containing_regimen> <Subsumes> "CEF/CMF" .
<Anthracycline-containing_regimen> <Subsumes> "CEEP" .
<Anthracycline-containing_regimen> <Subsumes> "CDE" .
<Anthracycline-containing_regimen> <Subsumes> "CCOP" .
<Anthracycline-containing_regimen> <Subsumes> "CC/DE_and_RT" .
<Anthracycline-containing_regimen> <Subsumes> "CBVM,_then_auto_HSCT" .
<Anthracycline-containing_regimen> <Subsumes> "CBV-Mx,_then_auto_HSCT" .
<Anthracycline-containing_regimen> <Subsumes> "CBV-Mx" .
<Anthracycline-containing_regimen> <Subsumes> "CAVE" .
<Anthracycline-containing_regimen> <Subsumes> "CAV/PE" .
<Anthracycline-containing_regimen> <Subsumes> "CAV_and_RT" .
<Anthracycline-containing_regimen> <Subsumes> "CAV" .
<Anthracycline-containing_regimen> <Subsumes> "CAP-BOP" .
<Anthracycline-containing_regimen> <Subsumes> "CAP_(Platinol)" .
<Anthracycline-containing_regimen> <Subsumes> "CAP" .
<Anthracycline-containing_regimen> <Subsumes> "CAMP" .
<Anthracycline-containing_regimen> <Subsumes> "CAMFP" .
<Anthracycline-containing_regimen> <Subsumes> "CAMF" .
<Anthracycline-containing_regimen> <Subsumes> "CALGB_8811_late_intensification" .
<Anthracycline-containing_regimen> <Subsumes> "CALGB_10-002_regimen" .
<Anthracycline-containing_regimen> <Subsumes> "CAFVP" .
<Anthracycline-containing_regimen> <Subsumes> "CAF_and_MPA" .
<Anthracycline-containing_regimen> <Subsumes> "CAD_and_G-CSF" .
<Anthracycline-containing_regimen> <Subsumes> "C-VAMP" .
<Anthracycline-containing_regimen> <Subsumes> "C-MOPP/ABV" .
<Anthracycline-containing_regimen> <Subsumes> "Bortezomib_and_Doxorubicin_liposomal" .
<Anthracycline-containing_regimen> <Subsumes> "BVDS" .
<Anthracycline-containing_regimen> <Subsumes> "BV-CHP" .
<Anthracycline-containing_regimen> <Subsumes> "BEACOPP-14_(Prednisolone)" .
<Anthracycline-containing_regimen> <Subsumes> "BEACOPP-14" .
<Anthracycline-containing_regimen> <Subsumes> "BEACOPP" .
<Anthracycline-containing_regimen> <Subsumes> "BCHOP" .
<Anthracycline-containing_regimen> <Subsumes> "BACO" .
<Anthracycline-containing_regimen> <Subsumes> "B-CAVe" .
<Anthracycline-containing_regimen> <Subsumes> "Augmented_Hyper-CVAD_and_Asparaginase" .
<Anthracycline-containing_regimen> <Subsumes> "Arsenic_trioxide,_then_ATRA_and_Daunorubicin" .
<Anthracycline-containing_regimen> <Subsumes> "Arsenic_trioxide,_ATRA,_Idarubicin" .
<Anthracycline-containing_regimen> <Subsumes> "Arsenic_trioxide_and_Idarubicin" .
<Anthracycline-containing_regimen> <Subsumes> "Amrubicin_monotherapy" .
<Anthracycline-containing_regimen> <Subsumes> "AVD" .
<Anthracycline-containing_regimen> <Subsumes> "AVCF" .
<Anthracycline-containing_regimen> <Subsumes> "AV-CMF" .
<Anthracycline-containing_regimen> <Subsumes> "ATRA,_Cytarabine,_Idarubicin" .
<Anthracycline-containing_regimen> <Subsumes> "ATRA,_Cytarabine,_Daunorubicin" .
<Anthracycline-containing_regimen> <Subsumes> "ATRA_and_Idarubicin" .
<Anthracycline-containing_regimen> <Subsumes> "ATRA_and_Daunorubicin" .
<Anthracycline-containing_regimen> <Subsumes> "AT_(Taxotere)" .
<Anthracycline-containing_regimen> <Subsumes> "AT_(Taxol)" .
<Anthracycline-containing_regimen> <Subsumes> "APO" .
<Anthracycline-containing_regimen> <Subsumes> "AIE" .
<Anthracycline-containing_regimen> <Subsumes> "ADOC" .
<Anthracycline-containing_regimen> <Subsumes> "ADE_and_ATRA" .
<Anthracycline-containing_regimen> <Subsumes> "ADE_(standard-dose_Ara-C)" .
<Anthracycline-containing_regimen> <Subsumes> "ADE_(high-dose_Ara-C)" .
<Anthracycline-containing_regimen> <Subsumes> "ACVBP-R" .
<Anthracycline-containing_regimen> <Subsumes> "ACVBP,_dose-adjusted" .
<Anthracycline-containing_regimen> <Subsumes> "ACVBP" .
<Anthracycline-containing_regimen> <Subsumes> "ACT" .
<Anthracycline-containing_regimen> <Subsumes> "ACOMLA" .
<Anthracycline-containing_regimen> <Subsumes> "ACH" .
<Anthracycline-containing_regimen> <Subsumes> "ACE" .
<Anthracycline-containing_regimen> <Subsumes> "AC-T" .
<Anthracycline-containing_regimen> <Subsumes> "AC_and_Bevacizumab" .
<Anthracycline-containing_regimen> <Subsumes> "AC" .
<Anthracycline-containing_regimen> <Subsumes> "ABVE-PC" .
<Anthracycline-containing_regimen> <Subsumes> "ABVDm" .
<Anthracycline-containing_regimen> <Subsumes> "ABVD,_DD-DI" .
<Anthracycline-containing_regimen> <Subsumes> "ABVD" .
<Anthracycline-containing_regimen> <Subsumes> "ABV_(Vincristine)" .
<Anthracycline-containing_regimen> <Subsumes> "ABV_(Vinblastine)" .
<Anthracycline-containing_regimen> <Subsumes> "ABP" .
<Anthracycline-containing_regimen> <Subsumes> "ABDIC" .
<Anthracycline-containing_regimen> <Subsumes> "ABCM" .
<Anthracycline-containing_regimen> <Subsumes> "A-AVD" .
<Anthracycline-containing_regimen> <Subsumes> "7_plus_5i" .
<Anthracycline-containing_regimen> <Subsumes> "7_plus_3m" .
<Anthracycline-containing_regimen> <Subsumes> "7_plus_3i_and_Vorinostat" .
<Anthracycline-containing_regimen> <Subsumes> "7_plus_3i_and_Sorafenib" .
<Anthracycline-containing_regimen> <Subsumes> "7_plus_3i_and_Panobinostat" .
<Anthracycline-containing_regimen> <Subsumes> "7_plus_3i" .
<Anthracycline-containing_regimen> <Subsumes> "7_plus_3d_and_Sorafenib" .
<Anthracycline-containing_regimen> <Subsumes> "7_plus_3d_and_Midostaurin" .
<Anthracycline-containing_regimen> <Subsumes> "7_plus_3d_and_Glasdegib" .
<Anthracycline-containing_regimen> <Subsumes> "7_plus_3d_and_GO" .
<Anthracycline-containing_regimen> <Subsumes> "7_plus_3d" .
<Anthracycline-containing_regimen> <Subsumes> "5_plus_3i" .
<Anthracycline-containing_regimen> <Subsumes> "5_plus_3d" .
<Anthracycline-containing_regimen> <Subsumes> "5_plus_2d" .
<Deposet> <Brand_name_of> "Methylprednisolone" .
<Ofatumumab_monotherapy> <Has_context> "Non-curative_therapy" .
<Ofatumumab_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Ofatumumab_monotherapy> <Has_context> "Non-curative_subsequent-line_consolidation_therapy" .
<Ofatumumab_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Ofatumumab_monotherapy> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<CMFV> <Has_modality> "Chemotherapy" .
<Dara-VD> <Has_modality> "Chemotherapy" .
<EAR_and_G-CSF> <Has_modality> "Chemotherapy" .
<Bosutinib_monotherapy> <Mapped_from> "Bosutinib_monotherapy" .
<Venetoclax_monotherapy> <Has_context> "Non-curative_therapy" .
<RT-PEPC> <Has_supportive_med> "Aspirin" .
<Radiotherapy_medication> <Subsumes> "Tositumomab_&_I-131" .
<Radiotherapy_medication> <Subsumes> "Strontium-89" .
<Radiotherapy_medication> <Subsumes> "Samarium-153" .
<Radiotherapy_medication> <Subsumes> "Radium-223" .
<Radiotherapy_medication> <Subsumes> "Radioimmunotherapeutic" .
<Radiotherapy_medication> <Subsumes> "Lutetium_Lu_177_dotatate" .
<Radiotherapy_medication> <Subsumes> "Iodine-131" .
<Radiotherapy_medication> <Subsumes> "Ibritumomab_tiuxetan" .
<Radiotherapy_medication> <Subsumes> "Alpha_emitter" .
<Radiotherapy_medication> <Subsumes> "Actinium_Ac_225_lintuzumab" .
<FLAG> <Has_supportive_med> "Lenograstim" .
<FLAG> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<FLAG> <Has_supportive_med> "Filgrastim" .
<Mucositis_prevention> <Is_a> "Supportive_medication" .
<Carboplatin,_Gemcitabine,_Bevacizumab> <Is_current_in> "Ovarian_cancer" .
<COP> <Has_antineoplastic> "Vincristine" .
<COP> <Has_antineoplastic> "Prednisone" .
<COP> <Has_antineoplastic> "Cyclophosphamide" .
<Ifosfamide_and_Methotrexate> <Maps_to> "Ifosfamide_and_Methotrexate" .
<Triptorelin_monotherapy> <Maps_to> "Triptorelin_monotherapy" .
<Carmustine> <Has_accepted_use> "Melanoma" .
<Carmustine> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Carmustine> <Has_accepted_use> "Hodgkin_lymphoma" .
<Carmustine> <Has_accepted_use> "HIV-associated_lymphoma" .
<Carmustine> <Has_accepted_use> "Glioblastoma" .
<Carmustine> <Has_accepted_use> "Follicular_lymphoma" .
<Carmustine> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Carmustine> <Has_accepted_use> "CNS_lymphoma" .
<Carmustine> <Has_accepted_use> "Anaplastic_glioma" .
<Lomidine> <Brand_name_of> "Pentamidine" .
<R-FCM> <Maps_to> "R-FCM" .
<Drugs_EMA_approved_in_2013> <Subsumes> "Pixantrone" .
<Yervoy> <Brand_name_of> "Ipilimumab" .
<Leustatin> <Brand_name_of> "Cladribine" .
<BuCyTBI> <Mapped_from> "BuCyTBI" .
<EPIC_regimen> <Has_modality> "Chemotherapy" .
<Trastuzumab> <Has_FDA_indication> "Gastric_cancer" .
<Trastuzumab> <Has_FDA_indication> "Breast_cancer" .
<Herpex> <Brand_name_of> "Acyclovir" .
<Wilfactin> <Brand_name_of> "Von_Willebrand_factor_and_factor_VIII_complex_human" .
<Curaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Idelalisib_and_Ofatumumab> <Maps_to> "Idelalisib_and_Ofatumumab" .
<Thrombotic_thrombocytopenic_purpura> <Is_a> "Thrombotic_disorder" .
<Thrombotic_thrombocytopenic_purpura> <Is_a> "Cytopenia" .
<Thrombotic_thrombocytopenic_purpura> <Is_a> "Autoimmune_hematologic_condition" .
<Monoclate-P> <Brand_name_of> "Factor_VIII_human" .
<Crenolanib> <Is_a> "PDGFR_inhibitor" .
<Crenolanib> <Is_a> "Kinase_inhibitor" .
<Crenolanib> <Is_a> "Investigational_drug" .
<Crenolanib> <Is_a> "FLT3_inhibitor" .
<CO-Trimoxazol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<RhIG_monotherapy> <Has_context> "Induction_therapy" .
<Hydroxyurea_and_RT> <Has_accepted_use> "Cervical_cancer" .
<Pegylated_liposomal_doxorubicin> <May_have_route> "Intravenous" .
<Gemcitabine_monotherapy> <Has_context> "Non-curative_therapy" .
<Gemcitabine_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Gemcitabine_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Gemcitabine_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Gemcitabine_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Gemcitabine_monotherapy> <Has_context> "Local_therapy" .
<Gemcitabine_monotherapy> <Has_context> "Induction_therapy" .
<Gemcitabine_monotherapy> <Has_context> "Adjuvant_therapy" .
<Leuprolide> <Has_accepted_use> "Prostate_cancer" .
<Leuprolide> <Has_accepted_use> "Breast_cancer" .
<Calfolin> <Brand_name_of> "Folinic_acid" .
<Indocid> <Brand_name_of> "Indomethacin" .
<Medrol> <Brand_name_of> "Methylprednisolone" .
<R-miniCHOP> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<R-miniCHOP> <Has_supportive_med> "Filgrastim" .
<Quinine> <Antineoplastic_of> "VAD-P/Q" .
<mFOLFOX6_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<RVD> <Has_supportive_med> "Valacyclovir" .
<RVD> <Has_supportive_med> "Low_molecular_weight_heparins" .
<RVD> <Has_supportive_med> "Bisphosphonates" .
<RVD> <Has_supportive_med> "Aspirin" .
<RVD> <Has_supportive_med> "Antivirals" .
<RVD> <Has_supportive_med> "Antibacterials" .
<RVD> <Has_supportive_med> "Amoxicillin" .
<RVD> <Has_supportive_med> "Acyclovir" .
<Daltepin> <Brand_name_of> "Dalteparin" .
<Lomustine_monotherapy> <Is_current_in> "Glioblastoma" .
<CLF> <Has_antineoplastic> "Folinic_acid" .
<CLF> <Has_antineoplastic> "Fluorouracil" .
<CLF> <Has_antineoplastic> "Cisplatin" .
<Methotrexate,_Pegaspargase,_Vincristine> <Has_antineoplastic> "Vincristine" .
<Methotrexate,_Pegaspargase,_Vincristine> <Has_antineoplastic> "Pegaspargase" .
<Methotrexate,_Pegaspargase,_Vincristine> <Has_antineoplastic> "Methotrexate" .
<Tevalen> <Brand_name_of> "Alendronate" .
<Mesna> <May_have_route> "Oral" .
<Mesna> <May_have_route> "Intravenous" .
<Olaparib> <Has_FDA_indication> "Pancreatic_cancer" .
<Olaparib> <Has_FDA_indication> "Ovarian_cancer" .
<Olaparib> <Has_FDA_indication> "Breast_cancer" .
<Ebetrexat> <Brand_name_of> "Methotrexate" .
<Temozolomide_and_NovoTTF-100A> <Has_local_therapy> "NovoTTF-100A_system_(Optune)" .
<Cisplatin,_Lomustine,_Vincristine> <Has_antineoplastic> "Vincristine" .
<Cisplatin,_Lomustine,_Vincristine> <Has_antineoplastic> "Lomustine" .
<Cisplatin,_Lomustine,_Vincristine> <Has_antineoplastic> "Cisplatin" .
<Carboplatin_and_Etoposide,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Tinzaparin_monotherapy> <Has_supportive_med> "Tinzaparin" .
<Peginterferon_alfa-2a_monotherapy> <Is_current_in> "Polycythemia_vera" .
<Peginterferon_alfa-2a_monotherapy> <Is_current_in> "Hypereosinophilic_syndrome" .
<Peginterferon_alfa-2a_monotherapy> <Is_current_in> "Essential_thrombocythemia" .
<Goserelin_and_RT> <Mapped_from> "Goserelin_and_RT" .
<Trastuzumab_monotherapy> <Has_modality> "Chemotherapy" .
<Interferon_gamma-1b> <Is_a> "Interferon" .
<Interferon_gamma-1b> <Is_a> "Immunotherapeutic" .
<Temozolomide_and_RT> <Has_accepted_use> "Glioblastoma" .
<Temozolomide_and_RT> <Has_accepted_use> "Anaplastic_glioma" .
<FCM> <Mapped_from> "FCM" .
<Antifibrinolytic_therapy> <Maps_to> "Antifibrinolytic_therapy" .
<MCF> <Has_antineoplastic> "Mitomycin" .
<MCF> <Has_antineoplastic> "Fluorouracil" .
<MCF> <Has_antineoplastic> "Cisplatin" .
<PACEBOM> <Has_antineoplastic> "Vincristine" .
<PACEBOM> <Has_antineoplastic> "Prednisolone" .
<PACEBOM> <Has_antineoplastic> "Methotrexate" .
<PACEBOM> <Has_antineoplastic> "Etoposide" .
<PACEBOM> <Has_antineoplastic> "Doxorubicin" .
<PACEBOM> <Has_antineoplastic> "Cyclophosphamide" .
<PACEBOM> <Has_antineoplastic> "Bleomycin" .
<Ferrodex> <Brand_name_of> "Iron_dextran" .
<Tamoxifen_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Tamoxifen_monotherapy> <Has_accepted_use> "Hereditary_hemorrhagic_telangiectasia" .
<Tamoxifen_monotherapy> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Tamoxifen_monotherapy> <Has_accepted_use> "Endometrial_cancer" .
<Tamoxifen_monotherapy> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Tamoxifen_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Vismodegib_monotherapy> <Has_antineoplastic> "Vismodegib" .
<Docetaxel_and_Gemcitabine> <Is_current_in> "Soft_tissue_sarcoma" .
<Docetaxel_and_Gemcitabine> <Is_current_in> "Osteosarcoma" .
<Docetaxel_and_Gemcitabine> <Is_current_in> "Leiomyosarcoma" .
<Docetaxel_and_Gemcitabine> <Is_current_in> "Ewing_sarcoma" .
<Docetaxel_and_Gemcitabine> <Is_current_in> "Breast_cancer" .
<Docetaxel_and_Gemcitabine> <Is_current_in> "Adenocarcinoma_of_unknown_primary" .
<Osteomepha> <Brand_name_of> "Alendronate" .
<Immunomodulatory_drugs_(IMiDs)> <Subsumes> "Thalidomide" .
<Immunomodulatory_drugs_(IMiDs)> <Subsumes> "Pomalidomide" .
<Immunomodulatory_drugs_(IMiDs)> <Subsumes> "Lenalidomide" .
<DA_3_plus_10> <Maps_to> "DA_3_plus_10" .
<Ultrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Temozolomide_and_low-dose_RT> <Has_context> "Adjuvant_therapy" .
<R-MACLO/R-IVAM> <Is_a> "Rituximab-containing_regimen" .
<R-MACLO/R-IVAM> <Is_a> "Anthracycline-containing_regimen" .
<Trastuzumab_and_hyaluronidase_monotherapy> <Mapped_from> "Trastuzumab_and_hyaluronidase_monotherapy" .
<Neratinib_and_Paclitaxel> <Has_context> "Neoadjuvant_therapy" .
<Peginterferon_alfa-2b_monotherapy> <Is_current_in> "Melanoma" .
<BEACOPP-14> <Maps_to> "BEACOPP-14" .
<Imatinib_and_Prednisone> <Has_local_therapy> "Methotrexate" .
<PEP-C> <Is_current_in> "Mantle_cell_lymphoma" .
<PEP-C> <Is_current_in> "Follicular_lymphoma" .
<EPOCH> <Is_a> "Anthracycline-containing_regimen" .
<Rivaroxaban> <Supportive_med_of> "Rivaroxaban_monotherapy" .
<Adiprin> <Brand_name_of> "Aspirin" .
<Apalutamide_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<Epirubicin_monotherapy> <Maps_to> "Epirubicin_monotherapy" .
<Hyper-CVAD/MA_and_Everolimus> <Has_supportive_med> "Pegfilgrastim" .
<Hyper-CVAD/MA_and_Everolimus> <Has_supportive_med> "Mesna" .
<Inherited_coagulopathy> <Accepted_use_of> "Rituximab-pvvr" .
<Inherited_coagulopathy> <Accepted_use_of> "Rituximab-abbs" .
<Inherited_coagulopathy> <Accepted_use_of> "Rituximab_monotherapy" .
<Inherited_coagulopathy> <Accepted_use_of> "Rituximab" .
<Inherited_coagulopathy> <Accepted_use_of> "Factor_XIII_concentrate_human" .
<Inherited_coagulopathy> <Accepted_use_of> "Factor_VIII_recombinant" .
<Inherited_coagulopathy> <Accepted_use_of> "Factor_VIII_human" .
<Inherited_coagulopathy> <Accepted_use_of> "Factor_IX_recombinant_Fc_fusion_protein" .
<Inherited_coagulopathy> <Accepted_use_of> "Factor_IX_recombinant" .
<Inherited_coagulopathy> <Accepted_use_of> "Factor_IX_human" .
<Inherited_coagulopathy> <Accepted_use_of> "Emicizumab_monotherapy" .
<Inherited_coagulopathy> <Accepted_use_of> "Emicizumab" .
<Inherited_coagulopathy> <Accepted_use_of> "Antithrombin_III" .
<Interferon> <Subsumes> "Ropeginterferon_alfa-2b" .
<Interferon> <Subsumes> "Peginterferon_alfa-2b" .
<Interferon> <Subsumes> "Peginterferon_alfa-2a" .
<Interferon> <Subsumes> "Interferon_gamma-1b" .
<Interferon> <Subsumes> "Interferon_alfa-2b" .
<Interferon> <Subsumes> "Interferon_alfa-2a" .
<Dara-Rd> <Maps_to> "Dara-Rd" .
<Roubac> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Kemoprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Radotinib> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Cyclosporine_and_Prednisone> <Has_immunosuppressor> "Prednisone" .
<Cyclosporine_and_Prednisone> <Has_immunosuppressor> "Cyclosporines" .
<Synotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<RABVD> <Has_modality> "Chemotherapy" .
<Interferon_alfa_and_Dexamethasone> <Has_antineoplastic> "Interferons" .
<Interferon_alfa_and_Dexamethasone> <Has_antineoplastic> "Dexamethasone" .
<Carfilzomib_and_Panobinostat> <Has_context> "Non-curative_therapy" .
<Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_context> "Non-curative_subsequent-line_consolidation_therapy" .
<Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_context> "Consolidation_after_upfront_therapy" .
<Fludarabine,_Busulfan,_ATG> <Mapped_from> "Fludarabine,_Busulfan,_ATG" .
<NRAS-mutated_Melanoma> <Accepted_use_of> "Dacarbazine_monotherapy" .
<NRAS-mutated_Melanoma> <Accepted_use_of> "Binimetinib_monotherapy" .
<Temozolomide_and_RT> <Maps_to> "Temozolomide_and_RT" .
<ACVBP-R> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<GemOx> <Has_modality> "Chemotherapy" .
<Bleomycin_and_Cisplatin> <Is_current_in> "Cutaneous_squamous_cell_carcinoma" .
<Bleomycin_and_Cisplatin> <Is_current_in> "Cutaneous_basal_cell_carcinoma" .
<Accelerated_BEP> <Has_context> "Upfront_therapy" .
<Tranexamic_acid_monotherapy> <Has_context> "All_lines_of_therapy" .
<BEAC> <Is_current_in> "Autologous_HSCT" .
<Cyclophosphamide_and_Prednisolone> <Is_current_in> "Acquired_coagulopathy" .
<Atypical_hemolytic_uremic_syndrome> <FDA_indication_of> "Eculizumab" .
<eBEACOPP_(Prednisolone)> <Has_supportive_med> "Pegfilgrastim" .
<eBEACOPP_(Prednisolone)> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Carboplatin_and_Bevacizumab> <Maps_to> "Carboplatin_and_Bevacizumab" .
<Drovitan> <Brand_name_of> "Alendronate" .
<FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation> <Has_modality> "Chemotherapy" .
<FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation> <Has_modality> "Chemoradiotherapy" .
<Lapatinib_and_Letrozole> <Maps_to> "Lapatinib_and_Letrozole" .
<Exemestane_and_Tucidinostat> <Has_antineoplastic> "Exemestane" .
<Exemestane_and_Tucidinostat> <Has_antineoplastic> "Chidamide" .
<Blinatumomab_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Blinatumomab_monotherapy> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Anti-IGF-1R_antibody> <Is_a> "Antibody_medication" .
<PACEBOM> <Has_context> "Induction_therapy" .
<FLOX> <Has_accepted_use> "Colon_cancer" .
<Acetosal> <Brand_name_of> "Aspirin" .
<Avelumab_monotherapy> <Has_supportive_med> "Diphenhydramine" .
<Avelumab_monotherapy> <Has_supportive_med> "Antihistamines" .
<Avelumab_monotherapy> <Has_supportive_med> "Acetaminophen" .
<Procarbazine> <Has_brand_name> "P-Carzine" .
<Procarbazine> <Has_brand_name> "Natulanar" .
<Procarbazine> <Has_brand_name> "Natulan" .
<Procarbazine> <Has_brand_name> "Matulane" .
<Procarbazine> <Has_brand_name> "Indicarb" .
<Cisplatin_and_Fluorouracil> <Maps_to> "Cisplatin_and_Fluorouracil" .
<Binimetinib,_Encorafenib,_Cetuximab> <Is_current_in> "Colon_cancer" .
<ATG_(Horse),_Cyclosporine,_Methylprednisolone> <Has_context> "Induction_therapy" .
<Clemastine> <Has_brand_name> "Tavist" .
<Clemastine> <Has_brand_name> "Tavegil" .
<Clemastine> <Has_brand_name> "Dayhist" .
<Clemastine> <Has_brand_name> "Clamist" .
<Dexaltin> <Brand_name_of> "Dexamethasone" .
<ATG_(Horse)_monotherapy> <Maps_to> "ATG_(Horse)_monotherapy" .
<Methylprednisolone> <Antineoplastic_of> "VAMP" .
<Methylprednisolone> <Antineoplastic_of> "R-ESHAP" .
<Methylprednisolone> <Antineoplastic_of> "R-CP" .
<Methylprednisolone> <Antineoplastic_of> "O-ESHAP" .
<Methylprednisolone> <Antineoplastic_of> "Melphalan_and_Methylprednisolone,_then_auto_HSCT" .
<Methylprednisolone> <Antineoplastic_of> "MVBP" .
<Methylprednisolone> <Antineoplastic_of> "Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone" .
<Methylprednisolone> <Antineoplastic_of> "Hyper-CVAD/MA_and_Everolimus" .
<Methylprednisolone> <Antineoplastic_of> "Hyper-CVAD/MA" .
<Methylprednisolone> <Antineoplastic_of> "HDMP-R" .
<Methylprednisolone> <Antineoplastic_of> "HDMP" .
<Methylprednisolone> <Antineoplastic_of> "ESHAP" .
<Methylprednisolone> <Antineoplastic_of> "DEP" .
<Methylprednisolone> <Antineoplastic_of> "C-VAMP" .
<Methylprednisolone> <Antineoplastic_of> "Alemtuzumab_and_Methylprednisolone" .
<Methylprednisolone> <Antineoplastic_of> "ABVDm" .
<RABVD> <Has_context> "Induction_therapy" .
<SC-EPOCH-RR> <Has_modality> "Chemotherapy" .
<Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat> <Has_antineoplastic> "Thalidomide" .
<Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat> <Has_antineoplastic> "Panobinostat" .
<Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat> <Has_antineoplastic> "Dexamethasone" .
<Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat> <Has_antineoplastic> "Bortezomib" .
<Everolimus_monotherapy> <Maps_to> "Everolimus_monotherapy" .
<Etoposide_monotherapy> <Has_modality> "Chemotherapy" .
<Thoracic_cancer> <Subsumes> "Thymoma" .
<Thoracic_cancer> <Subsumes> "Mesothelioma" .
<Thoracic_cancer> <Subsumes> "Lung_cancer" .
<Ranimustine> <May_have_route> "Intravenous" .
<Fexadron> <Brand_name_of> "Dexamethasone" .
<Fluorouracil_and_RT> <Maps_to> "Fluorouracil_and_RT" .
<Lomustine,_Vincristine,_Prednisone> <Mapped_from> "Lomustine,_Vincristine,_Prednisone" .
<Vincrisol> <Brand_name_of> "Vincristine" .
<Apixaban_monotherapy> <Maps_to> "Apixaban_monotherapy" .
<R-COPADM> <Is_a> "Rituximab-containing_regimen" .
<R-COPADM> <Is_a> "Anthracycline-containing_regimen" .
<Mesurin> <Brand_name_of> "Methylprednisolone" .
<Cyclophosphamide> <Antineoplastic_of> "maxi-R-CHOP/R-HiDAC" .
<Cyclophosphamide> <Antineoplastic_of> "mLSG15" .
<Cyclophosphamide> <Antineoplastic_of> "mCOP/MP" .
<Cyclophosphamide> <Antineoplastic_of> "m-BNCOD" .
<Cyclophosphamide> <Antineoplastic_of> "m-BACOD" .
<Cyclophosphamide> <Antineoplastic_of> "iddEPC" .
<Cyclophosphamide> <Antineoplastic_of> "eBEACOPP_(Prednisolone)" .
<Cyclophosphamide> <Antineoplastic_of> "eBEACOPP" .
<Cyclophosphamide> <Antineoplastic_of> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Cyclophosphamide> <Antineoplastic_of> "dmCODOX-M_-_Modified_Magrath" .
<Cyclophosphamide> <Antineoplastic_of> "ddFEC" .
<Cyclophosphamide> <Antineoplastic_of> "ddEC" .
<Cyclophosphamide> <Antineoplastic_of> "ddC" .
<Cyclophosphamide> <Antineoplastic_of> "ddAC-T" .
<Cyclophosphamide> <Antineoplastic_of> "ddAC" .
<Cyclophosphamide> <Antineoplastic_of> "VcR-CVAD" .
<Cyclophosphamide> <Antineoplastic_of> "VTD-PACE" .
<Cyclophosphamide> <Antineoplastic_of> "VR-CP" .
<Cyclophosphamide> <Antineoplastic_of> "VR-CHOP" .
<Cyclophosphamide> <Antineoplastic_of> "VR-CAP" .
<Cyclophosphamide> <Antineoplastic_of> "VNCOP-B" .
<Cyclophosphamide> <Antineoplastic_of> "VMV-VAC" .
<Cyclophosphamide> <Antineoplastic_of> "VMCP/VCAP" .
<Cyclophosphamide> <Antineoplastic_of> "VMCP/VBAP" .
<Cyclophosphamide> <Antineoplastic_of> "VMCP" .
<Cyclophosphamide> <Antineoplastic_of> "VI,_then_VDC/IE,_then_VAC,_then_VI" .
<Cyclophosphamide> <Antineoplastic_of> "VEPEMB" .
<Cyclophosphamide> <Antineoplastic_of> "VEPA" .
<Cyclophosphamide> <Antineoplastic_of> "VEBEP" .
<Cyclophosphamide> <Antineoplastic_of> "VDC/IE" .
<Cyclophosphamide> <Antineoplastic_of> "VDC" .
<Cyclophosphamide> <Antineoplastic_of> "VCP" .
<Cyclophosphamide> <Antineoplastic_of> "VCAP" .
<Cyclophosphamide> <Antineoplastic_of> "VBMCP/VBAD" .
<Cyclophosphamide> <Antineoplastic_of> "VBMCP" .
<Cyclophosphamide> <Antineoplastic_of> "VBMC" .
<Cyclophosphamide> <Antineoplastic_of> "VAdCA/IE" .
<Cyclophosphamide> <Antineoplastic_of> "VAdCA" .
<Cyclophosphamide> <Antineoplastic_of> "VACOP-B" .
<Cyclophosphamide> <Antineoplastic_of> "VACA/IE" .
<Cyclophosphamide> <Antineoplastic_of> "VACA" .
<Cyclophosphamide> <Antineoplastic_of> "VAC_(Adriamycin)" .
<Cyclophosphamide> <Antineoplastic_of> "VAC" .
<Cyclophosphamide> <Antineoplastic_of> "VAB-6" .
<Cyclophosphamide> <Antineoplastic_of> "V-HyperCAD" .
<Cyclophosphamide> <Antineoplastic_of> "Total_Therapy" .
<Cyclophosphamide> <Antineoplastic_of> "Tisagenlecleucel_monotherapy" .
<Cyclophosphamide> <Antineoplastic_of> "TFC,_then_allo_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "TCP" .
<Cyclophosphamide> <Antineoplastic_of> "TCH_(Taxotere,_Cyclophosphamide)" .
<Cyclophosphamide> <Antineoplastic_of> "TC,_then_IE,_VDoxoC,_VEC" .
<Cyclophosphamide> <Antineoplastic_of> "TC_(Taxotere)" .
<Cyclophosphamide> <Antineoplastic_of> "TAC_(Taxotere)" .
<Cyclophosphamide> <Antineoplastic_of> "STAMP-I" .
<Cyclophosphamide> <Antineoplastic_of> "SC-EPOCH-RR" .
<Cyclophosphamide> <Antineoplastic_of> "RVDC" .
<Cyclophosphamide> <Antineoplastic_of> "RT-PEPC" .
<Cyclophosphamide> <Antineoplastic_of> "RCC" .
<Cyclophosphamide> <Antineoplastic_of> "R2CHOP" .
<Cyclophosphamide> <Antineoplastic_of> "R-miniCHOP" .
<Cyclophosphamide> <Antineoplastic_of> "R-miniCEOP" .
<Cyclophosphamide> <Antineoplastic_of> "R-TBI/Cy,_then_auto_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "R-TBI/Cy" .
<Cyclophosphamide> <Antineoplastic_of> "R-MegaCHOP-14" .
<Cyclophosphamide> <Antineoplastic_of> "R-MegaCHOP" .
<Cyclophosphamide> <Antineoplastic_of> "R-MACLO/R-IVAM" .
<Cyclophosphamide> <Antineoplastic_of> "R-M-CHOP" .
<Cyclophosphamide> <Antineoplastic_of> "R-Hyper-CVAD/R-MA" .
<Cyclophosphamide> <Antineoplastic_of> "R-GCVP" .
<Cyclophosphamide> <Antineoplastic_of> "R-FCM" .
<Cyclophosphamide> <Antineoplastic_of> "R-EPOCH,_dose-escalated" .
<Cyclophosphamide> <Antineoplastic_of> "R-EPOCH" .
<Cyclophosphamide> <Antineoplastic_of> "R-CVP" .
<Cyclophosphamide> <Antineoplastic_of> "R-CVEP" .
<Cyclophosphamide> <Antineoplastic_of> "R-CP" .
<Cyclophosphamide> <Antineoplastic_of> "R-COPADM" .
<Cyclophosphamide> <Antineoplastic_of> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Cyclophosphamide> <Antineoplastic_of> "R-CODOX-M/R-IVAC" .
<Cyclophosphamide> <Antineoplastic_of> "R-CODOX-M_(Doxil_substituted)" .
<Cyclophosphamide> <Antineoplastic_of> "R-CODOX-M" .
<Cyclophosphamide> <Antineoplastic_of> "R-CHVP_plus_I" .
<Cyclophosphamide> <Antineoplastic_of> "R-CHOP/R-DHAP" .
<Cyclophosphamide> <Antineoplastic_of> "R-CHOP-14_(Rituximab_Hycela)" .
<Cyclophosphamide> <Antineoplastic_of> "R-CHOP-14_(Prednisolone)" .
<Cyclophosphamide> <Antineoplastic_of> "R-CHOP-14" .
<Cyclophosphamide> <Antineoplastic_of> "R-CHOP_(Rituximab_Hycela)" .
<Cyclophosphamide> <Antineoplastic_of> "R-CHOP_(Prednisolone)" .
<Cyclophosphamide> <Antineoplastic_of> "R-CHOP" .
<Cyclophosphamide> <Antineoplastic_of> "R-CHOEP-14" .
<Cyclophosphamide> <Antineoplastic_of> "R-CHMP" .
<Cyclophosphamide> <Antineoplastic_of> "R-CEOP90_(Epirubicin)" .
<Cyclophosphamide> <Antineoplastic_of> "R-CEOP_(Etoposide)" .
<Cyclophosphamide> <Antineoplastic_of> "R-CDOP" .
<Cyclophosphamide> <Antineoplastic_of> "R,_then_CHOP" .
<Cyclophosphamide> <Antineoplastic_of> "ProMACE-MOPP" .
<Cyclophosphamide> <Antineoplastic_of> "ProMACE-CytaBOM" .
<Cyclophosphamide> <Antineoplastic_of> "Pediatric-like_GRAALL_consolidation" .
<Cyclophosphamide> <Antineoplastic_of> "PMitCEBO" .
<Cyclophosphamide> <Antineoplastic_of> "PEP-C" .
<Cyclophosphamide> <Antineoplastic_of> "PCR" .
<Cyclophosphamide> <Antineoplastic_of> "PCP" .
<Cyclophosphamide> <Antineoplastic_of> "PCO" .
<Cyclophosphamide> <Antineoplastic_of> "PCDE" .
<Cyclophosphamide> <Antineoplastic_of> "PCD" .
<Cyclophosphamide> <Antineoplastic_of> "PATCO" .
<Cyclophosphamide> <Antineoplastic_of> "PAD/VCD" .
<Cyclophosphamide> <Antineoplastic_of> "PACEBOM" .
<Cyclophosphamide> <Antineoplastic_of> "PAC" .
<Cyclophosphamide> <Antineoplastic_of> "P/DOCE" .
<Cyclophosphamide> <Antineoplastic_of> "O-miniCHOP" .
<Cyclophosphamide> <Antineoplastic_of> "O-FC" .
<Cyclophosphamide> <Antineoplastic_of> "O-CHOP" .
<Cyclophosphamide> <Antineoplastic_of> "Nordic_Regimen,_younger_patients" .
<Cyclophosphamide> <Antineoplastic_of> "Nordic_Regimen,_older_patients" .
<Cyclophosphamide> <Antineoplastic_of> "Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin" .
<Cyclophosphamide> <Antineoplastic_of> "Methotrexate,_RT,_Cyclophosphamide" .
<Cyclophosphamide> <Antineoplastic_of> "MC" .
<Cyclophosphamide> <Antineoplastic_of> "MACOP-B" .
<Cyclophosphamide> <Antineoplastic_of> "MACC" .
<Cyclophosphamide> <Antineoplastic_of> "MA-BCD/AP" .
<Cyclophosphamide> <Antineoplastic_of> "MA-BCD" .
<Cyclophosphamide> <Antineoplastic_of> "M-BCD" .
<Cyclophosphamide> <Antineoplastic_of> "LSG15" .
<Cyclophosphamide> <Antineoplastic_of> "LEED,_then_auto_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "LEED" .
<Cyclophosphamide> <Antineoplastic_of> "LD-ACOP-B" .
<Cyclophosphamide> <Antineoplastic_of> "KCD" .
<Cyclophosphamide> <Antineoplastic_of> "International_ALL_Trial" .
<Cyclophosphamide> <Antineoplastic_of> "Imatinib-based_consolidation" .
<Cyclophosphamide> <Antineoplastic_of> "IP-BCD" .
<Cyclophosphamide> <Antineoplastic_of> "HyperCHidam" .
<Cyclophosphamide> <Antineoplastic_of> "Hyper-CVAD/MA_and_Everolimus" .
<Cyclophosphamide> <Antineoplastic_of> "Hyper-CVAD/MA" .
<Cyclophosphamide> <Antineoplastic_of> "Hyper-CVAD_and_Ponatinib" .
<Cyclophosphamide> <Antineoplastic_of> "Hyper-CVAD_and_Imatinib" .
<Cyclophosphamide> <Antineoplastic_of> "Hyper-CVAD_and_Dasatinib" .
<Cyclophosphamide> <Antineoplastic_of> "Hyper-CVAD" .
<Cyclophosphamide> <Antineoplastic_of> "Hexa-CAF" .
<Cyclophosphamide> <Antineoplastic_of> "GMALL-R" .
<Cyclophosphamide> <Antineoplastic_of> "G-FC" .
<Cyclophosphamide> <Antineoplastic_of> "G-CVP" .
<Cyclophosphamide> <Antineoplastic_of> "G-CHOP" .
<Cyclophosphamide> <Antineoplastic_of> "Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant" .
<Cyclophosphamide> <Antineoplastic_of> "Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "Fludarabine,_Cyclophosphamide,_ATG" .
<Cyclophosphamide> <Antineoplastic_of> "Fludarabine,_Busulfan,_Cyclophosphamide" .
<Cyclophosphamide> <Antineoplastic_of> "FluBuCy,_then_allo_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "FNC" .
<Cyclophosphamide> <Antineoplastic_of> "FEC_and_H_(SC)" .
<Cyclophosphamide> <Antineoplastic_of> "FEC_and_H" .
<Cyclophosphamide> <Antineoplastic_of> "FEC_and_Bevacizumab" .
<Cyclophosphamide> <Antineoplastic_of> "FEC" .
<Cyclophosphamide> <Antineoplastic_of> "FCR,_then_allo_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "FCR_(Rituximab_Hycela)" .
<Cyclophosphamide> <Antineoplastic_of> "FCR" .
<Cyclophosphamide> <Antineoplastic_of> "FCM" .
<Cyclophosphamide> <Antineoplastic_of> "FCA" .
<Cyclophosphamide> <Antineoplastic_of> "FC,_then_allo_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "FC" .
<Cyclophosphamide> <Antineoplastic_of> "FAC_and_Bevacizumab" .
<Cyclophosphamide> <Antineoplastic_of> "FAC_and_BCG" .
<Cyclophosphamide> <Antineoplastic_of> "FAC" .
<Cyclophosphamide> <Antineoplastic_of> "F-MACHOP" .
<Cyclophosphamide> <Antineoplastic_of> "EPOCH,_dose-escalated" .
<Cyclophosphamide> <Antineoplastic_of> "EPOCH" .
<Cyclophosphamide> <Antineoplastic_of> "EMA-CO" .
<Cyclophosphamide> <Antineoplastic_of> "ECT,_then_auto_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "ECH" .
<Cyclophosphamide> <Antineoplastic_of> "EC_and_Bevacizumab" .
<Cyclophosphamide> <Antineoplastic_of> "EC" .
<Cyclophosphamide> <Antineoplastic_of> "DTPACE" .
<Cyclophosphamide> <Antineoplastic_of> "DRC" .
<Cyclophosphamide> <Antineoplastic_of> "DICEP" .
<Cyclophosphamide> <Antineoplastic_of> "DI_EC" .
<Cyclophosphamide> <Antineoplastic_of> "DD-CHOP" .
<Cyclophosphamide> <Antineoplastic_of> "DCEP_and_G-CSF" .
<Cyclophosphamide> <Antineoplastic_of> "DCEP" .
<Cyclophosphamide> <Antineoplastic_of> "DA-R-EPOCH" .
<Cyclophosphamide> <Antineoplastic_of> "DA-EPOCH" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide,_Prednisone,_Diethylstilbestrol" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide,_Lomustine,_Methotrexate" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide,_Fludarabine,_Thiotepa" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide,_Etoposide,_TBI" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide,_Dacarbazine,_Vincristine" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide_monotherapy" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide_and_Vincristine" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide_and_Topotecan" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide_and_TBI,_then_auto_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide_and_TBI,_then_allo_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide_and_TBI" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide_and_Prednisone" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide_and_G-CSF" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide_and_Etoposide" .
<Cyclophosphamide> <Antineoplastic_of> "Cyclophosphamide_and_Dexamethasone" .
<Cyclophosphamide> <Antineoplastic_of> "Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b" .
<Cyclophosphamide> <Antineoplastic_of> "Cisplatin_and_Cyclophosphamide" .
<Cyclophosphamide> <Antineoplastic_of> "Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine" .
<Cyclophosphamide> <Antineoplastic_of> "Carboplatin_and_Cyclophosphamide" .
<Cyclophosphamide> <Antineoplastic_of> "CYKLONE" .
<Cyclophosphamide> <Antineoplastic_of> "CVP,_then_131Iodine-Tositumomab" .
<Cyclophosphamide> <Antineoplastic_of> "CVP_(Vinblastine/Prednisone)" .
<Cyclophosphamide> <Antineoplastic_of> "CVP_(Prednisolone)" .
<Cyclophosphamide> <Antineoplastic_of> "CVP" .
<Cyclophosphamide> <Antineoplastic_of> "CVAP" .
<Cyclophosphamide> <Antineoplastic_of> "CVAD" .
<Cyclophosphamide> <Antineoplastic_of> "CTD" .
<Cyclophosphamide> <Antineoplastic_of> "CTCb,_then_auto_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "CTCb" .
<Cyclophosphamide> <Antineoplastic_of> "CRd" .
<Cyclophosphamide> <Antineoplastic_of> "CRD" .
<Cyclophosphamide> <Antineoplastic_of> "CPR" .
<Cyclophosphamide> <Antineoplastic_of> "CPB" .
<Cyclophosphamide> <Antineoplastic_of> "COPP/ABVD" .
<Cyclophosphamide> <Antineoplastic_of> "COPDAC" .
<Cyclophosphamide> <Antineoplastic_of> "COPADM" .
<Cyclophosphamide> <Antineoplastic_of> "COPAD/CYVE" .
<Cyclophosphamide> <Antineoplastic_of> "COPAD" .
<Cyclophosphamide> <Antineoplastic_of> "COPA" .
<Cyclophosphamide> <Antineoplastic_of> "COP-Bleo" .
<Cyclophosphamide> <Antineoplastic_of> "COP" .
<Cyclophosphamide> <Antineoplastic_of> "COMP" .
<Cyclophosphamide> <Antineoplastic_of> "CODOX-M/IVAC" .
<Cyclophosphamide> <Antineoplastic_of> "CODOX-M" .
<Cyclophosphamide> <Antineoplastic_of> "CNOP_(Prednisolone)" .
<Cyclophosphamide> <Antineoplastic_of> "CNOP" .
<Cyclophosphamide> <Antineoplastic_of> "CMFVP" .
<Cyclophosphamide> <Antineoplastic_of> "CMFV" .
<Cyclophosphamide> <Antineoplastic_of> "CMFT" .
<Cyclophosphamide> <Antineoplastic_of> "CMFPT" .
<Cyclophosphamide> <Antineoplastic_of> "CMFP" .
<Cyclophosphamide> <Antineoplastic_of> "CMFL" .
<Cyclophosphamide> <Antineoplastic_of> "CMF" .
<Cyclophosphamide> <Antineoplastic_of> "CMED" .
<Cyclophosphamide> <Antineoplastic_of> "CMC" .
<Cyclophosphamide> <Antineoplastic_of> "CM" .
<Cyclophosphamide> <Antineoplastic_of> "CISCA/VB" .
<Cyclophosphamide> <Antineoplastic_of> "CISCA" .
<Cyclophosphamide> <Antineoplastic_of> "CHVmP-VB" .
<Cyclophosphamide> <Antineoplastic_of> "CHVmP" .
<Cyclophosphamide> <Antineoplastic_of> "CHVP-I" .
<Cyclophosphamide> <Antineoplastic_of> "CHVP" .
<Cyclophosphamide> <Antineoplastic_of> "CHUT,_then_auto_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "CHUT" .
<Cyclophosphamide> <Antineoplastic_of> "CHOP-BCG" .
<Cyclophosphamide> <Antineoplastic_of> "CHOP-B" .
<Cyclophosphamide> <Antineoplastic_of> "CHOP-AL" .
<Cyclophosphamide> <Antineoplastic_of> "CHOP-14" .
<Cyclophosphamide> <Antineoplastic_of> "CHOP,_then_131Iodine-Tositumomab" .
<Cyclophosphamide> <Antineoplastic_of> "CHOP_and_Everolimus" .
<Cyclophosphamide> <Antineoplastic_of> "CHOP_Modified_(Prednisolone)" .
<Cyclophosphamide> <Antineoplastic_of> "CHOP_Modified" .
<Cyclophosphamide> <Antineoplastic_of> "CHOP_(Prednisolone)" .
<Cyclophosphamide> <Antineoplastic_of> "CHOP" .
<Cyclophosphamide> <Antineoplastic_of> "CHOEP-21" .
<Cyclophosphamide> <Antineoplastic_of> "CHOEP-14" .
<Cyclophosphamide> <Antineoplastic_of> "CHAD" .
<Cyclophosphamide> <Antineoplastic_of> "CFP_and_Oophorectomy" .
<Cyclophosphamide> <Antineoplastic_of> "CFP" .
<Cyclophosphamide> <Antineoplastic_of> "CFAR" .
<Cyclophosphamide> <Antineoplastic_of> "CEV_and_RT" .
<Cyclophosphamide> <Antineoplastic_of> "CEV_(Cyclophosphamide/Etoposide)" .
<Cyclophosphamide> <Antineoplastic_of> "CEV_(Cyclophosphamide/Epirubicin)" .
<Cyclophosphamide> <Antineoplastic_of> "CEPP(B)" .
<Cyclophosphamide> <Antineoplastic_of> "CEP" .
<Cyclophosphamide> <Antineoplastic_of> "CEOP_(Prednisolone)" .
<Cyclophosphamide> <Antineoplastic_of> "CEOP" .
<Cyclophosphamide> <Antineoplastic_of> "CEF/CMF" .
<Cyclophosphamide> <Antineoplastic_of> "CEEP" .
<Cyclophosphamide> <Antineoplastic_of> "CDE" .
<Cyclophosphamide> <Antineoplastic_of> "CCOP" .
<Cyclophosphamide> <Antineoplastic_of> "CCE" .
<Cyclophosphamide> <Antineoplastic_of> "CC/DE_and_RT" .
<Cyclophosphamide> <Antineoplastic_of> "CC" .
<Cyclophosphamide> <Antineoplastic_of> "CBVM,_then_auto_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "CBV-Mx,_then_auto_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "CBV-Mx" .
<Cyclophosphamide> <Antineoplastic_of> "CBV,_then_auto_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "CBV" .
<Cyclophosphamide> <Antineoplastic_of> "CAVE" .
<Cyclophosphamide> <Antineoplastic_of> "CAV/PE" .
<Cyclophosphamide> <Antineoplastic_of> "CAV_and_RT" .
<Cyclophosphamide> <Antineoplastic_of> "CAV" .
<Cyclophosphamide> <Antineoplastic_of> "CAP-BOP" .
<Cyclophosphamide> <Antineoplastic_of> "CAP_(Platinol)" .
<Cyclophosphamide> <Antineoplastic_of> "CAP" .
<Cyclophosphamide> <Antineoplastic_of> "CAMP" .
<Cyclophosphamide> <Antineoplastic_of> "CAMFP" .
<Cyclophosphamide> <Antineoplastic_of> "CAMF" .
<Cyclophosphamide> <Antineoplastic_of> "CALGB_8811_late_intensification" .
<Cyclophosphamide> <Antineoplastic_of> "CALGB_8811_early_intensification" .
<Cyclophosphamide> <Antineoplastic_of> "CALGB_10-002_regimen" .
<Cyclophosphamide> <Antineoplastic_of> "CAFVP" .
<Cyclophosphamide> <Antineoplastic_of> "CAF_and_MPA" .
<Cyclophosphamide> <Antineoplastic_of> "CAD_and_G-CSF" .
<Cyclophosphamide> <Antineoplastic_of> "C-VAMP" .
<Cyclophosphamide> <Antineoplastic_of> "C-MOPP/ABV" .
<Cyclophosphamide> <Antineoplastic_of> "C-MOPP" .
<Cyclophosphamide> <Antineoplastic_of> "Busulfan_and_Cyclophosphamide,_then_allo_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "Busulfan_and_Cyclophosphamide" .
<Cyclophosphamide> <Antineoplastic_of> "BuCyTBI,_then_allo_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "BuCyTBI" .
<Cyclophosphamide> <Antineoplastic_of> "BuCy,_then_auto_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "BuCy,_then_allo_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "Bu/TT/Cy,_then_auto_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "Bu/TT/Cy" .
<Cyclophosphamide> <Antineoplastic_of> "Bortezomib_and_Cyclophosphamide" .
<Cyclophosphamide> <Antineoplastic_of> "BVCPP" .
<Cyclophosphamide> <Antineoplastic_of> "BV-CHP" .
<Cyclophosphamide> <Antineoplastic_of> "BEACOPP-14_(Prednisolone)" .
<Cyclophosphamide> <Antineoplastic_of> "BEACOPP-14" .
<Cyclophosphamide> <Antineoplastic_of> "BEACOPP" .
<Cyclophosphamide> <Antineoplastic_of> "BEAC,_then_auto_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "BEAC" .
<Cyclophosphamide> <Antineoplastic_of> "BCVPP" .
<Cyclophosphamide> <Antineoplastic_of> "BCOP" .
<Cyclophosphamide> <Antineoplastic_of> "BCHOP" .
<Cyclophosphamide> <Antineoplastic_of> "BASIC" .
<Cyclophosphamide> <Antineoplastic_of> "BACO" .
<Cyclophosphamide> <Antineoplastic_of> "Axicabtagene_ciloleucel_monotherapy" .
<Cyclophosphamide> <Antineoplastic_of> "Augmented_Hyper-CVAD_and_Asparaginase" .
<Cyclophosphamide> <Antineoplastic_of> "Augmented_BFM_consolidation" .
<Cyclophosphamide> <Antineoplastic_of> "AVCF" .
<Cyclophosphamide> <Antineoplastic_of> "AV-CMF" .
<Cyclophosphamide> <Antineoplastic_of> "ADOC" .
<Cyclophosphamide> <Antineoplastic_of> "ACVBP-R" .
<Cyclophosphamide> <Antineoplastic_of> "ACVBP,_dose-adjusted" .
<Cyclophosphamide> <Antineoplastic_of> "ACVBP" .
<Cyclophosphamide> <Antineoplastic_of> "ACT" .
<Cyclophosphamide> <Antineoplastic_of> "ACOMLA" .
<Cyclophosphamide> <Antineoplastic_of> "ACH" .
<Cyclophosphamide> <Antineoplastic_of> "ACE" .
<Cyclophosphamide> <Antineoplastic_of> "AC-T" .
<Cyclophosphamide> <Antineoplastic_of> "AC_and_Bevacizumab" .
<Cyclophosphamide> <Antineoplastic_of> "AC" .
<Cyclophosphamide> <Antineoplastic_of> "ABVE-PC" .
<Cyclophosphamide> <Antineoplastic_of> "ABCM" .
<Cyclophosphamide> <Antineoplastic_of> "AALL0232_consolidation" .
<Cyclophosphamide> <Antineoplastic_of> "(90)YFC,_then_allo_HSCT" .
<Cyclophosphamide> <Antineoplastic_of> "(90)YFC" .
<AC_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<AC_and_Bevacizumab> <Has_context> "Neoadjuvant_therapy" .
<OFAR> <Maps_to> "OFAR" .
<Fluorouracil_monotherapy> <Is_current_in> "Rectal_cancer" .
<Fluorouracil_monotherapy> <Is_current_in> "Pancreatic_cancer" .
<Fluorouracil_monotherapy> <Is_current_in> "Head_and_neck_cancer" .
<Fluorouracil_monotherapy> <Is_current_in> "Gastric_cancer" .
<Fluorouracil_monotherapy> <Is_current_in> "Colon_cancer" .
<FUIRI> <Has_modality> "Chemotherapy" .
<VAB-6> <Mapped_from> "VAB-6" .
<Cyclophosphamide,_Dacarbazine,_Vincristine> <Is_current_in> "Pheochromocytoma" .
<IT_Methotrexate_and_Methylprednisolone> <Maps_to> "IT_Methotrexate_and_Methylprednisolone" .
<Mephamesone-4> <Brand_name_of> "Dexamethasone" .
<Argatroban_monotherapy> <Has_accepted_use> "Venous_thromboembolism" .
<Argatroban_monotherapy> <Has_accepted_use> "Heparin-induced_thrombocytopenia" .
<Placebo> <Is_current_in> "Venous_thromboembolism" .
<Placebo> <Is_current_in> "Thyroid_cancer" .
<Placebo> <Is_current_in> "Thrombocytopenia_in_liver_disease" .
<Placebo> <Is_current_in> "Systemic_mastocytosis" .
<Placebo> <Is_current_in> "Soft_tissue_sarcoma" .
<Placebo> <Is_current_in> "Small_cell_lung_cancer" .
<Placebo> <Is_current_in> "Renal_cell_carcinoma" .
<Placebo> <Is_current_in> "Prostate_cancer" .
<Placebo> <Is_current_in> "Polycythemia_vera" .
<Placebo> <Is_current_in> "Paroxysmal_nocturnal_hemoglobinuria" .
<Placebo> <Is_current_in> "Pancreatic_cancer" .
<Placebo> <Is_current_in> "Pancreatic_NET" .
<Placebo> <Is_current_in> "Ovarian_cancer" .
<Placebo> <Is_current_in> "Non-small_cell_lung_cancer" .
<Placebo> <Is_current_in> "Neuroendocrine_tumor" .
<Placebo> <Is_current_in> "Myelofibrosis" .
<Placebo> <Is_current_in> "Myelodysplastic_syndrome" .
<Placebo> <Is_current_in> "Multiple_myeloma" .
<Placebo> <Is_current_in> "Mesothelioma" .
<Placebo> <Is_current_in> "Meningioma" .
<Placebo> <Is_current_in> "Melanoma" .
<Placebo> <Is_current_in> "Kaposi_sarcoma" .
<Placebo> <Is_current_in> "Immune_thrombocytopenia" .
<Placebo> <Is_current_in> "Hodgkin_lymphoma" .
<Placebo> <Is_current_in> "Hereditary_hemorrhagic_telangiectasia" .
<Placebo> <Is_current_in> "Hepatocellular_carcinoma" .
<Placebo> <Is_current_in> "Head_and_neck_cancer" .
<Placebo> <Is_current_in> "Gastrointestinal_stromal_tumor" .
<Placebo> <Is_current_in> "Gastric_cancer" .
<Placebo> <Is_current_in> "Follicular_lymphoma" .
<Placebo> <Is_current_in> "Esophageal_cancer" .
<Placebo> <Is_current_in> "Endometrial_cancer" .
<Placebo> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Placebo> <Is_current_in> "Cutaneous_T-cell_lymphoma" .
<Placebo> <Is_current_in> "Colon_cancer" .
<Placebo> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Placebo> <Is_current_in> "Castleman_disease" .
<Placebo> <Is_current_in> "Breast_cancer" .
<Placebo> <Is_current_in> "Bladder_cancer" .
<Placebo> <Is_current_in> "Adrenocortical_carcinoma" .
<Azacitidine> <Has_FDA_indication> "Myelodysplastic_syndrome" .
<Azacitidine> <Has_FDA_indication> "Chronic_myelomonocytic_leukemia" .
<Dopamine_receptor_antagonist> <Is_a> "Emesis_prevention" .
<R-DHAOx> <Is_current_in> "Mantle_cell_lymphoma" .
<R-DHAOx> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Labimion> <Brand_name_of> "Etoposide" .
<Sotret> <Brand_name_of> "Isotretinoin" .
<Platin> <Brand_name_of> "Cisplatin" .
<Evacet> <Brand_name_of> "Doxorubicin" .
<ADOC> <Maps_to> "ADOC" .
<IAP> <Is_a> "Anthracycline-containing_regimen" .
<Ixabepilone> <Has_FDA_indication> "Breast_cancer" .
<Pegaspargase,_Vincristine,_Prednisone> <Maps_to> "Pegaspargase,_Vincristine,_Prednisone" .
<LoDAC> <Is_current_in> "Myelodysplastic_syndrome" .
<LoDAC> <Is_current_in> "Acute_myeloid_leukemia" .
<Cytozol> <Brand_name_of> "Zoledronic_acid" .
<Leicita> <Brand_name_of> "Filgrastim" .
<Axitinib_and_Pembrolizumab> <Has_antineoplastic> "Pembrolizumab" .
<Axitinib_and_Pembrolizumab> <Has_antineoplastic> "Axitinib" .
<Octride> <Brand_name_of> "Octreotide" .
<CHOP-AL> <Maps_to> "CHOP-AL" .
<Cimetidine> <Has_brand_name> "Tagamet" .
<TL_(Taxol)> <Is_current_in> "Breast_cancer" .
<CapeOx,_Cetuximab,_RT> <Has_modality> "Radiotherapy" .
<CapeOx,_Cetuximab,_RT> <Has_modality> "Chemotherapy" .
<Everolimus_and_Rituximab> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Melanoma> <FDA_indication_of> "Vemurafenib" .
<Melanoma> <FDA_indication_of> "Trametinib" .
<Melanoma> <FDA_indication_of> "Talimogene_laherparepvec" .
<Melanoma> <FDA_indication_of> "Pembrolizumab" .
<Melanoma> <FDA_indication_of> "Peginterferon_alfa-2b" .
<Melanoma> <FDA_indication_of> "Nivolumab" .
<Melanoma> <FDA_indication_of> "Ipilimumab" .
<Melanoma> <FDA_indication_of> "Interferon_alfa-2b" .
<Melanoma> <FDA_indication_of> "Encorafenib" .
<Melanoma> <FDA_indication_of> "Dabrafenib" .
<Melanoma> <FDA_indication_of> "Cobimetinib" .
<Melanoma> <FDA_indication_of> "Binimetinib" .
<Dutasteride> <Is_a> "Endocrine_therapeutic" .
<Dutasteride> <Is_a> "Antiandrogen" .
<Dutasteride> <Is_a> "5_alpha-reductase_inhibitor" .
<Renal_cell_carcinoma> <Accepted_use_of> "Vinblastine_monotherapy" .
<Renal_cell_carcinoma> <Accepted_use_of> "Temsirolimus_monotherapy" .
<Renal_cell_carcinoma> <Accepted_use_of> "Temsirolimus" .
<Renal_cell_carcinoma> <Accepted_use_of> "Sunitinib_monotherapy" .
<Renal_cell_carcinoma> <Accepted_use_of> "Sunitinib" .
<Renal_cell_carcinoma> <Accepted_use_of> "Sorafenib_monotherapy" .
<Renal_cell_carcinoma> <Accepted_use_of> "Sorafenib" .
<Renal_cell_carcinoma> <Accepted_use_of> "Regorafenib_monotherapy" .
<Renal_cell_carcinoma> <Accepted_use_of> "Regorafenib" .
<Renal_cell_carcinoma> <Accepted_use_of> "Placebo" .
<Renal_cell_carcinoma> <Accepted_use_of> "Pembrolizumab" .
<Renal_cell_carcinoma> <Accepted_use_of> "Pazopanib_monotherapy" .
<Renal_cell_carcinoma> <Accepted_use_of> "Pazopanib" .
<Renal_cell_carcinoma> <Accepted_use_of> "Observation" .
<Renal_cell_carcinoma> <Accepted_use_of> "Nivolumab_monotherapy" .
<Renal_cell_carcinoma> <Accepted_use_of> "Nivolumab" .
<Renal_cell_carcinoma> <Accepted_use_of> "Megestrol_monotherapy" .
<Renal_cell_carcinoma> <Accepted_use_of> "Medroxyprogesterone_monotherapy" .
<Renal_cell_carcinoma> <Accepted_use_of> "Low-dose_Interleukin-2" .
<Renal_cell_carcinoma> <Accepted_use_of> "Lenvatinib_monotherapy" .
<Renal_cell_carcinoma> <Accepted_use_of> "Lenvatinib" .
<Renal_cell_carcinoma> <Accepted_use_of> "Ipilimumab_and_Nivolumab" .
<Renal_cell_carcinoma> <Accepted_use_of> "Ipilimumab" .
<Renal_cell_carcinoma> <Accepted_use_of> "Interferon_alfa-2c_monotherapy" .
<Renal_cell_carcinoma> <Accepted_use_of> "Interferon_alfa-2b_monotherapy" .
<Renal_cell_carcinoma> <Accepted_use_of> "Interferon_alfa-2b" .
<Renal_cell_carcinoma> <Accepted_use_of> "Interferon_alfa-2a_monotherapy" .
<Renal_cell_carcinoma> <Accepted_use_of> "Interferon_alfa-2a_and_Isotretinoin" .
<Renal_cell_carcinoma> <Accepted_use_of> "Interferon_alfa-2a_and_Interleukin-2" .
<Renal_cell_carcinoma> <Accepted_use_of> "Interferon_alfa-2a" .
<Renal_cell_carcinoma> <Accepted_use_of> "High-dose_Interleukin-2" .
<Renal_cell_carcinoma> <Accepted_use_of> "Gemcitabine_and_Sunitinib" .
<Renal_cell_carcinoma> <Accepted_use_of> "Gemcitabine" .
<Renal_cell_carcinoma> <Accepted_use_of> "FC,_then_allo_HSCT" .
<Renal_cell_carcinoma> <Accepted_use_of> "Everolimus_monotherapy" .
<Renal_cell_carcinoma> <Accepted_use_of> "Everolimus_and_Lenvatinib" .
<Renal_cell_carcinoma> <Accepted_use_of> "Everolimus" .
<Renal_cell_carcinoma> <Accepted_use_of> "Erlotinib_monotherapy" .
<Renal_cell_carcinoma> <Accepted_use_of> "Erlotinib_and_Bevacizumab" .
<Renal_cell_carcinoma> <Accepted_use_of> "Erlotinib" .
<Renal_cell_carcinoma> <Accepted_use_of> "Doxorubicin_and_Gemcitabine" .
<Renal_cell_carcinoma> <Accepted_use_of> "Doxorubicin" .
<Renal_cell_carcinoma> <Accepted_use_of> "Cabozantinib_monotherapy" .
<Renal_cell_carcinoma> <Accepted_use_of> "Cabozantinib" .
<Renal_cell_carcinoma> <Accepted_use_of> "Bevacizumab-bvzr" .
<Renal_cell_carcinoma> <Accepted_use_of> "Bevacizumab-awwb" .
<Renal_cell_carcinoma> <Accepted_use_of> "Bevacizumab_monotherapy" .
<Renal_cell_carcinoma> <Accepted_use_of> "Bevacizumab_and_Interferon_alfa-2a" .
<Renal_cell_carcinoma> <Accepted_use_of> "Bevacizumab" .
<Renal_cell_carcinoma> <Accepted_use_of> "Axitinib_monotherapy" .
<Renal_cell_carcinoma> <Accepted_use_of> "Axitinib_and_Pembrolizumab" .
<Renal_cell_carcinoma> <Accepted_use_of> "Axitinib_and_Avelumab" .
<Renal_cell_carcinoma> <Accepted_use_of> "Axitinib" .
<Renal_cell_carcinoma> <Accepted_use_of> "Avelumab" .
<Renal_cell_carcinoma> <Accepted_use_of> "Atezolizumab_and_Bevacizumab" .
<Renal_cell_carcinoma> <Accepted_use_of> "Atezolizumab" .
<Renal_cell_carcinoma> <Accepted_use_of> "Aldesleukin" .
<Antiviral> <Is_a> "Antibiotic" .
<Adrim> <Brand_name_of> "Doxorubicin" .
<AC-T> <Has_antineoplastic> "Paclitaxel" .
<AC-T> <Has_antineoplastic> "Doxorubicin" .
<AC-T> <Has_antineoplastic> "Cyclophosphamide" .
<Cyclophosphamide_and_TBI,_then_auto_HSCT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Cyclophosphamide_and_TBI,_then_auto_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine> <Mapped_from> "Cyclophosphamide,_Cytarabine,_Mercaptopurine" .
<R-EPOCH> <Maps_to> "R-EPOCH" .
<R-CVP> <Maps_to> "R-CVP" .
<Cetuximab_monotherapy> <Has_supportive_med> "Diphenhydramine" .
<Cetuximab_monotherapy> <Has_supportive_med> "Antihistamines" .
<LO-Aspirin> <Brand_name_of> "Aspirin" .
<Cisplatin,_Etoposide,_Irinotecan> <Is_a> "Irinotecan-containing_regimen" .
<Dexthasol> <Brand_name_of> "Dexamethasone" .
<Ceritinib> <Has_brand_name> "Zykadia" .
<FUIRI> <Mapped_from> "FUIRI" .
<Trastuzumab_and_ET> <Has_context> "Neoadjuvant_therapy" .
<Erlotinib_monotherapy> <Is_current_in> "Renal_cell_carcinoma" .
<Erlotinib_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Erlotinib_monotherapy> <Is_current_in> "Myelodysplastic_syndrome" .
<Erlotinib_monotherapy> <Is_current_in> "Esophageal_cancer" .
<Erlotinib_monotherapy> <Is_current_in> "EGFR-mutated_malignancy" .
<Hydroxyurea> <Has_brand_name> "Ureax" .
<Hydroxyurea> <Has_brand_name> "Syrea" .
<Hydroxyurea> <Has_brand_name> "Siklos" .
<Hydroxyurea> <Has_brand_name> "Onco_Carbide" .
<Hydroxyurea> <Has_brand_name> "Neodrea" .
<Hydroxyurea> <Has_brand_name> "Mylocel" .
<Hydroxyurea> <Has_brand_name> "Myelostat" .
<Hydroxyurea> <Has_brand_name> "Litalir" .
<Hydroxyurea> <Has_brand_name> "Hytas" .
<Hydroxyurea> <Has_brand_name> "Hydrourea" .
<Hydroxyurea> <Has_brand_name> "Hydrine" .
<Hydroxyurea> <Has_brand_name> "Hydrea" .
<Hydroxyurea> <Has_brand_name> "Hydab" .
<Hydroxyurea> <Has_brand_name> "Hondrea" .
<Hydroxyurea> <Has_brand_name> "Hidrea" .
<Hydroxyurea> <Has_brand_name> "Durea" .
<Hydroxyurea> <Has_brand_name> "Droxiurea" .
<Hydroxyurea> <Has_brand_name> "Droxia" .
<Hydroxyurea> <Has_brand_name> "Cytodrox" .
<Hydroxyurea> <Has_brand_name> "Biosupressin" .
<BR_and_Polatuzumab_vedotin> <Has_antineoplastic> "Rituximab" .
<BR_and_Polatuzumab_vedotin> <Has_antineoplastic> "Polatuzumab_vedotin" .
<BR_and_Polatuzumab_vedotin> <Has_antineoplastic> "Bendamustine" .
<Anti-CD194_antibody> <Subsumes> "Mogamulizumab" .
<Sindronat> <Brand_name_of> "Clodronate" .
<HDMP-R> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Rucaparib> <Is_a> "PARP_inhibitor" .
<Rucaparib> <Is_a> "Mutation-specific_medication" .
<Methotrexate_and_Rituximab> <Maps_to> "Methotrexate_and_Rituximab" .
<ESHAP> <Has_context> "Non-curative_therapy" .
<ESHAP> <Has_context> "Non-curative_subsequent-line_therapy" .
<ESHAP> <Has_context> "Consolidation_after_salvage_therapy" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "nab-Paclitaxel_monotherapy" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "mDCF_and_Bevacizumab" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "mDCF" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Temozolomide_monotherapy" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Temozolomide_and_RT" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "R-miniCHOP" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "PCV" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "OLF" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Mitotane_and_Streptozocin" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Irinotecan_monotherapy" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Gemcitabine,_Oxaliplatin,_Paclitaxel" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Gemcitabine_monotherapy" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Gemcitabine_and_Mitomycin" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "GemOx" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "ECF" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Docetaxel_and_Irinotecan" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Denosumab_monotherapy" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "DCF" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Clofarabine_and_Cytarabine" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Cisplatin_and_Vinorelbine" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Cisplatin_and_Gemcitabine" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Cisplatin_and_Etoposide" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Cisplatin_and_Doxorubicin" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Cisplatin_and_Docetaxel" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Carboplatin_monotherapy" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Carboplatin_and_Teniposide" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Carboplatin_and_Paclitaxel" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Carboplatin_and_Irinotecan" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Carboplatin_and_Etoposide" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Carboplatin_and_Doxorubicin_liposomal" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Carboplatin_and_Docetaxel" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Capecitabine_and_Mitomycin" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "CLF" .
<Serotonin_5-HT3_antagonists> <Supportive_med_of> "Bortezomib_monotherapy" .
<Kovar> <Brand_name_of> "Warfarin" .
<Biomarker-specific_medication> <Subsumes> "Protein_expression-specific_medication" .
<Biomarker-specific_medication> <Subsumes> "Mutation-specific_medication" .
<DCEP> <Has_supportive_med> "Filgrastim" .
<Cobimetinib_monotherapy> <Has_antineoplastic> "Cobimetinib" .
<CapeOx> <Has_accepted_use> "Rectal_cancer" .
<CapeOx> <Has_accepted_use> "Pancreatic_cancer" .
<CapeOx> <Has_accepted_use> "Hepatocellular_carcinoma" .
<CapeOx> <Has_accepted_use> "Gastric_cancer" .
<CapeOx> <Has_accepted_use> "Gallbladder_cancer" .
<CapeOx> <Has_accepted_use> "Esophageal_cancer" .
<CapeOx> <Has_accepted_use> "Colon_cancer" .
<CapeOx> <Has_accepted_use> "Cholangiocarcinoma" .
<Zactron> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Erivedge> <Brand_name_of> "Vismodegib" .
<Carboplatin,_Pemetrexed,_Pembrolizumab> <Has_context> "Non-curative_first-line_therapy" .
<Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide> <Has_modality> "Chemotherapy" .
<Liposarcoma> <FDA_indication_of> "Trabectedin" .
<Liposarcoma> <FDA_indication_of> "Eribulin" .
<O-FC> <Has_antineoplastic> "Ofatumumab" .
<O-FC> <Has_antineoplastic> "Fludarabine" .
<O-FC> <Has_antineoplastic> "Cyclophosphamide" .
<Cisplatin_and_Paclitaxel> <Mapped_from> "Cisplatin_and_Paclitaxel" .
<Gemcitabine,_Oxaliplatin,_Paclitaxel> <Mapped_from> "Gemcitabine,_Oxaliplatin,_Paclitaxel" .
<Veliparib> <Has_accepted_use> "Breast_cancer" .
<Centrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Formoxol> <Brand_name_of> "Paclitaxel" .
<Neratinib_monotherapy> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<Neratinib_monotherapy> <Has_accepted_use> "ERBB3-mutated_malignancy" .
<Neratinib_monotherapy> <Has_accepted_use> "ERBB2-mutated_malignancy" .
<Neratinib_monotherapy> <Has_accepted_use> "Breast_cancer" .
<FOLFIRI_and_Bevacizumab> <Has_context> "Non-curative_second-line_therapy" .
<FOLFIRI_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<Observation> <Mapped_from> "Observation" .
<Ribociclib_and_Tamoxifen> <Maps_to> "Ribociclib_and_Tamoxifen" .
<FC> <Mapped_from> "FC" .
<Bonomax> <Brand_name_of> "Alendronate" .
<Irinotecan_and_Bevacizumab> <Has_antineoplastic> "Irinotecan" .
<Irinotecan_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Ivosidenib> <Has_brand_name> "Tibsovo" .
<Irinotecan_and_S-1> <Mapped_from> "Irinotecan_and_S-1" .
<FOLFOX4_(L-Leucovorin)> <Mapped_from> "FOLFOX4_(L-Leucovorin)" .
<DEB-TACE> <Is_current_in> "Hepatocellular_carcinoma" .
<Trastuzumab_and_hyaluronidase_monotherapy> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<Trastuzumab_and_hyaluronidase_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Gemcitabine_and_Irinotecan> <Has_antineoplastic> "Irinotecan" .
<Gemcitabine_and_Irinotecan> <Has_antineoplastic> "Gemcitabine" .
<Pribac> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Teniposide_monotherapy> <Has_antineoplastic> "Teniposide" .
<Cetuximab_and_RT> <Maps_to> "Cetuximab_and_RT" .
<International_ALL_Trial> <Has_antineoplastic> "Vincristine" .
<International_ALL_Trial> <Has_antineoplastic> "Thioguanine" .
<International_ALL_Trial> <Has_antineoplastic> "Etoposide" .
<International_ALL_Trial> <Has_antineoplastic> "Dexamethasone" .
<International_ALL_Trial> <Has_antineoplastic> "Daunorubicin" .
<International_ALL_Trial> <Has_antineoplastic> "Cytarabine" .
<International_ALL_Trial> <Has_antineoplastic> "Cyclophosphamide" .
<ABCM> <Has_accepted_use> "Multiple_myeloma" .
<BLD> <Maps_to> "BLD" .
<Pallagicin> <Brand_name_of> "Doxorubicin" .
<Azacitidine_and_Sorafenib> <Has_antineoplastic> "Sorafenib" .
<Azacitidine_and_Sorafenib> <Has_antineoplastic> "Azacitidine" .
<Rimezone> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Deltasone> <Brand_name_of> "Prednisone" .
<7_plus_3d_and_GO> <Is_a> "Anthracycline-containing_regimen" .
<CMFPT> <Maps_to> "CMFPT" .
<FLEC> <Is_current_in> "Pancreatic_cancer" .
<PCV> <Has_antineoplastic> "Vincristine" .
<PCV> <Has_antineoplastic> "Procarbazine" .
<PCV> <Has_antineoplastic> "Lomustine" .
<B-CAVe> <Has_context> "Salvage_therapy" .
<Dexadron> <Brand_name_of> "Dexamethasone" .
<Enoxaparin> <Supportive_med_of> "Warfarin_monotherapy" .
<Enoxaparin> <Supportive_med_of> "VTD" .
<Enoxaparin> <Supportive_med_of> "VDC" .
<Enoxaparin> <Supportive_med_of> "TD" .
<Enoxaparin> <Supportive_med_of> "RVDC" .
<Enoxaparin> <Supportive_med_of> "MPT" .
<Enoxaparin> <Supportive_med_of> "Enoxaparin_monotherapy" .
<Enoxaparin> <Supportive_med_of> "Bortezomib_monotherapy" .
<Cyclophosphamide,_Mycophenolate_mofetil,_Tacrolimus> <Has_immunosuppressor> "Tacrolimus" .
<Cyclophosphamide,_Mycophenolate_mofetil,_Tacrolimus> <Has_immunosuppressor> "Mycophenolate_mofetil" .
<Cyclophosphamide,_Mycophenolate_mofetil,_Tacrolimus> <Has_immunosuppressor> "Cyclophosphamide" .
<Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone> <Maps_to> "Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone" .
<Ipatasertib> <Is_a> "Investigational_drug" .
<Ipatasertib> <Is_a> "AKT1_inhibitor" .
<Doxorubicin_non-pegylated_liposomal_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Doxorubicin_non-pegylated_liposomal_and_Bevacizumab> <Is_a> "Anthracycline-containing_regimen" .
<FR> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<FR> <Has_accepted_use> "Marginal_zone_lymphoma" .
<FR> <Has_accepted_use> "Mantle_cell_lymphoma" .
<FR> <Has_accepted_use> "Follicular_lymphoma" .
<FR> <Has_accepted_use> "Cold_agglutinin_disease" .
<FR> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Idelalisib_monotherapy> <Has_modality> "Chemotherapy" .
<Tamoxifen_and_OFS> <Has_supportive_med> "Triptorelin" .
<Tamoxifen_and_OFS> <Has_supportive_med> "Goserelin" .
<Tamoxifen_and_OFS> <Has_supportive_med> "External_beam_radiotherapy" .
<Tamoxifen_and_OFS> <Has_supportive_med> "Endocrine_ablation_surgery" .
<ABV_(Vincristine)> <Mapped_from> "ABV_(Vincristine)" .
<Ammoidin> <Brand_name_of> "Methoxsalen" .
<CNOP> <Is_a> "Anthracycline-containing_regimen" .
<Trebananib> <Has_accepted_use> "Ovarian_cancer" .
<CEOP> <Maps_to> "CEOP" .
<TAD_(Thalidomide)> <Maps_to> "TAD_(Thalidomide)" .
<Tamibarotene_monotherapy> <Has_modality> "Chemotherapy" .
<CABO> <Has_antineoplastic> "Vincristine" .
<CABO> <Has_antineoplastic> "Methotrexate" .
<CABO> <Has_antineoplastic> "Cisplatin" .
<CABO> <Has_antineoplastic> "Bleomycin" .
<Medovir> <Brand_name_of> "Acyclovir" .
<Cisplatin,_Doxorubicin,_Paclitaxel> <Has_modality> "Chemotherapy" .
<CEV_(Cyclophosphamide/Etoposide)> <Mapped_from> "CEV_(Cyclophosphamide/Etoposide)" .
<BR_and_Polatuzumab_vedotin> <Has_context> "Non-curative_subsequent-line_therapy" .
<Methotrexate_and_Prednisone> <Has_immunosuppressor> "Prednisone" .
<Methotrexate_and_Prednisone> <Has_immunosuppressor> "Methotrexate" .
<Anastrozole_and_Palbociclib> <Is_current_in> "Breast_cancer" .
<Abactrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cytarabine_and_Thioguanine> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Cytarabine_and_Thioguanine> <Has_context> "Consolidation_after_salvage_therapy" .
<Methoprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Trexeron> <Brand_name_of> "Methotrexate" .
<Vorinostat_monotherapy> <Mapped_from> "Vorinostat_monotherapy" .
<Dethamedin> <Brand_name_of> "Dexamethasone" .
<Interferon_alfa-2b_and_Prednisone> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Bevacizumab_and_Rituximab> <Has_context> "Non-curative_therapy" .
<Trastuzumab-dkst> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Trastuzumab-dkst> <Is_a> "Protein_expression-specific_medication" .
<Trastuzumab-dkst> <Is_a> "Neutral" .
<Trastuzumab-dkst> <Is_a> "Biosimilar" .
<Trastuzumab-dkst> <Is_a> "Antibody_medication" .
<Trastuzumab-dkst> <Is_a> "Anti-HER2_antibody" .
<CaRD> <Has_context> "Non-curative_first-line_therapy" .
<CaRD> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Cisplatin,_Etoposide,_RT> <Has_accepted_use> "Small_cell_lung_cancer" .
<Cisplatin,_Etoposide,_RT> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cisplatin,_Etoposide,_RT> <Has_accepted_use> "Esophageal_cancer" .
<F-SHAI> <Has_modality> "Chemotherapy" .
<Selumetinib> <May_have_route> "Oral" .
<NOVP> <Has_context> "Induction_therapy" .
<Zovirax> <Brand_name_of> "Acyclovir" .
<Rituximab-abbs> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Rituximab-abbs> <Has_accepted_use> "Transformed_lymphoma" .
<Rituximab-abbs> <Has_accepted_use> "Thrombotic_thrombocytopenic_purpura" .
<Rituximab-abbs> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<Rituximab-abbs> <Has_accepted_use> "Post-transplant_lymphoproliferative_disorder" .
<Rituximab-abbs> <Has_accepted_use> "Mediastinal_gray-zone_lymphoma" .
<Rituximab-abbs> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Rituximab-abbs> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Rituximab-abbs> <Has_accepted_use> "Inherited_coagulopathy" .
<Rituximab-abbs> <Has_accepted_use> "Immune_thrombocytopenia" .
<Rituximab-abbs> <Has_accepted_use> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<Rituximab-abbs> <Has_accepted_use> "Hodgkin_lymphoma" .
<Rituximab-abbs> <Has_accepted_use> "Hairy_cell_leukemia" .
<Rituximab-abbs> <Has_accepted_use> "HIV-associated_lymphoma" .
<Rituximab-abbs> <Has_accepted_use> "Follicular_lymphoma" .
<Rituximab-abbs> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Rituximab-abbs> <Has_accepted_use> "Cold_agglutinin_disease" .
<Rituximab-abbs> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Rituximab-abbs> <Has_accepted_use> "Castleman_disease" .
<Rituximab-abbs> <Has_accepted_use> "CNS_lymphoma" .
<Rituximab-abbs> <Has_accepted_use> "Burkitt_lymphoma" .
<Rituximab-abbs> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Rituximab-abbs> <Has_accepted_use> "Acquired_coagulopathy" .
<MVP_and_RT> <Maps_to> "MVP_and_RT" .
<Apixaban_monotherapy> <Has_supportive_med> "Apixaban" .
<VAC_(Adriamycin)> <Maps_to> "VAC_(Adriamycin)" .
<VAD_doxil> <Has_antineoplastic> "Vincristine" .
<VAD_doxil> <Has_antineoplastic> "Pegylated_liposomal_doxorubicin" .
<VAD_doxil> <Has_antineoplastic> "Dexamethasone" .
<Rd> <Has_accepted_use> "Plasma_cell_leukemia" .
<Rd> <Has_accepted_use> "POEMS_syndrome" .
<Rd> <Has_accepted_use> "Multiple_myeloma" .
<Rd> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<DAT> <Has_modality> "Chemotherapy" .
<Volasertib> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Itoxaril> <Brand_name_of> "Irinotecan" .
<Factor_VIII_recombinant> <Is_a> "Hemostasis_medication" .
<Factor_VIII_recombinant> <Is_a> "Hematology_medication" .
<Factor_VIII_recombinant> <Is_a> "Coagulation_factor" .
<Fluorouracil,_Hydroxyurea,_RT> <Is_current_in> "Head_and_neck_cancer" .
<MAPI> <Mapped_from> "MAPI" .
<Carboplatin,_Pemetrexed,_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Ivosidenib> <Has_FDA_indication> "Acute_myeloid_leukemia" .
<Leuprolide> <May_have_route> "Intramuscular" .
<Nivolumab> <May_have_route> "Intravenous" .
<FR> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<FR> <Is_current_in> "Marginal_zone_lymphoma" .
<FR> <Is_current_in> "Mantle_cell_lymphoma" .
<FR> <Is_current_in> "Follicular_lymphoma" .
<FR> <Is_current_in> "Cold_agglutinin_disease" .
<Pegylated_liposomal_doxorubicin> <Antineoplastic_of> "VAD_doxil" .
<Pegylated_liposomal_doxorubicin> <Antineoplastic_of> "TVAD_doxil" .
<Pegylated_liposomal_doxorubicin> <Antineoplastic_of> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Pegylated_liposomal_doxorubicin> <Antineoplastic_of> "R-CODOX-M_(Doxil_substituted)" .
<Pegylated_liposomal_doxorubicin> <Antineoplastic_of> "R-CHMP" .
<Pegylated_liposomal_doxorubicin> <Antineoplastic_of> "R-CDOP" .
<Pegylated_liposomal_doxorubicin> <Antineoplastic_of> "PAD/VCD" .
<Pegylated_liposomal_doxorubicin> <Antineoplastic_of> "PAD_doxil" .
<Pegylated_liposomal_doxorubicin> <Antineoplastic_of> "GVD" .
<Pegylated_liposomal_doxorubicin> <Antineoplastic_of> "Doxorubicin_pegylated_liposomal_monotherapy" .
<Pegylated_liposomal_doxorubicin> <Antineoplastic_of> "Doxorubicin_pegylated_liposomal_and_Trabectedin" .
<Pegylated_liposomal_doxorubicin> <Antineoplastic_of> "Doxorubicin_pegylated_liposomal_and_Gemcitabine" .
<Pegylated_liposomal_doxorubicin> <Antineoplastic_of> "Doxorubicin_pegylated_liposomal_and_Bevacizumab" .
<Pegylated_liposomal_doxorubicin> <Antineoplastic_of> "DEP" .
<Pegylated_liposomal_doxorubicin> <Antineoplastic_of> "Cisplatin,_Doxorubicin_liposomal,_Fluorouracil" .
<Pegylated_liposomal_doxorubicin> <Antineoplastic_of> "Carboplatin_and_Doxorubicin_liposomal" .
<Pegylated_liposomal_doxorubicin> <Antineoplastic_of> "CCOP" .
<Pegylated_liposomal_doxorubicin> <Antineoplastic_of> "Bortezomib_and_Doxorubicin_liposomal" .
<ICE> <Is_historical_in> "Small_cell_lung_cancer" .
<ICE> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<R-CHMP> <Has_antineoplastic> "Vincristine_liposomal" .
<R-CHMP> <Has_antineoplastic> "Rituximab" .
<R-CHMP> <Has_antineoplastic> "Prednisone" .
<R-CHMP> <Has_antineoplastic> "Pegylated_liposomal_doxorubicin" .
<R-CHMP> <Has_antineoplastic> "Cyclophosphamide" .
<VTP> <Has_antineoplastic> "Thalidomide" .
<VTP> <Has_antineoplastic> "Prednisone" .
<VTP> <Has_antineoplastic> "Bortezomib" .
<Lorlatinib_monotherapy> <Has_modality> "Chemotherapy" .
<R-EPOCH,_dose-escalated> <Has_context> "Upfront_therapy" .
<Carboplatin,_Fluorouracil,_RT> <Maps_to> "Carboplatin,_Fluorouracil,_RT" .
<Oxaliplatin_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Conmana> <Brand_name_of> "Icotinib" .
<5_plus_3d> <Is_historical_in> "Acute_myeloid_leukemia" .
<Doxorubicin,_Ifosfamide,_RT> <Has_supportive_med> "Mesna" .
<Doxorubicin,_Ifosfamide,_RT> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Pemetrexed_and_Pembrolizumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<Zophren> <Brand_name_of> "Ondansetron" .
<Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Flutamide> <Is_a> "Nonsteroidal_antiandrogen" .
<Hyper-CVAD/MA> <Has_supportive_med> "Valacyclovir" .
<Hyper-CVAD/MA> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Hyper-CVAD/MA> <Has_supportive_med> "Mesna" .
<Hyper-CVAD/MA> <Has_supportive_med> "Levofloxacin" .
<Hyper-CVAD/MA> <Has_supportive_med> "Folinic_acid" .
<Hyper-CVAD/MA> <Has_supportive_med> "Fluconazole" .
<Hyper-CVAD/MA> <Has_supportive_med> "Filgrastim" .
<Hyper-CVAD/MA> <Has_supportive_med> "Ciprofloxacin" .
<Hyper-CVAD/MA> <Has_supportive_med> "Acyclovir" .
<mFOLFOX_and_Sorafenib> <Is_current_in> "Hepatocellular_carcinoma" .
<Cisplatin,_Paclitaxel,_Bevacizumab> <Has_antineoplastic> "Paclitaxel" .
<Cisplatin,_Paclitaxel,_Bevacizumab> <Has_antineoplastic> "Cisplatin" .
<Cisplatin,_Paclitaxel,_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Cisplatin_and_Methotrexate> <Has_modality> "Chemotherapy" .
<Dapsone> <May_have_route> "Oral" .
<Tagraxofusp_monotherapy> <Is_current_in> "Blastic_plasmacytoid_dendritic_cell_neoplasm" .
<FMP> <Is_historical_in> "Follicular_lymphoma" .
<EC_and_Bevacizumab> <Mapped_from> "EC_and_Bevacizumab" .
<Cyclophosphamide_and_Topotecan> <Has_accepted_use> "Osteosarcoma" .
<Cyclophosphamide_and_Topotecan> <Has_accepted_use> "Ewing_sarcoma" .
<Gemcitabine/Fluorouracil_and_RT> <Mapped_from> "Gemcitabine/Fluorouracil_and_RT" .
<Mesna> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Mesna> <Is_a> "Chemotherapy_protective_agent" .
<Rabbit_ATG> <Is_current_in> "Graft_versus_host_disease" .
<CapeOx_and_Panitumumab> <Has_accepted_use> "KRAS_wild-type_Colon_cancer" .
<CapeOx_and_Panitumumab> <Has_accepted_use> "Colon_cancer" .
<Docetaxel,_Cetuximab,_RT> <Has_supportive_med> "Diphenhydramine" .
<Docetaxel,_Cetuximab,_RT> <Has_supportive_med> "Dexamethasone" .
<TT4> <Has_context> "Induction_therapy" .
<Cisplatin_and_Doxorubicin> <Mapped_from> "Cisplatin_and_Doxorubicin" .
<Forodesine_monotherapy> <Has_antineoplastic> "Forodesine" .
<RVD> <Mapped_from> "RVD" .
<G-FC> <Mapped_from> "G-FC" .
<Alpelisib> <Has_accepted_use> "Breast_cancer" .
<EVI> <Mapped_from> "EVI" .
<Onseran> <Brand_name_of> "Ondansetron" .
<Axitinib_and_Avelumab> <Has_accepted_use> "Renal_cell_carcinoma" .
<Dasatinib_and_Prednisone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<High-dose_Interleukin-2> <Has_accepted_use> "Renal_cell_carcinoma" .
<High-dose_Interleukin-2> <Has_accepted_use> "Melanoma" .
<Epirubicin_and_Ifosfamide> <Has_antineoplastic> "Ifosfamide" .
<Epirubicin_and_Ifosfamide> <Has_antineoplastic> "Epirubicin" .
<Gemcitabine_and_nab-Paclitaxel> <Maps_to> "Gemcitabine_and_nab-Paclitaxel" .
<Dabrafenib_monotherapy> <Has_modality> "Chemotherapy" .
<Cobimetinib_and_Vemurafenib> <Mapped_from> "Cobimetinib_and_Vemurafenib" .
<Temozolomide_and_Bevacizumab> <Mapped_from> "Temozolomide_and_Bevacizumab" .
<DA-EPOCH> <Has_context> "Induction_therapy" .
<Polycythemia_vera> <Accepted_use_of> "Thalidomide_monotherapy" .
<Polycythemia_vera> <Accepted_use_of> "Thalidomide" .
<Polycythemia_vera> <Accepted_use_of> "Ruxolitinib_monotherapy" .
<Polycythemia_vera> <Accepted_use_of> "Ruxolitinib" .
<Polycythemia_vera> <Accepted_use_of> "Ropeginterferon_alfa-2b" .
<Polycythemia_vera> <Accepted_use_of> "Placebo" .
<Polycythemia_vera> <Accepted_use_of> "Pipobroman_monotherapy" .
<Polycythemia_vera> <Accepted_use_of> "Peginterferon_alfa-2a_monotherapy" .
<Polycythemia_vera> <Accepted_use_of> "Peginterferon_alfa-2a" .
<Polycythemia_vera> <Accepted_use_of> "Lenalidomide_monotherapy" .
<Polycythemia_vera> <Accepted_use_of> "Lenalidomide" .
<Polycythemia_vera> <Accepted_use_of> "Hydroxyurea_monotherapy" .
<Polycythemia_vera> <Accepted_use_of> "Hydroxyurea" .
<Polycythemia_vera> <Accepted_use_of> "Aspirin_monotherapy" .
<Polycythemia_vera> <Accepted_use_of> "Anagrelide_monotherapy" .
<Polycythemia_vera> <Accepted_use_of> "Anagrelide" .
<Docetaxel_and_Prednisone> <Has_context> "Non-curative_therapy" .
<HDMP> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Ibrutinib_and_Rituximab> <Maps_to> "Ibrutinib_and_Rituximab" .
<CaRD> <Maps_to> "CaRD" .
<Pipobroman_monotherapy> <Maps_to> "Pipobroman_monotherapy" .
<dmCODOX-M_-_Modified_Magrath> <Is_current_in> "HIV-associated_lymphoma" .
<Guficap> <Brand_name_of> "Caspofungin" .
<Novotrimox> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Osimertinib_monotherapy" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Icotinib_monotherapy" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Gefitinib_monotherapy" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Gefitinib_and_Pemetrexed" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "GCP" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Erlotinib_monotherapy" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Erlotinib_and_Ramucirumab" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Erlotinib_and_Bevacizumab" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Docetaxel_and_Bevacizumab" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Dacomitinib_monotherapy" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_and_Vinorelbine" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_and_Pemetrexed" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_and_Gemcitabine/Erlotinib" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_and_Gemcitabine" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_and_Docetaxel" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin_and_Pemetrexed" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin_and_Paclitaxel" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin_and_Gemcitabine/Erlotinib" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin_and_Gemcitabine" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin_and_Docetaxel" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Afatinib_monotherapy" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Afatinib_and_Cetuximab" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Afatinib_and_Bevacizumab" .
<Dara-VTD> <Has_context> "Non-curative_first-line_therapy" .
<Methotrexate,_Pegaspargase,_Vincristine> <Maps_to> "Methotrexate,_Pegaspargase,_Vincristine" .
<Aitan> <Brand_name_of> "Apatinib" .
<Binimetinib_monotherapy> <Has_modality> "Chemotherapy" .
<Anastrozole_and_Trastuzumab> <Has_modality> "Hormonotherapy" .
<Anastrozole_and_Trastuzumab> <Has_modality> "Chemotherapy" .
<Trimel> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Ixazomib_and_Dexamethasone> <Has_accepted_use> "Multiple_myeloma" .
<Ixazomib_and_Dexamethasone> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<ddTH_(Taxotere)> <Has_supportive_med> "Filgrastim" .
<Leuprolide_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<Leuprolide_monotherapy> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Leuprolide_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Chlorambucil_monotherapy> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<Chlorambucil_monotherapy> <Is_current_in> "Marginal_zone_lymphoma" .
<Chlorambucil_monotherapy> <Is_current_in> "Follicular_lymphoma" .
<Carboplatin,_Gemcitabine,_Bevacizumab> <Has_antineoplastic> "Gemcitabine" .
<Carboplatin,_Gemcitabine,_Bevacizumab> <Has_antineoplastic> "Carboplatin" .
<Carboplatin,_Gemcitabine,_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<ERBB3_inhibitor> <Subsumes> "Neratinib" .
<Mini-BEAM> <Has_context> "Non-curative_therapy" .
<Cyclosporine_non-modified> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Cyclosporine_non-modified> <Has_accepted_use> "Aplastic_anemia" .
<FLEC> <Has_context> "Induction_therapy" .
<Altretamine> <Antineoplastic_of> "Hexa-CAF" .
<Altretamine> <Antineoplastic_of> "CHAD" .
<Altretamine> <Antineoplastic_of> "Altretamine_monotherapy" .
<Altretamine> <Antineoplastic_of> "Altretamine_and_Cisplatin" .
<Methotrexate,_Vinblastine,_Prednisone> <Has_context> "Induction_therapy" .
<CapeOx> <Has_modality> "Chemotherapy" .
<Dexamethasone_and_Rituximab> <Mapped_from> "Dexamethasone_and_Rituximab" .
<Neometho> <Brand_name_of> "Methotrexate" .
<EOX> <Has_accepted_use> "Gastric_cancer" .
<EOX> <Has_accepted_use> "Esophageal_cancer" .
<Temozolomide_and_NovoTTF-100A> <Maps_to> "Temozolomide_and_NovoTTF-100A" .
<Gengraf> <Brand_name_of> "Cyclosporine_modified" .
<CHOP_Modified_(Prednisolone)> <Has_context> "Induction_therapy" .
<Cladribine_and_Rituximab> <Maps_to> "Cladribine_and_Rituximab" .
<Deldoxin> <Brand_name_of> "Doxorubicin" .
<Crizanlizumab_monotherapy> <Mapped_from> "Crizanlizumab_monotherapy" .
<TEK_inhibitor> <Subsumes> "Vandetanib" .
<TEK_inhibitor> <Subsumes> "Regorafenib" .
<TEK_inhibitor> <Subsumes> "Cabozantinib" .
<FP/Capecitabine_and_RT> <Has_modality> "Radiotherapy" .
<FP/Capecitabine_and_RT> <Has_modality> "Chemotherapy" .
<Ibrutinib_and_Venetoclax> <Has_antineoplastic> "Venetoclax" .
<Ibrutinib_and_Venetoclax> <Has_antineoplastic> "Ibrutinib" .
<Acute_promyelocytic_leukemia> <FDA_indication_of> "Arsenic_trioxide" .
<Acute_promyelocytic_leukemia> <FDA_indication_of> "All-trans_retinoic_acid" .
<Letpro> <Brand_name_of> "Letrozole" .
<Sennosides> <May_have_route> "Oral" .
<FOLFOX_7/sLV5FU2_(L-Leucovorin)> <Mapped_from> "FOLFOX_7/sLV5FU2_(L-Leucovorin)" .
<Fam-trastuzumab_deruxtecan> <Antineoplastic_of> "Fam-trastuzumab_deruxtecan_monotherapy" .
<Imatinib_and_Interferon> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Carboplatin_and_Teniposide> <Has_context> "Non-curative_therapy" .
<R-TBI/Cy,_then_auto_HSCT> <Is_a> "Rituximab-containing_regimen" .
<Adjuvant_therapy> <Mapped_from> "Adjuvant_therapy" .
<FNC> <Has_antineoplastic> "Mitoxantrone" .
<FNC> <Has_antineoplastic> "Fluorouracil" .
<FNC> <Has_antineoplastic> "Cyclophosphamide" .
<Doxorubicin,_Methotrexate,_Vincristine,_Prednisone> <Has_modality> "Chemotherapy" .
<Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT> <Maps_to> "Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT" .
<GemOx_and_Sorafenib> <Has_context> "Non-curative_first-line_therapy" .
<CISCA/VB> <Maps_to> "CISCA/VB" .
<Rituxan> <Brand_name_of> "Rituximab" .
<ddEC> <Has_supportive_med> "Pegfilgrastim" .
<ddEC> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<ddEC> <Has_supportive_med> "Filgrastim" .
<ddEC> <Has_supportive_med> "Epoetin_alfa" .
<Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone> <Has_context> "Maintenance_after_upfront_therapy" .
<DeVIC_and_RT> <Has_modality> "Radiotherapy" .
<Dactinomycin> <May_have_route> "Intravenous" .
<Docetaxel_monotherapy> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Docetaxel_monotherapy> <Is_historical_in> "Breast_cancer" .
<VBM> <Is_current_in> "Penile_cancer" .
<Chlorambucil_and_Obinutuzumab> <Has_antineoplastic> "Obinutuzumab" .
<Chlorambucil_and_Obinutuzumab> <Has_antineoplastic> "Chlorambucil" .
<Doxorubicin_non-pegylated_liposomal_monotherapy> <Mapped_from> "Doxorubicin_non-pegylated_liposomal_monotherapy" .
<7_plus_3i_and_Panobinostat> <Has_antineoplastic> "Panobinostat" .
<7_plus_3i_and_Panobinostat> <Has_antineoplastic> "Idarubicin" .
<7_plus_3i_and_Panobinostat> <Has_antineoplastic> "Cytarabine" .
<Sulfagrand> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bowel_management> <Subsumes> "Laxative" .
<Bowel_management> <Subsumes> "Anti-diarrheal" .
<GemOx> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<GemOx> <Has_supportive_med> "Dexamethasone" .
<Ceritinib_monotherapy> <Maps_to> "Ceritinib_monotherapy" .
<ddAC-T> <Mapped_from> "ddAC-T" .
<Cortisolone> <Brand_name_of> "Prednisolone" .
<Ostat> <Brand_name_of> "Alendronate" .
<Burkitt_lymphoma> <FDA_indication_of> "Cyclophosphamide" .
<Aminoglutethimide> <Is_a> "Steroid_synthesis_inhibitor" .
<Aminoglutethimide> <Is_a> "Endocrine_therapeutic" .
<Aminoglutethimide> <Is_a> "Aromatase_inhibitor" .
<Medroxyprogesterone_monotherapy> <Has_context> "Non-curative_therapy" .
<Medroxyprogesterone_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<DTPACE> <Mapped_from> "DTPACE" .
<Enzalutamide> <Has_accepted_use> "Prostate_cancer" .
<Enzalutamide> <Has_accepted_use> "Breast_cancer" .
<Eculizumab_monotherapy> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Eculizumab_monotherapy> <Has_supportive_med> "Topotecan" .
<Eculizumab_monotherapy> <Has_supportive_med> "Penicillin_V" .
<Eculizumab_monotherapy> <Has_supportive_med> "Ondansetron" .
<Eculizumab_monotherapy> <Has_supportive_med> "Eltrombopag" .
<Eculizumab_monotherapy> <Has_supportive_med> "Acyclovir" .
<Hicot> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cytarabine_and_Daunorubicin> <Is_a> "Anthracycline-containing_regimen" .
<VEPA> <Maps_to> "VEPA" .
<Adjuvant_therapy> <Is_a> "Post-definitive_therapy" .
<Irinotecan,_Temozolomide,_Dinutuximab> <Has_supportive_med> "Sargramostim" .
<Bicalutamide_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Bicalutamide_and_RT> <Has_antineoplastic> "Bicalutamide" .
<Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone> <Is_a> "Anthracycline-containing_regimen" .
<Urodown> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<TCH_(Taxotere,_Carboplatin)> <Maps_to> "TCH_(Taxotere,_Carboplatin)" .
<Etoposide,_Ifosfamide,_Methotrexate> <Has_antineoplastic> "Methotrexate" .
<Etoposide,_Ifosfamide,_Methotrexate> <Has_antineoplastic> "Ifosfamide" .
<Etoposide,_Ifosfamide,_Methotrexate> <Has_antineoplastic> "Etoposide" .
<Sulthrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Non-pegylated_liposomal_doxorubicin> <Is_a> "Topoisomerase_inhibitor" .
<Non-pegylated_liposomal_doxorubicin> <Is_a> "Liposomal_chemotherapy" .
<Non-pegylated_liposomal_doxorubicin> <Is_a> "Health_Canada_approved_drug" .
<Non-pegylated_liposomal_doxorubicin> <Is_a> "EMA_approved_drug" .
<Non-pegylated_liposomal_doxorubicin> <Is_a> "Anthracycline" .
<Methotrexate_monotherapy> <Has_accepted_use> "Head_and_neck_cancer" .
<Methotrexate_monotherapy> <Has_accepted_use> "Gestational_trophoblastic_neoplasia" .
<Methotrexate_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Methotrexate_monotherapy> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Methotrexate_monotherapy> <Has_accepted_use> "CNS_lymphoma" .
<Methotrexate_monotherapy> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<MAPIE> <Mapped_from> "MAPIE" .
<Esophageal_cancer> <Accepted_use_of> "mFOLFOX6_and_Cetuximab" .
<Esophageal_cancer> <Accepted_use_of> "Trastuzumab-qyyp" .
<Esophageal_cancer> <Accepted_use_of> "Trastuzumab-pkrb" .
<Esophageal_cancer> <Accepted_use_of> "Trastuzumab-dttb" .
<Esophageal_cancer> <Accepted_use_of> "Trastuzumab-dkst" .
<Esophageal_cancer> <Accepted_use_of> "Trastuzumab-anns" .
<Esophageal_cancer> <Accepted_use_of> "Trastuzumab" .
<Esophageal_cancer> <Accepted_use_of> "Tegafur_and_uracil" .
<Esophageal_cancer> <Accepted_use_of> "S-1_monotherapy" .
<Esophageal_cancer> <Accepted_use_of> "Ramucirumab_monotherapy" .
<Esophageal_cancer> <Accepted_use_of> "Radiation_therapy" .
<Esophageal_cancer> <Accepted_use_of> "Placebo" .
<Esophageal_cancer> <Accepted_use_of> "Pembrolizumab_monotherapy" .
<Esophageal_cancer> <Accepted_use_of> "Pegylated_liposomal_doxorubicin" .
<Esophageal_cancer> <Accepted_use_of> "Paclitaxel_monotherapy" .
<Esophageal_cancer> <Accepted_use_of> "Paclitaxel_and_Ramucirumab" .
<Esophageal_cancer> <Accepted_use_of> "Paclitaxel" .
<Esophageal_cancer> <Accepted_use_of> "PCF" .
<Esophageal_cancer> <Accepted_use_of> "Oxaliplatin" .
<Esophageal_cancer> <Accepted_use_of> "Observation" .
<Esophageal_cancer> <Accepted_use_of> "No_neoadjuvant_therapy" .
<Esophageal_cancer> <Accepted_use_of> "Nivolumab_monotherapy" .
<Esophageal_cancer> <Accepted_use_of> "Mitomycin" .
<Esophageal_cancer> <Accepted_use_of> "MCF" .
<Esophageal_cancer> <Accepted_use_of> "Levoleucovorin" .
<Esophageal_cancer> <Accepted_use_of> "Irinotecan_monotherapy" .
<Esophageal_cancer> <Accepted_use_of> "Irinotecan_liposome" .
<Esophageal_cancer> <Accepted_use_of> "Irinotecan_liposomal_monotherapy" .
<Esophageal_cancer> <Accepted_use_of> "Irinotecan_and_S-1" .
<Esophageal_cancer> <Accepted_use_of> "Irinotecan_and_Mitomycin" .
<Esophageal_cancer> <Accepted_use_of> "Irinotecan" .
<Esophageal_cancer> <Accepted_use_of> "Gemcitabine" .
<Esophageal_cancer> <Accepted_use_of> "Folinic_acid" .
<Esophageal_cancer> <Accepted_use_of> "Fluorouracil,_Paclitaxel,_RT" .
<Esophageal_cancer> <Accepted_use_of> "Fluorouracil,_Oxaliplatin,_RT" .
<Esophageal_cancer> <Accepted_use_of> "Fluorouracil,_Folinic_acid,_Gemcitabine" .
<Esophageal_cancer> <Accepted_use_of> "Fluorouracil_and_Paclitaxel" .
<Esophageal_cancer> <Accepted_use_of> "Fluorouracil_and_Folinic_acid" .
<Esophageal_cancer> <Accepted_use_of> "Fluorouracil" .
<Esophageal_cancer> <Accepted_use_of> "FULV/FULV_and_RT" .
<Esophageal_cancer> <Accepted_use_of> "FOLFOX4_and_RT" .
<Esophageal_cancer> <Accepted_use_of> "FOLFOX4" .
<Esophageal_cancer> <Accepted_use_of> "FOLFIRI" .
<Esophageal_cancer> <Accepted_use_of> "FLOT" .
<Esophageal_cancer> <Accepted_use_of> "FLEP" .
<Esophageal_cancer> <Accepted_use_of> "Etoposide_monotherapy" .
<Esophageal_cancer> <Accepted_use_of> "Etoposide" .
<Esophageal_cancer> <Accepted_use_of> "Erlotinib_monotherapy" .
<Esophageal_cancer> <Accepted_use_of> "Erlotinib" .
<Esophageal_cancer> <Accepted_use_of> "Epirubicin" .
<Esophageal_cancer> <Accepted_use_of> "EOX" .
<Esophageal_cancer> <Accepted_use_of> "EOF" .
<Esophageal_cancer> <Accepted_use_of> "ECX" .
<Esophageal_cancer> <Accepted_use_of> "ECF/5-FU_and_RT" .
<Esophageal_cancer> <Accepted_use_of> "ECF" .
<Esophageal_cancer> <Accepted_use_of> "Docetaxel,_Fluorouracil,_RT" .
<Esophageal_cancer> <Accepted_use_of> "Docetaxel_monotherapy" .
<Esophageal_cancer> <Accepted_use_of> "Docetaxel_and_Irinotecan" .
<Esophageal_cancer> <Accepted_use_of> "Docetaxel" .
<Esophageal_cancer> <Accepted_use_of> "Cisplatin,_Vinorelbine,_RT" .
<Esophageal_cancer> <Accepted_use_of> "Cisplatin,_Paclitaxel,_RT" .
<Esophageal_cancer> <Accepted_use_of> "Cisplatin,_Irinotecan,_RT" .
<Esophageal_cancer> <Accepted_use_of> "Cisplatin,_Fluorouracil,_RT" .
<Esophageal_cancer> <Accepted_use_of> "Cisplatin,_Fluorouracil,_Cetuximab" .
<Esophageal_cancer> <Accepted_use_of> "Cisplatin,_Etoposide,_RT" .
<Esophageal_cancer> <Accepted_use_of> "Cisplatin,_Doxorubicin_liposomal,_Fluorouracil" .
<Esophageal_cancer> <Accepted_use_of> "Cisplatin,_Docetaxel,_RT" .
<Esophageal_cancer> <Accepted_use_of> "Cisplatin_and_Paclitaxel" .
<Esophageal_cancer> <Accepted_use_of> "Cisplatin_and_Irinotecan" .
<Esophageal_cancer> <Accepted_use_of> "Cisplatin_and_Fluorouracil" .
<Esophageal_cancer> <Accepted_use_of> "Cisplatin_and_Etoposide" .
<Esophageal_cancer> <Accepted_use_of> "Cisplatin_and_Docetaxel" .
<Esophageal_cancer> <Accepted_use_of> "Cisplatin" .
<Esophageal_cancer> <Accepted_use_of> "Cetuximab_monotherapy" .
<Esophageal_cancer> <Accepted_use_of> "Cetuximab" .
<Esophageal_cancer> <Accepted_use_of> "Carboplatin,_Paclitaxel,_RT" .
<Esophageal_cancer> <Accepted_use_of> "Carboplatin,_Fluorouracil,_RT" .
<Esophageal_cancer> <Accepted_use_of> "Carboplatin_and_Paclitaxel" .
<Esophageal_cancer> <Accepted_use_of> "Carboplatin" .
<Esophageal_cancer> <Accepted_use_of> "Capecitabine,_Paclitaxel,_RT" .
<Esophageal_cancer> <Accepted_use_of> "Capecitabine,_Oxaliplatin,_RT" .
<Esophageal_cancer> <Accepted_use_of> "Capecitabine,_Docetaxel,_RT" .
<Esophageal_cancer> <Accepted_use_of> "Capecitabine,_Docetaxel,_Oxaliplatin,_RT" .
<Esophageal_cancer> <Accepted_use_of> "Capecitabine,_Cisplatin,_RT" .
<Esophageal_cancer> <Accepted_use_of> "Capecitabine,_Carboplatin,_Paclitaxel,_RT" .
<Esophageal_cancer> <Accepted_use_of> "Capecitabine" .
<Esophageal_cancer> <Accepted_use_of> "CapeOx" .
<Esophageal_cancer> <Accepted_use_of> "CX-C" .
<Esophageal_cancer> <Accepted_use_of> "CX_and_Trastuzumab" .
<Esophageal_cancer> <Accepted_use_of> "CX" .
<Esophageal_cancer> <Accepted_use_of> "CLF" .
<Esophageal_cancer> <Accepted_use_of> "CF_and_Trastuzumab" .
<Esophageal_cancer> <Accepted_use_of> "CAPIRI" .
<Esophageal_cancer> <Accepted_use_of> "Bevacizumab-bvzr" .
<Esophageal_cancer> <Accepted_use_of> "Bevacizumab-awwb" .
<Esophageal_cancer> <Accepted_use_of> "Bevacizumab" .
<Esophageal_cancer> <Accepted_use_of> "Best_supportive_care" .
<Esophageal_cancer> <Accepted_use_of> "Apatinib_monotherapy" .
<Esophageal_cancer> <Accepted_use_of> "Apatinib" .
<Ferric_carboxymaltose> <Has_brand_name> "Injectafer" .
<FC,_then_allo_HSCT> <Maps_to> "FC,_then_allo_HSCT" .
<Doxorubicin_and_Olaratumab> <Is_historical_in> "Soft_tissue_sarcoma" .
<Cyclosporine_and_Prednisone> <Has_modality> "Immunosuppressive_therapy" .
<KTD> <Maps_to> "KTD" .
<Cyclophosphamide,_Lomustine,_Methotrexate> <Mapped_from> "Cyclophosphamide,_Lomustine,_Methotrexate" .
<Bonalon> <Brand_name_of> "Alendronate" .
<Cisplatin_and_S-1> <Maps_to> "Cisplatin_and_S-1" .
<CIA> <Is_current_in> "Acute_myeloid_leukemia" .
<Scandexon> <Brand_name_of> "Dexamethasone" .
<Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide> <Has_antineoplastic> "Vincristine" .
<Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide> <Has_antineoplastic> "Etoposide" .
<Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide> <Has_antineoplastic> "Cyclophosphamide" .
<Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide> <Has_antineoplastic> "Cisplatin" .
<CVAP> <Has_accepted_use> "Breast_cancer" .
<Meladinina> <Brand_name_of> "Methoxsalen" .
<COP> <Maps_to> "COP" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone> <Has_antineoplastic> "Vincristine" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone> <Has_antineoplastic> "Prednisone" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone> <Has_antineoplastic> "Daunorubicin" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone> <Has_antineoplastic> "Cyclophosphamide" .
<Thrombace_NEO> <Brand_name_of> "Aspirin" .
<MVBP> <Has_accepted_use> "CNS_lymphoma" .
<Cisplatin_and_Dacarbazine> <Has_accepted_use> "Melanoma" .
<Alkerana> <Brand_name_of> "Melphalan" .
<Docetaxel_and_Vandetanib> <Has_antineoplastic> "Vandetanib" .
<Docetaxel_and_Vandetanib> <Has_antineoplastic> "Docetaxel" .
<Lapatinib,_Letrozole,_Trastuzumab> <Maps_to> "Lapatinib,_Letrozole,_Trastuzumab" .
<BCHOP> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Zolebid> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<mDCF_and_Bevacizumab> <Mapped_from> "mDCF_and_Bevacizumab" .
<EOF> <Has_supportive_med> "Warfarin" .
<EOF> <Has_supportive_med> "Dexamethasone" .
<B-CAVe> <Is_historical_in> "Hodgkin_lymphoma" .
<Derise> <Brand_name_of> "Darbepoetin_alfa" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_supportive_med> "Lenograstim" .
<VCP> <Maps_to> "VCP" .
<Soluble_AAC> <Brand_name_of> "Aspirin" .
<DES_monotherapy> <Maps_to> "DES_monotherapy" .
<VAIA> <Is_current_in> "Ewing_sarcoma" .
<Aspirin_and_Warfarin> <Has_accepted_use> "Antiphospholipid_antibody_syndrome" .
<APO> <Mapped_from> "APO" .
<Eribulin> <Has_accepted_use> "Liposarcoma" .
<Eribulin> <Has_accepted_use> "Leiomyosarcoma" .
<Eribulin> <Has_accepted_use> "Breast_cancer" .
<Mismatch_repair_deficient_malignancy> <Accepted_use_of> "Pembrolizumab_monotherapy" .
<Mismatch_repair_deficient_malignancy> <Accepted_use_of> "Pembrolizumab" .
<Razene> <Brand_name_of> "Cetirizine" .
<Bevacizumab-awwb> <May_have_route> "Intravenous" .
<Venetoclax_and_Rituximab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Dexamethasone_monotherapy> <Has_antineoplastic> "Dexamethasone" .
<Heparin> <Subsumes> "Unfractionated_heparin" .
<Heparin> <Subsumes> "Tinzaparin" .
<Heparin> <Subsumes> "Semuloparin" .
<Heparin> <Subsumes> "Nadroparin" .
<Heparin> <Subsumes> "Enoxaparin" .
<Heparin> <Subsumes> "Danaparoid" .
<Heparin> <Subsumes> "Dalteparin" .
<Cycloblastin> <Brand_name_of> "Cyclophosphamide" .
<Cisplatin,_Fluorouracil,_Panitumumab> <Has_context> "Non-curative_first-line_therapy" .
<Dacarbazine_and_Tamoxifen> <Has_context> "Non-curative_therapy" .
<Famvir> <Brand_name_of> "Famciclovir" .
<Carboplatin_and_Gemcitabine/Erlotinib> <Has_context> "Non-curative_therapy" .
<Allopurinol> <May_have_route> "Oral" .
<Allopurinol> <May_have_route> "Intravenous" .
<DOLP_(Prednisolone)> <Is_a> "Anthracycline-containing_regimen" .
<FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation> <Is_current_in> "Pancreatic_cancer" .
<Prilosec> <Brand_name_of> "Omeprazole" .
<Elo-VD> <Has_antineoplastic> "Elotuzumab" .
<Elo-VD> <Has_antineoplastic> "Dexamethasone" .
<Elo-VD> <Has_antineoplastic> "Bortezomib" .
<Etoposide,_Vinblastine,_Prednisone> <Has_modality> "Chemotherapy" .
<Interferon_alfa_monotherapy> <Has_modality> "Immunotherapy" .
<Methylon> <Brand_name_of> "Methylprednisolone" .
<Aspirin_and_Dexamethasone> <Has_accepted_use> "Prostate_cancer" .
<Prednisolone_and_Rituximab> <Has_immunosuppressor> "Rituximab" .
<Prednisolone_and_Rituximab> <Has_immunosuppressor> "Prednisolone" .
<Eculizumab_monotherapy> <Mapped_from> "Eculizumab_monotherapy" .
<Erythropoietin_monotherapy> <Has_modality> "Growth_factor_therapy" .
<Duvelisib_monotherapy> <Maps_to> "Duvelisib_monotherapy" .
<Septra> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Crizanlizumab_monotherapy> <Is_current_in> "Sickle_cell_anemia" .
<Acuvert> <Brand_name_of> "Prochlorperazine" .
<Dexametin> <Brand_name_of> "Dexamethasone" .
<Rotianin> <Brand_name_of> "Fluorouracil" .
<Cisplatin,_Cetuximab,_RT> <Has_supportive_med> "Dolasetron" .
<Cisplatin,_Cetuximab,_RT> <Has_supportive_med> "Diphenhydramine" .
<Enanton> <Brand_name_of> "Leuprolide" .
<Carboplatin,_Vinorelbine,_RT> <Mapped_from> "Carboplatin,_Vinorelbine,_RT" .
<Megestrol_and_Tamoxifen> <Mapped_from> "Megestrol_and_Tamoxifen" .
<Bortezomib,_Dexamethasone,_Panobinostat> <Maps_to> "Bortezomib,_Dexamethasone,_Panobinostat" .
<Melphalan_and_TBI> <Has_accepted_use> "Autologous_HSCT" .
<Bivalirudin_monotherapy> <Maps_to> "Bivalirudin_monotherapy" .
<Interferon_alfa_and_Dexamethasone> <Mapped_from> "Interferon_alfa_and_Dexamethasone" .
<TAM6,_then_auto_HSCT> <Is_current_in> "Mantle_cell_lymphoma" .
<Carboplatin_and_Paclitaxel> <Has_antineoplastic> "Paclitaxel" .
<Carboplatin_and_Paclitaxel> <Has_antineoplastic> "Carboplatin" .
<Mononine> <Brand_name_of> "Factor_IX_human" .
<Aspirin_and_Hydroxyurea> <Has_context> "Non-curative_first-line_therapy" .
<Methotrexate,_then_Cytarabine_and_Thiotepa> <Has_accepted_use> "CNS_lymphoma" .
<Azaplast> <Brand_name_of> "Azacitidine" .
<Binimetinib,_Encorafenib,_Cetuximab> <Has_context> "Non-curative_third-line_therapy" .
<Vaflu> <Brand_name_of> "Fluorouracil" .
<Pheochromocytoma> <Current_treated_by> "Cyclophosphamide,_Dacarbazine,_Vincristine" .
<Pheochromocytoma> <Current_treated_by> "131I-Metaiodobenzylguanidine_(131I-MIBG)" .
<Z-BEAM,_then_auto_HSCT> <Has_antineoplastic> "Rituximab" .
<Z-BEAM,_then_auto_HSCT> <Has_antineoplastic> "Melphalan" .
<Z-BEAM,_then_auto_HSCT> <Has_antineoplastic> "Ibritumomab_tiuxetan" .
<Z-BEAM,_then_auto_HSCT> <Has_antineoplastic> "Etoposide" .
<Z-BEAM,_then_auto_HSCT> <Has_antineoplastic> "Cytarabine" .
<Z-BEAM,_then_auto_HSCT> <Has_antineoplastic> "Carmustine" .
<Dagonal> <Brand_name_of> "Warfarin" .
<THP_(Taxotere)> <Has_antineoplastic> "Trastuzumab" .
<THP_(Taxotere)> <Has_antineoplastic> "Pertuzumab" .
<THP_(Taxotere)> <Has_antineoplastic> "Docetaxel" .
<DI_EC> <Maps_to> "DI_EC" .
<Observation> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Observation> <Has_accepted_use> "Small_cell_lung_cancer" .
<Observation> <Has_accepted_use> "Renal_cell_carcinoma" .
<Observation> <Has_accepted_use> "Rectal_cancer" .
<Observation> <Has_accepted_use> "Prostate_cancer" .
<Observation> <Has_accepted_use> "Periampullary_adenocarcinoma" .
<Observation> <Has_accepted_use> "Pancreatic_cancer" .
<Observation> <Has_accepted_use> "Ovarian_cancer" .
<Observation> <Has_accepted_use> "Osteosarcoma" .
<Observation> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Observation> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<Observation> <Has_accepted_use> "Multiple_myeloma" .
<Observation> <Has_accepted_use> "Melanoma" .
<Observation> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Observation> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Observation> <Has_accepted_use> "Low-grade_glioma" .
<Observation> <Has_accepted_use> "Leiomyosarcoma" .
<Observation> <Has_accepted_use> "Hodgkin_lymphoma" .
<Observation> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Observation> <Has_accepted_use> "Gastric_cancer" .
<Observation> <Has_accepted_use> "Follicular_lymphoma" .
<Observation> <Has_accepted_use> "Essential_thrombocythemia" .
<Observation> <Has_accepted_use> "Esophageal_cancer" .
<Observation> <Has_accepted_use> "Endometrial_cancer" .
<Observation> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Observation> <Has_accepted_use> "Cutaneous_squamous_cell_carcinoma" .
<Observation> <Has_accepted_use> "Colon_cancer" .
<Observation> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Observation> <Has_accepted_use> "Cholangiocarcinoma" .
<Observation> <Has_accepted_use> "CNS_lymphoma" .
<Observation> <Has_accepted_use> "Breast_cancer" .
<Observation> <Has_accepted_use> "Bladder_cancer" .
<Observation> <Has_accepted_use> "Anaplastic_glioma" .
<Observation> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Observation> <Has_accepted_use> "Acute_myeloid_leukemia" .
<EGFR-mutated_Non-small_cell_lung_cancer> <Is_a> "Non-small_cell_lung_cancer" .
<Alendron> <Brand_name_of> "Alendronate" .
<Genzaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Dacmozen> <Brand_name_of> "Dactinomycin" .
<Cyclophosphamide,_Dacarbazine,_Vincristine> <Has_context> "All_lines_of_therapy" .
<Capecitabine_and_Neratinib> <Is_current_in> "Breast_cancer" .
<Cyclophosphane> <Brand_name_of> "Cyclophosphamide" .
<CAP_(Platinol)> <Has_accepted_use> "Ovarian_cancer" .
<CAP_(Platinol)> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Lomustine,_Temozolomide,_RT> <Has_modality> "Radiotherapy" .
<Lomustine,_Temozolomide,_RT> <Has_modality> "Chemotherapy" .
<FOLFOX4_and_Bevacizumab> <Is_current_in> "Colon_cancer" .
<Fluorouracil_and_Methotrexate> <Has_modality> "Chemotherapy" .
<7_plus_3d> <Is_current_in> "Acute_myeloid_leukemia" .
<MC> <Has_context> "Non-curative_first-line_therapy" .
<Dactinomycin_and_Vincristine> <Has_accepted_use> "Wilms_tumor" .
<Hepatobiliary_cancer> <Is_a> "Gastrointestinal_cancer" .
<Fedratinib_monotherapy> <Has_context> "All_lines_of_therapy" .
<L-Asparaginase_and_Methotrexate> <Has_modality> "Chemotherapy" .
<Altretamine> <Has_FDA_indication> "Ovarian_cancer" .
<GDPT> <Has_modality> "Chemotherapy" .
<Capecitabine_and_Paclitaxel,_nanoparticle_albumin-bound> <Maps_to> "Capecitabine_and_Paclitaxel,_nanoparticle_albumin-bound" .
<Doptelet> <Brand_name_of> "Avatrombopag" .
<Melphalan_and_TBI,_then_auto_HSCT> <Mapped_from> "Melphalan_and_TBI,_then_auto_HSCT" .
<Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant> <Has_modality> "Radiotherapy" .
<Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant> <Has_modality> "Chemotherapy" .
<O-DHAP> <Has_supportive_med> "Pegfilgrastim" .
<O-DHAP> <Has_supportive_med> "Filgrastim" .
<Depakote> <Brand_name_of> "Valproate" .
<Appetite_stimulant> <Subsumes> "Megestrol" .
<Appetite_stimulant> <Subsumes> "Cannabinoid" .
<Mogamulizumab_monotherapy> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<Mogamulizumab_monotherapy> <Is_current_in> "Cutaneous_T-cell_lymphoma" .
<Levamisole_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Factor_IX_recombinant_Fc_fusion_protein> <Has_brand_name> "Alprolix" .
<Clafen> <Brand_name_of> "Cyclophosphamide" .
<Retinoid> <Subsumes> "Tamibarotene" .
<Retinoid> <Subsumes> "Isotretinoin" .
<Retinoid> <Subsumes> "Bexarotene" .
<Retinoid> <Subsumes> "All-trans_retinoic_acid" .
<ABCP> <Maps_to> "ABCP" .
<Ofatumumab_monotherapy> <Mapped_from> "Ofatumumab_monotherapy" .
<MOF> <Has_antineoplastic> "Vincristine" .
<MOF> <Has_antineoplastic> "Semustine" .
<MOF> <Has_antineoplastic> "Fluorouracil" .
<ATG_(Horse),_Cyclosporine,_G-CSF> <Has_accepted_use> "Aplastic_anemia" .
<Trastuzumab> <Has_accepted_use> "Gastric_cancer" .
<Trastuzumab> <Has_accepted_use> "Esophageal_cancer" .
<Trastuzumab> <Has_accepted_use> "ERBB2-mutated_malignancy" .
<Trastuzumab> <Has_accepted_use> "Breast_cancer" .
<Promethazine> <Is_a> "Phenothiazine" .
<Promethazine> <Is_a> "Emesis_prevention" .
<Promethazine> <Is_a> "Dopamine_receptor_antagonist" .
<Cotrizol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cytarabine,_Idarubicin,_Imatinib> <Has_context> "Consolidation_after_upfront_therapy" .
<Busulfan_and_Fludarabine> <Has_context> "All_lines_of_therapy" .
<R-HiDAC> <Has_antineoplastic> "Rituximab" .
<R-HiDAC> <Has_antineoplastic> "Cytarabine" .
<VBMC> <Maps_to> "VBMC" .
<Paclitaxel_nanoparticle_albumin-bound> <Has_FDA_indication> "Pancreatic_cancer" .
<Paclitaxel_nanoparticle_albumin-bound> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Paclitaxel_nanoparticle_albumin-bound> <Has_FDA_indication> "Breast_cancer" .
<Degarelix_monotherapy> <Has_antineoplastic> "Degarelix" .
<Aspirin> <May_have_route> "Oral" .
<Halaven> <Brand_name_of> "Eribulin" .
<CAP_(Platinol)> <Mapped_from> "CAP_(Platinol)" .
<Deltafluorene> <Brand_name_of> "Dexamethasone" .
<Pegylated_medication> <Subsumes> "Pegylated_liposomal_doxorubicin" .
<Pegylated_medication> <Subsumes> "Peginterferon_alfa-2b" .
<Pegylated_medication> <Subsumes> "Peginterferon_alfa-2a" .
<Pegylated_medication> <Subsumes> "Pegfilgrastim-jmdb" .
<Pegylated_medication> <Subsumes> "Pegfilgrastim-cbqv" .
<Pegylated_medication> <Subsumes> "Pegfilgrastim" .
<Pegylated_medication> <Subsumes> "Pegaspargase" .
<Pegylated_medication> <Subsumes> "Lipefilgrastim" .
<Pegylated_medication> <Subsumes> "Calaspargase" .
<Alenato> <Brand_name_of> "Alendronate" .
<R-DexaBEAM> <Has_context> "Salvage_therapy" .
<R-DexaBEAM> <Has_context> "Non-curative_therapy" .
<CMFVP> <Is_historical_in> "Breast_cancer" .
<Fada_Dexametasona> <Brand_name_of> "Dexamethasone" .
<BEP> <Is_current_in> "Testicular_cancer" .
<BEP> <Is_current_in> "Adenocarcinoma_of_unknown_primary" .
<Dispred> <Brand_name_of> "Methylprednisolone" .
<nab-Paclitaxel_and_Atezolizumab> <Has_context> "Non-curative_first-line_therapy" .
<Tinzaparin_monotherapy> <Has_accepted_use> "Venous_thromboembolism" .
<Daratumumab_monotherapy> <Has_modality> "Chemotherapy" .
<M-Prednihexal> <Brand_name_of> "Methylprednisolone" .
<COPDAC> <Has_modality> "Chemotherapy" .
<CMFVP> <Mapped_from> "CMFVP" .
<Fluorouracil_and_Levamisole> <Mapped_from> "Fluorouracil_and_Levamisole" .
<Vepefos> <Brand_name_of> "Etoposide" .
<Busulfan_and_Cyclophosphamide> <Maps_to> "Busulfan_and_Cyclophosphamide" .
<MPT> <Has_modality> "Chemotherapy" .
<Belotecan_and_Cisplatin> <Is_current_in> "Small_cell_lung_cancer" .
<FOLFIRI_and_Ramucirumab> <Has_antineoplastic> "Ramucirumab" .
<FOLFIRI_and_Ramucirumab> <Has_antineoplastic> "Irinotecan" .
<FOLFIRI_and_Ramucirumab> <Has_antineoplastic> "Folinic_acid" .
<FOLFIRI_and_Ramucirumab> <Has_antineoplastic> "Fluorouracil" .
<VDC> <Has_supportive_med> "Warfarin" .
<VDC> <Has_supportive_med> "Valacyclovir" .
<VDC> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<VDC> <Has_supportive_med> "Proton_pump_inhibitors" .
<VDC> <Has_supportive_med> "PCP_prophylaxis" .
<VDC> <Has_supportive_med> "Fluoroquinolone" .
<VDC> <Has_supportive_med> "Enoxaparin" .
<VDC> <Has_supportive_med> "Bisphosphonates" .
<VDC> <Has_supportive_med> "Aspirin" .
<VDC> <Has_supportive_med> "Antivirals" .
<VDC> <Has_supportive_med> "Acyclovir" .
<ECF/5-FU_and_RT> <Has_context> "Adjuvant_therapy" .
<CEP> <Has_accepted_use> "Ovarian_cancer" .
<CEP> <Has_accepted_use> "Hodgkin_lymphoma" .
<Defibrotide> <Is_a> "Chemotherapy_protective_agent" .
<Tositumomab_&_I-131> <Has_accepted_use> "Transformed_lymphoma" .
<Tositumomab_&_I-131> <Has_accepted_use> "Follicular_lymphoma" .
<Quizartinib> <May_have_route> "Oral" .
<Cisplatin,_Vinblastine,_RT> <Maps_to> "Cisplatin,_Vinblastine,_RT" .
<Accure> <Brand_name_of> "Isotretinoin" .
<Zanubrutinib> <May_have_route> "Oral" .
<Fluorouracil_and_Streptozocin> <Mapped_from> "Fluorouracil_and_Streptozocin" .
<Dasatinib_monotherapy> <Has_context> "Salvage_therapy" .
<Dasatinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Dasatinib_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Dasatinib_monotherapy> <Has_context> "Maintenance_after_upfront_therapy" .
<Dasatinib_monotherapy> <Has_context> "Induction_therapy" .
<Dasatinib_monotherapy> <Has_context> "All_lines_of_therapy" .
<COPADM> <Maps_to> "COPADM" .
<Medroxyprogesterone_and_Tamoxifen> <Has_antineoplastic> "Tamoxifen" .
<Medroxyprogesterone_and_Tamoxifen> <Has_antineoplastic> "Medroxyprogesterone" .
<TAC_(Taxotere)> <Has_accepted_use> "Breast_cancer" .
<Demerol> <Brand_name_of> "Meperidine" .
<MPV> <Is_current_in> "CNS_lymphoma" .
<Melphalan,_then_auto_HSCT> <Has_accepted_use> "Plasma_cell_leukemia" .
<Melphalan,_then_auto_HSCT> <Has_accepted_use> "Multiple_myeloma" .
<Melphalan,_then_auto_HSCT> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<MF> <Has_context> "Adjuvant_therapy" .
<CEF/CMF> <Is_a> "Anthracycline-containing_regimen" .
<Acetylsalicylsyra> <Brand_name_of> "Aspirin" .
<BFR> <Has_modality> "Chemotherapy" .
<ERBB2_(HER2)_medication> <Subsumes> "Trastuzumab" .
<ERBB2_(HER2)_medication> <Subsumes> "Pertuzumab" .
<ERBB2_(HER2)_medication> <Subsumes> "Neratinib" .
<TMF> <Maps_to> "TMF" .
<Dexacollyre> <Brand_name_of> "Dexamethasone" .
<Thalide> <Brand_name_of> "Thalidomide" .
<Cisplatin,_Paclitaxel,_RT> <Has_antineoplastic> "Paclitaxel" .
<Cisplatin,_Paclitaxel,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Cisplatin,_Paclitaxel,_RT> <Has_antineoplastic> "Cisplatin" .
<Ostex> <Brand_name_of> "Alendronate" .
<Cisplatin,_Irinotecan,_RT> <Has_context> "Neoadjuvant_therapy" .
<Oncomide> <Brand_name_of> "Cyclophosphamide" .
<R-COPADM> <Is_current_in> "Burkitt_lymphoma" .
<Melphalan_and_TBI,_then_auto_HSCT> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Cisplatin,_Doxorubicin,_Paclitaxel> <Mapped_from> "Cisplatin,_Doxorubicin,_Paclitaxel" .
<Vallona> <Brand_name_of> "Valproate" .
<Bleomycin,_Methotrexate,_Vinblastine/RT> <Is_historical_in> "Head_and_neck_cancer" .
<VEPEMB> <Maps_to> "VEPEMB" .
<TBI,_then_auto_HSCT> <Has_modality> "Radiotherapy" .
<RCC> <Mapped_from> "RCC" .
<DUO_Septol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Vorinostat" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Temozolomide_monotherapy" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Temozolomide" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Prednisone" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Placebo" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Midostaurin_monotherapy" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Midostaurin" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Luspatercept_monotherapy" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Luspatercept" .
<Myelodysplastic_syndrome> <Accepted_use_of> "LoDAC" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Lenalidomide_monotherapy" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Lenalidomide" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Erythropoietin_monotherapy" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Erythropoetin_and_Lenalidomide" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Erlotinib_monotherapy" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Erlotinib" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Decitabine_monotherapy" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Decitabine" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Cyclosporine_non-modified" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Cyclosporine_monotherapy" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Cyclosporine_modified" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Clofarabine_monotherapy" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Clofarabine" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Busulfan_and_Cyclophosphamide,_then_allo_HSCT" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Best_supportive_care" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Azacitidine_monotherapy" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Azacitidine_and_Vorinostat" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Azacitidine_and_Lenalidomide" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Azacitidine" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Antithymocyte_globulin_rabbit_ATG" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Antithymocyte_globulin_horse_ATG" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Alemtuzumab_monotherapy" .
<Myelodysplastic_syndrome> <Accepted_use_of> "Alemtuzumab" .
<Myelodysplastic_syndrome> <Accepted_use_of> "ATG_(Rabbit)_monotherapy" .
<Myelodysplastic_syndrome> <Accepted_use_of> "ATG_(Horse)_monotherapy" .
<Myelodysplastic_syndrome> <Accepted_use_of> "ATG_(Horse)_and_Cyclosporine" .
<Lomustine_monotherapy> <Mapped_from> "Lomustine_monotherapy" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Current_treated_by> "Rituximab_monotherapy" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Current_treated_by> "R-EPOCH" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Current_treated_by> "R-CVP" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Current_treated_by> "R-CHOP" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Current_treated_by> "EPOCH" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Current_treated_by> "CVP_(Vinblastine/Prednisone)" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Current_treated_by> "CHOP" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Current_treated_by> "ABVD" .
<DE> <Is_a> "Anthracycline-containing_regimen" .
<DDGP> <Is_current_in> "NK-_and_T-cell_lymphoma" .
<Methotrexate> <Immunosuppressor_of> "Methotrexate,_Tacrolimus,_Vorinostat" .
<Methotrexate> <Immunosuppressor_of> "Methotrexate,_Tacrolimus,_Tocilizumab" .
<Methotrexate> <Immunosuppressor_of> "Methotrexate_and_Tacrolimus" .
<Methotrexate> <Immunosuppressor_of> "Methotrexate_and_Prednisone" .
<Methotrexate> <Immunosuppressor_of> "Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Methotrexate> <Immunosuppressor_of> "HLH-94_regimen" .
<Methotrexate> <Immunosuppressor_of> "Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Methotrexate> <Immunosuppressor_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT" .
<Methotrexate> <Immunosuppressor_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan" .
<Methotrexate> <Immunosuppressor_of> "Fludarabine,_Busulfan,_ATG" .
<Methotrexate> <Immunosuppressor_of> "Fludarabine_and_Melphalan" .
<Methotrexate> <Immunosuppressor_of> "Flu-Mel,_then_allo_HSCT" .
<Methotrexate> <Immunosuppressor_of> "FCR,_then_allo_HSCT" .
<Methotrexate> <Immunosuppressor_of> "FCR" .
<Methotrexate> <Immunosuppressor_of> "Cyclosporine,_Methotrexate,_Prednisone" .
<Methotrexate> <Immunosuppressor_of> "Cyclosporine,_Methotrexate,_Methylprednisolone" .
<Methotrexate> <Immunosuppressor_of> "Cyclosporine,_Methotrexate,_ATG" .
<Methotrexate> <Immunosuppressor_of> "Cyclosporine_and_Methotrexate" .
<Methotrexate> <Immunosuppressor_of> "Busulfan_and_Fludarabine" .
<Methotrexate> <Immunosuppressor_of> "BuFlu,_then_allo_HSCT" .
<Methotrexate> <Immunosuppressor_of> "BEAM,_then_allo_HSCT" .
<Methotrexate> <Immunosuppressor_of> "BEAM" .
<Methotrexate> <Immunosuppressor_of> "(90)YFC,_then_allo_HSCT" .
<Methotrexate> <Immunosuppressor_of> "(90)YFC" .
<Acalabrutinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Danodiol> <Brand_name_of> "Danazol" .
<Metrotex> <Brand_name_of> "Methotrexate" .
<Gilotrif> <Brand_name_of> "Afatinib" .
<Etoposide> <Immunosuppressor_of> "HLH-94_regimen" .
<Etoposide> <Immunosuppressor_of> "HLH-2004_regimen" .
<Plasma_exchange> <Has_supportive_med> "Dipyridamole" .
<Plasma_exchange> <Has_supportive_med> "Aspirin" .
<CYKLONE> <Has_supportive_med> "Low_molecular_weight_heparins" .
<CYKLONE> <Has_supportive_med> "Aspirin" .
<CYKLONE> <Has_supportive_med> "Antibacterials" .
<CYKLONE> <Has_supportive_med> "Acyclovir" .
<ADT_and_Enzalutamide> <Has_accepted_use> "Prostate_cancer" .
<DEP> <Is_current_in> "Hemophagocytic_lymphohistiocytosis" .
<VT> <Has_accepted_use> "Multiple_myeloma" .
<Cisplatin,_Gemcitabine,_nab-Paclitaxel> <Has_accepted_use> "Gallbladder_cancer" .
<Cisplatin,_Gemcitabine,_nab-Paclitaxel> <Has_accepted_use> "Cholangiocarcinoma" .
<Cisplatin,_Fluorouracil,_Hydroxyurea,_RT> <Has_antineoplastic> "Hydroxyurea" .
<Cisplatin,_Fluorouracil,_Hydroxyurea,_RT> <Has_antineoplastic> "Fluorouracil" .
<Cisplatin,_Fluorouracil,_Hydroxyurea,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Cisplatin,_Fluorouracil,_Hydroxyurea,_RT> <Has_antineoplastic> "Cisplatin" .
<Cisplatin,_Fluorouracil,_Hydroxyurea,_RT> <Has_antineoplastic> "Brachytherapy" .
<Bactrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<mCOP/MP> <Mapped_from> "mCOP/MP" .
<HDAC_and_G-CSF> <Has_antineoplastic> "Cytarabine" .
<Fludarabine_monotherapy> <Maps_to> "Fludarabine_monotherapy" .
<BR_and_Polatuzumab_vedotin> <Is_a> "Rituximab-containing_regimen" .
<Pentrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<BVD> <Mapped_from> "BVD" .
<Olaparib> <Has_accepted_use> "Prostate_cancer" .
<Olaparib> <Has_accepted_use> "Pancreatic_cancer" .
<Olaparib> <Has_accepted_use> "Ovarian_cancer" .
<Olaparib> <Has_accepted_use> "Breast_cancer" .
<Ifos> <Brand_name_of> "Ifosfamide" .
<PEN> <Has_antineoplastic> "Prednisone" .
<PEN> <Has_antineoplastic> "Mitoxantrone" .
<PEN> <Has_antineoplastic> "Etoposide" .
<Zolmed> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Alemtuzumab_and_Rituximab> <Maps_to> "Alemtuzumab_and_Rituximab" .
<Huma-Trimel> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Rituxan_Hycela> <Brand_name_of> "Rituximab_and_hyaluronidase_human" .
<Doxorubicin_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Doxorubicin_and_Bevacizumab> <Is_a> "Anthracycline-containing_regimen" .
<Cytarabine_and_G-CSF> <Has_modality> "Growth_factor_therapy" .
<Cytarabine_and_G-CSF> <Has_modality> "Chemotherapy" .
<FOLFIRI> <Is_a> "Irinotecan-containing_regimen" .
<CMFL> <Is_historical_in> "Breast_cancer" .
<Panataxel> <Brand_name_of> "Paclitaxel" .
<CAV/PE> <Has_modality> "Chemotherapy" .
<Decortin> <Brand_name_of> "Prednisone" .
<IGEV_and_G-CSF> <Has_modality> "Chemotherapy" .
<Topotecan> <Is_a> "Topoisomerase_inhibitor" .
<Topotecan> <Is_a> "Irritant" .
<Doxorubicin,_Ifosfamide,_RT> <Has_context> "Non-curative_therapy" .
<Elo-VD> <Maps_to> "Elo-VD" .
<Capecitabine> <Has_FDA_indication> "Colon_cancer" .
<Capecitabine> <Has_FDA_indication> "Breast_cancer" .
<Bendamustine_and_Brentuximab_vedotin> <Has_antineoplastic> "Brentuximab_vedotin" .
<Bendamustine_and_Brentuximab_vedotin> <Has_antineoplastic> "Bendamustine" .
<Anti-inhibitor_coagulant_complex> <May_have_route> "Intravenous" .
<BVP> <Mapped_from> "BVP" .
<Non-curative_first-line_therapy> <Maps_to> "Non-curative_first-line_therapy" .
<Carboplatin,_Vinorelbine,_RT> <Is_current_in> "Non-small_cell_lung_cancer" .
<Xyotin> <Brand_name_of> "Bendamustine" .
<FEC> <Is_current_in> "Breast_cancer" .
<Chlorambucil_and_Prednisolone> <Has_antineoplastic> "Prednisolone" .
<Chlorambucil_and_Prednisolone> <Has_antineoplastic> "Chlorambucil" .
<Epogin> <Brand_name_of> "Epoetin_alfa" .
<Salospir> <Brand_name_of> "Aspirin" .
<CAFVP> <Maps_to> "CAFVP" .
<Pertuzumab_and_T-DM1> <Has_context> "Non-curative_first-line_therapy" .
<Decafos> <Brand_name_of> "Dexamethasone" .
<FM> <Has_modality> "Chemotherapy" .
<Trastuzumab_monotherapy> <Has_context> "Non-curative_therapy" .
<Trastuzumab_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Trastuzumab_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Trastuzumab_monotherapy> <Has_context> "Neoadjuvant_therapy" .
<Trastuzumab_monotherapy> <Has_context> "Adjuvant_therapy" .
<O-ESHAP> <Has_context> "Non-curative_therapy" .
<Anti-inhibitor_coagulant_complex> <Has_accepted_use> "Acquired_coagulopathy" .
<Streptozocin> <May_have_route> "Intravenous" .
<Autoimmune_cytopenia> <Accepted_use_of> "Sirolimus_monotherapy" .
<Autoimmune_cytopenia> <Accepted_use_of> "Sirolimus" .
<Autoimmune_cytopenia> <Accepted_use_of> "Alemtuzumab_monotherapy" .
<Autoimmune_cytopenia> <Accepted_use_of> "Alemtuzumab" .
<Enasidenib_monotherapy> <Has_context> "Salvage_therapy" .
<Enasidenib_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<R-M-CHOP> <Mapped_from> "R-M-CHOP" .
<Neuroblastoma> <Accepted_use_of> "Temozolomide" .
<Neuroblastoma> <Accepted_use_of> "Sargramostim" .
<Neuroblastoma> <Accepted_use_of> "Isotretinoin_monotherapy" .
<Neuroblastoma> <Accepted_use_of> "Isotretinoin_and_Dinutuximab" .
<Neuroblastoma> <Accepted_use_of> "Isotretinoin" .
<Neuroblastoma> <Accepted_use_of> "Irinotecan,_Temozolomide,_Dinutuximab" .
<Neuroblastoma> <Accepted_use_of> "Irinotecan" .
<Neuroblastoma> <Accepted_use_of> "GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab" .
<Neuroblastoma> <Accepted_use_of> "Dinutuximab" .
<Neuroblastoma> <Accepted_use_of> "Cyclophosphamide_monotherapy" .
<Neuroblastoma> <Accepted_use_of> "Cyclophosphamide_and_Vincristine" .
<Neuroblastoma> <Accepted_use_of> "Busulfan_and_Melphalan,_then_auto_HSCT" .
<Neuroblastoma> <Accepted_use_of> "Aldesleukin" .
<Cisplatin_and_Vinblastine> <Has_context> "Non-curative_first-line_therapy" .
<Cisplatin_and_Vinblastine> <Has_context> "Induction_therapy" .
<Cisplatin_and_Vinblastine> <Has_context> "Adjuvant_therapy" .
<mDCF> <Is_current_in> "Gastric_cancer" .
<mDCF> <Is_current_in> "Anal_cancer" .
<VMCP> <Has_context> "Non-curative_first-line_therapy" .
<Carboplatin,_nab-Paclitaxel,_Atezolizumab> <Has_modality> "Immunotherapy" .
<Carboplatin,_nab-Paclitaxel,_Atezolizumab> <Has_modality> "Chemotherapy" .
<CCI> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Mikotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cyclophosphamide> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Cyclophosphamide> <Has_accepted_use> "Transformed_lymphoma" .
<Cyclophosphamide> <Has_accepted_use> "Thymoma" .
<Cyclophosphamide> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Cyclophosphamide> <Has_accepted_use> "Small_cell_lung_cancer" .
<Cyclophosphamide> <Has_accepted_use> "Rhabdomyosarcoma" .
<Cyclophosphamide> <Has_accepted_use> "Prostate_cancer" .
<Cyclophosphamide> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<Cyclophosphamide> <Has_accepted_use> "Post-transplant_lymphoproliferative_disorder" .
<Cyclophosphamide> <Has_accepted_use> "Plasma_cell_leukemia" .
<Cyclophosphamide> <Has_accepted_use> "Pheochromocytoma" .
<Cyclophosphamide> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Cyclophosphamide> <Has_accepted_use> "Osteosarcoma" .
<Cyclophosphamide> <Has_accepted_use> "Multiple_myeloma" .
<Cyclophosphamide> <Has_accepted_use> "Medulloblastoma" .
<Cyclophosphamide> <Has_accepted_use> "Mediastinal_gray-zone_lymphoma" .
<Cyclophosphamide> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Cyclophosphamide> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Cyclophosphamide> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Cyclophosphamide> <Has_accepted_use> "Large_granular_lymphocytic_leukemia" .
<Cyclophosphamide> <Has_accepted_use> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<Cyclophosphamide> <Has_accepted_use> "Hodgkin_lymphoma" .
<Cyclophosphamide> <Has_accepted_use> "HIV-associated_lymphoma" .
<Cyclophosphamide> <Has_accepted_use> "Glioblastoma" .
<Cyclophosphamide> <Has_accepted_use> "Follicular_lymphoma" .
<Cyclophosphamide> <Has_accepted_use> "Ewing_sarcoma" .
<Cyclophosphamide> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Cyclophosphamide> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Cyclophosphamide> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Cyclophosphamide> <Has_accepted_use> "CNS_lymphoma" .
<Cyclophosphamide> <Has_accepted_use> "Burkitt_lymphoma" .
<Cyclophosphamide> <Has_accepted_use> "Breast_cancer" .
<Cyclophosphamide> <Has_accepted_use> "Bladder_cancer" .
<Cyclophosphamide> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Cyclophosphamide> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<Cyclophosphamide> <Has_accepted_use> "Anaplastic_glioma" .
<Cyclophosphamide> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<Cyclophosphamide> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Cyclophosphamide> <Has_accepted_use> "Acquired_coagulopathy" .
<Fulvestrant_and_Palbociclib> <Mapped_from> "Fulvestrant_and_Palbociclib" .
<PT> <Mapped_from> "PT" .
<Lenalidomide> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Lenalidomide> <Has_accepted_use> "Transformed_lymphoma" .
<Lenalidomide> <Has_accepted_use> "Polycythemia_vera" .
<Lenalidomide> <Has_accepted_use> "Plasma_cell_leukemia" .
<Lenalidomide> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Lenalidomide> <Has_accepted_use> "POEMS_syndrome" .
<Lenalidomide> <Has_accepted_use> "Myelofibrosis" .
<Lenalidomide> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Lenalidomide> <Has_accepted_use> "Multiple_myeloma" .
<Lenalidomide> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Lenalidomide> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Lenalidomide> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Lenalidomide> <Has_accepted_use> "Hodgkin_lymphoma" .
<Lenalidomide> <Has_accepted_use> "Follicular_lymphoma" .
<Lenalidomide> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Lenalidomide> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Lenalidomide> <Has_accepted_use> "Chronic_myelomonocytic_leukemia" .
<Lenalidomide> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Lenalidomide> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<Equate_Daily> <Brand_name_of> "Aspirin" .
<Orbak> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Anti-C5_antibody> <Is_a> "Antibody_medication" .
<Cyclophosphamide_and_Prednisolone> <Has_accepted_use> "Acquired_coagulopathy" .
<CBV,_then_auto_HSCT> <Mapped_from> "CBV,_then_auto_HSCT" .
<Cyclophosphamide_and_Vincristine> <Is_current_in> "Neuroblastoma" .
<EVAIA> <Has_context> "Neoadjuvant_therapy" .
<EVAIA> <Has_context> "Adjuvant_therapy" .
<FOLFOX4_and_RT> <Has_context> "Definitive_therapy" .
<VIPD> <Has_supportive_med> "Mesna" .
<VIPD> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<COMP> <Has_antineoplastic> "Vincristine" .
<COMP> <Has_antineoplastic> "Prednisone" .
<COMP> <Has_antineoplastic> "Methotrexate" .
<COMP> <Has_antineoplastic> "Cyclophosphamide" .
<ZRd> <Has_context> "Non-curative_therapy" .
<Neoxane> <Brand_name_of> "Doxorubicin" .
<Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin> <Has_supportive_med> "Unfractionated_heparin" .
<Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin> <Has_supportive_med> "Tranexamic_acid" .
<Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin> <Has_supportive_med> "Methylprednisolone" .
<Docetaxel_and_Bevacizumab> <Maps_to> "Docetaxel_and_Bevacizumab" .
<7_plus_3m> <Has_antineoplastic> "Mitoxantrone" .
<7_plus_3m> <Has_antineoplastic> "Cytarabine" .
<Epirubicin_and_Vinorelbine> <Has_accepted_use> "Breast_cancer" .
<Imatinib> <May_have_route> "Oral" .
<Formestane_monotherapy> <Mapped_from> "Formestane_monotherapy" .
<Ipilimumab_and_RT> <Is_current_in> "Prostate_cancer" .
<R-MCP> <Is_current_in> "Follicular_lymphoma" .
<Phostarac> <Brand_name_of> "Alendronate" .
<Clopinam> <Brand_name_of> "Clopidogrel" .
<CLAG-M> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Levofloxacin> <Supportive_med_of> "R-M-CHOP" .
<Levofloxacin> <Supportive_med_of> "R-Hyper-CVAD/R-MA" .
<Levofloxacin> <Supportive_med_of> "Pentostatin_monotherapy" .
<Levofloxacin> <Supportive_med_of> "Hyper-CVAD/MA" .
<Levofloxacin> <Supportive_med_of> "Hyper-CVAD_and_Ponatinib" .
<Levofloxacin> <Supportive_med_of> "Hyper-CVAD_and_Imatinib" .
<Levofloxacin> <Supportive_med_of> "Hyper-CVAD_and_Dasatinib" .
<Levofloxacin> <Supportive_med_of> "EAR_and_G-CSF" .
<Levofloxacin> <Supportive_med_of> "DCF" .
<Levofloxacin> <Supportive_med_of> "Clofarabine_and_Cytarabine" .
<Levofloxacin> <Supportive_med_of> "Cladribine_and_Rituximab" .
<Levofloxacin> <Supportive_med_of> "CIA" .
<Levofloxacin> <Supportive_med_of> "CBV,_then_auto_HSCT" .
<Levofloxacin> <Supportive_med_of> "CBV" .
<GCD> <Has_context> "Non-curative_therapy" .
<Axitinib_and_TACE> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Bu/TT,_then_auto_HSCT> <Has_antineoplastic> "Thiotepa" .
<Bu/TT,_then_auto_HSCT> <Has_antineoplastic> "Busulfan" .
<Arsenic_trioxide_and_ATRA> <Has_antineoplastic> "Arsenic_trioxide" .
<Arsenic_trioxide_and_ATRA> <Has_antineoplastic> "All-trans_retinoic_acid" .
<VTD-PACE> <Is_current_in> "Multiple_myeloma" .
<CCOP> <Is_a> "Anthracycline-containing_regimen" .
<MINE> <Has_supportive_med> "Mesna" .
<FAMTX> <Has_context> "Non-curative_first-line_therapy" .
<Oftadek> <Brand_name_of> "Dexamethasone" .
<Carboplatin_and_Cisplatin> <Has_antineoplastic> "Cisplatin" .
<Carboplatin_and_Cisplatin> <Has_antineoplastic> "Carboplatin" .
<Medroxyprogesterone_and_Tamoxifen> <Is_a> "Antiestrogen-containing_regimen" .
<Tocilizumab_monotherapy> <Mapped_from> "Tocilizumab_monotherapy" .
<PVAG> <Mapped_from> "PVAG" .
<Azacitidine,_Vorinostat,_Gemtuzumab_ozogamicin> <Has_modality> "Chemotherapy" .
<Leubene> <Brand_name_of> "Filgrastim" .
<Pertuzumab> <Has_accepted_use> "ERBB2-mutated_malignancy" .
<Pertuzumab> <Has_accepted_use> "Breast_cancer" .
<VDC> <Mapped_from> "VDC" .
<Cisplatin,_Dacarbazine,_Tamoxifen> <Is_historical_in> "Melanoma" .
<Tandem_melphalan,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Toposin> <Brand_name_of> "Etoposide" .
<Cisplatin_and_Gemcitabine/Erlotinib> <Has_modality> "Chemotherapy" .
<Cephalotaxine> <Subsumes> "Omacetaxine" .
<Afatinib_and_Cetuximab> <Is_current_in> "Non-small_cell_lung_cancer" .
<Bioplatinex> <Brand_name_of> "Carboplatin" .
<Platinum_doublet> <Subsumes> "SOX" .
<Platinum_doublet> <Subsumes> "Ox-P" .
<Platinum_doublet> <Subsumes> "IROX" .
<Platinum_doublet> <Subsumes> "GemOx" .
<Platinum_doublet> <Subsumes> "FUOX" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Vinorelbine" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Vindesine" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Vinblastine" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Topotecan" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_S-1" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Raltitrexed" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Pemetrexed" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Paclitaxel" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Mitomycin" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Methotrexate" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Irinotecan" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Ifosfamide" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Gemcitabine" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Fluorouracil" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Etoposide" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Epirubicin" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Doxorubicin" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Docetaxel" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Dacarbazine" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Cyclophosphamide" .
<Platinum_doublet> <Subsumes> "Cisplatin_and_Cetuximab" .
<Platinum_doublet> <Subsumes> "Chlorambucil_and_Cisplatin" .
<Platinum_doublet> <Subsumes> "Carboplatin_and_nab-Paclitaxel" .
<Platinum_doublet> <Subsumes> "Carboplatin_and_Vinorelbine" .
<Platinum_doublet> <Subsumes> "Carboplatin_and_Vincristine" .
<Platinum_doublet> <Subsumes> "Carboplatin_and_Teniposide" .
<Platinum_doublet> <Subsumes> "Carboplatin_and_Pemetrexed" .
<Platinum_doublet> <Subsumes> "Carboplatin_and_Paclitaxel" .
<Platinum_doublet> <Subsumes> "Carboplatin_and_Irinotecan" .
<Platinum_doublet> <Subsumes> "Carboplatin_and_Ifosfamide" .
<Platinum_doublet> <Subsumes> "Carboplatin_and_Gemcitabine" .
<Platinum_doublet> <Subsumes> "Carboplatin_and_Fluorouracil" .
<Platinum_doublet> <Subsumes> "Carboplatin_and_Etoposide,_then_auto_HSCT" .
<Platinum_doublet> <Subsumes> "Carboplatin_and_Etoposide" .
<Platinum_doublet> <Subsumes> "Carboplatin_and_Doxorubicin_liposomal" .
<Platinum_doublet> <Subsumes> "Carboplatin_and_Docetaxel" .
<Platinum_doublet> <Subsumes> "Carboplatin_and_Cyclophosphamide" .
<Platinum_doublet> <Subsumes> "Carboplatin_and_Cisplatin" .
<Platinum_doublet> <Subsumes> "CapeOx" .
<Platinum_doublet> <Subsumes> "CX" .
<Platinum_doublet> <Subsumes> "Bleomycin_and_Cisplatin" .
<Platinum_doublet> <Subsumes> "Belotecan_and_Cisplatin" .
<Platinum_doublet> <Subsumes> "Altretamine_and_Cisplatin" .
<RT-PEPC> <Maps_to> "RT-PEPC" .
<FOLFIRI_and_Cetuximab> <Is_a> "Irinotecan-containing_regimen" .
<Obinutuzumab> <May_have_route> "Intravenous" .
<Cisplatin,_Doxorubicin_liposomal,_Fluorouracil> <Has_modality> "Chemotherapy" .
<Gastric_cancer> <Accepted_use_of> "nab-Paclitaxel_monotherapy" .
<Gastric_cancer> <Accepted_use_of> "mDCF_and_Bevacizumab" .
<Gastric_cancer> <Accepted_use_of> "mDCF" .
<Gastric_cancer> <Accepted_use_of> "UFTM" .
<Gastric_cancer> <Accepted_use_of> "Trifluridine_and_tipiracil_monotherapy" .
<Gastric_cancer> <Accepted_use_of> "Trifluridine_and_tipiracil" .
<Gastric_cancer> <Accepted_use_of> "Trastuzumab-qyyp" .
<Gastric_cancer> <Accepted_use_of> "Trastuzumab-pkrb" .
<Gastric_cancer> <Accepted_use_of> "Trastuzumab-dttb" .
<Gastric_cancer> <Accepted_use_of> "Trastuzumab-dkst" .
<Gastric_cancer> <Accepted_use_of> "Trastuzumab-anns" .
<Gastric_cancer> <Accepted_use_of> "Trastuzumab" .
<Gastric_cancer> <Accepted_use_of> "Tegafur_gimeracil_oteracil" .
<Gastric_cancer> <Accepted_use_of> "S-1_monotherapy" .
<Gastric_cancer> <Accepted_use_of> "Regorafenib_monotherapy" .
<Gastric_cancer> <Accepted_use_of> "Regorafenib" .
<Gastric_cancer> <Accepted_use_of> "Ramucirumab_monotherapy" .
<Gastric_cancer> <Accepted_use_of> "Ramucirumab" .
<Gastric_cancer> <Accepted_use_of> "Placebo" .
<Gastric_cancer> <Accepted_use_of> "Pembrolizumab_monotherapy" .
<Gastric_cancer> <Accepted_use_of> "Pembrolizumab" .
<Gastric_cancer> <Accepted_use_of> "Paclitaxel_nanoparticle_albumin-bound" .
<Gastric_cancer> <Accepted_use_of> "Paclitaxel_monotherapy" .
<Gastric_cancer> <Accepted_use_of> "Paclitaxel_and_S-1" .
<Gastric_cancer> <Accepted_use_of> "Paclitaxel_and_Ramucirumab" .
<Gastric_cancer> <Accepted_use_of> "Paclitaxel" .
<Gastric_cancer> <Accepted_use_of> "Oxaliplatin" .
<Gastric_cancer> <Accepted_use_of> "Observation" .
<Gastric_cancer> <Accepted_use_of> "OLF" .
<Gastric_cancer> <Accepted_use_of> "No_neoadjuvant_therapy" .
<Gastric_cancer> <Accepted_use_of> "Nivolumab_monotherapy" .
<Gastric_cancer> <Accepted_use_of> "Nivolumab" .
<Gastric_cancer> <Accepted_use_of> "Mitomycin" .
<Gastric_cancer> <Accepted_use_of> "Levoleucovorin" .
<Gastric_cancer> <Accepted_use_of> "Irinotecan_monotherapy" .
<Gastric_cancer> <Accepted_use_of> "Irinotecan_liposome" .
<Gastric_cancer> <Accepted_use_of> "Irinotecan_liposomal_monotherapy" .
<Gastric_cancer> <Accepted_use_of> "Irinotecan" .
<Gastric_cancer> <Accepted_use_of> "Folinic_acid" .
<Gastric_cancer> <Accepted_use_of> "Fluorouracil,_Folinic_acid,_Mitomycin" .
<Gastric_cancer> <Accepted_use_of> "Fluorouracil_monotherapy" .
<Gastric_cancer> <Accepted_use_of> "Fluorouracil_and_RT" .
<Gastric_cancer> <Accepted_use_of> "Fluorouracil_and_Mitomycin" .
<Gastric_cancer> <Accepted_use_of> "Fluorouracil" .
<Gastric_cancer> <Accepted_use_of> "FULV/FULV_and_RT" .
<Gastric_cancer> <Accepted_use_of> "FP/Capecitabine_and_RT" .
<Gastric_cancer> <Accepted_use_of> "FLOT" .
<Gastric_cancer> <Accepted_use_of> "FEMTX" .
<Gastric_cancer> <Accepted_use_of> "FAMTX" .
<Gastric_cancer> <Accepted_use_of> "FAM" .
<Gastric_cancer> <Accepted_use_of> "Epirubicin" .
<Gastric_cancer> <Accepted_use_of> "EOX" .
<Gastric_cancer> <Accepted_use_of> "EOF" .
<Gastric_cancer> <Accepted_use_of> "ECX" .
<Gastric_cancer> <Accepted_use_of> "ECF" .
<Gastric_cancer> <Accepted_use_of> "Doxorubicin_and_Fluorouracil" .
<Gastric_cancer> <Accepted_use_of> "Doxifluridine_and_Mitomycin" .
<Gastric_cancer> <Accepted_use_of> "Doxifluridine" .
<Gastric_cancer> <Accepted_use_of> "Docetaxel_monotherapy" .
<Gastric_cancer> <Accepted_use_of> "Docetaxel_and_S-1" .
<Gastric_cancer> <Accepted_use_of> "Docetaxel" .
<Gastric_cancer> <Accepted_use_of> "DCF" .
<Gastric_cancer> <Accepted_use_of> "Cisplatin,_Fluorouracil,_Pembrolizumab" .
<Gastric_cancer> <Accepted_use_of> "Cisplatin_and_S-1" .
<Gastric_cancer> <Accepted_use_of> "Cisplatin_and_Fluorouracil" .
<Gastric_cancer> <Accepted_use_of> "Cisplatin_and_Docetaxel" .
<Gastric_cancer> <Accepted_use_of> "Cisplatin" .
<Gastric_cancer> <Accepted_use_of> "Carboplatin_and_Paclitaxel" .
<Gastric_cancer> <Accepted_use_of> "Carboplatin_and_Docetaxel" .
<Gastric_cancer> <Accepted_use_of> "Carboplatin" .
<Gastric_cancer> <Accepted_use_of> "Capecitabine_monotherapy" .
<Gastric_cancer> <Accepted_use_of> "Capecitabine" .
<Gastric_cancer> <Accepted_use_of> "CapeOx" .
<Gastric_cancer> <Accepted_use_of> "CX_and_Trastuzumab" .
<Gastric_cancer> <Accepted_use_of> "CX" .
<Gastric_cancer> <Accepted_use_of> "CLF" .
<Gastric_cancer> <Accepted_use_of> "Best_supportive_care" .
<Gastric_cancer> <Accepted_use_of> "Apatinib_monotherapy" .
<Gastric_cancer> <Accepted_use_of> "Apatinib" .
<Osteomix> <Brand_name_of> "Alendronate" .
<Whole_brain_irradiation> <Maps_to> "Whole_brain_irradiation" .
<V-HyperCAD> <Is_a> "Anthracycline-containing_regimen" .
<BTD> <Has_antineoplastic> "Thalidomide" .
<BTD> <Has_antineoplastic> "Dexamethasone" .
<BTD> <Has_antineoplastic> "Bendamustine" .
<Cotril> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Radotinib_monotherapy> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<GCP> <Maps_to> "GCP" .
<TACE,_then_5-FU> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Panobinostat_and_Rituximab> <Has_context> "Non-curative_subsequent-line_therapy" .
<7_plus_3d> <Is_historical_in> "Acute_myeloid_leukemia" .
<Valric> <Brand_name_of> "Valproate" .
<G-CHOP> <Mapped_from> "G-CHOP" .
<Chidamide> <May_have_route> "Oral" .
<Chlorambucil_and_Obinutuzumab> <Mapped_from> "Chlorambucil_and_Obinutuzumab" .
<Treosulfan_monotherapy> <Maps_to> "Treosulfan_monotherapy" .
<Anastrozole> <Has_accepted_use> "Endometrial_cancer" .
<Anastrozole> <Has_accepted_use> "Breast_cancer" .
<VACOP-B> <Has_modality> "Chemotherapy" .
<ADOC> <Is_a> "Anthracycline-containing_regimen" .
<Hyper-CVAD/MA_and_Everolimus> <Has_context> "Non-curative_therapy" .
<VAD-P/Q> <Is_a> "Anthracycline-containing_regimen" .
<FR> <Has_antineoplastic> "Rituximab" .
<FR> <Has_antineoplastic> "Fludarabine" .
<Sipuleucel-T_monotherapy> <Has_context> "Non-curative_therapy" .
<Bactide> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<ATRA_and_Idarubicin> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Levofolan> <Brand_name_of> "Melphalan" .
<Cytarabine,_Idarubicin,_Imatinib> <Has_modality> "Chemotherapy" .
<Panobinostat_monotherapy> <Has_antineoplastic> "Panobinostat" .
<Abemaciclib_and_Anastrozole> <Is_a> "Antiestrogen-containing_regimen" .
<ddAC> <Maps_to> "ddAC" .
<Octreotide> <Is_a> "Somatostatin_analog" .
<Octreotide> <Is_a> "Endocrine_therapeutic" .
<Filgrastim> <Has_brand_name> "Topneuter" .
<Filgrastim> <Has_brand_name> "Nivestim" .
<Filgrastim> <Has_brand_name> "Nevkine" .
<Filgrastim> <Has_brand_name> "Neupogen" .
<Filgrastim> <Has_brand_name> "Neukine" .
<Filgrastim> <Has_brand_name> "Neitrostim" .
<Filgrastim> <Has_brand_name> "Neipogen" .
<Filgrastim> <Has_brand_name> "Myelostim" .
<Filgrastim> <Has_brand_name> "Mielastra" .
<Filgrastim> <Has_brand_name> "Lioplim" .
<Filgrastim> <Has_brand_name> "Leumostin" .
<Filgrastim> <Has_brand_name> "Leukokine" .
<Filgrastim> <Has_brand_name> "Leucostim" .
<Filgrastim> <Has_brand_name> "Leucokain" .
<Filgrastim> <Has_brand_name> "Leucocim" .
<Filgrastim> <Has_brand_name> "Leucin" .
<Filgrastim> <Has_brand_name> "Leubene" .
<Filgrastim> <Has_brand_name> "Leicita" .
<Filgrastim> <Has_brand_name> "Grastim" .
<Filgrastim> <Has_brand_name> "Grasin" .
<Filgrastim> <Has_brand_name> "Grasalva" .
<Filgrastim> <Has_brand_name> "Granulokine" .
<Filgrastim> <Has_brand_name> "Gran" .
<Filgrastim> <Has_brand_name> "Filgrastima" .
<Filgrastim> <Has_brand_name> "Filgen" .
<Filgrastim> <Has_brand_name> "Filatil" .
<Filgrastim> <Has_brand_name> "Euprotin" .
<Filgrastim> <Has_brand_name> "Biofilgran" .
<Filgrastim> <Has_brand_name> "Biofigran" .
<Filgrastim> <Has_brand_name> "Biocilin" .
<VAMP> <Maps_to> "VAMP" .
<Fostamatinib> <Has_brand_name> "Tavalisse" .
<Myelofibrosis> <Is_a> "Myeloproliferative_neoplasm" .
<Quizartinib_monotherapy> <Mapped_from> "Quizartinib_monotherapy" .
<LOPP/EVAP> <Is_a> "Anthracycline-containing_regimen" .
<Reglan> <Brand_name_of> "Metoclopramide" .
<CFP_and_Oophorectomy> <Has_antineoplastic> "Prednisone" .
<CFP_and_Oophorectomy> <Has_antineoplastic> "Fluorouracil" .
<CFP_and_Oophorectomy> <Has_antineoplastic> "Endocrine_ablation_surgery" .
<CFP_and_Oophorectomy> <Has_antineoplastic> "Cyclophosphamide" .
<SC-EPOCH-RR> <Mapped_from> "SC-EPOCH-RR" .
<CHOEP-21> <Mapped_from> "CHOEP-21" .
<Dasatinib_and_Prednisone> <Has_antineoplastic> "Prednisone" .
<Dasatinib_and_Prednisone> <Has_antineoplastic> "Dasatinib" .
<Ibrutinib_and_Obinutuzumab> <Mapped_from> "Ibrutinib_and_Obinutuzumab" .
<Pomalidomide_and_Prednisone> <Has_antineoplastic> "Prednisone" .
<Pomalidomide_and_Prednisone> <Has_antineoplastic> "Pomalidomide" .
<TXK_inhibitor> <Subsumes> "Ibrutinib" .
<CMF> <Is_current_in> "Breast_cancer" .
<CF_and_Trastuzumab> <Has_modality> "Chemotherapy" .
<L-Asparaginase,_Vincristine,_Prednisone> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone> <Has_antineoplastic> "Procarbazine" .
<Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone> <Has_antineoplastic> "Methylprednisolone" .
<Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone> <Has_antineoplastic> "Methotrexate" .
<Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone> <Has_antineoplastic> "Lomustine" .
<Megacort> <Brand_name_of> "Dexamethasone" .
<Paclitaxel> <Has_FDA_indication> "Ovarian_cancer" .
<Paclitaxel> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Paclitaxel> <Has_FDA_indication> "Kaposi_sarcoma" .
<Paclitaxel> <Has_FDA_indication> "Breast_cancer" .
<Etoposide,_Ifosfamide,_Imatinib> <Mapped_from> "Etoposide,_Ifosfamide,_Imatinib" .
<Dendritic_cell_vaccine> <Is_a> "Immune_effector_cell" .
<Prednisolone_and_Rituximab> <Mapped_from> "Prednisolone_and_Rituximab" .
<COP> <Mapped_from> "COP" .
<IT_Methotrexate_and_Hydrocortisone> <Has_accepted_use> "CNS_leukemia" .
<Uvtere> <Brand_name_of> "Docetaxel" .
<GDP> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<GDP> <Is_current_in> "Anaplastic_large_cell_lymphoma" .
<R-CDOP> <Has_accepted_use> "HIV-associated_lymphoma" .
<R-CDOP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<BEAM,_then_allo_HSCT> <Has_antineoplastic> "Melphalan" .
<BEAM,_then_allo_HSCT> <Has_antineoplastic> "Etoposide" .
<BEAM,_then_allo_HSCT> <Has_antineoplastic> "Cytarabine" .
<BEAM,_then_allo_HSCT> <Has_antineoplastic> "Carmustine" .
<BEAM,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<DHAP_-_time_intensified> <Maps_to> "DHAP_-_time_intensified" .
<Fulvestrant_and_Palbociclib> <Maps_to> "Fulvestrant_and_Palbociclib" .
<Docetaxel_and_Bevacizumab> <Mapped_from> "Docetaxel_and_Bevacizumab" .
<MAPIE> <Is_current_in> "Osteosarcoma" .
<Decita> <Brand_name_of> "Decitabine" .
<mFOLFIRINOX,_Gemcitabine,_RT> <Has_supportive_med> "Pegfilgrastim" .
<mFOLFIRINOX,_Gemcitabine,_RT> <Has_supportive_med> "Filgrastim" .
<R-IFE> <Has_context> "Salvage_therapy" .
<R-IFE> <Has_context> "Consolidation_after_upfront_therapy" .
<Erlotinib_and_Gemcitabine> <Maps_to> "Erlotinib_and_Gemcitabine" .
<Crizanlizumab_monotherapy> <Has_antineoplastic> "Crizanlizumab" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Vosaroxin_and_Cytarabine" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Vosaroxin" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Vorinostat_monotherapy" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Vorinostat" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Volasertib" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Venetoclax" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Valproate" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Vadastuximab_talirine" .
<Acute_myeloid_leukemia> <Accepted_use_of> "VAMP_(Amethopterin)" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Tosedostat" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Thioguanine" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Temozolomide_monotherapy" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Temozolomide" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Sorafenib_monotherapy" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Sorafenib" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Sapacitabine" .
<Acute_myeloid_leukemia> <Accepted_use_of> "SHAI" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Ruxolitinib_monotherapy" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Ruxolitinib" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Quizartinib_monotherapy" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Quizartinib" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Pravastatin" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Pracinostat" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Panobinostat_monotherapy" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Panobinostat" .
<Acute_myeloid_leukemia> <Accepted_use_of> "POMP" .
<Acute_myeloid_leukemia> <Accepted_use_of> "PATCO" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Omacetaxine" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Observation" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Norethandrolone" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Mitoxantrone" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Midostaurin_monotherapy" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Midostaurin" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Mercaptopurine_monotherapy" .
<Acute_myeloid_leukemia> <Accepted_use_of> "MEC" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Low-dose_TBI,_then_allo_HSCT" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Lomustine" .
<Acute_myeloid_leukemia> <Accepted_use_of> "LoDAC_and_Venetoclax" .
<Acute_myeloid_leukemia> <Accepted_use_of> "LoDAC" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Lenograstim" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Ivosidenib_monotherapy" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Ivosidenib" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Idarubicin" .
<Acute_myeloid_leukemia> <Accepted_use_of> "IDAC_and_Sorafenib" .
<Acute_myeloid_leukemia> <Accepted_use_of> "IDAC" .
<Acute_myeloid_leukemia> <Accepted_use_of> "ICL" .
<Acute_myeloid_leukemia> <Accepted_use_of> "IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone" .
<Acute_myeloid_leukemia> <Accepted_use_of> "IAP" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Hydroxyurea" .
<Acute_myeloid_leukemia> <Accepted_use_of> "HiDAC_and_Midostaurin" .
<Acute_myeloid_leukemia> <Accepted_use_of> "HiDAC" .
<Acute_myeloid_leukemia> <Accepted_use_of> "HDAC_and_G-CSF" .
<Acute_myeloid_leukemia> <Accepted_use_of> "HAM" .
<Acute_myeloid_leukemia> <Accepted_use_of> "HAD" .
<Acute_myeloid_leukemia> <Accepted_use_of> "HAA" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Glasdegib_and_LoDAC" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Glasdegib" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Gilteritinib_monotherapy" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Gemtuzumab_ozogamicin_monotherapy" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Gemtuzumab_ozogamicin" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Fludarabine_and_TBI,_then_allo_HSCT" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Fludarabine" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Filgrastim" .
<Acute_myeloid_leukemia> <Accepted_use_of> "FLAG-Ida" .
<Acute_myeloid_leukemia> <Accepted_use_of> "FLAG-DNX" .
<Acute_myeloid_leukemia> <Accepted_use_of> "FLAG" .
<Acute_myeloid_leukemia> <Accepted_use_of> "F-SHAI" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Etoposide_and_Mitoxantrone" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Etoposide" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Enasidenib_monotherapy" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Enasidenib" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Decitabine_monotherapy" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Decitabine_and_Venetoclax" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Decitabine_and_Valproate" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Decitabine" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Daunorubicin_monotherapy" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Daunorubicin_liposomal" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Daunorubicin" .
<Acute_myeloid_leukemia> <Accepted_use_of> "DCTER" .
<Acute_myeloid_leukemia> <Accepted_use_of> "DAT" .
<Acute_myeloid_leukemia> <Accepted_use_of> "DAC" .
<Acute_myeloid_leukemia> <Accepted_use_of> "DA_3_plus_10,_GO" .
<Acute_myeloid_leukemia> <Accepted_use_of> "DA_3_plus_10" .
<Acute_myeloid_leukemia> <Accepted_use_of> "D-ZAPO" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Cytarabine,_Idarubicin,_Vorinostat" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Cytarabine,_Idarubicin,_Sorafenib" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Cytarabine,_Daunorubicin,_Vincristine" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Cytarabine_monotherapy" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Cytarabine_and_daunorubicin_liposomal" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Cytarabine_and_Thioguanine" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Cytarabine_and_Mitoxantrone" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Cytarabine_and_Idarubicin" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Cytarabine_and_Daunorubicin" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Cytarabine" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Cyclophosphamide_and_TBI,_then_allo_HSCT" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Cyclophosphamide" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Clofarabine_monotherapy" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Clofarabine_and_Melphalan,_then_allo_HSCT" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Clofarabine_and_LoDAC/Decitabine" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Clofarabine_and_LoDAC" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Clofarabine_and_Cytarabine" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Clofarabine" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Cladribine_monotherapy" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Cladribine" .
<Acute_myeloid_leukemia> <Accepted_use_of> "CYVE" .
<Acute_myeloid_leukemia> <Accepted_use_of> "CPX-351_monotherapy" .
<Acute_myeloid_leukemia> <Accepted_use_of> "CLARA" .
<Acute_myeloid_leukemia> <Accepted_use_of> "CLAG-M" .
<Acute_myeloid_leukemia> <Accepted_use_of> "CLAG" .
<Acute_myeloid_leukemia> <Accepted_use_of> "CIA" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Busulfan" .
<Acute_myeloid_leukemia> <Accepted_use_of> "BuFlu,_then_allo_HSCT" .
<Acute_myeloid_leukemia> <Accepted_use_of> "BuCy,_then_auto_HSCT" .
<Acute_myeloid_leukemia> <Accepted_use_of> "BuCy,_then_allo_HSCT" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Best_supportive_care" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Barasertib" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Azacitidine,_Vorinostat,_Gemtuzumab_ozogamicin" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Azacitidine_monotherapy" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Azacitidine_and_Venetoclax" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Azacitidine_and_Sorafenib" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Azacitidine_and_Gemtuzumab_ozogamicin" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Azacitidine" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Amsacrine_and_Cytarabine" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Actinium_Ac_225_lintuzumab" .
<Acute_myeloid_leukemia> <Accepted_use_of> "Aclarubicin" .
<Acute_myeloid_leukemia> <Accepted_use_of> "AIE" .
<Acute_myeloid_leukemia> <Accepted_use_of> "ADE_(standard-dose_Ara-C)" .
<Acute_myeloid_leukemia> <Accepted_use_of> "ADE_(high-dose_Ara-C)" .
<Acute_myeloid_leukemia> <Accepted_use_of> "7_plus_5i" .
<Acute_myeloid_leukemia> <Accepted_use_of> "7_plus_3m" .
<Acute_myeloid_leukemia> <Accepted_use_of> "7_plus_3i_and_Vorinostat" .
<Acute_myeloid_leukemia> <Accepted_use_of> "7_plus_3i_and_Sorafenib" .
<Acute_myeloid_leukemia> <Accepted_use_of> "7_plus_3i_and_Panobinostat" .
<Acute_myeloid_leukemia> <Accepted_use_of> "7_plus_3i" .
<Acute_myeloid_leukemia> <Accepted_use_of> "7_plus_3d_and_Sorafenib" .
<Acute_myeloid_leukemia> <Accepted_use_of> "7_plus_3d_and_Midostaurin" .
<Acute_myeloid_leukemia> <Accepted_use_of> "7_plus_3d_and_Glasdegib" .
<Acute_myeloid_leukemia> <Accepted_use_of> "7_plus_3d_and_GO" .
<Acute_myeloid_leukemia> <Accepted_use_of> "7_plus_3d" .
<Acute_myeloid_leukemia> <Accepted_use_of> "5_plus_3i" .
<Acute_myeloid_leukemia> <Accepted_use_of> "5_plus_3d" .
<Acute_myeloid_leukemia> <Accepted_use_of> "5_plus_2d" .
<7_plus_3d_and_Glasdegib> <Mapped_from> "7_plus_3d_and_Glasdegib" .
<CAFVP> <Is_historical_in> "Breast_cancer" .
<Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone> <Maps_to> "Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone" .
<Fludarabine_monotherapy> <Has_supportive_med> "Valacyclovir" .
<Fludarabine_monotherapy> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Fludarabine_monotherapy> <Has_supportive_med> "Pentamidine" .
<Fludarabine_monotherapy> <Has_supportive_med> "Acyclovir" .
<Interferon_alfa-2b_monotherapy> <Maps_to> "Interferon_alfa-2b_monotherapy" .
<FLAG> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<FLAG> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone> <Has_modality> "Chemotherapy" .
<Docetaxel_and_Prednisone> <Has_supportive_med> "Emesis_prevention" .
<Docetaxel_and_Prednisone> <Has_supportive_med> "Dexamethasone" .
<Delta-Phoricol> <Brand_name_of> "Prednisolone" .
<Cyclophosphamide,_Etoposide,_TBI> <Is_current_in> "Autologous_HSCT" .
<Cortitop> <Brand_name_of> "Dexamethasone" .
<CBV-Mx,_then_auto_HSCT> <Is_a> "Anthracycline-containing_regimen" .
<Darolutamide> <Antineoplastic_of> "ADT_and_Darolutamide" .
<Valproate> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Fulvestrant_and_Ribociclib> <Mapped_from> "Fulvestrant_and_Ribociclib" .
<Whole_abdominal_radiation_(WAI)> <Has_modality> "Radiotherapy" .
<Dabrafenib> <Is_a> "Mutation-specific_medication" .
<Dabrafenib> <Is_a> "Kinase_inhibitor" .
<Dabrafenib> <Is_a> "BRAF_inhibitor" .
<DHAP> <Has_context> "Salvage_therapy" .
<DHAP> <Has_context> "Non-curative_therapy" .
<LEED,_then_auto_HSCT> <Has_antineoplastic> "Melphalan" .
<LEED,_then_auto_HSCT> <Has_antineoplastic> "Etoposide" .
<LEED,_then_auto_HSCT> <Has_antineoplastic> "Dexamethasone" .
<LEED,_then_auto_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<Dolasetron> <Is_a> "Serotonin_5-HT3_antagonist" .
<Dolasetron> <Is_a> "Emesis_prevention" .
<Isovorin> <Brand_name_of> "Folinic_acid" .
<Ipilimumab_monotherapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<Ipilimumab_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Ipilimumab_monotherapy> <Has_accepted_use> "Melanoma" .
<PCF> <Has_supportive_med> "Ranitidine" .
<PCF> <Has_supportive_med> "Ondansetron" .
<PCF> <Has_supportive_med> "Diphenhydramine" .
<PCF> <Has_supportive_med> "Dexamethasone" .
<PCF> <Has_supportive_med> "Cimetidine" .
<CHOP> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<CHOP> <Has_accepted_use> "Mantle_cell_lymphoma" .
<CHOP> <Has_accepted_use> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<CHOP> <Has_accepted_use> "HIV-associated_lymphoma" .
<CHOP> <Has_accepted_use> "Follicular_lymphoma" .
<CHOP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<CHOP> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<CHOP> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<Prednol_L> <Brand_name_of> "Methylprednisolone" .
<MP_(Prednisolone)> <Has_supportive_med> "Zoledronic_acid" .
<MP_(Prednisolone)> <Has_supportive_med> "Clodronate" .
<Exazol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<AC-T> <Mapped_from> "AC-T" .
<Decitabine_monotherapy> <Is_current_in> "Myelodysplastic_syndrome" .
<Decitabine_monotherapy> <Is_current_in> "Chronic_myelomonocytic_leukemia" .
<Decitabine_monotherapy> <Is_current_in> "Acute_myeloid_leukemia" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Vorinostat_monotherapy" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Vorinostat" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Vincristine" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Rituximab-pvvr" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Rituximab-abbs" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Rituximab_monotherapy" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Rituximab" .
<Marginal_zone_lymphoma> <Accepted_use_of> "R-CVP" .
<Marginal_zone_lymphoma> <Accepted_use_of> "R-CHOP" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Prednisone" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Prednisolone" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Pentostatin" .
<Marginal_zone_lymphoma> <Accepted_use_of> "PCR" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Oxaliplatin" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Ox-P" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Observation" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Mitoxantrone" .
<Marginal_zone_lymphoma> <Accepted_use_of> "MCP" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Lenalidomide_monotherapy" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Lenalidomide_and_Rituximab" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Lenalidomide" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Idelalisib_monotherapy" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Idelalisib" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Ibrutinib_monotherapy" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Ibrutinib" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Ibritumomab_tiuxetan_monotherapy" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Ibritumomab_tiuxetan" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Helicobacter_pylori_eradication_therapy" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Fludarabine_monotherapy" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Fludarabine" .
<Marginal_zone_lymphoma> <Accepted_use_of> "FR" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Doxycycline_monotherapy" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Doxycycline" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Doxorubicin" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Cyclophosphamide" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Clarithromycin_monotherapy" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Clarithromycin" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Cladribine_monotherapy" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Cladribine_and_Rituximab" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Cladribine" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Chlorambucil_monotherapy" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Chlorambucil_and_Rituximab" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Chlorambucil" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Bortezomib_monotherapy" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Bortezomib" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Bendamustine_monotherapy" .
<Marginal_zone_lymphoma> <Accepted_use_of> "Bendamustine" .
<Marginal_zone_lymphoma> <Accepted_use_of> "BR" .
<EDC> <Maps_to> "EDC" .
<Irinotecan> <Supportive_med_of> "Denosumab_monotherapy" .
<Irinotecan> <Supportive_med_of> "Cisplatin_and_Paclitaxel" .
<BeGEV> <Has_context> "Non-curative_therapy" .
<Vincristine_liposomal_monotherapy> <Has_modality> "Chemotherapy" .
<CEP> <Has_antineoplastic> "Lomustine" .
<CEP> <Has_antineoplastic> "Etoposide" .
<CEP> <Has_antineoplastic> "Epirubicin" .
<CEP> <Has_antineoplastic> "Cyclophosphamide" .
<CEP> <Has_antineoplastic> "Cisplatin" .
<FEC_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<GELOX/RT> <Maps_to> "GELOX/RT" .
<Alpha_emitter> <Is_a> "Radiotherapy_medication" .
<FOLFOX> <Has_modality> "Chemotherapy" .
<BRCA-mutated_Pancreatic_cancer> <Is_a> "Pancreatic_cancer" .
<Paclitaxel_monotherapy> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Paclitaxel_monotherapy> <Is_historical_in> "Breast_cancer" .
<Medroxyprogesterone> <Antineoplastic_of> "Medroxyprogesterone_monotherapy" .
<Medroxyprogesterone> <Antineoplastic_of> "Medroxyprogesterone_and_Tamoxifen" .
<Medroxyprogesterone> <Antineoplastic_of> "CAF_and_MPA" .
<Lameson> <Brand_name_of> "Methylprednisolone" .
<Carboplatin,_Vinorelbine,_RT> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Radiation_therapy> <Is_current_in> "Thymoma" .
<Radiation_therapy> <Is_current_in> "Testicular_cancer" .
<Radiation_therapy> <Is_current_in> "Small_cell_lung_cancer" .
<Radiation_therapy> <Is_current_in> "Rectal_cancer" .
<Radiation_therapy> <Is_current_in> "Primary_mediastinal_B-cell_lymphoma" .
<Radiation_therapy> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<Radiation_therapy> <Is_current_in> "Pancreatic_cancer" .
<Radiation_therapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Radiation_therapy> <Is_current_in> "Nasopharyngeal_carcinoma" .
<Radiation_therapy> <Is_current_in> "Low-grade_glioma" .
<Radiation_therapy> <Is_current_in> "Hodgkin_lymphoma" .
<Radiation_therapy> <Is_current_in> "Head_and_neck_cancer" .
<Radiation_therapy> <Is_current_in> "HIV-associated_lymphoma" .
<Radiation_therapy> <Is_current_in> "Glioblastoma" .
<Radiation_therapy> <Is_current_in> "Follicular_lymphoma" .
<Radiation_therapy> <Is_current_in> "Esophageal_cancer" .
<Radiation_therapy> <Is_current_in> "Endometrial_cancer" .
<Radiation_therapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Radiation_therapy> <Is_current_in> "Cervical_cancer" .
<Radiation_therapy> <Is_current_in> "Bladder_cancer" .
<Radiation_therapy> <Is_current_in> "Anaplastic_glioma" .
<Radiation_therapy> <Is_current_in> "Anal_cancer" .
<BEAC,_then_auto_HSCT> <Has_accepted_use> "Mantle_cell_lymphoma" .
<BEAC,_then_auto_HSCT> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Irinotecan> <Antineoplastic_of> "mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)" .
<Irinotecan> <Antineoplastic_of> "mFOLFIRINOX,_Gemcitabine,_RT" .
<Irinotecan> <Antineoplastic_of> "mFOLFIRINOX" .
<Irinotecan> <Antineoplastic_of> "VI,_then_VDC/IE,_then_VAC,_then_VI" .
<Irinotecan> <Antineoplastic_of> "Irinotecan,_Vemurafenib,_Cetuximab" .
<Irinotecan> <Antineoplastic_of> "Irinotecan,_Temozolomide,_Dinutuximab" .
<Irinotecan> <Antineoplastic_of> "Irinotecan_monotherapy" .
<Irinotecan> <Antineoplastic_of> "Irinotecan_and_Temozolomide" .
<Irinotecan> <Antineoplastic_of> "Irinotecan_and_S-1" .
<Irinotecan> <Antineoplastic_of> "Irinotecan_and_Mitomycin" .
<Irinotecan> <Antineoplastic_of> "Irinotecan_and_Cetuximab" .
<Irinotecan> <Antineoplastic_of> "Irinotecan_and_Bevacizumab" .
<Irinotecan> <Antineoplastic_of> "IROX" .
<Irinotecan> <Antineoplastic_of> "IRIS_and_Bevacizumab" .
<Irinotecan> <Antineoplastic_of> "IRIS" .
<Irinotecan> <Antineoplastic_of> "IFL_and_Bevacizumab" .
<Irinotecan> <Antineoplastic_of> "IFL" .
<Irinotecan> <Antineoplastic_of> "Gemcitabine_and_Irinotecan" .
<Irinotecan> <Antineoplastic_of> "FUIRI" .
<Irinotecan> <Antineoplastic_of> "FOLFOXIRI_and_Panitumumab" .
<Irinotecan> <Antineoplastic_of> "FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation" .
<Irinotecan> <Antineoplastic_of> "FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)" .
<Irinotecan> <Antineoplastic_of> "FOLFIRINOX" .
<Irinotecan> <Antineoplastic_of> "FOLFIRI_and_Ziv-aflibercept" .
<Irinotecan> <Antineoplastic_of> "FOLFIRI_and_Ramucirumab" .
<Irinotecan> <Antineoplastic_of> "FOLFIRI_and_Panitumumab" .
<Irinotecan> <Antineoplastic_of> "FOLFIRI_and_Cetuximab_(L-Leucovorin)" .
<Irinotecan> <Antineoplastic_of> "FOLFIRI_and_Cetuximab" .
<Irinotecan> <Antineoplastic_of> "FOLFIRI_and_Bevacizumab_(L-Leucovorin)" .
<Irinotecan> <Antineoplastic_of> "FOLFIRI_and_Bevacizumab" .
<Irinotecan> <Antineoplastic_of> "FOLFIRI_(L-Leucovorin)" .
<Irinotecan> <Antineoplastic_of> "FOLFIRI" .
<Irinotecan> <Antineoplastic_of> "Docetaxel_and_Irinotecan" .
<Irinotecan> <Antineoplastic_of> "Cisplatin,_Irinotecan,_RT" .
<Irinotecan> <Antineoplastic_of> "Cisplatin,_Etoposide,_Irinotecan" .
<Irinotecan> <Antineoplastic_of> "Cisplatin_and_Irinotecan" .
<Irinotecan> <Antineoplastic_of> "Carboplatin_and_Irinotecan" .
<Irinotecan> <Antineoplastic_of> "CAPIRI-Bev" .
<Irinotecan> <Antineoplastic_of> "CAPIRI" .
<Exemestane_monotherapy> <Maps_to> "Exemestane_monotherapy" .
<Fotemustine> <May_have_route> "Intravenous" .
<Bexarotene_and_Pralatrexate> <Is_current_in> "Cutaneous_T-cell_lymphoma" .
<CNOP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Low-dose_TBI> <Has_antineoplastic> "External_beam_radiotherapy" .
<FULV/FULV_and_RT> <Mapped_from> "FULV/FULV_and_RT" .
<Fiblaferon> <Brand_name_of> "Interferon_alfa-2b" .
<Duvelisib_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<Duvelisib_monotherapy> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Pentamidina> <Brand_name_of> "Pentamidine" .
<Sepmax> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<L-Asparaginase,_Vincristine,_Prednisolone> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<Pertuzumab_and_Trastuzumab> <Maps_to> "Pertuzumab_and_Trastuzumab" .
<CRD> <Has_context> "Non-curative_therapy" .
<Venetoclax_and_Rituximab> <Has_modality> "Chemotherapy" .
<Brentuximab_vedotin_monotherapy> <Has_supportive_med> "Pegfilgrastim" .
<Brentuximab_vedotin_monotherapy> <Has_supportive_med> "Filgrastim" .
<Brentuximab_vedotin_monotherapy> <Has_supportive_med> "Dexrazoxane" .
<DICE> <Has_modality> "Chemotherapy" .
<Cnoxane> <Brand_name_of> "Enoxaparin" .
<GEMOX-B> <Has_context> "Non-curative_therapy" .
<Chlorambucil_and_Cisplatin> <Has_modality> "Chemotherapy" .
<R-miniCHOP> <Is_a> "Rituximab-containing_regimen" .
<R-miniCHOP> <Is_a> "Anthracycline-containing_regimen" .
<Lenalidomide_and_Ofatumumab> <Mapped_from> "Lenalidomide_and_Ofatumumab" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine> <Has_local_therapy> "Methotrexate" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine> <Has_local_therapy> "External_beam_radiotherapy" .
<Entrectinib_monotherapy> <Has_antineoplastic> "Entrectinib" .
<Octreotide_and_Prednisone> <Has_context> "Non-curative_subsequent-line_therapy" .
<CYVE> <Maps_to> "CYVE" .
<Mustophoran> <Brand_name_of> "Fotemustine" .
<Fludarabine_and_TBI,_then_allo_HSCT> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Fludarabine_and_TBI,_then_allo_HSCT> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Tamibarotene> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Tegafur,_Uracil,_Folinic_acid> <Has_modality> "Chemotherapy" .
<FOLFOX4> <Mapped_from> "FOLFOX4" .
<R-CEOP_(Etoposide)> <Is_a> "Rituximab-containing_regimen" .
<Mitoxantrone> <May_have_route> "Intravenous" .
<Octreotide_and_Interferon_alfa> <Has_antineoplastic> "Octreotide" .
<Octreotide_and_Interferon_alfa> <Has_antineoplastic> "Interferon_alfa-2b" .
<Valrubicin> <Has_FDA_indication> "Bladder_cancer" .
<Nelarabine> <Has_brand_name> "Atriance" .
<Nelarabine> <Has_brand_name> "Arranon" .
<Flatran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Eltrombopag> <Has_FDA_indication> "Immune_thrombocytopenia" .
<Eltrombopag> <Has_FDA_indication> "Aplastic_anemia" .
<Fluorouracil_and_RT> <Has_context> "Non-curative_first-line_therapy" .
<Fluorouracil_and_RT> <Has_context> "Neoadjuvant_therapy" .
<Fluorouracil_and_RT> <Has_context> "Induction_therapy" .
<Fluorouracil_and_RT> <Has_context> "Definitive_therapy" .
<Fluorouracil_and_RT> <Has_context> "Adjuvant_therapy" .
<Toremifene_monotherapy> <Is_current_in> "Breast_cancer" .
<Rucaparib_monotherapy> <Is_current_in> "Ovarian_cancer" .
<Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT> <Has_context> "Non-curative_subsequent-line_consolidation_therapy" .
<Aditrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Belagenpumatucel-L> <May_have_route> "Intravenous" .
<Methobax> <Brand_name_of> "Methotrexate" .
<DCEP_and_G-CSF> <Is_current_in> "Stem_cell_mobilization" .
<Desonap> <Brand_name_of> "Desmopressin" .
<Exemestane_monotherapy> <Has_supportive_med> "Triptorelin" .
<Exemestane_monotherapy> <Has_supportive_med> "External_beam_radiotherapy" .
<Exemestane_monotherapy> <Has_supportive_med> "Endocrine_ablation_surgery" .
<PARP_inhibitor> <Subsumes> "Veliparib" .
<PARP_inhibitor> <Subsumes> "Talazoparib" .
<PARP_inhibitor> <Subsumes> "Rucaparib" .
<PARP_inhibitor> <Subsumes> "Olaparib" .
<PARP_inhibitor> <Subsumes> "Niraparib" .
<KTD> <Mapped_from> "KTD" .
<Lenalidomide_monotherapy> <Is_historical_in> "Chronic_lymphocytic_leukemia" .
<Carboplatin,_Paclitaxel,_Ipilimumab> <Mapped_from> "Carboplatin,_Paclitaxel,_Ipilimumab" .
<Metoclopramide> <Is_a> "WHO_Essential_Pain_and_Palliative_Care_Medicine" .
<Metoclopramide> <Is_a> "Emesis_prevention" .
<Metoclopramide> <Is_a> "Dopamine_receptor_antagonist" .
<Ipilimumab_and_RT> <Maps_to> "Ipilimumab_and_RT" .
<CHOP-14> <Is_a> "Anthracycline-containing_regimen" .
<VAMP_(Methotrexate)> <Is_current_in> "Hodgkin_lymphoma" .
<IROX> <Mapped_from> "IROX" .
<R-Hyper-CVAD/R-MA> <Has_context> "Non-curative_first-line_therapy" .
<R-Hyper-CVAD/R-MA> <Has_context> "Induction_therapy" .
<CO-Trimoxa> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Docusate> <Has_brand_name> "Colace" .
<DA_3_plus_10,_GO> <Has_context> "Induction_therapy" .
<Axicabtagene_ciloleucel_monotherapy> <Has_supportive_med> "Diphenhydramine" .
<Axicabtagene_ciloleucel_monotherapy> <Has_supportive_med> "Acetaminophen" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT> <Has_antineoplastic> "Rituximab" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT> <Has_antineoplastic> "Ibritumomab_tiuxetan" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT> <Has_antineoplastic> "Fludarabine" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT> <Has_antineoplastic> "Busulfan" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<Trelibec> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CMFPT> <Has_modality> "Hormonotherapy" .
<CMFPT> <Has_modality> "Chemotherapy" .
<Sirolimus_monotherapy> <Has_immunosuppressor> "Sirolimus" .
<Saptrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Amatuximab> <Has_accepted_use> "Mesothelioma" .
<Ofatumumab> <May_have_route> "Intravenous" .
<FOLFOX4> <Has_modality> "Chemotherapy" .
<Epirubicin> <Antineoplastic_of> "iddEPC" .
<Epirubicin> <Antineoplastic_of> "ddFEC" .
<Epirubicin> <Antineoplastic_of> "ddEC" .
<Epirubicin> <Antineoplastic_of> "ddE" .
<Epirubicin> <Antineoplastic_of> "VEBEP" .
<Epirubicin> <Antineoplastic_of> "TACE" .
<Epirubicin> <Antineoplastic_of> "R-miniCEOP" .
<Epirubicin> <Antineoplastic_of> "R-CEOP90_(Epirubicin)" .
<Epirubicin> <Antineoplastic_of> "PET" .
<Epirubicin> <Antineoplastic_of> "PEFG" .
<Epirubicin> <Antineoplastic_of> "PCDE" .
<Epirubicin> <Antineoplastic_of> "FLEC" .
<Epirubicin> <Antineoplastic_of> "FEMTX" .
<Epirubicin> <Antineoplastic_of> "FEC_and_H_(SC)" .
<Epirubicin> <Antineoplastic_of> "FEC_and_H" .
<Epirubicin> <Antineoplastic_of> "FEC_and_Bevacizumab" .
<Epirubicin> <Antineoplastic_of> "FEC" .
<Epirubicin> <Antineoplastic_of> "Epirubicin_monotherapy" .
<Epirubicin> <Antineoplastic_of> "Epirubicin_and_Vinorelbine" .
<Epirubicin> <Antineoplastic_of> "Epirubicin_and_Ifosfamide" .
<Epirubicin> <Antineoplastic_of> "EVI" .
<Epirubicin> <Antineoplastic_of> "EP" .
<Epirubicin> <Antineoplastic_of> "EOX" .
<Epirubicin> <Antineoplastic_of> "EOF" .
<Epirubicin> <Antineoplastic_of> "EDC" .
<Epirubicin> <Antineoplastic_of> "ECX" .
<Epirubicin> <Antineoplastic_of> "ECT,_then_auto_HSCT" .
<Epirubicin> <Antineoplastic_of> "ECH" .
<Epirubicin> <Antineoplastic_of> "ECF/5-FU_and_RT" .
<Epirubicin> <Antineoplastic_of> "ECF" .
<Epirubicin> <Antineoplastic_of> "EC_and_Bevacizumab" .
<Epirubicin> <Antineoplastic_of> "EC" .
<Epirubicin> <Antineoplastic_of> "EBVP" .
<Epirubicin> <Antineoplastic_of> "DI_EC" .
<Epirubicin> <Antineoplastic_of> "DE" .
<Epirubicin> <Antineoplastic_of> "Cisplatin,_Epirubicin,_Ifosfamide" .
<Epirubicin> <Antineoplastic_of> "Cisplatin_and_Epirubicin" .
<Epirubicin> <Antineoplastic_of> "CEV_and_RT" .
<Epirubicin> <Antineoplastic_of> "CEV_(Cyclophosphamide/Epirubicin)" .
<Epirubicin> <Antineoplastic_of> "CEP" .
<Epirubicin> <Antineoplastic_of> "CEOP_(Prednisolone)" .
<Epirubicin> <Antineoplastic_of> "CEOP" .
<Epirubicin> <Antineoplastic_of> "CEF/CMF" .
<Epirubicin> <Antineoplastic_of> "CEEP" .
<PAC> <Has_supportive_med> "Metoclopramide" .
<PAC> <Has_supportive_med> "Diphenhydramine" .
<Cyclophosphamide_and_Dexamethasone> <Has_context> "Non-curative_therapy" .
<Suprimass> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Ibrutinib_and_Rituximab> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Ibrutinib_and_Rituximab> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Ibrutinib_and_Rituximab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Canprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Leuprolide_monotherapy> <Is_current_in> "Prostate_cancer" .
<Leuprolide_monotherapy> <Is_current_in> "Breast_cancer" .
<FEC_and_Bevacizumab> <Maps_to> "FEC_and_Bevacizumab" .
<Thilodexine> <Brand_name_of> "Dexamethasone" .
<Flu-Mel,_then_allo_HSCT> <Maps_to> "Flu-Mel,_then_allo_HSCT" .
<Flacule> <Brand_name_of> "Fluorouracil" .
<Nelarabine> <Is_a> "Purine_analogue" .
<Nelarabine> <Is_a> "Neutral" .
<Nelarabine> <Is_a> "Antimetabolite" .
<Cabazitaxel_and_Prednisone> <Has_context> "Non-curative_therapy" .
<Clofarabine_and_Melphalan,_then_allo_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<ddA> <Has_accepted_use> "Breast_cancer" .
<BRAF-mutated_Thyroid_cancer> <Accepted_use_of> "Vemurafenib_monotherapy" .
<BRAF-mutated_Thyroid_cancer> <Accepted_use_of> "Dabrafenib_and_Trametinib" .
<Fludarabine,_Busulfan,_ATG> <Has_immunosuppressor> "Tacrolimus" .
<Fludarabine,_Busulfan,_ATG> <Has_immunosuppressor> "Methotrexate" .
<Fludarabine,_Busulfan,_ATG> <Has_immunosuppressor> "Cyclosporines" .
<Fludarabine,_Busulfan,_ATG> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<Fludarabine,_Busulfan,_ATG> <Has_immunosuppressor> "Antithymocyte_globulin" .
<PCR> <Is_a> "Rituximab-containing_regimen" .
<Mektovi> <Brand_name_of> "Binimetinib" .
<Surfent> <Brand_name_of> "Prasugrel" .
<Pericristine> <Brand_name_of> "Vincristine" .
<Lanreotide_monotherapy> <Has_modality> "Hormonotherapy" .
<FULV_and_Bevacizumab> <Maps_to> "FULV_and_Bevacizumab" .
<Suntrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cyclosporine,_Methotrexate,_Prednisone> <Maps_to> "Cyclosporine,_Methotrexate,_Prednisone" .
<IT_Cytarabine_and_Methotrexate> <Is_current_in> "CNS_leukemia" .
<Estrogen_receptor_inhibitor> <Is_a> "Endocrine_therapeutic" .
<Vonaz> <Brand_name_of> "Voriconazole" .
<Tamoxifen_monotherapy> <Has_modality> "Hormonotherapy" .
<Aminoglutethimide> <May_have_route> "Oral" .
<Carboplatin,_nab-Paclitaxel,_Atezolizumab> <Has_context> "Non-curative_first-line_therapy" .
<CIA> <Has_context> "Induction_therapy" .
<CIA> <Has_context> "Consolidation_after_upfront_therapy" .
<Entrectinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Entrectinib_monotherapy> <Has_context> "All_lines_of_therapy" .
<DE> <Has_context> "Non-curative_first-line_therapy" .
<DE> <Has_context> "Neoadjuvant_therapy" .
<Lenalidomide_and_Rituximab> <Has_context> "Non-curative_therapy" .
<Lenalidomide_and_Rituximab> <Has_context> "Non-curative_subsequent-line_therapy" .
<Lenalidomide_and_Rituximab> <Has_context> "Non-curative_second-line_consolidation_therapy" .
<Lenalidomide_and_Rituximab> <Has_context> "Non-curative_first-line_therapy" .
<Lenalidomide_and_Rituximab> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Lenalidomide_and_Rituximab> <Has_context> "All_lines_of_therapy" .
<ADT_and_Apalutamide> <Has_modality> "Hormonotherapy" .
<Dayhist> <Brand_name_of> "Clemastine" .
<Erdafitinib_monotherapy> <Maps_to> "Erdafitinib_monotherapy" .
<Nilotinib_monotherapy> <Has_context> "Salvage_therapy" .
<Nilotinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Nilotinib_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Nilotinib_monotherapy> <Has_context> "Maintenance_after_upfront_therapy" .
<Nilotinib_monotherapy> <Has_context> "All_lines_of_therapy" .
<TIP> <Has_supportive_med> "Ranitidine" .
<TIP> <Has_supportive_med> "Mesna" .
<TIP> <Has_supportive_med> "Filgrastim" .
<TIP> <Has_supportive_med> "Famotidine" .
<TIP> <Has_supportive_med> "Diphenhydramine" .
<TIP> <Has_supportive_med> "Dexamethasone" .
<TIP> <Has_supportive_med> "Cimetidine" .
<Unfractionated_heparin> <Is_a> "Heparin" .
<Unfractionated_heparin> <Is_a> "Anticoagulant" .
<CFAR> <Is_a> "Rituximab-containing_regimen" .
<R2CHOP> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Octreotide_and_Prednisone> <Mapped_from> "Octreotide_and_Prednisone" .
<Zydexa> <Brand_name_of> "Dexamethasone" .
<Trametinib_monotherapy> <Has_antineoplastic> "Trametinib" .
<R-CODOX-M> <Maps_to> "R-CODOX-M" .
<CapeOx_and_Panitumumab> <Is_current_in> "Colon_cancer" .
<Cytarabine,_Idarubicin,_Sorafenib> <Maps_to> "Cytarabine,_Idarubicin,_Sorafenib" .
<Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone> <Has_context> "Induction_therapy" .
<Exemestane> <May_have_route> "Oral" .
<VAMP_(Amethopterin)> <Maps_to> "VAMP_(Amethopterin)" .
<Profung> <Brand_name_of> "Caspofungin" .
<Cisplatin,_Irinotecan,_RT> <Has_antineoplastic> "Irinotecan" .
<Cisplatin,_Irinotecan,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Cisplatin,_Irinotecan,_RT> <Has_antineoplastic> "Cisplatin" .
<CYM> <Has_modality> "Chemotherapy" .
<Cisplatin,_Fluorouracil,_Cetuximab> <Has_context> "Non-curative_first-line_therapy" .
<Enoxaparin> <Has_brand_name> "Xaparin" .
<Enoxaparin> <Has_brand_name> "Pariparin" .
<Enoxaparin> <Has_brand_name> "Noxprin" .
<Enoxaparin> <Has_brand_name> "Microparin" .
<Enoxaparin> <Has_brand_name> "Markparin" .
<Enoxaparin> <Has_brand_name> "Lovenox" .
<Enoxaparin> <Has_brand_name> "Lmwx" .
<Enoxaparin> <Has_brand_name> "Eparin" .
<Enoxaparin> <Has_brand_name> "Enxoaealth" .
<Enoxaparin> <Has_brand_name> "Enoxol" .
<Enoxaparin> <Has_brand_name> "Enox" .
<Enoxaparin> <Has_brand_name> "Enclex" .
<Enoxaparin> <Has_brand_name> "Dutenox" .
<Enoxaparin> <Has_brand_name> "Cutenox" .
<Enoxaparin> <Has_brand_name> "Cnoxane" .
<Enoxaparin> <Has_brand_name> "Clotinex" .
<Enoxaparin> <Has_brand_name> "Clexane" .
<Enoxaparin> <Has_brand_name> "Clexan" .
<Enoxaparin> <Has_brand_name> "Cardinex" .
<Enoxaparin> <Has_brand_name> "Axoparin" .
<CMFP> <Mapped_from> "CMFP" .
<Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab> <Has_antineoplastic> "Paclitaxel_nanoparticle_albumin-bound" .
<Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<DaunoXome> <Brand_name_of> "Daunorubicin_liposomal" .
<Novaprin> <Brand_name_of> "Danazol" .
<Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Topotecan_monotherapy> <Has_supportive_med> "Ondansetron" .
<Topotecan_monotherapy> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Refludan> <Brand_name_of> "Lepirudin" .
<Platistil> <Brand_name_of> "Cisplatin" .
<Suprason> <Brand_name_of> "Dexamethasone" .
<ECX> <Has_accepted_use> "Gastric_cancer" .
<ECX> <Has_accepted_use> "Esophageal_cancer" .
<R-DHAP/R-VIM> <Is_a> "Rituximab-containing_regimen" .
<Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine> <Is_current_in> "Melanoma" .
<Fluorouracil_and_Levamisole> <Has_context> "Adjuvant_therapy" .
<7_plus_3d_and_Sorafenib> <Mapped_from> "7_plus_3d_and_Sorafenib" .
<Arsenic_trioxide_monotherapy> <Mapped_from> "Arsenic_trioxide_monotherapy" .
<Cisplatin_and_S-1> <Has_antineoplastic> "Tegafur_gimeracil_oteracil" .
<Cisplatin_and_S-1> <Has_antineoplastic> "Cisplatin" .
<Ifosfamide_monotherapy> <Has_modality> "Chemotherapy" .
<Methotrexate,_RT,_Cyclophosphamide> <Is_historical_in> "Small_cell_lung_cancer" .
<Etoposide_monotherapy> <Maps_to> "Etoposide_monotherapy" .
<Imatinib_and_LoDAC> <Is_current_in> "Chronic_myelogenous_leukemia" .
<R-ICE> <Is_a> "Rituximab-containing_regimen" .
<IDAC_and_Sorafenib> <Is_current_in> "Acute_myeloid_leukemia" .
<Cisplatin_and_Etoposide> <Is_current_in> "Thymoma" .
<Cisplatin_and_Etoposide> <Is_current_in> "Testicular_cancer" .
<Cisplatin_and_Etoposide> <Is_current_in> "Small_cell_lung_cancer" .
<Cisplatin_and_Etoposide> <Is_current_in> "Non-small_cell_lung_cancer" .
<Cisplatin_and_Etoposide> <Is_current_in> "Low-grade_glioma" .
<Cisplatin_and_Etoposide> <Is_current_in> "Esophageal_cancer" .
<BDR> <Maps_to> "BDR" .
<Dipyridamole> <May_have_route> "Oral" .
<Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone> <Has_antineoplastic> "Vincristine" .
<Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone> <Has_antineoplastic> "Prednisone" .
<Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone> <Has_antineoplastic> "Methotrexate" .
<Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone> <Has_antineoplastic> "Mercaptopurine" .
<Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone> <Has_antineoplastic> "Doxorubicin" .
<Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone> <Has_antineoplastic> "Asparaginase" .
<Esophageal_cancer> <Is_a> "Gastroesophageal_cancer" .
<Non-curative_second-line_therapy> <Context_of> "nab-Paclitaxel_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "mFOLFOX6_and_Bevacizumab" .
<Non-curative_second-line_therapy> <Context_of> "mFOLFOX6" .
<Non-curative_second-line_therapy> <Context_of> "Tamoxifen_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Sunitinib_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Sorafenib_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Rucaparib_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Prednisone_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Placebo" .
<Non-curative_second-line_therapy> <Context_of> "Pemetrexed_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Pazopanib_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Nivolumab_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Megestrol_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Lenvatinib_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Ketoconazole,_Hydrocortisone,_Dutasteride" .
<Non-curative_second-line_therapy> <Context_of> "Ketoconazole_and_Hydrocortisone" .
<Non-curative_second-line_therapy> <Context_of> "Irinotecan_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Irinotecan_and_Cetuximab" .
<Non-curative_second-line_therapy> <Context_of> "Interferon_alfa-2c_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Interferon_alfa-2a_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Interferon_alfa-2a_and_Isotretinoin" .
<Non-curative_second-line_therapy> <Context_of> "IROX" .
<Non-curative_second-line_therapy> <Context_of> "IRIS" .
<Non-curative_second-line_therapy> <Context_of> "Hydrocortisone_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Gemcitabine_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Gefitinib_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Fluorouracil_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "FOLFOX4" .
<Non-curative_second-line_therapy> <Context_of> "FOLFIRI_and_Ziv-aflibercept" .
<Non-curative_second-line_therapy> <Context_of> "FOLFIRI_and_Ramucirumab" .
<Non-curative_second-line_therapy> <Context_of> "FOLFIRI_and_Panitumumab" .
<Non-curative_second-line_therapy> <Context_of> "FOLFIRI_and_Bevacizumab_(L-Leucovorin)" .
<Non-curative_second-line_therapy> <Context_of> "FOLFIRI_and_Bevacizumab" .
<Non-curative_second-line_therapy> <Context_of> "FOLFIRI_(L-Leucovorin)" .
<Non-curative_second-line_therapy> <Context_of> "FOLFIRI" .
<Non-curative_second-line_therapy> <Context_of> "FC,_then_allo_HSCT" .
<Non-curative_second-line_therapy> <Context_of> "Everolimus_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Everolimus_and_Lenvatinib" .
<Non-curative_second-line_therapy> <Context_of> "Etoposide_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Enzalutamide_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Docetaxel_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Docetaxel_and_Vandetanib" .
<Non-curative_second-line_therapy> <Context_of> "Docetaxel_and_Ramucirumab" .
<Non-curative_second-line_therapy> <Context_of> "Cisplatin_and_Paclitaxel" .
<Non-curative_second-line_therapy> <Context_of> "Cisplatin_and_Gemcitabine" .
<Non-curative_second-line_therapy> <Context_of> "Carboplatin,_Paclitaxel,_Bevacizumab" .
<Non-curative_second-line_therapy> <Context_of> "Carboplatin,_Olaparib,_Paclitaxel" .
<Non-curative_second-line_therapy> <Context_of> "Carboplatin,_Gemcitabine,_Bevacizumab" .
<Non-curative_second-line_therapy> <Context_of> "Carboplatin_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Carboplatin_and_Pemetrexed" .
<Non-curative_second-line_therapy> <Context_of> "Carboplatin_and_Paclitaxel" .
<Non-curative_second-line_therapy> <Context_of> "Carboplatin_and_Gemcitabine" .
<Non-curative_second-line_therapy> <Context_of> "Carboplatin_and_Doxorubicin_liposomal" .
<Non-curative_second-line_therapy> <Context_of> "Carboplatin_and_Docetaxel" .
<Non-curative_second-line_therapy> <Context_of> "CapeOx" .
<Non-curative_second-line_therapy> <Context_of> "Cabozantinib_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Cabozantinib_and_Erlotinib" .
<Non-curative_second-line_therapy> <Context_of> "CAPIRI-Bev" .
<Non-curative_second-line_therapy> <Context_of> "CAPIRI" .
<Non-curative_second-line_therapy> <Context_of> "CAP_(Platinol)" .
<Non-curative_second-line_therapy> <Context_of> "Bicalutamide_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Bevacizumab_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Axitinib_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Apalutamide_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Antiandrogen_withdrawal" .
<Non-curative_second-line_therapy> <Context_of> "Altretamine_and_Cisplatin" .
<Non-curative_second-line_therapy> <Context_of> "Afatinib_monotherapy" .
<Non-curative_second-line_therapy> <Context_of> "Abiraterone_and_Prednisone" .
<COPAD/CYVE> <Has_antineoplastic> "Vincristine" .
<COPAD/CYVE> <Has_antineoplastic> "Prednisone" .
<COPAD/CYVE> <Has_antineoplastic> "Etoposide" .
<COPAD/CYVE> <Has_antineoplastic> "Doxorubicin" .
<COPAD/CYVE> <Has_antineoplastic> "Cytarabine" .
<COPAD/CYVE> <Has_antineoplastic> "Cyclophosphamide" .
<FLOX> <Has_antineoplastic> "Oxaliplatin" .
<FLOX> <Has_antineoplastic> "Folinic_acid" .
<FLOX> <Has_antineoplastic> "Fluorouracil" .
<Leukokine> <Brand_name_of> "Filgrastim" .
<Acquired_coagulopathy> <Current_treated_by> "Rituximab_monotherapy" .
<Acquired_coagulopathy> <Current_treated_by> "Prednisone_monotherapy" .
<Acquired_coagulopathy> <Current_treated_by> "Prednisolone_monotherapy" .
<Acquired_coagulopathy> <Current_treated_by> "Cyclophosphamide_and_Prednisone" .
<Acquired_coagulopathy> <Current_treated_by> "Cyclophosphamide_and_Prednisolone" .
<FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation> <Mapped_from> "FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation" .
<BCNU/TT> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Hyper-CVAD_and_Dasatinib> <Has_antineoplastic> "Vincristine" .
<Hyper-CVAD_and_Dasatinib> <Has_antineoplastic> "Methotrexate" .
<Hyper-CVAD_and_Dasatinib> <Has_antineoplastic> "Doxorubicin" .
<Hyper-CVAD_and_Dasatinib> <Has_antineoplastic> "Dexamethasone" .
<Hyper-CVAD_and_Dasatinib> <Has_antineoplastic> "Dasatinib" .
<Hyper-CVAD_and_Dasatinib> <Has_antineoplastic> "Cytarabine" .
<Hyper-CVAD_and_Dasatinib> <Has_antineoplastic> "Cyclophosphamide" .
<Depocyt> <Brand_name_of> "Cytarabine_liposomal" .
<Depocyt> <Brand_name_of> "Cytarabine" .
<Trabectedin> <Has_brand_name> "Yondelis" .
<Fosfoplus> <Brand_name_of> "Alendronate" .
<Cisplatin,_Etoposide,_Bevacizumab> <Mapped_from> "Cisplatin,_Etoposide,_Bevacizumab" .
<Custirsen> <Is_a> "Investigational_drug" .
<Custirsen> <Is_a> "Clusterin_inhibitor" .
<Flutamide_monotherapy> <Has_modality> "Hormonotherapy" .
<Chlorambucil_monotherapy> <Is_historical_in> "Chronic_lymphocytic_leukemia" .
<Trastuzumab_and_hyaluronidase_monotherapy> <Is_current_in> "Breast_cancer" .
<ACT> <Has_context> "Adjuvant_therapy" .
<Cisplatin,_Irinotecan,_RT> <Is_a> "Irinotecan-containing_regimen" .
<Irinotecan> <Has_brand_name> "Winol" .
<Irinotecan> <Has_brand_name> "Trinotecan" .
<Irinotecan> <Has_brand_name> "Toptecin" .
<Irinotecan> <Has_brand_name> "Tekamen" .
<Irinotecan> <Has_brand_name> "Tecnotecan" .
<Irinotecan> <Has_brand_name> "Satigene" .
<Irinotecan> <Has_brand_name> "Onivyde" .
<Irinotecan> <Has_brand_name> "Linatecan" .
<Irinotecan> <Has_brand_name> "Itoxaril" .
<Irinotecan> <Has_brand_name> "Irnocam" .
<Irinotecan> <Has_brand_name> "Irinotesin" .
<Irinotecan> <Has_brand_name> "Irinotel" .
<Irinotecan> <Has_brand_name> "Irinomedac" .
<Irinotecan> <Has_brand_name> "Irinogen" .
<Irinotecan> <Has_brand_name> "Irenax" .
<Irinotecan> <Has_brand_name> "Faultenocan" .
<Irinotecan> <Has_brand_name> "Elinatecan" .
<Irinotecan> <Has_brand_name> "Camptosar" .
<Irinotecan> <Has_brand_name> "Campto" .
<Irinotecan> <Has_brand_name> "Campostar" .
<Irinotecan> <Has_brand_name> "Biskam" .
<Irinotecan> <Has_brand_name> "Biotecan" .
<Irinotecan> <Has_brand_name> "Axinotecan" .
<Paclitax> <Brand_name_of> "Paclitaxel" .
<Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine> <Has_antineoplastic> "Pertuzumab" .
<Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine> <Has_antineoplastic> "Paclitaxel" .
<Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine> <Has_antineoplastic> "Ado-trastuzumab_emtansine" .
<MP> <Mapped_from> "MP" .
<Mulpleta> <Brand_name_of> "Lusutrombopag" .
<Pembrolizumab> <Has_FDA_indication> "Small_cell_lung_cancer" .
<Pembrolizumab> <Has_FDA_indication> "Renal_cell_carcinoma" .
<Pembrolizumab> <Has_FDA_indication> "Primary_mediastinal_B-cell_lymphoma" .
<Pembrolizumab> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Pembrolizumab> <Has_FDA_indication> "Mismatch_repair_deficient_malignancy" .
<Pembrolizumab> <Has_FDA_indication> "Merkel_cell_carcinoma" .
<Pembrolizumab> <Has_FDA_indication> "Melanoma" .
<Pembrolizumab> <Has_FDA_indication> "Hodgkin_lymphoma" .
<Pembrolizumab> <Has_FDA_indication> "Hepatocellular_carcinoma" .
<Pembrolizumab> <Has_FDA_indication> "Head_and_neck_cancer" .
<Pembrolizumab> <Has_FDA_indication> "Gastric_cancer" .
<Pembrolizumab> <Has_FDA_indication> "Esophageal_cancer" .
<Pembrolizumab> <Has_FDA_indication> "Endometrial_cancer" .
<Pembrolizumab> <Has_FDA_indication> "Cervical_cancer" .
<Pembrolizumab> <Has_FDA_indication> "Bladder_cancer" .
<FULV/FULV_and_RT> <Is_current_in> "Rectal_cancer" .
<FULV/FULV_and_RT> <Is_current_in> "Gastric_cancer" .
<FULV/FULV_and_RT> <Is_current_in> "Esophageal_cancer" .
<Panobinostat_and_Rituximab> <Has_antineoplastic> "Rituximab" .
<Panobinostat_and_Rituximab> <Has_antineoplastic> "Panobinostat" .
<BEAC> <Has_accepted_use> "Autologous_HSCT" .
<Muphoran> <Brand_name_of> "Fotemustine" .
<Bendamustine_and_Brentuximab_vedotin> <Has_accepted_use> "Hodgkin_lymphoma" .
<PAD_doxil> <Is_current_in> "Multiple_myeloma" .
<Capecitabine,_Sorafenib,_RT> <Maps_to> "Capecitabine,_Sorafenib,_RT" .
<Skin_cancer> <Subsumes> "Uveal_melanoma" .
<Skin_cancer> <Subsumes> "Non-melanoma_skin_cancer" .
<Skin_cancer> <Subsumes> "Merkel_cell_carcinoma" .
<Skin_cancer> <Subsumes> "Melanoma" .
<Skin_cancer> <Subsumes> "Cutaneous_lymphoma" .
<M-DEX> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<M-DEX> <Has_supportive_med> "Proton_pump_inhibitors" .
<M-DEX> <Has_supportive_med> "Omeprazole" .
<M-DEX> <Has_supportive_med> "Itraconazole" .
<M-DEX> <Has_supportive_med> "Ciprofloxacin" .
<Nucala> <Brand_name_of> "Mepolizumab" .
<Anakinra_monotherapy> <Has_modality> "Immunosuppressive_therapy" .
<KPD> <Has_modality> "Chemotherapy" .
<Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA> <Is_a> "Anthracycline-containing_regimen" .
<Carboplatin_and_Etoposide> <Is_a> "Platinum_doublet" .
<Stanford_V> <Has_accepted_use> "Hodgkin_lymphoma" .
<Stanford_V> <Has_accepted_use> "HIV-associated_lymphoma" .
<Melphalan,_then_auto_HSCT,_then_Melphalan_and_TBI,_then_auto_HSCT> <Has_modality> "Radiotherapy" .
<Melphalan,_then_auto_HSCT,_then_Melphalan_and_TBI,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Megakaryocyte_growth_factor> <Subsumes> "Romiplostim" .
<Megakaryocyte_growth_factor> <Subsumes> "Oprelvekin" .
<Megakaryocyte_growth_factor> <Subsumes> "Lusutrombopag" .
<Megakaryocyte_growth_factor> <Subsumes> "Eltrombopag" .
<Megakaryocyte_growth_factor> <Subsumes> "Avatrombopag" .
<Marfarin> <Brand_name_of> "Warfarin" .
<CVP,_then_131Iodine-Tositumomab> <Maps_to> "CVP,_then_131Iodine-Tositumomab" .
<CHOP_Modified> <Has_modality> "Chemotherapy" .
<Mepolizumab> <Has_accepted_use> "Hypereosinophilic_syndrome" .
<Pazopanib_monotherapy> <Maps_to> "Pazopanib_monotherapy" .
<Pred-Clysma> <Brand_name_of> "Prednisolone" .
<Acic> <Brand_name_of> "Acyclovir" .
<Fluorouracil,_Folinic_acid,_Levamisole> <Has_antineoplastic> "Levamisole" .
<Fluorouracil,_Folinic_acid,_Levamisole> <Has_antineoplastic> "Folinic_acid" .
<Fluorouracil,_Folinic_acid,_Levamisole> <Has_antineoplastic> "Fluorouracil" .
<Amrubicin_monotherapy> <Has_antineoplastic> "Amrubicin" .
<Binimetinib_and_Encorafenib> <Maps_to> "Binimetinib_and_Encorafenib" .
<Cetirizine> <Supportive_med_of> "Ofatumumab_monotherapy" .
<Cetirizine> <Supportive_med_of> "O-FC" .
<Cetirizine> <Supportive_med_of> "O-CHOP" .
<Cetirizine> <Supportive_med_of> "Daratumumab_monotherapy" .
<TAD_(Tamoxifen)> <Has_antineoplastic> "Tamoxifen" .
<TAD_(Tamoxifen)> <Has_antineoplastic> "Danazol" .
<TAD_(Tamoxifen)> <Has_antineoplastic> "Aminoglutethimide" .
<R-NIMP> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Dara-VD> <Maps_to> "Dara-VD" .
<KCD> <Maps_to> "KCD" .
<FEAM> <Maps_to> "FEAM" .
<Carboplatin,_Etoposide,_RT> <Mapped_from> "Carboplatin,_Etoposide,_RT" .
<Fosfaseron> <Brand_name_of> "Cyclophosphamide" .
<Chidamide_monotherapy> <Has_modality> "Chemotherapy" .
<Winsprin> <Brand_name_of> "Aspirin" .
<RVDC> <Has_supportive_med> "Warfarin" .
<RVDC> <Has_supportive_med> "PCP_prophylaxis" .
<RVDC> <Has_supportive_med> "Enoxaparin" .
<RVDC> <Has_supportive_med> "Bisphosphonates" .
<RVDC> <Has_supportive_med> "Aspirin" .
<RVDC> <Has_supportive_med> "Acyclovir" .
<Longastatina> <Brand_name_of> "Octreotide" .
<Apixaban_monotherapy> <Is_current_in> "Venous_thromboembolism" .
<AC> <Is_historical_in> "Breast_cancer" .
<Antiandrogen_withdrawal> <Has_modality> "Null_therapy" .
<Canalon> <Brand_name_of> "Dexamethasone" .
<Atovaquone> <Supportive_med_of> "R-EPOCH" .
<Atovaquone> <Supportive_med_of> "EPOCH" .
<Atovaquone> <Supportive_med_of> "DA-R-EPOCH" .
<Atovaquone> <Supportive_med_of> "DA-EPOCH" .
<Atovaquone> <Supportive_med_of> "Carboplatin_and_nab-Paclitaxel" .
<ddTH_(Taxol)> <Maps_to> "ddTH_(Taxol)" .
<CHUT,_then_auto_HSCT> <Has_antineoplastic> "Thiotepa" .
<CHUT,_then_auto_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<NovoTTF-100A_monotherapy> <Maps_to> "NovoTTF-100A_monotherapy" .
<Lastet_S> <Brand_name_of> "Etoposide" .
<Apoptosis_promoter> <Is_a> "Chemotherapeutic" .
<Bakton> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<DEB-TACE> <Has_context> "Local_therapy" .
<Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT> <Mapped_from> "Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT" .
<Nordic_Regimen,_younger_patients> <Maps_to> "Nordic_Regimen,_younger_patients" .
<Ifosfamide_and_Gemcitabine> <Mapped_from> "Ifosfamide_and_Gemcitabine" .
<O-DHAP> <Mapped_from> "O-DHAP" .
<Nilutamide_and_Orchiectomy> <Has_accepted_use> "Prostate_cancer" .
<Dactinomycin> <Has_accepted_use> "Wilms_tumor" .
<Dactinomycin> <Has_accepted_use> "Rhabdomyosarcoma" .
<Dactinomycin> <Has_accepted_use> "Osteosarcoma" .
<Dactinomycin> <Has_accepted_use> "Gestational_trophoblastic_neoplasia" .
<Dactinomycin> <Has_accepted_use> "Ewing_sarcoma" .
<Dactinomycin> <Has_accepted_use> "Endometrial_cancer" .
<Exemestane_monotherapy> <Mapped_from> "Exemestane_monotherapy" .
<HAM> <Has_context> "Salvage_therapy" .
<HAM> <Has_context> "Consolidation_after_upfront_therapy" .
<Bortezomib_and_Melphalan,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Mepron> <Brand_name_of> "Atovaquone" .
<Quizartinib_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Pertuzumab> <Antineoplastic_of> "THP_(Taxotere)" .
<Pertuzumab> <Antineoplastic_of> "THP_(Taxol)" .
<Pertuzumab> <Antineoplastic_of> "TCHP_(Taxotere)" .
<Pertuzumab> <Antineoplastic_of> "TCHP_(Taxol)" .
<Pertuzumab> <Antineoplastic_of> "Pertuzumab_and_Trastuzumab" .
<Pertuzumab> <Antineoplastic_of> "Pertuzumab_and_T-DM1" .
<Pertuzumab> <Antineoplastic_of> "Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine" .
<Pertuzumab> <Antineoplastic_of> "Capecitabine,_Pertuzumab,_Trastuzumab" .
<Oprelvekin> <Has_brand_name> "Neumega" .
<OXAFAFU> <Maps_to> "OXAFAFU" .
<Ofatumumab_monotherapy> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<Ofatumumab_monotherapy> <Is_current_in> "Follicular_lymphoma" .
<Ofatumumab_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Ofatumumab_monotherapy> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<CHOP,_then_131Iodine-Tositumomab> <Is_a> "Anthracycline-containing_regimen" .
<BCNU/TT> <Maps_to> "BCNU/TT" .
<B-CAVe> <Has_accepted_use> "Hodgkin_lymphoma" .
<Cyclophosphamide_and_Prednisone> <Has_immunosuppressor> "Prednisone" .
<Cyclophosphamide_and_Prednisone> <Has_immunosuppressor> "Cyclophosphamide" .
<Daunoblastin> <Brand_name_of> "Daunorubicin" .
<LoDAC> <Has_modality> "Chemotherapy" .
<Idelalisib_monotherapy> <Has_antineoplastic> "Idelalisib" .
<Ifosfamide_monotherapy> <Has_antineoplastic> "Mesna" .
<Ifosfamide_monotherapy> <Has_antineoplastic> "Ifosfamide" .
<R-DHAC> <Is_a> "Rituximab-containing_regimen" .
<ABVD,_DD-DI> <Is_a> "Anthracycline-containing_regimen" .
<Abemaciclib> <May_have_route> "Oral" .
<Pirarubicin_monotherapy> <Has_antineoplastic> "Pirarubicin" .
<VIDE> <Has_antineoplastic> "Vincristine" .
<VIDE> <Has_antineoplastic> "Ifosfamide" .
<VIDE> <Has_antineoplastic> "Etoposide" .
<VIDE> <Has_antineoplastic> "Doxorubicin" .
<Durvalumab_monotherapy> <Mapped_from> "Durvalumab_monotherapy" .
<Arsenic_trioxide_and_Chlorambucil> <Has_antineoplastic> "Chlorambucil" .
<Arsenic_trioxide_and_Chlorambucil> <Has_antineoplastic> "Arsenic_trioxide" .
<Hyper-CVAD_and_Dasatinib> <Has_modality> "Chemotherapy" .
<Deltason> <Brand_name_of> "Prednisone" .
<HDMP> <Is_historical_in> "Chronic_lymphocytic_leukemia" .
<Iretin> <Brand_name_of> "Cytarabine" .
<Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone> <Has_antineoplastic> "Prednisolone" .
<Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone> <Has_antineoplastic> "Mercaptopurine" .
<Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone> <Has_antineoplastic> "Daunorubicin" .
<Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone> <Has_antineoplastic> "Cytarabine" .
<VR> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<VR> <Has_accepted_use> "Mantle_cell_lymphoma" .
<VR> <Has_accepted_use> "Follicular_lymphoma" .
<AVD> <Maps_to> "AVD" .
<IT_Cytarabine_liposomal_monotherapy> <Has_modality> "Chemotherapy" .
<Cisplatin_and_Paclitaxel> <Has_context> "Non-curative_therapy" .
<Cisplatin_and_Paclitaxel> <Has_context> "Non-curative_second-line_therapy" .
<Cisplatin_and_Paclitaxel> <Has_context> "Non-curative_first-line_therapy" .
<Cisplatin_and_Paclitaxel> <Has_context> "Neoadjuvant_therapy" .
<Cisplatin_and_Paclitaxel> <Has_context> "Local_therapy" .
<Cisplatin_and_Paclitaxel> <Has_context> "Adjuvant_therapy" .
<Intravenous> <May_be_route_of> "Zoledronic_acid" .
<Intravenous> <May_be_route_of> "Ziv-aflibercept" .
<Intravenous> <May_be_route_of> "Vosaroxin" .
<Intravenous> <May_be_route_of> "Voriconazole" .
<Intravenous> <May_be_route_of> "Volasertib" .
<Intravenous> <May_be_route_of> "Vinorelbine" .
<Intravenous> <May_be_route_of> "Vinflunine" .
<Intravenous> <May_be_route_of> "Vindesine" .
<Intravenous> <May_be_route_of> "Vincristine_liposomal" .
<Intravenous> <May_be_route_of> "Vincristine" .
<Intravenous> <May_be_route_of> "Vinblastine" .
<Intravenous> <May_be_route_of> "Veltuzumab" .
<Intravenous> <May_be_route_of> "Vadastuximab_talirine" .
<Intravenous> <May_be_route_of> "Unfractionated_heparin" .
<Intravenous> <May_be_route_of> "Ublituximab" .
<Intravenous> <May_be_route_of> "Tropisetron" .
<Intravenous> <May_be_route_of> "Trimethoprim-Sulfamethoxazole" .
<Intravenous> <May_be_route_of> "Treosulfan" .
<Intravenous> <May_be_route_of> "Tremelimumab" .
<Intravenous> <May_be_route_of> "Trebananib" .
<Intravenous> <May_be_route_of> "Trastuzumab-qyyp" .
<Intravenous> <May_be_route_of> "Trastuzumab-pkrb" .
<Intravenous> <May_be_route_of> "Trastuzumab-dttb" .
<Intravenous> <May_be_route_of> "Trastuzumab-dkst" .
<Intravenous> <May_be_route_of> "Trastuzumab-anns" .
<Intravenous> <May_be_route_of> "Trastuzumab" .
<Intravenous> <May_be_route_of> "Tranexamic_acid" .
<Intravenous> <May_be_route_of> "Trabectedin" .
<Intravenous> <May_be_route_of> "Tositumomab_&_I-131" .
<Intravenous> <May_be_route_of> "Topotecan" .
<Intravenous> <May_be_route_of> "Tocilizumab" .
<Intravenous> <May_be_route_of> "Tisagenlecleucel" .
<Intravenous> <May_be_route_of> "Tirofiban" .
<Intravenous> <May_be_route_of> "Thiotepa" .
<Intravenous> <May_be_route_of> "Teniposide" .
<Intravenous> <May_be_route_of> "Temsirolimus" .
<Intravenous> <May_be_route_of> "Temozolomide" .
<Intravenous> <May_be_route_of> "Tagraxofusp" .
<Intravenous> <May_be_route_of> "Tacrolimus" .
<Intravenous> <May_be_route_of> "Strontium-89" .
<Intravenous> <May_be_route_of> "Streptozocin" .
<Intravenous> <May_be_route_of> "Sipuleucel-T" .
<Intravenous> <May_be_route_of> "Siltuximab" .
<Intravenous> <May_be_route_of> "Sargramostim" .
<Intravenous> <May_be_route_of> "Samarium-153" .
<Intravenous> <May_be_route_of> "Sacituzumab_govitecan" .
<Intravenous> <May_be_route_of> "Romidepsin" .
<Intravenous> <May_be_route_of> "Rolapitant" .
<Intravenous> <May_be_route_of> "Rituximab-pvvr" .
<Intravenous> <May_be_route_of> "Rituximab-abbs" .
<Intravenous> <May_be_route_of> "Rituximab" .
<Intravenous> <May_be_route_of> "Rilotumumab" .
<Intravenous> <May_be_route_of> "Rho(D)_immune_globulin" .
<Intravenous> <May_be_route_of> "Retaspimycin" .
<Intravenous> <May_be_route_of> "Ravulizumab" .
<Intravenous> <May_be_route_of> "Rasburicase" .
<Intravenous> <May_be_route_of> "Ranimustine" .
<Intravenous> <May_be_route_of> "Ramucirumab" .
<Intravenous> <May_be_route_of> "Ramosetron" .
<Intravenous> <May_be_route_of> "Raltitrexed" .
<Intravenous> <May_be_route_of> "Radium-223" .
<Intravenous> <May_be_route_of> "Prothrombin_Complex_Concentrate_human" .
<Intravenous> <May_be_route_of> "Protamine_sulfate" .
<Intravenous> <May_be_route_of> "Prochlorperazine" .
<Intravenous> <May_be_route_of> "Pralatrexate" .
<Intravenous> <May_be_route_of> "Porfimer" .
<Intravenous> <May_be_route_of> "Polatuzumab_vedotin" .
<Intravenous> <May_be_route_of> "Pixantrone" .
<Intravenous> <May_be_route_of> "Pirarubicin" .
<Intravenous> <May_be_route_of> "Pidilizumab" .
<Intravenous> <May_be_route_of> "Phytonadione" .
<Intravenous> <May_be_route_of> "Pertuzumab" .
<Intravenous> <May_be_route_of> "Pentostatin" .
<Intravenous> <May_be_route_of> "Pemetrexed" .
<Intravenous> <May_be_route_of> "Pembrolizumab" .
<Intravenous> <May_be_route_of> "Pegylated_liposomal_doxorubicin" .
<Intravenous> <May_be_route_of> "Pegaspargase" .
<Intravenous> <May_be_route_of> "Pantoprazole" .
<Intravenous> <May_be_route_of> "Panitumumab" .
<Intravenous> <May_be_route_of> "Pamidronate" .
<Intravenous> <May_be_route_of> "Palonosetron" .
<Intravenous> <May_be_route_of> "Palifermin" .
<Intravenous> <May_be_route_of> "Paclitaxel_nanoparticle_albumin-bound" .
<Intravenous> <May_be_route_of> "Paclitaxel" .
<Intravenous> <May_be_route_of> "Oxaliplatin" .
<Intravenous> <May_be_route_of> "Otlertuzumab" .
<Intravenous> <May_be_route_of> "Osocimab" .
<Intravenous> <May_be_route_of> "Ondansetron" .
<Intravenous> <May_be_route_of> "Onartuzumab" .
<Intravenous> <May_be_route_of> "Omeprazole" .
<Intravenous> <May_be_route_of> "Omacetaxine" .
<Intravenous> <May_be_route_of> "Olaratumab" .
<Intravenous> <May_be_route_of> "Ofatumumab" .
<Intravenous> <May_be_route_of> "Octreotide" .
<Intravenous> <May_be_route_of> "Obinutuzumab" .
<Intravenous> <May_be_route_of> "Non-pegylated_liposomal_doxorubicin" .
<Intravenous> <May_be_route_of> "Nolatrexed" .
<Intravenous> <May_be_route_of> "Nivolumab" .
<Intravenous> <May_be_route_of> "Nelarabine" .
<Intravenous> <May_be_route_of> "Nedaplatin" .
<Intravenous> <May_be_route_of> "Necitumumab" .
<Intravenous> <May_be_route_of> "Mycophenolate_mofetil" .
<Intravenous> <May_be_route_of> "Moxetumomab_pasudotox" .
<Intravenous> <May_be_route_of> "Mogamulizumab" .
<Intravenous> <May_be_route_of> "Mitoxantrone" .
<Intravenous> <May_be_route_of> "Mitomycin" .
<Intravenous> <May_be_route_of> "Metoclopramide" .
<Intravenous> <May_be_route_of> "Methylprednisolone" .
<Intravenous> <May_be_route_of> "Methoxsalen" .
<Intravenous> <May_be_route_of> "Methotrexate" .
<Intravenous> <May_be_route_of> "Mesna" .
<Intravenous> <May_be_route_of> "Mepolizumab" .
<Intravenous> <May_be_route_of> "Meperidine" .
<Intravenous> <May_be_route_of> "Melphalan" .
<Intravenous> <May_be_route_of> "Mechlorethamine" .
<Intravenous> <May_be_route_of> "Mannitol" .
<Intravenous> <May_be_route_of> "MOR208" .
<Intravenous> <May_be_route_of> "MOR202" .
<Intravenous> <May_be_route_of> "Lutetium_Lu_177_dotatate" .
<Intravenous> <May_be_route_of> "Lorazepam" .
<Intravenous> <May_be_route_of> "Lobaplatin" .
<Intravenous> <May_be_route_of> "Levoleucovorin" .
<Intravenous> <May_be_route_of> "Levofloxacin" .
<Intravenous> <May_be_route_of> "Lepirudin" .
<Intravenous> <May_be_route_of> "Lapuleucel-T" .
<Intravenous> <May_be_route_of> "Ixabepilone" .
<Intravenous> <May_be_route_of> "Itraconazole" .
<Intravenous> <May_be_route_of> "Isatuximab" .
<Intravenous> <May_be_route_of> "Iron_sucrose" .
<Intravenous> <May_be_route_of> "Iron_dextran" .
<Intravenous> <May_be_route_of> "Irinotecan_liposome" .
<Intravenous> <May_be_route_of> "Irinotecan" .
<Intravenous> <May_be_route_of> "Ipilimumab" .
<Intravenous> <May_be_route_of> "Iodine-131" .
<Intravenous> <May_be_route_of> "Interferon_alfa-2b" .
<Intravenous> <May_be_route_of> "Inotuzumab_ozogamicin" .
<Intravenous> <May_be_route_of> "Indomethacin" .
<Intravenous> <May_be_route_of> "Ifosfamide" .
<Intravenous> <May_be_route_of> "Idarubicin" .
<Intravenous> <May_be_route_of> "Ibritumomab_tiuxetan" .
<Intravenous> <May_be_route_of> "Ibandronate" .
<Intravenous> <May_be_route_of> "IPH_2101" .
<Intravenous> <May_be_route_of> "Hydrocortisone" .
<Intravenous> <May_be_route_of> "Heptaplatin" .
<Intravenous> <May_be_route_of> "Hematopoetic_progenitor_cells_cord_blood" .
<Intravenous> <May_be_route_of> "Haloperidol" .
<Intravenous> <May_be_route_of> "Guadecitabine" .
<Intravenous> <May_be_route_of> "Granisetron" .
<Intravenous> <May_be_route_of> "Glucarpidase" .
<Intravenous> <May_be_route_of> "Gemtuzumab_ozogamicin" .
<Intravenous> <May_be_route_of> "Gemcitabine" .
<Intravenous> <May_be_route_of> "Ganitumab" .
<Intravenous> <May_be_route_of> "Ganetespib" .
<Intravenous> <May_be_route_of> "Furosemide" .
<Intravenous> <May_be_route_of> "Fotemustine" .
<Intravenous> <May_be_route_of> "Fosaprepitant" .
<Intravenous> <May_be_route_of> "Folinic_acid" .
<Intravenous> <May_be_route_of> "Folic_acid" .
<Intravenous> <May_be_route_of> "Fluorouracil" .
<Intravenous> <May_be_route_of> "Fludarabine" .
<Intravenous> <May_be_route_of> "Fluconazole" .
<Intravenous> <May_be_route_of> "Filgrastim" .
<Intravenous> <May_be_route_of> "Ferumoxytol" .
<Intravenous> <May_be_route_of> "Ferric_gluconate" .
<Intravenous> <May_be_route_of> "Ferric_carboxymaltose" .
<Intravenous> <May_be_route_of> "Famotidine" .
<Intravenous> <May_be_route_of> "Fam-trastuzumab_deruxtecan" .
<Intravenous> <May_be_route_of> "Factor_Xa_recombinant_inactivated-zhzo" .
<Intravenous> <May_be_route_of> "Factor_XIII_concentrate_human" .
<Intravenous> <May_be_route_of> "Factor_VIIa_recombinant" .
<Intravenous> <May_be_route_of> "Factor_VIII_recombinant" .
<Intravenous> <May_be_route_of> "Factor_VIII_human" .
<Intravenous> <May_be_route_of> "Factor_IX_recombinant_Fc_fusion_protein" .
<Intravenous> <May_be_route_of> "Factor_IX_recombinant" .
<Intravenous> <May_be_route_of> "Factor_IX_human" .
<Intravenous> <May_be_route_of> "Etoposide" .
<Intravenous> <May_be_route_of> "Eribulin" .
<Intravenous> <May_be_route_of> "Eptifibatide" .
<Intravenous> <May_be_route_of> "Epratuzumab" .
<Intravenous> <May_be_route_of> "Epoetin_alfa" .
<Intravenous> <May_be_route_of> "Epirubicin" .
<Intravenous> <May_be_route_of> "Enfortumab_vedotin" .
<Intravenous> <May_be_route_of> "Emapalumab" .
<Intravenous> <May_be_route_of> "Elotuzumab" .
<Intravenous> <May_be_route_of> "Edrecolomab" .
<Intravenous> <May_be_route_of> "Eculizumab" .
<Intravenous> <May_be_route_of> "Durvalumab" .
<Intravenous> <May_be_route_of> "Doxorubicin" .
<Intravenous> <May_be_route_of> "Domperidone" .
<Intravenous> <May_be_route_of> "Dolasetron" .
<Intravenous> <May_be_route_of> "Docetaxel" .
<Intravenous> <May_be_route_of> "Diphenhydramine" .
<Intravenous> <May_be_route_of> "Dinutuximab" .
<Intravenous> <May_be_route_of> "Dinaciclib" .
<Intravenous> <May_be_route_of> "Dexrazoxane" .
<Intravenous> <May_be_route_of> "Desmopressin" .
<Intravenous> <May_be_route_of> "Denosumab" .
<Intravenous> <May_be_route_of> "Denintuzumab_mafodotin" .
<Intravenous> <May_be_route_of> "Denileukin_diftitox" .
<Intravenous> <May_be_route_of> "Defibrotide" .
<Intravenous> <May_be_route_of> "Deferoxamine" .
<Intravenous> <May_be_route_of> "Decitabine" .
<Intravenous> <May_be_route_of> "Daunorubicin_liposomal" .
<Intravenous> <May_be_route_of> "Daunorubicin" .
<Intravenous> <May_be_route_of> "Darbepoetin_alfa" .
<Intravenous> <May_be_route_of> "Daratumumab" .
<Intravenous> <May_be_route_of> "Dactinomycin" .
<Intravenous> <May_be_route_of> "Dacarbazine" .
<Intravenous> <May_be_route_of> "Cytomegalovirus_Immune_Globulin" .
<Intravenous> <May_be_route_of> "Cytarabine_and_daunorubicin_liposomal" .
<Intravenous> <May_be_route_of> "Cytarabine" .
<Intravenous> <May_be_route_of> "Cyclosporine_non-modified" .
<Intravenous> <May_be_route_of> "Cyclophosphamide" .
<Intravenous> <May_be_route_of> "Custirsen" .
<Intravenous> <May_be_route_of> "Crizanlizumab" .
<Intravenous> <May_be_route_of> "Copanlisib" .
<Intravenous> <May_be_route_of> "Coltuximab_ravtansine" .
<Intravenous> <May_be_route_of> "Clofarabine" .
<Intravenous> <May_be_route_of> "Cladribine" .
<Intravenous> <May_be_route_of> "Cixutumumab" .
<Intravenous> <May_be_route_of> "Cisplatin" .
<Intravenous> <May_be_route_of> "Ciprofloxacin" .
<Intravenous> <May_be_route_of> "Cetuximab" .
<Intravenous> <May_be_route_of> "Cemiplimab" .
<Intravenous> <May_be_route_of> "Caspofungin" .
<Intravenous> <May_be_route_of> "Carmustine" .
<Intravenous> <May_be_route_of> "Carfilzomib" .
<Intravenous> <May_be_route_of> "Carboplatin" .
<Intravenous> <May_be_route_of> "Calaspargase" .
<Intravenous> <May_be_route_of> "Cabazitaxel" .
<Intravenous> <May_be_route_of> "Busulfan" .
<Intravenous> <May_be_route_of> "Brentuximab_vedotin" .
<Intravenous> <May_be_route_of> "Bortezomib" .
<Intravenous> <May_be_route_of> "Blinatumomab" .
<Intravenous> <May_be_route_of> "Bleomycin" .
<Intravenous> <May_be_route_of> "Bivalirudin" .
<Intravenous> <May_be_route_of> "Bevacizumab-bvzr" .
<Intravenous> <May_be_route_of> "Bevacizumab-awwb" .
<Intravenous> <May_be_route_of> "Bevacizumab" .
<Intravenous> <May_be_route_of> "Benralizumab" .
<Intravenous> <May_be_route_of> "Bendamustine" .
<Intravenous> <May_be_route_of> "Belotecan" .
<Intravenous> <May_be_route_of> "Belinostat" .
<Intravenous> <May_be_route_of> "Belagenpumatucel-L" .
<Intravenous> <May_be_route_of> "Bavituximab" .
<Intravenous> <May_be_route_of> "BL22_immunotoxin" .
<Intravenous> <May_be_route_of> "BHQ880" .
<Intravenous> <May_be_route_of> "Azacitidine" .
<Intravenous> <May_be_route_of> "Axicabtagene_ciloleucel" .
<Intravenous> <May_be_route_of> "Avelumab" .
<Intravenous> <May_be_route_of> "Atezolizumab" .
<Intravenous> <May_be_route_of> "Asparaginase" .
<Intravenous> <May_be_route_of> "Arsenic_trioxide" .
<Intravenous> <May_be_route_of> "Argatroban" .
<Intravenous> <May_be_route_of> "Antithymocyte_globulin_rabbit_ATG" .
<Intravenous> <May_be_route_of> "Antithymocyte_globulin_horse_ATG" .
<Intravenous> <May_be_route_of> "Antithrombin_III" .
<Intravenous> <May_be_route_of> "Anti-inhibitor_coagulant_complex" .
<Intravenous> <May_be_route_of> "Amsacrine" .
<Intravenous> <May_be_route_of> "Amrubicin" .
<Intravenous> <May_be_route_of> "Aminocaproic_acid" .
<Intravenous> <May_be_route_of> "Amifostine" .
<Intravenous> <May_be_route_of> "Amatuximab" .
<Intravenous> <May_be_route_of> "Allopurinol" .
<Intravenous> <May_be_route_of> "Alemtuzumab" .
<Intravenous> <May_be_route_of> "Aldesleukin" .
<Intravenous> <May_be_route_of> "Ado-trastuzumab_emtansine" .
<Intravenous> <May_be_route_of> "Acyclovir" .
<Intravenous> <May_be_route_of> "Actinium_Ac_225_lintuzumab" .
<Intravenous> <May_be_route_of> "Aclarubicin" .
<Intravenous> <May_be_route_of> "Abciximab" .
<FAC_and_BCG> <Has_context> "Adjuvant_therapy" .
<Tisagenlecleucel> <Has_accepted_use> "Transformed_lymphoma" .
<Tisagenlecleucel> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Tisagenlecleucel> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<(90)YFC,_then_allo_HSCT> <Mapped_from> "(90)YFC,_then_allo_HSCT" .
<Voroste> <Brand_name_of> "Alendronate" .
<Rectal_cancer> <Accepted_use_of> "mFOLFOX6_and_RT" .
<Rectal_cancer> <Accepted_use_of> "UFT_monotherapy" .
<Rectal_cancer> <Accepted_use_of> "Tegafur_gimeracil_oteracil" .
<Rectal_cancer> <Accepted_use_of> "Tegafur_and_uracil" .
<Rectal_cancer> <Accepted_use_of> "S-1_monotherapy" .
<Rectal_cancer> <Accepted_use_of> "Radiation_therapy" .
<Rectal_cancer> <Accepted_use_of> "Oxaliplatin" .
<Rectal_cancer> <Accepted_use_of> "Observation" .
<Rectal_cancer> <Accepted_use_of> "Levoleucovorin" .
<Rectal_cancer> <Accepted_use_of> "Folinic_acid" .
<Rectal_cancer> <Accepted_use_of> "Fluorouracil/Fluorouracil_and_RT" .
<Rectal_cancer> <Accepted_use_of> "Fluorouracil,_Oxaliplatin,_RT" .
<Rectal_cancer> <Accepted_use_of> "Fluorouracil,_Folinic_acid,_RT" .
<Rectal_cancer> <Accepted_use_of> "Fluorouracil_monotherapy" .
<Rectal_cancer> <Accepted_use_of> "Fluorouracil_and_RT" .
<Rectal_cancer> <Accepted_use_of> "Fluorouracil_and_Folinic_acid" .
<Rectal_cancer> <Accepted_use_of> "Fluorouracil" .
<Rectal_cancer> <Accepted_use_of> "FULV/FULV_and_RT" .
<Rectal_cancer> <Accepted_use_of> "FOLFOX" .
<Rectal_cancer> <Accepted_use_of> "Capecitabine/Capecitabine_and_RT" .
<Rectal_cancer> <Accepted_use_of> "Capecitabine,_Sorafenib,_RT" .
<Rectal_cancer> <Accepted_use_of> "Capecitabine_monotherapy" .
<Rectal_cancer> <Accepted_use_of> "Capecitabine_and_RT" .
<Rectal_cancer> <Accepted_use_of> "Capecitabine" .
<Rectal_cancer> <Accepted_use_of> "CapeOx,_Cetuximab,_RT" .
<Rectal_cancer> <Accepted_use_of> "CapeOx" .
<Duralone> <Brand_name_of> "Methylprednisolone" .
<FULV_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Leuplin> <Brand_name_of> "Leuprolide" .
<VcR-CVAD> <Has_modality> "Chemotherapy" .
<Capecitabine_and_Mitomycin> <Has_accepted_use> "Gallbladder_cancer" .
<Capecitabine_and_Mitomycin> <Has_accepted_use> "Cholangiocarcinoma" .
<CAMF> <Has_antineoplastic> "Methotrexate" .
<CAMF> <Has_antineoplastic> "Fluorouracil" .
<CAMF> <Has_antineoplastic> "Doxorubicin" .
<CAMF> <Has_antineoplastic> "Cyclophosphamide" .
<Furosemide> <May_have_route> "Oral" .
<Furosemide> <May_have_route> "Intravenous" .
<Trametinib_monotherapy> <Maps_to> "Trametinib_monotherapy" .
<Tovok> <Brand_name_of> "Afatinib" .
<Hyper-CVAD_and_Imatinib> <Maps_to> "Hyper-CVAD_and_Imatinib" .
<CBV> <Has_modality> "Chemotherapy" .
<R-CODOX-M_(Doxil_substituted)> <Mapped_from> "R-CODOX-M_(Doxil_substituted)" .
<Bosulif> <Brand_name_of> "Bosutinib" .
<Desmotabs> <Brand_name_of> "Desmopressin" .
<Protamine_sulfate> <Is_a> "Hemostasis_medication" .
<Irinotecan,_Vemurafenib,_Cetuximab> <Mapped_from> "Irinotecan,_Vemurafenib,_Cetuximab" .
<BRAF_inhibitor> <Subsumes> "Vemurafenib" .
<BRAF_inhibitor> <Subsumes> "Sorafenib" .
<BRAF_inhibitor> <Subsumes> "Regorafenib" .
<BRAF_inhibitor> <Subsumes> "Encorafenib" .
<BRAF_inhibitor> <Subsumes> "Dabrafenib" .
<Cyclostin> <Brand_name_of> "Cyclophosphamide" .
<MINE> <Is_current_in> "Hodgkin_lymphoma" .
<MVAC> <Has_antineoplastic> "Vinblastine" .
<MVAC> <Has_antineoplastic> "Methotrexate" .
<MVAC> <Has_antineoplastic> "Doxorubicin" .
<MVAC> <Has_antineoplastic> "Cisplatin" .
<DeVIC_and_RT> <Mapped_from> "DeVIC_and_RT" .
<IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Hyper-CVAD_and_Imatinib> <Has_modality> "Chemotherapy" .
<Calidron> <Brand_name_of> "Alendronate" .
<Ibritumomab_tiuxetan_monotherapy> <Maps_to> "Ibritumomab_tiuxetan_monotherapy" .
<Fluorouracil,_Hydroxyurea,_RT> <Mapped_from> "Fluorouracil,_Hydroxyurea,_RT" .
<TX_(Taxotere)> <Has_context> "Non-curative_subsequent-line_therapy" .
<TX_(Taxotere)> <Has_context> "Non-curative_first-line_therapy" .
<TX_(Taxotere)> <Has_context> "Neoadjuvant_therapy" .
<Cisplatin,_Etoposide,_Irinotecan> <Mapped_from> "Cisplatin,_Etoposide,_Irinotecan" .
<Cisplatin,_Fluorouracil,_Vincristine> <Has_modality> "Chemotherapy" .
<5_plus_3d> <Has_accepted_use> "Acute_myeloid_leukemia" .
<TILs> <Has_modality> "Immunotherapy" .
<Ado-trastuzumab_emtansine_monotherapy> <Maps_to> "Ado-trastuzumab_emtansine_monotherapy" .
<Primasulf> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Carboplatin,_Pemetrexed,_Pembrolizumab> <Has_modality> "Immunotherapy" .
<Carboplatin,_Pemetrexed,_Pembrolizumab> <Has_modality> "Chemotherapy" .
<Antileukotriene> <Is_a> "Supportive_medication" .
<Radiation> <Subsumes> "Radiotherapy_medication" .
<Cisplatin,_Doxorubicin_liposomal,_Fluorouracil> <Has_accepted_use> "Esophageal_cancer" .
<Cisteen> <Brand_name_of> "Cisplatin" .
<Lanreotide_Depot/Autogel_monotherapy> <Is_current_in> "Pancreatic_NET" .
<Tranax> <Brand_name_of> "Alprazolam" .
<Cisplatin,_Etoposide,_Durvalumab> <Has_modality> "Chemotherapy" .
<Merex> <Brand_name_of> "Methotrexate" .
<m-BACOD> <Has_context> "Upfront_therapy" .
<m-BACOD> <Has_context> "Induction_therapy" .
<Zecaxon> <Brand_name_of> "Dexamethasone" .
<Cyclophosphamide_and_Dexamethasone> <Is_current_in> "Multiple_myeloma" .
<Degarelix> <Antineoplastic_of> "Degarelix_monotherapy" .
<Flutamide> <Has_FDA_indication> "Prostate_cancer" .
<Bicalutamide_and_RT> <Maps_to> "Bicalutamide_and_RT" .
<Gastrointestinal_cancer> <Is_a> "Malignant_solid_neoplasm" .
<Bortezomib_monotherapy> <Maps_to> "Bortezomib_monotherapy" .
<Norethandrolone> <May_have_route> "Oral" .
<Axitinib> <Is_a> "VEGFR_inhibitor" .
<Axitinib> <Is_a> "PDGFR_inhibitor" .
<Axitinib> <Is_a> "Kinase_inhibitor" .
<Axitinib> <Is_a> "KIT_inhibitor" .
<Methotrexate,_Vinblastine,_Prednisone> <Has_accepted_use> "Langerhans_cell_histiocytosis" .
<Ledoxina> <Brand_name_of> "Cyclophosphamide" .
<R-EPOCH,_dose-escalated> <Has_antineoplastic> "Vincristine" .
<R-EPOCH,_dose-escalated> <Has_antineoplastic> "Rituximab" .
<R-EPOCH,_dose-escalated> <Has_antineoplastic> "Prednisone" .
<R-EPOCH,_dose-escalated> <Has_antineoplastic> "Etoposide" .
<R-EPOCH,_dose-escalated> <Has_antineoplastic> "Doxorubicin" .
<R-EPOCH,_dose-escalated> <Has_antineoplastic> "Cyclophosphamide" .
<Ipilimumab> <May_have_route> "Intravenous" .
<Sirolimus> <Has_brand_name> "Rapamune" .
<Etopos> <Brand_name_of> "Etoposide" .
<Saltrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<LD-ACOP-B> <Has_antineoplastic> "Vincristine" .
<LD-ACOP-B> <Has_antineoplastic> "Prednisone" .
<LD-ACOP-B> <Has_antineoplastic> "Doxorubicin" .
<LD-ACOP-B> <Has_antineoplastic> "Cyclophosphamide" .
<LD-ACOP-B> <Has_antineoplastic> "Bleomycin" .
<KRAS_wild-type_Colon_cancer> <Is_a> "Colon_cancer" .
<Pazopanib> <Antineoplastic_of> "Pazopanib_monotherapy" .
<Pazopanib> <Antineoplastic_of> "Paclitaxel_and_Pazopanib" .
<Lomustine> <Has_accepted_use> "Medulloblastoma" .
<Lomustine> <Has_accepted_use> "Low-grade_glioma" .
<Lomustine> <Has_accepted_use> "Glioblastoma" .
<Lomustine> <Has_accepted_use> "CNS_lymphoma" .
<Lomustine> <Has_accepted_use> "Anaplastic_glioma" .
<Lomustine> <Has_accepted_use> "Acute_myeloid_leukemia" .
<PACEBOM> <Is_a> "Anthracycline-containing_regimen" .
<CNOP> <Has_antineoplastic> "Vincristine" .
<CNOP> <Has_antineoplastic> "Prednisone" .
<CNOP> <Has_antineoplastic> "Mitoxantrone" .
<CNOP> <Has_antineoplastic> "Cyclophosphamide" .
<Anemul> <Brand_name_of> "Dexamethasone" .
<CYVE> <Has_antineoplastic> "Etoposide" .
<CYVE> <Has_antineoplastic> "Cytarabine" .
<Venetoclax_and_Rituximab> <Maps_to> "Venetoclax_and_Rituximab" .
<mFOLFIRINOX> <Mapped_from> "mFOLFIRINOX" .
<maxi-R-CHOP/R-HiDAC> <Has_modality> "Chemotherapy" .
<Thymoma> <Accepted_use_of> "Vincristine" .
<Thymoma> <Accepted_use_of> "VIP" .
<Thymoma> <Accepted_use_of> "Sunitinib_monotherapy" .
<Thymoma> <Accepted_use_of> "Sunitinib" .
<Thymoma> <Accepted_use_of> "Radiation_therapy" .
<Thymoma> <Accepted_use_of> "Prednisone" .
<Thymoma> <Accepted_use_of> "Paclitaxel" .
<Thymoma> <Accepted_use_of> "PAC" .
<Thymoma> <Accepted_use_of> "Octreotide_monotherapy" .
<Thymoma> <Accepted_use_of> "Octreotide_and_Prednisone" .
<Thymoma> <Accepted_use_of> "Octreotide" .
<Thymoma> <Accepted_use_of> "Ifosfamide_monotherapy" .
<Thymoma> <Accepted_use_of> "Ifosfamide" .
<Thymoma> <Accepted_use_of> "Gemcitabine" .
<Thymoma> <Accepted_use_of> "Everolimus_monotherapy" .
<Thymoma> <Accepted_use_of> "Everolimus" .
<Thymoma> <Accepted_use_of> "Etoposide" .
<Thymoma> <Accepted_use_of> "Doxorubicin" .
<Thymoma> <Accepted_use_of> "Cyclophosphamide" .
<Thymoma> <Accepted_use_of> "Cixutumumab" .
<Thymoma> <Accepted_use_of> "Cisplatin_and_Etoposide" .
<Thymoma> <Accepted_use_of> "Cisplatin" .
<Thymoma> <Accepted_use_of> "Carboplatin_and_Paclitaxel" .
<Thymoma> <Accepted_use_of> "Carboplatin" .
<Thymoma> <Accepted_use_of> "Capecitabine_and_Gemcitabine" .
<Thymoma> <Accepted_use_of> "Capecitabine" .
<Thymoma> <Accepted_use_of> "ADOC" .
<Lapatinib_and_Letrozole> <Has_context> "Non-curative_first-line_therapy" .
<Alpelisib_and_Fulvestrant> <Is_a> "Antiestrogen-containing_regimen" .
<Drugs_by_vehicle> <Subsumes> "Pegylated_medication" .
<Drugs_by_vehicle> <Subsumes> "Nanoparticle_albumin_bound_chemotherapy" .
<Drugs_by_vehicle> <Subsumes> "Liposomal_chemotherapy" .
<Flutamide_monotherapy> <Has_context> "Non-curative_therapy" .
<Tagraxofusp> <Has_FDA_indication> "Blastic_plasmacytoid_dendritic_cell_neoplasm" .
<Neratinib> <Is_a> "Protein_expression-specific_medication" .
<Neratinib> <Is_a> "Kinase_inhibitor" .
<Neratinib> <Is_a> "ERBB4_inhibitor" .
<Neratinib> <Is_a> "ERBB3_inhibitor" .
<Neratinib> <Is_a> "ERBB3_(HER3)_medication" .
<Neratinib> <Is_a> "ERBB2_inhibitor" .
<Neratinib> <Is_a> "ERBB2_(HER2)_medication" .
<Neratinib> <Is_a> "EGFR_inhibitor" .
<ATG_(Rabbit)_monotherapy> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Coagulation_factor> <Is_a> "Classical_hematology_medication" .
<Amrubicin_monotherapy> <Has_modality> "Chemotherapy" .
<FOLFOX_chronotherapy> <Has_antineoplastic> "Oxaliplatin" .
<FOLFOX_chronotherapy> <Has_antineoplastic> "Folinic_acid" .
<FOLFOX_chronotherapy> <Has_antineoplastic> "Fluorouracil" .
<Relbovin> <Brand_name_of> "Vinorelbine" .
<CHUT> <Mapped_from> "CHUT" .
<Proteasome_inhibitor> <Is_a> "Chemotherapeutic" .
<Piqray> <Brand_name_of> "Alpelisib" .
<Decdan> <Brand_name_of> "Dexamethasone" .
<Carboplatino> <Brand_name_of> "Carboplatin" .
<Cisplatin_and_S-1> <Is_a> "Platinum_doublet" .
<Cisplatin_and_Etoposide> <Has_accepted_use> "Thymoma" .
<Cisplatin_and_Etoposide> <Has_accepted_use> "Testicular_cancer" .
<Cisplatin_and_Etoposide> <Has_accepted_use> "Small_cell_lung_cancer" .
<Cisplatin_and_Etoposide> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cisplatin_and_Etoposide> <Has_accepted_use> "Low-grade_glioma" .
<Cisplatin_and_Etoposide> <Has_accepted_use> "Esophageal_cancer" .
<PF> <Has_modality> "Chemotherapy" .
<Interferon_alfa-2b_and_DLI> <Mapped_from> "Interferon_alfa-2b_and_DLI" .
<RVDC> <Has_accepted_use> "Multiple_myeloma" .
<Effcil> <Brand_name_of> "Fluorouracil" .
<Non-curative_second-line_maintenance_therapy> <Maps_to> "Non-curative_second-line_maintenance_therapy" .
<Trisul> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Prednisone> <Is_a> "Steroid" .
<Prednisone> <Is_a> "Light-chain_(AL)_amyloidosis_medication" .
<Prednisone> <Is_a> "Immunosuppressant" .
<Zomib> <Brand_name_of> "Bortezomib" .
<CAP> <Is_a> "Anthracycline-containing_regimen" .
<BCVPP> <Has_context> "Induction_therapy" .
<MACC> <Has_accepted_use> "Small_cell_lung_cancer" .
<MACC> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<MATRix> <Has_modality> "Chemotherapy" .
<PAD_doxil> <Has_modality> "Chemotherapy" .
<Dacarbazine_and_Ipilimumab> <Has_antineoplastic> "Ipilimumab" .
<Dacarbazine_and_Ipilimumab> <Has_antineoplastic> "Dacarbazine" .
<Cabozantinib> <Has_FDA_indication> "Thyroid_cancer" .
<Cabozantinib> <Has_FDA_indication> "Renal_cell_carcinoma" .
<Cabozantinib> <Has_FDA_indication> "Hepatocellular_carcinoma" .
<Degarelix> <Has_accepted_use> "Prostate_cancer" .
<R-ESHAP> <Has_modality> "Chemotherapy" .
<Exemestane> <Has_FDA_indication> "Breast_cancer" .
<Regorafenib> <Has_FDA_indication> "Hepatocellular_carcinoma" .
<Regorafenib> <Has_FDA_indication> "Gastrointestinal_stromal_tumor" .
<Cisplatin,_Gemcitabine,_Bevacizumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<Vesicant> <Subsumes> "Vinorelbine" .
<Vesicant> <Subsumes> "Vinflunine" .
<Vesicant> <Subsumes> "Vindesine" .
<Vesicant> <Subsumes> "Vincristine_liposomal" .
<Vesicant> <Subsumes> "Vincristine" .
<Vesicant> <Subsumes> "Vinblastine" .
<Vesicant> <Subsumes> "Trabectedin" .
<Vesicant> <Subsumes> "Plicamycin" .
<Vesicant> <Subsumes> "Paclitaxel" .
<Vesicant> <Subsumes> "Mitomycin" .
<Vesicant> <Subsumes> "Mechlorethamine" .
<Vesicant> <Subsumes> "Idarubicin" .
<Vesicant> <Subsumes> "Epirubicin" .
<Vesicant> <Subsumes> "Doxorubicin" .
<Vesicant> <Subsumes> "Docetaxel" .
<Vesicant> <Subsumes> "Daunorubicin" .
<Vesicant> <Subsumes> "Dactinomycin" .
<Vesicant> <Subsumes> "Cisplatin" .
<Vesicant> <Subsumes> "Carmustine" .
<Vesicant> <Subsumes> "Bendamustine" .
<Vesicant> <Subsumes> "Amsacrine" .
<S-1_monotherapy> <Has_accepted_use> "Rectal_cancer" .
<S-1_monotherapy> <Has_accepted_use> "Pancreatic_cancer" .
<S-1_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<S-1_monotherapy> <Has_accepted_use> "Gastric_cancer" .
<S-1_monotherapy> <Has_accepted_use> "Esophageal_cancer" .
<S-1_monotherapy> <Has_accepted_use> "Colon_cancer" .
<S-1_monotherapy> <Has_accepted_use> "Breast_cancer" .
<ddAC> <Has_supportive_med> "Sargramostim" .
<ddAC> <Has_supportive_med> "Pegfilgrastim" .
<ddAC> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<ddAC> <Has_supportive_med> "Filgrastim" .
<ddAC> <Has_supportive_med> "Darbepoetin_alfa" .
<LoDAC_and_Venetoclax> <Has_modality> "Chemotherapy" .
<Ipilimumab_and_Nivolumab> <Mapped_from> "Ipilimumab_and_Nivolumab" .
<Elinatecan> <Brand_name_of> "Irinotecan" .
<Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Prostap> <Brand_name_of> "Leuprolide" .
<Rituximab> <Immunosuppressor_of> "TT4" .
<Rituximab> <Immunosuppressor_of> "Rituximab_monotherapy" .
<Rituximab> <Immunosuppressor_of> "Prednisone_and_Rituximab" .
<Rituximab> <Immunosuppressor_of> "Prednisolone_and_Rituximab" .
<Rituximab> <Immunosuppressor_of> "Dexamethasone_and_Rituximab" .
<Rituximab> <Immunosuppressor_of> "Cyclosporine,_Corticosteroids,_Rituximab" .
<Cisplatin_and_Vinblastine> <Mapped_from> "Cisplatin_and_Vinblastine" .
<TCP> <Has_context> "All_lines_of_therapy" .
<Acute_leukemia> <Is_a> "Leukemia" .
<RD> <Maps_to> "RD" .
<Doxorubicin_pegylated_liposomal_and_Bevacizumab> <Has_context> "Non-curative_therapy" .
<Doxorubicin_pegylated_liposomal_and_Bevacizumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<Mannitol> <May_have_route> "Intravenous" .
<Vincristinsulfat> <Brand_name_of> "Vincristine" .
<Bcr-Abl_inhibitor> <Subsumes> "Radotinib" .
<Bcr-Abl_inhibitor> <Subsumes> "Ponatinib" .
<Bcr-Abl_inhibitor> <Subsumes> "Nilotinib" .
<Bcr-Abl_inhibitor> <Subsumes> "Imatinib" .
<Bcr-Abl_inhibitor> <Subsumes> "Dasatinib" .
<Bcr-Abl_inhibitor> <Subsumes> "Bosutinib" .
<Bcr-Abl_inhibitor> <Subsumes> "Asciminib" .
<Daunorubicin_monotherapy> <Is_a> "Anthracycline-containing_regimen" .
<Fludarabine,_Busulfan,_ATG> <Has_antineoplastic> "Fludarabine" .
<Fludarabine,_Busulfan,_ATG> <Has_antineoplastic> "Busulfan" .
<ADE_(standard-dose_Ara-C)> <Has_antineoplastic> "Etoposide" .
<ADE_(standard-dose_Ara-C)> <Has_antineoplastic> "Daunorubicin" .
<ADE_(standard-dose_Ara-C)> <Has_antineoplastic> "Cytarabine" .
<Synastat> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Mercaptopurine_and_WBRT> <Has_modality> "Radiotherapy" .
<Mercaptopurine_and_WBRT> <Has_modality> "Chemotherapy" .
<Lanreotide_and_Interferon_alfa-2b> <Mapped_from> "Lanreotide_and_Interferon_alfa-2b" .
<Bu/TT/Cy> <Has_modality> "Chemotherapy" .
<Clodronate> <Is_a> "Bisphosphonate" .
<Capegard> <Brand_name_of> "Capecitabine" .
<Ipilimumab_monotherapy> <Has_antineoplastic> "Ipilimumab" .
<Danazol> <Has_accepted_use> "Immune_thrombocytopenia" .
<Gemcitabine_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<FCR,_then_allo_HSCT> <Has_accepted_use> "Follicular_lymphoma" .
<Ferric_gluconate> <May_have_route> "Intravenous" .
<Cyclophosphamide_and_Prednisone> <Has_context> "Non-curative_therapy" .
<Cyclophosphamide_and_Prednisone> <Has_context> "Induction_therapy" .
<Cyclophosphamide_and_Prednisone> <Has_context> "All_lines_of_therapy" .
<Declovir> <Brand_name_of> "Acyclovir" .
<TBI> <Has_antineoplastic> "External_beam_radiotherapy" .
<Methotrexate_and_Tacrolimus> <Maps_to> "Methotrexate_and_Tacrolimus" .
<dmCODOX-M_-_Modified_Magrath> <Maps_to> "dmCODOX-M_-_Modified_Magrath" .
<TL_(Taxol)> <Has_context> "Non-curative_first-line_therapy" .
<TL_(Taxol)> <Has_context> "Neoadjuvant_therapy" .
<R-CVP> <Has_context> "Non-curative_therapy" .
<R-CVP> <Has_context> "Non-curative_first-line_therapy" .
<R-CVP> <Has_context> "Induction_therapy" .
<Cyclophosphamide,_Etoposide,_TBI> <Has_accepted_use> "Autologous_HSCT" .
<Cisplatyl> <Brand_name_of> "Cisplatin" .
<Hyper-CVAD> <Has_accepted_use> "Multiple_myeloma" .
<IP-BCD> <Is_current_in> "Osteosarcoma" .
<Superprednol> <Brand_name_of> "Dexamethasone" .
<Flebogamma> <Brand_name_of> "Intravenous_immunoglobulin_(IVIG)" .
<Vincristine_monotherapy> <Maps_to> "Vincristine_monotherapy" .
<Chronic_myelomonocytic_leukemia> <Accepted_use_of> "Vorinostat" .
<Chronic_myelomonocytic_leukemia> <Accepted_use_of> "Lenalidomide" .
<Chronic_myelomonocytic_leukemia> <Accepted_use_of> "Decitabine_monotherapy" .
<Chronic_myelomonocytic_leukemia> <Accepted_use_of> "Decitabine" .
<Chronic_myelomonocytic_leukemia> <Accepted_use_of> "Azacitidine_monotherapy" .
<Chronic_myelomonocytic_leukemia> <Accepted_use_of> "Azacitidine_and_Vorinostat" .
<Chronic_myelomonocytic_leukemia> <Accepted_use_of> "Azacitidine_and_Lenalidomide" .
<Chronic_myelomonocytic_leukemia> <Accepted_use_of> "Azacitidine" .
<BEAM> <Has_modality> "Chemotherapy" .
<Oxzucia> <Brand_name_of> "Oxaliplatin" .
<Antithymocyte_globulin_horse_ATG> <Has_brand_name> "Thymogam" .
<Antithymocyte_globulin_horse_ATG> <Has_brand_name> "Lymphoglobuline" .
<Antithymocyte_globulin_horse_ATG> <Has_brand_name> "Atgam" .
<Colchicine_monotherapy> <Maps_to> "Colchicine_monotherapy" .
<Gynotril> <Brand_name_of> "Letrozole" .
<Protein_expression-specific_medication> <Subsumes> "Trastuzumab-qyyp" .
<Protein_expression-specific_medication> <Subsumes> "Trastuzumab-pkrb" .
<Protein_expression-specific_medication> <Subsumes> "Trastuzumab-dttb" .
<Protein_expression-specific_medication> <Subsumes> "Trastuzumab-dkst" .
<Protein_expression-specific_medication> <Subsumes> "Trastuzumab-anns" .
<Protein_expression-specific_medication> <Subsumes> "Trastuzumab_and_hyaluronidase" .
<Protein_expression-specific_medication> <Subsumes> "Trastuzumab" .
<Protein_expression-specific_medication> <Subsumes> "Tositumomab_&_I-131" .
<Protein_expression-specific_medication> <Subsumes> "Toremifene" .
<Protein_expression-specific_medication> <Subsumes> "Tamoxifen" .
<Protein_expression-specific_medication> <Subsumes> "Rituximab-pvvr" .
<Protein_expression-specific_medication> <Subsumes> "Rituximab-abbs" .
<Protein_expression-specific_medication> <Subsumes> "Rituximab" .
<Protein_expression-specific_medication> <Subsumes> "Ribociclib" .
<Protein_expression-specific_medication> <Subsumes> "Pertuzumab" .
<Protein_expression-specific_medication> <Subsumes> "Pembrolizumab" .
<Protein_expression-specific_medication> <Subsumes> "Panitumumab" .
<Protein_expression-specific_medication> <Subsumes> "Olaparib" .
<Protein_expression-specific_medication> <Subsumes> "Neratinib" .
<Protein_expression-specific_medication> <Subsumes> "Lutetium_Lu_177_dotatate" .
<Protein_expression-specific_medication> <Subsumes> "Leuprolide" .
<Protein_expression-specific_medication> <Subsumes> "Letrozole" .
<Protein_expression-specific_medication> <Subsumes> "Lapatinib" .
<Protein_expression-specific_medication> <Subsumes> "Imatinib" .
<Protein_expression-specific_medication> <Subsumes> "Gemtuzumab_ozogamicin" .
<Protein_expression-specific_medication> <Subsumes> "Fulvestrant" .
<Protein_expression-specific_medication> <Subsumes> "Fam-trastuzumab_deruxtecan" .
<Protein_expression-specific_medication> <Subsumes> "Exemestane" .
<Protein_expression-specific_medication> <Subsumes> "Everolimus" .
<Protein_expression-specific_medication> <Subsumes> "Denileukin_diftitox" .
<Protein_expression-specific_medication> <Subsumes> "Cetuximab" .
<Protein_expression-specific_medication> <Subsumes> "Brentuximab_vedotin" .
<Protein_expression-specific_medication> <Subsumes> "Atezolizumab" .
<Protein_expression-specific_medication> <Subsumes> "Anastrozole" .
<Protein_expression-specific_medication> <Subsumes> "Ado-trastuzumab_emtansine" .
<Protein_expression-specific_medication> <Subsumes> "Abemaciclib" .
<PCE> <Has_context> "Induction_therapy" .
<PCE> <Has_context> "All_lines_of_therapy" .
<Methyran> <Brand_name_of> "Methylprednisolone" .
<Balkatrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Diuretic> <Is_a> "Supportive_medication" .
<Dexamecortin> <Brand_name_of> "Dexamethasone" .
<Pentostatin_and_Alemtuzumab> <Maps_to> "Pentostatin_and_Alemtuzumab" .
<Coagulation_factor> <Subsumes> "Prothrombin_Complex_Concentrate_human" .
<Coagulation_factor> <Subsumes> "Factor_XIII_concentrate_human" .
<Coagulation_factor> <Subsumes> "Factor_VIIa_recombinant" .
<Coagulation_factor> <Subsumes> "Factor_VIII_recombinant" .
<Coagulation_factor> <Subsumes> "Factor_VIII_human" .
<Coagulation_factor> <Subsumes> "Factor_IX_recombinant" .
<Coagulation_factor> <Subsumes> "Factor_IX_human" .
<Coagulation_factor> <Subsumes> "Antithrombin_III" .
<7_plus_3i_and_Sorafenib> <Maps_to> "7_plus_3i_and_Sorafenib" .
<Ascardia> <Brand_name_of> "Aspirin" .
<R-EPOCH> <Has_antineoplastic> "Vincristine" .
<R-EPOCH> <Has_antineoplastic> "Rituximab" .
<R-EPOCH> <Has_antineoplastic> "Prednisone" .
<R-EPOCH> <Has_antineoplastic> "Etoposide" .
<R-EPOCH> <Has_antineoplastic> "Doxorubicin" .
<R-EPOCH> <Has_antineoplastic> "Cyclophosphamide" .
<Daunorubicin_liposomal> <Has_brand_name> "DaunoXome" .
<Luspatercept> <Has_brand_name> "Reblozyl" .
<FCR_(Rituximab_Hycela)> <Has_modality> "Chemotherapy" .
<IT_Cytarabine_and_Methotrexate> <Maps_to> "IT_Cytarabine_and_Methotrexate" .
<VMCP/VCAP> <Is_a> "Anthracycline-containing_regimen" .
<Prednisone_monotherapy> <Mapped_from> "Prednisone_monotherapy" .
<Cladribine_and_Rituximab> <Has_supportive_med> "Valacyclovir" .
<Cladribine_and_Rituximab> <Has_supportive_med> "Tropisetron" .
<Cladribine_and_Rituximab> <Has_supportive_med> "Pegfilgrastim" .
<Cladribine_and_Rituximab> <Has_supportive_med> "Ondansetron" .
<Cladribine_and_Rituximab> <Has_supportive_med> "Levofloxacin" .
<Cladribine_and_Rituximab> <Has_supportive_med> "Fluconazole" .
<Cladribine_and_Rituximab> <Has_supportive_med> "Filgrastim" .
<Cladribine_and_Rituximab> <Has_supportive_med> "Antihistamines" .
<Cladribine_and_Rituximab> <Has_supportive_med> "Acetaminophen" .
<R-MPV> <Has_context> "Upfront_therapy" .
<Factor_Xa_recombinant_inactivated-zhzo> <Is_a> "Hemostasis_medication" .
<Factor_Xa_recombinant_inactivated-zhzo> <Is_a> "Hematology_medication" .
<Afatinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Afatinib_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Afatinib_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Afatinib_monotherapy> <Has_context> "All_lines_of_therapy" .
<C-VAMP> <Maps_to> "C-VAMP" .
<Uniferon> <Brand_name_of> "Iron_dextran" .
<Polycythemia_vera> <FDA_indication_of> "Ruxolitinib" .
<Fluorouracil,_Folinic_acid,_Gemcitabine> <Is_current_in> "Gallbladder_cancer" .
<Fluorouracil,_Folinic_acid,_Gemcitabine> <Is_current_in> "Esophageal_cancer" .
<Fluorouracil,_Folinic_acid,_Gemcitabine> <Is_current_in> "Cholangiocarcinoma" .
<Nonsteroidal_androgen_receptor_inhibitors> <Antineoplastic_of> "ADT,_Docetaxel,_Estramustine" .
<Nonsteroidal_androgen_receptor_inhibitors> <Antineoplastic_of> "ADT_and_Docetaxel" .
<Cetuximab_and_RT> <Has_modality> "Radiotherapy" .
<Cetuximab_and_RT> <Has_modality> "Chemotherapy" .
<Erythropoietin_monotherapy> <Maps_to> "Erythropoietin_monotherapy" .
<MAP> <Mapped_from> "MAP" .
<Doxorubicin_pegylated_liposomal_and_Bevacizumab> <Is_current_in> "Ovarian_cancer" .
<Doxorubicin_pegylated_liposomal_and_Bevacizumab> <Is_current_in> "Breast_cancer" .
<maxi-R-CHOP/R-HiDAC> <Has_supportive_med> "Filgrastim" .
<VAC_(Adriamycin)> <Has_accepted_use> "Breast_cancer" .
<Axicabtagene_ciloleucel_monotherapy> <Maps_to> "Axicabtagene_ciloleucel_monotherapy" .
<DexaBEAM> <Is_current_in> "Hodgkin_lymphoma" .
<CHOP_Modified> <Has_antineoplastic> "Vincristine" .
<CHOP_Modified> <Has_antineoplastic> "Prednisone" .
<CHOP_Modified> <Has_antineoplastic> "Doxorubicin" .
<CHOP_Modified> <Has_antineoplastic> "Cyclophosphamide" .
<Randexa> <Brand_name_of> "Dexamethasone" .
<ACOMLA> <Has_modality> "Chemotherapy" .
<Avapritinib> <Is_a> "PDGFR_inhibitor" .
<Avapritinib> <Is_a> "Mutation-specific_medication" .
<Avapritinib> <Is_a> "Kinase_inhibitor" .
<Avapritinib> <Is_a> "KIT_inhibitor" .
<Ifosfamida> <Brand_name_of> "Ifosfamide" .
<CMF> <Has_context> "Non-curative_therapy" .
<CMF> <Has_context> "Non-curative_first-line_therapy" .
<CMF> <Has_context> "Adjuvant_therapy" .
<ACT> <Has_accepted_use> "Breast_cancer" .
<Tinprin> <Brand_name_of> "Tinzaparin" .
<M-BCD> <Has_modality> "Chemotherapy" .
<O-CHOP> <Maps_to> "O-CHOP" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan> <Is_current_in> "Allogeneic_HSCT" .
<BeGEV> <Has_antineoplastic> "Vinorelbine" .
<BeGEV> <Has_antineoplastic> "Prednisolone" .
<BeGEV> <Has_antineoplastic> "Gemcitabine" .
<BeGEV> <Has_antineoplastic> "Bendamustine" .
<Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone> <Has_local_therapy> "Methotrexate" .
<Arsenic_trioxide_and_Chlorambucil> <Has_modality> "Chemotherapy" .
<R-CHOEP-14> <Has_supportive_med> "Pegfilgrastim" .
<R-CHOEP-14> <Has_supportive_med> "Filgrastim" .
<Cytarabine,_Idarubicin,_Vorinostat> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Abemaciclib_monotherapy> <Has_accepted_use> "Breast_cancer" .
<BeRT> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Erbakar> <Brand_name_of> "Carboplatin" .
<Ondan> <Brand_name_of> "Ondansetron" .
<FEC_and_Bevacizumab> <Has_accepted_use> "Breast_cancer" .
<Carboplatin_and_Cisplatin> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Nordic_FLOX> <Maps_to> "Nordic_FLOX" .
<Necitumumab> <May_have_route> "Intravenous" .
<M-DEX> <Has_antineoplastic> "Melphalan" .
<M-DEX> <Has_antineoplastic> "Dexamethasone" .
<Pixantrone_monotherapy> <Maps_to> "Pixantrone_monotherapy" .
<Virest> <Brand_name_of> "Acyclovir" .
<Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan> <Mapped_from> "Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan" .
<Tesetaxel> <May_have_route> "Oral" .
<Oxaliplatin> <May_have_route> "Intravenous" .
<PVeBV> <Is_current_in> "Testicular_cancer" .
<HiDAC> <Is_historical_in> "Acute_myeloid_leukemia" .
<Arsenic_trioxide,_then_ATRA_and_Daunorubicin> <Has_context> "Consolidation_after_upfront_therapy" .
<Ponatinib_monotherapy> <Has_antineoplastic> "Ponatinib" .
<Thioguanine_monotherapy> <Maps_to> "Thioguanine_monotherapy" .
<ddT_(Taxotere)> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Benralizumab_monotherapy> <Has_antineoplastic> "Benralizumab" .
<MVBP> <Mapped_from> "MVBP" .
<Ferric_gluconate> <Is_a> "Iron" .
<Ferric_gluconate> <Is_a> "Hematology_medication" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone> <Has_antineoplastic> "Vincristine" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone> <Has_antineoplastic> "Teniposide" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone> <Has_antineoplastic> "Prednisone" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone> <Has_antineoplastic> "Daunorubicin" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone> <Has_antineoplastic> "Cytarabine" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone> <Has_antineoplastic> "Asparaginase" .
<Arcodexan> <Brand_name_of> "Dexamethasone" .
<Platino_II_Filaxis> <Brand_name_of> "Cisplatin" .
<COPP/ABVD> <Has_modality> "Chemotherapy" .
<BRAF-mutated_Colon_cancer> <Is_a> "Colon_cancer" .
<TSC2_inhibitor> <Is_a> "Chemotherapeutic" .
<T-cell_lymphoma> <Is_a> "T-cell_neoplasm" .
<T-cell_lymphoma> <Is_a> "Lymphoma" .
<Atezolizumab_and_Bevacizumab> <Is_current_in> "Renal_cell_carcinoma" .
<Atezolizumab_and_Bevacizumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<TMF> <Has_antineoplastic> "Thiotepa" .
<TMF> <Has_antineoplastic> "Methotrexate" .
<TMF> <Has_antineoplastic> "Fluorouracil" .
<Dutenox> <Brand_name_of> "Enoxaparin" .
<KIT_inhibitor> <Is_a> "Kinase_inhibitor" .
<KIT_inhibitor> <Is_a> "Growth_factor_inhibitor" .
<Doxorubicin_and_Fluorouracil> <Has_antineoplastic> "Fluorouracil" .
<Doxorubicin_and_Fluorouracil> <Has_antineoplastic> "Doxorubicin" .
<Taxomedac> <Brand_name_of> "Paclitaxel" .
<Pralatrexate_monotherapy> <Has_antineoplastic> "Pralatrexate" .
<FLEC> <Has_modality> "Chemotherapy" .
<Xpovio> <Brand_name_of> "Selinexor" .
<CEV_(Cyclophosphamide/Epirubicin)> <Is_a> "Anthracycline-containing_regimen" .
<Cyclophosphamide,_Prednisone,_Diethylstilbestrol> <Has_antineoplastic> "Prednisone" .
<Cyclophosphamide,_Prednisone,_Diethylstilbestrol> <Has_antineoplastic> "Diethylstilbestrol" .
<Cyclophosphamide,_Prednisone,_Diethylstilbestrol> <Has_antineoplastic> "Cyclophosphamide" .
<CHOP,_then_131Iodine-Tositumomab> <Has_antineoplastic> "Vincristine" .
<CHOP,_then_131Iodine-Tositumomab> <Has_antineoplastic> "Tositumomab_and_I-131_(Bexxar)" .
<CHOP,_then_131Iodine-Tositumomab> <Has_antineoplastic> "Prednisone" .
<CHOP,_then_131Iodine-Tositumomab> <Has_antineoplastic> "Doxorubicin" .
<CHOP,_then_131Iodine-Tositumomab> <Has_antineoplastic> "Cyclophosphamide" .
<CHOEP-21> <Maps_to> "CHOEP-21" .
<Tazemetostat> <Has_brand_name> "Tazverik" .
<Capecitabine_and_Fulvestrant> <Maps_to> "Capecitabine_and_Fulvestrant" .
<Cyrdanax> <Brand_name_of> "Dexrazoxane" .
<Lenalidomide,_Dexamethasone,_Rituximab> <Mapped_from> "Lenalidomide,_Dexamethasone,_Rituximab" .
<R-DHAC> <Has_antineoplastic> "Rituximab" .
<R-DHAC> <Has_antineoplastic> "Dexamethasone" .
<R-DHAC> <Has_antineoplastic> "Cytarabine" .
<R-DHAC> <Has_antineoplastic> "Carboplatin" .
<Amifostine> <May_have_route> "Intravenous" .
<FAC_and_BCG> <Is_historical_in> "Breast_cancer" .
<Tumor_treating_fields> <Modality_of> "Temozolomide_and_NovoTTF-100A" .
<Tumor_treating_fields> <Modality_of> "NovoTTF-100A_monotherapy" .
<Tumor_treating_fields> <Modality_of> "Cisplatin,_Pemetrexed,_TTFields" .
<Nordic_Regimen,_younger_patients> <Has_antineoplastic> "Vindesine" .
<Nordic_Regimen,_younger_patients> <Has_antineoplastic> "Vincristine" .
<Nordic_Regimen,_younger_patients> <Has_antineoplastic> "Rituximab" .
<Nordic_Regimen,_younger_patients> <Has_antineoplastic> "Methotrexate" .
<Nordic_Regimen,_younger_patients> <Has_antineoplastic> "Ifosfamide" .
<Nordic_Regimen,_younger_patients> <Has_antineoplastic> "Dexamethasone" .
<Nordic_Regimen,_younger_patients> <Has_antineoplastic> "Cytarabine_liposomal" .
<Nordic_Regimen,_younger_patients> <Has_antineoplastic> "Cytarabine" .
<Nordic_Regimen,_younger_patients> <Has_antineoplastic> "Cyclophosphamide" .
<CIM> <Has_modality> "Chemotherapy" .
<Agrylin> <Brand_name_of> "Anagrelide" .
<Cisplatin_and_Gemcitabine> <Mapped_from> "Cisplatin_and_Gemcitabine" .
<Afatinib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Afatinib> <Has_accepted_use> "Head_and_neck_cancer" .
<HyperCHidam> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Venetoclax_and_Obinutuzumab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<CFAR> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<MCP_(Prednisolone)> <Is_historical_in> "Follicular_lymphoma" .
<Cisplatin_and_Topotecan> <Has_modality> "Chemotherapy" .
<Protrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<FOLFOX4> <Has_context> "Non-curative_therapy" .
<FOLFOX4> <Has_context> "Non-curative_subsequent-line_therapy" .
<FOLFOX4> <Has_context> "Non-curative_second-line_therapy" .
<FOLFOX4> <Has_context> "Non-curative_first-line_therapy" .
<FOLFOX4> <Has_context> "Consolidation_after_upfront_therapy" .
<FOLFOX4> <Has_context> "Adjuvant_therapy" .
<CVP_(Prednisolone)> <Has_context> "Induction_therapy" .
<Capecitabine_and_Temozolomide> <Has_modality> "Chemotherapy" .
<Zanubrutinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Platinwas> <Brand_name_of> "Carboplatin" .
<Fluorouracil_and_Levamisole> <Has_antineoplastic> "Levamisole" .
<Fluorouracil_and_Levamisole> <Has_antineoplastic> "Fluorouracil" .
<TT4> <Is_current_in> "Immune_thrombocytopenia" .
<Cisplatin_and_Dacarbazine> <Has_modality> "Chemotherapy" .
<Whole_brain_irradiation> <Mapped_from> "Whole_brain_irradiation" .
<Tocilizumab_monotherapy> <Maps_to> "Tocilizumab_monotherapy" .
<Docetaxel_and_Estramustine> <Mapped_from> "Docetaxel_and_Estramustine" .
<Cytarabine_and_Mitoxantrone> <Is_a> "Anthracycline-containing_regimen" .
<Induction_therapy> <Is_a> "Pre-definitive_therapy" .
<Sanprima> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bleomycin,_Methotrexate,_Vinblastine/RT> <Has_context> "Definitive_therapy" .
<iddEPC> <Maps_to> "iddEPC" .
<Nabilone> <Is_a> "Emesis_prevention" .
<Nabilone> <Is_a> "Cannabinoid" .
<TBI,_then_auto_HSCT> <Has_context> "Non-curative_therapy" .
<TBI,_then_auto_HSCT> <Has_context> "Consolidation_after_upfront_therapy" .
<Rosai-Dorfman-Destombes_disease> <Accepted_use_of> "Cobimetinib_monotherapy" .
<Rosai-Dorfman-Destombes_disease> <Accepted_use_of> "Cobimetinib" .
<Recentin> <Brand_name_of> "Cediranib" .
<Paclitaxel_and_RT> <Has_modality> "Radiotherapy" .
<Paclitaxel_and_RT> <Has_modality> "Chemotherapy" .
<Non-curative_first-line_consolidation_therapy> <Is_a> "Non-curative_first-line_therapy" .
<AVD> <Has_modality> "Chemotherapy" .
<Sirolimus_and_Vorinostat> <Has_context> "Non-curative_subsequent-line_therapy" .
<Retinoid> <Is_a> "Chemotherapeutic" .
<Abciximab> <May_have_route> "Intravenous" .
<Levamisole_monotherapy> <Has_modality> "Immunotherapy" .
<Aliqopa> <Brand_name_of> "Copanlisib" .
<Doxil> <Brand_name_of> "Pegylated_liposomal_doxorubicin" .
<Cisplatin,_Dacarbazine,_Paclitaxel> <Maps_to> "Cisplatin,_Dacarbazine,_Paclitaxel" .
<Vosaroxin> <Antineoplastic_of> "Vosaroxin_and_Cytarabine" .
<Whole_abdominal_radiation_(WAI)> <Maps_to> "Whole_abdominal_radiation_(WAI)" .
<Pralatrexate_monotherapy> <Maps_to> "Pralatrexate_monotherapy" .
<Everolimus_monotherapy> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<Everolimus_monotherapy> <Is_current_in> "Thymoma" .
<Everolimus_monotherapy> <Is_current_in> "Renal_cell_carcinoma" .
<Everolimus_monotherapy> <Is_current_in> "Pancreatic_NET" .
<Everolimus_monotherapy> <Is_current_in> "Neuroendocrine_tumor" .
<Everolimus_monotherapy> <Is_current_in> "Mantle_cell_lymphoma" .
<Everolimus_monotherapy> <Is_current_in> "Hodgkin_lymphoma" .
<Everolimus_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Best_supportive_care> <Has_accepted_use> "Small_cell_lung_cancer" .
<Best_supportive_care> <Has_accepted_use> "Pancreatic_cancer" .
<Best_supportive_care> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Best_supportive_care> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Best_supportive_care> <Has_accepted_use> "Mesothelioma" .
<Best_supportive_care> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Best_supportive_care> <Has_accepted_use> "Head_and_neck_cancer" .
<Best_supportive_care> <Has_accepted_use> "Glioblastoma" .
<Best_supportive_care> <Has_accepted_use> "Gastrointestinal_stromal_tumor" .
<Best_supportive_care> <Has_accepted_use> "Gastric_cancer" .
<Best_supportive_care> <Has_accepted_use> "Gallbladder_cancer" .
<Best_supportive_care> <Has_accepted_use> "Esophageal_cancer" .
<Best_supportive_care> <Has_accepted_use> "Colon_cancer" .
<Best_supportive_care> <Has_accepted_use> "Cholangiocarcinoma" .
<Best_supportive_care> <Has_accepted_use> "Bladder_cancer" .
<Best_supportive_care> <Has_accepted_use> "Acute_myeloid_leukemia" .
<ChlVPP> <Mapped_from> "ChlVPP" .
<Capecitabine,_Cisplatin,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Capecitabine,_Cisplatin,_RT> <Has_antineoplastic> "Cisplatin" .
<Capecitabine,_Cisplatin,_RT> <Has_antineoplastic> "Capecitabine" .
<Ostasyn> <Brand_name_of> "Ondansetron" .
<IT_Methotrexate_and_WBRT> <Has_modality> "Radiotherapy" .
<IT_Methotrexate_and_WBRT> <Has_modality> "Chemotherapy" .
<Hedgehog_pathway_inhibitor> <Subsumes> "Vismodegib" .
<Hedgehog_pathway_inhibitor> <Subsumes> "Sonidegib" .
<Hedgehog_pathway_inhibitor> <Subsumes> "SMO_inhibitor" .
<Hedgehog_pathway_inhibitor> <Subsumes> "Glasdegib" .
<TCH_(Taxotere,_Cyclophosphamide)> <Has_supportive_med> "Pegfilgrastim" .
<TCH_(Taxotere,_Cyclophosphamide)> <Has_supportive_med> "Filgrastim" .
<ABVE-PC> <Is_a> "Anthracycline-containing_regimen" .
<Duvelisib> <May_have_route> "Oral" .
<EAR_and_G-CSF> <Has_accepted_use> "Stem_cell_mobilization" .
<Santeson> <Brand_name_of> "Dexamethasone" .
<Octreotide_LAR> <Has_brand_name> "Sandostatine_LAR" .
<Octreotide_LAR> <Has_brand_name> "Sandostatina_LAR" .
<Octreotide_LAR> <Has_brand_name> "Sandostatin_LAR_Depot" .
<Octreotide_LAR> <Has_brand_name> "Sandostatin_LAR" .
<Octreotide_LAR> <Has_brand_name> "Longastatina_LAR" .
<Axicabtagene_ciloleucel_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Axicabtagene_ciloleucel_monotherapy> <Has_context> "All_lines_of_therapy" .
<Dertrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cytarabine,_Idarubicin,_Rituximab> <Is_a> "Rituximab-containing_regimen" .
<Cytarabine,_Idarubicin,_Rituximab> <Is_a> "Anthracycline-containing_regimen" .
<Biovorin> <Brand_name_of> "Folinic_acid" .
<Antihistamine> <Subsumes> "Hydroxyzine" .
<Antihistamine> <Subsumes> "H2-receptor_antagonist" .
<Antihistamine> <Subsumes> "Diphenhydramine" .
<Antihistamine> <Subsumes> "Dexchlorpheniramine" .
<Antihistamine> <Subsumes> "Clemastine" .
<Antihistamine> <Subsumes> "Chlorpheniramine" .
<Antihistamine> <Subsumes> "Cetirizine" .
<R-GemOx> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Palbociclib> <May_have_route> "Oral" .
<Cancer_of_unknown_primary_medication> <Subsumes> "Carboplatin" .
<Flutamid> <Brand_name_of> "Flutamide" .
<Hexalen> <Brand_name_of> "Altretamine" .
<Fludabine> <Brand_name_of> "Fludarabine" .
<Tamoxifen_monotherapy> <Is_historical_in> "Ovarian_cancer" .
<Tamoxifen_monotherapy> <Is_historical_in> "Hepatocellular_carcinoma" .
<Imufor> <Brand_name_of> "Interferon_alfa-2b" .
<Pertuzumab> <Has_FDA_indication> "Breast_cancer" .
<Hedgehog_pathway-mutated_malignancy> <Current_treated_by> "Vismodegib_monotherapy" .
<Aspirinetas> <Brand_name_of> "Aspirin" .
<Fluorouracil_and_Semustine> <Has_context> "Non-curative_first-line_therapy" .
<Mini-BEAM> <Has_modality> "Chemotherapy" .
<ddTH_(Taxotere)> <Has_context> "Adjuvant_therapy" .
<VcR-CVAD> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone> <Is_current_in> "T-cell_acute_lymphoblastic_leukemia" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Hodgkin_lymphoma> <Is_a> "Aggressive_lymphoma" .
<R-MCP_(CCNU)> <Has_context> "Upfront_therapy" .
<Interferon_alfa-2b_and_DLI> <Is_current_in> "Chronic_myelogenous_leukemia" .
<Lanreotide_Depot/Autogel_monotherapy> <Has_accepted_use> "Pancreatic_NET" .
<Tamoxifen> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Tamoxifen> <Is_a> "Selective_estrogen_receptor_modulator" .
<Tamoxifen> <Is_a> "Protein_expression-specific_medication" .
<Docetaxel_monotherapy> <Mapped_from> "Docetaxel_monotherapy" .
<Rhabdomyosarcoma> <Accepted_use_of> "Vincristine" .
<Rhabdomyosarcoma> <Accepted_use_of> "VIE" .
<Rhabdomyosarcoma> <Accepted_use_of> "VI,_then_VDC/IE,_then_VAC,_then_VI" .
<Rhabdomyosarcoma> <Accepted_use_of> "VAI" .
<Rhabdomyosarcoma> <Accepted_use_of> "VAC" .
<Rhabdomyosarcoma> <Accepted_use_of> "VA" .
<Rhabdomyosarcoma> <Accepted_use_of> "Irinotecan" .
<Rhabdomyosarcoma> <Accepted_use_of> "Ifosfamide" .
<Rhabdomyosarcoma> <Accepted_use_of> "Etoposide" .
<Rhabdomyosarcoma> <Accepted_use_of> "Doxorubicin" .
<Rhabdomyosarcoma> <Accepted_use_of> "Dactinomycin_monotherapy" .
<Rhabdomyosarcoma> <Accepted_use_of> "Dactinomycin" .
<Rhabdomyosarcoma> <Accepted_use_of> "Cyclophosphamide" .
<VAI> <Has_supportive_med> "Mesna" .
<131Iodine-Tositumomab_monotherapy> <Is_current_in> "Transformed_lymphoma" .
<Hydroxyurea> <May_have_route> "Oral" .
<VeIP> <Mapped_from> "VeIP" .
<iddEPC> <Has_accepted_use> "Breast_cancer" .
<Helicobacter_pylori_eradication_therapy> <Has_context> "Non-curative_first-line_therapy" .
<Helicobacter_pylori_eradication_therapy> <Has_context> "Induction_therapy" .
<Ribofluor> <Brand_name_of> "Fluorouracil" .
<KTD> <Has_modality> "Chemotherapy" .
<ddE> <Is_current_in> "Breast_cancer" .
<Gemcitabine/Fluorouracil_and_RT> <Has_accepted_use> "Pancreatic_cancer" .
<Gemcitabine/Fluorouracil_and_RT> <Has_accepted_use> "Cholangiocarcinoma" .
<Intravenous_Immunoglobulin> <Is_current_in> "Heparin-induced_thrombocytopenia" .
<Biorrub> <Brand_name_of> "Doxorubicin" .
<Deronil> <Brand_name_of> "Dexamethasone" .
<Melphalan_monotherapy> <Is_historical_in> "Ovarian_cancer" .
<Melphalan_monotherapy> <Is_historical_in> "Multiple_myeloma" .
<Melphalan_monotherapy> <Is_historical_in> "Breast_cancer" .
<Actino_Hermal> <Brand_name_of> "Fluorouracil" .
<BuFlu,_then_allo_HSCT> <Maps_to> "BuFlu,_then_allo_HSCT" .
<5_alpha-reductase_inhibitor> <Subsumes> "Finasteride" .
<5_alpha-reductase_inhibitor> <Subsumes> "Dutasteride" .
<FEAM> <Has_antineoplastic> "Melphalan" .
<FEAM> <Has_antineoplastic> "Fotemustine" .
<FEAM> <Has_antineoplastic> "Etoposide" .
<FEAM> <Has_antineoplastic> "Cytarabine" .
<Bu/TT/Cy,_then_auto_HSCT> <Mapped_from> "Bu/TT/Cy,_then_auto_HSCT" .
<GnRH_agonists> <Antineoplastic_of> "Trastuzumab_and_ET" .
<GnRH_agonists> <Antineoplastic_of> "T-DM1_and_ET" .
<GnRH_agonists> <Antineoplastic_of> "Intermittent_ADT" .
<GnRH_agonists> <Antineoplastic_of> "ADT,_Docetaxel,_Estramustine" .
<GnRH_agonists> <Antineoplastic_of> "ADT_and_RT" .
<GnRH_agonists> <Antineoplastic_of> "ADT_and_Enzalutamide" .
<GnRH_agonists> <Antineoplastic_of> "ADT_and_Docetaxel" .
<GnRH_agonists> <Antineoplastic_of> "ADT_and_Darolutamide" .
<GnRH_agonists> <Antineoplastic_of> "ADT_and_Apalutamide" .
<GnRH_agonists> <Antineoplastic_of> "ADT_and_Abiraterone" .
<GnRH_agonists> <Antineoplastic_of> "ADT" .
<Rhabdomyosarcoma> <Is_a> "Soft_tissue_sarcoma" .
<Rhabdomyosarcoma> <Is_a> "Pediatric_cancer" .
<CC/DE_and_RT> <Is_historical_in> "Small_cell_lung_cancer" .
<Tinzaparin> <Has_accepted_use> "Venous_thromboembolism" .
<Carboplatin_and_Doxorubicin_liposomal> <Has_context> "Non-curative_therapy" .
<Carboplatin_and_Doxorubicin_liposomal> <Has_context> "Non-curative_second-line_therapy" .
<Carboplatin_and_Doxorubicin_liposomal> <Has_context> "Non-curative_first-line_therapy" .
<CTCb,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Cetirizine> <Has_brand_name> "Zyrtec" .
<Cetirizine> <Has_brand_name> "Razene" .
<Cetirizine> <Has_brand_name> "Piriteze" .
<Cetirizine> <Has_brand_name> "Glocet" .
<Cetirizine> <Has_brand_name> "Cetzine" .
<Cetirizine> <Has_brand_name> "Cetrine" .
<Arond> <Brand_name_of> "Alendronate" .
<Alendor> <Brand_name_of> "Alendronate" .
<Entrectinib> <Has_brand_name> "Rozlytrek" .
<ATRA_and_Idarubicin> <Has_modality> "Chemotherapy" .
<CVPP> <Is_historical_in> "Hodgkin_lymphoma" .
<FR> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<FR> <Has_supportive_med> "Diphenhydramine" .
<FR> <Has_supportive_med> "Allopurinol" .
<FR> <Has_supportive_med> "Acetaminophen" .
<Filanesib> <Is_a> "KSP_inhibitor" .
<Filanesib> <Is_a> "Investigational_drug" .
<Factor_IX_human> <May_have_route> "Intravenous" .
<Introcin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Doxorubicin_and_Gemcitabine> <Mapped_from> "Doxorubicin_and_Gemcitabine" .
<Tisagenlecleucel_monotherapy> <Has_context> "Non-curative_therapy" .
<Tisagenlecleucel_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Tisagenlecleucel_monotherapy> <Has_context> "All_lines_of_therapy" .
<Quisinostat> <Is_a> "Investigational_drug" .
<Quisinostat> <Is_a> "HDAC_inhibitor" .
<Tocilizumab_monotherapy> <Has_immunosuppressor> "Tocilizumab" .
<Icotinib_monotherapy> <Has_modality> "Chemotherapy" .
<Afatinib_and_Bevacizumab> <Has_context> "Non-curative_therapy" .
<Thioguanine> <May_have_route> "Oral" .
<Eribulin_monotherapy> <Maps_to> "Eribulin_monotherapy" .
<Mismatch_repair_deficient_malignancy> <Current_treated_by> "Pembrolizumab_monotherapy" .
<Sirolimus_and_Prednisone> <Has_modality> "Immunosuppressive_therapy" .
<VAD_doxil> <Mapped_from> "VAD_doxil" .
<Laroferon> <Brand_name_of> "Interferon_alfa-2b" .
<Fluorouracil,_Paclitaxel,_RT> <Has_antineoplastic> "Paclitaxel" .
<Fluorouracil,_Paclitaxel,_RT> <Has_antineoplastic> "Fluorouracil" .
<Fluorouracil,_Paclitaxel,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<TH_(Taxotere/SC)> <Is_current_in> "Breast_cancer" .
<Ixabepilone> <Has_brand_name> "Ixempra" .
<Fedratinib> <Antineoplastic_of> "Fedratinib_monotherapy" .
<A-AVD> <Has_antineoplastic> "Vinblastine" .
<A-AVD> <Has_antineoplastic> "Doxorubicin" .
<A-AVD> <Has_antineoplastic> "Dacarbazine" .
<A-AVD> <Has_antineoplastic> "Brentuximab_vedotin" .
<Elzonris> <Brand_name_of> "Tagraxofusp" .
<R-DHAOx> <Mapped_from> "R-DHAOx" .
<Icotinib_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Icotinib_monotherapy> <Is_current_in> "CNS_carcinoma" .
<EAR_and_G-CSF> <Mapped_from> "EAR_and_G-CSF" .
<ddFEC> <Maps_to> "ddFEC" .
<Enzalutamide> <Has_brand_name> "Xtandi" .
<Lepirudin_monotherapy> <Has_modality> "Anticoagulation" .
<TFC,_then_allo_HSCT> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<RT,_then_Carmustine> <Has_modality> "Radiotherapy" .
<RT,_then_Carmustine> <Has_modality> "Chemotherapy" .
<Temozolomide> <Has_accepted_use> "Uveal_melanoma" .
<Temozolomide> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Temozolomide> <Has_accepted_use> "Small_cell_lung_cancer" .
<Temozolomide> <Has_accepted_use> "Pancreatic_NET" .
<Temozolomide> <Has_accepted_use> "Neuroendocrine_tumor" .
<Temozolomide> <Has_accepted_use> "Neuroblastoma" .
<Temozolomide> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Temozolomide> <Has_accepted_use> "Melanoma" .
<Temozolomide> <Has_accepted_use> "Low-grade_glioma" .
<Temozolomide> <Has_accepted_use> "Glioblastoma" .
<Temozolomide> <Has_accepted_use> "Ewing_sarcoma" .
<Temozolomide> <Has_accepted_use> "CNS_lymphoma" .
<Temozolomide> <Has_accepted_use> "Anaplastic_glioma" .
<Temozolomide> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Clarithromycin> <Has_accepted_use> "Multiple_myeloma" .
<Clarithromycin> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Finoxi> <Brand_name_of> "Ondansetron" .
<THL_(Taxol)> <Has_modality> "Chemotherapy" .
<Carboplatin_and_Paclitaxel> <Has_supportive_med> "Steroids" .
<Carboplatin_and_Paclitaxel> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Carboplatin_and_Paclitaxel> <Has_supportive_med> "Ranitidine" .
<Carboplatin_and_Paclitaxel> <Has_supportive_med> "Ondansetron" .
<Carboplatin_and_Paclitaxel> <Has_supportive_med> "Methylprednisolone" .
<Carboplatin_and_Paclitaxel> <Has_supportive_med> "Granisetron" .
<Carboplatin_and_Paclitaxel> <Has_supportive_med> "Filgrastim" .
<Carboplatin_and_Paclitaxel> <Has_supportive_med> "Diphenhydramine" .
<Carboplatin_and_Paclitaxel> <Has_supportive_med> "Dexamethasone" .
<Carboplatin_and_Paclitaxel> <Has_supportive_med> "Cimetidine" .
<Carboplatin_and_Paclitaxel> <Has_supportive_med> "Chlorpheniramine" .
<Atezolizumab_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<R-BEAM> <Has_accepted_use> "Autologous_HSCT" .
<Mitomycin> <Has_accepted_use> "Mesothelioma" .
<Mitomycin> <Has_accepted_use> "Head_and_neck_cancer" .
<Mitomycin> <Has_accepted_use> "Gastric_cancer" .
<Mitomycin> <Has_accepted_use> "Esophageal_cancer" .
<Mitomycin> <Has_accepted_use> "Cholangiocarcinoma" .
<Mitomycin> <Has_accepted_use> "Cervical_cancer" .
<Mitomycin> <Has_accepted_use> "Bladder_cancer" .
<Mitomycin> <Has_accepted_use> "Anal_cancer" .
<Radiotherapy> <Maps_to> "Radiotherapy" .
<Busulfan_and_Cyclophosphamide> <Has_antineoplastic> "Cyclophosphamide" .
<Busulfan_and_Cyclophosphamide> <Has_antineoplastic> "Busulfan" .
<TPC> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<TPC> <Has_accepted_use> "Breast_cancer" .
<Erlotinib> <Has_FDA_indication> "Pancreatic_cancer" .
<Erlotinib> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Epratuzumab> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Samarium-153_with_stem_cell_support> <Has_accepted_use> "Osteosarcoma" .
<TVAD_doxil> <Has_modality> "Chemotherapy" .
<ATRA,_Cytarabine,_Idarubicin> <Is_current_in> "Acute_promyelocytic_leukemia" .
<GVD> <Maps_to> "GVD" .
<Vorinostat> <May_have_route> "Oral" .
<Clofarabine_and_Melphalan,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<Clofarabine_and_Melphalan,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<Mitoxantrone_monotherapy> <Has_antineoplastic> "Mitoxantrone" .
<FOLFIRI_(L-Leucovorin)> <Maps_to> "FOLFIRI_(L-Leucovorin)" .
<Anastrazol_Rontag> <Brand_name_of> "Anastrozole" .
<COP> <Is_current_in> "HIV-associated_lymphoma" .
<COP> <Is_current_in> "Burkitt_lymphoma" .
<Rivaroxaban_monotherapy> <Maps_to> "Rivaroxaban_monotherapy" .
<CISCA/VB> <Is_a> "Anthracycline-containing_regimen" .
<Afatinib> <May_have_route> "Oral" .
<Neupogen> <Brand_name_of> "Filgrastim" .
<Rescuvolin> <Brand_name_of> "Folinic_acid" .
<Liposarcoma> <Accepted_use_of> "Trabectedin_monotherapy" .
<Liposarcoma> <Accepted_use_of> "Trabectedin" .
<Liposarcoma> <Accepted_use_of> "Eribulin_monotherapy" .
<Liposarcoma> <Accepted_use_of> "Eribulin" .
<Liposarcoma> <Accepted_use_of> "Dacarbazine_monotherapy" .
<Liposarcoma> <Accepted_use_of> "Dacarbazine" .
<Farmorubicin> <Brand_name_of> "Epirubicin" .
<Cisplatin,_Doxorubicin,_Paclitaxel> <Maps_to> "Cisplatin,_Doxorubicin,_Paclitaxel" .
<Dacarbazine_and_Ipilimumab> <Is_current_in> "Melanoma" .
<Aromatase_inhibitor> <Is_a> "Endocrine_therapeutic" .
<Nascobal> <Brand_name_of> "Cyanocobalamin" .
<Tisagenlecleucel> <Has_brand_name> "Kymriah" .
<Methotrexate,_Tacrolimus,_Tocilizumab> <Has_modality> "Immunosuppressive_therapy" .
<COPADM> <Has_local_therapy> "Methotrexate" .
<COPADM> <Has_local_therapy> "Hydrocortisone" .
<COPADM> <Has_local_therapy> "Cytarabine" .
<Samarium-153_with_stem_cell_support> <Has_modality> "Radiotherapy" .
<Vomigo> <Brand_name_of> "Ondansetron" .
<EVI> <Has_context> "Induction_therapy" .
<Fedratinib_monotherapy> <Has_antineoplastic> "Fedratinib" .
<Capecitabine_and_Erlotinib> <Maps_to> "Capecitabine_and_Erlotinib" .
<Aspirinetta> <Brand_name_of> "Aspirin" .
<Vulvar_cancer> <Current_treated_by> "Paclitaxel_monotherapy" .
<Vulvar_cancer> <Current_treated_by> "Cisplatin_and_RT" .
<mFOLFIRINOX> <Is_a> "Irinotecan-containing_regimen" .
<Vinblastine_and_Prednisone> <Mapped_from> "Vinblastine_and_Prednisone" .
<ChlVPP> <Has_modality> "Chemotherapy" .
<Capecitabine_and_Paclitaxel,_nanoparticle_albumin-bound> <Has_accepted_use> "Breast_cancer" .
<VIP> <Has_context> "Upfront_therapy" .
<VIP> <Has_context> "Salvage_therapy" .
<VIP> <Has_context> "Non-curative_first-line_therapy" .
<VIP> <Has_context> "Induction_therapy" .
<131Iodine-Tositumomab_monotherapy> <Maps_to> "131Iodine-Tositumomab_monotherapy" .
<MVP_(Vindesine)> <Has_modality> "Chemotherapy" .
<Brentuximab_vedotin_and_Nivolumab> <Has_antineoplastic> "Nivolumab" .
<Brentuximab_vedotin_and_Nivolumab> <Has_antineoplastic> "Brentuximab_vedotin" .
<Fludarabine,_Busulfan,_ATG> <Has_accepted_use> "Allogeneic_HSCT" .
<R-MegaCHOP-14> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Alectinib> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<AIE> <Has_modality> "Chemotherapy" .
<Docetaxel_and_Prednisolone> <Has_context> "Non-curative_therapy" .
<THP_(Taxol)> <Maps_to> "THP_(Taxol)" .
<Dolasetron> <May_have_route> "Oral" .
<Dolasetron> <May_have_route> "Intravenous" .
<IAP> <Has_antineoplastic> "Pravastatin" .
<IAP> <Has_antineoplastic> "Idarubicin" .
<IAP> <Has_antineoplastic> "Cytarabine" .
<Vinblasin> <Brand_name_of> "Vinblastine" .
<Docusate> <Is_a> "WHO_Essential_Pain_and_Palliative_Care_Medicine" .
<Docusate> <Is_a> "OTC_medication" .
<Docusate> <Is_a> "Laxative" .
<Satigene> <Brand_name_of> "Irinotecan" .
<ECT,_then_auto_HSCT> <Is_a> "Anthracycline-containing_regimen" .
<Mantle_cell_lymphoma> <FDA_indication_of> "Zanubrutinib" .
<Mantle_cell_lymphoma> <FDA_indication_of> "Lenalidomide" .
<Mantle_cell_lymphoma> <FDA_indication_of> "Ibrutinib" .
<Mantle_cell_lymphoma> <FDA_indication_of> "Bortezomib" .
<Mantle_cell_lymphoma> <FDA_indication_of> "Acalabrutinib" .
<CTCb,_then_auto_HSCT> <Mapped_from> "CTCb,_then_auto_HSCT" .
<Docetaxel_and_Ramucirumab> <Has_modality> "Chemotherapy" .
<CAP-BOP> <Has_context> "Induction_therapy" .
<Crizotinib_monotherapy> <Has_accepted_use> "ROS1-positive_Non-small_cell_lung_cancer" .
<Crizotinib_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Crizotinib_monotherapy> <Has_accepted_use> "ALK-positive_Non-small_cell_lung_cancer" .
<Dabrafenib_monotherapy> <Has_accepted_use> "Melanoma" .
<Dabrafenib_monotherapy> <Has_accepted_use> "CNS_melanoma" .
<Dabrafenib_monotherapy> <Has_accepted_use> "BRAF-mutated_Melanoma" .
<FOLFIRI_and_Ziv-aflibercept> <Has_antineoplastic> "Ziv-aflibercept" .
<FOLFIRI_and_Ziv-aflibercept> <Has_antineoplastic> "Irinotecan" .
<FOLFIRI_and_Ziv-aflibercept> <Has_antineoplastic> "Folinic_acid" .
<FOLFIRI_and_Ziv-aflibercept> <Has_antineoplastic> "Fluorouracil" .
<Erythropoetin_and_Lenalidomide> <Maps_to> "Erythropoetin_and_Lenalidomide" .
<R-CHOP-14_(Rituximab_Hycela)> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Melone> <Brand_name_of> "Methylprednisolone" .
<Moxetumomab_pasudotox> <Is_a> "Immunotoxin" .
<Moxetumomab_pasudotox> <Is_a> "Antibody_medication" .
<Moxetumomab_pasudotox> <Is_a> "Anti-CD22_antibody" .
<Hyper-CVAD_and_Ponatinib> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Azom> <Brand_name_of> "Alprazolam" .
<Haloperidol> <May_have_route> "Oral" .
<Haloperidol> <May_have_route> "Intravenous" .
<CNOP> <Has_modality> "Chemotherapy" .
<Z-BEAM,_then_auto_HSCT> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<FND> <Maps_to> "FND" .
<Mogamulizumab_monotherapy> <Mapped_from> "Mogamulizumab_monotherapy" .
<ACH> <Mapped_from> "ACH" .
<Trastuzumab_and_ET> <Has_modality> "Chemotherapy" .
<ADT_and_RT> <Is_current_in> "Prostate_cancer" .
<Intermittent_ADT> <Mapped_from> "Intermittent_ADT" .
<HOP> <Is_a> "Anthracycline-containing_regimen" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib> <Is_a> "Anthracycline-containing_regimen" .
<BVD> <Has_modality> "Chemotherapy" .
<Ancasal> <Brand_name_of> "Aspirin" .
<Fotemustine> <Antineoplastic_of> "Fotemustine_monotherapy" .
<Fotemustine> <Antineoplastic_of> "FEAM,_then_auto_HSCT" .
<Fotemustine> <Antineoplastic_of> "FEAM" .
<Cyclophosphamide_monotherapy> <Mapped_from> "Cyclophosphamide_monotherapy" .
<Lomustine,_Methotrexate,_Procarbazine> <Has_accepted_use> "CNS_lymphoma" .
<Capecitabine_and_Bevacizumab> <Has_antineoplastic> "Capecitabine" .
<Capecitabine_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Afatinib_monotherapy> <Maps_to> "Afatinib_monotherapy" .
<Novidrine> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<FOLFIRI_(L-Leucovorin)> <Has_modality> "Chemotherapy" .
<Finnferon-Alpha> <Brand_name_of> "Interferon_alfa-2b" .
<Penicillin> <Subsumes> "Penicillin_V" .
<Penicillin> <Subsumes> "Amoxicillin" .
<Methotrexate,_then_Cytarabine> <Mapped_from> "Methotrexate,_then_Cytarabine" .
<Antifungal> <Is_a> "Antibiotic" .
<Sutaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Semustina> <Brand_name_of> "Semustine" .
<Sutent> <Brand_name_of> "Sunitinib" .
<Cisplatin_and_Irinotecan> <Mapped_from> "Cisplatin_and_Irinotecan" .
<Alrubicin> <Brand_name_of> "Epirubicin" .
<Glasdegib> <Is_a> "Hedgehog_pathway_inhibitor" .
<Myelodysplastic_syndrome> <FDA_indication_of> "Lenalidomide" .
<Myelodysplastic_syndrome> <FDA_indication_of> "Imatinib" .
<Myelodysplastic_syndrome> <FDA_indication_of> "Decitabine" .
<Myelodysplastic_syndrome> <FDA_indication_of> "Azacitidine" .
<HAD> <Has_context> "Induction_therapy" .
<Toldex> <Brand_name_of> "Aspirin" .
<Gramatic> <Brand_name_of> "Granisetron" .
<R-CDOP> <Has_antineoplastic> "Vincristine" .
<R-CDOP> <Has_antineoplastic> "Rituximab" .
<R-CDOP> <Has_antineoplastic> "Prednisone" .
<R-CDOP> <Has_antineoplastic> "Pegylated_liposomal_doxorubicin" .
<R-CDOP> <Has_antineoplastic> "Cyclophosphamide" .
<PCD> <Has_antineoplastic> "Pomalidomide" .
<PCD> <Has_antineoplastic> "Dexamethasone" .
<PCD> <Has_antineoplastic> "Cyclophosphamide" .
<Irinotecan_and_Mitomycin> <Has_modality> "Chemotherapy" .
<Pirarubicin> <Is_a> "Anthracycline" .
<Xospata> <Brand_name_of> "Gilteritinib" .
<SOX> <Has_modality> "Chemotherapy" .
<Artria-SR> <Brand_name_of> "Aspirin" .
<ABDIC> <Has_accepted_use> "Hodgkin_lymphoma" .
<Talazoparib_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Talazoparib_monotherapy> <Has_accepted_use> "BRCA-mutated_Breast_cancer" .
<FEC_and_H> <Is_current_in> "Breast_cancer" .
<Alphanine_SD> <Brand_name_of> "Factor_IX_human" .
<Anastrozole_and_Ribociclib> <Is_current_in> "Breast_cancer" .
<FOLFOX4_(L-Leucovorin)> <Has_modality> "Chemotherapy" .
<Fluoxan> <Brand_name_of> "Fluorouracil" .
<Carboplatin_and_Vincristine> <Has_context> "Adjuvant_therapy" .
<Antifolan> <Brand_name_of> "Methotrexate" .
<Topotecan_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Carboplatin_and_Paclitaxel> <Maps_to> "Carboplatin_and_Paclitaxel" .
<Irinotecan_monotherapy> <Is_a> "Irinotecan-containing_regimen" .
<Argatroban> <Has_accepted_use> "Venous_thromboembolism" .
<Argatroban> <Has_accepted_use> "Heparin-induced_thrombocytopenia" .
<Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone> <Mapped_from> "Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone" .
<CEEP> <Is_a> "Anthracycline-containing_regimen" .
<Methylprednisolone> <Has_brand_name> "Yumerole" .
<Methylprednisolone> <Has_brand_name> "Vanderm" .
<Methylprednisolone> <Has_brand_name> "Urbason" .
<Methylprednisolone> <Has_brand_name> "Unimedrol" .
<Methylprednisolone> <Has_brand_name> "Tropidrol" .
<Methylprednisolone> <Has_brand_name> "Thimelon" .
<Methylprednisolone> <Has_brand_name> "Supresol" .
<Methylprednisolone> <Has_brand_name> "Succimed" .
<Methylprednisolone> <Has_brand_name> "Stenirol" .
<Methylprednisolone> <Has_brand_name> "Somerol" .
<Methylprednisolone> <Has_brand_name> "Somelon" .
<Methylprednisolone> <Has_brand_name> "Solumedrol" .
<Methylprednisolone> <Has_brand_name> "Solu_Moderin" .
<Methylprednisolone> <Has_brand_name> "Solomet" .
<Methylprednisolone> <Has_brand_name> "Solocort-ACT" .
<Methylprednisolone> <Has_brand_name> "Sanexon" .
<Methylprednisolone> <Has_brand_name> "Salon_H9C" .
<Methylprednisolone> <Has_brand_name> "SOL-Melcort" .
<Methylprednisolone> <Has_brand_name> "Rumaxoi" .
<Methylprednisolone> <Has_brand_name> "Radilem" .
<Methylprednisolone> <Has_brand_name> "Promedrol" .
<Methylprednisolone> <Has_brand_name> "Pridol" .
<Methylprednisolone> <Has_brand_name> "Pretilon" .
<Methylprednisolone> <Has_brand_name> "Prednox" .
<Methylprednisolone> <Has_brand_name> "Prednovare" .
<Methylprednisolone> <Has_brand_name> "Prednol_L" .
<Methylprednisolone> <Has_brand_name> "Prednol" .
<Methylprednisolone> <Has_brand_name> "Prednilem" .
<Methylprednisolone> <Has_brand_name> "Predni-M-Tablinen" .
<Methylprednisolone> <Has_brand_name> "Predni_M" .
<Methylprednisolone> <Has_brand_name> "Predmetil" .
<Methylprednisolone> <Has_brand_name> "Predisol" .
<Methylprednisolone> <Has_brand_name> "Phadilon" .
<Methylprednisolone> <Has_brand_name> "Nirypan" .
<Methylprednisolone> <Has_brand_name> "NEO-Drol" .
<Methylprednisolone> <Has_brand_name> "Metysolon" .
<Methylprednisolone> <Has_brand_name> "Metypresol" .
<Methylprednisolone> <Has_brand_name> "Metypred" .
<Methylprednisolone> <Has_brand_name> "Metycortin" .
<Methylprednisolone> <Has_brand_name> "Metisone" .
<Methylprednisolone> <Has_brand_name> "Metipred" .
<Methylprednisolone> <Has_brand_name> "Metilprednizolon-H" .
<Methylprednisolone> <Has_brand_name> "Metilprednisolona" .
<Methylprednisolone> <Has_brand_name> "Metilbetasone" .
<Methylprednisolone> <Has_brand_name> "Metidrol" .
<Methylprednisolone> <Has_brand_name> "Meticort" .
<Methylprednisolone> <Has_brand_name> "Methyran" .
<Methylprednisolone> <Has_brand_name> "Methylprednisolonum" .
<Methylprednisolone> <Has_brand_name> "Methylprednisolon" .
<Methylprednisolone> <Has_brand_name> "Methylprednis" .
<Methylprednisolone> <Has_brand_name> "Methylone" .
<Methylprednisolone> <Has_brand_name> "Methylon" .
<Methylprednisolone> <Has_brand_name> "Methybon" .
<Methylprednisolone> <Has_brand_name> "Methisol" .
<Methylprednisolone> <Has_brand_name> "Methapred" .
<Methylprednisolone> <Has_brand_name> "Mesurin" .
<Methylprednisolone> <Has_brand_name> "Mesolone" .
<Methylprednisolone> <Has_brand_name> "Mepson" .
<Methylprednisolone> <Has_brand_name> "Mepsolone" .
<Methylprednisolone> <Has_brand_name> "Meproson" .
<Methylprednisolone> <Has_brand_name> "Meprolone_Unipak" .
<Methylprednisolone> <Has_brand_name> "Mepredron" .
<Methylprednisolone> <Has_brand_name> "Menisone" .
<Methylprednisolone> <Has_brand_name> "Menisolon" .
<Methylprednisolone> <Has_brand_name> "Melone" .
<Methylprednisolone> <Has_brand_name> "Melon" .
<Methylprednisolone> <Has_brand_name> "Medrone" .
<Methylprednisolone> <Has_brand_name> "Medrol" .
<Methylprednisolone> <Has_brand_name> "Medrate" .
<Methylprednisolone> <Has_brand_name> "Medralone" .
<Methylprednisolone> <Has_brand_name> "Mednin" .
<Methylprednisolone> <Has_brand_name> "Medlone" .
<Methylprednisolone> <Has_brand_name> "Medlin" .
<Methylprednisolone> <Has_brand_name> "Medixon" .
<Methylprednisolone> <Has_brand_name> "Medisolu" .
<Methylprednisolone> <Has_brand_name> "Medirona" .
<Methylprednisolone> <Has_brand_name> "Medason" .
<Methylprednisolone> <Has_brand_name> "M-Prednihexal" .
<Methylprednisolone> <Has_brand_name> "Lexxema" .
<Methylprednisolone> <Has_brand_name> "Lexcomet" .
<Methylprednisolone> <Has_brand_name> "Lesol" .
<Methylprednisolone> <Has_brand_name> "Lemod" .
<Methylprednisolone> <Has_brand_name> "Lameson" .
<Methylprednisolone> <Has_brand_name> "Ivepred" .
<Methylprednisolone> <Has_brand_name> "Intidrol" .
<Methylprednisolone> <Has_brand_name> "Indrol" .
<Methylprednisolone> <Has_brand_name> "Hexilon" .
<Methylprednisolone> <Has_brand_name> "Excelin" .
<Methylprednisolone> <Has_brand_name> "Epizolone" .
<Methylprednisolone> <Has_brand_name> "Duralone" .
<Methylprednisolone> <Has_brand_name> "Dispred" .
<Methylprednisolone> <Has_brand_name> "Deposet" .
<Methylprednisolone> <Has_brand_name> "Depomedrone" .
<Methylprednisolone> <Has_brand_name> "Depoject" .
<Methylprednisolone> <Has_brand_name> "Depo-Medrol" .
<Methylprednisolone> <Has_brand_name> "Depo-Medrate" .
<Methylprednisolone> <Has_brand_name> "Depo_Moderin" .
<Methylprednisolone> <Has_brand_name> "Depo_Melcort" .
<Methylprednisolone> <Has_brand_name> "Depmedalone" .
<Methylprednisolone> <Has_brand_name> "Decacort" .
<Methylprednisolone> <Has_brand_name> "Cortisolona" .
<Methylprednisolone> <Has_brand_name> "Cortesa" .
<Methylprednisolone> <Has_brand_name> "Belon" .
<Methylprednisolone> <Has_brand_name> "Avancort" .
<Methylprednisolone> <Has_brand_name> "Asmacortone" .
<Methylprednisolone> <Has_brand_name> "Amethapred" .
<Methylprednisolone> <Has_brand_name> "Alergolon" .
<Methylprednisolone> <Has_brand_name> "Adventan" .
<Methylprednisolone> <Has_brand_name> "Advantan" .
<Methylprednisolone> <Has_brand_name> "Adlone" .
<Irinotecan_and_Temozolomide> <Maps_to> "Irinotecan_and_Temozolomide" .
<Corodex> <Brand_name_of> "Dexamethasone" .
<Selinexor_and_Dexamethasone> <Has_context> "Non-curative_therapy" .
<KRAS-mutated_Non-small_cell_lung_cancer> <Is_a> "Non-small_cell_lung_cancer" .
<Epirubicin_and_Vinorelbine> <Is_a> "Anthracycline-containing_regimen" .
<Chidamide_monotherapy> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Hydroxyurea_and_Imatinib> <Has_context> "Non-curative_therapy" .
<TMF> <Has_accepted_use> "Breast_cancer" .
<ADT> <Maps_to> "ADT" .
<HLH-2004_regimen> <Has_accepted_use> "Hemophagocytic_lymphohistiocytosis" .
<Ovarian_cancer> <Accepted_use_of> "nab-Paclitaxel_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Vinorelbine_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Vinorelbine" .
<Ovarian_cancer> <Accepted_use_of> "Treosulfan_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Treosulfan" .
<Ovarian_cancer> <Accepted_use_of> "Trebananib" .
<Ovarian_cancer> <Accepted_use_of> "Trabectedin_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Trabectedin" .
<Ovarian_cancer> <Accepted_use_of> "Topotecan_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Topotecan_and_Bevacizumab" .
<Ovarian_cancer> <Accepted_use_of> "Topotecan" .
<Ovarian_cancer> <Accepted_use_of> "Tamoxifen_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "TC_and_Nintedanib" .
<Ovarian_cancer> <Accepted_use_of> "Selumetinib" .
<Ovarian_cancer> <Accepted_use_of> "Rucaparib_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Rucaparib" .
<Ovarian_cancer> <Accepted_use_of> "Placebo" .
<Ovarian_cancer> <Accepted_use_of> "Pemetrexed_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Pemetrexed" .
<Ovarian_cancer> <Accepted_use_of> "Pegylated_liposomal_doxorubicin" .
<Ovarian_cancer> <Accepted_use_of> "Pazopanib_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Pazopanib" .
<Ovarian_cancer> <Accepted_use_of> "Paclitaxel_nanoparticle_albumin-bound" .
<Ovarian_cancer> <Accepted_use_of> "Paclitaxel_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Paclitaxel_and_Pazopanib" .
<Ovarian_cancer> <Accepted_use_of> "Paclitaxel_and_Bevacizumab" .
<Ovarian_cancer> <Accepted_use_of> "Paclitaxel" .
<Ovarian_cancer> <Accepted_use_of> "Olaparib_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Olaparib" .
<Ovarian_cancer> <Accepted_use_of> "Observation" .
<Ovarian_cancer> <Accepted_use_of> "Niraparib_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Niraparib" .
<Ovarian_cancer> <Accepted_use_of> "Nintedanib" .
<Ovarian_cancer> <Accepted_use_of> "Melphalan_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Hexa-CAF" .
<Ovarian_cancer> <Accepted_use_of> "Gemcitabine_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Gemcitabine" .
<Ovarian_cancer> <Accepted_use_of> "Etoposide_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Etoposide" .
<Ovarian_cancer> <Accepted_use_of> "Doxorubicin_pegylated_liposomal_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Doxorubicin_pegylated_liposomal_and_Trabectedin" .
<Ovarian_cancer> <Accepted_use_of> "Doxorubicin_pegylated_liposomal_and_Gemcitabine" .
<Ovarian_cancer> <Accepted_use_of> "Doxorubicin_pegylated_liposomal_and_Bevacizumab" .
<Ovarian_cancer> <Accepted_use_of> "Docetaxel_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Docetaxel" .
<Ovarian_cancer> <Accepted_use_of> "Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b" .
<Ovarian_cancer> <Accepted_use_of> "Cisplatin_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Cisplatin_and_Paclitaxel" .
<Ovarian_cancer> <Accepted_use_of> "Cisplatin_and_Gemcitabine" .
<Ovarian_cancer> <Accepted_use_of> "Cisplatin_and_Cyclophosphamide" .
<Ovarian_cancer> <Accepted_use_of> "Cisplatin" .
<Ovarian_cancer> <Accepted_use_of> "Chlorambucil_and_Cisplatin" .
<Ovarian_cancer> <Accepted_use_of> "Carboplatin,_Paclitaxel,_Bevacizumab" .
<Ovarian_cancer> <Accepted_use_of> "Carboplatin,_Olaparib,_Paclitaxel" .
<Ovarian_cancer> <Accepted_use_of> "Carboplatin,_Gemcitabine,_Bevacizumab" .
<Ovarian_cancer> <Accepted_use_of> "Carboplatin_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Carboplatin_and_Paclitaxel" .
<Ovarian_cancer> <Accepted_use_of> "Carboplatin_and_Gemcitabine" .
<Ovarian_cancer> <Accepted_use_of> "Carboplatin_and_Doxorubicin_liposomal" .
<Ovarian_cancer> <Accepted_use_of> "Carboplatin_and_Docetaxel" .
<Ovarian_cancer> <Accepted_use_of> "Carboplatin_and_Cyclophosphamide" .
<Ovarian_cancer> <Accepted_use_of> "Carboplatin" .
<Ovarian_cancer> <Accepted_use_of> "CHAD" .
<Ovarian_cancer> <Accepted_use_of> "CEP" .
<Ovarian_cancer> <Accepted_use_of> "CAP_(Platinol)" .
<Ovarian_cancer> <Accepted_use_of> "Bevacizumab-bvzr" .
<Ovarian_cancer> <Accepted_use_of> "Bevacizumab-awwb" .
<Ovarian_cancer> <Accepted_use_of> "Bevacizumab_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Bevacizumab" .
<Ovarian_cancer> <Accepted_use_of> "Belotecan" .
<Ovarian_cancer> <Accepted_use_of> "Altretamine_monotherapy" .
<Ovarian_cancer> <Accepted_use_of> "Altretamine_and_Cisplatin" .
<Ovarian_cancer> <Accepted_use_of> "Altretamine" .
<Deferoxamine> <May_have_route> "Subcutaneous" .
<Deferoxamine> <May_have_route> "Intravenous" .
<Deferoxamine> <May_have_route> "Intramuscular" .
<FAM> <Maps_to> "FAM" .
<TBI,_then_auto_HSCT> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<TBI,_then_auto_HSCT> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Azacitidine,_Vorinostat,_Gemtuzumab_ozogamicin> <Has_context> "Non-curative_subsequent-line_therapy" .
<Lapatinib> <Has_brand_name> "Tykerb" .
<Moxetumomab_pasudotox_monotherapy> <Maps_to> "Moxetumomab_pasudotox_monotherapy" .
<Bactrilac> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<BVP> <Maps_to> "BVP" .
<Aspilets> <Brand_name_of> "Aspirin" .
<Smartrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Fluoroplex> <Brand_name_of> "Fluorouracil" .
<Idarubicin,_then_Mitoxantrone,_then_Idarubicin> <Has_antineoplastic> "Mitoxantrone" .
<Idarubicin,_then_Mitoxantrone,_then_Idarubicin> <Has_antineoplastic> "Idarubicin" .
<Mycophenolate_mofetil> <Immunosuppressor_of> "Mycophenolate_mofetil_monotherapy" .
<Mycophenolate_mofetil> <Immunosuppressor_of> "Low-dose_TBI,_then_allo_HSCT" .
<Mycophenolate_mofetil> <Immunosuppressor_of> "Low-dose_TBI" .
<Mycophenolate_mofetil> <Immunosuppressor_of> "Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant" .
<Mycophenolate_mofetil> <Immunosuppressor_of> "Fludarabine,_Busulfan,_Cyclophosphamide" .
<Mycophenolate_mofetil> <Immunosuppressor_of> "Fludarabine_and_TBI,_then_allo_HSCT" .
<Mycophenolate_mofetil> <Immunosuppressor_of> "Fludarabine_and_TBI" .
<Mycophenolate_mofetil> <Immunosuppressor_of> "FluBuCy,_then_allo_HSCT" .
<Mycophenolate_mofetil> <Immunosuppressor_of> "Cyclosporine,_Mycophenolate_mofetil,_Sirolimus" .
<Mycophenolate_mofetil> <Immunosuppressor_of> "Cyclosporine_and_Mycophenolate_mofetil" .
<Mycophenolate_mofetil> <Immunosuppressor_of> "Cyclophosphamide,_Mycophenolate_mofetil,_Tacrolimus" .
<Istubal> <Brand_name_of> "Tamoxifen" .
<Doxorubicin,_Methotrexate,_Vincristine,_Prednisone> <Has_antineoplastic> "Vincristine" .
<Doxorubicin,_Methotrexate,_Vincristine,_Prednisone> <Has_antineoplastic> "Prednisone" .
<Doxorubicin,_Methotrexate,_Vincristine,_Prednisone> <Has_antineoplastic> "Methotrexate" .
<Doxorubicin,_Methotrexate,_Vincristine,_Prednisone> <Has_antineoplastic> "Doxorubicin" .
<FluBuCy,_then_allo_HSCT> <Is_current_in> "Primary_mediastinal_B-cell_lymphoma" .
<FluBuCy,_then_allo_HSCT> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<FluBuCy,_then_allo_HSCT> <Is_current_in> "NK-_and_T-cell_lymphoma" .
<FluBuCy,_then_allo_HSCT> <Is_current_in> "Mantle_cell_lymphoma" .
<FluBuCy,_then_allo_HSCT> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<FluBuCy,_then_allo_HSCT> <Is_current_in> "Anaplastic_large_cell_lymphoma" .
<Hyper-CVAD_and_Imatinib> <Has_supportive_med> "Valacyclovir" .
<Hyper-CVAD_and_Imatinib> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Hyper-CVAD_and_Imatinib> <Has_supportive_med> "Rasburicase" .
<Hyper-CVAD_and_Imatinib> <Has_supportive_med> "Mesna" .
<Hyper-CVAD_and_Imatinib> <Has_supportive_med> "Levofloxacin" .
<Hyper-CVAD_and_Imatinib> <Has_supportive_med> "Folinic_acid" .
<Hyper-CVAD_and_Imatinib> <Has_supportive_med> "Fluconazole" .
<Hyper-CVAD_and_Imatinib> <Has_supportive_med> "Filgrastim" .
<Hyper-CVAD_and_Imatinib> <Has_supportive_med> "Ciprofloxacin" .
<Hyper-CVAD_and_Imatinib> <Has_supportive_med> "Allopurinol" .
<Hyper-CVAD_and_Imatinib> <Has_supportive_med> "Acyclovir" .
<Fadametasona> <Brand_name_of> "Dexamethasone" .
<Carboplatin,_Paclitaxel,_RT> <Maps_to> "Carboplatin,_Paclitaxel,_RT" .
<Loperamide> <May_have_route> "Oral" .
<Voricort> <Brand_name_of> "Voriconazole" .
<PCE> <Maps_to> "PCE" .
<BR> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<BR> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<BR> <Has_supportive_med> "Acyclovir" .
<CISCA> <Has_accepted_use> "Bladder_cancer" .
<Lymphoglobuline> <Brand_name_of> "Antithymocyte_globulin_horse_ATG" .
<DOLP> <Has_antineoplastic> "Vincristine" .
<DOLP> <Has_antineoplastic> "Prednisone" .
<DOLP> <Has_antineoplastic> "Daunorubicin" .
<DOLP> <Has_antineoplastic> "Asparaginase" .
<Hyper-CVAD/MA_and_Everolimus> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<MCP> <Has_antineoplastic> "Prednisone" .
<MCP> <Has_antineoplastic> "Mitoxantrone" .
<MCP> <Has_antineoplastic> "Chlorambucil" .
<Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b> <Is_historical_in> "Ovarian_cancer" .
<Gemcitabine_and_Rituximab> <Has_modality> "Chemotherapy" .
<Polatuzumab_vedotin> <Is_a> "Microtubule_inhibitor" .
<Polatuzumab_vedotin> <Is_a> "Antibody-drug_conjugate" .
<Polatuzumab_vedotin> <Is_a> "Antibody_medication" .
<Polatuzumab_vedotin> <Is_a> "Anti-CD79B_antibody" .
<Axitinib> <Has_accepted_use> "Thyroid_cancer" .
<Axitinib> <Has_accepted_use> "Renal_cell_carcinoma" .
<Axitinib> <Has_accepted_use> "Hepatocellular_carcinoma" .
<ADE_(high-dose_Ara-C)> <Mapped_from> "ADE_(high-dose_Ara-C)" .
<Belinostat> <Is_a> "HDAC_inhibitor" .
<Larotrectinib_monotherapy> <Has_antineoplastic> "Larotrectinib" .
<Carmustine_monotherapy> <Has_modality> "Chemotherapy" .
<IRIS_and_Bevacizumab> <Has_antineoplastic> "Tegafur_gimeracil_oteracil" .
<IRIS_and_Bevacizumab> <Has_antineoplastic> "Irinotecan" .
<IRIS_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<RP> <Has_context> "Non-curative_first-line_therapy" .
<RP> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<RP> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<PCR> <Mapped_from> "PCR" .
<C-VAMP> <Has_antineoplastic> "Vincristine" .
<C-VAMP> <Has_antineoplastic> "Methylprednisolone" .
<C-VAMP> <Has_antineoplastic> "Doxorubicin" .
<C-VAMP> <Has_antineoplastic> "Cyclophosphamide" .
<CBV,_then_auto_HSCT> <Is_current_in> "Mantle_cell_lymphoma" .
<CBV,_then_auto_HSCT> <Is_current_in> "Hodgkin_lymphoma" .
<CBV,_then_auto_HSCT> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<AV-CMF> <Has_context> "Adjuvant_therapy" .
<VMCP> <Has_modality> "Chemotherapy" .
<BEACOPP> <Has_accepted_use> "Hodgkin_lymphoma" .
<VH> <Has_context> "Non-curative_subsequent-line_therapy" .
<VH> <Has_context> "Non-curative_first-line_therapy" .
<VH> <Has_context> "Adjuvant_therapy" .
<THP_(Taxol)> <Has_context> "Adjuvant_therapy" .
<Trifluridine_and_tipiracil_monotherapy> <Has_accepted_use> "Gastric_cancer" .
<Trifluridine_and_tipiracil_monotherapy> <Has_accepted_use> "Colon_cancer" .
<Intraperitoneal_hyperthermic_mitomycin> <Has_accepted_use> "Colon_cancer" .
<Doxorubicin_and_Ifosfamide> <Has_antineoplastic> "Ifosfamide" .
<Doxorubicin_and_Ifosfamide> <Has_antineoplastic> "Doxorubicin" .
<Nordic_Regimen,_younger_patients> <Has_modality> "Chemotherapy" .
<Lanreotide_and_Interferon_alfa-2b> <Has_antineoplastic> "Lanreotide" .
<Lanreotide_and_Interferon_alfa-2b> <Has_antineoplastic> "Interferon_alfa-2b" .
<Ivosidenib> <Antineoplastic_of> "Ivosidenib_monotherapy" .
<Dexamethasone> <Local_therapy_of> "Mercaptopurine,_Methotrexate,_Vincristine" .
<Dexamethasone> <Local_therapy_of> "GMALL-R" .
<Dexamethasone> <Local_therapy_of> "Cyclophosphamide_and_Prednisone" .
<Dexamethasone> <Local_therapy_of> "Arsenic_trioxide_monotherapy" .
<Dexamethasone> <Local_therapy_of> "Arsenic_trioxide_and_Idarubicin" .
<Hydroxyurea_and_RT> <Is_current_in> "Cervical_cancer" .
<Arsenol> <Brand_name_of> "Arsenic_trioxide" .
<Carboplatin_and_Cisplatin> <Has_context> "Non-curative_first-line_therapy" .
<Lomustine,_Temozolomide,_RT> <Has_context> "Adjuvant_therapy" .
<EC_and_Bevacizumab> <Has_antineoplastic> "Epirubicin" .
<EC_and_Bevacizumab> <Has_antineoplastic> "Cyclophosphamide" .
<EC_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Lenalidomide,_Dexamethasone,_Rituximab> <Maps_to> "Lenalidomide,_Dexamethasone,_Rituximab" .
<Irinotecan_and_Mitomycin> <Is_a> "Irinotecan-containing_regimen" .
<Dasatinib,_Vincristine,_Prednisone> <Has_context> "Maintenance_after_upfront_therapy" .
<LOPP> <Has_modality> "Chemotherapy" .
<Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine> <Has_antineoplastic> "Vincristine" .
<Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine> <Has_antineoplastic> "Methotrexate" .
<Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine> <Has_antineoplastic> "Etoposide" .
<Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine> <Has_antineoplastic> "Cyclophosphamide" .
<Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine> <Has_antineoplastic> "Carboplatin" .
<FOLFOX4_and_Panitumumab> <Mapped_from> "FOLFOX4_and_Panitumumab" .
<Foli_Cell> <Brand_name_of> "Folinic_acid" .
<Taxodiol> <Brand_name_of> "Paclitaxel" .
<Non-curative_third-line_therapy> <Mapped_from> "Non-curative_third-line_therapy" .
<Bacillus_Calmette-Guerin_(BCG)_monotherapy> <Is_current_in> "Bladder_cancer" .
<GCD-R> <Is_current_in> "Hodgkin_lymphoma" .
<Cyclovir> <Brand_name_of> "Acyclovir" .
<Cisplatin,_Gemcitabine,_Bevacizumab> <Maps_to> "Cisplatin,_Gemcitabine,_Bevacizumab" .
<R-MegaCHOP> <Has_supportive_med> "Pegfilgrastim" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone> <Mapped_from> "Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Fluorouracil/Fluorouracil_and_RT> <Has_context> "Adjuvant_therapy" .
<Vemurafenib> <May_have_route> "Oral" .
<ATRA_and_Idarubicin> <Has_antineoplastic> "Idarubicin" .
<ATRA_and_Idarubicin> <Has_antineoplastic> "All-trans_retinoic_acid" .
<CODOX-M> <Has_local_therapy> "Methotrexate" .
<CODOX-M> <Has_local_therapy> "Hydrocortisone" .
<CODOX-M> <Has_local_therapy> "Cytarabine" .
<Cyclophosphamide_and_Prednisone> <Has_accepted_use> "Multiple_myeloma" .
<Cyclophosphamide_and_Prednisone> <Has_accepted_use> "Large_granular_lymphocytic_leukemia" .
<Cyclophosphamide_and_Prednisone> <Has_accepted_use> "Burkitt_lymphoma" .
<Cyclophosphamide_and_Prednisone> <Has_accepted_use> "Acquired_coagulopathy" .
<Oophorectomy> <Is_historical_in> "Breast_cancer" .
<Thalidomide_and_Prednisolone> <Mapped_from> "Thalidomide_and_Prednisolone" .
<Millicorten> <Brand_name_of> "Dexamethasone" .
<FLAG-Ida> <Has_antineoplastic> "Idarubicin" .
<FLAG-Ida> <Has_antineoplastic> "Fludarabine" .
<FLAG-Ida> <Has_antineoplastic> "Cytarabine" .
<IDAC_and_Sorafenib> <Has_modality> "Chemotherapy" .
<Augmented_BFM_consolidation> <Has_antineoplastic> "Vincristine" .
<Augmented_BFM_consolidation> <Has_antineoplastic> "Mercaptopurine" .
<Augmented_BFM_consolidation> <Has_antineoplastic> "Cytarabine" .
<Augmented_BFM_consolidation> <Has_antineoplastic> "Cyclophosphamide" .
<Augmented_BFM_consolidation> <Has_antineoplastic> "Asparaginase" .
<CCI> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<R-CVP> <Is_a> "Rituximab-containing_regimen" .
<HIV-associated_lymphoma> <Current_treated_by> "m-BACOD" .
<HIV-associated_lymphoma> <Current_treated_by> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<HIV-associated_lymphoma> <Current_treated_by> "dmCODOX-M_-_Modified_Magrath" .
<HIV-associated_lymphoma> <Current_treated_by> "Stanford_V" .
<HIV-associated_lymphoma> <Current_treated_by> "SC-EPOCH-RR" .
<HIV-associated_lymphoma> <Current_treated_by> "Rituximab_monotherapy" .
<HIV-associated_lymphoma> <Current_treated_by> "Radiation_therapy" .
<HIV-associated_lymphoma> <Current_treated_by> "R-EPOCH,_dose-escalated" .
<HIV-associated_lymphoma> <Current_treated_by> "R-CODOX-M/R-IVAC" .
<HIV-associated_lymphoma> <Current_treated_by> "R-CODOX-M" .
<HIV-associated_lymphoma> <Current_treated_by> "R-CHOP" .
<HIV-associated_lymphoma> <Current_treated_by> "R-CDOP" .
<HIV-associated_lymphoma> <Current_treated_by> "GMALL-R" .
<HIV-associated_lymphoma> <Current_treated_by> "EPOCH,_dose-escalated" .
<HIV-associated_lymphoma> <Current_treated_by> "COP" .
<HIV-associated_lymphoma> <Current_treated_by> "CODOX-M/IVAC" .
<HIV-associated_lymphoma> <Current_treated_by> "CODOX-M" .
<HIV-associated_lymphoma> <Current_treated_by> "CHOP" .
<HIV-associated_lymphoma> <Current_treated_by> "BEAM,_then_auto_HSCT" .
<L-Asparaginase,_Vincristine,_Prednisone> <Mapped_from> "L-Asparaginase,_Vincristine,_Prednisone" .
<Bortezomib_and_Melphalan,_then_auto_HSCT> <Has_antineoplastic> "Melphalan" .
<Bortezomib_and_Melphalan,_then_auto_HSCT> <Has_antineoplastic> "Bortezomib" .
<Winpred> <Brand_name_of> "Prednisone" .
<Octreotide_and_Prednisone> <Maps_to> "Octreotide_and_Prednisone" .
<Cisplatin,_Irinotecan,_RT> <Mapped_from> "Cisplatin,_Irinotecan,_RT" .
<Anastrozole_and_Ribociclib> <Has_context> "Non-curative_first-line_therapy" .
<Pemetrexed_monotherapy> <Has_supportive_med> "Folic_acid" .
<Pemetrexed_monotherapy> <Has_supportive_med> "Dexamethasone" .
<Pemetrexed_monotherapy> <Has_supportive_med> "Cyanocobalamin" .
<Varfarins> <Brand_name_of> "Warfarin" .
<Sicatem> <Brand_name_of> "Cisplatin" .
<ddFEC> <Has_context> "Adjuvant_therapy" .
<Cefixime> <Supportive_med_of> "Irinotecan_and_Temozolomide" .
<Trimexasol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<VBMCP/VBAD> <Mapped_from> "VBMCP/VBAD" .
<PrasuSafe> <Brand_name_of> "Prasugrel" .
<Cisplatin,_Fluorouracil,_Cetuximab> <Has_accepted_use> "Head_and_neck_cancer" .
<Cisplatin,_Fluorouracil,_Cetuximab> <Has_accepted_use> "Esophageal_cancer" .
<Tinzaparin> <Has_brand_name> "Tinprin" .
<Tinzaparin> <Has_brand_name> "Innohep" .
<Eltrombopag_monotherapy> <Mapped_from> "Eltrombopag_monotherapy" .
<CTCb> <Has_modality> "Chemotherapy" .
<Fluorouracil_and_Paclitaxel> <Mapped_from> "Fluorouracil_and_Paclitaxel" .
<Cytarabine> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Cytarabine> <Is_a> "Neutral" .
<Cytarabine> <Is_a> "Irritant" .
<Cytarabine> <Is_a> "Deoxycytidine_analogue" .
<Cytarabine> <Is_a> "Antimetabolite" .
<IDAC> <Is_current_in> "Acute_myeloid_leukemia" .
<CMFVP> <Has_antineoplastic> "Vincristine" .
<CMFVP> <Has_antineoplastic> "Prednisone" .
<CMFVP> <Has_antineoplastic> "Methotrexate" .
<CMFVP> <Has_antineoplastic> "Fluorouracil" .
<CMFVP> <Has_antineoplastic> "Cyclophosphamide" .
<EPOCH> <Mapped_from> "EPOCH" .
<mDCF_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Mundesine> <Brand_name_of> "Forodesine" .
<Dabrafenib,_Trametinib,_Panitumumab> <Mapped_from> "Dabrafenib,_Trametinib,_Panitumumab" .
<mFOLFOX6_and_Bevacizumab> <Mapped_from> "mFOLFOX6_and_Bevacizumab" .
<Etoposide_and_TBI,_then_allo_HSCT> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Etoposide_and_TBI,_then_allo_HSCT> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Etoposide_and_TBI,_then_allo_HSCT> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<RD> <Has_accepted_use> "Multiple_myeloma" .
<RD> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Ipilimumab> <Antineoplastic_of> "Nivolumab,_then_Ipilimumab" .
<Ipilimumab> <Antineoplastic_of> "Ipilimumab,_then_Nivolumab" .
<Ipilimumab> <Antineoplastic_of> "Ipilimumab_monotherapy" .
<Ipilimumab> <Antineoplastic_of> "Ipilimumab_and_RT" .
<Ipilimumab> <Antineoplastic_of> "Ipilimumab_and_Nivolumab" .
<Ipilimumab> <Antineoplastic_of> "Dacarbazine_and_Ipilimumab" .
<Ipilimumab> <Antineoplastic_of> "Carboplatin,_Paclitaxel,_Ipilimumab" .
<Doxorubicin_monotherapy> <Is_current_in> "Thyroid_cancer" .
<Doxorubicin_monotherapy> <Is_current_in> "Soft_tissue_sarcoma" .
<Doxorubicin_monotherapy> <Is_current_in> "Osteosarcoma" .
<Doxorubicin_monotherapy> <Is_current_in> "Mesothelioma" .
<Doxorubicin_monotherapy> <Is_current_in> "Hepatocellular_carcinoma" .
<Doxorubicin_monotherapy> <Is_current_in> "Endometrial_cancer" .
<Doxorubicin_monotherapy> <Is_current_in> "Breast_cancer" .
<Doxorubicin_monotherapy> <Is_current_in> "Bladder_cancer" .
<Rasburnat> <Brand_name_of> "Rasburicase" .
<FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)> <Maps_to> "FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)" .
<Tropisetron> <Has_brand_name> "Setrovel" .
<Tropisetron> <Has_brand_name> "Navoban" .
<Tropisetron> <Has_brand_name> "Hensetron" .
<Tropisetron> <Has_brand_name> "Abatoarin" .
<Midostaurin> <Antineoplastic_of> "Midostaurin_monotherapy" .
<Midostaurin> <Antineoplastic_of> "HiDAC_and_Midostaurin" .
<Midostaurin> <Antineoplastic_of> "7_plus_3d_and_Midostaurin" .
<Decitabine_monotherapy> <Mapped_from> "Decitabine_monotherapy" .
<Fludarabine_and_Melphalan> <Has_accepted_use> "Allogeneic_HSCT" .
<Procarbazine_monotherapy> <Mapped_from> "Procarbazine_monotherapy" .
<Cyclophosphamide_and_G-CSF> <Has_accepted_use> "Stem_cell_mobilization" .
<Netocur> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Daunorubicin_and_Prednisone> <Has_modality> "Chemotherapy" .
<Lepi-Cortinolo> <Brand_name_of> "Prednisolone" .
<Microtubule_inhibitor> <Subsumes> "Vinorelbine" .
<Microtubule_inhibitor> <Subsumes> "Vinflunine" .
<Microtubule_inhibitor> <Subsumes> "Vindesine" .
<Microtubule_inhibitor> <Subsumes> "Vincristine_liposomal" .
<Microtubule_inhibitor> <Subsumes> "Vincristine" .
<Microtubule_inhibitor> <Subsumes> "Vinca_alkaloid" .
<Microtubule_inhibitor> <Subsumes> "Vinblastine" .
<Microtubule_inhibitor> <Subsumes> "Taxane" .
<Microtubule_inhibitor> <Subsumes> "Polatuzumab_vedotin" .
<Microtubule_inhibitor> <Subsumes> "Paclitaxel_nanoparticle_albumin-bound" .
<Microtubule_inhibitor> <Subsumes> "Paclitaxel" .
<Microtubule_inhibitor> <Subsumes> "Ixabepilone" .
<Microtubule_inhibitor> <Subsumes> "Eribulin" .
<Microtubule_inhibitor> <Subsumes> "Enfortumab_vedotin" .
<Microtubule_inhibitor> <Subsumes> "Docetaxel" .
<Microtubule_inhibitor> <Subsumes> "Coltuximab_ravtansine" .
<Microtubule_inhibitor> <Subsumes> "Brentuximab_vedotin" .
<Microtubule_inhibitor> <Subsumes> "Ado-trastuzumab_emtansine" .
<VAdCA/IE> <Has_accepted_use> "Ewing_sarcoma" .
<Triptorelin> <Has_brand_name> "Variopeptyl" .
<Triptorelin> <Has_brand_name> "Trelstar_LA" .
<Triptorelin> <Has_brand_name> "Gonapeptyl" .
<Triptorelin> <Has_brand_name> "Diphereline" .
<Triptorelin> <Has_brand_name> "Decapeptyl" .
<Capecitabine_and_Bevacizumab> <Maps_to> "Capecitabine_and_Bevacizumab" .
<Didox> <Brand_name_of> "Doxifluridine" .
<Voraxaze> <Brand_name_of> "Glucarpidase" .
<Ultramop> <Brand_name_of> "Methoxsalen" .
<Plerixafor_and_G-CSF> <Mapped_from> "Plerixafor_and_G-CSF" .
<DAC> <Has_antineoplastic> "Daunorubicin" .
<DAC> <Has_antineoplastic> "Cytarabine" .
<DAC> <Has_antineoplastic> "Cladribine" .
<FOLFIRI_and_Panitumumab> <Has_accepted_use> "KRAS_wild-type_Colon_cancer" .
<FOLFIRI_and_Panitumumab> <Has_accepted_use> "Colon_cancer" .
<Neitrostim> <Brand_name_of> "Filgrastim" .
<Capecitabine,_Cisplatin,_RT> <Is_current_in> "Esophageal_cancer" .
<Blaztere> <Brand_name_of> "Zoledronic_acid" .
<KRd> <Mapped_from> "KRd" .
<Ponatinib_monotherapy> <Has_modality> "Chemotherapy" .
<IT_Methotrexate_and_Hydrocortisone> <Mapped_from> "IT_Methotrexate_and_Hydrocortisone" .
<COPDAC> <Mapped_from> "COPDAC" .
<Pneumopent> <Brand_name_of> "Pentamidine" .
<Spersadex> <Brand_name_of> "Dexamethasone" .
<VMV-VAC> <Has_modality> "Chemotherapy" .
<Pembrolizumab> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Pembrolizumab> <Is_a> "T-cell_activator" .
<Pembrolizumab> <Is_a> "Protein_expression-specific_medication" .
<Pembrolizumab> <Is_a> "PMDA_approved_drug" .
<Pembrolizumab> <Is_a> "Mutation-specific_medication" .
<Pembrolizumab> <Is_a> "Immunotherapeutic" .
<Pembrolizumab> <Is_a> "EMA_approved_drug" .
<Pembrolizumab> <Is_a> "Antibody_medication" .
<Pembrolizumab> <Is_a> "Anti-PD-1_antibody" .
<Methotrexate,_then_Cytarabine> <Has_context> "Upfront_therapy" .
<Trastuzumab_monotherapy> <Mapped_from> "Trastuzumab_monotherapy" .
<Dasatinib_monotherapy> <Maps_to> "Dasatinib_monotherapy" .
<Nufadex_M> <Brand_name_of> "Dexamethasone" .
<Carboplatin,_Docetaxel,_Prednisone> <Has_accepted_use> "Prostate_cancer" .
<Estramustine> <Has_accepted_use> "Prostate_cancer" .
<Leucoginase> <Brand_name_of> "Asparaginase" .
<Irinotecan,_Vemurafenib,_Cetuximab> <Has_accepted_use> "Colon_cancer" .
<Irinotecan,_Vemurafenib,_Cetuximab> <Has_accepted_use> "BRAF-mutated_Colon_cancer" .
<Lokar> <Brand_name_of> "Alendronate" .
<Ponatinib_monotherapy> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Ponatinib_monotherapy> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Ponatinib_monotherapy> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Gestational_trophoblastic_neoplasia> <Accepted_use_of> "Methotrexate_monotherapy" .
<Gestational_trophoblastic_neoplasia> <Accepted_use_of> "Methotrexate" .
<Gestational_trophoblastic_neoplasia> <Accepted_use_of> "Mercaptopurine_and_Methotrexate" .
<Gestational_trophoblastic_neoplasia> <Accepted_use_of> "EMA-CO" .
<Gestational_trophoblastic_neoplasia> <Accepted_use_of> "Dactinomycin_monotherapy" .
<Gestational_trophoblastic_neoplasia> <Accepted_use_of> "Dactinomycin" .
<Metypresol> <Brand_name_of> "Methylprednisolone" .
<CVD_(Vinblastine)> <Has_antineoplastic> "Vinblastine" .
<CVD_(Vinblastine)> <Has_antineoplastic> "Dacarbazine" .
<CVD_(Vinblastine)> <Has_antineoplastic> "Cisplatin" .
<TACE,_then_5-FU> <Mapped_from> "TACE,_then_5-FU" .
<Lomustine,_Methotrexate,_Procarbazine> <Mapped_from> "Lomustine,_Methotrexate,_Procarbazine" .
<ADT> <Mapped_from> "ADT" .
<VR-CAP> <Is_current_in> "Mantle_cell_lymphoma" .
<Rucaparib> <Antineoplastic_of> "Rucaparib_monotherapy" .
<Cisplatin_and_Gemcitabine> <Maps_to> "Cisplatin_and_Gemcitabine" .
<PUVA> <Has_modality> "Chemotherapy" .
<Mutation-specific_medication> <Is_a> "Biomarker-specific_medication" .
<ECX> <Has_context> "Non-curative_first-line_therapy" .
<ECX> <Has_context> "Neoadjuvant_therapy" .
<ECX> <Has_context> "Induction_therapy" .
<ECX> <Has_context> "Adjuvant_therapy" .
<Ketoconazole_and_Hydrocortisone> <Has_context> "Non-curative_second-line_therapy" .
<CHOP_(Prednisolone)> <Mapped_from> "CHOP_(Prednisolone)" .
<Bacterol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bicalutamide_and_RT> <Has_context> "Salvage_therapy" .
<Imatinib-based_consolidation> <Maps_to> "Imatinib-based_consolidation" .
<Osimertinib> <May_have_route> "Oral" .
<Triptorelin_monotherapy> <Mapped_from> "Triptorelin_monotherapy" .
<Methotrexate,_Tacrolimus,_Vorinostat> <Has_context> "Prophylaxis" .
<Hexa-CAF> <Maps_to> "Hexa-CAF" .
<Rucaparib_monotherapy> <Mapped_from> "Rucaparib_monotherapy" .
<Goserelin_monotherapy> <Has_context> "Non-curative_therapy" .
<Goserelin_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Goserelin_monotherapy> <Has_context> "Adjuvant_therapy" .
<Cisplatin,_Pemetrexed,_Pembrolizumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Onconase> <Brand_name_of> "Asparaginase" .
<Capecitabine,_Cisplatin,_RT> <Has_accepted_use> "Esophageal_cancer" .
<Novoprednisone> <Brand_name_of> "Prednisone" .
<Decitabine> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Decitabine> <Has_accepted_use> "Chronic_myelomonocytic_leukemia" .
<Decitabine> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Rituximab_monotherapy> <Has_antineoplastic> "Rituximab" .
<Neofluor> <Brand_name_of> "Fluorouracil" .
<Prednisone_monotherapy> <Has_immunosuppressor> "Prednisone" .
<FULV/FULV_and_RT> <Has_modality> "Radiotherapy" .
<FULV/FULV_and_RT> <Has_modality> "Chemotherapy" .
<NTRK-mutated_malignancy> <Accepted_use_of> "Larotrectinib_monotherapy" .
<NTRK-mutated_malignancy> <Accepted_use_of> "Larotrectinib" .
<NTRK-mutated_malignancy> <Accepted_use_of> "Entrectinib_monotherapy" .
<Cyclophosphamide_and_Etoposide> <Has_context> "Non-curative_subsequent-line_therapy" .
<Decdak> <Brand_name_of> "Dexamethasone" .
<Claragine> <Brand_name_of> "Aspirin" .
<Dexano> <Brand_name_of> "Dexamethasone" .
<Decitabine> <Has_brand_name> "Natdecita" .
<Decitabine> <Has_brand_name> "Decitex" .
<Decitabine> <Has_brand_name> "Decitas" .
<Decitabine> <Has_brand_name> "Decitafect" .
<Decitabine> <Has_brand_name> "Decita" .
<Decitabine> <Has_brand_name> "Decima" .
<Decitabine> <Has_brand_name> "Dacogen" .
<Amrubicin> <Antineoplastic_of> "Amrubicin_monotherapy" .
<Afatinib> <Has_brand_name> "Xovoltib" .
<Afatinib> <Has_brand_name> "Tovok" .
<Afatinib> <Has_brand_name> "Tomtovok" .
<Afatinib> <Has_brand_name> "Giotrif" .
<Afatinib> <Has_brand_name> "Gilotrif" .
<Afatinib> <Has_brand_name> "Afanix" .
<Bactrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<R-CDOP> <Has_supportive_med> "Sargramostim" .
<R-CDOP> <Has_supportive_med> "Pegfilgrastim" .
<R-CDOP> <Has_supportive_med> "PCP_prophylaxis" .
<R-CDOP> <Has_supportive_med> "Fluoroquinolone" .
<R-CDOP> <Has_supportive_med> "Filgrastim" .
<R-CDOP> <Has_supportive_med> "Epoetin_alfa" .
<R-CDOP> <Has_supportive_med> "Darbepoetin_alfa" .
<Chlorambucil_monotherapy> <Has_modality> "Chemotherapy" .
<Hsp90_inhibitor> <Subsumes> "Retaspimycin" .
<Hsp90_inhibitor> <Subsumes> "Ganetespib" .
<Sunitinib_monotherapy> <Is_current_in> "Thyroid_cancer" .
<Sunitinib_monotherapy> <Is_current_in> "Thymoma" .
<Sunitinib_monotherapy> <Is_current_in> "Testicular_cancer" .
<Sunitinib_monotherapy> <Is_current_in> "Small_cell_lung_cancer" .
<Sunitinib_monotherapy> <Is_current_in> "Renal_cell_carcinoma" .
<Sunitinib_monotherapy> <Is_current_in> "Pancreatic_NET" .
<Sunitinib_monotherapy> <Is_current_in> "Gastrointestinal_stromal_tumor" .
<FNC> <Is_historical_in> "Breast_cancer" .
<Venetoclax_and_Obinutuzumab> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Bacprotin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<High-grade_glioma> <Is_a> "CNS_cancer" .
<Refametinib> <Is_a> "MAP2K1_inhibitor" .
<Refametinib> <Is_a> "Kinase_inhibitor" .
<Refametinib> <Is_a> "Investigational_drug" .
<ADE_(standard-dose_Ara-C)> <Is_current_in> "Acute_myeloid_leukemia" .
<Romiplostim_monotherapy> <Has_accepted_use> "Immune_thrombocytopenia" .
<Panwarfine> <Brand_name_of> "Warfarin" .
<Dacarbazine_monotherapy> <Has_modality> "Chemotherapy" .
<Orimetene> <Brand_name_of> "Aminoglutethimide" .
<CAV> <Has_modality> "Chemotherapy" .
<Dara-VMP> <Has_accepted_use> "Multiple_myeloma" .
<Ophth-DEX> <Brand_name_of> "Dexamethasone" .
<Rituximab-pvvr> <May_have_route> "Intravenous" .
<Midostaurin_monotherapy> <Mapped_from> "Midostaurin_monotherapy" .
<CMFPT> <Mapped_from> "CMFPT" .
<MVBP> <Has_modality> "Chemotherapy" .
<Ibandronate> <Supportive_med_of> "VAD" .
<Ibandronate> <Supportive_med_of> "PAD" .
<CX-C> <Maps_to> "CX-C" .
<Amsacrine> <Has_brand_name> "Lamasine" .
<Amsacrine> <Has_brand_name> "Amsidyl" .
<Amsacrine> <Has_brand_name> "Amsidine" .
<Amsacrine> <Has_brand_name> "Amsa_P-D" .
<Amsacrine> <Has_brand_name> "Amekrin" .
<Metrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Trimesulf> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)> <Has_modality> "Chemotherapy" .
<Steroids> <Supportive_med_of> "Temozolomide_monotherapy" .
<Steroids> <Supportive_med_of> "Procarbazine_monotherapy" .
<Steroids> <Supportive_med_of> "Pemetrexed_and_Pembrolizumab" .
<Steroids> <Supportive_med_of> "PCV" .
<Steroids> <Supportive_med_of> "Ofatumumab_monotherapy" .
<Steroids> <Supportive_med_of> "Obinutuzumab_monotherapy" .
<Steroids> <Supportive_med_of> "Mitotane_and_Streptozocin" .
<Steroids> <Supportive_med_of> "Mitotane_and_EDP" .
<Steroids> <Supportive_med_of> "Lomustine_monotherapy" .
<Steroids> <Supportive_med_of> "Irinotecan_monotherapy" .
<Steroids> <Supportive_med_of> "Irinotecan_and_Bevacizumab" .
<Steroids> <Supportive_med_of> "GCP" .
<Steroids> <Supportive_med_of> "G-FC" .
<Steroids> <Supportive_med_of> "Docetaxel_and_Gemcitabine" .
<Steroids> <Supportive_med_of> "Cladribine_monotherapy" .
<Steroids> <Supportive_med_of> "Cisplatin,_Pemetrexed,_Pembrolizumab" .
<Steroids> <Supportive_med_of> "Cisplatin,_Gemcitabine,_Necitumumab" .
<Steroids> <Supportive_med_of> "Cisplatin_and_Gemcitabine" .
<Steroids> <Supportive_med_of> "Cisplatin_and_Etoposide" .
<Steroids> <Supportive_med_of> "Chlorambucil_and_Ofatumumab" .
<Steroids> <Supportive_med_of> "Carmustine_monotherapy" .
<Steroids> <Supportive_med_of> "Carboplatin,_Pemetrexed,_Pembrolizumab" .
<Steroids> <Supportive_med_of> "Carboplatin,_Paclitaxel,_Ipilimumab" .
<Steroids> <Supportive_med_of> "Carboplatin,_Paclitaxel,_Bevacizumab" .
<Steroids> <Supportive_med_of> "Carboplatin,_Docetaxel,_Prednisone" .
<Steroids> <Supportive_med_of> "Carboplatin_and_Teniposide" .
<Steroids> <Supportive_med_of> "Carboplatin_and_Paclitaxel" .
<Steroids> <Supportive_med_of> "Carboplatin_and_Doxorubicin_liposomal" .
<Steroids> <Supportive_med_of> "Carboplatin_and_Docetaxel" .
<Steroids> <Supportive_med_of> "Cabazitaxel_and_Prednisone" .
<Steroids> <Supportive_med_of> "CCE" .
<Steroids> <Supportive_med_of> "Bevacizumab_monotherapy" .
<Steroids> <Supportive_med_of> "Bendamustine_and_Obinutuzumab" .
<Fludarabine_and_Melphalan> <Has_antineoplastic> "Melphalan" .
<Fludarabine_and_Melphalan> <Has_antineoplastic> "Fludarabine" .
<Nitrumon> <Brand_name_of> "Carmustine" .
<Cisplatin_and_Dacarbazine> <Has_context> "Non-curative_therapy" .
<Anti-CD27_antibody> <Subsumes> "Varlilumab" .
<GPIIb-IIIa_inhibitor> <Is_a> "Antiplatelet_agent" .
<Definitive_therapy> <Context_of> "Radiation_therapy" .
<Definitive_therapy> <Context_of> "Paclitaxel_and_RT" .
<Definitive_therapy> <Context_of> "Oxaliplatin_and_RT" .
<Definitive_therapy> <Context_of> "Methotrexate,_RT,_Cyclophosphamide" .
<Definitive_therapy> <Context_of> "MVP_and_RT" .
<Definitive_therapy> <Context_of> "Ibritumomab_tiuxetan_monotherapy" .
<Definitive_therapy> <Context_of> "Hydroxyurea_and_RT" .
<Definitive_therapy> <Context_of> "Goserelin_and_RT" .
<Definitive_therapy> <Context_of> "Flutamide,_Leuprolide,_RT" .
<Definitive_therapy> <Context_of> "Flutamide,_Goserelin,_RT" .
<Definitive_therapy> <Context_of> "Fluorouracil,_Paclitaxel,_RT" .
<Definitive_therapy> <Context_of> "Fluorouracil,_Mitomycin,_RT" .
<Definitive_therapy> <Context_of> "Fluorouracil,_Hydroxyurea,_RT" .
<Definitive_therapy> <Context_of> "Fluorouracil_and_RT" .
<Definitive_therapy> <Context_of> "FOLFOX4_and_RT" .
<Definitive_therapy> <Context_of> "Docetaxel,_Fluorouracil,_Hydroxyurea,_RT" .
<Definitive_therapy> <Context_of> "Cisplatin,_Vinorelbine,_RT" .
<Definitive_therapy> <Context_of> "Cisplatin,_Vinblastine,_RT" .
<Definitive_therapy> <Context_of> "Cisplatin,_Paclitaxel,_RT" .
<Definitive_therapy> <Context_of> "Cisplatin,_Gemcitabine,_RT" .
<Definitive_therapy> <Context_of> "Cisplatin,_Fluorouracil,_RT" .
<Definitive_therapy> <Context_of> "Cisplatin,_Fluorouracil,_Hydroxyurea,_RT" .
<Definitive_therapy> <Context_of> "Cisplatin,_Etoposide,_RT" .
<Definitive_therapy> <Context_of> "Cisplatin,_Docetaxel,_RT" .
<Definitive_therapy> <Context_of> "Cisplatin_and_RT" .
<Definitive_therapy> <Context_of> "Cetuximab_and_RT" .
<Definitive_therapy> <Context_of> "Carboplatin,_Vinorelbine,_RT" .
<Definitive_therapy> <Context_of> "Carboplatin,_Paclitaxel,_RT" .
<Definitive_therapy> <Context_of> "Carboplatin,_Fluorouracil,_RT" .
<Definitive_therapy> <Context_of> "Carboplatin,_Fluorouracil,_Cetuximab,_RT" .
<Definitive_therapy> <Context_of> "Carboplatin,_Etoposide,_RT" .
<Definitive_therapy> <Context_of> "Carboplatin_and_RT" .
<Definitive_therapy> <Context_of> "Capecitabine,_Mitomycin,_RT" .
<Definitive_therapy> <Context_of> "Capecitabine,_Cisplatin,_RT" .
<Definitive_therapy> <Context_of> "CEV_and_RT" .
<Definitive_therapy> <Context_of> "CC/DE_and_RT" .
<Definitive_therapy> <Context_of> "CAV_and_RT" .
<Definitive_therapy> <Context_of> "Bleomycin,_Methotrexate,_Vinblastine/RT" .
<Definitive_therapy> <Context_of> "Active_surveillance" .
<Definitive_therapy> <Context_of> "ADT_and_RT" .
<Definitive_therapy> <Context_of> "ADT" .
<Eculizumab> <Immunosuppressor_of> "Eculizumab_monotherapy" .
<Ibrutinib_and_Ofatumumab> <Has_context> "Non-curative_therapy" .
<Ticlopidine> <Has_brand_name> "Tilopin" .
<Ticlopidine> <Has_brand_name> "Ticlid" .
<Ondanles> <Brand_name_of> "Ondansetron" .
<Talazoparib_monotherapy> <Has_antineoplastic> "Talazoparib" .
<Vinblastine_and_Prednisone> <Has_accepted_use> "Langerhans_cell_histiocytosis" .
<Sirolimus> <May_have_route> "Oral" .
<Fulvestrant> <Has_accepted_use> "Breast_cancer" .
<ECF> <Is_current_in> "Gastric_cancer" .
<ECF> <Is_current_in> "Gallbladder_cancer" .
<ECF> <Is_current_in> "Esophageal_cancer" .
<ECF> <Is_current_in> "Cholangiocarcinoma" .
<Vulvar_cancer> <Is_a> "Gynecologic_cancer" .
<Rectal_cancer> <FDA_indication_of> "Oxaliplatin" .
<Rectal_cancer> <FDA_indication_of> "Irinotecan" .
<Rectal_cancer> <FDA_indication_of> "Bevacizumab" .
<Zanubrutinib> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Lomustine_monotherapy> <Has_context> "Non-curative_therapy" .
<ACVBP-R> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<VNCOP-B> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Cisplatin,_Gemcitabine,_RT> <Is_current_in> "Cervical_cancer" .
<ITK_inhibitor> <Subsumes> "Ibrutinib" .
<Vemurafenib> <Is_a> "Mutation-specific_medication" .
<Vemurafenib> <Is_a> "MAP4K5_inhibitor" .
<Vemurafenib> <Is_a> "MAP3K20_inhibitor" .
<Vemurafenib> <Is_a> "MAP2K4_inhibitor" .
<Vemurafenib> <Is_a> "Kinase_inhibitor" .
<Vemurafenib> <Is_a> "BRAF_inhibitor" .
<VAdCA> <Has_local_therapy> "External_beam_radiotherapy" .
<Mycophenolate_mofetil_monotherapy> <Has_immunosuppressor> "Mycophenolate_mofetil" .
<VMCP> <Is_historical_in> "Multiple_myeloma" .
<Nedaplatin> <Is_a> "Platinum_agent" .
<Nedaplatin> <Is_a> "PMDA_approved_drug" .
<Nedaplatin> <Is_a> "Alkylating_agent" .
<Dexaflan> <Brand_name_of> "Dexamethasone" .
<Fludarabine_monotherapy> <Has_modality> "Chemotherapy" .
<R-CHOP> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<R-CHOP> <Is_current_in> "Primary_mediastinal_B-cell_lymphoma" .
<R-CHOP> <Is_current_in> "Post-transplant_lymphoproliferative_disorder" .
<R-CHOP> <Is_current_in> "Marginal_zone_lymphoma" .
<R-CHOP> <Is_current_in> "Mantle_cell_lymphoma" .
<R-CHOP> <Is_current_in> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<R-CHOP> <Is_current_in> "HIV-associated_lymphoma" .
<R-CHOP> <Is_current_in> "Follicular_lymphoma" .
<R-CHOP> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<IFL_and_Bevacizumab> <Has_accepted_use> "Colon_cancer" .
<BCNU/TT> <Has_antineoplastic> "Thiotepa" .
<BCNU/TT> <Has_antineoplastic> "Carmustine" .
<G-CHOP> <Maps_to> "G-CHOP" .
<VMCP/VBAP> <Mapped_from> "VMCP/VBAP" .
<ddTH_(Taxotere)> <Has_modality> "Chemotherapy" .
<Etoposide_monotherapy> <Has_accepted_use> "Testicular_cancer" .
<Etoposide_monotherapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<Etoposide_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Etoposide_monotherapy> <Has_accepted_use> "Kaposi_sarcoma" .
<Etoposide_monotherapy> <Has_accepted_use> "Esophageal_cancer" .
<Etoposide_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Etoposide_monotherapy> <Has_accepted_use> "Anaplastic_glioma" .
<Gazyva> <Brand_name_of> "Obinutuzumab" .
<Betrixaban> <Is_a> "Factor_Xa_inhibitor" .
<Betrixaban> <Is_a> "Direct_oral_anticoagulant" .
<Factor_VIII_human> <Is_a> "Hemostasis_medication" .
<Factor_VIII_human> <Is_a> "Hematology_medication" .
<Factor_VIII_human> <Is_a> "Fractionated_plasma_product" .
<Factor_VIII_human> <Is_a> "Coagulation_factor" .
<Sonidegib> <Has_brand_name> "Odomzo" .
<VAD> <Has_supportive_med> "Zoledronic_acid" .
<VAD> <Has_supportive_med> "Valacyclovir" .
<VAD> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<VAD> <Has_supportive_med> "Pamidronate" .
<VAD> <Has_supportive_med> "Ibandronate" .
<VAD> <Has_supportive_med> "Fluconazole" .
<VAD> <Has_supportive_med> "Cimetidine" .
<VAD> <Has_supportive_med> "Acyclovir" .
<Head_and_neck_cancer> <Subsumes> "Thyroid_cancer" .
<Head_and_neck_cancer> <Subsumes> "Oropharyngeal_cancer" .
<Head_and_neck_cancer> <Subsumes> "Nasopharyngeal_carcinoma" .
<Prednisolone_monotherapy> <Has_immunosuppressor> "Prednisolone" .
<Leucostim> <Brand_name_of> "Filgrastim" .
<Purplz> <Brand_name_of> "Bendamustine" .
<Levoleucovorin> <Has_accepted_use> "Rectal_cancer" .
<Levoleucovorin> <Has_accepted_use> "Pancreatic_cancer" .
<Levoleucovorin> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Levoleucovorin> <Has_accepted_use> "Gastric_cancer" .
<Levoleucovorin> <Has_accepted_use> "Esophageal_cancer" .
<Levoleucovorin> <Has_accepted_use> "Colon_cancer" .
<Levoleucovorin> <Has_accepted_use> "Cholangiocarcinoma" .
<Levoleucovorin> <Has_accepted_use> "Cervical_cancer" .
<CCOP> <Has_antineoplastic> "Vincristine" .
<CCOP> <Has_antineoplastic> "Prednisone" .
<CCOP> <Has_antineoplastic> "Pegylated_liposomal_doxorubicin" .
<CCOP> <Has_antineoplastic> "Cyclophosphamide" .
<Oxaliplatin> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Oxaliplatin> <Is_a> "Platinum_agent" .
<Fluorouracil,_Folinic_acid,_Mitomycin> <Mapped_from> "Fluorouracil,_Folinic_acid,_Mitomycin" .
<Corifact> <Brand_name_of> "Factor_XIII_concentrate_human" .
<R-DHAP/R-VIM> <Has_antineoplastic> "Rituximab" .
<R-DHAP/R-VIM> <Has_antineoplastic> "Methotrexate" .
<R-DHAP/R-VIM> <Has_antineoplastic> "Ifosfamide" .
<R-DHAP/R-VIM> <Has_antineoplastic> "Etoposide" .
<R-DHAP/R-VIM> <Has_antineoplastic> "Dexamethasone" .
<R-DHAP/R-VIM> <Has_antineoplastic> "Cytarabine" .
<R-DHAP/R-VIM> <Has_antineoplastic> "Cisplatin" .
<Regorafenib> <Antineoplastic_of> "Regorafenib_monotherapy" .
<Cyclophosphamide,_Mycophenolate_mofetil,_Tacrolimus> <Has_modality> "Immunosuppressive_therapy" .
<Tremetex> <Brand_name_of> "Methotrexate" .
<Cymer> <Brand_name_of> "Ranimustine" .
<Cytarabine,_Idarubicin,_Rituximab> <Has_antineoplastic> "Rituximab" .
<Cytarabine,_Idarubicin,_Rituximab> <Has_antineoplastic> "Idarubicin" .
<Cytarabine,_Idarubicin,_Rituximab> <Has_antineoplastic> "Cytarabine" .
<Benralizumab> <Has_accepted_use> "Hypereosinophilic_syndrome" .
<iddEPC> <Has_context> "Adjuvant_therapy" .
<Zoledronic_acid_therapy> <Is_current_in> "Multiple_myeloma" .
<Small_cell_lung_cancer> <Is_a> "Lung_cancer" .
<Phenothiazine> <Subsumes> "Promethazine" .
<Phenothiazine> <Subsumes> "Prochlorperazine" .
<Phenothiazine> <Subsumes> "Domperidone" .
<Cixutumumab> <May_have_route> "Intravenous" .
<Clotinex> <Brand_name_of> "Enoxaparin" .
<Cervical_cancer> <FDA_indication_of> "Topotecan" .
<Cervical_cancer> <FDA_indication_of> "Pembrolizumab" .
<Cervical_cancer> <FDA_indication_of> "Bevacizumab-awwb" .
<Cervical_cancer> <FDA_indication_of> "Bevacizumab" .
<OLF> <Has_modality> "Chemotherapy" .
<ATRA,_Cytarabine,_Daunorubicin> <Is_a> "Anthracycline-containing_regimen" .
<WBRT> <Has_context> "Local_therapy" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Ponatinib_monotherapy" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Nilotinib-based_consolidation" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Nilotinib_monotherapy" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Imatinib-based_consolidation" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Imatinib,_Vincristine,_Prednisone" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Imatinib,_Vincristine,_Dexamethasone" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Imatinib_monotherapy" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Imatinib_and_Prednisone" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Hyper-CVAD_and_Ponatinib" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Hyper-CVAD_and_Imatinib" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Hyper-CVAD_and_Dasatinib" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "HAM_and_Imatinib" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Etoposide,_Ifosfamide,_Imatinib" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Etoposide_and_TBI,_then_allo_HSCT" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Dasatinib,_Vincristine,_Prednisone" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Dasatinib_monotherapy" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Dasatinib_and_Prednisone" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cytarabine,_Idarubicin,_Imatinib" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cyclophosphamide_and_TBI,_then_allo_HSCT" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Bosutinib_monotherapy" .
<Ph-positive_B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Blinatumomab_monotherapy" .
<mFOLFOX6_and_RT> <Has_context> "Neoadjuvant_therapy" .
<Carboplatin_and_Cisplatin> <Is_a> "Platinum_doublet" .
<VAD_plus_C> <Is_a> "Anthracycline-containing_regimen" .
<Consolidation_after_salvage_therapy> <Is_a> "Salvage_therapy" .
<Dacarbazine> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Dacarbazine> <Is_a> "Triazene" .
<Dacarbazine> <Is_a> "Purine_analogue" .
<Dacarbazine> <Is_a> "Irritant" .
<Dacarbazine> <Is_a> "DNA_synthesis_inhibitor" .
<Dacarbazine> <Is_a> "Antimetabolite" .
<Dacarbazine> <Is_a> "Alkylating_agent" .
<Afatinib_and_Paclitaxel> <Is_current_in> "Non-small_cell_lung_cancer" .
<DeVIC_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Zomera> <Brand_name_of> "Zoledronic_acid" .
<Tocilizumab> <Is_a> "Antibody_medication" .
<Tocilizumab> <Is_a> "Anti-IL-6R_antibody" .
<Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone> <Maps_to> "Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone" .
<Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat> <Maps_to> "Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat" .
<TVAD_doxil> <Mapped_from> "TVAD_doxil" .
<Anti-PS_antibody> <Subsumes> "Bavituximab" .
<Paxene> <Brand_name_of> "Paclitaxel" .
<Carmustine_wafer_polifeprosan_20> <Has_brand_name> "Gliadel_wafer" .
<Carmustine_wafer_polifeprosan_20> <Has_brand_name> "Biodel" .
<BACO> <Maps_to> "BACO" .
<CRD> <Has_accepted_use> "Multiple_myeloma" .
<ACOMLA> <Mapped_from> "ACOMLA" .
<Dabigatran_monotherapy> <Is_current_in> "Venous_thromboembolism" .
<Pictilisib> <Is_a> "PI3K_delta_inhibitor" .
<Pictilisib> <Is_a> "PI3K_alpha_inhibitor" .
<Pictilisib> <Is_a> "Kinase_inhibitor" .
<Pictilisib> <Is_a> "Investigational_drug" .
<Cyclophosphamide_monotherapy> <Has_immunosuppressor> "Cyclophosphamide" .
<Cyclosporine,_Corticosteroids,_Rituximab> <Is_current_in> "Graft_versus_host_disease" .
<Lupoide_Depot> <Brand_name_of> "Leuprolide" .
<FULV/FULV_and_RT> <Has_accepted_use> "Rectal_cancer" .
<FULV/FULV_and_RT> <Has_accepted_use> "Gastric_cancer" .
<FULV/FULV_and_RT> <Has_accepted_use> "Esophageal_cancer" .
<Thioguanine> <Has_brand_name> "Tabloid" .
<nab-Paclitaxel_and_Trastuzumab> <Maps_to> "nab-Paclitaxel_and_Trastuzumab" .
<EC> <Maps_to> "EC" .
<HAIC_and_Sorafenib> <Mapped_from> "HAIC_and_Sorafenib" .
<FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)> <Has_antineoplastic> "Oxaliplatin" .
<FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)> <Has_antineoplastic> "Levoleucovorin" .
<FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)> <Has_antineoplastic> "Irinotecan" .
<FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)> <Has_antineoplastic> "Fluorouracil" .
<FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)> <Has_antineoplastic> "Bevacizumab" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<PCF> <Mapped_from> "PCF" .
<Niraparib_monotherapy> <Maps_to> "Niraparib_monotherapy" .
<Oseotenk> <Brand_name_of> "Alendronate" .
<Anasmol> <Brand_name_of> "Warfarin" .
<Cilostazol> <May_have_route> "Oral" .
<Caplacizumab> <Is_a> "Hematology_medication" .
<Caplacizumab> <Is_a> "Antibody_medication" .
<Caplacizumab> <Is_a> "Anti-vWF_medication" .
<Cold_agglutinin_disease> <Accepted_use_of> "Rituximab-pvvr" .
<Cold_agglutinin_disease> <Accepted_use_of> "Rituximab-abbs" .
<Cold_agglutinin_disease> <Accepted_use_of> "Rituximab_monotherapy" .
<Cold_agglutinin_disease> <Accepted_use_of> "Rituximab" .
<Cold_agglutinin_disease> <Accepted_use_of> "Fludarabine" .
<Cold_agglutinin_disease> <Accepted_use_of> "FR" .
<Cold_agglutinin_disease> <Accepted_use_of> "Eculizumab_monotherapy" .
<Cold_agglutinin_disease> <Accepted_use_of> "Eculizumab" .
<Cold_agglutinin_disease> <Accepted_use_of> "Bendamustine" .
<Cold_agglutinin_disease> <Accepted_use_of> "BR" .
<Tazemetostat> <May_have_route> "Oral" .
<Ferrlecit> <Brand_name_of> "Ferric_gluconate" .
<Cyclophosphamide,_Prednisone,_Diethylstilbestrol> <Has_supportive_med> "Warfarin" .
<Corsalbene> <Brand_name_of> "Aspirin" .
<Interferon_alfa-2b_and_Prednisone> <Has_accepted_use> "Multiple_myeloma" .
<Antithrombin_III> <Is_a> "Hematology_medication" .
<Antithrombin_III> <Is_a> "Fractionated_plasma_product" .
<Antithrombin_III> <Is_a> "Coagulation_factor" .
<Argatroban> <Has_brand_name> "Novastan" .
<Argatroban> <Has_brand_name> "Exembol" .
<Argatroban> <Has_brand_name> "Acova" .
<Azacitidine_and_Sorafenib> <Has_context> "Non-curative_subsequent-line_therapy" .
<MRD> <Has_context> "Non-curative_first-line_therapy" .
<Essential_thrombocythemia> <Is_a> "Myeloproliferative_neoplasm" .
<Oxaliplatin_and_Bevacizumab> <Mapped_from> "Oxaliplatin_and_Bevacizumab" .
<Larotrectinib> <Antineoplastic_of> "Larotrectinib_monotherapy" .
<CAMFP> <Has_accepted_use> "Breast_cancer" .
<FC> <Maps_to> "FC" .
<BFR> <Has_context> "All_lines_of_therapy" .
<Teniposide_and_WBRT> <Has_modality> "Radiotherapy" .
<Teniposide_and_WBRT> <Has_modality> "Chemotherapy" .
<Valrubicin> <Antineoplastic_of> "Valrubicin_monotherapy" .
<BCNU/TT,_then_auto_HSCT> <Has_context> "Consolidation_after_upfront_therapy" .
<Letrozole_monotherapy> <Maps_to> "Letrozole_monotherapy" .
<Zoldonat> <Brand_name_of> "Zoledronic_acid" .
<Dexawieb> <Brand_name_of> "Dexamethasone" .
<Ifosfamide_and_Gemcitabine> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Ascotran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cotrimaxazol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<FLOX> <Has_modality> "Chemotherapy" .
<Streptozocin> <Antineoplastic_of> "SCAB" .
<Streptozocin> <Antineoplastic_of> "Mitotane_and_Streptozocin" .
<Streptozocin> <Antineoplastic_of> "Fluorouracil_and_Streptozocin" .
<Streptozocin> <Antineoplastic_of> "FAS" .
<Streptozocin> <Antineoplastic_of> "Doxorubicin_and_Streptozocin" .
<Streptozocin> <Antineoplastic_of> "BVDS" .
<Carboplatin_and_Vinorelbine> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone> <Has_context> "Induction_therapy" .
<Avatrombopag_monotherapy> <Mapped_from> "Avatrombopag_monotherapy" .
<131I-Metaiodobenzylguanidine_(131I-MIBG)> <Maps_to> "131I-Metaiodobenzylguanidine_(131I-MIBG)" .
<Augmented_BFM_consolidation> <Maps_to> "Augmented_BFM_consolidation" .
<EGFR_inhibitor> <Subsumes> "Vandetanib" .
<EGFR_inhibitor> <Subsumes> "Rociletinib" .
<EGFR_inhibitor> <Subsumes> "Panitumumab" .
<EGFR_inhibitor> <Subsumes> "Osimertinib" .
<EGFR_inhibitor> <Subsumes> "Neratinib" .
<EGFR_inhibitor> <Subsumes> "Lapatinib" .
<EGFR_inhibitor> <Subsumes> "Icotinib" .
<EGFR_inhibitor> <Subsumes> "Ibrutinib" .
<EGFR_inhibitor> <Subsumes> "Gefitinib" .
<EGFR_inhibitor> <Subsumes> "Erlotinib" .
<EGFR_inhibitor> <Subsumes> "Dacomitinib" .
<EGFR_inhibitor> <Subsumes> "Brigatinib" .
<EGFR_inhibitor> <Subsumes> "Anti-EGFR_antibody" .
<EGFR_inhibitor> <Subsumes> "Afatinib" .
<R-ESHAP> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Tegafur_and_uracil> <Has_accepted_use> "Rectal_cancer" .
<Tegafur_and_uracil> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Tegafur_and_uracil> <Has_accepted_use> "Head_and_neck_cancer" .
<Tegafur_and_uracil> <Has_accepted_use> "Esophageal_cancer" .
<Tegafur_and_uracil> <Has_accepted_use> "Colon_cancer" .
<Biofilgran> <Brand_name_of> "Filgrastim" .
<MVBP> <Has_local_therapy> "Methylprednisolone" .
<MVBP> <Has_local_therapy> "Methotrexate" .
<MVBP> <Has_local_therapy> "Cytarabine" .
<RVDC> <Has_context> "Non-curative_first-line_therapy" .
<Cisplatin,_Docetaxel,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Cisplatin,_Docetaxel,_RT> <Has_antineoplastic> "Docetaxel" .
<Cisplatin,_Docetaxel,_RT> <Has_antineoplastic> "Cisplatin" .
<Carbomedac> <Brand_name_of> "Carboplatin" .
<Tuttozem_N> <Brand_name_of> "Dexamethasone" .
<Valeuprox> <Brand_name_of> "Leuprolide" .
<Bosutinib> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Bosutinib> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Osimertinib_monotherapy> <Has_antineoplastic> "Osimertinib" .
<ADT_and_Darolutamide> <Has_accepted_use> "Prostate_cancer" .
<Atezolizumab_monotherapy> <Has_modality> "Immunotherapy" .
<AV-CMF> <Maps_to> "AV-CMF" .
<Deca_Forte> <Brand_name_of> "Dexamethasone" .
<BiRd> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<BiRd> <Has_supportive_med> "Omeprazole" .
<BiRd> <Has_supportive_med> "Aspirin" .
<MCV> <Has_supportive_med> "Folinic_acid" .
<Contra-Schmerz_ASS> <Brand_name_of> "Aspirin" .
<Decasone> <Brand_name_of> "Dexamethasone" .
<Wellferon> <Brand_name_of> "Interferon_alfa-2b" .
<Entrectinib_monotherapy> <Mapped_from> "Entrectinib_monotherapy" .
<Enfortumab_vedotin_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<Trabectedin> <Is_a> "Vesicant" .
<Trabectedin> <Is_a> "Orphan_drug" .
<Bevacizumab_and_RT> <Is_current_in> "Glioblastoma" .
<Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide> <Has_accepted_use> "Medulloblastoma" .
<Anal_cancer> <Accepted_use_of> "mDCF" .
<Anal_cancer> <Accepted_use_of> "Radiation_therapy" .
<Anal_cancer> <Accepted_use_of> "Pembrolizumab_monotherapy" .
<Anal_cancer> <Accepted_use_of> "Nivolumab_monotherapy" .
<Anal_cancer> <Accepted_use_of> "Mitomycin" .
<Anal_cancer> <Accepted_use_of> "Fluorouracil,_Mitomycin,_RT" .
<Anal_cancer> <Accepted_use_of> "Fluorouracil" .
<Anal_cancer> <Accepted_use_of> "Cisplatin,_Fluorouracil,_RT" .
<Anal_cancer> <Accepted_use_of> "Cisplatin_and_Fluorouracil" .
<Anal_cancer> <Accepted_use_of> "Cisplatin" .
<Anal_cancer> <Accepted_use_of> "Carboplatin_and_Paclitaxel" .
<Anal_cancer> <Accepted_use_of> "Capecitabine,_Mitomycin,_RT" .
<Octreotide_LAR> <Is_a> "Somatostatin_analog" .
<Octreotide_LAR> <Is_a> "Endocrine_therapeutic" .
<Cisplatin,_Etoposide,_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<MBVP> <Is_current_in> "CNS_lymphoma" .
<Systemic_mastocytosis> <Accepted_use_of> "Placebo" .
<Systemic_mastocytosis> <Accepted_use_of> "Nilotinib_monotherapy" .
<Systemic_mastocytosis> <Accepted_use_of> "Nilotinib" .
<Systemic_mastocytosis> <Accepted_use_of> "Midostaurin_monotherapy" .
<Systemic_mastocytosis> <Accepted_use_of> "Midostaurin" .
<Systemic_mastocytosis> <Accepted_use_of> "Masitinib" .
<Systemic_mastocytosis> <Accepted_use_of> "Interferon_alfa-2b_monotherapy" .
<Systemic_mastocytosis> <Accepted_use_of> "Interferon_alfa-2b" .
<Systemic_mastocytosis> <Accepted_use_of> "Imatinib_monotherapy" .
<Systemic_mastocytosis> <Accepted_use_of> "Imatinib" .
<Systemic_mastocytosis> <Accepted_use_of> "Dasatinib_monotherapy" .
<Systemic_mastocytosis> <Accepted_use_of> "Dasatinib" .
<Systemic_mastocytosis> <Accepted_use_of> "Cladribine_monotherapy" .
<Systemic_mastocytosis> <Accepted_use_of> "Cladribine" .
<Apalutamide_monotherapy> <Maps_to> "Apalutamide_monotherapy" .
<Pembrolizumab_monotherapy> <Has_antineoplastic> "Pembrolizumab" .
<Ostel> <Brand_name_of> "Alendronate" .
<RT,_then_Temozolomide> <Mapped_from> "RT,_then_Temozolomide" .
<ABCM> <Is_a> "Anthracycline-containing_regimen" .
<Bexarotene> <Has_FDA_indication> "Cutaneous_T-cell_lymphoma" .
<Dara-Rd> <Mapped_from> "Dara-Rd" .
<Chidamide_monotherapy> <Mapped_from> "Chidamide_monotherapy" .
<CODOX-M/IVAC> <Has_supportive_med> "Sargramostim" .
<CODOX-M/IVAC> <Has_supportive_med> "Mesna" .
<CODOX-M/IVAC> <Has_supportive_med> "Folinic_acid" .
<CODOX-M/IVAC> <Has_supportive_med> "Filgrastim" .
<R-COPADM> <Has_local_therapy> "Methotrexate" .
<R-COPADM> <Has_local_therapy> "Hydrocortisone" .
<Natdecita> <Brand_name_of> "Decitabine" .
<Letrozole_and_Palbociclib> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Letrozole_and_Palbociclib> <Has_accepted_use> "Breast_cancer" .
<Eroprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Talazoparib_monotherapy> <Is_current_in> "Breast_cancer" .
<Bu/TT/Cy,_then_auto_HSCT> <Is_current_in> "CNS_lymphoma" .
<Docetaxel_and_Nintedanib> <Has_modality> "Chemotherapy" .
<Valganciclovir> <Is_a> "DNA_synthesis_inhibitor" .
<Valganciclovir> <Is_a> "Antiviral" .
<Venetoclax_and_Rituximab> <Is_a> "Rituximab-containing_regimen" .
<Paclitaxel_monotherapy> <Has_modality> "Chemotherapy" .
<Chlorpheniramine> <Supportive_med_of> "SMILE" .
<Chlorpheniramine> <Supportive_med_of> "R-GCVP" .
<Chlorpheniramine> <Supportive_med_of> "Paclitaxel_monotherapy" .
<Chlorpheniramine> <Supportive_med_of> "DCF" .
<Chlorpheniramine> <Supportive_med_of> "Carboplatin_and_Paclitaxel" .
<Chlorpheniramine> <Supportive_med_of> "CHOP-AL" .
<Percas> <Brand_name_of> "Etoposide" .
<Thiotepa_monotherapy> <Has_antineoplastic> "Thiotepa" .
<Amoxil> <Brand_name_of> "Amoxicillin" .
<CapeOx,_Cetuximab,_RT> <Has_context> "Neoadjuvant_therapy" .
<CAF_and_MPA> <Has_accepted_use> "Breast_cancer" .
<Carboplatin,_Fluorouracil,_RT> <Has_antineoplastic> "Fluorouracil" .
<Carboplatin,_Fluorouracil,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Carboplatin,_Fluorouracil,_RT> <Has_antineoplastic> "Carboplatin" .
<Biometrox> <Brand_name_of> "Methotrexate" .
<DICE> <Has_context> "Non-curative_subsequent-line_therapy" .
<Vincristin> <Brand_name_of> "Vincristine" .
<Trifluridine_and_tipiracil_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<DA-EPOCH> <Is_a> "Anthracycline-containing_regimen" .
<Melphalan_and_TBI> <Has_modality> "Radiotherapy" .
<Melphalan_and_TBI> <Has_modality> "Chemotherapy" .
<Cisplatin_and_Irinotecan> <Has_modality> "Chemotherapy" .
<FCA> <Has_supportive_med> "Valacyclovir" .
<FCA> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<FCA> <Has_supportive_med> "Acyclovir" .
<Ibritumomab_tiuxetan_monotherapy> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Ibritumomab_tiuxetan_monotherapy> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Ibritumomab_tiuxetan_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<Ibritumomab_tiuxetan_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Bortezomib_and_Melphalan> <Mapped_from> "Bortezomib_and_Melphalan" .
<Bortezomib_and_Vorinostat> <Has_antineoplastic> "Vorinostat" .
<Bortezomib_and_Vorinostat> <Has_antineoplastic> "Bortezomib" .
<Carfilzomib_monotherapy> <Is_current_in> "Multiple_myeloma" .
<ABP> <Maps_to> "ABP" .
<Evoltra> <Brand_name_of> "Clofarabine" .
<Iodine-131> <May_have_route> "Intravenous" .
<Cisplatin_and_Cetuximab> <Is_current_in> "Head_and_neck_cancer" .
<Carboplatin_and_Bevacizumab> <Has_antineoplastic> "Carboplatin" .
<Carboplatin_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Nitrourean> <Brand_name_of> "Carmustine" .
<Busulfan_monotherapy> <Has_context> "Non-curative_therapy" .
<EDC> <Mapped_from> "EDC" .
<PAD> <Has_modality> "Chemotherapy" .
<Matulane> <Brand_name_of> "Procarbazine" .
<Bleo> <Brand_name_of> "Bleomycin" .
<Anti-P-selectin_antibody> <Subsumes> "Crizanlizumab" .
<MACC> <Has_context> "Non-curative_first-line_therapy" .
<MACC> <Has_context> "Induction_therapy" .
<Krebin> <Brand_name_of> "Vincristine" .
<Diphenhydramine> <Is_a> "Antihistamine" .
<Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA> <Maps_to> "Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA" .
<Fludarabine_and_Alemtuzumab> <Has_antineoplastic> "Fludarabine" .
<Fludarabine_and_Alemtuzumab> <Has_antineoplastic> "Alemtuzumab" .
<Prednox> <Brand_name_of> "Methylprednisolone" .
<Omacetaxine_monotherapy> <Has_antineoplastic> "Omacetaxine" .
<GIP> <Has_antineoplastic> "Ifosfamide" .
<GIP> <Has_antineoplastic> "Gemcitabine" .
<GIP> <Has_antineoplastic> "Cisplatin" .
<Levoleucovorin> <Is_a> "Chemotherapy_protective_agent" .
<Lomustine> <Has_brand_name> "Gleostine" .
<Lomustine> <Has_brand_name> "CeeNu" .
<FNC> <Maps_to> "FNC" .
<Olaparib_monotherapy> <Maps_to> "Olaparib_monotherapy" .
<FAC> <Is_a> "Anthracycline-containing_regimen" .
<Niraparib> <Has_FDA_indication> "Ovarian_cancer" .
<MVPP> <Has_context> "Induction_therapy" .
<CHOP_Modified_(Prednisolone)> <Is_a> "Anthracycline-containing_regimen" .
<Tamoxifen_and_OFS> <Maps_to> "Tamoxifen_and_OFS" .
<Lapatinib,_Letrozole,_Trastuzumab> <Has_context> "Non-curative_first-line_therapy" .
<Bencole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin_and_Epirubicin> <Maps_to> "Cisplatin_and_Epirubicin" .
<Danazol> <Antineoplastic_of> "TAD_(Tamoxifen)" .
<Danazol> <Antineoplastic_of> "Danazol_monotherapy" .
<DICEP> <Has_modality> "Chemotherapy" .
<R-CP> <Has_context> "All_lines_of_therapy" .
<MACC> <Is_a> "Anthracycline-containing_regimen" .
<R-CHOP> <Is_a> "Rituximab-containing_regimen" .
<R-CHOP> <Is_a> "Anthracycline-containing_regimen" .
<Everolimus_and_Rituximab> <Mapped_from> "Everolimus_and_Rituximab" .
<Anti-IFNg_antibody> <Subsumes> "Emapalumab" .
<ADT> <Has_context> "Non-curative_therapy" .
<ADT> <Has_context> "Induction_therapy" .
<ADT> <Has_context> "Definitive_therapy" .
<Sipuleucel-T_monotherapy> <Has_supportive_med> "Antihistamines" .
<Sipuleucel-T_monotherapy> <Has_supportive_med> "Acetaminophen" .
<Docetaxel,_Fluorouracil,_RT> <Is_current_in> "Esophageal_cancer" .
<Eltrombopag> <Has_brand_name> "Revolade" .
<Eltrombopag> <Has_brand_name> "Promacta" .
<Eltrombopag> <Has_brand_name> "Eltrom" .
<R-CHOP-14> <Has_antineoplastic> "Vincristine" .
<R-CHOP-14> <Has_antineoplastic> "Rituximab" .
<R-CHOP-14> <Has_antineoplastic> "Prednisone" .
<R-CHOP-14> <Has_antineoplastic> "Doxorubicin" .
<R-CHOP-14> <Has_antineoplastic> "Cyclophosphamide" .
<Cisplatino> <Brand_name_of> "Cisplatin" .
<MAP> <Has_modality> "Chemotherapy" .
<PACEBOM> <Mapped_from> "PACEBOM" .
<Cisplatin,_Paclitaxel,_RT> <Is_current_in> "Head_and_neck_cancer" .
<Cisplatin,_Paclitaxel,_RT> <Is_current_in> "Esophageal_cancer" .
<Cisplatin,_Paclitaxel,_RT> <Is_current_in> "Bladder_cancer" .
<Daunorubicin> <Antineoplastic_of> "Nilotinib-based_consolidation" .
<Daunorubicin> <Antineoplastic_of> "Linker_regimen_(consolidation)" .
<Daunorubicin> <Antineoplastic_of> "International_ALL_Trial" .
<Daunorubicin> <Antineoplastic_of> "HAD" .
<Daunorubicin> <Antineoplastic_of> "Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib" .
<Daunorubicin> <Antineoplastic_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone" .
<Daunorubicin> <Antineoplastic_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Daunorubicin> <Antineoplastic_of> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib" .
<Daunorubicin> <Antineoplastic_of> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Daunorubicin> <Antineoplastic_of> "Daunorubicin_monotherapy" .
<Daunorubicin> <Antineoplastic_of> "Daunorubicin_and_Prednisone" .
<Daunorubicin> <Antineoplastic_of> "DOLP_(Prednisolone)" .
<Daunorubicin> <Antineoplastic_of> "DOLP" .
<Daunorubicin> <Antineoplastic_of> "DCTER" .
<Daunorubicin> <Antineoplastic_of> "DAT" .
<Daunorubicin> <Antineoplastic_of> "DAC" .
<Daunorubicin> <Antineoplastic_of> "DA_3_plus_10,_GO" .
<Daunorubicin> <Antineoplastic_of> "DA_3_plus_10" .
<Daunorubicin> <Antineoplastic_of> "D-ZAPO" .
<Daunorubicin> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_Vincristine" .
<Daunorubicin> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone" .
<Daunorubicin> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone" .
<Daunorubicin> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone" .
<Daunorubicin> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin" .
<Daunorubicin> <Antineoplastic_of> "Cytarabine_and_Daunorubicin" .
<Daunorubicin> <Antineoplastic_of> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone" .
<Daunorubicin> <Antineoplastic_of> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone" .
<Daunorubicin> <Antineoplastic_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab" .
<Daunorubicin> <Antineoplastic_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Daunorubicin> <Antineoplastic_of> "Calaspargase,_Daunorubicin,_Vincristine,_Prednisone" .
<Daunorubicin> <Antineoplastic_of> "Arsenic_trioxide,_then_ATRA_and_Daunorubicin" .
<Daunorubicin> <Antineoplastic_of> "ATRA,_Cytarabine,_Daunorubicin" .
<Daunorubicin> <Antineoplastic_of> "ATRA_and_Daunorubicin" .
<Daunorubicin> <Antineoplastic_of> "ADE_and_ATRA" .
<Daunorubicin> <Antineoplastic_of> "ADE_(standard-dose_Ara-C)" .
<Daunorubicin> <Antineoplastic_of> "ADE_(high-dose_Ara-C)" .
<Daunorubicin> <Antineoplastic_of> "7_plus_3d_and_Sorafenib" .
<Daunorubicin> <Antineoplastic_of> "7_plus_3d_and_Midostaurin" .
<Daunorubicin> <Antineoplastic_of> "7_plus_3d_and_Glasdegib" .
<Daunorubicin> <Antineoplastic_of> "7_plus_3d_and_GO" .
<Daunorubicin> <Antineoplastic_of> "7_plus_3d" .
<Daunorubicin> <Antineoplastic_of> "5_plus_3d" .
<Daunorubicin> <Antineoplastic_of> "5_plus_2d" .
<Tofacitinib> <Has_brand_name> "Xeljanz" .
<Consolidation_after_salvage_therapy> <Context_of> "Z-BEAM,_then_auto_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "Radiation_therapy" .
<Consolidation_after_salvage_therapy> <Context_of> "R-TBI/Cy,_then_auto_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "R-BEAM,_then_auto_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "LEED,_then_auto_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "FluBuCy,_then_allo_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "Flu-Mel,_then_allo_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "FEAM,_then_auto_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "Etoposide_monotherapy" .
<Consolidation_after_salvage_therapy> <Context_of> "ESHAP" .
<Consolidation_after_salvage_therapy> <Context_of> "Cytarabine_and_Thioguanine" .
<Consolidation_after_salvage_therapy> <Context_of> "Cyclophosphamide_and_TBI,_then_auto_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "Cyclophosphamide_and_TBI,_then_allo_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "Clofarabine_and_Melphalan,_then_allo_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "Carboplatin_and_Etoposide,_then_auto_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "CYVE" .
<Consolidation_after_salvage_therapy> <Context_of> "CBV-Mx,_then_auto_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "CBV,_then_auto_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "Busulfan_and_Melphalan,_then_auto_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "BuFlu,_then_allo_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "BuCy,_then_allo_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "Bu/TT/Cy,_then_auto_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "BeEAM,_then_auto_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "BFR,_then_allo_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "BEAM,_then_auto_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "BEAM,_then_allo_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "BEAC,_then_auto_HSCT" .
<Consolidation_after_salvage_therapy> <Context_of> "Arsenic_trioxide_monotherapy" .
<GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab> <Is_current_in> "Neuroblastoma" .
<COPADM> <Has_antineoplastic> "Vincristine" .
<COPADM> <Has_antineoplastic> "Prednisone" .
<COPADM> <Has_antineoplastic> "Methotrexate" .
<COPADM> <Has_antineoplastic> "Doxorubicin" .
<COPADM> <Has_antineoplastic> "Cyclophosphamide" .
<mDCF_and_Bevacizumab> <Has_antineoplastic> "Folinic_acid" .
<mDCF_and_Bevacizumab> <Has_antineoplastic> "Fluorouracil" .
<mDCF_and_Bevacizumab> <Has_antineoplastic> "Docetaxel" .
<mDCF_and_Bevacizumab> <Has_antineoplastic> "Cisplatin" .
<mDCF_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Ifosfamide> <Has_accepted_use> "Thymoma" .
<Ifosfamide> <Has_accepted_use> "Testicular_cancer" .
<Ifosfamide> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Ifosfamide> <Has_accepted_use> "Small_cell_lung_cancer" .
<Ifosfamide> <Has_accepted_use> "Rhabdomyosarcoma" .
<Ifosfamide> <Has_accepted_use> "Penile_cancer" .
<Ifosfamide> <Has_accepted_use> "Osteosarcoma" .
<Ifosfamide> <Has_accepted_use> "NK-_and_T-cell_lymphoma" .
<Ifosfamide> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Ifosfamide> <Has_accepted_use> "Hodgkin_lymphoma" .
<Ifosfamide> <Has_accepted_use> "HIV-associated_lymphoma" .
<Ifosfamide> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Ifosfamide> <Has_accepted_use> "Ewing_sarcoma" .
<Ifosfamide> <Has_accepted_use> "Endometrial_cancer" .
<Ifosfamide> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Ifosfamide> <Has_accepted_use> "Cervical_cancer" .
<Ifosfamide> <Has_accepted_use> "CNS_lymphoma" .
<Ifosfamide> <Has_accepted_use> "Burkitt_lymphoma" .
<VMCP/VCAP> <Is_historical_in> "Multiple_myeloma" .
<Biotrexate> <Brand_name_of> "Methotrexate" .
<Lactulose> <May_have_route> "Oral" .
<Dacarbazine> <Antineoplastic_of> "RABVD" .
<Dacarbazine> <Antineoplastic_of> "MOPP/ABVD" .
<Dacarbazine> <Antineoplastic_of> "MAID" .
<Dacarbazine> <Antineoplastic_of> "Dacarbazine_monotherapy" .
<Dacarbazine> <Antineoplastic_of> "Dacarbazine_and_Tamoxifen" .
<Dacarbazine> <Antineoplastic_of> "Dacarbazine_and_Ipilimumab" .
<Dacarbazine> <Antineoplastic_of> "Dacarbazine_and_Interferon_alfa-2a" .
<Dacarbazine> <Antineoplastic_of> "Dacarbazine_and_Gemcitabine" .
<Dacarbazine> <Antineoplastic_of> "Dacarbazine_and_Doxorubicin" .
<Dacarbazine> <Antineoplastic_of> "Cyclophosphamide,_Dacarbazine,_Vincristine" .
<Dacarbazine> <Antineoplastic_of> "Cisplatin,_Dacarbazine,_Tamoxifen" .
<Dacarbazine> <Antineoplastic_of> "Cisplatin,_Dacarbazine,_Paclitaxel" .
<Dacarbazine> <Antineoplastic_of> "Cisplatin,_Dacarbazine,_Interferon_alfa-2b" .
<Dacarbazine> <Antineoplastic_of> "Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine" .
<Dacarbazine> <Antineoplastic_of> "Cisplatin_and_Dacarbazine" .
<Dacarbazine> <Antineoplastic_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Dacarbazine> <Antineoplastic_of> "CVD_(Vindesine)" .
<Dacarbazine> <Antineoplastic_of> "CVD_(Vinblastine)" .
<Dacarbazine> <Antineoplastic_of> "COPP/ABVD" .
<Dacarbazine> <Antineoplastic_of> "COPDAC" .
<Dacarbazine> <Antineoplastic_of> "CDB" .
<Dacarbazine> <Antineoplastic_of> "Brentuximab_vedotin_and_Dacarbazine" .
<Dacarbazine> <Antineoplastic_of> "BVD" .
<Dacarbazine> <Antineoplastic_of> "BHD" .
<Dacarbazine> <Antineoplastic_of> "BCG_and_Dacarbazine" .
<Dacarbazine> <Antineoplastic_of> "AVD" .
<Dacarbazine> <Antineoplastic_of> "ABVDm" .
<Dacarbazine> <Antineoplastic_of> "ABVD,_DD-DI" .
<Dacarbazine> <Antineoplastic_of> "ABVD" .
<Dacarbazine> <Antineoplastic_of> "ABDIC" .
<Dacarbazine> <Antineoplastic_of> "A-AVD" .
<Clofarabine_and_Cytarabine> <Has_context> "Salvage_therapy" .
<Ceritinib> <Is_a> "ROS1_inhibitor" .
<Ceritinib> <Is_a> "Mutation-specific_medication" .
<Ceritinib> <Is_a> "Kinase_inhibitor" .
<Ceritinib> <Is_a> "IGFR_inhibitor" .
<Ceritinib> <Is_a> "FDA_approved_drug" .
<Ceritinib> <Is_a> "ALK_inhibitor" .
<Enoxaparin> <Has_accepted_use> "Venous_thromboembolism" .
<Streptozocin> <Has_accepted_use> "Pancreatic_NET" .
<Streptozocin> <Has_accepted_use> "Adrenocortical_carcinoma" .
<Darbepoetin_alfa> <Supportive_med_of> "ddAC" .
<Darbepoetin_alfa> <Supportive_med_of> "R-CDOP" .
<Darbepoetin_alfa> <Supportive_med_of> "Omacetaxine_monotherapy" .
<Darbepoetin_alfa> <Supportive_med_of> "DA-R-EPOCH" .
<Darbepoetin_alfa> <Supportive_med_of> "Carboplatin_and_nab-Paclitaxel" .
<Cyclosporine,_Methotrexate,_Prednisone> <Has_immunosuppressor> "Prednisone" .
<Cyclosporine,_Methotrexate,_Prednisone> <Has_immunosuppressor> "Methotrexate" .
<Cyclosporine,_Methotrexate,_Prednisone> <Has_immunosuppressor> "Cyclosporine_modified" .
<Breoprin> <Brand_name_of> "Aspirin" .
<AKT1_inhibitor> <Subsumes> "Perifosine" .
<AKT1_inhibitor> <Subsumes> "Ipatasertib" .
<AKT1_inhibitor> <Subsumes> "Capivasertib" .
<AKT1_inhibitor> <Subsumes> "Afuresertib" .
<Alemtuzumab_monotherapy> <Has_modality> "Immunosuppressive_therapy" .
<Alemtuzumab_monotherapy> <Has_modality> "Chemotherapy" .
<CHOP-BCG> <Has_modality> "Immunotherapy" .
<CHOP-BCG> <Has_modality> "Chemotherapy" .
<Maxaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<HiDAC_and_Midostaurin> <Mapped_from> "HiDAC_and_Midostaurin" .
<Stivarga> <Brand_name_of> "Regorafenib" .
<Lomustine_monotherapy> <Maps_to> "Lomustine_monotherapy" .
<Clofarabine_and_Melphalan,_then_allo_HSCT> <Is_current_in> "Acute_myeloid_leukemia" .
<Oropharyngeal_cancer> <Subsumes> "HPV-positive_Oropharyngeal_cancer" .
<Larotrectinib> <Has_brand_name> "Vitrakvi" .
<Chlorambucil> <Has_brand_name> "Linfoxan" .
<Chlorambucil> <Has_brand_name> "Leukeran" .
<Chlorambucil> <Has_brand_name> "Chlorobutin" .
<Chlorambucil> <Has_brand_name> "Chlorbutin" .
<Chlorambucil> <Has_brand_name> "Chloraminophene" .
<Chlorambucil> <Has_brand_name> "Chlorambusil" .
<Ipilimumab_monotherapy> <Has_modality> "Immunotherapy" .
<Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<MCP_(Prednisolone)> <Is_a> "Anthracycline-containing_regimen" .
<Imukin> <Brand_name_of> "Interferon_alfa-2b" .
<SMILE> <Has_antineoplastic> "Methotrexate" .
<SMILE> <Has_antineoplastic> "Mesna" .
<SMILE> <Has_antineoplastic> "Ifosfamide" .
<SMILE> <Has_antineoplastic> "Etoposide" .
<SMILE> <Has_antineoplastic> "Dexamethasone" .
<SMILE> <Has_antineoplastic> "Asparaginase" .
<Valrubicin_monotherapy> <Mapped_from> "Valrubicin_monotherapy" .
<Panitumumab_monotherapy> <Is_current_in> "Penile_cancer" .
<Panitumumab_monotherapy> <Is_current_in> "Colon_cancer" .
<Doxorubicin_and_Vinblastine> <Has_antineoplastic> "Vinblastine" .
<Doxorubicin_and_Vinblastine> <Has_antineoplastic> "Doxorubicin" .
<Lorazepam> <Supportive_med_of> "Docetaxel_monotherapy" .
<Lorazepam> <Supportive_med_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<BR_and_Polatuzumab_vedotin> <Mapped_from> "BR_and_Polatuzumab_vedotin" .
<Cisplatin_and_Docetaxel> <Has_modality> "Chemotherapy" .
<Diethylstilbestrol> <Has_accepted_use> "Prostate_cancer" .
<Diethylstilbestrol> <Has_accepted_use> "Breast_cancer" .
<Fasenra> <Brand_name_of> "Benralizumab" .
<Hematopoietic_growth_factors> <Supportive_med_of> "Imatinib_monotherapy" .
<Hematopoietic_growth_factors> <Supportive_med_of> "FCR" .
<Hematopoietic_growth_factors> <Supportive_med_of> "Dasatinib_monotherapy" .
<PFT> <Has_antineoplastic> "Tamoxifen" .
<PFT> <Has_antineoplastic> "Melphalan" .
<PFT> <Has_antineoplastic> "Fluorouracil" .
<Dexamethasone_monotherapy> <Has_accepted_use> "Multiple_myeloma" .
<Dexamethasone_monotherapy> <Has_accepted_use> "Immune_thrombocytopenia" .
<Dexamethasone_monotherapy> <Has_accepted_use> "CNS_carcinoma" .
<Metoxiprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<ERBB3_(HER3)_medication> <Subsumes> "Neratinib" .
<Ravulizumab_monotherapy> <Is_current_in> "Paroxysmal_nocturnal_hemoglobinuria" .
<MACOP-B> <Has_local_therapy> "Methotrexate" .
<Carboplatin_and_Docetaxel> <Has_modality> "Chemotherapy" .
<EIA> <Is_current_in> "Soft_tissue_sarcoma" .
<Erlanison> <Brand_name_of> "Prednisone" .
<Cyclophosphamide,_Lomustine,_Methotrexate> <Has_antineoplastic> "Methotrexate" .
<Cyclophosphamide,_Lomustine,_Methotrexate> <Has_antineoplastic> "Lomustine" .
<Cyclophosphamide,_Lomustine,_Methotrexate> <Has_antineoplastic> "Cyclophosphamide" .
<GEMOX-B> <Is_current_in> "Gallbladder_cancer" .
<GEMOX-B> <Is_current_in> "Cholangiocarcinoma" .
<Exemestane_monotherapy> <Has_antineoplastic> "Exemestane" .
<Cisplatin_and_Pemetrexed> <Is_current_in> "Non-small_cell_lung_cancer" .
<Cisplatin_and_Pemetrexed> <Is_current_in> "Mesothelioma" .
<Estramustine> <Antineoplastic_of> "Docetaxel_and_Estramustine" .
<Estramustine> <Antineoplastic_of> "ADT,_Docetaxel,_Estramustine" .
<MVP_and_RT> <Has_modality> "Radiotherapy" .
<MVP_and_RT> <Has_modality> "Chemotherapy" .
<IT_Cytarabine_and_WBRT> <Has_accepted_use> "CNS_leukemia" .
<Carboplatin_and_Fluorouracil> <Has_context> "Non-curative_first-line_therapy" .
<Carboplatin_and_Fluorouracil> <Has_context> "Adjuvant_therapy" .
<Erdafitinib> <Has_accepted_use> "Bladder_cancer" .
<CAPIRI> <Mapped_from> "CAPIRI" .
<Aprepitant> <Is_a> "Neurokinin_1_(NK1)_antagonist" .
<Aprepitant> <Is_a> "Emesis_prevention" .
<Essential_thrombocythemia> <Accepted_use_of> "Ruxolitinib_monotherapy" .
<Essential_thrombocythemia> <Accepted_use_of> "Peginterferon_alfa-2a_monotherapy" .
<Essential_thrombocythemia> <Accepted_use_of> "Peginterferon_alfa-2a" .
<Essential_thrombocythemia> <Accepted_use_of> "Observation" .
<Essential_thrombocythemia> <Accepted_use_of> "Imetelstat" .
<Essential_thrombocythemia> <Accepted_use_of> "Hydroxyurea_monotherapy" .
<Essential_thrombocythemia> <Accepted_use_of> "Hydroxyurea" .
<Essential_thrombocythemia> <Accepted_use_of> "Aspirin_and_Hydroxyurea" .
<Essential_thrombocythemia> <Accepted_use_of> "Aspirin_and_Anagrelide" .
<Essential_thrombocythemia> <Accepted_use_of> "Anagrelide_monotherapy" .
<Essential_thrombocythemia> <Accepted_use_of> "Anagrelide" .
<Ponatinib_monotherapy> <Is_current_in> "Chronic_myelogenous_leukemia" .
<Ponatinib_monotherapy> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Magnecyl> <Brand_name_of> "Aspirin" .
<CEV_(Carboplatin/Etoposide)> <Has_antineoplastic> "Vincristine" .
<CEV_(Carboplatin/Etoposide)> <Has_antineoplastic> "Etoposide" .
<CEV_(Carboplatin/Etoposide)> <Has_antineoplastic> "Carboplatin" .
<PAD_doxil> <Maps_to> "PAD_doxil" .
<Doxorubicin_non-pegylated_liposomal_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Prostate_cancer> <Accepted_use_of> "Vinblastine_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Triptorelin_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Triptorelin" .
<Prostate_cancer> <Accepted_use_of> "Sipuleucel-T_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Sipuleucel-T" .
<Prostate_cancer> <Accepted_use_of> "Samarium-153_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Samarium-153" .
<Prostate_cancer> <Accepted_use_of> "Radium-223_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Radium-223" .
<Prostate_cancer> <Accepted_use_of> "Radiation_therapy" .
<Prostate_cancer> <Accepted_use_of> "Prednisone_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Prednisone" .
<Prostate_cancer> <Accepted_use_of> "Prednisolone" .
<Prostate_cancer> <Accepted_use_of> "Placebo" .
<Prostate_cancer> <Accepted_use_of> "Paclitaxel" .
<Prostate_cancer> <Accepted_use_of> "Olaparib_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Olaparib" .
<Prostate_cancer> <Accepted_use_of> "Observation" .
<Prostate_cancer> <Accepted_use_of> "Nilutamide_and_Orchiectomy" .
<Prostate_cancer> <Accepted_use_of> "Nilutamide" .
<Prostate_cancer> <Accepted_use_of> "Mitoxantrone_and_Prednisone" .
<Prostate_cancer> <Accepted_use_of> "Mitoxantrone_and_Hydrocortisone" .
<Prostate_cancer> <Accepted_use_of> "Mitoxantrone" .
<Prostate_cancer> <Accepted_use_of> "Methotrexate" .
<Prostate_cancer> <Accepted_use_of> "Leuprolide_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Leuprolide" .
<Prostate_cancer> <Accepted_use_of> "Ketoconazole,_Hydrocortisone,_Dutasteride" .
<Prostate_cancer> <Accepted_use_of> "Ketoconazole_and_Hydrocortisone" .
<Prostate_cancer> <Accepted_use_of> "Ketoconazole" .
<Prostate_cancer> <Accepted_use_of> "Ipilimumab_and_RT" .
<Prostate_cancer> <Accepted_use_of> "Ipilimumab" .
<Prostate_cancer> <Accepted_use_of> "Intermittent_ADT" .
<Prostate_cancer> <Accepted_use_of> "Hydrocortisone_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Histrelin_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Histrelin" .
<Prostate_cancer> <Accepted_use_of> "Goserelin_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Goserelin_and_RT" .
<Prostate_cancer> <Accepted_use_of> "Goserelin" .
<Prostate_cancer> <Accepted_use_of> "Flutamide,_Leuprolide,_RT" .
<Prostate_cancer> <Accepted_use_of> "Flutamide,_Goserelin,_RT" .
<Prostate_cancer> <Accepted_use_of> "Flutamide_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Flutamide_and_Leuprolide" .
<Prostate_cancer> <Accepted_use_of> "Flutamide_and_Goserelin" .
<Prostate_cancer> <Accepted_use_of> "Flutamide" .
<Prostate_cancer> <Accepted_use_of> "Fluorouracil" .
<Prostate_cancer> <Accepted_use_of> "Finasteride" .
<Prostate_cancer> <Accepted_use_of> "Estramustine" .
<Prostate_cancer> <Accepted_use_of> "Enzalutamide_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Enzalutamide" .
<Prostate_cancer> <Accepted_use_of> "Dutasteride" .
<Prostate_cancer> <Accepted_use_of> "Doxorubicin_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Doxorubicin_and_Strontium-89" .
<Prostate_cancer> <Accepted_use_of> "Docetaxel_and_Prednisone" .
<Prostate_cancer> <Accepted_use_of> "Docetaxel_and_Prednisolone" .
<Prostate_cancer> <Accepted_use_of> "Docetaxel_and_Estramustine" .
<Prostate_cancer> <Accepted_use_of> "Docetaxel" .
<Prostate_cancer> <Accepted_use_of> "Diethylstilbestrol" .
<Prostate_cancer> <Accepted_use_of> "Degarelix_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Degarelix" .
<Prostate_cancer> <Accepted_use_of> "Darolutamide" .
<Prostate_cancer> <Accepted_use_of> "DES_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Cyproterone_acetate_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Cyproterone_acetate" .
<Prostate_cancer> <Accepted_use_of> "Cyclophosphamide,_Prednisone,_Diethylstilbestrol" .
<Prostate_cancer> <Accepted_use_of> "Cyclophosphamide_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Cyclophosphamide" .
<Prostate_cancer> <Accepted_use_of> "Custirsen" .
<Prostate_cancer> <Accepted_use_of> "Cortisone_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Castration" .
<Prostate_cancer> <Accepted_use_of> "Carboplatin,_Docetaxel,_Prednisone" .
<Prostate_cancer> <Accepted_use_of> "Carboplatin_and_Paclitaxel" .
<Prostate_cancer> <Accepted_use_of> "Carboplatin_and_Docetaxel" .
<Prostate_cancer> <Accepted_use_of> "Carboplatin" .
<Prostate_cancer> <Accepted_use_of> "Cabozantinib_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Cabozantinib" .
<Prostate_cancer> <Accepted_use_of> "Cabazitaxel_and_Prednisone" .
<Prostate_cancer> <Accepted_use_of> "Cabazitaxel" .
<Prostate_cancer> <Accepted_use_of> "CMF" .
<Prostate_cancer> <Accepted_use_of> "Bicalutamide_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Bicalutamide_and_RT" .
<Prostate_cancer> <Accepted_use_of> "Bicalutamide_and_Leuprolide" .
<Prostate_cancer> <Accepted_use_of> "Bicalutamide_and_Goserelin" .
<Prostate_cancer> <Accepted_use_of> "Bicalutamide" .
<Prostate_cancer> <Accepted_use_of> "Aspirin_and_Dexamethasone" .
<Prostate_cancer> <Accepted_use_of> "Apalutamide_monotherapy" .
<Prostate_cancer> <Accepted_use_of> "Apalutamide" .
<Prostate_cancer> <Accepted_use_of> "Antiandrogen_withdrawal" .
<Prostate_cancer> <Accepted_use_of> "Aminoglutethimide" .
<Prostate_cancer> <Accepted_use_of> "Active_surveillance" .
<Prostate_cancer> <Accepted_use_of> "Abiraterone_and_Prednisone" .
<Prostate_cancer> <Accepted_use_of> "Abiraterone" .
<Prostate_cancer> <Accepted_use_of> "ADT,_Docetaxel,_Estramustine" .
<Prostate_cancer> <Accepted_use_of> "ADT_and_RT" .
<Prostate_cancer> <Accepted_use_of> "ADT_and_Enzalutamide" .
<Prostate_cancer> <Accepted_use_of> "ADT_and_Docetaxel" .
<Prostate_cancer> <Accepted_use_of> "ADT_and_Darolutamide" .
<Prostate_cancer> <Accepted_use_of> "ADT_and_Apalutamide" .
<Prostate_cancer> <Accepted_use_of> "ADT_and_Abiraterone" .
<Prostate_cancer> <Accepted_use_of> "ADT" .
<Histrelin_monotherapy> <Has_context> "Non-curative_therapy" .
<EP> <Has_context> "Non-curative_first-line_therapy" .
<EP> <Has_context> "Neoadjuvant_therapy" .
<EP> <Has_context> "Adjuvant_therapy" .
<Nichiaspirin> <Brand_name_of> "Aspirin" .
<System> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Non-curative_first-line_maintenance_therapy> <Is_a> "Non-curative_first-line_therapy" .
<BASIC> <Is_a> "Rituximab-containing_regimen" .
<AspaMetDex_(Erwinaze)> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Pomalidomide,_Dexamethasone,_Pembrolizumab> <Has_accepted_use> "Multiple_myeloma" .
<Chemoradioimmunotherapy> <Maps_to> "Chemoradioimmunotherapy" .
<Doxocris> <Brand_name_of> "Doxorubicin" .
<Null_therapy> <Mapped_from> "Null_therapy" .
<Medroxyprogesterone_monotherapy> <Has_antineoplastic> "Medroxyprogesterone" .
<Sacituzumab_govitecan> <May_have_route> "Intravenous" .
<Porosal> <Brand_name_of> "Alendronate" .
<Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine> <Has_accepted_use> "Medulloblastoma" .
<Atezolizumab_and_Bevacizumab> <Maps_to> "Atezolizumab_and_Bevacizumab" .
<Velbastine> <Brand_name_of> "Vinblastine" .
<Siltuximab_monotherapy> <Has_accepted_use> "Castleman_disease" .
<ADT_and_Darolutamide> <Has_context> "Non-curative_therapy" .
<Lorlatinib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Hypomethylating_agent> <Is_a> "Drugs_by_class_effect" .
<GCD-R> <Is_a> "Rituximab-containing_regimen" .
<Ifamet> <Brand_name_of> "Methotrexate" .
<Methotrexate_and_Prednisone> <Has_accepted_use> "Large_granular_lymphocytic_leukemia" .
<GEMOX-B> <Has_antineoplastic> "Oxaliplatin" .
<GEMOX-B> <Has_antineoplastic> "Gemcitabine" .
<GEMOX-B> <Has_antineoplastic> "Bevacizumab" .
<Draspir> <Brand_name_of> "Aspirin" .
<Selectrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin> <Has_brand_name> "Unistin" .
<Cisplatin> <Has_brand_name> "Tisplal" .
<Cisplatin> <Has_brand_name> "Tecnoplatin" .
<Cisplatin> <Has_brand_name> "Sisplanil" .
<Cisplatin> <Has_brand_name> "Sinplatin" .
<Cisplatin> <Has_brand_name> "Sicatem" .
<Cisplatin> <Has_brand_name> "Romcis" .
<Cisplatin> <Has_brand_name> "Randa" .
<Cisplatin> <Has_brand_name> "Platosin" .
<Cisplatin> <Has_brand_name> "Platistine" .
<Cisplatin> <Has_brand_name> "Platistin" .
<Cisplatin> <Has_brand_name> "Platistil" .
<Cisplatin> <Has_brand_name> "Platiran" .
<Cisplatin> <Has_brand_name> "Platinoxan" .
<Cisplatin> <Has_brand_name> "Platinox" .
<Cisplatin> <Has_brand_name> "Platinol" .
<Cisplatin> <Has_brand_name> "Platino_II_Filaxis" .
<Cisplatin> <Has_brand_name> "Platinil" .
<Cisplatin> <Has_brand_name> "Platinex" .
<Cisplatin> <Has_brand_name> "Platin" .
<Cisplatin> <Has_brand_name> "Platimit" .
<Cisplatin> <Has_brand_name> "Platil" .
<Cisplatin> <Has_brand_name> "Platikem" .
<Cisplatin> <Has_brand_name> "Platidiam" .
<Cisplatin> <Has_brand_name> "Platicis" .
<Cisplatin> <Has_brand_name> "Platiblastin" .
<Cisplatin> <Has_brand_name> "Platamine" .
<Cisplatin> <Has_brand_name> "Platamin" .
<Cisplatin> <Has_brand_name> "Plastistil" .
<Cisplatin> <Has_brand_name> "Placis" .
<Cisplatin> <Has_brand_name> "Peyrone's_Salt" .
<Cisplatin> <Has_brand_name> "Peyrone's_Chloride" .
<Cisplatin> <Has_brand_name> "Oncoplatin_AQ" .
<Cisplatin> <Has_brand_name> "Noveldexis" .
<Cisplatin> <Has_brand_name> "Neoplatin" .
<Cisplatin> <Has_brand_name> "Neoplat" .
<Cisplatin> <Has_brand_name> "Metaplatin" .
<Cisplatin> <Has_brand_name> "Lederplatin" .
<Cisplatin> <Has_brand_name> "Kemoplat" .
<Cisplatin> <Has_brand_name> "Ifapla" .
<Cisplatin> <Has_brand_name> "Fauldcispla" .
<Cisplatin> <Has_brand_name> "Elvecis" .
<Cisplatin> <Has_brand_name> "Docistin" .
<Cisplatin> <Has_brand_name> "Cytoplatin" .
<Cisplatin> <Has_brand_name> "Cysplatyna" .
<Cisplatin> <Has_brand_name> "Citosin" .
<Cisplatin> <Has_brand_name> "Citoplatino" .
<Cisplatin> <Has_brand_name> "Cisteen" .
<Cisplatin> <Has_brand_name> "Cisplatyl" .
<Cisplatin> <Has_brand_name> "Cisplatino" .
<Cisplatin> <Has_brand_name> "Cisplatine" .
<Cisplatin> <Has_brand_name> "Cisplatex" .
<Cisplatin> <Has_brand_name> "Cisplasol" .
<Cisplatin> <Has_brand_name> "Cisplan" .
<Cisplatin> <Has_brand_name> "Cisplamerck" .
<Cisplatin> <Has_brand_name> "Cispatin" .
<Cisplatin> <Has_brand_name> "Cismaplat" .
<Cisplatin> <Has_brand_name> "Cis-GRY" .
<Cisplatin> <Has_brand_name> "Ciplexal" .
<Cisplatin> <Has_brand_name> "Ciplatan" .
<Cisplatin> <Has_brand_name> "Ceplatin" .
<Cisplatin> <Has_brand_name> "C-Platin" .
<Cisplatin> <Has_brand_name> "Brisplatin" .
<Cisplatin> <Has_brand_name> "Briplatin" .
<Cisplatin> <Has_brand_name> "Blastolem" .
<Cisplatin> <Has_brand_name> "Bioplatino" .
<Cisplatin> <Has_brand_name> "Biocisplatinum" .
<Cisplatin> <Has_brand_name> "Axiplat" .
<Cisplatin> <Has_brand_name> "Abiplatin" .
<Pertuzumab_and_Trastuzumab> <Has_antineoplastic> "Trastuzumab" .
<Pertuzumab_and_Trastuzumab> <Has_antineoplastic> "Pertuzumab" .
<Valganciclovir> <May_have_route> "Oral" .
<Bone_sarcoma> <FDA_indication_of> "Levoleucovorin" .
<Doxorubicin,_Methotrexate,_Vincristine,_Prednisone> <Is_a> "Anthracycline-containing_regimen" .
<Epidrone> <Brand_name_of> "Dexamethasone" .
<Mercaptopurine,_Methotrexate,_WB-XRT> <Mapped_from> "Mercaptopurine,_Methotrexate,_WB-XRT" .
<CEP> <Mapped_from> "CEP" .
<Decitabine_and_Venetoclax> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Anticoagulation> <Maps_to> "Anticoagulation" .
<Thalidomide_and_Rituximab> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<Oxaliplatin_and_RT> <Has_modality> "Radiotherapy" .
<Oxaliplatin_and_RT> <Has_modality> "Chemotherapy" .
<Nedaplatin> <Has_brand_name> "Jiebaishu" .
<Nedaplatin> <Has_brand_name> "Aqupla" .
<Fluoropyrimidine> <Is_a> "Pyrimidine_analogue" .
<TLI_and_ATG> <Mapped_from> "TLI_and_ATG" .
<R-MegaCHOP-14> <Is_a> "Rituximab-containing_regimen" .
<R-MegaCHOP-14> <Is_a> "Anthracycline-containing_regimen" .
<ProMACE-MOPP> <Maps_to> "ProMACE-MOPP" .
<ERBB3_inhibitor> <Is_a> "Kinase_inhibitor" .
<CVB> <Has_antineoplastic> "Vinblastine" .
<CVB> <Has_antineoplastic> "Lomustine" .
<CVB> <Has_antineoplastic> "Bleomycin" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone> <Has_modality> "Chemotherapy" .
<Nonsteroidal_anti-inflammatory_drugs_(NSAIDs)> <Subsumes> "COX-2_inhibitor" .
<Nonsteroidal_anti-inflammatory_drugs_(NSAIDs)> <Subsumes> "COX-1_inhibitor" .
<Bortezomib_and_Panobinostat> <Has_modality> "Chemotherapy" .
<Amsacrine_and_Cytarabine> <Has_accepted_use> "Acute_myeloid_leukemia" .
<ECT,_then_auto_HSCT> <Maps_to> "ECT,_then_auto_HSCT" .
<Gefitinib_and_Pemetrexed> <Has_antineoplastic> "Pemetrexed" .
<Gefitinib_and_Pemetrexed> <Has_antineoplastic> "Gefitinib" .
<Ipilimumab_and_RT> <Has_antineoplastic> "Ipilimumab" .
<Ipilimumab_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Peginterferon_alfa-2b> <Is_a> "Pegylated_medication" .
<Peginterferon_alfa-2b> <Is_a> "PMDA_approved_drug" .
<Peginterferon_alfa-2b> <Is_a> "Interferon" .
<Peginterferon_alfa-2b> <Is_a> "Immunotherapeutic" .
<Bioepicyna> <Brand_name_of> "Epirubicin" .
<Cyclophosphamide_and_Vincristine> <Maps_to> "Cyclophosphamide_and_Vincristine" .
<Venetoclax_and_Obinutuzumab> <Has_context> "Non-curative_first-line_therapy" .
<Mogamulizumab> <Antineoplastic_of> "Mogamulizumab_monotherapy" .
<Hyper-CVAD_and_Imatinib> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<OLF> <Has_accepted_use> "Pancreatic_cancer" .
<OLF> <Has_accepted_use> "Gastric_cancer" .
<Definitive_therapy> <Mapped_from> "Definitive_therapy" .
<IROX> <Is_current_in> "Colon_cancer" .
<RUI_Ting> <Brand_name_of> "Anastrozole" .
<Cytarabine,_Idarubicin,_Imatinib> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Cytarabine,_Idarubicin,_Imatinib> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Immune_thrombocytopenia> <Current_treated_by> "TT4" .
<Immune_thrombocytopenia> <Current_treated_by> "Romiplostim_monotherapy" .
<Immune_thrombocytopenia> <Current_treated_by> "Rituximab_monotherapy" .
<Immune_thrombocytopenia> <Current_treated_by> "RhIG_monotherapy" .
<Immune_thrombocytopenia> <Current_treated_by> "Prednisone_monotherapy" .
<Immune_thrombocytopenia> <Current_treated_by> "Placebo" .
<Immune_thrombocytopenia> <Current_treated_by> "Mycophenolate_mofetil_monotherapy" .
<Immune_thrombocytopenia> <Current_treated_by> "Intravenous_immunoglobulin_monotherapy" .
<Immune_thrombocytopenia> <Current_treated_by> "Fostamatinib_monotherapy" .
<Immune_thrombocytopenia> <Current_treated_by> "Eltrombopag_monotherapy" .
<Immune_thrombocytopenia> <Current_treated_by> "Dexamethasone_monotherapy" .
<Immune_thrombocytopenia> <Current_treated_by> "Dexamethasone_and_Rituximab" .
<Immune_thrombocytopenia> <Current_treated_by> "Dexamethasone_and_Eltrombopag" .
<Immune_thrombocytopenia> <Current_treated_by> "Danazol_monotherapy" .
<Immune_thrombocytopenia> <Current_treated_by> "Cyclosporine_monotherapy" .
<Immune_thrombocytopenia> <Current_treated_by> "Avatrombopag_monotherapy" .
<Immune_thrombocytopenia> <Current_treated_by> "ATRA_and_Danazol" .
<Etoposide_and_Mitoxantrone> <Has_context> "Salvage_therapy" .
<Etoposide_and_Mitoxantrone> <Has_context> "Consolidation_after_upfront_therapy" .
<Thiotepa_monotherapy> <Is_historical_in> "Breast_cancer" .
<PCR> <Maps_to> "PCR" .
<Etoposide,_Ifosfamide,_Methotrexate> <Mapped_from> "Etoposide,_Ifosfamide,_Methotrexate" .
<Graniset> <Brand_name_of> "Granisetron" .
<R-CHOP> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<R-CHOP> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<R-CHOP> <Has_accepted_use> "Post-transplant_lymphoproliferative_disorder" .
<R-CHOP> <Has_accepted_use> "Marginal_zone_lymphoma" .
<R-CHOP> <Has_accepted_use> "Mantle_cell_lymphoma" .
<R-CHOP> <Has_accepted_use> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<R-CHOP> <Has_accepted_use> "HIV-associated_lymphoma" .
<R-CHOP> <Has_accepted_use> "Follicular_lymphoma" .
<R-CHOP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Rheumatrex> <Brand_name_of> "Methotrexate" .
<Carboplatin_and_Vinorelbine> <Is_current_in> "Non-small_cell_lung_cancer" .
<MBVP> <Maps_to> "MBVP" .
<TH_(Taxotere)> <Has_modality> "Chemotherapy" .
<Taxane> <Is_a> "Microtubule_inhibitor" .
<Taxane> <Is_a> "Chemotherapeutic" .
<Pertuzumab> <Is_a> "Protein_expression-specific_medication" .
<Pertuzumab> <Is_a> "ERBB2_(HER2)_medication" .
<Pertuzumab> <Is_a> "Antibody_medication" .
<Pertuzumab> <Is_a> "Anti-HER2_antibody" .
<FOLFIRI_and_Cetuximab> <Has_modality> "Chemotherapy" .
<Paclitaxel_and_S-1> <Has_modality> "Chemotherapy" .
<CALGB_8811_late_intensification> <Has_modality> "Chemotherapy" .
<Xeroprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<VcR-CVAD> <Has_context> "Non-curative_first-line_therapy" .
<Melphalan> <May_have_route> "Oral" .
<Melphalan> <May_have_route> "Intravenous" .
<CEPP(B)> <Mapped_from> "CEPP(B)" .
<Modifical> <Brand_name_of> "Ondansetron" .
<Levamisole_monotherapy> <Is_historical_in> "Breast_cancer" .
<Carboplatin,_Docetaxel,_Prednisone> <Has_context> "Non-curative_therapy" .
<Clofarabine> <May_have_route> "Oral" .
<Clofarabine> <May_have_route> "Intravenous" .
<Cytarabine,_Idarubicin,_Sorafenib> <Has_modality> "Chemotherapy" .
<Oradin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Doxorubicinum> <Brand_name_of> "Doxorubicin" .
<FOLFOX4_(L-Leucovorin)> <Has_context> "Non-curative_subsequent-line_therapy" .
<FOLFOX4_(L-Leucovorin)> <Has_context> "Non-curative_first-line_therapy" .
<mFOLFOX7_(L-Leucovorin)> <Mapped_from> "mFOLFOX7_(L-Leucovorin)" .
<Ibrutinib_and_Ofatumumab> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Icotinib_monotherapy> <Has_antineoplastic> "Icotinib" .
<Hodgkin_lymphoma> <Historic_treated_by> "Vinblastine_monotherapy" .
<Hodgkin_lymphoma> <Historic_treated_by> "Sirolimus_and_Vorinostat" .
<Hodgkin_lymphoma> <Historic_treated_by> "SCAB" .
<Hodgkin_lymphoma> <Historic_treated_by> "NOVP" .
<Hodgkin_lymphoma> <Historic_treated_by> "Mechlorethamine_monotherapy" .
<Hodgkin_lymphoma> <Historic_treated_by> "MVPP" .
<Hodgkin_lymphoma> <Historic_treated_by> "MOPP/ABVD" .
<Hodgkin_lymphoma> <Historic_treated_by> "LOPP/EVAP" .
<Hodgkin_lymphoma> <Historic_treated_by> "LOPP" .
<Hodgkin_lymphoma> <Historic_treated_by> "Doxorubicin_and_Vinblastine" .
<Hodgkin_lymphoma> <Historic_treated_by> "Doxorubicin_and_Lomustine" .
<Hodgkin_lymphoma> <Historic_treated_by> "ChlVPP/PABIOE" .
<Hodgkin_lymphoma> <Historic_treated_by> "Carmustine_monotherapy" .
<Hodgkin_lymphoma> <Historic_treated_by> "CVPP" .
<Hodgkin_lymphoma> <Historic_treated_by> "CVB" .
<Hodgkin_lymphoma> <Historic_treated_by> "COPP/ABVD" .
<Hodgkin_lymphoma> <Historic_treated_by> "COPP_(CCNU)" .
<Hodgkin_lymphoma> <Historic_treated_by> "COMP" .
<Hodgkin_lymphoma> <Historic_treated_by> "CEP" .
<Hodgkin_lymphoma> <Historic_treated_by> "Bacillus_Calmette-Guerin_(BCG)_monotherapy" .
<Hodgkin_lymphoma> <Historic_treated_by> "BVDS" .
<Hodgkin_lymphoma> <Historic_treated_by> "BVCPP" .
<Hodgkin_lymphoma> <Historic_treated_by> "BCVPP" .
<Hodgkin_lymphoma> <Historic_treated_by> "B-CAVe" .
<Hodgkin_lymphoma> <Historic_treated_by> "ABVDm" .
<Hodgkin_lymphoma> <Historic_treated_by> "ABVD" .
<Hodgkin_lymphoma> <Historic_treated_by> "ABDIC" .
<VCP> <Has_context> "Non-curative_first-line_therapy" .
<Chlorpheniramine> <Has_brand_name> "Piriton" .
<Chlorpheniramine> <Has_brand_name> "Chlor-Trimeton" .
<Biocure> <Brand_name_of> "Bortezomib" .
<Calaspargase> <Is_a> "Pegylated_medication" .
<Calaspargase> <Is_a> "Neutral" .
<Calaspargase> <Is_a> "Enzyme" .
<Carboplatin,_Etoposide,_Bevacizumab> <Maps_to> "Carboplatin,_Etoposide,_Bevacizumab" .
<Tabloid> <Brand_name_of> "Thioguanine" .
<Lanreotide_monotherapy> <Has_antineoplastic> "Lanreotide" .
<Capecitabine_and_RT> <Is_current_in> "Rectal_cancer" .
<Cytomegalovirus_Immune_Globulin> <May_have_route> "Intravenous" .
<Interferon_alfa_monotherapy> <Is_current_in> "Mantle_cell_lymphoma" .
<Interferon_alfa_monotherapy> <Is_current_in> "Chronic_myelogenous_leukemia" .
<Dabrafenib> <Has_accepted_use> "Thyroid_cancer" .
<Dabrafenib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Dabrafenib> <Has_accepted_use> "Melanoma" .
<Dabrafenib> <Has_accepted_use> "BRAF-mutated_malignancy" .
<CMED> <Has_context> "Induction_therapy" .
<Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone> <Is_a> "Anthracycline-containing_regimen" .
<Eltrombopag> <Supportive_med_of> "Eltrombopag_monotherapy" .
<Eltrombopag> <Supportive_med_of> "Eculizumab_monotherapy" .
<Eltrombopag> <Supportive_med_of> "Dexamethasone_and_Eltrombopag" .
<Eltrombopag> <Supportive_med_of> "ATG_(Horse),_Cyclosporine,_Eltrombopag" .
<GVD> <Has_antineoplastic> "Vinorelbine" .
<GVD> <Has_antineoplastic> "Pegylated_liposomal_doxorubicin" .
<GVD> <Has_antineoplastic> "Gemcitabine" .
<Gefitinib_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Gefitinib_monotherapy> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<Lupron_Depot> <Brand_name_of> "Leuprolide" .
<Bortezomib> <Antineoplastic_of> "VcR-CVAD" .
<Bortezomib> <Antineoplastic_of> "VTP" .
<Bortezomib> <Antineoplastic_of> "VTD-PACE" .
<Bortezomib> <Antineoplastic_of> "VTD" .
<Bortezomib> <Antineoplastic_of> "VT" .
<Bortezomib> <Antineoplastic_of> "VR-CP" .
<Bortezomib> <Antineoplastic_of> "VR-CHOP" .
<Bortezomib> <Antineoplastic_of> "VR-CAP" .
<Bortezomib> <Antineoplastic_of> "VR" .
<Bortezomib> <Antineoplastic_of> "VP" .
<Bortezomib> <Antineoplastic_of> "VMPT" .
<Bortezomib> <Antineoplastic_of> "VMP/Rd" .
<Bortezomib> <Antineoplastic_of> "VMP,_then_Rd" .
<Bortezomib> <Antineoplastic_of> "VMP" .
<Bortezomib> <Antineoplastic_of> "VMD" .
<Bortezomib> <Antineoplastic_of> "VDC" .
<Bortezomib> <Antineoplastic_of> "VD" .
<Bortezomib> <Antineoplastic_of> "V-HyperCAD" .
<Bortezomib> <Antineoplastic_of> "Total_Therapy" .
<Bortezomib> <Antineoplastic_of> "RiPAD_plus_C" .
<Bortezomib> <Antineoplastic_of> "RVR" .
<Bortezomib> <Antineoplastic_of> "RVDC" .
<Bortezomib> <Antineoplastic_of> "RVD" .
<Bortezomib> <Antineoplastic_of> "PVD" .
<Bortezomib> <Antineoplastic_of> "PAD/VCD" .
<Bortezomib> <Antineoplastic_of> "PAD_doxil" .
<Bortezomib> <Antineoplastic_of> "PAD" .
<Bortezomib> <Antineoplastic_of> "Elo-VD" .
<Bortezomib> <Antineoplastic_of> "Dara-VTD" .
<Bortezomib> <Antineoplastic_of> "Dara-VMP" .
<Bortezomib> <Antineoplastic_of> "Dara-VD" .
<Bortezomib> <Antineoplastic_of> "Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat" .
<Bortezomib> <Antineoplastic_of> "Bortezomib,_Dexamethasone,_Panobinostat" .
<Bortezomib> <Antineoplastic_of> "Bortezomib_monotherapy" .
<Bortezomib> <Antineoplastic_of> "Bortezomib_and_Vorinostat" .
<Bortezomib> <Antineoplastic_of> "Bortezomib_and_Panobinostat" .
<Bortezomib> <Antineoplastic_of> "Bortezomib_and_Melphalan,_then_auto_HSCT" .
<Bortezomib> <Antineoplastic_of> "Bortezomib_and_Melphalan" .
<Bortezomib> <Antineoplastic_of> "Bortezomib_and_Doxorubicin_liposomal" .
<Bortezomib> <Antineoplastic_of> "Bortezomib_and_Cyclophosphamide" .
<Bortezomib> <Antineoplastic_of> "BVR" .
<Bortezomib> <Antineoplastic_of> "BDR" .
<Bortezomib> <Antineoplastic_of> "BCHOP" .
<Bortezomib> <Antineoplastic_of> "BBD" .
<Inflammitant> <Subsumes> "Methotrexate" .
<Inflammitant> <Subsumes> "Azacitidine" .
<Lenalidomide_monotherapy> <Maps_to> "Lenalidomide_monotherapy" .
<Doxifluridine> <May_have_route> "Oral" .
<Novatrex> <Brand_name_of> "Methotrexate" .
<Dhasolone> <Brand_name_of> "Prednisolone" .
<Samarium-153_with_stem_cell_support> <Is_current_in> "Osteosarcoma" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Has_local_therapy> "Methotrexate" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Has_local_therapy> "Folinic_acid" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Has_local_therapy> "Cytarabine" .
<BeEAM,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Pidexon> <Brand_name_of> "Dexamethasone" .
<FAMTX> <Is_a> "Anthracycline-containing_regimen" .
<Dasatinib,_Vincristine,_Prednisone> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Dasatinib,_Vincristine,_Prednisone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Elo-PD> <Is_current_in> "Multiple_myeloma" .
<Rextop> <Brand_name_of> "Methotrexate" .
<Carboplatin_and_Teniposide> <Has_antineoplastic> "Teniposide" .
<Carboplatin_and_Teniposide> <Has_antineoplastic> "Carboplatin" .
<Gobens_Trim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Clofarabine_and_LoDAC> <Has_modality> "Chemotherapy" .
<Cisplatin_and_Cetuximab> <Is_a> "Platinum_doublet" .
<Cisplatin_and_RT> <Has_context> "Neoadjuvant_therapy" .
<Cisplatin_and_RT> <Has_context> "Induction_therapy" .
<Cisplatin_and_RT> <Has_context> "Definitive_therapy" .
<Cisplatin_and_RT> <Has_context> "Consolidation_after_upfront_therapy" .
<Cisplatin_and_RT> <Has_context> "All_lines_of_therapy" .
<Cisplatin_and_RT> <Has_context> "Adjuvant_therapy" .
<TCHP_(Taxol)> <Mapped_from> "TCHP_(Taxol)" .
<Measurin> <Brand_name_of> "Aspirin" .
<Belinostat> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Belinostat> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Fluorouracil,_Folinic_acid,_RT> <Has_accepted_use> "Rectal_cancer" .
<BEAC> <Has_context> "All_lines_of_therapy" .
<Deoxycytidine_analogue> <Subsumes> "Cytarabine_liposomal" .
<Deoxycytidine_analogue> <Subsumes> "Cytarabine_and_daunorubicin_liposomal" .
<Deoxycytidine_analogue> <Subsumes> "Cytarabine" .
<Pentostatin_monotherapy> <Has_accepted_use> "Hairy_cell_leukemia" .
<Pentostatin_monotherapy> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Doxorubicina> <Brand_name_of> "Doxorubicin" .
<Tocilizumab> <Has_brand_name> "Actemra" .
<Kemoplat> <Brand_name_of> "Cisplatin" .
<Arsenic_trioxide,_then_ATRA_and_Daunorubicin> <Mapped_from> "Arsenic_trioxide,_then_ATRA_and_Daunorubicin" .
<Fluoropyrimidine> <Subsumes> "Trifluridine_and_tipiracil" .
<Fluoropyrimidine> <Subsumes> "Tegafur_gimeracil_oteracil" .
<Fluoropyrimidine> <Subsumes> "Tegafur_and_uracil" .
<Fluoropyrimidine> <Subsumes> "Fluorouracil" .
<Fluoropyrimidine> <Subsumes> "Floxuridine" .
<Fluoropyrimidine> <Subsumes> "Doxifluridine" .
<Fluoropyrimidine> <Subsumes> "Capecitabine" .
<Flocot> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<MA> <Is_current_in> "Osteosarcoma" .
<CRD> <Is_current_in> "Multiple_myeloma" .
<BR_and_Ibrutinib> <Mapped_from> "BR_and_Ibrutinib" .
<Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone> <Is_a> "Anthracycline-containing_regimen" .
<Dexamethasone_monotherapy> <Maps_to> "Dexamethasone_monotherapy" .
<Capecitabine_and_Temozolomide> <Has_accepted_use> "Pancreatic_NET" .
<Carboplatin,_Paclitaxel,_Bevacizumab> <Has_context> "Non-curative_second-line_therapy" .
<Carboplatin,_Paclitaxel,_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<Daunorubicin_liposomal_monotherapy> <Has_modality> "Chemotherapy" .
<POMP> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<POMP> <Has_context> "Maintenance_after_upfront_therapy" .
<POMP> <Has_context> "Consolidation_after_upfront_therapy" .
<CNS_leukemia> <Is_a> "CNS_cancer" .
<Hexastat> <Brand_name_of> "Altretamine" .
<Decacort> <Brand_name_of> "Methylprednisolone" .
<Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Mapped_from> "Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Maxibone> <Brand_name_of> "Alendronate" .
<Cisplatin_and_Cetuximab> <Has_antineoplastic> "Cisplatin" .
<Cisplatin_and_Cetuximab> <Has_antineoplastic> "Cetuximab" .
<Vandetanib_monotherapy> <Is_current_in> "Thyroid_cancer" .
<Carboplatin,_Vinorelbine,_RT> <Has_context> "Definitive_therapy" .
<THL_(Taxol)> <Maps_to> "THL_(Taxol)" .
<Dolasetron> <Supportive_med_of> "Irinotecan_monotherapy" .
<Dolasetron> <Supportive_med_of> "Irinotecan_and_Bevacizumab" .
<Dolasetron> <Supportive_med_of> "Cisplatin,_Cetuximab,_RT" .
<O-CHOP> <Mapped_from> "O-CHOP" .
<CHOEP-14> <Mapped_from> "CHOEP-14" .
<Orgastran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Hentaxel> <Brand_name_of> "Docetaxel" .
<Merkel_cell_carcinoma> <Is_a> "Skin_cancer" .
<MVP_and_RT> <Has_context> "Definitive_therapy" .
<Bu/TT> <Has_context> "All_lines_of_therapy" .
<Aminoglutethimide> <Has_brand_name> "Orimetene" .
<Aminoglutethimide> <Has_brand_name> "Orimeten" .
<Aminoglutethimide> <Has_brand_name> "Cytadren" .
<VAD-P> <Mapped_from> "VAD-P" .
<Alpelisib_and_Fulvestrant> <Has_antineoplastic> "Fulvestrant" .
<Alpelisib_and_Fulvestrant> <Has_antineoplastic> "Alpelisib" .
<M-Trim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Anagrelide_monotherapy> <Is_current_in> "Polycythemia_vera" .
<Anagrelide_monotherapy> <Is_current_in> "Essential_thrombocythemia" .
<Puvasoralen> <Brand_name_of> "Methoxsalen" .
<Pantoprazole> <Is_a> "Proton_pump_inhibitor" .
<Factor_XIII_concentrate_human> <Is_a> "Hemostasis_medication" .
<Factor_XIII_concentrate_human> <Is_a> "Hematology_medication" .
<Factor_XIII_concentrate_human> <Is_a> "Fractionated_plasma_product" .
<Factor_XIII_concentrate_human> <Is_a> "Coagulation_factor" .
<Induction_therapy> <Context_of> "mLSG15" .
<Induction_therapy> <Context_of> "mFOLFIRINOX,_Gemcitabine,_RT" .
<Induction_therapy> <Context_of> "m-BNCOD" .
<Induction_therapy> <Context_of> "m-BACOD" .
<Induction_therapy> <Context_of> "eBEACOPP" .
<Induction_therapy> <Context_of> "Vincristine_and_Prednisone" .
<Induction_therapy> <Context_of> "Vinblastine_monotherapy" .
<Induction_therapy> <Context_of> "Vinblastine_and_Prednisone" .
<Induction_therapy> <Context_of> "VR-CHOP" .
<Induction_therapy> <Context_of> "VNCOP-B" .
<Induction_therapy> <Context_of> "VMV-VAC" .
<Induction_therapy> <Context_of> "VIP" .
<Induction_therapy> <Context_of> "VEPEMB" .
<Induction_therapy> <Context_of> "VEPA" .
<Induction_therapy> <Context_of> "VEBEP" .
<Induction_therapy> <Context_of> "VCAP" .
<Induction_therapy> <Context_of> "VAMP_(Methotrexate)" .
<Induction_therapy> <Context_of> "VAMP_(Amethopterin)" .
<Induction_therapy> <Context_of> "VACOP-B" .
<Induction_therapy> <Context_of> "VABE" .
<Induction_therapy> <Context_of> "Teniposide_monotherapy" .
<Induction_therapy> <Context_of> "Tamibarotene_monotherapy" .
<Induction_therapy> <Context_of> "TT4" .
<Induction_therapy> <Context_of> "Stanford_V" .
<Induction_therapy> <Context_of> "SMILE" .
<Induction_therapy> <Context_of> "SCAB" .
<Induction_therapy> <Context_of> "Ruxolitinib_monotherapy" .
<Induction_therapy> <Context_of> "Rituximab_monotherapy" .
<Induction_therapy> <Context_of> "RhIG_monotherapy" .
<Induction_therapy> <Context_of> "Radiation_therapy" .
<Induction_therapy> <Context_of> "RABVD" .
<Induction_therapy> <Context_of> "R2CHOP" .
<Induction_therapy> <Context_of> "R-miniCHOP" .
<Induction_therapy> <Context_of> "R-miniCEOP" .
<Induction_therapy> <Context_of> "R-MegaCHOP-14" .
<Induction_therapy> <Context_of> "R-MegaCHOP" .
<Induction_therapy> <Context_of> "R-Hyper-CVAD/R-MA" .
<Induction_therapy> <Context_of> "R-GCVP" .
<Induction_therapy> <Context_of> "R-EPOCH" .
<Induction_therapy> <Context_of> "R-CVP" .
<Induction_therapy> <Context_of> "R-COPADM" .
<Induction_therapy> <Context_of> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Induction_therapy> <Context_of> "R-CODOX-M/R-IVAC" .
<Induction_therapy> <Context_of> "R-CODOX-M_(Doxil_substituted)" .
<Induction_therapy> <Context_of> "R-CODOX-M" .
<Induction_therapy> <Context_of> "R-CHOP-14_(Rituximab_Hycela)" .
<Induction_therapy> <Context_of> "R-CHOP-14_(Prednisolone)" .
<Induction_therapy> <Context_of> "R-CHOP-14" .
<Induction_therapy> <Context_of> "R-CHOP_(Rituximab_Hycela)" .
<Induction_therapy> <Context_of> "R-CHOP_(Prednisolone)" .
<Induction_therapy> <Context_of> "R-CHOP" .
<Induction_therapy> <Context_of> "R-CHOEP-14" .
<Induction_therapy> <Context_of> "R-CHMP" .
<Induction_therapy> <Context_of> "R-CEOP90_(Epirubicin)" .
<Induction_therapy> <Context_of> "R-CEOP_(Etoposide)" .
<Induction_therapy> <Context_of> "R-CDOP" .
<Induction_therapy> <Context_of> "R-BL" .
<Induction_therapy> <Context_of> "ProMACE-MOPP" .
<Induction_therapy> <Context_of> "ProMACE-CytaBOM" .
<Induction_therapy> <Context_of> "Prednisone_monotherapy" .
<Induction_therapy> <Context_of> "Prednisolone_monotherapy" .
<Induction_therapy> <Context_of> "Plasma_exchange" .
<Induction_therapy> <Context_of> "Pentostatin_monotherapy" .
<Induction_therapy> <Context_of> "Pentostatin_and_Alemtuzumab" .
<Induction_therapy> <Context_of> "Peginterferon_alfa-2a_monotherapy" .
<Induction_therapy> <Context_of> "Pegaspargase,_Vincristine,_Prednisone" .
<Induction_therapy> <Context_of> "Paclitaxel_and_RT" .
<Induction_therapy> <Context_of> "PVAG" .
<Induction_therapy> <Context_of> "PMitCEBO" .
<Induction_therapy> <Context_of> "PEV" .
<Induction_therapy> <Context_of> "PEN" .
<Induction_therapy> <Context_of> "PCF" .
<Induction_therapy> <Context_of> "PCE" .
<Induction_therapy> <Context_of> "PCDE" .
<Induction_therapy> <Context_of> "PATCO" .
<Induction_therapy> <Context_of> "PACEBOM" .
<Induction_therapy> <Context_of> "P/DOCE" .
<Induction_therapy> <Context_of> "OPPA" .
<Induction_therapy> <Context_of> "OEPA" .
<Induction_therapy> <Context_of> "O-miniCHOP" .
<Induction_therapy> <Context_of> "No_induction" .
<Induction_therapy> <Context_of> "NOVP" .
<Induction_therapy> <Context_of> "Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin" .
<Induction_therapy> <Context_of> "Methotrexate,_Vinblastine,_Prednisone" .
<Induction_therapy> <Context_of> "Methotrexate_and_Prednisone" .
<Induction_therapy> <Context_of> "Mercaptopurine_monotherapy" .
<Induction_therapy> <Context_of> "Mercaptopurine_and_Prednisone" .
<Induction_therapy> <Context_of> "Mercaptopurine_and_Methotrexate" .
<Induction_therapy> <Context_of> "Mechlorethamine_monotherapy" .
<Induction_therapy> <Context_of> "MVPP" .
<Induction_therapy> <Context_of> "MOPP/ABVD" .
<Induction_therapy> <Context_of> "MOPP-ABV" .
<Induction_therapy> <Context_of> "MOPP" .
<Induction_therapy> <Context_of> "MIC" .
<Induction_therapy> <Context_of> "MESA/RT" .
<Induction_therapy> <Context_of> "MEC" .
<Induction_therapy> <Context_of> "MACOP-B" .
<Induction_therapy> <Context_of> "MACC" .
<Induction_therapy> <Context_of> "Leuprolide_monotherapy" .
<Induction_therapy> <Context_of> "LVP_.22Sandwich.22" .
<Induction_therapy> <Context_of> "LSG15" .
<Induction_therapy> <Context_of> "LOPP/EVAP" .
<Induction_therapy> <Context_of> "LOPP" .
<Induction_therapy> <Context_of> "LD-ACOP-B" .
<Induction_therapy> <Context_of> "L-Asparaginase,_Vincristine,_Prednisone" .
<Induction_therapy> <Context_of> "L-Asparaginase,_Vincristine,_Prednisolone" .
<Induction_therapy> <Context_of> "L-Asparaginase,_Vincristine,_Dexamethasone" .
<Induction_therapy> <Context_of> "Intravenous_immunoglobulin_monotherapy" .
<Induction_therapy> <Context_of> "Interferon_alfa-2b_and_Zidovudine" .
<Induction_therapy> <Context_of> "Imatinib,_Vincristine,_Dexamethasone" .
<Induction_therapy> <Context_of> "Imatinib_monotherapy" .
<Induction_therapy> <Context_of> "Imatinib_and_Prednisone" .
<Induction_therapy> <Context_of> "Ifosfamide_monotherapy" .
<Induction_therapy> <Context_of> "ICL" .
<Induction_therapy> <Context_of> "ICE" .
<Induction_therapy> <Context_of> "HyperCHidam" .
<Induction_therapy> <Context_of> "Hyper-CVAD/MA" .
<Induction_therapy> <Context_of> "Hyper-CVAD_and_Ponatinib" .
<Induction_therapy> <Context_of> "Hyper-CVAD_and_Imatinib" .
<Induction_therapy> <Context_of> "Hyper-CVAD_and_Dasatinib" .
<Induction_therapy> <Context_of> "Hydroxyurea_and_Plicamycin" .
<Induction_therapy> <Context_of> "Helicobacter_pylori_eradication_therapy" .
<Induction_therapy> <Context_of> "HOP" .
<Induction_therapy> <Context_of> "HLH-94_regimen" .
<Induction_therapy> <Context_of> "HLH-2004_regimen" .
<Induction_therapy> <Context_of> "HAD" .
<Induction_therapy> <Context_of> "HAA" .
<Induction_therapy> <Context_of> "Gemcitabine,_Cetuximab,_RT" .
<Induction_therapy> <Context_of> "Gemcitabine_monotherapy" .
<Induction_therapy> <Context_of> "Gemcitabine_and_RT" .
<Induction_therapy> <Context_of> "GemOx" .
<Induction_therapy> <Context_of> "GMALL-R" .
<Induction_therapy> <Context_of> "GELOX/RT" .
<Induction_therapy> <Context_of> "GDPT" .
<Induction_therapy> <Context_of> "Flutamide_and_Goserelin" .
<Induction_therapy> <Context_of> "Fluorouracil,_Mitomycin,_RT" .
<Induction_therapy> <Context_of> "Fluorouracil_and_RT" .
<Induction_therapy> <Context_of> "FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation" .
<Induction_therapy> <Context_of> "FLOT" .
<Induction_therapy> <Context_of> "FLEP" .
<Induction_therapy> <Context_of> "FLEC" .
<Induction_therapy> <Context_of> "FLAG-Ida" .
<Induction_therapy> <Context_of> "F-MACHOP" .
<Induction_therapy> <Context_of> "Etoposide,_Vinblastine,_Prednisone" .
<Induction_therapy> <Context_of> "Etoposide_and_Prednisone" .
<Induction_therapy> <Context_of> "Erlotinib_and_Gemcitabine" .
<Induction_therapy> <Context_of> "EVI" .
<Induction_therapy> <Context_of> "EPOCH" .
<Induction_therapy> <Context_of> "EOX" .
<Induction_therapy> <Context_of> "EOF" .
<Induction_therapy> <Context_of> "ECX" .
<Induction_therapy> <Context_of> "ECF" .
<Induction_therapy> <Context_of> "EBVP" .
<Induction_therapy> <Context_of> "Doxorubicin,_Methotrexate,_Vincristine,_Prednisone" .
<Induction_therapy> <Context_of> "Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone" .
<Induction_therapy> <Context_of> "Doxorubicin_and_Vinblastine" .
<Induction_therapy> <Context_of> "Docetaxel,_Gemcitabine,_RT" .
<Induction_therapy> <Context_of> "Docetaxel_monotherapy" .
<Induction_therapy> <Context_of> "Dexamethasone_monotherapy" .
<Induction_therapy> <Context_of> "Dexamethasone_and_Rituximab" .
<Induction_therapy> <Context_of> "Dexamethasone_and_Eltrombopag" .
<Induction_therapy> <Context_of> "Decitabine_and_Valproate" .
<Induction_therapy> <Context_of> "DeVIC_and_RT" .
<Induction_therapy> <Context_of> "Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib" .
<Induction_therapy> <Context_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone" .
<Induction_therapy> <Context_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Induction_therapy> <Context_of> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib" .
<Induction_therapy> <Context_of> "Daunorubicin_monotherapy" .
<Induction_therapy> <Context_of> "Dasatinib_monotherapy" .
<Induction_therapy> <Context_of> "Dasatinib_and_Prednisone" .
<Induction_therapy> <Context_of> "DOLP_(Prednisolone)" .
<Induction_therapy> <Context_of> "DOLP" .
<Induction_therapy> <Context_of> "DICEP" .
<Induction_therapy> <Context_of> "DEP_and_RT" .
<Induction_therapy> <Context_of> "DD-CHOP" .
<Induction_therapy> <Context_of> "DCTER" .
<Induction_therapy> <Context_of> "DCF" .
<Induction_therapy> <Context_of> "DAT" .
<Induction_therapy> <Context_of> "DAC" .
<Induction_therapy> <Context_of> "DA-R-EPOCH" .
<Induction_therapy> <Context_of> "DA-EPOCH" .
<Induction_therapy> <Context_of> "DA_3_plus_10,_GO" .
<Induction_therapy> <Context_of> "DA_3_plus_10" .
<Induction_therapy> <Context_of> "D-ZAPO" .
<Induction_therapy> <Context_of> "Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone" .
<Induction_therapy> <Context_of> "Cytarabine,_Daunorubicin,_Vincristine" .
<Induction_therapy> <Context_of> "Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone" .
<Induction_therapy> <Context_of> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone" .
<Induction_therapy> <Context_of> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone" .
<Induction_therapy> <Context_of> "Cyclosporine_monotherapy" .
<Induction_therapy> <Context_of> "Cyclophosphamide,_Lomustine,_Methotrexate" .
<Induction_therapy> <Context_of> "Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone" .
<Induction_therapy> <Context_of> "Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone" .
<Induction_therapy> <Context_of> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone" .
<Induction_therapy> <Context_of> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone" .
<Induction_therapy> <Context_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab" .
<Induction_therapy> <Context_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Induction_therapy> <Context_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine" .
<Induction_therapy> <Context_of> "Cyclophosphamide_monotherapy" .
<Induction_therapy> <Context_of> "Cyclophosphamide_and_Prednisone" .
<Induction_therapy> <Context_of> "Cladribine_monotherapy" .
<Induction_therapy> <Context_of> "Cladribine_and_Rituximab" .
<Induction_therapy> <Context_of> "Cisplatin,_Paclitaxel,_RT" .
<Induction_therapy> <Context_of> "Cisplatin,_Fluorouracil,_RT" .
<Induction_therapy> <Context_of> "Cisplatin,_Etoposide,_Durvalumab" .
<Induction_therapy> <Context_of> "Cisplatin,_Etoposide,_Bevacizumab" .
<Induction_therapy> <Context_of> "Cisplatin_and_Vinblastine" .
<Induction_therapy> <Context_of> "Cisplatin_and_RT" .
<Induction_therapy> <Context_of> "Cisplatin_and_Irinotecan" .
<Induction_therapy> <Context_of> "Cisplatin_and_Gemcitabine" .
<Induction_therapy> <Context_of> "Cisplatin_and_Fluorouracil" .
<Induction_therapy> <Context_of> "Cisplatin_and_Etoposide" .
<Induction_therapy> <Context_of> "Cisplatin_and_Epirubicin" .
<Induction_therapy> <Context_of> "Cisplatin_and_Docetaxel" .
<Induction_therapy> <Context_of> "ChlVPP/PABIOE" .
<Induction_therapy> <Context_of> "ChlVPP/EVA" .
<Induction_therapy> <Context_of> "ChlVPP" .
<Induction_therapy> <Context_of> "Carboplatin,_Paclitaxel,_Ipilimumab" .
<Induction_therapy> <Context_of> "Carboplatin,_Etoposide,_Durvalumab" .
<Induction_therapy> <Context_of> "Carboplatin,_Etoposide,_Bevacizumab" .
<Induction_therapy> <Context_of> "Carboplatin,_Etoposide,_Atezolizumab" .
<Induction_therapy> <Context_of> "Carboplatin_and_Paclitaxel" .
<Induction_therapy> <Context_of> "Carboplatin_and_Irinotecan" .
<Induction_therapy> <Context_of> "Carboplatin_and_Etoposide" .
<Induction_therapy> <Context_of> "Caplacizumab_and_Plasma_exchange" .
<Induction_therapy> <Context_of> "Capecitabine_monotherapy" .
<Induction_therapy> <Context_of> "Calaspargase,_Daunorubicin,_Vincristine,_Prednisone" .
<Induction_therapy> <Context_of> "CX" .
<Induction_therapy> <Context_of> "CVPP" .
<Induction_therapy> <Context_of> "CVP_(Vinblastine/Prednisone)" .
<Induction_therapy> <Context_of> "CVP_(Prednisolone)" .
<Induction_therapy> <Context_of> "CVP" .
<Induction_therapy> <Context_of> "COPP/ABVD" .
<Induction_therapy> <Context_of> "COPP_(CCNU)" .
<Induction_therapy> <Context_of> "COPADM" .
<Induction_therapy> <Context_of> "COPAD" .
<Induction_therapy> <Context_of> "COP-Bleo" .
<Induction_therapy> <Context_of> "COP" .
<Induction_therapy> <Context_of> "COMP" .
<Induction_therapy> <Context_of> "CODOX-M/IVAC" .
<Induction_therapy> <Context_of> "CODOX-M" .
<Induction_therapy> <Context_of> "CNOP_(Prednisolone)" .
<Induction_therapy> <Context_of> "CNOP" .
<Induction_therapy> <Context_of> "CMED" .
<Induction_therapy> <Context_of> "CLF" .
<Induction_therapy> <Context_of> "CIA" .
<Induction_therapy> <Context_of> "CHVmP-VB" .
<Induction_therapy> <Context_of> "CHVmP" .
<Induction_therapy> <Context_of> "CHOP-BCG" .
<Induction_therapy> <Context_of> "CHOP-B" .
<Induction_therapy> <Context_of> "CHOP-AL" .
<Induction_therapy> <Context_of> "CHOP-14" .
<Induction_therapy> <Context_of> "CHOP_and_Everolimus" .
<Induction_therapy> <Context_of> "CHOP_Modified_(Prednisolone)" .
<Induction_therapy> <Context_of> "CHOP_Modified" .
<Induction_therapy> <Context_of> "CHOP" .
<Induction_therapy> <Context_of> "CHOEP-21" .
<Induction_therapy> <Context_of> "CHOEP-14" .
<Induction_therapy> <Context_of> "CEV_(Cyclophosphamide/Etoposide)" .
<Induction_therapy> <Context_of> "CEV_(Cyclophosphamide/Epirubicin)" .
<Induction_therapy> <Context_of> "CEV_(Carboplatin/Etoposide)" .
<Induction_therapy> <Context_of> "CEOP_(Prednisolone)" .
<Induction_therapy> <Context_of> "CEOP" .
<Induction_therapy> <Context_of> "CEEP" .
<Induction_therapy> <Context_of> "CDE" .
<Induction_therapy> <Context_of> "CCOP" .
<Induction_therapy> <Context_of> "CAVE" .
<Induction_therapy> <Context_of> "CAV/PE" .
<Induction_therapy> <Context_of> "CAV" .
<Induction_therapy> <Context_of> "CAP-BOP" .
<Induction_therapy> <Context_of> "CALGB_10-002_regimen" .
<Induction_therapy> <Context_of> "C-MOPP/ABV" .
<Induction_therapy> <Context_of> "C-MOPP" .
<Induction_therapy> <Context_of> "Brentuximab_vedotin_monotherapy" .
<Induction_therapy> <Context_of> "Brentuximab_vedotin_and_Dacarbazine" .
<Induction_therapy> <Context_of> "Bosutinib_monotherapy" .
<Induction_therapy> <Context_of> "Belotecan_and_Cisplatin" .
<Induction_therapy> <Context_of> "BV-CHP" .
<Induction_therapy> <Context_of> "BR" .
<Induction_therapy> <Context_of> "BEACOPP-14" .
<Induction_therapy> <Context_of> "BEACOPP" .
<Induction_therapy> <Context_of> "BCVPP" .
<Induction_therapy> <Context_of> "BCOP" .
<Induction_therapy> <Context_of> "BASIC" .
<Induction_therapy> <Context_of> "BACO" .
<Induction_therapy> <Context_of> "Arsenic_trioxide,_ATRA,_Idarubicin" .
<Induction_therapy> <Context_of> "Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin" .
<Induction_therapy> <Context_of> "Arsenic_trioxide_monotherapy" .
<Induction_therapy> <Context_of> "Arsenic_trioxide_and_Idarubicin" .
<Induction_therapy> <Context_of> "Arsenic_trioxide_and_ATRA" .
<Induction_therapy> <Context_of> "Aminopterin_monotherapy" .
<Induction_therapy> <Context_of> "Alemtuzumab_monotherapy" .
<Induction_therapy> <Context_of> "AVD" .
<Induction_therapy> <Context_of> "ATRA,_Cytarabine,_Idarubicin" .
<Induction_therapy> <Context_of> "ATRA,_Cytarabine,_Daunorubicin" .
<Induction_therapy> <Context_of> "ATRA_monotherapy" .
<Induction_therapy> <Context_of> "ATRA_and_Idarubicin" .
<Induction_therapy> <Context_of> "ATRA_and_Daunorubicin" .
<Induction_therapy> <Context_of> "ATG_(Rabbit)_and_Cyclosporine" .
<Induction_therapy> <Context_of> "ATG_(Horse),_Cyclosporine,_Sirolimus" .
<Induction_therapy> <Context_of> "ATG_(Horse),_Cyclosporine,_Methylprednisolone" .
<Induction_therapy> <Context_of> "ATG_(Horse),_Cyclosporine,_G-CSF" .
<Induction_therapy> <Context_of> "ATG_(Horse),_Cyclosporine,_Eltrombopag" .
<Induction_therapy> <Context_of> "ATG_(Horse)_and_Cyclosporine" .
<Induction_therapy> <Context_of> "APO" .
<Induction_therapy> <Context_of> "AIE" .
<Induction_therapy> <Context_of> "ADT" .
<Induction_therapy> <Context_of> "ADE_and_ATRA" .
<Induction_therapy> <Context_of> "ADE_(standard-dose_Ara-C)" .
<Induction_therapy> <Context_of> "ADE_(high-dose_Ara-C)" .
<Induction_therapy> <Context_of> "ACVBP-R" .
<Induction_therapy> <Context_of> "ACVBP" .
<Induction_therapy> <Context_of> "ACOMLA" .
<Induction_therapy> <Context_of> "ACE" .
<Induction_therapy> <Context_of> "ABVE-PC" .
<Induction_therapy> <Context_of> "ABVDm" .
<Induction_therapy> <Context_of> "ABVD,_DD-DI" .
<Induction_therapy> <Context_of> "ABVD" .
<Induction_therapy> <Context_of> "ABP" .
<Induction_therapy> <Context_of> "A-AVD" .
<Induction_therapy> <Context_of> "7_plus_5i" .
<Induction_therapy> <Context_of> "7_plus_3m" .
<Induction_therapy> <Context_of> "7_plus_3i_and_Vorinostat" .
<Induction_therapy> <Context_of> "7_plus_3i_and_Sorafenib" .
<Induction_therapy> <Context_of> "7_plus_3i_and_Panobinostat" .
<Induction_therapy> <Context_of> "7_plus_3i" .
<Induction_therapy> <Context_of> "7_plus_3d_and_Midostaurin" .
<Induction_therapy> <Context_of> "7_plus_3d_and_Glasdegib" .
<Induction_therapy> <Context_of> "7_plus_3d_and_GO" .
<Induction_therapy> <Context_of> "7_plus_3d" .
<Induction_therapy> <Context_of> "5_plus_3i" .
<Induction_therapy> <Context_of> "5_plus_3d" .
<Cisplatin,_Fluorouracil,_Hydroxyurea,_RT> <Has_context> "Definitive_therapy" .
<TVAD_doxil> <Has_accepted_use> "Multiple_myeloma" .
<Axicabtagene_ciloleucel> <Antineoplastic_of> "Axicabtagene_ciloleucel_monotherapy" .
<Vorapaxar> <Is_a> "PAR1_inhibitor" .
<ATG_(Rabbit)_and_Cyclosporine> <Has_modality> "Immunosuppressive_therapy" .
<Fotemustine_monotherapy> <Is_current_in> "Uveal_melanoma" .
<Fotemustine_monotherapy> <Is_current_in> "Melanoma" .
<Fotemustine_monotherapy> <Is_current_in> "CNS_melanoma" .
<Osteodur> <Brand_name_of> "Alendronate" .
<Durost> <Brand_name_of> "Alendronate" .
<Carboplatin_and_nab-Paclitaxel> <Has_modality> "Chemotherapy" .
<PEP-C> <Has_antineoplastic> "Procarbazine" .
<PEP-C> <Has_antineoplastic> "Prednisone" .
<PEP-C> <Has_antineoplastic> "Etoposide" .
<PEP-C> <Has_antineoplastic> "Cyclophosphamide" .
<Fluorouracil,_Folinic_acid,_RT> <Has_antineoplastic> "Folinic_acid" .
<Fluorouracil,_Folinic_acid,_RT> <Has_antineoplastic> "Fluorouracil" .
<Fluorouracil,_Folinic_acid,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Avapritinib_monotherapy> <Maps_to> "Avapritinib_monotherapy" .
<Doxorubicin_non-pegylated_liposomal_and_Bevacizumab> <Has_accepted_use> "Breast_cancer" .
<Carfilzomib_and_Panobinostat> <Has_antineoplastic> "Panobinostat" .
<Carfilzomib_and_Panobinostat> <Has_antineoplastic> "Carfilzomib" .
<Anastrozole_and_Fulvestrant> <Is_current_in> "Breast_cancer" .
<ECT,_then_auto_HSCT> <Mapped_from> "ECT,_then_auto_HSCT" .
<Idarubicin> <Has_brand_name> "Zavedose" .
<Idarubicin> <Has_brand_name> "Zavedos" .
<Idarubicin> <Has_brand_name> "Ondarubin" .
<Idarubicin> <Has_brand_name> "Idaru" .
<Idarubicin> <Has_brand_name> "Idamycin" .
<Aminoglutethimide_monotherapy> <Has_context> "Non-curative_therapy" .
<Gemcitabine,_Cisplatin,_S-1> <Has_modality> "Chemotherapy" .
<Methylprednisolone> <May_have_route> "Oral" .
<Methylprednisolone> <May_have_route> "Intravenous" .
<Methylprednisolone> <May_have_route> "Intrathecal" .
<Carboplatin_and_Vinorelbine> <Has_antineoplastic> "Vinorelbine" .
<Carboplatin_and_Vinorelbine> <Has_antineoplastic> "Carboplatin" .
<Hydroxyurea_and_Imatinib> <Is_current_in> "Glioblastoma" .
<Velbe> <Brand_name_of> "Vinblastine" .
<Clofarabine_and_Cytarabine> <Has_modality> "Chemotherapy" .
<Vinblastine> <May_have_route> "Intravenous" .
<R-CHOP_(Prednisolone)> <Is_current_in> "Primary_mediastinal_B-cell_lymphoma" .
<R-CHOP_(Prednisolone)> <Is_current_in> "Mantle_cell_lymphoma" .
<R-CHOP_(Prednisolone)> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Sirolimus_and_Prednisone> <Is_current_in> "Erdheim-Chester_disease" .
<Tisagenlecleucel_monotherapy> <Mapped_from> "Tisagenlecleucel_monotherapy" .
<Rocolone> <Brand_name_of> "Dexamethasone" .
<Bosutinib_monotherapy> <Is_current_in> "Chronic_myelogenous_leukemia" .
<Bosutinib_monotherapy> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Fluorouracil_and_Methotrexate> <Maps_to> "Fluorouracil_and_Methotrexate" .
<Drugs_EMA_approved_in_the_21st_century> <Is_a> "EMA_approved_drug" .
<Cisplatin,_Doxorubicin,_Paclitaxel> <Has_antineoplastic> "Paclitaxel" .
<Cisplatin,_Doxorubicin,_Paclitaxel> <Has_antineoplastic> "Doxorubicin" .
<Cisplatin,_Doxorubicin,_Paclitaxel> <Has_antineoplastic> "Cisplatin" .
<Combact> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Metotrexol> <Brand_name_of> "Methotrexate" .
<Onartuzumab> <May_have_route> "Intravenous" .
<Imatinib,_Vincristine,_Prednisone> <Mapped_from> "Imatinib,_Vincristine,_Prednisone" .
<D-ZAPO> <Is_a> "Anthracycline-containing_regimen" .
<BTD> <Mapped_from> "BTD" .
<ddC> <Is_current_in> "Breast_cancer" .
<Mercaptopurine> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Mercaptopurine> <Is_a> "Purine_analogue" .
<Mercaptopurine> <Is_a> "Immunosuppressant" .
<Mercaptopurine> <Is_a> "Antimetabolite" .
<Oophorectomy> <Has_accepted_use> "Breast_cancer" .
<Non-curative_third-line_consolidation_therapy> <Maps_to> "Non-curative_third-line_consolidation_therapy" .
<Cisplatin_and_Fluorouracil> <Has_accepted_use> "Penile_cancer" .
<Cisplatin_and_Fluorouracil> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<Cisplatin_and_Fluorouracil> <Has_accepted_use> "Head_and_neck_cancer" .
<Cisplatin_and_Fluorouracil> <Has_accepted_use> "Gastric_cancer" .
<Cisplatin_and_Fluorouracil> <Has_accepted_use> "Esophageal_cancer" .
<Cisplatin_and_Fluorouracil> <Has_accepted_use> "Anal_cancer" .
<Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<MAP> <Has_context> "Non-curative_first-line_therapy" .
<MAP> <Has_context> "Neoadjuvant_therapy" .
<MAP> <Has_context> "Adjuvant_therapy" .
<Aspirin_and_Hydroxyurea> <Maps_to> "Aspirin_and_Hydroxyurea" .
<MAPIE> <Has_antineoplastic> "Methotrexate" .
<MAPIE> <Has_antineoplastic> "Ifosfamide" .
<MAPIE> <Has_antineoplastic> "Etoposide" .
<MAPIE> <Has_antineoplastic> "Doxorubicin" .
<MAPIE> <Has_antineoplastic> "Cisplatin" .
<R-BL> <Has_antineoplastic> "Rituximab" .
<R-BL> <Has_antineoplastic> "Lenalidomide" .
<R-BL> <Has_antineoplastic> "Bendamustine" .
<Leukine> <Brand_name_of> "Sargramostim" .
<VDC/IE> <Has_accepted_use> "Ewing_sarcoma" .
<ATG_(Horse),_Cyclosporine,_Sirolimus> <Mapped_from> "ATG_(Horse),_Cyclosporine,_Sirolimus" .
<Fluorouracilo> <Brand_name_of> "Fluorouracil" .
<Carplan> <Brand_name_of> "Carboplatin" .
<Etoposide_and_Prednisone> <Has_antineoplastic> "Prednisone" .
<Etoposide_and_Prednisone> <Has_antineoplastic> "Etoposide" .
<MATRix> <Has_supportive_med> "Levoleucovorin" .
<DAC> <Is_current_in> "Acute_myeloid_leukemia" .
<mFOLFOX6_(L-Leucovorin)> <Maps_to> "mFOLFOX6_(L-Leucovorin)" .
<Geniolito> <Brand_name_of> "Aspirin" .
<Methotrexate,_Tacrolimus,_Vorinostat> <Has_accepted_use> "Graft_versus_host_disease" .
<Zofron> <Brand_name_of> "Ondansetron" .
<Fluoxymesterone_monotherapy> <Mapped_from> "Fluoxymesterone_monotherapy" .
<HiDAC_and_Midostaurin> <Has_antineoplastic> "Midostaurin" .
<HiDAC_and_Midostaurin> <Has_antineoplastic> "Cytarabine" .
<KTD> <Is_current_in> "Multiple_myeloma" .
<Capecitabine/Capecitabine_and_RT> <Has_modality> "Radiotherapy" .
<Capecitabine/Capecitabine_and_RT> <Has_modality> "Chemotherapy" .
<Abemaciclib> <Has_accepted_use> "Breast_cancer" .
<Jenamoxazol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Antiplatelet_agent> <Subsumes> "PDE_inhibitor" .
<Antiplatelet_agent> <Subsumes> "PAR1_inhibitor" .
<Antiplatelet_agent> <Subsumes> "P2Y12_ADP_inhibitor" .
<Antiplatelet_agent> <Subsumes> "GPIIb-IIIa_inhibitor" .
<Antiplatelet_agent> <Subsumes> "COX-1_inhibitor" .
<Pd> <Has_antineoplastic> "Pomalidomide" .
<Pd> <Has_antineoplastic> "Dexamethasone" .
<Cisplatin,_Doxorubicin,_Paclitaxel> <Is_a> "Anthracycline-containing_regimen" .
<7_plus_3d> <Has_modality> "Chemotherapy" .
<VAI> <Mapped_from> "VAI" .
<ABP> <Has_modality> "Chemotherapy" .
<Radotinib_monotherapy> <Is_current_in> "Chronic_myelogenous_leukemia" .
<Endoxan-N> <Brand_name_of> "Cyclophosphamide" .
<Ruxolitinib_monotherapy> <Has_antineoplastic> "Ruxolitinib" .
<Lenalidomide_monotherapy> <Has_antineoplastic> "Lenalidomide" .
<BR_and_Ibrutinib> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<VMCP> <Has_accepted_use> "Multiple_myeloma" .
<Cisplatin_and_Gemcitabine/Erlotinib> <Has_antineoplastic> "Gemcitabine" .
<Cisplatin_and_Gemcitabine/Erlotinib> <Has_antineoplastic> "Erlotinib" .
<Cisplatin_and_Gemcitabine/Erlotinib> <Has_antineoplastic> "Cisplatin" .
<Indolent_lymphoma> <Is_a> "Lymphoma" .
<Somatostatin_analog> <Subsumes> "Octreotide_LAR" .
<Somatostatin_analog> <Subsumes> "Octreotide" .
<Somatostatin_analog> <Subsumes> "Lanreotide" .
<IT_Methotrexate_and_WBRT> <Maps_to> "IT_Methotrexate_and_WBRT" .
<Aczone> <Brand_name_of> "Dapsone" .
<Bicalutamide_monotherapy> <Has_modality> "Hormonotherapy" .
<Lenalidomide_and_Rituximab> <Maps_to> "Lenalidomide_and_Rituximab" .
<Abiraterone_and_Prednisone> <Has_antineoplastic> "Prednisone" .
<Abiraterone_and_Prednisone> <Has_antineoplastic> "Abiraterone" .
<Neurokinin_1_(NK1)_antagonist> <Subsumes> "Rolapitant" .
<Neurokinin_1_(NK1)_antagonist> <Subsumes> "Netupitant_and_palonosetron" .
<Neurokinin_1_(NK1)_antagonist> <Subsumes> "Fosaprepitant" .
<Neurokinin_1_(NK1)_antagonist> <Subsumes> "Aprepitant" .
<Letromina> <Brand_name_of> "Letrozole" .
<Docefrez> <Brand_name_of> "Docetaxel" .
<Vancel> <Brand_name_of> "Carboplatin" .
<Lenograstim> <Is_a> "PMDA_approved_drug" .
<Lenograstim> <Is_a> "Granulocyte_colony-stimulating_factor" .
<Lenograstim> <Is_a> "EMA_approved_drug" .
<Calcium_Leucovorin> <Brand_name_of> "Folinic_acid" .
<CCE> <Has_modality> "Chemotherapy" .
<CF_and_Trastuzumab> <Is_current_in> "Esophageal_cancer" .
<Dara-Rd> <Has_antineoplastic> "Lenalidomide" .
<Dara-Rd> <Has_antineoplastic> "Dexamethasone" .
<Dara-Rd> <Has_antineoplastic> "Daratumumab" .
<Gemcitabine_and_Paclitaxel> <Has_modality> "Chemotherapy" .
<Hairy_cell_leukemia> <Is_a> "Indolent_lymphoma" .
<Cysplatyna> <Brand_name_of> "Cisplatin" .
<Cytarabine_and_daunorubicin_liposomal> <Has_FDA_indication> "Acute_myeloid_leukemia" .
<R-CDOP> <Maps_to> "R-CDOP" .
<PDE_inhibitor> <Is_a> "Antiplatelet_agent" .
<Cisplatin_and_Vinorelbine> <Has_context> "Non-curative_subsequent-line_therapy" .
<Cisplatin_and_Vinorelbine> <Has_context> "Non-curative_first-line_therapy" .
<Cisplatin_and_Vinorelbine> <Has_context> "Consolidation_after_upfront_therapy" .
<Cisplatin_and_Vinorelbine> <Has_context> "Adjuvant_therapy" .
<Lynparza> <Brand_name_of> "Olaparib" .
<Gefitinib_and_Pemetrexed> <Mapped_from> "Gefitinib_and_Pemetrexed" .
<Aspeter> <Brand_name_of> "Aspirin" .
<Granicip> <Brand_name_of> "Granisetron" .
<Citrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Imalek> <Brand_name_of> "Imatinib" .
<ATG_(Horse)_and_Cyclosporine> <Maps_to> "ATG_(Horse)_and_Cyclosporine" .
<Solusprin> <Brand_name_of> "Aspirin" .
<MATRix> <Mapped_from> "MATRix" .
<Octreotide_monotherapy> <Maps_to> "Octreotide_monotherapy" .
<Asotax> <Brand_name_of> "Paclitaxel" .
<VAIA> <Has_supportive_med> "Mesna" .
<Mazatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Jantoven> <Brand_name_of> "Warfarin" .
<CC/DE_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<CC/DE_and_RT> <Has_antineoplastic> "Etoposide" .
<CC/DE_and_RT> <Has_antineoplastic> "Doxorubicin" .
<CC/DE_and_RT> <Has_antineoplastic> "Cyclophosphamide" .
<CC/DE_and_RT> <Has_antineoplastic> "Cisplatin" .
<Mismatch_repair_deficient_malignancy> <FDA_indication_of> "Pembrolizumab" .
<Temozolomide_and_Thalidomide> <Maps_to> "Temozolomide_and_Thalidomide" .
<Dopamine_receptor_antagonist> <Subsumes> "Promethazine" .
<Dopamine_receptor_antagonist> <Subsumes> "Prochlorperazine" .
<Dopamine_receptor_antagonist> <Subsumes> "Olanzapine" .
<Dopamine_receptor_antagonist> <Subsumes> "Metoclopramide" .
<Dopamine_receptor_antagonist> <Subsumes> "Domperidone" .
<Local_therapy> <Context_of> "WBRT" .
<Local_therapy> <Context_of> "Valrubicin_monotherapy" .
<Local_therapy> <Context_of> "Thiotepa_monotherapy" .
<Local_therapy> <Context_of> "Talimogene_laherparepvec_monotherapy" .
<Local_therapy> <Context_of> "TACE" .
<Local_therapy> <Context_of> "Radioembolization" .
<Local_therapy> <Context_of> "Pirarubicin_monotherapy" .
<Local_therapy> <Context_of> "Pembrolizumab_monotherapy" .
<Local_therapy> <Context_of> "Observation" .
<Local_therapy> <Context_of> "Mitomycin_monotherapy" .
<Local_therapy> <Context_of> "Methotrexate_monotherapy" .
<Local_therapy> <Context_of> "Mercaptopurine_and_WBRT" .
<Local_therapy> <Context_of> "IT_Methotrexate_monotherapy" .
<Local_therapy> <Context_of> "IT_Methotrexate_and_WBRT" .
<Local_therapy> <Context_of> "IT_Methotrexate_and_Methylprednisolone" .
<Local_therapy> <Context_of> "IT_Methotrexate_and_Hydrocortisone" .
<Local_therapy> <Context_of> "IT_Cytarabine,_Methotrexate,_WBRT" .
<Local_therapy> <Context_of> "IT_Cytarabine,_Methotrexate,_Prednisone" .
<Local_therapy> <Context_of> "IT_Cytarabine,_Methotrexate,_Methylprednisolone" .
<Local_therapy> <Context_of> "IT_Cytarabine_monotherapy" .
<Local_therapy> <Context_of> "IT_Cytarabine_liposomal_monotherapy" .
<Local_therapy> <Context_of> "IT_Cytarabine_and_WBRT" .
<Local_therapy> <Context_of> "IT_Cytarabine_and_Methotrexate" .
<Local_therapy> <Context_of> "HiDAC" .
<Local_therapy> <Context_of> "Gemcitabine_monotherapy" .
<Local_therapy> <Context_of> "Doxorubicin_monotherapy" .
<Local_therapy> <Context_of> "DEB-TACE" .
<Local_therapy> <Context_of> "Cisplatin_and_Paclitaxel" .
<Local_therapy> <Context_of> "Cisplatin_and_Cyclophosphamide" .
<Local_therapy> <Context_of> "Bacillus_Calmette-Guerin_(BCG)_monotherapy" .
<Local_therapy> <Context_of> "Axitinib_and_TACE" .
<Melphalan> <Antineoplastic_of> "mCOP/MP" .
<Melphalan> <Antineoplastic_of> "Z-BEAM,_then_auto_HSCT" .
<Melphalan> <Antineoplastic_of> "Z-BEAM" .
<Melphalan> <Antineoplastic_of> "VMPT" .
<Melphalan> <Antineoplastic_of> "VMP/Rd" .
<Melphalan> <Antineoplastic_of> "VMP,_then_Rd" .
<Melphalan> <Antineoplastic_of> "VMP" .
<Melphalan> <Antineoplastic_of> "VMD" .
<Melphalan> <Antineoplastic_of> "VMCP/VCAP" .
<Melphalan> <Antineoplastic_of> "VMCP/VBAP" .
<Melphalan> <Antineoplastic_of> "VMCP" .
<Melphalan> <Antineoplastic_of> "VBMCP/VBAD" .
<Melphalan> <Antineoplastic_of> "VBMCP" .
<Melphalan> <Antineoplastic_of> "VBMC" .
<Melphalan> <Antineoplastic_of> "Total_Therapy" .
<Melphalan> <Antineoplastic_of> "Tandem_melphalan,_then_auto_HSCT" .
<Melphalan> <Antineoplastic_of> "TAM6,_then_auto_HSCT" .
<Melphalan> <Antineoplastic_of> "TAM6" .
<Melphalan> <Antineoplastic_of> "R-DexaBEAM" .
<Melphalan> <Antineoplastic_of> "R-BEAM,_then_auto_HSCT" .
<Melphalan> <Antineoplastic_of> "R-BEAM" .
<Melphalan> <Antineoplastic_of> "PFT" .
<Melphalan> <Antineoplastic_of> "PF" .
<Melphalan> <Antineoplastic_of> "PAF" .
<Melphalan> <Antineoplastic_of> "Mini-BEAM" .
<Melphalan> <Antineoplastic_of> "Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT" .
<Melphalan> <Antineoplastic_of> "Melphalan,_then_auto_HSCT,_then_Melphalan_and_TBI,_then_auto_HSCT" .
<Melphalan> <Antineoplastic_of> "Melphalan,_then_auto_HSCT,_then_Melphalan_and_Busulfan,_then_auto_HSCT" .
<Melphalan> <Antineoplastic_of> "Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Melphalan> <Antineoplastic_of> "Melphalan,_then_auto_HSCT" .
<Melphalan> <Antineoplastic_of> "Melphalan_monotherapy" .
<Melphalan> <Antineoplastic_of> "Melphalan_and_TBI,_then_auto_HSCT" .
<Melphalan> <Antineoplastic_of> "Melphalan_and_TBI" .
<Melphalan> <Antineoplastic_of> "Melphalan_and_Methylprednisolone,_then_auto_HSCT" .
<Melphalan> <Antineoplastic_of> "MRD" .
<Melphalan> <Antineoplastic_of> "MPT" .
<Melphalan> <Antineoplastic_of> "MPR" .
<Melphalan> <Antineoplastic_of> "MP_(Prednisolone)" .
<Melphalan> <Antineoplastic_of> "MP" .
<Melphalan> <Antineoplastic_of> "MEL200,_then_auto_HSCT,_then_MEL220_and_Dexamethasone,_then_auto_HSCT" .
<Melphalan> <Antineoplastic_of> "M-DEX" .
<Melphalan> <Antineoplastic_of> "LEED,_then_auto_HSCT" .
<Melphalan> <Antineoplastic_of> "LEED" .
<Melphalan> <Antineoplastic_of> "KMP" .
<Melphalan> <Antineoplastic_of> "Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT" .
<Melphalan> <Antineoplastic_of> "Fludarabine,_Melphalan,_Alemtuzumab" .
<Melphalan> <Antineoplastic_of> "Fludarabine_and_Melphalan" .
<Melphalan> <Antineoplastic_of> "Flu-Mel,_then_allo_HSCT" .
<Melphalan> <Antineoplastic_of> "FEAM,_then_auto_HSCT" .
<Melphalan> <Antineoplastic_of> "FEAM" .
<Melphalan> <Antineoplastic_of> "DexaBEAM_and_G-CSF" .
<Melphalan> <Antineoplastic_of> "DexaBEAM" .
<Melphalan> <Antineoplastic_of> "Dara-VMP" .
<Melphalan> <Antineoplastic_of> "Clofarabine_and_Melphalan,_then_allo_HSCT" .
<Melphalan> <Antineoplastic_of> "Clofarabine_and_Melphalan" .
<Melphalan> <Antineoplastic_of> "Busulfan_and_Melphalan,_then_auto_HSCT" .
<Melphalan> <Antineoplastic_of> "Busulfan_and_Melphalan" .
<Melphalan> <Antineoplastic_of> "Bortezomib_and_Melphalan,_then_auto_HSCT" .
<Melphalan> <Antineoplastic_of> "Bortezomib_and_Melphalan" .
<Melphalan> <Antineoplastic_of> "BeEAM,_then_auto_HSCT" .
<Melphalan> <Antineoplastic_of> "BeEAM" .
<Melphalan> <Antineoplastic_of> "BEAM,_then_auto_HSCT" .
<Melphalan> <Antineoplastic_of> "BEAM,_then_allo_HSCT" .
<Melphalan> <Antineoplastic_of> "BEAM" .
<Melphalan> <Antineoplastic_of> "ABCM" .
<Alpharadin> <Brand_name_of> "Radium-223" .
<Danogen> <Brand_name_of> "Danazol" .
<Busulfan_and_Melphalan> <Mapped_from> "Busulfan_and_Melphalan" .
<Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA> <Mapped_from> "Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA" .
<Emicizumab> <Supportive_med_of> "Emicizumab_monotherapy" .
<Emicizumab> <Supportive_med_of> "ABV_(Vincristine)" .
<Ultracorten> <Brand_name_of> "Prednisone" .
<COPDAC> <Has_accepted_use> "Hodgkin_lymphoma" .
<Levamisole_monotherapy> <Has_context> "Adjuvant_therapy" .
<Ristova> <Brand_name_of> "Rituximab" .
<Pentostatin_monotherapy> <Has_antineoplastic> "Pentostatin" .
<Fosaprepitant> <Is_a> "Neurokinin_1_(NK1)_antagonist" .
<Fosaprepitant> <Is_a> "Emesis_prevention" .
<VP> <Mapped_from> "VP" .
<KRd> <Has_modality> "Chemotherapy" .
<Methotrexate,_Tacrolimus,_Tocilizumab> <Has_accepted_use> "Graft_versus_host_disease" .
<Cortisone_monotherapy> <Is_historical_in> "Prostate_cancer" .
<Chlorambucil_and_Cisplatin> <Maps_to> "Chlorambucil_and_Cisplatin" .
<Colorectal_cancer> <Subsumes> "Rectal_cancer" .
<Colorectal_cancer> <Subsumes> "Colon_cancer" .
<R-M-CHOP> <Maps_to> "R-M-CHOP" .
<Crizanlizumab> <May_have_route> "Intravenous" .
<Disprin> <Brand_name_of> "Aspirin" .
<Medsatrexate> <Brand_name_of> "Methotrexate" .
<Erlocip> <Brand_name_of> "Erlotinib" .
<Goserelin_and_Tamoxifen> <Has_modality> "Hormonotherapy" .
<Helixate_FS> <Brand_name_of> "Factor_VIII_recombinant" .
<Uridine_triacetate> <Has_brand_name> "Vistogard" .
<ADE_(standard-dose_Ara-C)> <Has_context> "Salvage_therapy" .
<ADE_(standard-dose_Ara-C)> <Has_context> "Induction_therapy" .
<MEL200,_then_auto_HSCT,_then_MEL220_and_Dexamethasone,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Sirolimus,_Tacrolimus,_Prednisone> <Maps_to> "Sirolimus,_Tacrolimus,_Prednisone" .
<Zoledronic_acid_therapy> <Mapped_from> "Zoledronic_acid_therapy" .
<Semustine> <Has_brand_name> "Semustina" .
<Temsirolimus> <Has_FDA_indication> "Renal_cell_carcinoma" .
<Clonazepam> <Has_brand_name> "Klonopin" .
<ADT_and_Darolutamide> <Has_modality> "Hormonotherapy" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Nitrosourea> <Subsumes> "Streptozocin" .
<Nitrosourea> <Subsumes> "Semustine" .
<Nitrosourea> <Subsumes> "Ranimustine" .
<Nitrosourea> <Subsumes> "Nimustine" .
<Nitrosourea> <Subsumes> "Lomustine" .
<Nitrosourea> <Subsumes> "Fotemustine" .
<Nitrosourea> <Subsumes> "Carmustine_wafer_polifeprosan_20" .
<Nitrosourea> <Subsumes> "Carmustine" .
<Aggressive_lymphoma> <Subsumes> "Transformed_lymphoma" .
<Aggressive_lymphoma> <Subsumes> "Primary_mediastinal_B-cell_lymphoma" .
<Aggressive_lymphoma> <Subsumes> "Mediastinal_gray-zone_lymphoma" .
<Aggressive_lymphoma> <Subsumes> "Mantle_cell_lymphoma" .
<Aggressive_lymphoma> <Subsumes> "Hodgkin_lymphoma" .
<Aggressive_lymphoma> <Subsumes> "HIV-associated_lymphoma" .
<Aggressive_lymphoma> <Subsumes> "Diffuse_large_B-cell_lymphoma" .
<Aggressive_lymphoma> <Subsumes> "Burkitt_lymphoma" .
<Arsenic_trioxide_and_Chlorambucil> <Is_current_in> "Mantle_cell_lymphoma" .
<IT_Cytarabine,_Methotrexate,_Prednisone> <Has_modality> "Chemotherapy" .
<Anti-C5_antibody> <Subsumes> "Ravulizumab" .
<Anti-C5_antibody> <Subsumes> "Eculizumab" .
<Decordex> <Brand_name_of> "Dexamethasone" .
<VMCP/VBAP> <Is_a> "Anthracycline-containing_regimen" .
<TH_(Taxotere)> <Has_context> "Non-curative_first-line_therapy" .
<TH_(Taxotere)> <Has_context> "Neoadjuvant_therapy" .
<TH_(Taxotere)> <Has_context> "Adjuvant_therapy" .
<Xylotin> <Brand_name_of> "Oxaliplatin" .
<Ixazomib_and_Dexamethasone> <Has_supportive_med> "Ranitidine" .
<Ixazomib_and_Dexamethasone> <Has_supportive_med> "Elotuzumab" .
<Ixazomib_and_Dexamethasone> <Has_supportive_med> "Diphenhydramine" .
<Ixazomib_and_Dexamethasone> <Has_supportive_med> "Acetaminophen" .
<Lanreotide> <Antineoplastic_of> "Lanreotide_monotherapy" .
<Lanreotide> <Antineoplastic_of> "Lanreotide_and_Interferon_alfa-2b" .
<Lanreotide> <Antineoplastic_of> "Lanreotide_Depot/Autogel_monotherapy" .
<Klismacort> <Brand_name_of> "Prednisolone" .
<Cisplatin,_Fluorouracil,_RT> <Has_modality> "Radiotherapy" .
<Cisplatin,_Fluorouracil,_RT> <Has_modality> "Chemotherapy" .
<Trimosul> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Aspirin_monotherapy> <Is_current_in> "Venous_thromboembolism" .
<Aspirin_monotherapy> <Is_current_in> "Polycythemia_vera" .
<Radium-223_monotherapy> <Has_context> "Non-curative_therapy" .
<BEAM,_then_auto_HSCT> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<BEAM,_then_auto_HSCT> <Has_context> "Consolidation_after_upfront_therapy" .
<BEAM,_then_auto_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<Rociletinib> <May_have_route> "Oral" .
<Fluorouracil,_Mitomycin,_RT> <Mapped_from> "Fluorouracil,_Mitomycin,_RT" .
<R-CODOX-M_(Doxil_substituted)> <Is_current_in> "Burkitt_lymphoma" .
<Mitomycin_monotherapy> <Has_modality> "Chemotherapy" .
<Fluorouracil,_Paclitaxel,_RT> <Has_accepted_use> "Esophageal_cancer" .
<Capecitabine_and_Mitomycin> <Maps_to> "Capecitabine_and_Mitomycin" .
<COPADM> <Mapped_from> "COPADM" .
<IE> <Is_current_in> "Osteosarcoma" .
<IE> <Is_current_in> "Ewing_sarcoma" .
<Pirarubicin_monotherapy> <Has_context> "Local_therapy" .
<Interferon_alfa_monotherapy> <Has_antineoplastic> "Interferons" .
<EMA_approved_drug> <Is_a> "Approved_drug" .
<Enediyne_antibiotic> <Is_a> "Chemotherapeutic" .
<PVD> <Has_antineoplastic> "Pomalidomide" .
<PVD> <Has_antineoplastic> "Dexamethasone" .
<PVD> <Has_antineoplastic> "Bortezomib" .
<Alloimmune_hematologic_condition> <Subsumes> "Graft_versus_host_disease" .
<Bicalutamide_and_Goserelin> <Has_accepted_use> "Prostate_cancer" .
<Busulfan_and_Melphalan,_then_auto_HSCT> <Has_context> "Non-curative_therapy" .
<Busulfan_and_Melphalan,_then_auto_HSCT> <Has_context> "Consolidation_after_upfront_therapy" .
<Busulfan_and_Melphalan,_then_auto_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<Busulfan_and_Melphalan,_then_auto_HSCT> <Has_context> "Adjuvant_therapy" .
<Fluorouracil/Fluorouracil_and_RT> <Maps_to> "Fluorouracil/Fluorouracil_and_RT" .
<Carboplatin,_Olaparib,_Paclitaxel> <Has_context> "Non-curative_second-line_therapy" .
<MEC> <Is_current_in> "Acute_myeloid_leukemia" .
<Non-pegylated_liposomal_doxorubicin> <Has_brand_name> "Myocet" .
<CNS_leukemia> <Accepted_use_of> "WBRT" .
<CNS_leukemia> <Accepted_use_of> "Methylprednisolone" .
<CNS_leukemia> <Accepted_use_of> "Methotrexate" .
<CNS_leukemia> <Accepted_use_of> "Mercaptopurine_and_WBRT" .
<CNS_leukemia> <Accepted_use_of> "Mercaptopurine" .
<CNS_leukemia> <Accepted_use_of> "IT_Methotrexate_monotherapy" .
<CNS_leukemia> <Accepted_use_of> "IT_Methotrexate_and_WBRT" .
<CNS_leukemia> <Accepted_use_of> "IT_Methotrexate_and_Methylprednisolone" .
<CNS_leukemia> <Accepted_use_of> "IT_Methotrexate_and_Hydrocortisone" .
<CNS_leukemia> <Accepted_use_of> "IT_Cytarabine,_Methotrexate,_WBRT" .
<CNS_leukemia> <Accepted_use_of> "IT_Cytarabine,_Methotrexate,_Prednisone" .
<CNS_leukemia> <Accepted_use_of> "IT_Cytarabine,_Methotrexate,_Methylprednisolone" .
<CNS_leukemia> <Accepted_use_of> "IT_Cytarabine_and_WBRT" .
<CNS_leukemia> <Accepted_use_of> "IT_Cytarabine_and_Methotrexate" .
<CNS_leukemia> <Accepted_use_of> "Cytarabine_liposomal" .
<PEV> <Is_historical_in> "Non-small_cell_lung_cancer" .
<BeRT> <Is_a> "Rituximab-containing_regimen" .
<Abloric> <Brand_name_of> "Allopurinol" .
<Paclitaxel_and_RT> <Has_accepted_use> "Head_and_neck_cancer" .
<Paclitaxel_and_RT> <Has_accepted_use> "Bladder_cancer" .
<PCE> <Has_supportive_med> "Diphenhydramine" .
<PCE> <Has_supportive_med> "Dexamethasone" .
<PCE> <Has_supportive_med> "Cimetidine" .
<Intravenous_immunoglobulin_monotherapy> <Is_current_in> "Immune_thrombocytopenia" .
<Medroxyprogesterone_monotherapy> <Is_current_in> "Endometrial_cancer" .
<Armol> <Brand_name_of> "Alendronate" .
<BFR> <Mapped_from> "BFR" .
<Bactrizole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<5_plus_2d> <Has_antineoplastic> "Daunorubicin" .
<5_plus_2d> <Has_antineoplastic> "Cytarabine" .
<MVBP> <Has_antineoplastic> "Methylprednisolone" .
<MVBP> <Has_antineoplastic> "Methotrexate" .
<MVBP> <Has_antineoplastic> "Etoposide" .
<MVBP> <Has_antineoplastic> "Carmustine" .
<Sulfaton> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<FEMTX> <Has_accepted_use> "Gastric_cancer" .
<Flutamide_and_Goserelin> <Is_current_in> "Prostate_cancer" .
<HDAC_and_G-CSF> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Mepolizumab> <May_have_route> "Intravenous" .
<Paclitaxel_and_S-1> <Has_antineoplastic> "Tegafur_gimeracil_oteracil" .
<Paclitaxel_and_S-1> <Has_antineoplastic> "Paclitaxel" .
<VAD-P> <Has_antineoplastic> "Vincristine" .
<VAD-P> <Has_antineoplastic> "Prednisone" .
<VAD-P> <Has_antineoplastic> "Doxorubicin" .
<VAD-P> <Has_antineoplastic> "Dexamethasone" .
<Zoledronic_acid_therapy> <Has_accepted_use> "Multiple_myeloma" .
<Purbac> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Palonosetron> <May_have_route> "Intravenous" .
<Cisplatin,_Etoposide,_Bevacizumab> <Maps_to> "Cisplatin,_Etoposide,_Bevacizumab" .
<Orvor> <Brand_name_of> "Voriconazole" .
<Bavituximab> <Is_a> "Investigational_drug" .
<Bavituximab> <Is_a> "Immunotherapeutic" .
<Bavituximab> <Is_a> "Antibody_medication" .
<Bavituximab> <Is_a> "Anti-PS_antibody" .
<Bayaspirin> <Brand_name_of> "Aspirin" .
<Anti-inhibitor_coagulant_complex> <Is_a> "Fractionated_plasma_product" .
<BL22_immunotoxin> <Is_a> "Immunotoxin" .
<BL22_immunotoxin> <Is_a> "Halted_drug" .
<BL22_immunotoxin> <Is_a> "Antibody_medication" .
<BL22_immunotoxin> <Is_a> "Anti-CD22_antibody" .
<Dacarbazine_and_Tamoxifen> <Maps_to> "Dacarbazine_and_Tamoxifen" .
<COP-Bleo> <Has_context> "Induction_therapy" .
<VD> <Mapped_from> "VD" .
<Hepatocellular_carcinoma> <Is_a> "Hepatobiliary_cancer" .
<Histrelin_monotherapy> <Has_antineoplastic> "Histrelin" .
<Vincristine_and_Prednisone> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Vincristine_and_Prednisone> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Vincristine_and_Prednisone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Belinostat_monotherapy> <Has_antineoplastic> "Belinostat" .
<Epratuzumab> <Has_brand_name> "LymphoCide" .
<PAD/VCD> <Is_current_in> "Plasma_cell_leukemia" .
<Doxorubicin_non-pegylated_liposomal_and_Bevacizumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<IT_Cytarabine,_Methotrexate,_Prednisone> <Has_accepted_use> "CNS_leukemia" .
<IT_Methotrexate_and_WBRT> <Has_accepted_use> "CNS_leukemia" .
<PT> <Has_modality> "Hormonotherapy" .
<CFP_and_Oophorectomy> <Has_modality> "Hormonotherapy" .
<CFP_and_Oophorectomy> <Has_modality> "Chemotherapy" .
<Enhertu> <Brand_name_of> "Fam-trastuzumab_deruxtecan" .
<Vinorelbine_and_Bevacizumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<Sorafenib_monotherapy> <Maps_to> "Sorafenib_monotherapy" .
<Carmustine_wafer_polifeprosan_20> <Local_therapy_of> "Gliadel_wafer_monotherapy" .
<EPOCH> <Has_antineoplastic> "Vincristine" .
<EPOCH> <Has_antineoplastic> "Prednisone" .
<EPOCH> <Has_antineoplastic> "Etoposide" .
<EPOCH> <Has_antineoplastic> "Doxorubicin" .
<EPOCH> <Has_antineoplastic> "Cyclophosphamide" .
<Gemcitabine_and_Irinotecan> <Maps_to> "Gemcitabine_and_Irinotecan" .
<RVD> <Has_context> "Non-curative_therapy" .
<RVD> <Has_context> "Non-curative_second-line_maintenance_therapy" .
<RVD> <Has_context> "Non-curative_first-line_therapy" .
<RVD> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<RVD> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Nordic_Regimen,_older_patients> <Has_accepted_use> "CNS_lymphoma" .
<Irinotecan,_Temozolomide,_Dinutuximab> <Is_a> "Irinotecan-containing_regimen" .
<R-IFE> <Mapped_from> "R-IFE" .
<Cortisone_monotherapy> <Maps_to> "Cortisone_monotherapy" .
<ChlVPP> <Maps_to> "ChlVPP" .
<Decone> <Brand_name_of> "Dexamethasone" .
<OLF> <Has_context> "Non-curative_therapy" .
<OLF> <Has_context> "Non-curative_first-line_therapy" .
<Midostaurin> <Has_FDA_indication> "Systemic_mastocytosis" .
<Midostaurin> <Has_FDA_indication> "Acute_myeloid_leukemia" .
<Flutamide_and_Leuprolide> <Has_context> "Non-curative_therapy" .
<Lucibru> <Brand_name_of> "Ibrutinib" .
<Mantle_cell_lymphoma> <Accepted_use_of> "maxi-R-CHOP/R-HiDAC" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Zanubrutinib_monotherapy" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Zanubrutinib" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Vincristine" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Venetoclax" .
<Mantle_cell_lymphoma> <Accepted_use_of> "VcR-CVAD" .
<Mantle_cell_lymphoma> <Accepted_use_of> "VR-CHOP" .
<Mantle_cell_lymphoma> <Accepted_use_of> "VR-CAP" .
<Mantle_cell_lymphoma> <Accepted_use_of> "VR" .
<Mantle_cell_lymphoma> <Accepted_use_of> "VAD_plus_C" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Thalidomide" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Temsirolimus_monotherapy" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Temsirolimus_and_Rituximab" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Temsirolimus" .
<Mantle_cell_lymphoma> <Accepted_use_of> "TAM6,_then_auto_HSCT" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Rituximab-pvvr" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Rituximab-abbs" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Rituximab_monotherapy" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Rituximab" .
<Mantle_cell_lymphoma> <Accepted_use_of> "RiPAD_plus_C" .
<Mantle_cell_lymphoma> <Accepted_use_of> "RT-PEPC" .
<Mantle_cell_lymphoma> <Accepted_use_of> "R-VAD_plus_C" .
<Mantle_cell_lymphoma> <Accepted_use_of> "R-MACLO/R-IVAM" .
<Mantle_cell_lymphoma> <Accepted_use_of> "R-M-CHOP" .
<Mantle_cell_lymphoma> <Accepted_use_of> "R-Hyper-CVAD/R-MA" .
<Mantle_cell_lymphoma> <Accepted_use_of> "R-HiDAC" .
<Mantle_cell_lymphoma> <Accepted_use_of> "R-FCM" .
<Mantle_cell_lymphoma> <Accepted_use_of> "R-DHAP" .
<Mantle_cell_lymphoma> <Accepted_use_of> "R-DHAOx" .
<Mantle_cell_lymphoma> <Accepted_use_of> "R-DHAC" .
<Mantle_cell_lymphoma> <Accepted_use_of> "R-CVP" .
<Mantle_cell_lymphoma> <Accepted_use_of> "R-CHOP/R-DHAP" .
<Mantle_cell_lymphoma> <Accepted_use_of> "R-CHOP-14_(Prednisolone)" .
<Mantle_cell_lymphoma> <Accepted_use_of> "R-CHOP_(Prednisolone)" .
<Mantle_cell_lymphoma> <Accepted_use_of> "R-CHOP" .
<Mantle_cell_lymphoma> <Accepted_use_of> "R-BL" .
<Mantle_cell_lymphoma> <Accepted_use_of> "R-BEAM,_then_auto_HSCT" .
<Mantle_cell_lymphoma> <Accepted_use_of> "R-BAC" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Procarbazine" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Prednisone" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Prednisolone" .
<Mantle_cell_lymphoma> <Accepted_use_of> "PEP-C" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Oxaliplatin" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Observation" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Obinutuzumab_monotherapy" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Obinutuzumab" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Mitoxantrone" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Methotrexate" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Melphalan_and_TBI,_then_auto_HSCT" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Melphalan" .
<Mantle_cell_lymphoma> <Accepted_use_of> "MCP" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Lenalidomide_monotherapy" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Lenalidomide_and_Rituximab" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Lenalidomide" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Interferon_alfa_monotherapy" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Ifosfamide" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Ibrutinib_monotherapy" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Ibrutinib_and_Venetoclax" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Ibrutinib_and_Rituximab" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Ibrutinib" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Ibritumomab_tiuxetan_monotherapy" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Ibritumomab_tiuxetan" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Fludarabine" .
<Mantle_cell_lymphoma> <Accepted_use_of> "FluBuCy,_then_allo_HSCT" .
<Mantle_cell_lymphoma> <Accepted_use_of> "FR" .
<Mantle_cell_lymphoma> <Accepted_use_of> "FCR" .
<Mantle_cell_lymphoma> <Accepted_use_of> "FCM" .
<Mantle_cell_lymphoma> <Accepted_use_of> "FC" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Everolimus_monotherapy" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Everolimus" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Etoposide" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Doxorubicin" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Dexamethasone" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Cytarabine" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Cyclophosphamide_and_TBI,_then_auto_HSCT" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Cyclophosphamide" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Cladribine_monotherapy" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Cladribine_and_Rituximab" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Cladribine" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Cisplatin" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Chlorambucil_and_Rituximab" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Chlorambucil" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Carmustine" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Carboplatin" .
<Mantle_cell_lymphoma> <Accepted_use_of> "CVP_(Prednisolone)" .
<Mantle_cell_lymphoma> <Accepted_use_of> "CHOP_(Prednisolone)" .
<Mantle_cell_lymphoma> <Accepted_use_of> "CHOP" .
<Mantle_cell_lymphoma> <Accepted_use_of> "CBV,_then_auto_HSCT" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Bortezomib_monotherapy" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Bortezomib" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Bendamustine" .
<Mantle_cell_lymphoma> <Accepted_use_of> "BeRT" .
<Mantle_cell_lymphoma> <Accepted_use_of> "BR" .
<Mantle_cell_lymphoma> <Accepted_use_of> "BFR,_then_allo_HSCT" .
<Mantle_cell_lymphoma> <Accepted_use_of> "BEAM,_then_auto_HSCT" .
<Mantle_cell_lymphoma> <Accepted_use_of> "BEAC,_then_auto_HSCT" .
<Mantle_cell_lymphoma> <Accepted_use_of> "BDR" .
<Mantle_cell_lymphoma> <Accepted_use_of> "BCHOP" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Arsenic_trioxide_and_Chlorambucil" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Arsenic_trioxide" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Alisertib" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Acalabrutinib_monotherapy" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Acalabrutinib" .
<Mantle_cell_lymphoma> <Accepted_use_of> "Abexinostat" .
<ADE_(standard-dose_Ara-C)> <Has_modality> "Chemotherapy" .
<Bendamustine_and_Obinutuzumab> <Has_modality> "Chemotherapy" .
<VMPT> <Has_antineoplastic> "Thalidomide" .
<VMPT> <Has_antineoplastic> "Prednisone" .
<VMPT> <Has_antineoplastic> "Melphalan" .
<VMPT> <Has_antineoplastic> "Bortezomib" .
<CMFT> <Has_modality> "Hormonotherapy" .
<CMFT> <Has_modality> "Chemotherapy" .
<Amoxicillin> <May_have_route> "Oral" .
<PAD_doxil> <Has_antineoplastic> "Pegylated_liposomal_doxorubicin" .
<PAD_doxil> <Has_antineoplastic> "Dexamethasone" .
<PAD_doxil> <Has_antineoplastic> "Bortezomib" .
<Non-curative_subsequent-line_consolidation_therapy> <Context_of> "Rituximab_monotherapy" .
<Non-curative_subsequent-line_consolidation_therapy> <Context_of> "R-TBI/Cy,_then_auto_HSCT" .
<Non-curative_subsequent-line_consolidation_therapy> <Context_of> "R-BEAM,_then_auto_HSCT" .
<Non-curative_subsequent-line_consolidation_therapy> <Context_of> "Placebo" .
<Non-curative_subsequent-line_consolidation_therapy> <Context_of> "Ofatumumab_monotherapy" .
<Non-curative_subsequent-line_consolidation_therapy> <Context_of> "Observation" .
<Non-curative_subsequent-line_consolidation_therapy> <Context_of> "Ibritumomab_tiuxetan_monotherapy" .
<Non-curative_subsequent-line_consolidation_therapy> <Context_of> "Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT" .
<Non-curative_subsequent-line_consolidation_therapy> <Context_of> "Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Non-curative_subsequent-line_consolidation_therapy> <Context_of> "Fludarabine_and_TBI,_then_allo_HSCT" .
<Non-curative_subsequent-line_consolidation_therapy> <Context_of> "FCR,_then_allo_HSCT" .
<Non-curative_subsequent-line_consolidation_therapy> <Context_of> "FC,_then_allo_HSCT" .
<Non-curative_subsequent-line_consolidation_therapy> <Context_of> "Cyclophosphamide_and_TBI,_then_auto_HSCT" .
<Non-curative_subsequent-line_consolidation_therapy> <Context_of> "(90)YFC,_then_allo_HSCT" .
<Atossa> <Brand_name_of> "Ondansetron" .
<Cycloplatin> <Brand_name_of> "Carboplatin" .
<Cisplatin_and_Fluorouracil> <Is_a> "Platinum_doublet" .
<Oecotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CVP,_then_131Iodine-Tositumomab> <Has_accepted_use> "Follicular_lymphoma" .
<VR-CP> <Maps_to> "VR-CP" .
<Ceritinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Ceritinib_monotherapy> <Has_context> "All_lines_of_therapy" .
<Valgan> <Brand_name_of> "Valganciclovir" .
<CVD_(Vindesine)> <Is_current_in> "Melanoma" .
<Alvocidib> <May_have_route> "Oral" .
<7_plus_5i> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Pixantrone_monotherapy> <Mapped_from> "Pixantrone_monotherapy" .
<Cisplatin,_Pemetrexed,_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<Fludarabine_monotherapy> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Fludarabine_monotherapy> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Fludarabine_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<Fludarabine_monotherapy> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Aspen> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Sennosides> <Has_brand_name> "Senokot" .
<Sennosides> <Has_brand_name> "Perdiem" .
<Sennosides> <Has_brand_name> "Ex-Lax" .
<Cyclophosphamide,_Lomustine,_Methotrexate> <Has_modality> "Chemotherapy" .
<Rasburicase> <Has_brand_name> "Rasby" .
<Rasburicase> <Has_brand_name> "Rasburnat" .
<Rasburicase> <Has_brand_name> "Rasbelon" .
<Rasburicase> <Has_brand_name> "Fasturtec" .
<Rasburicase> <Has_brand_name> "Elitek" .
<Leuprolide> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Leuprolide> <Is_a> "Protein_expression-specific_medication" .
<Leuprolide> <Is_a> "PMDA_approved_drug" .
<Leuprolide> <Is_a> "GnRH_agonist" .
<Leuprolide> <Is_a> "Antiandrogen" .
<Hidrea> <Brand_name_of> "Hydroxyurea" .
<MAPI> <Has_accepted_use> "Osteosarcoma" .
<Serenace> <Brand_name_of> "Haloperidol" .
<Vascular_sarcoma> <Accepted_use_of> "Paclitaxel_monotherapy" .
<Vascular_sarcoma> <Accepted_use_of> "Paclitaxel" .
<Vascular_sarcoma> <Accepted_use_of> "Bevacizumab-bvzr" .
<Vascular_sarcoma> <Accepted_use_of> "Bevacizumab-awwb" .
<Vascular_sarcoma> <Accepted_use_of> "Bevacizumab_monotherapy" .
<Vascular_sarcoma> <Accepted_use_of> "Bevacizumab" .
<ABC> <Has_context> "Non-curative_therapy" .
<Fludarabine_and_Prednisone> <Maps_to> "Fludarabine_and_Prednisone" .
<Aratran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin_and_Vindesine> <Mapped_from> "Cisplatin_and_Vindesine" .
<Antithymocyte_globulin> <Subsumes> "Antithymocyte_globulin_rabbit_ATG" .
<Antithymocyte_globulin> <Subsumes> "Antithymocyte_globulin_horse_ATG" .
<Alectinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Alectinib_monotherapy> <Has_context> "All_lines_of_therapy" .
<Irinotecan_and_Temozolomide> <Has_antineoplastic> "Temozolomide" .
<Irinotecan_and_Temozolomide> <Has_antineoplastic> "Irinotecan" .
<Doxorubicin,_Ifosfamide,_RT> <Is_a> "Anthracycline-containing_regimen" .
<Mycostatin> <Has_brand_name> "Nystatin" .
<R-MCP> <Has_accepted_use> "Follicular_lymphoma" .
<Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Benralizumab_monotherapy> <Is_current_in> "Hypereosinophilic_syndrome" .
<Capecitabine_and_Paclitaxel> <Has_antineoplastic> "Paclitaxel" .
<Capecitabine_and_Paclitaxel> <Has_antineoplastic> "Capecitabine" .
<WBRT> <Is_current_in> "CNS_leukemia" .
<Nedaplatin> <May_have_route> "Intravenous" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Has_antineoplastic> "Vincristine" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Has_antineoplastic> "Methotrexate" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Has_antineoplastic> "Ifosfamide" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Has_antineoplastic> "Etoposide" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Has_antineoplastic> "Doxorubicin" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Has_antineoplastic> "Cytarabine" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Has_antineoplastic> "Cyclophosphamide" .
<Mitasone> <Brand_name_of> "Dexamethasone" .
<Inhalation> <May_be_route_of> "Pentamidine" .
<Olanzapine> <Is_a> "Emesis_prevention" .
<Olanzapine> <Is_a> "Dopamine_receptor_antagonist" .
<Olanzapine> <Is_a> "Antipsychotic" .
<Hydroxyurea> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Hydroxyurea> <Is_a> "DNA_synthesis_inhibitor" .
<Irinotecan_monotherapy> <Is_current_in> "Small_cell_lung_cancer" .
<Irinotecan_monotherapy> <Is_current_in> "Glioblastoma" .
<Irinotecan_monotherapy> <Is_current_in> "Gastric_cancer" .
<Irinotecan_monotherapy> <Is_current_in> "Esophageal_cancer" .
<Irinotecan_monotherapy> <Is_current_in> "Colon_cancer" .
<Irinotecan_monotherapy> <Is_current_in> "Cervical_cancer" .
<Irinotecan_monotherapy> <Is_current_in> "Anaplastic_glioma" .
<Warfarin_monotherapy> <Has_modality> "Anticoagulation" .
<Osaston> <Brand_name_of> "Alendronate" .
<Pixantrone_monotherapy> <Has_antineoplastic> "Pixantrone" .
<Caumadin> <Brand_name_of> "Warfarin" .
<Imatinib_and_Prednisone> <Maps_to> "Imatinib_and_Prednisone" .
<Axicabtagene_ciloleucel> <Has_brand_name> "Yescarta" .
<DOLP_(Prednisolone)> <Has_modality> "Chemotherapy" .
<Aspergum> <Brand_name_of> "Aspirin" .
<Coltuximab_ravtansine> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<FEC_and_H_(SC)> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<FEC_and_H_(SC)> <Has_accepted_use> "Breast_cancer" .
<ddT_(Taxotere)> <Is_current_in> "Breast_cancer" .
<Thoracic_oncology_medication> <Is_a> "Site-specific_medication" .
<Fruquintinib> <Is_a> "VEGFR_inhibitor" .
<Fruquintinib> <Is_a> "Kinase_inhibitor" .
<Fruquintinib> <Is_a> "Investigational_drug" .
<Interferon_alfa-2a_and_Isotretinoin> <Has_modality> "Immunotherapy" .
<Myelofibrosis> <Current_treated_by> "Ruxolitinib_monotherapy" .
<Myelofibrosis> <Current_treated_by> "Prednisone_monotherapy" .
<Myelofibrosis> <Current_treated_by> "Pomalidomide_monotherapy" .
<Myelofibrosis> <Current_treated_by> "Pomalidomide_and_Prednisone" .
<Myelofibrosis> <Current_treated_by> "Placebo" .
<Myelofibrosis> <Current_treated_by> "Lenalidomide_monotherapy" .
<Myelofibrosis> <Current_treated_by> "Hydroxyurea_monotherapy" .
<Myelofibrosis> <Current_treated_by> "Fedratinib_monotherapy" .
<Megestrol_and_Tamoxifen> <Has_modality> "Hormonotherapy" .
<VR-CP> <Mapped_from> "VR-CP" .
<Ibrutinib_and_Venetoclax> <Mapped_from> "Ibrutinib_and_Venetoclax" .
<Etoposide_and_TBI,_then_allo_HSCT> <Has_modality> "Radiotherapy" .
<Etoposide_and_TBI,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<Etoposide_and_TBI,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<L-asparaginase_monotherapy> <Has_modality> "Chemotherapy" .
<Tranexamic_acid_monotherapy> <Is_current_in> "Hereditary_hemorrhagic_telangiectasia" .
<Prednisolone_monotherapy> <Has_accepted_use> "Warm_autoimmune_hemolytic_anemia" .
<Prednisolone_monotherapy> <Has_accepted_use> "Multiple_myeloma" .
<Prednisolone_monotherapy> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Prednisolone_monotherapy> <Has_accepted_use> "Acquired_coagulopathy" .
<Dexacutis> <Brand_name_of> "Dexamethasone" .
<FOLFIRI_and_Bevacizumab> <Has_accepted_use> "KRAS_wild-type_Colon_cancer" .
<FOLFIRI_and_Bevacizumab> <Has_accepted_use> "Colon_cancer" .
<R-miniCHOP> <Has_modality> "Chemotherapy" .
<Clitaxel> <Brand_name_of> "Paclitaxel" .
<Fludarabine_monotherapy> <Is_historical_in> "Follicular_lymphoma" .
<Fludarabine_monotherapy> <Is_historical_in> "Chronic_lymphocytic_leukemia" .
<mFOLFIRINOX> <Maps_to> "mFOLFIRINOX" .
<Elo-Rd> <Has_context> "Non-curative_therapy" .
<Clofarabine_and_Cytarabine> <Has_accepted_use> "Acute_myeloid_leukemia" .
<ACE> <Has_accepted_use> "Small_cell_lung_cancer" .
<ACE> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Alemtuzumab_monotherapy> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Alemtuzumab_monotherapy> <Has_accepted_use> "T-cell_prolymphocytic_leukemia" .
<Alemtuzumab_monotherapy> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Alemtuzumab_monotherapy> <Has_accepted_use> "Hypereosinophilic_syndrome" .
<Alemtuzumab_monotherapy> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Alemtuzumab_monotherapy> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Alemtuzumab_monotherapy> <Has_accepted_use> "Autoimmune_cytopenia" .
<Alemtuzumab_monotherapy> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<CDE> <Has_accepted_use> "Small_cell_lung_cancer" .
<Cyclosporine,_Sirolimus,_Prednisone> <Mapped_from> "Cyclosporine,_Sirolimus,_Prednisone" .
<VMP,_then_Rd> <Is_current_in> "Multiple_myeloma" .
<Pehacort> <Brand_name_of> "Prednisone" .
<BEAM> <Is_current_in> "Autologous_HSCT" .
<BEAM> <Is_current_in> "Allogeneic_HSCT" .
<Placebo> <Has_context> "Prophylaxis" .
<Placebo> <Has_context> "Non-curative_third-line_therapy" .
<Placebo> <Has_context> "Non-curative_therapy" .
<Placebo> <Has_context> "Non-curative_subsequent-line_therapy" .
<Placebo> <Has_context> "Non-curative_subsequent-line_consolidation_therapy" .
<Placebo> <Has_context> "Non-curative_second-line_therapy" .
<Placebo> <Has_context> "Non-curative_second-line_maintenance_therapy" .
<Placebo> <Has_context> "Non-curative_first-line_therapy" .
<Placebo> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Placebo> <Has_context> "Neoadjuvant_therapy" .
<Placebo> <Has_context> "Maintenance_after_salvage_therapy" .
<Placebo> <Has_context> "Consolidation_after_upfront_therapy" .
<Placebo> <Has_context> "All_lines_of_therapy" .
<Placebo> <Has_context> "Adjuvant_therapy" .
<Cisplatin,_Lomustine,_Vincristine> <Maps_to> "Cisplatin,_Lomustine,_Vincristine" .
<Cephalosporin> <Subsumes> "Cephalexin" .
<Cephalosporin> <Subsumes> "Cefixime" .
<Alectinib> <Is_a> "Mutation-specific_medication" .
<Alectinib> <Is_a> "Kinase_inhibitor" .
<Alectinib> <Is_a> "FDA_approved_drug" .
<Alectinib> <Is_a> "ALK_inhibitor" .
<R-FND> <Has_context> "Non-curative_therapy" .
<R-FND> <Has_context> "Non-curative_first-line_therapy" .
<Granny> <Brand_name_of> "Granisetron" .
<Methoxsalen> <Antineoplastic_of> "PUVA" .
<Endocrine_cancer> <Is_a> "Malignant_solid_neoplasm" .
<CCOP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Ronal> <Brand_name_of> "Aspirin" .
<Antibacterials> <Supportive_med_of> "RVD" .
<Antibacterials> <Supportive_med_of> "CYKLONE" .
<Non-curative_first-line_therapy> <Mapped_from> "Non-curative_first-line_therapy" .
<Mitoxantrone_and_Hydrocortisone> <Is_a> "Anthracycline-containing_regimen" .
<Omnitarg> <Brand_name_of> "Pertuzumab" .
<Toremifene> <May_have_route> "Oral" .
<CHOP,_then_131Iodine-Tositumomab> <Has_context> "Non-curative_first-line_therapy" .
<Teniposide_and_WBRT> <Is_current_in> "CNS_carcinoma" .
<Edoxaban_monotherapy> <Is_current_in> "Venous_thromboembolism" .
<Myelodysplastic_syndrome> <Is_a> "Bone_marrow_failure_syndrome" .
<Nordic_FLOX> <Has_antineoplastic> "Oxaliplatin" .
<Nordic_FLOX> <Has_antineoplastic> "Folinic_acid" .
<Nordic_FLOX> <Has_antineoplastic> "Fluorouracil" .
<Cortisolona> <Brand_name_of> "Methylprednisolone" .
<CVAD> <Has_accepted_use> "Multiple_myeloma" .
<Dermadex> <Brand_name_of> "Dexamethasone" .
<BVDS> <Is_a> "Anthracycline-containing_regimen" .
<Methotrexate,_then_Cytarabine_and_Thiotepa> <Is_current_in> "CNS_lymphoma" .
<Vismodegib_monotherapy> <Maps_to> "Vismodegib_monotherapy" .
<Fludarabine,_Busulfan,_Cyclophosphamide> <Has_accepted_use> "Allogeneic_HSCT" .
<Omeprazole> <May_have_route> "Oral" .
<Omeprazole> <May_have_route> "Intravenous" .
<Lapatinib_and_Letrozole> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Lapatinib_and_Letrozole> <Has_accepted_use> "Breast_cancer" .
<Carboplatin_and_Cisplatin> <Has_modality> "Chemotherapy" .
<CFP_and_Oophorectomy> <Mapped_from> "CFP_and_Oophorectomy" .
<Doxorubicin_and_Gemcitabine> <Has_supportive_med> "Pegfilgrastim" .
<Doxorubicin_and_Gemcitabine> <Has_supportive_med> "Filgrastim" .
<VACOP-B> <Maps_to> "VACOP-B" .
<Irinotecan_and_Cetuximab> <Has_context> "Non-curative_subsequent-line_therapy" .
<Irinotecan_and_Cetuximab> <Has_context> "Non-curative_second-line_therapy" .
<Meti-derm> <Brand_name_of> "Prednisolone" .
<CEPP(B)> <Has_modality> "Chemotherapy" .
<Ramucirumab_monotherapy> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Ramucirumab_monotherapy> <Has_accepted_use> "Gastric_cancer" .
<Ramucirumab_monotherapy> <Has_accepted_use> "Esophageal_cancer" .
<CALGB_8811_early_intensification> <Has_local_therapy> "Methotrexate" .
<Hemostan> <Brand_name_of> "Tranexamic_acid" .
<R-CHOP_(Prednisolone)> <Has_modality> "Chemotherapy" .
<Ticalog> <Brand_name_of> "Ticagrelor" .
<CEF/CMF> <Has_accepted_use> "Breast_cancer" .
<Cytopenia> <Is_a> "Classical_hematologic_condition" .
<CAMP> <Mapped_from> "CAMP" .
<Amrubicin_monotherapy> <Has_context> "Non-curative_therapy" .
<Amrubicin_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Ibritumomab_tiuxetan> <Has_FDA_indication> "Transformed_lymphoma" .
<Ibritumomab_tiuxetan> <Has_FDA_indication> "Follicular_lymphoma" .
<Fulvestrant_and_Ribociclib> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Fulvestrant_and_Ribociclib> <Has_accepted_use> "Breast_cancer" .
<FOLFIRINOX> <Has_modality> "Chemotherapy" .
<Ifacap> <Brand_name_of> "Carboplatin" .
<Sustol> <Brand_name_of> "Granisetron" .
<R-DHAC> <Mapped_from> "R-DHAC" .
<Augmented_Hyper-CVAD_and_Asparaginase> <Maps_to> "Augmented_Hyper-CVAD_and_Asparaginase" .
<Docetaxel,_Gemcitabine,_RT> <Has_context> "Induction_therapy" .
<Ixempra> <Brand_name_of> "Ixabepilone" .
<Erwinaze> <Brand_name_of> "Asparaginase_Erwinia_chrysanthemi" .
<GCD-R> <Has_antineoplastic> "Rituximab" .
<GCD-R> <Has_antineoplastic> "Gemcitabine" .
<GCD-R> <Has_antineoplastic> "Dexamethasone" .
<GCD-R> <Has_antineoplastic> "Carboplatin" .
<Intermittent_ADT> <Has_antineoplastic> "Nonsteroidal_antiandrogens" .
<Intermittent_ADT> <Has_antineoplastic> "GnRH_agonists" .
<Erbablas> <Brand_name_of> "Vinblastine" .
<Doxorubicin_and_Lomustine> <Has_context> "Non-curative_subsequent-line_therapy" .
<Immunosuppressant> <Subsumes> "Steroid" .
<Immunosuppressant> <Subsumes> "Prednisone" .
<Immunosuppressant> <Subsumes> "Prednisolone" .
<Immunosuppressant> <Subsumes> "Mycophenolate_mofetil" .
<Immunosuppressant> <Subsumes> "Methylprednisolone" .
<Immunosuppressant> <Subsumes> "Methotrexate" .
<Immunosuppressant> <Subsumes> "Mercaptopurine" .
<Immunosuppressant> <Subsumes> "MTOR_inhibitor" .
<Immunosuppressant> <Subsumes> "Cyclophosphamide" .
<Immunosuppressant> <Subsumes> "Calcineurin_inhibitor" .
<Immunosuppressant> <Subsumes> "Antithymocyte_globulin" .
<mDCF> <Maps_to> "mDCF" .
<Docetaxel,_Gemcitabine,_RT> <Has_antineoplastic> "Gemcitabine" .
<Docetaxel,_Gemcitabine,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Docetaxel,_Gemcitabine,_RT> <Has_antineoplastic> "Docetaxel" .
<Carboplatin,_Pemetrexed,_Pembrolizumab> <Has_antineoplastic> "Pemetrexed" .
<Carboplatin,_Pemetrexed,_Pembrolizumab> <Has_antineoplastic> "Pembrolizumab" .
<Carboplatin,_Pemetrexed,_Pembrolizumab> <Has_antineoplastic> "Carboplatin" .
<Gemcitabine,_Oxaliplatin,_Paclitaxel> <Has_modality> "Chemotherapy" .
<Nordic_FLOX> <Has_accepted_use> "Colon_cancer" .
<Docetaxel_and_S-1> <Has_accepted_use> "Gastric_cancer" .
<Bortezomib_monotherapy> <Has_antineoplastic> "Bortezomib" .
<Carulon> <Brand_name_of> "Dexamethasone" .
<TC,_then_IE,_VDoxoC,_VEC> <Is_a> "Anthracycline-containing_regimen" .
<Betrixaban_monotherapy> <Has_supportive_med> "Betrixaban" .
<Grathazon> <Brand_name_of> "Dexamethasone" .
<CX_and_Trastuzumab> <Has_accepted_use> "Gastric_cancer" .
<CX_and_Trastuzumab> <Has_accepted_use> "Esophageal_cancer" .
<Medlone> <Brand_name_of> "Methylprednisolone" .
<Apalutamide_monotherapy> <Mapped_from> "Apalutamide_monotherapy" .
<CX-C> <Has_modality> "Chemotherapy" .
<Steroidal_androgen_receptor_inhibitor> <Is_a> "Androgen_receptor_inhibitor" .
<Epirubicin_and_Ifosfamide> <Has_modality> "Chemotherapy" .
<Hydroxyurea_monotherapy> <Has_modality> "Chemotherapy" .
<VAC> <Is_current_in> "Rhabdomyosarcoma" .
<Acesan> <Brand_name_of> "Aspirin" .
<EPIC_regimen> <Maps_to> "EPIC_regimen" .
<Warfarex> <Brand_name_of> "Warfarin" .
<Purinethol> <Brand_name_of> "Mercaptopurine" .
<Cisplatin,_Gemcitabine,_RT> <Has_modality> "Radiotherapy" .
<Cisplatin,_Gemcitabine,_RT> <Has_modality> "Chemotherapy" .
<Epirubicin_and_Ifosfamide> <Maps_to> "Epirubicin_and_Ifosfamide" .
<Cisplatin_and_Gemcitabine/Erlotinib> <Has_context> "Non-curative_therapy" .
<Antiphospholipid_antibody_syndrome> <Is_a> "Thrombotic_disorder" .
<Antiphospholipid_antibody_syndrome> <Is_a> "Autoimmune_hematologic_condition" .
<Aspirin_and_Hydroxyurea> <Has_supportive_med> "Clopidogrel" .
<Aspirin_and_Hydroxyurea> <Has_supportive_med> "Aspirin" .
<DCEP_and_G-CSF> <Mapped_from> "DCEP_and_G-CSF" .
<Trib> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Docetaxel_and_Prednisone> <Mapped_from> "Docetaxel_and_Prednisone" .
<IT_Cytarabine,_Methotrexate,_Prednisone> <Has_local_therapy> "Prednisone" .
<IT_Cytarabine,_Methotrexate,_Prednisone> <Has_local_therapy> "Methotrexate" .
<IT_Cytarabine,_Methotrexate,_Prednisone> <Has_local_therapy> "Cytarabine" .
<Fostamatinib_monotherapy> <Is_current_in> "Immune_thrombocytopenia" .
<CHAD> <Maps_to> "CHAD" .
<M-DEX> <Is_historical_in> "Multiple_myeloma" .
<Dutasteride> <Has_brand_name> "Avodart" .
<Oxaliplatin_monotherapy> <Maps_to> "Oxaliplatin_monotherapy" .
<Interferon_gamma-1b> <Antineoplastic_of> "Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b" .
<Total_Therapy> <Has_modality> "Chemotherapy" .
<Panitumumab> <Has_FDA_indication> "Colon_cancer" .
<Lusutrombopag> <Has_accepted_use> "Thrombocytopenia_in_liver_disease" .
<Unidexa> <Brand_name_of> "Dexamethasone" .
<Melphalan_and_TBI> <Has_context> "All_lines_of_therapy" .
<Carboplatin_monotherapy> <Is_current_in> "Testicular_cancer" .
<Carboplatin_monotherapy> <Is_current_in> "Ovarian_cancer" .
<Carboplatin_monotherapy> <Is_current_in> "Low-grade_glioma" .
<Carboplatin_monotherapy> <Is_current_in> "Endometrial_cancer" .
<Carboplatin_monotherapy> <Is_current_in> "Cervical_cancer" .
<Capecitabine/Capecitabine_and_RT> <Maps_to> "Capecitabine/Capecitabine_and_RT" .
<IGEV_and_G-CSF> <Mapped_from> "IGEV_and_G-CSF" .
<Daratumumab> <Has_accepted_use> "Multiple_myeloma" .
<Daratumumab> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Cyclophosphamide,_Lomustine,_Methotrexate> <Maps_to> "Cyclophosphamide,_Lomustine,_Methotrexate" .
<Durvalumab_monotherapy> <Is_current_in> "Small_cell_lung_cancer" .
<Durvalumab_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Durvalumab_monotherapy> <Is_current_in> "Bladder_cancer" .
<Clolar> <Brand_name_of> "Clofarabine" .
<BASIC> <Is_current_in> "Burkitt_lymphoma" .
<IAP> <Mapped_from> "IAP" .
<Cyclosporine_and_Mycophenolate_mofetil> <Is_current_in> "Graft_versus_host_disease" .
<Carboplatin_and_Docetaxel> <Mapped_from> "Carboplatin_and_Docetaxel" .
<Rydapt> <Brand_name_of> "Midostaurin" .
<Enfortumab_vedotin_monotherapy> <Maps_to> "Enfortumab_vedotin_monotherapy" .
<Duoctrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Radiation_therapy> <Mapped_from> "Radiation_therapy" .
<R-CODOX-M_(Doxil_substituted)> <Has_context> "Induction_therapy" .
<Cisplatin,_Lomustine,_Vincristine> <Has_accepted_use> "Medulloblastoma" .
<Aminopterin_monotherapy> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<R-MegaCHOP-14> <Has_modality> "Chemotherapy" .
<BuCyTBI,_then_allo_HSCT> <Maps_to> "BuCyTBI,_then_allo_HSCT" .
<Anti-CCR4_antibody> <Is_a> "Antibody_medication" .
<RANK_ligand_inhibitor> <Subsumes> "Denosumab" .
<Blinatumomab> <Antineoplastic_of> "Blinatumomab_monotherapy" .
<Cyclosporine_monotherapy> <Maps_to> "Cyclosporine_monotherapy" .
<Thalidomide_and_Rituximab> <Maps_to> "Thalidomide_and_Rituximab" .
<Paxenor> <Brand_name_of> "Paclitaxel" .
<Warfarin> <Is_a> "Vitamin_K_antagonist" .
<Warfarin> <Is_a> "Anticoagulant" .
<FULV_and_Bevacizumab> <Mapped_from> "FULV_and_Bevacizumab" .
<IT_Cytarabine,_Methotrexate,_Methylprednisolone> <Has_local_therapy> "Methylprednisolone" .
<IT_Cytarabine,_Methotrexate,_Methylprednisolone> <Has_local_therapy> "Methotrexate" .
<IT_Cytarabine,_Methotrexate,_Methylprednisolone> <Has_local_therapy> "Cytarabine" .
<Nozia> <Brand_name_of> "Ramosetron" .
<MVAC,_dose-dense> <Is_current_in> "Bladder_cancer" .
<Epirubicin_and_Vinorelbine> <Maps_to> "Epirubicin_and_Vinorelbine" .
<Ruxolitinib_monotherapy> <Maps_to> "Ruxolitinib_monotherapy" .
<Angettes> <Brand_name_of> "Aspirin" .
<Interferon_gamma-1b> <Has_brand_name> "Actimmune" .
<Dacarbazine_and_Interferon_alfa-2a> <Is_current_in> "Melanoma" .
<Carboplatin,_Paclitaxel,_Pembrolizumab> <Mapped_from> "Carboplatin,_Paclitaxel,_Pembrolizumab" .
<Sargramostim> <Antineoplastic_of> "GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab" .
<ABVDm> <Has_context> "Induction_therapy" .
<m-BACOD> <Mapped_from> "m-BACOD" .
<Ramucirumab_monotherapy> <Has_modality> "Chemotherapy" .
<Navoban> <Brand_name_of> "Tropisetron" .
<Cytarabine,_Daunorubicin,_Vincristine> <Has_modality> "Chemotherapy" .
<Fulvestrant_monotherapy> <Has_antineoplastic> "Fulvestrant" .
<Vincristine> <Local_therapy_of> "R-Hyper-CVAD/R-MA" .
<SOX_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Octreotide_and_Interferon_alfa> <Maps_to> "Octreotide_and_Interferon_alfa" .
<Alendil> <Brand_name_of> "Alendronate" .
<CMFT> <Is_a> "Antiestrogen-containing_regimen" .
<IGEV> <Has_antineoplastic> "Vinorelbine" .
<IGEV> <Has_antineoplastic> "Prednisolone" .
<IGEV> <Has_antineoplastic> "Ifosfamide" .
<IGEV> <Has_antineoplastic> "Gemcitabine" .
<Denileukin_diftitox> <May_have_route> "Intravenous" .
<GDP> <Has_context> "Salvage_therapy" .
<GDP> <Has_context> "Non-curative_therapy" .
<GDP> <Has_context> "Non-curative_subsequent-line_therapy" .
<Longastatina_LAR> <Brand_name_of> "Octreotide_LAR" .
<Cytosar-U> <Brand_name_of> "Cytarabine" .
<Mogamulizumab_monotherapy> <Has_modality> "Chemotherapy" .
<Cisplatin_and_Ifosfamide> <Has_context> "Non-curative_first-line_therapy" .
<FLOX> <Mapped_from> "FLOX" .
<Procarbazine_monotherapy> <Has_modality> "Chemotherapy" .
<Bevacizumab-bvzr> <Is_a> "VEGFR_inhibitor" .
<Bevacizumab-bvzr> <Is_a> "Neutral" .
<Bevacizumab-bvzr> <Is_a> "Biosimilar" .
<Bevacizumab-bvzr> <Is_a> "Antibody_medication" .
<Bevacizumab-bvzr> <Is_a> "Anti-VEGFR_antibody" .
<EC_and_Bevacizumab> <Has_accepted_use> "triple_negative_Breast_cancer" .
<EC_and_Bevacizumab> <Has_accepted_use> "Breast_cancer" .
<Carboplatin,_Fluorouracil,_RT> <Has_accepted_use> "Head_and_neck_cancer" .
<Carboplatin,_Fluorouracil,_RT> <Has_accepted_use> "Esophageal_cancer" .
<Paclitaxel_and_Topotecan> <Maps_to> "Paclitaxel_and_Topotecan" .
<mFOLFOX6> <Has_context> "Non-curative_therapy" .
<mFOLFOX6> <Has_context> "Non-curative_second-line_therapy" .
<mFOLFOX6> <Has_context> "Non-curative_first-line_therapy" .
<mFOLFOX6> <Has_context> "Adjuvant_therapy" .
<Acetylsalicylzuur> <Brand_name_of> "Aspirin" .
<M-EI> <Has_context> "Neoadjuvant_therapy" .
<M-EI> <Has_context> "Adjuvant_therapy" .
<Head_and_neck_cancer> <Current_treated_by> "Tegafur_and_Uracil" .
<Head_and_neck_cancer> <Current_treated_by> "Radiation_therapy" .
<Head_and_neck_cancer> <Current_treated_by> "Placebo" .
<Head_and_neck_cancer> <Current_treated_by> "Pembrolizumab_monotherapy" .
<Head_and_neck_cancer> <Current_treated_by> "Paclitaxel_monotherapy" .
<Head_and_neck_cancer> <Current_treated_by> "Paclitaxel_and_RT" .
<Head_and_neck_cancer> <Current_treated_by> "PCF" .
<Head_and_neck_cancer> <Current_treated_by> "No_induction" .
<Head_and_neck_cancer> <Current_treated_by> "Nivolumab_monotherapy" .
<Head_and_neck_cancer> <Current_treated_by> "Methotrexate_monotherapy" .
<Head_and_neck_cancer> <Current_treated_by> "Fluorouracil,_Mitomycin,_RT" .
<Head_and_neck_cancer> <Current_treated_by> "Fluorouracil,_Hydroxyurea,_RT" .
<Head_and_neck_cancer> <Current_treated_by> "Fluorouracil_monotherapy" .
<Head_and_neck_cancer> <Current_treated_by> "Fluorouracil_and_RT" .
<Head_and_neck_cancer> <Current_treated_by> "Docetaxel,_Fluorouracil,_Hydroxyurea,_RT" .
<Head_and_neck_cancer> <Current_treated_by> "Docetaxel,_Cetuximab,_RT" .
<Head_and_neck_cancer> <Current_treated_by> "Docetaxel_monotherapy" .
<Head_and_neck_cancer> <Current_treated_by> "DCF" .
<Head_and_neck_cancer> <Current_treated_by> "Cisplatin,_Paclitaxel,_RT" .
<Head_and_neck_cancer> <Current_treated_by> "Cisplatin,_Fluorouracil,_RT" .
<Head_and_neck_cancer> <Current_treated_by> "Cisplatin,_Fluorouracil,_Panitumumab" .
<Head_and_neck_cancer> <Current_treated_by> "Cisplatin,_Fluorouracil,_Cetuximab" .
<Head_and_neck_cancer> <Current_treated_by> "Cisplatin,_Cetuximab,_RT" .
<Head_and_neck_cancer> <Current_treated_by> "Cisplatin_monotherapy" .
<Head_and_neck_cancer> <Current_treated_by> "Cisplatin_and_RT" .
<Head_and_neck_cancer> <Current_treated_by> "Cisplatin_and_Paclitaxel" .
<Head_and_neck_cancer> <Current_treated_by> "Cisplatin_and_Fluorouracil" .
<Head_and_neck_cancer> <Current_treated_by> "Cisplatin_and_Docetaxel" .
<Head_and_neck_cancer> <Current_treated_by> "Cisplatin_and_Cetuximab" .
<Head_and_neck_cancer> <Current_treated_by> "Cetuximab_monotherapy" .
<Head_and_neck_cancer> <Current_treated_by> "Cetuximab_and_RT" .
<Head_and_neck_cancer> <Current_treated_by> "Carboplatin,_Paclitaxel,_RT" .
<Head_and_neck_cancer> <Current_treated_by> "Carboplatin,_Fluorouracil,_RT" .
<Head_and_neck_cancer> <Current_treated_by> "Carboplatin,_Fluorouracil,_Cetuximab,_RT" .
<Head_and_neck_cancer> <Current_treated_by> "Carboplatin,_Fluorouracil,_Cetuximab" .
<Head_and_neck_cancer> <Current_treated_by> "Carboplatin_and_RT" .
<Head_and_neck_cancer> <Current_treated_by> "Carboplatin_and_Fluorouracil" .
<Head_and_neck_cancer> <Current_treated_by> "Carboplatin_and_Docetaxel" .
<Head_and_neck_cancer> <Current_treated_by> "Best_supportive_care" .
<Head_and_neck_cancer> <Current_treated_by> "Afatinib_monotherapy" .
<Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone> <Has_modality> "Chemotherapy" .
<TT4> <Mapped_from> "TT4" .
<Pomalidomide_monotherapy> <Mapped_from> "Pomalidomide_monotherapy" .
<Alendronate> <Has_brand_name> "Zophost" .
<Alendronate> <Has_brand_name> "Voroste" .
<Alendronate> <Has_brand_name> "Tilios" .
<Alendronate> <Has_brand_name> "Tibone" .
<Alendronate> <Has_brand_name> "Tibolene" .
<Alendronate> <Has_brand_name> "Tevanate" .
<Alendronate> <Has_brand_name> "Tevalen" .
<Alendronate> <Has_brand_name> "Terost" .
<Alendronate> <Has_brand_name> "Teiroc" .
<Alendronate> <Has_brand_name> "Synostep" .
<Alendronate> <Has_brand_name> "Sinfract" .
<Alendronate> <Has_brand_name> "Silidral" .
<Alendronate> <Has_brand_name> "Romax" .
<Alendronate> <Has_brand_name> "Reventa" .
<Alendronate> <Has_brand_name> "Restofos" .
<Alendronate> <Has_brand_name> "Rekostin" .
<Alendronate> <Has_brand_name> "Regenesis" .
<Alendronate> <Has_brand_name> "Recalfe" .
<Alendronate> <Has_brand_name> "Ralenost" .
<Alendronate> <Has_brand_name> "Porosin" .
<Alendronate> <Has_brand_name> "Porosal" .
<Alendronate> <Has_brand_name> "Poris" .
<Alendronate> <Has_brand_name> "Phostarac" .
<Alendronate> <Has_brand_name> "Oxtalen" .
<Alendronate> <Has_brand_name> "Ostonat" .
<Alendronate> <Has_brand_name> "Ostolek" .
<Alendronate> <Has_brand_name> "Ostex" .
<Alendronate> <Has_brand_name> "Osteotrat" .
<Alendronate> <Has_brand_name> "Osteotec" .
<Alendronate> <Has_brand_name> "Osteoral" .
<Alendronate> <Has_brand_name> "Osteonato" .
<Alendronate> <Has_brand_name> "Osteomix" .
<Alendronate> <Has_brand_name> "Osteomepha" .
<Alendronate> <Has_brand_name> "Osteomel" .
<Alendronate> <Has_brand_name> "Osteomed" .
<Alendronate> <Has_brand_name> "Osteomax" .
<Alendronate> <Has_brand_name> "Osteofose" .
<Alendronate> <Has_brand_name> "Osteofos" .
<Alendronate> <Has_brand_name> "Osteofene" .
<Alendronate> <Has_brand_name> "Osteofel" .
<Alendronate> <Has_brand_name> "Osteofar" .
<Alendronate> <Has_brand_name> "Osteodur" .
<Alendronate> <Has_brand_name> "Osteobon" .
<Alendronate> <Has_brand_name> "Ostenan" .
<Alendronate> <Has_brand_name> "Ostemax_Comfort" .
<Alendronate> <Has_brand_name> "Ostel" .
<Alendronate> <Has_brand_name> "Ostat" .
<Alendronate> <Has_brand_name> "Ossomax" .
<Alendronate> <Has_brand_name> "Ossifix" .
<Alendronate> <Has_brand_name> "Oslene" .
<Alendronate> <Has_brand_name> "Osficar" .
<Alendronate> <Has_brand_name> "Oseotenk" .
<Alendronate> <Has_brand_name> "Oseotal" .
<Alendronate> <Has_brand_name> "Oseomax" .
<Alendronate> <Has_brand_name> "Oseolen" .
<Alendronate> <Has_brand_name> "Osdronat" .
<Alendronate> <Has_brand_name> "Osaston" .
<Alendronate> <Has_brand_name> "Osalen" .
<Alendronate> <Has_brand_name> "Orthonate" .
<Alendronate> <Has_brand_name> "Onclast" .
<Alendronate> <Has_brand_name> "Nichospor" .
<Alendronate> <Has_brand_name> "Minusorb" .
<Alendronate> <Has_brand_name> "Maxibone" .
<Alendronate> <Has_brand_name> "Marvil" .
<Alendronate> <Has_brand_name> "Lokar" .
<Alendronate> <Has_brand_name> "Lindron" .
<Alendronate> <Has_brand_name> "Leodrin" .
<Alendronate> <Has_brand_name> "Lendronal" .
<Alendronate> <Has_brand_name> "Landrolen" .
<Alendronate> <Has_brand_name> "Lafedam" .
<Alendronate> <Has_brand_name> "Holadren" .
<Alendronate> <Has_brand_name> "Gynodron" .
<Alendronate> <Has_brand_name> "Gerical" .
<Alendronate> <Has_brand_name> "Genalmen" .
<Alendronate> <Has_brand_name> "Genalen" .
<Alendronate> <Has_brand_name> "Fosval" .
<Alendronate> <Has_brand_name> "Fostepor" .
<Alendronate> <Has_brand_name> "Fosmin" .
<Alendronate> <Has_brand_name> "Fosfoplus" .
<Alendronate> <Has_brand_name> "Fosfalen" .
<Alendronate> <Has_brand_name> "Fosavance" .
<Alendronate> <Has_brand_name> "Fosaqueen" .
<Alendronate> <Has_brand_name> "Fosanet" .
<Alendronate> <Has_brand_name> "Fosamax" .
<Alendronate> <Has_brand_name> "Fosamac" .
<Alendronate> <Has_brand_name> "Fosalong" .
<Alendronate> <Has_brand_name> "Fosalen" .
<Alendronate> <Has_brand_name> "Fosalan" .
<Alendronate> <Has_brand_name> "Fosaalen" .
<Alendronate> <Has_brand_name> "Forenmax" .
<Alendronate> <Has_brand_name> "Folend" .
<Alendronate> <Has_brand_name> "Fixopan" .
<Alendronate> <Has_brand_name> "Firmofos" .
<Alendronate> <Has_brand_name> "Findeclin" .
<Alendronate> <Has_brand_name> "Eucalen" .
<Alendronate> <Has_brand_name> "Endrox" .
<Alendronate> <Has_brand_name> "Endrostan" .
<Alendronate> <Has_brand_name> "Endronax" .
<Alendronate> <Has_brand_name> "Endronal" .
<Alendronate> <Has_brand_name> "Elandur" .
<Alendronate> <Has_brand_name> "Durost" .
<Alendronate> <Has_brand_name> "Drovitan" .
<Alendronate> <Has_brand_name> "Dronat" .
<Alendronate> <Has_brand_name> "Dronalent" .
<Alendronate> <Has_brand_name> "Dronal" .
<Alendronate> <Has_brand_name> "Dronadil" .
<Alendronate> <Has_brand_name> "Drate" .
<Alendronate> <Has_brand_name> "Denfos" .
<Alendronate> <Has_brand_name> "Defixal" .
<Alendronate> <Has_brand_name> "Cleveron" .
<Alendronate> <Has_brand_name> "Calidron" .
<Alendronate> <Has_brand_name> "Brek" .
<Alendronate> <Has_brand_name> "Bostrong" .
<Alendronate> <Has_brand_name> "Bonomax" .
<Alendronate> <Has_brand_name> "Bonmax" .
<Alendronate> <Has_brand_name> "Bongard" .
<Alendronate> <Has_brand_name> "Bonemax" .
<Alendronate> <Has_brand_name> "Bonapex" .
<Alendronate> <Has_brand_name> "Bonamax" .
<Alendronate> <Has_brand_name> "Bonalon" .
<Alendronate> <Has_brand_name> "Bonaid" .
<Alendronate> <Has_brand_name> "Bolend" .
<Alendronate> <Has_brand_name> "Blindafe" .
<Alendronate> <Has_brand_name> "Bisbon" .
<Alendronate> <Has_brand_name> "Binosto" .
<Alendronate> <Has_brand_name> "Bifosmac" .
<Alendronate> <Has_brand_name> "Bifosa" .
<Alendronate> <Has_brand_name> "Bifemelan" .
<Alendronate> <Has_brand_name> "Berlex" .
<Alendronate> <Has_brand_name> "Arond" .
<Alendronate> <Has_brand_name> "Armol" .
<Alendronate> <Has_brand_name> "Arendal" .
<Alendronate> <Has_brand_name> "Apodrolen" .
<Alendronate> <Has_brand_name> "Alovell" .
<Alendronate> <Has_brand_name> "Alont" .
<Alendronate> <Has_brand_name> "Allenmax" .
<Alendronate> <Has_brand_name> "Aliot" .
<Alendronate> <Has_brand_name> "Alentop" .
<Alendronate> <Has_brand_name> "Alent" .
<Alendronate> <Has_brand_name> "Alenost" .
<Alendronate> <Has_brand_name> "Alenmax" .
<Alendronate> <Has_brand_name> "Alendros" .
<Alendronate> <Has_brand_name> "Alendronstad" .
<Alendronate> <Has_brand_name> "Alendronsaeure" .
<Alendronate> <Has_brand_name> "Alendroninezuur" .
<Alendronate> <Has_brand_name> "Alendroninezr" .
<Alendronate> <Has_brand_name> "Alendronhexal" .
<Alendronate> <Has_brand_name> "Alendronato" .
<Alendronate> <Has_brand_name> "Alendronat" .
<Alendronate> <Has_brand_name> "Alendron" .
<Alendronate> <Has_brand_name> "Alendromax" .
<Alendronate> <Has_brand_name> "Alendro" .
<Alendronate> <Has_brand_name> "Alendrin" .
<Alendronate> <Has_brand_name> "Alendrate" .
<Alendronate> <Has_brand_name> "Alendral" .
<Alendronate> <Has_brand_name> "Alendra_7" .
<Alendronate> <Has_brand_name> "Alendor" .
<Alendronate> <Has_brand_name> "Alendon" .
<Alendronate> <Has_brand_name> "Alendomax" .
<Alendronate> <Has_brand_name> "Alendil" .
<Alendronate> <Has_brand_name> "Alendex" .
<Alendronate> <Has_brand_name> "Alendene" .
<Alendronate> <Has_brand_name> "Alend" .
<Alendronate> <Has_brand_name> "Alenbon" .
<Alendronate> <Has_brand_name> "Alenato" .
<Alendronate> <Has_brand_name> "Alenat" .
<Alendronate> <Has_brand_name> "Alemax" .
<Alendronate> <Has_brand_name> "Aldronac" .
<Alendronate> <Has_brand_name> "Aldren" .
<Alendronate> <Has_brand_name> "Aidbone" .
<Alendronate> <Has_brand_name> "Adronat" .
<Cyproterone_acetate_monotherapy> <Mapped_from> "Cyproterone_acetate_monotherapy" .
<VBM> <Has_accepted_use> "Penile_cancer" .
<MAID> <Is_current_in> "Soft_tissue_sarcoma" .
<Carboplatin_and_Etoposide,_then_auto_HSCT> <Maps_to> "Carboplatin_and_Etoposide,_then_auto_HSCT" .
<Frisolona> <Brand_name_of> "Prednisolone" .
<IDAC> <Has_antineoplastic> "Cytarabine" .
<Trimocom> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Docetaxel_and_Prednisolone> <Has_supportive_med> "Dexamethasone" .
<Paclitaxel_and_Ramucirumab> <Has_accepted_use> "Gastric_cancer" .
<Paclitaxel_and_Ramucirumab> <Has_accepted_use> "Esophageal_cancer" .
<Methotrexate,_then_Cytarabine> <Is_current_in> "CNS_lymphoma" .
<Carboplatin_and_nab-Paclitaxel> <Has_context> "Non-curative_therapy" .
<Carboplatin_and_nab-Paclitaxel> <Has_context> "Non-curative_first-line_therapy" .
<Carboplatin_and_nab-Paclitaxel> <Has_context> "Neoadjuvant_therapy" .
<CVB> <Has_accepted_use> "Hodgkin_lymphoma" .
<Ostemax_Comfort> <Brand_name_of> "Alendronate" .
<7_plus_3d_and_GO> <Has_antineoplastic> "Gemtuzumab_ozogamicin" .
<7_plus_3d_and_GO> <Has_antineoplastic> "Daunorubicin" .
<7_plus_3d_and_GO> <Has_antineoplastic> "Cytarabine" .
<SRC_inhibitor> <Is_a> "Kinase_inhibitor" .
<Anti-CD20_antibody> <Is_a> "Antibody_medication" .
<NK-_and_T-cell_lymphoma> <Is_a> "T-cell_lymphoma" .
<CapeOx_and_Panitumumab> <Mapped_from> "CapeOx_and_Panitumumab" .
<Farydak> <Brand_name_of> "Panobinostat" .
<R-ESHAP> <Has_antineoplastic> "Rituximab" .
<R-ESHAP> <Has_antineoplastic> "Methylprednisolone" .
<R-ESHAP> <Has_antineoplastic> "Etoposide" .
<R-ESHAP> <Has_antineoplastic> "Cytarabine" .
<R-ESHAP> <Has_antineoplastic> "Cisplatin" .
<Alemtuzumab_and_Methylprednisolone> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Fulvestrant> <May_have_route> "Intramuscular" .
<triple_negative_Breast_cancer> <Accepted_use_of> "nab-Paclitaxel_monotherapy" .
<triple_negative_Breast_cancer> <Accepted_use_of> "nab-Paclitaxel_and_Atezolizumab" .
<triple_negative_Breast_cancer> <Accepted_use_of> "ddAC" .
<triple_negative_Breast_cancer> <Accepted_use_of> "Paclitaxel_monotherapy" .
<triple_negative_Breast_cancer> <Accepted_use_of> "FAC" .
<triple_negative_Breast_cancer> <Accepted_use_of> "Enzalutamide_monotherapy" .
<triple_negative_Breast_cancer> <Accepted_use_of> "EC_and_Bevacizumab" .
<triple_negative_Breast_cancer> <Accepted_use_of> "Docetaxel_monotherapy" .
<triple_negative_Breast_cancer> <Accepted_use_of> "Docetaxel_and_Bevacizumab" .
<triple_negative_Breast_cancer> <Accepted_use_of> "Cisplatin_monotherapy" .
<triple_negative_Breast_cancer> <Accepted_use_of> "Cisplatin_and_Gemcitabine" .
<triple_negative_Breast_cancer> <Accepted_use_of> "Cisplatin_and_Docetaxel" .
<triple_negative_Breast_cancer> <Accepted_use_of> "Carboplatin_and_nab-Paclitaxel" .
<triple_negative_Breast_cancer> <Accepted_use_of> "Carboplatin_and_Paclitaxel" .
<triple_negative_Breast_cancer> <Accepted_use_of> "Carboplatin_and_Gemcitabine" .
<triple_negative_Breast_cancer> <Accepted_use_of> "Carboplatin_and_Docetaxel" .
<triple_negative_Breast_cancer> <Accepted_use_of> "Capecitabine_monotherapy" .
<triple_negative_Breast_cancer> <Accepted_use_of> "Capecitabine_and_Ixabepilone" .
<triple_negative_Breast_cancer> <Accepted_use_of> "CMF" .
<triple_negative_Breast_cancer> <Accepted_use_of> "Bevacizumab-containing_therapy" .
<triple_negative_Breast_cancer> <Accepted_use_of> "AC" .
<Mycostatin> <May_have_route> "Topical" .
<Mycostatin> <May_have_route> "Oral" .
<Everolimus_and_Tamoxifen> <Has_antineoplastic> "Tamoxifen" .
<Everolimus_and_Tamoxifen> <Has_antineoplastic> "Everolimus" .
<FOLFIRI_and_Cetuximab> <Has_antineoplastic> "Irinotecan" .
<FOLFIRI_and_Cetuximab> <Has_antineoplastic> "Folinic_acid" .
<FOLFIRI_and_Cetuximab> <Has_antineoplastic> "Fluorouracil" .
<FOLFIRI_and_Cetuximab> <Has_antineoplastic> "Cetuximab" .
<Radioimmunotherapy> <Mapped_from> "Radioimmunotherapy" .
<Oxaliplatin_and_RT> <Is_current_in> "Nasopharyngeal_carcinoma" .
<Tranexamic_acid> <Has_brand_name> "Tranofast" .
<Tranexamic_acid> <Has_brand_name> "Temsy" .
<Tranexamic_acid> <Has_brand_name> "Prexam" .
<Tranexamic_acid> <Has_brand_name> "Hemostan" .
<Tranexamic_acid> <Has_brand_name> "Cyklokapron" .
<Tranexamic_acid> <Has_brand_name> "Amixam" .
<R-TBI/Cy> <Has_accepted_use> "Autologous_HSCT" .
<FOLFIRI_and_Bevacizumab_(L-Leucovorin)> <Has_antineoplastic> "Levoleucovorin" .
<FOLFIRI_and_Bevacizumab_(L-Leucovorin)> <Has_antineoplastic> "Irinotecan" .
<FOLFIRI_and_Bevacizumab_(L-Leucovorin)> <Has_antineoplastic> "Fluorouracil" .
<FOLFIRI_and_Bevacizumab_(L-Leucovorin)> <Has_antineoplastic> "Bevacizumab" .
<ABDIC> <Is_historical_in> "Hodgkin_lymphoma" .
<Dacomitinib_monotherapy> <Has_antineoplastic> "Dacomitinib" .
<Doxorubicin_pegylated_liposomal_and_Trabectedin> <Has_antineoplastic> "Trabectedin" .
<Doxorubicin_pegylated_liposomal_and_Trabectedin> <Has_antineoplastic> "Pegylated_liposomal_doxorubicin" .
<Azacitidine_and_Gemtuzumab_ozogamicin> <Mapped_from> "Azacitidine_and_Gemtuzumab_ozogamicin" .
<Capecitabine_and_RT> <Mapped_from> "Capecitabine_and_RT" .
<Methotrexate,_Pegaspargase,_Vincristine> <Has_context> "Maintenance_after_upfront_therapy" .
<DCEP_and_G-CSF> <Maps_to> "DCEP_and_G-CSF" .
<Miantrex_CS> <Brand_name_of> "Methotrexate" .
<AVCF> <Has_context> "Adjuvant_therapy" .
<Fludarabine,_Cyclophosphamide,_ATG> <Has_modality> "Immunosuppressive_therapy" .
<Fludarabine,_Cyclophosphamide,_ATG> <Has_modality> "Chemotherapy" .
<R-CHOP_(Rituximab_Hycela)> <Has_antineoplastic> "Vincristine" .
<R-CHOP_(Rituximab_Hycela)> <Has_antineoplastic> "Rituximab_and_hyaluronidase_human" .
<R-CHOP_(Rituximab_Hycela)> <Has_antineoplastic> "Rituximab" .
<R-CHOP_(Rituximab_Hycela)> <Has_antineoplastic> "Prednisone" .
<R-CHOP_(Rituximab_Hycela)> <Has_antineoplastic> "Doxorubicin" .
<R-CHOP_(Rituximab_Hycela)> <Has_antineoplastic> "Cyclophosphamide" .
<COPP/ABVD> <Maps_to> "COPP/ABVD" .
<Altretamine_monotherapy> <Has_antineoplastic> "Altretamine" .
<Ascorbic_acid> <May_have_route> "Oral" .
<Lenalidomide_monotherapy> <Has_modality> "Chemotherapy" .
<Erlotinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Erlotinib_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Erlotinib_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Erlotinib_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Erlotinib_monotherapy> <Has_context> "All_lines_of_therapy" .
<FAC> <Has_accepted_use> "triple_negative_Breast_cancer" .
<FAC> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<FAC> <Has_accepted_use> "Breast_cancer" .
<Dexaron> <Brand_name_of> "Dexamethasone" .
<EC_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<EC_and_Bevacizumab> <Has_context> "Neoadjuvant_therapy" .
<Norethandrolone> <Antineoplastic_of> "IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone" .
<Kadcyla> <Brand_name_of> "Ado-trastuzumab_emtansine" .
<VACA/IE> <Has_accepted_use> "Ewing_sarcoma" .
<Tazemetostat> <Has_accepted_use> "Epithelioid_sarcoma" .
<Bortezomib_and_Melphalan,_then_auto_HSCT> <Has_accepted_use> "Multiple_myeloma" .
<Bortezomib_and_Melphalan,_then_auto_HSCT> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Cisplatin,_Gemcitabine,_RT> <Has_antineoplastic> "Gemcitabine" .
<Cisplatin,_Gemcitabine,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Cisplatin,_Gemcitabine,_RT> <Has_antineoplastic> "Cisplatin" .
<TCH_(Taxotere,_Carboplatin)> <Has_antineoplastic> "Trastuzumab" .
<TCH_(Taxotere,_Carboplatin)> <Has_antineoplastic> "Docetaxel" .
<TCH_(Taxotere,_Carboplatin)> <Has_antineoplastic> "Carboplatin" .
<Doxycycline> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Xarelto> <Brand_name_of> "Rivaroxaban" .
<Abitaxel> <Brand_name_of> "Paclitaxel" .
<FluBuCy,_then_allo_HSCT> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<FluBuCy,_then_allo_HSCT> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<FluBuCy,_then_allo_HSCT> <Has_accepted_use> "NK-_and_T-cell_lymphoma" .
<FluBuCy,_then_allo_HSCT> <Has_accepted_use> "Mantle_cell_lymphoma" .
<FluBuCy,_then_allo_HSCT> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<FluBuCy,_then_allo_HSCT> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<TVAD_doxil> <Is_current_in> "Multiple_myeloma" .
<Denintuzumab_mafodotin> <May_have_route> "Intravenous" .
<FOLFOX4_and_Bevacizumab> <Mapped_from> "FOLFOX4_and_Bevacizumab" .
<IGEV_and_G-CSF> <Has_context> "All_lines_of_therapy" .
<Filgrastim> <Supportive_med_of> "nab-Paclitaxel_monotherapy" .
<Filgrastim> <Supportive_med_of> "maxi-R-CHOP/R-HiDAC" .
<Filgrastim> <Supportive_med_of> "mFOLFIRINOX,_Gemcitabine,_RT" .
<Filgrastim> <Supportive_med_of> "mDCF_and_Bevacizumab" .
<Filgrastim> <Supportive_med_of> "mDCF" .
<Filgrastim> <Supportive_med_of> "eBEACOPP" .
<Filgrastim> <Supportive_med_of> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Filgrastim> <Supportive_med_of> "dmCODOX-M_-_Modified_Magrath" .
<Filgrastim> <Supportive_med_of> "ddTH_(Taxotere)" .
<Filgrastim> <Supportive_med_of> "ddFEC" .
<Filgrastim> <Supportive_med_of> "ddEC" .
<Filgrastim> <Supportive_med_of> "ddE" .
<Filgrastim> <Supportive_med_of> "ddC" .
<Filgrastim> <Supportive_med_of> "ddAC-T" .
<Filgrastim> <Supportive_med_of> "ddAC" .
<Filgrastim> <Supportive_med_of> "ddA" .
<Filgrastim> <Supportive_med_of> "Z-BEAM,_then_auto_HSCT" .
<Filgrastim> <Supportive_med_of> "Z-BEAM" .
<Filgrastim> <Supportive_med_of> "VcR-CVAD" .
<Filgrastim> <Supportive_med_of> "VIP" .
<Filgrastim> <Supportive_med_of> "VIDE" .
<Filgrastim> <Supportive_med_of> "VDC/IE" .
<Filgrastim> <Supportive_med_of> "Total_Therapy" .
<Filgrastim> <Supportive_med_of> "TTR" .
<Filgrastim> <Supportive_med_of> "TIP" .
<Filgrastim> <Supportive_med_of> "TCH_(Taxotere,_Cyclophosphamide)" .
<Filgrastim> <Supportive_med_of> "TC,_then_IE,_VDoxoC,_VEC" .
<Filgrastim> <Supportive_med_of> "TC_(Taxotere)" .
<Filgrastim> <Supportive_med_of> "TAM6,_then_auto_HSCT" .
<Filgrastim> <Supportive_med_of> "TAM6" .
<Filgrastim> <Supportive_med_of> "TAC_(Taxotere)" .
<Filgrastim> <Supportive_med_of> "Stanford_V" .
<Filgrastim> <Supportive_med_of> "Samarium-153_with_stem_cell_support" .
<Filgrastim> <Supportive_med_of> "SMILE" .
<Filgrastim> <Supportive_med_of> "SC-EPOCH-RR" .
<Filgrastim> <Supportive_med_of> "RICER" .
<Filgrastim> <Supportive_med_of> "R-miniCHOP" .
<Filgrastim> <Supportive_med_of> "R-M-CHOP" .
<Filgrastim> <Supportive_med_of> "R-ICE" .
<Filgrastim> <Supportive_med_of> "R-Hyper-CVAD/R-MA" .
<Filgrastim> <Supportive_med_of> "R-EPOCH,_dose-escalated" .
<Filgrastim> <Supportive_med_of> "R-EPOCH" .
<Filgrastim> <Supportive_med_of> "R-DHAP" .
<Filgrastim> <Supportive_med_of> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Filgrastim> <Supportive_med_of> "R-CODOX-M/R-IVAC" .
<Filgrastim> <Supportive_med_of> "R-CODOX-M_(Doxil_substituted)" .
<Filgrastim> <Supportive_med_of> "R-CODOX-M" .
<Filgrastim> <Supportive_med_of> "R-CHOP-14_(Rituximab_Hycela)" .
<Filgrastim> <Supportive_med_of> "R-CHOP-14" .
<Filgrastim> <Supportive_med_of> "R-CHOP" .
<Filgrastim> <Supportive_med_of> "R-CHOEP-14" .
<Filgrastim> <Supportive_med_of> "R-CDOP" .
<Filgrastim> <Supportive_med_of> "Pentostatin_monotherapy" .
<Filgrastim> <Supportive_med_of> "Paclitaxel_monotherapy" .
<Filgrastim> <Supportive_med_of> "PD" .
<Filgrastim> <Supportive_med_of> "PCR" .
<Filgrastim> <Supportive_med_of> "OLF" .
<Filgrastim> <Supportive_med_of> "O-ICE" .
<Filgrastim> <Supportive_med_of> "O-DHAP" .
<Filgrastim> <Supportive_med_of> "Methotrexate,_then_Cytarabine" .
<Filgrastim> <Supportive_med_of> "MVAC" .
<Filgrastim> <Supportive_med_of> "Imatinib,_Vincristine,_Dexamethasone" .
<Filgrastim> <Supportive_med_of> "Ifosfamide_monotherapy" .
<Filgrastim> <Supportive_med_of> "Ifosfamide_and_Vinorelbine" .
<Filgrastim> <Supportive_med_of> "Ifosfamide_and_Paclitaxel" .
<Filgrastim> <Supportive_med_of> "IGEV" .
<Filgrastim> <Supportive_med_of> "IDAC" .
<Filgrastim> <Supportive_med_of> "ICE" .
<Filgrastim> <Supportive_med_of> "Hyper-CVAD/MA" .
<Filgrastim> <Supportive_med_of> "Hyper-CVAD_and_Ponatinib" .
<Filgrastim> <Supportive_med_of> "Hyper-CVAD_and_Imatinib" .
<Filgrastim> <Supportive_med_of> "Hyper-CVAD_and_Dasatinib" .
<Filgrastim> <Supportive_med_of> "HDAC_and_G-CSF" .
<Filgrastim> <Supportive_med_of> "Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant" .
<Filgrastim> <Supportive_med_of> "FOLFIRI" .
<Filgrastim> <Supportive_med_of> "FLAG-Ida" .
<Filgrastim> <Supportive_med_of> "FLAG-DNX" .
<Filgrastim> <Supportive_med_of> "FLAG" .
<Filgrastim> <Supportive_med_of> "FCR" .
<Filgrastim> <Supportive_med_of> "FAC" .
<Filgrastim> <Supportive_med_of> "Everolimus_monotherapy" .
<Filgrastim> <Supportive_med_of> "ESHAP" .
<Filgrastim> <Supportive_med_of> "EPOCH,_dose-escalated" .
<Filgrastim> <Supportive_med_of> "EPOCH" .
<Filgrastim> <Supportive_med_of> "ECF" .
<Filgrastim> <Supportive_med_of> "EAR_and_G-CSF" .
<Filgrastim> <Supportive_med_of> "Doxorubicin_pegylated_liposomal_monotherapy" .
<Filgrastim> <Supportive_med_of> "Doxorubicin_and_Gemcitabine" .
<Filgrastim> <Supportive_med_of> "Docetaxel_monotherapy" .
<Filgrastim> <Supportive_med_of> "Docetaxel_and_Gemcitabine" .
<Filgrastim> <Supportive_med_of> "DeVIC_and_RT" .
<Filgrastim> <Supportive_med_of> "Daunorubicin_liposomal_monotherapy" .
<Filgrastim> <Supportive_med_of> "DHAP_-_time_intensified" .
<Filgrastim> <Supportive_med_of> "DCF" .
<Filgrastim> <Supportive_med_of> "DCEP_and_G-CSF" .
<Filgrastim> <Supportive_med_of> "DCEP" .
<Filgrastim> <Supportive_med_of> "DA-R-EPOCH" .
<Filgrastim> <Supportive_med_of> "DA-EPOCH" .
<Filgrastim> <Supportive_med_of> "Cytarabine,_Ifosfamide,_G-CSF" .
<Filgrastim> <Supportive_med_of> "Cytarabine_and_G-CSF" .
<Filgrastim> <Supportive_med_of> "Cyclophosphamide_and_Topotecan" .
<Filgrastim> <Supportive_med_of> "Cyclophosphamide_and_G-CSF" .
<Filgrastim> <Supportive_med_of> "Cladribine_and_Rituximab" .
<Filgrastim> <Supportive_med_of> "Cisplatin,_Paclitaxel,_RT" .
<Filgrastim> <Supportive_med_of> "Cisplatin,_Doxorubicin,_Paclitaxel" .
<Filgrastim> <Supportive_med_of> "Cisplatin_and_Paclitaxel" .
<Filgrastim> <Supportive_med_of> "Cisplatin_and_Fluorouracil" .
<Filgrastim> <Supportive_med_of> "Cisplatin_and_Epirubicin" .
<Filgrastim> <Supportive_med_of> "Cisplatin_and_Doxorubicin" .
<Filgrastim> <Supportive_med_of> "Cisplatin_and_Docetaxel" .
<Filgrastim> <Supportive_med_of> "Carboplatin_and_nab-Paclitaxel" .
<Filgrastim> <Supportive_med_of> "Carboplatin_and_Paclitaxel" .
<Filgrastim> <Supportive_med_of> "Carboplatin_and_Docetaxel" .
<Filgrastim> <Supportive_med_of> "CYVE_and_G-CSF" .
<Filgrastim> <Supportive_med_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Filgrastim> <Supportive_med_of> "CODOX-M/IVAC" .
<Filgrastim> <Supportive_med_of> "CODOX-M" .
<Filgrastim> <Supportive_med_of> "CLARA" .
<Filgrastim> <Supportive_med_of> "CLAG-M" .
<Filgrastim> <Supportive_med_of> "CLAG" .
<Filgrastim> <Supportive_med_of> "CHOP-14" .
<Filgrastim> <Supportive_med_of> "CHOP" .
<Filgrastim> <Supportive_med_of> "CHOEP-21" .
<Filgrastim> <Supportive_med_of> "CHOEP-14" .
<Filgrastim> <Supportive_med_of> "CBV,_then_auto_HSCT" .
<Filgrastim> <Supportive_med_of> "CBV" .
<Filgrastim> <Supportive_med_of> "CALGB_10-002_regimen" .
<Filgrastim> <Supportive_med_of> "CAD_and_G-CSF" .
<Filgrastim> <Supportive_med_of> "Busulfan_and_Cyclophosphamide,_then_allo_HSCT" .
<Filgrastim> <Supportive_med_of> "Busulfan_and_Cyclophosphamide" .
<Filgrastim> <Supportive_med_of> "BuCy,_then_allo_HSCT" .
<Filgrastim> <Supportive_med_of> "Brentuximab_vedotin_monotherapy" .
<Filgrastim> <Supportive_med_of> "Bortezomib_monotherapy" .
<Filgrastim> <Supportive_med_of> "Bevacizumab_monotherapy" .
<Filgrastim> <Supportive_med_of> "Bendamustine_monotherapy" .
<Filgrastim> <Supportive_med_of> "BVR" .
<Filgrastim> <Supportive_med_of> "BEAM,_then_auto_HSCT" .
<Filgrastim> <Supportive_med_of> "BEAM" .
<Filgrastim> <Supportive_med_of> "BEACOPP-14" .
<Filgrastim> <Supportive_med_of> "BEACOPP" .
<Filgrastim> <Supportive_med_of> "BASIC" .
<Filgrastim> <Supportive_med_of> "ATG_(Horse),_Cyclosporine,_G-CSF" .
<Filgrastim> <Supportive_med_of> "ACVBP-R" .
<Filgrastim> <Supportive_med_of> "ABVE-PC" .
<R-miniCEOP> <Maps_to> "R-miniCEOP" .
<Chlorambucil> <Supportive_med_of> "FC" .
<VAD-P/Q> <Is_current_in> "Multiple_myeloma" .
<Cisplatin_monotherapy> <Has_context> "Non-curative_therapy" .
<Cisplatin_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Cisplatin_monotherapy> <Has_context> "Neoadjuvant_therapy" .
<Cisplatin_monotherapy> <Has_context> "All_lines_of_therapy" .
<Pancreatic_cancer> <Is_a> "Gastrointestinal_cancer" .
<BVDS> <Mapped_from> "BVDS" .
<Hepatocellular_carcinoma> <FDA_indication_of> "Sorafenib" .
<Hepatocellular_carcinoma> <FDA_indication_of> "Regorafenib" .
<Hepatocellular_carcinoma> <FDA_indication_of> "Ramucirumab" .
<Hepatocellular_carcinoma> <FDA_indication_of> "Pembrolizumab" .
<Hepatocellular_carcinoma> <FDA_indication_of> "Nivolumab" .
<Hepatocellular_carcinoma> <FDA_indication_of> "Lenvatinib" .
<Hepatocellular_carcinoma> <FDA_indication_of> "Cabozantinib" .
<Fludarabine,_then_131Iodine-Tositumomab> <Mapped_from> "Fludarabine,_then_131Iodine-Tositumomab" .
<Oprozomib> <May_have_route> "Oral" .
<Midostaurin> <Is_a> "PDGFR_inhibitor" .
<Midostaurin> <Is_a> "Mutation-specific_medication" .
<Midostaurin> <Is_a> "Kinase_inhibitor" .
<Midostaurin> <Is_a> "KIT_inhibitor" .
<Midostaurin> <Is_a> "FLT3_inhibitor" .
<Midostaurin> <Is_a> "FDA_approved_drug" .
<Midostaurin> <Is_a> "EMA_approved_drug" .
<Trastuzumab_and_hyaluronidase> <Is_a> "Protein_expression-specific_medication" .
<Trastuzumab_and_hyaluronidase> <Is_a> "Neutral" .
<Trastuzumab_and_hyaluronidase> <Is_a> "Antibody_medication" .
<Trastuzumab_and_hyaluronidase> <Is_a> "Anti-HER2_antibody" .
<Osteosarcoma> <Is_a> "Pediatric_cancer" .
<Osteosarcoma> <Is_a> "Bone_sarcoma" .
<Spondy-Dexa> <Brand_name_of> "Dexamethasone" .
<ChlVPP/EVA> <Maps_to> "ChlVPP/EVA" .
<BVR> <Has_supportive_med> "Filgrastim" .
<Decaprednil> <Brand_name_of> "Prednisolone" .
<Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin> <Has_modality> "Chemotherapy" .
<Romesa> <Brand_name_of> "Warfarin" .
<Cytarabins> <Brand_name_of> "Cytarabine" .
<Hyper-CVAD_and_Dasatinib> <Mapped_from> "Hyper-CVAD_and_Dasatinib" .
<Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone> <Has_local_therapy> "Methotrexate" .
<Lomustine,_Temozolomide,_RT> <Maps_to> "Lomustine,_Temozolomide,_RT" .
<Arsenic_trioxide,_ATRA,_Idarubicin> <Is_current_in> "Acute_promyelocytic_leukemia" .
<Vinorelbine_monotherapy> <Has_supportive_med> "Ondansetron" .
<Vinorelbine_monotherapy> <Has_supportive_med> "Metoclopramide" .
<Vinorelbine_monotherapy> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Vinorelbine_monotherapy> <Has_supportive_med> "Granisetron" .
<Vinorelbine_monotherapy> <Has_supportive_med> "Folic_acid" .
<Vinorelbine_monotherapy> <Has_supportive_med> "Emesis_prevention" .
<Low-dose_Interleukin-2> <Has_antineoplastic> "Aldesleukin" .
<Endocrine_therapeutic> <Is_a> "Drugs_by_class_effect" .
<Daunorubicin> <May_have_route> "Intravenous" .
<Cytarabine_and_Thioguanine> <Has_modality> "Chemotherapy" .
<Fluorouracil,_Paclitaxel,_RT> <Has_modality> "Radiotherapy" .
<Fluorouracil,_Paclitaxel,_RT> <Has_modality> "Chemotherapy" .
<Ipstyl> <Brand_name_of> "Lanreotide" .
<Salitison> <Brand_name_of> "Aspirin" .
<FAC> <Mapped_from> "FAC" .
<HDAC_and_G-CSF> <Has_context> "Consolidation_after_upfront_therapy" .
<Contrimoxazole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<PATCO> <Has_modality> "Chemotherapy" .
<Caspofungin> <Is_a> "Antifungal" .
<Capecitabine,_Paclitaxel,_RT> <Mapped_from> "Capecitabine,_Paclitaxel,_RT" .
<Ixazomib_and_Dexamethasone> <Maps_to> "Ixazomib_and_Dexamethasone" .
<Carboplatin_and_Etoposide> <Has_modality> "Chemotherapy" .
<IFL> <Has_context> "Non-curative_first-line_therapy" .
<Elo-VD> <Mapped_from> "Elo-VD" .
<DOLP> <Maps_to> "DOLP" .
<Lanreotide_and_Interferon_alfa-2b> <Has_modality> "Immunotherapy" .
<Lanreotide_and_Interferon_alfa-2b> <Has_modality> "Hormonotherapy" .
<Flutamide_and_Leuprolide> <Is_current_in> "Prostate_cancer" .
<Selinexor> <Has_brand_name> "Xpovio" .
<Ciprofloxacin> <Has_brand_name> "Cipro" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone> <Maps_to> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone" .
<Finasteride> <Has_brand_name> "Proscar" .
<Mitotane_and_Streptozocin> <Mapped_from> "Mitotane_and_Streptozocin" .
<Doxorubicin_and_Olaratumab> <Has_modality> "Chemotherapy" .
<ATRA_monotherapy> <Maps_to> "ATRA_monotherapy" .
<Udicort> <Brand_name_of> "Dexamethasone" .
<PCO> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Azacitidine_and_Sorafenib> <Is_current_in> "Acute_myeloid_leukemia" .
<Selinexor> <Antineoplastic_of> "Selinexor_and_Dexamethasone" .
<Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine> <Maps_to> "Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine" .
<Bactramin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<R-miniCHOP> <Maps_to> "R-miniCHOP" .
<ATRA_and_Daunorubicin> <Has_antineoplastic> "Daunorubicin" .
<ATRA_and_Daunorubicin> <Has_antineoplastic> "All-trans_retinoic_acid" .
<Danaparoid_monotherapy> <Has_modality> "Anticoagulation" .
<HDAC_and_G-CSF> <Maps_to> "HDAC_and_G-CSF" .
<Predni-Helvacort> <Brand_name_of> "Prednisolone" .
<Bortezomib_and_Doxorubicin_liposomal> <Maps_to> "Bortezomib_and_Doxorubicin_liposomal" .
<DI_EC> <Is_a> "Anthracycline-containing_regimen" .
<FLAG-DNX> <Is_a> "Anthracycline-containing_regimen" .
<Danazol_monotherapy> <Has_accepted_use> "Immune_thrombocytopenia" .
<HAD> <Has_antineoplastic> "Omacetaxine" .
<HAD> <Has_antineoplastic> "Daunorubicin" .
<HAD> <Has_antineoplastic> "Cytarabine" .
<Cisplatin_and_Gemcitabine> <Is_a> "Platinum_doublet" .
<CX-C> <Has_context> "Non-curative_first-line_therapy" .
<Cemiplimab> <Is_a> "T-cell_activator" .
<Cemiplimab> <Is_a> "Immunotherapeutic" .
<Cemiplimab> <Is_a> "Antibody_medication" .
<Cemiplimab> <Is_a> "Anti-PD-1_antibody" .
<Bactricid> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CMFT> <Is_current_in> "Breast_cancer" .
<Anti-GPIIb-IIIa_antibody> <Is_a> "Antibody_medication" .
<Methotrexate_and_Vincristine> <Mapped_from> "Methotrexate_and_Vincristine" .
<VAP> <Is_historical_in> "Breast_cancer" .
<Tazemetostat_monotherapy> <Is_current_in> "Epithelioid_sarcoma" .
<Tamibarotene_monotherapy> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Carboplatin_and_Docetaxel> <Maps_to> "Carboplatin_and_Docetaxel" .
<RhoGAM> <Brand_name_of> "Rho(D)_immune_globulin" .
<VAdCA/IE> <Has_modality> "Chemotherapy" .
<Epirubicine> <Brand_name_of> "Epirubicin" .
<IT_Methotrexate_and_WBRT> <Has_context> "Local_therapy" .
<Anti-CD38_antibody> <Is_a> "Antibody_medication" .
<FOLFIRINOX> <Has_context> "Non-curative_first-line_therapy" .
<CMFVP> <Has_context> "Non-curative_therapy" .
<CMFVP> <Has_context> "Adjuvant_therapy" .
<Bladder_cancer> <Accepted_use_of> "nab-Paclitaxel_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Vinflunine_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Vinflunine" .
<Bladder_cancer> <Accepted_use_of> "Vinblastine" .
<Bladder_cancer> <Accepted_use_of> "Valrubicin_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Valrubicin" .
<Bladder_cancer> <Accepted_use_of> "Thiotepa_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Thiotepa" .
<Bladder_cancer> <Accepted_use_of> "Ramucirumab" .
<Bladder_cancer> <Accepted_use_of> "Radiation_therapy" .
<Bladder_cancer> <Accepted_use_of> "Placebo" .
<Bladder_cancer> <Accepted_use_of> "Pirarubicin_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Pirarubicin" .
<Bladder_cancer> <Accepted_use_of> "Pemetrexed_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Pemetrexed" .
<Bladder_cancer> <Accepted_use_of> "Pembrolizumab_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Pembrolizumab" .
<Bladder_cancer> <Accepted_use_of> "Paclitaxel_nanoparticle_albumin-bound" .
<Bladder_cancer> <Accepted_use_of> "Paclitaxel_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Paclitaxel_and_RT" .
<Bladder_cancer> <Accepted_use_of> "Paclitaxel" .
<Bladder_cancer> <Accepted_use_of> "PGC" .
<Bladder_cancer> <Accepted_use_of> "Observation" .
<Bladder_cancer> <Accepted_use_of> "No_neoadjuvant_therapy" .
<Bladder_cancer> <Accepted_use_of> "Nivolumab_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Nivolumab" .
<Bladder_cancer> <Accepted_use_of> "Mitomycin_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Mitomycin" .
<Bladder_cancer> <Accepted_use_of> "Methotrexate" .
<Bladder_cancer> <Accepted_use_of> "MVAC,_dose-dense" .
<Bladder_cancer> <Accepted_use_of> "MVAC" .
<Bladder_cancer> <Accepted_use_of> "MCV" .
<Bladder_cancer> <Accepted_use_of> "Lapuleucel-T" .
<Bladder_cancer> <Accepted_use_of> "Gemcitabine_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Gemcitabine_and_RT" .
<Bladder_cancer> <Accepted_use_of> "Gemcitabine_and_Paclitaxel" .
<Bladder_cancer> <Accepted_use_of> "Gemcitabine" .
<Bladder_cancer> <Accepted_use_of> "Fluorouracil,_Mitomycin,_RT" .
<Bladder_cancer> <Accepted_use_of> "Fluorouracil" .
<Bladder_cancer> <Accepted_use_of> "Erdafitinib_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Erdafitinib" .
<Bladder_cancer> <Accepted_use_of> "Enfortumab_vedotin_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Enfortumab_vedotin" .
<Bladder_cancer> <Accepted_use_of> "Durvalumab_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Durvalumab" .
<Bladder_cancer> <Accepted_use_of> "Doxorubicin_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Doxorubicin" .
<Bladder_cancer> <Accepted_use_of> "Docetaxel_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Docetaxel_and_Ramucirumab" .
<Bladder_cancer> <Accepted_use_of> "Docetaxel" .
<Bladder_cancer> <Accepted_use_of> "Cyclophosphamide" .
<Bladder_cancer> <Accepted_use_of> "Cisplatin,_Paclitaxel,_RT" .
<Bladder_cancer> <Accepted_use_of> "Cisplatin,_Fluorouracil,_RT" .
<Bladder_cancer> <Accepted_use_of> "Cisplatin_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Cisplatin_and_RT" .
<Bladder_cancer> <Accepted_use_of> "Cisplatin_and_Methotrexate" .
<Bladder_cancer> <Accepted_use_of> "Cisplatin_and_Gemcitabine" .
<Bladder_cancer> <Accepted_use_of> "Cisplatin" .
<Bladder_cancer> <Accepted_use_of> "Carboplatin_and_Paclitaxel" .
<Bladder_cancer> <Accepted_use_of> "Carboplatin_and_Gemcitabine" .
<Bladder_cancer> <Accepted_use_of> "Carboplatin" .
<Bladder_cancer> <Accepted_use_of> "CISCA" .
<Bladder_cancer> <Accepted_use_of> "Best_supportive_care" .
<Bladder_cancer> <Accepted_use_of> "Bacillus_Calmette-Guerin_(BCG)_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Bacillus_Calmette-Guerin" .
<Bladder_cancer> <Accepted_use_of> "Avelumab_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Avelumab" .
<Bladder_cancer> <Accepted_use_of> "Atezolizumab_monotherapy" .
<Bladder_cancer> <Accepted_use_of> "Atezolizumab" .
<Fludarabine,_Busulfan,_ATG> <Is_current_in> "Allogeneic_HSCT" .
<Axitinib_and_Avelumab> <Mapped_from> "Axitinib_and_Avelumab" .
<Lomustine,_Methotrexate,_Procarbazine> <Is_current_in> "CNS_lymphoma" .
<Cisplatin,_Dacarbazine,_Tamoxifen> <Has_antineoplastic> "Tamoxifen" .
<Cisplatin,_Dacarbazine,_Tamoxifen> <Has_antineoplastic> "Dacarbazine" .
<Cisplatin,_Dacarbazine,_Tamoxifen> <Has_antineoplastic> "Cisplatin" .
<HyperCHidam> <Has_modality> "Chemotherapy" .
<Coumadine> <Brand_name_of> "Warfarin" .
<Heparin-induced_thrombocytopenia> <Current_treated_by> "Rivaroxaban_monotherapy" .
<Heparin-induced_thrombocytopenia> <Current_treated_by> "Lepirudin_monotherapy" .
<Heparin-induced_thrombocytopenia> <Current_treated_by> "Intravenous_Immunoglobulin" .
<Heparin-induced_thrombocytopenia> <Current_treated_by> "Fondaparinux_monotherapy" .
<Heparin-induced_thrombocytopenia> <Current_treated_by> "Danaparoid_monotherapy" .
<Heparin-induced_thrombocytopenia> <Current_treated_by> "Argatroban_monotherapy" .
<Wilms_tumor> <Current_treated_by> "Vincristine_monotherapy" .
<Wilms_tumor> <Current_treated_by> "Dactinomycin_monotherapy" .
<Wilms_tumor> <Current_treated_by> "Dactinomycin_and_Vincristine" .
<Doxorubicin_pegylated_liposomal_and_Gemcitabine> <Is_a> "Anthracycline-containing_regimen" .
<Bacxal> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Vorinostat_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Vorinostat" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Romidepsin_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Romidepsin" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Quisinostat" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Pralatrexate_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Pralatrexate" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Placebo" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "PUVA" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Mogamulizumab_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Mogamulizumab" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Methoxsalen" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Methotrexate_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Methotrexate" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Lenalidomide_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Lenalidomide" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Denileukin_diftitox_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Denileukin_diftitox" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Brentuximab_vedotin_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Brentuximab_vedotin" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Bexarotene_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Bexarotene_and_Pralatrexate" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Bexarotene" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Bendamustine_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Bendamustine" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Belinostat_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Belinostat" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Alemtuzumab_monotherapy" .
<Cutaneous_T-cell_lymphoma> <Accepted_use_of> "Alemtuzumab" .
<Capecitabine_and_Mitomycin> <Is_current_in> "Gallbladder_cancer" .
<Capecitabine_and_Mitomycin> <Is_current_in> "Cholangiocarcinoma" .
<LD-ACOP-B> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Lumexon> <Brand_name_of> "Methotrexate" .
<O-CHOP> <Is_current_in> "Follicular_lymphoma" .
<GDP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Starasid> <Brand_name_of> "Cytarabine" .
<Letrozole_and_Bevacizumab> <Mapped_from> "Letrozole_and_Bevacizumab" .
<Tegafur,_Uracil,_Folinic_acid> <Mapped_from> "Tegafur,_Uracil,_Folinic_acid" .
<Samarium-153_monotherapy> <Has_supportive_med> "Sipuleucel-T" .
<Samarium-153_monotherapy> <Has_supportive_med> "Antihistamines" .
<Samarium-153_monotherapy> <Has_supportive_med> "Acetaminophen" .
<Interferon_alfa-2a> <Is_a> "Interferon" .
<Dekesu> <Brand_name_of> "Dexamethasone" .
<BFR> <Is_current_in> "Allogeneic_HSCT" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA> <Has_local_therapy> "Methylprednisolone" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA> <Has_local_therapy> "Methotrexate" .
<CEF/CMF> <Is_historical_in> "Breast_cancer" .
<Abemaciclib_and_Fulvestrant> <Is_current_in> "Breast_cancer" .
<Bcl-2_inhibitor> <Is_a> "Apoptosis_promoter" .
<VR-CP> <Has_supportive_med> "Procarbazine" .
<VR-CP> <Has_supportive_med> "Ondansetron" .
<R-NIMP> <Maps_to> "R-NIMP" .
<Ixazomib_and_Dexamethasone> <Has_context> "Non-curative_therapy" .
<Lapatinib_and_Letrozole> <Is_current_in> "Breast_cancer" .
<ABVD,_DD-DI> <Maps_to> "ABVD,_DD-DI" .
<TAC_(Taxotere)> <Maps_to> "TAC_(Taxotere)" .
<Alemtuzumab_and_Rituximab> <Mapped_from> "Alemtuzumab_and_Rituximab" .
<Bendamustine_monotherapy> <Maps_to> "Bendamustine_monotherapy" .
<Axitinib> <Antineoplastic_of> "Axitinib_monotherapy" .
<Axitinib> <Antineoplastic_of> "Axitinib_and_TACE" .
<Axitinib> <Antineoplastic_of> "Axitinib_and_Pembrolizumab" .
<Axitinib> <Antineoplastic_of> "Axitinib_and_Avelumab" .
<Globuren> <Brand_name_of> "Epoetin_alfa" .
<mFOLFIRINOX> <Has_antineoplastic> "Oxaliplatin" .
<mFOLFIRINOX> <Has_antineoplastic> "Irinotecan" .
<mFOLFIRINOX> <Has_antineoplastic> "Folinic_acid" .
<mFOLFIRINOX> <Has_antineoplastic> "Fluorouracil" .
<Pentraxin_2> <Is_a> "Investigational_drug" .
<Amoxi> <Brand_name_of> "Amoxicillin" .
<Toremifene_monotherapy> <Has_modality> "Hormonotherapy" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib> <Mapped_from> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib" .
<CBV,_then_auto_HSCT> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<CBV,_then_auto_HSCT> <Has_supportive_med> "Levofloxacin" .
<CBV,_then_auto_HSCT> <Has_supportive_med> "Fluconazole" .
<CBV,_then_auto_HSCT> <Has_supportive_med> "Filgrastim" .
<CBV,_then_auto_HSCT> <Has_supportive_med> "Acyclovir" .
<Ibrutinib> <Antineoplastic_of> "Ibrutinib_monotherapy" .
<Ibrutinib> <Antineoplastic_of> "Ibrutinib_and_Venetoclax" .
<Ibrutinib> <Antineoplastic_of> "Ibrutinib_and_Rituximab" .
<Ibrutinib> <Antineoplastic_of> "Ibrutinib_and_Ofatumumab" .
<Ibrutinib> <Antineoplastic_of> "Ibrutinib_and_Obinutuzumab" .
<Ibrutinib> <Antineoplastic_of> "BR_and_Ibrutinib" .
<Methotrexate_and_Prednisone> <Has_modality> "Immunosuppressive_therapy" .
<CLARA> <Has_antineoplastic> "Cytarabine" .
<CLARA> <Has_antineoplastic> "Clofarabine" .
<Sindaxel> <Brand_name_of> "Paclitaxel" .
<Rucaparib> <May_have_route> "Oral" .
<VNCOP-B> <Has_context> "Induction_therapy" .
<Nisone> <Brand_name_of> "Prednisone" .
<iddEPC> <Is_current_in> "Breast_cancer" .
<Cyclosporine_monotherapy> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Cyclosporine_monotherapy> <Has_accepted_use> "Immune_thrombocytopenia" .
<Cyclosporine_monotherapy> <Has_accepted_use> "Castleman_disease" .
<Cyclosporine_monotherapy> <Has_accepted_use> "Aplastic_anemia" .
<Ductaclose> <Brand_name_of> "Indomethacin" .
<Heparin-induced_thrombocytopenia> <Is_a> "Thrombotic_disorder" .
<Heparin-induced_thrombocytopenia> <Is_a> "Autoimmune_hematologic_condition" .
<Oxaliplatin> <Has_FDA_indication> "Rectal_cancer" .
<Oxaliplatin> <Has_FDA_indication> "Colon_cancer" .
<Carboplatin,_Paclitaxel,_Ipilimumab> <Has_modality> "Immunotherapy" .
<Carboplatin,_Paclitaxel,_Ipilimumab> <Has_modality> "Chemotherapy" .
<Ciplatan> <Brand_name_of> "Cisplatin" .
<Ifomide> <Brand_name_of> "Ifosfamide" .
<Melphalan,_then_auto_HSCT,_then_Melphalan_and_Busulfan,_then_auto_HSCT> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Tamibarotene_monotherapy> <Mapped_from> "Tamibarotene_monotherapy" .
<TIP> <Mapped_from> "TIP" .
<Lutetium_Lu_177_dotatate> <Has_brand_name> "Lutathera" .
<Pralatrexate_monotherapy> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<Pralatrexate_monotherapy> <Is_current_in> "Cutaneous_T-cell_lymphoma" .
<Megestrol_monotherapy> <Has_modality> "Hormonotherapy" .
<PT> <Is_a> "Antiestrogen-containing_regimen" .
<Autoimmune_cytopenia> <Current_treated_by> "Sirolimus_monotherapy" .
<Autoimmune_cytopenia> <Current_treated_by> "Alemtuzumab_monotherapy" .
<FOLFOX_7/sLV5FU2> <Has_modality> "Chemotherapy" .
<O-ESHAP> <Maps_to> "O-ESHAP" .
<Pomalidomide_and_Prednisone> <Is_current_in> "Myelofibrosis" .
<Pomalidomide_and_Prednisone> <Is_current_in> "Multiple_myeloma" .
<Dacarbazine_and_Gemcitabine> <Mapped_from> "Dacarbazine_and_Gemcitabine" .
<Opticort> <Brand_name_of> "Dexamethasone" .
<B_Dexzol> <Brand_name_of> "Dexamethasone" .
<TCH_(Taxotere,_Carboplatin)> <Has_context> "Non-curative_first-line_therapy" .
<TCH_(Taxotere,_Carboplatin)> <Has_context> "Adjuvant_therapy" .
<BLD> <Has_supportive_med> "Proton_pump_inhibitors" .
<BLD> <Has_supportive_med> "H2-receptor_antagonists" .
<BLD> <Has_supportive_med> "Aspirin" .
<Fluoxymesterone> <Has_accepted_use> "Breast_cancer" .
<Pegaspargase,_Vincristine,_Prednisone> <Has_antineoplastic> "Vincristine" .
<Pegaspargase,_Vincristine,_Prednisone> <Has_antineoplastic> "Prednisone" .
<Pegaspargase,_Vincristine,_Prednisone> <Has_antineoplastic> "Pegaspargase" .
<KPD> <Has_context> "Non-curative_therapy" .
<KPD> <Has_context> "Non-curative_second-line_maintenance_therapy" .
<Cisplatin,_Fluorouracil,_Vincristine> <Has_accepted_use> "Hepatoblastoma" .
<Prexam> <Brand_name_of> "Tranexamic_acid" .
<IT_Cytarabine,_Methotrexate,_Methylprednisolone> <Has_accepted_use> "CNS_leukemia" .
<CVP> <Maps_to> "CVP" .
<Busulfan> <Has_brand_name> "Myleran" .
<Busulfan> <Has_brand_name> "Busulfex" .
<Interferon_alfa-2a> <May_have_route> "Subcutaneous" .
<Growth_factor_inhibitor> <Is_a> "Chemotherapeutic" .
<CHVmP> <Has_antineoplastic> "Teniposide" .
<CHVmP> <Has_antineoplastic> "Prednisone" .
<CHVmP> <Has_antineoplastic> "Doxorubicin" .
<CHVmP> <Has_antineoplastic> "Cyclophosphamide" .
<Light-chain_(AL)_amyloidosis> <Is_a> "Plasma_cell_dyscrasia" .
<Vemurafenib_monotherapy> <Is_current_in> "Thyroid_cancer" .
<Vemurafenib_monotherapy> <Is_current_in> "Multiple_myeloma" .
<Vemurafenib_monotherapy> <Is_current_in> "Melanoma" .
<Vemurafenib_monotherapy> <Is_current_in> "Langerhans_cell_histiocytosis" .
<Vemurafenib_monotherapy> <Is_current_in> "Hairy_cell_leukemia" .
<Vemurafenib_monotherapy> <Is_current_in> "Erdheim-Chester_disease" .
<Vemurafenib_monotherapy> <Is_current_in> "CNS_melanoma" .
<Vemurafenib_monotherapy> <Is_current_in> "BRAF-mutated_malignancy" .
<Malignant_solid_neoplasm> <Is_a> "Condition" .
<Cetadexon> <Brand_name_of> "Dexamethasone" .
<Prasudoc> <Brand_name_of> "Prasugrel" .
<CIM> <Mapped_from> "CIM" .
<Topical> <May_be_route_of> "Scopolamine" .
<Topical> <May_be_route_of> "Mycostatin" .
<Topical> <May_be_route_of> "Indomethacin" .
<Topical> <May_be_route_of> "Granisetron" .
<Topical> <May_be_route_of> "Fluorouracil" .
<Topical> <May_be_route_of> "Bexarotene" .
<Topical> <May_be_route_of> "Acyclovir" .
<FOLFOX4_and_Panitumumab> <Has_accepted_use> "KRAS_wild-type_Colon_cancer" .
<FOLFOX4_and_Panitumumab> <Has_accepted_use> "Colon_cancer" .
<Cladribine_and_Rituximab> <Is_a> "Rituximab-containing_regimen" .
<Fluoxymesterone> <Is_a> "Discontinued_drug" .
<Fluoxymesterone> <Is_a> "Anabolic_steroid" .
<COPA> <Is_a> "Anthracycline-containing_regimen" .
<Cutaneous_lymphoma> <Is_a> "Skin_cancer" .
<Cutaneous_lymphoma> <Is_a> "Non-Hodgkin_lymphoma" .
<7_plus_3d_and_Glasdegib> <Has_modality> "Chemotherapy" .
<Mycophenolate_mofetil_monotherapy> <Maps_to> "Mycophenolate_mofetil_monotherapy" .
<Non-curative_third-line_maintenance_therapy> <Maps_to> "Non-curative_third-line_maintenance_therapy" .
<Tosedostat> <Is_a> "Investigational_drug" .
<Tosedostat> <Is_a> "Aminopeptidase_inhibitor" .
<Neratinib_and_Paclitaxel> <Has_supportive_med> "Loperamide" .
<Lenvatinib_and_Pembrolizumab> <Is_current_in> "Endometrial_cancer" .
<Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT> <Is_current_in> "Hodgkin_lymphoma" .
<Advacan> <Brand_name_of> "Everolimus" .
<VMCP/VCAP> <Maps_to> "VMCP/VCAP" .
<Gemcitabine_and_Vinorelbine> <Has_modality> "Chemotherapy" .
<CLAG-M> <Mapped_from> "CLAG-M" .
<Amethapred> <Brand_name_of> "Methylprednisolone" .
<Plicamycin_monotherapy> <Has_antineoplastic> "Plicamycin" .
<Paraplatin> <Brand_name_of> "Carboplatin" .
<CapeOx_and_Panitumumab> <Has_antineoplastic> "Panitumumab" .
<CapeOx_and_Panitumumab> <Has_antineoplastic> "Oxaliplatin" .
<CapeOx_and_Panitumumab> <Has_antineoplastic> "Capecitabine" .
<Peginterferon_alfa-2a_monotherapy> <Has_modality> "Immunotherapy" .
<Accelerated_BEP> <Is_current_in> "Testicular_cancer" .
<Paclitaxel,_Topotecan,_Bevacizumab> <Maps_to> "Paclitaxel,_Topotecan,_Bevacizumab" .
<O-FC> <Has_modality> "Chemotherapy" .
<Ketoconazole_and_Hydrocortisone> <Has_antineoplastic> "Ketoconazole" .
<Ketoconazole_and_Hydrocortisone> <Has_antineoplastic> "Hydrocortisone" .
<Bevacizumab_and_Interferon_alfa-2a> <Has_accepted_use> "Renal_cell_carcinoma" .
<Irinotecan_and_Bevacizumab> <Has_context> "Salvage_therapy" .
<Irinotecan_and_Bevacizumab> <Has_context> "Non-curative_therapy" .
<Irinotecan_and_Bevacizumab> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<ATG_(Horse),_Cyclosporine,_Methylprednisolone> <Has_modality> "Immunosuppressive_therapy" .
<International_ALL_Trial> <Has_local_therapy> "External_beam_radiotherapy" .
<International_ALL_Trial> <Has_local_therapy> "Cytarabine" .
<Larotrectinib> <May_have_route> "Oral" .
<BV-CHP> <Has_modality> "Chemotherapy" .
<FAC> <Has_antineoplastic> "Fluorouracil" .
<FAC> <Has_antineoplastic> "Doxorubicin" .
<FAC> <Has_antineoplastic> "Cyclophosphamide" .
<Necitumumab> <Is_a> "Antibody_medication" .
<Necitumumab> <Is_a> "Anti-EGFR_antibody" .
<FELV> <Mapped_from> "FELV" .
<FUIRI> <Is_current_in> "Colon_cancer" .
<Anti-HER2_medication> <Is_a> "Chemotherapeutic" .
<Acalabrutinib> <Antineoplastic_of> "Acalabrutinib_monotherapy" .
<Cyclophosphamide_and_Topotecan> <Mapped_from> "Cyclophosphamide_and_Topotecan" .
<mFOLFIRINOX> <Has_accepted_use> "Pancreatic_cancer" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine> <Is_current_in> "T-cell_acute_lymphoblastic_leukemia" .
<CAP> <Has_context> "Non-curative_subsequent-line_therapy" .
<CAP> <Has_context> "Non-curative_first-line_therapy" .
<Thalidomide_monotherapy> <Maps_to> "Thalidomide_monotherapy" .
<Daltepan> <Brand_name_of> "Dalteparin" .
<HAA> <Has_modality> "Chemotherapy" .
<FEC> <Mapped_from> "FEC" .
<Imatinib> <Has_accepted_use> "Systemic_mastocytosis" .
<Imatinib> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Imatinib> <Has_accepted_use> "Melanoma" .
<Imatinib> <Has_accepted_use> "Hypereosinophilic_syndrome" .
<Imatinib> <Has_accepted_use> "Glioblastoma" .
<Imatinib> <Has_accepted_use> "Gastrointestinal_stromal_tumor" .
<Imatinib> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Imatinib> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Dacarbazine_and_Ipilimumab> <Has_modality> "Chemotherapy" .
<CAD_and_G-CSF> <Is_current_in> "Stem_cell_mobilization" .
<Dexart> <Brand_name_of> "Dexamethasone" .
<Non-curative_first-line_therapy> <Is_a> "Non-curative_therapy" .
<Cetuximab_and_RT> <Has_supportive_med> "Diphenhydramine" .
<Doxifluridine> <Has_brand_name> "Didox" .
<Everolimus_and_Exemestane> <Maps_to> "Everolimus_and_Exemestane" .
<Hyper-CVAD/MA_and_Everolimus> <Has_modality> "Chemotherapy" .
<Carboplatin_and_Etoposide,_then_auto_HSCT> <Has_context> "Salvage_therapy" .
<Carboplatin_and_Etoposide,_then_auto_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<Bostrong> <Brand_name_of> "Alendronate" .
<Bevacizumab_and_Interferon_alfa-2a> <Is_a> "Bevacizumab-containing_regimen" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine> <Has_antineoplastic> "Vincristine" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine> <Has_antineoplastic> "Pegaspargase" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine> <Has_antineoplastic> "Mercaptopurine" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine> <Has_antineoplastic> "Cytarabine" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine> <Has_antineoplastic> "Cyclophosphamide" .
<CAMFP> <Maps_to> "CAMFP" .
<Cisplatin,_Etoposide,_RT> <Is_current_in> "Small_cell_lung_cancer" .
<Cisplatin,_Etoposide,_RT> <Is_current_in> "Non-small_cell_lung_cancer" .
<Cisplatin,_Etoposide,_RT> <Is_current_in> "Esophageal_cancer" .
<Septazol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Apixaban_monotherapy> <Has_modality> "Anticoagulation" .
<mFOLFOX6_and_Bevacizumab> <Has_context> "Non-curative_second-line_therapy" .
<mFOLFOX6_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<mFOLFOX6_and_Bevacizumab> <Has_context> "Adjuvant_therapy" .
<Pediatric-like_GRAALL_consolidation> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Menisone> <Brand_name_of> "Methylprednisolone" .
<Abemaciclib_and_Fulvestrant> <Has_antineoplastic> "Fulvestrant" .
<Abemaciclib_and_Fulvestrant> <Has_antineoplastic> "Abemaciclib" .
<Talazoparib_monotherapy> <Mapped_from> "Talazoparib_monotherapy" .
<Hostacortin_H> <Brand_name_of> "Prednisolone" .
<Interferon_alfa-2b_and_Prednisone> <Maps_to> "Interferon_alfa-2b_and_Prednisone" .
<CMFPT> <Has_antineoplastic> "Tamoxifen" .
<CMFPT> <Has_antineoplastic> "Prednisone" .
<CMFPT> <Has_antineoplastic> "Methotrexate" .
<CMFPT> <Has_antineoplastic> "Fluorouracil" .
<CMFPT> <Has_antineoplastic> "Cyclophosphamide" .
<Bicalutamide_and_Goserelin> <Has_modality> "Hormonotherapy" .
<Deltisona> <Brand_name_of> "Prednisone" .
<IP-BCD> <Has_context> "Adjuvant_therapy" .
<Lanreotide_monotherapy> <Has_context> "All_lines_of_therapy" .
<Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b> <Has_context> "Non-curative_first-line_therapy" .
<Sacituzumab_govitecan> <Is_a> "Topoisomerase_inhibitor" .
<Sacituzumab_govitecan> <Is_a> "Investigational_drug" .
<Sacituzumab_govitecan> <Is_a> "Antibody-drug_conjugate" .
<Sacituzumab_govitecan> <Is_a> "Antibody_medication" .
<Sacituzumab_govitecan> <Is_a> "Anti-TACSTD2_antibody" .
<Cytarbel> <Brand_name_of> "Cytarabine" .
<Dexamethasone_monotherapy> <Has_supportive_med> "Dexamethasone" .
<Dexamethasone_monotherapy> <Has_supportive_med> "Aspirin" .
<Dexamethasone_monotherapy> <Has_supportive_med> "Acyclovir" .
<Fosamax> <Brand_name_of> "Alendronate" .
<Pegaspargase,_Vincristine,_Prednisone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<MV> <Has_accepted_use> "Breast_cancer" .
<Direct_oral_anticoagulant> <Subsumes> "Rivaroxaban" .
<Direct_oral_anticoagulant> <Subsumes> "Edoxaban" .
<Direct_oral_anticoagulant> <Subsumes> "Dabigatran" .
<Direct_oral_anticoagulant> <Subsumes> "Betrixaban" .
<Direct_oral_anticoagulant> <Subsumes> "Apixaban" .
<Fluorouracile> <Brand_name_of> "Fluorouracil" .
<Hyper-CVAD/MA_and_Everolimus> <Maps_to> "Hyper-CVAD/MA_and_Everolimus" .
<IRIS> <Maps_to> "IRIS" .
<Octreotide_and_Prednisone> <Has_accepted_use> "Thymoma" .
<Carfilzomib> <Has_FDA_indication> "Multiple_myeloma" .
<CEF/CMF> <Has_context> "Adjuvant_therapy" .
<Oxaliplatin_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Flagoda> <Brand_name_of> "Capecitabine" .
<Doxorubicin_and_Bevacizumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<CFP_and_Oophorectomy> <Has_context> "Adjuvant_therapy" .
<TIP> <Has_antineoplastic> "Paclitaxel" .
<TIP> <Has_antineoplastic> "Ifosfamide" .
<TIP> <Has_antineoplastic> "Cisplatin" .
<R-CODOX-M/R-IVAC> <Is_a> "Rituximab-containing_regimen" .
<R-CODOX-M/R-IVAC> <Is_a> "Anthracycline-containing_regimen" .
<Reclast> <Brand_name_of> "Zoledronic_acid" .
<Dicosheun> <Brand_name_of> "Dexamethasone" .
<PAC> <Is_a> "Anthracycline-containing_regimen" .
<Fluorouracil_and_Mitomycin> <Has_modality> "Chemotherapy" .
<Carboplatin_and_Etoposide> <Has_antineoplastic> "Etoposide" .
<Carboplatin_and_Etoposide> <Has_antineoplastic> "Carboplatin" .
<Interferon_alfa-2a_and_Interleukin-2> <Has_accepted_use> "Renal_cell_carcinoma" .
<Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin> <Has_modality> "Chemotherapy" .
<TCHP_(Taxol)> <Has_modality> "Chemotherapy" .
<Brentuximab_vedotin> <Is_a> "Protein_expression-specific_medication" .
<Brentuximab_vedotin> <Is_a> "Microtubule_inhibitor" .
<Brentuximab_vedotin> <Is_a> "Antibody-drug_conjugate" .
<Brentuximab_vedotin> <Is_a> "Antibody_medication" .
<Brentuximab_vedotin> <Is_a> "Anti-CD30_antibody" .
<Goserelin_monotherapy> <Has_modality> "Hormonotherapy" .
<Holoxane> <Brand_name_of> "Ifosfamide" .
<Regorafenib_monotherapy> <Mapped_from> "Regorafenib_monotherapy" .
<Cladribine_and_Cytarabine> <Is_current_in> "Langerhans_cell_histiocytosis" .
<Cladribine_and_Cytarabine> <Is_current_in> "Hypereosinophilic_syndrome" .
<Endocrine_ablation_surgery> <Supportive_med_of> "Tamoxifen_and_OFS" .
<Endocrine_ablation_surgery> <Supportive_med_of> "Exemestane_monotherapy" .
<MVP_and_RT> <Mapped_from> "MVP_and_RT" .
<Azacitidine_and_Vorinostat> <Maps_to> "Azacitidine_and_Vorinostat" .
<Follicular_lymphoma> <Historic_treated_by> "ProMACE-MOPP" .
<Follicular_lymphoma> <Historic_treated_by> "MCP_(Prednisolone)" .
<Follicular_lymphoma> <Historic_treated_by> "MCP" .
<Follicular_lymphoma> <Historic_treated_by> "Interferon_alfa-2a_monotherapy" .
<Follicular_lymphoma> <Historic_treated_by> "Interferon_alfa_monotherapy" .
<Follicular_lymphoma> <Historic_treated_by> "Fludarabine,_then_131Iodine-Tositumomab" .
<Follicular_lymphoma> <Historic_treated_by> "Fludarabine_monotherapy" .
<Follicular_lymphoma> <Historic_treated_by> "FR" .
<Follicular_lymphoma> <Historic_treated_by> "FND" .
<Follicular_lymphoma> <Historic_treated_by> "FMP" .
<Follicular_lymphoma> <Historic_treated_by> "FM" .
<Follicular_lymphoma> <Historic_treated_by> "FCM" .
<Follicular_lymphoma> <Historic_treated_by> "FC" .
<Follicular_lymphoma> <Historic_treated_by> "CVP,_then_131Iodine-Tositumomab" .
<Follicular_lymphoma> <Historic_treated_by> "CVP" .
<Follicular_lymphoma> <Historic_treated_by> "COPA" .
<Follicular_lymphoma> <Historic_treated_by> "CHVP-I" .
<Follicular_lymphoma> <Historic_treated_by> "CHVP" .
<Follicular_lymphoma> <Historic_treated_by> "CHOP-B" .
<Follicular_lymphoma> <Historic_treated_by> "CHOP,_then_131Iodine-Tositumomab" .
<Follicular_lymphoma> <Historic_treated_by> "CHOP" .
<Follicular_lymphoma> <Historic_treated_by> "131Iodine-Tositumomab_monotherapy" .
<DD-CHOP> <Has_modality> "Chemotherapy" .
<TVAD_doxil> <Maps_to> "TVAD_doxil" .
<Ivosidenib_monotherapy> <Has_context> "Salvage_therapy" .
<Ivosidenib_monotherapy> <Has_context> "Non-curative_therapy" .
<Ivosidenib_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Caplacizumab_and_Plasma_exchange> <Has_supportive_med> "Caplacizumab" .
<7_plus_5i> <Has_modality> "Chemotherapy" .
<Dasatinib> <May_have_route> "Oral" .
<Ibrutinib> <Has_FDA_indication> "Waldenstroem_macroglobulinemia" .
<Ibrutinib> <Has_FDA_indication> "Marginal_zone_lymphoma" .
<Ibrutinib> <Has_FDA_indication> "Mantle_cell_lymphoma" .
<Ibrutinib> <Has_FDA_indication> "Graft_versus_host_disease" .
<Ibrutinib> <Has_FDA_indication> "Chronic_lymphocytic_leukemia" .
<ECH> <Mapped_from> "ECH" .
<TACE,_then_5-FU> <Has_context> "Non-curative_first-line_therapy" .
<Babypyrin> <Brand_name_of> "Aspirin" .
<FOLFOX4_and_RT> <Maps_to> "FOLFOX4_and_RT" .
<Tandem_melphalan,_then_auto_HSCT> <Is_current_in> "Multiple_myeloma" .
<Epirubicin_and_Vinorelbine> <Has_context> "Non-curative_first-line_therapy" .
<R-CMD> <Has_modality> "Chemotherapy" .
<Paclitaxel,_Topotecan,_Bevacizumab> <Is_current_in> "Cervical_cancer" .
<PGC> <Is_current_in> "Bladder_cancer" .
<Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Mapped_from> "Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Indocrom> <Brand_name_of> "Indomethacin" .
<Cladribine_monotherapy> <Is_historical_in> "Acute_myeloid_leukemia" .
<Tegafur,_Uracil,_Folinic_acid> <Has_context> "Adjuvant_therapy" .
<ADT_and_Abiraterone> <Has_supportive_med> "Prednisone" .
<ADT_and_Abiraterone> <Has_supportive_med> "Prednisolone" .
<Temsan> <Brand_name_of> "Imatinib" .
<FOLFIRI> <Mapped_from> "FOLFIRI" .
<Fluorouracil/Fluorouracil_and_RT> <Mapped_from> "Fluorouracil/Fluorouracil_and_RT" .
<Itraconazole> <Is_a> "WHO_Essential_Anti-infective_Medicine" .
<Itraconazole> <Is_a> "Antifungal" .
<Afatinib_and_Cetuximab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Afatinib_and_Cetuximab> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<CEOP_(Prednisolone)> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Parexel> <Brand_name_of> "Paclitaxel" .
<Non-curative_first-line_therapy> <Subsumes> "Non-curative_first-line_maintenance_therapy" .
<Non-curative_first-line_therapy> <Subsumes> "Non-curative_first-line_induction_therapy" .
<Non-curative_first-line_therapy> <Subsumes> "Non-curative_first-line_consolidation_therapy" .
<Hjerdyl> <Brand_name_of> "Aspirin" .
<Palifermin> <Has_brand_name> "Kepivance" .
<CapeOx,_Cetuximab,_RT> <Is_current_in> "Rectal_cancer" .
<Interferon_alfa-2b_and_DLI> <Has_modality> "Immunotherapy" .
<Asarid> <Brand_name_of> "Aspirin" .
<Darolutamide> <Has_FDA_indication> "Prostate_cancer" .
<Predson> <Brand_name_of> "Prednisone" .
<Phartex> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Ado-trastuzumab_emtansine> <Is_a> "Protein_expression-specific_medication" .
<Ado-trastuzumab_emtansine> <Is_a> "Microtubule_inhibitor" .
<Ado-trastuzumab_emtansine> <Is_a> "Irritant" .
<Ado-trastuzumab_emtansine> <Is_a> "Antibody-drug_conjugate" .
<Ado-trastuzumab_emtansine> <Is_a> "Antibody_medication" .
<Ado-trastuzumab_emtansine> <Is_a> "Anti-HER2_antibody" .
<Fostamatinib_monotherapy> <Has_accepted_use> "Immune_thrombocytopenia" .
<Ifosfamide_and_Paclitaxel> <Has_context> "Salvage_therapy" .
<Ifosfamide_and_Paclitaxel> <Has_context> "Non-curative_therapy" .
<Rasby> <Brand_name_of> "Rasburicase" .
<Bacillus_Calmette-Guerin_(BCG)_monotherapy> <Has_modality> "Immunotherapy" .
<Aldren> <Brand_name_of> "Alendronate" .
<Temozolomide,_then_Temozolomide_and_RT,_then_Temozolomide> <Has_modality> "Radiotherapy" .
<Temozolomide,_then_Temozolomide_and_RT,_then_Temozolomide> <Has_modality> "Chemotherapy" .
<Hereditary_hemorrhagic_telangiectasia> <Is_a> "Hemolytic_process" .
<IE> <Has_context> "Non-curative_therapy" .
<IE> <Has_context> "Non-curative_subsequent-line_therapy" .
<IE> <Has_context> "Adjuvant_therapy" .
<Bortezomib_monotherapy> <Has_context> "Non-curative_therapy" .
<Bortezomib_monotherapy> <Has_context> "Non-curative_second-line_maintenance_therapy" .
<Bortezomib_monotherapy> <Has_context> "Non-curative_second-line_consolidation_therapy" .
<Bortezomib_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Bortezomib_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Bortezomib_monotherapy> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Bortezomib_monotherapy> <Has_context> "All_lines_of_therapy" .
<Granulocyte_colony-stimulating_factor> <Is_a> "Granulocyte_growth_factor" .
<Lastrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<VTD-PACE> <Has_antineoplastic> "Thalidomide" .
<VTD-PACE> <Has_antineoplastic> "Etoposide" .
<VTD-PACE> <Has_antineoplastic> "Doxorubicin" .
<VTD-PACE> <Has_antineoplastic> "Dexamethasone" .
<VTD-PACE> <Has_antineoplastic> "Cyclophosphamide" .
<VTD-PACE> <Has_antineoplastic> "Cisplatin" .
<VTD-PACE> <Has_antineoplastic> "Bortezomib" .
<Vinca_alkaloid> <Is_a> "Microtubule_inhibitor" .
<Vinca_alkaloid> <Is_a> "Chemotherapeutic" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Mapped_from> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<FEC_and_H> <Is_a> "Anthracycline-containing_regimen" .
<Letroplex> <Brand_name_of> "Letrozole" .
<CBVM,_then_auto_HSCT> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<PCD> <Maps_to> "PCD" .
<FAMTX> <Is_historical_in> "Gastric_cancer" .
<Hemophagocytic_lymphohistiocytosis> <Accepted_use_of> "Pegylated_liposomal_doxorubicin" .
<Hemophagocytic_lymphohistiocytosis> <Accepted_use_of> "Methylprednisolone" .
<Hemophagocytic_lymphohistiocytosis> <Accepted_use_of> "Methotrexate" .
<Hemophagocytic_lymphohistiocytosis> <Accepted_use_of> "HLH-94_regimen" .
<Hemophagocytic_lymphohistiocytosis> <Accepted_use_of> "HLH-2004_regimen" .
<Hemophagocytic_lymphohistiocytosis> <Accepted_use_of> "Etoposide" .
<Hemophagocytic_lymphohistiocytosis> <Accepted_use_of> "Emapalumab" .
<Hemophagocytic_lymphohistiocytosis> <Accepted_use_of> "Dexamethasone" .
<Hemophagocytic_lymphohistiocytosis> <Accepted_use_of> "DEP" .
<Hemophagocytic_lymphohistiocytosis> <Accepted_use_of> "Cyclosporine_modified" .
<Anti-CD47_antibody> <Subsumes> "Hu5F9-G4" .
<Dabrafenib_monotherapy> <Mapped_from> "Dabrafenib_monotherapy" .
<Antithymocyte_globulin_rabbit_ATG> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Antithymocyte_globulin_rabbit_ATG> <Has_accepted_use> "Graft_versus_host_disease" .
<Antithymocyte_globulin_rabbit_ATG> <Has_accepted_use> "Aplastic_anemia" .
<Null_therapy> <Modality_of> "Reduction_of_immunosuppression" .
<Null_therapy> <Modality_of> "Placebo" .
<Null_therapy> <Modality_of> "Observation" .
<Null_therapy> <Modality_of> "No_neoadjuvant_therapy" .
<Null_therapy> <Modality_of> "No_induction" .
<Null_therapy> <Modality_of> "Best_supportive_care" .
<Null_therapy> <Modality_of> "Antiandrogen_withdrawal" .
<Null_therapy> <Modality_of> "Active_surveillance" .
<Hyper-CVAD/MA> <Maps_to> "Hyper-CVAD/MA" .
<Telomerase_inhibitor> <Subsumes> "Imetelstat" .
<Gynecologic_cancer> <Subsumes> "Vulvar_cancer" .
<Gynecologic_cancer> <Subsumes> "Ovarian_cancer" .
<Gynecologic_cancer> <Subsumes> "Gestational_trophoblastic_neoplasia" .
<Gynecologic_cancer> <Subsumes> "Endometrial_cancer" .
<Gynecologic_cancer> <Subsumes> "Cervical_cancer" .
<R-BEAM> <Has_modality> "Chemotherapy" .
<DEB-TACE> <Has_modality> "Chemotherapy" .
<Cisplatin,_Doxorubicin,_Paclitaxel> <Has_accepted_use> "Endometrial_cancer" .
<Glasdegib_and_LoDAC> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Medroxyprogesterone_and_Tamoxifen> <Has_context> "Non-curative_therapy" .
<Plenair> <Brand_name_of> "Montelukast" .
<Intra-arterial> <May_be_route_of> "Floxuridine" .
<Intra-arterial> <May_be_route_of> "Doxorubicin" .
<HAM> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Mercaptopurine_and_Prednisone> <Has_modality> "Chemotherapy" .
<Busulfan_and_Fludarabine> <Maps_to> "Busulfan_and_Fludarabine" .
<Azadine> <Brand_name_of> "Azacitidine" .
<X-Trant> <Brand_name_of> "Estramustine" .
<Deson> <Brand_name_of> "Dexamethasone" .
<MOR202> <May_have_route> "Intravenous" .
<FCM> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<FCM> <Has_supportive_med> "Allopurinol" .
<Aspirin_and_dipyridamole> <Is_a> "PDE_inhibitor" .
<Aspirin_and_dipyridamole> <Is_a> "FDA_approved_drug" .
<Aspirin_and_dipyridamole> <Is_a> "COX-1_inhibitor" .
<Aspirin_and_dipyridamole> <Is_a> "Antipyretic" .
<FOLFOX4_and_Panitumumab> <Maps_to> "FOLFOX4_and_Panitumumab" .
<Paclitaxel_nanoparticle_albumin-bound> <Has_brand_name> "Abraxane" .
<Grastim> <Brand_name_of> "Filgrastim" .
<Augmented_BFM_consolidation> <Mapped_from> "Augmented_BFM_consolidation" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine> <Has_local_therapy> "Methotrexate" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine> <Has_local_therapy> "External_beam_radiotherapy" .
<Nimustine_and_RT> <Has_modality> "Radiotherapy" .
<Nimustine_and_RT> <Has_modality> "Chemotherapy" .
<Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin> <Mapped_from> "Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin" .
<Mannitol> <Supportive_med_of> "R-ESHAP" .
<Mannitol> <Supportive_med_of> "Everolimus_monotherapy" .
<Mannitol> <Supportive_med_of> "ESHAP" .
<Mannitol> <Supportive_med_of> "Cisplatin_and_Mitomycin" .
<RD> <Has_modality> "Chemotherapy" .
<Cisplatin,_Vinblastine,_RT> <Mapped_from> "Cisplatin,_Vinblastine,_RT" .
<Capecitabine,_Docetaxel,_Oxaliplatin,_RT> <Is_current_in> "Esophageal_cancer" .
<Antivirals> <Supportive_med_of> "VMP/Rd" .
<Antivirals> <Supportive_med_of> "VMP,_then_Rd" .
<Antivirals> <Supportive_med_of> "VDC" .
<Antivirals> <Supportive_med_of> "VD" .
<Antivirals> <Supportive_med_of> "TD" .
<Antivirals> <Supportive_med_of> "Rd" .
<Antivirals> <Supportive_med_of> "RVD" .
<Antivirals> <Supportive_med_of> "R-FCM" .
<Antivirals> <Supportive_med_of> "O-FC" .
<Antivirals> <Supportive_med_of> "KRd" .
<Antivirals> <Supportive_med_of> "KPD" .
<Antivirals> <Supportive_med_of> "G-FC" .
<Antivirals> <Supportive_med_of> "FCR" .
<Antivirals> <Supportive_med_of> "Bendamustine_and_Obinutuzumab" .
<Dasatinib,_Vincristine,_Prednisone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Disprina> <Brand_name_of> "Aspirin" .
<Isotretinoin_monotherapy> <Is_current_in> "Neuroblastoma" .
<Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT> <Has_antineoplastic> "Melphalan" .
<Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<Irinotecan_and_Bevacizumab> <Mapped_from> "Irinotecan_and_Bevacizumab" .
<Etoposide_and_TBI> <Maps_to> "Etoposide_and_TBI" .
<CHOP-14> <Has_supportive_med> "Filgrastim" .
<Avelumab_monotherapy> <Is_current_in> "Merkel_cell_carcinoma" .
<Avelumab_monotherapy> <Is_current_in> "Bladder_cancer" .
<Runabicon> <Brand_name_of> "Daunorubicin" .
<Danazol> <Supportive_med_of> "ATRA_and_Danazol" .
<Cytarabine_monotherapy> <Has_context> "Non-curative_therapy" .
<Cytarabine_monotherapy> <Has_context> "Consolidation_after_upfront_therapy" .
<FEMTX> <Has_modality> "Chemotherapy" .
<Cotran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Letrozole_and_Palbociclib> <Is_a> "Antiestrogen-containing_regimen" .
<7_plus_3d_and_GO> <Has_modality> "Chemotherapy" .
<CHOP> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<CHOP> <Is_current_in> "Mantle_cell_lymphoma" .
<CHOP> <Is_current_in> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<CHOP> <Is_current_in> "HIV-associated_lymphoma" .
<CHOP> <Is_current_in> "Anaplastic_large_cell_lymphoma" .
<Cyclosporine,_Corticosteroids,_Rituximab> <Has_immunosuppressor> "Steroids" .
<Cyclosporine,_Corticosteroids,_Rituximab> <Has_immunosuppressor> "Rituximab" .
<Cyclosporine,_Corticosteroids,_Rituximab> <Has_immunosuppressor> "Prednisone" .
<Cyclosporine,_Corticosteroids,_Rituximab> <Has_immunosuppressor> "Cyclosporines" .
<DI_EC> <Is_current_in> "Breast_cancer" .
<RhIG_monotherapy> <Maps_to> "RhIG_monotherapy" .
<Fuvestrol> <Brand_name_of> "Fulvestrant" .
<CMFT> <Has_antineoplastic> "Tamoxifen" .
<CMFT> <Has_antineoplastic> "Methotrexate" .
<CMFT> <Has_antineoplastic> "Fluorouracil" .
<CMFT> <Has_antineoplastic> "Cyclophosphamide" .
<R-EPOCH,_dose-escalated> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<R-EPOCH,_dose-escalated> <Has_supportive_med> "Pegfilgrastim" .
<R-EPOCH,_dose-escalated> <Has_supportive_med> "Fluconazole" .
<R-EPOCH,_dose-escalated> <Has_supportive_med> "Filgrastim" .
<R-EPOCH,_dose-escalated> <Has_supportive_med> "Ciprofloxacin" .
<CIM> <Has_accepted_use> "Endometrial_cancer" .
<Klovireks-l> <Brand_name_of> "Acyclovir" .
<Bleomycin_and_Vinblastine> <Maps_to> "Bleomycin_and_Vinblastine" .
<PEV> <Has_antineoplastic> "Vinblastine" .
<PEV> <Has_antineoplastic> "Etoposide" .
<PEV> <Has_antineoplastic> "Cisplatin" .
<BV-CHP> <Has_context> "Induction_therapy" .
<Autoimmune_cytopenia> <Is_a> "Hemolytic_process" .
<Autoimmune_cytopenia> <Is_a> "Cytopenia" .
<Autoimmune_cytopenia> <Is_a> "Autoimmune_hematologic_condition" .
<131Iodine-Tositumomab_monotherapy> <Has_accepted_use> "Transformed_lymphoma" .
<131Iodine-Tositumomab_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<GTX> <Is_current_in> "Pancreatic_cancer" .
<Trimoxavin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<VAB-6> <Has_antineoplastic> "Vinblastine" .
<VAB-6> <Has_antineoplastic> "Dactinomycin" .
<VAB-6> <Has_antineoplastic> "Cyclophosphamide" .
<VAB-6> <Has_antineoplastic> "Cisplatin" .
<VAB-6> <Has_antineoplastic> "Bleomycin" .
<Cisplatin,_Dacarbazine,_Paclitaxel> <Has_accepted_use> "Melanoma" .
<Low-dose_Interleukin-2> <Has_context> "Non-curative_therapy" .
<Low-dose_Interleukin-2> <Has_context> "Non-curative_first-line_therapy" .
<R-CHOP> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<R-CHOP> <Has_supportive_med> "Pentamidine" .
<R-CHOP> <Has_supportive_med> "PCP_prophylaxis" .
<R-CHOP> <Has_supportive_med> "Lenograstim" .
<R-CHOP> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<R-CHOP> <Has_supportive_med> "Filgrastim" .
<R-CHOP> <Has_supportive_med> "Dapsone" .
<R-CODOX-M> <Has_context> "Upfront_therapy" .
<R-CODOX-M> <Has_context> "Induction_therapy" .
<Heparin_monotherapy> <Has_supportive_med> "Unfractionated_heparin" .
<Mercaptopurine_and_Prednisone> <Mapped_from> "Mercaptopurine_and_Prednisone" .
<Pomalyst> <Brand_name_of> "Pomalidomide" .
<Blinatumomab> <Has_brand_name> "Blincyto" .
<Vinorelbine_monotherapy> <Has_modality> "Chemotherapy" .
<CAPIRI> <Maps_to> "CAPIRI" .
<Non-curative_second-line_maintenance_therapy> <Context_of> "VR" .
<Non-curative_second-line_maintenance_therapy> <Context_of> "Rucaparib_monotherapy" .
<Non-curative_second-line_maintenance_therapy> <Context_of> "Rituximab_monotherapy" .
<Non-curative_second-line_maintenance_therapy> <Context_of> "RVD" .
<Non-curative_second-line_maintenance_therapy> <Context_of> "Pomalidomide_monotherapy" .
<Non-curative_second-line_maintenance_therapy> <Context_of> "Pomalidomide_and_Prednisone" .
<Non-curative_second-line_maintenance_therapy> <Context_of> "Placebo" .
<Non-curative_second-line_maintenance_therapy> <Context_of> "Olaparib_monotherapy" .
<Non-curative_second-line_maintenance_therapy> <Context_of> "Observation" .
<Non-curative_second-line_maintenance_therapy> <Context_of> "Niraparib_monotherapy" .
<Non-curative_second-line_maintenance_therapy> <Context_of> "Lenalidomide_monotherapy" .
<Non-curative_second-line_maintenance_therapy> <Context_of> "KPD" .
<Non-curative_second-line_maintenance_therapy> <Context_of> "Daratumumab_monotherapy" .
<Non-curative_second-line_maintenance_therapy> <Context_of> "Bortezomib_monotherapy" .
<Non-curative_second-line_maintenance_therapy> <Context_of> "Bortezomib_and_Cyclophosphamide" .
<Non-curative_second-line_maintenance_therapy> <Context_of> "Bevacizumab_monotherapy" .
<Non-curative_second-line_maintenance_therapy> <Context_of> "Arsenic_trioxide_and_Chlorambucil" .
<CMFVP> <Has_accepted_use> "Breast_cancer" .
<GELOX/RT> <Is_current_in> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Brentuximab_vedotin_monotherapy> <Has_antineoplastic> "Brentuximab_vedotin" .
<IROX> <Has_modality> "Chemotherapy" .
<Isotretinoin_and_Dinutuximab> <Mapped_from> "Isotretinoin_and_Dinutuximab" .
<Geffy> <Brand_name_of> "Gefitinib" .
<O-miniCHOP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<TAM6,_then_auto_HSCT> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<BO> <Mapped_from> "BO" .
<PVD> <Has_context> "Non-curative_therapy" .
<Chlorpheniramine> <Is_a> "OTC_medication" .
<Chlorpheniramine> <Is_a> "Antihistamine" .
<Blastocarb> <Brand_name_of> "Carboplatin" .
<Trametinib_monotherapy> <Has_context> "Non-curative_therapy" .
<COPAD> <Is_current_in> "Burkitt_lymphoma" .
<Lenvatinib_and_Pembrolizumab> <Maps_to> "Lenvatinib_and_Pembrolizumab" .
<Predcor> <Brand_name_of> "Prednisolone" .
<FEC_and_H> <Has_antineoplastic> "Trastuzumab" .
<FEC_and_H> <Has_antineoplastic> "Fluorouracil" .
<FEC_and_H> <Has_antineoplastic> "Epirubicin" .
<FEC_and_H> <Has_antineoplastic> "Cyclophosphamide" .
<Carcinil> <Brand_name_of> "Leuprolide" .
<Docetaxel_and_Gemcitabine> <Maps_to> "Docetaxel_and_Gemcitabine" .
<ADE_(high-dose_Ara-C)> <Has_modality> "Chemotherapy" .
<Everolimus_and_Rituximab> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<TX_(Taxotere)> <Has_antineoplastic> "Docetaxel" .
<TX_(Taxotere)> <Has_antineoplastic> "Capecitabine" .
<Auxison> <Brand_name_of> "Dexamethasone" .
<Trastuzumab-anns> <May_have_route> "Intravenous" .
<Vorinostat_and_Rituximab> <Has_modality> "Chemotherapy" .
<Qualaquin> <Brand_name_of> "Quinine" .
<R-Hyper-CVAD/R-MA> <Has_accepted_use> "Mantle_cell_lymphoma" .
<R-Hyper-CVAD/R-MA> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<R-Hyper-CVAD/R-MA> <Has_accepted_use> "Burkitt_lymphoma" .
<R-Hyper-CVAD/R-MA> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone> <Is_a> "Anthracycline-containing_regimen" .
<PEV> <Maps_to> "PEV" .
<CVD_(Vinblastine)> <Mapped_from> "CVD_(Vinblastine)" .
<Apatinib_monotherapy> <Has_antineoplastic> "Apatinib" .
<VAI> <Has_modality> "Chemotherapy" .
<BeRT> <Has_modality> "Chemotherapy" .
<Inatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Chlor-Trimeton> <Brand_name_of> "Chlorpheniramine" .
<R-DHAP/R-VIM> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<ATRA_monotherapy> <Has_antineoplastic> "All-trans_retinoic_acid" .
<CVPP> <Has_context> "Salvage_therapy" .
<CVPP> <Has_context> "Induction_therapy" .
<COPAD> <Has_modality> "Chemotherapy" .
<Gemcitabine_and_RT> <Maps_to> "Gemcitabine_and_RT" .
<Hemoglobinopathy> <Subsumes> "Inherited_hemoglobinopathy" .
<EOX> <Has_antineoplastic> "Oxaliplatin" .
<EOX> <Has_antineoplastic> "Epirubicin" .
<EOX> <Has_antineoplastic> "Capecitabine" .
<Copiktra> <Brand_name_of> "Duvelisib" .
<Aromatase_inhibitors> <Antineoplastic_of> "Trastuzumab_and_ET" .
<Aromatase_inhibitors> <Antineoplastic_of> "T-DM1_and_ET" .
<Anastrozole_and_Trastuzumab> <Mapped_from> "Anastrozole_and_Trastuzumab" .
<R-miniCEOP> <Mapped_from> "R-miniCEOP" .
<ATG_(Horse),_Cyclosporine,_Sirolimus> <Has_immunosuppressor> "Sirolimus" .
<ATG_(Horse),_Cyclosporine,_Sirolimus> <Has_immunosuppressor> "Cyclosporines" .
<ATG_(Horse),_Cyclosporine,_Sirolimus> <Has_immunosuppressor> "Antithymocyte_globulin_horse_ATG" .
<Cyclosporine_and_Mycophenolate_mofetil> <Has_immunosuppressor> "Mycophenolate_mofetil" .
<Cyclosporine_and_Mycophenolate_mofetil> <Has_immunosuppressor> "Cyclosporine_modified" .
<Ixazomib_monotherapy> <Has_antineoplastic> "Ixazomib" .
<VAD_plus_C> <Has_antineoplastic> "Vincristine" .
<VAD_plus_C> <Has_antineoplastic> "Doxorubicin" .
<VAD_plus_C> <Has_antineoplastic> "Dexamethasone" .
<VAD_plus_C> <Has_antineoplastic> "Chlorambucil" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine> <Mapped_from> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine" .
<Ondemet> <Brand_name_of> "Ondansetron" .
<Lepirudin_monotherapy> <Has_context> "Anticoagulation" .
<Lepirudin_monotherapy> <Has_context> "All_lines_of_therapy" .
<Temozolomide_and_low-dose_RT> <Has_modality> "Radiotherapy" .
<Temozolomide_and_low-dose_RT> <Has_modality> "Chemotherapy" .
<5_plus_3i> <Has_context> "Induction_therapy" .
<Ostac> <Brand_name_of> "Clodronate" .
<R2CHOP> <Has_local_therapy> "Methotrexate" .
<Trastuzumab-pkrb> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Trastuzumab-pkrb> <Is_a> "Protein_expression-specific_medication" .
<Trastuzumab-pkrb> <Is_a> "Neutral" .
<Trastuzumab-pkrb> <Is_a> "Biosimilar" .
<Trastuzumab-pkrb> <Is_a> "Antibody_medication" .
<Trastuzumab-pkrb> <Is_a> "Anti-HER2_antibody" .
<Salvage_therapy> <Mapped_from> "Salvage_therapy" .
<Mitotane_monotherapy> <Is_current_in> "Adrenocortical_carcinoma" .
<Markparin> <Brand_name_of> "Enoxaparin" .
<Lokalison-F> <Brand_name_of> "Dexamethasone" .
<Doxorubicin,_Methotrexate,_Vincristine,_Prednisone> <Mapped_from> "Doxorubicin,_Methotrexate,_Vincristine,_Prednisone" .
<Emetra> <Brand_name_of> "Ondansetron" .
<Anastrozole_and_Goserelin> <Is_current_in> "Breast_cancer" .
<Fam-trastuzumab_deruxtecan> <Has_accepted_use> "Breast_cancer" .
<HLH-94_regimen> <Has_context> "Induction_therapy" .
<Cytarabine_and_G-CSF> <Has_accepted_use> "Stem_cell_mobilization" .
<Busulfan_and_Cyclophosphamide,_then_allo_HSCT> <Has_supportive_med> "Methotrexate" .
<Busulfan_and_Cyclophosphamide,_then_allo_HSCT> <Has_supportive_med> "Filgrastim" .
<Busulfan_and_Cyclophosphamide,_then_allo_HSCT> <Has_supportive_med> "Cyclosporine_non-modified" .
<Gemcite> <Brand_name_of> "Gemcitabine" .
<Gemzar> <Brand_name_of> "Gemcitabine" .
<Crizotinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Capecitabine_and_Neratinib> <Has_modality> "Chemotherapy" .
<eBEACOPP> <Is_current_in> "Hodgkin_lymphoma" .
<Cisplatin,_Vinorelbine,_Cetuximab> <Maps_to> "Cisplatin,_Vinorelbine,_Cetuximab" .
<Obinutuzumab_monotherapy> <Mapped_from> "Obinutuzumab_monotherapy" .
<Carboplatin,_Fluorouracil,_Cetuximab> <Has_accepted_use> "Head_and_neck_cancer" .
<DA_3_plus_10> <Is_current_in> "Acute_myeloid_leukemia" .
<Vindesine_monotherapy> <Maps_to> "Vindesine_monotherapy" .
<Pertuzumab_and_T-DM1> <Maps_to> "Pertuzumab_and_T-DM1" .
<All_lines_of_therapy> <Context_of> "Z-BEAM" .
<All_lines_of_therapy> <Context_of> "Whole_brain_irradiation" .
<All_lines_of_therapy> <Context_of> "Warfarin_monotherapy" .
<All_lines_of_therapy> <Context_of> "Vismodegib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Vincristine_monotherapy" .
<All_lines_of_therapy> <Context_of> "Vemurafenib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Vandetanib_monotherapy" .
<All_lines_of_therapy> <Context_of> "VIE" .
<All_lines_of_therapy> <Context_of> "VI,_then_VDC/IE,_then_VAC,_then_VI" .
<All_lines_of_therapy> <Context_of> "VAI" .
<All_lines_of_therapy> <Context_of> "VAC" .
<All_lines_of_therapy> <Context_of> "VA" .
<All_lines_of_therapy> <Context_of> "Tranexamic_acid_monotherapy" .
<All_lines_of_therapy> <Context_of> "Trabectedin_monotherapy" .
<All_lines_of_therapy> <Context_of> "Tocilizumab_monotherapy" .
<All_lines_of_therapy> <Context_of> "Tisagenlecleucel_monotherapy" .
<All_lines_of_therapy> <Context_of> "Tinzaparin_monotherapy" .
<All_lines_of_therapy> <Context_of> "Thalidomide_monotherapy" .
<All_lines_of_therapy> <Context_of> "Teniposide_and_WBRT" .
<All_lines_of_therapy> <Context_of> "Temozolomide_monotherapy" .
<All_lines_of_therapy> <Context_of> "Temozolomide_and_Thalidomide" .
<All_lines_of_therapy> <Context_of> "Temozolomide_and_Bevacizumab" .
<All_lines_of_therapy> <Context_of> "Tazemetostat_monotherapy" .
<All_lines_of_therapy> <Context_of> "Tamoxifen_monotherapy" .
<All_lines_of_therapy> <Context_of> "Tagraxofusp_monotherapy" .
<All_lines_of_therapy> <Context_of> "TLI_and_ATG" .
<All_lines_of_therapy> <Context_of> "TCP" .
<All_lines_of_therapy> <Context_of> "TBI" .
<All_lines_of_therapy> <Context_of> "TAM6" .
<All_lines_of_therapy> <Context_of> "Sunitinib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Sorafenib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Sirolimus,_Tacrolimus,_Prednisone" .
<All_lines_of_therapy> <Context_of> "Sirolimus_monotherapy" .
<All_lines_of_therapy> <Context_of> "Sirolimus_and_Prednisone" .
<All_lines_of_therapy> <Context_of> "Siltuximab_monotherapy" .
<All_lines_of_therapy> <Context_of> "SMILE" .
<All_lines_of_therapy> <Context_of> "Ruxolitinib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Rivaroxaban_monotherapy" .
<All_lines_of_therapy> <Context_of> "Rituximab_monotherapy" .
<All_lines_of_therapy> <Context_of> "Reduction_of_immunosuppression" .
<All_lines_of_therapy> <Context_of> "Rd" .
<All_lines_of_therapy> <Context_of> "Ravulizumab_monotherapy" .
<All_lines_of_therapy> <Context_of> "Radioiodine_ablation" .
<All_lines_of_therapy> <Context_of> "RBC_transfusions" .
<All_lines_of_therapy> <Context_of> "R-TBI/Cy" .
<All_lines_of_therapy> <Context_of> "R-GDP" .
<All_lines_of_therapy> <Context_of> "R-EPOCH" .
<All_lines_of_therapy> <Context_of> "R-DHAP" .
<All_lines_of_therapy> <Context_of> "R-CP" .
<All_lines_of_therapy> <Context_of> "R-CHOP" .
<All_lines_of_therapy> <Context_of> "R-BEAM" .
<All_lines_of_therapy> <Context_of> "R,_then_CHOP" .
<All_lines_of_therapy> <Context_of> "Prednisone_monotherapy" .
<All_lines_of_therapy> <Context_of> "Prednisone_and_Rituximab" .
<All_lines_of_therapy> <Context_of> "Prednisolone_monotherapy" .
<All_lines_of_therapy> <Context_of> "Prednisolone_and_Rituximab" .
<All_lines_of_therapy> <Context_of> "Pomalidomide_monotherapy" .
<All_lines_of_therapy> <Context_of> "Pomalidomide_and_Prednisone" .
<All_lines_of_therapy> <Context_of> "Plerixafor_monotherapy" .
<All_lines_of_therapy> <Context_of> "Plerixafor_and_G-CSF" .
<All_lines_of_therapy> <Context_of> "Placebo" .
<All_lines_of_therapy> <Context_of> "Pertuzumab_and_Trastuzumab" .
<All_lines_of_therapy> <Context_of> "Pembrolizumab_monotherapy" .
<All_lines_of_therapy> <Context_of> "Peginterferon_alfa-2a_monotherapy" .
<All_lines_of_therapy> <Context_of> "Pazopanib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Paclitaxel_monotherapy" .
<All_lines_of_therapy> <Context_of> "PCF" .
<All_lines_of_therapy> <Context_of> "PCE" .
<All_lines_of_therapy> <Context_of> "Osimertinib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Octreotide_monotherapy" .
<All_lines_of_therapy> <Context_of> "Octreotide_and_Interferon_alfa" .
<All_lines_of_therapy> <Context_of> "Octreotide_LAR_monotherapy" .
<All_lines_of_therapy> <Context_of> "Observation" .
<All_lines_of_therapy> <Context_of> "OFAR" .
<All_lines_of_therapy> <Context_of> "Nilotinib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Neratinib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Midostaurin_monotherapy" .
<All_lines_of_therapy> <Context_of> "Methotrexate_monotherapy" .
<All_lines_of_therapy> <Context_of> "Mercaptopurine_and_Methotrexate" .
<All_lines_of_therapy> <Context_of> "Mepolizumab_monotherapy" .
<All_lines_of_therapy> <Context_of> "Melphalan_monotherapy" .
<All_lines_of_therapy> <Context_of> "Melphalan_and_TBI" .
<All_lines_of_therapy> <Context_of> "MP" .
<All_lines_of_therapy> <Context_of> "Lutetium_Lu_177_dotatate_and_Octreotide_LAR" .
<All_lines_of_therapy> <Context_of> "Lusutrombopag_monotherapy" .
<All_lines_of_therapy> <Context_of> "Low-dose_TBI" .
<All_lines_of_therapy> <Context_of> "Lepirudin_monotherapy" .
<All_lines_of_therapy> <Context_of> "Lenvatinib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Lenalidomide_monotherapy" .
<All_lines_of_therapy> <Context_of> "Lenalidomide_and_Rituximab" .
<All_lines_of_therapy> <Context_of> "Larotrectinib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Lanreotide_monotherapy" .
<All_lines_of_therapy> <Context_of> "Lanreotide_and_Interferon_alfa-2b" .
<All_lines_of_therapy> <Context_of> "Lanreotide_Depot/Autogel_monotherapy" .
<All_lines_of_therapy> <Context_of> "LEED" .
<All_lines_of_therapy> <Context_of> "L-glutamine_monotherapy" .
<All_lines_of_therapy> <Context_of> "Ipilimumab_and_Nivolumab" .
<All_lines_of_therapy> <Context_of> "Interferon_alfa-2b_monotherapy" .
<All_lines_of_therapy> <Context_of> "Interferon_alfa-2a_monotherapy" .
<All_lines_of_therapy> <Context_of> "Imatinib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Icotinib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Ibrutinib_monotherapy" .
<All_lines_of_therapy> <Context_of> "IGEV_and_G-CSF" .
<All_lines_of_therapy> <Context_of> "Hydroxyurea_monotherapy" .
<All_lines_of_therapy> <Context_of> "Heparin_monotherapy" .
<All_lines_of_therapy> <Context_of> "Gemcitabine_and_Irinotecan" .
<All_lines_of_therapy> <Context_of> "GCP" .
<All_lines_of_therapy> <Context_of> "Fotemustine_monotherapy" .
<All_lines_of_therapy> <Context_of> "Fondaparinux_monotherapy" .
<All_lines_of_therapy> <Context_of> "Fluorouracil_and_Streptozocin" .
<All_lines_of_therapy> <Context_of> "Fludarabine,_Melphalan,_Alemtuzumab" .
<All_lines_of_therapy> <Context_of> "Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant" .
<All_lines_of_therapy> <Context_of> "Fludarabine,_Cyclophosphamide,_ATG" .
<All_lines_of_therapy> <Context_of> "Fludarabine,_Busulfan,_Cyclophosphamide" .
<All_lines_of_therapy> <Context_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan" .
<All_lines_of_therapy> <Context_of> "Fludarabine,_Busulfan,_ATG" .
<All_lines_of_therapy> <Context_of> "Fludarabine_and_TBI" .
<All_lines_of_therapy> <Context_of> "Fludarabine_and_Melphalan" .
<All_lines_of_therapy> <Context_of> "FluBuCy,_then_allo_HSCT" .
<All_lines_of_therapy> <Context_of> "Fedratinib_monotherapy" .
<All_lines_of_therapy> <Context_of> "FR" .
<All_lines_of_therapy> <Context_of> "FEAM" .
<All_lines_of_therapy> <Context_of> "FCR" .
<All_lines_of_therapy> <Context_of> "FC" .
<All_lines_of_therapy> <Context_of> "FAS" .
<All_lines_of_therapy> <Context_of> "Everolimus_monotherapy" .
<All_lines_of_therapy> <Context_of> "Everolimus_and_Octreotide" .
<All_lines_of_therapy> <Context_of> "Etoposide_monotherapy" .
<All_lines_of_therapy> <Context_of> "Etoposide_and_TBI" .
<All_lines_of_therapy> <Context_of> "Erlotinib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Erlotinib_and_Bevacizumab" .
<All_lines_of_therapy> <Context_of> "Eribulin_monotherapy" .
<All_lines_of_therapy> <Context_of> "Entrectinib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Enoxaparin_monotherapy" .
<All_lines_of_therapy> <Context_of> "Emicizumab_monotherapy" .
<All_lines_of_therapy> <Context_of> "Edoxaban_monotherapy" .
<All_lines_of_therapy> <Context_of> "Eculizumab_monotherapy" .
<All_lines_of_therapy> <Context_of> "EMA-CO" .
<All_lines_of_therapy> <Context_of> "EAR_and_G-CSF" .
<All_lines_of_therapy> <Context_of> "Doxorubicin_pegylated_liposomal_monotherapy" .
<All_lines_of_therapy> <Context_of> "Doxorubicin_and_Streptozocin" .
<All_lines_of_therapy> <Context_of> "Docetaxel_and_Gemcitabine" .
<All_lines_of_therapy> <Context_of> "Dexamethasone_monotherapy" .
<All_lines_of_therapy> <Context_of> "Dexamethasone_and_WBRT" .
<All_lines_of_therapy> <Context_of> "DexaBEAM_and_G-CSF" .
<All_lines_of_therapy> <Context_of> "Denosumab_monotherapy" .
<All_lines_of_therapy> <Context_of> "Defibrotide_monotherapy" .
<All_lines_of_therapy> <Context_of> "Daunorubicin_liposomal_monotherapy" .
<All_lines_of_therapy> <Context_of> "Dasatinib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Dalteparin_monotherapy" .
<All_lines_of_therapy> <Context_of> "Dactinomycin_monotherapy" .
<All_lines_of_therapy> <Context_of> "Dactinomycin_and_Vincristine" .
<All_lines_of_therapy> <Context_of> "Dacarbazine_monotherapy" .
<All_lines_of_therapy> <Context_of> "Dabrafenib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Dabrafenib_and_Trametinib" .
<All_lines_of_therapy> <Context_of> "Dabigatran_monotherapy" .
<All_lines_of_therapy> <Context_of> "DDGP" .
<All_lines_of_therapy> <Context_of> "DCF" .
<All_lines_of_therapy> <Context_of> "DCEP_and_G-CSF" .
<All_lines_of_therapy> <Context_of> "Cytarabine,_Ifosfamide,_G-CSF" .
<All_lines_of_therapy> <Context_of> "Cytarabine_and_G-CSF" .
<All_lines_of_therapy> <Context_of> "Cyclosporine,_Sirolimus,_Prednisone" .
<All_lines_of_therapy> <Context_of> "Cyclosporine,_Corticosteroids,_Rituximab" .
<All_lines_of_therapy> <Context_of> "Cyclosporine_monotherapy" .
<All_lines_of_therapy> <Context_of> "Cyclosporine_and_Prednisone" .
<All_lines_of_therapy> <Context_of> "Cyclophosphamide,_Fludarabine,_Thiotepa" .
<All_lines_of_therapy> <Context_of> "Cyclophosphamide,_Etoposide,_TBI" .
<All_lines_of_therapy> <Context_of> "Cyclophosphamide,_Dacarbazine,_Vincristine" .
<All_lines_of_therapy> <Context_of> "Cyclophosphamide_and_TBI" .
<All_lines_of_therapy> <Context_of> "Cyclophosphamide_and_Prednisone" .
<All_lines_of_therapy> <Context_of> "Cyclophosphamide_and_Prednisolone" .
<All_lines_of_therapy> <Context_of> "Cyclophosphamide_and_G-CSF" .
<All_lines_of_therapy> <Context_of> "Crizanlizumab_monotherapy" .
<All_lines_of_therapy> <Context_of> "Cobimetinib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Clofarabine_and_Melphalan" .
<All_lines_of_therapy> <Context_of> "Cladribine_monotherapy" .
<All_lines_of_therapy> <Context_of> "Cladribine_and_Cytarabine" .
<All_lines_of_therapy> <Context_of> "Cisplatin,_Fluorouracil,_Vincristine" .
<All_lines_of_therapy> <Context_of> "Cisplatin_monotherapy" .
<All_lines_of_therapy> <Context_of> "Cisplatin_and_RT" .
<All_lines_of_therapy> <Context_of> "Cisplatin_and_Irinotecan" .
<All_lines_of_therapy> <Context_of> "Cisplatin_and_Gemcitabine" .
<All_lines_of_therapy> <Context_of> "Cisplatin_and_Doxorubicin" .
<All_lines_of_therapy> <Context_of> "Cisplatin_and_Docetaxel" .
<All_lines_of_therapy> <Context_of> "Ceritinib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Carboplatin_and_Paclitaxel" .
<All_lines_of_therapy> <Context_of> "Carboplatin_and_Docetaxel" .
<All_lines_of_therapy> <Context_of> "Capecitabine_and_Trastuzumab" .
<All_lines_of_therapy> <Context_of> "Capecitabine_and_Temozolomide" .
<All_lines_of_therapy> <Context_of> "Capecitabine_and_Lapatinib" .
<All_lines_of_therapy> <Context_of> "Cabozantinib_monotherapy" .
<All_lines_of_therapy> <Context_of> "CYVE_and_G-CSF" .
<All_lines_of_therapy> <Context_of> "CYVE" .
<All_lines_of_therapy> <Context_of> "CTCb" .
<All_lines_of_therapy> <Context_of> "CHUT" .
<All_lines_of_therapy> <Context_of> "CBV-Mx" .
<All_lines_of_therapy> <Context_of> "CBV" .
<All_lines_of_therapy> <Context_of> "CAD_and_G-CSF" .
<All_lines_of_therapy> <Context_of> "Busulfan_and_Melphalan" .
<All_lines_of_therapy> <Context_of> "Busulfan_and_Fludarabine" .
<All_lines_of_therapy> <Context_of> "Busulfan_and_Cyclophosphamide" .
<All_lines_of_therapy> <Context_of> "BuCyTBI" .
<All_lines_of_therapy> <Context_of> "Bu/TT/Cy" .
<All_lines_of_therapy> <Context_of> "Bu/TT" .
<All_lines_of_therapy> <Context_of> "Bortezomib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Bortezomib_and_Melphalan" .
<All_lines_of_therapy> <Context_of> "Bivalirudin_monotherapy" .
<All_lines_of_therapy> <Context_of> "Bevacizumab_monotherapy" .
<All_lines_of_therapy> <Context_of> "Benralizumab_monotherapy" .
<All_lines_of_therapy> <Context_of> "Bendamustine_monotherapy" .
<All_lines_of_therapy> <Context_of> "BeEAM" .
<All_lines_of_therapy> <Context_of> "BR" .
<All_lines_of_therapy> <Context_of> "BFR" .
<All_lines_of_therapy> <Context_of> "BEP" .
<All_lines_of_therapy> <Context_of> "BEAM" .
<All_lines_of_therapy> <Context_of> "BEAC" .
<All_lines_of_therapy> <Context_of> "BCNU/TT" .
<All_lines_of_therapy> <Context_of> "Axicabtagene_ciloleucel_monotherapy" .
<All_lines_of_therapy> <Context_of> "Avatrombopag_monotherapy" .
<All_lines_of_therapy> <Context_of> "Aspirin_monotherapy" .
<All_lines_of_therapy> <Context_of> "Aspirin_and_Warfarin" .
<All_lines_of_therapy> <Context_of> "Argatroban_monotherapy" .
<All_lines_of_therapy> <Context_of> "Apixaban_monotherapy" .
<All_lines_of_therapy> <Context_of> "Anakinra_monotherapy" .
<All_lines_of_therapy> <Context_of> "Alemtuzumab_monotherapy" .
<All_lines_of_therapy> <Context_of> "Alectinib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Afatinib_monotherapy" .
<All_lines_of_therapy> <Context_of> "Ado-trastuzumab_emtansine_monotherapy" .
<All_lines_of_therapy> <Context_of> "ACVBP,_dose-adjusted" .
<All_lines_of_therapy> <Context_of> "ABV_(Vincristine)" .
<All_lines_of_therapy> <Context_of> "ABV_(Vinblastine)" .
<All_lines_of_therapy> <Context_of> "131Iodine-Tositumomab_monotherapy" .
<All_lines_of_therapy> <Context_of> "131I-Metaiodobenzylguanidine_(131I-MIBG)" .
<All_lines_of_therapy> <Context_of> "(90)YFC" .
<Encorafenib> <May_have_route> "Oral" .
<Vinflunine> <Has_accepted_use> "Bladder_cancer" .
<PAC> <Has_accepted_use> "Thymoma" .
<Cisplatin,_Fluorouracil,_Hydroxyurea,_RT> <Has_modality> "Radiotherapy" .
<Cisplatin,_Fluorouracil,_Hydroxyurea,_RT> <Has_modality> "Chemotherapy" .
<Gefitero> <Brand_name_of> "Gefitinib" .
<Doxifluridine> <Has_accepted_use> "Gastric_cancer" .
<Megestrol_and_Tamoxifen> <Has_context> "Non-curative_therapy" .
<Oncodac> <Brand_name_of> "Dacarbazine" .
<Humoferon> <Brand_name_of> "Interferon_alfa-2b" .
<FMP> <Has_accepted_use> "Follicular_lymphoma" .
<Lopigrol> <Brand_name_of> "Clopidogrel" .
<Epoetin_alfa-epbx> <Is_a> "Hematopoietic_growth_factor" .
<Epoetin_alfa-epbx> <Is_a> "Erythrocyte_growth_factor" .
<Epoetin_alfa-epbx> <Is_a> "Biosimilar" .
<Yondelis> <Brand_name_of> "Trabectedin" .
<Valproate> <May_have_route> "Oral" .
<PCV> <Maps_to> "PCV" .
<Dabrafenib_monotherapy> <Has_antineoplastic> "Dabrafenib" .
<Growth_factor_therapy> <Modality_of> "Romiplostim_monotherapy" .
<Growth_factor_therapy> <Modality_of> "Plerixafor_monotherapy" .
<Growth_factor_therapy> <Modality_of> "Plerixafor_and_G-CSF" .
<Growth_factor_therapy> <Modality_of> "Lusutrombopag_monotherapy" .
<Growth_factor_therapy> <Modality_of> "Luspatercept_monotherapy" .
<Growth_factor_therapy> <Modality_of> "HDAC_and_G-CSF" .
<Growth_factor_therapy> <Modality_of> "FLAG-Ida" .
<Growth_factor_therapy> <Modality_of> "FLAG-DNX" .
<Growth_factor_therapy> <Modality_of> "FLAG" .
<Growth_factor_therapy> <Modality_of> "Erythropoietin_monotherapy" .
<Growth_factor_therapy> <Modality_of> "Erythropoetin_and_Lenalidomide" .
<Growth_factor_therapy> <Modality_of> "Eltrombopag_monotherapy" .
<Growth_factor_therapy> <Modality_of> "Dexamethasone_and_Eltrombopag" .
<Growth_factor_therapy> <Modality_of> "DexaBEAM_and_G-CSF" .
<Growth_factor_therapy> <Modality_of> "Cytarabine,_Ifosfamide,_G-CSF" .
<Growth_factor_therapy> <Modality_of> "Cytarabine_and_G-CSF" .
<Growth_factor_therapy> <Modality_of> "Cyclophosphamide_and_G-CSF" .
<Growth_factor_therapy> <Modality_of> "CYVE_and_G-CSF" .
<Growth_factor_therapy> <Modality_of> "CLARA" .
<Growth_factor_therapy> <Modality_of> "CLAG-M" .
<Growth_factor_therapy> <Modality_of> "CLAG" .
<Growth_factor_therapy> <Modality_of> "CAD_and_G-CSF" .
<Growth_factor_therapy> <Modality_of> "Avatrombopag_monotherapy" .
<Growth_factor_therapy> <Modality_of> "ATG_(Horse),_Cyclosporine,_G-CSF" .
<Biocilin> <Brand_name_of> "Filgrastim" .
<TX_(Taxotere)> <Maps_to> "TX_(Taxotere)" .
<Ramucirumab> <May_have_route> "Intravenous" .
<Mitoxantrone_and_Prednisone> <Has_antineoplastic> "Prednisone" .
<Mitoxantrone_and_Prednisone> <Has_antineoplastic> "Mitoxantrone" .
<Pixantrone> <Is_a> "Topoisomerase_inhibitor" .
<Pixantrone> <Is_a> "Drugs_EMA_approved_in_2013" .
<MA-BCD> <Mapped_from> "MA-BCD" .
<Detametazon> <Brand_name_of> "Dexamethasone" .
<Docetaxel,_Fluorouracil,_RT> <Has_supportive_med> "Dexamethasone" .
<Neodrea> <Brand_name_of> "Hydroxyurea" .
<Medulloblastoma> <Current_treated_by> "Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide" .
<Medulloblastoma> <Current_treated_by> "Cisplatin,_Lomustine,_Vincristine" .
<Medulloblastoma> <Current_treated_by> "Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine" .
<Azacitidine,_Vorinostat,_Gemtuzumab_ozogamicin> <Has_antineoplastic> "Vorinostat" .
<Azacitidine,_Vorinostat,_Gemtuzumab_ozogamicin> <Has_antineoplastic> "Gemtuzumab_ozogamicin" .
<Azacitidine,_Vorinostat,_Gemtuzumab_ozogamicin> <Has_antineoplastic> "Azacitidine" .
<Interferon_alfa-2c_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Lenvatinib_monotherapy> <Maps_to> "Lenvatinib_monotherapy" .
<Chronic_myelomonocytic_leukemia> <Current_treated_by> "Decitabine_monotherapy" .
<Chronic_myelomonocytic_leukemia> <Current_treated_by> "Azacitidine_monotherapy" .
<Chronic_myelomonocytic_leukemia> <Current_treated_by> "Azacitidine_and_Vorinostat" .
<Chronic_myelomonocytic_leukemia> <Current_treated_by> "Azacitidine_and_Lenalidomide" .
<Medsavorina> <Brand_name_of> "Folinic_acid" .
<NovoSeven_room_temperature_stable> <Brand_name_of> "Factor_VIIa_recombinant" .
<Carboplatin,_Pemetrexed,_Bevacizumab> <Maps_to> "Carboplatin,_Pemetrexed,_Bevacizumab" .
<MEL200,_then_auto_HSCT,_then_MEL220_and_Dexamethasone,_then_auto_HSCT> <Has_antineoplastic> "Melphalan" .
<MEL200,_then_auto_HSCT,_then_MEL220_and_Dexamethasone,_then_auto_HSCT> <Has_antineoplastic> "Dexamethasone" .
<Methoxsalen> <Has_FDA_indication> "Cutaneous_T-cell_lymphoma" .
<Trastuzumab-dkst> <Has_brand_name> "Ogivri" .
<Capecitabine_monotherapy> <Mapped_from> "Capecitabine_monotherapy" .
<VIDE> <Is_current_in> "Ewing_sarcoma" .
<Trimoxazole-BC> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Alectinib_monotherapy> <Has_antineoplastic> "Alectinib" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Steroid_synthesis_inhibitor> <Is_a> "Endocrine_therapeutic" .
<Chlorambucil,_Dactinomycin,_Methotrexate> <Has_modality> "Chemotherapy" .
<Paclitaxel_nanoparticle_albumin-bound> <May_have_route> "Intravenous" .
<Dasatinib,_Vincristine,_Prednisone> <Mapped_from> "Dasatinib,_Vincristine,_Prednisone" .
<Mocetinostat> <Has_accepted_use> "Hodgkin_lymphoma" .
<FM> <Has_accepted_use> "Follicular_lymphoma" .
<Vinstin> <Brand_name_of> "Vincristine" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone> <Is_a> "Anthracycline-containing_regimen" .
<Cosulf> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Calutide> <Brand_name_of> "Bicalutamide" .
<Retrovir> <Brand_name_of> "Zidovudine" .
<Valrubicin> <May_have_route> "Intravesical" .
<Viadur> <Brand_name_of> "Leuprolide" .
<Cisplatin,_Dacarbazine,_Interferon_alfa-2b> <Has_antineoplastic> "Interferon_alfa-2b" .
<Cisplatin,_Dacarbazine,_Interferon_alfa-2b> <Has_antineoplastic> "Dacarbazine" .
<Cisplatin,_Dacarbazine,_Interferon_alfa-2b> <Has_antineoplastic> "Cisplatin" .
<EP> <Has_modality> "Chemotherapy" .
<Gemcitabine_and_Mitomycin> <Has_accepted_use> "Gallbladder_cancer" .
<Gemcitabine_and_Mitomycin> <Has_accepted_use> "Cholangiocarcinoma" .
<Estradiol> <May_have_route> "Oral" .
<Clonazepam> <Supportive_med_of> "Bu/TT/Cy,_then_auto_HSCT" .
<CVAD> <Has_antineoplastic> "Vincristine" .
<CVAD> <Has_antineoplastic> "Doxorubicin" .
<CVAD> <Has_antineoplastic> "Dexamethasone" .
<CVAD> <Has_antineoplastic> "Cyclophosphamide" .
<Egicalm> <Brand_name_of> "Aspirin" .
<Etoposide_monotherapy> <Has_antineoplastic> "Etoposide" .
<Aranestp> <Brand_name_of> "Darbepoetin_alfa" .
<Cytoxan> <Brand_name_of> "Cyclophosphamide" .
<CEV_and_RT> <Has_antineoplastic> "Vincristine" .
<CEV_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<CEV_and_RT> <Has_antineoplastic> "Epirubicin" .
<CEV_and_RT> <Has_antineoplastic> "Cyclophosphamide" .
<ATG_(Horse)_and_Cyclosporine> <Has_accepted_use> "Myelodysplastic_syndrome" .
<ATG_(Horse)_and_Cyclosporine> <Has_accepted_use> "Aplastic_anemia" .
<Bleeding_disorder> <Subsumes> "Inherited_coagulopathy" .
<Bleeding_disorder> <Subsumes> "Immune_thrombocytopenia" .
<Bleeding_disorder> <Subsumes> "Acquired_coagulopathy" .
<Raltitrexed> <Antineoplastic_of> "Cisplatin_and_Raltitrexed" .
<V-HyperCAD> <Mapped_from> "V-HyperCAD" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone> <Has_modality> "Chemotherapy" .
<Head_and_neck_cancer> <Historic_treated_by> "CABO" .
<Head_and_neck_cancer> <Historic_treated_by> "Bleomycin,_Methotrexate,_Vinblastine/RT" .
<Axitinib_and_Pembrolizumab> <Has_accepted_use> "Renal_cell_carcinoma" .
<CAP_(Platinol)> <Maps_to> "CAP_(Platinol)" .
<T-cell_activator> <Subsumes> "Tremelimumab" .
<T-cell_activator> <Subsumes> "Pidilizumab" .
<T-cell_activator> <Subsumes> "Pembrolizumab" .
<T-cell_activator> <Subsumes> "Nivolumab" .
<T-cell_activator> <Subsumes> "Ipilimumab" .
<T-cell_activator> <Subsumes> "Durvalumab" .
<T-cell_activator> <Subsumes> "Cemiplimab" .
<T-cell_activator> <Subsumes> "Catumaxomab" .
<T-cell_activator> <Subsumes> "Blinatumomab" .
<T-cell_activator> <Subsumes> "Belagenpumatucel-L" .
<T-cell_activator> <Subsumes> "Bacillus_Calmette-Guerin" .
<T-cell_activator> <Subsumes> "Avelumab" .
<T-cell_activator> <Subsumes> "Atezolizumab" .
<T-cell_activator> <Subsumes> "Aldesleukin" .
<T-cell_activator> <Subsumes> "AMG_330" .
<Vidaza> <Brand_name_of> "Azacitidine" .
<Maintenance_after_salvage_therapy> <Mapped_from> "Maintenance_after_salvage_therapy" .
<Bosutinib_monotherapy> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Bosutinib_monotherapy> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Bosutinib_monotherapy> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Non-small_cell_lung_cancer> <Is_a> "Lung_cancer" .
<maxi-R-CHOP/R-HiDAC> <Has_antineoplastic> "Vincristine" .
<maxi-R-CHOP/R-HiDAC> <Has_antineoplastic> "Rituximab" .
<maxi-R-CHOP/R-HiDAC> <Has_antineoplastic> "Prednisone" .
<maxi-R-CHOP/R-HiDAC> <Has_antineoplastic> "Doxorubicin" .
<maxi-R-CHOP/R-HiDAC> <Has_antineoplastic> "Cytarabine" .
<maxi-R-CHOP/R-HiDAC> <Has_antineoplastic> "Cyclophosphamide" .
<CDK_inhibitor> <Is_a> "Kinase_inhibitor" .
<Neoplat> <Brand_name_of> "Cisplatin" .
<Fosamac> <Brand_name_of> "Alendronate" .
<MESA/RT> <Is_current_in> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<FCA> <Has_antineoplastic> "Fludarabine" .
<FCA> <Has_antineoplastic> "Cyclophosphamide" .
<FCA> <Has_antineoplastic> "Alemtuzumab" .
<Fisopred> <Brand_name_of> "Prednisolone" .
<Trimetotal> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<TL_(Taxol)> <Mapped_from> "TL_(Taxol)" .
<Bactigram> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin_and_Vinblastine> <Has_antineoplastic> "Vinblastine" .
<Cisplatin_and_Vinblastine> <Has_antineoplastic> "Cisplatin" .
<TC_(Taxotere)> <Has_supportive_med> "Filgrastim" .
<Sultrivon-F> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<EPOCH> <Has_context> "Non-curative_subsequent-line_therapy" .
<EPOCH> <Has_context> "Induction_therapy" .
<Doxorubicin> <Has_brand_name> "Zodox" .
<Doxorubicin> <Has_brand_name> "Varidoxo" .
<Doxorubicin> <Has_brand_name> "Rubex" .
<Doxorubicin> <Has_brand_name> "Roxorin" .
<Doxorubicin> <Has_brand_name> "Ribodoxo" .
<Doxorubicin> <Has_brand_name> "Rastocin" .
<Doxorubicin> <Has_brand_name> "Ranxas" .
<Doxorubicin> <Has_brand_name> "Pallagicin" .
<Doxorubicin> <Has_brand_name> "Onkostatil" .
<Doxorubicin> <Has_brand_name> "Onkodox" .
<Doxorubicin> <Has_brand_name> "Oncodria" .
<Doxorubicin> <Has_brand_name> "Nuaze" .
<Doxorubicin> <Has_brand_name> "Neoxane" .
<Doxorubicin> <Has_brand_name> "Nagun" .
<Doxorubicin> <Has_brand_name> "Lyphidox" .
<Doxorubicin> <Has_brand_name> "Lipodox" .
<Doxorubicin> <Has_brand_name> "Kemodoxa" .
<Doxorubicin> <Has_brand_name> "Ifadox" .
<Doxorubicin> <Has_brand_name> "Flavicina" .
<Doxorubicin> <Has_brand_name> "Fauldoxo" .
<Doxorubicin> <Has_brand_name> "Farmiblastina" .
<Doxorubicin> <Has_brand_name> "Evacet" .
<Doxorubicin> <Has_brand_name> "Duxocin" .
<Doxorubicin> <Has_brand_name> "Doxtie" .
<Doxorubicin> <Has_brand_name> "Doxotec" .
<Doxorubicin> <Has_brand_name> "Doxorubin" .
<Doxorubicin> <Has_brand_name> "Doxorubicinum" .
<Doxorubicin> <Has_brand_name> "Doxorubicine" .
<Doxorubicin> <Has_brand_name> "Doxorubicina" .
<Doxorubicin> <Has_brand_name> "Doxoruben" .
<Doxorubicin> <Has_brand_name> "Doxorrubicina_Colhidrol" .
<Doxorubicin> <Has_brand_name> "Doxorrubicina" .
<Doxorubicin> <Has_brand_name> "Doxor" .
<Doxorubicin> <Has_brand_name> "Doxonolver" .
<Doxorubicin> <Has_brand_name> "Doxolem" .
<Doxorubicin> <Has_brand_name> "Doxokebir" .
<Doxorubicin> <Has_brand_name> "Doxocris" .
<Doxorubicin> <Has_brand_name> "Doxobin" .
<Doxorubicin> <Has_brand_name> "Doxo_Cell" .
<Doxorubicin> <Has_brand_name> "Doxo" .
<Doxorubicin> <Has_brand_name> "Dobixin" .
<Doxorubicin> <Has_brand_name> "Dobicin" .
<Doxorubicin> <Has_brand_name> "Dicladox" .
<Doxorubicin> <Has_brand_name> "Deldoxin" .
<Doxorubicin> <Has_brand_name> "Daxotel" .
<Doxorubicin> <Has_brand_name> "Cloridrato_DE" .
<Doxorubicin> <Has_brand_name> "Carcinocin" .
<Doxorubicin> <Has_brand_name> "Cadria" .
<Doxorubicin> <Has_brand_name> "Biorubina" .
<Doxorubicin> <Has_brand_name> "Biorrub" .
<Doxorubicin> <Has_brand_name> "Antraciclin" .
<Doxorubicin> <Has_brand_name> "Adrosal" .
<Doxorubicin> <Has_brand_name> "Adrimedac" .
<Doxorubicin> <Has_brand_name> "Adrim" .
<Doxorubicin> <Has_brand_name> "Adricin" .
<Doxorubicin> <Has_brand_name> "Adricept" .
<Doxorubicin> <Has_brand_name> "Adriblastine" .
<Doxorubicin> <Has_brand_name> "Adriblastina" .
<Doxorubicin> <Has_brand_name> "Adriblastin" .
<Doxorubicin> <Has_brand_name> "Adriamycine" .
<Doxorubicin> <Has_brand_name> "Adriamycin" .
<Doxorubicin> <Has_brand_name> "Adriacin" .
<Doxorubicin> <Has_brand_name> "Adriacept" .
<Doxorubicin> <Has_brand_name> "Adriablastina" .
<Fostepor> <Brand_name_of> "Alendronate" .
<Apotrinelax> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Daunorubicin_liposomal_monotherapy> <Has_supportive_med> "Filgrastim" .
<DDR_inhibitor> <Subsumes> "Nilotinib" .
<Cotribase> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Ifosfamide_and_Paclitaxel> <Maps_to> "Ifosfamide_and_Paclitaxel" .
<RICER> <Has_antineoplastic> "Rituximab" .
<RICER> <Has_antineoplastic> "Mesna" .
<RICER> <Has_antineoplastic> "Lenalidomide" .
<RICER> <Has_antineoplastic> "Ifosfamide" .
<RICER> <Has_antineoplastic> "Etoposide" .
<RICER> <Has_antineoplastic> "Carboplatin" .
<IFL> <Has_antineoplastic> "Irinotecan" .
<IFL> <Has_antineoplastic> "Folinic_acid" .
<IFL> <Has_antineoplastic> "Fluorouracil" .
<Methotrexate_and_Prednisone> <Maps_to> "Methotrexate_and_Prednisone" .
<CMFL> <Maps_to> "CMFL" .
<Syrea> <Brand_name_of> "Hydroxyurea" .
<Granulocyte_colony-stimulating_factor> <Subsumes> "Tbo-filgrastim" .
<Granulocyte_colony-stimulating_factor> <Subsumes> "Pegfilgrastim-jmdb" .
<Granulocyte_colony-stimulating_factor> <Subsumes> "Pegfilgrastim-cbqv" .
<Granulocyte_colony-stimulating_factor> <Subsumes> "Pegfilgrastim" .
<Granulocyte_colony-stimulating_factor> <Subsumes> "Lipefilgrastim" .
<Granulocyte_colony-stimulating_factor> <Subsumes> "Lenograstim" .
<Granulocyte_colony-stimulating_factor> <Subsumes> "Filgrastim-sndz" .
<Granulocyte_colony-stimulating_factor> <Subsumes> "Filgrastim" .
<Paclitaxel_and_S-1> <Mapped_from> "Paclitaxel_and_S-1" .
<Romidepsin> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Romidepsin> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Cytarabine_and_Thioguanine> <Mapped_from> "Cytarabine_and_Thioguanine" .
<L-Asparaginase_and_Methotrexate> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Novotrimel> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Erwinase> <Brand_name_of> "Asparaginase_Erwinia_chrysanthemi" .
<Corsona> <Brand_name_of> "Dexamethasone" .
<Cytarabine_and_Interferon_alfa-2b> <Has_antineoplastic> "Interferon_alfa-2b" .
<Cytarabine_and_Interferon_alfa-2b> <Has_antineoplastic> "Cytarabine" .
<VAP> <Mapped_from> "VAP" .
<Dexamethasone_and_Eltrombopag> <Has_supportive_med> "Eltrombopag" .
<Thioguanine_monotherapy> <Mapped_from> "Thioguanine_monotherapy" .
<O-miniCHOP> <Mapped_from> "O-miniCHOP" .
<Levact> <Brand_name_of> "Bendamustine" .
<ABVD> <Mapped_from> "ABVD" .
<FOLFIRI_and_Ziv-aflibercept> <Has_accepted_use> "Colon_cancer" .
<VR-CHOP> <Has_antineoplastic> "Vincristine" .
<VR-CHOP> <Has_antineoplastic> "Rituximab" .
<VR-CHOP> <Has_antineoplastic> "Prednisone" .
<VR-CHOP> <Has_antineoplastic> "Doxorubicin" .
<VR-CHOP> <Has_antineoplastic> "Cyclophosphamide" .
<VR-CHOP> <Has_antineoplastic> "Bortezomib" .
<Forodesine_monotherapy> <Has_modality> "Chemotherapy" .
<Rontafor> <Brand_name_of> "Folinic_acid" .
<Zanubrutinib> <Has_FDA_indication> "Mantle_cell_lymphoma" .
<Prothrombin_Complex_Concentrate_human> <May_have_route> "Intravenous" .
<Medroxyprogesterone_monotherapy> <Has_modality> "Hormonotherapy" .
<Clarithromycin_monotherapy> <Mapped_from> "Clarithromycin_monotherapy" .
<Idelalisib_monotherapy> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Idelalisib_monotherapy> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Idelalisib_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<Idelalisib_monotherapy> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Ibrutinib_and_Ofatumumab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT> <Maps_to> "Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT" .
<Sonidegib_monotherapy> <Has_modality> "Chemotherapy" .
<CIM> <Is_current_in> "Endometrial_cancer" .
<Furosemide> <Supportive_med_of> "nab-Paclitaxel_monotherapy" .
<Furosemide> <Supportive_med_of> "MAP" .
<Furosemide> <Supportive_med_of> "Cyclophosphamide_and_Topotecan" .
<Furosemide> <Supportive_med_of> "Cisplatin_and_Vinorelbine" .
<Furosemide> <Supportive_med_of> "Cisplatin_and_Mitomycin" .
<Furosemide> <Supportive_med_of> "Cisplatin_and_Doxorubicin" .
<Daratumumab> <Antineoplastic_of> "Daratumumab_monotherapy" .
<Daratumumab> <Antineoplastic_of> "Dara-VTD" .
<Daratumumab> <Antineoplastic_of> "Dara-VMP" .
<Daratumumab> <Antineoplastic_of> "Dara-VD" .
<Daratumumab> <Antineoplastic_of> "Dara-Rd" .
<Daratumumab> <Antineoplastic_of> "Dara-PD" .
<Daratumumab> <Antineoplastic_of> "Dara-KD" .
<Elo-VD> <Is_current_in> "Multiple_myeloma" .
<CHUT,_then_auto_HSCT> <Maps_to> "CHUT,_then_auto_HSCT" .
<MP> <Is_historical_in> "Multiple_myeloma" .
<mFOLFIRINOX,_Gemcitabine,_RT> <Has_accepted_use> "Pancreatic_cancer" .
<Chemohormonotherapy> <Maps_to> "Chemohormonotherapy" .
<Carboplatin_and_Cyclophosphamide> <Maps_to> "Carboplatin_and_Cyclophosphamide" .
<CIA> <Maps_to> "CIA" .
<Doxorubicin_and_Streptozocin> <Is_a> "Anthracycline-containing_regimen" .
<Atgam> <Brand_name_of> "Cytomegalovirus_Immune_Globulin" .
<Atgam> <Brand_name_of> "Antithymocyte_globulin_horse_ATG" .
<ABCM> <Has_context> "Non-curative_first-line_therapy" .
<Mekinist> <Brand_name_of> "Trametinib" .
<Infergen> <Brand_name_of> "Interferon_alfa-2b" .
<Vorinostat_monotherapy> <Has_context> "Non-curative_therapy" .
<Vorinostat_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Ifosfamide_and_Vinorelbine> <Is_current_in> "Hodgkin_lymphoma" .
<Docetaxel_and_Vandetanib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Unistin> <Brand_name_of> "Cisplatin" .
<ECT,_then_auto_HSCT> <Has_accepted_use> "Breast_cancer" .
<Palbociclib> <Has_FDA_indication> "Breast_cancer" .
<BCNU/TT,_then_auto_HSCT> <Maps_to> "BCNU/TT,_then_auto_HSCT" .
<CHOP-14> <Has_context> "Induction_therapy" .
<B-CAVe> <Has_antineoplastic> "Vinblastine" .
<B-CAVe> <Has_antineoplastic> "Lomustine" .
<B-CAVe> <Has_antineoplastic> "Doxorubicin" .
<B-CAVe> <Has_antineoplastic> "Bleomycin" .
<Vomiz> <Brand_name_of> "Ondansetron" .
<Carmustine_and_Doxorubicin> <Has_antineoplastic> "Doxorubicin" .
<Carmustine_and_Doxorubicin> <Has_antineoplastic> "Carmustine" .
<Vincristinesulfaat> <Brand_name_of> "Vincristine" .
<Prednisone_monotherapy> <Maps_to> "Prednisone_monotherapy" .
<Cobimetinib_and_Vemurafenib> <Has_modality> "Chemotherapy" .
<Elo-Rd> <Mapped_from> "Elo-Rd" .
<Growth_factor_therapy> <Mapped_from> "Growth_factor_therapy" .
<CHOP_(Prednisolone)> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Daunorubicin_monotherapy> <Maps_to> "Daunorubicin_monotherapy" .
<Arsenic_trioxide_and_ATRA> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Dacarbazine_and_Doxorubicin> <Has_modality> "Chemotherapy" .
<Valproate> <Is_a> "HDAC_inhibitor" .
<Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine> <Has_modality> "Immunotherapy" .
<Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine> <Has_modality> "Chemotherapy" .
<Ixabepilone> <Has_accepted_use> "Breast_cancer" .
<Arranon> <Brand_name_of> "Nelarabine" .
<Adriablastina> <Brand_name_of> "Doxorubicin" .
<Palifermin> <Is_a> "Mucositis_prevention" .
<Palifermin> <Is_a> "Chemotherapy_protective_agent" .
<Fludarabine,_Busulfan,_Cyclophosphamide> <Is_current_in> "Allogeneic_HSCT" .
<Xasone> <Brand_name_of> "Dexamethasone" .
<Non-curative_subsequent-line_maintenance_therapy> <Maps_to> "Non-curative_subsequent-line_maintenance_therapy" .
<Clamist> <Brand_name_of> "Clemastine" .
<Decadolone> <Brand_name_of> "Dexamethasone" .
<Exemestane_monotherapy> <Has_modality> "Hormonotherapy" .
<Folinac> <Brand_name_of> "Folinic_acid" .
<Mitotane> <Antineoplastic_of> "Mitotane_monotherapy" .
<Mitotane> <Antineoplastic_of> "Mitotane_and_Streptozocin" .
<Mitotane> <Antineoplastic_of> "Mitotane_and_EDP" .
<Cobimetinib> <Has_FDA_indication> "Melanoma" .
<Bonaid> <Brand_name_of> "Alendronate" .
<Cotrimoxazol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<L-Asparaginase_and_Methotrexate> <Mapped_from> "L-Asparaginase_and_Methotrexate" .
<Lorlatinib_monotherapy> <Maps_to> "Lorlatinib_monotherapy" .
<Decortin_H> <Brand_name_of> "Prednisolone" .
<Pentostatin_monotherapy> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<Mechlorethamine_monotherapy> <Has_accepted_use> "Hodgkin_lymphoma" .
<Vinces> <Brand_name_of> "Vincristine" .
<Cytarabine,_Ifosfamide,_G-CSF> <Has_modality> "Growth_factor_therapy" .
<Cytarabine,_Ifosfamide,_G-CSF> <Has_modality> "Chemotherapy" .
<R-miniCEOP> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<R-miniCEOP> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Raltitrexed> <Has_accepted_use> "Mesothelioma" .
<Raltitrexed> <Has_accepted_use> "Colon_cancer" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "VR" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "Thioguanine_monotherapy" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "Thalidomide_and_Rituximab" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "Rituximab_monotherapy" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "RVR" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "R-CHOP" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "Panobinostat_monotherapy" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "PCR" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "Ofatumumab_monotherapy" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "Lenalidomide_monotherapy" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "Idelalisib_monotherapy" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "Ibrutinib_monotherapy" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "Ibrutinib_and_Rituximab" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "Fludarabine_monotherapy" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "FR" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "FCR" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "Everolimus_monotherapy" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "DRC" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "Cladribine_and_Rituximab" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "Chlorambucil_monotherapy" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "CaRD" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "Bortezomib_monotherapy" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "BR" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "BDR" .
<Waldenstroem_macroglobulinemia> <Current_treated_by> "Alemtuzumab_monotherapy" .
<CAFVP> <Has_accepted_use> "Breast_cancer" .
<Topotecan_monotherapy> <Has_modality> "Chemotherapy" .
<Cyproterone_acetate> <Antineoplastic_of> "Cyproterone_acetate_monotherapy" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Mini-BEAM> <Has_accepted_use> "Hodgkin_lymphoma" .
<Bevacizumab-containing_therapy> <Mapped_from> "Bevacizumab-containing_therapy" .
<Ogivri> <Brand_name_of> "Trastuzumab-dkst" .
<MAP2K4_inhibitor> <Is_a> "MEK_inhibitor" .
<5_alpha-reductase_inhibitor> <Is_a> "Endocrine_therapeutic" .
<Tacrolimus> <Immunosuppressor_of> "Sirolimus,_Tacrolimus,_Prednisone" .
<Tacrolimus> <Immunosuppressor_of> "Methotrexate,_Tacrolimus,_Vorinostat" .
<Tacrolimus> <Immunosuppressor_of> "Methotrexate,_Tacrolimus,_Tocilizumab" .
<Tacrolimus> <Immunosuppressor_of> "Methotrexate_and_Tacrolimus" .
<Tacrolimus> <Immunosuppressor_of> "Low-dose_TBI,_then_allo_HSCT" .
<Tacrolimus> <Immunosuppressor_of> "Low-dose_TBI" .
<Tacrolimus> <Immunosuppressor_of> "Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant" .
<Tacrolimus> <Immunosuppressor_of> "Fludarabine,_Busulfan,_Cyclophosphamide" .
<Tacrolimus> <Immunosuppressor_of> "Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Tacrolimus> <Immunosuppressor_of> "Fludarabine,_Busulfan,_ATG" .
<Tacrolimus> <Immunosuppressor_of> "Fludarabine_and_Melphalan" .
<Tacrolimus> <Immunosuppressor_of> "FluBuCy,_then_allo_HSCT" .
<Tacrolimus> <Immunosuppressor_of> "Flu-Mel,_then_allo_HSCT" .
<Tacrolimus> <Immunosuppressor_of> "FCR,_then_allo_HSCT" .
<Tacrolimus> <Immunosuppressor_of> "FCR" .
<Tacrolimus> <Immunosuppressor_of> "Cyclophosphamide,_Mycophenolate_mofetil,_Tacrolimus" .
<Tacrolimus> <Immunosuppressor_of> "Busulfan_and_Fludarabine" .
<Tacrolimus> <Immunosuppressor_of> "BuFlu,_then_allo_HSCT" .
<Tacrolimus> <Immunosuppressor_of> "BEAM,_then_allo_HSCT" .
<Tacrolimus> <Immunosuppressor_of> "BEAM" .
<Tacrolimus> <Immunosuppressor_of> "(90)YFC,_then_allo_HSCT" .
<Tacrolimus> <Immunosuppressor_of> "(90)YFC" .
<GTX> <Mapped_from> "GTX" .
<Decans> <Brand_name_of> "Dexamethasone" .
<Fragmin> <Brand_name_of> "Dalteparin" .
<IT_Methotrexate_monotherapy> <Has_accepted_use> "CNS_leukemia" .
<Carmustine_wafer_polifeprosan_20> <Has_FDA_indication> "Glioblastoma" .
<All-trans_retinoic_acid> <May_have_route> "Oral" .
<Luspatercept> <Is_a> "Hematopoietic_growth_factor" .
<Luspatercept> <Is_a> "Erythrocyte_growth_factor" .
<Carbotec> <Brand_name_of> "Carboplatin" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "Vincristine" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "VIPD" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "SMILE" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "Prednisolone" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "Pegaspargase" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "Oxaliplatin" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "Methotrexate" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "MESA/RT" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "LVP_.22Sandwich.22" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "L-Asparaginase,_Vincristine,_Prednisolone" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "Ifosfamide" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "Gemcitabine" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "GELOX/RT" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "Etoposide" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "Dexamethasone" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "DeVIC_and_RT" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "DEP_and_RT" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "Cisplatin_and_RT" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "Cisplatin" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "Carboplatin" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "Asparaginase_Erwinia_chrysanthemi" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "Asparaginase" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "AspaMetDex_(Erwinaze)" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Accepted_use_of> "AspaMetDex" .
<Obinutuzumab> <Has_brand_name> "Gazyva" .
<Nordic_Regimen,_older_patients> <Is_a> "Rituximab-containing_regimen" .
<MA-BCD> <Is_a> "Anthracycline-containing_regimen" .
<BCVPP> <Is_historical_in> "Hodgkin_lymphoma" .
<CLARA> <Maps_to> "CLARA" .
<Trastuzumab-anns> <Has_accepted_use> "Gastric_cancer" .
<Trastuzumab-anns> <Has_accepted_use> "Esophageal_cancer" .
<Trastuzumab-anns> <Has_accepted_use> "Breast_cancer" .
<Reduction_of_immunosuppression> <Mapped_from> "Reduction_of_immunosuppression" .
<Clarithromycin_monotherapy> <Has_modality> "Antibiotic_therapy" .
<EPOCH> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<EPOCH> <Has_supportive_med> "Pentamidine" .
<EPOCH> <Has_supportive_med> "Filgrastim" .
<EPOCH> <Has_supportive_med> "Atovaquone" .
<TFC,_then_allo_HSCT> <Has_antineoplastic> "Thiotepa" .
<TFC,_then_allo_HSCT> <Has_antineoplastic> "Fludarabine" .
<TFC,_then_allo_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<TFC,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<Dexasolone> <Brand_name_of> "Dexamethasone" .
<Fluorouracil_and_RT> <Has_accepted_use> "Rectal_cancer" .
<Fluorouracil_and_RT> <Has_accepted_use> "Pancreatic_cancer" .
<Fluorouracil_and_RT> <Has_accepted_use> "Head_and_neck_cancer" .
<Fluorouracil_and_RT> <Has_accepted_use> "Gastric_cancer" .
<Fluorouracil_and_RT> <Has_accepted_use> "Cervical_cancer" .
<Bexarotene> <Is_a> "Retinoid" .
<Docusate> <Supportive_med_of> "SC-EPOCH-RR" .
<Docusate> <Supportive_med_of> "DA-R-EPOCH" .
<Docusate> <Supportive_med_of> "DA-EPOCH" .
<RCC> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Acetazona> <Brand_name_of> "Dexamethasone" .
<R-EPOCH,_dose-escalated> <Mapped_from> "R-EPOCH,_dose-escalated" .
<Augmented_Hyper-CVAD_and_Asparaginase> <Has_antineoplastic> "Vincristine" .
<Augmented_Hyper-CVAD_and_Asparaginase> <Has_antineoplastic> "Pegaspargase" .
<Augmented_Hyper-CVAD_and_Asparaginase> <Has_antineoplastic> "Doxorubicin" .
<Augmented_Hyper-CVAD_and_Asparaginase> <Has_antineoplastic> "Dexamethasone" .
<Augmented_Hyper-CVAD_and_Asparaginase> <Has_antineoplastic> "Cyclophosphamide" .
<ChlVPP/EVA> <Has_modality> "Chemotherapy" .
<Lenvatinib_and_Pembrolizumab> <Has_accepted_use> "Endometrial_cancer" .
<ADT_and_Abiraterone> <Has_context> "Non-curative_therapy" .
<FOLFIRI_and_Cetuximab> <Maps_to> "FOLFIRI_and_Cetuximab" .
<Imatinib,_Vincristine,_Dexamethasone> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Imatinib,_Vincristine,_Dexamethasone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Mapatumumab> <Is_a> "Investigational_drug" .
<Mapatumumab> <Is_a> "Antibody_medication" .
<Mapatumumab> <Is_a> "Anti-TRAIL-R1_antibody" .
<Dexameson> <Brand_name_of> "Dexamethasone" .
<Everolimus_and_Lenvatinib> <Is_current_in> "Renal_cell_carcinoma" .
<Yewtaxan> <Brand_name_of> "Paclitaxel" .
<Tronoxal> <Brand_name_of> "Ifosfamide" .
<Avatrombopag_monotherapy> <Maps_to> "Avatrombopag_monotherapy" .
<Uprina> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<VMP> <Has_antineoplastic> "Prednisone" .
<VMP> <Has_antineoplastic> "Melphalan" .
<VMP> <Has_antineoplastic> "Bortezomib" .
<Bicalutamide_and_Leuprolide> <Has_accepted_use> "Prostate_cancer" .
<Prednicap> <Brand_name_of> "Prednisone" .
<FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation> <Is_a> "Irinotecan-containing_regimen" .
<Osfolato> <Brand_name_of> "Folinic_acid" .
<Plerixafor> <May_have_route> "Subcutaneous" .
<Doxycycline> <May_have_route> "Oral" .
<R-MPV> <Has_supportive_med> "Folinic_acid" .
<Etoposide_monotherapy> <Has_context> "Salvage_therapy" .
<Etoposide_monotherapy> <Has_context> "Non-curative_therapy" .
<Etoposide_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Etoposide_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Etoposide_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Etoposide_monotherapy> <Has_context> "Consolidation_after_salvage_therapy" .
<Etoposide_monotherapy> <Has_context> "All_lines_of_therapy" .
<Hyper-CVAD_and_Dasatinib> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Nivolumab> <Has_brand_name> "Opdivo" .
<Cisplatin,_Fluorouracil,_RT> <Is_current_in> "Nasopharyngeal_carcinoma" .
<Cisplatin,_Fluorouracil,_RT> <Is_current_in> "Head_and_neck_cancer" .
<Cisplatin,_Fluorouracil,_RT> <Is_current_in> "Esophageal_cancer" .
<Cisplatin,_Fluorouracil,_RT> <Is_current_in> "Cervical_cancer" .
<Cisplatin,_Fluorouracil,_RT> <Is_current_in> "Bladder_cancer" .
<Cisplatin,_Fluorouracil,_RT> <Is_current_in> "Anal_cancer" .
<Sisoprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Revlimid> <Brand_name_of> "Lenalidomide" .
<HAM> <Has_antineoplastic> "Mitoxantrone" .
<HAM> <Has_antineoplastic> "Cytarabine" .
<Metalexina> <Brand_name_of> "Dexamethasone" .
<Ravulizumab_monotherapy> <Maps_to> "Ravulizumab_monotherapy" .
<Belotecan_and_Cisplatin> <Maps_to> "Belotecan_and_Cisplatin" .
<Dexasol> <Brand_name_of> "Dexamethasone" .
<PAR1_inhibitor> <Subsumes> "Vorapaxar" .
<Cold_agglutinin_disease> <Is_a> "Hemolytic_process" .
<Cold_agglutinin_disease> <Is_a> "Complementopathy" .
<Aclarubicin> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Capecitabine_and_Paclitaxel> <Mapped_from> "Capecitabine_and_Paclitaxel" .
<Mesothelioma> <FDA_indication_of> "Pemetrexed" .
<Chlorambucil> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Chlorambucil> <Is_a> "Nitrogen_mustard" .
<Chlorambucil> <Is_a> "Alkylating_agent" .
<Abemaciclib_and_Fulvestrant> <Mapped_from> "Abemaciclib_and_Fulvestrant" .
<Atezolizumab> <Antineoplastic_of> "nab-Paclitaxel_and_Atezolizumab" .
<Atezolizumab> <Antineoplastic_of> "Carboplatin,_nab-Paclitaxel,_Atezolizumab" .
<Atezolizumab> <Antineoplastic_of> "Carboplatin,_Etoposide,_Atezolizumab" .
<Atezolizumab> <Antineoplastic_of> "Atezolizumab_monotherapy" .
<Atezolizumab> <Antineoplastic_of> "Atezolizumab_and_Bevacizumab" .
<Atezolizumab> <Antineoplastic_of> "ABCP" .
<Azacitidine_and_Lenalidomide> <Maps_to> "Azacitidine_and_Lenalidomide" .
<IT_Methotrexate_and_WBRT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Pd> <Has_context> "Non-curative_therapy" .
<Sipuleucel-T_monotherapy> <Has_modality> "Immunotherapy" .
<VCP> <Mapped_from> "VCP" .
<Varubi_IV> <Brand_name_of> "Rolapitant" .
<BEACOPP-14> <Is_current_in> "Hodgkin_lymphoma" .
<MESA/RT> <Maps_to> "MESA/RT" .
<Dexaleniens> <Brand_name_of> "Dexamethasone" .
<Regorafenib_monotherapy> <Has_context> "Non-curative_third-line_therapy" .
<Regorafenib_monotherapy> <Has_context> "Non-curative_therapy" .
<Regorafenib_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Regorafenib_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Eltrombopag_monotherapy> <Has_accepted_use> "Immune_thrombocytopenia" .
<Eltrombopag_monotherapy> <Has_accepted_use> "Aplastic_anemia" .
<Acquired_coagulopathy> <Is_a> "Bleeding_disorder" .
<Acquired_coagulopathy> <Is_a> "Autoimmune_hematologic_condition" .
<Antifolate> <Subsumes> "Trimethoprim-Sulfamethoxazole" .
<Antifolate> <Subsumes> "Raltitrexed" .
<Antifolate> <Subsumes> "Pralatrexate" .
<Antifolate> <Subsumes> "Pemetrexed" .
<Antifolate> <Subsumes> "Nolatrexed" .
<Antifolate> <Subsumes> "Methotrexate" .
<Antifolate> <Subsumes> "Aminopterin" .
<Sunitinib_monotherapy> <Has_modality> "Chemotherapy" .
<Idelalisib_and_Ofatumumab> <Has_modality> "Chemotherapy" .
<Selinexor> <May_have_route> "Oral" .
<E.P.R_Elvetium> <Brand_name_of> "Epirubicin" .
<Lenograstim> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Bevacizumab> <Is_a> "VEGFR_inhibitor" .
<Bevacizumab> <Is_a> "PMDA_approved_drug" .
<Bevacizumab> <Is_a> "Neutral" .
<Bevacizumab> <Is_a> "Antibody_medication" .
<Bevacizumab> <Is_a> "Anti-VEGFR_antibody" .
<Lenalidomide_monotherapy> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<Lenalidomide_monotherapy> <Is_current_in> "Transformed_lymphoma" .
<Lenalidomide_monotherapy> <Is_current_in> "Polycythemia_vera" .
<Lenalidomide_monotherapy> <Is_current_in> "Plasma_cell_leukemia" .
<Lenalidomide_monotherapy> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<Lenalidomide_monotherapy> <Is_current_in> "Myelofibrosis" .
<Lenalidomide_monotherapy> <Is_current_in> "Myelodysplastic_syndrome" .
<Lenalidomide_monotherapy> <Is_current_in> "Multiple_myeloma" .
<Lenalidomide_monotherapy> <Is_current_in> "Marginal_zone_lymphoma" .
<Lenalidomide_monotherapy> <Is_current_in> "Mantle_cell_lymphoma" .
<Lenalidomide_monotherapy> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<Lenalidomide_monotherapy> <Is_current_in> "Hodgkin_lymphoma" .
<Lenalidomide_monotherapy> <Is_current_in> "Follicular_lymphoma" .
<Lenalidomide_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Lenalidomide_monotherapy> <Is_current_in> "Cutaneous_T-cell_lymphoma" .
<Lenalidomide_monotherapy> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Lenalidomide_monotherapy> <Is_current_in> "Adult_T-cell_leukemia-lymphoma" .
<Tocilizumab> <Has_accepted_use> "Castleman_disease" .
<Fluorouracil,_Mitomycin,_RT> <Has_antineoplastic> "Mitomycin" .
<Fluorouracil,_Mitomycin,_RT> <Has_antineoplastic> "Fluorouracil" .
<Fluorouracil,_Mitomycin,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Uveal_melanoma> <Current_treated_by> "Temozolomide_monotherapy" .
<Uveal_melanoma> <Current_treated_by> "TILs" .
<Uveal_melanoma> <Current_treated_by> "TACE" .
<Uveal_melanoma> <Current_treated_by> "Fotemustine_monotherapy" .
<Uveal_melanoma> <Current_treated_by> "Dacarbazine_monotherapy" .
<PCP> <Has_antineoplastic> "Prednisone" .
<PCP> <Has_antineoplastic> "Pomalidomide" .
<PCP> <Has_antineoplastic> "Cyclophosphamide" .
<Axicabtagene_ciloleucel> <Has_FDA_indication> "Transformed_lymphoma" .
<Axicabtagene_ciloleucel> <Has_FDA_indication> "Primary_mediastinal_B-cell_lymphoma" .
<Axicabtagene_ciloleucel> <Has_FDA_indication> "Diffuse_large_B-cell_lymphoma" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib> <Has_context> "Induction_therapy" .
<MTOR_inhibitor> <Subsumes> "Temsirolimus" .
<MTOR_inhibitor> <Subsumes> "Sirolimus" .
<MTOR_inhibitor> <Subsumes> "Everolimus" .
<Bicalutamide_and_Leuprolide> <Has_context> "Non-curative_therapy" .
<PCE> <Has_accepted_use> "Small_cell_lung_cancer" .
<PCE> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<Busulfan_and_Fludarabine> <Has_accepted_use> "Allogeneic_HSCT" .
<Lacreozole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<mDCF> <Has_accepted_use> "Gastric_cancer" .
<mDCF> <Has_accepted_use> "Anal_cancer" .
<R-DHAC> <Has_context> "Non-curative_first-line_therapy" .
<GCD> <Has_antineoplastic> "Gemcitabine" .
<GCD> <Has_antineoplastic> "Dexamethasone" .
<GCD> <Has_antineoplastic> "Carboplatin" .
<Euromethasone> <Brand_name_of> "Dexamethasone" .
<Exemestane_and_Tucidinostat> <Maps_to> "Exemestane_and_Tucidinostat" .
<Opredsone> <Brand_name_of> "Prednisolone" .
<Brigatinib> <Antineoplastic_of> "Brigatinib_monotherapy" .
<Thalidomide_monotherapy> <Is_current_in> "Polycythemia_vera" .
<Thalidomide_monotherapy> <Is_current_in> "Multiple_myeloma" .
<SOX_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<R-BEAM,_then_auto_HSCT> <Maps_to> "R-BEAM,_then_auto_HSCT" .
<Mejoral_Infantil> <Brand_name_of> "Aspirin" .
<Hepatocellular_carcinoma> <Historic_treated_by> "Tamoxifen_monotherapy" .
<Hepatocellular_carcinoma> <Historic_treated_by> "Sunitinib_monotherapy" .
<CYM> <Has_local_therapy> "Methotrexate" .
<CYM> <Has_local_therapy> "Hydrocortisone" .
<CYM> <Has_local_therapy> "Cytarabine" .
<7_plus_3i_and_Sorafenib> <Is_a> "Anthracycline-containing_regimen" .
<Doxorubicin_and_Bevacizumab> <Has_accepted_use> "Breast_cancer" .
<H2-receptor_antagonists> <Supportive_med_of> "Paclitaxel_monotherapy" .
<H2-receptor_antagonists> <Supportive_med_of> "BLD" .
<FM> <Maps_to> "FM" .
<Gemcitabine_and_Sunitinib> <Has_antineoplastic> "Sunitinib" .
<Gemcitabine_and_Sunitinib> <Has_antineoplastic> "Gemcitabine" .
<CX> <Mapped_from> "CX" .
<Carboplatin_and_Irinotecan> <Has_antineoplastic> "Irinotecan" .
<Carboplatin_and_Irinotecan> <Has_antineoplastic> "Carboplatin" .
<Azacitidine_and_Vorinostat> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Azacitidine_and_Vorinostat> <Has_accepted_use> "Chronic_myelomonocytic_leukemia" .
<R-CHOP-14_(Prednisolone)> <Has_antineoplastic> "Vincristine" .
<R-CHOP-14_(Prednisolone)> <Has_antineoplastic> "Rituximab" .
<R-CHOP-14_(Prednisolone)> <Has_antineoplastic> "Prednisolone" .
<R-CHOP-14_(Prednisolone)> <Has_antineoplastic> "Doxorubicin" .
<R-CHOP-14_(Prednisolone)> <Has_antineoplastic> "Cyclophosphamide" .
<Panitumumab_monotherapy> <Maps_to> "Panitumumab_monotherapy" .
<PFT> <Mapped_from> "PFT" .
<SMILE> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<SMILE> <Has_supportive_med> "Pentamidine" .
<SMILE> <Has_supportive_med> "Mesna" .
<SMILE> <Has_supportive_med> "Hydrocortisone" .
<SMILE> <Has_supportive_med> "Folinic_acid" .
<SMILE> <Has_supportive_med> "Filgrastim" .
<SMILE> <Has_supportive_med> "Famotidine" .
<SMILE> <Has_supportive_med> "Chlorpheniramine" .
<Dabrafenib_and_Trametinib> <Has_context> "Non-curative_therapy" .
<Dabrafenib_and_Trametinib> <Has_context> "Non-curative_first-line_therapy" .
<Dabrafenib_and_Trametinib> <Has_context> "All_lines_of_therapy" .
<Dabrafenib_and_Trametinib> <Has_context> "Adjuvant_therapy" .
<Encaprin> <Brand_name_of> "Aspirin" .
<Danazol_monotherapy> <Has_antineoplastic> "Danazol" .
<Hedgehog_pathway_inhibitor> <Is_a> "Chemotherapeutic" .
<Bexarotene_monotherapy> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<EPOCH,_dose-escalated> <Is_current_in> "HIV-associated_lymphoma" .
<Interferons> <Antineoplastic_of> "Interferon_alfa_monotherapy" .
<Interferons> <Antineoplastic_of> "Interferon_alfa_and_Dexamethasone" .
<P/DOCE> <Mapped_from> "P/DOCE" .
<Kalmethasone> <Brand_name_of> "Dexamethasone" .
<Abemaciclib_and_Letrozole> <Has_modality> "Hormonotherapy" .
<Abemaciclib_and_Letrozole> <Has_modality> "Chemotherapy" .
<CM> <Is_current_in> "Breast_cancer" .
<Anakinra_monotherapy> <Has_accepted_use> "Castleman_disease" .
<Rituximab-abbs> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Rituximab-abbs> <Is_a> "Protein_expression-specific_medication" .
<Rituximab-abbs> <Is_a> "Neutral" .
<Rituximab-abbs> <Is_a> "Biosimilar" .
<Rituximab-abbs> <Is_a> "Antibody_medication" .
<Rituximab-abbs> <Is_a> "Anti-CD20_antibody" .
<CALGB_10-002_regimen> <Is_a> "Rituximab-containing_regimen" .
<CALGB_10-002_regimen> <Is_a> "Anthracycline-containing_regimen" .
<Becortem> <Brand_name_of> "Prednisone" .
<Pancreatic_cancer> <FDA_indication_of> "Paclitaxel_nanoparticle_albumin-bound" .
<Pancreatic_cancer> <FDA_indication_of> "Olaparib" .
<Pancreatic_cancer> <FDA_indication_of> "Irinotecan_liposome" .
<Pancreatic_cancer> <FDA_indication_of> "Gemcitabine" .
<Pancreatic_cancer> <FDA_indication_of> "Erlotinib" .
<R-IFE> <Has_supportive_med> "Pegfilgrastim" .
<R-IFE> <Has_supportive_med> "Mesna" .
<ddFEC> <Has_supportive_med> "Pegfilgrastim" .
<ddFEC> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<ddFEC> <Has_supportive_med> "Filgrastim" .
<Radioembolization> <Has_antineoplastic> "Brachytherapy" .
<Warfin> <Brand_name_of> "Warfarin" .
<Carboplatin,_Paclitaxel,_Pembrolizumab> <Has_antineoplastic> "Pembrolizumab" .
<Carboplatin,_Paclitaxel,_Pembrolizumab> <Has_antineoplastic> "Paclitaxel" .
<Carboplatin,_Paclitaxel,_Pembrolizumab> <Has_antineoplastic> "Carboplatin" .
<Obinutuzumab> <Is_a> "Immunotherapeutic" .
<Obinutuzumab> <Is_a> "Antibody_medication" .
<Obinutuzumab> <Is_a> "Anti-CD20_medication" .
<Obinutuzumab> <Is_a> "Anti-CD20_antibody" .
<Niraparib> <Antineoplastic_of> "Niraparib_monotherapy" .
<Mitotane_monotherapy> <Has_context> "Non-curative_therapy" .
<Mitotane_monotherapy> <Has_context> "Adjuvant_therapy" .
<Mechlorethamine> <May_have_route> "Intravenous" .
<Mechlorethamine> <May_have_route> "Intracavitary" .
<Erlonat> <Brand_name_of> "Erlotinib" .
<F-SHAI> <Is_current_in> "Acute_myeloid_leukemia" .
<Cetuximab> <Has_accepted_use> "Pancreatic_cancer" .
<Cetuximab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cetuximab> <Has_accepted_use> "Head_and_neck_cancer" .
<Cetuximab> <Has_accepted_use> "Esophageal_cancer" .
<Cetuximab> <Has_accepted_use> "Cutaneous_squamous_cell_carcinoma" .
<Cetuximab> <Has_accepted_use> "Colon_cancer" .
<Mitomycin_monotherapy> <Is_current_in> "Bladder_cancer" .
<Doxifluridine> <Is_a> "Fluoropyrimidine" .
<Medroxyprogesterone_monotherapy> <Is_historical_in> "Renal_cell_carcinoma" .
<Medroxyprogesterone_monotherapy> <Is_historical_in> "Breast_cancer" .
<Eribulin> <Is_a> "Microtubule_inhibitor" .
<Triphimox> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cyclophosphamide_and_G-CSF> <Has_modality> "Growth_factor_therapy" .
<Cyclophosphamide_and_G-CSF> <Has_modality> "Chemotherapy" .
<Erotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Ifosfamide_and_Vinorelbine> <Has_modality> "Chemotherapy" .
<Trimetop_Duplo> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Dara-VTD> <Maps_to> "Dara-VTD" .
<PEN> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Maxtrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Non-curative_second-line_therapy> <Mapped_from> "Non-curative_second-line_therapy" .
<Folinic_acid> <Antineoplastic_of> "mFOLFOX7" .
<Folinic_acid> <Antineoplastic_of> "mFOLFOX6_and_RT" .
<Folinic_acid> <Antineoplastic_of> "mFOLFOX6_and_Cetuximab" .
<Folinic_acid> <Antineoplastic_of> "mFOLFOX6_and_Bevacizumab" .
<Folinic_acid> <Antineoplastic_of> "mFOLFOX6" .
<Folinic_acid> <Antineoplastic_of> "mFOLFOX_and_Sorafenib" .
<Folinic_acid> <Antineoplastic_of> "mFOLFIRINOX,_Gemcitabine,_RT" .
<Folinic_acid> <Antineoplastic_of> "mFOLFIRINOX" .
<Folinic_acid> <Antineoplastic_of> "mDCF_and_Bevacizumab" .
<Folinic_acid> <Antineoplastic_of> "mDCF" .
<Folinic_acid> <Antineoplastic_of> "Tegafur,_Uracil,_Folinic_acid" .
<Folinic_acid> <Antineoplastic_of> "OXAFAFU" .
<Folinic_acid> <Antineoplastic_of> "OLF" .
<Folinic_acid> <Antineoplastic_of> "Nordic_FLOX" .
<Folinic_acid> <Antineoplastic_of> "Intraperitoneal_5-FU" .
<Folinic_acid> <Antineoplastic_of> "IFL_and_Bevacizumab" .
<Folinic_acid> <Antineoplastic_of> "IFL" .
<Folinic_acid> <Antineoplastic_of> "HAIC_and_Sorafenib" .
<Folinic_acid> <Antineoplastic_of> "Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan" .
<Folinic_acid> <Antineoplastic_of> "Fluorouracil,_Folinic_acid,_RT" .
<Folinic_acid> <Antineoplastic_of> "Fluorouracil,_Folinic_acid,_Mitomycin" .
<Folinic_acid> <Antineoplastic_of> "Fluorouracil,_Folinic_acid,_Levamisole" .
<Folinic_acid> <Antineoplastic_of> "Fluorouracil,_Folinic_acid,_Gemcitabine" .
<Folinic_acid> <Antineoplastic_of> "Fluorouracil_and_Folinic_acid" .
<Folinic_acid> <Antineoplastic_of> "FULV/FULV_and_RT" .
<Folinic_acid> <Antineoplastic_of> "FULV_and_Bevacizumab" .
<Folinic_acid> <Antineoplastic_of> "FUIRI" .
<Folinic_acid> <Antineoplastic_of> "FOLFOX4_and_RT" .
<Folinic_acid> <Antineoplastic_of> "FOLFOX4_and_Panitumumab" .
<Folinic_acid> <Antineoplastic_of> "FOLFOX4_and_Cetuximab" .
<Folinic_acid> <Antineoplastic_of> "FOLFOX4_and_Bevacizumab" .
<Folinic_acid> <Antineoplastic_of> "FOLFOX4" .
<Folinic_acid> <Antineoplastic_of> "FOLFOX2" .
<Folinic_acid> <Antineoplastic_of> "FOLFOX_chronotherapy" .
<Folinic_acid> <Antineoplastic_of> "FOLFOX_7/sLV5FU2" .
<Folinic_acid> <Antineoplastic_of> "FOLFOX" .
<Folinic_acid> <Antineoplastic_of> "FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation" .
<Folinic_acid> <Antineoplastic_of> "FOLFIRINOX" .
<Folinic_acid> <Antineoplastic_of> "FOLFIRI_and_Ziv-aflibercept" .
<Folinic_acid> <Antineoplastic_of> "FOLFIRI_and_Ramucirumab" .
<Folinic_acid> <Antineoplastic_of> "FOLFIRI_and_Panitumumab" .
<Folinic_acid> <Antineoplastic_of> "FOLFIRI_and_Cetuximab" .
<Folinic_acid> <Antineoplastic_of> "FOLFIRI_and_Bevacizumab" .
<Folinic_acid> <Antineoplastic_of> "FOLFIRI" .
<Folinic_acid> <Antineoplastic_of> "FLOX" .
<Folinic_acid> <Antineoplastic_of> "FLOT" .
<Folinic_acid> <Antineoplastic_of> "FLEP" .
<Folinic_acid> <Antineoplastic_of> "FLEC" .
<Folinic_acid> <Antineoplastic_of> "FELV" .
<Folinic_acid> <Antineoplastic_of> "CMFL" .
<Folinic_acid> <Antineoplastic_of> "CLF" .
<Onsat> <Brand_name_of> "Ondansetron" .
<Menisolon> <Brand_name_of> "Methylprednisolone" .
<Temzol> <Brand_name_of> "Temozolomide" .
<Elitek> <Brand_name_of> "Rasburicase" .
<F-SHAI> <Is_a> "Anthracycline-containing_regimen" .
<Best_supportive_care> <Is_current_in> "Small_cell_lung_cancer" .
<Best_supportive_care> <Is_current_in> "Pancreatic_cancer" .
<Best_supportive_care> <Is_current_in> "Non-small_cell_lung_cancer" .
<Best_supportive_care> <Is_current_in> "Myelodysplastic_syndrome" .
<Best_supportive_care> <Is_current_in> "Mesothelioma" .
<Best_supportive_care> <Is_current_in> "Hepatocellular_carcinoma" .
<Best_supportive_care> <Is_current_in> "Head_and_neck_cancer" .
<Best_supportive_care> <Is_current_in> "Glioblastoma" .
<Best_supportive_care> <Is_current_in> "Gastrointestinal_stromal_tumor" .
<Best_supportive_care> <Is_current_in> "Gastric_cancer" .
<Best_supportive_care> <Is_current_in> "Gallbladder_cancer" .
<Best_supportive_care> <Is_current_in> "Esophageal_cancer" .
<Best_supportive_care> <Is_current_in> "Colon_cancer" .
<Best_supportive_care> <Is_current_in> "Cholangiocarcinoma" .
<Best_supportive_care> <Is_current_in> "Bladder_cancer" .
<Best_supportive_care> <Is_current_in> "Acute_myeloid_leukemia" .
<Rivaroxaban_monotherapy> <Has_modality> "Anticoagulation" .
<Panobinostat> <Has_brand_name> "Farydak" .
<Panobinostat> <Has_brand_name> "Faridak" .
<Cisplatin_and_Vinblastine> <Maps_to> "Cisplatin_and_Vinblastine" .
<Aspirina> <Brand_name_of> "Aspirin" .
<Cisplatin,_Doxorubicin_liposomal,_Fluorouracil> <Is_current_in> "Esophageal_cancer" .
<Letrozole> <Antineoplastic_of> "Letrozole_monotherapy" .
<Letrozole> <Antineoplastic_of> "Letrozole_and_Ribociclib" .
<Letrozole> <Antineoplastic_of> "Letrozole_and_Palbociclib" .
<Letrozole> <Antineoplastic_of> "Letrozole_and_Bevacizumab" .
<Letrozole> <Antineoplastic_of> "Lapatinib,_Letrozole,_Trastuzumab" .
<Letrozole> <Antineoplastic_of> "Lapatinib_and_Letrozole" .
<Letrozole> <Antineoplastic_of> "Abemaciclib_and_Letrozole" .
<Fludarabine_and_Prednisone> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Upsalgina> <Brand_name_of> "Aspirin" .
<Rituximab_monotherapy> <Is_a> "Rituximab-containing_regimen" .
<Nordic_Regimen,_older_patients> <Has_modality> "Chemotherapy" .
<Cisplatin_and_Gemcitabine/Erlotinib> <Is_current_in> "Non-small_cell_lung_cancer" .
<Cytarabine,_Idarubicin,_Imatinib> <Has_local_therapy> "Methotrexate" .
<Gran> <Brand_name_of> "Filgrastim" .
<IP-BCD> <Has_antineoplastic> "Mesna" .
<IP-BCD> <Has_antineoplastic> "Ifosfamide" .
<IP-BCD> <Has_antineoplastic> "Dactinomycin" .
<IP-BCD> <Has_antineoplastic> "Cyclophosphamide" .
<IP-BCD> <Has_antineoplastic> "Cisplatin" .
<IP-BCD> <Has_antineoplastic> "Bleomycin" .
<BCNU/TT> <Has_context> "All_lines_of_therapy" .
<Nordic_FLOX> <Is_current_in> "Colon_cancer" .
<Volasertib> <May_have_route> "Intravenous" .
<Sulfotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin_and_Methotrexate> <Is_a> "Platinum_doublet" .
<Carboplatin,_nab-Paclitaxel,_Atezolizumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<Dexatab> <Brand_name_of> "Dexamethasone" .
<Trimetrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Nordic_Regimen,_older_patients> <Mapped_from> "Nordic_Regimen,_older_patients" .
<LEED,_then_auto_HSCT> <Mapped_from> "LEED,_then_auto_HSCT" .
<Medroxyprogesterone_and_Tamoxifen> <Mapped_from> "Medroxyprogesterone_and_Tamoxifen" .
<DICEP> <Has_antineoplastic> "Etoposide" .
<DICEP> <Has_antineoplastic> "Cyclophosphamide" .
<DICEP> <Has_antineoplastic> "Cisplatin" .
<VMP,_then_Rd> <Maps_to> "VMP,_then_Rd" .
<Alemtuzumab_monotherapy> <Mapped_from> "Alemtuzumab_monotherapy" .
<Ofatumumab> <Has_brand_name> "Arzerra" .
<Pravastatin> <May_have_route> "Oral" .
<CVD_(Vinblastine)> <Has_supportive_med> "Emesis_prevention" .
<CVD_(Vinblastine)> <Has_supportive_med> "Dexamethasone" .
<ECF> <Is_a> "Anthracycline-containing_regimen" .
<Heptaplatin> <Is_a> "Platinum_agent" .
<Heptaplatin> <Is_a> "KFDA_approved_drug" .
<Heptaplatin> <Is_a> "Alkylating_agent" .
<Kaposi_sarcoma> <Current_treated_by> "Pomalidomide_monotherapy" .
<Kaposi_sarcoma> <Current_treated_by> "Placebo" .
<Kaposi_sarcoma> <Current_treated_by> "Paclitaxel_monotherapy" .
<Kaposi_sarcoma> <Current_treated_by> "Interferon_alfa-2b_monotherapy" .
<Kaposi_sarcoma> <Current_treated_by> "Interferon_alfa-2a_monotherapy" .
<Kaposi_sarcoma> <Current_treated_by> "Etoposide_monotherapy" .
<Kaposi_sarcoma> <Current_treated_by> "Doxorubicin_pegylated_liposomal_monotherapy" .
<Kaposi_sarcoma> <Current_treated_by> "Daunorubicin_liposomal_monotherapy" .
<Kaposi_sarcoma> <Current_treated_by> "Bevacizumab_monotherapy" .
<Kaposi_sarcoma> <Current_treated_by> "ABV_(Vincristine)" .
<Kaposi_sarcoma> <Current_treated_by> "ABV_(Vinblastine)" .
<BEAM,_then_auto_HSCT> <Has_antineoplastic> "Melphalan" .
<BEAM,_then_auto_HSCT> <Has_antineoplastic> "Etoposide" .
<BEAM,_then_auto_HSCT> <Has_antineoplastic> "Cytarabine" .
<BEAM,_then_auto_HSCT> <Has_antineoplastic> "Carmustine" .
<FLAG> <Has_context> "Salvage_therapy" .
<FLAG> <Has_context> "Non-curative_therapy" .
<Anti-TACSTD2_antibody> <Is_a> "Antibody_medication" .
<Vosaroxin> <Is_a> "Topoisomerase_inhibitor" .
<Vosaroxin> <Is_a> "Investigational_drug" .
<Deexa> <Brand_name_of> "Dexamethasone" .
<EOX> <Is_current_in> "Gastric_cancer" .
<EOX> <Is_current_in> "Esophageal_cancer" .
<Fostamatinib_monotherapy> <Has_context> "Non-curative_therapy" .
<FOLFIRI_and_Cetuximab_(L-Leucovorin)> <Has_accepted_use> "KRAS_wild-type_Colon_cancer" .
<FOLFIRI_and_Cetuximab_(L-Leucovorin)> <Has_accepted_use> "Colon_cancer" .
<BHD> <Has_context> "Non-curative_therapy" .
<Eltrombopag_monotherapy> <Has_supportive_med> "Eltrombopag" .
<Creptrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<DexaBEAM_and_G-CSF> <Has_antineoplastic> "Melphalan" .
<DexaBEAM_and_G-CSF> <Has_antineoplastic> "Etoposide" .
<DexaBEAM_and_G-CSF> <Has_antineoplastic> "Dexamethasone" .
<DexaBEAM_and_G-CSF> <Has_antineoplastic> "Cytarabine" .
<DexaBEAM_and_G-CSF> <Has_antineoplastic> "Carmustine" .
<Panobinostat_monotherapy> <Mapped_from> "Panobinostat_monotherapy" .
<Vepsid> <Brand_name_of> "Etoposide" .
<BR_and_Idelalisib> <Has_antineoplastic> "Rituximab" .
<BR_and_Idelalisib> <Has_antineoplastic> "Idelalisib" .
<BR_and_Idelalisib> <Has_antineoplastic> "Bendamustine" .
<Vindesine> <Has_accepted_use> "Small_cell_lung_cancer" .
<Vindesine> <Has_accepted_use> "Post-transplant_lymphoproliferative_disorder" .
<Vindesine> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Vindesine> <Has_accepted_use> "Melanoma" .
<Vindesine> <Has_accepted_use> "HIV-associated_lymphoma" .
<Vindesine> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Vindesine> <Has_accepted_use> "CNS_lymphoma" .
<Vindesine> <Has_accepted_use> "Burkitt_lymphoma" .
<Vindesine> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<Cladribine_and_Cytarabine> <Maps_to> "Cladribine_and_Cytarabine" .
<Trimexazol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Non-curative_first-line_maintenance_therapy> <Maps_to> "Non-curative_first-line_maintenance_therapy" .
<Z-BEAM,_then_auto_HSCT> <Has_modality> "Chemoradioimmunotherapy" .
<BHD> <Has_modality> "Chemotherapy" .
<VNCOP-B> <Maps_to> "VNCOP-B" .
<R-miniCHOP> <Has_antineoplastic> "Vincristine" .
<R-miniCHOP> <Has_antineoplastic> "Rituximab" .
<R-miniCHOP> <Has_antineoplastic> "Prednisone" .
<R-miniCHOP> <Has_antineoplastic> "Doxorubicin" .
<R-miniCHOP> <Has_antineoplastic> "Cyclophosphamide" .
<B-cell_acute_lymphoblastic_leukemia> <Subsumes> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<BeGEV> <Has_supportive_med> "Pegfilgrastim" .
<BeGEV> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<MVAC> <Has_accepted_use> "Bladder_cancer" .
<BRAF-mutated_malignancy> <Accepted_use_of> "Vemurafenib_monotherapy" .
<BRAF-mutated_malignancy> <Accepted_use_of> "Vemurafenib" .
<BRAF-mutated_malignancy> <Accepted_use_of> "Trametinib" .
<BRAF-mutated_malignancy> <Accepted_use_of> "Dabrafenib_and_Trametinib" .
<BRAF-mutated_malignancy> <Accepted_use_of> "Dabrafenib" .
<Micristin> <Brand_name_of> "Aspirin" .
<Cotrazen> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<VACA/IE> <Mapped_from> "VACA/IE" .
<Aminopterin> <May_have_route> "Intramuscular" .
<EIA> <Mapped_from> "EIA" .
<Tamoxifen_monotherapy> <Maps_to> "Tamoxifen_monotherapy" .
<Methotrexate_and_Vincristine> <Has_accepted_use> "Osteosarcoma" .
<Methotrexate_and_Vincristine> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Dara-VTD> <Has_accepted_use> "Multiple_myeloma" .
<Dasatinib_and_Prednisone> <Has_context> "Induction_therapy" .
<Vosaroxin_and_Cytarabine> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Cyclosporine,_Mycophenolate_mofetil,_Sirolimus> <Has_immunosuppressor> "Sirolimus" .
<Cyclosporine,_Mycophenolate_mofetil,_Sirolimus> <Has_immunosuppressor> "Mycophenolate_mofetil" .
<Cyclosporine,_Mycophenolate_mofetil,_Sirolimus> <Has_immunosuppressor> "Cyclosporine_modified" .
<Cyclophosphamide_and_Vincristine> <Mapped_from> "Cyclophosphamide_and_Vincristine" .
<L-glutamine> <Has_accepted_use> "Sickle_cell_anemia" .
<Cytarabine,_Methotrexate,_Rituximab> <Maps_to> "Cytarabine,_Methotrexate,_Rituximab" .
<Mephamesone> <Brand_name_of> "Dexamethasone" .
<Pridol> <Brand_name_of> "Methylprednisolone" .
<CDB> <Is_historical_in> "Melanoma" .
<CAV/PE> <Is_historical_in> "Small_cell_lung_cancer" .
<Cyclosporine,_Mycophenolate_mofetil,_Sirolimus> <Has_modality> "Immunosuppressive_therapy" .
<Sultiprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Larotrectinib_monotherapy> <Has_accepted_use> "NTRK-mutated_malignancy" .
<Fam-trastuzumab_deruxtecan_monotherapy> <Is_current_in> "Breast_cancer" .
<CBV-Mx> <Has_modality> "Chemotherapy" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone> <Has_context> "Induction_therapy" .
<Vinflunine> <Has_brand_name> "Javlor" .
<Enterosarine> <Brand_name_of> "Aspirin" .
<Axitinib_and_Pembrolizumab> <Is_current_in> "Renal_cell_carcinoma" .
<Flutamide,_Goserelin,_RT> <Has_accepted_use> "Prostate_cancer" .
<SOX> <Has_context> "Non-curative_first-line_therapy" .
<SOX> <Has_context> "Adjuvant_therapy" .
<ATG-Fresenius> <Brand_name_of> "Antithymocyte_globulin_rabbit_ATG" .
<Aspirin> <Has_accepted_use> "Venous_thromboembolism" .
<FCA> <Has_modality> "Chemotherapy" .
<HAM_and_Imatinib> <Has_context> "Consolidation_after_upfront_therapy" .
<VIDE> <Has_accepted_use> "Ewing_sarcoma" .
<Enasidenib> <Has_FDA_indication> "Acute_myeloid_leukemia" .
<Endometrial_cancer> <Is_a> "Gynecologic_cancer" .
<Groven> <Brand_name_of> "Cytarabine" .
<ADE_and_ATRA> <Is_a> "Anthracycline-containing_regimen" .
<Ribociclib_and_Tamoxifen> <Has_supportive_med> "Goserelin" .
<R-TBI/Cy> <Has_antineoplastic> "Rituximab" .
<R-TBI/Cy> <Has_antineoplastic> "External_beam_radiotherapy" .
<R-TBI/Cy> <Has_antineoplastic> "Cyclophosphamide" .
<Carboplatin_and_Doxorubicin_liposomal> <Is_a> "Platinum_doublet" .
<Carboplatin_and_Doxorubicin_liposomal> <Is_a> "Anthracycline-containing_regimen" .
<Calc_Leucovorn> <Brand_name_of> "Folinic_acid" .
<Mitotane_and_Streptozocin> <Has_accepted_use> "Adrenocortical_carcinoma" .
<ddAC-T> <Maps_to> "ddAC-T" .
<Metilprednizolon-H> <Brand_name_of> "Methylprednisolone" .
<Alpelisib> <Has_FDA_indication> "Breast_cancer" .
<ProMACE-CytaBOM> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<CSF1R_inhibitor> <Subsumes> "Nilotinib" .
<CHOP-B> <Has_antineoplastic> "Vincristine" .
<CHOP-B> <Has_antineoplastic> "Prednisone" .
<CHOP-B> <Has_antineoplastic> "Doxorubicin" .
<CHOP-B> <Has_antineoplastic> "Cyclophosphamide" .
<CHOP-B> <Has_antineoplastic> "Bleomycin" .
<Polycythemia_vera> <Current_treated_by> "Thalidomide_monotherapy" .
<Polycythemia_vera> <Current_treated_by> "Ruxolitinib_monotherapy" .
<Polycythemia_vera> <Current_treated_by> "Placebo" .
<Polycythemia_vera> <Current_treated_by> "Pipobroman_monotherapy" .
<Polycythemia_vera> <Current_treated_by> "Peginterferon_alfa-2a_monotherapy" .
<Polycythemia_vera> <Current_treated_by> "Lenalidomide_monotherapy" .
<Polycythemia_vera> <Current_treated_by> "Hydroxyurea_monotherapy" .
<Polycythemia_vera> <Current_treated_by> "Aspirin_monotherapy" .
<Polycythemia_vera> <Current_treated_by> "Anagrelide_monotherapy" .
<Septoprin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cabozantinib_monotherapy> <Mapped_from> "Cabozantinib_monotherapy" .
<PAD/VCD> <Has_modality> "Chemotherapy" .
<Nausedron> <Brand_name_of> "Ondansetron" .
<Uniaspirin> <Brand_name_of> "Aspirin" .
<Carboplatin,_Fluorouracil,_Cetuximab,_RT> <Has_antineoplastic> "Fluorouracil" .
<Carboplatin,_Fluorouracil,_Cetuximab,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Carboplatin,_Fluorouracil,_Cetuximab,_RT> <Has_antineoplastic> "Cetuximab" .
<Carboplatin,_Fluorouracil,_Cetuximab,_RT> <Has_antineoplastic> "Carboplatin" .
<MIC> <Has_antineoplastic> "Mitomycin" .
<MIC> <Has_antineoplastic> "Ifosfamide" .
<MIC> <Has_antineoplastic> "Cisplatin" .
<Oxaliplatin_and_RT> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<CapeOx,_Cetuximab,_RT> <Maps_to> "CapeOx,_Cetuximab,_RT" .
<Interferon_alfa-2a_monotherapy> <Mapped_from> "Interferon_alfa-2a_monotherapy" .
<Doxorubicin_and_Olaratumab> <Has_antineoplastic> "Olaratumab" .
<Doxorubicin_and_Olaratumab> <Has_antineoplastic> "Doxorubicin" .
<Vinorelbine_monotherapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<Vinorelbine_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Vinorelbine_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Vinorelbine_monotherapy> <Has_accepted_use> "Mesothelioma" .
<Vinorelbine_monotherapy> <Has_accepted_use> "Hodgkin_lymphoma" .
<Vinorelbine_monotherapy> <Has_accepted_use> "HER2-positive_-_historical_Breast_cancer" .
<Vinorelbine_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Vinorelbine_monotherapy> <Has_accepted_use> "Cervical_cancer" .
<Vinorelbine_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Vinorelbine_monotherapy> <Has_accepted_use> "BRCA-mutated_Breast_cancer" .
<CVP> <Has_antineoplastic> "Vincristine" .
<CVP> <Has_antineoplastic> "Prednisone" .
<CVP> <Has_antineoplastic> "Cyclophosphamide" .
<Vincristine_liposomal> <Has_brand_name> "Marqibo" .
<Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin> <Has_context> "Induction_therapy" .
<Bendamustine> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Bendamustine> <Is_a> "Vesicant" .
<Bendamustine> <Is_a> "PMDA_approved_drug" .
<Bendamustine> <Is_a> "Nitrogen_mustard" .
<Bendamustine> <Is_a> "Alkylating_agent" .
<Deksa> <Brand_name_of> "Dexamethasone" .
<CHOEP-14> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<IGEV_and_G-CSF> <Is_current_in> "Stem_cell_mobilization" .
<Factor_VIII_recombinant> <Has_accepted_use> "Inherited_coagulopathy" .
<EOF> <Mapped_from> "EOF" .
<BACO> <Is_historical_in> "Small_cell_lung_cancer" .
<Cyclophosphamide_and_TBI,_then_allo_HSCT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Cyclophosphamide_and_TBI,_then_allo_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<Cyclophosphamide_and_TBI,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<PCP_prophylaxis> <Supportive_med_of> "VDC" .
<PCP_prophylaxis> <Supportive_med_of> "RVDC" .
<PCP_prophylaxis> <Supportive_med_of> "R-FCM" .
<PCP_prophylaxis> <Supportive_med_of> "R-CHOP" .
<PCP_prophylaxis> <Supportive_med_of> "R-CDOP" .
<PCP_prophylaxis> <Supportive_med_of> "R,_then_CHOP" .
<PCP_prophylaxis> <Supportive_med_of> "O-FC" .
<PCP_prophylaxis> <Supportive_med_of> "G-FC" .
<PCP_prophylaxis> <Supportive_med_of> "FCR" .
<PCP_prophylaxis> <Supportive_med_of> "Bortezomib_monotherapy" .
<PCP_prophylaxis> <Supportive_med_of> "Bendamustine_and_Obinutuzumab" .
<Ophthasona> <Brand_name_of> "Dexamethasone" .
<Doxifluridine_and_Mitomycin> <Maps_to> "Doxifluridine_and_Mitomycin" .
<Domperidone> <May_have_route> "Rectal" .
<Domperidone> <May_have_route> "Oral" .
<Domperidone> <May_have_route> "Intravenous" .
<Domperidone> <May_have_route> "Intramuscular" .
<Edrecolomab> <Is_a> "EMA_approved_drug" .
<Edrecolomab> <Is_a> "Discontinued_drug" .
<Edrecolomab> <Is_a> "Antibody_medication" .
<Edrecolomab> <Is_a> "Anti-EpCAM_antibody" .
<Irinotecan_and_S-1> <Has_modality> "Chemotherapy" .
<BEAC> <Maps_to> "BEAC" .
<Ixazomib_monotherapy> <Mapped_from> "Ixazomib_monotherapy" .
<7_plus_3d_and_Glasdegib> <Maps_to> "7_plus_3d_and_Glasdegib" .
<Danaparoid_monotherapy> <Is_current_in> "Heparin-induced_thrombocytopenia" .
<Crizotinib> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Trimoxis> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Nivolumab,_then_Ipilimumab> <Has_antineoplastic> "Nivolumab" .
<Nivolumab,_then_Ipilimumab> <Has_antineoplastic> "Ipilimumab" .
<PACEBOM> <Has_modality> "Chemotherapy" .
<Bortezomib_and_Cyclophosphamide> <Has_context> "Non-curative_second-line_maintenance_therapy" .
<Zanubrutinib_monotherapy> <Has_modality> "Chemotherapy" .
<mFOLFOX_and_Sorafenib> <Maps_to> "mFOLFOX_and_Sorafenib" .
<BDR> <Has_supportive_med> "Valacyclovir" .
<BDR> <Has_supportive_med> "Diphenhydramine" .
<BDR> <Has_supportive_med> "Acyclovir" .
<BDR> <Has_supportive_med> "Acetaminophen" .
<EP> <Has_antineoplastic> "Paclitaxel" .
<EP> <Has_antineoplastic> "Epirubicin" .
<Clofarabine_monotherapy> <Maps_to> "Clofarabine_monotherapy" .
<Z-BEAM,_then_auto_HSCT> <Has_context> "Consolidation_after_upfront_therapy" .
<Z-BEAM,_then_auto_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<VBMCP/VBAD> <Has_antineoplastic> "Vincristine" .
<VBMCP/VBAD> <Has_antineoplastic> "Prednisone" .
<VBMCP/VBAD> <Has_antineoplastic> "Melphalan" .
<VBMCP/VBAD> <Has_antineoplastic> "Doxorubicin" .
<VBMCP/VBAD> <Has_antineoplastic> "Dexamethasone" .
<VBMCP/VBAD> <Has_antineoplastic> "Cyclophosphamide" .
<VBMCP/VBAD> <Has_antineoplastic> "Carmustine" .
<Predsone> <Brand_name_of> "Prednisone" .
<VAI> <Has_accepted_use> "Rhabdomyosarcoma" .
<VAI> <Has_accepted_use> "Ewing_sarcoma" .
<KMP> <Has_modality> "Chemotherapy" .
<Eusaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Hydroxyurea_and_Interferon_alfa-2a> <Is_current_in> "Chronic_myelogenous_leukemia" .
<Irinotecan_monotherapy> <Has_context> "Salvage_therapy" .
<Irinotecan_monotherapy> <Has_context> "Non-curative_therapy" .
<Irinotecan_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Irinotecan_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Irinotecan_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Daunorubicin_monotherapy> <Mapped_from> "Daunorubicin_monotherapy" .
<Farmorubicine> <Brand_name_of> "Epirubicin" .
<VMPT> <Has_accepted_use> "Multiple_myeloma" .
<Ropeginterferon_alfa-2b> <May_have_route> "Subcutaneous" .
<Ibritumomab_tiuxetan> <Antineoplastic_of> "Z-BEAM,_then_auto_HSCT" .
<Ibritumomab_tiuxetan> <Antineoplastic_of> "Z-BEAM" .
<Ibritumomab_tiuxetan> <Antineoplastic_of> "Ibritumomab_tiuxetan_monotherapy" .
<Ibritumomab_tiuxetan> <Antineoplastic_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT" .
<Ibritumomab_tiuxetan> <Antineoplastic_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan" .
<Ibritumomab_tiuxetan> <Antineoplastic_of> "(90)YFC,_then_allo_HSCT" .
<Ibritumomab_tiuxetan> <Antineoplastic_of> "(90)YFC" .
<FEMTX> <Has_context> "Non-curative_first-line_therapy" .
<Cortisone_monotherapy> <Has_modality> "Hormonotherapy" .
<CRd> <Mapped_from> "CRd" .
<Gemcitabine_and_RT> <Has_accepted_use> "Pancreatic_cancer" .
<Gemcitabine_and_RT> <Has_accepted_use> "Bladder_cancer" .
<TAC_(Taxotere)> <Has_antineoplastic> "Doxorubicin" .
<TAC_(Taxotere)> <Has_antineoplastic> "Docetaxel" .
<TAC_(Taxotere)> <Has_antineoplastic> "Cyclophosphamide" .
<FAM> <Has_accepted_use> "Gastric_cancer" .
<Aggrastat> <Brand_name_of> "Tirofiban" .
<Geftiwel> <Brand_name_of> "Gefitinib" .
<Aplastic_anemia> <Is_a> "Cytopenia" .
<Aplastic_anemia> <Is_a> "Bone_marrow_failure_syndrome" .
<BEACOPP-14_(Prednisolone)> <Has_supportive_med> "Pegfilgrastim" .
<BEACOPP-14_(Prednisolone)> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<EDC> <Has_context> "Neoadjuvant_therapy" .
<Millipred> <Brand_name_of> "Prednisolone" .
<Methylprednisolone_monotherapy> <Has_modality> "Immunosuppressive_therapy" .
<Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b> <Has_modality> "Immunotherapy" .
<Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b> <Has_modality> "Chemotherapy" .
<R-DexaBEAM> <Is_current_in> "Follicular_lymphoma" .
<R-DexaBEAM> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<MINE> <Has_antineoplastic> "Mitoxantrone" .
<MINE> <Has_antineoplastic> "Mesna" .
<MINE> <Has_antineoplastic> "Ifosfamide" .
<MINE> <Has_antineoplastic> "Etoposide" .
<Interferon> <Is_a> "Cytokine" .
<Trastuzumab-dkst> <Has_accepted_use> "Gastric_cancer" .
<Trastuzumab-dkst> <Has_accepted_use> "Esophageal_cancer" .
<Trastuzumab-dkst> <Has_accepted_use> "Breast_cancer" .
<BBD> <Has_modality> "Chemotherapy" .
<HDAC_inhibitor> <Is_a> "Enzyme_inhibitor" .
<STAMP-I> <Mapped_from> "STAMP-I" .
<Iclusig> <Brand_name_of> "Ponatinib" .
<Bendamustine_and_Ofatumumab> <Has_accepted_use> "Follicular_lymphoma" .
<Bendamustine_and_Ofatumumab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Cisplatin,_Fluorouracil,_Pembrolizumab> <Maps_to> "Cisplatin,_Fluorouracil,_Pembrolizumab" .
<Crizotinib_monotherapy> <Mapped_from> "Crizotinib_monotherapy" .
<Epirubicin_monotherapy> <Has_antineoplastic> "Epirubicin" .
<Prednisone> <Immunosuppressor_of> "Sirolimus,_Tacrolimus,_Prednisone" .
<Prednisone> <Immunosuppressor_of> "Sirolimus_and_Prednisone" .
<Prednisone> <Immunosuppressor_of> "Prednisone_monotherapy" .
<Prednisone> <Immunosuppressor_of> "Prednisone_and_Rituximab" .
<Prednisone> <Immunosuppressor_of> "Methotrexate_and_Prednisone" .
<Prednisone> <Immunosuppressor_of> "Dexamethasone_monotherapy" .
<Prednisone> <Immunosuppressor_of> "Cyclosporine,_Sirolimus,_Prednisone" .
<Prednisone> <Immunosuppressor_of> "Cyclosporine,_Methotrexate,_Prednisone" .
<Prednisone> <Immunosuppressor_of> "Cyclosporine,_Corticosteroids,_Rituximab" .
<Prednisone> <Immunosuppressor_of> "Cyclosporine_and_Prednisone" .
<Prednisone> <Immunosuppressor_of> "Cyclophosphamide_and_Prednisone" .
<Etoposide> <Antineoplastic_of> "mLSG15" .
<Etoposide> <Antineoplastic_of> "eBEACOPP_(Prednisolone)" .
<Etoposide> <Antineoplastic_of> "eBEACOPP" .
<Etoposide> <Antineoplastic_of> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Etoposide> <Antineoplastic_of> "Z-BEAM,_then_auto_HSCT" .
<Etoposide> <Antineoplastic_of> "Z-BEAM" .
<Etoposide> <Antineoplastic_of> "VTD-PACE" .
<Etoposide> <Antineoplastic_of> "VNCOP-B" .
<Etoposide> <Antineoplastic_of> "VMV-VAC" .
<Etoposide> <Antineoplastic_of> "VIPD" .
<Etoposide> <Antineoplastic_of> "VIP" .
<Etoposide> <Antineoplastic_of> "VIM" .
<Etoposide> <Antineoplastic_of> "VIE" .
<Etoposide> <Antineoplastic_of> "VIDE" .
<Etoposide> <Antineoplastic_of> "VI,_then_VDC/IE,_then_VAC,_then_VI" .
<Etoposide> <Antineoplastic_of> "VEPEMB" .
<Etoposide> <Antineoplastic_of> "VEBEP" .
<Etoposide> <Antineoplastic_of> "VDC/IE" .
<Etoposide> <Antineoplastic_of> "VAdCA/IE" .
<Etoposide> <Antineoplastic_of> "VACOP-B" .
<Etoposide> <Antineoplastic_of> "VACA/IE" .
<Etoposide> <Antineoplastic_of> "VABE" .
<Etoposide> <Antineoplastic_of> "Total_Therapy" .
<Etoposide> <Antineoplastic_of> "TC,_then_IE,_VDoxoC,_VEC" .
<Etoposide> <Antineoplastic_of> "Stanford_V" .
<Etoposide> <Antineoplastic_of> "SMILE" .
<Etoposide> <Antineoplastic_of> "SC-EPOCH-RR" .
<Etoposide> <Antineoplastic_of> "RT-PEPC" .
<Etoposide> <Antineoplastic_of> "RICER" .
<Etoposide> <Antineoplastic_of> "R-MACLO/R-IVAM" .
<Etoposide> <Antineoplastic_of> "R-IFE" .
<Etoposide> <Antineoplastic_of> "R-ICE" .
<Etoposide> <Antineoplastic_of> "R-ESHAP" .
<Etoposide> <Antineoplastic_of> "R-EPOCH,_dose-escalated" .
<Etoposide> <Antineoplastic_of> "R-EPOCH" .
<Etoposide> <Antineoplastic_of> "R-DexaBEAM" .
<Etoposide> <Antineoplastic_of> "R-DHAP/R-VIM" .
<Etoposide> <Antineoplastic_of> "R-CVEP" .
<Etoposide> <Antineoplastic_of> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Etoposide> <Antineoplastic_of> "R-CODOX-M/R-IVAC" .
<Etoposide> <Antineoplastic_of> "R-CHVP_plus_I" .
<Etoposide> <Antineoplastic_of> "R-CHOEP-14" .
<Etoposide> <Antineoplastic_of> "R-CEOP_(Etoposide)" .
<Etoposide> <Antineoplastic_of> "R-BEAM,_then_auto_HSCT" .
<Etoposide> <Antineoplastic_of> "R-BEAM" .
<Etoposide> <Antineoplastic_of> "ProMACE-MOPP" .
<Etoposide> <Antineoplastic_of> "ProMACE-CytaBOM" .
<Etoposide> <Antineoplastic_of> "Pediatric-like_GRAALL_consolidation" .
<Etoposide> <Antineoplastic_of> "PVeBV" .
<Etoposide> <Antineoplastic_of> "PMitCEBO" .
<Etoposide> <Antineoplastic_of> "PEV" .
<Etoposide> <Antineoplastic_of> "PEP-C" .
<Etoposide> <Antineoplastic_of> "PEN" .
<Etoposide> <Antineoplastic_of> "PCE" .
<Etoposide> <Antineoplastic_of> "PCDE" .
<Etoposide> <Antineoplastic_of> "PACEBOM" .
<Etoposide> <Antineoplastic_of> "P/DOCE" .
<Etoposide> <Antineoplastic_of> "OEPA" .
<Etoposide> <Antineoplastic_of> "O-ICE" .
<Etoposide> <Antineoplastic_of> "O-ESHAP" .
<Etoposide> <Antineoplastic_of> "Nilotinib-based_consolidation" .
<Etoposide> <Antineoplastic_of> "Mitotane_and_EDP" .
<Etoposide> <Antineoplastic_of> "Mini-BEAM" .
<Etoposide> <Antineoplastic_of> "MVBP" .
<Etoposide> <Antineoplastic_of> "MINE" .
<Etoposide> <Antineoplastic_of> "MESA/RT" .
<Etoposide> <Antineoplastic_of> "MEC" .
<Etoposide> <Antineoplastic_of> "MAPIE" .
<Etoposide> <Antineoplastic_of> "M-EI" .
<Etoposide> <Antineoplastic_of> "LSG15" .
<Etoposide> <Antineoplastic_of> "LOPP/EVAP" .
<Etoposide> <Antineoplastic_of> "LEED,_then_auto_HSCT" .
<Etoposide> <Antineoplastic_of> "LEED" .
<Etoposide> <Antineoplastic_of> "International_ALL_Trial" .
<Etoposide> <Antineoplastic_of> "IE" .
<Etoposide> <Antineoplastic_of> "ICE" .
<Etoposide> <Antineoplastic_of> "GMALL-R" .
<Etoposide> <Antineoplastic_of> "FLEP" .
<Etoposide> <Antineoplastic_of> "FELV" .
<Etoposide> <Antineoplastic_of> "FEAM,_then_auto_HSCT" .
<Etoposide> <Antineoplastic_of> "FEAM" .
<Etoposide> <Antineoplastic_of> "Etoposide,_Vinblastine,_Prednisone" .
<Etoposide> <Antineoplastic_of> "Etoposide,_Ifosfamide,_Methotrexate" .
<Etoposide> <Antineoplastic_of> "Etoposide,_Ifosfamide,_Imatinib" .
<Etoposide> <Antineoplastic_of> "Etoposide_monotherapy" .
<Etoposide> <Antineoplastic_of> "Etoposide_and_TBI,_then_allo_HSCT" .
<Etoposide> <Antineoplastic_of> "Etoposide_and_TBI" .
<Etoposide> <Antineoplastic_of> "Etoposide_and_Prednisone" .
<Etoposide> <Antineoplastic_of> "Etoposide_and_Mitoxantrone" .
<Etoposide> <Antineoplastic_of> "EVAIA" .
<Etoposide> <Antineoplastic_of> "ESHAP" .
<Etoposide> <Antineoplastic_of> "EPOCH,_dose-escalated" .
<Etoposide> <Antineoplastic_of> "EPOCH" .
<Etoposide> <Antineoplastic_of> "EPIC_regimen" .
<Etoposide> <Antineoplastic_of> "EMA-CO" .
<Etoposide> <Antineoplastic_of> "EIA" .
<Etoposide> <Antineoplastic_of> "EDAP" .
<Etoposide> <Antineoplastic_of> "EAR_and_G-CSF" .
<Etoposide> <Antineoplastic_of> "DexaBEAM_and_G-CSF" .
<Etoposide> <Antineoplastic_of> "DexaBEAM" .
<Etoposide> <Antineoplastic_of> "DTPACE" .
<Etoposide> <Antineoplastic_of> "DICEP" .
<Etoposide> <Antineoplastic_of> "DICE" .
<Etoposide> <Antineoplastic_of> "DEP_and_RT" .
<Etoposide> <Antineoplastic_of> "DEP" .
<Etoposide> <Antineoplastic_of> "DCTER" .
<Etoposide> <Antineoplastic_of> "DCEP_and_G-CSF" .
<Etoposide> <Antineoplastic_of> "DCEP" .
<Etoposide> <Antineoplastic_of> "DA-R-EPOCH" .
<Etoposide> <Antineoplastic_of> "DA-EPOCH" .
<Etoposide> <Antineoplastic_of> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA" .
<Etoposide> <Antineoplastic_of> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine" .
<Etoposide> <Antineoplastic_of> "Cyclophosphamide,_Etoposide,_TBI" .
<Etoposide> <Antineoplastic_of> "Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide" .
<Etoposide> <Antineoplastic_of> "Cyclophosphamide_and_Etoposide" .
<Etoposide> <Antineoplastic_of> "Cisplatin,_Etoposide,_RT" .
<Etoposide> <Antineoplastic_of> "Cisplatin,_Etoposide,_Irinotecan" .
<Etoposide> <Antineoplastic_of> "Cisplatin,_Etoposide,_Durvalumab" .
<Etoposide> <Antineoplastic_of> "Cisplatin,_Etoposide,_Bevacizumab" .
<Etoposide> <Antineoplastic_of> "Cisplatin_and_Etoposide" .
<Etoposide> <Antineoplastic_of> "ChlVPP/PABIOE" .
<Etoposide> <Antineoplastic_of> "ChlVPP/EVA" .
<Etoposide> <Antineoplastic_of> "Carboplatin,_Etoposide,_RT" .
<Etoposide> <Antineoplastic_of> "Carboplatin,_Etoposide,_Durvalumab" .
<Etoposide> <Antineoplastic_of> "Carboplatin,_Etoposide,_Bevacizumab" .
<Etoposide> <Antineoplastic_of> "Carboplatin,_Etoposide,_Atezolizumab" .
<Etoposide> <Antineoplastic_of> "Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine" .
<Etoposide> <Antineoplastic_of> "Carboplatin_and_Etoposide,_then_auto_HSCT" .
<Etoposide> <Antineoplastic_of> "Carboplatin_and_Etoposide" .
<Etoposide> <Antineoplastic_of> "CYVE_and_G-CSF" .
<Etoposide> <Antineoplastic_of> "CYVE" .
<Etoposide> <Antineoplastic_of> "COPAD/CYVE" .
<Etoposide> <Antineoplastic_of> "CODOX-M/IVAC" .
<Etoposide> <Antineoplastic_of> "CMED" .
<Etoposide> <Antineoplastic_of> "CHOEP-21" .
<Etoposide> <Antineoplastic_of> "CHOEP-14" .
<Etoposide> <Antineoplastic_of> "CEV_(Cyclophosphamide/Etoposide)" .
<Etoposide> <Antineoplastic_of> "CEV_(Carboplatin/Etoposide)" .
<Etoposide> <Antineoplastic_of> "CEPP(B)" .
<Etoposide> <Antineoplastic_of> "CEP" .
<Etoposide> <Antineoplastic_of> "CDE" .
<Etoposide> <Antineoplastic_of> "CCE" .
<Etoposide> <Antineoplastic_of> "CC/DE_and_RT" .
<Etoposide> <Antineoplastic_of> "CBVM,_then_auto_HSCT" .
<Etoposide> <Antineoplastic_of> "CBV-Mx,_then_auto_HSCT" .
<Etoposide> <Antineoplastic_of> "CBV-Mx" .
<Etoposide> <Antineoplastic_of> "CBV,_then_auto_HSCT" .
<Etoposide> <Antineoplastic_of> "CBV" .
<Etoposide> <Antineoplastic_of> "CAVE" .
<Etoposide> <Antineoplastic_of> "CAV/PE" .
<Etoposide> <Antineoplastic_of> "CALGB_10-002_regimen" .
<Etoposide> <Antineoplastic_of> "BeEAM,_then_auto_HSCT" .
<Etoposide> <Antineoplastic_of> "BeEAM" .
<Etoposide> <Antineoplastic_of> "BEP" .
<Etoposide> <Antineoplastic_of> "BEAM,_then_auto_HSCT" .
<Etoposide> <Antineoplastic_of> "BEAM,_then_allo_HSCT" .
<Etoposide> <Antineoplastic_of> "BEAM" .
<Etoposide> <Antineoplastic_of> "BEACOPP-14_(Prednisolone)" .
<Etoposide> <Antineoplastic_of> "BEACOPP-14" .
<Etoposide> <Antineoplastic_of> "BEACOPP" .
<Etoposide> <Antineoplastic_of> "BEAC,_then_auto_HSCT" .
<Etoposide> <Antineoplastic_of> "BEAC" .
<Etoposide> <Antineoplastic_of> "Accelerated_BEP" .
<Etoposide> <Antineoplastic_of> "AIE" .
<Etoposide> <Antineoplastic_of> "ADE_and_ATRA" .
<Etoposide> <Antineoplastic_of> "ADE_(standard-dose_Ara-C)" .
<Etoposide> <Antineoplastic_of> "ADE_(high-dose_Ara-C)" .
<Etoposide> <Antineoplastic_of> "ACVBP" .
<Etoposide> <Antineoplastic_of> "ACE" .
<Etoposide> <Antineoplastic_of> "ABVE-PC" .
<VD> <Has_accepted_use> "Multiple_myeloma" .
<VD> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Fluril> <Brand_name_of> "Fluorouracil" .
<Fludarabine_and_Melphalan> <Has_context> "All_lines_of_therapy" .
<Nimustine> <Is_a> "Nitrosourea" .
<Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine> <Has_context> "Adjuvant_therapy" .
<Dexamethasone_and_WBRT> <Mapped_from> "Dexamethasone_and_WBRT" .
<R-ESHAP> <Maps_to> "R-ESHAP" .
<Pomalidomide_and_Prednisone> <Has_supportive_med> "Low_molecular_weight_heparins" .
<Pomalidomide_and_Prednisone> <Has_supportive_med> "Aspirin" .
<NK-_and_T-cell_lymphoma> <Accepted_use_of> "SMILE" .
<NK-_and_T-cell_lymphoma> <Accepted_use_of> "Pegaspargase" .
<NK-_and_T-cell_lymphoma> <Accepted_use_of> "Methotrexate" .
<NK-_and_T-cell_lymphoma> <Accepted_use_of> "Ifosfamide" .
<NK-_and_T-cell_lymphoma> <Accepted_use_of> "Gemcitabine" .
<NK-_and_T-cell_lymphoma> <Accepted_use_of> "FluBuCy,_then_allo_HSCT" .
<NK-_and_T-cell_lymphoma> <Accepted_use_of> "Etoposide" .
<NK-_and_T-cell_lymphoma> <Accepted_use_of> "Dexamethasone" .
<NK-_and_T-cell_lymphoma> <Accepted_use_of> "DDGP" .
<NK-_and_T-cell_lymphoma> <Accepted_use_of> "Asparaginase_Erwinia_chrysanthemi" .
<NK-_and_T-cell_lymphoma> <Accepted_use_of> "Asparaginase" .
<Glasdegib_and_LoDAC> <Is_current_in> "Acute_myeloid_leukemia" .
<Epsidox> <Brand_name_of> "Etoposide" .
<Doxorubicin> <Antineoplastic_of> "maxi-R-CHOP/R-HiDAC" .
<Doxorubicin> <Antineoplastic_of> "mLSG15" .
<Doxorubicin> <Antineoplastic_of> "m-BACOD" .
<Doxorubicin> <Antineoplastic_of> "eBEACOPP_(Prednisolone)" .
<Doxorubicin> <Antineoplastic_of> "eBEACOPP" .
<Doxorubicin> <Antineoplastic_of> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Doxorubicin> <Antineoplastic_of> "dmCODOX-M_-_Modified_Magrath" .
<Doxorubicin> <Antineoplastic_of> "ddAC-T" .
<Doxorubicin> <Antineoplastic_of> "ddAC" .
<Doxorubicin> <Antineoplastic_of> "ddA" .
<Doxorubicin> <Antineoplastic_of> "VcR-CVAD" .
<Doxorubicin> <Antineoplastic_of> "VTD-PACE" .
<Doxorubicin> <Antineoplastic_of> "VR-CHOP" .
<Doxorubicin> <Antineoplastic_of> "VR-CAP" .
<Doxorubicin> <Antineoplastic_of> "VMV-VAC" .
<Doxorubicin> <Antineoplastic_of> "VMCP/VCAP" .
<Doxorubicin> <Antineoplastic_of> "VMCP/VBAP" .
<Doxorubicin> <Antineoplastic_of> "VIDE" .
<Doxorubicin> <Antineoplastic_of> "VI,_then_VDC/IE,_then_VAC,_then_VI" .
<Doxorubicin> <Antineoplastic_of> "VEPA" .
<Doxorubicin> <Antineoplastic_of> "VDC/IE" .
<Doxorubicin> <Antineoplastic_of> "VCAP" .
<Doxorubicin> <Antineoplastic_of> "VBMCP/VBAD" .
<Doxorubicin> <Antineoplastic_of> "VAdCA/IE" .
<Doxorubicin> <Antineoplastic_of> "VAdCA" .
<Doxorubicin> <Antineoplastic_of> "VAP" .
<Doxorubicin> <Antineoplastic_of> "VAMP_(Methotrexate)" .
<Doxorubicin> <Antineoplastic_of> "VAMP" .
<Doxorubicin> <Antineoplastic_of> "VAIA" .
<Doxorubicin> <Antineoplastic_of> "VAD-P/Q" .
<Doxorubicin> <Antineoplastic_of> "VAD-P" .
<Doxorubicin> <Antineoplastic_of> "VAD_plus_C" .
<Doxorubicin> <Antineoplastic_of> "VAD_and_Cyclosporine" .
<Doxorubicin> <Antineoplastic_of> "VAD" .
<Doxorubicin> <Antineoplastic_of> "VACOP-B" .
<Doxorubicin> <Antineoplastic_of> "VACA/IE" .
<Doxorubicin> <Antineoplastic_of> "VACA" .
<Doxorubicin> <Antineoplastic_of> "VAC_(Adriamycin)" .
<Doxorubicin> <Antineoplastic_of> "VABE" .
<Doxorubicin> <Antineoplastic_of> "V-HyperCAD" .
<Doxorubicin> <Antineoplastic_of> "Total_Therapy" .
<Doxorubicin> <Antineoplastic_of> "TC,_then_IE,_VDoxoC,_VEC" .
<Doxorubicin> <Antineoplastic_of> "TAD_(Thalidomide)" .
<Doxorubicin> <Antineoplastic_of> "TACE,_then_5-FU" .
<Doxorubicin> <Antineoplastic_of> "TACE" .
<Doxorubicin> <Antineoplastic_of> "TAC_(Taxotere)" .
<Doxorubicin> <Antineoplastic_of> "Stanford_V" .
<Doxorubicin> <Antineoplastic_of> "SCAB" .
<Doxorubicin> <Antineoplastic_of> "SC-EPOCH-RR" .
<Doxorubicin> <Antineoplastic_of> "RiPAD_plus_C" .
<Doxorubicin> <Antineoplastic_of> "RABVD" .
<Doxorubicin> <Antineoplastic_of> "R2CHOP" .
<Doxorubicin> <Antineoplastic_of> "R-miniCHOP" .
<Doxorubicin> <Antineoplastic_of> "R-VAD_plus_C" .
<Doxorubicin> <Antineoplastic_of> "R-MegaCHOP-14" .
<Doxorubicin> <Antineoplastic_of> "R-MegaCHOP" .
<Doxorubicin> <Antineoplastic_of> "R-MACLO/R-IVAM" .
<Doxorubicin> <Antineoplastic_of> "R-M-CHOP" .
<Doxorubicin> <Antineoplastic_of> "R-Hyper-CVAD/R-MA" .
<Doxorubicin> <Antineoplastic_of> "R-EPOCH,_dose-escalated" .
<Doxorubicin> <Antineoplastic_of> "R-EPOCH" .
<Doxorubicin> <Antineoplastic_of> "R-COPADM" .
<Doxorubicin> <Antineoplastic_of> "R-CODOX-M/R-IVAC" .
<Doxorubicin> <Antineoplastic_of> "R-CODOX-M" .
<Doxorubicin> <Antineoplastic_of> "R-CHVP_plus_I" .
<Doxorubicin> <Antineoplastic_of> "R-CHOP/R-DHAP" .
<Doxorubicin> <Antineoplastic_of> "R-CHOP-14_(Rituximab_Hycela)" .
<Doxorubicin> <Antineoplastic_of> "R-CHOP-14_(Prednisolone)" .
<Doxorubicin> <Antineoplastic_of> "R-CHOP-14" .
<Doxorubicin> <Antineoplastic_of> "R-CHOP_(Rituximab_Hycela)" .
<Doxorubicin> <Antineoplastic_of> "R-CHOP_(Prednisolone)" .
<Doxorubicin> <Antineoplastic_of> "R-CHOP" .
<Doxorubicin> <Antineoplastic_of> "R-CHOEP-14" .
<Doxorubicin> <Antineoplastic_of> "R,_then_CHOP" .
<Doxorubicin> <Antineoplastic_of> "ProMACE-MOPP" .
<Doxorubicin> <Antineoplastic_of> "ProMACE-CytaBOM" .
<Doxorubicin> <Antineoplastic_of> "PVAG" .
<Doxorubicin> <Antineoplastic_of> "PAF" .
<Doxorubicin> <Antineoplastic_of> "PAD" .
<Doxorubicin> <Antineoplastic_of> "PACEBOM" .
<Doxorubicin> <Antineoplastic_of> "PAC" .
<Doxorubicin> <Antineoplastic_of> "P/DOCE" .
<Doxorubicin> <Antineoplastic_of> "OPPA" .
<Doxorubicin> <Antineoplastic_of> "OEPA" .
<Doxorubicin> <Antineoplastic_of> "O-miniCHOP" .
<Doxorubicin> <Antineoplastic_of> "O-CHOP" .
<Doxorubicin> <Antineoplastic_of> "Mitotane_and_EDP" .
<Doxorubicin> <Antineoplastic_of> "MVAC,_dose-dense" .
<Doxorubicin> <Antineoplastic_of> "MVAC" .
<Doxorubicin> <Antineoplastic_of> "MOPP/ABVD" .
<Doxorubicin> <Antineoplastic_of> "MOPP-ABV" .
<Doxorubicin> <Antineoplastic_of> "MAPIE" .
<Doxorubicin> <Antineoplastic_of> "MAPI" .
<Doxorubicin> <Antineoplastic_of> "MAP" .
<Doxorubicin> <Antineoplastic_of> "MAID" .
<Doxorubicin> <Antineoplastic_of> "MACOP-B" .
<Doxorubicin> <Antineoplastic_of> "MACC" .
<Doxorubicin> <Antineoplastic_of> "MA-BCD/AP" .
<Doxorubicin> <Antineoplastic_of> "MA-BCD" .
<Doxorubicin> <Antineoplastic_of> "MA" .
<Doxorubicin> <Antineoplastic_of> "LSG15" .
<Doxorubicin> <Antineoplastic_of> "LOPP/EVAP" .
<Doxorubicin> <Antineoplastic_of> "LD-ACOP-B" .
<Doxorubicin> <Antineoplastic_of> "Hyper-CVAD/MA_and_Everolimus" .
<Doxorubicin> <Antineoplastic_of> "Hyper-CVAD/MA" .
<Doxorubicin> <Antineoplastic_of> "Hyper-CVAD_and_Ponatinib" .
<Doxorubicin> <Antineoplastic_of> "Hyper-CVAD_and_Imatinib" .
<Doxorubicin> <Antineoplastic_of> "Hyper-CVAD_and_Dasatinib" .
<Doxorubicin> <Antineoplastic_of> "Hyper-CVAD" .
<Doxorubicin> <Antineoplastic_of> "HOP" .
<Doxorubicin> <Antineoplastic_of> "GMALL-R" .
<Doxorubicin> <Antineoplastic_of> "G-CHOP" .
<Doxorubicin> <Antineoplastic_of> "FAS" .
<Doxorubicin> <Antineoplastic_of> "FAMTX" .
<Doxorubicin> <Antineoplastic_of> "FAM" .
<Doxorubicin> <Antineoplastic_of> "FAC_and_Bevacizumab" .
<Doxorubicin> <Antineoplastic_of> "FAC_and_BCG" .
<Doxorubicin> <Antineoplastic_of> "FAC" .
<Doxorubicin> <Antineoplastic_of> "F-MACHOP" .
<Doxorubicin> <Antineoplastic_of> "EVAIA" .
<Doxorubicin> <Antineoplastic_of> "EPOCH,_dose-escalated" .
<Doxorubicin> <Antineoplastic_of> "EPOCH" .
<Doxorubicin> <Antineoplastic_of> "EIA" .
<Doxorubicin> <Antineoplastic_of> "Doxorubicin,_Methotrexate,_Vincristine,_Prednisone" .
<Doxorubicin> <Antineoplastic_of> "Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone" .
<Doxorubicin> <Antineoplastic_of> "Doxorubicin,_Ifosfamide,_RT" .
<Doxorubicin> <Antineoplastic_of> "Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone" .
<Doxorubicin> <Antineoplastic_of> "Doxorubicin_monotherapy" .
<Doxorubicin> <Antineoplastic_of> "Doxorubicin_and_Vinblastine" .
<Doxorubicin> <Antineoplastic_of> "Doxorubicin_and_Strontium-89" .
<Doxorubicin> <Antineoplastic_of> "Doxorubicin_and_Streptozocin" .
<Doxorubicin> <Antineoplastic_of> "Doxorubicin_and_Olaratumab" .
<Doxorubicin> <Antineoplastic_of> "Doxorubicin_and_Lomustine" .
<Doxorubicin> <Antineoplastic_of> "Doxorubicin_and_Ifosfamide" .
<Doxorubicin> <Antineoplastic_of> "Doxorubicin_and_Gemcitabine" .
<Doxorubicin> <Antineoplastic_of> "Doxorubicin_and_Fluorouracil" .
<Doxorubicin> <Antineoplastic_of> "Doxorubicin_and_Bevacizumab" .
<Doxorubicin> <Antineoplastic_of> "Dacarbazine_and_Doxorubicin" .
<Doxorubicin> <Antineoplastic_of> "DTPACE" .
<Doxorubicin> <Antineoplastic_of> "DEB-TACE" .
<Doxorubicin> <Antineoplastic_of> "DD-CHOP" .
<Doxorubicin> <Antineoplastic_of> "DA-R-EPOCH" .
<Doxorubicin> <Antineoplastic_of> "DA-EPOCH" .
<Doxorubicin> <Antineoplastic_of> "Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone" .
<Doxorubicin> <Antineoplastic_of> "Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone" .
<Doxorubicin> <Antineoplastic_of> "Cisplatin,_Doxorubicin,_Paclitaxel" .
<Doxorubicin> <Antineoplastic_of> "Cisplatin_and_Doxorubicin" .
<Doxorubicin> <Antineoplastic_of> "ChlVPP/PABIOE" .
<Doxorubicin> <Antineoplastic_of> "ChlVPP/EVA" .
<Doxorubicin> <Antineoplastic_of> "Carmustine_and_Doxorubicin" .
<Doxorubicin> <Antineoplastic_of> "CVAP" .
<Doxorubicin> <Antineoplastic_of> "CVAD" .
<Doxorubicin> <Antineoplastic_of> "COPP/ABVD" .
<Doxorubicin> <Antineoplastic_of> "COPADM" .
<Doxorubicin> <Antineoplastic_of> "COPAD/CYVE" .
<Doxorubicin> <Antineoplastic_of> "COPAD" .
<Doxorubicin> <Antineoplastic_of> "COPA" .
<Doxorubicin> <Antineoplastic_of> "CODOX-M/IVAC" .
<Doxorubicin> <Antineoplastic_of> "CODOX-M" .
<Doxorubicin> <Antineoplastic_of> "CISCA/VB" .
<Doxorubicin> <Antineoplastic_of> "CISCA" .
<Doxorubicin> <Antineoplastic_of> "CHVmP-VB" .
<Doxorubicin> <Antineoplastic_of> "CHVmP" .
<Doxorubicin> <Antineoplastic_of> "CHVP-I" .
<Doxorubicin> <Antineoplastic_of> "CHVP" .
<Doxorubicin> <Antineoplastic_of> "CHOP-BCG" .
<Doxorubicin> <Antineoplastic_of> "CHOP-B" .
<Doxorubicin> <Antineoplastic_of> "CHOP-AL" .
<Doxorubicin> <Antineoplastic_of> "CHOP-14" .
<Doxorubicin> <Antineoplastic_of> "CHOP,_then_131Iodine-Tositumomab" .
<Doxorubicin> <Antineoplastic_of> "CHOP_and_Everolimus" .
<Doxorubicin> <Antineoplastic_of> "CHOP_Modified_(Prednisolone)" .
<Doxorubicin> <Antineoplastic_of> "CHOP_Modified" .
<Doxorubicin> <Antineoplastic_of> "CHOP_(Prednisolone)" .
<Doxorubicin> <Antineoplastic_of> "CHOP" .
<Doxorubicin> <Antineoplastic_of> "CHOEP-21" .
<Doxorubicin> <Antineoplastic_of> "CHOEP-14" .
<Doxorubicin> <Antineoplastic_of> "CHAD" .
<Doxorubicin> <Antineoplastic_of> "CDE" .
<Doxorubicin> <Antineoplastic_of> "CC/DE_and_RT" .
<Doxorubicin> <Antineoplastic_of> "CAVE" .
<Doxorubicin> <Antineoplastic_of> "CAV/PE" .
<Doxorubicin> <Antineoplastic_of> "CAV_and_RT" .
<Doxorubicin> <Antineoplastic_of> "CAV" .
<Doxorubicin> <Antineoplastic_of> "CAP-BOP" .
<Doxorubicin> <Antineoplastic_of> "CAP_(Platinol)" .
<Doxorubicin> <Antineoplastic_of> "CAP" .
<Doxorubicin> <Antineoplastic_of> "CAMP" .
<Doxorubicin> <Antineoplastic_of> "CAMFP" .
<Doxorubicin> <Antineoplastic_of> "CAMF" .
<Doxorubicin> <Antineoplastic_of> "CALGB_8811_late_intensification" .
<Doxorubicin> <Antineoplastic_of> "CALGB_10-002_regimen" .
<Doxorubicin> <Antineoplastic_of> "CAFVP" .
<Doxorubicin> <Antineoplastic_of> "CAF_and_MPA" .
<Doxorubicin> <Antineoplastic_of> "CAD_and_G-CSF" .
<Doxorubicin> <Antineoplastic_of> "C-VAMP" .
<Doxorubicin> <Antineoplastic_of> "C-MOPP/ABV" .
<Doxorubicin> <Antineoplastic_of> "BVDS" .
<Doxorubicin> <Antineoplastic_of> "BV-CHP" .
<Doxorubicin> <Antineoplastic_of> "BEACOPP-14_(Prednisolone)" .
<Doxorubicin> <Antineoplastic_of> "BEACOPP-14" .
<Doxorubicin> <Antineoplastic_of> "BEACOPP" .
<Doxorubicin> <Antineoplastic_of> "BCHOP" .
<Doxorubicin> <Antineoplastic_of> "BACO" .
<Doxorubicin> <Antineoplastic_of> "B-CAVe" .
<Doxorubicin> <Antineoplastic_of> "Augmented_Hyper-CVAD_and_Asparaginase" .
<Doxorubicin> <Antineoplastic_of> "AVD" .
<Doxorubicin> <Antineoplastic_of> "AVCF" .
<Doxorubicin> <Antineoplastic_of> "AV-CMF" .
<Doxorubicin> <Antineoplastic_of> "AT_(Taxotere)" .
<Doxorubicin> <Antineoplastic_of> "AT_(Taxol)" .
<Doxorubicin> <Antineoplastic_of> "APO" .
<Doxorubicin> <Antineoplastic_of> "ADOC" .
<Doxorubicin> <Antineoplastic_of> "ACVBP-R" .
<Doxorubicin> <Antineoplastic_of> "ACVBP,_dose-adjusted" .
<Doxorubicin> <Antineoplastic_of> "ACVBP" .
<Doxorubicin> <Antineoplastic_of> "ACT" .
<Doxorubicin> <Antineoplastic_of> "ACOMLA" .
<Doxorubicin> <Antineoplastic_of> "ACH" .
<Doxorubicin> <Antineoplastic_of> "ACE" .
<Doxorubicin> <Antineoplastic_of> "AC-T" .
<Doxorubicin> <Antineoplastic_of> "AC_and_Bevacizumab" .
<Doxorubicin> <Antineoplastic_of> "AC" .
<Doxorubicin> <Antineoplastic_of> "ABVE-PC" .
<Doxorubicin> <Antineoplastic_of> "ABVDm" .
<Doxorubicin> <Antineoplastic_of> "ABVD,_DD-DI" .
<Doxorubicin> <Antineoplastic_of> "ABVD" .
<Doxorubicin> <Antineoplastic_of> "ABV_(Vincristine)" .
<Doxorubicin> <Antineoplastic_of> "ABV_(Vinblastine)" .
<Doxorubicin> <Antineoplastic_of> "ABP" .
<Doxorubicin> <Antineoplastic_of> "ABDIC" .
<Doxorubicin> <Antineoplastic_of> "ABCM" .
<Doxorubicin> <Antineoplastic_of> "A-AVD" .
<Fluolex> <Brand_name_of> "Fluorouracil" .
<ECT,_then_auto_HSCT> <Has_context> "Adjuvant_therapy" .
<VMPT> <Mapped_from> "VMPT" .
<Roaccutane> <Brand_name_of> "Isotretinoin" .
<Firmofos> <Brand_name_of> "Alendronate" .
<Ribociclib> <May_have_route> "Oral" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "m-BNCOD" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "m-BACOD" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "VR-CHOP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "VNCOP-B" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "VIPD" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "VIM" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "VEPA" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "VCAP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "VACOP-B" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "VABE" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "R-INO" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "ProMACE-MOPP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "ProMACE-CytaBOM" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "PMitCEBO" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "PEN" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "PACEBOM" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "P/DOCE" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "MINE" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "MACOP-B" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "LD-ACOP-B" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "ICE" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "HOP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "HAM" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "GDP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "F-MACHOP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "Etoposide,_Ifosfamide,_Methotrexate" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "ESHAP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "EPOCH" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "EPIC_regimen" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "DICEP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "DICE" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "DHAP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "DA-EPOCH" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "Cyclophosphamide_and_TBI" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "CVP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "COP-Bleo" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "COMP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "CNOP_(Prednisolone)" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "CNOP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "CHVmP-VB" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "CHVmP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "CHOP-BCG" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "CHOP-B" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "CHOP-14" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "CHOP_Modified_(Prednisolone)" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "CHOP_Modified" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "CHOP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "CHOEP-21" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "CHOEP-14" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "CEPP(B)" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "CEOP_(Prednisolone)" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "CEOP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "CEEP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "CCOP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "CAP-BOP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "C-MOPP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "BCOP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "APO" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "ACVBP" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "ACOMLA" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "ACE" .
<Diffuse_large_B-cell_lymphoma> <Historic_treated_by> "ABP" .
<Clarithromycin_monotherapy> <Is_current_in> "Marginal_zone_lymphoma" .
<All-trans_retinoic_acid> <Antineoplastic_of> "Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA" .
<All-trans_retinoic_acid> <Antineoplastic_of> "Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA" .
<All-trans_retinoic_acid> <Antineoplastic_of> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA" .
<All-trans_retinoic_acid> <Antineoplastic_of> "Arsenic_trioxide,_then_ATRA_and_Daunorubicin" .
<All-trans_retinoic_acid> <Antineoplastic_of> "Arsenic_trioxide,_ATRA,_Idarubicin" .
<All-trans_retinoic_acid> <Antineoplastic_of> "Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin" .
<All-trans_retinoic_acid> <Antineoplastic_of> "Arsenic_trioxide_and_ATRA" .
<All-trans_retinoic_acid> <Antineoplastic_of> "ATRA,_Mercaptopurine,_Methotrexate" .
<All-trans_retinoic_acid> <Antineoplastic_of> "ATRA,_Cytarabine,_Idarubicin" .
<All-trans_retinoic_acid> <Antineoplastic_of> "ATRA,_Cytarabine,_Daunorubicin" .
<All-trans_retinoic_acid> <Antineoplastic_of> "ATRA_monotherapy" .
<All-trans_retinoic_acid> <Antineoplastic_of> "ATRA_and_Idarubicin" .
<All-trans_retinoic_acid> <Antineoplastic_of> "ATRA_and_Daunorubicin" .
<All-trans_retinoic_acid> <Antineoplastic_of> "ADE_and_ATRA" .
<Adjuvant_therapy> <Maps_to> "Adjuvant_therapy" .
<CPB> <Mapped_from> "CPB" .
<Bexarotene_monotherapy> <Is_current_in> "Cutaneous_T-cell_lymphoma" .
<Azacitidine> <Is_a> "Pyrimidine_analogue" .
<Azacitidine> <Is_a> "Inflammitant" .
<Azacitidine> <Is_a> "Hypomethylating_agent" .
<Azacitidine> <Is_a> "DNA_methyltransferase_inhibitor" .
<mFOLFOX6_(L-Leucovorin)> <Has_antineoplastic> "Oxaliplatin" .
<mFOLFOX6_(L-Leucovorin)> <Has_antineoplastic> "Levoleucovorin" .
<mFOLFOX6_(L-Leucovorin)> <Has_antineoplastic> "Fluorouracil" .
<CVPP> <Maps_to> "CVPP" .
<DE> <Maps_to> "DE" .
<FOLFOX4_(L-Leucovorin)> <Has_antineoplastic> "Oxaliplatin" .
<FOLFOX4_(L-Leucovorin)> <Has_antineoplastic> "Levoleucovorin" .
<FOLFOX4_(L-Leucovorin)> <Has_antineoplastic> "Fluorouracil" .
<Plerixafor> <Is_a> "PMDA_approved_drug" .
<Plerixafor> <Is_a> "CXCR4_inhibitor" .
<Petaxel> <Brand_name_of> "Paclitaxel" .
<Ibrance> <Brand_name_of> "Palbociclib" .
<CEOP_(Prednisolone)> <Mapped_from> "CEOP_(Prednisolone)" .
<Cisplatin,_Doxorubicin,_Paclitaxel> <Is_current_in> "Endometrial_cancer" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Vincristine" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Dexamethasone" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Daunorubicin" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Cytarabine" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Asparaginase" .
<Thymoma> <Current_treated_by> "VIP" .
<Thymoma> <Current_treated_by> "Sunitinib_monotherapy" .
<Thymoma> <Current_treated_by> "Radiation_therapy" .
<Thymoma> <Current_treated_by> "PAC" .
<Thymoma> <Current_treated_by> "Octreotide_monotherapy" .
<Thymoma> <Current_treated_by> "Octreotide_and_Prednisone" .
<Thymoma> <Current_treated_by> "Ifosfamide_monotherapy" .
<Thymoma> <Current_treated_by> "Everolimus_monotherapy" .
<Thymoma> <Current_treated_by> "Cisplatin_and_Etoposide" .
<Thymoma> <Current_treated_by> "Carboplatin_and_Paclitaxel" .
<Thymoma> <Current_treated_by> "Capecitabine_and_Gemcitabine" .
<Thymoma> <Current_treated_by> "ADOC" .
<Acard> <Brand_name_of> "Aspirin" .
<SOX> <Is_current_in> "Colon_cancer" .
<Acetard> <Brand_name_of> "Aspirin" .
<Fondaparinux_monotherapy> <Maps_to> "Fondaparinux_monotherapy" .
<R-TBI/Cy,_then_auto_HSCT> <Has_accepted_use> "Follicular_lymphoma" .
<R-TBI/Cy,_then_auto_HSCT> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Imatinib,_Vincristine,_Prednisone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<CHOP_(Prednisolone)> <Has_context> "Non-curative_therapy" .
<Dara-PD> <Is_current_in> "Multiple_myeloma" .
<Iodine-131> <Has_accepted_use> "Thyroid_cancer" .
<CALGB_10-002_regimen> <Maps_to> "CALGB_10-002_regimen" .
<Alemtuzumab_monotherapy> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<Alemtuzumab_monotherapy> <Is_current_in> "T-cell_prolymphocytic_leukemia" .
<Alemtuzumab_monotherapy> <Is_current_in> "Myelodysplastic_syndrome" .
<Alemtuzumab_monotherapy> <Is_current_in> "Hypereosinophilic_syndrome" .
<Alemtuzumab_monotherapy> <Is_current_in> "Cutaneous_T-cell_lymphoma" .
<Alemtuzumab_monotherapy> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Alemtuzumab_monotherapy> <Is_current_in> "Autoimmune_cytopenia" .
<Alemtuzumab_monotherapy> <Is_current_in> "Adult_T-cell_leukemia-lymphoma" .
<Cisplatin_and_Cyclophosphamide> <Mapped_from> "Cisplatin_and_Cyclophosphamide" .
<MPR> <Has_context> "Non-curative_first-line_therapy" .
<MPR> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Emicizumab> <Has_accepted_use> "Inherited_coagulopathy" .
<Carboplatin,_Etoposide,_RT> <Has_context> "Definitive_therapy" .
<Everolimus_and_Lenvatinib> <Has_context> "Non-curative_second-line_therapy" .
<Cortidexason> <Brand_name_of> "Dexamethasone" .
<Cisplatin,_Dacarbazine,_Paclitaxel> <Has_modality> "Chemotherapy" .
<CMFL> <Has_modality> "Chemotherapy" .
<Castration> <Has_accepted_use> "Prostate_cancer" .
<Doxorubicin> <May_have_route> "Intravesical" .
<Doxorubicin> <May_have_route> "Intravenous" .
<Doxorubicin> <May_have_route> "Intra-arterial" .
<Raseptol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Tosedostat> <May_have_route> "Oral" .
<Feratab> <Brand_name_of> "Ferrous_sulfate" .
<Chlorambucil,_Dactinomycin,_Methotrexate> <Has_accepted_use> "Testicular_cancer" .
<Dalteparin> <May_have_route> "Subcutaneous" .
<ICL> <Maps_to> "ICL" .
<R-CODOX-M> <Has_accepted_use> "HIV-associated_lymphoma" .
<R-CODOX-M> <Has_accepted_use> "Burkitt_lymphoma" .
<Miratrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<GMALL-R> <Is_a> "Rituximab-containing_regimen" .
<GMALL-R> <Is_a> "Anthracycline-containing_regimen" .
<High-dose_Interleukin-2> <Maps_to> "High-dose_Interleukin-2" .
<Tisagenlecleucel> <Is_a> "REMS_program" .
<Tisagenlecleucel> <Is_a> "Chimeric_antigen_receptor_T-cell" .
<Defixal> <Brand_name_of> "Alendronate" .
<TAM6,_then_auto_HSCT> <Maps_to> "TAM6,_then_auto_HSCT" .
<BVCPP> <Is_historical_in> "Hodgkin_lymphoma" .
<Climaclod> <Brand_name_of> "Clodronate" .
<PATCO> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Lupectrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bicalutamide_and_RT> <Is_current_in> "Prostate_cancer" .
<Rituximab-pvvr> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Rituximab-pvvr> <Has_accepted_use> "Transformed_lymphoma" .
<Rituximab-pvvr> <Has_accepted_use> "Thrombotic_thrombocytopenic_purpura" .
<Rituximab-pvvr> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<Rituximab-pvvr> <Has_accepted_use> "Post-transplant_lymphoproliferative_disorder" .
<Rituximab-pvvr> <Has_accepted_use> "Mediastinal_gray-zone_lymphoma" .
<Rituximab-pvvr> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Rituximab-pvvr> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Rituximab-pvvr> <Has_accepted_use> "Inherited_coagulopathy" .
<Rituximab-pvvr> <Has_accepted_use> "Immune_thrombocytopenia" .
<Rituximab-pvvr> <Has_accepted_use> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<Rituximab-pvvr> <Has_accepted_use> "Hodgkin_lymphoma" .
<Rituximab-pvvr> <Has_accepted_use> "Hairy_cell_leukemia" .
<Rituximab-pvvr> <Has_accepted_use> "HIV-associated_lymphoma" .
<Rituximab-pvvr> <Has_accepted_use> "Follicular_lymphoma" .
<Rituximab-pvvr> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Rituximab-pvvr> <Has_accepted_use> "Cold_agglutinin_disease" .
<Rituximab-pvvr> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Rituximab-pvvr> <Has_accepted_use> "Castleman_disease" .
<Rituximab-pvvr> <Has_accepted_use> "CNS_lymphoma" .
<Rituximab-pvvr> <Has_accepted_use> "Burkitt_lymphoma" .
<Rituximab-pvvr> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Rituximab-pvvr> <Has_accepted_use> "Acquired_coagulopathy" .
<CHOP_Modified_(Prednisolone)> <Maps_to> "CHOP_Modified_(Prednisolone)" .
<FC> <Has_supportive_med> "Valacyclovir" .
<FC> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<FC> <Has_supportive_med> "Prednisolone" .
<FC> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<FC> <Has_supportive_med> "Chlorambucil" .
<FC> <Has_supportive_med> "Allopurinol" .
<FC> <Has_supportive_med> "Acyclovir" .
<IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone> <Is_a> "Anthracycline-containing_regimen" .
<Aspirin_and_Warfarin> <Is_current_in> "Antiphospholipid_antibody_syndrome" .
<Aclacinon> <Brand_name_of> "Aclarubicin" .
<Pirarubicin> <Has_accepted_use> "Bladder_cancer" .
<Methybon> <Brand_name_of> "Methylprednisolone" .
<Afatinib_and_Cetuximab> <Has_antineoplastic> "Cetuximab" .
<Afatinib_and_Cetuximab> <Has_antineoplastic> "Afatinib" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Is_a> "Anthracycline-containing_regimen" .
<Cabozantinib_and_Erlotinib> <Maps_to> "Cabozantinib_and_Erlotinib" .
<Cetuximab_and_RT> <Mapped_from> "Cetuximab_and_RT" .
<CPX-351_monotherapy> <Mapped_from> "CPX-351_monotherapy" .
<A-AVD> <Has_context> "Induction_therapy" .
<Erlotinib_monotherapy> <Maps_to> "Erlotinib_monotherapy" .
<CMF> <Is_historical_in> "Prostate_cancer" .
<PMitCEBO> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Plagril> <Brand_name_of> "Clopidogrel" .
<Intralesional> <May_be_route_of> "Talimogene_laherparepvec" .
<Intralesional> <May_be_route_of> "Interferon_alfa-2b" .
<Intralesional> <May_be_route_of> "Carmustine_wafer_polifeprosan_20" .
<VMP,_then_Rd> <Has_accepted_use> "Multiple_myeloma" .
<CapeOx_and_Bevacizumab> <Has_accepted_use> "Hepatocellular_carcinoma" .
<CapeOx_and_Bevacizumab> <Has_accepted_use> "Colon_cancer" .
<7_plus_3i> <Has_antineoplastic> "Idarubicin" .
<7_plus_3i> <Has_antineoplastic> "Cytarabine" .
<Diphenhydramine> <Supportive_med_of> "ddAC-T" .
<Diphenhydramine> <Supportive_med_of> "VR-CHOP" .
<Diphenhydramine> <Supportive_med_of> "VR" .
<Diphenhydramine> <Supportive_med_of> "Temsirolimus_monotherapy" .
<Diphenhydramine> <Supportive_med_of> "TTR" .
<Diphenhydramine> <Supportive_med_of> "TIP" .
<Diphenhydramine> <Supportive_med_of> "Rituximab_monotherapy" .
<Diphenhydramine> <Supportive_med_of> "R-ICE" .
<Diphenhydramine> <Supportive_med_of> "R-FCM" .
<Diphenhydramine> <Supportive_med_of> "Paclitaxel_monotherapy" .
<Diphenhydramine> <Supportive_med_of> "PCR" .
<Diphenhydramine> <Supportive_med_of> "PCF" .
<Diphenhydramine> <Supportive_med_of> "PCE" .
<Diphenhydramine> <Supportive_med_of> "PAC" .
<Diphenhydramine> <Supportive_med_of> "Ofatumumab_monotherapy" .
<Diphenhydramine> <Supportive_med_of> "Obinutuzumab_monotherapy" .
<Diphenhydramine> <Supportive_med_of> "O-miniCHOP" .
<Diphenhydramine> <Supportive_med_of> "Methotrexate_monotherapy" .
<Diphenhydramine> <Supportive_med_of> "Ixazomib_and_Dexamethasone" .
<Diphenhydramine> <Supportive_med_of> "Irinotecan_monotherapy" .
<Diphenhydramine> <Supportive_med_of> "Ifosfamide_and_Paclitaxel" .
<Diphenhydramine> <Supportive_med_of> "IRd" .
<Diphenhydramine> <Supportive_med_of> "High-dose_Interleukin-2" .
<Diphenhydramine> <Supportive_med_of> "HDMP-R" .
<Diphenhydramine> <Supportive_med_of> "Gemcitabine,_Oxaliplatin,_Paclitaxel" .
<Diphenhydramine> <Supportive_med_of> "Gemcitabine_and_Paclitaxel" .
<Diphenhydramine> <Supportive_med_of> "GCP" .
<Diphenhydramine> <Supportive_med_of> "G-FC" .
<Diphenhydramine> <Supportive_med_of> "FR" .
<Diphenhydramine> <Supportive_med_of> "FCR" .
<Diphenhydramine> <Supportive_med_of> "Elo-VD" .
<Diphenhydramine> <Supportive_med_of> "Elo-Rd" .
<Diphenhydramine> <Supportive_med_of> "Elo-PD" .
<Diphenhydramine> <Supportive_med_of> "Docetaxel,_Cetuximab,_RT" .
<Diphenhydramine> <Supportive_med_of> "Docetaxel_monotherapy" .
<Diphenhydramine> <Supportive_med_of> "Docetaxel_and_Gemcitabine" .
<Diphenhydramine> <Supportive_med_of> "Daratumumab_monotherapy" .
<Diphenhydramine> <Supportive_med_of> "Dara-KD" .
<Diphenhydramine> <Supportive_med_of> "DHAP" .
<Diphenhydramine> <Supportive_med_of> "DD-CHOP" .
<Diphenhydramine> <Supportive_med_of> "Cyclophosphamide,_Etoposide,_TBI" .
<Diphenhydramine> <Supportive_med_of> "Cisplatin,_Paclitaxel,_RT" .
<Diphenhydramine> <Supportive_med_of> "Cisplatin,_Docetaxel,_RT" .
<Diphenhydramine> <Supportive_med_of> "Cisplatin,_Cetuximab,_RT" .
<Diphenhydramine> <Supportive_med_of> "Cisplatin_and_Paclitaxel" .
<Diphenhydramine> <Supportive_med_of> "Cisplatin_and_Etoposide" .
<Diphenhydramine> <Supportive_med_of> "Cetuximab_monotherapy" .
<Diphenhydramine> <Supportive_med_of> "Cetuximab_and_RT" .
<Diphenhydramine> <Supportive_med_of> "Carboplatin,_Paclitaxel,_RT" .
<Diphenhydramine> <Supportive_med_of> "Carboplatin_and_Paclitaxel" .
<Diphenhydramine> <Supportive_med_of> "Carboplatin_and_Fluorouracil" .
<Diphenhydramine> <Supportive_med_of> "Carboplatin_and_Docetaxel" .
<Diphenhydramine> <Supportive_med_of> "CVP,_then_131Iodine-Tositumomab" .
<Diphenhydramine> <Supportive_med_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Diphenhydramine> <Supportive_med_of> "CHOP,_then_131Iodine-Tositumomab" .
<Diphenhydramine> <Supportive_med_of> "CFAR" .
<Diphenhydramine> <Supportive_med_of> "CC" .
<Diphenhydramine> <Supportive_med_of> "Bortezomib_monotherapy" .
<Diphenhydramine> <Supportive_med_of> "Bendamustine_and_Ofatumumab" .
<Diphenhydramine> <Supportive_med_of> "Bendamustine_and_Obinutuzumab" .
<Diphenhydramine> <Supportive_med_of> "BDR" .
<Diphenhydramine> <Supportive_med_of> "Axicabtagene_ciloleucel_monotherapy" .
<Diphenhydramine> <Supportive_med_of> "Avelumab_monotherapy" .
<Diphenhydramine> <Supportive_med_of> "Alemtuzumab_monotherapy" .
<Diphenhydramine> <Supportive_med_of> "131Iodine-Tositumomab_monotherapy" .
<CVP> <Mapped_from> "CVP" .
<Temozolomide_and_Bevacizumab> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Temozolomide_and_Bevacizumab> <Has_supportive_med> "Acyclovir" .
<Dronal> <Brand_name_of> "Alendronate" .
<Pentostatin_and_Alemtuzumab> <Has_accepted_use> "T-cell_prolymphocytic_leukemia" .
<PAD_doxil> <Has_accepted_use> "Multiple_myeloma" .
<Neoadjuvant_therapy> <Mapped_from> "Neoadjuvant_therapy" .
<Carboplatin_and_Gemcitabine> <Maps_to> "Carboplatin_and_Gemcitabine" .
<R-MegaCHOP> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Axitinib_and_TACE> <Has_context> "Local_therapy" .
<Ox-P> <Is_a> "Platinum_doublet" .
<Temsirolimus_and_Rituximab> <Has_modality> "Chemotherapy" .
<Avatrombopag_monotherapy> <Has_modality> "Growth_factor_therapy" .
<Hormonotherapy> <Modality_of> "VAP" .
<Hormonotherapy> <Modality_of> "Triptorelin_monotherapy" .
<Hormonotherapy> <Modality_of> "Toremifene_monotherapy" .
<Hormonotherapy> <Modality_of> "Tamoxifen_monotherapy" .
<Hormonotherapy> <Modality_of> "Tamoxifen_and_Prednisolone" .
<Hormonotherapy> <Modality_of> "Tamoxifen_and_OFS" .
<Hormonotherapy> <Modality_of> "TAD_(Tamoxifen)" .
<Hormonotherapy> <Modality_of> "T-DM1_and_ET" .
<Hormonotherapy> <Modality_of> "Ribociclib_and_Tamoxifen" .
<Hormonotherapy> <Modality_of> "Prednisone_monotherapy" .
<Hormonotherapy> <Modality_of> "PT" .
<Hormonotherapy> <Modality_of> "PFT" .
<Hormonotherapy> <Modality_of> "Oophorectomy" .
<Hormonotherapy> <Modality_of> "Octreotide_monotherapy" .
<Hormonotherapy> <Modality_of> "Octreotide_and_Prednisone" .
<Hormonotherapy> <Modality_of> "Octreotide_and_Interferon_alfa" .
<Hormonotherapy> <Modality_of> "Octreotide_LAR_monotherapy" .
<Hormonotherapy> <Modality_of> "Nilutamide_and_Orchiectomy" .
<Hormonotherapy> <Modality_of> "Mitoxantrone_and_Prednisone" .
<Hormonotherapy> <Modality_of> "Mitoxantrone_and_Hydrocortisone" .
<Hormonotherapy> <Modality_of> "Megestrol_monotherapy" .
<Hormonotherapy> <Modality_of> "Megestrol_and_Tamoxifen" .
<Hormonotherapy> <Modality_of> "Medroxyprogesterone_monotherapy" .
<Hormonotherapy> <Modality_of> "Medroxyprogesterone_and_Tamoxifen" .
<Hormonotherapy> <Modality_of> "Lutetium_Lu_177_dotatate_and_Octreotide_LAR" .
<Hormonotherapy> <Modality_of> "Leuprolide_monotherapy" .
<Hormonotherapy> <Modality_of> "Letrozole_monotherapy" .
<Hormonotherapy> <Modality_of> "Letrozole_and_Ribociclib" .
<Hormonotherapy> <Modality_of> "Letrozole_and_Palbociclib" .
<Hormonotherapy> <Modality_of> "Letrozole_and_Bevacizumab" .
<Hormonotherapy> <Modality_of> "Lapatinib,_Letrozole,_Trastuzumab" .
<Hormonotherapy> <Modality_of> "Lapatinib_and_Letrozole" .
<Hormonotherapy> <Modality_of> "Lanreotide_monotherapy" .
<Hormonotherapy> <Modality_of> "Lanreotide_and_Interferon_alfa-2b" .
<Hormonotherapy> <Modality_of> "Lanreotide_Depot/Autogel_monotherapy" .
<Hormonotherapy> <Modality_of> "Ketoconazole,_Hydrocortisone,_Dutasteride" .
<Hormonotherapy> <Modality_of> "Ketoconazole_and_Hydrocortisone" .
<Hormonotherapy> <Modality_of> "Intermittent_ADT" .
<Hormonotherapy> <Modality_of> "IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone" .
<Hormonotherapy> <Modality_of> "Hydrocortisone_monotherapy" .
<Hormonotherapy> <Modality_of> "Histrelin_monotherapy" .
<Hormonotherapy> <Modality_of> "Goserelin_monotherapy" .
<Hormonotherapy> <Modality_of> "Goserelin_and_Tamoxifen" .
<Hormonotherapy> <Modality_of> "Goserelin_and_RT" .
<Hormonotherapy> <Modality_of> "Fulvestrant_monotherapy" .
<Hormonotherapy> <Modality_of> "Fulvestrant_and_Ribociclib" .
<Hormonotherapy> <Modality_of> "Fulvestrant_and_Palbociclib" .
<Hormonotherapy> <Modality_of> "Formestane_monotherapy" .
<Hormonotherapy> <Modality_of> "Flutamide,_Leuprolide,_RT" .
<Hormonotherapy> <Modality_of> "Flutamide,_Goserelin,_RT" .
<Hormonotherapy> <Modality_of> "Flutamide_monotherapy" .
<Hormonotherapy> <Modality_of> "Flutamide_and_Leuprolide" .
<Hormonotherapy> <Modality_of> "Flutamide_and_Goserelin" .
<Hormonotherapy> <Modality_of> "Fluoxymesterone_monotherapy" .
<Hormonotherapy> <Modality_of> "Exemestane_monotherapy" .
<Hormonotherapy> <Modality_of> "Exemestane_and_Tucidinostat" .
<Hormonotherapy> <Modality_of> "Everolimus_and_Tamoxifen" .
<Hormonotherapy> <Modality_of> "Everolimus_and_Octreotide" .
<Hormonotherapy> <Modality_of> "Everolimus_and_Exemestane" .
<Hormonotherapy> <Modality_of> "Estradiol_monotherapy" .
<Hormonotherapy> <Modality_of> "Enzalutamide_monotherapy" .
<Hormonotherapy> <Modality_of> "Docetaxel_and_Prednisone" .
<Hormonotherapy> <Modality_of> "Docetaxel_and_Prednisolone" .
<Hormonotherapy> <Modality_of> "Docetaxel_and_Estramustine" .
<Hormonotherapy> <Modality_of> "Degarelix_monotherapy" .
<Hormonotherapy> <Modality_of> "Danazol_monotherapy" .
<Hormonotherapy> <Modality_of> "Dacarbazine_and_Tamoxifen" .
<Hormonotherapy> <Modality_of> "DES_monotherapy" .
<Hormonotherapy> <Modality_of> "Cyproterone_acetate_monotherapy" .
<Hormonotherapy> <Modality_of> "Cyclophosphamide,_Prednisone,_Diethylstilbestrol" .
<Hormonotherapy> <Modality_of> "Cortisone_monotherapy" .
<Hormonotherapy> <Modality_of> "Cisplatin,_Dacarbazine,_Tamoxifen" .
<Hormonotherapy> <Modality_of> "Chlorambucil_and_Prednisolone" .
<Hormonotherapy> <Modality_of> "Castration" .
<Hormonotherapy> <Modality_of> "Carboplatin,_Docetaxel,_Prednisone" .
<Hormonotherapy> <Modality_of> "Capecitabine_and_Fulvestrant" .
<Hormonotherapy> <Modality_of> "Cabazitaxel_and_Prednisone" .
<Hormonotherapy> <Modality_of> "CVAP" .
<Hormonotherapy> <Modality_of> "CMFVP" .
<Hormonotherapy> <Modality_of> "CMFT" .
<Hormonotherapy> <Modality_of> "CMFPT" .
<Hormonotherapy> <Modality_of> "CMFP" .
<Hormonotherapy> <Modality_of> "CFP_and_Oophorectomy" .
<Hormonotherapy> <Modality_of> "CFP" .
<Hormonotherapy> <Modality_of> "CAMFP" .
<Hormonotherapy> <Modality_of> "CAFVP" .
<Hormonotherapy> <Modality_of> "CAF_and_MPA" .
<Hormonotherapy> <Modality_of> "Bicalutamide_monotherapy" .
<Hormonotherapy> <Modality_of> "Bicalutamide_and_RT" .
<Hormonotherapy> <Modality_of> "Bicalutamide_and_Leuprolide" .
<Hormonotherapy> <Modality_of> "Bicalutamide_and_Goserelin" .
<Hormonotherapy> <Modality_of> "Aspirin_and_Dexamethasone" .
<Hormonotherapy> <Modality_of> "Apalutamide_monotherapy" .
<Hormonotherapy> <Modality_of> "Anastrozole_monotherapy" .
<Hormonotherapy> <Modality_of> "Anastrozole_and_Trastuzumab" .
<Hormonotherapy> <Modality_of> "Anastrozole_and_Ribociclib" .
<Hormonotherapy> <Modality_of> "Anastrozole_and_Palbociclib" .
<Hormonotherapy> <Modality_of> "Anastrozole_and_Goserelin" .
<Hormonotherapy> <Modality_of> "Anastrozole_and_Fulvestrant" .
<Hormonotherapy> <Modality_of> "Aminoglutethimide_monotherapy" .
<Hormonotherapy> <Modality_of> "Alpelisib_and_Fulvestrant" .
<Hormonotherapy> <Modality_of> "Abiraterone_and_Prednisone" .
<Hormonotherapy> <Modality_of> "Abemaciclib_and_Letrozole" .
<Hormonotherapy> <Modality_of> "Abemaciclib_and_Fulvestrant" .
<Hormonotherapy> <Modality_of> "Abemaciclib_and_Anastrozole" .
<Hormonotherapy> <Modality_of> "ADT,_Docetaxel,_Estramustine" .
<Hormonotherapy> <Modality_of> "ADT_and_RT" .
<Hormonotherapy> <Modality_of> "ADT_and_Enzalutamide" .
<Hormonotherapy> <Modality_of> "ADT_and_Docetaxel" .
<Hormonotherapy> <Modality_of> "ADT_and_Darolutamide" .
<Hormonotherapy> <Modality_of> "ADT_and_Apalutamide" .
<Hormonotherapy> <Modality_of> "ADT_and_Abiraterone" .
<Hormonotherapy> <Modality_of> "ADT" .
<Hormonotherapy> <Modality_of> "ACT" .
<CFDA_approved_drug> <Subsumes> "Lobaplatin" .
<CFDA_approved_drug> <Subsumes> "Icotinib" .
<CFDA_approved_drug> <Subsumes> "Chidamide" .
<CFDA_approved_drug> <Subsumes> "Apatinib" .
<CLAG> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Idarubicin,_then_Mitoxantrone,_then_Idarubicin> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Cisplatin,_Fluorouracil,_Cetuximab> <Is_current_in> "Head_and_neck_cancer" .
<Cisplatin,_Fluorouracil,_Cetuximab> <Is_current_in> "Esophageal_cancer" .
<Dara-KD> <Mapped_from> "Dara-KD" .
<Endocrine_therapeutic> <Subsumes> "Tryptophan_hydroxylase_inhibitor" .
<Endocrine_therapeutic> <Subsumes> "Triptorelin" .
<Endocrine_therapeutic> <Subsumes> "Toremifene" .
<Endocrine_therapeutic> <Subsumes> "Steroid_synthesis_inhibitor" .
<Endocrine_therapeutic> <Subsumes> "Somatostatin_analog" .
<Endocrine_therapeutic> <Subsumes> "Selective_estrogen_receptor_modulator" .
<Endocrine_therapeutic> <Subsumes> "Raloxifene" .
<Endocrine_therapeutic> <Subsumes> "Orteronel" .
<Endocrine_therapeutic> <Subsumes> "Octreotide_LAR" .
<Endocrine_therapeutic> <Subsumes> "Octreotide" .
<Endocrine_therapeutic> <Subsumes> "Megestrol" .
<Endocrine_therapeutic> <Subsumes> "Medroxyprogesterone" .
<Endocrine_therapeutic> <Subsumes> "Letrozole" .
<Endocrine_therapeutic> <Subsumes> "Lanreotide" .
<Endocrine_therapeutic> <Subsumes> "Ketoconazole" .
<Endocrine_therapeutic> <Subsumes> "Histrelin" .
<Endocrine_therapeutic> <Subsumes> "GnRH_antagonist" .
<Endocrine_therapeutic> <Subsumes> "GnRH_agonist" .
<Endocrine_therapeutic> <Subsumes> "Galeterone" .
<Endocrine_therapeutic> <Subsumes> "Fulvestrant" .
<Endocrine_therapeutic> <Subsumes> "Finasteride" .
<Endocrine_therapeutic> <Subsumes> "Exemestane" .
<Endocrine_therapeutic> <Subsumes> "Estrogen_receptor_inhibitor" .
<Endocrine_therapeutic> <Subsumes> "Dutasteride" .
<Endocrine_therapeutic> <Subsumes> "Diethylstilbestrol" .
<Endocrine_therapeutic> <Subsumes> "Degarelix" .
<Endocrine_therapeutic> <Subsumes> "Danazol" .
<Endocrine_therapeutic> <Subsumes> "Aromatase_inhibitor" .
<Endocrine_therapeutic> <Subsumes> "Antiandrogen" .
<Endocrine_therapeutic> <Subsumes> "Androgen_receptor_inhibitor" .
<Endocrine_therapeutic> <Subsumes> "Anabolic_steroid" .
<Endocrine_therapeutic> <Subsumes> "Aminoglutethimide" .
<Endocrine_therapeutic> <Subsumes> "Abiraterone" .
<Endocrine_therapeutic> <Subsumes> "5_alpha-reductase_inhibitor" .
<Lapatinib> <Has_accepted_use> "Breast_cancer" .
<Ondansetron> <May_have_route> "Oral" .
<Ondansetron> <May_have_route> "Intravenous" .
<Neotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Anti-PDGFR_antibody> <Subsumes> "Olaratumab" .
<Histrelin> <Antineoplastic_of> "Histrelin_monotherapy" .
<CODOX-M/IVAC> <Has_context> "Upfront_therapy" .
<CODOX-M/IVAC> <Has_context> "Induction_therapy" .
<Fludarabine_and_Prednisone> <Has_modality> "Chemotherapy" .
<VDC> <Has_modality> "Chemotherapy" .
<R-TBI/Cy> <Is_a> "Rituximab-containing_regimen" .
<Folinic_acid> <Immunosuppressor_of> "Busulfan_and_Fludarabine" .
<Intraperitoneal_5-FU> <Has_antineoplastic> "Folinic_acid" .
<Intraperitoneal_5-FU> <Has_antineoplastic> "Fluorouracil" .
<CVAD> <Is_current_in> "Multiple_myeloma" .
<Lapatinib_and_Trastuzumab> <Has_accepted_use> "HER2-positive_Colon_cancer" .
<Lapatinib_and_Trastuzumab> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<Lapatinib_and_Trastuzumab> <Has_accepted_use> "Colon_cancer" .
<Lapatinib_and_Trastuzumab> <Has_accepted_use> "Breast_cancer" .
<Busulfan_and_Fludarabine> <Has_antineoplastic> "Fludarabine" .
<Busulfan_and_Fludarabine> <Has_antineoplastic> "Busulfan" .
<Entrectinib_monotherapy> <Has_modality> "Chemotherapy" .
<PVD> <Has_modality> "Chemotherapy" .
<Temozolomide,_then_Temozolomide_and_RT,_then_Temozolomide> <Has_accepted_use> "Anaplastic_glioma" .
<Floxuridine> <Has_accepted_use> "Colon_cancer" .
<Aminopterin_monotherapy> <Has_context> "Induction_therapy" .
<Altretamine_monotherapy> <Maps_to> "Altretamine_monotherapy" .
<7_plus_3d> <Has_accepted_use> "FLT3-positive_Acute_myeloid_leukemia" .
<7_plus_3d> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Dara-VMP> <Has_context> "Non-curative_first-line_therapy" .
<ECT,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Erlotinib_monotherapy> <Has_antineoplastic> "Erlotinib" .
<Lenvatinib_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Lenvatinib_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Lenvatinib_monotherapy> <Has_context> "All_lines_of_therapy" .
<TCH_(Taxotere,_Carboplatin)> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<TCH_(Taxotere,_Carboplatin)> <Has_accepted_use> "Breast_cancer" .
<Zoltem> <Brand_name_of> "Ondansetron" .
<Primsulfon> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Pretilon> <Brand_name_of> "Methylprednisolone" .
<Orazone> <Brand_name_of> "Dexamethasone" .
<Carboplatin,_Fluorouracil,_RT> <Mapped_from> "Carboplatin,_Fluorouracil,_RT" .
<Melphalan_monotherapy> <Mapped_from> "Melphalan_monotherapy" .
<CVPP> <Has_accepted_use> "Hodgkin_lymphoma" .
<Carboplatin_and_Gemcitabine/Erlotinib> <Maps_to> "Carboplatin_and_Gemcitabine/Erlotinib" .
<Bleomycin,_Methotrexate,_Vinblastine/RT> <Has_antineoplastic> "Vinblastine" .
<Bleomycin,_Methotrexate,_Vinblastine/RT> <Has_antineoplastic> "Methotrexate" .
<Bleomycin,_Methotrexate,_Vinblastine/RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Bleomycin,_Methotrexate,_Vinblastine/RT> <Has_antineoplastic> "Bleomycin" .
<Docetaxel,_Fluorouracil,_RT> <Maps_to> "Docetaxel,_Fluorouracil,_RT" .
<Capecitabine,_Mitomycin,_RT> <Has_antineoplastic> "Mitomycin" .
<Capecitabine,_Mitomycin,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Capecitabine,_Mitomycin,_RT> <Has_antineoplastic> "Capecitabine" .
<Cephalotaxine> <Is_a> "Chemotherapeutic" .
<Platosin> <Brand_name_of> "Cisplatin" .
<Ibrutinib_and_Rituximab> <Has_antineoplastic> "Rituximab" .
<Ibrutinib_and_Rituximab> <Has_antineoplastic> "Ibrutinib" .
<Thrombosis_medication> <Is_a> "Hematology_medication" .
<Anticoagulant> <Is_a> "Supportive_medication" .
<Anticoagulant> <Is_a> "Classical_hematology_medication" .
<Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin> <Is_current_in> "Acute_promyelocytic_leukemia" .
<Topotecan> <May_have_route> "Intravenous" .
<Exemestane_and_Tucidinostat> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Exemestane_and_Tucidinostat> <Has_accepted_use> "Breast_cancer" .
<Ganitumab> <Is_a> "Investigational_drug" .
<Ganitumab> <Is_a> "Antibody_medication" .
<Ganitumab> <Is_a> "Anti-IGF-1R_antibody" .
<Docetaxel_and_Irinotecan> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Docetaxel_and_Irinotecan> <Has_supportive_med> "Loperamide" .
<Docetaxel_and_Irinotecan> <Has_supportive_med> "Dexamethasone" .
<Cytarabine,_Ifosfamide,_G-CSF> <Maps_to> "Cytarabine,_Ifosfamide,_G-CSF" .
<Flamacorten> <Brand_name_of> "Prednisone" .
<7_plus_3d_and_Midostaurin> <Has_supportive_med> "Hydroxyurea" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Etoposide_and_TBI,_then_allo_HSCT> <Is_current_in> "T-cell_acute_lymphoblastic_leukemia" .
<Etoposide_and_TBI,_then_allo_HSCT> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Goserelin_and_RT> <Has_modality> "Radiotherapy" .
<Goserelin_and_RT> <Has_modality> "Hormonotherapy" .
<IGEV> <Has_context> "Non-curative_therapy" .
<Fluorouracil,_Oxaliplatin,_RT> <Mapped_from> "Fluorouracil,_Oxaliplatin,_RT" .
<Inferax> <Brand_name_of> "Interferon_alfa-2b" .
<VAD-P/Q> <Has_context> "Non-curative_first-line_therapy" .
<Cisplatin,_Fluorouracil,_Hydroxyurea,_RT> <Is_current_in> "Cervical_cancer" .
<CNOP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<CEF/CMF> <Mapped_from> "CEF/CMF" .
<Lenalidomide,_Dexamethasone,_Rituximab> <Is_a> "Rituximab-containing_regimen" .
<Befarin> <Brand_name_of> "Warfarin" .
<Ener-B> <Brand_name_of> "Cyanocobalamin" .
<Rituximab> <Supportive_med_of> "Rituximab_monotherapy" .
<Rituximab> <Supportive_med_of> "Obinutuzumab_monotherapy" .
<Bevacizumab-containing_therapy> <Is_current_in> "Breast_cancer" .
<Factor_IX_recombinant_Fc_fusion_protein> <May_have_route> "Intravenous" .
<IT_Methotrexate_and_Methylprednisolone> <Mapped_from> "IT_Methotrexate_and_Methylprednisolone" .
<Amrubicin_monotherapy> <Mapped_from> "Amrubicin_monotherapy" .
<Calaspargase,_Daunorubicin,_Vincristine,_Prednisone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Trixilem> <Brand_name_of> "Methotrexate" .
<Tegafur_and_uracil> <May_have_route> "Oral" .
<Pixantrone> <May_have_route> "Intravenous" .
<Necitumumab_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Ibrutinib_monotherapy> <Has_antineoplastic> "Ibrutinib" .
<ProMACE-MOPP> <Has_accepted_use> "Follicular_lymphoma" .
<ProMACE-MOPP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<CVB> <Is_historical_in> "Hodgkin_lymphoma" .
<Cytarabine_and_Thioguanine> <Is_current_in> "Acute_myeloid_leukemia" .
<Everolimus_and_Octreotide> <Mapped_from> "Everolimus_and_Octreotide" .
<VH> <Is_current_in> "Breast_cancer" .
<Melphalan_and_Methylprednisolone,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Medifolin> <Brand_name_of> "Folinic_acid" .
<Cytarabine,_Daunorubicin,_Vincristine> <Has_antineoplastic> "Vincristine" .
<Cytarabine,_Daunorubicin,_Vincristine> <Has_antineoplastic> "Daunorubicin" .
<Cytarabine,_Daunorubicin,_Vincristine> <Has_antineoplastic> "Cytarabine" .
<Anti-CD33_antibody> <Subsumes> "Vadastuximab_talirine" .
<Anti-CD33_antibody> <Subsumes> "Gemtuzumab_ozogamicin" .
<Anti-CD33_antibody> <Subsumes> "Actinium_Ac_225_lintuzumab" .
<Anti-CD33_antibody> <Subsumes> "AMG_330" .
<Epirubicin> <Has_accepted_use> "Testicular_cancer" .
<Epirubicin> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Epirubicin> <Has_accepted_use> "Small_cell_lung_cancer" .
<Epirubicin> <Has_accepted_use> "Pancreatic_cancer" .
<Epirubicin> <Has_accepted_use> "Osteosarcoma" .
<Epirubicin> <Has_accepted_use> "Hodgkin_lymphoma" .
<Epirubicin> <Has_accepted_use> "Gastric_cancer" .
<Epirubicin> <Has_accepted_use> "Esophageal_cancer" .
<Epirubicin> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Epirubicin> <Has_accepted_use> "Cholangiocarcinoma" .
<Epirubicin> <Has_accepted_use> "Breast_cancer" .
<Idelalisib_and_Rituximab> <Has_antineoplastic> "Rituximab" .
<Idelalisib_and_Rituximab> <Has_antineoplastic> "Idelalisib" .
<Belotecan_and_Cisplatin> <Has_accepted_use> "Small_cell_lung_cancer" .
<Gefitinib_and_Pemetrexed> <Has_context> "Non-curative_therapy" .
<ADT,_Docetaxel,_Estramustine> <Is_current_in> "Prostate_cancer" .
<Hexaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Hydroxyzine> <Has_brand_name> "Atarax" .
<Trabectedin_monotherapy> <Mapped_from> "Trabectedin_monotherapy" .
<Lutetium_Lu_177_dotatate_and_Octreotide_LAR> <Mapped_from> "Lutetium_Lu_177_dotatate_and_Octreotide_LAR" .
<R-CVEP> <Is_a> "Rituximab-containing_regimen" .
<Belotecan> <Has_brand_name> "Camptobell" .
<Methotrexate_and_Tacrolimus> <Mapped_from> "Methotrexate_and_Tacrolimus" .
<LD-ACOP-B> <Has_modality> "Chemotherapy" .
<D-ZAPO> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Docetaxel_and_Nintedanib> <Maps_to> "Docetaxel_and_Nintedanib" .
<Famotidine> <May_have_route> "Oral" .
<Famotidine> <May_have_route> "Intravenous" .
<ChlVPP/EVA> <Mapped_from> "ChlVPP/EVA" .
<VACA/IE> <Has_context> "Neoadjuvant_therapy" .
<ddAC-T> <Is_current_in> "Breast_cancer" .
<Cisplatin,_Vinorelbine,_RT> <Has_modality> "Radiotherapy" .
<Cisplatin,_Vinorelbine,_RT> <Has_modality> "Chemotherapy" .
<G-CHOP> <Is_a> "Anthracycline-containing_regimen" .
<Remcyta> <Brand_name_of> "Cytarabine" .
<Panobinostat> <May_have_route> "Oral" .
<Fulvestrant_and_Ribociclib> <Has_modality> "Hormonotherapy" .
<Fulvestrant_and_Ribociclib> <Has_modality> "Chemotherapy" .
<Idelalisib> <Antineoplastic_of> "Idelalisib_monotherapy" .
<Idelalisib> <Antineoplastic_of> "Idelalisib_and_Rituximab" .
<Idelalisib> <Antineoplastic_of> "Idelalisib_and_Ofatumumab" .
<Idelalisib> <Antineoplastic_of> "BR_and_Idelalisib" .
<Pegaspargase> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Pegaspargase> <Is_a> "Pegylated_medication" .
<Pegaspargase> <Is_a> "Neutral" .
<Pegaspargase> <Is_a> "Enzyme" .
<STAMP-I> <Has_accepted_use> "Breast_cancer" .
<Capecitabine_and_Fulvestrant> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Capecitabine_and_Fulvestrant> <Has_accepted_use> "Breast_cancer" .
<Cyclosporine_modified> <May_have_route> "Oral" .
<GDPT> <Has_supportive_med> "Aspirin" .
<Melphalan,_then_auto_HSCT> <Maps_to> "Melphalan,_then_auto_HSCT" .
<Aspirin_and_Hydroxyurea> <Has_accepted_use> "Essential_thrombocythemia" .
<ProMACE-CytaBOM> <Mapped_from> "ProMACE-CytaBOM" .
<Duvelisib> <Antineoplastic_of> "Duvelisib_monotherapy" .
<Pazopanib> <Has_brand_name> "Votrient" .
<CEOP_(Prednisolone)> <Has_context> "Induction_therapy" .
<Venetoclax_and_Rituximab> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<MVP_and_RT> <Has_antineoplastic> "Vindesine" .
<MVP_and_RT> <Has_antineoplastic> "Mitomycin" .
<MVP_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<MVP_and_RT> <Has_antineoplastic> "Cisplatin" .
<R-Hyper-CVAD/R-MA> <Mapped_from> "R-Hyper-CVAD/R-MA" .
<Temsirolimus_monotherapy> <Has_accepted_use> "Renal_cell_carcinoma" .
<Temsirolimus_monotherapy> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Temsirolimus_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<Temsirolimus_monotherapy> <Has_accepted_use> "Endometrial_cancer" .
<Temsirolimus_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Temsirolimus_monotherapy> <Has_accepted_use> "CNS_lymphoma" .
<Gilteritinib_monotherapy> <Has_modality> "Chemotherapy" .
<Paclitaxel,_Topotecan,_Bevacizumab> <Has_antineoplastic> "Topotecan" .
<Paclitaxel,_Topotecan,_Bevacizumab> <Has_antineoplastic> "Paclitaxel" .
<Paclitaxel,_Topotecan,_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Granulocyte_macrophage_colony-stimulating_factor> <Is_a> "Granulocyte_growth_factor" .
<Acapodene> <Brand_name_of> "Toremifene" .
<ERBB3-mutated_malignancy> <Is_a> "Malignant_solid_neoplasm" .
<Castration> <Is_historical_in> "Prostate_cancer" .
<Pazopanib_monotherapy> <Has_antineoplastic> "Pazopanib" .
<COPADM> <Is_a> "Anthracycline-containing_regimen" .
<Clofarabine_monotherapy> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Clofarabine_monotherapy> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Clofarabine_monotherapy> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Dazine> <Brand_name_of> "Dacarbazine" .
<Enfortumab_vedotin_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<VAD_doxil> <Has_modality> "Chemotherapy" .
<Lyphidox> <Brand_name_of> "Doxorubicin" .
<Perfolate> <Brand_name_of> "Folinic_acid" .
<VEPA> <Has_context> "Induction_therapy" .
<LEED> <Has_antineoplastic> "Melphalan" .
<LEED> <Has_antineoplastic> "Etoposide" .
<LEED> <Has_antineoplastic> "Dexamethasone" .
<LEED> <Has_antineoplastic> "Cyclophosphamide" .
<Afatinib_and_Cetuximab> <Maps_to> "Afatinib_and_Cetuximab" .
<Dabrafenib,_Trametinib,_Panitumumab> <Is_current_in> "Colon_cancer" .
<Hydab> <Brand_name_of> "Hydroxyurea" .
<Dexameth> <Brand_name_of> "Dexamethasone" .
<Nelarabine> <Antineoplastic_of> "Nelarabine_monotherapy" .
<Nelarabine> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine" .
<Trimeril> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Suptrex> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<EVAIA> <Has_antineoplastic> "Vincristine" .
<EVAIA> <Has_antineoplastic> "Ifosfamide" .
<EVAIA> <Has_antineoplastic> "Etoposide" .
<EVAIA> <Has_antineoplastic> "Doxorubicin" .
<EVAIA> <Has_antineoplastic> "Dactinomycin" .
<BMP> <Has_antineoplastic> "Methotrexate" .
<BMP> <Has_antineoplastic> "Cisplatin" .
<BMP> <Has_antineoplastic> "Bleomycin" .
<mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)> <Mapped_from> "mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)" .
<Carbomerck> <Brand_name_of> "Carboplatin" .
<FOLFIRI_and_Bevacizumab> <Mapped_from> "FOLFIRI_and_Bevacizumab" .
<HAM_and_Imatinib> <Is_a> "Anthracycline-containing_regimen" .
<Nilotinib-based_consolidation> <Is_a> "Anthracycline-containing_regimen" .
<Radiation> <Is_a> "Intervention_index" .
<Lomustine_and_Bevacizumab> <Mapped_from> "Lomustine_and_Bevacizumab" .
<ADT_and_RT> <Has_antineoplastic> "GnRH_agonists" .
<ADT_and_RT> <Has_antineoplastic> "Flutamide" .
<ADT_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<ADT_and_RT> <Has_antineoplastic> "Endocrine_ablation_surgery" .
<ADT_and_RT> <Has_antineoplastic> "Bicalutamide" .
<Zapron> <Brand_name_of> "Ondansetron" .
<HiDAC_and_Midostaurin> <Has_accepted_use> "FLT3-positive_Acute_myeloid_leukemia" .
<HiDAC_and_Midostaurin> <Has_accepted_use> "Acute_myeloid_leukemia" .
<IT_Cytarabine_and_Methotrexate> <Has_context> "Local_therapy" .
<Twelve_Resin-K> <Brand_name_of> "Cyanocobalamin" .
<Cladribine_monotherapy> <Is_current_in> "Systemic_mastocytosis" .
<Cladribine_monotherapy> <Is_current_in> "Marginal_zone_lymphoma" .
<Cladribine_monotherapy> <Is_current_in> "Mantle_cell_lymphoma" .
<Cladribine_monotherapy> <Is_current_in> "Langerhans_cell_histiocytosis" .
<Cladribine_monotherapy> <Is_current_in> "Hairy_cell_leukemia" .
<Cladribine_monotherapy> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Cyclostine> <Brand_name_of> "Cyclophosphamide" .
<Thalidomide> <Has_brand_name> "Zuvimide" .
<Thalidomide> <Has_brand_name> "Thalomid" .
<Thalidomide> <Has_brand_name> "Thalix" .
<Thalidomide> <Has_brand_name> "Thalide" .
<Thalidomide> <Has_brand_name> "Thaangio" .
<Penicillin_V> <May_have_route> "Oral" .
<CEV_(Carboplatin/Etoposide)> <Has_accepted_use> "Small_cell_lung_cancer" .
<VAMP_(Amethopterin)> <Has_accepted_use> "Acute_myeloid_leukemia" .
<CHVmP> <Mapped_from> "CHVmP" .
<ddC> <Has_antineoplastic> "Cyclophosphamide" .
<Dactinomycin_monotherapy> <Has_modality> "Chemotherapy" .
<Temozolomide_and_RT,_then_Temozolomide> <Maps_to> "Temozolomide_and_RT,_then_Temozolomide" .
<Irinogen> <Brand_name_of> "Irinotecan" .
<Dexacortal> <Brand_name_of> "Dexamethasone" .
<Nitrosourea> <Is_a> "Alkylating_agent" .
<Cobimetinib_monotherapy> <Mapped_from> "Cobimetinib_monotherapy" .
<Axitinib_and_Pembrolizumab> <Has_modality> "Immunotherapy" .
<Axitinib_and_Pembrolizumab> <Has_modality> "Chemotherapy" .
<Genoxzole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Prednicen-M> <Brand_name_of> "Prednisone" .
<Accelerated_BEP> <Has_supportive_med> "Pegfilgrastim" .
<Thalidomide_and_Prednisone> <Has_modality> "Chemotherapy" .
<Trancodol> <Brand_name_of> "Haloperidol" .
<Ofatumumab> <Is_a> "Antibody_medication" .
<Ofatumumab> <Is_a> "Anti-CD20_medication" .
<Ofatumumab> <Is_a> "Anti-CD20_antibody" .
<Capecitabine,_Docetaxel,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Capecitabine,_Docetaxel,_RT> <Has_antineoplastic> "Docetaxel" .
<Capecitabine,_Docetaxel,_RT> <Has_antineoplastic> "Capecitabine" .
<Veliparib> <May_have_route> "Oral" .
<Brentuximab_vedotin> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Brentuximab_vedotin> <Has_accepted_use> "Mediastinal_gray-zone_lymphoma" .
<Brentuximab_vedotin> <Has_accepted_use> "Hodgkin_lymphoma" .
<Brentuximab_vedotin> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Brentuximab_vedotin> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Brentuximab_vedotin> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<Folotyn> <Brand_name_of> "Pralatrexate" .
<Depoject> <Brand_name_of> "Methylprednisolone" .
<Vincristine_liposomal_monotherapy> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<COP-Bleo> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<AALL0232_consolidation> <Mapped_from> "AALL0232_consolidation" .
<CTCb> <Maps_to> "CTCb" .
<Samarium-153_monotherapy> <Mapped_from> "Samarium-153_monotherapy" .
<Amoxihexal> <Brand_name_of> "Amoxicillin" .
<TMF> <Is_historical_in> "Breast_cancer" .
<Nitrogen_mustard> <Is_a> "Alkylating_agent" .
<Zoledronic_acid_therapy> <Maps_to> "Zoledronic_acid_therapy" .
<Temsirolimus_and_Rituximab> <Is_current_in> "Mantle_cell_lymphoma" .
<Nordic_Regimen,_younger_patients> <Is_current_in> "CNS_lymphoma" .
<EDC> <Is_a> "Anthracycline-containing_regimen" .
<Epomax> <Brand_name_of> "Epoetin_alfa" .
<Hydroxyurea_monotherapy> <Maps_to> "Hydroxyurea_monotherapy" .
<Kodolo> <Brand_name_of> "Dexamethasone" .
<Carmubris> <Brand_name_of> "Carmustine" .
<Omacetaxine_monotherapy> <Has_modality> "Chemotherapy" .
<R-DHAP> <Maps_to> "R-DHAP" .
<Acesal> <Brand_name_of> "Aspirin" .
<RT,_then_Temozolomide> <Has_accepted_use> "Anaplastic_glioma" .
<CCI> <Maps_to> "CCI" .
<Temozolomide> <Antineoplastic_of> "Temozolomide,_then_Temozolomide_and_RT,_then_Temozolomide" .
<Temozolomide> <Antineoplastic_of> "Temozolomide_monotherapy" .
<Temozolomide> <Antineoplastic_of> "Temozolomide_and_low-dose_RT" .
<Temozolomide> <Antineoplastic_of> "Temozolomide_and_Thalidomide" .
<Temozolomide> <Antineoplastic_of> "Temozolomide_and_RT,_then_Temozolomide" .
<Temozolomide> <Antineoplastic_of> "Temozolomide_and_RT" .
<Temozolomide> <Antineoplastic_of> "Temozolomide_and_NovoTTF-100A" .
<Temozolomide> <Antineoplastic_of> "Temozolomide_and_Bevacizumab" .
<Temozolomide> <Antineoplastic_of> "RT,_then_Temozolomide" .
<Temozolomide> <Antineoplastic_of> "MT-R" .
<Temozolomide> <Antineoplastic_of> "Lomustine,_Temozolomide,_RT" .
<Temozolomide> <Antineoplastic_of> "Irinotecan,_Temozolomide,_Dinutuximab" .
<Temozolomide> <Antineoplastic_of> "Irinotecan_and_Temozolomide" .
<Temozolomide> <Antineoplastic_of> "Capecitabine_and_Temozolomide" .
<R-INO> <Has_antineoplastic> "Rituximab" .
<R-INO> <Has_antineoplastic> "Inotuzumab_ozogamicin" .
<Carboplatin_and_Paclitaxel> <Has_modality> "Chemotherapy" .
<Penetrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Capecitabine_and_Ixabepilone> <Has_context> "Non-curative_subsequent-line_therapy" .
<Pentam> <Brand_name_of> "Pentamidine" .
<Fluorouracil,_Mitomycin,_RT> <Is_current_in> "Head_and_neck_cancer" .
<Fluorouracil,_Mitomycin,_RT> <Is_current_in> "Cervical_cancer" .
<Fluorouracil,_Mitomycin,_RT> <Is_current_in> "Bladder_cancer" .
<Fluorouracil,_Mitomycin,_RT> <Is_current_in> "Anal_cancer" .
<COPDAC> <Maps_to> "COPDAC" .
<PCR> <Has_antineoplastic> "Rituximab" .
<PCR> <Has_antineoplastic> "Pentostatin" .
<PCR> <Has_antineoplastic> "Cyclophosphamide" .
<Carboplatin_and_Bevacizumab> <Mapped_from> "Carboplatin_and_Bevacizumab" .
<Dexamethasone_and_Rituximab> <Maps_to> "Dexamethasone_and_Rituximab" .
<Lanreotide> <Is_a> "Somatostatin_analog" .
<Lanreotide> <Is_a> "Endocrine_therapeutic" .
<SAL-Adult> <Brand_name_of> "Aspirin" .
<Dabrafenib_and_Trametinib> <Maps_to> "Dabrafenib_and_Trametinib" .
<Vascular_sarcoma> <Is_a> "Soft_tissue_sarcoma" .
<Sipuleucel-T> <Has_accepted_use> "Prostate_cancer" .
<IT_Cytarabine,_Methotrexate,_WBRT> <Has_local_therapy> "Methotrexate" .
<IT_Cytarabine,_Methotrexate,_WBRT> <Has_local_therapy> "Cytarabine" .
<Megestrol> <May_have_route> "Oral" .
<CAD_and_G-CSF> <Has_modality> "Growth_factor_therapy" .
<CAD_and_G-CSF> <Has_modality> "Chemotherapy" .
<Depakine> <Brand_name_of> "Valproate" .
<Rituximab_and_hyaluronidase_monotherapy> <Is_current_in> "Follicular_lymphoma" .
<Methylprednisolone_monotherapy> <Has_accepted_use> "Thrombotic_thrombocytopenic_purpura" .
<Anthracin> <Brand_name_of> "Epirubicin" .
<TAM6,_then_auto_HSCT> <Has_antineoplastic> "Melphalan" .
<TAM6,_then_auto_HSCT> <Has_antineoplastic> "External_beam_radiotherapy" .
<TAM6,_then_auto_HSCT> <Has_antineoplastic> "Cytarabine" .
<Helicobacter_pylori_eradication_therapy> <Maps_to> "Helicobacter_pylori_eradication_therapy" .
<DTPACE> <Is_current_in> "Multiple_myeloma" .
<Rimazole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cytarabine_and_Idarubicin> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Cytarabine_and_Idarubicin> <Is_current_in> "Acute_promyelocytic_leukemia" .
<Cytarabine_and_Idarubicin> <Is_current_in> "Acute_myeloid_leukemia" .
<Castleman_disease> <FDA_indication_of> "Siltuximab" .
<Cyclosporine_and_Prednisone> <Has_context> "All_lines_of_therapy" .
<Deltasoralen> <Brand_name_of> "Methoxsalen" .
<R-GCVP> <Has_local_therapy> "Methotrexate" .
<Cytarabine,_Idarubicin,_Vorinostat> <Has_supportive_med> "Methylprednisolone" .
<M-DEX> <Has_accepted_use> "Multiple_myeloma" .
<M-DEX> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Obinutuzumab_monotherapy> <Has_modality> "Chemotherapy" .
<Antithymocyte_globulin_horse_ATG> <Immunosuppressor_of> "FCR,_then_allo_HSCT" .
<Antithymocyte_globulin_horse_ATG> <Immunosuppressor_of> "FCR" .
<Antithymocyte_globulin_horse_ATG> <Immunosuppressor_of> "ATG_(Horse),_Cyclosporine,_Sirolimus" .
<Antithymocyte_globulin_horse_ATG> <Immunosuppressor_of> "ATG_(Horse),_Cyclosporine,_Methylprednisolone" .
<Antithymocyte_globulin_horse_ATG> <Immunosuppressor_of> "ATG_(Horse),_Cyclosporine,_G-CSF" .
<Antithymocyte_globulin_horse_ATG> <Immunosuppressor_of> "ATG_(Horse),_Cyclosporine,_Eltrombopag" .
<Antithymocyte_globulin_horse_ATG> <Immunosuppressor_of> "ATG_(Horse)_monotherapy" .
<Antithymocyte_globulin_horse_ATG> <Immunosuppressor_of> "ATG_(Horse)_and_Cyclosporine" .
<Tazverik> <Brand_name_of> "Tazemetostat" .
<Ropeginterferon_alfa-2b> <Is_a> "Investigational_drug" .
<Ropeginterferon_alfa-2b> <Is_a> "Interferon" .
<Ropeginterferon_alfa-2b> <Is_a> "Immunotherapeutic" .
<Nexadron> <Brand_name_of> "Dexamethasone" .
<Lisaspin> <Brand_name_of> "Aspirin" .
<Decitabine_monotherapy> <Maps_to> "Decitabine_monotherapy" .
<PAF> <Mapped_from> "PAF" .
<R-CP> <Has_antineoplastic> "Rituximab" .
<R-CP> <Has_antineoplastic> "Prednisone" .
<R-CP> <Has_antineoplastic> "Methylprednisolone" .
<R-CP> <Has_antineoplastic> "Cyclophosphamide" .
<BRAF-mutated_malignancy> <Is_a> "Malignant_solid_neoplasm" .
<R-DHAP> <Is_a> "Rituximab-containing_regimen" .
<Methylprednisolone> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Methylprednisolone> <Is_a> "Steroid" .
<Methylprednisolone> <Is_a> "Immunosuppressant" .
<Enzyme> <Is_a> "Drugs_by_class_effect" .
<Cabazitaxel> <Is_a> "Taxane" .
<Aspirisucre> <Brand_name_of> "Aspirin" .
<Dexinga> <Brand_name_of> "Dexamethasone" .
<EDAP> <Has_context> "Non-curative_therapy" .
<EDAP> <Has_context> "Non-curative_first-line_therapy" .
<FUOX> <Has_antineoplastic> "Oxaliplatin" .
<FUOX> <Has_antineoplastic> "Fluorouracil" .
<O-miniCHOP> <Has_antineoplastic> "Vincristine" .
<O-miniCHOP> <Has_antineoplastic> "Prednisone" .
<O-miniCHOP> <Has_antineoplastic> "Ofatumumab" .
<O-miniCHOP> <Has_antineoplastic> "Doxorubicin" .
<O-miniCHOP> <Has_antineoplastic> "Cyclophosphamide" .
<7_plus_3d_and_Glasdegib> <Has_antineoplastic> "Glasdegib" .
<7_plus_3d_and_Glasdegib> <Has_antineoplastic> "Daunorubicin" .
<7_plus_3d_and_Glasdegib> <Has_antineoplastic> "Cytarabine" .
<Gliadel_wafer_monotherapy> <Maps_to> "Gliadel_wafer_monotherapy" .
<Hyper-CVAD_and_Ponatinib> <Has_antineoplastic> "Vincristine" .
<Hyper-CVAD_and_Ponatinib> <Has_antineoplastic> "Ponatinib" .
<Hyper-CVAD_and_Ponatinib> <Has_antineoplastic> "Methotrexate" .
<Hyper-CVAD_and_Ponatinib> <Has_antineoplastic> "Doxorubicin" .
<Hyper-CVAD_and_Ponatinib> <Has_antineoplastic> "Dexamethasone" .
<Hyper-CVAD_and_Ponatinib> <Has_antineoplastic> "Cytarabine" .
<Hyper-CVAD_and_Ponatinib> <Has_antineoplastic> "Cyclophosphamide" .
<Ruxolitinib> <Has_FDA_indication> "Polycythemia_vera" .
<Ruxolitinib> <Has_FDA_indication> "Myelofibrosis" .
<Ruxolitinib> <Has_FDA_indication> "Graft_versus_host_disease" .
<Fludarabine,_Busulfan,_Cyclophosphamide> <Has_immunosuppressor> "Tacrolimus" .
<Fludarabine,_Busulfan,_Cyclophosphamide> <Has_immunosuppressor> "Mycophenolate_mofetil" .
<Fludarabine,_Busulfan,_Cyclophosphamide> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<Finaber> <Brand_name_of> "Ondansetron" .
<VCAP> <Maps_to> "VCAP" .
<PUVA> <Is_current_in> "Cutaneous_T-cell_lymphoma" .
<Temozolomide_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Betrixaban_monotherapy> <Maps_to> "Betrixaban_monotherapy" .
<R-INO> <Has_accepted_use> "Follicular_lymphoma" .
<R-INO> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<FEMTX> <Mapped_from> "FEMTX" .
<Ixabepilone_monotherapy> <Is_current_in> "Breast_cancer" .
<Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone> <Has_context> "Induction_therapy" .
<Thiotepa_monotherapy> <Mapped_from> "Thiotepa_monotherapy" .
<Interferon_alfa-n1_monotherapy> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<AALL0232_consolidation> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<OLF> <Maps_to> "OLF" .
<Talazoparib> <Has_accepted_use> "Breast_cancer" .
<VI,_then_VDC/IE,_then_VAC,_then_VI> <Has_accepted_use> "Rhabdomyosarcoma" .
<Mogamulizumab_monotherapy> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Mogamulizumab_monotherapy> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Chlorambucil_and_Cisplatin> <Mapped_from> "Chlorambucil_and_Cisplatin" .
<ICE> <Has_accepted_use> "Small_cell_lung_cancer" .
<ICE> <Has_accepted_use> "Osteosarcoma" .
<ICE> <Has_accepted_use> "Hodgkin_lymphoma" .
<ICE> <Has_accepted_use> "Ewing_sarcoma" .
<ICE> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Cisplatin,_Etoposide,_Durvalumab> <Has_context> "Induction_therapy" .
<Bendamustine_and_Brentuximab_vedotin> <Has_modality> "Chemotherapy" .
<Bortezomib_and_Panobinostat> <Mapped_from> "Bortezomib_and_Panobinostat" .
<Biocrist> <Brand_name_of> "Vincristine" .
<Periblastine> <Brand_name_of> "Vinblastine" .
<Lenalidomide_and_Ofatumumab> <Has_antineoplastic> "Ofatumumab" .
<Lenalidomide_and_Ofatumumab> <Has_antineoplastic> "Lenalidomide" .
<Novantrone> <Brand_name_of> "Mitoxantrone" .
<FAC> <Has_modality> "Chemotherapy" .
<Cytarabine_and_Daunorubicin> <Is_current_in> "Acute_promyelocytic_leukemia" .
<Cytarabine_and_Daunorubicin> <Is_current_in> "Acute_myeloid_leukemia" .
<R2CHOP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Carmustine_monotherapy> <Has_antineoplastic> "Carmustine" .
<GTPase-activating_protein_inhibitor> <Is_a> "Chemotherapeutic" .
<Vorinostat_monotherapy> <Maps_to> "Vorinostat_monotherapy" .
<MAPI> <Has_antineoplastic> "Methotrexate" .
<MAPI> <Has_antineoplastic> "Mesna" .
<MAPI> <Has_antineoplastic> "Ifosfamide" .
<MAPI> <Has_antineoplastic> "Doxorubicin" .
<MAPI> <Has_antineoplastic> "Cisplatin" .
<Methotrexate,_then_Cytarabine> <Has_accepted_use> "CNS_lymphoma" .
<Lung_cancer> <Is_a> "Thoracic_cancer" .
<Ceritinib_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Ceritinib_monotherapy> <Is_current_in> "CNS_carcinoma" .
<Bicalutamide_and_Leuprolide> <Has_antineoplastic> "Leuprolide" .
<Bicalutamide_and_Leuprolide> <Has_antineoplastic> "Bicalutamide" .
<Gastric_cancer> <Historic_treated_by> "Fluorouracil_monotherapy" .
<Gastric_cancer> <Historic_treated_by> "Fluorouracil_and_RT" .
<Gastric_cancer> <Historic_treated_by> "Fluorouracil_and_Mitomycin" .
<Gastric_cancer> <Historic_treated_by> "FEMTX" .
<Gastric_cancer> <Historic_treated_by> "FAMTX" .
<Gastric_cancer> <Historic_treated_by> "FAM" .
<Gastric_cancer> <Historic_treated_by> "Doxorubicin_and_Fluorouracil" .
<Gastric_cancer> <Historic_treated_by> "Doxifluridine_and_Mitomycin" .
<Gastric_cancer> <Historic_treated_by> "Best_supportive_care" .
<BEAC,_then_auto_HSCT> <Maps_to> "BEAC,_then_auto_HSCT" .
<Cisplatin_and_Etoposide> <Is_a> "Platinum_doublet" .
<Cyclophospham> <Brand_name_of> "Cyclophosphamide" .
<Lenalidomide_and_Ofatumumab> <Has_context> "Non-curative_therapy" .
<Mercaptopurine,_Methotrexate,_WB-XRT> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Amatuximab> <Is_a> "Investigational_drug" .
<Amatuximab> <Is_a> "Antibody_medication" .
<Amatuximab> <Is_a> "Anti-mesothelin_antibody" .
<Bevacizumab_and_RT> <Mapped_from> "Bevacizumab_and_RT" .
<Vasopressin_analog> <Is_a> "Classical_hematology_medication" .
<FOLFIRI_and_Cetuximab_(L-Leucovorin)> <Has_context> "Non-curative_first-line_therapy" .
<Tilios> <Brand_name_of> "Alendronate" .
<Sonidegib> <Has_FDA_indication> "Cutaneous_basal_cell_carcinoma" .
<CISCA/VB> <Has_context> "Upfront_therapy" .
<CEP> <Has_context> "Salvage_therapy" .
<CEP> <Has_context> "Non-curative_first-line_therapy" .
<CBV> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<CBV> <Has_supportive_med> "Levofloxacin" .
<CBV> <Has_supportive_med> "Fluconazole" .
<CBV> <Has_supportive_med> "Filgrastim" .
<CBV> <Has_supportive_med> "Acyclovir" .
<Teniposide_and_WBRT> <Has_accepted_use> "CNS_carcinoma" .
<Docetaxel_and_Gemcitabine> <Mapped_from> "Docetaxel_and_Gemcitabine" .
<Cutaneous_basal_cell_carcinoma> <Current_treated_by> "Vismodegib_monotherapy" .
<Cutaneous_basal_cell_carcinoma> <Current_treated_by> "Sonidegib_monotherapy" .
<Cutaneous_basal_cell_carcinoma> <Current_treated_by> "Cisplatin_and_Paclitaxel" .
<Cutaneous_basal_cell_carcinoma> <Current_treated_by> "Cisplatin_and_Doxorubicin" .
<Cutaneous_basal_cell_carcinoma> <Current_treated_by> "Bleomycin_and_Cisplatin" .
<PEN> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Cisplatin,_Etoposide,_Bevacizumab> <Has_antineoplastic> "Etoposide" .
<Cisplatin,_Etoposide,_Bevacizumab> <Has_antineoplastic> "Cisplatin" .
<Cisplatin,_Etoposide,_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<RCC> <Has_modality> "Chemotherapy" .
<HAIC_and_Sorafenib> <Has_context> "Non-curative_first-line_therapy" .
<Amixam> <Brand_name_of> "Tranexamic_acid" .
<F-MACHOP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Interferon_alfa-2a_and_Interleukin-2> <Mapped_from> "Interferon_alfa-2a_and_Interleukin-2" .
<Anastrozole_and_Fulvestrant> <Has_modality> "Hormonotherapy" .
<Gemcitabine_and_Paclitaxel> <Mapped_from> "Gemcitabine_and_Paclitaxel" .
<Solcort> <Brand_name_of> "Dexamethasone" .
<Bandrobon> <Brand_name_of> "Ibandronate" .
<Lederfoline> <Brand_name_of> "Folinic_acid" .
<L-glutamine> <Has_brand_name> "Endari" .
<7_plus_3d> <Is_a> "Anthracycline-containing_regimen" .
<VBMC> <Has_modality> "Chemotherapy" .
<Induction_therapy> <Maps_to> "Induction_therapy" .
<Bendamustine_and_Ofatumumab> <Has_context> "Non-curative_therapy" .
<Bendamustine_and_Ofatumumab> <Has_context> "Non-curative_first-line_therapy" .
<HOP> <Has_modality> "Chemotherapy" .
<STAMP-I> <Has_context> "Non-curative_therapy" .
<Peripheral_T-cell_lymphoma> <Is_a> "T-cell_lymphoma" .
<Ucalon> <Brand_name_of> "Dexamethasone" .
<Pixantrone_monotherapy> <Has_modality> "Chemotherapy" .
<R-MACLO/R-IVAM> <Mapped_from> "R-MACLO/R-IVAM" .
<BRAF-mutated_Melanoma> <Accepted_use_of> "Vemurafenib_monotherapy" .
<BRAF-mutated_Melanoma> <Accepted_use_of> "Trametinib_monotherapy" .
<BRAF-mutated_Melanoma> <Accepted_use_of> "Paclitaxel_monotherapy" .
<BRAF-mutated_Melanoma> <Accepted_use_of> "Dacarbazine_monotherapy" .
<BRAF-mutated_Melanoma> <Accepted_use_of> "Dabrafenib_monotherapy" .
<BRAF-mutated_Melanoma> <Accepted_use_of> "Dabrafenib_and_Trametinib" .
<BRAF-mutated_Melanoma> <Accepted_use_of> "Cobimetinib_and_Vemurafenib" .
<BRAF-mutated_Melanoma> <Accepted_use_of> "Binimetinib_and_Encorafenib" .
<Ezadex> <Brand_name_of> "Fluorouracil" .
<Panwarfin> <Brand_name_of> "Warfarin" .
<DICEP> <Mapped_from> "DICEP" .
<Lomustine,_Temozolomide,_RT> <Has_antineoplastic> "Temozolomide" .
<Lomustine,_Temozolomide,_RT> <Has_antineoplastic> "Lomustine" .
<Lomustine,_Temozolomide,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Capecitabine_and_Gemcitabine> <Mapped_from> "Capecitabine_and_Gemcitabine" .
<CNOP_(Prednisolone)> <Has_modality> "Chemotherapy" .
<nab-Paclitaxel_and_Atezolizumab> <Maps_to> "nab-Paclitaxel_and_Atezolizumab" .
<Pembrolizumab_monotherapy> <Maps_to> "Pembrolizumab_monotherapy" .
<Cisplatin,_Gemcitabine,_Bevacizumab> <Has_antineoplastic> "Gemcitabine" .
<Cisplatin,_Gemcitabine,_Bevacizumab> <Has_antineoplastic> "Cisplatin" .
<Cisplatin,_Gemcitabine,_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Fluoxymesterone> <May_have_route> "Oral" .
<L-Asparaginase,_Vincristine,_Dexamethasone> <Maps_to> "L-Asparaginase,_Vincristine,_Dexamethasone" .
<Oncolytic_viral_therapy> <Subsumes> "Talimogene_laherparepvec" .
<5_plus_3d> <Is_a> "Anthracycline-containing_regimen" .
<Mielastra> <Brand_name_of> "Filgrastim" .
<Alemtuzumab> <Antineoplastic_of> "Pentostatin_and_Alemtuzumab" .
<Alemtuzumab> <Antineoplastic_of> "Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT" .
<Alemtuzumab> <Antineoplastic_of> "Fludarabine,_Melphalan,_Alemtuzumab" .
<Alemtuzumab> <Antineoplastic_of> "Fludarabine_and_Alemtuzumab" .
<Alemtuzumab> <Antineoplastic_of> "FluCam" .
<Alemtuzumab> <Antineoplastic_of> "FCA" .
<Alemtuzumab> <Antineoplastic_of> "CHOP-AL" .
<Alemtuzumab> <Antineoplastic_of> "CFAR" .
<Alemtuzumab> <Antineoplastic_of> "Alemtuzumab_monotherapy" .
<Alemtuzumab> <Antineoplastic_of> "Alemtuzumab_and_Rituximab" .
<Alemtuzumab> <Antineoplastic_of> "Alemtuzumab_and_Methylprednisolone" .
<CALGB_10-002_regimen> <Has_modality> "Chemotherapy" .
<Asparaginase_Erwinia_chrysanthemi> <Antineoplastic_of> "Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone" .
<Asparaginase_Erwinia_chrysanthemi> <Antineoplastic_of> "AspaMetDex_(Erwinaze)" .
<Moxetumomab_pasudotox_monotherapy> <Mapped_from> "Moxetumomab_pasudotox_monotherapy" .
<Merideca> <Brand_name_of> "Dexamethasone" .
<Cisplatin_and_Docetaxel> <Has_accepted_use> "triple_negative_Breast_cancer" .
<Cisplatin_and_Docetaxel> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cisplatin_and_Docetaxel> <Has_accepted_use> "Head_and_neck_cancer" .
<Cisplatin_and_Docetaxel> <Has_accepted_use> "Gastric_cancer" .
<Cisplatin_and_Docetaxel> <Has_accepted_use> "Esophageal_cancer" .
<Cisplatin_and_Docetaxel> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<Cisplatin_and_Docetaxel> <Has_accepted_use> "Breast_cancer" .
<Cisplatin_and_Docetaxel> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<CHUT> <Has_accepted_use> "Autologous_HSCT" .
<TCHP_(Taxol)> <Maps_to> "TCHP_(Taxol)" .
<Doxorubicin_pegylated_liposomal_and_Trabectedin> <Has_accepted_use> "Ovarian_cancer" .
<Dacomitinib_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Emicizumab_monotherapy> <Maps_to> "Emicizumab_monotherapy" .
<Intermittent_ADT> <Has_context> "Non-curative_therapy" .
<PAD/VCD> <Has_context> "Non-curative_first-line_therapy" .
<VAI> <Has_context> "Non-curative_therapy" .
<VAI> <Has_context> "All_lines_of_therapy" .
<VAI> <Has_context> "Adjuvant_therapy" .
<Cytax> <Brand_name_of> "Paclitaxel" .
<PCF> <Has_antineoplastic> "Paclitaxel" .
<PCF> <Has_antineoplastic> "Fluorouracil" .
<PCF> <Has_antineoplastic> "Cisplatin" .
<Vorapaxar> <Has_brand_name> "Zontivity" .
<Ribociclib> <Has_brand_name> "Kisqali" .
<IDAC_and_Sorafenib> <Has_antineoplastic> "Sorafenib" .
<IDAC_and_Sorafenib> <Has_antineoplastic> "Cytarabine" .
<Caxeta> <Brand_name_of> "Capecitabine" .
<Fam-trastuzumab_deruxtecan_monotherapy> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<Fam-trastuzumab_deruxtecan_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Imatinib-based_consolidation> <Mapped_from> "Imatinib-based_consolidation" .
<BEAC,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Droxiurea> <Brand_name_of> "Hydroxyurea" .
<Platamine> <Brand_name_of> "Cisplatin" .
<Chemoimmunotherapy> <Mapped_from> "Chemoimmunotherapy" .
<Pharmauracil> <Brand_name_of> "Fluorouracil" .
<Romiplostim> <Supportive_med_of> "Romiplostim_monotherapy" .
<Dacarbazine_and_Ipilimumab> <Mapped_from> "Dacarbazine_and_Ipilimumab" .
<Primox> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Paclitaxel_and_Vinorelbine> <Has_modality> "Chemotherapy" .
<Enzalutamide_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Enzalutamide_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<VAMP_(Methotrexate)> <Maps_to> "VAMP_(Methotrexate)" .
<Decitabine_and_Venetoclax> <Mapped_from> "Decitabine_and_Venetoclax" .
<Calquence> <Brand_name_of> "Acalabrutinib" .
<Docetaxel,_Fluorouracil,_Hydroxyurea,_RT> <Is_current_in> "Head_and_neck_cancer" .
<Fulvestrant_and_Palbociclib> <Is_current_in> "Breast_cancer" .
<VMP> <Has_modality> "Chemotherapy" .
<Pamidronate> <May_have_route> "Intravenous" .
<Copanlisib_monotherapy> <Mapped_from> "Copanlisib_monotherapy" .
<BEP> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<CVD_(Vinblastine)> <Has_context> "Non-curative_therapy" .
<Dectancyl> <Brand_name_of> "Dexamethasone" .
<Histiocytosis> <Is_a> "Malignant_hematologic_neoplasm" .
<FluBuCy,_then_allo_HSCT> <Mapped_from> "FluBuCy,_then_allo_HSCT" .
<Venous_thromboembolism> <Is_a> "Thrombotic_disorder" .
<DNA_synthesis_inhibitor> <Subsumes> "Zidovudine" .
<DNA_synthesis_inhibitor> <Subsumes> "Valganciclovir" .
<DNA_synthesis_inhibitor> <Subsumes> "Valacyclovir" .
<DNA_synthesis_inhibitor> <Subsumes> "Trifluridine_and_tipiracil" .
<DNA_synthesis_inhibitor> <Subsumes> "Procarbazine" .
<DNA_synthesis_inhibitor> <Subsumes> "Plicamycin" .
<DNA_synthesis_inhibitor> <Subsumes> "Mitomycin" .
<DNA_synthesis_inhibitor> <Subsumes> "Hydroxyurea" .
<DNA_synthesis_inhibitor> <Subsumes> "Fludarabine" .
<DNA_synthesis_inhibitor> <Subsumes> "Epirubicin" .
<DNA_synthesis_inhibitor> <Subsumes> "Dactinomycin" .
<DNA_synthesis_inhibitor> <Subsumes> "Dacarbazine" .
<DNA_synthesis_inhibitor> <Subsumes> "Bleomycin" .
<DNA_synthesis_inhibitor> <Subsumes> "Amsacrine" .
<CX_and_Trastuzumab> <Has_context> "Non-curative_first-line_therapy" .
<Dexamethasone_and_WBRT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Lung_cancer> <Subsumes> "Small_cell_lung_cancer" .
<Lung_cancer> <Subsumes> "Non-small_cell_lung_cancer" .
<Capecitabine,_Bevacizumab,_Trastuzumab> <Has_context> "Non-curative_first-line_therapy" .
<Encorafenib> <Has_brand_name> "Braftovi" .
<Capecitabine_monotherapy> <Has_context> "Non-curative_therapy" .
<Capecitabine_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Capecitabine_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Capecitabine_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Capecitabine_monotherapy> <Has_context> "Induction_therapy" .
<Capecitabine_monotherapy> <Has_context> "Adjuvant_therapy" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Mapped_from> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Valtrex> <Brand_name_of> "Valacyclovir" .
<SunPla> <Brand_name_of> "Heptaplatin" .
<Dalteparin_monotherapy> <Mapped_from> "Dalteparin_monotherapy" .
<DexaBEAM> <Has_context> "Non-curative_therapy" .
<Vumon> <Brand_name_of> "Teniposide" .
<Cyclosporine,_Methotrexate,_Methylprednisolone> <Has_accepted_use> "Graft_versus_host_disease" .
<CHOP-BCG> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Bevacizumab-awwb> <Has_brand_name> "Mvasi" .
<Vincristinum> <Brand_name_of> "Vincristine" .
<CBV,_then_auto_HSCT> <Maps_to> "CBV,_then_auto_HSCT" .
<Ipilimumab,_then_Nivolumab> <Has_accepted_use> "Melanoma" .
<Drxaline> <Brand_name_of> "Dexamethasone" .
<Procarbazine> <Antineoplastic_of> "eBEACOPP_(Prednisolone)" .
<Procarbazine> <Antineoplastic_of> "eBEACOPP" .
<Procarbazine> <Antineoplastic_of> "VEPEMB" .
<Procarbazine> <Antineoplastic_of> "RT-PEPC" .
<Procarbazine> <Antineoplastic_of> "R-MPV" .
<Procarbazine> <Antineoplastic_of> "R-MP" .
<Procarbazine> <Antineoplastic_of> "R-MCP_(CCNU)" .
<Procarbazine> <Antineoplastic_of> "Procarbazine_monotherapy" .
<Procarbazine> <Antineoplastic_of> "ProMACE-MOPP" .
<Procarbazine> <Antineoplastic_of> "PEP-C" .
<Procarbazine> <Antineoplastic_of> "PCV" .
<Procarbazine> <Antineoplastic_of> "OPPA" .
<Procarbazine> <Antineoplastic_of> "MVPP" .
<Procarbazine> <Antineoplastic_of> "MPV" .
<Procarbazine> <Antineoplastic_of> "MOPP/ABVD" .
<Procarbazine> <Antineoplastic_of> "MOPP-ABV" .
<Procarbazine> <Antineoplastic_of> "MOPP" .
<Procarbazine> <Antineoplastic_of> "Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone" .
<Procarbazine> <Antineoplastic_of> "Lomustine,_Methotrexate,_Procarbazine" .
<Procarbazine> <Antineoplastic_of> "LOPP/EVAP" .
<Procarbazine> <Antineoplastic_of> "LOPP" .
<Procarbazine> <Antineoplastic_of> "ChlVPP/PABIOE" .
<Procarbazine> <Antineoplastic_of> "ChlVPP/EVA" .
<Procarbazine> <Antineoplastic_of> "ChlVPP" .
<Procarbazine> <Antineoplastic_of> "CVPP" .
<Procarbazine> <Antineoplastic_of> "COPP/ABVD" .
<Procarbazine> <Antineoplastic_of> "COPP_(CCNU)" .
<Procarbazine> <Antineoplastic_of> "CEPP(B)" .
<Procarbazine> <Antineoplastic_of> "CAP-BOP" .
<Procarbazine> <Antineoplastic_of> "CAMP" .
<Procarbazine> <Antineoplastic_of> "C-MOPP/ABV" .
<Procarbazine> <Antineoplastic_of> "C-MOPP" .
<Procarbazine> <Antineoplastic_of> "BVCPP" .
<Procarbazine> <Antineoplastic_of> "BEACOPP-14_(Prednisolone)" .
<Procarbazine> <Antineoplastic_of> "BEACOPP-14" .
<Procarbazine> <Antineoplastic_of> "BEACOPP" .
<Procarbazine> <Antineoplastic_of> "BCVPP" .
<R-CEOP_(Etoposide)> <Has_context> "Induction_therapy" .
<(90)YFC,_then_allo_HSCT> <Maps_to> "(90)YFC,_then_allo_HSCT" .
<Nivolumab_monotherapy> <Maps_to> "Nivolumab_monotherapy" .
<Chlorambucil_and_Prednisolone> <Mapped_from> "Chlorambucil_and_Prednisolone" .
<Bendamustine> <Has_FDA_indication> "Chronic_lymphocytic_leukemia" .
<Exjade> <Brand_name_of> "Deferasirox" .
<ER-positive_Breast_cancer> <Is_a> "Breast_cancer" .
<FMP> <Has_context> "Non-curative_therapy" .
<Anti-CD30_antibody> <Subsumes> "Brentuximab_vedotin" .
<R-M-CHOP> <Is_a> "Rituximab-containing_regimen" .
<R-M-CHOP> <Is_a> "Anthracycline-containing_regimen" .
<Lenalidomide,_Dexamethasone,_Rituximab> <Has_context> "Non-curative_therapy" .
<Invomit> <Brand_name_of> "Ondansetron" .
<C-MOPP> <Has_modality> "Chemotherapy" .
<Revimmune> <Brand_name_of> "Cyclophosphamide" .
<Septrin-S> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<FEC_and_H_(SC)> <Is_a> "Anthracycline-containing_regimen" .
<Bortezomib_and_Panobinostat> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<nab-Paclitaxel_monotherapy> <Has_context> "Non-curative_therapy" .
<nab-Paclitaxel_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<nab-Paclitaxel_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<nab-Paclitaxel_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<nab-Paclitaxel_monotherapy> <Has_context> "Neoadjuvant_therapy" .
<VAD_plus_C> <Has_context> "Non-curative_first-line_therapy" .
<Amazole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Fluorouracil,_Folinic_acid,_RT> <Has_modality> "Radiotherapy" .
<Fluorouracil,_Folinic_acid,_RT> <Has_modality> "Chemotherapy" .
<CHOP-14> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Irinotecan_and_Temozolomide> <Has_modality> "Chemotherapy" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan> <Has_antineoplastic> "Rituximab" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan> <Has_antineoplastic> "Ibritumomab_tiuxetan" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan> <Has_antineoplastic> "Fludarabine" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan> <Has_antineoplastic> "Busulfan" .
<Acenterine> <Brand_name_of> "Aspirin" .
<R-ESHAP> <Has_context> "Salvage_therapy" .
<mLSG15> <Mapped_from> "mLSG15" .
<ECF/5-FU_and_RT> <Has_antineoplastic> "Fluorouracil" .
<ECF/5-FU_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<ECF/5-FU_and_RT> <Has_antineoplastic> "Epirubicin" .
<ECF/5-FU_and_RT> <Has_antineoplastic> "Cisplatin" .
<MAP4K5_inhibitor> <Subsumes> "Vemurafenib" .
<EIA> <Has_context> "Neoadjuvant_therapy" .
<EIA> <Has_context> "Adjuvant_therapy" .
<Acquired_coagulopathy> <Accepted_use_of> "Rituximab-pvvr" .
<Acquired_coagulopathy> <Accepted_use_of> "Rituximab-abbs" .
<Acquired_coagulopathy> <Accepted_use_of> "Rituximab_monotherapy" .
<Acquired_coagulopathy> <Accepted_use_of> "Rituximab" .
<Acquired_coagulopathy> <Accepted_use_of> "Prednisone_monotherapy" .
<Acquired_coagulopathy> <Accepted_use_of> "Prednisone" .
<Acquired_coagulopathy> <Accepted_use_of> "Prednisolone_monotherapy" .
<Acquired_coagulopathy> <Accepted_use_of> "Prednisolone" .
<Acquired_coagulopathy> <Accepted_use_of> "Cyclophosphamide_and_Prednisone" .
<Acquired_coagulopathy> <Accepted_use_of> "Cyclophosphamide_and_Prednisolone" .
<Acquired_coagulopathy> <Accepted_use_of> "Cyclophosphamide" .
<Acquired_coagulopathy> <Accepted_use_of> "Anti-inhibitor_coagulant_complex" .
<Danason> <Brand_name_of> "Dexamethasone" .
<Pirarubicin_monotherapy> <Is_current_in> "Bladder_cancer" .
<DOLP> <Is_current_in> "T-cell_acute_lymphoblastic_leukemia" .
<DOLP> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Radiation_therapy> <Maps_to> "Radiation_therapy" .
<BR> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<BR> <Is_current_in> "Marginal_zone_lymphoma" .
<BR> <Is_current_in> "Mantle_cell_lymphoma" .
<BR> <Is_current_in> "Hairy_cell_leukemia" .
<BR> <Is_current_in> "Follicular_lymphoma" .
<BR> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<BR> <Is_current_in> "Cold_agglutinin_disease" .
<BR> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<COMP> <Has_modality> "Chemotherapy" .
<DOLP_(Prednisolone)> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<L-glutamine_monotherapy> <Has_context> "All_lines_of_therapy" .
<Gemisona> <Brand_name_of> "Dexamethasone" .
<Fluconazole> <May_have_route> "Oral" .
<Fluconazole> <May_have_route> "Intravenous" .
<Z-BEAM> <Has_antineoplastic> "Rituximab" .
<Z-BEAM> <Has_antineoplastic> "Melphalan" .
<Z-BEAM> <Has_antineoplastic> "Ibritumomab_tiuxetan" .
<Z-BEAM> <Has_antineoplastic> "Etoposide" .
<Z-BEAM> <Has_antineoplastic> "Cytarabine" .
<Z-BEAM> <Has_antineoplastic> "Carmustine" .
<Cisplatin,_Pemetrexed,_TTFields> <Mapped_from> "Cisplatin,_Pemetrexed,_TTFields" .
<CISCA> <Maps_to> "CISCA" .
<Carcinocin> <Brand_name_of> "Doxorubicin" .
<Peginterferon_alfa-2b_monotherapy> <Maps_to> "Peginterferon_alfa-2b_monotherapy" .
<Octreotide_and_Prednisone> <Has_modality> "Hormonotherapy" .
<Eculizumab> <Has_FDA_indication> "Paroxysmal_nocturnal_hemoglobinuria" .
<Eculizumab> <Has_FDA_indication> "Atypical_hemolytic_uremic_syndrome" .
<mFOLFOX6_and_Bevacizumab_(L-Leucovorin)> <Has_accepted_use> "Colon_cancer" .
<Carboplatin,_Etoposide,_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<SCAB> <Has_modality> "Chemotherapy" .
<Cyclosporine_and_Prednisone> <Mapped_from> "Cyclosporine_and_Prednisone" .
<Docetaxel_and_Prednisolone> <Is_current_in> "Prostate_cancer" .
<AT_(Taxotere)> <Mapped_from> "AT_(Taxotere)" .
<Prednison> <Brand_name_of> "Prednisone" .
<CPR> <Has_supportive_med> "Warfarin" .
<CPR> <Has_supportive_med> "Low_molecular_weight_heparins" .
<CPR> <Has_supportive_med> "Aspirin" .
<R-COPADM> <Has_supportive_med> "Folinic_acid" .
<Interferon_alfa-2a_and_Isotretinoin> <Has_context> "Non-curative_second-line_therapy" .
<Temcad> <Brand_name_of> "Temozolomide" .
<Hyper-CVAD/MA> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Panobinostat> <Has_FDA_indication> "Multiple_myeloma" .
<Capecitabine,_Sorafenib,_RT> <Mapped_from> "Capecitabine,_Sorafenib,_RT" .
<Epirubicin_and_Ifosfamide> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Epirubicin_and_Ifosfamide> <Has_accepted_use> "Small_cell_lung_cancer" .
<Fludarabine_and_Alemtuzumab> <Has_modality> "Chemotherapy" .
<Lomustine,_Temozolomide,_RT> <Has_accepted_use> "Glioblastoma" .
<Ramucirumab_monotherapy> <Maps_to> "Ramucirumab_monotherapy" .
<Filgrastim-sndz> <Is_a> "Granulocyte_colony-stimulating_factor" .
<Filgrastim-sndz> <Is_a> "Biosimilar" .
<VMV-VAC> <Maps_to> "VMV-VAC" .
<FGFR_inhibitor> <Subsumes> "Regorafenib" .
<FGFR_inhibitor> <Subsumes> "Ponatinib" .
<FGFR_inhibitor> <Subsumes> "Pazopanib" .
<FGFR_inhibitor> <Subsumes> "Nintedanib" .
<FGFR_inhibitor> <Subsumes> "Masitinib" .
<FGFR_inhibitor> <Subsumes> "Lenvatinib" .
<FGFR_inhibitor> <Subsumes> "Infigratinib" .
<FGFR_inhibitor> <Subsumes> "Erdafitinib" .
<FGFR_inhibitor> <Subsumes> "Dovitinib" .
<Trimezole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<HDMP> <Has_antineoplastic> "Methylprednisolone" .
<Procarbazine> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Procarbazine> <Is_a> "Triazene" .
<Procarbazine> <Is_a> "DNA_synthesis_inhibitor" .
<Procarbazine> <Is_a> "Alkylating_agent" .
<R-CDOP> <Is_current_in> "HIV-associated_lymphoma" .
<R-CDOP> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Cisplatin_and_Vinorelbine> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cisplatin_and_Vinorelbine> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<Cisplatin_and_Vinorelbine> <Has_accepted_use> "Cervical_cancer" .
<Cisplatin_and_Vinorelbine> <Has_accepted_use> "Breast_cancer" .
<Ibrutinib_and_Obinutuzumab> <Has_antineoplastic> "Obinutuzumab" .
<Ibrutinib_and_Obinutuzumab> <Has_antineoplastic> "Ibrutinib" .
<Zoledronic_acid_therapy> <Has_supportive_med> "Zoledronic_acid" .
<Melphalan_and_Methylprednisolone,_then_auto_HSCT> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Colfarit> <Brand_name_of> "Aspirin" .
<Unituxin> <Brand_name_of> "Dinutuximab" .
<Carboplatin,_Etoposide,_Atezolizumab> <Maps_to> "Carboplatin,_Etoposide,_Atezolizumab" .
<Gefitinib> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Gefitinib> <Is_a> "Mutation-specific_medication" .
<Gefitinib> <Is_a> "Kinase_inhibitor" .
<Gefitinib> <Is_a> "EGFR_inhibitor" .
<ZRd> <Is_current_in> "Multiple_myeloma" .
<Tamoxifen_and_Prednisolone> <Maps_to> "Tamoxifen_and_Prednisolone" .
<ADT_and_Docetaxel> <Mapped_from> "ADT_and_Docetaxel" .
<Herpevex> <Brand_name_of> "Acyclovir" .
<Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone> <Is_current_in> "T-cell_acute_lymphoblastic_leukemia" .
<Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Chidamide_monotherapy> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<Acute_myeloid_leukemia> <Current_treated_by> "Temozolomide_monotherapy" .
<Acute_myeloid_leukemia> <Current_treated_by> "Sorafenib_monotherapy" .
<Acute_myeloid_leukemia> <Current_treated_by> "Ruxolitinib_monotherapy" .
<Acute_myeloid_leukemia> <Current_treated_by> "Quizartinib_monotherapy" .
<Acute_myeloid_leukemia> <Current_treated_by> "Observation" .
<Acute_myeloid_leukemia> <Current_treated_by> "Midostaurin_monotherapy" .
<Acute_myeloid_leukemia> <Current_treated_by> "MEC" .
<Acute_myeloid_leukemia> <Current_treated_by> "Low-dose_TBI,_then_allo_HSCT" .
<Acute_myeloid_leukemia> <Current_treated_by> "LoDAC_and_Venetoclax" .
<Acute_myeloid_leukemia> <Current_treated_by> "LoDAC" .
<Acute_myeloid_leukemia> <Current_treated_by> "Ivosidenib_monotherapy" .
<Acute_myeloid_leukemia> <Current_treated_by> "IDAC_and_Sorafenib" .
<Acute_myeloid_leukemia> <Current_treated_by> "IDAC" .
<Acute_myeloid_leukemia> <Current_treated_by> "ICL" .
<Acute_myeloid_leukemia> <Current_treated_by> "IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone" .
<Acute_myeloid_leukemia> <Current_treated_by> "HiDAC_and_Midostaurin" .
<Acute_myeloid_leukemia> <Current_treated_by> "HiDAC" .
<Acute_myeloid_leukemia> <Current_treated_by> "HDAC_and_G-CSF" .
<Acute_myeloid_leukemia> <Current_treated_by> "HAM" .
<Acute_myeloid_leukemia> <Current_treated_by> "HAD" .
<Acute_myeloid_leukemia> <Current_treated_by> "HAA" .
<Acute_myeloid_leukemia> <Current_treated_by> "Glasdegib_and_LoDAC" .
<Acute_myeloid_leukemia> <Current_treated_by> "Gilteritinib_monotherapy" .
<Acute_myeloid_leukemia> <Current_treated_by> "Gemtuzumab_ozogamicin_monotherapy" .
<Acute_myeloid_leukemia> <Current_treated_by> "Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Acute_myeloid_leukemia> <Current_treated_by> "Fludarabine_and_TBI,_then_allo_HSCT" .
<Acute_myeloid_leukemia> <Current_treated_by> "FLAG-Ida" .
<Acute_myeloid_leukemia> <Current_treated_by> "FLAG" .
<Acute_myeloid_leukemia> <Current_treated_by> "F-SHAI" .
<Acute_myeloid_leukemia> <Current_treated_by> "Etoposide_and_Mitoxantrone" .
<Acute_myeloid_leukemia> <Current_treated_by> "Enasidenib_monotherapy" .
<Acute_myeloid_leukemia> <Current_treated_by> "Decitabine_monotherapy" .
<Acute_myeloid_leukemia> <Current_treated_by> "Decitabine_and_Venetoclax" .
<Acute_myeloid_leukemia> <Current_treated_by> "DAC" .
<Acute_myeloid_leukemia> <Current_treated_by> "DA_3_plus_10,_GO" .
<Acute_myeloid_leukemia> <Current_treated_by> "DA_3_plus_10" .
<Acute_myeloid_leukemia> <Current_treated_by> "Cytarabine,_Idarubicin,_Sorafenib" .
<Acute_myeloid_leukemia> <Current_treated_by> "Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin" .
<Acute_myeloid_leukemia> <Current_treated_by> "Cytarabine_and_Thioguanine" .
<Acute_myeloid_leukemia> <Current_treated_by> "Cytarabine_and_Mitoxantrone" .
<Acute_myeloid_leukemia> <Current_treated_by> "Cytarabine_and_Idarubicin" .
<Acute_myeloid_leukemia> <Current_treated_by> "Cytarabine_and_Daunorubicin" .
<Acute_myeloid_leukemia> <Current_treated_by> "Cyclophosphamide_and_TBI,_then_allo_HSCT" .
<Acute_myeloid_leukemia> <Current_treated_by> "Clofarabine_monotherapy" .
<Acute_myeloid_leukemia> <Current_treated_by> "Clofarabine_and_Melphalan,_then_allo_HSCT" .
<Acute_myeloid_leukemia> <Current_treated_by> "Clofarabine_and_LoDAC/Decitabine" .
<Acute_myeloid_leukemia> <Current_treated_by> "Clofarabine_and_LoDAC" .
<Acute_myeloid_leukemia> <Current_treated_by> "Clofarabine_and_Cytarabine" .
<Acute_myeloid_leukemia> <Current_treated_by> "CYVE" .
<Acute_myeloid_leukemia> <Current_treated_by> "CPX-351_monotherapy" .
<Acute_myeloid_leukemia> <Current_treated_by> "CLARA" .
<Acute_myeloid_leukemia> <Current_treated_by> "CLAG-M" .
<Acute_myeloid_leukemia> <Current_treated_by> "CLAG" .
<Acute_myeloid_leukemia> <Current_treated_by> "CIA" .
<Acute_myeloid_leukemia> <Current_treated_by> "BuFlu,_then_allo_HSCT" .
<Acute_myeloid_leukemia> <Current_treated_by> "BuCy,_then_auto_HSCT" .
<Acute_myeloid_leukemia> <Current_treated_by> "BuCy,_then_allo_HSCT" .
<Acute_myeloid_leukemia> <Current_treated_by> "Best_supportive_care" .
<Acute_myeloid_leukemia> <Current_treated_by> "Azacitidine_monotherapy" .
<Acute_myeloid_leukemia> <Current_treated_by> "Azacitidine_and_Venetoclax" .
<Acute_myeloid_leukemia> <Current_treated_by> "Azacitidine_and_Sorafenib" .
<Acute_myeloid_leukemia> <Current_treated_by> "Azacitidine_and_Gemtuzumab_ozogamicin" .
<Acute_myeloid_leukemia> <Current_treated_by> "AIE" .
<Acute_myeloid_leukemia> <Current_treated_by> "ADE_(standard-dose_Ara-C)" .
<Acute_myeloid_leukemia> <Current_treated_by> "ADE_(high-dose_Ara-C)" .
<Acute_myeloid_leukemia> <Current_treated_by> "7_plus_3m" .
<Acute_myeloid_leukemia> <Current_treated_by> "7_plus_3i_and_Sorafenib" .
<Acute_myeloid_leukemia> <Current_treated_by> "7_plus_3i" .
<Acute_myeloid_leukemia> <Current_treated_by> "7_plus_3d_and_Sorafenib" .
<Acute_myeloid_leukemia> <Current_treated_by> "7_plus_3d_and_Midostaurin" .
<Acute_myeloid_leukemia> <Current_treated_by> "7_plus_3d_and_Glasdegib" .
<Acute_myeloid_leukemia> <Current_treated_by> "7_plus_3d_and_GO" .
<Acute_myeloid_leukemia> <Current_treated_by> "7_plus_3d" .
<Acute_myeloid_leukemia> <Current_treated_by> "5_plus_2d" .
<Bucokon> <Brand_name_of> "Dexamethasone" .
<Cyclosporine_and_Mycophenolate_mofetil> <Maps_to> "Cyclosporine_and_Mycophenolate_mofetil" .
<DexaBEAM_and_G-CSF> <Maps_to> "DexaBEAM_and_G-CSF" .
<VEPEMB> <Has_context> "Induction_therapy" .
<Maxtorin> <Brand_name_of> "Bendamustine" .
<Vorapaxar> <May_have_route> "Oral" .
<High-grade_glioma> <Accepted_use_of> "Carmustine_wafer_polifeprosan_20" .
<Mercaptopurine,_Methotrexate,_WB-XRT> <Has_context> "Maintenance_after_upfront_therapy" .
<Dalteparin_monotherapy> <Has_context> "Prophylaxis" .
<Dalteparin_monotherapy> <Has_context> "All_lines_of_therapy" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Vincristine" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Prednisone_monotherapy" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Prednisone" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Pegaspargase" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Nelarabine_monotherapy" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Nelarabine" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Mitoxantrone" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Methylprednisolone" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Methotrexate,_Pegaspargase,_Vincristine" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Methotrexate" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Mercaptopurine,_Methotrexate,_Vincristine" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Mercaptopurine" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "L-asparaginase_monotherapy" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Etoposide_and_TBI,_then_allo_HSCT" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Dexamethasone" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Daunorubicin" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "DOLP" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cytarabine" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cyclophosphamide" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Clofarabine" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Calaspargase" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Asparaginase_Erwinia_chrysanthemi" .
<T-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Asparaginase" .
<Lapatinib_and_Trastuzumab> <Has_modality> "Chemotherapy" .
<Allopurinol> <Is_a> "Xanthine_oxidase_inhibitor" .
<Allopurinol> <Is_a> "WHO_Essential_Cancer_Medicine" .
<RBC_transfusions> <Has_modality> "Supportive_therapy" .
<Exemestane> <Antineoplastic_of> "Exemestane_monotherapy" .
<Exemestane> <Antineoplastic_of> "Exemestane_and_Tucidinostat" .
<Exemestane> <Antineoplastic_of> "Everolimus_and_Exemestane" .
<ATG_(Horse),_Cyclosporine,_Methylprednisolone> <Mapped_from> "ATG_(Horse),_Cyclosporine,_Methylprednisolone" .
<Acalabrutinib> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Acalabrutinib> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<VNCOP-B> <Mapped_from> "VNCOP-B" .
<Kentricid> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Fluorourcil> <Brand_name_of> "Fluorouracil" .
<IFL> <Is_current_in> "Colon_cancer" .
<International_ALL_Trial> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Carpsol> <Brand_name_of> "Carboplatin" .
<CC/DE_and_RT> <Maps_to> "CC/DE_and_RT" .
<Tegafur_and_uracil> <Has_brand_name> "Uracel" .
<Tegafur_and_uracil> <Has_brand_name> "Ufur" .
<Tegafur_and_uracil> <Has_brand_name> "Uftoral" .
<Tegafur_and_uracil> <Has_brand_name> "Tefudex" .
<Tegafur_and_uracil> <Has_brand_name> "Luporal" .
<Tegafur_and_uracil> <Has_brand_name> "Ftorafur" .
<Panitumumab> <Has_brand_name> "Vectibix" .
<Adriacept> <Brand_name_of> "Doxorubicin" .
<Mitoxantrone_and_Hydrocortisone> <Is_current_in> "Prostate_cancer" .
<Carfilzomib_and_Panobinostat> <Is_current_in> "Multiple_myeloma" .
<Cisplatin,_Vinorelbine,_Cetuximab> <Mapped_from> "Cisplatin,_Vinorelbine,_Cetuximab" .
<Stemetil> <Brand_name_of> "Prochlorperazine" .
<Cisplatin,_Pemetrexed,_TTFields> <Is_current_in> "Mesothelioma" .
<Durvalumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Durvalumab> <Has_accepted_use> "Bladder_cancer" .
<Anticoagulants> <Supportive_med_of> "TD" .
<Anticoagulants> <Supportive_med_of> "Rd" .
<Anticoagulants> <Supportive_med_of> "KRd" .
<C-MOPP/ABV> <Has_context> "Induction_therapy" .
<Plicamycin> <Is_a> "Vesicant" .
<Plicamycin> <Is_a> "Irritant" .
<Plicamycin> <Is_a> "Discontinued_drug" .
<Plicamycin> <Is_a> "DNA_synthesis_inhibitor" .
<Panobinostat_and_Rituximab> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Corson> <Brand_name_of> "Dexamethasone" .
<Nintedanib_and_Pemetrexed> <Has_context> "Non-curative_subsequent-line_therapy" .
<Carboplatin_monotherapy> <Maps_to> "Carboplatin_monotherapy" .
<BEAC,_then_auto_HSCT> <Mapped_from> "BEAC,_then_auto_HSCT" .
<Campath-1H> <Brand_name_of> "Alemtuzumab" .
<GMALL-R> <Maps_to> "GMALL-R" .
<PAD> <Has_antineoplastic> "Doxorubicin" .
<PAD> <Has_antineoplastic> "Dexamethasone" .
<PAD> <Has_antineoplastic> "Bortezomib" .
<Mercaptopurine_and_Methotrexate> <Is_current_in> "Gestational_trophoblastic_neoplasia" .
<Mercaptopurine_and_Methotrexate> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Mercaptopurine_and_Methotrexate> <Is_current_in> "Acute_promyelocytic_leukemia" .
<Cetuximab_monotherapy> <Is_current_in> "Head_and_neck_cancer" .
<Cetuximab_monotherapy> <Is_current_in> "Esophageal_cancer" .
<Cetuximab_monotherapy> <Is_current_in> "Cutaneous_squamous_cell_carcinoma" .
<Cetuximab_monotherapy> <Is_current_in> "Colon_cancer" .
<Ibritumomab_tiuxetan> <May_have_route> "Intravenous" .
<Alemtuzumab_and_Rituximab> <Has_antineoplastic> "Rituximab" .
<Alemtuzumab_and_Rituximab> <Has_antineoplastic> "Alemtuzumab" .
<CAVE> <Has_modality> "Chemotherapy" .
<Vosaroxin_and_Cytarabine> <Has_modality> "Chemotherapy" .
<TAM6> <Mapped_from> "TAM6" .
<Inotuzumab_ozogamicin> <Is_a> "Antibody-drug_conjugate" .
<Inotuzumab_ozogamicin> <Is_a> "Antibody_medication" .
<Inotuzumab_ozogamicin> <Is_a> "Anti-CD22_antibody" .
<ATRA_monotherapy> <Mapped_from> "ATRA_monotherapy" .
<R-HiDAC> <Has_context> "Non-curative_first-line_therapy" .
<Dabigatran> <May_have_route> "Oral" .
<Benralizumab_monotherapy> <Mapped_from> "Benralizumab_monotherapy" .
<Cisplatin_and_Mitomycin> <Mapped_from> "Cisplatin_and_Mitomycin" .
<Granocyte> <Brand_name_of> "Lenograstim" .
<Radium-223> <May_have_route> "Intravenous" .
<Cortisone_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<Megaplatin> <Brand_name_of> "Carboplatin" .
<FCR> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<FCR> <Is_current_in> "Mantle_cell_lymphoma" .
<FCR> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<FCR> <Is_current_in> "Allogeneic_HSCT" .
<Cisplatin,_Etoposide,_Irinotecan> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<CAPIRI> <Is_a> "Irinotecan-containing_regimen" .
<Ravulizumab_monotherapy> <Has_accepted_use> "Paroxysmal_nocturnal_hemoglobinuria" .
<Capecitabine,_Bevacizumab,_Trastuzumab> <Has_antineoplastic> "Trastuzumab" .
<Capecitabine,_Bevacizumab,_Trastuzumab> <Has_antineoplastic> "Capecitabine" .
<Capecitabine,_Bevacizumab,_Trastuzumab> <Has_antineoplastic> "Bevacizumab" .
<Docetaxel_and_S-1> <Has_antineoplastic> "Tegafur_gimeracil_oteracil" .
<Docetaxel_and_S-1> <Has_antineoplastic> "Docetaxel" .
<Fluorouracil,_Folinic_acid,_Mitomycin> <Maps_to> "Fluorouracil,_Folinic_acid,_Mitomycin" .
<MA-BCD/AP> <Is_a> "Anthracycline-containing_regimen" .
<Curative_therapy> <Is_a> "All_lines_of_therapy" .
<Inotuzumab_ozogamicin> <Has_brand_name> "Besponsa" .
<Paclitaxel_and_Ramucirumab> <Has_antineoplastic> "Ramucirumab" .
<Paclitaxel_and_Ramucirumab> <Has_antineoplastic> "Paclitaxel" .
<HiDAC> <Has_context> "Salvage_therapy" .
<HiDAC> <Has_context> "Local_therapy" .
<HiDAC> <Has_context> "Consolidation_after_upfront_therapy" .
<AspaMetDex_(Erwinaze)> <Mapped_from> "AspaMetDex_(Erwinaze)" .
<Exembol> <Brand_name_of> "Argatroban" .
<Supportive_medication> <Subsumes> "Uric_acid_lowering_agent" .
<Supportive_medication> <Subsumes> "Proton_pump_inhibitor" .
<Supportive_medication> <Subsumes> "Phenytoin" .
<Supportive_medication> <Subsumes> "Nonsteroidal_anti-inflammatory_drugs_(NSAIDs)" .
<Supportive_medication> <Subsumes> "Mucositis_prevention" .
<Supportive_medication> <Subsumes> "Meperidine" .
<Supportive_medication> <Subsumes> "Hematopoietic_growth_factor" .
<Supportive_medication> <Subsumes> "Emesis_prevention" .
<Supportive_medication> <Subsumes> "Diuretic" .
<Supportive_medication> <Subsumes> "Chemotherapy_protective_agent" .
<Supportive_medication> <Subsumes> "Chelator" .
<Supportive_medication> <Subsumes> "Bowel_management" .
<Supportive_medication> <Subsumes> "Bone_protective_medication" .
<Supportive_medication> <Subsumes> "Atropine" .
<Supportive_medication> <Subsumes> "Appetite_stimulant" .
<Supportive_medication> <Subsumes> "Antipyretic" .
<Supportive_medication> <Subsumes> "Antiplatelet_agent" .
<Supportive_medication> <Subsumes> "Antileukotriene" .
<Supportive_medication> <Subsumes> "Antihistamine" .
<Supportive_medication> <Subsumes> "Anticoagulant" .
<Supportive_medication> <Subsumes> "Antibiotic" .
<Supportive_medication> <Subsumes> "Adrenergic_receptor_agonist" .
<Bisultrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Tryseptolum> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Acute_myeloid_leukemia> <Is_a> "Acute_leukemia" .
<Sultrima> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone> <Mapped_from> "Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone" .
<IP-BCD> <Has_accepted_use> "Osteosarcoma" .
<GCD-R> <Mapped_from> "GCD-R" .
<Octreotide> <Has_accepted_use> "Thymoma" .
<Octreotide> <Has_accepted_use> "Pancreatic_NET" .
<Octreotide> <Has_accepted_use> "Neuroendocrine_tumor" .
<Doxorubicin_pegylated_liposomal_and_Bevacizumab> <Has_antineoplastic> "Pegylated_liposomal_doxorubicin" .
<Doxorubicin_pegylated_liposomal_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Ostenan> <Brand_name_of> "Alendronate" .
<CAMF> <Is_historical_in> "Breast_cancer" .
<Enfortumab_vedotin_monotherapy> <Mapped_from> "Enfortumab_vedotin_monotherapy" .
<S-1_monotherapy> <Has_antineoplastic> "Tegafur_gimeracil_oteracil" .
<Atezolizumab_and_Bevacizumab> <Mapped_from> "Atezolizumab_and_Bevacizumab" .
<Moxetumomab_pasudotox> <Antineoplastic_of> "Moxetumomab_pasudotox_monotherapy" .
<Daratumumab_monotherapy> <Has_supportive_med> "Methylprednisolone" .
<Daratumumab_monotherapy> <Has_supportive_med> "Diphenhydramine" .
<Daratumumab_monotherapy> <Has_supportive_med> "Dexamethasone" .
<Daratumumab_monotherapy> <Has_supportive_med> "Clemastine" .
<Daratumumab_monotherapy> <Has_supportive_med> "Cetirizine" .
<Daratumumab_monotherapy> <Has_supportive_med> "Acetaminophen" .
<AspaMetDex_(Erwinaze)> <Has_supportive_med> "Valacyclovir" .
<AspaMetDex_(Erwinaze)> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<AspaMetDex_(Erwinaze)> <Has_supportive_med> "Folinic_acid" .
<Promedrol> <Brand_name_of> "Methylprednisolone" .
<Colircusi_Dexametasona> <Brand_name_of> "Dexamethasone" .
<Fluorouracil> <Antineoplastic_of> "mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)" .
<Fluorouracil> <Antineoplastic_of> "mFOLFOX7_(L-Leucovorin)" .
<Fluorouracil> <Antineoplastic_of> "mFOLFOX7" .
<Fluorouracil> <Antineoplastic_of> "mFOLFOX6_and_RT" .
<Fluorouracil> <Antineoplastic_of> "mFOLFOX6_and_Cetuximab" .
<Fluorouracil> <Antineoplastic_of> "mFOLFOX6_and_Bevacizumab_(L-Leucovorin)" .
<Fluorouracil> <Antineoplastic_of> "mFOLFOX6_and_Bevacizumab" .
<Fluorouracil> <Antineoplastic_of> "mFOLFOX6_(L-Leucovorin)" .
<Fluorouracil> <Antineoplastic_of> "mFOLFOX6" .
<Fluorouracil> <Antineoplastic_of> "mFOLFOX_and_Sorafenib" .
<Fluorouracil> <Antineoplastic_of> "mFOLFIRINOX,_Gemcitabine,_RT" .
<Fluorouracil> <Antineoplastic_of> "mFOLFIRINOX" .
<Fluorouracil> <Antineoplastic_of> "mDCF_and_Bevacizumab" .
<Fluorouracil> <Antineoplastic_of> "mDCF" .
<Fluorouracil> <Antineoplastic_of> "ddFEC" .
<Fluorouracil> <Antineoplastic_of> "TMF" .
<Fluorouracil> <Antineoplastic_of> "TACE,_then_5-FU" .
<Fluorouracil> <Antineoplastic_of> "PFT" .
<Fluorouracil> <Antineoplastic_of> "PF" .
<Fluorouracil> <Antineoplastic_of> "PEFG" .
<Fluorouracil> <Antineoplastic_of> "PCF" .
<Fluorouracil> <Antineoplastic_of> "PAF" .
<Fluorouracil> <Antineoplastic_of> "OXAFAFU" .
<Fluorouracil> <Antineoplastic_of> "OLF" .
<Fluorouracil> <Antineoplastic_of> "Nordic_FLOX" .
<Fluorouracil> <Antineoplastic_of> "MOF" .
<Fluorouracil> <Antineoplastic_of> "MF" .
<Fluorouracil> <Antineoplastic_of> "MCF" .
<Fluorouracil> <Antineoplastic_of> "Intraperitoneal_5-FU" .
<Fluorouracil> <Antineoplastic_of> "IFL_and_Bevacizumab" .
<Fluorouracil> <Antineoplastic_of> "IFL" .
<Fluorouracil> <Antineoplastic_of> "Hexa-CAF" .
<Fluorouracil> <Antineoplastic_of> "HAIC_and_Sorafenib" .
<Fluorouracil> <Antineoplastic_of> "Gemcitabine/Fluorouracil_and_RT" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil/Fluorouracil_and_RT" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil,_Paclitaxel,_RT" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil,_Oxaliplatin,_RT" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil,_Mitomycin,_RT" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil,_Hydroxyurea,_RT" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil,_Folinic_acid,_RT" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil,_Folinic_acid,_Mitomycin" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil,_Folinic_acid,_Levamisole" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil,_Folinic_acid,_Gemcitabine" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil_monotherapy" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil_and_Streptozocin" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil_and_Semustine" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil_and_RT" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil_and_Paclitaxel" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil_and_Mitomycin" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil_and_Methotrexate" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil_and_Levoleucovorin" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil_and_Levamisole" .
<Fluorouracil> <Antineoplastic_of> "Fluorouracil_and_Folinic_acid" .
<Fluorouracil> <Antineoplastic_of> "FUOX" .
<Fluorouracil> <Antineoplastic_of> "FULV/FULV_and_RT" .
<Fluorouracil> <Antineoplastic_of> "FULV_and_Bevacizumab" .
<Fluorouracil> <Antineoplastic_of> "FP/Capecitabine_and_RT" .
<Fluorouracil> <Antineoplastic_of> "FOLFOXIRI_and_Panitumumab" .
<Fluorouracil> <Antineoplastic_of> "FOLFOX4_and_RT" .
<Fluorouracil> <Antineoplastic_of> "FOLFOX4_and_Panitumumab" .
<Fluorouracil> <Antineoplastic_of> "FOLFOX4_and_Cetuximab" .
<Fluorouracil> <Antineoplastic_of> "FOLFOX4_and_Bevacizumab" .
<Fluorouracil> <Antineoplastic_of> "FOLFOX4_(L-Leucovorin)" .
<Fluorouracil> <Antineoplastic_of> "FOLFOX4" .
<Fluorouracil> <Antineoplastic_of> "FOLFOX2" .
<Fluorouracil> <Antineoplastic_of> "FOLFOX_chronotherapy" .
<Fluorouracil> <Antineoplastic_of> "FOLFOX_7/sLV5FU2_(L-Leucovorin)" .
<Fluorouracil> <Antineoplastic_of> "FOLFOX_7/sLV5FU2" .
<Fluorouracil> <Antineoplastic_of> "FOLFOX" .
<Fluorouracil> <Antineoplastic_of> "FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation" .
<Fluorouracil> <Antineoplastic_of> "FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)" .
<Fluorouracil> <Antineoplastic_of> "FOLFIRINOX" .
<Fluorouracil> <Antineoplastic_of> "FOLFIRI_and_Ziv-aflibercept" .
<Fluorouracil> <Antineoplastic_of> "FOLFIRI_and_Ramucirumab" .
<Fluorouracil> <Antineoplastic_of> "FOLFIRI_and_Panitumumab" .
<Fluorouracil> <Antineoplastic_of> "FOLFIRI_and_Cetuximab_(L-Leucovorin)" .
<Fluorouracil> <Antineoplastic_of> "FOLFIRI_and_Cetuximab" .
<Fluorouracil> <Antineoplastic_of> "FOLFIRI_and_Bevacizumab_(L-Leucovorin)" .
<Fluorouracil> <Antineoplastic_of> "FOLFIRI_and_Bevacizumab" .
<Fluorouracil> <Antineoplastic_of> "FOLFIRI_(L-Leucovorin)" .
<Fluorouracil> <Antineoplastic_of> "FOLFIRI" .
<Fluorouracil> <Antineoplastic_of> "FNC" .
<Fluorouracil> <Antineoplastic_of> "FLOX" .
<Fluorouracil> <Antineoplastic_of> "FLOT" .
<Fluorouracil> <Antineoplastic_of> "FLEP" .
<Fluorouracil> <Antineoplastic_of> "FLEC" .
<Fluorouracil> <Antineoplastic_of> "FEMTX" .
<Fluorouracil> <Antineoplastic_of> "FELV" .
<Fluorouracil> <Antineoplastic_of> "FEC_and_H_(SC)" .
<Fluorouracil> <Antineoplastic_of> "FEC_and_H" .
<Fluorouracil> <Antineoplastic_of> "FEC_and_Bevacizumab" .
<Fluorouracil> <Antineoplastic_of> "FEC" .
<Fluorouracil> <Antineoplastic_of> "FAS" .
<Fluorouracil> <Antineoplastic_of> "FAMTX" .
<Fluorouracil> <Antineoplastic_of> "FAM" .
<Fluorouracil> <Antineoplastic_of> "FAC_and_Bevacizumab" .
<Fluorouracil> <Antineoplastic_of> "FAC_and_BCG" .
<Fluorouracil> <Antineoplastic_of> "FAC" .
<Fluorouracil> <Antineoplastic_of> "F-MACHOP" .
<Fluorouracil> <Antineoplastic_of> "EOF" .
<Fluorouracil> <Antineoplastic_of> "ECF/5-FU_and_RT" .
<Fluorouracil> <Antineoplastic_of> "ECF" .
<Fluorouracil> <Antineoplastic_of> "Doxorubicin_and_Fluorouracil" .
<Fluorouracil> <Antineoplastic_of> "Docetaxel,_Fluorouracil,_RT" .
<Fluorouracil> <Antineoplastic_of> "Docetaxel,_Fluorouracil,_Hydroxyurea,_RT" .
<Fluorouracil> <Antineoplastic_of> "DCF" .
<Fluorouracil> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_Vincristine" .
<Fluorouracil> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_RT" .
<Fluorouracil> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_Pembrolizumab" .
<Fluorouracil> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_Panitumumab" .
<Fluorouracil> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_Hydroxyurea,_RT" .
<Fluorouracil> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_Cetuximab" .
<Fluorouracil> <Antineoplastic_of> "Cisplatin,_Doxorubicin_liposomal,_Fluorouracil" .
<Fluorouracil> <Antineoplastic_of> "Cisplatin_and_Fluorouracil" .
<Fluorouracil> <Antineoplastic_of> "Carboplatin,_Fluorouracil,_RT" .
<Fluorouracil> <Antineoplastic_of> "Carboplatin,_Fluorouracil,_Cetuximab,_RT" .
<Fluorouracil> <Antineoplastic_of> "Carboplatin,_Fluorouracil,_Cetuximab" .
<Fluorouracil> <Antineoplastic_of> "Carboplatin_and_Fluorouracil" .
<Fluorouracil> <Antineoplastic_of> "CMFVP" .
<Fluorouracil> <Antineoplastic_of> "CMFV" .
<Fluorouracil> <Antineoplastic_of> "CMFT" .
<Fluorouracil> <Antineoplastic_of> "CMFPT" .
<Fluorouracil> <Antineoplastic_of> "CMFP" .
<Fluorouracil> <Antineoplastic_of> "CMFL" .
<Fluorouracil> <Antineoplastic_of> "CMF" .
<Fluorouracil> <Antineoplastic_of> "CLF" .
<Fluorouracil> <Antineoplastic_of> "CFP_and_Oophorectomy" .
<Fluorouracil> <Antineoplastic_of> "CFP" .
<Fluorouracil> <Antineoplastic_of> "CF_and_Trastuzumab" .
<Fluorouracil> <Antineoplastic_of> "CEF/CMF" .
<Fluorouracil> <Antineoplastic_of> "CAMFP" .
<Fluorouracil> <Antineoplastic_of> "CAMF" .
<Fluorouracil> <Antineoplastic_of> "CAFVP" .
<Fluorouracil> <Antineoplastic_of> "CAF_and_MPA" .
<Fluorouracil> <Antineoplastic_of> "AVCF" .
<Fluorouracil> <Antineoplastic_of> "AV-CMF" .
<Pinix> <Brand_name_of> "Alprazolam" .
<Abemaciclib_monotherapy> <Mapped_from> "Abemaciclib_monotherapy" .
<Dexamine> <Brand_name_of> "Dexamethasone" .
<V-HyperCAD> <Has_modality> "Chemotherapy" .
<Ralenost> <Brand_name_of> "Alendronate" .
<Chemozole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Docetaxel_and_Nintedanib> <Mapped_from> "Docetaxel_and_Nintedanib" .
<BuCy,_then_auto_HSCT> <Is_current_in> "Acute_myeloid_leukemia" .
<Amoxicillin> <Is_a> "WHO_Essential_Anti-infective_Medicine" .
<Amoxicillin> <Is_a> "Penicillin" .
<Trifluridine_and_tipiracil_monotherapy> <Mapped_from> "Trifluridine_and_tipiracil_monotherapy" .
<Capecitabine,_Docetaxel,_RT> <Has_context> "Neoadjuvant_therapy" .
<Rituximab> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Rituximab> <Has_accepted_use> "Transformed_lymphoma" .
<Rituximab> <Has_accepted_use> "Thrombotic_thrombocytopenic_purpura" .
<Rituximab> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<Rituximab> <Has_accepted_use> "Post-transplant_lymphoproliferative_disorder" .
<Rituximab> <Has_accepted_use> "Mediastinal_gray-zone_lymphoma" .
<Rituximab> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Rituximab> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Rituximab> <Has_accepted_use> "Inherited_coagulopathy" .
<Rituximab> <Has_accepted_use> "Immune_thrombocytopenia" .
<Rituximab> <Has_accepted_use> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<Rituximab> <Has_accepted_use> "Hodgkin_lymphoma" .
<Rituximab> <Has_accepted_use> "Hairy_cell_leukemia" .
<Rituximab> <Has_accepted_use> "HIV-associated_lymphoma" .
<Rituximab> <Has_accepted_use> "Follicular_lymphoma" .
<Rituximab> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Rituximab> <Has_accepted_use> "Cold_agglutinin_disease" .
<Rituximab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Rituximab> <Has_accepted_use> "Castleman_disease" .
<Rituximab> <Has_accepted_use> "CNS_lymphoma" .
<Rituximab> <Has_accepted_use> "Burkitt_lymphoma" .
<Rituximab> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Rituximab> <Has_accepted_use> "Acquired_coagulopathy" .
<Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA> <Maps_to> "Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA" .
<R-MegaCHOP-14> <Mapped_from> "R-MegaCHOP-14" .
<Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT> <Has_modality> "Radiotherapy" .
<Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<VCAP> <Has_context> "Induction_therapy" .
<TLI_and_ATG> <Has_antineoplastic> "External_beam_radiotherapy" .
<Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin> <Maps_to> "Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin" .
<Salix> <Brand_name_of> "Furosemide" .
<Capecitabine,_Paclitaxel,_RT> <Has_antineoplastic> "Paclitaxel" .
<Capecitabine,_Paclitaxel,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Capecitabine,_Paclitaxel,_RT> <Has_antineoplastic> "Capecitabine" .
<ACVBP> <Is_a> "Anthracycline-containing_regimen" .
<Irinotecan_and_Cetuximab> <Mapped_from> "Irinotecan_and_Cetuximab" .
<Andol> <Brand_name_of> "Aspirin" .
<Dexaderm> <Brand_name_of> "Dexamethasone" .
<Maxidauno> <Brand_name_of> "Daunorubicin" .
<CABO> <Has_accepted_use> "Head_and_neck_cancer" .
<CNS_carcinoma> <Accepted_use_of> "Whole_brain_irradiation" .
<CNS_carcinoma> <Accepted_use_of> "Teniposide_and_WBRT" .
<CNS_carcinoma> <Accepted_use_of> "Osimertinib_monotherapy" .
<CNS_carcinoma> <Accepted_use_of> "Icotinib_monotherapy" .
<CNS_carcinoma> <Accepted_use_of> "Icotinib" .
<CNS_carcinoma> <Accepted_use_of> "Dexamethasone_monotherapy" .
<CNS_carcinoma> <Accepted_use_of> "Dexamethasone_and_WBRT" .
<CNS_carcinoma> <Accepted_use_of> "Ceritinib_monotherapy" .
<CNS_carcinoma> <Accepted_use_of> "Capecitabine_and_Trastuzumab" .
<CNS_carcinoma> <Accepted_use_of> "Capecitabine_and_Lapatinib" .
<CNS_carcinoma> <Accepted_use_of> "Alectinib_monotherapy" .
<CNS_carcinoma> <Accepted_use_of> "Afatinib_monotherapy" .
<FND> <Has_antineoplastic> "Mitoxantrone" .
<FND> <Has_antineoplastic> "Fludarabine" .
<FND> <Has_antineoplastic> "Dexamethasone" .
<Citomid> <Brand_name_of> "Vincristine" .
<Suftrex> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Gemcitabine_and_RT> <Has_context> "Induction_therapy" .
<Everolimus_and_Tamoxifen> <Has_modality> "Hormonotherapy" .
<Everolimus_and_Tamoxifen> <Has_modality> "Chemotherapy" .
<eBEACOPP_(Prednisolone)> <Has_antineoplastic> "Vincristine" .
<eBEACOPP_(Prednisolone)> <Has_antineoplastic> "Procarbazine" .
<eBEACOPP_(Prednisolone)> <Has_antineoplastic> "Prednisolone" .
<eBEACOPP_(Prednisolone)> <Has_antineoplastic> "Etoposide" .
<eBEACOPP_(Prednisolone)> <Has_antineoplastic> "Doxorubicin" .
<eBEACOPP_(Prednisolone)> <Has_antineoplastic> "Cyclophosphamide" .
<eBEACOPP_(Prednisolone)> <Has_antineoplastic> "Bleomycin" .
<VMP> <Has_context> "Non-curative_first-line_therapy" .
<VMP> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<HDMP-R> <Mapped_from> "HDMP-R" .
<Vincristine_liposomal> <Is_a> "Vinca_alkaloid" .
<Vincristine_liposomal> <Is_a> "Vesicant" .
<Vincristine_liposomal> <Is_a> "Microtubule_inhibitor" .
<Vincristine_liposomal> <Is_a> "Liposomal_chemotherapy" .
<Vincristine_liposomal> <Is_a> "Irritant" .
<Gemtuzumab_ozogamicin_monotherapy> <Mapped_from> "Gemtuzumab_ozogamicin_monotherapy" .
<CLARA> <Is_current_in> "Acute_myeloid_leukemia" .
<Eculizumab_monotherapy> <Is_current_in> "Paroxysmal_nocturnal_hemoglobinuria" .
<Eculizumab_monotherapy> <Is_current_in> "Cold_agglutinin_disease" .
<Eculizumab_monotherapy> <Is_current_in> "Atypical_hemolytic_uremic_syndrome" .
<Denosumab_monotherapy> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Denosumab_monotherapy> <Has_supportive_med> "Irinotecan" .
<Denosumab_monotherapy> <Has_supportive_med> "Dexamethasone" .
<Denosumab_monotherapy> <Has_supportive_med> "Atropine" .
<VcR-CVAD> <Maps_to> "VcR-CVAD" .
<B-CAVe> <Has_modality> "Chemotherapy" .
<FEAM> <Mapped_from> "FEAM" .
<Eribulin_monotherapy> <Has_modality> "Chemotherapy" .
<Flutamide> <Has_accepted_use> "Prostate_cancer" .
<Vulvar_cancer> <Accepted_use_of> "Paclitaxel_monotherapy" .
<Vulvar_cancer> <Accepted_use_of> "Paclitaxel" .
<Vulvar_cancer> <Accepted_use_of> "Cisplatin_and_RT" .
<Vulvar_cancer> <Accepted_use_of> "Cisplatin" .
<CHOP,_then_131Iodine-Tositumomab> <Has_supportive_med> "Diphenhydramine" .
<CHOP,_then_131Iodine-Tositumomab> <Has_supportive_med> "Allopurinol" .
<CHOP,_then_131Iodine-Tositumomab> <Has_supportive_med> "Acetaminophen" .
<Erlotinib> <Has_accepted_use> "Renal_cell_carcinoma" .
<Erlotinib> <Has_accepted_use> "Pancreatic_cancer" .
<Erlotinib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Erlotinib> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Erlotinib> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Erlotinib> <Has_accepted_use> "Esophageal_cancer" .
<Erlotinib> <Has_accepted_use> "EGFR-mutated_malignancy" .
<Erlotinib> <Has_accepted_use> "Cholangiocarcinoma" .
<Erlotinib> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<Myelostat> <Brand_name_of> "Hydroxyurea" .
<Assepium> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<PI3K_delta_inhibitor> <Subsumes> "Pictilisib" .
<PI3K_delta_inhibitor> <Subsumes> "Idelalisib" .
<PI3K_delta_inhibitor> <Subsumes> "Duvelisib" .
<PI3K_delta_inhibitor> <Subsumes> "Copanlisib" .
<ABVD,_DD-DI> <Has_supportive_med> "Lenograstim" .
<Arsenic_trioxide,_ATRA,_Idarubicin> <Has_context> "Induction_therapy" .
<VeIP> <Has_context> "Salvage_therapy" .
<BID> <Maps_to> "BID" .
<Irinotecan_and_Temozolomide> <Has_accepted_use> "Ewing_sarcoma" .
<Procarbazine> <May_have_route> "Oral" .
<IT_Methotrexate_and_Hydrocortisone> <Maps_to> "IT_Methotrexate_and_Hydrocortisone" .
<Methotrexate_and_Rituximab> <Mapped_from> "Methotrexate_and_Rituximab" .
<Cisplatin,_Pemetrexed,_TTFields> <Has_context> "Non-curative_first-line_therapy" .
<Hydroxyzine> <May_have_route> "Oral" .
<Etoposide_and_Prednisone> <Is_current_in> "Langerhans_cell_histiocytosis" .
<Paclitaxel> <Antineoplastic_of> "iddEPC" .
<Paclitaxel> <Antineoplastic_of> "ddTH_(Taxol)" .
<Paclitaxel> <Antineoplastic_of> "ddAC-T" .
<Paclitaxel> <Antineoplastic_of> "TTR" .
<Paclitaxel> <Antineoplastic_of> "TPC" .
<Paclitaxel> <Antineoplastic_of> "TL_(Taxol)" .
<Paclitaxel> <Antineoplastic_of> "TIP" .
<Paclitaxel> <Antineoplastic_of> "THP_(Taxol)" .
<Paclitaxel> <Antineoplastic_of> "THL_(Taxol)" .
<Paclitaxel> <Antineoplastic_of> "TH_(Taxol)" .
<Paclitaxel> <Antineoplastic_of> "TCHP_(Taxol)" .
<Paclitaxel> <Antineoplastic_of> "TC_and_Nintedanib" .
<Paclitaxel> <Antineoplastic_of> "Paclitaxel,_Topotecan,_Bevacizumab" .
<Paclitaxel> <Antineoplastic_of> "Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine" .
<Paclitaxel> <Antineoplastic_of> "Paclitaxel_monotherapy" .
<Paclitaxel> <Antineoplastic_of> "Paclitaxel_and_Vinorelbine" .
<Paclitaxel> <Antineoplastic_of> "Paclitaxel_and_Topotecan" .
<Paclitaxel> <Antineoplastic_of> "Paclitaxel_and_S-1" .
<Paclitaxel> <Antineoplastic_of> "Paclitaxel_and_Ramucirumab" .
<Paclitaxel> <Antineoplastic_of> "Paclitaxel_and_RT" .
<Paclitaxel> <Antineoplastic_of> "Paclitaxel_and_Pazopanib" .
<Paclitaxel> <Antineoplastic_of> "Paclitaxel_and_Bevacizumab" .
<Paclitaxel> <Antineoplastic_of> "PGC" .
<Paclitaxel> <Antineoplastic_of> "PET" .
<Paclitaxel> <Antineoplastic_of> "PCF" .
<Paclitaxel> <Antineoplastic_of> "PCE" .
<Paclitaxel> <Antineoplastic_of> "Neratinib_and_Paclitaxel" .
<Paclitaxel> <Antineoplastic_of> "M-TIP" .
<Paclitaxel> <Antineoplastic_of> "Ifosfamide_and_Paclitaxel" .
<Paclitaxel> <Antineoplastic_of> "Gemcitabine,_Oxaliplatin,_Paclitaxel" .
<Paclitaxel> <Antineoplastic_of> "Gemcitabine_and_Paclitaxel" .
<Paclitaxel> <Antineoplastic_of> "GCP" .
<Paclitaxel> <Antineoplastic_of> "Fluorouracil,_Paclitaxel,_RT" .
<Paclitaxel> <Antineoplastic_of> "Fluorouracil_and_Paclitaxel" .
<Paclitaxel> <Antineoplastic_of> "EP" .
<Paclitaxel> <Antineoplastic_of> "Cisplatin,_Paclitaxel,_RT" .
<Paclitaxel> <Antineoplastic_of> "Cisplatin,_Paclitaxel,_Bevacizumab" .
<Paclitaxel> <Antineoplastic_of> "Cisplatin,_Doxorubicin,_Paclitaxel" .
<Paclitaxel> <Antineoplastic_of> "Cisplatin,_Dacarbazine,_Paclitaxel" .
<Paclitaxel> <Antineoplastic_of> "Cisplatin_and_Paclitaxel" .
<Paclitaxel> <Antineoplastic_of> "Carboplatin,_Paclitaxel,_RT" .
<Paclitaxel> <Antineoplastic_of> "Carboplatin,_Paclitaxel,_Pembrolizumab" .
<Paclitaxel> <Antineoplastic_of> "Carboplatin,_Paclitaxel,_Ipilimumab" .
<Paclitaxel> <Antineoplastic_of> "Carboplatin,_Paclitaxel,_Bevacizumab" .
<Paclitaxel> <Antineoplastic_of> "Carboplatin,_Olaparib,_Paclitaxel" .
<Paclitaxel> <Antineoplastic_of> "Carboplatin_and_Paclitaxel" .
<Paclitaxel> <Antineoplastic_of> "Capecitabine,_Paclitaxel,_RT" .
<Paclitaxel> <Antineoplastic_of> "Capecitabine,_Carboplatin,_Paclitaxel,_RT" .
<Paclitaxel> <Antineoplastic_of> "Capecitabine_and_Paclitaxel" .
<Paclitaxel> <Antineoplastic_of> "Afatinib_and_Paclitaxel" .
<Paclitaxel> <Antineoplastic_of> "AT_(Taxol)" .
<Paclitaxel> <Antineoplastic_of> "AC-T" .
<Paclitaxel> <Antineoplastic_of> "ABCP" .
<A-AVD> <Is_a> "Anthracycline-containing_regimen" .
<Imatinib,_Vincristine,_Prednisone> <Has_antineoplastic> "Vincristine" .
<Imatinib,_Vincristine,_Prednisone> <Has_antineoplastic> "Prednisone" .
<Imatinib,_Vincristine,_Prednisone> <Has_antineoplastic> "Imatinib" .
<Cladribine_and_Rituximab> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Cladribine_and_Rituximab> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Cladribine_and_Rituximab> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Cladribine_and_Rituximab> <Has_accepted_use> "Hairy_cell_leukemia" .
<O-FC> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Prostate_cancer> <FDA_indication_of> "Triptorelin" .
<Prostate_cancer> <FDA_indication_of> "Sipuleucel-T" .
<Prostate_cancer> <FDA_indication_of> "Radium-223" .
<Prostate_cancer> <FDA_indication_of> "Mitoxantrone" .
<Prostate_cancer> <FDA_indication_of> "Leuprolide" .
<Prostate_cancer> <FDA_indication_of> "Histrelin" .
<Prostate_cancer> <FDA_indication_of> "Flutamide" .
<Prostate_cancer> <FDA_indication_of> "Enzalutamide" .
<Prostate_cancer> <FDA_indication_of> "Docetaxel" .
<Prostate_cancer> <FDA_indication_of> "Degarelix" .
<Prostate_cancer> <FDA_indication_of> "Darolutamide" .
<Prostate_cancer> <FDA_indication_of> "Cabazitaxel" .
<Prostate_cancer> <FDA_indication_of> "Bicalutamide" .
<Prostate_cancer> <FDA_indication_of> "Apalutamide" .
<Prostate_cancer> <FDA_indication_of> "Abiraterone" .
<TheraCys> <Brand_name_of> "Bacillus_Calmette-Guerin" .
<Cyanocobalamin> <May_have_route> "Subcutaneous" .
<Cyanocobalamin> <May_have_route> "Oral" .
<Cyanocobalamin> <May_have_route> "Nasal" .
<Cyanocobalamin> <May_have_route> "Intramuscular" .
<Dacarbazine_and_Ipilimumab> <Has_context> "Non-curative_therapy" .
<VIPD> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<VIPD> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Dexin> <Brand_name_of> "Dexamethasone" .
<Fluorouracil,_Folinic_acid,_Gemcitabine> <Has_modality> "Chemotherapy" .
<Thiotepa> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Thiotepa> <Has_accepted_use> "CNS_lymphoma" .
<Thiotepa> <Has_accepted_use> "Breast_cancer" .
<Thiotepa> <Has_accepted_use> "Bladder_cancer" .
<Denintuzumab_mafodotin> <Is_a> "Halted_drug" .
<Denintuzumab_mafodotin> <Is_a> "Antibody-drug_conjugate" .
<Denintuzumab_mafodotin> <Is_a> "Antibody_medication" .
<Denintuzumab_mafodotin> <Is_a> "Anti-CD19_antibody" .
<CHUT,_then_auto_HSCT> <Has_context> "Non-curative_therapy" .
<Tisagenlecleucel_monotherapy> <Maps_to> "Tisagenlecleucel_monotherapy" .
<Pegfilgrastim-cbqv> <Has_brand_name> "Fulphila" .
<R-CHVP_plus_I> <Has_antineoplastic> "Rituximab" .
<R-CHVP_plus_I> <Has_antineoplastic> "Prednisolone" .
<R-CHVP_plus_I> <Has_antineoplastic> "Etoposide" .
<R-CHVP_plus_I> <Has_antineoplastic> "Doxorubicin" .
<R-CHVP_plus_I> <Has_antineoplastic> "Cyclophosphamide" .
<Methylone> <Brand_name_of> "Methylprednisolone" .
<Factor_IX_recombinant_Fc_fusion_protein> <Has_accepted_use> "Inherited_coagulopathy" .
<Enoxaparin> <May_have_route> "Subcutaneous" .
<ADT_and_Enzalutamide> <Has_context> "Non-curative_therapy" .
<Utrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Erlotinib> <May_have_route> "Oral" .
<FEC> <Is_a> "Anthracycline-containing_regimen" .
<Gastrointestinal_stromal_tumor> <Is_a> "Soft_tissue_sarcoma" .
<Gastrointestinal_stromal_tumor> <Is_a> "Gastrointestinal_cancer" .
<Eltrombopag> <Is_a> "Megakaryocyte_growth_factor" .
<Eltrombopag> <Is_a> "Hematopoietic_growth_factor" .
<Talimogene_laherparepvec> <Antineoplastic_of> "Talimogene_laherparepvec_monotherapy" .
<Cisplatin_and_RT> <Has_accepted_use> "Vulvar_cancer" .
<Cisplatin_and_RT> <Has_accepted_use> "Oropharyngeal_cancer" .
<Cisplatin_and_RT> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cisplatin_and_RT> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<Cisplatin_and_RT> <Has_accepted_use> "Head_and_neck_cancer" .
<Cisplatin_and_RT> <Has_accepted_use> "HPV-positive_Oropharyngeal_cancer" .
<Cisplatin_and_RT> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Cisplatin_and_RT> <Has_accepted_use> "Endometrial_cancer" .
<Cisplatin_and_RT> <Has_accepted_use> "Cervical_cancer" .
<Cisplatin_and_RT> <Has_accepted_use> "Bladder_cancer" .
<Trenantone> <Brand_name_of> "Leuprolide" .
<Trametinib> <Is_a> "Mutation-specific_medication" .
<Trametinib> <Is_a> "MAP2K2_inhibitor" .
<Trametinib> <Is_a> "MAP2K1_inhibitor" .
<Trametinib> <Is_a> "Kinase_inhibitor" .
<Fluracil> <Brand_name_of> "Fluorouracil" .
<Exemestane> <Has_brand_name> "Xtane" .
<Exemestane> <Has_brand_name> "Aromex" .
<Exemestane> <Has_brand_name> "Aromasin" .
<Exemestane> <Has_brand_name> "Aromadex" .
<Ibrutinib> <Is_a> "TXK_inhibitor" .
<Ibrutinib> <Is_a> "TEC_inhibitor" .
<Ibrutinib> <Is_a> "PMDA_approved_drug" .
<Ibrutinib> <Is_a> "Mutation-specific_medication" .
<Ibrutinib> <Is_a> "Kinase_inhibitor" .
<Ibrutinib> <Is_a> "ITK_inhibitor" .
<Ibrutinib> <Is_a> "EGFR_inhibitor" .
<Ibrutinib> <Is_a> "BTK_inhibitor" .
<Platimit> <Brand_name_of> "Cisplatin" .
<Decitabine_monotherapy> <Has_antineoplastic> "Decitabine" .
<Nisocortec> <Brand_name_of> "Prednisone" .
<Prasugrel> <Is_a> "P2Y12_ADP_inhibitor" .
<CYVE> <Has_accepted_use> "CNS_lymphoma" .
<CYVE> <Has_accepted_use> "Burkitt_lymphoma" .
<CYVE> <Has_accepted_use> "Autologous_HSCT" .
<CYVE> <Has_accepted_use> "Acute_myeloid_leukemia" .
<CIM> <Has_context> "Non-curative_therapy" .
<CIM> <Has_context> "Adjuvant_therapy" .
<CVD_(Vindesine)> <Has_context> "Non-curative_therapy" .
<Alpelisib> <May_have_route> "Oral" .
<VAC_(Adriamycin)> <Is_a> "Anthracycline-containing_regimen" .
<POMP> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<POMP> <Has_accepted_use> "Acute_myeloid_leukemia" .
<EOF> <Has_modality> "Chemotherapy" .
<Sandostatine_LAR> <Brand_name_of> "Octreotide_LAR" .
<PEV> <Has_context> "Induction_therapy" .
<MACOP-B> <Has_modality> "Chemotherapy" .
<Decazol> <Brand_name_of> "Dexamethasone" .
<P/DOCE> <Is_a> "Anthracycline-containing_regimen" .
<Alemtuzumab_monotherapy> <Has_immunosuppressor> "Alemtuzumab" .
<Etoposide_and_TBI> <Has_modality> "Radiotherapy" .
<Etoposide_and_TBI> <Has_modality> "Chemotherapy" .
<Cyclophosphamide,_Mycophenolate_mofetil,_Tacrolimus> <Mapped_from> "Cyclophosphamide,_Mycophenolate_mofetil,_Tacrolimus" .
<Altretamine_and_Cisplatin> <Has_modality> "Chemotherapy" .
<Idelalisib_monotherapy> <Maps_to> "Idelalisib_monotherapy" .
<Docetaxel,_Gemcitabine,_RT> <Has_supportive_med> "Proton_pump_inhibitors" .
<Etoposide> <Has_brand_name> "Vepside" .
<Etoposide> <Has_brand_name> "Vepsid" .
<Etoposide> <Has_brand_name> "Vepeside" .
<Etoposide> <Has_brand_name> "Vepesid" .
<Etoposide> <Has_brand_name> "Vepefos" .
<Etoposide> <Has_brand_name> "Tosuben" .
<Etoposide> <Has_brand_name> "Topresid" .
<Etoposide> <Has_brand_name> "Toposin" .
<Etoposide> <Has_brand_name> "Toposide" .
<Etoposide> <Has_brand_name> "Toposar" .
<Etoposide> <Has_brand_name> "Sintopozid" .
<Etoposide> <Has_brand_name> "Riboposid" .
<Etoposide> <Has_brand_name> "Posyd" .
<Etoposide> <Has_brand_name> "Posidon" .
<Etoposide> <Has_brand_name> "Posid" .
<Etoposide> <Has_brand_name> "Percas" .
<Etoposide> <Has_brand_name> "Optasid" .
<Etoposide> <Has_brand_name> "Onkoposid" .
<Etoposide> <Has_brand_name> "Nexvep" .
<Etoposide> <Has_brand_name> "Neoplaxol" .
<Etoposide> <Has_brand_name> "Lastet_S" .
<Etoposide> <Has_brand_name> "Lastet" .
<Etoposide> <Has_brand_name> "Labimion" .
<Etoposide> <Has_brand_name> "Fytosid" .
<Etoposide> <Has_brand_name> "Fytop" .
<Etoposide> <Has_brand_name> "Exitop" .
<Etoposide> <Has_brand_name> "Euvaxon" .
<Etoposide> <Has_brand_name> "Eunades_CS" .
<Etoposide> <Has_brand_name> "Etosin" .
<Etoposide> <Has_brand_name> "Etosid" .
<Etoposide> <Has_brand_name> "Etopul" .
<Etoposide> <Has_brand_name> "Etopoxan" .
<Etoposide> <Has_brand_name> "Etoposido" .
<Etoposide> <Has_brand_name> "Etoposid" .
<Etoposide> <Has_brand_name> "Etopos" .
<Etoposide> <Has_brand_name> "Etopophos" .
<Etoposide> <Has_brand_name> "Etopofos" .
<Etoposide> <Has_brand_name> "Etonolver" .
<Etoposide> <Has_brand_name> "Etomedac" .
<Etoposide> <Has_brand_name> "Etocris" .
<Etoposide> <Has_brand_name> "Epsidox" .
<Etoposide> <Has_brand_name> "Eposin" .
<Etoposide> <Has_brand_name> "Eposido" .
<Etoposide> <Has_brand_name> "Eposide" .
<Etoposide> <Has_brand_name> "Eposid" .
<Etoposide> <Has_brand_name> "Epocin" .
<Etoposide> <Has_brand_name> "ETO" .
<Etoposide> <Has_brand_name> "Citodox" .
<Etoposide> <Has_brand_name> "Celltop" .
<Etoposide> <Has_brand_name> "Bioposide" .
<Etoposide> <Has_brand_name> "Beposid" .
<Etoposide> <Has_brand_name> "Aside" .
<Vismodegib> <Is_a> "SMO_or_PTCH-1_(Hedgehog)_medication" .
<Vismodegib> <Is_a> "SMO_inhibitor" .
<Vismodegib> <Is_a> "Hedgehog_pathway_inhibitor" .
<DRC> <Has_modality> "Chemotherapy" .
<Dasatinib> <Has_brand_name> "Sprycel" .
<Desferal> <Brand_name_of> "Deferoxamine" .
<Azacitidine_and_Gemtuzumab_ozogamicin> <Maps_to> "Azacitidine_and_Gemtuzumab_ozogamicin" .
<Ketoconazole> <Antineoplastic_of> "Ketoconazole,_Hydrocortisone,_Dutasteride" .
<Ketoconazole> <Antineoplastic_of> "Ketoconazole_and_Hydrocortisone" .
<Kalciumfolinat_Perivita> <Brand_name_of> "Folinic_acid" .
<IGFR_inhibitor> <Is_a> "Kinase_inhibitor" .
<IGFR_inhibitor> <Is_a> "Growth_factor_inhibitor" .
<ABVE-PC> <Has_modality> "Chemotherapy" .
<Vorina> <Brand_name_of> "Folinic_acid" .
<PCD> <Has_modality> "Chemotherapy" .
<AC_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<AC_and_Bevacizumab> <Is_a> "Anthracycline-containing_regimen" .
<Apixaban_monotherapy> <Has_accepted_use> "Venous_thromboembolism" .
<Mercaptopurine> <Has_brand_name> "Purixan_(oral_suspension_formulation)" .
<Mercaptopurine> <Has_brand_name> "Purinethol" .
<D-ZAPO> <Has_antineoplastic> "Vincristine" .
<D-ZAPO> <Has_antineoplastic> "Prednisone" .
<D-ZAPO> <Has_antineoplastic> "Daunorubicin" .
<D-ZAPO> <Has_antineoplastic> "Cytarabine" .
<D-ZAPO> <Has_antineoplastic> "Azacitidine" .
<Supportive_therapy> <Maps_to> "Supportive_therapy" .
<Cervical_cancer> <Is_a> "Gynecologic_cancer" .
<Site-specific_medication> <Subsumes> "Thoracic_oncology_medication" .
<Site-specific_medication> <Subsumes> "Neurooncology_medication" .
<Site-specific_medication> <Subsumes> "Malignant_hematology_medication" .
<Site-specific_medication> <Subsumes> "Gynecologic_oncology_medication" .
<Site-specific_medication> <Subsumes> "Genitourinary_oncology_medication" .
<Site-specific_medication> <Subsumes> "Gastrointestinal_oncology_medication" .
<Site-specific_medication> <Subsumes> "Endocrine_oncology_medication" .
<Carboplatin_and_Gemcitabine> <Has_context> "Non-curative_therapy" .
<Carboplatin_and_Gemcitabine> <Has_context> "Non-curative_subsequent-line_therapy" .
<Carboplatin_and_Gemcitabine> <Has_context> "Non-curative_second-line_therapy" .
<Carboplatin_and_Gemcitabine> <Has_context> "Non-curative_first-line_therapy" .
<Etoposide_and_TBI> <Has_antineoplastic> "External_beam_radiotherapy" .
<Etoposide_and_TBI> <Has_antineoplastic> "Etoposide" .
<IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone> <Has_context> "Consolidation_after_upfront_therapy" .
<Aspirin_and_Dexamethasone> <Maps_to> "Aspirin_and_Dexamethasone" .
<Aspirin_and_Anagrelide> <Is_current_in> "Essential_thrombocythemia" .
<Valrubicin_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<Taxewell> <Brand_name_of> "Docetaxel" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Zoledronic_acid" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Vinorelbine" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Vincristine" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Vinblastine" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Trastuzumab-qyyp" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Trastuzumab-pkrb" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Trastuzumab-dttb" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Trastuzumab-dkst" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Trastuzumab-anns" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Trastuzumab" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Thioguanine" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Thalidomide" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Tamoxifen" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Rituximab-pvvr" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Rituximab-abbs" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Rituximab" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Procarbazine" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Prednisolone" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Pembrolizumab" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Pegaspargase" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Paclitaxel" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Oxaliplatin" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Nivolumab" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Nilotinib" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Methylprednisolone" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Methotrexate" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Mesna" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Mercaptopurine" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Melphalan" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Leuprolide" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Lenalidomide" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Irinotecan" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Imatinib" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Ifosfamide" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Hydroxyurea" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Hydrocortisone" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Gemcitabine" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Gefitinib" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Folinic_acid" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Fluorouracil" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Fludarabine" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Filgrastim" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Etoposide" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Erlotinib" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Doxorubicin" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Docetaxel" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Dexamethasone" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Daunorubicin" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Dasatinib" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Dactinomycin" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Dacarbazine" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Cytarabine" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Cyclophosphamide" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Cisplatin" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Chlorambucil" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Carboplatin" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Capecitabine" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Bortezomib" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Bleomycin" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Bicalutamide" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Bendamustine" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Asparaginase" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Arsenic_trioxide" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Anastrozole" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Allopurinol" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "All-trans_retinoic_acid" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Afatinib" .
<WHO_Essential_Cancer_Medicine> <Subsumes> "Abiraterone" .
<CHVP-I> <Has_accepted_use> "Follicular_lymphoma" .
<Meticorten> <Brand_name_of> "Prednisone" .
<Antipyretic> <Is_a> "Supportive_medication" .
<Tisagenlecleucel_monotherapy> <Is_current_in> "Transformed_lymphoma" .
<Tisagenlecleucel_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Tisagenlecleucel_monotherapy> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Gemcitabine_and_Bevacizumab> <Has_accepted_use> "Breast_cancer" .
<Cisplatin> <Has_accepted_use> "Vulvar_cancer" .
<Cisplatin> <Has_accepted_use> "Transformed_lymphoma" .
<Cisplatin> <Has_accepted_use> "Thymoma" .
<Cisplatin> <Has_accepted_use> "Testicular_cancer" .
<Cisplatin> <Has_accepted_use> "Small_cell_lung_cancer" .
<Cisplatin> <Has_accepted_use> "SCC_of_unknown_primary" .
<Cisplatin> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<Cisplatin> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Cisplatin> <Has_accepted_use> "Penile_cancer" .
<Cisplatin> <Has_accepted_use> "Pancreatic_cancer" .
<Cisplatin> <Has_accepted_use> "Ovarian_cancer" .
<Cisplatin> <Has_accepted_use> "Osteosarcoma" .
<Cisplatin> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cisplatin> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<Cisplatin> <Has_accepted_use> "Multiple_myeloma" .
<Cisplatin> <Has_accepted_use> "Mesothelioma" .
<Cisplatin> <Has_accepted_use> "Melanoma" .
<Cisplatin> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Cisplatin> <Has_accepted_use> "Low-grade_glioma" .
<Cisplatin> <Has_accepted_use> "Hodgkin_lymphoma" .
<Cisplatin> <Has_accepted_use> "Hepatoblastoma" .
<Cisplatin> <Has_accepted_use> "Head_and_neck_cancer" .
<Cisplatin> <Has_accepted_use> "Gastric_cancer" .
<Cisplatin> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Cisplatin> <Has_accepted_use> "Esophageal_cancer" .
<Cisplatin> <Has_accepted_use> "Endometrial_cancer" .
<Cisplatin> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Cisplatin> <Has_accepted_use> "Cutaneous_squamous_cell_carcinoma" .
<Cisplatin> <Has_accepted_use> "Cutaneous_basal_cell_carcinoma" .
<Cisplatin> <Has_accepted_use> "Cholangiocarcinoma" .
<Cisplatin> <Has_accepted_use> "Cervical_cancer" .
<Cisplatin> <Has_accepted_use> "Breast_cancer" .
<Cisplatin> <Has_accepted_use> "Bladder_cancer" .
<Cisplatin> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<Cisplatin> <Has_accepted_use> "Anal_cancer" .
<Cisplatin> <Has_accepted_use> "Adrenocortical_carcinoma" .
<Cisplatin> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<ADE_(high-dose_Ara-C)> <Maps_to> "ADE_(high-dose_Ara-C)" .
<Aspirina-G> <Brand_name_of> "Aspirin" .
<VBMC> <Has_antineoplastic> "Vincristine" .
<VBMC> <Has_antineoplastic> "Melphalan" .
<VBMC> <Has_antineoplastic> "Cyclophosphamide" .
<VBMC> <Has_antineoplastic> "Carmustine" .
<Taxane> <Subsumes> "Tesetaxel" .
<Taxane> <Subsumes> "Paclitaxel_nanoparticle_albumin-bound" .
<Taxane> <Subsumes> "Paclitaxel" .
<Taxane> <Subsumes> "Docetaxel" .
<Taxane> <Subsumes> "Cabazitaxel" .
<Imatib> <Brand_name_of> "Imatinib" .
<Pegfilgrastim> <Has_brand_name> "Onpro" .
<Pegfilgrastim> <Has_brand_name> "Neulasta" .
<PAF> <Is_a> "Anthracycline-containing_regimen" .
<Copanlisib_monotherapy> <Has_modality> "Chemotherapy" .
<Carboplatin_and_Paclitaxel> <Has_accepted_use> "triple_negative_Breast_cancer" .
<Carboplatin_and_Paclitaxel> <Has_accepted_use> "Thymoma" .
<Carboplatin_and_Paclitaxel> <Has_accepted_use> "Prostate_cancer" .
<Carboplatin_and_Paclitaxel> <Has_accepted_use> "Ovarian_cancer" .
<Carboplatin_and_Paclitaxel> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Carboplatin_and_Paclitaxel> <Has_accepted_use> "Melanoma" .
<Carboplatin_and_Paclitaxel> <Has_accepted_use> "Gastric_cancer" .
<Carboplatin_and_Paclitaxel> <Has_accepted_use> "Esophageal_cancer" .
<Carboplatin_and_Paclitaxel> <Has_accepted_use> "Endometrial_cancer" .
<Carboplatin_and_Paclitaxel> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<Carboplatin_and_Paclitaxel> <Has_accepted_use> "Cervical_cancer" .
<Carboplatin_and_Paclitaxel> <Has_accepted_use> "Breast_cancer" .
<Carboplatin_and_Paclitaxel> <Has_accepted_use> "Bladder_cancer" .
<Carboplatin_and_Paclitaxel> <Has_accepted_use> "Anal_cancer" .
<Carboplatin_and_Paclitaxel> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<Irenax> <Brand_name_of> "Irinotecan" .
<IDH2_inhibitor> <Subsumes> "Enasidenib" .
<Fluorouracil,_Mitomycin,_RT> <Has_accepted_use> "Head_and_neck_cancer" .
<Fluorouracil,_Mitomycin,_RT> <Has_accepted_use> "Cervical_cancer" .
<Fluorouracil,_Mitomycin,_RT> <Has_accepted_use> "Bladder_cancer" .
<Fluorouracil,_Mitomycin,_RT> <Has_accepted_use> "Anal_cancer" .
<CBVM,_then_auto_HSCT> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Gleevec> <Brand_name_of> "Imatinib" .
<Doxorubicin_and_Gemcitabine> <Has_accepted_use> "Renal_cell_carcinoma" .
<Primary_mediastinal_B-cell_lymphoma> <Is_a> "Non-Hodgkin_lymphoma" .
<Primary_mediastinal_B-cell_lymphoma> <Is_a> "Aggressive_lymphoma" .
<ADOC> <Has_antineoplastic> "Vincristine" .
<ADOC> <Has_antineoplastic> "Doxorubicin" .
<ADOC> <Has_antineoplastic> "Cyclophosphamide" .
<ADOC> <Has_antineoplastic> "Cisplatin" .
<Cycloblastine> <Brand_name_of> "Cyclophosphamide" .
<Bendamustine_and_Brentuximab_vedotin> <Is_current_in> "Hodgkin_lymphoma" .
<Mercaptopurine,_Methotrexate,_Vincristine> <Mapped_from> "Mercaptopurine,_Methotrexate,_Vincristine" .
<VAMP_(Methotrexate)> <Has_accepted_use> "Hodgkin_lymphoma" .
<Guadecitabine> <May_have_route> "Intravenous" .
<CAD_and_G-CSF> <Is_a> "Anthracycline-containing_regimen" .
<Cisplatin,_Interferon_alfa-2a,_Isotretinoin> <Has_modality> "Immunotherapy" .
<Cisplatin,_Interferon_alfa-2a,_Isotretinoin> <Has_modality> "Chemotherapy" .
<Ixazomib> <Has_FDA_indication> "Multiple_myeloma" .
<Predcort> <Brand_name_of> "Prednisone" .
<Non-melanoma_skin_cancer> <Subsumes> "Cutaneous_squamous_cell_carcinoma" .
<Non-melanoma_skin_cancer> <Subsumes> "Cutaneous_basal_cell_carcinoma" .
<CTD> <Is_current_in> "Multiple_myeloma" .
<CTD> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<Aclarubicin> <Has_brand_name> "Jaclacin" .
<Aclarubicin> <Has_brand_name> "Aclaplastin" .
<Aclarubicin> <Has_brand_name> "Aclacinon" .
<Aclarubicin> <Has_brand_name> "Aclacinomycine" .
<Aclarubicin> <Has_brand_name> "Aclacin" .
<ZRd> <Maps_to> "ZRd" .
<FULV_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Tositumomab_&_I-131> <Is_a> "Radiotherapy_medication" .
<Tositumomab_&_I-131> <Is_a> "Radioimmunotherapeutic" .
<Tositumomab_&_I-131> <Is_a> "Protein_expression-specific_medication" .
<Tositumomab_&_I-131> <Is_a> "Discontinued_drug" .
<Tositumomab_&_I-131> <Is_a> "Antibody_medication" .
<Tositumomab_&_I-131> <Is_a> "Anti-CD20_medication" .
<Tositumomab_&_I-131> <Is_a> "Anti-CD20_antibody" .
<Anagrelide_monotherapy> <Has_modality> "Anticoagulation" .
<Bortezomib_and_Vorinostat> <Has_context> "Non-curative_therapy" .
<Icotinib> <Has_brand_name> "Conmana" .
<Flutamide_and_Leuprolide> <Has_accepted_use> "Prostate_cancer" .
<VEPA> <Has_modality> "Chemotherapy" .
<Keflex> <Brand_name_of> "Cephalexin" .
<Apalutamide_monotherapy> <Has_antineoplastic> "Apalutamide" .
<Sultropim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Marginal_zone_lymphoma> <Current_treated_by> "Vorinostat_monotherapy" .
<Marginal_zone_lymphoma> <Current_treated_by> "Rituximab_monotherapy" .
<Marginal_zone_lymphoma> <Current_treated_by> "R-CVP" .
<Marginal_zone_lymphoma> <Current_treated_by> "R-CHOP" .
<Marginal_zone_lymphoma> <Current_treated_by> "PCR" .
<Marginal_zone_lymphoma> <Current_treated_by> "Ox-P" .
<Marginal_zone_lymphoma> <Current_treated_by> "Observation" .
<Marginal_zone_lymphoma> <Current_treated_by> "MCP" .
<Marginal_zone_lymphoma> <Current_treated_by> "Lenalidomide_monotherapy" .
<Marginal_zone_lymphoma> <Current_treated_by> "Lenalidomide_and_Rituximab" .
<Marginal_zone_lymphoma> <Current_treated_by> "Idelalisib_monotherapy" .
<Marginal_zone_lymphoma> <Current_treated_by> "Ibrutinib_monotherapy" .
<Marginal_zone_lymphoma> <Current_treated_by> "Ibritumomab_tiuxetan_monotherapy" .
<Marginal_zone_lymphoma> <Current_treated_by> "Helicobacter_pylori_eradication_therapy" .
<Marginal_zone_lymphoma> <Current_treated_by> "Fludarabine_monotherapy" .
<Marginal_zone_lymphoma> <Current_treated_by> "FR" .
<Marginal_zone_lymphoma> <Current_treated_by> "Doxycycline_monotherapy" .
<Marginal_zone_lymphoma> <Current_treated_by> "Clarithromycin_monotherapy" .
<Marginal_zone_lymphoma> <Current_treated_by> "Cladribine_monotherapy" .
<Marginal_zone_lymphoma> <Current_treated_by> "Cladribine_and_Rituximab" .
<Marginal_zone_lymphoma> <Current_treated_by> "Chlorambucil_monotherapy" .
<Marginal_zone_lymphoma> <Current_treated_by> "Chlorambucil_and_Rituximab" .
<Marginal_zone_lymphoma> <Current_treated_by> "Bortezomib_monotherapy" .
<Marginal_zone_lymphoma> <Current_treated_by> "Bendamustine_monotherapy" .
<Marginal_zone_lymphoma> <Current_treated_by> "BR" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine> <Is_a> "Anthracycline-containing_regimen" .
<Docetaxel_and_Vinorelbine> <Mapped_from> "Docetaxel_and_Vinorelbine" .
<VAMP_(Amethopterin)> <Is_historical_in> "Acute_myeloid_leukemia" .
<VAD_doxil> <Is_a> "Anthracycline-containing_regimen" .
<HuMax-CD38> <Brand_name_of> "Daratumumab" .
<FOLFOX4_and_RT> <Has_modality> "Radiotherapy" .
<FOLFOX4_and_RT> <Has_modality> "Chemotherapy" .
<FUIRI> <Has_accepted_use> "Colon_cancer" .
<Capecitabine,_Oxaliplatin,_RT> <Mapped_from> "Capecitabine,_Oxaliplatin,_RT" .
<VIM> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<NEO-Drol> <Brand_name_of> "Methylprednisolone" .
<Flutamide_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<Goserelin_monotherapy> <Maps_to> "Goserelin_monotherapy" .
<Hydroxyurea_and_Interferon_alfa-2a> <Has_modality> "Immunotherapy" .
<Hydroxyurea_and_Interferon_alfa-2a> <Has_modality> "Chemotherapy" .
<IE> <Mapped_from> "IE" .
<Rematrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<RP> <Has_accepted_use> "Multiple_myeloma" .
<Imatinib,_Vincristine,_Prednisone> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Imatinib,_Vincristine,_Prednisone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Uracil_mustard_monotherapy> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Dexason> <Brand_name_of> "Dexamethasone" .
<Cotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<LEED> <Maps_to> "LEED" .
<ddE> <Is_a> "Anthracycline-containing_regimen" .
<Vismodegib> <Antineoplastic_of> "Vismodegib_monotherapy" .
<Temozolomide,_then_Temozolomide_and_RT,_then_Temozolomide> <Maps_to> "Temozolomide,_then_Temozolomide_and_RT,_then_Temozolomide" .
<Ado-trastuzumab_emtansine> <Has_FDA_indication> "Breast_cancer" .
<Biseptrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Imatinib_monotherapy> <Has_supportive_med> "Prednisone" .
<Imatinib_monotherapy> <Has_supportive_med> "Hematopoietic_growth_factors" .
<Mitoxantrone_and_Hydrocortisone> <Mapped_from> "Mitoxantrone_and_Hydrocortisone" .
<Cisplatin,_Etoposide,_Durvalumab> <Has_accepted_use> "Small_cell_lung_cancer" .
<Deferiprone> <Is_a> "Hematology_medication" .
<Deferiprone> <Is_a> "Chelator" .
<PAD> <Is_current_in> "Multiple_myeloma" .
<FCR> <Mapped_from> "FCR" .
<Delta-Cortef> <Brand_name_of> "Prednisolone" .
<FEC_and_H> <Maps_to> "FEC_and_H" .
<GDP> <Has_antineoplastic> "Gemcitabine" .
<GDP> <Has_antineoplastic> "Dexamethasone" .
<GDP> <Has_antineoplastic> "Cisplatin" .
<Vomceran> <Brand_name_of> "Ondansetron" .
<Chimeric_antigen_receptor_T-cell> <Is_a> "Immune_effector_cell" .
<Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_modality> "Immunosuppressive_therapy" .
<Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<Abemaciclib_monotherapy> <Maps_to> "Abemaciclib_monotherapy" .
<Bortetrust> <Brand_name_of> "Bortezomib" .
<Predinis> <Brand_name_of> "Prednisone" .
<Mesnil> <Brand_name_of> "Mesna" .
<Denileukin_diftitox_monotherapy> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Gemcitabine_and_Mitomycin> <Has_modality> "Chemotherapy" .
<Chlorambucil,_Dactinomycin,_Methotrexate> <Has_antineoplastic> "Methotrexate" .
<Chlorambucil,_Dactinomycin,_Methotrexate> <Has_antineoplastic> "Dactinomycin" .
<Chlorambucil,_Dactinomycin,_Methotrexate> <Has_antineoplastic> "Chlorambucil" .
<Thioguanine_monotherapy> <Has_antineoplastic> "Thioguanine" .
<Rituximab> <Has_FDA_indication> "Follicular_lymphoma" .
<Rituximab> <Has_FDA_indication> "Diffuse_large_B-cell_lymphoma" .
<Rituximab> <Has_FDA_indication> "Chronic_lymphocytic_leukemia" .
<RD> <Has_antineoplastic> "Lenalidomide" .
<RD> <Has_antineoplastic> "Dexamethasone" .
<Valproate> <Antineoplastic_of> "Decitabine_and_Valproate" .
<Carboplatin,_Paclitaxel,_Ipilimumab> <Has_context> "Non-curative_first-line_therapy" .
<Carboplatin,_Paclitaxel,_Ipilimumab> <Has_context> "Induction_therapy" .
<Amekrin> <Brand_name_of> "Amsacrine" .
<VIPD> <Has_context> "Salvage_therapy" .
<VIPD> <Has_context> "Consolidation_after_upfront_therapy" .
<Castleman_disease> <Accepted_use_of> "Tocilizumab_monotherapy" .
<Castleman_disease> <Accepted_use_of> "Tocilizumab" .
<Castleman_disease> <Accepted_use_of> "TCP" .
<Castleman_disease> <Accepted_use_of> "Sirolimus_monotherapy" .
<Castleman_disease> <Accepted_use_of> "Sirolimus" .
<Castleman_disease> <Accepted_use_of> "Siltuximab_monotherapy" .
<Castleman_disease> <Accepted_use_of> "Siltuximab" .
<Castleman_disease> <Accepted_use_of> "Rituximab-pvvr" .
<Castleman_disease> <Accepted_use_of> "Rituximab-abbs" .
<Castleman_disease> <Accepted_use_of> "Rituximab_monotherapy" .
<Castleman_disease> <Accepted_use_of> "Rituximab" .
<Castleman_disease> <Accepted_use_of> "Placebo" .
<Castleman_disease> <Accepted_use_of> "Cyclosporine_monotherapy" .
<Castleman_disease> <Accepted_use_of> "Cyclosporine_modified" .
<Castleman_disease> <Accepted_use_of> "Bortezomib_monotherapy" .
<Castleman_disease> <Accepted_use_of> "Bortezomib" .
<Castleman_disease> <Accepted_use_of> "Anakinra_monotherapy" .
<Treosulfan_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Cisplatin,_Pemetrexed,_TTFields> <Has_accepted_use> "Mesothelioma" .
<SC-EPOCH-RR> <Has_local_therapy> "Methotrexate" .
<CCE> <Has_antineoplastic> "Etoposide" .
<CCE> <Has_antineoplastic> "Cyclophosphamide" .
<CCE> <Has_antineoplastic> "Clofarabine" .
<Dara-VTD> <Has_modality> "Chemotherapy" .
<Cetuximab_monotherapy> <Mapped_from> "Cetuximab_monotherapy" .
<Capecitabine_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<BEACOPP> <Is_a> "Anthracycline-containing_regimen" .
<Hydrocortisone> <Antineoplastic_of> "Mitoxantrone_and_Hydrocortisone" .
<Hydrocortisone> <Antineoplastic_of> "Ketoconazole,_Hydrocortisone,_Dutasteride" .
<Hydrocortisone> <Antineoplastic_of> "Ketoconazole_and_Hydrocortisone" .
<Hydrocortisone> <Antineoplastic_of> "Hydrocortisone_monotherapy" .
<Tavalisse> <Brand_name_of> "Fostamatinib" .
<BuCy,_then_allo_HSCT> <Mapped_from> "BuCy,_then_allo_HSCT" .
<IRd> <Has_supportive_med> "Ranitidine" .
<IRd> <Has_supportive_med> "Elotuzumab" .
<IRd> <Has_supportive_med> "Diphenhydramine" .
<IRd> <Has_supportive_med> "Acetaminophen" .
<COPP_(CCNU)> <Has_antineoplastic> "Vincristine" .
<COPP_(CCNU)> <Has_antineoplastic> "Procarbazine" .
<COPP_(CCNU)> <Has_antineoplastic> "Prednisone" .
<COPP_(CCNU)> <Has_antineoplastic> "Lomustine" .
<FM> <Has_context> "Non-curative_first-line_therapy" .
<CF_and_Trastuzumab> <Has_context> "Non-curative_first-line_therapy" .
<Lepirudin> <May_have_route> "Intravenous" .
<FC> <Has_modality> "Chemotherapy" .
<Fludarabine_and_Alemtuzumab> <Mapped_from> "Fludarabine_and_Alemtuzumab" .
<Sorafenib_monotherapy> <Has_antineoplastic> "Sorafenib" .
<OFAR> <Has_antineoplastic> "Rituximab" .
<OFAR> <Has_antineoplastic> "Oxaliplatin" .
<OFAR> <Has_antineoplastic> "Fludarabine" .
<OFAR> <Has_antineoplastic> "Cytarabine" .
<Vosaroxin_and_Cytarabine> <Maps_to> "Vosaroxin_and_Cytarabine" .
<HDMP-R> <Has_modality> "Chemotherapy" .
<VNCOP-B> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<MAPIE> <Maps_to> "MAPIE" .
<Methotrexate_and_Prednisone> <Has_context> "Induction_therapy" .
<Cyclophosphamide_and_Prednisone> <Mapped_from> "Cyclophosphamide_and_Prednisone" .
<Cyclam> <Brand_name_of> "Cyclophosphamide" .
<Zarxio> <Brand_name_of> "Filgrastim-sndz" .
<GCP> <Has_modality> "Chemotherapy" .
<Transformed_lymphoma> <FDA_indication_of> "Tisagenlecleucel" .
<Transformed_lymphoma> <FDA_indication_of> "Ibritumomab_tiuxetan" .
<Transformed_lymphoma> <FDA_indication_of> "Axicabtagene_ciloleucel" .
<PEP-C> <Has_modality> "Chemotherapy" .
<Peptibody_medication> <Subsumes> "Trebananib" .
<CO-Trim-Tablinen> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Anastrozole_and_Fulvestrant> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Anastrozole_and_Fulvestrant> <Has_accepted_use> "Breast_cancer" .
<Vinblastine_monotherapy> <Has_accepted_use> "Renal_cell_carcinoma" .
<Vinblastine_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<Vinblastine_monotherapy> <Has_accepted_use> "Hodgkin_lymphoma" .
<Moxetumomab_pasudotox_monotherapy> <Is_current_in> "Hairy_cell_leukemia" .
<Heparin> <Is_a> "Anticoagulant" .
<Anti-CD19_antibody> <Is_a> "Antibody_medication" .
<Dexamethasone_monotherapy> <Mapped_from> "Dexamethasone_monotherapy" .
<Cobimetinib> <Has_accepted_use> "Rosai-Dorfman-Destombes_disease" .
<Cobimetinib> <Has_accepted_use> "Melanoma" .
<Low-dose_TBI> <Has_accepted_use> "Allogeneic_HSCT" .
<Ferrous_sulfate> <Has_brand_name> "Ferro-Bob" .
<Ferrous_sulfate> <Has_brand_name> "Ferra-TD" .
<Ferrous_sulfate> <Has_brand_name> "Ferra_T.D._Caps" .
<Ferrous_sulfate> <Has_brand_name> "FeroSul" .
<Ferrous_sulfate> <Has_brand_name> "Feratab" .
<Ferrous_sulfate> <Has_brand_name> "Fer-in-Sol" .
<Ferrous_sulfate> <Has_brand_name> "Fer-Iron" .
<Ferrous_sulfate> <Has_brand_name> "Fer-Gen-Sol" .
<Ferrous_sulfate> <Has_brand_name> "Fer_Iron" .
<Ferrous_sulfate> <Has_brand_name> "Feosol" .
<Ferrous_sulfate> <Has_brand_name> "Fe_Tabs" .
<Cytarabine,_Methotrexate,_Rituximab> <Has_local_therapy> "Cytarabine_liposomal" .
<Evorabin> <Brand_name_of> "Clofarabine" .
<Daratumumab_monotherapy> <Has_accepted_use> "Multiple_myeloma" .
<Daratumumab_monotherapy> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Stanford_V> <Has_context> "Upfront_therapy" .
<Stanford_V> <Has_context> "Induction_therapy" .
<BeEAM> <Has_accepted_use> "Autologous_HSCT" .
<MA-BCD/AP> <Has_modality> "Chemotherapy" .
<CAFVP> <Has_modality> "Hormonotherapy" .
<CAFVP> <Has_modality> "Chemotherapy" .
<Mercaptopurine,_Methotrexate,_Vincristine> <Has_local_therapy> "Methotrexate" .
<Mercaptopurine,_Methotrexate,_Vincristine> <Has_local_therapy> "Dexamethasone" .
<Adricin> <Brand_name_of> "Doxorubicin" .
<IFL> <Is_a> "Irinotecan-containing_regimen" .
<Vincrex> <Brand_name_of> "Vincristine" .
<Pyrimidine_analogue> <Subsumes> "Uridine_triacetate" .
<Pyrimidine_analogue> <Subsumes> "Sapacitabine" .
<Pyrimidine_analogue> <Subsumes> "Gemcitabine" .
<Pyrimidine_analogue> <Subsumes> "Fluoropyrimidine" .
<Pyrimidine_analogue> <Subsumes> "Decitabine" .
<Pyrimidine_analogue> <Subsumes> "Azacitidine" .
<Primazole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Inrebic> <Brand_name_of> "Fedratinib" .
<Tumor_treating_fields> <Mapped_from> "Tumor_treating_fields" .
<Low_Liquemin> <Brand_name_of> "Dalteparin" .
<Toptecin> <Brand_name_of> "Irinotecan" .
<Ranimustine> <Is_a> "PMDA_approved_drug" .
<Ranimustine> <Is_a> "Nitrosourea" .
<Omacetaxine> <Has_FDA_indication> "Chronic_myelogenous_leukemia" .
<Gliadel_wafer_monotherapy> <Has_accepted_use> "Glioblastoma" .
<VP> <Has_modality> "Chemotherapy" .
<Venetoclax> <Is_a> "Mutation-specific_medication" .
<Venetoclax> <Is_a> "Bcl-2_inhibitor" .
<ECX> <Mapped_from> "ECX" .
<Cisplatin_monotherapy> <Is_current_in> "Soft_tissue_sarcoma" .
<Cisplatin_monotherapy> <Is_current_in> "Mesothelioma" .
<Cisplatin_monotherapy> <Is_current_in> "Hepatoblastoma" .
<Cisplatin_monotherapy> <Is_current_in> "Head_and_neck_cancer" .
<Cisplatin_monotherapy> <Is_current_in> "Cervical_cancer" .
<Cisplatin_monotherapy> <Is_current_in> "Breast_cancer" .
<Cisplatin_monotherapy> <Is_current_in> "Bladder_cancer" .
<Cisplatin_monotherapy> <Is_current_in> "Adenocarcinoma_of_unknown_primary" .
<Cisplatin,_Gemcitabine,_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<Fludarabine_and_Melphalan> <Maps_to> "Fludarabine_and_Melphalan" .
<Lapatinib,_Letrozole,_Trastuzumab> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Lapatinib,_Letrozole,_Trastuzumab> <Has_accepted_use> "Breast_cancer" .
<Lomustine> <Antineoplastic_of> "SCAB" .
<Lomustine> <Antineoplastic_of> "R-MCP_(CCNU)" .
<Lomustine> <Antineoplastic_of> "PCV" .
<Lomustine> <Antineoplastic_of> "MACC" .
<Lomustine> <Antineoplastic_of> "Lomustine,_Vincristine,_Prednisone" .
<Lomustine> <Antineoplastic_of> "Lomustine,_Temozolomide,_RT" .
<Lomustine> <Antineoplastic_of> "Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone" .
<Lomustine> <Antineoplastic_of> "Lomustine,_Methotrexate,_Procarbazine" .
<Lomustine> <Antineoplastic_of> "Lomustine_monotherapy" .
<Lomustine> <Antineoplastic_of> "Lomustine_and_Bevacizumab" .
<Lomustine> <Antineoplastic_of> "ICL" .
<Lomustine> <Antineoplastic_of> "Doxorubicin_and_Lomustine" .
<Lomustine> <Antineoplastic_of> "Cyclophosphamide,_Lomustine,_Methotrexate" .
<Lomustine> <Antineoplastic_of> "Cisplatin,_Lomustine,_Vincristine" .
<Lomustine> <Antineoplastic_of> "CVPP" .
<Lomustine> <Antineoplastic_of> "CVB" .
<Lomustine> <Antineoplastic_of> "COPP_(CCNU)" .
<Lomustine> <Antineoplastic_of> "CEP" .
<Lomustine> <Antineoplastic_of> "B-CAVe" .
<Lomustine> <Antineoplastic_of> "ABDIC" .
<ACVBP,_dose-adjusted> <Is_current_in> "Post-transplant_lymphoproliferative_disorder" .
<Ketoconazole_and_Hydrocortisone> <Mapped_from> "Ketoconazole_and_Hydrocortisone" .
<CHVP-I> <Has_modality> "Immunotherapy" .
<CHVP-I> <Has_modality> "Chemotherapy" .
<Pixantrone_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Methotrexate,_Tacrolimus,_Vorinostat> <Maps_to> "Methotrexate,_Tacrolimus,_Vorinostat" .
<AT_(Taxotere)> <Maps_to> "AT_(Taxotere)" .
<Zyrtec> <Brand_name_of> "Cetirizine" .
<Ox-P> <Has_accepted_use> "Marginal_zone_lymphoma" .
<PMitCEBO> <Mapped_from> "PMitCEBO" .
<Leuprolide> <Has_FDA_indication> "Prostate_cancer" .
<DexaBEAM_and_G-CSF> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Octreotide_and_Interferon_alfa> <Has_context> "All_lines_of_therapy" .
<Leodrin> <Brand_name_of> "Alendronate" .
<Atezolizumab> <May_have_route> "Intravenous" .
<Gemcitabine_and_Irinotecan> <Is_current_in> "Adenocarcinoma_of_unknown_primary" .
<Denosumab> <Has_accepted_use> "Giant-cell_tumor_of_bone" .
<Niraparib_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Sulbacta> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<FAC_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<Hormonotherapy> <Mapped_from> "Hormonotherapy" .
<R-MPV> <Is_current_in> "CNS_lymphoma" .
<KCD> <Has_accepted_use> "Multiple_myeloma" .
<GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab> <Mapped_from> "GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab" .
<GDP> <Maps_to> "GDP" .
<RT,_then_Carmustine> <Mapped_from> "RT,_then_Carmustine" .
<Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Octreotide> <Antineoplastic_of> "Octreotide_monotherapy" .
<Octreotide> <Antineoplastic_of> "Octreotide_and_Prednisone" .
<Octreotide> <Antineoplastic_of> "Octreotide_and_Interferon_alfa" .
<Pacritinib> <Has_accepted_use> "Myelofibrosis" .
<Cetuximab_monotherapy> <Has_context> "Non-curative_therapy" .
<Cetuximab_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Cetuximab_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<(90)YFC> <Maps_to> "(90)YFC" .
<Alprazolam> <Has_brand_name> "Xanor" .
<Alprazolam> <Has_brand_name> "Xanax" .
<Alprazolam> <Has_brand_name> "Tranax" .
<Alprazolam> <Has_brand_name> "Tafil" .
<Alprazolam> <Has_brand_name> "Pinix" .
<Alprazolam> <Has_brand_name> "Onax" .
<Alprazolam> <Has_brand_name> "Frixitas" .
<Alprazolam> <Has_brand_name> "Copax" .
<Alprazolam> <Has_brand_name> "Azor" .
<Alprazolam> <Has_brand_name> "Azom" .
<Alprazolam> <Has_brand_name> "Apazol" .
<Alprazolam> <Has_brand_name> "Alplax" .
<Alprazolam> <Has_brand_name> "Alcalm" .
<Alprazolam> <Has_brand_name> "Alam-PH" .
<Alprazolam> <Has_brand_name> "Actazolam" .
<ATG_(Horse),_Cyclosporine,_Sirolimus> <Maps_to> "ATG_(Horse),_Cyclosporine,_Sirolimus" .
<CMFPT> <Has_context> "Adjuvant_therapy" .
<Dactinomycin_monotherapy> <Is_current_in> "Wilms_tumor" .
<Dactinomycin_monotherapy> <Is_current_in> "Rhabdomyosarcoma" .
<Dactinomycin_monotherapy> <Is_current_in> "Gestational_trophoblastic_neoplasia" .
<Dactinomycin_monotherapy> <Is_current_in> "Endometrial_cancer" .
<Brentuximab_vedotin_monotherapy> <Has_context> "Salvage_therapy" .
<Brentuximab_vedotin_monotherapy> <Has_context> "Non-curative_therapy" .
<Brentuximab_vedotin_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Brentuximab_vedotin_monotherapy> <Has_context> "Maintenance_after_salvage_therapy" .
<Brentuximab_vedotin_monotherapy> <Has_context> "Induction_therapy" .
<GnRH_agonist> <Subsumes> "Triptorelin" .
<GnRH_agonist> <Subsumes> "Leuprolide" .
<GnRH_agonist> <Subsumes> "Histrelin" .
<GnRH_agonist> <Subsumes> "Goserelin" .
<BeRT> <Mapped_from> "BeRT" .
<Canferon_A> <Brand_name_of> "Interferon_alfa-2b" .
<CHVP-I> <Is_historical_in> "Follicular_lymphoma" .
<Etonolver> <Brand_name_of> "Etoposide" .
<Tamibarotene_monotherapy> <Has_antineoplastic> "Tamibarotene" .
<Fluorouracil_and_Levoleucovorin> <Has_accepted_use> "Colon_cancer" .
<Chlorambucil_and_Ofatumumab> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<ALK-positive_Non-small_cell_lung_cancer> <Accepted_use_of> "Pemetrexed_monotherapy" .
<ALK-positive_Non-small_cell_lung_cancer> <Accepted_use_of> "Lorlatinib_monotherapy" .
<ALK-positive_Non-small_cell_lung_cancer> <Accepted_use_of> "Docetaxel_monotherapy" .
<ALK-positive_Non-small_cell_lung_cancer> <Accepted_use_of> "Crizotinib_monotherapy" .
<ALK-positive_Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_and_Pemetrexed" .
<ALK-positive_Non-small_cell_lung_cancer> <Accepted_use_of> "Ceritinib_monotherapy" .
<ALK-positive_Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin_and_Pemetrexed" .
<ALK-positive_Non-small_cell_lung_cancer> <Accepted_use_of> "Brigatinib_monotherapy" .
<ALK-positive_Non-small_cell_lung_cancer> <Accepted_use_of> "Alectinib_monotherapy" .
<Depo-Eligard> <Brand_name_of> "Leuprolide" .
<Methotrexate,_Pegaspargase,_Vincristine> <Is_current_in> "T-cell_acute_lymphoblastic_leukemia" .
<Lusutrombopag_monotherapy> <Maps_to> "Lusutrombopag_monotherapy" .
<Fondaparinux> <Has_accepted_use> "Venous_thromboembolism" .
<Fondaparinux> <Has_accepted_use> "Heparin-induced_thrombocytopenia" .
<Aplastic_anemia> <FDA_indication_of> "Eltrombopag" .
<Xovir> <Brand_name_of> "Acyclovir" .
<FOLFOX4_and_Cetuximab> <Is_current_in> "Colon_cancer" .
<Isotretinoin_monotherapy> <Mapped_from> "Isotretinoin_monotherapy" .
<IAP> <Has_context> "Salvage_therapy" .
<CDE> <Has_modality> "Chemotherapy" .
<BACO> <Is_a> "Anthracycline-containing_regimen" .
<Faultenocan> <Brand_name_of> "Irinotecan" .
<Granisev> <Brand_name_of> "Granisetron" .
<Helixate> <Brand_name_of> "Factor_VIII_recombinant" .
<Mozobil> <Brand_name_of> "Plerixafor" .
<Sorafenib_monotherapy> <Has_modality> "Chemotherapy" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "VMD" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "VDC" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "VD" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "Rd" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "RD" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "Pd" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "No_induction" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "Melphalan,_then_auto_HSCT" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "MRD" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "MP" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "M-DEX" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "Lenalidomide_monotherapy" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "Ixazomib_monotherapy" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "Ixazomib_and_Dexamethasone" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "Daratumumab_monotherapy" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "Colchicine_monotherapy" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "CTD" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "CRd" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "Bortezomib_monotherapy" .
<Light-chain_(AL)_amyloidosis> <Current_treated_by> "Bortezomib_and_Melphalan,_then_auto_HSCT" .
<VT> <Has_modality> "Chemotherapy" .
<Arsenic_trioxide> <May_have_route> "Intravenous" .
<Smile> <Brand_name_of> "Dexamethasone" .
<BHD> <Has_antineoplastic> "Hydroxyurea" .
<BHD> <Has_antineoplastic> "Dacarbazine" .
<BHD> <Has_antineoplastic> "Carmustine" .
<VI,_then_VDC/IE,_then_VAC,_then_VI> <Has_context> "All_lines_of_therapy" .
<Ublituximab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Cisplatin,_Etoposide,_Irinotecan> <Is_current_in> "Small_cell_lung_cancer" .
<Carfilzomib_monotherapy> <Mapped_from> "Carfilzomib_monotherapy" .
<Cisplatin> <Antineoplastic_of> "mDCF_and_Bevacizumab" .
<Cisplatin> <Antineoplastic_of> "mDCF" .
<Cisplatin> <Antineoplastic_of> "VeIP" .
<Cisplatin> <Antineoplastic_of> "VTD-PACE" .
<Cisplatin> <Antineoplastic_of> "VIPD" .
<Cisplatin> <Antineoplastic_of> "VIP" .
<Cisplatin> <Antineoplastic_of> "VAB-6" .
<Cisplatin> <Antineoplastic_of> "Total_Therapy" .
<Cisplatin> <Antineoplastic_of> "TIP" .
<Cisplatin> <Antineoplastic_of> "STAMP-I" .
<Cisplatin> <Antineoplastic_of> "R-GDP" .
<Cisplatin> <Antineoplastic_of> "R-ESHAP" .
<Cisplatin> <Antineoplastic_of> "R-DHAP/R-VIM" .
<Cisplatin> <Antineoplastic_of> "R-DHAP" .
<Cisplatin> <Antineoplastic_of> "R-CHOP/R-DHAP" .
<Cisplatin> <Antineoplastic_of> "PVeBV" .
<Cisplatin> <Antineoplastic_of> "PGC" .
<Cisplatin> <Antineoplastic_of> "PEV" .
<Cisplatin> <Antineoplastic_of> "PET" .
<Cisplatin> <Antineoplastic_of> "PEFG" .
<Cisplatin> <Antineoplastic_of> "PCF" .
<Cisplatin> <Antineoplastic_of> "PCDE" .
<Cisplatin> <Antineoplastic_of> "PAC" .
<Cisplatin> <Antineoplastic_of> "O-ESHAP" .
<Cisplatin> <Antineoplastic_of> "O-DHAP" .
<Cisplatin> <Antineoplastic_of> "Mitotane_and_EDP" .
<Cisplatin> <Antineoplastic_of> "MVP_and_RT" .
<Cisplatin> <Antineoplastic_of> "MVP_(Vindesine)" .
<Cisplatin> <Antineoplastic_of> "MVP_(Vinblastine)" .
<Cisplatin> <Antineoplastic_of> "MVAC,_dose-dense" .
<Cisplatin> <Antineoplastic_of> "MVAC" .
<Cisplatin> <Antineoplastic_of> "MIC" .
<Cisplatin> <Antineoplastic_of> "MCV" .
<Cisplatin> <Antineoplastic_of> "MCF" .
<Cisplatin> <Antineoplastic_of> "MAPIE" .
<Cisplatin> <Antineoplastic_of> "MAPI" .
<Cisplatin> <Antineoplastic_of> "MAP" .
<Cisplatin> <Antineoplastic_of> "MA-BCD/AP" .
<Cisplatin> <Antineoplastic_of> "M-TIP" .
<Cisplatin> <Antineoplastic_of> "IP-BCD" .
<Cisplatin> <Antineoplastic_of> "Gemcitabine,_Cisplatin,_S-1" .
<Cisplatin> <Antineoplastic_of> "GIP" .
<Cisplatin> <Antineoplastic_of> "GDPT" .
<Cisplatin> <Antineoplastic_of> "GDP" .
<Cisplatin> <Antineoplastic_of> "FP/Capecitabine_and_RT" .
<Cisplatin> <Antineoplastic_of> "FLEP" .
<Cisplatin> <Antineoplastic_of> "ESHAP" .
<Cisplatin> <Antineoplastic_of> "EDAP" .
<Cisplatin> <Antineoplastic_of> "ECX" .
<Cisplatin> <Antineoplastic_of> "ECF/5-FU_and_RT" .
<Cisplatin> <Antineoplastic_of> "ECF" .
<Cisplatin> <Antineoplastic_of> "DTPACE" .
<Cisplatin> <Antineoplastic_of> "DICEP" .
<Cisplatin> <Antineoplastic_of> "DHAP_-_time_intensified" .
<Cisplatin> <Antineoplastic_of> "DHAP" .
<Cisplatin> <Antineoplastic_of> "DEP_and_RT" .
<Cisplatin> <Antineoplastic_of> "DDGP" .
<Cisplatin> <Antineoplastic_of> "DCF" .
<Cisplatin> <Antineoplastic_of> "DCEP_and_G-CSF" .
<Cisplatin> <Antineoplastic_of> "DCEP" .
<Cisplatin> <Antineoplastic_of> "Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Vinorelbine,_RT" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Vinorelbine,_Cetuximab" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Vinblastine,_RT" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Pemetrexed,_TTFields" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Pemetrexed,_Pembrolizumab" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Pemetrexed,_Bevacizumab" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Paclitaxel,_RT" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Paclitaxel,_Bevacizumab" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Lomustine,_Vincristine" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Irinotecan,_RT" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Interferon_alfa-2a,_Isotretinoin" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Gemcitabine,_nab-Paclitaxel" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Gemcitabine,_RT" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Gemcitabine,_Necitumumab" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Gemcitabine,_Bevacizumab" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_Vincristine" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_RT" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_Pembrolizumab" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_Panitumumab" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_Hydroxyurea,_RT" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_Cetuximab" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Etoposide,_RT" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Etoposide,_Irinotecan" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Etoposide,_Durvalumab" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Etoposide,_Bevacizumab" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Epirubicin,_Ifosfamide" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Doxorubicin,_Paclitaxel" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Doxorubicin_liposomal,_Fluorouracil" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Docetaxel,_RT" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Dacarbazine,_Tamoxifen" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Dacarbazine,_Paclitaxel" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Dacarbazine,_Interferon_alfa-2b" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b" .
<Cisplatin> <Antineoplastic_of> "Cisplatin,_Cetuximab,_RT" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_monotherapy" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Vinorelbine" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Vindesine" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Vinblastine" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Topotecan" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_S-1" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Raltitrexed" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_RT" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Pemetrexed" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Paclitaxel" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Mitomycin" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Methotrexate" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Irinotecan" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Ifosfamide" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Gemcitabine/Erlotinib" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Gemcitabine" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Fluorouracil" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Etoposide" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Epirubicin" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Doxorubicin" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Docetaxel" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Dacarbazine" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Cyclophosphamide" .
<Cisplatin> <Antineoplastic_of> "Cisplatin_and_Cetuximab" .
<Cisplatin> <Antineoplastic_of> "Chlorambucil_and_Cisplatin" .
<Cisplatin> <Antineoplastic_of> "Carboplatin_and_Cisplatin" .
<Cisplatin> <Antineoplastic_of> "Capecitabine,_Cisplatin,_RT" .
<Cisplatin> <Antineoplastic_of> "CX-C" .
<Cisplatin> <Antineoplastic_of> "CX_and_Trastuzumab" .
<Cisplatin> <Antineoplastic_of> "CX" .
<Cisplatin> <Antineoplastic_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Cisplatin> <Antineoplastic_of> "CVD_(Vindesine)" .
<Cisplatin> <Antineoplastic_of> "CVD_(Vinblastine)" .
<Cisplatin> <Antineoplastic_of> "CPB" .
<Cisplatin> <Antineoplastic_of> "CLF" .
<Cisplatin> <Antineoplastic_of> "CISCA/VB" .
<Cisplatin> <Antineoplastic_of> "CISCA" .
<Cisplatin> <Antineoplastic_of> "CIM" .
<Cisplatin> <Antineoplastic_of> "CHAD" .
<Cisplatin> <Antineoplastic_of> "CF_and_Trastuzumab" .
<Cisplatin> <Antineoplastic_of> "CEP" .
<Cisplatin> <Antineoplastic_of> "CDB" .
<Cisplatin> <Antineoplastic_of> "CCI" .
<Cisplatin> <Antineoplastic_of> "CC/DE_and_RT" .
<Cisplatin> <Antineoplastic_of> "CAV/PE" .
<Cisplatin> <Antineoplastic_of> "CAP_(Platinol)" .
<Cisplatin> <Antineoplastic_of> "CABO" .
<Cisplatin> <Antineoplastic_of> "C-BOP" .
<Cisplatin> <Antineoplastic_of> "Bleomycin_and_Cisplatin" .
<Cisplatin> <Antineoplastic_of> "Belotecan_and_Cisplatin" .
<Cisplatin> <Antineoplastic_of> "BVP" .
<Cisplatin> <Antineoplastic_of> "BMP" .
<Cisplatin> <Antineoplastic_of> "BEP" .
<Cisplatin> <Antineoplastic_of> "Altretamine_and_Cisplatin" .
<Cisplatin> <Antineoplastic_of> "Accelerated_BEP" .
<Cisplatin> <Antineoplastic_of> "ADOC" .
<BV-CHP> <Maps_to> "BV-CHP" .
<Cyclophosphamide,_Fludarabine,_Thiotepa> <Has_accepted_use> "Allogeneic_HSCT" .
<Intravenous_immunoglobulin_(IVIG)> <Antineoplastic_of> "Intravenous_Immunoglobulin" .
<BVDS> <Has_context> "Salvage_therapy" .
<Evermil> <Brand_name_of> "Everolimus" .
<Egiferon> <Brand_name_of> "Interferon_alfa-2b" .
<AT_(Taxotere)> <Is_current_in> "Breast_cancer" .
<FOLFOX> <Is_current_in> "Rectal_cancer" .
<FOLFOX> <Is_current_in> "Pancreatic_cancer" .
<O-FC> <Has_supportive_med> "Prednisolone" .
<O-FC> <Has_supportive_med> "PCP_prophylaxis" .
<O-FC> <Has_supportive_med> "Cetirizine" .
<O-FC> <Has_supportive_med> "Antivirals" .
<O-FC> <Has_supportive_med> "Allopurinol" .
<O-FC> <Has_supportive_med> "Acetaminophen" .
<Cisplatin_and_Cetuximab> <Has_accepted_use> "Head_and_neck_cancer" .
<R-MCP> <Has_modality> "Chemotherapy" .
<Arsenic_trioxide_monotherapy> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Carboplatin,_Paclitaxel,_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Cephalexin> <May_have_route> "Oral" .
<EOF> <Is_a> "Anthracycline-containing_regimen" .
<Prostate_cancer> <Is_a> "Genitourinary_cancer" .
<PUVA> <Has_context> "Upfront_therapy" .
<Mitotane> <Has_brand_name> "Lysodren" .
<Vismodegib_monotherapy> <Is_current_in> "Hedgehog_pathway-mutated_malignancy" .
<Vismodegib_monotherapy> <Is_current_in> "Cutaneous_basal_cell_carcinoma" .
<Non-curative_subsequent-line_consolidation_therapy> <Maps_to> "Non-curative_subsequent-line_consolidation_therapy" .
<MOPP> <Has_modality> "Chemotherapy" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone> <Maps_to> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone" .
<Dacarbazine_and_Gemcitabine> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Dacarbazine_and_Gemcitabine> <Has_accepted_use> "Leiomyosarcoma" .
<Elotuzumab> <Supportive_med_of> "Ixazomib_and_Dexamethasone" .
<Elotuzumab> <Supportive_med_of> "IRd" .
<Melphalan_monotherapy> <Is_current_in> "Autologous_HSCT" .
<Sargramostim> <May_have_route> "Subcutaneous" .
<Sargramostim> <May_have_route> "Intravenous" .
<Getrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<IGEV_and_G-CSF> <Has_antineoplastic> "Vinorelbine" .
<IGEV_and_G-CSF> <Has_antineoplastic> "Prednisolone" .
<IGEV_and_G-CSF> <Has_antineoplastic> "Ifosfamide" .
<IGEV_and_G-CSF> <Has_antineoplastic> "Gemcitabine" .
<Amumetazon> <Brand_name_of> "Dexamethasone" .
<Aspirin_monotherapy> <Has_modality> "Anticoagulation" .
<Tamoxifen_and_Prednisolone> <Mapped_from> "Tamoxifen_and_Prednisolone" .
<GVD> <Mapped_from> "GVD" .
<BeEAM,_then_auto_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<Nilotinib-based_consolidation> <Maps_to> "Nilotinib-based_consolidation" .
<Capecitabine,_Mitomycin,_RT> <Has_modality> "Radiotherapy" .
<Capecitabine,_Mitomycin,_RT> <Has_modality> "Chemotherapy" .
<Docetaxel_and_Vinorelbine> <Has_modality> "Chemotherapy" .
<Imatinib_and_LoDAC> <Has_modality> "Chemotherapy" .
<Docetaxel,_Cetuximab,_RT> <Has_context> "Adjuvant_therapy" .
<Dacarbazine_and_Doxorubicin> <Maps_to> "Dacarbazine_and_Doxorubicin" .
<O-DHAP> <Maps_to> "O-DHAP" .
<Chlorambucil_and_Prednisone> <Mapped_from> "Chlorambucil_and_Prednisone" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<DA_3_plus_10,_GO> <Mapped_from> "DA_3_plus_10,_GO" .
<Cytarabine_and_daunorubicin_liposomal> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Toremifene_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Toremifene_monotherapy> <Has_context> "Adjuvant_therapy" .
<CISCA> <Has_antineoplastic> "Doxorubicin" .
<CISCA> <Has_antineoplastic> "Cyclophosphamide" .
<CISCA> <Has_antineoplastic> "Cisplatin" .
<Carboplatin_and_Gemcitabine> <Has_antineoplastic> "Gemcitabine" .
<Carboplatin_and_Gemcitabine> <Has_antineoplastic> "Carboplatin" .
<PEFG> <Is_a> "Anthracycline-containing_regimen" .
<Fluorouracil,_Folinic_acid,_Gemcitabine> <Has_accepted_use> "Gallbladder_cancer" .
<Fluorouracil,_Folinic_acid,_Gemcitabine> <Has_accepted_use> "Esophageal_cancer" .
<Fluorouracil,_Folinic_acid,_Gemcitabine> <Has_accepted_use> "Cholangiocarcinoma" .
<CMFP> <Is_historical_in> "Breast_cancer" .
<Leunase> <Brand_name_of> "Asparaginase" .
<XPO1_inhibitor> <Subsumes> "Selinexor" .
<Romidepsin_monotherapy> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Romidepsin_monotherapy> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Baludon> <Brand_name_of> "Aspirin" .
<Motesanib> <Is_a> "VEGFR_inhibitor" .
<Motesanib> <Is_a> "RET_inhibitor" .
<Motesanib> <Is_a> "PDGFR_inhibitor" .
<Motesanib> <Is_a> "Kinase_inhibitor" .
<Motesanib> <Is_a> "KIT_inhibitor" .
<Motesanib> <Is_a> "Investigational_drug" .
<Bufacyl> <Brand_name_of> "Aspirin" .
<CDK_inhibitor> <Subsumes> "Ribociclib" .
<CDK_inhibitor> <Subsumes> "Palbociclib" .
<CDK_inhibitor> <Subsumes> "Dinaciclib" .
<CDK_inhibitor> <Subsumes> "Alvocidib" .
<CDK_inhibitor> <Subsumes> "Abemaciclib" .
<Tocilizumab_monotherapy> <Is_current_in> "Castleman_disease" .
<PT> <Is_historical_in> "Breast_cancer" .
<Sonidegib_monotherapy> <Mapped_from> "Sonidegib_monotherapy" .
<Carmustine_wafer_polifeprosan_20> <May_have_route> "Intralesional" .
<VIM> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Paclitaxel> <May_have_route> "Intravenous" .
<Paclitaxel> <May_have_route> "Intracavitary" .
<R-DHAC> <Is_current_in> "Mantle_cell_lymphoma" .
<Dacarbazine_monotherapy> <Maps_to> "Dacarbazine_monotherapy" .
<Paclitaxin> <Brand_name_of> "Paclitaxel" .
<Voraze> <Brand_name_of> "Voriconazole" .
<Deferasirox> <Has_brand_name> "Jadenu" .
<Deferasirox> <Has_brand_name> "Exjade" .
<Fosval> <Brand_name_of> "Alendronate" .
<Interferon_alfa-2a_and_Isotretinoin> <Has_accepted_use> "Renal_cell_carcinoma" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<ddA> <Has_antineoplastic> "Doxorubicin" .
<R-INO> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<VAD> <Maps_to> "VAD" .
<Trabectedin_monotherapy> <Maps_to> "Trabectedin_monotherapy" .
<Mercaptopurine,_Methotrexate,_Vincristine> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Mercaptopurine,_Methotrexate,_Vincristine> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Dara-VD> <Mapped_from> "Dara-VD" .
<TVAD_doxil> <Has_antineoplastic> "Vincristine" .
<TVAD_doxil> <Has_antineoplastic> "Thalidomide" .
<TVAD_doxil> <Has_antineoplastic> "Pegylated_liposomal_doxorubicin" .
<TVAD_doxil> <Has_antineoplastic> "Dexamethasone" .
<Cisplatin_and_Docetaxel> <Maps_to> "Cisplatin_and_Docetaxel" .
<Suninat> <Brand_name_of> "Sunitinib" .
<Crizanlizumab_monotherapy> <Maps_to> "Crizanlizumab_monotherapy" .
<CAV/PE> <Has_accepted_use> "Small_cell_lung_cancer" .
<Prasita> <Brand_name_of> "Prasugrel" .
<Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone> <Has_context> "Non-curative_therapy" .
<Malignant_hematology_medication> <Is_a> "Site-specific_medication" .
<GDP> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<GDP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<GDP> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<Gilteritinib_monotherapy> <Mapped_from> "Gilteritinib_monotherapy" .
<Sanifolin> <Brand_name_of> "Folinic_acid" .
<Cisplamerck> <Brand_name_of> "Cisplatin" .
<Low-dose_Interleukin-2> <Has_accepted_use> "Renal_cell_carcinoma" .
<Low-dose_Interleukin-2> <Has_accepted_use> "Melanoma" .
<CHOP> <Has_antineoplastic> "Vincristine" .
<CHOP> <Has_antineoplastic> "Prednisone" .
<CHOP> <Has_antineoplastic> "Doxorubicin" .
<CHOP> <Has_antineoplastic> "Cyclophosphamide" .
<Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine> <Has_accepted_use> "Breast_cancer" .
<Vismodegib> <Has_FDA_indication> "Cutaneous_basal_cell_carcinoma" .
<Deviplat> <Brand_name_of> "Clopidogrel" .
<HDAC_and_G-CSF> <Is_current_in> "Acute_myeloid_leukemia" .
<Panorex> <Brand_name_of> "Edrecolomab" .
<Tofacitinib> <Is_a> "JAK_inhibitor" .
<CMFV> <Maps_to> "CMFV" .
<TCH_(Taxotere,_Cyclophosphamide)> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<TCH_(Taxotere,_Cyclophosphamide)> <Has_accepted_use> "Breast_cancer" .
<IT_Methotrexate_and_Methylprednisolone> <Has_accepted_use> "CNS_leukemia" .
<Ixazomib_and_Dexamethasone> <Has_modality> "Chemotherapy" .
<Bleomycin> <Antineoplastic_of> "m-BNCOD" .
<Bleomycin> <Antineoplastic_of> "m-BACOD" .
<Bleomycin> <Antineoplastic_of> "eBEACOPP_(Prednisolone)" .
<Bleomycin> <Antineoplastic_of> "eBEACOPP" .
<Bleomycin> <Antineoplastic_of> "VNCOP-B" .
<Bleomycin> <Antineoplastic_of> "VEPEMB" .
<Bleomycin> <Antineoplastic_of> "VEBEP" .
<Bleomycin> <Antineoplastic_of> "VBM" .
<Bleomycin> <Antineoplastic_of> "VACOP-B" .
<Bleomycin> <Antineoplastic_of> "VABE" .
<Bleomycin> <Antineoplastic_of> "VAB-6" .
<Bleomycin> <Antineoplastic_of> "Stanford_V" .
<Bleomycin> <Antineoplastic_of> "SCAB" .
<Bleomycin> <Antineoplastic_of> "RABVD" .
<Bleomycin> <Antineoplastic_of> "ProMACE-CytaBOM" .
<Bleomycin> <Antineoplastic_of> "PVeBV" .
<Bleomycin> <Antineoplastic_of> "PMitCEBO" .
<Bleomycin> <Antineoplastic_of> "PACEBOM" .
<Bleomycin> <Antineoplastic_of> "MOPP/ABVD" .
<Bleomycin> <Antineoplastic_of> "MOPP-ABV" .
<Bleomycin> <Antineoplastic_of> "MACOP-B" .
<Bleomycin> <Antineoplastic_of> "MA-BCD/AP" .
<Bleomycin> <Antineoplastic_of> "MA-BCD" .
<Bleomycin> <Antineoplastic_of> "M-BCD" .
<Bleomycin> <Antineoplastic_of> "LD-ACOP-B" .
<Bleomycin> <Antineoplastic_of> "IP-BCD" .
<Bleomycin> <Antineoplastic_of> "EBVP" .
<Bleomycin> <Antineoplastic_of> "ChlVPP/PABIOE" .
<Bleomycin> <Antineoplastic_of> "CVB" .
<Bleomycin> <Antineoplastic_of> "COPP/ABVD" .
<Bleomycin> <Antineoplastic_of> "COP-Bleo" .
<Bleomycin> <Antineoplastic_of> "CISCA/VB" .
<Bleomycin> <Antineoplastic_of> "CHVmP-VB" .
<Bleomycin> <Antineoplastic_of> "CHOP-B" .
<Bleomycin> <Antineoplastic_of> "CEPP(B)" .
<Bleomycin> <Antineoplastic_of> "CAP-BOP" .
<Bleomycin> <Antineoplastic_of> "CABO" .
<Bleomycin> <Antineoplastic_of> "C-MOPP/ABV" .
<Bleomycin> <Antineoplastic_of> "C-BOP" .
<Bleomycin> <Antineoplastic_of> "Bleomycin,_Methotrexate,_Vinblastine/RT" .
<Bleomycin> <Antineoplastic_of> "Bleomycin_and_Vinblastine" .
<Bleomycin> <Antineoplastic_of> "Bleomycin_and_Cisplatin" .
<Bleomycin> <Antineoplastic_of> "BVP" .
<Bleomycin> <Antineoplastic_of> "BVDS" .
<Bleomycin> <Antineoplastic_of> "BO" .
<Bleomycin> <Antineoplastic_of> "BMP" .
<Bleomycin> <Antineoplastic_of> "BEP" .
<Bleomycin> <Antineoplastic_of> "BEACOPP-14_(Prednisolone)" .
<Bleomycin> <Antineoplastic_of> "BEACOPP-14" .
<Bleomycin> <Antineoplastic_of> "BEACOPP" .
<Bleomycin> <Antineoplastic_of> "BACO" .
<Bleomycin> <Antineoplastic_of> "B-CAVe" .
<Bleomycin> <Antineoplastic_of> "Accelerated_BEP" .
<Bleomycin> <Antineoplastic_of> "ACVBP-R" .
<Bleomycin> <Antineoplastic_of> "ACVBP,_dose-adjusted" .
<Bleomycin> <Antineoplastic_of> "ACVBP" .
<Bleomycin> <Antineoplastic_of> "ABVE-PC" .
<Bleomycin> <Antineoplastic_of> "ABVDm" .
<Bleomycin> <Antineoplastic_of> "ABVD,_DD-DI" .
<Bleomycin> <Antineoplastic_of> "ABVD" .
<Bleomycin> <Antineoplastic_of> "ABV_(Vincristine)" .
<Bleomycin> <Antineoplastic_of> "ABV_(Vinblastine)" .
<Bleomycin> <Antineoplastic_of> "ABP" .
<Bleomycin> <Antineoplastic_of> "ABDIC" .
<EPOCH> <Has_accepted_use> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<EPOCH> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Trabectedin_monotherapy> <Is_current_in> "Soft_tissue_sarcoma" .
<Trabectedin_monotherapy> <Is_current_in> "Ovarian_cancer" .
<Trabectedin_monotherapy> <Is_current_in> "Liposarcoma" .
<Trabectedin_monotherapy> <Is_current_in> "Leiomyosarcoma" .
<Fluorouracil_and_Streptozocin> <Is_current_in> "Pancreatic_NET" .
<Fluorouracil_and_Streptozocin> <Is_current_in> "Neuroendocrine_tumor" .
<ABVE-PC> <Has_accepted_use> "Hodgkin_lymphoma" .
<Cisplatin,_Irinotecan,_RT> <Has_accepted_use> "Esophageal_cancer" .
<Thalidomide_monotherapy> <Has_modality> "Chemotherapy" .
<Copanlisib> <Has_FDA_indication> "Follicular_lymphoma" .
<Goserelin> <Has_brand_name> "Zoladex" .
<Goserelin> <Has_brand_name> "Novgos" .
<Lapikot> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Aminoglutethimide> <Has_accepted_use> "Prostate_cancer" .
<Aminoglutethimide> <Has_accepted_use> "Breast_cancer" .
<Phytonadione> <May_have_route> "Subcutaneous" .
<Phytonadione> <May_have_route> "Oral" .
<Phytonadione> <May_have_route> "Intravenous" .
<AK-DEX> <Brand_name_of> "Dexamethasone" .
<Oxitan> <Brand_name_of> "Oxaliplatin" .
<Globentyl> <Brand_name_of> "Aspirin" .
<Rituximab-abbs> <Has_brand_name> "Truxima" .
<Cosat> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CYKLONE> <Has_context> "Non-curative_first-line_therapy" .
<Lomustine> <May_have_route> "Oral" .
<ATRA,_Cytarabine,_Idarubicin> <Has_antineoplastic> "Idarubicin" .
<ATRA,_Cytarabine,_Idarubicin> <Has_antineoplastic> "Cytarabine" .
<ATRA,_Cytarabine,_Idarubicin> <Has_antineoplastic> "All-trans_retinoic_acid" .
<Vemurafenib> <Has_accepted_use> "Thyroid_cancer" .
<Vemurafenib> <Has_accepted_use> "Multiple_myeloma" .
<Vemurafenib> <Has_accepted_use> "Melanoma" .
<Vemurafenib> <Has_accepted_use> "Langerhans_cell_histiocytosis" .
<Vemurafenib> <Has_accepted_use> "Hairy_cell_leukemia" .
<Vemurafenib> <Has_accepted_use> "Erdheim-Chester_disease" .
<Vemurafenib> <Has_accepted_use> "BRAF-mutated_malignancy" .
<GTX> <Has_antineoplastic> "Gemcitabine" .
<GTX> <Has_antineoplastic> "Docetaxel" .
<GTX> <Has_antineoplastic> "Capecitabine" .
<Polopiryna> <Brand_name_of> "Aspirin" .
<Cisplatin,_Cetuximab,_RT> <Mapped_from> "Cisplatin,_Cetuximab,_RT" .
<Fulvestrant_and_Ribociclib> <Maps_to> "Fulvestrant_and_Ribociclib" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "eBEACOPP_(Prednisolone)" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "ddT_(Taxotere)" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "ddFEC" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "ddEC" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "ddAC" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Vinorelbine_monotherapy" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "VR" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "VIPD" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "VIP" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Topotecan_monotherapy" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "TCH_(Taxotere,_Carboplatin)" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "R2CHOP" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "R-miniCEOP" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "R-MACLO/R-IVAM" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "R-FM" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "R-FCM" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "R-CVP" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "R-CHOP-14_(Prednisolone)" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "R-CHOP" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "R-BAC" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "R,_then_CHOP" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Prednisolone_and_Rituximab" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Plerixafor_and_G-CSF" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Paclitaxel_monotherapy" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Obinutuzumab_monotherapy" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "MVAC,_dose-dense" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Lenalidomide_and_Ofatumumab" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "HyperCHidam" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Gemcitabine_monotherapy" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "FOLFIRI_and_Ziv-aflibercept" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "FM" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "FLAG" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "FCR" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "FCM" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "FC" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "F-SHAI" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Everolimus_monotherapy" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Etoposide_monotherapy" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Epirubicin_and_Ifosfamide" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Doxorubicin,_Ifosfamide,_RT" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Doxorubicin_and_Ifosfamide" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Docetaxel_and_Gemcitabine" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "DexaBEAM_and_G-CSF" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "DexaBEAM" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "DD-CHOP" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "DCF" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "DAC" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "DA-EPOCH" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Cisplatin,_Etoposide,_RT" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Cisplatin,_Etoposide,_Irinotecan" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Cisplatin_and_Irinotecan" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Cisplatin_and_Etoposide" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Carboplatin,_Etoposide,_RT" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Carboplatin_and_Etoposide" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Carboplatin_and_Doxorubicin_liposomal" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "CIA" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "CHOP" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "CAV" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "BeGEV" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "BR" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "BEP" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "BEACOPP-14_(Prednisolone)" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "BCNU/TT,_then_auto_HSCT" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "BCNU/TT" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "Alemtuzumab_monotherapy" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "ACVBP" .
<Granulocyte_colony-stimulating_factors> <Supportive_med_of> "7_plus_3d" .
<Enzalutamide> <May_have_route> "Oral" .
<Carboplatin,_Olaparib,_Paclitaxel> <Mapped_from> "Carboplatin,_Olaparib,_Paclitaxel" .
<Phenodex> <Brand_name_of> "Dexamethasone" .
<PD> <Has_antineoplastic> "Pomalidomide" .
<PD> <Has_antineoplastic> "Dexamethasone" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib> <Has_antineoplastic> "Vincristine" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib> <Has_antineoplastic> "Prednisone" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib> <Has_antineoplastic> "Imatinib" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib> <Has_antineoplastic> "Daunorubicin" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib> <Has_antineoplastic> "Asparaginase" .
<Ondant> <Brand_name_of> "Ondansetron" .
<D-ZAPO> <Has_context> "Induction_therapy" .
<DTPACE> <Is_a> "Anthracycline-containing_regimen" .
<Teikason_Nidek> <Brand_name_of> "Dexamethasone" .
<L-Asparaginase,_Vincristine,_Prednisolone> <Has_modality> "Chemotherapy" .
<Everolimus_and_Exemestane> <Mapped_from> "Everolimus_and_Exemestane" .
<Zanubrutinib_monotherapy> <Has_antineoplastic> "Zanubrutinib" .
<Ibrutinib_monotherapy> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<Ibrutinib_monotherapy> <Is_current_in> "Marginal_zone_lymphoma" .
<Ibrutinib_monotherapy> <Is_current_in> "Mantle_cell_lymphoma" .
<Ibrutinib_monotherapy> <Is_current_in> "Graft_versus_host_disease" .
<Ibrutinib_monotherapy> <Is_current_in> "Follicular_lymphoma" .
<Ibrutinib_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Ibrutinib_monotherapy> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Erythropoietin_monotherapy> <Has_supportive_med> "Epoetin_alfa" .
<Docetaxel_and_Nedaplatin> <Mapped_from> "Docetaxel_and_Nedaplatin" .
<Capecitabine_and_Gemcitabine> <Has_accepted_use> "Thymoma" .
<Capecitabine_and_Gemcitabine> <Has_accepted_use> "Pancreatic_cancer" .
<Capecitabine_and_Gemcitabine> <Has_accepted_use> "Gallbladder_cancer" .
<Capecitabine_and_Gemcitabine> <Has_accepted_use> "Cholangiocarcinoma" .
<7_plus_3m> <Is_a> "Anthracycline-containing_regimen" .
<Leukemia> <Is_a> "Malignant_hematologic_neoplasm" .
<Anti-mesothelin_antibody> <Is_a> "Antibody_medication" .
<Ifosfamide_and_Vinorelbine> <Has_context> "Non-curative_therapy" .
<ProMACE-CytaBOM> <Is_a> "Anthracycline-containing_regimen" .
<Imatinib_and_Interferon> <Maps_to> "Imatinib_and_Interferon" .
<CEV_(Cyclophosphamide/Epirubicin)> <Has_accepted_use> "Small_cell_lung_cancer" .
<Cytarabine,_Daunorubicin,_Vincristine> <Mapped_from> "Cytarabine,_Daunorubicin,_Vincristine" .
<Arsenic_trioxide_and_ATRA> <Maps_to> "Arsenic_trioxide_and_ATRA" .
<FOLFIRI_(L-Leucovorin)> <Has_context> "Non-curative_second-line_therapy" .
<FOLFIRI_(L-Leucovorin)> <Has_context> "Non-curative_first-line_therapy" .
<Amnolake> <Brand_name_of> "Tamibarotene" .
<FR> <Maps_to> "FR" .
<CO-Traisole_480> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Azacitidina> <Brand_name_of> "Azacitidine" .
<TAM6,_then_auto_HSCT> <Mapped_from> "TAM6,_then_auto_HSCT" .
<Accutane> <Brand_name_of> "Isotretinoin" .
<Wilms_tumor> <Accepted_use_of> "Vincristine_monotherapy" .
<Wilms_tumor> <Accepted_use_of> "Vincristine" .
<Wilms_tumor> <Accepted_use_of> "Dactinomycin_monotherapy" .
<Wilms_tumor> <Accepted_use_of> "Dactinomycin_and_Vincristine" .
<Wilms_tumor> <Accepted_use_of> "Dactinomycin" .
<Filgrastim> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Filgrastim> <Is_a> "Granulocyte_colony-stimulating_factor" .
<Gynecologic_oncology_medication> <Is_a> "Site-specific_medication" .
<PEV> <Has_modality> "Chemotherapy" .
<Encorton> <Brand_name_of> "Prednisone" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Has_antineoplastic> "Vincristine" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Has_antineoplastic> "Rituximab" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Has_antineoplastic> "Pegylated_liposomal_doxorubicin" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Has_antineoplastic> "Methotrexate" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Has_antineoplastic> "Ifosfamide" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Has_antineoplastic> "Etoposide" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Has_antineoplastic> "Cytarabine" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Has_antineoplastic> "Cyclophosphamide" .
<CO-Sultrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Momelotinib> <Is_a> "Kinase_inhibitor" .
<Momelotinib> <Is_a> "JAK_inhibitor" .
<Momelotinib> <Is_a> "Investigational_drug" .
<Wilms_tumor> <Is_a> "Pediatric_cancer" .
<Aloxi> <Brand_name_of> "Palonosetron" .
<ATG_(Horse)_monotherapy> <Has_modality> "Immunosuppressive_therapy" .
<Ixazomib> <Has_brand_name> "Ninlaro" .
<VBMC> <Mapped_from> "VBMC" .
<Enasidenib_monotherapy> <Has_modality> "Chemotherapy" .
<Fluoxymesterone_monotherapy> <Maps_to> "Fluoxymesterone_monotherapy" .
<Gunametrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Zudan> <Brand_name_of> "Ondansetron" .
<Venetoclax_monotherapy> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Daunoblastina> <Brand_name_of> "Daunorubicin" .
<Refacto> <Brand_name_of> "Factor_VIII_recombinant" .
<Intervention_index> <Subsumes> "Radiation" .
<Intervention_index> <Subsumes> "Biologic_product" .
<Eribulin_monotherapy> <Mapped_from> "Eribulin_monotherapy" .
<Rucaparib_monotherapy> <Has_modality> "Chemotherapy" .
<ABP> <Is_a> "Anthracycline-containing_regimen" .
<R-BAC> <Is_current_in> "Mantle_cell_lymphoma" .
<R-BAC> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<CHVP-I> <Mapped_from> "CHVP-I" .
<ERBB3_(HER3)_medication> <Is_a> "Site-agnostic_medication" .
<Fosmin> <Brand_name_of> "Alendronate" .
<Carboplatin,_Etoposide,_Durvalumab> <Maps_to> "Carboplatin,_Etoposide,_Durvalumab" .
<GVP> <Has_accepted_use> "Hodgkin_lymphoma" .
<R-DHAP> <Has_accepted_use> "Transformed_lymphoma" .
<R-DHAP> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<R-DHAP> <Has_accepted_use> "Mantle_cell_lymphoma" .
<R-DHAP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Calaspargase,_Daunorubicin,_Vincristine,_Prednisone> <Has_modality> "Chemotherapy" .
<BRAF-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Dabrafenib_and_Trametinib" .
<Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA> <Has_context> "Consolidation_after_upfront_therapy" .
<Temozolomide_and_RT,_then_Temozolomide> <Is_current_in> "Anaplastic_glioma" .
<R-TBI/Cy,_then_auto_HSCT> <Is_current_in> "Follicular_lymphoma" .
<R-TBI/Cy,_then_auto_HSCT> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<IT_Methotrexate_and_Hydrocortisone> <Has_modality> "Chemotherapy" .
<Hydroxyurea_and_Imatinib> <Has_accepted_use> "Glioblastoma" .
<Sandimmune> <Brand_name_of> "Cyclosporine_non-modified" .
<CVP_(Prednisolone)> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Pembrolizumab_monotherapy> <Has_accepted_use> "Transformed_lymphoma" .
<Pembrolizumab_monotherapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<Pembrolizumab_monotherapy> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<Pembrolizumab_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Pembrolizumab_monotherapy> <Has_accepted_use> "Mismatch_repair_deficient_malignancy" .
<Pembrolizumab_monotherapy> <Has_accepted_use> "Merkel_cell_carcinoma" .
<Pembrolizumab_monotherapy> <Has_accepted_use> "Melanoma" .
<Pembrolizumab_monotherapy> <Has_accepted_use> "Hodgkin_lymphoma" .
<Pembrolizumab_monotherapy> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Pembrolizumab_monotherapy> <Has_accepted_use> "Head_and_neck_cancer" .
<Pembrolizumab_monotherapy> <Has_accepted_use> "Gastric_cancer" .
<Pembrolizumab_monotherapy> <Has_accepted_use> "Esophageal_cancer" .
<Pembrolizumab_monotherapy> <Has_accepted_use> "Endometrial_cancer" .
<Pembrolizumab_monotherapy> <Has_accepted_use> "Colon_cancer" .
<Pembrolizumab_monotherapy> <Has_accepted_use> "Cholangiocarcinoma" .
<Pembrolizumab_monotherapy> <Has_accepted_use> "Cervical_cancer" .
<Pembrolizumab_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<Pembrolizumab_monotherapy> <Has_accepted_use> "Anal_cancer" .
<BBD> <Mapped_from> "BBD" .
<Cetuximab_monotherapy> <Has_antineoplastic> "Cetuximab" .
<EDAP> <Has_antineoplastic> "Etoposide" .
<EDAP> <Has_antineoplastic> "Dexamethasone" .
<EDAP> <Has_antineoplastic> "Cytarabine" .
<EDAP> <Has_antineoplastic> "Cisplatin" .
<ChlVPP/PABIOE> <Has_modality> "Chemotherapy" .
<ATRA,_Cytarabine,_Idarubicin> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Nelarabine_monotherapy> <Has_antineoplastic> "Nelarabine" .
<Bonviva> <Brand_name_of> "Ibandronate" .
<Hydroxyzine> <Supportive_med_of> "High-dose_Interleukin-2" .
<Hydroxyzine> <Supportive_med_of> "Docetaxel_monotherapy" .
<Hydroxyzine> <Supportive_med_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Biodoxan> <Brand_name_of> "Cyclophosphamide" .
<Dexpak> <Brand_name_of> "Dexamethasone" .
<FOLFIRI_and_Ramucirumab> <Is_a> "Irinotecan-containing_regimen" .
<Ibrutinib> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Ibrutinib> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Ibrutinib> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Ibrutinib> <Has_accepted_use> "Graft_versus_host_disease" .
<Ibrutinib> <Has_accepted_use> "Follicular_lymphoma" .
<Ibrutinib> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Ibrutinib> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Cisplatin,_Vinorelbine,_RT> <Has_antineoplastic> "Vinorelbine" .
<Cisplatin,_Vinorelbine,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Cisplatin,_Vinorelbine,_RT> <Has_antineoplastic> "Cisplatin" .
<Cytarabine,_Idarubicin,_Imatinib> <Maps_to> "Cytarabine,_Idarubicin,_Imatinib" .
<Hydroxyurea_and_Imatinib> <Mapped_from> "Hydroxyurea_and_Imatinib" .
<7_plus_5i> <Has_context> "Induction_therapy" .
<GIP> <Mapped_from> "GIP" .
<Penodex> <Brand_name_of> "Dexamethasone" .
<Pharmacin> <Brand_name_of> "Aspirin" .
<Binimetinib> <Has_FDA_indication> "Melanoma" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<COPP/ABVD> <Is_a> "Anthracycline-containing_regimen" .
<Hydroxyurea_and_RT> <Has_context> "Definitive_therapy" .
<Whole_brain_irradiation> <Has_accepted_use> "Small_cell_lung_cancer" .
<Whole_brain_irradiation> <Has_accepted_use> "CNS_lymphoma" .
<Whole_brain_irradiation> <Has_accepted_use> "CNS_carcinoma" .
<PLK1_inhibitor> <Is_a> "Kinase_inhibitor" .
<Lusutrombopag> <May_have_route> "Oral" .
<Chephacardin> <Brand_name_of> "Asparaginase" .
<Acova> <Brand_name_of> "Argatroban" .
<R-DHAOx> <Has_accepted_use> "Mantle_cell_lymphoma" .
<R-DHAOx> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<131Iodine-Tositumomab_monotherapy> <Has_modality> "Radioimmunotherapy" .
<CEOP> <Has_context> "Induction_therapy" .
<Copanlisib_monotherapy> <Maps_to> "Copanlisib_monotherapy" .
<CHOEP-21> <Has_antineoplastic> "Vincristine" .
<CHOEP-21> <Has_antineoplastic> "Prednisone" .
<CHOEP-21> <Has_antineoplastic> "Etoposide" .
<CHOEP-21> <Has_antineoplastic> "Doxorubicin" .
<CHOEP-21> <Has_antineoplastic> "Cyclophosphamide" .
<Mesna> <Has_brand_name> "Varimesna" .
<Mesna> <Has_brand_name> "Uroprot" .
<Mesna> <Has_brand_name> "Uromitexan" .
<Mesna> <Has_brand_name> "Uromes" .
<Mesna> <Has_brand_name> "Siruta" .
<Mesna> <Has_brand_name> "Novacarel" .
<Mesna> <Has_brand_name> "Neper" .
<Mesna> <Has_brand_name> "Mucolene" .
<Mesna> <Has_brand_name> "Mitexan" .
<Mesna> <Has_brand_name> "Mistabronco" .
<Mesna> <Has_brand_name> "Mistabron" .
<Mesna> <Has_brand_name> "Mestian" .
<Mesna> <Has_brand_name> "Mesnil" .
<Mesna> <Has_brand_name> "Mesnex" .
<Mesna> <Has_brand_name> "Mesa" .
<Mesna> <Has_brand_name> "Anti_Uron" .
<Siltuximab> <May_have_route> "Intravenous" .
<Post-definitive_therapy> <Mapped_from> "Post-definitive_therapy" .
<Condition> <Subsumes> "Malignant_solid_neoplasm" .
<Condition> <Subsumes> "Malignant_hematologic_neoplasm" .
<Condition> <Subsumes> "Cross-disciplinary_condition" .
<Condition> <Subsumes> "Classical_hematologic_condition" .
<Vinflunine> <May_have_route> "Intravenous" .
<Olaparib_monotherapy> <Has_antineoplastic> "Olaparib" .
<Letrozole_and_Bevacizumab> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Letrozole_and_Bevacizumab> <Has_accepted_use> "Breast_cancer" .
<Epilem> <Brand_name_of> "Epirubicin" .
<Atezolizumab_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Atezolizumab_and_Bevacizumab> <Has_antineoplastic> "Atezolizumab" .
<Toremifene_monotherapy> <Has_antineoplastic> "Toremifene" .
<Tegafur,_Uracil,_Folinic_acid> <Has_antineoplastic> "Tegafur_and_uracil" .
<Tegafur,_Uracil,_Folinic_acid> <Has_antineoplastic> "Folinic_acid" .
<Cardioxane> <Brand_name_of> "Dexrazoxane" .
<Chlorambucil_and_Cisplatin> <Is_historical_in> "Ovarian_cancer" .
<CMED> <Has_modality> "Chemotherapy" .
<SCAB> <Is_historical_in> "Hodgkin_lymphoma" .
<Epirubicin_and_Ifosfamide> <Has_supportive_med> "Ondansetron" .
<Epirubicin_and_Ifosfamide> <Has_supportive_med> "Mesna" .
<Epirubicin_and_Ifosfamide> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Epirubicin_and_Ifosfamide> <Has_supportive_med> "Dexamethasone" .
<(90)YFC,_then_allo_HSCT> <Is_a> "Rituximab-containing_regimen" .
<Cyanocobalamin> <Supportive_med_of> "Pralatrexate_monotherapy" .
<Cyanocobalamin> <Supportive_med_of> "Pemetrexed_monotherapy" .
<Cyanocobalamin> <Supportive_med_of> "Pemetrexed_and_Pembrolizumab" .
<Cyanocobalamin> <Supportive_med_of> "Pemetrexed_and_Bevacizumab" .
<Cyanocobalamin> <Supportive_med_of> "Cisplatin,_Pemetrexed,_Pembrolizumab" .
<Cyanocobalamin> <Supportive_med_of> "Cisplatin,_Pemetrexed,_Bevacizumab" .
<Cyanocobalamin> <Supportive_med_of> "Cisplatin_and_Pemetrexed" .
<Cyanocobalamin> <Supportive_med_of> "Carboplatin,_Pemetrexed,_Pembrolizumab" .
<Cyanocobalamin> <Supportive_med_of> "Carboplatin_and_Pemetrexed" .
<Cyanocobalamin> <Supportive_med_of> "131I-Metaiodobenzylguanidine_(131I-MIBG)" .
<Afatinib_and_Bevacizumab> <Maps_to> "Afatinib_and_Bevacizumab" .
<Erdafitinib> <Has_FDA_indication> "Bladder_cancer" .
<CaRD> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<Trametinib_monotherapy> <Has_accepted_use> "Melanoma" .
<Trametinib_monotherapy> <Has_accepted_use> "BRAF-mutated_Melanoma" .
<Interferon_alfa-n1_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Altretamine_monotherapy> <Has_modality> "Chemotherapy" .
<FLT3-positive_Acute_myeloid_leukemia> <Accepted_use_of> "Sorafenib_monotherapy" .
<FLT3-positive_Acute_myeloid_leukemia> <Accepted_use_of> "Quizartinib_monotherapy" .
<FLT3-positive_Acute_myeloid_leukemia> <Accepted_use_of> "Midostaurin_monotherapy" .
<FLT3-positive_Acute_myeloid_leukemia> <Accepted_use_of> "MEC" .
<FLT3-positive_Acute_myeloid_leukemia> <Accepted_use_of> "LoDAC" .
<FLT3-positive_Acute_myeloid_leukemia> <Accepted_use_of> "IDAC_and_Sorafenib" .
<FLT3-positive_Acute_myeloid_leukemia> <Accepted_use_of> "HiDAC_and_Midostaurin" .
<FLT3-positive_Acute_myeloid_leukemia> <Accepted_use_of> "Gilteritinib_monotherapy" .
<FLT3-positive_Acute_myeloid_leukemia> <Accepted_use_of> "FLAG-Ida" .
<FLT3-positive_Acute_myeloid_leukemia> <Accepted_use_of> "Azacitidine_and_Sorafenib" .
<FLT3-positive_Acute_myeloid_leukemia> <Accepted_use_of> "7_plus_3d_and_Sorafenib" .
<FLT3-positive_Acute_myeloid_leukemia> <Accepted_use_of> "7_plus_3d_and_Midostaurin" .
<FLT3-positive_Acute_myeloid_leukemia> <Accepted_use_of> "7_plus_3d" .
<Anagrelide_monotherapy> <Has_context> "Non-curative_therapy" .
<Anagrelide_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Fludarabine_monotherapy> <Has_context> "Non-curative_therapy" .
<Fludarabine_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Fludarabine_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Neoben> <Brand_name_of> "Vinorelbine" .
<Tranexamic_acid> <Has_accepted_use> "Hereditary_hemorrhagic_telangiectasia" .
<Zavedos> <Brand_name_of> "Idarubicin" .
<Ceritinib> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Bortezomib_monotherapy> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<Bortezomib_monotherapy> <Is_current_in> "Multiple_myeloma" .
<Bortezomib_monotherapy> <Is_current_in> "Marginal_zone_lymphoma" .
<Bortezomib_monotherapy> <Is_current_in> "Mantle_cell_lymphoma" .
<Bortezomib_monotherapy> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<Bortezomib_monotherapy> <Is_current_in> "Follicular_lymphoma" .
<Bortezomib_monotherapy> <Is_current_in> "Castleman_disease" .
<Cyclosporine,_Mycophenolate_mofetil,_Sirolimus> <Maps_to> "Cyclosporine,_Mycophenolate_mofetil,_Sirolimus" .
<Anastrozole> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Anastrozole> <Is_a> "Steroid_synthesis_inhibitor" .
<Anastrozole> <Is_a> "Protein_expression-specific_medication" .
<Anastrozole> <Is_a> "Aromatase_inhibitor" .
<FCM> <Is_current_in> "Mantle_cell_lymphoma" .
<FCM> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<WBRT> <Maps_to> "WBRT" .
<Imatinib,_Vincristine,_Dexamethasone> <Has_supportive_med> "Filgrastim" .
<Apixaban_monotherapy> <Has_context> "Prophylaxis" .
<Apixaban_monotherapy> <Has_context> "All_lines_of_therapy" .
<Cotrimhexal> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin,_Pemetrexed,_Bevacizumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cisplatin,_Pemetrexed,_Bevacizumab> <Has_accepted_use> "Mesothelioma" .
<Iodine-131> <Is_a> "Radiotherapy_medication" .
<Anti-CD20_medication> <Is_a> "Immunotherapeutic" .
<Anti-CD20_medication> <Is_a> "Chemotherapeutic" .
<R-Hyper-CVAD/R-MA> <Has_antineoplastic> "Vincristine" .
<R-Hyper-CVAD/R-MA> <Has_antineoplastic> "Rituximab" .
<R-Hyper-CVAD/R-MA> <Has_antineoplastic> "Methotrexate" .
<R-Hyper-CVAD/R-MA> <Has_antineoplastic> "Doxorubicin" .
<R-Hyper-CVAD/R-MA> <Has_antineoplastic> "Dexamethasone" .
<R-Hyper-CVAD/R-MA> <Has_antineoplastic> "Cytarabine" .
<R-Hyper-CVAD/R-MA> <Has_antineoplastic> "Cyclophosphamide" .
<Aspirin_and_Anagrelide> <Has_context> "Non-curative_first-line_therapy" .
<Pd> <Mapped_from> "Pd" .
<Fluoroquinolone> <Supportive_med_of> "VDC" .
<Fluoroquinolone> <Supportive_med_of> "R-Hyper-CVAD/R-MA" .
<Fluoroquinolone> <Supportive_med_of> "R-CDOP" .
<Arsenic_trioxide_monotherapy> <Has_local_therapy> "Prednisolone" .
<Arsenic_trioxide_monotherapy> <Has_local_therapy> "Methotrexate" .
<Arsenic_trioxide_monotherapy> <Has_local_therapy> "Dexamethasone" .
<Arsenic_trioxide_monotherapy> <Has_local_therapy> "Cytarabine" .
<Busulfan_and_Melphalan,_then_auto_HSCT> <Has_accepted_use> "Neuroblastoma" .
<Busulfan_and_Melphalan,_then_auto_HSCT> <Has_accepted_use> "Ewing_sarcoma" .
<Busulfan_and_Melphalan,_then_auto_HSCT> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Irinotecan_and_Cetuximab> <Maps_to> "Irinotecan_and_Cetuximab" .
<Fulvestrant_and_Ribociclib> <Is_current_in> "Breast_cancer" .
<Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine> <Has_accepted_use> "Melanoma" .
<COMP> <Has_accepted_use> "Hodgkin_lymphoma" .
<COMP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<COMP> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Cotrimax> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<EDC> <Has_accepted_use> "Breast_cancer" .
<FOLFOX4_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Melphalan,_then_auto_HSCT,_then_Melphalan_and_Busulfan,_then_auto_HSCT> <Has_antineoplastic> "Melphalan" .
<Melphalan,_then_auto_HSCT,_then_Melphalan_and_Busulfan,_then_auto_HSCT> <Has_antineoplastic> "Busulfan" .
<Dacin> <Brand_name_of> "Dacarbazine" .
<Paclitaxel_monotherapy> <Is_current_in> "Vulvar_cancer" .
<Paclitaxel_monotherapy> <Is_current_in> "Vascular_sarcoma" .
<Paclitaxel_monotherapy> <Is_current_in> "Small_cell_lung_cancer" .
<Paclitaxel_monotherapy> <Is_current_in> "Penile_cancer" .
<Paclitaxel_monotherapy> <Is_current_in> "Ovarian_cancer" .
<Paclitaxel_monotherapy> <Is_current_in> "Melanoma" .
<Paclitaxel_monotherapy> <Is_current_in> "Kaposi_sarcoma" .
<Paclitaxel_monotherapy> <Is_current_in> "Head_and_neck_cancer" .
<Paclitaxel_monotherapy> <Is_current_in> "Gastric_cancer" .
<Paclitaxel_monotherapy> <Is_current_in> "Esophageal_cancer" .
<Paclitaxel_monotherapy> <Is_current_in> "Endometrial_cancer" .
<Paclitaxel_monotherapy> <Is_current_in> "Cervical_cancer" .
<Paclitaxel_monotherapy> <Is_current_in> "Breast_cancer" .
<Paclitaxel_monotherapy> <Is_current_in> "Bladder_cancer" .
<Pipobroman_monotherapy> <Has_modality> "Chemotherapy" .
<Non-curative_subsequent-line_therapy> <Maps_to> "Non-curative_subsequent-line_therapy" .
<R-CMD> <Has_context> "Non-curative_first-line_therapy" .
<Capecitabine_and_Paclitaxel,_nanoparticle_albumin-bound> <Mapped_from> "Capecitabine_and_Paclitaxel,_nanoparticle_albumin-bound" .
<ATRA,_Mercaptopurine,_Methotrexate> <Has_modality> "Chemotherapy" .
<Predisol> <Brand_name_of> "Methylprednisolone" .
<Bethaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Reconaz> <Brand_name_of> "Voriconazole" .
<Amsa_P-D> <Brand_name_of> "Amsacrine" .
<Dexamethasone_monotherapy> <Has_context> "Non-curative_therapy" .
<Dexamethasone_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Dexamethasone_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Dexamethasone_monotherapy> <Has_context> "Induction_therapy" .
<Dexamethasone_monotherapy> <Has_context> "All_lines_of_therapy" .
<Mercaptopurine_and_Prednisone> <Has_antineoplastic> "Prednisone" .
<Mercaptopurine_and_Prednisone> <Has_antineoplastic> "Mercaptopurine" .
<IRd> <Has_modality> "Chemotherapy" .
<Gemcitabine_and_Mitomycin> <Mapped_from> "Gemcitabine_and_Mitomycin" .
<Adjuvant_therapy> <Context_of> "mFOLFOX6_and_Cetuximab" .
<Adjuvant_therapy> <Context_of> "mFOLFOX6_and_Bevacizumab" .
<Adjuvant_therapy> <Context_of> "mFOLFOX6_(L-Leucovorin)" .
<Adjuvant_therapy> <Context_of> "mFOLFOX6" .
<Adjuvant_therapy> <Context_of> "mFOLFIRINOX" .
<Adjuvant_therapy> <Context_of> "iddEPC" .
<Adjuvant_therapy> <Context_of> "ddTH_(Taxotere)" .
<Adjuvant_therapy> <Context_of> "ddTH_(Taxol)" .
<Adjuvant_therapy> <Context_of> "ddT_(Taxotere)" .
<Adjuvant_therapy> <Context_of> "ddFEC" .
<Adjuvant_therapy> <Context_of> "ddEC" .
<Adjuvant_therapy> <Context_of> "ddE" .
<Adjuvant_therapy> <Context_of> "ddC" .
<Adjuvant_therapy> <Context_of> "ddAC-T" .
<Adjuvant_therapy> <Context_of> "ddAC" .
<Adjuvant_therapy> <Context_of> "ddA" .
<Adjuvant_therapy> <Context_of> "Whole_abdominal_radiation_(WAI)" .
<Adjuvant_therapy> <Context_of> "Vinorelbine_monotherapy" .
<Adjuvant_therapy> <Context_of> "VH" .
<Adjuvant_therapy> <Context_of> "VAIA" .
<Adjuvant_therapy> <Context_of> "VAI" .
<Adjuvant_therapy> <Context_of> "VACA" .
<Adjuvant_therapy> <Context_of> "UFT_monotherapy" .
<Adjuvant_therapy> <Context_of> "Trastuzumab_monotherapy" .
<Adjuvant_therapy> <Context_of> "Trastuzumab_and_hyaluronidase_monotherapy" .
<Adjuvant_therapy> <Context_of> "Toremifene_monotherapy" .
<Adjuvant_therapy> <Context_of> "Thiotepa_monotherapy" .
<Adjuvant_therapy> <Context_of> "Temozolomide,_then_Temozolomide_and_RT,_then_Temozolomide" .
<Adjuvant_therapy> <Context_of> "Temozolomide_monotherapy" .
<Adjuvant_therapy> <Context_of> "Temozolomide_and_low-dose_RT" .
<Adjuvant_therapy> <Context_of> "Temozolomide_and_RT,_then_Temozolomide" .
<Adjuvant_therapy> <Context_of> "Temozolomide_and_RT" .
<Adjuvant_therapy> <Context_of> "Tegafur,_Uracil,_Folinic_acid" .
<Adjuvant_therapy> <Context_of> "Tegafur_and_Uracil" .
<Adjuvant_therapy> <Context_of> "Tamoxifen_monotherapy" .
<Adjuvant_therapy> <Context_of> "Tamoxifen_and_OFS" .
<Adjuvant_therapy> <Context_of> "TMF" .
<Adjuvant_therapy> <Context_of> "TIP" .
<Adjuvant_therapy> <Context_of> "THP_(Taxotere)" .
<Adjuvant_therapy> <Context_of> "THP_(Taxol)" .
<Adjuvant_therapy> <Context_of> "TH_(Taxotere/SC)" .
<Adjuvant_therapy> <Context_of> "TH_(Taxotere)" .
<Adjuvant_therapy> <Context_of> "TH_(Taxol)" .
<Adjuvant_therapy> <Context_of> "TCHP_(Taxotere)" .
<Adjuvant_therapy> <Context_of> "TCH_(Taxotere,_Cyclophosphamide)" .
<Adjuvant_therapy> <Context_of> "TCH_(Taxotere,_Carboplatin)" .
<Adjuvant_therapy> <Context_of> "TC_(Taxotere)" .
<Adjuvant_therapy> <Context_of> "TACE" .
<Adjuvant_therapy> <Context_of> "TAC_(Taxotere)" .
<Adjuvant_therapy> <Context_of> "Sunitinib_monotherapy" .
<Adjuvant_therapy> <Context_of> "SOX" .
<Adjuvant_therapy> <Context_of> "S-1_monotherapy" .
<Adjuvant_therapy> <Context_of> "Radiation_therapy" .
<Adjuvant_therapy> <Context_of> "RT,_then_Temozolomide" .
<Adjuvant_therapy> <Context_of> "RT,_then_Carmustine" .
<Adjuvant_therapy> <Context_of> "Placebo" .
<Adjuvant_therapy> <Context_of> "Pembrolizumab_monotherapy" .
<Adjuvant_therapy> <Context_of> "Peginterferon_alfa-2b_monotherapy" .
<Adjuvant_therapy> <Context_of> "Paclitaxel_monotherapy" .
<Adjuvant_therapy> <Context_of> "PT" .
<Adjuvant_therapy> <Context_of> "PGC" .
<Adjuvant_therapy> <Context_of> "PFT" .
<Adjuvant_therapy> <Context_of> "PF" .
<Adjuvant_therapy> <Context_of> "PCV" .
<Adjuvant_therapy> <Context_of> "PAF" .
<Adjuvant_therapy> <Context_of> "PAC" .
<Adjuvant_therapy> <Context_of> "Oophorectomy" .
<Adjuvant_therapy> <Context_of> "Observation" .
<Adjuvant_therapy> <Context_of> "Nivolumab_monotherapy" .
<Adjuvant_therapy> <Context_of> "Nimustine_and_RT" .
<Adjuvant_therapy> <Context_of> "Neratinib_monotherapy" .
<Adjuvant_therapy> <Context_of> "Mitotane_monotherapy" .
<Adjuvant_therapy> <Context_of> "Mitotane_and_Streptozocin" .
<Adjuvant_therapy> <Context_of> "Methotrexate_and_Vincristine" .
<Adjuvant_therapy> <Context_of> "Melphalan_monotherapy" .
<Adjuvant_therapy> <Context_of> "MV" .
<Adjuvant_therapy> <Context_of> "MOF" .
<Adjuvant_therapy> <Context_of> "MF" .
<Adjuvant_therapy> <Context_of> "MCV" .
<Adjuvant_therapy> <Context_of> "MAPIE" .
<Adjuvant_therapy> <Context_of> "MAPI" .
<Adjuvant_therapy> <Context_of> "MAP" .
<Adjuvant_therapy> <Context_of> "MA-BCD/AP" .
<Adjuvant_therapy> <Context_of> "MA" .
<Adjuvant_therapy> <Context_of> "M-EI" .
<Adjuvant_therapy> <Context_of> "M-BCD" .
<Adjuvant_therapy> <Context_of> "Lomustine,_Vincristine,_Prednisone" .
<Adjuvant_therapy> <Context_of> "Lomustine,_Temozolomide,_RT" .
<Adjuvant_therapy> <Context_of> "Levamisole_monotherapy" .
<Adjuvant_therapy> <Context_of> "Leuprolide_monotherapy" .
<Adjuvant_therapy> <Context_of> "Letrozole_monotherapy" .
<Adjuvant_therapy> <Context_of> "Lapatinib_and_Trastuzumab" .
<Adjuvant_therapy> <Context_of> "Ipilimumab_monotherapy" .
<Adjuvant_therapy> <Context_of> "Interferon_alfa-2b_monotherapy" .
<Adjuvant_therapy> <Context_of> "Interferon_alfa-2a_monotherapy" .
<Adjuvant_therapy> <Context_of> "Imatinib_monotherapy" .
<Adjuvant_therapy> <Context_of> "IP-BCD" .
<Adjuvant_therapy> <Context_of> "IE" .
<Adjuvant_therapy> <Context_of> "Goserelin_monotherapy" .
<Adjuvant_therapy> <Context_of> "Goserelin_and_Tamoxifen" .
<Adjuvant_therapy> <Context_of> "Gemcitabine/Fluorouracil_and_RT" .
<Adjuvant_therapy> <Context_of> "Gemcitabine_monotherapy" .
<Adjuvant_therapy> <Context_of> "GemOx" .
<Adjuvant_therapy> <Context_of> "Gefitinib_monotherapy" .
<Adjuvant_therapy> <Context_of> "Fluorouracil/Fluorouracil_and_RT" .
<Adjuvant_therapy> <Context_of> "Fluorouracil,_Folinic_acid,_Levamisole" .
<Adjuvant_therapy> <Context_of> "Fluorouracil_monotherapy" .
<Adjuvant_therapy> <Context_of> "Fluorouracil_and_RT" .
<Adjuvant_therapy> <Context_of> "Fluorouracil_and_Mitomycin" .
<Adjuvant_therapy> <Context_of> "Fluorouracil_and_Levoleucovorin" .
<Adjuvant_therapy> <Context_of> "Fluorouracil_and_Levamisole" .
<Adjuvant_therapy> <Context_of> "Fluorouracil_and_Folinic_acid" .
<Adjuvant_therapy> <Context_of> "FULV/FULV_and_RT" .
<Adjuvant_therapy> <Context_of> "FP/Capecitabine_and_RT" .
<Adjuvant_therapy> <Context_of> "FOLFOX4" .
<Adjuvant_therapy> <Context_of> "FOLFOX" .
<Adjuvant_therapy> <Context_of> "FNC" .
<Adjuvant_therapy> <Context_of> "FLOX" .
<Adjuvant_therapy> <Context_of> "FLOT" .
<Adjuvant_therapy> <Context_of> "FEC_and_H" .
<Adjuvant_therapy> <Context_of> "FEC" .
<Adjuvant_therapy> <Context_of> "FAC_and_BCG" .
<Adjuvant_therapy> <Context_of> "FAC" .
<Adjuvant_therapy> <Context_of> "Exemestane_monotherapy" .
<Adjuvant_therapy> <Context_of> "Epirubicin_monotherapy" .
<Adjuvant_therapy> <Context_of> "Edrecolomab_monotherapy" .
<Adjuvant_therapy> <Context_of> "EVAIA" .
<Adjuvant_therapy> <Context_of> "EP" .
<Adjuvant_therapy> <Context_of> "EOX" .
<Adjuvant_therapy> <Context_of> "EOF" .
<Adjuvant_therapy> <Context_of> "EIA" .
<Adjuvant_therapy> <Context_of> "ECX" .
<Adjuvant_therapy> <Context_of> "ECT,_then_auto_HSCT" .
<Adjuvant_therapy> <Context_of> "ECF/5-FU_and_RT" .
<Adjuvant_therapy> <Context_of> "ECF" .
<Adjuvant_therapy> <Context_of> "EC" .
<Adjuvant_therapy> <Context_of> "Doxorubicin_monotherapy" .
<Adjuvant_therapy> <Context_of> "Doxorubicin_and_Fluorouracil" .
<Adjuvant_therapy> <Context_of> "Doxifluridine_and_Mitomycin" .
<Adjuvant_therapy> <Context_of> "Docetaxel,_Cetuximab,_RT" .
<Adjuvant_therapy> <Context_of> "Docetaxel_monotherapy" .
<Adjuvant_therapy> <Context_of> "Docetaxel_and_S-1" .
<Adjuvant_therapy> <Context_of> "Dabrafenib_and_Trametinib" .
<Adjuvant_therapy> <Context_of> "DCF" .
<Adjuvant_therapy> <Context_of> "Cyclophosphamide_monotherapy" .
<Adjuvant_therapy> <Context_of> "Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide" .
<Adjuvant_therapy> <Context_of> "Cisplatin,_Lomustine,_Vincristine" .
<Adjuvant_therapy> <Context_of> "Cisplatin,_Epirubicin,_Ifosfamide" .
<Adjuvant_therapy> <Context_of> "Cisplatin,_Cetuximab,_RT" .
<Adjuvant_therapy> <Context_of> "Cisplatin_and_Vinorelbine" .
<Adjuvant_therapy> <Context_of> "Cisplatin_and_Vindesine" .
<Adjuvant_therapy> <Context_of> "Cisplatin_and_Vinblastine" .
<Adjuvant_therapy> <Context_of> "Cisplatin_and_RT" .
<Adjuvant_therapy> <Context_of> "Cisplatin_and_Pemetrexed" .
<Adjuvant_therapy> <Context_of> "Cisplatin_and_Paclitaxel" .
<Adjuvant_therapy> <Context_of> "Cisplatin_and_Methotrexate" .
<Adjuvant_therapy> <Context_of> "Cisplatin_and_Irinotecan" .
<Adjuvant_therapy> <Context_of> "Cisplatin_and_Gemcitabine" .
<Adjuvant_therapy> <Context_of> "Cisplatin_and_Fluorouracil" .
<Adjuvant_therapy> <Context_of> "Cisplatin_and_Etoposide" .
<Adjuvant_therapy> <Context_of> "Cisplatin_and_Doxorubicin" .
<Adjuvant_therapy> <Context_of> "Cisplatin_and_Docetaxel" .
<Adjuvant_therapy> <Context_of> "Cisplatin_and_Cyclophosphamide" .
<Adjuvant_therapy> <Context_of> "Carmustine_monotherapy" .
<Adjuvant_therapy> <Context_of> "Carmustine_and_RT" .
<Adjuvant_therapy> <Context_of> "Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine" .
<Adjuvant_therapy> <Context_of> "Carboplatin_monotherapy" .
<Adjuvant_therapy> <Context_of> "Carboplatin_and_Vincristine" .
<Adjuvant_therapy> <Context_of> "Carboplatin_and_Paclitaxel" .
<Adjuvant_therapy> <Context_of> "Carboplatin_and_Ifosfamide" .
<Adjuvant_therapy> <Context_of> "Carboplatin_and_Fluorouracil" .
<Adjuvant_therapy> <Context_of> "Carboplatin_and_Docetaxel" .
<Adjuvant_therapy> <Context_of> "Capecitabine/Capecitabine_and_RT" .
<Adjuvant_therapy> <Context_of> "Capecitabine_monotherapy" .
<Adjuvant_therapy> <Context_of> "Capecitabine_and_RT" .
<Adjuvant_therapy> <Context_of> "Capecitabine_and_Gemcitabine" .
<Adjuvant_therapy> <Context_of> "CapeOx" .
<Adjuvant_therapy> <Context_of> "CX" .
<Adjuvant_therapy> <Context_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Adjuvant_therapy> <Context_of> "CTCb,_then_auto_HSCT" .
<Adjuvant_therapy> <Context_of> "CPB" .
<Adjuvant_therapy> <Context_of> "CMFVP" .
<Adjuvant_therapy> <Context_of> "CMFT" .
<Adjuvant_therapy> <Context_of> "CMFPT" .
<Adjuvant_therapy> <Context_of> "CMFP" .
<Adjuvant_therapy> <Context_of> "CMFL" .
<Adjuvant_therapy> <Context_of> "CMF" .
<Adjuvant_therapy> <Context_of> "CIM" .
<Adjuvant_therapy> <Context_of> "CFP_and_Oophorectomy" .
<Adjuvant_therapy> <Context_of> "CFP" .
<Adjuvant_therapy> <Context_of> "CEF/CMF" .
<Adjuvant_therapy> <Context_of> "CAMFP" .
<Adjuvant_therapy> <Context_of> "Busulfan_and_Melphalan,_then_auto_HSCT" .
<Adjuvant_therapy> <Context_of> "Bicalutamide_and_Goserelin" .
<Adjuvant_therapy> <Context_of> "Bevacizumab-containing_therapy" .
<Adjuvant_therapy> <Context_of> "Bevacizumab_monotherapy" .
<Adjuvant_therapy> <Context_of> "Bevacizumab_and_RT" .
<Adjuvant_therapy> <Context_of> "Best_supportive_care" .
<Adjuvant_therapy> <Context_of> "Bacillus_Calmette-Guerin_(BCG)_monotherapy" .
<Adjuvant_therapy> <Context_of> "BVP" .
<Adjuvant_therapy> <Context_of> "BEP" .
<Adjuvant_therapy> <Context_of> "Anastrozole_monotherapy" .
<Adjuvant_therapy> <Context_of> "Ado-trastuzumab_emtansine_monotherapy" .
<Adjuvant_therapy> <Context_of> "AVCF" .
<Adjuvant_therapy> <Context_of> "AV-CMF" .
<Adjuvant_therapy> <Context_of> "AT_(Taxol)" .
<Adjuvant_therapy> <Context_of> "ACT" .
<Adjuvant_therapy> <Context_of> "AC-T" .
<Adjuvant_therapy> <Context_of> "AC" .
<Botepar> <Brand_name_of> "Bortezomib" .
<Cyproterone_acetate> <Has_accepted_use> "Prostate_cancer" .
<TC_(Taxotere)> <Has_context> "Adjuvant_therapy" .
<Tositumomab_&_I-131> <May_have_route> "Intravenous" .
<VT> <Maps_to> "VT" .
<Thrombo> <Brand_name_of> "Aspirin" .
<FND> <Mapped_from> "FND" .
<Prednisolone_monotherapy> <Mapped_from> "Prednisolone_monotherapy" .
<Cortesa> <Brand_name_of> "Methylprednisolone" .
<Antiestrogen-containing_regimen> <Subsumes> "Trastuzumab_and_ET" .
<Antiestrogen-containing_regimen> <Subsumes> "Toremifene_monotherapy" .
<Antiestrogen-containing_regimen> <Subsumes> "Tamoxifen_monotherapy" .
<Antiestrogen-containing_regimen> <Subsumes> "Tamoxifen_and_Prednisolone" .
<Antiestrogen-containing_regimen> <Subsumes> "Tamoxifen_and_OFS" .
<Antiestrogen-containing_regimen> <Subsumes> "TAD_(Tamoxifen)" .
<Antiestrogen-containing_regimen> <Subsumes> "T-DM1_and_ET" .
<Antiestrogen-containing_regimen> <Subsumes> "Ribociclib_and_Tamoxifen" .
<Antiestrogen-containing_regimen> <Subsumes> "PT" .
<Antiestrogen-containing_regimen> <Subsumes> "PFT" .
<Antiestrogen-containing_regimen> <Subsumes> "Megestrol_and_Tamoxifen" .
<Antiestrogen-containing_regimen> <Subsumes> "Medroxyprogesterone_and_Tamoxifen" .
<Antiestrogen-containing_regimen> <Subsumes> "Letrozole_monotherapy" .
<Antiestrogen-containing_regimen> <Subsumes> "Letrozole_and_Ribociclib" .
<Antiestrogen-containing_regimen> <Subsumes> "Letrozole_and_Palbociclib" .
<Antiestrogen-containing_regimen> <Subsumes> "Letrozole_and_Bevacizumab" .
<Antiestrogen-containing_regimen> <Subsumes> "Lapatinib,_Letrozole,_Trastuzumab" .
<Antiestrogen-containing_regimen> <Subsumes> "Lapatinib_and_Letrozole" .
<Antiestrogen-containing_regimen> <Subsumes> "Goserelin_and_Tamoxifen" .
<Antiestrogen-containing_regimen> <Subsumes> "Fulvestrant_monotherapy" .
<Antiestrogen-containing_regimen> <Subsumes> "Fulvestrant_and_Ribociclib" .
<Antiestrogen-containing_regimen> <Subsumes> "Fulvestrant_and_Palbociclib" .
<Antiestrogen-containing_regimen> <Subsumes> "Exemestane_monotherapy" .
<Antiestrogen-containing_regimen> <Subsumes> "Exemestane_and_Tucidinostat" .
<Antiestrogen-containing_regimen> <Subsumes> "Everolimus_and_Tamoxifen" .
<Antiestrogen-containing_regimen> <Subsumes> "Everolimus_and_Exemestane" .
<Antiestrogen-containing_regimen> <Subsumes> "Dacarbazine_and_Tamoxifen" .
<Antiestrogen-containing_regimen> <Subsumes> "Cisplatin,_Dacarbazine,_Tamoxifen" .
<Antiestrogen-containing_regimen> <Subsumes> "Capecitabine_and_Fulvestrant" .
<Antiestrogen-containing_regimen> <Subsumes> "CMFT" .
<Antiestrogen-containing_regimen> <Subsumes> "CMFPT" .
<Antiestrogen-containing_regimen> <Subsumes> "Anastrozole_monotherapy" .
<Antiestrogen-containing_regimen> <Subsumes> "Anastrozole_and_Trastuzumab" .
<Antiestrogen-containing_regimen> <Subsumes> "Anastrozole_and_Ribociclib" .
<Antiestrogen-containing_regimen> <Subsumes> "Anastrozole_and_Palbociclib" .
<Antiestrogen-containing_regimen> <Subsumes> "Anastrozole_and_Goserelin" .
<Antiestrogen-containing_regimen> <Subsumes> "Anastrozole_and_Fulvestrant" .
<Antiestrogen-containing_regimen> <Subsumes> "Aminoglutethimide_monotherapy" .
<Antiestrogen-containing_regimen> <Subsumes> "Alpelisib_and_Fulvestrant" .
<Antiestrogen-containing_regimen> <Subsumes> "Abemaciclib_and_Letrozole" .
<Antiestrogen-containing_regimen> <Subsumes> "Abemaciclib_and_Fulvestrant" .
<Antiestrogen-containing_regimen> <Subsumes> "Abemaciclib_and_Anastrozole" .
<Antiestrogen-containing_regimen> <Subsumes> "ACT" .
<Asparaginase> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Asparaginase> <Has_accepted_use> "NK-_and_T-cell_lymphoma" .
<Asparaginase> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Asparaginase> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<AVCF> <Has_modality> "Chemotherapy" .
<Asalite> <Brand_name_of> "Aspirin" .
<Primotren> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Idelalisib_and_Ofatumumab> <Mapped_from> "Idelalisib_and_Ofatumumab" .
<VMPT> <Has_modality> "Chemotherapy" .
<Sanexon> <Brand_name_of> "Methylprednisolone" .
<R-BL> <Mapped_from> "R-BL" .
<Fluoro-Uracile_ICN> <Brand_name_of> "Fluorouracil" .
<Zanubrutinib_monotherapy> <Maps_to> "Zanubrutinib_monotherapy" .
<CVAP> <Maps_to> "CVAP" .
<Erythropoetin_and_Lenalidomide> <Mapped_from> "Erythropoetin_and_Lenalidomide" .
<Predni-M-Tablinen> <Brand_name_of> "Methylprednisolone" .
<Mitotane_and_EDP> <Has_supportive_med> "Steroids" .
<CNOP_(Prednisolone)> <Has_context> "Induction_therapy" .
<Pd> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Methotrexate,_then_Cytarabine_and_Thiotepa> <Has_antineoplastic> "Thiotepa" .
<Methotrexate,_then_Cytarabine_and_Thiotepa> <Has_antineoplastic> "Methotrexate" .
<Methotrexate,_then_Cytarabine_and_Thiotepa> <Has_antineoplastic> "Cytarabine" .
<Ferbon> <Brand_name_of> "Folinic_acid" .
<TILs> <Has_accepted_use> "Uveal_melanoma" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone> <Has_context> "Induction_therapy" .
<Doxorubicin_non-pegylated_liposomal_and_Bevacizumab> <Maps_to> "Doxorubicin_non-pegylated_liposomal_and_Bevacizumab" .
<BCG_and_Dacarbazine> <Mapped_from> "BCG_and_Dacarbazine" .
<Findeclin> <Brand_name_of> "Alendronate" .
<Carmustine_and_RT> <Mapped_from> "Carmustine_and_RT" .
<Capecitabine_monotherapy> <Is_historical_in> "Breast_cancer" .
<Cytarabine,_Idarubicin,_Imatinib> <Mapped_from> "Cytarabine,_Idarubicin,_Imatinib" .
<HLH-2004_regimen> <Maps_to> "HLH-2004_regimen" .
<Microdyn> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Temsirolimus> <May_have_route> "Intravenous" .
<ABVDm> <Has_accepted_use> "Hodgkin_lymphoma" .
<Dexabene> <Brand_name_of> "Dexamethasone" .
<Ruxolitinib_monotherapy> <Has_accepted_use> "Polycythemia_vera" .
<Ruxolitinib_monotherapy> <Has_accepted_use> "Myelofibrosis" .
<Ruxolitinib_monotherapy> <Has_accepted_use> "Hypereosinophilic_syndrome" .
<Ruxolitinib_monotherapy> <Has_accepted_use> "Essential_thrombocythemia" .
<Ruxolitinib_monotherapy> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Ruxolitinib_monotherapy> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Citarabin> <Brand_name_of> "Cytarabine" .
<Cytarabine_and_G-CSF> <Has_antineoplastic> "Cytarabine" .
<SMILE> <Has_accepted_use> "NK-_and_T-cell_lymphoma" .
<SMILE> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<CBV-Mx> <Is_a> "Anthracycline-containing_regimen" .
<Zandron> <Brand_name_of> "Nilutamide" .
<Methotrexatum> <Brand_name_of> "Methotrexate" .
<Temoside> <Brand_name_of> "Temozolomide" .
<Epirubicin_and_Vinorelbine> <Has_modality> "Chemotherapy" .
<Talimogene_laherparepvec_monotherapy> <Has_modality> "Immunotherapy" .
<Pomalidomide_and_Prednisone> <Mapped_from> "Pomalidomide_and_Prednisone" .
<Goserelin_monotherapy> <Is_current_in> "Prostate_cancer" .
<Goserelin_monotherapy> <Is_current_in> "Breast_cancer" .
<TLI_and_ATG> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<Laracit> <Brand_name_of> "Cytarabine" .
<ADT_and_Abiraterone> <Is_current_in> "Prostate_cancer" .
<Doxorubicin_and_Vinblastine> <Is_a> "Anthracycline-containing_regimen" .
<Linatecan> <Brand_name_of> "Irinotecan" .
<Cyclophosphamide> <Immunosuppressor_of> "Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant" .
<Cyclophosphamide> <Immunosuppressor_of> "Cyclophosphamide,_Mycophenolate_mofetil,_Tacrolimus" .
<Cyclophosphamide> <Immunosuppressor_of> "Cyclophosphamide_monotherapy" .
<Cyclophosphamide> <Immunosuppressor_of> "Cyclophosphamide_and_Prednisone" .
<Cyclophosphamide> <Immunosuppressor_of> "Cyclophosphamide_and_Prednisolone" .
<Cyclophosphamide> <Immunosuppressor_of> "Busulfan_and_Fludarabine" .
<Cyclophosphamide> <Immunosuppressor_of> "BuFlu,_then_allo_HSCT" .
<Dabrafenib> <Has_brand_name> "Tafinlar" .
<BCNU/TT,_then_auto_HSCT> <Is_current_in> "CNS_lymphoma" .
<TACE> <Antineoplastic_of> "TACE,_then_5-FU" .
<TACE> <Antineoplastic_of> "DEB-TACE" .
<TACE> <Antineoplastic_of> "Axitinib_and_TACE" .
<Lapatinib,_Letrozole,_Trastuzumab> <Has_modality> "Hormonotherapy" .
<Lapatinib,_Letrozole,_Trastuzumab> <Has_modality> "Chemotherapy" .
<Gratryl> <Brand_name_of> "Granisetron" .
<Ixazomib_and_Dexamethasone> <Is_current_in> "Multiple_myeloma" .
<Ixazomib_and_Dexamethasone> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<FCR_(Rituximab_Hycela)> <Maps_to> "FCR_(Rituximab_Hycela)" .
<Vindesine_monotherapy> <Is_historical_in> "Non-small_cell_lung_cancer" .
<CODOX-M/IVAC> <Has_modality> "Chemotherapy" .
<L-Asparaginase,_Vincristine,_Prednisolone> <Maps_to> "L-Asparaginase,_Vincristine,_Prednisolone" .
<Bortezomib_and_Melphalan> <Maps_to> "Bortezomib_and_Melphalan" .
<Nintedanib_and_Pemetrexed> <Is_current_in> "Non-small_cell_lung_cancer" .
<Trabectedin_monotherapy> <Has_modality> "Chemotherapy" .
<VMP/Rd> <Has_context> "Non-curative_first-line_therapy" .
<Nova-Phase> <Brand_name_of> "Aspirin" .
<Amilene> <Brand_name_of> "Ondansetron" .
<Letrozole_and_Palbociclib> <Mapped_from> "Letrozole_and_Palbociclib" .
<FOLFOX4_and_Bevacizumab> <Has_antineoplastic> "Oxaliplatin" .
<FOLFOX4_and_Bevacizumab> <Has_antineoplastic> "Folinic_acid" .
<FOLFOX4_and_Bevacizumab> <Has_antineoplastic> "Fluorouracil" .
<FOLFOX4_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Clarithromycin_monotherapy> <Has_context> "Non-curative_therapy" .
<Chelator> <Subsumes> "Dexrazoxane" .
<Chelator> <Subsumes> "Deferoxamine" .
<Chelator> <Subsumes> "Deferiprone" .
<Chelator> <Subsumes> "Deferasirox" .
<TPC> <Is_current_in> "Breast_cancer" .
<Sinfract> <Brand_name_of> "Alendronate" .
<Cyclosporine_and_Prednisone> <Maps_to> "Cyclosporine_and_Prednisone" .
<Moly> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Tipifarnib> <Has_brand_name> "Zarnestra" .
<ABC> <Mapped_from> "ABC" .
<FLAG-DNX> <Has_accepted_use> "Acute_myeloid_leukemia" .
<CHOP_and_Everolimus> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Antrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Prasugrel> <Has_brand_name> "Targol" .
<Prasugrel> <Has_brand_name> "Surfent" .
<Prasugrel> <Has_brand_name> "Prax" .
<Prasugrel> <Has_brand_name> "Prasudoc" .
<Prasugrel> <Has_brand_name> "PrasuSafe" .
<Prasugrel> <Has_brand_name> "Prasita" .
<Prasugrel> <Has_brand_name> "Glitax" .
<Prasugrel> <Has_brand_name> "Efient" .
<Prasugrel> <Has_brand_name> "Effient" .
<Easprin> <Brand_name_of> "Aspirin" .
<Fluorouracil,_Hydroxyurea,_RT> <Has_modality> "Radiotherapy" .
<Fluorouracil,_Hydroxyurea,_RT> <Has_modality> "Chemotherapy" .
<Pirarubicin_monotherapy> <Maps_to> "Pirarubicin_monotherapy" .
<Everolimus_and_Exemestane> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Everolimus_and_Exemestane> <Has_accepted_use> "Breast_cancer" .
<Cablivi> <Brand_name_of> "Caplacizumab" .
<Everecan> <Brand_name_of> "Everolimus" .
<L-Trim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Corticoidex> <Brand_name_of> "Dexamethasone" .
<Cisplatin,_Doxorubicin_liposomal,_Fluorouracil> <Has_context> "Non-curative_first-line_therapy" .
<Steroids> <Immunosuppressor_of> "Cyclosporine,_Corticosteroids,_Rituximab" .
<Cobimetinib_monotherapy> <Has_modality> "Chemotherapy" .
<Elo-PD> <Maps_to> "Elo-PD" .
<Okatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Enasidenib_monotherapy> <Has_accepted_use> "IDH-mutated_Acute_myeloid_leukemia" .
<Enasidenib_monotherapy> <Has_accepted_use> "Acute_myeloid_leukemia" .
<TIP> <Has_modality> "Chemotherapy" .
<Exemestane_monotherapy> <Is_a> "Antiestrogen-containing_regimen" .
<Daunorubicin_liposomal> <Is_a> "Topoisomerase_inhibitor" .
<Daunorubicin_liposomal> <Is_a> "Liposomal_chemotherapy" .
<Daunorubicin_liposomal> <Is_a> "Irritant" .
<Daunorubicin_liposomal> <Is_a> "Discontinued_drug" .
<Daunorubicin_liposomal> <Is_a> "Anthracycline" .
<Methotrexate,_then_Cytarabine_and_Thiotepa> <Has_modality> "Chemotherapy" .
<Interferon_alfa-2b> <Has_brand_name> "Wellferon" .
<Interferon_alfa-2b> <Has_brand_name> "Sumiferon" .
<Interferon_alfa-2b> <Has_brand_name> "Roceron-A" .
<Interferon_alfa-2b> <Has_brand_name> "Realdiron" .
<Interferon_alfa-2b> <Has_brand_name> "Polyferon" .
<Interferon_alfa-2b> <Has_brand_name> "OIF" .
<Interferon_alfa-2b> <Has_brand_name> "Namalvin" .
<Interferon_alfa-2b> <Has_brand_name> "Multiferon" .
<Interferon_alfa-2b> <Has_brand_name> "Laroferon" .
<Interferon_alfa-2b> <Has_brand_name> "Intron-A" .
<Interferon_alfa-2b> <Has_brand_name> "Interferonum_Leucocyticum" .
<Interferon_alfa-2b> <Has_brand_name> "Interferon_Lymphoblastoid" .
<Interferon_alfa-2b> <Has_brand_name> "Interferon_Leucocyticum" .
<Interferon_alfa-2b> <Has_brand_name> "Interferon_Human" .
<Interferon_alfa-2b> <Has_brand_name> "Interferon_Alfanative" .
<Interferon_alfa-2b> <Has_brand_name> "Interfero" .
<Interferon_alfa-2b> <Has_brand_name> "Inmutag" .
<Interferon_alfa-2b> <Has_brand_name> "Infergen" .
<Interferon_alfa-2b> <Has_brand_name> "Inferax" .
<Interferon_alfa-2b> <Has_brand_name> "Imukin" .
<Interferon_alfa-2b> <Has_brand_name> "Imufor" .
<Interferon_alfa-2b> <Has_brand_name> "INF" .
<Interferon_alfa-2b> <Has_brand_name> "IFN_Alpha" .
<Interferon_alfa-2b> <Has_brand_name> "Humoferon" .
<Interferon_alfa-2b> <Has_brand_name> "Heberon_Alfa_R" .
<Interferon_alfa-2b> <Has_brand_name> "Frone" .
<Interferon_alfa-2b> <Has_brand_name> "Finnferon-Alpha" .
<Interferon_alfa-2b> <Has_brand_name> "Fiblaferon" .
<Interferon_alfa-2b> <Has_brand_name> "Feron" .
<Interferon_alfa-2b> <Has_brand_name> "Egiferon" .
<Interferon_alfa-2b> <Has_brand_name> "Cytoferon" .
<Interferon_alfa-2b> <Has_brand_name> "Canferon_A" .
<Interferon_alfa-2b> <Has_brand_name> "Biogamma" .
<Interferon_alfa-2b> <Has_brand_name> "Berofor" .
<Interferon_alfa-2b> <Has_brand_name> "Alfaferone" .
<Interferon_alfa-2b> <Has_brand_name> "Advaferon" .
<Pemetrexed_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Antithymocyte_globulin_horse_ATG> <Is_a> "Fractionated_plasma_product" .
<Antithymocyte_globulin_horse_ATG> <Is_a> "Antithymocyte_globulin" .
<Antithymocyte_globulin_horse_ATG> <Is_a> "Antibody_medication" .
<CEPP(B)> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<ADT> <Is_current_in> "Prostate_cancer" .
<Docetaxel_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Head_and_neck_cancer> <Accepted_use_of> "Tegafur_and_uracil" .
<Head_and_neck_cancer> <Accepted_use_of> "Tegafur_and_Uracil" .
<Head_and_neck_cancer> <Accepted_use_of> "Radiation_therapy" .
<Head_and_neck_cancer> <Accepted_use_of> "Placebo" .
<Head_and_neck_cancer> <Accepted_use_of> "Pembrolizumab_monotherapy" .
<Head_and_neck_cancer> <Accepted_use_of> "Pembrolizumab" .
<Head_and_neck_cancer> <Accepted_use_of> "Panitumumab" .
<Head_and_neck_cancer> <Accepted_use_of> "Paclitaxel_monotherapy" .
<Head_and_neck_cancer> <Accepted_use_of> "Paclitaxel_and_RT" .
<Head_and_neck_cancer> <Accepted_use_of> "Paclitaxel" .
<Head_and_neck_cancer> <Accepted_use_of> "PCF" .
<Head_and_neck_cancer> <Accepted_use_of> "No_induction" .
<Head_and_neck_cancer> <Accepted_use_of> "Nivolumab_monotherapy" .
<Head_and_neck_cancer> <Accepted_use_of> "Nivolumab" .
<Head_and_neck_cancer> <Accepted_use_of> "Mitomycin" .
<Head_and_neck_cancer> <Accepted_use_of> "Methotrexate_monotherapy" .
<Head_and_neck_cancer> <Accepted_use_of> "Methotrexate" .
<Head_and_neck_cancer> <Accepted_use_of> "Hydroxyurea" .
<Head_and_neck_cancer> <Accepted_use_of> "Fluorouracil,_Mitomycin,_RT" .
<Head_and_neck_cancer> <Accepted_use_of> "Fluorouracil,_Hydroxyurea,_RT" .
<Head_and_neck_cancer> <Accepted_use_of> "Fluorouracil_monotherapy" .
<Head_and_neck_cancer> <Accepted_use_of> "Fluorouracil_and_RT" .
<Head_and_neck_cancer> <Accepted_use_of> "Fluorouracil" .
<Head_and_neck_cancer> <Accepted_use_of> "Docetaxel,_Fluorouracil,_Hydroxyurea,_RT" .
<Head_and_neck_cancer> <Accepted_use_of> "Docetaxel,_Cetuximab,_RT" .
<Head_and_neck_cancer> <Accepted_use_of> "Docetaxel_monotherapy" .
<Head_and_neck_cancer> <Accepted_use_of> "Docetaxel" .
<Head_and_neck_cancer> <Accepted_use_of> "DCF" .
<Head_and_neck_cancer> <Accepted_use_of> "Cisplatin,_Paclitaxel,_RT" .
<Head_and_neck_cancer> <Accepted_use_of> "Cisplatin,_Fluorouracil,_RT" .
<Head_and_neck_cancer> <Accepted_use_of> "Cisplatin,_Fluorouracil,_Panitumumab" .
<Head_and_neck_cancer> <Accepted_use_of> "Cisplatin,_Fluorouracil,_Cetuximab" .
<Head_and_neck_cancer> <Accepted_use_of> "Cisplatin,_Cetuximab,_RT" .
<Head_and_neck_cancer> <Accepted_use_of> "Cisplatin_monotherapy" .
<Head_and_neck_cancer> <Accepted_use_of> "Cisplatin_and_RT" .
<Head_and_neck_cancer> <Accepted_use_of> "Cisplatin_and_Paclitaxel" .
<Head_and_neck_cancer> <Accepted_use_of> "Cisplatin_and_Fluorouracil" .
<Head_and_neck_cancer> <Accepted_use_of> "Cisplatin_and_Docetaxel" .
<Head_and_neck_cancer> <Accepted_use_of> "Cisplatin_and_Cetuximab" .
<Head_and_neck_cancer> <Accepted_use_of> "Cisplatin" .
<Head_and_neck_cancer> <Accepted_use_of> "Cetuximab_monotherapy" .
<Head_and_neck_cancer> <Accepted_use_of> "Cetuximab_and_RT" .
<Head_and_neck_cancer> <Accepted_use_of> "Cetuximab" .
<Head_and_neck_cancer> <Accepted_use_of> "Carboplatin,_Paclitaxel,_RT" .
<Head_and_neck_cancer> <Accepted_use_of> "Carboplatin,_Fluorouracil,_RT" .
<Head_and_neck_cancer> <Accepted_use_of> "Carboplatin,_Fluorouracil,_Cetuximab,_RT" .
<Head_and_neck_cancer> <Accepted_use_of> "Carboplatin,_Fluorouracil,_Cetuximab" .
<Head_and_neck_cancer> <Accepted_use_of> "Carboplatin_and_RT" .
<Head_and_neck_cancer> <Accepted_use_of> "Carboplatin_and_Fluorouracil" .
<Head_and_neck_cancer> <Accepted_use_of> "Carboplatin_and_Docetaxel" .
<Head_and_neck_cancer> <Accepted_use_of> "Carboplatin" .
<Head_and_neck_cancer> <Accepted_use_of> "CABO" .
<Head_and_neck_cancer> <Accepted_use_of> "Bleomycin,_Methotrexate,_Vinblastine/RT" .
<Head_and_neck_cancer> <Accepted_use_of> "Best_supportive_care" .
<Head_and_neck_cancer> <Accepted_use_of> "Afatinib_monotherapy" .
<Head_and_neck_cancer> <Accepted_use_of> "Afatinib" .
<CAMFP> <Is_historical_in> "Breast_cancer" .
<EVAIA> <Mapped_from> "EVAIA" .
<Immunosuppressive_therapy> <Mapped_from> "Immunosuppressive_therapy" .
<MAP3K20_inhibitor> <Is_a> "Kinase_inhibitor" .
<Clarithromycin> <Is_a> "Antibacterial" .
<CEP> <Is_historical_in> "Ovarian_cancer" .
<CEP> <Is_historical_in> "Hodgkin_lymphoma" .
<Tavegil> <Brand_name_of> "Clemastine" .
<Clemastine> <Supportive_med_of> "Paclitaxel_monotherapy" .
<Clemastine> <Supportive_med_of> "FluCam" .
<Clemastine> <Supportive_med_of> "Daratumumab_monotherapy" .
<Clemastine> <Supportive_med_of> "Cladribine_monotherapy" .
<Clemastine> <Supportive_med_of> "Cisplatin_and_Paclitaxel" .
<Clemastine> <Supportive_med_of> "Carboplatin,_Paclitaxel,_RT" .
<DCEP_and_G-CSF> <Has_modality> "Chemotherapy" .
<Atezolizumab> <Has_accepted_use> "Small_cell_lung_cancer" .
<Atezolizumab> <Has_accepted_use> "Renal_cell_carcinoma" .
<Atezolizumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Atezolizumab> <Has_accepted_use> "Breast_cancer" .
<Atezolizumab> <Has_accepted_use> "Bladder_cancer" .
<Platinex> <Brand_name_of> "Cisplatin" .
<Cisplatin_and_Epirubicin> <Has_accepted_use> "Testicular_cancer" .
<Cisplatin_and_Epirubicin> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<Cisplatin_and_Epirubicin> <Has_context> "Salvage_therapy" .
<Cisplatin_and_Epirubicin> <Has_context> "Induction_therapy" .
<P/DOCE> <Has_context> "Induction_therapy" .
<5_plus_2d> <Is_a> "Anthracycline-containing_regimen" .
<Actazolam> <Brand_name_of> "Alprazolam" .
<BID> <Has_context> "Non-curative_therapy" .
<Dexamethasone> <Antineoplastic_of> "m-BNCOD" .
<Dexamethasone> <Antineoplastic_of> "m-BACOD" .
<Dexamethasone> <Antineoplastic_of> "ZRd" .
<Dexamethasone> <Antineoplastic_of> "VcR-CVAD" .
<Dexamethasone> <Antineoplastic_of> "VTD-PACE" .
<Dexamethasone> <Antineoplastic_of> "VTD" .
<Dexamethasone> <Antineoplastic_of> "VMP/Rd" .
<Dexamethasone> <Antineoplastic_of> "VMP,_then_Rd" .
<Dexamethasone> <Antineoplastic_of> "VMD" .
<Dexamethasone> <Antineoplastic_of> "VIPD" .
<Dexamethasone> <Antineoplastic_of> "VDC" .
<Dexamethasone> <Antineoplastic_of> "VD" .
<Dexamethasone> <Antineoplastic_of> "VBMCP/VBAD" .
<Dexamethasone> <Antineoplastic_of> "VAD-P/Q" .
<Dexamethasone> <Antineoplastic_of> "VAD-P" .
<Dexamethasone> <Antineoplastic_of> "VAD_plus_C" .
<Dexamethasone> <Antineoplastic_of> "VAD_doxil" .
<Dexamethasone> <Antineoplastic_of> "VAD_and_Cyclosporine" .
<Dexamethasone> <Antineoplastic_of> "VAD" .
<Dexamethasone> <Antineoplastic_of> "V-HyperCAD" .
<Dexamethasone> <Antineoplastic_of> "Total_Therapy" .
<Dexamethasone> <Antineoplastic_of> "TVAD_doxil" .
<Dexamethasone> <Antineoplastic_of> "TD" .
<Dexamethasone> <Antineoplastic_of> "TAD_(Thalidomide)" .
<Dexamethasone> <Antineoplastic_of> "Selinexor_and_Dexamethasone" .
<Dexamethasone> <Antineoplastic_of> "SMILE" .
<Dexamethasone> <Antineoplastic_of> "RiPAD_plus_C" .
<Dexamethasone> <Antineoplastic_of> "Rd" .
<Dexamethasone> <Antineoplastic_of> "RVDC" .
<Dexamethasone> <Antineoplastic_of> "RVD" .
<Dexamethasone> <Antineoplastic_of> "RD" .
<Dexamethasone> <Antineoplastic_of> "R-VAD_plus_C" .
<Dexamethasone> <Antineoplastic_of> "R-Hyper-CVAD/R-MA" .
<Dexamethasone> <Antineoplastic_of> "R-GDP" .
<Dexamethasone> <Antineoplastic_of> "R-FND" .
<Dexamethasone> <Antineoplastic_of> "R-DexaBEAM" .
<Dexamethasone> <Antineoplastic_of> "R-DHAP/R-VIM" .
<Dexamethasone> <Antineoplastic_of> "R-DHAP" .
<Dexamethasone> <Antineoplastic_of> "R-DHAOx" .
<Dexamethasone> <Antineoplastic_of> "R-DHAC" .
<Dexamethasone> <Antineoplastic_of> "R-CMD" .
<Dexamethasone> <Antineoplastic_of> "R-CHOP/R-DHAP" .
<Dexamethasone> <Antineoplastic_of> "Pomalidomide,_Dexamethasone,_Pembrolizumab" .
<Dexamethasone> <Antineoplastic_of> "Pediatric-like_GRAALL_consolidation" .
<Dexamethasone> <Antineoplastic_of> "Pd" .
<Dexamethasone> <Antineoplastic_of> "PVD" .
<Dexamethasone> <Antineoplastic_of> "PD" .
<Dexamethasone> <Antineoplastic_of> "PCD" .
<Dexamethasone> <Antineoplastic_of> "PAD/VCD" .
<Dexamethasone> <Antineoplastic_of> "PAD_doxil" .
<Dexamethasone> <Antineoplastic_of> "PAD" .
<Dexamethasone> <Antineoplastic_of> "O-DHAP" .
<Dexamethasone> <Antineoplastic_of> "Nordic_Regimen,_younger_patients" .
<Dexamethasone> <Antineoplastic_of> "Nordic_Regimen,_older_patients" .
<Dexamethasone> <Antineoplastic_of> "Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Dexamethasone> <Antineoplastic_of> "Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone" .
<Dexamethasone> <Antineoplastic_of> "Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin" .
<Dexamethasone> <Antineoplastic_of> "Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone" .
<Dexamethasone> <Antineoplastic_of> "MRD" .
<Dexamethasone> <Antineoplastic_of> "MESA/RT" .
<Dexamethasone> <Antineoplastic_of> "MEL200,_then_auto_HSCT,_then_MEL220_and_Dexamethasone,_then_auto_HSCT" .
<Dexamethasone> <Antineoplastic_of> "M-DEX" .
<Dexamethasone> <Antineoplastic_of> "Lenalidomide,_Dexamethasone,_Rituximab" .
<Dexamethasone> <Antineoplastic_of> "LEED,_then_auto_HSCT" .
<Dexamethasone> <Antineoplastic_of> "LEED" .
<Dexamethasone> <Antineoplastic_of> "L-Asparaginase,_Vincristine,_Dexamethasone" .
<Dexamethasone> <Antineoplastic_of> "KTD" .
<Dexamethasone> <Antineoplastic_of> "KRd" .
<Dexamethasone> <Antineoplastic_of> "KPD" .
<Dexamethasone> <Antineoplastic_of> "KD" .
<Dexamethasone> <Antineoplastic_of> "KCD" .
<Dexamethasone> <Antineoplastic_of> "Ixazomib_and_Dexamethasone" .
<Dexamethasone> <Antineoplastic_of> "International_ALL_Trial" .
<Dexamethasone> <Antineoplastic_of> "Interferon_alfa_and_Dexamethasone" .
<Dexamethasone> <Antineoplastic_of> "Imatinib,_Vincristine,_Dexamethasone" .
<Dexamethasone> <Antineoplastic_of> "IRd" .
<Dexamethasone> <Antineoplastic_of> "Hyper-CVAD/MA_and_Everolimus" .
<Dexamethasone> <Antineoplastic_of> "Hyper-CVAD/MA" .
<Dexamethasone> <Antineoplastic_of> "Hyper-CVAD_and_Ponatinib" .
<Dexamethasone> <Antineoplastic_of> "Hyper-CVAD_and_Imatinib" .
<Dexamethasone> <Antineoplastic_of> "Hyper-CVAD_and_Dasatinib" .
<Dexamethasone> <Antineoplastic_of> "Hyper-CVAD" .
<Dexamethasone> <Antineoplastic_of> "GMALL-R" .
<Dexamethasone> <Antineoplastic_of> "GDP" .
<Dexamethasone> <Antineoplastic_of> "GCD-R" .
<Dexamethasone> <Antineoplastic_of> "GCD" .
<Dexamethasone> <Antineoplastic_of> "FRD" .
<Dexamethasone> <Antineoplastic_of> "FND" .
<Dexamethasone> <Antineoplastic_of> "Elo-VD" .
<Dexamethasone> <Antineoplastic_of> "Elo-Rd" .
<Dexamethasone> <Antineoplastic_of> "Elo-PD" .
<Dexamethasone> <Antineoplastic_of> "EDAP" .
<Dexamethasone> <Antineoplastic_of> "Dexamethasone_monotherapy" .
<Dexamethasone> <Antineoplastic_of> "DexaBEAM_and_G-CSF" .
<Dexamethasone> <Antineoplastic_of> "DexaBEAM" .
<Dexamethasone> <Antineoplastic_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Dexamethasone> <Antineoplastic_of> "Dara-VTD" .
<Dexamethasone> <Antineoplastic_of> "Dara-VD" .
<Dexamethasone> <Antineoplastic_of> "Dara-Rd" .
<Dexamethasone> <Antineoplastic_of> "Dara-PD" .
<Dexamethasone> <Antineoplastic_of> "Dara-KD" .
<Dexamethasone> <Antineoplastic_of> "DTPACE" .
<Dexamethasone> <Antineoplastic_of> "DRC" .
<Dexamethasone> <Antineoplastic_of> "DICE" .
<Dexamethasone> <Antineoplastic_of> "DHAP_-_time_intensified" .
<Dexamethasone> <Antineoplastic_of> "DHAP" .
<Dexamethasone> <Antineoplastic_of> "DEX-IFN" .
<Dexamethasone> <Antineoplastic_of> "DEP_and_RT" .
<Dexamethasone> <Antineoplastic_of> "DDGP" .
<Dexamethasone> <Antineoplastic_of> "DCTER" .
<Dexamethasone> <Antineoplastic_of> "DCEP_and_G-CSF" .
<Dexamethasone> <Antineoplastic_of> "DCEP" .
<Dexamethasone> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone" .
<Dexamethasone> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone" .
<Dexamethasone> <Antineoplastic_of> "Cyclophosphamide_and_Dexamethasone" .
<Dexamethasone> <Antineoplastic_of> "CaRD" .
<Dexamethasone> <Antineoplastic_of> "CYKLONE" .
<Dexamethasone> <Antineoplastic_of> "CVAD" .
<Dexamethasone> <Antineoplastic_of> "CTD" .
<Dexamethasone> <Antineoplastic_of> "CRd" .
<Dexamethasone> <Antineoplastic_of> "CRD" .
<Dexamethasone> <Antineoplastic_of> "CMED" .
<Dexamethasone> <Antineoplastic_of> "CALGB_8811_late_intensification" .
<Dexamethasone> <Antineoplastic_of> "CALGB_10-002_regimen" .
<Dexamethasone> <Antineoplastic_of> "CAD_and_G-CSF" .
<Dexamethasone> <Antineoplastic_of> "Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat" .
<Dexamethasone> <Antineoplastic_of> "Bortezomib,_Dexamethasone,_Panobinostat" .
<Dexamethasone> <Antineoplastic_of> "BiRd" .
<Dexamethasone> <Antineoplastic_of> "BTD" .
<Dexamethasone> <Antineoplastic_of> "BLD" .
<Dexamethasone> <Antineoplastic_of> "BID" .
<Dexamethasone> <Antineoplastic_of> "BDR" .
<Dexamethasone> <Antineoplastic_of> "BBD" .
<Dexamethasone> <Antineoplastic_of> "Augmented_Hyper-CVAD_and_Asparaginase" .
<Dexamethasone> <Antineoplastic_of> "Aspirin_and_Dexamethasone" .
<Dexamethasone> <Antineoplastic_of> "AspaMetDex_(Erwinaze)" .
<Dexamethasone> <Antineoplastic_of> "AspaMetDex" .
<Ribociclib> <Has_accepted_use> "Breast_cancer" .
<CHVP-I> <Has_context> "Non-curative_first-line_therapy" .
<Duvelisib> <Is_a> "REMS_program" .
<Duvelisib> <Is_a> "PI3K_gamma_inhibitor" .
<Duvelisib> <Is_a> "PI3K_delta_inhibitor" .
<Duvelisib> <Is_a> "Kinase_inhibitor" .
<Pentostatin> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Pentostatin> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Pentostatin> <Has_accepted_use> "Hairy_cell_leukemia" .
<Pentostatin> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Elo-PD> <Has_antineoplastic> "Pomalidomide" .
<Elo-PD> <Has_antineoplastic> "Elotuzumab" .
<Elo-PD> <Has_antineoplastic> "Dexamethasone" .
<Neuroendocrine_tumor> <Accepted_use_of> "Thalidomide" .
<Neuroendocrine_tumor> <Accepted_use_of> "Temozolomide_monotherapy" .
<Neuroendocrine_tumor> <Accepted_use_of> "Temozolomide" .
<Neuroendocrine_tumor> <Accepted_use_of> "Telotristat" .
<Neuroendocrine_tumor> <Accepted_use_of> "Placebo" .
<Neuroendocrine_tumor> <Accepted_use_of> "Octreotide_monotherapy" .
<Neuroendocrine_tumor> <Accepted_use_of> "Octreotide_and_Interferon_alfa" .
<Neuroendocrine_tumor> <Accepted_use_of> "Octreotide_LAR_monotherapy" .
<Neuroendocrine_tumor> <Accepted_use_of> "Octreotide_LAR" .
<Neuroendocrine_tumor> <Accepted_use_of> "Octreotide" .
<Neuroendocrine_tumor> <Accepted_use_of> "Lutetium_Lu_177_dotatate_and_Octreotide_LAR" .
<Neuroendocrine_tumor> <Accepted_use_of> "Lutetium_Lu_177_dotatate" .
<Neuroendocrine_tumor> <Accepted_use_of> "Lanreotide_monotherapy" .
<Neuroendocrine_tumor> <Accepted_use_of> "Lanreotide_and_Interferon_alfa-2b" .
<Neuroendocrine_tumor> <Accepted_use_of> "Lanreotide" .
<Neuroendocrine_tumor> <Accepted_use_of> "Interferon_alfa-2b_monotherapy" .
<Neuroendocrine_tumor> <Accepted_use_of> "Interferon_alfa-2b" .
<Neuroendocrine_tumor> <Accepted_use_of> "Interferon_alfa-2a" .
<Neuroendocrine_tumor> <Accepted_use_of> "Fluorouracil_and_Streptozocin" .
<Neuroendocrine_tumor> <Accepted_use_of> "Everolimus_monotherapy" .
<Neuroendocrine_tumor> <Accepted_use_of> "Everolimus_and_Octreotide" .
<Neuroendocrine_tumor> <Accepted_use_of> "Everolimus" .
<Neuroendocrine_tumor> <Accepted_use_of> "Bevacizumab-bvzr" .
<Neuroendocrine_tumor> <Accepted_use_of> "Bevacizumab-awwb" .
<Neuroendocrine_tumor> <Accepted_use_of> "Bevacizumab" .
<m-BACOD> <Has_local_therapy> "Cytarabine" .
<Lezole> <Brand_name_of> "Letrozole" .
<Soltamox> <Brand_name_of> "Tamoxifen" .
<VDC> <Maps_to> "VDC" .
<Oxaliplatin_and_Bevacizumab> <Maps_to> "Oxaliplatin_and_Bevacizumab" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone> <Is_a> "Anthracycline-containing_regimen" .
<Doxorubicin_pegylated_liposomal_monotherapy> <Is_current_in> "Ovarian_cancer" .
<Doxorubicin_pegylated_liposomal_monotherapy> <Is_current_in> "Kaposi_sarcoma" .
<Doxorubicin_pegylated_liposomal_monotherapy> <Is_current_in> "Breast_cancer" .
<Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Maps_to> "Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Thioguanine_monotherapy> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<Inotuzumab_ozogamicin_monotherapy> <Maps_to> "Inotuzumab_ozogamicin_monotherapy" .
<Cardinex> <Brand_name_of> "Enoxaparin" .
<FOLFOX_7/sLV5FU2_(L-Leucovorin)> <Is_current_in> "Colon_cancer" .
<FCA> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Radioembolization> <Has_context> "Local_therapy" .
<Aqupla> <Brand_name_of> "Nedaplatin" .
<Fulvestrant_and_Palbociclib> <Has_antineoplastic> "Palbociclib" .
<Fulvestrant_and_Palbociclib> <Has_antineoplastic> "Fulvestrant" .
<Medrone> <Brand_name_of> "Methylprednisolone" .
<SHAI> <Mapped_from> "SHAI" .
<CX_and_Trastuzumab> <Has_modality> "Chemotherapy" .
<CAPIRI-Bev> <Has_antineoplastic> "Irinotecan" .
<CAPIRI-Bev> <Has_antineoplastic> "Capecitabine" .
<CAPIRI-Bev> <Has_antineoplastic> "Bevacizumab" .
<C-MOPP> <Maps_to> "C-MOPP" .
<Afinitor> <Brand_name_of> "Everolimus" .
<Meningioma> <Accepted_use_of> "Placebo" .
<Mitoxantrone_and_Prednisone> <Is_current_in> "Prostate_cancer" .
<Lorlatinib> <Has_brand_name> "Lorbrena" .
<THP_(Taxol)> <Has_antineoplastic> "Trastuzumab" .
<THP_(Taxol)> <Has_antineoplastic> "Pertuzumab" .
<THP_(Taxol)> <Has_antineoplastic> "Paclitaxel" .
<R-BEAM,_then_auto_HSCT> <Has_context> "Non-curative_subsequent-line_consolidation_therapy" .
<R-BEAM,_then_auto_HSCT> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<R-BEAM,_then_auto_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<K.B.famate> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin_and_Raltitrexed> <Has_antineoplastic> "Raltitrexed" .
<Cisplatin_and_Raltitrexed> <Has_antineoplastic> "Cisplatin" .
<Glasdegib_and_LoDAC> <Has_antineoplastic> "Glasdegib" .
<Glasdegib_and_LoDAC> <Has_antineoplastic> "Cytarabine" .
<Falprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cabazitaxel_and_Prednisone> <Has_modality> "Hormonotherapy" .
<Cabazitaxel_and_Prednisone> <Has_modality> "Chemotherapy" .
<Erdafitinib_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<Anti-GD2_antibody> <Subsumes> "Dinutuximab" .
<FOLFOX4> <Has_accepted_use> "KRAS_wild-type_Colon_cancer" .
<FOLFOX4> <Has_accepted_use> "Hepatocellular_carcinoma" .
<FOLFOX4> <Has_accepted_use> "Esophageal_cancer" .
<FOLFOX4> <Has_accepted_use> "Colon_cancer" .
<VMD> <Has_antineoplastic> "Melphalan" .
<VMD> <Has_antineoplastic> "Dexamethasone" .
<VMD> <Has_antineoplastic> "Bortezomib" .
<Peginterferon_alfa-2b> <Antineoplastic_of> "Peginterferon_alfa-2b_monotherapy" .
<Fluorouracil> <Has_accepted_use> "SCC_of_unknown_primary" .
<Fluorouracil> <Has_accepted_use> "Rectal_cancer" .
<Fluorouracil> <Has_accepted_use> "Prostate_cancer" .
<Fluorouracil> <Has_accepted_use> "Penile_cancer" .
<Fluorouracil> <Has_accepted_use> "Pancreatic_cancer" .
<Fluorouracil> <Has_accepted_use> "Pancreatic_NET" .
<Fluorouracil> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<Fluorouracil> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Fluorouracil> <Has_accepted_use> "Head_and_neck_cancer" .
<Fluorouracil> <Has_accepted_use> "Gastric_cancer" .
<Fluorouracil> <Has_accepted_use> "Esophageal_cancer" .
<Fluorouracil> <Has_accepted_use> "Colon_cancer" .
<Fluorouracil> <Has_accepted_use> "Cholangiocarcinoma" .
<Fluorouracil> <Has_accepted_use> "Cervical_cancer" .
<Fluorouracil> <Has_accepted_use> "Breast_cancer" .
<Fluorouracil> <Has_accepted_use> "Bladder_cancer" .
<Fluorouracil> <Has_accepted_use> "Anal_cancer" .
<Radotinib_monotherapy> <Has_antineoplastic> "Radotinib" .
<Lanadexon> <Brand_name_of> "Dexamethasone" .
<Clofarabine_monotherapy> <Has_context> "Non-curative_therapy" .
<Clofarabine_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Clofarabine_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Clofarabine_monotherapy> <Has_context> "Non-curative_first-line_induction_therapy" .
<AT_(Taxotere)> <Has_antineoplastic> "Doxorubicin" .
<AT_(Taxotere)> <Has_antineoplastic> "Docetaxel" .
<Gemcitabine,_Cisplatin,_S-1> <Maps_to> "Gemcitabine,_Cisplatin,_S-1" .
<RiPAD_plus_C> <Maps_to> "RiPAD_plus_C" .
<CAD_and_G-CSF> <Has_accepted_use> "Stem_cell_mobilization" .
<Salvage_therapy> <Is_a> "Curative_therapy" .
<Dolasetron> <Has_brand_name> "Anzemet" .
<Hepatobiliary_cancer> <Subsumes> "Periampullary_adenocarcinoma" .
<Hepatobiliary_cancer> <Subsumes> "Hepatocellular_carcinoma" .
<Hepatobiliary_cancer> <Subsumes> "Gallbladder_cancer" .
<Hepatobiliary_cancer> <Subsumes> "Cholangiocarcinoma" .
<Temozolomide_and_low-dose_RT> <Maps_to> "Temozolomide_and_low-dose_RT" .
<Plicamycin> <Antineoplastic_of> "Plicamycin_monotherapy" .
<Plicamycin> <Antineoplastic_of> "Hydroxyurea_and_Plicamycin" .
<Lescot> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Dexmesone> <Brand_name_of> "Dexamethasone" .
<mFOLFOX6_and_Cetuximab> <Maps_to> "mFOLFOX6_and_Cetuximab" .
<Oral> <May_be_route_of> "Zidovudine" .
<Oral> <May_be_route_of> "Zanubrutinib" .
<Oral> <May_be_route_of> "Warfarin" .
<Oral> <May_be_route_of> "Vorinostat" .
<Oral> <May_be_route_of> "Voriconazole" .
<Oral> <May_be_route_of> "Vorapaxar" .
<Oral> <May_be_route_of> "Vismodegib" .
<Oral> <May_be_route_of> "Venetoclax" .
<Oral> <May_be_route_of> "Vemurafenib" .
<Oral> <May_be_route_of> "Veliparib" .
<Oral> <May_be_route_of> "Vandetanib" .
<Oral> <May_be_route_of> "Valproate" .
<Oral> <May_be_route_of> "Valganciclovir" .
<Oral> <May_be_route_of> "Valacyclovir" .
<Oral> <May_be_route_of> "Uridine_triacetate" .
<Oral> <May_be_route_of> "Uracil_mustard" .
<Oral> <May_be_route_of> "Tropisetron" .
<Oral> <May_be_route_of> "Trimethoprim-Sulfamethoxazole" .
<Oral> <May_be_route_of> "Trifluridine_and_tipiracil" .
<Oral> <May_be_route_of> "Treosulfan" .
<Oral> <May_be_route_of> "Tranexamic_acid" .
<Oral> <May_be_route_of> "Trametinib" .
<Oral> <May_be_route_of> "Tosedostat" .
<Oral> <May_be_route_of> "Toremifene" .
<Oral> <May_be_route_of> "Tofacitinib" .
<Oral> <May_be_route_of> "Tivozanib" .
<Oral> <May_be_route_of> "Tivantinib" .
<Oral> <May_be_route_of> "Tipifarnib" .
<Oral> <May_be_route_of> "Ticlopidine" .
<Oral> <May_be_route_of> "Ticagrelor" .
<Oral> <May_be_route_of> "Thioguanine" .
<Oral> <May_be_route_of> "Thalidomide" .
<Oral> <May_be_route_of> "Tesetaxel" .
<Oral> <May_be_route_of> "Temozolomide" .
<Oral> <May_be_route_of> "Telotristat" .
<Oral> <May_be_route_of> "Tegafur_gimeracil_oteracil" .
<Oral> <May_be_route_of> "Tegafur_and_uracil" .
<Oral> <May_be_route_of> "Tazemetostat" .
<Oral> <May_be_route_of> "Tamoxifen" .
<Oral> <May_be_route_of> "Tamibarotene" .
<Oral> <May_be_route_of> "Talazoparib" .
<Oral> <May_be_route_of> "Tacrolimus" .
<Oral> <May_be_route_of> "Sunitinib" .
<Oral> <May_be_route_of> "Sorafenib" .
<Oral> <May_be_route_of> "Sonidegib" .
<Oral> <May_be_route_of> "Sirolimus" .
<Oral> <May_be_route_of> "Sennosides" .
<Oral> <May_be_route_of> "Semustine" .
<Oral> <May_be_route_of> "Selumetinib" .
<Oral> <May_be_route_of> "Selinexor" .
<Oral> <May_be_route_of> "Sapacitabine" .
<Oral> <May_be_route_of> "Ruxolitinib" .
<Oral> <May_be_route_of> "Rucaparib" .
<Oral> <May_be_route_of> "Rolapitant" .
<Oral> <May_be_route_of> "Rociletinib" .
<Oral> <May_be_route_of> "Rivaroxaban" .
<Oral> <May_be_route_of> "Ricolinostat" .
<Oral> <May_be_route_of> "Ribociclib" .
<Oral> <May_be_route_of> "Regorafenib" .
<Oral> <May_be_route_of> "Refametinib" .
<Oral> <May_be_route_of> "Ranitidine" .
<Oral> <May_be_route_of> "Ramosetron" .
<Oral> <May_be_route_of> "Raloxifene" .
<Oral> <May_be_route_of> "Radotinib" .
<Oral> <May_be_route_of> "Rabeprazole" .
<Oral> <May_be_route_of> "Quizartinib" .
<Oral> <May_be_route_of> "Quisinostat" .
<Oral> <May_be_route_of> "Quinine" .
<Oral> <May_be_route_of> "Promethazine" .
<Oral> <May_be_route_of> "Prochlorperazine" .
<Oral> <May_be_route_of> "Procarbazine" .
<Oral> <May_be_route_of> "Prednisone" .
<Oral> <May_be_route_of> "Prednisolone" .
<Oral> <May_be_route_of> "Pravastatin" .
<Oral> <May_be_route_of> "Prasugrel" .
<Oral> <May_be_route_of> "Ponatinib" .
<Oral> <May_be_route_of> "Pomalidomide" .
<Oral> <May_be_route_of> "Plinabulin" .
<Oral> <May_be_route_of> "Pictilisib" .
<Oral> <May_be_route_of> "Phytonadione" .
<Oral> <May_be_route_of> "Phenytoin" .
<Oral> <May_be_route_of> "Perifosine" .
<Oral> <May_be_route_of> "Penicillin_V" .
<Oral> <May_be_route_of> "Pazopanib" .
<Oral> <May_be_route_of> "Pantoprazole" .
<Oral> <May_be_route_of> "Panobinostat" .
<Oral> <May_be_route_of> "Palbociclib" .
<Oral> <May_be_route_of> "Pacritinib" .
<Oral> <May_be_route_of> "Osimertinib" .
<Oral> <May_be_route_of> "Oprozomib" .
<Oral> <May_be_route_of> "Ondansetron" .
<Oral> <May_be_route_of> "Omeprazole" .
<Oral> <May_be_route_of> "Olaparib" .
<Oral> <May_be_route_of> "Olanzapine" .
<Oral> <May_be_route_of> "Norethandrolone" .
<Oral> <May_be_route_of> "Niraparib" .
<Oral> <May_be_route_of> "Nintedanib" .
<Oral> <May_be_route_of> "Nimustine" .
<Oral> <May_be_route_of> "Nilutamide" .
<Oral> <May_be_route_of> "Nilotinib" .
<Oral> <May_be_route_of> "Netupitant_and_palonosetron" .
<Oral> <May_be_route_of> "Neratinib" .
<Oral> <May_be_route_of> "Nabilone" .
<Oral> <May_be_route_of> "Mycostatin" .
<Oral> <May_be_route_of> "Mycophenolate_mofetil" .
<Oral> <May_be_route_of> "Motesanib" .
<Oral> <May_be_route_of> "Montelukast" .
<Oral> <May_be_route_of> "Momelotinib" .
<Oral> <May_be_route_of> "Mocetinostat" .
<Oral> <May_be_route_of> "Mitotane" .
<Oral> <May_be_route_of> "Midostaurin" .
<Oral> <May_be_route_of> "Metoclopramide" .
<Oral> <May_be_route_of> "Methylprednisolone" .
<Oral> <May_be_route_of> "Methotrexate" .
<Oral> <May_be_route_of> "Mesna" .
<Oral> <May_be_route_of> "Mercaptopurine" .
<Oral> <May_be_route_of> "Meperidine" .
<Oral> <May_be_route_of> "Melphalan" .
<Oral> <May_be_route_of> "Megestrol" .
<Oral> <May_be_route_of> "Medroxyprogesterone" .
<Oral> <May_be_route_of> "Masitinib" .
<Oral> <May_be_route_of> "Lusutrombopag" .
<Oral> <May_be_route_of> "Lorlatinib" .
<Oral> <May_be_route_of> "Lorazepam" .
<Oral> <May_be_route_of> "Loperamide" .
<Oral> <May_be_route_of> "Lomustine" .
<Oral> <May_be_route_of> "Levofloxacin" .
<Oral> <May_be_route_of> "Levamisole" .
<Oral> <May_be_route_of> "Letrozole" .
<Oral> <May_be_route_of> "Lenvatinib" .
<Oral> <May_be_route_of> "Lenalidomide" .
<Oral> <May_be_route_of> "Larotrectinib" .
<Oral> <May_be_route_of> "Lapatinib" .
<Oral> <May_be_route_of> "Lansoprazole" .
<Oral> <May_be_route_of> "Lamivudine" .
<Oral> <May_be_route_of> "Lactulose" .
<Oral> <May_be_route_of> "L-glutamine" .
<Oral> <May_be_route_of> "Ketoconazole" .
<Oral> <May_be_route_of> "Ixazomib" .
<Oral> <May_be_route_of> "Ivosidenib" .
<Oral> <May_be_route_of> "Itraconazole" .
<Oral> <May_be_route_of> "Isotretinoin" .
<Oral> <May_be_route_of> "Ipatasertib" .
<Oral> <May_be_route_of> "Infigratinib" .
<Oral> <May_be_route_of> "Indomethacin" .
<Oral> <May_be_route_of> "Imatinib" .
<Oral> <May_be_route_of> "Idelalisib" .
<Oral> <May_be_route_of> "Icotinib" .
<Oral> <May_be_route_of> "Ibrutinib" .
<Oral> <May_be_route_of> "Ibandronate" .
<Oral> <May_be_route_of> "Hydroxyzine" .
<Oral> <May_be_route_of> "Hydroxyurea" .
<Oral> <May_be_route_of> "Haloperidol" .
<Oral> <May_be_route_of> "Granisetron" .
<Oral> <May_be_route_of> "Glasdegib" .
<Oral> <May_be_route_of> "Gilteritinib" .
<Oral> <May_be_route_of> "Gefitinib" .
<Oral> <May_be_route_of> "Galeterone" .
<Oral> <May_be_route_of> "Furosemide" .
<Oral> <May_be_route_of> "Fruquintinib" .
<Oral> <May_be_route_of> "Forodesine" .
<Oral> <May_be_route_of> "Folinic_acid" .
<Oral> <May_be_route_of> "Folic_acid" .
<Oral> <May_be_route_of> "Flutamide" .
<Oral> <May_be_route_of> "Fluoxymesterone" .
<Oral> <May_be_route_of> "Fludarabine" .
<Oral> <May_be_route_of> "Fluconazole" .
<Oral> <May_be_route_of> "Finasteride" .
<Oral> <May_be_route_of> "Ferrous_sulfate" .
<Oral> <May_be_route_of> "Fedratinib" .
<Oral> <May_be_route_of> "Famotidine" .
<Oral> <May_be_route_of> "Famciclovir" .
<Oral> <May_be_route_of> "Exemestane" .
<Oral> <May_be_route_of> "Everolimus" .
<Oral> <May_be_route_of> "Etoposide" .
<Oral> <May_be_route_of> "Estramustine" .
<Oral> <May_be_route_of> "Estradiol" .
<Oral> <May_be_route_of> "Erlotinib" .
<Oral> <May_be_route_of> "Erdafitinib" .
<Oral> <May_be_route_of> "Enzalutamide" .
<Oral> <May_be_route_of> "Entrectinib" .
<Oral> <May_be_route_of> "Entospletinib" .
<Oral> <May_be_route_of> "Entinostat" .
<Oral> <May_be_route_of> "Ensartinib" .
<Oral> <May_be_route_of> "Encorafenib" .
<Oral> <May_be_route_of> "Enasidenib" .
<Oral> <May_be_route_of> "Eltrombopag" .
<Oral> <May_be_route_of> "Edoxaban" .
<Oral> <May_be_route_of> "Duvelisib" .
<Oral> <May_be_route_of> "Dutasteride" .
<Oral> <May_be_route_of> "Dronabinol" .
<Oral> <May_be_route_of> "Doxycycline" .
<Oral> <May_be_route_of> "Doxifluridine" .
<Oral> <May_be_route_of> "Dovitinib" .
<Oral> <May_be_route_of> "Domperidone" .
<Oral> <May_be_route_of> "Dolasetron" .
<Oral> <May_be_route_of> "Docusate" .
<Oral> <May_be_route_of> "Dipyridamole" .
<Oral> <May_be_route_of> "Diphenhydramine" .
<Oral> <May_be_route_of> "Diethylstilbestrol" .
<Oral> <May_be_route_of> "Dexchlorpheniramine" .
<Oral> <May_be_route_of> "Desmopressin" .
<Oral> <May_be_route_of> "Deferiprone" .
<Oral> <May_be_route_of> "Deferasirox" .
<Oral> <May_be_route_of> "Dasatinib" .
<Oral> <May_be_route_of> "Darolutamide" .
<Oral> <May_be_route_of> "Dapsone" .
<Oral> <May_be_route_of> "Danazol" .
<Oral> <May_be_route_of> "Dacomitinib" .
<Oral> <May_be_route_of> "Dabrafenib" .
<Oral> <May_be_route_of> "Dabigatran" .
<Oral> <May_be_route_of> "Cyproterone_acetate" .
<Oral> <May_be_route_of> "Cyclosporine_non-modified" .
<Oral> <May_be_route_of> "Cyclosporine_modified" .
<Oral> <May_be_route_of> "Cyclophosphamide" .
<Oral> <May_be_route_of> "Cyanocobalamin" .
<Oral> <May_be_route_of> "Crizotinib" .
<Oral> <May_be_route_of> "Cortisone" .
<Oral> <May_be_route_of> "Cobimetinib" .
<Oral> <May_be_route_of> "Clopidogrel" .
<Oral> <May_be_route_of> "Clonazepam" .
<Oral> <May_be_route_of> "Clofarabine" .
<Oral> <May_be_route_of> "Clodronate" .
<Oral> <May_be_route_of> "Clemastine" .
<Oral> <May_be_route_of> "Clarithromycin" .
<Oral> <May_be_route_of> "Ciprofloxacin" .
<Oral> <May_be_route_of> "Cimetidine" .
<Oral> <May_be_route_of> "Cilostazol" .
<Oral> <May_be_route_of> "Chlorpheniramine" .
<Oral> <May_be_route_of> "Chlorambucil" .
<Oral> <May_be_route_of> "Chidamide" .
<Oral> <May_be_route_of> "Cetirizine" .
<Oral> <May_be_route_of> "Ceritinib" .
<Oral> <May_be_route_of> "Cephalexin" .
<Oral> <May_be_route_of> "Cefixime" .
<Oral> <May_be_route_of> "Cediranib" .
<Oral> <May_be_route_of> "Capivasertib" .
<Oral> <May_be_route_of> "Capecitabine" .
<Oral> <May_be_route_of> "Cangrelor" .
<Oral> <May_be_route_of> "Calcium_phosphate_rinse" .
<Oral> <May_be_route_of> "Cabozantinib" .
<Oral> <May_be_route_of> "Busulfan" .
<Oral> <May_be_route_of> "Buparlisib" .
<Oral> <May_be_route_of> "Brigatinib" .
<Oral> <May_be_route_of> "Bosutinib" .
<Oral> <May_be_route_of> "Binimetinib" .
<Oral> <May_be_route_of> "Bicalutamide" .
<Oral> <May_be_route_of> "Bexarotene" .
<Oral> <May_be_route_of> "Betrixaban" .
<Oral> <May_be_route_of> "Barasertib" .
<Oral> <May_be_route_of> "Axitinib" .
<Oral> <May_be_route_of> "Avatrombopag" .
<Oral> <May_be_route_of> "Avapritinib" .
<Oral> <May_be_route_of> "Atropine" .
<Oral> <May_be_route_of> "Atovaquone" .
<Oral> <May_be_route_of> "Aspirin_and_dipyridamole" .
<Oral> <May_be_route_of> "Aspirin" .
<Oral> <May_be_route_of> "Ascorbic_acid" .
<Oral> <May_be_route_of> "Asciminib" .
<Oral> <May_be_route_of> "Aprepitant" .
<Oral> <May_be_route_of> "Apixaban" .
<Oral> <May_be_route_of> "Apatinib" .
<Oral> <May_be_route_of> "Apalutamide" .
<Oral> <May_be_route_of> "Anastrozole" .
<Oral> <May_be_route_of> "Anagrelide" .
<Oral> <May_be_route_of> "Amoxicillin" .
<Oral> <May_be_route_of> "Aminoglutethimide" .
<Oral> <May_be_route_of> "Aminocaproic_acid" .
<Oral> <May_be_route_of> "Alvocidib" .
<Oral> <May_be_route_of> "Altretamine" .
<Oral> <May_be_route_of> "Alprazolam" .
<Oral> <May_be_route_of> "Alpelisib" .
<Oral> <May_be_route_of> "Allopurinol" .
<Oral> <May_be_route_of> "All-trans_retinoic_acid" .
<Oral> <May_be_route_of> "Alisertib" .
<Oral> <May_be_route_of> "Alendronate" .
<Oral> <May_be_route_of> "Alectinib" .
<Oral> <May_be_route_of> "Afuresertib" .
<Oral> <May_be_route_of> "Afatinib" .
<Oral> <May_be_route_of> "Acyclovir" .
<Oral> <May_be_route_of> "Acetaminophen" .
<Oral> <May_be_route_of> "Acalabrutinib" .
<Oral> <May_be_route_of> "Abiraterone" .
<Oral> <May_be_route_of> "Abexinostat" .
<Oral> <May_be_route_of> "Abemaciclib" .
<Dexamethason> <Brand_name_of> "Dexamethasone" .
<RP> <Has_modality> "Chemotherapy" .
<DNA_methyltransferase_inhibitor> <Subsumes> "Guadecitabine" .
<DNA_methyltransferase_inhibitor> <Subsumes> "Decitabine" .
<DNA_methyltransferase_inhibitor> <Subsumes> "Azacitidine" .
<Eunades> <Brand_name_of> "Vinorelbine" .
<Vacrax> <Brand_name_of> "Acyclovir" .
<MA> <Is_a> "Anthracycline-containing_regimen" .
<CISCA> <Has_context> "Non-curative_first-line_therapy" .
<Edoxaban_monotherapy> <Maps_to> "Edoxaban_monotherapy" .
<FR> <Mapped_from> "FR" .
<Fedratinib_monotherapy> <Mapped_from> "Fedratinib_monotherapy" .
<Busulfan_and_Cyclophosphamide> <Has_accepted_use> "Autologous_HSCT" .
<Busulfan_and_Cyclophosphamide> <Has_accepted_use> "Allogeneic_HSCT" .
<Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone> <Has_context> "Maintenance_after_upfront_therapy" .
<Carboplatin_and_nab-Paclitaxel> <Maps_to> "Carboplatin_and_nab-Paclitaxel" .
<Cyclosporine,_Methotrexate,_Prednisone> <Is_current_in> "Graft_versus_host_disease" .
<Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine> <Maps_to> "Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine" .
<Pralatrexate> <Has_brand_name> "Folotyn" .
<Namalvin> <Brand_name_of> "Interferon_alfa-2b" .
<Alectinib_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Alectinib_monotherapy> <Has_accepted_use> "CNS_carcinoma" .
<Alectinib_monotherapy> <Has_accepted_use> "ALK-positive_Non-small_cell_lung_cancer" .
<TAM6> <Has_accepted_use> "Autologous_HSCT" .
<Momelotinib> <Has_accepted_use> "Myelofibrosis" .
<PCP_prophylaxis> <Subsumes> "Trimethoprim-Sulfamethoxazole" .
<PCP_prophylaxis> <Subsumes> "Pentamidine" .
<PCP_prophylaxis> <Subsumes> "Dapsone" .
<PCP_prophylaxis> <Subsumes> "Atovaquone" .
<Cisplatin_and_Pemetrexed> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Tivantinib> <May_have_route> "Oral" .
<Sulgotri> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Capecitabine_and_Neratinib> <Mapped_from> "Capecitabine_and_Neratinib" .
<Becenun> <Brand_name_of> "Carmustine" .
<Androcur> <Brand_name_of> "Cyproterone_acetate" .
<D-ZAPO> <Maps_to> "D-ZAPO" .
<Sinaspir> <Brand_name_of> "Aspirin" .
<ADT_and_Enzalutamide> <Is_current_in> "Prostate_cancer" .
<Strim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Onkocristin> <Brand_name_of> "Vincristine" .
<Nespo> <Brand_name_of> "Darbepoetin_alfa" .
<Capecitabine,_Mitomycin,_RT> <Has_context> "Definitive_therapy" .
<Doxorubicin_non-pegylated_liposomal_and_Bevacizumab> <Mapped_from> "Doxorubicin_non-pegylated_liposomal_and_Bevacizumab" .
<Tagamet> <Brand_name_of> "Cimetidine" .
<KTD> <Has_context> "Non-curative_first-line_therapy" .
<KTD> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<F-MACHOP> <Mapped_from> "F-MACHOP" .
<Ibrunib> <Brand_name_of> "Ibrutinib" .
<Benralizumab> <Is_a> "Antibody_medication" .
<Benralizumab> <Is_a> "Anti-IL-5_antibody" .
<ddC> <Has_context> "Adjuvant_therapy" .
<Bendamustine_and_Obinutuzumab> <Mapped_from> "Bendamustine_and_Obinutuzumab" .
<R-MP> <Has_context> "Upfront_therapy" .
<Brentuximab_vedotin> <Has_brand_name> "Adcetris" .
<ABV_(Vinblastine)> <Has_context> "All_lines_of_therapy" .
<Helicobacter_pylori_eradication_therapy> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Helicobacter_pylori_eradication_therapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Ultomiris> <Brand_name_of> "Ravulizumab" .
<ABC> <Has_modality> "Chemotherapy" .
<ddEC> <Has_context> "Adjuvant_therapy" .
<VP> <Has_context> "Non-curative_first-line_therapy" .
<VP> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Cisplatin_and_Etoposide> <Has_local_therapy> "Methotrexate" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib> <Maps_to> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib" .
<R-MP> <Has_modality> "Chemotherapy" .
<Bu/TT/Cy,_then_auto_HSCT> <Has_accepted_use> "CNS_lymphoma" .
<GMALL-R> <Has_supportive_med> "Folinic_acid" .
<Leucokain> <Brand_name_of> "Filgrastim" .
<VMCP> <Mapped_from> "VMCP" .
<mFOLFOX6_and_Bevacizumab> <Maps_to> "mFOLFOX6_and_Bevacizumab" .
<Fosavance> <Brand_name_of> "Alendronate" .
<VcR-CVAD> <Is_a> "Rituximab-containing_regimen" .
<VcR-CVAD> <Is_a> "Anthracycline-containing_regimen" .
<VAMP_(Methotrexate)> <Has_antineoplastic> "Vinblastine" .
<VAMP_(Methotrexate)> <Has_antineoplastic> "Prednisone" .
<VAMP_(Methotrexate)> <Has_antineoplastic> "Methotrexate" .
<VAMP_(Methotrexate)> <Has_antineoplastic> "Doxorubicin" .
<Uveal_melanoma> <Accepted_use_of> "Temozolomide_monotherapy" .
<Uveal_melanoma> <Accepted_use_of> "Temozolomide" .
<Uveal_melanoma> <Accepted_use_of> "TILs" .
<Uveal_melanoma> <Accepted_use_of> "TACE" .
<Uveal_melanoma> <Accepted_use_of> "Fotemustine_monotherapy" .
<Uveal_melanoma> <Accepted_use_of> "Fotemustine" .
<Uveal_melanoma> <Accepted_use_of> "Dacarbazine_monotherapy" .
<Uveal_melanoma> <Accepted_use_of> "Dacarbazine" .
<Cisplatin,_Pemetrexed,_Pembrolizumab> <Has_supportive_med> "Steroids" .
<Cisplatin,_Pemetrexed,_Pembrolizumab> <Has_supportive_med> "Folic_acid" .
<Cisplatin,_Pemetrexed,_Pembrolizumab> <Has_supportive_med> "Cyanocobalamin" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_local_therapy> "Methylprednisolone" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_local_therapy> "Methotrexate" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_local_therapy> "Cytarabine" .
<Bleomycin_and_Vinblastine> <Mapped_from> "Bleomycin_and_Vinblastine" .
<Sipuleucel-T> <May_have_route> "Intravenous" .
<Bleomycin_and_Vinblastine> <Has_antineoplastic> "Vinblastine" .
<Bleomycin_and_Vinblastine> <Has_antineoplastic> "Bleomycin" .
<mFOLFOX7> <Is_current_in> "Colon_cancer" .
<Mitotane_and_Streptozocin> <Has_antineoplastic> "Streptozocin" .
<Mitotane_and_Streptozocin> <Has_antineoplastic> "Mitotane" .
<Toremifene_monotherapy> <Maps_to> "Toremifene_monotherapy" .
<CLF> <Has_modality> "Chemotherapy" .
<Brentuximab_vedotin_and_Dacarbazine> <Mapped_from> "Brentuximab_vedotin_and_Dacarbazine" .
<PVD> <Has_supportive_med> "Warfarin" .
<PVD> <Has_supportive_med> "Low_molecular_weight_heparins" .
<PVD> <Has_supportive_med> "Aspirin" .
<PVD> <Has_supportive_med> "Acyclovir" .
<Interferon_alfa-2b_monotherapy> <Has_accepted_use> "Systemic_mastocytosis" .
<Interferon_alfa-2b_monotherapy> <Has_accepted_use> "Renal_cell_carcinoma" .
<Interferon_alfa-2b_monotherapy> <Has_accepted_use> "Neuroendocrine_tumor" .
<Interferon_alfa-2b_monotherapy> <Has_accepted_use> "Multiple_myeloma" .
<Interferon_alfa-2b_monotherapy> <Has_accepted_use> "Melanoma" .
<Interferon_alfa-2b_monotherapy> <Has_accepted_use> "Kaposi_sarcoma" .
<Interferon_alfa-2b_monotherapy> <Has_accepted_use> "Hairy_cell_leukemia" .
<Interferon_alfa-2b_monotherapy> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<EPIC_regimen> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Systemic_mastocytosis> <Is_a> "Myeloproliferative_neoplasm" .
<VDC> <Is_current_in> "Multiple_myeloma" .
<VDC> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<Interferon_alfa_and_Dexamethasone> <Has_accepted_use> "Multiple_myeloma" .
<Ontruzant> <Brand_name_of> "Trastuzumab-dttb" .
<Fludarabine,_Cyclophosphamide,_ATG> <Is_current_in> "Allogeneic_HSCT" .
<Irinotecan,_Vemurafenib,_Cetuximab> <Is_a> "Irinotecan-containing_regimen" .
<Cabazitaxel> <May_have_route> "Intravenous" .
<Pharmaniaga> <Brand_name_of> "Acyclovir" .
<Tranexamic_acid> <May_have_route> "Oral" .
<Tranexamic_acid> <May_have_route> "Intravenous" .
<BLD> <Has_antineoplastic> "Lenalidomide" .
<BLD> <Has_antineoplastic> "Dexamethasone" .
<BLD> <Has_antineoplastic> "Bendamustine" .
<Alenost> <Brand_name_of> "Alendronate" .
<R-FM> <Has_antineoplastic> "Rituximab" .
<R-FM> <Has_antineoplastic> "Mitoxantrone" .
<R-FM> <Has_antineoplastic> "Fludarabine" .
<Beneflur> <Brand_name_of> "Fludarabine" .
<VAMP> <Mapped_from> "VAMP" .
<MF> <Has_modality> "Chemotherapy" .
<Chloraminophene> <Brand_name_of> "Chlorambucil" .
<Alemtuzumab_monotherapy> <Has_supportive_med> "Valacyclovir" .
<Alemtuzumab_monotherapy> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Alemtuzumab_monotherapy> <Has_supportive_med> "Sargramostim" .
<Alemtuzumab_monotherapy> <Has_supportive_med> "Pentamidine" .
<Alemtuzumab_monotherapy> <Has_supportive_med> "Hydrocortisone" .
<Alemtuzumab_monotherapy> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Alemtuzumab_monotherapy> <Has_supportive_med> "Famciclovir" .
<Alemtuzumab_monotherapy> <Has_supportive_med> "Diphenhydramine" .
<Alemtuzumab_monotherapy> <Has_supportive_med> "Dapsone" .
<Alemtuzumab_monotherapy> <Has_supportive_med> "Ciprofloxacin" .
<Alemtuzumab_monotherapy> <Has_supportive_med> "Cimetidine" .
<Alemtuzumab_monotherapy> <Has_supportive_med> "Acyclovir" .
<Alemtuzumab_monotherapy> <Has_supportive_med> "Acetaminophen" .
<Clofarabine_and_LoDAC/Decitabine> <Is_current_in> "Acute_myeloid_leukemia" .
<Pertuzumab> <May_have_route> "Intravenous" .
<Novo-Seven> <Brand_name_of> "Factor_VIIa_recombinant" .
<FOLFIRI_and_Cetuximab_(L-Leucovorin)> <Maps_to> "FOLFIRI_and_Cetuximab_(L-Leucovorin)" .
<Cellular_therapy> <Is_a> "Immunotherapeutic" .
<Cellular_therapy> <Is_a> "Biologic_product" .
<RD> <Is_historical_in> "Multiple_myeloma" .
<DICEP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Advagraf> <Brand_name_of> "Tacrolimus" .
<Cisplatin,_Etoposide,_RT> <Mapped_from> "Cisplatin,_Etoposide,_RT" .
<Doxorubicin_and_Ifosfamide> <Is_a> "Anthracycline-containing_regimen" .
<Ultrazole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<7_plus_3d_and_Sorafenib> <Is_current_in> "Acute_myeloid_leukemia" .
<Daunorubicin_and_Prednisone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<ViraferonPeg> <Brand_name_of> "Peginterferon_alfa-2b" .
<Epirubicin> <Has_brand_name> "Rubifarm" .
<Epirubicin> <Has_brand_name> "Riboepi" .
<Epirubicin> <Has_brand_name> "Pharmorubicin" .
<Epirubicin> <Has_brand_name> "Farmorubicine" .
<Epirubicin> <Has_brand_name> "Farmorubicina" .
<Epirubicin> <Has_brand_name> "Farmorubicin" .
<Epirubicin> <Has_brand_name> "Famorubicin" .
<Epirubicin> <Has_brand_name> "Eracin" .
<Epirubicin> <Has_brand_name> "Epricin" .
<Epirubicin> <Has_brand_name> "Epizin" .
<Epirubicin> <Has_brand_name> "Epirubicine" .
<Epirubicin> <Has_brand_name> "Epilem" .
<Epirubicin> <Has_brand_name> "Epifil" .
<Epirubicin> <Has_brand_name> "Epidoxo" .
<Epirubicin> <Has_brand_name> "Ellence" .
<Epirubicin> <Has_brand_name> "E.P.R_Elvetium" .
<Epirubicin> <Has_brand_name> "Crisabon" .
<Epirubicin> <Has_brand_name> "Bioepicyna" .
<Epirubicin> <Has_brand_name> "Binarin" .
<Epirubicin> <Has_brand_name> "Anthracin" .
<Epirubicin> <Has_brand_name> "Alrubicin" .
<GCP> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<GCP> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<GCP> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<Nilutamide_and_Orchiectomy> <Has_antineoplastic> "Nilutamide" .
<Nilutamide_and_Orchiectomy> <Has_antineoplastic> "Endocrine_ablation_surgery" .
<CVP_(Vinblastine/Prednisone)> <Mapped_from> "CVP_(Vinblastine/Prednisone)" .
<Thiotepa_monotherapy> <Has_context> "Non-curative_therapy" .
<Thiotepa_monotherapy> <Has_context> "Local_therapy" .
<Thiotepa_monotherapy> <Has_context> "Adjuvant_therapy" .
<Metrexan> <Brand_name_of> "Methotrexate" .
<Talimogene_laherparepvec> <Has_accepted_use> "Melanoma" .
<Capsain> <Brand_name_of> "Caspofungin" .
<Carboplatin_and_Pemetrexed> <Is_current_in> "Non-small_cell_lung_cancer" .
<Carboplatin_and_Pemetrexed> <Is_current_in> "Mesothelioma" .
<Mepolizumab_monotherapy> <Has_context> "All_lines_of_therapy" .
<R-DHAP> <Has_local_therapy> "Methotrexate" .
<R-DHAP> <Has_local_therapy> "Cytarabine" .
<Avapritinib> <Antineoplastic_of> "Avapritinib_monotherapy" .
<MOPP> <Mapped_from> "MOPP" .
<Augmented_BFM_consolidation> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Anti-c-Met_antibody> <Subsumes> "Onartuzumab" .
<R-BEAM,_then_auto_HSCT> <Is_a> "Rituximab-containing_regimen" .
<MPT> <Maps_to> "MPT" .
<Ziv-aflibercept> <Antineoplastic_of> "FOLFIRI_and_Ziv-aflibercept" .
<Extranodal_NK-_and_T-cell_lymphoma_nasal_type> <Is_a> "T-cell_lymphoma" .
<Cytarabine> <May_have_route> "Subcutaneous" .
<Cytarabine> <May_have_route> "Intravenous" .
<Cytarabine> <May_have_route> "Intrathecal" .
<VMPT> <Is_current_in> "Multiple_myeloma" .
<Rho(D)_immune_globulin> <May_have_route> "Intravenous" .
<Plicamycin_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<ATRA,_Mercaptopurine,_Methotrexate> <Maps_to> "ATRA,_Mercaptopurine,_Methotrexate" .
<Danaparoid> <May_have_route> "Subcutaneous" .
<Asaphen> <Brand_name_of> "Aspirin" .
<CM> <Mapped_from> "CM" .
<Epoetin_alfa> <Has_brand_name> "Wepox" .
<Epoetin_alfa> <Has_brand_name> "Vintor" .
<Epoetin_alfa> <Has_brand_name> "Vepox" .
<Epoetin_alfa> <Has_brand_name> "Recormon" .
<Epoetin_alfa> <Has_brand_name> "Procrit" .
<Epoetin_alfa> <Has_brand_name> "LG_Espogen" .
<Epoetin_alfa> <Has_brand_name> "Hemax" .
<Epoetin_alfa> <Has_brand_name> "Hemapo" .
<Epoetin_alfa> <Has_brand_name> "Globuren" .
<Epoetin_alfa> <Has_brand_name> "Espo" .
<Epoetin_alfa> <Has_brand_name> "Erythrostim" .
<Epoetin_alfa> <Has_brand_name> "Erypo" .
<Epoetin_alfa> <Has_brand_name> "Eritrelan" .
<Epoetin_alfa> <Has_brand_name> "Eprex" .
<Epoetin_alfa> <Has_brand_name> "Epoyet" .
<Epoetin_alfa> <Has_brand_name> "Epox" .
<Epoetin_alfa> <Has_brand_name> "Epopen" .
<Epoetin_alfa> <Has_brand_name> "Epomax" .
<Epoetin_alfa> <Has_brand_name> "Epoimmun" .
<Epoetin_alfa> <Has_brand_name> "Epogin" .
<Epoetin_alfa> <Has_brand_name> "Epogen" .
<Epoetin_alfa> <Has_brand_name> "Epofer" .
<Epoetin_alfa> <Has_brand_name> "Epoch" .
<Epoetin_alfa> <Has_brand_name> "Dynepo" .
<Epoetin_alfa> <Has_brand_name> "Ceriton" .
<Cisplatin,_Pemetrexed,_TTFields> <Has_antineoplastic> "Pemetrexed" .
<Cisplatin,_Pemetrexed,_TTFields> <Has_antineoplastic> "NovoTTF-100A_system_(Optune)" .
<Cisplatin,_Pemetrexed,_TTFields> <Has_antineoplastic> "Cisplatin" .
<ACVBP-R> <Is_a> "Rituximab-containing_regimen" .
<ACVBP-R> <Is_a> "Anthracycline-containing_regimen" .
<MVP_(Vindesine)> <Has_context> "Non-curative_first-line_therapy" .
<Tegafur_and_uracil> <Antineoplastic_of> "UFTM" .
<Tegafur_and_uracil> <Antineoplastic_of> "UFT_monotherapy" .
<Tegafur_and_uracil> <Antineoplastic_of> "Tegafur,_Uracil,_Folinic_acid" .
<Tegafur_and_uracil> <Antineoplastic_of> "Tegafur_and_Uracil" .
<Mitoxantrone_and_Hydrocortisone> <Has_modality> "Hormonotherapy" .
<Mitoxantrone_and_Hydrocortisone> <Has_modality> "Chemotherapy" .
<Rasburicase> <Supportive_med_of> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Rasburicase> <Supportive_med_of> "dmCODOX-M_-_Modified_Magrath" .
<Rasburicase> <Supportive_med_of> "Hyper-CVAD_and_Ponatinib" .
<Rasburicase> <Supportive_med_of> "Hyper-CVAD_and_Imatinib" .
<Rasburicase> <Supportive_med_of> "Hyper-CVAD_and_Dasatinib" .
<Rasburicase> <Supportive_med_of> "G-FC" .
<Rasburicase> <Supportive_med_of> "Bendamustine_and_Ofatumumab" .
<Rasburicase> <Supportive_med_of> "Bendamustine_and_Obinutuzumab" .
<Bortezomib,_Dexamethasone,_Panobinostat> <Has_context> "Non-curative_therapy" .
<Glymesason> <Brand_name_of> "Dexamethasone" .
<MATRix> <Has_accepted_use> "CNS_lymphoma" .
<GDPT> <Has_context> "Induction_therapy" .
<Cisplatin,_Pemetrexed,_Bevacizumab> <Has_modality> "Chemotherapy" .
<KPD> <Has_antineoplastic> "Pomalidomide" .
<KPD> <Has_antineoplastic> "Dexamethasone" .
<KPD> <Has_antineoplastic> "Carfilzomib" .
<Arsenic_trioxide> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Arsenic_trioxide> <Is_a> "Mutation-specific_medication" .
<R-CEOP90_(Epirubicin)> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Bortezomib> <Has_FDA_indication> "Multiple_myeloma" .
<Bortezomib> <Has_FDA_indication> "Mantle_cell_lymphoma" .
<Letrozole_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Letrozole_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Letrozole_monotherapy> <Has_context> "Neoadjuvant_therapy" .
<Letrozole_monotherapy> <Has_context> "Adjuvant_therapy" .
<Mistabronco> <Brand_name_of> "Mesna" .
<Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone> <Is_historical_in> "Acute_myeloid_leukemia" .
<Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT> <Is_historical_in> "Multiple_myeloma" .
<MVAC,_dose-dense> <Maps_to> "MVAC,_dose-dense" .
<Nimustine_and_RT> <Maps_to> "Nimustine_and_RT" .
<ACVBP> <Maps_to> "ACVBP" .
<Accusite> <Brand_name_of> "Fluorouracil" .
<Cyclophosphamide_monotherapy> <Has_antineoplastic> "Cyclophosphamide" .
<Interferon_alfa-2b_and_Thalidomide> <Maps_to> "Interferon_alfa-2b_and_Thalidomide" .
<Tricomox> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<IT_Methotrexate_monotherapy> <Mapped_from> "IT_Methotrexate_monotherapy" .
<Clarithromycin_monotherapy> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Ferumoxytol> <Is_a> "Iron" .
<Ferumoxytol> <Is_a> "Hematology_medication" .
<Gynodron> <Brand_name_of> "Alendronate" .
<Aspirin> <Is_a> "WHO_Essential_Pain_and_Palliative_Care_Medicine" .
<Aspirin> <Is_a> "OTC_medication" .
<Aspirin> <Is_a> "COX-1_inhibitor" .
<Aspirin> <Is_a> "Antipyretic" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine> <Has_context> "Induction_therapy" .
<Nordic_Regimen,_younger_patients> <Is_a> "Rituximab-containing_regimen" .
<Carboplatin_and_Pemetrexed> <Has_context> "Non-curative_therapy" .
<Carboplatin_and_Pemetrexed> <Has_context> "Non-curative_second-line_therapy" .
<Carboplatin_and_Pemetrexed> <Has_context> "Non-curative_first-line_therapy" .
<Capecitabine,_Carboplatin,_Paclitaxel,_RT> <Has_modality> "Radiotherapy" .
<Capecitabine,_Carboplatin,_Paclitaxel,_RT> <Has_modality> "Chemotherapy" .
<T-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Prednisone_monotherapy" .
<T-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Nelarabine_monotherapy" .
<T-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone" .
<T-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone" .
<T-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Methotrexate,_Pegaspargase,_Vincristine" .
<T-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Mercaptopurine,_Methotrexate,_Vincristine" .
<T-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "L-asparaginase_monotherapy" .
<T-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Etoposide_and_TBI,_then_allo_HSCT" .
<T-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone" .
<T-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone" .
<T-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone" .
<T-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "DOLP" .
<T-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<T-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine" .
<T-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine" .
<R-FCM> <Mapped_from> "R-FCM" .
<Lomustine,_Vincristine,_Prednisone> <Has_accepted_use> "Anaplastic_glioma" .
<Vantas> <Brand_name_of> "Histrelin" .
<Hyper-CVAD> <Mapped_from> "Hyper-CVAD" .
<Follicular_lymphoma> <Accepted_use_of> "Vorinostat_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Vorinostat_and_Rituximab" .
<Follicular_lymphoma> <Accepted_use_of> "Vorinostat" .
<Follicular_lymphoma> <Accepted_use_of> "Vincristine" .
<Follicular_lymphoma> <Accepted_use_of> "VR-CP" .
<Follicular_lymphoma> <Accepted_use_of> "VR-CHOP" .
<Follicular_lymphoma> <Accepted_use_of> "VR" .
<Follicular_lymphoma> <Accepted_use_of> "Tositumomab_&_I-131" .
<Follicular_lymphoma> <Accepted_use_of> "Temsirolimus_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Temsirolimus" .
<Follicular_lymphoma> <Accepted_use_of> "Rituximab-pvvr" .
<Follicular_lymphoma> <Accepted_use_of> "Rituximab-abbs" .
<Follicular_lymphoma> <Accepted_use_of> "Rituximab_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Rituximab_and_hyaluronidase_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Rituximab_and_hyaluronidase_human" .
<Follicular_lymphoma> <Accepted_use_of> "Rituximab" .
<Follicular_lymphoma> <Accepted_use_of> "Radiation_therapy" .
<Follicular_lymphoma> <Accepted_use_of> "R-TBI/Cy,_then_auto_HSCT" .
<Follicular_lymphoma> <Accepted_use_of> "R-MCP" .
<Follicular_lymphoma> <Accepted_use_of> "R-INO" .
<Follicular_lymphoma> <Accepted_use_of> "R-FND" .
<Follicular_lymphoma> <Accepted_use_of> "R-FM" .
<Follicular_lymphoma> <Accepted_use_of> "R-FCM" .
<Follicular_lymphoma> <Accepted_use_of> "R-DexaBEAM" .
<Follicular_lymphoma> <Accepted_use_of> "R-CVP" .
<Follicular_lymphoma> <Accepted_use_of> "R-CMD" .
<Follicular_lymphoma> <Accepted_use_of> "R-CHVP_plus_I" .
<Follicular_lymphoma> <Accepted_use_of> "R-CHOP" .
<Follicular_lymphoma> <Accepted_use_of> "R-BEAM,_then_auto_HSCT" .
<Follicular_lymphoma> <Accepted_use_of> "Procarbazine" .
<Follicular_lymphoma> <Accepted_use_of> "ProMACE-MOPP" .
<Follicular_lymphoma> <Accepted_use_of> "Prednisone" .
<Follicular_lymphoma> <Accepted_use_of> "Prednisolone" .
<Follicular_lymphoma> <Accepted_use_of> "Placebo" .
<Follicular_lymphoma> <Accepted_use_of> "Pidilizumab" .
<Follicular_lymphoma> <Accepted_use_of> "PEP-C" .
<Follicular_lymphoma> <Accepted_use_of> "PCR" .
<Follicular_lymphoma> <Accepted_use_of> "Ofatumumab_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Ofatumumab" .
<Follicular_lymphoma> <Accepted_use_of> "Observation" .
<Follicular_lymphoma> <Accepted_use_of> "Obinutuzumab_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Obinutuzumab" .
<Follicular_lymphoma> <Accepted_use_of> "O-CHOP" .
<Follicular_lymphoma> <Accepted_use_of> "Mitoxantrone" .
<Follicular_lymphoma> <Accepted_use_of> "Melphalan" .
<Follicular_lymphoma> <Accepted_use_of> "MCP_(Prednisolone)" .
<Follicular_lymphoma> <Accepted_use_of> "MCP" .
<Follicular_lymphoma> <Accepted_use_of> "Lenalidomide,_Dexamethasone,_Rituximab" .
<Follicular_lymphoma> <Accepted_use_of> "Lenalidomide_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Lenalidomide_and_Rituximab" .
<Follicular_lymphoma> <Accepted_use_of> "Lenalidomide" .
<Follicular_lymphoma> <Accepted_use_of> "Interferon_alfa-2a_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Interferon_alfa-2a" .
<Follicular_lymphoma> <Accepted_use_of> "Interferon_alfa_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Inotuzumab_ozogamicin_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Inotuzumab_ozogamicin" .
<Follicular_lymphoma> <Accepted_use_of> "Idelalisib_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Idelalisib" .
<Follicular_lymphoma> <Accepted_use_of> "Ibrutinib_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Ibrutinib" .
<Follicular_lymphoma> <Accepted_use_of> "Ibritumomab_tiuxetan_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Ibritumomab_tiuxetan" .
<Follicular_lymphoma> <Accepted_use_of> "G-CVP" .
<Follicular_lymphoma> <Accepted_use_of> "G-CHOP" .
<Follicular_lymphoma> <Accepted_use_of> "Fludarabine,_then_131Iodine-Tositumomab" .
<Follicular_lymphoma> <Accepted_use_of> "Fludarabine_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Fludarabine" .
<Follicular_lymphoma> <Accepted_use_of> "FR" .
<Follicular_lymphoma> <Accepted_use_of> "FND" .
<Follicular_lymphoma> <Accepted_use_of> "FMP" .
<Follicular_lymphoma> <Accepted_use_of> "FM" .
<Follicular_lymphoma> <Accepted_use_of> "FCR,_then_allo_HSCT" .
<Follicular_lymphoma> <Accepted_use_of> "FCM" .
<Follicular_lymphoma> <Accepted_use_of> "FC" .
<Follicular_lymphoma> <Accepted_use_of> "Etoposide" .
<Follicular_lymphoma> <Accepted_use_of> "Duvelisib_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Duvelisib" .
<Follicular_lymphoma> <Accepted_use_of> "Doxorubicin" .
<Follicular_lymphoma> <Accepted_use_of> "Dexamethasone" .
<Follicular_lymphoma> <Accepted_use_of> "Cyclophosphamide_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Cyclophosphamide_and_TBI,_then_auto_HSCT" .
<Follicular_lymphoma> <Accepted_use_of> "Cyclophosphamide" .
<Follicular_lymphoma> <Accepted_use_of> "Copanlisib_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Copanlisib" .
<Follicular_lymphoma> <Accepted_use_of> "Chlorambucil_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Chlorambucil" .
<Follicular_lymphoma> <Accepted_use_of> "Carmustine" .
<Follicular_lymphoma> <Accepted_use_of> "CVP,_then_131Iodine-Tositumomab" .
<Follicular_lymphoma> <Accepted_use_of> "CVP" .
<Follicular_lymphoma> <Accepted_use_of> "COPA" .
<Follicular_lymphoma> <Accepted_use_of> "CHVP-I" .
<Follicular_lymphoma> <Accepted_use_of> "CHVP" .
<Follicular_lymphoma> <Accepted_use_of> "CHOP-B" .
<Follicular_lymphoma> <Accepted_use_of> "CHOP,_then_131Iodine-Tositumomab" .
<Follicular_lymphoma> <Accepted_use_of> "CHOP" .
<Follicular_lymphoma> <Accepted_use_of> "Bortezomib_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Bortezomib" .
<Follicular_lymphoma> <Accepted_use_of> "Bevacizumab-bvzr" .
<Follicular_lymphoma> <Accepted_use_of> "Bevacizumab-awwb" .
<Follicular_lymphoma> <Accepted_use_of> "Bevacizumab_and_Rituximab" .
<Follicular_lymphoma> <Accepted_use_of> "Bevacizumab" .
<Follicular_lymphoma> <Accepted_use_of> "Bendamustine_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "Bendamustine_and_Ofatumumab" .
<Follicular_lymphoma> <Accepted_use_of> "Bendamustine_and_Obinutuzumab" .
<Follicular_lymphoma> <Accepted_use_of> "Bendamustine" .
<Follicular_lymphoma> <Accepted_use_of> "BVR" .
<Follicular_lymphoma> <Accepted_use_of> "BR" .
<Follicular_lymphoma> <Accepted_use_of> "Abexinostat" .
<Follicular_lymphoma> <Accepted_use_of> "131Iodine-Tositumomab_monotherapy" .
<Follicular_lymphoma> <Accepted_use_of> "(90)YFC,_then_allo_HSCT" .
<Crizanlizumab_monotherapy> <Has_accepted_use> "Sickle_cell_anemia" .
<Cytarabine_and_Idarubicin> <Has_context> "Non-curative_therapy" .
<Cytarabine_and_Idarubicin> <Has_context> "Consolidation_after_upfront_therapy" .
<HER2-positive_Breast_cancer> <Is_a> "Breast_cancer" .
<MPR> <Has_modality> "Chemotherapy" .
<EPIC_regimen> <Has_antineoplastic> "Prednisolone" .
<EPIC_regimen> <Has_antineoplastic> "Ifosfamide" .
<EPIC_regimen> <Has_antineoplastic> "Etoposide" .
<EPIC_regimen> <Has_antineoplastic> "Carboplatin" .
<MT-R> <Is_a> "Rituximab-containing_regimen" .
<Interferon_alfa-2b_and_Thalidomide> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Pemetrexed_and_Pembrolizumab> <Has_supportive_med> "Steroids" .
<Pemetrexed_and_Pembrolizumab> <Has_supportive_med> "Folic_acid" .
<Pemetrexed_and_Pembrolizumab> <Has_supportive_med> "Cyanocobalamin" .
<Bismoral> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Allenmax> <Brand_name_of> "Alendronate" .
<Zytiga> <Brand_name_of> "Abiraterone" .
<Teniposide_and_WBRT> <Mapped_from> "Teniposide_and_WBRT" .
<Nexavar> <Brand_name_of> "Sorafenib" .
<Lodexa> <Brand_name_of> "Dexamethasone" .
<VBMCP> <Has_context> "Non-curative_first-line_therapy" .
<FC,_then_allo_HSCT> <Is_historical_in> "Renal_cell_carcinoma" .
<Vincristine_and_Prednisone> <Maps_to> "Vincristine_and_Prednisone" .
<Bacillus_Calmette-Guerin_(BCG)_monotherapy> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Bacillus_Calmette-Guerin_(BCG)_monotherapy> <Is_historical_in> "Hodgkin_lymphoma" .
<Bacillus_Calmette-Guerin_(BCG)_monotherapy> <Is_historical_in> "Colon_cancer" .
<Bacillus_Calmette-Guerin_(BCG)_monotherapy> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<Heparin_monotherapy> <Has_modality> "Anticoagulation" .
<Acetylsalicylsaeure> <Brand_name_of> "Aspirin" .
<Ninlaro> <Brand_name_of> "Ixazomib" .
<Vincristine> <Antineoplastic_of> "maxi-R-CHOP/R-HiDAC" .
<Vincristine> <Antineoplastic_of> "mLSG15" .
<Vincristine> <Antineoplastic_of> "mCOP/MP" .
<Vincristine> <Antineoplastic_of> "m-BNCOD" .
<Vincristine> <Antineoplastic_of> "m-BACOD" .
<Vincristine> <Antineoplastic_of> "eBEACOPP_(Prednisolone)" .
<Vincristine> <Antineoplastic_of> "eBEACOPP" .
<Vincristine> <Antineoplastic_of> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Vincristine> <Antineoplastic_of> "dmCODOX-M_-_Modified_Magrath" .
<Vincristine> <Antineoplastic_of> "Vincristine_monotherapy" .
<Vincristine> <Antineoplastic_of> "Vincristine_and_Prednisone" .
<Vincristine> <Antineoplastic_of> "VcR-CVAD" .
<Vincristine> <Antineoplastic_of> "VR-CHOP" .
<Vincristine> <Antineoplastic_of> "VNCOP-B" .
<Vincristine> <Antineoplastic_of> "VMV-VAC" .
<Vincristine> <Antineoplastic_of> "VMCP/VCAP" .
<Vincristine> <Antineoplastic_of> "VMCP/VBAP" .
<Vincristine> <Antineoplastic_of> "VMCP" .
<Vincristine> <Antineoplastic_of> "VIE" .
<Vincristine> <Antineoplastic_of> "VIDE" .
<Vincristine> <Antineoplastic_of> "VI,_then_VDC/IE,_then_VAC,_then_VI" .
<Vincristine> <Antineoplastic_of> "VEPA" .
<Vincristine> <Antineoplastic_of> "VDC/IE" .
<Vincristine> <Antineoplastic_of> "VCP" .
<Vincristine> <Antineoplastic_of> "VBMCP/VBAD" .
<Vincristine> <Antineoplastic_of> "VBMCP" .
<Vincristine> <Antineoplastic_of> "VBMC" .
<Vincristine> <Antineoplastic_of> "VBM" .
<Vincristine> <Antineoplastic_of> "VAdCA/IE" .
<Vincristine> <Antineoplastic_of> "VAdCA" .
<Vincristine> <Antineoplastic_of> "VAP" .
<Vincristine> <Antineoplastic_of> "VAMP_(Amethopterin)" .
<Vincristine> <Antineoplastic_of> "VAMP" .
<Vincristine> <Antineoplastic_of> "VAIA" .
<Vincristine> <Antineoplastic_of> "VAI" .
<Vincristine> <Antineoplastic_of> "VAD-P/Q" .
<Vincristine> <Antineoplastic_of> "VAD-P" .
<Vincristine> <Antineoplastic_of> "VAD_plus_C" .
<Vincristine> <Antineoplastic_of> "VAD_doxil" .
<Vincristine> <Antineoplastic_of> "VAD_and_Cyclosporine" .
<Vincristine> <Antineoplastic_of> "VAD" .
<Vincristine> <Antineoplastic_of> "VACOP-B" .
<Vincristine> <Antineoplastic_of> "VACA/IE" .
<Vincristine> <Antineoplastic_of> "VACA" .
<Vincristine> <Antineoplastic_of> "VAC_(Adriamycin)" .
<Vincristine> <Antineoplastic_of> "VAC" .
<Vincristine> <Antineoplastic_of> "VABE" .
<Vincristine> <Antineoplastic_of> "VA" .
<Vincristine> <Antineoplastic_of> "TVAD_doxil" .
<Vincristine> <Antineoplastic_of> "TC,_then_IE,_VDoxoC,_VEC" .
<Vincristine> <Antineoplastic_of> "Stanford_V" .
<Vincristine> <Antineoplastic_of> "SC-EPOCH-RR" .
<Vincristine> <Antineoplastic_of> "R2CHOP" .
<Vincristine> <Antineoplastic_of> "R-miniCHOP" .
<Vincristine> <Antineoplastic_of> "R-VAD_plus_C" .
<Vincristine> <Antineoplastic_of> "R-MegaCHOP-14" .
<Vincristine> <Antineoplastic_of> "R-MegaCHOP" .
<Vincristine> <Antineoplastic_of> "R-MPV" .
<Vincristine> <Antineoplastic_of> "R-MACLO/R-IVAM" .
<Vincristine> <Antineoplastic_of> "R-M-CHOP" .
<Vincristine> <Antineoplastic_of> "R-Hyper-CVAD/R-MA" .
<Vincristine> <Antineoplastic_of> "R-GCVP" .
<Vincristine> <Antineoplastic_of> "R-EPOCH,_dose-escalated" .
<Vincristine> <Antineoplastic_of> "R-EPOCH" .
<Vincristine> <Antineoplastic_of> "R-CVP" .
<Vincristine> <Antineoplastic_of> "R-COPADM" .
<Vincristine> <Antineoplastic_of> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Vincristine> <Antineoplastic_of> "R-CODOX-M/R-IVAC" .
<Vincristine> <Antineoplastic_of> "R-CODOX-M_(Doxil_substituted)" .
<Vincristine> <Antineoplastic_of> "R-CODOX-M" .
<Vincristine> <Antineoplastic_of> "R-CHOP/R-DHAP" .
<Vincristine> <Antineoplastic_of> "R-CHOP-14_(Rituximab_Hycela)" .
<Vincristine> <Antineoplastic_of> "R-CHOP-14_(Prednisolone)" .
<Vincristine> <Antineoplastic_of> "R-CHOP-14" .
<Vincristine> <Antineoplastic_of> "R-CHOP_(Rituximab_Hycela)" .
<Vincristine> <Antineoplastic_of> "R-CHOP_(Prednisolone)" .
<Vincristine> <Antineoplastic_of> "R-CHOP" .
<Vincristine> <Antineoplastic_of> "R-CHOEP-14" .
<Vincristine> <Antineoplastic_of> "R-CEOP90_(Epirubicin)" .
<Vincristine> <Antineoplastic_of> "R-CEOP_(Etoposide)" .
<Vincristine> <Antineoplastic_of> "R-CDOP" .
<Vincristine> <Antineoplastic_of> "R,_then_CHOP" .
<Vincristine> <Antineoplastic_of> "ProMACE-MOPP" .
<Vincristine> <Antineoplastic_of> "ProMACE-CytaBOM" .
<Vincristine> <Antineoplastic_of> "Pegaspargase,_Vincristine,_Prednisone" .
<Vincristine> <Antineoplastic_of> "Pediatric-like_GRAALL_consolidation" .
<Vincristine> <Antineoplastic_of> "POMP" .
<Vincristine> <Antineoplastic_of> "PMitCEBO" .
<Vincristine> <Antineoplastic_of> "PCV" .
<Vincristine> <Antineoplastic_of> "PATCO" .
<Vincristine> <Antineoplastic_of> "PACEBOM" .
<Vincristine> <Antineoplastic_of> "P/DOCE" .
<Vincristine> <Antineoplastic_of> "OPPA" .
<Vincristine> <Antineoplastic_of> "OEPA" .
<Vincristine> <Antineoplastic_of> "O-miniCHOP" .
<Vincristine> <Antineoplastic_of> "O-CHOP" .
<Vincristine> <Antineoplastic_of> "Nordic_Regimen,_younger_patients" .
<Vincristine> <Antineoplastic_of> "Nilotinib-based_consolidation" .
<Vincristine> <Antineoplastic_of> "NOVP" .
<Vincristine> <Antineoplastic_of> "Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Vincristine> <Antineoplastic_of> "Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone" .
<Vincristine> <Antineoplastic_of> "Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin" .
<Vincristine> <Antineoplastic_of> "Methotrexate,_Pegaspargase,_Vincristine" .
<Vincristine> <Antineoplastic_of> "Methotrexate_and_Vincristine" .
<Vincristine> <Antineoplastic_of> "Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone" .
<Vincristine> <Antineoplastic_of> "Mercaptopurine,_Methotrexate,_Vincristine" .
<Vincristine> <Antineoplastic_of> "MPV" .
<Vincristine> <Antineoplastic_of> "MOPP/ABVD" .
<Vincristine> <Antineoplastic_of> "MOPP-ABV" .
<Vincristine> <Antineoplastic_of> "MOPP" .
<Vincristine> <Antineoplastic_of> "MOF" .
<Vincristine> <Antineoplastic_of> "MACOP-B" .
<Vincristine> <Antineoplastic_of> "Lomustine,_Vincristine,_Prednisone" .
<Vincristine> <Antineoplastic_of> "Linker_regimen_(consolidation)" .
<Vincristine> <Antineoplastic_of> "LVP_.22Sandwich.22" .
<Vincristine> <Antineoplastic_of> "LSG15" .
<Vincristine> <Antineoplastic_of> "LOPP/EVAP" .
<Vincristine> <Antineoplastic_of> "LOPP" .
<Vincristine> <Antineoplastic_of> "LD-ACOP-B" .
<Vincristine> <Antineoplastic_of> "L-Asparaginase,_Vincristine,_Prednisone" .
<Vincristine> <Antineoplastic_of> "L-Asparaginase,_Vincristine,_Prednisolone" .
<Vincristine> <Antineoplastic_of> "L-Asparaginase,_Vincristine,_Dexamethasone" .
<Vincristine> <Antineoplastic_of> "International_ALL_Trial" .
<Vincristine> <Antineoplastic_of> "Imatinib,_Vincristine,_Prednisone" .
<Vincristine> <Antineoplastic_of> "Imatinib,_Vincristine,_Dexamethasone" .
<Vincristine> <Antineoplastic_of> "Hyper-CVAD/MA_and_Everolimus" .
<Vincristine> <Antineoplastic_of> "Hyper-CVAD/MA" .
<Vincristine> <Antineoplastic_of> "Hyper-CVAD_and_Ponatinib" .
<Vincristine> <Antineoplastic_of> "Hyper-CVAD_and_Imatinib" .
<Vincristine> <Antineoplastic_of> "Hyper-CVAD_and_Dasatinib" .
<Vincristine> <Antineoplastic_of> "Hyper-CVAD" .
<Vincristine> <Antineoplastic_of> "HOP" .
<Vincristine> <Antineoplastic_of> "GMALL-R" .
<Vincristine> <Antineoplastic_of> "G-CVP" .
<Vincristine> <Antineoplastic_of> "G-CHOP" .
<Vincristine> <Antineoplastic_of> "F-MACHOP" .
<Vincristine> <Antineoplastic_of> "EVAIA" .
<Vincristine> <Antineoplastic_of> "EPOCH,_dose-escalated" .
<Vincristine> <Antineoplastic_of> "EPOCH" .
<Vincristine> <Antineoplastic_of> "EMA-CO" .
<Vincristine> <Antineoplastic_of> "Doxorubicin,_Methotrexate,_Vincristine,_Prednisone" .
<Vincristine> <Antineoplastic_of> "Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone" .
<Vincristine> <Antineoplastic_of> "Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone" .
<Vincristine> <Antineoplastic_of> "Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib" .
<Vincristine> <Antineoplastic_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone" .
<Vincristine> <Antineoplastic_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Vincristine> <Antineoplastic_of> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib" .
<Vincristine> <Antineoplastic_of> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Vincristine> <Antineoplastic_of> "Dasatinib,_Vincristine,_Prednisone" .
<Vincristine> <Antineoplastic_of> "Dactinomycin_and_Vincristine" .
<Vincristine> <Antineoplastic_of> "DOLP_(Prednisolone)" .
<Vincristine> <Antineoplastic_of> "DOLP" .
<Vincristine> <Antineoplastic_of> "DD-CHOP" .
<Vincristine> <Antineoplastic_of> "DA-R-EPOCH" .
<Vincristine> <Antineoplastic_of> "DA-EPOCH" .
<Vincristine> <Antineoplastic_of> "D-ZAPO" .
<Vincristine> <Antineoplastic_of> "Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone" .
<Vincristine> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_Vincristine" .
<Vincristine> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone" .
<Vincristine> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone" .
<Vincristine> <Antineoplastic_of> "Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone" .
<Vincristine> <Antineoplastic_of> "Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone" .
<Vincristine> <Antineoplastic_of> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone" .
<Vincristine> <Antineoplastic_of> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone" .
<Vincristine> <Antineoplastic_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab" .
<Vincristine> <Antineoplastic_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Vincristine> <Antineoplastic_of> "Cyclophosphamide,_Dacarbazine,_Vincristine" .
<Vincristine> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone" .
<Vincristine> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine" .
<Vincristine> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine" .
<Vincristine> <Antineoplastic_of> "Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide" .
<Vincristine> <Antineoplastic_of> "Cyclophosphamide_and_Vincristine" .
<Vincristine> <Antineoplastic_of> "Cisplatin,_Lomustine,_Vincristine" .
<Vincristine> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_Vincristine" .
<Vincristine> <Antineoplastic_of> "ChlVPP/PABIOE" .
<Vincristine> <Antineoplastic_of> "ChlVPP/EVA" .
<Vincristine> <Antineoplastic_of> "Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine" .
<Vincristine> <Antineoplastic_of> "Carboplatin_and_Vincristine" .
<Vincristine> <Antineoplastic_of> "Calaspargase,_Daunorubicin,_Vincristine,_Prednisone" .
<Vincristine> <Antineoplastic_of> "CVP,_then_131Iodine-Tositumomab" .
<Vincristine> <Antineoplastic_of> "CVP_(Prednisolone)" .
<Vincristine> <Antineoplastic_of> "CVP" .
<Vincristine> <Antineoplastic_of> "CVAP" .
<Vincristine> <Antineoplastic_of> "CVAD" .
<Vincristine> <Antineoplastic_of> "COPP/ABVD" .
<Vincristine> <Antineoplastic_of> "COPP_(CCNU)" .
<Vincristine> <Antineoplastic_of> "COPDAC" .
<Vincristine> <Antineoplastic_of> "COPADM" .
<Vincristine> <Antineoplastic_of> "COPAD/CYVE" .
<Vincristine> <Antineoplastic_of> "COPAD" .
<Vincristine> <Antineoplastic_of> "COPA" .
<Vincristine> <Antineoplastic_of> "COP-Bleo" .
<Vincristine> <Antineoplastic_of> "COP" .
<Vincristine> <Antineoplastic_of> "COMP" .
<Vincristine> <Antineoplastic_of> "CODOX-M/IVAC" .
<Vincristine> <Antineoplastic_of> "CODOX-M" .
<Vincristine> <Antineoplastic_of> "CNOP_(Prednisolone)" .
<Vincristine> <Antineoplastic_of> "CNOP" .
<Vincristine> <Antineoplastic_of> "CMFVP" .
<Vincristine> <Antineoplastic_of> "CMFV" .
<Vincristine> <Antineoplastic_of> "CHVmP-VB" .
<Vincristine> <Antineoplastic_of> "CHOP-BCG" .
<Vincristine> <Antineoplastic_of> "CHOP-B" .
<Vincristine> <Antineoplastic_of> "CHOP-AL" .
<Vincristine> <Antineoplastic_of> "CHOP-14" .
<Vincristine> <Antineoplastic_of> "CHOP,_then_131Iodine-Tositumomab" .
<Vincristine> <Antineoplastic_of> "CHOP_and_Everolimus" .
<Vincristine> <Antineoplastic_of> "CHOP_Modified_(Prednisolone)" .
<Vincristine> <Antineoplastic_of> "CHOP_Modified" .
<Vincristine> <Antineoplastic_of> "CHOP_(Prednisolone)" .
<Vincristine> <Antineoplastic_of> "CHOP" .
<Vincristine> <Antineoplastic_of> "CHOEP-21" .
<Vincristine> <Antineoplastic_of> "CHOEP-14" .
<Vincristine> <Antineoplastic_of> "CEV_and_RT" .
<Vincristine> <Antineoplastic_of> "CEV_(Cyclophosphamide/Etoposide)" .
<Vincristine> <Antineoplastic_of> "CEV_(Cyclophosphamide/Epirubicin)" .
<Vincristine> <Antineoplastic_of> "CEV_(Carboplatin/Etoposide)" .
<Vincristine> <Antineoplastic_of> "CEOP_(Prednisolone)" .
<Vincristine> <Antineoplastic_of> "CEOP" .
<Vincristine> <Antineoplastic_of> "CCOP" .
<Vincristine> <Antineoplastic_of> "CAVE" .
<Vincristine> <Antineoplastic_of> "CAV/PE" .
<Vincristine> <Antineoplastic_of> "CAV_and_RT" .
<Vincristine> <Antineoplastic_of> "CAV" .
<Vincristine> <Antineoplastic_of> "CAP-BOP" .
<Vincristine> <Antineoplastic_of> "CALGB_8811_late_intensification" .
<Vincristine> <Antineoplastic_of> "CALGB_8811_early_intensification" .
<Vincristine> <Antineoplastic_of> "CALGB_10-002_regimen" .
<Vincristine> <Antineoplastic_of> "CAFVP" .
<Vincristine> <Antineoplastic_of> "CABO" .
<Vincristine> <Antineoplastic_of> "C-VAMP" .
<Vincristine> <Antineoplastic_of> "C-MOPP/ABV" .
<Vincristine> <Antineoplastic_of> "C-MOPP" .
<Vincristine> <Antineoplastic_of> "C-BOP" .
<Vincristine> <Antineoplastic_of> "BVD" .
<Vincristine> <Antineoplastic_of> "BO" .
<Vincristine> <Antineoplastic_of> "BEACOPP-14_(Prednisolone)" .
<Vincristine> <Antineoplastic_of> "BEACOPP-14" .
<Vincristine> <Antineoplastic_of> "BEACOPP" .
<Vincristine> <Antineoplastic_of> "BCVPP" .
<Vincristine> <Antineoplastic_of> "BCOP" .
<Vincristine> <Antineoplastic_of> "BCHOP" .
<Vincristine> <Antineoplastic_of> "BASIC" .
<Vincristine> <Antineoplastic_of> "BACO" .
<Vincristine> <Antineoplastic_of> "Augmented_Hyper-CVAD_and_Asparaginase" .
<Vincristine> <Antineoplastic_of> "Augmented_BFM_consolidation" .
<Vincristine> <Antineoplastic_of> "AVCF" .
<Vincristine> <Antineoplastic_of> "APO" .
<Vincristine> <Antineoplastic_of> "ADOC" .
<Vincristine> <Antineoplastic_of> "ACOMLA" .
<Vincristine> <Antineoplastic_of> "ABVE-PC" .
<Vincristine> <Antineoplastic_of> "ABV_(Vincristine)" .
<Vincristine> <Antineoplastic_of> "AALL0232_consolidation" .
<FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)> <Has_context> "Non-curative_first-line_therapy" .
<CBVM,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Trabectedin_monotherapy> <Has_supportive_med> "Dexamethasone" .
<Capecitabine_and_Gemcitabine> <Has_antineoplastic> "Gemcitabine" .
<Capecitabine_and_Gemcitabine> <Has_antineoplastic> "Capecitabine" .
<Stanford_V> <Has_antineoplastic> "Vincristine" .
<Stanford_V> <Has_antineoplastic> "Vinblastine" .
<Stanford_V> <Has_antineoplastic> "Prednisone" .
<Stanford_V> <Has_antineoplastic> "Mechlorethamine" .
<Stanford_V> <Has_antineoplastic> "Etoposide" .
<Stanford_V> <Has_antineoplastic> "Doxorubicin" .
<Stanford_V> <Has_antineoplastic> "Bleomycin" .
<Melphalan_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Melphalan_monotherapy> <Has_accepted_use> "Multiple_myeloma" .
<Melphalan_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Melphalan_monotherapy> <Has_accepted_use> "Autologous_HSCT" .
<Non-curative_subsequent-line_therapy> <Context_of> "nab-Paclitaxel_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Vinorelbine_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Vinorelbine_and_Bevacizumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Vinflunine_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "VH" .
<Non-curative_subsequent-line_therapy> <Context_of> "Trifluridine_and_tipiracil_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Trastuzumab_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Topotecan_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Tisagenlecleucel_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Temsirolimus_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Temozolomide_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Tamoxifen_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "TX_(Taxotere)" .
<Non-curative_subsequent-line_therapy> <Context_of> "TTR" .
<Non-curative_subsequent-line_therapy> <Context_of> "Sunitinib_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Sorafenib_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Sirolimus_and_Vorinostat" .
<Non-curative_subsequent-line_therapy> <Context_of> "Samarium-153_with_stem_cell_support" .
<Non-curative_subsequent-line_therapy> <Context_of> "S-1_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Ruxolitinib_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Rituximab_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Regorafenib_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Ramucirumab_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "R-INO" .
<Non-curative_subsequent-line_therapy> <Context_of> "R-GemOx" .
<Non-curative_subsequent-line_therapy> <Context_of> "R-CVEP" .
<Non-curative_subsequent-line_therapy> <Context_of> "R-BL" .
<Non-curative_subsequent-line_therapy> <Context_of> "Quizartinib_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Plicamycin_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Placebo" .
<Non-curative_subsequent-line_therapy> <Context_of> "Pixantrone_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Pertuzumab_and_Trastuzumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Pemetrexed_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Pembrolizumab_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Panobinostat_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Panobinostat_and_Rituximab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Panitumumab_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine" .
<Non-curative_subsequent-line_therapy> <Context_of> "Paclitaxel_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Paclitaxel_and_Ramucirumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Paclitaxel_and_Bevacizumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Oxaliplatin_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Oxaliplatin_and_Bevacizumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Ofatumumab_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Octreotide_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Octreotide_and_Prednisone" .
<Non-curative_subsequent-line_therapy> <Context_of> "Obinutuzumab_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Nivolumab_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Nintedanib_and_Pemetrexed" .
<Non-curative_subsequent-line_therapy> <Context_of> "Mitoxantrone_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Methotrexate_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "MVAC" .
<Non-curative_subsequent-line_therapy> <Context_of> "MEC" .
<Non-curative_subsequent-line_therapy> <Context_of> "LoDAC" .
<Non-curative_subsequent-line_therapy> <Context_of> "Letrozole_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Lenalidomide_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Lenalidomide_and_Rituximab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Lapatinib_and_Trastuzumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Ixabepilone_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Irinotecan_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Irinotecan_liposomal_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Irinotecan_and_S-1" .
<Non-curative_subsequent-line_therapy> <Context_of> "Irinotecan_and_Mitomycin" .
<Non-curative_subsequent-line_therapy> <Context_of> "Irinotecan_and_Cetuximab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Ipilimumab_and_Nivolumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Ifosfamide_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Icotinib_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Ibrutinib_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Ibritumomab_tiuxetan_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "IE" .
<Non-curative_subsequent-line_therapy> <Context_of> "IDAC" .
<Non-curative_subsequent-line_therapy> <Context_of> "ICE" .
<Non-curative_subsequent-line_therapy> <Context_of> "HDMP" .
<Non-curative_subsequent-line_therapy> <Context_of> "Gilteritinib_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Gemtuzumab_ozogamicin_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Gemcitabine,_Oxaliplatin,_Paclitaxel" .
<Non-curative_subsequent-line_therapy> <Context_of> "Gemcitabine_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Gemcitabine_and_Vinorelbine" .
<Non-curative_subsequent-line_therapy> <Context_of> "Gemcitabine_and_Trastuzumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Gemcitabine_and_Rituximab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Gemcitabine_and_Paclitaxel" .
<Non-curative_subsequent-line_therapy> <Context_of> "Gemcitabine_and_Bevacizumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "GemOx" .
<Non-curative_subsequent-line_therapy> <Context_of> "Gefitinib_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "GVD" .
<Non-curative_subsequent-line_therapy> <Context_of> "GDP" .
<Non-curative_subsequent-line_therapy> <Context_of> "Fulvestrant_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Fulvestrant_and_Ribociclib" .
<Non-curative_subsequent-line_therapy> <Context_of> "Fulvestrant_and_Palbociclib" .
<Non-curative_subsequent-line_therapy> <Context_of> "Fluorouracil,_Folinic_acid,_Mitomycin" .
<Non-curative_subsequent-line_therapy> <Context_of> "Fluorouracil_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Fluorouracil_and_Folinic_acid" .
<Non-curative_subsequent-line_therapy> <Context_of> "Fludarabine_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Fam-trastuzumab_deruxtecan_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "FULV_and_Bevacizumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "FOLFOX4_and_Bevacizumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "FOLFOX4_(L-Leucovorin)" .
<Non-curative_subsequent-line_therapy> <Context_of> "FOLFOX4" .
<Non-curative_subsequent-line_therapy> <Context_of> "FLAG-Ida" .
<Non-curative_subsequent-line_therapy> <Context_of> "FC" .
<Non-curative_subsequent-line_therapy> <Context_of> "Exemestane_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Exemestane_and_Tucidinostat" .
<Non-curative_subsequent-line_therapy> <Context_of> "Everolimus_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Everolimus_and_Tamoxifen" .
<Non-curative_subsequent-line_therapy> <Context_of> "Everolimus_and_Rituximab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Everolimus_and_Exemestane" .
<Non-curative_subsequent-line_therapy> <Context_of> "Etoposide,_Ifosfamide,_Methotrexate" .
<Non-curative_subsequent-line_therapy> <Context_of> "Etoposide_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Erlotinib_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Eribulin_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Erdafitinib_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Enzalutamide_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Enfortumab_vedotin_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "ESHAP" .
<Non-curative_subsequent-line_therapy> <Context_of> "EPOCH" .
<Non-curative_subsequent-line_therapy> <Context_of> "Durvalumab_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Doxorubicin_pegylated_liposomal_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Doxorubicin_pegylated_liposomal_and_Bevacizumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Doxorubicin_non-pegylated_liposomal_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Doxorubicin_non-pegylated_liposomal_and_Bevacizumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Doxorubicin_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Doxorubicin_and_Lomustine" .
<Non-curative_subsequent-line_therapy> <Context_of> "Doxorubicin_and_Bevacizumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Docetaxel_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Docetaxel_and_Ramucirumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Docetaxel_and_Nintedanib" .
<Non-curative_subsequent-line_therapy> <Context_of> "Docetaxel_and_Irinotecan" .
<Non-curative_subsequent-line_therapy> <Context_of> "Docetaxel_and_Gemcitabine" .
<Non-curative_subsequent-line_therapy> <Context_of> "Docetaxel_and_Bevacizumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Denileukin_diftitox_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "DICEP" .
<Non-curative_subsequent-line_therapy> <Context_of> "DICE" .
<Non-curative_subsequent-line_therapy> <Context_of> "Cyclophosphamide_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Cyclophosphamide_and_Topotecan" .
<Non-curative_subsequent-line_therapy> <Context_of> "Cyclophosphamide_and_Etoposide" .
<Non-curative_subsequent-line_therapy> <Context_of> "Clofarabine_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Cladribine_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Cisplatin_and_Vinorelbine" .
<Non-curative_subsequent-line_therapy> <Context_of> "Cisplatin_and_Gemcitabine" .
<Non-curative_subsequent-line_therapy> <Context_of> "Cetuximab_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Carmustine_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Carboplatin_and_Gemcitabine" .
<Non-curative_subsequent-line_therapy> <Context_of> "Capecitabine,_Pertuzumab,_Trastuzumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Capecitabine_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Capecitabine_and_Trastuzumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Capecitabine_and_Neratinib" .
<Non-curative_subsequent-line_therapy> <Context_of> "Capecitabine_and_Lapatinib" .
<Non-curative_subsequent-line_therapy> <Context_of> "Capecitabine_and_Ixabepilone" .
<Non-curative_subsequent-line_therapy> <Context_of> "Capecitabine_and_Gemcitabine" .
<Non-curative_subsequent-line_therapy> <Context_of> "Capecitabine_and_Fulvestrant" .
<Non-curative_subsequent-line_therapy> <Context_of> "Capecitabine_and_Bevacizumab" .
<Non-curative_subsequent-line_therapy> <Context_of> "Cabozantinib_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "CM" .
<Non-curative_subsequent-line_therapy> <Context_of> "CEPP(B)" .
<Non-curative_subsequent-line_therapy> <Context_of> "CAPIRI" .
<Non-curative_subsequent-line_therapy> <Context_of> "CAP" .
<Non-curative_subsequent-line_therapy> <Context_of> "Brentuximab_vedotin_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Blinatumomab_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Bevacizumab_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Best_supportive_care" .
<Non-curative_subsequent-line_therapy> <Context_of> "Bendamustine_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "BR_and_Polatuzumab_vedotin" .
<Non-curative_subsequent-line_therapy> <Context_of> "BR" .
<Non-curative_subsequent-line_therapy> <Context_of> "Azacitidine,_Vorinostat,_Gemtuzumab_ozogamicin" .
<Non-curative_subsequent-line_therapy> <Context_of> "Azacitidine_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Azacitidine_and_Sorafenib" .
<Non-curative_subsequent-line_therapy> <Context_of> "Axicabtagene_ciloleucel_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Avelumab_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Atezolizumab_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Apatinib_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Anastrozole_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Anastrozole_and_Fulvestrant" .
<Non-curative_subsequent-line_therapy> <Context_of> "Amrubicin_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Afatinib_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Afatinib_and_Paclitaxel" .
<Non-curative_subsequent-line_therapy> <Context_of> "Ado-trastuzumab_emtansine_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Abemaciclib_monotherapy" .
<Non-curative_subsequent-line_therapy> <Context_of> "Abemaciclib_and_Fulvestrant" .
<Lenvatinib_and_Pembrolizumab> <Has_modality> "Immunotherapy" .
<Lenvatinib_and_Pembrolizumab> <Has_modality> "Chemotherapy" .
<LoDAC> <Mapped_from> "LoDAC" .
<Anastrozole_and_Fulvestrant> <Has_antineoplastic> "Fulvestrant" .
<Anastrozole_and_Fulvestrant> <Has_antineoplastic> "Anastrozole" .
<CHOP-AL> <Is_a> "Anthracycline-containing_regimen" .
<DAT> <Is_historical_in> "Acute_myeloid_leukemia" .
<Daratumumab_monotherapy> <Is_current_in> "Multiple_myeloma" .
<Daratumumab_monotherapy> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<Angiomax> <Brand_name_of> "Bivalirudin" .
<Axitinib_and_Avelumab> <Has_antineoplastic> "Axitinib" .
<Axitinib_and_Avelumab> <Has_antineoplastic> "Avelumab" .
<Mercaptopurine_and_Prednisone> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<Decitabine_and_Venetoclax> <Maps_to> "Decitabine_and_Venetoclax" .
<CAMP> <Maps_to> "CAMP" .
<Synbac> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Pomalidomide> <Antineoplastic_of> "Pomalidomide,_Dexamethasone,_Pembrolizumab" .
<Pomalidomide> <Antineoplastic_of> "Pomalidomide_monotherapy" .
<Pomalidomide> <Antineoplastic_of> "Pomalidomide_and_Prednisone" .
<Pomalidomide> <Antineoplastic_of> "Pd" .
<Pomalidomide> <Antineoplastic_of> "PVD" .
<Pomalidomide> <Antineoplastic_of> "PD" .
<Pomalidomide> <Antineoplastic_of> "PCP" .
<Pomalidomide> <Antineoplastic_of> "PCD" .
<Pomalidomide> <Antineoplastic_of> "KPD" .
<Pomalidomide> <Antineoplastic_of> "Elo-PD" .
<Pomalidomide> <Antineoplastic_of> "Dara-PD" .
<Ulosagen> <Brand_name_of> "Fluorouracil" .
<Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin> <Maps_to> "Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin" .
<CIA> <Mapped_from> "CIA" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan> <Is_a> "Rituximab-containing_regimen" .
<O-ICE> <Mapped_from> "O-ICE" .
<CTCb,_then_auto_HSCT> <Has_context> "Non-curative_therapy" .
<CTCb,_then_auto_HSCT> <Has_context> "Adjuvant_therapy" .
<mFOLFOX6_and_Bevacizumab_(L-Leucovorin)> <Has_modality> "Chemotherapy" .
<Ipilimumab,_then_Nivolumab> <Has_modality> "Immunotherapy" .
<Imatinib_and_Prednisone> <Has_context> "Induction_therapy" .
<Moticlod> <Brand_name_of> "Clodronate" .
<PCDE> <Mapped_from> "PCDE" .
<Docetaxel_and_Prednisone> <Has_antineoplastic> "Prednisone" .
<Docetaxel_and_Prednisone> <Has_antineoplastic> "Docetaxel" .
<Non-curative_first-line_induction_therapy> <Mapped_from> "Non-curative_first-line_induction_therapy" .
<Ixabepilone_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<R-IFE> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Paclitaxel,_Topotecan,_Bevacizumab> <Mapped_from> "Paclitaxel,_Topotecan,_Bevacizumab" .
<Anastrozole_and_Trastuzumab> <Is_a> "Antiestrogen-containing_regimen" .
<Danazol_monotherapy> <Maps_to> "Danazol_monotherapy" .
<Imatinib,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Vincristine" .
<Imatinib,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Imatinib" .
<Imatinib,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Dexamethasone" .
<Cisplatin_and_Cetuximab> <Maps_to> "Cisplatin_and_Cetuximab" .
<Tegafur_and_uracil> <Is_a> "PMDA_approved_drug" .
<Tegafur_and_uracil> <Is_a> "Fluoropyrimidine" .
<R-DHAP> <Mapped_from> "R-DHAP" .
<Ribotax> <Brand_name_of> "Paclitaxel" .
<Hydrocortisone_monotherapy> <Has_modality> "Hormonotherapy" .
<BiRd> <Has_antineoplastic> "Lenalidomide" .
<BiRd> <Has_antineoplastic> "Dexamethasone" .
<BiRd> <Has_antineoplastic> "Clarithromycin" .
<Talavir> <Brand_name_of> "Valacyclovir" .
<Irinotecan_and_Cetuximab> <Has_supportive_med> "Ondansetron" .
<Irinotecan_and_Cetuximab> <Has_supportive_med> "Dexamethasone" .
<Irinotecan_and_Cetuximab> <Has_supportive_med> "Antihistamines" .
<TAM6,_then_auto_HSCT> <Has_modality> "Radiotherapy" .
<TAM6,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Niraparib_monotherapy> <Has_context> "Non-curative_therapy" .
<Niraparib_monotherapy> <Has_context> "Non-curative_second-line_maintenance_therapy" .
<Obinutuzumab_monotherapy> <Has_context> "Non-curative_therapy" .
<Obinutuzumab_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Obinutuzumab_monotherapy> <Has_context> "Non-curative_subsequent-line_maintenance_therapy" .
<Obinutuzumab_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Obinutuzumab_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<ABCP> <Mapped_from> "ABCP" .
<Dicladox> <Brand_name_of> "Doxorubicin" .
<KD> <Has_antineoplastic> "Dexamethasone" .
<KD> <Has_antineoplastic> "Carfilzomib" .
<ABVD> <Is_historical_in> "Hodgkin_lymphoma" .
<Peginterferon_alfa-2a_monotherapy> <Has_supportive_med> "Aspirin" .
<Oseolen> <Brand_name_of> "Alendronate" .
<CEV_(Cyclophosphamide/Etoposide)> <Has_antineoplastic> "Vincristine" .
<CEV_(Cyclophosphamide/Etoposide)> <Has_antineoplastic> "Etoposide" .
<CEV_(Cyclophosphamide/Etoposide)> <Has_antineoplastic> "Cyclophosphamide" .
<Mitoxantrone_and_Prednisone> <Mapped_from> "Mitoxantrone_and_Prednisone" .
<FAM> <Has_antineoplastic> "Mitomycin" .
<FAM> <Has_antineoplastic> "Fluorouracil" .
<FAM> <Has_antineoplastic> "Doxorubicin" .
<FOLFIRI_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Vorwell> <Brand_name_of> "Voriconazole" .
<Panitumumab> <Antineoplastic_of> "Panitumumab_monotherapy" .
<Panitumumab> <Antineoplastic_of> "FOLFOXIRI_and_Panitumumab" .
<Panitumumab> <Antineoplastic_of> "FOLFOX4_and_Panitumumab" .
<Panitumumab> <Antineoplastic_of> "FOLFIRI_and_Panitumumab" .
<Panitumumab> <Antineoplastic_of> "Dabrafenib,_Trametinib,_Panitumumab" .
<Panitumumab> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_Panitumumab" .
<Panitumumab> <Antineoplastic_of> "CapeOx_and_Panitumumab" .
<VBMCP/VBAD> <Has_context> "Non-curative_first-line_therapy" .
<Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide> <Is_current_in> "Medulloblastoma" .
<Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone> <Maps_to> "Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone" .
<CC> <Has_antineoplastic> "Cyclophosphamide" .
<CC> <Has_antineoplastic> "Cladribine" .
<MA-BCD/AP> <Has_context> "Adjuvant_therapy" .
<Carfilzomib_and_Panobinostat> <Has_modality> "Chemotherapy" .
<VMCP/VBAP> <Maps_to> "VMCP/VBAP" .
<No_neoadjuvant_therapy> <Mapped_from> "No_neoadjuvant_therapy" .
<GMALL-R> <Has_antineoplastic> "Vindesine" .
<GMALL-R> <Has_antineoplastic> "Vincristine" .
<GMALL-R> <Has_antineoplastic> "Teniposide" .
<GMALL-R> <Has_antineoplastic> "Rituximab" .
<GMALL-R> <Has_antineoplastic> "Prednisone" .
<GMALL-R> <Has_antineoplastic> "Methotrexate" .
<GMALL-R> <Has_antineoplastic> "Ifosfamide" .
<GMALL-R> <Has_antineoplastic> "Etoposide" .
<GMALL-R> <Has_antineoplastic> "Doxorubicin" .
<GMALL-R> <Has_antineoplastic> "Dexamethasone" .
<GMALL-R> <Has_antineoplastic> "Cytarabine" .
<GMALL-R> <Has_antineoplastic> "Cyclophosphamide" .
<Sonidegib_monotherapy> <Is_current_in> "Cutaneous_basal_cell_carcinoma" .
<Tamoxifen_monotherapy> <Has_supportive_med> "Goserelin" .
<Mepolizumab_monotherapy> <Has_accepted_use> "Hypereosinophilic_syndrome" .
<Aspirin_and_Dexamethasone> <Is_historical_in> "Prostate_cancer" .
<DCEP_and_G-CSF> <Has_accepted_use> "Stem_cell_mobilization" .
<Hematopoetic_progenitor_cells_cord_blood> <May_have_route> "Intravenous" .
<Enasidenib_monotherapy> <Mapped_from> "Enasidenib_monotherapy" .
<DTPACE> <Has_accepted_use> "Multiple_myeloma" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT> <Maps_to> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT" .
<Sumiferon> <Brand_name_of> "Interferon_alfa-2b" .
<BID> <Has_antineoplastic> "Ixazomib" .
<BID> <Has_antineoplastic> "Dexamethasone" .
<BID> <Has_antineoplastic> "Bendamustine" .
<EBVP> <Mapped_from> "EBVP" .
<PGC> <Has_context> "Non-curative_first-line_therapy" .
<PGC> <Has_context> "Adjuvant_therapy" .
<CHOEP-21> <Has_supportive_med> "Filgrastim" .
<CFAR> <Mapped_from> "CFAR" .
<Nelarabine_monotherapy> <Has_modality> "Chemotherapy" .
<Paclitaxel_monotherapy> <Has_supportive_med> "Sargramostim" .
<Paclitaxel_monotherapy> <Has_supportive_med> "Ranitidine" .
<Paclitaxel_monotherapy> <Has_supportive_med> "Pegfilgrastim" .
<Paclitaxel_monotherapy> <Has_supportive_med> "Metoclopramide" .
<Paclitaxel_monotherapy> <Has_supportive_med> "Hydrocortisone" .
<Paclitaxel_monotherapy> <Has_supportive_med> "H2-receptor_antagonists" .
<Paclitaxel_monotherapy> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Paclitaxel_monotherapy> <Has_supportive_med> "Filgrastim" .
<Paclitaxel_monotherapy> <Has_supportive_med> "Famotidine" .
<Paclitaxel_monotherapy> <Has_supportive_med> "Emesis_prevention" .
<Paclitaxel_monotherapy> <Has_supportive_med> "Diphenhydramine" .
<Paclitaxel_monotherapy> <Has_supportive_med> "Dexchlorpheniramine" .
<Paclitaxel_monotherapy> <Has_supportive_med> "Dexamethasone" .
<Paclitaxel_monotherapy> <Has_supportive_med> "Clemastine" .
<Paclitaxel_monotherapy> <Has_supportive_med> "Cimetidine" .
<Paclitaxel_monotherapy> <Has_supportive_med> "Chlorpheniramine" .
<Kabifungin> <Brand_name_of> "Caspofungin" .
<Cemiplimab_monotherapy> <Has_context> "Non-curative_therapy" .
<Vinflunine_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<Vincristine_liposomal_monotherapy> <Maps_to> "Vincristine_liposomal_monotherapy" .
<Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Mitotane_monotherapy> <Has_accepted_use> "Adrenocortical_carcinoma" .
<Cytarabine_and_Daunorubicin> <Has_local_therapy> "Methotrexate" .
<Cytarabine_and_Daunorubicin> <Has_local_therapy> "Cytarabine" .
<CBV> <Maps_to> "CBV" .
<Ifacil> <Brand_name_of> "Fluorouracil" .
<BFR> <Has_antineoplastic> "Rituximab" .
<BFR> <Has_antineoplastic> "Fludarabine" .
<BFR> <Has_antineoplastic> "Bendamustine" .
<Melphalan_monotherapy> <Has_modality> "Chemotherapy" .
<Hydroxyurea> <Has_FDA_indication> "Sickle_cell_anemia" .
<Ponatinib> <Has_brand_name> "Iclusig" .
<Leupromer> <Brand_name_of> "Leuprolide" .
<FOLFOXIRI_and_Panitumumab> <Has_modality> "Chemotherapy" .
<CPB> <Has_modality> "Chemotherapy" .
<CF_and_Trastuzumab> <Has_accepted_use> "Esophageal_cancer" .
<Axitinib_and_TACE> <Has_modality> "Chemotherapy" .
<R-MCP_(CCNU)> <Has_antineoplastic> "Rituximab" .
<R-MCP_(CCNU)> <Has_antineoplastic> "Procarbazine" .
<R-MCP_(CCNU)> <Has_antineoplastic> "Methotrexate" .
<R-MCP_(CCNU)> <Has_antineoplastic> "Lomustine" .
<Brentuximab_vedotin_and_Dacarbazine> <Is_current_in> "Hodgkin_lymphoma" .
<Carboplatin,_Paclitaxel,_Bevacizumab> <Mapped_from> "Carboplatin,_Paclitaxel,_Bevacizumab" .
<MCP> <Is_historical_in> "Follicular_lymphoma" .
<Cisplatin_and_Mitomycin> <Maps_to> "Cisplatin_and_Mitomycin" .
<Decorex> <Brand_name_of> "Dexamethasone" .
<Factor_IX_recombinant> <May_have_route> "Intravenous" .
<Arsenic_trioxide_monotherapy> <Has_antineoplastic> "Arsenic_trioxide" .
<Fedratinib> <Is_a> "Kinase_inhibitor" .
<Fedratinib> <Is_a> "JAK_inhibitor" .
<VAP> <Has_antineoplastic> "Vincristine" .
<VAP> <Has_antineoplastic> "Prednisolone" .
<VAP> <Has_antineoplastic> "Doxorubicin" .
<PMitCEBO> <Has_antineoplastic> "Vincristine" .
<PMitCEBO> <Has_antineoplastic> "Prednisolone" .
<PMitCEBO> <Has_antineoplastic> "Mitoxantrone" .
<PMitCEBO> <Has_antineoplastic> "Etoposide" .
<PMitCEBO> <Has_antineoplastic> "Cyclophosphamide" .
<PMitCEBO> <Has_antineoplastic> "Bleomycin" .
<FEC_and_H_(SC)> <Has_context> "Neoadjuvant_therapy" .
<Mitoxantrone_and_Hydrocortisone> <Has_accepted_use> "Prostate_cancer" .
<mLSG15> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<GVD> <Is_a> "Anthracycline-containing_regimen" .
<Transformed_lymphoma> <Is_a> "Non-Hodgkin_lymphoma" .
<Transformed_lymphoma> <Is_a> "Aggressive_lymphoma" .
<Cisplatin_monotherapy> <Has_antineoplastic> "Cisplatin" .
<AV-CMF> <Is_a> "Anthracycline-containing_regimen" .
<PCP> <Has_modality> "Chemotherapy" .
<Cloridrato_DE> <Brand_name_of> "Doxorubicin" .
<Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone> <Has_accepted_use> "Langerhans_cell_histiocytosis" .
<Anaplastic_large_cell_lymphoma> <Is_a> "T-cell_lymphoma" .
<Inherited_hemoglobinopathy> <Subsumes> "Sickle_cell_anemia" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Is_current_in> "HIV-associated_lymphoma" .
<Langerhans_cell_histiocytosis> <Is_a> "Histiocytosis" .
<VMD> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<COPP/ABVD> <Mapped_from> "COPP/ABVD" .
<Ketoconazole_and_Hydrocortisone> <Has_accepted_use> "Prostate_cancer" .
<VABE> <Maps_to> "VABE" .
<Crizanlizumab_monotherapy> <Has_modality> "Chemotherapy" .
<Lepirudin_monotherapy> <Has_accepted_use> "Venous_thromboembolism" .
<Lepirudin_monotherapy> <Has_accepted_use> "Heparin-induced_thrombocytopenia" .
<Ifosfamide_monotherapy> <Has_accepted_use> "Thymoma" .
<Ifosfamide_monotherapy> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Ifosfamide_monotherapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<Ifosfamide_monotherapy> <Has_accepted_use> "Endometrial_cancer" .
<Ifosfamide_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Ifosfamide_monotherapy> <Has_accepted_use> "Cervical_cancer" .
<Calaspargase,_Daunorubicin,_Vincristine,_Prednisone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Vinorelbine_and_Bevacizumab> <Mapped_from> "Vinorelbine_and_Bevacizumab" .
<DCEP_and_G-CSF> <Has_context> "All_lines_of_therapy" .
<FC> <Has_context> "Non-curative_subsequent-line_therapy" .
<FC> <Has_context> "Non-curative_first-line_therapy" .
<FC> <Has_context> "All_lines_of_therapy" .
<Gemcitabine_and_Sunitinib> <Has_modality> "Chemotherapy" .
<ddC> <Maps_to> "ddC" .
<Paclitaxel_monotherapy> <Has_accepted_use> "triple_negative_Breast_cancer" .
<Paclitaxel_monotherapy> <Has_accepted_use> "Vulvar_cancer" .
<Paclitaxel_monotherapy> <Has_accepted_use> "Vascular_sarcoma" .
<Paclitaxel_monotherapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<Paclitaxel_monotherapy> <Has_accepted_use> "Penile_cancer" .
<Paclitaxel_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Paclitaxel_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Paclitaxel_monotherapy> <Has_accepted_use> "Melanoma" .
<Paclitaxel_monotherapy> <Has_accepted_use> "Kaposi_sarcoma" .
<Paclitaxel_monotherapy> <Has_accepted_use> "Head_and_neck_cancer" .
<Paclitaxel_monotherapy> <Has_accepted_use> "HER2-positive_-_historical_Breast_cancer" .
<Paclitaxel_monotherapy> <Has_accepted_use> "Gastric_cancer" .
<Paclitaxel_monotherapy> <Has_accepted_use> "Esophageal_cancer" .
<Paclitaxel_monotherapy> <Has_accepted_use> "Endometrial_cancer" .
<Paclitaxel_monotherapy> <Has_accepted_use> "Cervical_cancer" .
<Paclitaxel_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Paclitaxel_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<Paclitaxel_monotherapy> <Has_accepted_use> "BRAF-mutated_Melanoma" .
<Cofatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Razylan> <Brand_name_of> "Raloxifene" .
<R-MACLO/R-IVAM> <Has_supportive_med> "Mesna" .
<R-MACLO/R-IVAM> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<R-MACLO/R-IVAM> <Has_supportive_med> "Folinic_acid" .
<Capecitabine/Capecitabine_and_RT> <Is_current_in> "Rectal_cancer" .
<Osimertinib_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Osimertinib_monotherapy> <Is_current_in> "CNS_carcinoma" .
<Zexate> <Brand_name_of> "Methotrexate" .
<REMS_program> <Is_a> "FDA_approved_drug" .
<Thyroid_cancer> <Is_a> "Head_and_neck_cancer" .
<Thyroid_cancer> <Is_a> "Endocrine_cancer" .
<Nadroparin> <Supportive_med_of> "MPT" .
<RT-PEPC> <Is_current_in> "Mantle_cell_lymphoma" .
<PAD/VCD> <Is_a> "Anthracycline-containing_regimen" .
<5_plus_3d> <Has_context> "Induction_therapy" .
<Degarelix> <Has_FDA_indication> "Prostate_cancer" .
<IFL> <Mapped_from> "IFL" .
<Reduction_of_immunosuppression> <Maps_to> "Reduction_of_immunosuppression" .
<Minirin> <Brand_name_of> "Desmopressin" .
<Carboplatin> <Has_accepted_use> "Thymoma" .
<Carboplatin> <Has_accepted_use> "Testicular_cancer" .
<Carboplatin> <Has_accepted_use> "Small_cell_lung_cancer" .
<Carboplatin> <Has_accepted_use> "Prostate_cancer" .
<Carboplatin> <Has_accepted_use> "Pancreatic_cancer" .
<Carboplatin> <Has_accepted_use> "Ovarian_cancer" .
<Carboplatin> <Has_accepted_use> "Osteosarcoma" .
<Carboplatin> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Carboplatin> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<Carboplatin> <Has_accepted_use> "Mesothelioma" .
<Carboplatin> <Has_accepted_use> "Melanoma" .
<Carboplatin> <Has_accepted_use> "Medulloblastoma" .
<Carboplatin> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Carboplatin> <Has_accepted_use> "Low-grade_glioma" .
<Carboplatin> <Has_accepted_use> "Hodgkin_lymphoma" .
<Carboplatin> <Has_accepted_use> "Head_and_neck_cancer" .
<Carboplatin> <Has_accepted_use> "Glioblastoma" .
<Carboplatin> <Has_accepted_use> "Gastric_cancer" .
<Carboplatin> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Carboplatin> <Has_accepted_use> "Ewing_sarcoma" .
<Carboplatin> <Has_accepted_use> "Esophageal_cancer" .
<Carboplatin> <Has_accepted_use> "Endometrial_cancer" .
<Carboplatin> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Carboplatin> <Has_accepted_use> "Cervical_cancer" .
<Carboplatin> <Has_accepted_use> "Breast_cancer" .
<Carboplatin> <Has_accepted_use> "Bladder_cancer" .
<Carboplatin> <Has_accepted_use> "Anaplastic_glioma" .
<Carboplatin> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<Chlorambucil_and_Obinutuzumab> <Has_context> "Non-curative_first-line_therapy" .
<TC_(Taxotere)> <Mapped_from> "TC_(Taxotere)" .
<Mycophenolate_mofetil> <Has_brand_name> "CellCept" .
<MCP> <Is_current_in> "Marginal_zone_lymphoma" .
<MCP> <Is_current_in> "Mantle_cell_lymphoma" .
<Radioiodine_ablation> <Mapped_from> "Radioiodine_ablation" .
<BuCy,_then_allo_HSCT> <Has_supportive_med> "Methotrexate" .
<BuCy,_then_allo_HSCT> <Has_supportive_med> "Filgrastim" .
<BuCy,_then_allo_HSCT> <Has_supportive_med> "Cyclosporine_non-modified" .
<VACA> <Is_a> "Anthracycline-containing_regimen" .
<Neocel> <Brand_name_of> "Docetaxel" .
<Apcetrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Carboplatin,_nab-Paclitaxel,_Pembrolizumab> <Has_modality> "Immunotherapy" .
<Carboplatin,_nab-Paclitaxel,_Pembrolizumab> <Has_modality> "Chemotherapy" .
<Low-dose_TBI> <Mapped_from> "Low-dose_TBI" .
<Danaparoid> <Has_brand_name> "Orgaran" .
<Erlotinib_and_Bevacizumab> <Has_antineoplastic> "Erlotinib" .
<Erlotinib_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<FCM> <Has_antineoplastic> "Mitoxantrone" .
<FCM> <Has_antineoplastic> "Fludarabine" .
<FCM> <Has_antineoplastic> "Cyclophosphamide" .
<Intraperitoneal_5-FU> <Maps_to> "Intraperitoneal_5-FU" .
<MCV> <Has_modality> "Chemotherapy" .
<IDAC> <Has_supportive_med> "Filgrastim" .
<Trimetoger> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Caretran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Carboplatin_and_Irinotecan> <Has_context> "Induction_therapy" .
<Exemestane_and_Tucidinostat> <Is_a> "Antiestrogen-containing_regimen" .
<Avlotrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Carmustine_monotherapy> <Maps_to> "Carmustine_monotherapy" .
<BCHOP> <Is_current_in> "Mantle_cell_lymphoma" .
<Calcium_phosphate_rinse> <Is_a> "Mucositis_prevention" .
<Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib> <Has_local_therapy> "Methotrexate" .
<Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib> <Has_local_therapy> "Hydrocortisone" .
<Cladribine_and_Rituximab> <Has_context> "Non-curative_therapy" .
<Cladribine_and_Rituximab> <Has_context> "Non-curative_first-line_therapy" .
<Cladribine_and_Rituximab> <Has_context> "Induction_therapy" .
<AspaMetDex_(Erwinaze)> <Has_antineoplastic> "Methotrexate" .
<AspaMetDex_(Erwinaze)> <Has_antineoplastic> "Dexamethasone" .
<AspaMetDex_(Erwinaze)> <Has_antineoplastic> "Asparaginase_Erwinia_chrysanthemi" .
<BVP> <Has_modality> "Chemotherapy" .
<R-CVEP> <Maps_to> "R-CVEP" .
<Teutrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone> <Has_modality> "Chemotherapy" .
<External_beam_radiotherapy> <Local_therapy_of> "VAdCA/IE" .
<External_beam_radiotherapy> <Local_therapy_of> "VAdCA" .
<External_beam_radiotherapy> <Local_therapy_of> "VAIA" .
<External_beam_radiotherapy> <Local_therapy_of> "VACA" .
<External_beam_radiotherapy> <Local_therapy_of> "TC,_then_IE,_VDoxoC,_VEC" .
<External_beam_radiotherapy> <Local_therapy_of> "R-M-CHOP" .
<External_beam_radiotherapy> <Local_therapy_of> "International_ALL_Trial" .
<External_beam_radiotherapy> <Local_therapy_of> "Hyper-CVAD_and_Imatinib" .
<External_beam_radiotherapy> <Local_therapy_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine" .
<External_beam_radiotherapy> <Local_therapy_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine" .
<Streptozocin> <Has_FDA_indication> "Pancreatic_NET" .
<Fludarabine_and_Alemtuzumab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<CHOP-BCG> <Mapped_from> "CHOP-BCG" .
<Interferon_alfa-2b_and_DLI> <Has_context> "Non-curative_therapy" .
<Carboplatin,_Etoposide,_Durvalumab> <Has_accepted_use> "Small_cell_lung_cancer" .
<Sipuleucel-T> <Has_brand_name> "Provenge" .
<O-CHOP> <Is_a> "Anthracycline-containing_regimen" .
<FUOX> <Is_a> "Platinum_doublet" .
<M-TIP> <Has_antineoplastic> "Paclitaxel" .
<M-TIP> <Has_antineoplastic> "Methotrexate" .
<M-TIP> <Has_antineoplastic> "Ifosfamide" .
<M-TIP> <Has_antineoplastic> "Cisplatin" .
<Alemax> <Brand_name_of> "Alendronate" .
<CC/DE_and_RT> <Has_modality> "Radiotherapy" .
<CC/DE_and_RT> <Has_modality> "Chemotherapy" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone> <Has_modality> "Chemotherapy" .
<Fodosine> <Brand_name_of> "Forodesine" .
<Helmine> <Brand_name_of> "Ondansetron" .
<Arsenic_trioxide,_ATRA,_Idarubicin> <Has_supportive_med> "Prednisone" .
<IFL_and_Bevacizumab> <Maps_to> "IFL_and_Bevacizumab" .
<Thioguanine_monotherapy> <Has_modality> "Chemotherapy" .
<VMP/Rd> <Has_modality> "Chemotherapy" .
<Anastrozole_and_Fulvestrant> <Is_a> "Antiestrogen-containing_regimen" .
<Dara-VTD> <Is_current_in> "Multiple_myeloma" .
<Consolidation_after_salvage_therapy> <Maps_to> "Consolidation_after_salvage_therapy" .
<CNOP_(Prednisolone)> <Mapped_from> "CNOP_(Prednisolone)" .
<HLH-94_regimen> <Maps_to> "HLH-94_regimen" .
<IT_Cytarabine_monotherapy> <Mapped_from> "IT_Cytarabine_monotherapy" .
<AC_and_Bevacizumab> <Maps_to> "AC_and_Bevacizumab" .
<Samarium-153> <Has_accepted_use> "Prostate_cancer" .
<Samarium-153> <Has_accepted_use> "Osteosarcoma" .
<Fulvestrant> <Has_FDA_indication> "Breast_cancer" .
<Thioguanine_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Medirona> <Brand_name_of> "Methylprednisolone" .
<Cyclophosphamide,_Prednisone,_Diethylstilbestrol> <Maps_to> "Cyclophosphamide,_Prednisone,_Diethylstilbestrol" .
<MAP2K1_inhibitor> <Is_a> "MEK_inhibitor" .
<DEX-IFN> <Has_antineoplastic> "Interferon_alfa-2b" .
<DEX-IFN> <Has_antineoplastic> "Dexamethasone" .
<PCP> <Has_accepted_use> "Multiple_myeloma" .
<Fluorouracil_and_Levamisole> <Is_historical_in> "Colon_cancer" .
<Zonax> <Brand_name_of> "Ondansetron" .
<Cetuximab_monotherapy> <Maps_to> "Cetuximab_monotherapy" .
<Forodesine_monotherapy> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<Clofarabine_and_Melphalan> <Mapped_from> "Clofarabine_and_Melphalan" .
<Bioplak> <Brand_name_of> "Aspirin" .
<FCA> <Has_context> "Non-curative_first-line_therapy" .
<Fulvestrant_monotherapy> <Maps_to> "Fulvestrant_monotherapy" .
<Encoprin> <Brand_name_of> "Aspirin" .
<PEP-C> <Mapped_from> "PEP-C" .
<Arsenic_trioxide_and_Idarubicin> <Is_current_in> "Acute_promyelocytic_leukemia" .
<BRAF-mutated_Thyroid_cancer> <Is_a> "Thyroid_cancer" .
<Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone> <Has_modality> "Chemotherapy" .
<Bu/TT/Cy> <Has_accepted_use> "Autologous_HSCT" .
<Docetaxel,_Fluorouracil,_RT> <Has_context> "Neoadjuvant_therapy" .
<Gamunex> <Brand_name_of> "Intravenous_immunoglobulin_(IVIG)" .
<Doxorubicin_non-pegylated_liposomal_monotherapy> <Is_current_in> "Breast_cancer" .
<Romidepsin> <Is_a> "HDAC_inhibitor" .
<Doxorubicin,_Ifosfamide,_RT> <Has_antineoplastic> "Ifosfamide" .
<Doxorubicin,_Ifosfamide,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Doxorubicin,_Ifosfamide,_RT> <Has_antineoplastic> "Doxorubicin" .
<FLAG-DNX> <Has_context> "Salvage_therapy" .
<Apodrolen> <Brand_name_of> "Alendronate" .
<Emigo> <Brand_name_of> "Ondansetron" .
<Factor_VIII_human> <Has_brand_name> "Monoclate-P" .
<Factor_VIII_human> <Has_brand_name> "Monarc-M" .
<Factor_VIII_human> <Has_brand_name> "Koate-HP" .
<Factor_VIII_human> <Has_brand_name> "Koate-DVI" .
<Factor_VIII_human> <Has_brand_name> "Hemofil-M" .
<Alemtuzumab_and_Methylprednisolone> <Maps_to> "Alemtuzumab_and_Methylprednisolone" .
<Fludarabine,_Melphalan,_Alemtuzumab> <Has_accepted_use> "Allogeneic_HSCT" .
<Darbazine> <Brand_name_of> "Dacarbazine" .
<R-CP> <Has_modality> "Chemotherapy" .
<Erythropoetin_and_Lenalidomide> <Has_modality> "Growth_factor_therapy" .
<Erythropoetin_and_Lenalidomide> <Has_modality> "Chemotherapy" .
<CMFV> <Has_antineoplastic> "Vincristine" .
<CMFV> <Has_antineoplastic> "Methotrexate" .
<CMFV> <Has_antineoplastic> "Fluorouracil" .
<CMFV> <Has_antineoplastic> "Cyclophosphamide" .
<Zidovudine> <May_have_route> "Oral" .
<Mercaptopurine_and_WBRT> <Has_antineoplastic> "Mercaptopurine" .
<Mercaptopurine_and_WBRT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Spectrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Padexol> <Brand_name_of> "Paclitaxel" .
<NovoTTF-100A_monotherapy> <Is_current_in> "Glioblastoma" .
<BCNU/TT,_then_auto_HSCT> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Elo-Rd> <Is_current_in> "Multiple_myeloma" .
<Temsirolimus_and_Rituximab> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Pomalidomide_monotherapy> <Has_antineoplastic> "Pomalidomide" .
<Carboplatin_and_Vincristine> <Is_a> "Platinum_doublet" .
<Anti-CD19_antibody> <Subsumes> "MOR208" .
<Anti-CD19_antibody> <Subsumes> "Denintuzumab_mafodotin" .
<Anti-CD19_antibody> <Subsumes> "Coltuximab_ravtansine" .
<Anti-CD19_antibody> <Subsumes> "Blinatumomab" .
<Capecitabine,_Cisplatin,_RT> <Has_modality> "Radiotherapy" .
<Capecitabine,_Cisplatin,_RT> <Has_modality> "Chemotherapy" .
<BCG_and_Dacarbazine> <Maps_to> "BCG_and_Dacarbazine" .
<Ufur> <Brand_name_of> "Tegafur_and_uracil" .
<Egybort> <Brand_name_of> "Bortezomib" .
<Pemetrexed_and_Pembrolizumab> <Maps_to> "Pemetrexed_and_Pembrolizumab" .
<Ketoconazole_and_Hydrocortisone> <Has_modality> "Hormonotherapy" .
<Avatrombopag> <Has_brand_name> "Doptelet" .
<Cemiplimab> <Has_brand_name> "Libtayo" .
<BuFlu,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<BuFlu,_then_allo_HSCT> <Has_modality> "Immunosuppressive_therapy" .
<BuFlu,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<Graft_versus_host_disease> <Accepted_use_of> "Sirolimus,_Tacrolimus,_Prednisone" .
<Graft_versus_host_disease> <Accepted_use_of> "Ruxolitinib" .
<Graft_versus_host_disease> <Accepted_use_of> "Rabbit_ATG" .
<Graft_versus_host_disease> <Accepted_use_of> "Methotrexate,_Tacrolimus,_Vorinostat" .
<Graft_versus_host_disease> <Accepted_use_of> "Methotrexate,_Tacrolimus,_Tocilizumab" .
<Graft_versus_host_disease> <Accepted_use_of> "Methotrexate_and_Tacrolimus" .
<Graft_versus_host_disease> <Accepted_use_of> "Ibrutinib_monotherapy" .
<Graft_versus_host_disease> <Accepted_use_of> "Ibrutinib" .
<Graft_versus_host_disease> <Accepted_use_of> "Cyclosporine,_Sirolimus,_Prednisone" .
<Graft_versus_host_disease> <Accepted_use_of> "Cyclosporine,_Mycophenolate_mofetil,_Sirolimus" .
<Graft_versus_host_disease> <Accepted_use_of> "Cyclosporine,_Methotrexate,_Prednisone" .
<Graft_versus_host_disease> <Accepted_use_of> "Cyclosporine,_Methotrexate,_Methylprednisolone" .
<Graft_versus_host_disease> <Accepted_use_of> "Cyclosporine,_Methotrexate,_ATG" .
<Graft_versus_host_disease> <Accepted_use_of> "Cyclosporine,_Corticosteroids,_Rituximab" .
<Graft_versus_host_disease> <Accepted_use_of> "Cyclosporine_and_Prednisone" .
<Graft_versus_host_disease> <Accepted_use_of> "Cyclosporine_and_Mycophenolate_mofetil" .
<Graft_versus_host_disease> <Accepted_use_of> "Cyclosporine_and_Methotrexate" .
<Graft_versus_host_disease> <Accepted_use_of> "Cyclophosphamide,_Mycophenolate_mofetil,_Tacrolimus" .
<Graft_versus_host_disease> <Accepted_use_of> "Antithymocyte_globulin_rabbit_ATG" .
<Graft_versus_host_disease> <Accepted_use_of> "Antithymocyte_globulin_horse_ATG" .
<HDMP> <Has_context> "Non-curative_subsequent-line_therapy" .
<DDGP> <Has_context> "All_lines_of_therapy" .
<Decima> <Brand_name_of> "Decitabine" .
<Immunotherapeutic> <Subsumes> "Varlilumab" .
<Immunotherapeutic> <Subsumes> "Tremelimumab" .
<Immunotherapeutic> <Subsumes> "Thalidomide" .
<Immunotherapeutic> <Subsumes> "T-cell_activator" .
<Immunotherapeutic> <Subsumes> "Ropeginterferon_alfa-2b" .
<Immunotherapeutic> <Subsumes> "Radioimmunotherapeutic" .
<Immunotherapeutic> <Subsumes> "Pidilizumab" .
<Immunotherapeutic> <Subsumes> "Pembrolizumab" .
<Immunotherapeutic> <Subsumes> "Peginterferon_alfa-2b" .
<Immunotherapeutic> <Subsumes> "Peginterferon_alfa-2a" .
<Immunotherapeutic> <Subsumes> "Obinutuzumab" .
<Immunotherapeutic> <Subsumes> "Nivolumab" .
<Immunotherapeutic> <Subsumes> "Lapuleucel-T" .
<Immunotherapeutic> <Subsumes> "Ipilimumab" .
<Immunotherapeutic> <Subsumes> "Interferon_gamma-1b" .
<Immunotherapeutic> <Subsumes> "Interferon_alfa-2b" .
<Immunotherapeutic> <Subsumes> "Immunomodulatory_drugs_(IMiDs)" .
<Immunotherapeutic> <Subsumes> "IPH_2101" .
<Immunotherapeutic> <Subsumes> "Hu5F9-G4" .
<Immunotherapeutic> <Subsumes> "Epratuzumab" .
<Immunotherapeutic> <Subsumes> "Durvalumab" .
<Immunotherapeutic> <Subsumes> "Denileukin_diftitox" .
<Immunotherapeutic> <Subsumes> "Cytokine" .
<Immunotherapeutic> <Subsumes> "Coltuximab_ravtansine" .
<Immunotherapeutic> <Subsumes> "Cemiplimab" .
<Immunotherapeutic> <Subsumes> "Cellular_therapy" .
<Immunotherapeutic> <Subsumes> "Catumaxomab" .
<Immunotherapeutic> <Subsumes> "Blinatumomab" .
<Immunotherapeutic> <Subsumes> "Bavituximab" .
<Immunotherapeutic> <Subsumes> "Bacillus_Calmette-Guerin" .
<Immunotherapeutic> <Subsumes> "Avelumab" .
<Immunotherapeutic> <Subsumes> "Atezolizumab" .
<Immunotherapeutic> <Subsumes> "Anti-CD20_medication" .
<Immunotherapeutic> <Subsumes> "Alemtuzumab" .
<Immunotherapeutic> <Subsumes> "Aldesleukin" .
<Immunotherapeutic> <Subsumes> "AMG_330" .
<Trastuzumab_and_ET> <Is_a> "Antiestrogen-containing_regimen" .
<Osetron> <Brand_name_of> "Ondansetron" .
<Rabbit_ATG> <Has_context> "Prophylaxis" .
<COPADM> <Has_context> "Maintenance_after_upfront_therapy" .
<COPADM> <Has_context> "Induction_therapy" .
<Valrubicin> <Has_brand_name> "Valtaxin" .
<Valrubicin> <Has_brand_name> "Valstar" .
<PEN> <Maps_to> "PEN" .
<Colchicine_monotherapy> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<Chlorambucil> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Chlorambucil> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Chlorambucil> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Chlorambucil> <Has_accepted_use> "Hodgkin_lymphoma" .
<Chlorambucil> <Has_accepted_use> "Follicular_lymphoma" .
<Chlorambucil> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Dara-VMP> <Has_supportive_med> "Dexamethasone" .
<Vinflunine_monotherapy> <Has_modality> "Chemotherapy" .
<CMC> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Prednisone_and_Rituximab> <Has_modality> "Immunosuppressive_therapy" .
<Upfront_therapy> <Subsumes> "Pre-definitive_therapy" .
<Upfront_therapy> <Subsumes> "Post-definitive_therapy" .
<Upfront_therapy> <Subsumes> "Definitive_therapy" .
<ABV_(Vincristine)> <Has_modality> "Chemotherapy" .
<Etoposide_and_Prednisone> <Has_context> "Induction_therapy" .
<Yescarta> <Brand_name_of> "Axicabtagene_ciloleucel" .
<Cyclophosphamide,_Fludarabine,_Thiotepa> <Has_context> "All_lines_of_therapy" .
<ABCP> <Has_antineoplastic> "Paclitaxel" .
<ABCP> <Has_antineoplastic> "Carboplatin" .
<ABCP> <Has_antineoplastic> "Bevacizumab" .
<ABCP> <Has_antineoplastic> "Atezolizumab" .
<ZRd> <Mapped_from> "ZRd" .
<Carboplatin,_Docetaxel,_Prednisone> <Mapped_from> "Carboplatin,_Docetaxel,_Prednisone" .
<Steroid_synthesis_inhibitor> <Subsumes> "Orteronel" .
<Steroid_synthesis_inhibitor> <Subsumes> "Letrozole" .
<Steroid_synthesis_inhibitor> <Subsumes> "Galeterone" .
<Steroid_synthesis_inhibitor> <Subsumes> "Exemestane" .
<Steroid_synthesis_inhibitor> <Subsumes> "Anastrozole" .
<Steroid_synthesis_inhibitor> <Subsumes> "Aminoglutethimide" .
<Steroid_synthesis_inhibitor> <Subsumes> "Abiraterone" .
<O_Fluor> <Brand_name_of> "Fluorouracil" .
<CMC> <Has_antineoplastic> "Mitoxantrone" .
<CMC> <Has_antineoplastic> "Cyclophosphamide" .
<CMC> <Has_antineoplastic> "Cladribine" .
<Bivalirudin> <Supportive_med_of> "Bivalirudin_monotherapy" .
<Anti-CD22_antibody> <Subsumes> "Moxetumomab_pasudotox" .
<Anti-CD22_antibody> <Subsumes> "Inotuzumab_ozogamicin" .
<Anti-CD22_antibody> <Subsumes> "Epratuzumab" .
<Anti-CD22_antibody> <Subsumes> "BL22_immunotoxin" .
<Idaru> <Brand_name_of> "Idarubicin" .
<GVP> <Mapped_from> "GVP" .
<R-BL> <Has_context> "Non-curative_therapy" .
<R-BL> <Has_context> "Non-curative_subsequent-line_therapy" .
<R-BL> <Has_context> "Induction_therapy" .
<CEV_(Carboplatin/Etoposide)> <Is_historical_in> "Small_cell_lung_cancer" .
<Clofarabine> <Antineoplastic_of> "Clofarabine_monotherapy" .
<Clofarabine> <Antineoplastic_of> "Clofarabine_and_Melphalan,_then_allo_HSCT" .
<Clofarabine> <Antineoplastic_of> "Clofarabine_and_Melphalan" .
<Clofarabine> <Antineoplastic_of> "Clofarabine_and_LoDAC/Decitabine" .
<Clofarabine> <Antineoplastic_of> "Clofarabine_and_LoDAC" .
<Clofarabine> <Antineoplastic_of> "Clofarabine_and_Cytarabine" .
<Clofarabine> <Antineoplastic_of> "CLARA" .
<Clofarabine> <Antineoplastic_of> "CIA" .
<Clofarabine> <Antineoplastic_of> "CCE" .
<Dexone> <Brand_name_of> "Dexamethasone" .
<FUOX> <Has_modality> "Chemotherapy" .
<Bortezomib_and_Doxorubicin_liposomal> <Mapped_from> "Bortezomib_and_Doxorubicin_liposomal" .
<ProMACE-MOPP> <Is_historical_in> "Follicular_lymphoma" .
<ProMACE-MOPP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Bioposide> <Brand_name_of> "Etoposide" .
<Methotrexate> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Methotrexate> <Has_accepted_use> "Small_cell_lung_cancer" .
<Methotrexate> <Has_accepted_use> "Prostate_cancer" .
<Methotrexate> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Methotrexate> <Has_accepted_use> "Penile_cancer" .
<Methotrexate> <Has_accepted_use> "Osteosarcoma" .
<Methotrexate> <Has_accepted_use> "NK-_and_T-cell_lymphoma" .
<Methotrexate> <Has_accepted_use> "Medulloblastoma" .
<Methotrexate> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Methotrexate> <Has_accepted_use> "Large_granular_lymphocytic_leukemia" .
<Methotrexate> <Has_accepted_use> "Langerhans_cell_histiocytosis" .
<Methotrexate> <Has_accepted_use> "Hemophagocytic_lymphohistiocytosis" .
<Methotrexate> <Has_accepted_use> "Head_and_neck_cancer" .
<Methotrexate> <Has_accepted_use> "HIV-associated_lymphoma" .
<Methotrexate> <Has_accepted_use> "Gestational_trophoblastic_neoplasia" .
<Methotrexate> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Methotrexate> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Methotrexate> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Methotrexate> <Has_accepted_use> "CNS_lymphoma" .
<Methotrexate> <Has_accepted_use> "CNS_leukemia" .
<Methotrexate> <Has_accepted_use> "Burkitt_lymphoma" .
<Methotrexate> <Has_accepted_use> "Breast_cancer" .
<Methotrexate> <Has_accepted_use> "Bladder_cancer" .
<Methotrexate> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Methotrexate> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<Methotrexate> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Antiviral> <Subsumes> "Zidovudine" .
<Antiviral> <Subsumes> "Valganciclovir" .
<Antiviral> <Subsumes> "Valacyclovir" .
<Antiviral> <Subsumes> "Lamivudine" .
<Antiviral> <Subsumes> "Famciclovir" .
<Antiviral> <Subsumes> "Acyclovir" .
<FC,_then_allo_HSCT> <Mapped_from> "FC,_then_allo_HSCT" .
<Temsirolimus_monotherapy> <Has_modality> "Chemotherapy" .
<Biceltis> <Brand_name_of> "Trastuzumab" .
<ATRA_and_Daunorubicin> <Is_current_in> "Acute_promyelocytic_leukemia" .
<Whole_abdominal_radiation_(WAI)> <Has_accepted_use> "Endometrial_cancer" .
<Iron_sucrose> <Has_brand_name> "Venofer" .
<mCOP/MP> <Is_historical_in> "Multiple_myeloma" .
<Erdafitinib_monotherapy> <Is_current_in> "Bladder_cancer" .
<BR_and_Polatuzumab_vedotin> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<ddA> <Has_supportive_med> "Filgrastim" .
<Daunorubicin_and_Prednisone> <Is_a> "Anthracycline-containing_regimen" .
<PAD> <Has_supportive_med> "Zoledronic_acid" .
<PAD> <Has_supportive_med> "Valacyclovir" .
<PAD> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<PAD> <Has_supportive_med> "Pamidronate" .
<PAD> <Has_supportive_med> "Ibandronate" .
<PAD> <Has_supportive_med> "Bisphosphonates" .
<PAD> <Has_supportive_med> "Acyclovir" .
<Mitomycin> <Is_a> "Vesicant" .
<Mitomycin> <Is_a> "DNA_synthesis_inhibitor" .
<Methylprednisolone> <Local_therapy_of> "MVBP" .
<Methylprednisolone> <Local_therapy_of> "IT_Methotrexate_and_Methylprednisolone" .
<Methylprednisolone> <Local_therapy_of> "IT_Cytarabine,_Methotrexate,_Methylprednisolone" .
<Methylprednisolone> <Local_therapy_of> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA" .
<Methylprednisolone> <Local_therapy_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab" .
<Methylprednisolone> <Local_therapy_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Erbitux> <Brand_name_of> "Cetuximab" .
<VBMCP> <Has_antineoplastic> "Vincristine" .
<VBMCP> <Has_antineoplastic> "Prednisone" .
<VBMCP> <Has_antineoplastic> "Melphalan" .
<VBMCP> <Has_antineoplastic> "Cyclophosphamide" .
<VBMCP> <Has_antineoplastic> "Carmustine" .
<RT,_then_Carmustine> <Maps_to> "RT,_then_Carmustine" .
<CEOP> <Is_a> "Anthracycline-containing_regimen" .
<Rituximab_and_hyaluronidase_human> <Is_a> "Antibody_medication" .
<Rituximab_and_hyaluronidase_human> <Is_a> "Anti-CD20_antibody" .
<O-DHAP> <Has_context> "Salvage_therapy" .
<ADT_and_Enzalutamide> <Has_antineoplastic> "GnRH_antagonists" .
<ADT_and_Enzalutamide> <Has_antineoplastic> "GnRH_agonists" .
<ADT_and_Enzalutamide> <Has_antineoplastic> "Enzalutamide" .
<ADT_and_Enzalutamide> <Has_antineoplastic> "Endocrine_ablation_surgery" .
<Pertuzumab_and_T-DM1> <Has_modality> "Chemotherapy" .
<Empirin> <Brand_name_of> "Aspirin" .
<Darbepoetin_alfa> <May_have_route> "Subcutaneous" .
<Darbepoetin_alfa> <May_have_route> "Intravenous" .
<Low-dose_TBI,_then_allo_HSCT> <Mapped_from> "Low-dose_TBI,_then_allo_HSCT" .
<CHOP-B> <Has_modality> "Chemotherapy" .
<Avelumab> <Has_accepted_use> "Renal_cell_carcinoma" .
<Avelumab> <Has_accepted_use> "Merkel_cell_carcinoma" .
<Avelumab> <Has_accepted_use> "Bladder_cancer" .
<Brentuximab_vedotin_and_Nivolumab> <Has_accepted_use> "Hodgkin_lymphoma" .
<Avelumab_monotherapy> <Has_context> "Non-curative_therapy" .
<Avelumab_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Ofev> <Brand_name_of> "Nintedanib" .
<Lepirudin> <Has_brand_name> "Refludan" .
<Panobinostat_monotherapy> <Has_modality> "Chemotherapy" .
<Medisolu> <Brand_name_of> "Methylprednisolone" .
<Dasatinib> <Antineoplastic_of> "Hyper-CVAD_and_Dasatinib" .
<Dasatinib> <Antineoplastic_of> "Dasatinib,_Vincristine,_Prednisone" .
<Dasatinib> <Antineoplastic_of> "Dasatinib_monotherapy" .
<Dasatinib> <Antineoplastic_of> "Dasatinib_and_Prednisone" .
<Docetaxel_and_Vandetanib> <Mapped_from> "Docetaxel_and_Vandetanib" .
<CRd> <Has_accepted_use> "Multiple_myeloma" .
<CRd> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Drugs_PMDA_approved_in_2017> <Subsumes> "Forodesine" .
<Bactronil> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Forodesine> <May_have_route> "Oral" .
<Afatinib> <Antineoplastic_of> "Afatinib_monotherapy" .
<Afatinib> <Antineoplastic_of> "Afatinib_and_Paclitaxel" .
<Afatinib> <Antineoplastic_of> "Afatinib_and_Cetuximab" .
<Afatinib> <Antineoplastic_of> "Afatinib_and_Bevacizumab" .
<Sirolimus_and_Prednisone> <Mapped_from> "Sirolimus_and_Prednisone" .
<MEL200,_then_auto_HSCT,_then_MEL220_and_Dexamethasone,_then_auto_HSCT> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Azacitidine_and_Sorafenib> <Maps_to> "Azacitidine_and_Sorafenib" .
<Cutaneous_squamous_cell_carcinoma> <Current_treated_by> "Observation" .
<Cutaneous_squamous_cell_carcinoma> <Current_treated_by> "Cisplatin,_Interferon_alfa-2a,_Isotretinoin" .
<Cutaneous_squamous_cell_carcinoma> <Current_treated_by> "Cisplatin_and_Doxorubicin" .
<Cutaneous_squamous_cell_carcinoma> <Current_treated_by> "Cetuximab_monotherapy" .
<Cutaneous_squamous_cell_carcinoma> <Current_treated_by> "Cemiplimab_monotherapy" .
<Cutaneous_squamous_cell_carcinoma> <Current_treated_by> "Bleomycin_and_Cisplatin" .
<Methotrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Chemotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Javlor> <Brand_name_of> "Vinflunine" .
<Dubac> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Vorinostat> <Immunosuppressor_of> "Methotrexate,_Tacrolimus,_Vorinostat" .
<Methotrexate_monotherapy> <Maps_to> "Methotrexate_monotherapy" .
<Castration> <Maps_to> "Castration" .
<Genexol> <Brand_name_of> "Paclitaxel" .
<MOPP> <Has_context> "Induction_therapy" .
<VI,_then_VDC/IE,_then_VAC,_then_VI> <Maps_to> "VI,_then_VDC/IE,_then_VAC,_then_VI" .
<Cisplatin,_Pemetrexed,_TTFields> <Maps_to> "Cisplatin,_Pemetrexed,_TTFields" .
<Selinexor_and_Dexamethasone> <Has_accepted_use> "Multiple_myeloma" .
<Mesna> <Antineoplastic_of> "SMILE" .
<Mesna> <Antineoplastic_of> "RICER" .
<Mesna> <Antineoplastic_of> "R-ICE" .
<Mesna> <Antineoplastic_of> "O-ICE" .
<Mesna> <Antineoplastic_of> "MINE" .
<Mesna> <Antineoplastic_of> "MAPI" .
<Mesna> <Antineoplastic_of> "M-EI" .
<Mesna> <Antineoplastic_of> "Ifosfamide_monotherapy" .
<Mesna> <Antineoplastic_of> "Ifosfamide_and_Vinorelbine" .
<Mesna> <Antineoplastic_of> "IP-BCD" .
<Mesna> <Antineoplastic_of> "IE" .
<Mesna> <Antineoplastic_of> "ICE" .
<Mesna> <Antineoplastic_of> "Cisplatin,_Epirubicin,_Ifosfamide" .
<Mesna> <Antineoplastic_of> "CIM" .
<Acalabrutinib_monotherapy> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Acalabrutinib_monotherapy> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Avatrombopag_monotherapy> <Has_context> "Non-curative_therapy" .
<Avatrombopag_monotherapy> <Has_context> "All_lines_of_therapy" .
<Cytarabine,_Methotrexate,_Rituximab> <Is_current_in> "CNS_lymphoma" .
<RhIG_monotherapy> <Has_supportive_med> "Rho(D)_immune_globulin" .
<RhIG_monotherapy> <Has_supportive_med> "Prednisone" .
<RhIG_monotherapy> <Has_supportive_med> "Acetaminophen" .
<Tomudex> <Brand_name_of> "Raltitrexed" .
<COMP> <Mapped_from> "COMP" .
<Crizanlizumab> <Has_brand_name> "Adakveo" .
<Methoblastin> <Brand_name_of> "Methotrexate" .
<Gemcitabine_monotherapy> <Has_antineoplastic> "Gemcitabine" .
<VIM> <Is_a> "Anthracycline-containing_regimen" .
<O-ESHAP> <Has_antineoplastic> "Ofatumumab" .
<O-ESHAP> <Has_antineoplastic> "Methylprednisolone" .
<O-ESHAP> <Has_antineoplastic> "Etoposide" .
<O-ESHAP> <Has_antineoplastic> "Cytarabine" .
<O-ESHAP> <Has_antineoplastic> "Cisplatin" .
<Etoposide_monotherapy> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Rabeprazole> <Has_brand_name> "Rablet" .
<Rabeprazole> <Has_brand_name> "Pariet" .
<Rabeprazole> <Has_brand_name> "Aciphex" .
<DRC> <Is_a> "Rituximab-containing_regimen" .
<Trabectedin_monotherapy> <Has_antineoplastic> "Trabectedin" .
<CLAG-M> <Is_a> "Anthracycline-containing_regimen" .
<Aldocumar> <Brand_name_of> "Warfarin" .
<RABVD> <Is_current_in> "Hodgkin_lymphoma" .
<VT> <Has_antineoplastic> "Thalidomide" .
<VT> <Has_antineoplastic> "Bortezomib" .
<Soluble_decoy_receptor> <Subsumes> "Ziv-aflibercept" .
<Forodesine_monotherapy> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<BR_and_Ibrutinib> <Has_modality> "Chemotherapy" .
<Carboplatin_and_Docetaxel> <Is_a> "Platinum_doublet" .
<Anabrez> <Brand_name_of> "Anastrozole" .
<ddAC-T> <Is_a> "Anthracycline-containing_regimen" .
<Dexamethasone_and_Eltrombopag> <Has_context> "Induction_therapy" .
<Azacitidine> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Azacitidine> <Has_accepted_use> "Chronic_myelomonocytic_leukemia" .
<Azacitidine> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Azacitidine_and_Vorinostat> <Has_antineoplastic> "Vorinostat" .
<Azacitidine_and_Vorinostat> <Has_antineoplastic> "Azacitidine" .
<Hodgkin_lymphoma> <FDA_indication_of> "Pembrolizumab" .
<Hodgkin_lymphoma> <FDA_indication_of> "Nivolumab" .
<Hodgkin_lymphoma> <FDA_indication_of> "Doxorubicin" .
<Hodgkin_lymphoma> <FDA_indication_of> "Cyclophosphamide" .
<Hodgkin_lymphoma> <FDA_indication_of> "Brentuximab_vedotin" .
<Copax> <Brand_name_of> "Alprazolam" .
<VAD-P> <Is_a> "Anthracycline-containing_regimen" .
<COPADM> <Has_modality> "Chemotherapy" .
<Pentostatin> <Antineoplastic_of> "Pentostatin_monotherapy" .
<Pentostatin> <Antineoplastic_of> "Pentostatin_and_Alemtuzumab" .
<Pentostatin> <Antineoplastic_of> "PCR" .
<Pentostatin> <Antineoplastic_of> "PCO" .
<Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone> <Has_modality> "Chemotherapy" .
<DCF> <Has_context> "Non-curative_first-line_therapy" .
<DCF> <Has_context> "Induction_therapy" .
<DCF> <Has_context> "All_lines_of_therapy" .
<DCF> <Has_context> "Adjuvant_therapy" .
<Zanubrutinib> <Antineoplastic_of> "Zanubrutinib_monotherapy" .
<Cisplatin_and_Vindesine> <Has_modality> "Chemotherapy" .
<Cisplatin_and_Docetaxel> <Has_context> "Non-curative_therapy" .
<Cisplatin_and_Docetaxel> <Has_context> "Non-curative_first-line_therapy" .
<Cisplatin_and_Docetaxel> <Has_context> "Neoadjuvant_therapy" .
<Cisplatin_and_Docetaxel> <Has_context> "Induction_therapy" .
<Cisplatin_and_Docetaxel> <Has_context> "All_lines_of_therapy" .
<Cisplatin_and_Docetaxel> <Has_context> "Adjuvant_therapy" .
<C-BOP> <Has_antineoplastic> "Vincristine" .
<C-BOP> <Has_antineoplastic> "Cisplatin" .
<C-BOP> <Has_antineoplastic> "Carboplatin" .
<C-BOP> <Has_antineoplastic> "Bleomycin" .
<Epidexone> <Brand_name_of> "Dexamethasone" .
<R-miniCEOP> <Has_antineoplastic> "Vinblastine" .
<R-miniCEOP> <Has_antineoplastic> "Rituximab" .
<R-miniCEOP> <Has_antineoplastic> "Prednisone" .
<R-miniCEOP> <Has_antineoplastic> "Epirubicin" .
<R-miniCEOP> <Has_antineoplastic> "Cyclophosphamide" .
<Carboplatin_and_nab-Paclitaxel> <Has_antineoplastic> "Paclitaxel_nanoparticle_albumin-bound" .
<Carboplatin_and_nab-Paclitaxel> <Has_antineoplastic> "Carboplatin" .
<Carboplatin_and_Etoposide,_then_auto_HSCT> <Is_a> "Platinum_doublet" .
<Calcineurin_inhibitor> <Subsumes> "Tacrolimus" .
<Calcineurin_inhibitor> <Subsumes> "Cyclosporine_non-modified" .
<Calcineurin_inhibitor> <Subsumes> "Cyclosporine_modified" .
<Calcineurin_inhibitor> <Subsumes> "Cyclosporine" .
<CHVP-I> <Maps_to> "CHVP-I" .
<AspaMetDex> <Has_modality> "Chemotherapy" .
<Baserin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<VAD_plus_C> <Is_current_in> "Mantle_cell_lymphoma" .
<C-MOPP/ABV> <Has_antineoplastic> "Vincristine" .
<C-MOPP/ABV> <Has_antineoplastic> "Vinblastine" .
<C-MOPP/ABV> <Has_antineoplastic> "Procarbazine" .
<C-MOPP/ABV> <Has_antineoplastic> "Prednisone" .
<C-MOPP/ABV> <Has_antineoplastic> "Doxorubicin" .
<C-MOPP/ABV> <Has_antineoplastic> "Cyclophosphamide" .
<C-MOPP/ABV> <Has_antineoplastic> "Bleomycin" .
<Cisplatin_and_Irinotecan> <Has_accepted_use> "Small_cell_lung_cancer" .
<Cisplatin_and_Irinotecan> <Has_accepted_use> "Penile_cancer" .
<Cisplatin_and_Irinotecan> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cisplatin_and_Irinotecan> <Has_accepted_use> "Esophageal_cancer" .
<Cisplatin_and_Irinotecan> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<Cytarabine_and_Mitoxantrone> <Mapped_from> "Cytarabine_and_Mitoxantrone" .
<Cisplatin,_Gemcitabine,_nab-Paclitaxel> <Maps_to> "Cisplatin,_Gemcitabine,_nab-Paclitaxel" .
<VIM> <Has_antineoplastic> "Mitoxantrone" .
<VIM> <Has_antineoplastic> "Ifosfamide" .
<VIM> <Has_antineoplastic> "Etoposide" .
<Soranib> <Brand_name_of> "Sorafenib" .
<Caplacizumab_and_Plasma_exchange> <Has_context> "Induction_therapy" .
<CRD> <Mapped_from> "CRD" .
<FC,_then_allo_HSCT> <Has_context> "Non-curative_subsequent-line_consolidation_therapy" .
<FC,_then_allo_HSCT> <Has_context> "Non-curative_second-line_therapy" .
<Vinflunine> <Antineoplastic_of> "Vinflunine_monotherapy" .
<IDAC> <Mapped_from> "IDAC" .
<VEBEP> <Is_current_in> "Hodgkin_lymphoma" .
<Interferon_alfa-2a> <Antineoplastic_of> "Interferon_alfa-2a_monotherapy" .
<Interferon_alfa-2a> <Antineoplastic_of> "Interferon_alfa-2a_and_Isotretinoin" .
<Interferon_alfa-2a> <Antineoplastic_of> "Interferon_alfa-2a_and_Interleukin-2" .
<Interferon_alfa-2a> <Antineoplastic_of> "Imatinib_and_Interferon" .
<Interferon_alfa-2a> <Antineoplastic_of> "Hydroxyurea_and_Interferon_alfa-2a" .
<Interferon_alfa-2a> <Antineoplastic_of> "Dacarbazine_and_Interferon_alfa-2a" .
<Interferon_alfa-2a> <Antineoplastic_of> "Cisplatin,_Interferon_alfa-2a,_Isotretinoin" .
<Interferon_alfa-2a> <Antineoplastic_of> "Bevacizumab_and_Interferon_alfa-2a" .
<Niraparib> <Has_accepted_use> "Ovarian_cancer" .
<Fluorouracil_monotherapy> <Is_historical_in> "Gastric_cancer" .
<Fluorouracil_monotherapy> <Is_historical_in> "Colon_cancer" .
<Meditran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Imfinzi> <Brand_name_of> "Durvalumab" .
<Pirarubicin_monotherapy> <Is_a> "Anthracycline-containing_regimen" .
<Amrubicin_monotherapy> <Is_a> "Anthracycline-containing_regimen" .
<Azacitidine_and_Venetoclax> <Has_antineoplastic> "Venetoclax" .
<Azacitidine_and_Venetoclax> <Has_antineoplastic> "Azacitidine" .
<Bavituximab> <May_have_route> "Intravenous" .
<Venetoclax_and_Rituximab> <Has_context> "Non-curative_therapy" .
<Pediatric-like_GRAALL_consolidation> <Mapped_from> "Pediatric-like_GRAALL_consolidation" .
<Mercaptopurine,_Methotrexate,_Vincristine> <Has_modality> "Chemotherapy" .
<Vadastuximab_talirine> <May_have_route> "Intravenous" .
<Carboplatin,_Gemcitabine,_Bevacizumab> <Has_accepted_use> "Ovarian_cancer" .
<Bexarotene_monotherapy> <Has_antineoplastic> "Bexarotene" .
<FOLFIRI_and_Bevacizumab> <Maps_to> "FOLFIRI_and_Bevacizumab" .
<Tamoxifen_monotherapy> <Mapped_from> "Tamoxifen_monotherapy" .
<R-CHOEP-14> <Has_antineoplastic> "Vincristine" .
<R-CHOEP-14> <Has_antineoplastic> "Rituximab" .
<R-CHOEP-14> <Has_antineoplastic> "Prednisone" .
<R-CHOEP-14> <Has_antineoplastic> "Etoposide" .
<R-CHOEP-14> <Has_antineoplastic> "Doxorubicin" .
<R-CHOEP-14> <Has_antineoplastic> "Cyclophosphamide" .
<Pazopanib_monotherapy> <Has_modality> "Chemotherapy" .
<Pediatric-like_GRAALL_consolidation> <Maps_to> "Pediatric-like_GRAALL_consolidation" .
<Cisplatin,_Cetuximab,_RT> <Has_context> "Adjuvant_therapy" .
<Dacarbazine_and_Interferon_alfa-2a> <Maps_to> "Dacarbazine_and_Interferon_alfa-2a" .
<Gallbladder_cancer> <Is_a> "Hepatobiliary_cancer" .
<Trastuzumab_and_hyaluronidase_monotherapy> <Has_modality> "Chemotherapy" .
<Denileukin_diftitox> <Is_a> "Protein_expression-specific_medication" .
<Denileukin_diftitox> <Is_a> "Immunotoxin" .
<Denileukin_diftitox> <Is_a> "Immunotherapeutic" .
<Denileukin_diftitox> <Is_a> "Discontinued_drug" .
<Fondaparinux> <Has_brand_name> "Quixidar" .
<Fondaparinux> <Has_brand_name> "Arixtra" .
<CellCept> <Brand_name_of> "Mycophenolate_mofetil" .
<Carboplatin,_Etoposide,_Bevacizumab> <Has_antineoplastic> "Etoposide" .
<Carboplatin,_Etoposide,_Bevacizumab> <Has_antineoplastic> "Carboplatin" .
<Carboplatin,_Etoposide,_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Dalteparin_monotherapy> <Has_accepted_use> "Venous_thromboembolism" .
<Thymoglobulin> <Brand_name_of> "Antithymocyte_globulin_rabbit_ATG" .
<VACOP-B> <Is_a> "Anthracycline-containing_regimen" .
<Cyclotox> <Brand_name_of> "Cyclophosphamide" .
<R-DHAC> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Citodox> <Brand_name_of> "Etoposide" .
<CYVE> <Has_context> "Salvage_therapy" .
<CYVE> <Has_context> "Consolidation_after_upfront_therapy" .
<CYVE> <Has_context> "Consolidation_after_salvage_therapy" .
<CYVE> <Has_context> "All_lines_of_therapy" .
<Prednisona> <Brand_name_of> "Prednisone" .
<Vincristina> <Brand_name_of> "Vincristine" .
<Methapred> <Brand_name_of> "Methylprednisolone" .
<Letrozole_and_Ribociclib> <Is_current_in> "Breast_cancer" .
<Ravulizumab_monotherapy> <Has_immunosuppressor> "Ravulizumab" .
<Bevacizumab_and_Interferon_alfa-2a> <Is_current_in> "Renal_cell_carcinoma" .
<Pembrolizumab> <Has_accepted_use> "Small_cell_lung_cancer" .
<Pembrolizumab> <Has_accepted_use> "Renal_cell_carcinoma" .
<Pembrolizumab> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<Pembrolizumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Pembrolizumab> <Has_accepted_use> "Mismatch_repair_deficient_malignancy" .
<Pembrolizumab> <Has_accepted_use> "Merkel_cell_carcinoma" .
<Pembrolizumab> <Has_accepted_use> "Melanoma" .
<Pembrolizumab> <Has_accepted_use> "Hodgkin_lymphoma" .
<Pembrolizumab> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Pembrolizumab> <Has_accepted_use> "Head_and_neck_cancer" .
<Pembrolizumab> <Has_accepted_use> "Gastric_cancer" .
<Pembrolizumab> <Has_accepted_use> "Endometrial_cancer" .
<Pembrolizumab> <Has_accepted_use> "Colon_cancer" .
<Pembrolizumab> <Has_accepted_use> "Cervical_cancer" .
<Pembrolizumab> <Has_accepted_use> "Bladder_cancer" .
<Chidamide> <Has_brand_name> "Epidaza" .
<ABVD,_DD-DI> <Has_antineoplastic> "Vinblastine" .
<ABVD,_DD-DI> <Has_antineoplastic> "Doxorubicin" .
<ABVD,_DD-DI> <Has_antineoplastic> "Dacarbazine" .
<ABVD,_DD-DI> <Has_antineoplastic> "Bleomycin" .
<THL_(Taxol)> <Mapped_from> "THL_(Taxol)" .
<LoDAC> <Has_context> "Non-curative_subsequent-line_therapy" .
<LoDAC> <Has_context> "Non-curative_first-line_therapy" .
<LoDAC> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<LoDAC> <Has_context> "Non-curative_first-line_induction_therapy" .
<Doxorubicin_pegylated_liposomal_monotherapy> <Maps_to> "Doxorubicin_pegylated_liposomal_monotherapy" .
<Sumitran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<MCP> <Mapped_from> "MCP" .
<Glioblastoma> <FDA_indication_of> "Temozolomide" .
<Glioblastoma> <FDA_indication_of> "Carmustine_wafer_polifeprosan_20" .
<Glioblastoma> <FDA_indication_of> "Bevacizumab-awwb" .
<Glioblastoma> <FDA_indication_of> "Bevacizumab" .
<Rhabdomyosarcoma> <FDA_indication_of> "Dactinomycin" .
<Amnoid> <Brand_name_of> "Tamibarotene" .
<Edoxaban> <Has_accepted_use> "Venous_thromboembolism" .
<Ipilimumab> <Is_a> "T-cell_activator" .
<Ipilimumab> <Is_a> "PMDA_approved_drug" .
<Ipilimumab> <Is_a> "Mutation-specific_medication" .
<Ipilimumab> <Is_a> "Immunotherapeutic" .
<Ipilimumab> <Is_a> "Antibody_medication" .
<Ipilimumab> <Is_a> "Anti-CTLA-4_antibody" .
<Voriva> <Brand_name_of> "Voriconazole" .
<Bacteric> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Vincristine" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Thiotepa" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Thalidomide" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "TFC,_then_allo_HSCT" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Romidepsin_monotherapy" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Romidepsin" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Radiation_therapy" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Prednisone" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Pralatrexate_monotherapy" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Pralatrexate" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Panobinostat" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Mogamulizumab_monotherapy" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Mogamulizumab" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Methotrexate" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Lenalidomide_monotherapy" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Lenalidomide" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "HyperCHidam" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Gemcitabine_monotherapy" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Gemcitabine" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "GDPT" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "GDP" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Forodesine_monotherapy" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Forodesine" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Fludarabine" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "FluBuCy,_then_allo_HSCT" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Everolimus" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Etoposide" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Doxorubicin" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Dexamethasone" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Denileukin_diftitox" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "DHAP" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "DD-CHOP" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "DA-EPOCH" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Cytarabine" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Cyclophosphamide_and_TBI,_then_auto_HSCT" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Cyclophosphamide" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Cisplatin" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Chidamide_monotherapy" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Chidamide" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "CMED" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "CHOP-AL" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "CHOP_and_Everolimus" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "CHOP" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "CHOEP-14" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Brentuximab_vedotin_monotherapy" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Brentuximab_vedotin" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Bortezomib_and_Panobinostat" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Bortezomib" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Bendamustine_monotherapy" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Bendamustine" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Belinostat_monotherapy" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Belinostat" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "BV-CHP" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "BEAM,_then_auto_HSCT" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Alisertib" .
<Peripheral_T-cell_lymphoma> <Accepted_use_of> "Alemtuzumab" .
<Foliplus> <Brand_name_of> "Folinic_acid" .
<PET> <Is_current_in> "Breast_cancer" .
<Azacitidine_monotherapy> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Azacitidine_monotherapy> <Has_accepted_use> "Chronic_myelomonocytic_leukemia" .
<Azacitidine_monotherapy> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Primary_mediastinal_B-cell_lymphoma> <FDA_indication_of> "Pembrolizumab" .
<Primary_mediastinal_B-cell_lymphoma> <FDA_indication_of> "Axicabtagene_ciloleucel" .
<Adventan> <Brand_name_of> "Methylprednisolone" .
<Terbosulfa> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<R-EPOCH> <Is_a> "Rituximab-containing_regimen" .
<R-EPOCH> <Is_a> "Anthracycline-containing_regimen" .
<Docetaxel_and_Gemcitabine> <Is_historical_in> "Non-small_cell_lung_cancer" .
<CPX-351_monotherapy> <Has_context> "Non-curative_first-line_induction_therapy" .
<CPX-351_monotherapy> <Has_context> "Consolidation_after_upfront_therapy" .
<Pepcid> <Brand_name_of> "Famotidine" .
<ADT_and_RT> <Has_context> "Definitive_therapy" .
<R-BL> <Maps_to> "R-BL" .
<FCR> <Maps_to> "FCR" .
<ddTH_(Taxol)> <Has_supportive_med> "Pegfilgrastim" .
<Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone> <Mapped_from> "Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Polatuzumab_vedotin> <Has_FDA_indication> "Diffuse_large_B-cell_lymphoma" .
<Avatrombopag> <Is_a> "Megakaryocyte_growth_factor" .
<Avatrombopag> <Is_a> "Hematopoietic_growth_factor" .
<CAP-BOP> <Mapped_from> "CAP-BOP" .
<Pirarubicin> <Has_brand_name> "Therarubicin" .
<Pirarubicin> <Has_brand_name> "Pinorubin" .
<Pirarubicin> <Has_brand_name> "Pinorubicin" .
<R-CHOP> <Has_local_therapy> "Methotrexate" .
<R-CHOP> <Has_local_therapy> "Hydrocortisone" .
<R-CHOP> <Has_local_therapy> "Cytarabine" .
<ChlVPP/PABIOE> <Is_historical_in> "Hodgkin_lymphoma" .
<KRAS_wild-type_Colon_cancer> <Accepted_use_of> "mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)" .
<KRAS_wild-type_Colon_cancer> <Accepted_use_of> "mFOLFOX6_and_Cetuximab" .
<KRAS_wild-type_Colon_cancer> <Accepted_use_of> "mFOLFOX6" .
<KRAS_wild-type_Colon_cancer> <Accepted_use_of> "Panitumumab_monotherapy" .
<KRAS_wild-type_Colon_cancer> <Accepted_use_of> "Irinotecan_monotherapy" .
<KRAS_wild-type_Colon_cancer> <Accepted_use_of> "Irinotecan_and_Cetuximab" .
<KRAS_wild-type_Colon_cancer> <Accepted_use_of> "FOLFOXIRI_and_Panitumumab" .
<KRAS_wild-type_Colon_cancer> <Accepted_use_of> "FOLFOX4_and_Panitumumab" .
<KRAS_wild-type_Colon_cancer> <Accepted_use_of> "FOLFOX4_and_Cetuximab" .
<KRAS_wild-type_Colon_cancer> <Accepted_use_of> "FOLFOX4" .
<KRAS_wild-type_Colon_cancer> <Accepted_use_of> "FOLFIRI_and_Panitumumab" .
<KRAS_wild-type_Colon_cancer> <Accepted_use_of> "FOLFIRI_and_Cetuximab_(L-Leucovorin)" .
<KRAS_wild-type_Colon_cancer> <Accepted_use_of> "FOLFIRI_and_Cetuximab" .
<KRAS_wild-type_Colon_cancer> <Accepted_use_of> "FOLFIRI_and_Bevacizumab" .
<KRAS_wild-type_Colon_cancer> <Accepted_use_of> "FOLFIRI" .
<KRAS_wild-type_Colon_cancer> <Accepted_use_of> "Cetuximab_monotherapy" .
<KRAS_wild-type_Colon_cancer> <Accepted_use_of> "CapeOx_and_Panitumumab" .
<Azacitidine_monotherapy> <Has_antineoplastic> "Azacitidine" .
<TAD_(Tamoxifen)> <Is_historical_in> "Breast_cancer" .
<Qiftrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Everolimus_and_Rituximab> <Is_a> "Rituximab-containing_regimen" .
<FUIRI> <Maps_to> "FUIRI" .
<Clofarabine_and_LoDAC/Decitabine> <Has_antineoplastic> "Decitabine" .
<Clofarabine_and_LoDAC/Decitabine> <Has_antineoplastic> "Cytarabine" .
<Clofarabine_and_LoDAC/Decitabine> <Has_antineoplastic> "Clofarabine" .
<Hypereosinophilic_syndrome> <FDA_indication_of> "Imatinib" .
<NovoSeven> <Brand_name_of> "Factor_VIIa_recombinant" .
<Prednisolone_monotherapy> <Maps_to> "Prednisolone_monotherapy" .
<Erlotinib_and_Gemcitabine> <Has_antineoplastic> "Gemcitabine" .
<Erlotinib_and_Gemcitabine> <Has_antineoplastic> "Erlotinib" .
<Vizimpro> <Brand_name_of> "Dacomitinib" .
<CHOP-BCG> <Is_a> "Anthracycline-containing_regimen" .
<Chemotherapy> <Maps_to> "Chemotherapy" .
<Azacitidine_and_Lenalidomide> <Mapped_from> "Azacitidine_and_Lenalidomide" .
<Cusiviral> <Brand_name_of> "Acyclovir" .
<Romidepsin_monotherapy> <Has_context> "Non-curative_therapy" .
<Forodesine> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Jadenu> <Brand_name_of> "Deferasirox" .
<Cure-X> <Brand_name_of> "Oxaliplatin" .
<Ipilimumab> <Has_brand_name> "Yervoy" .
<Vincristine> <Has_accepted_use> "Wilms_tumor" .
<Vincristine> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Vincristine> <Has_accepted_use> "Transformed_lymphoma" .
<Vincristine> <Has_accepted_use> "Thymoma" .
<Vincristine> <Has_accepted_use> "Thrombotic_thrombocytopenic_purpura" .
<Vincristine> <Has_accepted_use> "Testicular_cancer" .
<Vincristine> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Vincristine> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Vincristine> <Has_accepted_use> "Small_cell_lung_cancer" .
<Vincristine> <Has_accepted_use> "Rhabdomyosarcoma" .
<Vincristine> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<Vincristine> <Has_accepted_use> "Post-transplant_lymphoproliferative_disorder" .
<Vincristine> <Has_accepted_use> "Pheochromocytoma" .
<Vincristine> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Vincristine> <Has_accepted_use> "Penile_cancer" .
<Vincristine> <Has_accepted_use> "Multiple_myeloma" .
<Vincristine> <Has_accepted_use> "Medulloblastoma" .
<Vincristine> <Has_accepted_use> "Mediastinal_gray-zone_lymphoma" .
<Vincristine> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Vincristine> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Vincristine> <Has_accepted_use> "Low-grade_glioma" .
<Vincristine> <Has_accepted_use> "Kaposi_sarcoma" .
<Vincristine> <Has_accepted_use> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<Vincristine> <Has_accepted_use> "Hodgkin_lymphoma" .
<Vincristine> <Has_accepted_use> "HIV-associated_lymphoma" .
<Vincristine> <Has_accepted_use> "Glioblastoma" .
<Vincristine> <Has_accepted_use> "Follicular_lymphoma" .
<Vincristine> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Vincristine> <Has_accepted_use> "Ewing_sarcoma" .
<Vincristine> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Vincristine> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Vincristine> <Has_accepted_use> "CNS_lymphoma" .
<Vincristine> <Has_accepted_use> "Burkitt_lymphoma" .
<Vincristine> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Vincristine> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<Vincristine> <Has_accepted_use> "Anaplastic_glioma" .
<Vincristine> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<FAC_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<FAC_and_Bevacizumab> <Is_a> "Anthracycline-containing_regimen" .
<Midostaurin> <Has_brand_name> "Rydapt" .
<Binimetinib> <Is_a> "Mutation-specific_medication" .
<Binimetinib> <Is_a> "MAP2K2_inhibitor" .
<Binimetinib> <Is_a> "MAP2K1_inhibitor" .
<Binimetinib> <Is_a> "Kinase_inhibitor" .
<Olaparib> <Has_brand_name> "Lynparza" .
<Clarithromycin_monotherapy> <Maps_to> "Clarithromycin_monotherapy" .
<Dacortin> <Brand_name_of> "Prednisone" .
<Interferon_alfa-2b_and_Thalidomide> <Mapped_from> "Interferon_alfa-2b_and_Thalidomide" .
<Nivolumab> <Antineoplastic_of> "Nivolumab,_then_Ipilimumab" .
<Nivolumab> <Antineoplastic_of> "Nivolumab_monotherapy" .
<Nivolumab> <Antineoplastic_of> "Ipilimumab,_then_Nivolumab" .
<Nivolumab> <Antineoplastic_of> "Ipilimumab_and_Nivolumab" .
<Nivolumab> <Antineoplastic_of> "Brentuximab_vedotin_and_Nivolumab" .
<RT-PEPC> <Is_a> "Rituximab-containing_regimen" .
<R-CVEP> <Mapped_from> "R-CVEP" .
<Doxorubicin_non-pegylated_liposomal_monotherapy> <Has_antineoplastic> "Non-pegylated_liposomal_doxorubicin" .
<Non-curative_first-line_consolidation_therapy> <Mapped_from> "Non-curative_first-line_consolidation_therapy" .
<THP_(Taxotere)> <Has_modality> "Chemotherapy" .
<Prednisolone_and_Rituximab> <Is_current_in> "Warm_autoimmune_hemolytic_anemia" .
<IT_Cytarabine_and_Methotrexate> <Has_accepted_use> "CNS_leukemia" .
<Ramucirumab> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Ramucirumab> <Has_FDA_indication> "Hepatocellular_carcinoma" .
<Ramucirumab> <Has_FDA_indication> "Gastric_cancer" .
<Ramucirumab> <Has_FDA_indication> "Colon_cancer" .
<Encorafenib> <Is_a> "Mutation-specific_medication" .
<Encorafenib> <Is_a> "Kinase_inhibitor" .
<Encorafenib> <Is_a> "BRAF_inhibitor" .
<ddA> <Maps_to> "ddA" .
<Cisplatin,_Gemcitabine,_Necitumumab> <Has_supportive_med> "Steroids" .
<Cisplatin,_Gemcitabine,_Necitumumab> <Has_supportive_med> "Paclitaxel" .
<Hormonoradiotherapy> <Mapped_from> "Hormonoradiotherapy" .
<Lomustine,_Methotrexate,_Procarbazine> <Has_context> "Upfront_therapy" .
<Lomustine,_Methotrexate,_Procarbazine> <Has_context> "Consolidation_after_upfront_therapy" .
<Leukemia> <Subsumes> "Acute_leukemia" .
<Bevacizumab_and_RT> <Maps_to> "Bevacizumab_and_RT" .
<CVP_(Vinblastine/Prednisone)> <Has_context> "Induction_therapy" .
<Hostacortin> <Brand_name_of> "Prednisone" .
<Ascorbic_acid> <Supportive_med_of> "Arsenic_trioxide_and_Chlorambucil" .
<CEV_(Cyclophosphamide/Etoposide)> <Is_historical_in> "Small_cell_lung_cancer" .
<IL-2_monotherapy> <Mapped_from> "IL-2_monotherapy" .
<Pemetrexed> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Pemetrexed> <Has_FDA_indication> "Mesothelioma" .
<Cyclosporine,_Corticosteroids,_Rituximab> <Has_context> "All_lines_of_therapy" .
<Pediatric_cancer> <Is_a> "Cross-disciplinary_condition" .
<Braftovi> <Brand_name_of> "Encorafenib" .
<Braftovi> <Brand_name_of> "Binimetinib" .
<Hyper-CVAD_and_Ponatinib> <Is_a> "Anthracycline-containing_regimen" .
<Post-transplant_lymphoproliferative_disorder> <Current_treated_by> "Rituximab_monotherapy" .
<Post-transplant_lymphoproliferative_disorder> <Current_treated_by> "Reduction_of_immunosuppression" .
<Post-transplant_lymphoproliferative_disorder> <Current_treated_by> "R-CP" .
<Post-transplant_lymphoproliferative_disorder> <Current_treated_by> "R-CHOP" .
<Post-transplant_lymphoproliferative_disorder> <Current_treated_by> "R,_then_CHOP" .
<Post-transplant_lymphoproliferative_disorder> <Current_treated_by> "ACVBP,_dose-adjusted" .
<Bicalutamide_and_Goserelin> <Is_current_in> "Prostate_cancer" .
<Erlotinib_and_Ramucirumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<ATG_(Rabbit)_monotherapy> <Maps_to> "ATG_(Rabbit)_monotherapy" .
<Danaparoid> <Is_a> "Low_molecular_weight_heparin" .
<Danaparoid> <Is_a> "Heparin" .
<Danaparoid> <Is_a> "Discontinued_drug" .
<Danaparoid> <Is_a> "Anticoagulant" .
<Octreotide> <Has_brand_name> "Sandostatine" .
<Octreotide> <Has_brand_name> "Sandostatina" .
<Octreotide> <Has_brand_name> "Sandostatin" .
<Octreotide> <Has_brand_name> "Samilstin" .
<Octreotide> <Has_brand_name> "Proclose" .
<Octreotide> <Has_brand_name> "Okeron" .
<Octreotide> <Has_brand_name> "Octride" .
<Octreotide> <Has_brand_name> "Octrestatin" .
<Octreotide> <Has_brand_name> "Longastatina" .
<Doxorubicin,_Methotrexate,_Vincristine,_Prednisone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Carboplatin,_Fluorouracil,_Cetuximab,_RT> <Has_context> "Definitive_therapy" .
<COPP_(CCNU)> <Is_historical_in> "Hodgkin_lymphoma" .
<Pemetrexed> <Has_accepted_use> "Ovarian_cancer" .
<Pemetrexed> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Pemetrexed> <Has_accepted_use> "Mesothelioma" .
<Pemetrexed> <Has_accepted_use> "Cervical_cancer" .
<Pemetrexed> <Has_accepted_use> "Breast_cancer" .
<Pemetrexed> <Has_accepted_use> "Bladder_cancer" .
<NTRK-mutated_malignancy> <Current_treated_by> "Larotrectinib_monotherapy" .
<NTRK-mutated_malignancy> <Current_treated_by> "Entrectinib_monotherapy" .
<Antithymocyte_globulin> <Is_a> "Immunosuppressant" .
<Erlotinib_and_Gemcitabine> <Mapped_from> "Erlotinib_and_Gemcitabine" .
<Plerixafor_monotherapy> <Has_context> "All_lines_of_therapy" .
<Hydrocortisone> <Supportive_med_of> "SMILE" .
<Hydrocortisone> <Supportive_med_of> "Paclitaxel_monotherapy" .
<Hydrocortisone> <Supportive_med_of> "Mitotane_monotherapy" .
<Hydrocortisone> <Supportive_med_of> "Mitotane_and_Streptozocin" .
<Hydrocortisone> <Supportive_med_of> "Cyclophosphamide,_Etoposide,_TBI" .
<Hydrocortisone> <Supportive_med_of> "CFAR" .
<Hydrocortisone> <Supportive_med_of> "Aminoglutethimide_monotherapy" .
<Hydrocortisone> <Supportive_med_of> "Alemtuzumab_monotherapy" .
<Gemtuzumab_ozogamicin> <Is_a> "Protein_expression-specific_medication" .
<Gemtuzumab_ozogamicin> <Is_a> "FDA_approved_drug" .
<Gemtuzumab_ozogamicin> <Is_a> "Enediyne_antibiotic" .
<Gemtuzumab_ozogamicin> <Is_a> "Antibody-drug_conjugate" .
<Gemtuzumab_ozogamicin> <Is_a> "Antibody_medication" .
<Gemtuzumab_ozogamicin> <Is_a> "Anti-CD33_antibody" .
<VNCOP-B> <Has_antineoplastic> "Vincristine" .
<VNCOP-B> <Has_antineoplastic> "Prednisone" .
<VNCOP-B> <Has_antineoplastic> "Mitoxantrone" .
<VNCOP-B> <Has_antineoplastic> "Etoposide" .
<VNCOP-B> <Has_antineoplastic> "Cyclophosphamide" .
<VNCOP-B> <Has_antineoplastic> "Bleomycin" .
<Carboplatin_and_Pemetrexed> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Carboplatin_and_Pemetrexed> <Has_accepted_use> "Mesothelioma" .
<Carboplatin_and_Pemetrexed> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<Carboplatin_and_Pemetrexed> <Has_accepted_use> "ALK-positive_Non-small_cell_lung_cancer" .
<Microbid> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<R-CHOP_(Rituximab_Hycela)> <Has_context> "Induction_therapy" .
<Bortezomib_and_Vorinostat> <Maps_to> "Bortezomib_and_Vorinostat" .
<Microsupos_Amigdalar> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CISCA/VB> <Has_accepted_use> "Testicular_cancer" .
<Espectroprima> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Precortisyl> <Brand_name_of> "Prednisolone" .
<CPR> <Has_accepted_use> "Multiple_myeloma" .
<Predicort> <Brand_name_of> "Prednisolone" .
<Lapatinib_and_Trastuzumab> <Is_current_in> "Colon_cancer" .
<Lapatinib_and_Trastuzumab> <Is_current_in> "Breast_cancer" .
<Erythropoietin_monotherapy> <Is_current_in> "Myelodysplastic_syndrome" .
<V-HyperCAD> <Maps_to> "V-HyperCAD" .
<IRd> <Has_antineoplastic> "Lenalidomide" .
<IRd> <Has_antineoplastic> "Ixazomib" .
<IRd> <Has_antineoplastic> "Dexamethasone" .
<L-Asparaginase,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Vincristine" .
<L-Asparaginase,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Dexamethasone" .
<L-Asparaginase,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Asparaginase" .
<Cisplatin_and_Cetuximab> <Has_modality> "Chemotherapy" .
<Elo-VD> <Has_context> "Non-curative_therapy" .
<nab-Paclitaxel_monotherapy> <Has_supportive_med> "Vinorelbine" .
<nab-Paclitaxel_monotherapy> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<nab-Paclitaxel_monotherapy> <Has_supportive_med> "Furosemide" .
<nab-Paclitaxel_monotherapy> <Has_supportive_med> "Filgrastim" .
<nab-Paclitaxel_monotherapy> <Has_supportive_med> "Cisplatin" .
<Erleada> <Brand_name_of> "Apalutamide" .
<Decaspray> <Brand_name_of> "Dexamethasone" .
<Carboplatin_and_Doxorubicin_liposomal> <Is_current_in> "Ovarian_cancer" .
<Carboplatin_and_Doxorubicin_liposomal> <Is_current_in> "Endometrial_cancer" .
<MT-R> <Has_supportive_med> "Folinic_acid" .
<Trabectedin_monotherapy> <Has_context> "Non-curative_therapy" .
<Trabectedin_monotherapy> <Has_context> "All_lines_of_therapy" .
<VMCP/VBAP> <Has_modality> "Chemotherapy" .
<DES_monotherapy> <Has_antineoplastic> "Diethylstilbestrol" .
<Uno-Enantone> <Brand_name_of> "Leuprolide" .
<Intravenous_immunoglobulin_monotherapy> <Has_context> "Induction_therapy" .
<Binimetinib,_Encorafenib,_Cetuximab> <Maps_to> "Binimetinib,_Encorafenib,_Cetuximab" .
<DDGP> <Has_accepted_use> "NK-_and_T-cell_lymphoma" .
<Bevacizumab> <Has_brand_name> "Bevarest" .
<Bevacizumab> <Has_brand_name> "BevaciRel" .
<Bevacizumab> <Has_brand_name> "Avastin" .
<Bevacizumab> <Has_brand_name> "Altuzan" .
<R-MP> <Maps_to> "R-MP" .
<Metolate> <Brand_name_of> "Methotrexate" .
<Autologous_HSCT> <Current_treated_by> "Z-BEAM" .
<Autologous_HSCT> <Current_treated_by> "TBI" .
<Autologous_HSCT> <Current_treated_by> "TAM6" .
<Autologous_HSCT> <Current_treated_by> "R-TBI/Cy" .
<Autologous_HSCT> <Current_treated_by> "R-BEAM" .
<Autologous_HSCT> <Current_treated_by> "Melphalan_monotherapy" .
<Autologous_HSCT> <Current_treated_by> "Melphalan_and_TBI" .
<Autologous_HSCT> <Current_treated_by> "LEED" .
<Autologous_HSCT> <Current_treated_by> "FEAM" .
<Autologous_HSCT> <Current_treated_by> "FC" .
<Autologous_HSCT> <Current_treated_by> "Etoposide_and_TBI" .
<Autologous_HSCT> <Current_treated_by> "Cyclophosphamide,_Etoposide,_TBI" .
<Autologous_HSCT> <Current_treated_by> "Cyclophosphamide_and_TBI" .
<Autologous_HSCT> <Current_treated_by> "CYVE" .
<Autologous_HSCT> <Current_treated_by> "CTCb" .
<Autologous_HSCT> <Current_treated_by> "CHUT" .
<Autologous_HSCT> <Current_treated_by> "CBV-Mx" .
<Autologous_HSCT> <Current_treated_by> "CBV" .
<Autologous_HSCT> <Current_treated_by> "Busulfan_and_Melphalan" .
<Autologous_HSCT> <Current_treated_by> "Busulfan_and_Cyclophosphamide" .
<Autologous_HSCT> <Current_treated_by> "Bu/TT/Cy" .
<Autologous_HSCT> <Current_treated_by> "Bu/TT" .
<Autologous_HSCT> <Current_treated_by> "Bortezomib_and_Melphalan" .
<Autologous_HSCT> <Current_treated_by> "Bendamustine_monotherapy" .
<Autologous_HSCT> <Current_treated_by> "BeEAM" .
<Autologous_HSCT> <Current_treated_by> "BEAM" .
<Autologous_HSCT> <Current_treated_by> "BEAC" .
<Autologous_HSCT> <Current_treated_by> "BCNU/TT" .
<Firmagon> <Brand_name_of> "Degarelix" .
<FAC_and_BCG> <Maps_to> "FAC_and_BCG" .
<CAVE> <Mapped_from> "CAVE" .
<Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_immunosuppressor> "Tacrolimus" .
<Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_immunosuppressor> "Methotrexate" .
<Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<BHD> <Has_accepted_use> "Melanoma" .
<Tibone> <Brand_name_of> "Alendronate" .
<Flutamide_and_Leuprolide> <Mapped_from> "Flutamide_and_Leuprolide" .
<Diuretic> <Subsumes> "Furosemide" .
<Vemurafenib_monotherapy> <Mapped_from> "Vemurafenib_monotherapy" .
<Pemetero> <Brand_name_of> "Pemetrexed" .
<BEAC,_then_auto_HSCT> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<BEAC,_then_auto_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<Fludarabine_and_TBI,_then_allo_HSCT> <Has_modality> "Radiotherapy" .
<Fludarabine_and_TBI,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<Fludarabine_and_TBI,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<Gemcitabine_and_Vinorelbine> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Gemcitabine_and_Vinorelbine> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Gemcitabine_and_Vinorelbine> <Has_accepted_use> "Mesothelioma" .
<GTX> <Has_accepted_use> "Pancreatic_cancer" .
<Interferon_alfa_monotherapy> <Has_accepted_use> "Multiple_myeloma" .
<Interferon_alfa_monotherapy> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Interferon_alfa_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<Interferon_alfa_monotherapy> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Mitotane_and_Streptozocin> <Has_supportive_med> "Steroids" .
<Mitotane_and_Streptozocin> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Mitotane_and_Streptozocin> <Has_supportive_med> "Hydrocortisone" .
<Flutamide_and_Goserelin> <Has_modality> "Hormonotherapy" .
<Etoposide,_Vinblastine,_Prednisone> <Has_antineoplastic> "Vinblastine" .
<Etoposide,_Vinblastine,_Prednisone> <Has_antineoplastic> "Prednisone" .
<Etoposide,_Vinblastine,_Prednisone> <Has_antineoplastic> "Etoposide" .
<IT_Methotrexate_and_Hydrocortisone> <Is_current_in> "CNS_leukemia" .
<ddE> <Has_modality> "Chemotherapy" .
<CMFV> <Mapped_from> "CMFV" .
<Maintenance_after_upfront_therapy> <Context_of> "Sorafenib_monotherapy" .
<Maintenance_after_upfront_therapy> <Context_of> "Rituximab_monotherapy" .
<Maintenance_after_upfront_therapy> <Context_of> "POMP" .
<Maintenance_after_upfront_therapy> <Context_of> "Observation" .
<Maintenance_after_upfront_therapy> <Context_of> "Nilotinib_monotherapy" .
<Maintenance_after_upfront_therapy> <Context_of> "Midostaurin_monotherapy" .
<Maintenance_after_upfront_therapy> <Context_of> "Methotrexate,_Pegaspargase,_Vincristine" .
<Maintenance_after_upfront_therapy> <Context_of> "Methotrexate_monotherapy" .
<Maintenance_after_upfront_therapy> <Context_of> "Methotrexate_and_Vincristine" .
<Maintenance_after_upfront_therapy> <Context_of> "Methotrexate_and_Pegaspargase" .
<Maintenance_after_upfront_therapy> <Context_of> "Mercaptopurine,_Methotrexate,_WB-XRT" .
<Maintenance_after_upfront_therapy> <Context_of> "Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone" .
<Maintenance_after_upfront_therapy> <Context_of> "Mercaptopurine,_Methotrexate,_Vincristine" .
<Maintenance_after_upfront_therapy> <Context_of> "Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone" .
<Maintenance_after_upfront_therapy> <Context_of> "Mercaptopurine_and_Methotrexate" .
<Maintenance_after_upfront_therapy> <Context_of> "Lenalidomide_monotherapy" .
<Maintenance_after_upfront_therapy> <Context_of> "Imatinib,_Vincristine,_Prednisone" .
<Maintenance_after_upfront_therapy> <Context_of> "Dasatinib,_Vincristine,_Prednisone" .
<Maintenance_after_upfront_therapy> <Context_of> "Dasatinib_monotherapy" .
<Maintenance_after_upfront_therapy> <Context_of> "COPADM" .
<Maintenance_after_upfront_therapy> <Context_of> "COPAD/CYVE" .
<Maintenance_after_upfront_therapy> <Context_of> "Best_supportive_care" .
<Maintenance_after_upfront_therapy> <Context_of> "Bacillus_Calmette-Guerin_(BCG)_monotherapy" .
<Maintenance_after_upfront_therapy> <Context_of> "Arsenic_trioxide_monotherapy" .
<Maintenance_after_upfront_therapy> <Context_of> "ATRA,_Mercaptopurine,_Methotrexate" .
<Maintenance_after_upfront_therapy> <Context_of> "ATRA_monotherapy" .
<MOPP/ABVD> <Has_accepted_use> "Hodgkin_lymphoma" .
<Methylprednisolone_monotherapy> <Maps_to> "Methylprednisolone_monotherapy" .
<Azacitidine> <Has_brand_name> "Xpreza" .
<Azacitidine> <Has_brand_name> "Vidaza" .
<Azacitidine> <Has_brand_name> "Myelotex" .
<Azacitidine> <Has_brand_name> "MyAza" .
<Azacitidine> <Has_brand_name> "Citaza" .
<Azacitidine> <Has_brand_name> "Azaplast" .
<Azacitidine> <Has_brand_name> "Azafect" .
<Azacitidine> <Has_brand_name> "Azadine" .
<Azacitidine> <Has_brand_name> "Azacytin" .
<Azacitidine> <Has_brand_name> "Azacitidina" .
<Cytarabine_and_Daunorubicin> <Maps_to> "Cytarabine_and_Daunorubicin" .
<Rituximab_and_hyaluronidase_human> <May_have_route> "Subcutaneous" .
<Jakafi> <Brand_name_of> "Ruxolitinib" .
<Mitotane> <May_have_route> "Oral" .
<R-CHOP-14_(Rituximab_Hycela)> <Has_antineoplastic> "Vincristine" .
<R-CHOP-14_(Rituximab_Hycela)> <Has_antineoplastic> "Rituximab_and_hyaluronidase_human" .
<R-CHOP-14_(Rituximab_Hycela)> <Has_antineoplastic> "Rituximab" .
<R-CHOP-14_(Rituximab_Hycela)> <Has_antineoplastic> "Prednisone" .
<R-CHOP-14_(Rituximab_Hycela)> <Has_antineoplastic> "Doxorubicin" .
<R-CHOP-14_(Rituximab_Hycela)> <Has_antineoplastic> "Cyclophosphamide" .
<ACOMLA> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Aspirin_and_Dexamethasone> <Has_antineoplastic> "Dexamethasone" .
<Aspirin_and_Dexamethasone> <Has_antineoplastic> "Aspirin" .
<Erlotinib_and_Gemcitabine> <Is_current_in> "Pancreatic_cancer" .
<R-CODOX-M/R-IVAC> <Has_accepted_use> "HIV-associated_lymphoma" .
<R-CODOX-M/R-IVAC> <Has_accepted_use> "Burkitt_lymphoma" .
<T-cell_neoplasm> <Is_a> "Malignant_hematologic_neoplasm" .
<Neratinib> <Antineoplastic_of> "Neratinib_monotherapy" .
<Neratinib> <Antineoplastic_of> "Neratinib_and_Paclitaxel" .
<Neratinib> <Antineoplastic_of> "Capecitabine_and_Neratinib" .
<BiRd> <Mapped_from> "BiRd" .
<Helicobacter_pylori_eradication_therapy> <Has_modality> "Antibiotic_therapy" .
<Carboplatin,_Etoposide,_Atezolizumab> <Has_context> "Induction_therapy" .
<Temozolomide,_then_Temozolomide_and_RT,_then_Temozolomide> <Is_current_in> "Anaplastic_glioma" .
<Mikrosid> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin,_Cetuximab,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Cisplatin,_Cetuximab,_RT> <Has_antineoplastic> "Cisplatin" .
<Cisplatin,_Cetuximab,_RT> <Has_antineoplastic> "Cetuximab" .
<Naprocap> <Brand_name_of> "Capecitabine" .
<Cyclosporine,_Methotrexate,_ATG> <Mapped_from> "Cyclosporine,_Methotrexate,_ATG" .
<Etomedac> <Brand_name_of> "Etoposide" .
<AALL0232_consolidation> <Has_context> "Consolidation_after_upfront_therapy" .
<Estracit> <Brand_name_of> "Estramustine" .
<Irinotecan_and_Bevacizumab> <Maps_to> "Irinotecan_and_Bevacizumab" .
<BVCPP> <Maps_to> "BVCPP" .
<Navatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Larotrectinib_monotherapy> <Has_modality> "Chemotherapy" .
<All_lines_of_therapy> <Subsumes> "Prophylaxis" .
<All_lines_of_therapy> <Subsumes> "Non-curative_therapy" .
<All_lines_of_therapy> <Subsumes> "Local_therapy" .
<All_lines_of_therapy> <Subsumes> "Curative_therapy" .
<Crizotinib> <Has_brand_name> "Xalkori" .
<Drane> <Brand_name_of> "Danazol" .
<Cisplatin_and_Raltitrexed> <Has_modality> "Chemotherapy" .
<Genoxal> <Brand_name_of> "Cyclophosphamide" .
<Lenvatinib_and_Pembrolizumab> <Mapped_from> "Lenvatinib_and_Pembrolizumab" .
<ABCM> <Has_antineoplastic> "Melphalan" .
<ABCM> <Has_antineoplastic> "Doxorubicin" .
<ABCM> <Has_antineoplastic> "Cyclophosphamide" .
<ABCM> <Has_antineoplastic> "Carmustine" .
<Interferon_alfa_monotherapy> <Is_historical_in> "Multiple_myeloma" .
<Interferon_alfa_monotherapy> <Is_historical_in> "Follicular_lymphoma" .
<D-Cort> <Brand_name_of> "Dexamethasone" .
<FCR> <Has_antineoplastic> "Rituximab" .
<FCR> <Has_antineoplastic> "Fludarabine" .
<FCR> <Has_antineoplastic> "Cyclophosphamide" .
<Gemcitabine,_Cetuximab,_RT> <Has_context> "Induction_therapy" .
<Pertuzumab_and_Trastuzumab> <Has_accepted_use> "HER2-positive_Colon_cancer" .
<Pertuzumab_and_Trastuzumab> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<Pertuzumab_and_Trastuzumab> <Has_accepted_use> "ERBB2-mutated_malignancy" .
<Pertuzumab_and_Trastuzumab> <Has_accepted_use> "Colon_cancer" .
<Pertuzumab_and_Trastuzumab> <Has_accepted_use> "Breast_cancer" .
<mLSG15> <Has_modality> "Chemotherapy" .
<CX_and_Trastuzumab> <Mapped_from> "CX_and_Trastuzumab" .
<PATCO> <Maps_to> "PATCO" .
<PVeBV> <Has_accepted_use> "Testicular_cancer" .
<Semustine> <May_have_route> "Oral" .
<PCDE> <Has_accepted_use> "Small_cell_lung_cancer" .
<Tabine> <Brand_name_of> "Cytarabine" .
<Cyclophosphamide_and_Dexamethasone> <Has_modality> "Chemotherapy" .
<PLK1_inhibitor> <Subsumes> "Volasertib" .
<DM_Solone> <Brand_name_of> "Dexamethasone" .
<Carboplatin,_Etoposide,_Durvalumab> <Has_modality> "Chemotherapy" .
<Anti-mesothelin_antibody> <Subsumes> "Amatuximab" .
<Rabinefil> <Brand_name_of> "Vinblastine" .
<TC_and_Nintedanib> <Has_antineoplastic> "Paclitaxel" .
<TC_and_Nintedanib> <Has_antineoplastic> "Nintedanib" .
<TC_and_Nintedanib> <Has_antineoplastic> "Carboplatin" .
<Methotrexate_monotherapy> <Has_context> "Upfront_therapy" .
<Methotrexate_monotherapy> <Has_context> "Non-curative_therapy" .
<Methotrexate_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Methotrexate_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Methotrexate_monotherapy> <Has_context> "Maintenance_after_upfront_therapy" .
<Methotrexate_monotherapy> <Has_context> "Local_therapy" .
<Methotrexate_monotherapy> <Has_context> "Consolidation_after_upfront_therapy" .
<Methotrexate_monotherapy> <Has_context> "All_lines_of_therapy" .
<Cisplatin_and_Topotecan> <Has_accepted_use> "Cervical_cancer" .
<7_plus_3i_and_Panobinostat> <Has_modality> "Chemotherapy" .
<Samarium-153_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<Renal_cell_carcinoma> <Current_treated_by> "Temsirolimus_monotherapy" .
<Renal_cell_carcinoma> <Current_treated_by> "Sunitinib_monotherapy" .
<Renal_cell_carcinoma> <Current_treated_by> "Sorafenib_monotherapy" .
<Renal_cell_carcinoma> <Current_treated_by> "Regorafenib_monotherapy" .
<Renal_cell_carcinoma> <Current_treated_by> "Placebo" .
<Renal_cell_carcinoma> <Current_treated_by> "Pazopanib_monotherapy" .
<Renal_cell_carcinoma> <Current_treated_by> "Observation" .
<Renal_cell_carcinoma> <Current_treated_by> "Nivolumab_monotherapy" .
<Renal_cell_carcinoma> <Current_treated_by> "Low-dose_Interleukin-2" .
<Renal_cell_carcinoma> <Current_treated_by> "Lenvatinib_monotherapy" .
<Renal_cell_carcinoma> <Current_treated_by> "Ipilimumab_and_Nivolumab" .
<Renal_cell_carcinoma> <Current_treated_by> "Interferon_alfa-2b_monotherapy" .
<Renal_cell_carcinoma> <Current_treated_by> "Interferon_alfa-2a_monotherapy" .
<Renal_cell_carcinoma> <Current_treated_by> "Interferon_alfa-2a_and_Interleukin-2" .
<Renal_cell_carcinoma> <Current_treated_by> "High-dose_Interleukin-2" .
<Renal_cell_carcinoma> <Current_treated_by> "Gemcitabine_and_Sunitinib" .
<Renal_cell_carcinoma> <Current_treated_by> "Everolimus_monotherapy" .
<Renal_cell_carcinoma> <Current_treated_by> "Everolimus_and_Lenvatinib" .
<Renal_cell_carcinoma> <Current_treated_by> "Erlotinib_monotherapy" .
<Renal_cell_carcinoma> <Current_treated_by> "Erlotinib_and_Bevacizumab" .
<Renal_cell_carcinoma> <Current_treated_by> "Doxorubicin_and_Gemcitabine" .
<Renal_cell_carcinoma> <Current_treated_by> "Cabozantinib_monotherapy" .
<Renal_cell_carcinoma> <Current_treated_by> "Bevacizumab_monotherapy" .
<Renal_cell_carcinoma> <Current_treated_by> "Bevacizumab_and_Interferon_alfa-2a" .
<Renal_cell_carcinoma> <Current_treated_by> "Axitinib_monotherapy" .
<Renal_cell_carcinoma> <Current_treated_by> "Axitinib_and_Pembrolizumab" .
<Renal_cell_carcinoma> <Current_treated_by> "Axitinib_and_Avelumab" .
<Renal_cell_carcinoma> <Current_treated_by> "Atezolizumab_and_Bevacizumab" .
<Thrombotic_thrombocytopenic_purpura> <Accepted_use_of> "Vincristine_monotherapy" .
<Thrombotic_thrombocytopenic_purpura> <Accepted_use_of> "Vincristine" .
<Thrombotic_thrombocytopenic_purpura> <Accepted_use_of> "Rituximab-pvvr" .
<Thrombotic_thrombocytopenic_purpura> <Accepted_use_of> "Rituximab-abbs" .
<Thrombotic_thrombocytopenic_purpura> <Accepted_use_of> "Rituximab_monotherapy" .
<Thrombotic_thrombocytopenic_purpura> <Accepted_use_of> "Rituximab" .
<Thrombotic_thrombocytopenic_purpura> <Accepted_use_of> "Plasma_exchange" .
<Thrombotic_thrombocytopenic_purpura> <Accepted_use_of> "Methylprednisolone_monotherapy" .
<Thrombotic_thrombocytopenic_purpura> <Accepted_use_of> "Methylprednisolone" .
<Thrombotic_thrombocytopenic_purpura> <Accepted_use_of> "Caplacizumab_and_Plasma_exchange" .
<Thrombotic_thrombocytopenic_purpura> <Accepted_use_of> "Caplacizumab" .
<Zycram> <Brand_name_of> "Cyclophosphamide" .
<Afatinib_and_Cetuximab> <Mapped_from> "Afatinib_and_Cetuximab" .
<Imatinib,_Vincristine,_Dexamethasone> <Has_modality> "Chemotherapy" .
<G-CVP> <Maps_to> "G-CVP" .
<Azacitidine_and_Venetoclax> <Has_modality> "Chemotherapy" .
<ATRA,_Cytarabine,_Daunorubicin> <Is_current_in> "Acute_promyelocytic_leukemia" .
<ddT_(Taxotere)> <Has_antineoplastic> "Docetaxel" .
<Fludarabine_and_TBI> <Has_immunosuppressor> "Mycophenolate_mofetil" .
<Fludarabine_and_TBI> <Has_immunosuppressor> "Cyclosporines" .
<Selinexor_and_Dexamethasone> <Is_current_in> "Multiple_myeloma" .
<Mitomycin> <May_have_route> "Intravesical" .
<Mitomycin> <May_have_route> "Intravenous" .
<Phenothiazine> <Is_a> "Emesis_prevention" .
<Cortisone> <Antineoplastic_of> "Cortisone_monotherapy" .
<ddTH_(Taxol)> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<ddTH_(Taxol)> <Has_accepted_use> "Breast_cancer" .
<Gefonib> <Brand_name_of> "Gefitinib" .
<Stanford_V> <Maps_to> "Stanford_V" .
<ADOC> <Has_modality> "Chemotherapy" .
<Aminoglutethimide_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine> <Mapped_from> "Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine" .
<Venous_thromboembolism> <FDA_indication_of> "Apixaban" .
<Irinotecan_monotherapy> <Mapped_from> "Irinotecan_monotherapy" .
<HyperCHidam> <Has_context> "Induction_therapy" .
<PCD> <Has_context> "Non-curative_therapy" .
<Altretamine_and_Cisplatin> <Is_a> "Platinum_doublet" .
<Capecitabine_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Capecitabine_and_RT> <Has_antineoplastic> "Capecitabine" .
<Durvalumab> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Durvalumab> <Has_FDA_indication> "Bladder_cancer" .
<Tratoben> <Brand_name_of> "Methotrexate" .
<Cabozantinib_and_Erlotinib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Doxorubicin_and_Gemcitabine> <Is_a> "Anthracycline-containing_regimen" .
<Anti-IL-6R_antibody> <Is_a> "Antibody_medication" .
<Carboplatin_and_Teniposide> <Mapped_from> "Carboplatin_and_Teniposide" .
<Sandostatin> <Brand_name_of> "Octreotide" .
<Capsoid> <Brand_name_of> "Prednisolone" .
<STAMP-I> <Maps_to> "STAMP-I" .
<Altraz> <Brand_name_of> "Anastrozole" .
<Fer-Gen-Sol> <Brand_name_of> "Ferrous_sulfate" .
<Bivalirudin> <Is_a> "Direct_thrombin_inhibitor" .
<Bivalirudin> <Is_a> "Anticoagulant" .
<Pemetrexed_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<Pemetrexed_and_Bevacizumab> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Cisplatin,_Vinblastine,_RT> <Is_current_in> "Non-small_cell_lung_cancer" .
<Epithelioid_sarcoma> <FDA_indication_of> "Tazemetostat" .
<Interferon_alfa-2a_and_Isotretinoin> <Has_antineoplastic> "Isotretinoin" .
<Interferon_alfa-2a_and_Isotretinoin> <Has_antineoplastic> "Interferon_alfa-2a" .
<Fluorouracil,_Paclitaxel,_RT> <Maps_to> "Fluorouracil,_Paclitaxel,_RT" .
<Trametinib> <Has_accepted_use> "Thyroid_cancer" .
<Trametinib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Trametinib> <Has_accepted_use> "Melanoma" .
<Trametinib> <Has_accepted_use> "BRAF-mutated_malignancy" .
<Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_antineoplastic> "Melphalan" .
<Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_antineoplastic> "Fludarabine" .
<Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_antineoplastic> "Busulfan" .
<Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<CEV_(Cyclophosphamide/Etoposide)> <Maps_to> "CEV_(Cyclophosphamide/Etoposide)" .
<Sirolimus_and_Prednisone> <Has_immunosuppressor> "Sirolimus" .
<Sirolimus_and_Prednisone> <Has_immunosuppressor> "Prednisone" .
<Daunorubicin_liposomal_monotherapy> <Mapped_from> "Daunorubicin_liposomal_monotherapy" .
<BCOP> <Has_context> "Induction_therapy" .
<Pemetrexed_and_Bevacizumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Post-transplant_lymphoproliferative_disorder> <Is_a> "Lymphoproliferative_disorder" .
<Bosutinib> <Has_brand_name> "Bosulif" .
<Dexametazon> <Brand_name_of> "Dexamethasone" .
<TCHP_(Taxol)> <Is_current_in> "Breast_cancer" .
<Cytarabine,_Idarubicin,_Vorinostat> <Is_historical_in> "Acute_myeloid_leukemia" .
<Cisplatin_monotherapy> <Mapped_from> "Cisplatin_monotherapy" .
<GVD> <Has_modality> "Chemotherapy" .
<IRd> <Has_accepted_use> "Multiple_myeloma" .
<Taclipaxol> <Brand_name_of> "Paclitaxel" .
<Provenge> <Brand_name_of> "Sipuleucel-T" .
<Non-pegylated_liposomal_doxorubicin> <Has_accepted_use> "Breast_cancer" .
<MPV> <Has_local_therapy> "Methotrexate" .
<LD-ACOP-B> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Capecitabine,_Mitomycin,_RT> <Mapped_from> "Capecitabine,_Mitomycin,_RT" .
<WHIM_syndrome> <Current_treated_by> "Plerixafor_monotherapy" .
<Steroid> <Subsumes> "Prednisone" .
<Steroid> <Subsumes> "Prednisolone" .
<Steroid> <Subsumes> "Methylprednisolone" .
<Steroid> <Subsumes> "Hydrocortisone" .
<Steroid> <Subsumes> "Dexamethasone" .
<Steroid> <Subsumes> "Cortisone" .
<CAV/PE> <Maps_to> "CAV/PE" .
<PCV> <Is_current_in> "Low-grade_glioma" .
<PCV> <Is_current_in> "Glioblastoma" .
<PCV> <Is_current_in> "Anaplastic_glioma" .
<FluCam> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<GCD> <Mapped_from> "GCD" .
<Fluorouracil,_Oxaliplatin,_RT> <Is_current_in> "Rectal_cancer" .
<Fluorouracil,_Oxaliplatin,_RT> <Is_current_in> "Esophageal_cancer" .
<Jasotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Oxaliplatin_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Hexa-CAF> <Has_context> "Non-curative_first-line_therapy" .
<EGFR-mutated_malignancy> <Current_treated_by> "Erlotinib_monotherapy" .
<Vincristine_liposomal> <Antineoplastic_of> "Vincristine_liposomal_monotherapy" .
<Vincristine_liposomal> <Antineoplastic_of> "R-CHMP" .
<Letrozol> <Brand_name_of> "Letrozole" .
<Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<AspaMetDex> <Has_antineoplastic> "Methotrexate" .
<AspaMetDex> <Has_antineoplastic> "Dexamethasone" .
<AspaMetDex> <Has_antineoplastic> "Asparaginase" .
<BCVPP> <Has_accepted_use> "Hodgkin_lymphoma" .
<Cyclosporine_monotherapy> <Is_current_in> "Myelodysplastic_syndrome" .
<Cyclosporine_monotherapy> <Is_current_in> "Immune_thrombocytopenia" .
<Cyclosporine_monotherapy> <Is_current_in> "Castleman_disease" .
<Cyclosporine_monotherapy> <Is_current_in> "Aplastic_anemia" .
<Cyclophosphamide,_Lomustine,_Methotrexate> <Has_accepted_use> "Small_cell_lung_cancer" .
<BuCyTBI,_then_allo_HSCT> <Has_context> "Non-curative_therapy" .
<Non-curative_therapy> <Context_of> "nab-Paclitaxel_monotherapy" .
<Non-curative_therapy> <Context_of> "mFOLFOX6_and_Cetuximab" .
<Non-curative_therapy> <Context_of> "mFOLFOX6_(L-Leucovorin)" .
<Non-curative_therapy> <Context_of> "mFOLFOX6" .
<Non-curative_therapy> <Context_of> "eBEACOPP_(Prednisolone)" .
<Non-curative_therapy> <Context_of> "eBEACOPP" .
<Non-curative_therapy> <Context_of> "Zanubrutinib_monotherapy" .
<Non-curative_therapy> <Context_of> "ZRd" .
<Non-curative_therapy> <Context_of> "Vorinostat_monotherapy" .
<Non-curative_therapy> <Context_of> "Vorinostat_and_Rituximab" .
<Non-curative_therapy> <Context_of> "Vismodegib_monotherapy" .
<Non-curative_therapy> <Context_of> "Vinorelbine_monotherapy" .
<Non-curative_therapy> <Context_of> "Vincristine_monotherapy" .
<Non-curative_therapy> <Context_of> "Vincristine_liposomal_monotherapy" .
<Non-curative_therapy> <Context_of> "Vinblastine_monotherapy" .
<Non-curative_therapy> <Context_of> "Venetoclax_monotherapy" .
<Non-curative_therapy> <Context_of> "Venetoclax_and_Rituximab" .
<Non-curative_therapy> <Context_of> "Vemurafenib_monotherapy" .
<Non-curative_therapy> <Context_of> "VTD" .
<Non-curative_therapy> <Context_of> "VR-CP" .
<Non-curative_therapy> <Context_of> "VR" .
<Non-curative_therapy> <Context_of> "VMPT" .
<Non-curative_therapy> <Context_of> "VIDE" .
<Non-curative_therapy> <Context_of> "VDC" .
<Non-curative_therapy> <Context_of> "VD" .
<Non-curative_therapy> <Context_of> "VAdCA/IE" .
<Non-curative_therapy> <Context_of> "VAdCA" .
<Non-curative_therapy> <Context_of> "VAP" .
<Non-curative_therapy> <Context_of> "VAI" .
<Non-curative_therapy> <Context_of> "VAD_and_Cyclosporine" .
<Non-curative_therapy> <Context_of> "VAD" .
<Non-curative_therapy> <Context_of> "VAC_(Adriamycin)" .
<Non-curative_therapy> <Context_of> "V-HyperCAD" .
<Non-curative_therapy> <Context_of> "Triptorelin_monotherapy" .
<Non-curative_therapy> <Context_of> "Treosulfan_monotherapy" .
<Non-curative_therapy> <Context_of> "Trastuzumab_monotherapy" .
<Non-curative_therapy> <Context_of> "Trametinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Trabectedin_monotherapy" .
<Non-curative_therapy> <Context_of> "Topotecan_monotherapy" .
<Non-curative_therapy> <Context_of> "Topotecan_and_Bevacizumab" .
<Non-curative_therapy> <Context_of> "Tisagenlecleucel_monotherapy" .
<Non-curative_therapy> <Context_of> "Thiotepa_monotherapy" .
<Non-curative_therapy> <Context_of> "Thalidomide_monotherapy" .
<Non-curative_therapy> <Context_of> "Temsirolimus_monotherapy" .
<Non-curative_therapy> <Context_of> "Temsirolimus_and_Rituximab" .
<Non-curative_therapy> <Context_of> "Temozolomide_monotherapy" .
<Non-curative_therapy> <Context_of> "Temozolomide_and_Bevacizumab" .
<Non-curative_therapy> <Context_of> "Tamoxifen_monotherapy" .
<Non-curative_therapy> <Context_of> "Talazoparib_monotherapy" .
<Non-curative_therapy> <Context_of> "TIP" .
<Non-curative_therapy> <Context_of> "TILs" .
<Non-curative_therapy> <Context_of> "TD" .
<Non-curative_therapy> <Context_of> "TC,_then_IE,_VDoxoC,_VEC" .
<Non-curative_therapy> <Context_of> "TBI,_then_auto_HSCT" .
<Non-curative_therapy> <Context_of> "TAD_(Tamoxifen)" .
<Non-curative_therapy> <Context_of> "TACE" .
<Non-curative_therapy> <Context_of> "Sunitinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Sorafenib_monotherapy" .
<Non-curative_therapy> <Context_of> "Sonidegib_monotherapy" .
<Non-curative_therapy> <Context_of> "Sirolimus_monotherapy" .
<Non-curative_therapy> <Context_of> "Sipuleucel-T_monotherapy" .
<Non-curative_therapy> <Context_of> "Selinexor_and_Dexamethasone" .
<Non-curative_therapy> <Context_of> "Samarium-153_monotherapy" .
<Non-curative_therapy> <Context_of> "STAMP-I" .
<Non-curative_therapy> <Context_of> "SMILE" .
<Non-curative_therapy> <Context_of> "S-1_monotherapy" .
<Non-curative_therapy> <Context_of> "Ruxolitinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Romiplostim_monotherapy" .
<Non-curative_therapy> <Context_of> "Romidepsin_monotherapy" .
<Non-curative_therapy> <Context_of> "Rituximab_monotherapy" .
<Non-curative_therapy> <Context_of> "Regorafenib_monotherapy" .
<Non-curative_therapy> <Context_of> "Rd" .
<Non-curative_therapy> <Context_of> "Radium-223_monotherapy" .
<Non-curative_therapy> <Context_of> "RVR" .
<Non-curative_therapy> <Context_of> "RVD" .
<Non-curative_therapy> <Context_of> "RT-PEPC" .
<Non-curative_therapy> <Context_of> "RD" .
<Non-curative_therapy> <Context_of> "R-INO" .
<Non-curative_therapy> <Context_of> "R-FND" .
<Non-curative_therapy> <Context_of> "R-FCM" .
<Non-curative_therapy> <Context_of> "R-DexaBEAM" .
<Non-curative_therapy> <Context_of> "R-CVP" .
<Non-curative_therapy> <Context_of> "R-CHOP" .
<Non-curative_therapy> <Context_of> "R-BL" .
<Non-curative_therapy> <Context_of> "R-BAC" .
<Non-curative_therapy> <Context_of> "Procarbazine_monotherapy" .
<Non-curative_therapy> <Context_of> "Pralatrexate_monotherapy" .
<Non-curative_therapy> <Context_of> "Ponatinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Pomalidomide,_Dexamethasone,_Pembrolizumab" .
<Non-curative_therapy> <Context_of> "Pomalidomide_monotherapy" .
<Non-curative_therapy> <Context_of> "Placebo" .
<Non-curative_therapy> <Context_of> "Pipobroman_monotherapy" .
<Non-curative_therapy> <Context_of> "Pertuzumab_and_Trastuzumab" .
<Non-curative_therapy> <Context_of> "Pentostatin_monotherapy" .
<Non-curative_therapy> <Context_of> "Pemetrexed_monotherapy" .
<Non-curative_therapy> <Context_of> "Pembrolizumab_monotherapy" .
<Non-curative_therapy> <Context_of> "Peginterferon_alfa-2a_monotherapy" .
<Non-curative_therapy> <Context_of> "Pd" .
<Non-curative_therapy> <Context_of> "Pazopanib_monotherapy" .
<Non-curative_therapy> <Context_of> "Panobinostat_monotherapy" .
<Non-curative_therapy> <Context_of> "Panitumumab_monotherapy" .
<Non-curative_therapy> <Context_of> "Paclitaxel_monotherapy" .
<Non-curative_therapy> <Context_of> "Paclitaxel_and_Pazopanib" .
<Non-curative_therapy> <Context_of> "Paclitaxel_and_Bevacizumab" .
<Non-curative_therapy> <Context_of> "PVD" .
<Non-curative_therapy> <Context_of> "PEP-C" .
<Non-curative_therapy> <Context_of> "PD" .
<Non-curative_therapy> <Context_of> "PCV" .
<Non-curative_therapy> <Context_of> "PCR" .
<Non-curative_therapy> <Context_of> "PCP" .
<Non-curative_therapy> <Context_of> "PCF" .
<Non-curative_therapy> <Context_of> "PCD" .
<Non-curative_therapy> <Context_of> "PAD" .
<Non-curative_therapy> <Context_of> "Ox-P" .
<Non-curative_therapy> <Context_of> "Osimertinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Omacetaxine_monotherapy" .
<Non-curative_therapy> <Context_of> "Olaparib_monotherapy" .
<Non-curative_therapy> <Context_of> "Ofatumumab_monotherapy" .
<Non-curative_therapy> <Context_of> "Observation" .
<Non-curative_therapy> <Context_of> "Obinutuzumab_monotherapy" .
<Non-curative_therapy> <Context_of> "OLF" .
<Non-curative_therapy> <Context_of> "OFAR" .
<Non-curative_therapy> <Context_of> "O-FC" .
<Non-curative_therapy> <Context_of> "O-ESHAP" .
<Non-curative_therapy> <Context_of> "NovoTTF-100A_monotherapy" .
<Non-curative_therapy> <Context_of> "Nivolumab,_then_Ipilimumab" .
<Non-curative_therapy> <Context_of> "Nivolumab_monotherapy" .
<Non-curative_therapy> <Context_of> "Niraparib_monotherapy" .
<Non-curative_therapy> <Context_of> "Nilutamide_and_Orchiectomy" .
<Non-curative_therapy> <Context_of> "Nilotinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Nelarabine_monotherapy" .
<Non-curative_therapy> <Context_of> "Mycophenolate_mofetil_monotherapy" .
<Non-curative_therapy> <Context_of> "Moxetumomab_pasudotox_monotherapy" .
<Non-curative_therapy> <Context_of> "Mogamulizumab_monotherapy" .
<Non-curative_therapy> <Context_of> "Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Non-curative_therapy> <Context_of> "Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone" .
<Non-curative_therapy> <Context_of> "Mitoxantrone_monotherapy" .
<Non-curative_therapy> <Context_of> "Mitoxantrone_and_Prednisone" .
<Non-curative_therapy> <Context_of> "Mitoxantrone_and_Hydrocortisone" .
<Non-curative_therapy> <Context_of> "Mitotane_monotherapy" .
<Non-curative_therapy> <Context_of> "Mitotane_and_Streptozocin" .
<Non-curative_therapy> <Context_of> "Mitotane_and_EDP" .
<Non-curative_therapy> <Context_of> "Mini-BEAM" .
<Non-curative_therapy> <Context_of> "Midostaurin_monotherapy" .
<Non-curative_therapy> <Context_of> "Methylprednisolone_monotherapy" .
<Non-curative_therapy> <Context_of> "Methotrexate_monotherapy" .
<Non-curative_therapy> <Context_of> "Methotrexate_and_Thiotepa" .
<Non-curative_therapy> <Context_of> "Melphalan_monotherapy" .
<Non-curative_therapy> <Context_of> "Megestrol_monotherapy" .
<Non-curative_therapy> <Context_of> "Megestrol_and_Tamoxifen" .
<Non-curative_therapy> <Context_of> "Medroxyprogesterone_monotherapy" .
<Non-curative_therapy> <Context_of> "Medroxyprogesterone_and_Tamoxifen" .
<Non-curative_therapy> <Context_of> "MINE" .
<Non-curative_therapy> <Context_of> "MAID" .
<Non-curative_therapy> <Context_of> "Low-dose_Interleukin-2" .
<Non-curative_therapy> <Context_of> "Lorlatinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Lomustine_monotherapy" .
<Non-curative_therapy> <Context_of> "Lomustine_and_Bevacizumab" .
<Non-curative_therapy> <Context_of> "Leuprolide_monotherapy" .
<Non-curative_therapy> <Context_of> "Lenvatinib_and_Pembrolizumab" .
<Non-curative_therapy> <Context_of> "Lenalidomide,_Dexamethasone,_Rituximab" .
<Non-curative_therapy> <Context_of> "Lenalidomide_monotherapy" .
<Non-curative_therapy> <Context_of> "Lenalidomide_and_Rituximab" .
<Non-curative_therapy> <Context_of> "Lenalidomide_and_Ofatumumab" .
<Non-curative_therapy> <Context_of> "L-Asparaginase,_Vincristine,_Prednisone" .
<Non-curative_therapy> <Context_of> "L-Asparaginase,_Vincristine,_Prednisolone" .
<Non-curative_therapy> <Context_of> "KRd" .
<Non-curative_therapy> <Context_of> "KPD" .
<Non-curative_therapy> <Context_of> "KD" .
<Non-curative_therapy> <Context_of> "Ixazomib_monotherapy" .
<Non-curative_therapy> <Context_of> "Ixazomib_and_Dexamethasone" .
<Non-curative_therapy> <Context_of> "Ivosidenib_monotherapy" .
<Non-curative_therapy> <Context_of> "Irinotecan,_Temozolomide,_Dinutuximab" .
<Non-curative_therapy> <Context_of> "Irinotecan_monotherapy" .
<Non-curative_therapy> <Context_of> "Irinotecan_liposomal_monotherapy" .
<Non-curative_therapy> <Context_of> "Irinotecan_and_Temozolomide" .
<Non-curative_therapy> <Context_of> "Irinotecan_and_Bevacizumab" .
<Non-curative_therapy> <Context_of> "Ipilimumab,_then_Nivolumab" .
<Non-curative_therapy> <Context_of> "Ipilimumab_monotherapy" .
<Non-curative_therapy> <Context_of> "Ipilimumab_and_RT" .
<Non-curative_therapy> <Context_of> "Ipilimumab_and_Nivolumab" .
<Non-curative_therapy> <Context_of> "Intraperitoneal_hyperthermic_mitomycin" .
<Non-curative_therapy> <Context_of> "Intraperitoneal_5-FU" .
<Non-curative_therapy> <Context_of> "Intermittent_ADT" .
<Non-curative_therapy> <Context_of> "Interferon_alfa-2b_monotherapy" .
<Non-curative_therapy> <Context_of> "Interferon_alfa-2b_and_DLI" .
<Non-curative_therapy> <Context_of> "Interferon_alfa_monotherapy" .
<Non-curative_therapy> <Context_of> "Inotuzumab_ozogamicin_monotherapy" .
<Non-curative_therapy> <Context_of> "Imatinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Ifosfamide_monotherapy" .
<Non-curative_therapy> <Context_of> "Ifosfamide_and_Vinorelbine" .
<Non-curative_therapy> <Context_of> "Ifosfamide_and_Paclitaxel" .
<Non-curative_therapy> <Context_of> "Idelalisib_monotherapy" .
<Non-curative_therapy> <Context_of> "Idelalisib_and_Rituximab" .
<Non-curative_therapy> <Context_of> "Idelalisib_and_Ofatumumab" .
<Non-curative_therapy> <Context_of> "Icotinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Ibrutinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Ibrutinib_and_Venetoclax" .
<Non-curative_therapy> <Context_of> "Ibrutinib_and_Rituximab" .
<Non-curative_therapy> <Context_of> "Ibrutinib_and_Ofatumumab" .
<Non-curative_therapy> <Context_of> "Ibritumomab_tiuxetan_monotherapy" .
<Non-curative_therapy> <Context_of> "IRd" .
<Non-curative_therapy> <Context_of> "IL-2_monotherapy" .
<Non-curative_therapy> <Context_of> "IGEV" .
<Non-curative_therapy> <Context_of> "IE" .
<Non-curative_therapy> <Context_of> "ICE" .
<Non-curative_therapy> <Context_of> "Hyper-CVAD/MA_and_Everolimus" .
<Non-curative_therapy> <Context_of> "Hyper-CVAD" .
<Non-curative_therapy> <Context_of> "Hydroxyurea_monotherapy" .
<Non-curative_therapy> <Context_of> "Hydroxyurea_and_Imatinib" .
<Non-curative_therapy> <Context_of> "Histrelin_monotherapy" .
<Non-curative_therapy> <Context_of> "High-dose_Interleukin-2" .
<Non-curative_therapy> <Context_of> "Hepatic_arterial_chemotherapy" .
<Non-curative_therapy> <Context_of> "HDMP-R" .
<Non-curative_therapy> <Context_of> "Goserelin_monotherapy" .
<Non-curative_therapy> <Context_of> "Gliadel_wafer_monotherapy" .
<Non-curative_therapy> <Context_of> "Gemcitabine,_Cisplatin,_S-1" .
<Non-curative_therapy> <Context_of> "Gemcitabine_monotherapy" .
<Non-curative_therapy> <Context_of> "Gemcitabine_and_nab-Paclitaxel" .
<Non-curative_therapy> <Context_of> "Gemcitabine_and_Vinorelbine" .
<Non-curative_therapy> <Context_of> "Gemcitabine_and_S-1" .
<Non-curative_therapy> <Context_of> "Gemcitabine_and_Rituximab" .
<Non-curative_therapy> <Context_of> "Gemcitabine_and_Mitomycin" .
<Non-curative_therapy> <Context_of> "GemOx" .
<Non-curative_therapy> <Context_of> "Gefitinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Gefitinib_and_Pemetrexed" .
<Non-curative_therapy> <Context_of> "GVP" .
<Non-curative_therapy> <Context_of> "GVD" .
<Non-curative_therapy> <Context_of> "GEMOX-B" .
<Non-curative_therapy> <Context_of> "GDP" .
<Non-curative_therapy> <Context_of> "GCP" .
<Non-curative_therapy> <Context_of> "GCD-R" .
<Non-curative_therapy> <Context_of> "GCD" .
<Non-curative_therapy> <Context_of> "Fotemustine_monotherapy" .
<Non-curative_therapy> <Context_of> "Fostamatinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Forodesine_monotherapy" .
<Non-curative_therapy> <Context_of> "Formestane_monotherapy" .
<Non-curative_therapy> <Context_of> "Flutamide_monotherapy" .
<Non-curative_therapy> <Context_of> "Flutamide_and_Leuprolide" .
<Non-curative_therapy> <Context_of> "Flutamide_and_Goserelin" .
<Non-curative_therapy> <Context_of> "Fluoxymesterone_monotherapy" .
<Non-curative_therapy> <Context_of> "Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan" .
<Non-curative_therapy> <Context_of> "Fluorouracil,_Folinic_acid,_Gemcitabine" .
<Non-curative_therapy> <Context_of> "Fluorouracil_and_Folinic_acid" .
<Non-curative_therapy> <Context_of> "Fludarabine_monotherapy" .
<Non-curative_therapy> <Context_of> "Fludarabine_and_Prednisone" .
<Non-curative_therapy> <Context_of> "FluCam" .
<Non-curative_therapy> <Context_of> "FRD" .
<Non-curative_therapy> <Context_of> "FR" .
<Non-curative_therapy> <Context_of> "FOLFOX4" .
<Non-curative_therapy> <Context_of> "FOLFOX" .
<Non-curative_therapy> <Context_of> "FOLFIRI_and_Cetuximab" .
<Non-curative_therapy> <Context_of> "FOLFIRI" .
<Non-curative_therapy> <Context_of> "FMP" .
<Non-curative_therapy> <Context_of> "FLAG" .
<Non-curative_therapy> <Context_of> "FELV" .
<Non-curative_therapy> <Context_of> "FCR" .
<Non-curative_therapy> <Context_of> "FCM" .
<Non-curative_therapy> <Context_of> "Everolimus_monotherapy" .
<Non-curative_therapy> <Context_of> "Etoposide_monotherapy" .
<Non-curative_therapy> <Context_of> "Estradiol_monotherapy" .
<Non-curative_therapy> <Context_of> "Erlotinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Erlotinib_and_Ramucirumab" .
<Non-curative_therapy> <Context_of> "Erlotinib_and_Bevacizumab" .
<Non-curative_therapy> <Context_of> "Eribulin_monotherapy" .
<Non-curative_therapy> <Context_of> "Epirubicin_monotherapy" .
<Non-curative_therapy> <Context_of> "Epirubicin_and_Ifosfamide" .
<Non-curative_therapy> <Context_of> "Entrectinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Eltrombopag_monotherapy" .
<Non-curative_therapy> <Context_of> "Elo-VD" .
<Non-curative_therapy> <Context_of> "Elo-Rd" .
<Non-curative_therapy> <Context_of> "Elo-PD" .
<Non-curative_therapy> <Context_of> "ESHAP" .
<Non-curative_therapy> <Context_of> "EDAP" .
<Non-curative_therapy> <Context_of> "ECF" .
<Non-curative_therapy> <Context_of> "Duvelisib_monotherapy" .
<Non-curative_therapy> <Context_of> "Doxycycline_monotherapy" .
<Non-curative_therapy> <Context_of> "Doxorubicin,_Ifosfamide,_RT" .
<Non-curative_therapy> <Context_of> "Doxorubicin_pegylated_liposomal_monotherapy" .
<Non-curative_therapy> <Context_of> "Doxorubicin_pegylated_liposomal_and_Trabectedin" .
<Non-curative_therapy> <Context_of> "Doxorubicin_pegylated_liposomal_and_Gemcitabine" .
<Non-curative_therapy> <Context_of> "Doxorubicin_pegylated_liposomal_and_Bevacizumab" .
<Non-curative_therapy> <Context_of> "Doxorubicin_monotherapy" .
<Non-curative_therapy> <Context_of> "Doxorubicin_and_Strontium-89" .
<Non-curative_therapy> <Context_of> "Doxorubicin_and_Olaratumab" .
<Non-curative_therapy> <Context_of> "Doxorubicin_and_Ifosfamide" .
<Non-curative_therapy> <Context_of> "Docetaxel_monotherapy" .
<Non-curative_therapy> <Context_of> "Docetaxel_and_Prednisone" .
<Non-curative_therapy> <Context_of> "Docetaxel_and_Prednisolone" .
<Non-curative_therapy> <Context_of> "Docetaxel_and_Gemcitabine" .
<Non-curative_therapy> <Context_of> "Docetaxel_and_Estramustine" .
<Non-curative_therapy> <Context_of> "Docetaxel_and_Bevacizumab" .
<Non-curative_therapy> <Context_of> "Dexamethasone_monotherapy" .
<Non-curative_therapy> <Context_of> "Dexamethasone_and_Rituximab" .
<Non-curative_therapy> <Context_of> "DexaBEAM" .
<Non-curative_therapy> <Context_of> "Denileukin_diftitox_monotherapy" .
<Non-curative_therapy> <Context_of> "Degarelix_monotherapy" .
<Non-curative_therapy> <Context_of> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Non-curative_therapy> <Context_of> "Daunorubicin_and_Prednisone" .
<Non-curative_therapy> <Context_of> "Dasatinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Daratumumab_monotherapy" .
<Non-curative_therapy> <Context_of> "Dara-VD" .
<Non-curative_therapy> <Context_of> "Dara-Rd" .
<Non-curative_therapy> <Context_of> "Dara-PD" .
<Non-curative_therapy> <Context_of> "Dara-KD" .
<Non-curative_therapy> <Context_of> "Danazol_monotherapy" .
<Non-curative_therapy> <Context_of> "Dactinomycin_monotherapy" .
<Non-curative_therapy> <Context_of> "Dacomitinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Dacarbazine_monotherapy" .
<Non-curative_therapy> <Context_of> "Dacarbazine_and_Tamoxifen" .
<Non-curative_therapy> <Context_of> "Dacarbazine_and_Ipilimumab" .
<Non-curative_therapy> <Context_of> "Dacarbazine_and_Interferon_alfa-2a" .
<Non-curative_therapy> <Context_of> "Dacarbazine_and_Gemcitabine" .
<Non-curative_therapy> <Context_of> "Dacarbazine_and_Doxorubicin" .
<Non-curative_therapy> <Context_of> "Dabrafenib_monotherapy" .
<Non-curative_therapy> <Context_of> "Dabrafenib_and_Trametinib" .
<Non-curative_therapy> <Context_of> "DTPACE" .
<Non-curative_therapy> <Context_of> "DHAP_-_time_intensified" .
<Non-curative_therapy> <Context_of> "DHAP" .
<Non-curative_therapy> <Context_of> "DES_monotherapy" .
<Non-curative_therapy> <Context_of> "DEP" .
<Non-curative_therapy> <Context_of> "DCEP" .
<Non-curative_therapy> <Context_of> "Cytarabine,_Idarubicin,_Rituximab" .
<Non-curative_therapy> <Context_of> "Cytarabine_monotherapy" .
<Non-curative_therapy> <Context_of> "Cytarabine_and_Mitoxantrone" .
<Non-curative_therapy> <Context_of> "Cytarabine_and_Idarubicin" .
<Non-curative_therapy> <Context_of> "Cyproterone_acetate_monotherapy" .
<Non-curative_therapy> <Context_of> "Cyclosporine_monotherapy" .
<Non-curative_therapy> <Context_of> "Cyclophosphamide,_Prednisone,_Diethylstilbestrol" .
<Non-curative_therapy> <Context_of> "Cyclophosphamide_monotherapy" .
<Non-curative_therapy> <Context_of> "Cyclophosphamide_and_Vincristine" .
<Non-curative_therapy> <Context_of> "Cyclophosphamide_and_Topotecan" .
<Non-curative_therapy> <Context_of> "Cyclophosphamide_and_TBI,_then_allo_HSCT" .
<Non-curative_therapy> <Context_of> "Cyclophosphamide_and_Prednisone" .
<Non-curative_therapy> <Context_of> "Cyclophosphamide_and_Dexamethasone" .
<Non-curative_therapy> <Context_of> "Crizotinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Cortisone_monotherapy" .
<Non-curative_therapy> <Context_of> "Copanlisib_monotherapy" .
<Non-curative_therapy> <Context_of> "Cobimetinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Cobimetinib_and_Vemurafenib" .
<Non-curative_therapy> <Context_of> "Clofarabine_monotherapy" .
<Non-curative_therapy> <Context_of> "Clarithromycin_monotherapy" .
<Non-curative_therapy> <Context_of> "Cladribine_monotherapy" .
<Non-curative_therapy> <Context_of> "Cladribine_and_Rituximab" .
<Non-curative_therapy> <Context_of> "Cladribine_and_Cytarabine" .
<Non-curative_therapy> <Context_of> "Cisplatin,_Interferon_alfa-2a,_Isotretinoin" .
<Non-curative_therapy> <Context_of> "Cisplatin,_Gemcitabine,_nab-Paclitaxel" .
<Non-curative_therapy> <Context_of> "Cisplatin,_Etoposide,_Irinotecan" .
<Non-curative_therapy> <Context_of> "Cisplatin,_Doxorubicin,_Paclitaxel" .
<Non-curative_therapy> <Context_of> "Cisplatin,_Dacarbazine,_Tamoxifen" .
<Non-curative_therapy> <Context_of> "Cisplatin,_Dacarbazine,_Paclitaxel" .
<Non-curative_therapy> <Context_of> "Cisplatin,_Dacarbazine,_Interferon_alfa-2b" .
<Non-curative_therapy> <Context_of> "Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine" .
<Non-curative_therapy> <Context_of> "Cisplatin_monotherapy" .
<Non-curative_therapy> <Context_of> "Cisplatin_and_Pemetrexed" .
<Non-curative_therapy> <Context_of> "Cisplatin_and_Paclitaxel" .
<Non-curative_therapy> <Context_of> "Cisplatin_and_Irinotecan" .
<Non-curative_therapy> <Context_of> "Cisplatin_and_Gemcitabine/Erlotinib" .
<Non-curative_therapy> <Context_of> "Cisplatin_and_Gemcitabine" .
<Non-curative_therapy> <Context_of> "Cisplatin_and_Fluorouracil" .
<Non-curative_therapy> <Context_of> "Cisplatin_and_Etoposide" .
<Non-curative_therapy> <Context_of> "Cisplatin_and_Doxorubicin" .
<Non-curative_therapy> <Context_of> "Cisplatin_and_Docetaxel" .
<Non-curative_therapy> <Context_of> "Cisplatin_and_Dacarbazine" .
<Non-curative_therapy> <Context_of> "Chlorambucil_and_Prednisolone" .
<Non-curative_therapy> <Context_of> "Chidamide_monotherapy" .
<Non-curative_therapy> <Context_of> "Cetuximab_monotherapy" .
<Non-curative_therapy> <Context_of> "Ceritinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Cemiplimab_monotherapy" .
<Non-curative_therapy> <Context_of> "Castration" .
<Non-curative_therapy> <Context_of> "Carmustine_monotherapy" .
<Non-curative_therapy> <Context_of> "Carmustine_and_Doxorubicin" .
<Non-curative_therapy> <Context_of> "Carfilzomib_monotherapy" .
<Non-curative_therapy> <Context_of> "Carfilzomib_and_Panobinostat" .
<Non-curative_therapy> <Context_of> "Carboplatin,_Docetaxel,_Prednisone" .
<Non-curative_therapy> <Context_of> "Carboplatin_monotherapy" .
<Non-curative_therapy> <Context_of> "Carboplatin_and_nab-Paclitaxel" .
<Non-curative_therapy> <Context_of> "Carboplatin_and_Teniposide" .
<Non-curative_therapy> <Context_of> "Carboplatin_and_Pemetrexed" .
<Non-curative_therapy> <Context_of> "Carboplatin_and_Paclitaxel" .
<Non-curative_therapy> <Context_of> "Carboplatin_and_Gemcitabine/Erlotinib" .
<Non-curative_therapy> <Context_of> "Carboplatin_and_Gemcitabine" .
<Non-curative_therapy> <Context_of> "Carboplatin_and_Doxorubicin_liposomal" .
<Non-curative_therapy> <Context_of> "Carboplatin_and_Docetaxel" .
<Non-curative_therapy> <Context_of> "Carboplatin_and_Bevacizumab" .
<Non-curative_therapy> <Context_of> "Capecitabine_monotherapy" .
<Non-curative_therapy> <Context_of> "Capecitabine_and_Mitomycin" .
<Non-curative_therapy> <Context_of> "Capecitabine_and_Erlotinib" .
<Non-curative_therapy> <Context_of> "CapeOx" .
<Non-curative_therapy> <Context_of> "Cabozantinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Cabazitaxel_and_Prednisone" .
<Non-curative_therapy> <Context_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Non-curative_therapy> <Context_of> "CVD_(Vindesine)" .
<Non-curative_therapy> <Context_of> "CVD_(Vinblastine)" .
<Non-curative_therapy> <Context_of> "CTD" .
<Non-curative_therapy> <Context_of> "CTCb,_then_auto_HSCT" .
<Non-curative_therapy> <Context_of> "CRd" .
<Non-curative_therapy> <Context_of> "CRD" .
<Non-curative_therapy> <Context_of> "CPR" .
<Non-curative_therapy> <Context_of> "CMFVP" .
<Non-curative_therapy> <Context_of> "CMFV" .
<Non-curative_therapy> <Context_of> "CMFP" .
<Non-curative_therapy> <Context_of> "CMF" .
<Non-curative_therapy> <Context_of> "CIM" .
<Non-curative_therapy> <Context_of> "CHUT,_then_auto_HSCT" .
<Non-curative_therapy> <Context_of> "CHOP_(Prednisolone)" .
<Non-curative_therapy> <Context_of> "CHOP" .
<Non-curative_therapy> <Context_of> "CFP" .
<Non-curative_therapy> <Context_of> "CFAR" .
<Non-curative_therapy> <Context_of> "CDE" .
<Non-curative_therapy> <Context_of> "CDB" .
<Non-curative_therapy> <Context_of> "CCE" .
<Non-curative_therapy> <Context_of> "CAV" .
<Non-curative_therapy> <Context_of> "CAMF" .
<Non-curative_therapy> <Context_of> "CAFVP" .
<Non-curative_therapy> <Context_of> "CAF_and_MPA" .
<Non-curative_therapy> <Context_of> "Busulfan_monotherapy" .
<Non-curative_therapy> <Context_of> "Busulfan_and_Melphalan,_then_auto_HSCT" .
<Non-curative_therapy> <Context_of> "BuCyTBI,_then_allo_HSCT" .
<Non-curative_therapy> <Context_of> "Brigatinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Brentuximab_vedotin_monotherapy" .
<Non-curative_therapy> <Context_of> "Brentuximab_vedotin_and_Nivolumab" .
<Non-curative_therapy> <Context_of> "Bosutinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat" .
<Non-curative_therapy> <Context_of> "Bortezomib,_Dexamethasone,_Panobinostat" .
<Non-curative_therapy> <Context_of> "Bortezomib_monotherapy" .
<Non-curative_therapy> <Context_of> "Bortezomib_and_Vorinostat" .
<Non-curative_therapy> <Context_of> "Bortezomib_and_Panobinostat" .
<Non-curative_therapy> <Context_of> "Bortezomib_and_Doxorubicin_liposomal" .
<Non-curative_therapy> <Context_of> "Blinatumomab_monotherapy" .
<Non-curative_therapy> <Context_of> "Binimetinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Binimetinib_and_Encorafenib" .
<Non-curative_therapy> <Context_of> "Bicalutamide_monotherapy" .
<Non-curative_therapy> <Context_of> "Bicalutamide_and_Leuprolide" .
<Non-curative_therapy> <Context_of> "Bicalutamide_and_Goserelin" .
<Non-curative_therapy> <Context_of> "Bexarotene_monotherapy" .
<Non-curative_therapy> <Context_of> "Bexarotene_and_Pralatrexate" .
<Non-curative_therapy> <Context_of> "Bevacizumab_monotherapy" .
<Non-curative_therapy> <Context_of> "Bevacizumab_and_Rituximab" .
<Non-curative_therapy> <Context_of> "Best_supportive_care" .
<Non-curative_therapy> <Context_of> "Bendamustine_monotherapy" .
<Non-curative_therapy> <Context_of> "Bendamustine_and_Ofatumumab" .
<Non-curative_therapy> <Context_of> "Bendamustine_and_Obinutuzumab" .
<Non-curative_therapy> <Context_of> "Bendamustine_and_Brentuximab_vedotin" .
<Non-curative_therapy> <Context_of> "Belinostat_monotherapy" .
<Non-curative_therapy> <Context_of> "BeRT" .
<Non-curative_therapy> <Context_of> "BeGEV" .
<Non-curative_therapy> <Context_of> "Bacillus_Calmette-Guerin_(BCG)_monotherapy" .
<Non-curative_therapy> <Context_of> "BVR" .
<Non-curative_therapy> <Context_of> "BVD" .
<Non-curative_therapy> <Context_of> "BVB" .
<Non-curative_therapy> <Context_of> "BTD" .
<Non-curative_therapy> <Context_of> "BR_and_Idelalisib" .
<Non-curative_therapy> <Context_of> "BR_and_Ibrutinib" .
<Non-curative_therapy> <Context_of> "BR" .
<Non-curative_therapy> <Context_of> "BMP" .
<Non-curative_therapy> <Context_of> "BLD" .
<Non-curative_therapy> <Context_of> "BID" .
<Non-curative_therapy> <Context_of> "BHD" .
<Non-curative_therapy> <Context_of> "BEACOPP-14_(Prednisolone)" .
<Non-curative_therapy> <Context_of> "BEACOPP" .
<Non-curative_therapy> <Context_of> "BDR" .
<Non-curative_therapy> <Context_of> "BCHOP" .
<Non-curative_therapy> <Context_of> "BCG_and_Dacarbazine" .
<Non-curative_therapy> <Context_of> "BBD" .
<Non-curative_therapy> <Context_of> "Axitinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Avelumab_monotherapy" .
<Non-curative_therapy> <Context_of> "Avatrombopag_monotherapy" .
<Non-curative_therapy> <Context_of> "Avapritinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Augmented_Hyper-CVAD_and_Asparaginase" .
<Non-curative_therapy> <Context_of> "Aspirin_and_Dexamethasone" .
<Non-curative_therapy> <Context_of> "AspaMetDex_(Erwinaze)" .
<Non-curative_therapy> <Context_of> "AspaMetDex" .
<Non-curative_therapy> <Context_of> "Arsenic_trioxide_and_Chlorambucil" .
<Non-curative_therapy> <Context_of> "Anastrozole_monotherapy" .
<Non-curative_therapy> <Context_of> "Anagrelide_monotherapy" .
<Non-curative_therapy> <Context_of> "Amrubicin_monotherapy" .
<Non-curative_therapy> <Context_of> "Aminoglutethimide_monotherapy" .
<Non-curative_therapy> <Context_of> "Alpelisib_and_Fulvestrant" .
<Non-curative_therapy> <Context_of> "Alemtuzumab_monotherapy" .
<Non-curative_therapy> <Context_of> "Alemtuzumab_and_Rituximab" .
<Non-curative_therapy> <Context_of> "Alectinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Afatinib_monotherapy" .
<Non-curative_therapy> <Context_of> "Afatinib_and_Cetuximab" .
<Non-curative_therapy> <Context_of> "Afatinib_and_Bevacizumab" .
<Non-curative_therapy> <Context_of> "Acalabrutinib_monotherapy" .
<Non-curative_therapy> <Context_of> "ATRA_and_Danazol" .
<Non-curative_therapy> <Context_of> "ATG_(Rabbit)_and_Cyclosporine" .
<Non-curative_therapy> <Context_of> "ADT,_Docetaxel,_Estramustine" .
<Non-curative_therapy> <Context_of> "ADT_and_Enzalutamide" .
<Non-curative_therapy> <Context_of> "ADT_and_Docetaxel" .
<Non-curative_therapy> <Context_of> "ADT_and_Darolutamide" .
<Non-curative_therapy> <Context_of> "ADT_and_Apalutamide" .
<Non-curative_therapy> <Context_of> "ADT_and_Abiraterone" .
<Non-curative_therapy> <Context_of> "ADT" .
<Non-curative_therapy> <Context_of> "ABVD" .
<Non-curative_therapy> <Context_of> "ABC" .
<Non-curative_therapy> <Context_of> "131Iodine-Tositumomab_monotherapy" .
<Kuhlprednon> <Brand_name_of> "Prednisolone" .
<Rivaroxaban> <Is_a> "Factor_Xa_inhibitor" .
<Rivaroxaban> <Is_a> "Direct_oral_anticoagulant" .
<Edoxaban> <May_have_route> "Oral" .
<FOLFIRI> <Has_antineoplastic> "Irinotecan" .
<FOLFIRI> <Has_antineoplastic> "Folinic_acid" .
<FOLFIRI> <Has_antineoplastic> "Fluorouracil" .
<Resfolin> <Brand_name_of> "Folinic_acid" .
<Bio-Clopi> <Brand_name_of> "Clopidogrel" .
<Methotrexate,_Pegaspargase,_Vincristine> <Mapped_from> "Methotrexate,_Pegaspargase,_Vincristine" .
<Bamycor> <Brand_name_of> "Aspirin" .
<Regonix> <Brand_name_of> "Regorafenib" .
<Linker_regimen_(consolidation)> <Maps_to> "Linker_regimen_(consolidation)" .
<CNS_lymphoma> <Is_a> "CNS_cancer" .
<Gemtuzumab_ozogamicin_monotherapy> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Granisetron> <May_have_route> "Topical" .
<Granisetron> <May_have_route> "Subcutaneous" .
<Granisetron> <May_have_route> "Oral" .
<Granisetron> <May_have_route> "Intravenous" .
<Vinorelbine_monotherapy> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Vinorelbine_monotherapy> <Is_historical_in> "Breast_cancer" .
<Cladribine_and_Cytarabine> <Has_context> "Non-curative_therapy" .
<Cladribine_and_Cytarabine> <Has_context> "All_lines_of_therapy" .
<Rituximab_and_hyaluronidase_monotherapy> <Mapped_from> "Rituximab_and_hyaluronidase_monotherapy" .
<Low-dose_TBI> <Has_immunosuppressor> "Tacrolimus" .
<Low-dose_TBI> <Has_immunosuppressor> "Mycophenolate_mofetil" .
<Low-dose_TBI> <Has_immunosuppressor> "Cyclosporine_non-modified" .
<Dermidron> <Brand_name_of> "Dexamethasone" .
<Kidrolase> <Brand_name_of> "Asparaginase" .
<Fulvestrant_and_Palbociclib> <Is_a> "Antiestrogen-containing_regimen" .
<VTP> <Has_modality> "Chemotherapy" .
<Mopsoralen> <Brand_name_of> "Methoxsalen" .
<Dexamonozon_N> <Brand_name_of> "Dexamethasone" .
<Anti-CD37_antibody> <Is_a> "Antibody_medication" .
<Aracytin> <Brand_name_of> "Cytarabine" .
<Lusutrombopag> <Has_FDA_indication> "Thrombocytopenia_in_liver_disease" .
<Lamivudine> <May_have_route> "Oral" .
<Anti-IFNg_antibody> <Is_a> "Antibody_medication" .
<Doxifluridine_and_Mitomycin> <Mapped_from> "Doxifluridine_and_Mitomycin" .
<Hepatoblastoma> <Current_treated_by> "Cisplatin,_Fluorouracil,_Vincristine" .
<Hepatoblastoma> <Current_treated_by> "Cisplatin_monotherapy" .
<Hepatoblastoma> <Current_treated_by> "Cisplatin_and_Doxorubicin" .
<Dilantin> <Brand_name_of> "Phenytoin" .
<CBV> <Is_current_in> "Autologous_HSCT" .
<Duvelisib> <Has_FDA_indication> "Follicular_lymphoma" .
<Duvelisib> <Has_FDA_indication> "Chronic_lymphocytic_leukemia" .
<Fluorouracil_and_Levoleucovorin> <Maps_to> "Fluorouracil_and_Levoleucovorin" .
<TCH_(Taxotere,_Cyclophosphamide)> <Has_antineoplastic> "Trastuzumab" .
<TCH_(Taxotere,_Cyclophosphamide)> <Has_antineoplastic> "Docetaxel" .
<TCH_(Taxotere,_Cyclophosphamide)> <Has_antineoplastic> "Cyclophosphamide" .
<Zidovudine> <Has_brand_name> "Retrovir" .
<Zidovudine> <Has_brand_name> "Aztec" .
<Dexmene> <Brand_name_of> "Dexamethasone" .
<VCAP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Methotrexate_and_Pegaspargase> <Has_local_therapy> "Methotrexate" .
<GDPT> <Has_antineoplastic> "Thalidomide" .
<GDPT> <Has_antineoplastic> "Prednisone" .
<GDPT> <Has_antineoplastic> "Gemcitabine" .
<GDPT> <Has_antineoplastic> "Cisplatin" .
<PT> <Has_antineoplastic> "Tamoxifen" .
<PT> <Has_antineoplastic> "Prednisone" .
<Ibrutix> <Brand_name_of> "Ibrutinib" .
<MV> <Is_historical_in> "Breast_cancer" .
<CLARA> <Has_modality> "Growth_factor_therapy" .
<CLARA> <Has_modality> "Chemotherapy" .
<PAD/VCD> <Mapped_from> "PAD/VCD" .
<Betrixaban_monotherapy> <Mapped_from> "Betrixaban_monotherapy" .
<Ravulizumab_monotherapy> <Has_context> "All_lines_of_therapy" .
<Pralatrexate> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Pralatrexate> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Colchicine_monotherapy> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<CNS_lymphoma> <Current_treated_by> "Whole_brain_irradiation" .
<CNS_lymphoma> <Current_treated_by> "Topotecan_monotherapy" .
<CNS_lymphoma> <Current_treated_by> "Temsirolimus_monotherapy" .
<CNS_lymphoma> <Current_treated_by> "Temozolomide_monotherapy" .
<CNS_lymphoma> <Current_treated_by> "Rituximab_monotherapy" .
<CNS_lymphoma> <Current_treated_by> "R-MPV" .
<CNS_lymphoma> <Current_treated_by> "R-MP" .
<CNS_lymphoma> <Current_treated_by> "R-MCP_(CCNU)" .
<CNS_lymphoma> <Current_treated_by> "Procarbazine_monotherapy" .
<CNS_lymphoma> <Current_treated_by> "Observation" .
<CNS_lymphoma> <Current_treated_by> "Nordic_Regimen,_younger_patients" .
<CNS_lymphoma> <Current_treated_by> "Nordic_Regimen,_older_patients" .
<CNS_lymphoma> <Current_treated_by> "Methotrexate,_then_Cytarabine_and_Thiotepa" .
<CNS_lymphoma> <Current_treated_by> "Methotrexate,_then_Cytarabine" .
<CNS_lymphoma> <Current_treated_by> "Methotrexate_monotherapy" .
<CNS_lymphoma> <Current_treated_by> "Methotrexate_and_Rituximab" .
<CNS_lymphoma> <Current_treated_by> "MVBP" .
<CNS_lymphoma> <Current_treated_by> "MT-R" .
<CNS_lymphoma> <Current_treated_by> "MPV" .
<CNS_lymphoma> <Current_treated_by> "MBVP" .
<CNS_lymphoma> <Current_treated_by> "MATRix" .
<CNS_lymphoma> <Current_treated_by> "Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone" .
<CNS_lymphoma> <Current_treated_by> "Lomustine,_Methotrexate,_Procarbazine" .
<CNS_lymphoma> <Current_treated_by> "Ifosfamide_and_Methotrexate" .
<CNS_lymphoma> <Current_treated_by> "IT_Cytarabine_monotherapy" .
<CNS_lymphoma> <Current_treated_by> "IT_Cytarabine_liposomal_monotherapy" .
<CNS_lymphoma> <Current_treated_by> "HiDAC" .
<CNS_lymphoma> <Current_treated_by> "Cytarabine,_Methotrexate,_Rituximab" .
<CNS_lymphoma> <Current_treated_by> "CYVE" .
<CNS_lymphoma> <Current_treated_by> "CYM" .
<CNS_lymphoma> <Current_treated_by> "Bu/TT/Cy,_then_auto_HSCT" .
<CNS_lymphoma> <Current_treated_by> "Bu/TT,_then_auto_HSCT" .
<CNS_lymphoma> <Current_treated_by> "BEAM,_then_auto_HSCT" .
<CNS_lymphoma> <Current_treated_by> "BCNU/TT,_then_auto_HSCT" .
<TBI,_then_auto_HSCT> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<Ivosidenib_monotherapy> <Maps_to> "Ivosidenib_monotherapy" .
<MIC> <Maps_to> "MIC" .
<Anastrozole_monotherapy> <Has_modality> "Hormonotherapy" .
<CMED> <Maps_to> "CMED" .
<Ruxolitinib> <Has_brand_name> "Jakavi" .
<Ruxolitinib> <Has_brand_name> "Jakafi" .
<Capecitabine_and_Trastuzumab> <Has_antineoplastic> "Trastuzumab" .
<Capecitabine_and_Trastuzumab> <Has_antineoplastic> "Capecitabine" .
<Ifarab> <Brand_name_of> "Cytarabine" .
<Fludarabine> <Has_brand_name> "Oforta" .
<Fludarabine> <Has_brand_name> "Lymfuda" .
<Fludarabine> <Has_brand_name> "Fludara" .
<Fludarabine> <Has_brand_name> "Fludabine" .
<Fludarabine> <Has_brand_name> "Beneflur" .
<Prednicortelone> <Brand_name_of> "Prednisolone" .
<Trastuzumab_monotherapy> <Is_current_in> "Breast_cancer" .
<R-BAC> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Midostaurin_monotherapy> <Has_accepted_use> "Systemic_mastocytosis" .
<Midostaurin_monotherapy> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Midostaurin_monotherapy> <Has_accepted_use> "FLT3-positive_Acute_myeloid_leukemia" .
<Midostaurin_monotherapy> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Interferon_alfa-2b_monotherapy> <Has_antineoplastic> "Interferon_alfa-2b" .
<Carboplatin_and_Irinotecan> <Maps_to> "Carboplatin_and_Irinotecan" .
<Colisone> <Brand_name_of> "Prednisone" .
<C-MOPP> <Mapped_from> "C-MOPP" .
<Soptrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<MP_(Prednisolone)> <Has_accepted_use> "Multiple_myeloma" .
<Antiandrogen_withdrawal> <Maps_to> "Antiandrogen_withdrawal" .
<Bortezomib_monotherapy> <Has_modality> "Chemotherapy" .
<Cyclophosphamide,_Prednisone,_Diethylstilbestrol> <Has_modality> "Hormonotherapy" .
<Cyclophosphamide,_Prednisone,_Diethylstilbestrol> <Has_modality> "Chemotherapy" .
<Dipyridamole> <Has_brand_name> "Persantine" .
<Prednisolone_monotherapy> <Is_current_in> "Warm_autoimmune_hemolytic_anemia" .
<Prednisolone_monotherapy> <Is_current_in> "Acquired_coagulopathy" .
<Capecitabine_and_Temozolomide> <Has_context> "All_lines_of_therapy" .
<TLI_and_ATG> <Is_current_in> "Allogeneic_HSCT" .
<Procion> <Brand_name_of> "Prednisone" .
<MabThera> <Brand_name_of> "Rituximab" .
<Sirolimus,_Tacrolimus,_Prednisone> <Has_immunosuppressor> "Tacrolimus" .
<Sirolimus,_Tacrolimus,_Prednisone> <Has_immunosuppressor> "Sirolimus" .
<Sirolimus,_Tacrolimus,_Prednisone> <Has_immunosuppressor> "Prednisone" .
<Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Vincristine" .
<Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Mitoxantrone" .
<Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Dexamethasone" .
<Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Asparaginase_Erwinia_chrysanthemi" .
<Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone> <Has_modality> "Chemotherapy" .
<Skytrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CEV_(Cyclophosphamide/Epirubicin)> <Is_historical_in> "Small_cell_lung_cancer" .
<Vandetanib_monotherapy> <Has_accepted_use> "Thyroid_cancer" .
<R-CEOP90_(Epirubicin)> <Maps_to> "R-CEOP90_(Epirubicin)" .
<R-CHVP_plus_I> <Has_accepted_use> "Follicular_lymphoma" .
<PEFG> <Has_accepted_use> "Pancreatic_cancer" .
<Solupen> <Brand_name_of> "Dexamethasone" .
<Carboplatin,_Paclitaxel,_Bevacizumab> <Is_current_in> "Ovarian_cancer" .
<Carboplatin,_Paclitaxel,_Bevacizumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<Octil-S> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone> <Mapped_from> "Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone" .
<R-EPOCH,_dose-escalated> <Has_accepted_use> "HIV-associated_lymphoma" .
<ChlVPP/PABIOE> <Has_antineoplastic> "Vincristine" .
<ChlVPP/PABIOE> <Has_antineoplastic> "Vinblastine" .
<ChlVPP/PABIOE> <Has_antineoplastic> "Procarbazine" .
<ChlVPP/PABIOE> <Has_antineoplastic> "Prednisolone" .
<ChlVPP/PABIOE> <Has_antineoplastic> "Etoposide" .
<ChlVPP/PABIOE> <Has_antineoplastic> "Doxorubicin" .
<ChlVPP/PABIOE> <Has_antineoplastic> "Chlorambucil" .
<ChlVPP/PABIOE> <Has_antineoplastic> "Bleomycin" .
<R-HiDAC> <Mapped_from> "R-HiDAC" .
<Pemetrexed_monotherapy> <Has_antineoplastic> "Pemetrexed" .
<Altretamine_and_Cisplatin> <Maps_to> "Altretamine_and_Cisplatin" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone> <Is_a> "Anthracycline-containing_regimen" .
<LG_Espogen> <Brand_name_of> "Epoetin_alfa" .
<GTPase-activating_protein_inhibitor> <Subsumes> "TSC1_inhibitor" .
<Ixabepilone> <May_have_route> "Intravenous" .
<Filgrastim-sndz> <Has_brand_name> "Zarxio" .
<VP> <Has_accepted_use> "Multiple_myeloma" .
<Clofarabine_and_LoDAC/Decitabine> <Mapped_from> "Clofarabine_and_LoDAC/Decitabine" .
<Capebin> <Brand_name_of> "Capecitabine" .
<Doxel> <Brand_name_of> "Docetaxel" .
<Carfilzomib_monotherapy> <Maps_to> "Carfilzomib_monotherapy" .
<Vorinostat_and_Rituximab> <Is_a> "Rituximab-containing_regimen" .
<CVAD> <Has_modality> "Chemotherapy" .
<Herclon> <Brand_name_of> "Trastuzumab" .
<Carboplatin,_Olaparib,_Paclitaxel> <Maps_to> "Carboplatin,_Olaparib,_Paclitaxel" .
<Carboplatin_and_Ifosfamide> <Has_context> "Adjuvant_therapy" .
<Fraxiparine> <Brand_name_of> "Nadroparin" .
<CVP,_then_131Iodine-Tositumomab> <Mapped_from> "CVP,_then_131Iodine-Tositumomab" .
<Gemcitabine_and_Irinotecan> <Mapped_from> "Gemcitabine_and_Irinotecan" .
<Caspogin> <Brand_name_of> "Caspofungin" .
<Mitomycin_monotherapy> <Has_antineoplastic> "Mitomycin" .
<S-1_monotherapy> <Has_context> "Non-curative_therapy" .
<S-1_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<S-1_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<S-1_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<S-1_monotherapy> <Has_context> "Adjuvant_therapy" .
<FMP> <Has_antineoplastic> "Prednisone" .
<FMP> <Has_antineoplastic> "Mitoxantrone" .
<FMP> <Has_antineoplastic> "Fludarabine" .
<Thioguanine> <Antineoplastic_of> "Thioguanine_monotherapy" .
<Thioguanine> <Antineoplastic_of> "PATCO" .
<Thioguanine> <Antineoplastic_of> "International_ALL_Trial" .
<Thioguanine> <Antineoplastic_of> "DCTER" .
<Thioguanine> <Antineoplastic_of> "DAT" .
<Thioguanine> <Antineoplastic_of> "Cytarabine_and_Thioguanine" .
<Thioguanine> <Antineoplastic_of> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA" .
<Thioguanine> <Antineoplastic_of> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine" .
<Thioguanine> <Antineoplastic_of> "Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone" .
<Thioguanine> <Antineoplastic_of> "CALGB_8811_late_intensification" .
<DA_3_plus_10,_GO> <Is_current_in> "Acute_myeloid_leukemia" .
<GemOx> <Has_context> "Non-curative_therapy" .
<GemOx> <Has_context> "Non-curative_subsequent-line_therapy" .
<GemOx> <Has_context> "Non-curative_first-line_therapy" .
<GemOx> <Has_context> "Induction_therapy" .
<GemOx> <Has_context> "Adjuvant_therapy" .
<Anastrozole> <Antineoplastic_of> "Anastrozole_monotherapy" .
<Anastrozole> <Antineoplastic_of> "Anastrozole_and_Trastuzumab" .
<Anastrozole> <Antineoplastic_of> "Anastrozole_and_Ribociclib" .
<Anastrozole> <Antineoplastic_of> "Anastrozole_and_Palbociclib" .
<Anastrozole> <Antineoplastic_of> "Anastrozole_and_Goserelin" .
<Anastrozole> <Antineoplastic_of> "Anastrozole_and_Fulvestrant" .
<Anastrozole> <Antineoplastic_of> "Abemaciclib_and_Anastrozole" .
<Imatinib,_Vincristine,_Prednisone> <Has_modality> "Chemotherapy" .
<Tepadina> <Brand_name_of> "Thiotepa" .
<CBV,_then_auto_HSCT> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<CBV,_then_auto_HSCT> <Has_context> "Consolidation_after_upfront_therapy" .
<CBV,_then_auto_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<Hypomethylating_agent> <Subsumes> "Guadecitabine" .
<Hypomethylating_agent> <Subsumes> "Decitabine" .
<Hypomethylating_agent> <Subsumes> "Azacitidine" .
<DI_EC> <Has_modality> "Chemotherapy" .
<AIE> <Mapped_from> "AIE" .
<Strontium-89> <Antineoplastic_of> "Doxorubicin_and_Strontium-89" .
<Reduction_of_immunosuppression> <Has_modality> "Null_therapy" .
<Leukeran> <Brand_name_of> "Chlorambucil" .
<Cyclophosphamide_and_Etoposide> <Has_antineoplastic> "Etoposide" .
<Cyclophosphamide_and_Etoposide> <Has_antineoplastic> "Cyclophosphamide" .
<BS> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Dabigatran_monotherapy> <Has_context> "All_lines_of_therapy" .
<Intrathecal> <May_be_route_of> "Thiotepa" .
<Intrathecal> <May_be_route_of> "Methylprednisolone" .
<Intrathecal> <May_be_route_of> "Methotrexate" .
<Intrathecal> <May_be_route_of> "Hydrocortisone" .
<Intrathecal> <May_be_route_of> "Cytarabine_liposomal" .
<Intrathecal> <May_be_route_of> "Cytarabine" .
<R-EPOCH,_dose-escalated> <Has_modality> "Chemotherapy" .
<Carmustine_and_Doxorubicin> <Is_a> "Anthracycline-containing_regimen" .
<HGF_inhibitor> <Is_a> "Growth_factor_inhibitor" .
<R-VAD_plus_C> <Has_modality> "Chemotherapy" .
<Drazone> <Brand_name_of> "Prednisone" .
<Norisep> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Chidamide> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Chidamide> <Has_accepted_use> "Breast_cancer" .
<Interferon_alfa-2b_and_Prednisone> <Is_historical_in> "Multiple_myeloma" .
<ACVBP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<C-MOPP/ABV> <Has_accepted_use> "Hodgkin_lymphoma" .
<Platistine> <Brand_name_of> "Cisplatin" .
<Berlex> <Brand_name_of> "Alendronate" .
<FOLFIRI_and_Bevacizumab_(L-Leucovorin)> <Has_accepted_use> "Colon_cancer" .
<Tinzaparin_monotherapy> <Mapped_from> "Tinzaparin_monotherapy" .
<m-BNCOD> <Is_a> "Anthracycline-containing_regimen" .
<Cisplatin_and_Fluorouracil> <Is_current_in> "Penile_cancer" .
<Cisplatin_and_Fluorouracil> <Is_current_in> "Nasopharyngeal_carcinoma" .
<Cisplatin_and_Fluorouracil> <Is_current_in> "Head_and_neck_cancer" .
<Cisplatin_and_Fluorouracil> <Is_current_in> "Gastric_cancer" .
<Cisplatin_and_Fluorouracil> <Is_current_in> "Esophageal_cancer" .
<Cisplatin_and_Fluorouracil> <Is_current_in> "Anal_cancer" .
<MT-R> <Maps_to> "MT-R" .
<MC> <Has_antineoplastic> "Non-pegylated_liposomal_doxorubicin" .
<MC> <Has_antineoplastic> "Cyclophosphamide" .
<Ibrutinib> <Has_brand_name> "Lucibru" .
<Ibrutinib> <Has_brand_name> "Imbruvica" .
<Ibrutinib> <Has_brand_name> "Ibrutix" .
<Ibrutinib> <Has_brand_name> "Ibrunib" .
<mFOLFOX6_(L-Leucovorin)> <Is_current_in> "Colon_cancer" .
<Dasatinib,_Vincristine,_Prednisone> <Has_modality> "Chemotherapy" .
<Sirolimus> <Antineoplastic_of> "Sirolimus_and_Vorinostat" .
<Carboplatin,_Gemcitabine,_Bevacizumab> <Has_modality> "Chemotherapy" .
<Bacitran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Nintedanib> <Has_brand_name> "Vargatef" .
<Nintedanib> <Has_brand_name> "Ofev" .
<Ifosfamide_monotherapy> <Mapped_from> "Ifosfamide_monotherapy" .
<FluCam> <Maps_to> "FluCam" .
<Cotrimoxin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<VTD-PACE> <Has_accepted_use> "Multiple_myeloma" .
<Letrozole_and_Bevacizumab> <Is_current_in> "Breast_cancer" .
<Cyproterone_acetate_monotherapy> <Maps_to> "Cyproterone_acetate_monotherapy" .
<Muscarinic_receptor_antagonist> <Is_a> "Emesis_prevention" .
<Irinotecan_and_S-1> <Has_antineoplastic> "Tegafur_gimeracil_oteracil" .
<Irinotecan_and_S-1> <Has_antineoplastic> "Irinotecan" .
<PTK2_inhibitor> <Is_a> "Kinase_inhibitor" .
<Tranexamic_acid> <Supportive_med_of> "Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin" .
<Bacillus_Calmette-Guerin_(BCG)_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Bacillus_Calmette-Guerin_(BCG)_monotherapy> <Has_accepted_use> "Hodgkin_lymphoma" .
<Bacillus_Calmette-Guerin_(BCG)_monotherapy> <Has_accepted_use> "Colon_cancer" .
<Bacillus_Calmette-Guerin_(BCG)_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<Bacillus_Calmette-Guerin_(BCG)_monotherapy> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Hydroxyurea_and_RT> <Maps_to> "Hydroxyurea_and_RT" .
<Uridine_triacetate> <Is_a> "Pyrimidine_analogue" .
<Uridine_triacetate> <Is_a> "Chemotherapy_protective_agent" .
<Ruxolitinib> <Has_accepted_use> "Polycythemia_vera" .
<Ruxolitinib> <Has_accepted_use> "Myelofibrosis" .
<Ruxolitinib> <Has_accepted_use> "Hypereosinophilic_syndrome" .
<Ruxolitinib> <Has_accepted_use> "Graft_versus_host_disease" .
<Ruxolitinib> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Ruxolitinib> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Capecitabine_and_RT> <Maps_to> "Capecitabine_and_RT" .
<Arsenic_trioxide_and_Idarubicin> <Is_a> "Anthracycline-containing_regimen" .
<Azacitidine,_Vorinostat,_Gemtuzumab_ozogamicin> <Is_historical_in> "Acute_myeloid_leukemia" .
<Mestian> <Brand_name_of> "Mesna" .
<Antiandrogen_withdrawal> <Is_current_in> "Prostate_cancer" .
<Paclitaxel> <Supportive_med_of> "Methotrexate_monotherapy" .
<Paclitaxel> <Supportive_med_of> "Cisplatin,_Gemcitabine,_Necitumumab" .
<Paclitaxel> <Supportive_med_of> "Cisplatin_and_Etoposide" .
<Olaparib> <Antineoplastic_of> "Olaparib_monotherapy" .
<Olaparib> <Antineoplastic_of> "Carboplatin,_Olaparib,_Paclitaxel" .
<CALGB_8811_early_intensification> <Has_antineoplastic> "Vincristine" .
<CALGB_8811_early_intensification> <Has_antineoplastic> "Mercaptopurine" .
<CALGB_8811_early_intensification> <Has_antineoplastic> "Cytarabine" .
<CALGB_8811_early_intensification> <Has_antineoplastic> "Cyclophosphamide" .
<CALGB_8811_early_intensification> <Has_antineoplastic> "Asparaginase" .
<Albrotran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bleomycin_and_Cisplatin> <Has_modality> "Chemotherapy" .
<Imatinib_and_Prednisone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<NOVP> <Is_historical_in> "Hodgkin_lymphoma" .
<Enfortumab_vedotin> <Has_accepted_use> "Bladder_cancer" .
<Hydroxyurea_and_Interferon_alfa-2a> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Polytran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<FAMTX> <Has_accepted_use> "Gastric_cancer" .
<Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone> <Mapped_from> "Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone" .
<BEACOPP-14_(Prednisolone)> <Maps_to> "BEACOPP-14_(Prednisolone)" .
<Rituximab_monotherapy> <Has_immunosuppressor> "Rituximab" .
<CDB> <Has_modality> "Chemotherapy" .
<Larotrectinib_monotherapy> <Maps_to> "Larotrectinib_monotherapy" .
<C-VAMP> <Has_context> "Non-curative_first-line_therapy" .
<Teniposide_monotherapy> <Has_modality> "Chemotherapy" .
<HPV-positive_Oropharyngeal_cancer> <Is_a> "Oropharyngeal_cancer" .
<Icotinib> <May_have_route> "Oral" .
<CHAD> <Has_modality> "Chemotherapy" .
<Erdheim-Chester_disease> <Current_treated_by> "Vemurafenib_monotherapy" .
<Erdheim-Chester_disease> <Current_treated_by> "Sirolimus_and_Prednisone" .
<Erdheim-Chester_disease> <Current_treated_by> "Cobimetinib_monotherapy" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone> <Has_context> "Induction_therapy" .
<PVD> <Mapped_from> "PVD" .
<Fulvestrant> <Antineoplastic_of> "Fulvestrant_monotherapy" .
<Fulvestrant> <Antineoplastic_of> "Fulvestrant_and_Ribociclib" .
<Fulvestrant> <Antineoplastic_of> "Fulvestrant_and_Palbociclib" .
<Fulvestrant> <Antineoplastic_of> "Capecitabine_and_Fulvestrant" .
<Fulvestrant> <Antineoplastic_of> "Anastrozole_and_Fulvestrant" .
<Fulvestrant> <Antineoplastic_of> "Alpelisib_and_Fulvestrant" .
<Fulvestrant> <Antineoplastic_of> "Abemaciclib_and_Fulvestrant" .
<Pentostatin_monotherapy> <Has_modality> "Chemotherapy" .
<Hexadrol> <Brand_name_of> "Dexamethasone" .
<Cyclosporine_non-modified> <May_have_route> "Oral" .
<Cyclosporine_non-modified> <May_have_route> "Intravenous" .
<Haloperidol> <Is_a> "WHO_Essential_Pain_and_Palliative_Care_Medicine" .
<Haloperidol> <Is_a> "Emesis_prevention" .
<Haloperidol> <Is_a> "Antipsychotic" .
<Medisyl> <Brand_name_of> "Aspirin" .
<Cisplatin_and_Epirubicin> <Has_supportive_med> "Pegfilgrastim" .
<Cisplatin_and_Epirubicin> <Has_supportive_med> "Filgrastim" .
<Bandrone> <Brand_name_of> "Ibandronate" .
<Isotretinoin_and_Dinutuximab> <Is_current_in> "Neuroblastoma" .
<ADT_and_Docetaxel> <Has_antineoplastic> "Nonsteroidal_androgen_receptor_inhibitors" .
<ADT_and_Docetaxel> <Has_antineoplastic> "GnRH_antagonists" .
<ADT_and_Docetaxel> <Has_antineoplastic> "GnRH_agonists" .
<ADT_and_Docetaxel> <Has_antineoplastic> "Endocrine_ablation_surgery" .
<ADT_and_Docetaxel> <Has_antineoplastic> "Docetaxel" .
<ADT_and_Docetaxel> <Has_antineoplastic> "Bicalutamide" .
<Fostamatinib_monotherapy> <Mapped_from> "Fostamatinib_monotherapy" .
<Pertuzumab> <Has_brand_name> "Perjeta" .
<Pertuzumab> <Has_brand_name> "Omnitarg" .
<Melphalan,_then_auto_HSCT,_then_Melphalan_and_Busulfan,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Goserelin_and_Tamoxifen> <Is_current_in> "Breast_cancer" .
<Dactinomycin_and_Vincristine> <Has_antineoplastic> "Vincristine" .
<Dactinomycin_and_Vincristine> <Has_antineoplastic> "Dactinomycin" .
<CAV> <Has_antineoplastic> "Vincristine" .
<CAV> <Has_antineoplastic> "Doxorubicin" .
<CAV> <Has_antineoplastic> "Cyclophosphamide" .
<Dabrafenib_and_Trametinib> <Is_current_in> "Thyroid_cancer" .
<Dabrafenib_and_Trametinib> <Is_current_in> "Non-small_cell_lung_cancer" .
<Dabrafenib_and_Trametinib> <Is_current_in> "Melanoma" .
<Dabrafenib_and_Trametinib> <Is_current_in> "CNS_melanoma" .
<Dabrafenib_and_Trametinib> <Is_current_in> "BRAF-mutated_malignancy" .
<ERBB2-mutated_malignancy> <Accepted_use_of> "Trastuzumab" .
<ERBB2-mutated_malignancy> <Accepted_use_of> "Pertuzumab_and_Trastuzumab" .
<ERBB2-mutated_malignancy> <Accepted_use_of> "Pertuzumab" .
<ERBB2-mutated_malignancy> <Accepted_use_of> "Neratinib_monotherapy" .
<ERBB2-mutated_malignancy> <Accepted_use_of> "Neratinib" .
<ERBB2-mutated_malignancy> <Accepted_use_of> "Ado-trastuzumab_emtansine_monotherapy" .
<Binimetinib_monotherapy> <Is_current_in> "Melanoma" .
<Docetaxel,_Cetuximab,_RT> <Has_accepted_use> "Head_and_neck_cancer" .
<Lomustine_and_Bevacizumab> <Has_context> "Non-curative_therapy" .
<7_plus_3m> <Has_modality> "Chemotherapy" .
<Dolectran> <Brand_name_of> "Docetaxel" .
<Itraconazole> <Supportive_med_of> "M-DEX" .
<Itraconazole> <Supportive_med_of> "CIA" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_supportive_med> "Ranitidine" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_supportive_med> "Ondansetron" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_supportive_med> "Meperidine" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_supportive_med> "Lorazepam" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_supportive_med> "Hydroxyzine" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_supportive_med> "Filgrastim" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_supportive_med> "Diphenhydramine" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_supportive_med> "Ciprofloxacin" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_supportive_med> "Cephalexin" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_supportive_med> "Acetaminophen" .
<Alendral> <Brand_name_of> "Alendronate" .
<Methotrexate_and_Rituximab> <Has_accepted_use> "CNS_lymphoma" .
<Cisplatin_and_Etoposide> <Has_antineoplastic> "Etoposide" .
<Cisplatin_and_Etoposide> <Has_antineoplastic> "Cisplatin" .
<CAMF> <Has_context> "Non-curative_therapy" .
<CHOP-BCG> <Has_antineoplastic> "Vincristine" .
<CHOP-BCG> <Has_antineoplastic> "Prednisone" .
<CHOP-BCG> <Has_antineoplastic> "Doxorubicin" .
<CHOP-BCG> <Has_antineoplastic> "Cyclophosphamide" .
<CHOP-BCG> <Has_antineoplastic> "Bacillus_Calmette-Guerin" .
<Odomzo> <Brand_name_of> "Sonidegib" .
<Moxatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CAP> <Has_antineoplastic> "Prednisone" .
<CAP> <Has_antineoplastic> "Doxorubicin" .
<CAP> <Has_antineoplastic> "Cyclophosphamide" .
<VagaCyte> <Brand_name_of> "Valganciclovir" .
<Fibrinolysis_inhibitor> <Subsumes> "Tranexamic_acid" .
<Fibrinolysis_inhibitor> <Subsumes> "Aminocaproic_acid" .
<Hyper-CVAD_and_Ponatinib> <Has_context> "Induction_therapy" .
<CNS_melanoma> <Is_a> "CNS_cancer" .
<VAD_doxil> <Has_accepted_use> "Multiple_myeloma" .
<HAM_and_Imatinib> <Mapped_from> "HAM_and_Imatinib" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Maps_to> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Nivolumab> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Nivolumab> <Is_a> "T-cell_activator" .
<Nivolumab> <Is_a> "PMDA_approved_drug" .
<Nivolumab> <Is_a> "Mutation-specific_medication" .
<Nivolumab> <Is_a> "Immunotherapeutic" .
<Nivolumab> <Is_a> "Antibody_medication" .
<Nivolumab> <Is_a> "Anti-PD-1_antibody" .
<Methotrexate,_then_Cytarabine> <Maps_to> "Methotrexate,_then_Cytarabine" .
<Carfilzomib_monotherapy> <Has_antineoplastic> "Carfilzomib" .
<Fulvidax> <Brand_name_of> "Fulvestrant" .
<Letrozole_and_Ribociclib> <Mapped_from> "Letrozole_and_Ribociclib" .
<Dendritic_cell_vaccine> <Subsumes> "Sipuleucel-T" .
<Leuprolide_monotherapy> <Has_context> "Non-curative_therapy" .
<Leuprolide_monotherapy> <Has_context> "Induction_therapy" .
<Leuprolide_monotherapy> <Has_context> "Adjuvant_therapy" .
<PGC> <Maps_to> "PGC" .
<R-CP> <Mapped_from> "R-CP" .
<P-Carzine> <Brand_name_of> "Procarbazine" .
<Capecitabine,_Sorafenib,_RT> <Has_antineoplastic> "Sorafenib" .
<Capecitabine,_Sorafenib,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Capecitabine,_Sorafenib,_RT> <Has_antineoplastic> "Capecitabine" .
<ESHAP> <Has_accepted_use> "Hodgkin_lymphoma" .
<ESHAP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Bladder_cancer> <Is_a> "Genitourinary_cancer" .
<Liposomal_chemotherapy> <Subsumes> "Vincristine_liposomal" .
<Liposomal_chemotherapy> <Subsumes> "Pegylated_liposomal_doxorubicin" .
<Liposomal_chemotherapy> <Subsumes> "Non-pegylated_liposomal_doxorubicin" .
<Liposomal_chemotherapy> <Subsumes> "Irinotecan_liposome" .
<Liposomal_chemotherapy> <Subsumes> "Daunorubicin_liposomal" .
<Liposomal_chemotherapy> <Subsumes> "Cytarabine_liposomal" .
<Liposomal_chemotherapy> <Subsumes> "Cytarabine_and_daunorubicin_liposomal" .
<Apalutamide> <Is_a> "Nonsteroidal_antiandrogen" .
<BEAC,_then_auto_HSCT> <Is_current_in> "Mantle_cell_lymphoma" .
<BEAC,_then_auto_HSCT> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Ligofragmin> <Brand_name_of> "Dalteparin" .
<GCP> <Mapped_from> "GCP" .
<HAA> <Is_a> "Anthracycline-containing_regimen" .
<Intermittent_ADT> <Has_accepted_use> "Prostate_cancer" .
<Fulvestrant_monotherapy> <Has_modality> "Hormonotherapy" .
<CAMP> <Has_context> "Non-curative_first-line_therapy" .
<IROX> <Has_accepted_use> "Colon_cancer" .
<Interferon_alfa-2b_and_Zidovudine> <Maps_to> "Interferon_alfa-2b_and_Zidovudine" .
<Pomalidomide> <Has_brand_name> "Pomalyst" .
<Pomalidomide> <Has_brand_name> "Pomalid" .
<Pomalidomide> <Has_brand_name> "Imnovid" .
<Pomalidomide> <Has_brand_name> "Ibipolid" .
<Pomalidomide> <Has_brand_name> "Actimid" .
<MPT> <Has_supportive_med> "Pamidronate" .
<MPT> <Has_supportive_med> "Nadroparin" .
<MPT> <Has_supportive_med> "Low_molecular_weight_heparins" .
<MPT> <Has_supportive_med> "Enoxaparin" .
<MPT> <Has_supportive_med> "Clodronate" .
<MPT> <Has_supportive_med> "Bisphosphonates" .
<MPT> <Has_supportive_med> "Aspirin" .
<Clemastine> <Is_a> "Antihistamine" .
<Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat> <Has_context> "Non-curative_therapy" .
<Diphenhydramine> <Has_brand_name> "Benadryl" .
<Moxetumomab_pasudotox> <Has_brand_name> "Lumoxiti" .
<Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT> <Maps_to> "Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT" .
<Cabozantinib> <Has_accepted_use> "Thyroid_cancer" .
<Cabozantinib> <Has_accepted_use> "Renal_cell_carcinoma" .
<Cabozantinib> <Has_accepted_use> "Prostate_cancer" .
<Cabozantinib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cabozantinib> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Omedexon> <Brand_name_of> "Dexamethasone" .
<FOLFIRINOX> <Is_a> "Irinotecan-containing_regimen" .
<CaRD> <Has_antineoplastic> "Rituximab" .
<CaRD> <Has_antineoplastic> "Dexamethasone" .
<CaRD> <Has_antineoplastic> "Carfilzomib" .
<CEV_(Carboplatin/Etoposide)> <Mapped_from> "CEV_(Carboplatin/Etoposide)" .
<THL_(Taxol)> <Has_antineoplastic> "Trastuzumab" .
<THL_(Taxol)> <Has_antineoplastic> "Paclitaxel" .
<THL_(Taxol)> <Has_antineoplastic> "Lapatinib" .
<Imatinib_monotherapy> <Has_context> "Salvage_therapy" .
<Imatinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Imatinib_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Imatinib_monotherapy> <Has_context> "Neoadjuvant_therapy" .
<Imatinib_monotherapy> <Has_context> "Induction_therapy" .
<Imatinib_monotherapy> <Has_context> "All_lines_of_therapy" .
<Imatinib_monotherapy> <Has_context> "Adjuvant_therapy" .
<Caplenal> <Brand_name_of> "Allopurinol" .
<Ipilimumab_monotherapy> <Maps_to> "Ipilimumab_monotherapy" .
<R,_then_CHOP> <Has_context> "All_lines_of_therapy" .
<Betrixaban> <Has_brand_name> "Bevyxxa" .
<Antifibrinolytic_therapy> <Mapped_from> "Antifibrinolytic_therapy" .
<GemOx_and_Sorafenib> <Has_modality> "Chemotherapy" .
<Z-BEAM,_then_auto_HSCT> <Has_supportive_med> "Valacyclovir" .
<Z-BEAM,_then_auto_HSCT> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Z-BEAM,_then_auto_HSCT> <Has_supportive_med> "Filgrastim" .
<Z-BEAM,_then_auto_HSCT> <Has_supportive_med> "Acyclovir" .
<VAD> <Has_modality> "Chemotherapy" .
<Low-dose_TBI> <Has_modality> "Radiotherapy" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan> <Maps_to> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan" .
<PegIntron> <Brand_name_of> "Peginterferon_alfa-2b" .
<Luspatercept_monotherapy> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Fisat> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Carboplat> <Brand_name_of> "Carboplatin" .
<CC/DE_and_RT> <Has_accepted_use> "Small_cell_lung_cancer" .
<Bendamustine_and_Ofatumumab> <Has_modality> "Chemotherapy" .
<Periampullary_adenocarcinoma> <Accepted_use_of> "Observation" .
<CEOP> <Has_antineoplastic> "Vincristine" .
<CEOP> <Has_antineoplastic> "Prednisone" .
<CEOP> <Has_antineoplastic> "Epirubicin" .
<CEOP> <Has_antineoplastic> "Cyclophosphamide" .
<Cemirit> <Brand_name_of> "Aspirin" .
<R-CODOX-M/R-IVAC> <Maps_to> "R-CODOX-M/R-IVAC" .
<Procarbazine_monotherapy> <Has_supportive_med> "Steroids" .
<Peginterferon_alfa-2a> <May_have_route> "Subcutaneous" .
<Cytarabine_and_Daunorubicin> <Has_modality> "Chemotherapy" .
<Uracel> <Brand_name_of> "Tegafur_and_uracil" .
<Fluorouracil_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Fluorouracil_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Fluorouracil_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Fluorouracil_monotherapy> <Has_context> "Adjuvant_therapy" .
<Carboplatin_and_Doxorubicin_liposomal> <Maps_to> "Carboplatin_and_Doxorubicin_liposomal" .
<MP_(Prednisolone)> <Mapped_from> "MP_(Prednisolone)" .
<CEPP(B)> <Has_antineoplastic> "Procarbazine" .
<CEPP(B)> <Has_antineoplastic> "Prednisone" .
<CEPP(B)> <Has_antineoplastic> "Etoposide" .
<CEPP(B)> <Has_antineoplastic> "Cyclophosphamide" .
<CEPP(B)> <Has_antineoplastic> "Bleomycin" .
<Upfront_therapy> <Maps_to> "Upfront_therapy" .
<Cytarabine,_Idarubicin,_Sorafenib> <Has_antineoplastic> "Sorafenib" .
<Cytarabine,_Idarubicin,_Sorafenib> <Has_antineoplastic> "Idarubicin" .
<Cytarabine,_Idarubicin,_Sorafenib> <Has_antineoplastic> "Cytarabine" .
<Campto> <Brand_name_of> "Irinotecan" .
<Oxaliplatin_and_RT> <Mapped_from> "Oxaliplatin_and_RT" .
<Steron> <Brand_name_of> "Dexamethasone" .
<Dexacom> <Brand_name_of> "Dexamethasone" .
<Doxtie> <Brand_name_of> "Doxorubicin" .
<VR-CHOP> <Has_accepted_use> "Mantle_cell_lymphoma" .
<VR-CHOP> <Has_accepted_use> "Follicular_lymphoma" .
<VR-CHOP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Arsenic_trioxide> <Has_brand_name> "Trisenox" .
<Arsenic_trioxide> <Has_brand_name> "Leusenox" .
<Arsenic_trioxide> <Has_brand_name> "Arsenox" .
<Arsenic_trioxide> <Has_brand_name> "Arsenol" .
<mFOLFIRINOX> <Is_current_in> "Pancreatic_cancer" .
<Capivasertib> <May_have_route> "Oral" .
<HAD> <Has_accepted_use> "Acute_myeloid_leukemia" .
<SOX> <Maps_to> "SOX" .
<Goserelin> <Supportive_med_of> "Tamoxifen_monotherapy" .
<Goserelin> <Supportive_med_of> "Tamoxifen_and_OFS" .
<Goserelin> <Supportive_med_of> "Ribociclib_and_Tamoxifen" .
<Goserelin> <Supportive_med_of> "Letrozole_monotherapy" .
<Goserelin> <Supportive_med_of> "Letrozole_and_Ribociclib" .
<Goserelin> <Supportive_med_of> "Anastrozole_monotherapy" .
<Goserelin> <Supportive_med_of> "Anastrozole_and_Ribociclib" .
<Mustargen> <Brand_name_of> "Mechlorethamine" .
<Bactekod> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Trimeta> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Procarbazine_monotherapy> <Has_accepted_use> "Glioblastoma" .
<Procarbazine_monotherapy> <Has_accepted_use> "CNS_lymphoma" .
<Promacta> <Brand_name_of> "Eltrombopag" .
<Isotretinoin_and_Dinutuximab> <Has_context> "Consolidation_after_upfront_therapy" .
<CHVP> <Is_historical_in> "Follicular_lymphoma" .
<Lederfolat> <Brand_name_of> "Folinic_acid" .
<CNS_cancer> <Subsumes> "Meningioma" .
<CNS_cancer> <Subsumes> "Low-grade_glioma" .
<CNS_cancer> <Subsumes> "High-grade_glioma" .
<CNS_cancer> <Subsumes> "CNS_melanoma" .
<CNS_cancer> <Subsumes> "CNS_lymphoma" .
<CNS_cancer> <Subsumes> "CNS_leukemia" .
<CNS_cancer> <Subsumes> "CNS_carcinoma" .
<Teniposide_and_WBRT> <Has_context> "All_lines_of_therapy" .
<BEP> <Has_accepted_use> "Testicular_cancer" .
<BEP> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<Zobone> <Brand_name_of> "Zoledronic_acid" .
<KCD> <Is_current_in> "Multiple_myeloma" .
<SYK_inhibitor> <Subsumes> "Fostamatinib" .
<SYK_inhibitor> <Subsumes> "Entospletinib" .
<SYK_inhibitor> <Subsumes> "Dasatinib" .
<Quizartinib> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Anti-Factor_XIa_antibody> <Subsumes> "Osocimab" .
<Paclitaxel> <Has_brand_name> "Yewtaxan" .
<Paclitaxel> <Has_brand_name> "Unitaxel" .
<Paclitaxel> <Has_brand_name> "Taycovit" .
<Paclitaxel> <Has_brand_name> "Taxomedac" .
<Paclitaxel> <Has_brand_name> "Taxol" .
<Paclitaxel> <Has_brand_name> "Taxodiol" .
<Paclitaxel> <Has_brand_name> "Taxocris" .
<Paclitaxel> <Has_brand_name> "Tarvexol" .
<Paclitaxel> <Has_brand_name> "Taclipaxol" .
<Paclitaxel> <Has_brand_name> "Sindaxel" .
<Paclitaxel> <Has_brand_name> "Ribotax" .
<Paclitaxel> <Has_brand_name> "Praxel" .
<Paclitaxel> <Has_brand_name> "Poltaxel" .
<Paclitaxel> <Has_brand_name> "Phyxol" .
<Paclitaxel> <Has_brand_name> "Petaxel" .
<Paclitaxel> <Has_brand_name> "Paxus" .
<Paclitaxel> <Has_brand_name> "Paxenor" .
<Paclitaxel> <Has_brand_name> "Paxene" .
<Paclitaxel> <Has_brand_name> "Parexel" .
<Paclitaxel> <Has_brand_name> "Panataxel" .
<Paclitaxel> <Has_brand_name> "Paklitaxfil" .
<Paclitaxel> <Has_brand_name> "Padexol" .
<Paclitaxel> <Has_brand_name> "Pacxel" .
<Paclitaxel> <Has_brand_name> "Pacliteva" .
<Paclitaxel> <Has_brand_name> "Paclitaxin" .
<Paclitaxel> <Has_brand_name> "Paclitax" .
<Paclitaxel> <Has_brand_name> "Onxol" .
<Paclitaxel> <Has_brand_name> "Oncotaxel" .
<Paclitaxel> <Has_brand_name> "Ofoxel" .
<Paclitaxel> <Has_brand_name> "Neotaxl" .
<Paclitaxel> <Has_brand_name> "Neotaxan" .
<Paclitaxel> <Has_brand_name> "Neotacs" .
<Paclitaxel> <Has_brand_name> "Mitotax" .
<Paclitaxel> <Has_brand_name> "Medixel" .
<Paclitaxel> <Has_brand_name> "Magytax" .
<Paclitaxel> <Has_brand_name> "Intaxel" .
<Paclitaxel> <Has_brand_name> "Ifaxol" .
<Paclitaxel> <Has_brand_name> "Gros" .
<Paclitaxel> <Has_brand_name> "Genexol" .
<Paclitaxel> <Has_brand_name> "Genetaxyl" .
<Paclitaxel> <Has_brand_name> "Formoxol" .
<Paclitaxel> <Has_brand_name> "Ebetaxel" .
<Paclitaxel> <Has_brand_name> "Drifen" .
<Paclitaxel> <Has_brand_name> "Dalys" .
<Paclitaxel> <Has_brand_name> "Daburex" .
<Paclitaxel> <Has_brand_name> "Cytax" .
<Paclitaxel> <Has_brand_name> "Clitaxel" .
<Paclitaxel> <Has_brand_name> "Britaxol" .
<Paclitaxel> <Has_brand_name> "Bristaxol" .
<Paclitaxel> <Has_brand_name> "Betaxel" .
<Paclitaxel> <Has_brand_name> "Asotax" .
<Paclitaxel> <Has_brand_name> "Anzatec" .
<Paclitaxel> <Has_brand_name> "Anzatax" .
<Paclitaxel> <Has_brand_name> "Altaxel" .
<Paclitaxel> <Has_brand_name> "Abitaxel" .
<Ado-trastuzumab_emtansine_monotherapy> <Has_modality> "Chemotherapy" .
<AC-T> <Has_accepted_use> "Breast_cancer" .
<O-miniCHOP> <Maps_to> "O-miniCHOP" .
<Avelumab> <Is_a> "T-cell_activator" .
<Avelumab> <Is_a> "Immunotherapeutic" .
<Avelumab> <Is_a> "Antibody_medication" .
<Avelumab> <Is_a> "Anti-PD-L1_antibody" .
<Sulfometh> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Afuresertib> <Has_accepted_use> "Multiple_myeloma" .
<Alprolix> <Brand_name_of> "Factor_IX_recombinant_Fc_fusion_protein" .
<Ribociclib_and_Tamoxifen> <Has_antineoplastic> "Tamoxifen" .
<Ribociclib_and_Tamoxifen> <Has_antineoplastic> "Ribociclib" .
<Paclitaxel_and_S-1> <Is_current_in> "Gastric_cancer" .
<Lymphoma> <Subsumes> "T-cell_lymphoma" .
<Lymphoma> <Subsumes> "Non-Hodgkin_lymphoma" .
<Lymphoma> <Subsumes> "Indolent_lymphoma" .
<Lymphoma> <Subsumes> "Aggressive_lymphoma" .
<CHAD> <Has_context> "Non-curative_first-line_therapy" .
<Doxorubicin_and_Fluorouracil> <Has_context> "Adjuvant_therapy" .
<Daunorubicine> <Brand_name_of> "Daunorubicin" .
<Hydroxyurea_monotherapy> <Has_accepted_use> "Sickle_cell_anemia" .
<Hydroxyurea_monotherapy> <Has_accepted_use> "Polycythemia_vera" .
<Hydroxyurea_monotherapy> <Has_accepted_use> "Myelofibrosis" .
<Hydroxyurea_monotherapy> <Has_accepted_use> "Hypereosinophilic_syndrome" .
<Hydroxyurea_monotherapy> <Has_accepted_use> "Glioblastoma" .
<Hydroxyurea_monotherapy> <Has_accepted_use> "Essential_thrombocythemia" .
<Gemcitabine_and_Bevacizumab> <Mapped_from> "Gemcitabine_and_Bevacizumab" .
<Glucarpidase> <Has_brand_name> "Voraxaze" .
<Marginal_zone_lymphoma> <FDA_indication_of> "Lenalidomide" .
<Marginal_zone_lymphoma> <FDA_indication_of> "Ibrutinib" .
<Cutaneous_basal_cell_carcinoma> <FDA_indication_of> "Vismodegib" .
<Cutaneous_basal_cell_carcinoma> <FDA_indication_of> "Sonidegib" .
<Dacarbazine_monotherapy> <Mapped_from> "Dacarbazine_monotherapy" .
<Mogamulizumab> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Mogamulizumab> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Fluorouracil/Fluorouracil_and_RT> <Has_antineoplastic> "Fluorouracil" .
<Fluorouracil/Fluorouracil_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<FP/Capecitabine_and_RT> <Has_antineoplastic> "Fluorouracil" .
<FP/Capecitabine_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<FP/Capecitabine_and_RT> <Has_antineoplastic> "Cisplatin" .
<FP/Capecitabine_and_RT> <Has_antineoplastic> "Capecitabine" .
<Lucrin_Depot> <Brand_name_of> "Leuprolide" .
<Enasidenib_monotherapy> <Is_current_in> "Acute_myeloid_leukemia" .
<Carfilzomib_monotherapy> <Has_supportive_med> "Palonosetron" .
<Carfilzomib_monotherapy> <Has_supportive_med> "Dexamethasone" .
<Carfilzomib_monotherapy> <Has_supportive_med> "Ciprofloxacin" .
<Carfilzomib_monotherapy> <Has_supportive_med> "Acyclovir" .
<Dabrafenib_and_Trametinib> <Has_modality> "Chemotherapy" .
<Icotinib> <Antineoplastic_of> "Icotinib_monotherapy" .
<Raltitrexed> <Is_a> "Health_Canada_approved_drug" .
<Raltitrexed> <Is_a> "EMA_approved_drug" .
<Raltitrexed> <Is_a> "Antimetabolite" .
<Raltitrexed> <Is_a> "Antifolate" .
<Cisplatin_and_Raltitrexed> <Is_a> "Platinum_doublet" .
<Bcr-Abl_inhibitor> <Is_a> "Kinase_inhibitor" .
<Zyoway> <Brand_name_of> "Allopurinol" .
<Docetaxel_and_Irinotecan> <Mapped_from> "Docetaxel_and_Irinotecan" .
<Actorise> <Brand_name_of> "Darbepoetin_alfa" .
<Orasone> <Brand_name_of> "Prednisone" .
<BVCPP> <Mapped_from> "BVCPP" .
<Bonapex> <Brand_name_of> "Alendronate" .
<Oncodria> <Brand_name_of> "Doxorubicin" .
<Nystatin> <Brand_name_of> "Mycostatin" .
<WBRT> <Has_accepted_use> "CNS_leukemia" .
<Diometa> <Brand_name_of> "Dexamethasone" .
<RT-PEPC> <Mapped_from> "RT-PEPC" .
<Decortisyl> <Brand_name_of> "Prednisone" .
<Fondaparinux> <Is_a> "Anticoagulant" .
<MAPIE> <Has_accepted_use> "Osteosarcoma" .
<KRd> <Maps_to> "KRd" .
<Bexgratin> <Brand_name_of> "Bexarotene" .
<Mylotarg> <Brand_name_of> "Gemtuzumab_ozogamicin" .
<Tumor_vaccine> <Is_a> "Biologic_product" .
<Fluorouracil_and_RT> <Mapped_from> "Fluorouracil_and_RT" .
<Daiphen> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CRd> <Maps_to> "CRd" .
<Somatuline_LP> <Brand_name_of> "Lanreotide" .
<Sawasone> <Brand_name_of> "Dexamethasone" .
<Larotrectinib_monotherapy> <Mapped_from> "Larotrectinib_monotherapy" .
<CVAD> <Mapped_from> "CVAD" .
<Capecitabine,_Paclitaxel,_RT> <Has_accepted_use> "Esophageal_cancer" .
<Radotinib> <Is_a> "PDGFR_inhibitor" .
<Radotinib> <Is_a> "Kinase_inhibitor" .
<Radotinib> <Is_a> "KFDA_approved_drug" .
<Radotinib> <Is_a> "Bcr-Abl_inhibitor" .
<Cadria> <Brand_name_of> "Doxorubicin" .
<Navelbine> <Brand_name_of> "Vinorelbine" .
<Cotribene> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Dasatinib,_Vincristine,_Prednisone> <Maps_to> "Dasatinib,_Vincristine,_Prednisone" .
<Triazene> <Subsumes> "Temozolomide" .
<Triazene> <Subsumes> "Procarbazine" .
<Triazene> <Subsumes> "Dacarbazine" .
<Dellacorta> <Brand_name_of> "Prednisone" .
<Abciximab> <Has_brand_name> "ReoPro" .
<Abciximab> <Has_brand_name> "Clotinab" .
<CHVP> <Is_a> "Anthracycline-containing_regimen" .
<Ixabepilone_monotherapy> <Has_antineoplastic> "Ixabepilone" .
<IRIS> <Mapped_from> "IRIS" .
<mFOLFOX7> <Mapped_from> "mFOLFOX7" .
<Dacarex> <Brand_name_of> "Dacarbazine" .
<ACVBP,_dose-adjusted> <Has_modality> "Chemotherapy" .
<Tinzaparin_monotherapy> <Has_modality> "Anticoagulation" .
<CYM> <Has_context> "Upfront_therapy" .
<CYM> <Has_context> "Consolidation_after_upfront_therapy" .
<Famotidine> <Has_brand_name> "Pepcid" .
<Aggressive_lymphoma> <Is_a> "Lymphoma" .
<Plerixafor> <Has_brand_name> "Mozobil" .
<Paclitaxel_and_Vinorelbine> <Has_accepted_use> "Breast_cancer" .
<Azacitidine_and_Vorinostat> <Has_context> "Non-curative_first-line_therapy" .
<7_plus_3d_and_GO> <Maps_to> "7_plus_3d_and_GO" .
<Myocet> <Brand_name_of> "Non-pegylated_liposomal_doxorubicin" .
<EOX> <Has_modality> "Chemotherapy" .
<Prodexon> <Brand_name_of> "Dexamethasone" .
<FOLFIRI_and_Ramucirumab> <Has_accepted_use> "Colon_cancer" .
<Siltuximab_monotherapy> <Is_current_in> "Castleman_disease" .
<Calaspargase> <May_have_route> "Intravenous" .
<Calaspargase> <May_have_route> "Intramuscular" .
<Carboplatin_and_Ifosfamide> <Has_modality> "Chemotherapy" .
<CTD> <Has_supportive_med> "Zoledronic_acid" .
<CTD> <Has_supportive_med> "Warfarin" .
<CTD> <Has_supportive_med> "Valacyclovir" .
<CTD> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<CTD> <Has_supportive_med> "Proton_pump_inhibitors" .
<CTD> <Has_supportive_med> "Low_molecular_weight_heparins" .
<CTD> <Has_supportive_med> "Clodronate" .
<CTD> <Has_supportive_med> "Aspirin" .
<Sulfawal-T> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Osteoral> <Brand_name_of> "Alendronate" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab> <Has_context> "Induction_therapy" .
<TRK_inhibitor> <Subsumes> "Larotrectinib" .
<TRK_inhibitor> <Subsumes> "Entrectinib" .
<TRK_inhibitor> <Subsumes> "Cabozantinib" .
<Cromatonbic_Folinico> <Brand_name_of> "Folinic_acid" .
<Sultase> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_modality> "Immunosuppressive_therapy" .
<Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<Virax> <Brand_name_of> "Acyclovir" .
<Cannabinoid> <Subsumes> "Nabilone" .
<Cannabinoid> <Subsumes> "Dronabinol" .
<Antiphospholipid_antibody_syndrome> <Accepted_use_of> "Warfarin_monotherapy" .
<Antiphospholipid_antibody_syndrome> <Accepted_use_of> "Warfarin" .
<Antiphospholipid_antibody_syndrome> <Accepted_use_of> "Rivaroxaban_monotherapy" .
<Antiphospholipid_antibody_syndrome> <Accepted_use_of> "Rituximab_monotherapy" .
<Antiphospholipid_antibody_syndrome> <Accepted_use_of> "Aspirin_and_Warfarin" .
<Avatrombopag> <Has_accepted_use> "Thrombocytopenia_in_liver_disease" .
<Avatrombopag> <Has_accepted_use> "Immune_thrombocytopenia" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Is_current_in> "T-cell_acute_lymphoblastic_leukemia" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Aspirin> <Antineoplastic_of> "Aspirin_and_Dexamethasone" .
<CHOP-AL> <Mapped_from> "CHOP-AL" .
<Cyclophosphamide_monotherapy> <Has_modality> "Immunosuppressive_therapy" .
<Cyclophosphamide_monotherapy> <Has_modality> "Chemotherapy" .
<mFOLFIRINOX,_Gemcitabine,_RT> <Is_current_in> "Pancreatic_cancer" .
<Soft_tissue_sarcoma> <Is_a> "Sarcoma" .
<Copanlisib_monotherapy> <Has_antineoplastic> "Copanlisib" .
<Capecitabine,_Oxaliplatin,_RT> <Has_accepted_use> "Esophageal_cancer" .
<Allogeneic_HSCT> <Accepted_use_of> "TLI_and_ATG" .
<Allogeneic_HSCT> <Accepted_use_of> "Low-dose_TBI" .
<Allogeneic_HSCT> <Accepted_use_of> "Fludarabine,_Melphalan,_Alemtuzumab" .
<Allogeneic_HSCT> <Accepted_use_of> "Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant" .
<Allogeneic_HSCT> <Accepted_use_of> "Fludarabine,_Cyclophosphamide,_ATG" .
<Allogeneic_HSCT> <Accepted_use_of> "Fludarabine,_Busulfan,_Cyclophosphamide" .
<Allogeneic_HSCT> <Accepted_use_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan" .
<Allogeneic_HSCT> <Accepted_use_of> "Fludarabine,_Busulfan,_ATG" .
<Allogeneic_HSCT> <Accepted_use_of> "Fludarabine_and_TBI" .
<Allogeneic_HSCT> <Accepted_use_of> "Fludarabine_and_Melphalan" .
<Allogeneic_HSCT> <Accepted_use_of> "FCR" .
<Allogeneic_HSCT> <Accepted_use_of> "FC" .
<Allogeneic_HSCT> <Accepted_use_of> "Etoposide_and_TBI" .
<Allogeneic_HSCT> <Accepted_use_of> "Defibrotide_monotherapy" .
<Allogeneic_HSCT> <Accepted_use_of> "Cyclophosphamide,_Fludarabine,_Thiotepa" .
<Allogeneic_HSCT> <Accepted_use_of> "Cyclophosphamide_and_TBI" .
<Allogeneic_HSCT> <Accepted_use_of> "Clofarabine_and_Melphalan" .
<Allogeneic_HSCT> <Accepted_use_of> "Busulfan_and_Fludarabine" .
<Allogeneic_HSCT> <Accepted_use_of> "Busulfan_and_Cyclophosphamide" .
<Allogeneic_HSCT> <Accepted_use_of> "BuCyTBI" .
<Allogeneic_HSCT> <Accepted_use_of> "BFR" .
<Allogeneic_HSCT> <Accepted_use_of> "BEAM" .
<Allogeneic_HSCT> <Accepted_use_of> "(90)YFC" .
<AT_(Taxotere)> <Has_accepted_use> "Breast_cancer" .
<Arefarin> <Brand_name_of> "Warfarin" .
<VACA> <Has_accepted_use> "Ewing_sarcoma" .
<Carboplatin_and_Ifosfamide> <Is_current_in> "Cervical_cancer" .
<Topotec> <Brand_name_of> "Topotecan" .
<Bevacizumab_monotherapy> <Has_context> "Salvage_therapy" .
<Bevacizumab_monotherapy> <Has_context> "Non-curative_therapy" .
<Bevacizumab_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Bevacizumab_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Bevacizumab_monotherapy> <Has_context> "Non-curative_second-line_maintenance_therapy" .
<Bevacizumab_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Bevacizumab_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Bevacizumab_monotherapy> <Has_context> "All_lines_of_therapy" .
<Bevacizumab_monotherapy> <Has_context> "Adjuvant_therapy" .
<Ruxolitinib> <Antineoplastic_of> "Ruxolitinib_monotherapy" .
<Cisplatin_and_Etoposide> <Has_supportive_med> "Steroids" .
<Cisplatin_and_Etoposide> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Cisplatin_and_Etoposide> <Has_supportive_med> "Prochlorperazine" .
<Cisplatin_and_Etoposide> <Has_supportive_med> "Paclitaxel" .
<Cisplatin_and_Etoposide> <Has_supportive_med> "Metoclopramide" .
<Cisplatin_and_Etoposide> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Cisplatin_and_Etoposide> <Has_supportive_med> "Diphenhydramine" .
<Cisplatin_and_Etoposide> <Has_supportive_med> "Dexamethasone" .
<Cisplatin_and_Etoposide> <Has_supportive_med> "Cimetidine" .
<Ovarian_cancer> <Current_treated_by> "nab-Paclitaxel_monotherapy" .
<Ovarian_cancer> <Current_treated_by> "Vinorelbine_monotherapy" .
<Ovarian_cancer> <Current_treated_by> "Treosulfan_monotherapy" .
<Ovarian_cancer> <Current_treated_by> "Trabectedin_monotherapy" .
<Ovarian_cancer> <Current_treated_by> "Topotecan_monotherapy" .
<Ovarian_cancer> <Current_treated_by> "Topotecan_and_Bevacizumab" .
<Ovarian_cancer> <Current_treated_by> "TC_and_Nintedanib" .
<Ovarian_cancer> <Current_treated_by> "Rucaparib_monotherapy" .
<Ovarian_cancer> <Current_treated_by> "Placebo" .
<Ovarian_cancer> <Current_treated_by> "Pemetrexed_monotherapy" .
<Ovarian_cancer> <Current_treated_by> "Pazopanib_monotherapy" .
<Ovarian_cancer> <Current_treated_by> "Paclitaxel_monotherapy" .
<Ovarian_cancer> <Current_treated_by> "Paclitaxel_and_Pazopanib" .
<Ovarian_cancer> <Current_treated_by> "Paclitaxel_and_Bevacizumab" .
<Ovarian_cancer> <Current_treated_by> "Olaparib_monotherapy" .
<Ovarian_cancer> <Current_treated_by> "Observation" .
<Ovarian_cancer> <Current_treated_by> "Niraparib_monotherapy" .
<Ovarian_cancer> <Current_treated_by> "Gemcitabine_monotherapy" .
<Ovarian_cancer> <Current_treated_by> "Etoposide_monotherapy" .
<Ovarian_cancer> <Current_treated_by> "Doxorubicin_pegylated_liposomal_monotherapy" .
<Ovarian_cancer> <Current_treated_by> "Doxorubicin_pegylated_liposomal_and_Trabectedin" .
<Ovarian_cancer> <Current_treated_by> "Doxorubicin_pegylated_liposomal_and_Gemcitabine" .
<Ovarian_cancer> <Current_treated_by> "Doxorubicin_pegylated_liposomal_and_Bevacizumab" .
<Ovarian_cancer> <Current_treated_by> "Docetaxel_monotherapy" .
<Ovarian_cancer> <Current_treated_by> "Cisplatin_and_Paclitaxel" .
<Ovarian_cancer> <Current_treated_by> "Cisplatin_and_Gemcitabine" .
<Ovarian_cancer> <Current_treated_by> "Carboplatin,_Paclitaxel,_Bevacizumab" .
<Ovarian_cancer> <Current_treated_by> "Carboplatin,_Olaparib,_Paclitaxel" .
<Ovarian_cancer> <Current_treated_by> "Carboplatin,_Gemcitabine,_Bevacizumab" .
<Ovarian_cancer> <Current_treated_by> "Carboplatin_monotherapy" .
<Ovarian_cancer> <Current_treated_by> "Carboplatin_and_Paclitaxel" .
<Ovarian_cancer> <Current_treated_by> "Carboplatin_and_Gemcitabine" .
<Ovarian_cancer> <Current_treated_by> "Carboplatin_and_Doxorubicin_liposomal" .
<Ovarian_cancer> <Current_treated_by> "Carboplatin_and_Docetaxel" .
<Ovarian_cancer> <Current_treated_by> "Bevacizumab_monotherapy" .
<Ovarian_cancer> <Current_treated_by> "Altretamine_monotherapy" .
<Ovarian_cancer> <Current_treated_by> "Altretamine_and_Cisplatin" .
<Cisplatin,_Vinorelbine,_Cetuximab> <Has_context> "Non-curative_first-line_therapy" .
<Etosin> <Brand_name_of> "Etoposide" .
<Pariparin> <Brand_name_of> "Enoxaparin" .
<Cisplatin_and_RT> <Maps_to> "Cisplatin_and_RT" .
<Udicil> <Brand_name_of> "Cytarabine" .
<mFOLFOX6_and_Bevacizumab> <Has_accepted_use> "Colon_cancer" .
<Periampullary_adenocarcinoma> <Current_treated_by> "Observation" .
<PATCO> <Mapped_from> "PATCO" .
<Mercaptopurine_and_Methotrexate> <Mapped_from> "Mercaptopurine_and_Methotrexate" .
<Docetaxel,_Cetuximab,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Docetaxel,_Cetuximab,_RT> <Has_antineoplastic> "Docetaxel" .
<Docetaxel,_Cetuximab,_RT> <Has_antineoplastic> "Cetuximab" .
<Nivolumab_monotherapy> <Is_current_in> "Small_cell_lung_cancer" .
<Nivolumab_monotherapy> <Is_current_in> "Renal_cell_carcinoma" .
<Nivolumab_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Nivolumab_monotherapy> <Is_current_in> "Melanoma" .
<Nivolumab_monotherapy> <Is_current_in> "Hodgkin_lymphoma" .
<Nivolumab_monotherapy> <Is_current_in> "Hepatocellular_carcinoma" .
<Nivolumab_monotherapy> <Is_current_in> "Head_and_neck_cancer" .
<Nivolumab_monotherapy> <Is_current_in> "Gastric_cancer" .
<Nivolumab_monotherapy> <Is_current_in> "Esophageal_cancer" .
<Nivolumab_monotherapy> <Is_current_in> "Colon_cancer" .
<Nivolumab_monotherapy> <Is_current_in> "Bladder_cancer" .
<Nivolumab_monotherapy> <Is_current_in> "Anal_cancer" .
<Afinitor_Disperz> <Brand_name_of> "Everolimus" .
<Lomustine_monotherapy> <Has_supportive_med> "Steroids" .
<Lomustine_monotherapy> <Has_supportive_med> "Ondansetron" .
<L-asparaginase_monotherapy> <Maps_to> "L-asparaginase_monotherapy" .
<Isoprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin,_Pemetrexed,_TTFields> <Has_modality> "Tumor_treating_fields" .
<Cisplatin,_Pemetrexed,_TTFields> <Has_modality> "Chemotherapy" .
<Deferoxamine> <Has_brand_name> "Desferal" .
<Ribociclib> <Is_a> "Protein_expression-specific_medication" .
<Ribociclib> <Is_a> "Kinase_inhibitor" .
<Ribociclib> <Is_a> "CDK_inhibitor" .
<Calaspargase> <Has_brand_name> "Asparlas" .
<Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA> <Has_modality> "Chemotherapy" .
<Trastuzumab_and_hyaluronidase_monotherapy> <Maps_to> "Trastuzumab_and_hyaluronidase_monotherapy" .
<Procarbazine_monotherapy> <Has_antineoplastic> "Procarbazine" .
<Dulcipirina> <Brand_name_of> "Aspirin" .
<PUVA> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Imatinib_and_Interferon> <Has_antineoplastic> "Peginterferon_alfa-2a" .
<Imatinib_and_Interferon> <Has_antineoplastic> "Interferon_alfa-2b" .
<Imatinib_and_Interferon> <Has_antineoplastic> "Interferon_alfa-2a" .
<Imatinib_and_Interferon> <Has_antineoplastic> "Imatinib" .
<Anastrozole_and_Fulvestrant> <Mapped_from> "Anastrozole_and_Fulvestrant" .
<CVD_(Vindesine)> <Maps_to> "CVD_(Vindesine)" .
<CRd> <Has_antineoplastic> "Lenalidomide" .
<CRd> <Has_antineoplastic> "Dexamethasone" .
<CRd> <Has_antineoplastic> "Cyclophosphamide" .
<Nodilon> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Kabillon> <Brand_name_of> "Lenalidomide" .
<Strontium-89> <Has_brand_name> "Metastron" .
<R-MegaCHOP> <Has_context> "Induction_therapy" .
<Atropen> <Brand_name_of> "Atropine" .
<Binimetinib,_Encorafenib,_Cetuximab> <Mapped_from> "Binimetinib,_Encorafenib,_Cetuximab" .
<Carboplatin> <Has_brand_name> "Vancel" .
<Carboplatin> <Has_brand_name> "Tecnocarb" .
<Carboplatin> <Has_brand_name> "Ribocarbo" .
<Carboplatin> <Has_brand_name> "Platinwas" .
<Carboplatin> <Has_brand_name> "Platamine_CS" .
<Carboplatin> <Has_brand_name> "Pharmaplatin" .
<Carboplatin> <Has_brand_name> "Paraplatine" .
<Carboplatin> <Has_brand_name> "Paraplatin" .
<Carboplatin> <Has_brand_name> "Oncocarb" .
<Carboplatin> <Has_brand_name> "Neocarbo" .
<Carboplatin> <Has_brand_name> "Neocarb" .
<Carboplatin> <Has_brand_name> "Nealorin" .
<Carboplatin> <Has_brand_name> "Megaplatin" .
<Carboplatin> <Has_brand_name> "Kemocarb" .
<Carboplatin> <Has_brand_name> "Ifacap" .
<Carboplatin> <Has_brand_name> "Fauldcarbo" .
<Carboplatin> <Has_brand_name> "Ercar" .
<Carboplatin> <Has_brand_name> "Erbakar" .
<Carboplatin> <Has_brand_name> "Emorzim" .
<Carboplatin> <Has_brand_name> "Cycloplatinum" .
<Carboplatin> <Has_brand_name> "Cycloplatin" .
<Carboplatin> <Has_brand_name> "Crobextin" .
<Carboplatin> <Has_brand_name> "Carpsol" .
<Carboplatin> <Has_brand_name> "Carplanil" .
<Carboplatin> <Has_brand_name> "Carplan" .
<Carboplatin> <Has_brand_name> "Careptin" .
<Carboplatin> <Has_brand_name> "Carbotinol" .
<Carboplatin> <Has_brand_name> "Carbotec" .
<Carboplatin> <Has_brand_name> "Carbotanil" .
<Carboplatin> <Has_brand_name> "Carbosin" .
<Carboplatin> <Has_brand_name> "Carboplatinum" .
<Carboplatin> <Has_brand_name> "Carboplatino" .
<Carboplatin> <Has_brand_name> "Carboplatine" .
<Carboplatin> <Has_brand_name> "Carboplat" .
<Carboplatin> <Has_brand_name> "Carbomerck" .
<Carboplatin> <Has_brand_name> "Carbomedac" .
<Carboplatin> <Has_brand_name> "Carbokem" .
<Carboplatin> <Has_brand_name> "Carbo" .
<Carboplatin> <Has_brand_name> "CBDCA" .
<Carboplatin> <Has_brand_name> "Boplatex" .
<Carboplatin> <Has_brand_name> "Bonaplatin" .
<Carboplatin> <Has_brand_name> "Blastocarb" .
<Carboplatin> <Has_brand_name> "Biovinate" .
<Carboplatin> <Has_brand_name> "Bioplatinex" .
<Carboplatin> <Has_brand_name> "Biocarbo" .
<Carboplatin> <Has_brand_name> "Biocarb" .
<Samarium-153_monotherapy> <Has_modality> "Radiotherapy" .
<Pemetrexed_and_Pembrolizumab> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Lisaprin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CLAG> <Has_supportive_med> "Filgrastim" .
<Cisplatin_and_Doxorubicin> <Is_a> "Platinum_doublet" .
<Cisplatin_and_Doxorubicin> <Is_a> "Anthracycline-containing_regimen" .
<Carboplatin_and_RT> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Carboplatin_and_RT> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<Carboplatin_and_RT> <Has_accepted_use> "Head_and_neck_cancer" .
<Carboplatin_and_RT> <Has_accepted_use> "Cervical_cancer" .
<Eulexin> <Brand_name_of> "Flutamide" .
<Rexaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Gilteritinib> <Has_brand_name> "Xospata" .
<Interferon_alfa-n1_monotherapy> <Has_modality> "Immunotherapy" .
<COP> <Has_context> "Induction_therapy" .
<Chlorambucil_and_Prednisone> <Is_historical_in> "Chronic_lymphocytic_leukemia" .
<Etopul> <Brand_name_of> "Etoposide" .
<ABCM> <Is_historical_in> "Multiple_myeloma" .
<Capecitabine,_Carboplatin,_Paclitaxel,_RT> <Has_antineoplastic> "Paclitaxel" .
<Capecitabine,_Carboplatin,_Paclitaxel,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Capecitabine,_Carboplatin,_Paclitaxel,_RT> <Has_antineoplastic> "Carboplatin" .
<Capecitabine,_Carboplatin,_Paclitaxel,_RT> <Has_antineoplastic> "Capecitabine" .
<COP> <Has_modality> "Chemotherapy" .
<Alendene> <Brand_name_of> "Alendronate" .
<Topotecan> <Has_accepted_use> "Small_cell_lung_cancer" .
<Topotecan> <Has_accepted_use> "Ovarian_cancer" .
<Topotecan> <Has_accepted_use> "Osteosarcoma" .
<Topotecan> <Has_accepted_use> "Ewing_sarcoma" .
<Topotecan> <Has_accepted_use> "Endometrial_cancer" .
<Topotecan> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Topotecan> <Has_accepted_use> "Cervical_cancer" .
<Topotecan> <Has_accepted_use> "CNS_lymphoma" .
<Tamibarotene> <Antineoplastic_of> "Tamibarotene_monotherapy" .
<CFAR> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Calaspargase,_Daunorubicin,_Vincristine,_Prednisone> <Has_antineoplastic> "Vincristine" .
<Calaspargase,_Daunorubicin,_Vincristine,_Prednisone> <Has_antineoplastic> "Prednisone" .
<Calaspargase,_Daunorubicin,_Vincristine,_Prednisone> <Has_antineoplastic> "Daunorubicin" .
<Calaspargase,_Daunorubicin,_Vincristine,_Prednisone> <Has_antineoplastic> "Calaspargase" .
<Epoetin_alfa> <Is_a> "Hematopoietic_growth_factor" .
<Epoetin_alfa> <Is_a> "Erythrocyte_growth_factor" .
<Abexinostat> <May_have_route> "Oral" .
<PEV> <Mapped_from> "PEV" .
<Capecitabine_and_Trastuzumab> <Is_current_in> "CNS_carcinoma" .
<Capecitabine_and_Trastuzumab> <Is_current_in> "Breast_cancer" .
<Mercaptopurine,_Methotrexate,_Vincristine> <Has_antineoplastic> "Vincristine" .
<Mercaptopurine,_Methotrexate,_Vincristine> <Has_antineoplastic> "Methotrexate" .
<Mercaptopurine,_Methotrexate,_Vincristine> <Has_antineoplastic> "Mercaptopurine" .
<ABVD,_DD-DI> <Has_context> "Induction_therapy" .
<Non-curative_third-line_therapy> <Context_of> "Sorafenib_monotherapy" .
<Non-curative_third-line_therapy> <Context_of> "Regorafenib_monotherapy" .
<Non-curative_third-line_therapy> <Context_of> "Placebo" .
<Non-curative_third-line_therapy> <Context_of> "Pertuzumab_and_Trastuzumab" .
<Non-curative_third-line_therapy> <Context_of> "Lapatinib_and_Trastuzumab" .
<Non-curative_third-line_therapy> <Context_of> "Irinotecan,_Vemurafenib,_Cetuximab" .
<Non-curative_third-line_therapy> <Context_of> "FOLFIRI" .
<Non-curative_third-line_therapy> <Context_of> "Docetaxel_monotherapy" .
<Non-curative_third-line_therapy> <Context_of> "Dabrafenib,_Trametinib,_Panitumumab" .
<Non-curative_third-line_therapy> <Context_of> "CapeOx" .
<Non-curative_third-line_therapy> <Context_of> "Cabozantinib_monotherapy" .
<Non-curative_third-line_therapy> <Context_of> "Cabozantinib_and_Erlotinib" .
<Non-curative_third-line_therapy> <Context_of> "Binimetinib,_Encorafenib,_Cetuximab" .
<Ceritinib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cisplatin_and_Ifosfamide> <Maps_to> "Cisplatin_and_Ifosfamide" .
<Salvage_therapy> <Context_of> "Whole_brain_irradiation" .
<Salvage_therapy> <Context_of> "Vosaroxin_and_Cytarabine" .
<Salvage_therapy> <Context_of> "VeIP" .
<Salvage_therapy> <Context_of> "VIPD" .
<Salvage_therapy> <Context_of> "VIP" .
<Salvage_therapy> <Context_of> "VIM" .
<Salvage_therapy> <Context_of> "Temozolomide_monotherapy" .
<Salvage_therapy> <Context_of> "TIP" .
<Salvage_therapy> <Context_of> "SHAI" .
<Salvage_therapy> <Context_of> "SCAB" .
<Salvage_therapy> <Context_of> "Radiation_therapy" .
<Salvage_therapy> <Context_of> "RICER" .
<Salvage_therapy> <Context_of> "R-NIMP" .
<Salvage_therapy> <Context_of> "R-IFE" .
<Salvage_therapy> <Context_of> "R-ICE" .
<Salvage_therapy> <Context_of> "R-GDP" .
<Salvage_therapy> <Context_of> "R-ESHAP" .
<Salvage_therapy> <Context_of> "R-EPOCH" .
<Salvage_therapy> <Context_of> "R-DexaBEAM" .
<Salvage_therapy> <Context_of> "R-DHAP/R-VIM" .
<Salvage_therapy> <Context_of> "R-DHAP" .
<Salvage_therapy> <Context_of> "R-DHAOx" .
<Salvage_therapy> <Context_of> "Ponatinib_monotherapy" .
<Salvage_therapy> <Context_of> "Pentostatin_and_Alemtuzumab" .
<Salvage_therapy> <Context_of> "PCV" .
<Salvage_therapy> <Context_of> "Omacetaxine_monotherapy" .
<Salvage_therapy> <Context_of> "O-ICE" .
<Salvage_therapy> <Context_of> "O-DHAP" .
<Salvage_therapy> <Context_of> "Nilotinib_monotherapy" .
<Salvage_therapy> <Context_of> "Midostaurin_monotherapy" .
<Salvage_therapy> <Context_of> "MINE" .
<Salvage_therapy> <Context_of> "MEC" .
<Salvage_therapy> <Context_of> "Ivosidenib_monotherapy" .
<Salvage_therapy> <Context_of> "Irinotecan_monotherapy" .
<Salvage_therapy> <Context_of> "Irinotecan_and_Bevacizumab" .
<Salvage_therapy> <Context_of> "Imatinib_monotherapy" .
<Salvage_therapy> <Context_of> "Ifosfamide_and_Paclitaxel" .
<Salvage_therapy> <Context_of> "Ifosfamide_and_Methotrexate" .
<Salvage_therapy> <Context_of> "Ibrutinib_and_Venetoclax" .
<Salvage_therapy> <Context_of> "IAP" .
<Salvage_therapy> <Context_of> "HiDAC" .
<Salvage_therapy> <Context_of> "HAM" .
<Salvage_therapy> <Context_of> "Goserelin_and_RT" .
<Salvage_therapy> <Context_of> "Gemtuzumab_ozogamicin_monotherapy" .
<Salvage_therapy> <Context_of> "GIP" .
<Salvage_therapy> <Context_of> "GDP" .
<Salvage_therapy> <Context_of> "FLAG-Ida" .
<Salvage_therapy> <Context_of> "FLAG-DNX" .
<Salvage_therapy> <Context_of> "FLAG" .
<Salvage_therapy> <Context_of> "F-SHAI" .
<Salvage_therapy> <Context_of> "Etoposide_monotherapy" .
<Salvage_therapy> <Context_of> "Etoposide_and_Mitoxantrone" .
<Salvage_therapy> <Context_of> "Enasidenib_monotherapy" .
<Salvage_therapy> <Context_of> "EPIC_regimen" .
<Salvage_therapy> <Context_of> "Dasatinib_monotherapy" .
<Salvage_therapy> <Context_of> "DHAP" .
<Salvage_therapy> <Context_of> "Cytarabine_and_Mitoxantrone" .
<Salvage_therapy> <Context_of> "Cyclophosphamide_monotherapy" .
<Salvage_therapy> <Context_of> "Clofarabine_and_Cytarabine" .
<Salvage_therapy> <Context_of> "Cisplatin_and_Epirubicin" .
<Salvage_therapy> <Context_of> "Carboplatin_and_Etoposide,_then_auto_HSCT" .
<Salvage_therapy> <Context_of> "Carboplatin_and_Bevacizumab" .
<Salvage_therapy> <Context_of> "CYVE" .
<Salvage_therapy> <Context_of> "CVPP" .
<Salvage_therapy> <Context_of> "CVB" .
<Salvage_therapy> <Context_of> "CLARA" .
<Salvage_therapy> <Context_of> "CLAG-M" .
<Salvage_therapy> <Context_of> "CLAG" .
<Salvage_therapy> <Context_of> "CEP" .
<Salvage_therapy> <Context_of> "Brentuximab_vedotin_monotherapy" .
<Salvage_therapy> <Context_of> "Bicalutamide_and_RT" .
<Salvage_therapy> <Context_of> "Bevacizumab_monotherapy" .
<Salvage_therapy> <Context_of> "Bendamustine_monotherapy" .
<Salvage_therapy> <Context_of> "BVDS" .
<Salvage_therapy> <Context_of> "BVCPP" .
<Salvage_therapy> <Context_of> "B-CAVe" .
<Salvage_therapy> <Context_of> "ADE_(standard-dose_Ara-C)" .
<Salvage_therapy> <Context_of> "ABVD" .
<Salvage_therapy> <Context_of> "ABDIC" .
<Salvage_therapy> <Context_of> "5_plus_2d" .
<Vyxeos> <Brand_name_of> "Cytarabine_and_daunorubicin_liposomal" .
<Carboplatin_and_Cyclophosphamide> <Mapped_from> "Carboplatin_and_Cyclophosphamide" .
<KMP> <Has_context> "Non-curative_first-line_therapy" .
<Sulphaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CBV-Mx> <Has_accepted_use> "Autologous_HSCT" .
<FOLFIRI_and_Ramucirumab> <Has_modality> "Chemotherapy" .
<Octreotide_monotherapy> <Has_accepted_use> "Thymoma" .
<Octreotide_monotherapy> <Has_accepted_use> "Pancreatic_NET" .
<Octreotide_monotherapy> <Has_accepted_use> "Neuroendocrine_tumor" .
<Carboplatin,_Docetaxel,_Prednisone> <Has_modality> "Hormonotherapy" .
<Carboplatin,_Docetaxel,_Prednisone> <Has_modality> "Chemotherapy" .
<Zuviphos> <Brand_name_of> "Cyclophosphamide" .
<Fibrinolysis_inhibitor> <Is_a> "Classical_hematology_medication" .
<Mitotane_and_EDP> <Has_modality> "Chemotherapy" .
<Methasone> <Brand_name_of> "Dexamethasone" .
<Peyrone's_Chloride> <Brand_name_of> "Cisplatin" .
<PATCO> <Is_historical_in> "Acute_myeloid_leukemia" .
<Biocisplatinum> <Brand_name_of> "Cisplatin" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Methisol> <Brand_name_of> "Methylprednisolone" .
<Thaangio> <Brand_name_of> "Thalidomide" .
<Asacard> <Brand_name_of> "Aspirin" .
<Paclitaxel,_Topotecan,_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<Fluhomer> <Brand_name_of> "Fluorouracil" .
<Caplacizumab> <Supportive_med_of> "Caplacizumab_and_Plasma_exchange" .
<FUIRI> <Has_antineoplastic> "Irinotecan" .
<FUIRI> <Has_antineoplastic> "Folinic_acid" .
<Fluorouracil_and_Streptozocin> <Has_accepted_use> "Pancreatic_NET" .
<Fluorouracil_and_Streptozocin> <Has_accepted_use> "Neuroendocrine_tumor" .
<Ibrutinib_and_Venetoclax> <Has_context> "Salvage_therapy" .
<Ibrutinib_and_Venetoclax> <Has_context> "Non-curative_therapy" .
<Ibrutinib_and_Venetoclax> <Has_context> "Non-curative_first-line_therapy" .
<FLAG> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<FLAG> <Is_current_in> "Acute_myeloid_leukemia" .
<Fluorouracil_and_Mitomycin> <Is_historical_in> "Gastric_cancer" .
<Fluorouracil_and_Mitomycin> <Is_historical_in> "Colon_cancer" .
<Prasugrel> <May_have_route> "Oral" .
<Syklofosfamid> <Brand_name_of> "Cyclophosphamide" .
<CODOX-M> <Has_supportive_med> "Folinic_acid" .
<CODOX-M> <Has_supportive_med> "Filgrastim" .
<EC_and_Bevacizumab> <Maps_to> "EC_and_Bevacizumab" .
<Enclex> <Brand_name_of> "Enoxaparin" .
<Dacomitinib> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Chlorambucil_and_Cisplatin> <Is_a> "Platinum_doublet" .
<CDE> <Is_a> "Anthracycline-containing_regimen" .
<FRD> <Has_context> "Non-curative_therapy" .
<Texot> <Brand_name_of> "Docetaxel" .
<Remin_S> <Brand_name_of> "Aspirin" .
<Primatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Thiotepa> <Is_a> "Neutral" .
<Thiotepa> <Is_a> "Irritant" .
<Thiotepa> <Is_a> "Alkylating_agent" .
<DA_3_plus_10,_GO> <Has_modality> "Chemotherapy" .
<FLAG-DNX> <Has_supportive_med> "Filgrastim" .
<M-BCD> <Has_accepted_use> "Osteosarcoma" .
<Docetaxel_and_Gemcitabine> <Has_antineoplastic> "Gemcitabine" .
<Docetaxel_and_Gemcitabine> <Has_antineoplastic> "Docetaxel" .
<CHVmP-VB> <Has_context> "Induction_therapy" .
<Edoxaban_monotherapy> <Has_accepted_use> "Venous_thromboembolism" .
<Flutamide_and_Goserelin> <Maps_to> "Flutamide_and_Goserelin" .
<Octreotide_monotherapy> <Has_modality> "Hormonotherapy" .
<Clofarabine_and_Melphalan> <Maps_to> "Clofarabine_and_Melphalan" .
<Gliadel_wafer_monotherapy> <Has_local_therapy> "Carmustine_wafer_polifeprosan_20" .
<Decitabine> <May_have_route> "Intravenous" .
<Bone_sarcoma> <Is_a> "Sarcoma" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "m-BNCOD" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "m-BACOD" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Z-BEAM,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Vorinostat" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Vinorelbine_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Vinorelbine" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Vindesine" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Vincristine_liposomal" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Vincristine_and_Prednisone" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Vincristine" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Vinblastine" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "VR-CHOP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "VNCOP-B" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "VIPD" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "VIM" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "VEPA" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "VCAP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "VACOP-B" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "VABE" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Topotecan" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Tisagenlecleucel_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Tisagenlecleucel" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Temsirolimus_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Temsirolimus" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "TTR" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "TBI,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Rituximab-pvvr" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Rituximab-abbs" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Rituximab_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Rituximab_and_hyaluronidase_human" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Rituximab" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Radiation_therapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "RICER" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R2CHOP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-miniCHOP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-miniCEOP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-TBI/Cy,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-NIMP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-MegaCHOP-14" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-MegaCHOP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-INO" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-IFE" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-ICE" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-Hyper-CVAD/R-MA" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-GemOx" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-GDP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-GCVP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-ESHAP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-EPOCH" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-DexaBEAM" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-DHAP/R-VIM" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-DHAP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-DHAOx" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-CVEP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-CHOP-14_(Rituximab_Hycela)" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-CHOP-14_(Prednisolone)" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-CHOP-14" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-CHOP_(Rituximab_Hycela)" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-CHOP_(Prednisolone)" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-CHOP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-CHOEP-14" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-CHMP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-CEOP90_(Epirubicin)" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-CEOP_(Etoposide)" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-CDOP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-BL" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "R-BEAM,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "ProMACE-MOPP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "ProMACE-CytaBOM" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Prednisone" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Prednisolone" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Polatuzumab_vedotin" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Placebo" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Pixantrone_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Pixantrone" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Pidilizumab" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Pegylated_liposomal_doxorubicin" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Panobinostat_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Panobinostat_and_Rituximab" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Paclitaxel" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "PMitCEBO" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "PEN" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "PACEBOM" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "P/DOCE" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Oxaliplatin_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Oxaliplatin" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Ofatumumab_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Ofatumumab" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Observation" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Obinutuzumab_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Obinutuzumab" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "O-miniCHOP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "O-ICE" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "O-DHAP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Mitoxantrone_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Mitoxantrone" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Methylprednisolone" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Methotrexate_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Methotrexate" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Melphalan" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "MOR208" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "MINE" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "MACOP-B" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Lenalidomide_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Lenalidomide_and_Rituximab" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Lenalidomide" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "LEED,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "LD-ACOP-B" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Inotuzumab_ozogamicin" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Ifosfamide_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Ifosfamide" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Ibrutinib_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Ibrutinib" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Ibritumomab_tiuxetan_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Ibritumomab_tiuxetan" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "ICE" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Helicobacter_pylori_eradication_therapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "HOP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "HAM" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Gemcitabine_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Gemcitabine_and_Rituximab" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Gemcitabine" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "GVD" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "GDP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "FluBuCy,_then_allo_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "FEAM,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "F-MACHOP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Everolimus_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Everolimus_and_Rituximab" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Everolimus" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Etoposide,_Ifosfamide,_Methotrexate" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Etoposide_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Etoposide" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Epirubicin" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "ESHAP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "EPOCH" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "EPIC_regimen" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Doxorubicin" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Dexamethasone" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "DICEP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "DICE" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "DHAP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "DA-R-EPOCH" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "DA-EPOCH" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Cytarabine_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Cytarabine" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Cyclophosphamide_and_TBI,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Cyclophosphamide_and_TBI" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Cyclophosphamide" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Coltuximab_ravtansine" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Cisplatin" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Carmustine" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Carboplatin" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CVP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "COP-Bleo" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "COMP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CNOP_(Prednisolone)" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CNOP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CHVmP-VB" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CHVmP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CHOP-BCG" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CHOP-B" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CHOP-14" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CHOP_Modified_(Prednisolone)" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CHOP_Modified" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CHOP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CHOEP-21" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CHOEP-14" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CEPP(B)" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CEOP_(Prednisolone)" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CEOP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CEEP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CCOP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CBVM,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CBV,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "CAP-BOP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "C-MOPP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Brentuximab_vedotin_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Brentuximab_vedotin" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Bortezomib" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Blinatumomab_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Blinatumomab" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Bleomycin" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Bendamustine_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Bendamustine" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "BeEAM,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "BR_and_Polatuzumab_vedotin" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "BR" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "BEAM,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "BEAM,_then_allo_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "BEAC,_then_auto_HSCT" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "BCOP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Axicabtagene_ciloleucel_monotherapy" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "Axicabtagene_ciloleucel" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "APO" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "ACVBP-R" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "ACVBP" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "ACOMLA" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "ACE" .
<Diffuse_large_B-cell_lymphoma> <Accepted_use_of> "ABP" .
<CANMab> <Brand_name_of> "Trastuzumab" .
<Chlorambucil_and_Ofatumumab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<mCOP/MP> <Maps_to> "mCOP/MP" .
<SOX_and_Bevacizumab> <Maps_to> "SOX_and_Bevacizumab" .
<Mercaptopurine_and_WBRT> <Mapped_from> "Mercaptopurine_and_WBRT" .
<Savaysa> <Brand_name_of> "Edoxaban" .
<GCP> <Has_antineoplastic> "Pemetrexed" .
<GCP> <Has_antineoplastic> "Paclitaxel" .
<GCP> <Has_antineoplastic> "Gemcitabine" .
<GCP> <Has_antineoplastic> "Gefitinib" .
<GCP> <Has_antineoplastic> "Carboplatin" .
<MOF> <Has_context> "Adjuvant_therapy" .
<Cisplatin,_Gemcitabine,_Necitumumab> <Has_antineoplastic> "Necitumumab" .
<Cisplatin,_Gemcitabine,_Necitumumab> <Has_antineoplastic> "Gemcitabine" .
<Cisplatin,_Gemcitabine,_Necitumumab> <Has_antineoplastic> "Cisplatin" .
<Necitumumab_monotherapy> <Maps_to> "Necitumumab_monotherapy" .
<Antiandrogen_withdrawal> <Mapped_from> "Antiandrogen_withdrawal" .
<Degarelix_monotherapy> <Is_current_in> "Prostate_cancer" .
<Cotrisul> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Grafalon> <Brand_name_of> "Antithymocyte_globulin_rabbit_ATG" .
<Factor_IX_human> <Is_a> "Hemostasis_medication" .
<Factor_IX_human> <Is_a> "Hematology_medication" .
<Factor_IX_human> <Is_a> "Fractionated_plasma_product" .
<Factor_IX_human> <Is_a> "Coagulation_factor" .
<FLEP> <Has_modality> "Chemotherapy" .
<Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone> <Mapped_from> "Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone" .
<Prednisone_and_Rituximab> <Has_immunosuppressor> "Rituximab" .
<Prednisone_and_Rituximab> <Has_immunosuppressor> "Prednisone" .
<Irinotecan_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<HiDAC_and_Midostaurin> <Has_modality> "Chemotherapy" .
<mFOLFOX6_and_Cetuximab> <Mapped_from> "mFOLFOX6_and_Cetuximab" .
<Methotrexate_and_Vincristine> <Has_supportive_med> "Folinic_acid" .
<TEK_inhibitor> <Is_a> "Kinase_inhibitor" .
<PEN> <Mapped_from> "PEN" .
<Neosar> <Brand_name_of> "Cyclophosphamide" .
<Mechlorethamine> <Antineoplastic_of> "Stanford_V" .
<Mechlorethamine> <Antineoplastic_of> "ProMACE-MOPP" .
<Mechlorethamine> <Antineoplastic_of> "Mechlorethamine_monotherapy" .
<Mechlorethamine> <Antineoplastic_of> "MVPP" .
<Mechlorethamine> <Antineoplastic_of> "MOPP/ABVD" .
<Mechlorethamine> <Antineoplastic_of> "MOPP-ABV" .
<Mechlorethamine> <Antineoplastic_of> "MOPP" .
<Pracinostat> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Inotuzumab_ozogamicin_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<Inotuzumab_ozogamicin_monotherapy> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Axitinib_and_Avelumab> <Is_current_in> "Renal_cell_carcinoma" .
<Entrectinib> <May_have_route> "Oral" .
<BVB> <Has_accepted_use> "Hodgkin_lymphoma" .
<Dacomitinib_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Dacomitinib_monotherapy> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<Bifosmac> <Brand_name_of> "Alendronate" .
<Flutamide_monotherapy> <Has_antineoplastic> "Flutamide" .
<Capecitabine_and_Temozolomide> <Maps_to> "Capecitabine_and_Temozolomide" .
<MA> <Has_modality> "Chemotherapy" .
<Farmistin_CS> <Brand_name_of> "Vincristine" .
<Pulkrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<ADT> <Has_modality> "Hormonotherapy" .
<A-AVD> <Maps_to> "A-AVD" .
<Delta-Diona> <Brand_name_of> "Prednisolone" .
<Anti-Factor_Xa_antibody> <Subsumes> "Emicizumab" .
<Dabrafenib,_Trametinib,_Panitumumab> <Has_context> "Non-curative_third-line_therapy" .
<Dolorosan> <Brand_name_of> "Aspirin" .
<mFOLFOX6> <Maps_to> "mFOLFOX6" .
<AT_(Taxol)> <Is_current_in> "Breast_cancer" .
<Amsacrine_and_Cytarabine> <Has_context> "Consolidation_after_upfront_therapy" .
<Chlorambucil_and_Cisplatin> <Has_context> "Non-curative_first-line_therapy" .
<Hexa-CAF> <Has_modality> "Chemotherapy" .
<Bifosa> <Brand_name_of> "Alendronate" .
<FOLFOX4_(L-Leucovorin)> <Maps_to> "FOLFOX4_(L-Leucovorin)" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine> <Has_modality> "Chemotherapy" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Has_context> "Induction_therapy" .
<HAD> <Is_a> "Anthracycline-containing_regimen" .
<Ixazomib> <Is_a> "Proteasome_inhibitor" .
<Ixazomib> <Is_a> "Light-chain_(AL)_amyloidosis_medication" .
<CaRD> <Has_modality> "Chemotherapy" .
<R-miniCEOP> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<ABV_(Vinblastine)> <Mapped_from> "ABV_(Vinblastine)" .
<Cytarabine_and_Daunorubicin> <Mapped_from> "Cytarabine_and_Daunorubicin" .
<Trastuzumab-dkst> <Has_FDA_indication> "Gastric_cancer" .
<Trastuzumab-dkst> <Has_FDA_indication> "Breast_cancer" .
<GCP> <Has_supportive_med> "Steroids" .
<GCP> <Has_supportive_med> "Diphenhydramine" .
<GCP> <Has_supportive_med> "Cimetidine" .
<Vincristine_monotherapy> <Has_modality> "Chemotherapy" .
<VMP,_then_Rd> <Mapped_from> "VMP,_then_Rd" .
<Maforan> <Brand_name_of> "Warfarin" .
<Interferon_alfa-n1_monotherapy> <Mapped_from> "Interferon_alfa-n1_monotherapy" .
<CLAG> <Mapped_from> "CLAG" .
<Prednisone_monotherapy> <Is_current_in> "Warm_autoimmune_hemolytic_anemia" .
<Prednisone_monotherapy> <Is_current_in> "T-cell_acute_lymphoblastic_leukemia" .
<Prednisone_monotherapy> <Is_current_in> "Prostate_cancer" .
<Prednisone_monotherapy> <Is_current_in> "Myelofibrosis" .
<Prednisone_monotherapy> <Is_current_in> "Immune_thrombocytopenia" .
<Prednisone_monotherapy> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Prednisone_monotherapy> <Is_current_in> "Acquired_coagulopathy" .
<Cladribine_monotherapy> <Has_accepted_use> "Systemic_mastocytosis" .
<Cladribine_monotherapy> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Cladribine_monotherapy> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Cladribine_monotherapy> <Has_accepted_use> "Langerhans_cell_histiocytosis" .
<Cladribine_monotherapy> <Has_accepted_use> "Hairy_cell_leukemia" .
<Cladribine_monotherapy> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Cladribine_monotherapy> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Dara-PD> <Has_antineoplastic> "Pomalidomide" .
<Dara-PD> <Has_antineoplastic> "Dexamethasone" .
<Dara-PD> <Has_antineoplastic> "Daratumumab" .
<Lipefilgrastim> <May_have_route> "Subcutaneous" .
<Trastuzumab-anns> <Has_FDA_indication> "Gastric_cancer" .
<Trastuzumab-anns> <Has_FDA_indication> "Breast_cancer" .
<Abemaciclib> <Has_FDA_indication> "Breast_cancer" .
<Lutetium_Lu_177_dotatate_and_Octreotide_LAR> <Has_context> "All_lines_of_therapy" .
<VR-CHOP> <Has_supportive_med> "Diphenhydramine" .
<VR-CHOP> <Has_supportive_med> "Acetaminophen" .
<Sopran> <Brand_name_of> "Ondansetron" .
<Ketoconazole,_Hydrocortisone,_Dutasteride> <Is_current_in> "Prostate_cancer" .
<R-CODOX-M/R-IVAC> <Mapped_from> "R-CODOX-M/R-IVAC" .
<nab-Paclitaxel_and_Trastuzumab> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<nab-Paclitaxel_and_Trastuzumab> <Has_accepted_use> "Breast_cancer" .
<Degarelix_monotherapy> <Has_modality> "Hormonotherapy" .
<HAM_and_Imatinib> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Tranexamic_acid_monotherapy> <Has_antineoplastic> "Tranexamic_acid" .
<VMCP/VCAP> <Has_accepted_use> "Multiple_myeloma" .
<All-trans_retinoic_acid> <Is_a> "WHO_Essential_Cancer_Medicine" .
<All-trans_retinoic_acid> <Is_a> "Retinoid" .
<All-trans_retinoic_acid> <Is_a> "Mutation-specific_medication" .
<Eculizumab> <Is_a> "REMS_program" .
<Eculizumab> <Is_a> "Hematology_medication" .
<Eculizumab> <Is_a> "Antibody_medication" .
<Eculizumab> <Is_a> "Anti-C5_antibody" .
<ICL> <Is_current_in> "Acute_myeloid_leukemia" .
<CALGB_10-002_regimen> <Has_accepted_use> "Burkitt_lymphoma" .
<IT_Cytarabine,_Methotrexate,_Prednisone> <Mapped_from> "IT_Cytarabine,_Methotrexate,_Prednisone" .
<Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT> <Has_antineoplastic> "Fludarabine" .
<Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<Ganetespib> <Is_a> "Investigational_drug" .
<Ganetespib> <Is_a> "Hsp90_inhibitor" .
<Gemcitabine_and_Rituximab> <Has_antineoplastic> "Rituximab" .
<Gemcitabine_and_Rituximab> <Has_antineoplastic> "Gemcitabine" .
<VACA> <Maps_to> "VACA" .
<Ravulizumab> <Immunosuppressor_of> "Ravulizumab_monotherapy" .
<Anastrozole_and_Fulvestrant> <Maps_to> "Anastrozole_and_Fulvestrant" .
<ddAC-T> <Has_context> "Adjuvant_therapy" .
<Carboplatin,_nab-Paclitaxel,_Atezolizumab> <Has_antineoplastic> "Paclitaxel_nanoparticle_albumin-bound" .
<Carboplatin,_nab-Paclitaxel,_Atezolizumab> <Has_antineoplastic> "Carboplatin" .
<Carboplatin,_nab-Paclitaxel,_Atezolizumab> <Has_antineoplastic> "Atezolizumab" .
<Dasatinib,_Vincristine,_Prednisone> <Has_antineoplastic> "Vincristine" .
<Dasatinib,_Vincristine,_Prednisone> <Has_antineoplastic> "Prednisone" .
<Dasatinib,_Vincristine,_Prednisone> <Has_antineoplastic> "Dasatinib" .
<Cisplatin_and_Docetaxel> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Cisplatin_and_Docetaxel> <Has_supportive_med> "Ondansetron" .
<Cisplatin_and_Docetaxel> <Has_supportive_med> "Granisetron" .
<Cisplatin_and_Docetaxel> <Has_supportive_med> "Filgrastim" .
<Cisplatin_and_Docetaxel> <Has_supportive_med> "Dexamethasone" .
<DAT> <Mapped_from> "DAT" .
<Edoxaban_monotherapy> <Has_modality> "Anticoagulation" .
<Oprozomib> <Is_a> "Proteasome_inhibitor" .
<Oprozomib> <Is_a> "Investigational_drug" .
<Ravulizumab> <Has_brand_name> "Ultomiris" .
<Bendamustine> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Bendamustine> <Has_accepted_use> "Transformed_lymphoma" .
<Bendamustine> <Has_accepted_use> "Small_cell_lung_cancer" .
<Bendamustine> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Bendamustine> <Has_accepted_use> "Multiple_myeloma" .
<Bendamustine> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Bendamustine> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Bendamustine> <Has_accepted_use> "Hodgkin_lymphoma" .
<Bendamustine> <Has_accepted_use> "Hairy_cell_leukemia" .
<Bendamustine> <Has_accepted_use> "Follicular_lymphoma" .
<Bendamustine> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Bendamustine> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Bendamustine> <Has_accepted_use> "Cold_agglutinin_disease" .
<Bendamustine> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Hertraz> <Brand_name_of> "Trastuzumab" .
<Bicalutamide> <Has_FDA_indication> "Prostate_cancer" .
<Citarax> <Brand_name_of> "Cytarabine" .
<Tekamen> <Brand_name_of> "Irinotecan" .
<Montelukast> <Is_a> "Antileukotriene" .
<ACVBP,_dose-adjusted> <Mapped_from> "ACVBP,_dose-adjusted" .
<Omacetaxine> <Is_a> "Cephalotaxine" .
<MVP_(Vindesine)> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Chemotherapy> <Mapped_from> "Chemotherapy" .
<Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat> <Has_accepted_use> "Multiple_myeloma" .
<Docetaxel_and_Vandetanib> <Has_modality> "Chemotherapy" .
<Anset> <Brand_name_of> "Ondansetron" .
<Abiraterone> <Antineoplastic_of> "Abiraterone_and_Prednisone" .
<Abiraterone> <Antineoplastic_of> "ADT_and_Abiraterone" .
<Sarcoma> <Is_a> "Malignant_solid_neoplasm" .
<Decitabine_and_Valproate> <Has_accepted_use> "Acute_myeloid_leukemia" .
<ATG_(Horse)_monotherapy> <Has_supportive_med> "Prednisone" .
<Yumerole> <Brand_name_of> "Methylprednisolone" .
<Pronison> <Brand_name_of> "Prednisone" .
<Prenilone> <Brand_name_of> "Prednisolone" .
<COX-2_inhibitor> <Is_a> "Nonsteroidal_anti-inflammatory_drugs_(NSAIDs)" .
<Marvil> <Brand_name_of> "Alendronate" .
<Hydroxyurea_and_Plicamycin> <Has_modality> "Chemotherapy" .
<Vemurafenib_monotherapy> <Has_modality> "Chemotherapy" .
<Non-curative_subsequent-line_induction_therapy> <Mapped_from> "Non-curative_subsequent-line_induction_therapy" .
<P/DOCE> <Has_modality> "Chemotherapy" .
<FLOX> <Has_context> "Adjuvant_therapy" .
<Tirofiban> <Has_brand_name> "Aggrastat" .
<Brentuximab_vedotin_and_Nivolumab> <Mapped_from> "Brentuximab_vedotin_and_Nivolumab" .
<Cisplatin_and_Epirubicin> <Has_modality> "Chemotherapy" .
<Ciprofloxacin> <May_have_route> "Oral" .
<Ciprofloxacin> <May_have_route> "Intravenous" .
<Lovenox> <Brand_name_of> "Enoxaparin" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "mLSG15" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "Zidovudine" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "Vindesine" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "Vincristine" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "Ranimustine" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "Prednisone" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "Methotrexate" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "Lenalidomide_monotherapy" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "Lenalidomide" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "LSG15" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "Interferon_alfa-2b_and_Zidovudine" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "Interferon_alfa-2b" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "Etoposide" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "Doxorubicin" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "Cytarabine" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "Cyclophosphamide" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "Carboplatin" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "CHOP-14" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "Alemtuzumab_monotherapy" .
<Adult_T-cell_leukemia-lymphoma> <Accepted_use_of> "Alemtuzumab" .
<Hematopoetic_progenitor_cells_cord_blood> <Has_brand_name> "Hemacord" .
<Medixon> <Brand_name_of> "Methylprednisolone" .
<Neratinib> <Has_brand_name> "Nerlynx" .
<KRAS-mutated_Non-small_cell_lung_cancer> <Accepted_use_of> "Docetaxel_monotherapy" .
<Adrekon> <Brand_name_of> "Dexamethasone" .
<BEACOPP-14_(Prednisolone)> <Has_antineoplastic> "Vincristine" .
<BEACOPP-14_(Prednisolone)> <Has_antineoplastic> "Procarbazine" .
<BEACOPP-14_(Prednisolone)> <Has_antineoplastic> "Prednisolone" .
<BEACOPP-14_(Prednisolone)> <Has_antineoplastic> "Etoposide" .
<BEACOPP-14_(Prednisolone)> <Has_antineoplastic> "Doxorubicin" .
<BEACOPP-14_(Prednisolone)> <Has_antineoplastic> "Cyclophosphamide" .
<BEACOPP-14_(Prednisolone)> <Has_antineoplastic> "Bleomycin" .
<Cisplatin,_Fluorouracil,_Vincristine> <Is_current_in> "Hepatoblastoma" .
<Desametasone_Fosf> <Brand_name_of> "Dexamethasone" .
<Silpin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<mFOLFOX7> <Has_antineoplastic> "Oxaliplatin" .
<mFOLFOX7> <Has_antineoplastic> "Folinic_acid" .
<mFOLFOX7> <Has_antineoplastic> "Fluorouracil" .
<PEFG> <Maps_to> "PEFG" .
<Premaspin> <Brand_name_of> "Aspirin" .
<Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Vincristine" .
<Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Thioguanine" .
<Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Pegaspargase" .
<Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Dexamethasone" .
<Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Cytarabine" .
<Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Cyclophosphamide" .
<Gemcitabine,_Oxaliplatin,_Paclitaxel> <Has_accepted_use> "Testicular_cancer" .
<Cladribine> <Has_brand_name> "Movectro" .
<Cladribine> <Has_brand_name> "Litak" .
<Cladribine> <Has_brand_name> "Leustatin" .
<Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone> <Has_context> "Upfront_therapy" .
<Linker_regimen_(consolidation)> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<R-M-CHOP> <Has_modality> "Chemotherapy" .
<LSG15> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<ddE> <Maps_to> "ddE" .
<Fasturtec> <Brand_name_of> "Rasburicase" .
<Fluorouracil,_Folinic_acid,_Gemcitabine> <Has_context> "Non-curative_therapy" .
<Fluorouracil,_Folinic_acid,_Gemcitabine> <Has_context> "Non-curative_first-line_therapy" .
<ddA> <Mapped_from> "ddA" .
<mFOLFOX6_and_Bevacizumab_(L-Leucovorin)> <Has_context> "Non-curative_first-line_therapy" .
<R-CVP> <Is_current_in> "Marginal_zone_lymphoma" .
<R-CVP> <Is_current_in> "Mantle_cell_lymphoma" .
<R-CVP> <Is_current_in> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<R-CVP> <Is_current_in> "Follicular_lymphoma" .
<BCHOP> <Maps_to> "BCHOP" .
<VNCOP-B> <Has_modality> "Chemotherapy" .
<Azacitidine_and_Sorafenib> <Mapped_from> "Azacitidine_and_Sorafenib" .
<Methylprednisolone_monotherapy> <Mapped_from> "Methylprednisolone_monotherapy" .
<Cilostazol> <Has_brand_name> "Pletal" .
<Docetaxel_monotherapy> <Is_current_in> "Small_cell_lung_cancer" .
<Docetaxel_monotherapy> <Is_current_in> "Ovarian_cancer" .
<Docetaxel_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Docetaxel_monotherapy> <Is_current_in> "Melanoma" .
<Docetaxel_monotherapy> <Is_current_in> "Head_and_neck_cancer" .
<Docetaxel_monotherapy> <Is_current_in> "Gastric_cancer" .
<Docetaxel_monotherapy> <Is_current_in> "Esophageal_cancer" .
<Docetaxel_monotherapy> <Is_current_in> "Cervical_cancer" .
<Docetaxel_monotherapy> <Is_current_in> "Breast_cancer" .
<Docetaxel_monotherapy> <Is_current_in> "Bladder_cancer" .
<TTR> <Maps_to> "TTR" .
<AryoSeven> <Brand_name_of> "Factor_VIIa_recombinant" .
<Cyclophosphamide,_Dacarbazine,_Vincristine> <Maps_to> "Cyclophosphamide,_Dacarbazine,_Vincristine" .
<Cytarabine_and_daunorubicin_liposomal> <Antineoplastic_of> "CPX-351_monotherapy" .
<Albyl> <Brand_name_of> "Aspirin" .
<Carboplatin_and_Ifosfamide> <Mapped_from> "Carboplatin_and_Ifosfamide" .
<Chemoradioimmunotherapy> <Modality_of> "Z-BEAM,_then_auto_HSCT" .
<Chemoradioimmunotherapy> <Modality_of> "Z-BEAM" .
<Chemoradioimmunotherapy> <Modality_of> "(90)YFC,_then_allo_HSCT" .
<Chemoradioimmunotherapy> <Modality_of> "(90)YFC" .
<Cyproterone_acetate_monotherapy> <Has_antineoplastic> "Cyproterone_acetate" .
<Movectro> <Brand_name_of> "Cladribine" .
<Bexarotene_and_Pralatrexate> <Maps_to> "Bexarotene_and_Pralatrexate" .
<FOLFIRINOX> <Has_antineoplastic> "Oxaliplatin" .
<FOLFIRINOX> <Has_antineoplastic> "Irinotecan" .
<FOLFIRINOX> <Has_antineoplastic> "Folinic_acid" .
<FOLFIRINOX> <Has_antineoplastic> "Fluorouracil" .
<Vindesine_monotherapy> <Has_antineoplastic> "Vindesine" .
<Tandem_melphalan,_then_auto_HSCT> <Maps_to> "Tandem_melphalan,_then_auto_HSCT" .
<Intidrol> <Brand_name_of> "Methylprednisolone" .
<Endocrine_oncology_medication> <Is_a> "Site-specific_medication" .
<Aggrenox> <Brand_name_of> "Aspirin_and_dipyridamole" .
<Euflex> <Brand_name_of> "Flutamide" .
<Capecitabine_and_Ixabepilone> <Has_antineoplastic> "Ixabepilone" .
<Capecitabine_and_Ixabepilone> <Has_antineoplastic> "Capecitabine" .
<Ifosfamide_monotherapy> <Maps_to> "Ifosfamide_monotherapy" .
<RP> <Maps_to> "RP" .
<Diffuse_large_B-cell_lymphoma> <Is_a> "Non-Hodgkin_lymphoma" .
<Diffuse_large_B-cell_lymphoma> <Is_a> "Aggressive_lymphoma" .
<VA> <Has_modality> "Chemotherapy" .
<Avapritinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Cytarabine,_Idarubicin,_Imatinib> <Is_a> "Anthracycline-containing_regimen" .
<Adrenocortical_carcinoma> <Is_a> "Endocrine_cancer" .
<Bactrium_DS> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Tacrolimus> <Is_a> "Calcineurin_inhibitor" .
<CM> <Has_context> "Non-curative_subsequent-line_therapy" .
<Doxorubicin_and_Ifosfamide> <Mapped_from> "Doxorubicin_and_Ifosfamide" .
<Reventa> <Brand_name_of> "Alendronate" .
<Ataspin> <Brand_name_of> "Aspirin" .
<Fluracedyl> <Brand_name_of> "Fluorouracil" .
<Capecitabine_and_Erlotinib> <Has_accepted_use> "Pancreatic_cancer" .
<Faridexon> <Brand_name_of> "Dexamethasone" .
<CF_and_Trastuzumab> <Mapped_from> "CF_and_Trastuzumab" .
<Carboplatin,_Etoposide,_Atezolizumab> <Has_accepted_use> "Small_cell_lung_cancer" .
<Mechlorethamine> <Is_a> "Vesicant" .
<Mechlorethamine> <Is_a> "Nitrogen_mustard" .
<Mechlorethamine> <Is_a> "Alkylating_agent" .
<CapeOx> <Has_antineoplastic> "Oxaliplatin" .
<CapeOx> <Has_antineoplastic> "Capecitabine" .
<Venetoclax> <Has_brand_name> "Venclexta" .
<CHOP_and_Everolimus> <Has_modality> "Chemotherapy" .
<Anastrozole_and_Palbociclib> <Has_modality> "Hormonotherapy" .
<Anastrozole_and_Palbociclib> <Has_modality> "Chemotherapy" .
<VEPEMB> <Mapped_from> "VEPEMB" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT> <Has_modality> "Radioimmunotherapy" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<Periampullary_adenocarcinoma> <Is_a> "Hepatobiliary_cancer" .
<Pertuzumab_and_T-DM1> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<Pertuzumab_and_T-DM1> <Has_accepted_use> "Breast_cancer" .
<Meperidine> <Supportive_med_of> "IL-2_monotherapy" .
<Meperidine> <Supportive_med_of> "High-dose_Interleukin-2" .
<Meperidine> <Supportive_med_of> "Docetaxel_monotherapy" .
<Meperidine> <Supportive_med_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<BEAC> <Has_antineoplastic> "Etoposide" .
<BEAC> <Has_antineoplastic> "Cytarabine" .
<BEAC> <Has_antineoplastic> "Cyclophosphamide" .
<BEAC> <Has_antineoplastic> "Carmustine" .
<Sirolimus> <Immunosuppressor_of> "Sirolimus,_Tacrolimus,_Prednisone" .
<Sirolimus> <Immunosuppressor_of> "Sirolimus_monotherapy" .
<Sirolimus> <Immunosuppressor_of> "Sirolimus_and_Prednisone" .
<Sirolimus> <Immunosuppressor_of> "Cyclosporine,_Sirolimus,_Prednisone" .
<Sirolimus> <Immunosuppressor_of> "Cyclosporine,_Mycophenolate_mofetil,_Sirolimus" .
<Sirolimus> <Immunosuppressor_of> "ATG_(Horse),_Cyclosporine,_Sirolimus" .
<Irinotecan_and_Bevacizumab> <Is_a> "Irinotecan-containing_regimen" .
<Irinotecan_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<KMP> <Has_accepted_use> "Multiple_myeloma" .
<R-miniCHOP> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Busulfan_and_Cyclophosphamide> <Has_context> "All_lines_of_therapy" .
<Paclitaxel_and_Bevacizumab> <Mapped_from> "Paclitaxel_and_Bevacizumab" .
<FAS> <Has_antineoplastic> "Streptozocin" .
<FAS> <Has_antineoplastic> "Fluorouracil" .
<FAS> <Has_antineoplastic> "Doxorubicin" .
<Decitex> <Brand_name_of> "Decitabine" .
<L-Asparaginase,_Vincristine,_Prednisolone> <Mapped_from> "L-Asparaginase,_Vincristine,_Prednisolone" .
<CPX-351_monotherapy> <Maps_to> "CPX-351_monotherapy" .
<Clarithromycin> <Antineoplastic_of> "Helicobacter_pylori_eradication_therapy" .
<Clarithromycin> <Antineoplastic_of> "Clarithromycin_monotherapy" .
<Clarithromycin> <Antineoplastic_of> "BiRd" .
<Dacarbazine_and_Interferon_alfa-2a> <Mapped_from> "Dacarbazine_and_Interferon_alfa-2a" .
<FNC> <Has_context> "Adjuvant_therapy" .
<Cisplatin,_Etoposide,_Bevacizumab> <Has_modality> "Chemotherapy" .
<Axitinib_monotherapy> <Maps_to> "Axitinib_monotherapy" .
<Durvalumab> <Is_a> "T-cell_activator" .
<Durvalumab> <Is_a> "Immunotherapeutic" .
<Durvalumab> <Is_a> "Antibody_medication" .
<Durvalumab> <Is_a> "Anti-PD-L1_antibody" .
<Alendronsaeure> <Brand_name_of> "Alendronate" .
<FOLFIRI> <Has_supportive_med> "Ondansetron" .
<FOLFIRI> <Has_supportive_med> "Loperamide" .
<FOLFIRI> <Has_supportive_med> "Filgrastim" .
<FOLFIRI> <Has_supportive_med> "Dexamethasone" .
<FOLFIRI> <Has_supportive_med> "Atropine" .
<R-CHOP> <Mapped_from> "R-CHOP" .
<LoDAC_and_Venetoclax> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Methylprednisolonum> <Brand_name_of> "Methylprednisolone" .
<Pentostatin_and_Alemtuzumab> <Has_antineoplastic> "Pentostatin" .
<Pentostatin_and_Alemtuzumab> <Has_antineoplastic> "Alemtuzumab" .
<R-BL> <Is_a> "Rituximab-containing_regimen" .
<ABVD,_DD-DI> <Is_current_in> "Hodgkin_lymphoma" .
<Gastric_cancer> <Current_treated_by> "nab-Paclitaxel_monotherapy" .
<Gastric_cancer> <Current_treated_by> "mDCF_and_Bevacizumab" .
<Gastric_cancer> <Current_treated_by> "mDCF" .
<Gastric_cancer> <Current_treated_by> "UFTM" .
<Gastric_cancer> <Current_treated_by> "Trifluridine_and_tipiracil_monotherapy" .
<Gastric_cancer> <Current_treated_by> "S-1_monotherapy" .
<Gastric_cancer> <Current_treated_by> "Regorafenib_monotherapy" .
<Gastric_cancer> <Current_treated_by> "Ramucirumab_monotherapy" .
<Gastric_cancer> <Current_treated_by> "Placebo" .
<Gastric_cancer> <Current_treated_by> "Pembrolizumab_monotherapy" .
<Gastric_cancer> <Current_treated_by> "Paclitaxel_monotherapy" .
<Gastric_cancer> <Current_treated_by> "Paclitaxel_and_S-1" .
<Gastric_cancer> <Current_treated_by> "Paclitaxel_and_Ramucirumab" .
<Gastric_cancer> <Current_treated_by> "Observation" .
<Gastric_cancer> <Current_treated_by> "OLF" .
<Gastric_cancer> <Current_treated_by> "No_neoadjuvant_therapy" .
<Gastric_cancer> <Current_treated_by> "Nivolumab_monotherapy" .
<Gastric_cancer> <Current_treated_by> "Irinotecan_monotherapy" .
<Gastric_cancer> <Current_treated_by> "Irinotecan_liposomal_monotherapy" .
<Gastric_cancer> <Current_treated_by> "Fluorouracil,_Folinic_acid,_Mitomycin" .
<Gastric_cancer> <Current_treated_by> "Fluorouracil_monotherapy" .
<Gastric_cancer> <Current_treated_by> "FULV/FULV_and_RT" .
<Gastric_cancer> <Current_treated_by> "FP/Capecitabine_and_RT" .
<Gastric_cancer> <Current_treated_by> "FLOT" .
<Gastric_cancer> <Current_treated_by> "EOX" .
<Gastric_cancer> <Current_treated_by> "EOF" .
<Gastric_cancer> <Current_treated_by> "ECX" .
<Gastric_cancer> <Current_treated_by> "ECF" .
<Gastric_cancer> <Current_treated_by> "Docetaxel_monotherapy" .
<Gastric_cancer> <Current_treated_by> "Docetaxel_and_S-1" .
<Gastric_cancer> <Current_treated_by> "DCF" .
<Gastric_cancer> <Current_treated_by> "Cisplatin,_Fluorouracil,_Pembrolizumab" .
<Gastric_cancer> <Current_treated_by> "Cisplatin_and_S-1" .
<Gastric_cancer> <Current_treated_by> "Cisplatin_and_Fluorouracil" .
<Gastric_cancer> <Current_treated_by> "Cisplatin_and_Docetaxel" .
<Gastric_cancer> <Current_treated_by> "Carboplatin_and_Paclitaxel" .
<Gastric_cancer> <Current_treated_by> "Carboplatin_and_Docetaxel" .
<Gastric_cancer> <Current_treated_by> "Capecitabine_monotherapy" .
<Gastric_cancer> <Current_treated_by> "CapeOx" .
<Gastric_cancer> <Current_treated_by> "CX_and_Trastuzumab" .
<Gastric_cancer> <Current_treated_by> "CX" .
<Gastric_cancer> <Current_treated_by> "CLF" .
<Gastric_cancer> <Current_treated_by> "Best_supportive_care" .
<Gastric_cancer> <Current_treated_by> "Apatinib_monotherapy" .
<Oxaliplatin_monotherapy> <Has_modality> "Chemotherapy" .
<Carfilzomib> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Carfilzomib> <Has_accepted_use> "Multiple_myeloma" .
<Saforax> <Brand_name_of> "Acyclovir" .
<Irinotecan_and_Mitomycin> <Maps_to> "Irinotecan_and_Mitomycin" .
<Efient> <Brand_name_of> "Prasugrel" .
<Montair> <Brand_name_of> "Montelukast" .
<VMP/Rd> <Has_accepted_use> "Multiple_myeloma" .
<Mycophenolate_mofetil_monotherapy> <Has_modality> "Immunosuppressive_therapy" .
<IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone> <Has_antineoplastic> "Norethandrolone" .
<IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone> <Has_antineoplastic> "Methotrexate" .
<IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone> <Has_antineoplastic> "Mercaptopurine" .
<IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone> <Has_antineoplastic> "Idarubicin" .
<IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone> <Has_antineoplastic> "Cytarabine" .
<R-CHMP> <Has_context> "Induction_therapy" .
<Famciclovir> <May_have_route> "Oral" .
<Cyclosporine_non-modified> <Supportive_med_of> "Busulfan_and_Cyclophosphamide,_then_allo_HSCT" .
<Cyclosporine_non-modified> <Supportive_med_of> "Busulfan_and_Cyclophosphamide" .
<Cyclosporine_non-modified> <Supportive_med_of> "BuCy,_then_allo_HSCT" .
<Ibrutinib_and_Ofatumumab> <Has_modality> "Chemotherapy" .
<R-CEOP_(Etoposide)> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<IT_Cytarabine,_Methotrexate,_Methylprednisolone> <Has_modality> "Chemotherapy" .
<Xofigo> <Brand_name_of> "Radium-223" .
<Curaplat> <Brand_name_of> "Oxaliplatin" .
<Fluorouracil_and_Levoleucovorin> <Is_current_in> "Colon_cancer" .
<Capecitabine_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<R-FCM> <Is_a> "Rituximab-containing_regimen" .
<R-FCM> <Is_a> "Anthracycline-containing_regimen" .
<Cyclophosphamide_and_TBI,_then_allo_HSCT> <Has_modality> "Radiotherapy" .
<Cyclophosphamide_and_TBI,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<Cyclophosphamide_and_TBI,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<Ceriton> <Brand_name_of> "Epoetin_alfa" .
<Cytarabine,_Daunorubicin,_Vincristine> <Maps_to> "Cytarabine,_Daunorubicin,_Vincristine" .
<Cyclosporine_modified> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Cyclosporine_modified> <Has_accepted_use> "Hemophagocytic_lymphohistiocytosis" .
<Cyclosporine_modified> <Has_accepted_use> "Castleman_disease" .
<Cyclosporine_modified> <Has_accepted_use> "Aplastic_anemia" .
<Toremifene> <Has_brand_name> "Fareston" .
<Toremifene> <Has_brand_name> "Acapodene" .
<Amtran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<R-MegaCHOP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Letrozole_and_Bevacizumab> <Maps_to> "Letrozole_and_Bevacizumab" .
<Oratane> <Brand_name_of> "Isotretinoin" .
<FOLFOX4_and_Cetuximab> <Has_accepted_use> "KRAS_wild-type_Colon_cancer" .
<FOLFOX4_and_Cetuximab> <Has_accepted_use> "Colon_cancer" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Venetoclax_monotherapy" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Venetoclax_and_Rituximab" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Venetoclax_and_Obinutuzumab" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Ruxolitinib_monotherapy" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Rituximab_monotherapy" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "RCC" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "R-BAC" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Placebo" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "PCR" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "PCO" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Ofatumumab_monotherapy" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Observation" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Obinutuzumab_monotherapy" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "OFAR" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "O-FC" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Lenalidomide_monotherapy" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Lenalidomide_and_Rituximab" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Lenalidomide_and_Ofatumumab" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Idelalisib_monotherapy" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Idelalisib_and_Rituximab" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Idelalisib_and_Ofatumumab" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Ibrutinib_monotherapy" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Ibrutinib_and_Venetoclax" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Ibrutinib_and_Rituximab" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Ibrutinib_and_Ofatumumab" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Ibrutinib_and_Obinutuzumab" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "HDMP-R" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "G-FC" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Fludarabine_monotherapy" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Fludarabine_and_TBI,_then_allo_HSCT" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Fludarabine_and_Prednisone" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Fludarabine_and_Alemtuzumab" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "FluCam" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "FCR_(Rituximab_Hycela)" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "FCR" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "FCM" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "FCA" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "FC,_then_allo_HSCT" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Duvelisib_monotherapy" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Cladribine_monotherapy" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Chlorambucil_and_Rituximab" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Chlorambucil_and_Ofatumumab" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Chlorambucil_and_Obinutuzumab" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "CMC" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "CFAR" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "CC" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Bendamustine_monotherapy" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Bendamustine_and_Ofatumumab" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Bendamustine_and_Obinutuzumab" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "BR_and_Idelalisib" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "BR_and_Ibrutinib" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "BR" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Alemtuzumab_monotherapy" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Alemtuzumab_and_Rituximab" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Alemtuzumab_and_Methylprednisolone" .
<Chronic_lymphocytic_leukemia> <Current_treated_by> "Acalabrutinib_monotherapy" .
<Aspirin_monotherapy> <Has_accepted_use> "Venous_thromboembolism" .
<Aspirin_monotherapy> <Has_accepted_use> "Polycythemia_vera" .
<Carboplatin,_Etoposide,_Durvalumab> <Has_context> "Induction_therapy" .
<DEP> <Has_modality> "Chemotherapy" .
<Bortezomib_and_Melphalan,_then_auto_HSCT> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Filgrastim> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Filgrastim> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Immune_effector_cell> <Is_a> "Cellular_therapy" .
<CAV/PE> <Has_antineoplastic> "Vincristine" .
<CAV/PE> <Has_antineoplastic> "Etoposide" .
<CAV/PE> <Has_antineoplastic> "Doxorubicin" .
<CAV/PE> <Has_antineoplastic> "Cyclophosphamide" .
<CAV/PE> <Has_antineoplastic> "Cisplatin" .
<MCV> <Has_context> "Neoadjuvant_therapy" .
<MCV> <Has_context> "Adjuvant_therapy" .
<EOX> <Mapped_from> "EOX" .
<Clofarabine_and_LoDAC/Decitabine> <Has_modality> "Chemotherapy" .
<nab-Paclitaxel_monotherapy> <Is_current_in> "Pancreatic_cancer" .
<nab-Paclitaxel_monotherapy> <Is_current_in> "Ovarian_cancer" .
<nab-Paclitaxel_monotherapy> <Is_current_in> "Melanoma" .
<nab-Paclitaxel_monotherapy> <Is_current_in> "Gastric_cancer" .
<nab-Paclitaxel_monotherapy> <Is_current_in> "Breast_cancer" .
<nab-Paclitaxel_monotherapy> <Is_current_in> "Bladder_cancer" .
<PCR> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<PCR> <Is_current_in> "Marginal_zone_lymphoma" .
<PCR> <Is_current_in> "Follicular_lymphoma" .
<PCR> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<L_Asparaginasum> <Brand_name_of> "Asparaginase" .
<Ganetespib> <May_have_route> "Intravenous" .
<TFC,_then_allo_HSCT> <Maps_to> "TFC,_then_allo_HSCT" .
<Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant> <Has_immunosuppressor> "Tacrolimus" .
<Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant> <Has_immunosuppressor> "Mycophenolate_mofetil" .
<Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant> <Has_immunosuppressor> "Cyclosporines" .
<Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant> <Has_immunosuppressor> "Cyclosporine_non-modified" .
<Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant> <Has_immunosuppressor> "Cyclosporine_modified" .
<Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant> <Has_immunosuppressor> "Cyclophosphamide" .
<RT,_then_Carmustine> <Has_context> "Adjuvant_therapy" .
<Gemcitabine,_Cetuximab,_RT> <Has_accepted_use> "Pancreatic_cancer" .
<Cabozantinib> <Is_a> "VEGFR_inhibitor" .
<Cabozantinib> <Is_a> "TRK_inhibitor" .
<Cabozantinib> <Is_a> "TEK_inhibitor" .
<Cabozantinib> <Is_a> "ROS1_inhibitor" .
<Cabozantinib> <Is_a> "RET_inhibitor" .
<Cabozantinib> <Is_a> "MET_inhibitor" .
<Cabozantinib> <Is_a> "Kinase_inhibitor" .
<Cabozantinib> <Is_a> "KIT_inhibitor" .
<Cabozantinib> <Is_a> "FLT3_inhibitor" .
<Cabozantinib> <Is_a> "AXL_inhibitor" .
<Interferon_alfa-2b_and_Thalidomide> <Has_accepted_use> "Multiple_myeloma" .
<Lorazepam> <Is_a> "Emesis_prevention" .
<Lorazepam> <Is_a> "Benzodiazepine" .
<PCD> <Is_current_in> "Multiple_myeloma" .
<Irinotecan_liposome> <Antineoplastic_of> "Irinotecan_liposomal_monotherapy" .
<Irinotecan_liposome> <Antineoplastic_of> "Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan" .
<FND> <Has_accepted_use> "Follicular_lymphoma" .
<CEP> <Is_a> "Anthracycline-containing_regimen" .
<Antrimox> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<VBM> <Maps_to> "VBM" .
<Methotrexato> <Brand_name_of> "Methotrexate" .
<Methotrexate_and_Vincristine> <Maps_to> "Methotrexate_and_Vincristine" .
<Lipefilgrastim> <Is_a> "Pegylated_medication" .
<Lipefilgrastim> <Is_a> "Investigational_drug" .
<Lipefilgrastim> <Is_a> "Granulocyte_colony-stimulating_factor" .
<Atezolizumab_monotherapy> <Mapped_from> "Atezolizumab_monotherapy" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Vincristine" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Pegaspargase" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Dexamethasone" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Daunorubicin" .
<Granovell> <Brand_name_of> "Granisetron" .
<Azacitidine_and_Sorafenib> <Has_accepted_use> "FLT3-positive_Acute_myeloid_leukemia" .
<Azacitidine_and_Sorafenib> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Naspro> <Brand_name_of> "Aspirin" .
<Gemcitabine,_Cetuximab,_RT> <Has_antineoplastic> "Gemcitabine" .
<Gemcitabine,_Cetuximab,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Gemcitabine,_Cetuximab,_RT> <Has_antineoplastic> "Cetuximab" .
<HiDAC> <Has_modality> "Chemotherapy" .
<VAD_plus_C> <Mapped_from> "VAD_plus_C" .
<Onsia> <Brand_name_of> "Ondansetron" .
<Lyovac> <Brand_name_of> "Dactinomycin" .
<Doxorubicin_and_Lomustine> <Maps_to> "Doxorubicin_and_Lomustine" .
<Triminex> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<BuCy,_then_auto_HSCT> <Has_accepted_use> "Acute_myeloid_leukemia" .
<GELOX/RT> <Has_antineoplastic> "Oxaliplatin" .
<GELOX/RT> <Has_antineoplastic> "Gemcitabine" .
<GELOX/RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<GELOX/RT> <Has_antineoplastic> "Asparaginase" .
<Granulocyte_macrophage_colony-stimulating_factor> <Subsumes> "Sargramostim" .
<Lansoprazole> <Is_a> "Proton_pump_inhibitor" .
<CapeOx_and_Bevacizumab> <Maps_to> "CapeOx_and_Bevacizumab" .
<TFC,_then_allo_HSCT> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Flavicina> <Brand_name_of> "Doxorubicin" .
<Doxorubicin_and_Ifosfamide> <Is_current_in> "Soft_tissue_sarcoma" .
<Bacillus_Calmette-Guerin_(BCG)_monotherapy> <Has_context> "Non-curative_therapy" .
<Bacillus_Calmette-Guerin_(BCG)_monotherapy> <Has_context> "Maintenance_after_upfront_therapy" .
<Bacillus_Calmette-Guerin_(BCG)_monotherapy> <Has_context> "Local_therapy" .
<Bacillus_Calmette-Guerin_(BCG)_monotherapy> <Has_context> "Consolidation_after_upfront_therapy" .
<Bacillus_Calmette-Guerin_(BCG)_monotherapy> <Has_context> "Adjuvant_therapy" .
<Haemato-FU> <Brand_name_of> "Fluorouracil" .
<CALGB_8811_late_intensification> <Mapped_from> "CALGB_8811_late_intensification" .
<Cyclosporines> <Immunosuppressor_of> "TT4" .
<Cyclosporines> <Immunosuppressor_of> "Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Cyclosporines> <Immunosuppressor_of> "HLH-94_regimen" .
<Cyclosporines> <Immunosuppressor_of> "HLH-2004_regimen" .
<Cyclosporines> <Immunosuppressor_of> "Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant" .
<Cyclosporines> <Immunosuppressor_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT" .
<Cyclosporines> <Immunosuppressor_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan" .
<Cyclosporines> <Immunosuppressor_of> "Fludarabine,_Busulfan,_ATG" .
<Cyclosporines> <Immunosuppressor_of> "Fludarabine_and_TBI,_then_allo_HSCT" .
<Cyclosporines> <Immunosuppressor_of> "Fludarabine_and_TBI" .
<Cyclosporines> <Immunosuppressor_of> "Fludarabine_and_Melphalan" .
<Cyclosporines> <Immunosuppressor_of> "Flu-Mel,_then_allo_HSCT" .
<Cyclosporines> <Immunosuppressor_of> "Cyclosporine,_Sirolimus,_Prednisone" .
<Cyclosporines> <Immunosuppressor_of> "Cyclosporine,_Methotrexate,_ATG" .
<Cyclosporines> <Immunosuppressor_of> "Cyclosporine,_Corticosteroids,_Rituximab" .
<Cyclosporines> <Immunosuppressor_of> "Cyclosporine_monotherapy" .
<Cyclosporines> <Immunosuppressor_of> "Cyclosporine_and_Prednisone" .
<Cyclosporines> <Immunosuppressor_of> "Cyclosporine_and_Methotrexate" .
<Cyclosporines> <Immunosuppressor_of> "ATG_(Rabbit)_and_Cyclosporine" .
<Cyclosporines> <Immunosuppressor_of> "ATG_(Horse),_Cyclosporine,_Sirolimus" .
<Cyclosporines> <Immunosuppressor_of> "ATG_(Horse),_Cyclosporine,_G-CSF" .
<Cyclosporines> <Immunosuppressor_of> "ATG_(Horse),_Cyclosporine,_Eltrombopag" .
<Cyclosporines> <Immunosuppressor_of> "ATG_(Horse)_and_Cyclosporine" .
<Dexameral> <Brand_name_of> "Dexamethasone" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Toremifene_monotherapy" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Tamoxifen_monotherapy" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Tamoxifen_and_Prednisolone" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Tamoxifen_and_OFS" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Ribociclib_and_Tamoxifen" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Leuprolide_monotherapy" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Letrozole_monotherapy" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Letrozole_and_Ribociclib" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Letrozole_and_Palbociclib" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Letrozole_and_Bevacizumab" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Lapatinib,_Letrozole,_Trastuzumab" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Lapatinib_and_Letrozole" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Goserelin_monotherapy" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Goserelin_and_Tamoxifen" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Fulvestrant_monotherapy" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Fulvestrant_and_Ribociclib" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Fulvestrant_and_Palbociclib" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Exemestane_monotherapy" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Exemestane_and_Tucidinostat" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Everolimus_and_Tamoxifen" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Everolimus_and_Exemestane" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Capecitabine_and_Fulvestrant" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Anastrozole_monotherapy" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Anastrozole_and_Trastuzumab" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Anastrozole_and_Ribociclib" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Anastrozole_and_Palbociclib" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Anastrozole_and_Goserelin" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Anastrozole_and_Fulvestrant" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Abemaciclib_and_Letrozole" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Abemaciclib_and_Fulvestrant" .
<ER-positive_Breast_cancer> <Accepted_use_of> "Abemaciclib_and_Anastrozole" .
<Fulvestrant_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Fulvestrant_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<A-AVD> <Mapped_from> "A-AVD" .
<Effient> <Brand_name_of> "Prasugrel" .
<RP> <Mapped_from> "RP" .
<Ledertrexate> <Brand_name_of> "Methotrexate" .
<Non-curative_second-line_consolidation_therapy> <Is_a> "Non-curative_second-line_therapy" .
<Ibrutinib_and_Ofatumumab> <Maps_to> "Ibrutinib_and_Ofatumumab" .
<HyperCHidam> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Clofarabine_monotherapy> <Is_historical_in> "Acute_myeloid_leukemia" .
<Arsenic_trioxide> <Has_FDA_indication> "Acute_promyelocytic_leukemia" .
<Capecitabine_and_Erlotinib> <Has_modality> "Chemotherapy" .
<Dexazona> <Brand_name_of> "Dexamethasone" .
<Pletal> <Brand_name_of> "Cilostazol" .
<Docetaxel,_Cetuximab,_RT> <Is_current_in> "Head_and_neck_cancer" .
<Gemtuzumab_ozogamicin> <May_have_route> "Intravenous" .
<Hairy_cell_leukemia> <Accepted_use_of> "Vemurafenib_monotherapy" .
<Hairy_cell_leukemia> <Accepted_use_of> "Vemurafenib" .
<Hairy_cell_leukemia> <Accepted_use_of> "Rituximab-pvvr" .
<Hairy_cell_leukemia> <Accepted_use_of> "Rituximab-abbs" .
<Hairy_cell_leukemia> <Accepted_use_of> "Rituximab_monotherapy" .
<Hairy_cell_leukemia> <Accepted_use_of> "Rituximab" .
<Hairy_cell_leukemia> <Accepted_use_of> "Pentostatin_monotherapy" .
<Hairy_cell_leukemia> <Accepted_use_of> "Pentostatin" .
<Hairy_cell_leukemia> <Accepted_use_of> "Moxetumomab_pasudotox_monotherapy" .
<Hairy_cell_leukemia> <Accepted_use_of> "Moxetumomab_pasudotox" .
<Hairy_cell_leukemia> <Accepted_use_of> "Interferon_alfa-2b_monotherapy" .
<Hairy_cell_leukemia> <Accepted_use_of> "Interferon_alfa-2b" .
<Hairy_cell_leukemia> <Accepted_use_of> "Interferon_alfa-2a" .
<Hairy_cell_leukemia> <Accepted_use_of> "Cladribine_monotherapy" .
<Hairy_cell_leukemia> <Accepted_use_of> "Cladribine_and_Rituximab" .
<Hairy_cell_leukemia> <Accepted_use_of> "Cladribine" .
<Hairy_cell_leukemia> <Accepted_use_of> "Bendamustine" .
<Hairy_cell_leukemia> <Accepted_use_of> "BR" .
<Rituximab_and_hyaluronidase_human> <Has_brand_name> "Rituxan_Hycela" .
<C-MOPP> <Has_accepted_use> "Hodgkin_lymphoma" .
<C-MOPP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Hyper-CVAD/MA> <Has_antineoplastic> "Vincristine" .
<Hyper-CVAD/MA> <Has_antineoplastic> "Methylprednisolone" .
<Hyper-CVAD/MA> <Has_antineoplastic> "Methotrexate" .
<Hyper-CVAD/MA> <Has_antineoplastic> "Doxorubicin" .
<Hyper-CVAD/MA> <Has_antineoplastic> "Dexamethasone" .
<Hyper-CVAD/MA> <Has_antineoplastic> "Cytarabine" .
<Hyper-CVAD/MA> <Has_antineoplastic> "Cyclophosphamide" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine> <Is_current_in> "Acute_promyelocytic_leukemia" .
<Hydrocortisone_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Abciximab> <Is_a> "GPIIb-IIIa_inhibitor" .
<Abciximab> <Is_a> "Anti-GPIIb-IIIa_antibody" .
<Fludarabine_and_TBI> <Mapped_from> "Fludarabine_and_TBI" .
<Synac> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Paclitaxel_and_S-1> <Maps_to> "Paclitaxel_and_S-1" .
<Denosumab_monotherapy> <Has_antineoplastic> "Denosumab" .
<Dexaminor> <Brand_name_of> "Dexamethasone" .
<Fludarabine_and_TBI> <Maps_to> "Fludarabine_and_TBI" .
<Burkitt_lymphoma> <Accepted_use_of> "Vindesine" .
<Burkitt_lymphoma> <Accepted_use_of> "Vincristine" .
<Burkitt_lymphoma> <Accepted_use_of> "Teniposide" .
<Burkitt_lymphoma> <Accepted_use_of> "Rituximab-pvvr" .
<Burkitt_lymphoma> <Accepted_use_of> "Rituximab-abbs" .
<Burkitt_lymphoma> <Accepted_use_of> "Rituximab" .
<Burkitt_lymphoma> <Accepted_use_of> "R-Hyper-CVAD/R-MA" .
<Burkitt_lymphoma> <Accepted_use_of> "R-COPADM" .
<Burkitt_lymphoma> <Accepted_use_of> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Burkitt_lymphoma> <Accepted_use_of> "R-CODOX-M/R-IVAC" .
<Burkitt_lymphoma> <Accepted_use_of> "R-CODOX-M_(Doxil_substituted)" .
<Burkitt_lymphoma> <Accepted_use_of> "R-CODOX-M" .
<Burkitt_lymphoma> <Accepted_use_of> "Prednisone" .
<Burkitt_lymphoma> <Accepted_use_of> "Prednisolone" .
<Burkitt_lymphoma> <Accepted_use_of> "Pegylated_liposomal_doxorubicin" .
<Burkitt_lymphoma> <Accepted_use_of> "Methotrexate" .
<Burkitt_lymphoma> <Accepted_use_of> "Ifosfamide" .
<Burkitt_lymphoma> <Accepted_use_of> "GMALL-R" .
<Burkitt_lymphoma> <Accepted_use_of> "Etoposide" .
<Burkitt_lymphoma> <Accepted_use_of> "Doxorubicin" .
<Burkitt_lymphoma> <Accepted_use_of> "Dexamethasone" .
<Burkitt_lymphoma> <Accepted_use_of> "DA-R-EPOCH" .
<Burkitt_lymphoma> <Accepted_use_of> "Cytarabine" .
<Burkitt_lymphoma> <Accepted_use_of> "Cyclophosphamide_and_Prednisone" .
<Burkitt_lymphoma> <Accepted_use_of> "Cyclophosphamide" .
<Burkitt_lymphoma> <Accepted_use_of> "CYVE" .
<Burkitt_lymphoma> <Accepted_use_of> "CYM" .
<Burkitt_lymphoma> <Accepted_use_of> "COPADM" .
<Burkitt_lymphoma> <Accepted_use_of> "COPAD/CYVE" .
<Burkitt_lymphoma> <Accepted_use_of> "COPAD" .
<Burkitt_lymphoma> <Accepted_use_of> "COP" .
<Burkitt_lymphoma> <Accepted_use_of> "CODOX-M/IVAC" .
<Burkitt_lymphoma> <Accepted_use_of> "CODOX-M" .
<Burkitt_lymphoma> <Accepted_use_of> "CALGB_10-002_regimen" .
<Burkitt_lymphoma> <Accepted_use_of> "BASIC" .
<Cyclophosphamide_and_G-CSF> <Has_supportive_med> "Lenograstim" .
<Cyclophosphamide_and_G-CSF> <Has_supportive_med> "Filgrastim" .
<Arsenic_trioxide,_then_ATRA_and_Daunorubicin> <Is_a> "Anthracycline-containing_regimen" .
<BEACOPP-14_(Prednisolone)> <Is_a> "Anthracycline-containing_regimen" .
<VIPD> <Mapped_from> "VIPD" .
<Ticagrelor> <May_have_route> "Oral" .
<Busulfan_and_Cyclophosphamide,_then_allo_HSCT> <Is_current_in> "Myelodysplastic_syndrome" .
<MVPP> <Maps_to> "MVPP" .
<Anastrozole_and_Palbociclib> <Maps_to> "Anastrozole_and_Palbociclib" .
<VMCP/VCAP> <Has_antineoplastic> "Vincristine" .
<VMCP/VCAP> <Has_antineoplastic> "Prednisone" .
<VMCP/VCAP> <Has_antineoplastic> "Melphalan" .
<VMCP/VCAP> <Has_antineoplastic> "Doxorubicin" .
<VMCP/VCAP> <Has_antineoplastic> "Cyclophosphamide" .
<VAD_and_Cyclosporine> <Has_context> "Non-curative_therapy" .
<Encorafenib> <Has_FDA_indication> "Melanoma" .
<Hemacord> <Brand_name_of> "Hematopoetic_progenitor_cells_cord_blood" .
<Emicizumab> <May_have_route> "Subcutaneous" .
<PI3K_inhibitor> <Subsumes> "PI3K_gamma_inhibitor" .
<PI3K_inhibitor> <Subsumes> "PI3K_delta_inhibitor" .
<PI3K_inhibitor> <Subsumes> "PI3K_alpha_inhibitor" .
<PI3K_inhibitor> <Subsumes> "Buparlisib" .
<PI3K_inhibitor> <Subsumes> "Alpelisib" .
<FLOT> <Has_context> "Non-curative_first-line_therapy" .
<FLOT> <Has_context> "Neoadjuvant_therapy" .
<FLOT> <Has_context> "Induction_therapy" .
<FLOT> <Has_context> "Adjuvant_therapy" .
<Procarbazine_monotherapy> <Maps_to> "Procarbazine_monotherapy" .
<Uracil_mustard_monotherapy> <Has_modality> "Chemotherapy" .
<Goserelin_and_Tamoxifen> <Maps_to> "Goserelin_and_Tamoxifen" .
<VI,_then_VDC/IE,_then_VAC,_then_VI> <Has_modality> "Chemotherapy" .
<Cisplatin_and_Vinorelbine> <Is_a> "Platinum_doublet" .
<Dovitinib> <Is_a> "Kinase_inhibitor" .
<Dovitinib> <Is_a> "Investigational_drug" .
<Dovitinib> <Is_a> "FGFR_inhibitor" .
<HDMP-R> <Is_a> "Rituximab-containing_regimen" .
<Dinaciclib> <Is_a> "Kinase_inhibitor" .
<Dinaciclib> <Is_a> "Investigational_drug" .
<Dinaciclib> <Is_a> "CDK_inhibitor" .
<Desmopressin> <May_have_route> "Subcutaneous" .
<Desmopressin> <May_have_route> "Oral" .
<Desmopressin> <May_have_route> "Nasal" .
<Desmopressin> <May_have_route> "Intravenous" .
<Amsacrine_and_Cytarabine> <Maps_to> "Amsacrine_and_Cytarabine" .
<CDB> <Has_antineoplastic> "Dacarbazine" .
<CDB> <Has_antineoplastic> "Cisplatin" .
<CDB> <Has_antineoplastic> "Carmustine" .
<Dacarbazine> <May_have_route> "Intravenous" .
<Albyl-Selters> <Brand_name_of> "Aspirin" .
<Vinracine> <Brand_name_of> "Vincristine" .
<Anaplastic_glioma> <Current_treated_by> "Temozolomide,_then_Temozolomide_and_RT,_then_Temozolomide" .
<Anaplastic_glioma> <Current_treated_by> "Temozolomide_monotherapy" .
<Anaplastic_glioma> <Current_treated_by> "Temozolomide_and_RT,_then_Temozolomide" .
<Anaplastic_glioma> <Current_treated_by> "Temozolomide_and_RT" .
<Anaplastic_glioma> <Current_treated_by> "Radiation_therapy" .
<Anaplastic_glioma> <Current_treated_by> "RT,_then_Temozolomide" .
<Anaplastic_glioma> <Current_treated_by> "RT,_then_Carmustine" .
<Anaplastic_glioma> <Current_treated_by> "PCV" .
<Anaplastic_glioma> <Current_treated_by> "Observation" .
<Anaplastic_glioma> <Current_treated_by> "Lomustine,_Vincristine,_Prednisone" .
<Anaplastic_glioma> <Current_treated_by> "Irinotecan_monotherapy" .
<Anaplastic_glioma> <Current_treated_by> "Irinotecan_and_Bevacizumab" .
<Anaplastic_glioma> <Current_treated_by> "Etoposide_monotherapy" .
<Anaplastic_glioma> <Current_treated_by> "Cyclophosphamide_monotherapy" .
<Anaplastic_glioma> <Current_treated_by> "Carmustine_monotherapy" .
<Anaplastic_glioma> <Current_treated_by> "Carboplatin_and_Bevacizumab" .
<Anaplastic_glioma> <Current_treated_by> "Bevacizumab_monotherapy" .
<Bleomycin_and_Cisplatin> <Has_accepted_use> "Cutaneous_squamous_cell_carcinoma" .
<Bleomycin_and_Cisplatin> <Has_accepted_use> "Cutaneous_basal_cell_carcinoma" .
<Ecotrin_650> <Brand_name_of> "Aspirin" .
<Cholangiocarcinoma> <Current_treated_by> "Regorafenib_monotherapy" .
<Cholangiocarcinoma> <Current_treated_by> "Pembrolizumab_monotherapy" .
<Cholangiocarcinoma> <Current_treated_by> "Observation" .
<Cholangiocarcinoma> <Current_treated_by> "Ivosidenib_monotherapy" .
<Cholangiocarcinoma> <Current_treated_by> "Gemcitabine/Fluorouracil_and_RT" .
<Cholangiocarcinoma> <Current_treated_by> "Gemcitabine,_Cisplatin,_S-1" .
<Cholangiocarcinoma> <Current_treated_by> "Gemcitabine_monotherapy" .
<Cholangiocarcinoma> <Current_treated_by> "Gemcitabine_and_nab-Paclitaxel" .
<Cholangiocarcinoma> <Current_treated_by> "Gemcitabine_and_S-1" .
<Cholangiocarcinoma> <Current_treated_by> "Gemcitabine_and_Mitomycin" .
<Cholangiocarcinoma> <Current_treated_by> "GemOx" .
<Cholangiocarcinoma> <Current_treated_by> "GEMOX-B" .
<Cholangiocarcinoma> <Current_treated_by> "Fluorouracil,_Folinic_acid,_Gemcitabine" .
<Cholangiocarcinoma> <Current_treated_by> "Fluorouracil_and_Folinic_acid" .
<Cholangiocarcinoma> <Current_treated_by> "FELV" .
<Cholangiocarcinoma> <Current_treated_by> "Erlotinib_and_Bevacizumab" .
<Cholangiocarcinoma> <Current_treated_by> "ECF" .
<Cholangiocarcinoma> <Current_treated_by> "Cisplatin,_Gemcitabine,_nab-Paclitaxel" .
<Cholangiocarcinoma> <Current_treated_by> "Cisplatin_and_Gemcitabine" .
<Cholangiocarcinoma> <Current_treated_by> "Capecitabine_monotherapy" .
<Cholangiocarcinoma> <Current_treated_by> "Capecitabine_and_Mitomycin" .
<Cholangiocarcinoma> <Current_treated_by> "Capecitabine_and_Gemcitabine" .
<Cholangiocarcinoma> <Current_treated_by> "CapeOx" .
<Cholangiocarcinoma> <Current_treated_by> "Best_supportive_care" .
<ABCM> <Has_modality> "Chemotherapy" .
<Irinotecan_liposomal_monotherapy> <Maps_to> "Irinotecan_liposomal_monotherapy" .
<Regorafenib> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Regorafenib> <Has_accepted_use> "Renal_cell_carcinoma" .
<Regorafenib> <Has_accepted_use> "Leiomyosarcoma" .
<Regorafenib> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Regorafenib> <Has_accepted_use> "Gastrointestinal_stromal_tumor" .
<Regorafenib> <Has_accepted_use> "Gastric_cancer" .
<Regorafenib> <Has_accepted_use> "Colon_cancer" .
<Regorafenib> <Has_accepted_use> "Cholangiocarcinoma" .
<Hyper-CVAD/MA_and_Everolimus> <Mapped_from> "Hyper-CVAD/MA_and_Everolimus" .
<Bevacizumab_and_Rituximab> <Is_current_in> "Follicular_lymphoma" .
<Azacitidine,_Vorinostat,_Gemtuzumab_ozogamicin> <Maps_to> "Azacitidine,_Vorinostat,_Gemtuzumab_ozogamicin" .
<Mexazole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Megace> <Brand_name_of> "Megestrol" .
<Etoposide,_Ifosfamide,_Imatinib> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Etoposide,_Ifosfamide,_Imatinib> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Acalabrutinib_monotherapy> <Is_current_in> "Mantle_cell_lymphoma" .
<Acalabrutinib_monotherapy> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Cross-disciplinary_condition> <Is_a> "Condition" .
<R-MPV> <Maps_to> "R-MPV" .
<Doxetal> <Brand_name_of> "Docetaxel" .
<Immunotherapeutic> <Is_a> "Drugs_by_class_effect" .
<MCV> <Is_current_in> "Bladder_cancer" .
<Alend> <Brand_name_of> "Alendronate" .
<DES_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<DES_monotherapy> <Has_accepted_use> "Breast_cancer" .
<R-COPADM> <Has_antineoplastic> "Vincristine" .
<R-COPADM> <Has_antineoplastic> "Rituximab" .
<R-COPADM> <Has_antineoplastic> "Prednisolone" .
<R-COPADM> <Has_antineoplastic> "Methotrexate" .
<R-COPADM> <Has_antineoplastic> "Doxorubicin" .
<R-COPADM> <Has_antineoplastic> "Cyclophosphamide" .
<Teiroc> <Brand_name_of> "Alendronate" .
<Ginecrin> <Brand_name_of> "Leuprolide" .
<ABP> <Mapped_from> "ABP" .
<Erythrostim> <Brand_name_of> "Epoetin_alfa" .
<Taxocris> <Brand_name_of> "Paclitaxel" .
<CEEP> <Mapped_from> "CEEP" .
<Temozolomide_and_Thalidomide> <Has_accepted_use> "Pancreatic_NET" .
<Doxorrubicina_Colhidrol> <Brand_name_of> "Doxorubicin" .
<Carboplatin,_Fluorouracil,_Cetuximab> <Is_current_in> "Head_and_neck_cancer" .
<Temozolomide_and_low-dose_RT> <Has_accepted_use> "Glioblastoma" .
<Gemcitabine,_Cisplatin,_S-1> <Has_context> "Non-curative_therapy" .
<Uric_acid_lowering_agent> <Is_a> "Supportive_medication" .
<ECX> <Is_a> "Anthracycline-containing_regimen" .
<PEFG> <Has_context> "Non-curative_first-line_therapy" .
<Dacarbazine_and_Gemcitabine> <Has_antineoplastic> "Gemcitabine" .
<Dacarbazine_and_Gemcitabine> <Has_antineoplastic> "Dacarbazine" .
<VI,_then_VDC/IE,_then_VAC,_then_VI> <Is_a> "Irinotecan-containing_regimen" .
<VI,_then_VDC/IE,_then_VAC,_then_VI> <Is_a> "Anthracycline-containing_regimen" .
<Steralol> <Brand_name_of> "Dexamethasone" .
<FeroSul> <Brand_name_of> "Ferrous_sulfate" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine> <Mapped_from> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine" .
<Cisplatin,_Doxorubicin_liposomal,_Fluorouracil> <Has_antineoplastic> "Pegylated_liposomal_doxorubicin" .
<Cisplatin,_Doxorubicin_liposomal,_Fluorouracil> <Has_antineoplastic> "Fluorouracil" .
<Cisplatin,_Doxorubicin_liposomal,_Fluorouracil> <Has_antineoplastic> "Cisplatin" .
<G-CVP> <Mapped_from> "G-CVP" .
<Bortezomib_and_Panobinostat> <Has_context> "Non-curative_therapy" .
<COPA> <Is_historical_in> "Follicular_lymphoma" .
<Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone> <Is_current_in> "T-cell_acute_lymphoblastic_leukemia" .
<Noxprin> <Brand_name_of> "Enoxaparin" .
<Non-pegylated_liposomal_doxorubicin> <May_have_route> "Intravenous" .
<Moxetumomab_pasudotox> <May_have_route> "Intravenous" .
<ACVBP-R> <Maps_to> "ACVBP-R" .
<Clofarabine_and_Cytarabine> <Mapped_from> "Clofarabine_and_Cytarabine" .
<Curative_therapy> <Mapped_from> "Curative_therapy" .
<Natulanar> <Brand_name_of> "Procarbazine" .
<VTD> <Maps_to> "VTD" .
<Carboplatin_and_Cyclophosphamide> <Has_antineoplastic> "Cyclophosphamide" .
<Carboplatin_and_Cyclophosphamide> <Has_antineoplastic> "Carboplatin" .
<Docetaxel_monotherapy> <Maps_to> "Docetaxel_monotherapy" .
<Trabectedin> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Trabectedin> <Has_accepted_use> "Ovarian_cancer" .
<Trabectedin> <Has_accepted_use> "Liposarcoma" .
<Trabectedin> <Has_accepted_use> "Leiomyosarcoma" .
<R-CHOP/R-DHAP> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Duvelisib> <Has_accepted_use> "Follicular_lymphoma" .
<Duvelisib> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Romax> <Brand_name_of> "Alendronate" .
<Irinotecan> <May_have_route> "Intravenous" .
<CYM> <Has_supportive_med> "Levoleucovorin" .
<CYM> <Has_supportive_med> "Folinic_acid" .
<Netupitant_and_palonosetron> <Is_a> "Serotonin_5-HT3_antagonist" .
<Netupitant_and_palonosetron> <Is_a> "Neurokinin_1_(NK1)_antagonist" .
<Netupitant_and_palonosetron> <Is_a> "Emesis_prevention" .
<Vonau> <Brand_name_of> "Ondansetron" .
<VEPEMB> <Has_modality> "Chemotherapy" .
<Molecular_chaperone_inhibitor> <Is_a> "Chemotherapeutic" .
<Groseptol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Amoxazol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Medrate> <Brand_name_of> "Methylprednisolone" .
<Dara-Rd> <Has_modality> "Chemotherapy" .
<CBV-Mx,_then_auto_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<VH> <Has_modality> "Chemotherapy" .
<Cyclophosphamide> <Has_brand_name> "Zytoxan" .
<Cyclophosphamide> <Has_brand_name> "Zycram" .
<Cyclophosphamide> <Has_brand_name> "Zuviphos" .
<Cyclophosphamide> <Has_brand_name> "Tymtran" .
<Cyclophosphamide> <Has_brand_name> "Syklofosfamid" .
<Cyclophosphamide> <Has_brand_name> "Siklofos" .
<Cyclophosphamide> <Has_brand_name> "Sendoxan" .
<Cyclophosphamide> <Has_brand_name> "Revimmune" .
<Cyclophosphamide> <Has_brand_name> "Procytox" .
<Cyclophosphamide> <Has_brand_name> "Oncophos" .
<Cyclophosphamide> <Has_brand_name> "Oncomide" .
<Cyclophosphamide> <Has_brand_name> "Neosar" .
<Cyclophosphamide> <Has_brand_name> "Neophos" .
<Cyclophosphamide> <Has_brand_name> "Mitoxan" .
<Cyclophosphamide> <Has_brand_name> "Ledoxina" .
<Cyclophosphamide> <Has_brand_name> "Ledoxan" .
<Cyclophosphamide> <Has_brand_name> "Hidrofosmin" .
<Cyclophosphamide> <Has_brand_name> "Genuxal" .
<Cyclophosphamide> <Has_brand_name> "Genoxal" .
<Cyclophosphamide> <Has_brand_name> "Fosfaseron" .
<Cyclophosphamide> <Has_brand_name> "Formitex" .
<Cyclophosphamide> <Has_brand_name> "Enduxan" .
<Cyclophosphamide> <Has_brand_name> "Endoxana" .
<Cyclophosphamide> <Has_brand_name> "Endoxan-N" .
<Cyclophosphamide> <Has_brand_name> "Endoxan" .
<Cyclophosphamide> <Has_brand_name> "Cytoxan_Lyophilized" .
<Cyclophosphamide> <Has_brand_name> "Cytoxan" .
<Cyclophosphamide> <Has_brand_name> "Cytophosphan" .
<Cyclophosphamide> <Has_brand_name> "Cyphos" .
<Cyclophosphamide> <Has_brand_name> "Cyklofosfamid" .
<Cyclophosphamide> <Has_brand_name> "Cydoxan" .
<Cyclophosphamide> <Has_brand_name> "Cycram" .
<Cyclophosphamide> <Has_brand_name> "Cycloxan" .
<Cyclophosphamide> <Has_brand_name> "Cyclotox" .
<Cyclophosphamide> <Has_brand_name> "Cyclostine" .
<Cyclophosphamide> <Has_brand_name> "Cyclostin" .
<Cyclophosphamide> <Has_brand_name> "Cyclophosphane" .
<Cyclophosphamide> <Has_brand_name> "Cyclophosphamid" .
<Cyclophosphamide> <Has_brand_name> "Cyclophospham" .
<Cyclophosphamide> <Has_brand_name> "Cyclophar" .
<Cyclophosphamide> <Has_brand_name> "Cyclomide" .
<Cyclophosphamide> <Has_brand_name> "Cycloferon" .
<Cyclophosphamide> <Has_brand_name> "Cycloblastine" .
<Cyclophosphamide> <Has_brand_name> "Cycloblastin" .
<Cyclophosphamide> <Has_brand_name> "Cyclam" .
<Cyclophosphamide> <Has_brand_name> "Claphene" .
<Cyclophosphamide> <Has_brand_name> "Clafen" .
<Cyclophosphamide> <Has_brand_name> "Cicloxal" .
<Cyclophosphamide> <Has_brand_name> "Ciclokebir" .
<Cyclophosphamide> <Has_brand_name> "Ciclofosfamida" .
<Cyclophosphamide> <Has_brand_name> "Carloxan" .
<Cyclophosphamide> <Has_brand_name> "CYCLO-cell" .
<Cyclophosphamide> <Has_brand_name> "Biodoxan" .
<Cyclophosphamide> <Has_brand_name> "Alkyloxan" .
<Capecitabine,_Paclitaxel,_RT> <Has_context> "Neoadjuvant_therapy" .
<Ikgdar> <Brand_name_of> "Rituximab" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Vorinostat_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "VT" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "VR" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "VP" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "VD" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Thalidomide_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Thalidomide_and_Prednisone" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Thalidomide_and_Prednisolone" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Temozolomide_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Temozolomide_and_NovoTTF-100A" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "TD" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Sunitinib_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Sorafenib_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "S-1_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Rituximab_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Rituximab_and_hyaluronidase_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Rd" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "RVD" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "RP" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Prednisone_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Prednisolone_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Placebo" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Pemetrexed_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Pemetrexed_and_Pembrolizumab" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Pemetrexed_and_Bevacizumab" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Pembrolizumab_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Pazopanib_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Panobinostat_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Paclitaxel_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "POMP" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Olaparib_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Observation" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Obinutuzumab_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Necitumumab_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "LoDAC" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Lenalidomide_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Lenalidomide_and_Rituximab" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "KRd" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Ixazomib_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Irinotecan_and_Bevacizumab" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Ipilimumab_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Interferon_alfa-2b_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Interferon_alfa-2b_and_Thalidomide" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Interferon_alfa-2b_and_Prednisone" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Interferon_alfa-2a_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Interferon_alfa_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Interferon_alfa_and_Dexamethasone" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Gemtuzumab_ozogamicin_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Gemcitabine_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Gemcitabine_and_Paclitaxel" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Erlotinib_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Durvalumab_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Dexamethasone_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Decitabine_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Daratumumab_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Cytarabine_and_Thioguanine" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Cetuximab_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Carfilzomib_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Capecitabine_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Capecitabine_and_Bevacizumab" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "CaRD" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Bortezomib_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Bevacizumab_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Azacitidine_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Atezolizumab_monotherapy" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Atezolizumab_and_Bevacizumab" .
<Non-curative_first-line_maintenance_therapy> <Context_of> "Altretamine_monotherapy" .
<Cyclosporine_and_Methotrexate> <Mapped_from> "Cyclosporine_and_Methotrexate" .
<MRD> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<CRd> <Is_current_in> "Multiple_myeloma" .
<CRd> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<Dexmetha> <Brand_name_of> "Dexamethasone" .
<Avatrombopag> <Has_FDA_indication> "Thrombocytopenia_in_liver_disease" .
<Dexamex> <Brand_name_of> "Dexamethasone" .
<LoDAC> <Has_antineoplastic> "Cytarabine" .
<Octreotide_monotherapy> <Is_current_in> "Thymoma" .
<Octreotide_monotherapy> <Is_current_in> "Pancreatic_NET" .
<Octreotide_monotherapy> <Is_current_in> "Neuroendocrine_tumor" .
<Neratinib_and_Paclitaxel> <Has_antineoplastic> "Paclitaxel" .
<Neratinib_and_Paclitaxel> <Has_antineoplastic> "Neratinib" .
<Niraparib_monotherapy> <Is_current_in> "Ovarian_cancer" .
<CBV> <Has_context> "All_lines_of_therapy" .
<CBVM,_then_auto_HSCT> <Maps_to> "CBVM,_then_auto_HSCT" .
<FOLFIRI_and_Cetuximab_(L-Leucovorin)> <Mapped_from> "FOLFIRI_and_Cetuximab_(L-Leucovorin)" .
<EOF> <Has_antineoplastic> "Oxaliplatin" .
<EOF> <Has_antineoplastic> "Fluorouracil" .
<EOF> <Has_antineoplastic> "Epirubicin" .
<Mechlorethamine_monotherapy> <Has_modality> "Chemotherapy" .
<EAR_and_G-CSF> <Is_current_in> "Stem_cell_mobilization" .
<Cytarabine_monotherapy> <Has_modality> "Chemotherapy" .
<Mitoxantrone_monotherapy> <Is_historical_in> "Breast_cancer" .
<FOLFOX4_and_Panitumumab> <Has_antineoplastic> "Panitumumab" .
<FOLFOX4_and_Panitumumab> <Has_antineoplastic> "Oxaliplatin" .
<FOLFOX4_and_Panitumumab> <Has_antineoplastic> "Folinic_acid" .
<FOLFOX4_and_Panitumumab> <Has_antineoplastic> "Fluorouracil" .
<Malignant_hematology_medication> <Subsumes> "Histiocytoses_medication" .
<Trastuzumab_and_ET> <Mapped_from> "Trastuzumab_and_ET" .
<Cisplatin,_Irinotecan,_RT> <Maps_to> "Cisplatin,_Irinotecan,_RT" .
<Targol> <Brand_name_of> "Prasugrel" .
<Letrozole_and_Palbociclib> <Has_antineoplastic> "Palbociclib" .
<Letrozole_and_Palbociclib> <Has_antineoplastic> "Letrozole" .
<Irinotecan_and_Cetuximab> <Is_a> "Irinotecan-containing_regimen" .
<Erpalfa> <Brand_name_of> "Cytarabine" .
<VIE> <Is_current_in> "Rhabdomyosarcoma" .
<Epirubicin_and_Ifosfamide> <Is_current_in> "Soft_tissue_sarcoma" .
<Epirubicin_and_Ifosfamide> <Is_current_in> "Small_cell_lung_cancer" .
<Timadin> <Brand_name_of> "Fluorouracil" .
<Masitinib> <May_have_route> "Oral" .
<Cytarabine_and_Mitoxantrone> <Maps_to> "Cytarabine_and_Mitoxantrone" .
<Imatinib-based_consolidation> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<R-ESHAP> <Is_a> "Rituximab-containing_regimen" .
<Romidepsin_monotherapy> <Mapped_from> "Romidepsin_monotherapy" .
<Zantac> <Brand_name_of> "Ranitidine" .
<Capecitabine_and_Fulvestrant> <Has_modality> "Hormonotherapy" .
<Capecitabine_and_Fulvestrant> <Has_modality> "Chemotherapy" .
<Cisplatex> <Brand_name_of> "Cisplatin" .
<Methotrexate,_RT,_Cyclophosphamide> <Has_modality> "Radiotherapy" .
<Methotrexate,_RT,_Cyclophosphamide> <Has_modality> "Chemotherapy" .
<FOLFIRI_and_Ziv-aflibercept> <Mapped_from> "FOLFIRI_and_Ziv-aflibercept" .
<Bevacizumab-bvzr> <May_have_route> "Intravenous" .
<Nordic_Regimen,_younger_patients> <Mapped_from> "Nordic_Regimen,_younger_patients" .
<Non-curative_first-line_consolidation_therapy> <Maps_to> "Non-curative_first-line_consolidation_therapy" .
<Danaparoid_monotherapy> <Has_supportive_med> "Danaparoid" .
<Ipilimumab,_then_Nivolumab> <Mapped_from> "Ipilimumab,_then_Nivolumab" .
<Bicalutamide_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<Mogamulizumab> <Has_FDA_indication> "Cutaneous_T-cell_lymphoma" .
<Merkel_cell_carcinoma> <FDA_indication_of> "Pembrolizumab" .
<Merkel_cell_carcinoma> <FDA_indication_of> "Avelumab" .
<CISCA/VB> <Has_antineoplastic> "Vinblastine" .
<CISCA/VB> <Has_antineoplastic> "Doxorubicin" .
<CISCA/VB> <Has_antineoplastic> "Cyclophosphamide" .
<CISCA/VB> <Has_antineoplastic> "Cisplatin" .
<CISCA/VB> <Has_antineoplastic> "Bleomycin" .
<CHOP-B> <Is_a> "Anthracycline-containing_regimen" .
<IT_Cytarabine,_Methotrexate,_WBRT> <Mapped_from> "IT_Cytarabine,_Methotrexate,_WBRT" .
<Cyclosporines> <Antineoplastic_of> "VAD_and_Cyclosporine" .
<Fluorouracil_and_Levoleucovorin> <Has_antineoplastic> "Levoleucovorin" .
<Fluorouracil_and_Levoleucovorin> <Has_antineoplastic> "Fluorouracil" .
<FOLFOX4_and_Cetuximab> <Has_modality> "Chemotherapy" .
<7_plus_3d_and_GO> <Is_current_in> "Acute_myeloid_leukemia" .
<Fluoruracilo> <Brand_name_of> "Fluorouracil" .
<Thalidomide_and_Rituximab> <Has_antineoplastic> "Thalidomide" .
<Thalidomide_and_Rituximab> <Has_antineoplastic> "Rituximab" .
<Selective_estrogen_receptor_modulator> <Is_a> "Endocrine_therapeutic" .
<Chlorambucil_and_Rituximab> <Has_antineoplastic> "Rituximab" .
<Chlorambucil_and_Rituximab> <Has_antineoplastic> "Chlorambucil" .
<BR_and_Idelalisib> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Dabigatran_monotherapy> <Has_accepted_use> "Venous_thromboembolism" .
<Gemcitabine/Fluorouracil_and_RT> <Has_modality> "Radiotherapy" .
<Gemcitabine/Fluorouracil_and_RT> <Has_modality> "Chemotherapy" .
<Supresol> <Brand_name_of> "Methylprednisolone" .
<Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA> <Is_current_in> "Acute_promyelocytic_leukemia" .
<BR> <Has_modality> "Chemotherapy" .
<CFP> <Mapped_from> "CFP" .
<ABV_(Vincristine)> <Has_supportive_med> "Emicizumab" .
<Kisqali> <Brand_name_of> "Ribociclib" .
<ACT> <Maps_to> "ACT" .
<Cisplatin,_Gemcitabine,_RT> <Mapped_from> "Cisplatin,_Gemcitabine,_RT" .
<CC> <Mapped_from> "CC" .
<Hemlibra> <Brand_name_of> "Emicizumab" .
<PCO> <Has_context> "Non-curative_first-line_therapy" .
<Mitozytrex> <Brand_name_of> "Mitomycin" .
<Anti-TRAIL-R2_antibody> <Is_a> "Antibody_medication" .
<Fulvestrant_and_Palbociclib> <Has_modality> "Hormonotherapy" .
<Fulvestrant_and_Palbociclib> <Has_modality> "Chemotherapy" .
<Coltuximab_ravtansine> <May_have_route> "Intravenous" .
<UFTM> <Maps_to> "UFTM" .
<Bortezomib_and_Melphalan> <Has_modality> "Chemotherapy" .
<Letrozole_and_Ribociclib> <Maps_to> "Letrozole_and_Ribociclib" .
<Ado-trastuzumab_emtansine> <Antineoplastic_of> "T-DM1_and_ET" .
<Ado-trastuzumab_emtansine> <Antineoplastic_of> "Pertuzumab_and_T-DM1" .
<Ado-trastuzumab_emtansine> <Antineoplastic_of> "Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine" .
<Ado-trastuzumab_emtansine> <Antineoplastic_of> "Ado-trastuzumab_emtansine_monotherapy" .
<Plerixafor_monotherapy> <Mapped_from> "Plerixafor_monotherapy" .
<VAIA> <Mapped_from> "VAIA" .
<Tamoxifen> <Has_FDA_indication> "Breast_cancer" .
<Anastrozole_and_Trastuzumab> <Maps_to> "Anastrozole_and_Trastuzumab" .
<R-TBI/Cy> <Has_modality> "Radiotherapy" .
<R-TBI/Cy> <Has_modality> "Chemotherapy" .
<Lenalidomide_and_Rituximab> <Mapped_from> "Lenalidomide_and_Rituximab" .
<CAV> <Has_accepted_use> "Small_cell_lung_cancer" .
<Cisplatin,_Fluorouracil,_Hydroxyurea,_RT> <Maps_to> "Cisplatin,_Fluorouracil,_Hydroxyurea,_RT" .
<Soliris> <Brand_name_of> "Eculizumab" .
<FEAM> <Has_accepted_use> "Autologous_HSCT" .
<Radioembolization> <Maps_to> "Radioembolization" .
<Ibrutinib_and_Ofatumumab> <Mapped_from> "Ibrutinib_and_Ofatumumab" .
<Ureax> <Brand_name_of> "Hydroxyurea" .
<CLAG-M> <Has_modality> "Growth_factor_therapy" .
<CLAG-M> <Has_modality> "Chemotherapy" .
<TC_and_Nintedanib> <Has_accepted_use> "Ovarian_cancer" .
<Cisplatin_and_Topotecan> <Has_antineoplastic> "Topotecan" .
<Cisplatin_and_Topotecan> <Has_antineoplastic> "Cisplatin" .
<Atropine> <Supportive_med_of> "Irinotecan_monotherapy" .
<Atropine> <Supportive_med_of> "Irinotecan_and_Bevacizumab" .
<Atropine> <Supportive_med_of> "FOLFIRI_and_Ziv-aflibercept" .
<Atropine> <Supportive_med_of> "FOLFIRI" .
<Atropine> <Supportive_med_of> "Denosumab_monotherapy" .
<Atropine> <Supportive_med_of> "Cisplatin_and_Paclitaxel" .
<Atropine> <Supportive_med_of> "Cisplatin_and_Irinotecan" .
<Atropine> <Supportive_med_of> "Cisplatin_and_Fluorouracil" .
<Atropine> <Supportive_med_of> "CAPIRI" .
<Gemcitabine_and_Paclitaxel> <Has_accepted_use> "Testicular_cancer" .
<Gemcitabine_and_Paclitaxel> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Gemcitabine_and_Paclitaxel> <Has_accepted_use> "Breast_cancer" .
<Gemcitabine_and_Paclitaxel> <Has_accepted_use> "Bladder_cancer" .
<MPV> <Maps_to> "MPV" .
<Elo-VD> <Has_accepted_use> "Multiple_myeloma" .
<Doxorubicin_and_Vinblastine> <Mapped_from> "Doxorubicin_and_Vinblastine" .
<Samofaron> <Brand_name_of> "Warfarin" .
<EPOCH,_dose-escalated> <Has_context> "Upfront_therapy" .
<Ado-trastuzumab_emtansine> <May_have_route> "Intravenous" .
<Appetite_stimulant> <Is_a> "Supportive_medication" .
<FCA> <Maps_to> "FCA" .
<Sirolimus_monotherapy> <Has_context> "Non-curative_therapy" .
<Sirolimus_monotherapy> <Has_context> "All_lines_of_therapy" .
<R-DHAP/R-VIM> <Has_context> "Salvage_therapy" .
<Apixaban> <May_have_route> "Oral" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Tofacitinib> <May_have_route> "Oral" .
<Dronadil> <Brand_name_of> "Alendronate" .
<FUOX> <Has_context> "Non-curative_first-line_therapy" .
<Carboplatin_and_Paclitaxel> <Is_a> "Platinum_doublet" .
<Soludecadron> <Brand_name_of> "Dexamethasone" .
<A-AVD> <Has_accepted_use> "Hodgkin_lymphoma" .
<Mepolizumab> <Antineoplastic_of> "Mepolizumab_monotherapy" .
<Brentuximab_vedotin_and_Nivolumab> <Is_current_in> "Hodgkin_lymphoma" .
<Cediranib> <May_have_route> "Oral" .
<Avelumab> <Has_FDA_indication> "Renal_cell_carcinoma" .
<Avelumab> <Has_FDA_indication> "Merkel_cell_carcinoma" .
<Avelumab> <Has_FDA_indication> "Bladder_cancer" .
<DEP> <Mapped_from> "DEP" .
<Pertuzumab_and_Trastuzumab> <Is_current_in> "ERBB2-mutated_malignancy" .
<Pertuzumab_and_Trastuzumab> <Is_current_in> "Colon_cancer" .
<Pertuzumab_and_Trastuzumab> <Is_current_in> "Breast_cancer" .
<UFTM> <Has_modality> "Chemotherapy" .
<Crasnitin> <Brand_name_of> "Asparaginase" .
<CC> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Quizartinib_monotherapy> <Is_current_in> "Acute_myeloid_leukemia" .
<Amtril> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Afatinib_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Interferon_alfa-2a_and_Interleukin-2> <Is_current_in> "Renal_cell_carcinoma" .
<Thrombotic_thrombocytopenic_purpura> <FDA_indication_of> "Caplacizumab" .
<Periset> <Brand_name_of> "Ondansetron" .
<ATRA_and_Danazol> <Has_context> "Non-curative_therapy" .
<IRd> <Is_current_in> "Multiple_myeloma" .
<Aprepitant> <May_have_route> "Oral" .
<Endrostan> <Brand_name_of> "Alendronate" .
<Sonidegib> <Has_accepted_use> "Cutaneous_basal_cell_carcinoma" .
<Pixantrone_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<ACVBP> <Has_supportive_med> "Mesna" .
<ACVBP> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<ACVBP> <Has_supportive_med> "Folinic_acid" .
<5_plus_3i> <Is_a> "Anthracycline-containing_regimen" .
<Pembrolizumab_monotherapy> <Mapped_from> "Pembrolizumab_monotherapy" .
<VMV-VAC> <Has_accepted_use> "Small_cell_lung_cancer" .
<Breast_cancer> <Current_treated_by> "nab-Paclitaxel_monotherapy" .
<Breast_cancer> <Current_treated_by> "nab-Paclitaxel_and_Trastuzumab" .
<Breast_cancer> <Current_treated_by> "nab-Paclitaxel_and_Atezolizumab" .
<Breast_cancer> <Current_treated_by> "iddEPC" .
<Breast_cancer> <Current_treated_by> "ddTH_(Taxotere)" .
<Breast_cancer> <Current_treated_by> "ddTH_(Taxol)" .
<Breast_cancer> <Current_treated_by> "ddT_(Taxotere)" .
<Breast_cancer> <Current_treated_by> "ddFEC" .
<Breast_cancer> <Current_treated_by> "ddEC" .
<Breast_cancer> <Current_treated_by> "ddE" .
<Breast_cancer> <Current_treated_by> "ddC" .
<Breast_cancer> <Current_treated_by> "ddAC-T" .
<Breast_cancer> <Current_treated_by> "ddAC" .
<Breast_cancer> <Current_treated_by> "ddA" .
<Breast_cancer> <Current_treated_by> "Vinorelbine_monotherapy" .
<Breast_cancer> <Current_treated_by> "Vinorelbine_and_Bevacizumab" .
<Breast_cancer> <Current_treated_by> "VH" .
<Breast_cancer> <Current_treated_by> "Trastuzumab_monotherapy" .
<Breast_cancer> <Current_treated_by> "Trastuzumab_and_hyaluronidase_monotherapy" .
<Breast_cancer> <Current_treated_by> "Trastuzumab_and_ET" .
<Breast_cancer> <Current_treated_by> "Toremifene_monotherapy" .
<Breast_cancer> <Current_treated_by> "Tamoxifen_monotherapy" .
<Breast_cancer> <Current_treated_by> "Tamoxifen_and_Prednisolone" .
<Breast_cancer> <Current_treated_by> "Tamoxifen_and_OFS" .
<Breast_cancer> <Current_treated_by> "Talazoparib_monotherapy" .
<Breast_cancer> <Current_treated_by> "TX_(Taxotere)" .
<Breast_cancer> <Current_treated_by> "TPC" .
<Breast_cancer> <Current_treated_by> "TL_(Taxol)" .
<Breast_cancer> <Current_treated_by> "THP_(Taxotere)" .
<Breast_cancer> <Current_treated_by> "THP_(Taxol)" .
<Breast_cancer> <Current_treated_by> "THL_(Taxol)" .
<Breast_cancer> <Current_treated_by> "TH_(Taxotere/SC)" .
<Breast_cancer> <Current_treated_by> "TH_(Taxotere)" .
<Breast_cancer> <Current_treated_by> "TH_(Taxol)" .
<Breast_cancer> <Current_treated_by> "TCHP_(Taxotere)" .
<Breast_cancer> <Current_treated_by> "TCHP_(Taxol)" .
<Breast_cancer> <Current_treated_by> "TCH_(Taxotere,_Cyclophosphamide)" .
<Breast_cancer> <Current_treated_by> "TCH_(Taxotere,_Carboplatin)" .
<Breast_cancer> <Current_treated_by> "TC_(Taxotere)" .
<Breast_cancer> <Current_treated_by> "TAC_(Taxotere)" .
<Breast_cancer> <Current_treated_by> "T-DM1_and_ET" .
<Breast_cancer> <Current_treated_by> "S-1_monotherapy" .
<Breast_cancer> <Current_treated_by> "Ribociclib_and_Tamoxifen" .
<Breast_cancer> <Current_treated_by> "Placebo" .
<Breast_cancer> <Current_treated_by> "Pertuzumab_and_Trastuzumab" .
<Breast_cancer> <Current_treated_by> "Pertuzumab_and_T-DM1" .
<Breast_cancer> <Current_treated_by> "Pemetrexed_monotherapy" .
<Breast_cancer> <Current_treated_by> "Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab" .
<Breast_cancer> <Current_treated_by> "Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine" .
<Breast_cancer> <Current_treated_by> "Paclitaxel_monotherapy" .
<Breast_cancer> <Current_treated_by> "Paclitaxel_and_Vinorelbine" .
<Breast_cancer> <Current_treated_by> "Paclitaxel_and_Bevacizumab" .
<Breast_cancer> <Current_treated_by> "PET" .
<Breast_cancer> <Current_treated_by> "Olaparib_monotherapy" .
<Breast_cancer> <Current_treated_by> "Observation" .
<Breast_cancer> <Current_treated_by> "Neratinib_monotherapy" .
<Breast_cancer> <Current_treated_by> "Neratinib_and_Paclitaxel" .
<Breast_cancer> <Current_treated_by> "MC" .
<Breast_cancer> <Current_treated_by> "Leuprolide_monotherapy" .
<Breast_cancer> <Current_treated_by> "Letrozole_monotherapy" .
<Breast_cancer> <Current_treated_by> "Letrozole_and_Ribociclib" .
<Breast_cancer> <Current_treated_by> "Letrozole_and_Palbociclib" .
<Breast_cancer> <Current_treated_by> "Letrozole_and_Bevacizumab" .
<Breast_cancer> <Current_treated_by> "Lapatinib,_Letrozole,_Trastuzumab" .
<Breast_cancer> <Current_treated_by> "Lapatinib_and_Trastuzumab" .
<Breast_cancer> <Current_treated_by> "Lapatinib_and_Letrozole" .
<Breast_cancer> <Current_treated_by> "Ixabepilone_monotherapy" .
<Breast_cancer> <Current_treated_by> "Goserelin_monotherapy" .
<Breast_cancer> <Current_treated_by> "Goserelin_and_Tamoxifen" .
<Breast_cancer> <Current_treated_by> "Gemcitabine_monotherapy" .
<Breast_cancer> <Current_treated_by> "Gemcitabine_and_Trastuzumab" .
<Breast_cancer> <Current_treated_by> "Gemcitabine_and_Paclitaxel" .
<Breast_cancer> <Current_treated_by> "Gemcitabine_and_Bevacizumab" .
<Breast_cancer> <Current_treated_by> "Fulvestrant_monotherapy" .
<Breast_cancer> <Current_treated_by> "Fulvestrant_and_Ribociclib" .
<Breast_cancer> <Current_treated_by> "Fulvestrant_and_Palbociclib" .
<Breast_cancer> <Current_treated_by> "Fam-trastuzumab_deruxtecan_monotherapy" .
<Breast_cancer> <Current_treated_by> "FEC_and_H_(SC)" .
<Breast_cancer> <Current_treated_by> "FEC_and_H" .
<Breast_cancer> <Current_treated_by> "FEC_and_Bevacizumab" .
<Breast_cancer> <Current_treated_by> "FEC" .
<Breast_cancer> <Current_treated_by> "FAC_and_Bevacizumab" .
<Breast_cancer> <Current_treated_by> "FAC" .
<Breast_cancer> <Current_treated_by> "Exemestane_monotherapy" .
<Breast_cancer> <Current_treated_by> "Exemestane_and_Tucidinostat" .
<Breast_cancer> <Current_treated_by> "Everolimus_and_Tamoxifen" .
<Breast_cancer> <Current_treated_by> "Everolimus_and_Exemestane" .
<Breast_cancer> <Current_treated_by> "Eribulin_monotherapy" .
<Breast_cancer> <Current_treated_by> "Epirubicin_monotherapy" .
<Breast_cancer> <Current_treated_by> "Epirubicin_and_Vinorelbine" .
<Breast_cancer> <Current_treated_by> "Enzalutamide_monotherapy" .
<Breast_cancer> <Current_treated_by> "EP" .
<Breast_cancer> <Current_treated_by> "EDC" .
<Breast_cancer> <Current_treated_by> "ECH" .
<Breast_cancer> <Current_treated_by> "EC_and_Bevacizumab" .
<Breast_cancer> <Current_treated_by> "EC" .
<Breast_cancer> <Current_treated_by> "Doxorubicin_pegylated_liposomal_monotherapy" .
<Breast_cancer> <Current_treated_by> "Doxorubicin_pegylated_liposomal_and_Bevacizumab" .
<Breast_cancer> <Current_treated_by> "Doxorubicin_non-pegylated_liposomal_monotherapy" .
<Breast_cancer> <Current_treated_by> "Doxorubicin_non-pegylated_liposomal_and_Bevacizumab" .
<Breast_cancer> <Current_treated_by> "Doxorubicin_monotherapy" .
<Breast_cancer> <Current_treated_by> "Doxorubicin_and_Bevacizumab" .
<Breast_cancer> <Current_treated_by> "Docetaxel_monotherapy" .
<Breast_cancer> <Current_treated_by> "Docetaxel_and_Gemcitabine" .
<Breast_cancer> <Current_treated_by> "Docetaxel_and_Bevacizumab" .
<Breast_cancer> <Current_treated_by> "DI_EC" .
<Breast_cancer> <Current_treated_by> "DE" .
<Breast_cancer> <Current_treated_by> "Cyclophosphamide_monotherapy" .
<Breast_cancer> <Current_treated_by> "Cisplatin_monotherapy" .
<Breast_cancer> <Current_treated_by> "Cisplatin_and_Vinorelbine" .
<Breast_cancer> <Current_treated_by> "Cisplatin_and_Gemcitabine" .
<Breast_cancer> <Current_treated_by> "Cisplatin_and_Docetaxel" .
<Breast_cancer> <Current_treated_by> "Carboplatin_and_nab-Paclitaxel" .
<Breast_cancer> <Current_treated_by> "Carboplatin_and_Paclitaxel" .
<Breast_cancer> <Current_treated_by> "Carboplatin_and_Gemcitabine" .
<Breast_cancer> <Current_treated_by> "Carboplatin_and_Docetaxel" .
<Breast_cancer> <Current_treated_by> "Capecitabine,_Pertuzumab,_Trastuzumab" .
<Breast_cancer> <Current_treated_by> "Capecitabine,_Bevacizumab,_Trastuzumab" .
<Breast_cancer> <Current_treated_by> "Capecitabine_monotherapy" .
<Breast_cancer> <Current_treated_by> "Capecitabine_and_Trastuzumab" .
<Breast_cancer> <Current_treated_by> "Capecitabine_and_Paclitaxel,_nanoparticle_albumin-bound" .
<Breast_cancer> <Current_treated_by> "Capecitabine_and_Paclitaxel" .
<Breast_cancer> <Current_treated_by> "Capecitabine_and_Neratinib" .
<Breast_cancer> <Current_treated_by> "Capecitabine_and_Lapatinib" .
<Breast_cancer> <Current_treated_by> "Capecitabine_and_Ixabepilone" .
<Breast_cancer> <Current_treated_by> "Capecitabine_and_Fulvestrant" .
<Breast_cancer> <Current_treated_by> "Capecitabine_and_Bevacizumab" .
<Breast_cancer> <Current_treated_by> "CMFT" .
<Breast_cancer> <Current_treated_by> "CMF" .
<Breast_cancer> <Current_treated_by> "CM" .
<Breast_cancer> <Current_treated_by> "Bevacizumab-containing_therapy" .
<Breast_cancer> <Current_treated_by> "Bevacizumab_monotherapy" .
<Breast_cancer> <Current_treated_by> "Anastrozole_monotherapy" .
<Breast_cancer> <Current_treated_by> "Anastrozole_and_Trastuzumab" .
<Breast_cancer> <Current_treated_by> "Anastrozole_and_Ribociclib" .
<Breast_cancer> <Current_treated_by> "Anastrozole_and_Palbociclib" .
<Breast_cancer> <Current_treated_by> "Anastrozole_and_Goserelin" .
<Breast_cancer> <Current_treated_by> "Anastrozole_and_Fulvestrant" .
<Breast_cancer> <Current_treated_by> "Alpelisib_and_Fulvestrant" .
<Breast_cancer> <Current_treated_by> "Ado-trastuzumab_emtansine_monotherapy" .
<Breast_cancer> <Current_treated_by> "Abemaciclib_monotherapy" .
<Breast_cancer> <Current_treated_by> "Abemaciclib_and_Letrozole" .
<Breast_cancer> <Current_treated_by> "Abemaciclib_and_Fulvestrant" .
<Breast_cancer> <Current_treated_by> "Abemaciclib_and_Anastrozole" .
<Breast_cancer> <Current_treated_by> "AT_(Taxotere)" .
<Breast_cancer> <Current_treated_by> "AT_(Taxol)" .
<Breast_cancer> <Current_treated_by> "ACH" .
<Breast_cancer> <Current_treated_by> "AC-T" .
<Breast_cancer> <Current_treated_by> "AC_and_Bevacizumab" .
<Breast_cancer> <Current_treated_by> "AC" .
<Cisplatin,_Etoposide,_Durvalumab> <Mapped_from> "Cisplatin,_Etoposide,_Durvalumab" .
<Dexamethasone_monotherapy> <Has_immunosuppressor> "Prednisone" .
<Dexamethasone_monotherapy> <Has_immunosuppressor> "Dexamethasone" .
<Low-grade_glioma> <Accepted_use_of> "Vincristine" .
<Low-grade_glioma> <Accepted_use_of> "Teniposide" .
<Low-grade_glioma> <Accepted_use_of> "Temozolomide_monotherapy" .
<Low-grade_glioma> <Accepted_use_of> "Temozolomide" .
<Low-grade_glioma> <Accepted_use_of> "Radiation_therapy" .
<Low-grade_glioma> <Accepted_use_of> "Procarbazine" .
<Low-grade_glioma> <Accepted_use_of> "PCV" .
<Low-grade_glioma> <Accepted_use_of> "Observation" .
<Low-grade_glioma> <Accepted_use_of> "Lomustine" .
<Low-grade_glioma> <Accepted_use_of> "Etoposide" .
<Low-grade_glioma> <Accepted_use_of> "Cisplatin_and_Etoposide" .
<Low-grade_glioma> <Accepted_use_of> "Cisplatin" .
<Low-grade_glioma> <Accepted_use_of> "Carboplatin_monotherapy" .
<Low-grade_glioma> <Accepted_use_of> "Carboplatin_and_Vincristine" .
<Low-grade_glioma> <Accepted_use_of> "Carboplatin_and_Teniposide" .
<Low-grade_glioma> <Accepted_use_of> "Carboplatin" .
<Paclitaxel_and_Bevacizumab> <Has_context> "Non-curative_therapy" .
<Paclitaxel_and_Bevacizumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<Paclitaxel_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<ATRA_and_Idarubicin> <Maps_to> "ATRA_and_Idarubicin" .
<FEMTX> <Has_antineoplastic> "Methotrexate" .
<FEMTX> <Has_antineoplastic> "Fluorouracil" .
<FEMTX> <Has_antineoplastic> "Epirubicin" .
<EMA-CO> <Has_antineoplastic> "Vincristine" .
<EMA-CO> <Has_antineoplastic> "Methotrexate" .
<EMA-CO> <Has_antineoplastic> "Etoposide" .
<EMA-CO> <Has_antineoplastic> "Dactinomycin" .
<EMA-CO> <Has_antineoplastic> "Cyclophosphamide" .
<VTP> <Mapped_from> "VTP" .
<Doxorubicin_pegylated_liposomal_and_Bevacizumab> <Has_accepted_use> "Ovarian_cancer" .
<Doxorubicin_pegylated_liposomal_and_Bevacizumab> <Has_accepted_use> "Breast_cancer" .
<Cladribine> <May_have_route> "Subcutaneous" .
<Cladribine> <May_have_route> "Intravenous" .
<Benzodiazepine> <Is_a> "Emesis_prevention" .
<Dapsone> <Is_a> "PCP_prophylaxis" .
<Dapsone> <Is_a> "Antibacterial" .
<Alpelisib> <Is_a> "PI3K_inhibitor" .
<Alpelisib> <Is_a> "Mutation-specific_medication" .
<Alpelisib> <Is_a> "Kinase_inhibitor" .
<Ofatumumab_monotherapy> <Has_antineoplastic> "Ofatumumab" .
<EMA-CO> <Maps_to> "EMA-CO" .
<Ferra-TD> <Brand_name_of> "Ferrous_sulfate" .
<Eribulin_monotherapy> <Has_antineoplastic> "Eribulin" .
<Osimertinib> <Has_brand_name> "Tagrisso" .
<PAF> <Maps_to> "PAF" .
<R-CHOP-14_(Rituximab_Hycela)> <Has_context> "Induction_therapy" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_context> "Non-curative_therapy" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Has_context> "Adjuvant_therapy" .
<Warin> <Brand_name_of> "Warfarin" .
<Tranexamic_acid_monotherapy> <Mapped_from> "Tranexamic_acid_monotherapy" .
<DD-CHOP> <Maps_to> "DD-CHOP" .
<Anastrozole_and_Palbociclib> <Mapped_from> "Anastrozole_and_Palbociclib" .
<ABC> <Is_current_in> "Melanoma" .
<Lucanix> <Brand_name_of> "Belagenpumatucel-L" .
<Retaspimycin> <Is_a> "Investigational_drug" .
<Retaspimycin> <Is_a> "Hsp90_inhibitor" .
<Letrozole_and_Bevacizumab> <Has_antineoplastic> "Letrozole" .
<Letrozole_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<CEV_(Carboplatin/Etoposide)> <Has_context> "Induction_therapy" .
<Roxorin> <Brand_name_of> "Doxorubicin" .
<CHUT,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<RVR> <Has_modality> "Chemotherapy" .
<Cabazitaxel_and_Prednisone> <Has_accepted_use> "Prostate_cancer" .
<ChlVPP/PABIOE> <Is_a> "Anthracycline-containing_regimen" .
<Paclitaxel_and_RT> <Mapped_from> "Paclitaxel_and_RT" .
<Irinotecan_monotherapy> <Maps_to> "Irinotecan_monotherapy" .
<Inotuzumab_ozogamicin> <Has_accepted_use> "Follicular_lymphoma" .
<Inotuzumab_ozogamicin> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Inotuzumab_ozogamicin> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Lomustine,_Methotrexate,_Procarbazine> <Maps_to> "Lomustine,_Methotrexate,_Procarbazine" .
<TX_(Taxotere)> <Has_modality> "Chemotherapy" .
<IT_Cytarabine_liposomal_monotherapy> <Mapped_from> "IT_Cytarabine_liposomal_monotherapy" .
<Thalidomide_and_Prednisolone> <Has_antineoplastic> "Thalidomide" .
<Thalidomide_and_Prednisolone> <Has_antineoplastic> "Prednisolone" .
<CHOP_Modified> <Is_a> "Anthracycline-containing_regimen" .
<7_plus_3i_and_Panobinostat> <Is_a> "Anthracycline-containing_regimen" .
<Dinutuximab> <Has_brand_name> "Unituxin" .
<Onkostatil> <Brand_name_of> "Doxorubicin" .
<CVD_(Vindesine)> <Has_accepted_use> "Melanoma" .
<R-GDP> <Is_a> "Rituximab-containing_regimen" .
<TCHP_(Taxotere)> <Has_modality> "Chemotherapy" .
<Strontium-89> <May_have_route> "Intravenous" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Maps_to> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Large_granular_lymphocytic_leukemia> <Current_treated_by> "Methotrexate_and_Prednisone" .
<Large_granular_lymphocytic_leukemia> <Current_treated_by> "Cyclophosphamide_monotherapy" .
<Large_granular_lymphocytic_leukemia> <Current_treated_by> "Cyclophosphamide_and_Prednisone" .
<PCD> <Mapped_from> "PCD" .
<Melhoral_Infantil> <Brand_name_of> "Aspirin" .
<Pemetrexed_and_Bevacizumab> <Mapped_from> "Pemetrexed_and_Bevacizumab" .
<IT_Cytarabine_monotherapy> <Has_accepted_use> "CNS_lymphoma" .
<Fluoxymesterone_monotherapy> <Is_historical_in> "Breast_cancer" .
<C-BOP> <Has_modality> "Chemotherapy" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab> <Has_supportive_med> "Lenograstim" .
<Vandetanib_monotherapy> <Has_modality> "Chemotherapy" .
<CHOP> <Is_a> "Anthracycline-containing_regimen" .
<Chemix> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Docetaxel_monotherapy> <Has_context> "Non-curative_third-line_therapy" .
<Docetaxel_monotherapy> <Has_context> "Non-curative_therapy" .
<Docetaxel_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Docetaxel_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Docetaxel_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Docetaxel_monotherapy> <Has_context> "Neoadjuvant_therapy" .
<Docetaxel_monotherapy> <Has_context> "Induction_therapy" .
<Docetaxel_monotherapy> <Has_context> "Adjuvant_therapy" .
<Carmustine> <Antineoplastic_of> "Z-BEAM,_then_auto_HSCT" .
<Carmustine> <Antineoplastic_of> "Z-BEAM" .
<Carmustine> <Antineoplastic_of> "VMCP/VBAP" .
<Carmustine> <Antineoplastic_of> "VBMCP/VBAD" .
<Carmustine> <Antineoplastic_of> "VBMCP" .
<Carmustine> <Antineoplastic_of> "VBMC" .
<Carmustine> <Antineoplastic_of> "STAMP-I" .
<Carmustine> <Antineoplastic_of> "RT,_then_Carmustine" .
<Carmustine> <Antineoplastic_of> "R-DexaBEAM" .
<Carmustine> <Antineoplastic_of> "R-BEAM,_then_auto_HSCT" .
<Carmustine> <Antineoplastic_of> "R-BEAM" .
<Carmustine> <Antineoplastic_of> "Mini-BEAM" .
<Carmustine> <Antineoplastic_of> "MVBP" .
<Carmustine> <Antineoplastic_of> "MBVP" .
<Carmustine> <Antineoplastic_of> "DexaBEAM_and_G-CSF" .
<Carmustine> <Antineoplastic_of> "DexaBEAM" .
<Carmustine> <Antineoplastic_of> "Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine" .
<Carmustine> <Antineoplastic_of> "Carmustine_monotherapy" .
<Carmustine> <Antineoplastic_of> "Carmustine_and_RT" .
<Carmustine> <Antineoplastic_of> "Carmustine_and_Doxorubicin" .
<Carmustine> <Antineoplastic_of> "CPB" .
<Carmustine> <Antineoplastic_of> "CDB" .
<Carmustine> <Antineoplastic_of> "CBVM,_then_auto_HSCT" .
<Carmustine> <Antineoplastic_of> "CBV-Mx,_then_auto_HSCT" .
<Carmustine> <Antineoplastic_of> "CBV-Mx" .
<Carmustine> <Antineoplastic_of> "CBV,_then_auto_HSCT" .
<Carmustine> <Antineoplastic_of> "CBV" .
<Carmustine> <Antineoplastic_of> "BVD" .
<Carmustine> <Antineoplastic_of> "BVCPP" .
<Carmustine> <Antineoplastic_of> "BHD" .
<Carmustine> <Antineoplastic_of> "BEAM,_then_auto_HSCT" .
<Carmustine> <Antineoplastic_of> "BEAM,_then_allo_HSCT" .
<Carmustine> <Antineoplastic_of> "BEAM" .
<Carmustine> <Antineoplastic_of> "BEAC,_then_auto_HSCT" .
<Carmustine> <Antineoplastic_of> "BEAC" .
<Carmustine> <Antineoplastic_of> "BCVPP" .
<Carmustine> <Antineoplastic_of> "BCOP" .
<Carmustine> <Antineoplastic_of> "BCNU/TT,_then_auto_HSCT" .
<Carmustine> <Antineoplastic_of> "BCNU/TT" .
<Carmustine> <Antineoplastic_of> "ABCM" .
<Sirolimus_and_Vorinostat> <Maps_to> "Sirolimus_and_Vorinostat" .
<Letrozole_and_Palbociclib> <Maps_to> "Letrozole_and_Palbociclib" .
<Upfront_therapy> <Is_a> "Curative_therapy" .
<Proscan> <Brand_name_of> "Flutamide" .
<ACE> <Is_a> "Anthracycline-containing_regimen" .
<Integrilin> <Brand_name_of> "Eptifibatide" .
<Therasept> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Novasen> <Brand_name_of> "Aspirin" .
<MyAza> <Brand_name_of> "Azacitidine" .
<VACA> <Has_supportive_med> "Mesna" .
<Hyper-CVAD_and_Dasatinib> <Is_a> "Anthracycline-containing_regimen" .
<Imlygic> <Brand_name_of> "Talimogene_laherparepvec" .
<Prochlorperazine> <Has_brand_name> "Stemetil" .
<Prochlorperazine> <Has_brand_name> "Dvometil" .
<Prochlorperazine> <Has_brand_name> "Compro" .
<Prochlorperazine> <Has_brand_name> "Compazine" .
<Prochlorperazine> <Has_brand_name> "Acuvert" .
<MV> <Has_modality> "Chemotherapy" .
<Cisplatin,_Fluorouracil,_Panitumumab> <Mapped_from> "Cisplatin,_Fluorouracil,_Panitumumab" .
<Enantone> <Brand_name_of> "Leuprolide" .
<Docetaxel_and_Irinotecan> <Has_accepted_use> "Esophageal_cancer" .
<Decaderm> <Brand_name_of> "Dexamethasone" .
<Intraperitoneal_5-FU> <Has_context> "Non-curative_therapy" .
<FCR,_then_allo_HSCT> <Has_antineoplastic> "Rituximab" .
<FCR,_then_allo_HSCT> <Has_antineoplastic> "Fludarabine" .
<FCR,_then_allo_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<FCR,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<Aclarubicin> <May_have_route> "Intravenous" .
<VR-CP> <Is_a> "Rituximab-containing_regimen" .
<Ultrasept> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Docetaxel_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Topotecan> <Has_FDA_indication> "Small_cell_lung_cancer" .
<Topotecan> <Has_FDA_indication> "Ovarian_cancer" .
<Topotecan> <Has_FDA_indication> "Cervical_cancer" .
<SCAB> <Is_a> "Anthracycline-containing_regimen" .
<Peginterferon_alfa-2a> <Has_brand_name> "Pegasys" .
<Idelalisib_and_Rituximab> <Maps_to> "Idelalisib_and_Rituximab" .
<CAP_(Platinol)> <Is_a> "Anthracycline-containing_regimen" .
<Adenocarcinoma_of_unknown_primary> <Is_a> "Malignant_solid_neoplasm" .
<CTD> <Has_antineoplastic> "Thalidomide" .
<CTD> <Has_antineoplastic> "Dexamethasone" .
<CTD> <Has_antineoplastic> "Cyclophosphamide" .
<ADE_(high-dose_Ara-C)> <Is_a> "Anthracycline-containing_regimen" .
<Cisplatin_and_Vinorelbine> <Is_current_in> "Non-small_cell_lung_cancer" .
<Cisplatin_and_Vinorelbine> <Is_current_in> "Cervical_cancer" .
<Cisplatin_and_Vinorelbine> <Is_current_in> "Breast_cancer" .
<Cisplatin_and_Epirubicin> <Mapped_from> "Cisplatin_and_Epirubicin" .
<PFT> <Maps_to> "PFT" .
<VAD-P/Q> <Has_modality> "Chemotherapy" .
<Daburex> <Brand_name_of> "Paclitaxel" .
<Anti-diarrheal> <Is_a> "Bowel_management" .
<Cisplatin_and_Vindesine> <Has_antineoplastic> "Vindesine" .
<Cisplatin_and_Vindesine> <Has_antineoplastic> "Cisplatin" .
<Somelon> <Brand_name_of> "Methylprednisolone" .
<Hydroxyurea_and_Plicamycin> <Maps_to> "Hydroxyurea_and_Plicamycin" .
<MP> <Has_supportive_med> "Pamidronate" .
<MP> <Has_supportive_med> "Clodronate" .
<MP> <Has_supportive_med> "Aspirin" .
<FLAG-DNX> <Is_historical_in> "Acute_myeloid_leukemia" .
<Epirubicin_monotherapy> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Epirubicin_monotherapy> <Has_accepted_use> "Breast_cancer" .
<131I-Metaiodobenzylguanidine_(131I-MIBG)> <Has_supportive_med> "Pralatrexate" .
<131I-Metaiodobenzylguanidine_(131I-MIBG)> <Has_supportive_med> "Folic_acid" .
<131I-Metaiodobenzylguanidine_(131I-MIBG)> <Has_supportive_med> "Cyanocobalamin" .
<R-MPV> <Mapped_from> "R-MPV" .
<Alendronat> <Brand_name_of> "Alendronate" .
<FLAG> <Has_antineoplastic> "Fludarabine" .
<FLAG> <Has_antineoplastic> "Cytarabine" .
<Randa> <Brand_name_of> "Cisplatin" .
<Alemtuzumab_and_Rituximab> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Crizotinib> <Antineoplastic_of> "Crizotinib_monotherapy" .
<Anti-CCR4_antibody> <Subsumes> "Mogamulizumab" .
<DA_3_plus_10,_GO> <Maps_to> "DA_3_plus_10,_GO" .
<Formestane_monotherapy> <Has_modality> "Hormonotherapy" .
<Talimogene_laherparepvec_monotherapy> <Has_accepted_use> "Melanoma" .
<Anti-RANKL_antibody> <Is_a> "Antibody_medication" .
<Docetaxel,_Cetuximab,_RT> <Maps_to> "Docetaxel,_Cetuximab,_RT" .
<Bexxar> <Brand_name_of> "Tositumomab_&_I-131" .
<R-ICE> <Maps_to> "R-ICE" .
<Cyclophosphamide> <Has_FDA_indication> "Ovarian_cancer" .
<Cyclophosphamide> <Has_FDA_indication> "Neuroblastoma" .
<Cyclophosphamide> <Has_FDA_indication> "Multiple_myeloma" .
<Cyclophosphamide> <Has_FDA_indication> "Hodgkin_lymphoma" .
<Cyclophosphamide> <Has_FDA_indication> "Diffuse_large_B-cell_lymphoma" .
<Cyclophosphamide> <Has_FDA_indication> "Cutaneous_T-cell_lymphoma" .
<Cyclophosphamide> <Has_FDA_indication> "Chronic_lymphocytic_leukemia" .
<Cyclophosphamide> <Has_FDA_indication> "Burkitt_lymphoma" .
<Cyclophosphamide> <Has_FDA_indication> "Breast_cancer" .
<m-BNCOD> <Has_context> "Induction_therapy" .
<Cytarabine_and_Interferon_alfa-2b> <Is_current_in> "Chronic_myelogenous_leukemia" .
<Capecitabine_monotherapy> <Maps_to> "Capecitabine_monotherapy" .
<nab-Paclitaxel_and_Atezolizumab> <Is_current_in> "Breast_cancer" .
<Cortisone> <May_have_route> "Oral" .
<AT_(Taxol)> <Has_accepted_use> "Breast_cancer" .
<MPV> <Has_supportive_med> "Folinic_acid" .
<MPV> <Has_supportive_med> "Dexamethasone" .
<Belon> <Brand_name_of> "Methylprednisolone" .
<Ontrax> <Brand_name_of> "Ondansetron" .
<Kepivance> <Brand_name_of> "Palifermin" .
<Amsacrine_and_Cytarabine> <Is_historical_in> "Acute_myeloid_leukemia" .
<AT_(Taxotere)> <Is_a> "Anthracycline-containing_regimen" .
<mFOLFIRINOX,_Gemcitabine,_RT> <Maps_to> "mFOLFIRINOX,_Gemcitabine,_RT" .
<7_plus_5i> <Mapped_from> "7_plus_5i" .
<ADT_and_Abiraterone> <Has_accepted_use> "Prostate_cancer" .
<Auxiloson> <Brand_name_of> "Dexamethasone" .
<BVDS> <Has_accepted_use> "Hodgkin_lymphoma" .
<Irinomedac> <Brand_name_of> "Irinotecan" .
<Citoplatino> <Brand_name_of> "Cisplatin" .
<Endocrine_cancer> <Subsumes> "Thyroid_cancer" .
<Endocrine_cancer> <Subsumes> "Pheochromocytoma" .
<Endocrine_cancer> <Subsumes> "Pancreatic_NET" .
<Endocrine_cancer> <Subsumes> "Neuroendocrine_tumor" .
<Endocrine_cancer> <Subsumes> "Adrenocortical_carcinoma" .
<KPD> <Has_accepted_use> "Multiple_myeloma" .
<Irinotecan_monotherapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<Irinotecan_monotherapy> <Has_accepted_use> "KRAS_wild-type_Colon_cancer" .
<Irinotecan_monotherapy> <Has_accepted_use> "Glioblastoma" .
<Irinotecan_monotherapy> <Has_accepted_use> "Gastric_cancer" .
<Irinotecan_monotherapy> <Has_accepted_use> "Esophageal_cancer" .
<Irinotecan_monotherapy> <Has_accepted_use> "Colon_cancer" .
<Irinotecan_monotherapy> <Has_accepted_use> "Cervical_cancer" .
<Irinotecan_monotherapy> <Has_accepted_use> "Anaplastic_glioma" .
<Fludarabine_and_Prednisone> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Couparin> <Brand_name_of> "Warfarin" .
<Megestrol_monotherapy> <Has_accepted_use> "Renal_cell_carcinoma" .
<Megestrol_monotherapy> <Has_accepted_use> "Endometrial_cancer" .
<Megestrol_monotherapy> <Has_accepted_use> "Breast_cancer" .
<DEX-IFN> <Has_context> "Non-curative_first-line_therapy" .
<mDCF> <Has_modality> "Chemotherapy" .
<Bortezomib_and_Melphalan,_then_auto_HSCT> <Is_current_in> "Multiple_myeloma" .
<Bortezomib_and_Melphalan,_then_auto_HSCT> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<MCP_(Prednisolone)> <Has_antineoplastic> "Prednisolone" .
<MCP_(Prednisolone)> <Has_antineoplastic> "Mitoxantrone" .
<MCP_(Prednisolone)> <Has_antineoplastic> "Chlorambucil" .
<COPAD/CYVE> <Maps_to> "COPAD/CYVE" .
<R-TBI/Cy,_then_auto_HSCT> <Has_antineoplastic> "Rituximab" .
<R-TBI/Cy,_then_auto_HSCT> <Has_antineoplastic> "External_beam_radiotherapy" .
<R-TBI/Cy,_then_auto_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<Doxorubicin_pegylated_liposomal_monotherapy> <Mapped_from> "Doxorubicin_pegylated_liposomal_monotherapy" .
<Quinine> <Has_brand_name> "Qualaquin" .
<Peripheral_T-cell_lymphoma> <FDA_indication_of> "Romidepsin" .
<Peripheral_T-cell_lymphoma> <FDA_indication_of> "Pralatrexate" .
<Peripheral_T-cell_lymphoma> <FDA_indication_of> "Brentuximab_vedotin" .
<Peripheral_T-cell_lymphoma> <FDA_indication_of> "Belinostat" .
<Prednisolone_monotherapy> <Has_modality> "Immunosuppressive_therapy" .
<Prednisolone_monotherapy> <Has_modality> "Chemotherapy" .
<IGEV> <Is_current_in> "Hodgkin_lymphoma" .
<Durvalumab_monotherapy> <Has_antineoplastic> "Durvalumab" .
<Ixazomib_monotherapy> <Has_modality> "Chemotherapy" .
<Fauldleuco> <Brand_name_of> "Folinic_acid" .
<7_plus_3i_and_Sorafenib> <Has_antineoplastic> "Sorafenib" .
<7_plus_3i_and_Sorafenib> <Has_antineoplastic> "Idarubicin" .
<7_plus_3i_and_Sorafenib> <Has_antineoplastic> "Cytarabine" .
<Cytoplatin> <Brand_name_of> "Cisplatin" .
<Goserelin_and_RT> <Has_context> "Salvage_therapy" .
<Goserelin_and_RT> <Has_context> "Definitive_therapy" .
<CaRD> <Is_a> "Rituximab-containing_regimen" .
<Antibiotic_therapy> <Mapped_from> "Antibiotic_therapy" .
<Adrenocortical_carcinoma> <Accepted_use_of> "Streptozocin" .
<Adrenocortical_carcinoma> <Accepted_use_of> "Placebo" .
<Adrenocortical_carcinoma> <Accepted_use_of> "Mitotane_monotherapy" .
<Adrenocortical_carcinoma> <Accepted_use_of> "Mitotane_and_Streptozocin" .
<Adrenocortical_carcinoma> <Accepted_use_of> "Mitotane_and_EDP" .
<Adrenocortical_carcinoma> <Accepted_use_of> "Mitotane" .
<Adrenocortical_carcinoma> <Accepted_use_of> "Etoposide" .
<Adrenocortical_carcinoma> <Accepted_use_of> "Doxorubicin" .
<Adrenocortical_carcinoma> <Accepted_use_of> "Cixutumumab" .
<Adrenocortical_carcinoma> <Accepted_use_of> "Cisplatin" .
<Lapatinib_and_Letrozole> <Has_modality> "Hormonotherapy" .
<Lapatinib_and_Letrozole> <Has_modality> "Chemotherapy" .
<CFAR> <Has_antineoplastic> "Rituximab" .
<CFAR> <Has_antineoplastic> "Fludarabine" .
<CFAR> <Has_antineoplastic> "Cyclophosphamide" .
<CFAR> <Has_antineoplastic> "Alemtuzumab" .
<ddFEC> <Is_a> "Anthracycline-containing_regimen" .
<Daunorubicin_monotherapy> <Is_current_in> "Acute_promyelocytic_leukemia" .
<Valnov> <Brand_name_of> "Valganciclovir" .
<PATCO> <Has_context> "Induction_therapy" .
<7_plus_3i> <Has_accepted_use> "Acute_myeloid_leukemia" .
<DA-EPOCH> <Maps_to> "DA-EPOCH" .
<Whole_brain_irradiation> <Has_antineoplastic> "External_beam_radiotherapy" .
<PMDA_approved_drug> <Is_a> "Approved_drug" .
<Thyroid_cancer> <Current_treated_by> "Vemurafenib_monotherapy" .
<Thyroid_cancer> <Current_treated_by> "Vandetanib_monotherapy" .
<Thyroid_cancer> <Current_treated_by> "Sunitinib_monotherapy" .
<Thyroid_cancer> <Current_treated_by> "Sorafenib_monotherapy" .
<Thyroid_cancer> <Current_treated_by> "Radioiodine_ablation" .
<Thyroid_cancer> <Current_treated_by> "Placebo" .
<Thyroid_cancer> <Current_treated_by> "Pazopanib_monotherapy" .
<Thyroid_cancer> <Current_treated_by> "Lenvatinib_monotherapy" .
<Thyroid_cancer> <Current_treated_by> "Doxorubicin_monotherapy" .
<Thyroid_cancer> <Current_treated_by> "Dabrafenib_and_Trametinib" .
<Thyroid_cancer> <Current_treated_by> "Cabozantinib_monotherapy" .
<Thyroid_cancer> <Current_treated_by> "Axitinib_monotherapy" .
<Plasma_cell_dyscrasia> <Subsumes> "Plasma_cell_leukemia" .
<Plasma_cell_dyscrasia> <Subsumes> "POEMS_syndrome" .
<Plasma_cell_dyscrasia> <Subsumes> "Multiple_myeloma" .
<Plasma_cell_dyscrasia> <Subsumes> "Light-chain_(AL)_amyloidosis" .
<IROX> <Has_antineoplastic> "Oxaliplatin" .
<IROX> <Has_antineoplastic> "Irinotecan" .
<Epirubicin_and_Vinorelbine> <Mapped_from> "Epirubicin_and_Vinorelbine" .
<Promethazine> <Has_brand_name> "Phenergan" .
<Carboplatin_and_Doxorubicin_liposomal> <Has_antineoplastic> "Pegylated_liposomal_doxorubicin" .
<Carboplatin_and_Doxorubicin_liposomal> <Has_antineoplastic> "Carboplatin" .
<Depacon> <Brand_name_of> "Valproate" .
<Valcivir> <Brand_name_of> "Valacyclovir" .
<Chimeric_antigen_receptor_T-cell> <Subsumes> "Tisagenlecleucel" .
<Chimeric_antigen_receptor_T-cell> <Subsumes> "Axicabtagene_ciloleucel" .
<R-CHOP-14> <Maps_to> "R-CHOP-14" .
<Holadren> <Brand_name_of> "Alendronate" .
<Capecitabine_and_Ixabepilone> <Has_accepted_use> "triple_negative_Breast_cancer" .
<Capecitabine_and_Ixabepilone> <Has_accepted_use> "Breast_cancer" .
<Cyclophosphamide_monotherapy> <Maps_to> "Cyclophosphamide_monotherapy" .
<Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin> <Maps_to> "Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin" .
<Peginterferon_alfa-2b_monotherapy> <Mapped_from> "Peginterferon_alfa-2b_monotherapy" .
<Pinorubicin> <Brand_name_of> "Pirarubicin" .
<Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Is_historical_in> "Multiple_myeloma" .
<Castleman_disease> <Is_a> "Lymphoproliferative_disorder" .
<Rolapitant> <Has_brand_name> "Varubi_IV" .
<Rolapitant> <Has_brand_name> "Varubi" .
<Intravenous_Immunoglobulin> <Maps_to> "Intravenous_Immunoglobulin" .
<Dactinomycin> <Has_brand_name> "Lyovac" .
<Dactinomycin> <Has_brand_name> "Dacmozen" .
<Dactinomycin> <Has_brand_name> "Cosmegen" .
<Docetaxel,_Fluorouracil,_RT> <Mapped_from> "Docetaxel,_Fluorouracil,_RT" .
<BEACOPP-14_(Prednisolone)> <Has_modality> "Chemotherapy" .
<Doxorubicin_monotherapy> <Has_context> "Non-curative_therapy" .
<Doxorubicin_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Doxorubicin_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Doxorubicin_monotherapy> <Has_context> "Local_therapy" .
<Doxorubicin_monotherapy> <Has_context> "Adjuvant_therapy" .
<CHOP_Modified_(Prednisolone)> <Has_antineoplastic> "Vincristine" .
<CHOP_Modified_(Prednisolone)> <Has_antineoplastic> "Prednisolone" .
<CHOP_Modified_(Prednisolone)> <Has_antineoplastic> "Doxorubicin" .
<CHOP_Modified_(Prednisolone)> <Has_antineoplastic> "Cyclophosphamide" .
<Taxotere> <Brand_name_of> "Docetaxel" .
<Flutamide_and_Leuprolide> <Has_antineoplastic> "Leuprolide" .
<Flutamide_and_Leuprolide> <Has_antineoplastic> "Flutamide" .
<G-FC> <Has_context> "Non-curative_first-line_therapy" .
<FOLFOX4> <Has_antineoplastic> "Oxaliplatin" .
<FOLFOX4> <Has_antineoplastic> "Folinic_acid" .
<FOLFOX4> <Has_antineoplastic> "Fluorouracil" .
<Sepiran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<FM> <Mapped_from> "FM" .
<C-MOPP/ABV> <Maps_to> "C-MOPP/ABV" .
<Infectrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<CALGB_8811_early_intensification> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Cotri> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Atropine> <Has_brand_name> "Atropen" .
<Trastuzumab-dttb> <Has_FDA_indication> "Gastric_cancer" .
<Trastuzumab-dttb> <Has_FDA_indication> "Breast_cancer" .
<CVAP> <Is_historical_in> "Breast_cancer" .
<Lenograstim> <Has_brand_name> "Neutrogin" .
<Lenograstim> <Has_brand_name> "Granocyte" .
<CLAG> <Has_context> "Salvage_therapy" .
<Elotuzumab> <May_have_route> "Intravenous" .
<Trixazol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Chlorambucil_and_Rituximab> <Mapped_from> "Chlorambucil_and_Rituximab" .
<PET> <Has_context> "Neoadjuvant_therapy" .
<AC-T> <Has_modality> "Chemotherapy" .
<Dexanil> <Brand_name_of> "Dexamethasone" .
<Bavituximab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<KPD> <Is_current_in> "Multiple_myeloma" .
<HLH-94_regimen> <Has_modality> "Immunosuppressive_therapy" .
<Epinephrine_autoinjector> <May_have_route> "Intramuscular" .
<MOPP/ABVD> <Maps_to> "MOPP/ABVD" .
<Ifosfamide> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Ifosfamide> <Is_a> "Nitrogen_mustard" .
<Ifosfamide> <Is_a> "Neutral" .
<Ifosfamide> <Is_a> "Irritant" .
<Carboplatin,_Pemetrexed,_Bevacizumab> <Has_antineoplastic> "Pemetrexed" .
<Carboplatin,_Pemetrexed,_Bevacizumab> <Has_antineoplastic> "Carboplatin" .
<Carboplatin,_Pemetrexed,_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Docetaxel_and_Irinotecan> <Has_modality> "Chemotherapy" .
<Bicalutamide> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Bicalutamide> <Is_a> "Nonsteroidal_antiandrogen" .
<Meprotrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<FLOT> <Has_supportive_med> "Dexamethasone" .
<CHOP_Modified_(Prednisolone)> <Mapped_from> "CHOP_Modified_(Prednisolone)" .
<RET_inhibitor> <Is_a> "Kinase_inhibitor" .
<BEAM,_then_allo_HSCT> <Has_immunosuppressor> "Tacrolimus" .
<BEAM,_then_allo_HSCT> <Has_immunosuppressor> "Methotrexate" .
<BEAM,_then_allo_HSCT> <Has_immunosuppressor> "Filgrastim" .
<R-FND> <Has_modality> "Chemotherapy" .
<Carboplatin_and_Etoposide> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Carboplatin_and_Etoposide> <Has_supportive_med> "Loperamide" .
<Carboplatin_and_Etoposide> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Carboplatin_and_Etoposide> <Has_supportive_med> "Granisetron" .
<Carboplatin_and_Etoposide> <Has_supportive_med> "Dexamethasone" .
<DCF> <Maps_to> "DCF" .
<Nilotinib-based_consolidation> <Has_modality> "Chemotherapy" .
<Megestrol_and_Tamoxifen> <Maps_to> "Megestrol_and_Tamoxifen" .
<Bu/TT,_then_auto_HSCT> <Mapped_from> "Bu/TT,_then_auto_HSCT" .
<Dexagel> <Brand_name_of> "Dexamethasone" .
<CTCb> <Has_accepted_use> "Autologous_HSCT" .
<Gefitinib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Ceritinib_monotherapy> <Mapped_from> "Ceritinib_monotherapy" .
<Regorafenib_monotherapy> <Maps_to> "Regorafenib_monotherapy" .
<Antrex> <Brand_name_of> "Folinic_acid" .
<Decitas> <Brand_name_of> "Decitabine" .
<Cisplatin,_Dacarbazine,_Interferon_alfa-2b> <Has_accepted_use> "Melanoma" .
<Methotrexate_and_Pegaspargase> <Has_context> "Maintenance_after_upfront_therapy" .
<Chlorbutin> <Brand_name_of> "Chlorambucil" .
<Doxorubicin_monotherapy> <Has_antineoplastic> "Doxorubicin" .
<Brigatinib_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Brigatinib_monotherapy> <Has_accepted_use> "ALK-positive_Non-small_cell_lung_cancer" .
<Tamid> <Brand_name_of> "Flutamide" .
<Abiraterone> <Has_brand_name> "Zytiga" .
<Prednisolone> <Antineoplastic_of> "mCOP/MP" .
<Prednisolone> <Antineoplastic_of> "eBEACOPP_(Prednisolone)" .
<Prednisolone> <Antineoplastic_of> "VEPA" .
<Prednisolone> <Antineoplastic_of> "VEBEP" .
<Prednisolone> <Antineoplastic_of> "VAP" .
<Prednisolone> <Antineoplastic_of> "Thalidomide_and_Prednisolone" .
<Prednisolone> <Antineoplastic_of> "Tamoxifen_and_Prednisolone" .
<Prednisolone> <Antineoplastic_of> "R-MCP" .
<Prednisolone> <Antineoplastic_of> "R-GCVP" .
<Prednisolone> <Antineoplastic_of> "R-COPADM" .
<Prednisolone> <Antineoplastic_of> "R-CHVP_plus_I" .
<Prednisolone> <Antineoplastic_of> "R-CHOP-14_(Prednisolone)" .
<Prednisolone> <Antineoplastic_of> "R-CHOP_(Prednisolone)" .
<Prednisolone> <Antineoplastic_of> "R-CEOP90_(Epirubicin)" .
<Prednisolone> <Antineoplastic_of> "Prednisolone_monotherapy" .
<Prednisolone> <Antineoplastic_of> "PMitCEBO" .
<Prednisolone> <Antineoplastic_of> "PACEBOM" .
<Prednisolone> <Antineoplastic_of> "Nilotinib-based_consolidation" .
<Prednisolone> <Antineoplastic_of> "Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone" .
<Prednisolone> <Antineoplastic_of> "MP_(Prednisolone)" .
<Prednisolone> <Antineoplastic_of> "MCP_(Prednisolone)" .
<Prednisolone> <Antineoplastic_of> "LVP_.22Sandwich.22" .
<Prednisolone> <Antineoplastic_of> "L-Asparaginase,_Vincristine,_Prednisolone" .
<Prednisolone> <Antineoplastic_of> "IGEV_and_G-CSF" .
<Prednisolone> <Antineoplastic_of> "IGEV" .
<Prednisolone> <Antineoplastic_of> "GVP" .
<Prednisolone> <Antineoplastic_of> "EPIC_regimen" .
<Prednisolone> <Antineoplastic_of> "Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone" .
<Prednisolone> <Antineoplastic_of> "Docetaxel_and_Prednisolone" .
<Prednisolone> <Antineoplastic_of> "Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib" .
<Prednisolone> <Antineoplastic_of> "DOLP_(Prednisolone)" .
<Prednisolone> <Antineoplastic_of> "Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone" .
<Prednisolone> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone" .
<Prednisolone> <Antineoplastic_of> "Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone" .
<Prednisolone> <Antineoplastic_of> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone" .
<Prednisolone> <Antineoplastic_of> "Chlorambucil_and_Prednisolone" .
<Prednisolone> <Antineoplastic_of> "ChlVPP/PABIOE" .
<Prednisolone> <Antineoplastic_of> "ChlVPP/EVA" .
<Prednisolone> <Antineoplastic_of> "CVP_(Vinblastine/Prednisone)" .
<Prednisolone> <Antineoplastic_of> "CVP_(Prednisolone)" .
<Prednisolone> <Antineoplastic_of> "CVAP" .
<Prednisolone> <Antineoplastic_of> "CNOP_(Prednisolone)" .
<Prednisolone> <Antineoplastic_of> "CHOP_Modified_(Prednisolone)" .
<Prednisolone> <Antineoplastic_of> "CHOP_(Prednisolone)" .
<Prednisolone> <Antineoplastic_of> "CEOP_(Prednisolone)" .
<Prednisolone> <Antineoplastic_of> "BeGEV" .
<Prednisolone> <Antineoplastic_of> "BEACOPP-14_(Prednisolone)" .
<Prednisolone> <Antineoplastic_of> "BCHOP" .
<Cyclosporine,_Mycophenolate_mofetil,_Sirolimus> <Has_context> "Prophylaxis" .
<Docetaxel_and_Ramucirumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<Docetaxel_and_Ramucirumab> <Has_context> "Non-curative_second-line_therapy" .
<Mitocin> <Brand_name_of> "Mitomycin" .
<Betaxel> <Brand_name_of> "Paclitaxel" .
<DRC> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<Dexametonal> <Brand_name_of> "Dexamethasone" .
<Quizartinib_monotherapy> <Maps_to> "Quizartinib_monotherapy" .
<Cabozantinib_and_Erlotinib> <Has_context> "Non-curative_third-line_therapy" .
<Cabozantinib_and_Erlotinib> <Has_context> "Non-curative_second-line_therapy" .
<Altretamine_and_Cisplatin> <Has_accepted_use> "Ovarian_cancer" .
<Lodex> <Brand_name_of> "Dexamethasone" .
<Acetylsalisylsyre> <Brand_name_of> "Aspirin" .
<CHOP-B> <Maps_to> "CHOP-B" .
<Clopidogrel> <Supportive_med_of> "TD" .
<Clopidogrel> <Supportive_med_of> "Rd" .
<Clopidogrel> <Supportive_med_of> "KRd" .
<Clopidogrel> <Supportive_med_of> "Aspirin_and_Hydroxyurea" .
<Clopidogrel> <Supportive_med_of> "Anagrelide_monotherapy" .
<FND> <Is_a> "Anthracycline-containing_regimen" .
<Ottoprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin_and_Doxorubicin> <Has_context> "Non-curative_therapy" .
<Cisplatin_and_Doxorubicin> <Has_context> "Non-curative_first-line_therapy" .
<Cisplatin_and_Doxorubicin> <Has_context> "Neoadjuvant_therapy" .
<Cisplatin_and_Doxorubicin> <Has_context> "All_lines_of_therapy" .
<Cisplatin_and_Doxorubicin> <Has_context> "Adjuvant_therapy" .
<mFOLFOX7_(L-Leucovorin)> <Has_accepted_use> "Colon_cancer" .
<Intraperitoneal_hyperthermic_mitomycin> <Mapped_from> "Intraperitoneal_hyperthermic_mitomycin" .
<C-BOP> <Maps_to> "C-BOP" .
<Bacfar> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Eculizumab> <Has_accepted_use> "Paroxysmal_nocturnal_hemoglobinuria" .
<Eculizumab> <Has_accepted_use> "Cold_agglutinin_disease" .
<Eculizumab> <Has_accepted_use> "Atypical_hemolytic_uremic_syndrome" .
<Ifosfamide_and_Methotrexate> <Has_modality> "Chemotherapy" .
<Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan> <Has_context> "Non-curative_therapy" .
<Avelumab_monotherapy> <Has_accepted_use> "Merkel_cell_carcinoma" .
<Avelumab_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<Prednisolone> <Local_therapy_of> "HLH-2004_regimen" .
<Prednisolone> <Local_therapy_of> "Arsenic_trioxide_monotherapy" .
<Prednisolone> <Local_therapy_of> "Arsenic_trioxide_and_Idarubicin" .
<Selective_estrogen_receptor_modulator> <Subsumes> "Toremifene" .
<Selective_estrogen_receptor_modulator> <Subsumes> "Tamoxifen" .
<Selective_estrogen_receptor_modulator> <Subsumes> "Raloxifene" .
<Dhatrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<MEC> <Has_context> "Salvage_therapy" .
<MEC> <Has_context> "Non-curative_subsequent-line_therapy" .
<MEC> <Has_context> "Induction_therapy" .
<Clariprin> <Brand_name_of> "Aspirin" .
<Oseotal> <Brand_name_of> "Alendronate" .
<Epithelioid_sarcoma> <Accepted_use_of> "Tazemetostat_monotherapy" .
<Epithelioid_sarcoma> <Accepted_use_of> "Tazemetostat" .
<Sorafenib> <Is_a> "VEGFR_inhibitor" .
<Sorafenib> <Is_a> "RET_inhibitor" .
<Sorafenib> <Is_a> "PDGFR_inhibitor" .
<Sorafenib> <Is_a> "Kinase_inhibitor" .
<Sorafenib> <Is_a> "KIT_inhibitor" .
<Sorafenib> <Is_a> "FLT3_inhibitor" .
<Sorafenib> <Is_a> "BRAF_inhibitor" .
<Epoyet> <Brand_name_of> "Epoetin_alfa" .
<Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine> <Has_modality> "Chemotherapy" .
<Doloprin> <Brand_name_of> "Aspirin" .
<Predicorten> <Brand_name_of> "Prednisone" .
<Cytarabine,_Idarubicin,_Rituximab> <Maps_to> "Cytarabine,_Idarubicin,_Rituximab" .
<Dexagrin> <Brand_name_of> "Dexamethasone" .
<Non-curative_third-line_induction_therapy> <Is_a> "Non-curative_third-line_therapy" .
<CODOX-M> <Has_antineoplastic> "Vincristine" .
<CODOX-M> <Has_antineoplastic> "Methotrexate" .
<CODOX-M> <Has_antineoplastic> "Doxorubicin" .
<CODOX-M> <Has_antineoplastic> "Cyclophosphamide" .
<Fam-trastuzumab_deruxtecan_monotherapy> <Mapped_from> "Fam-trastuzumab_deruxtecan_monotherapy" .
<Edoxaban> <Supportive_med_of> "Edoxaban_monotherapy" .
<Calaspargase> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Calaspargase> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Fluorouracil,_Folinic_acid,_Gemcitabine> <Has_antineoplastic> "Gemcitabine" .
<Fluorouracil,_Folinic_acid,_Gemcitabine> <Has_antineoplastic> "Folinic_acid" .
<Fluorouracil,_Folinic_acid,_Gemcitabine> <Has_antineoplastic> "Fluorouracil" .
<Metrexato> <Brand_name_of> "Methotrexate" .
<Adriamycine> <Brand_name_of> "Doxorubicin" .
<Evista> <Brand_name_of> "Raloxifene" .
<Teanlang> <Brand_name_of> "Dexamethasone" .
<TC,_then_IE,_VDoxoC,_VEC> <Has_context> "Non-curative_therapy" .
<EDC> <Has_modality> "Chemotherapy" .
<Penicillin_V> <Is_a> "WHO_Essential_Anti-infective_Medicine" .
<Penicillin_V> <Is_a> "Penicillin" .
<Tandem_melphalan,_then_auto_HSCT> <Mapped_from> "Tandem_melphalan,_then_auto_HSCT" .
<Ativan> <Brand_name_of> "Lorazepam" .
<Ifosfamide> <Supportive_med_of> "Amrubicin_monotherapy" .
<Clofarabine_monotherapy> <Has_antineoplastic> "Clofarabine" .
<PCE> <Has_modality> "Chemotherapy" .
<Anal_cancer> <Is_a> "Gastrointestinal_cancer" .
<Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT> <Mapped_from> "Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT" .
<ADE_and_ATRA> <Maps_to> "ADE_and_ATRA" .
<ATRA,_Cytarabine,_Daunorubicin> <Maps_to> "ATRA,_Cytarabine,_Daunorubicin" .
<Chidamide> <Antineoplastic_of> "Exemestane_and_Tucidinostat" .
<Chidamide> <Antineoplastic_of> "Chidamide_monotherapy" .
<Mitomycin_monotherapy> <Maps_to> "Mitomycin_monotherapy" .
<Sennosides> <Is_a> "WHO_Essential_Pain_and_Palliative_Care_Medicine" .
<Sennosides> <Is_a> "OTC_medication" .
<Sennosides> <Is_a> "Laxative" .
<Icotinib> <Is_a> "Kinase_inhibitor" .
<Icotinib> <Is_a> "EGFR_inhibitor" .
<Icotinib> <Is_a> "CFDA_approved_drug" .
<Lepirudin> <Is_a> "Discontinued_drug" .
<Lepirudin> <Is_a> "Direct_thrombin_inhibitor" .
<Lepirudin> <Is_a> "Anticoagulant" .
<FOLFOX2> <Mapped_from> "FOLFOX2" .
<Luspatercept> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Lepirudin_monotherapy> <Has_supportive_med> "Lepirudin" .
<Tbo-filgrastim> <Has_brand_name> "Neutroval" .
<Tbo-filgrastim> <Has_brand_name> "Granix" .
<Cisplatin,_Interferon_alfa-2a,_Isotretinoin> <Mapped_from> "Cisplatin,_Interferon_alfa-2a,_Isotretinoin" .
<Hydroxyurea_monotherapy> <Has_context> "Non-curative_therapy" .
<Hydroxyurea_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Hydroxyurea_monotherapy> <Has_context> "All_lines_of_therapy" .
<mFOLFOX6_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Toposar> <Brand_name_of> "Etoposide" .
<Acyclovir> <Supportive_med_of> "Z-BEAM,_then_auto_HSCT" .
<Acyclovir> <Supportive_med_of> "Z-BEAM" .
<Acyclovir> <Supportive_med_of> "VTP" .
<Acyclovir> <Supportive_med_of> "VTD" .
<Acyclovir> <Supportive_med_of> "VT" .
<Acyclovir> <Supportive_med_of> "VR" .
<Acyclovir> <Supportive_med_of> "VP" .
<Acyclovir> <Supportive_med_of> "VMP" .
<Acyclovir> <Supportive_med_of> "VDC" .
<Acyclovir> <Supportive_med_of> "VD" .
<Acyclovir> <Supportive_med_of> "VAD" .
<Acyclovir> <Supportive_med_of> "V-HyperCAD" .
<Acyclovir> <Supportive_med_of> "Temozolomide_and_Bevacizumab" .
<Acyclovir> <Supportive_med_of> "TD" .
<Acyclovir> <Supportive_med_of> "Stanford_V" .
<Acyclovir> <Supportive_med_of> "RVDC" .
<Acyclovir> <Supportive_med_of> "RVD" .
<Acyclovir> <Supportive_med_of> "R-Hyper-CVAD/R-MA" .
<Acyclovir> <Supportive_med_of> "Pomalidomide_monotherapy" .
<Acyclovir> <Supportive_med_of> "PVD" .
<Acyclovir> <Supportive_med_of> "POMP" .
<Acyclovir> <Supportive_med_of> "PCR" .
<Acyclovir> <Supportive_med_of> "PAD_doxil" .
<Acyclovir> <Supportive_med_of> "PAD" .
<Acyclovir> <Supportive_med_of> "Hyper-CVAD/MA" .
<Acyclovir> <Supportive_med_of> "Hyper-CVAD_and_Ponatinib" .
<Acyclovir> <Supportive_med_of> "Hyper-CVAD_and_Imatinib" .
<Acyclovir> <Supportive_med_of> "Hyper-CVAD_and_Dasatinib" .
<Acyclovir> <Supportive_med_of> "HDMP-R" .
<Acyclovir> <Supportive_med_of> "Fludarabine_monotherapy" .
<Acyclovir> <Supportive_med_of> "FCR" .
<Acyclovir> <Supportive_med_of> "FCA" .
<Acyclovir> <Supportive_med_of> "FC" .
<Acyclovir> <Supportive_med_of> "Everolimus_monotherapy" .
<Acyclovir> <Supportive_med_of> "Eculizumab_monotherapy" .
<Acyclovir> <Supportive_med_of> "EAR_and_G-CSF" .
<Acyclovir> <Supportive_med_of> "Dexamethasone_monotherapy" .
<Acyclovir> <Supportive_med_of> "Clofarabine_and_Cytarabine" .
<Acyclovir> <Supportive_med_of> "Carfilzomib_monotherapy" .
<Acyclovir> <Supportive_med_of> "CaRD" .
<Acyclovir> <Supportive_med_of> "CYKLONE" .
<Acyclovir> <Supportive_med_of> "CBV,_then_auto_HSCT" .
<Acyclovir> <Supportive_med_of> "CBV" .
<Acyclovir> <Supportive_med_of> "Bortezomib_monotherapy" .
<Acyclovir> <Supportive_med_of> "Bendamustine_and_Ofatumumab" .
<Acyclovir> <Supportive_med_of> "BR" .
<Acyclovir> <Supportive_med_of> "BEAM,_then_auto_HSCT" .
<Acyclovir> <Supportive_med_of> "BEAM" .
<Acyclovir> <Supportive_med_of> "BDR" .
<Acyclovir> <Supportive_med_of> "BCHOP" .
<Acyclovir> <Supportive_med_of> "Alemtuzumab_monotherapy" .
<7_plus_3d_and_Glasdegib> <Is_current_in> "Acute_myeloid_leukemia" .
<Cytarabine_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Cytarabine_monotherapy> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Cytarabine_monotherapy> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Vorinostat_monotherapy> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Vorinostat_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<Vorinostat_monotherapy> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Vorinostat_monotherapy> <Has_accepted_use> "Acute_myeloid_leukemia" .
<BID> <Has_modality> "Chemotherapy" .
<Virox> <Brand_name_of> "Acyclovir" .
<Medroxyprogesterone> <May_have_route> "Subcutaneous" .
<Medroxyprogesterone> <May_have_route> "Oral" .
<Medroxyprogesterone> <May_have_route> "Intramuscular" .
<ProMACE-MOPP> <Has_context> "Non-curative_first-line_therapy" .
<ProMACE-MOPP> <Has_context> "Induction_therapy" .
<BeRT> <Has_context> "Non-curative_therapy" .
<Stanford_V> <Is_a> "Anthracycline-containing_regimen" .
<Vandetanib> <Is_a> "VEGFR_inhibitor" .
<Vandetanib> <Is_a> "TEK_inhibitor" .
<Vandetanib> <Is_a> "SRC_inhibitor" .
<Vandetanib> <Is_a> "RET_inhibitor" .
<Vandetanib> <Is_a> "REMS_program" .
<Vandetanib> <Is_a> "PMDA_approved_drug" .
<Vandetanib> <Is_a> "PDGFR_inhibitor" .
<Vandetanib> <Is_a> "Kinase_inhibitor" .
<Vandetanib> <Is_a> "EGFR_inhibitor" .
<Thalidomide_and_Rituximab> <Mapped_from> "Thalidomide_and_Rituximab" .
<HAA> <Has_antineoplastic> "Omacetaxine" .
<HAA> <Has_antineoplastic> "Cytarabine" .
<HAA> <Has_antineoplastic> "Aclarubicin" .
<FAC_and_BCG> <Has_antineoplastic> "Fluorouracil" .
<FAC_and_BCG> <Has_antineoplastic> "Doxorubicin" .
<FAC_and_BCG> <Has_antineoplastic> "Cyclophosphamide" .
<FAC_and_BCG> <Has_antineoplastic> "Bacillus_Calmette-Guerin" .
<HyperCHidam> <Has_antineoplastic> "Methotrexate" .
<HyperCHidam> <Has_antineoplastic> "Cytarabine" .
<HyperCHidam> <Has_antineoplastic> "Cyclophosphamide" .
<R-CHOP-14_(Rituximab_Hycela)> <Has_supportive_med> "Pegfilgrastim" .
<R-CHOP-14_(Rituximab_Hycela)> <Has_supportive_med> "Filgrastim" .
<Cisplatin,_Gemcitabine,_Bevacizumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Dabrafenib_monotherapy> <Has_context> "Non-curative_therapy" .
<Dabrafenib_monotherapy> <Has_context> "All_lines_of_therapy" .
<VR> <Is_a> "Rituximab-containing_regimen" .
<WHIM_syndrome> <Is_a> "Cytopenia" .
<Anti-diarrheal> <Subsumes> "Loperamide" .
<Vesanoid> <Brand_name_of> "All-trans_retinoic_acid" .
<BiRd> <Has_accepted_use> "Multiple_myeloma" .
<Goserelin> <Is_a> "GnRH_agonist" .
<R-FM> <Has_accepted_use> "Follicular_lymphoma" .
<Sirolimus,_Tacrolimus,_Prednisone> <Has_accepted_use> "Graft_versus_host_disease" .
<Cisplatin,_Vinorelbine,_RT> <Maps_to> "Cisplatin,_Vinorelbine,_RT" .
<R-FND> <Is_current_in> "Follicular_lymphoma" .
<R-VAD_plus_C> <Has_antineoplastic> "Vincristine" .
<R-VAD_plus_C> <Has_antineoplastic> "Rituximab" .
<R-VAD_plus_C> <Has_antineoplastic> "Doxorubicin" .
<R-VAD_plus_C> <Has_antineoplastic> "Dexamethasone" .
<R-VAD_plus_C> <Has_antineoplastic> "Chlorambucil" .
<CX> <Has_accepted_use> "Gastric_cancer" .
<CX> <Has_accepted_use> "Esophageal_cancer" .
<FCM> <Maps_to> "FCM" .
<Belinostat> <Has_FDA_indication> "Peripheral_T-cell_lymphoma" .
<Hyper-CVAD> <Is_current_in> "Multiple_myeloma" .
<ATRA_and_Idarubicin> <Mapped_from> "ATRA_and_Idarubicin" .
<Cyproterone_acetate_monotherapy> <Has_modality> "Hormonotherapy" .
<Nubeqa> <Brand_name_of> "Darolutamide" .
<Mesothelioma> <Current_treated_by> "Vinorelbine_monotherapy" .
<Mesothelioma> <Current_treated_by> "Placebo" .
<Mesothelioma> <Current_treated_by> "Pemetrexed_monotherapy" .
<Mesothelioma> <Current_treated_by> "Gemcitabine_monotherapy" .
<Mesothelioma> <Current_treated_by> "Gemcitabine_and_Vinorelbine" .
<Mesothelioma> <Current_treated_by> "Doxorubicin_monotherapy" .
<Mesothelioma> <Current_treated_by> "Cisplatin,_Pemetrexed,_TTFields" .
<Mesothelioma> <Current_treated_by> "Cisplatin,_Pemetrexed,_Bevacizumab" .
<Mesothelioma> <Current_treated_by> "Cisplatin_monotherapy" .
<Mesothelioma> <Current_treated_by> "Cisplatin_and_Raltitrexed" .
<Mesothelioma> <Current_treated_by> "Cisplatin_and_Pemetrexed" .
<Mesothelioma> <Current_treated_by> "Cisplatin_and_Gemcitabine" .
<Mesothelioma> <Current_treated_by> "Carboplatin_and_Pemetrexed" .
<Mesothelioma> <Current_treated_by> "Best_supportive_care" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone> <Has_local_therapy> "Methotrexate" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone> <Has_local_therapy> "Cytarabine" .
<Moxetumomab_pasudotox_monotherapy> <Has_accepted_use> "Hairy_cell_leukemia" .
<MA> <Has_supportive_med> "Folinic_acid" .
<Daunocin> <Brand_name_of> "Daunorubicin" .
<TC_and_Nintedanib> <Has_context> "Non-curative_first-line_therapy" .
<Aspirin_and_Hydroxyurea> <Has_modality> "Chemotherapy" .
<Gemtuzumab_ozogamicin> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Gemtuzumab_ozogamicin> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Methotrexate_and_Vincristine> <Is_current_in> "Osteosarcoma" .
<Methotrexate_and_Vincristine> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Asparlas> <Brand_name_of> "Calaspargase" .
<Panitumumab> <May_have_route> "Intravenous" .
<Vorinostat_and_Rituximab> <Mapped_from> "Vorinostat_and_Rituximab" .
<Sigaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<FCR_(Rituximab_Hycela)> <Has_antineoplastic> "Rituximab_and_hyaluronidase_human" .
<FCR_(Rituximab_Hycela)> <Has_antineoplastic> "Rituximab" .
<FCR_(Rituximab_Hycela)> <Has_antineoplastic> "Fludarabine" .
<FCR_(Rituximab_Hycela)> <Has_antineoplastic> "Cyclophosphamide" .
<Iron> <Is_a> "Classical_hematology_medication" .
<Voriconazole> <Supportive_med_of> "Clofarabine_and_Cytarabine" .
<Nordic_FLOX> <Has_modality> "Chemotherapy" .
<Chronic_lymphocytic_leukemia> <Historic_treated_by> "Uracil_mustard_monotherapy" .
<Chronic_lymphocytic_leukemia> <Historic_treated_by> "Tisagenlecleucel_monotherapy" .
<Chronic_lymphocytic_leukemia> <Historic_treated_by> "R-FCM" .
<Chronic_lymphocytic_leukemia> <Historic_treated_by> "Lenalidomide_monotherapy" .
<Chronic_lymphocytic_leukemia> <Historic_treated_by> "HDMP" .
<Chronic_lymphocytic_leukemia> <Historic_treated_by> "Fludarabine_monotherapy" .
<Chronic_lymphocytic_leukemia> <Historic_treated_by> "Fludarabine_and_Prednisone" .
<Chronic_lymphocytic_leukemia> <Historic_treated_by> "FR" .
<Chronic_lymphocytic_leukemia> <Historic_treated_by> "FC" .
<Chronic_lymphocytic_leukemia> <Historic_treated_by> "Chlorambucil_monotherapy" .
<Chronic_lymphocytic_leukemia> <Historic_treated_by> "Chlorambucil_and_Prednisone" .
<Chronic_lymphocytic_leukemia> <Historic_treated_by> "CVP" .
<Chronic_lymphocytic_leukemia> <Historic_treated_by> "CHOP" .
<Chronic_lymphocytic_leukemia> <Historic_treated_by> "CAP" .
<Linker_regimen_(consolidation)> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Beriplex> <Brand_name_of> "Prothrombin_Complex_Concentrate_human" .
<Cytarabine,_Idarubicin,_Sorafenib> <Mapped_from> "Cytarabine,_Idarubicin,_Sorafenib" .
<Tomtovok> <Brand_name_of> "Afatinib" .
<Solu_Moderin> <Brand_name_of> "Methylprednisolone" .
<Dinaciclib> <May_have_route> "Intravenous" .
<DEP> <Is_a> "Anthracycline-containing_regimen" .
<Hidrofosmin> <Brand_name_of> "Cyclophosphamide" .
<Fluorouracil/Fluorouracil_and_RT> <Has_accepted_use> "Rectal_cancer" .
<Fluorouracil/Fluorouracil_and_RT> <Has_accepted_use> "Pancreatic_cancer" .
<Aspecard> <Brand_name_of> "Aspirin" .
<Cyclophosphamide_and_Topotecan> <Is_current_in> "Osteosarcoma" .
<Cyclophosphamide_and_Topotecan> <Is_current_in> "Ewing_sarcoma" .
<Fosalen> <Brand_name_of> "Alendronate" .
<Carboplatin,_Paclitaxel,_Bevacizumab> <Maps_to> "Carboplatin,_Paclitaxel,_Bevacizumab" .
<Everolimus_and_Octreotide> <Has_antineoplastic> "Octreotide_LAR" .
<Everolimus_and_Octreotide> <Has_antineoplastic> "Everolimus" .
<R-GemOx> <Mapped_from> "R-GemOx" .
<Nilutamide> <Antineoplastic_of> "Nilutamide_and_Orchiectomy" .
<Local_therapy> <Mapped_from> "Local_therapy" .
<Fractionated_plasma_product> <Subsumes> "Prothrombin_Complex_Concentrate_human" .
<Fractionated_plasma_product> <Subsumes> "Factor_XIII_concentrate_human" .
<Fractionated_plasma_product> <Subsumes> "Factor_VIII_human" .
<Fractionated_plasma_product> <Subsumes> "Factor_IX_human" .
<Fractionated_plasma_product> <Subsumes> "Cytomegalovirus_Immune_Globulin" .
<Fractionated_plasma_product> <Subsumes> "Antithymocyte_globulin_rabbit_ATG" .
<Fractionated_plasma_product> <Subsumes> "Antithymocyte_globulin_horse_ATG" .
<Fractionated_plasma_product> <Subsumes> "Antithrombin_III" .
<Fractionated_plasma_product> <Subsumes> "Anti-inhibitor_coagulant_complex" .
<Gemtuzumab_ozogamicin> <Antineoplastic_of> "Gemtuzumab_ozogamicin_monotherapy" .
<Gemtuzumab_ozogamicin> <Antineoplastic_of> "DA_3_plus_10,_GO" .
<Gemtuzumab_ozogamicin> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin" .
<Gemtuzumab_ozogamicin> <Antineoplastic_of> "Azacitidine,_Vorinostat,_Gemtuzumab_ozogamicin" .
<Gemtuzumab_ozogamicin> <Antineoplastic_of> "Azacitidine_and_Gemtuzumab_ozogamicin" .
<Gemtuzumab_ozogamicin> <Antineoplastic_of> "Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin" .
<Gemtuzumab_ozogamicin> <Antineoplastic_of> "7_plus_3d_and_GO" .
<Lodronat> <Brand_name_of> "Clodronate" .
<Daunorubicin_monotherapy> <Has_antineoplastic> "Daunorubicin" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Prostate_cancer> <Historic_treated_by> "Vinblastine_monotherapy" .
<Prostate_cancer> <Historic_treated_by> "Radiation_therapy" .
<Prostate_cancer> <Historic_treated_by> "Placebo" .
<Prostate_cancer> <Historic_treated_by> "Doxorubicin_monotherapy" .
<Prostate_cancer> <Historic_treated_by> "Doxorubicin_and_Strontium-89" .
<Prostate_cancer> <Historic_treated_by> "DES_monotherapy" .
<Prostate_cancer> <Historic_treated_by> "Cyproterone_acetate_monotherapy" .
<Prostate_cancer> <Historic_treated_by> "Cyclophosphamide_monotherapy" .
<Prostate_cancer> <Historic_treated_by> "Cortisone_monotherapy" .
<Prostate_cancer> <Historic_treated_by> "Castration" .
<Prostate_cancer> <Historic_treated_by> "CMF" .
<Prostate_cancer> <Historic_treated_by> "Aspirin_and_Dexamethasone" .
<Alemtuzumab_monotherapy> <Has_context> "Non-curative_therapy" .
<Alemtuzumab_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Alemtuzumab_monotherapy> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Alemtuzumab_monotherapy> <Has_context> "Induction_therapy" .
<Alemtuzumab_monotherapy> <Has_context> "All_lines_of_therapy" .
<Non-curative_third-line_therapy> <Subsumes> "Non-curative_third-line_maintenance_therapy" .
<Non-curative_third-line_therapy> <Subsumes> "Non-curative_third-line_induction_therapy" .
<Non-curative_third-line_therapy> <Subsumes> "Non-curative_third-line_consolidation_therapy" .
<Epratuzumab> <May_have_route> "Intravenous" .
<EC> <Mapped_from> "EC" .
<Elvefocal> <Brand_name_of> "Folinic_acid" .
<Rectodelt> <Brand_name_of> "Prednisone" .
<Ribocarbo> <Brand_name_of> "Carboplatin" .
<CLAG-M> <Has_supportive_med> "Filgrastim" .
<Daunomicina> <Brand_name_of> "Daunorubicin" .
<Lomustine,_Methotrexate,_Procarbazine> <Has_supportive_med> "Folinic_acid" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine> <Has_antineoplastic> "Vincristine" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine> <Has_antineoplastic> "Pegaspargase" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine> <Has_antineoplastic> "Nelarabine" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine> <Has_antineoplastic> "Mercaptopurine" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine> <Has_antineoplastic> "Cytarabine" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine> <Has_antineoplastic> "Cyclophosphamide" .
<Entrectinib> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Letrozole_and_Ribociclib> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Letrozole_and_Ribociclib> <Has_accepted_use> "Breast_cancer" .
<Flurablastin> <Brand_name_of> "Fluorouracil" .
<Paraplatine> <Brand_name_of> "Carboplatin" .
<Carboplatin,_Paclitaxel,_RT> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Carboplatin,_Paclitaxel,_RT> <Has_accepted_use> "Head_and_neck_cancer" .
<Carboplatin,_Paclitaxel,_RT> <Has_accepted_use> "Esophageal_cancer" .
<131I-Metaiodobenzylguanidine_(131I-MIBG)> <Has_context> "All_lines_of_therapy" .
<HyperCHidam> <Mapped_from> "HyperCHidam" .
<Fludarabine,_Melphalan,_Alemtuzumab> <Has_modality> "Chemotherapy" .
<Dexamethasone_and_WBRT> <Has_supportive_med> "Dexamethasone" .
<VR-CHOP> <Is_current_in> "Mantle_cell_lymphoma" .
<VR-CHOP> <Is_current_in> "Follicular_lymphoma" .
<Abemaciclib_and_Fulvestrant> <Has_modality> "Hormonotherapy" .
<Abemaciclib_and_Fulvestrant> <Has_modality> "Chemotherapy" .
<Bioplatino> <Brand_name_of> "Cisplatin" .
<Lunapon> <Brand_name_of> "Fluorouracil" .
<Kalumid> <Brand_name_of> "Bicalutamide" .
<mDCF_and_Bevacizumab> <Maps_to> "mDCF_and_Bevacizumab" .
<Nimustine_and_RT> <Has_context> "Adjuvant_therapy" .
<Telotristat> <May_have_route> "Oral" .
<KRd> <Has_supportive_med> "Warfarin" .
<KRd> <Has_supportive_med> "Valacyclovir" .
<KRd> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<KRd> <Has_supportive_med> "Proton_pump_inhibitors" .
<KRd> <Has_supportive_med> "Low_molecular_weight_heparins" .
<KRd> <Has_supportive_med> "Lansoprazole" .
<KRd> <Has_supportive_med> "Clopidogrel" .
<KRd> <Has_supportive_med> "Ciprofloxacin" .
<KRd> <Has_supportive_med> "Bisphosphonates" .
<KRd> <Has_supportive_med> "Aspirin" .
<KRd> <Has_supportive_med> "Antivirals" .
<KRd> <Has_supportive_med> "Antiplatelet_agents" .
<KRd> <Has_supportive_med> "Anticoagulants" .
<KRd> <Has_supportive_med> "Amoxicillin" .
<Virin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<No_neoadjuvant_therapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<No_neoadjuvant_therapy> <Has_accepted_use> "Gastric_cancer" .
<No_neoadjuvant_therapy> <Has_accepted_use> "Esophageal_cancer" .
<No_neoadjuvant_therapy> <Has_accepted_use> "Cervical_cancer" .
<No_neoadjuvant_therapy> <Has_accepted_use> "Bladder_cancer" .
<Lipodox> <Brand_name_of> "Doxorubicin" .
<Growth_factor_inhibitor> <Subsumes> "VEGFR_inhibitor" .
<Growth_factor_inhibitor> <Subsumes> "PDGFR_inhibitor" .
<Growth_factor_inhibitor> <Subsumes> "KIT_inhibitor" .
<Growth_factor_inhibitor> <Subsumes> "IGFR_inhibitor" .
<Growth_factor_inhibitor> <Subsumes> "HGF_inhibitor" .
<Growth_factor_inhibitor> <Subsumes> "FGFR_inhibitor" .
<Growth_factor_inhibitor> <Subsumes> "EGFR_inhibitor" .
<Growth_factor_inhibitor> <Subsumes> "CSF1R_inhibitor" .
<DAT> <Is_a> "Anthracycline-containing_regimen" .
<Flu-Mel,_then_allo_HSCT> <Is_current_in> "Hodgkin_lymphoma" .
<Bosutinib> <Antineoplastic_of> "Bosutinib_monotherapy" .
<Dexacip> <Brand_name_of> "Dexamethasone" .
<Ruxience> <Brand_name_of> "Rituximab-pvvr" .
<Melphalan,_then_auto_HSCT,_then_Melphalan_and_TBI,_then_auto_HSCT> <Mapped_from> "Melphalan,_then_auto_HSCT,_then_Melphalan_and_TBI,_then_auto_HSCT" .
<Darbepoetin_alfa> <Has_brand_name> "Nespo" .
<Darbepoetin_alfa> <Has_brand_name> "Nesp" .
<Darbepoetin_alfa> <Has_brand_name> "Kabidarba" .
<Darbepoetin_alfa> <Has_brand_name> "Derise" .
<Darbepoetin_alfa> <Has_brand_name> "Darbex" .
<Darbepoetin_alfa> <Has_brand_name> "Darbetin" .
<Darbepoetin_alfa> <Has_brand_name> "Cresp" .
<Darbepoetin_alfa> <Has_brand_name> "Bionesp" .
<Darbepoetin_alfa> <Has_brand_name> "Aranestp" .
<Darbepoetin_alfa> <Has_brand_name> "Actorise" .
<Paclitaxel_and_Topotecan> <Has_accepted_use> "Cervical_cancer" .
<Dexacron> <Brand_name_of> "Dexamethasone" .
<Biosupressin> <Brand_name_of> "Hydroxyurea" .
<Cisplatin_and_RT> <Is_current_in> "Vulvar_cancer" .
<Cisplatin_and_RT> <Is_current_in> "Oropharyngeal_cancer" .
<Cisplatin_and_RT> <Is_current_in> "Non-small_cell_lung_cancer" .
<Cisplatin_and_RT> <Is_current_in> "Nasopharyngeal_carcinoma" .
<Cisplatin_and_RT> <Is_current_in> "Head_and_neck_cancer" .
<Cisplatin_and_RT> <Is_current_in> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Cisplatin_and_RT> <Is_current_in> "Endometrial_cancer" .
<Cisplatin_and_RT> <Is_current_in> "Cervical_cancer" .
<Cisplatin_and_RT> <Is_current_in> "Bladder_cancer" .
<Daunorubicin_liposomal> <May_have_route> "Intravenous" .
<BR> <Is_a> "Rituximab-containing_regimen" .
<Taxe-RTU> <Brand_name_of> "Docetaxel" .
<CX> <Is_a> "Platinum_doublet" .
<CX_and_Trastuzumab> <Maps_to> "CX_and_Trastuzumab" .
<Leucerom> <Brand_name_of> "Carmustine" .
<Clofarabine_and_Melphalan> <Is_current_in> "Allogeneic_HSCT" .
<Decitabine_and_Valproate> <Has_antineoplastic> "Valproate" .
<Decitabine_and_Valproate> <Has_antineoplastic> "Decitabine" .
<Wiltran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Trastuzumab_and_ET> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<Trastuzumab_and_ET> <Has_accepted_use> "Breast_cancer" .
<Caplacizumab> <Has_brand_name> "Cablivi" .
<Selumetinib> <Has_accepted_use> "Thyroid_cancer" .
<Selumetinib> <Has_accepted_use> "Ovarian_cancer" .
<Cyclophosphamide_and_Prednisolone> <Has_context> "All_lines_of_therapy" .
<Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Enxoaealth> <Brand_name_of> "Enoxaparin" .
<Non-curative_first-line_induction_therapy> <Context_of> "Temozolomide_monotherapy" .
<Non-curative_first-line_induction_therapy> <Context_of> "LoDAC_and_Venetoclax" .
<Non-curative_first-line_induction_therapy> <Context_of> "LoDAC" .
<Non-curative_first-line_induction_therapy> <Context_of> "Glasdegib_and_LoDAC" .
<Non-curative_first-line_induction_therapy> <Context_of> "Gemtuzumab_ozogamicin_monotherapy" .
<Non-curative_first-line_induction_therapy> <Context_of> "Decitabine_monotherapy" .
<Non-curative_first-line_induction_therapy> <Context_of> "Decitabine_and_Venetoclax" .
<Non-curative_first-line_induction_therapy> <Context_of> "Clofarabine_monotherapy" .
<Non-curative_first-line_induction_therapy> <Context_of> "Clofarabine_and_LoDAC" .
<Non-curative_first-line_induction_therapy> <Context_of> "CPX-351_monotherapy" .
<Non-curative_first-line_induction_therapy> <Context_of> "Best_supportive_care" .
<Non-curative_first-line_induction_therapy> <Context_of> "Azacitidine_monotherapy" .
<Non-curative_first-line_induction_therapy> <Context_of> "Azacitidine_and_Venetoclax" .
<Non-curative_first-line_induction_therapy> <Context_of> "Azacitidine_and_Gemtuzumab_ozogamicin" .
<Non-curative_first-line_induction_therapy> <Context_of> "7_plus_3d_and_Sorafenib" .
<SHAI> <Has_accepted_use> "Acute_myeloid_leukemia" .
<7_plus_3d_and_Glasdegib> <Is_a> "Anthracycline-containing_regimen" .
<Methotrexate_and_Pegaspargase> <Has_modality> "Chemotherapy" .
<Vorinostat> <Has_brand_name> "Zolinza" .
<M-TIP> <Mapped_from> "M-TIP" .
<Abemaciclib_and_Fulvestrant> <Maps_to> "Abemaciclib_and_Fulvestrant" .
<STAMP-I> <Has_modality> "Chemotherapy" .
<Melphalan_monotherapy> <Has_antineoplastic> "Melphalan" .
<Definitive_therapy> <Maps_to> "Definitive_therapy" .
<Carmustine_monotherapy> <Has_context> "Non-curative_therapy" .
<Carmustine_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Carmustine_monotherapy> <Has_context> "Adjuvant_therapy" .
<Helicobacter_pylori_eradication_therapy> <Is_current_in> "Marginal_zone_lymphoma" .
<Helicobacter_pylori_eradication_therapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<BRAF-mutated_malignancy> <FDA_indication_of> "Vemurafenib" .
<FEC_and_H> <Has_modality> "Chemotherapy" .
<Sylatron> <Brand_name_of> "Peginterferon_alfa-2b" .
<Carboplatin_and_Etoposide,_then_auto_HSCT> <Has_antineoplastic> "Etoposide" .
<Carboplatin_and_Etoposide,_then_auto_HSCT> <Has_antineoplastic> "Carboplatin" .
<Lytos> <Brand_name_of> "Clodronate" .
<Dactinomycin_monotherapy> <Mapped_from> "Dactinomycin_monotherapy" .
<VR-CHOP> <Has_modality> "Chemotherapy" .
<Luspatercept_monotherapy> <Has_modality> "Growth_factor_therapy" .
<ATG_(Horse),_Cyclosporine,_Sirolimus> <Is_current_in> "Aplastic_anemia" .
<Idarubicin> <Is_a> "Vesicant" .
<Idarubicin> <Is_a> "Topoisomerase_inhibitor" .
<Idarubicin> <Is_a> "Anthracycline" .
<Decitabine> <Antineoplastic_of> "Decitabine_monotherapy" .
<Decitabine> <Antineoplastic_of> "Decitabine_and_Venetoclax" .
<Decitabine> <Antineoplastic_of> "Decitabine_and_Valproate" .
<Decitabine> <Antineoplastic_of> "Clofarabine_and_LoDAC/Decitabine" .
<Methotrexate,_then_Cytarabine_and_Thiotepa> <Mapped_from> "Methotrexate,_then_Cytarabine_and_Thiotepa" .
<Reduction_of_immunosuppression> <Is_current_in> "Post-transplant_lymphoproliferative_disorder" .
<Enfortumab_vedotin_monotherapy> <Has_modality> "Chemotherapy" .
<Rastocin> <Brand_name_of> "Doxorubicin" .
<Mycophenolate_mofetil> <May_have_route> "Oral" .
<Mycophenolate_mofetil> <May_have_route> "Intravenous" .
<CHOP_Modified> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<MC> <Mapped_from> "MC" .
<C-BOP> <Has_context> "Upfront_therapy" .
<Floxuridine> <Has_brand_name> "FUDF" .
<Bosutinib_monotherapy> <Has_antineoplastic> "Bosutinib" .
<VTD> <Has_accepted_use> "Multiple_myeloma" .
<Recombinate> <Brand_name_of> "Factor_VIII_recombinant" .
<Quinton> <Brand_name_of> "Aspirin" .
<Chlorambucil_and_Rituximab> <Has_context> "Non-curative_first-line_therapy" .
<Chlorambucil_and_Rituximab> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Cytarabine,_Methotrexate,_Rituximab> <Mapped_from> "Cytarabine,_Methotrexate,_Rituximab" .
<Athrombin-K> <Brand_name_of> "Warfarin" .
<Epocin> <Brand_name_of> "Etoposide" .
<ABDIC> <Is_a> "Anthracycline-containing_regimen" .
<SHAI> <Maps_to> "SHAI" .
<BDR> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<BDR> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Afatinib_and_Paclitaxel> <Maps_to> "Afatinib_and_Paclitaxel" .
<Carboplatin,_Pemetrexed,_Bevacizumab> <Mapped_from> "Carboplatin,_Pemetrexed,_Bevacizumab" .
<Carboplatin_and_Teniposide> <Is_current_in> "Low-grade_glioma" .
<Hsp90_inhibitor> <Is_a> "Molecular_chaperone_inhibitor" .
<Sisplanil> <Brand_name_of> "Cisplatin" .
<Fludarabine_and_Alemtuzumab> <Has_context> "Non-curative_first-line_therapy" .
<FC,_then_allo_HSCT> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Lomustine_and_Bevacizumab> <Is_current_in> "Glioblastoma" .
<Prednisone_monotherapy> <Is_historical_in> "Multiple_myeloma" .
<Prednisone_monotherapy> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<CALGB_10-002_regimen> <Has_context> "Induction_therapy" .
<Alemtuzumab_and_Methylprednisolone> <Has_modality> "Chemotherapy" .
<mFOLFIRINOX,_Gemcitabine,_RT> <Has_context> "Induction_therapy" .
<Cladribine_monotherapy> <Has_context> "Non-curative_therapy" .
<Cladribine_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Cladribine_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Cladribine_monotherapy> <Has_context> "Induction_therapy" .
<Cladribine_monotherapy> <Has_context> "Consolidation_after_upfront_therapy" .
<Cladribine_monotherapy> <Has_context> "All_lines_of_therapy" .
<Doxorubicin_and_Gemcitabine> <Has_modality> "Chemotherapy" .
<R-DHAP/R-VIM> <Has_modality> "Chemotherapy" .
<MOPP-ABV> <Has_antineoplastic> "Vincristine" .
<MOPP-ABV> <Has_antineoplastic> "Vinblastine" .
<MOPP-ABV> <Has_antineoplastic> "Procarbazine" .
<MOPP-ABV> <Has_antineoplastic> "Prednisone" .
<MOPP-ABV> <Has_antineoplastic> "Mechlorethamine" .
<MOPP-ABV> <Has_antineoplastic> "Doxorubicin" .
<MOPP-ABV> <Has_antineoplastic> "Bleomycin" .
<GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab> <Has_antineoplastic> "Sargramostim" .
<GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab> <Has_antineoplastic> "Isotretinoin" .
<GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab> <Has_antineoplastic> "Dinutuximab" .
<GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab> <Has_antineoplastic> "Aldesleukin" .
<Carboplatin,_Paclitaxel,_RT> <Is_current_in> "Non-small_cell_lung_cancer" .
<Carboplatin,_Paclitaxel,_RT> <Is_current_in> "Head_and_neck_cancer" .
<Carboplatin,_Paclitaxel,_RT> <Is_current_in> "Esophageal_cancer" .
<Degarelix_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<FMP> <Is_a> "Anthracycline-containing_regimen" .
<Mogamulizumab_monotherapy> <Maps_to> "Mogamulizumab_monotherapy" .
<Fluorouracil,_Oxaliplatin,_RT> <Has_modality> "Radiotherapy" .
<Fluorouracil,_Oxaliplatin,_RT> <Has_modality> "Chemotherapy" .
<CHVmP> <Maps_to> "CHVmP" .
<GCD> <Has_modality> "Chemotherapy" .
<Fludara> <Brand_name_of> "Fludarabine" .
<Radioiodine_ablation> <Maps_to> "Radioiodine_ablation" .
<Xtane> <Brand_name_of> "Exemestane" .
<Irinotecan,_Vemurafenib,_Cetuximab> <Is_current_in> "Colon_cancer" .
<Methotrexate,_Vinblastine,_Prednisone> <Has_antineoplastic> "Vinblastine" .
<Methotrexate,_Vinblastine,_Prednisone> <Has_antineoplastic> "Prednisone" .
<Methotrexate,_Vinblastine,_Prednisone> <Has_antineoplastic> "Methotrexate" .
<ICE> <Maps_to> "ICE" .
<Nelarabine_monotherapy> <Mapped_from> "Nelarabine_monotherapy" .
<Methotrexate,_RT,_Cyclophosphamide> <Has_accepted_use> "Small_cell_lung_cancer" .
<Primaspan> <Brand_name_of> "Aspirin" .
<EPOCH,_dose-escalated> <Maps_to> "EPOCH,_dose-escalated" .
<FOLFOXIRI_and_Panitumumab> <Is_current_in> "Colon_cancer" .
<Antimetabolite> <Subsumes> "Trimethoprim-Sulfamethoxazole" .
<Antimetabolite> <Subsumes> "Thioguanine" .
<Antimetabolite> <Subsumes> "Raltitrexed" .
<Antimetabolite> <Subsumes> "Pyrimidine_analogue" .
<Antimetabolite> <Subsumes> "Purine_analogue" .
<Antimetabolite> <Subsumes> "Pralatrexate" .
<Antimetabolite> <Subsumes> "Pentostatin" .
<Antimetabolite> <Subsumes> "Pemetrexed" .
<Antimetabolite> <Subsumes> "Nolatrexed" .
<Antimetabolite> <Subsumes> "Nelarabine" .
<Antimetabolite> <Subsumes> "Methotrexate" .
<Antimetabolite> <Subsumes> "Mercaptopurine" .
<Antimetabolite> <Subsumes> "Gemcitabine" .
<Antimetabolite> <Subsumes> "Fludarabine" .
<Antimetabolite> <Subsumes> "Deoxycytidine_analogue" .
<Antimetabolite> <Subsumes> "Dacarbazine" .
<Antimetabolite> <Subsumes> "Cytarabine_liposomal" .
<Antimetabolite> <Subsumes> "Cytarabine_and_daunorubicin_liposomal" .
<Antimetabolite> <Subsumes> "Cytarabine" .
<Antimetabolite> <Subsumes> "Clofarabine" .
<Antimetabolite> <Subsumes> "Cladribine" .
<Antimetabolite> <Subsumes> "Antifolate" .
<Antimetabolite> <Subsumes> "Aminopterin" .
<Dobicin> <Brand_name_of> "Doxorubicin" .
<Meprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Vadastuximab_talirine> <Has_accepted_use> "Acute_myeloid_leukemia" .
<BBD> <Has_accepted_use> "Multiple_myeloma" .
<Triosules> <Brand_name_of> "Fluorouracil" .
<Lusutrombopag_monotherapy> <Has_supportive_med> "Lusutrombopag" .
<7_plus_3i_and_Vorinostat> <Has_context> "Induction_therapy" .
<Axitinib_monotherapy> <Mapped_from> "Axitinib_monotherapy" .
<Sulfatropim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Paronal> <Brand_name_of> "Asparaginase" .
<131I-Metaiodobenzylguanidine_(131I-MIBG)> <Is_current_in> "Pheochromocytoma" .
<DHAP> <Maps_to> "DHAP" .
<Interferon_alfa-2a_and_Interleukin-2> <Has_modality> "Immunotherapy" .
<MA-BCD> <Has_antineoplastic> "Methotrexate" .
<MA-BCD> <Has_antineoplastic> "Doxorubicin" .
<MA-BCD> <Has_antineoplastic> "Dactinomycin" .
<MA-BCD> <Has_antineoplastic> "Cyclophosphamide" .
<MA-BCD> <Has_antineoplastic> "Bleomycin" .
<VBMCP> <Mapped_from> "VBMCP" .
<Antifungal> <Subsumes> "Voriconazole" .
<Antifungal> <Subsumes> "Pentamidine" .
<Antifungal> <Subsumes> "Mycostatin" .
<Antifungal> <Subsumes> "Ketoconazole" .
<Antifungal> <Subsumes> "Itraconazole" .
<Antifungal> <Subsumes> "Fluconazole" .
<Antifungal> <Subsumes> "Caspofungin" .
<Interferon_Alfanative> <Brand_name_of> "Interferon_alfa-2b" .
<Venopirin> <Brand_name_of> "Aspirin" .
<VCAP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Teniposide> <Antineoplastic_of> "Teniposide_monotherapy" .
<Teniposide> <Antineoplastic_of> "Teniposide_and_WBRT" .
<Teniposide> <Antineoplastic_of> "MBVP" .
<Teniposide> <Antineoplastic_of> "Linker_regimen_(consolidation)" .
<Teniposide> <Antineoplastic_of> "GMALL-R" .
<Teniposide> <Antineoplastic_of> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone" .
<Teniposide> <Antineoplastic_of> "Carboplatin_and_Teniposide" .
<Teniposide> <Antineoplastic_of> "CHVmP-VB" .
<Teniposide> <Antineoplastic_of> "CHVmP" .
<Teniposide> <Antineoplastic_of> "CHVP-I" .
<Teniposide> <Antineoplastic_of> "CHVP" .
<TAD_(Tamoxifen)> <Has_accepted_use> "Breast_cancer" .
<Dacarbazine_and_Interferon_alfa-2a> <Has_antineoplastic> "Interferon_alfa-2a" .
<Dacarbazine_and_Interferon_alfa-2a> <Has_antineoplastic> "Dacarbazine" .
<Estradiol_monotherapy> <Has_modality> "Hormonotherapy" .
<Entrectinib> <Is_a> "TRK_inhibitor" .
<Entrectinib> <Is_a> "ROS1_inhibitor" .
<Entrectinib> <Is_a> "Mutation-specific_medication" .
<Entrectinib> <Is_a> "Kinase_inhibitor" .
<Entrectinib> <Is_a> "ALK_inhibitor" .
<Bicalutamide> <Has_accepted_use> "Prostate_cancer" .
<Cisplatin_and_Pemetrexed> <Has_antineoplastic> "Pemetrexed" .
<Cisplatin_and_Pemetrexed> <Has_antineoplastic> "Cisplatin" .
<Carboplatin_and_Docetaxel> <Has_context> "Non-curative_therapy" .
<Carboplatin_and_Docetaxel> <Has_context> "Non-curative_second-line_therapy" .
<Carboplatin_and_Docetaxel> <Has_context> "Non-curative_first-line_therapy" .
<Carboplatin_and_Docetaxel> <Has_context> "Neoadjuvant_therapy" .
<Carboplatin_and_Docetaxel> <Has_context> "All_lines_of_therapy" .
<Carboplatin_and_Docetaxel> <Has_context> "Adjuvant_therapy" .
<FLEP> <Maps_to> "FLEP" .
<Methotrexate,_then_Cytarabine> <Has_antineoplastic> "Methotrexate" .
<Methotrexate,_then_Cytarabine> <Has_antineoplastic> "Cytarabine" .
<Aclaplastin> <Brand_name_of> "Aclarubicin" .
<Bleomycin_and_Cisplatin> <Has_context> "Neoadjuvant_therapy" .
<EVI> <Is_historical_in> "Small_cell_lung_cancer" .
<EPOCH,_dose-escalated> <Mapped_from> "EPOCH,_dose-escalated" .
<R-M-CHOP> <Has_supportive_med> "Levofloxacin" .
<R-M-CHOP> <Has_supportive_med> "Folinic_acid" .
<R-M-CHOP> <Has_supportive_med> "Fluconazole" .
<R-M-CHOP> <Has_supportive_med> "Filgrastim" .
<Pd> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<Melphalan_and_TBI> <Has_antineoplastic> "Melphalan" .
<Melphalan_and_TBI> <Has_antineoplastic> "External_beam_radiotherapy" .
<ATG_(Rabbit)_and_Cyclosporine> <Has_accepted_use> "Aplastic_anemia" .
<Forteprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Dacarbazine_and_Tamoxifen> <Is_historical_in> "Melanoma" .
<Gastrointestinal_stromal_tumor> <FDA_indication_of> "Sunitinib" .
<Gastrointestinal_stromal_tumor> <FDA_indication_of> "Regorafenib" .
<Gastrointestinal_stromal_tumor> <FDA_indication_of> "Imatinib" .
<Gastrointestinal_stromal_tumor> <FDA_indication_of> "Avapritinib" .
<Capecitabine_and_Paclitaxel,_nanoparticle_albumin-bound> <Is_current_in> "Breast_cancer" .
<Fluorouracil,_Folinic_acid,_Levamisole> <Is_historical_in> "Colon_cancer" .
<Paclitaxel_and_Pazopanib> <Has_context> "Non-curative_therapy" .
<Abiraterone> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Abiraterone> <Is_a> "Steroid_synthesis_inhibitor" .
<Abiraterone> <Is_a> "Endocrine_therapeutic" .
<Abiraterone> <Is_a> "Antiandrogen" .
<POMP> <Has_supportive_med> "Valacyclovir" .
<POMP> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<POMP> <Has_supportive_med> "Acyclovir" .
<Neuroendocrine_tumor> <Is_a> "Endocrine_cancer" .
<Non-pegylated_liposomal_doxorubicin> <Antineoplastic_of> "MC" .
<Non-pegylated_liposomal_doxorubicin> <Antineoplastic_of> "Doxorubicin_non-pegylated_liposomal_monotherapy" .
<Non-pegylated_liposomal_doxorubicin> <Antineoplastic_of> "Doxorubicin_non-pegylated_liposomal_and_Bevacizumab" .
<Cixutumumab> <Has_accepted_use> "Thymoma" .
<Cixutumumab> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Cixutumumab> <Has_accepted_use> "Osteosarcoma" .
<Cixutumumab> <Has_accepted_use> "Adrenocortical_carcinoma" .
<Crizotinib> <May_have_route> "Oral" .
<Penicillin_V> <Supportive_med_of> "Eculizumab_monotherapy" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_modality> "Chemotherapy" .
<R-M-CHOP> <Has_antineoplastic> "Vincristine" .
<R-M-CHOP> <Has_antineoplastic> "Rituximab" .
<R-M-CHOP> <Has_antineoplastic> "Prednisone" .
<R-M-CHOP> <Has_antineoplastic> "Methotrexate" .
<R-M-CHOP> <Has_antineoplastic> "Doxorubicin" .
<R-M-CHOP> <Has_antineoplastic> "Cyclophosphamide" .
<Adlone> <Brand_name_of> "Methylprednisolone" .
<Anti-PD-L1_antibody> <Is_a> "Antibody_medication" .
<Copanlisib> <Antineoplastic_of> "Copanlisib_monotherapy" .
<Mini-BEAM> <Mapped_from> "Mini-BEAM" .
<Anti-VEGFR_antibody> <Subsumes> "Ramucirumab" .
<Anti-VEGFR_antibody> <Subsumes> "Bevacizumab-bvzr" .
<Anti-VEGFR_antibody> <Subsumes> "Bevacizumab-awwb" .
<Anti-VEGFR_antibody> <Subsumes> "Bevacizumab" .
<Bacteracin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cyclophosphamide_and_G-CSF> <Mapped_from> "Cyclophosphamide_and_G-CSF" .
<BuFlu,_then_allo_HSCT> <Has_context> "Consolidation_after_upfront_therapy" .
<BuFlu,_then_allo_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<Osfolate> <Brand_name_of> "Folinic_acid" .
<Denileukin_diftitox_monotherapy> <Has_context> "Non-curative_therapy" .
<Denileukin_diftitox_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Farmorubicina> <Brand_name_of> "Epirubicin" .
<ProMACE-MOPP> <Mapped_from> "ProMACE-MOPP" .
<Macromed> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<FOLFOX4_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<UFT_monotherapy> <Maps_to> "UFT_monotherapy" .
<CHOP-B> <Is_historical_in> "Follicular_lymphoma" .
<CHOP-B> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Cytarabine_and_Mitoxantrone> <Has_context> "Salvage_therapy" .
<Cytarabine_and_Mitoxantrone> <Has_context> "Non-curative_therapy" .
<R-CHMP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Antifungals> <Supportive_med_of> "HLH-94_regimen" .
<Antifungals> <Supportive_med_of> "HLH-2004_regimen" .
<Aspisol> <Brand_name_of> "Aspirin" .
<Cabozantinib_and_Erlotinib> <Has_antineoplastic> "Erlotinib" .
<Cabozantinib_and_Erlotinib> <Has_antineoplastic> "Cabozantinib" .
<Olaratumab> <Has_FDA_indication> "Soft_tissue_sarcoma" .
<FOLFOX4_and_Bevacizumab> <Maps_to> "FOLFOX4_and_Bevacizumab" .
<HDMP> <Maps_to> "HDMP" .
<Famciclovir> <Is_a> "Antiviral" .
<Nilium> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Decitabine_and_Valproate> <Has_context> "Induction_therapy" .
<Topotecan_monotherapy> <Mapped_from> "Topotecan_monotherapy" .
<Ofatumumab_monotherapy> <Has_modality> "Chemotherapy" .
<Capecitabine_and_Neratinib> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<Capecitabine_and_Neratinib> <Has_accepted_use> "Breast_cancer" .
<Adcetris> <Brand_name_of> "Brentuximab_vedotin" .
<High-dose_Interleukin-2> <Has_antineoplastic> "Aldesleukin" .
<Teysuno> <Brand_name_of> "Tegafur_gimeracil_oteracil" .
<Cobimetinib> <Has_brand_name> "Cotellic" .
<Rituximab_monotherapy> <Mapped_from> "Rituximab_monotherapy" .
<IRIS> <Is_a> "Irinotecan-containing_regimen" .
<Cisplatin_and_Cetuximab> <Mapped_from> "Cisplatin_and_Cetuximab" .
<CHOP,_then_131Iodine-Tositumomab> <Maps_to> "CHOP,_then_131Iodine-Tositumomab" .
<Copanlisib> <Has_brand_name> "Aliqopa" .
<COPADM> <Has_accepted_use> "Burkitt_lymphoma" .
<Antiandrogen_withdrawal> <Has_context> "Non-curative_second-line_therapy" .
<ReoPro> <Brand_name_of> "Abciximab" .
<Camptobell> <Brand_name_of> "Belotecan" .
<Fluorouracil_and_Folinic_acid> <Mapped_from> "Fluorouracil_and_Folinic_acid" .
<Cisplatin_and_Docetaxel> <Is_current_in> "Non-small_cell_lung_cancer" .
<Cisplatin_and_Docetaxel> <Is_current_in> "Head_and_neck_cancer" .
<Cisplatin_and_Docetaxel> <Is_current_in> "Gastric_cancer" .
<Cisplatin_and_Docetaxel> <Is_current_in> "Esophageal_cancer" .
<Cisplatin_and_Docetaxel> <Is_current_in> "Breast_cancer" .
<Cisplatin_and_Docetaxel> <Is_current_in> "Adenocarcinoma_of_unknown_primary" .
<Kombina> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Depo-Provera> <Brand_name_of> "Medroxyprogesterone" .
<Carboplatin> <Antineoplastic_of> "mLSG15" .
<Carboplatin> <Antineoplastic_of> "TPC" .
<Carboplatin> <Antineoplastic_of> "TCHP_(Taxotere)" .
<Carboplatin> <Antineoplastic_of> "TCHP_(Taxol)" .
<Carboplatin> <Antineoplastic_of> "TCH_(Taxotere,_Carboplatin)" .
<Carboplatin> <Antineoplastic_of> "TC_and_Nintedanib" .
<Carboplatin> <Antineoplastic_of> "TACE" .
<Carboplatin> <Antineoplastic_of> "RICER" .
<Carboplatin> <Antineoplastic_of> "R-ICE" .
<Carboplatin> <Antineoplastic_of> "R-DHAC" .
<Carboplatin> <Antineoplastic_of> "PCE" .
<Carboplatin> <Antineoplastic_of> "O-ICE" .
<Carboplatin> <Antineoplastic_of> "LSG15" .
<Carboplatin> <Antineoplastic_of> "ICE" .
<Carboplatin> <Antineoplastic_of> "GCP" .
<Carboplatin> <Antineoplastic_of> "GCD-R" .
<Carboplatin> <Antineoplastic_of> "GCD" .
<Carboplatin> <Antineoplastic_of> "FLEC" .
<Carboplatin> <Antineoplastic_of> "EPIC_regimen" .
<Carboplatin> <Antineoplastic_of> "DICE" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_nab-Paclitaxel,_Pembrolizumab" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_nab-Paclitaxel,_Atezolizumab" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_Vinorelbine,_RT" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_Pemetrexed,_Pembrolizumab" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_Pemetrexed,_Bevacizumab" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_Paclitaxel,_RT" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_Paclitaxel,_Pembrolizumab" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_Paclitaxel,_Ipilimumab" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_Paclitaxel,_Bevacizumab" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_Olaparib,_Paclitaxel" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_Gemcitabine,_Bevacizumab" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_Fluorouracil,_RT" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_Fluorouracil,_Cetuximab,_RT" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_Fluorouracil,_Cetuximab" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_Etoposide,_RT" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_Etoposide,_Durvalumab" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_Etoposide,_Bevacizumab" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_Etoposide,_Atezolizumab" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_Docetaxel,_Prednisone" .
<Carboplatin> <Antineoplastic_of> "Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_monotherapy" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_and_nab-Paclitaxel" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_and_Vinorelbine" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_and_Vincristine" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_and_Teniposide" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_and_RT" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_and_Pemetrexed" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_and_Paclitaxel" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_and_Irinotecan" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_and_Ifosfamide" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_and_Gemcitabine/Erlotinib" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_and_Gemcitabine" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_and_Fluorouracil" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_and_Etoposide,_then_auto_HSCT" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_and_Etoposide" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_and_Doxorubicin_liposomal" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_and_Docetaxel" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_and_Cyclophosphamide" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_and_Cisplatin" .
<Carboplatin> <Antineoplastic_of> "Carboplatin_and_Bevacizumab" .
<Carboplatin> <Antineoplastic_of> "Capecitabine,_Carboplatin,_Paclitaxel,_RT" .
<Carboplatin> <Antineoplastic_of> "CTCb,_then_auto_HSCT" .
<Carboplatin> <Antineoplastic_of> "CTCb" .
<Carboplatin> <Antineoplastic_of> "CEV_(Carboplatin/Etoposide)" .
<Carboplatin> <Antineoplastic_of> "CCI" .
<Carboplatin> <Antineoplastic_of> "C-BOP" .
<Carboplatin> <Antineoplastic_of> "ABCP" .
<Carboplatin> <Antineoplastic_of> "ABC" .
<Erlotinib_and_Ramucirumab> <Mapped_from> "Erlotinib_and_Ramucirumab" .
<CODOX-M/IVAC> <Maps_to> "CODOX-M/IVAC" .
<Low-dose_TBI,_then_allo_HSCT> <Maps_to> "Low-dose_TBI,_then_allo_HSCT" .
<Cyclophosphamide,_Lomustine,_Methotrexate> <Is_historical_in> "Small_cell_lung_cancer" .
<Carboplatin_and_Ifosfamide> <Has_antineoplastic> "Ifosfamide" .
<Carboplatin_and_Ifosfamide> <Has_antineoplastic> "Carboplatin" .
<Qiftrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<MINE> <Has_modality> "Chemotherapy" .
<Carloxan> <Brand_name_of> "Cyclophosphamide" .
<Anaplastic_glioma> <Accepted_use_of> "Vincristine" .
<Anaplastic_glioma> <Accepted_use_of> "Temozolomide,_then_Temozolomide_and_RT,_then_Temozolomide" .
<Anaplastic_glioma> <Accepted_use_of> "Temozolomide_monotherapy" .
<Anaplastic_glioma> <Accepted_use_of> "Temozolomide_and_RT,_then_Temozolomide" .
<Anaplastic_glioma> <Accepted_use_of> "Temozolomide_and_RT" .
<Anaplastic_glioma> <Accepted_use_of> "Temozolomide" .
<Anaplastic_glioma> <Accepted_use_of> "Radiation_therapy" .
<Anaplastic_glioma> <Accepted_use_of> "RT,_then_Temozolomide" .
<Anaplastic_glioma> <Accepted_use_of> "RT,_then_Carmustine" .
<Anaplastic_glioma> <Accepted_use_of> "Procarbazine" .
<Anaplastic_glioma> <Accepted_use_of> "PCV" .
<Anaplastic_glioma> <Accepted_use_of> "Observation" .
<Anaplastic_glioma> <Accepted_use_of> "Nimustine" .
<Anaplastic_glioma> <Accepted_use_of> "Lomustine,_Vincristine,_Prednisone" .
<Anaplastic_glioma> <Accepted_use_of> "Lomustine" .
<Anaplastic_glioma> <Accepted_use_of> "Irinotecan_monotherapy" .
<Anaplastic_glioma> <Accepted_use_of> "Irinotecan_and_Bevacizumab" .
<Anaplastic_glioma> <Accepted_use_of> "Irinotecan" .
<Anaplastic_glioma> <Accepted_use_of> "Etoposide_monotherapy" .
<Anaplastic_glioma> <Accepted_use_of> "Etoposide" .
<Anaplastic_glioma> <Accepted_use_of> "Cyclophosphamide_monotherapy" .
<Anaplastic_glioma> <Accepted_use_of> "Cyclophosphamide" .
<Anaplastic_glioma> <Accepted_use_of> "Carmustine_monotherapy" .
<Anaplastic_glioma> <Accepted_use_of> "Carmustine" .
<Anaplastic_glioma> <Accepted_use_of> "Carboplatin_and_Bevacizumab" .
<Anaplastic_glioma> <Accepted_use_of> "Carboplatin" .
<Anaplastic_glioma> <Accepted_use_of> "Bevacizumab-bvzr" .
<Anaplastic_glioma> <Accepted_use_of> "Bevacizumab-awwb" .
<Anaplastic_glioma> <Accepted_use_of> "Bevacizumab_monotherapy" .
<Anaplastic_glioma> <Accepted_use_of> "Bevacizumab" .
<Dacarbazine_monotherapy> <Is_current_in> "Uveal_melanoma" .
<Dacarbazine_monotherapy> <Is_current_in> "Soft_tissue_sarcoma" .
<Dacarbazine_monotherapy> <Is_current_in> "Melanoma" .
<Dacarbazine_monotherapy> <Is_current_in> "Liposarcoma" .
<Dacarbazine_monotherapy> <Is_current_in> "Leiomyosarcoma" .
<Thiotepa_monotherapy> <Has_modality> "Chemotherapy" .
<Revolade> <Brand_name_of> "Eltrombopag" .
<Methoxsalen> <Has_brand_name> "Xanthotoxin" .
<Methoxsalen> <Has_brand_name> "Uvadex" .
<Methoxsalen> <Has_brand_name> "Ultramop" .
<Methoxsalen> <Has_brand_name> "Puvasoralen" .
<Methoxsalen> <Has_brand_name> "Oxsoralen-Ultra" .
<Methoxsalen> <Has_brand_name> "Oxsoralen" .
<Methoxsalen> <Has_brand_name> "Mopsoralen" .
<Methoxsalen> <Has_brand_name> "Metoxaleno" .
<Methoxsalen> <Has_brand_name> "Meladinine" .
<Methoxsalen> <Has_brand_name> "Meladinina" .
<Methoxsalen> <Has_brand_name> "Geroxalen" .
<Methoxsalen> <Has_brand_name> "Geralen" .
<Methoxsalen> <Has_brand_name> "Dermox" .
<Methoxsalen> <Has_brand_name> "Deltasoralen" .
<Methoxsalen> <Has_brand_name> "Ammoidin" .
<MCP_(Prednisolone)> <Has_accepted_use> "Follicular_lymphoma" .
<Cytarabine,_Idarubicin,_Vorinostat> <Has_modality> "Chemotherapy" .
<FCR_(Rituximab_Hycela)> <Is_a> "Rituximab-containing_regimen" .
<CHOP_(Prednisolone)> <Is_a> "Anthracycline-containing_regimen" .
<Dexamethasone_and_Eltrombopag> <Has_immunosuppressor> "Dexamethasone" .
<Sumetrolim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Idelalisib_and_Rituximab> <Has_context> "Non-curative_therapy" .
<Idelalisib_and_Rituximab> <Has_context> "Non-curative_first-line_therapy" .
<ATRA,_Cytarabine,_Idarubicin> <Mapped_from> "ATRA,_Cytarabine,_Idarubicin" .
<Zodox> <Brand_name_of> "Doxorubicin" .
<Trametinib_monotherapy> <Mapped_from> "Trametinib_monotherapy" .
<Xtandi> <Brand_name_of> "Enzalutamide" .
<Docetaxel_and_Ramucirumab> <Maps_to> "Docetaxel_and_Ramucirumab" .
<Dexsol> <Brand_name_of> "Dexamethasone" .
<Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone> <Is_current_in> "T-cell_acute_lymphoblastic_leukemia" .
<Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<RCC> <Maps_to> "RCC" .
<Kunyrin> <Brand_name_of> "Folinic_acid" .
<Panitumumab_monotherapy> <Has_antineoplastic> "Panitumumab" .
<Marivarin> <Brand_name_of> "Warfarin" .
<Heparin_monotherapy> <Is_current_in> "Venous_thromboembolism" .
<CAPIRI> <Is_current_in> "Esophageal_cancer" .
<CAPIRI> <Is_current_in> "Colon_cancer" .
<Imatinib> <Antineoplastic_of> "Imatinib-based_consolidation" .
<Imatinib> <Antineoplastic_of> "Imatinib,_Vincristine,_Prednisone" .
<Imatinib> <Antineoplastic_of> "Imatinib,_Vincristine,_Dexamethasone" .
<Imatinib> <Antineoplastic_of> "Imatinib_monotherapy" .
<Imatinib> <Antineoplastic_of> "Imatinib_and_Prednisone" .
<Imatinib> <Antineoplastic_of> "Imatinib_and_LoDAC" .
<Imatinib> <Antineoplastic_of> "Imatinib_and_Interferon" .
<Imatinib> <Antineoplastic_of> "Hyper-CVAD_and_Imatinib" .
<Imatinib> <Antineoplastic_of> "Hydroxyurea_and_Imatinib" .
<Imatinib> <Antineoplastic_of> "HAM_and_Imatinib" .
<Imatinib> <Antineoplastic_of> "Etoposide,_Ifosfamide,_Imatinib" .
<Imatinib> <Antineoplastic_of> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib" .
<Imatinib> <Antineoplastic_of> "Cytarabine,_Idarubicin,_Imatinib" .
<Galeterone> <May_have_route> "Oral" .
<Capecitabine,_Pertuzumab,_Trastuzumab> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<Capecitabine,_Pertuzumab,_Trastuzumab> <Has_accepted_use> "Breast_cancer" .
<Otlertuzumab> <May_have_route> "Intravenous" .
<Denileukin_diftitox> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Denileukin_diftitox> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Letrozole_and_Palbociclib> <Is_current_in> "Breast_cancer" .
<Ketoconazole> <May_have_route> "Oral" .
<Azacitidine_and_Vorinostat> <Mapped_from> "Azacitidine_and_Vorinostat" .
<Trastuzumab-qyyp> <May_have_route> "Intravenous" .
<Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone> <Has_modality> "Chemotherapy" .
<Cladribine_and_Rituximab> <Has_modality> "Chemotherapy" .
<Doxorubicin_pegylated_liposomal_monotherapy> <Has_modality> "Chemotherapy" .
<Methotrexate_and_Rituximab> <Is_a> "Rituximab-containing_regimen" .
<MAP> <Has_antineoplastic> "Methotrexate" .
<MAP> <Has_antineoplastic> "Doxorubicin" .
<MAP> <Has_antineoplastic> "Cisplatin" .
<Capecitabine_and_Temozolomide> <Has_supportive_med> "Ondansetron" .
<ACE> <Is_historical_in> "Small_cell_lung_cancer" .
<ACE> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<BACO> <Has_accepted_use> "Small_cell_lung_cancer" .
<ADE_and_ATRA> <Is_current_in> "Acute_promyelocytic_leukemia" .
<Cisplatin,_Docetaxel,_RT> <Is_current_in> "Non-small_cell_lung_cancer" .
<Cisplatin,_Docetaxel,_RT> <Is_current_in> "Esophageal_cancer" .
<Eptifibatide> <Has_brand_name> "Integrilin" .
<Factor_Xa_inhibitor> <Is_a> "Anticoagulant" .
<LOPP> <Has_antineoplastic> "Vincristine" .
<LOPP> <Has_antineoplastic> "Procarbazine" .
<LOPP> <Has_antineoplastic> "Prednisone" .
<LOPP> <Has_antineoplastic> "Chlorambucil" .
<Doxorubicin_and_Vinblastine> <Is_historical_in> "Hodgkin_lymphoma" .
<Endocrine_ablation_surgery> <Antineoplastic_of> "Oophorectomy" .
<Endocrine_ablation_surgery> <Antineoplastic_of> "Nilutamide_and_Orchiectomy" .
<Endocrine_ablation_surgery> <Antineoplastic_of> "Castration" .
<Endocrine_ablation_surgery> <Antineoplastic_of> "CFP_and_Oophorectomy" .
<Endocrine_ablation_surgery> <Antineoplastic_of> "ADT,_Docetaxel,_Estramustine" .
<Endocrine_ablation_surgery> <Antineoplastic_of> "ADT_and_RT" .
<Endocrine_ablation_surgery> <Antineoplastic_of> "ADT_and_Enzalutamide" .
<Endocrine_ablation_surgery> <Antineoplastic_of> "ADT_and_Docetaxel" .
<Endocrine_ablation_surgery> <Antineoplastic_of> "ADT_and_Apalutamide" .
<Endocrine_ablation_surgery> <Antineoplastic_of> "ADT_and_Abiraterone" .
<Endocrine_ablation_surgery> <Antineoplastic_of> "ADT" .
<Dexan> <Brand_name_of> "Dexamethasone" .
<ACT> <Has_antineoplastic> "Tamoxifen" .
<ACT> <Has_antineoplastic> "Doxorubicin" .
<ACT> <Has_antineoplastic> "Cyclophosphamide" .
<Fauldmetro> <Brand_name_of> "Methotrexate" .
<IRIS> <Has_antineoplastic> "Tegafur_gimeracil_oteracil" .
<IRIS> <Has_antineoplastic> "Irinotecan" .
<CO-Tasian> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Fludarabine_and_Alemtuzumab> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<VcR-CVAD> <Is_current_in> "Mantle_cell_lymphoma" .
<Ifosfamide_and_Gemcitabine> <Has_context> "Non-curative_first-line_therapy" .
<SC-EPOCH-RR> <Is_a> "Rituximab-containing_regimen" .
<SC-EPOCH-RR> <Is_a> "Anthracycline-containing_regimen" .
<Keytruda> <Brand_name_of> "Pembrolizumab" .
<TD> <Has_modality> "Chemotherapy" .
<Enzalutamide_monotherapy> <Has_antineoplastic> "Enzalutamide" .
<Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone> <Maps_to> "Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone" .
<Bortezomib,_Dexamethasone,_Panobinostat> <Is_current_in> "Multiple_myeloma" .
<Imatinib-based_consolidation> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Imatinib-based_consolidation> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Gastrointestinal_stromal_tumor> <Current_treated_by> "Sunitinib_monotherapy" .
<Gastrointestinal_stromal_tumor> <Current_treated_by> "Sorafenib_monotherapy" .
<Gastrointestinal_stromal_tumor> <Current_treated_by> "Regorafenib_monotherapy" .
<Gastrointestinal_stromal_tumor> <Current_treated_by> "Placebo" .
<Gastrointestinal_stromal_tumor> <Current_treated_by> "Pazopanib_monotherapy" .
<Gastrointestinal_stromal_tumor> <Current_treated_by> "Imatinib_monotherapy" .
<Gastrointestinal_stromal_tumor> <Current_treated_by> "Best_supportive_care" .
<Gastrointestinal_stromal_tumor> <Current_treated_by> "Avapritinib_monotherapy" .
<ddT_(Taxotere)> <Has_accepted_use> "Breast_cancer" .
<Prednisolone_and_Rituximab> <Has_modality> "Immunosuppressive_therapy" .
<PMDA_approved_drug> <Subsumes> "Vandetanib" .
<PMDA_approved_drug> <Subsumes> "Tropisetron" .
<PMDA_approved_drug> <Subsumes> "Tegafur_gimeracil_oteracil" .
<PMDA_approved_drug> <Subsumes> "Tegafur_and_uracil" .
<PMDA_approved_drug> <Subsumes> "Tamibarotene" .
<PMDA_approved_drug> <Subsumes> "Ruxolitinib" .
<PMDA_approved_drug> <Subsumes> "Rituximab" .
<PMDA_approved_drug> <Subsumes> "Ranimustine" .
<PMDA_approved_drug> <Subsumes> "Ramucirumab" .
<PMDA_approved_drug> <Subsumes> "Ramosetron" .
<PMDA_approved_drug> <Subsumes> "Prednisolone" .
<PMDA_approved_drug> <Subsumes> "Ponatinib" .
<PMDA_approved_drug> <Subsumes> "Plerixafor" .
<PMDA_approved_drug> <Subsumes> "Pembrolizumab" .
<PMDA_approved_drug> <Subsumes> "Peginterferon_alfa-2b" .
<PMDA_approved_drug> <Subsumes> "Panobinostat" .
<PMDA_approved_drug> <Subsumes> "Paclitaxel" .
<PMDA_approved_drug> <Subsumes> "Nivolumab" .
<PMDA_approved_drug> <Subsumes> "Nedaplatin" .
<PMDA_approved_drug> <Subsumes> "Leuprolide" .
<PMDA_approved_drug> <Subsumes> "Lenograstim" .
<PMDA_approved_drug> <Subsumes> "Ipilimumab" .
<PMDA_approved_drug> <Subsumes> "Ibrutinib" .
<PMDA_approved_drug> <Subsumes> "Everolimus" .
<PMDA_approved_drug> <Subsumes> "Elotuzumab" .
<PMDA_approved_drug> <Subsumes> "Drugs_PMDA_approved_in_the_21st_century" .
<PMDA_approved_drug> <Subsumes> "Cyclophosphamide" .
<PMDA_approved_drug> <Subsumes> "Carfilzomib" .
<PMDA_approved_drug> <Subsumes> "Capecitabine" .
<PMDA_approved_drug> <Subsumes> "Bortezomib" .
<PMDA_approved_drug> <Subsumes> "Bevacizumab" .
<PMDA_approved_drug> <Subsumes> "Bendamustine" .
<PMDA_approved_drug> <Subsumes> "Asparaginase_Erwinia_chrysanthemi" .
<PMDA_approved_drug> <Subsumes> "Amrubicin" .
<PMDA_approved_drug> <Subsumes> "Aclarubicin" .
<IT_Methotrexate_and_Hydrocortisone> <Has_context> "Local_therapy" .
<Abiraterone> <Has_FDA_indication> "Prostate_cancer" .
<Rho(D)_immune_globulin> <Has_brand_name> "RhoGAM" .
<VAD_plus_C> <Has_accepted_use> "Mantle_cell_lymphoma" .
<ADE_(high-dose_Ara-C)> <Has_antineoplastic> "Etoposide" .
<ADE_(high-dose_Ara-C)> <Has_antineoplastic> "Daunorubicin" .
<ADE_(high-dose_Ara-C)> <Has_antineoplastic> "Cytarabine" .
<VT> <Has_supportive_med> "Low_molecular_weight_heparins" .
<VT> <Has_supportive_med> "Bisphosphonates" .
<VT> <Has_supportive_med> "Aspirin" .
<VT> <Has_supportive_med> "Acyclovir" .
<ICL> <Has_antineoplastic> "Lomustine" .
<ICL> <Has_antineoplastic> "Idarubicin" .
<ICL> <Has_antineoplastic> "Cytarabine" .
<Ibrutinib_and_Ofatumumab> <Has_antineoplastic> "Ofatumumab" .
<Ibrutinib_and_Ofatumumab> <Has_antineoplastic> "Ibrutinib" .
<Bacillus_Calmette-Guerin> <Is_a> "T-cell_activator" .
<Bacillus_Calmette-Guerin> <Is_a> "Immunotherapeutic" .
<Bacillus_Calmette-Guerin> <Is_a> "FDA_approved_drug" .
<Mini-BEAM> <Has_antineoplastic> "Melphalan" .
<Mini-BEAM> <Has_antineoplastic> "Etoposide" .
<Mini-BEAM> <Has_antineoplastic> "Cytarabine" .
<Mini-BEAM> <Has_antineoplastic> "Carmustine" .
<CHUT> <Has_antineoplastic> "Thiotepa" .
<CHUT> <Has_antineoplastic> "Cyclophosphamide" .
<Aspenter> <Brand_name_of> "Aspirin" .
<HOP> <Has_context> "Induction_therapy" .
<Inotuzumab_ozogamicin> <Antineoplastic_of> "R-INO" .
<Inotuzumab_ozogamicin> <Antineoplastic_of> "Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin" .
<Inotuzumab_ozogamicin> <Antineoplastic_of> "Inotuzumab_ozogamicin_monotherapy" .
<Strontium-89> <Is_a> "Radiotherapy_medication" .
<Blinatumomab_monotherapy> <Maps_to> "Blinatumomab_monotherapy" .
<Lisacort> <Brand_name_of> "Prednisone" .
<BVP> <Has_accepted_use> "Testicular_cancer" .
<VD> <Has_context> "Non-curative_therapy" .
<VD> <Has_context> "Non-curative_first-line_therapy" .
<VD> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<VD> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Megadex> <Brand_name_of> "Dexamethasone" .
<Cladon> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<nab-Paclitaxel_and_Atezolizumab> <Has_accepted_use> "triple_negative_Breast_cancer" .
<nab-Paclitaxel_and_Atezolizumab> <Has_accepted_use> "Breast_cancer" .
<Luspatercept_monotherapy> <Has_supportive_med> "Luspatercept" .
<BV-CHP> <Has_antineoplastic> "Prednisone" .
<BV-CHP> <Has_antineoplastic> "Doxorubicin" .
<BV-CHP> <Has_antineoplastic> "Cyclophosphamide" .
<BV-CHP> <Has_antineoplastic> "Brentuximab_vedotin" .
<Tamoxifen_and_Prednisolone> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Tamoxifen_and_Prednisolone> <Has_accepted_use> "Breast_cancer" .
<Vemurafenib_monotherapy> <Maps_to> "Vemurafenib_monotherapy" .
<SCAB> <Maps_to> "SCAB" .
<Lenalidomide,_Dexamethasone,_Rituximab> <Is_current_in> "Follicular_lymphoma" .
<Acalabrutinib> <Is_a> "Kinase_inhibitor" .
<Acalabrutinib> <Is_a> "BTK_inhibitor" .
<CPR> <Maps_to> "CPR" .
<IT_Cytarabine_liposomal_monotherapy> <Has_accepted_use> "CNS_lymphoma" .
<CBV> <Mapped_from> "CBV" .
<Irinotecan,_Vemurafenib,_Cetuximab> <Maps_to> "Irinotecan,_Vemurafenib,_Cetuximab" .
<Ribofolin> <Brand_name_of> "Folinic_acid" .
<ICL> <Mapped_from> "ICL" .
<VMP> <Is_current_in> "Multiple_myeloma" .
<Fondaparinux_monotherapy> <Mapped_from> "Fondaparinux_monotherapy" .
<DRC> <Maps_to> "DRC" .
<Succimed> <Brand_name_of> "Methylprednisolone" .
<Carboplatin_and_RT> <Maps_to> "Carboplatin_and_RT" .
<Etoposide_and_Mitoxantrone> <Maps_to> "Etoposide_and_Mitoxantrone" .
<Siklos> <Brand_name_of> "Hydroxyurea" .
<Carboplatin_and_Teniposide> <Has_supportive_med> "Steroids" .
<Carboplatin_and_Teniposide> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Neutrogin> <Brand_name_of> "Lenograstim" .
<DEX-IFN> <Has_accepted_use> "Multiple_myeloma" .
<Cytosar> <Brand_name_of> "Cytarabine" .
<VAD_and_Cyclosporine> <Is_historical_in> "Multiple_myeloma" .
<Bicalutamide> <May_have_route> "Oral" .
<Binimetinib_monotherapy> <Maps_to> "Binimetinib_monotherapy" .
<DHAP> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<DHAP> <Is_current_in> "Hodgkin_lymphoma" .
<DHAP> <Is_current_in> "Anaplastic_large_cell_lymphoma" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Decadronal> <Brand_name_of> "Dexamethasone" .
<Pipobroman_monotherapy> <Has_context> "Non-curative_therapy" .
<KRd> <Has_accepted_use> "Multiple_myeloma" .
<Larotrectinib> <Has_accepted_use> "NTRK-mutated_malignancy" .
<L-glutamine_monotherapy> <Is_current_in> "Sickle_cell_anemia" .
<Bactazol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<VAB-6> <Maps_to> "VAB-6" .
<Arsenic_trioxide,_ATRA,_Idarubicin> <Has_antineoplastic> "Idarubicin" .
<Arsenic_trioxide,_ATRA,_Idarubicin> <Has_antineoplastic> "Arsenic_trioxide" .
<Arsenic_trioxide,_ATRA,_Idarubicin> <Has_antineoplastic> "All-trans_retinoic_acid" .
<ChlVPP> <Has_context> "Induction_therapy" .
<Docetaxel_and_S-1> <Mapped_from> "Docetaxel_and_S-1" .
<Belinostat_monotherapy> <Maps_to> "Belinostat_monotherapy" .
<Maintenance_after_upfront_therapy> <Is_a> "Post-definitive_therapy" .
<D-ZAPO> <Mapped_from> "D-ZAPO" .
<Methaderm> <Brand_name_of> "Dexamethasone" .
<Pancreatic_NET> <Current_treated_by> "Temozolomide_monotherapy" .
<Pancreatic_NET> <Current_treated_by> "Temozolomide_and_Thalidomide" .
<Pancreatic_NET> <Current_treated_by> "Temozolomide_and_Bevacizumab" .
<Pancreatic_NET> <Current_treated_by> "Sunitinib_monotherapy" .
<Pancreatic_NET> <Current_treated_by> "Placebo" .
<Pancreatic_NET> <Current_treated_by> "Octreotide_monotherapy" .
<Pancreatic_NET> <Current_treated_by> "Octreotide_and_Interferon_alfa" .
<Pancreatic_NET> <Current_treated_by> "Octreotide_LAR_monotherapy" .
<Pancreatic_NET> <Current_treated_by> "Lutetium_Lu_177_dotatate_and_Octreotide_LAR" .
<Pancreatic_NET> <Current_treated_by> "Lanreotide_and_Interferon_alfa-2b" .
<Pancreatic_NET> <Current_treated_by> "Lanreotide_Depot/Autogel_monotherapy" .
<Pancreatic_NET> <Current_treated_by> "Fluorouracil_and_Streptozocin" .
<Pancreatic_NET> <Current_treated_by> "FAS" .
<Pancreatic_NET> <Current_treated_by> "Everolimus_monotherapy" .
<Pancreatic_NET> <Current_treated_by> "Everolimus_and_Octreotide" .
<Pancreatic_NET> <Current_treated_by> "Doxorubicin_and_Streptozocin" .
<Pancreatic_NET> <Current_treated_by> "Capecitabine_and_Temozolomide" .
<Tamibarotene> <Has_brand_name> "Amnolake" .
<Tamibarotene> <Has_brand_name> "Amnoid" .
<KCD> <Mapped_from> "KCD" .
<Larotrectinib_monotherapy> <Has_context> "All_lines_of_therapy" .
<Apalutamide_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Selinexor> <Has_FDA_indication> "Multiple_myeloma" .
<MCP_(Prednisolone)> <Has_context> "Non-curative_first-line_therapy" .
<Tocilizumab_monotherapy> <Has_modality> "Immunosuppressive_therapy" .
<MOPP-ABV> <Has_accepted_use> "Hodgkin_lymphoma" .
<Cyclophosphamide_and_Prednisolone> <Has_immunosuppressor> "Prednisolone" .
<Cyclophosphamide_and_Prednisolone> <Has_immunosuppressor> "Cyclophosphamide" .
<PCV> <Mapped_from> "PCV" .
<Temsirolimus_and_Rituximab> <Mapped_from> "Temsirolimus_and_Rituximab" .
<MOF> <Has_accepted_use> "Colon_cancer" .
<Fectrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<VBMC> <Is_historical_in> "Multiple_myeloma" .
<Busulfan> <Antineoplastic_of> "Melphalan,_then_auto_HSCT,_then_Melphalan_and_Busulfan,_then_auto_HSCT" .
<Busulfan> <Antineoplastic_of> "Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Busulfan> <Antineoplastic_of> "Fludarabine,_Busulfan,_Cyclophosphamide" .
<Busulfan> <Antineoplastic_of> "Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Busulfan> <Antineoplastic_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT" .
<Busulfan> <Antineoplastic_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan" .
<Busulfan> <Antineoplastic_of> "Fludarabine,_Busulfan,_ATG" .
<Busulfan> <Antineoplastic_of> "FluBuCy,_then_allo_HSCT" .
<Busulfan> <Antineoplastic_of> "Busulfan_monotherapy" .
<Busulfan> <Antineoplastic_of> "Busulfan_and_Melphalan,_then_auto_HSCT" .
<Busulfan> <Antineoplastic_of> "Busulfan_and_Melphalan" .
<Busulfan> <Antineoplastic_of> "Busulfan_and_Fludarabine" .
<Busulfan> <Antineoplastic_of> "Busulfan_and_Cyclophosphamide,_then_allo_HSCT" .
<Busulfan> <Antineoplastic_of> "Busulfan_and_Cyclophosphamide" .
<Busulfan> <Antineoplastic_of> "BuFlu,_then_allo_HSCT" .
<Busulfan> <Antineoplastic_of> "BuCyTBI,_then_allo_HSCT" .
<Busulfan> <Antineoplastic_of> "BuCyTBI" .
<Busulfan> <Antineoplastic_of> "BuCy,_then_auto_HSCT" .
<Busulfan> <Antineoplastic_of> "BuCy,_then_allo_HSCT" .
<Busulfan> <Antineoplastic_of> "Bu/TT/Cy,_then_auto_HSCT" .
<Busulfan> <Antineoplastic_of> "Bu/TT/Cy" .
<Busulfan> <Antineoplastic_of> "Bu/TT,_then_auto_HSCT" .
<Busulfan> <Antineoplastic_of> "Bu/TT" .
<Icotinib_monotherapy> <Maps_to> "Icotinib_monotherapy" .
<Neodex> <Brand_name_of> "Dexamethasone" .
<Clodronate> <Supportive_med_of> "Thalidomide_monotherapy" .
<Clodronate> <Supportive_med_of> "MPT" .
<Clodronate> <Supportive_med_of> "MP_(Prednisolone)" .
<Clodronate> <Supportive_med_of> "MP" .
<Clodronate> <Supportive_med_of> "CVAD" .
<Clodronate> <Supportive_med_of> "CTD" .
<Cisplatin,_Pemetrexed,_Pembrolizumab> <Has_context> "Non-curative_first-line_therapy" .
<R-DexaBEAM> <Mapped_from> "R-DexaBEAM" .
<Afatinib_and_Cetuximab> <Has_modality> "Chemotherapy" .
<PUVA> <Maps_to> "PUVA" .
<Mercaptopurine_and_WBRT> <Maps_to> "Mercaptopurine_and_WBRT" .
<Acivir> <Brand_name_of> "Acyclovir" .
<Valganciclovir> <Supportive_med_of> "CFAR" .
<Fresubaru> <Brand_name_of> "Dalteparin" .
<Onclast> <Brand_name_of> "Alendronate" .
<ATRA_and_Danazol> <Maps_to> "ATRA_and_Danazol" .
<Neratinib_monotherapy> <Mapped_from> "Neratinib_monotherapy" .
<ATG_(Horse)_and_Cyclosporine> <Has_supportive_med> "Valacyclovir" .
<ATG_(Horse)_and_Cyclosporine> <Has_supportive_med> "Prednisone" .
<ATG_(Horse)_and_Cyclosporine> <Has_supportive_med> "Prednisolone" .
<ATG_(Horse)_and_Cyclosporine> <Has_supportive_med> "Pentamidine" .
<FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation> <Has_accepted_use> "Pancreatic_cancer" .
<TLI_and_ATG> <Has_modality> "Radiotherapy" .
<TLI_and_ATG> <Has_modality> "Immunosuppressive_therapy" .
<MVPP> <Has_antineoplastic> "Vinblastine" .
<MVPP> <Has_antineoplastic> "Procarbazine" .
<MVPP> <Has_antineoplastic> "Prednisone" .
<MVPP> <Has_antineoplastic> "Mechlorethamine" .
<Cobavite> <Brand_name_of> "Cyanocobalamin" .
<Methotrexate_and_Thiotepa> <Has_antineoplastic> "Thiotepa" .
<Methotrexate_and_Thiotepa> <Has_antineoplastic> "Methotrexate" .
<Telomerase_inhibitor> <Is_a> "Enzyme_inhibitor" .
<Vectibix> <Brand_name_of> "Panitumumab" .
<TCH_(Taxotere,_Carboplatin)> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Cisplatin,_Gemcitabine,_nab-Paclitaxel> <Has_modality> "Chemotherapy" .
<TTR> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<MV> <Has_supportive_med> "Folinic_acid" .
<EP> <Has_accepted_use> "Breast_cancer" .
<Topotecan_monotherapy> <Has_antineoplastic> "Topotecan" .
<Profilnine> <Brand_name_of> "Prothrombin_Complex_Concentrate_human" .
<Fostamatinib_monotherapy> <Has_modality> "Chemotherapy" .
<IRIS> <Has_accepted_use> "Colon_cancer" .
<Doxorubicin_and_Lomustine> <Has_accepted_use> "Hodgkin_lymphoma" .
<AC> <Has_modality> "Chemotherapy" .
<BVDS> <Maps_to> "BVDS" .
<Hydrocortisone> <May_have_route> "Intravenous" .
<Hydrocortisone> <May_have_route> "Intrathecal" .
<Vepeside> <Brand_name_of> "Etoposide" .
<BFR> <Has_accepted_use> "Allogeneic_HSCT" .
<Medroxyprogesterone_monotherapy> <Has_accepted_use> "Renal_cell_carcinoma" .
<Medroxyprogesterone_monotherapy> <Has_accepted_use> "Endometrial_cancer" .
<Medroxyprogesterone_monotherapy> <Has_accepted_use> "Breast_cancer" .
<AC_and_Bevacizumab> <Has_antineoplastic> "Doxorubicin" .
<AC_and_Bevacizumab> <Has_antineoplastic> "Cyclophosphamide" .
<AC_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<GIP> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Decitabine> <Has_FDA_indication> "Myelodysplastic_syndrome" .
<Fildesin> <Brand_name_of> "Vindesine" .
<Methotrexate_and_Pegaspargase> <Maps_to> "Methotrexate_and_Pegaspargase" .
<HDMP-R> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<R-DHAP/R-VIM> <Mapped_from> "R-DHAP/R-VIM" .
<COPAD/CYVE> <Mapped_from> "COPAD/CYVE" .
<FAC_and_Bevacizumab> <Has_accepted_use> "Breast_cancer" .
<Carboplatin_and_Fluorouracil> <Has_antineoplastic> "Fluorouracil" .
<Carboplatin_and_Fluorouracil> <Has_antineoplastic> "Carboplatin" .
<Trifluridine_and_tipiracil_monotherapy> <Has_antineoplastic> "Trifluridine_and_tipiracil" .
<TAC_(Taxotere)> <Is_a> "Anthracycline-containing_regimen" .
<Interferon_alfa-2b_and_Zidovudine> <Is_current_in> "Adult_T-cell_leukemia-lymphoma" .
<Romidepsin_monotherapy> <Has_modality> "Chemotherapy" .
<Neophos> <Brand_name_of> "Cyclophosphamide" .
<Lenalidomide_and_Ofatumumab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<CNS_melanoma> <Current_treated_by> "Vemurafenib_monotherapy" .
<CNS_melanoma> <Current_treated_by> "Ipilimumab_and_Nivolumab" .
<CNS_melanoma> <Current_treated_by> "Fotemustine_monotherapy" .
<CNS_melanoma> <Current_treated_by> "Dabrafenib_monotherapy" .
<CNS_melanoma> <Current_treated_by> "Dabrafenib_and_Trametinib" .
<Dexaglos> <Brand_name_of> "Dexamethasone" .
<VTD> <Mapped_from> "VTD" .
<Osimertinib> <Is_a> "Mutation-specific_medication" .
<Osimertinib> <Is_a> "Kinase_inhibitor" .
<Osimertinib> <Is_a> "EGFR_inhibitor" .
<Depo_Moderin> <Brand_name_of> "Methylprednisolone" .
<Pyradexon> <Brand_name_of> "Dexamethasone" .
<Carboplatin_and_Docetaxel> <Has_accepted_use> "triple_negative_Breast_cancer" .
<Carboplatin_and_Docetaxel> <Has_accepted_use> "Prostate_cancer" .
<Carboplatin_and_Docetaxel> <Has_accepted_use> "Ovarian_cancer" .
<Carboplatin_and_Docetaxel> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Carboplatin_and_Docetaxel> <Has_accepted_use> "Head_and_neck_cancer" .
<Carboplatin_and_Docetaxel> <Has_accepted_use> "Gastric_cancer" .
<Carboplatin_and_Docetaxel> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<Carboplatin_and_Docetaxel> <Has_accepted_use> "Cervical_cancer" .
<Carboplatin_and_Docetaxel> <Has_accepted_use> "Breast_cancer" .
<Carboplatin_and_Docetaxel> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<TH_(Taxotere/SC)> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<TH_(Taxotere/SC)> <Has_accepted_use> "Breast_cancer" .
<Carboplatin,_Paclitaxel,_Pembrolizumab> <Has_modality> "Immunotherapy" .
<Carboplatin,_Paclitaxel,_Pembrolizumab> <Has_modality> "Chemotherapy" .
<Aldron> <Brand_name_of> "Dexamethasone" .
<ATG_(Horse)_and_Cyclosporine> <Has_immunosuppressor> "Cyclosporines" .
<ATG_(Horse)_and_Cyclosporine> <Has_immunosuppressor> "Antithymocyte_globulin_horse_ATG" .
<Binimetinib,_Encorafenib,_Cetuximab> <Has_modality> "Chemotherapy" .
<Imatinib_and_Prednisone> <Has_modality> "Chemotherapy" .
<ADT_and_Apalutamide> <Has_context> "Non-curative_therapy" .
<Belinostat_monotherapy> <Has_modality> "Chemotherapy" .
<Anastrozole_and_Ribociclib> <Has_antineoplastic> "Ribociclib" .
<Anastrozole_and_Ribociclib> <Has_antineoplastic> "Anastrozole" .
<Ticlopidine> <Is_a> "P2Y12_ADP_inhibitor" .
<BEACOPP> <Has_modality> "Chemotherapy" .
<Active_surveillance> <Is_current_in> "Prostate_cancer" .
<Adrecort> <Brand_name_of> "Dexamethasone" .
<Bendamustine_and_Obinutuzumab> <Has_supportive_med> "Steroids" .
<Bendamustine_and_Obinutuzumab> <Has_supportive_med> "Rasburicase" .
<Bendamustine_and_Obinutuzumab> <Has_supportive_med> "Prednisolone" .
<Bendamustine_and_Obinutuzumab> <Has_supportive_med> "PCP_prophylaxis" .
<Bendamustine_and_Obinutuzumab> <Has_supportive_med> "Diphenhydramine" .
<Bendamustine_and_Obinutuzumab> <Has_supportive_med> "Antivirals" .
<Bendamustine_and_Obinutuzumab> <Has_supportive_med> "Antihistamines" .
<Bendamustine_and_Obinutuzumab> <Has_supportive_med> "Allopurinol" .
<Bendamustine_and_Obinutuzumab> <Has_supportive_med> "Acetaminophen" .
<Anti-EpCAM_antibody> <Subsumes> "Edrecolomab" .
<Anti-EpCAM_antibody> <Subsumes> "Catumaxomab" .
<Autologous_HSCT> <Accepted_use_of> "Z-BEAM" .
<Autologous_HSCT> <Accepted_use_of> "TBI" .
<Autologous_HSCT> <Accepted_use_of> "TAM6" .
<Autologous_HSCT> <Accepted_use_of> "R-TBI/Cy" .
<Autologous_HSCT> <Accepted_use_of> "R-BEAM" .
<Autologous_HSCT> <Accepted_use_of> "Melphalan_monotherapy" .
<Autologous_HSCT> <Accepted_use_of> "Melphalan_and_TBI" .
<Autologous_HSCT> <Accepted_use_of> "LEED" .
<Autologous_HSCT> <Accepted_use_of> "FEAM" .
<Autologous_HSCT> <Accepted_use_of> "FC" .
<Autologous_HSCT> <Accepted_use_of> "Etoposide_and_TBI" .
<Autologous_HSCT> <Accepted_use_of> "Cyclophosphamide,_Etoposide,_TBI" .
<Autologous_HSCT> <Accepted_use_of> "Cyclophosphamide_and_TBI" .
<Autologous_HSCT> <Accepted_use_of> "CYVE" .
<Autologous_HSCT> <Accepted_use_of> "CTCb" .
<Autologous_HSCT> <Accepted_use_of> "CHUT" .
<Autologous_HSCT> <Accepted_use_of> "CBV-Mx" .
<Autologous_HSCT> <Accepted_use_of> "CBV" .
<Autologous_HSCT> <Accepted_use_of> "Busulfan_and_Melphalan" .
<Autologous_HSCT> <Accepted_use_of> "Busulfan_and_Cyclophosphamide" .
<Autologous_HSCT> <Accepted_use_of> "Bu/TT/Cy" .
<Autologous_HSCT> <Accepted_use_of> "Bu/TT" .
<Autologous_HSCT> <Accepted_use_of> "Bortezomib_and_Melphalan" .
<Autologous_HSCT> <Accepted_use_of> "Bendamustine_monotherapy" .
<Autologous_HSCT> <Accepted_use_of> "BeEAM" .
<Autologous_HSCT> <Accepted_use_of> "BEAM" .
<Autologous_HSCT> <Accepted_use_of> "BEAC" .
<Autologous_HSCT> <Accepted_use_of> "BCNU/TT" .
<Brulin> <Brand_name_of> "Dexamethasone" .
<CBV-Mx> <Has_antineoplastic> "Mitoxantrone" .
<CBV-Mx> <Has_antineoplastic> "Etoposide" .
<CBV-Mx> <Has_antineoplastic> "Cyclophosphamide" .
<CBV-Mx> <Has_antineoplastic> "Carmustine" .
<MCF> <Has_accepted_use> "Esophageal_cancer" .
<Dabrafenib> <Has_FDA_indication> "Thyroid_cancer" .
<Dabrafenib> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Dabrafenib> <Has_FDA_indication> "Melanoma" .
<Non-curative_second-line_therapy> <Is_a> "Non-curative_therapy" .
<Dronabinol> <Has_brand_name> "Marinol" .
<Edrecolomab_monotherapy> <Maps_to> "Edrecolomab_monotherapy" .
<Sipuleucel-T> <Supportive_med_of> "Samarium-153_monotherapy" .
<O-FC> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<CC/DE_and_RT> <Is_a> "Anthracycline-containing_regimen" .
<Sulfametoxazol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Vosaroxin> <May_have_route> "Intravenous" .
<DOLP> <Has_modality> "Chemotherapy" .
<Carboplatin,_nab-Paclitaxel,_Pembrolizumab> <Maps_to> "Carboplatin,_nab-Paclitaxel,_Pembrolizumab" .
<Paclitaxel_monotherapy> <Has_context> "Non-curative_therapy" .
<Paclitaxel_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Paclitaxel_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Paclitaxel_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Paclitaxel_monotherapy> <Has_context> "Neoadjuvant_therapy" .
<Paclitaxel_monotherapy> <Has_context> "All_lines_of_therapy" .
<Paclitaxel_monotherapy> <Has_context> "Adjuvant_therapy" .
<Lepirudin_monotherapy> <Mapped_from> "Lepirudin_monotherapy" .
<CABO> <Has_modality> "Chemotherapy" .
<OEPA> <Has_antineoplastic> "Vincristine" .
<OEPA> <Has_antineoplastic> "Prednisone" .
<OEPA> <Has_antineoplastic> "Etoposide" .
<OEPA> <Has_antineoplastic> "Doxorubicin" .
<Pirarubicin> <May_have_route> "Intravesical" .
<Pirarubicin> <May_have_route> "Intravenous" .
<Olaratumab> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Prednisone_monotherapy> <Has_local_therapy> "Methotrexate" .
<Cisplatin,_Fluorouracil,_Cetuximab> <Maps_to> "Cisplatin,_Fluorouracil,_Cetuximab" .
<Decaron> <Brand_name_of> "Dexamethasone" .
<Fotemustine_monotherapy> <Has_context> "Non-curative_therapy" .
<Fotemustine_monotherapy> <Has_context> "All_lines_of_therapy" .
<RVD> <Is_current_in> "Multiple_myeloma" .
<Prothrombin_Complex_Concentrate_human> <Is_a> "Hemostasis_medication" .
<Prothrombin_Complex_Concentrate_human> <Is_a> "Hematology_medication" .
<Prothrombin_Complex_Concentrate_human> <Is_a> "Fractionated_plasma_product" .
<Prothrombin_Complex_Concentrate_human> <Is_a> "Coagulation_factor" .
<Bortezomib> <May_have_route> "Subcutaneous" .
<Bortezomib> <May_have_route> "Intravenous" .
<Belagenpumatucel-L> <Has_brand_name> "Lucanix" .
<TCH_(Taxotere,_Carboplatin)> <Mapped_from> "TCH_(Taxotere,_Carboplatin)" .
<Aspirtab> <Brand_name_of> "Aspirin" .
<DOLP_(Prednisolone)> <Maps_to> "DOLP_(Prednisolone)" .
<BR_and_Idelalisib> <Has_context> "Non-curative_therapy" .
<Eposide> <Brand_name_of> "Etoposide" .
<Lepirudin_monotherapy> <Is_current_in> "Venous_thromboembolism" .
<Lepirudin_monotherapy> <Is_current_in> "Heparin-induced_thrombocytopenia" .
<Pazopanib> <May_have_route> "Oral" .
<Lenvatinib> <Has_brand_name> "Lenvima" .
<Cabazitaxel_and_Prednisone> <Has_supportive_med> "Steroids" .
<Cabazitaxel_and_Prednisone> <Has_supportive_med> "Dexamethasone" .
<Cabazitaxel_and_Prednisone> <Has_supportive_med> "Antihistamines" .
<MEC> <Is_a> "Anthracycline-containing_regimen" .
<Cytarabine,_Methotrexate,_Rituximab> <Has_modality> "Chemotherapy" .
<Adult_T-cell_leukemia-lymphoma> <Current_treated_by> "mLSG15" .
<Adult_T-cell_leukemia-lymphoma> <Current_treated_by> "Lenalidomide_monotherapy" .
<Adult_T-cell_leukemia-lymphoma> <Current_treated_by> "LSG15" .
<Adult_T-cell_leukemia-lymphoma> <Current_treated_by> "Interferon_alfa-2b_and_Zidovudine" .
<Adult_T-cell_leukemia-lymphoma> <Current_treated_by> "CHOP-14" .
<Adult_T-cell_leukemia-lymphoma> <Current_treated_by> "Alemtuzumab_monotherapy" .
<Asparaginase_Erwinia_chrysanthemi> <Is_a> "PMDA_approved_drug" .
<Asparaginase_Erwinia_chrysanthemi> <Is_a> "Enzyme" .
<CEV_(Cyclophosphamide/Epirubicin)> <Mapped_from> "CEV_(Cyclophosphamide/Epirubicin)" .
<Oxaliplatin_and_RT> <Maps_to> "Oxaliplatin_and_RT" .
<Epirubicin_monotherapy> <Has_context> "Non-curative_therapy" .
<Epirubicin_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Epirubicin_monotherapy> <Has_context> "Neoadjuvant_therapy" .
<Epirubicin_monotherapy> <Has_context> "Adjuvant_therapy" .
<Gemcitabine_and_Bevacizumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<Interferon_alfa_and_Dexamethasone> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Ticlid> <Brand_name_of> "Ticlopidine" .
<ABDIC> <Maps_to> "ABDIC" .
<Cyclophosphamide,_Fludarabine,_Thiotepa> <Maps_to> "Cyclophosphamide,_Fludarabine,_Thiotepa" .
<O-ESHAP> <Has_modality> "Chemotherapy" .
<Histrelin> <May_have_route> "Subcutaneous" .
<Decitabine_and_Venetoclax> <Is_current_in> "Acute_myeloid_leukemia" .
<Zildox> <Brand_name_of> "Oxaliplatin" .
<Degarelix> <May_have_route> "Subcutaneous" .
<Neratinib_monotherapy> <Has_antineoplastic> "Neratinib" .
<Axicabtagene_ciloleucel_monotherapy> <Has_accepted_use> "Transformed_lymphoma" .
<Axicabtagene_ciloleucel_monotherapy> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<Axicabtagene_ciloleucel_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Erythropoietin_monotherapy> <Has_accepted_use> "Myelodysplastic_syndrome" .
<SHAI> <Is_historical_in> "Acute_myeloid_leukemia" .
<Plerixafor_monotherapy> <Is_current_in> "WHIM_syndrome" .
<Dacarbazine_and_Ipilimumab> <Maps_to> "Dacarbazine_and_Ipilimumab" .
<R-FCM> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<R-FCM> <Has_supportive_med> "Pegfilgrastim" .
<R-FCM> <Has_supportive_med> "PCP_prophylaxis" .
<R-FCM> <Has_supportive_med> "Ondansetron" .
<R-FCM> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<R-FCM> <Has_supportive_med> "Diphenhydramine" .
<R-FCM> <Has_supportive_med> "Antivirals" .
<R-FCM> <Has_supportive_med> "Allopurinol" .
<R-FCM> <Has_supportive_med> "Acetaminophen" .
<Solocort-ACT> <Brand_name_of> "Methylprednisolone" .
<LSG15> <Is_a> "Anthracycline-containing_regimen" .
<PDGFR_inhibitor> <Is_a> "Kinase_inhibitor" .
<PDGFR_inhibitor> <Is_a> "Growth_factor_inhibitor" .
<Whole_abdominal_radiation_(WAI)> <Is_current_in> "Endometrial_cancer" .
<Doxorubicin_pegylated_liposomal_and_Trabectedin> <Has_modality> "Chemotherapy" .
<Azacitidine_and_Lenalidomide> <Has_antineoplastic> "Lenalidomide" .
<Azacitidine_and_Lenalidomide> <Has_antineoplastic> "Azacitidine" .
<Emend_for_Injection> <Brand_name_of> "Fosaprepitant" .
<Frone> <Brand_name_of> "Interferon_alfa-2b" .
<Bleomycin,_Methotrexate,_Vinblastine/RT> <Mapped_from> "Bleomycin,_Methotrexate,_Vinblastine/RT" .
<Docetaxel,_Cetuximab,_RT> <Has_modality> "Radiotherapy" .
<Docetaxel,_Cetuximab,_RT> <Has_modality> "Chemotherapy" .
<Bevacizumab_monotherapy> <Has_accepted_use> "Vascular_sarcoma" .
<Bevacizumab_monotherapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<Bevacizumab_monotherapy> <Has_accepted_use> "Renal_cell_carcinoma" .
<Bevacizumab_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Bevacizumab_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Bevacizumab_monotherapy> <Has_accepted_use> "Kaposi_sarcoma" .
<Bevacizumab_monotherapy> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Bevacizumab_monotherapy> <Has_accepted_use> "Glioblastoma" .
<Bevacizumab_monotherapy> <Has_accepted_use> "Endometrial_cancer" .
<Bevacizumab_monotherapy> <Has_accepted_use> "Colon_cancer" .
<Bevacizumab_monotherapy> <Has_accepted_use> "Cervical_cancer" .
<Bevacizumab_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Bevacizumab_monotherapy> <Has_accepted_use> "Anaplastic_glioma" .
<FLAG-Ida> <Maps_to> "FLAG-Ida" .
<Oncotaxel> <Brand_name_of> "Paclitaxel" .
<Anagrelide> <May_have_route> "Oral" .
<OLF> <Mapped_from> "OLF" .
<Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine> <Has_antineoplastic> "Interferon_alfa-2b" .
<Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine> <Has_antineoplastic> "Dacarbazine" .
<Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine> <Has_antineoplastic> "Cisplatin" .
<Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine> <Has_antineoplastic> "Carmustine" .
<Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine> <Has_antineoplastic> "Aldesleukin" .
<Apalutamide> <May_have_route> "Oral" .
<Rectal_cancer> <Current_treated_by> "mFOLFOX6_and_RT" .
<Rectal_cancer> <Current_treated_by> "UFT_monotherapy" .
<Rectal_cancer> <Current_treated_by> "S-1_monotherapy" .
<Rectal_cancer> <Current_treated_by> "Radiation_therapy" .
<Rectal_cancer> <Current_treated_by> "Observation" .
<Rectal_cancer> <Current_treated_by> "Fluorouracil/Fluorouracil_and_RT" .
<Rectal_cancer> <Current_treated_by> "Fluorouracil,_Oxaliplatin,_RT" .
<Rectal_cancer> <Current_treated_by> "Fluorouracil,_Folinic_acid,_RT" .
<Rectal_cancer> <Current_treated_by> "Fluorouracil_monotherapy" .
<Rectal_cancer> <Current_treated_by> "Fluorouracil_and_RT" .
<Rectal_cancer> <Current_treated_by> "Fluorouracil_and_Folinic_acid" .
<Rectal_cancer> <Current_treated_by> "FULV/FULV_and_RT" .
<Rectal_cancer> <Current_treated_by> "FOLFOX" .
<Rectal_cancer> <Current_treated_by> "Capecitabine/Capecitabine_and_RT" .
<Rectal_cancer> <Current_treated_by> "Capecitabine,_Sorafenib,_RT" .
<Rectal_cancer> <Current_treated_by> "Capecitabine_monotherapy" .
<Rectal_cancer> <Current_treated_by> "Capecitabine_and_RT" .
<Rectal_cancer> <Current_treated_by> "CapeOx,_Cetuximab,_RT" .
<Rectal_cancer> <Current_treated_by> "CapeOx" .
<Lasdol> <Brand_name_of> "Aspirin" .
<Fytop> <Brand_name_of> "Etoposide" .
<VBMCP/VBAD> <Has_accepted_use> "Multiple_myeloma" .
<Chlorambucil_and_Prednisolone> <Has_modality> "Hormonotherapy" .
<Chlorambucil_and_Prednisolone> <Has_modality> "Chemotherapy" .
<MACOP-B> <Has_antineoplastic> "Vincristine" .
<MACOP-B> <Has_antineoplastic> "Prednisone" .
<MACOP-B> <Has_antineoplastic> "Methotrexate" .
<MACOP-B> <Has_antineoplastic> "Doxorubicin" .
<MACOP-B> <Has_antineoplastic> "Cyclophosphamide" .
<MACOP-B> <Has_antineoplastic> "Bleomycin" .
<R-HiDAC> <Maps_to> "R-HiDAC" .
<Basatin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Doxorubicin_non-pegylated_liposomal_monotherapy> <Maps_to> "Doxorubicin_non-pegylated_liposomal_monotherapy" .
<Sulfort> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Metilbetasone> <Brand_name_of> "Methylprednisolone" .
<Antiandrogen> <Subsumes> "Triptorelin" .
<Antiandrogen> <Subsumes> "Orteronel" .
<Antiandrogen> <Subsumes> "Nonsteroidal_antiandrogen" .
<Antiandrogen> <Subsumes> "Leuprolide" .
<Antiandrogen> <Subsumes> "Ketoconazole" .
<Antiandrogen> <Subsumes> "Galeterone" .
<Antiandrogen> <Subsumes> "Finasteride" .
<Antiandrogen> <Subsumes> "Dutasteride" .
<Antiandrogen> <Subsumes> "Cyproterone_acetate" .
<Antiandrogen> <Subsumes> "Abiraterone" .
<Omacetaxine> <Has_brand_name> "Synribo" .
<Omacetaxine> <Has_brand_name> "Omapro" .
<Genitourinary_cancer> <Is_a> "Malignant_solid_neoplasm" .
<R-VAD_plus_C> <Mapped_from> "R-VAD_plus_C" .
<Alplax> <Brand_name_of> "Alprazolam" .
<Cutaneous_lymphoma> <Subsumes> "Cutaneous_T-cell_lymphoma" .
<FAC_and_BCG> <Is_a> "Anthracycline-containing_regimen" .
<Samarium-153> <Has_brand_name> "Quadramet" .
<Letrozole_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<Irnocam> <Brand_name_of> "Irinotecan" .
<VAD-P> <Is_current_in> "Multiple_myeloma" .
<CFAR> <Has_supportive_med> "Valganciclovir" .
<CFAR> <Has_supportive_med> "Valacyclovir" .
<CFAR> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<CFAR> <Has_supportive_med> "Pegfilgrastim" .
<CFAR> <Has_supportive_med> "Hydrocortisone" .
<CFAR> <Has_supportive_med> "Diphenhydramine" .
<CFAR> <Has_supportive_med> "Allopurinol" .
<CFAR> <Has_supportive_med> "Acetaminophen" .
<Transera-Kit> <Brand_name_of> "Rituximab" .
<DICEP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Trastuzumab-qyyp> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Trastuzumab-qyyp> <Is_a> "Protein_expression-specific_medication" .
<Trastuzumab-qyyp> <Is_a> "Neutral" .
<Trastuzumab-qyyp> <Is_a> "Biosimilar" .
<Trastuzumab-qyyp> <Is_a> "Antibody_medication" .
<Trastuzumab-qyyp> <Is_a> "Anti-HER2_antibody" .
<mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)> <Has_accepted_use> "KRAS_wild-type_Colon_cancer" .
<mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)> <Has_accepted_use> "Colon_cancer" .
<Capecitabine_and_Bevacizumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<Capecitabine_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<Capecitabine_and_Bevacizumab> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<DE> <Mapped_from> "DE" .
<Temozolomide_and_RT> <Has_modality> "Radiotherapy" .
<Temozolomide_and_RT> <Has_modality> "Chemotherapy" .
<Cebaspirine> <Brand_name_of> "Aspirin" .
<Vinracin> <Brand_name_of> "Vincristine" .
<Paclitaxel_and_Vinorelbine> <Maps_to> "Paclitaxel_and_Vinorelbine" .
<Lapatinib,_Letrozole,_Trastuzumab> <Is_current_in> "Breast_cancer" .
<Onkodox> <Brand_name_of> "Doxorubicin" .
<Ribociclib_and_Tamoxifen> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Ribociclib_and_Tamoxifen> <Has_accepted_use> "Breast_cancer" .
<FLEP> <Has_context> "Induction_therapy" .
<Melphalan,_then_auto_HSCT,_then_Melphalan_and_Busulfan,_then_auto_HSCT> <Is_historical_in> "Multiple_myeloma" .
<Cisplatin,_Paclitaxel,_RT> <Has_modality> "Radiotherapy" .
<Cisplatin,_Paclitaxel,_RT> <Has_modality> "Chemotherapy" .
<Anastrozole_monotherapy> <Has_antineoplastic> "Anastrozole" .
<FOLFOX2> <Has_context> "Non-curative_first-line_therapy" .
<AT_(Taxol)> <Maps_to> "AT_(Taxol)" .
<UFT_monotherapy> <Mapped_from> "UFT_monotherapy" .
<Enfortumab_vedotin> <Antineoplastic_of> "Enfortumab_vedotin_monotherapy" .
<Gemcitabine_and_RT> <Has_antineoplastic> "Gemcitabine" .
<Gemcitabine_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<7_plus_3d_and_Midostaurin> <Has_context> "Induction_therapy" .
<Farnesyltransferase_inhibitor> <Is_a> "Enzyme_inhibitor" .
<HER2-positive_Colon_cancer> <Accepted_use_of> "Pertuzumab_and_Trastuzumab" .
<HER2-positive_Colon_cancer> <Accepted_use_of> "Lapatinib_and_Trastuzumab" .
<Amrubicin_monotherapy> <Maps_to> "Amrubicin_monotherapy" .
<Head_and_neck_cancer> <FDA_indication_of> "Pembrolizumab" .
<Head_and_neck_cancer> <FDA_indication_of> "Nivolumab" .
<Head_and_neck_cancer> <FDA_indication_of> "Docetaxel" .
<Head_and_neck_cancer> <FDA_indication_of> "Cetuximab" .
<Mitotane_monotherapy> <Has_modality> "Chemotherapy" .
<Docetaxel> <May_have_route> "Intravenous" .
<CVP_(Prednisolone)> <Is_current_in> "Mantle_cell_lymphoma" .
<FEC_and_H> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<FEC_and_H> <Has_accepted_use> "Breast_cancer" .
<Vincristine_liposomal_monotherapy> <Has_context> "Non-curative_therapy" .
<MRD> <Has_supportive_med> "Proton_pump_inhibitors" .
<MRD> <Has_supportive_med> "Low_molecular_weight_heparins" .
<MRD> <Has_supportive_med> "Aspirin" .
<Mitotane> <Has_accepted_use> "Adrenocortical_carcinoma" .
<Cisplatin_and_Cyclophosphamide> <Has_accepted_use> "Ovarian_cancer" .
<Capecitabine,_Sorafenib,_RT> <Is_current_in> "Rectal_cancer" .
<Drugs_PMDA_approved_in_the_21st_century> <Is_a> "PMDA_approved_drug" .
<Anti-SLAMF7_antibody> <Is_a> "Antibody_medication" .
<Active_surveillance> <Maps_to> "Active_surveillance" .
<GVD> <Has_accepted_use> "Hodgkin_lymphoma" .
<GVD> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<B-CAVe> <Maps_to> "B-CAVe" .
<R-FCM> <Has_antineoplastic> "Rituximab" .
<R-FCM> <Has_antineoplastic> "Mitoxantrone" .
<R-FCM> <Has_antineoplastic> "Fludarabine" .
<R-FCM> <Has_antineoplastic> "Cyclophosphamide" .
<Etoposide> <May_have_route> "Oral" .
<Etoposide> <May_have_route> "Intravenous" .
<Vinblastine_monotherapy> <Mapped_from> "Vinblastine_monotherapy" .
<Babyprin> <Brand_name_of> "Aspirin" .
<Non-curative_subsequent-line_therapy> <Mapped_from> "Non-curative_subsequent-line_therapy" .
<Arsenic_trioxide_monotherapy> <Maps_to> "Arsenic_trioxide_monotherapy" .
<Azacitidine_and_Gemtuzumab_ozogamicin> <Has_modality> "Chemotherapy" .
<Methotrexate,_Vinblastine,_Prednisone> <Mapped_from> "Methotrexate,_Vinblastine,_Prednisone" .
<R-TBI/Cy,_then_auto_HSCT> <Has_modality> "Radiotherapy" .
<R-TBI/Cy,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Bendamustine> <May_have_route> "Intravenous" .
<PVAG> <Has_modality> "Chemotherapy" .
<Obinutuzumab_monotherapy> <Has_antineoplastic> "Obinutuzumab" .
<R-BAC> <Maps_to> "R-BAC" .
<Doxorubicin_pegylated_liposomal_and_Bevacizumab> <Maps_to> "Doxorubicin_pegylated_liposomal_and_Bevacizumab" .
<Duratrimet> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Ixazomib_monotherapy> <Has_context> "Non-curative_therapy" .
<Ixazomib_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<O-CHOP> <Has_context> "Non-curative_first-line_therapy" .
<Bendamustine_and_Ofatumumab> <Maps_to> "Bendamustine_and_Ofatumumab" .
<Cyclophosphamide,_Mycophenolate_mofetil,_Tacrolimus> <Maps_to> "Cyclophosphamide,_Mycophenolate_mofetil,_Tacrolimus" .
<TCP> <Mapped_from> "TCP" .
<Capecitabine,_Docetaxel,_Oxaliplatin,_RT> <Has_context> "Neoadjuvant_therapy" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab> <Has_modality> "Chemotherapy" .
<Granisetron> <Supportive_med_of> "Vinorelbine_monotherapy" .
<Granisetron> <Supportive_med_of> "Irinotecan_monotherapy" .
<Granisetron> <Supportive_med_of> "Irinotecan_and_Mitomycin" .
<Granisetron> <Supportive_med_of> "Irinotecan_and_Bevacizumab" .
<Granisetron> <Supportive_med_of> "IL-2_monotherapy" .
<Granisetron> <Supportive_med_of> "Cisplatin,_Etoposide,_RT" .
<Granisetron> <Supportive_med_of> "Cisplatin,_Docetaxel,_RT" .
<Granisetron> <Supportive_med_of> "Cisplatin_and_Paclitaxel" .
<Granisetron> <Supportive_med_of> "Cisplatin_and_Irinotecan" .
<Granisetron> <Supportive_med_of> "Cisplatin_and_Docetaxel" .
<Granisetron> <Supportive_med_of> "Carboplatin,_Paclitaxel,_RT" .
<Granisetron> <Supportive_med_of> "Carboplatin,_Etoposide,_RT" .
<Granisetron> <Supportive_med_of> "Carboplatin_and_Paclitaxel" .
<Granisetron> <Supportive_med_of> "Carboplatin_and_Etoposide" .
<Granisetron> <Supportive_med_of> "Carboplatin_and_Doxorubicin_liposomal" .
<Granisetron> <Supportive_med_of> "Carboplatin_and_Docetaxel" .
<Septocid_R_+> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<FR> <Is_a> "Rituximab-containing_regimen" .
<Selftison> <Brand_name_of> "Dexamethasone" .
<BEAM> <Has_antineoplastic> "Melphalan" .
<BEAM> <Has_antineoplastic> "Etoposide" .
<BEAM> <Has_antineoplastic> "Cytarabine" .
<BEAM> <Has_antineoplastic> "Carmustine" .
<FP/Capecitabine_and_RT> <Maps_to> "FP/Capecitabine_and_RT" .
<Ibritumomab_tiuxetan_monotherapy> <Has_context> "Non-curative_therapy" .
<Ibritumomab_tiuxetan_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Ibritumomab_tiuxetan_monotherapy> <Has_context> "Non-curative_subsequent-line_consolidation_therapy" .
<Ibritumomab_tiuxetan_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Ibritumomab_tiuxetan_monotherapy> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Ibritumomab_tiuxetan_monotherapy> <Has_context> "Definitive_therapy" .
<Ibritumomab_tiuxetan_monotherapy> <Has_context> "Consolidation_after_upfront_therapy" .
<Bortezomib_and_Melphalan,_then_auto_HSCT> <Maps_to> "Bortezomib_and_Melphalan,_then_auto_HSCT" .
<ABVE-PC> <Maps_to> "ABVE-PC" .
<Ferrous_sulfate> <Is_a> "Iron" .
<Ferrous_sulfate> <Is_a> "Hematology_medication" .
<ATRA_and_Danazol> <Has_modality> "Supportive_therapy" .
<Virless> <Brand_name_of> "Acyclovir" .
<Letrozole_monotherapy> <Mapped_from> "Letrozole_monotherapy" .
<Britaxol> <Brand_name_of> "Paclitaxel" .
<OFAR> <Has_modality> "Chemotherapy" .
<Aspirin_and_Anagrelide> <Has_modality> "Anticoagulation" .
<Trebananib> <Is_a> "Peptibody_medication" .
<Trebananib> <Is_a> "Investigational_drug" .
<Cephalexin> <Supportive_med_of> "Docetaxel_monotherapy" .
<Cephalexin> <Supportive_med_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Prochlorperazine> <May_have_route> "Rectal" .
<Prochlorperazine> <May_have_route> "Oral" .
<Prochlorperazine> <May_have_route> "Intravenous" .
<Bonmax> <Brand_name_of> "Alendronate" .
<Romiplostim> <Is_a> "Megakaryocyte_growth_factor" .
<Romiplostim> <Is_a> "Hematopoietic_growth_factor" .
<Romiplostim> <Is_a> "Hematology_medication" .
<Pixantrone> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Cabozantinib_monotherapy> <Has_modality> "Chemotherapy" .
<Cobimetinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Cobimetinib_monotherapy> <Has_context> "All_lines_of_therapy" .
<Enzyme_inhibitor> <Is_a> "Chemotherapeutic" .
<Calcifolin> <Brand_name_of> "Folinic_acid" .
<BEACOPP-14_(Prednisolone)> <Has_accepted_use> "Hodgkin_lymphoma" .
<Elo-VD> <Has_modality> "Chemotherapy" .
<Bevacizumab_monotherapy> <Is_a> "Bevacizumab-containing_regimen" .
<Rho(D)_immune_globulin> <Supportive_med_of> "RhIG_monotherapy" .
<mDCF_and_Bevacizumab> <Has_accepted_use> "Gastric_cancer" .
<No_neoadjuvant_therapy> <Has_context> "Neoadjuvant_therapy" .
<Netupitant_and_palonosetron> <Has_brand_name> "Akynzeo" .
<maxi-R-CHOP/R-HiDAC> <Is_a> "Rituximab-containing_regimen" .
<maxi-R-CHOP/R-HiDAC> <Is_a> "Anthracycline-containing_regimen" .
<MEC> <Has_accepted_use> "FLT3-positive_Acute_myeloid_leukemia" .
<MEC> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Aminopeptidase_inhibitor> <Is_a> "Enzyme_inhibitor" .
<HyperCHidam> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<Milurit> <Brand_name_of> "Allopurinol" .
<Prevacid> <Brand_name_of> "Lansoprazole" .
<Cisplatin,_Fluorouracil,_RT> <Maps_to> "Cisplatin,_Fluorouracil,_RT" .
<TC_(Taxotere)> <Maps_to> "TC_(Taxotere)" .
<Topecan> <Brand_name_of> "Topotecan" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "Radiation_therapy" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "Oxaliplatin_and_RT" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "Oxaliplatin" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "Observation" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "No_induction" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "Nedaplatin" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "Gemcitabine_monotherapy" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "Gemcitabine" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "Fluorouracil" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "Docetaxel" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "DCF" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "Cisplatin,_Fluorouracil,_RT" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "Cisplatin_and_RT" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "Cisplatin_and_Gemcitabine" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "Cisplatin_and_Fluorouracil" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "Cisplatin_and_Epirubicin" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "Cisplatin" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "Carboplatin_and_RT" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "Carboplatin_and_Fluorouracil" .
<Nasopharyngeal_carcinoma> <Accepted_use_of> "Carboplatin" .
<AT_(Taxotere)> <Has_modality> "Chemotherapy" .
<CHUT> <Is_current_in> "Autologous_HSCT" .
<FOLFOX_chronotherapy> <Mapped_from> "FOLFOX_chronotherapy" .
<FCR> <Has_supportive_med> "Valacyclovir" .
<FCR> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<FCR> <Has_supportive_med> "Pegfilgrastim" .
<FCR> <Has_supportive_med> "PCP_prophylaxis" .
<FCR> <Has_supportive_med> "Ondansetron" .
<FCR> <Has_supportive_med> "Hematopoietic_growth_factors" .
<FCR> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<FCR> <Has_supportive_med> "Filgrastim" .
<FCR> <Has_supportive_med> "Diphenhydramine" .
<FCR> <Has_supportive_med> "Dexamethasone" .
<FCR> <Has_supportive_med> "Antivirals" .
<FCR> <Has_supportive_med> "Allopurinol" .
<FCR> <Has_supportive_med> "Acyclovir" .
<FCR> <Has_supportive_med> "Acetaminophen" .
<Alpelisib_and_Fulvestrant> <Has_accepted_use> "PIK3CA-mutated_Breast_cancer" .
<Alpelisib_and_Fulvestrant> <Has_accepted_use> "Breast_cancer" .
<BTD> <Has_context> "Non-curative_therapy" .
<Myeloproliferative_neoplasm> <Subsumes> "Systemic_mastocytosis" .
<Myeloproliferative_neoplasm> <Subsumes> "Polycythemia_vera" .
<Myeloproliferative_neoplasm> <Subsumes> "Myelofibrosis" .
<Myeloproliferative_neoplasm> <Subsumes> "Hypereosinophilic_syndrome" .
<Myeloproliferative_neoplasm> <Subsumes> "Essential_thrombocythemia" .
<Myeloproliferative_neoplasm> <Subsumes> "Chronic_myelomonocytic_leukemia" .
<Myeloproliferative_neoplasm> <Subsumes> "Chronic_myelogenous_leukemia" .
<CYCLO-cell> <Brand_name_of> "Cyclophosphamide" .
<Dabigatran_monotherapy> <Has_modality> "Anticoagulation" .
<Hydrocortisone_monotherapy> <Has_antineoplastic> "Hydrocortisone" .
<R,_then_CHOP> <Has_accepted_use> "Post-transplant_lymphoproliferative_disorder" .
<IRIS_and_Bevacizumab> <Has_accepted_use> "Colon_cancer" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Is_current_in> "Burkitt_lymphoma" .
<DTPACE> <Has_context> "Non-curative_therapy" .
<Cladribine> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Cladribine> <Has_accepted_use> "Systemic_mastocytosis" .
<Cladribine> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Cladribine> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Cladribine> <Has_accepted_use> "Langerhans_cell_histiocytosis" .
<Cladribine> <Has_accepted_use> "Hypereosinophilic_syndrome" .
<Cladribine> <Has_accepted_use> "Hairy_cell_leukemia" .
<Cladribine> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Cladribine> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Gemcitabine_and_Mitomycin> <Has_context> "Non-curative_therapy" .
<Non-curative_third-line_therapy> <Is_a> "Non-curative_therapy" .
<Cetuximab> <May_have_route> "Intravenous" .
<R-CEOP90_(Epirubicin)> <Has_antineoplastic> "Vincristine" .
<R-CEOP90_(Epirubicin)> <Has_antineoplastic> "Rituximab" .
<R-CEOP90_(Epirubicin)> <Has_antineoplastic> "Prednisolone" .
<R-CEOP90_(Epirubicin)> <Has_antineoplastic> "Epirubicin" .
<R-CEOP90_(Epirubicin)> <Has_antineoplastic> "Cyclophosphamide" .
<ICL> <Has_modality> "Chemotherapy" .
<DEP_and_RT> <Mapped_from> "DEP_and_RT" .
<DOLP_(Prednisolone)> <Has_context> "Induction_therapy" .
<International_ALL_Trial> <Mapped_from> "International_ALL_Trial" .
<Lorlatinib_monotherapy> <Mapped_from> "Lorlatinib_monotherapy" .
<AV-CMF> <Has_antineoplastic> "Vinblastine" .
<AV-CMF> <Has_antineoplastic> "Methotrexate" .
<AV-CMF> <Has_antineoplastic> "Fluorouracil" .
<AV-CMF> <Has_antineoplastic> "Doxorubicin" .
<AV-CMF> <Has_antineoplastic> "Cyclophosphamide" .
<Edrecolomab> <Antineoplastic_of> "Edrecolomab_monotherapy" .
<Rituximab_and_hyaluronidase_human> <Antineoplastic_of> "Rituximab_and_hyaluronidase_monotherapy" .
<Rituximab_and_hyaluronidase_human> <Antineoplastic_of> "R-CHOP-14_(Rituximab_Hycela)" .
<Rituximab_and_hyaluronidase_human> <Antineoplastic_of> "R-CHOP_(Rituximab_Hycela)" .
<Rituximab_and_hyaluronidase_human> <Antineoplastic_of> "FCR_(Rituximab_Hycela)" .
<ABDIC> <Has_modality> "Chemotherapy" .
<Porfimer> <Has_brand_name> "Photofrin" .
<Asparaginase_Erwinia_chrysanthemi> <May_have_route> "Intramuscular" .
<Antibacterial> <Subsumes> "Trimethoprim-Sulfamethoxazole" .
<Antibacterial> <Subsumes> "Penicillin" .
<Antibacterial> <Subsumes> "Fluoroquinolone" .
<Antibacterial> <Subsumes> "Dapsone" .
<Antibacterial> <Subsumes> "Clarithromycin" .
<Antibacterial> <Subsumes> "Cephalosporin" .
<Tavesona> <Brand_name_of> "Dexamethasone" .
<Busulfan_and_Cyclophosphamide> <Has_modality> "Chemotherapy" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone> <Has_context> "Induction_therapy" .
<VMP/Rd> <Mapped_from> "VMP/Rd" .
<Biologic_product> <Is_a> "Intervention_index" .
<Ethitrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Promethazine> <Supportive_med_of> "Denileukin_diftitox_monotherapy" .
<7_plus_3d_and_Midostaurin> <Mapped_from> "7_plus_3d_and_Midostaurin" .
<Aprednislon> <Brand_name_of> "Prednisolone" .
<IFO_Cell> <Brand_name_of> "Ifosfamide" .
<Radiation_therapy> <Has_accepted_use> "Thymoma" .
<Radiation_therapy> <Has_accepted_use> "Testicular_cancer" .
<Radiation_therapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<Radiation_therapy> <Has_accepted_use> "Rectal_cancer" .
<Radiation_therapy> <Has_accepted_use> "Prostate_cancer" .
<Radiation_therapy> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<Radiation_therapy> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Radiation_therapy> <Has_accepted_use> "Pancreatic_cancer" .
<Radiation_therapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Radiation_therapy> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<Radiation_therapy> <Has_accepted_use> "Low-grade_glioma" .
<Radiation_therapy> <Has_accepted_use> "Hodgkin_lymphoma" .
<Radiation_therapy> <Has_accepted_use> "Head_and_neck_cancer" .
<Radiation_therapy> <Has_accepted_use> "HIV-associated_lymphoma" .
<Radiation_therapy> <Has_accepted_use> "Glioblastoma" .
<Radiation_therapy> <Has_accepted_use> "Follicular_lymphoma" .
<Radiation_therapy> <Has_accepted_use> "Esophageal_cancer" .
<Radiation_therapy> <Has_accepted_use> "Endometrial_cancer" .
<Radiation_therapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Radiation_therapy> <Has_accepted_use> "Cervical_cancer" .
<Radiation_therapy> <Has_accepted_use> "Bladder_cancer" .
<Radiation_therapy> <Has_accepted_use> "Anaplastic_glioma" .
<Radiation_therapy> <Has_accepted_use> "Anal_cancer" .
<PCO> <Maps_to> "PCO" .
<Sintopozid> <Brand_name_of> "Etoposide" .
<Paclitaxel_and_Pazopanib> <Has_modality> "Chemotherapy" .
<Junior_Asprin> <Brand_name_of> "Aspirin" .
<Vorzole> <Brand_name_of> "Voriconazole" .
<7_plus_3d_and_Glasdegib> <Has_accepted_use> "Acute_myeloid_leukemia" .
<ddTH_(Taxotere)> <Maps_to> "ddTH_(Taxotere)" .
<AspaMetDex_(Erwinaze)> <Is_current_in> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<IGEV> <Maps_to> "IGEV" .
<Etopophos> <Brand_name_of> "Etoposide" .
<Fedratinib_monotherapy> <Has_accepted_use> "Myelofibrosis" .
<Imatinib-based_consolidation> <Has_modality> "Chemotherapy" .
<Cisplatin,_Epirubicin,_Ifosfamide> <Has_antineoplastic> "Mesna" .
<Cisplatin,_Epirubicin,_Ifosfamide> <Has_antineoplastic> "Ifosfamide" .
<Cisplatin,_Epirubicin,_Ifosfamide> <Has_antineoplastic> "Epirubicin" .
<Cisplatin,_Epirubicin,_Ifosfamide> <Has_antineoplastic> "Cisplatin" .
<VAC> <Has_context> "All_lines_of_therapy" .
<TACE,_then_5-FU> <Has_antineoplastic> "TACE" .
<TACE,_then_5-FU> <Has_antineoplastic> "Fluorouracil" .
<TACE,_then_5-FU> <Has_antineoplastic> "Doxorubicin" .
<Everolimus_and_Exemestane> <Is_current_in> "Breast_cancer" .
<VAD> <Is_a> "Anthracycline-containing_regimen" .
<Unitrexate> <Brand_name_of> "Methotrexate" .
<Ox-P> <Has_modality> "Chemotherapy" .
<ABVE-PC> <Is_current_in> "Hodgkin_lymphoma" .
<Levamisole> <Has_brand_name> "Ergamisol" .
<Duvelisib_monotherapy> <Has_modality> "Chemotherapy" .
<ECF> <Mapped_from> "ECF" .
<Nilutamide_and_Orchiectomy> <Is_current_in> "Prostate_cancer" .
<Letrozole_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Letrozole_and_Bevacizumab> <Is_a> "Antiestrogen-containing_regimen" .
<Vinblastine_and_Prednisone> <Has_context> "Induction_therapy" .
<MOPP/ABVD> <Has_antineoplastic> "Vincristine" .
<MOPP/ABVD> <Has_antineoplastic> "Vinblastine" .
<MOPP/ABVD> <Has_antineoplastic> "Procarbazine" .
<MOPP/ABVD> <Has_antineoplastic> "Prednisone" .
<MOPP/ABVD> <Has_antineoplastic> "Mechlorethamine" .
<MOPP/ABVD> <Has_antineoplastic> "Doxorubicin" .
<MOPP/ABVD> <Has_antineoplastic> "Dacarbazine" .
<MOPP/ABVD> <Has_antineoplastic> "Bleomycin" .
<MVAC> <Has_supportive_med> "Filgrastim" .
<DEP_and_RT> <Has_context> "Induction_therapy" .
<Trametinib> <May_have_route> "Oral" .
<BFR,_then_allo_HSCT> <Has_accepted_use> "Transformed_lymphoma" .
<BFR,_then_allo_HSCT> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Amicar> <Brand_name_of> "Aminocaproic_acid" .
<Veltuzumab> <May_have_route> "Intravenous" .
<Cladribine_and_Cytarabine> <Mapped_from> "Cladribine_and_Cytarabine" .
<Eliquis> <Brand_name_of> "Apixaban" .
<No_induction> <Mapped_from> "No_induction" .
<Doxifluridine_and_Mitomycin> <Has_antineoplastic> "Mitomycin" .
<Doxifluridine_and_Mitomycin> <Has_antineoplastic> "Doxifluridine" .
<m-BNCOD> <Maps_to> "m-BNCOD" .
<Fludarabine_and_TBI,_then_allo_HSCT> <Has_context> "Non-curative_subsequent-line_consolidation_therapy" .
<Fludarabine_and_TBI,_then_allo_HSCT> <Has_context> "Consolidation_after_upfront_therapy" .
<Capecitabine,_Carboplatin,_Paclitaxel,_RT> <Has_context> "Neoadjuvant_therapy" .
<Azacitidine_monotherapy> <Is_current_in> "Myelodysplastic_syndrome" .
<Azacitidine_monotherapy> <Is_current_in> "Chronic_myelomonocytic_leukemia" .
<Azacitidine_monotherapy> <Is_current_in> "Acute_myeloid_leukemia" .
<Fluoxymesterone_monotherapy> <Has_modality> "Hormonotherapy" .
<Carboplatin,_Fluorouracil,_RT> <Is_current_in> "Head_and_neck_cancer" .
<Carboplatin,_Fluorouracil,_RT> <Is_current_in> "Esophageal_cancer" .
<Octreotide_and_Interferon_alfa> <Has_accepted_use> "Pancreatic_NET" .
<Octreotide_and_Interferon_alfa> <Has_accepted_use> "Neuroendocrine_tumor" .
<Melphalan,_then_auto_HSCT,_then_Melphalan_and_Busulfan,_then_auto_HSCT> <Has_accepted_use> "Multiple_myeloma" .
<Cisplatin,_Vinblastine,_RT> <Has_antineoplastic> "Vinblastine" .
<Cisplatin,_Vinblastine,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Cisplatin,_Vinblastine,_RT> <Has_antineoplastic> "Cisplatin" .
<Herzuma> <Brand_name_of> "Trastuzumab-pkrb" .
<EPOCH> <Is_current_in> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<VMCP/VCAP> <Mapped_from> "VMCP/VCAP" .
<Cyclophosphamide_and_Dexamethasone> <Has_antineoplastic> "Dexamethasone" .
<Cyclophosphamide_and_Dexamethasone> <Has_antineoplastic> "Cyclophosphamide" .
<Cytarabine_liposomal> <Is_a> "Liposomal_chemotherapy" .
<Cytarabine_liposomal> <Is_a> "Irritant" .
<Cytarabine_liposomal> <Is_a> "Deoxycytidine_analogue" .
<Cytarabine_liposomal> <Is_a> "Antimetabolite" .
<Trisolvat> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Raltitrexed> <Has_brand_name> "Tomudex" .
<VMD> <Has_context> "Non-curative_first-line_therapy" .
<Mocetinostat> <May_have_route> "Oral" .
<Lanreotide_Depot/Autogel_monotherapy> <Has_modality> "Hormonotherapy" .
<Serotonin_5-HT3_antagonist> <Is_a> "Emesis_prevention" .
<Nisona> <Brand_name_of> "Prednisone" .
<Aspirin_and_dipyridamole> <May_have_route> "Oral" .
<Bactricin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Topotecan> <Antineoplastic_of> "Topotecan_monotherapy" .
<Topotecan> <Antineoplastic_of> "Topotecan_and_Bevacizumab" .
<Topotecan> <Antineoplastic_of> "TTR" .
<Topotecan> <Antineoplastic_of> "TC,_then_IE,_VDoxoC,_VEC" .
<Topotecan> <Antineoplastic_of> "Paclitaxel,_Topotecan,_Bevacizumab" .
<Topotecan> <Antineoplastic_of> "Paclitaxel_and_Topotecan" .
<Topotecan> <Antineoplastic_of> "Cyclophosphamide_and_Topotecan" .
<Topotecan> <Antineoplastic_of> "Cisplatin_and_Topotecan" .
<Cyclosporine,_Methotrexate,_ATG> <Has_immunosuppressor> "Methotrexate" .
<Cyclosporine,_Methotrexate,_ATG> <Has_immunosuppressor> "Cyclosporines" .
<Cyclosporine,_Methotrexate,_ATG> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<Interferon_alfa_monotherapy> <Has_context> "Non-curative_therapy" .
<Interferon_alfa_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Interferon_alfa_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Granisol> <Brand_name_of> "Granisetron" .
<Rituximab-pvvr> <Has_brand_name> "Ruxience" .
<DE> <Has_antineoplastic> "Epirubicin" .
<DE> <Has_antineoplastic> "Docetaxel" .
<Buparlisib> <Is_a> "PI3K_inhibitor" .
<Buparlisib> <Is_a> "Kinase_inhibitor" .
<Buparlisib> <Is_a> "Investigational_drug" .
<MVP_(Vinblastine)> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<HAM> <Is_current_in> "Acute_myeloid_leukemia" .
<Ibrutinib_monotherapy> <Has_immunosuppressor> "Ibrutinib" .
<Mannitol> <Is_a> "Chemotherapy_protective_agent" .
<Edrecolomab> <May_have_route> "Intravenous" .
<Erdafitinib_monotherapy> <Has_modality> "Chemotherapy" .
<R-CODOX-M_(Doxil_substituted)> <Has_modality> "Chemotherapy" .
<Acetysal> <Brand_name_of> "Aspirin" .
<Zoltrijem> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<KO-Kure> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Vitamin_K_antagonist> <Subsumes> "Warfarin" .
<BEACOPP-14> <Has_supportive_med> "Filgrastim" .
<IDH2_inhibitor> <Is_a> "Enzyme_inhibitor" .
<Temonat> <Brand_name_of> "Temozolomide" .
<Lenalidomide> <Has_FDA_indication> "Myelodysplastic_syndrome" .
<Lenalidomide> <Has_FDA_indication> "Multiple_myeloma" .
<Lenalidomide> <Has_FDA_indication> "Marginal_zone_lymphoma" .
<Lenalidomide> <Has_FDA_indication> "Mantle_cell_lymphoma" .
<Lenalidomide> <Has_FDA_indication> "Follicular_lymphoma" .
<GTX> <Maps_to> "GTX" .
<Yatrox> <Brand_name_of> "Ondansetron" .
<OPPA> <Mapped_from> "OPPA" .
<R-miniCEOP> <Has_context> "Induction_therapy" .
<Capecitabine,_Oxaliplatin,_RT> <Has_modality> "Radiotherapy" .
<Capecitabine,_Oxaliplatin,_RT> <Has_modality> "Chemotherapy" .
<IRIS_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<Doxorubicin_and_Bevacizumab> <Has_antineoplastic> "Doxorubicin" .
<Doxorubicin_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Eldesine> <Brand_name_of> "Vindesine" .
<Capivasertib> <Is_a> "Kinase_inhibitor" .
<Capivasertib> <Is_a> "Investigational_drug" .
<Capivasertib> <Is_a> "AKT1_inhibitor" .
<Cytarabine> <Has_brand_name> "Udicil" .
<Cytarabine> <Has_brand_name> "Tabine" .
<Cytarabine> <Has_brand_name> "Tabin" .
<Cytarabine> <Has_brand_name> "Starasid" .
<Cytarabine> <Has_brand_name> "Remcyta" .
<Cytarabine> <Has_brand_name> "Novutrax" .
<Cytarabine> <Has_brand_name> "Medsara" .
<Cytarabine> <Has_brand_name> "Laracit" .
<Cytarabine> <Has_brand_name> "Iretin" .
<Cytarabine> <Has_brand_name> "Ifarab" .
<Cytarabine> <Has_brand_name> "Groven" .
<Cytarabine> <Has_brand_name> "Fauldcita" .
<Cytarabine> <Has_brand_name> "Erpalfa" .
<Cytarabine> <Has_brand_name> "Erbabin" .
<Cytarabine> <Has_brand_name> "Depocyte" .
<Cytarabine> <Has_brand_name> "Depocyt" .
<Cytarabine> <Has_brand_name> "Cytrosar" .
<Cytarabine> <Has_brand_name> "Cytosar-U" .
<Cytarabine> <Has_brand_name> "Cytosar" .
<Cytarabine> <Has_brand_name> "Cytarine" .
<Cytarabine> <Has_brand_name> "Cytarbel" .
<Cytarabine> <Has_brand_name> "Cytarabinum" .
<Cytarabine> <Has_brand_name> "Cytarabins" .
<Cytarabine> <Has_brand_name> "Cytarabin" .
<Cytarabine> <Has_brand_name> "Cylocide" .
<Cytarabine> <Has_brand_name> "Citarax" .
<Cytarabine> <Has_brand_name> "Citarabins" .
<Cytarabine> <Has_brand_name> "Citarabina" .
<Cytarabine> <Has_brand_name> "Citarabin" .
<Cytarabine> <Has_brand_name> "Citaloxan" .
<Cytarabine> <Has_brand_name> "Citagenin" .
<Cytarabine> <Has_brand_name> "Aracytine" .
<Cytarabine> <Has_brand_name> "Aracytin" .
<Cytarabine> <Has_brand_name> "Aracitin" .
<Cytarabine> <Has_brand_name> "Arabitin" .
<Cytarabine> <Has_brand_name> "Arabine" .
<Cytarabine> <Has_brand_name> "Alexan" .
<Cytarabine> <Has_brand_name> "Alcysten" .
<Cytarabine> <Has_brand_name> "ARA" .
<5_plus_2d> <Has_modality> "Chemotherapy" .
<Cellcristin> <Brand_name_of> "Vincristine" .
<Antithymocyte_globulin_rabbit_ATG> <Has_brand_name> "Thymoglobulin" .
<Antithymocyte_globulin_rabbit_ATG> <Has_brand_name> "Grafalon" .
<Antithymocyte_globulin_rabbit_ATG> <Has_brand_name> "ATG-Fresenius" .
<Edoxaban_monotherapy> <Has_context> "All_lines_of_therapy" .
<Erlotinib_monotherapy> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Tipifarnib> <Is_a> "Investigational_drug" .
<Tipifarnib> <Is_a> "Farnesyltransferase_inhibitor" .
<Aminoglutethimide_monotherapy> <Mapped_from> "Aminoglutethimide_monotherapy" .
<Enfortumab_vedotin_monotherapy> <Has_antineoplastic> "Enfortumab_vedotin" .
<Rhusal> <Brand_name_of> "Aspirin" .
<Nivolumab_monotherapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<Nivolumab_monotherapy> <Has_accepted_use> "Renal_cell_carcinoma" .
<Nivolumab_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Nivolumab_monotherapy> <Has_accepted_use> "Melanoma" .
<Nivolumab_monotherapy> <Has_accepted_use> "Hodgkin_lymphoma" .
<Nivolumab_monotherapy> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Nivolumab_monotherapy> <Has_accepted_use> "Head_and_neck_cancer" .
<Nivolumab_monotherapy> <Has_accepted_use> "Gastric_cancer" .
<Nivolumab_monotherapy> <Has_accepted_use> "Esophageal_cancer" .
<Nivolumab_monotherapy> <Has_accepted_use> "Colon_cancer" .
<Nivolumab_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<Nivolumab_monotherapy> <Has_accepted_use> "Anal_cancer" .
<Regorafenib> <Has_brand_name> "Stivarga" .
<Regorafenib> <Has_brand_name> "Resihance" .
<Regorafenib> <Has_brand_name> "Renib" .
<Regorafenib> <Has_brand_name> "Regonix" .
<Regorafenib> <Has_brand_name> "Nublexa" .
<Erdafitinib_monotherapy> <Mapped_from> "Erdafitinib_monotherapy" .
<LVP_.22Sandwich.22> <Mapped_from> "LVP_.22Sandwich.22" .
<DEX-IFN> <Is_historical_in> "Multiple_myeloma" .
<Fluorouracil_monotherapy> <Has_antineoplastic> "Fluorouracil" .
<TC_(Taxotere)> <Has_antineoplastic> "Docetaxel" .
<TC_(Taxotere)> <Has_antineoplastic> "Cyclophosphamide" .
<Venetoclax_and_Obinutuzumab> <Has_modality> "Chemotherapy" .
<Ondansetron> <Supportive_med_of> "Vinorelbine_monotherapy" .
<Ondansetron> <Supportive_med_of> "VR-CP" .
<Ondansetron> <Supportive_med_of> "Topotecan_monotherapy" .
<Ondansetron> <Supportive_med_of> "Temozolomide_monotherapy" .
<Ondansetron> <Supportive_med_of> "R-FCM" .
<Ondansetron> <Supportive_med_of> "PEP-C" .
<Ondansetron> <Supportive_med_of> "PCV" .
<Ondansetron> <Supportive_med_of> "PCR" .
<Ondansetron> <Supportive_med_of> "PCF" .
<Ondansetron> <Supportive_med_of> "MVAC,_dose-dense" .
<Ondansetron> <Supportive_med_of> "Lutetium_Lu_177_dotatate_and_Octreotide_LAR" .
<Ondansetron> <Supportive_med_of> "Lomustine_monotherapy" .
<Ondansetron> <Supportive_med_of> "Irinotecan_monotherapy" .
<Ondansetron> <Supportive_med_of> "Irinotecan_and_Mitomycin" .
<Ondansetron> <Supportive_med_of> "Irinotecan_and_Cetuximab" .
<Ondansetron> <Supportive_med_of> "Irinotecan_and_Bevacizumab" .
<Ondansetron> <Supportive_med_of> "IL-2_monotherapy" .
<Ondansetron> <Supportive_med_of> "FOLFIRI" .
<Ondansetron> <Supportive_med_of> "FCR" .
<Ondansetron> <Supportive_med_of> "Epirubicin_and_Ifosfamide" .
<Ondansetron> <Supportive_med_of> "Eculizumab_monotherapy" .
<Ondansetron> <Supportive_med_of> "Docetaxel_monotherapy" .
<Ondansetron> <Supportive_med_of> "Docetaxel_and_Gemcitabine" .
<Ondansetron> <Supportive_med_of> "DHAP_-_time_intensified" .
<Ondansetron> <Supportive_med_of> "DCF" .
<Ondansetron> <Supportive_med_of> "Cyclophosphamide_monotherapy" .
<Ondansetron> <Supportive_med_of> "Cladribine_and_Rituximab" .
<Ondansetron> <Supportive_med_of> "Cisplatin_and_RT" .
<Ondansetron> <Supportive_med_of> "Cisplatin_and_Paclitaxel" .
<Ondansetron> <Supportive_med_of> "Cisplatin_and_Irinotecan" .
<Ondansetron> <Supportive_med_of> "Cisplatin_and_Fluorouracil" .
<Ondansetron> <Supportive_med_of> "Cisplatin_and_Docetaxel" .
<Ondansetron> <Supportive_med_of> "Carmustine_monotherapy" .
<Ondansetron> <Supportive_med_of> "Carboplatin,_Paclitaxel,_RT" .
<Ondansetron> <Supportive_med_of> "Carboplatin_and_Paclitaxel" .
<Ondansetron> <Supportive_med_of> "Carboplatin_and_Doxorubicin_liposomal" .
<Ondansetron> <Supportive_med_of> "Carboplatin_and_Docetaxel" .
<Ondansetron> <Supportive_med_of> "Capecitabine_and_Temozolomide" .
<Ondansetron> <Supportive_med_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Ondansetron> <Supportive_med_of> "Bortezomib_monotherapy" .
<Migradexan> <Brand_name_of> "Dexamethasone" .
<R-CMD> <Mapped_from> "R-CMD" .
<Ewing_sarcoma> <Is_a> "Pediatric_cancer" .
<Ewing_sarcoma> <Is_a> "Bone_sarcoma" .
<DCEP> <Has_modality> "Chemotherapy" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone> <Has_antineoplastic> "Vincristine" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone> <Has_antineoplastic> "Prednisone" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone> <Has_antineoplastic> "Pegaspargase" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone> <Has_antineoplastic> "Daunorubicin" .
<MOPP/ABVD> <Is_a> "Anthracycline-containing_regimen" .
<HLH-94_regimen> <Has_accepted_use> "Hemophagocytic_lymphohistiocytosis" .
<Epoimmun> <Brand_name_of> "Epoetin_alfa" .
<Dara-VMP> <Maps_to> "Dara-VMP" .
<Ferriprox> <Brand_name_of> "Deferiprone" .
<ACVBP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Eurotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Elotuzumab> <Has_accepted_use> "Multiple_myeloma" .
<Resihance> <Brand_name_of> "Regorafenib" .
<Levius> <Brand_name_of> "Aspirin" .
<Antipsychotic> <Subsumes> "Olanzapine" .
<Antipsychotic> <Subsumes> "Haloperidol" .
<Lenvatinib_and_Pembrolizumab> <Has_antineoplastic> "Pembrolizumab" .
<Lenvatinib_and_Pembrolizumab> <Has_antineoplastic> "Lenvatinib" .
<ABVDm> <Mapped_from> "ABVDm" .
<CEV_(Cyclophosphamide/Epirubicin)> <Has_antineoplastic> "Vincristine" .
<CEV_(Cyclophosphamide/Epirubicin)> <Has_antineoplastic> "Epirubicin" .
<CEV_(Cyclophosphamide/Epirubicin)> <Has_antineoplastic> "Cyclophosphamide" .
<Loperamide> <Has_brand_name> "Imodium" .
<Folinfabra> <Brand_name_of> "Folinic_acid" .
<Ondansetron> <Is_a> "WHO_Essential_Pain_and_Palliative_Care_Medicine" .
<Ondansetron> <Is_a> "Serotonin_5-HT3_antagonist" .
<Ondansetron> <Is_a> "Emesis_prevention" .
<MACOP-B> <Has_context> "Induction_therapy" .
<R-VAD_plus_C> <Maps_to> "R-VAD_plus_C" .
<Direct_thrombin_inhibitor> <Is_a> "Anticoagulant" .
<Sonidegib> <Is_a> "SMO_inhibitor" .
<Sonidegib> <Is_a> "Hedgehog_pathway_inhibitor" .
<Capecitabine_and_Paclitaxel> <Maps_to> "Capecitabine_and_Paclitaxel" .
<Fulvestrant_and_Palbociclib> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Fulvestrant_and_Palbociclib> <Has_accepted_use> "Breast_cancer" .
<Fludarabine,_then_131Iodine-Tositumomab> <Maps_to> "Fludarabine,_then_131Iodine-Tositumomab" .
<Lomustine_monotherapy> <Has_modality> "Chemotherapy" .
<Icotinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Icotinib_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Icotinib_monotherapy> <Has_context> "All_lines_of_therapy" .
<Rituximab> <Has_brand_name> "Transera-Kit" .
<Rituximab> <Has_brand_name> "Rituxim" .
<Rituximab> <Has_brand_name> "Rituxan" .
<Rituximab> <Has_brand_name> "Ristova" .
<Rituximab> <Has_brand_name> "Reditux" .
<Rituximab> <Has_brand_name> "Mabtas" .
<Rituximab> <Has_brand_name> "MabThera" .
<Rituximab> <Has_brand_name> "Ikgdar" .
<S-1_monotherapy> <Is_current_in> "Rectal_cancer" .
<S-1_monotherapy> <Is_current_in> "Pancreatic_cancer" .
<S-1_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<S-1_monotherapy> <Is_current_in> "Gastric_cancer" .
<S-1_monotherapy> <Is_current_in> "Esophageal_cancer" .
<S-1_monotherapy> <Is_current_in> "Colon_cancer" .
<S-1_monotherapy> <Is_current_in> "Breast_cancer" .
<Rivaroxaban_monotherapy> <Is_current_in> "Venous_thromboembolism" .
<Rivaroxaban_monotherapy> <Is_current_in> "Heparin-induced_thrombocytopenia" .
<Rivaroxaban_monotherapy> <Is_current_in> "Antiphospholipid_antibody_syndrome" .
<Cisplatin,_Etoposide,_Irinotecan> <Has_modality> "Chemotherapy" .
<Fludarabine,_Busulfan,_ATG> <Has_context> "All_lines_of_therapy" .
<Carmustine_and_RT> <Has_modality> "Radiotherapy" .
<Carmustine_and_RT> <Has_modality> "Chemotherapy" .
<DCEP> <Has_context> "Non-curative_therapy" .
<DCEP> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Cyclosporine,_Corticosteroids,_Rituximab> <Maps_to> "Cyclosporine,_Corticosteroids,_Rituximab" .
<VAP> <Has_accepted_use> "Breast_cancer" .
<(90)YFC,_then_allo_HSCT> <Has_context> "Non-curative_subsequent-line_consolidation_therapy" .
<Cemiplimab> <Has_FDA_indication> "Cutaneous_squamous_cell_carcinoma" .
<SMILE> <Mapped_from> "SMILE" .
<Zaxol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Alenat> <Brand_name_of> "Alendronate" .
<Rupedex> <Brand_name_of> "Dexamethasone" .
<Clopidro> <Brand_name_of> "Clopidogrel" .
<PI3K_alpha_inhibitor> <Is_a> "PI3K_inhibitor" .
<Maintenance_after_salvage_therapy> <Maps_to> "Maintenance_after_salvage_therapy" .
<Anti-IL-6R_antibody> <Subsumes> "Tocilizumab" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<Sipuleucel-T_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<Fericard> <Brand_name_of> "Warfarin" .
<Lutetium_Lu_177_dotatate_and_Octreotide_LAR> <Is_current_in> "Pancreatic_NET" .
<Lutetium_Lu_177_dotatate_and_Octreotide_LAR> <Is_current_in> "Neuroendocrine_tumor" .
<Adrimedac> <Brand_name_of> "Doxorubicin" .
<Melphalan,_then_auto_HSCT> <Is_current_in> "Plasma_cell_leukemia" .
<Melphalan,_then_auto_HSCT> <Is_current_in> "Multiple_myeloma" .
<Melphalan,_then_auto_HSCT> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<Prednisone> <Has_brand_name> "Winpred" .
<Prednisone> <Has_brand_name> "Vitazon" .
<Prednisone> <Has_brand_name> "Ultracorten" .
<Prednisone> <Has_brand_name> "Trolic" .
<Prednisone> <Has_brand_name> "Sterapred" .
<Prednisone> <Has_brand_name> "Steerometz" .
<Prednisone> <Has_brand_name> "Sone" .
<Prednisone> <Has_brand_name> "Senterlic" .
<Prednisone> <Has_brand_name> "Rectodelt" .
<Prednisone> <Has_brand_name> "Pulmison" .
<Prednisone> <Has_brand_name> "Pronison" .
<Prednisone> <Has_brand_name> "Prolix" .
<Prednisone> <Has_brand_name> "Procion" .
<Prednisone> <Has_brand_name> "Predval" .
<Prednisone> <Has_brand_name> "Predsone" .
<Prednisone> <Has_brand_name> "Predson" .
<Prednisone> <Has_brand_name> "Prednitone" .
<Prednisone> <Has_brand_name> "Prednisonum" .
<Prednisone> <Has_brand_name> "Prednisona" .
<Prednisone> <Has_brand_name> "Prednison" .
<Prednisone> <Has_brand_name> "Predniment" .
<Prednisone> <Has_brand_name> "Prednilonga-Retard" .
<Prednisone> <Has_brand_name> "Prednicen-M" .
<Prednisone> <Has_brand_name> "Prednicap" .
<Prednisone> <Has_brand_name> "Prednax" .
<Prednisone> <Has_brand_name> "Preditec" .
<Prednisone> <Has_brand_name> "Predinis" .
<Prednisone> <Has_brand_name> "Predicorten" .
<Prednisone> <Has_brand_name> "Predicor" .
<Prednisone> <Has_brand_name> "Predeltin" .
<Prednisone> <Has_brand_name> "Predcort" .
<Prednisone> <Has_brand_name> "Precortil" .
<Prednisone> <Has_brand_name> "Pharmapred" .
<Prednisone> <Has_brand_name> "Pehacort" .
<Prednisone> <Has_brand_name> "Panasol-S" .
<Prednisone> <Has_brand_name> "Panafcort" .
<Prednisone> <Has_brand_name> "Orasone" .
<Prednisone> <Has_brand_name> "Novoprednisone" .
<Prednisone> <Has_brand_name> "Nosipren" .
<Prednisone> <Has_brand_name> "Nizon" .
<Prednisone> <Has_brand_name> "Nisone" .
<Prednisone> <Has_brand_name> "Nisona" .
<Prednisone> <Has_brand_name> "Nisocortec" .
<Prednisone> <Has_brand_name> "Meticorten" .
<Prednisone> <Has_brand_name> "ME_Korti" .
<Prednisone> <Has_brand_name> "Lisacort" .
<Prednisone> <Has_brand_name> "Isolone" .
<Prednisone> <Has_brand_name> "Ifison" .
<Prednisone> <Has_brand_name> "Hostacortin" .
<Prednisone> <Has_brand_name> "Flamacorten" .
<Prednisone> <Has_brand_name> "Erlanison" .
<Prednisone> <Has_brand_name> "Encorton" .
<Prednisone> <Has_brand_name> "Ednaprom" .
<Prednisone> <Has_brand_name> "Econosone" .
<Prednisone> <Has_brand_name> "Drazone" .
<Prednisone> <Has_brand_name> "Dispersona" .
<Prednisone> <Has_brand_name> "Deltisona" .
<Prednisone> <Has_brand_name> "Deltasone" .
<Prednisone> <Has_brand_name> "Deltason" .
<Prednisone> <Has_brand_name> "Deltacortone" .
<Prednisone> <Has_brand_name> "Deltacortene" .
<Prednisone> <Has_brand_name> "Delta-Cortisone" .
<Prednisone> <Has_brand_name> "Delta_Cortelan" .
<Prednisone> <Has_brand_name> "Dellacorta" .
<Prednisone> <Has_brand_name> "Delcortin" .
<Prednisone> <Has_brand_name> "Dehydrocortison" .
<Prednisone> <Has_brand_name> "Decortisyl" .
<Prednisone> <Has_brand_name> "Decortin" .
<Prednisone> <Has_brand_name> "Decortancyl" .
<Prednisone> <Has_brand_name> "Dacortin" .
<Prednisone> <Has_brand_name> "Cutason" .
<Prednisone> <Has_brand_name> "Cortiprex" .
<Prednisone> <Has_brand_name> "Cortiol" .
<Prednisone> <Has_brand_name> "Cortigen" .
<Prednisone> <Has_brand_name> "Corticorten" .
<Prednisone> <Has_brand_name> "Cortancyl" .
<Prednisone> <Has_brand_name> "Colisone" .
<Prednisone> <Has_brand_name> "Bersen" .
<Prednisone> <Has_brand_name> "Becortem" .
<Prednisone> <Has_brand_name> "Artrizona" .
<Prednisone> <Has_brand_name> "Artinizona" .
<Cyclosporine,_Methotrexate,_Prednisone> <Has_modality> "Immunosuppressive_therapy" .
<Cisplatin,_Fluorouracil,_RT> <Has_context> "Neoadjuvant_therapy" .
<Cisplatin,_Fluorouracil,_RT> <Has_context> "Induction_therapy" .
<Cisplatin,_Fluorouracil,_RT> <Has_context> "Definitive_therapy" .
<Cisplatin,_Fluorouracil,_RT> <Has_context> "Consolidation_after_upfront_therapy" .
<Quixidar> <Brand_name_of> "Fondaparinux" .
<Actimmune> <Brand_name_of> "Interferon_gamma-1b" .
<Cyclophosphamide_and_Vincristine> <Has_antineoplastic> "Vincristine" .
<Cyclophosphamide_and_Vincristine> <Has_antineoplastic> "Cyclophosphamide" .
<Irinotecan_and_Mitomycin> <Has_supportive_med> "Ondansetron" .
<Irinotecan_and_Mitomycin> <Has_supportive_med> "Loperamide" .
<Irinotecan_and_Mitomycin> <Has_supportive_med> "Granisetron" .
<Irinotecan_and_Mitomycin> <Has_supportive_med> "Dexamethasone" .
<Alcorim-F> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Scribcin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Thalidomide_and_Prednisone> <Mapped_from> "Thalidomide_and_Prednisone" .
<mFOLFOX6_and_Cetuximab> <Has_accepted_use> "KRAS_wild-type_Colon_cancer" .
<mFOLFOX6_and_Cetuximab> <Has_accepted_use> "Esophageal_cancer" .
<mFOLFOX6_and_Cetuximab> <Has_accepted_use> "Colon_cancer" .
<CYKLONE> <Has_modality> "Chemotherapy" .
<Sirolimus_monotherapy> <Mapped_from> "Sirolimus_monotherapy" .
<Pharmaplatin> <Brand_name_of> "Carboplatin" .
<Clasteon> <Brand_name_of> "Clodronate" .
<DA-EPOCH> <Has_antineoplastic> "Vincristine" .
<DA-EPOCH> <Has_antineoplastic> "Prednisone" .
<DA-EPOCH> <Has_antineoplastic> "Etoposide" .
<DA-EPOCH> <Has_antineoplastic> "Doxorubicin" .
<DA-EPOCH> <Has_antineoplastic> "Cyclophosphamide" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Has_accepted_use> "Burkitt_lymphoma" .
<Xovoltib> <Brand_name_of> "Afatinib" .
<Temozolomide_and_RT,_then_Temozolomide> <Has_antineoplastic> "Temozolomide" .
<Temozolomide_and_RT,_then_Temozolomide> <Has_antineoplastic> "External_beam_radiotherapy" .
<Alendroninezr> <Brand_name_of> "Alendronate" .
<Cytodrox> <Brand_name_of> "Hydroxyurea" .
<MAID> <Has_supportive_med> "Mesna" .
<OFAR> <Has_supportive_med> "Pegfilgrastim" .
<VAD-P> <Has_modality> "Chemotherapy" .
<Posyd> <Brand_name_of> "Etoposide" .
<Cytarabine_and_Idarubicin> <Has_modality> "Chemotherapy" .
<Docetaxel> <Has_brand_name> "Uvtere" .
<Docetaxel> <Has_brand_name> "Trixotene" .
<Docetaxel> <Has_brand_name> "Texot" .
<Docetaxel> <Has_brand_name> "Taxotere" .
<Docetaxel> <Has_brand_name> "Taxewell" .
<Docetaxel> <Has_brand_name> "Taxe-RTU" .
<Docetaxel> <Has_brand_name> "Taceedo" .
<Docetaxel> <Has_brand_name> "Sibatere" .
<Docetaxel> <Has_brand_name> "Plustaxano" .
<Docetaxel> <Has_brand_name> "Oncodocel" .
<Docetaxel> <Has_brand_name> "Neocel" .
<Docetaxel> <Has_brand_name> "Hentaxel" .
<Docetaxel> <Has_brand_name> "Doxetal" .
<Docetaxel> <Has_brand_name> "Doxel" .
<Docetaxel> <Has_brand_name> "Dolectran" .
<Docetaxel> <Has_brand_name> "Docshil" .
<Docetaxel> <Has_brand_name> "Docetere" .
<Docetaxel> <Has_brand_name> "Docetec" .
<Docetaxel> <Has_brand_name> "Docetax" .
<Docetaxel> <Has_brand_name> "Docepar" .
<Docetaxel> <Has_brand_name> "Docenat" .
<Docetaxel> <Has_brand_name> "Docemax" .
<Docetaxel> <Has_brand_name> "Doceglob" .
<Docetaxel> <Has_brand_name> "Docegem" .
<Docetaxel> <Has_brand_name> "Docefrez" .
<Docetaxel> <Has_brand_name> "DoceXan" .
<Docetaxel> <Has_brand_name> "Daxotel" .
<Docetaxel> <Has_brand_name> "Asodocel" .
<Elo-PD> <Mapped_from> "Elo-PD" .
<Z-BEAM> <Has_modality> "Chemoradioimmunotherapy" .
<Flonida> <Brand_name_of> "Fluorouracil" .
<Bortezomib_monotherapy> <Has_supportive_med> "Warfarin" .
<Bortezomib_monotherapy> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Bortezomib_monotherapy> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Bortezomib_monotherapy> <Has_supportive_med> "Pentostatin" .
<Bortezomib_monotherapy> <Has_supportive_med> "PCP_prophylaxis" .
<Bortezomib_monotherapy> <Has_supportive_med> "Ondansetron" .
<Bortezomib_monotherapy> <Has_supportive_med> "Filgrastim" .
<Bortezomib_monotherapy> <Has_supportive_med> "Enoxaparin" .
<Bortezomib_monotherapy> <Has_supportive_med> "Diphenhydramine" .
<Bortezomib_monotherapy> <Has_supportive_med> "Bisphosphonates" .
<Bortezomib_monotherapy> <Has_supportive_med> "Aspirin" .
<Bortezomib_monotherapy> <Has_supportive_med> "Allopurinol" .
<Bortezomib_monotherapy> <Has_supportive_med> "Acyclovir" .
<KMP> <Maps_to> "KMP" .
<Cisplatin,_Vinorelbine,_Cetuximab> <Has_antineoplastic> "Vinorelbine" .
<Cisplatin,_Vinorelbine,_Cetuximab> <Has_antineoplastic> "Cisplatin" .
<Cisplatin,_Vinorelbine,_Cetuximab> <Has_antineoplastic> "Cetuximab" .
<Ondace> <Brand_name_of> "Ondansetron" .
<Fusilev> <Brand_name_of> "Levoleucovorin" .
<dmCODOX-M_-_Modified_Magrath> <Mapped_from> "dmCODOX-M_-_Modified_Magrath" .
<VD> <Maps_to> "VD" .
<Lemtrada> <Brand_name_of> "Alemtuzumab" .
<Hepatic_arterial_chemotherapy> <Has_accepted_use> "Colon_cancer" .
<Local_therapy> <Is_a> "All_lines_of_therapy" .
<AMG_330> <Is_a> "T-cell_activator" .
<AMG_330> <Is_a> "Investigational_drug" .
<AMG_330> <Is_a> "Immunotherapeutic" .
<AMG_330> <Is_a> "BiTE_antibody" .
<AMG_330> <Is_a> "Antibody_medication" .
<AMG_330> <Is_a> "Anti-CD33_antibody" .
<AMG_330> <Is_a> "Anti-CD3_antibody" .
<VAD-P/Q> <Mapped_from> "VAD-P/Q" .
<Lamasine> <Brand_name_of> "Amsacrine" .
<R-COPADM> <Maps_to> "R-COPADM" .
<R-CEOP_(Etoposide)> <Has_antineoplastic> "Vincristine" .
<R-CEOP_(Etoposide)> <Has_antineoplastic> "Rituximab" .
<R-CEOP_(Etoposide)> <Has_antineoplastic> "Prednisone" .
<R-CEOP_(Etoposide)> <Has_antineoplastic> "Etoposide" .
<R-CEOP_(Etoposide)> <Has_antineoplastic> "Cyclophosphamide" .
<DDAVP> <Brand_name_of> "Desmopressin" .
<EVI> <Has_accepted_use> "Small_cell_lung_cancer" .
<Cisplatin_and_Cyclophosphamide> <Has_context> "Non-curative_first-line_therapy" .
<Cisplatin_and_Cyclophosphamide> <Has_context> "Local_therapy" .
<Cisplatin_and_Cyclophosphamide> <Has_context> "Adjuvant_therapy" .
<THP_(Taxotere)> <Has_context> "Non-curative_first-line_therapy" .
<THP_(Taxotere)> <Has_context> "Neoadjuvant_therapy" .
<THP_(Taxotere)> <Has_context> "Adjuvant_therapy" .
<Hyper-CVAD> <Has_supportive_med> "Valacyclovir" .
<Hyper-CVAD> <Has_supportive_med> "Pegfilgrastim" .
<Hyper-CVAD> <Has_supportive_med> "Mesna" .
<Sonidegib> <Antineoplastic_of> "Sonidegib_monotherapy" .
<Radium-223_monotherapy> <Mapped_from> "Radium-223_monotherapy" .
<MVP_(Vinblastine)> <Has_modality> "Chemotherapy" .
<Busulfan_and_Melphalan,_then_auto_HSCT> <Has_antineoplastic> "Melphalan" .
<Busulfan_and_Melphalan,_then_auto_HSCT> <Has_antineoplastic> "Busulfan" .
<Vincristine_monotherapy> <Has_antineoplastic> "Vincristine" .
<Binorel> <Brand_name_of> "Vinorelbine" .
<Cisplatin,_Epirubicin,_Ifosfamide> <Has_context> "Neoadjuvant_therapy" .
<Cisplatin,_Epirubicin,_Ifosfamide> <Has_context> "Adjuvant_therapy" .
<Bu/TT> <Is_current_in> "Autologous_HSCT" .
<FEMTX> <Maps_to> "FEMTX" .
<OXAFAFU> <Has_context> "Non-curative_first-line_therapy" .
<Prophylaxis> <Is_a> "All_lines_of_therapy" .
<ADE_(standard-dose_Ara-C)> <Maps_to> "ADE_(standard-dose_Ara-C)" .
<Omacetaxine> <Antineoplastic_of> "Omacetaxine_monotherapy" .
<Omacetaxine> <Antineoplastic_of> "HAD" .
<Omacetaxine> <Antineoplastic_of> "HAA" .
<MVAC> <Is_current_in> "Bladder_cancer" .
<Cytarabine,_Idarubicin,_Vorinostat> <Mapped_from> "Cytarabine,_Idarubicin,_Vorinostat" .
<Osimertinib_monotherapy> <Has_modality> "Chemotherapy" .
<Difosfonal> <Brand_name_of> "Clodronate" .
<Non-curative_second-line_consolidation_therapy> <Context_of> "Melphalan,_then_auto_HSCT" .
<Non-curative_second-line_consolidation_therapy> <Context_of> "Lenalidomide_and_Rituximab" .
<Non-curative_second-line_consolidation_therapy> <Context_of> "FluBuCy,_then_allo_HSCT" .
<Non-curative_second-line_consolidation_therapy> <Context_of> "Bortezomib_monotherapy" .
<Non-curative_second-line_consolidation_therapy> <Context_of> "BFR,_then_allo_HSCT" .
<Filatil> <Brand_name_of> "Filgrastim" .
<Nilotinib> <Has_accepted_use> "Systemic_mastocytosis" .
<Nilotinib> <Has_accepted_use> "Hypereosinophilic_syndrome" .
<Nilotinib> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Nilotinib> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Erdafitinib_monotherapy> <Has_antineoplastic> "Erdafitinib" .
<Loperamide> <Is_a> "WHO_Essential_Pain_and_Palliative_Care_Medicine" .
<Loperamide> <Is_a> "OTC_medication" .
<Loperamide> <Is_a> "Anti-diarrheal" .
<IROX> <Maps_to> "IROX" .
<R-INO> <Is_a> "Rituximab-containing_regimen" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone> <Mapped_from> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone" .
<Fluorouracil_and_Streptozocin> <Has_modality> "Chemotherapy" .
<Tampyrine> <Brand_name_of> "Aspirin" .
<Cytofos> <Brand_name_of> "Amifostine" .
<FOLFOX_7/sLV5FU2> <Has_context> "Non-curative_first-line_therapy" .
<ATRA_and_Daunorubicin> <Has_context> "Induction_therapy" .
<ATRA_and_Daunorubicin> <Has_context> "Consolidation_after_upfront_therapy" .
<VEPEMB> <Has_accepted_use> "Hodgkin_lymphoma" .
<Thoprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Dabrafenib_and_Trametinib> <Has_antineoplastic> "Trametinib" .
<Dabrafenib_and_Trametinib> <Has_antineoplastic> "Dabrafenib" .
<Fludarabine> <Antineoplastic_of> "Tisagenlecleucel_monotherapy" .
<Fludarabine> <Antineoplastic_of> "TFC,_then_allo_HSCT" .
<Fludarabine> <Antineoplastic_of> "R-FND" .
<Fludarabine> <Antineoplastic_of> "R-FM" .
<Fludarabine> <Antineoplastic_of> "R-FCM" .
<Fludarabine> <Antineoplastic_of> "OFAR" .
<Fludarabine> <Antineoplastic_of> "O-FC" .
<Fludarabine> <Antineoplastic_of> "Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Fludarabine> <Antineoplastic_of> "G-FC" .
<Fludarabine> <Antineoplastic_of> "Fludarabine,_then_131Iodine-Tositumomab" .
<Fludarabine> <Antineoplastic_of> "Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT" .
<Fludarabine> <Antineoplastic_of> "Fludarabine,_Melphalan,_Alemtuzumab" .
<Fludarabine> <Antineoplastic_of> "Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant" .
<Fludarabine> <Antineoplastic_of> "Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT" .
<Fludarabine> <Antineoplastic_of> "Fludarabine,_Cyclophosphamide,_ATG" .
<Fludarabine> <Antineoplastic_of> "Fludarabine,_Busulfan,_Cyclophosphamide" .
<Fludarabine> <Antineoplastic_of> "Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Fludarabine> <Antineoplastic_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT" .
<Fludarabine> <Antineoplastic_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan" .
<Fludarabine> <Antineoplastic_of> "Fludarabine,_Busulfan,_ATG" .
<Fludarabine> <Antineoplastic_of> "Fludarabine_monotherapy" .
<Fludarabine> <Antineoplastic_of> "Fludarabine_and_TBI,_then_allo_HSCT" .
<Fludarabine> <Antineoplastic_of> "Fludarabine_and_TBI" .
<Fludarabine> <Antineoplastic_of> "Fludarabine_and_Prednisone" .
<Fludarabine> <Antineoplastic_of> "Fludarabine_and_Melphalan" .
<Fludarabine> <Antineoplastic_of> "Fludarabine_and_Alemtuzumab" .
<Fludarabine> <Antineoplastic_of> "FluCam" .
<Fludarabine> <Antineoplastic_of> "FluBuCy,_then_allo_HSCT" .
<Fludarabine> <Antineoplastic_of> "Flu-Mel,_then_allo_HSCT" .
<Fludarabine> <Antineoplastic_of> "FR" .
<Fludarabine> <Antineoplastic_of> "FND" .
<Fludarabine> <Antineoplastic_of> "FMP" .
<Fludarabine> <Antineoplastic_of> "FM" .
<Fludarabine> <Antineoplastic_of> "FLAG-Ida" .
<Fludarabine> <Antineoplastic_of> "FLAG-DNX" .
<Fludarabine> <Antineoplastic_of> "FLAG" .
<Fludarabine> <Antineoplastic_of> "FCR,_then_allo_HSCT" .
<Fludarabine> <Antineoplastic_of> "FCR_(Rituximab_Hycela)" .
<Fludarabine> <Antineoplastic_of> "FCR" .
<Fludarabine> <Antineoplastic_of> "FCM" .
<Fludarabine> <Antineoplastic_of> "FCA" .
<Fludarabine> <Antineoplastic_of> "FC,_then_allo_HSCT" .
<Fludarabine> <Antineoplastic_of> "FC" .
<Fludarabine> <Antineoplastic_of> "F-SHAI" .
<Fludarabine> <Antineoplastic_of> "Cyclophosphamide,_Fludarabine,_Thiotepa" .
<Fludarabine> <Antineoplastic_of> "CFAR" .
<Fludarabine> <Antineoplastic_of> "Busulfan_and_Fludarabine" .
<Fludarabine> <Antineoplastic_of> "BuFlu,_then_allo_HSCT" .
<Fludarabine> <Antineoplastic_of> "BFR,_then_allo_HSCT" .
<Fludarabine> <Antineoplastic_of> "BFR" .
<Fludarabine> <Antineoplastic_of> "Axicabtagene_ciloleucel_monotherapy" .
<Fludarabine> <Antineoplastic_of> "(90)YFC,_then_allo_HSCT" .
<Fludarabine> <Antineoplastic_of> "(90)YFC" .
<R-MP> <Is_current_in> "CNS_lymphoma" .
<CFAR> <Has_context> "Non-curative_therapy" .
<CFAR> <Has_context> "Non-curative_first-line_therapy" .
<Doxorubicin_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<IL-2_monotherapy> <Maps_to> "IL-2_monotherapy" .
<Pentostatin_and_Alemtuzumab> <Is_current_in> "T-cell_prolymphocytic_leukemia" .
<FULV_and_Bevacizumab> <Has_antineoplastic> "Folinic_acid" .
<FULV_and_Bevacizumab> <Has_antineoplastic> "Fluorouracil" .
<FULV_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Dexametax> <Brand_name_of> "Dexamethasone" .
<Fam-trastuzumab_deruxtecan> <Has_FDA_indication> "Breast_cancer" .
<Radioimmunotherapeutic> <Subsumes> "Tositumomab_&_I-131" .
<Radioimmunotherapeutic> <Subsumes> "Ibritumomab_tiuxetan" .
<Batrox> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<MPV> <Has_modality> "Chemotherapy" .
<Siltuximab_monotherapy> <Mapped_from> "Siltuximab_monotherapy" .
<Plasma_cell_leukemia> <Accepted_use_of> "Rd" .
<Plasma_cell_leukemia> <Accepted_use_of> "Pegylated_liposomal_doxorubicin" .
<Plasma_cell_leukemia> <Accepted_use_of> "PAD/VCD" .
<Plasma_cell_leukemia> <Accepted_use_of> "Melphalan,_then_auto_HSCT" .
<Plasma_cell_leukemia> <Accepted_use_of> "Melphalan" .
<Plasma_cell_leukemia> <Accepted_use_of> "Lenalidomide_monotherapy" .
<Plasma_cell_leukemia> <Accepted_use_of> "Lenalidomide" .
<Plasma_cell_leukemia> <Accepted_use_of> "Dexamethasone" .
<Plasma_cell_leukemia> <Accepted_use_of> "Cyclophosphamide" .
<Plasma_cell_leukemia> <Accepted_use_of> "Bortezomib" .
<Direct_oral_anticoagulant> <Is_a> "Anticoagulant" .
<Aminoglutethimide> <Antineoplastic_of> "TAD_(Tamoxifen)" .
<Aminoglutethimide> <Antineoplastic_of> "Aminoglutethimide_monotherapy" .
<Gliadel_wafer_monotherapy> <Is_current_in> "Glioblastoma" .
<Chlorambucil_and_Ofatumumab> <Maps_to> "Chlorambucil_and_Ofatumumab" .
<Carboplatin_and_Pemetrexed> <Maps_to> "Carboplatin_and_Pemetrexed" .
<Irinotecan_and_Cetuximab> <Has_modality> "Chemotherapy" .
<Soft_tissue_sarcoma> <FDA_indication_of> "Pazopanib" .
<Soft_tissue_sarcoma> <FDA_indication_of> "Olaratumab" .
<Soft_tissue_sarcoma> <FDA_indication_of> "Imatinib" .
<Soft_tissue_sarcoma> <FDA_indication_of> "Doxorubicin" .
<Soft_tissue_sarcoma> <FDA_indication_of> "Denosumab" .
<Osteofel> <Brand_name_of> "Alendronate" .
<R-MCP> <Maps_to> "R-MCP" .
<CEV_and_RT> <Has_modality> "Radiotherapy" .
<CEV_and_RT> <Has_modality> "Chemotherapy" .
<Lutetium_Lu_177_dotatate> <Antineoplastic_of> "Lutetium_Lu_177_dotatate_and_Octreotide_LAR" .
<Abemaciclib_and_Fulvestrant> <Is_a> "Antiestrogen-containing_regimen" .
<BeGEV> <Maps_to> "BeGEV" .
<Vincristine_liposomal> <May_have_route> "Intravenous" .
<VR-CAP> <Is_a> "Rituximab-containing_regimen" .
<VR-CAP> <Is_a> "Anthracycline-containing_regimen" .
<Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b> <Has_accepted_use> "Ovarian_cancer" .
<Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<(90)YFC> <Has_context> "All_lines_of_therapy" .
<FUOX> <Is_current_in> "Colon_cancer" .
<EBVP> <Is_a> "Anthracycline-containing_regimen" .
<Dexagreen> <Brand_name_of> "Dexamethasone" .
<EVAIA> <Maps_to> "EVAIA" .
<ADT_and_Docetaxel> <Has_supportive_med> "Dexamethasone" .
<VTP> <Has_supportive_med> "Low_molecular_weight_heparins" .
<VTP> <Has_supportive_med> "Bisphosphonates" .
<VTP> <Has_supportive_med> "Aspirin" .
<VTP> <Has_supportive_med> "Acyclovir" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Ecotrin> <Brand_name_of> "Aspirin" .
<Carboplatin,_Etoposide,_Atezolizumab> <Has_antineoplastic> "Etoposide" .
<Carboplatin,_Etoposide,_Atezolizumab> <Has_antineoplastic> "Carboplatin" .
<Carboplatin,_Etoposide,_Atezolizumab> <Has_antineoplastic> "Atezolizumab" .
<AC> <Maps_to> "AC" .
<Panafcort> <Brand_name_of> "Prednisone" .
<Tamoxifen> <Has_brand_name> "Valodex" .
<Tamoxifen> <Has_brand_name> "Soltamox" .
<Tamoxifen> <Has_brand_name> "Nolvadex" .
<Tamoxifen> <Has_brand_name> "Istubal" .
<MOPP-ABV> <Is_current_in> "Hodgkin_lymphoma" .
<Anastrozole_monotherapy> <Has_accepted_use> "Endometrial_cancer" .
<Anastrozole_monotherapy> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Anastrozole_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Estradiol_monotherapy> <Has_accepted_use> "Breast_cancer" .
<R-DexaBEAM> <Maps_to> "R-DexaBEAM" .
<Nilotinib-based_consolidation> <Has_context> "Consolidation_after_upfront_therapy" .
<FOLFIRI_and_Cetuximab> <Has_accepted_use> "KRAS_wild-type_Colon_cancer" .
<FOLFIRI_and_Cetuximab> <Has_accepted_use> "Colon_cancer" .
<Cisplatin,_Cetuximab,_RT> <Has_modality> "Radiotherapy" .
<Cisplatin,_Cetuximab,_RT> <Has_modality> "Chemotherapy" .
<Factor_XIII_concentrate_human> <May_have_route> "Intravenous" .
<Capecitabine,_Docetaxel,_RT> <Maps_to> "Capecitabine,_Docetaxel,_RT" .
<ADE_and_ATRA> <Has_context> "Induction_therapy" .
<Augmented_BFM_consolidation> <Has_modality> "Chemotherapy" .
<Anti-SLAMF7_antibody> <Subsumes> "Elotuzumab" .
<ABDIC> <Has_antineoplastic> "Prednisone" .
<ABDIC> <Has_antineoplastic> "Lomustine" .
<ABDIC> <Has_antineoplastic> "Doxorubicin" .
<ABDIC> <Has_antineoplastic> "Dacarbazine" .
<ABDIC> <Has_antineoplastic> "Bleomycin" .
<Doxo_Cell> <Brand_name_of> "Doxorubicin" .
<mDCF_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<VACOP-B> <Has_context> "Induction_therapy" .
<Denileukin_diftitox> <Has_FDA_indication> "Cutaneous_T-cell_lymphoma" .
<Polatuzumab_vedotin> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Pentamidine> <May_have_route> "Inhalation" .
<R-CHOP_(Prednisolone)> <Has_antineoplastic> "Vincristine" .
<R-CHOP_(Prednisolone)> <Has_antineoplastic> "Rituximab" .
<R-CHOP_(Prednisolone)> <Has_antineoplastic> "Prednisolone" .
<R-CHOP_(Prednisolone)> <Has_antineoplastic> "Doxorubicin" .
<R-CHOP_(Prednisolone)> <Has_antineoplastic> "Cyclophosphamide" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab> <Has_antineoplastic> "Vincristine" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab> <Has_antineoplastic> "Rituximab" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab> <Has_antineoplastic> "Prednisone" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab> <Has_antineoplastic> "Daunorubicin" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab> <Has_antineoplastic> "Cyclophosphamide" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab> <Has_antineoplastic> "Asparaginase" .
<Inherited_coagulopathy> <Current_treated_by> "Rituximab_monotherapy" .
<Inherited_coagulopathy> <Current_treated_by> "Emicizumab_monotherapy" .
<mFOLFOX6_(L-Leucovorin)> <Has_accepted_use> "Colon_cancer" .
<FOLFIRI_and_Cetuximab_(L-Leucovorin)> <Has_modality> "Chemotherapy" .
<Redexon> <Brand_name_of> "Dexamethasone" .
<Lapatinib,_Letrozole,_Trastuzumab> <Has_antineoplastic> "Trastuzumab" .
<Lapatinib,_Letrozole,_Trastuzumab> <Has_antineoplastic> "Letrozole" .
<Lapatinib,_Letrozole,_Trastuzumab> <Has_antineoplastic> "Lapatinib" .
<Cisplatin,_Fluorouracil,_Cetuximab> <Mapped_from> "Cisplatin,_Fluorouracil,_Cetuximab" .
<MAP2K4_inhibitor> <Subsumes> "Vemurafenib" .
<Ratrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Plerixafor> <Has_accepted_use> "WHIM_syndrome" .
<Durvalumab_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Durvalumab_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Durvalumab_monotherapy> <Has_context> "Consolidation_after_upfront_therapy" .
<Flutamide,_Leuprolide,_RT> <Has_antineoplastic> "Leuprolide" .
<Flutamide,_Leuprolide,_RT> <Has_antineoplastic> "Flutamide" .
<Flutamide,_Leuprolide,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Deotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Lactulose> <Supportive_med_of> "SC-EPOCH-RR" .
<Lactulose> <Supportive_med_of> "DA-R-EPOCH" .
<Dexamo> <Brand_name_of> "Dexamethasone" .
<RBC_transfusions> <Has_supportive_med> "L-glutamine" .
<ICE> <Is_current_in> "Osteosarcoma" .
<ICE> <Is_current_in> "Hodgkin_lymphoma" .
<ICE> <Is_current_in> "Ewing_sarcoma" .
<Zoltrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<PT> <Maps_to> "PT" .
<NovoTTF-100A_system_(Optune)> <Antineoplastic_of> "Cisplatin,_Pemetrexed,_TTFields" .
<Carboplatin_and_Fluorouracil> <Has_modality> "Chemotherapy" .
<Paclitaxel_and_RT> <Has_antineoplastic> "Paclitaxel" .
<Paclitaxel_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Anastrozole_and_Goserelin> <Has_context> "Neoadjuvant_therapy" .
<Grasin> <Brand_name_of> "Filgrastim" .
<LEED,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Busulfan> <Is_a> "Irritant" .
<Busulfan> <Is_a> "Alkylating_agent" .
<Alergolon> <Brand_name_of> "Methylprednisolone" .
<Dronat> <Brand_name_of> "Alendronate" .
<Cisplatin_and_Epirubicin> <Has_antineoplastic> "Epirubicin" .
<Cisplatin_and_Epirubicin> <Has_antineoplastic> "Cisplatin" .
<BEACOPP> <Has_supportive_med> "Filgrastim" .
<Hyper-CVAD/MA_and_Everolimus> <Has_antineoplastic> "Vincristine" .
<Hyper-CVAD/MA_and_Everolimus> <Has_antineoplastic> "Methylprednisolone" .
<Hyper-CVAD/MA_and_Everolimus> <Has_antineoplastic> "Methotrexate" .
<Hyper-CVAD/MA_and_Everolimus> <Has_antineoplastic> "Everolimus" .
<Hyper-CVAD/MA_and_Everolimus> <Has_antineoplastic> "Doxorubicin" .
<Hyper-CVAD/MA_and_Everolimus> <Has_antineoplastic> "Dexamethasone" .
<Hyper-CVAD/MA_and_Everolimus> <Has_antineoplastic> "Cytarabine" .
<Hyper-CVAD/MA_and_Everolimus> <Has_antineoplastic> "Cyclophosphamide" .
<Cyramza> <Brand_name_of> "Ramucirumab" .
<Erlotinib> <Has_brand_name> "Tarceva" .
<Erlotinib> <Has_brand_name> "Melacyte" .
<Erlotinib> <Has_brand_name> "Erlonat" .
<Erlotinib> <Has_brand_name> "Erlocip" .
<Dacomitinib> <Antineoplastic_of> "Dacomitinib_monotherapy" .
<MT-R> <Mapped_from> "MT-R" .
<ABC> <Is_a> "Bevacizumab-containing_regimen" .
<Etoposide,_Ifosfamide,_Methotrexate> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Exemestane_monotherapy> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Exemestane_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Barasertib> <May_have_route> "Oral" .
<Cisplatin_and_Vinorelbine> <Maps_to> "Cisplatin_and_Vinorelbine" .
<FOLFOX_7/sLV5FU2> <Has_antineoplastic> "Oxaliplatin" .
<FOLFOX_7/sLV5FU2> <Has_antineoplastic> "Folinic_acid" .
<FOLFOX_7/sLV5FU2> <Has_antineoplastic> "Fluorouracil" .
<Colon_cancer_medications_(historic)> <Subsumes> "Vincristine" .
<Brigatinib> <May_have_route> "Oral" .
<Oxaliplatin_and_Bevacizumab> <Has_accepted_use> "Testicular_cancer" .
<DAT> <Maps_to> "DAT" .
<ATG_(Horse),_Cyclosporine,_Sirolimus> <Has_accepted_use> "Aplastic_anemia" .
<Ipilimumab_and_Nivolumab> <Maps_to> "Ipilimumab_and_Nivolumab" .
<Capecitabine,_Bevacizumab,_Trastuzumab> <Mapped_from> "Capecitabine,_Bevacizumab,_Trastuzumab" .
<Anti-CD79B_antibody> <Subsumes> "Polatuzumab_vedotin" .
<nab-Paclitaxel_monotherapy> <Mapped_from> "nab-Paclitaxel_monotherapy" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Vinorelbine" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Vincristine" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Trabectedin_monotherapy" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Trabectedin" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Temozolomide_monotherapy" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Temozolomide" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Sorafenib_monotherapy" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Regorafenib_monotherapy" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Regorafenib" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Placebo" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Pazopanib_monotherapy" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Pazopanib" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Olaratumab" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Observation" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Masitinib" .
<Soft_tissue_sarcoma> <Accepted_use_of> "MAID" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Imatinib_monotherapy" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Imatinib" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Ifosfamide_monotherapy" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Ifosfamide" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Gemcitabine_and_Vinorelbine" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Gemcitabine" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Etoposide" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Epirubicin_monotherapy" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Epirubicin_and_Ifosfamide" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Epirubicin" .
<Soft_tissue_sarcoma> <Accepted_use_of> "EIA" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Doxorubicin,_Ifosfamide,_RT" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Doxorubicin_monotherapy" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Doxorubicin_and_Olaratumab" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Doxorubicin_and_Ifosfamide" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Doxorubicin" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Docetaxel_and_Gemcitabine" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Docetaxel" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Dacarbazine_monotherapy" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Dacarbazine_and_Gemcitabine" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Dacarbazine_and_Doxorubicin" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Dacarbazine" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Cixutumumab" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Cisplatin_monotherapy" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Bevacizumab-bvzr" .
<Soft_tissue_sarcoma> <Accepted_use_of> "Bevacizumab-awwb" .
<Mitoxantrone_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Mitoxantrone_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Carboplatin_and_Irinotecan> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Carboplatin_and_Irinotecan> <Has_supportive_med> "Loperamide" .
<Cinvanti> <Brand_name_of> "Aprepitant" .
<Darbetin> <Brand_name_of> "Darbepoetin_alfa" .
<Talazoparib> <Has_FDA_indication> "Breast_cancer" .
<Ribociclib_and_Tamoxifen> <Mapped_from> "Ribociclib_and_Tamoxifen" .
<Nivolumab_monotherapy> <Mapped_from> "Nivolumab_monotherapy" .
<Apalutamide> <Has_FDA_indication> "Prostate_cancer" .
<Coraspin> <Brand_name_of> "Aspirin" .
<CDB> <Maps_to> "CDB" .
<Everolimus_and_Octreotide> <Is_current_in> "Pancreatic_NET" .
<Everolimus_and_Octreotide> <Is_current_in> "Neuroendocrine_tumor" .
<Cytarabine,_Idarubicin,_Sorafenib> <Is_a> "Anthracycline-containing_regimen" .
<Perifosine> <May_have_route> "Oral" .
<Prednisone_monotherapy> <Has_antineoplastic> "Prednisone" .
<Dasatinib_and_Prednisone> <Has_local_therapy> "Methotrexate" .
<CC> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Procarbazine> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Procarbazine> <Has_accepted_use> "Low-grade_glioma" .
<Procarbazine> <Has_accepted_use> "Hodgkin_lymphoma" .
<Procarbazine> <Has_accepted_use> "Glioblastoma" .
<Procarbazine> <Has_accepted_use> "Follicular_lymphoma" .
<Procarbazine> <Has_accepted_use> "CNS_lymphoma" .
<Procarbazine> <Has_accepted_use> "Anaplastic_glioma" .
<Gemcitabine_and_Mitomycin> <Has_antineoplastic> "Mitomycin" .
<Gemcitabine_and_Mitomycin> <Has_antineoplastic> "Gemcitabine" .
<Bortezomib_and_Cyclophosphamide> <Has_modality> "Chemotherapy" .
<Urbason> <Brand_name_of> "Methylprednisolone" .
<Avasyl> <Brand_name_of> "Aspirin" .
<Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib> <Is_a> "Anthracycline-containing_regimen" .
<P/DOCE> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Systemic_mastocytosis> <Current_treated_by> "Placebo" .
<Systemic_mastocytosis> <Current_treated_by> "Nilotinib_monotherapy" .
<Systemic_mastocytosis> <Current_treated_by> "Midostaurin_monotherapy" .
<Systemic_mastocytosis> <Current_treated_by> "Interferon_alfa-2b_monotherapy" .
<Systemic_mastocytosis> <Current_treated_by> "Imatinib_monotherapy" .
<Systemic_mastocytosis> <Current_treated_by> "Dasatinib_monotherapy" .
<Systemic_mastocytosis> <Current_treated_by> "Cladribine_monotherapy" .
<Lusutrombopag_monotherapy> <Mapped_from> "Lusutrombopag_monotherapy" .
<Zuvimide> <Brand_name_of> "Thalidomide" .
<Panobinostat_and_Rituximab> <Is_a> "Rituximab-containing_regimen" .
<SMILE> <Has_modality> "Chemotherapy" .
<Hydroxyurea> <Has_accepted_use> "Sickle_cell_anemia" .
<Hydroxyurea> <Has_accepted_use> "Polycythemia_vera" .
<Hydroxyurea> <Has_accepted_use> "Myelofibrosis" .
<Hydroxyurea> <Has_accepted_use> "Hypereosinophilic_syndrome" .
<Hydroxyurea> <Has_accepted_use> "Head_and_neck_cancer" .
<Hydroxyurea> <Has_accepted_use> "Glioblastoma" .
<Hydroxyurea> <Has_accepted_use> "Essential_thrombocythemia" .
<Hydroxyurea> <Has_accepted_use> "Cervical_cancer" .
<Hydroxyurea> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Hydroxyurea> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Ox-P> <Is_current_in> "Marginal_zone_lymphoma" .
<GemOx> <Has_accepted_use> "Testicular_cancer" .
<GemOx> <Has_accepted_use> "Pancreatic_cancer" .
<GemOx> <Has_accepted_use> "Hepatocellular_carcinoma" .
<GemOx> <Has_accepted_use> "Gallbladder_cancer" .
<GemOx> <Has_accepted_use> "Cholangiocarcinoma" .
<Genalmen> <Brand_name_of> "Alendronate" .
<PET> <Has_accepted_use> "Breast_cancer" .
<Carboplatin_and_Gemcitabine> <Is_current_in> "Ovarian_cancer" .
<Carboplatin_and_Gemcitabine> <Is_current_in> "Non-small_cell_lung_cancer" .
<Carboplatin_and_Gemcitabine> <Is_current_in> "Breast_cancer" .
<Carboplatin_and_Gemcitabine> <Is_current_in> "Bladder_cancer" .
<Medulloblastoma> <Accepted_use_of> "Vincristine" .
<Medulloblastoma> <Accepted_use_of> "Methotrexate" .
<Medulloblastoma> <Accepted_use_of> "Lomustine" .
<Medulloblastoma> <Accepted_use_of> "Etoposide" .
<Medulloblastoma> <Accepted_use_of> "Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide" .
<Medulloblastoma> <Accepted_use_of> "Cyclophosphamide" .
<Medulloblastoma> <Accepted_use_of> "Cisplatin,_Lomustine,_Vincristine" .
<Medulloblastoma> <Accepted_use_of> "Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine" .
<Medulloblastoma> <Accepted_use_of> "Carboplatin" .
<Paclitaxel_and_Pazopanib> <Has_antineoplastic> "Pazopanib" .
<Paclitaxel_and_Pazopanib> <Has_antineoplastic> "Paclitaxel" .
<Erlotinib_monotherapy> <Has_modality> "Chemotherapy" .
<Fotemustine_monotherapy> <Maps_to> "Fotemustine_monotherapy" .
<PCP> <Is_current_in> "Multiple_myeloma" .
<CMC> <Maps_to> "CMC" .
<Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib> <Has_context> "Induction_therapy" .
<Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_antineoplastic> "Fludarabine" .
<Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_antineoplastic> "Busulfan" .
<Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<T-cell_leukemia> <Subsumes> "T-cell_prolymphocytic_leukemia" .
<T-cell_leukemia> <Subsumes> "T-cell_acute_lymphoblastic_leukemia" .
<T-cell_leukemia> <Subsumes> "Adult_T-cell_leukemia-lymphoma" .
<Gemcitabine_and_Sunitinib> <Has_context> "Non-curative_first-line_therapy" .
<Ipilimumab_and_RT> <Has_context> "Non-curative_therapy" .
<Genprin> <Brand_name_of> "Aspirin" .
<R-CHOP> <Has_antineoplastic> "Vincristine" .
<R-CHOP> <Has_antineoplastic> "Rituximab" .
<R-CHOP> <Has_antineoplastic> "Prednisone" .
<R-CHOP> <Has_antineoplastic> "Doxorubicin" .
<R-CHOP> <Has_antineoplastic> "Cyclophosphamide" .
<CAP> <Is_historical_in> "Chronic_lymphocytic_leukemia" .
<Cyclosporine_non-modified> <Has_brand_name> "Sandimmune" .
<Docetaxel,_Fluorouracil,_RT> <Has_antineoplastic> "Fluorouracil" .
<Docetaxel,_Fluorouracil,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Docetaxel,_Fluorouracil,_RT> <Has_antineoplastic> "Docetaxel" .
<PDE_inhibitor> <Subsumes> "Dipyridamole" .
<PDE_inhibitor> <Subsumes> "Cilostazol" .
<PDE_inhibitor> <Subsumes> "Aspirin_and_dipyridamole" .
<Wepox> <Brand_name_of> "Epoetin_alfa" .
<Interferon_alfa-2c_monotherapy> <Mapped_from> "Interferon_alfa-2c_monotherapy" .
<Bexarotene_and_Pralatrexate> <Mapped_from> "Bexarotene_and_Pralatrexate" .
<ACVBP-R> <Has_local_therapy> "Methotrexate" .
<Zydac> <Brand_name_of> "Dacarbazine" .
<VA> <Has_accepted_use> "Rhabdomyosarcoma" .
<CVD_(Vindesine)> <Has_antineoplastic> "Vindesine" .
<CVD_(Vindesine)> <Has_antineoplastic> "Dacarbazine" .
<CVD_(Vindesine)> <Has_antineoplastic> "Cisplatin" .
<Seftrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Pomalidomide_monotherapy> <Has_context> "Non-curative_therapy" .
<Pomalidomide_monotherapy> <Has_context> "Non-curative_second-line_maintenance_therapy" .
<Pomalidomide_monotherapy> <Has_context> "All_lines_of_therapy" .
<Nesp> <Brand_name_of> "Darbepoetin_alfa" .
<Dexatotal> <Brand_name_of> "Dexamethasone" .
<VAIA> <Is_a> "Anthracycline-containing_regimen" .
<Venetoclax_monotherapy> <Maps_to> "Venetoclax_monotherapy" .
<VCAP> <Mapped_from> "VCAP" .
<Ossomax> <Brand_name_of> "Alendronate" .
<Ibandronate> <May_have_route> "Oral" .
<Ibandronate> <May_have_route> "Intravenous" .
<Bortezomib_monotherapy> <Mapped_from> "Bortezomib_monotherapy" .
<Radioiodine_ablation> <Is_current_in> "Thyroid_cancer" .
<TAC_(Taxotere)> <Has_modality> "Chemotherapy" .
<Small_cell_lung_cancer> <FDA_indication_of> "Topotecan" .
<Small_cell_lung_cancer> <FDA_indication_of> "Pembrolizumab" .
<Small_cell_lung_cancer> <FDA_indication_of> "Nivolumab" .
<Small_cell_lung_cancer> <FDA_indication_of> "Etoposide" .
<Small_cell_lung_cancer> <FDA_indication_of> "Doxorubicin" .
<Small_cell_lung_cancer> <FDA_indication_of> "Atezolizumab" .
<BEAM,_then_allo_HSCT> <Mapped_from> "BEAM,_then_allo_HSCT" .
<Etoposide_and_TBI> <Has_context> "All_lines_of_therapy" .
<Immunosuppressive_therapy> <Modality_of> "Tocilizumab_monotherapy" .
<Immunosuppressive_therapy> <Modality_of> "TT4" .
<Immunosuppressive_therapy> <Modality_of> "TLI_and_ATG" .
<Immunosuppressive_therapy> <Modality_of> "Sirolimus,_Tacrolimus,_Prednisone" .
<Immunosuppressive_therapy> <Modality_of> "Sirolimus_monotherapy" .
<Immunosuppressive_therapy> <Modality_of> "Sirolimus_and_Prednisone" .
<Immunosuppressive_therapy> <Modality_of> "Siltuximab_monotherapy" .
<Immunosuppressive_therapy> <Modality_of> "Rituximab_monotherapy" .
<Immunosuppressive_therapy> <Modality_of> "Ravulizumab_monotherapy" .
<Immunosuppressive_therapy> <Modality_of> "Rabbit_ATG" .
<Immunosuppressive_therapy> <Modality_of> "Prednisone_monotherapy" .
<Immunosuppressive_therapy> <Modality_of> "Prednisone_and_Rituximab" .
<Immunosuppressive_therapy> <Modality_of> "Prednisolone_monotherapy" .
<Immunosuppressive_therapy> <Modality_of> "Prednisolone_and_Rituximab" .
<Immunosuppressive_therapy> <Modality_of> "Mycophenolate_mofetil_monotherapy" .
<Immunosuppressive_therapy> <Modality_of> "Methylprednisolone_monotherapy" .
<Immunosuppressive_therapy> <Modality_of> "Methotrexate,_Tacrolimus,_Vorinostat" .
<Immunosuppressive_therapy> <Modality_of> "Methotrexate,_Tacrolimus,_Tocilizumab" .
<Immunosuppressive_therapy> <Modality_of> "Methotrexate_and_Tacrolimus" .
<Immunosuppressive_therapy> <Modality_of> "Methotrexate_and_Prednisone" .
<Immunosuppressive_therapy> <Modality_of> "Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Immunosuppressive_therapy> <Modality_of> "Ibrutinib_monotherapy" .
<Immunosuppressive_therapy> <Modality_of> "HLH-94_regimen" .
<Immunosuppressive_therapy> <Modality_of> "HLH-2004_regimen" .
<Immunosuppressive_therapy> <Modality_of> "Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT" .
<Immunosuppressive_therapy> <Modality_of> "Fludarabine,_Cyclophosphamide,_ATG" .
<Immunosuppressive_therapy> <Modality_of> "Fludarabine,_Busulfan,_Cyclophosphamide" .
<Immunosuppressive_therapy> <Modality_of> "Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Immunosuppressive_therapy> <Modality_of> "Fludarabine,_Busulfan,_ATG" .
<Immunosuppressive_therapy> <Modality_of> "Fludarabine_and_Melphalan" .
<Immunosuppressive_therapy> <Modality_of> "FluBuCy,_then_allo_HSCT" .
<Immunosuppressive_therapy> <Modality_of> "Flu-Mel,_then_allo_HSCT" .
<Immunosuppressive_therapy> <Modality_of> "FCR,_then_allo_HSCT" .
<Immunosuppressive_therapy> <Modality_of> "FCR" .
<Immunosuppressive_therapy> <Modality_of> "Eculizumab_monotherapy" .
<Immunosuppressive_therapy> <Modality_of> "Dexamethasone_monotherapy" .
<Immunosuppressive_therapy> <Modality_of> "Dexamethasone_and_Rituximab" .
<Immunosuppressive_therapy> <Modality_of> "Dexamethasone_and_Eltrombopag" .
<Immunosuppressive_therapy> <Modality_of> "Cyclosporine,_Sirolimus,_Prednisone" .
<Immunosuppressive_therapy> <Modality_of> "Cyclosporine,_Mycophenolate_mofetil,_Sirolimus" .
<Immunosuppressive_therapy> <Modality_of> "Cyclosporine,_Methotrexate,_Prednisone" .
<Immunosuppressive_therapy> <Modality_of> "Cyclosporine,_Methotrexate,_Methylprednisolone" .
<Immunosuppressive_therapy> <Modality_of> "Cyclosporine,_Methotrexate,_ATG" .
<Immunosuppressive_therapy> <Modality_of> "Cyclosporine,_Corticosteroids,_Rituximab" .
<Immunosuppressive_therapy> <Modality_of> "Cyclosporine_monotherapy" .
<Immunosuppressive_therapy> <Modality_of> "Cyclosporine_and_Prednisone" .
<Immunosuppressive_therapy> <Modality_of> "Cyclosporine_and_Mycophenolate_mofetil" .
<Immunosuppressive_therapy> <Modality_of> "Cyclosporine_and_Methotrexate" .
<Immunosuppressive_therapy> <Modality_of> "Cyclophosphamide,_Mycophenolate_mofetil,_Tacrolimus" .
<Immunosuppressive_therapy> <Modality_of> "Cyclophosphamide_monotherapy" .
<Immunosuppressive_therapy> <Modality_of> "Cyclophosphamide_and_Prednisone" .
<Immunosuppressive_therapy> <Modality_of> "Cyclophosphamide_and_Prednisolone" .
<Immunosuppressive_therapy> <Modality_of> "Busulfan_and_Fludarabine" .
<Immunosuppressive_therapy> <Modality_of> "BuFlu,_then_allo_HSCT" .
<Immunosuppressive_therapy> <Modality_of> "Anakinra_monotherapy" .
<Immunosuppressive_therapy> <Modality_of> "Alemtuzumab_monotherapy" .
<Immunosuppressive_therapy> <Modality_of> "ATG_(Rabbit)_monotherapy" .
<Immunosuppressive_therapy> <Modality_of> "ATG_(Rabbit)_and_Cyclosporine" .
<Immunosuppressive_therapy> <Modality_of> "ATG_(Horse),_Cyclosporine,_Sirolimus" .
<Immunosuppressive_therapy> <Modality_of> "ATG_(Horse),_Cyclosporine,_Methylprednisolone" .
<Immunosuppressive_therapy> <Modality_of> "ATG_(Horse),_Cyclosporine,_G-CSF" .
<Immunosuppressive_therapy> <Modality_of> "ATG_(Horse),_Cyclosporine,_Eltrombopag" .
<Immunosuppressive_therapy> <Modality_of> "ATG_(Horse)_monotherapy" .
<Immunosuppressive_therapy> <Modality_of> "ATG_(Horse)_and_Cyclosporine" .
<Immunosuppressive_therapy> <Modality_of> "(90)YFC,_then_allo_HSCT" .
<Immunosuppressive_therapy> <Modality_of> "(90)YFC" .
<Crizanlizumab> <Antineoplastic_of> "Crizanlizumab_monotherapy" .
<Trimetsol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Platet> <Brand_name_of> "Aspirin" .
<MCF> <Has_supportive_med> "Warfarin" .
<Telotristat> <Has_accepted_use> "Neuroendocrine_tumor" .
<Cisplatin_and_Cyclophosphamide> <Has_antineoplastic> "Cyclophosphamide" .
<Cisplatin_and_Cyclophosphamide> <Has_antineoplastic> "Cisplatin" .
<Zoral> <Brand_name_of> "Acyclovir" .
<IDAC> <Has_modality> "Chemotherapy" .
<Carboplatin_and_Irinotecan> <Has_modality> "Chemotherapy" .
<Triptorelin> <Has_FDA_indication> "Prostate_cancer" .
<Tamoxifen_and_OFS> <Has_context> "Adjuvant_therapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Whole_brain_irradiation" .
<Small_cell_lung_cancer> <Accepted_use_of> "Vinorelbine_monotherapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Vinorelbine" .
<Small_cell_lung_cancer> <Accepted_use_of> "Vindesine" .
<Small_cell_lung_cancer> <Accepted_use_of> "Vincristine" .
<Small_cell_lung_cancer> <Accepted_use_of> "VMV-VAC" .
<Small_cell_lung_cancer> <Accepted_use_of> "VIP" .
<Small_cell_lung_cancer> <Accepted_use_of> "Topotecan_monotherapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Topotecan" .
<Small_cell_lung_cancer> <Accepted_use_of> "Teniposide_monotherapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Teniposide" .
<Small_cell_lung_cancer> <Accepted_use_of> "Temozolomide_monotherapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Temozolomide" .
<Small_cell_lung_cancer> <Accepted_use_of> "Sunitinib_monotherapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Sunitinib" .
<Small_cell_lung_cancer> <Accepted_use_of> "Radiation_therapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Placebo" .
<Small_cell_lung_cancer> <Accepted_use_of> "Pembrolizumab_monotherapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Pembrolizumab" .
<Small_cell_lung_cancer> <Accepted_use_of> "Paclitaxel_monotherapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Paclitaxel" .
<Small_cell_lung_cancer> <Accepted_use_of> "PCE" .
<Small_cell_lung_cancer> <Accepted_use_of> "PCDE" .
<Small_cell_lung_cancer> <Accepted_use_of> "Observation" .
<Small_cell_lung_cancer> <Accepted_use_of> "Nivolumab_monotherapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Nivolumab" .
<Small_cell_lung_cancer> <Accepted_use_of> "Methotrexate,_RT,_Cyclophosphamide" .
<Small_cell_lung_cancer> <Accepted_use_of> "Methotrexate" .
<Small_cell_lung_cancer> <Accepted_use_of> "MACC" .
<Small_cell_lung_cancer> <Accepted_use_of> "Irinotecan_monotherapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Irinotecan" .
<Small_cell_lung_cancer> <Accepted_use_of> "Ipilimumab_monotherapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Ipilimumab_and_Nivolumab" .
<Small_cell_lung_cancer> <Accepted_use_of> "Ifosfamide_monotherapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Ifosfamide_and_Paclitaxel" .
<Small_cell_lung_cancer> <Accepted_use_of> "Ifosfamide" .
<Small_cell_lung_cancer> <Accepted_use_of> "ICE" .
<Small_cell_lung_cancer> <Accepted_use_of> "Gemcitabine_monotherapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Gemcitabine" .
<Small_cell_lung_cancer> <Accepted_use_of> "Etoposide_monotherapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Etoposide" .
<Small_cell_lung_cancer> <Accepted_use_of> "Epirubicin_and_Ifosfamide" .
<Small_cell_lung_cancer> <Accepted_use_of> "Epirubicin" .
<Small_cell_lung_cancer> <Accepted_use_of> "EVI" .
<Small_cell_lung_cancer> <Accepted_use_of> "Durvalumab_monotherapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Doxorubicin" .
<Small_cell_lung_cancer> <Accepted_use_of> "Docetaxel_monotherapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Docetaxel" .
<Small_cell_lung_cancer> <Accepted_use_of> "Cyclophosphamide,_Lomustine,_Methotrexate" .
<Small_cell_lung_cancer> <Accepted_use_of> "Cyclophosphamide" .
<Small_cell_lung_cancer> <Accepted_use_of> "Cisplatin,_Etoposide,_RT" .
<Small_cell_lung_cancer> <Accepted_use_of> "Cisplatin,_Etoposide,_Irinotecan" .
<Small_cell_lung_cancer> <Accepted_use_of> "Cisplatin,_Etoposide,_Durvalumab" .
<Small_cell_lung_cancer> <Accepted_use_of> "Cisplatin,_Etoposide,_Bevacizumab" .
<Small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_and_Irinotecan" .
<Small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_and_Etoposide" .
<Small_cell_lung_cancer> <Accepted_use_of> "Cisplatin" .
<Small_cell_lung_cancer> <Accepted_use_of> "Carboplatin,_Paclitaxel,_Ipilimumab" .
<Small_cell_lung_cancer> <Accepted_use_of> "Carboplatin,_Etoposide,_RT" .
<Small_cell_lung_cancer> <Accepted_use_of> "Carboplatin,_Etoposide,_Durvalumab" .
<Small_cell_lung_cancer> <Accepted_use_of> "Carboplatin,_Etoposide,_Bevacizumab" .
<Small_cell_lung_cancer> <Accepted_use_of> "Carboplatin,_Etoposide,_Atezolizumab" .
<Small_cell_lung_cancer> <Accepted_use_of> "Carboplatin_and_Irinotecan" .
<Small_cell_lung_cancer> <Accepted_use_of> "Carboplatin_and_Etoposide" .
<Small_cell_lung_cancer> <Accepted_use_of> "Carboplatin" .
<Small_cell_lung_cancer> <Accepted_use_of> "CEV_and_RT" .
<Small_cell_lung_cancer> <Accepted_use_of> "CEV_(Cyclophosphamide/Etoposide)" .
<Small_cell_lung_cancer> <Accepted_use_of> "CEV_(Cyclophosphamide/Epirubicin)" .
<Small_cell_lung_cancer> <Accepted_use_of> "CEV_(Carboplatin/Etoposide)" .
<Small_cell_lung_cancer> <Accepted_use_of> "CDE" .
<Small_cell_lung_cancer> <Accepted_use_of> "CC/DE_and_RT" .
<Small_cell_lung_cancer> <Accepted_use_of> "CAVE" .
<Small_cell_lung_cancer> <Accepted_use_of> "CAV/PE" .
<Small_cell_lung_cancer> <Accepted_use_of> "CAV_and_RT" .
<Small_cell_lung_cancer> <Accepted_use_of> "CAV" .
<Small_cell_lung_cancer> <Accepted_use_of> "Bevacizumab-bvzr" .
<Small_cell_lung_cancer> <Accepted_use_of> "Bevacizumab-awwb" .
<Small_cell_lung_cancer> <Accepted_use_of> "Bevacizumab_monotherapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Bevacizumab" .
<Small_cell_lung_cancer> <Accepted_use_of> "Best_supportive_care" .
<Small_cell_lung_cancer> <Accepted_use_of> "Bendamustine_monotherapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Bendamustine" .
<Small_cell_lung_cancer> <Accepted_use_of> "Belotecan_and_Cisplatin" .
<Small_cell_lung_cancer> <Accepted_use_of> "Belotecan" .
<Small_cell_lung_cancer> <Accepted_use_of> "BACO" .
<Small_cell_lung_cancer> <Accepted_use_of> "Atezolizumab_monotherapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Atezolizumab" .
<Small_cell_lung_cancer> <Accepted_use_of> "Amrubicin_monotherapy" .
<Small_cell_lung_cancer> <Accepted_use_of> "Amrubicin" .
<Small_cell_lung_cancer> <Accepted_use_of> "ACE" .
<S-1_monotherapy> <Mapped_from> "S-1_monotherapy" .
<Tacrolimus> <May_have_route> "Oral" .
<Tacrolimus> <May_have_route> "Intravenous" .
<Cardirene> <Brand_name_of> "Aspirin" .
<Etoposide,_Ifosfamide,_Imatinib> <Has_antineoplastic> "Imatinib" .
<Etoposide,_Ifosfamide,_Imatinib> <Has_antineoplastic> "Ifosfamide" .
<Etoposide,_Ifosfamide,_Imatinib> <Has_antineoplastic> "Etoposide" .
<VIM> <Maps_to> "VIM" .
<MINE> <Maps_to> "MINE" .
<Cefixime> <May_have_route> "Oral" .
<Mantle_cell_lymphoma> <Is_a> "Non-Hodgkin_lymphoma" .
<Mantle_cell_lymphoma> <Is_a> "Aggressive_lymphoma" .
<FRD> <Has_accepted_use> "Multiple_myeloma" .
<FOLFIRINOX> <Maps_to> "FOLFIRINOX" .
<Rho(D)_immune_globulin> <Has_accepted_use> "Immune_thrombocytopenia" .
<Dexrazoxane> <Has_brand_name> "Zinecard" .
<Dexrazoxane> <Has_brand_name> "Totect" .
<Dexrazoxane> <Has_brand_name> "Savene" .
<Dexrazoxane> <Has_brand_name> "Cyrdanax" .
<Dexrazoxane> <Has_brand_name> "Cardioxane" .
<Cyclosporine,_Methotrexate,_ATG> <Is_current_in> "Graft_versus_host_disease" .
<Everolimus> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Everolimus> <Has_accepted_use> "Thymoma" .
<Everolimus> <Has_accepted_use> "Renal_cell_carcinoma" .
<Everolimus> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Everolimus> <Has_accepted_use> "Pancreatic_NET" .
<Everolimus> <Has_accepted_use> "Neuroendocrine_tumor" .
<Everolimus> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Everolimus> <Has_accepted_use> "Hodgkin_lymphoma" .
<Everolimus> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Everolimus> <Has_accepted_use> "Breast_cancer" .
<Everolimus> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Lanreotide_monotherapy> <Has_accepted_use> "Neuroendocrine_tumor" .
<Dalteparin> <Has_brand_name> "Resolmin" .
<Dalteparin> <Has_brand_name> "Low_Liquemin" .
<Dalteparin> <Has_brand_name> "Ligofragmin" .
<Dalteparin> <Has_brand_name> "Hepagumin" .
<Dalteparin> <Has_brand_name> "Hepachron" .
<Dalteparin> <Has_brand_name> "Fresubaru" .
<Dalteparin> <Has_brand_name> "Fragminject" .
<Dalteparin> <Has_brand_name> "Fragmine" .
<Dalteparin> <Has_brand_name> "Fragmin" .
<Dalteparin> <Has_brand_name> "Fluzepamin" .
<Dalteparin> <Has_brand_name> "Daltepin" .
<Dalteparin> <Has_brand_name> "Daltepan" .
<Irinotecan,_Temozolomide,_Dinutuximab> <Has_modality> "Immunotherapy" .
<Irinotecan,_Temozolomide,_Dinutuximab> <Has_modality> "Chemotherapy" .
<BVR> <Has_context> "Non-curative_therapy" .
<Geroxalen> <Brand_name_of> "Methoxsalen" .
<Bactille-TS> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<FEC> <Has_context> "Non-curative_first-line_therapy" .
<FEC> <Has_context> "Neoadjuvant_therapy" .
<FEC> <Has_context> "Adjuvant_therapy" .
<Flutamide_and_Leuprolide> <Has_modality> "Hormonotherapy" .
<Intravenous_Immunoglobulin> <Has_accepted_use> "Heparin-induced_thrombocytopenia" .
<Octreotide_monotherapy> <Mapped_from> "Octreotide_monotherapy" .
<Carboplatin,_Etoposide,_Durvalumab> <Mapped_from> "Carboplatin,_Etoposide,_Durvalumab" .
<R-EPOCH,_dose-escalated> <Maps_to> "R-EPOCH,_dose-escalated" .
<Sirolimus_and_Vorinostat> <Has_accepted_use> "Hodgkin_lymphoma" .
<Sonexa> <Brand_name_of> "Dexamethasone" .
<Ves-ATRA> <Brand_name_of> "All-trans_retinoic_acid" .
<Trimerazin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Trifluridine_and_tipiracil> <Has_FDA_indication> "Gastric_cancer" .
<Zanubrutinib> <Is_a> "Kinase_inhibitor" .
<Zanubrutinib> <Is_a> "BTK_inhibitor" .
<Prednax> <Brand_name_of> "Prednisone" .
<VAdCA> <Mapped_from> "VAdCA" .
<PD> <Is_current_in> "Multiple_myeloma" .
<Tamoxifen_and_OFS> <Has_modality> "Hormonotherapy" .
<Cisplatin,_Docetaxel,_RT> <Mapped_from> "Cisplatin,_Docetaxel,_RT" .
<CEP> <Maps_to> "CEP" .
<Cross-disciplinary_condition> <Subsumes> "Skin_cancer" .
<Cross-disciplinary_condition> <Subsumes> "Pediatric_cancer" .
<Cross-disciplinary_condition> <Subsumes> "CNS_cancer" .
<Cross-disciplinary_condition> <Subsumes> "Bone_marrow_failure_syndrome" .
<Cross-disciplinary_condition> <Subsumes> "Alloimmune_hematologic_condition" .
<Doxoruben> <Brand_name_of> "Doxorubicin" .
<Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone> <Has_supportive_med> "Folinic_acid" .
<X-Plat> <Brand_name_of> "Oxaliplatin" .
<Vinflunine_monotherapy> <Mapped_from> "Vinflunine_monotherapy" .
<MA-BCD> <Has_accepted_use> "Osteosarcoma" .
<Brigatinib> <Has_brand_name> "Alunbrig" .
<HAD> <Has_modality> "Chemotherapy" .
<Methotrexate_and_Tacrolimus> <Has_accepted_use> "Graft_versus_host_disease" .
<MPR> <Maps_to> "MPR" .
<Obinutuzumab_monotherapy> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Obinutuzumab_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<Obinutuzumab_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Obinutuzumab_monotherapy> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<CF_and_Trastuzumab> <Has_antineoplastic> "Trastuzumab" .
<CF_and_Trastuzumab> <Has_antineoplastic> "Fluorouracil" .
<CF_and_Trastuzumab> <Has_antineoplastic> "Cisplatin" .
<Lykaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Macrolin> <Brand_name_of> "Aldesleukin" .
<AVCF> <Mapped_from> "AVCF" .
<FCR,_then_allo_HSCT> <Is_a> "Rituximab-containing_regimen" .
<FLAG-DNX> <Mapped_from> "FLAG-DNX" .
<Pehatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Topotecan_and_Bevacizumab> <Has_context> "Non-curative_therapy" .
<Bevacizumab-containing_therapy> <Has_accepted_use> "triple_negative_Breast_cancer" .
<Bevacizumab-containing_therapy> <Has_accepted_use> "Breast_cancer" .
<131Iodine-Tositumomab_monotherapy> <Mapped_from> "131Iodine-Tositumomab_monotherapy" .
<Risofos> <Brand_name_of> "Risedronate" .
<Sirolimus_and_Prednisone> <Maps_to> "Sirolimus_and_Prednisone" .
<Cicoxil> <Brand_name_of> "Warfarin" .
<Capecitabine_and_Fulvestrant> <Is_current_in> "Breast_cancer" .
<Etoposide> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Etoposide> <Is_a> "Topoisomerase_inhibitor" .
<Etoposide> <Is_a> "Irritant" .
<Vinblastina> <Brand_name_of> "Vinblastine" .
<GCP> <Is_current_in> "Non-small_cell_lung_cancer" .
<GCP> <Is_current_in> "Adenocarcinoma_of_unknown_primary" .
<Levoleucovorin> <Supportive_med_of> "MATRix" .
<Levoleucovorin> <Supportive_med_of> "Cytarabine,_Methotrexate,_Rituximab" .
<Levoleucovorin> <Supportive_med_of> "CYM" .
<T-cell_prolymphocytic_leukemia> <Is_a> "T-cell_leukemia" .
<DEP> <Maps_to> "DEP" .
<Pradax> <Brand_name_of> "Dabigatran" .
<Marqibo> <Brand_name_of> "Vincristine_liposomal" .
<Health_Canada_approved_drug> <Is_a> "Approved_drug" .
<CMFT> <Has_accepted_use> "Breast_cancer" .
<Etopoxan> <Brand_name_of> "Etoposide" .
<Ivosidenib_monotherapy> <Has_accepted_use> "IDH-mutated_Acute_myeloid_leukemia" .
<Ivosidenib_monotherapy> <Has_accepted_use> "Cholangiocarcinoma" .
<Ivosidenib_monotherapy> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Doxorubicin_pegylated_liposomal_monotherapy> <Has_context> "Non-curative_therapy" .
<Doxorubicin_pegylated_liposomal_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Doxorubicin_pegylated_liposomal_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Doxorubicin_pegylated_liposomal_monotherapy> <Has_context> "All_lines_of_therapy" .
<IT_Methotrexate_and_WBRT> <Has_local_therapy> "Methotrexate" .
<Hyper-CVAD_and_Dasatinib> <Maps_to> "Hyper-CVAD_and_Dasatinib" .
<Virupos> <Brand_name_of> "Acyclovir" .
<Cutaneous_squamous_cell_carcinoma> <Accepted_use_of> "Observation" .
<Cutaneous_squamous_cell_carcinoma> <Accepted_use_of> "Isotretinoin" .
<Cutaneous_squamous_cell_carcinoma> <Accepted_use_of> "Interferon_alfa-2a" .
<Cutaneous_squamous_cell_carcinoma> <Accepted_use_of> "Doxorubicin" .
<Cutaneous_squamous_cell_carcinoma> <Accepted_use_of> "Cisplatin,_Interferon_alfa-2a,_Isotretinoin" .
<Cutaneous_squamous_cell_carcinoma> <Accepted_use_of> "Cisplatin_and_Doxorubicin" .
<Cutaneous_squamous_cell_carcinoma> <Accepted_use_of> "Cisplatin" .
<Cutaneous_squamous_cell_carcinoma> <Accepted_use_of> "Cetuximab_monotherapy" .
<Cutaneous_squamous_cell_carcinoma> <Accepted_use_of> "Cetuximab" .
<Cutaneous_squamous_cell_carcinoma> <Accepted_use_of> "Cemiplimab_monotherapy" .
<Cutaneous_squamous_cell_carcinoma> <Accepted_use_of> "Cemiplimab" .
<Cutaneous_squamous_cell_carcinoma> <Accepted_use_of> "Bleomycin_and_Cisplatin" .
<Cutaneous_squamous_cell_carcinoma> <Accepted_use_of> "Bleomycin" .
<ECX> <Is_current_in> "Gastric_cancer" .
<ECX> <Is_current_in> "Esophageal_cancer" .
<Apalutamide> <Has_accepted_use> "Prostate_cancer" .
<Hydroxyurea_and_Plicamycin> <Mapped_from> "Hydroxyurea_and_Plicamycin" .
<Carboplatin,_Etoposide,_Bevacizumab> <Has_accepted_use> "Small_cell_lung_cancer" .
<PAC> <Has_context> "Non-curative_first-line_therapy" .
<PAC> <Has_context> "Neoadjuvant_therapy" .
<PAC> <Has_context> "Adjuvant_therapy" .
<D-ZAPO> <Is_historical_in> "Acute_myeloid_leukemia" .
<VBMCP> <Maps_to> "VBMCP" .
<Carboplatin> <May_have_route> "Intravenous" .
<BuCy,_then_allo_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<BuCy,_then_allo_HSCT> <Has_antineoplastic> "Busulfan" .
<BuCy,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<VIM> <Has_modality> "Chemotherapy" .
<Reduction_of_immunosuppression> <Has_context> "All_lines_of_therapy" .
<Cisplatin,_Doxorubicin,_Paclitaxel> <Has_supportive_med> "Filgrastim" .
<PCO> <Has_supportive_med> "Valacyclovir" .
<PCO> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<PCO> <Has_supportive_med> "Pegfilgrastim" .
<PCO> <Has_supportive_med> "Methylprednisolone" .
<PCO> <Has_supportive_med> "Allopurinol" .
<EIA> <Has_modality> "Chemotherapy" .
<Ronic> <Brand_name_of> "Dexamethasone" .
<Chemitrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Folic_acid> <May_have_route> "Oral" .
<Folic_acid> <May_have_route> "Intravenous" .
<Emesis_prevention> <Subsumes> "Tropisetron" .
<Emesis_prevention> <Subsumes> "Thalidomide" .
<Emesis_prevention> <Subsumes> "Steroid" .
<Emesis_prevention> <Subsumes> "Serotonin_5-HT3_antagonist" .
<Emesis_prevention> <Subsumes> "Scopolamine" .
<Emesis_prevention> <Subsumes> "Rolapitant" .
<Emesis_prevention> <Subsumes> "Ramosetron" .
<Emesis_prevention> <Subsumes> "Promethazine" .
<Emesis_prevention> <Subsumes> "Prochlorperazine" .
<Emesis_prevention> <Subsumes> "Phenothiazine" .
<Emesis_prevention> <Subsumes> "Palonosetron" .
<Emesis_prevention> <Subsumes> "Ondansetron" .
<Emesis_prevention> <Subsumes> "Olanzapine" .
<Emesis_prevention> <Subsumes> "Neurokinin_1_(NK1)_antagonist" .
<Emesis_prevention> <Subsumes> "Netupitant_and_palonosetron" .
<Emesis_prevention> <Subsumes> "Nabilone" .
<Emesis_prevention> <Subsumes> "Muscarinic_receptor_antagonist" .
<Emesis_prevention> <Subsumes> "Metoclopramide" .
<Emesis_prevention> <Subsumes> "Lorazepam" .
<Emesis_prevention> <Subsumes> "Haloperidol" .
<Emesis_prevention> <Subsumes> "Granisetron" .
<Emesis_prevention> <Subsumes> "Fosaprepitant" .
<Emesis_prevention> <Subsumes> "Dronabinol" .
<Emesis_prevention> <Subsumes> "Dopamine_receptor_antagonist" .
<Emesis_prevention> <Subsumes> "Domperidone" .
<Emesis_prevention> <Subsumes> "Dolasetron" .
<Emesis_prevention> <Subsumes> "Cannabinoid" .
<Emesis_prevention> <Subsumes> "Benzodiazepine" .
<Emesis_prevention> <Subsumes> "Aprepitant" .
<Emesis_prevention> <Subsumes> "Antipsychotic" .
<Emesis_prevention> <Subsumes> "Alprazolam" .
<Riboepi> <Brand_name_of> "Epirubicin" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Z-BEAM,_then_auto_HSCT" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Z-BEAM" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "VR" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "VDC" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "VAD_doxil" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "VAD" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Temozolomide_monotherapy" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Temozolomide_and_RT" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Temozolomide_and_Bevacizumab" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "TD" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Stanford_V" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "SMILE" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "SC-EPOCH-RR" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Rd" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "R2CHOP" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "R-miniCEOP" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "R-Hyper-CVAD/R-MA" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "R-FCM" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "R-EPOCH,_dose-escalated" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "R-EPOCH" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "R-CHOP-14_(Prednisolone)" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "R-CHOP_(Prednisolone)" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "R-CHOP" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "ProMACE-CytaBOM" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "POMP" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "PCR" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "PCO" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "PAD" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "MACOP-B" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "M-DEX" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "KRd" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Hyper-CVAD/MA" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Hyper-CVAD_and_Ponatinib" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Hyper-CVAD_and_Imatinib" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Hyper-CVAD_and_Dasatinib" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "HLH-94_regimen" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "HLH-2004_regimen" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "HDMP-R" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Fludarabine_monotherapy" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "FluCam" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "FR" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "FCR" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "FCA" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "FC" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Everolimus_monotherapy" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Eculizumab_monotherapy" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "EPOCH" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "EAR_and_G-CSF" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "DA-R-EPOCH" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "DA-EPOCH" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Cladribine_monotherapy" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Chlorambucil_monotherapy" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Carboplatin_and_nab-Paclitaxel" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "CTD" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "CRd" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "CHOP" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "CFAR" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "CC" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "CBV,_then_auto_HSCT" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "CBV" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Bortezomib_monotherapy" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "BiRd" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Bendamustine_and_Ofatumumab" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "BR" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "BEAM,_then_auto_HSCT" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "BEAM" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "AspaMetDex_(Erwinaze)" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "AspaMetDex" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Alemtuzumab_monotherapy" .
<Trimethoprim-Sulfamethoxazole> <Supportive_med_of> "Alemtuzumab_and_Rituximab" .
<Tamoxifen> <Antineoplastic_of> "Trastuzumab_and_ET" .
<Tamoxifen> <Antineoplastic_of> "Tamoxifen_monotherapy" .
<Tamoxifen> <Antineoplastic_of> "Tamoxifen_and_Prednisolone" .
<Tamoxifen> <Antineoplastic_of> "Tamoxifen_and_OFS" .
<Tamoxifen> <Antineoplastic_of> "TAD_(Tamoxifen)" .
<Tamoxifen> <Antineoplastic_of> "T-DM1_and_ET" .
<Tamoxifen> <Antineoplastic_of> "Ribociclib_and_Tamoxifen" .
<Tamoxifen> <Antineoplastic_of> "PT" .
<Tamoxifen> <Antineoplastic_of> "PFT" .
<Tamoxifen> <Antineoplastic_of> "Megestrol_and_Tamoxifen" .
<Tamoxifen> <Antineoplastic_of> "Medroxyprogesterone_and_Tamoxifen" .
<Tamoxifen> <Antineoplastic_of> "Goserelin_and_Tamoxifen" .
<Tamoxifen> <Antineoplastic_of> "Everolimus_and_Tamoxifen" .
<Tamoxifen> <Antineoplastic_of> "Dacarbazine_and_Tamoxifen" .
<Tamoxifen> <Antineoplastic_of> "Cisplatin,_Dacarbazine,_Tamoxifen" .
<Tamoxifen> <Antineoplastic_of> "CMFT" .
<Tamoxifen> <Antineoplastic_of> "CMFPT" .
<Tamoxifen> <Antineoplastic_of> "ACT" .
<R-GDP> <Has_accepted_use> "Transformed_lymphoma" .
<R-GDP> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<R-GDP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Cyproterone_acetate_monotherapy> <Is_historical_in> "Prostate_cancer" .
<RICER> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Hepatoblastoma> <Is_a> "Pediatric_cancer" .
<TBI,_then_auto_HSCT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Thomapyrin_Akut> <Brand_name_of> "Aspirin" .
<TFC,_then_allo_HSCT> <Mapped_from> "TFC,_then_allo_HSCT" .
<Decason> <Brand_name_of> "Dexamethasone" .
<Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone> <Has_accepted_use> "CNS_lymphoma" .
<Cytarabine_and_Interferon_alfa-2b> <Has_context> "Non-curative_first-line_therapy" .
<Deferoxamine> <Is_a> "Hematology_medication" .
<Deferoxamine> <Is_a> "Chelator" .
<Arsenic_trioxide,_ATRA,_Idarubicin> <Maps_to> "Arsenic_trioxide,_ATRA,_Idarubicin" .
<Tegafur_and_Uracil> <Maps_to> "Tegafur_and_Uracil" .
<Mitotane_monotherapy> <Mapped_from> "Mitotane_monotherapy" .
<COPAD/CYVE> <Has_accepted_use> "Burkitt_lymphoma" .
<Ravulizumab_monotherapy> <Mapped_from> "Ravulizumab_monotherapy" .
<High-dose_Interleukin-2> <Is_current_in> "Renal_cell_carcinoma" .
<High-dose_Interleukin-2> <Is_current_in> "Melanoma" .
<VR-CHOP> <Maps_to> "VR-CHOP" .
<Hyper-CVAD_and_Imatinib> <Has_context> "Induction_therapy" .
<VIDE> <Has_modality> "Chemotherapy" .
<BACO> <Has_context> "Induction_therapy" .
<IT_Cytarabine,_Methotrexate,_WBRT> <Maps_to> "IT_Cytarabine,_Methotrexate,_WBRT" .
<Vinorelbine> <Supportive_med_of> "nab-Paclitaxel_monotherapy" .
<Lumoxiti> <Brand_name_of> "Moxetumomab_pasudotox" .
<FLEP> <Is_current_in> "Esophageal_cancer" .
<CHOP> <Has_context> "Upfront_therapy" .
<CHOP> <Has_context> "Non-curative_therapy" .
<CHOP> <Has_context> "Non-curative_first-line_therapy" .
<CHOP> <Has_context> "Induction_therapy" .
<Gemcitabine_and_Bevacizumab> <Has_antineoplastic> "Gemcitabine" .
<Gemcitabine_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Nebupent> <Brand_name_of> "Pentamidine" .
<FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)> <Is_a> "Irinotecan-containing_regimen" .
<FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)> <Is_a> "Bevacizumab-containing_regimen" .
<T-cell_lymphoma> <Subsumes> "Peripheral_T-cell_lymphoma" .
<T-cell_lymphoma> <Subsumes> "NK-_and_T-cell_lymphoma" .
<T-cell_lymphoma> <Subsumes> "Large_granular_lymphocytic_leukemia" .
<T-cell_lymphoma> <Subsumes> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<T-cell_lymphoma> <Subsumes> "Cutaneous_T-cell_lymphoma" .
<T-cell_lymphoma> <Subsumes> "Anaplastic_large_cell_lymphoma" .
<T-cell_lymphoma> <Subsumes> "Adult_T-cell_leukemia-lymphoma" .
<R-CMD> <Maps_to> "R-CMD" .
<Fluoxymesterone_monotherapy> <Has_antineoplastic> "Fluoxymesterone" .
<Cisplatin,_Etoposide,_Irinotecan> <Has_accepted_use> "Small_cell_lung_cancer" .
<Gemcitabine,_Cisplatin,_S-1> <Mapped_from> "Gemcitabine,_Cisplatin,_S-1" .
<LOPP> <Mapped_from> "LOPP" .
<Alendex> <Brand_name_of> "Alendronate" .
<DCTER> <Is_historical_in> "Acute_myeloid_leukemia" .
<7_plus_3d> <Has_context> "Induction_therapy" .
<ATryn> <Brand_name_of> "Antithrombin_III" .
<FRD> <Has_modality> "Chemotherapy" .
<Herceptin_Hylecta> <Brand_name_of> "Trastuzumab_and_hyaluronidase" .
<VACA/IE> <Is_current_in> "Ewing_sarcoma" .
<ACVBP> <Has_modality> "Chemotherapy" .
<Active_surveillance> <Has_context> "Definitive_therapy" .
<Taxol> <Brand_name_of> "Paclitaxel" .
<Comoxol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Dara-PD> <Has_accepted_use> "Multiple_myeloma" .
<ATRA_monotherapy> <Has_modality> "Chemotherapy" .
<Ublituximab> <Is_a> "Investigational_drug" .
<Ublituximab> <Is_a> "Antibody_medication" .
<Ublituximab> <Is_a> "Anti-CD20_antibody" .
<Pomalidomide_monotherapy> <Has_modality> "Chemotherapy" .
<Carfilzomib_and_Panobinostat> <Has_accepted_use> "Multiple_myeloma" .
<Eribulin> <May_have_route> "Intravenous" .
<Gemcitabine,_Cisplatin,_S-1> <Has_antineoplastic> "Tegafur_gimeracil_oteracil" .
<Gemcitabine,_Cisplatin,_S-1> <Has_antineoplastic> "Gemcitabine" .
<Gemcitabine,_Cisplatin,_S-1> <Has_antineoplastic> "Cisplatin" .
<Brentuximab_vedotin> <Has_FDA_indication> "Peripheral_T-cell_lymphoma" .
<Brentuximab_vedotin> <Has_FDA_indication> "Hodgkin_lymphoma" .
<Brentuximab_vedotin> <Has_FDA_indication> "Cutaneous_T-cell_lymphoma" .
<Brentuximab_vedotin> <Has_FDA_indication> "Anaplastic_large_cell_lymphoma" .
<CHOEP-14> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<CHOEP-14> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<CHOEP-14> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<Dacrosone> <Brand_name_of> "Dexamethasone" .
<Biologic_product> <Subsumes> "Tumor_vaccine" .
<Biologic_product> <Subsumes> "Fractionated_plasma_product" .
<Biologic_product> <Subsumes> "Cellular_therapy" .
<VNCOP-B> <Is_a> "Anthracycline-containing_regimen" .
<Dacarbazine_and_Tamoxifen> <Has_antineoplastic> "Tamoxifen" .
<Dacarbazine_and_Tamoxifen> <Has_antineoplastic> "Dacarbazine" .
<mFOLFOX6_and_Cetuximab> <Is_current_in> "Esophageal_cancer" .
<mFOLFOX6_and_Cetuximab> <Is_current_in> "Colon_cancer" .
<Denosumab> <May_have_route> "Intravenous" .
<ICL> <Has_accepted_use> "Acute_myeloid_leukemia" .
<T-DM1_and_ET> <Has_modality> "Hormonotherapy" .
<T-DM1_and_ET> <Has_modality> "Chemotherapy" .
<CLF> <Has_accepted_use> "Gastric_cancer" .
<CLF> <Has_accepted_use> "Esophageal_cancer" .
<Regtin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Gefitinib> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Arsenic_trioxide,_ATRA,_Idarubicin> <Has_modality> "Chemotherapy" .
<Riboposid> <Brand_name_of> "Etoposide" .
<BR_and_Idelalisib> <Maps_to> "BR_and_Idelalisib" .
<Cisplatin_and_Pemetrexed> <Maps_to> "Cisplatin_and_Pemetrexed" .
<Quizartinib> <Antineoplastic_of> "Quizartinib_monotherapy" .
<Irinotecan,_Temozolomide,_Dinutuximab> <Has_accepted_use> "Neuroblastoma" .
<ARA> <Brand_name_of> "Cytarabine" .
<O_Folin> <Brand_name_of> "Folinic_acid" .
<ECH> <Is_current_in> "Breast_cancer" .
<Enison> <Brand_name_of> "Vindesine" .
<Acalabrutinib_monotherapy> <Maps_to> "Acalabrutinib_monotherapy" .
<Cyproterone_acetate> <Has_brand_name> "Androcur" .
<Antibody-drug_conjugate> <Subsumes> "Vadastuximab_talirine" .
<Antibody-drug_conjugate> <Subsumes> "Sacituzumab_govitecan" .
<Antibody-drug_conjugate> <Subsumes> "Polatuzumab_vedotin" .
<Antibody-drug_conjugate> <Subsumes> "Inotuzumab_ozogamicin" .
<Antibody-drug_conjugate> <Subsumes> "Gemtuzumab_ozogamicin" .
<Antibody-drug_conjugate> <Subsumes> "Fam-trastuzumab_deruxtecan" .
<Antibody-drug_conjugate> <Subsumes> "Enfortumab_vedotin" .
<Antibody-drug_conjugate> <Subsumes> "Denintuzumab_mafodotin" .
<Antibody-drug_conjugate> <Subsumes> "Coltuximab_ravtansine" .
<Antibody-drug_conjugate> <Subsumes> "Brentuximab_vedotin" .
<Antibody-drug_conjugate> <Subsumes> "Ado-trastuzumab_emtansine" .
<Tosedostat> <Has_accepted_use> "Acute_myeloid_leukemia" .
<SCC_of_unknown_primary> <Accepted_use_of> "Paclitaxel" .
<SCC_of_unknown_primary> <Accepted_use_of> "PCF" .
<SCC_of_unknown_primary> <Accepted_use_of> "Fluorouracil" .
<SCC_of_unknown_primary> <Accepted_use_of> "Docetaxel" .
<SCC_of_unknown_primary> <Accepted_use_of> "DCF" .
<SCC_of_unknown_primary> <Accepted_use_of> "Cisplatin" .
<Vandetanib_monotherapy> <Has_antineoplastic> "Vandetanib" .
<m-BNCOD> <Mapped_from> "m-BNCOD" .
<TC_and_Nintedanib> <Is_current_in> "Ovarian_cancer" .
<Valrubicin_monotherapy> <Has_antineoplastic> "Valrubicin" .
<Medidex> <Brand_name_of> "Dexamethasone" .
<Osteostab> <Brand_name_of> "Clodronate" .
<Formestane_monotherapy> <Has_antineoplastic> "Formestane" .
<R-DexaBEAM> <Is_a> "Rituximab-containing_regimen" .
<Chlorambucil_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Chlorambucil_monotherapy> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Avorax> <Brand_name_of> "Acyclovir" .
<Formestane_monotherapy> <Is_historical_in> "Breast_cancer" .
<Sone> <Brand_name_of> "Prednisone" .
<BMP> <Has_modality> "Chemotherapy" .
<Selective_inhibitors_of_nuclear_export> <Is_a> "Chemotherapeutic" .
<CAV_and_RT> <Is_a> "Anthracycline-containing_regimen" .
<CAFVP> <Mapped_from> "CAFVP" .
<CHOEP-14> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<CHOEP-14> <Is_current_in> "Anaplastic_large_cell_lymphoma" .
<Abditri> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Pentostatin_monotherapy> <Is_current_in> "Hairy_cell_leukemia" .
<Fludarabine> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Fludarabine> <Has_accepted_use> "Transformed_lymphoma" .
<Fludarabine> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Fludarabine> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Fludarabine> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Fludarabine> <Has_accepted_use> "Hodgkin_lymphoma" .
<Fludarabine> <Has_accepted_use> "Follicular_lymphoma" .
<Fludarabine> <Has_accepted_use> "Cold_agglutinin_disease" .
<Fludarabine> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Fludarabine> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Fludarabine> <Has_accepted_use> "Acute_myeloid_leukemia" .
<R-Hyper-CVAD/R-MA> <Maps_to> "R-Hyper-CVAD/R-MA" .
<BCNU/TT> <Has_accepted_use> "Autologous_HSCT" .
<Asciminib> <Is_a> "Kinase_inhibitor" .
<Asciminib> <Is_a> "Investigational_drug" .
<Asciminib> <Is_a> "Bcr-Abl_inhibitor" .
<Hydrocortisone> <Local_therapy_of> "R-COPADM" .
<Hydrocortisone> <Local_therapy_of> "R-CODOX-M/R-IVAC" .
<Hydrocortisone> <Local_therapy_of> "R-CODOX-M" .
<Hydrocortisone> <Local_therapy_of> "R-CHOP" .
<Hydrocortisone> <Local_therapy_of> "IT_Methotrexate_and_Hydrocortisone" .
<Hydrocortisone> <Local_therapy_of> "Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib" .
<Hydrocortisone> <Local_therapy_of> "CYM" .
<Hydrocortisone> <Local_therapy_of> "COPADM" .
<Hydrocortisone> <Local_therapy_of> "COPAD/CYVE" .
<Hydrocortisone> <Local_therapy_of> "COP" .
<Hydrocortisone> <Local_therapy_of> "CODOX-M/IVAC" .
<Hydrocortisone> <Local_therapy_of> "CODOX-M" .
<Hydrocortisone> <Local_therapy_of> "CALGB_10-002_regimen" .
<Hydrocortisone> <Local_therapy_of> "BASIC" .
<Risedronate> <Has_brand_name> "Risofos" .
<Risedronate> <Has_brand_name> "Risedol" .
<Risedronate> <Has_brand_name> "Ribone" .
<Risedronate> <Has_brand_name> "Orafix" .
<Risedronate> <Has_brand_name> "Actonel" .
<Cyclosporine,_Mycophenolate_mofetil,_Sirolimus> <Mapped_from> "Cyclosporine,_Mycophenolate_mofetil,_Sirolimus" .
<Indolent_lymphoma> <Subsumes> "Waldenstroem_macroglobulinemia" .
<Indolent_lymphoma> <Subsumes> "Marginal_zone_lymphoma" .
<Indolent_lymphoma> <Subsumes> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<Indolent_lymphoma> <Subsumes> "Hairy_cell_leukemia" .
<Indolent_lymphoma> <Subsumes> "Follicular_lymphoma" .
<Indolent_lymphoma> <Subsumes> "Chronic_lymphocytic_leukemia" .
<Bonamax> <Brand_name_of> "Alendronate" .
<Panobinostat_monotherapy> <Maps_to> "Panobinostat_monotherapy" .
<Octreotide_LAR_monotherapy> <Has_context> "All_lines_of_therapy" .
<Leucovorine> <Brand_name_of> "Folinic_acid" .
<7_plus_3d_and_Midostaurin> <Has_accepted_use> "FLT3-positive_Acute_myeloid_leukemia" .
<7_plus_3d_and_Midostaurin> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Doxorubicin_pegylated_liposomal_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Doxorubicin_pegylated_liposomal_monotherapy> <Has_accepted_use> "Kaposi_sarcoma" .
<Doxorubicin_pegylated_liposomal_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Carboplatin,_Etoposide,_Atezolizumab> <Mapped_from> "Carboplatin,_Etoposide,_Atezolizumab" .
<PCF> <Has_modality> "Chemotherapy" .
<Gemcitabine_and_Vinorelbine> <Has_context> "Non-curative_therapy" .
<Gemcitabine_and_Vinorelbine> <Has_context> "Non-curative_subsequent-line_therapy" .
<Gemcitabine_and_Vinorelbine> <Has_context> "Non-curative_first-line_therapy" .
<Docetaxel_and_Vandetanib> <Maps_to> "Docetaxel_and_Vandetanib" .
<MVAC> <Has_context> "Non-curative_subsequent-line_therapy" .
<MVAC> <Has_context> "Non-curative_first-line_therapy" .
<MVAC> <Has_context> "Neoadjuvant_therapy" .
<Wilate> <Brand_name_of> "Von_Willebrand_factor_and_factor_VIII_complex_human" .
<RVR> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<CHVP-I> <Has_antineoplastic> "Teniposide" .
<CHVP-I> <Has_antineoplastic> "Prednisone" .
<CHVP-I> <Has_antineoplastic> "Interferon_alfa-2b" .
<CHVP-I> <Has_antineoplastic> "Doxorubicin" .
<CHVP-I> <Has_antineoplastic> "Cyclophosphamide" .
<Cisplatin_and_Ifosfamide> <Is_current_in> "Cervical_cancer" .
<CBV-Mx,_then_auto_HSCT> <Has_accepted_use> "Hodgkin_lymphoma" .
<Meningioma> <Current_treated_by> "Placebo" .
<Cisplatin_and_Paclitaxel> <Has_modality> "Chemotherapy" .
<Vorirx> <Brand_name_of> "Voriconazole" .
<ERBB2-mutated_malignancy> <Is_a> "Malignant_solid_neoplasm" .
<Trimethox> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine> <Has_antineoplastic> "Mercaptopurine" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine> <Has_antineoplastic> "Cytarabine" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine> <Has_antineoplastic> "Cyclophosphamide" .
<Ramucirumab> <Antineoplastic_of> "Ramucirumab_monotherapy" .
<Ramucirumab> <Antineoplastic_of> "Paclitaxel_and_Ramucirumab" .
<Ramucirumab> <Antineoplastic_of> "FOLFIRI_and_Ramucirumab" .
<Ramucirumab> <Antineoplastic_of> "Erlotinib_and_Ramucirumab" .
<Ramucirumab> <Antineoplastic_of> "Docetaxel_and_Ramucirumab" .
<Nivolumab,_then_Ipilimumab> <Is_current_in> "Melanoma" .
<Doxorubicin_pegylated_liposomal_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Indomethacin> <Has_brand_name> "Welldom" .
<Indomethacin> <Has_brand_name> "Tivorbex" .
<Indomethacin> <Has_brand_name> "Inmecin" .
<Indomethacin> <Has_brand_name> "Indoga" .
<Indomethacin> <Has_brand_name> "Indocrom" .
<Indomethacin> <Has_brand_name> "Indocin" .
<Indomethacin> <Has_brand_name> "Indocid" .
<Indomethacin> <Has_brand_name> "Elmetacin" .
<Indomethacin> <Has_brand_name> "Ductaclose" .
<R-MCP_(CCNU)> <Is_a> "Rituximab-containing_regimen" .
<Ondem> <Brand_name_of> "Ondansetron" .
<HDAC_and_G-CSF> <Has_modality> "Growth_factor_therapy" .
<HDAC_and_G-CSF> <Has_modality> "Chemotherapy" .
<MESA/RT> <Mapped_from> "MESA/RT" .
<Capecitabine_and_Mitomycin> <Has_context> "Non-curative_therapy" .
<Procrit> <Brand_name_of> "Epoetin_alfa" .
<Medesone> <Brand_name_of> "Dexamethasone" .
<Flutamide_monotherapy> <Maps_to> "Flutamide_monotherapy" .
<Dexamethasone> <Immunosuppressor_of> "TT4" .
<Dexamethasone> <Immunosuppressor_of> "HLH-94_regimen" .
<Dexamethasone> <Immunosuppressor_of> "HLH-2004_regimen" .
<Dexamethasone> <Immunosuppressor_of> "Dexamethasone_monotherapy" .
<Dexamethasone> <Immunosuppressor_of> "Dexamethasone_and_Rituximab" .
<Dexamethasone> <Immunosuppressor_of> "Dexamethasone_and_Eltrombopag" .
<TICE_BCG> <Brand_name_of> "Bacillus_Calmette-Guerin" .
<ddAC-T> <Has_antineoplastic> "Paclitaxel" .
<ddAC-T> <Has_antineoplastic> "Doxorubicin" .
<ddAC-T> <Has_antineoplastic> "Cyclophosphamide" .
<VI,_then_VDC/IE,_then_VAC,_then_VI> <Is_current_in> "Rhabdomyosarcoma" .
<Arsenic_trioxide_monotherapy> <Is_current_in> "Acute_promyelocytic_leukemia" .
<FOLFOX_chronotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Maintenance_after_upfront_therapy> <Mapped_from> "Maintenance_after_upfront_therapy" .
<Decitabine_monotherapy> <Has_modality> "Chemotherapy" .
<BeGEV> <Mapped_from> "BeGEV" .
<Crizanlizumab_monotherapy> <Has_context> "All_lines_of_therapy" .
<Anti-inhibitor_coagulant_complex> <Has_brand_name> "FEIBA_NF" .
<Asmacortone> <Brand_name_of> "Methylprednisolone" .
<Avatrombopag> <May_have_route> "Oral" .
<EC> <Has_antineoplastic> "Epirubicin" .
<EC> <Has_antineoplastic> "Cyclophosphamide" .
<Ferrous_sulfate> <May_have_route> "Oral" .
<O-ICE> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Nonsteroidal_anti-inflammatory_drugs_(NSAIDs)> <Is_a> "Supportive_medication" .
<Megakaryocyte_growth_factor> <Is_a> "Hematopoietic_growth_factor" .
<Abemaciclib_monotherapy> <Has_modality> "Chemotherapy" .
<Cytarabine_and_Interferon_alfa-2b> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Vinorelbine_monotherapy> <Is_current_in> "Small_cell_lung_cancer" .
<Vinorelbine_monotherapy> <Is_current_in> "Ovarian_cancer" .
<Vinorelbine_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Vinorelbine_monotherapy> <Is_current_in> "Mesothelioma" .
<Vinorelbine_monotherapy> <Is_current_in> "Hodgkin_lymphoma" .
<Vinorelbine_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Vinorelbine_monotherapy> <Is_current_in> "Cervical_cancer" .
<Vinorelbine_monotherapy> <Is_current_in> "Breast_cancer" .
<FAMTX> <Has_antineoplastic> "Methotrexate" .
<FAMTX> <Has_antineoplastic> "Fluorouracil" .
<FAMTX> <Has_antineoplastic> "Doxorubicin" .
<Ruxolitinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Ruxolitinib_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Ruxolitinib_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Ruxolitinib_monotherapy> <Has_context> "Induction_therapy" .
<Ruxolitinib_monotherapy> <Has_context> "All_lines_of_therapy" .
<BO> <Has_modality> "Chemotherapy" .
<Warfilone> <Brand_name_of> "Warfarin" .
<Plicamycin> <Has_brand_name> "Mithracin" .
<FluBuCy,_then_allo_HSCT> <Maps_to> "FluBuCy,_then_allo_HSCT" .
<CVP_(Vinblastine/Prednisone)> <Is_current_in> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<Neratinib> <Has_FDA_indication> "Breast_cancer" .
<Bicalutamide_monotherapy> <Has_antineoplastic> "Bicalutamide" .
<Capecitabine,_Docetaxel,_Oxaliplatin,_RT> <Mapped_from> "Capecitabine,_Docetaxel,_Oxaliplatin,_RT" .
<ATG_(Horse),_Cyclosporine,_G-CSF> <Has_supportive_med> "Prednisolone" .
<ATG_(Horse),_Cyclosporine,_G-CSF> <Has_supportive_med> "Lenograstim" .
<ATG_(Horse),_Cyclosporine,_G-CSF> <Has_supportive_med> "Filgrastim" .
<Sipuleucel-T> <Is_a> "Dendritic_cell_vaccine" .
<GemOx_and_Sorafenib> <Has_antineoplastic> "Sorafenib" .
<GemOx_and_Sorafenib> <Has_antineoplastic> "Oxaliplatin" .
<GemOx_and_Sorafenib> <Has_antineoplastic> "Gemcitabine" .
<Padcev> <Brand_name_of> "Enfortumab_vedotin" .
<CHOEP-21> <Has_context> "Induction_therapy" .
<Cyclophosphamide,_Etoposide,_TBI> <Has_context> "All_lines_of_therapy" .
<Capecitabine,_Oxaliplatin,_RT> <Has_context> "Neoadjuvant_therapy" .
<EPOCH,_dose-escalated> <Has_modality> "Chemotherapy" .
<Atezolizumab> <Is_a> "T-cell_activator" .
<Atezolizumab> <Is_a> "Protein_expression-specific_medication" .
<Atezolizumab> <Is_a> "Immunotherapeutic" .
<Atezolizumab> <Is_a> "Antibody_medication" .
<Atezolizumab> <Is_a> "Anti-PD-L1_antibody" .
<F-MACHOP> <Maps_to> "F-MACHOP" .
<DICEP> <Maps_to> "DICEP" .
<FOLFOXIRI_and_Panitumumab> <Mapped_from> "FOLFOXIRI_and_Panitumumab" .
<Avatrombopag> <Supportive_med_of> "Avatrombopag_monotherapy" .
<Doxorubicin_non-pegylated_liposomal_and_Bevacizumab> <Is_current_in> "Breast_cancer" .
<Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine> <Mapped_from> "Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine" .
<7_plus_3i> <Has_context> "Induction_therapy" .
<BCOP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Carboplatin_and_Etoposide> <Is_current_in> "Small_cell_lung_cancer" .
<Carboplatin_and_Etoposide> <Is_current_in> "Non-small_cell_lung_cancer" .
<Carboplatin_and_Etoposide> <Has_context> "Non-curative_first-line_therapy" .
<Carboplatin_and_Etoposide> <Has_context> "Induction_therapy" .
<VEPEMB> <Is_a> "Anthracycline-containing_regimen" .
<Alloimmune_hematologic_condition> <Is_a> "Cross-disciplinary_condition" .
<Glendan> <Brand_name_of> "Ondansetron" .
<Bone_marrow_failure_syndrome> <Subsumes> "Paroxysmal_nocturnal_hemoglobinuria" .
<Bone_marrow_failure_syndrome> <Subsumes> "Myelodysplastic_syndrome" .
<Bone_marrow_failure_syndrome> <Subsumes> "Aplastic_anemia" .
<Gemcitabine> <Antineoplastic_of> "mFOLFIRINOX,_Gemcitabine,_RT" .
<Gemcitabine> <Antineoplastic_of> "R-GemOx" .
<Gemcitabine> <Antineoplastic_of> "R-GDP" .
<Gemcitabine> <Antineoplastic_of> "R-GCVP" .
<Gemcitabine> <Antineoplastic_of> "PVAG" .
<Gemcitabine> <Antineoplastic_of> "PGC" .
<Gemcitabine> <Antineoplastic_of> "PEFG" .
<Gemcitabine> <Antineoplastic_of> "Ifosfamide_and_Gemcitabine" .
<Gemcitabine> <Antineoplastic_of> "IGEV_and_G-CSF" .
<Gemcitabine> <Antineoplastic_of> "IGEV" .
<Gemcitabine> <Antineoplastic_of> "Gemcitabine/Fluorouracil_and_RT" .
<Gemcitabine> <Antineoplastic_of> "Gemcitabine,_Oxaliplatin,_Paclitaxel" .
<Gemcitabine> <Antineoplastic_of> "Gemcitabine,_Cisplatin,_S-1" .
<Gemcitabine> <Antineoplastic_of> "Gemcitabine,_Cetuximab,_RT" .
<Gemcitabine> <Antineoplastic_of> "Gemcitabine_monotherapy" .
<Gemcitabine> <Antineoplastic_of> "Gemcitabine_and_nab-Paclitaxel" .
<Gemcitabine> <Antineoplastic_of> "Gemcitabine_and_Vinorelbine" .
<Gemcitabine> <Antineoplastic_of> "Gemcitabine_and_Trastuzumab" .
<Gemcitabine> <Antineoplastic_of> "Gemcitabine_and_Sunitinib" .
<Gemcitabine> <Antineoplastic_of> "Gemcitabine_and_S-1" .
<Gemcitabine> <Antineoplastic_of> "Gemcitabine_and_Rituximab" .
<Gemcitabine> <Antineoplastic_of> "Gemcitabine_and_RT" .
<Gemcitabine> <Antineoplastic_of> "Gemcitabine_and_Paclitaxel" .
<Gemcitabine> <Antineoplastic_of> "Gemcitabine_and_Mitomycin" .
<Gemcitabine> <Antineoplastic_of> "Gemcitabine_and_Irinotecan" .
<Gemcitabine> <Antineoplastic_of> "Gemcitabine_and_Bevacizumab" .
<Gemcitabine> <Antineoplastic_of> "GemOx_and_Sorafenib" .
<Gemcitabine> <Antineoplastic_of> "GemOx" .
<Gemcitabine> <Antineoplastic_of> "GVP" .
<Gemcitabine> <Antineoplastic_of> "GVD" .
<Gemcitabine> <Antineoplastic_of> "GTX" .
<Gemcitabine> <Antineoplastic_of> "GIP" .
<Gemcitabine> <Antineoplastic_of> "GEMOX-B" .
<Gemcitabine> <Antineoplastic_of> "GELOX/RT" .
<Gemcitabine> <Antineoplastic_of> "GDPT" .
<Gemcitabine> <Antineoplastic_of> "GDP" .
<Gemcitabine> <Antineoplastic_of> "GCP" .
<Gemcitabine> <Antineoplastic_of> "GCD-R" .
<Gemcitabine> <Antineoplastic_of> "GCD" .
<Gemcitabine> <Antineoplastic_of> "Fluorouracil,_Folinic_acid,_Gemcitabine" .
<Gemcitabine> <Antineoplastic_of> "Erlotinib_and_Gemcitabine" .
<Gemcitabine> <Antineoplastic_of> "Doxorubicin_pegylated_liposomal_and_Gemcitabine" .
<Gemcitabine> <Antineoplastic_of> "Doxorubicin_and_Gemcitabine" .
<Gemcitabine> <Antineoplastic_of> "Docetaxel,_Gemcitabine,_RT" .
<Gemcitabine> <Antineoplastic_of> "Docetaxel_and_Gemcitabine" .
<Gemcitabine> <Antineoplastic_of> "Dacarbazine_and_Gemcitabine" .
<Gemcitabine> <Antineoplastic_of> "DDGP" .
<Gemcitabine> <Antineoplastic_of> "Cisplatin,_Gemcitabine,_nab-Paclitaxel" .
<Gemcitabine> <Antineoplastic_of> "Cisplatin,_Gemcitabine,_RT" .
<Gemcitabine> <Antineoplastic_of> "Cisplatin,_Gemcitabine,_Necitumumab" .
<Gemcitabine> <Antineoplastic_of> "Cisplatin,_Gemcitabine,_Bevacizumab" .
<Gemcitabine> <Antineoplastic_of> "Cisplatin_and_Gemcitabine/Erlotinib" .
<Gemcitabine> <Antineoplastic_of> "Cisplatin_and_Gemcitabine" .
<Gemcitabine> <Antineoplastic_of> "Carboplatin,_Gemcitabine,_Bevacizumab" .
<Gemcitabine> <Antineoplastic_of> "Carboplatin_and_Gemcitabine/Erlotinib" .
<Gemcitabine> <Antineoplastic_of> "Carboplatin_and_Gemcitabine" .
<Gemcitabine> <Antineoplastic_of> "Capecitabine_and_Gemcitabine" .
<Gemcitabine> <Antineoplastic_of> "BeGEV" .
<Abitrexate> <Brand_name_of> "Methotrexate" .
<Rubex> <Brand_name_of> "Doxorubicin" .
<FOLFOX4_and_RT> <Has_accepted_use> "Esophageal_cancer" .
<Ifison> <Brand_name_of> "Prednisone" .
<Ixazomib> <May_have_route> "Oral" .
<NK-_and_T-cell_lymphoma> <Current_treated_by> "SMILE" .
<NK-_and_T-cell_lymphoma> <Current_treated_by> "FluBuCy,_then_allo_HSCT" .
<NK-_and_T-cell_lymphoma> <Current_treated_by> "DDGP" .
<THL_(Taxol)> <Has_context> "Neoadjuvant_therapy" .
<Tegafur_and_Uracil> <Has_antineoplastic> "Tegafur_and_uracil" .
<R-MCP_(CCNU)> <Has_supportive_med> "Folinic_acid" .
<Bendamustine_monotherapy> <Has_accepted_use> "Transformed_lymphoma" .
<Bendamustine_monotherapy> <Has_accepted_use> "T-cell_prolymphocytic_leukemia" .
<Bendamustine_monotherapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<Bendamustine_monotherapy> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Bendamustine_monotherapy> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Bendamustine_monotherapy> <Has_accepted_use> "Hodgkin_lymphoma" .
<Bendamustine_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<Bendamustine_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Bendamustine_monotherapy> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Bendamustine_monotherapy> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Bendamustine_monotherapy> <Has_accepted_use> "Autologous_HSCT" .
<Erphatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Osteobon> <Brand_name_of> "Alendronate" .
<Docepar> <Brand_name_of> "Docetaxel" .
<Doxycycline_monotherapy> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Hairy_cell_leukemia> <FDA_indication_of> "Moxetumomab_pasudotox" .
<Hairy_cell_leukemia> <FDA_indication_of> "Interferon_alfa-2b" .
<Blincyto> <Brand_name_of> "Blinatumomab" .
<Binimetinib_monotherapy> <Has_accepted_use> "NRAS-mutated_Melanoma" .
<Binimetinib_monotherapy> <Has_accepted_use> "Melanoma" .
<Entrectinib_monotherapy> <Maps_to> "Entrectinib_monotherapy" .
<ProMACE-MOPP> <Has_antineoplastic> "Vincristine" .
<ProMACE-MOPP> <Has_antineoplastic> "Procarbazine" .
<ProMACE-MOPP> <Has_antineoplastic> "Prednisone" .
<ProMACE-MOPP> <Has_antineoplastic> "Methotrexate" .
<ProMACE-MOPP> <Has_antineoplastic> "Mechlorethamine" .
<ProMACE-MOPP> <Has_antineoplastic> "Etoposide" .
<ProMACE-MOPP> <Has_antineoplastic> "Doxorubicin" .
<ProMACE-MOPP> <Has_antineoplastic> "Cyclophosphamide" .
<ACE> <Has_context> "Induction_therapy" .
<Fludarabine_and_TBI,_then_allo_HSCT> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Fludarabine_and_TBI,_then_allo_HSCT> <Is_current_in> "Acute_myeloid_leukemia" .
<Rubifarm> <Brand_name_of> "Epirubicin" .
<Enliven> <Brand_name_of> "Imatinib" .
<Bortezomib_and_Cyclophosphamide> <Maps_to> "Bortezomib_and_Cyclophosphamide" .
<Warfar> <Brand_name_of> "Warfarin" .
<FULV_and_Bevacizumab> <Is_current_in> "Colon_cancer" .
<ChlVPP/PABIOE> <Maps_to> "ChlVPP/PABIOE" .
<DEB-TACE> <Mapped_from> "DEB-TACE" .
<Etoposide> <Has_accepted_use> "Transformed_lymphoma" .
<Etoposide> <Has_accepted_use> "Thymoma" .
<Etoposide> <Has_accepted_use> "Testicular_cancer" .
<Etoposide> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Etoposide> <Has_accepted_use> "Small_cell_lung_cancer" .
<Etoposide> <Has_accepted_use> "Rhabdomyosarcoma" .
<Etoposide> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<Etoposide> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Etoposide> <Has_accepted_use> "Ovarian_cancer" .
<Etoposide> <Has_accepted_use> "Osteosarcoma" .
<Etoposide> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Etoposide> <Has_accepted_use> "NK-_and_T-cell_lymphoma" .
<Etoposide> <Has_accepted_use> "Multiple_myeloma" .
<Etoposide> <Has_accepted_use> "Medulloblastoma" .
<Etoposide> <Has_accepted_use> "Mediastinal_gray-zone_lymphoma" .
<Etoposide> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Etoposide> <Has_accepted_use> "Low-grade_glioma" .
<Etoposide> <Has_accepted_use> "Langerhans_cell_histiocytosis" .
<Etoposide> <Has_accepted_use> "Kaposi_sarcoma" .
<Etoposide> <Has_accepted_use> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<Etoposide> <Has_accepted_use> "Hodgkin_lymphoma" .
<Etoposide> <Has_accepted_use> "Hemophagocytic_lymphohistiocytosis" .
<Etoposide> <Has_accepted_use> "HIV-associated_lymphoma" .
<Etoposide> <Has_accepted_use> "Follicular_lymphoma" .
<Etoposide> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Etoposide> <Has_accepted_use> "Ewing_sarcoma" .
<Etoposide> <Has_accepted_use> "Esophageal_cancer" .
<Etoposide> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Etoposide> <Has_accepted_use> "Cholangiocarcinoma" .
<Etoposide> <Has_accepted_use> "CNS_lymphoma" .
<Etoposide> <Has_accepted_use> "Burkitt_lymphoma" .
<Etoposide> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Etoposide> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<Etoposide> <Has_accepted_use> "Anaplastic_glioma" .
<Etoposide> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<Etoposide> <Has_accepted_use> "Adrenocortical_carcinoma" .
<Etoposide> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<Etoposide> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Etoposide> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Pegfilgrastim-jmdb> <Has_brand_name> "Fulphila" .
<CEOP_(Prednisolone)> <Is_a> "Anthracycline-containing_regimen" .
<Bortezomib_and_Doxorubicin_liposomal> <Has_accepted_use> "Multiple_myeloma" .
<Ixazomib> <Has_accepted_use> "Multiple_myeloma" .
<Ixazomib> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<7_plus_3i_and_Panobinostat> <Has_accepted_use> "Acute_myeloid_leukemia" .
<ABCM> <Mapped_from> "ABCM" .
<Everolimus_and_Exemestane> <Has_antineoplastic> "Exemestane" .
<Everolimus_and_Exemestane> <Has_antineoplastic> "Everolimus" .
<Osteofose> <Brand_name_of> "Alendronate" .
<Docetaxel_and_Estramustine> <Has_modality> "Hormonotherapy" .
<Docetaxel_and_Estramustine> <Has_modality> "Chemotherapy" .
<FLOT> <Maps_to> "FLOT" .
<Capecitabine,_Pertuzumab,_Trastuzumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<CX-C> <Has_antineoplastic> "Cisplatin" .
<CX-C> <Has_antineoplastic> "Cetuximab" .
<CX-C> <Has_antineoplastic> "Capecitabine" .
<Dexchlorpheniramine> <Is_a> "Discontinued_drug" .
<Dexchlorpheniramine> <Is_a> "Antihistamine" .
<VAD_plus_C> <Has_modality> "Chemotherapy" .
<Cisplatin_and_Gemcitabine> <Has_supportive_med> "Steroids" .
<Cisplatin_and_Gemcitabine> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Cisplatin_and_Gemcitabine> <Has_supportive_med> "Prochlorperazine" .
<Cisplatin_and_Gemcitabine> <Has_supportive_med> "Phenothiazines" .
<Cisplatin_and_Gemcitabine> <Has_supportive_med> "Dexamethasone" .
<Arsenic_trioxide_and_Chlorambucil> <Has_supportive_med> "Ascorbic_acid" .
<COPADM> <Has_supportive_med> "Folinic_acid" .
<Lusutrombopag_monotherapy> <Is_current_in> "Thrombocytopenia_in_liver_disease" .
<Dexamethazon> <Brand_name_of> "Dexamethasone" .
<Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA> <Has_antineoplastic> "Mitoxantrone" .
<Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA> <Has_antineoplastic> "Idarubicin" .
<Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA> <Has_antineoplastic> "All-trans_retinoic_acid" .
<Quisinostat> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Carboplatin_monotherapy> <Has_antineoplastic> "Carboplatin" .
<Trastuzumab_and_hyaluronidase> <Has_accepted_use> "Breast_cancer" .
<CAP_(Platinol)> <Has_modality> "Chemotherapy" .
<Bortezomib_and_Doxorubicin_liposomal> <Has_antineoplastic> "Pegylated_liposomal_doxorubicin" .
<Bortezomib_and_Doxorubicin_liposomal> <Has_antineoplastic> "Bortezomib" .
<Uracil_mustard_monotherapy> <Maps_to> "Uracil_mustard_monotherapy" .
<Nordic_Regimen,_younger_patients> <Has_context> "Upfront_therapy" .
<BEACOPP-14_(Prednisolone)> <Mapped_from> "BEACOPP-14_(Prednisolone)" .
<Fluorouracil,_Folinic_acid,_RT> <Maps_to> "Fluorouracil,_Folinic_acid,_RT" .
<Melphalan_and_TBI> <Is_current_in> "Autologous_HSCT" .
<Cabozantinib> <Antineoplastic_of> "Cabozantinib_monotherapy" .
<Cabozantinib> <Antineoplastic_of> "Cabozantinib_and_Erlotinib" .
<Pemetrexed_and_Pembrolizumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Dexmethsone> <Brand_name_of> "Dexamethasone" .
<Nealorin> <Brand_name_of> "Carboplatin" .
<Baczin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Antithymocyte_globulin> <Immunosuppressor_of> "Fludarabine,_Busulfan,_ATG" .
<Antithymocyte_globulin> <Immunosuppressor_of> "Fludarabine_and_Melphalan" .
<Antithymocyte_globulin> <Immunosuppressor_of> "Flu-Mel,_then_allo_HSCT" .
<Mitomycin_monotherapy> <Has_context> "Local_therapy" .
<CODOX-M/IVAC> <Has_accepted_use> "HIV-associated_lymphoma" .
<CODOX-M/IVAC> <Has_accepted_use> "Burkitt_lymphoma" .
<Abemaciclib_and_Anastrozole> <Is_current_in> "Breast_cancer" .
<Floxuridine> <May_have_route> "Intra-arterial" .
<Trastuzumab-qyyp> <Has_brand_name> "Trazimera" .
<Carbokem> <Brand_name_of> "Carboplatin" .
<GVD> <Has_context> "Non-curative_therapy" .
<GVD> <Has_context> "Non-curative_subsequent-line_therapy" .
<R-ICE> <Has_antineoplastic> "Rituximab" .
<R-ICE> <Has_antineoplastic> "Mesna" .
<R-ICE> <Has_antineoplastic> "Ifosfamide" .
<R-ICE> <Has_antineoplastic> "Etoposide" .
<R-ICE> <Has_antineoplastic> "Carboplatin" .
<Romiplostim_monotherapy> <Has_supportive_med> "Romiplostim" .
<Aspirin_and_Warfarin> <Mapped_from> "Aspirin_and_Warfarin" .
<Altretamine> <Has_brand_name> "Hexastat" .
<Altretamine> <Has_brand_name> "Hexalen" .
<R-BL> <Has_modality> "Chemotherapy" .
<Adriamycin> <Brand_name_of> "Doxorubicin" .
<Chemotherapy_protective_agent> <Is_a> "Supportive_medication" .
<Gemcitabine> <May_have_route> "Intravesical" .
<Gemcitabine> <May_have_route> "Intravenous" .
<O-FC> <Has_context> "Non-curative_therapy" .
<O-FC> <Has_context> "Non-curative_first-line_therapy" .
<Nimustine_and_RT> <Mapped_from> "Nimustine_and_RT" .
<FOLFOXIRI_and_Panitumumab> <Maps_to> "FOLFOXIRI_and_Panitumumab" .
<Maxitrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Trabectedin> <Supportive_med_of> "Carboplatin_monotherapy" .
<R,_then_CHOP> <Is_current_in> "Post-transplant_lymphoproliferative_disorder" .
<BFR,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<BFR,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<Cortigen> <Brand_name_of> "Prednisone" .
<Ifosfamide> <Antineoplastic_of> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Ifosfamide> <Antineoplastic_of> "VeIP" .
<Ifosfamide> <Antineoplastic_of> "VIPD" .
<Ifosfamide> <Antineoplastic_of> "VIP" .
<Ifosfamide> <Antineoplastic_of> "VIM" .
<Ifosfamide> <Antineoplastic_of> "VIE" .
<Ifosfamide> <Antineoplastic_of> "VIDE" .
<Ifosfamide> <Antineoplastic_of> "VI,_then_VDC/IE,_then_VAC,_then_VI" .
<Ifosfamide> <Antineoplastic_of> "VDC/IE" .
<Ifosfamide> <Antineoplastic_of> "VAdCA/IE" .
<Ifosfamide> <Antineoplastic_of> "VAIA" .
<Ifosfamide> <Antineoplastic_of> "VAI" .
<Ifosfamide> <Antineoplastic_of> "VACA/IE" .
<Ifosfamide> <Antineoplastic_of> "TIP" .
<Ifosfamide> <Antineoplastic_of> "TC,_then_IE,_VDoxoC,_VEC" .
<Ifosfamide> <Antineoplastic_of> "SMILE" .
<Ifosfamide> <Antineoplastic_of> "RICER" .
<Ifosfamide> <Antineoplastic_of> "R-NIMP" .
<Ifosfamide> <Antineoplastic_of> "R-MACLO/R-IVAM" .
<Ifosfamide> <Antineoplastic_of> "R-IFE" .
<Ifosfamide> <Antineoplastic_of> "R-ICE" .
<Ifosfamide> <Antineoplastic_of> "R-DHAP/R-VIM" .
<Ifosfamide> <Antineoplastic_of> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Ifosfamide> <Antineoplastic_of> "R-CODOX-M/R-IVAC" .
<Ifosfamide> <Antineoplastic_of> "O-ICE" .
<Ifosfamide> <Antineoplastic_of> "Nordic_Regimen,_younger_patients" .
<Ifosfamide> <Antineoplastic_of> "Nordic_Regimen,_older_patients" .
<Ifosfamide> <Antineoplastic_of> "MINE" .
<Ifosfamide> <Antineoplastic_of> "MIC" .
<Ifosfamide> <Antineoplastic_of> "MAPIE" .
<Ifosfamide> <Antineoplastic_of> "MAPI" .
<Ifosfamide> <Antineoplastic_of> "MAID" .
<Ifosfamide> <Antineoplastic_of> "M-TIP" .
<Ifosfamide> <Antineoplastic_of> "M-EI" .
<Ifosfamide> <Antineoplastic_of> "Ifosfamide_monotherapy" .
<Ifosfamide> <Antineoplastic_of> "Ifosfamide_and_Vinorelbine" .
<Ifosfamide> <Antineoplastic_of> "Ifosfamide_and_Paclitaxel" .
<Ifosfamide> <Antineoplastic_of> "Ifosfamide_and_Methotrexate" .
<Ifosfamide> <Antineoplastic_of> "Ifosfamide_and_Gemcitabine" .
<Ifosfamide> <Antineoplastic_of> "IP-BCD" .
<Ifosfamide> <Antineoplastic_of> "IGEV_and_G-CSF" .
<Ifosfamide> <Antineoplastic_of> "IGEV" .
<Ifosfamide> <Antineoplastic_of> "IE" .
<Ifosfamide> <Antineoplastic_of> "ICE" .
<Ifosfamide> <Antineoplastic_of> "GMALL-R" .
<Ifosfamide> <Antineoplastic_of> "GIP" .
<Ifosfamide> <Antineoplastic_of> "Etoposide,_Ifosfamide,_Methotrexate" .
<Ifosfamide> <Antineoplastic_of> "Etoposide,_Ifosfamide,_Imatinib" .
<Ifosfamide> <Antineoplastic_of> "Epirubicin_and_Ifosfamide" .
<Ifosfamide> <Antineoplastic_of> "EVI" .
<Ifosfamide> <Antineoplastic_of> "EVAIA" .
<Ifosfamide> <Antineoplastic_of> "EPIC_regimen" .
<Ifosfamide> <Antineoplastic_of> "EIA" .
<Ifosfamide> <Antineoplastic_of> "Doxorubicin,_Ifosfamide,_RT" .
<Ifosfamide> <Antineoplastic_of> "Doxorubicin_and_Ifosfamide" .
<Ifosfamide> <Antineoplastic_of> "DICE" .
<Ifosfamide> <Antineoplastic_of> "Cytarabine,_Ifosfamide,_G-CSF" .
<Ifosfamide> <Antineoplastic_of> "Cisplatin,_Epirubicin,_Ifosfamide" .
<Ifosfamide> <Antineoplastic_of> "Cisplatin_and_Ifosfamide" .
<Ifosfamide> <Antineoplastic_of> "Carboplatin_and_Ifosfamide" .
<Ifosfamide> <Antineoplastic_of> "CODOX-M/IVAC" .
<Ifosfamide> <Antineoplastic_of> "CIM" .
<Ifosfamide> <Antineoplastic_of> "CCI" .
<Ifosfamide> <Antineoplastic_of> "CALGB_10-002_regimen" .
<Ifosfamide> <Antineoplastic_of> "ACVBP" .
<LSG15> <Mapped_from> "LSG15" .
<AspaMetDex_(Erwinaze)> <Has_context> "Non-curative_therapy" .
<Zyloprim> <Brand_name_of> "Allopurinol" .
<ABVDm> <Is_historical_in> "Hodgkin_lymphoma" .
<Kemocarb> <Brand_name_of> "Carboplatin" .
<Glioblastoma> <Is_a> "High-grade_glioma" .
<VAI> <Has_antineoplastic> "Vincristine" .
<VAI> <Has_antineoplastic> "Ifosfamide" .
<VAI> <Has_antineoplastic> "Dactinomycin" .
<Daratumumab_monotherapy> <Has_context> "Non-curative_therapy" .
<Daratumumab_monotherapy> <Has_context> "Non-curative_second-line_maintenance_therapy" .
<Daratumumab_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Glasdegib_and_LoDAC> <Has_context> "Non-curative_first-line_induction_therapy" .
<Depo_Melcort> <Brand_name_of> "Methylprednisolone" .
<Coagadex> <Brand_name_of> "Factor_X_human_(Coagadex)" .
<Aspirin_and_Warfarin> <Maps_to> "Aspirin_and_Warfarin" .
<Pemetrexed_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Pemetrexed_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Pemetrexed_monotherapy> <Has_accepted_use> "Mesothelioma" .
<Pemetrexed_monotherapy> <Has_accepted_use> "Cervical_cancer" .
<Pemetrexed_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Pemetrexed_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<Pemetrexed_monotherapy> <Has_accepted_use> "ALK-positive_Non-small_cell_lung_cancer" .
<FCA> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<VAMP_(Methotrexate)> <Mapped_from> "VAMP_(Methotrexate)" .
<GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab> <Has_modality> "Immunotherapy" .
<GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab> <Has_modality> "Chemotherapy" .
<Cytarabine_liposomal> <Antineoplastic_of> "Nordic_Regimen,_younger_patients" .
<Cytarabine_liposomal> <Antineoplastic_of> "Nordic_Regimen,_older_patients" .
<Pemnat> <Brand_name_of> "Pemetrexed" .
<Fludarabine,_Melphalan,_Alemtuzumab> <Mapped_from> "Fludarabine,_Melphalan,_Alemtuzumab" .
<Mercaptopurine_and_Methotrexate> <Has_context> "Maintenance_after_upfront_therapy" .
<Mercaptopurine_and_Methotrexate> <Has_context> "Induction_therapy" .
<Mercaptopurine_and_Methotrexate> <Has_context> "Consolidation_after_upfront_therapy" .
<Mercaptopurine_and_Methotrexate> <Has_context> "All_lines_of_therapy" .
<L-Asparaginase,_Vincristine,_Dexamethasone> <Mapped_from> "L-Asparaginase,_Vincristine,_Dexamethasone" .
<Imatinib,_Vincristine,_Dexamethasone> <Maps_to> "Imatinib,_Vincristine,_Dexamethasone" .
<DexaBEAM> <Has_antineoplastic> "Melphalan" .
<DexaBEAM> <Has_antineoplastic> "Etoposide" .
<DexaBEAM> <Has_antineoplastic> "Dexamethasone" .
<DexaBEAM> <Has_antineoplastic> "Cytarabine" .
<DexaBEAM> <Has_antineoplastic> "Carmustine" .
<Docetaxel_and_Nintedanib> <Is_current_in> "Non-small_cell_lung_cancer" .
<Helveprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Fam-trastuzumab_deruxtecan_monotherapy> <Has_antineoplastic> "Fam-trastuzumab_deruxtecan" .
<INF> <Brand_name_of> "Interferon_alfa-2b" .
<CBV> <Has_accepted_use> "Autologous_HSCT" .
<Carboplatin_monotherapy> <Has_accepted_use> "Testicular_cancer" .
<Carboplatin_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Carboplatin_monotherapy> <Has_accepted_use> "Low-grade_glioma" .
<Carboplatin_monotherapy> <Has_accepted_use> "Endometrial_cancer" .
<Carboplatin_monotherapy> <Has_accepted_use> "Cervical_cancer" .
<Eloxatin> <Brand_name_of> "Oxaliplatin" .
<Dermox> <Brand_name_of> "Methoxsalen" .
<Aplastic_anemia> <Accepted_use_of> "Sirolimus" .
<Aplastic_anemia> <Accepted_use_of> "Eltrombopag_monotherapy" .
<Aplastic_anemia> <Accepted_use_of> "Eltrombopag" .
<Aplastic_anemia> <Accepted_use_of> "Cyclosporine_non-modified" .
<Aplastic_anemia> <Accepted_use_of> "Cyclosporine_monotherapy" .
<Aplastic_anemia> <Accepted_use_of> "Cyclosporine_modified" .
<Aplastic_anemia> <Accepted_use_of> "Antithymocyte_globulin_rabbit_ATG" .
<Aplastic_anemia> <Accepted_use_of> "Antithymocyte_globulin_horse_ATG" .
<Aplastic_anemia> <Accepted_use_of> "ATG_(Rabbit)_and_Cyclosporine" .
<Aplastic_anemia> <Accepted_use_of> "ATG_(Horse),_Cyclosporine,_Sirolimus" .
<Aplastic_anemia> <Accepted_use_of> "ATG_(Horse),_Cyclosporine,_Methylprednisolone" .
<Aplastic_anemia> <Accepted_use_of> "ATG_(Horse),_Cyclosporine,_G-CSF" .
<Aplastic_anemia> <Accepted_use_of> "ATG_(Horse),_Cyclosporine,_Eltrombopag" .
<Aplastic_anemia> <Accepted_use_of> "ATG_(Horse)_and_Cyclosporine" .
<Growth_factor_therapy> <Maps_to> "Growth_factor_therapy" .
<Indrol> <Brand_name_of> "Methylprednisolone" .
<VAC_(Adriamycin)> <Has_modality> "Chemotherapy" .
<Topotecan_monotherapy> <Maps_to> "Topotecan_monotherapy" .
<Phenergan> <Brand_name_of> "Promethazine" .
<FOLFOX4_and_Cetuximab> <Maps_to> "FOLFOX4_and_Cetuximab" .
<CODOX-M> <Has_accepted_use> "HIV-associated_lymphoma" .
<CODOX-M> <Has_accepted_use> "Burkitt_lymphoma" .
<Hypereosinophilic_syndrome> <Current_treated_by> "Ruxolitinib_monotherapy" .
<Hypereosinophilic_syndrome> <Current_treated_by> "Peginterferon_alfa-2a_monotherapy" .
<Hypereosinophilic_syndrome> <Current_treated_by> "Nilotinib_monotherapy" .
<Hypereosinophilic_syndrome> <Current_treated_by> "Mepolizumab_monotherapy" .
<Hypereosinophilic_syndrome> <Current_treated_by> "Imatinib_monotherapy" .
<Hypereosinophilic_syndrome> <Current_treated_by> "Hydroxyurea_monotherapy" .
<Hypereosinophilic_syndrome> <Current_treated_by> "Cladribine_and_Cytarabine" .
<Hypereosinophilic_syndrome> <Current_treated_by> "Benralizumab_monotherapy" .
<Hypereosinophilic_syndrome> <Current_treated_by> "Alemtuzumab_monotherapy" .
<Temodal> <Brand_name_of> "Temozolomide" .
<Clusterin_inhibitor> <Is_a> "Molecular_chaperone_inhibitor" .
<Dexametisona> <Brand_name_of> "Dexamethasone" .
<Clofarabine> <Has_brand_name> "Evorabin" .
<Clofarabine> <Has_brand_name> "Evoltra" .
<Clofarabine> <Has_brand_name> "Clolar" .
<Nintedanib> <Has_accepted_use> "Ovarian_cancer" .
<Nintedanib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<CHUT> <Maps_to> "CHUT" .
<Talimogene_laherparepvec_monotherapy> <Mapped_from> "Talimogene_laherparepvec_monotherapy" .
<CABO> <Maps_to> "CABO" .
<Carboplatin_and_Gemcitabine/Erlotinib> <Has_modality> "Chemotherapy" .
<TH_(Taxotere)> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<TH_(Taxotere)> <Has_accepted_use> "Breast_cancer" .
<Imatinib,_Vincristine,_Prednisone> <Maps_to> "Imatinib,_Vincristine,_Prednisone" .
<Cortisone_monotherapy> <Has_antineoplastic> "Cortisone" .
<CVD_(Vindesine)> <Mapped_from> "CVD_(Vindesine)" .
<Romidepsin> <Has_brand_name> "Istodax" .
<Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone> <Has_modality> "Chemotherapy" .
<Anopyrin> <Brand_name_of> "Aspirin" .
<Medroxyprogesterone_monotherapy> <Maps_to> "Medroxyprogesterone_monotherapy" .
<Perifosine> <Is_a> "Orphan_drug" .
<Perifosine> <Is_a> "MEK_inhibitor" .
<Perifosine> <Is_a> "Kinase_inhibitor" .
<Perifosine> <Is_a> "Investigational_drug" .
<Perifosine> <Is_a> "AKT1_inhibitor" .
<Imatinib_and_LoDAC> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Satelol> <Brand_name_of> "Fluorouracil" .
<Mercaptopurine> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Mercaptopurine> <Has_accepted_use> "Langerhans_cell_histiocytosis" .
<Mercaptopurine> <Has_accepted_use> "CNS_leukemia" .
<Mercaptopurine> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Mercaptopurine> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<M-DEX> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<Cellblastin> <Brand_name_of> "Vinblastine" .
<Cisplatin_and_Paclitaxel> <Has_accepted_use> "Ovarian_cancer" .
<Cisplatin_and_Paclitaxel> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cisplatin_and_Paclitaxel> <Has_accepted_use> "Head_and_neck_cancer" .
<Cisplatin_and_Paclitaxel> <Has_accepted_use> "Esophageal_cancer" .
<Cisplatin_and_Paclitaxel> <Has_accepted_use> "Endometrial_cancer" .
<Cisplatin_and_Paclitaxel> <Has_accepted_use> "Cutaneous_basal_cell_carcinoma" .
<Cisplatin_and_Paclitaxel> <Has_accepted_use> "Cervical_cancer" .
<Sumetrolin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<G-CHOP> <Has_accepted_use> "Follicular_lymphoma" .
<CVAD> <Maps_to> "CVAD" .
<Docetaxel_and_Prednisolone> <Has_accepted_use> "Prostate_cancer" .
<F-MACHOP> <Is_a> "Anthracycline-containing_regimen" .
<Methotrexate,_RT,_Cyclophosphamide> <Mapped_from> "Methotrexate,_RT,_Cyclophosphamide" .
<Bamyl_S> <Brand_name_of> "Aspirin" .
<EOF> <Maps_to> "EOF" .
<131Iodine-Tositumomab_monotherapy> <Is_historical_in> "Follicular_lymphoma" .
<Novotrim_Plus> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Carboplatin,_Paclitaxel,_Ipilimumab> <Has_accepted_use> "Small_cell_lung_cancer" .
<Carboplatin,_Paclitaxel,_Ipilimumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<COP-Bleo> <Has_modality> "Chemotherapy" .
<PCE> <Is_current_in> "Adenocarcinoma_of_unknown_primary" .
<Capecitabine,_Docetaxel,_RT> <Has_modality> "Radiotherapy" .
<Capecitabine,_Docetaxel,_RT> <Has_modality> "Chemotherapy" .
<COPAD/CYVE> <Is_current_in> "Burkitt_lymphoma" .
<Enzalutamide_monotherapy> <Maps_to> "Enzalutamide_monotherapy" .
<Cisplatin_and_Methotrexate> <Has_accepted_use> "Bladder_cancer" .
<VDC> <Has_accepted_use> "Multiple_myeloma" .
<VDC> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Abemaciclib_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Trizole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cyclophosphamide_and_G-CSF> <Has_antineoplastic> "Cyclophosphamide" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Has_supportive_med> "Mesna" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Has_supportive_med> "Folinic_acid" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Has_supportive_med> "Filgrastim" .
<Peginterferon_alfa-2b_monotherapy> <Has_context> "Adjuvant_therapy" .
<PCO> <Has_modality> "Chemotherapy" .
<Fluorouracil,_Hydroxyurea,_RT> <Has_accepted_use> "Head_and_neck_cancer" .
<DA-R-EPOCH> <Is_a> "Rituximab-containing_regimen" .
<DA-R-EPOCH> <Is_a> "Anthracycline-containing_regimen" .
<Epirubicin> <Has_FDA_indication> "Breast_cancer" .
<PGC> <Has_accepted_use> "Bladder_cancer" .
<ECX> <Has_antineoplastic> "Epirubicin" .
<ECX> <Has_antineoplastic> "Cisplatin" .
<ECX> <Has_antineoplastic> "Capecitabine" .
<Rituximab_and_hyaluronidase_monotherapy> <Is_a> "Rituximab-containing_regimen" .
<Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<Politrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Glioblastoma> <Accepted_use_of> "Vincristine" .
<Glioblastoma> <Accepted_use_of> "Temozolomide_monotherapy" .
<Glioblastoma> <Accepted_use_of> "Temozolomide_and_low-dose_RT" .
<Glioblastoma> <Accepted_use_of> "Temozolomide_and_RT" .
<Glioblastoma> <Accepted_use_of> "Temozolomide_and_NovoTTF-100A" .
<Glioblastoma> <Accepted_use_of> "Temozolomide" .
<Glioblastoma> <Accepted_use_of> "Radiation_therapy" .
<Glioblastoma> <Accepted_use_of> "Procarbazine_monotherapy" .
<Glioblastoma> <Accepted_use_of> "Procarbazine" .
<Glioblastoma> <Accepted_use_of> "PCV" .
<Glioblastoma> <Accepted_use_of> "NovoTTF-100A_monotherapy" .
<Glioblastoma> <Accepted_use_of> "Nimustine_and_RT" .
<Glioblastoma> <Accepted_use_of> "Nimustine" .
<Glioblastoma> <Accepted_use_of> "Lomustine,_Temozolomide,_RT" .
<Glioblastoma> <Accepted_use_of> "Lomustine_monotherapy" .
<Glioblastoma> <Accepted_use_of> "Lomustine_and_Bevacizumab" .
<Glioblastoma> <Accepted_use_of> "Lomustine" .
<Glioblastoma> <Accepted_use_of> "Irinotecan_monotherapy" .
<Glioblastoma> <Accepted_use_of> "Irinotecan_and_Bevacizumab" .
<Glioblastoma> <Accepted_use_of> "Irinotecan" .
<Glioblastoma> <Accepted_use_of> "Imatinib" .
<Glioblastoma> <Accepted_use_of> "Hydroxyurea_monotherapy" .
<Glioblastoma> <Accepted_use_of> "Hydroxyurea_and_Imatinib" .
<Glioblastoma> <Accepted_use_of> "Hydroxyurea" .
<Glioblastoma> <Accepted_use_of> "Gliadel_wafer_monotherapy" .
<Glioblastoma> <Accepted_use_of> "Cyclophosphamide_monotherapy" .
<Glioblastoma> <Accepted_use_of> "Cyclophosphamide" .
<Glioblastoma> <Accepted_use_of> "Carmustine_wafer_polifeprosan_20" .
<Glioblastoma> <Accepted_use_of> "Carmustine_monotherapy" .
<Glioblastoma> <Accepted_use_of> "Carmustine_and_RT" .
<Glioblastoma> <Accepted_use_of> "Carmustine" .
<Glioblastoma> <Accepted_use_of> "Carboplatin_and_Bevacizumab" .
<Glioblastoma> <Accepted_use_of> "Carboplatin" .
<Glioblastoma> <Accepted_use_of> "Bevacizumab-bvzr" .
<Glioblastoma> <Accepted_use_of> "Bevacizumab-awwb" .
<Glioblastoma> <Accepted_use_of> "Bevacizumab_monotherapy" .
<Glioblastoma> <Accepted_use_of> "Bevacizumab_and_RT" .
<Glioblastoma> <Accepted_use_of> "Bevacizumab" .
<Glioblastoma> <Accepted_use_of> "Best_supportive_care" .
<Septinix> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<R-CHOP-14_(Rituximab_Hycela)> <Has_modality> "Chemotherapy" .
<GIP> <Has_accepted_use> "Testicular_cancer" .
<GIP> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Daidoron> <Brand_name_of> "Dexamethasone" .
<Triptorelin> <Antineoplastic_of> "Triptorelin_monotherapy" .
<Belotecan_and_Cisplatin> <Mapped_from> "Belotecan_and_Cisplatin" .
<Bortezomib_and_Cyclophosphamide> <Mapped_from> "Bortezomib_and_Cyclophosphamide" .
<VR-CAP> <Has_accepted_use> "Mantle_cell_lymphoma" .
<RABVD> <Has_accepted_use> "Hodgkin_lymphoma" .
<Siltuximab_monotherapy> <Has_modality> "Immunosuppressive_therapy" .
<Alectinib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Furosemide> <Is_a> "Diuretic" .
<Depo-Medrol> <Brand_name_of> "Methylprednisolone" .
<Rablet> <Brand_name_of> "Rabeprazole" .
<Midostaurin_monotherapy> <Is_current_in> "Systemic_mastocytosis" .
<Midostaurin_monotherapy> <Is_current_in> "Myelodysplastic_syndrome" .
<Midostaurin_monotherapy> <Is_current_in> "Acute_myeloid_leukemia" .
<Capecitabine,_Carboplatin,_Paclitaxel,_RT> <Maps_to> "Capecitabine,_Carboplatin,_Paclitaxel,_RT" .
<Thiotepa_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Thiotepa_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<Ox-P> <Mapped_from> "Ox-P" .
<OncoVEX\u005EGM-CSF> <Brand_name_of> "Talimogene_laherparepvec" .
<Aprepitant> <Has_brand_name> "Emend_Trifold" .
<Aprepitant> <Has_brand_name> "Emend" .
<Aprepitant> <Has_brand_name> "Cinvanti" .
<Rasburicase> <Is_a> "Uric_acid_lowering_agent" .
<Rasburicase> <Is_a> "Enzyme" .
<R-CODOX-M/R-IVAC> <Has_supportive_med> "Pegfilgrastim" .
<R-CODOX-M/R-IVAC> <Has_supportive_med> "Mesna" .
<R-CODOX-M/R-IVAC> <Has_supportive_med> "Folinic_acid" .
<R-CODOX-M/R-IVAC> <Has_supportive_med> "Filgrastim" .
<Cyclophosphamide_and_Topotecan> <Has_antineoplastic> "Topotecan" .
<Cyclophosphamide_and_Topotecan> <Has_antineoplastic> "Cyclophosphamide" .
<Nasopharyngeal_carcinoma> <Is_a> "Head_and_neck_cancer" .
<MEC> <Maps_to> "MEC" .
<AALL0232_consolidation> <Has_antineoplastic> "Vincristine" .
<AALL0232_consolidation> <Has_antineoplastic> "Pegaspargase" .
<AALL0232_consolidation> <Has_antineoplastic> "Mercaptopurine" .
<AALL0232_consolidation> <Has_antineoplastic> "Cytarabine" .
<AALL0232_consolidation> <Has_antineoplastic> "Cyclophosphamide" .
<Sulphytrim_Forte> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Drugs_by_class_effect> <Subsumes> "Immunotherapeutic" .
<Drugs_by_class_effect> <Subsumes> "Immunosuppressant" .
<Drugs_by_class_effect> <Subsumes> "Hypomethylating_agent" .
<Drugs_by_class_effect> <Subsumes> "Enzyme" .
<Drugs_by_class_effect> <Subsumes> "Endocrine_therapeutic" .
<Drugs_by_class_effect> <Subsumes> "Chemotherapeutic" .
<R-GemOx> <Has_modality> "Chemotherapy" .
<Letrozole_monotherapy> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Letrozole_monotherapy> <Has_accepted_use> "Breast_cancer" .
<DA_3_plus_10,_GO> <Is_a> "Anthracycline-containing_regimen" .
<Elotuzumab> <Has_FDA_indication> "Multiple_myeloma" .
<Synetra> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Inotuzumab_ozogamicin_monotherapy> <Is_current_in> "Follicular_lymphoma" .
<Inotuzumab_ozogamicin_monotherapy> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Resprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<R-TBI/Cy,_then_auto_HSCT> <Has_context> "Non-curative_subsequent-line_consolidation_therapy" .
<R-TBI/Cy,_then_auto_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<eBEACOPP> <Has_modality> "Chemotherapy" .
<Cisplatin,_Doxorubicin_liposomal,_Fluorouracil> <Maps_to> "Cisplatin,_Doxorubicin_liposomal,_Fluorouracil" .
<Stem_cell_mobilization> <Current_treated_by> "Plerixafor_and_G-CSF" .
<Stem_cell_mobilization> <Current_treated_by> "IGEV_and_G-CSF" .
<Stem_cell_mobilization> <Current_treated_by> "EAR_and_G-CSF" .
<Stem_cell_mobilization> <Current_treated_by> "DexaBEAM_and_G-CSF" .
<Stem_cell_mobilization> <Current_treated_by> "DCEP_and_G-CSF" .
<Stem_cell_mobilization> <Current_treated_by> "Cytarabine,_Ifosfamide,_G-CSF" .
<Stem_cell_mobilization> <Current_treated_by> "Cytarabine_and_G-CSF" .
<Stem_cell_mobilization> <Current_treated_by> "Cyclophosphamide_and_G-CSF" .
<Stem_cell_mobilization> <Current_treated_by> "CYVE_and_G-CSF" .
<Stem_cell_mobilization> <Current_treated_by> "CAD_and_G-CSF" .
<Penzole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<FRD> <Is_current_in> "Multiple_myeloma" .
<(90)YFC> <Has_accepted_use> "Allogeneic_HSCT" .
<ProMACE-CytaBOM> <Has_modality> "Chemotherapy" .
<GVP> <Has_antineoplastic> "Vinorelbine" .
<GVP> <Has_antineoplastic> "Prednisolone" .
<GVP> <Has_antineoplastic> "Gemcitabine" .
<FOLFIRI_and_Ramucirumab> <Mapped_from> "FOLFIRI_and_Ramucirumab" .
<R-CEOP90_(Epirubicin)> <Has_modality> "Chemotherapy" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT> <Has_immunosuppressor> "Methotrexate" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT> <Has_immunosuppressor> "Cyclosporines" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<Tegafur_gimeracil_oteracil> <Is_a> "PMDA_approved_drug" .
<Tegafur_gimeracil_oteracil> <Is_a> "Fluoropyrimidine" .
<Tegafur_gimeracil_oteracil> <Is_a> "EMA_approved_drug" .
<R-CODOX-M/R-IVAC_(Doxil_substituted)> <Has_modality> "Chemotherapy" .
<Oxaliplatin_monotherapy> <Mapped_from> "Oxaliplatin_monotherapy" .
<DA-EPOCH> <Has_modality> "Chemotherapy" .
<Nivolumab,_then_Ipilimumab> <Has_accepted_use> "Melanoma" .
<Rolapitant> <Is_a> "Neurokinin_1_(NK1)_antagonist" .
<Rolapitant> <Is_a> "Emesis_prevention" .
<Kang_Ning> <Brand_name_of> "Fluorouracil" .
<Cisplatin_and_S-1> <Has_modality> "Chemotherapy" .
<Vinblastine> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Vinblastine> <Is_a> "Vinca_alkaloid" .
<Vinblastine> <Is_a> "Vesicant" .
<Vinblastine> <Is_a> "Microtubule_inhibitor" .
<Ferro-Bob> <Brand_name_of> "Ferrous_sulfate" .
<Denileukin_diftitox_monotherapy> <Is_current_in> "Cutaneous_T-cell_lymphoma" .
<VEGFR_inhibitor> <Is_a> "Kinase_inhibitor" .
<VEGFR_inhibitor> <Is_a> "Growth_factor_inhibitor" .
<ddAC-T> <Has_modality> "Chemotherapy" .
<Adtrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Dalteparin_monotherapy> <Has_supportive_med> "Dalteparin" .
<Leuconolver> <Brand_name_of> "Folinic_acid" .
<BEAM> <Has_context> "All_lines_of_therapy" .
<Radioiodine_ablation> <Has_antineoplastic> "Iodine-131" .
<PEG-Intron> <Brand_name_of> "Peginterferon_alfa-2b" .
<Cetuxim> <Brand_name_of> "Cetuximab" .
<Hyper-CVAD_and_Imatinib> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Hyper-CVAD_and_Imatinib> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<R-FND> <Is_a> "Rituximab-containing_regimen" .
<R-FND> <Is_a> "Anthracycline-containing_regimen" .
<IT_Cytarabine_monotherapy> <Has_modality> "Chemotherapy" .
<Ceramos> <Brand_name_of> "Ondansetron" .
<MAPIE> <Has_modality> "Chemotherapy" .
<Asprimox_ID> <Brand_name_of> "Aspirin" .
<Thrombo_ASS> <Brand_name_of> "Aspirin" .
<Anti-IL-6_antibody> <Is_a> "Antibody_medication" .
<Ipilimumab> <Has_accepted_use> "Renal_cell_carcinoma" .
<Ipilimumab> <Has_accepted_use> "Prostate_cancer" .
<Ipilimumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Ipilimumab> <Has_accepted_use> "Melanoma" .
<Capecitabine_monotherapy> <Has_accepted_use> "triple_negative_Breast_cancer" .
<Capecitabine_monotherapy> <Has_accepted_use> "Rectal_cancer" .
<Capecitabine_monotherapy> <Has_accepted_use> "Pancreatic_cancer" .
<Capecitabine_monotherapy> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Capecitabine_monotherapy> <Has_accepted_use> "HER2-positive_-_historical_Breast_cancer" .
<Capecitabine_monotherapy> <Has_accepted_use> "Gastric_cancer" .
<Capecitabine_monotherapy> <Has_accepted_use> "Gallbladder_cancer" .
<Capecitabine_monotherapy> <Has_accepted_use> "Colon_cancer" .
<Capecitabine_monotherapy> <Has_accepted_use> "Cholangiocarcinoma" .
<Capecitabine_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Capecitabine_monotherapy> <Has_accepted_use> "BRCA-mutated_Breast_cancer" .
<Chlorambucil_and_Obinutuzumab> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Trabectedin> <Antineoplastic_of> "Trabectedin_monotherapy" .
<Trabectedin> <Antineoplastic_of> "Doxorubicin_pegylated_liposomal_and_Trabectedin" .
<Anitrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Quadramet> <Brand_name_of> "Samarium-153" .
<Mercaptopurine,_Methotrexate,_Vincristine> <Has_supportive_med> "Folinic_acid" .
<R-GDP> <Is_current_in> "Transformed_lymphoma" .
<R-GDP> <Is_current_in> "Primary_mediastinal_B-cell_lymphoma" .
<R-GDP> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Cyphos> <Brand_name_of> "Cyclophosphamide" .
<Teniposide_and_WBRT> <Has_antineoplastic> "Teniposide" .
<Teniposide_and_WBRT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Colorectal_cancer> <Is_a> "Gastrointestinal_cancer" .
<R-MCP> <Has_antineoplastic> "Rituximab" .
<R-MCP> <Has_antineoplastic> "Prednisolone" .
<R-MCP> <Has_antineoplastic> "Mitoxantrone" .
<R-MCP> <Has_antineoplastic> "Chlorambucil" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Whole_brain_irradiation" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "VTD" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "VR" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "VMP" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "VD" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Tandem_melphalan,_then_auto_HSCT" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "TD" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "TAM6,_then_auto_HSCT" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Rituximab_monotherapy" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "RVD" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "RP" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "R-BEAM,_then_auto_HSCT" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Ofatumumab_monotherapy" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Observation" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Melphalan,_then_auto_HSCT,_then_Melphalan_and_TBI,_then_auto_HSCT" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Melphalan,_then_auto_HSCT,_then_Melphalan_and_Busulfan,_then_auto_HSCT" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Melphalan,_then_auto_HSCT" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Melphalan_monotherapy" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Melphalan_and_TBI,_then_auto_HSCT" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Melphalan_and_Methylprednisolone,_then_auto_HSCT" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "MPR" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "MEL200,_then_auto_HSCT,_then_MEL220_and_Dexamethasone,_then_auto_HSCT" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Lenalidomide_monotherapy" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "KTD" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Ibritumomab_tiuxetan_monotherapy" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "DCEP" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Cyclophosphamide_and_TBI,_then_auto_HSCT" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Chlorambucil_monotherapy" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Chlorambucil_and_Rituximab" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "CBV,_then_auto_HSCT" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Busulfan_and_Cyclophosphamide,_then_allo_HSCT" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Bortezomib_monotherapy" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Bortezomib_and_Melphalan,_then_auto_HSCT" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "BEAM,_then_auto_HSCT" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "BEAC,_then_auto_HSCT" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "Alemtuzumab_monotherapy" .
<Non-curative_first-line_consolidation_therapy> <Context_of> "131Iodine-Tositumomab_monotherapy" .
<MF> <Maps_to> "MF" .
<R-HiDAC> <Has_accepted_use> "Mantle_cell_lymphoma" .
<BTK_inhibitor> <Subsumes> "Zanubrutinib" .
<BTK_inhibitor> <Subsumes> "Spebrutinib" .
<BTK_inhibitor> <Subsumes> "Ibrutinib" .
<BTK_inhibitor> <Subsumes> "Dasatinib" .
<BTK_inhibitor> <Subsumes> "Acalabrutinib" .
<Colace> <Brand_name_of> "Docusate" .
<Fluzepamin> <Brand_name_of> "Dalteparin" .
<Loperamide> <Supportive_med_of> "Neratinib_monotherapy" .
<Loperamide> <Supportive_med_of> "Neratinib_and_Paclitaxel" .
<Loperamide> <Supportive_med_of> "Mitotane_monotherapy" .
<Loperamide> <Supportive_med_of> "Irinotecan_monotherapy" .
<Loperamide> <Supportive_med_of> "Irinotecan_and_Temozolomide" .
<Loperamide> <Supportive_med_of> "Irinotecan_and_Mitomycin" .
<Loperamide> <Supportive_med_of> "Irinotecan_and_Bevacizumab" .
<Loperamide> <Supportive_med_of> "Fluorouracil_and_Levoleucovorin" .
<Loperamide> <Supportive_med_of> "Fluorouracil_and_Folinic_acid" .
<Loperamide> <Supportive_med_of> "FOLFIRI" .
<Loperamide> <Supportive_med_of> "Docetaxel_and_Irinotecan" .
<Loperamide> <Supportive_med_of> "Cisplatin_and_Fluorouracil" .
<Loperamide> <Supportive_med_of> "Carboplatin_and_Irinotecan" .
<Loperamide> <Supportive_med_of> "Carboplatin_and_Etoposide" .
<Loperamide> <Supportive_med_of> "CAPIRI" .
<Etoposide,_Vinblastine,_Prednisone> <Has_accepted_use> "Langerhans_cell_histiocytosis" .
<Tromalyt> <Brand_name_of> "Aspirin" .
<FMP> <Has_modality> "Chemotherapy" .
<CHOEP-14> <Has_context> "Induction_therapy" .
<Daunorubicin_liposomal_monotherapy> <Has_context> "All_lines_of_therapy" .
<Ifosfamide_and_Gemcitabine> <Has_antineoplastic> "Ifosfamide" .
<Ifosfamide_and_Gemcitabine> <Has_antineoplastic> "Gemcitabine" .
<Katrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Calaspargase,_Daunorubicin,_Vincristine,_Prednisone> <Maps_to> "Calaspargase,_Daunorubicin,_Vincristine,_Prednisone" .
<DICE> <Has_antineoplastic> "Ifosfamide" .
<DICE> <Has_antineoplastic> "Etoposide" .
<DICE> <Has_antineoplastic> "Dexamethasone" .
<DICE> <Has_antineoplastic> "Carboplatin" .
<Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone> <Has_local_therapy> "Methotrexate" .
<MATRix> <Is_current_in> "CNS_lymphoma" .
<Pralatrexate_monotherapy> <Has_context> "Non-curative_therapy" .
<Trimesol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<ECH> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<ECH> <Has_accepted_use> "Breast_cancer" .
<IGEV> <Has_supportive_med> "Mesna" .
<IGEV> <Has_supportive_med> "Filgrastim" .
<Tirofiban> <Is_a> "GPIIb-IIIa_inhibitor" .
<Anastrozole_and_Ribociclib> <Has_supportive_med> "Goserelin" .
<RT,_then_Temozolomide> <Has_context> "Adjuvant_therapy" .
<CLARA> <Mapped_from> "CLARA" .
<Letrozole_and_Ribociclib> <Has_context> "Non-curative_first-line_therapy" .
<Amrubicin> <Has_brand_name> "Calsed" .
<Paclitaxel_and_Pazopanib> <Mapped_from> "Paclitaxel_and_Pazopanib" .
<Elmetacin> <Brand_name_of> "Indomethacin" .
<R-CP> <Maps_to> "R-CP" .
<Ivosidenib> <May_have_route> "Oral" .
<Sulphatran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Gemcitabine,_Oxaliplatin,_Paclitaxel> <Has_context> "Non-curative_subsequent-line_therapy" .
<Zovir> <Brand_name_of> "Acyclovir" .
<Vincrisul> <Brand_name_of> "Vincristine" .
<SHAI> <Has_modality> "Chemotherapy" .
<VEBEP> <Has_antineoplastic> "Prednisolone" .
<VEBEP> <Has_antineoplastic> "Etoposide" .
<VEBEP> <Has_antineoplastic> "Epirubicin" .
<VEBEP> <Has_antineoplastic> "Cyclophosphamide" .
<VEBEP> <Has_antineoplastic> "Bleomycin" .
<ICE> <Has_supportive_med> "Filgrastim" .
<VAC_(Adriamycin)> <Mapped_from> "VAC_(Adriamycin)" .
<CHOP_and_Everolimus> <Mapped_from> "CHOP_and_Everolimus" .
<BCG_and_Dacarbazine> <Has_modality> "Immunotherapy" .
<BCG_and_Dacarbazine> <Has_modality> "Chemotherapy" .
<Emicizumab_monotherapy> <Has_supportive_med> "Emicizumab" .
<GELOX/RT> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Deflaren> <Brand_name_of> "Dexamethasone" .
<Selumetinib> <Is_a> "MAP2K2_inhibitor" .
<Selumetinib> <Is_a> "MAP2K1_inhibitor" .
<Selumetinib> <Is_a> "Kinase_inhibitor" .
<Selumetinib> <Is_a> "Investigational_drug" .
<Mercaptopurine> <May_have_route> "Oral" .
<COPP/ABVD> <Is_historical_in> "Hodgkin_lymphoma" .
<Varidoxo> <Brand_name_of> "Doxorubicin" .
<Cisplatin_and_Ifosfamide> <Has_accepted_use> "Cervical_cancer" .
<Deferasirox> <May_have_route> "Oral" .
<MA-BCD> <Has_supportive_med> "Folinic_acid" .
<BCHOP> <Mapped_from> "BCHOP" .
<Moxetumomab_pasudotox_monotherapy> <Has_context> "Non-curative_therapy" .
<HAM_and_Imatinib> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<HAM_and_Imatinib> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Apatinib> <Is_a> "VEGFR_inhibitor" .
<Apatinib> <Is_a> "SRC_inhibitor" .
<Apatinib> <Is_a> "Kinase_inhibitor" .
<Apatinib> <Is_a> "KIT_inhibitor" .
<Apatinib> <Is_a> "CFDA_approved_drug" .
<Bu/TT> <Mapped_from> "Bu/TT" .
<Testicular_cancer> <Is_a> "Genitourinary_cancer" .
<Ribodoxo> <Brand_name_of> "Doxorubicin" .
<Ivosidenib_monotherapy> <Has_modality> "Chemotherapy" .
<Somatuline_Autogel> <Brand_name_of> "Lanreotide" .
<Non-curative_first-line_maintenance_therapy> <Mapped_from> "Non-curative_first-line_maintenance_therapy" .
<Cytarabine,_Idarubicin,_Sorafenib> <Has_accepted_use> "Acute_myeloid_leukemia" .
<ACVBP-R> <Has_context> "Induction_therapy" .
<ATRA,_Cytarabine,_Daunorubicin> <Has_context> "Induction_therapy" .
<Bendamustine_and_Ofatumumab> <Has_antineoplastic> "Ofatumumab" .
<Bendamustine_and_Ofatumumab> <Has_antineoplastic> "Bendamustine" .
<Midostaurin_monotherapy> <Has_antineoplastic> "Midostaurin" .
<FUOX> <Has_accepted_use> "Colon_cancer" .
<Interferon_alfa_and_Dexamethasone> <Has_modality> "Immunotherapy" .
<Interferon_alfa_and_Dexamethasone> <Has_modality> "Chemotherapy" .
<Caphosol> <Brand_name_of> "Calcium_phosphate_rinse" .
<PD> <Has_supportive_med> "Warfarin" .
<PD> <Has_supportive_med> "Low_molecular_weight_heparins" .
<PD> <Has_supportive_med> "Filgrastim" .
<PD> <Has_supportive_med> "Aspirin" .
<L-asparaginase_monotherapy> <Has_antineoplastic> "Asparaginase" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Has_supportive_med> "Rasburicase" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Has_supportive_med> "Mesna" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Has_supportive_med> "Folinic_acid" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Has_supportive_med> "Filgrastim" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Has_supportive_med> "Allopurinol" .
<Cisplatin,_Etoposide,_Durvalumab> <Maps_to> "Cisplatin,_Etoposide,_Durvalumab" .
<Osimertinib_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Osimertinib_monotherapy> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<Osimertinib_monotherapy> <Has_accepted_use> "CNS_carcinoma" .
<Mexaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<BeEAM> <Is_current_in> "Autologous_HSCT" .
<BEAM,_then_auto_HSCT> <Has_supportive_med> "Valacyclovir" .
<BEAM,_then_auto_HSCT> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<BEAM,_then_auto_HSCT> <Has_supportive_med> "Mycostatin" .
<BEAM,_then_auto_HSCT> <Has_supportive_med> "Fluconazole" .
<BEAM,_then_auto_HSCT> <Has_supportive_med> "Filgrastim" .
<BEAM,_then_auto_HSCT> <Has_supportive_med> "Ciprofloxacin" .
<BEAM,_then_auto_HSCT> <Has_supportive_med> "Acyclovir" .
<Non-curative_second-line_maintenance_therapy> <Mapped_from> "Non-curative_second-line_maintenance_therapy" .
<Letoval> <Brand_name_of> "Letrozole" .
<Trimeran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Spectrem> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<LEED> <Is_current_in> "Autologous_HSCT" .
<Decitabine_and_Venetoclax> <Has_antineoplastic> "Venetoclax" .
<Decitabine_and_Venetoclax> <Has_antineoplastic> "Decitabine" .
<Non-curative_subsequent-line_maintenance_therapy> <Is_a> "Non-curative_subsequent-line_therapy" .
<Bactoreduct> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<ChlVPP/PABIOE> <Has_context> "Induction_therapy" .
<Carmustine_monotherapy> <Is_current_in> "Glioblastoma" .
<Carmustine_monotherapy> <Is_current_in> "Anaplastic_glioma" .
<Cytarabine_liposomal> <Has_accepted_use> "CNS_lymphoma" .
<Cytarabine_liposomal> <Has_accepted_use> "CNS_leukemia" .
<R-CHOP-14> <Has_modality> "Chemotherapy" .
<Cabozantinib_monotherapy> <Maps_to> "Cabozantinib_monotherapy" .
<VP> <Has_supportive_med> "Bisphosphonates" .
<VP> <Has_supportive_med> "Acyclovir" .
<Lenvatinib_monotherapy> <Has_modality> "Chemotherapy" .
<R-CHOP/R-DHAP> <Has_modality> "Chemotherapy" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine> <Maps_to> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine" .
<Oslene> <Brand_name_of> "Alendronate" .
<MAPI> <Is_current_in> "Osteosarcoma" .
<VMCP/VBAP> <Has_antineoplastic> "Vincristine" .
<VMCP/VBAP> <Has_antineoplastic> "Prednisone" .
<VMCP/VBAP> <Has_antineoplastic> "Melphalan" .
<VMCP/VBAP> <Has_antineoplastic> "Doxorubicin" .
<VMCP/VBAP> <Has_antineoplastic> "Cyclophosphamide" .
<VMCP/VBAP> <Has_antineoplastic> "Carmustine" .
<Selinexor_and_Dexamethasone> <Maps_to> "Selinexor_and_Dexamethasone" .
<Itraconazole> <May_have_route> "Oral" .
<Itraconazole> <May_have_route> "Intravenous" .
<Aspirin_and_Warfarin> <Has_context> "All_lines_of_therapy" .
<REMS_program> <Subsumes> "Vandetanib" .
<REMS_program> <Subsumes> "Tisagenlecleucel" .
<REMS_program> <Subsumes> "Thalidomide" .
<REMS_program> <Subsumes> "Ponatinib" .
<REMS_program> <Subsumes> "Pomalidomide" .
<REMS_program> <Subsumes> "Panobinostat" .
<REMS_program> <Subsumes> "Lenalidomide" .
<REMS_program> <Subsumes> "Idelalisib" .
<REMS_program> <Subsumes> "Eculizumab" .
<REMS_program> <Subsumes> "Duvelisib" .
<REMS_program> <Subsumes> "Blinatumomab" .
<REMS_program> <Subsumes> "Axicabtagene_ciloleucel" .
<REMS_program> <Subsumes> "Alemtuzumab" .
<Cyclosporine,_Corticosteroids,_Rituximab> <Has_modality> "Immunosuppressive_therapy" .
<Levofloxacin> <Is_a> "Fluoroquinolone" .
<Fluorouracil_and_Paclitaxel> <Has_context> "Consolidation_after_upfront_therapy" .
<Daratumumab> <Has_brand_name> "HuMax-CD38" .
<Daratumumab> <Has_brand_name> "Darzalex" .
<Anastrozole_and_Trastuzumab> <Is_current_in> "Breast_cancer" .
<Sickle_cell_anemia> <FDA_indication_of> "L-glutamine" .
<Sickle_cell_anemia> <FDA_indication_of> "Hydroxyurea" .
<Sickle_cell_anemia> <FDA_indication_of> "Crizanlizumab" .
<MVAC,_dose-dense> <Has_antineoplastic> "Vinblastine" .
<MVAC,_dose-dense> <Has_antineoplastic> "Methotrexate" .
<MVAC,_dose-dense> <Has_antineoplastic> "Doxorubicin" .
<MVAC,_dose-dense> <Has_antineoplastic> "Cisplatin" .
<Carboplatin_and_Irinotecan> <Has_accepted_use> "Small_cell_lung_cancer" .
<Aspirin_and_Anagrelide> <Mapped_from> "Aspirin_and_Anagrelide" .
<Denosumab> <Has_FDA_indication> "Soft_tissue_sarcoma" .
<Dexafar> <Brand_name_of> "Dexamethasone" .
<Sirolimus_and_Vorinostat> <Has_antineoplastic> "Vorinostat" .
<Sirolimus_and_Vorinostat> <Has_antineoplastic> "Sirolimus" .
<BMP> <Maps_to> "BMP" .
<VAdCA/IE> <Is_a> "Anthracycline-containing_regimen" .
<Deltacortone> <Brand_name_of> "Prednisone" .
<Vorinostat_monotherapy> <Is_current_in> "Marginal_zone_lymphoma" .
<Vorinostat_monotherapy> <Is_current_in> "Follicular_lymphoma" .
<Vorinostat_monotherapy> <Is_current_in> "Cutaneous_T-cell_lymphoma" .
<Ceritinib_monotherapy> <Has_modality> "Chemotherapy" .
<Nivolumab,_then_Ipilimumab> <Has_modality> "Immunotherapy" .
<Belotecan> <Is_a> "Topoisomerase_inhibitor" .
<Belotecan> <Is_a> "KFDA_approved_drug" .
<Belotecan> <Is_a> "Irritant" .
<MCF> <Maps_to> "MCF" .
<Mabcampath> <Brand_name_of> "Alemtuzumab" .
<Dexamethasone> <Supportive_med_of> "mDCF_and_Bevacizumab" .
<Dexamethasone> <Supportive_med_of> "mDCF" .
<Dexamethasone> <Supportive_med_of> "ddAC-T" .
<Dexamethasone> <Supportive_med_of> "Trabectedin_monotherapy" .
<Dexamethasone> <Supportive_med_of> "TTR" .
<Dexamethasone> <Supportive_med_of> "TIP" .
<Dexamethasone> <Supportive_med_of> "TH_(Taxotere)" .
<Dexamethasone> <Supportive_med_of> "TAC_(Taxotere)" .
<Dexamethasone> <Supportive_med_of> "Pemetrexed_monotherapy" .
<Dexamethasone> <Supportive_med_of> "Pemetrexed_and_Bevacizumab" .
<Dexamethasone> <Supportive_med_of> "Paclitaxel_monotherapy" .
<Dexamethasone> <Supportive_med_of> "PCF" .
<Dexamethasone> <Supportive_med_of> "PCE" .
<Dexamethasone> <Supportive_med_of> "Methotrexate_monotherapy" .
<Dexamethasone> <Supportive_med_of> "MVAC,_dose-dense" .
<Dexamethasone> <Supportive_med_of> "MPV" .
<Dexamethasone> <Supportive_med_of> "Irinotecan_monotherapy" .
<Dexamethasone> <Supportive_med_of> "Irinotecan_and_Mitomycin" .
<Dexamethasone> <Supportive_med_of> "Irinotecan_and_Cetuximab" .
<Dexamethasone> <Supportive_med_of> "Irinotecan_and_Bevacizumab" .
<Dexamethasone> <Supportive_med_of> "Ifosfamide_and_Paclitaxel" .
<Dexamethasone> <Supportive_med_of> "Hepatic_arterial_chemotherapy" .
<Dexamethasone> <Supportive_med_of> "HLH-94_regimen" .
<Dexamethasone> <Supportive_med_of> "Gemcitabine,_Oxaliplatin,_Paclitaxel" .
<Dexamethasone> <Supportive_med_of> "Gemcitabine_and_Paclitaxel" .
<Dexamethasone> <Supportive_med_of> "Gemcitabine_and_Mitomycin" .
<Dexamethasone> <Supportive_med_of> "GemOx" .
<Dexamethasone> <Supportive_med_of> "FOLFIRI" .
<Dexamethasone> <Supportive_med_of> "FLOT" .
<Dexamethasone> <Supportive_med_of> "FCR" .
<Dexamethasone> <Supportive_med_of> "Epirubicin_and_Ifosfamide" .
<Dexamethasone> <Supportive_med_of> "EOX" .
<Dexamethasone> <Supportive_med_of> "EOF" .
<Dexamethasone> <Supportive_med_of> "Docetaxel,_Fluorouracil,_RT" .
<Dexamethasone> <Supportive_med_of> "Docetaxel,_Cetuximab,_RT" .
<Dexamethasone> <Supportive_med_of> "Docetaxel_monotherapy" .
<Dexamethasone> <Supportive_med_of> "Docetaxel_and_Ramucirumab" .
<Dexamethasone> <Supportive_med_of> "Docetaxel_and_Prednisone" .
<Dexamethasone> <Supportive_med_of> "Docetaxel_and_Prednisolone" .
<Dexamethasone> <Supportive_med_of> "Docetaxel_and_Irinotecan" .
<Dexamethasone> <Supportive_med_of> "Docetaxel_and_Gemcitabine" .
<Dexamethasone> <Supportive_med_of> "Dexamethasone_monotherapy" .
<Dexamethasone> <Supportive_med_of> "Dexamethasone_and_WBRT" .
<Dexamethasone> <Supportive_med_of> "Denosumab_monotherapy" .
<Dexamethasone> <Supportive_med_of> "Daratumumab_monotherapy" .
<Dexamethasone> <Supportive_med_of> "Dara-VMP" .
<Dexamethasone> <Supportive_med_of> "DD-CHOP" .
<Dexamethasone> <Supportive_med_of> "DCF" .
<Dexamethasone> <Supportive_med_of> "Cyclophosphamide_monotherapy" .
<Dexamethasone> <Supportive_med_of> "Clofarabine_and_Cytarabine" .
<Dexamethasone> <Supportive_med_of> "Cladribine_monotherapy" .
<Dexamethasone> <Supportive_med_of> "Cisplatin,_Pemetrexed,_Bevacizumab" .
<Dexamethasone> <Supportive_med_of> "Cisplatin,_Paclitaxel,_RT" .
<Dexamethasone> <Supportive_med_of> "Cisplatin,_Etoposide,_RT" .
<Dexamethasone> <Supportive_med_of> "Cisplatin,_Docetaxel,_RT" .
<Dexamethasone> <Supportive_med_of> "Cisplatin_and_RT" .
<Dexamethasone> <Supportive_med_of> "Cisplatin_and_Pemetrexed" .
<Dexamethasone> <Supportive_med_of> "Cisplatin_and_Paclitaxel" .
<Dexamethasone> <Supportive_med_of> "Cisplatin_and_Irinotecan" .
<Dexamethasone> <Supportive_med_of> "Cisplatin_and_Gemcitabine" .
<Dexamethasone> <Supportive_med_of> "Cisplatin_and_Fluorouracil" .
<Dexamethasone> <Supportive_med_of> "Cisplatin_and_Etoposide" .
<Dexamethasone> <Supportive_med_of> "Cisplatin_and_Doxorubicin" .
<Dexamethasone> <Supportive_med_of> "Cisplatin_and_Docetaxel" .
<Dexamethasone> <Supportive_med_of> "Carfilzomib_monotherapy" .
<Dexamethasone> <Supportive_med_of> "Carboplatin,_Paclitaxel,_RT" .
<Dexamethasone> <Supportive_med_of> "Carboplatin,_Etoposide,_RT" .
<Dexamethasone> <Supportive_med_of> "Carboplatin,_Docetaxel,_Prednisone" .
<Dexamethasone> <Supportive_med_of> "Carboplatin_monotherapy" .
<Dexamethasone> <Supportive_med_of> "Carboplatin_and_Pemetrexed" .
<Dexamethasone> <Supportive_med_of> "Carboplatin_and_Paclitaxel" .
<Dexamethasone> <Supportive_med_of> "Carboplatin_and_Fluorouracil" .
<Dexamethasone> <Supportive_med_of> "Carboplatin_and_Etoposide" .
<Dexamethasone> <Supportive_med_of> "Carboplatin_and_Doxorubicin_liposomal" .
<Dexamethasone> <Supportive_med_of> "Carboplatin_and_Docetaxel" .
<Dexamethasone> <Supportive_med_of> "Capecitabine,_Docetaxel,_Oxaliplatin,_RT" .
<Dexamethasone> <Supportive_med_of> "Capecitabine_and_Mitomycin" .
<Dexamethasone> <Supportive_med_of> "Cabazitaxel_and_Prednisone" .
<Dexamethasone> <Supportive_med_of> "CVD_(Vinblastine)" .
<Dexamethasone> <Supportive_med_of> "Blinatumomab_monotherapy" .
<Dexamethasone> <Supportive_med_of> "Arsenic_trioxide_and_ATRA" .
<Dexamethasone> <Supportive_med_of> "ADT_and_Docetaxel" .
<Hydroxyurea_and_Plicamycin> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Paclitaxel_and_Ramucirumab> <Is_current_in> "Gastric_cancer" .
<Paclitaxel_and_Ramucirumab> <Is_current_in> "Esophageal_cancer" .
<CLAG> <Maps_to> "CLAG" .
<Bendamax> <Brand_name_of> "Bendamustine" .
<R-NIMP> <Is_a> "Rituximab-containing_regimen" .
<R-NIMP> <Is_a> "Anthracycline-containing_regimen" .
<Cotripharm> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Ox-P> <Has_context> "Non-curative_therapy" .
<Irinotecan_liposome> <Has_brand_name> "Onivyde" .
<Jevtana> <Brand_name_of> "Cabazitaxel" .
<Temsirolimus> <Is_a> "MTOR_inhibitor" .
<Temsirolimus> <Is_a> "Kinase_inhibitor" .
<Anti-IL-5_antibody> <Is_a> "Antibody_medication" .
<Ifosfamide_and_Gemcitabine> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Kinase_inhibitor> <Subsumes> "Zanubrutinib" .
<Kinase_inhibitor> <Subsumes> "Volasertib" .
<Kinase_inhibitor> <Subsumes> "Vemurafenib" .
<Kinase_inhibitor> <Subsumes> "Vandetanib" .
<Kinase_inhibitor> <Subsumes> "VEGFR_inhibitor" .
<Kinase_inhibitor> <Subsumes> "Trametinib" .
<Kinase_inhibitor> <Subsumes> "Tivantinib" .
<Kinase_inhibitor> <Subsumes> "Temsirolimus" .
<Kinase_inhibitor> <Subsumes> "TXK_inhibitor" .
<Kinase_inhibitor> <Subsumes> "TRK_inhibitor" .
<Kinase_inhibitor> <Subsumes> "TEK_inhibitor" .
<Kinase_inhibitor> <Subsumes> "TEC_inhibitor" .
<Kinase_inhibitor> <Subsumes> "Sunitinib" .
<Kinase_inhibitor> <Subsumes> "Spebrutinib" .
<Kinase_inhibitor> <Subsumes> "Sorafenib" .
<Kinase_inhibitor> <Subsumes> "Sirolimus" .
<Kinase_inhibitor> <Subsumes> "Selumetinib" .
<Kinase_inhibitor> <Subsumes> "SYK_inhibitor" .
<Kinase_inhibitor> <Subsumes> "SRC_inhibitor" .
<Kinase_inhibitor> <Subsumes> "Ruxolitinib" .
<Kinase_inhibitor> <Subsumes> "Rociletinib" .
<Kinase_inhibitor> <Subsumes> "Ribociclib" .
<Kinase_inhibitor> <Subsumes> "Regorafenib" .
<Kinase_inhibitor> <Subsumes> "Refametinib" .
<Kinase_inhibitor> <Subsumes> "Radotinib" .
<Kinase_inhibitor> <Subsumes> "ROS1_inhibitor" .
<Kinase_inhibitor> <Subsumes> "RET_inhibitor" .
<Kinase_inhibitor> <Subsumes> "Quizartinib" .
<Kinase_inhibitor> <Subsumes> "Pracinostat" .
<Kinase_inhibitor> <Subsumes> "Ponatinib" .
<Kinase_inhibitor> <Subsumes> "Pictilisib" .
<Kinase_inhibitor> <Subsumes> "Perifosine" .
<Kinase_inhibitor> <Subsumes> "Pazopanib" .
<Kinase_inhibitor> <Subsumes> "Palbociclib" .
<Kinase_inhibitor> <Subsumes> "Pacritinib" .
<Kinase_inhibitor> <Subsumes> "PTK2_inhibitor" .
<Kinase_inhibitor> <Subsumes> "PLK1_inhibitor" .
<Kinase_inhibitor> <Subsumes> "PI3K_inhibitor" .
<Kinase_inhibitor> <Subsumes> "PDGFR_inhibitor" .
<Kinase_inhibitor> <Subsumes> "Osimertinib" .
<Kinase_inhibitor> <Subsumes> "Nintedanib" .
<Kinase_inhibitor> <Subsumes> "Nilotinib" .
<Kinase_inhibitor> <Subsumes> "Neratinib" .
<Kinase_inhibitor> <Subsumes> "Motesanib" .
<Kinase_inhibitor> <Subsumes> "Momelotinib" .
<Kinase_inhibitor> <Subsumes> "Midostaurin" .
<Kinase_inhibitor> <Subsumes> "Masitinib" .
<Kinase_inhibitor> <Subsumes> "MTOR_inhibitor" .
<Kinase_inhibitor> <Subsumes> "MET_inhibitor" .
<Kinase_inhibitor> <Subsumes> "MEK_inhibitor" .
<Kinase_inhibitor> <Subsumes> "MAP4K5_inhibitor" .
<Kinase_inhibitor> <Subsumes> "MAP3K20_inhibitor" .
<Kinase_inhibitor> <Subsumes> "Lorlatinib" .
<Kinase_inhibitor> <Subsumes> "Lestaurtinib" .
<Kinase_inhibitor> <Subsumes> "Lenvatinib" .
<Kinase_inhibitor> <Subsumes> "Larotrectinib" .
<Kinase_inhibitor> <Subsumes> "Lapatinib" .
<Kinase_inhibitor> <Subsumes> "KIT_inhibitor" .
<Kinase_inhibitor> <Subsumes> "JAK_inhibitor" .
<Kinase_inhibitor> <Subsumes> "Imatinib" .
<Kinase_inhibitor> <Subsumes> "Idelalisib" .
<Kinase_inhibitor> <Subsumes> "Icotinib" .
<Kinase_inhibitor> <Subsumes> "Ibrutinib" .
<Kinase_inhibitor> <Subsumes> "ITK_inhibitor" .
<Kinase_inhibitor> <Subsumes> "IGFR_inhibitor" .
<Kinase_inhibitor> <Subsumes> "Gilteritinib" .
<Kinase_inhibitor> <Subsumes> "Gefitinib" .
<Kinase_inhibitor> <Subsumes> "Fruquintinib" .
<Kinase_inhibitor> <Subsumes> "Fostamatinib" .
<Kinase_inhibitor> <Subsumes> "Fedratinib" .
<Kinase_inhibitor> <Subsumes> "FLT3_inhibitor" .
<Kinase_inhibitor> <Subsumes> "FGFR_inhibitor" .
<Kinase_inhibitor> <Subsumes> "Everolimus" .
<Kinase_inhibitor> <Subsumes> "Erlotinib" .
<Kinase_inhibitor> <Subsumes> "Erdafitinib" .
<Kinase_inhibitor> <Subsumes> "Entrectinib" .
<Kinase_inhibitor> <Subsumes> "Entospletinib" .
<Kinase_inhibitor> <Subsumes> "Ensartinib" .
<Kinase_inhibitor> <Subsumes> "Encorafenib" .
<Kinase_inhibitor> <Subsumes> "ERBB4_inhibitor" .
<Kinase_inhibitor> <Subsumes> "ERBB3_inhibitor" .
<Kinase_inhibitor> <Subsumes> "ERBB2_inhibitor" .
<Kinase_inhibitor> <Subsumes> "EGFR_inhibitor" .
<Kinase_inhibitor> <Subsumes> "Duvelisib" .
<Kinase_inhibitor> <Subsumes> "Dovitinib" .
<Kinase_inhibitor> <Subsumes> "Dinaciclib" .
<Kinase_inhibitor> <Subsumes> "Dasatinib" .
<Kinase_inhibitor> <Subsumes> "Dacomitinib" .
<Kinase_inhibitor> <Subsumes> "Dabrafenib" .
<Kinase_inhibitor> <Subsumes> "DDR_inhibitor" .
<Kinase_inhibitor> <Subsumes> "Crizotinib" .
<Kinase_inhibitor> <Subsumes> "Crenolanib" .
<Kinase_inhibitor> <Subsumes> "Copanlisib" .
<Kinase_inhibitor> <Subsumes> "Cobimetinib" .
<Kinase_inhibitor> <Subsumes> "Ceritinib" .
<Kinase_inhibitor> <Subsumes> "Capivasertib" .
<Kinase_inhibitor> <Subsumes> "Cabozantinib" .
<Kinase_inhibitor> <Subsumes> "CSF1R_inhibitor" .
<Kinase_inhibitor> <Subsumes> "CDK_inhibitor" .
<Kinase_inhibitor> <Subsumes> "Buparlisib" .
<Kinase_inhibitor> <Subsumes> "Brigatinib" .
<Kinase_inhibitor> <Subsumes> "Bosutinib" .
<Kinase_inhibitor> <Subsumes> "Binimetinib" .
<Kinase_inhibitor> <Subsumes> "Bcr-Abl_inhibitor" .
<Kinase_inhibitor> <Subsumes> "Barasertib" .
<Kinase_inhibitor> <Subsumes> "BTK_inhibitor" .
<Kinase_inhibitor> <Subsumes> "BRAF_inhibitor" .
<Kinase_inhibitor> <Subsumes> "Axitinib" .
<Kinase_inhibitor> <Subsumes> "Avapritinib" .
<Kinase_inhibitor> <Subsumes> "Aurora_kinase_inhibitor" .
<Kinase_inhibitor> <Subsumes> "Asciminib" .
<Kinase_inhibitor> <Subsumes> "Apatinib" .
<Kinase_inhibitor> <Subsumes> "Alvocidib" .
<Kinase_inhibitor> <Subsumes> "Alpelisib" .
<Kinase_inhibitor> <Subsumes> "Alisertib" .
<Kinase_inhibitor> <Subsumes> "Alectinib" .
<Kinase_inhibitor> <Subsumes> "Afuresertib" .
<Kinase_inhibitor> <Subsumes> "Afatinib" .
<Kinase_inhibitor> <Subsumes> "Acalabrutinib" .
<Kinase_inhibitor> <Subsumes> "Abemaciclib" .
<Kinase_inhibitor> <Subsumes> "AXL_inhibitor" .
<Kinase_inhibitor> <Subsumes> "ALK_inhibitor" .
<Kinase_inhibitor> <Subsumes> "AKT1_inhibitor" .
<Cyclosporine_and_Methotrexate> <Has_immunosuppressor> "Methotrexate" .
<Cyclosporine_and_Methotrexate> <Has_immunosuppressor> "Cyclosporines" .
<R-GCVP> <Has_context> "Induction_therapy" .
<Dexagee> <Brand_name_of> "Dexamethasone" .
<CAP-BOP> <Has_modality> "Chemotherapy" .
<ABC> <Has_antineoplastic> "Paclitaxel_nanoparticle_albumin-bound" .
<ABC> <Has_antineoplastic> "Carboplatin" .
<ABC> <Has_antineoplastic> "Bevacizumab" .
<CMF> <Maps_to> "CMF" .
<Ifosfamide_and_Gemcitabine> <Has_modality> "Chemotherapy" .
<Infectran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<mFOLFOX6_and_Bevacizumab_(L-Leucovorin)> <Has_antineoplastic> "Oxaliplatin" .
<mFOLFOX6_and_Bevacizumab_(L-Leucovorin)> <Has_antineoplastic> "Levoleucovorin" .
<mFOLFOX6_and_Bevacizumab_(L-Leucovorin)> <Has_antineoplastic> "Fluorouracil" .
<mFOLFOX6_and_Bevacizumab_(L-Leucovorin)> <Has_antineoplastic> "Bevacizumab" .
<Bevacizumab_and_Interferon_alfa-2a> <Has_context> "Non-curative_first-line_therapy" .
<Ranimustine> <Antineoplastic_of> "mLSG15" .
<Ranimustine> <Antineoplastic_of> "LSG15" .
<Demasone> <Brand_name_of> "Dexamethasone" .
<Fluorouracil_and_Methotrexate> <Has_accepted_use> "Colon_cancer" .
<Asparaginase> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Asparaginase> <Is_a> "Neutral" .
<Asparaginase> <Is_a> "Enzyme" .
<Asparaginase> <Is_a> "Discontinued_drug" .
<Anastrozole_and_Palbociclib> <Has_antineoplastic> "Palbociclib" .
<Anastrozole_and_Palbociclib> <Has_antineoplastic> "Anastrozole" .
<CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy> <Is_current_in> "Melanoma" .
<Medexasone> <Brand_name_of> "Dexamethasone" .
<Carboplatin_and_Cyclophosphamide> <Is_historical_in> "Ovarian_cancer" .
<Cytarabine_monotherapy> <Maps_to> "Cytarabine_monotherapy" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib> <Has_local_therapy> "Methotrexate" .
<Docetaxel,_Gemcitabine,_RT> <Maps_to> "Docetaxel,_Gemcitabine,_RT" .
<Carboplatin,_Pemetrexed,_Pembrolizumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<Hemostasis_medication> <Is_a> "Hematology_medication" .
<Persantine> <Brand_name_of> "Dipyridamole" .
<KD> <Maps_to> "KD" .
<BRAF-mutated_Non-small_cell_lung_cancer> <Is_a> "Non-small_cell_lung_cancer" .
<CAMFP> <Is_a> "Anthracycline-containing_regimen" .
<ADT_and_Apalutamide> <Is_current_in> "Prostate_cancer" .
<Bortenat> <Brand_name_of> "Bortezomib" .
<ChlVPP> <Is_current_in> "Hodgkin_lymphoma" .
<Cyproterone_acetate_monotherapy> <Has_context> "Non-curative_therapy" .
<Imbruvica> <Brand_name_of> "Ibrutinib" .
<Cisplatin_and_S-1> <Has_accepted_use> "Gastric_cancer" .
<Coryphen> <Brand_name_of> "Aspirin" .
<CNOP> <Mapped_from> "CNOP" .
<Benralizumab> <May_have_route> "Intravenous" .
<Cisplatin,_Lomustine,_Vincristine> <Mapped_from> "Cisplatin,_Lomustine,_Vincristine" .
<CHOP-14> <Is_current_in> "Adult_T-cell_leukemia-lymphoma" .
<Fulvestrant> <Is_a> "Protein_expression-specific_medication" .
<Fulvestrant> <Is_a> "Estrogen_receptor_inhibitor" .
<Fulvestrant> <Is_a> "Endocrine_therapeutic" .
<PAD> <Has_context> "Non-curative_therapy" .
<PAD> <Has_context> "Non-curative_first-line_therapy" .
<Octreotide_LAR> <Antineoplastic_of> "Octreotide_LAR_monotherapy" .
<Octreotide_LAR> <Antineoplastic_of> "Lutetium_Lu_177_dotatate_and_Octreotide_LAR" .
<Octreotide_LAR> <Antineoplastic_of> "Everolimus_and_Octreotide" .
<Chlorambucil_monotherapy> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Chlorambucil_monotherapy> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Chlorambucil_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<Chlorambucil_monotherapy> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Fluorouracil_and_Folinic_acid> <Has_antineoplastic> "Folinic_acid" .
<Fluorouracil_and_Folinic_acid> <Has_antineoplastic> "Fluorouracil" .
<O-ICE> <Has_supportive_med> "Pegfilgrastim" .
<O-ICE> <Has_supportive_med> "Filgrastim" .
<R-COPADM> <Has_accepted_use> "Burkitt_lymphoma" .
<MAP4K5_inhibitor> <Is_a> "Kinase_inhibitor" .
<Carboplatin,_Pemetrexed,_Bevacizumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<COPAD> <Is_a> "Anthracycline-containing_regimen" .
<Plinabulin> <May_have_route> "Oral" .
<Lenvatinib> <Has_FDA_indication> "Thyroid_cancer" .
<Lenvatinib> <Has_FDA_indication> "Renal_cell_carcinoma" .
<Lenvatinib> <Has_FDA_indication> "Hepatocellular_carcinoma" .
<Lenvatinib> <Has_FDA_indication> "Endometrial_cancer" .
<Bispecific_antibody_medication> <Is_a> "Antibody_medication" .
<RICER> <Has_modality> "Chemotherapy" .
<Nimustine> <Has_accepted_use> "Glioblastoma" .
<Nimustine> <Has_accepted_use> "Anaplastic_glioma" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Is_a> "Indolent_lymphoma" .
<CM> <Has_antineoplastic> "Methotrexate" .
<CM> <Has_antineoplastic> "Cyclophosphamide" .
<Osteomax> <Brand_name_of> "Alendronate" .
<Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone> <Maps_to> "Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone" .
<Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone> <Has_modality> "Chemotherapy" .
<Tecnovorin> <Brand_name_of> "Folinic_acid" .
<Vincran> <Brand_name_of> "Vincristine" .
<C-VAMP> <Mapped_from> "C-VAMP" .
<TPC> <Has_modality> "Chemotherapy" .
<R-BAC> <Is_a> "Rituximab-containing_regimen" .
<LEED> <Has_accepted_use> "Autologous_HSCT" .
<Dexaden> <Brand_name_of> "Dexamethasone" .
<ABV_(Vincristine)> <Has_accepted_use> "Kaposi_sarcoma" .
<CAMFP> <Has_context> "Adjuvant_therapy" .
<Pegylated_liposomal_doxorubicin> <Has_FDA_indication> "Ovarian_cancer" .
<Pegylated_liposomal_doxorubicin> <Has_FDA_indication> "Multiple_myeloma" .
<Pegylated_liposomal_doxorubicin> <Has_FDA_indication> "Kaposi_sarcoma" .
<O-ESHAP> <Mapped_from> "O-ESHAP" .
<eBEACOPP_(Prednisolone)> <Is_a> "Anthracycline-containing_regimen" .
<Vincosid> <Brand_name_of> "Vincristine" .
<Cisplatin_and_Etoposide> <Has_context> "Upfront_therapy" .
<Cisplatin_and_Etoposide> <Has_context> "Non-curative_therapy" .
<Cisplatin_and_Etoposide> <Has_context> "Non-curative_first-line_therapy" .
<Cisplatin_and_Etoposide> <Has_context> "Induction_therapy" .
<Cisplatin_and_Etoposide> <Has_context> "Consolidation_after_upfront_therapy" .
<Cisplatin_and_Etoposide> <Has_context> "Adjuvant_therapy" .
<Zelitrex> <Brand_name_of> "Valacyclovir" .
<Emapalumab> <Is_a> "Antibody_medication" .
<Emapalumab> <Is_a> "Anti-IFNg_antibody" .
<Daratumumab> <May_have_route> "Intravenous" .
<Gestational_trophoblastic_neoplasia> <FDA_indication_of> "Dactinomycin" .
<L-glutamine_monotherapy> <Has_accepted_use> "Sickle_cell_anemia" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Maps_to> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Eylea> <Brand_name_of> "Ziv-aflibercept" .
<LSG15> <Is_current_in> "Adult_T-cell_leukemia-lymphoma" .
<CVP> <Has_context> "Non-curative_first-line_therapy" .
<CVP> <Has_context> "Induction_therapy" .
<Cotellic> <Brand_name_of> "Cobimetinib" .
<Busulfan_and_Fludarabine> <Has_immunosuppressor> "Tacrolimus" .
<Busulfan_and_Fludarabine> <Has_immunosuppressor> "Phenytoin" .
<Busulfan_and_Fludarabine> <Has_immunosuppressor> "Methotrexate" .
<Busulfan_and_Fludarabine> <Has_immunosuppressor> "Mesna" .
<Busulfan_and_Fludarabine> <Has_immunosuppressor> "Folinic_acid" .
<Busulfan_and_Fludarabine> <Has_immunosuppressor> "Filgrastim" .
<Busulfan_and_Fludarabine> <Has_immunosuppressor> "Cyclosporine_non-modified" .
<Busulfan_and_Fludarabine> <Has_immunosuppressor> "Cyclosporine_modified" .
<Busulfan_and_Fludarabine> <Has_immunosuppressor> "Cyclophosphamide" .
<Busulfan_and_Fludarabine> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<Sunitinib> <Has_FDA_indication> "Renal_cell_carcinoma" .
<Sunitinib> <Has_FDA_indication> "Pancreatic_NET" .
<Sunitinib> <Has_FDA_indication> "Gastrointestinal_stromal_tumor" .
<Dexamethasone> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Dexamethasone> <Has_accepted_use> "Transformed_lymphoma" .
<Dexamethasone> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Dexamethasone> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<Dexamethasone> <Has_accepted_use> "Plasma_cell_leukemia" .
<Dexamethasone> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Dexamethasone> <Has_accepted_use> "POEMS_syndrome" .
<Dexamethasone> <Has_accepted_use> "NK-_and_T-cell_lymphoma" .
<Dexamethasone> <Has_accepted_use> "Multiple_myeloma" .
<Dexamethasone> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Dexamethasone> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Dexamethasone> <Has_accepted_use> "Immune_thrombocytopenia" .
<Dexamethasone> <Has_accepted_use> "Hodgkin_lymphoma" .
<Dexamethasone> <Has_accepted_use> "Hemophagocytic_lymphohistiocytosis" .
<Dexamethasone> <Has_accepted_use> "HIV-associated_lymphoma" .
<Dexamethasone> <Has_accepted_use> "Follicular_lymphoma" .
<Dexamethasone> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Dexamethasone> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Dexamethasone> <Has_accepted_use> "CNS_lymphoma" .
<Dexamethasone> <Has_accepted_use> "Burkitt_lymphoma" .
<Dexamethasone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Dexamethasone> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<Cisplatin_and_Mitomycin> <Has_modality> "Chemotherapy" .
<R-EPOCH> <Has_context> "Salvage_therapy" .
<R-EPOCH> <Has_context> "Induction_therapy" .
<R-EPOCH> <Has_context> "All_lines_of_therapy" .
<Ixabepilone_monotherapy> <Maps_to> "Ixabepilone_monotherapy" .
<Prolix> <Brand_name_of> "Prednisone" .
<Mitotane_and_EDP> <Is_current_in> "Adrenocortical_carcinoma" .
<Capecitabine,_Sorafenib,_RT> <Has_context> "Neoadjuvant_therapy" .
<Cisplatin,_Paclitaxel,_Bevacizumab> <Mapped_from> "Cisplatin,_Paclitaxel,_Bevacizumab" .
<Ibrutinib_and_Rituximab> <Has_modality> "Chemotherapy" .
<Clexan> <Brand_name_of> "Enoxaparin" .
<Geftilon> <Brand_name_of> "Gefitinib" .
<Clofarabine_and_Melphalan> <Has_antineoplastic> "Melphalan" .
<Clofarabine_and_Melphalan> <Has_antineoplastic> "Clofarabine" .
<Alendra_7> <Brand_name_of> "Alendronate" .
<Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Nordic_Regimen,_older_patients> <Has_context> "Upfront_therapy" .
<VACA/IE> <Maps_to> "VACA/IE" .
<Follicular_lymphoma> <Current_treated_by> "Vorinostat_monotherapy" .
<Follicular_lymphoma> <Current_treated_by> "Vorinostat_and_Rituximab" .
<Follicular_lymphoma> <Current_treated_by> "VR-CP" .
<Follicular_lymphoma> <Current_treated_by> "VR-CHOP" .
<Follicular_lymphoma> <Current_treated_by> "VR" .
<Follicular_lymphoma> <Current_treated_by> "Temsirolimus_monotherapy" .
<Follicular_lymphoma> <Current_treated_by> "Rituximab_monotherapy" .
<Follicular_lymphoma> <Current_treated_by> "Rituximab_and_hyaluronidase_monotherapy" .
<Follicular_lymphoma> <Current_treated_by> "Radiation_therapy" .
<Follicular_lymphoma> <Current_treated_by> "R-TBI/Cy,_then_auto_HSCT" .
<Follicular_lymphoma> <Current_treated_by> "R-MCP" .
<Follicular_lymphoma> <Current_treated_by> "R-INO" .
<Follicular_lymphoma> <Current_treated_by> "R-FND" .
<Follicular_lymphoma> <Current_treated_by> "R-FM" .
<Follicular_lymphoma> <Current_treated_by> "R-FCM" .
<Follicular_lymphoma> <Current_treated_by> "R-DexaBEAM" .
<Follicular_lymphoma> <Current_treated_by> "R-CVP" .
<Follicular_lymphoma> <Current_treated_by> "R-CMD" .
<Follicular_lymphoma> <Current_treated_by> "R-CHVP_plus_I" .
<Follicular_lymphoma> <Current_treated_by> "R-CHOP" .
<Follicular_lymphoma> <Current_treated_by> "R-BEAM,_then_auto_HSCT" .
<Follicular_lymphoma> <Current_treated_by> "Placebo" .
<Follicular_lymphoma> <Current_treated_by> "PEP-C" .
<Follicular_lymphoma> <Current_treated_by> "PCR" .
<Follicular_lymphoma> <Current_treated_by> "Ofatumumab_monotherapy" .
<Follicular_lymphoma> <Current_treated_by> "Observation" .
<Follicular_lymphoma> <Current_treated_by> "Obinutuzumab_monotherapy" .
<Follicular_lymphoma> <Current_treated_by> "O-CHOP" .
<Follicular_lymphoma> <Current_treated_by> "Lenalidomide,_Dexamethasone,_Rituximab" .
<Follicular_lymphoma> <Current_treated_by> "Lenalidomide_monotherapy" .
<Follicular_lymphoma> <Current_treated_by> "Lenalidomide_and_Rituximab" .
<Follicular_lymphoma> <Current_treated_by> "Inotuzumab_ozogamicin_monotherapy" .
<Follicular_lymphoma> <Current_treated_by> "Idelalisib_monotherapy" .
<Follicular_lymphoma> <Current_treated_by> "Ibrutinib_monotherapy" .
<Follicular_lymphoma> <Current_treated_by> "Ibritumomab_tiuxetan_monotherapy" .
<Follicular_lymphoma> <Current_treated_by> "G-CVP" .
<Follicular_lymphoma> <Current_treated_by> "G-CHOP" .
<Follicular_lymphoma> <Current_treated_by> "FR" .
<Follicular_lymphoma> <Current_treated_by> "FCR,_then_allo_HSCT" .
<Follicular_lymphoma> <Current_treated_by> "Duvelisib_monotherapy" .
<Follicular_lymphoma> <Current_treated_by> "Cyclophosphamide_monotherapy" .
<Follicular_lymphoma> <Current_treated_by> "Cyclophosphamide_and_TBI,_then_auto_HSCT" .
<Follicular_lymphoma> <Current_treated_by> "Copanlisib_monotherapy" .
<Follicular_lymphoma> <Current_treated_by> "Chlorambucil_monotherapy" .
<Follicular_lymphoma> <Current_treated_by> "Bortezomib_monotherapy" .
<Follicular_lymphoma> <Current_treated_by> "Bevacizumab_and_Rituximab" .
<Follicular_lymphoma> <Current_treated_by> "Bendamustine_monotherapy" .
<Follicular_lymphoma> <Current_treated_by> "Bendamustine_and_Ofatumumab" .
<Follicular_lymphoma> <Current_treated_by> "Bendamustine_and_Obinutuzumab" .
<Follicular_lymphoma> <Current_treated_by> "BVR" .
<Follicular_lymphoma> <Current_treated_by> "BR" .
<Follicular_lymphoma> <Current_treated_by> "(90)YFC,_then_allo_HSCT" .
<EMA-CO> <Has_context> "All_lines_of_therapy" .
<CaRD> <Mapped_from> "CaRD" .
<BEAM,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<BEAM,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<DI_EC> <Has_context> "Neoadjuvant_therapy" .
<Acetato_DE_Dexametasona> <Brand_name_of> "Dexamethasone" .
<Icotinib_monotherapy> <Mapped_from> "Icotinib_monotherapy" .
<HiDAC_and_Midostaurin> <Is_current_in> "Acute_myeloid_leukemia" .
<Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT> <Has_accepted_use> "Hodgkin_lymphoma" .
<Adrucil> <Brand_name_of> "Fluorouracil" .
<Von_Willebrand_factor_and_factor_VIII_complex_human> <Has_brand_name> "Wilfactin" .
<Von_Willebrand_factor_and_factor_VIII_complex_human> <Has_brand_name> "Wilate" .
<Von_Willebrand_factor_and_factor_VIII_complex_human> <Has_brand_name> "Humate-P" .
<Von_Willebrand_factor_and_factor_VIII_complex_human> <Has_brand_name> "Alphanate" .
<Plicamycin_monotherapy> <Mapped_from> "Plicamycin_monotherapy" .
<Berofor> <Brand_name_of> "Interferon_alfa-2b" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "Vincristine" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "Prednisone" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "Gemcitabine" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "GDP" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "FluBuCy,_then_allo_HSCT" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "Etoposide" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "Doxorubicin" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "Dexamethasone" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "DHAP" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "DA-EPOCH" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "Cytarabine" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "Cyclophosphamide" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "Cisplatin" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "CHOP" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "CHOEP-21" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "CHOEP-14" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "Brentuximab_vedotin_monotherapy" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "Brentuximab_vedotin" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "BV-CHP" .
<Anaplastic_large_cell_lymphoma> <Accepted_use_of> "APO" .
<VIPD> <Has_modality> "Chemotherapy" .
<CVP,_then_131Iodine-Tositumomab> <Has_supportive_med> "Diphenhydramine" .
<CVP,_then_131Iodine-Tositumomab> <Has_supportive_med> "Acetaminophen" .
<DEP> <Has_context> "Non-curative_therapy" .
<CFAR> <Has_modality> "Chemotherapy" .
<Anagrelide_monotherapy> <Mapped_from> "Anagrelide_monotherapy" .
<Arixtra> <Brand_name_of> "Fondaparinux" .
<Erdafitinib> <Antineoplastic_of> "Erdafitinib_monotherapy" .
<Aciphex> <Brand_name_of> "Rabeprazole" .
<R-CHOP-14_(Rituximab_Hycela)> <Maps_to> "R-CHOP-14_(Rituximab_Hycela)" .
<Dara-PD> <Maps_to> "Dara-PD" .
<Elo-Rd> <Has_supportive_med> "Ranitidine" .
<Elo-Rd> <Has_supportive_med> "Diphenhydramine" .
<Elo-Rd> <Has_supportive_med> "Acetaminophen" .
<Nagun> <Brand_name_of> "Doxorubicin" .
<Anti-GD2_antibody> <Is_a> "Antibody_medication" .
<DES_monotherapy> <Mapped_from> "DES_monotherapy" .
<VACA> <Is_current_in> "Ewing_sarcoma" .
<Gammagard> <Brand_name_of> "Intravenous_immunoglobulin_(IVIG)" .
<ProMACE-CytaBOM> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Scopoderm> <Brand_name_of> "Scopolamine" .
<Docetaxel> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Docetaxel> <Is_a> "Vesicant" .
<Docetaxel> <Is_a> "Taxane" .
<Docetaxel> <Is_a> "Microtubule_inhibitor" .
<Docetaxel> <Is_a> "Irritant" .
<Hodgkin_lymphoma> <Current_treated_by> "eBEACOPP_(Prednisolone)" .
<Hodgkin_lymphoma> <Current_treated_by> "eBEACOPP" .
<Hodgkin_lymphoma> <Current_treated_by> "Vinorelbine_monotherapy" .
<Hodgkin_lymphoma> <Current_treated_by> "Vinblastine_monotherapy" .
<Hodgkin_lymphoma> <Current_treated_by> "VEPEMB" .
<Hodgkin_lymphoma> <Current_treated_by> "VEBEP" .
<Hodgkin_lymphoma> <Current_treated_by> "VAMP_(Methotrexate)" .
<Hodgkin_lymphoma> <Current_treated_by> "Stanford_V" .
<Hodgkin_lymphoma> <Current_treated_by> "Rituximab_monotherapy" .
<Hodgkin_lymphoma> <Current_treated_by> "Radiation_therapy" .
<Hodgkin_lymphoma> <Current_treated_by> "RABVD" .
<Hodgkin_lymphoma> <Current_treated_by> "Placebo" .
<Hodgkin_lymphoma> <Current_treated_by> "Pembrolizumab_monotherapy" .
<Hodgkin_lymphoma> <Current_treated_by> "Panobinostat_monotherapy" .
<Hodgkin_lymphoma> <Current_treated_by> "PVAG" .
<Hodgkin_lymphoma> <Current_treated_by> "Observation" .
<Hodgkin_lymphoma> <Current_treated_by> "OPPA" .
<Hodgkin_lymphoma> <Current_treated_by> "OEPA" .
<Hodgkin_lymphoma> <Current_treated_by> "O-ESHAP" .
<Hodgkin_lymphoma> <Current_treated_by> "Nivolumab_monotherapy" .
<Hodgkin_lymphoma> <Current_treated_by> "Mini-BEAM" .
<Hodgkin_lymphoma> <Current_treated_by> "MOPP-ABV" .
<Hodgkin_lymphoma> <Current_treated_by> "MOPP" .
<Hodgkin_lymphoma> <Current_treated_by> "MINE" .
<Hodgkin_lymphoma> <Current_treated_by> "Lenalidomide_monotherapy" .
<Hodgkin_lymphoma> <Current_treated_by> "Ifosfamide_and_Vinorelbine" .
<Hodgkin_lymphoma> <Current_treated_by> "IGEV" .
<Hodgkin_lymphoma> <Current_treated_by> "ICE" .
<Hodgkin_lymphoma> <Current_treated_by> "Gemcitabine_monotherapy" .
<Hodgkin_lymphoma> <Current_treated_by> "Gemcitabine_and_Rituximab" .
<Hodgkin_lymphoma> <Current_treated_by> "GVP" .
<Hodgkin_lymphoma> <Current_treated_by> "GVD" .
<Hodgkin_lymphoma> <Current_treated_by> "GCD-R" .
<Hodgkin_lymphoma> <Current_treated_by> "GCD" .
<Hodgkin_lymphoma> <Current_treated_by> "Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT" .
<Hodgkin_lymphoma> <Current_treated_by> "Flu-Mel,_then_allo_HSCT" .
<Hodgkin_lymphoma> <Current_treated_by> "FEAM,_then_auto_HSCT" .
<Hodgkin_lymphoma> <Current_treated_by> "Everolimus_monotherapy" .
<Hodgkin_lymphoma> <Current_treated_by> "ESHAP" .
<Hodgkin_lymphoma> <Current_treated_by> "EBVP" .
<Hodgkin_lymphoma> <Current_treated_by> "DexaBEAM" .
<Hodgkin_lymphoma> <Current_treated_by> "DHAP_-_time_intensified" .
<Hodgkin_lymphoma> <Current_treated_by> "DHAP" .
<Hodgkin_lymphoma> <Current_treated_by> "ChlVPP/EVA" .
<Hodgkin_lymphoma> <Current_treated_by> "ChlVPP" .
<Hodgkin_lymphoma> <Current_treated_by> "COPDAC" .
<Hodgkin_lymphoma> <Current_treated_by> "CBV-Mx,_then_auto_HSCT" .
<Hodgkin_lymphoma> <Current_treated_by> "CBV,_then_auto_HSCT" .
<Hodgkin_lymphoma> <Current_treated_by> "C-MOPP/ABV" .
<Hodgkin_lymphoma> <Current_treated_by> "C-MOPP" .
<Hodgkin_lymphoma> <Current_treated_by> "Brentuximab_vedotin_monotherapy" .
<Hodgkin_lymphoma> <Current_treated_by> "Brentuximab_vedotin_and_Nivolumab" .
<Hodgkin_lymphoma> <Current_treated_by> "Brentuximab_vedotin_and_Dacarbazine" .
<Hodgkin_lymphoma> <Current_treated_by> "Bendamustine_monotherapy" .
<Hodgkin_lymphoma> <Current_treated_by> "Bendamustine_and_Brentuximab_vedotin" .
<Hodgkin_lymphoma> <Current_treated_by> "BeGEV" .
<Hodgkin_lymphoma> <Current_treated_by> "BeEAM,_then_auto_HSCT" .
<Hodgkin_lymphoma> <Current_treated_by> "BVB" .
<Hodgkin_lymphoma> <Current_treated_by> "BEAM,_then_auto_HSCT" .
<Hodgkin_lymphoma> <Current_treated_by> "BEAM,_then_allo_HSCT" .
<Hodgkin_lymphoma> <Current_treated_by> "BEACOPP-14_(Prednisolone)" .
<Hodgkin_lymphoma> <Current_treated_by> "BEACOPP-14" .
<Hodgkin_lymphoma> <Current_treated_by> "BEACOPP" .
<Hodgkin_lymphoma> <Current_treated_by> "AVD" .
<Hodgkin_lymphoma> <Current_treated_by> "ABVE-PC" .
<Hodgkin_lymphoma> <Current_treated_by> "ABVD,_DD-DI" .
<Hodgkin_lymphoma> <Current_treated_by> "ABVD" .
<Hodgkin_lymphoma> <Current_treated_by> "A-AVD" .
<Carmustine_monotherapy> <Mapped_from> "Carmustine_monotherapy" .
<dmCODOX-M_-_Modified_Magrath> <Is_a> "Anthracycline-containing_regimen" .
<CAP-BOP> <Has_antineoplastic> "Vincristine" .
<CAP-BOP> <Has_antineoplastic> "Procarbazine" .
<CAP-BOP> <Has_antineoplastic> "Prednisone" .
<CAP-BOP> <Has_antineoplastic> "Doxorubicin" .
<CAP-BOP> <Has_antineoplastic> "Cyclophosphamide" .
<CAP-BOP> <Has_antineoplastic> "Bleomycin" .
<ECF> <Has_accepted_use> "Gastric_cancer" .
<ECF> <Has_accepted_use> "Gallbladder_cancer" .
<ECF> <Has_accepted_use> "Esophageal_cancer" .
<ECF> <Has_accepted_use> "Cholangiocarcinoma" .
<Carboplatin,_Etoposide,_RT> <Has_accepted_use> "Small_cell_lung_cancer" .
<Fluorouracil,_Hydroxyurea,_RT> <Maps_to> "Fluorouracil,_Hydroxyurea,_RT" .
<Veenat> <Brand_name_of> "Imatinib" .
<Crizotinib_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Calaspargase,_Daunorubicin,_Vincristine,_Prednisone> <Has_context> "Induction_therapy" .
<Busulfan_and_Melphalan,_then_auto_HSCT> <Mapped_from> "Busulfan_and_Melphalan,_then_auto_HSCT" .
<Darzalex> <Brand_name_of> "Daratumumab" .
<Non-curative_subsequent-line_therapy> <Is_a> "Non-curative_therapy" .
<Lenzest> <Brand_name_of> "Lenalidomide" .
<Anastrozole_and_Trastuzumab> <Has_context> "Non-curative_first-line_therapy" .
<Temozolomide_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<ATG_(Horse),_Cyclosporine,_Methylprednisolone> <Has_immunosuppressor> "Methylprednisolone" .
<ATG_(Horse),_Cyclosporine,_Methylprednisolone> <Has_immunosuppressor> "Cyclosporine_non-modified" .
<ATG_(Horse),_Cyclosporine,_Methylprednisolone> <Has_immunosuppressor> "Antithymocyte_globulin_horse_ATG" .
<Metoclopramide> <Has_brand_name> "Reglan" .
<Waldenstroem_macroglobulinemia> <FDA_indication_of> "Ibrutinib" .
<Blinatumomab> <May_have_route> "Intravenous" .
<Enfortumab_vedotin> <Is_a> "Microtubule_inhibitor" .
<Enfortumab_vedotin> <Is_a> "Antibody-drug_conjugate" .
<Enfortumab_vedotin> <Is_a> "Antibody_medication" .
<Enfortumab_vedotin> <Is_a> "Anti-nectin-4_antibody" .
<Lederplatin> <Brand_name_of> "Cisplatin" .
<Antihistamine> <Is_a> "Supportive_medication" .
<Plerixafor_monotherapy> <Maps_to> "Plerixafor_monotherapy" .
<CIA> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Bortrac> <Brand_name_of> "Bortezomib" .
<Marginal_zone_lymphoma> <Is_a> "Non-Hodgkin_lymphoma" .
<Marginal_zone_lymphoma> <Is_a> "Indolent_lymphoma" .
<Synermed> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Melphalan_and_Methylprednisolone,_then_auto_HSCT> <Has_accepted_use> "Multiple_myeloma" .
<Lenalidomide_and_Ofatumumab> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<MOF> <Has_modality> "Chemotherapy" .
<Welldom> <Brand_name_of> "Indomethacin" .
<Pemetrex> <Brand_name_of> "Pemetrexed" .
<Alquimid> <Brand_name_of> "Ifosfamide" .
<ATG_(Horse),_Cyclosporine,_Eltrombopag> <Has_supportive_med> "Valacyclovir" .
<ATG_(Horse),_Cyclosporine,_Eltrombopag> <Has_supportive_med> "Pentamidine" .
<ATG_(Horse),_Cyclosporine,_Eltrombopag> <Has_supportive_med> "Eltrombopag" .
<CAVE> <Has_antineoplastic> "Vincristine" .
<CAVE> <Has_antineoplastic> "Etoposide" .
<CAVE> <Has_antineoplastic> "Doxorubicin" .
<CAVE> <Has_antineoplastic> "Cyclophosphamide" .
<Doxorubicin_and_Fluorouracil> <Mapped_from> "Doxorubicin_and_Fluorouracil" .
<Hydroxyurea_and_Imatinib> <Has_modality> "Chemotherapy" .
<Endometrial_cancer> <FDA_indication_of> "Pembrolizumab" .
<Endometrial_cancer> <FDA_indication_of> "Lenvatinib" .
<Allopurinol> <Has_brand_name> "Zyoway" .
<Allopurinol> <Has_brand_name> "Zyloric" .
<Allopurinol> <Has_brand_name> "Zyloprim" .
<Allopurinol> <Has_brand_name> "Milurit" .
<Allopurinol> <Has_brand_name> "Caplenal" .
<Allopurinol> <Has_brand_name> "Aloprim" .
<Allopurinol> <Has_brand_name> "Abloric" .
<MCP> <Has_context> "Non-curative_first-line_therapy" .
<Metotrexato> <Brand_name_of> "Methotrexate" .
<Anastrozole_and_Goserelin> <Maps_to> "Anastrozole_and_Goserelin" .
<Carbotinol> <Brand_name_of> "Carboplatin" .
<Cyclophosphamide_and_TBI> <Is_current_in> "Autologous_HSCT" .
<Cyclophosphamide_and_TBI> <Is_current_in> "Allogeneic_HSCT" .
<Anaplastic_glioma> <FDA_indication_of> "Temozolomide" .
<PET> <Has_modality> "Chemotherapy" .
<Cabozantinib_monotherapy> <Has_accepted_use> "Thyroid_cancer" .
<Cabozantinib_monotherapy> <Has_accepted_use> "Renal_cell_carcinoma" .
<Cabozantinib_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<Cabozantinib_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cabozantinib_monotherapy> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Esophageal_cancer> <FDA_indication_of> "Pembrolizumab" .
<Fludarabine,_Cyclophosphamide,_ATG> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<OPPA> <Has_accepted_use> "Hodgkin_lymphoma" .
<Neuroendocrine_tumor> <FDA_indication_of> "Lutetium_Lu_177_dotatate" .
<Neuroendocrine_tumor> <FDA_indication_of> "Lanreotide" .
<Neuroendocrine_tumor> <FDA_indication_of> "Everolimus" .
<Paclitaxel_and_Topotecan> <Is_current_in> "Cervical_cancer" .
<Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Vincristine" .
<Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Pegaspargase" .
<Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Mitoxantrone" .
<Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Dexamethasone" .
<Pralatrexate_monotherapy> <Has_supportive_med> "Folic_acid" .
<Pralatrexate_monotherapy> <Has_supportive_med> "Cyanocobalamin" .
<Ribociclib> <Antineoplastic_of> "Ribociclib_and_Tamoxifen" .
<Ribociclib> <Antineoplastic_of> "Letrozole_and_Ribociclib" .
<Ribociclib> <Antineoplastic_of> "Fulvestrant_and_Ribociclib" .
<Ribociclib> <Antineoplastic_of> "Anastrozole_and_Ribociclib" .
<Paclitaxel,_Topotecan,_Bevacizumab> <Has_accepted_use> "Cervical_cancer" .
<Ellence> <Brand_name_of> "Epirubicin" .
<Tagraxofusp> <Has_accepted_use> "Blastic_plasmacytoid_dendritic_cell_neoplasm" .
<Ponatinib_monotherapy> <Has_context> "Salvage_therapy" .
<Ponatinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Alendomax> <Brand_name_of> "Alendronate" .
<Anprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Velban> <Brand_name_of> "Vinblastine" .
<R-DHAC> <Maps_to> "R-DHAC" .
<Radium-223> <Has_accepted_use> "Prostate_cancer" .
<FAS> <Has_context> "All_lines_of_therapy" .
<Transderm_Scop> <Brand_name_of> "Scopolamine" .
<Anastrozole_and_Ribociclib> <Has_modality> "Hormonotherapy" .
<Anastrozole_and_Ribociclib> <Has_modality> "Chemotherapy" .
<BVDS> <Is_historical_in> "Hodgkin_lymphoma" .
<Siltuximab_monotherapy> <Has_immunosuppressor> "Siltuximab" .
<Trimaxazole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<ChlVPP/PABIOE> <Has_accepted_use> "Hodgkin_lymphoma" .
<Teof> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Selinexor_and_Dexamethasone> <Has_modality> "Chemotherapy" .
<BEACOPP> <Has_antineoplastic> "Vincristine" .
<BEACOPP> <Has_antineoplastic> "Procarbazine" .
<BEACOPP> <Has_antineoplastic> "Prednisone" .
<BEACOPP> <Has_antineoplastic> "Etoposide" .
<BEACOPP> <Has_antineoplastic> "Doxorubicin" .
<BEACOPP> <Has_antineoplastic> "Cyclophosphamide" .
<BEACOPP> <Has_antineoplastic> "Bleomycin" .
<Thalidomide_and_Rituximab> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Carbo> <Brand_name_of> "Carboplatin" .
<Fludarabine,_Cyclophosphamide,_ATG> <Has_context> "All_lines_of_therapy" .
<BVB> <Has_modality> "Chemotherapy" .
<Trastuzumab-pkrb> <May_have_route> "Intravenous" .
<BR> <Maps_to> "BR" .
<Leumostin> <Brand_name_of> "Filgrastim" .
<CNOP_(Prednisolone)> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Cobimetinib_monotherapy> <Is_current_in> "Rosai-Dorfman-Destombes_disease" .
<Cobimetinib_monotherapy> <Is_current_in> "Langerhans_cell_histiocytosis" .
<Cobimetinib_monotherapy> <Is_current_in> "Erdheim-Chester_disease" .
<Temozolomide_and_RT> <Is_current_in> "Glioblastoma" .
<Temozolomide_and_RT> <Is_current_in> "Anaplastic_glioma" .
<Xanthine_oxidase_inhibitor> <Is_a> "Uric_acid_lowering_agent" .
<Iron_dextran> <May_have_route> "Intravenous" .
<Iron_dextran> <May_have_route> "Intramuscular" .
<Vinblastine_and_Prednisone> <Is_current_in> "Langerhans_cell_histiocytosis" .
<Thalidomide_and_Prednisolone> <Has_modality> "Chemotherapy" .
<ABVD,_DD-DI> <Has_accepted_use> "Hodgkin_lymphoma" .
<Veravorin> <Brand_name_of> "Folinic_acid" .
<Uridine_triacetate> <May_have_route> "Oral" .
<CTD> <Has_context> "Non-curative_therapy" .
<CTD> <Has_context> "Non-curative_first-line_therapy" .
<CMED> <Mapped_from> "CMED" .
<Nadroparin> <Is_a> "Low_molecular_weight_heparin" .
<Nadroparin> <Is_a> "Heparin" .
<Nadroparin> <Is_a> "Health_Canada_approved_drug" .
<Nadroparin> <Is_a> "Anticoagulant" .
<Ibritumomab_tiuxetan_monotherapy> <Is_current_in> "Marginal_zone_lymphoma" .
<Ibritumomab_tiuxetan_monotherapy> <Is_current_in> "Mantle_cell_lymphoma" .
<Ibritumomab_tiuxetan_monotherapy> <Is_current_in> "Follicular_lymphoma" .
<Ibritumomab_tiuxetan_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Thiotepa_monotherapy> <Maps_to> "Thiotepa_monotherapy" .
<CEOP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<ddE> <Mapped_from> "ddE" .
<ETA_Cortilen> <Brand_name_of> "Dexamethasone" .
<Factor_VIII_human> <Has_accepted_use> "Inherited_coagulopathy" .
<IT_Methotrexate_and_Methylprednisolone> <Has_local_therapy> "Methylprednisolone" .
<IT_Methotrexate_and_Methylprednisolone> <Has_local_therapy> "Methotrexate" .
<Mycophenolate_mofetil> <Is_a> "Immunosuppressant" .
<Editrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Irinotecan_liposomal_monotherapy> <Has_context> "Non-curative_therapy" .
<Irinotecan_liposomal_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Imatinib,_Vincristine,_Prednisone> <Has_context> "Maintenance_after_upfront_therapy" .
<RiPAD_plus_C> <Has_accepted_use> "Mantle_cell_lymphoma" .
<maxi-R-CHOP/R-HiDAC> <Maps_to> "maxi-R-CHOP/R-HiDAC" .
<Argatroban> <May_have_route> "Intravenous" .
<Dasatinib_monotherapy> <Has_supportive_med> "Hematopoietic_growth_factors" .
<CAD_and_G-CSF> <Has_antineoplastic> "Doxorubicin" .
<CAD_and_G-CSF> <Has_antineoplastic> "Dexamethasone" .
<CAD_and_G-CSF> <Has_antineoplastic> "Cyclophosphamide" .
<Diethylstilbestrol> <Antineoplastic_of> "DES_monotherapy" .
<Diethylstilbestrol> <Antineoplastic_of> "Cyclophosphamide,_Prednisone,_Diethylstilbestrol" .
<RABVD> <Is_a> "Rituximab-containing_regimen" .
<RABVD> <Is_a> "Anthracycline-containing_regimen" .
<ABV_(Vinblastine)> <Has_modality> "Chemotherapy" .
<VAdCA> <Maps_to> "VAdCA" .
<Apatinib_monotherapy> <Is_current_in> "Gastric_cancer" .
<Apatinib_monotherapy> <Is_current_in> "Esophageal_cancer" .
<Encorate> <Brand_name_of> "Valproate" .
<R-GDP> <Maps_to> "R-GDP" .
<Approved_drug> <Subsumes> "PMDA_approved_drug" .
<Approved_drug> <Subsumes> "KFDA_approved_drug" .
<Approved_drug> <Subsumes> "Health_Canada_approved_drug" .
<Approved_drug> <Subsumes> "FDA_approved_drug" .
<Approved_drug> <Subsumes> "EMA_approved_drug" .
<Approved_drug> <Subsumes> "CFDA_approved_drug" .
<Epopen> <Brand_name_of> "Epoetin_alfa" .
<Busulfan_and_Melphalan,_then_auto_HSCT> <Is_current_in> "Neuroblastoma" .
<Busulfan_and_Melphalan,_then_auto_HSCT> <Is_current_in> "Ewing_sarcoma" .
<Busulfan_and_Melphalan,_then_auto_HSCT> <Is_current_in> "Acute_promyelocytic_leukemia" .
<Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone> <Has_antineoplastic> "Vincristine" .
<Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone> <Has_antineoplastic> "Prednisolone" .
<Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone> <Has_antineoplastic> "Pegaspargase" .
<Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone> <Has_antineoplastic> "Mercaptopurine" .
<Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone> <Has_antineoplastic> "Doxorubicin" .
<Iodine-131> <Antineoplastic_of> "Radioiodine_ablation" .
<Carmustine_and_RT> <Maps_to> "Carmustine_and_RT" .
<Pre-definitive_therapy> <Maps_to> "Pre-definitive_therapy" .
<Odanex> <Brand_name_of> "Ondansetron" .
<5_plus_2d> <Is_current_in> "Acute_myeloid_leukemia" .
<Calcium_Leucovorn> <Brand_name_of> "Folinic_acid" .
<ddT_(Taxotere)> <Has_modality> "Chemotherapy" .
<Irinotecan_monotherapy> <Has_supportive_med> "Steroids" .
<Irinotecan_monotherapy> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Irinotecan_monotherapy> <Has_supportive_med> "Prochlorperazine" .
<Irinotecan_monotherapy> <Has_supportive_med> "Ondansetron" .
<Irinotecan_monotherapy> <Has_supportive_med> "Mesna" .
<Irinotecan_monotherapy> <Has_supportive_med> "Loperamide" .
<Irinotecan_monotherapy> <Has_supportive_med> "Granisetron" .
<Irinotecan_monotherapy> <Has_supportive_med> "Emesis_prevention" .
<Irinotecan_monotherapy> <Has_supportive_med> "Dolasetron" .
<Irinotecan_monotherapy> <Has_supportive_med> "Diphenhydramine" .
<Irinotecan_monotherapy> <Has_supportive_med> "Dexamethasone" .
<Irinotecan_monotherapy> <Has_supportive_med> "Atropine" .
<Fluorouracil,_Folinic_acid,_Levamisole> <Maps_to> "Fluorouracil,_Folinic_acid,_Levamisole" .
<Cisplatin,_Vinorelbine,_Cetuximab> <Is_current_in> "Non-small_cell_lung_cancer" .
<Nilotinib_monotherapy> <Is_current_in> "Systemic_mastocytosis" .
<Nilotinib_monotherapy> <Is_current_in> "Hypereosinophilic_syndrome" .
<Nilotinib_monotherapy> <Is_current_in> "Chronic_myelogenous_leukemia" .
<Nilotinib_monotherapy> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Mediastinal_gray-zone_lymphoma> <Accepted_use_of> "Vincristine" .
<Mediastinal_gray-zone_lymphoma> <Accepted_use_of> "Rituximab-pvvr" .
<Mediastinal_gray-zone_lymphoma> <Accepted_use_of> "Rituximab-abbs" .
<Mediastinal_gray-zone_lymphoma> <Accepted_use_of> "Rituximab" .
<Mediastinal_gray-zone_lymphoma> <Accepted_use_of> "Prednisone" .
<Mediastinal_gray-zone_lymphoma> <Accepted_use_of> "Etoposide" .
<Mediastinal_gray-zone_lymphoma> <Accepted_use_of> "Doxorubicin" .
<Mediastinal_gray-zone_lymphoma> <Accepted_use_of> "DA-R-EPOCH" .
<Mediastinal_gray-zone_lymphoma> <Accepted_use_of> "Cyclophosphamide" .
<Mediastinal_gray-zone_lymphoma> <Accepted_use_of> "Brentuximab_vedotin_monotherapy" .
<Mediastinal_gray-zone_lymphoma> <Accepted_use_of> "Brentuximab_vedotin" .
<Doxorubicin_monotherapy> <Has_supportive_med> "Dexrazoxane" .
<FLOX> <Maps_to> "FLOX" .
<VR-CP> <Has_context> "Non-curative_therapy" .
<MOPP-ABV> <Has_modality> "Chemotherapy" .
<Methotrexate_and_Thiotepa> <Has_modality> "Chemotherapy" .
<CALGB_10-002_regimen> <Is_current_in> "Burkitt_lymphoma" .
<Sipuleucel-T> <Antineoplastic_of> "Sipuleucel-T_monotherapy" .
<CHVP> <Mapped_from> "CHVP" .
<Docetaxel_and_Nedaplatin> <Has_context> "Non-curative_first-line_therapy" .
<Nilotinib> <Has_brand_name> "Tasigna" .
<ATRA_and_Idarubicin> <Is_a> "Anthracycline-containing_regimen" .
<Fentinol> <Brand_name_of> "Phenytoin" .
<DHAP_-_time_intensified> <Has_context> "Non-curative_therapy" .
<Omacetaxine_monotherapy> <Is_current_in> "Chronic_myelogenous_leukemia" .
<Cisplatin,_Dacarbazine,_Interferon_alfa-2b> <Is_historical_in> "Melanoma" .
<CEF/CMF> <Has_antineoplastic> "Methotrexate" .
<CEF/CMF> <Has_antineoplastic> "Fluorouracil" .
<CEF/CMF> <Has_antineoplastic> "Epirubicin" .
<CEF/CMF> <Has_antineoplastic> "Cyclophosphamide" .
<Pheochromocytoma> <Is_a> "Endocrine_cancer" .
<Pegaspargase> <Has_brand_name> "Oncaspar" .
<Carboplatin_and_Cyclophosphamide> <Is_a> "Platinum_doublet" .
<Procarbazine> <Supportive_med_of> "VR-CP" .
<Nicotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CMFVP> <Maps_to> "CMFVP" .
<CYVE_and_G-CSF> <Has_modality> "Growth_factor_therapy" .
<CYVE_and_G-CSF> <Has_modality> "Chemotherapy" .
<RiPAD_plus_C> <Is_a> "Rituximab-containing_regimen" .
<RiPAD_plus_C> <Is_a> "Anthracycline-containing_regimen" .
<CYVE_and_G-CSF> <Maps_to> "CYVE_and_G-CSF" .
<Thalomid> <Brand_name_of> "Thalidomide" .
<Ruxolitinib_monotherapy> <Mapped_from> "Ruxolitinib_monotherapy" .
<FND> <Has_modality> "Chemotherapy" .
<Neulasta> <Brand_name_of> "Pegfilgrastim" .
<Doronil> <Brand_name_of> "Dexamethasone" .
<Castration> <Has_antineoplastic> "Endocrine_ablation_surgery" .
<Singulair> <Brand_name_of> "Montelukast" .
<Dara-VMP> <Has_antineoplastic> "Prednisone" .
<Dara-VMP> <Has_antineoplastic> "Melphalan" .
<Dara-VMP> <Has_antineoplastic> "Daratumumab" .
<Dara-VMP> <Has_antineoplastic> "Bortezomib" .
<Radotinib_monotherapy> <Maps_to> "Radotinib_monotherapy" .
<Trifluridine_and_tipiracil_monotherapy> <Has_modality> "Chemotherapy" .
<IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone> <Is_current_in> "Acute_myeloid_leukemia" .
<COMP> <Maps_to> "COMP" .
<Oncophos> <Brand_name_of> "Cyclophosphamide" .
<Nintedanib_and_Pemetrexed> <Mapped_from> "Nintedanib_and_Pemetrexed" .
<CHOP_and_Everolimus> <Maps_to> "CHOP_and_Everolimus" .
<ATG_(Horse)_monotherapy> <Mapped_from> "ATG_(Horse)_monotherapy" .
<TIP> <Has_context> "Salvage_therapy" .
<TIP> <Has_context> "Non-curative_therapy" .
<TIP> <Has_context> "Neoadjuvant_therapy" .
<TIP> <Has_context> "Adjuvant_therapy" .
<Prochlorperazine> <Supportive_med_of> "Irinotecan_monotherapy" .
<Prochlorperazine> <Supportive_med_of> "Irinotecan_and_Bevacizumab" .
<Prochlorperazine> <Supportive_med_of> "Denileukin_diftitox_monotherapy" .
<Prochlorperazine> <Supportive_med_of> "Cyclophosphamide_monotherapy" .
<Prochlorperazine> <Supportive_med_of> "Cisplatin_and_RT" .
<Prochlorperazine> <Supportive_med_of> "Cisplatin_and_Gemcitabine" .
<Prochlorperazine> <Supportive_med_of> "Cisplatin_and_Etoposide" .
<Cobimetinib> <Is_a> "Mutation-specific_medication" .
<Cobimetinib> <Is_a> "MAP2K2_inhibitor" .
<Cobimetinib> <Is_a> "MAP2K1_inhibitor" .
<Cobimetinib> <Is_a> "Kinase_inhibitor" .
<DI_EC> <Has_antineoplastic> "Epirubicin" .
<DI_EC> <Has_antineoplastic> "Cyclophosphamide" .
<Erdheim-Chester_disease> <FDA_indication_of> "Vemurafenib" .
<Pralatrexate> <Supportive_med_of> "131I-Metaiodobenzylguanidine_(131I-MIBG)" .
<Primasul> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Pre-definitive_therapy> <Mapped_from> "Pre-definitive_therapy" .
<BuCy,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<BuCy,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<Gefitinib_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<ATRA_and_Danazol> <Mapped_from> "ATRA_and_Danazol" .
<Immunotherapy> <Maps_to> "Immunotherapy" .
<eBEACOPP_(Prednisolone)> <Has_accepted_use> "Hodgkin_lymphoma" .
<Inotuzumab_ozogamicin_monotherapy> <Has_context> "Non-curative_therapy" .
<Prednisone_monotherapy> <Has_accepted_use> "Warm_autoimmune_hemolytic_anemia" .
<Prednisone_monotherapy> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Prednisone_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<Prednisone_monotherapy> <Has_accepted_use> "Myelofibrosis" .
<Prednisone_monotherapy> <Has_accepted_use> "Multiple_myeloma" .
<Prednisone_monotherapy> <Has_accepted_use> "Immune_thrombocytopenia" .
<Prednisone_monotherapy> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Prednisone_monotherapy> <Has_accepted_use> "Acquired_coagulopathy" .
<Venetoclax_and_Rituximab> <Mapped_from> "Venetoclax_and_Rituximab" .
<Samarium-153_monotherapy> <Maps_to> "Samarium-153_monotherapy" .
<FOLFIRI_and_Ziv-aflibercept> <Is_a> "Irinotecan-containing_regimen" .
<Cabazitaxel> <Antineoplastic_of> "Cabazitaxel_and_Prednisone" .
<Clarithromycin_monotherapy> <Has_antineoplastic> "Clarithromycin" .
<Vinflunine> <Is_a> "Vinca_alkaloid" .
<Vinflunine> <Is_a> "Vesicant" .
<Vinflunine> <Is_a> "Microtubule_inhibitor" .
<Vinflunine> <Is_a> "EMA_approved_drug" .
<Mitosol> <Brand_name_of> "Mitomycin" .
<Methotrexate_monotherapy> <Has_modality> "Chemotherapy" .
<Doxorubicin_pegylated_liposomal_and_Gemcitabine> <Maps_to> "Doxorubicin_pegylated_liposomal_and_Gemcitabine" .
<BCHOP> <Has_modality> "Chemotherapy" .
<Diffuse_large_B-cell_lymphoma> <FDA_indication_of> "Tisagenlecleucel" .
<Diffuse_large_B-cell_lymphoma> <FDA_indication_of> "Rituximab-pvvr" .
<Diffuse_large_B-cell_lymphoma> <FDA_indication_of> "Rituximab_and_hyaluronidase_human" .
<Diffuse_large_B-cell_lymphoma> <FDA_indication_of> "Rituximab" .
<Diffuse_large_B-cell_lymphoma> <FDA_indication_of> "Polatuzumab_vedotin" .
<Diffuse_large_B-cell_lymphoma> <FDA_indication_of> "Cyclophosphamide" .
<Diffuse_large_B-cell_lymphoma> <FDA_indication_of> "Axicabtagene_ciloleucel" .
<Fluorouracil_and_Folinic_acid> <Has_context> "Non-curative_therapy" .
<Fluorouracil_and_Folinic_acid> <Has_context> "Non-curative_subsequent-line_therapy" .
<Fluorouracil_and_Folinic_acid> <Has_context> "Non-curative_first-line_therapy" .
<Fluorouracil_and_Folinic_acid> <Has_context> "Adjuvant_therapy" .
<Chlorambucil> <May_have_route> "Oral" .
<Zyfoss> <Brand_name_of> "Zoledronic_acid" .
<POEMS_syndrome> <Is_a> "Plasma_cell_dyscrasia" .
<Cladribine> <Antineoplastic_of> "RCC" .
<Cladribine> <Antineoplastic_of> "R-CMD" .
<Cladribine> <Antineoplastic_of> "DAC" .
<Cladribine> <Antineoplastic_of> "Cladribine_monotherapy" .
<Cladribine> <Antineoplastic_of> "Cladribine_and_Rituximab" .
<Cladribine> <Antineoplastic_of> "Cladribine_and_Cytarabine" .
<Cladribine> <Antineoplastic_of> "CMC" .
<Cladribine> <Antineoplastic_of> "CLAG-M" .
<Cladribine> <Antineoplastic_of> "CLAG" .
<Cladribine> <Antineoplastic_of> "CC" .
<Bicalutamide_and_RT> <Has_accepted_use> "Prostate_cancer" .
<Helicobacter_pylori_eradication_therapy> <Has_antineoplastic> "Omeprazole" .
<Helicobacter_pylori_eradication_therapy> <Has_antineoplastic> "Clarithromycin" .
<Helicobacter_pylori_eradication_therapy> <Has_antineoplastic> "Amoxicillin" .
<Atypical_hemolytic_uremic_syndrome> <Is_a> "Hemolytic_process" .
<Atypical_hemolytic_uremic_syndrome> <Is_a> "Complementopathy" .
<Trametinib> <Antineoplastic_of> "Trametinib_monotherapy" .
<Trametinib> <Antineoplastic_of> "Dabrafenib,_Trametinib,_Panitumumab" .
<Trametinib> <Antineoplastic_of> "Dabrafenib_and_Trametinib" .
<Neocarb> <Brand_name_of> "Carboplatin" .
<G-FC> <Has_modality> "Chemotherapy" .
<Docetaxel_monotherapy> <Has_accepted_use> "triple_negative_Breast_cancer" .
<Docetaxel_monotherapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<Docetaxel_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Docetaxel_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Docetaxel_monotherapy> <Has_accepted_use> "Melanoma" .
<Docetaxel_monotherapy> <Has_accepted_use> "KRAS-mutated_Non-small_cell_lung_cancer" .
<Docetaxel_monotherapy> <Has_accepted_use> "Head_and_neck_cancer" .
<Docetaxel_monotherapy> <Has_accepted_use> "HER2-positive_-_historical_Breast_cancer" .
<Docetaxel_monotherapy> <Has_accepted_use> "Gastric_cancer" .
<Docetaxel_monotherapy> <Has_accepted_use> "Esophageal_cancer" .
<Docetaxel_monotherapy> <Has_accepted_use> "Cervical_cancer" .
<Docetaxel_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Docetaxel_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<Docetaxel_monotherapy> <Has_accepted_use> "ALK-positive_Non-small_cell_lung_cancer" .
<R-MCP_(CCNU)> <Mapped_from> "R-MCP_(CCNU)" .
<Derson> <Brand_name_of> "Dexamethasone" .
<VTD-PACE> <Has_context> "Non-curative_first-line_therapy" .
<Ramucirumab_monotherapy> <Is_current_in> "Hepatocellular_carcinoma" .
<Ramucirumab_monotherapy> <Is_current_in> "Gastric_cancer" .
<Ramucirumab_monotherapy> <Is_current_in> "Esophageal_cancer" .
<CDE> <Is_historical_in> "Small_cell_lung_cancer" .
<Emapalumab> <Has_FDA_indication> "Hemophagocytic_lymphohistiocytosis" .
<Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat> <Has_modality> "Chemotherapy" .
<7_plus_3i_and_Sorafenib> <Has_context> "Induction_therapy" .
<Adriblastina> <Brand_name_of> "Doxorubicin" .
<Capecitabine> <Antineoplastic_of> "TX_(Taxotere)" .
<Capecitabine> <Antineoplastic_of> "GTX" .
<Capecitabine> <Antineoplastic_of> "FP/Capecitabine_and_RT" .
<Capecitabine> <Antineoplastic_of> "EOX" .
<Capecitabine> <Antineoplastic_of> "EDC" .
<Capecitabine> <Antineoplastic_of> "ECX" .
<Capecitabine> <Antineoplastic_of> "Capecitabine/Capecitabine_and_RT" .
<Capecitabine> <Antineoplastic_of> "Capecitabine,_Sorafenib,_RT" .
<Capecitabine> <Antineoplastic_of> "Capecitabine,_Pertuzumab,_Trastuzumab" .
<Capecitabine> <Antineoplastic_of> "Capecitabine,_Paclitaxel,_RT" .
<Capecitabine> <Antineoplastic_of> "Capecitabine,_Oxaliplatin,_RT" .
<Capecitabine> <Antineoplastic_of> "Capecitabine,_Mitomycin,_RT" .
<Capecitabine> <Antineoplastic_of> "Capecitabine,_Docetaxel,_RT" .
<Capecitabine> <Antineoplastic_of> "Capecitabine,_Docetaxel,_Oxaliplatin,_RT" .
<Capecitabine> <Antineoplastic_of> "Capecitabine,_Cisplatin,_RT" .
<Capecitabine> <Antineoplastic_of> "Capecitabine,_Carboplatin,_Paclitaxel,_RT" .
<Capecitabine> <Antineoplastic_of> "Capecitabine,_Bevacizumab,_Trastuzumab" .
<Capecitabine> <Antineoplastic_of> "Capecitabine_monotherapy" .
<Capecitabine> <Antineoplastic_of> "Capecitabine_and_Trastuzumab" .
<Capecitabine> <Antineoplastic_of> "Capecitabine_and_Temozolomide" .
<Capecitabine> <Antineoplastic_of> "Capecitabine_and_RT" .
<Capecitabine> <Antineoplastic_of> "Capecitabine_and_Paclitaxel,_nanoparticle_albumin-bound" .
<Capecitabine> <Antineoplastic_of> "Capecitabine_and_Paclitaxel" .
<Capecitabine> <Antineoplastic_of> "Capecitabine_and_Neratinib" .
<Capecitabine> <Antineoplastic_of> "Capecitabine_and_Mitomycin" .
<Capecitabine> <Antineoplastic_of> "Capecitabine_and_Lapatinib" .
<Capecitabine> <Antineoplastic_of> "Capecitabine_and_Ixabepilone" .
<Capecitabine> <Antineoplastic_of> "Capecitabine_and_Gemcitabine" .
<Capecitabine> <Antineoplastic_of> "Capecitabine_and_Fulvestrant" .
<Capecitabine> <Antineoplastic_of> "Capecitabine_and_Erlotinib" .
<Capecitabine> <Antineoplastic_of> "Capecitabine_and_Bevacizumab" .
<Capecitabine> <Antineoplastic_of> "CapeOx,_Cetuximab,_RT" .
<Capecitabine> <Antineoplastic_of> "CapeOx_and_Panitumumab" .
<Capecitabine> <Antineoplastic_of> "CapeOx_and_Bevacizumab" .
<Capecitabine> <Antineoplastic_of> "CapeOx" .
<Capecitabine> <Antineoplastic_of> "CX-C" .
<Capecitabine> <Antineoplastic_of> "CX_and_Trastuzumab" .
<Capecitabine> <Antineoplastic_of> "CX" .
<Capecitabine> <Antineoplastic_of> "CAPIRI-Bev" .
<Capecitabine> <Antineoplastic_of> "CAPIRI" .
<ABV_(Vincristine)> <Is_current_in> "Kaposi_sarcoma" .
<Vincristine_liposomal_monotherapy> <Has_antineoplastic> "Vincristine_liposomal" .
<Paclitaxel_and_Bevacizumab> <Maps_to> "Paclitaxel_and_Bevacizumab" .
<Mitoxantrone_and_Prednisone> <Has_modality> "Hormonotherapy" .
<Mitoxantrone_and_Prednisone> <Has_modality> "Chemotherapy" .
<All-trans_retinoic_acid> <Has_accepted_use> "Immune_thrombocytopenia" .
<All-trans_retinoic_acid> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Ervemin> <Brand_name_of> "Methotrexate" .
<Radotinib_monotherapy> <Mapped_from> "Radotinib_monotherapy" .
<Rumaxoi> <Brand_name_of> "Methylprednisolone" .
<Osocimab> <May_have_route> "Intravenous" .
<Onfran> <Brand_name_of> "Ondansetron" .
<Lenalidomide_and_Ofatumumab> <Maps_to> "Lenalidomide_and_Ofatumumab" .
<TAD_(Tamoxifen)> <Has_context> "Non-curative_therapy" .
<Letrozole_and_Palbociclib> <Has_modality> "Hormonotherapy" .
<Letrozole_and_Palbociclib> <Has_modality> "Chemotherapy" .
<Carboplatin_and_Ifosfamide> <Maps_to> "Carboplatin_and_Ifosfamide" .
<Daunorubicin_and_Prednisone> <Has_context> "Non-curative_therapy" .
<LOPP/EVAP> <Mapped_from> "LOPP/EVAP" .
<Valproate> <Has_brand_name> "Valric" .
<Valproate> <Has_brand_name> "Vallona" .
<Valproate> <Has_brand_name> "Leeporate" .
<Valproate> <Has_brand_name> "Epival" .
<Valproate> <Has_brand_name> "Epilim" .
<Valproate> <Has_brand_name> "Epibest" .
<Valproate> <Has_brand_name> "Encorate" .
<Valproate> <Has_brand_name> "Depakote" .
<Valproate> <Has_brand_name> "Depakine" .
<Valproate> <Has_brand_name> "Depacon" .
<Renib> <Brand_name_of> "Regorafenib" .
<CAD_and_G-CSF> <Has_context> "All_lines_of_therapy" .
<Idarubicin,_then_Mitoxantrone,_then_Idarubicin> <Maps_to> "Idarubicin,_then_Mitoxantrone,_then_Idarubicin" .
<Venous_thromboembolism> <Current_treated_by> "Warfarin_monotherapy" .
<Venous_thromboembolism> <Current_treated_by> "Tinzaparin_monotherapy" .
<Venous_thromboembolism> <Current_treated_by> "Rivaroxaban_monotherapy" .
<Venous_thromboembolism> <Current_treated_by> "Placebo" .
<Venous_thromboembolism> <Current_treated_by> "Lepirudin_monotherapy" .
<Venous_thromboembolism> <Current_treated_by> "Heparin_monotherapy" .
<Venous_thromboembolism> <Current_treated_by> "Fondaparinux_monotherapy" .
<Venous_thromboembolism> <Current_treated_by> "Enoxaparin_monotherapy" .
<Venous_thromboembolism> <Current_treated_by> "Edoxaban_monotherapy" .
<Venous_thromboembolism> <Current_treated_by> "Dalteparin_monotherapy" .
<Venous_thromboembolism> <Current_treated_by> "Dabigatran_monotherapy" .
<Venous_thromboembolism> <Current_treated_by> "Bivalirudin_monotherapy" .
<Venous_thromboembolism> <Current_treated_by> "Betrixaban_monotherapy" .
<Venous_thromboembolism> <Current_treated_by> "Aspirin_monotherapy" .
<Venous_thromboembolism> <Current_treated_by> "Argatroban_monotherapy" .
<Venous_thromboembolism> <Current_treated_by> "Apixaban_monotherapy" .
<O-CHOP> <Has_supportive_med> "Prednisolone" .
<O-CHOP> <Has_supportive_med> "Cetirizine" .
<O-CHOP> <Has_supportive_med> "Acetaminophen" .
<Nonsteroidal_antiandrogen> <Subsumes> "Nilutamide" .
<Nonsteroidal_antiandrogen> <Subsumes> "Flutamide" .
<Nonsteroidal_antiandrogen> <Subsumes> "Enzalutamide" .
<Nonsteroidal_antiandrogen> <Subsumes> "Darolutamide" .
<Nonsteroidal_antiandrogen> <Subsumes> "Cimetidine" .
<Nonsteroidal_antiandrogen> <Subsumes> "Bicalutamide" .
<Nonsteroidal_antiandrogen> <Subsumes> "Apalutamide" .
<Cyclophosphamide_and_Etoposide> <Mapped_from> "Cyclophosphamide_and_Etoposide" .
<Cinkef-U> <Brand_name_of> "Fluorouracil" .
<C-VAMP> <Is_a> "Anthracycline-containing_regimen" .
<Carboplatin_and_Paclitaxel> <Is_current_in> "Thymoma" .
<Carboplatin_and_Paclitaxel> <Is_current_in> "Prostate_cancer" .
<Carboplatin_and_Paclitaxel> <Is_current_in> "Ovarian_cancer" .
<Carboplatin_and_Paclitaxel> <Is_current_in> "Non-small_cell_lung_cancer" .
<Carboplatin_and_Paclitaxel> <Is_current_in> "Melanoma" .
<Carboplatin_and_Paclitaxel> <Is_current_in> "Gastric_cancer" .
<Carboplatin_and_Paclitaxel> <Is_current_in> "Esophageal_cancer" .
<Carboplatin_and_Paclitaxel> <Is_current_in> "Endometrial_cancer" .
<Carboplatin_and_Paclitaxel> <Is_current_in> "Cervical_cancer" .
<Carboplatin_and_Paclitaxel> <Is_current_in> "Breast_cancer" .
<Carboplatin_and_Paclitaxel> <Is_current_in> "Bladder_cancer" .
<Carboplatin_and_Paclitaxel> <Is_current_in> "Anal_cancer" .
<Carboplatin_and_Paclitaxel> <Is_current_in> "Adenocarcinoma_of_unknown_primary" .
<Danazol_monotherapy> <Mapped_from> "Danazol_monotherapy" .
<Ecofol> <Brand_name_of> "Folinic_acid" .
<NET_of_unknown_primary> <Is_a> "Malignant_solid_neoplasm" .
<Vinorelbel> <Brand_name_of> "Vinorelbine" .
<Docetaxel_and_Ramucirumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Docetaxel_and_Ramucirumab> <Has_accepted_use> "Bladder_cancer" .
<VAdCA/IE> <Has_context> "Non-curative_therapy" .
<Platinol> <Brand_name_of> "Cisplatin" .
<Ox-P> <Has_antineoplastic> "Prednisone" .
<Ox-P> <Has_antineoplastic> "Oxaliplatin" .
<IPH_2101> <May_have_route> "Intravenous" .
<Primavon> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Advaferon> <Brand_name_of> "Interferon_alfa-2b" .
<Ipatasertib> <Has_accepted_use> "Breast_cancer" .
<Methotrexat> <Brand_name_of> "Methotrexate" .
<L-Asparaginase_and_Methotrexate> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<V-HyperCAD> <Has_accepted_use> "Multiple_myeloma" .
<Rd> <Has_modality> "Chemotherapy" .
<Enzalutamide> <Has_FDA_indication> "Prostate_cancer" .
<Pentostatin> <May_have_route> "Intravenous" .
<Erlotinib_and_Gemcitabine> <Has_accepted_use> "Pancreatic_cancer" .
<Linker_regimen_(consolidation)> <Has_antineoplastic> "Vincristine" .
<Linker_regimen_(consolidation)> <Has_antineoplastic> "Teniposide" .
<Linker_regimen_(consolidation)> <Has_antineoplastic> "Prednisone" .
<Linker_regimen_(consolidation)> <Has_antineoplastic> "Methotrexate" .
<Linker_regimen_(consolidation)> <Has_antineoplastic> "Daunorubicin" .
<Linker_regimen_(consolidation)> <Has_antineoplastic> "Cytarabine" .
<Linker_regimen_(consolidation)> <Has_antineoplastic> "Asparaginase" .
<Irinotel> <Brand_name_of> "Irinotecan" .
<Tibsovo> <Brand_name_of> "Ivosidenib" .
<R-CHOP_(Prednisolone)> <Has_context> "Non-curative_first-line_therapy" .
<R-CHOP_(Prednisolone)> <Has_context> "Induction_therapy" .
<Medlin> <Brand_name_of> "Methylprednisolone" .
<Octreotide_LAR_monotherapy> <Is_current_in> "Pancreatic_NET" .
<Octreotide_LAR_monotherapy> <Is_current_in> "Neuroendocrine_tumor" .
<CNOP> <Maps_to> "CNOP" .
<Gemcitabine_and_Vinorelbine> <Has_antineoplastic> "Vinorelbine" .
<Gemcitabine_and_Vinorelbine> <Has_antineoplastic> "Gemcitabine" .
<OEPA> <Has_accepted_use> "Hodgkin_lymphoma" .
<Lemod> <Brand_name_of> "Methylprednisolone" .
<Tumor_vaccine> <Subsumes> "Belagenpumatucel-L" .
<Bantizol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Osimertinib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Bleomycin_and_Cisplatin> <Has_antineoplastic> "Cisplatin" .
<Bleomycin_and_Cisplatin> <Has_antineoplastic> "Bleomycin" .
<Cyclophosphamide_and_Dexamethasone> <Mapped_from> "Cyclophosphamide_and_Dexamethasone" .
<GCP> <Has_context> "Non-curative_therapy" .
<GCP> <Has_context> "All_lines_of_therapy" .
<Quisinostat> <May_have_route> "Oral" .
<Hepachron> <Brand_name_of> "Dalteparin" .
<Carboplatin_and_Cyclophosphamide> <Has_modality> "Chemotherapy" .
<Gemcitabine_monotherapy> <Has_accepted_use> "Small_cell_lung_cancer" .
<Gemcitabine_monotherapy> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Gemcitabine_monotherapy> <Has_accepted_use> "Pancreatic_cancer" .
<Gemcitabine_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Gemcitabine_monotherapy> <Has_accepted_use> "Osteosarcoma" .
<Gemcitabine_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Gemcitabine_monotherapy> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<Gemcitabine_monotherapy> <Has_accepted_use> "Mesothelioma" .
<Gemcitabine_monotherapy> <Has_accepted_use> "Hodgkin_lymphoma" .
<Gemcitabine_monotherapy> <Has_accepted_use> "Gallbladder_cancer" .
<Gemcitabine_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Gemcitabine_monotherapy> <Has_accepted_use> "Cholangiocarcinoma" .
<Gemcitabine_monotherapy> <Has_accepted_use> "Cervical_cancer" .
<Gemcitabine_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Gemcitabine_monotherapy> <Has_accepted_use> "Bladder_cancer" .
<TL_(Taxol)> <Maps_to> "TL_(Taxol)" .
<Dacarbazine_and_Interferon_alfa-2a> <Has_context> "Non-curative_therapy" .
<Interferon_Human> <Brand_name_of> "Interferon_alfa-2b" .
<Dacarbazine_and_Gemcitabine> <Is_current_in> "Soft_tissue_sarcoma" .
<Dacarbazine_and_Gemcitabine> <Is_current_in> "Leiomyosarcoma" .
<IT_Methotrexate_monotherapy> <Is_current_in> "CNS_leukemia" .
<BEACOPP> <Maps_to> "BEACOPP" .
<MP> <Has_modality> "Chemotherapy" .
<R-Hyper-CVAD/R-MA> <Is_current_in> "Mantle_cell_lymphoma" .
<R-Hyper-CVAD/R-MA> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<R-Hyper-CVAD/R-MA> <Is_current_in> "Burkitt_lymphoma" .
<R-Hyper-CVAD/R-MA> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<nab-Paclitaxel_monotherapy> <Has_modality> "Chemotherapy" .
<R-miniCEOP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Imatinib_and_Interferon> <Has_modality> "Immunotherapy" .
<Imatinib_and_Interferon> <Has_modality> "Chemotherapy" .
<Cisplatin_and_S-1> <Has_context> "Non-curative_first-line_therapy" .
<Anti-CD30_antibody> <Is_a> "Antibody_medication" .
<Anti-DKK1_antibody> <Is_a> "Antibody_medication" .
<Irinotecan_liposomal_monotherapy> <Mapped_from> "Irinotecan_liposomal_monotherapy" .
<CYVE_and_G-CSF> <Has_context> "All_lines_of_therapy" .
<G-CHOP> <Has_antineoplastic> "Vincristine" .
<G-CHOP> <Has_antineoplastic> "Prednisone" .
<G-CHOP> <Has_antineoplastic> "Obinutuzumab" .
<G-CHOP> <Has_antineoplastic> "Doxorubicin" .
<G-CHOP> <Has_antineoplastic> "Cyclophosphamide" .
<CPB> <Is_historical_in> "Breast_cancer" .
<Cardegic> <Brand_name_of> "Aspirin" .
<ddAC> <Has_accepted_use> "triple_negative_Breast_cancer" .
<ddAC> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<ddAC> <Has_accepted_use> "Breast_cancer" .
<Ciclofosfamida> <Brand_name_of> "Cyclophosphamide" .
<POMP> <Maps_to> "POMP" .
<Trisolak_Forte> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Panobinostat_monotherapy> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<Panobinostat_monotherapy> <Is_current_in> "Hodgkin_lymphoma" .
<Panobinostat_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_antineoplastic> "Vincristine" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_antineoplastic> "Prednisone" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_antineoplastic> "Daunorubicin" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_antineoplastic> "Cyclophosphamide" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_antineoplastic> "Asparaginase" .
<Demoprin_Novum> <Brand_name_of> "Aspirin" .
<Bortezomib,_Dexamethasone,_Panobinostat> <Has_accepted_use> "Multiple_myeloma" .
<FEAM,_then_auto_HSCT> <Is_current_in> "Hodgkin_lymphoma" .
<FEAM,_then_auto_HSCT> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<CHOEP-14> <Has_modality> "Chemotherapy" .
<Lagatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bromadene> <Brand_name_of> "Bortezomib" .
<Nintedanib_and_Pemetrexed> <Has_antineoplastic> "Pemetrexed" .
<Nintedanib_and_Pemetrexed> <Has_antineoplastic> "Nintedanib" .
<G-CHOP> <Has_context> "Non-curative_first-line_therapy" .
<Xanthotoxin> <Brand_name_of> "Methoxsalen" .
<Trozolet> <Brand_name_of> "Anastrozole" .
<Vascular_sarcoma> <Subsumes> "Kaposi_sarcoma" .
<Pentostatin_monotherapy> <Maps_to> "Pentostatin_monotherapy" .
<Methotrexate,_then_Cytarabine_and_Thiotepa> <Has_context> "Upfront_therapy" .
<Alemtuzumab_monotherapy> <Maps_to> "Alemtuzumab_monotherapy" .
<EAR_and_G-CSF> <Has_antineoplastic> "Rituximab" .
<EAR_and_G-CSF> <Has_antineoplastic> "Etoposide" .
<EAR_and_G-CSF> <Has_antineoplastic> "Cytarabine" .
<Alemtuzumab> <Is_a> "REMS_program" .
<Alemtuzumab> <Is_a> "Neutral" .
<Alemtuzumab> <Is_a> "Immunotherapeutic" .
<Alemtuzumab> <Is_a> "Antibody_medication" .
<Alemtuzumab> <Is_a> "Anti-CD52_antibody" .
<Abiraterone_and_Prednisone> <Has_context> "Non-curative_second-line_therapy" .
<PF> <Has_accepted_use> "Breast_cancer" .
<Busulfan_and_Melphalan> <Is_current_in> "Autologous_HSCT" .
<BuCyTBI,_then_allo_HSCT> <Is_current_in> "Chronic_myelogenous_leukemia" .
<Liposomal_chemotherapy> <Is_a> "Drugs_by_vehicle" .
<Docetaxel> <Has_FDA_indication> "Prostate_cancer" .
<Docetaxel> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Docetaxel> <Has_FDA_indication> "Head_and_neck_cancer" .
<Docetaxel> <Has_FDA_indication> "Gastric_cancer" .
<Docetaxel> <Has_FDA_indication> "Breast_cancer" .
<HAIC_and_Sorafenib> <Has_antineoplastic> "Sorafenib" .
<HAIC_and_Sorafenib> <Has_antineoplastic> "Oxaliplatin" .
<HAIC_and_Sorafenib> <Has_antineoplastic> "Folinic_acid" .
<HAIC_and_Sorafenib> <Has_antineoplastic> "Fluorouracil" .
<Irinotecan,_Temozolomide,_Dinutuximab> <Mapped_from> "Irinotecan,_Temozolomide,_Dinutuximab" .
<VTD-PACE> <Is_a> "Anthracycline-containing_regimen" .
<Bivalirudin> <May_have_route> "Intravenous" .
<Sirolimus_and_Vorinostat> <Mapped_from> "Sirolimus_and_Vorinostat" .
<Zidovudine> <Is_a> "DNA_synthesis_inhibitor" .
<Zidovudine> <Is_a> "Antiviral" .
<Alkeran> <Brand_name_of> "Melphalan" .
<Biprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin,_Paclitaxel,_Bevacizumab> <Has_modality> "Chemotherapy" .
<ACVBP,_dose-adjusted> <Has_antineoplastic> "Vindesine" .
<ACVBP,_dose-adjusted> <Has_antineoplastic> "Prednisone" .
<ACVBP,_dose-adjusted> <Has_antineoplastic> "Doxorubicin" .
<ACVBP,_dose-adjusted> <Has_antineoplastic> "Cyclophosphamide" .
<ACVBP,_dose-adjusted> <Has_antineoplastic> "Bleomycin" .
<Mitoxantrone_monotherapy> <Mapped_from> "Mitoxantrone_monotherapy" .
<Nortrime> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Drate> <Brand_name_of> "Alendronate" .
<Irzamethazone> <Brand_name_of> "Dexamethasone" .
<PCV> <Has_modality> "Chemotherapy" .
<CMFL> <Has_accepted_use> "Breast_cancer" .
<BeRT> <Has_antineoplastic> "Temsirolimus" .
<BeRT> <Has_antineoplastic> "Rituximab" .
<BeRT> <Has_antineoplastic> "Bendamustine" .
<Non-curative_second-line_induction_therapy> <Mapped_from> "Non-curative_second-line_induction_therapy" .
<Thrombocytopenia_in_liver_disease> <Accepted_use_of> "Placebo" .
<Thrombocytopenia_in_liver_disease> <Accepted_use_of> "Lusutrombopag_monotherapy" .
<Thrombocytopenia_in_liver_disease> <Accepted_use_of> "Lusutrombopag" .
<Thrombocytopenia_in_liver_disease> <Accepted_use_of> "Avatrombopag_monotherapy" .
<Thrombocytopenia_in_liver_disease> <Accepted_use_of> "Avatrombopag" .
<Remtrex> <Brand_name_of> "Methotrexate" .
<FCR_(Rituximab_Hycela)> <Has_context> "Non-curative_first-line_therapy" .
<Cetuximab_and_RT> <Has_accepted_use> "Head_and_neck_cancer" .
<Caditrex> <Brand_name_of> "Methotrexate" .
<Forcrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CNOP_(Prednisolone)> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Erlotinib_and_Bevacizumab> <Has_accepted_use> "Renal_cell_carcinoma" .
<Erlotinib_and_Bevacizumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Erlotinib_and_Bevacizumab> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Erlotinib_and_Bevacizumab> <Has_accepted_use> "Gallbladder_cancer" .
<Erlotinib_and_Bevacizumab> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<Erlotinib_and_Bevacizumab> <Has_accepted_use> "Cholangiocarcinoma" .
<Erlotinib_and_Bevacizumab> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<Isatuximab> <May_have_route> "Intravenous" .
<Cyclosporine_and_Prednisone> <Has_accepted_use> "Graft_versus_host_disease" .
<Enoxaparin_monotherapy> <Is_current_in> "Venous_thromboembolism" .
<Mercaptopurine,_Methotrexate,_WB-XRT> <Has_local_therapy> "Methotrexate" .
<Cyclophosphamide_and_Topotecan> <Maps_to> "Cyclophosphamide_and_Topotecan" .
<Biaxin> <Brand_name_of> "Clarithromycin" .
<BuCyTBI,_then_allo_HSCT> <Has_antineoplastic> "External_beam_radiotherapy" .
<BuCyTBI,_then_allo_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<BuCyTBI,_then_allo_HSCT> <Has_antineoplastic> "Busulfan" .
<BuCyTBI,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<Valrubicin> <Has_accepted_use> "Bladder_cancer" .
<BR> <Has_antineoplastic> "Rituximab" .
<BR> <Has_antineoplastic> "Bendamustine" .
<S-1_monotherapy> <Maps_to> "S-1_monotherapy" .
<Mercaptopurine_monotherapy> <Has_accepted_use> "Acute_myeloid_leukemia" .
<7_plus_3d_and_Sorafenib> <Is_a> "Anthracycline-containing_regimen" .
<Dextrasone> <Brand_name_of> "Dexamethasone" .
<R-MegaCHOP-14> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Kovintong> <Brand_name_of> "Dexamethasone" .
<BCOP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Diphenhydramine> <May_have_route> "Oral" .
<Diphenhydramine> <May_have_route> "Intravenous" .
<Tegafur_and_Uracil> <Has_modality> "Chemotherapy" .
<Neoset> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin,_Etoposide,_RT> <Has_context> "Neoadjuvant_therapy" .
<Cisplatin,_Etoposide,_RT> <Has_context> "Definitive_therapy" .
<BBD> <Has_antineoplastic> "Dexamethasone" .
<BBD> <Has_antineoplastic> "Bortezomib" .
<BBD> <Has_antineoplastic> "Bendamustine" .
<Denosumab_monotherapy> <Has_accepted_use> "Giant-cell_tumor_of_bone" .
<IDAC> <Maps_to> "IDAC" .
<Cisplatin,_Fluorouracil,_Pembrolizumab> <Mapped_from> "Cisplatin,_Fluorouracil,_Pembrolizumab" .
<Dutasteride> <Has_accepted_use> "Prostate_cancer" .
<MVP_and_RT> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine> <Has_context> "Consolidation_after_upfront_therapy" .
<Primzole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Lorazepam> <Has_brand_name> "Ativan" .
<Tisagenlecleucel_monotherapy> <Has_accepted_use> "Transformed_lymphoma" .
<Tisagenlecleucel_monotherapy> <Has_accepted_use> "Multiple_myeloma" .
<Tisagenlecleucel_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Tisagenlecleucel_monotherapy> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Tisagenlecleucel_monotherapy> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Cisplatin_and_Vindesine> <Has_context> "Non-curative_first-line_therapy" .
<Cisplatin_and_Vindesine> <Has_context> "Adjuvant_therapy" .
<Vinblastin> <Brand_name_of> "Vinblastine" .
<Vincristine> <Has_brand_name> "Vintec" .
<Vincristine> <Has_brand_name> "Vinstin" .
<Vincristine> <Has_brand_name> "Vinracine" .
<Vincristine> <Has_brand_name> "Vinracin" .
<Vincristine> <Has_brand_name> "Vincrisul" .
<Vincristine> <Has_brand_name> "Vincristinum" .
<Vincristine> <Has_brand_name> "Vincristinsulfat" .
<Vincristine> <Has_brand_name> "Vincristinesulfaat" .
<Vincristine> <Has_brand_name> "Vincristina" .
<Vincristine> <Has_brand_name> "Vincristin" .
<Vincristine> <Has_brand_name> "Vincrisol" .
<Vincristine> <Has_brand_name> "Vincrisin" .
<Vincristine> <Has_brand_name> "Vincrin" .
<Vincristine> <Has_brand_name> "Vincrifil" .
<Vincristine> <Has_brand_name> "Vincrex" .
<Vincristine> <Has_brand_name> "Vincran" .
<Vincristine> <Has_brand_name> "Vincosid" .
<Vincristine> <Has_brand_name> "Vinces" .
<Vincristine> <Has_brand_name> "Vincasar" .
<Vincristine> <Has_brand_name> "Tecnocris" .
<Vincristine> <Has_brand_name> "Pharmacristine" .
<Vincristine> <Has_brand_name> "Pericristine" .
<Vincristine> <Has_brand_name> "Onkocristin" .
<Vincristine> <Has_brand_name> "Oncovin" .
<Vincristine> <Has_brand_name> "Nevexitin" .
<Vincristine> <Has_brand_name> "Kyocristine" .
<Vincristine> <Has_brand_name> "Krebin" .
<Vincristine> <Has_brand_name> "Fauldvincri" .
<Vincristine> <Has_brand_name> "Farmistin_CS" .
<Vincristine> <Has_brand_name> "Cytomid" .
<Vincristine> <Has_brand_name> "Crivosin" .
<Vincristine> <Has_brand_name> "Citomid" .
<Vincristine> <Has_brand_name> "Cellcristin" .
<Vincristine> <Has_brand_name> "Biocrystin" .
<Vincristine> <Has_brand_name> "Biocrist" .
<Vincristine> <Has_brand_name> "Alcrist" .
<Elo-PD> <Has_accepted_use> "Multiple_myeloma" .
<Nintedanib> <Antineoplastic_of> "TC_and_Nintedanib" .
<Nintedanib> <Antineoplastic_of> "Nintedanib_and_Pemetrexed" .
<Nintedanib> <Antineoplastic_of> "Docetaxel_and_Nintedanib" .
<Cisplatin_and_S-1> <Mapped_from> "Cisplatin_and_S-1" .
<131Iodine-Tositumomab_monotherapy> <Has_context> "Non-curative_therapy" .
<131Iodine-Tositumomab_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<131Iodine-Tositumomab_monotherapy> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<131Iodine-Tositumomab_monotherapy> <Has_context> "All_lines_of_therapy" .
<Medroxyprogesterone> <Has_accepted_use> "Endometrial_cancer" .
<FOLFIRI_and_Ramucirumab> <Maps_to> "FOLFIRI_and_Ramucirumab" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "nab-Paclitaxel_and_Trastuzumab" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "ddTH_(Taxotere)" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "ddTH_(Taxol)" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "ddFEC" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "ddEC" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "ddAC" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "VH" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "Trastuzumab_monotherapy" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "Trastuzumab_and_hyaluronidase_monotherapy" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "Trastuzumab_and_ET" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "TPC" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "TL_(Taxol)" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "THP_(Taxotere)" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "THP_(Taxol)" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "THL_(Taxol)" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "TH_(Taxotere/SC)" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "TH_(Taxotere)" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "TH_(Taxol)" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "TCHP_(Taxotere)" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "TCHP_(Taxol)" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "TCH_(Taxotere,_Cyclophosphamide)" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "TCH_(Taxotere,_Carboplatin)" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "T-DM1_and_ET" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "Pertuzumab_and_Trastuzumab" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "Pertuzumab_and_T-DM1" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "Neratinib_monotherapy" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "Neratinib_and_Paclitaxel" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "Lapatinib_and_Trastuzumab" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "Gemcitabine_and_Trastuzumab" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "Fam-trastuzumab_deruxtecan_monotherapy" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "FEC_and_H_(SC)" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "FEC_and_H" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "FEC" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "FAC" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "ECH" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "EC" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "Capecitabine,_Pertuzumab,_Trastuzumab" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "Capecitabine,_Bevacizumab,_Trastuzumab" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "Capecitabine_and_Trastuzumab" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "Capecitabine_and_Neratinib" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "Capecitabine_and_Lapatinib" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "Ado-trastuzumab_emtansine_monotherapy" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "ACH" .
<HER2-positive_Breast_cancer> <Accepted_use_of> "AC" .
<Ricolinostat> <Is_a> "Investigational_drug" .
<Ricolinostat> <Is_a> "HDAC_inhibitor" .
<Dacarbazine> <Has_accepted_use> "Uveal_melanoma" .
<Dacarbazine> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Dacarbazine> <Has_accepted_use> "Pheochromocytoma" .
<Dacarbazine> <Has_accepted_use> "Melanoma" .
<Dacarbazine> <Has_accepted_use> "Liposarcoma" .
<Dacarbazine> <Has_accepted_use> "Leiomyosarcoma" .
<Dacarbazine> <Has_accepted_use> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<Dacarbazine> <Has_accepted_use> "Hodgkin_lymphoma" .
<Fluorouracil_and_Levamisole> <Has_accepted_use> "Colon_cancer" .
<Ipilimumab_and_RT> <Has_modality> "Radiotherapy" .
<Ipilimumab_and_RT> <Has_modality> "Immunotherapy" .
<Interferon_alfa-n1_monotherapy> <Is_current_in> "Chronic_myelogenous_leukemia" .
<Panobinostat_and_Rituximab> <Mapped_from> "Panobinostat_and_Rituximab" .
<Cisplatin_and_Irinotecan> <Maps_to> "Cisplatin_and_Irinotecan" .
<MP> <Is_current_in> "Multiple_myeloma" .
<MP> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<Depocyte> <Brand_name_of> "Cytarabine" .
<Fedimed> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Paclitaxel,_Topotecan,_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Radioembolization> <Is_current_in> "Hepatocellular_carcinoma" .
<Chronic_lymphocytic_leukemia> <Is_a> "Indolent_lymphoma" .
<Realdiron> <Brand_name_of> "Interferon_alfa-2b" .
<Recalfe> <Brand_name_of> "Alendronate" .
<CBVM,_then_auto_HSCT> <Has_antineoplastic> "Mitoxantrone" .
<CBVM,_then_auto_HSCT> <Has_antineoplastic> "Etoposide" .
<CBVM,_then_auto_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<CBVM,_then_auto_HSCT> <Has_antineoplastic> "Carmustine" .
<Trimosulfa> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin_and_Methotrexate> <Maps_to> "Cisplatin_and_Methotrexate" .
<BCG_and_Dacarbazine> <Has_accepted_use> "Melanoma" .
<Caplacizumab_and_Plasma_exchange> <Has_accepted_use> "Thrombotic_thrombocytopenic_purpura" .
<Pharmazol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<AC_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Osteonorm> <Brand_name_of> "Clodronate" .
<Nilotinib> <Has_FDA_indication> "Chronic_myelogenous_leukemia" .
<ACT> <Has_modality> "Hormonotherapy" .
<ACT> <Has_modality> "Chemotherapy" .
<Deksalon> <Brand_name_of> "Dexamethasone" .
<Daunorubicin_and_Prednisone> <Has_antineoplastic> "Prednisone" .
<Daunorubicin_and_Prednisone> <Has_antineoplastic> "Daunorubicin" .
<Plerixafor_and_G-CSF> <Has_accepted_use> "Stem_cell_mobilization" .
<Ixabepilone> <Antineoplastic_of> "Ixabepilone_monotherapy" .
<Ixabepilone> <Antineoplastic_of> "Capecitabine_and_Ixabepilone" .
<R-GemOx> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Emthexate> <Brand_name_of> "Methotrexate" .
<Epirubicin_monotherapy> <Is_historical_in> "Breast_cancer" .
<BCNU/TT,_then_auto_HSCT> <Has_accepted_use> "CNS_lymphoma" .
<Sipuleucel-T_monotherapy> <Is_current_in> "Prostate_cancer" .
<Lapatinib> <Antineoplastic_of> "TL_(Taxol)" .
<Lapatinib> <Antineoplastic_of> "THL_(Taxol)" .
<Lapatinib> <Antineoplastic_of> "Lapatinib,_Letrozole,_Trastuzumab" .
<Lapatinib> <Antineoplastic_of> "Lapatinib_and_Trastuzumab" .
<Lapatinib> <Antineoplastic_of> "Lapatinib_and_Letrozole" .
<Lapatinib> <Antineoplastic_of> "Capecitabine_and_Lapatinib" .
<Claphene> <Brand_name_of> "Cyclophosphamide" .
<Cefixime> <Has_brand_name> "Suprax" .
<High-dose_Interleukin-2> <Has_supportive_med> "Ranitidine" .
<High-dose_Interleukin-2> <Has_supportive_med> "Meperidine" .
<High-dose_Interleukin-2> <Has_supportive_med> "Indomethacin" .
<High-dose_Interleukin-2> <Has_supportive_med> "Hydroxyzine" .
<High-dose_Interleukin-2> <Has_supportive_med> "Famotidine" .
<High-dose_Interleukin-2> <Has_supportive_med> "Diphenhydramine" .
<High-dose_Interleukin-2> <Has_supportive_med> "Ciprofloxacin" .
<High-dose_Interleukin-2> <Has_supportive_med> "Cimetidine" .
<High-dose_Interleukin-2> <Has_supportive_med> "Acetaminophen" .
<Anticoagulant> <Subsumes> "Warfarin" .
<Anticoagulant> <Subsumes> "Vitamin_K_antagonist" .
<Anticoagulant> <Subsumes> "Unfractionated_heparin" .
<Anticoagulant> <Subsumes> "Ultralow_molecular_weight_heparin" .
<Anticoagulant> <Subsumes> "Tinzaparin" .
<Anticoagulant> <Subsumes> "Semuloparin" .
<Anticoagulant> <Subsumes> "Nadroparin" .
<Anticoagulant> <Subsumes> "Low_molecular_weight_heparin" .
<Anticoagulant> <Subsumes> "Lepirudin" .
<Anticoagulant> <Subsumes> "Heparin" .
<Anticoagulant> <Subsumes> "Fondaparinux" .
<Anticoagulant> <Subsumes> "Factor_Xa_inhibitor" .
<Anticoagulant> <Subsumes> "Enoxaparin" .
<Anticoagulant> <Subsumes> "Direct_thrombin_inhibitor" .
<Anticoagulant> <Subsumes> "Direct_oral_anticoagulant" .
<Anticoagulant> <Subsumes> "Danaparoid" .
<Anticoagulant> <Subsumes> "Dalteparin" .
<Anticoagulant> <Subsumes> "Bivalirudin" .
<Anticoagulant> <Subsumes> "Argatroban" .
<Cetuximab_and_RT> <Has_context> "Definitive_therapy" .
<Intramuscular> <May_be_route_of> "Triptorelin" .
<Intramuscular> <May_be_route_of> "Pegaspargase" .
<Intramuscular> <May_be_route_of> "Olanzapine" .
<Intramuscular> <May_be_route_of> "Octreotide_LAR" .
<Intramuscular> <May_be_route_of> "Methotrexate" .
<Intramuscular> <May_be_route_of> "Medroxyprogesterone" .
<Intramuscular> <May_be_route_of> "Leuprolide" .
<Intramuscular> <May_be_route_of> "Iron_dextran" .
<Intramuscular> <May_be_route_of> "Interferon_alfa-2b" .
<Intramuscular> <May_be_route_of> "Fulvestrant" .
<Intramuscular> <May_be_route_of> "Formestane" .
<Intramuscular> <May_be_route_of> "Folinic_acid" .
<Intramuscular> <May_be_route_of> "Epinephrine_autoinjector" .
<Intramuscular> <May_be_route_of> "Domperidone" .
<Intramuscular> <May_be_route_of> "Deferoxamine" .
<Intramuscular> <May_be_route_of> "Cyproterone_acetate" .
<Intramuscular> <May_be_route_of> "Cyanocobalamin" .
<Intramuscular> <May_be_route_of> "Calaspargase" .
<Intramuscular> <May_be_route_of> "Bleomycin" .
<Intramuscular> <May_be_route_of> "Asparaginase_Erwinia_chrysanthemi" .
<Intramuscular> <May_be_route_of> "Asparaginase" .
<Intramuscular> <May_be_route_of> "Aminopterin" .
<BO> <Maps_to> "BO" .
<Docetaxel_monotherapy> <Has_supportive_med> "Ranitidine" .
<Docetaxel_monotherapy> <Has_supportive_med> "Ondansetron" .
<Docetaxel_monotherapy> <Has_supportive_med> "Meperidine" .
<Docetaxel_monotherapy> <Has_supportive_med> "Lorazepam" .
<Docetaxel_monotherapy> <Has_supportive_med> "Hydroxyzine" .
<Docetaxel_monotherapy> <Has_supportive_med> "Filgrastim" .
<Docetaxel_monotherapy> <Has_supportive_med> "Emesis_prevention" .
<Docetaxel_monotherapy> <Has_supportive_med> "Diphenhydramine" .
<Docetaxel_monotherapy> <Has_supportive_med> "Dexamethasone" .
<Docetaxel_monotherapy> <Has_supportive_med> "Ciprofloxacin" .
<Docetaxel_monotherapy> <Has_supportive_med> "Cephalexin" .
<Docetaxel_monotherapy> <Has_supportive_med> "Acetaminophen" .
<Meperidine> <May_have_route> "Oral" .
<Meperidine> <May_have_route> "Intravenous" .
<Supportive_therapy> <Modality_of> "Zoledronic_acid_therapy" .
<Supportive_therapy> <Modality_of> "RhIG_monotherapy" .
<Supportive_therapy> <Modality_of> "RBC_transfusions" .
<Supportive_therapy> <Modality_of> "Plasma_exchange" .
<Supportive_therapy> <Modality_of> "L-glutamine_monotherapy" .
<Supportive_therapy> <Modality_of> "Intravenous_immunoglobulin_monotherapy" .
<Supportive_therapy> <Modality_of> "Emicizumab_monotherapy" .
<Supportive_therapy> <Modality_of> "Dexamethasone_monotherapy" .
<Supportive_therapy> <Modality_of> "Defibrotide_monotherapy" .
<Supportive_therapy> <Modality_of> "Caplacizumab_and_Plasma_exchange" .
<Supportive_therapy> <Modality_of> "ATRA_and_Danazol" .
<Konakion> <Brand_name_of> "Phytonadione" .
<SC-EPOCH-RR> <Has_accepted_use> "HIV-associated_lymphoma" .
<MEL200,_then_auto_HSCT,_then_MEL220_and_Dexamethasone,_then_auto_HSCT> <Has_accepted_use> "Multiple_myeloma" .
<ATG_(Horse)_monotherapy> <Has_immunosuppressor> "Antithymocyte_globulin_horse_ATG" .
<NovoTTF-100A_monotherapy> <Has_accepted_use> "Glioblastoma" .
<Irinotecan_and_S-1> <Maps_to> "Irinotecan_and_S-1" .
<CBV,_then_auto_HSCT> <Has_accepted_use> "Mantle_cell_lymphoma" .
<CBV,_then_auto_HSCT> <Has_accepted_use> "Hodgkin_lymphoma" .
<CBV,_then_auto_HSCT> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Melanoma> <Current_treated_by> "nab-Paclitaxel_monotherapy" .
<Melanoma> <Current_treated_by> "Vemurafenib_monotherapy" .
<Melanoma> <Current_treated_by> "Trametinib_monotherapy" .
<Melanoma> <Current_treated_by> "Temozolomide_monotherapy" .
<Melanoma> <Current_treated_by> "Temozolomide_and_Bevacizumab" .
<Melanoma> <Current_treated_by> "Talimogene_laherparepvec_monotherapy" .
<Melanoma> <Current_treated_by> "Placebo" .
<Melanoma> <Current_treated_by> "Pembrolizumab_monotherapy" .
<Melanoma> <Current_treated_by> "Peginterferon_alfa-2b_monotherapy" .
<Melanoma> <Current_treated_by> "Paclitaxel_monotherapy" .
<Melanoma> <Current_treated_by> "Observation" .
<Melanoma> <Current_treated_by> "Nivolumab,_then_Ipilimumab" .
<Melanoma> <Current_treated_by> "Nivolumab_monotherapy" .
<Melanoma> <Current_treated_by> "Low-dose_Interleukin-2" .
<Melanoma> <Current_treated_by> "Ipilimumab,_then_Nivolumab" .
<Melanoma> <Current_treated_by> "Ipilimumab_monotherapy" .
<Melanoma> <Current_treated_by> "Ipilimumab_and_Nivolumab" .
<Melanoma> <Current_treated_by> "Interferon_alfa-2b_monotherapy" .
<Melanoma> <Current_treated_by> "Interferon_alfa-2a_monotherapy" .
<Melanoma> <Current_treated_by> "Imatinib_monotherapy" .
<Melanoma> <Current_treated_by> "IL-2_monotherapy" .
<Melanoma> <Current_treated_by> "High-dose_Interleukin-2" .
<Melanoma> <Current_treated_by> "Fotemustine_monotherapy" .
<Melanoma> <Current_treated_by> "Docetaxel_monotherapy" .
<Melanoma> <Current_treated_by> "Dacarbazine_monotherapy" .
<Melanoma> <Current_treated_by> "Dacarbazine_and_Ipilimumab" .
<Melanoma> <Current_treated_by> "Dacarbazine_and_Interferon_alfa-2a" .
<Melanoma> <Current_treated_by> "Dabrafenib_monotherapy" .
<Melanoma> <Current_treated_by> "Dabrafenib_and_Trametinib" .
<Melanoma> <Current_treated_by> "Cobimetinib_and_Vemurafenib" .
<Melanoma> <Current_treated_by> "Cisplatin,_Dacarbazine,_Paclitaxel" .
<Melanoma> <Current_treated_by> "Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine" .
<Melanoma> <Current_treated_by> "Cisplatin_and_Dacarbazine" .
<Melanoma> <Current_treated_by> "Carboplatin_and_nab-Paclitaxel" .
<Melanoma> <Current_treated_by> "Carboplatin_and_Paclitaxel" .
<Melanoma> <Current_treated_by> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Melanoma> <Current_treated_by> "CVD_(Vindesine)" .
<Melanoma> <Current_treated_by> "CVD_(Vinblastine)" .
<Melanoma> <Current_treated_by> "Binimetinib_monotherapy" .
<Melanoma> <Current_treated_by> "Binimetinib_and_Encorafenib" .
<Melanoma> <Current_treated_by> "ABC" .
<Letrozole_and_Ribociclib> <Has_supportive_med> "Goserelin" .
<Avelumab> <May_have_route> "Intravenous" .
<Mycostatin> <Is_a> "WHO_Essential_Anti-infective_Medicine" .
<Mycostatin> <Is_a> "Antifungal" .
<PI3K_gamma_inhibitor> <Subsumes> "Duvelisib" .
<Casponova> <Brand_name_of> "Caspofungin" .
<Hydroxyzine> <Is_a> "Antihistamine" .
<PARP_inhibitor> <Is_a> "Enzyme_inhibitor" .
<Nivolumab> <Has_FDA_indication> "Small_cell_lung_cancer" .
<Nivolumab> <Has_FDA_indication> "Renal_cell_carcinoma" .
<Nivolumab> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Nivolumab> <Has_FDA_indication> "Melanoma" .
<Nivolumab> <Has_FDA_indication> "Hodgkin_lymphoma" .
<Nivolumab> <Has_FDA_indication> "Hepatocellular_carcinoma" .
<Nivolumab> <Has_FDA_indication> "Head_and_neck_cancer" .
<Nivolumab> <Has_FDA_indication> "Bladder_cancer" .
<T-DM1_and_ET> <Maps_to> "T-DM1_and_ET" .
<VR> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<VR> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<VR> <Has_supportive_med> "Erythrocyte_growth_factors" .
<VR> <Has_supportive_med> "Diphenhydramine" .
<VR> <Has_supportive_med> "Acyclovir" .
<VR> <Has_supportive_med> "Acetaminophen" .
<Costazole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Glasdegib> <Has_FDA_indication> "Acute_myeloid_leukemia" .
<R-CODOX-M_(Doxil_substituted)> <Is_a> "Rituximab-containing_regimen" .
<R-CODOX-M_(Doxil_substituted)> <Is_a> "Anthracycline-containing_regimen" .
<Gemtuzumab_ozogamicin_monotherapy> <Has_context> "Salvage_therapy" .
<Gemtuzumab_ozogamicin_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Gemtuzumab_ozogamicin_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Gemtuzumab_ozogamicin_monotherapy> <Has_context> "Non-curative_first-line_induction_therapy" .
<Rho(D)_immune_globulin> <Is_a> "Hematology_medication" .
<Medi-RUB> <Brand_name_of> "Aspirin" .
<Etoposide_and_Mitoxantrone> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Dara-KD> <Is_current_in> "Multiple_myeloma" .
<Dacomitinib_monotherapy> <Has_modality> "Chemotherapy" .
<Flutamide,_Leuprolide,_RT> <Mapped_from> "Flutamide,_Leuprolide,_RT" .
<HER2-positive_Colon_cancer> <Is_a> "Colon_cancer" .
<PAC> <Has_modality> "Chemotherapy" .
<eBEACOPP> <Has_accepted_use> "Hodgkin_lymphoma" .
<CDB> <Has_context> "Non-curative_therapy" .
<Ibrutinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Ibrutinib_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Ibrutinib_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Ibrutinib_monotherapy> <Has_context> "All_lines_of_therapy" .
<Lenalidomide> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Lenalidomide> <Is_a> "REMS_program" .
<Lenalidomide> <Is_a> "Mutation-specific_medication" .
<Lenalidomide> <Is_a> "Light-chain_(AL)_amyloidosis_medication" .
<Lenalidomide> <Is_a> "Immunomodulatory_drugs_(IMiDs)" .
<Docetaxel_and_Nedaplatin> <Is_current_in> "Non-small_cell_lung_cancer" .
<Bendamustine> <Antineoplastic_of> "Tisagenlecleucel_monotherapy" .
<Bendamustine> <Antineoplastic_of> "R-BL" .
<Bendamustine> <Antineoplastic_of> "R-BAC" .
<Bendamustine> <Antineoplastic_of> "Bendamustine_monotherapy" .
<Bendamustine> <Antineoplastic_of> "Bendamustine_and_Ofatumumab" .
<Bendamustine> <Antineoplastic_of> "Bendamustine_and_Obinutuzumab" .
<Bendamustine> <Antineoplastic_of> "Bendamustine_and_Brentuximab_vedotin" .
<Bendamustine> <Antineoplastic_of> "BeRT" .
<Bendamustine> <Antineoplastic_of> "BeGEV" .
<Bendamustine> <Antineoplastic_of> "BeEAM,_then_auto_HSCT" .
<Bendamustine> <Antineoplastic_of> "BeEAM" .
<Bendamustine> <Antineoplastic_of> "BVR" .
<Bendamustine> <Antineoplastic_of> "BVB" .
<Bendamustine> <Antineoplastic_of> "BTD" .
<Bendamustine> <Antineoplastic_of> "BR_and_Polatuzumab_vedotin" .
<Bendamustine> <Antineoplastic_of> "BR_and_Idelalisib" .
<Bendamustine> <Antineoplastic_of> "BR_and_Ibrutinib" .
<Bendamustine> <Antineoplastic_of> "BR" .
<Bendamustine> <Antineoplastic_of> "BLD" .
<Bendamustine> <Antineoplastic_of> "BID" .
<Bendamustine> <Antineoplastic_of> "BFR,_then_allo_HSCT" .
<Bendamustine> <Antineoplastic_of> "BFR" .
<Bendamustine> <Antineoplastic_of> "BBD" .
<Cisplatin,_Paclitaxel,_RT> <Maps_to> "Cisplatin,_Paclitaxel,_RT" .
<Cytarabine_and_Daunorubicin> <Has_antineoplastic> "Daunorubicin" .
<Cytarabine_and_Daunorubicin> <Has_antineoplastic> "Cytarabine" .
<Renatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Adronat> <Brand_name_of> "Alendronate" .
<Dexamet> <Brand_name_of> "Dexamethasone" .
<Imatinib,_Vincristine,_Dexamethasone> <Has_context> "Induction_therapy" .
<CAF_and_MPA> <Maps_to> "CAF_and_MPA" .
<Z-BEAM,_then_auto_HSCT> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Salgatran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Brigatinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Eribulin_monotherapy> <Has_context> "Non-curative_therapy" .
<Eribulin_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Eribulin_monotherapy> <Has_context> "All_lines_of_therapy" .
<ABP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Anastrozole> <May_have_route> "Oral" .
<Aminopterin> <Antineoplastic_of> "Aminopterin_monotherapy" .
<ATG_(Horse),_Cyclosporine,_G-CSF> <Has_context> "Induction_therapy" .
<Carboplatin,_Gemcitabine,_Bevacizumab> <Mapped_from> "Carboplatin,_Gemcitabine,_Bevacizumab" .
<Capecitabine_and_Erlotinib> <Is_current_in> "Pancreatic_cancer" .
<Cortisone> <Is_a> "Steroid" .
<Gemcitabine_and_Irinotecan> <Has_modality> "Chemotherapy" .
<Nitrogen_mustard> <Subsumes> "Melphalan" .
<Nitrogen_mustard> <Subsumes> "Mechlorethamine" .
<Nitrogen_mustard> <Subsumes> "Ifosfamide" .
<Nitrogen_mustard> <Subsumes> "Estramustine" .
<Nitrogen_mustard> <Subsumes> "Cyclophosphamide" .
<Nitrogen_mustard> <Subsumes> "Chlorambucil" .
<Nitrogen_mustard> <Subsumes> "Bendamustine" .
<EC_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<EC_and_Bevacizumab> <Is_a> "Anthracycline-containing_regimen" .
<VMCP/VCAP> <Has_context> "Non-curative_first-line_therapy" .
<BCNU/TT> <Mapped_from> "BCNU/TT" .
<Bexarotene_monotherapy> <Mapped_from> "Bexarotene_monotherapy" .
<Gemcitabine_and_nab-Paclitaxel> <Has_context> "Non-curative_therapy" .
<Gemcitabine_and_nab-Paclitaxel> <Has_context> "Non-curative_first-line_therapy" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Hyper-CVAD> <Is_a> "Anthracycline-containing_regimen" .
<Docetaxel_and_Nedaplatin> <Has_antineoplastic> "Nedaplatin" .
<Docetaxel_and_Nedaplatin> <Has_antineoplastic> "Docetaxel" .
<Coraspirina> <Brand_name_of> "Aspirin" .
<Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone> <Has_modality> "Chemotherapy" .
<Trastuzumab-qyyp> <Has_accepted_use> "Gastric_cancer" .
<Trastuzumab-qyyp> <Has_accepted_use> "Esophageal_cancer" .
<Trastuzumab-qyyp> <Has_accepted_use> "Breast_cancer" .
<KabiGef> <Brand_name_of> "Gefitinib" .
<Carboplatin,_Gemcitabine,_Bevacizumab> <Maps_to> "Carboplatin,_Gemcitabine,_Bevacizumab" .
<Avapritinib_monotherapy> <Has_accepted_use> "Gastrointestinal_stromal_tumor" .
<Zavedose> <Brand_name_of> "Idarubicin" .
<MA-BCD/AP> <Maps_to> "MA-BCD/AP" .
<Idarubicin,_then_Mitoxantrone,_then_Idarubicin> <Has_modality> "Chemotherapy" .
<Prochlorperazine> <Is_a> "Phenothiazine" .
<Prochlorperazine> <Is_a> "Emesis_prevention" .
<Prochlorperazine> <Is_a> "Dopamine_receptor_antagonist" .
<R,_then_CHOP> <Has_modality> "Chemotherapy" .
<Fluorouracil,_Folinic_acid,_Levamisole> <Has_modality> "Immunotherapy" .
<Fluorouracil,_Folinic_acid,_Levamisole> <Has_modality> "Chemotherapy" .
<Non-curative_first-line_therapy> <Context_of> "nab-Paclitaxel_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "nab-Paclitaxel_and_Trastuzumab" .
<Non-curative_first-line_therapy> <Context_of> "nab-Paclitaxel_and_Atezolizumab" .
<Non-curative_first-line_therapy> <Context_of> "maxi-R-CHOP/R-HiDAC" .
<Non-curative_first-line_therapy> <Context_of> "mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)" .
<Non-curative_first-line_therapy> <Context_of> "mFOLFOX7_(L-Leucovorin)" .
<Non-curative_first-line_therapy> <Context_of> "mFOLFOX7" .
<Non-curative_first-line_therapy> <Context_of> "mFOLFOX6_and_Cetuximab" .
<Non-curative_first-line_therapy> <Context_of> "mFOLFOX6_and_Bevacizumab_(L-Leucovorin)" .
<Non-curative_first-line_therapy> <Context_of> "mFOLFOX6_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "mFOLFOX6_(L-Leucovorin)" .
<Non-curative_first-line_therapy> <Context_of> "mFOLFOX6" .
<Non-curative_first-line_therapy> <Context_of> "mFOLFOX_and_Sorafenib" .
<Non-curative_first-line_therapy> <Context_of> "mDCF_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "mDCF" .
<Non-curative_first-line_therapy> <Context_of> "mCOP/MP" .
<Non-curative_first-line_therapy> <Context_of> "Zoledronic_acid_therapy" .
<Non-curative_first-line_therapy> <Context_of> "Vinorelbine_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Vindesine_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Vinblastine_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Venetoclax_and_Obinutuzumab" .
<Non-curative_first-line_therapy> <Context_of> "VcR-CVAD" .
<Non-curative_first-line_therapy> <Context_of> "VTP" .
<Non-curative_first-line_therapy> <Context_of> "VTD-PACE" .
<Non-curative_first-line_therapy> <Context_of> "VTD" .
<Non-curative_first-line_therapy> <Context_of> "VR-CHOP" .
<Non-curative_first-line_therapy> <Context_of> "VR-CAP" .
<Non-curative_first-line_therapy> <Context_of> "VR" .
<Non-curative_first-line_therapy> <Context_of> "VP" .
<Non-curative_first-line_therapy> <Context_of> "VMPT" .
<Non-curative_first-line_therapy> <Context_of> "VMP/Rd" .
<Non-curative_first-line_therapy> <Context_of> "VMP,_then_Rd" .
<Non-curative_first-line_therapy> <Context_of> "VMP" .
<Non-curative_first-line_therapy> <Context_of> "VMD" .
<Non-curative_first-line_therapy> <Context_of> "VMCP/VCAP" .
<Non-curative_first-line_therapy> <Context_of> "VMCP/VBAP" .
<Non-curative_first-line_therapy> <Context_of> "VMCP" .
<Non-curative_first-line_therapy> <Context_of> "VIP" .
<Non-curative_first-line_therapy> <Context_of> "VH" .
<Non-curative_first-line_therapy> <Context_of> "VDC" .
<Non-curative_first-line_therapy> <Context_of> "VD" .
<Non-curative_first-line_therapy> <Context_of> "VCP" .
<Non-curative_first-line_therapy> <Context_of> "VBMCP/VBAD" .
<Non-curative_first-line_therapy> <Context_of> "VBMCP" .
<Non-curative_first-line_therapy> <Context_of> "VBMC" .
<Non-curative_first-line_therapy> <Context_of> "VAMP" .
<Non-curative_first-line_therapy> <Context_of> "VAD-P/Q" .
<Non-curative_first-line_therapy> <Context_of> "VAD-P" .
<Non-curative_first-line_therapy> <Context_of> "VAD_plus_C" .
<Non-curative_first-line_therapy> <Context_of> "VAD_doxil" .
<Non-curative_first-line_therapy> <Context_of> "VAD" .
<Non-curative_first-line_therapy> <Context_of> "Uracil_mustard_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "UFTM" .
<Non-curative_first-line_therapy> <Context_of> "Trastuzumab_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Total_Therapy" .
<Non-curative_first-line_therapy> <Context_of> "Toremifene_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Topotecan_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Thioguanine_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Thalidomide_and_Rituximab" .
<Non-curative_first-line_therapy> <Context_of> "Temsirolimus_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Temozolomide_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Tamoxifen_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Tamoxifen_and_Prednisolone" .
<Non-curative_first-line_therapy> <Context_of> "TX_(Taxotere)" .
<Non-curative_first-line_therapy> <Context_of> "TVAD_doxil" .
<Non-curative_first-line_therapy> <Context_of> "TPC" .
<Non-curative_first-line_therapy> <Context_of> "TL_(Taxol)" .
<Non-curative_first-line_therapy> <Context_of> "THP_(Taxotere)" .
<Non-curative_first-line_therapy> <Context_of> "TH_(Taxotere)" .
<Non-curative_first-line_therapy> <Context_of> "TH_(Taxol)" .
<Non-curative_first-line_therapy> <Context_of> "TD" .
<Non-curative_first-line_therapy> <Context_of> "TCH_(Taxotere,_Carboplatin)" .
<Non-curative_first-line_therapy> <Context_of> "TC_and_Nintedanib" .
<Non-curative_first-line_therapy> <Context_of> "TAD_(Thalidomide)" .
<Non-curative_first-line_therapy> <Context_of> "TACE,_then_5-FU" .
<Non-curative_first-line_therapy> <Context_of> "Sunitinib_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Sorafenib_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "SOX_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "SOX" .
<Non-curative_first-line_therapy> <Context_of> "S-1_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Ruxolitinib_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Rituximab_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Ribociclib_and_Tamoxifen" .
<Non-curative_first-line_therapy> <Context_of> "RiPAD_plus_C" .
<Non-curative_first-line_therapy> <Context_of> "Regorafenib_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Rd" .
<Non-curative_first-line_therapy> <Context_of> "Radotinib_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "RVDC" .
<Non-curative_first-line_therapy> <Context_of> "RVD" .
<Non-curative_first-line_therapy> <Context_of> "RP" .
<Non-curative_first-line_therapy> <Context_of> "RD" .
<Non-curative_first-line_therapy> <Context_of> "RCC" .
<Non-curative_first-line_therapy> <Context_of> "R-VAD_plus_C" .
<Non-curative_first-line_therapy> <Context_of> "R-MCP" .
<Non-curative_first-line_therapy> <Context_of> "R-MACLO/R-IVAM" .
<Non-curative_first-line_therapy> <Context_of> "R-M-CHOP" .
<Non-curative_first-line_therapy> <Context_of> "R-Hyper-CVAD/R-MA" .
<Non-curative_first-line_therapy> <Context_of> "R-HiDAC" .
<Non-curative_first-line_therapy> <Context_of> "R-FND" .
<Non-curative_first-line_therapy> <Context_of> "R-FM" .
<Non-curative_first-line_therapy> <Context_of> "R-FCM" .
<Non-curative_first-line_therapy> <Context_of> "R-DHAP" .
<Non-curative_first-line_therapy> <Context_of> "R-DHAOx" .
<Non-curative_first-line_therapy> <Context_of> "R-DHAC" .
<Non-curative_first-line_therapy> <Context_of> "R-CVP" .
<Non-curative_first-line_therapy> <Context_of> "R-CMD" .
<Non-curative_first-line_therapy> <Context_of> "R-CHVP_plus_I" .
<Non-curative_first-line_therapy> <Context_of> "R-CHOP/R-DHAP" .
<Non-curative_first-line_therapy> <Context_of> "R-CHOP-14_(Prednisolone)" .
<Non-curative_first-line_therapy> <Context_of> "R-CHOP_(Prednisolone)" .
<Non-curative_first-line_therapy> <Context_of> "R-CHOP" .
<Non-curative_first-line_therapy> <Context_of> "R-BAC" .
<Non-curative_first-line_therapy> <Context_of> "ProMACE-MOPP" .
<Non-curative_first-line_therapy> <Context_of> "Placebo" .
<Non-curative_first-line_therapy> <Context_of> "Pertuzumab_and_T-DM1" .
<Non-curative_first-line_therapy> <Context_of> "Pemetrexed_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Pemetrexed_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "Pembrolizumab_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Peginterferon_alfa-2a_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Pazopanib_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "Paclitaxel,_Topotecan,_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "Paclitaxel_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Paclitaxel_and_Vinorelbine" .
<Non-curative_first-line_therapy> <Context_of> "Paclitaxel_and_Topotecan" .
<Non-curative_first-line_therapy> <Context_of> "Paclitaxel_and_S-1" .
<Non-curative_first-line_therapy> <Context_of> "Paclitaxel_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "PGC" .
<Non-curative_first-line_therapy> <Context_of> "PEFG" .
<Non-curative_first-line_therapy> <Context_of> "PCR" .
<Non-curative_first-line_therapy> <Context_of> "PCO" .
<Non-curative_first-line_therapy> <Context_of> "PAD/VCD" .
<Non-curative_first-line_therapy> <Context_of> "PAD_doxil" .
<Non-curative_first-line_therapy> <Context_of> "PAD" .
<Non-curative_first-line_therapy> <Context_of> "PAC" .
<Non-curative_first-line_therapy> <Context_of> "Ofatumumab_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Observation" .
<Non-curative_first-line_therapy> <Context_of> "Obinutuzumab_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "OXAFAFU" .
<Non-curative_first-line_therapy> <Context_of> "OLF" .
<Non-curative_first-line_therapy> <Context_of> "O-FC" .
<Non-curative_first-line_therapy> <Context_of> "O-CHOP" .
<Non-curative_first-line_therapy> <Context_of> "Nordic_FLOX" .
<Non-curative_first-line_therapy> <Context_of> "No_induction" .
<Non-curative_first-line_therapy> <Context_of> "Nivolumab_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Nilotinib_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Methotrexate_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Melphalan_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Medroxyprogesterone_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "MVP_(Vindesine)" .
<Non-curative_first-line_therapy> <Context_of> "MVP_(Vinblastine)" .
<Non-curative_first-line_therapy> <Context_of> "MVAC,_dose-dense" .
<Non-curative_first-line_therapy> <Context_of> "MVAC" .
<Non-curative_first-line_therapy> <Context_of> "MRD" .
<Non-curative_first-line_therapy> <Context_of> "MPT" .
<Non-curative_first-line_therapy> <Context_of> "MPR" .
<Non-curative_first-line_therapy> <Context_of> "MP_(Prednisolone)" .
<Non-curative_first-line_therapy> <Context_of> "MP" .
<Non-curative_first-line_therapy> <Context_of> "MIC" .
<Non-curative_first-line_therapy> <Context_of> "MCP_(Prednisolone)" .
<Non-curative_first-line_therapy> <Context_of> "MCP" .
<Non-curative_first-line_therapy> <Context_of> "MCF" .
<Non-curative_first-line_therapy> <Context_of> "MC" .
<Non-curative_first-line_therapy> <Context_of> "MAP" .
<Non-curative_first-line_therapy> <Context_of> "MACC" .
<Non-curative_first-line_therapy> <Context_of> "M-DEX" .
<Non-curative_first-line_therapy> <Context_of> "Low-dose_Interleukin-2" .
<Non-curative_first-line_therapy> <Context_of> "LoDAC" .
<Non-curative_first-line_therapy> <Context_of> "Letrozole_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Letrozole_and_Ribociclib" .
<Non-curative_first-line_therapy> <Context_of> "Letrozole_and_Palbociclib" .
<Non-curative_first-line_therapy> <Context_of> "Letrozole_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "Lenvatinib_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Lenalidomide_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Lenalidomide_and_Rituximab" .
<Non-curative_first-line_therapy> <Context_of> "Lapatinib,_Letrozole,_Trastuzumab" .
<Non-curative_first-line_therapy> <Context_of> "Lapatinib_and_Letrozole" .
<Non-curative_first-line_therapy> <Context_of> "KTD" .
<Non-curative_first-line_therapy> <Context_of> "KRd" .
<Non-curative_first-line_therapy> <Context_of> "KMP" .
<Non-curative_first-line_therapy> <Context_of> "KCD" .
<Non-curative_first-line_therapy> <Context_of> "Ivosidenib_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Irinotecan_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Irinotecan_and_Mitomycin" .
<Non-curative_first-line_therapy> <Context_of> "Ipilimumab_and_Nivolumab" .
<Non-curative_first-line_therapy> <Context_of> "Interferon_alfa-n1_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Interferon_alfa-2b_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Interferon_alfa-2a_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Interferon_alfa-2a_and_Interleukin-2" .
<Non-curative_first-line_therapy> <Context_of> "Interferon_alfa_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Imatinib_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Imatinib_and_LoDAC" .
<Non-curative_first-line_therapy> <Context_of> "Imatinib_and_Interferon" .
<Non-curative_first-line_therapy> <Context_of> "Ifosfamide_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Ifosfamide_and_Gemcitabine" .
<Non-curative_first-line_therapy> <Context_of> "Idelalisib_and_Rituximab" .
<Non-curative_first-line_therapy> <Context_of> "Ibrutinib_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Ibrutinib_and_Venetoclax" .
<Non-curative_first-line_therapy> <Context_of> "Ibrutinib_and_Rituximab" .
<Non-curative_first-line_therapy> <Context_of> "Ibrutinib_and_Obinutuzumab" .
<Non-curative_first-line_therapy> <Context_of> "Ibritumomab_tiuxetan_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "IRd" .
<Non-curative_first-line_therapy> <Context_of> "IROX" .
<Non-curative_first-line_therapy> <Context_of> "IRIS_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "IFL_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "IFL" .
<Non-curative_first-line_therapy> <Context_of> "Hydroxyurea_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Hydroxyurea_and_Interferon_alfa-2a" .
<Non-curative_first-line_therapy> <Context_of> "High-dose_Interleukin-2" .
<Non-curative_first-line_therapy> <Context_of> "Hexa-CAF" .
<Non-curative_first-line_therapy> <Context_of> "Helicobacter_pylori_eradication_therapy" .
<Non-curative_first-line_therapy> <Context_of> "HDMP-R" .
<Non-curative_first-line_therapy> <Context_of> "HAIC_and_Sorafenib" .
<Non-curative_first-line_therapy> <Context_of> "Goserelin_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Goserelin_and_Tamoxifen" .
<Non-curative_first-line_therapy> <Context_of> "Gemcitabine_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Gemcitabine_and_nab-Paclitaxel" .
<Non-curative_first-line_therapy> <Context_of> "Gemcitabine_and_Vinorelbine" .
<Non-curative_first-line_therapy> <Context_of> "Gemcitabine_and_Sunitinib" .
<Non-curative_first-line_therapy> <Context_of> "Gemcitabine_and_Paclitaxel" .
<Non-curative_first-line_therapy> <Context_of> "GemOx_and_Sorafenib" .
<Non-curative_first-line_therapy> <Context_of> "GemOx" .
<Non-curative_first-line_therapy> <Context_of> "Gefitinib_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "GTX" .
<Non-curative_first-line_therapy> <Context_of> "GIP" .
<Non-curative_first-line_therapy> <Context_of> "G-FC" .
<Non-curative_first-line_therapy> <Context_of> "G-CVP" .
<Non-curative_first-line_therapy> <Context_of> "G-CHOP" .
<Non-curative_first-line_therapy> <Context_of> "Fulvestrant_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Fulvestrant_and_Ribociclib" .
<Non-curative_first-line_therapy> <Context_of> "Fluorouracil,_Folinic_acid,_Mitomycin" .
<Non-curative_first-line_therapy> <Context_of> "Fluorouracil,_Folinic_acid,_Gemcitabine" .
<Non-curative_first-line_therapy> <Context_of> "Fluorouracil_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Fluorouracil_and_Semustine" .
<Non-curative_first-line_therapy> <Context_of> "Fluorouracil_and_RT" .
<Non-curative_first-line_therapy> <Context_of> "Fluorouracil_and_Mitomycin" .
<Non-curative_first-line_therapy> <Context_of> "Fluorouracil_and_Methotrexate" .
<Non-curative_first-line_therapy> <Context_of> "Fluorouracil_and_Levoleucovorin" .
<Non-curative_first-line_therapy> <Context_of> "Fluorouracil_and_Folinic_acid" .
<Non-curative_first-line_therapy> <Context_of> "Fludarabine,_then_131Iodine-Tositumomab" .
<Non-curative_first-line_therapy> <Context_of> "Fludarabine_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Fludarabine_and_Prednisone" .
<Non-curative_first-line_therapy> <Context_of> "Fludarabine_and_Alemtuzumab" .
<Non-curative_first-line_therapy> <Context_of> "FUOX" .
<Non-curative_first-line_therapy> <Context_of> "FUIRI" .
<Non-curative_first-line_therapy> <Context_of> "FR" .
<Non-curative_first-line_therapy> <Context_of> "FOLFOXIRI_and_Panitumumab" .
<Non-curative_first-line_therapy> <Context_of> "FOLFOX4_and_Panitumumab" .
<Non-curative_first-line_therapy> <Context_of> "FOLFOX4_and_Cetuximab" .
<Non-curative_first-line_therapy> <Context_of> "FOLFOX4_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "FOLFOX4_(L-Leucovorin)" .
<Non-curative_first-line_therapy> <Context_of> "FOLFOX4" .
<Non-curative_first-line_therapy> <Context_of> "FOLFOX2" .
<Non-curative_first-line_therapy> <Context_of> "FOLFOX_chronotherapy" .
<Non-curative_first-line_therapy> <Context_of> "FOLFOX_7/sLV5FU2_(L-Leucovorin)" .
<Non-curative_first-line_therapy> <Context_of> "FOLFOX_7/sLV5FU2" .
<Non-curative_first-line_therapy> <Context_of> "FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)" .
<Non-curative_first-line_therapy> <Context_of> "FOLFIRINOX" .
<Non-curative_first-line_therapy> <Context_of> "FOLFIRI_and_Cetuximab_(L-Leucovorin)" .
<Non-curative_first-line_therapy> <Context_of> "FOLFIRI_and_Cetuximab" .
<Non-curative_first-line_therapy> <Context_of> "FOLFIRI_and_Bevacizumab_(L-Leucovorin)" .
<Non-curative_first-line_therapy> <Context_of> "FOLFIRI_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "FOLFIRI_(L-Leucovorin)" .
<Non-curative_first-line_therapy> <Context_of> "FOLFIRI" .
<Non-curative_first-line_therapy> <Context_of> "FND" .
<Non-curative_first-line_therapy> <Context_of> "FM" .
<Non-curative_first-line_therapy> <Context_of> "FLOT" .
<Non-curative_first-line_therapy> <Context_of> "FEMTX" .
<Non-curative_first-line_therapy> <Context_of> "FEC_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "FEC" .
<Non-curative_first-line_therapy> <Context_of> "FCR_(Rituximab_Hycela)" .
<Non-curative_first-line_therapy> <Context_of> "FCR" .
<Non-curative_first-line_therapy> <Context_of> "FCM" .
<Non-curative_first-line_therapy> <Context_of> "FCA" .
<Non-curative_first-line_therapy> <Context_of> "FC" .
<Non-curative_first-line_therapy> <Context_of> "FAMTX" .
<Non-curative_first-line_therapy> <Context_of> "FAM" .
<Non-curative_first-line_therapy> <Context_of> "FAC_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "FAC" .
<Non-curative_first-line_therapy> <Context_of> "Exemestane_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Everolimus_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Etoposide_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Erlotinib_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Erlotinib_and_Gemcitabine" .
<Non-curative_first-line_therapy> <Context_of> "Erlotinib_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "Epirubicin_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Epirubicin_and_Vinorelbine" .
<Non-curative_first-line_therapy> <Context_of> "Enasidenib_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "EP" .
<Non-curative_first-line_therapy> <Context_of> "EOX" .
<Non-curative_first-line_therapy> <Context_of> "EOF" .
<Non-curative_first-line_therapy> <Context_of> "EDAP" .
<Non-curative_first-line_therapy> <Context_of> "ECX" .
<Non-curative_first-line_therapy> <Context_of> "ECH" .
<Non-curative_first-line_therapy> <Context_of> "ECF" .
<Non-curative_first-line_therapy> <Context_of> "EC_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "EC" .
<Non-curative_first-line_therapy> <Context_of> "Doxycycline_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Doxorubicin_pegylated_liposomal_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Doxorubicin_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Doxorubicin_and_Gemcitabine" .
<Non-curative_first-line_therapy> <Context_of> "Docetaxel_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Docetaxel_and_Vinorelbine" .
<Non-curative_first-line_therapy> <Context_of> "Docetaxel_and_S-1" .
<Non-curative_first-line_therapy> <Context_of> "Docetaxel_and_Nedaplatin" .
<Non-curative_first-line_therapy> <Context_of> "Docetaxel_and_Irinotecan" .
<Non-curative_first-line_therapy> <Context_of> "Docetaxel_and_Gemcitabine" .
<Non-curative_first-line_therapy> <Context_of> "Docetaxel_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "Dexamethasone_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Decitabine_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Dasatinib_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Dara-VTD" .
<Non-curative_first-line_therapy> <Context_of> "Dara-VMP" .
<Non-curative_first-line_therapy> <Context_of> "Dara-Rd" .
<Non-curative_first-line_therapy> <Context_of> "Dabrafenib_and_Trametinib" .
<Non-curative_first-line_therapy> <Context_of> "DRC" .
<Non-curative_first-line_therapy> <Context_of> "DEX-IFN" .
<Non-curative_first-line_therapy> <Context_of> "DE" .
<Non-curative_first-line_therapy> <Context_of> "DCF" .
<Non-curative_first-line_therapy> <Context_of> "Cytarabine_and_Interferon_alfa-2b" .
<Non-curative_first-line_therapy> <Context_of> "Cyclosporine_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Cyclophosphamide_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Colchicine_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Clofarabine_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Cladribine_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Cladribine_and_Rituximab" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin,_Vinorelbine,_Cetuximab" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin,_Pemetrexed,_TTFields" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin,_Pemetrexed,_Pembrolizumab" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin,_Pemetrexed,_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin,_Paclitaxel,_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin,_Gemcitabine,_Necitumumab" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin,_Gemcitabine,_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin,_Fluorouracil,_Pembrolizumab" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin,_Fluorouracil,_Panitumumab" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin,_Fluorouracil,_Cetuximab" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin,_Doxorubicin_liposomal,_Fluorouracil" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin_and_Vinorelbine" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin_and_Vindesine" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin_and_Vinblastine" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin_and_Topotecan" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin_and_S-1" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin_and_Raltitrexed" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin_and_Pemetrexed" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin_and_Paclitaxel" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin_and_Mitomycin" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin_and_Irinotecan" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin_and_Ifosfamide" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin_and_Gemcitabine" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin_and_Fluorouracil" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin_and_Etoposide" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin_and_Doxorubicin" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin_and_Docetaxel" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin_and_Cyclophosphamide" .
<Non-curative_first-line_therapy> <Context_of> "Cisplatin_and_Cetuximab" .
<Non-curative_first-line_therapy> <Context_of> "Chlorambucil_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Chlorambucil_and_Rituximab" .
<Non-curative_first-line_therapy> <Context_of> "Chlorambucil_and_Prednisone" .
<Non-curative_first-line_therapy> <Context_of> "Chlorambucil_and_Ofatumumab" .
<Non-curative_first-line_therapy> <Context_of> "Chlorambucil_and_Obinutuzumab" .
<Non-curative_first-line_therapy> <Context_of> "Chlorambucil_and_Cisplatin" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin,_nab-Paclitaxel,_Pembrolizumab" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin,_nab-Paclitaxel,_Atezolizumab" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin,_Pemetrexed,_Pembrolizumab" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin,_Pemetrexed,_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin,_Paclitaxel,_Pembrolizumab" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin,_Paclitaxel,_Ipilimumab" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin,_Paclitaxel,_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin,_Fluorouracil,_Cetuximab" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin_and_nab-Paclitaxel" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin_and_Vinorelbine" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin_and_Pemetrexed" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin_and_Paclitaxel" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin_and_Gemcitabine" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin_and_Fluorouracil" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin_and_Etoposide" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin_and_Doxorubicin_liposomal" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin_and_Docetaxel" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin_and_Cyclophosphamide" .
<Non-curative_first-line_therapy> <Context_of> "Carboplatin_and_Cisplatin" .
<Non-curative_first-line_therapy> <Context_of> "Capecitabine,_Bevacizumab,_Trastuzumab" .
<Non-curative_first-line_therapy> <Context_of> "Capecitabine_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Capecitabine_and_Trastuzumab" .
<Non-curative_first-line_therapy> <Context_of> "Capecitabine_and_Paclitaxel,_nanoparticle_albumin-bound" .
<Non-curative_first-line_therapy> <Context_of> "Capecitabine_and_Paclitaxel" .
<Non-curative_first-line_therapy> <Context_of> "Capecitabine_and_Lapatinib" .
<Non-curative_first-line_therapy> <Context_of> "Capecitabine_and_Gemcitabine" .
<Non-curative_first-line_therapy> <Context_of> "Capecitabine_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "CapeOx_and_Panitumumab" .
<Non-curative_first-line_therapy> <Context_of> "CapeOx_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "CapeOx" .
<Non-curative_first-line_therapy> <Context_of> "Cabozantinib_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "CaRD" .
<Non-curative_first-line_therapy> <Context_of> "CYKLONE" .
<Non-curative_first-line_therapy> <Context_of> "CX-C" .
<Non-curative_first-line_therapy> <Context_of> "CX_and_Trastuzumab" .
<Non-curative_first-line_therapy> <Context_of> "CX" .
<Non-curative_first-line_therapy> <Context_of> "CVP,_then_131Iodine-Tositumomab" .
<Non-curative_first-line_therapy> <Context_of> "CVP" .
<Non-curative_first-line_therapy> <Context_of> "CVAD" .
<Non-curative_first-line_therapy> <Context_of> "CTD" .
<Non-curative_first-line_therapy> <Context_of> "CRd" .
<Non-curative_first-line_therapy> <Context_of> "CPR" .
<Non-curative_first-line_therapy> <Context_of> "COPA" .
<Non-curative_first-line_therapy> <Context_of> "CMFT" .
<Non-curative_first-line_therapy> <Context_of> "CMF" .
<Non-curative_first-line_therapy> <Context_of> "CMC" .
<Non-curative_first-line_therapy> <Context_of> "CLF" .
<Non-curative_first-line_therapy> <Context_of> "CISCA" .
<Non-curative_first-line_therapy> <Context_of> "CHVP-I" .
<Non-curative_first-line_therapy> <Context_of> "CHVP" .
<Non-curative_first-line_therapy> <Context_of> "CHOP-B" .
<Non-curative_first-line_therapy> <Context_of> "CHOP,_then_131Iodine-Tositumomab" .
<Non-curative_first-line_therapy> <Context_of> "CHOP" .
<Non-curative_first-line_therapy> <Context_of> "CHAD" .
<Non-curative_first-line_therapy> <Context_of> "CFAR" .
<Non-curative_first-line_therapy> <Context_of> "CF_and_Trastuzumab" .
<Non-curative_first-line_therapy> <Context_of> "CEP" .
<Non-curative_first-line_therapy> <Context_of> "CCI" .
<Non-curative_first-line_therapy> <Context_of> "CC" .
<Non-curative_first-line_therapy> <Context_of> "CAPIRI-Bev" .
<Non-curative_first-line_therapy> <Context_of> "CAPIRI" .
<Non-curative_first-line_therapy> <Context_of> "CAP_(Platinol)" .
<Non-curative_first-line_therapy> <Context_of> "CAP" .
<Non-curative_first-line_therapy> <Context_of> "CAMP" .
<Non-curative_first-line_therapy> <Context_of> "CABO" .
<Non-curative_first-line_therapy> <Context_of> "C-VAMP" .
<Non-curative_first-line_therapy> <Context_of> "Bosutinib_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Bortezomib_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "BiRd" .
<Non-curative_first-line_therapy> <Context_of> "Bevacizumab_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Bevacizumab_and_Interferon_alfa-2a" .
<Non-curative_first-line_therapy> <Context_of> "Best_supportive_care" .
<Non-curative_first-line_therapy> <Context_of> "Bendamustine_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Bendamustine_and_Ofatumumab" .
<Non-curative_first-line_therapy> <Context_of> "Bendamustine_and_Obinutuzumab" .
<Non-curative_first-line_therapy> <Context_of> "BR" .
<Non-curative_first-line_therapy> <Context_of> "BDR" .
<Non-curative_first-line_therapy> <Context_of> "BBD" .
<Non-curative_first-line_therapy> <Context_of> "Azacitidine_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Azacitidine_and_Vorinostat" .
<Non-curative_first-line_therapy> <Context_of> "Azacitidine_and_Lenalidomide" .
<Non-curative_first-line_therapy> <Context_of> "Axitinib_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Axitinib_and_Pembrolizumab" .
<Non-curative_first-line_therapy> <Context_of> "Axitinib_and_Avelumab" .
<Non-curative_first-line_therapy> <Context_of> "Atezolizumab_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Atezolizumab_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "Aspirin_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Aspirin_and_Hydroxyurea" .
<Non-curative_first-line_therapy> <Context_of> "Aspirin_and_Anagrelide" .
<Non-curative_first-line_therapy> <Context_of> "Anastrozole_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Anastrozole_and_Trastuzumab" .
<Non-curative_first-line_therapy> <Context_of> "Anastrozole_and_Ribociclib" .
<Non-curative_first-line_therapy> <Context_of> "Anastrozole_and_Fulvestrant" .
<Non-curative_first-line_therapy> <Context_of> "Anagrelide_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Altretamine_and_Cisplatin" .
<Non-curative_first-line_therapy> <Context_of> "Alemtuzumab_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Alemtuzumab_and_Methylprednisolone" .
<Non-curative_first-line_therapy> <Context_of> "Ado-trastuzumab_emtansine_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "Abemaciclib_and_Letrozole" .
<Non-curative_first-line_therapy> <Context_of> "Abemaciclib_and_Anastrozole" .
<Non-curative_first-line_therapy> <Context_of> "ATG_(Rabbit)_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "ATG_(Horse)_monotherapy" .
<Non-curative_first-line_therapy> <Context_of> "ATG_(Horse)_and_Cyclosporine" .
<Non-curative_first-line_therapy> <Context_of> "AT_(Taxotere)" .
<Non-curative_first-line_therapy> <Context_of> "AT_(Taxol)" .
<Non-curative_first-line_therapy> <Context_of> "ADOC" .
<Non-curative_first-line_therapy> <Context_of> "ACH" .
<Non-curative_first-line_therapy> <Context_of> "AC_and_Bevacizumab" .
<Non-curative_first-line_therapy> <Context_of> "AC" .
<Non-curative_first-line_therapy> <Context_of> "ABCP" .
<Non-curative_first-line_therapy> <Context_of> "ABCM" .
<Non-curative_first-line_therapy> <Context_of> "131Iodine-Tositumomab_monotherapy" .
<Interferon_alfa-2a_and_Interleukin-2> <Has_context> "Non-curative_first-line_therapy" .
<R-FM> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Cyclosporine_and_Mycophenolate_mofetil> <Has_modality> "Immunosuppressive_therapy" .
<Steroid> <Is_a> "Immunosuppressant" .
<Steroid> <Is_a> "Emesis_prevention" .
<Septabid> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin,_Epirubicin,_Ifosfamide> <Is_current_in> "Osteosarcoma" .
<RhIG_monotherapy> <Mapped_from> "RhIG_monotherapy" .
<Methotrexate_and_Prednisone> <Mapped_from> "Methotrexate_and_Prednisone" .
<Neratinib_monotherapy> <Is_current_in> "ERBB3-mutated_malignancy" .
<Neratinib_monotherapy> <Is_current_in> "ERBB2-mutated_malignancy" .
<Neratinib_monotherapy> <Is_current_in> "Breast_cancer" .
<PD> <Has_context> "Non-curative_therapy" .
<Valrubicin_monotherapy> <Is_a> "Anthracycline-containing_regimen" .
<EOX> <Has_supportive_med> "Dexamethasone" .
<FEC_and_H> <Mapped_from> "FEC_and_H" .
<R-GemOx> <Has_antineoplastic> "Rituximab" .
<R-GemOx> <Has_antineoplastic> "Oxaliplatin" .
<R-GemOx> <Has_antineoplastic> "Gemcitabine" .
<Binimetinib> <Has_brand_name> "Mektovi" .
<Binimetinib> <Has_brand_name> "Braftovi" .
<Etoposide_and_Mitoxantrone> <Has_modality> "Chemotherapy" .
<Z-BEAM> <Maps_to> "Z-BEAM" .
<Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone> <Is_current_in> "CNS_lymphoma" .
<Binimetinib_and_Encorafenib> <Has_accepted_use> "Melanoma" .
<Binimetinib_and_Encorafenib> <Has_accepted_use> "BRAF-mutated_Melanoma" .
<Treosulfan_monotherapy> <Has_context> "Non-curative_therapy" .
<CAV_and_RT> <Has_antineoplastic> "Vincristine" .
<CAV_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<CAV_and_RT> <Has_antineoplastic> "Doxorubicin" .
<CAV_and_RT> <Has_antineoplastic> "Cyclophosphamide" .
<EVI> <Maps_to> "EVI" .
<Mebonat> <Brand_name_of> "Clodronate" .
<ECT,_then_auto_HSCT> <Is_historical_in> "Breast_cancer" .
<CODOX-M> <Is_current_in> "HIV-associated_lymphoma" .
<CODOX-M> <Is_current_in> "Burkitt_lymphoma" .
<ATRA,_Mercaptopurine,_Methotrexate> <Mapped_from> "ATRA,_Mercaptopurine,_Methotrexate" .
<Antithymocyte_globulin_horse_ATG> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Antithymocyte_globulin_horse_ATG> <Has_accepted_use> "Graft_versus_host_disease" .
<Antithymocyte_globulin_horse_ATG> <Has_accepted_use> "Aplastic_anemia" .
<FM> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<FM> <Has_supportive_med> "Allopurinol" .
<Binimetinib_and_Encorafenib> <Has_modality> "Chemotherapy" .
<Fluoxymesterone> <Antineoplastic_of> "Fluoxymesterone_monotherapy" .
<Longiprednil> <Brand_name_of> "Prednisolone" .
<Blinatumomab_monotherapy> <Has_context> "Non-curative_therapy" .
<Blinatumomab_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Blinatumomab_monotherapy> <Has_context> "Non-curative_subsequent-line_maintenance_therapy" .
<Blinatumomab_monotherapy> <Has_context> "Consolidation_after_upfront_therapy" .
<Irinotecan_and_Mitomycin> <Mapped_from> "Irinotecan_and_Mitomycin" .
<Etoposide_and_TBI,_then_allo_HSCT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Etoposide_and_TBI,_then_allo_HSCT> <Has_antineoplastic> "Etoposide" .
<Etoposide_and_TBI,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<Valcyte> <Brand_name_of> "Valganciclovir" .
<ERBB2_inhibitor> <Subsumes> "Neratinib" .
<ERBB2_inhibitor> <Subsumes> "Lapatinib" .
<ERBB2_inhibitor> <Subsumes> "Afatinib" .
<Venetoclax_and_Obinutuzumab> <Mapped_from> "Venetoclax_and_Obinutuzumab" .
<CMFT> <Maps_to> "CMFT" .
<CHVmP-VB> <Maps_to> "CHVmP-VB" .
<Dactinomycin_and_Vincristine> <Has_context> "All_lines_of_therapy" .
<AVD> <Has_accepted_use> "Hodgkin_lymphoma" .
<BiRd> <Has_context> "Non-curative_first-line_therapy" .
<Stanford_V> <Is_current_in> "Hodgkin_lymphoma" .
<Stanford_V> <Is_current_in> "HIV-associated_lymphoma" .
<Tekuron> <Brand_name_of> "Dexamethasone" .
<Nivolumab_monotherapy> <Has_context> "Non-curative_therapy" .
<Nivolumab_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Nivolumab_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Nivolumab_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Nivolumab_monotherapy> <Has_context> "Maintenance_after_salvage_therapy" .
<Nivolumab_monotherapy> <Has_context> "Adjuvant_therapy" .
<Teniposide> <Is_a> "Topoisomerase_inhibitor" .
<Teniposide> <Is_a> "Irritant" .
<Radioembolization> <Mapped_from> "Radioembolization" .
<Hexa-CAF> <Mapped_from> "Hexa-CAF" .
<Formestane_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Palonosetron> <Is_a> "Serotonin_5-HT3_antagonist" .
<Palonosetron> <Is_a> "Emesis_prevention" .
<Histrelin_monotherapy> <Mapped_from> "Histrelin_monotherapy" .
<Gemcitabine_monotherapy> <Has_modality> "Chemotherapy" .
<Liposarcoma> <Is_a> "Soft_tissue_sarcoma" .
<CHOP-14> <Has_local_therapy> "Prednisone" .
<CHOP-14> <Has_local_therapy> "Methotrexate" .
<CHOP-14> <Has_local_therapy> "Cytarabine" .
<CAPIRI-Bev> <Mapped_from> "CAPIRI-Bev" .
<Pemetrexed_monotherapy> <Has_context> "Non-curative_therapy" .
<Pemetrexed_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Pemetrexed_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Pemetrexed_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Pemetrexed_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Famciclovir> <Supportive_med_of> "CC" .
<Famciclovir> <Supportive_med_of> "Alemtuzumab_monotherapy" .
<IT_Cytarabine_and_Methotrexate> <Has_local_therapy> "Methotrexate" .
<IT_Cytarabine_and_Methotrexate> <Has_local_therapy> "Cytarabine" .
<Doxycycline_monotherapy> <Has_modality> "Antibiotic_therapy" .
<MPT> <Has_antineoplastic> "Thalidomide" .
<MPT> <Has_antineoplastic> "Prednisone" .
<MPT> <Has_antineoplastic> "Melphalan" .
<BeEAM,_then_auto_HSCT> <Maps_to> "BeEAM,_then_auto_HSCT" .
<COMP> <Has_context> "Induction_therapy" .
<Prednisone> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Prednisone> <Has_accepted_use> "Transformed_lymphoma" .
<Prednisone> <Has_accepted_use> "Thymoma" .
<Prednisone> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Prednisone> <Has_accepted_use> "Prostate_cancer" .
<Prednisone> <Has_accepted_use> "Primary_mediastinal_B-cell_lymphoma" .
<Prednisone> <Has_accepted_use> "Post-transplant_lymphoproliferative_disorder" .
<Prednisone> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Prednisone> <Has_accepted_use> "Myelofibrosis" .
<Prednisone> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Prednisone> <Has_accepted_use> "Multiple_myeloma" .
<Prednisone> <Has_accepted_use> "Mediastinal_gray-zone_lymphoma" .
<Prednisone> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Prednisone> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Prednisone> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Prednisone> <Has_accepted_use> "Large_granular_lymphocytic_leukemia" .
<Prednisone> <Has_accepted_use> "Langerhans_cell_histiocytosis" .
<Prednisone> <Has_accepted_use> "Immune_thrombocytopenia" .
<Prednisone> <Has_accepted_use> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<Prednisone> <Has_accepted_use> "Hodgkin_lymphoma" .
<Prednisone> <Has_accepted_use> "HIV-associated_lymphoma" .
<Prednisone> <Has_accepted_use> "Follicular_lymphoma" .
<Prednisone> <Has_accepted_use> "Erdheim-Chester_disease" .
<Prednisone> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Prednisone> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Prednisone> <Has_accepted_use> "Burkitt_lymphoma" .
<Prednisone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Prednisone> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<Prednisone> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<Prednisone> <Has_accepted_use> "Acquired_coagulopathy" .
<CMF> <Has_antineoplastic> "Methotrexate" .
<CMF> <Has_antineoplastic> "Fluorouracil" .
<CMF> <Has_antineoplastic> "Cyclophosphamide" .
<Melon> <Brand_name_of> "Methylprednisolone" .
<Cimetidine> <May_have_route> "Oral" .
<Gemcitabine_and_Vinorelbine> <Is_current_in> "Soft_tissue_sarcoma" .
<Gemcitabine_and_Vinorelbine> <Is_current_in> "Non-small_cell_lung_cancer" .
<Gemcitabine_and_Vinorelbine> <Is_current_in> "Mesothelioma" .
<Cotrimaxazole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<FLEP> <Has_accepted_use> "Esophageal_cancer" .
<Darbepoetin_alfa> <Is_a> "Hematopoietic_growth_factor" .
<Darbepoetin_alfa> <Is_a> "Erythrocyte_growth_factor" .
<Octreotide_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Octreotide_monotherapy> <Has_context> "All_lines_of_therapy" .
<Histiocytoses_medication> <Is_a> "Malignant_hematology_medication" .
<Catalgine> <Brand_name_of> "Aspirin" .
<Anastrozole_and_Palbociclib> <Is_a> "Antiestrogen-containing_regimen" .
<Mercaptopurine_and_Methotrexate> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<Anastrozole_monotherapy> <Is_current_in> "Endometrial_cancer" .
<Anastrozole_monotherapy> <Is_current_in> "Breast_cancer" .
<Peginterferon_alfa-2a_monotherapy> <Has_context> "Non-curative_therapy" .
<Peginterferon_alfa-2a_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Peginterferon_alfa-2a_monotherapy> <Has_context> "Induction_therapy" .
<Peginterferon_alfa-2a_monotherapy> <Has_context> "All_lines_of_therapy" .
<Octreotide_and_Interferon_alfa> <Has_modality> "Immunotherapy" .
<Octreotide_and_Interferon_alfa> <Has_modality> "Hormonotherapy" .
<Warfarin> <Has_brand_name> "Werifrin" .
<Warfarin> <Has_brand_name> "Warnerin" .
<Warfarin> <Has_brand_name> "Warlin" .
<Warfarin> <Has_brand_name> "Warin" .
<Warfarin> <Has_brand_name> "Warfin" .
<Warfarin> <Has_brand_name> "Warfilone" .
<Warfarin> <Has_brand_name> "Warfil" .
<Warfarin> <Has_brand_name> "Warfarex" .
<Warfarin> <Has_brand_name> "Warfar" .
<Warfarin> <Has_brand_name> "Warfant" .
<Warfarin> <Has_brand_name> "Warfa" .
<Warfarin> <Has_brand_name> "Warf" .
<Warfarin> <Has_brand_name> "Waran" .
<Warfarin> <Has_brand_name> "Varfine" .
<Warfarin> <Has_brand_name> "Varfarins" .
<Warfarin> <Has_brand_name> "Tedicumar" .
<Warfarin> <Has_brand_name> "Simarc" .
<Warfarin> <Has_brand_name> "Samofaron" .
<Warfarin> <Has_brand_name> "Romesa" .
<Warfarin> <Has_brand_name> "Panwarfine" .
<Warfarin> <Has_brand_name> "Panwarfin" .
<Warfarin> <Has_brand_name> "Orfarin" .
<Warfarin> <Has_brand_name> "Marivarin" .
<Warfarin> <Has_brand_name> "Marivanil" .
<Warfarin> <Has_brand_name> "Marfarin" .
<Warfarin> <Has_brand_name> "Maforan" .
<Warfarin> <Has_brand_name> "Lawarin" .
<Warfarin> <Has_brand_name> "Kovar" .
<Warfarin> <Has_brand_name> "Jantoven" .
<Warfarin> <Has_brand_name> "Haemofarin" .
<Warfarin> <Has_brand_name> "Fericard" .
<Warfarin> <Has_brand_name> "Ferevan" .
<Warfarin> <Has_brand_name> "Farin" .
<Warfarin> <Has_brand_name> "Dagonal" .
<Warfarin> <Has_brand_name> "Couparin" .
<Warfarin> <Has_brand_name> "Coumadine" .
<Warfarin> <Has_brand_name> "Coumadin" .
<Warfarin> <Has_brand_name> "Circuvit" .
<Warfarin> <Has_brand_name> "Cicoxil" .
<Warfarin> <Has_brand_name> "Caumadin" .
<Warfarin> <Has_brand_name> "Befarin" .
<Warfarin> <Has_brand_name> "Athrombin-K" .
<Warfarin> <Has_brand_name> "Arefarin" .
<Warfarin> <Has_brand_name> "Anticoag" .
<Warfarin> <Has_brand_name> "Anasmol" .
<Warfarin> <Has_brand_name> "Aldocumar" .
<FOLFOX> <Has_context> "Non-curative_therapy" .
<FOLFOX> <Has_context> "Adjuvant_therapy" .
<Irinotecan_and_Temozolomide> <Mapped_from> "Irinotecan_and_Temozolomide" .
<VAMP> <Is_historical_in> "Multiple_myeloma" .
<MINE> <Has_context> "Salvage_therapy" .
<MINE> <Has_context> "Non-curative_therapy" .
<FEC_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<R-CHOP_(Rituximab_Hycela)> <Maps_to> "R-CHOP_(Rituximab_Hycela)" .
<Dacarbazine_and_Gemcitabine> <Has_context> "Non-curative_therapy" .
<OXAFAFU> <Has_accepted_use> "Colon_cancer" .
<Cannabinoid> <Is_a> "Emesis_prevention" .
<Cannabinoid> <Is_a> "Appetite_stimulant" .
<Vanderm> <Brand_name_of> "Methylprednisolone" .
<BVDS> <Has_modality> "Chemotherapy" .
<Bivalirudin_monotherapy> <Is_current_in> "Venous_thromboembolism" .
<Methotrexate_and_Vincristine> <Has_context> "Maintenance_after_upfront_therapy" .
<Methotrexate_and_Vincristine> <Has_context> "Adjuvant_therapy" .
<Bleomycin,_Methotrexate,_Vinblastine/RT> <Maps_to> "Bleomycin,_Methotrexate,_Vinblastine/RT" .
<Anastrozole_and_Palbociclib> <Has_context> "Neoadjuvant_therapy" .
<Bexarotene_and_Pralatrexate> <Has_modality> "Chemotherapy" .
<PVeBV> <Has_context> "Upfront_therapy" .
<5_plus_3i> <Has_antineoplastic> "Idarubicin" .
<5_plus_3i> <Has_antineoplastic> "Cytarabine" .
<Ruxolitinib_monotherapy> <Is_current_in> "Polycythemia_vera" .
<Ruxolitinib_monotherapy> <Is_current_in> "Myelofibrosis" .
<Ruxolitinib_monotherapy> <Is_current_in> "Hypereosinophilic_syndrome" .
<Ruxolitinib_monotherapy> <Is_current_in> "Essential_thrombocythemia" .
<Ruxolitinib_monotherapy> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Ruxolitinib_monotherapy> <Is_current_in> "Acute_myeloid_leukemia" .
<FEC_and_Bevacizumab> <Is_current_in> "Breast_cancer" .
<JAK_inhibitor> <Is_a> "Kinase_inhibitor" .
<MCF> <Mapped_from> "MCF" .
<Proton_pump_inhibitors> <Supportive_med_of> "VDC" .
<Proton_pump_inhibitors> <Supportive_med_of> "VD" .
<Proton_pump_inhibitors> <Supportive_med_of> "TD" .
<Proton_pump_inhibitors> <Supportive_med_of> "Rd" .
<Proton_pump_inhibitors> <Supportive_med_of> "MRD" .
<Proton_pump_inhibitors> <Supportive_med_of> "M-DEX" .
<Proton_pump_inhibitors> <Supportive_med_of> "KRd" .
<Proton_pump_inhibitors> <Supportive_med_of> "Gemcitabine,_Cetuximab,_RT" .
<Proton_pump_inhibitors> <Supportive_med_of> "Docetaxel,_Gemcitabine,_RT" .
<Proton_pump_inhibitors> <Supportive_med_of> "Dacarbazine_monotherapy" .
<Proton_pump_inhibitors> <Supportive_med_of> "CTD" .
<Proton_pump_inhibitors> <Supportive_med_of> "CRd" .
<Proton_pump_inhibitors> <Supportive_med_of> "BLD" .
<No_neoadjuvant_therapy> <Maps_to> "No_neoadjuvant_therapy" .
<Stimate> <Brand_name_of> "Desmopressin" .
<Busulfan_and_Melphalan,_then_auto_HSCT> <Maps_to> "Busulfan_and_Melphalan,_then_auto_HSCT" .
<Cyanocobalamin> <Has_brand_name> "Twelve_Resin-K" .
<Cyanocobalamin> <Has_brand_name> "Nascobal" .
<Cyanocobalamin> <Has_brand_name> "Ener-B" .
<Cyanocobalamin> <Has_brand_name> "Cobavite" .
<Cyanocobalamin> <Has_brand_name> "CaloMist" .
<Cyanocobalamin> <Has_brand_name> "Berubigen" .
<Dutasteride> <May_have_route> "Oral" .
<ATG_(Rabbit)_and_Cyclosporine> <Has_supportive_med> "Valacyclovir" .
<ATG_(Rabbit)_and_Cyclosporine> <Has_supportive_med> "Pentamidine" .
<MCP> <Has_modality> "Chemotherapy" .
<Lanreotide_monotherapy> <Maps_to> "Lanreotide_monotherapy" .
<Acivirax> <Brand_name_of> "Acyclovir" .
<FND> <Is_historical_in> "Follicular_lymphoma" .
<Sitrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Brilique> <Brand_name_of> "Ticagrelor" .
<Anti-KIR_antibody> <Is_a> "Antibody_medication" .
<Mycophenolate_mofetil> <Has_accepted_use> "Immune_thrombocytopenia" .
<Aminoglutethimide_monotherapy> <Has_modality> "Hormonotherapy" .
<Rivasa> <Brand_name_of> "Aspirin" .
<Cisplatin_and_Dacarbazine> <Is_current_in> "Melanoma" .
<Cyclosporine,_Methotrexate,_Prednisone> <Has_context> "Prophylaxis" .
<All_lines_of_therapy> <Maps_to> "All_lines_of_therapy" .
<Copanlisib> <Has_accepted_use> "Follicular_lymphoma" .
<HLH-2004_regimen> <Has_modality> "Immunosuppressive_therapy" .
<Apixaban> <Has_FDA_indication> "Venous_thromboembolism" .
<Gastrointestinal_oncology_medication> <Is_a> "Site-specific_medication" .
<Chemotherapy> <Modality_of> "nab-Paclitaxel_monotherapy" .
<Chemotherapy> <Modality_of> "nab-Paclitaxel_and_Trastuzumab" .
<Chemotherapy> <Modality_of> "nab-Paclitaxel_and_Atezolizumab" .
<Chemotherapy> <Modality_of> "maxi-R-CHOP/R-HiDAC" .
<Chemotherapy> <Modality_of> "mLSG15" .
<Chemotherapy> <Modality_of> "mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)" .
<Chemotherapy> <Modality_of> "mFOLFOX7_(L-Leucovorin)" .
<Chemotherapy> <Modality_of> "mFOLFOX7" .
<Chemotherapy> <Modality_of> "mFOLFOX6_and_RT" .
<Chemotherapy> <Modality_of> "mFOLFOX6_and_Cetuximab" .
<Chemotherapy> <Modality_of> "mFOLFOX6_and_Bevacizumab_(L-Leucovorin)" .
<Chemotherapy> <Modality_of> "mFOLFOX6_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "mFOLFOX6_(L-Leucovorin)" .
<Chemotherapy> <Modality_of> "mFOLFOX6" .
<Chemotherapy> <Modality_of> "mFOLFOX_and_Sorafenib" .
<Chemotherapy> <Modality_of> "mFOLFIRINOX,_Gemcitabine,_RT" .
<Chemotherapy> <Modality_of> "mFOLFIRINOX" .
<Chemotherapy> <Modality_of> "mDCF_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "mDCF" .
<Chemotherapy> <Modality_of> "mCOP/MP" .
<Chemotherapy> <Modality_of> "m-BNCOD" .
<Chemotherapy> <Modality_of> "m-BACOD" .
<Chemotherapy> <Modality_of> "iddEPC" .
<Chemotherapy> <Modality_of> "eBEACOPP_(Prednisolone)" .
<Chemotherapy> <Modality_of> "eBEACOPP" .
<Chemotherapy> <Modality_of> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Chemotherapy> <Modality_of> "dmCODOX-M_-_Modified_Magrath" .
<Chemotherapy> <Modality_of> "ddTH_(Taxotere)" .
<Chemotherapy> <Modality_of> "ddTH_(Taxol)" .
<Chemotherapy> <Modality_of> "ddT_(Taxotere)" .
<Chemotherapy> <Modality_of> "ddFEC" .
<Chemotherapy> <Modality_of> "ddEC" .
<Chemotherapy> <Modality_of> "ddE" .
<Chemotherapy> <Modality_of> "ddC" .
<Chemotherapy> <Modality_of> "ddAC-T" .
<Chemotherapy> <Modality_of> "ddAC" .
<Chemotherapy> <Modality_of> "ddA" .
<Chemotherapy> <Modality_of> "Zanubrutinib_monotherapy" .
<Chemotherapy> <Modality_of> "ZRd" .
<Chemotherapy> <Modality_of> "Vosaroxin_and_Cytarabine" .
<Chemotherapy> <Modality_of> "Vorinostat_monotherapy" .
<Chemotherapy> <Modality_of> "Vorinostat_and_Rituximab" .
<Chemotherapy> <Modality_of> "Vismodegib_monotherapy" .
<Chemotherapy> <Modality_of> "Vinorelbine_monotherapy" .
<Chemotherapy> <Modality_of> "Vinorelbine_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "Vinflunine_monotherapy" .
<Chemotherapy> <Modality_of> "Vindesine_monotherapy" .
<Chemotherapy> <Modality_of> "Vincristine_monotherapy" .
<Chemotherapy> <Modality_of> "Vincristine_liposomal_monotherapy" .
<Chemotherapy> <Modality_of> "Vincristine_and_Prednisone" .
<Chemotherapy> <Modality_of> "Vinblastine_monotherapy" .
<Chemotherapy> <Modality_of> "Vinblastine_and_Prednisone" .
<Chemotherapy> <Modality_of> "Venetoclax_monotherapy" .
<Chemotherapy> <Modality_of> "Venetoclax_and_Rituximab" .
<Chemotherapy> <Modality_of> "Venetoclax_and_Obinutuzumab" .
<Chemotherapy> <Modality_of> "Vemurafenib_monotherapy" .
<Chemotherapy> <Modality_of> "VeIP" .
<Chemotherapy> <Modality_of> "VcR-CVAD" .
<Chemotherapy> <Modality_of> "Vandetanib_monotherapy" .
<Chemotherapy> <Modality_of> "Valrubicin_monotherapy" .
<Chemotherapy> <Modality_of> "VTP" .
<Chemotherapy> <Modality_of> "VTD-PACE" .
<Chemotherapy> <Modality_of> "VTD" .
<Chemotherapy> <Modality_of> "VT" .
<Chemotherapy> <Modality_of> "VR-CP" .
<Chemotherapy> <Modality_of> "VR-CHOP" .
<Chemotherapy> <Modality_of> "VR-CAP" .
<Chemotherapy> <Modality_of> "VR" .
<Chemotherapy> <Modality_of> "VP" .
<Chemotherapy> <Modality_of> "VNCOP-B" .
<Chemotherapy> <Modality_of> "VMV-VAC" .
<Chemotherapy> <Modality_of> "VMPT" .
<Chemotherapy> <Modality_of> "VMP/Rd" .
<Chemotherapy> <Modality_of> "VMP,_then_Rd" .
<Chemotherapy> <Modality_of> "VMP" .
<Chemotherapy> <Modality_of> "VMD" .
<Chemotherapy> <Modality_of> "VMCP/VCAP" .
<Chemotherapy> <Modality_of> "VMCP/VBAP" .
<Chemotherapy> <Modality_of> "VMCP" .
<Chemotherapy> <Modality_of> "VIPD" .
<Chemotherapy> <Modality_of> "VIP" .
<Chemotherapy> <Modality_of> "VIM" .
<Chemotherapy> <Modality_of> "VIE" .
<Chemotherapy> <Modality_of> "VIDE" .
<Chemotherapy> <Modality_of> "VI,_then_VDC/IE,_then_VAC,_then_VI" .
<Chemotherapy> <Modality_of> "VH" .
<Chemotherapy> <Modality_of> "VEPEMB" .
<Chemotherapy> <Modality_of> "VEPA" .
<Chemotherapy> <Modality_of> "VEBEP" .
<Chemotherapy> <Modality_of> "VDC/IE" .
<Chemotherapy> <Modality_of> "VDC" .
<Chemotherapy> <Modality_of> "VD" .
<Chemotherapy> <Modality_of> "VCP" .
<Chemotherapy> <Modality_of> "VCAP" .
<Chemotherapy> <Modality_of> "VBMCP/VBAD" .
<Chemotherapy> <Modality_of> "VBMCP" .
<Chemotherapy> <Modality_of> "VBMC" .
<Chemotherapy> <Modality_of> "VBM" .
<Chemotherapy> <Modality_of> "VAdCA/IE" .
<Chemotherapy> <Modality_of> "VAdCA" .
<Chemotherapy> <Modality_of> "VAP" .
<Chemotherapy> <Modality_of> "VAMP_(Methotrexate)" .
<Chemotherapy> <Modality_of> "VAMP_(Amethopterin)" .
<Chemotherapy> <Modality_of> "VAMP" .
<Chemotherapy> <Modality_of> "VAIA" .
<Chemotherapy> <Modality_of> "VAI" .
<Chemotherapy> <Modality_of> "VAD-P/Q" .
<Chemotherapy> <Modality_of> "VAD-P" .
<Chemotherapy> <Modality_of> "VAD_plus_C" .
<Chemotherapy> <Modality_of> "VAD_doxil" .
<Chemotherapy> <Modality_of> "VAD_and_Cyclosporine" .
<Chemotherapy> <Modality_of> "VAD" .
<Chemotherapy> <Modality_of> "VACOP-B" .
<Chemotherapy> <Modality_of> "VACA/IE" .
<Chemotherapy> <Modality_of> "VACA" .
<Chemotherapy> <Modality_of> "VAC_(Adriamycin)" .
<Chemotherapy> <Modality_of> "VAC" .
<Chemotherapy> <Modality_of> "VABE" .
<Chemotherapy> <Modality_of> "VAB-6" .
<Chemotherapy> <Modality_of> "VA" .
<Chemotherapy> <Modality_of> "V-HyperCAD" .
<Chemotherapy> <Modality_of> "Uracil_mustard_monotherapy" .
<Chemotherapy> <Modality_of> "UFTM" .
<Chemotherapy> <Modality_of> "UFT_monotherapy" .
<Chemotherapy> <Modality_of> "Trifluridine_and_tipiracil_monotherapy" .
<Chemotherapy> <Modality_of> "Treosulfan_monotherapy" .
<Chemotherapy> <Modality_of> "Trastuzumab_monotherapy" .
<Chemotherapy> <Modality_of> "Trastuzumab_and_hyaluronidase_monotherapy" .
<Chemotherapy> <Modality_of> "Trastuzumab_and_ET" .
<Chemotherapy> <Modality_of> "Trametinib_monotherapy" .
<Chemotherapy> <Modality_of> "Trabectedin_monotherapy" .
<Chemotherapy> <Modality_of> "Total_Therapy" .
<Chemotherapy> <Modality_of> "Topotecan_monotherapy" .
<Chemotherapy> <Modality_of> "Topotecan_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "Thiotepa_monotherapy" .
<Chemotherapy> <Modality_of> "Thioguanine_monotherapy" .
<Chemotherapy> <Modality_of> "Thalidomide_monotherapy" .
<Chemotherapy> <Modality_of> "Thalidomide_and_Rituximab" .
<Chemotherapy> <Modality_of> "Thalidomide_and_Prednisone" .
<Chemotherapy> <Modality_of> "Thalidomide_and_Prednisolone" .
<Chemotherapy> <Modality_of> "Teniposide_monotherapy" .
<Chemotherapy> <Modality_of> "Teniposide_and_WBRT" .
<Chemotherapy> <Modality_of> "Temsirolimus_monotherapy" .
<Chemotherapy> <Modality_of> "Temsirolimus_and_Rituximab" .
<Chemotherapy> <Modality_of> "Temozolomide,_then_Temozolomide_and_RT,_then_Temozolomide" .
<Chemotherapy> <Modality_of> "Temozolomide_monotherapy" .
<Chemotherapy> <Modality_of> "Temozolomide_and_low-dose_RT" .
<Chemotherapy> <Modality_of> "Temozolomide_and_Thalidomide" .
<Chemotherapy> <Modality_of> "Temozolomide_and_RT,_then_Temozolomide" .
<Chemotherapy> <Modality_of> "Temozolomide_and_RT" .
<Chemotherapy> <Modality_of> "Temozolomide_and_NovoTTF-100A" .
<Chemotherapy> <Modality_of> "Temozolomide_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "Tegafur,_Uracil,_Folinic_acid" .
<Chemotherapy> <Modality_of> "Tegafur_and_Uracil" .
<Chemotherapy> <Modality_of> "Tazemetostat_monotherapy" .
<Chemotherapy> <Modality_of> "Tandem_melphalan,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "Tamibarotene_monotherapy" .
<Chemotherapy> <Modality_of> "Talazoparib_monotherapy" .
<Chemotherapy> <Modality_of> "Tagraxofusp_monotherapy" .
<Chemotherapy> <Modality_of> "TX_(Taxotere)" .
<Chemotherapy> <Modality_of> "TVAD_doxil" .
<Chemotherapy> <Modality_of> "TTR" .
<Chemotherapy> <Modality_of> "TPC" .
<Chemotherapy> <Modality_of> "TMF" .
<Chemotherapy> <Modality_of> "TL_(Taxol)" .
<Chemotherapy> <Modality_of> "TIP" .
<Chemotherapy> <Modality_of> "THP_(Taxotere)" .
<Chemotherapy> <Modality_of> "THP_(Taxol)" .
<Chemotherapy> <Modality_of> "THL_(Taxol)" .
<Chemotherapy> <Modality_of> "TH_(Taxotere/SC)" .
<Chemotherapy> <Modality_of> "TH_(Taxotere)" .
<Chemotherapy> <Modality_of> "TH_(Taxol)" .
<Chemotherapy> <Modality_of> "TFC,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "TD" .
<Chemotherapy> <Modality_of> "TCP" .
<Chemotherapy> <Modality_of> "TCHP_(Taxotere)" .
<Chemotherapy> <Modality_of> "TCHP_(Taxol)" .
<Chemotherapy> <Modality_of> "TCH_(Taxotere,_Cyclophosphamide)" .
<Chemotherapy> <Modality_of> "TCH_(Taxotere,_Carboplatin)" .
<Chemotherapy> <Modality_of> "TC,_then_IE,_VDoxoC,_VEC" .
<Chemotherapy> <Modality_of> "TC_and_Nintedanib" .
<Chemotherapy> <Modality_of> "TC_(Taxotere)" .
<Chemotherapy> <Modality_of> "TAM6,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "TAM6" .
<Chemotherapy> <Modality_of> "TAD_(Thalidomide)" .
<Chemotherapy> <Modality_of> "TACE,_then_5-FU" .
<Chemotherapy> <Modality_of> "TACE" .
<Chemotherapy> <Modality_of> "TAC_(Taxotere)" .
<Chemotherapy> <Modality_of> "T-DM1_and_ET" .
<Chemotherapy> <Modality_of> "Sunitinib_monotherapy" .
<Chemotherapy> <Modality_of> "Stanford_V" .
<Chemotherapy> <Modality_of> "Sorafenib_monotherapy" .
<Chemotherapy> <Modality_of> "Sonidegib_monotherapy" .
<Chemotherapy> <Modality_of> "Sirolimus_and_Vorinostat" .
<Chemotherapy> <Modality_of> "Selinexor_and_Dexamethasone" .
<Chemotherapy> <Modality_of> "STAMP-I" .
<Chemotherapy> <Modality_of> "SOX_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "SOX" .
<Chemotherapy> <Modality_of> "SMILE" .
<Chemotherapy> <Modality_of> "SHAI" .
<Chemotherapy> <Modality_of> "SCAB" .
<Chemotherapy> <Modality_of> "SC-EPOCH-RR" .
<Chemotherapy> <Modality_of> "S-1_monotherapy" .
<Chemotherapy> <Modality_of> "Ruxolitinib_monotherapy" .
<Chemotherapy> <Modality_of> "Rucaparib_monotherapy" .
<Chemotherapy> <Modality_of> "Romidepsin_monotherapy" .
<Chemotherapy> <Modality_of> "Rituximab_monotherapy" .
<Chemotherapy> <Modality_of> "Rituximab_and_hyaluronidase_monotherapy" .
<Chemotherapy> <Modality_of> "Ribociclib_and_Tamoxifen" .
<Chemotherapy> <Modality_of> "RiPAD_plus_C" .
<Chemotherapy> <Modality_of> "Regorafenib_monotherapy" .
<Chemotherapy> <Modality_of> "Rd" .
<Chemotherapy> <Modality_of> "Ramucirumab_monotherapy" .
<Chemotherapy> <Modality_of> "Radotinib_monotherapy" .
<Chemotherapy> <Modality_of> "RVR" .
<Chemotherapy> <Modality_of> "RVDC" .
<Chemotherapy> <Modality_of> "RVD" .
<Chemotherapy> <Modality_of> "RT-PEPC" .
<Chemotherapy> <Modality_of> "RT,_then_Temozolomide" .
<Chemotherapy> <Modality_of> "RT,_then_Carmustine" .
<Chemotherapy> <Modality_of> "RP" .
<Chemotherapy> <Modality_of> "RICER" .
<Chemotherapy> <Modality_of> "RD" .
<Chemotherapy> <Modality_of> "RCC" .
<Chemotherapy> <Modality_of> "RABVD" .
<Chemotherapy> <Modality_of> "R2CHOP" .
<Chemotherapy> <Modality_of> "R-miniCHOP" .
<Chemotherapy> <Modality_of> "R-miniCEOP" .
<Chemotherapy> <Modality_of> "R-VAD_plus_C" .
<Chemotherapy> <Modality_of> "R-TBI/Cy,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "R-TBI/Cy" .
<Chemotherapy> <Modality_of> "R-NIMP" .
<Chemotherapy> <Modality_of> "R-MegaCHOP-14" .
<Chemotherapy> <Modality_of> "R-MegaCHOP" .
<Chemotherapy> <Modality_of> "R-MPV" .
<Chemotherapy> <Modality_of> "R-MP" .
<Chemotherapy> <Modality_of> "R-MCP_(CCNU)" .
<Chemotherapy> <Modality_of> "R-MCP" .
<Chemotherapy> <Modality_of> "R-MACLO/R-IVAM" .
<Chemotherapy> <Modality_of> "R-M-CHOP" .
<Chemotherapy> <Modality_of> "R-INO" .
<Chemotherapy> <Modality_of> "R-IFE" .
<Chemotherapy> <Modality_of> "R-ICE" .
<Chemotherapy> <Modality_of> "R-Hyper-CVAD/R-MA" .
<Chemotherapy> <Modality_of> "R-HiDAC" .
<Chemotherapy> <Modality_of> "R-GemOx" .
<Chemotherapy> <Modality_of> "R-GDP" .
<Chemotherapy> <Modality_of> "R-GCVP" .
<Chemotherapy> <Modality_of> "R-FND" .
<Chemotherapy> <Modality_of> "R-FM" .
<Chemotherapy> <Modality_of> "R-FCM" .
<Chemotherapy> <Modality_of> "R-ESHAP" .
<Chemotherapy> <Modality_of> "R-EPOCH,_dose-escalated" .
<Chemotherapy> <Modality_of> "R-EPOCH" .
<Chemotherapy> <Modality_of> "R-DexaBEAM" .
<Chemotherapy> <Modality_of> "R-DHAP/R-VIM" .
<Chemotherapy> <Modality_of> "R-DHAP" .
<Chemotherapy> <Modality_of> "R-DHAOx" .
<Chemotherapy> <Modality_of> "R-DHAC" .
<Chemotherapy> <Modality_of> "R-CVP" .
<Chemotherapy> <Modality_of> "R-CVEP" .
<Chemotherapy> <Modality_of> "R-CP" .
<Chemotherapy> <Modality_of> "R-COPADM" .
<Chemotherapy> <Modality_of> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Chemotherapy> <Modality_of> "R-CODOX-M/R-IVAC" .
<Chemotherapy> <Modality_of> "R-CODOX-M_(Doxil_substituted)" .
<Chemotherapy> <Modality_of> "R-CODOX-M" .
<Chemotherapy> <Modality_of> "R-CMD" .
<Chemotherapy> <Modality_of> "R-CHVP_plus_I" .
<Chemotherapy> <Modality_of> "R-CHOP/R-DHAP" .
<Chemotherapy> <Modality_of> "R-CHOP-14_(Rituximab_Hycela)" .
<Chemotherapy> <Modality_of> "R-CHOP-14_(Prednisolone)" .
<Chemotherapy> <Modality_of> "R-CHOP-14" .
<Chemotherapy> <Modality_of> "R-CHOP_(Rituximab_Hycela)" .
<Chemotherapy> <Modality_of> "R-CHOP_(Prednisolone)" .
<Chemotherapy> <Modality_of> "R-CHOP" .
<Chemotherapy> <Modality_of> "R-CHOEP-14" .
<Chemotherapy> <Modality_of> "R-CHMP" .
<Chemotherapy> <Modality_of> "R-CEOP90_(Epirubicin)" .
<Chemotherapy> <Modality_of> "R-CEOP_(Etoposide)" .
<Chemotherapy> <Modality_of> "R-CDOP" .
<Chemotherapy> <Modality_of> "R-BL" .
<Chemotherapy> <Modality_of> "R-BEAM,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "R-BEAM" .
<Chemotherapy> <Modality_of> "R-BAC" .
<Chemotherapy> <Modality_of> "R,_then_CHOP" .
<Chemotherapy> <Modality_of> "Quizartinib_monotherapy" .
<Chemotherapy> <Modality_of> "Procarbazine_monotherapy" .
<Chemotherapy> <Modality_of> "ProMACE-MOPP" .
<Chemotherapy> <Modality_of> "ProMACE-CytaBOM" .
<Chemotherapy> <Modality_of> "Prednisone_monotherapy" .
<Chemotherapy> <Modality_of> "Prednisolone_monotherapy" .
<Chemotherapy> <Modality_of> "Pralatrexate_monotherapy" .
<Chemotherapy> <Modality_of> "Ponatinib_monotherapy" .
<Chemotherapy> <Modality_of> "Pomalidomide,_Dexamethasone,_Pembrolizumab" .
<Chemotherapy> <Modality_of> "Pomalidomide_monotherapy" .
<Chemotherapy> <Modality_of> "Pomalidomide_and_Prednisone" .
<Chemotherapy> <Modality_of> "Plicamycin_monotherapy" .
<Chemotherapy> <Modality_of> "Pixantrone_monotherapy" .
<Chemotherapy> <Modality_of> "Pirarubicin_monotherapy" .
<Chemotherapy> <Modality_of> "Pipobroman_monotherapy" .
<Chemotherapy> <Modality_of> "Pertuzumab_and_Trastuzumab" .
<Chemotherapy> <Modality_of> "Pertuzumab_and_T-DM1" .
<Chemotherapy> <Modality_of> "Pentostatin_monotherapy" .
<Chemotherapy> <Modality_of> "Pentostatin_and_Alemtuzumab" .
<Chemotherapy> <Modality_of> "Pemetrexed_monotherapy" .
<Chemotherapy> <Modality_of> "Pemetrexed_and_Pembrolizumab" .
<Chemotherapy> <Modality_of> "Pemetrexed_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "Pegaspargase,_Vincristine,_Prednisone" .
<Chemotherapy> <Modality_of> "Pediatric-like_GRAALL_consolidation" .
<Chemotherapy> <Modality_of> "Pd" .
<Chemotherapy> <Modality_of> "Pazopanib_monotherapy" .
<Chemotherapy> <Modality_of> "Panobinostat_monotherapy" .
<Chemotherapy> <Modality_of> "Panobinostat_and_Rituximab" .
<Chemotherapy> <Modality_of> "Panitumumab_monotherapy" .
<Chemotherapy> <Modality_of> "Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "Paclitaxel,_Topotecan,_Bevacizumab" .
<Chemotherapy> <Modality_of> "Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine" .
<Chemotherapy> <Modality_of> "Paclitaxel_monotherapy" .
<Chemotherapy> <Modality_of> "Paclitaxel_and_Vinorelbine" .
<Chemotherapy> <Modality_of> "Paclitaxel_and_Topotecan" .
<Chemotherapy> <Modality_of> "Paclitaxel_and_S-1" .
<Chemotherapy> <Modality_of> "Paclitaxel_and_Ramucirumab" .
<Chemotherapy> <Modality_of> "Paclitaxel_and_RT" .
<Chemotherapy> <Modality_of> "Paclitaxel_and_Pazopanib" .
<Chemotherapy> <Modality_of> "Paclitaxel_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "PVeBV" .
<Chemotherapy> <Modality_of> "PVD" .
<Chemotherapy> <Modality_of> "PVAG" .
<Chemotherapy> <Modality_of> "PUVA" .
<Chemotherapy> <Modality_of> "POMP" .
<Chemotherapy> <Modality_of> "PMitCEBO" .
<Chemotherapy> <Modality_of> "PGC" .
<Chemotherapy> <Modality_of> "PFT" .
<Chemotherapy> <Modality_of> "PF" .
<Chemotherapy> <Modality_of> "PEV" .
<Chemotherapy> <Modality_of> "PET" .
<Chemotherapy> <Modality_of> "PEP-C" .
<Chemotherapy> <Modality_of> "PEN" .
<Chemotherapy> <Modality_of> "PEFG" .
<Chemotherapy> <Modality_of> "PD" .
<Chemotherapy> <Modality_of> "PCV" .
<Chemotherapy> <Modality_of> "PCR" .
<Chemotherapy> <Modality_of> "PCP" .
<Chemotherapy> <Modality_of> "PCO" .
<Chemotherapy> <Modality_of> "PCF" .
<Chemotherapy> <Modality_of> "PCE" .
<Chemotherapy> <Modality_of> "PCDE" .
<Chemotherapy> <Modality_of> "PCD" .
<Chemotherapy> <Modality_of> "PATCO" .
<Chemotherapy> <Modality_of> "PAF" .
<Chemotherapy> <Modality_of> "PAD/VCD" .
<Chemotherapy> <Modality_of> "PAD_doxil" .
<Chemotherapy> <Modality_of> "PAD" .
<Chemotherapy> <Modality_of> "PACEBOM" .
<Chemotherapy> <Modality_of> "PAC" .
<Chemotherapy> <Modality_of> "P/DOCE" .
<Chemotherapy> <Modality_of> "Oxaliplatin_monotherapy" .
<Chemotherapy> <Modality_of> "Oxaliplatin_and_RT" .
<Chemotherapy> <Modality_of> "Oxaliplatin_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "Ox-P" .
<Chemotherapy> <Modality_of> "Osimertinib_monotherapy" .
<Chemotherapy> <Modality_of> "Omacetaxine_monotherapy" .
<Chemotherapy> <Modality_of> "Olaparib_monotherapy" .
<Chemotherapy> <Modality_of> "Ofatumumab_monotherapy" .
<Chemotherapy> <Modality_of> "Obinutuzumab_monotherapy" .
<Chemotherapy> <Modality_of> "OXAFAFU" .
<Chemotherapy> <Modality_of> "OPPA" .
<Chemotherapy> <Modality_of> "OLF" .
<Chemotherapy> <Modality_of> "OFAR" .
<Chemotherapy> <Modality_of> "OEPA" .
<Chemotherapy> <Modality_of> "O-miniCHOP" .
<Chemotherapy> <Modality_of> "O-ICE" .
<Chemotherapy> <Modality_of> "O-FC" .
<Chemotherapy> <Modality_of> "O-ESHAP" .
<Chemotherapy> <Modality_of> "O-DHAP" .
<Chemotherapy> <Modality_of> "O-CHOP" .
<Chemotherapy> <Modality_of> "Nordic_Regimen,_younger_patients" .
<Chemotherapy> <Modality_of> "Nordic_Regimen,_older_patients" .
<Chemotherapy> <Modality_of> "Nordic_FLOX" .
<Chemotherapy> <Modality_of> "Niraparib_monotherapy" .
<Chemotherapy> <Modality_of> "Nintedanib_and_Pemetrexed" .
<Chemotherapy> <Modality_of> "Nimustine_and_RT" .
<Chemotherapy> <Modality_of> "Nilotinib-based_consolidation" .
<Chemotherapy> <Modality_of> "Nilotinib_monotherapy" .
<Chemotherapy> <Modality_of> "Neratinib_monotherapy" .
<Chemotherapy> <Modality_of> "Neratinib_and_Paclitaxel" .
<Chemotherapy> <Modality_of> "Nelarabine_monotherapy" .
<Chemotherapy> <Modality_of> "Necitumumab_monotherapy" .
<Chemotherapy> <Modality_of> "NOVP" .
<Chemotherapy> <Modality_of> "Moxetumomab_pasudotox_monotherapy" .
<Chemotherapy> <Modality_of> "Mogamulizumab_monotherapy" .
<Chemotherapy> <Modality_of> "Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Chemotherapy> <Modality_of> "Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone" .
<Chemotherapy> <Modality_of> "Mitoxantrone_monotherapy" .
<Chemotherapy> <Modality_of> "Mitoxantrone_and_Prednisone" .
<Chemotherapy> <Modality_of> "Mitoxantrone_and_Hydrocortisone" .
<Chemotherapy> <Modality_of> "Mitotane_monotherapy" .
<Chemotherapy> <Modality_of> "Mitotane_and_Streptozocin" .
<Chemotherapy> <Modality_of> "Mitotane_and_EDP" .
<Chemotherapy> <Modality_of> "Mitomycin_monotherapy" .
<Chemotherapy> <Modality_of> "Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin" .
<Chemotherapy> <Modality_of> "Mini-BEAM" .
<Chemotherapy> <Modality_of> "Midostaurin_monotherapy" .
<Chemotherapy> <Modality_of> "Methotrexate,_then_Cytarabine_and_Thiotepa" .
<Chemotherapy> <Modality_of> "Methotrexate,_then_Cytarabine" .
<Chemotherapy> <Modality_of> "Methotrexate,_Vinblastine,_Prednisone" .
<Chemotherapy> <Modality_of> "Methotrexate,_RT,_Cyclophosphamide" .
<Chemotherapy> <Modality_of> "Methotrexate,_Pegaspargase,_Vincristine" .
<Chemotherapy> <Modality_of> "Methotrexate_monotherapy" .
<Chemotherapy> <Modality_of> "Methotrexate_and_Vincristine" .
<Chemotherapy> <Modality_of> "Methotrexate_and_Thiotepa" .
<Chemotherapy> <Modality_of> "Methotrexate_and_Rituximab" .
<Chemotherapy> <Modality_of> "Methotrexate_and_Pegaspargase" .
<Chemotherapy> <Modality_of> "Mercaptopurine,_Methotrexate,_WB-XRT" .
<Chemotherapy> <Modality_of> "Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone" .
<Chemotherapy> <Modality_of> "Mercaptopurine,_Methotrexate,_Vincristine" .
<Chemotherapy> <Modality_of> "Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone" .
<Chemotherapy> <Modality_of> "Mercaptopurine_monotherapy" .
<Chemotherapy> <Modality_of> "Mercaptopurine_and_WBRT" .
<Chemotherapy> <Modality_of> "Mercaptopurine_and_Prednisone" .
<Chemotherapy> <Modality_of> "Mercaptopurine_and_Methotrexate" .
<Chemotherapy> <Modality_of> "Mepolizumab_monotherapy" .
<Chemotherapy> <Modality_of> "Melphalan,_then_auto_HSCT,_then_TBI,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "Melphalan,_then_auto_HSCT,_then_Melphalan_and_TBI,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "Melphalan,_then_auto_HSCT,_then_Melphalan_and_Busulfan,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "Melphalan,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "Melphalan_monotherapy" .
<Chemotherapy> <Modality_of> "Melphalan_and_TBI,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "Melphalan_and_TBI" .
<Chemotherapy> <Modality_of> "Melphalan_and_Methylprednisolone,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "Mechlorethamine_monotherapy" .
<Chemotherapy> <Modality_of> "MVPP" .
<Chemotherapy> <Modality_of> "MVP_and_RT" .
<Chemotherapy> <Modality_of> "MVP_(Vindesine)" .
<Chemotherapy> <Modality_of> "MVP_(Vinblastine)" .
<Chemotherapy> <Modality_of> "MVBP" .
<Chemotherapy> <Modality_of> "MVAC,_dose-dense" .
<Chemotherapy> <Modality_of> "MVAC" .
<Chemotherapy> <Modality_of> "MV" .
<Chemotherapy> <Modality_of> "MT-R" .
<Chemotherapy> <Modality_of> "MRD" .
<Chemotherapy> <Modality_of> "MPV" .
<Chemotherapy> <Modality_of> "MPT" .
<Chemotherapy> <Modality_of> "MPR" .
<Chemotherapy> <Modality_of> "MP_(Prednisolone)" .
<Chemotherapy> <Modality_of> "MP" .
<Chemotherapy> <Modality_of> "MOPP/ABVD" .
<Chemotherapy> <Modality_of> "MOPP-ABV" .
<Chemotherapy> <Modality_of> "MOPP" .
<Chemotherapy> <Modality_of> "MOF" .
<Chemotherapy> <Modality_of> "MINE" .
<Chemotherapy> <Modality_of> "MIC" .
<Chemotherapy> <Modality_of> "MF" .
<Chemotherapy> <Modality_of> "MESA/RT" .
<Chemotherapy> <Modality_of> "MEL200,_then_auto_HSCT,_then_MEL220_and_Dexamethasone,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "MEC" .
<Chemotherapy> <Modality_of> "MCV" .
<Chemotherapy> <Modality_of> "MCP_(Prednisolone)" .
<Chemotherapy> <Modality_of> "MCP" .
<Chemotherapy> <Modality_of> "MCF" .
<Chemotherapy> <Modality_of> "MC" .
<Chemotherapy> <Modality_of> "MBVP" .
<Chemotherapy> <Modality_of> "MATRix" .
<Chemotherapy> <Modality_of> "MAPIE" .
<Chemotherapy> <Modality_of> "MAPI" .
<Chemotherapy> <Modality_of> "MAP" .
<Chemotherapy> <Modality_of> "MAID" .
<Chemotherapy> <Modality_of> "MACOP-B" .
<Chemotherapy> <Modality_of> "MACC" .
<Chemotherapy> <Modality_of> "MA-BCD/AP" .
<Chemotherapy> <Modality_of> "MA-BCD" .
<Chemotherapy> <Modality_of> "MA" .
<Chemotherapy> <Modality_of> "M-TIP" .
<Chemotherapy> <Modality_of> "M-EI" .
<Chemotherapy> <Modality_of> "M-DEX" .
<Chemotherapy> <Modality_of> "M-BCD" .
<Chemotherapy> <Modality_of> "Lorlatinib_monotherapy" .
<Chemotherapy> <Modality_of> "Lomustine,_Vincristine,_Prednisone" .
<Chemotherapy> <Modality_of> "Lomustine,_Temozolomide,_RT" .
<Chemotherapy> <Modality_of> "Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone" .
<Chemotherapy> <Modality_of> "Lomustine,_Methotrexate,_Procarbazine" .
<Chemotherapy> <Modality_of> "Lomustine_monotherapy" .
<Chemotherapy> <Modality_of> "Lomustine_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "LoDAC_and_Venetoclax" .
<Chemotherapy> <Modality_of> "LoDAC" .
<Chemotherapy> <Modality_of> "Linker_regimen_(consolidation)" .
<Chemotherapy> <Modality_of> "Letrozole_and_Ribociclib" .
<Chemotherapy> <Modality_of> "Letrozole_and_Palbociclib" .
<Chemotherapy> <Modality_of> "Letrozole_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "Lenvatinib_monotherapy" .
<Chemotherapy> <Modality_of> "Lenvatinib_and_Pembrolizumab" .
<Chemotherapy> <Modality_of> "Lenalidomide,_Dexamethasone,_Rituximab" .
<Chemotherapy> <Modality_of> "Lenalidomide_monotherapy" .
<Chemotherapy> <Modality_of> "Lenalidomide_and_Rituximab" .
<Chemotherapy> <Modality_of> "Lenalidomide_and_Ofatumumab" .
<Chemotherapy> <Modality_of> "Larotrectinib_monotherapy" .
<Chemotherapy> <Modality_of> "Lapatinib,_Letrozole,_Trastuzumab" .
<Chemotherapy> <Modality_of> "Lapatinib_and_Trastuzumab" .
<Chemotherapy> <Modality_of> "Lapatinib_and_Letrozole" .
<Chemotherapy> <Modality_of> "LVP_.22Sandwich.22" .
<Chemotherapy> <Modality_of> "LSG15" .
<Chemotherapy> <Modality_of> "LOPP/EVAP" .
<Chemotherapy> <Modality_of> "LOPP" .
<Chemotherapy> <Modality_of> "LEED,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "LEED" .
<Chemotherapy> <Modality_of> "LD-ACOP-B" .
<Chemotherapy> <Modality_of> "L-asparaginase_monotherapy" .
<Chemotherapy> <Modality_of> "L-Asparaginase,_Vincristine,_Prednisone" .
<Chemotherapy> <Modality_of> "L-Asparaginase,_Vincristine,_Prednisolone" .
<Chemotherapy> <Modality_of> "L-Asparaginase,_Vincristine,_Dexamethasone" .
<Chemotherapy> <Modality_of> "L-Asparaginase_and_Methotrexate" .
<Chemotherapy> <Modality_of> "KTD" .
<Chemotherapy> <Modality_of> "KRd" .
<Chemotherapy> <Modality_of> "KPD" .
<Chemotherapy> <Modality_of> "KMP" .
<Chemotherapy> <Modality_of> "KD" .
<Chemotherapy> <Modality_of> "KCD" .
<Chemotherapy> <Modality_of> "Ixazomib_monotherapy" .
<Chemotherapy> <Modality_of> "Ixazomib_and_Dexamethasone" .
<Chemotherapy> <Modality_of> "Ixabepilone_monotherapy" .
<Chemotherapy> <Modality_of> "Ivosidenib_monotherapy" .
<Chemotherapy> <Modality_of> "Isotretinoin_monotherapy" .
<Chemotherapy> <Modality_of> "Isotretinoin_and_Dinutuximab" .
<Chemotherapy> <Modality_of> "Irinotecan,_Vemurafenib,_Cetuximab" .
<Chemotherapy> <Modality_of> "Irinotecan,_Temozolomide,_Dinutuximab" .
<Chemotherapy> <Modality_of> "Irinotecan_monotherapy" .
<Chemotherapy> <Modality_of> "Irinotecan_liposomal_monotherapy" .
<Chemotherapy> <Modality_of> "Irinotecan_and_Temozolomide" .
<Chemotherapy> <Modality_of> "Irinotecan_and_S-1" .
<Chemotherapy> <Modality_of> "Irinotecan_and_Mitomycin" .
<Chemotherapy> <Modality_of> "Irinotecan_and_Cetuximab" .
<Chemotherapy> <Modality_of> "Irinotecan_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "Intraperitoneal_hyperthermic_mitomycin" .
<Chemotherapy> <Modality_of> "Intraperitoneal_5-FU" .
<Chemotherapy> <Modality_of> "International_ALL_Trial" .
<Chemotherapy> <Modality_of> "Interferon_alfa-2b_and_Thalidomide" .
<Chemotherapy> <Modality_of> "Interferon_alfa-2b_and_Prednisone" .
<Chemotherapy> <Modality_of> "Interferon_alfa_and_Dexamethasone" .
<Chemotherapy> <Modality_of> "Inotuzumab_ozogamicin_monotherapy" .
<Chemotherapy> <Modality_of> "Imatinib-based_consolidation" .
<Chemotherapy> <Modality_of> "Imatinib,_Vincristine,_Prednisone" .
<Chemotherapy> <Modality_of> "Imatinib,_Vincristine,_Dexamethasone" .
<Chemotherapy> <Modality_of> "Imatinib_monotherapy" .
<Chemotherapy> <Modality_of> "Imatinib_and_Prednisone" .
<Chemotherapy> <Modality_of> "Imatinib_and_LoDAC" .
<Chemotherapy> <Modality_of> "Imatinib_and_Interferon" .
<Chemotherapy> <Modality_of> "Ifosfamide_monotherapy" .
<Chemotherapy> <Modality_of> "Ifosfamide_and_Vinorelbine" .
<Chemotherapy> <Modality_of> "Ifosfamide_and_Paclitaxel" .
<Chemotherapy> <Modality_of> "Ifosfamide_and_Methotrexate" .
<Chemotherapy> <Modality_of> "Ifosfamide_and_Gemcitabine" .
<Chemotherapy> <Modality_of> "Idelalisib_monotherapy" .
<Chemotherapy> <Modality_of> "Idelalisib_and_Rituximab" .
<Chemotherapy> <Modality_of> "Idelalisib_and_Ofatumumab" .
<Chemotherapy> <Modality_of> "Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA" .
<Chemotherapy> <Modality_of> "Idarubicin,_then_Mitoxantrone,_then_Idarubicin" .
<Chemotherapy> <Modality_of> "Icotinib_monotherapy" .
<Chemotherapy> <Modality_of> "Ibrutinib_monotherapy" .
<Chemotherapy> <Modality_of> "Ibrutinib_and_Venetoclax" .
<Chemotherapy> <Modality_of> "Ibrutinib_and_Rituximab" .
<Chemotherapy> <Modality_of> "Ibrutinib_and_Ofatumumab" .
<Chemotherapy> <Modality_of> "Ibrutinib_and_Obinutuzumab" .
<Chemotherapy> <Modality_of> "Ibritumomab_tiuxetan_monotherapy" .
<Chemotherapy> <Modality_of> "IT_Methotrexate_monotherapy" .
<Chemotherapy> <Modality_of> "IT_Methotrexate_and_WBRT" .
<Chemotherapy> <Modality_of> "IT_Methotrexate_and_Methylprednisolone" .
<Chemotherapy> <Modality_of> "IT_Methotrexate_and_Hydrocortisone" .
<Chemotherapy> <Modality_of> "IT_Cytarabine,_Methotrexate,_WBRT" .
<Chemotherapy> <Modality_of> "IT_Cytarabine,_Methotrexate,_Prednisone" .
<Chemotherapy> <Modality_of> "IT_Cytarabine,_Methotrexate,_Methylprednisolone" .
<Chemotherapy> <Modality_of> "IT_Cytarabine_monotherapy" .
<Chemotherapy> <Modality_of> "IT_Cytarabine_liposomal_monotherapy" .
<Chemotherapy> <Modality_of> "IT_Cytarabine_and_WBRT" .
<Chemotherapy> <Modality_of> "IT_Cytarabine_and_Methotrexate" .
<Chemotherapy> <Modality_of> "IRd" .
<Chemotherapy> <Modality_of> "IROX" .
<Chemotherapy> <Modality_of> "IRIS_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "IRIS" .
<Chemotherapy> <Modality_of> "IP-BCD" .
<Chemotherapy> <Modality_of> "IGEV_and_G-CSF" .
<Chemotherapy> <Modality_of> "IGEV" .
<Chemotherapy> <Modality_of> "IFL_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "IFL" .
<Chemotherapy> <Modality_of> "IE" .
<Chemotherapy> <Modality_of> "IDAC_and_Sorafenib" .
<Chemotherapy> <Modality_of> "IDAC" .
<Chemotherapy> <Modality_of> "ICL" .
<Chemotherapy> <Modality_of> "ICE" .
<Chemotherapy> <Modality_of> "IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone" .
<Chemotherapy> <Modality_of> "IAP" .
<Chemotherapy> <Modality_of> "HyperCHidam" .
<Chemotherapy> <Modality_of> "Hyper-CVAD/MA_and_Everolimus" .
<Chemotherapy> <Modality_of> "Hyper-CVAD/MA" .
<Chemotherapy> <Modality_of> "Hyper-CVAD_and_Ponatinib" .
<Chemotherapy> <Modality_of> "Hyper-CVAD_and_Imatinib" .
<Chemotherapy> <Modality_of> "Hyper-CVAD_and_Dasatinib" .
<Chemotherapy> <Modality_of> "Hyper-CVAD" .
<Chemotherapy> <Modality_of> "Hydroxyurea_monotherapy" .
<Chemotherapy> <Modality_of> "Hydroxyurea_and_RT" .
<Chemotherapy> <Modality_of> "Hydroxyurea_and_Plicamycin" .
<Chemotherapy> <Modality_of> "Hydroxyurea_and_Interferon_alfa-2a" .
<Chemotherapy> <Modality_of> "Hydroxyurea_and_Imatinib" .
<Chemotherapy> <Modality_of> "HiDAC_and_Midostaurin" .
<Chemotherapy> <Modality_of> "HiDAC" .
<Chemotherapy> <Modality_of> "Hexa-CAF" .
<Chemotherapy> <Modality_of> "Hepatic_arterial_chemotherapy" .
<Chemotherapy> <Modality_of> "HOP" .
<Chemotherapy> <Modality_of> "HDMP-R" .
<Chemotherapy> <Modality_of> "HDMP" .
<Chemotherapy> <Modality_of> "HDAC_and_G-CSF" .
<Chemotherapy> <Modality_of> "HAM_and_Imatinib" .
<Chemotherapy> <Modality_of> "HAM" .
<Chemotherapy> <Modality_of> "HAIC_and_Sorafenib" .
<Chemotherapy> <Modality_of> "HAD" .
<Chemotherapy> <Modality_of> "HAA" .
<Chemotherapy> <Modality_of> "Gliadel_wafer_monotherapy" .
<Chemotherapy> <Modality_of> "Glasdegib_and_LoDAC" .
<Chemotherapy> <Modality_of> "Gilteritinib_monotherapy" .
<Chemotherapy> <Modality_of> "Gemtuzumab_ozogamicin_monotherapy" .
<Chemotherapy> <Modality_of> "Gemcitabine/Fluorouracil_and_RT" .
<Chemotherapy> <Modality_of> "Gemcitabine,_Oxaliplatin,_Paclitaxel" .
<Chemotherapy> <Modality_of> "Gemcitabine,_Cisplatin,_S-1" .
<Chemotherapy> <Modality_of> "Gemcitabine,_Cetuximab,_RT" .
<Chemotherapy> <Modality_of> "Gemcitabine_monotherapy" .
<Chemotherapy> <Modality_of> "Gemcitabine_and_nab-Paclitaxel" .
<Chemotherapy> <Modality_of> "Gemcitabine_and_Vinorelbine" .
<Chemotherapy> <Modality_of> "Gemcitabine_and_Trastuzumab" .
<Chemotherapy> <Modality_of> "Gemcitabine_and_Sunitinib" .
<Chemotherapy> <Modality_of> "Gemcitabine_and_S-1" .
<Chemotherapy> <Modality_of> "Gemcitabine_and_Rituximab" .
<Chemotherapy> <Modality_of> "Gemcitabine_and_RT" .
<Chemotherapy> <Modality_of> "Gemcitabine_and_Paclitaxel" .
<Chemotherapy> <Modality_of> "Gemcitabine_and_Mitomycin" .
<Chemotherapy> <Modality_of> "Gemcitabine_and_Irinotecan" .
<Chemotherapy> <Modality_of> "Gemcitabine_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "GemOx_and_Sorafenib" .
<Chemotherapy> <Modality_of> "GemOx" .
<Chemotherapy> <Modality_of> "Gefitinib_monotherapy" .
<Chemotherapy> <Modality_of> "Gefitinib_and_Pemetrexed" .
<Chemotherapy> <Modality_of> "GVP" .
<Chemotherapy> <Modality_of> "GVD" .
<Chemotherapy> <Modality_of> "GTX" .
<Chemotherapy> <Modality_of> "GMALL-R" .
<Chemotherapy> <Modality_of> "GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab" .
<Chemotherapy> <Modality_of> "GIP" .
<Chemotherapy> <Modality_of> "GEMOX-B" .
<Chemotherapy> <Modality_of> "GELOX/RT" .
<Chemotherapy> <Modality_of> "GDPT" .
<Chemotherapy> <Modality_of> "GDP" .
<Chemotherapy> <Modality_of> "GCP" .
<Chemotherapy> <Modality_of> "GCD-R" .
<Chemotherapy> <Modality_of> "GCD" .
<Chemotherapy> <Modality_of> "G-FC" .
<Chemotherapy> <Modality_of> "G-CVP" .
<Chemotherapy> <Modality_of> "G-CHOP" .
<Chemotherapy> <Modality_of> "Fulvestrant_and_Ribociclib" .
<Chemotherapy> <Modality_of> "Fulvestrant_and_Palbociclib" .
<Chemotherapy> <Modality_of> "Fotemustine_monotherapy" .
<Chemotherapy> <Modality_of> "Fostamatinib_monotherapy" .
<Chemotherapy> <Modality_of> "Forodesine_monotherapy" .
<Chemotherapy> <Modality_of> "Fluorouracil/Fluorouracil_and_RT" .
<Chemotherapy> <Modality_of> "Fluorouracil,_Paclitaxel,_RT" .
<Chemotherapy> <Modality_of> "Fluorouracil,_Oxaliplatin,_RT" .
<Chemotherapy> <Modality_of> "Fluorouracil,_Mitomycin,_RT" .
<Chemotherapy> <Modality_of> "Fluorouracil,_Hydroxyurea,_RT" .
<Chemotherapy> <Modality_of> "Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan" .
<Chemotherapy> <Modality_of> "Fluorouracil,_Folinic_acid,_RT" .
<Chemotherapy> <Modality_of> "Fluorouracil,_Folinic_acid,_Mitomycin" .
<Chemotherapy> <Modality_of> "Fluorouracil,_Folinic_acid,_Levamisole" .
<Chemotherapy> <Modality_of> "Fluorouracil,_Folinic_acid,_Gemcitabine" .
<Chemotherapy> <Modality_of> "Fluorouracil_monotherapy" .
<Chemotherapy> <Modality_of> "Fluorouracil_and_Streptozocin" .
<Chemotherapy> <Modality_of> "Fluorouracil_and_Semustine" .
<Chemotherapy> <Modality_of> "Fluorouracil_and_RT" .
<Chemotherapy> <Modality_of> "Fluorouracil_and_Paclitaxel" .
<Chemotherapy> <Modality_of> "Fluorouracil_and_Mitomycin" .
<Chemotherapy> <Modality_of> "Fluorouracil_and_Methotrexate" .
<Chemotherapy> <Modality_of> "Fluorouracil_and_Levoleucovorin" .
<Chemotherapy> <Modality_of> "Fluorouracil_and_Levamisole" .
<Chemotherapy> <Modality_of> "Fluorouracil_and_Folinic_acid" .
<Chemotherapy> <Modality_of> "Fludarabine,_then_131Iodine-Tositumomab" .
<Chemotherapy> <Modality_of> "Fludarabine,_Melphalan,_Alemtuzumab,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "Fludarabine,_Melphalan,_Alemtuzumab" .
<Chemotherapy> <Modality_of> "Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant" .
<Chemotherapy> <Modality_of> "Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "Fludarabine,_Cyclophosphamide,_ATG" .
<Chemotherapy> <Modality_of> "Fludarabine,_Busulfan,_Cyclophosphamide" .
<Chemotherapy> <Modality_of> "Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan" .
<Chemotherapy> <Modality_of> "Fludarabine,_Busulfan,_ATG" .
<Chemotherapy> <Modality_of> "Fludarabine_monotherapy" .
<Chemotherapy> <Modality_of> "Fludarabine_and_TBI,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "Fludarabine_and_TBI" .
<Chemotherapy> <Modality_of> "Fludarabine_and_Prednisone" .
<Chemotherapy> <Modality_of> "Fludarabine_and_Melphalan" .
<Chemotherapy> <Modality_of> "Fludarabine_and_Alemtuzumab" .
<Chemotherapy> <Modality_of> "FluCam" .
<Chemotherapy> <Modality_of> "FluBuCy,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "Flu-Mel,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "Fedratinib_monotherapy" .
<Chemotherapy> <Modality_of> "Fam-trastuzumab_deruxtecan_monotherapy" .
<Chemotherapy> <Modality_of> "FUOX" .
<Chemotherapy> <Modality_of> "FULV/FULV_and_RT" .
<Chemotherapy> <Modality_of> "FULV_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "FUIRI" .
<Chemotherapy> <Modality_of> "FRD" .
<Chemotherapy> <Modality_of> "FR" .
<Chemotherapy> <Modality_of> "FP/Capecitabine_and_RT" .
<Chemotherapy> <Modality_of> "FOLFOXIRI_and_Panitumumab" .
<Chemotherapy> <Modality_of> "FOLFOX4_and_RT" .
<Chemotherapy> <Modality_of> "FOLFOX4_and_Panitumumab" .
<Chemotherapy> <Modality_of> "FOLFOX4_and_Cetuximab" .
<Chemotherapy> <Modality_of> "FOLFOX4_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "FOLFOX4_(L-Leucovorin)" .
<Chemotherapy> <Modality_of> "FOLFOX4" .
<Chemotherapy> <Modality_of> "FOLFOX2" .
<Chemotherapy> <Modality_of> "FOLFOX_chronotherapy" .
<Chemotherapy> <Modality_of> "FOLFOX_7/sLV5FU2_(L-Leucovorin)" .
<Chemotherapy> <Modality_of> "FOLFOX_7/sLV5FU2" .
<Chemotherapy> <Modality_of> "FOLFOX" .
<Chemotherapy> <Modality_of> "FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation" .
<Chemotherapy> <Modality_of> "FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)" .
<Chemotherapy> <Modality_of> "FOLFIRINOX" .
<Chemotherapy> <Modality_of> "FOLFIRI_and_Ziv-aflibercept" .
<Chemotherapy> <Modality_of> "FOLFIRI_and_Ramucirumab" .
<Chemotherapy> <Modality_of> "FOLFIRI_and_Panitumumab" .
<Chemotherapy> <Modality_of> "FOLFIRI_and_Cetuximab_(L-Leucovorin)" .
<Chemotherapy> <Modality_of> "FOLFIRI_and_Cetuximab" .
<Chemotherapy> <Modality_of> "FOLFIRI_and_Bevacizumab_(L-Leucovorin)" .
<Chemotherapy> <Modality_of> "FOLFIRI_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "FOLFIRI_(L-Leucovorin)" .
<Chemotherapy> <Modality_of> "FOLFIRI" .
<Chemotherapy> <Modality_of> "FND" .
<Chemotherapy> <Modality_of> "FNC" .
<Chemotherapy> <Modality_of> "FMP" .
<Chemotherapy> <Modality_of> "FM" .
<Chemotherapy> <Modality_of> "FLOX" .
<Chemotherapy> <Modality_of> "FLOT" .
<Chemotherapy> <Modality_of> "FLEP" .
<Chemotherapy> <Modality_of> "FLEC" .
<Chemotherapy> <Modality_of> "FLAG-Ida" .
<Chemotherapy> <Modality_of> "FLAG-DNX" .
<Chemotherapy> <Modality_of> "FLAG" .
<Chemotherapy> <Modality_of> "FEMTX" .
<Chemotherapy> <Modality_of> "FELV" .
<Chemotherapy> <Modality_of> "FEC_and_H_(SC)" .
<Chemotherapy> <Modality_of> "FEC_and_H" .
<Chemotherapy> <Modality_of> "FEC_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "FEC" .
<Chemotherapy> <Modality_of> "FEAM,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "FEAM" .
<Chemotherapy> <Modality_of> "FCR,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "FCR_(Rituximab_Hycela)" .
<Chemotherapy> <Modality_of> "FCR" .
<Chemotherapy> <Modality_of> "FCM" .
<Chemotherapy> <Modality_of> "FCA" .
<Chemotherapy> <Modality_of> "FC,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "FC" .
<Chemotherapy> <Modality_of> "FAS" .
<Chemotherapy> <Modality_of> "FAMTX" .
<Chemotherapy> <Modality_of> "FAM" .
<Chemotherapy> <Modality_of> "FAC_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "FAC_and_BCG" .
<Chemotherapy> <Modality_of> "FAC" .
<Chemotherapy> <Modality_of> "F-SHAI" .
<Chemotherapy> <Modality_of> "F-MACHOP" .
<Chemotherapy> <Modality_of> "Exemestane_and_Tucidinostat" .
<Chemotherapy> <Modality_of> "Everolimus_monotherapy" .
<Chemotherapy> <Modality_of> "Everolimus_and_Tamoxifen" .
<Chemotherapy> <Modality_of> "Everolimus_and_Rituximab" .
<Chemotherapy> <Modality_of> "Everolimus_and_Octreotide" .
<Chemotherapy> <Modality_of> "Everolimus_and_Lenvatinib" .
<Chemotherapy> <Modality_of> "Everolimus_and_Exemestane" .
<Chemotherapy> <Modality_of> "Etoposide,_Vinblastine,_Prednisone" .
<Chemotherapy> <Modality_of> "Etoposide,_Ifosfamide,_Methotrexate" .
<Chemotherapy> <Modality_of> "Etoposide,_Ifosfamide,_Imatinib" .
<Chemotherapy> <Modality_of> "Etoposide_monotherapy" .
<Chemotherapy> <Modality_of> "Etoposide_and_TBI,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "Etoposide_and_TBI" .
<Chemotherapy> <Modality_of> "Etoposide_and_Prednisone" .
<Chemotherapy> <Modality_of> "Etoposide_and_Mitoxantrone" .
<Chemotherapy> <Modality_of> "Erythropoetin_and_Lenalidomide" .
<Chemotherapy> <Modality_of> "Erlotinib_monotherapy" .
<Chemotherapy> <Modality_of> "Erlotinib_and_Ramucirumab" .
<Chemotherapy> <Modality_of> "Erlotinib_and_Gemcitabine" .
<Chemotherapy> <Modality_of> "Erlotinib_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "Eribulin_monotherapy" .
<Chemotherapy> <Modality_of> "Erdafitinib_monotherapy" .
<Chemotherapy> <Modality_of> "Epirubicin_monotherapy" .
<Chemotherapy> <Modality_of> "Epirubicin_and_Vinorelbine" .
<Chemotherapy> <Modality_of> "Epirubicin_and_Ifosfamide" .
<Chemotherapy> <Modality_of> "Entrectinib_monotherapy" .
<Chemotherapy> <Modality_of> "Enfortumab_vedotin_monotherapy" .
<Chemotherapy> <Modality_of> "Enasidenib_monotherapy" .
<Chemotherapy> <Modality_of> "Elo-VD" .
<Chemotherapy> <Modality_of> "Elo-Rd" .
<Chemotherapy> <Modality_of> "Elo-PD" .
<Chemotherapy> <Modality_of> "Edrecolomab_monotherapy" .
<Chemotherapy> <Modality_of> "EVI" .
<Chemotherapy> <Modality_of> "EVAIA" .
<Chemotherapy> <Modality_of> "ESHAP" .
<Chemotherapy> <Modality_of> "EPOCH,_dose-escalated" .
<Chemotherapy> <Modality_of> "EPOCH" .
<Chemotherapy> <Modality_of> "EPIC_regimen" .
<Chemotherapy> <Modality_of> "EP" .
<Chemotherapy> <Modality_of> "EOX" .
<Chemotherapy> <Modality_of> "EOF" .
<Chemotherapy> <Modality_of> "EMA-CO" .
<Chemotherapy> <Modality_of> "EIA" .
<Chemotherapy> <Modality_of> "EDC" .
<Chemotherapy> <Modality_of> "EDAP" .
<Chemotherapy> <Modality_of> "ECX" .
<Chemotherapy> <Modality_of> "ECT,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "ECH" .
<Chemotherapy> <Modality_of> "ECF/5-FU_and_RT" .
<Chemotherapy> <Modality_of> "ECF" .
<Chemotherapy> <Modality_of> "EC_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "EC" .
<Chemotherapy> <Modality_of> "EBVP" .
<Chemotherapy> <Modality_of> "EAR_and_G-CSF" .
<Chemotherapy> <Modality_of> "Duvelisib_monotherapy" .
<Chemotherapy> <Modality_of> "Doxorubicin,_Methotrexate,_Vincristine,_Prednisone" .
<Chemotherapy> <Modality_of> "Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone" .
<Chemotherapy> <Modality_of> "Doxorubicin,_Ifosfamide,_RT" .
<Chemotherapy> <Modality_of> "Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone" .
<Chemotherapy> <Modality_of> "Doxorubicin_pegylated_liposomal_monotherapy" .
<Chemotherapy> <Modality_of> "Doxorubicin_pegylated_liposomal_and_Trabectedin" .
<Chemotherapy> <Modality_of> "Doxorubicin_pegylated_liposomal_and_Gemcitabine" .
<Chemotherapy> <Modality_of> "Doxorubicin_pegylated_liposomal_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "Doxorubicin_non-pegylated_liposomal_monotherapy" .
<Chemotherapy> <Modality_of> "Doxorubicin_non-pegylated_liposomal_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "Doxorubicin_monotherapy" .
<Chemotherapy> <Modality_of> "Doxorubicin_and_Vinblastine" .
<Chemotherapy> <Modality_of> "Doxorubicin_and_Strontium-89" .
<Chemotherapy> <Modality_of> "Doxorubicin_and_Streptozocin" .
<Chemotherapy> <Modality_of> "Doxorubicin_and_Olaratumab" .
<Chemotherapy> <Modality_of> "Doxorubicin_and_Lomustine" .
<Chemotherapy> <Modality_of> "Doxorubicin_and_Ifosfamide" .
<Chemotherapy> <Modality_of> "Doxorubicin_and_Gemcitabine" .
<Chemotherapy> <Modality_of> "Doxorubicin_and_Fluorouracil" .
<Chemotherapy> <Modality_of> "Doxorubicin_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "Doxifluridine_and_Mitomycin" .
<Chemotherapy> <Modality_of> "Docetaxel,_Gemcitabine,_RT" .
<Chemotherapy> <Modality_of> "Docetaxel,_Fluorouracil,_RT" .
<Chemotherapy> <Modality_of> "Docetaxel,_Fluorouracil,_Hydroxyurea,_RT" .
<Chemotherapy> <Modality_of> "Docetaxel,_Cetuximab,_RT" .
<Chemotherapy> <Modality_of> "Docetaxel_monotherapy" .
<Chemotherapy> <Modality_of> "Docetaxel_and_Vinorelbine" .
<Chemotherapy> <Modality_of> "Docetaxel_and_Vandetanib" .
<Chemotherapy> <Modality_of> "Docetaxel_and_S-1" .
<Chemotherapy> <Modality_of> "Docetaxel_and_Ramucirumab" .
<Chemotherapy> <Modality_of> "Docetaxel_and_Prednisone" .
<Chemotherapy> <Modality_of> "Docetaxel_and_Prednisolone" .
<Chemotherapy> <Modality_of> "Docetaxel_and_Nintedanib" .
<Chemotherapy> <Modality_of> "Docetaxel_and_Nedaplatin" .
<Chemotherapy> <Modality_of> "Docetaxel_and_Irinotecan" .
<Chemotherapy> <Modality_of> "Docetaxel_and_Gemcitabine" .
<Chemotherapy> <Modality_of> "Docetaxel_and_Estramustine" .
<Chemotherapy> <Modality_of> "Docetaxel_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "Dexamethasone_monotherapy" .
<Chemotherapy> <Modality_of> "DexaBEAM_and_G-CSF" .
<Chemotherapy> <Modality_of> "DexaBEAM" .
<Chemotherapy> <Modality_of> "Denosumab_monotherapy" .
<Chemotherapy> <Modality_of> "Denileukin_diftitox_monotherapy" .
<Chemotherapy> <Modality_of> "Decitabine_monotherapy" .
<Chemotherapy> <Modality_of> "Decitabine_and_Venetoclax" .
<Chemotherapy> <Modality_of> "Decitabine_and_Valproate" .
<Chemotherapy> <Modality_of> "Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib" .
<Chemotherapy> <Modality_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone" .
<Chemotherapy> <Modality_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Chemotherapy> <Modality_of> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib" .
<Chemotherapy> <Modality_of> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Chemotherapy> <Modality_of> "Daunorubicin_monotherapy" .
<Chemotherapy> <Modality_of> "Daunorubicin_liposomal_monotherapy" .
<Chemotherapy> <Modality_of> "Daunorubicin_and_Prednisone" .
<Chemotherapy> <Modality_of> "Dasatinib,_Vincristine,_Prednisone" .
<Chemotherapy> <Modality_of> "Dasatinib_monotherapy" .
<Chemotherapy> <Modality_of> "Dasatinib_and_Prednisone" .
<Chemotherapy> <Modality_of> "Daratumumab_monotherapy" .
<Chemotherapy> <Modality_of> "Dara-VTD" .
<Chemotherapy> <Modality_of> "Dara-VMP" .
<Chemotherapy> <Modality_of> "Dara-VD" .
<Chemotherapy> <Modality_of> "Dara-Rd" .
<Chemotherapy> <Modality_of> "Dara-PD" .
<Chemotherapy> <Modality_of> "Dara-KD" .
<Chemotherapy> <Modality_of> "Dactinomycin_monotherapy" .
<Chemotherapy> <Modality_of> "Dactinomycin_and_Vincristine" .
<Chemotherapy> <Modality_of> "Dacomitinib_monotherapy" .
<Chemotherapy> <Modality_of> "Dacarbazine_monotherapy" .
<Chemotherapy> <Modality_of> "Dacarbazine_and_Tamoxifen" .
<Chemotherapy> <Modality_of> "Dacarbazine_and_Ipilimumab" .
<Chemotherapy> <Modality_of> "Dacarbazine_and_Interferon_alfa-2a" .
<Chemotherapy> <Modality_of> "Dacarbazine_and_Gemcitabine" .
<Chemotherapy> <Modality_of> "Dacarbazine_and_Doxorubicin" .
<Chemotherapy> <Modality_of> "Dabrafenib,_Trametinib,_Panitumumab" .
<Chemotherapy> <Modality_of> "Dabrafenib_monotherapy" .
<Chemotherapy> <Modality_of> "Dabrafenib_and_Trametinib" .
<Chemotherapy> <Modality_of> "DTPACE" .
<Chemotherapy> <Modality_of> "DRC" .
<Chemotherapy> <Modality_of> "DOLP_(Prednisolone)" .
<Chemotherapy> <Modality_of> "DOLP" .
<Chemotherapy> <Modality_of> "DICEP" .
<Chemotherapy> <Modality_of> "DICE" .
<Chemotherapy> <Modality_of> "DI_EC" .
<Chemotherapy> <Modality_of> "DHAP_-_time_intensified" .
<Chemotherapy> <Modality_of> "DHAP" .
<Chemotherapy> <Modality_of> "DEX-IFN" .
<Chemotherapy> <Modality_of> "DEP_and_RT" .
<Chemotherapy> <Modality_of> "DEP" .
<Chemotherapy> <Modality_of> "DEB-TACE" .
<Chemotherapy> <Modality_of> "DE" .
<Chemotherapy> <Modality_of> "DDGP" .
<Chemotherapy> <Modality_of> "DD-CHOP" .
<Chemotherapy> <Modality_of> "DCTER" .
<Chemotherapy> <Modality_of> "DCF" .
<Chemotherapy> <Modality_of> "DCEP_and_G-CSF" .
<Chemotherapy> <Modality_of> "DCEP" .
<Chemotherapy> <Modality_of> "DAT" .
<Chemotherapy> <Modality_of> "DAC" .
<Chemotherapy> <Modality_of> "DA-R-EPOCH" .
<Chemotherapy> <Modality_of> "DA-EPOCH" .
<Chemotherapy> <Modality_of> "DA_3_plus_10,_GO" .
<Chemotherapy> <Modality_of> "DA_3_plus_10" .
<Chemotherapy> <Modality_of> "D-ZAPO" .
<Chemotherapy> <Modality_of> "Cytarabine,_Methotrexate,_Rituximab" .
<Chemotherapy> <Modality_of> "Cytarabine,_Ifosfamide,_G-CSF" .
<Chemotherapy> <Modality_of> "Cytarabine,_Idarubicin,_Vorinostat" .
<Chemotherapy> <Modality_of> "Cytarabine,_Idarubicin,_Sorafenib" .
<Chemotherapy> <Modality_of> "Cytarabine,_Idarubicin,_Rituximab" .
<Chemotherapy> <Modality_of> "Cytarabine,_Idarubicin,_Imatinib" .
<Chemotherapy> <Modality_of> "Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone" .
<Chemotherapy> <Modality_of> "Cytarabine,_Daunorubicin,_Vincristine" .
<Chemotherapy> <Modality_of> "Cytarabine,_Daunorubicin,_Mercaptopurine,_Prednisolone" .
<Chemotherapy> <Modality_of> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone" .
<Chemotherapy> <Modality_of> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone" .
<Chemotherapy> <Modality_of> "Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin" .
<Chemotherapy> <Modality_of> "Cytarabine_monotherapy" .
<Chemotherapy> <Modality_of> "Cytarabine_and_Thioguanine" .
<Chemotherapy> <Modality_of> "Cytarabine_and_Mitoxantrone" .
<Chemotherapy> <Modality_of> "Cytarabine_and_Interferon_alfa-2b" .
<Chemotherapy> <Modality_of> "Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA" .
<Chemotherapy> <Modality_of> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA" .
<Chemotherapy> <Modality_of> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine" .
<Chemotherapy> <Modality_of> "Cytarabine_and_Idarubicin" .
<Chemotherapy> <Modality_of> "Cytarabine_and_G-CSF" .
<Chemotherapy> <Modality_of> "Cytarabine_and_Daunorubicin" .
<Chemotherapy> <Modality_of> "Cyclophosphamide,_Prednisone,_Diethylstilbestrol" .
<Chemotherapy> <Modality_of> "Cyclophosphamide,_Lomustine,_Methotrexate" .
<Chemotherapy> <Modality_of> "Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone" .
<Chemotherapy> <Modality_of> "Cyclophosphamide,_Fludarabine,_Thiotepa" .
<Chemotherapy> <Modality_of> "Cyclophosphamide,_Etoposide,_TBI" .
<Chemotherapy> <Modality_of> "Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone" .
<Chemotherapy> <Modality_of> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone" .
<Chemotherapy> <Modality_of> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone" .
<Chemotherapy> <Modality_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab" .
<Chemotherapy> <Modality_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Chemotherapy> <Modality_of> "Cyclophosphamide,_Dacarbazine,_Vincristine" .
<Chemotherapy> <Modality_of> "Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone" .
<Chemotherapy> <Modality_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine" .
<Chemotherapy> <Modality_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine" .
<Chemotherapy> <Modality_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine" .
<Chemotherapy> <Modality_of> "Cyclophosphamide_monotherapy" .
<Chemotherapy> <Modality_of> "Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide" .
<Chemotherapy> <Modality_of> "Cyclophosphamide_and_Vincristine" .
<Chemotherapy> <Modality_of> "Cyclophosphamide_and_Topotecan" .
<Chemotherapy> <Modality_of> "Cyclophosphamide_and_TBI,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "Cyclophosphamide_and_TBI,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "Cyclophosphamide_and_TBI" .
<Chemotherapy> <Modality_of> "Cyclophosphamide_and_Prednisone" .
<Chemotherapy> <Modality_of> "Cyclophosphamide_and_G-CSF" .
<Chemotherapy> <Modality_of> "Cyclophosphamide_and_Etoposide" .
<Chemotherapy> <Modality_of> "Cyclophosphamide_and_Dexamethasone" .
<Chemotherapy> <Modality_of> "Crizotinib_monotherapy" .
<Chemotherapy> <Modality_of> "Crizanlizumab_monotherapy" .
<Chemotherapy> <Modality_of> "Copanlisib_monotherapy" .
<Chemotherapy> <Modality_of> "Colchicine_monotherapy" .
<Chemotherapy> <Modality_of> "Cobimetinib_monotherapy" .
<Chemotherapy> <Modality_of> "Cobimetinib_and_Vemurafenib" .
<Chemotherapy> <Modality_of> "Clofarabine_monotherapy" .
<Chemotherapy> <Modality_of> "Clofarabine_and_Melphalan,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "Clofarabine_and_Melphalan" .
<Chemotherapy> <Modality_of> "Clofarabine_and_LoDAC/Decitabine" .
<Chemotherapy> <Modality_of> "Clofarabine_and_LoDAC" .
<Chemotherapy> <Modality_of> "Clofarabine_and_Cytarabine" .
<Chemotherapy> <Modality_of> "Cladribine_monotherapy" .
<Chemotherapy> <Modality_of> "Cladribine_and_Rituximab" .
<Chemotherapy> <Modality_of> "Cladribine_and_Cytarabine" .
<Chemotherapy> <Modality_of> "Cisplatin,_Vinorelbine,_RT" .
<Chemotherapy> <Modality_of> "Cisplatin,_Vinorelbine,_Cetuximab" .
<Chemotherapy> <Modality_of> "Cisplatin,_Vinblastine,_RT" .
<Chemotherapy> <Modality_of> "Cisplatin,_Pemetrexed,_TTFields" .
<Chemotherapy> <Modality_of> "Cisplatin,_Pemetrexed,_Pembrolizumab" .
<Chemotherapy> <Modality_of> "Cisplatin,_Pemetrexed,_Bevacizumab" .
<Chemotherapy> <Modality_of> "Cisplatin,_Paclitaxel,_RT" .
<Chemotherapy> <Modality_of> "Cisplatin,_Paclitaxel,_Bevacizumab" .
<Chemotherapy> <Modality_of> "Cisplatin,_Lomustine,_Vincristine" .
<Chemotherapy> <Modality_of> "Cisplatin,_Irinotecan,_RT" .
<Chemotherapy> <Modality_of> "Cisplatin,_Interferon_alfa-2a,_Isotretinoin" .
<Chemotherapy> <Modality_of> "Cisplatin,_Gemcitabine,_nab-Paclitaxel" .
<Chemotherapy> <Modality_of> "Cisplatin,_Gemcitabine,_RT" .
<Chemotherapy> <Modality_of> "Cisplatin,_Gemcitabine,_Necitumumab" .
<Chemotherapy> <Modality_of> "Cisplatin,_Gemcitabine,_Bevacizumab" .
<Chemotherapy> <Modality_of> "Cisplatin,_Fluorouracil,_Vincristine" .
<Chemotherapy> <Modality_of> "Cisplatin,_Fluorouracil,_RT" .
<Chemotherapy> <Modality_of> "Cisplatin,_Fluorouracil,_Pembrolizumab" .
<Chemotherapy> <Modality_of> "Cisplatin,_Fluorouracil,_Panitumumab" .
<Chemotherapy> <Modality_of> "Cisplatin,_Fluorouracil,_Hydroxyurea,_RT" .
<Chemotherapy> <Modality_of> "Cisplatin,_Fluorouracil,_Cetuximab" .
<Chemotherapy> <Modality_of> "Cisplatin,_Etoposide,_RT" .
<Chemotherapy> <Modality_of> "Cisplatin,_Etoposide,_Irinotecan" .
<Chemotherapy> <Modality_of> "Cisplatin,_Etoposide,_Durvalumab" .
<Chemotherapy> <Modality_of> "Cisplatin,_Etoposide,_Bevacizumab" .
<Chemotherapy> <Modality_of> "Cisplatin,_Epirubicin,_Ifosfamide" .
<Chemotherapy> <Modality_of> "Cisplatin,_Doxorubicin,_Paclitaxel" .
<Chemotherapy> <Modality_of> "Cisplatin,_Doxorubicin_liposomal,_Fluorouracil" .
<Chemotherapy> <Modality_of> "Cisplatin,_Docetaxel,_RT" .
<Chemotherapy> <Modality_of> "Cisplatin,_Dacarbazine,_Tamoxifen" .
<Chemotherapy> <Modality_of> "Cisplatin,_Dacarbazine,_Paclitaxel" .
<Chemotherapy> <Modality_of> "Cisplatin,_Dacarbazine,_Interferon_alfa-2b" .
<Chemotherapy> <Modality_of> "Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine" .
<Chemotherapy> <Modality_of> "Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b" .
<Chemotherapy> <Modality_of> "Cisplatin,_Cetuximab,_RT" .
<Chemotherapy> <Modality_of> "Cisplatin_monotherapy" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Vinorelbine" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Vindesine" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Vinblastine" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Topotecan" .
<Chemotherapy> <Modality_of> "Cisplatin_and_S-1" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Raltitrexed" .
<Chemotherapy> <Modality_of> "Cisplatin_and_RT" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Pemetrexed" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Paclitaxel" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Mitomycin" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Methotrexate" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Irinotecan" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Ifosfamide" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Gemcitabine/Erlotinib" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Gemcitabine" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Fluorouracil" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Etoposide" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Epirubicin" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Doxorubicin" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Docetaxel" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Dacarbazine" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Cyclophosphamide" .
<Chemotherapy> <Modality_of> "Cisplatin_and_Cetuximab" .
<Chemotherapy> <Modality_of> "Chlorambucil,_Dactinomycin,_Methotrexate" .
<Chemotherapy> <Modality_of> "Chlorambucil_monotherapy" .
<Chemotherapy> <Modality_of> "Chlorambucil_and_Rituximab" .
<Chemotherapy> <Modality_of> "Chlorambucil_and_Prednisone" .
<Chemotherapy> <Modality_of> "Chlorambucil_and_Prednisolone" .
<Chemotherapy> <Modality_of> "Chlorambucil_and_Ofatumumab" .
<Chemotherapy> <Modality_of> "Chlorambucil_and_Obinutuzumab" .
<Chemotherapy> <Modality_of> "Chlorambucil_and_Cisplatin" .
<Chemotherapy> <Modality_of> "ChlVPP/PABIOE" .
<Chemotherapy> <Modality_of> "ChlVPP/EVA" .
<Chemotherapy> <Modality_of> "ChlVPP" .
<Chemotherapy> <Modality_of> "Chidamide_monotherapy" .
<Chemotherapy> <Modality_of> "Cetuximab_monotherapy" .
<Chemotherapy> <Modality_of> "Cetuximab_and_RT" .
<Chemotherapy> <Modality_of> "Ceritinib_monotherapy" .
<Chemotherapy> <Modality_of> "Carmustine_monotherapy" .
<Chemotherapy> <Modality_of> "Carmustine_and_RT" .
<Chemotherapy> <Modality_of> "Carmustine_and_Doxorubicin" .
<Chemotherapy> <Modality_of> "Carfilzomib_monotherapy" .
<Chemotherapy> <Modality_of> "Carfilzomib_and_Panobinostat" .
<Chemotherapy> <Modality_of> "Carboplatin,_nab-Paclitaxel,_Pembrolizumab" .
<Chemotherapy> <Modality_of> "Carboplatin,_nab-Paclitaxel,_Atezolizumab" .
<Chemotherapy> <Modality_of> "Carboplatin,_Vinorelbine,_RT" .
<Chemotherapy> <Modality_of> "Carboplatin,_Pemetrexed,_Pembrolizumab" .
<Chemotherapy> <Modality_of> "Carboplatin,_Pemetrexed,_Bevacizumab" .
<Chemotherapy> <Modality_of> "Carboplatin,_Paclitaxel,_RT" .
<Chemotherapy> <Modality_of> "Carboplatin,_Paclitaxel,_Pembrolizumab" .
<Chemotherapy> <Modality_of> "Carboplatin,_Paclitaxel,_Ipilimumab" .
<Chemotherapy> <Modality_of> "Carboplatin,_Paclitaxel,_Bevacizumab" .
<Chemotherapy> <Modality_of> "Carboplatin,_Olaparib,_Paclitaxel" .
<Chemotherapy> <Modality_of> "Carboplatin,_Gemcitabine,_Bevacizumab" .
<Chemotherapy> <Modality_of> "Carboplatin,_Fluorouracil,_RT" .
<Chemotherapy> <Modality_of> "Carboplatin,_Fluorouracil,_Cetuximab,_RT" .
<Chemotherapy> <Modality_of> "Carboplatin,_Fluorouracil,_Cetuximab" .
<Chemotherapy> <Modality_of> "Carboplatin,_Etoposide,_RT" .
<Chemotherapy> <Modality_of> "Carboplatin,_Etoposide,_Durvalumab" .
<Chemotherapy> <Modality_of> "Carboplatin,_Etoposide,_Bevacizumab" .
<Chemotherapy> <Modality_of> "Carboplatin,_Etoposide,_Atezolizumab" .
<Chemotherapy> <Modality_of> "Carboplatin,_Docetaxel,_Prednisone" .
<Chemotherapy> <Modality_of> "Carboplatin,_Cyclophosphamide,_Etoposide,_Methotrexate,_Vincristine" .
<Chemotherapy> <Modality_of> "Carboplatin_monotherapy" .
<Chemotherapy> <Modality_of> "Carboplatin_and_nab-Paclitaxel" .
<Chemotherapy> <Modality_of> "Carboplatin_and_Vinorelbine" .
<Chemotherapy> <Modality_of> "Carboplatin_and_Vincristine" .
<Chemotherapy> <Modality_of> "Carboplatin_and_Teniposide" .
<Chemotherapy> <Modality_of> "Carboplatin_and_RT" .
<Chemotherapy> <Modality_of> "Carboplatin_and_Pemetrexed" .
<Chemotherapy> <Modality_of> "Carboplatin_and_Paclitaxel" .
<Chemotherapy> <Modality_of> "Carboplatin_and_Irinotecan" .
<Chemotherapy> <Modality_of> "Carboplatin_and_Ifosfamide" .
<Chemotherapy> <Modality_of> "Carboplatin_and_Gemcitabine/Erlotinib" .
<Chemotherapy> <Modality_of> "Carboplatin_and_Gemcitabine" .
<Chemotherapy> <Modality_of> "Carboplatin_and_Fluorouracil" .
<Chemotherapy> <Modality_of> "Carboplatin_and_Etoposide,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "Carboplatin_and_Etoposide" .
<Chemotherapy> <Modality_of> "Carboplatin_and_Doxorubicin_liposomal" .
<Chemotherapy> <Modality_of> "Carboplatin_and_Docetaxel" .
<Chemotherapy> <Modality_of> "Carboplatin_and_Cyclophosphamide" .
<Chemotherapy> <Modality_of> "Carboplatin_and_Cisplatin" .
<Chemotherapy> <Modality_of> "Carboplatin_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "Capecitabine/Capecitabine_and_RT" .
<Chemotherapy> <Modality_of> "Capecitabine,_Sorafenib,_RT" .
<Chemotherapy> <Modality_of> "Capecitabine,_Pertuzumab,_Trastuzumab" .
<Chemotherapy> <Modality_of> "Capecitabine,_Paclitaxel,_RT" .
<Chemotherapy> <Modality_of> "Capecitabine,_Oxaliplatin,_RT" .
<Chemotherapy> <Modality_of> "Capecitabine,_Mitomycin,_RT" .
<Chemotherapy> <Modality_of> "Capecitabine,_Docetaxel,_RT" .
<Chemotherapy> <Modality_of> "Capecitabine,_Docetaxel,_Oxaliplatin,_RT" .
<Chemotherapy> <Modality_of> "Capecitabine,_Cisplatin,_RT" .
<Chemotherapy> <Modality_of> "Capecitabine,_Carboplatin,_Paclitaxel,_RT" .
<Chemotherapy> <Modality_of> "Capecitabine,_Bevacizumab,_Trastuzumab" .
<Chemotherapy> <Modality_of> "Capecitabine_monotherapy" .
<Chemotherapy> <Modality_of> "Capecitabine_and_Trastuzumab" .
<Chemotherapy> <Modality_of> "Capecitabine_and_Temozolomide" .
<Chemotherapy> <Modality_of> "Capecitabine_and_RT" .
<Chemotherapy> <Modality_of> "Capecitabine_and_Paclitaxel,_nanoparticle_albumin-bound" .
<Chemotherapy> <Modality_of> "Capecitabine_and_Paclitaxel" .
<Chemotherapy> <Modality_of> "Capecitabine_and_Neratinib" .
<Chemotherapy> <Modality_of> "Capecitabine_and_Mitomycin" .
<Chemotherapy> <Modality_of> "Capecitabine_and_Lapatinib" .
<Chemotherapy> <Modality_of> "Capecitabine_and_Ixabepilone" .
<Chemotherapy> <Modality_of> "Capecitabine_and_Gemcitabine" .
<Chemotherapy> <Modality_of> "Capecitabine_and_Fulvestrant" .
<Chemotherapy> <Modality_of> "Capecitabine_and_Erlotinib" .
<Chemotherapy> <Modality_of> "Capecitabine_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "CapeOx,_Cetuximab,_RT" .
<Chemotherapy> <Modality_of> "CapeOx_and_Panitumumab" .
<Chemotherapy> <Modality_of> "CapeOx_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "CapeOx" .
<Chemotherapy> <Modality_of> "Calaspargase,_Daunorubicin,_Vincristine,_Prednisone" .
<Chemotherapy> <Modality_of> "Cabozantinib_monotherapy" .
<Chemotherapy> <Modality_of> "Cabozantinib_and_Erlotinib" .
<Chemotherapy> <Modality_of> "Cabazitaxel_and_Prednisone" .
<Chemotherapy> <Modality_of> "CaRD" .
<Chemotherapy> <Modality_of> "CYVE_and_G-CSF" .
<Chemotherapy> <Modality_of> "CYVE" .
<Chemotherapy> <Modality_of> "CYM" .
<Chemotherapy> <Modality_of> "CYKLONE" .
<Chemotherapy> <Modality_of> "CX-C" .
<Chemotherapy> <Modality_of> "CX_and_Trastuzumab" .
<Chemotherapy> <Modality_of> "CX" .
<Chemotherapy> <Modality_of> "CVPP" .
<Chemotherapy> <Modality_of> "CVP,_then_131Iodine-Tositumomab" .
<Chemotherapy> <Modality_of> "CVP_(Vinblastine/Prednisone)" .
<Chemotherapy> <Modality_of> "CVP_(Prednisolone)" .
<Chemotherapy> <Modality_of> "CVP" .
<Chemotherapy> <Modality_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Chemotherapy> <Modality_of> "CVD_(Vindesine)" .
<Chemotherapy> <Modality_of> "CVD_(Vinblastine)" .
<Chemotherapy> <Modality_of> "CVB" .
<Chemotherapy> <Modality_of> "CVAP" .
<Chemotherapy> <Modality_of> "CVAD" .
<Chemotherapy> <Modality_of> "CTD" .
<Chemotherapy> <Modality_of> "CTCb,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "CTCb" .
<Chemotherapy> <Modality_of> "CRd" .
<Chemotherapy> <Modality_of> "CRD" .
<Chemotherapy> <Modality_of> "CPX-351_monotherapy" .
<Chemotherapy> <Modality_of> "CPR" .
<Chemotherapy> <Modality_of> "CPB" .
<Chemotherapy> <Modality_of> "COPP/ABVD" .
<Chemotherapy> <Modality_of> "COPP_(CCNU)" .
<Chemotherapy> <Modality_of> "COPDAC" .
<Chemotherapy> <Modality_of> "COPADM" .
<Chemotherapy> <Modality_of> "COPAD/CYVE" .
<Chemotherapy> <Modality_of> "COPAD" .
<Chemotherapy> <Modality_of> "COPA" .
<Chemotherapy> <Modality_of> "COP-Bleo" .
<Chemotherapy> <Modality_of> "COP" .
<Chemotherapy> <Modality_of> "COMP" .
<Chemotherapy> <Modality_of> "CODOX-M/IVAC" .
<Chemotherapy> <Modality_of> "CODOX-M" .
<Chemotherapy> <Modality_of> "CNOP_(Prednisolone)" .
<Chemotherapy> <Modality_of> "CNOP" .
<Chemotherapy> <Modality_of> "CMFVP" .
<Chemotherapy> <Modality_of> "CMFV" .
<Chemotherapy> <Modality_of> "CMFT" .
<Chemotherapy> <Modality_of> "CMFPT" .
<Chemotherapy> <Modality_of> "CMFP" .
<Chemotherapy> <Modality_of> "CMFL" .
<Chemotherapy> <Modality_of> "CMF" .
<Chemotherapy> <Modality_of> "CMED" .
<Chemotherapy> <Modality_of> "CMC" .
<Chemotherapy> <Modality_of> "CM" .
<Chemotherapy> <Modality_of> "CLF" .
<Chemotherapy> <Modality_of> "CLARA" .
<Chemotherapy> <Modality_of> "CLAG-M" .
<Chemotherapy> <Modality_of> "CLAG" .
<Chemotherapy> <Modality_of> "CISCA/VB" .
<Chemotherapy> <Modality_of> "CISCA" .
<Chemotherapy> <Modality_of> "CIM" .
<Chemotherapy> <Modality_of> "CIA" .
<Chemotherapy> <Modality_of> "CHVmP-VB" .
<Chemotherapy> <Modality_of> "CHVmP" .
<Chemotherapy> <Modality_of> "CHVP-I" .
<Chemotherapy> <Modality_of> "CHVP" .
<Chemotherapy> <Modality_of> "CHUT,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "CHUT" .
<Chemotherapy> <Modality_of> "CHOP-BCG" .
<Chemotherapy> <Modality_of> "CHOP-B" .
<Chemotherapy> <Modality_of> "CHOP-AL" .
<Chemotherapy> <Modality_of> "CHOP-14" .
<Chemotherapy> <Modality_of> "CHOP,_then_131Iodine-Tositumomab" .
<Chemotherapy> <Modality_of> "CHOP_and_Everolimus" .
<Chemotherapy> <Modality_of> "CHOP_Modified_(Prednisolone)" .
<Chemotherapy> <Modality_of> "CHOP_Modified" .
<Chemotherapy> <Modality_of> "CHOP_(Prednisolone)" .
<Chemotherapy> <Modality_of> "CHOP" .
<Chemotherapy> <Modality_of> "CHOEP-21" .
<Chemotherapy> <Modality_of> "CHOEP-14" .
<Chemotherapy> <Modality_of> "CHAD" .
<Chemotherapy> <Modality_of> "CFP_and_Oophorectomy" .
<Chemotherapy> <Modality_of> "CFP" .
<Chemotherapy> <Modality_of> "CFAR" .
<Chemotherapy> <Modality_of> "CF_and_Trastuzumab" .
<Chemotherapy> <Modality_of> "CEV_and_RT" .
<Chemotherapy> <Modality_of> "CEV_(Cyclophosphamide/Etoposide)" .
<Chemotherapy> <Modality_of> "CEV_(Cyclophosphamide/Epirubicin)" .
<Chemotherapy> <Modality_of> "CEV_(Carboplatin/Etoposide)" .
<Chemotherapy> <Modality_of> "CEPP(B)" .
<Chemotherapy> <Modality_of> "CEP" .
<Chemotherapy> <Modality_of> "CEOP_(Prednisolone)" .
<Chemotherapy> <Modality_of> "CEOP" .
<Chemotherapy> <Modality_of> "CEF/CMF" .
<Chemotherapy> <Modality_of> "CEEP" .
<Chemotherapy> <Modality_of> "CDE" .
<Chemotherapy> <Modality_of> "CDB" .
<Chemotherapy> <Modality_of> "CCOP" .
<Chemotherapy> <Modality_of> "CCI" .
<Chemotherapy> <Modality_of> "CCE" .
<Chemotherapy> <Modality_of> "CC/DE_and_RT" .
<Chemotherapy> <Modality_of> "CC" .
<Chemotherapy> <Modality_of> "CBVM,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "CBV-Mx,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "CBV-Mx" .
<Chemotherapy> <Modality_of> "CBV,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "CBV" .
<Chemotherapy> <Modality_of> "CAVE" .
<Chemotherapy> <Modality_of> "CAV/PE" .
<Chemotherapy> <Modality_of> "CAV_and_RT" .
<Chemotherapy> <Modality_of> "CAV" .
<Chemotherapy> <Modality_of> "CAPIRI-Bev" .
<Chemotherapy> <Modality_of> "CAPIRI" .
<Chemotherapy> <Modality_of> "CAP-BOP" .
<Chemotherapy> <Modality_of> "CAP_(Platinol)" .
<Chemotherapy> <Modality_of> "CAP" .
<Chemotherapy> <Modality_of> "CAMP" .
<Chemotherapy> <Modality_of> "CAMFP" .
<Chemotherapy> <Modality_of> "CAMF" .
<Chemotherapy> <Modality_of> "CALGB_8811_late_intensification" .
<Chemotherapy> <Modality_of> "CALGB_8811_early_intensification" .
<Chemotherapy> <Modality_of> "CALGB_10-002_regimen" .
<Chemotherapy> <Modality_of> "CAFVP" .
<Chemotherapy> <Modality_of> "CAF_and_MPA" .
<Chemotherapy> <Modality_of> "CAD_and_G-CSF" .
<Chemotherapy> <Modality_of> "CABO" .
<Chemotherapy> <Modality_of> "C-VAMP" .
<Chemotherapy> <Modality_of> "C-MOPP/ABV" .
<Chemotherapy> <Modality_of> "C-MOPP" .
<Chemotherapy> <Modality_of> "C-BOP" .
<Chemotherapy> <Modality_of> "Busulfan_monotherapy" .
<Chemotherapy> <Modality_of> "Busulfan_and_Melphalan,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "Busulfan_and_Melphalan" .
<Chemotherapy> <Modality_of> "Busulfan_and_Fludarabine" .
<Chemotherapy> <Modality_of> "Busulfan_and_Cyclophosphamide,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "Busulfan_and_Cyclophosphamide" .
<Chemotherapy> <Modality_of> "BuFlu,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "BuCyTBI,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "BuCyTBI" .
<Chemotherapy> <Modality_of> "BuCy,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "BuCy,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "Bu/TT/Cy,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "Bu/TT/Cy" .
<Chemotherapy> <Modality_of> "Bu/TT,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "Bu/TT" .
<Chemotherapy> <Modality_of> "Brigatinib_monotherapy" .
<Chemotherapy> <Modality_of> "Brentuximab_vedotin_monotherapy" .
<Chemotherapy> <Modality_of> "Brentuximab_vedotin_and_Nivolumab" .
<Chemotherapy> <Modality_of> "Brentuximab_vedotin_and_Dacarbazine" .
<Chemotherapy> <Modality_of> "Bosutinib_monotherapy" .
<Chemotherapy> <Modality_of> "Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat" .
<Chemotherapy> <Modality_of> "Bortezomib,_Dexamethasone,_Panobinostat" .
<Chemotherapy> <Modality_of> "Bortezomib_monotherapy" .
<Chemotherapy> <Modality_of> "Bortezomib_and_Vorinostat" .
<Chemotherapy> <Modality_of> "Bortezomib_and_Panobinostat" .
<Chemotherapy> <Modality_of> "Bortezomib_and_Melphalan,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "Bortezomib_and_Melphalan" .
<Chemotherapy> <Modality_of> "Bortezomib_and_Doxorubicin_liposomal" .
<Chemotherapy> <Modality_of> "Bortezomib_and_Cyclophosphamide" .
<Chemotherapy> <Modality_of> "Blinatumomab_monotherapy" .
<Chemotherapy> <Modality_of> "Bleomycin,_Methotrexate,_Vinblastine/RT" .
<Chemotherapy> <Modality_of> "Bleomycin_and_Vinblastine" .
<Chemotherapy> <Modality_of> "Bleomycin_and_Cisplatin" .
<Chemotherapy> <Modality_of> "Binimetinib,_Encorafenib,_Cetuximab" .
<Chemotherapy> <Modality_of> "Binimetinib_monotherapy" .
<Chemotherapy> <Modality_of> "Binimetinib_and_Encorafenib" .
<Chemotherapy> <Modality_of> "BiRd" .
<Chemotherapy> <Modality_of> "Bexarotene_monotherapy" .
<Chemotherapy> <Modality_of> "Bexarotene_and_Pralatrexate" .
<Chemotherapy> <Modality_of> "Bevacizumab-containing_therapy" .
<Chemotherapy> <Modality_of> "Bevacizumab_monotherapy" .
<Chemotherapy> <Modality_of> "Bevacizumab_and_Rituximab" .
<Chemotherapy> <Modality_of> "Bevacizumab_and_RT" .
<Chemotherapy> <Modality_of> "Bevacizumab_and_Interferon_alfa-2a" .
<Chemotherapy> <Modality_of> "Benralizumab_monotherapy" .
<Chemotherapy> <Modality_of> "Bendamustine_monotherapy" .
<Chemotherapy> <Modality_of> "Bendamustine_and_Ofatumumab" .
<Chemotherapy> <Modality_of> "Bendamustine_and_Obinutuzumab" .
<Chemotherapy> <Modality_of> "Bendamustine_and_Brentuximab_vedotin" .
<Chemotherapy> <Modality_of> "Belotecan_and_Cisplatin" .
<Chemotherapy> <Modality_of> "Belinostat_monotherapy" .
<Chemotherapy> <Modality_of> "BeRT" .
<Chemotherapy> <Modality_of> "BeGEV" .
<Chemotherapy> <Modality_of> "BeEAM,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "BeEAM" .
<Chemotherapy> <Modality_of> "BVR" .
<Chemotherapy> <Modality_of> "BVP" .
<Chemotherapy> <Modality_of> "BVDS" .
<Chemotherapy> <Modality_of> "BVD" .
<Chemotherapy> <Modality_of> "BVCPP" .
<Chemotherapy> <Modality_of> "BVB" .
<Chemotherapy> <Modality_of> "BV-CHP" .
<Chemotherapy> <Modality_of> "BTD" .
<Chemotherapy> <Modality_of> "BR_and_Polatuzumab_vedotin" .
<Chemotherapy> <Modality_of> "BR_and_Idelalisib" .
<Chemotherapy> <Modality_of> "BR_and_Ibrutinib" .
<Chemotherapy> <Modality_of> "BR" .
<Chemotherapy> <Modality_of> "BO" .
<Chemotherapy> <Modality_of> "BMP" .
<Chemotherapy> <Modality_of> "BLD" .
<Chemotherapy> <Modality_of> "BID" .
<Chemotherapy> <Modality_of> "BHD" .
<Chemotherapy> <Modality_of> "BFR,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "BFR" .
<Chemotherapy> <Modality_of> "BEP" .
<Chemotherapy> <Modality_of> "BEAM,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "BEAM,_then_allo_HSCT" .
<Chemotherapy> <Modality_of> "BEAM" .
<Chemotherapy> <Modality_of> "BEACOPP-14_(Prednisolone)" .
<Chemotherapy> <Modality_of> "BEACOPP-14" .
<Chemotherapy> <Modality_of> "BEACOPP" .
<Chemotherapy> <Modality_of> "BEAC,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "BEAC" .
<Chemotherapy> <Modality_of> "BDR" .
<Chemotherapy> <Modality_of> "BCVPP" .
<Chemotherapy> <Modality_of> "BCOP" .
<Chemotherapy> <Modality_of> "BCNU/TT,_then_auto_HSCT" .
<Chemotherapy> <Modality_of> "BCNU/TT" .
<Chemotherapy> <Modality_of> "BCHOP" .
<Chemotherapy> <Modality_of> "BCG_and_Dacarbazine" .
<Chemotherapy> <Modality_of> "BBD" .
<Chemotherapy> <Modality_of> "BASIC" .
<Chemotherapy> <Modality_of> "BACO" .
<Chemotherapy> <Modality_of> "B-CAVe" .
<Chemotherapy> <Modality_of> "Azacitidine,_Vorinostat,_Gemtuzumab_ozogamicin" .
<Chemotherapy> <Modality_of> "Azacitidine_monotherapy" .
<Chemotherapy> <Modality_of> "Azacitidine_and_Vorinostat" .
<Chemotherapy> <Modality_of> "Azacitidine_and_Venetoclax" .
<Chemotherapy> <Modality_of> "Azacitidine_and_Sorafenib" .
<Chemotherapy> <Modality_of> "Azacitidine_and_Lenalidomide" .
<Chemotherapy> <Modality_of> "Azacitidine_and_Gemtuzumab_ozogamicin" .
<Chemotherapy> <Modality_of> "Axitinib_monotherapy" .
<Chemotherapy> <Modality_of> "Axitinib_and_TACE" .
<Chemotherapy> <Modality_of> "Axitinib_and_Pembrolizumab" .
<Chemotherapy> <Modality_of> "Axitinib_and_Avelumab" .
<Chemotherapy> <Modality_of> "Avapritinib_monotherapy" .
<Chemotherapy> <Modality_of> "Augmented_Hyper-CVAD_and_Asparaginase" .
<Chemotherapy> <Modality_of> "Augmented_BFM_consolidation" .
<Chemotherapy> <Modality_of> "Atezolizumab_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "Aspirin_and_Hydroxyurea" .
<Chemotherapy> <Modality_of> "AspaMetDex_(Erwinaze)" .
<Chemotherapy> <Modality_of> "AspaMetDex" .
<Chemotherapy> <Modality_of> "Arsenic_trioxide,_then_ATRA_and_Daunorubicin" .
<Chemotherapy> <Modality_of> "Arsenic_trioxide,_ATRA,_Idarubicin" .
<Chemotherapy> <Modality_of> "Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin" .
<Chemotherapy> <Modality_of> "Arsenic_trioxide_monotherapy" .
<Chemotherapy> <Modality_of> "Arsenic_trioxide_and_Idarubicin" .
<Chemotherapy> <Modality_of> "Arsenic_trioxide_and_Chlorambucil" .
<Chemotherapy> <Modality_of> "Arsenic_trioxide_and_ATRA" .
<Chemotherapy> <Modality_of> "Apatinib_monotherapy" .
<Chemotherapy> <Modality_of> "Anastrozole_and_Trastuzumab" .
<Chemotherapy> <Modality_of> "Anastrozole_and_Ribociclib" .
<Chemotherapy> <Modality_of> "Anastrozole_and_Palbociclib" .
<Chemotherapy> <Modality_of> "Amsacrine_and_Cytarabine" .
<Chemotherapy> <Modality_of> "Amrubicin_monotherapy" .
<Chemotherapy> <Modality_of> "Aminopterin_monotherapy" .
<Chemotherapy> <Modality_of> "Altretamine_monotherapy" .
<Chemotherapy> <Modality_of> "Altretamine_and_Cisplatin" .
<Chemotherapy> <Modality_of> "Alpelisib_and_Fulvestrant" .
<Chemotherapy> <Modality_of> "Alemtuzumab_monotherapy" .
<Chemotherapy> <Modality_of> "Alemtuzumab_and_Rituximab" .
<Chemotherapy> <Modality_of> "Alemtuzumab_and_Methylprednisolone" .
<Chemotherapy> <Modality_of> "Alectinib_monotherapy" .
<Chemotherapy> <Modality_of> "Afatinib_monotherapy" .
<Chemotherapy> <Modality_of> "Afatinib_and_Paclitaxel" .
<Chemotherapy> <Modality_of> "Afatinib_and_Cetuximab" .
<Chemotherapy> <Modality_of> "Afatinib_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "Ado-trastuzumab_emtansine_monotherapy" .
<Chemotherapy> <Modality_of> "Accelerated_BEP" .
<Chemotherapy> <Modality_of> "Acalabrutinib_monotherapy" .
<Chemotherapy> <Modality_of> "Abemaciclib_monotherapy" .
<Chemotherapy> <Modality_of> "Abemaciclib_and_Letrozole" .
<Chemotherapy> <Modality_of> "Abemaciclib_and_Fulvestrant" .
<Chemotherapy> <Modality_of> "Abemaciclib_and_Anastrozole" .
<Chemotherapy> <Modality_of> "AVD" .
<Chemotherapy> <Modality_of> "AVCF" .
<Chemotherapy> <Modality_of> "AV-CMF" .
<Chemotherapy> <Modality_of> "ATRA,_Mercaptopurine,_Methotrexate" .
<Chemotherapy> <Modality_of> "ATRA,_Cytarabine,_Idarubicin" .
<Chemotherapy> <Modality_of> "ATRA,_Cytarabine,_Daunorubicin" .
<Chemotherapy> <Modality_of> "ATRA_monotherapy" .
<Chemotherapy> <Modality_of> "ATRA_and_Idarubicin" .
<Chemotherapy> <Modality_of> "ATRA_and_Daunorubicin" .
<Chemotherapy> <Modality_of> "AT_(Taxotere)" .
<Chemotherapy> <Modality_of> "AT_(Taxol)" .
<Chemotherapy> <Modality_of> "APO" .
<Chemotherapy> <Modality_of> "AIE" .
<Chemotherapy> <Modality_of> "ADT,_Docetaxel,_Estramustine" .
<Chemotherapy> <Modality_of> "ADT_and_Docetaxel" .
<Chemotherapy> <Modality_of> "ADOC" .
<Chemotherapy> <Modality_of> "ADE_and_ATRA" .
<Chemotherapy> <Modality_of> "ADE_(standard-dose_Ara-C)" .
<Chemotherapy> <Modality_of> "ADE_(high-dose_Ara-C)" .
<Chemotherapy> <Modality_of> "ACVBP-R" .
<Chemotherapy> <Modality_of> "ACVBP,_dose-adjusted" .
<Chemotherapy> <Modality_of> "ACVBP" .
<Chemotherapy> <Modality_of> "ACT" .
<Chemotherapy> <Modality_of> "ACOMLA" .
<Chemotherapy> <Modality_of> "ACH" .
<Chemotherapy> <Modality_of> "ACE" .
<Chemotherapy> <Modality_of> "AC-T" .
<Chemotherapy> <Modality_of> "AC_and_Bevacizumab" .
<Chemotherapy> <Modality_of> "AC" .
<Chemotherapy> <Modality_of> "ABVE-PC" .
<Chemotherapy> <Modality_of> "ABVDm" .
<Chemotherapy> <Modality_of> "ABVD,_DD-DI" .
<Chemotherapy> <Modality_of> "ABVD" .
<Chemotherapy> <Modality_of> "ABV_(Vincristine)" .
<Chemotherapy> <Modality_of> "ABV_(Vinblastine)" .
<Chemotherapy> <Modality_of> "ABP" .
<Chemotherapy> <Modality_of> "ABDIC" .
<Chemotherapy> <Modality_of> "ABCP" .
<Chemotherapy> <Modality_of> "ABCM" .
<Chemotherapy> <Modality_of> "ABC" .
<Chemotherapy> <Modality_of> "AALL0232_consolidation" .
<Chemotherapy> <Modality_of> "A-AVD" .
<Chemotherapy> <Modality_of> "7_plus_5i" .
<Chemotherapy> <Modality_of> "7_plus_3m" .
<Chemotherapy> <Modality_of> "7_plus_3i_and_Vorinostat" .
<Chemotherapy> <Modality_of> "7_plus_3i_and_Sorafenib" .
<Chemotherapy> <Modality_of> "7_plus_3i_and_Panobinostat" .
<Chemotherapy> <Modality_of> "7_plus_3i" .
<Chemotherapy> <Modality_of> "7_plus_3d_and_Sorafenib" .
<Chemotherapy> <Modality_of> "7_plus_3d_and_Midostaurin" .
<Chemotherapy> <Modality_of> "7_plus_3d_and_Glasdegib" .
<Chemotherapy> <Modality_of> "7_plus_3d_and_GO" .
<Chemotherapy> <Modality_of> "7_plus_3d" .
<Chemotherapy> <Modality_of> "5_plus_3i" .
<Chemotherapy> <Modality_of> "5_plus_3d" .
<Chemotherapy> <Modality_of> "5_plus_2d" .
<TAM6> <Has_supportive_med> "Filgrastim" .
<CAV_and_RT> <Maps_to> "CAV_and_RT" .
<MIC> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Hydroxyurea_and_Interferon_alfa-2a> <Has_context> "Non-curative_first-line_therapy" .
<Medsara> <Brand_name_of> "Cytarabine" .
<Cisplatin,_Gemcitabine,_Necitumumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<R-GemOx> <Maps_to> "R-GemOx" .
<ACOMLA> <Has_context> "Induction_therapy" .
<BEAM> <Mapped_from> "BEAM" .
<Tprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cobal_ST> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Gemcitabine,_Oxaliplatin,_Paclitaxel> <Has_antineoplastic> "Paclitaxel" .
<Gemcitabine,_Oxaliplatin,_Paclitaxel> <Has_antineoplastic> "Oxaliplatin" .
<Gemcitabine,_Oxaliplatin,_Paclitaxel> <Has_antineoplastic> "Gemcitabine" .
<CALGB_10-002_regimen> <Has_antineoplastic> "Vincristine" .
<CALGB_10-002_regimen> <Has_antineoplastic> "Rituximab" .
<CALGB_10-002_regimen> <Has_antineoplastic> "Methotrexate" .
<CALGB_10-002_regimen> <Has_antineoplastic> "Ifosfamide" .
<CALGB_10-002_regimen> <Has_antineoplastic> "Etoposide" .
<CALGB_10-002_regimen> <Has_antineoplastic> "Doxorubicin" .
<CALGB_10-002_regimen> <Has_antineoplastic> "Dexamethasone" .
<CALGB_10-002_regimen> <Has_antineoplastic> "Cytarabine" .
<CALGB_10-002_regimen> <Has_antineoplastic> "Cyclophosphamide" .
<GemOx_and_Sorafenib> <Mapped_from> "GemOx_and_Sorafenib" .
<NovoTTF-100A_monotherapy> <Mapped_from> "NovoTTF-100A_monotherapy" .
<Ferric_gluconate> <Has_brand_name> "Ferrlecit" .
<Sibatere> <Brand_name_of> "Docetaxel" .
<Rhonal> <Brand_name_of> "Aspirin" .
<Fluorouracil,_Oxaliplatin,_RT> <Maps_to> "Fluorouracil,_Oxaliplatin,_RT" .
<LSG15> <Has_modality> "Chemotherapy" .
<OXAFAFU> <Has_modality> "Chemotherapy" .
<Deltacortril> <Brand_name_of> "Prednisolone" .
<Nolatrexed> <Has_brand_name> "Thymitaq" .
<GCD> <Has_accepted_use> "Hodgkin_lymphoma" .
<GDPT> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Porfimer> <May_have_route> "Intravenous" .
<Axitinib_and_TACE> <Has_antineoplastic> "TACE" .
<Axitinib_and_TACE> <Has_antineoplastic> "Axitinib" .
<Temsirolimus_and_Rituximab> <Maps_to> "Temsirolimus_and_Rituximab" .
<Radium-223_monotherapy> <Is_current_in> "Prostate_cancer" .
<Cemiplimab> <Has_accepted_use> "Cutaneous_squamous_cell_carcinoma" .
<Romiplostim> <Has_accepted_use> "Immune_thrombocytopenia" .
<Mitotane_and_Streptozocin> <Has_context> "Non-curative_therapy" .
<Mitotane_and_Streptozocin> <Has_context> "Adjuvant_therapy" .
<Dacarbazine_monotherapy> <Has_supportive_med> "Proton_pump_inhibitors" .
<Dacarbazine_monotherapy> <Has_supportive_med> "Mesna" .
<Dacarbazine_monotherapy> <Has_supportive_med> "Aspirin" .
<Bexarotene> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Bu/TT,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<FOLFOX4_and_RT> <Mapped_from> "FOLFOX4_and_RT" .
<Capecitabine_and_Fulvestrant> <Has_context> "Non-curative_subsequent-line_therapy" .
<Interferon_alfa-2a> <Has_brand_name> "Roferon-A" .
<Daxilone> <Brand_name_of> "Dexamethasone" .
<Exemestane_and_Tucidinostat> <Has_context> "Non-curative_subsequent-line_therapy" .
<Visumetazone> <Brand_name_of> "Dexamethasone" .
<Anastrozole_and_Ribociclib> <Is_a> "Antiestrogen-containing_regimen" .
<Clodeosten> <Brand_name_of> "Clodronate" .
<CHVmP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Furosemide> <Has_brand_name> "Salix" .
<Furosemide> <Has_brand_name> "Lasix" .
<Lorlatinib> <Is_a> "ROS1_inhibitor" .
<Lorlatinib> <Is_a> "Kinase_inhibitor" .
<Lorlatinib> <Is_a> "ALK_inhibitor" .
<BLD> <Is_current_in> "Multiple_myeloma" .
<TACE,_then_5-FU> <Is_a> "Anthracycline-containing_regimen" .
<Acute_leukemia> <Subsumes> "Blastic_plasmacytoid_dendritic_cell_neoplasm" .
<Acute_leukemia> <Subsumes> "Adult_T-cell_leukemia-lymphoma" .
<Acute_leukemia> <Subsumes> "Acute_promyelocytic_leukemia" .
<Acute_leukemia> <Subsumes> "Acute_myeloid_leukemia" .
<Local_therapy> <Maps_to> "Local_therapy" .
<Azacitidine_monotherapy> <Has_modality> "Chemotherapy" .
<Leiomyosarcoma> <Current_treated_by> "Trabectedin_monotherapy" .
<Leiomyosarcoma> <Current_treated_by> "Regorafenib_monotherapy" .
<Leiomyosarcoma> <Current_treated_by> "Observation" .
<Leiomyosarcoma> <Current_treated_by> "Eribulin_monotherapy" .
<Leiomyosarcoma> <Current_treated_by> "Docetaxel_and_Gemcitabine" .
<Leiomyosarcoma> <Current_treated_by> "Dacarbazine_monotherapy" .
<Leiomyosarcoma> <Current_treated_by> "Dacarbazine_and_Gemcitabine" .
<Afatinib_and_Paclitaxel> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Ondansetron> <Has_brand_name> "Zudan" .
<Ondansetron> <Has_brand_name> "Zophren" .
<Ondansetron> <Has_brand_name> "Zondan" .
<Ondansetron> <Has_brand_name> "Zonax" .
<Ondansetron> <Has_brand_name> "Zoltem" .
<Ondansetron> <Has_brand_name> "Zofron" .
<Ondansetron> <Has_brand_name> "Zofran_ODT" .
<Ondansetron> <Has_brand_name> "Zofran" .
<Ondansetron> <Has_brand_name> "Zofer" .
<Ondansetron> <Has_brand_name> "Zemitron" .
<Ondansetron> <Has_brand_name> "Zapron" .
<Ondansetron> <Has_brand_name> "Zantron" .
<Ondansetron> <Has_brand_name> "Yatrox" .
<Ondansetron> <Has_brand_name> "Vonau" .
<Ondansetron> <Has_brand_name> "Vomiz" .
<Ondansetron> <Has_brand_name> "Vomitron" .
<Ondansetron> <Has_brand_name> "Vomiset" .
<Ondansetron> <Has_brand_name> "Vomikind" .
<Ondansetron> <Has_brand_name> "Vomigo" .
<Ondansetron> <Has_brand_name> "Vomiban" .
<Ondansetron> <Has_brand_name> "Vomceran" .
<Ondansetron> <Has_brand_name> "Trorix" .
<Ondansetron> <Has_brand_name> "Sopran" .
<Ondansetron> <Has_brand_name> "Setronon" .
<Ondansetron> <Has_brand_name> "Setronax" .
<Ondansetron> <Has_brand_name> "Seton" .
<Ondansetron> <Has_brand_name> "Quimiofran" .
<Ondansetron> <Has_brand_name> "Periset" .
<Ondansetron> <Has_brand_name> "Otobrol" .
<Ondansetron> <Has_brand_name> "Ostasyn" .
<Ondansetron> <Has_brand_name> "Osetron" .
<Ondansetron> <Has_brand_name> "Onzod" .
<Ondansetron> <Has_brand_name> "Ontrax" .
<Ondansetron> <Has_brand_name> "Onsia" .
<Ondansetron> <Has_brand_name> "Onsett" .
<Ondansetron> <Has_brand_name> "Onsetron" .
<Ondansetron> <Has_brand_name> "Onset" .
<Ondansetron> <Has_brand_name> "Onseran" .
<Ondansetron> <Has_brand_name> "Onsat" .
<Ondansetron> <Has_brand_name> "Onilat" .
<Ondansetron> <Has_brand_name> "Onfran" .
<Ondansetron> <Has_brand_name> "Ondemet" .
<Ondansetron> <Has_brand_name> "Ondem" .
<Ondansetron> <Has_brand_name> "Ondavell" .
<Ondansetron> <Has_brand_name> "Ondatie" .
<Ondansetron> <Has_brand_name> "Ondasetron" .
<Ondansetron> <Has_brand_name> "Ondaren" .
<Ondansetron> <Has_brand_name> "Ondant" .
<Ondansetron> <Has_brand_name> "Ondansetron-Z" .
<Ondansetron> <Has_brand_name> "Ondanles" .
<Ondansetron> <Has_brand_name> "Ondan" .
<Ondansetron> <Has_brand_name> "Ondace" .
<Ondansetron> <Has_brand_name> "Onda" .
<Ondansetron> <Has_brand_name> "Oncotor" .
<Ondansetron> <Has_brand_name> "Onaset" .
<Ondansetron> <Has_brand_name> "Omstron" .
<Ondansetron> <Has_brand_name> "Ometic" .
<Ondansetron> <Has_brand_name> "Odanse" .
<Ondansetron> <Has_brand_name> "Odanex" .
<Ondansetron> <Has_brand_name> "O.N.D." .
<Ondansetron> <Has_brand_name> "Nuset" .
<Ondansetron> <Has_brand_name> "Neomit" .
<Ondansetron> <Has_brand_name> "Nautah" .
<Ondansetron> <Has_brand_name> "Nausedron" .
<Ondansetron> <Has_brand_name> "Narfoz" .
<Ondansetron> <Has_brand_name> "Modifical" .
<Ondansetron> <Has_brand_name> "Latran" .
<Ondansetron> <Has_brand_name> "Izofran" .
<Ondansetron> <Has_brand_name> "Invomit" .
<Ondansetron> <Has_brand_name> "Insetron" .
<Ondansetron> <Has_brand_name> "Injectrax" .
<Ondansetron> <Has_brand_name> "Helmine" .
<Ondansetron> <Has_brand_name> "Glendan" .
<Ondansetron> <Has_brand_name> "Frazon" .
<Ondansetron> <Has_brand_name> "Finoxi" .
<Ondansetron> <Has_brand_name> "Finaber" .
<Ondansetron> <Has_brand_name> "Espasevit" .
<Ondansetron> <Has_brand_name> "Emivox" .
<Ondansetron> <Has_brand_name> "Emistat" .
<Ondansetron> <Has_brand_name> "Emigo" .
<Ondansetron> <Has_brand_name> "Emetron" .
<Ondansetron> <Has_brand_name> "Emetra" .
<Ondansetron> <Has_brand_name> "Emeset" .
<Ondansetron> <Has_brand_name> "Emeran" .
<Ondansetron> <Has_brand_name> "Dantenk" .
<Ondansetron> <Has_brand_name> "Danofran" .
<Ondansetron> <Has_brand_name> "Ceramos" .
<Ondansetron> <Has_brand_name> "Cedantron" .
<Ondansetron> <Has_brand_name> "Bryterol" .
<Ondansetron> <Has_brand_name> "Atossa" .
<Ondansetron> <Has_brand_name> "Anset" .
<Ondansetron> <Has_brand_name> "Ansentron" .
<Ondansetron> <Has_brand_name> "Amilene" .
<Ondansetron> <Has_brand_name> "Alencar" .
<CMFPT> <Is_historical_in> "Breast_cancer" .
<mFOLFOX_and_Sorafenib> <Has_antineoplastic> "Sorafenib" .
<mFOLFOX_and_Sorafenib> <Has_antineoplastic> "Oxaliplatin" .
<mFOLFOX_and_Sorafenib> <Has_antineoplastic> "Folinic_acid" .
<mFOLFOX_and_Sorafenib> <Has_antineoplastic> "Fluorouracil" .
<R-BL> <Is_current_in> "Mantle_cell_lymphoma" .
<R-BL> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Mutamycin> <Brand_name_of> "Mitomycin" .
<BFR> <Is_a> "Rituximab-containing_regimen" .
<CYM> <Has_antineoplastic> "Methotrexate" .
<CYM> <Has_antineoplastic> "Cytarabine" .
<ATRA_and_Daunorubicin> <Maps_to> "ATRA_and_Daunorubicin" .
<Neratinib_monotherapy> <Has_supportive_med> "Loperamide" .
<FOLFIRI_and_Cetuximab> <Is_current_in> "Colon_cancer" .
<VAD-P/Q> <Maps_to> "VAD-P/Q" .
<BID> <Mapped_from> "BID" .
<ProMACE-CytaBOM> <Has_context> "Induction_therapy" .
<Sonidegib_monotherapy> <Has_context> "Non-curative_therapy" .
<LD-ACOP-B> <Maps_to> "LD-ACOP-B" .
<Citaloxan> <Brand_name_of> "Cytarabine" .
<CMC> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<VTD> <Has_supportive_med> "Warfarin" .
<VTD> <Has_supportive_med> "Low_molecular_weight_heparins" .
<VTD> <Has_supportive_med> "Enoxaparin" .
<VTD> <Has_supportive_med> "Aspirin" .
<VTD> <Has_supportive_med> "Acyclovir" .
<Vindesine_monotherapy> <Has_modality> "Chemotherapy" .
<ABC> <Maps_to> "ABC" .
<Avelumab_monotherapy> <Mapped_from> "Avelumab_monotherapy" .
<Anti-CD52_antibody> <Subsumes> "Alemtuzumab" .
<Leeporate> <Brand_name_of> "Valproate" .
<Atezolizumab_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<Atezolizumab_and_Bevacizumab> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Vincristine_liposomal_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Vincristine_and_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Tisagenlecleucel_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "R-Hyper-CVAD/R-MA" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Prednisone_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Ponatinib_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Pegaspargase,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Pediatric-like_GRAALL_consolidation" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "POMP" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Nilotinib-based_consolidation" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Nilotinib_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Methotrexate_and_Vincristine" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Methotrexate_and_Pegaspargase" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Mercaptopurine,_Methotrexate,_WB-XRT" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Mercaptopurine,_Methotrexate,_Vincristine" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Mercaptopurine_and_Methotrexate" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Linker_regimen_(consolidation)" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "L-Asparaginase_and_Methotrexate" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "International_ALL_Trial" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Inotuzumab_ozogamicin_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Imatinib-based_consolidation" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Imatinib,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Imatinib,_Vincristine,_Dexamethasone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Imatinib_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Imatinib_and_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Hyper-CVAD/MA_and_Everolimus" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Hyper-CVAD/MA" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Hyper-CVAD_and_Ponatinib" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Hyper-CVAD_and_Imatinib" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Hyper-CVAD_and_Dasatinib" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "HAM_and_Imatinib" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "FLAG" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Etoposide,_Ifosfamide,_Imatinib" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Etoposide_and_TBI,_then_allo_HSCT" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Dasatinib,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Dasatinib_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Dasatinib_and_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "DOLP_(Prednisolone)" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "DOLP" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Cytarabine,_Idarubicin,_Rituximab" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Cytarabine,_Idarubicin,_Imatinib" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Cytarabine_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Cytarabine_and_Mitoxantrone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Cytarabine_and_Idarubicin" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Cyclophosphamide,_Cytarabine,_Mercaptopurine" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Cyclophosphamide_and_TBI,_then_allo_HSCT" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Clofarabine_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Calaspargase,_Daunorubicin,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "CCE" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "CALGB_8811_late_intensification" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "CALGB_8811_early_intensification" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Bosutinib_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Blinatumomab_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Augmented_Hyper-CVAD_and_Asparaginase" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "Augmented_BFM_consolidation" .
<B-cell_acute_lymphoblastic_leukemia> <Current_treated_by> "AALL0232_consolidation" .
<BiCNU> <Brand_name_of> "Carmustine" .
<Dosatran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<HiDAC> <Is_current_in> "CNS_lymphoma" .
<HiDAC> <Is_current_in> "Acute_myeloid_leukemia" .
<Quimio-PED> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Gilteritinib_monotherapy> <Has_accepted_use> "FLT3-positive_Acute_myeloid_leukemia" .
<Gilteritinib_monotherapy> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Zorprin> <Brand_name_of> "Aspirin" .
<Olaparib_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<Olaparib_monotherapy> <Has_accepted_use> "Pancreatic_cancer" .
<Olaparib_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Olaparib_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Olaparib_monotherapy> <Has_accepted_use> "BRCA-mutated_Pancreatic_cancer" .
<Olaparib_monotherapy> <Has_accepted_use> "BRCA-mutated_Ovarian_cancer" .
<Olaparib_monotherapy> <Has_accepted_use> "BRCA-mutated_Breast_cancer" .
<Chlorambucil_and_Prednisone> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<m-BACOD> <Is_a> "Anthracycline-containing_regimen" .
<Carboplatin,_Vinorelbine,_RT> <Maps_to> "Carboplatin,_Vinorelbine,_RT" .
<Dronalent> <Brand_name_of> "Alendronate" .
<VMV-VAC> <Is_a> "Anthracycline-containing_regimen" .
<FAC_and_BCG> <Has_modality> "Immunotherapy" .
<FAC_and_BCG> <Has_modality> "Chemotherapy" .
<Octreotide_LAR_monotherapy> <Has_antineoplastic> "Octreotide_LAR" .
<Antifolate> <Is_a> "Antimetabolite" .
<Capecitabine_and_Mitomycin> <Has_antineoplastic> "Mitomycin" .
<Capecitabine_and_Mitomycin> <Has_antineoplastic> "Capecitabine" .
<Cytarabine,_Idarubicin,_Rituximab> <Mapped_from> "Cytarabine,_Idarubicin,_Rituximab" .
<Clarithromycin> <May_have_route> "Oral" .
<Low-dose_TBI> <Is_current_in> "Allogeneic_HSCT" .
<VTD> <Has_context> "Non-curative_therapy" .
<VTD> <Has_context> "Non-curative_first-line_therapy" .
<VTD> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Topoisomerase_inhibitor> <Subsumes> "Vosaroxin" .
<Topoisomerase_inhibitor> <Subsumes> "Topotecan" .
<Topoisomerase_inhibitor> <Subsumes> "Teniposide" .
<Topoisomerase_inhibitor> <Subsumes> "Sacituzumab_govitecan" .
<Topoisomerase_inhibitor> <Subsumes> "Pixantrone" .
<Topoisomerase_inhibitor> <Subsumes> "Pegylated_liposomal_doxorubicin" .
<Topoisomerase_inhibitor> <Subsumes> "Non-pegylated_liposomal_doxorubicin" .
<Topoisomerase_inhibitor> <Subsumes> "Mitoxantrone" .
<Topoisomerase_inhibitor> <Subsumes> "Irinotecan_liposome" .
<Topoisomerase_inhibitor> <Subsumes> "Irinotecan" .
<Topoisomerase_inhibitor> <Subsumes> "Idarubicin" .
<Topoisomerase_inhibitor> <Subsumes> "Fam-trastuzumab_deruxtecan" .
<Topoisomerase_inhibitor> <Subsumes> "Etoposide" .
<Topoisomerase_inhibitor> <Subsumes> "Epirubicin" .
<Topoisomerase_inhibitor> <Subsumes> "Doxorubicin" .
<Topoisomerase_inhibitor> <Subsumes> "Daunorubicin_liposomal" .
<Topoisomerase_inhibitor> <Subsumes> "Daunorubicin" .
<Topoisomerase_inhibitor> <Subsumes> "Cytarabine_and_daunorubicin_liposomal" .
<Topoisomerase_inhibitor> <Subsumes> "Belotecan" .
<Topoisomerase_inhibitor> <Subsumes> "Amsacrine" .
<Topoisomerase_inhibitor> <Subsumes> "Amrubicin" .
<Topoisomerase_inhibitor> <Subsumes> "Aclarubicin" .
<Ofatumumab> <Antineoplastic_of> "PCO" .
<Ofatumumab> <Antineoplastic_of> "Ofatumumab_monotherapy" .
<Ofatumumab> <Antineoplastic_of> "O-miniCHOP" .
<Ofatumumab> <Antineoplastic_of> "O-ICE" .
<Ofatumumab> <Antineoplastic_of> "O-FC" .
<Ofatumumab> <Antineoplastic_of> "O-ESHAP" .
<Ofatumumab> <Antineoplastic_of> "O-DHAP" .
<Ofatumumab> <Antineoplastic_of> "O-CHOP" .
<Ofatumumab> <Antineoplastic_of> "Lenalidomide_and_Ofatumumab" .
<Ofatumumab> <Antineoplastic_of> "Idelalisib_and_Ofatumumab" .
<Ofatumumab> <Antineoplastic_of> "Ibrutinib_and_Ofatumumab" .
<Ofatumumab> <Antineoplastic_of> "Chlorambucil_and_Ofatumumab" .
<Ofatumumab> <Antineoplastic_of> "Bendamustine_and_Ofatumumab" .
<Neipogen> <Brand_name_of> "Filgrastim" .
<Fluorouracil,_Oxaliplatin,_RT> <Has_context> "Neoadjuvant_therapy" .
<TACE,_then_5-FU> <Is_current_in> "Hepatocellular_carcinoma" .
<Mitotane_and_EDP> <Maps_to> "Mitotane_and_EDP" .
<ADOC> <Has_context> "Non-curative_first-line_therapy" .
<Duvelisib_monotherapy> <Has_context> "Non-curative_therapy" .
<FEAM,_then_auto_HSCT> <Mapped_from> "FEAM,_then_auto_HSCT" .
<Orafix> <Brand_name_of> "Risedronate" .
<Cipaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Gemcitabine_and_S-1> <Has_antineoplastic> "Tegafur_gimeracil_oteracil" .
<Gemcitabine_and_S-1> <Has_antineoplastic> "Gemcitabine" .
<Venetoclax_monotherapy> <Has_modality> "Chemotherapy" .
<Evertor> <Brand_name_of> "Everolimus" .
<Oncoplatin_AQ> <Brand_name_of> "Cisplatin" .
<Cyclophosphamide,_Etoposide,_TBI> <Has_antineoplastic> "External_beam_radiotherapy" .
<Cyclophosphamide,_Etoposide,_TBI> <Has_antineoplastic> "Etoposide" .
<Cyclophosphamide,_Etoposide,_TBI> <Has_antineoplastic> "Cyclophosphamide" .
<Capecitabine,_Sorafenib,_RT> <Has_modality> "Radiotherapy" .
<Capecitabine,_Sorafenib,_RT> <Has_modality> "Chemotherapy" .
<R-FM> <Is_a> "Rituximab-containing_regimen" .
<R-FM> <Is_a> "Anthracycline-containing_regimen" .
<Degalin> <Brand_name_of> "Folinic_acid" .
<Diphereline> <Brand_name_of> "Triptorelin" .
<FOLFIRI_and_Bevacizumab_(L-Leucovorin)> <Is_current_in> "Colon_cancer" .
<FOLFIRI_and_Ramucirumab> <Is_current_in> "Colon_cancer" .
<Ticagrelor> <Has_brand_name> "Ticalog" .
<Ticagrelor> <Has_brand_name> "Brilique" .
<Ticagrelor> <Has_brand_name> "Brilinta" .
<VEPA> <Has_antineoplastic> "Vincristine" .
<VEPA> <Has_antineoplastic> "Prednisolone" .
<VEPA> <Has_antineoplastic> "Doxorubicin" .
<VEPA> <Has_antineoplastic> "Cyclophosphamide" .
<FOLFOX> <Mapped_from> "FOLFOX" .
<Selinexor_and_Dexamethasone> <Mapped_from> "Selinexor_and_Dexamethasone" .
<Pazopanib_monotherapy> <Has_context> "Non-curative_therapy" .
<Pazopanib_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<Pazopanib_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Pazopanib_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Pazopanib_monotherapy> <Has_context> "All_lines_of_therapy" .
<ddTH_(Taxol)> <Has_antineoplastic> "Trastuzumab" .
<ddTH_(Taxol)> <Has_antineoplastic> "Paclitaxel" .
<Lapatinib> <Has_FDA_indication> "Breast_cancer" .
<Cisplan> <Brand_name_of> "Cisplatin" .
<Acalabrutinib> <Has_brand_name> "Calquence" .
<Interferon_alfa-2b_and_Prednisone> <Has_antineoplastic> "Prednisone" .
<Interferon_alfa-2b_and_Prednisone> <Has_antineoplastic> "Interferon_alfa-2b" .
<Carboplatin,_Olaparib,_Paclitaxel> <Has_antineoplastic> "Paclitaxel" .
<Carboplatin,_Olaparib,_Paclitaxel> <Has_antineoplastic> "Olaparib" .
<Carboplatin,_Olaparib,_Paclitaxel> <Has_antineoplastic> "Carboplatin" .
<Dacomitinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Fulvestrant_monotherapy> <Is_a> "Antiestrogen-containing_regimen" .
<POEMS_syndrome> <Accepted_use_of> "Rd" .
<POEMS_syndrome> <Accepted_use_of> "Lenalidomide" .
<POEMS_syndrome> <Accepted_use_of> "Dexamethasone" .
<ECX> <Has_modality> "Chemotherapy" .
<Medason> <Brand_name_of> "Methylprednisolone" .
<Soldesam> <Brand_name_of> "Dexamethasone" .
<ddA> <Is_current_in> "Breast_cancer" .
<Lutetium_Lu_177_dotatate_and_Octreotide_LAR> <Has_supportive_med> "Temozolomide" .
<Lutetium_Lu_177_dotatate_and_Octreotide_LAR> <Has_supportive_med> "Ondansetron" .
<Intraperitoneal_5-FU> <Is_current_in> "Colon_cancer" .
<Nordic_FLOX> <Mapped_from> "Nordic_FLOX" .
<Imodium> <Brand_name_of> "Loperamide" .
<Ketoconazole> <Is_a> "Endocrine_therapeutic" .
<Ketoconazole> <Is_a> "Antifungal" .
<Ketoconazole> <Is_a> "Antiandrogen" .
<Hopamethasone> <Brand_name_of> "Dexamethasone" .
<CBV-Mx> <Is_current_in> "Autologous_HSCT" .
<PCV> <Has_accepted_use> "Low-grade_glioma" .
<PCV> <Has_accepted_use> "Glioblastoma" .
<PCV> <Has_accepted_use> "Anaplastic_glioma" .
<Cisplatin,_Pemetrexed,_Bevacizumab> <Has_supportive_med> "Folic_acid" .
<Cisplatin,_Pemetrexed,_Bevacizumab> <Has_supportive_med> "Dexamethasone" .
<Cisplatin,_Pemetrexed,_Bevacizumab> <Has_supportive_med> "Cyanocobalamin" .
<Andoprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<R-CEOP_(Etoposide)> <Has_modality> "Chemotherapy" .
<G-CHOP> <Is_current_in> "Follicular_lymphoma" .
<Amsacrine_and_Cytarabine> <Mapped_from> "Amsacrine_and_Cytarabine" .
<HOP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Rituximab_and_hyaluronidase_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<FOLFOX4_and_Panitumumab> <Has_modality> "Chemotherapy" .
<Koate-DVI> <Brand_name_of> "Factor_VIII_human" .
<Temozolomide,_then_Temozolomide_and_RT,_then_Temozolomide> <Has_context> "Adjuvant_therapy" .
<Mitotane_and_EDP> <Has_context> "Non-curative_therapy" .
<Cyclosporine_modified> <Has_brand_name> "Neoral" .
<Cyclosporine_modified> <Has_brand_name> "Gengraf" .
<Necitumumab> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Vincristine_monotherapy> <Has_accepted_use> "Wilms_tumor" .
<Vincristine_monotherapy> <Has_accepted_use> "Thrombotic_thrombocytopenic_purpura" .
<Bortezomib_monotherapy> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Bortezomib_monotherapy> <Has_accepted_use> "Multiple_myeloma" .
<Bortezomib_monotherapy> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Bortezomib_monotherapy> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Bortezomib_monotherapy> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Bortezomib_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<Bortezomib_monotherapy> <Has_accepted_use> "Castleman_disease" .
<Alendronato> <Brand_name_of> "Alendronate" .
<Dexrazoxane> <Supportive_med_of> "Doxorubicin_monotherapy" .
<Dexrazoxane> <Supportive_med_of> "Doxorubicin_and_Olaratumab" .
<Dexrazoxane> <Supportive_med_of> "Brentuximab_vedotin_monotherapy" .
<Dexrazoxane> <Supportive_med_of> "ABVE-PC" .
<VEPEMB> <Is_current_in> "Hodgkin_lymphoma" .
<BVR> <Has_antineoplastic> "Rituximab" .
<BVR> <Has_antineoplastic> "Bortezomib" .
<BVR> <Has_antineoplastic> "Bendamustine" .
<Treakisym> <Brand_name_of> "Bendamustine" .
<Lindron> <Brand_name_of> "Alendronate" .
<Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<Dexaedo> <Brand_name_of> "Dexamethasone" .
<BR_and_Ibrutinib> <Is_a> "Rituximab-containing_regimen" .
<Myctrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<R-ICE> <Has_context> "Salvage_therapy" .
<Hyper-CVAD_and_Imatinib> <Has_local_therapy> "Methotrexate" .
<Hyper-CVAD_and_Imatinib> <Has_local_therapy> "External_beam_radiotherapy" .
<Hyper-CVAD_and_Imatinib> <Has_local_therapy> "Cytarabine" .
<PCV> <Has_supportive_med> "Steroids" .
<PCV> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<PCV> <Has_supportive_med> "Ondansetron" .
<PCV> <Has_supportive_med> "Metoclopramide" .
<PCV> <Has_supportive_med> "Domperidone" .
<VI,_then_VDC/IE,_then_VAC,_then_VI> <Mapped_from> "VI,_then_VDC/IE,_then_VAC,_then_VI" .
<Daunorubicin_liposomal_monotherapy> <Is_a> "Anthracycline-containing_regimen" .
<Gamactrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Wymesone> <Brand_name_of> "Dexamethasone" .
<Etoposide_and_Prednisone> <Has_accepted_use> "Langerhans_cell_histiocytosis" .
<MAPIE> <Has_context> "Adjuvant_therapy" .
<CCE> <Mapped_from> "CCE" .
<Erdafitinib> <Is_a> "Mutation-specific_medication" .
<Erdafitinib> <Is_a> "Kinase_inhibitor" .
<Erdafitinib> <Is_a> "FGFR_inhibitor" .
<Copanlisib_monotherapy> <Is_current_in> "Follicular_lymphoma" .
<Pembrolizumab> <Antineoplastic_of> "Pomalidomide,_Dexamethasone,_Pembrolizumab" .
<Pembrolizumab> <Antineoplastic_of> "Pemetrexed_and_Pembrolizumab" .
<Pembrolizumab> <Antineoplastic_of> "Pembrolizumab_monotherapy" .
<Pembrolizumab> <Antineoplastic_of> "Lenvatinib_and_Pembrolizumab" .
<Pembrolizumab> <Antineoplastic_of> "Cisplatin,_Pemetrexed,_Pembrolizumab" .
<Pembrolizumab> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_Pembrolizumab" .
<Pembrolizumab> <Antineoplastic_of> "Carboplatin,_nab-Paclitaxel,_Pembrolizumab" .
<Pembrolizumab> <Antineoplastic_of> "Carboplatin,_Pemetrexed,_Pembrolizumab" .
<Pembrolizumab> <Antineoplastic_of> "Carboplatin,_Paclitaxel,_Pembrolizumab" .
<Pembrolizumab> <Antineoplastic_of> "Axitinib_and_Pembrolizumab" .
<CAMF> <Maps_to> "CAMF" .
<VAP> <Maps_to> "VAP" .
<ATRA,_Mercaptopurine,_Methotrexate> <Has_context> "Maintenance_after_upfront_therapy" .
<A-AVD> <Has_modality> "Chemotherapy" .
<VCAP> <Has_antineoplastic> "Vindesine" .
<VCAP> <Has_antineoplastic> "Prednisone" .
<VCAP> <Has_antineoplastic> "Doxorubicin" .
<VCAP> <Has_antineoplastic> "Cyclophosphamide" .
<Ibrutinib_monotherapy> <Maps_to> "Ibrutinib_monotherapy" .
<Temozolomide> <Has_brand_name> "Temzol" .
<Temozolomide> <Has_brand_name> "Temoz" .
<Temozolomide> <Has_brand_name> "Temoside" .
<Temozolomide> <Has_brand_name> "Temonat" .
<Temozolomide> <Has_brand_name> "Temodar" .
<Temozolomide> <Has_brand_name> "Temodal" .
<Temozolomide> <Has_brand_name> "Temizole" .
<Temozolomide> <Has_brand_name> "Temcad" .
<Temozolomide> <Has_brand_name> "Gliotem" .
<Lobaplatin> <May_have_route> "Intravenous" .
<Docetaxel_and_Gemcitabine> <Has_context> "Non-curative_therapy" .
<Docetaxel_and_Gemcitabine> <Has_context> "Non-curative_subsequent-line_therapy" .
<Docetaxel_and_Gemcitabine> <Has_context> "Non-curative_first-line_therapy" .
<Docetaxel_and_Gemcitabine> <Has_context> "All_lines_of_therapy" .
<Asaflow> <Brand_name_of> "Aspirin" .
<CTD> <Has_accepted_use> "Multiple_myeloma" .
<CTD> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Poteligeo> <Brand_name_of> "Mogamulizumab" .
<CALGB_8811_late_intensification> <Has_context> "Consolidation_after_upfront_therapy" .
<7_plus_3m> <Has_accepted_use> "Acute_myeloid_leukemia" .
<V-HyperCAD> <Is_current_in> "Multiple_myeloma" .
<Carboplatin,_Pemetrexed,_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<Letroz> <Brand_name_of> "Letrozole" .
<EIA> <Has_accepted_use> "Soft_tissue_sarcoma" .
<ADT_and_Enzalutamide> <Mapped_from> "ADT_and_Enzalutamide" .
<Antiplatelet_agents> <Supportive_med_of> "TD" .
<Antiplatelet_agents> <Supportive_med_of> "Rd" .
<Antiplatelet_agents> <Supportive_med_of> "KRd" .
<Bortezomib> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Bortezomib> <Has_accepted_use> "Plasma_cell_leukemia" .
<Bortezomib> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Bortezomib> <Has_accepted_use> "Multiple_myeloma" .
<Bortezomib> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Bortezomib> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Bortezomib> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Bortezomib> <Has_accepted_use> "Follicular_lymphoma" .
<Bortezomib> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Bortezomib> <Has_accepted_use> "Castleman_disease" .
<Vemurafenib> <Has_brand_name> "Zelboraf" .
<ATG_(Rabbit)_monotherapy> <Is_current_in> "Myelodysplastic_syndrome" .
<Heparin_monotherapy> <Maps_to> "Heparin_monotherapy" .
<mFOLFOX7> <Maps_to> "mFOLFOX7" .
<m-BACOD> <Has_modality> "Chemotherapy" .
<Dacarbazine_and_Tamoxifen> <Has_modality> "Hormonotherapy" .
<Dacarbazine_and_Tamoxifen> <Has_modality> "Chemotherapy" .
<Danaparoid_monotherapy> <Has_accepted_use> "Heparin-induced_thrombocytopenia" .
<Clofarabine_and_Melphalan,_then_allo_HSCT> <Maps_to> "Clofarabine_and_Melphalan,_then_allo_HSCT" .
<Bacin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CAVE> <Has_context> "Induction_therapy" .
<Gemcitabine_monotherapy> <Is_current_in> "Small_cell_lung_cancer" .
<Gemcitabine_monotherapy> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<Gemcitabine_monotherapy> <Is_current_in> "Pancreatic_cancer" .
<Gemcitabine_monotherapy> <Is_current_in> "Ovarian_cancer" .
<Gemcitabine_monotherapy> <Is_current_in> "Osteosarcoma" .
<Gemcitabine_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Gemcitabine_monotherapy> <Is_current_in> "Nasopharyngeal_carcinoma" .
<Gemcitabine_monotherapy> <Is_current_in> "Mesothelioma" .
<Gemcitabine_monotherapy> <Is_current_in> "Hodgkin_lymphoma" .
<Gemcitabine_monotherapy> <Is_current_in> "Gallbladder_cancer" .
<Gemcitabine_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Gemcitabine_monotherapy> <Is_current_in> "Cholangiocarcinoma" .
<Gemcitabine_monotherapy> <Is_current_in> "Cervical_cancer" .
<Gemcitabine_monotherapy> <Is_current_in> "Breast_cancer" .
<Gemcitabine_monotherapy> <Is_current_in> "Bladder_cancer" .
<ddE> <Has_accepted_use> "Breast_cancer" .
<Fluorouracil_and_Semustine> <Has_antineoplastic> "Semustine" .
<Fluorouracil_and_Semustine> <Has_antineoplastic> "Fluorouracil" .
<FOLFOX_chronotherapy> <Has_modality> "Chemotherapy" .
<R-CHOP-14_(Prednisolone)> <Mapped_from> "R-CHOP-14_(Prednisolone)" .
<ChlVPP/EVA> <Is_a> "Anthracycline-containing_regimen" .
<Active_surveillance> <Mapped_from> "Active_surveillance" .
<DICE> <Maps_to> "DICE" .
<Epival> <Brand_name_of> "Valproate" .
<Prednisolone_monotherapy> <Is_historical_in> "Multiple_myeloma" .
<Prednisolone_monotherapy> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<Aclacinomycine> <Brand_name_of> "Aclarubicin" .
<Fosfidex> <Brand_name_of> "Ifosfamide" .
<OPPA> <Has_antineoplastic> "Vincristine" .
<OPPA> <Has_antineoplastic> "Procarbazine" .
<OPPA> <Has_antineoplastic> "Prednisone" .
<OPPA> <Has_antineoplastic> "Doxorubicin" .
<Emthexat> <Brand_name_of> "Methotrexate" .
<Pralatrexate> <Is_a> "Antimetabolite" .
<Pralatrexate> <Is_a> "Antifolate" .
<MVP_(Vindesine)> <Mapped_from> "MVP_(Vindesine)" .
<Formestane> <Is_a> "Discontinued_drug" .
<NOVP> <Mapped_from> "NOVP" .
<FAM> <Has_modality> "Chemotherapy" .
<mDCF_and_Bevacizumab> <Is_current_in> "Gastric_cancer" .
<Azacitidine_and_Vorinostat> <Is_current_in> "Myelodysplastic_syndrome" .
<Azacitidine_and_Vorinostat> <Is_current_in> "Chronic_myelomonocytic_leukemia" .
<Triptorelin> <Is_a> "GnRH_agonist" .
<Triptorelin> <Is_a> "Endocrine_therapeutic" .
<Triptorelin> <Is_a> "Antiandrogen" .
<Cemiplimab_monotherapy> <Maps_to> "Cemiplimab_monotherapy" .
<Daunorubicin_monotherapy> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Daunorubicin_monotherapy> <Has_accepted_use> "Acute_myeloid_leukemia" .
<ABVD> <Is_current_in> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<ABVD> <Is_current_in> "Hodgkin_lymphoma" .
<AVCF> <Maps_to> "AVCF" .
<Interferon_alfa-2a_monotherapy> <Is_current_in> "Renal_cell_carcinoma" .
<Interferon_alfa-2a_monotherapy> <Is_current_in> "Melanoma" .
<Interferon_alfa-2a_monotherapy> <Is_current_in> "Kaposi_sarcoma" .
<Interferon_alfa-2a_monotherapy> <Is_current_in> "Chronic_myelogenous_leukemia" .
<CDE> <Has_antineoplastic> "Etoposide" .
<CDE> <Has_antineoplastic> "Doxorubicin" .
<CDE> <Has_antineoplastic> "Cyclophosphamide" .
<VAD-P/Q> <Has_antineoplastic> "Vincristine" .
<VAD-P/Q> <Has_antineoplastic> "Quinine" .
<VAD-P/Q> <Has_antineoplastic> "Prednisone" .
<VAD-P/Q> <Has_antineoplastic> "Doxorubicin" .
<VAD-P/Q> <Has_antineoplastic> "Dexamethasone" .
<VMP/Rd> <Has_antineoplastic> "Prednisone" .
<VMP/Rd> <Has_antineoplastic> "Melphalan" .
<VMP/Rd> <Has_antineoplastic> "Lenalidomide" .
<VMP/Rd> <Has_antineoplastic> "Dexamethasone" .
<VMP/Rd> <Has_antineoplastic> "Bortezomib" .
<Campostar> <Brand_name_of> "Irinotecan" .
<MIC> <Has_context> "Non-curative_first-line_therapy" .
<MIC> <Has_context> "Neoadjuvant_therapy" .
<MIC> <Has_context> "Induction_therapy" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Olanzapine> <May_have_route> "Oral" .
<Olanzapine> <May_have_route> "Intramuscular" .
<Cisplatin,_Fluorouracil,_Pembrolizumab> <Has_context> "Non-curative_first-line_therapy" .
<Trifluridine_and_tipiracil> <Has_brand_name> "Lonsurf" .
<Ponatinib_monotherapy> <Mapped_from> "Ponatinib_monotherapy" .
<IT_Methotrexate_monotherapy> <Has_local_therapy> "Methotrexate" .
<Mitotane_monotherapy> <Has_supportive_med> "Metoclopramide" .
<Mitotane_monotherapy> <Has_supportive_med> "Loperamide" .
<Mitotane_monotherapy> <Has_supportive_med> "Hydrocortisone" .
<Docetaxel_and_Nedaplatin> <Maps_to> "Docetaxel_and_Nedaplatin" .
<EAR_and_G-CSF> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<EAR_and_G-CSF> <Has_supportive_med> "Levofloxacin" .
<EAR_and_G-CSF> <Has_supportive_med> "Fluconazole" .
<EAR_and_G-CSF> <Has_supportive_med> "Filgrastim" .
<EAR_and_G-CSF> <Has_supportive_med> "Acyclovir" .
<Sickle_cell_anemia> <Accepted_use_of> "RBC_transfusions" .
<Sickle_cell_anemia> <Accepted_use_of> "L-glutamine_monotherapy" .
<Sickle_cell_anemia> <Accepted_use_of> "L-glutamine" .
<Sickle_cell_anemia> <Accepted_use_of> "Hydroxyurea_monotherapy" .
<Sickle_cell_anemia> <Accepted_use_of> "Hydroxyurea" .
<Sickle_cell_anemia> <Accepted_use_of> "Crizanlizumab_monotherapy" .
<Sickle_cell_anemia> <Accepted_use_of> "Crizanlizumab" .
<Rabbit_ATG> <Maps_to> "Rabbit_ATG" .
<CAPIRI> <Has_context> "Non-curative_subsequent-line_therapy" .
<CAPIRI> <Has_context> "Non-curative_second-line_therapy" .
<CAPIRI> <Has_context> "Non-curative_first-line_therapy" .
<Fulvestrant_monotherapy> <Is_current_in> "Breast_cancer" .
<HLH-94_regimen> <Mapped_from> "HLH-94_regimen" .
<Dronabinol> <Is_a> "Emesis_prevention" .
<Dronabinol> <Is_a> "Cannabinoid" .
<mFOLFOX7_(L-Leucovorin)> <Has_modality> "Chemotherapy" .
<Onartuzumab> <Is_a> "Investigational_drug" .
<Onartuzumab> <Is_a> "Antibody_medication" .
<Onartuzumab> <Is_a> "Anti-c-Met_antibody" .
<CapeOx_and_Bevacizumab> <Is_current_in> "Hepatocellular_carcinoma" .
<CapeOx_and_Bevacizumab> <Is_current_in> "Colon_cancer" .
<Trastuzumab-dttb> <Has_accepted_use> "Gastric_cancer" .
<Trastuzumab-dttb> <Has_accepted_use> "Esophageal_cancer" .
<Trastuzumab-dttb> <Has_accepted_use> "Breast_cancer" .
<R-BEAM> <Has_antineoplastic> "Rituximab" .
<R-BEAM> <Has_antineoplastic> "Melphalan" .
<R-BEAM> <Has_antineoplastic> "Etoposide" .
<R-BEAM> <Has_antineoplastic> "Cytarabine" .
<R-BEAM> <Has_antineoplastic> "Carmustine" .
<Carboplatin_and_Pemetrexed> <Has_antineoplastic> "Pemetrexed" .
<Carboplatin_and_Pemetrexed> <Has_antineoplastic> "Carboplatin" .
<Kecimeton_Tatumi> <Brand_name_of> "Fluorouracil" .
<Paclitaxel_and_RT> <Maps_to> "Paclitaxel_and_RT" .
<CBDCA> <Brand_name_of> "Carboplatin" .
<Mogamulizumab> <May_have_route> "Intravenous" .
<Azacitidine_and_Venetoclax> <Is_current_in> "Acute_myeloid_leukemia" .
<Engenase> <Brand_name_of> "Asparaginase" .
<FLEC> <Has_accepted_use> "Pancreatic_cancer" .
<Ceritinib_monotherapy> <Has_accepted_use> "ROS1-positive_Non-small_cell_lung_cancer" .
<Ceritinib_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Ceritinib_monotherapy> <Has_accepted_use> "CNS_carcinoma" .
<Ceritinib_monotherapy> <Has_accepted_use> "ALK-positive_Non-small_cell_lung_cancer" .
<P2Y12_ADP_inhibitor> <Is_a> "Antiplatelet_agent" .
<Aclacin> <Brand_name_of> "Aclarubicin" .
<Cyclosporine_modified> <Immunosuppressor_of> "Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant" .
<Cyclosporine_modified> <Immunosuppressor_of> "Cyclosporine,_Mycophenolate_mofetil,_Sirolimus" .
<Cyclosporine_modified> <Immunosuppressor_of> "Cyclosporine,_Methotrexate,_Prednisone" .
<Cyclosporine_modified> <Immunosuppressor_of> "Cyclosporine,_Methotrexate,_Methylprednisolone" .
<Cyclosporine_modified> <Immunosuppressor_of> "Cyclosporine_monotherapy" .
<Cyclosporine_modified> <Immunosuppressor_of> "Cyclosporine_and_Mycophenolate_mofetil" .
<Cyclosporine_modified> <Immunosuppressor_of> "Busulfan_and_Fludarabine" .
<Cyclosporine_modified> <Immunosuppressor_of> "BuFlu,_then_allo_HSCT" .
<DCF> <Has_accepted_use> "SCC_of_unknown_primary" .
<DCF> <Has_accepted_use> "Penile_cancer" .
<DCF> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<DCF> <Has_accepted_use> "Head_and_neck_cancer" .
<DCF> <Has_accepted_use> "Gastric_cancer" .
<VABE> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<R-EPOCH,_dose-escalated> <Is_a> "Rituximab-containing_regimen" .
<R-EPOCH,_dose-escalated> <Is_a> "Anthracycline-containing_regimen" .
<Cisplatin,_Cetuximab,_RT> <Maps_to> "Cisplatin,_Cetuximab,_RT" .
<Pentraxin_2> <Has_accepted_use> "Myelofibrosis" .
<Osdronat> <Brand_name_of> "Alendronate" .
<Chlorambucil_and_Obinutuzumab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Eprex> <Brand_name_of> "Epoetin_alfa" .
<Intravesical> <May_be_route_of> "Valrubicin" .
<Intravesical> <May_be_route_of> "Thiotepa" .
<Intravesical> <May_be_route_of> "Pirarubicin" .
<Intravesical> <May_be_route_of> "Mitomycin" .
<Intravesical> <May_be_route_of> "Gemcitabine" .
<Intravesical> <May_be_route_of> "Doxorubicin" .
<Intravesical> <May_be_route_of> "Bacillus_Calmette-Guerin" .
<Flutamide> <Antineoplastic_of> "Flutamide,_Leuprolide,_RT" .
<Flutamide> <Antineoplastic_of> "Flutamide,_Goserelin,_RT" .
<Flutamide> <Antineoplastic_of> "Flutamide_monotherapy" .
<Flutamide> <Antineoplastic_of> "Flutamide_and_Leuprolide" .
<Flutamide> <Antineoplastic_of> "Flutamide_and_Goserelin" .
<Flutamide> <Antineoplastic_of> "ADT_and_RT" .
<Flutamide> <Antineoplastic_of> "ADT" .
<Gemcitabine_and_Trastuzumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<AV-CMF> <Has_accepted_use> "Breast_cancer" .
<Decitabine_and_Valproate> <Mapped_from> "Decitabine_and_Valproate" .
<Carboplatin,_Paclitaxel,_Pembrolizumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<MOPP-ABV> <Has_context> "Induction_therapy" .
<BEAM,_then_auto_HSCT> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<BEAM,_then_auto_HSCT> <Has_accepted_use> "Mantle_cell_lymphoma" .
<BEAM,_then_auto_HSCT> <Has_accepted_use> "Hodgkin_lymphoma" .
<BEAM,_then_auto_HSCT> <Has_accepted_use> "HIV-associated_lymphoma" .
<BEAM,_then_auto_HSCT> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<BEAM,_then_auto_HSCT> <Has_accepted_use> "CNS_lymphoma" .
<Mediastinal_gray-zone_lymphoma> <Is_a> "Non-Hodgkin_lymphoma" .
<Mediastinal_gray-zone_lymphoma> <Is_a> "Aggressive_lymphoma" .
<BuCyTBI,_then_allo_HSCT> <Has_modality> "Radiotherapy" .
<BuCyTBI,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<BuCyTBI,_then_allo_HSCT> <Has_modality> "Chemotherapy" .
<Denileukin_diftitox> <Antineoplastic_of> "Denileukin_diftitox_monotherapy" .
<Denileukin_diftitox> <Antineoplastic_of> "DD-CHOP" .
<FOLFOX_7/sLV5FU2_(L-Leucovorin)> <Has_context> "Non-curative_first-line_therapy" .
<Tamoxifen_monotherapy> <Is_current_in> "Hereditary_hemorrhagic_telangiectasia" .
<Tamoxifen_monotherapy> <Is_current_in> "Endometrial_cancer" .
<Tamoxifen_monotherapy> <Is_current_in> "Breast_cancer" .
<Atypical_hemolytic_uremic_syndrome> <Accepted_use_of> "Eculizumab_monotherapy" .
<Atypical_hemolytic_uremic_syndrome> <Accepted_use_of> "Eculizumab" .
<Alencar> <Brand_name_of> "Ondansetron" .
<Floxuridine> <Is_a> "Irritant" .
<Floxuridine> <Is_a> "Fluoropyrimidine" .
<Valganciclovir> <Has_brand_name> "Virolfi" .
<Valganciclovir> <Has_brand_name> "Valnov" .
<Valganciclovir> <Has_brand_name> "Valixa" .
<Valganciclovir> <Has_brand_name> "Valgan" .
<Valganciclovir> <Has_brand_name> "Valcyte" .
<Valganciclovir> <Has_brand_name> "Valcyclovir" .
<Valganciclovir> <Has_brand_name> "VagaCyte" .
<Valganciclovir> <Has_brand_name> "V-Gavir" .
<Valganciclovir> <Has_brand_name> "Cytomega" .
<COPP_(CCNU)> <Mapped_from> "COPP_(CCNU)" .
<dmCODOX-M/IVAC_-_Modified_Magrath> <Mapped_from> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Dara-Rd> <Is_current_in> "Multiple_myeloma" .
<PEN> <Is_a> "Anthracycline-containing_regimen" .
<Gemcitabine_and_Bevacizumab> <Is_current_in> "Breast_cancer" .
<Cisplatin_and_Methotrexate> <Has_antineoplastic> "Methotrexate" .
<Cisplatin_and_Methotrexate> <Has_antineoplastic> "Cisplatin" .
<Chlorambucil_monotherapy> <Mapped_from> "Chlorambucil_monotherapy" .
<Fludarabine_and_Melphalan> <Has_modality> "Immunosuppressive_therapy" .
<Fludarabine_and_Melphalan> <Has_modality> "Chemotherapy" .
<Hydroxyurea_and_Imatinib> <Has_antineoplastic> "Imatinib" .
<Hydroxyurea_and_Imatinib> <Has_antineoplastic> "Hydroxyurea" .
<CPB> <Has_context> "Adjuvant_therapy" .
<BHQ880> <Is_a> "Investigational_drug" .
<BHQ880> <Is_a> "Antibody_medication" .
<BHQ880> <Is_a> "Anti-DKK1_antibody" .
<Abemaciclib_and_Letrozole> <Maps_to> "Abemaciclib_and_Letrozole" .
<Binarin> <Brand_name_of> "Epirubicin" .
<High-dose_Interleukin-2> <Has_modality> "Immunotherapy" .
<Cisplatin,_Dacarbazine,_Tamoxifen> <Has_context> "Non-curative_therapy" .
<Dara-VTD> <Mapped_from> "Dara-VTD" .
<Gemcitabine_and_Vinorelbine> <Has_supportive_med> "Emesis_prevention" .
<VR> <Maps_to> "VR" .
<Amrubicin_monotherapy> <Has_supportive_med> "Mesna" .
<Amrubicin_monotherapy> <Has_supportive_med> "Ifosfamide" .
<Finasteride> <Is_a> "Endocrine_therapeutic" .
<Finasteride> <Is_a> "Antiandrogen" .
<Finasteride> <Is_a> "5_alpha-reductase_inhibitor" .
<VBM> <Has_antineoplastic> "Vincristine" .
<VBM> <Has_antineoplastic> "Methotrexate" .
<VBM> <Has_antineoplastic> "Bleomycin" .
<Temodar> <Brand_name_of> "Temozolomide" .
<Cytarabine,_Ifosfamide,_G-CSF> <Has_supportive_med> "Filgrastim" .
<Femara> <Brand_name_of> "Letrozole" .
<SOX_and_Bevacizumab> <Has_antineoplastic> "Tegafur_gimeracil_oteracil" .
<SOX_and_Bevacizumab> <Has_antineoplastic> "Oxaliplatin" .
<SOX_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Virucid> <Brand_name_of> "Acyclovir" .
<Unidex> <Brand_name_of> "Dexamethasone" .
<Melphalan,_then_auto_HSCT,_then_Melphalan_and_Busulfan,_then_auto_HSCT> <Maps_to> "Melphalan,_then_auto_HSCT,_then_Melphalan_and_Busulfan,_then_auto_HSCT" .
<R-CODOX-M> <Is_current_in> "HIV-associated_lymphoma" .
<R-CODOX-M> <Is_current_in> "Burkitt_lymphoma" .
<Everolimus_monotherapy> <Has_antineoplastic> "Everolimus" .
<Carboplatin,_Fluorouracil,_Cetuximab,_RT> <Has_accepted_use> "Head_and_neck_cancer" .
<Calfolex> <Brand_name_of> "Folinic_acid" .
<VAD> <Has_context> "Non-curative_therapy" .
<VAD> <Has_context> "Non-curative_first-line_therapy" .
<Tagraxofusp_monotherapy> <Has_context> "All_lines_of_therapy" .
<Bortezomib_and_Melphalan> <Has_antineoplastic> "Melphalan" .
<Bortezomib_and_Melphalan> <Has_antineoplastic> "Bortezomib" .
<Doxorubicin_monotherapy> <Maps_to> "Doxorubicin_monotherapy" .
<Dara-KD> <Has_modality> "Chemotherapy" .
<Formestane> <Has_brand_name> "Lentaron" .
<Non-curative_third-line_maintenance_therapy> <Is_a> "Non-curative_third-line_therapy" .
<Testicular_cancer> <Accepted_use_of> "Vincristine" .
<Testicular_cancer> <Accepted_use_of> "Vinblastine" .
<Testicular_cancer> <Accepted_use_of> "VeIP" .
<Testicular_cancer> <Accepted_use_of> "VIP" .
<Testicular_cancer> <Accepted_use_of> "VAB-6" .
<Testicular_cancer> <Accepted_use_of> "TIP" .
<Testicular_cancer> <Accepted_use_of> "Sunitinib_monotherapy" .
<Testicular_cancer> <Accepted_use_of> "Sunitinib" .
<Testicular_cancer> <Accepted_use_of> "Radiation_therapy" .
<Testicular_cancer> <Accepted_use_of> "Plicamycin_monotherapy" .
<Testicular_cancer> <Accepted_use_of> "Plicamycin" .
<Testicular_cancer> <Accepted_use_of> "Paclitaxel" .
<Testicular_cancer> <Accepted_use_of> "PVeBV" .
<Testicular_cancer> <Accepted_use_of> "Oxaliplatin_and_Bevacizumab" .
<Testicular_cancer> <Accepted_use_of> "Oxaliplatin" .
<Testicular_cancer> <Accepted_use_of> "M-TIP" .
<Testicular_cancer> <Accepted_use_of> "Ifosfamide_and_Paclitaxel" .
<Testicular_cancer> <Accepted_use_of> "Ifosfamide" .
<Testicular_cancer> <Accepted_use_of> "Gemcitabine,_Oxaliplatin,_Paclitaxel" .
<Testicular_cancer> <Accepted_use_of> "Gemcitabine_and_Paclitaxel" .
<Testicular_cancer> <Accepted_use_of> "Gemcitabine" .
<Testicular_cancer> <Accepted_use_of> "GemOx" .
<Testicular_cancer> <Accepted_use_of> "GIP" .
<Testicular_cancer> <Accepted_use_of> "Etoposide_monotherapy" .
<Testicular_cancer> <Accepted_use_of> "Etoposide" .
<Testicular_cancer> <Accepted_use_of> "Epirubicin" .
<Testicular_cancer> <Accepted_use_of> "Cisplatin_and_Etoposide" .
<Testicular_cancer> <Accepted_use_of> "Cisplatin_and_Epirubicin" .
<Testicular_cancer> <Accepted_use_of> "Cisplatin" .
<Testicular_cancer> <Accepted_use_of> "Chlorambucil,_Dactinomycin,_Methotrexate" .
<Testicular_cancer> <Accepted_use_of> "Carboplatin_monotherapy" .
<Testicular_cancer> <Accepted_use_of> "Carboplatin_and_Etoposide,_then_auto_HSCT" .
<Testicular_cancer> <Accepted_use_of> "Carboplatin" .
<Testicular_cancer> <Accepted_use_of> "CISCA/VB" .
<Testicular_cancer> <Accepted_use_of> "C-BOP" .
<Testicular_cancer> <Accepted_use_of> "Bleomycin_and_Vinblastine" .
<Testicular_cancer> <Accepted_use_of> "Bleomycin" .
<Testicular_cancer> <Accepted_use_of> "Bevacizumab-bvzr" .
<Testicular_cancer> <Accepted_use_of> "Bevacizumab-awwb" .
<Testicular_cancer> <Accepted_use_of> "Bevacizumab" .
<Testicular_cancer> <Accepted_use_of> "BVP" .
<Testicular_cancer> <Accepted_use_of> "BO" .
<Testicular_cancer> <Accepted_use_of> "BEP" .
<Testicular_cancer> <Accepted_use_of> "Accelerated_BEP" .
<Irinotecan_and_S-1> <Has_accepted_use> "Esophageal_cancer" .
<HAA> <Is_current_in> "Acute_myeloid_leukemia" .
<VAMP_(Methotrexate)> <Has_modality> "Chemotherapy" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Trametinib" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Ramucirumab" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Pemetrexed" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Pembrolizumab" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Paclitaxel_nanoparticle_albumin-bound" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Paclitaxel" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Osimertinib" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Nivolumab" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Necitumumab" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Lorlatinib" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Gemcitabine" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Gefitinib" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Erlotinib" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Entrectinib" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Durvalumab" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Docetaxel" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Dacomitinib" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Dabrafenib" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Crizotinib" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Ceritinib" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Brigatinib" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Bevacizumab-awwb" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Bevacizumab" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Atezolizumab" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Alectinib" .
<Non-small_cell_lung_cancer> <FDA_indication_of> "Afatinib" .
<No_induction> <Has_context> "Non-curative_first-line_therapy" .
<No_induction> <Has_context> "Induction_therapy" .
<CAMFP> <Mapped_from> "CAMFP" .
<CHVmP> <Is_a> "Anthracycline-containing_regimen" .
<Investigational_drug> <Subsumes> "Vosaroxin" .
<Investigational_drug> <Subsumes> "Volasertib" .
<Investigational_drug> <Subsumes> "Veltuzumab" .
<Investigational_drug> <Subsumes> "Veliparib" .
<Investigational_drug> <Subsumes> "Varlilumab" .
<Investigational_drug> <Subsumes> "Vadastuximab_talirine" .
<Investigational_drug> <Subsumes> "Ublituximab" .
<Investigational_drug> <Subsumes> "Tremelimumab" .
<Investigational_drug> <Subsumes> "Trebananib" .
<Investigational_drug> <Subsumes> "Tosedostat" .
<Investigational_drug> <Subsumes> "Tivozanib" .
<Investigational_drug> <Subsumes> "Tivantinib" .
<Investigational_drug> <Subsumes> "Tipifarnib" .
<Investigational_drug> <Subsumes> "Tigatuzumab" .
<Investigational_drug> <Subsumes> "Tesetaxel" .
<Investigational_drug> <Subsumes> "Spebrutinib" .
<Investigational_drug> <Subsumes> "Semuloparin" .
<Investigational_drug> <Subsumes> "Selumetinib" .
<Investigational_drug> <Subsumes> "Sapacitabine" .
<Investigational_drug> <Subsumes> "Sacituzumab_govitecan" .
<Investigational_drug> <Subsumes> "Ropeginterferon_alfa-2b" .
<Investigational_drug> <Subsumes> "Rociletinib" .
<Investigational_drug> <Subsumes> "Rilotumumab" .
<Investigational_drug> <Subsumes> "Ricolinostat" .
<Investigational_drug> <Subsumes> "Retaspimycin" .
<Investigational_drug> <Subsumes> "Refametinib" .
<Investigational_drug> <Subsumes> "Quizartinib" .
<Investigational_drug> <Subsumes> "Quisinostat" .
<Investigational_drug> <Subsumes> "Plinabulin" .
<Investigational_drug> <Subsumes> "Pidilizumab" .
<Investigational_drug> <Subsumes> "Pictilisib" .
<Investigational_drug> <Subsumes> "Perifosine" .
<Investigational_drug> <Subsumes> "Pentraxin_2" .
<Investigational_drug> <Subsumes> "Pacritinib" .
<Investigational_drug> <Subsumes> "Otlertuzumab" .
<Investigational_drug> <Subsumes> "Osocimab" .
<Investigational_drug> <Subsumes> "Orteronel" .
<Investigational_drug> <Subsumes> "Oprozomib" .
<Investigational_drug> <Subsumes> "Onartuzumab" .
<Investigational_drug> <Subsumes> "Motesanib" .
<Investigational_drug> <Subsumes> "Momelotinib" .
<Investigational_drug> <Subsumes> "Mocetinostat" .
<Investigational_drug> <Subsumes> "Masitinib" .
<Investigational_drug> <Subsumes> "Mapatumumab" .
<Investigational_drug> <Subsumes> "MOR208" .
<Investigational_drug> <Subsumes> "Lipefilgrastim" .
<Investigational_drug> <Subsumes> "Lestaurtinib" .
<Investigational_drug> <Subsumes> "Lapuleucel-T" .
<Investigational_drug> <Subsumes> "Isatuximab" .
<Investigational_drug> <Subsumes> "Ipatasertib" .
<Investigational_drug> <Subsumes> "Infigratinib" .
<Investigational_drug> <Subsumes> "Imetelstat" .
<Investigational_drug> <Subsumes> "IPH_2101" .
<Investigational_drug> <Subsumes> "Hu5F9-G4" .
<Investigational_drug> <Subsumes> "Guadecitabine" .
<Investigational_drug> <Subsumes> "Ganitumab" .
<Investigational_drug> <Subsumes> "Ganetespib" .
<Investigational_drug> <Subsumes> "Fruquintinib" .
<Investigational_drug> <Subsumes> "Filanesib" .
<Investigational_drug> <Subsumes> "Epratuzumab" .
<Investigational_drug> <Subsumes> "Entospletinib" .
<Investigational_drug> <Subsumes> "Entinostat" .
<Investigational_drug> <Subsumes> "Ensartinib" .
<Investigational_drug> <Subsumes> "Dovitinib" .
<Investigational_drug> <Subsumes> "Dinaciclib" .
<Investigational_drug> <Subsumes> "Custirsen" .
<Investigational_drug> <Subsumes> "Crenolanib" .
<Investigational_drug> <Subsumes> "Coltuximab_ravtansine" .
<Investigational_drug> <Subsumes> "Cixutumumab" .
<Investigational_drug> <Subsumes> "Cediranib" .
<Investigational_drug> <Subsumes> "Capivasertib" .
<Investigational_drug> <Subsumes> "Buparlisib" .
<Investigational_drug> <Subsumes> "Bavituximab" .
<Investigational_drug> <Subsumes> "Barasertib" .
<Investigational_drug> <Subsumes> "BHQ880" .
<Investigational_drug> <Subsumes> "Asciminib" .
<Investigational_drug> <Subsumes> "Aminopterin" .
<Investigational_drug> <Subsumes> "Amatuximab" .
<Investigational_drug> <Subsumes> "Alvocidib" .
<Investigational_drug> <Subsumes> "Alisertib" .
<Investigational_drug> <Subsumes> "Afuresertib" .
<Investigational_drug> <Subsumes> "Actinium_Ac_225_lintuzumab" .
<Investigational_drug> <Subsumes> "Abexinostat" .
<Investigational_drug> <Subsumes> "AMG_330" .
<Anti-EpCAM_antibody> <Is_a> "Antibody_medication" .
<Sorafenib> <May_have_route> "Oral" .
<CABO> <Has_context> "Non-curative_first-line_therapy" .
<Cisplatin,_Epirubicin,_Ifosfamide> <Has_accepted_use> "Osteosarcoma" .
<Dravyr> <Brand_name_of> "Acyclovir" .
<Rd> <Has_antineoplastic> "Lenalidomide" .
<Rd> <Has_antineoplastic> "Dexamethasone" .
<Salon_H9C> <Brand_name_of> "Methylprednisolone" .
<Osteomed> <Brand_name_of> "Alendronate" .
<Dasatinib_monotherapy> <Has_modality> "Chemotherapy" .
<Forodesine> <Antineoplastic_of> "Forodesine_monotherapy" .
<Fosfalen> <Brand_name_of> "Alendronate" .
<7_plus_3i_and_Vorinostat> <Is_historical_in> "Acute_myeloid_leukemia" .
<FAM> <Is_a> "Anthracycline-containing_regimen" .
<VTP> <Is_current_in> "Multiple_myeloma" .
<Bevacizumab_monotherapy> <Is_current_in> "Vascular_sarcoma" .
<Bevacizumab_monotherapy> <Is_current_in> "Small_cell_lung_cancer" .
<Bevacizumab_monotherapy> <Is_current_in> "Renal_cell_carcinoma" .
<Bevacizumab_monotherapy> <Is_current_in> "Ovarian_cancer" .
<Bevacizumab_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Bevacizumab_monotherapy> <Is_current_in> "Kaposi_sarcoma" .
<Bevacizumab_monotherapy> <Is_current_in> "Hepatocellular_carcinoma" .
<Bevacizumab_monotherapy> <Is_current_in> "Glioblastoma" .
<Bevacizumab_monotherapy> <Is_current_in> "Endometrial_cancer" .
<Bevacizumab_monotherapy> <Is_current_in> "Colon_cancer" .
<Bevacizumab_monotherapy> <Is_current_in> "Cervical_cancer" .
<Bevacizumab_monotherapy> <Is_current_in> "Breast_cancer" .
<Bevacizumab_monotherapy> <Is_current_in> "Anaplastic_glioma" .
<VIE> <Mapped_from> "VIE" .
<Antithymocyte_globulin_rabbit_ATG> <May_have_route> "Intravenous" .
<Melphalan_and_Methylprednisolone,_then_auto_HSCT> <Is_historical_in> "Multiple_myeloma" .
<Cisplatin_and_Gemcitabine/Erlotinib> <Maps_to> "Cisplatin_and_Gemcitabine/Erlotinib" .
<Afuresertib> <Is_a> "Kinase_inhibitor" .
<Afuresertib> <Is_a> "Investigational_drug" .
<Afuresertib> <Is_a> "AKT1_inhibitor" .
<Purixan_(oral_suspension_formulation)> <Brand_name_of> "Mercaptopurine" .
<Temsirolimus> <Has_accepted_use> "Renal_cell_carcinoma" .
<Temsirolimus> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Temsirolimus> <Has_accepted_use> "Follicular_lymphoma" .
<Temsirolimus> <Has_accepted_use> "Endometrial_cancer" .
<Temsirolimus> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Temsirolimus> <Has_accepted_use> "CNS_lymphoma" .
<Tegafur_and_Uracil> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Tegafur_and_Uracil> <Has_accepted_use> "Head_and_neck_cancer" .
<Cetuximab_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Cetuximab_and_RT> <Has_antineoplastic> "Cetuximab" .
<Irinotecan_liposome> <Has_FDA_indication> "Pancreatic_cancer" .
<ADT_and_Darolutamide> <Is_current_in> "Prostate_cancer" .
<Endari> <Brand_name_of> "L-glutamine" .
<7_plus_3i_and_Vorinostat> <Mapped_from> "7_plus_3i_and_Vorinostat" .
<OTC_medication> <Subsumes> "Sennosides" .
<OTC_medication> <Subsumes> "Omeprazole" .
<OTC_medication> <Subsumes> "Loperamide" .
<OTC_medication> <Subsumes> "Lactulose" .
<OTC_medication> <Subsumes> "Docusate" .
<OTC_medication> <Subsumes> "Cimetidine" .
<OTC_medication> <Subsumes> "Chlorpheniramine" .
<OTC_medication> <Subsumes> "Aspirin" .
<OTC_medication> <Subsumes> "Ascorbic_acid" .
<OTC_medication> <Subsumes> "Acetaminophen" .
<7_plus_3i_and_Panobinostat> <Maps_to> "7_plus_3i_and_Panobinostat" .
<Flutamide,_Goserelin,_RT> <Maps_to> "Flutamide,_Goserelin,_RT" .
<Gemcitabine_and_Mitomycin> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Gemcitabine_and_Mitomycin> <Has_supportive_med> "Dexamethasone" .
<ACH> <Is_current_in> "Breast_cancer" .
<Everolimus_and_Lenvatinib> <Mapped_from> "Everolimus_and_Lenvatinib" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan> <Mapped_from> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan" .
<VAdCA/IE> <Maps_to> "VAdCA/IE" .
<PAD_doxil> <Is_a> "Anthracycline-containing_regimen" .
<R-CHOEP-14> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<CYVE_and_G-CSF> <Has_supportive_med> "Filgrastim" .
<R-GDP> <Has_modality> "Chemotherapy" .
<Rituximab> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Rituximab> <Is_a> "Protein_expression-specific_medication" .
<Rituximab> <Is_a> "PMDA_approved_drug" .
<Rituximab> <Is_a> "Neutral" .
<Rituximab> <Is_a> "Antibody_medication" .
<Rituximab> <Is_a> "Anti-CD20_antibody" .
<KRd> <Has_antineoplastic> "Lenalidomide" .
<KRd> <Has_antineoplastic> "Dexamethasone" .
<KRd> <Has_antineoplastic> "Carfilzomib" .
<Osteotrat> <Brand_name_of> "Alendronate" .
<Brigatinib_monotherapy> <Has_antineoplastic> "Brigatinib" .
<Mitexan> <Brand_name_of> "Mesna" .
<Curacil> <Brand_name_of> "Fluorouracil" .
<Comox> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<7_plus_3d_and_Sorafenib> <Has_accepted_use> "FLT3-positive_Acute_myeloid_leukemia" .
<7_plus_3d_and_Sorafenib> <Has_accepted_use> "Acute_myeloid_leukemia" .
<F-SHAI> <Mapped_from> "F-SHAI" .
<Carboplatin_and_Ifosfamide> <Is_a> "Platinum_doublet" .
<Fer_Iron> <Brand_name_of> "Ferrous_sulfate" .
<Thalidomide_and_Rituximab> <Has_modality> "Chemotherapy" .
<EDAP> <Mapped_from> "EDAP" .
<Pentostatin_and_Alemtuzumab> <Has_modality> "Chemotherapy" .
<Flutamide,_Goserelin,_RT> <Is_current_in> "Prostate_cancer" .
<Carboplatin,_Docetaxel,_Prednisone> <Is_current_in> "Prostate_cancer" .
<Desmopressin> <Has_brand_name> "Stimate" .
<Desmopressin> <Has_brand_name> "Minirin" .
<Desmopressin> <Has_brand_name> "Desonap" .
<Desmopressin> <Has_brand_name> "Desmotabs" .
<Desmopressin> <Has_brand_name> "DesmoMelt" .
<Desmopressin> <Has_brand_name> "DDAVP" .
<Hyper-CVAD_and_Ponatinib> <Mapped_from> "Hyper-CVAD_and_Ponatinib" .
<Trastuzumab_and_hyaluronidase> <Has_FDA_indication> "Breast_cancer" .
<Setrovel> <Brand_name_of> "Tropisetron" .
<Pemetrexed_and_Bevacizumab> <Has_supportive_med> "Folic_acid" .
<Pemetrexed_and_Bevacizumab> <Has_supportive_med> "Dexamethasone" .
<Pemetrexed_and_Bevacizumab> <Has_supportive_med> "Cyanocobalamin" .
<OPPA> <Is_a> "Anthracycline-containing_regimen" .
<BFR,_then_allo_HSCT> <Has_context> "Non-curative_second-line_consolidation_therapy" .
<BFR,_then_allo_HSCT> <Has_context> "Consolidation_after_salvage_therapy" .
<Apatinib> <May_have_route> "Oral" .
<Axitinib_and_Pembrolizumab> <Mapped_from> "Axitinib_and_Pembrolizumab" .
<Retrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Nivolumab> <Has_accepted_use> "Small_cell_lung_cancer" .
<Nivolumab> <Has_accepted_use> "Renal_cell_carcinoma" .
<Nivolumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Nivolumab> <Has_accepted_use> "Melanoma" .
<Nivolumab> <Has_accepted_use> "Hodgkin_lymphoma" .
<Nivolumab> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Nivolumab> <Has_accepted_use> "Head_and_neck_cancer" .
<Nivolumab> <Has_accepted_use> "Gastric_cancer" .
<Nivolumab> <Has_accepted_use> "Bladder_cancer" .
<Roaccutan> <Brand_name_of> "Isotretinoin" .
<Orapred> <Brand_name_of> "Prednisolone" .
<Hyper-CVAD> <Has_modality> "Chemotherapy" .
<Truxima> <Brand_name_of> "Rituximab-abbs" .
<ESHAP> <Has_antineoplastic> "Methylprednisolone" .
<ESHAP> <Has_antineoplastic> "Etoposide" .
<ESHAP> <Has_antineoplastic> "Cytarabine" .
<ESHAP> <Has_antineoplastic> "Cisplatin" .
<ATG_(Rabbit)_monotherapy> <Has_modality> "Immunosuppressive_therapy" .
<Cidaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CMFPT> <Is_a> "Antiestrogen-containing_regimen" .
<BCNU/TT> <Is_current_in> "Autologous_HSCT" .
<Carboplatin_and_Gemcitabine> <Has_modality> "Chemotherapy" .
<BEAC,_then_auto_HSCT> <Has_supportive_med> "Mesna" .
<Plasma_exchange> <Mapped_from> "Plasma_exchange" .
<PD> <Has_accepted_use> "Multiple_myeloma" .
<DEX-IFN> <Maps_to> "DEX-IFN" .
<ChlVPP/PABIOE> <Mapped_from> "ChlVPP/PABIOE" .
<Wellcovorin> <Brand_name_of> "Folinic_acid" .
<Intravenous_Immunoglobulin> <Mapped_from> "Intravenous_Immunoglobulin" .
<Binimetinib_and_Encorafenib> <Is_current_in> "Melanoma" .
<Bactricida> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Rituximab_and_hyaluronidase_monotherapy> <Maps_to> "Rituximab_and_hyaluronidase_monotherapy" .
<Minidex> <Brand_name_of> "Dexamethasone" .
<Cilostazol> <Is_a> "PDE_inhibitor" .
<Ipilimumab> <Has_FDA_indication> "Renal_cell_carcinoma" .
<Ipilimumab> <Has_FDA_indication> "Melanoma" .
<VACA/IE> <Has_antineoplastic> "Vincristine" .
<VACA/IE> <Has_antineoplastic> "Ifosfamide" .
<VACA/IE> <Has_antineoplastic> "Etoposide" .
<VACA/IE> <Has_antineoplastic> "Doxorubicin" .
<VACA/IE> <Has_antineoplastic> "Dactinomycin" .
<VACA/IE> <Has_antineoplastic> "Cyclophosphamide" .
<Interferon_alfa-2b_and_Zidovudine> <Has_antineoplastic> "Zidovudine" .
<Interferon_alfa-2b_and_Zidovudine> <Has_antineoplastic> "Interferon_alfa-2b" .
<Hypereosinophilic_syndrome> <Is_a> "Myeloproliferative_neoplasm" .
<Pemetrexed_monotherapy> <Has_modality> "Chemotherapy" .
<Niklod> <Brand_name_of> "Clodronate" .
<Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA> <Mapped_from> "Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA" .
<Melphalan_and_TBI> <Maps_to> "Melphalan_and_TBI" .
<Cisplatin_and_Irinotecan> <Has_context> "Non-curative_therapy" .
<Cisplatin_and_Irinotecan> <Has_context> "Non-curative_first-line_therapy" .
<Cisplatin_and_Irinotecan> <Has_context> "Induction_therapy" .
<Cisplatin_and_Irinotecan> <Has_context> "Consolidation_after_upfront_therapy" .
<Cisplatin_and_Irinotecan> <Has_context> "All_lines_of_therapy" .
<Cisplatin_and_Irinotecan> <Has_context> "Adjuvant_therapy" .
<Cedcozine> <Brand_name_of> "Dacarbazine" .
<Cyclophosphamide_and_TBI,_then_auto_HSCT> <Has_modality> "Radiotherapy" .
<Cyclophosphamide_and_TBI,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Vorinostat_monotherapy> <Has_antineoplastic> "Vorinostat" .
<Bortezomib_and_Vorinostat> <Mapped_from> "Bortezomib_and_Vorinostat" .
<Alpelisib_and_Fulvestrant> <Mapped_from> "Alpelisib_and_Fulvestrant" .
<Dara-PD> <Has_context> "Non-curative_therapy" .
<Phyxol> <Brand_name_of> "Paclitaxel" .
<Fluorouracil_and_Levoleucovorin> <Mapped_from> "Fluorouracil_and_Levoleucovorin" .
<R-MP> <Mapped_from> "R-MP" .
<Gleevac> <Brand_name_of> "Imatinib" .
<Ortrex> <Brand_name_of> "Voriconazole" .
<TTR> <Has_antineoplastic> "Topotecan" .
<TTR> <Has_antineoplastic> "Rituximab" .
<TTR> <Has_antineoplastic> "Paclitaxel" .
<Ranimustine> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<Dexamethasone_and_Eltrombopag> <Mapped_from> "Dexamethasone_and_Eltrombopag" .
<Pentafu> <Brand_name_of> "Fluorouracil" .
<Arsenic_trioxide_and_Chlorambucil> <Has_context> "Non-curative_therapy" .
<Arsenic_trioxide_and_Chlorambucil> <Has_context> "Non-curative_second-line_maintenance_therapy" .
<Arsenic_trioxide,_then_ATRA_and_Daunorubicin> <Maps_to> "Arsenic_trioxide,_then_ATRA_and_Daunorubicin" .
<Dexawal> <Brand_name_of> "Dexamethasone" .
<Betrixaban_monotherapy> <Has_accepted_use> "Venous_thromboembolism" .
<Coyensu> <Brand_name_of> "Dexamethasone" .
<Thioguanine_monotherapy> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Carboplatin_and_Vincristine> <Mapped_from> "Carboplatin_and_Vincristine" .
<Daunorubicin_liposomal> <Antineoplastic_of> "FLAG-DNX" .
<Daunorubicin_liposomal> <Antineoplastic_of> "Daunorubicin_liposomal_monotherapy" .
<Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib> <Has_modality> "Chemotherapy" .
<Pakzole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Mitotane_and_Streptozocin> <Is_current_in> "Adrenocortical_carcinoma" .
<Ponatinib> <Is_a> "VEGFR_inhibitor" .
<Ponatinib> <Is_a> "SRC_inhibitor" .
<Ponatinib> <Is_a> "RET_inhibitor" .
<Ponatinib> <Is_a> "REMS_program" .
<Ponatinib> <Is_a> "PMDA_approved_drug" .
<Ponatinib> <Is_a> "PDGFR_inhibitor" .
<Ponatinib> <Is_a> "Mutation-specific_medication" .
<Ponatinib> <Is_a> "Kinase_inhibitor" .
<Ponatinib> <Is_a> "KIT_inhibitor" .
<Ponatinib> <Is_a> "FLT3_inhibitor" .
<Ponatinib> <Is_a> "FGFR_inhibitor" .
<Ponatinib> <Is_a> "Bcr-Abl_inhibitor" .
<Sinotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Chemizol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<L-glutamine_monotherapy> <Maps_to> "L-glutamine_monotherapy" .
<Dexamethasone_and_WBRT> <Maps_to> "Dexamethasone_and_WBRT" .
<R-MegaCHOP-14> <Has_antineoplastic> "Vincristine" .
<R-MegaCHOP-14> <Has_antineoplastic> "Rituximab" .
<R-MegaCHOP-14> <Has_antineoplastic> "Prednisone" .
<R-MegaCHOP-14> <Has_antineoplastic> "Doxorubicin" .
<R-MegaCHOP-14> <Has_antineoplastic> "Cyclophosphamide" .
<BBD> <Maps_to> "BBD" .
<Total_Therapy> <Mapped_from> "Total_Therapy" .
<Cisplatin,_Lomustine,_Vincristine> <Has_context> "Adjuvant_therapy" .
<Gemcitabine_and_Trastuzumab> <Has_modality> "Chemotherapy" .
<Aspirin_monotherapy> <Has_context> "Prophylaxis" .
<Aspirin_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Aspirin_monotherapy> <Has_context> "All_lines_of_therapy" .
<Samarium-153_with_stem_cell_support> <Has_antineoplastic> "Samarium-153" .
<Cisplatin,_Dacarbazine,_Paclitaxel> <Is_current_in> "Melanoma" .
<Zondan> <Brand_name_of> "Ondansetron" .
<Flutamide,_Leuprolide,_RT> <Maps_to> "Flutamide,_Leuprolide,_RT" .
<LymphoCide> <Brand_name_of> "Epratuzumab" .
<AC> <Is_a> "Anthracycline-containing_regimen" .
<Placebo> <Has_modality> "Null_therapy" .
<Dexchlorpheniramine> <Supportive_med_of> "R-GemOx" .
<Dexchlorpheniramine> <Supportive_med_of> "Paclitaxel_monotherapy" .
<Avapritinib_monotherapy> <Mapped_from> "Avapritinib_monotherapy" .
<EAR_and_G-CSF> <Maps_to> "EAR_and_G-CSF" .
<Vorinostat> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Vorinostat> <Has_accepted_use> "Multiple_myeloma" .
<Vorinostat> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Vorinostat> <Has_accepted_use> "Hodgkin_lymphoma" .
<Vorinostat> <Has_accepted_use> "Follicular_lymphoma" .
<Vorinostat> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Vorinostat> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Vorinostat> <Has_accepted_use> "Chronic_myelomonocytic_leukemia" .
<Vorinostat> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Azacitidine_monotherapy> <Has_supportive_med> "Prednisone" .
<Azacitidine_monotherapy> <Has_supportive_med> "Antibiotics" .
<Setronax> <Brand_name_of> "Ondansetron" .
<Rucaparib> <Has_brand_name> "Rubraca" .
<Hematopoietic_growth_factor> <Is_a> "Supportive_medication" .
<HiDAC> <Has_antineoplastic> "Cytarabine" .
<Thioguanine> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Thioguanine> <Is_a> "Purine_analogue" .
<Thioguanine> <Is_a> "Antimetabolite" .
<Holoxan> <Brand_name_of> "Ifosfamide" .
<EDAP> <Has_modality> "Chemotherapy" .
<TBI,_then_auto_HSCT> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Alemtuzumab_and_Rituximab> <Has_supportive_med> "Valacyclovir" .
<Alemtuzumab_and_Rituximab> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Bacillus_Calmette-Guerin> <Has_brand_name> "TheraCys" .
<Bacillus_Calmette-Guerin> <Has_brand_name> "TICE_BCG" .
<Dexa> <Brand_name_of> "Dexamethasone" .
<Alovell> <Brand_name_of> "Alendronate" .
<Eliprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<BHD> <Is_historical_in> "Melanoma" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Accepted_use_of> "Vincristine" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Accepted_use_of> "Vinblastine" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Accepted_use_of> "Rituximab-pvvr" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Accepted_use_of> "Rituximab-abbs" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Accepted_use_of> "Rituximab_monotherapy" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Accepted_use_of> "Rituximab" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Accepted_use_of> "R-EPOCH" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Accepted_use_of> "R-CVP" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Accepted_use_of> "R-CHOP" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Accepted_use_of> "Prednisone" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Accepted_use_of> "Etoposide" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Accepted_use_of> "EPOCH" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Accepted_use_of> "Doxorubicin" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Accepted_use_of> "Dacarbazine" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Accepted_use_of> "Cyclophosphamide" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Accepted_use_of> "CVP_(Vinblastine/Prednisone)" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Accepted_use_of> "CHOP" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Accepted_use_of> "Bleomycin" .
<Hodgkin_lymphoma_nodular_lymphocyte-predominant> <Accepted_use_of> "ABVD" .
<Total_Therapy> <Has_context> "Non-curative_first-line_therapy" .
<R-DHAOx> <Has_supportive_med> "Pegfilgrastim" .
<POMP> <Mapped_from> "POMP" .
<Blinatumomab> <Has_FDA_indication> "B-cell_acute_lymphoblastic_leukemia" .
<Lenalidomide_monotherapy> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Lenalidomide_monotherapy> <Has_accepted_use> "Transformed_lymphoma" .
<Lenalidomide_monotherapy> <Has_accepted_use> "Polycythemia_vera" .
<Lenalidomide_monotherapy> <Has_accepted_use> "Plasma_cell_leukemia" .
<Lenalidomide_monotherapy> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Lenalidomide_monotherapy> <Has_accepted_use> "Myelofibrosis" .
<Lenalidomide_monotherapy> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Lenalidomide_monotherapy> <Has_accepted_use> "Multiple_myeloma" .
<Lenalidomide_monotherapy> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Lenalidomide_monotherapy> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Lenalidomide_monotherapy> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Lenalidomide_monotherapy> <Has_accepted_use> "Hodgkin_lymphoma" .
<Lenalidomide_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<Lenalidomide_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Lenalidomide_monotherapy> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Lenalidomide_monotherapy> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Lenalidomide_monotherapy> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<Busulfan_and_Melphalan> <Has_antineoplastic> "Melphalan" .
<Busulfan_and_Melphalan> <Has_antineoplastic> "Busulfan" .
<Helicobacter_pylori_eradication_therapy> <Mapped_from> "Helicobacter_pylori_eradication_therapy" .
<TMF> <Has_context> "Adjuvant_therapy" .
<Karmyl> <Brand_name_of> "Aspirin" .
<Chlorambucil_and_Ofatumumab> <Has_antineoplastic> "Ofatumumab" .
<Chlorambucil_and_Ofatumumab> <Has_antineoplastic> "Chlorambucil" .
<Eculizumab_monotherapy> <Maps_to> "Eculizumab_monotherapy" .
<Z-BEAM,_then_auto_HSCT> <Is_a> "Rituximab-containing_regimen" .
<HDAC_and_G-CSF> <Has_supportive_med> "Filgrastim" .
<Folinvit> <Brand_name_of> "Folinic_acid" .
<Ifosfamide_and_Vinorelbine> <Mapped_from> "Ifosfamide_and_Vinorelbine" .
<R-CODOX-M> <Mapped_from> "R-CODOX-M" .
<Letrozole_and_Ribociclib> <Is_a> "Antiestrogen-containing_regimen" .
<DOLP_(Prednisolone)> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<ABV_(Vinblastine)> <Is_a> "Anthracycline-containing_regimen" .
<Deksamet> <Brand_name_of> "Dexamethasone" .
<Osteofos> <Brand_name_of> "Alendronate" .
<Orgaran> <Brand_name_of> "Danaparoid" .
<Besponsa> <Brand_name_of> "Inotuzumab_ozogamicin" .
<CAP_(Platinol)> <Has_context> "Non-curative_second-line_therapy" .
<CAP_(Platinol)> <Has_context> "Non-curative_first-line_therapy" .
<Emicizumab_monotherapy> <Is_current_in> "Inherited_coagulopathy" .
<Isotretinoin_monotherapy> <Has_antineoplastic> "Isotretinoin" .
<Carboplatin_and_Docetaxel> <Has_antineoplastic> "Docetaxel" .
<Carboplatin_and_Docetaxel> <Has_antineoplastic> "Carboplatin" .
<ADT_and_Darolutamide> <Has_antineoplastic> "GnRH_antagonists" .
<ADT_and_Darolutamide> <Has_antineoplastic> "GnRH_agonists" .
<ADT_and_Darolutamide> <Has_antineoplastic> "Darolutamide" .
<IT_Cytarabine_and_WBRT> <Has_local_therapy> "Cytarabine" .
<Cytarabine_and_G-CSF> <Mapped_from> "Cytarabine_and_G-CSF" .
<VMP> <Has_supportive_med> "Bisphosphonates" .
<VMP> <Has_supportive_med> "Acyclovir" .
<Ipatasertib> <May_have_route> "Oral" .
<Aspro> <Brand_name_of> "Aspirin" .
<Imatinib-based_consolidation> <Has_context> "Consolidation_after_upfront_therapy" .
<Caplacizumab_and_Plasma_exchange> <Is_current_in> "Thrombotic_thrombocytopenic_purpura" .
<CYKLONE> <Mapped_from> "CYKLONE" .
<SOX> <Has_accepted_use> "Colon_cancer" .
<Imatinib_and_Interferon> <Mapped_from> "Imatinib_and_Interferon" .
<ATRA,_Cytarabine,_Daunorubicin> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Cytarabine_and_Daunorubicin> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Cytarabine_and_Daunorubicin> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Cisplatin,_Fluorouracil,_Panitumumab> <Has_accepted_use> "Head_and_neck_cancer" .
<IDH1_inhibitor> <Is_a> "Enzyme_inhibitor" .
<Erlotinib_and_Ramucirumab> <Maps_to> "Erlotinib_and_Ramucirumab" .
<Ipamide> <Brand_name_of> "Ifosfamide" .
<DA_3_plus_10> <Has_antineoplastic> "Daunorubicin" .
<DA_3_plus_10> <Has_antineoplastic> "Cytarabine" .
<Cediranib> <Has_brand_name> "Recentin" .
<Casodex> <Brand_name_of> "Bicalutamide" .
<BEP> <Has_context> "Upfront_therapy" .
<BEP> <Has_context> "All_lines_of_therapy" .
<BEP> <Has_context> "Adjuvant_therapy" .
<Vinblastine_monotherapy> <Has_context> "Non-curative_therapy" .
<Vinblastine_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Vinblastine_monotherapy> <Has_context> "Induction_therapy" .
<Platinum_agent> <Subsumes> "Oxaliplatin" .
<Platinum_agent> <Subsumes> "Nedaplatin" .
<Platinum_agent> <Subsumes> "Lobaplatin" .
<Platinum_agent> <Subsumes> "Heptaplatin" .
<Platinum_agent> <Subsumes> "Cisplatin" .
<Platinum_agent> <Subsumes> "Carboplatin" .
<Fluorouracil_and_Semustine> <Has_accepted_use> "Colon_cancer" .
<Pomalidomide_and_Prednisone> <Has_accepted_use> "Myelofibrosis" .
<Pomalidomide_and_Prednisone> <Has_accepted_use> "Multiple_myeloma" .
<Cyclophosphamide_and_TBI> <Mapped_from> "Cyclophosphamide_and_TBI" .
<Medroxyprogesterone_and_Tamoxifen> <Is_current_in> "Endometrial_cancer" .
<R-CEOP90_(Epirubicin)> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Sibatin> <Brand_name_of> "Oxaliplatin" .
<Aminopterin> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Cytarabine_and_G-CSF> <Has_supportive_med> "Filgrastim" .
<Cyclophosphamide_and_Vincristine> <Has_modality> "Chemotherapy" .
<mFOLFOX6> <Has_antineoplastic> "Oxaliplatin" .
<mFOLFOX6> <Has_antineoplastic> "Folinic_acid" .
<mFOLFOX6> <Has_antineoplastic> "Fluorouracil" .
<Teniposide_monotherapy> <Is_current_in> "Small_cell_lung_cancer" .
<ECF> <Maps_to> "ECF" .
<Thalidomide> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Thalidomide> <Has_accepted_use> "Polycythemia_vera" .
<Thalidomide> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Thalidomide> <Has_accepted_use> "Pancreatic_NET" .
<Thalidomide> <Has_accepted_use> "Neuroendocrine_tumor" .
<Thalidomide> <Has_accepted_use> "Multiple_myeloma" .
<Thalidomide> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Thalidomide> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<M-EI> <Has_antineoplastic> "Methotrexate" .
<M-EI> <Has_antineoplastic> "Mesna" .
<M-EI> <Has_antineoplastic> "Ifosfamide" .
<M-EI> <Has_antineoplastic> "Etoposide" .
<COPAD/CYVE> <Has_local_therapy> "Methotrexate" .
<COPAD/CYVE> <Has_local_therapy> "Hydrocortisone" .
<COPAD/CYVE> <Has_local_therapy> "Cytarabine" .
<Docenat> <Brand_name_of> "Docetaxel" .
<Carboplatin_and_Cisplatin> <Mapped_from> "Carboplatin_and_Cisplatin" .
<TPC> <Maps_to> "TPC" .
<Phytonadione> <Has_brand_name> "Konakion" .
<Phytonadione> <Has_brand_name> "AquaMephyton" .
<Methotrexate_and_Pegaspargase> <Has_antineoplastic> "Pegaspargase" .
<Methotrexate_and_Pegaspargase> <Has_antineoplastic> "Methotrexate" .
<Altretamine_monotherapy> <Is_current_in> "Ovarian_cancer" .
<Trim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin,_Etoposide,_Irinotecan> <Has_context> "Non-curative_therapy" .
<Cisplasol> <Brand_name_of> "Cisplatin" .
<DA-EPOCH> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<DA-EPOCH> <Is_current_in> "Anaplastic_large_cell_lymphoma" .
<Pariet> <Brand_name_of> "Rabeprazole" .
<Arsenic_trioxide_and_ATRA> <Has_supportive_med> "Prednisone" .
<Arsenic_trioxide_and_ATRA> <Has_supportive_med> "Hydroxyurea" .
<Arsenic_trioxide_and_ATRA> <Has_supportive_med> "Dexamethasone" .
<Telotristat> <Has_brand_name> "Xermelo" .
<R-GDP> <Has_context> "Salvage_therapy" .
<R-GDP> <Has_context> "All_lines_of_therapy" .
<Altretamine_and_Cisplatin> <Has_antineoplastic> "Cisplatin" .
<Altretamine_and_Cisplatin> <Has_antineoplastic> "Altretamine" .
<Carboplatin_and_Doxorubicin_liposomal> <Has_supportive_med> "Steroids" .
<Carboplatin_and_Doxorubicin_liposomal> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Carboplatin_and_Doxorubicin_liposomal> <Has_supportive_med> "Ondansetron" .
<Carboplatin_and_Doxorubicin_liposomal> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Carboplatin_and_Doxorubicin_liposomal> <Has_supportive_med> "Granisetron" .
<Carboplatin_and_Doxorubicin_liposomal> <Has_supportive_med> "Docetaxel" .
<Carboplatin_and_Doxorubicin_liposomal> <Has_supportive_med> "Dexamethasone" .
<Cardiopirin> <Brand_name_of> "Aspirin" .
<Factor_IX_recombinant> <Has_accepted_use> "Inherited_coagulopathy" .
<R-CHOEP-14> <Maps_to> "R-CHOEP-14" .
<Eloxatine> <Brand_name_of> "Oxaliplatin" .
<PATCO> <Has_antineoplastic> "Vincristine" .
<PATCO> <Has_antineoplastic> "Thioguanine" .
<PATCO> <Has_antineoplastic> "Prednisone" .
<PATCO> <Has_antineoplastic> "Cytarabine" .
<PATCO> <Has_antineoplastic> "Cyclophosphamide" .
<Bexarotene_and_Pralatrexate> <Has_context> "Non-curative_therapy" .
<Everolimus> <Has_brand_name> "Zortress" .
<Everolimus> <Has_brand_name> "Votubia" .
<Everolimus> <Has_brand_name> "Rolimus" .
<Everolimus> <Has_brand_name> "Rapact" .
<Everolimus> <Has_brand_name> "Evertor" .
<Everolimus> <Has_brand_name> "Evermil" .
<Everolimus> <Has_brand_name> "Everecan" .
<Everolimus> <Has_brand_name> "EverGraf" .
<Everolimus> <Has_brand_name> "Certican" .
<Everolimus> <Has_brand_name> "Afinitor_Disperz" .
<Everolimus> <Has_brand_name> "Afinitor" .
<Everolimus> <Has_brand_name> "Advacan" .
<VR-CAP> <Maps_to> "VR-CAP" .
<Cisplatin,_Etoposide,_RT> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Cisplatin,_Etoposide,_RT> <Has_supportive_med> "Granisetron" .
<Cisplatin,_Etoposide,_RT> <Has_supportive_med> "Dexamethasone" .
<Venclexta> <Brand_name_of> "Venetoclax" .
<Lexel> <Brand_name_of> "Letrozole" .
<Palonosetron> <Has_brand_name> "Aloxi" .
<EMA-CO> <Is_current_in> "Gestational_trophoblastic_neoplasia" .
<Dexadrol> <Brand_name_of> "Dexamethasone" .
<THP_(Taxotere)> <Mapped_from> "THP_(Taxotere)" .
<CFP_and_Oophorectomy> <Is_historical_in> "Breast_cancer" .
<Imatinib_and_Prednisone> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Imatinib_and_Prednisone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Osocimab> <Is_a> "Investigational_drug" .
<Osocimab> <Is_a> "Anti-Factor_XIa_antibody" .
<Purine_nucleoside_phosphorylase_(PNP)_inhibitor> <Subsumes> "Forodesine" .
<Oseomax> <Brand_name_of> "Alendronate" .
<MAID> <Maps_to> "MAID" .
<Bone_protective_medication> <Subsumes> "RANK_ligand_inhibitor" .
<Bone_protective_medication> <Subsumes> "Bisphosphonate" .
<Doxorubicin_and_Olaratumab> <Has_supportive_med> "Dexrazoxane" .
<CAPIRI-Bev> <Maps_to> "CAPIRI-Bev" .
<TBI> <Has_modality> "Radiotherapy" .
<VACA/IE> <Has_modality> "Chemotherapy" .
<MyMust> <Brand_name_of> "Bendamustine" .
<R-EPOCH,_dose-escalated> <Is_current_in> "HIV-associated_lymphoma" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone> <Mapped_from> "Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone" .
<Semustine> <Has_accepted_use> "Colon_cancer" .
<BRCA-mutated_Ovarian_cancer> <Is_a> "Ovarian_cancer" .
<Cyclophosphamide_and_TBI> <Maps_to> "Cyclophosphamide_and_TBI" .
<IDAC> <Has_context> "Non-curative_subsequent-line_therapy" .
<IDAC> <Has_context> "Consolidation_after_upfront_therapy" .
<Pertuzumab_and_Trastuzumab> <Mapped_from> "Pertuzumab_and_Trastuzumab" .
<Phosphodiesterase_inhibitor> <Subsumes> "Anagrelide" .
<Cytarabine_and_Interferon_alfa-2b> <Mapped_from> "Cytarabine_and_Interferon_alfa-2b" .
<Clofarabine_and_Melphalan,_then_allo_HSCT> <Has_antineoplastic> "Melphalan" .
<Clofarabine_and_Melphalan,_then_allo_HSCT> <Has_antineoplastic> "Clofarabine" .
<Clofarabine_and_Melphalan,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<Briplatin> <Brand_name_of> "Cisplatin" .
<Danazol> <Has_brand_name> "Novaprin" .
<Danazol> <Has_brand_name> "Ladogal" .
<Danazol> <Has_brand_name> "Drane" .
<Danazol> <Has_brand_name> "Danogen" .
<Danazol> <Has_brand_name> "Danodiol" .
<Danazol> <Has_brand_name> "Danocrine" .
<Danazol> <Has_brand_name> "Danatrol" .
<Eptifibatide> <Is_a> "GPIIb-IIIa_inhibitor" .
<CCE> <Has_supportive_med> "Steroids" .
<Busulfan_and_Cyclophosphamide> <Has_supportive_med> "Methotrexate" .
<Busulfan_and_Cyclophosphamide> <Has_supportive_med> "Filgrastim" .
<Busulfan_and_Cyclophosphamide> <Has_supportive_med> "Cyclosporine_non-modified" .
<Bowel_management> <Is_a> "Supportive_medication" .
<VDC/IE> <Maps_to> "VDC/IE" .
<Bleowel> <Brand_name_of> "Bleomycin" .
<Emicizumab_monotherapy> <Mapped_from> "Emicizumab_monotherapy" .
<Melphalan_and_TBI,_then_auto_HSCT> <Has_accepted_use> "Multiple_myeloma" .
<Melphalan_and_TBI,_then_auto_HSCT> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Cycloferon> <Brand_name_of> "Cyclophosphamide" .
<5_plus_3i> <Has_modality> "Chemotherapy" .
<Duvelisib> <Has_brand_name> "Copiktra" .
<Talazoparib> <Has_brand_name> "Talzenna" .
<Gatrima> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<GDP> <Mapped_from> "GDP" .
<CDB> <Has_accepted_use> "Melanoma" .
<Trimozol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Vinflunine_monotherapy> <Is_current_in> "Bladder_cancer" .
<FOLFOX4_and_Panitumumab> <Has_context> "Non-curative_first-line_therapy" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine> <Has_antineoplastic> "Thioguanine" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine> <Has_antineoplastic> "Mitoxantrone" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine> <Has_antineoplastic> "Idarubicin" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine> <Has_antineoplastic> "Etoposide" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine> <Has_antineoplastic> "Cytarabine" .
<RVDC> <Has_antineoplastic> "Lenalidomide" .
<RVDC> <Has_antineoplastic> "Dexamethasone" .
<RVDC> <Has_antineoplastic> "Cyclophosphamide" .
<RVDC> <Has_antineoplastic> "Bortezomib" .
<SOL-Melcort> <Brand_name_of> "Methylprednisolone" .
<Cladribine_and_Rituximab> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<Cladribine_and_Rituximab> <Is_current_in> "Marginal_zone_lymphoma" .
<Cladribine_and_Rituximab> <Is_current_in> "Mantle_cell_lymphoma" .
<Cladribine_and_Rituximab> <Is_current_in> "Hairy_cell_leukemia" .
<Praxbind> <Brand_name_of> "Idarucizumab" .
<BEACOPP-14_(Prednisolone)> <Is_current_in> "Hodgkin_lymphoma" .
<Alendronstad> <Brand_name_of> "Alendronate" .
<VIPD> <Has_antineoplastic> "Ifosfamide" .
<VIPD> <Has_antineoplastic> "Etoposide" .
<VIPD> <Has_antineoplastic> "Dexamethasone" .
<VIPD> <Has_antineoplastic> "Cisplatin" .
<Anastrozole_and_Goserelin> <Has_antineoplastic> "Goserelin" .
<Anastrozole_and_Goserelin> <Has_antineoplastic> "Anastrozole" .
<Gliadel_wafer_monotherapy> <Mapped_from> "Gliadel_wafer_monotherapy" .
<VR-CP> <Has_modality> "Chemotherapy" .
<CYM> <Has_accepted_use> "CNS_lymphoma" .
<CYM> <Has_accepted_use> "Burkitt_lymphoma" .
<Zinecard> <Brand_name_of> "Dexrazoxane" .
<Thalidomide_and_Rituximab> <Is_a> "Rituximab-containing_regimen" .
<GELOX/RT> <Has_context> "Induction_therapy" .
<Dasatinib_and_Prednisone> <Mapped_from> "Dasatinib_and_Prednisone" .
<DCEP> <Has_antineoplastic> "Etoposide" .
<DCEP> <Has_antineoplastic> "Dexamethasone" .
<DCEP> <Has_antineoplastic> "Cyclophosphamide" .
<DCEP> <Has_antineoplastic> "Cisplatin" .
<Warlin> <Brand_name_of> "Warfarin" .
<Mogamulizumab_monotherapy> <Has_context> "Non-curative_therapy" .
<PCP> <Has_supportive_med> "Low_molecular_weight_heparins" .
<PCP> <Has_supportive_med> "Aspirin" .
<ABC> <Has_accepted_use> "Melanoma" .
<Cyproterone_acetate_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<BV-CHP> <Is_a> "Anthracycline-containing_regimen" .
<Votubia> <Brand_name_of> "Everolimus" .
<Anti-Factor_IXa_antibody> <Is_a> "Antibody_medication" .
<CAMP> <Has_antineoplastic> "Procarbazine" .
<CAMP> <Has_antineoplastic> "Methotrexate" .
<CAMP> <Has_antineoplastic> "Doxorubicin" .
<CAMP> <Has_antineoplastic> "Cyclophosphamide" .
<SHAI> <Is_a> "Anthracycline-containing_regimen" .
<CHVP> <Has_modality> "Chemotherapy" .
<Sunitinib> <May_have_route> "Oral" .
<Durvalumab> <May_have_route> "Intravenous" .
<TACE,_then_5-FU> <Has_modality> "Chemotherapy" .
<MAPIE> <Has_supportive_med> "Mesna" .
<MAPIE> <Has_supportive_med> "Folinic_acid" .
<Cisplatin,_Epirubicin,_Ifosfamide> <Is_a> "Anthracycline-containing_regimen" .
<mLSG15> <Is_current_in> "Adult_T-cell_leukemia-lymphoma" .
<FOLFOXIRI_and_Panitumumab> <Is_a> "Irinotecan-containing_regimen" .
<VD> <Has_antineoplastic> "Dexamethasone" .
<VD> <Has_antineoplastic> "Bortezomib" .
<Carmustine_wafer_polifeprosan_20> <Has_accepted_use> "High-grade_glioma" .
<Carmustine_wafer_polifeprosan_20> <Has_accepted_use> "Glioblastoma" .
<Herixina> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<O-miniCHOP> <Has_modality> "Chemotherapy" .
<Temozolomide_and_Bevacizumab> <Has_accepted_use> "Pancreatic_NET" .
<Temozolomide_and_Bevacizumab> <Has_accepted_use> "Melanoma" .
<ABV_(Vinblastine)> <Has_accepted_use> "Kaposi_sarcoma" .
<DextraCare> <Brand_name_of> "Iron_dextran" .
<Renal_cell_carcinoma> <Historic_treated_by> "Vinblastine_monotherapy" .
<Renal_cell_carcinoma> <Historic_treated_by> "Megestrol_monotherapy" .
<Renal_cell_carcinoma> <Historic_treated_by> "Medroxyprogesterone_monotherapy" .
<Renal_cell_carcinoma> <Historic_treated_by> "Interferon_alfa-2c_monotherapy" .
<Renal_cell_carcinoma> <Historic_treated_by> "Interferon_alfa-2a_monotherapy" .
<Renal_cell_carcinoma> <Historic_treated_by> "Interferon_alfa-2a_and_Isotretinoin" .
<Renal_cell_carcinoma> <Historic_treated_by> "FC,_then_allo_HSCT" .
<Prednisone> <Local_therapy_of> "mLSG15" .
<Prednisone> <Local_therapy_of> "IT_Cytarabine,_Methotrexate,_Prednisone" .
<Prednisone> <Local_therapy_of> "CHOP-14" .
<Large_granular_lymphocytic_leukemia> <Accepted_use_of> "Prednisone" .
<Large_granular_lymphocytic_leukemia> <Accepted_use_of> "Methotrexate_and_Prednisone" .
<Large_granular_lymphocytic_leukemia> <Accepted_use_of> "Methotrexate" .
<Large_granular_lymphocytic_leukemia> <Accepted_use_of> "Cyclophosphamide_monotherapy" .
<Large_granular_lymphocytic_leukemia> <Accepted_use_of> "Cyclophosphamide_and_Prednisone" .
<Large_granular_lymphocytic_leukemia> <Accepted_use_of> "Cyclophosphamide" .
<Active_surveillance> <Has_accepted_use> "Prostate_cancer" .
<Bortezomib_and_Doxorubicin_liposomal> <Has_context> "Non-curative_therapy" .
<DDR_inhibitor> <Is_a> "Kinase_inhibitor" .
<FOLFIRI_and_Ziv-aflibercept> <Is_current_in> "Colon_cancer" .
<Nabilone> <Has_brand_name> "Cesamet" .
<Metisone> <Brand_name_of> "Methylprednisolone" .
<CHOP-14> <Mapped_from> "CHOP-14" .
<Idelalisib> <May_have_route> "Oral" .
<Clofarabine_and_LoDAC> <Maps_to> "Clofarabine_and_LoDAC" .
<Sorafenib_monotherapy> <Has_accepted_use> "Thyroid_cancer" .
<Sorafenib_monotherapy> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Sorafenib_monotherapy> <Has_accepted_use> "Renal_cell_carcinoma" .
<Sorafenib_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Sorafenib_monotherapy> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Sorafenib_monotherapy> <Has_accepted_use> "Gastrointestinal_stromal_tumor" .
<Sorafenib_monotherapy> <Has_accepted_use> "FLT3-positive_Acute_myeloid_leukemia" .
<Sorafenib_monotherapy> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Espo> <Brand_name_of> "Epoetin_alfa" .
<R-DHAP> <Has_context> "Salvage_therapy" .
<R-DHAP> <Has_context> "Non-curative_first-line_therapy" .
<R-DHAP> <Has_context> "All_lines_of_therapy" .
<Mechlorethamine_monotherapy> <Mapped_from> "Mechlorethamine_monotherapy" .
<Nanoparticle_albumin_bound_chemotherapy> <Is_a> "Drugs_by_vehicle" .
<BuCyTBI> <Is_current_in> "Allogeneic_HSCT" .
<Fluorouracil_and_Levoleucovorin> <Has_context> "Non-curative_first-line_therapy" .
<Fluorouracil_and_Levoleucovorin> <Has_context> "Adjuvant_therapy" .
<IT_Methotrexate_and_Methylprednisolone> <Has_modality> "Chemotherapy" .
<Pd> <Has_modality> "Chemotherapy" .
<Alemtuzumab> <Has_brand_name> "Mabcampath" .
<Alemtuzumab> <Has_brand_name> "Lemtrada" .
<Alemtuzumab> <Has_brand_name> "Campath-1H" .
<Alemtuzumab> <Has_brand_name> "Campath" .
<BRCA-mutated_Pancreatic_cancer> <Accepted_use_of> "Placebo" .
<BRCA-mutated_Pancreatic_cancer> <Accepted_use_of> "Olaparib_monotherapy" .
<RiPAD_plus_C> <Has_context> "Non-curative_first-line_therapy" .
<Palifermin> <May_have_route> "Intravenous" .
<Gefitinib_monotherapy> <Has_modality> "Chemotherapy" .
<Hydroxyurea_monotherapy> <Mapped_from> "Hydroxyurea_monotherapy" .
<Linfoxan> <Brand_name_of> "Chlorambucil" .
<Trisfides> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Camptosar> <Brand_name_of> "Irinotecan" .
<FOLFIRI_and_Panitumumab> <Has_modality> "Chemotherapy" .
<ddFEC> <Has_antineoplastic> "Fluorouracil" .
<ddFEC> <Has_antineoplastic> "Epirubicin" .
<ddFEC> <Has_antineoplastic> "Cyclophosphamide" .
<VEBEP> <Has_context> "Induction_therapy" .
<Interferon_alfa-2c_monotherapy> <Is_historical_in> "Renal_cell_carcinoma" .
<F-SHAI> <Has_context> "Salvage_therapy" .
<Ondarubin> <Brand_name_of> "Idarubicin" .
<Cytokine> <Is_a> "Immunotherapeutic" .
<Bactipront> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Nelarabine_monotherapy> <Is_current_in> "T-cell_acute_lymphoblastic_leukemia" .
<Alemtuzumab_and_Rituximab> <Has_modality> "Chemotherapy" .
<Unfractionated_heparin> <May_have_route> "Subcutaneous" .
<Unfractionated_heparin> <May_have_route> "Intravenous" .
<Tazemetostat_monotherapy> <Maps_to> "Tazemetostat_monotherapy" .
<Fostamatinib> <Is_a> "SYK_inhibitor" .
<Fostamatinib> <Is_a> "Kinase_inhibitor" .
<Fostamatinib> <Is_a> "Hematology_medication" .
<Catumaxomab> <Has_brand_name> "Removab" .
<KD> <Has_accepted_use> "Multiple_myeloma" .
<FLOT> <Is_current_in> "Gastric_cancer" .
<FLOT> <Is_current_in> "Esophageal_cancer" .
<R-INO> <Maps_to> "R-INO" .
<MACC> <Has_antineoplastic> "Methotrexate" .
<MACC> <Has_antineoplastic> "Lomustine" .
<MACC> <Has_antineoplastic> "Doxorubicin" .
<MACC> <Has_antineoplastic> "Cyclophosphamide" .
<Pharmorubicin> <Brand_name_of> "Epirubicin" .
<Anaplastic_large_cell_lymphoma> <Current_treated_by> "GDP" .
<Anaplastic_large_cell_lymphoma> <Current_treated_by> "FluBuCy,_then_allo_HSCT" .
<Anaplastic_large_cell_lymphoma> <Current_treated_by> "DHAP" .
<Anaplastic_large_cell_lymphoma> <Current_treated_by> "DA-EPOCH" .
<Anaplastic_large_cell_lymphoma> <Current_treated_by> "CHOP" .
<Anaplastic_large_cell_lymphoma> <Current_treated_by> "CHOEP-21" .
<Anaplastic_large_cell_lymphoma> <Current_treated_by> "CHOEP-14" .
<Anaplastic_large_cell_lymphoma> <Current_treated_by> "Brentuximab_vedotin_monotherapy" .
<Anaplastic_large_cell_lymphoma> <Current_treated_by> "BV-CHP" .
<Anaplastic_large_cell_lymphoma> <Current_treated_by> "APO" .
<Fluorouracil,_Mitomycin,_RT> <Has_context> "Induction_therapy" .
<Fluorouracil,_Mitomycin,_RT> <Has_context> "Definitive_therapy" .
<Famorubicin> <Brand_name_of> "Epirubicin" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone> <Maps_to> "Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Sunitinib_monotherapy> <Mapped_from> "Sunitinib_monotherapy" .
<Onxol> <Brand_name_of> "Paclitaxel" .
<Ifocris> <Brand_name_of> "Ifosfamide" .
<Obinutuzumab> <Has_FDA_indication> "Follicular_lymphoma" .
<Obinutuzumab> <Has_FDA_indication> "Chronic_lymphocytic_leukemia" .
<Eligard> <Brand_name_of> "Leuprolide" .
<Hydroxyurea_and_RT> <Has_modality> "Radiotherapy" .
<Hydroxyurea_and_RT> <Has_modality> "Chemotherapy" .
<Ketoconazole> <Has_brand_name> "Nizoral" .
<Arsenic_trioxide_and_ATRA> <Is_current_in> "Acute_promyelocytic_leukemia" .
<Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin> <Has_modality> "Chemotherapy" .
<Capecitabine_and_Ixabepilone> <Is_current_in> "Breast_cancer" .
<Onzod> <Brand_name_of> "Ondansetron" .
<FOLFOXIRI_and_Panitumumab> <Has_accepted_use> "KRAS_wild-type_Colon_cancer" .
<FOLFOXIRI_and_Panitumumab> <Has_accepted_use> "Colon_cancer" .
<Aidbone> <Brand_name_of> "Alendronate" .
<Galeterone> <Is_a> "Steroidal_androgen_receptor_inhibitor" .
<Galeterone> <Is_a> "Steroid_synthesis_inhibitor" .
<Galeterone> <Is_a> "Halted_drug" .
<Galeterone> <Is_a> "Endocrine_therapeutic" .
<Galeterone> <Is_a> "Antiandrogen" .
<mFOLFOX7_(L-Leucovorin)> <Maps_to> "mFOLFOX7_(L-Leucovorin)" .
<Supasa> <Brand_name_of> "Aspirin" .
<Anti-CD20_medication> <Subsumes> "Veltuzumab" .
<Anti-CD20_medication> <Subsumes> "Tositumomab_&_I-131" .
<Anti-CD20_medication> <Subsumes> "Ofatumumab" .
<Anti-CD20_medication> <Subsumes> "Obinutuzumab" .
<Anti-CD20_medication> <Subsumes> "Ibritumomab_tiuxetan" .
<Syndexa> <Brand_name_of> "Dexamethasone" .
<Samarium-153> <Is_a> "Radiotherapy_medication" .
<Depmedalone> <Brand_name_of> "Methylprednisolone" .
<Samarium-153_with_stem_cell_support> <Has_context> "Non-curative_subsequent-line_therapy" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Paclitaxel" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "PCE" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Irinotecan" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Gemcitabine_and_Irinotecan" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Gemcitabine" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "GCP" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Etoposide" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Erlotinib_and_Bevacizumab" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Erlotinib" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Docetaxel_and_Gemcitabine" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Docetaxel" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Cisplatin_monotherapy" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Cisplatin_and_Irinotecan" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Cisplatin_and_Gemcitabine" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Cisplatin_and_Docetaxel" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Cisplatin" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Carboplatin_and_Paclitaxel" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Carboplatin_and_Docetaxel" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Bleomycin" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Bevacizumab-bvzr" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Bevacizumab-awwb" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "Bevacizumab" .
<Adenocarcinoma_of_unknown_primary> <Accepted_use_of> "BEP" .
<R-CHOP> <Maps_to> "R-CHOP" .
<Melphalan_and_TBI,_then_auto_HSCT> <Has_modality> "Radiotherapy" .
<Melphalan_and_TBI,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<Dabigatran> <Has_brand_name> "Prazaxa" .
<Dabigatran> <Has_brand_name> "Pradaxa" .
<Dabigatran> <Has_brand_name> "Pradax" .
<Martiprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Faslodex> <Brand_name_of> "Fulvestrant" .
<COPAD> <Mapped_from> "COPAD" .
<Gemcitabine> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Gemcitabine> <Is_a> "Pyrimidine_analogue" .
<Gemcitabine> <Is_a> "Neutral" .
<Gemcitabine> <Is_a> "Irritant" .
<Gemcitabine> <Is_a> "Antimetabolite" .
<Azacitidine_and_Venetoclax> <Has_context> "Non-curative_first-line_induction_therapy" .
<Temozolomide_and_RT,_then_Temozolomide> <Has_accepted_use> "Anaplastic_glioma" .
<M-TIP> <Maps_to> "M-TIP" .
<Cortancyl> <Brand_name_of> "Prednisone" .
<Capecitabine_and_Temozolomide> <Mapped_from> "Capecitabine_and_Temozolomide" .
<Cyclophosphamide_and_TBI,_then_auto_HSCT> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Cyclophosphamide_and_TBI,_then_auto_HSCT> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Cyclophosphamide_and_TBI,_then_auto_HSCT> <Has_accepted_use> "Follicular_lymphoma" .
<Cyclophosphamide_and_TBI,_then_auto_HSCT> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Granney> <Brand_name_of> "Granisetron" .
<Capecitabine_and_Trastuzumab> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<Capecitabine_and_Trastuzumab> <Has_accepted_use> "CNS_carcinoma" .
<Capecitabine_and_Trastuzumab> <Has_accepted_use> "Breast_cancer" .
<Ectaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin,_Cetuximab,_RT> <Is_current_in> "Head_and_neck_cancer" .
<Cytadren> <Brand_name_of> "Aminoglutethimide" .
<OPPA> <Has_modality> "Chemotherapy" .
<Selinexor> <Has_accepted_use> "Multiple_myeloma" .
<Rolimus> <Brand_name_of> "Everolimus" .
<NRAS-mutated_Melanoma> <Is_a> "Melanoma" .
<C-VAMP> <Has_modality> "Chemotherapy" .
<Crizotinib> <Is_a> "ROS1_inhibitor" .
<Crizotinib> <Is_a> "Mutation-specific_medication" .
<Crizotinib> <Is_a> "MET_inhibitor" .
<Crizotinib> <Is_a> "Kinase_inhibitor" .
<Crizotinib> <Is_a> "ALK_inhibitor" .
<Cisplatin,_Vinorelbine,_RT> <Mapped_from> "Cisplatin,_Vinorelbine,_RT" .
<Cabozantinib_monotherapy> <Is_current_in> "Thyroid_cancer" .
<Cabozantinib_monotherapy> <Is_current_in> "Renal_cell_carcinoma" .
<Cabozantinib_monotherapy> <Is_current_in> "Prostate_cancer" .
<Cabozantinib_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Cabozantinib_monotherapy> <Is_current_in> "Hepatocellular_carcinoma" .
<Radium-223_monotherapy> <Has_antineoplastic> "Radium-223" .
<Consolidation_after_upfront_therapy> <Context_of> "Z-BEAM,_then_auto_HSCT" .
<Consolidation_after_upfront_therapy> <Context_of> "Whole_brain_irradiation" .
<Consolidation_after_upfront_therapy> <Context_of> "VIPD" .
<Consolidation_after_upfront_therapy> <Context_of> "Temozolomide_monotherapy" .
<Consolidation_after_upfront_therapy> <Context_of> "TFC,_then_allo_HSCT" .
<Consolidation_after_upfront_therapy> <Context_of> "TBI,_then_auto_HSCT" .
<Consolidation_after_upfront_therapy> <Context_of> "Rituximab_monotherapy" .
<Consolidation_after_upfront_therapy> <Context_of> "Radiation_therapy" .
<Consolidation_after_upfront_therapy> <Context_of> "R-IFE" .
<Consolidation_after_upfront_therapy> <Context_of> "Procarbazine_monotherapy" .
<Consolidation_after_upfront_therapy> <Context_of> "Placebo" .
<Consolidation_after_upfront_therapy> <Context_of> "Pediatric-like_GRAALL_consolidation" .
<Consolidation_after_upfront_therapy> <Context_of> "Paclitaxel_and_RT" .
<Consolidation_after_upfront_therapy> <Context_of> "POMP" .
<Consolidation_after_upfront_therapy> <Context_of> "Observation" .
<Consolidation_after_upfront_therapy> <Context_of> "Nilotinib-based_consolidation" .
<Consolidation_after_upfront_therapy> <Context_of> "Methotrexate_monotherapy" .
<Consolidation_after_upfront_therapy> <Context_of> "Mercaptopurine,_Methotrexate,_Vincristine" .
<Consolidation_after_upfront_therapy> <Context_of> "Mercaptopurine_and_Methotrexate" .
<Consolidation_after_upfront_therapy> <Context_of> "Low-dose_TBI,_then_allo_HSCT" .
<Consolidation_after_upfront_therapy> <Context_of> "Lomustine,_Methotrexate,_Procarbazine" .
<Consolidation_after_upfront_therapy> <Context_of> "Linker_regimen_(consolidation)" .
<Consolidation_after_upfront_therapy> <Context_of> "L-asparaginase_monotherapy" .
<Consolidation_after_upfront_therapy> <Context_of> "L-Asparaginase_and_Methotrexate" .
<Consolidation_after_upfront_therapy> <Context_of> "Isotretinoin_monotherapy" .
<Consolidation_after_upfront_therapy> <Context_of> "Isotretinoin_and_Dinutuximab" .
<Consolidation_after_upfront_therapy> <Context_of> "International_ALL_Trial" .
<Consolidation_after_upfront_therapy> <Context_of> "Imatinib-based_consolidation" .
<Consolidation_after_upfront_therapy> <Context_of> "Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA" .
<Consolidation_after_upfront_therapy> <Context_of> "Idarubicin,_then_Mitoxantrone,_then_Idarubicin" .
<Consolidation_after_upfront_therapy> <Context_of> "Ibritumomab_tiuxetan_monotherapy" .
<Consolidation_after_upfront_therapy> <Context_of> "IDAC_and_Sorafenib" .
<Consolidation_after_upfront_therapy> <Context_of> "IDAC" .
<Consolidation_after_upfront_therapy> <Context_of> "IC_and_Norethandrolone/6-MP,_MTX,_Norethandrolone" .
<Consolidation_after_upfront_therapy> <Context_of> "HiDAC_and_Midostaurin" .
<Consolidation_after_upfront_therapy> <Context_of> "HiDAC" .
<Consolidation_after_upfront_therapy> <Context_of> "HDAC_and_G-CSF" .
<Consolidation_after_upfront_therapy> <Context_of> "HAM_and_Imatinib" .
<Consolidation_after_upfront_therapy> <Context_of> "HAM" .
<Consolidation_after_upfront_therapy> <Context_of> "GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab" .
<Consolidation_after_upfront_therapy> <Context_of> "Fluorouracil_and_Paclitaxel" .
<Consolidation_after_upfront_therapy> <Context_of> "Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Consolidation_after_upfront_therapy> <Context_of> "Fludarabine_and_TBI,_then_allo_HSCT" .
<Consolidation_after_upfront_therapy> <Context_of> "FOLFOX4" .
<Consolidation_after_upfront_therapy> <Context_of> "Etoposide,_Ifosfamide,_Imatinib" .
<Consolidation_after_upfront_therapy> <Context_of> "Etoposide_and_TBI,_then_allo_HSCT" .
<Consolidation_after_upfront_therapy> <Context_of> "Etoposide_and_Mitoxantrone" .
<Consolidation_after_upfront_therapy> <Context_of> "Durvalumab_monotherapy" .
<Consolidation_after_upfront_therapy> <Context_of> "Doxorubicin,_L-asparaginase,_Mercaptopurine,_Methotrexate,_Vincristine,_Prednisone" .
<Consolidation_after_upfront_therapy> <Context_of> "Daunorubicin_monotherapy" .
<Consolidation_after_upfront_therapy> <Context_of> "Cytarabine,_Idarubicin,_Vorinostat" .
<Consolidation_after_upfront_therapy> <Context_of> "Cytarabine,_Idarubicin,_Sorafenib" .
<Consolidation_after_upfront_therapy> <Context_of> "Cytarabine,_Idarubicin,_Imatinib" .
<Consolidation_after_upfront_therapy> <Context_of> "Cytarabine,_Daunorubicin,_Gemtuzumab_ozogamicin" .
<Consolidation_after_upfront_therapy> <Context_of> "Cytarabine_monotherapy" .
<Consolidation_after_upfront_therapy> <Context_of> "Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA" .
<Consolidation_after_upfront_therapy> <Context_of> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA" .
<Consolidation_after_upfront_therapy> <Context_of> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine" .
<Consolidation_after_upfront_therapy> <Context_of> "Cytarabine_and_Idarubicin" .
<Consolidation_after_upfront_therapy> <Context_of> "Cytarabine_and_Daunorubicin" .
<Consolidation_after_upfront_therapy> <Context_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<Consolidation_after_upfront_therapy> <Context_of> "Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone" .
<Consolidation_after_upfront_therapy> <Context_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Pegaspargase,_Vincristine" .
<Consolidation_after_upfront_therapy> <Context_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine" .
<Consolidation_after_upfront_therapy> <Context_of> "Cyclophosphamide_and_TBI,_then_auto_HSCT" .
<Consolidation_after_upfront_therapy> <Context_of> "Cyclophosphamide_and_TBI,_then_allo_HSCT" .
<Consolidation_after_upfront_therapy> <Context_of> "Cyclophosphamide_and_TBI" .
<Consolidation_after_upfront_therapy> <Context_of> "Clofarabine_and_LoDAC/Decitabine" .
<Consolidation_after_upfront_therapy> <Context_of> "Cladribine_monotherapy" .
<Consolidation_after_upfront_therapy> <Context_of> "Cisplatin,_Paclitaxel,_RT" .
<Consolidation_after_upfront_therapy> <Context_of> "Cisplatin,_Fluorouracil,_RT" .
<Consolidation_after_upfront_therapy> <Context_of> "Cisplatin_and_Vinorelbine" .
<Consolidation_after_upfront_therapy> <Context_of> "Cisplatin_and_RT" .
<Consolidation_after_upfront_therapy> <Context_of> "Cisplatin_and_Irinotecan" .
<Consolidation_after_upfront_therapy> <Context_of> "Cisplatin_and_Fluorouracil" .
<Consolidation_after_upfront_therapy> <Context_of> "Cisplatin_and_Etoposide" .
<Consolidation_after_upfront_therapy> <Context_of> "Carboplatin_and_Paclitaxel" .
<Consolidation_after_upfront_therapy> <Context_of> "CYVE" .
<Consolidation_after_upfront_therapy> <Context_of> "CYM" .
<Consolidation_after_upfront_therapy> <Context_of> "CPX-351_monotherapy" .
<Consolidation_after_upfront_therapy> <Context_of> "COPDAC" .
<Consolidation_after_upfront_therapy> <Context_of> "CLARA" .
<Consolidation_after_upfront_therapy> <Context_of> "CIA" .
<Consolidation_after_upfront_therapy> <Context_of> "CBVM,_then_auto_HSCT" .
<Consolidation_after_upfront_therapy> <Context_of> "CBV,_then_auto_HSCT" .
<Consolidation_after_upfront_therapy> <Context_of> "CALGB_8811_late_intensification" .
<Consolidation_after_upfront_therapy> <Context_of> "CALGB_8811_early_intensification" .
<Consolidation_after_upfront_therapy> <Context_of> "C-MOPP" .
<Consolidation_after_upfront_therapy> <Context_of> "Busulfan_and_Melphalan,_then_auto_HSCT" .
<Consolidation_after_upfront_therapy> <Context_of> "BuFlu,_then_allo_HSCT" .
<Consolidation_after_upfront_therapy> <Context_of> "BuCy,_then_auto_HSCT" .
<Consolidation_after_upfront_therapy> <Context_of> "Bu/TT/Cy,_then_auto_HSCT" .
<Consolidation_after_upfront_therapy> <Context_of> "Bu/TT,_then_auto_HSCT" .
<Consolidation_after_upfront_therapy> <Context_of> "Blinatumomab_monotherapy" .
<Consolidation_after_upfront_therapy> <Context_of> "Bacillus_Calmette-Guerin_(BCG)_monotherapy" .
<Consolidation_after_upfront_therapy> <Context_of> "BEAM,_then_auto_HSCT" .
<Consolidation_after_upfront_therapy> <Context_of> "BCNU/TT,_then_auto_HSCT" .
<Consolidation_after_upfront_therapy> <Context_of> "BASIC" .
<Consolidation_after_upfront_therapy> <Context_of> "Azacitidine_monotherapy" .
<Consolidation_after_upfront_therapy> <Context_of> "Azacitidine_and_Gemtuzumab_ozogamicin" .
<Consolidation_after_upfront_therapy> <Context_of> "Augmented_BFM_consolidation" .
<Consolidation_after_upfront_therapy> <Context_of> "Arsenic_trioxide,_then_ATRA_and_Daunorubicin" .
<Consolidation_after_upfront_therapy> <Context_of> "Arsenic_trioxide_monotherapy" .
<Consolidation_after_upfront_therapy> <Context_of> "Arsenic_trioxide_and_ATRA" .
<Consolidation_after_upfront_therapy> <Context_of> "Amsacrine_and_Cytarabine" .
<Consolidation_after_upfront_therapy> <Context_of> "ATRA_and_Daunorubicin" .
<Consolidation_after_upfront_therapy> <Context_of> "AALL0232_consolidation" .
<Consolidation_after_upfront_therapy> <Context_of> "5_plus_2d" .
<Chlorambucil,_Dactinomycin,_Methotrexate> <Mapped_from> "Chlorambucil,_Dactinomycin,_Methotrexate" .
<Adrenol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Bevacizumab_monotherapy> <Has_antineoplastic> "Bevacizumab" .
<TH_(Taxol)> <Has_context> "Non-curative_first-line_therapy" .
<TH_(Taxol)> <Has_context> "Neoadjuvant_therapy" .
<TH_(Taxol)> <Has_context> "Adjuvant_therapy" .
<Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone> <Has_context> "Non-curative_therapy" .
<Cisplatin,_Dacarbazine,_Tamoxifen> <Mapped_from> "Cisplatin,_Dacarbazine,_Tamoxifen" .
<TTR> <Has_modality> "Chemotherapy" .
<Vincristine_and_Prednisone> <Has_antineoplastic> "Vincristine" .
<Vincristine_and_Prednisone> <Has_antineoplastic> "Prednisone" .
<FLAG-DNX> <Maps_to> "FLAG-DNX" .
<DCTER> <Has_context> "Induction_therapy" .
<Cisplatin_and_Pemetrexed> <Is_a> "Platinum_doublet" .
<Bryterol> <Brand_name_of> "Ondansetron" .
<Capecitabine_and_Ixabepilone> <Mapped_from> "Capecitabine_and_Ixabepilone" .
<External_beam_radiotherapy> <Supportive_med_of> "Tamoxifen_and_OFS" .
<External_beam_radiotherapy> <Supportive_med_of> "Exemestane_monotherapy" .
<VBMC> <Has_context> "Non-curative_first-line_therapy" .
<Tilopin> <Brand_name_of> "Ticlopidine" .
<MACOP-B> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Lenalidomide_and_Rituximab> <Has_supportive_med> "Low_molecular_weight_heparins" .
<Lenalidomide_and_Rituximab> <Has_supportive_med> "Aspirin" .
<Lenalidomide_and_Rituximab> <Has_supportive_med> "Allopurinol" .
<Carboplatin,_Etoposide,_RT> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Carboplatin,_Etoposide,_RT> <Has_supportive_med> "Granisetron" .
<Carboplatin,_Etoposide,_RT> <Has_supportive_med> "Dexamethasone" .
<Artinizona> <Brand_name_of> "Prednisone" .
<Dalteparin_monotherapy> <Is_current_in> "Venous_thromboembolism" .
<Nilotinib> <Antineoplastic_of> "Nilotinib-based_consolidation" .
<Nilotinib> <Antineoplastic_of> "Nilotinib_monotherapy" .
<Nilotinib> <Antineoplastic_of> "Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib" .
<Cytarabine_and_Mitoxantrone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Cytarabine_and_Mitoxantrone> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Placebo> <Has_accepted_use> "Venous_thromboembolism" .
<Placebo> <Has_accepted_use> "Thyroid_cancer" .
<Placebo> <Has_accepted_use> "Thrombocytopenia_in_liver_disease" .
<Placebo> <Has_accepted_use> "Systemic_mastocytosis" .
<Placebo> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Placebo> <Has_accepted_use> "Small_cell_lung_cancer" .
<Placebo> <Has_accepted_use> "Renal_cell_carcinoma" .
<Placebo> <Has_accepted_use> "Prostate_cancer" .
<Placebo> <Has_accepted_use> "Polycythemia_vera" .
<Placebo> <Has_accepted_use> "Paroxysmal_nocturnal_hemoglobinuria" .
<Placebo> <Has_accepted_use> "Pancreatic_cancer" .
<Placebo> <Has_accepted_use> "Pancreatic_NET" .
<Placebo> <Has_accepted_use> "Ovarian_cancer" .
<Placebo> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Placebo> <Has_accepted_use> "Neuroendocrine_tumor" .
<Placebo> <Has_accepted_use> "Myelofibrosis" .
<Placebo> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Placebo> <Has_accepted_use> "Multiple_myeloma" .
<Placebo> <Has_accepted_use> "Mesothelioma" .
<Placebo> <Has_accepted_use> "Meningioma" .
<Placebo> <Has_accepted_use> "Melanoma" .
<Placebo> <Has_accepted_use> "Kaposi_sarcoma" .
<Placebo> <Has_accepted_use> "Immune_thrombocytopenia" .
<Placebo> <Has_accepted_use> "Hodgkin_lymphoma" .
<Placebo> <Has_accepted_use> "Hereditary_hemorrhagic_telangiectasia" .
<Placebo> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Placebo> <Has_accepted_use> "Head_and_neck_cancer" .
<Placebo> <Has_accepted_use> "Gastrointestinal_stromal_tumor" .
<Placebo> <Has_accepted_use> "Gastric_cancer" .
<Placebo> <Has_accepted_use> "Follicular_lymphoma" .
<Placebo> <Has_accepted_use> "Esophageal_cancer" .
<Placebo> <Has_accepted_use> "Endometrial_cancer" .
<Placebo> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Placebo> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Placebo> <Has_accepted_use> "Colon_cancer" .
<Placebo> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Placebo> <Has_accepted_use> "Castleman_disease" .
<Placebo> <Has_accepted_use> "Breast_cancer" .
<Placebo> <Has_accepted_use> "Bladder_cancer" .
<Placebo> <Has_accepted_use> "BRCA-mutated_Pancreatic_cancer" .
<Placebo> <Has_accepted_use> "BRCA-mutated_Ovarian_cancer" .
<Placebo> <Has_accepted_use> "Adrenocortical_carcinoma" .
<MOF> <Mapped_from> "MOF" .
<Carboplatin_and_Bevacizumab> <Is_current_in> "Glioblastoma" .
<Carboplatin_and_Bevacizumab> <Is_current_in> "Anaplastic_glioma" .
<Cyclosporine,_Methotrexate,_Methylprednisolone> <Is_current_in> "Graft_versus_host_disease" .
<TH_(Taxotere/SC)> <Has_modality> "Chemotherapy" .
<APO> <Has_antineoplastic> "Vincristine" .
<APO> <Has_antineoplastic> "Prednisone" .
<APO> <Has_antineoplastic> "Doxorubicin" .
<Sargramostim> <Has_brand_name> "Leukine" .
<Tegafur_and_Uracil> <Is_current_in> "Non-small_cell_lung_cancer" .
<Tegafur_and_Uracil> <Is_current_in> "Head_and_neck_cancer" .
<R-FM> <Is_current_in> "Follicular_lymphoma" .
<Intraperitoneal_hyperthermic_mitomycin> <Maps_to> "Intraperitoneal_hyperthermic_mitomycin" .
<Abemaciclib_and_Letrozole> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Abemaciclib_and_Letrozole> <Has_accepted_use> "Breast_cancer" .
<Kemocid> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<GemOx_and_Sorafenib> <Has_accepted_use> "Hepatocellular_carcinoma" .
<T-DM1_and_ET> <Is_a> "Antiestrogen-containing_regimen" .
<Antibac> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<DAC> <Has_accepted_use> "Acute_myeloid_leukemia" .
<FLOT> <Has_accepted_use> "Gastric_cancer" .
<FLOT> <Has_accepted_use> "Esophageal_cancer" .
<Plustaxano> <Brand_name_of> "Docetaxel" .
<AspaMetDex_(Erwinaze)> <Maps_to> "AspaMetDex_(Erwinaze)" .
<G-CVP> <Has_modality> "Chemotherapy" .
<Doxifluridine_and_Mitomycin> <Is_historical_in> "Gastric_cancer" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Vinorelbine_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Vinorelbine" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Vindesine_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Vindesine" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Vinblastine" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Vandetanib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "VIP" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Trametinib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Tegafur_gimeracil_oteracil" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Tegafur_and_uracil" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Tegafur_and_Uracil" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Sorafenib_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Sorafenib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "S-1_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Ramucirumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Radiation_therapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Plinabulin" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Placebo" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Pemetrexed_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Pemetrexed_and_Pembrolizumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Pemetrexed_and_Bevacizumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Pemetrexed" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Pembrolizumab_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Pembrolizumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Paclitaxel_nanoparticle_albumin-bound" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Paclitaxel_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Paclitaxel" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "PEV" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Osimertinib_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Osimertinib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Observation" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "No_neoadjuvant_therapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "No_induction" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Nivolumab_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Nivolumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Nintedanib_and_Pemetrexed" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Nintedanib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Nedaplatin" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Necitumumab_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Necitumumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "MVP_and_RT" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "MVP_(Vindesine)" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "MVP_(Vinblastine)" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "MIC" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "MACC" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Lorlatinib_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Lorlatinib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Irinotecan" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Ipilimumab_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Ipilimumab_and_Nivolumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Ipilimumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Ifosfamide_and_Gemcitabine" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Icotinib_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Icotinib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Gemcitabine_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Gemcitabine_and_Vinorelbine" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Gemcitabine_and_Paclitaxel" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Gemcitabine" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Gefitinib_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Gefitinib_and_Pemetrexed" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Gefitinib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "GIP" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "GCP" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Etoposide" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Erlotinib_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Erlotinib_and_Ramucirumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Erlotinib_and_Bevacizumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Erlotinib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Entrectinib_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Ensartinib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Durvalumab_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Durvalumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Docetaxel_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Docetaxel_and_Vinorelbine" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Docetaxel_and_Vandetanib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Docetaxel_and_Ramucirumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Docetaxel_and_Nintedanib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Docetaxel_and_Nedaplatin" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Docetaxel_and_Gemcitabine" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Docetaxel_and_Bevacizumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Docetaxel" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Dacomitinib_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Dacomitinib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Dabrafenib_and_Trametinib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Dabrafenib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Custirsen" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Crizotinib_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Crizotinib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin,_Vinorelbine,_RT" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin,_Vinorelbine,_Cetuximab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin,_Vinblastine,_RT" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin,_Pemetrexed,_Pembrolizumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin,_Pemetrexed,_Bevacizumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin,_Gemcitabine,_Necitumumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin,_Gemcitabine,_Bevacizumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin,_Etoposide,_RT" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin,_Docetaxel,_RT" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_and_Vinorelbine" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_and_Vindesine" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_and_Vinblastine" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_and_RT" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_and_Pemetrexed" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_and_Paclitaxel" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_and_Irinotecan" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_and_Gemcitabine/Erlotinib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_and_Gemcitabine" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_and_Etoposide" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin_and_Docetaxel" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cisplatin" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cetuximab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Ceritinib_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Ceritinib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin,_nab-Paclitaxel,_Pembrolizumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin,_nab-Paclitaxel,_Atezolizumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin,_Vinorelbine,_RT" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin,_Pemetrexed,_Pembrolizumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin,_Pemetrexed,_Bevacizumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin,_Paclitaxel,_RT" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin,_Paclitaxel,_Pembrolizumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin,_Paclitaxel,_Ipilimumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin,_Paclitaxel,_Bevacizumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin_and_nab-Paclitaxel" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin_and_Vinorelbine" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin_and_RT" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin_and_Pemetrexed" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin_and_Paclitaxel" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin_and_Gemcitabine/Erlotinib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin_and_Gemcitabine" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin_and_Etoposide" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin_and_Docetaxel" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin_and_Cisplatin" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Carboplatin" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cabozantinib_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cabozantinib_and_Erlotinib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Cabozantinib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "CCI" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "CAP_(Platinol)" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "CAMP" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Brigatinib_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Brigatinib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Bevacizumab-bvzr" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Bevacizumab-awwb" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Bevacizumab_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Bevacizumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Best_supportive_care" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Bavituximab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Bacillus_Calmette-Guerin_(BCG)_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Atezolizumab_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Atezolizumab_and_Bevacizumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Atezolizumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Amrubicin_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Amrubicin" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Alectinib_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Alectinib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Afatinib_monotherapy" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Afatinib_and_Paclitaxel" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Afatinib_and_Cetuximab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Afatinib_and_Bevacizumab" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "Afatinib" .
<Non-small_cell_lung_cancer> <Accepted_use_of> "ABCP" .
<Procren> <Brand_name_of> "Leuprolide" .
<Estramustine> <Is_a> "Nitrogen_mustard" .
<Graft_versus_host_disease> <Is_a> "Alloimmune_hematologic_condition" .
<BVR> <Maps_to> "BVR" .
<No_induction> <Maps_to> "No_induction" .
<Zolinza> <Brand_name_of> "Vorinostat" .
<Irinotecan,_Vemurafenib,_Cetuximab> <Has_context> "Non-curative_third-line_therapy" .
<Clofarabine_monotherapy> <Mapped_from> "Clofarabine_monotherapy" .
<Dactinomycin_and_Vincristine> <Is_current_in> "Wilms_tumor" .
<Bu/TT,_then_auto_HSCT> <Has_accepted_use> "CNS_lymphoma" .
<Albyl_Minor> <Brand_name_of> "Aspirin" .
<VAD_and_Cyclosporine> <Has_accepted_use> "Multiple_myeloma" .
<Carboplatin,_Paclitaxel,_Bevacizumab> <Has_supportive_med> "Steroids" .
<Cytomegalovirus_Immune_Globulin> <Is_a> "Fractionated_plasma_product" .
<Non-curative_therapy> <Mapped_from> "Non-curative_therapy" .
<Kilios> <Brand_name_of> "Aspirin" .
<Alam-PH> <Brand_name_of> "Alprazolam" .
<Arsenic_trioxide_and_Chlorambucil> <Mapped_from> "Arsenic_trioxide_and_Chlorambucil" .
<UFT_monotherapy> <Has_antineoplastic> "Tegafur_and_uracil" .
<Nipent> <Brand_name_of> "Pentostatin" .
<MF> <Is_historical_in> "Breast_cancer" .
<Japtrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Chronic_myelogenous_leukemia> <FDA_indication_of> "Ponatinib" .
<Chronic_myelogenous_leukemia> <FDA_indication_of> "Omacetaxine" .
<Chronic_myelogenous_leukemia> <FDA_indication_of> "Nilotinib" .
<Chronic_myelogenous_leukemia> <FDA_indication_of> "Imatinib" .
<Chronic_myelogenous_leukemia> <FDA_indication_of> "Dasatinib" .
<Chronic_myelogenous_leukemia> <FDA_indication_of> "Bosutinib" .
<5_plus_2d> <Has_context> "Salvage_therapy" .
<5_plus_2d> <Has_context> "Consolidation_after_upfront_therapy" .
<R-FCM> <Is_historical_in> "Chronic_lymphocytic_leukemia" .
<LEED> <Mapped_from> "LEED" .
<Pralatrexate_monotherapy> <Mapped_from> "Pralatrexate_monotherapy" .
<VAD_doxil> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<VAD_doxil> <Has_supportive_med> "Fluconazole" .
<Romiplostim_monotherapy> <Mapped_from> "Romiplostim_monotherapy" .
<O-miniCHOP> <Is_a> "Anthracycline-containing_regimen" .
<Fludarabine,_Busulfan,_Cyclophosphamide> <Has_modality> "Immunosuppressive_therapy" .
<Fludarabine,_Busulfan,_Cyclophosphamide> <Has_modality> "Chemotherapy" .
<Trisural> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<R-miniCHOP> <Mapped_from> "R-miniCHOP" .
<Prednisonum> <Brand_name_of> "Prednisone" .
<CapeOx> <Maps_to> "CapeOx" .
<TCHP_(Taxotere)> <Mapped_from> "TCHP_(Taxotere)" .
<Azacitidine> <May_have_route> "Subcutaneous" .
<Azacitidine> <May_have_route> "Intravenous" .
<Carboplatin_and_nab-Paclitaxel> <Is_a> "Platinum_doublet" .
<Ayvakit> <Brand_name_of> "Avapritinib" .
<Gemcitabine> <Has_FDA_indication> "Pancreatic_cancer" .
<Gemcitabine> <Has_FDA_indication> "Ovarian_cancer" .
<Gemcitabine> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Gemcitabine> <Has_FDA_indication> "Breast_cancer" .
<IRIS_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Afanix> <Brand_name_of> "Afatinib" .
<Entospletinib> <May_have_route> "Oral" .
<Pidilizumab> <Has_accepted_use> "Follicular_lymphoma" .
<Pidilizumab> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Busulfan_monotherapy> <Mapped_from> "Busulfan_monotherapy" .
<m-BACOD> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<ddTH_(Taxotere)> <Is_current_in> "Breast_cancer" .
<Anakinra_monotherapy> <Maps_to> "Anakinra_monotherapy" .
<VBMCP/VBAD> <Is_a> "Anthracycline-containing_regimen" .
<Talazoparib> <May_have_route> "Oral" .
<CBV-Mx,_then_auto_HSCT> <Mapped_from> "CBV-Mx,_then_auto_HSCT" .
<SP_Cordexa> <Brand_name_of> "Dexamethasone" .
<Cisplatin,_Etoposide,_RT> <Maps_to> "Cisplatin,_Etoposide,_RT" .
<BeneFix> <Brand_name_of> "Factor_IX_recombinant" .
<Samarium-153_monotherapy> <Has_context> "Non-curative_therapy" .
<Femorel> <Brand_name_of> "Ibandronate" .
<MEC> <Has_modality> "Chemotherapy" .
<Ado-trastuzumab_emtansine_monotherapy> <Is_current_in> "ERBB2-mutated_malignancy" .
<Ado-trastuzumab_emtansine_monotherapy> <Is_current_in> "Breast_cancer" .
<Temsirolimus> <Antineoplastic_of> "Temsirolimus_monotherapy" .
<Temsirolimus> <Antineoplastic_of> "Temsirolimus_and_Rituximab" .
<Temsirolimus> <Antineoplastic_of> "BeRT" .
<Rituximab> <Antineoplastic_of> "maxi-R-CHOP/R-HiDAC" .
<Rituximab> <Antineoplastic_of> "Z-BEAM,_then_auto_HSCT" .
<Rituximab> <Antineoplastic_of> "Z-BEAM" .
<Rituximab> <Antineoplastic_of> "Vorinostat_and_Rituximab" .
<Rituximab> <Antineoplastic_of> "Venetoclax_and_Rituximab" .
<Rituximab> <Antineoplastic_of> "VcR-CVAD" .
<Rituximab> <Antineoplastic_of> "VR-CP" .
<Rituximab> <Antineoplastic_of> "VR-CHOP" .
<Rituximab> <Antineoplastic_of> "VR-CAP" .
<Rituximab> <Antineoplastic_of> "VR" .
<Rituximab> <Antineoplastic_of> "Thalidomide_and_Rituximab" .
<Rituximab> <Antineoplastic_of> "Temsirolimus_and_Rituximab" .
<Rituximab> <Antineoplastic_of> "TTR" .
<Rituximab> <Antineoplastic_of> "SC-EPOCH-RR" .
<Rituximab> <Antineoplastic_of> "Rituximab_monotherapy" .
<Rituximab> <Antineoplastic_of> "RiPAD_plus_C" .
<Rituximab> <Antineoplastic_of> "RVR" .
<Rituximab> <Antineoplastic_of> "RT-PEPC" .
<Rituximab> <Antineoplastic_of> "RICER" .
<Rituximab> <Antineoplastic_of> "RCC" .
<Rituximab> <Antineoplastic_of> "RABVD" .
<Rituximab> <Antineoplastic_of> "R2CHOP" .
<Rituximab> <Antineoplastic_of> "R-miniCHOP" .
<Rituximab> <Antineoplastic_of> "R-miniCEOP" .
<Rituximab> <Antineoplastic_of> "R-VAD_plus_C" .
<Rituximab> <Antineoplastic_of> "R-TBI/Cy,_then_auto_HSCT" .
<Rituximab> <Antineoplastic_of> "R-TBI/Cy" .
<Rituximab> <Antineoplastic_of> "R-NIMP" .
<Rituximab> <Antineoplastic_of> "R-MegaCHOP-14" .
<Rituximab> <Antineoplastic_of> "R-MegaCHOP" .
<Rituximab> <Antineoplastic_of> "R-MPV" .
<Rituximab> <Antineoplastic_of> "R-MP" .
<Rituximab> <Antineoplastic_of> "R-MCP_(CCNU)" .
<Rituximab> <Antineoplastic_of> "R-MCP" .
<Rituximab> <Antineoplastic_of> "R-MACLO/R-IVAM" .
<Rituximab> <Antineoplastic_of> "R-M-CHOP" .
<Rituximab> <Antineoplastic_of> "R-INO" .
<Rituximab> <Antineoplastic_of> "R-IFE" .
<Rituximab> <Antineoplastic_of> "R-ICE" .
<Rituximab> <Antineoplastic_of> "R-Hyper-CVAD/R-MA" .
<Rituximab> <Antineoplastic_of> "R-HiDAC" .
<Rituximab> <Antineoplastic_of> "R-GemOx" .
<Rituximab> <Antineoplastic_of> "R-GDP" .
<Rituximab> <Antineoplastic_of> "R-GCVP" .
<Rituximab> <Antineoplastic_of> "R-FND" .
<Rituximab> <Antineoplastic_of> "R-FM" .
<Rituximab> <Antineoplastic_of> "R-FCM" .
<Rituximab> <Antineoplastic_of> "R-ESHAP" .
<Rituximab> <Antineoplastic_of> "R-EPOCH,_dose-escalated" .
<Rituximab> <Antineoplastic_of> "R-EPOCH" .
<Rituximab> <Antineoplastic_of> "R-DexaBEAM" .
<Rituximab> <Antineoplastic_of> "R-DHAP/R-VIM" .
<Rituximab> <Antineoplastic_of> "R-DHAP" .
<Rituximab> <Antineoplastic_of> "R-DHAOx" .
<Rituximab> <Antineoplastic_of> "R-DHAC" .
<Rituximab> <Antineoplastic_of> "R-CVP" .
<Rituximab> <Antineoplastic_of> "R-CVEP" .
<Rituximab> <Antineoplastic_of> "R-CP" .
<Rituximab> <Antineoplastic_of> "R-COPADM" .
<Rituximab> <Antineoplastic_of> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Rituximab> <Antineoplastic_of> "R-CODOX-M/R-IVAC" .
<Rituximab> <Antineoplastic_of> "R-CODOX-M_(Doxil_substituted)" .
<Rituximab> <Antineoplastic_of> "R-CODOX-M" .
<Rituximab> <Antineoplastic_of> "R-CMD" .
<Rituximab> <Antineoplastic_of> "R-CHVP_plus_I" .
<Rituximab> <Antineoplastic_of> "R-CHOP/R-DHAP" .
<Rituximab> <Antineoplastic_of> "R-CHOP-14_(Rituximab_Hycela)" .
<Rituximab> <Antineoplastic_of> "R-CHOP-14_(Prednisolone)" .
<Rituximab> <Antineoplastic_of> "R-CHOP-14" .
<Rituximab> <Antineoplastic_of> "R-CHOP_(Rituximab_Hycela)" .
<Rituximab> <Antineoplastic_of> "R-CHOP_(Prednisolone)" .
<Rituximab> <Antineoplastic_of> "R-CHOP" .
<Rituximab> <Antineoplastic_of> "R-CHOEP-14" .
<Rituximab> <Antineoplastic_of> "R-CHMP" .
<Rituximab> <Antineoplastic_of> "R-CEOP90_(Epirubicin)" .
<Rituximab> <Antineoplastic_of> "R-CEOP_(Etoposide)" .
<Rituximab> <Antineoplastic_of> "R-CDOP" .
<Rituximab> <Antineoplastic_of> "R-BL" .
<Rituximab> <Antineoplastic_of> "R-BEAM,_then_auto_HSCT" .
<Rituximab> <Antineoplastic_of> "R-BEAM" .
<Rituximab> <Antineoplastic_of> "R-BAC" .
<Rituximab> <Antineoplastic_of> "R,_then_CHOP" .
<Rituximab> <Antineoplastic_of> "Panobinostat_and_Rituximab" .
<Rituximab> <Antineoplastic_of> "PCR" .
<Rituximab> <Antineoplastic_of> "OFAR" .
<Rituximab> <Antineoplastic_of> "Nordic_Regimen,_younger_patients" .
<Rituximab> <Antineoplastic_of> "Nordic_Regimen,_older_patients" .
<Rituximab> <Antineoplastic_of> "Methotrexate_and_Rituximab" .
<Rituximab> <Antineoplastic_of> "MT-R" .
<Rituximab> <Antineoplastic_of> "MATRix" .
<Rituximab> <Antineoplastic_of> "Lenalidomide,_Dexamethasone,_Rituximab" .
<Rituximab> <Antineoplastic_of> "Lenalidomide_and_Rituximab" .
<Rituximab> <Antineoplastic_of> "Idelalisib_and_Rituximab" .
<Rituximab> <Antineoplastic_of> "Ibrutinib_and_Rituximab" .
<Rituximab> <Antineoplastic_of> "Ibritumomab_tiuxetan_monotherapy" .
<Rituximab> <Antineoplastic_of> "HDMP-R" .
<Rituximab> <Antineoplastic_of> "Gemcitabine_and_Rituximab" .
<Rituximab> <Antineoplastic_of> "GMALL-R" .
<Rituximab> <Antineoplastic_of> "GCD-R" .
<Rituximab> <Antineoplastic_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT" .
<Rituximab> <Antineoplastic_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan" .
<Rituximab> <Antineoplastic_of> "FR" .
<Rituximab> <Antineoplastic_of> "FCR,_then_allo_HSCT" .
<Rituximab> <Antineoplastic_of> "FCR_(Rituximab_Hycela)" .
<Rituximab> <Antineoplastic_of> "FCR" .
<Rituximab> <Antineoplastic_of> "Everolimus_and_Rituximab" .
<Rituximab> <Antineoplastic_of> "EAR_and_G-CSF" .
<Rituximab> <Antineoplastic_of> "DRC" .
<Rituximab> <Antineoplastic_of> "DA-R-EPOCH" .
<Rituximab> <Antineoplastic_of> "Cytarabine,_Methotrexate,_Rituximab" .
<Rituximab> <Antineoplastic_of> "Cytarabine,_Idarubicin,_Rituximab" .
<Rituximab> <Antineoplastic_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab" .
<Rituximab> <Antineoplastic_of> "Cladribine_and_Rituximab" .
<Rituximab> <Antineoplastic_of> "Chlorambucil_and_Rituximab" .
<Rituximab> <Antineoplastic_of> "CaRD" .
<Rituximab> <Antineoplastic_of> "CFAR" .
<Rituximab> <Antineoplastic_of> "CBV,_then_auto_HSCT" .
<Rituximab> <Antineoplastic_of> "CALGB_10-002_regimen" .
<Rituximab> <Antineoplastic_of> "Bevacizumab_and_Rituximab" .
<Rituximab> <Antineoplastic_of> "BeRT" .
<Rituximab> <Antineoplastic_of> "BVR" .
<Rituximab> <Antineoplastic_of> "BR_and_Polatuzumab_vedotin" .
<Rituximab> <Antineoplastic_of> "BR_and_Idelalisib" .
<Rituximab> <Antineoplastic_of> "BR_and_Ibrutinib" .
<Rituximab> <Antineoplastic_of> "BR" .
<Rituximab> <Antineoplastic_of> "BFR,_then_allo_HSCT" .
<Rituximab> <Antineoplastic_of> "BFR" .
<Rituximab> <Antineoplastic_of> "BDR" .
<Rituximab> <Antineoplastic_of> "BASIC" .
<Rituximab> <Antineoplastic_of> "Alemtuzumab_and_Rituximab" .
<Rituximab> <Antineoplastic_of> "ACVBP-R" .
<Rituximab> <Antineoplastic_of> "(90)YFC,_then_allo_HSCT" .
<Rituximab> <Antineoplastic_of> "(90)YFC" .
<Intraperitoneal_5-FU> <Has_modality> "Chemotherapy" .
<Factor_Xa_recombinant_inactivated-zhzo> <Has_brand_name> "Andexxa" .
<Carboplatin,_Etoposide,_Atezolizumab> <Has_modality> "Immunotherapy" .
<Carboplatin,_Etoposide,_Atezolizumab> <Has_modality> "Chemotherapy" .
<Septazole> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Carboplatin_and_Teniposide> <Maps_to> "Carboplatin_and_Teniposide" .
<Dexasonlin> <Brand_name_of> "Dexamethasone" .
<Siltuximab> <Has_brand_name> "Sylvant" .
<Letrozole_monotherapy> <Has_modality> "Hormonotherapy" .
<Mogamulizumab_monotherapy> <Has_antineoplastic> "Mogamulizumab" .
<IDAC_and_Sorafenib> <Has_context> "Consolidation_after_upfront_therapy" .
<7_plus_3d_and_GO> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Zoledronic_acid_therapy> <Has_modality> "Supportive_therapy" .
<Denileukin_diftitox_monotherapy> <Maps_to> "Denileukin_diftitox_monotherapy" .
<Carboplatin,_nab-Paclitaxel,_Atezolizumab> <Maps_to> "Carboplatin,_nab-Paclitaxel,_Atezolizumab" .
<FOLFOX_7/sLV5FU2> <Has_accepted_use> "Colon_cancer" .
<MA-BCD/AP> <Is_current_in> "Osteosarcoma" .
<Mercaptopurine,_Methotrexate,_WB-XRT> <Maps_to> "Mercaptopurine,_Methotrexate,_WB-XRT" .
<Cyclophosphamide,_Etoposide,_TBI> <Has_supportive_med> "Hydrocortisone" .
<Cyclophosphamide,_Etoposide,_TBI> <Has_supportive_med> "Diphenhydramine" .
<CBV,_then_auto_HSCT> <Is_a> "Rituximab-containing_regimen" .
<ABVD> <Has_antineoplastic> "Vinblastine" .
<ABVD> <Has_antineoplastic> "Doxorubicin" .
<ABVD> <Has_antineoplastic> "Dacarbazine" .
<ABVD> <Has_antineoplastic> "Bleomycin" .
<Hypereosinophilic_syndrome> <Accepted_use_of> "Ruxolitinib_monotherapy" .
<Hypereosinophilic_syndrome> <Accepted_use_of> "Ruxolitinib" .
<Hypereosinophilic_syndrome> <Accepted_use_of> "Peginterferon_alfa-2a_monotherapy" .
<Hypereosinophilic_syndrome> <Accepted_use_of> "Peginterferon_alfa-2a" .
<Hypereosinophilic_syndrome> <Accepted_use_of> "Nilotinib_monotherapy" .
<Hypereosinophilic_syndrome> <Accepted_use_of> "Nilotinib" .
<Hypereosinophilic_syndrome> <Accepted_use_of> "Mepolizumab_monotherapy" .
<Hypereosinophilic_syndrome> <Accepted_use_of> "Mepolizumab" .
<Hypereosinophilic_syndrome> <Accepted_use_of> "Imatinib_monotherapy" .
<Hypereosinophilic_syndrome> <Accepted_use_of> "Imatinib" .
<Hypereosinophilic_syndrome> <Accepted_use_of> "Hydroxyurea_monotherapy" .
<Hypereosinophilic_syndrome> <Accepted_use_of> "Hydroxyurea" .
<Hypereosinophilic_syndrome> <Accepted_use_of> "Cytarabine" .
<Hypereosinophilic_syndrome> <Accepted_use_of> "Cladribine_and_Cytarabine" .
<Hypereosinophilic_syndrome> <Accepted_use_of> "Cladribine" .
<Hypereosinophilic_syndrome> <Accepted_use_of> "Benralizumab_monotherapy" .
<Hypereosinophilic_syndrome> <Accepted_use_of> "Benralizumab" .
<Hypereosinophilic_syndrome> <Accepted_use_of> "Alemtuzumab_monotherapy" .
<Hypereosinophilic_syndrome> <Accepted_use_of> "Alemtuzumab" .
<DEP> <Has_accepted_use> "Hemophagocytic_lymphohistiocytosis" .
<Xagrid> <Brand_name_of> "Anagrelide" .
<Methotrexate,_RT,_Cyclophosphamide> <Maps_to> "Methotrexate,_RT,_Cyclophosphamide" .
<Ibrutinib_and_Rituximab> <Is_a> "Rituximab-containing_regimen" .
<Isotretinoin_and_Dinutuximab> <Has_modality> "Immunotherapy" .
<Isotretinoin_and_Dinutuximab> <Has_modality> "Chemotherapy" .
<Alltrex> <Brand_name_of> "Methotrexate" .
<FOLFOX2> <Maps_to> "FOLFOX2" .
<Trastuzumab_and_hyaluronidase> <May_have_route> "Subcutaneous" .
<Pomalidomide> <May_have_route> "Oral" .
<Arsenic_trioxide_and_Idarubicin> <Mapped_from> "Arsenic_trioxide_and_Idarubicin" .
<BCVPP> <Has_modality> "Chemotherapy" .
<R-CHOP-14_(Prednisolone)> <Is_current_in> "Primary_mediastinal_B-cell_lymphoma" .
<R-CHOP-14_(Prednisolone)> <Is_current_in> "Mantle_cell_lymphoma" .
<R-CHOP-14_(Prednisolone)> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Aptrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<SCAB> <Mapped_from> "SCAB" .
<RT-PEPC> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Shirodex> <Brand_name_of> "Dexamethasone" .
<R-BEAM,_then_auto_HSCT> <Is_current_in> "Mantle_cell_lymphoma" .
<R-BEAM,_then_auto_HSCT> <Is_current_in> "Follicular_lymphoma" .
<R-BEAM,_then_auto_HSCT> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Coprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Docetaxel,_Fluorouracil,_Hydroxyurea,_RT> <Has_antineoplastic> "Hydroxyurea" .
<Docetaxel,_Fluorouracil,_Hydroxyurea,_RT> <Has_antineoplastic> "Fluorouracil" .
<Docetaxel,_Fluorouracil,_Hydroxyurea,_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Docetaxel,_Fluorouracil,_Hydroxyurea,_RT> <Has_antineoplastic> "Docetaxel" .
<Levamisole_monotherapy> <Mapped_from> "Levamisole_monotherapy" .
<Chlormethine> <Brand_name_of> "Mechlorethamine" .
<mFOLFIRINOX> <Has_modality> "Chemotherapy" .
<Regorafenib> <May_have_route> "Oral" .
<R2CHOP> <Has_context> "Induction_therapy" .
<Defibrotide_monotherapy> <Mapped_from> "Defibrotide_monotherapy" .
<Pemetrexed_and_Pembrolizumab> <Has_modality> "Chemotherapy" .
<Fotemustine> <Is_a> "Nitrosourea" .
<Fotemustine> <Is_a> "EMA_approved_drug" .
<HDAC_and_G-CSF> <Mapped_from> "HDAC_and_G-CSF" .
<Hydroxyurea_and_Imatinib> <Maps_to> "Hydroxyurea_and_Imatinib" .
<Chemoprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Sprycel> <Brand_name_of> "Dasatinib" .
<Metidrol> <Brand_name_of> "Methylprednisolone" .
<Fluor-Uracil> <Brand_name_of> "Fluorouracil" .
<Bicalutamide_and_Goserelin> <Maps_to> "Bicalutamide_and_Goserelin" .
<Metilprednisolona> <Brand_name_of> "Methylprednisolone" .
<Carmustine_and_Doxorubicin> <Has_accepted_use> "Multiple_myeloma" .
<Interferon_alfa-2c_monotherapy> <Has_accepted_use> "Renal_cell_carcinoma" .
<Omsat> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Rhabdomyosarcoma> <Current_treated_by> "VIE" .
<Rhabdomyosarcoma> <Current_treated_by> "VI,_then_VDC/IE,_then_VAC,_then_VI" .
<Rhabdomyosarcoma> <Current_treated_by> "VAI" .
<Rhabdomyosarcoma> <Current_treated_by> "VAC" .
<Rhabdomyosarcoma> <Current_treated_by> "VA" .
<Rhabdomyosarcoma> <Current_treated_by> "Dactinomycin_monotherapy" .
<TC,_then_IE,_VDoxoC,_VEC> <Has_local_therapy> "External_beam_radiotherapy" .
<Non-Hodgkin_lymphoma> <Subsumes> "Transformed_lymphoma" .
<Non-Hodgkin_lymphoma> <Subsumes> "Primary_mediastinal_B-cell_lymphoma" .
<Non-Hodgkin_lymphoma> <Subsumes> "Mediastinal_gray-zone_lymphoma" .
<Non-Hodgkin_lymphoma> <Subsumes> "Marginal_zone_lymphoma" .
<Non-Hodgkin_lymphoma> <Subsumes> "Mantle_cell_lymphoma" .
<Non-Hodgkin_lymphoma> <Subsumes> "Follicular_lymphoma" .
<Non-Hodgkin_lymphoma> <Subsumes> "Diffuse_large_B-cell_lymphoma" .
<Non-Hodgkin_lymphoma> <Subsumes> "Cutaneous_lymphoma" .
<Non-Hodgkin_lymphoma> <Subsumes> "Burkitt_lymphoma" .
<PCDE> <Is_a> "Anthracycline-containing_regimen" .
<Vorinostat> <Antineoplastic_of> "ZRd" .
<Vorinostat> <Antineoplastic_of> "Vorinostat_monotherapy" .
<Vorinostat> <Antineoplastic_of> "Vorinostat_and_Rituximab" .
<Vorinostat> <Antineoplastic_of> "Sirolimus_and_Vorinostat" .
<Vorinostat> <Antineoplastic_of> "R-CVEP" .
<Vorinostat> <Antineoplastic_of> "Cytarabine,_Idarubicin,_Vorinostat" .
<Vorinostat> <Antineoplastic_of> "Bortezomib_and_Vorinostat" .
<Vorinostat> <Antineoplastic_of> "Azacitidine,_Vorinostat,_Gemtuzumab_ozogamicin" .
<Vorinostat> <Antineoplastic_of> "Azacitidine_and_Vorinostat" .
<Vorinostat> <Antineoplastic_of> "7_plus_3i_and_Vorinostat" .
<Dalteparin> <Has_accepted_use> "Venous_thromboembolism" .
<Fluorouracil> <Has_brand_name> "Vafu" .
<Fluorouracil> <Has_brand_name> "Vaflu" .
<Fluorouracil> <Has_brand_name> "Utoral" .
<Fluorouracil> <Has_brand_name> "Uraciflor" .
<Fluorouracil> <Has_brand_name> "Ulup" .
<Fluorouracil> <Has_brand_name> "Ulosagen" .
<Fluorouracil> <Has_brand_name> "Uflahex" .
<Fluorouracil> <Has_brand_name> "Triosules" .
<Fluorouracil> <Has_brand_name> "Timadin" .
<Fluorouracil> <Has_brand_name> "Tecflu" .
<Fluorouracil> <Has_brand_name> "Seco_Uracil" .
<Fluorouracil> <Has_brand_name> "Satelol" .
<Fluorouracil> <Has_brand_name> "Rotianin" .
<Fluorouracil> <Has_brand_name> "Ribofluor" .
<Fluorouracil> <Has_brand_name> "Phtoruracil" .
<Fluorouracil> <Has_brand_name> "Phthoruracil" .
<Fluorouracil> <Has_brand_name> "Pharmauracil" .
<Fluorouracil> <Has_brand_name> "Pentafu" .
<Fluorouracil> <Has_brand_name> "Onkofluor" .
<Fluorouracil> <Has_brand_name> "Oncofu" .
<Fluorouracil> <Has_brand_name> "O_Fluor" .
<Fluorouracil> <Has_brand_name> "Neofluor" .
<Fluorouracil> <Has_brand_name> "Natira_U" .
<Fluorouracil> <Has_brand_name> "Lunapon" .
<Fluorouracil> <Has_brand_name> "Lunachol" .
<Fluorouracil> <Has_brand_name> "Killit" .
<Fluorouracil> <Has_brand_name> "Kecimeton_Tatumi" .
<Fluorouracil> <Has_brand_name> "Kang_Ning" .
<Fluorouracil> <Has_brand_name> "Ifacil" .
<Fluorouracil> <Has_brand_name> "Haemato-FU" .
<Fluorouracil> <Has_brand_name> "Ftouracil" .
<Fluorouracil> <Has_brand_name> "Ftoruracil" .
<Fluorouracil> <Has_brand_name> "Fluroblastine" .
<Fluorouracil> <Has_brand_name> "Fluroblastin" .
<Fluorouracil> <Has_brand_name> "Fluril" .
<Fluorouracil> <Has_brand_name> "Fluracil" .
<Fluorouracil> <Has_brand_name> "Fluracedyl" .
<Fluorouracil> <Has_brand_name> "Flurac" .
<Fluorouracil> <Has_brand_name> "Flurablastin" .
<Fluorouracil> <Has_brand_name> "Fluoxan" .
<Fluorouracil> <Has_brand_name> "Fluoruracilo" .
<Fluorouracil> <Has_brand_name> "Fluorourcil" .
<Fluorouracil> <Has_brand_name> "Fluorouracilo" .
<Fluorouracil> <Has_brand_name> "Fluorouracile" .
<Fluorouracil> <Has_brand_name> "Fluoroplex" .
<Fluorouracil> <Has_brand_name> "Fluoro-Uracile_ICN" .
<Fluorouracil> <Has_brand_name> "Fluoro-Uracil_ICN" .
<Fluorouracil> <Has_brand_name> "Fluor-Uracil" .
<Fluorouracil> <Has_brand_name> "Fluolex" .
<Fluorouracil> <Has_brand_name> "Fluhomer" .
<Fluorouracil> <Has_brand_name> "Florac" .
<Fluorouracil> <Has_brand_name> "Flonida" .
<Fluorouracil> <Has_brand_name> "Flacule" .
<Fluorouracil> <Has_brand_name> "Fivoflu" .
<Fluorouracil> <Has_brand_name> "Fivocil" .
<Fluorouracil> <Has_brand_name> "Fauldfluor" .
<Fluorouracil> <Has_brand_name> "Ezadex" .
<Fluorouracil> <Has_brand_name> "Efurix" .
<Fluorouracil> <Has_brand_name> "Efudex" .
<Fluorouracil> <Has_brand_name> "Effcil" .
<Fluorouracil> <Has_brand_name> "Curacil" .
<Fluorouracil> <Has_brand_name> "Cinkef-U" .
<Fluorouracil> <Has_brand_name> "Cinco-FU" .
<Fluorouracil> <Has_brand_name> "Carzonal" .
<Fluorouracil> <Has_brand_name> "Carebin" .
<Fluorouracil> <Has_brand_name> "Carac" .
<Fluorouracil> <Has_brand_name> "Biofur" .
<Fluorouracil> <Has_brand_name> "Benton" .
<Fluorouracil> <Has_brand_name> "Arumel" .
<Fluorouracil> <Has_brand_name> "Adrucil" .
<Fluorouracil> <Has_brand_name> "Actino_Hermal" .
<Fluorouracil> <Has_brand_name> "Accusite" .
<R-CHOP-14_(Prednisolone)> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<R-CHOP-14_(Prednisolone)> <Has_supportive_med> "Lenograstim" .
<R-CHOP-14_(Prednisolone)> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<R-CHOP-14_(Prednisolone)> <Has_supportive_med> "Allopurinol" .
<BBD> <Has_supportive_med> "Zoledronic_acid" .
<Cosudex> <Brand_name_of> "Bicalutamide" .
<R-MegaCHOP-14> <Has_context> "Induction_therapy" .
<Plicamycin> <Has_accepted_use> "Testicular_cancer" .
<Lipotalon> <Brand_name_of> "Dexamethasone" .
<GEMOX-B> <Mapped_from> "GEMOX-B" .
<FAC> <Is_current_in> "Breast_cancer" .
<AC_and_Bevacizumab> <Mapped_from> "AC_and_Bevacizumab" .
<Post-definitive_therapy> <Subsumes> "Maintenance_after_upfront_therapy" .
<Post-definitive_therapy> <Subsumes> "Consolidation_after_upfront_therapy" .
<Post-definitive_therapy> <Subsumes> "Adjuvant_therapy" .
<Carfilzomib_monotherapy> <Has_modality> "Chemotherapy" .
<Emicizumab> <Is_a> "Bispecific_antibody_medication" .
<Emicizumab> <Is_a> "Anti-Factor_Xa_antibody" .
<Emicizumab> <Is_a> "Anti-Factor_IXa_antibody" .
<ADOC> <Is_current_in> "Thymoma" .
<Flu-Mel,_then_allo_HSCT> <Mapped_from> "Flu-Mel,_then_allo_HSCT" .
<Cotolone> <Brand_name_of> "Prednisolone" .
<Dynepo> <Brand_name_of> "Epoetin_alfa" .
<Cinco-FU> <Brand_name_of> "Fluorouracil" .
<Axitinib_monotherapy> <Has_accepted_use> "Thyroid_cancer" .
<Axitinib_monotherapy> <Has_accepted_use> "Renal_cell_carcinoma" .
<Decilone> <Brand_name_of> "Dexamethasone" .
<MAID> <Is_a> "Anthracycline-containing_regimen" .
<TD> <Maps_to> "TD" .
<VTD-PACE> <Maps_to> "VTD-PACE" .
<Pancreatic_NET> <Accepted_use_of> "Thalidomide" .
<Pancreatic_NET> <Accepted_use_of> "Temozolomide_monotherapy" .
<Pancreatic_NET> <Accepted_use_of> "Temozolomide_and_Thalidomide" .
<Pancreatic_NET> <Accepted_use_of> "Temozolomide_and_Bevacizumab" .
<Pancreatic_NET> <Accepted_use_of> "Temozolomide" .
<Pancreatic_NET> <Accepted_use_of> "Sunitinib_monotherapy" .
<Pancreatic_NET> <Accepted_use_of> "Sunitinib" .
<Pancreatic_NET> <Accepted_use_of> "Streptozocin" .
<Pancreatic_NET> <Accepted_use_of> "Placebo" .
<Pancreatic_NET> <Accepted_use_of> "Octreotide_monotherapy" .
<Pancreatic_NET> <Accepted_use_of> "Octreotide_and_Interferon_alfa" .
<Pancreatic_NET> <Accepted_use_of> "Octreotide_LAR_monotherapy" .
<Pancreatic_NET> <Accepted_use_of> "Octreotide_LAR" .
<Pancreatic_NET> <Accepted_use_of> "Octreotide" .
<Pancreatic_NET> <Accepted_use_of> "Lutetium_Lu_177_dotatate_and_Octreotide_LAR" .
<Pancreatic_NET> <Accepted_use_of> "Lanreotide_and_Interferon_alfa-2b" .
<Pancreatic_NET> <Accepted_use_of> "Lanreotide_Depot/Autogel_monotherapy" .
<Pancreatic_NET> <Accepted_use_of> "Lanreotide" .
<Pancreatic_NET> <Accepted_use_of> "Interferon_alfa-2b" .
<Pancreatic_NET> <Accepted_use_of> "Fluorouracil_and_Streptozocin" .
<Pancreatic_NET> <Accepted_use_of> "Fluorouracil" .
<Pancreatic_NET> <Accepted_use_of> "FAS" .
<Pancreatic_NET> <Accepted_use_of> "Everolimus_monotherapy" .
<Pancreatic_NET> <Accepted_use_of> "Everolimus_and_Octreotide" .
<Pancreatic_NET> <Accepted_use_of> "Everolimus" .
<Pancreatic_NET> <Accepted_use_of> "Doxorubicin_and_Streptozocin" .
<Pancreatic_NET> <Accepted_use_of> "Doxorubicin" .
<Pancreatic_NET> <Accepted_use_of> "Capecitabine_and_Temozolomide" .
<Pancreatic_NET> <Accepted_use_of> "Capecitabine" .
<Pancreatic_NET> <Accepted_use_of> "Bevacizumab-bvzr" .
<Pancreatic_NET> <Accepted_use_of> "Bevacizumab-awwb" .
<Pancreatic_NET> <Accepted_use_of> "Bevacizumab" .
<Erlotinib_and_Bevacizumab> <Mapped_from> "Erlotinib_and_Bevacizumab" .
<Etoposide,_Vinblastine,_Prednisone> <Is_current_in> "Langerhans_cell_histiocytosis" .
<Mercaptopurine_and_WBRT> <Is_current_in> "CNS_leukemia" .
<Talimogene_laherparepvec> <Has_FDA_indication> "Melanoma" .
<Rekostin> <Brand_name_of> "Alendronate" .
<Pentamidine> <Is_a> "PCP_prophylaxis" .
<Pentamidine> <Is_a> "Antifungal" .
<FCR,_then_allo_HSCT> <Is_current_in> "Follicular_lymphoma" .
<Onilat> <Brand_name_of> "Ondansetron" .
<Micinovo> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Onax> <Brand_name_of> "Alprazolam" .
<Daunorubicin> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Daunorubicin> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Daunorubicin> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Daunorubicin> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Hemophagocytic_lymphohistiocytosis> <Current_treated_by> "HLH-94_regimen" .
<Hemophagocytic_lymphohistiocytosis> <Current_treated_by> "HLH-2004_regimen" .
<Hemophagocytic_lymphohistiocytosis> <Current_treated_by> "DEP" .
<Chlorambucil_and_Ofatumumab> <Has_modality> "Chemotherapy" .
<Xyntha> <Brand_name_of> "Factor_VIII_recombinant" .
<Low-dose_Interleukin-2> <Is_current_in> "Renal_cell_carcinoma" .
<Low-dose_Interleukin-2> <Is_current_in> "Melanoma" .
<HLH-2004_regimen> <Has_context> "Induction_therapy" .
<Capecitabine,_Carboplatin,_Paclitaxel,_RT> <Has_accepted_use> "Esophageal_cancer" .
<Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Fludarabine,_Cyclophosphamide,_ATG> <Maps_to> "Fludarabine,_Cyclophosphamide,_ATG" .
<Colitran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Paclitaxel_and_Topotecan> <Has_antineoplastic> "Topotecan" .
<Paclitaxel_and_Topotecan> <Has_antineoplastic> "Paclitaxel" .
<Abraxane> <Brand_name_of> "Paclitaxel_nanoparticle_albumin-bound" .
<Fludarabine_and_TBI,_then_allo_HSCT> <Has_antineoplastic> "Fludarabine" .
<Fludarabine_and_TBI,_then_allo_HSCT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Fludarabine_and_TBI,_then_allo_HSCT> <Has_antineoplastic> "Allogeneic_stem_cells" .
<Brigatinib> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Fauldoxo> <Brand_name_of> "Doxorubicin" .
<Chlorambucil_and_Prednisolone> <Is_historical_in> "Breast_cancer" .
<FOLFIRI_and_Bevacizumab_(L-Leucovorin)> <Maps_to> "FOLFIRI_and_Bevacizumab_(L-Leucovorin)" .
<Carboplatin,_Fluorouracil,_RT> <Has_context> "Neoadjuvant_therapy" .
<Carboplatin,_Fluorouracil,_RT> <Has_context> "Definitive_therapy" .
<WBRT> <Has_modality> "Radiotherapy" .
<Rituximab_monotherapy> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<Rituximab_monotherapy> <Has_accepted_use> "Thrombotic_thrombocytopenic_purpura" .
<Rituximab_monotherapy> <Has_accepted_use> "Post-transplant_lymphoproliferative_disorder" .
<Rituximab_monotherapy> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Rituximab_monotherapy> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Rituximab_monotherapy> <Has_accepted_use> "Inherited_coagulopathy" .
<Rituximab_monotherapy> <Has_accepted_use> "Immune_thrombocytopenia" .
<Rituximab_monotherapy> <Has_accepted_use> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<Rituximab_monotherapy> <Has_accepted_use> "Hodgkin_lymphoma" .
<Rituximab_monotherapy> <Has_accepted_use> "Hairy_cell_leukemia" .
<Rituximab_monotherapy> <Has_accepted_use> "HIV-associated_lymphoma" .
<Rituximab_monotherapy> <Has_accepted_use> "Follicular_lymphoma" .
<Rituximab_monotherapy> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Rituximab_monotherapy> <Has_accepted_use> "Cold_agglutinin_disease" .
<Rituximab_monotherapy> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Rituximab_monotherapy> <Has_accepted_use> "Castleman_disease" .
<Rituximab_monotherapy> <Has_accepted_use> "CNS_lymphoma" .
<Rituximab_monotherapy> <Has_accepted_use> "Antiphospholipid_antibody_syndrome" .
<Rituximab_monotherapy> <Has_accepted_use> "Acquired_coagulopathy" .
<Xalkori> <Brand_name_of> "Crizotinib" .
<Cisplatin,_Dacarbazine,_Paclitaxel> <Has_context> "Non-curative_therapy" .
<Alpelisib_and_Fulvestrant> <Maps_to> "Alpelisib_and_Fulvestrant" .
<Fludarabine,_then_131Iodine-Tositumomab> <Has_modality> "Radioimmunotherapy" .
<Fludarabine,_then_131Iodine-Tositumomab> <Has_modality> "Chemotherapy" .
<Treosulfan_monotherapy> <Is_current_in> "Ovarian_cancer" .
<CHOP,_then_131Iodine-Tositumomab> <Is_historical_in> "Follicular_lymphoma" .
<CBVM,_then_auto_HSCT> <Mapped_from> "CBVM,_then_auto_HSCT" .
<Clusterin_inhibitor> <Subsumes> "Custirsen" .
<ADT_and_Darolutamide> <Mapped_from> "ADT_and_Darolutamide" .
<Folinic_acid> <Supportive_med_of> "m-BACOD" .
<Folinic_acid> <Supportive_med_of> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Folinic_acid> <Supportive_med_of> "dmCODOX-M_-_Modified_Magrath" .
<Folinic_acid> <Supportive_med_of> "Siltuximab_monotherapy" .
<Folinic_acid> <Supportive_med_of> "SMILE" .
<Folinic_acid> <Supportive_med_of> "R-MPV" .
<Folinic_acid> <Supportive_med_of> "R-MCP_(CCNU)" .
<Folinic_acid> <Supportive_med_of> "R-MACLO/R-IVAM" .
<Folinic_acid> <Supportive_med_of> "R-M-CHOP" .
<Folinic_acid> <Supportive_med_of> "R-Hyper-CVAD/R-MA" .
<Folinic_acid> <Supportive_med_of> "R-COPADM" .
<Folinic_acid> <Supportive_med_of> "R-CODOX-M/R-IVAC_(Doxil_substituted)" .
<Folinic_acid> <Supportive_med_of> "R-CODOX-M/R-IVAC" .
<Folinic_acid> <Supportive_med_of> "R-CODOX-M_(Doxil_substituted)" .
<Folinic_acid> <Supportive_med_of> "R-CODOX-M" .
<Folinic_acid> <Supportive_med_of> "ProMACE-CytaBOM" .
<Folinic_acid> <Supportive_med_of> "Nilotinib-based_consolidation" .
<Folinic_acid> <Supportive_med_of> "Methotrexate,_then_Cytarabine_and_Thiotepa" .
<Folinic_acid> <Supportive_med_of> "Methotrexate,_then_Cytarabine" .
<Folinic_acid> <Supportive_med_of> "Methotrexate_monotherapy" .
<Folinic_acid> <Supportive_med_of> "Methotrexate_and_Vincristine" .
<Folinic_acid> <Supportive_med_of> "Mercaptopurine,_Methotrexate,_Vincristine" .
<Folinic_acid> <Supportive_med_of> "MVBP" .
<Folinic_acid> <Supportive_med_of> "MV" .
<Folinic_acid> <Supportive_med_of> "MT-R" .
<Folinic_acid> <Supportive_med_of> "MPV" .
<Folinic_acid> <Supportive_med_of> "MCV" .
<Folinic_acid> <Supportive_med_of> "MAPIE" .
<Folinic_acid> <Supportive_med_of> "MAPI" .
<Folinic_acid> <Supportive_med_of> "MAP" .
<Folinic_acid> <Supportive_med_of> "MA-BCD" .
<Folinic_acid> <Supportive_med_of> "MA" .
<Folinic_acid> <Supportive_med_of> "M-TIP" .
<Folinic_acid> <Supportive_med_of> "M-EI" .
<Folinic_acid> <Supportive_med_of> "M-BCD" .
<Folinic_acid> <Supportive_med_of> "Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone" .
<Folinic_acid> <Supportive_med_of> "Lomustine,_Methotrexate,_Procarbazine" .
<Folinic_acid> <Supportive_med_of> "Linker_regimen_(consolidation)" .
<Folinic_acid> <Supportive_med_of> "L-Asparaginase_and_Methotrexate" .
<Folinic_acid> <Supportive_med_of> "Ifosfamide_and_Methotrexate" .
<Folinic_acid> <Supportive_med_of> "Hyper-CVAD/MA" .
<Folinic_acid> <Supportive_med_of> "Hyper-CVAD_and_Ponatinib" .
<Folinic_acid> <Supportive_med_of> "Hyper-CVAD_and_Imatinib" .
<Folinic_acid> <Supportive_med_of> "Hyper-CVAD_and_Dasatinib" .
<Folinic_acid> <Supportive_med_of> "GMALL-R" .
<Folinic_acid> <Supportive_med_of> "Cisplatin_and_Irinotecan" .
<Folinic_acid> <Supportive_med_of> "CYM" .
<Folinic_acid> <Supportive_med_of> "COPADM" .
<Folinic_acid> <Supportive_med_of> "CODOX-M/IVAC" .
<Folinic_acid> <Supportive_med_of> "CODOX-M" .
<Folinic_acid> <Supportive_med_of> "CMED" .
<Folinic_acid> <Supportive_med_of> "CALGB_10-002_regimen" .
<Folinic_acid> <Supportive_med_of> "BMP" .
<Folinic_acid> <Supportive_med_of> "BASIC" .
<Folinic_acid> <Supportive_med_of> "AspaMetDex_(Erwinaze)" .
<Folinic_acid> <Supportive_med_of> "AspaMetDex" .
<Folinic_acid> <Supportive_med_of> "ACVBP" .
<Zerrprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Polopiryna_S> <Brand_name_of> "Aspirin" .
<GMALL-R> <Mapped_from> "GMALL-R" .
<Rivaroxaban_monotherapy> <Has_supportive_med> "Rivaroxaban" .
<mLSG15> <Has_antineoplastic> "Vindesine" .
<mLSG15> <Has_antineoplastic> "Vincristine" .
<mLSG15> <Has_antineoplastic> "Ranimustine" .
<mLSG15> <Has_antineoplastic> "Prednisone" .
<mLSG15> <Has_antineoplastic> "Etoposide" .
<mLSG15> <Has_antineoplastic> "Doxorubicin" .
<mLSG15> <Has_antineoplastic> "Cyclophosphamide" .
<mLSG15> <Has_antineoplastic> "Carboplatin" .
<Stibrol> <Brand_name_of> "Diethylstilbestrol" .
<PACEBOM> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<(90)YFC> <Mapped_from> "(90)YFC" .
<Cytarabine,_Idarubicin,_Imatinib> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<FOLFOX4> <Maps_to> "FOLFOX4" .
<BuFlu,_then_allo_HSCT> <Mapped_from> "BuFlu,_then_allo_HSCT" .
<Cutaneous_squamous_cell_carcinoma> <FDA_indication_of> "Cemiplimab" .
<Cytokine> <Subsumes> "Interferon" .
<Cytokine> <Subsumes> "Aldesleukin" .
<CHVP> <Has_accepted_use> "Follicular_lymphoma" .
<Hydrea> <Brand_name_of> "Hydroxyurea" .
<Methorex> <Brand_name_of> "Methotrexate" .
<CHUT,_then_auto_HSCT> <Is_historical_in> "Breast_cancer" .
<Prednisone_and_Rituximab> <Is_current_in> "Warm_autoimmune_hemolytic_anemia" .
<FEC> <Maps_to> "FEC" .
<FluCam> <Has_antineoplastic> "Fludarabine" .
<FluCam> <Has_antineoplastic> "Alemtuzumab" .
<Verzenio> <Brand_name_of> "Abemaciclib" .
<L-glutamine_monotherapy> <Has_supportive_med> "L-glutamine" .
<FLAG> <Maps_to> "FLAG" .
<Treanda> <Brand_name_of> "Bendamustine" .
<Doxorubicin_pegylated_liposomal_and_Trabectedin> <Mapped_from> "Doxorubicin_pegylated_liposomal_and_Trabectedin" .
<VA> <Has_antineoplastic> "Vincristine" .
<VA> <Has_antineoplastic> "Dactinomycin" .
<Abiraterone_and_Prednisone> <Is_current_in> "Prostate_cancer" .
<CXCR4_inhibitor> <Subsumes> "Plerixafor" .
<Regorafenib_monotherapy> <Has_modality> "Chemotherapy" .
<Genoctrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Methotrexate_monotherapy> <Is_current_in> "Head_and_neck_cancer" .
<Methotrexate_monotherapy> <Is_current_in> "Gestational_trophoblastic_neoplasia" .
<Methotrexate_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Methotrexate_monotherapy> <Is_current_in> "Cutaneous_T-cell_lymphoma" .
<Methotrexate_monotherapy> <Is_current_in> "CNS_lymphoma" .
<Lanreotide_monotherapy> <Mapped_from> "Lanreotide_monotherapy" .
<Cisplatin_and_Topotecan> <Has_context> "Non-curative_first-line_therapy" .
<Maxtrex> <Brand_name_of> "Methotrexate" .
<L-Asparaginase_and_Methotrexate> <Maps_to> "L-Asparaginase_and_Methotrexate" .
<Bortezomib_and_Vorinostat> <Has_modality> "Chemotherapy" .
<Ibrutinib_and_Rituximab> <Has_context> "Non-curative_therapy" .
<Ibrutinib_and_Rituximab> <Has_context> "Non-curative_first-line_therapy" .
<Therarubicin> <Brand_name_of> "Pirarubicin" .
<Ticagrelor> <Is_a> "P2Y12_ADP_inhibitor" .
<EPOCH,_dose-escalated> <Has_supportive_med> "Filgrastim" .
<MA-BCD> <Is_current_in> "Osteosarcoma" .
<CTD> <Has_modality> "Chemotherapy" .
<MEC> <Mapped_from> "MEC" .
<Cyclophosphamide_and_Dexamethasone> <Maps_to> "Cyclophosphamide_and_Dexamethasone" .
<Capecitabine,_Paclitaxel,_RT> <Is_current_in> "Esophageal_cancer" .
<Doxycycline_monotherapy> <Has_context> "Non-curative_therapy" .
<Doxycycline_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<CVP> <Has_modality> "Chemotherapy" .
<Rituximab_and_hyaluronidase_human> <Has_FDA_indication> "Follicular_lymphoma" .
<Rituximab_and_hyaluronidase_human> <Has_FDA_indication> "Diffuse_large_B-cell_lymphoma" .
<Rituximab_and_hyaluronidase_human> <Has_FDA_indication> "Chronic_lymphocytic_leukemia" .
<BuFlu,_then_allo_HSCT> <Has_immunosuppressor> "Tacrolimus" .
<BuFlu,_then_allo_HSCT> <Has_immunosuppressor> "Phenytoin" .
<BuFlu,_then_allo_HSCT> <Has_immunosuppressor> "Methotrexate" .
<BuFlu,_then_allo_HSCT> <Has_immunosuppressor> "Mesna" .
<BuFlu,_then_allo_HSCT> <Has_immunosuppressor> "Filgrastim" .
<BuFlu,_then_allo_HSCT> <Has_immunosuppressor> "Cyclosporine_non-modified" .
<BuFlu,_then_allo_HSCT> <Has_immunosuppressor> "Cyclosporine_modified" .
<BuFlu,_then_allo_HSCT> <Has_immunosuppressor> "Cyclophosphamide" .
<BuFlu,_then_allo_HSCT> <Has_immunosuppressor> "Antithymocyte_globulin_rabbit_ATG" .
<Asparaginasa> <Brand_name_of> "Asparaginase" .
<Moxetumomab_pasudotox> <Has_FDA_indication> "Hairy_cell_leukemia" .
<Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Natulan> <Brand_name_of> "Procarbazine" .
<Methotrexate_monotherapy> <Has_antineoplastic> "Methotrexate" .
<Intraperitoneal_hyperthermic_mitomycin> <Is_current_in> "Colon_cancer" .
<Osteomel> <Brand_name_of> "Alendronate" .
<Pemetrexed_monotherapy> <Mapped_from> "Pemetrexed_monotherapy" .
<PAF> <Has_context> "Adjuvant_therapy" .
<RT,_then_Carmustine> <Has_antineoplastic> "External_beam_radiotherapy" .
<RT,_then_Carmustine> <Has_antineoplastic> "Carmustine" .
<Prophylaxis> <Context_of> "Warfarin_monotherapy" .
<Prophylaxis> <Context_of> "Rivaroxaban_monotherapy" .
<Prophylaxis> <Context_of> "Rabbit_ATG" .
<Prophylaxis> <Context_of> "Placebo" .
<Prophylaxis> <Context_of> "Methotrexate,_Tacrolimus,_Vorinostat" .
<Prophylaxis> <Context_of> "Methotrexate,_Tacrolimus,_Tocilizumab" .
<Prophylaxis> <Context_of> "Methotrexate_and_Tacrolimus" .
<Prophylaxis> <Context_of> "Enoxaparin_monotherapy" .
<Prophylaxis> <Context_of> "Dalteparin_monotherapy" .
<Prophylaxis> <Context_of> "Cyclosporine,_Mycophenolate_mofetil,_Sirolimus" .
<Prophylaxis> <Context_of> "Cyclosporine,_Methotrexate,_Prednisone" .
<Prophylaxis> <Context_of> "Cyclosporine,_Methotrexate,_Methylprednisolone" .
<Prophylaxis> <Context_of> "Cyclosporine,_Methotrexate,_ATG" .
<Prophylaxis> <Context_of> "Cyclosporine_and_Mycophenolate_mofetil" .
<Prophylaxis> <Context_of> "Cyclosporine_and_Methotrexate" .
<Prophylaxis> <Context_of> "Cyclophosphamide,_Mycophenolate_mofetil,_Tacrolimus" .
<Prophylaxis> <Context_of> "Betrixaban_monotherapy" .
<Prophylaxis> <Context_of> "Aspirin_monotherapy" .
<Prophylaxis> <Context_of> "Apixaban_monotherapy" .
<Capecitabine_and_Temozolomide> <Is_current_in> "Pancreatic_NET" .
<Neurooncology_medication> <Is_a> "Site-specific_medication" .
<Warfarin_monotherapy> <Has_context> "Prophylaxis" .
<Warfarin_monotherapy> <Has_context> "All_lines_of_therapy" .
<RT,_then_Temozolomide> <Is_current_in> "Anaplastic_glioma" .
<MACC> <Maps_to> "MACC" .
<Epirubicin_and_Vinorelbine> <Has_antineoplastic> "Vinorelbine" .
<Epirubicin_and_Vinorelbine> <Has_antineoplastic> "Epirubicin" .
<Thrombo_AS> <Brand_name_of> "Aspirin" .
<Oxaliplatin> <Has_accepted_use> "Transformed_lymphoma" .
<Oxaliplatin> <Has_accepted_use> "Testicular_cancer" .
<Oxaliplatin> <Has_accepted_use> "Rectal_cancer" .
<Oxaliplatin> <Has_accepted_use> "Pancreatic_cancer" .
<Oxaliplatin> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<Oxaliplatin> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Oxaliplatin> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Oxaliplatin> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Oxaliplatin> <Has_accepted_use> "Gastric_cancer" .
<Oxaliplatin> <Has_accepted_use> "Gallbladder_cancer" .
<Oxaliplatin> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Oxaliplatin> <Has_accepted_use> "Esophageal_cancer" .
<Oxaliplatin> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Oxaliplatin> <Has_accepted_use> "Colon_cancer" .
<Oxaliplatin> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Oxaliplatin> <Has_accepted_use> "Cholangiocarcinoma" .
<Rilotumumab> <Is_a> "Investigational_drug" .
<Rilotumumab> <Is_a> "HGF_inhibitor" .
<Rilotumumab> <Is_a> "Antibody_medication" .
<Marivanil> <Brand_name_of> "Warfarin" .
<Quizartinib_monotherapy> <Has_antineoplastic> "Quizartinib" .
<VR> <Has_antineoplastic> "Rituximab" .
<VR> <Has_antineoplastic> "Bortezomib" .
<Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone> <Has_context> "Induction_therapy" .
<Denosumab_monotherapy> <Has_context> "All_lines_of_therapy" .
<Alemtuzumab> <Immunosuppressor_of> "Alemtuzumab_monotherapy" .
<Rivaroxaban> <Has_accepted_use> "Venous_thromboembolism" .
<Rivaroxaban> <Has_accepted_use> "Heparin-induced_thrombocytopenia" .
<ADT_and_Apalutamide> <Mapped_from> "ADT_and_Apalutamide" .
<ATG_(Horse),_Cyclosporine,_Eltrombopag> <Is_current_in> "Aplastic_anemia" .
<Legifol> <Brand_name_of> "Folinic_acid" .
<Docetaxel,_Fluorouracil,_Hydroxyurea,_RT> <Has_context> "Definitive_therapy" .
<Granulokine> <Brand_name_of> "Filgrastim" .
<Low-grade_glioma> <Current_treated_by> "Temozolomide_monotherapy" .
<Low-grade_glioma> <Current_treated_by> "Radiation_therapy" .
<Low-grade_glioma> <Current_treated_by> "PCV" .
<Low-grade_glioma> <Current_treated_by> "Observation" .
<Low-grade_glioma> <Current_treated_by> "Cisplatin_and_Etoposide" .
<Low-grade_glioma> <Current_treated_by> "Carboplatin_monotherapy" .
<Low-grade_glioma> <Current_treated_by> "Carboplatin_and_Vincristine" .
<Low-grade_glioma> <Current_treated_by> "Carboplatin_and_Teniposide" .
<Ftoruracil> <Brand_name_of> "Fluorouracil" .
<Telotristat> <Is_a> "Tryptophan_hydroxylase_inhibitor" .
<R-MACLO/R-IVAM> <Has_modality> "Chemotherapy" .
<Kyocristine> <Brand_name_of> "Vincristine" .
<VBMCP> <Has_modality> "Chemotherapy" .
<Bevacizumab_and_Interferon_alfa-2a> <Maps_to> "Bevacizumab_and_Interferon_alfa-2a" .
<EBVP> <Has_accepted_use> "Hodgkin_lymphoma" .
<CapeOx> <Has_context> "Non-curative_third-line_therapy" .
<CapeOx> <Has_context> "Non-curative_therapy" .
<CapeOx> <Has_context> "Non-curative_second-line_therapy" .
<CapeOx> <Has_context> "Non-curative_first-line_therapy" .
<CapeOx> <Has_context> "Neoadjuvant_therapy" .
<CapeOx> <Has_context> "Adjuvant_therapy" .
<Aspirin_and_Anagrelide> <Maps_to> "Aspirin_and_Anagrelide" .
<Autoimmune_hematologic_condition> <Is_a> "Classical_hematologic_condition" .
<Synribo> <Brand_name_of> "Omacetaxine" .
<Calinat> <Brand_name_of> "Folinic_acid" .
<VTD> <Is_current_in> "Multiple_myeloma" .
<Predniment> <Brand_name_of> "Prednisone" .
<FEMTX> <Is_historical_in> "Gastric_cancer" .
<Erlotinib> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Erlotinib> <Is_a> "Mutation-specific_medication" .
<Erlotinib> <Is_a> "Kinase_inhibitor" .
<Erlotinib> <Is_a> "EGFR_inhibitor" .
<Scopolamine> <Is_a> "Muscarinic_receptor_antagonist" .
<Scopolamine> <Is_a> "Emesis_prevention" .
<Lanreotide_and_Interferon_alfa-2b> <Has_context> "All_lines_of_therapy" .
<Clofarabine_and_LoDAC> <Is_current_in> "Acute_myeloid_leukemia" .
<Utoral> <Brand_name_of> "Fluorouracil" .
<Ultandren> <Brand_name_of> "Fluoxymesterone" .
<Trastuzumab-dttb> <Has_brand_name> "Ontruzant" .
<DCTER> <Maps_to> "DCTER" .
<Radotinib> <May_have_route> "Oral" .
<Cisplatin_and_Fluorouracil> <Has_context> "Non-curative_therapy" .
<Cisplatin_and_Fluorouracil> <Has_context> "Non-curative_first-line_therapy" .
<Cisplatin_and_Fluorouracil> <Has_context> "Neoadjuvant_therapy" .
<Cisplatin_and_Fluorouracil> <Has_context> "Induction_therapy" .
<Cisplatin_and_Fluorouracil> <Has_context> "Consolidation_after_upfront_therapy" .
<Cisplatin_and_Fluorouracil> <Has_context> "Adjuvant_therapy" .
<Mercaptopurine_monotherapy> <Maps_to> "Mercaptopurine_monotherapy" .
<CEV_(Cyclophosphamide/Epirubicin)> <Maps_to> "CEV_(Cyclophosphamide/Epirubicin)" .
<Argatroban_monotherapy> <Has_supportive_med> "Argatroban" .
<DAC> <Has_modality> "Chemotherapy" .
<MOPP/ABVD> <Has_context> "Induction_therapy" .
<Carboplatin_and_Teniposide> <Is_a> "Platinum_doublet" .
<R-Hyper-CVAD/R-MA> <Has_modality> "Chemotherapy" .
<Ipilimumab_and_Nivolumab> <Has_accepted_use> "Small_cell_lung_cancer" .
<Ipilimumab_and_Nivolumab> <Has_accepted_use> "Renal_cell_carcinoma" .
<Ipilimumab_and_Nivolumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Ipilimumab_and_Nivolumab> <Has_accepted_use> "Melanoma" .
<Ipilimumab_and_Nivolumab> <Has_accepted_use> "Colon_cancer" .
<Ipilimumab_and_Nivolumab> <Has_accepted_use> "CNS_melanoma" .
<ATG_(Horse),_Cyclosporine,_Eltrombopag> <Has_accepted_use> "Aplastic_anemia" .
<Cisplatin,_Vinorelbine,_RT> <Has_context> "Neoadjuvant_therapy" .
<Cisplatin,_Vinorelbine,_RT> <Has_context> "Definitive_therapy" .
<Hemophagocytic_lymphohistiocytosis> <FDA_indication_of> "Emapalumab" .
<Sulfarim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<ROS1-positive_Non-small_cell_lung_cancer> <Accepted_use_of> "Lorlatinib_monotherapy" .
<ROS1-positive_Non-small_cell_lung_cancer> <Accepted_use_of> "Entrectinib_monotherapy" .
<ROS1-positive_Non-small_cell_lung_cancer> <Accepted_use_of> "Crizotinib_monotherapy" .
<ROS1-positive_Non-small_cell_lung_cancer> <Accepted_use_of> "Ceritinib_monotherapy" .
<DOLP> <Has_context> "Induction_therapy" .
<Gemcitabine_and_Trastuzumab> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<Gemcitabine_and_Trastuzumab> <Has_accepted_use> "Breast_cancer" .
<THP_(Taxol)> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<THP_(Taxol)> <Has_accepted_use> "Breast_cancer" .
<Interferon_alfa-2a_and_Isotretinoin> <Mapped_from> "Interferon_alfa-2a_and_Isotretinoin" .
<Busulfan_and_Cyclophosphamide,_then_allo_HSCT> <Mapped_from> "Busulfan_and_Cyclophosphamide,_then_allo_HSCT" .
<Hondrea> <Brand_name_of> "Hydroxyurea" .
<Sulphathoprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CHOP_(Prednisolone)> <Is_current_in> "Mantle_cell_lymphoma" .
<R-CHOP_(Rituximab_Hycela)> <Has_modality> "Chemotherapy" .
<Etoposide,_Ifosfamide,_Methotrexate> <Has_context> "Non-curative_subsequent-line_therapy" .
<Fludarabine_and_TBI,_then_allo_HSCT> <Has_immunosuppressor> "Mycophenolate_mofetil" .
<Fludarabine_and_TBI,_then_allo_HSCT> <Has_immunosuppressor> "Cyclosporines" .
<Fludarabine,_Busulfan,_Cyclophosphamide> <Has_antineoplastic> "Fludarabine" .
<Fludarabine,_Busulfan,_Cyclophosphamide> <Has_antineoplastic> "Cyclophosphamide" .
<Fludarabine,_Busulfan,_Cyclophosphamide> <Has_antineoplastic> "Busulfan" .
<Etoposide_monotherapy> <Is_current_in> "Testicular_cancer" .
<Etoposide_monotherapy> <Is_current_in> "Small_cell_lung_cancer" .
<Etoposide_monotherapy> <Is_current_in> "Ovarian_cancer" .
<Etoposide_monotherapy> <Is_current_in> "Kaposi_sarcoma" .
<Etoposide_monotherapy> <Is_current_in> "Esophageal_cancer" .
<Etoposide_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Etoposide_monotherapy> <Is_current_in> "Anaplastic_glioma" .
<Imutrex> <Brand_name_of> "Methotrexate" .
<Nasal> <May_be_route_of> "Desmopressin" .
<Nasal> <May_be_route_of> "Cyanocobalamin" .
<Fulvestrant_and_Ribociclib> <Is_a> "Antiestrogen-containing_regimen" .
<IT_Cytarabine_monotherapy> <Maps_to> "IT_Cytarabine_monotherapy" .
<Lutetium_Lu_177_dotatate_and_Octreotide_LAR> <Has_antineoplastic> "Octreotide_LAR" .
<Lutetium_Lu_177_dotatate_and_Octreotide_LAR> <Has_antineoplastic> "Lutetium_Lu_177_dotatate" .
<Capecitabine_and_Ixabepilone> <Maps_to> "Capecitabine_and_Ixabepilone" .
<CNS_lymphoma> <Accepted_use_of> "Whole_brain_irradiation" .
<CNS_lymphoma> <Accepted_use_of> "Vindesine" .
<CNS_lymphoma> <Accepted_use_of> "Vincristine" .
<CNS_lymphoma> <Accepted_use_of> "Topotecan_monotherapy" .
<CNS_lymphoma> <Accepted_use_of> "Topotecan" .
<CNS_lymphoma> <Accepted_use_of> "Thiotepa" .
<CNS_lymphoma> <Accepted_use_of> "Teniposide" .
<CNS_lymphoma> <Accepted_use_of> "Temsirolimus_monotherapy" .
<CNS_lymphoma> <Accepted_use_of> "Temsirolimus" .
<CNS_lymphoma> <Accepted_use_of> "Temozolomide_monotherapy" .
<CNS_lymphoma> <Accepted_use_of> "Temozolomide" .
<CNS_lymphoma> <Accepted_use_of> "Rituximab-pvvr" .
<CNS_lymphoma> <Accepted_use_of> "Rituximab-abbs" .
<CNS_lymphoma> <Accepted_use_of> "Rituximab_monotherapy" .
<CNS_lymphoma> <Accepted_use_of> "Rituximab" .
<CNS_lymphoma> <Accepted_use_of> "R-MPV" .
<CNS_lymphoma> <Accepted_use_of> "R-MP" .
<CNS_lymphoma> <Accepted_use_of> "R-MCP_(CCNU)" .
<CNS_lymphoma> <Accepted_use_of> "Procarbazine_monotherapy" .
<CNS_lymphoma> <Accepted_use_of> "Procarbazine" .
<CNS_lymphoma> <Accepted_use_of> "Observation" .
<CNS_lymphoma> <Accepted_use_of> "Nordic_Regimen,_younger_patients" .
<CNS_lymphoma> <Accepted_use_of> "Nordic_Regimen,_older_patients" .
<CNS_lymphoma> <Accepted_use_of> "Methylprednisolone" .
<CNS_lymphoma> <Accepted_use_of> "Methotrexate,_then_Cytarabine_and_Thiotepa" .
<CNS_lymphoma> <Accepted_use_of> "Methotrexate,_then_Cytarabine" .
<CNS_lymphoma> <Accepted_use_of> "Methotrexate_monotherapy" .
<CNS_lymphoma> <Accepted_use_of> "Methotrexate_and_Rituximab" .
<CNS_lymphoma> <Accepted_use_of> "Methotrexate" .
<CNS_lymphoma> <Accepted_use_of> "Melphalan" .
<CNS_lymphoma> <Accepted_use_of> "MVBP" .
<CNS_lymphoma> <Accepted_use_of> "MT-R" .
<CNS_lymphoma> <Accepted_use_of> "MPV" .
<CNS_lymphoma> <Accepted_use_of> "MBVP" .
<CNS_lymphoma> <Accepted_use_of> "MATRix" .
<CNS_lymphoma> <Accepted_use_of> "Lomustine,_Methotrexate,_Procarbazine,_Methylprednisolone" .
<CNS_lymphoma> <Accepted_use_of> "Lomustine,_Methotrexate,_Procarbazine" .
<CNS_lymphoma> <Accepted_use_of> "Lomustine" .
<CNS_lymphoma> <Accepted_use_of> "Ifosfamide_and_Methotrexate" .
<CNS_lymphoma> <Accepted_use_of> "Ifosfamide" .
<CNS_lymphoma> <Accepted_use_of> "IT_Cytarabine_monotherapy" .
<CNS_lymphoma> <Accepted_use_of> "IT_Cytarabine_liposomal_monotherapy" .
<CNS_lymphoma> <Accepted_use_of> "HiDAC" .
<CNS_lymphoma> <Accepted_use_of> "Etoposide" .
<CNS_lymphoma> <Accepted_use_of> "Dexamethasone" .
<CNS_lymphoma> <Accepted_use_of> "Cytarabine,_Methotrexate,_Rituximab" .
<CNS_lymphoma> <Accepted_use_of> "Cytarabine_liposomal" .
<CNS_lymphoma> <Accepted_use_of> "Cytarabine" .
<CNS_lymphoma> <Accepted_use_of> "Cyclophosphamide" .
<CNS_lymphoma> <Accepted_use_of> "Carmustine" .
<CNS_lymphoma> <Accepted_use_of> "CYVE" .
<CNS_lymphoma> <Accepted_use_of> "CYM" .
<CNS_lymphoma> <Accepted_use_of> "Busulfan" .
<CNS_lymphoma> <Accepted_use_of> "Bu/TT/Cy,_then_auto_HSCT" .
<CNS_lymphoma> <Accepted_use_of> "Bu/TT,_then_auto_HSCT" .
<CNS_lymphoma> <Accepted_use_of> "BEAM,_then_auto_HSCT" .
<CNS_lymphoma> <Accepted_use_of> "BCNU/TT,_then_auto_HSCT" .
<Alpelisib_and_Fulvestrant> <Is_current_in> "Breast_cancer" .
<Rd> <Mapped_from> "Rd" .
<Pertuzumab_and_T-DM1> <Has_antineoplastic> "Pertuzumab" .
<Pertuzumab_and_T-DM1> <Has_antineoplastic> "Ado-trastuzumab_emtansine" .
<Cisplatin_and_Pemetrexed> <Has_modality> "Chemotherapy" .
<Anti-c-Met_antibody> <Is_a> "Antibody_medication" .
<EDAP> <Is_historical_in> "Multiple_myeloma" .
<Gastric_cancer> <FDA_indication_of> "Trifluridine_and_tipiracil" .
<Gastric_cancer> <FDA_indication_of> "Trastuzumab-qyyp" .
<Gastric_cancer> <FDA_indication_of> "Trastuzumab-dttb" .
<Gastric_cancer> <FDA_indication_of> "Trastuzumab-dkst" .
<Gastric_cancer> <FDA_indication_of> "Trastuzumab-anns" .
<Gastric_cancer> <FDA_indication_of> "Trastuzumab" .
<Gastric_cancer> <FDA_indication_of> "Ramucirumab" .
<Gastric_cancer> <FDA_indication_of> "Pembrolizumab" .
<Gastric_cancer> <FDA_indication_of> "Doxorubicin" .
<Gastric_cancer> <FDA_indication_of> "Docetaxel" .
<TCP> <Has_modality> "Chemotherapy" .
<Linker_regimen_(consolidation)> <Is_a> "Anthracycline-containing_regimen" .
<Altrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CCI> <Has_antineoplastic> "Ifosfamide" .
<CCI> <Has_antineoplastic> "Cisplatin" .
<CCI> <Has_antineoplastic> "Carboplatin" .
<Bu/TT/Cy> <Is_current_in> "Autologous_HSCT" .
<T-cell_acute_lymphoblastic_leukemia> <Is_a> "T-cell_leukemia" .
<T-cell_acute_lymphoblastic_leukemia> <Is_a> "Pediatric_cancer" .
<T-cell_acute_lymphoblastic_leukemia> <Is_a> "Acute_lymphoblastic_leukemia" .
<Megestrol_monotherapy> <Has_context> "Non-curative_therapy" .
<Megestrol_monotherapy> <Has_context> "Non-curative_second-line_therapy" .
<7_plus_3i> <Is_a> "Anthracycline-containing_regimen" .
<Prednisone> <Supportive_med_of> "Rituximab_monotherapy" .
<Prednisone> <Supportive_med_of> "RhIG_monotherapy" .
<Prednisone> <Supportive_med_of> "Imatinib_monotherapy" .
<Prednisone> <Supportive_med_of> "Ifosfamide_and_Vinorelbine" .
<Prednisone> <Supportive_med_of> "FluCam" .
<Prednisone> <Supportive_med_of> "Clofarabine_monotherapy" .
<Prednisone> <Supportive_med_of> "Azacitidine_monotherapy" .
<Prednisone> <Supportive_med_of> "Arsenic_trioxide,_ATRA,_Idarubicin" .
<Prednisone> <Supportive_med_of> "Arsenic_trioxide_and_ATRA" .
<Prednisone> <Supportive_med_of> "ATG_(Rabbit)_monotherapy" .
<Prednisone> <Supportive_med_of> "ATG_(Horse),_Cyclosporine,_Sirolimus" .
<Prednisone> <Supportive_med_of> "ATG_(Horse)_monotherapy" .
<Prednisone> <Supportive_med_of> "ATG_(Horse)_and_Cyclosporine" .
<Prednisone> <Supportive_med_of> "ADT_and_Abiraterone" .
<Hedgehog_pathway-mutated_malignancy> <Is_a> "Malignant_solid_neoplasm" .
<Cyclosporine,_Methotrexate,_ATG> <Maps_to> "Cyclosporine,_Methotrexate,_ATG" .
<Ceritinib> <Antineoplastic_of> "Ceritinib_monotherapy" .
<Fosalong> <Brand_name_of> "Alendronate" .
<VAMP_(Methotrexate)> <Is_a> "Anthracycline-containing_regimen" .
<Dara-PD> <Has_supportive_med> "Antihistamines" .
<Dara-PD> <Has_supportive_med> "Acetaminophen" .
<Allogeneic_HSCT> <Current_treated_by> "TLI_and_ATG" .
<Allogeneic_HSCT> <Current_treated_by> "Low-dose_TBI" .
<Allogeneic_HSCT> <Current_treated_by> "Fludarabine,_Melphalan,_Alemtuzumab" .
<Allogeneic_HSCT> <Current_treated_by> "Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant" .
<Allogeneic_HSCT> <Current_treated_by> "Fludarabine,_Cyclophosphamide,_ATG" .
<Allogeneic_HSCT> <Current_treated_by> "Fludarabine,_Busulfan,_Cyclophosphamide" .
<Allogeneic_HSCT> <Current_treated_by> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan" .
<Allogeneic_HSCT> <Current_treated_by> "Fludarabine,_Busulfan,_ATG" .
<Allogeneic_HSCT> <Current_treated_by> "Fludarabine_and_TBI" .
<Allogeneic_HSCT> <Current_treated_by> "Fludarabine_and_Melphalan" .
<Allogeneic_HSCT> <Current_treated_by> "FCR" .
<Allogeneic_HSCT> <Current_treated_by> "FC" .
<Allogeneic_HSCT> <Current_treated_by> "Etoposide_and_TBI" .
<Allogeneic_HSCT> <Current_treated_by> "Defibrotide_monotherapy" .
<Allogeneic_HSCT> <Current_treated_by> "Cyclophosphamide,_Fludarabine,_Thiotepa" .
<Allogeneic_HSCT> <Current_treated_by> "Cyclophosphamide_and_TBI" .
<Allogeneic_HSCT> <Current_treated_by> "Clofarabine_and_Melphalan" .
<Allogeneic_HSCT> <Current_treated_by> "Busulfan_and_Fludarabine" .
<Allogeneic_HSCT> <Current_treated_by> "Busulfan_and_Cyclophosphamide" .
<Allogeneic_HSCT> <Current_treated_by> "BuCyTBI" .
<Allogeneic_HSCT> <Current_treated_by> "BFR" .
<Allogeneic_HSCT> <Current_treated_by> "BEAM" .
<Allogeneic_HSCT> <Current_treated_by> "(90)YFC" .
<Nonsteroidal_antiandrogen> <Is_a> "Antiandrogen" .
<Fludarabine_and_TBI> <Has_accepted_use> "Allogeneic_HSCT" .
<Everolimus_and_Tamoxifen> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Everolimus_and_Tamoxifen> <Has_accepted_use> "Breast_cancer" .
<Ovarian_cancer> <Historic_treated_by> "Tamoxifen_monotherapy" .
<Ovarian_cancer> <Historic_treated_by> "Melphalan_monotherapy" .
<Ovarian_cancer> <Historic_treated_by> "Hexa-CAF" .
<Ovarian_cancer> <Historic_treated_by> "Cisplatin,_Cyclophosphamide,_Interferon_gamma-1b" .
<Ovarian_cancer> <Historic_treated_by> "Cisplatin_monotherapy" .
<Ovarian_cancer> <Historic_treated_by> "Cisplatin_and_Cyclophosphamide" .
<Ovarian_cancer> <Historic_treated_by> "Chlorambucil_and_Cisplatin" .
<Ovarian_cancer> <Historic_treated_by> "Carboplatin_and_Cyclophosphamide" .
<Ovarian_cancer> <Historic_treated_by> "CHAD" .
<Ovarian_cancer> <Historic_treated_by> "CEP" .
<Ovarian_cancer> <Historic_treated_by> "CAP_(Platinol)" .
<Ovarian_cancer> <Historic_treated_by> "Altretamine_and_Cisplatin" .
<Ketoconazole_and_Hydrocortisone> <Is_current_in> "Prostate_cancer" .
<Cytarabine_and_Daunorubicin> <Has_context> "Consolidation_after_upfront_therapy" .
<Blexon> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Kaarmepakkaus> <Brand_name_of> "Dexamethasone" .
<BEAM,_then_auto_HSCT> <Mapped_from> "BEAM,_then_auto_HSCT" .
<Paxus> <Brand_name_of> "Paclitaxel" .
<Abemaciclib_monotherapy> <Has_antineoplastic> "Abemaciclib" .
<VR-CHOP> <Mapped_from> "VR-CHOP" .
<Degarelix_monotherapy> <Maps_to> "Degarelix_monotherapy" .
<Capecitabine,_Docetaxel,_Oxaliplatin,_RT> <Has_supportive_med> "Dexamethasone" .
<T-DM1_and_ET> <Is_current_in> "Breast_cancer" .
<FEC_and_Bevacizumab> <Mapped_from> "FEC_and_Bevacizumab" .
<R-HiDAC> <Is_current_in> "Mantle_cell_lymphoma" .
<RANK_ligand_inhibitor> <Is_a> "Bone_protective_medication" .
<Cyclophosphamide_and_TBI,_then_allo_HSCT> <Mapped_from> "Cyclophosphamide_and_TBI,_then_allo_HSCT" .
<GMALL-R> <Has_modality> "Chemotherapy" .
<ABVD,_DD-DI> <Has_modality> "Chemotherapy" .
<Carboplatin,_Paclitaxel,_Bevacizumab> <Has_accepted_use> "Ovarian_cancer" .
<Carboplatin,_Paclitaxel,_Bevacizumab> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<DCEP_and_G-CSF> <Has_supportive_med> "Filgrastim" .
<Entrophen> <Brand_name_of> "Aspirin" .
<Oncaspar> <Brand_name_of> "Pegaspargase" .
<Aloprim> <Brand_name_of> "Allopurinol" .
<Bicalutamide_and_Leuprolide> <Is_current_in> "Prostate_cancer" .
<Licoson> <Brand_name_of> "Dexamethasone" .
<Lasix> <Brand_name_of> "Furosemide" .
<Gefitinib_and_Pemetrexed> <Maps_to> "Gefitinib_and_Pemetrexed" .
<Atezolizumab> <Has_brand_name> "Tecentriq" .
<Cisplatin,_Fluorouracil,_Panitumumab> <Is_current_in> "Head_and_neck_cancer" .
<GMALL-R> <Has_context> "Upfront_therapy" .
<GMALL-R> <Has_context> "Induction_therapy" .
<BuCy,_then_auto_HSCT> <Has_context> "Consolidation_after_upfront_therapy" .
<Cyclosporine,_Corticosteroids,_Rituximab> <Has_accepted_use> "Graft_versus_host_disease" .
<VAMP> <Has_antineoplastic> "Vincristine" .
<VAMP> <Has_antineoplastic> "Methylprednisolone" .
<VAMP> <Has_antineoplastic> "Doxorubicin" .
<Cixutumumab> <Is_a> "Investigational_drug" .
<Cixutumumab> <Is_a> "Antibody_medication" .
<Cixutumumab> <Is_a> "Anti-IGF-1R_antibody" .
<PAD> <Has_accepted_use> "Multiple_myeloma" .
<Asodocel> <Brand_name_of> "Docetaxel" .
<Doxorubicin_and_Lomustine> <Mapped_from> "Doxorubicin_and_Lomustine" .
<Decitabine_and_Valproate> <Is_historical_in> "Acute_myeloid_leukemia" .
<Asalent> <Brand_name_of> "Aspirin" .
<VAIA> <Has_antineoplastic> "Vincristine" .
<VAIA> <Has_antineoplastic> "Ifosfamide" .
<VAIA> <Has_antineoplastic> "Doxorubicin" .
<VAIA> <Has_antineoplastic> "Dactinomycin" .
<Sipuleucel-T> <Has_FDA_indication> "Prostate_cancer" .
<ATRA,_Mercaptopurine,_Methotrexate> <Is_current_in> "Acute_promyelocytic_leukemia" .
<Nolatrexed> <Is_a> "Antimetabolite" .
<Nolatrexed> <Is_a> "Antifolate" .
<maxi-R-CHOP/R-HiDAC> <Has_context> "Non-curative_first-line_therapy" .
<Uracil_mustard> <Antineoplastic_of> "Uracil_mustard_monotherapy" .
<Pomalidomide_monotherapy> <Maps_to> "Pomalidomide_monotherapy" .
<Opdivo> <Brand_name_of> "Nivolumab" .
<Nadroparin> <May_have_route> "Subcutaneous" .
<Lenalidomide_and_Ofatumumab> <Has_modality> "Chemotherapy" .
<Ibrutinib_and_Venetoclax> <Has_accepted_use> "T-cell_prolymphocytic_leukemia" .
<Ibrutinib_and_Venetoclax> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Ibrutinib_and_Venetoclax> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<CFP> <Has_accepted_use> "Breast_cancer" .
<Ado-trastuzumab_emtansine_monotherapy> <Has_antineoplastic> "Ado-trastuzumab_emtansine" .
<DeVIC_and_RT> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<nab-Paclitaxel_and_Atezolizumab> <Has_modality> "Chemotherapy" .
<Enoxaparin_monotherapy> <Has_accepted_use> "Venous_thromboembolism" .
<Cimetidine> <Supportive_med_of> "ddAC-T" .
<Cimetidine> <Supportive_med_of> "VAD" .
<Cimetidine> <Supportive_med_of> "TIP" .
<Cimetidine> <Supportive_med_of> "Rituximab_monotherapy" .
<Cimetidine> <Supportive_med_of> "Paclitaxel_monotherapy" .
<Cimetidine> <Supportive_med_of> "PCF" .
<Cimetidine> <Supportive_med_of> "PCE" .
<Cimetidine> <Supportive_med_of> "Ifosfamide_and_Paclitaxel" .
<Cimetidine> <Supportive_med_of> "High-dose_Interleukin-2" .
<Cimetidine> <Supportive_med_of> "HDMP-R" .
<Cimetidine> <Supportive_med_of> "Gemcitabine,_Oxaliplatin,_Paclitaxel" .
<Cimetidine> <Supportive_med_of> "Gemcitabine_and_Paclitaxel" .
<Cimetidine> <Supportive_med_of> "GCP" .
<Cimetidine> <Supportive_med_of> "Cisplatin,_Paclitaxel,_RT" .
<Cimetidine> <Supportive_med_of> "Cisplatin,_Docetaxel,_RT" .
<Cimetidine> <Supportive_med_of> "Cisplatin_and_Paclitaxel" .
<Cimetidine> <Supportive_med_of> "Cisplatin_and_Etoposide" .
<Cimetidine> <Supportive_med_of> "Carboplatin_and_Paclitaxel" .
<Cimetidine> <Supportive_med_of> "Alemtuzumab_monotherapy" .
<Ferric_carboxymaltose> <May_have_route> "Intravenous" .
<Imatinib_monotherapy> <Is_current_in> "Systemic_mastocytosis" .
<Imatinib_monotherapy> <Is_current_in> "Soft_tissue_sarcoma" .
<Imatinib_monotherapy> <Is_current_in> "Melanoma" .
<Imatinib_monotherapy> <Is_current_in> "Hypereosinophilic_syndrome" .
<Imatinib_monotherapy> <Is_current_in> "Gastrointestinal_stromal_tumor" .
<Imatinib_monotherapy> <Is_current_in> "Chronic_myelogenous_leukemia" .
<Imatinib_monotherapy> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<FOLFOX_chronotherapy> <Maps_to> "FOLFOX_chronotherapy" .
<Cisplatin,_Gemcitabine,_Necitumumab> <Has_context> "Non-curative_first-line_therapy" .
<CHOEP-21> <Is_a> "Anthracycline-containing_regimen" .
<Hydrocortisone> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Hydrocortisone> <Is_a> "Steroid" .
<Yekaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Poltaxel> <Brand_name_of> "Paclitaxel" .
<CeeNu> <Brand_name_of> "Lomustine" .
<AVCF> <Is_historical_in> "Breast_cancer" .
<mFOLFOX6_and_Bevacizumab_(L-Leucovorin)> <Is_a> "Bevacizumab-containing_regimen" .
<Carboplatin_and_Vinorelbine> <Is_a> "Platinum_doublet" .
<Omacetaxine_monotherapy> <Has_context> "Salvage_therapy" .
<Omacetaxine_monotherapy> <Has_context> "Non-curative_therapy" .
<Tbo-filgrastim> <May_have_route> "Subcutaneous" .
<CVAP> <Is_a> "Anthracycline-containing_regimen" .
<Enasidenib> <May_have_route> "Oral" .
<Nilandron> <Brand_name_of> "Nilutamide" .
<TC_(Taxotere)> <Is_current_in> "Breast_cancer" .
<Pomalidomide,_Dexamethasone,_Pembrolizumab> <Is_historical_in> "Multiple_myeloma" .
<MC> <Has_modality> "Chemotherapy" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab> <Mapped_from> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab" .
<Ponatinib> <May_have_route> "Oral" .
<Pegaspargase,_Vincristine,_Prednisone> <Mapped_from> "Pegaspargase,_Vincristine,_Prednisone" .
<LoDAC_and_Venetoclax> <Has_context> "Non-curative_first-line_induction_therapy" .
<Estramustine> <May_have_route> "Oral" .
<Cisplatin_and_Irinotecan> <Has_supportive_med> "Ondansetron" .
<Cisplatin_and_Irinotecan> <Has_supportive_med> "Methotrexate" .
<Cisplatin_and_Irinotecan> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Cisplatin_and_Irinotecan> <Has_supportive_med> "Granisetron" .
<Cisplatin_and_Irinotecan> <Has_supportive_med> "Folinic_acid" .
<Cisplatin_and_Irinotecan> <Has_supportive_med> "Dexamethasone" .
<Cisplatin_and_Irinotecan> <Has_supportive_med> "Atropine" .
<MPV> <Has_accepted_use> "CNS_lymphoma" .
<VAC> <Has_modality> "Chemotherapy" .
<Melphalan,_then_auto_HSCT,_then_Melphalan_and_TBI,_then_auto_HSCT> <Has_antineoplastic> "Melphalan" .
<Melphalan,_then_auto_HSCT,_then_Melphalan_and_TBI,_then_auto_HSCT> <Has_antineoplastic> "External_beam_radiotherapy" .
<GnRH_agonist> <Is_a> "Endocrine_therapeutic" .
<Inthesa-5> <Brand_name_of> "Dexamethasone" .
<Vemurafenib> <Antineoplastic_of> "Vemurafenib_monotherapy" .
<Vemurafenib> <Antineoplastic_of> "Irinotecan,_Vemurafenib,_Cetuximab" .
<Vemurafenib> <Antineoplastic_of> "Cobimetinib_and_Vemurafenib" .
<Bexarotene_and_Pralatrexate> <Has_antineoplastic> "Pralatrexate" .
<Bexarotene_and_Pralatrexate> <Has_antineoplastic> "Bexarotene" .
<ProMACE-CytaBOM> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<ProMACE-CytaBOM> <Has_supportive_med> "Folinic_acid" .
<CALGB_8811_early_intensification> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Trixotene> <Brand_name_of> "Docetaxel" .
<Capecitabine,_Paclitaxel,_RT> <Maps_to> "Capecitabine,_Paclitaxel,_RT" .
<Lenvatinib> <May_have_route> "Oral" .
<BEAC,_then_auto_HSCT> <Has_antineoplastic> "Etoposide" .
<BEAC,_then_auto_HSCT> <Has_antineoplastic> "Cytarabine" .
<BEAC,_then_auto_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<BEAC,_then_auto_HSCT> <Has_antineoplastic> "Carmustine" .
<Optune> <Brand_name_of> "NovoTTF-100A_system_(Optune)" .
<GDPT> <Mapped_from> "GDPT" .
<Gefitinib_monotherapy> <Maps_to> "Gefitinib_monotherapy" .
<Estradiol_monotherapy> <Mapped_from> "Estradiol_monotherapy" .
<CEV_and_RT> <Mapped_from> "CEV_and_RT" .
<Mercaptopurine_monotherapy> <Has_context> "Induction_therapy" .
<Cisplatin_and_Gemcitabine/Erlotinib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cisplatin_and_Gemcitabine/Erlotinib> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<Fludarabine_and_Prednisone> <Is_historical_in> "Chronic_lymphocytic_leukemia" .
<Topotecan> <Supportive_med_of> "Eculizumab_monotherapy" .
<MEC> <Has_antineoplastic> "Mitoxantrone" .
<MEC> <Has_antineoplastic> "Etoposide" .
<MEC> <Has_antineoplastic> "Cytarabine" .
<Cisplatin_and_Irinotecan> <Is_current_in> "Small_cell_lung_cancer" .
<Cisplatin_and_Irinotecan> <Is_current_in> "Penile_cancer" .
<Cisplatin_and_Irinotecan> <Is_current_in> "Non-small_cell_lung_cancer" .
<Cisplatin_and_Irinotecan> <Is_current_in> "Esophageal_cancer" .
<Cisplatin_and_Irinotecan> <Is_current_in> "Adenocarcinoma_of_unknown_primary" .
<COPDAC> <Is_current_in> "Hodgkin_lymphoma" .
<Abemaciclib_and_Fulvestrant> <Has_context> "Non-curative_subsequent-line_therapy" .
<Dabrafenib,_Trametinib,_Panitumumab> <Has_modality> "Chemotherapy" .
<R-ESHAP> <Has_supportive_med> "Metoclopramide" .
<R-ESHAP> <Has_supportive_med> "Mannitol" .
<Sirolimus,_Tacrolimus,_Prednisone> <Mapped_from> "Sirolimus,_Tacrolimus,_Prednisone" .
<Optasid> <Brand_name_of> "Etoposide" .
<Ivepred> <Brand_name_of> "Methylprednisolone" .
<CLF> <Is_current_in> "Gastric_cancer" .
<CLF> <Is_current_in> "Esophageal_cancer" .
<ECF/5-FU_and_RT> <Is_a> "Anthracycline-containing_regimen" .
<EPIC_regimen> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Fludarabine_monotherapy> <Mapped_from> "Fludarabine_monotherapy" .
<Ifosfamide_and_Methotrexate> <Mapped_from> "Ifosfamide_and_Methotrexate" .
<Voritrol> <Brand_name_of> "Voriconazole" .
<Octreotide_LAR> <Has_accepted_use> "Pancreatic_NET" .
<Octreotide_LAR> <Has_accepted_use> "Neuroendocrine_tumor" .
<APO> <Has_modality> "Chemotherapy" .
<Fluorouracil_and_Levoleucovorin> <Has_modality> "Chemotherapy" .
<Arsenic_trioxide_and_Idarubicin> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Cisplatin,_Gemcitabine,_RT> <Maps_to> "Cisplatin,_Gemcitabine,_RT" .
<R,_then_CHOP> <Is_a> "Rituximab-containing_regimen" .
<R,_then_CHOP> <Is_a> "Anthracycline-containing_regimen" .
<Isodexam> <Brand_name_of> "Dexamethasone" .
<Sorafenib_monotherapy> <Is_current_in> "Thyroid_cancer" .
<Sorafenib_monotherapy> <Is_current_in> "Soft_tissue_sarcoma" .
<Sorafenib_monotherapy> <Is_current_in> "Renal_cell_carcinoma" .
<Sorafenib_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Sorafenib_monotherapy> <Is_current_in> "Hepatocellular_carcinoma" .
<Sorafenib_monotherapy> <Is_current_in> "Gastrointestinal_stromal_tumor" .
<Sorafenib_monotherapy> <Is_current_in> "Acute_myeloid_leukemia" .
<Sultorim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Non-curative_first-line_induction_therapy> <Maps_to> "Non-curative_first-line_induction_therapy" .
<PAD> <Mapped_from> "PAD" .
<Doxorubicin_pegylated_liposomal_and_Trabectedin> <Is_a> "Anthracycline-containing_regimen" .
<NOVP> <Has_antineoplastic> "Vincristine" .
<NOVP> <Has_antineoplastic> "Vinblastine" .
<NOVP> <Has_antineoplastic> "Prednisone" .
<NOVP> <Has_antineoplastic> "Mitoxantrone" .
<DCEP> <Is_current_in> "Multiple_myeloma" .
<Fer-in-Sol> <Brand_name_of> "Ferrous_sulfate" .
<IBset> <Brand_name_of> "Ramosetron" .
<Fixopan> <Brand_name_of> "Alendronate" .
<No_induction> <Is_current_in> "Non-small_cell_lung_cancer" .
<No_induction> <Is_current_in> "Nasopharyngeal_carcinoma" .
<No_induction> <Is_current_in> "Light-chain_(AL)_amyloidosis" .
<No_induction> <Is_current_in> "Head_and_neck_cancer" .
<COPP_(CCNU)> <Has_accepted_use> "Hodgkin_lymphoma" .
<Cemiplimab_monotherapy> <Has_antineoplastic> "Cemiplimab" .
<Capecitabine_and_Trastuzumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<Capecitabine_and_Trastuzumab> <Has_context> "Non-curative_first-line_therapy" .
<Capecitabine_and_Trastuzumab> <Has_context> "All_lines_of_therapy" .
<Euprotin> <Brand_name_of> "Filgrastim" .
<Idarucizumab> <Is_a> "Hemostasis_medication" .
<Idarucizumab> <Is_a> "Hematology_medication" .
<Idarucizumab> <Is_a> "Antibody_medication" .
<Afatinib_and_Bevacizumab> <Mapped_from> "Afatinib_and_Bevacizumab" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone> <Is_a> "Anthracycline-containing_regimen" .
<dmCODOX-M_-_Modified_Magrath> <Has_antineoplastic> "Vincristine" .
<dmCODOX-M_-_Modified_Magrath> <Has_antineoplastic> "Methotrexate" .
<dmCODOX-M_-_Modified_Magrath> <Has_antineoplastic> "Doxorubicin" .
<dmCODOX-M_-_Modified_Magrath> <Has_antineoplastic> "Cyclophosphamide" .
<Cisplatin,_Dacarbazine,_Interferon_alfa-2b> <Maps_to> "Cisplatin,_Dacarbazine,_Interferon_alfa-2b" .
<Cisplatin_and_Vinblastine> <Is_historical_in> "Non-small_cell_lung_cancer" .
<Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Is_a> "Anthracycline-containing_regimen" .
<Anastrozole_and_Trastuzumab> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Anastrozole_and_Trastuzumab> <Has_accepted_use> "Breast_cancer" .
<Polaramine> <Brand_name_of> "Dexchlorpheniramine" .
<KD> <Has_modality> "Chemotherapy" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "Vinorelbine_monotherapy" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "Vindesine_monotherapy" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "VIP" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "Radiation_therapy" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "Placebo" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "Paclitaxel_monotherapy" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "PEV" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "MVP_and_RT" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "MVP_(Vindesine)" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "MVP_(Vinblastine)" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "MIC" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "MACC" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "Ifosfamide_and_Gemcitabine" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "Gemcitabine_monotherapy" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "GIP" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "Erlotinib_monotherapy" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "Docetaxel_monotherapy" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "Docetaxel_and_Gemcitabine" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "Cisplatin_monotherapy" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "Cisplatin_and_Vindesine" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "Cisplatin_and_Vinblastine" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "Cisplatin_and_Pemetrexed" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "Carboplatin_and_Cisplatin" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "CCI" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "CAP_(Platinol)" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "CAMP" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "Best_supportive_care" .
<Non-small_cell_lung_cancer> <Historic_treated_by> "Bacillus_Calmette-Guerin_(BCG)_monotherapy" .
<FC> <Is_historical_in> "Follicular_lymphoma" .
<FC> <Is_historical_in> "Chronic_lymphocytic_leukemia" .
<Biorubina> <Brand_name_of> "Doxorubicin" .
<DEX-IFN> <Has_modality> "Immunotherapy" .
<DEX-IFN> <Has_modality> "Chemotherapy" .
<Fluorouracil,_Folinic_acid,_Mitomycin> <Is_current_in> "Gastric_cancer" .
<Nilotinib-based_consolidation> <Has_antineoplastic> "Vincristine" .
<Nilotinib-based_consolidation> <Has_antineoplastic> "Prednisolone" .
<Nilotinib-based_consolidation> <Has_antineoplastic> "Nilotinib" .
<Nilotinib-based_consolidation> <Has_antineoplastic> "Methotrexate" .
<Nilotinib-based_consolidation> <Has_antineoplastic> "Etoposide" .
<Nilotinib-based_consolidation> <Has_antineoplastic> "Daunorubicin" .
<Nilotinib-based_consolidation> <Has_antineoplastic> "Cytarabine" .
<ABVDm> <Is_a> "Anthracycline-containing_regimen" .
<MAP> <Is_a> "Anthracycline-containing_regimen" .
<ATRA,_Cytarabine,_Daunorubicin> <Has_modality> "Chemotherapy" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone> <Mapped_from> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone" .
<Lymphoma> <Is_a> "Malignant_hematologic_neoplasm" .
<131Iodine-Tositumomab_monotherapy> <Has_antineoplastic> "Tositumomab_and_I-131_(Bexxar)" .
<Lowasa> <Brand_name_of> "Aspirin" .
<Carboplatin,_Fluorouracil,_RT> <Has_modality> "Radiotherapy" .
<Carboplatin,_Fluorouracil,_RT> <Has_modality> "Chemotherapy" .
<Eltrom> <Brand_name_of> "Eltrombopag" .
<BuCy,_then_auto_HSCT> <Has_antineoplastic> "Cyclophosphamide" .
<BuCy,_then_auto_HSCT> <Has_antineoplastic> "Busulfan" .
<Valstar> <Brand_name_of> "Valrubicin" .
<Ravulizumab> <May_have_route> "Intravenous" .
<Fluorouracil,_Folinic_acid,_Gemcitabine> <Mapped_from> "Fluorouracil,_Folinic_acid,_Gemcitabine" .
<AXL_inhibitor> <Subsumes> "Gilteritinib" .
<AXL_inhibitor> <Subsumes> "Cabozantinib" .
<Everolimus_and_Exemestane> <Has_modality> "Hormonotherapy" .
<Everolimus_and_Exemestane> <Has_modality> "Chemotherapy" .
<PCD> <Has_accepted_use> "Multiple_myeloma" .
<Rituximab-abbs> <Has_FDA_indication> "Follicular_lymphoma" .
<Docetaxel_and_Irinotecan> <Has_context> "Non-curative_subsequent-line_therapy" .
<Docetaxel_and_Irinotecan> <Has_context> "Non-curative_first-line_therapy" .
<GMALL-R> <Is_current_in> "HIV-associated_lymphoma" .
<GMALL-R> <Is_current_in> "Burkitt_lymphoma" .
<FOLFIRI_and_Ziv-aflibercept> <Has_modality> "Chemotherapy" .
<Oncotrex> <Brand_name_of> "Methotrexate" .
<MOPP> <Maps_to> "MOPP" .
<VR-CAP> <Mapped_from> "VR-CAP" .
<Dasatinib_and_Prednisone> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Dasatinib_and_Prednisone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Orteronel> <Is_a> "Steroid_synthesis_inhibitor" .
<Orteronel> <Is_a> "Investigational_drug" .
<Orteronel> <Is_a> "Endocrine_therapeutic" .
<Orteronel> <Is_a> "Antiandrogen" .
<MINE> <Is_a> "Anthracycline-containing_regimen" .
<Cyclosporine,_Mycophenolate_mofetil,_Sirolimus> <Is_current_in> "Graft_versus_host_disease" .
<VIP> <Is_current_in> "Thymoma" .
<VIP> <Is_current_in> "Testicular_cancer" .
<PF> <Has_antineoplastic> "Melphalan" .
<PF> <Has_antineoplastic> "Fluorouracil" .
<MPV> <Mapped_from> "MPV" .
<Hensetron> <Brand_name_of> "Tropisetron" .
<Cisplatin,_Paclitaxel,_Bevacizumab> <Is_current_in> "Cervical_cancer" .
<Idelalisib_and_Rituximab> <Mapped_from> "Idelalisib_and_Rituximab" .
<Fludarabine,_Cyclophosphamide,_TBI_for_dUCB_or_haploidentical_transplant> <Is_current_in> "Allogeneic_HSCT" .
<Vinorelbine> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Vinorelbine> <Is_a> "Vinca_alkaloid" .
<Vinorelbine> <Is_a> "Vesicant" .
<Vinorelbine> <Is_a> "Microtubule_inhibitor" .
<VABE> <Mapped_from> "VABE" .
<Decitabine> <Is_a> "Pyrimidine_analogue" .
<Decitabine> <Is_a> "Hypomethylating_agent" .
<Decitabine> <Is_a> "DNA_methyltransferase_inhibitor" .
<HLH-2004_regimen> <Has_immunosuppressor> "Etoposide" .
<HLH-2004_regimen> <Has_immunosuppressor> "Dexamethasone" .
<HLH-2004_regimen> <Has_immunosuppressor> "Cyclosporines" .
<IL-2_monotherapy> <Has_antineoplastic> "Aldesleukin" .
<Samarium-153_monotherapy> <Has_antineoplastic> "Samarium-153" .
<Carboplatin,_Etoposide,_Bevacizumab> <Has_context> "Induction_therapy" .
<Imatinib_and_Interferon> <Has_context> "Non-curative_first-line_therapy" .
<Voriconazole> <May_have_route> "Oral" .
<Voriconazole> <May_have_route> "Intravenous" .
<Trastuzumab_and_ET> <Has_antineoplastic> "Trastuzumab" .
<Trastuzumab_and_ET> <Has_antineoplastic> "Tamoxifen" .
<Trastuzumab_and_ET> <Has_antineoplastic> "GnRH_agonists" .
<Trastuzumab_and_ET> <Has_antineoplastic> "Aromatase_inhibitors" .
<7_plus_5i> <Maps_to> "7_plus_5i" .
<Cisplatin,_Pemetrexed,_Pembrolizumab> <Has_antineoplastic> "Pemetrexed" .
<Cisplatin,_Pemetrexed,_Pembrolizumab> <Has_antineoplastic> "Pembrolizumab" .
<Cisplatin,_Pemetrexed,_Pembrolizumab> <Has_antineoplastic> "Cisplatin" .
<Bevacizumab_and_RT> <Is_a> "Bevacizumab-containing_regimen" .
<VAD> <Mapped_from> "VAD" .
<CA_ATRA> <Brand_name_of> "All-trans_retinoic_acid" .
<Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide> <Maps_to> "Cyclophosphamide_and_Vincristine/Cisplatin_and_Etoposide" .
<UFTM> <Has_accepted_use> "Gastric_cancer" .
<Fondaparinux_monotherapy> <Has_modality> "Anticoagulation" .
<BVD> <Has_accepted_use> "Melanoma" .
<RD> <Has_supportive_med> "Zoledronic_acid" .
<RD> <Has_supportive_med> "Pamidronate" .
<Filgrastima> <Brand_name_of> "Filgrastim" .
<Carboplatin_and_Paclitaxel> <Has_context> "Non-curative_therapy" .
<Carboplatin_and_Paclitaxel> <Has_context> "Non-curative_second-line_therapy" .
<Carboplatin_and_Paclitaxel> <Has_context> "Non-curative_first-line_therapy" .
<Carboplatin_and_Paclitaxel> <Has_context> "Neoadjuvant_therapy" .
<Carboplatin_and_Paclitaxel> <Has_context> "Induction_therapy" .
<Carboplatin_and_Paclitaxel> <Has_context> "Consolidation_after_upfront_therapy" .
<Carboplatin_and_Paclitaxel> <Has_context> "All_lines_of_therapy" .
<Carboplatin_and_Paclitaxel> <Has_context> "Adjuvant_therapy" .
<ACVBP> <Has_context> "Induction_therapy" .
<Binimetinib> <May_have_route> "Oral" .
<Thalidomide_monotherapy> <Has_accepted_use> "Polycythemia_vera" .
<Thalidomide_monotherapy> <Has_accepted_use> "Multiple_myeloma" .
<Rabeprazole> <May_have_route> "Oral" .
<Soltrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<R-INO> <Has_context> "Non-curative_therapy" .
<R-INO> <Has_context> "Non-curative_subsequent-line_therapy" .
<ATRA_and_Danazol> <Is_current_in> "Immune_thrombocytopenia" .
<Ensartinib> <May_have_route> "Oral" .
<Formestane> <Antineoplastic_of> "Formestane_monotherapy" .
<VMP/Rd> <Has_supportive_med> "Low_molecular_weight_heparins" .
<VMP/Rd> <Has_supportive_med> "Bisphosphonates" .
<VMP/Rd> <Has_supportive_med> "Aspirin" .
<VMP/Rd> <Has_supportive_med> "Antivirals" .
<Apatinib_monotherapy> <Mapped_from> "Apatinib_monotherapy" .
<Atezolizumab_and_Bevacizumab> <Has_modality> "Immunotherapy" .
<Atezolizumab_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Mesothelioma> <Accepted_use_of> "Vinorelbine_monotherapy" .
<Mesothelioma> <Accepted_use_of> "Vinorelbine" .
<Mesothelioma> <Accepted_use_of> "Raltitrexed" .
<Mesothelioma> <Accepted_use_of> "Placebo" .
<Mesothelioma> <Accepted_use_of> "Pemetrexed_monotherapy" .
<Mesothelioma> <Accepted_use_of> "Pemetrexed" .
<Mesothelioma> <Accepted_use_of> "Mitomycin" .
<Mesothelioma> <Accepted_use_of> "Gemcitabine_monotherapy" .
<Mesothelioma> <Accepted_use_of> "Gemcitabine_and_Vinorelbine" .
<Mesothelioma> <Accepted_use_of> "Gemcitabine" .
<Mesothelioma> <Accepted_use_of> "Doxorubicin_monotherapy" .
<Mesothelioma> <Accepted_use_of> "Cisplatin,_Pemetrexed,_TTFields" .
<Mesothelioma> <Accepted_use_of> "Cisplatin,_Pemetrexed,_Bevacizumab" .
<Mesothelioma> <Accepted_use_of> "Cisplatin_monotherapy" .
<Mesothelioma> <Accepted_use_of> "Cisplatin_and_Raltitrexed" .
<Mesothelioma> <Accepted_use_of> "Cisplatin_and_Pemetrexed" .
<Mesothelioma> <Accepted_use_of> "Cisplatin_and_Gemcitabine" .
<Mesothelioma> <Accepted_use_of> "Cisplatin" .
<Mesothelioma> <Accepted_use_of> "Carboplatin_and_Pemetrexed" .
<Mesothelioma> <Accepted_use_of> "Carboplatin" .
<Mesothelioma> <Accepted_use_of> "Bevacizumab-bvzr" .
<Mesothelioma> <Accepted_use_of> "Bevacizumab-awwb" .
<Mesothelioma> <Accepted_use_of> "Bevacizumab" .
<Mesothelioma> <Accepted_use_of> "Best_supportive_care" .
<Mesothelioma> <Accepted_use_of> "Amatuximab" .
<Cisplatin,_Interferon_alfa-2a,_Isotretinoin> <Has_accepted_use> "Cutaneous_squamous_cell_carcinoma" .
<VeIP> <Has_supportive_med> "Mesna" .
<Fluorouracil_and_Folinic_acid> <Has_supportive_med> "Metoclopramide" .
<Fluorouracil_and_Folinic_acid> <Has_supportive_med> "Loperamide" .
<Fluorouracil_and_Folinic_acid> <Has_supportive_med> "Emesis_prevention" .
<Fluorouracil_and_Folinic_acid> <Has_supportive_med> "Anti-diarrheals" .
<BVD> <Is_historical_in> "Melanoma" .
<PET> <Mapped_from> "PET" .
<VIE> <Has_context> "All_lines_of_therapy" .
<Karomex> <Brand_name_of> "Anastrozole" .
<Imatinib-based_consolidation> <Has_antineoplastic> "Mercaptopurine" .
<Imatinib-based_consolidation> <Has_antineoplastic> "Imatinib" .
<Imatinib-based_consolidation> <Has_antineoplastic> "Cytarabine" .
<Imatinib-based_consolidation> <Has_antineoplastic> "Cyclophosphamide" .
<Aredia> <Brand_name_of> "Pamidronate" .
<Cyclophosphamide,_Dacarbazine,_Vincristine> <Has_modality> "Chemotherapy" .
<R2CHOP> <Has_modality> "Chemotherapy" .
<BTD> <Is_current_in> "Multiple_myeloma" .
<Omegtrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Dexaphos> <Brand_name_of> "Dexamethasone" .
<Everolimus_and_Lenvatinib> <Maps_to> "Everolimus_and_Lenvatinib" .
<Dexaven> <Brand_name_of> "Dexamethasone" .
<Tegafur,_Uracil,_Folinic_acid> <Has_accepted_use> "Colon_cancer" .
<R-DHAP> <Has_modality> "Chemotherapy" .
<FluCam> <Has_context> "Non-curative_therapy" .
<ACE> <Maps_to> "ACE" .
<FOLFOX_7/sLV5FU2_(L-Leucovorin)> <Maps_to> "FOLFOX_7/sLV5FU2_(L-Leucovorin)" .
<Lanreotide> <Has_brand_name> "Somatuline_PR" .
<Lanreotide> <Has_brand_name> "Somatuline_LP" .
<Lanreotide> <Has_brand_name> "Somatuline_LA" .
<Lanreotide> <Has_brand_name> "Somatuline_Depot" .
<Lanreotide> <Has_brand_name> "Somatuline_Autogel" .
<Lanreotide> <Has_brand_name> "Lanreotide_Autogel" .
<Lanreotide> <Has_brand_name> "Ipstyl" .
<Nivestim> <Brand_name_of> "Filgrastim" .
<Anti-P-selectin_antibody> <Is_a> "Antibody_medication" .
<Mitoxantrone> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Mitoxantrone> <Has_accepted_use> "Prostate_cancer" .
<Mitoxantrone> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Mitoxantrone> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Mitoxantrone> <Has_accepted_use> "Hodgkin_lymphoma" .
<Mitoxantrone> <Has_accepted_use> "Follicular_lymphoma" .
<Mitoxantrone> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Mitoxantrone> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Mitoxantrone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Mitoxantrone> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Mitoxantrone> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Doxorubicin_pegylated_liposomal_and_Trabectedin> <Maps_to> "Doxorubicin_pegylated_liposomal_and_Trabectedin" .
<CAP_(Platinol)> <Is_historical_in> "Ovarian_cancer" .
<CAP_(Platinol)> <Is_historical_in> "Non-small_cell_lung_cancer" .
<CYVE_and_G-CSF> <Has_antineoplastic> "Etoposide" .
<CYVE_and_G-CSF> <Has_antineoplastic> "Cytarabine" .
<Alectinib_monotherapy> <Has_modality> "Chemotherapy" .
<ECX> <Maps_to> "ECX" .
<IE> <Has_modality> "Chemotherapy" .
<Rubomycin> <Brand_name_of> "Daunorubicin" .
<Rituximab_monotherapy> <Has_supportive_med> "Rituximab" .
<Rituximab_monotherapy> <Has_supportive_med> "Ranitidine" .
<Rituximab_monotherapy> <Has_supportive_med> "Prednisone" .
<Rituximab_monotherapy> <Has_supportive_med> "Methylprednisolone" .
<Rituximab_monotherapy> <Has_supportive_med> "Diphenhydramine" .
<Rituximab_monotherapy> <Has_supportive_med> "Cimetidine" .
<Rituximab_monotherapy> <Has_supportive_med> "Allopurinol" .
<Rituximab_monotherapy> <Has_supportive_med> "Acetaminophen" .
<Soft_tissue_sarcoma> <Subsumes> "Vascular_sarcoma" .
<Soft_tissue_sarcoma> <Subsumes> "Rhabdomyosarcoma" .
<Soft_tissue_sarcoma> <Subsumes> "Liposarcoma" .
<Soft_tissue_sarcoma> <Subsumes> "Leiomyosarcoma" .
<Soft_tissue_sarcoma> <Subsumes> "Gastrointestinal_stromal_tumor" .
<Soft_tissue_sarcoma> <Subsumes> "Epithelioid_sarcoma" .
<Platinum_agent> <Is_a> "Chemotherapeutic" .
<Nilevar> <Brand_name_of> "Norethandrolone" .
<Capecitabine,_Mitomycin,_RT> <Has_accepted_use> "Anal_cancer" .
<HAIC_and_Sorafenib> <Maps_to> "HAIC_and_Sorafenib" .
<Cisplatin_and_Docetaxel> <Is_a> "Platinum_doublet" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "TLI_and_ATG" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "Rabbit_ATG" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "Fludarabine,_Cyclophosphamide,_ATG" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "Fludarabine,_Busulfan,_Cyclophosphamide" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "Fludarabine,_Busulfan,_ATG,_then_allo_HSCT" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "Fludarabine,_Busulfan,_ATG" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "Fludarabine_and_Melphalan" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "FluBuCy,_then_allo_HSCT" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "Flu-Mel,_then_allo_HSCT" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "Cyclosporine,_Methotrexate,_ATG" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "Busulfan_and_Fludarabine" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "BuFlu,_then_allo_HSCT" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "ATG_(Rabbit)_monotherapy" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "ATG_(Rabbit)_and_Cyclosporine" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "(90)YFC,_then_allo_HSCT" .
<Antithymocyte_globulin_rabbit_ATG> <Immunosuppressor_of> "(90)YFC" .
<Fluoro-Uracil_ICN> <Brand_name_of> "Fluorouracil" .
<Low-dose_TBI,_then_allo_HSCT> <Has_accepted_use> "Acute_myeloid_leukemia" .
<B-CAVe> <Mapped_from> "B-CAVe" .
<Idelalisib> <Is_a> "REMS_program" .
<Idelalisib> <Is_a> "PI3K_delta_inhibitor" .
<Idelalisib> <Is_a> "Kinase_inhibitor" .
<Osimertinib> <Antineoplastic_of> "Osimertinib_monotherapy" .
<Brentuximab_vedotin_and_Dacarbazine> <Has_antineoplastic> "Dacarbazine" .
<Brentuximab_vedotin_and_Dacarbazine> <Has_antineoplastic> "Brentuximab_vedotin" .
<Aspirin_and_Anagrelide> <Has_accepted_use> "Essential_thrombocythemia" .
<Predmetil> <Brand_name_of> "Methylprednisolone" .
<R-VAD_plus_C> <Has_context> "Non-curative_first-line_therapy" .
<RICER> <Mapped_from> "RICER" .
<Topotecan_and_Bevacizumab> <Mapped_from> "Topotecan_and_Bevacizumab" .
<TTR> <Mapped_from> "TTR" .
<Atovaquone> <May_have_route> "Oral" .
<Arsenic_trioxide_and_Idarubicin> <Has_context> "Induction_therapy" .
<Imetelstat> <Is_a> "Telomerase_inhibitor" .
<Imetelstat> <Is_a> "Investigational_drug" .
<Doxorubicin_and_Streptozocin> <Maps_to> "Doxorubicin_and_Streptozocin" .
<Aphtasolon> <Brand_name_of> "Dexamethasone" .
<Cabazitaxel_and_Prednisone> <Maps_to> "Cabazitaxel_and_Prednisone" .
<Ravulizumab> <Has_accepted_use> "Paroxysmal_nocturnal_hemoglobinuria" .
<SMO_inhibitor> <Subsumes> "Vismodegib" .
<SMO_inhibitor> <Subsumes> "Sonidegib" .
<Itraconazole> <Has_brand_name> "Sporanox" .
<PMitCEBO> <Has_modality> "Chemotherapy" .
<MOPP/ABVD> <Is_historical_in> "Hodgkin_lymphoma" .
<Octreotide_monotherapy> <Has_antineoplastic> "Octreotide" .
<Bacticel> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<mDCF> <Has_antineoplastic> "Folinic_acid" .
<mDCF> <Has_antineoplastic> "Fluorouracil" .
<mDCF> <Has_antineoplastic> "Docetaxel" .
<mDCF> <Has_antineoplastic> "Cisplatin" .
<R-FND> <Has_antineoplastic> "Rituximab" .
<R-FND> <Has_antineoplastic> "Mitoxantrone" .
<R-FND> <Has_antineoplastic> "Fludarabine" .
<R-FND> <Has_antineoplastic> "Dexamethasone" .
<MCF> <Is_current_in> "Esophageal_cancer" .
<Docetaxel_and_Bevacizumab> <Has_context> "Non-curative_therapy" .
<Docetaxel_and_Bevacizumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<Docetaxel_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<Docetaxel_and_Bevacizumab> <Has_context> "Neoadjuvant_therapy" .
<R-TBI/Cy,_then_auto_HSCT> <Mapped_from> "R-TBI/Cy,_then_auto_HSCT" .
<R-GCVP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<FAMTX> <Maps_to> "FAMTX" .
<Inotuzumab_ozogamicin> <Has_FDA_indication> "B-cell_acute_lymphoblastic_leukemia" .
<Vorinostat_and_Rituximab> <Has_context> "Non-curative_therapy" .
<VAC_(Adriamycin)> <Has_context> "Non-curative_therapy" .
<Irinotecan_liposome> <Has_accepted_use> "Pancreatic_cancer" .
<Irinotecan_liposome> <Has_accepted_use> "Gastric_cancer" .
<Irinotecan_liposome> <Has_accepted_use> "Esophageal_cancer" .
<Vintec> <Brand_name_of> "Vincristine" .
<Alendon> <Brand_name_of> "Alendronate" .
<FEC_and_H_(SC)> <Maps_to> "FEC_and_H_(SC)" .
<Nabilone> <May_have_route> "Oral" .
<Dellamethasone> <Brand_name_of> "Dexamethasone" .
<Emend> <Brand_name_of> "Aprepitant" .
<Kaposi_sarcoma> <FDA_indication_of> "Pegylated_liposomal_doxorubicin" .
<Kaposi_sarcoma> <FDA_indication_of> "Paclitaxel" .
<Kaposi_sarcoma> <FDA_indication_of> "Interferon_alfa-2b" .
<Kaposi_sarcoma> <FDA_indication_of> "Daunorubicin_liposomal" .
<Carbosin> <Brand_name_of> "Carboplatin" .
<Cisplatin,_Vinorelbine,_RT> <Is_current_in> "Non-small_cell_lung_cancer" .
<Cisplatin,_Vinorelbine,_RT> <Is_current_in> "Esophageal_cancer" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_context> "Induction_therapy" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Has_context> "Consolidation_after_upfront_therapy" .
<Midostaurin> <May_have_route> "Oral" .
<Posid> <Brand_name_of> "Etoposide" .
<NovoTTF-100A_system_(Optune)> <Local_therapy_of> "Temozolomide_and_NovoTTF-100A" .
<NovoTTF-100A_system_(Optune)> <Local_therapy_of> "NovoTTF-100A_monotherapy" .
<KTD> <Has_accepted_use> "Multiple_myeloma" .
<LVP_.22Sandwich.22> <Has_antineoplastic> "Vincristine" .
<LVP_.22Sandwich.22> <Has_antineoplastic> "Prednisolone" .
<LVP_.22Sandwich.22> <Has_antineoplastic> "External_beam_radiotherapy" .
<LVP_.22Sandwich.22> <Has_antineoplastic> "Asparaginase" .
<DD-CHOP> <Has_antineoplastic> "Vincristine" .
<DD-CHOP> <Has_antineoplastic> "Prednisone" .
<DD-CHOP> <Has_antineoplastic> "Doxorubicin" .
<DD-CHOP> <Has_antineoplastic> "Denileukin_diftitox" .
<DD-CHOP> <Has_antineoplastic> "Cyclophosphamide" .
<Dekisachosei> <Brand_name_of> "Dexamethasone" .
<Ponatinib_monotherapy> <Maps_to> "Ponatinib_monotherapy" .
<CEV_and_RT> <Is_historical_in> "Small_cell_lung_cancer" .
<Ifosfamide_and_Vinorelbine> <Has_antineoplastic> "Vinorelbine" .
<Ifosfamide_and_Vinorelbine> <Has_antineoplastic> "Mesna" .
<Ifosfamide_and_Vinorelbine> <Has_antineoplastic> "Ifosfamide" .
<Betrixaban_monotherapy> <Has_context> "Prophylaxis" .
<Ecotrin_Maximum_Strenght> <Brand_name_of> "Aspirin" .
<Isopto> <Brand_name_of> "Dexamethasone" .
<Trastuzumab-anns> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Trastuzumab-anns> <Is_a> "Protein_expression-specific_medication" .
<Trastuzumab-anns> <Is_a> "Neutral" .
<Trastuzumab-anns> <Is_a> "Biosimilar" .
<Trastuzumab-anns> <Is_a> "Antibody_medication" .
<Trastuzumab-anns> <Is_a> "Anti-HER2_antibody" .
<MP> <Maps_to> "MP" .
<IDH-mutated_Acute_myeloid_leukemia> <Accepted_use_of> "Ivosidenib_monotherapy" .
<IDH-mutated_Acute_myeloid_leukemia> <Accepted_use_of> "Enasidenib_monotherapy" .
<HyperCHidam> <Maps_to> "HyperCHidam" .
<Weiditrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Lutetium_Lu_177_dotatate_and_Octreotide_LAR> <Has_accepted_use> "Pancreatic_NET" .
<Lutetium_Lu_177_dotatate_and_Octreotide_LAR> <Has_accepted_use> "Neuroendocrine_tumor" .
<Anastrozole_and_Trastuzumab> <Has_antineoplastic> "Trastuzumab" .
<Anastrozole_and_Trastuzumab> <Has_antineoplastic> "Anastrozole" .
<EVAIA> <Has_modality> "Chemotherapy" .
<Epivir> <Brand_name_of> "Lamivudine" .
<Temozolomide_monotherapy> <Has_modality> "Chemotherapy" .
<Acisal> <Brand_name_of> "Aspirin" .
<Triptorelin_monotherapy> <Has_context> "Non-curative_therapy" .
<Isotrex> <Brand_name_of> "Isotretinoin" .
<Abemaciclib_and_Anastrozole> <Has_antineoplastic> "Anastrozole" .
<Abemaciclib_and_Anastrozole> <Has_antineoplastic> "Abemaciclib" .
<Bortezomib_and_Melphalan> <Is_current_in> "Autologous_HSCT" .
<Cyclophosphamide_and_Dexamethasone> <Has_accepted_use> "Multiple_myeloma" .
<Kabipem> <Brand_name_of> "Pemetrexed" .
<Lenalidomide,_Dexamethasone,_Rituximab> <Has_antineoplastic> "Rituximab" .
<Lenalidomide,_Dexamethasone,_Rituximab> <Has_antineoplastic> "Lenalidomide" .
<Lenalidomide,_Dexamethasone,_Rituximab> <Has_antineoplastic> "Dexamethasone" .
<Decacin> <Brand_name_of> "Dexamethasone" .
<Bevacizumab-containing_therapy> <Has_modality> "Chemotherapy" .
<Cotrimstada> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Brentuximab_vedotin_and_Dacarbazine> <Has_modality> "Chemotherapy" .
<Serotonin_5-HT3_antagonist> <Subsumes> "Tropisetron" .
<Serotonin_5-HT3_antagonist> <Subsumes> "Ramosetron" .
<Serotonin_5-HT3_antagonist> <Subsumes> "Palonosetron" .
<Serotonin_5-HT3_antagonist> <Subsumes> "Ondansetron" .
<Serotonin_5-HT3_antagonist> <Subsumes> "Netupitant_and_palonosetron" .
<Serotonin_5-HT3_antagonist> <Subsumes> "Granisetron" .
<Serotonin_5-HT3_antagonist> <Subsumes> "Dolasetron" .
<Daunorubicin_and_Prednisone> <Mapped_from> "Daunorubicin_and_Prednisone" .
<BCOP> <Has_antineoplastic> "Vincristine" .
<BCOP> <Has_antineoplastic> "Prednisone" .
<BCOP> <Has_antineoplastic> "Cyclophosphamide" .
<BCOP> <Has_antineoplastic> "Carmustine" .
<Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone> <Mapped_from> "Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone" .
<Non-curative_subsequent-line_therapy> <Subsumes> "Non-curative_subsequent-line_maintenance_therapy" .
<Non-curative_subsequent-line_therapy> <Subsumes> "Non-curative_subsequent-line_induction_therapy" .
<Non-curative_subsequent-line_therapy> <Subsumes> "Non-curative_subsequent-line_consolidation_therapy" .
<Carmustine_and_Doxorubicin> <Is_historical_in> "Multiple_myeloma" .
<Zeptra> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cisplatin_and_Docetaxel> <Has_antineoplastic> "Docetaxel" .
<Cisplatin_and_Docetaxel> <Has_antineoplastic> "Cisplatin" .
<Zoledronic_acid> <Supportive_med_of> "Zoledronic_acid_therapy" .
<Zoledronic_acid> <Supportive_med_of> "VD" .
<Zoledronic_acid> <Supportive_med_of> "VAD" .
<Zoledronic_acid> <Supportive_med_of> "Thalidomide_monotherapy" .
<Zoledronic_acid> <Supportive_med_of> "Rd" .
<Zoledronic_acid> <Supportive_med_of> "RD" .
<Zoledronic_acid> <Supportive_med_of> "PAD" .
<Zoledronic_acid> <Supportive_med_of> "MP_(Prednisolone)" .
<Zoledronic_acid> <Supportive_med_of> "CVAD" .
<Zoledronic_acid> <Supportive_med_of> "CTD" .
<Zoledronic_acid> <Supportive_med_of> "BBD" .
<maxi-R-CHOP/R-HiDAC> <Is_current_in> "Mantle_cell_lymphoma" .
<R-FND> <Mapped_from> "R-FND" .
<Tamoxifen_and_Prednisolone> <Is_current_in> "Breast_cancer" .
<Waldenstroem_macroglobulinemia> <Is_a> "Indolent_lymphoma" .
<Talimogene_laherparepvec> <Is_a> "Oncolytic_viral_therapy" .
<Eculizumab_monotherapy> <Has_context> "All_lines_of_therapy" .
<Bortezomib_and_Melphalan,_then_auto_HSCT> <Mapped_from> "Bortezomib_and_Melphalan,_then_auto_HSCT" .
<CHVP> <Has_context> "Non-curative_first-line_therapy" .
<Dexamethasone_monotherapy> <Has_modality> "Supportive_therapy" .
<Dexamethasone_monotherapy> <Has_modality> "Immunosuppressive_therapy" .
<Dexamethasone_monotherapy> <Has_modality> "Chemotherapy" .
<HOP> <Has_antineoplastic> "Vincristine" .
<HOP> <Has_antineoplastic> "Prednisone" .
<HOP> <Has_antineoplastic> "Doxorubicin" .
<Low-dose_TBI,_then_allo_HSCT> <Has_context> "Consolidation_after_upfront_therapy" .
<Landrolen> <Brand_name_of> "Alendronate" .
<Lenalidomide_monotherapy> <Mapped_from> "Lenalidomide_monotherapy" .
<Doxor> <Brand_name_of> "Doxorubicin" .
<ddFEC> <Mapped_from> "ddFEC" .
<Vincristine> <May_have_route> "Intravenous" .
<Ipilimumab,_then_Nivolumab> <Maps_to> "Ipilimumab,_then_Nivolumab" .
<Decitafect> <Brand_name_of> "Decitabine" .
<Amoxicillin> <Supportive_med_of> "TD" .
<Amoxicillin> <Supportive_med_of> "Rd" .
<Amoxicillin> <Supportive_med_of> "RVD" .
<Amoxicillin> <Supportive_med_of> "KRd" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Vincristine" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "VR" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Thioguanine_monotherapy" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Thioguanine" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Thalidomide_and_Rituximab" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Thalidomide" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Rituximab-pvvr" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Rituximab-abbs" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Rituximab_monotherapy" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Rituximab" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "RVR" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "R-CHOP" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Prednisone" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Pentostatin" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Panobinostat_monotherapy" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Panobinostat" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "PCR" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Ofatumumab_monotherapy" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Ofatumumab" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Lenalidomide_monotherapy" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Lenalidomide" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Idelalisib_monotherapy" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Idelalisib" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Ibrutinib_monotherapy" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Ibrutinib_and_Rituximab" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Ibrutinib" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Fludarabine_monotherapy" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Fludarabine" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "FR" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "FCR" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Everolimus_monotherapy" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Everolimus" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Doxorubicin" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Dexamethasone" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "DRC" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Cyclophosphamide" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Cladribine_and_Rituximab" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Cladribine" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Chlorambucil_monotherapy" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Chlorambucil" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Carfilzomib" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "CaRD" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Bortezomib_monotherapy" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Bortezomib" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Bendamustine" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "BR" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "BDR" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Alemtuzumab_monotherapy" .
<Waldenstroem_macroglobulinemia> <Accepted_use_of> "Alemtuzumab" .
<DeVIC_and_RT> <Maps_to> "DeVIC_and_RT" .
<Etoposide,_Ifosfamide,_Methotrexate> <Maps_to> "Etoposide,_Ifosfamide,_Methotrexate" .
<Tumor_treating_fields> <Maps_to> "Tumor_treating_fields" .
<Multiple_myeloma> <FDA_indication_of> "Thalidomide" .
<Multiple_myeloma> <FDA_indication_of> "Selinexor" .
<Multiple_myeloma> <FDA_indication_of> "Pomalidomide" .
<Multiple_myeloma> <FDA_indication_of> "Perifosine" .
<Multiple_myeloma> <FDA_indication_of> "Pegylated_liposomal_doxorubicin" .
<Multiple_myeloma> <FDA_indication_of> "Panobinostat" .
<Multiple_myeloma> <FDA_indication_of> "Melphalan" .
<Multiple_myeloma> <FDA_indication_of> "Lenalidomide" .
<Multiple_myeloma> <FDA_indication_of> "Ixazomib" .
<Multiple_myeloma> <FDA_indication_of> "Elotuzumab" .
<Multiple_myeloma> <FDA_indication_of> "Daratumumab" .
<Multiple_myeloma> <FDA_indication_of> "Cyclophosphamide" .
<Multiple_myeloma> <FDA_indication_of> "Carfilzomib" .
<Multiple_myeloma> <FDA_indication_of> "Bortezomib" .
<Nelarabine> <May_have_route> "Intravenous" .
<Cytarabine_and_Idarubicin> <Has_antineoplastic> "Idarubicin" .
<Cytarabine_and_Idarubicin> <Has_antineoplastic> "Cytarabine" .
<Dexametazona> <Brand_name_of> "Dexamethasone" .
<Daurismo> <Brand_name_of> "Glasdegib" .
<Bacidal> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<MVAC> <Has_modality> "Chemotherapy" .
<Cisplatin,_Docetaxel,_RT> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cisplatin,_Docetaxel,_RT> <Has_accepted_use> "Esophageal_cancer" .
<Alectinib_monotherapy> <Maps_to> "Alectinib_monotherapy" .
<Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA> <Has_context> "Consolidation_after_upfront_therapy" .
<Cisplatin,_Epirubicin,_Ifosfamide> <Has_modality> "Chemotherapy" .
<R-CEOP_(Etoposide)> <Mapped_from> "R-CEOP_(Etoposide)" .
<Everolimus_and_Octreotide> <Has_modality> "Hormonotherapy" .
<Everolimus_and_Octreotide> <Has_modality> "Chemotherapy" .
<CVPP> <Has_antineoplastic> "Vinblastine" .
<CVPP> <Has_antineoplastic> "Procarbazine" .
<CVPP> <Has_antineoplastic> "Prednisone" .
<CVPP> <Has_antineoplastic> "Lomustine" .
<Soluble_decoy_receptor> <Is_a> "Chemotherapeutic" .
<Lexxema> <Brand_name_of> "Methylprednisolone" .
<Carboplatin,_Olaparib,_Paclitaxel> <Has_accepted_use> "Ovarian_cancer" .
<Ossiten> <Brand_name_of> "Clodronate" .
<R-CHOP-14_(Prednisolone)> <Has_context> "Non-curative_first-line_therapy" .
<R-CHOP-14_(Prednisolone)> <Has_context> "Induction_therapy" .
<Myelofibrosis> <FDA_indication_of> "Ruxolitinib" .
<Myelofibrosis> <FDA_indication_of> "Fedratinib" .
<Diethylstilbestrol> <May_have_route> "Oral" .
<BACO> <Has_antineoplastic> "Vincristine" .
<BACO> <Has_antineoplastic> "Doxorubicin" .
<BACO> <Has_antineoplastic> "Cyclophosphamide" .
<BACO> <Has_antineoplastic> "Bleomycin" .
<Elo-PD> <Has_supportive_med> "Ranitidine" .
<Elo-PD> <Has_supportive_med> "Diphenhydramine" .
<Elo-PD> <Has_supportive_med> "Acetaminophen" .
<VR-CHOP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Cangrelor> <May_have_route> "Oral" .
<Aminopterin> <Is_a> "Investigational_drug" .
<Aminopterin> <Is_a> "Discontinued_drug" .
<Aminopterin> <Is_a> "Antimetabolite" .
<Aminopterin> <Is_a> "Antifolate" .
<Bleomycin> <Has_brand_name> "Bleowel" .
<Bleomycin> <Has_brand_name> "Bleopar" .
<Bleomycin> <Has_brand_name> "Bleocip" .
<Bleomycin> <Has_brand_name> "Bleocin" .
<Bleomycin> <Has_brand_name> "Bleo" .
<Bleomycin> <Has_brand_name> "Blenoxane" .
<Regorafenib_monotherapy> <Is_current_in> "Soft_tissue_sarcoma" .
<Regorafenib_monotherapy> <Is_current_in> "Renal_cell_carcinoma" .
<Regorafenib_monotherapy> <Is_current_in> "Leiomyosarcoma" .
<Regorafenib_monotherapy> <Is_current_in> "Hepatocellular_carcinoma" .
<Regorafenib_monotherapy> <Is_current_in> "Gastrointestinal_stromal_tumor" .
<Regorafenib_monotherapy> <Is_current_in> "Gastric_cancer" .
<Regorafenib_monotherapy> <Is_current_in> "Gallbladder_cancer" .
<Regorafenib_monotherapy> <Is_current_in> "Colon_cancer" .
<Regorafenib_monotherapy> <Is_current_in> "Cholangiocarcinoma" .
<CMFL> <Has_context> "Adjuvant_therapy" .
<Dexamethazone> <Brand_name_of> "Dexamethasone" .
<Chlorambucil_and_Prednisolone> <Has_context> "Non-curative_therapy" .
<Acetaminophen> <May_have_route> "Rectal" .
<Acetaminophen> <May_have_route> "Oral" .
<TEC_inhibitor> <Subsumes> "Ibrutinib" .
<Carmustine> <Has_brand_name> "Nitrumon" .
<Carmustine> <Has_brand_name> "Nitrourean" .
<Carmustine> <Has_brand_name> "Leucerom" .
<Carmustine> <Has_brand_name> "Carmubris" .
<Carmustine> <Has_brand_name> "BiCNU" .
<Carmustine> <Has_brand_name> "Becenun" .
<Isotretinoin_monotherapy> <Maps_to> "Isotretinoin_monotherapy" .
<TCHP_(Taxotere)> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<TCHP_(Taxotere)> <Has_accepted_use> "Breast_cancer" .
<R-MCP_(CCNU)> <Is_current_in> "CNS_lymphoma" .
<Bevacizumab_monotherapy> <Has_modality> "Chemotherapy" .
<Plicamycin_monotherapy> <Has_accepted_use> "Testicular_cancer" .
<Heparin_monotherapy> <Mapped_from> "Heparin_monotherapy" .
<Salvage_therapy> <Maps_to> "Salvage_therapy" .
<Bu/TT> <Has_modality> "Chemotherapy" .
<IT_Cytarabine,_Methotrexate,_Prednisone> <Maps_to> "IT_Cytarabine,_Methotrexate,_Prednisone" .
<Mitoxantrone_monotherapy> <Is_a> "Anthracycline-containing_regimen" .
<Cyclophosphamide,_Fludarabine,_Thiotepa> <Mapped_from> "Cyclophosphamide,_Fludarabine,_Thiotepa" .
<Gilteritinib_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<HiDAC_and_Midostaurin> <Maps_to> "HiDAC_and_Midostaurin" .
<DA_3_plus_10> <Has_modality> "Chemotherapy" .
<Polatuzumab_vedotin> <Has_brand_name> "Polivy" .
<Factor_IX_human> <Has_accepted_use> "Inherited_coagulopathy" .
<Hyper-CVAD_and_Dasatinib> <Has_local_therapy> "Methotrexate" .
<Hyper-CVAD_and_Dasatinib> <Has_local_therapy> "Cytarabine" .
<HAA> <Maps_to> "HAA" .
<Azacitidine_and_Lenalidomide> <Has_context> "Non-curative_first-line_therapy" .
<FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)> <Has_accepted_use> "Colon_cancer" .
<Endrox> <Brand_name_of> "Alendronate" .
<CIA> <Is_a> "Anthracycline-containing_regimen" .
<Patrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Lenalidomide_and_Rituximab> <Has_modality> "Chemotherapy" .
<PCDE> <Has_modality> "Chemotherapy" .
<Intravenous_immunoglobulin_(IVIG)> <Supportive_med_of> "Intravenous_immunoglobulin_monotherapy" .
<Intravenous_immunoglobulin_(IVIG)> <Supportive_med_of> "HLH-2004_regimen" .
<Farmiblastina> <Brand_name_of> "Doxorubicin" .
<Cisplatin_and_Vinorelbine> <Has_supportive_med> "Serotonin_5-HT3_antagonists" .
<Cisplatin_and_Vinorelbine> <Has_supportive_med> "Furosemide" .
<Fludarabine,_Melphalan,_Alemtuzumab> <Maps_to> "Fludarabine,_Melphalan,_Alemtuzumab" .
<Hemostasis_medication> <Subsumes> "Tranexamic_acid" .
<Hemostasis_medication> <Subsumes> "Prothrombin_Complex_Concentrate_human" .
<Hemostasis_medication> <Subsumes> "Protamine_sulfate" .
<Hemostasis_medication> <Subsumes> "Idarucizumab" .
<Hemostasis_medication> <Subsumes> "Factor_Xa_recombinant_inactivated-zhzo" .
<Hemostasis_medication> <Subsumes> "Factor_XIII_concentrate_human" .
<Hemostasis_medication> <Subsumes> "Factor_VIIa_recombinant" .
<Hemostasis_medication> <Subsumes> "Factor_VIII_recombinant" .
<Hemostasis_medication> <Subsumes> "Factor_VIII_human" .
<Hemostasis_medication> <Subsumes> "Factor_IX_human" .
<Hemostasis_medication> <Subsumes> "Desmopressin" .
<Hemostasis_medication> <Subsumes> "Aminocaproic_acid" .
<Bevacizumab-awwb> <Has_FDA_indication> "Renal_cell_carcinoma" .
<Bevacizumab-awwb> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Bevacizumab-awwb> <Has_FDA_indication> "Glioblastoma" .
<Bevacizumab-awwb> <Has_FDA_indication> "Cervical_cancer" .
<GIP> <Has_context> "Salvage_therapy" .
<GIP> <Has_context> "Non-curative_first-line_therapy" .
<Tibolene> <Brand_name_of> "Alendronate" .
<Lawarin> <Brand_name_of> "Warfarin" .
<Gastrointestinal_cancer> <Subsumes> "Pancreatic_cancer" .
<Gastrointestinal_cancer> <Subsumes> "Pancreatic_NET" .
<Gastrointestinal_cancer> <Subsumes> "Hepatobiliary_cancer" .
<Gastrointestinal_cancer> <Subsumes> "Gastrointestinal_stromal_tumor" .
<Gastrointestinal_cancer> <Subsumes> "Colorectal_cancer" .
<Gastrointestinal_cancer> <Subsumes> "Anal_cancer" .
<CVB> <Mapped_from> "CVB" .
<CALGB_10-002_regimen> <Has_local_therapy> "Methotrexate" .
<CALGB_10-002_regimen> <Has_local_therapy> "Hydrocortisone" .
<CALGB_10-002_regimen> <Has_local_therapy> "Cytarabine" .
<Gemcitabine_and_nab-Paclitaxel> <Has_modality> "Chemotherapy" .
<BVR> <Mapped_from> "BVR" .
<Bevacizumab-containing_regimen> <Subsumes> "mFOLFOX6_and_Bevacizumab_(L-Leucovorin)" .
<Bevacizumab-containing_regimen> <Subsumes> "mFOLFOX6_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "mDCF_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Vinorelbine_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Topotecan_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Temozolomide_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "SOX_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Pemetrexed_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Paclitaxel,_Topotecan,_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Paclitaxel_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Oxaliplatin_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Lomustine_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Letrozole_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Irinotecan_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "IRIS_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "IFL_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Gemcitabine_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "GEMOX-B" .
<Bevacizumab-containing_regimen> <Subsumes> "FULV_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "FOLFOX4_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)" .
<Bevacizumab-containing_regimen> <Subsumes> "FOLFIRI_and_Bevacizumab_(L-Leucovorin)" .
<Bevacizumab-containing_regimen> <Subsumes> "FOLFIRI_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "FEC_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "FAC_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Erlotinib_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "EC_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Doxorubicin_pegylated_liposomal_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Doxorubicin_non-pegylated_liposomal_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Doxorubicin_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Docetaxel_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Cisplatin,_Pemetrexed,_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Cisplatin,_Paclitaxel,_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Cisplatin,_Gemcitabine,_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Cisplatin,_Etoposide,_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Carboplatin,_Pemetrexed,_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Carboplatin,_Paclitaxel,_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Carboplatin,_Gemcitabine,_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Carboplatin,_Etoposide,_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Carboplatin_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Capecitabine,_Bevacizumab,_Trastuzumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Capecitabine_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "CapeOx_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "CAPIRI-Bev" .
<Bevacizumab-containing_regimen> <Subsumes> "Bevacizumab-containing_therapy" .
<Bevacizumab-containing_regimen> <Subsumes> "Bevacizumab_monotherapy" .
<Bevacizumab-containing_regimen> <Subsumes> "Bevacizumab_and_Rituximab" .
<Bevacizumab-containing_regimen> <Subsumes> "Bevacizumab_and_RT" .
<Bevacizumab-containing_regimen> <Subsumes> "Bevacizumab_and_Interferon_alfa-2a" .
<Bevacizumab-containing_regimen> <Subsumes> "Atezolizumab_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "Afatinib_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "AC_and_Bevacizumab" .
<Bevacizumab-containing_regimen> <Subsumes> "ABCP" .
<Bevacizumab-containing_regimen> <Subsumes> "ABC" .
<Pravastatin> <Antineoplastic_of> "IAP" .
<Daratumumab> <Has_FDA_indication> "Multiple_myeloma" .
<Pertuzumab_and_T-DM1> <Mapped_from> "Pertuzumab_and_T-DM1" .
<Biovelbin> <Brand_name_of> "Vinorelbine" .
<Neurokinin_1_(NK1)_antagonist> <Is_a> "Emesis_prevention" .
<Plastistil> <Brand_name_of> "Cisplatin" .
<Kalsiumfolinat> <Brand_name_of> "Folinic_acid" .
<Adnisolone> <Brand_name_of> "Prednisolone" .
<Belfactrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<ATG_(Horse),_Cyclosporine,_Eltrombopag> <Has_context> "Induction_therapy" .
<Anti-HER2_medication> <Subsumes> "Lapuleucel-T" .
<Anti-HER2_medication> <Subsumes> "ERBB2_inhibitor" .
<Anti-HER2_medication> <Subsumes> "Anti-HER2_antibody" .
<Thalidomide_and_Prednisolone> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Sonidegib> <May_have_route> "Oral" .
<Cyclophosphamide_and_Etoposide> <Has_supportive_med> "Mesna" .
<Carboplatin_and_RT> <Has_context> "Definitive_therapy" .
<Hemolytic_process> <Is_a> "Classical_hematologic_condition" .
<Cangib> <Brand_name_of> "Gefitinib" .
<Pinorubin> <Brand_name_of> "Pirarubicin" .
<CTCb> <Has_context> "All_lines_of_therapy" .
<Catumaxomab> <May_have_route> "Intracavitary" .
<F-MACHOP> <Has_modality> "Chemotherapy" .
<R-CVEP> <Has_modality> "Chemotherapy" .
<Hyper-CVAD/MA> <Has_local_therapy> "Methotrexate" .
<Hyper-CVAD/MA> <Has_local_therapy> "Cytarabine" .
<Vindesine_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<TCHP_(Taxotere)> <Has_context> "Neoadjuvant_therapy" .
<TCHP_(Taxotere)> <Has_context> "Adjuvant_therapy" .
<Sickle_cell_anemia> <Is_a> "Inherited_hemoglobinopathy" .
<Sickle_cell_anemia> <Is_a> "Hemolytic_process" .
<Cisplatin,_Gemcitabine,_Necitumumab> <Mapped_from> "Cisplatin,_Gemcitabine,_Necitumumab" .
<Ewing_sarcoma> <Accepted_use_of> "Vincristine" .
<Ewing_sarcoma> <Accepted_use_of> "VIDE" .
<Ewing_sarcoma> <Accepted_use_of> "VDC/IE" .
<Ewing_sarcoma> <Accepted_use_of> "VAdCA/IE" .
<Ewing_sarcoma> <Accepted_use_of> "VAdCA" .
<Ewing_sarcoma> <Accepted_use_of> "VAIA" .
<Ewing_sarcoma> <Accepted_use_of> "VAI" .
<Ewing_sarcoma> <Accepted_use_of> "VACA/IE" .
<Ewing_sarcoma> <Accepted_use_of> "VACA" .
<Ewing_sarcoma> <Accepted_use_of> "Topotecan" .
<Ewing_sarcoma> <Accepted_use_of> "Temozolomide" .
<Ewing_sarcoma> <Accepted_use_of> "TC,_then_IE,_VDoxoC,_VEC" .
<Ewing_sarcoma> <Accepted_use_of> "Melphalan" .
<Ewing_sarcoma> <Accepted_use_of> "Irinotecan_and_Temozolomide" .
<Ewing_sarcoma> <Accepted_use_of> "Irinotecan" .
<Ewing_sarcoma> <Accepted_use_of> "Ifosfamide" .
<Ewing_sarcoma> <Accepted_use_of> "IE" .
<Ewing_sarcoma> <Accepted_use_of> "ICE" .
<Ewing_sarcoma> <Accepted_use_of> "Gemcitabine" .
<Ewing_sarcoma> <Accepted_use_of> "Etoposide" .
<Ewing_sarcoma> <Accepted_use_of> "EVAIA" .
<Ewing_sarcoma> <Accepted_use_of> "Doxorubicin" .
<Ewing_sarcoma> <Accepted_use_of> "Docetaxel_and_Gemcitabine" .
<Ewing_sarcoma> <Accepted_use_of> "Docetaxel" .
<Ewing_sarcoma> <Accepted_use_of> "Dactinomycin" .
<Ewing_sarcoma> <Accepted_use_of> "Cyclophosphamide_and_Topotecan" .
<Ewing_sarcoma> <Accepted_use_of> "Cyclophosphamide" .
<Ewing_sarcoma> <Accepted_use_of> "Carboplatin" .
<Ewing_sarcoma> <Accepted_use_of> "Busulfan_and_Melphalan,_then_auto_HSCT" .
<Ewing_sarcoma> <Accepted_use_of> "Busulfan" .
<OEPA> <Is_current_in> "Hodgkin_lymphoma" .
<Luspatercept_monotherapy> <Is_current_in> "Myelodysplastic_syndrome" .
<Dara-KD> <Has_antineoplastic> "Dexamethasone" .
<Dara-KD> <Has_antineoplastic> "Daratumumab" .
<Dara-KD> <Has_antineoplastic> "Carfilzomib" .
<C-MOPP/ABV> <Is_current_in> "Hodgkin_lymphoma" .
<R-CODOX-M_(Doxil_substituted)> <Has_accepted_use> "Burkitt_lymphoma" .
<Bicalutamide_and_Goserelin> <Mapped_from> "Bicalutamide_and_Goserelin" .
<Busulfan_monotherapy> <Maps_to> "Busulfan_monotherapy" .
<Lorlatinib_monotherapy> <Has_context> "Non-curative_therapy" .
<Tranexamic_acid_monotherapy> <Has_accepted_use> "Hereditary_hemorrhagic_telangiectasia" .
<R-CVEP> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<R-MCP_(CCNU)> <Maps_to> "R-MCP_(CCNU)" .
<Prothrombin_Complex_Concentrate_human> <Has_brand_name> "Profilnine" .
<Prothrombin_Complex_Concentrate_human> <Has_brand_name> "Octaplex" .
<Prothrombin_Complex_Concentrate_human> <Has_brand_name> "Kcentra" .
<Prothrombin_Complex_Concentrate_human> <Has_brand_name> "Confidex" .
<Prothrombin_Complex_Concentrate_human> <Has_brand_name> "Beriplex" .
<Irinotecan_and_Temozolomide> <Is_current_in> "Ewing_sarcoma" .
<Adenocarcinoma_of_unknown_primary> <Current_treated_by> "PCE" .
<Adenocarcinoma_of_unknown_primary> <Current_treated_by> "Gemcitabine_and_Irinotecan" .
<Adenocarcinoma_of_unknown_primary> <Current_treated_by> "GCP" .
<Adenocarcinoma_of_unknown_primary> <Current_treated_by> "Erlotinib_and_Bevacizumab" .
<Adenocarcinoma_of_unknown_primary> <Current_treated_by> "Docetaxel_and_Gemcitabine" .
<Adenocarcinoma_of_unknown_primary> <Current_treated_by> "Cisplatin_monotherapy" .
<Adenocarcinoma_of_unknown_primary> <Current_treated_by> "Cisplatin_and_Irinotecan" .
<Adenocarcinoma_of_unknown_primary> <Current_treated_by> "Cisplatin_and_Gemcitabine" .
<Adenocarcinoma_of_unknown_primary> <Current_treated_by> "Cisplatin_and_Docetaxel" .
<Adenocarcinoma_of_unknown_primary> <Current_treated_by> "Carboplatin_and_Paclitaxel" .
<Adenocarcinoma_of_unknown_primary> <Current_treated_by> "Carboplatin_and_Docetaxel" .
<Adenocarcinoma_of_unknown_primary> <Current_treated_by> "BEP" .
<CEF/CMF> <Maps_to> "CEF/CMF" .
<Colsprin> <Brand_name_of> "Aspirin" .
<IROX> <Is_a> "Platinum_doublet" .
<IROX> <Is_a> "Irinotecan-containing_regimen" .
<Bu/TT,_then_auto_HSCT> <Is_current_in> "CNS_lymphoma" .
<Best_supportive_care> <Has_context> "Non-curative_therapy" .
<Best_supportive_care> <Has_context> "Non-curative_subsequent-line_therapy" .
<Best_supportive_care> <Has_context> "Non-curative_first-line_therapy" .
<Best_supportive_care> <Has_context> "Non-curative_first-line_induction_therapy" .
<Best_supportive_care> <Has_context> "Maintenance_after_upfront_therapy" .
<Best_supportive_care> <Has_context> "Adjuvant_therapy" .
<Dexacilin> <Brand_name_of> "Dexamethasone" .
<Erdheim-Chester_disease> <Accepted_use_of> "Vemurafenib_monotherapy" .
<Erdheim-Chester_disease> <Accepted_use_of> "Vemurafenib" .
<Erdheim-Chester_disease> <Accepted_use_of> "Sirolimus_and_Prednisone" .
<Erdheim-Chester_disease> <Accepted_use_of> "Sirolimus" .
<Erdheim-Chester_disease> <Accepted_use_of> "Prednisone" .
<Erdheim-Chester_disease> <Accepted_use_of> "Cobimetinib_monotherapy" .
<Streptozocin> <Has_brand_name> "Zanosar" .
<Soft_tissue_sarcoma> <Historic_treated_by> "Doxorubicin_and_Olaratumab" .
<VR> <Has_modality> "Chemotherapy" .
<Cisplatin,_Paclitaxel,_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<AVD> <Has_antineoplastic> "Vinblastine" .
<AVD> <Has_antineoplastic> "Doxorubicin" .
<AVD> <Has_antineoplastic> "Dacarbazine" .
<Mitotane_monotherapy> <Maps_to> "Mitotane_monotherapy" .
<Alendronhexal> <Brand_name_of> "Alendronate" .
<CALGB_10-002_regimen> <Has_supportive_med> "Mesna" .
<CALGB_10-002_regimen> <Has_supportive_med> "Folinic_acid" .
<CALGB_10-002_regimen> <Has_supportive_med> "Filgrastim" .
<Octrestatin> <Brand_name_of> "Octreotide" .
<Colchicine_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Mepredron> <Brand_name_of> "Methylprednisolone" .
<Apatinib> <Antineoplastic_of> "Apatinib_monotherapy" .
<Bleomycin_and_Vinblastine> <Is_historical_in> "Testicular_cancer" .
<Abetrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Delta-Cortisone> <Brand_name_of> "Prednisone" .
<Burkitt_lymphoma> <Is_a> "Non-Hodgkin_lymphoma" .
<Burkitt_lymphoma> <Is_a> "Aggressive_lymphoma" .
<VTD-PACE> <Mapped_from> "VTD-PACE" .
<Cortidex> <Brand_name_of> "Dexamethasone" .
<Chlorambucil_and_Prednisolone> <Maps_to> "Chlorambucil_and_Prednisolone" .
<DA_3_plus_10> <Mapped_from> "DA_3_plus_10" .
<Quimiofran> <Brand_name_of> "Ondansetron" .
<Blastic_plasmacytoid_dendritic_cell_neoplasm> <Current_treated_by> "Tagraxofusp_monotherapy" .
<Cytomid> <Brand_name_of> "Vincristine" .
<Cytomid> <Brand_name_of> "Flutamide" .
<Dexacort> <Brand_name_of> "Dexamethasone" .
<Suprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Plerixafor_monotherapy> <Has_accepted_use> "WHIM_syndrome" .
<Oophorectomy> <Has_modality> "Hormonotherapy" .
<Tafinlar> <Brand_name_of> "Dabrafenib" .
<R-MP> <Has_antineoplastic> "Rituximab" .
<R-MP> <Has_antineoplastic> "Procarbazine" .
<R-MP> <Has_antineoplastic> "Methotrexate" .
<FCR> <Has_modality> "Immunosuppressive_therapy" .
<FCR> <Has_modality> "Chemotherapy" .
<Acalabrutinib_monotherapy> <Has_modality> "Chemotherapy" .
<Head_and_neck_cancer> <Is_a> "Malignant_solid_neoplasm" .
<Fulvestrant_and_Palbociclib> <Has_context> "Non-curative_subsequent-line_therapy" .
<Cyclophosphamide,_Cytarabine,_Mercaptopurine,_Nelarabine,_Pegaspargase,_Vincristine> <Has_modality> "Chemotherapy" .
<Binimetinib> <Has_accepted_use> "Melanoma" .
<Triptorelin> <May_have_route> "Intramuscular" .
<Lymphoproliferative_disorder> <Is_a> "Malignant_hematologic_neoplasm" .
<BVR> <Has_accepted_use> "Follicular_lymphoma" .
<CHOP_Modified_(Prednisolone)> <Has_modality> "Chemotherapy" .
<EBVP> <Maps_to> "EBVP" .
<Mechlorethamine> <Has_brand_name> "Mustine" .
<Mechlorethamine> <Has_brand_name> "Mustargen" .
<Mechlorethamine> <Has_brand_name> "Chlormethine" .
<Trastuzumab> <Has_brand_name> "Hertraz" .
<Trastuzumab> <Has_brand_name> "Herclon" .
<Trastuzumab> <Has_brand_name> "Herceptin" .
<Trastuzumab> <Has_brand_name> "CANMab" .
<Trastuzumab> <Has_brand_name> "Biceltis" .
<Rd> <Has_context> "Non-curative_therapy" .
<Rd> <Has_context> "Non-curative_first-line_therapy" .
<Rd> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Rd> <Has_context> "All_lines_of_therapy" .
<Megestrol> <Is_a> "Endocrine_therapeutic" .
<Megestrol> <Is_a> "Appetite_stimulant" .
<DEP_and_RT> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Nonsteroidal_antiandrogens> <Antineoplastic_of> "Intermittent_ADT" .
<Calaspargase,_Daunorubicin,_Vincristine,_Prednisone> <Is_a> "Anthracycline-containing_regimen" .
<LVP_.22Sandwich.22> <Has_modality> "Radiotherapy" .
<LVP_.22Sandwich.22> <Has_modality> "Chemotherapy" .
<Belinostat> <Antineoplastic_of> "Belinostat_monotherapy" .
<Primadex> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Interferon_alfa_monotherapy> <Maps_to> "Interferon_alfa_monotherapy" .
<C-MOPP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Bleocin> <Brand_name_of> "Bleomycin" .
<Carboplatin,_Paclitaxel,_Bevacizumab> <Has_modality> "Chemotherapy" .
<Pazopanib_monotherapy> <Mapped_from> "Pazopanib_monotherapy" .
<Nintedanib_and_Pemetrexed> <Maps_to> "Nintedanib_and_Pemetrexed" .
<Cabazitaxel> <Supportive_med_of> "Carboplatin,_Docetaxel,_Prednisone" .
<Cabazitaxel> <Supportive_med_of> "Carboplatin_and_Docetaxel" .
<Catumaxomab> <Is_a> "T-cell_activator" .
<Catumaxomab> <Is_a> "Immunotherapeutic" .
<Catumaxomab> <Is_a> "EMA_approved_drug" .
<Catumaxomab> <Is_a> "Discontinued_drug" .
<Catumaxomab> <Is_a> "BiTE_antibody" .
<Catumaxomab> <Is_a> "Antibody_medication" .
<Catumaxomab> <Is_a> "Anti-EpCAM_antibody" .
<Catumaxomab> <Is_a> "Anti-CD3_antibody" .
<Calciumfolin> <Brand_name_of> "Folinic_acid" .
<Trastuzumab-dttb> <May_have_route> "Intravenous" .
<KMP> <Has_antineoplastic> "Prednisone" .
<KMP> <Has_antineoplastic> "Melphalan" .
<KMP> <Has_antineoplastic> "Carfilzomib" .
<VABE> <Has_antineoplastic> "Vincristine" .
<VABE> <Has_antineoplastic> "Prednisone" .
<VABE> <Has_antineoplastic> "Etoposide" .
<VABE> <Has_antineoplastic> "Doxorubicin" .
<VABE> <Has_antineoplastic> "Bleomycin" .
<Loverine> <Brand_name_of> "Dexamethasone" .
<Epirubicin_monotherapy> <Is_a> "Anthracycline-containing_regimen" .
<Cyclosporine_modified> <Is_a> "Cyclosporine" .
<Cyclosporine_modified> <Is_a> "Calcineurin_inhibitor" .
<Mercaptopurine_and_WBRT> <Has_context> "Local_therapy" .
<BASIC> <Has_antineoplastic> "Vincristine" .
<BASIC> <Has_antineoplastic> "Rituximab" .
<BASIC> <Has_antineoplastic> "Prednisone" .
<BASIC> <Has_antineoplastic> "Methotrexate" .
<BASIC> <Has_antineoplastic> "Cyclophosphamide" .
<mFOLFOX6_and_Cetuximab> <Has_modality> "Chemotherapy" .
<Dara-Rd> <Has_accepted_use> "Multiple_myeloma" .
<Doxo> <Brand_name_of> "Doxorubicin" .
<Cisplatin_and_S-1> <Is_current_in> "Gastric_cancer" .
<Radioiodine_ablation> <Has_context> "All_lines_of_therapy" .
<Melfalan> <Brand_name_of> "Melphalan" .
<Actinium_Ac_225_lintuzumab> <May_have_route> "Intravenous" .
<Uracil_mustard_monotherapy> <Has_antineoplastic> "Uracil_mustard" .
<Licyl> <Brand_name_of> "Aspirin" .
<Gupisone> <Brand_name_of> "Prednisolone" .
<Bortezomib_and_Cyclophosphamide> <Is_current_in> "Multiple_myeloma" .
<R-BEAM,_then_auto_HSCT> <Mapped_from> "R-BEAM,_then_auto_HSCT" .
<Fluorouracil_monotherapy> <Has_modality> "Chemotherapy" .
<Citabin> <Brand_name_of> "Capecitabine" .
<Pediatric-like_GRAALL_consolidation> <Has_antineoplastic> "Vincristine" .
<Pediatric-like_GRAALL_consolidation> <Has_antineoplastic> "Methotrexate" .
<Pediatric-like_GRAALL_consolidation> <Has_antineoplastic> "Mercaptopurine" .
<Pediatric-like_GRAALL_consolidation> <Has_antineoplastic> "Etoposide" .
<Pediatric-like_GRAALL_consolidation> <Has_antineoplastic> "Dexamethasone" .
<Pediatric-like_GRAALL_consolidation> <Has_antineoplastic> "Cytarabine" .
<Pediatric-like_GRAALL_consolidation> <Has_antineoplastic> "Cyclophosphamide" .
<Pediatric-like_GRAALL_consolidation> <Has_antineoplastic> "Asparaginase" .
<Carboplatin_monotherapy> <Has_modality> "Chemotherapy" .
<Zevin> <Brand_name_of> "Acyclovir" .
<Pharmacristine> <Brand_name_of> "Vincristine" .
<R-MegaCHOP-14> <Maps_to> "R-MegaCHOP-14" .
<EGFR-mutated_malignancy> <Accepted_use_of> "Erlotinib_monotherapy" .
<EGFR-mutated_malignancy> <Accepted_use_of> "Erlotinib" .
<R-CHOP-14> <Has_context> "Induction_therapy" .
<VDC/IE> <Has_antineoplastic> "Vincristine" .
<VDC/IE> <Has_antineoplastic> "Ifosfamide" .
<VDC/IE> <Has_antineoplastic> "Etoposide" .
<VDC/IE> <Has_antineoplastic> "Doxorubicin" .
<VDC/IE> <Has_antineoplastic> "Cyclophosphamide" .
<Fluorouracil,_Oxaliplatin,_RT> <Has_accepted_use> "Rectal_cancer" .
<Fluorouracil,_Oxaliplatin,_RT> <Has_accepted_use> "Esophageal_cancer" .
<Icotinib_monotherapy> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Icotinib_monotherapy> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<Icotinib_monotherapy> <Has_accepted_use> "CNS_carcinoma" .
<Interferon_alfa-2a_and_Isotretinoin> <Is_historical_in> "Renal_cell_carcinoma" .
<Folic_acid> <Is_a> "Chemotherapy_protective_agent" .
<mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)> <Has_antineoplastic> "Oxaliplatin" .
<mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)> <Has_antineoplastic> "Levoleucovorin" .
<mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)> <Has_antineoplastic> "Irinotecan" .
<mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)> <Has_antineoplastic> "Fluorouracil" .
<mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)> <Has_antineoplastic> "Cetuximab" .
<Mustine> <Brand_name_of> "Mechlorethamine" .
<Doxorubicin_non-pegylated_liposomal_monotherapy> <Has_modality> "Chemotherapy" .
<Active_surveillance> <Has_modality> "Null_therapy" .
<LEED,_then_auto_HSCT> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Fedolen> <Brand_name_of> "Folinic_acid" .
<Temozolomide,_then_Temozolomide_and_RT,_then_Temozolomide> <Has_antineoplastic> "Temozolomide" .
<Temozolomide,_then_Temozolomide_and_RT,_then_Temozolomide> <Has_antineoplastic> "External_beam_radiotherapy" .
<Cisplatin_and_Fluorouracil> <Mapped_from> "Cisplatin_and_Fluorouracil" .
<VAP> <Has_context> "Non-curative_therapy" .
<Nilotinib_monotherapy> <Has_antineoplastic> "Nilotinib" .
<S-1_monotherapy> <Has_modality> "Chemotherapy" .
<Ado-trastuzumab_emtansine_monotherapy> <Mapped_from> "Ado-trastuzumab_emtansine_monotherapy" .
<Promethazine> <May_have_route> "Rectal" .
<Promethazine> <May_have_route> "Oral" .
<Erdafitinib> <May_have_route> "Oral" .
<Observation> <Has_antineoplastic> "Bacillus_Calmette-Guerin" .
<RCC> <Has_context> "Non-curative_first-line_therapy" .
<Aspirin> <Supportive_med_of> "VTP" .
<Aspirin> <Supportive_med_of> "VTD" .
<Aspirin> <Supportive_med_of> "VT" .
<Aspirin> <Supportive_med_of> "VMP/Rd" .
<Aspirin> <Supportive_med_of> "VMP,_then_Rd" .
<Aspirin> <Supportive_med_of> "VDC" .
<Aspirin> <Supportive_med_of> "Thalidomide_monotherapy" .
<Aspirin> <Supportive_med_of> "TD" .
<Aspirin> <Supportive_med_of> "Rd" .
<Aspirin> <Supportive_med_of> "RVDC" .
<Aspirin> <Supportive_med_of> "RVD" .
<Aspirin> <Supportive_med_of> "RT-PEPC" .
<Aspirin> <Supportive_med_of> "RP" .
<Aspirin> <Supportive_med_of> "RICER" .
<Aspirin> <Supportive_med_of> "R2CHOP" .
<Aspirin> <Supportive_med_of> "Pomalidomide_monotherapy" .
<Aspirin> <Supportive_med_of> "Pomalidomide_and_Prednisone" .
<Aspirin> <Supportive_med_of> "Plasma_exchange" .
<Aspirin> <Supportive_med_of> "Peginterferon_alfa-2a_monotherapy" .
<Aspirin> <Supportive_med_of> "Pd" .
<Aspirin> <Supportive_med_of> "PVD" .
<Aspirin> <Supportive_med_of> "PD" .
<Aspirin> <Supportive_med_of> "PCP" .
<Aspirin> <Supportive_med_of> "PCD" .
<Aspirin> <Supportive_med_of> "PAD_doxil" .
<Aspirin> <Supportive_med_of> "MRD" .
<Aspirin> <Supportive_med_of> "MPT" .
<Aspirin> <Supportive_med_of> "MPR" .
<Aspirin> <Supportive_med_of> "MP" .
<Aspirin> <Supportive_med_of> "Lenalidomide_monotherapy" .
<Aspirin> <Supportive_med_of> "Lenalidomide_and_Rituximab" .
<Aspirin> <Supportive_med_of> "KRd" .
<Aspirin> <Supportive_med_of> "KPD" .
<Aspirin> <Supportive_med_of> "GDPT" .
<Aspirin> <Supportive_med_of> "Dexamethasone_monotherapy" .
<Aspirin> <Supportive_med_of> "Dacarbazine_monotherapy" .
<Aspirin> <Supportive_med_of> "CYKLONE" .
<Aspirin> <Supportive_med_of> "CTD" .
<Aspirin> <Supportive_med_of> "CRd" .
<Aspirin> <Supportive_med_of> "CRD" .
<Aspirin> <Supportive_med_of> "CPR" .
<Aspirin> <Supportive_med_of> "Bortezomib_monotherapy" .
<Aspirin> <Supportive_med_of> "BiRd" .
<Aspirin> <Supportive_med_of> "BLD" .
<Aspirin> <Supportive_med_of> "Aspirin_monotherapy" .
<Aspirin> <Supportive_med_of> "Aspirin_and_Warfarin" .
<Aspirin> <Supportive_med_of> "Aspirin_and_Hydroxyurea" .
<Aspirin> <Supportive_med_of> "Aspirin_and_Anagrelide" .
<Aspirin> <Supportive_med_of> "Anagrelide_monotherapy" .
<Augmented_Hyper-CVAD_and_Asparaginase> <Mapped_from> "Augmented_Hyper-CVAD_and_Asparaginase" .
<FOLFOX4_and_RT> <Has_antineoplastic> "Oxaliplatin" .
<FOLFOX4_and_RT> <Has_antineoplastic> "Folinic_acid" .
<FOLFOX4_and_RT> <Has_antineoplastic> "Fluorouracil" .
<FOLFOX4_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<ADT> <Has_antineoplastic> "GnRH_antagonists" .
<ADT> <Has_antineoplastic> "GnRH_agonists" .
<ADT> <Has_antineoplastic> "Flutamide" .
<ADT> <Has_antineoplastic> "Endocrine_ablation_surgery" .
<ADT> <Has_antineoplastic> "Bicalutamide" .
<Omacetaxine> <May_have_route> "Subcutaneous" .
<Omacetaxine> <May_have_route> "Intravenous" .
<Radotinib_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<PVAG> <Is_a> "Anthracycline-containing_regimen" .
<Bactrisan> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Imatinib_and_Prednisone> <Has_antineoplastic> "Prednisone" .
<Imatinib_and_Prednisone> <Has_antineoplastic> "Imatinib" .
<Temozolomide_and_Bevacizumab> <Has_context> "Non-curative_therapy" .
<Temozolomide_and_Bevacizumab> <Has_context> "All_lines_of_therapy" .
<Factor_VIIa_recombinant> <May_have_route> "Intravenous" .
<Hydroxyurea_monotherapy> <Is_current_in> "Sickle_cell_anemia" .
<Hydroxyurea_monotherapy> <Is_current_in> "Polycythemia_vera" .
<Hydroxyurea_monotherapy> <Is_current_in> "Myelofibrosis" .
<Hydroxyurea_monotherapy> <Is_current_in> "Hypereosinophilic_syndrome" .
<Hydroxyurea_monotherapy> <Is_current_in> "Glioblastoma" .
<Hydroxyurea_monotherapy> <Is_current_in> "Essential_thrombocythemia" .
<FR> <Has_modality> "Chemotherapy" .
<Iron_dextran> <Is_a> "Iron" .
<Iron_dextran> <Is_a> "Hematology_medication" .
<Carfilzomib_and_Panobinostat> <Maps_to> "Carfilzomib_and_Panobinostat" .
<CMFL> <Mapped_from> "CMFL" .
<Placis> <Brand_name_of> "Cisplatin" .
<Carboplatin,_nab-Paclitaxel,_Pembrolizumab> <Mapped_from> "Carboplatin,_nab-Paclitaxel,_Pembrolizumab" .
<Peginterferon_alfa-2a_monotherapy> <Has_antineoplastic> "Peginterferon_alfa-2a" .
<Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone> <Is_a> "Anthracycline-containing_regimen" .
<Saferon> <Brand_name_of> "Iron_dextran" .
<Gemcitabine/Fluorouracil_and_RT> <Has_antineoplastic> "Gemcitabine" .
<Gemcitabine/Fluorouracil_and_RT> <Has_antineoplastic> "Fluorouracil" .
<Gemcitabine/Fluorouracil_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Emicizumab_monotherapy> <Has_context> "All_lines_of_therapy" .
<VBMC> <Has_accepted_use> "Multiple_myeloma" .
<VAD_and_Cyclosporine> <Mapped_from> "VAD_and_Cyclosporine" .
<Intravenous_immunoglobulin_monotherapy> <Mapped_from> "Intravenous_immunoglobulin_monotherapy" .
<Carboplatin_and_Gemcitabine/Erlotinib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Carboplatin_and_Gemcitabine/Erlotinib> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<Cafenol> <Brand_name_of> "Aspirin" .
<CMFV> <Has_context> "Non-curative_therapy" .
<Cyclophosphamide_and_G-CSF> <Is_current_in> "Stem_cell_mobilization" .
<Sargramostim> <Has_accepted_use> "Neuroblastoma" .
<Paclitaxel_and_Bevacizumab> <Is_current_in> "Ovarian_cancer" .
<Paclitaxel_and_Bevacizumab> <Is_current_in> "Breast_cancer" .
<TCP> <Has_accepted_use> "Castleman_disease" .
<Non-curative_third-line_consolidation_therapy> <Mapped_from> "Non-curative_third-line_consolidation_therapy" .
<7_plus_3d_and_GO> <Has_context> "Induction_therapy" .
<Ribatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Tegafur_and_Uracil> <Has_context> "Adjuvant_therapy" .
<Zaltrap> <Brand_name_of> "Ziv-aflibercept" .
<ICL> <Is_a> "Anthracycline-containing_regimen" .
<Folinoral> <Brand_name_of> "Folinic_acid" .
<ATG_(Horse)_and_Cyclosporine> <Mapped_from> "ATG_(Horse)_and_Cyclosporine" .
<Topotecan_and_Bevacizumab> <Is_current_in> "Ovarian_cancer" .
<M-DEX> <Mapped_from> "M-DEX" .
<AspaMetDex> <Has_supportive_med> "Valacyclovir" .
<AspaMetDex> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<AspaMetDex> <Has_supportive_med> "Folinic_acid" .
<ADT_and_RT> <Mapped_from> "ADT_and_RT" .
<CODOX-M> <Mapped_from> "CODOX-M" .
<Ivosidenib> <Is_a> "Mutation-specific_medication" .
<Ivosidenib> <Is_a> "IDH1_inhibitor" .
<Bendamustine_and_Obinutuzumab> <Has_antineoplastic> "Obinutuzumab" .
<Bendamustine_and_Obinutuzumab> <Has_antineoplastic> "Bendamustine" .
<Axitinib> <May_have_route> "Oral" .
<Histrelin> <Has_FDA_indication> "Prostate_cancer" .
<BeRT> <Maps_to> "BeRT" .
<Methylprednisolone_monotherapy> <Has_immunosuppressor> "Methylprednisolone" .
<Medcotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Enasidenib_monotherapy> <Has_antineoplastic> "Enasidenib" .
<Rituximab_monotherapy> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<Rituximab_monotherapy> <Is_current_in> "Thrombotic_thrombocytopenic_purpura" .
<Rituximab_monotherapy> <Is_current_in> "Post-transplant_lymphoproliferative_disorder" .
<Rituximab_monotherapy> <Is_current_in> "Marginal_zone_lymphoma" .
<Rituximab_monotherapy> <Is_current_in> "Mantle_cell_lymphoma" .
<Rituximab_monotherapy> <Is_current_in> "Inherited_coagulopathy" .
<Rituximab_monotherapy> <Is_current_in> "Immune_thrombocytopenia" .
<Rituximab_monotherapy> <Is_current_in> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<Rituximab_monotherapy> <Is_current_in> "Hodgkin_lymphoma" .
<Rituximab_monotherapy> <Is_current_in> "Hairy_cell_leukemia" .
<Rituximab_monotherapy> <Is_current_in> "HIV-associated_lymphoma" .
<Rituximab_monotherapy> <Is_current_in> "Follicular_lymphoma" .
<Rituximab_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Rituximab_monotherapy> <Is_current_in> "Cold_agglutinin_disease" .
<Rituximab_monotherapy> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Rituximab_monotherapy> <Is_current_in> "Castleman_disease" .
<Rituximab_monotherapy> <Is_current_in> "CNS_lymphoma" .
<Rituximab_monotherapy> <Is_current_in> "Antiphospholipid_antibody_syndrome" .
<Rituximab_monotherapy> <Is_current_in> "Acquired_coagulopathy" .
<Radium-223_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<Panitumumab_monotherapy> <Mapped_from> "Panitumumab_monotherapy" .
<Flonorbin> <Brand_name_of> "Vinorelbine" .
<Vinblastine_monotherapy> <Maps_to> "Vinblastine_monotherapy" .
<Stanford_V> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Stanford_V> <Has_supportive_med> "Ranitidine" .
<Stanford_V> <Has_supportive_med> "Ketoconazole" .
<Stanford_V> <Has_supportive_med> "Fluconazole" .
<Stanford_V> <Has_supportive_med> "Filgrastim" .
<Stanford_V> <Has_supportive_med> "Acyclovir" .
<Ipilimumab_and_Nivolumab> <Is_current_in> "Small_cell_lung_cancer" .
<Ipilimumab_and_Nivolumab> <Is_current_in> "Renal_cell_carcinoma" .
<Ipilimumab_and_Nivolumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<Ipilimumab_and_Nivolumab> <Is_current_in> "Melanoma" .
<Ipilimumab_and_Nivolumab> <Is_current_in> "Colon_cancer" .
<Ipilimumab_and_Nivolumab> <Is_current_in> "CNS_melanoma" .
<Idelalisib_and_Rituximab> <Has_modality> "Chemotherapy" .
<Durvalumab_monotherapy> <Has_modality> "Immunotherapy" .
<Everolimus_and_Octreotide> <Has_accepted_use> "Pancreatic_NET" .
<Everolimus_and_Octreotide> <Has_accepted_use> "Neuroendocrine_tumor" .
<Aside> <Brand_name_of> "Etoposide" .
<Totect> <Brand_name_of> "Dexrazoxane" .
<IT_Cytarabine_and_Methotrexate> <Has_modality> "Chemotherapy" .
<Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab> <Is_current_in> "Breast_cancer" .
<FOLFIRI_(L-Leucovorin)> <Mapped_from> "FOLFIRI_(L-Leucovorin)" .
<Dacarbazine> <Has_brand_name> "Zydac" .
<Dacarbazine> <Has_brand_name> "Oncodac" .
<Dacarbazine> <Has_brand_name> "Decarb" .
<Dacarbazine> <Has_brand_name> "Dazine" .
<Dacarbazine> <Has_brand_name> "Darbazine" .
<Dacarbazine> <Has_brand_name> "Dacmed" .
<Dacarbazine> <Has_brand_name> "Dacin" .
<Dacarbazine> <Has_brand_name> "Dacarex" .
<Dacarbazine> <Has_brand_name> "Dacarba" .
<Dacarbazine> <Has_brand_name> "Cedcozine" .
<Dacarbazine> <Has_brand_name> "Bazipar" .
<TBI> <Has_context> "All_lines_of_therapy" .
<Tamibarotene> <May_have_route> "Oral" .
<R-DHAOx> <Has_antineoplastic> "Rituximab" .
<R-DHAOx> <Has_antineoplastic> "Oxaliplatin" .
<R-DHAOx> <Has_antineoplastic> "Dexamethasone" .
<R-DHAOx> <Has_antineoplastic> "Cytarabine" .
<Nasea> <Brand_name_of> "Ramosetron" .
<Cisplatin,_Dacarbazine,_Interferon_alfa-2b> <Has_context> "Non-curative_therapy" .
<Thalidomide_and_Prednisolone> <Has_accepted_use> "Multiple_myeloma" .
<Thimelon> <Brand_name_of> "Methylprednisolone" .
<Trisenox> <Brand_name_of> "Arsenic_trioxide" .
<Chronic_myelogenous_leukemia> <Is_a> "Myeloproliferative_neoplasm" .
<Chemotrin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Ifosfamide_and_Paclitaxel> <Is_current_in> "Testicular_cancer" .
<Ifosfamide_and_Paclitaxel> <Is_current_in> "Small_cell_lung_cancer" .
<Ifosfamide_and_Paclitaxel> <Is_current_in> "Endometrial_cancer" .
<Pheochromocytoma> <Accepted_use_of> "Vincristine" .
<Pheochromocytoma> <Accepted_use_of> "Dacarbazine" .
<Pheochromocytoma> <Accepted_use_of> "Cyclophosphamide,_Dacarbazine,_Vincristine" .
<Pheochromocytoma> <Accepted_use_of> "Cyclophosphamide" .
<Pheochromocytoma> <Accepted_use_of> "131I-Metaiodobenzylguanidine_(131I-MIBG)" .
<Capecitabine,_Docetaxel,_RT> <Is_current_in> "Esophageal_cancer" .
<Antileukotriene> <Subsumes> "Montelukast" .
<BLD> <Has_modality> "Chemotherapy" .
<Dantenk> <Brand_name_of> "Ondansetron" .
<Oprelvekin> <Is_a> "Megakaryocyte_growth_factor" .
<Oprelvekin> <Is_a> "Hematopoietic_growth_factor" .
<Non-curative_subsequent-line_maintenance_therapy> <Context_of> "VR" .
<Non-curative_subsequent-line_maintenance_therapy> <Context_of> "Rituximab_monotherapy" .
<Non-curative_subsequent-line_maintenance_therapy> <Context_of> "Obinutuzumab_monotherapy" .
<Non-curative_subsequent-line_maintenance_therapy> <Context_of> "Lenalidomide_monotherapy" .
<Non-curative_subsequent-line_maintenance_therapy> <Context_of> "Everolimus_monotherapy" .
<Non-curative_subsequent-line_maintenance_therapy> <Context_of> "Blinatumomab_monotherapy" .
<Tamoxifen_and_Prednisolone> <Has_modality> "Hormonotherapy" .
<R-BEAM> <Mapped_from> "R-BEAM" .
<Afatinib_and_Paclitaxel> <Mapped_from> "Afatinib_and_Paclitaxel" .
<VACA> <Mapped_from> "VACA" .
<Tagraxofusp_monotherapy> <Has_modality> "Chemotherapy" .
<Everolimus_and_Rituximab> <Has_antineoplastic> "Rituximab" .
<Everolimus_and_Rituximab> <Has_antineoplastic> "Everolimus" .
<Anagrelide_monotherapy> <Has_accepted_use> "Polycythemia_vera" .
<Anagrelide_monotherapy> <Has_accepted_use> "Essential_thrombocythemia" .
<Pacritinib> <Is_a> "Kinase_inhibitor" .
<Pacritinib> <Is_a> "JAK_inhibitor" .
<Pacritinib> <Is_a> "Investigational_drug" .
<Pacritinib> <Is_a> "FLT3_inhibitor" .
<Triptorelin_monotherapy> <Has_accepted_use> "Prostate_cancer" .
<BCOP> <Mapped_from> "BCOP" .
<PVAG> <Has_accepted_use> "Hodgkin_lymphoma" .
<CEV_(Cyclophosphamide/Etoposide)> <Has_accepted_use> "Small_cell_lung_cancer" .
<Prednisolone> <May_have_route> "Oral" .
<7_plus_3d_and_Midostaurin> <Has_modality> "Chemotherapy" .
<DA_3_plus_10> <Is_a> "Anthracycline-containing_regimen" .
<Tafil> <Brand_name_of> "Alprazolam" .
<Letocan> <Brand_name_of> "Caspofungin" .
<Trazimera> <Brand_name_of> "Trastuzumab-qyyp" .
<Bu/TT/Cy> <Has_antineoplastic> "Thiotepa" .
<Bu/TT/Cy> <Has_antineoplastic> "Cyclophosphamide" .
<Bu/TT/Cy> <Has_antineoplastic> "Busulfan" .
<Decarb> <Brand_name_of> "Dacarbazine" .
<Paclitaxel,_Pertuzumab,_Ado-trastuzumab_emtansine> <Has_modality> "Chemotherapy" .
<Etoposide,_Vinblastine,_Prednisone> <Has_context> "Induction_therapy" .
<Busulfan_and_Melphalan> <Maps_to> "Busulfan_and_Melphalan" .
<Pomalidomide,_Dexamethasone,_Pembrolizumab> <Mapped_from> "Pomalidomide,_Dexamethasone,_Pembrolizumab" .
<Imatinib> <Has_FDA_indication> "Systemic_mastocytosis" .
<Imatinib> <Has_FDA_indication> "Soft_tissue_sarcoma" .
<Imatinib> <Has_FDA_indication> "Myelodysplastic_syndrome" .
<Imatinib> <Has_FDA_indication> "Hypereosinophilic_syndrome" .
<Imatinib> <Has_FDA_indication> "Gastrointestinal_stromal_tumor" .
<Imatinib> <Has_FDA_indication> "Chronic_myelogenous_leukemia" .
<Imatinib> <Has_FDA_indication> "B-cell_acute_lymphoblastic_leukemia" .
<CHOP-AL> <Has_supportive_med> "Chlorpheniramine" .
<CHOP-AL> <Has_supportive_med> "Acetaminophen" .
<Goserelin_and_Tamoxifen> <Has_context> "Non-curative_first-line_therapy" .
<Goserelin_and_Tamoxifen> <Has_context> "Neoadjuvant_therapy" .
<Goserelin_and_Tamoxifen> <Has_context> "Adjuvant_therapy" .
<Carzonal> <Brand_name_of> "Fluorouracil" .
<PCR> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<PCR> <Has_supportive_med> "Ondansetron" .
<PCR> <Has_supportive_med> "Filgrastim" .
<PCR> <Has_supportive_med> "Diphenhydramine" .
<PCR> <Has_supportive_med> "Allopurinol" .
<PCR> <Has_supportive_med> "Acyclovir" .
<R-CHOP_(Prednisolone)> <Is_a> "Rituximab-containing_regimen" .
<R-CHOP_(Prednisolone)> <Is_a> "Anthracycline-containing_regimen" .
<HLH-2004_regimen> <Mapped_from> "HLH-2004_regimen" .
<FOLFOX4> <Is_current_in> "Hepatocellular_carcinoma" .
<FOLFOX4> <Is_current_in> "Esophageal_cancer" .
<FOLFOX4> <Is_current_in> "Colon_cancer" .
<Ibandronate> <Has_brand_name> "Femorel" .
<Ibandronate> <Has_brand_name> "Bonviva" .
<Ibandronate> <Has_brand_name> "Bondronat" .
<Ibandronate> <Has_brand_name> "Bondenza" .
<Ibandronate> <Has_brand_name> "Bandrone" .
<Ibandronate> <Has_brand_name> "Bandrobon" .
<Forodesine_monotherapy> <Has_context> "Non-curative_therapy" .
<ESHAP> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Tevanate> <Brand_name_of> "Alendronate" .
<Meticil> <Brand_name_of> "Methotrexate" .
<Mepolizumab> <Has_brand_name> "Nucala" .
<Mepolizumab> <Has_brand_name> "Bosatria" .
<EP> <Is_current_in> "Breast_cancer" .
<Melphalan_and_TBI,_then_auto_HSCT> <Has_antineoplastic> "Melphalan" .
<Melphalan_and_TBI,_then_auto_HSCT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Irinotecan_and_Mitomycin> <Is_current_in> "Esophageal_cancer" .
<Irinotecan> <Has_accepted_use> "Small_cell_lung_cancer" .
<Irinotecan> <Has_accepted_use> "Rhabdomyosarcoma" .
<Irinotecan> <Has_accepted_use> "Penile_cancer" .
<Irinotecan> <Has_accepted_use> "Pancreatic_cancer" .
<Irinotecan> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Irinotecan> <Has_accepted_use> "Neuroblastoma" .
<Irinotecan> <Has_accepted_use> "Glioblastoma" .
<Irinotecan> <Has_accepted_use> "Gastric_cancer" .
<Irinotecan> <Has_accepted_use> "Ewing_sarcoma" .
<Irinotecan> <Has_accepted_use> "Esophageal_cancer" .
<Irinotecan> <Has_accepted_use> "Colon_cancer" .
<Irinotecan> <Has_accepted_use> "Cervical_cancer" .
<Irinotecan> <Has_accepted_use> "Anaplastic_glioma" .
<Irinotecan> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<Non-curative_second-line_consolidation_therapy> <Maps_to> "Non-curative_second-line_consolidation_therapy" .
<TIP> <Has_accepted_use> "Testicular_cancer" .
<TIP> <Has_accepted_use> "Penile_cancer" .
<CapeOx_and_Panitumumab> <Maps_to> "CapeOx_and_Panitumumab" .
<Genitourinary_oncology_medication> <Is_a> "Site-specific_medication" .
<Methotrexate_and_Tacrolimus> <Has_immunosuppressor> "Tacrolimus" .
<Methotrexate_and_Tacrolimus> <Has_immunosuppressor> "Methotrexate" .
<Carboplatin,_nab-Paclitaxel,_Pembrolizumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<Ifosfamide_monotherapy> <Has_supportive_med> "Mesna" .
<Ifosfamide_monotherapy> <Has_supportive_med> "Filgrastim" .
<Ifosfamide_monotherapy> <Has_supportive_med> "Emesis_prevention" .
<CHVmP-VB> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<Sickle_cell_anemia> <Current_treated_by> "RBC_transfusions" .
<Sickle_cell_anemia> <Current_treated_by> "L-glutamine_monotherapy" .
<Sickle_cell_anemia> <Current_treated_by> "Hydroxyurea_monotherapy" .
<Sickle_cell_anemia> <Current_treated_by> "Crizanlizumab_monotherapy" .
<Carboplatin_and_Gemcitabine> <Mapped_from> "Carboplatin_and_Gemcitabine" .
<Cisplatine> <Brand_name_of> "Cisplatin" .
<FM> <Is_historical_in> "Follicular_lymphoma" .
<CIA> <Has_modality> "Chemotherapy" .
<R-MegaCHOP> <Mapped_from> "R-MegaCHOP" .
<PGC> <Has_antineoplastic> "Paclitaxel" .
<PGC> <Has_antineoplastic> "Gemcitabine" .
<PGC> <Has_antineoplastic> "Cisplatin" .
<R-BEAM> <Has_context> "All_lines_of_therapy" .
<Pemetra> <Brand_name_of> "Pemetrexed" .
<Capecitabine_and_Gemcitabine> <Maps_to> "Capecitabine_and_Gemcitabine" .
<BVP> <Has_antineoplastic> "Vinblastine" .
<BVP> <Has_antineoplastic> "Cisplatin" .
<BVP> <Has_antineoplastic> "Bleomycin" .
<Fludarabine_and_Prednisone> <Has_context> "Non-curative_therapy" .
<Fludarabine_and_Prednisone> <Has_context> "Non-curative_first-line_therapy" .
<R-CHOP_(Prednisolone)> <Mapped_from> "R-CHOP_(Prednisolone)" .
<CPX-351_monotherapy> <Has_modality> "Chemotherapy" .
<Irinotecan_liposomal_monotherapy> <Has_accepted_use> "Pancreatic_cancer" .
<Irinotecan_liposomal_monotherapy> <Has_accepted_use> "Gastric_cancer" .
<Irinotecan_liposomal_monotherapy> <Has_accepted_use> "Esophageal_cancer" .
<Tinzaparin> <May_have_route> "Subcutaneous" .
<Oophorectomy> <Has_context> "Adjuvant_therapy" .
<Capecitabine_monotherapy> <Has_modality> "Chemotherapy" .
<APO> <Is_a> "Anthracycline-containing_regimen" .
<Palbociclib> <Is_a> "Kinase_inhibitor" .
<Palbociclib> <Is_a> "FDA_approved_drug" .
<Palbociclib> <Is_a> "CDK_inhibitor" .
<APO_Sulfatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Lapatinib_and_Trastuzumab> <Mapped_from> "Lapatinib_and_Trastuzumab" .
<Unimedrol> <Brand_name_of> "Methylprednisolone" .
<Toremifene_monotherapy> <Has_accepted_use> "ER-positive_Breast_cancer" .
<Toremifene_monotherapy> <Has_accepted_use> "Breast_cancer" .
<Bacoprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Procarbazine_monotherapy> <Has_context> "Non-curative_therapy" .
<Procarbazine_monotherapy> <Has_context> "Consolidation_after_upfront_therapy" .
<ACT> <Mapped_from> "ACT" .
<Pentostatin> <Is_a> "Purine_analogue" .
<Pentostatin> <Is_a> "Neutral" .
<Pentostatin> <Is_a> "Antimetabolite" .
<Olaratumab> <Has_brand_name> "Lartruvo" .
<Augmented_Hyper-CVAD_and_Asparaginase> <Is_a> "Anthracycline-containing_regimen" .
<GELOX/RT> <Mapped_from> "GELOX/RT" .
<Mitotane_and_EDP> <Has_antineoplastic> "Mitotane" .
<Mitotane_and_EDP> <Has_antineoplastic> "Etoposide" .
<Mitotane_and_EDP> <Has_antineoplastic> "Doxorubicin" .
<Mitotane_and_EDP> <Has_antineoplastic> "Cisplatin" .
<CAF_and_MPA> <Has_context> "Non-curative_therapy" .
<Melanoma> <Subsumes> "NRAS-mutated_Melanoma" .
<Melanoma> <Subsumes> "KIT-mutated_Melanoma" .
<Melanoma> <Subsumes> "BRAF-mutated_Melanoma" .
<Cobact> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CO-Trimed> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<mLSG15> <Has_local_therapy> "Prednisone" .
<mLSG15> <Has_local_therapy> "Methotrexate" .
<mLSG15> <Has_local_therapy> "Cytarabine" .
<TSC1_inhibitor> <Is_a> "GTPase-activating_protein_inhibitor" .
<Meprolone_Unipak> <Brand_name_of> "Methylprednisolone" .
<VIP> <Has_modality> "Chemotherapy" .
<Doxorubicine> <Brand_name_of> "Doxorubicin" .
<Ifosfamide> <May_have_route> "Intravenous" .
<mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)> <Is_a> "Irinotecan-containing_regimen" .
<Everolimus> <May_have_route> "Oral" .
<Bosutinib_monotherapy> <Has_modality> "Chemotherapy" .
<131I-Metaiodobenzylguanidine_(131I-MIBG)> <Has_accepted_use> "Pheochromocytoma" .
<COP-Bleo> <Has_antineoplastic> "Vincristine" .
<COP-Bleo> <Has_antineoplastic> "Prednisone" .
<COP-Bleo> <Has_antineoplastic> "Cyclophosphamide" .
<COP-Bleo> <Has_antineoplastic> "Bleomycin" .
<Filgen> <Brand_name_of> "Filgrastim" .
<Aminopterin_monotherapy> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Pemetrexed_monotherapy> <Maps_to> "Pemetrexed_monotherapy" .
<Zirax> <Brand_name_of> "Acyclovir" .
<Madroxin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Folinic_acid> <Local_therapy_of> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Folinic_acid> <Local_therapy_of> "dmCODOX-M_-_Modified_Magrath" .
<Folinoxan> <Brand_name_of> "Folinic_acid" .
<Rolprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<OEPA> <Has_modality> "Chemotherapy" .
<AXL_inhibitor> <Is_a> "Kinase_inhibitor" .
<Deron_S> <Brand_name_of> "Dexamethasone" .
<TH_(Taxol)> <Maps_to> "TH_(Taxol)" .
<Non-melanoma_skin_cancer> <Is_a> "Skin_cancer" .
<Carboplatin,_Vinorelbine,_RT> <Has_modality> "Radiotherapy" .
<Carboplatin,_Vinorelbine,_RT> <Has_modality> "Chemotherapy" .
<PCR> <Has_accepted_use> "Waldenstroem_macroglobulinemia" .
<PCR> <Has_accepted_use> "Marginal_zone_lymphoma" .
<PCR> <Has_accepted_use> "Follicular_lymphoma" .
<PCR> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<ATG_(Horse),_Cyclosporine,_Sirolimus> <Has_supportive_med> "Valacyclovir" .
<ATG_(Horse),_Cyclosporine,_Sirolimus> <Has_supportive_med> "Prednisone" .
<ATG_(Horse),_Cyclosporine,_Sirolimus> <Has_supportive_med> "Pentamidine" .
<Anti-CD38_antibody> <Subsumes> "MOR202" .
<Anti-CD38_antibody> <Subsumes> "Isatuximab" .
<Anti-CD38_antibody> <Subsumes> "Daratumumab" .
<Amsidine> <Brand_name_of> "Amsacrine" .
<PAF> <Has_antineoplastic> "Melphalan" .
<PAF> <Has_antineoplastic> "Fluorouracil" .
<PAF> <Has_antineoplastic> "Doxorubicin" .
<Fotemustine_monotherapy> <Mapped_from> "Fotemustine_monotherapy" .
<Omeprazole> <Is_a> "Proton_pump_inhibitor" .
<Omeprazole> <Is_a> "OTC_medication" .
<Anti-CD194_antibody> <Is_a> "Antibody_medication" .
<CAMF> <Has_accepted_use> "Breast_cancer" .
<Bexarotene_and_Pralatrexate> <Has_accepted_use> "Cutaneous_T-cell_lymphoma" .
<Capecitabine,_Oxaliplatin,_RT> <Maps_to> "Capecitabine,_Oxaliplatin,_RT" .
<Anastrozole_and_Goserelin> <Is_a> "Antiestrogen-containing_regimen" .
<Doxorubicin_pegylated_liposomal_and_Gemcitabine> <Has_modality> "Chemotherapy" .
<FAS> <Has_modality> "Chemotherapy" .
<Orthonate> <Brand_name_of> "Alendronate" .
<Chlorambucil_and_Prednisone> <Has_modality> "Chemotherapy" .
<HDAC_inhibitor> <Subsumes> "Vorinostat" .
<HDAC_inhibitor> <Subsumes> "Valproate" .
<HDAC_inhibitor> <Subsumes> "Romidepsin" .
<HDAC_inhibitor> <Subsumes> "Ricolinostat" .
<HDAC_inhibitor> <Subsumes> "Quisinostat" .
<HDAC_inhibitor> <Subsumes> "Pracinostat" .
<HDAC_inhibitor> <Subsumes> "Panobinostat" .
<HDAC_inhibitor> <Subsumes> "Mocetinostat" .
<HDAC_inhibitor> <Subsumes> "Entinostat" .
<HDAC_inhibitor> <Subsumes> "Chidamide" .
<HDAC_inhibitor> <Subsumes> "Belinostat" .
<HDAC_inhibitor> <Subsumes> "Abexinostat" .
<Polycythemia_vera> <Is_a> "Myeloproliferative_neoplasm" .
<Doxorubicin_non-pegylated_liposomal_and_Bevacizumab> <Has_antineoplastic> "Non-pegylated_liposomal_doxorubicin" .
<Doxorubicin_non-pegylated_liposomal_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<VABE> <Has_context> "Induction_therapy" .
<Lorlatinib_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Mepolizumab_monotherapy> <Is_current_in> "Hypereosinophilic_syndrome" .
<Asovorin> <Brand_name_of> "Folinic_acid" .
<Docetaxel_and_Estramustine> <Has_antineoplastic> "Estramustine" .
<Docetaxel_and_Estramustine> <Has_antineoplastic> "Docetaxel" .
<Bioprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Crizotinib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Erdheim-Chester_disease> <Is_a> "Histiocytosis" .
<Nilotinib-based_consolidation> <Mapped_from> "Nilotinib-based_consolidation" .
<Busulfan_and_Melphalan,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<FOLFIRI_and_Cetuximab_(L-Leucovorin)> <Has_antineoplastic> "Levoleucovorin" .
<FOLFIRI_and_Cetuximab_(L-Leucovorin)> <Has_antineoplastic> "Irinotecan" .
<FOLFIRI_and_Cetuximab_(L-Leucovorin)> <Has_antineoplastic> "Fluorouracil" .
<FOLFIRI_and_Cetuximab_(L-Leucovorin)> <Has_antineoplastic> "Cetuximab" .
<Alendronate> <Is_a> "Bisphosphonate" .
<(90)YFC,_then_allo_HSCT> <Is_current_in> "Follicular_lymphoma" .
<Graniz> <Brand_name_of> "Granisetron" .
<R-CHOP_(Rituximab_Hycela)> <Is_a> "Rituximab-containing_regimen" .
<R-CHOP_(Rituximab_Hycela)> <Is_a> "Anthracycline-containing_regimen" .
<DTPACE> <Has_antineoplastic> "Thalidomide" .
<DTPACE> <Has_antineoplastic> "Etoposide" .
<DTPACE> <Has_antineoplastic> "Doxorubicin" .
<DTPACE> <Has_antineoplastic> "Dexamethasone" .
<DTPACE> <Has_antineoplastic> "Cyclophosphamide" .
<DTPACE> <Has_antineoplastic> "Cisplatin" .
<VAC> <Has_accepted_use> "Rhabdomyosarcoma" .
<Daunorubicin_liposomal_monotherapy> <Has_accepted_use> "Kaposi_sarcoma" .
<Heberon_Alfa_R> <Brand_name_of> "Interferon_alfa-2b" .
<VMP> <Mapped_from> "VMP" .
<Panobinostat> <Antineoplastic_of> "Panobinostat_monotherapy" .
<Panobinostat> <Antineoplastic_of> "Panobinostat_and_Rituximab" .
<Panobinostat> <Antineoplastic_of> "FRD" .
<Panobinostat> <Antineoplastic_of> "Carfilzomib_and_Panobinostat" .
<Panobinostat> <Antineoplastic_of> "Bortezomib,_Thalidomide,_Dexamethasone,_Panobinostat" .
<Panobinostat> <Antineoplastic_of> "Bortezomib,_Dexamethasone,_Panobinostat" .
<Panobinostat> <Antineoplastic_of> "Bortezomib_and_Panobinostat" .
<Panobinostat> <Antineoplastic_of> "7_plus_3i_and_Panobinostat" .
<R-CP> <Is_current_in> "Post-transplant_lymphoproliferative_disorder" .
<Carboplatin_and_Vinorelbine> <Maps_to> "Carboplatin_and_Vinorelbine" .
<Irinotecan_liposome> <Is_a> "Topoisomerase_inhibitor" .
<Irinotecan_liposome> <Is_a> "Liposomal_chemotherapy" .
<Z-BEAM> <Mapped_from> "Z-BEAM" .
<Amsacrine> <Antineoplastic_of> "Amsacrine_and_Cytarabine" .
<PCDE> <Has_context> "Induction_therapy" .
<Stroka> <Brand_name_of> "Clopidogrel" .
<Cemiplimab_monotherapy> <Has_accepted_use> "Cutaneous_squamous_cell_carcinoma" .
<Pancreatic_cancer> <Accepted_use_of> "nab-Paclitaxel_monotherapy" .
<Pancreatic_cancer> <Accepted_use_of> "mFOLFIRINOX,_Gemcitabine,_RT" .
<Pancreatic_cancer> <Accepted_use_of> "mFOLFIRINOX" .
<Pancreatic_cancer> <Accepted_use_of> "Tegafur_gimeracil_oteracil" .
<Pancreatic_cancer> <Accepted_use_of> "S-1_monotherapy" .
<Pancreatic_cancer> <Accepted_use_of> "Radiation_therapy" .
<Pancreatic_cancer> <Accepted_use_of> "Placebo" .
<Pancreatic_cancer> <Accepted_use_of> "Paclitaxel_nanoparticle_albumin-bound" .
<Pancreatic_cancer> <Accepted_use_of> "PEFG" .
<Pancreatic_cancer> <Accepted_use_of> "Oxaliplatin" .
<Pancreatic_cancer> <Accepted_use_of> "Olaparib_monotherapy" .
<Pancreatic_cancer> <Accepted_use_of> "Olaparib" .
<Pancreatic_cancer> <Accepted_use_of> "Observation" .
<Pancreatic_cancer> <Accepted_use_of> "OLF" .
<Pancreatic_cancer> <Accepted_use_of> "Masitinib" .
<Pancreatic_cancer> <Accepted_use_of> "Levoleucovorin" .
<Pancreatic_cancer> <Accepted_use_of> "Irinotecan_liposome" .
<Pancreatic_cancer> <Accepted_use_of> "Irinotecan_liposomal_monotherapy" .
<Pancreatic_cancer> <Accepted_use_of> "Irinotecan" .
<Pancreatic_cancer> <Accepted_use_of> "Gemcitabine/Fluorouracil_and_RT" .
<Pancreatic_cancer> <Accepted_use_of> "Gemcitabine,_Cetuximab,_RT" .
<Pancreatic_cancer> <Accepted_use_of> "Gemcitabine_monotherapy" .
<Pancreatic_cancer> <Accepted_use_of> "Gemcitabine_and_nab-Paclitaxel" .
<Pancreatic_cancer> <Accepted_use_of> "Gemcitabine_and_RT" .
<Pancreatic_cancer> <Accepted_use_of> "Gemcitabine" .
<Pancreatic_cancer> <Accepted_use_of> "GemOx" .
<Pancreatic_cancer> <Accepted_use_of> "GTX" .
<Pancreatic_cancer> <Accepted_use_of> "Folinic_acid" .
<Pancreatic_cancer> <Accepted_use_of> "Fluorouracil/Fluorouracil_and_RT" .
<Pancreatic_cancer> <Accepted_use_of> "Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan" .
<Pancreatic_cancer> <Accepted_use_of> "Fluorouracil_monotherapy" .
<Pancreatic_cancer> <Accepted_use_of> "Fluorouracil_and_RT" .
<Pancreatic_cancer> <Accepted_use_of> "Fluorouracil_and_Folinic_acid" .
<Pancreatic_cancer> <Accepted_use_of> "Fluorouracil" .
<Pancreatic_cancer> <Accepted_use_of> "FOLFOX" .
<Pancreatic_cancer> <Accepted_use_of> "FOLFIRINOX/modified_FOLFIRINOX_plus_/-_Chemoradiation" .
<Pancreatic_cancer> <Accepted_use_of> "FOLFIRINOX" .
<Pancreatic_cancer> <Accepted_use_of> "FOLFIRI" .
<Pancreatic_cancer> <Accepted_use_of> "FLEC" .
<Pancreatic_cancer> <Accepted_use_of> "Erlotinib_and_Gemcitabine" .
<Pancreatic_cancer> <Accepted_use_of> "Erlotinib" .
<Pancreatic_cancer> <Accepted_use_of> "Epirubicin" .
<Pancreatic_cancer> <Accepted_use_of> "Docetaxel,_Gemcitabine,_RT" .
<Pancreatic_cancer> <Accepted_use_of> "Docetaxel" .
<Pancreatic_cancer> <Accepted_use_of> "Cisplatin_and_Gemcitabine" .
<Pancreatic_cancer> <Accepted_use_of> "Cisplatin" .
<Pancreatic_cancer> <Accepted_use_of> "Cetuximab" .
<Pancreatic_cancer> <Accepted_use_of> "Carboplatin" .
<Pancreatic_cancer> <Accepted_use_of> "Capecitabine_monotherapy" .
<Pancreatic_cancer> <Accepted_use_of> "Capecitabine_and_Gemcitabine" .
<Pancreatic_cancer> <Accepted_use_of> "Capecitabine_and_Erlotinib" .
<Pancreatic_cancer> <Accepted_use_of> "Capecitabine" .
<Pancreatic_cancer> <Accepted_use_of> "CapeOx" .
<Pancreatic_cancer> <Accepted_use_of> "Best_supportive_care" .
<Capecitabine_and_RT> <Has_modality> "Radiotherapy" .
<Capecitabine_and_RT> <Has_modality> "Chemotherapy" .
<Accelerated_BEP> <Maps_to> "Accelerated_BEP" .
<Siltuximab_monotherapy> <Has_context> "All_lines_of_therapy" .
<Fareston> <Brand_name_of> "Toremifene" .
<Lonsurf> <Brand_name_of> "Trifluridine_and_tipiracil" .
<Treosulfan> <Has_accepted_use> "Ovarian_cancer" .
<Neocarbo> <Brand_name_of> "Carboplatin" .
<Gemcitabine_and_Rituximab> <Mapped_from> "Gemcitabine_and_Rituximab" .
<Octreotide_and_Prednisone> <Is_current_in> "Thymoma" .
<VAI> <Is_current_in> "Rhabdomyosarcoma" .
<VAI> <Is_current_in> "Ewing_sarcoma" .
<Docetaxel,_Gemcitabine,_RT> <Has_modality> "Radiotherapy" .
<Docetaxel,_Gemcitabine,_RT> <Has_modality> "Chemotherapy" .
<Montelukast> <May_have_route> "Oral" .
<Axicabtagene_ciloleucel_monotherapy> <Has_modality> "Immunotherapy" .
<Brachytherapy> <Antineoplastic_of> "Radioembolization" .
<Brachytherapy> <Antineoplastic_of> "Radiation_therapy" .
<Brachytherapy> <Antineoplastic_of> "Hydroxyurea_and_RT" .
<Brachytherapy> <Antineoplastic_of> "Fluorouracil_and_RT" .
<Brachytherapy> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_Hydroxyurea,_RT" .
<Brachytherapy> <Antineoplastic_of> "Cisplatin_and_RT" .
<Luprodex_Depot> <Brand_name_of> "Leuprolide" .
<Thalidomide_monotherapy> <Has_antineoplastic> "Thalidomide" .
<CMFV> <Has_accepted_use> "Breast_cancer" .
<Ondansetron-Z> <Brand_name_of> "Ondansetron" .
<Justeprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<ICE> <Has_context> "Non-curative_therapy" .
<ICE> <Has_context> "Non-curative_subsequent-line_therapy" .
<ICE> <Has_context> "Induction_therapy" .
<Cisplatin_and_Doxorubicin> <Has_modality> "Chemotherapy" .
<Sancuso> <Brand_name_of> "Granisetron" .
<Aurora_kinase_inhibitor> <Subsumes> "Barasertib" .
<Aurora_kinase_inhibitor> <Subsumes> "Alisertib" .
<Plerixafor_and_G-CSF> <Has_context> "All_lines_of_therapy" .
<LEED,_then_auto_HSCT> <Maps_to> "LEED,_then_auto_HSCT" .
<Caprin> <Brand_name_of> "Aspirin" .
<Dexamethasone_and_WBRT> <Has_accepted_use> "CNS_carcinoma" .
<SCAB> <Has_accepted_use> "Hodgkin_lymphoma" .
<Z-BEAM> <Is_current_in> "Autologous_HSCT" .
<Dabigatran_monotherapy> <Has_supportive_med> "Dabigatran" .
<R-IFE> <Has_modality> "Chemotherapy" .
<O-ICE> <Maps_to> "O-ICE" .
<Glocet> <Brand_name_of> "Cetirizine" .
<Capecitabine,_Sorafenib,_RT> <Has_accepted_use> "Rectal_cancer" .
<Vosaroxin_and_Cytarabine> <Has_context> "Salvage_therapy" .
<FEC> <Has_modality> "Chemotherapy" .
<Gemcitabine_and_Bevacizumab> <Is_a> "Bevacizumab-containing_regimen" .
<Cisplatin,_Vinorelbine,_RT> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cisplatin,_Vinorelbine,_RT> <Has_accepted_use> "Esophageal_cancer" .
<VAD_doxil> <Maps_to> "VAD_doxil" .
<Cyclophosphamide_and_TBI,_then_allo_HSCT> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Cyclophosphamide_and_TBI,_then_allo_HSCT> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Cyclophosphamide_and_TBI,_then_allo_HSCT> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Cyclophosphamide_and_TBI,_then_allo_HSCT> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone> <Mapped_from> "Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone" .
<Cisplatin,_Etoposide,_Bevacizumab> <Has_accepted_use> "Small_cell_lung_cancer" .
<Immunotoxin> <Is_a> "Chemotherapeutic" .
<Clofarabine_and_Melphalan> <Has_modality> "Chemotherapy" .
<VeIP> <Has_accepted_use> "Testicular_cancer" .
<Nolvadex> <Brand_name_of> "Tamoxifen" .
<Cetuximab> <Antineoplastic_of> "mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)" .
<Cetuximab> <Antineoplastic_of> "mFOLFOX6_and_Cetuximab" .
<Cetuximab> <Antineoplastic_of> "Irinotecan,_Vemurafenib,_Cetuximab" .
<Cetuximab> <Antineoplastic_of> "Irinotecan_and_Cetuximab" .
<Cetuximab> <Antineoplastic_of> "Gemcitabine,_Cetuximab,_RT" .
<Cetuximab> <Antineoplastic_of> "FOLFOX4_and_Cetuximab" .
<Cetuximab> <Antineoplastic_of> "FOLFIRI_and_Cetuximab_(L-Leucovorin)" .
<Cetuximab> <Antineoplastic_of> "FOLFIRI_and_Cetuximab" .
<Cetuximab> <Antineoplastic_of> "Docetaxel,_Cetuximab,_RT" .
<Cetuximab> <Antineoplastic_of> "Cisplatin,_Vinorelbine,_Cetuximab" .
<Cetuximab> <Antineoplastic_of> "Cisplatin,_Fluorouracil,_Cetuximab" .
<Cetuximab> <Antineoplastic_of> "Cisplatin,_Cetuximab,_RT" .
<Cetuximab> <Antineoplastic_of> "Cisplatin_and_Cetuximab" .
<Cetuximab> <Antineoplastic_of> "Cetuximab_monotherapy" .
<Cetuximab> <Antineoplastic_of> "Cetuximab_and_RT" .
<Cetuximab> <Antineoplastic_of> "Carboplatin,_Fluorouracil,_Cetuximab,_RT" .
<Cetuximab> <Antineoplastic_of> "Carboplatin,_Fluorouracil,_Cetuximab" .
<Cetuximab> <Antineoplastic_of> "CapeOx,_Cetuximab,_RT" .
<Cetuximab> <Antineoplastic_of> "CX-C" .
<Cetuximab> <Antineoplastic_of> "Binimetinib,_Encorafenib,_Cetuximab" .
<Cetuximab> <Antineoplastic_of> "Afatinib_and_Cetuximab" .
<Tamoxifen_and_Prednisolone> <Has_antineoplastic> "Tamoxifen" .
<Tamoxifen_and_Prednisolone> <Has_antineoplastic> "Prednisolone" .
<Carboplatin_and_Bevacizumab> <Has_context> "Salvage_therapy" .
<Carboplatin_and_Bevacizumab> <Has_context> "Non-curative_therapy" .
<Pidilizumab> <Is_a> "T-cell_activator" .
<Pidilizumab> <Is_a> "Investigational_drug" .
<Pidilizumab> <Is_a> "Immunotherapeutic" .
<Pidilizumab> <Is_a> "Antibody_medication" .
<Pidilizumab> <Is_a> "Anti-PD-1_antibody" .
<Interferon_alfa-2b> <Is_a> "Interferon" .
<Interferon_alfa-2b> <Is_a> "Immunotherapeutic" .
<Neoplatin> <Brand_name_of> "Cisplatin" .
<Lapatinib_and_Letrozole> <Mapped_from> "Lapatinib_and_Letrozole" .
<Cisplatin,_Paclitaxel,_Bevacizumab> <Maps_to> "Cisplatin,_Paclitaxel,_Bevacizumab" .
<DCTER> <Mapped_from> "DCTER" .
<Siklofos> <Brand_name_of> "Cyclophosphamide" .
<Low-dose_TBI,_then_allo_HSCT> <Has_modality> "Radiotherapy" .
<Low-dose_TBI,_then_allo_HSCT> <Has_modality> "Immunotherapy" .
<Cladribine_monotherapy> <Maps_to> "Cladribine_monotherapy" .
<MCP_(Prednisolone)> <Mapped_from> "MCP_(Prednisolone)" .
<Cutaneous_basal_cell_carcinoma> <Accepted_use_of> "Vismodegib_monotherapy" .
<Cutaneous_basal_cell_carcinoma> <Accepted_use_of> "Vismodegib" .
<Cutaneous_basal_cell_carcinoma> <Accepted_use_of> "Sonidegib_monotherapy" .
<Cutaneous_basal_cell_carcinoma> <Accepted_use_of> "Sonidegib" .
<Cutaneous_basal_cell_carcinoma> <Accepted_use_of> "Paclitaxel" .
<Cutaneous_basal_cell_carcinoma> <Accepted_use_of> "Doxorubicin" .
<Cutaneous_basal_cell_carcinoma> <Accepted_use_of> "Cisplatin_and_Paclitaxel" .
<Cutaneous_basal_cell_carcinoma> <Accepted_use_of> "Cisplatin_and_Doxorubicin" .
<Cutaneous_basal_cell_carcinoma> <Accepted_use_of> "Cisplatin" .
<Cutaneous_basal_cell_carcinoma> <Accepted_use_of> "Bleomycin_and_Cisplatin" .
<Cutaneous_basal_cell_carcinoma> <Accepted_use_of> "Bleomycin" .
<DD-CHOP> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<Gemcitabine,_Oxaliplatin,_Paclitaxel> <Maps_to> "Gemcitabine,_Oxaliplatin,_Paclitaxel" .
<CHOP-14> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<CHOP-14> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<CYKLONE> <Is_current_in> "Multiple_myeloma" .
<Emicizumab_monotherapy> <Has_accepted_use> "Inherited_coagulopathy" .
<Eldisin> <Brand_name_of> "Vindesine" .
<RVDC> <Mapped_from> "RVDC" .
<Sapacitabine> <Is_a> "Pyrimidine_analogue" .
<Sapacitabine> <Is_a> "Investigational_drug" .
<Oxaliplatin_and_RT> <Has_context> "Definitive_therapy" .
<Dacarbazine_and_Interferon_alfa-2a> <Has_modality> "Immunotherapy" .
<Dacarbazine_and_Interferon_alfa-2a> <Has_modality> "Chemotherapy" .
<R-CHOEP-14> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Docetaxel_and_Nintedanib> <Has_context> "Non-curative_subsequent-line_therapy" .
<BVCPP> <Has_accepted_use> "Hodgkin_lymphoma" .
<BeEAM> <Mapped_from> "BeEAM" .
<FOLFOX_7/sLV5FU2_(L-Leucovorin)> <Has_modality> "Chemotherapy" .
<DE> <Has_modality> "Chemotherapy" .
<Hexa-CAF> <Has_antineoplastic> "Methotrexate" .
<Hexa-CAF> <Has_antineoplastic> "Fluorouracil" .
<Hexa-CAF> <Has_antineoplastic> "Cyclophosphamide" .
<Hexa-CAF> <Has_antineoplastic> "Altretamine" .
<Tinzaparin_monotherapy> <Maps_to> "Tinzaparin_monotherapy" .
<Rucaparib_monotherapy> <Has_accepted_use> "Ovarian_cancer" .
<Zytofolin> <Brand_name_of> "Folinic_acid" .
<Docetaxel,_Fluorouracil,_Hydroxyurea,_RT> <Has_accepted_use> "Head_and_neck_cancer" .
<Etoposide_and_Prednisone> <Has_modality> "Chemotherapy" .
<Interferon_alfa-2b> <Antineoplastic_of> "Octreotide_and_Interferon_alfa" .
<Interferon_alfa-2b> <Antineoplastic_of> "Lanreotide_and_Interferon_alfa-2b" .
<Interferon_alfa-2b> <Antineoplastic_of> "Interferon_alfa-2b_monotherapy" .
<Interferon_alfa-2b> <Antineoplastic_of> "Interferon_alfa-2b_and_Zidovudine" .
<Interferon_alfa-2b> <Antineoplastic_of> "Interferon_alfa-2b_and_Thalidomide" .
<Interferon_alfa-2b> <Antineoplastic_of> "Interferon_alfa-2b_and_Prednisone" .
<Interferon_alfa-2b> <Antineoplastic_of> "Interferon_alfa-2b_and_DLI" .
<Interferon_alfa-2b> <Antineoplastic_of> "Imatinib_and_Interferon" .
<Interferon_alfa-2b> <Antineoplastic_of> "DEX-IFN" .
<Interferon_alfa-2b> <Antineoplastic_of> "Cytarabine_and_Interferon_alfa-2b" .
<Interferon_alfa-2b> <Antineoplastic_of> "Cisplatin,_Dacarbazine,_Interferon_alfa-2b" .
<Interferon_alfa-2b> <Antineoplastic_of> "Cisplatin,_Dacarbazine,_IL-2,_IFN_alfa-2b_plus_/-_Carmustine" .
<Interferon_alfa-2b> <Antineoplastic_of> "CVD,_IL-2,_IFN_alfa-2b_-_sequential_biochemotherapy" .
<Interferon_alfa-2b> <Antineoplastic_of> "CHVP-I" .
<ERBB3-mutated_malignancy> <Accepted_use_of> "Neratinib_monotherapy" .
<ERBB3-mutated_malignancy> <Accepted_use_of> "Neratinib" .
<MEL200,_then_auto_HSCT,_then_MEL220_and_Dexamethasone,_then_auto_HSCT> <Mapped_from> "MEL200,_then_auto_HSCT,_then_MEL220_and_Dexamethasone,_then_auto_HSCT" .
<Castration> <Has_context> "Non-curative_therapy" .
<IT_Methotrexate_monotherapy> <Has_context> "Local_therapy" .
<Sorafenib> <Has_FDA_indication> "Thyroid_cancer" .
<Sorafenib> <Has_FDA_indication> "Renal_cell_carcinoma" .
<Sorafenib> <Has_FDA_indication> "Hepatocellular_carcinoma" .
<Tecentriq> <Brand_name_of> "Atezolizumab" .
<Bu/TT,_then_auto_HSCT> <Maps_to> "Bu/TT,_then_auto_HSCT" .
<CHOP_and_Everolimus> <Has_context> "Induction_therapy" .
<Sulfatrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Light-chain_(AL)_amyloidosis_medication> <Subsumes> "Thalidomide" .
<Light-chain_(AL)_amyloidosis_medication> <Subsumes> "Prednisone" .
<Light-chain_(AL)_amyloidosis_medication> <Subsumes> "Pomalidomide" .
<Light-chain_(AL)_amyloidosis_medication> <Subsumes> "NEOD001" .
<Light-chain_(AL)_amyloidosis_medication> <Subsumes> "Melphalan" .
<Light-chain_(AL)_amyloidosis_medication> <Subsumes> "Lenalidomide" .
<Light-chain_(AL)_amyloidosis_medication> <Subsumes> "Ixazomib" .
<Light-chain_(AL)_amyloidosis_medication> <Subsumes> "Dexamethasone" .
<Light-chain_(AL)_amyloidosis_medication> <Subsumes> "Daratumumab" .
<Light-chain_(AL)_amyloidosis_medication> <Subsumes> "Cyclophosphamide" .
<Light-chain_(AL)_amyloidosis_medication> <Subsumes> "Bortezomib" .
<Cisplatin,_Fluorouracil,_Pembrolizumab> <Has_modality> "Immunotherapy" .
<Cisplatin,_Fluorouracil,_Pembrolizumab> <Has_modality> "Chemotherapy" .
<Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<Megestrol_monotherapy> <Is_historical_in> "Renal_cell_carcinoma" .
<Megestrol_monotherapy> <Is_historical_in> "Breast_cancer" .
<Bu/TT/Cy> <Has_context> "All_lines_of_therapy" .
<Sirolimus_and_Prednisone> <Has_accepted_use> "Erdheim-Chester_disease" .
<Lanreotide> <Has_FDA_indication> "Neuroendocrine_tumor" .
<EP> <Maps_to> "EP" .
<Oxsoralen> <Brand_name_of> "Methoxsalen" .
<Dara-KD> <Has_supportive_med> "Diphenhydramine" .
<Dara-KD> <Has_supportive_med> "Acetaminophen" .
<Plerixafor_and_G-CSF> <Has_modality> "Growth_factor_therapy" .
<Caplacizumab_and_Plasma_exchange> <Mapped_from> "Caplacizumab_and_Plasma_exchange" .
<Eltrombopag_monotherapy> <Has_modality> "Growth_factor_therapy" .
<Vindesine> <May_have_route> "Intravenous" .
<Cisplatin_and_Etoposide> <Maps_to> "Cisplatin_and_Etoposide" .
<IDAC_and_Sorafenib> <Has_accepted_use> "FLT3-positive_Acute_myeloid_leukemia" .
<IDAC_and_Sorafenib> <Has_accepted_use> "Acute_myeloid_leukemia" .
<TBI> <Has_accepted_use> "Autologous_HSCT" .
<Medralone> <Brand_name_of> "Methylprednisolone" .
<CAD_and_G-CSF> <Maps_to> "CAD_and_G-CSF" .
<VAB-6> <Has_context> "Upfront_therapy" .
<CEPP(B)> <Has_context> "Non-curative_subsequent-line_therapy" .
<Dacplat> <Brand_name_of> "Oxaliplatin" .
<Panitumumab_monotherapy> <Has_context> "Non-curative_therapy" .
<Panitumumab_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<MACC> <Has_modality> "Chemotherapy" .
<Cytarabine,_Doxorubicin,_Vincristine,_Prednisolone> <Is_a> "Anthracycline-containing_regimen" .
<Platinil> <Brand_name_of> "Cisplatin" .
<Alectinib_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Alectinib_monotherapy> <Is_current_in> "CNS_carcinoma" .
<Multiferon> <Brand_name_of> "Interferon_alfa-2b" .
<Naftran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Capecitabine_and_Neratinib> <Maps_to> "Capecitabine_and_Neratinib" .
<CYVE> <Mapped_from> "CYVE" .
<Domperidone> <Has_brand_name> "Motilium" .
<Ifolem> <Brand_name_of> "Ifosfamide" .
<Metaplatin> <Brand_name_of> "Cisplatin" .
<Vincristine_and_Prednisone> <Has_context> "Induction_therapy" .
<Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT> <Mapped_from> "Fludarabine,_Busulfan,_ATG,_Ibritumomab_tiuxetan,_then_allo_HSCT" .
<Longasal> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<R,_then_CHOP> <Mapped_from> "R,_then_CHOP" .
<ECF/5-FU_and_RT> <Mapped_from> "ECF/5-FU_and_RT" .
<PCO> <Mapped_from> "PCO" .
<Carboplatin,_Paclitaxel,_Pembrolizumab> <Maps_to> "Carboplatin,_Paclitaxel,_Pembrolizumab" .
<BASIC> <Has_supportive_med> "Mesna" .
<BASIC> <Has_supportive_med> "Folinic_acid" .
<BASIC> <Has_supportive_med> "Filgrastim" .
<Vorinostat_and_Rituximab> <Is_current_in> "Follicular_lymphoma" .
<CYVE_and_G-CSF> <Has_accepted_use> "Stem_cell_mobilization" .
<Anti-CTLA-4_antibody> <Is_a> "Antibody_medication" .
<Accelerated_BEP> <Has_accepted_use> "Testicular_cancer" .
<Fotemustine_monotherapy> <Has_accepted_use> "Uveal_melanoma" .
<Fotemustine_monotherapy> <Has_accepted_use> "Melanoma" .
<Fotemustine_monotherapy> <Has_accepted_use> "CNS_melanoma" .
<Imatinib_monotherapy> <Has_accepted_use> "Systemic_mastocytosis" .
<Imatinib_monotherapy> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Imatinib_monotherapy> <Has_accepted_use> "Ph-positive_B-cell_acute_lymphoblastic_leukemia" .
<Imatinib_monotherapy> <Has_accepted_use> "Melanoma" .
<Imatinib_monotherapy> <Has_accepted_use> "KIT-mutated_Melanoma" .
<Imatinib_monotherapy> <Has_accepted_use> "Hypereosinophilic_syndrome" .
<Imatinib_monotherapy> <Has_accepted_use> "Gastrointestinal_stromal_tumor" .
<Imatinib_monotherapy> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Imatinib_monotherapy> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Temozolomide_and_NovoTTF-100A> <Has_accepted_use> "Glioblastoma" .
<Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan> <Has_antineoplastic> "Irinotecan_liposome" .
<Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan> <Has_antineoplastic> "Folinic_acid" .
<Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan> <Has_antineoplastic> "Fluorouracil" .
<Erythropoetin_and_Lenalidomide> <Has_antineoplastic> "Lenalidomide" .
<Folend> <Brand_name_of> "Alendronate" .
<Roximeth> <Brand_name_of> "Dexamethasone" .
<Megestrol> <Has_brand_name> "Megace" .
<Hereditary_hemorrhagic_telangiectasia> <Current_treated_by> "Tranexamic_acid_monotherapy" .
<Hereditary_hemorrhagic_telangiectasia> <Current_treated_by> "Tamoxifen_monotherapy" .
<Hereditary_hemorrhagic_telangiectasia> <Current_treated_by> "Placebo" .
<TVAD_doxil> <Is_a> "Anthracycline-containing_regimen" .
<Litrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Leucocalcin> <Brand_name_of> "Folinic_acid" .
<DES_monotherapy> <Has_context> "Non-curative_therapy" .
<HLH-94_regimen> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<HLH-94_regimen> <Has_supportive_med> "Dexamethasone" .
<HLH-94_regimen> <Has_supportive_med> "Antifungals" .
<Haldol> <Brand_name_of> "Haloperidol" .
<CHVmP> <Has_modality> "Chemotherapy" .
<Valacyclovir> <Supportive_med_of> "Z-BEAM,_then_auto_HSCT" .
<Valacyclovir> <Supportive_med_of> "Z-BEAM" .
<Valacyclovir> <Supportive_med_of> "VDC" .
<Valacyclovir> <Supportive_med_of> "VAD" .
<Valacyclovir> <Supportive_med_of> "TD" .
<Valacyclovir> <Supportive_med_of> "Rd" .
<Valacyclovir> <Supportive_med_of> "RVD" .
<Valacyclovir> <Supportive_med_of> "R-Hyper-CVAD/R-MA" .
<Valacyclovir> <Supportive_med_of> "Pentostatin_monotherapy" .
<Valacyclovir> <Supportive_med_of> "POMP" .
<Valacyclovir> <Supportive_med_of> "PCO" .
<Valacyclovir> <Supportive_med_of> "PAD" .
<Valacyclovir> <Supportive_med_of> "KRd" .
<Valacyclovir> <Supportive_med_of> "Hyper-CVAD/MA" .
<Valacyclovir> <Supportive_med_of> "Hyper-CVAD_and_Ponatinib" .
<Valacyclovir> <Supportive_med_of> "Hyper-CVAD_and_Imatinib" .
<Valacyclovir> <Supportive_med_of> "Hyper-CVAD_and_Dasatinib" .
<Valacyclovir> <Supportive_med_of> "Hyper-CVAD" .
<Valacyclovir> <Supportive_med_of> "Fludarabine_monotherapy" .
<Valacyclovir> <Supportive_med_of> "FluCam" .
<Valacyclovir> <Supportive_med_of> "FCR" .
<Valacyclovir> <Supportive_med_of> "FCA" .
<Valacyclovir> <Supportive_med_of> "FC" .
<Valacyclovir> <Supportive_med_of> "Cladribine_monotherapy" .
<Valacyclovir> <Supportive_med_of> "Cladribine_and_Rituximab" .
<Valacyclovir> <Supportive_med_of> "CTD" .
<Valacyclovir> <Supportive_med_of> "CRd" .
<Valacyclovir> <Supportive_med_of> "CIA" .
<Valacyclovir> <Supportive_med_of> "CFAR" .
<Valacyclovir> <Supportive_med_of> "Bortezomib_and_Cyclophosphamide" .
<Valacyclovir> <Supportive_med_of> "BEAM,_then_auto_HSCT" .
<Valacyclovir> <Supportive_med_of> "BEAM" .
<Valacyclovir> <Supportive_med_of> "BDR" .
<Valacyclovir> <Supportive_med_of> "AspaMetDex_(Erwinaze)" .
<Valacyclovir> <Supportive_med_of> "AspaMetDex" .
<Valacyclovir> <Supportive_med_of> "Alemtuzumab_monotherapy" .
<Valacyclovir> <Supportive_med_of> "Alemtuzumab_and_Rituximab" .
<Valacyclovir> <Supportive_med_of> "ATG_(Rabbit)_and_Cyclosporine" .
<Valacyclovir> <Supportive_med_of> "ATG_(Horse),_Cyclosporine,_Sirolimus" .
<Valacyclovir> <Supportive_med_of> "ATG_(Horse),_Cyclosporine,_Eltrombopag" .
<Valacyclovir> <Supportive_med_of> "ATG_(Horse)_and_Cyclosporine" .
<FAMTX> <Mapped_from> "FAMTX" .
<FNC> <Has_modality> "Chemotherapy" .
<Doxorubicin_pegylated_liposomal_monotherapy> <Is_a> "Anthracycline-containing_regimen" .
<Talazoparib> <Is_a> "PARP_inhibitor" .
<Methotrexate,_Tacrolimus,_Vorinostat> <Is_current_in> "Graft_versus_host_disease" .
<Reumyl> <Brand_name_of> "Aspirin" .
<CAP> <Has_modality> "Chemotherapy" .
<ECH> <Is_a> "Anthracycline-containing_regimen" .
<CHVP> <Has_antineoplastic> "Teniposide" .
<CHVP> <Has_antineoplastic> "Prednisone" .
<CHVP> <Has_antineoplastic> "Doxorubicin" .
<CHVP> <Has_antineoplastic> "Cyclophosphamide" .
<Anti-TRAIL-R1_antibody> <Subsumes> "Mapatumumab" .
<Atezolizumab_monotherapy> <Is_current_in> "Small_cell_lung_cancer" .
<Atezolizumab_monotherapy> <Is_current_in> "Non-small_cell_lung_cancer" .
<Atezolizumab_monotherapy> <Is_current_in> "Bladder_cancer" .
<Nimustine_and_RT> <Has_accepted_use> "Glioblastoma" .
<HAM_and_Imatinib> <Maps_to> "HAM_and_Imatinib" .
<Panobinostat_and_Rituximab> <Has_modality> "Chemotherapy" .
<MATRix> <Has_context> "Upfront_therapy" .
<Tylenol> <Brand_name_of> "Acetaminophen" .
<DI_EC> <Has_accepted_use> "Breast_cancer" .
<Degarelix_monotherapy> <Has_context> "Non-curative_therapy" .
<Cisplatin,_Pemetrexed,_Pembrolizumab> <Is_current_in> "Non-small_cell_lung_cancer" .
<ABVDm> <Has_antineoplastic> "Vinblastine" .
<ABVDm> <Has_antineoplastic> "Methylprednisolone" .
<ABVDm> <Has_antineoplastic> "Doxorubicin" .
<ABVDm> <Has_antineoplastic> "Dacarbazine" .
<ABVDm> <Has_antineoplastic> "Bleomycin" .
<R-CHOP_(Rituximab_Hycela)> <Mapped_from> "R-CHOP_(Rituximab_Hycela)" .
<Methotrexate> <Supportive_med_of> "Cisplatin_and_Irinotecan" .
<Methotrexate> <Supportive_med_of> "Busulfan_and_Cyclophosphamide,_then_allo_HSCT" .
<Methotrexate> <Supportive_med_of> "Busulfan_and_Cyclophosphamide" .
<Methotrexate> <Supportive_med_of> "BuCy,_then_allo_HSCT" .
<Trametinib> <Has_FDA_indication> "Thyroid_cancer" .
<Trametinib> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Trametinib> <Has_FDA_indication> "Melanoma" .
<LoDAC_and_Venetoclax> <Is_current_in> "Acute_myeloid_leukemia" .
<Exemestane_and_Tucidinostat> <Mapped_from> "Exemestane_and_Tucidinostat" .
<Hematopoietic_growth_factor> <Subsumes> "Romiplostim" .
<Hematopoietic_growth_factor> <Subsumes> "Oprelvekin" .
<Hematopoietic_growth_factor> <Subsumes> "Megakaryocyte_growth_factor" .
<Hematopoietic_growth_factor> <Subsumes> "Lusutrombopag" .
<Hematopoietic_growth_factor> <Subsumes> "Luspatercept" .
<Hematopoietic_growth_factor> <Subsumes> "Granulocyte_growth_factor" .
<Hematopoietic_growth_factor> <Subsumes> "Erythrocyte_growth_factor" .
<Hematopoietic_growth_factor> <Subsumes> "Epoetin_alfa-epbx" .
<Hematopoietic_growth_factor> <Subsumes> "Epoetin_alfa" .
<Hematopoietic_growth_factor> <Subsumes> "Eltrombopag" .
<Hematopoietic_growth_factor> <Subsumes> "Darbepoetin_alfa" .
<Hematopoietic_growth_factor> <Subsumes> "Avatrombopag" .
<CAPIRI-Bev> <Is_current_in> "Colon_cancer" .
<RD> <Has_context> "Non-curative_therapy" .
<RD> <Has_context> "Non-curative_first-line_therapy" .
<Cyclophosphamide> <May_have_route> "Oral" .
<Cyclophosphamide> <May_have_route> "Intravenous" .
<POMP> <Has_modality> "Chemotherapy" .
<IP-BCD> <Mapped_from> "IP-BCD" .
<Salospir-A> <Brand_name_of> "Aspirin" .
<Aspirin_and_Warfarin> <Has_modality> "Anticoagulation" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone> <Mapped_from> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone" .
<Enoxaparin_monotherapy> <Has_context> "Prophylaxis" .
<Enoxaparin_monotherapy> <Has_context> "All_lines_of_therapy" .
<Bevacizumab> <Has_FDA_indication> "Renal_cell_carcinoma" .
<Bevacizumab> <Has_FDA_indication> "Rectal_cancer" .
<Bevacizumab> <Has_FDA_indication> "Ovarian_cancer" .
<Bevacizumab> <Has_FDA_indication> "Non-small_cell_lung_cancer" .
<Bevacizumab> <Has_FDA_indication> "Glioblastoma" .
<Bevacizumab> <Has_FDA_indication> "Colon_cancer" .
<Bevacizumab> <Has_FDA_indication> "Cervical_cancer" .
<Bevacizumab> <Has_FDA_indication> "Breast_cancer" .
<Cephalexin> <Is_a> "WHO_Essential_Anti-infective_Medicine" .
<Cephalexin> <Is_a> "Cephalosporin" .
<Fludarabine,_Cyclophosphamide,_ATG,_then_allo_HSCT> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Arsenic_trioxide_and_ATRA> <Has_context> "Induction_therapy" .
<Arsenic_trioxide_and_ATRA> <Has_context> "Consolidation_after_upfront_therapy" .
<IFL_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Visualin> <Brand_name_of> "Dexamethasone" .
<NEOD001> <Has_accepted_use> "Light-chain_(AL)_amyloidosis" .
<Intravenous_immunoglobulin_(IVIG)> <Has_brand_name> "Privigen" .
<Intravenous_immunoglobulin_(IVIG)> <Has_brand_name> "Octagam" .
<Intravenous_immunoglobulin_(IVIG)> <Has_brand_name> "Gamunex" .
<Intravenous_immunoglobulin_(IVIG)> <Has_brand_name> "Gammagard" .
<Intravenous_immunoglobulin_(IVIG)> <Has_brand_name> "Flebogamma" .
<Palbociclib> <Has_brand_name> "Ibrance" .
<Topotecan_and_Bevacizumab> <Has_antineoplastic> "Topotecan" .
<Topotecan_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<MVP_(Vinblastine)> <Mapped_from> "MVP_(Vinblastine)" .
<Surodex> <Brand_name_of> "Dexamethasone" .
<Peginterferon_alfa-2b_monotherapy> <Has_accepted_use> "Melanoma" .
<m-BNCOD> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<C-MOPP/ABV> <Mapped_from> "C-MOPP/ABV" .
<Everolimus_and_Exemestane> <Has_context> "Non-curative_subsequent-line_therapy" .
<Borater> <Brand_name_of> "Bortezomib" .
<Pegylated_medication> <Is_a> "Drugs_by_vehicle" .
<Idarubicin> <Has_FDA_indication> "Acute_myeloid_leukemia" .
<Endometrial_cancer> <Current_treated_by> "Whole_abdominal_radiation_(WAI)" .
<Endometrial_cancer> <Current_treated_by> "Topotecan_monotherapy" .
<Endometrial_cancer> <Current_treated_by> "Temsirolimus_monotherapy" .
<Endometrial_cancer> <Current_treated_by> "Tamoxifen_monotherapy" .
<Endometrial_cancer> <Current_treated_by> "Radiation_therapy" .
<Endometrial_cancer> <Current_treated_by> "Placebo" .
<Endometrial_cancer> <Current_treated_by> "Pembrolizumab_monotherapy" .
<Endometrial_cancer> <Current_treated_by> "Paclitaxel_monotherapy" .
<Endometrial_cancer> <Current_treated_by> "Observation" .
<Endometrial_cancer> <Current_treated_by> "Megestrol_monotherapy" .
<Endometrial_cancer> <Current_treated_by> "Megestrol_and_Tamoxifen" .
<Endometrial_cancer> <Current_treated_by> "Medroxyprogesterone_monotherapy" .
<Endometrial_cancer> <Current_treated_by> "Medroxyprogesterone_and_Tamoxifen" .
<Endometrial_cancer> <Current_treated_by> "Lenvatinib_and_Pembrolizumab" .
<Endometrial_cancer> <Current_treated_by> "Ifosfamide_monotherapy" .
<Endometrial_cancer> <Current_treated_by> "Ifosfamide_and_Paclitaxel" .
<Endometrial_cancer> <Current_treated_by> "Doxorubicin_monotherapy" .
<Endometrial_cancer> <Current_treated_by> "Dactinomycin_monotherapy" .
<Endometrial_cancer> <Current_treated_by> "Cisplatin,_Doxorubicin,_Paclitaxel" .
<Endometrial_cancer> <Current_treated_by> "Cisplatin_and_RT" .
<Endometrial_cancer> <Current_treated_by> "Cisplatin_and_Paclitaxel" .
<Endometrial_cancer> <Current_treated_by> "Cisplatin_and_Doxorubicin" .
<Endometrial_cancer> <Current_treated_by> "Carboplatin_monotherapy" .
<Endometrial_cancer> <Current_treated_by> "Carboplatin_and_Paclitaxel" .
<Endometrial_cancer> <Current_treated_by> "Carboplatin_and_Doxorubicin_liposomal" .
<Endometrial_cancer> <Current_treated_by> "CIM" .
<Endometrial_cancer> <Current_treated_by> "Bevacizumab_monotherapy" .
<Endometrial_cancer> <Current_treated_by> "Anastrozole_monotherapy" .
<CEOP_(Prednisolone)> <Maps_to> "CEOP_(Prednisolone)" .
<7_plus_3i_and_Vorinostat> <Has_accepted_use> "Acute_myeloid_leukemia" .
<BTD> <Has_accepted_use> "Multiple_myeloma" .
<Regenesis> <Brand_name_of> "Alendronate" .
<Lomustine,_Vincristine,_Prednisone> <Is_current_in> "Anaplastic_glioma" .
<Maxiprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cemiplimab> <Antineoplastic_of> "Cemiplimab_monotherapy" .
<Zantran> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Trolic> <Brand_name_of> "Prednisone" .
<CAF_and_MPA> <Mapped_from> "CAF_and_MPA" .
<FRD> <Mapped_from> "FRD" .
<Octreotide_LAR_monotherapy> <Maps_to> "Octreotide_LAR_monotherapy" .
<Altretamine_and_Cisplatin> <Has_context> "Non-curative_second-line_therapy" .
<Altretamine_and_Cisplatin> <Has_context> "Non-curative_first-line_therapy" .
<Tarceva> <Brand_name_of> "Erlotinib" .
<Tremelimumab> <May_have_route> "Intravenous" .
<Plasma_exchange> <Is_current_in> "Thrombotic_thrombocytopenic_purpura" .
<IT_Cytarabine_liposomal_monotherapy> <Has_local_therapy> "Cytarabine_liposomal" .
<Sirolimus> <Is_a> "MTOR_inhibitor" .
<Sirolimus> <Is_a> "Kinase_inhibitor" .
<Thalidomide_and_Prednisone> <Has_accepted_use> "Multiple_myeloma" .
<AC-T> <Has_context> "Neoadjuvant_therapy" .
<AC-T> <Has_context> "Adjuvant_therapy" .
<Bicalutamide> <Antineoplastic_of> "Bicalutamide_monotherapy" .
<Bicalutamide> <Antineoplastic_of> "Bicalutamide_and_RT" .
<Bicalutamide> <Antineoplastic_of> "Bicalutamide_and_Leuprolide" .
<Bicalutamide> <Antineoplastic_of> "Bicalutamide_and_Goserelin" .
<Bicalutamide> <Antineoplastic_of> "ADT_and_RT" .
<Bicalutamide> <Antineoplastic_of> "ADT_and_Docetaxel" .
<Bicalutamide> <Antineoplastic_of> "ADT" .
<Axitinib_monotherapy> <Has_modality> "Chemotherapy" .
<Nimustine_and_RT> <Has_antineoplastic> "Nimustine" .
<Nimustine_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<CSF1R_inhibitor> <Is_a> "Kinase_inhibitor" .
<CSF1R_inhibitor> <Is_a> "Growth_factor_inhibitor" .
<Cyclophosphamide,_Fludarabine,_Thiotepa> <Is_current_in> "Allogeneic_HSCT" .
<FluCam> <Has_modality> "Chemotherapy" .
<Carboplatin_and_Doxorubicin_liposomal> <Mapped_from> "Carboplatin_and_Doxorubicin_liposomal" .
<COP-Bleo> <Mapped_from> "COP-Bleo" .
<Bendamustine_and_Brentuximab_vedotin> <Maps_to> "Bendamustine_and_Brentuximab_vedotin" .
<Actinium_Ac_225_lintuzumab> <Is_a> "Radiotherapy_medication" .
<Actinium_Ac_225_lintuzumab> <Is_a> "Investigational_drug" .
<Actinium_Ac_225_lintuzumab> <Is_a> "Antibody_medication" .
<Actinium_Ac_225_lintuzumab> <Is_a> "Anti-CD33_antibody" .
<FEC> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<FEC> <Has_accepted_use> "Breast_cancer" .
<Chlorambucil_and_Rituximab> <Has_accepted_use> "Marginal_zone_lymphoma" .
<Chlorambucil_and_Rituximab> <Has_accepted_use> "Mantle_cell_lymphoma" .
<Chlorambucil_and_Rituximab> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Tisagenlecleucel> <Has_FDA_indication> "Transformed_lymphoma" .
<Tisagenlecleucel> <Has_FDA_indication> "Diffuse_large_B-cell_lymphoma" .
<Tisagenlecleucel> <Has_FDA_indication> "B-cell_acute_lymphoblastic_leukemia" .
<Fauldvincri> <Brand_name_of> "Vincristine" .
<Lomustine_monotherapy> <Has_antineoplastic> "Lomustine" .
<Bortezomib> <Has_brand_name> "Zuricade" .
<Bortezomib> <Has_brand_name> "Zomib" .
<Bortezomib> <Has_brand_name> "Velcade" .
<Bortezomib> <Has_brand_name> "Ortez" .
<Bortezomib> <Has_brand_name> "Norvelzo" .
<Bortezomib> <Has_brand_name> "Myezom" .
<Bortezomib> <Has_brand_name> "Mibor" .
<Bortezomib> <Has_brand_name> "Egybort" .
<Bortezomib> <Has_brand_name> "Bromadene" .
<Bortezomib> <Has_brand_name> "Botepar" .
<Bortezomib> <Has_brand_name> "Borviz" .
<Bortezomib> <Has_brand_name> "Borvex" .
<Bortezomib> <Has_brand_name> "Bortrac" .
<Bortezomib> <Has_brand_name> "Bortetrust" .
<Bortezomib> <Has_brand_name> "Bortenat" .
<Bortezomib> <Has_brand_name> "Bortemib" .
<Bortezomib> <Has_brand_name> "Bortecad" .
<Bortezomib> <Has_brand_name> "Borater" .
<Bortezomib> <Has_brand_name> "Biocure" .
<Carmustine_monotherapy> <Has_supportive_med> "Steroids" .
<Carmustine_monotherapy> <Has_supportive_med> "Ondansetron" .
<FEC_and_H_(SC)> <Has_antineoplastic> "Trastuzumab_and_hyaluronidase" .
<FEC_and_H_(SC)> <Has_antineoplastic> "Fluorouracil" .
<FEC_and_H_(SC)> <Has_antineoplastic> "Epirubicin" .
<FEC_and_H_(SC)> <Has_antineoplastic> "Cyclophosphamide" .
<Luspatercept> <Supportive_med_of> "Luspatercept_monotherapy" .
<DEB-TACE> <Maps_to> "DEB-TACE" .
<Erythropoetin_and_Lenalidomide> <Has_accepted_use> "Myelodysplastic_syndrome" .
<BDR> <Is_a> "Rituximab-containing_regimen" .
<Toremifene_monotherapy> <Is_a> "Antiestrogen-containing_regimen" .
<Darbex> <Brand_name_of> "Darbepoetin_alfa" .
<Docusate> <May_have_route> "Oral" .
<CAMFP> <Has_modality> "Hormonotherapy" .
<CAMFP> <Has_modality> "Chemotherapy" .
<Doxifluridine_and_Mitomycin> <Has_modality> "Chemotherapy" .
<Cisplatin,_Fluorouracil,_Pembrolizumab> <Is_current_in> "Gastric_cancer" .
<G-CVP> <Is_current_in> "Follicular_lymphoma" .
<IGFR_inhibitor> <Subsumes> "Ceritinib" .
<IGFR_inhibitor> <Subsumes> "Brigatinib" .
<Anti-CTLA-4_antibody> <Subsumes> "Tremelimumab" .
<Anti-CTLA-4_antibody> <Subsumes> "Ipilimumab" .
<Trelstar_LA> <Brand_name_of> "Triptorelin" .
<Chlorambucil,_Dactinomycin,_Methotrexate> <Has_context> "Upfront_therapy" .
<Sipuleucel-T_monotherapy> <Mapped_from> "Sipuleucel-T_monotherapy" .
<Neotrexate> <Brand_name_of> "Methotrexate" .
<VAdCA/IE> <Has_antineoplastic> "Vincristine" .
<VAdCA/IE> <Has_antineoplastic> "Ifosfamide" .
<VAdCA/IE> <Has_antineoplastic> "Etoposide" .
<VAdCA/IE> <Has_antineoplastic> "Doxorubicin" .
<VAdCA/IE> <Has_antineoplastic> "Dactinomycin" .
<VAdCA/IE> <Has_antineoplastic> "Cyclophosphamide" .
<Irinotecan_monotherapy> <Has_modality> "Chemotherapy" .
<Sultra> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Nadroparin> <Has_accepted_use> "Venous_thromboembolism" .
<Gemcitabine_and_Paclitaxel> <Has_antineoplastic> "Paclitaxel" .
<Gemcitabine_and_Paclitaxel> <Has_antineoplastic> "Gemcitabine" .
<CVB> <Maps_to> "CVB" .
<Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Vincristine" .
<Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Methotrexate" .
<Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Mercaptopurine" .
<Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone> <Has_antineoplastic> "Dexamethasone" .
<Emistat> <Brand_name_of> "Ondansetron" .
<Sapacitabine> <May_have_route> "Oral" .
<TL_(Taxol)> <Has_antineoplastic> "Paclitaxel" .
<TL_(Taxol)> <Has_antineoplastic> "Lapatinib" .
<R-CDOP> <Has_context> "Upfront_therapy" .
<R-CDOP> <Has_context> "Induction_therapy" .
<Ifomida> <Brand_name_of> "Ifosfamide" .
<Daratumumab> <Is_a> "Light-chain_(AL)_amyloidosis_medication" .
<Daratumumab> <Is_a> "Antibody_medication" .
<Daratumumab> <Is_a> "Anti-CD38_antibody" .
<Sunitinib_monotherapy> <Is_historical_in> "Hepatocellular_carcinoma" .
<Megestrol_monotherapy> <Has_antineoplastic> "Megestrol" .
<CAV> <Is_a> "Anthracycline-containing_regimen" .
<GIP> <Has_modality> "Chemotherapy" .
<TACE> <Is_a> "Anthracycline-containing_regimen" .
<MA-BCD> <Maps_to> "MA-BCD" .
<Irinotecan,_Temozolomide,_Dinutuximab> <Is_current_in> "Neuroblastoma" .
<Mechlorethamine_monotherapy> <Is_historical_in> "Hodgkin_lymphoma" .
<Alcysten> <Brand_name_of> "Cytarabine" .
<Upsarin> <Brand_name_of> "Aspirin" .
<GVD> <Is_current_in> "Hodgkin_lymphoma" .
<GVD> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<CRD> <Has_antineoplastic> "Lenalidomide" .
<CRD> <Has_antineoplastic> "Dexamethasone" .
<CRD> <Has_antineoplastic> "Cyclophosphamide" .
<Bacsulfaprin> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Chlorambucil,_Dactinomycin,_Methotrexate> <Maps_to> "Chlorambucil,_Dactinomycin,_Methotrexate" .
<Advate_rAHF-PFM> <Brand_name_of> "Factor_VIII_recombinant" .
<Thymoma> <Is_a> "Thoracic_cancer" .
<Langerhans_cell_histiocytosis> <Current_treated_by> "Vinblastine_and_Prednisone" .
<Langerhans_cell_histiocytosis> <Current_treated_by> "Vemurafenib_monotherapy" .
<Langerhans_cell_histiocytosis> <Current_treated_by> "Methotrexate,_Vinblastine,_Prednisone" .
<Langerhans_cell_histiocytosis> <Current_treated_by> "Mercaptopurine,_Methotrexate,_Vinblastine,_Prednisolone" .
<Langerhans_cell_histiocytosis> <Current_treated_by> "Etoposide,_Vinblastine,_Prednisone" .
<Langerhans_cell_histiocytosis> <Current_treated_by> "Etoposide_and_Prednisone" .
<Langerhans_cell_histiocytosis> <Current_treated_by> "Cobimetinib_monotherapy" .
<Langerhans_cell_histiocytosis> <Current_treated_by> "Cladribine_monotherapy" .
<Langerhans_cell_histiocytosis> <Current_treated_by> "Cladribine_and_Cytarabine" .
<Maxzol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Melphalan> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Melphalan> <Is_a> "Nitrogen_mustard" .
<Melphalan> <Is_a> "Neutral" .
<Melphalan> <Is_a> "Light-chain_(AL)_amyloidosis_medication" .
<Melphalan> <Is_a> "Irritant" .
<Melphalan> <Is_a> "Alkylating_agent" .
<Chlorambucil_and_Prednisone> <Maps_to> "Chlorambucil_and_Prednisone" .
<DI_EC> <Mapped_from> "DI_EC" .
<Letrozole_and_Ribociclib> <Has_modality> "Hormonotherapy" .
<Letrozole_and_Ribociclib> <Has_modality> "Chemotherapy" .
<Litak> <Brand_name_of> "Cladribine" .
<Cobimetinib_and_Vemurafenib> <Maps_to> "Cobimetinib_and_Vemurafenib" .
<Cyclosporine_and_Methotrexate> <Maps_to> "Cyclosporine_and_Methotrexate" .
<ddA> <Has_modality> "Chemotherapy" .
<Lapatinib> <May_have_route> "Oral" .
<Cyclophosphamide_and_Etoposide> <Maps_to> "Cyclophosphamide_and_Etoposide" .
<Zydelig> <Brand_name_of> "Idelalisib" .
<VAC> <Mapped_from> "VAC" .
<Capecitabine_and_Paclitaxel> <Has_modality> "Chemotherapy" .
<Afatinib_and_Paclitaxel> <Has_modality> "Chemotherapy" .
<Fastovorin> <Brand_name_of> "Folinic_acid" .
<Dapsone> <Supportive_med_of> "R-CHOP" .
<Dapsone> <Supportive_med_of> "CHOP" .
<Dapsone> <Supportive_med_of> "Alemtuzumab_monotherapy" .
<Hematology_medication> <Subsumes> "Thrombosis_medication" .
<Hematology_medication> <Subsumes> "Semuloparin" .
<Hematology_medication> <Subsumes> "Romiplostim" .
<Hematology_medication> <Subsumes> "Rho(D)_immune_globulin" .
<Hematology_medication> <Subsumes> "Ravulizumab" .
<Hematology_medication> <Subsumes> "Prothrombin_Complex_Concentrate_human" .
<Hematology_medication> <Subsumes> "Phytonadione" .
<Hematology_medication> <Subsumes> "Iron_sucrose" .
<Hematology_medication> <Subsumes> "Iron_dextran" .
<Hematology_medication> <Subsumes> "Idarucizumab" .
<Hematology_medication> <Subsumes> "Hemostasis_medication" .
<Hematology_medication> <Subsumes> "Fostamatinib" .
<Hematology_medication> <Subsumes> "Ferumoxytol" .
<Hematology_medication> <Subsumes> "Ferrous_sulfate" .
<Hematology_medication> <Subsumes> "Ferric_gluconate" .
<Hematology_medication> <Subsumes> "Ferric_carboxymaltose" .
<Hematology_medication> <Subsumes> "Factor_Xa_recombinant_inactivated-zhzo" .
<Hematology_medication> <Subsumes> "Factor_XIII_concentrate_human" .
<Hematology_medication> <Subsumes> "Factor_VIIa_recombinant" .
<Hematology_medication> <Subsumes> "Factor_VIII_recombinant" .
<Hematology_medication> <Subsumes> "Factor_VIII_human" .
<Hematology_medication> <Subsumes> "Factor_IX_recombinant_Fc_fusion_protein" .
<Hematology_medication> <Subsumes> "Factor_IX_recombinant" .
<Hematology_medication> <Subsumes> "Factor_IX_human" .
<Hematology_medication> <Subsumes> "Eculizumab" .
<Hematology_medication> <Subsumes> "Desmopressin" .
<Hematology_medication> <Subsumes> "Deferoxamine" .
<Hematology_medication> <Subsumes> "Deferiprone" .
<Hematology_medication> <Subsumes> "Deferasirox" .
<Hematology_medication> <Subsumes> "Caplacizumab" .
<Hematology_medication> <Subsumes> "Antithrombin_III" .
<Hematology_medication> <Subsumes> "Anagrelide" .
<Hematology_medication> <Subsumes> "Aminocaproic_acid" .
<Doxifluridine> <Antineoplastic_of> "Doxifluridine_and_Mitomycin" .
<Docetaxel_and_Estramustine> <Maps_to> "Docetaxel_and_Estramustine" .
<IDAC> <Is_historical_in> "Acute_myeloid_leukemia" .
<Asparaginase_Erwinia_chrysanthemi> <Has_accepted_use> "T-cell_acute_lymphoblastic_leukemia" .
<Asparaginase_Erwinia_chrysanthemi> <Has_accepted_use> "NK-_and_T-cell_lymphoma" .
<Asparaginase_Erwinia_chrysanthemi> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<Asparaginase_Erwinia_chrysanthemi> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Afatinib_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Afatinib_and_Bevacizumab> <Has_antineoplastic> "Afatinib" .
<Cyclophosphamide_and_Etoposide> <Has_modality> "Chemotherapy" .
<Dekort> <Brand_name_of> "Dexamethasone" .
<Melphalan,_then_auto_HSCT,_then_Fludarabine,_Busulfan,_ATG,_then_allo_HSCT> <Has_accepted_use> "Multiple_myeloma" .
<Cyanocobalamin> <Is_a> "FDA_approved_drug" .
<Cyanocobalamin> <Is_a> "Chemotherapy_protective_agent" .
<Wofungin> <Brand_name_of> "Caspofungin" .
<Tricban> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Estramustine> <Has_brand_name> "X-Trant" .
<Estramustine> <Has_brand_name> "Estramin" .
<Estramustine> <Has_brand_name> "Estram" .
<Estramustine> <Has_brand_name> "Estracit" .
<Estramustine> <Has_brand_name> "Emcyt" .
<Saspryl> <Brand_name_of> "Aspirin" .
<Vorizol> <Brand_name_of> "Voriconazole" .
<Interferon_alfa-2b_monotherapy> <Is_historical_in> "Multiple_myeloma" .
<Edrecolomab> <Has_brand_name> "Panorex" .
<R-BEAM> <Is_a> "Rituximab-containing_regimen" .
<Mutation-specific_medication> <Subsumes> "Venetoclax" .
<Mutation-specific_medication> <Subsumes> "Vemurafenib" .
<Mutation-specific_medication> <Subsumes> "Trametinib" .
<Mutation-specific_medication> <Subsumes> "Rucaparib" .
<Mutation-specific_medication> <Subsumes> "Ponatinib" .
<Mutation-specific_medication> <Subsumes> "Pembrolizumab" .
<Mutation-specific_medication> <Subsumes> "Panitumumab" .
<Mutation-specific_medication> <Subsumes> "Osimertinib" .
<Mutation-specific_medication> <Subsumes> "Olaparib" .
<Mutation-specific_medication> <Subsumes> "Nivolumab" .
<Mutation-specific_medication> <Subsumes> "Niraparib" .
<Mutation-specific_medication> <Subsumes> "Nilotinib" .
<Mutation-specific_medication> <Subsumes> "Midostaurin" .
<Mutation-specific_medication> <Subsumes> "Lenalidomide" .
<Mutation-specific_medication> <Subsumes> "Larotrectinib" .
<Mutation-specific_medication> <Subsumes> "Ivosidenib" .
<Mutation-specific_medication> <Subsumes> "Ipilimumab" .
<Mutation-specific_medication> <Subsumes> "Imatinib" .
<Mutation-specific_medication> <Subsumes> "Ibrutinib" .
<Mutation-specific_medication> <Subsumes> "Gilteritinib" .
<Mutation-specific_medication> <Subsumes> "Gefitinib" .
<Mutation-specific_medication> <Subsumes> "Erlotinib" .
<Mutation-specific_medication> <Subsumes> "Erdafitinib" .
<Mutation-specific_medication> <Subsumes> "Entrectinib" .
<Mutation-specific_medication> <Subsumes> "Encorafenib" .
<Mutation-specific_medication> <Subsumes> "Enasidenib" .
<Mutation-specific_medication> <Subsumes> "Dasatinib" .
<Mutation-specific_medication> <Subsumes> "Dacomitinib" .
<Mutation-specific_medication> <Subsumes> "Dabrafenib" .
<Mutation-specific_medication> <Subsumes> "Crizotinib" .
<Mutation-specific_medication> <Subsumes> "Cobimetinib" .
<Mutation-specific_medication> <Subsumes> "Cetuximab" .
<Mutation-specific_medication> <Subsumes> "Ceritinib" .
<Mutation-specific_medication> <Subsumes> "Brigatinib" .
<Mutation-specific_medication> <Subsumes> "Bosutinib" .
<Mutation-specific_medication> <Subsumes> "Binimetinib" .
<Mutation-specific_medication> <Subsumes> "Avapritinib" .
<Mutation-specific_medication> <Subsumes> "Arsenic_trioxide" .
<Mutation-specific_medication> <Subsumes> "Alpelisib" .
<Mutation-specific_medication> <Subsumes> "All-trans_retinoic_acid" .
<Mutation-specific_medication> <Subsumes> "Alectinib" .
<Mutation-specific_medication> <Subsumes> "Afatinib" .
<Capecitabine_and_Gemcitabine> <Is_current_in> "Thymoma" .
<Capecitabine_and_Gemcitabine> <Is_current_in> "Pancreatic_cancer" .
<Capecitabine_and_Gemcitabine> <Is_current_in> "Gallbladder_cancer" .
<Capecitabine_and_Gemcitabine> <Is_current_in> "Cholangiocarcinoma" .
<Daunorubicin_liposomal> <Has_FDA_indication> "Kaposi_sarcoma" .
<MEL200,_then_auto_HSCT,_then_MEL220_and_Dexamethasone,_then_auto_HSCT> <Is_historical_in> "Multiple_myeloma" .
<5_plus_3d> <Has_antineoplastic> "Daunorubicin" .
<5_plus_3d> <Has_antineoplastic> "Cytarabine" .
<Belagenpumatucel-L> <Is_a> "Tumor_vaccine" .
<Belagenpumatucel-L> <Is_a> "T-cell_activator" .
<Belagenpumatucel-L> <Is_a> "Halted_drug" .
<TAD_(Tamoxifen)> <Maps_to> "TAD_(Tamoxifen)" .
<ADT_and_Abiraterone> <Mapped_from> "ADT_and_Abiraterone" .
<Lactulose> <Is_a> "WHO_Essential_Pain_and_Palliative_Care_Medicine" .
<Lactulose> <Is_a> "OTC_medication" .
<Lactulose> <Is_a> "Laxative" .
<ACOMLA> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<DCEP_and_G-CSF> <Has_antineoplastic> "Etoposide" .
<DCEP_and_G-CSF> <Has_antineoplastic> "Dexamethasone" .
<DCEP_and_G-CSF> <Has_antineoplastic> "Cyclophosphamide" .
<DCEP_and_G-CSF> <Has_antineoplastic> "Cisplatin" .
<Sandostatin_LAR> <Brand_name_of> "Octreotide_LAR" .
<BEAM> <Has_accepted_use> "Autologous_HSCT" .
<BEAM> <Has_accepted_use> "Allogeneic_HSCT" .
<NOVP> <Has_accepted_use> "Hodgkin_lymphoma" .
<Ceplatin> <Brand_name_of> "Cisplatin" .
<THP_(Taxotere)> <Maps_to> "THP_(Taxotere)" .
<Alent> <Brand_name_of> "Alendronate" .
<Halted_drug> <Subsumes> "NEOD001" .
<Halted_drug> <Subsumes> "MOR202" .
<Halted_drug> <Subsumes> "Galeterone" .
<Halted_drug> <Subsumes> "Denintuzumab_mafodotin" .
<Halted_drug> <Subsumes> "Belagenpumatucel-L" .
<Halted_drug> <Subsumes> "BL22_immunotoxin" .
<GM-CSF,_IL-2,_Isotretinoin,_Dinutuximab> <Has_context> "Consolidation_after_upfront_therapy" .
<Melphalan_and_TBI,_then_auto_HSCT> <Is_current_in> "Mantle_cell_lymphoma" .
<Ibritumomab_tiuxetan_monotherapy> <Has_modality> "Radioimmunotherapy" .
<Ibritumomab_tiuxetan_monotherapy> <Has_modality> "Chemotherapy" .
<Mitoxantrone> <Has_FDA_indication> "Prostate_cancer" .
<O-ICE> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Dexrazoxane> <May_have_route> "Intravenous" .
<Disperin> <Brand_name_of> "Aspirin" .
<Andexxa> <Brand_name_of> "Factor_Xa_recombinant_inactivated-zhzo" .
<Bacsultrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Axiplat> <Brand_name_of> "Cisplatin" .
<Carmustine_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Carmustine_and_RT> <Has_antineoplastic> "Carmustine" .
<Cytarabine_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Cytarabine_monotherapy> <Is_current_in> "B-cell_acute_lymphoblastic_leukemia" .
<DexaBEAM> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<Fluconazole> <Supportive_med_of> "VAD_doxil" .
<Fluconazole> <Supportive_med_of> "VAD" .
<Fluconazole> <Supportive_med_of> "Stanford_V" .
<Fluconazole> <Supportive_med_of> "R-M-CHOP" .
<Fluconazole> <Supportive_med_of> "R-Hyper-CVAD/R-MA" .
<Fluconazole> <Supportive_med_of> "R-EPOCH,_dose-escalated" .
<Fluconazole> <Supportive_med_of> "Pentostatin_monotherapy" .
<Fluconazole> <Supportive_med_of> "Hyper-CVAD/MA" .
<Fluconazole> <Supportive_med_of> "Hyper-CVAD_and_Ponatinib" .
<Fluconazole> <Supportive_med_of> "Hyper-CVAD_and_Imatinib" .
<Fluconazole> <Supportive_med_of> "Hyper-CVAD_and_Dasatinib" .
<Fluconazole> <Supportive_med_of> "HDMP-R" .
<Fluconazole> <Supportive_med_of> "FluCam" .
<Fluconazole> <Supportive_med_of> "EAR_and_G-CSF" .
<Fluconazole> <Supportive_med_of> "DA-EPOCH" .
<Fluconazole> <Supportive_med_of> "Cladribine_monotherapy" .
<Fluconazole> <Supportive_med_of> "Cladribine_and_Rituximab" .
<Fluconazole> <Supportive_med_of> "CBV,_then_auto_HSCT" .
<Fluconazole> <Supportive_med_of> "CBV" .
<Fluconazole> <Supportive_med_of> "BEAM,_then_auto_HSCT" .
<Fluconazole> <Supportive_med_of> "BEAM" .
<Aminoglutethimide_monotherapy> <Is_historical_in> "Breast_cancer" .
<Calsed> <Brand_name_of> "Amrubicin" .
<RBC_transfusions> <Maps_to> "RBC_transfusions" .
<R-MPV> <Has_local_therapy> "Methotrexate" .
<Blastic_plasmacytoid_dendritic_cell_neoplasm> <FDA_indication_of> "Tagraxofusp" .
<Irinotesin> <Brand_name_of> "Irinotecan" .
<Bendamustine_monotherapy> <Has_context> "Salvage_therapy" .
<Bendamustine_monotherapy> <Has_context> "Non-curative_therapy" .
<Bendamustine_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Bendamustine_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Bendamustine_monotherapy> <Has_context> "All_lines_of_therapy" .
<CaRD> <Has_supportive_med> "Famotidine" .
<CaRD> <Has_supportive_med> "Acyclovir" .
<Gemcitabine_and_Sunitinib> <Maps_to> "Gemcitabine_and_Sunitinib" .
<Defibrotide> <May_have_route> "Intravenous" .
<Docetaxel_and_Prednisone> <Has_modality> "Hormonotherapy" .
<Docetaxel_and_Prednisone> <Has_modality> "Chemotherapy" .
<R-DHAOx> <Is_a> "Rituximab-containing_regimen" .
<Cobimetinib> <May_have_route> "Oral" .
<Levamisole> <Antineoplastic_of> "Levamisole_monotherapy" .
<Levamisole> <Antineoplastic_of> "Fluorouracil,_Folinic_acid,_Levamisole" .
<Levamisole> <Antineoplastic_of> "Fluorouracil_and_Levamisole" .
<Avatrombopag_monotherapy> <Is_current_in> "Thrombocytopenia_in_liver_disease" .
<Avatrombopag_monotherapy> <Is_current_in> "Immune_thrombocytopenia" .
<Synco-Smzt> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin> <Has_antineoplastic> "Vincristine" .
<Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin> <Has_antineoplastic> "Methotrexate" .
<Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin> <Has_antineoplastic> "Inotuzumab_ozogamicin" .
<Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin> <Has_antineoplastic> "Dexamethasone" .
<Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin> <Has_antineoplastic> "Cytarabine" .
<Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin> <Has_antineoplastic> "Cyclophosphamide" .
<Maintenance_after_salvage_therapy> <Context_of> "Rituximab_monotherapy" .
<Maintenance_after_salvage_therapy> <Context_of> "Placebo" .
<Maintenance_after_salvage_therapy> <Context_of> "Observation" .
<Maintenance_after_salvage_therapy> <Context_of> "Nivolumab_monotherapy" .
<Maintenance_after_salvage_therapy> <Context_of> "Lenalidomide_monotherapy" .
<Maintenance_after_salvage_therapy> <Context_of> "Brentuximab_vedotin_monotherapy" .
<Alfaferone> <Brand_name_of> "Interferon_alfa-2b" .
<Abemaciclib_and_Letrozole> <Has_context> "Non-curative_first-line_therapy" .
<CVP_(Prednisolone)> <Mapped_from> "CVP_(Prednisolone)" .
<R-miniCEOP> <Is_a> "Rituximab-containing_regimen" .
<R-miniCEOP> <Is_a> "Anthracycline-containing_regimen" .
<FND> <Has_context> "Non-curative_first-line_therapy" .
<mFOLFIRINOX> <Has_context> "Adjuvant_therapy" .
<TH_(Taxol)> <Has_accepted_use> "HER2-positive_Breast_cancer" .
<TH_(Taxol)> <Has_accepted_use> "Breast_cancer" .
<Bevacizumab_and_Rituximab> <Is_a> "Rituximab-containing_regimen" .
<Bevacizumab_and_Rituximab> <Is_a> "Bevacizumab-containing_regimen" .
<Thalidomide> <Has_FDA_indication> "Multiple_myeloma" .
<BASIC> <Has_local_therapy> "Hydrocortisone" .
<BASIC> <Has_local_therapy> "Cytarabine" .
<MPT> <Is_current_in> "Multiple_myeloma" .
<Everolimus_and_Octreotide> <Has_context> "All_lines_of_therapy" .
<CAPIRI-Bev> <Has_accepted_use> "Colon_cancer" .
<Ovarian_cancer> <Subsumes> "BRCA-mutated_Ovarian_cancer" .
<Gammacorten> <Brand_name_of> "Dexamethasone" .
<ddC> <Has_accepted_use> "Breast_cancer" .
<VEPA> <Is_a> "Anthracycline-containing_regimen" .
<CapeOx_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<Maradex> <Brand_name_of> "Dexamethasone" .
<Cancer_of_unknown_primary_medication> <Is_a> "Site-agnostic_medication" .
<DAC> <Mapped_from> "DAC" .
<Olaparib_monotherapy> <Has_modality> "Chemotherapy" .
<Cedantron> <Brand_name_of> "Ondansetron" .
<HI-Methasone> <Brand_name_of> "Dexamethasone" .
<Carboplatin,_Etoposide,_RT> <Has_modality> "Radiotherapy" .
<Carboplatin,_Etoposide,_RT> <Has_modality> "Chemotherapy" .
<Danaparoid> <Has_accepted_use> "Venous_thromboembolism" .
<Danaparoid> <Has_accepted_use> "Heparin-induced_thrombocytopenia" .
<CVP> <Has_accepted_use> "Follicular_lymphoma" .
<CVP> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<CVP> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Asdol> <Brand_name_of> "Aspirin" .
<Methylprednisolone> <Supportive_med_of> "Rituximab_monotherapy" .
<Methylprednisolone> <Supportive_med_of> "R-GemOx" .
<Methylprednisolone> <Supportive_med_of> "PCO" .
<Methylprednisolone> <Supportive_med_of> "Doxorubicin_pegylated_liposomal_monotherapy" .
<Methylprednisolone> <Supportive_med_of> "Daratumumab_monotherapy" .
<Methylprednisolone> <Supportive_med_of> "Cytarabine,_Idarubicin,_Vorinostat" .
<Methylprednisolone> <Supportive_med_of> "Carboplatin_and_Paclitaxel" .
<Methylprednisolone> <Supportive_med_of> "CLF" .
<Methylprednisolone> <Supportive_med_of> "Bendamustine_and_Ofatumumab" .
<Methylprednisolone> <Supportive_med_of> "Arsenic_trioxide,_ATRA,_Gemtuzumab_ozogamicin" .
<Methylprednisolone> <Supportive_med_of> "7_plus_3i_and_Vorinostat" .
<OIF> <Brand_name_of> "Interferon_alfa-2b" .
<m-BACOD> <Is_current_in> "HIV-associated_lymphoma" .
<Bleocip> <Brand_name_of> "Bleomycin" .
<Melphalan> <Has_FDA_indication> "Ovarian_cancer" .
<Melphalan> <Has_FDA_indication> "Multiple_myeloma" .
<VMP,_then_Rd> <Has_context> "Non-curative_first-line_therapy" .
<Zyprexa> <Brand_name_of> "Olanzapine" .
<Edrecolomab_monotherapy> <Is_historical_in> "Colon_cancer" .
<R-MACLO/R-IVAM> <Is_current_in> "Mantle_cell_lymphoma" .
<Lusutrombopag_monotherapy> <Has_accepted_use> "Thrombocytopenia_in_liver_disease" .
<Molecular_chaperone_inhibitor> <Subsumes> "Hsp90_inhibitor" .
<Molecular_chaperone_inhibitor> <Subsumes> "Clusterin_inhibitor" .
<Astrix> <Brand_name_of> "Aspirin" .
<Euvaxon> <Brand_name_of> "Etoposide" .
<eBEACOPP_(Prednisolone)> <Maps_to> "eBEACOPP_(Prednisolone)" .
<KSP_inhibitor> <Is_a> "Chemotherapeutic" .
<Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone> <Has_modality> "Chemotherapy" .
<FEC_and_Bevacizumab> <Has_antineoplastic> "Fluorouracil" .
<FEC_and_Bevacizumab> <Has_antineoplastic> "Epirubicin" .
<FEC_and_Bevacizumab> <Has_antineoplastic> "Cyclophosphamide" .
<FEC_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Vincristine_monotherapy> <Has_context> "Non-curative_therapy" .
<Vincristine_monotherapy> <Has_context> "All_lines_of_therapy" .
<GCD> <Is_current_in> "Hodgkin_lymphoma" .
<Cabazitaxel> <Has_accepted_use> "Prostate_cancer" .
<Interferon_alfa-2b_and_DLI> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Allopurinol> <Supportive_med_of> "dmCODOX-M/IVAC_-_Modified_Magrath" .
<Allopurinol> <Supportive_med_of> "dmCODOX-M_-_Modified_Magrath" .
<Allopurinol> <Supportive_med_of> "Rituximab_monotherapy" .
<Allopurinol> <Supportive_med_of> "R-FCM" .
<Allopurinol> <Supportive_med_of> "R-CHOP-14_(Prednisolone)" .
<Allopurinol> <Supportive_med_of> "R-CHOP_(Prednisolone)" .
<Allopurinol> <Supportive_med_of> "PCR" .
<Allopurinol> <Supportive_med_of> "PCO" .
<Allopurinol> <Supportive_med_of> "O-FC" .
<Allopurinol> <Supportive_med_of> "Lenalidomide_monotherapy" .
<Allopurinol> <Supportive_med_of> "Lenalidomide_and_Rituximab" .
<Allopurinol> <Supportive_med_of> "Lenalidomide_and_Ofatumumab" .
<Allopurinol> <Supportive_med_of> "Hyper-CVAD_and_Ponatinib" .
<Allopurinol> <Supportive_med_of> "Hyper-CVAD_and_Imatinib" .
<Allopurinol> <Supportive_med_of> "Hyper-CVAD_and_Dasatinib" .
<Allopurinol> <Supportive_med_of> "HDMP-R" .
<Allopurinol> <Supportive_med_of> "G-FC" .
<Allopurinol> <Supportive_med_of> "FluCam" .
<Allopurinol> <Supportive_med_of> "FR" .
<Allopurinol> <Supportive_med_of> "FM" .
<Allopurinol> <Supportive_med_of> "FCR" .
<Allopurinol> <Supportive_med_of> "FCM" .
<Allopurinol> <Supportive_med_of> "FC" .
<Allopurinol> <Supportive_med_of> "Cyclophosphamide_and_Prednisone" .
<Allopurinol> <Supportive_med_of> "CHOP,_then_131Iodine-Tositumomab" .
<Allopurinol> <Supportive_med_of> "CFAR" .
<Allopurinol> <Supportive_med_of> "Bortezomib_monotherapy" .
<Allopurinol> <Supportive_med_of> "Bendamustine_and_Ofatumumab" .
<Allopurinol> <Supportive_med_of> "Bendamustine_and_Obinutuzumab" .
<TH_(Taxotere)> <Has_antineoplastic> "Trastuzumab" .
<TH_(Taxotere)> <Has_antineoplastic> "Docetaxel" .
<Dapsone> <Has_brand_name> "Aczone" .
<Fluorouracil_and_Methotrexate> <Has_context> "Non-curative_first-line_therapy" .
<BVR> <Is_a> "Rituximab-containing_regimen" .
<Bleopar> <Brand_name_of> "Bleomycin" .
<Anal_cancer> <Current_treated_by> "mDCF" .
<Anal_cancer> <Current_treated_by> "Radiation_therapy" .
<Anal_cancer> <Current_treated_by> "Pembrolizumab_monotherapy" .
<Anal_cancer> <Current_treated_by> "Nivolumab_monotherapy" .
<Anal_cancer> <Current_treated_by> "Fluorouracil,_Mitomycin,_RT" .
<Anal_cancer> <Current_treated_by> "Cisplatin,_Fluorouracil,_RT" .
<Anal_cancer> <Current_treated_by> "Cisplatin_and_Fluorouracil" .
<Anal_cancer> <Current_treated_by> "Carboplatin_and_Paclitaxel" .
<Anal_cancer> <Current_treated_by> "Capecitabine,_Mitomycin,_RT" .
<Alkylating_agent> <Is_a> "Chemotherapeutic" .
<Cisplatin,_Fluorouracil,_Panitumumab> <Has_antineoplastic> "Panitumumab" .
<Cisplatin,_Fluorouracil,_Panitumumab> <Has_antineoplastic> "Fluorouracil" .
<Cisplatin,_Fluorouracil,_Panitumumab> <Has_antineoplastic> "Cisplatin" .
<Tegafur_gimeracil_oteracil> <Has_accepted_use> "Rectal_cancer" .
<Tegafur_gimeracil_oteracil> <Has_accepted_use> "Pancreatic_cancer" .
<Tegafur_gimeracil_oteracil> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Tegafur_gimeracil_oteracil> <Has_accepted_use> "Gastric_cancer" .
<Tegafur_gimeracil_oteracil> <Has_accepted_use> "Colon_cancer" .
<Tegafur_gimeracil_oteracil> <Has_accepted_use> "Cholangiocarcinoma" .
<Tegafur_gimeracil_oteracil> <Has_accepted_use> "Breast_cancer" .
<(90)YFC,_then_allo_HSCT> <Has_accepted_use> "Follicular_lymphoma" .
<Catalgix> <Brand_name_of> "Aspirin" .
<Regorafenib_monotherapy> <Has_accepted_use> "Soft_tissue_sarcoma" .
<Regorafenib_monotherapy> <Has_accepted_use> "Renal_cell_carcinoma" .
<Regorafenib_monotherapy> <Has_accepted_use> "Leiomyosarcoma" .
<Regorafenib_monotherapy> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Regorafenib_monotherapy> <Has_accepted_use> "Gastrointestinal_stromal_tumor" .
<Regorafenib_monotherapy> <Has_accepted_use> "Gastric_cancer" .
<Regorafenib_monotherapy> <Has_accepted_use> "Gallbladder_cancer" .
<Regorafenib_monotherapy> <Has_accepted_use> "Colon_cancer" .
<Regorafenib_monotherapy> <Has_accepted_use> "Cholangiocarcinoma" .
<Prefolic> <Brand_name_of> "Folinic_acid" .
<AIE> <Is_a> "Anthracycline-containing_regimen" .
<Dynaprim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<MC> <Has_accepted_use> "Breast_cancer" .
<Lobaplatin> <Is_a> "Platinum_agent" .
<Lobaplatin> <Is_a> "CFDA_approved_drug" .
<Lobaplatin> <Is_a> "Alkylating_agent" .
<Cisplatin_and_Gemcitabine> <Has_accepted_use> "triple_negative_Breast_cancer" .
<Cisplatin_and_Gemcitabine> <Has_accepted_use> "Pancreatic_cancer" .
<Cisplatin_and_Gemcitabine> <Has_accepted_use> "Ovarian_cancer" .
<Cisplatin_and_Gemcitabine> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Cisplatin_and_Gemcitabine> <Has_accepted_use> "Nasopharyngeal_carcinoma" .
<Cisplatin_and_Gemcitabine> <Has_accepted_use> "Mesothelioma" .
<Cisplatin_and_Gemcitabine> <Has_accepted_use> "Gallbladder_cancer" .
<Cisplatin_and_Gemcitabine> <Has_accepted_use> "EGFR-mutated_Non-small_cell_lung_cancer" .
<Cisplatin_and_Gemcitabine> <Has_accepted_use> "Cholangiocarcinoma" .
<Cisplatin_and_Gemcitabine> <Has_accepted_use> "Cervical_cancer" .
<Cisplatin_and_Gemcitabine> <Has_accepted_use> "Breast_cancer" .
<Cisplatin_and_Gemcitabine> <Has_accepted_use> "Bladder_cancer" .
<Cisplatin_and_Gemcitabine> <Has_accepted_use> "Adenocarcinoma_of_unknown_primary" .
<Gemcitabine_and_Trastuzumab> <Mapped_from> "Gemcitabine_and_Trastuzumab" .
<Microtubule_inhibitor> <Is_a> "Chemotherapeutic" .
<Etoposide_and_TBI> <Is_current_in> "Autologous_HSCT" .
<Etoposide_and_TBI> <Is_current_in> "Allogeneic_HSCT" .
<Bosutinib_monotherapy> <Maps_to> "Bosutinib_monotherapy" .
<R-CVP> <Has_accepted_use> "Marginal_zone_lymphoma" .
<R-CVP> <Has_accepted_use> "Mantle_cell_lymphoma" .
<R-CVP> <Has_accepted_use> "Hodgkin_lymphoma_nodular_lymphocyte-predominant" .
<R-CVP> <Has_accepted_use> "Follicular_lymphoma" .
<R-GCVP> <Has_supportive_med> "Pegfilgrastim" .
<R-GCVP> <Has_supportive_med> "Chlorpheniramine" .
<R-GCVP> <Has_supportive_med> "Acetaminophen" .
<Killit> <Brand_name_of> "Fluorouracil" .
<Leuprolide_monotherapy> <Maps_to> "Leuprolide_monotherapy" .
<Busulfan_and_Cyclophosphamide,_then_allo_HSCT> <Maps_to> "Busulfan_and_Cyclophosphamide,_then_allo_HSCT" .
<Osteotec> <Brand_name_of> "Alendronate" .
<Varubi> <Brand_name_of> "Rolapitant" .
<Cisplatin_and_Epirubicin> <Is_current_in> "Testicular_cancer" .
<Cisplatin_and_Epirubicin> <Is_current_in> "Nasopharyngeal_carcinoma" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone> <Maps_to> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone" .
<Ifosfamide> <Has_brand_name> "Tronoxal" .
<Ifosfamide> <Has_brand_name> "Mitoxana" .
<Ifosfamide> <Has_brand_name> "Macdafen" .
<Ifosfamide> <Has_brand_name> "Isoxan" .
<Ifosfamide> <Has_brand_name> "Isophosphamide" .
<Ifosfamide> <Has_brand_name> "Ipamide" .
<Ifosfamide> <Has_brand_name> "Ifoxan" .
<Ifosfamide> <Has_brand_name> "Ifosfamida" .
<Ifosfamide> <Has_brand_name> "Ifos" .
<Ifosfamide> <Has_brand_name> "Ifomide" .
<Ifosfamide> <Has_brand_name> "Ifomida" .
<Ifosfamide> <Has_brand_name> "Ifolem" .
<Ifosfamide> <Has_brand_name> "Ifocris" .
<Ifosfamide> <Has_brand_name> "Ifex" .
<Ifosfamide> <Has_brand_name> "IFX" .
<Ifosfamide> <Has_brand_name> "IFO_Cell" .
<Ifosfamide> <Has_brand_name> "Holoxane" .
<Ifosfamide> <Has_brand_name> "Holoxan" .
<Ifosfamide> <Has_brand_name> "Haloxan" .
<Ifosfamide> <Has_brand_name> "Fosfidex" .
<Ifosfamide> <Has_brand_name> "Fentul" .
<Ifosfamide> <Has_brand_name> "Duvaxan" .
<Ifosfamide> <Has_brand_name> "Alquimid" .
<DA-R-EPOCH> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<DA-R-EPOCH> <Has_supportive_med> "Sennosides" .
<DA-R-EPOCH> <Has_supportive_med> "Pentamidine" .
<DA-R-EPOCH> <Has_supportive_med> "Pegfilgrastim" .
<DA-R-EPOCH> <Has_supportive_med> "Omeprazole" .
<DA-R-EPOCH> <Has_supportive_med> "Lactulose" .
<DA-R-EPOCH> <Has_supportive_med> "Filgrastim" .
<DA-R-EPOCH> <Has_supportive_med> "Docusate" .
<DA-R-EPOCH> <Has_supportive_med> "Darbepoetin_alfa" .
<DA-R-EPOCH> <Has_supportive_med> "Atovaquone" .
<R-MACLO/R-IVAM> <Maps_to> "R-MACLO/R-IVAM" .
<RT,_then_Carmustine> <Is_current_in> "Anaplastic_glioma" .
<Lansoprazole> <Has_brand_name> "Prevacid" .
<M-EI> <Has_accepted_use> "Osteosarcoma" .
<VR-CP> <Is_current_in> "Follicular_lymphoma" .
<FEAM> <Has_context> "All_lines_of_therapy" .
<BEAC> <Has_modality> "Chemotherapy" .
<Interferon_alfa_and_Dexamethasone> <Maps_to> "Interferon_alfa_and_Dexamethasone" .
<Tropisetron> <May_have_route> "Oral" .
<Tropisetron> <May_have_route> "Intravenous" .
<Altaxel> <Brand_name_of> "Paclitaxel" .
<Indexon> <Brand_name_of> "Dexamethasone" .
<Reditux> <Brand_name_of> "Rituximab" .
<Observation> <Maps_to> "Observation" .
<Cyclophosphamide_monotherapy> <Has_supportive_med> "Prochlorperazine" .
<Cyclophosphamide_monotherapy> <Has_supportive_med> "Ondansetron" .
<Cyclophosphamide_monotherapy> <Has_supportive_med> "Dexamethasone" .
<Mitoxantrone_monotherapy> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<Gemcitabine_and_Paclitaxel> <Is_current_in> "Testicular_cancer" .
<Gemcitabine_and_Paclitaxel> <Is_current_in> "Non-small_cell_lung_cancer" .
<Gemcitabine_and_Paclitaxel> <Is_current_in> "Breast_cancer" .
<Gemcitabine_and_Paclitaxel> <Is_current_in> "Bladder_cancer" .
<VH> <Has_antineoplastic> "Vinorelbine" .
<VH> <Has_antineoplastic> "Trastuzumab" .
<Espasevit> <Brand_name_of> "Ondansetron" .
<Eptoin> <Brand_name_of> "Phenytoin" .
<Bortezomib_and_Panobinostat> <Has_accepted_use> "Peripheral_T-cell_lymphoma" .
<Erythropoietin_monotherapy> <Mapped_from> "Erythropoietin_monotherapy" .
<DEP_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<DEP_and_RT> <Has_antineoplastic> "Etoposide" .
<DEP_and_RT> <Has_antineoplastic> "Dexamethasone" .
<DEP_and_RT> <Has_antineoplastic> "Cisplatin" .
<Eutrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Roferon-A> <Brand_name_of> "Interferon_alfa-2a" .
<Cisplatin_and_Etoposide> <Mapped_from> "Cisplatin_and_Etoposide" .
<Rituximab-pvvr> <Is_a> "WHO_Essential_Cancer_Medicine" .
<Rituximab-pvvr> <Is_a> "Protein_expression-specific_medication" .
<Rituximab-pvvr> <Is_a> "Neutral" .
<Rituximab-pvvr> <Is_a> "Biosimilar" .
<Rituximab-pvvr> <Is_a> "Antibody_medication" .
<Rituximab-pvvr> <Is_a> "Anti-CD20_antibody" .
<Erlotinib_and_Bevacizumab> <Has_modality> "Chemotherapy" .
<ATG_(Horse),_Cyclosporine,_Sirolimus> <Has_modality> "Immunosuppressive_therapy" .
<BEAM,_then_auto_HSCT> <Is_current_in> "Peripheral_T-cell_lymphoma" .
<BEAM,_then_auto_HSCT> <Is_current_in> "Mantle_cell_lymphoma" .
<BEAM,_then_auto_HSCT> <Is_current_in> "Hodgkin_lymphoma" .
<BEAM,_then_auto_HSCT> <Is_current_in> "HIV-associated_lymphoma" .
<BEAM,_then_auto_HSCT> <Is_current_in> "Diffuse_large_B-cell_lymphoma" .
<BEAM,_then_auto_HSCT> <Is_current_in> "CNS_lymphoma" .
<Ivosidenib_monotherapy> <Is_current_in> "Cholangiocarcinoma" .
<Ivosidenib_monotherapy> <Is_current_in> "Acute_myeloid_leukemia" .
<CMED> <Has_supportive_med> "Folinic_acid" .
<CapeOx> <Mapped_from> "CapeOx" .
<Tamibarotene_monotherapy> <Is_current_in> "Acute_promyelocytic_leukemia" .
<CEOP_(Prednisolone)> <Has_antineoplastic> "Vincristine" .
<CEOP_(Prednisolone)> <Has_antineoplastic> "Prednisolone" .
<CEOP_(Prednisolone)> <Has_antineoplastic> "Epirubicin" .
<CEOP_(Prednisolone)> <Has_antineoplastic> "Cyclophosphamide" .
<IE> <Has_supportive_med> "Mesna" .
<Docetaxel,_Fluorouracil,_Hydroxyurea,_RT> <Has_modality> "Radiotherapy" .
<Docetaxel,_Fluorouracil,_Hydroxyurea,_RT> <Has_modality> "Chemotherapy" .
<F-MACHOP> <Has_context> "Induction_therapy" .
<TTR> <Has_context> "Non-curative_subsequent-line_therapy" .
<Abemaciclib_and_Letrozole> <Has_antineoplastic> "Letrozole" .
<Abemaciclib_and_Letrozole> <Has_antineoplastic> "Abemaciclib" .
<Pomalidomide_and_Prednisone> <Has_modality> "Chemotherapy" .
<Benralizumab> <Has_brand_name> "Fasenra" .
<VAD_plus_C> <Maps_to> "VAD_plus_C" .
<Cyclophosphamide_and_TBI,_then_auto_HSCT> <Mapped_from> "Cyclophosphamide_and_TBI,_then_auto_HSCT" .
<KRd> <Is_current_in> "Multiple_myeloma" .
<L-Asparaginase_and_Methotrexate> <Has_supportive_med> "Folinic_acid" .
<COPDAC> <Has_antineoplastic> "Vincristine" .
<COPDAC> <Has_antineoplastic> "Prednisone" .
<COPDAC> <Has_antineoplastic> "Dacarbazine" .
<COPDAC> <Has_antineoplastic> "Cyclophosphamide" .
<Sonidegib_monotherapy> <Maps_to> "Sonidegib_monotherapy" .
<MACOP-B> <Is_historical_in> "Diffuse_large_B-cell_lymphoma" .
<GTX> <Has_context> "Non-curative_first-line_therapy" .
<Lutetium_Lu_177_dotatate_and_Octreotide_LAR> <Has_modality> "Radiotherapy" .
<Lutetium_Lu_177_dotatate_and_Octreotide_LAR> <Has_modality> "Hormonotherapy" .
<Hytas> <Brand_name_of> "Hydroxyurea" .
<Peginterferon_alfa-2b> <Has_accepted_use> "Melanoma" .
<Defibrotide_monotherapy> <Is_current_in> "Allogeneic_HSCT" .
<Sunitinib> <Antineoplastic_of> "Sunitinib_monotherapy" .
<Sunitinib> <Antineoplastic_of> "Gemcitabine_and_Sunitinib" .
<CHOP,_then_131Iodine-Tositumomab> <Mapped_from> "CHOP,_then_131Iodine-Tositumomab" .
<Estilsona> <Brand_name_of> "Prednisolone" .
<MPR> <Has_antineoplastic> "Prednisone" .
<MPR> <Has_antineoplastic> "Melphalan" .
<MPR> <Has_antineoplastic> "Lenalidomide" .
<Neuroblastoma> <Is_a> "Pediatric_cancer" .
<Maxidex> <Brand_name_of> "Dexamethasone" .
<nab-Paclitaxel_monotherapy> <Has_antineoplastic> "Paclitaxel_nanoparticle_albumin-bound" .
<Bevacizumab> <Antineoplastic_of> "mFOLFOX6_and_Bevacizumab_(L-Leucovorin)" .
<Bevacizumab> <Antineoplastic_of> "mFOLFOX6_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "mDCF_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Vinorelbine_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Topotecan_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Temozolomide_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "SOX_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Pemetrexed_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Paclitaxel,_nanoparticle_albumin-bound_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Paclitaxel,_Topotecan,_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Paclitaxel_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Oxaliplatin_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Lomustine_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Letrozole_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Irinotecan_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "IRIS_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "IFL_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Gemcitabine_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "GEMOX-B" .
<Bevacizumab> <Antineoplastic_of> "FULV_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "FOLFOX4_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)" .
<Bevacizumab> <Antineoplastic_of> "FOLFIRI_and_Bevacizumab_(L-Leucovorin)" .
<Bevacizumab> <Antineoplastic_of> "FOLFIRI_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "FEC_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "FAC_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Erlotinib_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "EC_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Doxorubicin_pegylated_liposomal_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Doxorubicin_non-pegylated_liposomal_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Doxorubicin_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Docetaxel_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Cisplatin,_Pemetrexed,_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Cisplatin,_Paclitaxel,_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Cisplatin,_Gemcitabine,_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Cisplatin,_Etoposide,_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Carboplatin,_Pemetrexed,_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Carboplatin,_Paclitaxel,_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Carboplatin,_Gemcitabine,_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Carboplatin,_Etoposide,_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Carboplatin_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Capecitabine,_Bevacizumab,_Trastuzumab" .
<Bevacizumab> <Antineoplastic_of> "Capecitabine_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "CapeOx_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "CAPIRI-Bev" .
<Bevacizumab> <Antineoplastic_of> "Bevacizumab-containing_therapy" .
<Bevacizumab> <Antineoplastic_of> "Bevacizumab_monotherapy" .
<Bevacizumab> <Antineoplastic_of> "Bevacizumab_and_Rituximab" .
<Bevacizumab> <Antineoplastic_of> "Bevacizumab_and_RT" .
<Bevacizumab> <Antineoplastic_of> "Bevacizumab_and_Interferon_alfa-2a" .
<Bevacizumab> <Antineoplastic_of> "Atezolizumab_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "Afatinib_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "AC_and_Bevacizumab" .
<Bevacizumab> <Antineoplastic_of> "ABCP" .
<Bevacizumab> <Antineoplastic_of> "ABC" .
<Carfilzomib> <Antineoplastic_of> "KTD" .
<Carfilzomib> <Antineoplastic_of> "KRd" .
<Carfilzomib> <Antineoplastic_of> "KPD" .
<Carfilzomib> <Antineoplastic_of> "KMP" .
<Carfilzomib> <Antineoplastic_of> "KD" .
<Carfilzomib> <Antineoplastic_of> "KCD" .
<Carfilzomib> <Antineoplastic_of> "Dara-KD" .
<Carfilzomib> <Antineoplastic_of> "Carfilzomib_monotherapy" .
<Carfilzomib> <Antineoplastic_of> "Carfilzomib_and_Panobinostat" .
<Carfilzomib> <Antineoplastic_of> "CaRD" .
<Carfilzomib> <Antineoplastic_of> "CYKLONE" .
<Biocarbo> <Brand_name_of> "Carboplatin" .
<Decadron> <Brand_name_of> "Dexamethasone" .
<Giant-cell_tumor_of_bone> <Current_treated_by> "Denosumab_monotherapy" .
<R-ICE> <Mapped_from> "R-ICE" .
<Ketoconazole> <Has_accepted_use> "Prostate_cancer" .
<AKT1_inhibitor> <Is_a> "Kinase_inhibitor" .
<Bestpirin> <Brand_name_of> "Aspirin" .
<Melphalan_and_Methylprednisolone,_then_auto_HSCT> <Mapped_from> "Melphalan_and_Methylprednisolone,_then_auto_HSCT" .
<Tavist> <Brand_name_of> "Clemastine" .
<Risedronate> <Is_a> "Bisphosphonate" .
<Aldesleukin> <Has_accepted_use> "Renal_cell_carcinoma" .
<Aldesleukin> <Has_accepted_use> "Neuroblastoma" .
<Aldesleukin> <Has_accepted_use> "Melanoma" .
<MBVP> <Has_antineoplastic> "Teniposide" .
<MBVP> <Has_antineoplastic> "Prednisone" .
<MBVP> <Has_antineoplastic> "Methotrexate" .
<MBVP> <Has_antineoplastic> "Carmustine" .
<Capecitabine_and_Mitomycin> <Mapped_from> "Capecitabine_and_Mitomycin" .
<Sandostatina> <Brand_name_of> "Octreotide" .
<PVAG> <Is_current_in> "Hodgkin_lymphoma" .
<Lenalidomide_monotherapy> <Has_context> "Non-curative_therapy" .
<Lenalidomide_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<Lenalidomide_monotherapy> <Has_context> "Non-curative_subsequent-line_maintenance_therapy" .
<Lenalidomide_monotherapy> <Has_context> "Non-curative_second-line_maintenance_therapy" .
<Lenalidomide_monotherapy> <Has_context> "Non-curative_first-line_therapy" .
<Lenalidomide_monotherapy> <Has_context> "Non-curative_first-line_maintenance_therapy" .
<Lenalidomide_monotherapy> <Has_context> "Non-curative_first-line_consolidation_therapy" .
<Lenalidomide_monotherapy> <Has_context> "Maintenance_after_upfront_therapy" .
<Lenalidomide_monotherapy> <Has_context> "Maintenance_after_salvage_therapy" .
<Lenalidomide_monotherapy> <Has_context> "All_lines_of_therapy" .
<Herceptin> <Brand_name_of> "Trastuzumab" .
<Radotinib> <Antineoplastic_of> "Radotinib_monotherapy" .
<Neratinib_monotherapy> <Maps_to> "Neratinib_monotherapy" .
<Bevacizumab_monotherapy> <Mapped_from> "Bevacizumab_monotherapy" .
<ATG_(Rabbit)_and_Cyclosporine> <Maps_to> "ATG_(Rabbit)_and_Cyclosporine" .
<Paclitaxel_and_RT> <Has_context> "Induction_therapy" .
<Paclitaxel_and_RT> <Has_context> "Definitive_therapy" .
<Paclitaxel_and_RT> <Has_context> "Consolidation_after_upfront_therapy" .
<LOPP> <Has_context> "Induction_therapy" .
<CEPP(B)> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone> <Has_antineoplastic> "Vincristine" .
<Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone> <Has_antineoplastic> "Prednisone" .
<Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone> <Has_antineoplastic> "Idarubicin" .
<Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone> <Has_antineoplastic> "Cyclophosphamide" .
<ABP> <Has_antineoplastic> "Prednisone" .
<ABP> <Has_antineoplastic> "Doxorubicin" .
<ABP> <Has_antineoplastic> "Bleomycin" .
<Baktar> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<BuCy,_then_allo_HSCT> <Maps_to> "BuCy,_then_allo_HSCT" .
<Foliben> <Brand_name_of> "Folinic_acid" .
<Perifosine> <Has_FDA_indication> "Neuroblastoma" .
<Perifosine> <Has_FDA_indication> "Multiple_myeloma" .
<Trastuzumab_and_hyaluronidase_monotherapy> <Has_antineoplastic> "Trastuzumab_and_hyaluronidase" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Vincristine_liposomal_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Vincristine_liposomal" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Vincristine_and_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Vincristine" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Tisagenlecleucel_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Tisagenlecleucel" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Thioguanine" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Teniposide" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "TBI,_then_auto_HSCT" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Rituximab-pvvr" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Rituximab-abbs" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Rituximab" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "R-Hyper-CVAD/R-MA" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Prednisone_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Prednisolone_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Prednisolone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Ponatinib_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Ponatinib" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Pentostatin_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Pegaspargase,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Pegaspargase" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Pediatric-like_GRAALL_consolidation" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "POMP" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Nilotinib-based_consolidation" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Nilotinib_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Nilotinib" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Mitoxantrone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Mini-Hyper-CVD/MA_and_Inotuzumab_ozogamicin" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Methylprednisolone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Methotrexate_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Methotrexate_and_Vincristine" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Methotrexate_and_Pegaspargase" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Methotrexate" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Mercaptopurine,_Methotrexate,_WB-XRT" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Mercaptopurine,_Methotrexate,_Vincristine,_Dexamethasone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Mercaptopurine,_Methotrexate,_Vincristine" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Mercaptopurine_and_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Mercaptopurine_and_Methotrexate" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Mercaptopurine" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Linker_regimen_(consolidation)" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "L-Asparaginase,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "L-Asparaginase,_Vincristine,_Prednisolone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "L-Asparaginase,_Vincristine,_Dexamethasone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "L-Asparaginase_and_Methotrexate" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "International_ALL_Trial" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Inotuzumab_ozogamicin_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Inotuzumab_ozogamicin" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Imatinib-based_consolidation" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Imatinib,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Imatinib,_Vincristine,_Dexamethasone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Imatinib_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Imatinib_and_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Imatinib" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Idarubicin" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Hyper-CVAD/MA_and_Everolimus" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Hyper-CVAD/MA" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Hyper-CVAD_and_Ponatinib" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Hyper-CVAD_and_Imatinib" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Hyper-CVAD_and_Dasatinib" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "HAM_and_Imatinib" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Fludarabine" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Filgrastim" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "FLAG" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Everolimus" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Etoposide,_Ifosfamide,_Imatinib" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Etoposide_and_TBI,_then_allo_HSCT" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Etoposide" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Epratuzumab" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Doxorubicin,_Methotrexate,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Doxorubicin,_6-MP,_Pegaspargase,_Vincristine,_Prednisolone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Doxorubicin" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Dexamethasone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Daunorubicin,_Vincristine,_Prednisolone,_Nilotinib" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Daunorubicin,_Pegaspargase,_Vincristine,_Dexamethasone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Imatinib" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Daunorubicin_and_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Daunorubicin" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Dasatinib,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Dasatinib_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Dasatinib_and_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Dasatinib" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "DOLP_(Prednisolone)" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "DOLP" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cytarabine,_Idarubicin,_Rituximab" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cytarabine,_Idarubicin,_Imatinib" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cytarabine,_Daunorubicin,_L-Asparaginase,_Teniposide,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cytarabine_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cytarabine_and_Mitoxantrone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cytarabine_and_Idarubicin" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cytarabine" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cyclophosphamide,_Idarubicin,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cyclophosphamide,_Doxorubicin,_L-Asparaginase,_Vincristine,_Prednisolone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cyclophosphamide,_Daunorubicin,_Vincristine,_Prednisolone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone,_Rituximab" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cyclophosphamide,_Daunorubicin,_L-Asparaginase,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cyclophosphamide,_Cytarabine,_Pegaspargase,_Thioguanine,_Vincristine,_Dexamethasone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cyclophosphamide,_Cytarabine,_Mercaptopurine" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cyclophosphamide_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cyclophosphamide_and_TBI,_then_allo_HSCT" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Cyclophosphamide" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Clofarabine_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Clofarabine" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Calaspargase,_Daunorubicin,_Vincristine,_Prednisone" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Calaspargase" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "COMP" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "CCE" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "CALGB_8811_late_intensification" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "CALGB_8811_early_intensification" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Bosutinib_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Bosutinib" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Blinatumomab_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Blinatumomab" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Bacillus_Calmette-Guerin_(BCG)_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Augmented_Hyper-CVAD_and_Asparaginase" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Augmented_BFM_consolidation" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Asparaginase_Erwinia_chrysanthemi" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Asparaginase" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Aminopterin_monotherapy" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "Aminopterin" .
<B-cell_acute_lymphoblastic_leukemia> <Accepted_use_of> "AALL0232_consolidation" .
<Pertuzumab_and_Trastuzumab> <Has_context> "Non-curative_third-line_therapy" .
<Pertuzumab_and_Trastuzumab> <Has_context> "Non-curative_therapy" .
<Pertuzumab_and_Trastuzumab> <Has_context> "Non-curative_subsequent-line_therapy" .
<Pertuzumab_and_Trastuzumab> <Has_context> "All_lines_of_therapy" .
<IFL_and_Bevacizumab> <Is_current_in> "Colon_cancer" .
<Peginterferon_alfa-2a> <Antineoplastic_of> "Peginterferon_alfa-2a_monotherapy" .
<Peginterferon_alfa-2a> <Antineoplastic_of> "Imatinib_and_Interferon" .
<Latrotal> <Brand_name_of> "Letrozole" .
<R-MegaCHOP> <Maps_to> "R-MegaCHOP" .
<Predni-Coelin> <Brand_name_of> "Prednisolone" .
<Fulphila> <Brand_name_of> "Pegfilgrastim-jmdb" .
<Fulphila> <Brand_name_of> "Pegfilgrastim-cbqv" .
<Mediamethasone> <Brand_name_of> "Dexamethasone" .
<Chronic_myelomonocytic_leukemia> <FDA_indication_of> "Azacitidine" .
<CapeOx> <Is_a> "Platinum_doublet" .
<Cyclosporine,_Sirolimus,_Prednisone> <Has_modality> "Immunosuppressive_therapy" .
<L-glutamine_monotherapy> <Mapped_from> "L-glutamine_monotherapy" .
<Pamidronate> <Supportive_med_of> "VD" .
<Pamidronate> <Supportive_med_of> "VAD" .
<Pamidronate> <Supportive_med_of> "Thalidomide_monotherapy" .
<Pamidronate> <Supportive_med_of> "Rd" .
<Pamidronate> <Supportive_med_of> "RD" .
<Pamidronate> <Supportive_med_of> "PAD" .
<Pamidronate> <Supportive_med_of> "MPT" .
<Pamidronate> <Supportive_med_of> "MPR" .
<Pamidronate> <Supportive_med_of> "MP" .
<Pamidronate> <Supportive_med_of> "Lenalidomide_monotherapy" .
<Azacitidine_and_Gemtuzumab_ozogamicin> <Has_supportive_med> "Hydroxyurea" .
<Paclitaxel_and_Bevacizumab> <Has_antineoplastic> "Paclitaxel" .
<Paclitaxel_and_Bevacizumab> <Has_antineoplastic> "Bevacizumab" .
<Graft_versus_host_disease> <Current_treated_by> "Sirolimus,_Tacrolimus,_Prednisone" .
<Graft_versus_host_disease> <Current_treated_by> "Rabbit_ATG" .
<Graft_versus_host_disease> <Current_treated_by> "Methotrexate,_Tacrolimus,_Vorinostat" .
<Graft_versus_host_disease> <Current_treated_by> "Methotrexate,_Tacrolimus,_Tocilizumab" .
<Graft_versus_host_disease> <Current_treated_by> "Methotrexate_and_Tacrolimus" .
<Graft_versus_host_disease> <Current_treated_by> "Ibrutinib_monotherapy" .
<Graft_versus_host_disease> <Current_treated_by> "Cyclosporine,_Sirolimus,_Prednisone" .
<Graft_versus_host_disease> <Current_treated_by> "Cyclosporine,_Mycophenolate_mofetil,_Sirolimus" .
<Graft_versus_host_disease> <Current_treated_by> "Cyclosporine,_Methotrexate,_Prednisone" .
<Graft_versus_host_disease> <Current_treated_by> "Cyclosporine,_Methotrexate,_Methylprednisolone" .
<Graft_versus_host_disease> <Current_treated_by> "Cyclosporine,_Methotrexate,_ATG" .
<Graft_versus_host_disease> <Current_treated_by> "Cyclosporine,_Corticosteroids,_Rituximab" .
<Graft_versus_host_disease> <Current_treated_by> "Cyclosporine_and_Prednisone" .
<Graft_versus_host_disease> <Current_treated_by> "Cyclosporine_and_Mycophenolate_mofetil" .
<Graft_versus_host_disease> <Current_treated_by> "Cyclosporine_and_Methotrexate" .
<Graft_versus_host_disease> <Current_treated_by> "Cyclophosphamide,_Mycophenolate_mofetil,_Tacrolimus" .
<TCH_(Taxotere,_Cyclophosphamide)> <Mapped_from> "TCH_(Taxotere,_Cyclophosphamide)" .
<Septiolan> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cytarabine,_Daunorubicin,_L-Asparaginase,_Vincristine,_Dexamethasone> <Has_accepted_use> "B-cell_acute_lymphoblastic_leukemia" .
<Warnerin> <Brand_name_of> "Warfarin" .
<Venetoclax_and_Rituximab> <Has_antineoplastic> "Venetoclax" .
<Venetoclax_and_Rituximab> <Has_antineoplastic> "Rituximab" .
<Chromo-Z> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Alemtuzumab_and_Methylprednisolone> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Nucotrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Cyclophosphamide_and_Vincristine> <Has_context> "Non-curative_therapy" .
<Denfos> <Brand_name_of> "Alendronate" .
<Iron_sucrose> <Is_a> "Iron" .
<Iron_sucrose> <Is_a> "Hematology_medication" .
<Vepox> <Brand_name_of> "Epoetin_alfa" .
<CHOP> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<CHOP> <Has_supportive_med> "Pentamidine" .
<CHOP> <Has_supportive_med> "Granulocyte_colony-stimulating_factors" .
<CHOP> <Has_supportive_med> "Filgrastim" .
<CHOP> <Has_supportive_med> "Dapsone" .
<ADT_and_Abiraterone> <Has_antineoplastic> "GnRH_antagonists" .
<ADT_and_Abiraterone> <Has_antineoplastic> "GnRH_agonists" .
<ADT_and_Abiraterone> <Has_antineoplastic> "Endocrine_ablation_surgery" .
<ADT_and_Abiraterone> <Has_antineoplastic> "Abiraterone" .
<Trimezol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Romidepsin> <Antineoplastic_of> "Romidepsin_monotherapy" .
<Hyper-CVAD_and_Dasatinib> <Has_supportive_med> "Valacyclovir" .
<Hyper-CVAD_and_Dasatinib> <Has_supportive_med> "Trimethoprim-Sulfamethoxazole" .
<Hyper-CVAD_and_Dasatinib> <Has_supportive_med> "Rasburicase" .
<Hyper-CVAD_and_Dasatinib> <Has_supportive_med> "Mesna" .
<Hyper-CVAD_and_Dasatinib> <Has_supportive_med> "Levofloxacin" .
<Hyper-CVAD_and_Dasatinib> <Has_supportive_med> "Folinic_acid" .
<Hyper-CVAD_and_Dasatinib> <Has_supportive_med> "Fluconazole" .
<Hyper-CVAD_and_Dasatinib> <Has_supportive_med> "Filgrastim" .
<Hyper-CVAD_and_Dasatinib> <Has_supportive_med> "Ciprofloxacin" .
<Hyper-CVAD_and_Dasatinib> <Has_supportive_med> "Allopurinol" .
<Hyper-CVAD_and_Dasatinib> <Has_supportive_med> "Acyclovir" .
<Docetaxel_and_Prednisone> <Has_accepted_use> "Prostate_cancer" .
<PAR1_inhibitor> <Is_a> "Antiplatelet_agent" .
<Docetaxel_monotherapy> <Has_modality> "Chemotherapy" .
<Cyclophosphamide,_Prednisone,_Diethylstilbestrol> <Has_context> "Non-curative_therapy" .
<Fulvestrant> <Has_brand_name> "Fuvestrol" .
<Fulvestrant> <Has_brand_name> "Fulvidax" .
<Fulvestrant> <Has_brand_name> "Fulvenat" .
<Fulvestrant> <Has_brand_name> "Fasnorm" .
<Fulvestrant> <Has_brand_name> "Faslodex" .
<TACE> <Has_modality> "Chemotherapy" .
<Cisplatin,_Fluorouracil,_Cetuximab> <Has_modality> "Chemotherapy" .
<Gemtuzumab_ozogamicin> <Has_FDA_indication> "Acute_myeloid_leukemia" .
<Medixel> <Brand_name_of> "Paclitaxel" .
<Paclitaxel,_Topotecan,_Bevacizumab> <Has_modality> "Chemotherapy" .
<FULV/FULV_and_RT> <Has_antineoplastic> "Folinic_acid" .
<FULV/FULV_and_RT> <Has_antineoplastic> "Fluorouracil" .
<FULV/FULV_and_RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<Sorafenib> <Has_accepted_use> "Thyroid_cancer" .
<Sorafenib> <Has_accepted_use> "Renal_cell_carcinoma" .
<Sorafenib> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Sorafenib> <Has_accepted_use> "Hepatocellular_carcinoma" .
<Sorafenib> <Has_accepted_use> "Acute_myeloid_leukemia" .
<MOPP> <Has_antineoplastic> "Vincristine" .
<MOPP> <Has_antineoplastic> "Procarbazine" .
<MOPP> <Has_antineoplastic> "Prednisone" .
<MOPP> <Has_antineoplastic> "Mechlorethamine" .
<Acalabrutinib_monotherapy> <Mapped_from> "Acalabrutinib_monotherapy" .
<Trexall> <Brand_name_of> "Methotrexate" .
<MAP2K2_inhibitor> <Subsumes> "Trametinib" .
<MAP2K2_inhibitor> <Subsumes> "Selumetinib" .
<MAP2K2_inhibitor> <Subsumes> "Cobimetinib" .
<MAP2K2_inhibitor> <Subsumes> "Binimetinib" .
<C-VAMP> <Is_historical_in> "Multiple_myeloma" .
<R-TBI/Cy,_then_auto_HSCT> <Maps_to> "R-TBI/Cy,_then_auto_HSCT" .
<Mitoxantrone_and_Prednisone> <Has_context> "Non-curative_therapy" .
<Cyclosporine> <Subsumes> "Cyclosporine_non-modified" .
<Cyclosporine> <Subsumes> "Cyclosporine_modified" .
<Octrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Capecitabine_and_Lapatinib> <Is_current_in> "CNS_carcinoma" .
<Capecitabine_and_Lapatinib> <Is_current_in> "Breast_cancer" .
<CRD> <Has_supportive_med> "Aspirin" .
<Bendamustine_and_Ofatumumab> <Is_current_in> "Follicular_lymphoma" .
<Bendamustine_and_Ofatumumab> <Is_current_in> "Chronic_lymphocytic_leukemia" .
<Mitoxantrone> <Antineoplastic_of> "m-BNCOD" .
<Mitoxantrone> <Antineoplastic_of> "VNCOP-B" .
<Mitoxantrone> <Antineoplastic_of> "VIM" .
<Mitoxantrone> <Antineoplastic_of> "VEPEMB" .
<Mitoxantrone> <Antineoplastic_of> "R-NIMP" .
<Mitoxantrone> <Antineoplastic_of> "R-MCP" .
<Mitoxantrone> <Antineoplastic_of> "R-FND" .
<Mitoxantrone> <Antineoplastic_of> "R-FM" .
<Mitoxantrone> <Antineoplastic_of> "R-FCM" .
<Mitoxantrone> <Antineoplastic_of> "R-CMD" .
<Mitoxantrone> <Antineoplastic_of> "PMitCEBO" .
<Mitoxantrone> <Antineoplastic_of> "PEN" .
<Mitoxantrone> <Antineoplastic_of> "NOVP" .
<Mitoxantrone> <Antineoplastic_of> "Mitoxantrone,_Pegaspargase,_Vincristine,_Dexamethasone" .
<Mitoxantrone> <Antineoplastic_of> "Mitoxantrone,_Asparaginase_Erwinia_chrysanthemi,_Vincristine,_Dexamethasone" .
<Mitoxantrone> <Antineoplastic_of> "Mitoxantrone_monotherapy" .
<Mitoxantrone> <Antineoplastic_of> "Mitoxantrone_and_Prednisone" .
<Mitoxantrone> <Antineoplastic_of> "Mitoxantrone_and_Hydrocortisone" .
<Mitoxantrone> <Antineoplastic_of> "MINE" .
<Mitoxantrone> <Antineoplastic_of> "MEC" .
<Mitoxantrone> <Antineoplastic_of> "MCP_(Prednisolone)" .
<Mitoxantrone> <Antineoplastic_of> "MCP" .
<Mitoxantrone> <Antineoplastic_of> "Idarubicin,_then_Mitoxantrone,_then_Idarubicin,_with_ATRA" .
<Mitoxantrone> <Antineoplastic_of> "Idarubicin,_then_Mitoxantrone,_then_Idarubicin" .
<Mitoxantrone> <Antineoplastic_of> "HAM_and_Imatinib" .
<Mitoxantrone> <Antineoplastic_of> "HAM" .
<Mitoxantrone> <Antineoplastic_of> "FND" .
<Mitoxantrone> <Antineoplastic_of> "FNC" .
<Mitoxantrone> <Antineoplastic_of> "FMP" .
<Mitoxantrone> <Antineoplastic_of> "FM" .
<Mitoxantrone> <Antineoplastic_of> "FCM" .
<Mitoxantrone> <Antineoplastic_of> "Etoposide_and_Mitoxantrone" .
<Mitoxantrone> <Antineoplastic_of> "Cytarabine_and_Mitoxantrone" .
<Mitoxantrone> <Antineoplastic_of> "Cytarabine_and_Idarubicin,_then_Mitoxantrone,_then_Cytarabine_and_Idarubicin,_with_ATRA" .
<Mitoxantrone> <Antineoplastic_of> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine,_with_ATRA" .
<Mitoxantrone> <Antineoplastic_of> "Cytarabine_and_Idarubicin,_then_Etoposide_and_Mitoxantrone,_then_Cytarabine,_Idarubicin,_Thioguanine" .
<Mitoxantrone> <Antineoplastic_of> "CNOP_(Prednisolone)" .
<Mitoxantrone> <Antineoplastic_of> "CNOP" .
<Mitoxantrone> <Antineoplastic_of> "CMC" .
<Mitoxantrone> <Antineoplastic_of> "CLAG-M" .
<Mitoxantrone> <Antineoplastic_of> "CBVM,_then_auto_HSCT" .
<Mitoxantrone> <Antineoplastic_of> "CBV-Mx,_then_auto_HSCT" .
<Mitoxantrone> <Antineoplastic_of> "CBV-Mx" .
<Mitoxantrone> <Antineoplastic_of> "7_plus_3m" .
<Chlorambucil_and_Rituximab> <Has_modality> "Chemotherapy" .
<Non-curative_second-line_consolidation_therapy> <Mapped_from> "Non-curative_second-line_consolidation_therapy" .
<Meproson> <Brand_name_of> "Methylprednisolone" .
<Carbotanil> <Brand_name_of> "Carboplatin" .
<Halotestin> <Brand_name_of> "Fluoxymesterone" .
<PEP-C> <Has_context> "Non-curative_therapy" .
<Fluorouracil,_Folinic_acid,_nanoliposomal_Irinotecan> <Is_current_in> "Pancreatic_cancer" .
<R-COPADM> <Has_modality> "Chemotherapy" .
<Edrecolomab_monotherapy> <Has_context> "Adjuvant_therapy" .
<DE> <Has_accepted_use> "Breast_cancer" .
<CBV-Mx,_then_auto_HSCT> <Has_modality> "Chemotherapy" .
<RVR> <Maps_to> "RVR" .
<Lapatinib_and_Trastuzumab> <Has_antineoplastic> "Trastuzumab" .
<Lapatinib_and_Trastuzumab> <Has_antineoplastic> "Lapatinib" .
<Hyper-CVAD_and_Imatinib> <Mapped_from> "Hyper-CVAD_and_Imatinib" .
<Acalabrutinib_monotherapy> <Has_antineoplastic> "Acalabrutinib" .
<Daratumumab_monotherapy> <Maps_to> "Daratumumab_monotherapy" .
<Linola-H-Fett_N> <Brand_name_of> "Prednisolone" .
<Lomustine> <Is_a> "Nitrosourea" .
<CHAD> <Has_accepted_use> "Ovarian_cancer" .
<Otrim> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Trastuzumab_and_ET> <Is_current_in> "Breast_cancer" .
<eBEACOPP> <Has_supportive_med> "Filgrastim" .
<DTPACE> <Maps_to> "DTPACE" .
<Cisplatin_and_Methotrexate> <Has_context> "Adjuvant_therapy" .
<Vismodegib> <Has_accepted_use> "Hedgehog_pathway-mutated_malignancy" .
<Vismodegib> <Has_accepted_use> "Cutaneous_basal_cell_carcinoma" .
<FOLFIRI_and_Panitumumab> <Has_context> "Non-curative_second-line_therapy" .
<Vinblastine_monotherapy> <Is_current_in> "Hodgkin_lymphoma" .
<Factor_VIII_recombinant> <Has_brand_name> "Xyntha" .
<Factor_VIII_recombinant> <Has_brand_name> "Refacto" .
<Factor_VIII_recombinant> <Has_brand_name> "Recombinate" .
<Factor_VIII_recombinant> <Has_brand_name> "Kogenate_FS" .
<Factor_VIII_recombinant> <Has_brand_name> "Kogenate" .
<Factor_VIII_recombinant> <Has_brand_name> "Helixate_FS" .
<Factor_VIII_recombinant> <Has_brand_name> "Helixate" .
<Factor_VIII_recombinant> <Has_brand_name> "Advate_rAHF-PFM" .
<TH_(Taxol)> <Has_antineoplastic> "Trastuzumab" .
<TH_(Taxol)> <Has_antineoplastic> "Paclitaxel" .
<Prednisone_and_Rituximab> <Has_context> "All_lines_of_therapy" .
<Zidovudine> <Has_accepted_use> "Adult_T-cell_leukemia-lymphoma" .
<Crizotinib_monotherapy> <Has_antineoplastic> "Crizotinib" .
<VACA/IE> <Is_a> "Anthracycline-containing_regimen" .
<Carboplatin_and_Etoposide> <Has_accepted_use> "Small_cell_lung_cancer" .
<Carboplatin_and_Etoposide> <Has_accepted_use> "Non-small_cell_lung_cancer" .
<Fluorouracil,_Folinic_acid,_Mitomycin> <Has_context> "Non-curative_subsequent-line_therapy" .
<Fluorouracil,_Folinic_acid,_Mitomycin> <Has_context> "Non-curative_first-line_therapy" .
<Chlorambucil_and_Rituximab> <Maps_to> "Chlorambucil_and_Rituximab" .
<Sirolimus,_Tacrolimus,_Prednisone> <Is_current_in> "Graft_versus_host_disease" .
<Sirolimus,_Tacrolimus,_Prednisone> <Has_context> "All_lines_of_therapy" .
<Radium-223_monotherapy> <Maps_to> "Radium-223_monotherapy" .
<Argatroban> <Is_a> "Direct_thrombin_inhibitor" .
<Argatroban> <Is_a> "Anticoagulant" .
<DeVIC_and_RT> <Has_supportive_med> "Filgrastim" .
<Metastron> <Brand_name_of> "Strontium-89" .
<R-CHOP/R-DHAP> <Is_current_in> "Mantle_cell_lymphoma" .
<CHOP_and_Everolimus> <Is_a> "Anthracycline-containing_regimen" .
<MAPI> <Has_supportive_med> "Folinic_acid" .
<Danazol_monotherapy> <Has_modality> "Hormonotherapy" .
<Asrin> <Brand_name_of> "Aspirin" .
<IL-2_monotherapy> <Has_supportive_med> "Sargramostim" .
<IL-2_monotherapy> <Has_supportive_med> "Ondansetron" .
<IL-2_monotherapy> <Has_supportive_med> "Omeprazole" .
<IL-2_monotherapy> <Has_supportive_med> "Meperidine" .
<IL-2_monotherapy> <Has_supportive_med> "Granisetron" .
<IL-2_monotherapy> <Has_supportive_med> "Acetaminophen" .
<NOVP> <Maps_to> "NOVP" .
<Trimoxsul> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<BCHOP> <Has_supportive_med> "Acyclovir" .
<H2-receptor_antagonist> <Subsumes> "Ranitidine" .
<H2-receptor_antagonist> <Subsumes> "Famotidine" .
<H2-receptor_antagonist> <Subsumes> "Cimetidine" .
<Lutetium_Lu_177_dotatate_and_Octreotide_LAR> <Maps_to> "Lutetium_Lu_177_dotatate_and_Octreotide_LAR" .
<Trisep> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<CLARA> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Entospletinib> <Is_a> "SYK_inhibitor" .
<Entospletinib> <Is_a> "Kinase_inhibitor" .
<Entospletinib> <Is_a> "Investigational_drug" .
<Motesanib> <May_have_route> "Oral" .
<Classical_hematologic_condition> <Is_a> "Condition" .
<ATG_(Horse)_and_Cyclosporine> <Has_context> "Non-curative_first-line_therapy" .
<ATG_(Horse)_and_Cyclosporine> <Has_context> "Induction_therapy" .
<Carboplatin_and_Irinotecan> <Is_current_in> "Small_cell_lung_cancer" .
<IRIS> <Has_modality> "Chemotherapy" .
<R2CHOP> <Is_a> "Rituximab-containing_regimen" .
<R2CHOP> <Is_a> "Anthracycline-containing_regimen" .
<Semozol> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Zyofolin> <Brand_name_of> "Folinic_acid" .
<RP> <Has_antineoplastic> "Prednisone" .
<RP> <Has_antineoplastic> "Lenalidomide" .
<Gemtuzumab_ozogamicin> <Has_brand_name> "Mylotarg" .
<Ramosetron> <Has_brand_name> "Nozia" .
<Ramosetron> <Has_brand_name> "Nasea" .
<Ramosetron> <Has_brand_name> "Iribo" .
<Ramosetron> <Has_brand_name> "IBset" .
<MVAC,_dose-dense> <Is_a> "Anthracycline-containing_regimen" .
<KSP_inhibitor> <Subsumes> "Filanesib" .
<Clodronate> <May_have_route> "Oral" .
<Etoposide_and_Prednisone> <Maps_to> "Etoposide_and_Prednisone" .
<Treosulfan> <Is_a> "Alkylating_agent" .
<Exal> <Brand_name_of> "Vinblastine" .
<Desmopressin> <Is_a> "Vasopressin_analog" .
<Desmopressin> <Is_a> "Hemostasis_medication" .
<Desmopressin> <Is_a> "Hematology_medication" .
<Gemcitabine_and_Rituximab> <Maps_to> "Gemcitabine_and_Rituximab" .
<Tefudex> <Brand_name_of> "Tegafur_and_uracil" .
<Shuayan> <Brand_name_of> "Dexamethasone" .
<Dinutuximab> <May_have_route> "Intravenous" .
<GMALL-R> <Has_local_therapy> "Methotrexate" .
<GMALL-R> <Has_local_therapy> "Dexamethasone" .
<GMALL-R> <Has_local_therapy> "Cytarabine" .
<Calaspargase,_Daunorubicin,_Vincristine,_Prednisone> <Mapped_from> "Calaspargase,_Daunorubicin,_Vincristine,_Prednisone" .
<Cyclophosphamide_monotherapy> <Is_historical_in> "Prostate_cancer" .
<Cyclophosphamide_monotherapy> <Is_historical_in> "Multiple_myeloma" .
<Cyclophosphamide_monotherapy> <Is_historical_in> "Breast_cancer" .
<Cyclophosphamide_monotherapy> <Is_historical_in> "B-cell_acute_lymphoblastic_leukemia" .
<MESA/RT> <Has_modality> "Radiotherapy" .
<MESA/RT> <Has_modality> "Chemotherapy" .
<Lusutrombopag_monotherapy> <Has_modality> "Growth_factor_therapy" .
<Non-curative_therapy> <Is_a> "All_lines_of_therapy" .
<ATRA_and_Danazol> <Has_supportive_med> "Danazol" .
<ATRA_and_Danazol> <Has_supportive_med> "All-trans_retinoic_acid" .
<Acetaminophen> <Has_brand_name> "Tylenol" .
<Acetaminophen> <Has_brand_name> "Panadol" .
<Acetaminophen> <Has_brand_name> "Calpol" .
<Warf> <Brand_name_of> "Warfarin" .
<Lepirudin> <Has_accepted_use> "Venous_thromboembolism" .
<Lepirudin> <Has_accepted_use> "Heparin-induced_thrombocytopenia" .
<Pegaspargase> <May_have_route> "Intravenous" .
<Pegaspargase> <May_have_route> "Intramuscular" .
<Rasburicase> <May_have_route> "Intravenous" .
<PAF> <Has_accepted_use> "Breast_cancer" .
<M-TIP> <Has_supportive_med> "Folinic_acid" .
<nab-Paclitaxel_and_Atezolizumab> <Has_antineoplastic> "Paclitaxel_nanoparticle_albumin-bound" .
<nab-Paclitaxel_and_Atezolizumab> <Has_antineoplastic> "Atezolizumab" .
<UFT_monotherapy> <Has_accepted_use> "Rectal_cancer" .
<BDR> <Is_current_in> "Waldenstroem_macroglobulinemia" .
<BDR> <Is_current_in> "Mantle_cell_lymphoma" .
<Calcineurin_inhibitor> <Is_a> "Immunosuppressant" .
<ACVBP,_dose-adjusted> <Has_accepted_use> "Post-transplant_lymphoproliferative_disorder" .
<Lusutrombopag> <Is_a> "Megakaryocyte_growth_factor" .
<Lusutrombopag> <Is_a> "Hematopoietic_growth_factor" .
<Cetuximab> <Supportive_med_of> "Carboplatin_and_Fluorouracil" .
<Androgen_receptor_inhibitor> <Is_a> "Endocrine_therapeutic" .
<Sinplatin> <Brand_name_of> "Cisplatin" .
<Dexamil> <Brand_name_of> "Dexamethasone" .
<Busulfan_and_Melphalan> <Has_modality> "Chemotherapy" .
<Avelumab_monotherapy> <Has_modality> "Immunotherapy" .
<Danocrine> <Brand_name_of> "Danazol" .
<Midostaurin> <Has_accepted_use> "Systemic_mastocytosis" .
<Midostaurin> <Has_accepted_use> "Myelodysplastic_syndrome" .
<Midostaurin> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Cyclosporine,_Sirolimus,_Prednisone> <Maps_to> "Cyclosporine,_Sirolimus,_Prednisone" .
<Valixa> <Brand_name_of> "Valganciclovir" .
<Flutamide,_Goserelin,_RT> <Mapped_from> "Flutamide,_Goserelin,_RT" .
<Mercaptopurine,_Methotrexate,_Vincristine> <Has_context> "Maintenance_after_upfront_therapy" .
<Mercaptopurine,_Methotrexate,_Vincristine> <Has_context> "Consolidation_after_upfront_therapy" .
<PAD_doxil> <Has_context> "Non-curative_first-line_therapy" .
<Maintenance_after_salvage_therapy> <Is_a> "Salvage_therapy" .
<DA-EPOCH> <Mapped_from> "DA-EPOCH" .
<Pomalidomide_monotherapy> <Is_current_in> "Myelofibrosis" .
<Pomalidomide_monotherapy> <Is_current_in> "Multiple_myeloma" .
<Pomalidomide_monotherapy> <Is_current_in> "Kaposi_sarcoma" .
<APO> <Has_accepted_use> "Diffuse_large_B-cell_lymphoma" .
<APO> <Has_accepted_use> "Anaplastic_large_cell_lymphoma" .
<Cisplatin_and_Raltitrexed> <Maps_to> "Cisplatin_and_Raltitrexed" .
<Dexamethasone_and_Rituximab> <Has_immunosuppressor> "Rituximab" .
<Dexamethasone_and_Rituximab> <Has_immunosuppressor> "Dexamethasone" .
<FAC_and_BCG> <Has_accepted_use> "Breast_cancer" .
<Bu/TT/Cy> <Maps_to> "Bu/TT/Cy" .
<Ifosfamide_and_Methotrexate> <Has_context> "Salvage_therapy" .
<Colon_cancer> <Current_treated_by> "mFOLFOXIRI_and_Cetuximab_(L-Leucovorin)" .
<Colon_cancer> <Current_treated_by> "mFOLFOX7_(L-Leucovorin)" .
<Colon_cancer> <Current_treated_by> "mFOLFOX7" .
<Colon_cancer> <Current_treated_by> "mFOLFOX6_and_Cetuximab" .
<Colon_cancer> <Current_treated_by> "mFOLFOX6_and_Bevacizumab_(L-Leucovorin)" .
<Colon_cancer> <Current_treated_by> "mFOLFOX6_and_Bevacizumab" .
<Colon_cancer> <Current_treated_by> "mFOLFOX6_(L-Leucovorin)" .
<Colon_cancer> <Current_treated_by> "mFOLFOX6" .
<Colon_cancer> <Current_treated_by> "Trifluridine_and_tipiracil_monotherapy" .
<Colon_cancer> <Current_treated_by> "Tegafur,_Uracil,_Folinic_acid" .
<Colon_cancer> <Current_treated_by> "SOX_and_Bevacizumab" .
<Colon_cancer> <Current_treated_by> "SOX" .
<Colon_cancer> <Current_treated_by> "S-1_monotherapy" .
<Colon_cancer> <Current_treated_by> "Regorafenib_monotherapy" .
<Colon_cancer> <Current_treated_by> "Placebo" .
<Colon_cancer> <Current_treated_by> "Pertuzumab_and_Trastuzumab" .
<Colon_cancer> <Current_treated_by> "Pembrolizumab_monotherapy" .
<Colon_cancer> <Current_treated_by> "Panitumumab_monotherapy" .
<Colon_cancer> <Current_treated_by> "Observation" .
<Colon_cancer> <Current_treated_by> "OXAFAFU" .
<Colon_cancer> <Current_treated_by> "Nordic_FLOX" .
<Colon_cancer> <Current_treated_by> "Nivolumab_monotherapy" .
<Colon_cancer> <Current_treated_by> "Lapatinib_and_Trastuzumab" .
<Colon_cancer> <Current_treated_by> "Irinotecan,_Vemurafenib,_Cetuximab" .
<Colon_cancer> <Current_treated_by> "Irinotecan_monotherapy" .
<Colon_cancer> <Current_treated_by> "Irinotecan_and_Cetuximab" .
<Colon_cancer> <Current_treated_by> "Ipilimumab_and_Nivolumab" .
<Colon_cancer> <Current_treated_by> "Intraperitoneal_hyperthermic_mitomycin" .
<Colon_cancer> <Current_treated_by> "Intraperitoneal_5-FU" .
<Colon_cancer> <Current_treated_by> "IROX" .
<Colon_cancer> <Current_treated_by> "IRIS_and_Bevacizumab" .
<Colon_cancer> <Current_treated_by> "IRIS" .
<Colon_cancer> <Current_treated_by> "IFL_and_Bevacizumab" .
<Colon_cancer> <Current_treated_by> "IFL" .
<Colon_cancer> <Current_treated_by> "Hepatic_arterial_chemotherapy" .
<Colon_cancer> <Current_treated_by> "Fluorouracil_monotherapy" .
<Colon_cancer> <Current_treated_by> "Fluorouracil_and_Levoleucovorin" .
<Colon_cancer> <Current_treated_by> "Fluorouracil_and_Folinic_acid" .
<Colon_cancer> <Current_treated_by> "FUOX" .
<Colon_cancer> <Current_treated_by> "FULV_and_Bevacizumab" .
<Colon_cancer> <Current_treated_by> "FUIRI" .
<Colon_cancer> <Current_treated_by> "FOLFOXIRI_and_Panitumumab" .
<Colon_cancer> <Current_treated_by> "FOLFOX4_and_Panitumumab" .
<Colon_cancer> <Current_treated_by> "FOLFOX4_and_Cetuximab" .
<Colon_cancer> <Current_treated_by> "FOLFOX4_and_Bevacizumab" .
<Colon_cancer> <Current_treated_by> "FOLFOX4_(L-Leucovorin)" .
<Colon_cancer> <Current_treated_by> "FOLFOX4" .
<Colon_cancer> <Current_treated_by> "FOLFOX2" .
<Colon_cancer> <Current_treated_by> "FOLFOX_7/sLV5FU2_(L-Leucovorin)" .
<Colon_cancer> <Current_treated_by> "FOLFOX_7/sLV5FU2" .
<Colon_cancer> <Current_treated_by> "FOLFIRINOX_and_Bevacizumab_(L-Leucovorin)" .
<Colon_cancer> <Current_treated_by> "FOLFIRINOX" .
<Colon_cancer> <Current_treated_by> "FOLFIRI_and_Ziv-aflibercept" .
<Colon_cancer> <Current_treated_by> "FOLFIRI_and_Ramucirumab" .
<Colon_cancer> <Current_treated_by> "FOLFIRI_and_Panitumumab" .
<Colon_cancer> <Current_treated_by> "FOLFIRI_and_Cetuximab_(L-Leucovorin)" .
<Colon_cancer> <Current_treated_by> "FOLFIRI_and_Cetuximab" .
<Colon_cancer> <Current_treated_by> "FOLFIRI_and_Bevacizumab_(L-Leucovorin)" .
<Colon_cancer> <Current_treated_by> "FOLFIRI_and_Bevacizumab" .
<Colon_cancer> <Current_treated_by> "FOLFIRI_(L-Leucovorin)" .
<Colon_cancer> <Current_treated_by> "FOLFIRI" .
<Colon_cancer> <Current_treated_by> "FLOX" .
<Colon_cancer> <Current_treated_by> "Dabrafenib,_Trametinib,_Panitumumab" .
<Colon_cancer> <Current_treated_by> "Cetuximab_monotherapy" .
<Colon_cancer> <Current_treated_by> "Capecitabine_monotherapy" .
<Colon_cancer> <Current_treated_by> "Capecitabine_and_Bevacizumab" .
<Colon_cancer> <Current_treated_by> "CapeOx_and_Panitumumab" .
<Colon_cancer> <Current_treated_by> "CapeOx_and_Bevacizumab" .
<Colon_cancer> <Current_treated_by> "CapeOx" .
<Colon_cancer> <Current_treated_by> "CAPIRI-Bev" .
<Colon_cancer> <Current_treated_by> "CAPIRI" .
<Colon_cancer> <Current_treated_by> "Binimetinib,_Encorafenib,_Cetuximab" .
<Colon_cancer> <Current_treated_by> "Bevacizumab_monotherapy" .
<Colon_cancer> <Current_treated_by> "Best_supportive_care" .
<Dexamethasone_and_WBRT> <Has_context> "All_lines_of_therapy" .
<Cephalosporin> <Is_a> "Antibacterial" .
<Hatrix> <Brand_name_of> "Trimethoprim-Sulfamethoxazole" .
<Hexadecadrol> <Brand_name_of> "Dexamethasone" .
<Radioembolization> <Has_accepted_use> "Hepatocellular_carcinoma" .
<DCTER> <Has_accepted_use> "Acute_myeloid_leukemia" .
<Dabrafenib,_Trametinib,_Panitumumab> <Has_accepted_use> "Colon_cancer" .
<Dabrafenib,_Trametinib,_Panitumumab> <Has_accepted_use> "BRAF-mutated_Colon_cancer" .
<THP_(Taxol)> <Has_modality> "Chemotherapy" .
<Cisplatin,_Gemcitabine,_nab-Paclitaxel> <Has_antineoplastic> "Paclitaxel_nanoparticle_albumin-bound" .
<Cisplatin,_Gemcitabine,_nab-Paclitaxel> <Has_antineoplastic> "Gemcitabine" .
<Cisplatin,_Gemcitabine,_nab-Paclitaxel> <Has_antineoplastic> "Cisplatin" .
<Chlorpheniramine> <May_have_route> "Oral" .
<Peginterferon_alfa-2b> <May_have_route> "Subcutaneous" .
<Apatinib_monotherapy> <Has_context> "Non-curative_subsequent-line_therapy" .
<7_plus_3m> <Has_context> "Induction_therapy" .
<FEMTX> <Is_a> "Anthracycline-containing_regimen" .
<CHVmP> <Has_context> "Induction_therapy" .
<Anticoagulation> <Context_of> "Rivaroxaban_monotherapy" .
<Anticoagulation> <Context_of> "Lepirudin_monotherapy" .
<Anticoagulation> <Context_of> "Fondaparinux_monotherapy" .
<Anticoagulation> <Context_of> "Danaparoid_monotherapy" .
<Anticoagulation> <Context_of> "Argatroban_monotherapy" .
<LVP_.22Sandwich.22> <Has_accepted_use> "Extranodal_NK-_and_T-cell_lymphoma_nasal_type" .
<TCHP_(Taxol)> <Has_context> "Neoadjuvant_therapy" .
<R-CHMP> <Mapped_from> "R-CHMP" .
<R-DHAP> <Has_antineoplastic> "Rituximab" .
<R-DHAP> <Has_antineoplastic> "Dexamethasone" .
<R-DHAP> <Has_antineoplastic> "Cytarabine" .
<R-DHAP> <Has_antineoplastic> "Cisplatin" .
<Ultralow_molecular_weight_heparin> <Is_a> "Anticoagulant" .
<HiDAC> <Maps_to> "HiDAC" .
<Decicort> <Brand_name_of> "Dexamethasone" .
<IFL_and_Bevacizumab> <Has_context> "Non-curative_first-line_therapy" .
<Retaspimycin> <May_have_route> "Intravenous" .
<Fluorouracil_and_Paclitaxel> <Maps_to> "Fluorouracil_and_Paclitaxel" .
<NEOD001> <Is_a> "Light-chain_(AL)_amyloidosis_medication" .
<NEOD001> <Is_a> "Halted_drug" .
<NEOD001> <Is_a> "Antibody_medication" .
<NEOD001> <Is_a> "Anti-amyloid_antibody" .
<BVCPP> <Has_antineoplastic> "Vinblastine" .
<BVCPP> <Has_antineoplastic> "Procarbazine" .
<BVCPP> <Has_antineoplastic> "Prednisone" .
<BVCPP> <Has_antineoplastic> "Cyclophosphamide" .
<BVCPP> <Has_antineoplastic> "Carmustine" .
<Non-curative_third-line_therapy> <Maps_to> "Non-curative_third-line_therapy" .
<BHQ880> <May_have_route> "Intravenous" .
<DRC> <Mapped_from> "DRC" .
<Interferon_alfa_and_Dexamethasone> <Is_historical_in> "Multiple_myeloma" .
<Vitamin_K_antagonist> <Is_a> "Anticoagulant" .
<CISCA> <Is_current_in> "Bladder_cancer" .
<CF_and_Trastuzumab> <Maps_to> "CF_and_Trastuzumab" .
<CVPP> <Mapped_from> "CVPP" .
<DexaBEAM_and_G-CSF> <Has_context> "All_lines_of_therapy" .
<PAC> <Mapped_from> "PAC" .
<Micropirin> <Brand_name_of> "Aspirin" .
<MESA/RT> <Has_antineoplastic> "Pegaspargase" .
<MESA/RT> <Has_antineoplastic> "Methotrexate" .
<MESA/RT> <Has_antineoplastic> "External_beam_radiotherapy" .
<MESA/RT> <Has_antineoplastic> "Etoposide" .
<MESA/RT> <Has_antineoplastic> "Dexamethasone" .
<Fotemustine> <Has_brand_name> "Mustophoran" .
<Fotemustine> <Has_brand_name> "Muphoran" .
<Novutrax> <Brand_name_of> "Cytarabine" .
<Busulfan> <Has_accepted_use> "Multiple_myeloma" .
<Busulfan> <Has_accepted_use> "Ewing_sarcoma" .
<Busulfan> <Has_accepted_use> "Chronic_myelogenous_leukemia" .
<Busulfan> <Has_accepted_use> "Chronic_lymphocytic_leukemia" .
<Busulfan> <Has_accepted_use> "CNS_lymphoma" .
<Busulfan> <Has_accepted_use> "Acute_promyelocytic_leukemia" .
<Busulfan> <Has_accepted_use> "Acute_myeloid_leukemia" .
<ACVBP,_dose-adjusted> <Maps_to> "ACVBP,_dose-adjusted" .
<Cytophosphan> <Brand_name_of> "Cyclophosphamide" .
